0	1	Stimulation	0	None
1	2	of	0	None
2	3	ciliary	0	None
3	4	motility	0	None
4	5	mediated	0	None
5	6	by	0	None
6	7	atypical	0	None
7	8	beta-adrenoceptor	3	GENE-N
8	9	in	0	None
9	10	canine	0	None
10	11	bronchial	0	None
11	12	epithelium	0	None
12	13	.	0	None
13	14	Using	0	None
14	15	radioligand	0	None
15	16	binding	0	None
16	17	assays	0	None
17	18	,	0	None
18	19	we	0	None
19	20	determined	0	None
20	21	the	0	None
21	22	equilibrium	0	None
22	23	dissociation	0	None
23	24	constants	0	None
24	25	(	0	None
25	26	KD's	0	None
26	27	)	0	None
27	28	for	0	None
28	29	37	0	None
29	30	antidepressants	0	None
30	31	,	0	None
31	32	three	0	None
32	33	of	0	None
33	34	their	0	None
34	35	metabolites	0	None
35	36	(	0	None
36	37	desmethylcitalopram	0	None
37	38	,	0	None
38	39	desmethylsertraline	0	None
39	40	,	0	None
40	41	and	0	None
41	42	norfluoxetine	2	CHEMICAL
42	43	)	0	None
43	44	,	0	None
44	45	some	0	None
45	46	mood	0	None
46	47	stabilizers	0	None
47	48	,	0	None
48	49	and	0	None
49	50	assorted	0	None
50	51	other	0	None
51	52	compounds	0	None
52	53	(	0	None
53	54	some	0	None
54	55	antiepileptics	0	None
55	56	,	0	None
56	57	Ca2	0	None
57	58	+	0	None
58	59	channel	0	None
59	60	antagonists	0	None
60	61	,	0	None
61	62	benzodiazepines	0	None
62	63	,	0	None
63	64	psychostimulants	0	None
64	65	,	0	None
65	66	antihistamines	0	None
66	67	,	0	None
67	68	and	0	None
68	69	monoamines	2	CHEMICAL
69	70	)	0	None
70	71	for	0	None
71	72	the	0	None
72	73	human	0	None
73	74	serotonin	0	None
74	75	,	0	None
75	76	norepinephrine	2	CHEMICAL
76	77	,	0	None
77	78	and	0	None
78	79	dopamine	0	None
79	80	transporters	0	None
80	81	.	0	None

82	83	Among	0	None
83	84	the	0	None
84	85	compounds	0	None
85	86	that	0	None
86	87	we	0	None
87	88	tested	0	None
88	89	,	0	None
89	90	mazindol	0	None
90	91	was	0	None
91	92	the	0	None
92	93	most	0	None
93	94	potent	0	None
94	95	at	0	None
95	96	the	0	None
96	101	human norepinephrine and dopamine transporters	3	GENE-N
101	102	with	0	None
102	103	KD's	0	None
103	104	of	0	None
104	105	0	0	None
105	106	.	0	None
106	107	45	0	None
107	108	+	0	None
108	109	/	0	None
109	110	-	0	None
110	111	0	0	None
111	112	.	0	None
112	113	03	0	None
113	114	nM	0	None
114	115	and	0	None
115	116	8	0	None
116	117	.	0	None
117	118	1	0	None
118	119	+	0	None
119	120	/	0	None
120	121	-	0	None
121	122	0	0	None
122	123	.	0	None
123	124	4	0	None
124	125	nM	0	None
125	126	,	0	None
126	127	respectively	0	None
127	128	.	0	None

129	130	Sertraline	0	None
130	131	(	0	None
131	132	KD	0	None
132	133	=	0	None
133	134	25	0	None
134	135	+	0	None
135	136	/	0	None
136	137	-	0	None
137	138	2	0	None
138	139	nM	0	None
139	140	)	0	None
140	141	and	0	None
141	142	nomifensine	0	None
142	143	(	0	None
143	144	56	0	None
144	145	+	0	None
145	146	/	0	None
146	147	-	0	None
147	148	3	0	None
148	149	nM	0	None
149	150	)	0	None
150	151	were	0	None
151	152	the	0	None
152	153	two	0	None
153	154	most	0	None
154	155	potent	0	None
155	156	antidepressants	0	None
156	157	at	0	None
157	158	the	0	None
158	159	human	0	None
159	160	dopamine	0	None
160	161	transporter	0	None
161	162	.	0	None

163	164	We	0	None
164	165	showed	0	None
165	166	significant	0	None
166	167	correlations	0	None
167	168	for	0	None
168	169	antidepressant	0	None
169	170	affinities	0	None
170	171	at	0	None
171	172	binding	0	None
172	173	to	0	None
173	174	serotonin	0	None
174	175	(	0	None
175	176	R	0	None
176	177	=	0	None
177	178	0	0	None
178	179	.	0	None
179	180	93	0	None
180	181	)	0	None
181	182	,	0	None
182	183	norepinephrine	2	CHEMICAL
183	184	(	0	None
184	185	R	0	None
185	186	=	0	None
186	187	0	0	None
187	188	.	0	None
188	189	97	0	None
189	190	)	0	None
190	191	,	0	None
191	192	and	0	None
192	193	dopamine	0	None
193	194	(	0	None
194	195	R	0	None
195	196	=	0	None
196	197	0	0	None
197	198	.	0	None
198	199	87	0	None
199	200	)	0	None
200	201	transporters	0	None
201	202	in	0	None
202	203	comparison	0	None
203	204	to	0	None
204	205	their	0	None
205	206	respective	0	None
206	207	values	0	None
207	208	for	0	None
208	209	inhibiting	0	None
209	210	uptake	0	None
210	211	of	0	None
211	212	monoamines	2	CHEMICAL
212	213	into	0	None
213	214	rat	0	None
214	215	brain	0	None
215	216	synaptosomes	0	None
216	217	.	0	None

218	219	These	0	None
219	220	data	0	None
220	221	are	0	None
221	222	useful	0	None
222	223	in	0	None
223	224	predicting	0	None
224	225	some	0	None
225	226	possible	0	None
226	227	adverse	0	None
227	228	effects	0	None
228	229	and	0	None
229	230	drug-drug	0	None
230	231	interactions	0	None
231	232	of	0	None
232	233	antidepressants	0	None
233	234	and	0	None
234	235	related	0	None
235	236	compounds	0	None
236	237	.	0	None
237	238	Role	0	None
238	239	of	0	None
239	240	quercetin	0	None
240	241	in	0	None
241	242	cadmium-induced	0	None
242	243	oxidative	0	None
243	244	stress	0	None
244	245	,	0	None
245	246	neuronal	0	None
246	247	damage	0	None
247	248	,	0	None
248	249	and	0	None
249	250	apoptosis	0	None
250	251	in	0	None
251	252	rats	0	None
252	253	.	0	None
253	254	Pyridoxal-5'-phosphate	0	None
254	255	(	0	None
255	256	PLP	0	None
256	257	)	0	None
257	258	,	0	None
258	259	the	0	None
259	260	bioactive	0	None
260	261	form	0	None
261	262	of	0	None
262	263	vitamin	0	None
263	264	B6	0	None
264	265	,	0	None
265	266	reportedly	0	None
266	267	functions	0	None
267	268	as	0	None
268	269	a	0	None
269	270	prosthetic	0	None
270	271	group	0	None
271	272	for	0	None
272	273	>4%	0	None
273	274	of	0	None
274	275	classified	0	None
275	276	enzymatic	0	None
276	277	activities	0	None
277	278	of	0	None
278	279	the	0	None
279	280	cell	0	None
280	281	.	0	None

282	283	It	0	None
283	284	is	0	None
284	285	therefore	0	None
285	286	not	0	None
286	287	surprising	0	None
287	288	that	0	None
288	289	alterations	0	None
289	290	of	0	None
290	291	vitamin	0	None
291	292	B6	0	None
292	293	metabolism	0	None
293	294	have	0	None
294	295	been	0	None
295	296	associated	0	None
296	297	with	0	None
297	298	multiple	0	None
298	299	human	0	None
299	300	diseases	0	None
300	301	.	0	None

302	303	As	0	None
303	304	a	0	None
304	305	striking	0	None
305	306	example	0	None
306	307	,	0	None
307	308	mutations	0	None
308	309	in	0	None
309	310	the	0	None
310	311	gene	0	None
311	312	coding	0	None
312	313	for	0	None
313	314	antiquitin	0	None
314	315	,	0	None
315	316	an	0	None
316	317	evolutionary	0	None
317	318	old	0	None
318	320	aldehyde dehydrogenase	3	GENE-N
320	321	,	0	None
321	322	result	0	None
322	323	in	0	None
323	324	pyridoxine-dependent	0	None
324	325	seizures	0	None
325	326	,	0	None
326	327	owing	0	None
327	328	to	0	None
328	329	the	0	None
329	330	accumulation	0	None
330	331	of	0	None
331	332	a	0	None
332	333	metabolic	0	None
333	334	intermediate	0	None
334	335	that	0	None
335	336	inactivates	0	None
336	337	PLP	0	None
337	338	.	0	None

339	340	In	0	None
340	341	addition	0	None
341	342	,	0	None
342	343	PLP	0	None
343	344	is	0	None
344	345	required	0	None
345	346	for	0	None
346	347	the	0	None
347	348	catabolism	0	None
348	349	of	0	None
349	350	homocysteine	0	None
350	351	by	0	None
351	352	transsulfuration	0	None
352	353	.	0	None

354	355	Hence	0	None
355	356	,	0	None
356	357	reduced	0	None
357	358	circulating	0	None
358	359	levels	0	None
359	360	of	0	None
360	361	B6	0	None
361	362	vitamers	0	None
362	363	(	0	None
363	364	including	0	None
364	365	PLP	0	None
365	366	as	0	None
366	367	well	0	None
367	368	as	0	None
368	369	its	0	None
369	370	major	0	None
370	371	precursor	0	None
371	372	pyridoxine	0	None
372	373	)	0	None
373	374	are	0	None
374	375	frequently	0	None
375	376	paralleled	0	None
376	377	by	0	None
377	378	hyperhomocysteinemia	0	None
378	379	,	0	None
379	380	a	0	None
380	381	condition	0	None
381	382	that	0	None
382	383	has	0	None
383	384	been	0	None
384	385	associated	0	None
385	386	with	0	None
386	387	an	0	None
387	388	increased	0	None
388	389	risk	0	None
389	390	for	0	None
390	391	multiple	0	None
391	392	cardiovascular	0	None
392	393	diseases	0	None
393	394	.	0	None

395	396	During	0	None
396	397	the	0	None
397	398	past	0	None
398	399	30	0	None
399	400	years	0	None
400	401	,	0	None
401	402	an	0	None
402	403	intense	0	None
403	404	wave	0	None
404	405	of	0	None
405	406	clinical	0	None
406	407	investigation	0	None
407	408	has	0	None
408	409	attempted	0	None
409	410	to	0	None
410	411	dissect	0	None
411	412	the	0	None
412	413	putative	0	None
413	414	links	0	None
414	415	between	0	None
415	416	vitamin	0	None
416	417	B6	0	None
417	418	and	0	None
418	419	cancer	0	None
419	420	.	0	None

421	422	Thus	0	None
422	423	,	0	None
423	424	high	0	None
424	425	circulating	0	None
425	426	levels	0	None
426	427	of	0	None
427	428	vitamin	0	None
428	429	B6	0	None
429	430	,	0	None
430	431	as	0	None
431	432	such	0	None
432	433	or	0	None
433	434	as	0	None
434	435	they	0	None
435	436	reflected	0	None
436	437	reduced	0	None
437	438	amounts	0	None
438	439	of	0	None
439	440	circulating	0	None
440	441	homocysteine	0	None
441	442	,	0	None
442	443	have	0	None
443	444	been	0	None
444	445	associated	0	None
445	446	with	0	None
446	447	improved	0	None
447	448	disease	0	None
448	449	outcome	0	None
449	450	in	0	None
450	451	patients	0	None
451	452	bearing	0	None
452	453	a	0	None
453	454	wide	0	None
454	455	range	0	None
455	456	of	0	None
456	457	hematological	0	None
457	458	and	0	None
458	459	solid	0	None
459	460	neoplasms	0	None
460	461	.	0	None

462	463	More	0	None
463	464	recently	0	None
464	465	,	0	None
465	466	the	0	None
466	467	proficiency	0	None
467	468	of	0	None
468	469	vitamin	0	None
469	470	B6	0	None
470	471	metabolism	0	None
471	472	has	0	None
472	473	been	0	None
473	474	shown	0	None
474	475	to	0	None
475	476	modulate	0	None
476	477	the	0	None
477	478	adaptive	0	None
478	479	response	0	None
479	480	of	0	None
480	481	tumor	0	None
481	482	cells	0	None
482	483	to	0	None
483	484	a	0	None
484	485	plethora	0	None
485	486	of	0	None
486	487	physical	0	None
487	488	and	0	None
488	489	chemical	0	None
489	490	stress	0	None
490	491	conditions	0	None
491	492	.	0	None

493	494	Moreover	0	None
494	495	,	0	None
495	496	elevated	0	None
496	497	levels	0	None
497	498	of	0	None
498	499	pyridoxal	2	CHEMICAL
499	500	kinase	0	None
500	501	(	0	None
501	502	PDXK	0	None
502	503	)	0	None
503	504	,	0	None
504	505	the	0	None
505	506	enzyme	0	None
506	507	that	0	None
507	508	converts	0	None
508	509	pyridoxine	0	None
509	510	and	0	None
510	511	other	0	None
511	512	vitamin	0	None
512	513	B6	0	None
513	514	precursors	0	None
514	515	into	0	None
515	516	PLP	0	None
516	517	,	0	None
517	518	have	0	None
518	519	been	0	None
519	520	shown	0	None
520	521	to	0	None
521	522	constitute	0	None
522	523	a	0	None
523	524	good	0	None
524	525	,	0	None
525	526	therapy-independent	0	None
526	527	prognostic	0	None
527	528	marker	0	None
528	529	in	0	None
529	530	patients	0	None
530	531	affected	0	None
531	532	by	0	None
532	533	non-small	0	None
533	534	cell	0	None
534	535	lung	0	None
535	536	carcinoma	0	None
536	537	(	0	None
537	538	NSCLC	0	None
538	539	)	0	None
539	540	.	0	None

541	542	Here	0	None
542	543	,	0	None
543	544	we	0	None
544	545	will	0	None
545	546	discuss	0	None
546	547	the	0	None
547	548	clinical	0	None
548	549	relevance	0	None
549	550	of	0	None
550	551	vitamin	0	None
551	552	B6	0	None
552	553	metabolism	0	None
553	554	as	0	None
554	555	a	0	None
555	556	prognostic	0	None
556	557	factor	0	None
557	558	in	0	None
558	559	cancer	0	None
559	560	patients	0	None
560	561	.	0	None

562	563	Oncogene	0	None
563	564	advance	0	None
564	565	online	0	None
565	566	publication	0	None
566	567	,	0	None
567	568	21	0	None
568	569	January	0	None
569	570	2013;	0	None
570	571	doi	0	None
571	572	:	0	None
572	573	10	0	None
573	574	.	0	None
574	575	1038	0	None
575	576	/	0	None
576	577	onc	0	None
577	578	.	0	None
578	579	2012	0	None
579	580	.	0	None
580	581	623	0	None
581	582	.	0	None
582	583	The	0	None
583	584	mechanisms	0	None
584	585	of	0	None
585	586	progression	0	None
586	587	from	0	None
587	588	Barrett's	0	None
588	589	esophagus	0	None
589	590	(	0	None
590	591	BE	0	None
591	592	)	0	None
592	593	to	0	None
593	594	esophageal	0	None
594	595	adenocarcinoma	0	None
595	596	(	0	None
596	597	EA	0	None
597	598	)	0	None
598	599	are	0	None
599	600	not	0	None
600	601	known	0	None
601	602	.	0	None

603	604	Cycloxygenase-2	0	None
604	605	(	0	None
605	606	COX-2	0	None
606	607	)	0	None
607	608	-derived	0	None
608	609	prostaglandin	0	None
609	610	E2	0	None
610	611	(	0	None
611	612	PGE2	2	CHEMICAL
612	613	)	0	None
613	614	has	0	None
614	615	been	0	None
615	616	shown	0	None
616	617	to	0	None
617	618	be	0	None
618	619	important	0	None
619	620	in	0	None
620	621	esophageal	0	None
621	622	tumorigenesis	0	None
622	623	.	0	None

624	625	We	0	None
625	626	have	0	None
626	627	shown	0	None
627	628	that	0	None
628	629	COX-2	0	None
629	630	mediates	0	None
630	631	acid-induced	0	None
631	632	PGE2	2	CHEMICAL
632	633	production	0	None
633	634	.	0	None

635	636	The	0	None
636	637	prostaglandin	0	None
637	638	E	0	None
638	639	synthase	0	None
639	640	(	0	None
640	641	PGES	0	None
641	642	)	0	None
642	643	responsible	0	None
643	644	for	0	None
644	645	acid-induced	0	None
645	646	PGE2	2	CHEMICAL
646	647	production	0	None
647	648	in	0	None
648	649	BE	0	None
649	650	,	0	None
650	651	however	0	None
651	652	,	0	None
652	653	is	0	None
653	654	not	0	None
654	655	known	0	None
655	656	.	0	None

657	658	We	0	None
658	659	found	0	None
659	660	that	0	None
660	661	microsomal	0	None
661	662	PGES1	0	None
662	663	(	0	None
663	664	mPGES1	0	None
664	665	)	0	None
665	666	,	0	None
666	667	mPGES2	0	None
667	668	,	0	None
668	669	and	0	None
669	670	cytosolic	0	None
670	671	PGES	0	None
671	672	(	0	None
672	673	cPGES	0	None
673	674	)	0	None
674	675	were	0	None
675	676	present	0	None
676	677	in	0	None
677	678	FLO	0	None
678	679	EA	0	None
679	680	cells	0	None
680	681	.	0	None

682	683	Pulsed	0	None
683	684	acid	0	None
684	685	treatment	0	None
685	686	significantly	0	None
686	687	increased	0	None
687	688	mPGES1	0	None
688	689	mRNA	0	None
689	690	and	0	None
690	691	protein	0	None
691	692	levels	0	None
692	693	but	0	None
693	694	had	0	None
694	695	little	0	None
695	696	or	0	None
696	697	no	0	None
697	698	effect	0	None
698	699	on	0	None
699	700	mPGES2	0	None
700	701	or	0	None
701	702	cPGES	0	None
702	703	mRNA	0	None
703	704	.	0	None

705	706	Knockdown	0	None
706	707	of	0	None
707	708	mPGES1	0	None
708	709	by	0	None
709	710	mPGES1	0	None
710	711	small	0	None
711	712	interfering	0	None
712	713	RNA	0	None
713	714	(	0	None
714	715	siRNA	0	None
715	716	)	0	None
716	717	blocked	0	None
717	718	acid-induced	0	None
718	719	increase	0	None
719	720	in	0	None
720	721	PGE2	2	CHEMICAL
721	722	production	0	None
722	723	and	0	None
723	724	thymidine	2	CHEMICAL
724	725	incorporation	0	None
725	726	.	0	None

727	728	Knockdown	0	None
728	729	of	0	None
729	730	NADPH	0	None
730	731	oxidase	0	None
731	732	,	0	None
732	733	NOX5-S	0	None
733	734	,	0	None
734	735	a	0	None
735	736	variant	0	None
736	737	lacking	0	None
737	738	calcium-binding	0	None
738	739	domains	0	None
739	740	,	0	None
740	741	by	0	None
741	742	NOX5	0	None
742	743	siRNA	0	None
743	744	significantly	0	None
744	745	inhibited	0	None
745	746	acid-induced	0	None
746	747	increase	0	None
747	748	in	0	None
748	749	mPGES1	0	None
749	750	expression	0	None
750	751	,	0	None
751	752	thymidine	2	CHEMICAL
752	753	incorporation	0	None
753	754	,	0	None
754	755	and	0	None
755	756	PGE2	2	CHEMICAL
756	757	production	0	None
757	758	.	0	None

759	760	Overexpression	0	None
760	761	of	0	None
761	762	NOX5-S	0	None
762	763	significantly	0	None
763	764	increased	0	None
764	765	the	0	None
765	766	luciferase	0	None
766	767	activity	0	None
767	768	in	0	None
768	769	FLO	0	None
769	770	cells	0	None
770	771	transfected	0	None
771	772	with	0	None
772	773	a	0	None
773	775	nuclear factor	3	GENE-N
775	776	κB	0	None
776	777	(	0	None
777	778	NF-κB	0	None
778	779	)	0	None
779	780	in	0	None
780	781	vivo	0	None
781	782	activation	0	None
782	783	reporter	0	None
783	784	plasmid	0	None
784	785	pNF-κB-Luc	0	None
785	786	.	0	None

787	788	Knockdown	0	None
788	789	of	0	None
789	790	NF-κB1	0	None
790	791	p50	0	None
791	792	by	0	None
792	793	p50	0	None
793	794	siRNA	0	None
794	795	significantly	0	None
795	796	decreased	0	None
796	797	acid-induced	0	None
797	798	increase	0	None
798	799	in	0	None
799	800	mPGES1	0	None
800	801	expression	0	None
801	802	,	0	None
802	803	thymidine	2	CHEMICAL
803	804	incorporation	0	None
804	805	,	0	None
805	806	and	0	None
806	807	PGE2	2	CHEMICAL
807	808	production	0	None
808	809	.	0	None

810	811	Two	0	None
811	812	novel	0	None
812	813	NF-κB	0	None
813	814	binding	0	None
814	815	elements	0	None
815	816	,	0	None
816	817	GGAGTCTCCC	0	None
817	818	and	0	None
818	819	CGGGACACCC	0	None
819	820	,	0	None
820	821	were	0	None
821	822	identified	0	None
822	823	in	0	None
823	824	the	0	None
824	825	mPGES1	0	None
825	826	gene	0	None
826	827	promoter	0	None
827	828	.	0	None

829	830	We	0	None
830	831	conclude	0	None
831	832	that	0	None
832	833	mPGES1	0	None
833	834	mediates	0	None
834	835	acid-induced	0	None
835	836	increase	0	None
836	837	in	0	None
837	838	PGE2	2	CHEMICAL
838	839	production	0	None
839	840	and	0	None
840	841	cell	0	None
841	842	proliferation	0	None
842	843	.	0	None

844	845	Acid-induced	0	None
845	846	mPGES1	0	None
846	847	expression	0	None
847	848	depends	0	None
848	849	on	0	None
849	850	activation	0	None
850	851	of	0	None
851	852	NOX5-S	0	None
852	853	and	0	None
853	854	NF-κB1	0	None
854	855	p50	0	None
855	856	.	0	None

857	858	Microsomal	0	None
858	859	PGES1	0	None
859	860	may	0	None
860	861	be	0	None
861	862	a	0	None
862	863	potential	0	None
863	864	target	0	None
864	865	to	0	None
865	866	prevent	0	None
866	867	or	0	None
867	868	treat	0	None
868	869	EA	0	None
869	870	.	0	None
870	871	Probing	0	None
871	872	for	0	None
872	873	a	0	None
873	874	hydrophobic	0	None
874	875	a	0	None
875	876	binding	0	None
876	877	register	0	None
877	878	in	0	None
878	879	prostate-specific	0	None
879	880	membrane	0	None
880	881	antigen	0	None
881	882	with	0	None
882	883	phenylalkylphosphonamidates	0	None
883	884	.	0	None
884	885	PURPOSE	0	None
885	886	:	0	None
886	887	Activating	0	None
887	888	mutations	0	None
888	889	in	0	None
889	890	FGFR2	0	None
890	891	have	0	None
891	892	been	0	None
892	893	identified	0	None
893	894	as	0	None
894	895	potential	0	None
895	896	therapeutic	0	None
896	897	targets	0	None
897	898	in	0	None
898	899	endometrial	0	None
899	900	cancer	0	None
900	901	,	0	None
901	902	typically	0	None
902	903	occurring	0	None
903	904	alongside	0	None
904	905	genetic	0	None
905	906	alterations	0	None
906	907	that	0	None
907	908	disrupt	0	None
908	909	the	0	None
909	910	mTOR	0	None
910	911	pathway	0	None
911	912	,	0	None
912	913	such	0	None
913	914	as	0	None
914	915	PTEN	0	None
915	916	loss	0	None
916	917	.	0	None

918	919	These	0	None
919	920	observations	0	None
920	921	suggest	0	None
921	922	that	0	None
922	923	the	0	None
923	924	mTOR	0	None
924	925	pathway	0	None
925	926	may	0	None
926	927	act	0	None
927	928	in	0	None
928	929	concert	0	None
929	930	with	0	None
930	931	oncogenic	0	None
931	932	FGFR2	0	None
932	933	to	0	None
933	934	drive	0	None
934	935	endometrial	0	None
935	936	cancer	0	None
936	937	growth	0	None
937	938	in	0	None
938	939	a	0	None
939	940	subset	0	None
940	941	of	0	None
941	942	patients	0	None
942	943	.	0	None

944	945	The	0	None
945	946	aim	0	None
946	947	of	0	None
947	948	this	0	None
948	949	study	0	None
949	950	was	0	None
950	951	to	0	None
951	952	examine	0	None
952	953	the	0	None
953	954	therapeutic	0	None
954	955	potential	0	None
955	956	of	0	None
956	957	a	0	None
957	958	rational	0	None
958	959	drug	0	None
959	960	combination	0	None
960	961	based	0	None
961	962	on	0	None
962	963	the	0	None
963	964	simultaneous	0	None
964	965	targeting	0	None
965	966	of	0	None
966	967	mutant-FGFR2	0	None
967	968	and	0	None
968	969	mTOR-driven	0	None
969	970	signaling	0	None
970	971	pathways	0	None
971	972	in	0	None
972	973	endometrial	0	None
973	974	cancer	0	None
974	975	cells	0	None
975	976	.	0	None

977	978	METHODS	0	None
978	979	:	0	None
979	980	Ponatinib	2	CHEMICAL
980	981	is	0	None
981	982	an	0	None
982	983	oral	0	None
983	984	multitargeted	0	None
984	985	kinase	0	None
985	986	inhibitor	0	None
986	987	that	0	None
987	988	potently	0	None
988	989	inhibits	0	None
989	990	all	0	None
990	991	4	0	None
991	992	members	0	None
992	993	of	0	None
993	994	the	0	None
994	995	FGFR	0	None
995	996	family	0	None
996	997	.	0	None

998	999	Ridaforolimus	0	None
999	1000	is	0	None
1000	1001	a	0	None
1001	1002	selective	0	None
1002	1003	inhibitor	0	None
1003	1004	of	0	None
1004	1005	mTOR	0	None
1005	1006	that	0	None
1006	1007	has	0	None
1007	1008	demonstrated	0	None
1008	1009	positive	0	None
1009	1010	clinical	0	None
1010	1011	activity	0	None
1011	1012	in	0	None
1012	1013	endometrial	0	None
1013	1014	cancer	0	None
1014	1015	.	0	None

1016	1017	The	0	None
1017	1018	combinatorial	0	None
1018	1019	effects	0	None
1019	1020	of	0	None
1020	1021	ponatinib	2	CHEMICAL
1021	1022	and	0	None
1022	1023	ridaforolimus	0	None
1023	1024	on	0	None
1024	1025	growth	0	None
1025	1026	of	0	None
1026	1027	endometrial	0	None
1027	1028	cancer	0	None
1028	1029	models	0	None
1029	1030	,	0	None
1030	1031	and	0	None
1031	1032	their	0	None
1032	1033	modes	0	None
1033	1034	of	0	None
1034	1035	action	0	None
1035	1036	,	0	None
1036	1037	were	0	None
1037	1038	evaluated	0	None
1038	1039	in	0	None
1039	1040	vitro	0	None
1040	1041	and	0	None
1041	1042	in	0	None
1042	1043	vivo	0	None
1043	1044	.	0	None

1045	1046	RESULTS	0	None
1046	1047	:	0	None
1047	1048	The	0	None
1048	1049	combination	0	None
1049	1050	of	0	None
1050	1051	ponatinib	2	CHEMICAL
1051	1052	and	0	None
1052	1053	ridaforolimus	0	None
1053	1054	had	0	None
1054	1055	a	0	None
1055	1056	synergistic	0	None
1056	1057	effect	0	None
1057	1058	on	0	None
1058	1059	the	0	None
1059	1060	in	0	None
1060	1061	vitro	0	None
1061	1062	growth	0	None
1062	1063	of	0	None
1063	1064	endometrial	0	None
1064	1065	lines	0	None
1065	1066	bearing	0	None
1066	1067	an	0	None
1067	1068	activating	0	None
1068	1069	FGFR2	0	None
1069	1070	mutation	0	None
1070	1071	,	0	None
1071	1072	irrespective	0	None
1072	1073	of	0	None
1073	1074	PTEN	0	None
1074	1075	status	0	None
1075	1076	.	0	None

1077	1078	Concomitant	0	None
1078	1079	inhibition	0	None
1079	1080	of	0	None
1080	1081	both	0	None
1081	1082	FGFR2	0	None
1082	1083	and	0	None
1083	1084	mTOR	0	None
1084	1085	signaling	0	None
1085	1086	pathways	0	None
1086	1087	was	0	None
1087	1088	observed	0	None
1088	1089	,	0	None
1089	1090	with	0	None
1090	1091	simultaneous	0	None
1091	1092	blockade	0	None
1092	1093	resulting	0	None
1093	1094	in	0	None
1094	1095	enhanced	0	None
1095	1096	cell	0	None
1096	1097	cycle	0	None
1097	1098	arrest	0	None
1098	1099	.	0	None

1100	1101	Ponatinib	2	CHEMICAL
1101	1102	and	0	None
1102	1103	ridaforolimus	0	None
1103	1104	each	0	None
1104	1105	demonstrated	0	None
1105	1106	inhibition	0	None
1106	1107	of	0	None
1107	1108	tumor	0	None
1108	1109	growth	0	None
1109	1110	in	0	None
1110	1111	vivo	0	None
1111	1112	,	0	None
1112	1113	but	0	None
1113	1114	dual	0	None
1114	1115	inhibition	0	None
1115	1116	by	0	None
1116	1117	the	0	None
1117	1118	combination	0	None
1118	1119	of	0	None
1119	1120	agents	0	None
1120	1121	resulted	0	None
1121	1122	in	0	None
1122	1123	superior	0	None
1123	1124	efficacy	0	None
1124	1125	and	0	None
1125	1126	induced	0	None
1126	1127	tumor	0	None
1127	1128	regression	0	None
1128	1129	in	0	None
1129	1130	an	0	None
1130	1131	endometrial	0	None
1131	1132	xenograft	0	None
1132	1133	.	0	None

1134	1135	CONCLUSIONS	0	None
1135	1136	:	0	None
1136	1137	These	0	None
1137	1138	encouraging	0	None
1138	1139	preclinical	0	None
1139	1140	findings	0	None
1140	1141	suggest	0	None
1141	1142	the	0	None
1142	1143	inhibition	0	None
1143	1144	of	0	None
1144	1145	both	0	None
1145	1146	FGFR2	0	None
1146	1147	and	0	None
1147	1148	mTOR	0	None
1148	1149	by	0	None
1149	1150	the	0	None
1150	1151	ponatinib-ridaforolimus	0	None
1151	1152	combination	0	None
1152	1153	may	0	None
1153	1154	provide	0	None
1154	1155	a	0	None
1155	1156	new	0	None
1156	1157	therapeutic	0	None
1157	1158	strategy	0	None
1158	1159	to	0	None
1159	1160	treat	0	None
1160	1161	advanced	0	None
1161	1162	endometrial	0	None
1162	1163	cancers	0	None
1163	1164	with	0	None
1164	1165	dual	0	None
1165	1166	pathway	0	None
1166	1167	dysregulation	0	None
1167	1168	.	0	None
1168	1169	In	0	None
1169	1170	the	0	None
1170	1171	present	0	None
1171	1172	paper	0	None
1172	1173	,	0	None
1173	1174	the	0	None
1174	1175	cloning	0	None
1175	1176	and	0	None
1176	1177	expression	0	None
1177	1178	of	0	None
1178	1179	the	0	None
1179	1180	guinea	0	None
1180	1181	pig	0	None
1181	1182	alpha	0	None
1182	1183	(	0	None
1183	1184	1A	0	None
1184	1185	)	0	None
1185	1186	-adrenoceptor	0	None
1186	1187	is	0	None
1187	1188	presented	0	None
1188	1189	.	0	None

1190	1191	The	0	None
1191	1192	nucleotide	0	None
1192	1193	sequence	0	None
1193	1194	had	0	None
1194	1195	an	0	None
1195	1196	open	0	None
1196	1197	reading	0	None
1197	1198	frame	0	None
1198	1199	of	0	None
1199	1200	1401	0	None
1200	1201	bp	0	None
1201	1202	that	0	None
1202	1203	encoded	0	None
1203	1204	a	0	None
1204	1205	466	0	None
1205	1206	amino-acid	0	None
1206	1207	protein	0	None
1207	1208	with	0	None
1208	1209	an	0	None
1209	1210	estimated	0	None
1210	1211	molecular	0	None
1211	1212	mass	0	None
1212	1213	of	0	None
1213	1214	approximately	0	None
1214	1215	51	0	None
1215	1216	.	0	None
1216	1217	5	0	None
1217	1218	kDa	0	None
1218	1219	.	0	None

1220	1221	When	0	None
1221	1222	the	0	None
1222	1223	clone	0	None
1223	1224	was	0	None
1224	1225	expressed	0	None
1225	1226	in	0	None
1226	1227	Cos-1	0	None
1227	1228	cells	0	None
1228	1229	,	0	None
1229	1230	specific	0	None
1230	1231	high-affinity	0	None
1231	1232	binding	0	None
1232	1233	of	0	None
1233	1234	[	0	None
1234	1235	(	0	None
1235	1236	3	0	None
1236	1237	)	0	None
1237	1238	H	0	None
1238	1239	]	0	None
1239	1240	prazosin	0	None
1240	1241	and	0	None
1241	1242	[	0	None
1242	1243	(	0	None
1243	1244	3	0	None
1244	1245	)	0	None
1245	1246	H	0	None
1246	1247	]	0	None
1247	1248	tamsulosin	2	CHEMICAL
1248	1249	was	0	None
1249	1250	observed	0	None
1250	1251	.	0	None

1252	1253	Chloroethylclonidine	0	None
1253	1254	treatment	0	None
1254	1255	of	0	None
1255	1256	membranes	0	None
1256	1257	slightly	0	None
1257	1258	decreased	0	None
1258	1259	the	0	None
1259	1260	total	0	None
1260	1261	binding	0	None
1261	1262	with	0	None
1262	1263	both	0	None
1263	1264	radioligands	0	None
1264	1265	.	0	None

1266	1267	Binding	0	None
1267	1268	competition	0	None
1268	1269	experiments	0	None
1269	1270	using	0	None
1270	1271	[	0	None
1271	1272	(	0	None
1272	1273	3	0	None
1273	1274	)	0	None
1274	1275	H	0	None
1275	1276	]	0	None
1276	1277	tamsulosin	2	CHEMICAL
1277	1278	showed	0	None
1278	1279	the	0	None
1279	1280	following	0	None
1280	1281	potency	0	None
1281	1282	order	0	None
1282	1283	:	0	None
1283	1284	(	0	None
1284	1285	a	0	None
1285	1286	)	0	None
1286	1287	for	0	None
1287	1288	agonists	0	None
1288	1289	:	0	None
1289	1290	oxymetazoline	2	CHEMICAL
1290	1291	>>epinephrine>norepinephrine>methoxamine	0	None
1291	1292	,	0	None
1292	1293	and	0	None
1293	1294	(	0	None
1294	1295	b	0	None
1295	1296	)	0	None
1296	1297	for	0	None
1297	1298	antagonists	0	None
1298	1299	:	0	None
1299	1300	prazosin>	0	None
1300	1301	or	0	None
1301	1302	5-methyl-urapidil	0	None
1302	1303	=	0	None
1303	1304	benoxathian>phentolamine>>BMY	0	None
1304	1305	7378	0	None
1305	1306	(	0	None
1306	1307	8-	0	None
1307	1308	[	0	None
1308	1309	2-	0	None
1309	1310	[	0	None
1310	1311	4-	0	None
1311	1312	(	0	None
1312	1313	2-methoxyphenyl	0	None
1313	1314	)	0	None
1314	1315	-1-piperazinyl	0	None
1315	1316	]	0	None
1316	1317	ethyl	2	CHEMICAL
1317	1318	]	0	None
1318	1319	-8-azaspiro	0	None
1319	1320	[	0	None
1320	1321	4	0	None
1321	1322	,	0	None
1322	1323	5	0	None
1323	1324	]	0	None
1324	1325	decane-7	0	None
1325	1326	,	0	None
1326	1327	9-dione	0	None
1327	1328	)	0	None
1328	1329	.	0	None

1330	1331	Photoaffinity	0	None
1331	1332	labeling	0	None
1332	1333	using	0	None
1333	1334	[	0	None
1334	1335	(	0	None
1335	1336	125	0	None
1336	1337	)	0	None
1337	1338	I-aryl	0	None
1338	1339	]	0	None
1339	1340	azido-prazosin	0	None
1340	1341	revealed	0	None
1341	1342	a	0	None
1342	1343	major	0	None
1343	1344	broad	0	None
1344	1345	band	0	None
1345	1346	with	0	None
1346	1347	a	0	None
1347	1348	molecular	0	None
1348	1349	mass	0	None
1349	1350	between	0	None
1350	1351	70	0	None
1351	1352	and	0	None
1352	1353	80	0	None
1353	1354	kDa	0	None
1354	1355	.	0	None

1356	1357	The	0	None
1357	1358	receptor	0	None
1358	1359	was	0	None
1359	1360	functional	0	None
1360	1361	,	0	None
1361	1362	as	0	None
1362	1363	evidenced	0	None
1363	1364	by	0	None
1364	1365	an	0	None
1365	1366	epinephrine-increased	0	None
1366	1367	production	0	None
1367	1368	of	0	None
1368	1369	[	0	None
1369	1370	(	0	None
1370	1371	3	0	None
1371	1372	)	0	None
1372	1373	H	0	None
1373	1374	]	0	None
1374	1375	inositol	0	None
1375	1376	phosphates	0	None
1376	1377	that	0	None
1377	1378	was	0	None
1378	1379	blocked	0	None
1379	1380	by	0	None
1380	1381	prazosin	0	None
1381	1382	.	0	None
1382	1383	Pharmacodynamic	0	None
1383	1384	profile	0	None
1384	1385	of	0	None
1385	1386	the	0	None
1386	1387	direct	0	None
1387	1388	thrombin	0	None
1388	1389	antagonist	0	None
1389	1390	bivalirudin	0	None
1390	1391	given	0	None
1391	1392	in	0	None
1392	1393	combination	0	None
1393	1394	with	0	None
1394	1395	the	0	None
1395	1396	glycoprotein	0	None
1396	1397	IIb	0	None
1397	1398	/	0	None
1398	1399	IIIa	0	None
1399	1400	antagonist	0	None
1400	1401	eptifibatide	0	None
1401	1402	.	0	None
1402	1403	Increased	0	None
1403	1404	expression	0	None
1404	1405	of	0	None
1405	1406	tissue	0	None
1406	1407	factor	0	None
1407	1408	procoagulant	0	None
1408	1409	by	0	None
1409	1410	peripheral	0	None
1410	1411	blood	0	None
1411	1412	monocytes	0	None
1412	1413	has	0	None
1413	1414	been	0	None
1414	1415	implicated	0	None
1415	1416	in	0	None
1416	1417	a	0	None
1417	1418	number	0	None
1418	1419	of	0	None
1419	1420	thrombotic	0	None
1420	1421	disorders	0	None
1421	1422	.	0	None

1423	1424	The	0	None
1424	1425	present	0	None
1425	1426	studies	0	None
1426	1427	were	0	None
1427	1428	undertaken	0	None
1428	1429	to	0	None
1429	1430	determine	0	None
1430	1431	whether	0	None
1431	1432	stable	0	None
1432	1433	analogues	0	None
1433	1434	of	0	None
1434	1435	prostacyclin	2	CHEMICAL
1435	1436	,	0	None
1436	1437	a	0	None
1437	1438	potent	0	None
1438	1439	endothelium-derived	0	None
1439	1440	platelet	0	None
1440	1441	inhibitor	0	None
1441	1442	and	0	None
1442	1443	vasodilator	0	None
1443	1444	,	0	None
1444	1445	could	0	None
1445	1446	inhibit	0	None
1446	1447	tissue	0	None
1447	1448	factor	0	None
1448	1449	expression	0	None
1449	1450	by	0	None
1450	1451	human	0	None
1451	1452	monocytic	0	None
1452	1453	cells	0	None
1453	1454	.	0	None

1455	1456	Exposure	0	None
1456	1457	of	0	None
1457	1458	monocytic	0	None
1458	1459	tumor	0	None
1459	1460	THP-1	0	None
1460	1461	cells	0	None
1461	1462	to	0	None
1462	1463	100	0	None
1463	1464	ng	0	None
1464	1465	/	0	None
1465	1466	ml	0	None
1466	1467	endotoxin	0	None
1467	1468	,	0	None
1468	1469	2	0	None
1469	1470	units	0	None
1470	1471	/	0	None
1471	1472	ml	0	None
1472	1473	interleukin-1	0	None
1473	1474	beta	0	None
1474	1475	,	0	None
1475	1476	or	0	None
1476	1477	5	0	None
1477	1478	ng	0	None
1478	1479	/	0	None
1479	1480	ml	0	None
1480	1481	tumor	0	None
1481	1482	necrosis	0	None
1482	1483	factor-alpha	0	None
1483	1484	for	0	None
1484	1485	4	0	None
1485	1486	hours	0	None
1486	1487	led	0	None
1487	1488	to	0	None
1488	1489	increased	0	None
1489	1490	tissue	0	None
1490	1491	factor	0	None
1491	1492	procoagulant	0	None
1492	1493	activity	0	None
1493	1494	.	0	None

1495	1496	Preincubation	0	None
1496	1497	for	0	None
1497	1498	30	0	None
1498	1499	minutes	0	None
1499	1500	with	0	None
1500	1501	iloprost	0	None
1501	1502	,	0	None
1502	1503	ciprostene	0	None
1503	1504	,	0	None
1504	1505	and	0	None
1505	1506	carbacyclin	0	None
1506	1507	led	0	None
1507	1508	to	0	None
1508	1509	a	0	None
1509	1510	dose-dependent	0	None
1510	1511	inhibition	0	None
1511	1512	of	0	None
1512	1513	tissue	0	None
1513	1514	factor	0	None
1514	1515	expression	0	None
1515	1516	induced	0	None
1516	1517	by	0	None
1517	1518	all	0	None
1518	1519	three	0	None
1519	1520	challenging	0	None
1520	1521	agents	0	None
1521	1522	.	0	None

1523	1524	Iloprost	0	None
1524	1525	was	0	None
1525	1526	the	0	None
1526	1527	most	0	None
1527	1528	potent	0	None
1528	1529	:	0	None
1529	1530	50%	0	None
1530	1531	inhibition	0	None
1531	1532	occurred	0	None
1532	1533	at	0	None
1533	1534	5	0	None
1534	1535	nM	0	None
1535	1536	,	0	None
1536	1537	a	0	None
1537	1538	concentration	0	None
1538	1539	close	0	None
1539	1540	to	0	None
1540	1541	the	0	None
1541	1542	reported	0	None
1542	1543	dissociation	0	None
1543	1544	constant	0	None
1544	1545	for	0	None
1545	1546	iloprost	0	None
1546	1547	binding	0	None
1547	1548	to	0	None
1548	1549	the	0	None
1549	1552	platelet prostacyclin receptor	1	GENE-Y
1552	1553	.	0	None

1554	1555	An	0	None
1555	1556	orally	0	None
1556	1557	active	0	None
1557	1558	analogue	0	None
1558	1559	,	0	None
1559	1560	cicaprost	0	None
1560	1561	,	0	None
1561	1562	was	0	None
1562	1563	equally	0	None
1563	1564	effective	0	None
1564	1565	against	0	None
1565	1566	endotoxin-induced	0	None
1566	1567	tissue	0	None
1567	1568	factor	0	None
1568	1569	expression	0	None
1569	1570	.	0	None

1571	1572	Carbacyclin	0	None
1572	1573	and	0	None
1573	1574	ciprostene	0	None
1574	1575	were	0	None
1575	1576	100	0	None
1576	1577	times	0	None
1577	1578	less	0	None
1578	1579	potent	0	None
1579	1580	.	0	None

1581	1582	Iloprost	0	None
1582	1583	prevented	0	None
1583	1584	the	0	None
1584	1585	endotoxin-induced	0	None
1585	1586	expression	0	None
1586	1587	of	0	None
1587	1588	tissue	0	None
1588	1589	factor	0	None
1589	1590	antigen	0	None
1590	1591	on	0	None
1591	1592	the	0	None
1592	1593	surface	0	None
1593	1594	of	0	None
1594	1595	THP-1	0	None
1595	1596	cells	0	None
1596	1597	,	0	None
1597	1598	as	0	None
1598	1599	determined	0	None
1599	1600	by	0	None
1600	1601	flow	0	None
1601	1602	cytometry	0	None
1602	1603	.	0	None

1604	1605	Iloprost	0	None
1605	1606	(	0	None
1606	1607	500	0	None
1607	1608	pM-50	0	None
1608	1609	nM	0	None
1609	1610	)	0	None
1610	1611	increased	0	None
1611	1612	intracellular	0	None
1612	1613	levels	0	None
1613	1614	of	0	None
1614	1615	cyclic	0	None
1615	1616	AMP	0	None
1616	1617	.	0	None

1618	1619	This	0	None
1619	1620	effect	0	None
1620	1621	was	0	None
1621	1622	potentiated	0	None
1622	1623	by	0	None
1623	1624	isobutylmethylxanthine	0	None
1624	1625	,	0	None
1625	1626	an	0	None
1626	1627	inhibitor	0	None
1627	1628	of	0	None
1628	1629	phosphodiesterase	3	GENE-N
1629	1630	.	0	None

1631	1632	The	0	None
1632	1633	inhibitory	0	None
1633	1634	effects	0	None
1634	1635	of	0	None
1635	1636	iloprost	0	None
1636	1637	on	0	None
1637	1638	tissue	0	None
1638	1639	factor	0	None
1639	1640	expression	0	None
1640	1641	were	0	None
1641	1642	also	0	None
1642	1643	potentiated	0	None
1643	1644	by	0	None
1644	1645	isobutylmethylxanthine	0	None
1645	1646	and	0	None
1646	1647	mimicked	0	None
1647	1648	by	0	None
1648	1649	forskolin	0	None
1649	1650	and	0	None
1650	1651	dibutyryl	0	None
1651	1652	cyclic	0	None
1652	1653	AMP	0	None
1653	1654	but	0	None
1654	1655	not	0	None
1655	1656	dibutyryl	0	None
1656	1658	cyclic GMP	2	CHEMICAL
1658	1659	.	0	None

1660	1661	These	0	None
1661	1662	results	0	None
1662	1663	suggest	0	None
1663	1664	that	0	None
1664	1665	prostacyclin	2	CHEMICAL
1665	1666	may	0	None
1666	1667	play	0	None
1667	1668	a	0	None
1668	1669	role	0	None
1669	1670	in	0	None
1670	1671	downregulating	0	None
1671	1672	tissue	0	None
1672	1673	factor	0	None
1673	1674	expression	0	None
1674	1675	in	0	None
1675	1676	monocytes	0	None
1676	1677	,	0	None
1677	1678	at	0	None
1678	1679	least	0	None
1679	1680	in	0	None
1680	1681	part	0	None
1681	1682	via	0	None
1682	1683	elevation	0	None
1683	1684	of	0	None
1684	1685	intracellular	0	None
1685	1686	levels	0	None
1686	1687	of	0	None
1687	1688	cyclic	0	None
1688	1689	AMP	0	None
1689	1690	.	0	None
1690	1691	Sodium	2	CHEMICAL
1691	1692	fluoride	0	None
1692	1693	induces	0	None
1693	1694	apoptosis	0	None
1694	1695	in	0	None
1695	1696	odontoblasts	0	None
1696	1697	via	0	None
1697	1698	a	0	None
1698	1699	JNK-dependent	0	None
1699	1700	mechanism	0	None
1700	1701	.	0	None
1701	1702	Selective	0	None
1702	1703	and	0	None
1703	1704	potent	0	None
1704	1705	adenosine	0	None
1705	1707	A3 receptor	1	GENE-Y
1707	1708	antagonists	0	None
1708	1709	by	0	None
1709	1710	methoxyaryl	0	None
1710	1711	substitution	0	None
1711	1712	on	0	None
1712	1713	the	0	None
1713	1714	N-	0	None
1714	1715	(	0	None
1715	1716	2	0	None
1716	1717	,	0	None
1717	1718	6-diarylpyrimidin-4-yl	0	None
1718	1719	)	0	None
1719	1720	acetamide	0	None
1720	1721	scaffold	0	None
1721	1722	.	0	None
1722	1723	Alcohol	0	None
1723	1724	is	0	None
1724	1725	one	0	None
1725	1726	of	0	None
1726	1727	the	0	None
1727	1728	most	0	None
1728	1729	commonly	0	None
1729	1730	abused	0	None
1730	1731	substances	0	None
1731	1732	,	0	None
1732	1733	and	0	None
1733	1734	its	0	None
1734	1735	chronic	0	None
1735	1736	intake	0	None
1736	1737	leads	0	None
1737	1738	to	0	None
1738	1739	the	0	None
1739	1740	development	0	None
1740	1741	of	0	None
1741	1742	ethanol	2	CHEMICAL
1742	1743	dependence	0	None
1743	1744	in	0	None
1744	1745	both	0	None
1745	1746	humans	0	None
1746	1747	and	0	None
1747	1748	laboratory	0	None
1748	1749	animals	0	None
1749	1750	.	0	None

1751	1752	In	0	None
1752	1753	many	0	None
1753	1754	countries	0	None
1754	1755	,	0	None
1755	1756	a	0	None
1756	1757	mu-opioid	0	None
1757	1758	receptor	0	None
1758	1759	antagonist	0	None
1759	1760	naltrexone	2	CHEMICAL
1760	1761	has	0	None
1761	1762	been	0	None
1762	1763	used	0	None
1763	1764	in	0	None
1764	1765	the	0	None
1765	1766	treatment	0	None
1766	1767	of	0	None
1767	1768	alcohol	2	CHEMICAL
1768	1769	dependence	0	None
1769	1770	.	0	None

1771	1772	The	0	None
1772	1773	introduction	0	None
1773	1774	of	0	None
1774	1775	naltrexone	2	CHEMICAL
1775	1776	for	0	None
1776	1777	the	0	None
1777	1778	treatment	0	None
1778	1779	of	0	None
1779	1780	alcohol	2	CHEMICAL
1780	1781	dependence	0	None
1781	1782	has	0	None
1782	1783	been	0	None
1783	1784	mainly	0	None
1784	1785	based	0	None
1785	1786	on	0	None
1786	1787	behavioral	0	None
1787	1788	animal	0	None
1788	1789	models	0	None
1789	1790	that	0	None
1790	1791	provide	0	None
1791	1792	evidence	0	None
1792	1793	of	0	None
1793	1794	the	0	None
1794	1795	involvement	0	None
1795	1796	of	0	None
1796	1797	the	0	None
1797	1798	endogenous	0	None
1798	1799	opioid	0	None
1799	1800	system	0	None
1800	1801	in	0	None
1801	1802	alcohol	2	CHEMICAL
1802	1803	drinking	0	None
1803	1804	and	0	None
1804	1805	dependence	0	None
1805	1806	.	0	None

1807	1808	It	0	None
1808	1809	has	0	None
1809	1810	been	0	None
1810	1811	well	0	None
1811	1812	known	0	None
1812	1813	that	0	None
1813	1814	alcohol	2	CHEMICAL
1814	1815	leads	0	None
1815	1816	to	0	None
1816	1817	the	0	None
1817	1818	activation	0	None
1818	1819	of	0	None
1819	1820	the	0	None
1820	1821	endogenous	0	None
1821	1822	opioid	0	None
1822	1823	system	0	None
1823	1824	.	0	None

1825	1826	The	0	None
1826	1827	endogenous	0	None
1827	1828	opioid	0	None
1828	1829	agonists	0	None
1829	1830	,	0	None
1830	1831	such	0	None
1831	1832	as	0	None
1832	1833	beta-endorphin	0	None
1833	1834	,	0	None
1834	1835	increase	0	None
1835	1836	the	0	None
1836	1837	activity	0	None
1837	1838	of	0	None
1838	1839	the	0	None
1839	1840	mesolimbic	0	None
1840	1841	dopaminergic	0	None
1841	1842	system	0	None
1842	1843	through	0	None
1843	1844	the	0	None
1844	1845	inhibition	0	None
1845	1846	of	0	None
1846	1847	the	0	None
1847	1848	gamma-aminobutyric	0	None
1848	1849	acid	0	None
1849	1850	(	0	None
1850	1851	GABA	2	CHEMICAL
1851	1852	)	0	None
1852	1853	-containing	0	None
1853	1854	inhibitory	0	None
1854	1855	interneurons	0	None
1855	1856	in	0	None
1856	1857	the	0	None
1857	1858	ventral	0	None
1858	1859	tegmental	0	None
1859	1860	area	0	None
1860	1861	,	0	None
1861	1862	resulting	0	None
1862	1863	in	0	None
1863	1864	the	0	None
1864	1865	expression	0	None
1865	1866	of	0	None
1866	1867	alcohol	2	CHEMICAL
1867	1868	reinforcement	0	None
1868	1869	and	0	None
1869	1870	/	0	None
1870	1871	or	0	None
1871	1872	rewarding	0	None
1872	1873	effect	0	None
1873	1874	.	0	None

1875	1876	Therefore	0	None
1876	1877	,	0	None
1877	1878	naltrexone	2	CHEMICAL
1878	1879	,	0	None
1879	1880	which	0	None
1880	1881	is	0	None
1881	1882	useful	0	None
1882	1883	for	0	None
1883	1884	alcohol	2	CHEMICAL
1884	1885	dependence	0	None
1885	1886	therapy	0	None
1886	1887	,	0	None
1887	1888	may	0	None
1888	1889	attenuate	0	None
1889	1890	the	0	None
1890	1891	rewarding	0	None
1891	1892	effect	0	None
1892	1893	of	0	None
1893	1894	ethanol	2	CHEMICAL
1894	1895	by	0	None
1895	1896	interfering	0	None
1896	1897	with	0	None
1897	1898	the	0	None
1898	1899	ethanol-induced	0	None
1899	1900	stimulation	0	None
1900	1901	of	0	None
1901	1902	the	0	None
1902	1903	mesolimbic	0	None
1903	1904	dopaminergic	0	None
1904	1905	system	0	None
1905	1906	.	0	None

1907	1908	The	0	None
1908	1909	following	0	None
1909	1910	review	0	None
1910	1911	provides	0	None
1911	1912	a	0	None
1912	1913	summary	0	None
1913	1914	of	0	None
1914	1915	the	0	None
1915	1916	interactions	0	None
1916	1917	between	0	None
1917	1918	endogenous	0	None
1918	1919	opioid	0	None
1919	1920	system	0	None
1920	1921	and	0	None
1921	1922	mesolimbic	0	None
1922	1923	dopaminergic	0	None
1923	1924	system	0	None
1924	1925	in	0	None
1925	1926	alcohol	2	CHEMICAL
1926	1927	dependence	0	None
1927	1928	.	0	None
1928	1929	Aldo-keto	0	None
1929	1930	reductases	0	None
1930	1931	in	0	None
1931	1932	retinoid	0	None
1932	1933	metabolism	0	None
1933	1934	:	0	None
1934	1935	search	0	None
1935	1936	for	0	None
1936	1937	substrate	0	None
1937	1938	specificity	0	None
1938	1939	and	0	None
1939	1940	inhibitor	0	None
1940	1941	selectivity	0	None
1941	1942	.	0	None
1942	1943	The	0	None
1943	1944	cAMP	0	None
1944	1945	signaling	0	None
1945	1946	system	0	None
1946	1947	can	0	None
1947	1948	trigger	0	None
1948	1949	precise	0	None
1949	1950	physiological	0	None
1950	1951	cellular	0	None
1951	1952	responses	0	None
1952	1953	that	0	None
1953	1954	depend	0	None
1954	1955	on	0	None
1955	1956	the	0	None
1956	1957	fidelity	0	None
1957	1958	of	0	None
1958	1959	many	0	None
1959	1960	protein-protein	0	None
1960	1961	interactions	0	None
1961	1962	,	0	None
1962	1963	which	0	None
1963	1964	act	0	None
1964	1965	to	0	None
1965	1966	bring	0	None
1966	1967	together	0	None
1967	1968	signaling	0	None
1968	1969	intermediates	0	None
1969	1970	at	0	None
1970	1971	defined	0	None
1971	1972	locations	0	None
1972	1973	within	0	None
1973	1974	cells	0	None
1974	1975	.	0	None

1976	1977	In	0	None
1977	1978	the	0	None
1978	1979	heart	0	None
1979	1980	,	0	None
1980	1981	cAMP	0	None
1981	1982	participates	0	None
1982	1983	in	0	None
1983	1984	the	0	None
1984	1985	fine	0	None
1985	1986	control	0	None
1986	1987	of	0	None
1987	1988	excitation-contraction	0	None
1988	1989	coupling	0	None
1989	1990	,	0	None
1990	1991	hence	0	None
1991	1992	,	0	None
1992	1993	any	0	None
1993	1994	disregulation	0	None
1994	1995	of	0	None
1995	1996	this	0	None
1996	1997	signaling	0	None
1997	1998	cascade	0	None
1998	1999	can	0	None
1999	2000	lead	0	None
2000	2001	to	0	None
2001	2002	cardiac	0	None
2002	2003	disease	0	None
2003	2004	.	0	None

2005	2006	Due	0	None
2006	2007	to	0	None
2007	2008	the	0	None
2008	2009	ubiquitous	0	None
2009	2010	nature	0	None
2010	2011	of	0	None
2011	2012	the	0	None
2012	2013	cAMP	0	None
2013	2014	pathway	0	None
2014	2015	,	0	None
2015	2016	general	0	None
2016	2017	inhibitors	0	None
2017	2018	of	0	None
2018	2019	cAMP	0	None
2019	2020	signaling	0	None
2020	2021	proteins	0	None
2021	2022	such	0	None
2022	2023	as	0	None
2023	2024	PKA	0	None
2024	2025	,	0	None
2025	2026	EPAC	0	None
2026	2027	and	0	None
2027	2028	PDEs	0	None
2028	2029	would	0	None
2029	2030	act	0	None
2030	2031	non-specifically	0	None
2031	2032	and	0	None
2032	2033	universally	0	None
2033	2034	,	0	None
2034	2035	increasing	0	None
2035	2036	the	0	None
2036	2037	likelihood	0	None
2037	2038	of	0	None
2038	2039	serious	0	None
2039	2040	'off	0	None
2040	2041	target'	0	None
2041	2042	effects	0	None
2042	2043	.	0	None

2044	2045	Recent	0	None
2045	2046	advances	0	None
2046	2047	in	0	None
2047	2048	the	0	None
2048	2049	discovery	0	None
2049	2050	of	0	None
2050	2051	peptides	0	None
2051	2052	and	0	None
2052	2053	small	0	None
2053	2054	molecules	0	None
2054	2055	that	0	None
2055	2056	disrupt	0	None
2056	2057	the	0	None
2057	2058	protein-protein	0	None
2058	2059	interactions	0	None
2059	2060	that	0	None
2060	2061	underpin	0	None
2061	2062	cellular	0	None
2062	2063	targeting	0	None
2063	2064	of	0	None
2064	2065	cAMP	0	None
2065	2066	signaling	0	None
2066	2067	proteins	0	None
2067	2068	are	0	None
2068	2069	described	0	None
2069	2070	and	0	None
2070	2071	discussed	0	None
2071	2072	.	0	None
2072	2074	Arsenic trioxide	2	CHEMICAL
2074	2075	induces	0	None
2075	2076	cardiac	0	None
2076	2077	fibroblast	0	None
2077	2078	apoptosis	0	None
2078	2079	in	0	None
2079	2080	vitro	0	None
2080	2081	and	0	None
2081	2082	in	0	None
2082	2083	vivo	0	None
2083	2084	by	0	None
2084	2085	up-regulating	0	None
2085	2086	TGF-β1	0	None
2086	2087	expression	0	None
2087	2088	.	0	None
2088	2089	Substituted	0	None
2089	2090	imidazopyridazines	0	None
2090	2091	are	0	None
2091	2092	potent	0	None
2092	2093	and	0	None
2093	2094	selective	0	None
2094	2095	inhibitors	0	None
2095	2096	of	0	None
2096	2097	Plasmodium	0	None
2097	2098	falciparum	0	None
2098	2099	calcium-dependent	0	None
2099	2102	protein kinase 1	3	GENE-N
2102	2103	(	0	None
2103	2104	PfCDPK1	0	None
2104	2105	)	0	None
2105	2106	.	0	None
2106	2107	SNAIL	0	None
2107	2108	Induces	0	None
2108	2109	Epithelial-to-Mesenchymal	0	None
2109	2110	Transition	0	None
2110	2111	and	0	None
2111	2112	Cancer	0	None
2112	2113	Stem	0	None
2113	2114	Cell-like	0	None
2114	2115	Properties	0	None
2115	2116	in	0	None
2116	2117	Aldehyde	2	CHEMICAL
2117	2118	Dehydroghenase-Negative	0	None
2118	2119	Thyroid	0	None
2119	2120	Cancer	0	None
2120	2121	Cells	0	None
2121	2122	.	0	None
2122	2124	Glucocorticoid receptor	3	GENE-N
2124	2125	binding	0	None
2125	2126	:	0	None
2126	2127	a	0	None
2127	2128	biphasic	0	None
2128	2129	dependence	0	None
2129	2130	on	0	None
2130	2131	molecular	0	None
2131	2132	size	0	None
2132	2133	as	0	None
2133	2134	revealed	0	None
2134	2135	by	0	None
2135	2136	the	0	None
2136	2137	bilinear	0	None
2137	2138	LinBiExp	0	None
2138	2139	model	0	None
2139	2140	.	0	None
2140	2141	Osteoporosis	0	None
2141	2142	is	0	None
2142	2143	a	0	None
2143	2144	common	0	None
2144	2145	disease	0	None
2145	2146	characterized	0	None
2146	2147	by	0	None
2147	2148	an	0	None
2148	2149	increased	0	None
2149	2150	susceptibility	0	None
2150	2151	to	0	None
2151	2152	fracture	0	None
2152	2153	.	0	None

2154	2155	It	0	None
2155	2156	is	0	None
2156	2157	a	0	None
2157	2158	complex	0	None
2158	2159	disorder	0	None
2159	2160	resulting	0	None
2160	2161	from	0	None
2161	2162	the	0	None
2162	2163	interaction	0	None
2163	2164	of	0	None
2164	2165	several	0	None
2165	2166	polymorphisms	0	None
2166	2167	in	0	None
2167	2168	different	0	None
2168	2169	genes	0	None
2169	2170	and	0	None
2170	2171	environmental	0	None
2171	2172	factors	0	None
2172	2173	.	0	None

2174	2175	Since	0	None
2175	2176	we	0	None
2176	2177	recently	0	None
2177	2178	reported	0	None
2178	2179	a	0	None
2179	2180	role	0	None
2180	2181	for	0	None
2181	2182	low	0	None
2182	2183	density	0	None
2183	2184	lipoprotein-related	0	None
2184	2185	protein	0	None
2185	2186	(	0	None
2186	2187	LRP	0	None
2187	2188	)	0	None
2188	2189	-4	0	None
2189	2190	in	0	None
2190	2191	monogenic	0	None
2191	2192	disorders	0	None
2192	2193	with	0	None
2193	2194	bone	0	None
2194	2195	overgrowth	0	None
2195	2196	,	0	None
2196	2197	we	0	None
2197	2198	now	0	None
2198	2199	wanted	0	None
2199	2200	to	0	None
2200	2201	evaluate	0	None
2201	2202	whether	0	None
2202	2203	genetic	0	None
2203	2204	variation	0	None
2204	2205	in	0	None
2205	2206	the	0	None
2206	2207	LRP4	0	None
2207	2208	gene	0	None
2208	2209	has	0	None
2209	2210	an	0	None
2210	2211	effect	0	None
2211	2212	on	0	None
2212	2213	the	0	None
2213	2214	susceptibility	0	None
2214	2215	to	0	None
2215	2216	osteoporosis	0	None
2216	2217	in	0	None
2217	2218	a	0	None
2218	2219	population	0	None
2219	2220	based	0	None
2220	2221	cohort	0	None
2221	2222	from	0	None
2222	2223	the	0	None
2223	2224	Odense	0	None
2224	2225	Androgen	0	None
2225	2226	Study	0	None
2226	2227	.	0	None

2228	2229	We	0	None
2229	2230	chose	0	None
2230	2231	to	0	None
2231	2232	genotype	0	None
2232	2233	four	0	None
2233	2234	common	0	None
2234	2235	(	0	None
2235	2236	minor	0	None
2236	2237	allele	0	None
2237	2238	frequency	0	None
2238	2239	(	0	None
2239	2240	MAF	0	None
2240	2241	)	0	None
2241	2242	≥0	0	None
2242	2243	.	0	None
2243	2244	05	0	None
2244	2245	)	0	None
2245	2246	and	0	None
2246	2247	non-synonymous	0	None
2247	2248	coding	0	None
2248	2249	polymorphisms	0	None
2249	2250	located	0	None
2250	2251	in	0	None
2251	2252	the	0	None
2252	2254	extracellular region	1	GENE-Y
2254	2255	of	0	None
2255	2256	the	0	None
2256	2257	LRP4	0	None
2257	2258	protein	0	None
2258	2259	:	0	None
2259	2260	rs3816614	0	None
2260	2261	(	0	None
2261	2262	A	0	None
2262	2263	/	0	None
2263	2264	g	0	None
2264	2265	)	0	None
2265	2266	,	0	None
2266	2267	rs2306029	0	None
2267	2268	(	0	None
2268	2269	G	0	None
2269	2270	/	0	None
2270	2271	a	0	None
2271	2272	)	0	None
2272	2273	,	0	None
2273	2274	rs2306033	0	None
2274	2275	(	0	None
2275	2276	C	0	None
2276	2277	/	0	None
2277	2278	t	0	None
2278	2279	)	0	None
2279	2280	and	0	None
2280	2281	rs6485702	0	None
2281	2282	(	0	None
2282	2283	G	0	None
2283	2284	/	0	None
2284	2285	a	0	None
2285	2286	)	0	None
2286	2287	(	0	None
2287	2288	large	0	None
2288	2289	and	0	None
2289	2290	small	0	None
2290	2291	characters	0	None
2291	2292	indicate	0	None
2292	2293	major	0	None
2293	2294	and	0	None
2294	2295	minor	0	None
2295	2296	alleles	0	None
2296	2297	,	0	None
2297	2298	respectively	0	None
2298	2299	)	0	None
2299	2300	.	0	None

2301	2302	Bone	0	None
2302	2303	mineral	0	None
2303	2304	density	0	None
2304	2305	(	0	None
2305	2306	BMD	0	None
2306	2307	)	0	None
2307	2308	measurements	0	None
2308	2309	of	0	None
2309	2310	the	0	None
2310	2311	hip	0	None
2311	2312	,	0	None
2312	2313	the	0	None
2313	2314	spine	0	None
2314	2315	and	0	None
2315	2316	whole	0	None
2316	2317	body	0	None
2317	2318	as	0	None
2318	2319	well	0	None
2319	2320	as	0	None
2320	2321	different	0	None
2321	2322	hip	0	None
2322	2323	geometry	0	None
2323	2324	parameters	0	None
2324	2325	were	0	None
2325	2326	available	0	None
2326	2327	for	0	None
2327	2328	a	0	None
2328	2329	total	0	None
2329	2330	of	0	None
2330	2331	1404	0	None
2331	2332	Danish	0	None
2332	2333	men	0	None
2333	2334	from	0	None
2334	2335	two	0	None
2335	2336	age	0	None
2336	2337	groups	0	None
2337	2338	(	0	None
2338	2339	[	0	None
2339	2340	20-29	0	None
2340	2341	years	0	None
2341	2342	]	0	None
2342	2343	:	0	None
2343	2344	n	0	None
2344	2345	=	0	None
2345	2346	804;	0	None
2346	2347	[	0	None
2347	2348	60-74	0	None
2348	2349	years	0	None
2349	2350	]	0	None
2350	2351	:	0	None
2351	2352	n	0	None
2352	2353	=	0	None
2353	2354	600	0	None
2354	2355	)	0	None
2355	2356	.	0	None

2357	2358	Using	0	None
2358	2359	linear	0	None
2359	2360	regression	0	None
2360	2361	analysis	0	None
2361	2362	adjusted	0	None
2362	2363	for	0	None
2363	2364	age	0	None
2364	2365	,	0	None
2365	2366	height	0	None
2366	2367	and	0	None
2367	2368	weight	0	None
2368	2369	,	0	None
2369	2370	we	0	None
2370	2371	found	0	None
2371	2372	significant	0	None
2372	2373	associations	0	None
2373	2374	between	0	None
2374	2375	both	0	None
2375	2376	rs2306029	0	None
2376	2377	and	0	None
2377	2378	rs6485702	0	None
2378	2379	and	0	None
2379	2380	BMD	0	None
2380	2381	at	0	None
2381	2382	all	0	None
2382	2383	sites	0	None
2383	2384	except	0	None
2384	2385	the	0	None
2385	2386	lumbar	0	None
2386	2387	spine	0	None
2387	2388	.	0	None

2389	2390	The	0	None
2390	2391	most	0	None
2391	2392	significant	0	None
2392	2393	association	0	None
2393	2394	was	0	None
2394	2395	found	0	None
2395	2396	with	0	None
2396	2397	whole	0	None
2397	2398	body	0	None
2398	2399	BMD	0	None
2399	2400	(	0	None
2400	2401	p	0	None
2401	2402	=	0	None
2402	2403	4	0	None
2403	2404	.	0	None
2404	2405	7×10	0	None
2405	2406	(	0	None
2406	2407	-5	0	None
2407	2408	)	0	None
2408	2409	)	0	None
2409	2410	.	0	None

2411	2412	In	0	None
2412	2413	addition	0	None
2413	2414	,	0	None
2414	2415	we	0	None
2415	2416	found	0	None
2416	2417	these	0	None
2417	2418	two	0	None
2418	2419	polymorphisms	0	None
2419	2420	to	0	None
2420	2421	be	0	None
2421	2422	associated	0	None
2422	2423	with	0	None
2423	2424	different	0	None
2424	2425	geometry	0	None
2425	2426	parameters	0	None
2426	2427	especially	0	None
2427	2428	of	0	None
2428	2429	the	0	None
2429	2430	femoral	0	None
2430	2431	shaft	0	None
2431	2432	.	0	None

2433	2434	Analysis	0	None
2434	2435	of	0	None
2435	2436	the	0	None
2436	2437	two	0	None
2437	2438	associated	0	None
2438	2439	SNPs	0	None
2439	2440	in	0	None
2440	2441	the	0	None
2441	2442	separate	0	None
2442	2443	age	0	None
2443	2444	groups	0	None
2444	2445	demonstrated	0	None
2445	2446	that	0	None
2446	2447	most	0	None
2447	2448	associations	0	None
2448	2449	are	0	None
2449	2450	only	0	None
2450	2451	present	0	None
2451	2452	in	0	None
2452	2453	the	0	None
2453	2454	youngest	0	None
2454	2455	group	0	None
2455	2456	of	0	None
2456	2457	Danish	0	None
2457	2458	men	0	None
2458	2459	.	0	None

2460	2461	In	0	None
2461	2462	the	0	None
2462	2463	group	0	None
2463	2464	of	0	None
2464	2465	elderly	0	None
2465	2466	men	0	None
2466	2467	,	0	None
2467	2468	one	0	None
2468	2469	Bonferroni	0	None
2469	2470	corrected	0	None
2470	2471	association	0	None
2471	2472	between	0	None
2472	2473	whole	0	None
2473	2474	body	0	None
2474	2475	BMD	0	None
2475	2476	and	0	None
2476	2477	rs6485702	0	None
2477	2478	was	0	None
2478	2479	found	0	None
2479	2480	to	0	None
2480	2481	be	0	None
2481	2482	significant	0	None
2482	2483	.	0	None

2484	2485	Subsequently	0	None
2485	2486	,	0	None
2486	2487	all	0	None
2487	2488	polymorphisms	0	None
2488	2489	were	0	None
2489	2490	included	0	None
2490	2491	in	0	None
2491	2492	haplotype	0	None
2492	2493	analyses	0	None
2493	2494	using	0	None
2494	2495	the	0	None
2495	2496	PLINK	0	None
2496	2497	software	0	None
2497	2498	(	0	None
2498	2499	v1	0	None
2499	2500	.	0	None
2500	2501	07	0	None
2501	2502	)	0	None
2502	2503	.	0	None

2504	2505	After	0	None
2505	2506	adjusting	0	None
2506	2507	for	0	None
2507	2508	age	0	None
2508	2509	,	0	None
2509	2510	height	0	None
2510	2511	and	0	None
2511	2512	weight	0	None
2512	2513	,	0	None
2513	2514	two	0	None
2514	2515	out	0	None
2515	2516	of	0	None
2516	2517	five	0	None
2517	2518	common	0	None
2518	2519	haplotypes	0	None
2519	2520	(	0	None
2520	2521	MAF≥0	0	None
2521	2522	.	0	None
2522	2523	01	0	None
2523	2524	)	0	None
2524	2525	were	0	None
2525	2526	found	0	None
2526	2527	to	0	None
2527	2528	be	0	None
2528	2529	of	0	None
2529	2530	particular	0	None
2530	2531	interest	0	None
2531	2532	in	0	None
2532	2533	the	0	None
2533	2534	regulation	0	None
2534	2535	of	0	None
2535	2536	hip	0	None
2536	2537	and	0	None
2537	2538	whole	0	None
2538	2539	body	0	None
2539	2540	BMD	0	None
2540	2541	(	0	None
2541	2542	AGCG	0	None
2542	2543	,	0	None
2543	2544	AACA	0	None
2544	2545	)	0	None
2545	2546	.	0	None

2547	2548	Additional	0	None
2548	2549	analysis	0	None
2549	2550	suggested	0	None
2550	2551	that	0	None
2551	2552	these	0	None
2552	2553	latter	0	None
2553	2554	associations	0	None
2554	2555	are	0	None
2555	2556	driven	0	None
2556	2557	by	0	None
2557	2558	the	0	None
2558	2559	association	0	None
2559	2560	of	0	None
2560	2561	rs6485702	0	None
2561	2562	.	0	None

2563	2564	We	0	None
2564	2565	suggest	0	None
2565	2566	,	0	None
2566	2567	based	0	None
2567	2568	on	0	None
2568	2569	these	0	None
2569	2570	results	0	None
2570	2571	and	0	None
2571	2572	the	0	None
2572	2573	localisation	0	None
2573	2574	of	0	None
2574	2575	the	0	None
2575	2576	variant	0	None
2576	2577	in	0	None
2577	2578	the	0	None
2578	2579	third	0	None
2579	2580	β-propeller	0	None
2580	2581	domain	0	None
2581	2582	of	0	None
2582	2583	LRP4	0	None
2583	2584	,	0	None
2584	2585	that	0	None
2585	2586	the	0	None
2586	2587	variant	0	None
2587	2588	has	0	None
2588	2589	possibly	0	None
2589	2590	a	0	None
2590	2591	functional	0	None
2591	2592	effect	0	None
2592	2593	.	0	None

2594	2595	Hereby	0	None
2595	2596	,	0	None
2596	2597	we	0	None
2597	2598	conclude	0	None
2598	2599	that	0	None
2599	2600	common	0	None
2600	2601	variation	0	None
2601	2602	in	0	None
2602	2603	the	0	None
2603	2604	LRP4	0	None
2604	2605	gene	0	None
2605	2606	determines	0	None
2606	2607	hip	0	None
2607	2608	and	0	None
2608	2609	whole	0	None
2609	2610	body	0	None
2610	2611	BMD	0	None
2611	2612	and	0	None
2612	2613	thus	0	None
2613	2614	confirm	0	None
2614	2615	previous	0	None
2615	2616	results	0	None
2616	2617	from	0	None
2617	2618	different	0	None
2618	2619	GWAs	0	None
2619	2620	.	0	None

2621	2622	In	0	None
2622	2623	addition	0	None
2623	2624	,	0	None
2624	2625	our	0	None
2625	2626	data	0	None
2626	2627	proves	0	None
2627	2628	an	0	None
2628	2629	additional	0	None
2629	2630	role	0	None
2630	2631	for	0	None
2631	2632	LRP4	0	None
2632	2633	in	0	None
2633	2634	regulating	0	None
2634	2635	hip	0	None
2635	2636	structure	0	None
2636	2637	.	0	None

2638	2639	Finally	0	None
2639	2640	,	0	None
2640	2641	interaction	0	None
2641	2642	analysis	0	None
2642	2643	for	0	None
2643	2644	LRP4	0	None
2644	2645	with	0	None
2645	2646	SOST	0	None
2646	2647	and	0	None
2647	2648	LRP5	1	GENE-Y
2648	2649	showed	0	None
2649	2650	interaction	0	None
2650	2651	with	0	None
2651	2652	LRP5	1	GENE-Y
2652	2653	for	0	None
2653	2654	femoral	0	None
2654	2655	shaft	0	None
2655	2656	geometry	0	None
2656	2657	.	0	None
2657	2658	The	0	None
2658	2659	present	0	None
2659	2660	study	0	None
2660	2661	describes	0	None
2661	2662	the	0	None
2662	2663	characterization	0	None
2663	2664	of	0	None
2664	2665	the	0	None
2665	2666	binding	0	None
2666	2667	properties	0	None
2667	2668	and	0	None
2668	2669	autoradiographic	0	None
2669	2670	distribution	0	None
2670	2671	of	0	None
2671	2672	a	0	None
2672	2673	new	0	None
2673	2674	nonpeptide	0	None
2674	2675	antagonist	0	None
2675	2676	of	0	None
2676	2677	neurotensin	0	None
2677	2678	receptors	0	None
2678	2679	,	0	None
2679	2680	[	0	None
2680	2681	3H	0	None
2681	2682	]	0	None
2682	2683	SR	2	CHEMICAL
2683	2684	142948A	0	None
2684	2685	(	0	None
2685	2686	2-	0	None
2686	2687	[	0	None
2687	2688	[	0	None
2688	2689	5-	0	None
2689	2690	(	0	None
2690	2691	2	0	None
2691	2692	,	0	None
2692	2693	6-dimethoxyphenyl	0	None
2693	2694	)	0	None
2694	2695	-1-	0	None
2695	2696	(	0	None
2696	2697	4-	0	None
2697	2698	(	0	None
2698	2699	N-	0	None
2699	2700	(	0	None
2700	2701	3-dimethylaminopropyl	0	None
2701	2702	)	0	None
2702	2703	-N-methyl	0	None
2703	2704	carbamoyl	0	None
2704	2705	)	0	None
2705	2706	-2-isopropylphenyl	0	None
2706	2707	)	0	None
2707	2708	-1H-pyrazole-3-carbonyl	0	None
2708	2709	]	0	None
2709	2710	-amino	0	None
2710	2711	]	0	None
2711	2712	-ad	0	None
2712	2713	amantane-2-carboxylic	0	None
2713	2714	acid	0	None
2714	2715	,	0	None
2715	2716	hydrochloride	2	CHEMICAL
2716	2717	)	0	None
2717	2718	,	0	None
2718	2719	in	0	None
2719	2720	the	0	None
2720	2721	rat	0	None
2721	2722	brain	0	None
2722	2723	.	0	None

2724	2725	The	0	None
2725	2726	binding	0	None
2726	2727	of	0	None
2727	2728	[	0	None
2728	2729	3H	0	None
2729	2730	]	0	None
2730	2731	SR	2	CHEMICAL
2731	2732	142948A	0	None
2732	2733	in	0	None
2733	2734	brain	0	None
2734	2735	membrane	0	None
2735	2736	homogenates	0	None
2736	2737	was	0	None
2737	2738	specific	0	None
2738	2739	,	0	None
2739	2740	time-dependent	0	None
2740	2741	,	0	None
2741	2742	reversible	0	None
2742	2743	and	0	None
2743	2744	saturable	0	None
2744	2745	.	0	None

2746	2747	[	0	None
2747	2748	3H	0	None
2748	2749	]	0	None
2749	2750	SR	2	CHEMICAL
2750	2751	142948A	0	None
2751	2752	bound	0	None
2752	2753	to	0	None
2753	2754	an	0	None
2754	2755	apparently	0	None
2755	2756	homogeneous	0	None
2756	2757	population	0	None
2757	2758	of	0	None
2758	2759	sites	0	None
2759	2760	,	0	None
2760	2761	with	0	None
2761	2762	a	0	None
2762	2763	Kd	0	None
2763	2764	of	0	None
2764	2765	3	0	None
2765	2766	.	0	None
2766	2767	5	0	None
2767	2768	nM	0	None
2768	2769	and	0	None
2769	2770	a	0	None
2770	2771	Bmax	0	None
2771	2772	value	0	None
2772	2773	of	0	None
2773	2774	508	0	None
2774	2775	fmol	0	None
2775	2776	/	0	None
2776	2777	mg	2	CHEMICAL
2777	2778	of	0	None
2778	2779	protein	0	None
2779	2780	,	0	None
2780	2781	which	0	None
2781	2782	was	0	None
2782	2783	80%	0	None
2783	2784	higher	0	None
2784	2785	than	0	None
2785	2786	that	0	None
2786	2787	observed	0	None
2787	2788	in	0	None
2788	2789	saturation	0	None
2789	2790	experiments	0	None
2790	2791	with	0	None
2791	2792	[	0	None
2792	2793	3H	0	None
2793	2794	]	0	None
2794	2795	neurotensin	0	None
2795	2796	.	0	None

2797	2798	[	0	None
2798	2799	3H	0	None
2799	2800	]	0	None
2800	2801	SR	2	CHEMICAL
2801	2802	142948A	0	None
2802	2803	binding	0	None
2803	2804	was	0	None
2804	2805	inhibited	0	None
2805	2806	by	0	None
2806	2807	SR	2	CHEMICAL
2807	2808	142948A	0	None
2808	2809	,	0	None
2809	2810	the	0	None
2810	2811	related	0	None
2811	2812	nonpeptide	0	None
2812	2813	receptor	0	None
2813	2814	antagonist	0	None
2814	2815	,	0	None
2815	2817	SR 48692	2	CHEMICAL
2817	2818	(	0	None
2818	2819	2-	0	None
2819	2820	[	0	None
2820	2821	[	0	None
2821	2822	1-	0	None
2822	2823	(	0	None
2823	2824	7-chloroquinolin-4-yl	0	None
2824	2825	)	0	None
2825	2826	-5-	0	None
2826	2827	(	0	None
2827	2828	2	0	None
2828	2829	,	0	None
2829	2830	6-dimethoxyphenyl	0	None
2830	2831	)	0	None
2831	2832	-1H-pyrazole	0	None
2832	2833	-3-carbonyl	0	None
2833	2834	]	0	None
2834	2835	amino	0	None
2835	2836	]	0	None
2836	2837	-adamantane-2-carboxylic	0	None
2837	2838	acid	0	None
2838	2839	)	0	None
2839	2840	and	0	None
2840	2841	neurotensin	0	None
2841	2842	.	0	None

2843	2844	Saturation	0	None
2844	2845	and	0	None
2845	2846	competition	0	None
2846	2847	studies	0	None
2847	2848	in	0	None
2848	2849	the	0	None
2849	2850	presence	0	None
2850	2851	or	0	None
2851	2852	absence	0	None
2852	2853	of	0	None
2853	2854	the	0	None
2854	2857	histamine H1 receptor	1	GENE-Y
2857	2858	antagonist	0	None
2858	2859	,	0	None
2859	2860	levocabastine	0	None
2860	2861	,	0	None
2861	2862	revealed	0	None
2862	2863	that	0	None
2863	2864	[	0	None
2864	2865	3H	0	None
2865	2866	]	0	None
2866	2867	SR	2	CHEMICAL
2867	2868	142948A	0	None
2868	2869	bound	0	None
2869	2870	with	0	None
2870	2871	similar	0	None
2871	2872	affinities	0	None
2872	2873	to	0	None
2873	2874	both	0	None
2874	2875	the	0	None
2875	2876	levocabastine-insensitive	0	None
2876	2879	neurotensin NT1 receptors	1	GENE-Y
2879	2880	(	0	None
2880	2881	20%	0	None
2881	2882	of	0	None
2882	2883	the	0	None
2883	2884	total	0	None
2884	2885	binding	0	None
2885	2886	population	0	None
2886	2887	)	0	None
2887	2888	and	0	None
2888	2889	the	0	None
2889	2890	recently	0	None
2890	2891	cloned	0	None
2891	2892	levocabastine-sensitive	0	None
2892	2893	neurotensin	0	None
2893	2894	NT2	0	None
2894	2895	receptors	0	None
2895	2896	(	0	None
2896	2897	80%	0	None
2897	2898	of	0	None
2898	2899	the	0	None
2899	2900	receptors	0	None
2900	2901	)	0	None
2901	2902	(	0	None
2902	2903	Kd	0	None
2903	2904	=	0	None
2904	2905	6	0	None
2905	2906	.	0	None
2906	2907	8	0	None
2907	2908	and	0	None
2908	2909	4	0	None
2909	2910	.	0	None
2910	2911	8	0	None
2911	2912	nM	0	None
2912	2913	,	0	None
2913	2914	respectively	0	None
2914	2915	)	0	None
2915	2916	.	0	None

2917	2918	The	0	None
2918	2919	regional	0	None
2919	2920	distribution	0	None
2920	2921	of	0	None
2921	2922	[	0	None
2922	2923	3H	0	None
2923	2924	]	0	None
2924	2925	SR	2	CHEMICAL
2925	2926	142948A	0	None
2926	2927	binding	0	None
2927	2928	in	0	None
2928	2929	the	0	None
2929	2930	rat	0	None
2930	2931	brain	0	None
2931	2932	closely	0	None
2932	2933	matched	0	None
2933	2934	the	0	None
2934	2935	distribution	0	None
2935	2936	of	0	None
2936	2937	[	0	None
2937	2938	125I	2	CHEMICAL
2938	2939	]	0	None
2939	2940	neurotensin	0	None
2940	2941	binding	0	None
2941	2942	.	0	None

2943	2944	In	0	None
2944	2945	conclusion	0	None
2945	2946	,	0	None
2946	2947	these	0	None
2947	2948	findings	0	None
2948	2949	indicate	0	None
2949	2950	that	0	None
2950	2951	[	0	None
2951	2952	3H	0	None
2952	2953	]	0	None
2953	2954	SR	2	CHEMICAL
2954	2955	142948A	0	None
2955	2956	is	0	None
2956	2957	a	0	None
2957	2958	new	0	None
2958	2959	potent	0	None
2959	2960	antagonist	0	None
2960	2961	radioligand	0	None
2961	2962	which	0	None
2962	2963	recognizes	0	None
2963	2964	with	0	None
2964	2965	high	0	None
2965	2966	affinity	0	None
2966	2967	both	0	None
2967	2968	neurotensin	0	None
2968	2969	NT1	0	None
2969	2970	and	0	None
2970	2971	NT2	0	None
2971	2972	receptors	0	None
2972	2973	and	0	None
2973	2974	represents	0	None
2974	2975	thus	0	None
2975	2976	an	0	None
2976	2977	excellent	0	None
2977	2978	tool	0	None
2978	2979	to	0	None
2979	2980	study	0	None
2980	2981	neurotensin	0	None
2981	2982	receptors	0	None
2982	2983	in	0	None
2983	2984	the	0	None
2984	2985	rat	0	None
2985	2986	brain	0	None
2986	2987	.	0	None
2987	2988	Anti-inflammatory	0	None
2988	2989	activity	0	None
2989	2990	of	0	None
2990	2991	Cymbopogon	0	None
2991	2992	citratus	0	None
2992	2993	leaves	0	None
2993	2994	infusion	0	None
2994	2995	via	0	None
2995	2996	proteasome	3	GENE-N
2996	2997	and	0	None
2997	2998	nuclear	0	None
2998	2999	factor-κB	0	None
2999	3000	pathway	0	None
3000	3001	inhibition	0	None
3001	3002	:	0	None
3002	3003	Contribution	0	None
3003	3004	of	0	None
3004	3005	chlorogenic	0	None
3005	3006	acid	0	None
3006	3007	.	0	None
3007	3008	TCDD	0	None
3008	3009	inhibition	0	None
3009	3010	of	0	None
3010	3011	canonical	0	None
3011	3012	wnt	0	None
3012	3013	signaling	0	None
3013	3014	disrupts	0	None
3014	3015	prostatic	0	None
3015	3016	bud	0	None
3016	3017	formation	0	None
3017	3018	in	0	None
3018	3019	mouse	0	None
3019	3020	urogenital	0	None
3020	3021	sinus	0	None
3021	3022	.	0	None
3022	3023	Incoherent	0	None
3023	3024	neutron	0	None
3024	3025	scattering	0	None
3025	3026	is	0	None
3026	3027	one	0	None
3027	3028	of	0	None
3028	3029	the	0	None
3029	3030	most	0	None
3030	3031	powerful	0	None
3031	3032	tools	0	None
3032	3033	for	0	None
3033	3034	studying	0	None
3034	3035	dynamics	0	None
3035	3036	in	0	None
3036	3037	biological	0	None
3037	3038	matter	0	None
3038	3039	.	0	None

3040	3041	Using	0	None
3041	3042	the	0	None
3042	3043	cold	0	None
3043	3044	neutron	0	None
3044	3045	backscattering	0	None
3045	3046	spectrometer	0	None
3046	3047	IN16	0	None
3047	3048	at	0	None
3048	3049	the	0	None
3049	3050	Institut	0	None
3050	3051	Laue	0	None
3051	3052	Langevin	0	None
3052	3053	(	0	None
3053	3054	ILL	0	None
3054	3055	,	0	None
3055	3056	Grenoble	0	None
3056	3057	,	0	None
3057	3058	France	0	None
3058	3059	)	0	None
3059	3060	,	0	None
3060	3061	temperature	0	None
3061	3062	dependence	0	None
3062	3063	of	0	None
3063	3064	cholinesterases'	0	None
3064	3065	dynamics	0	None
3065	3066	(	0	None
3066	3067	human	0	None
3067	3068	butyrylcholinesterase	0	None
3068	3069	from	0	None
3069	3070	plasma	0	None
3070	3071	:	0	None
3071	3072	hBChE;	0	None
3072	3073	recombinant	0	None
3073	3074	human	0	None
3074	3075	acetylcholinesterase	0	None
3075	3076	:	0	None
3076	3077	hAChE	0	None
3077	3078	and	0	None
3078	3079	recombinant	0	None
3079	3080	mouse	0	None
3080	3081	acetylcholinesterase	0	None
3081	3082	:	0	None
3082	3083	mAChE	0	None
3083	3084	)	0	None
3084	3085	was	0	None
3085	3086	examined	0	None
3086	3087	using	0	None
3087	3088	elastic	0	None
3088	3089	incoherent	0	None
3089	3090	neutron	0	None
3090	3091	scattering	0	None
3091	3092	(	0	None
3092	3093	EINS	0	None
3093	3094	)	0	None
3094	3095	.	0	None

3096	3097	The	0	None
3097	3098	dynamics	0	None
3098	3099	was	0	None
3099	3100	characterized	0	None
3100	3101	by	0	None
3101	3102	the	0	None
3102	3103	averaged	0	None
3103	3104	atomic	0	None
3104	3105	mean	0	None
3105	3106	square	0	None
3106	3107	displacement	0	None
3107	3108	(	0	None
3108	3109	MSD	0	None
3109	3110	)	0	None
3110	3111	,	0	None
3111	3112	associated	0	None
3112	3113	with	0	None
3113	3114	the	0	None
3114	3115	sample	0	None
3115	3116	flexibility	0	None
3116	3117	at	0	None
3117	3118	a	0	None
3118	3119	given	0	None
3119	3120	temperature	0	None
3120	3121	.	0	None

3122	3123	We	0	None
3123	3124	found	0	None
3124	3125	MSD	0	None
3125	3126	values	0	None
3126	3127	of	0	None
3127	3128	hAChE	0	None
3128	3129	above	0	None
3129	3130	the	0	None
3130	3131	dynamical	0	None
3131	3132	transition	0	None
3132	3133	temperature	0	None
3133	3134	(	0	None
3134	3135	around	0	None
3135	3136	200K	0	None
3136	3137	)	0	None
3137	3138	larger	0	None
3138	3139	than	0	None
3139	3140	for	0	None
3140	3141	mAChE	0	None
3141	3142	and	0	None
3142	3143	hBChE	1	GENE-Y
3143	3144	,	0	None
3144	3145	implying	0	None
3145	3146	that	0	None
3146	3147	hAChE	0	None
3147	3148	is	0	None
3148	3149	more	0	None
3149	3150	flexible	0	None
3150	3151	than	0	None
3151	3152	the	0	None
3152	3153	other	0	None
3153	3154	ChEs	0	None
3154	3155	.	0	None

3156	3157	Activation	0	None
3157	3158	energies	0	None
3158	3159	for	0	None
3159	3160	thermodynamical	0	None
3160	3161	transition	0	None
3161	3162	were	0	None
3162	3163	extracted	0	None
3163	3164	through	0	None
3164	3165	the	0	None
3165	3166	frequency	0	None
3166	3167	window	0	None
3167	3168	model	0	None
3168	3169	(	0	None
3169	3170	FWM	0	None
3170	3171	)	0	None
3171	3172	(	0	None
3172	3173	Becker	0	None
3173	3174	et	0	None
3174	3175	al	0	None
3175	3176	.	0	None

3177	3178	2004	0	None
3178	3179	)	0	None
3179	3180	[	0	None
3180	3181	1	0	None
3181	3182	]	0	None
3182	3183	and	0	None
3183	3184	turned	0	None
3184	3185	out	0	None
3185	3186	to	0	None
3186	3187	increase	0	None
3187	3188	from	0	None
3188	3189	hBChE	1	GENE-Y
3189	3190	to	0	None
3190	3191	mAChE	0	None
3191	3192	and	0	None
3192	3193	finally	0	None
3193	3194	to	0	None
3194	3195	hAChE	0	None
3195	3196	,	0	None
3196	3197	inversely	0	None
3197	3198	to	0	None
3198	3199	the	0	None
3199	3200	MSDs	0	None
3200	3201	relations	0	None
3201	3202	.	0	None

3203	3204	Between	0	None
3204	3205	280	0	None
3205	3206	and	0	None
3206	3207	316K	0	None
3207	3208	,	0	None
3208	3209	catalytic	0	None
3209	3210	studies	0	None
3210	3211	of	0	None
3211	3212	these	0	None
3212	3213	enzymes	0	None
3213	3214	were	0	None
3214	3215	carried	0	None
3215	3216	out	0	None
3216	3217	using	0	None
3217	3218	thiocholine	2	CHEMICAL
3218	3219	esters	0	None
3219	3220	:	0	None
3220	3221	at	0	None
3221	3222	the	0	None
3222	3223	same	0	None
3223	3224	temperature	0	None
3224	3225	,	0	None
3225	3226	the	0	None
3226	3227	hAChE	0	None
3227	3228	activity	0	None
3228	3229	was	0	None
3229	3230	systematically	0	None
3230	3231	higher	0	None
3231	3232	than	0	None
3232	3233	the	0	None
3233	3234	mAChE	0	None
3234	3235	or	0	None
3235	3236	hBChE	1	GENE-Y
3236	3237	ones	0	None
3237	3238	.	0	None

3239	3240	Our	0	None
3240	3241	results	0	None
3241	3242	thus	0	None
3242	3243	suggest	0	None
3243	3244	a	0	None
3244	3245	strong	0	None
3245	3246	correlation	0	None
3246	3247	between	0	None
3247	3248	dynamics	0	None
3248	3249	and	0	None
3249	3250	activity	0	None
3250	3251	within	0	None
3251	3252	the	0	None
3252	3253	ChE	1	GENE-Y
3253	3254	family	0	None
3254	3255	.	0	None

3256	3257	We	0	None
3257	3258	also	0	None
3258	3259	studied	0	None
3259	3260	and	0	None
3260	3261	compared	0	None
3261	3262	the	0	None
3262	3263	ChEs	0	None
3263	3264	thermal	0	None
3264	3265	inactivation	0	None
3265	3266	kinetics	0	None
3266	3267	.	0	None

3268	3269	Here	0	None
3269	3270	,	0	None
3270	3271	no	0	None
3271	3272	direct	0	None
3272	3273	correlation	0	None
3273	3274	with	0	None
3274	3275	the	0	None
3275	3276	dynamics	0	None
3276	3277	was	0	None
3277	3278	observed	0	None
3278	3279	,	0	None
3279	3280	thus	0	None
3280	3281	suggesting	0	None
3281	3282	that	0	None
3282	3283	relations	0	None
3283	3284	between	0	None
3284	3285	enzyme	0	None
3285	3286	dynamics	0	None
3286	3287	and	0	None
3287	3288	catalytic	0	None
3288	3289	stability	0	None
3289	3290	are	0	None
3290	3291	more	0	None
3291	3292	complex	0	None
3292	3293	.	0	None

3294	3295	Finally	0	None
3295	3296	,	0	None
3296	3297	the	0	None
3297	3298	possible	0	None
3298	3299	relation	0	None
3299	3300	between	0	None
3300	3301	flexibility	0	None
3301	3302	and	0	None
3302	3303	protein	0	None
3303	3304	ability	0	None
3304	3305	to	0	None
3305	3306	grow	0	None
3306	3307	in	0	None
3307	3308	crystals	0	None
3308	3309	is	0	None
3309	3310	discussed	0	None
3310	3311	.	0	None
3311	3312	The	0	None
3312	3313	pharmacological	0	None
3313	3314	dosage	0	None
3314	3315	of	0	None
3315	3316	dehydroepiandrosterone	0	None
3316	3317	(	0	None
3317	3318	DHEA	0	None
3318	3319	)	0	None
3319	3320	protects	0	None
3320	3321	against	0	None
3321	3322	chemically	0	None
3322	3323	induced	0	None
3323	3324	carcinogenesis	0	None
3324	3325	.	0	None

3326	3327	The	0	None
3327	3328	chemoprotective	0	None
3328	3329	activity	0	None
3329	3330	of	0	None
3330	3331	DHEA	0	None
3331	3332	is	0	None
3332	3333	attributed	0	None
3333	3334	to	0	None
3334	3335	its	0	None
3335	3336	inhibitory	0	None
3336	3337	potential	0	None
3337	3338	for	0	None
3338	3339	the	0	None
3339	3340	expression	0	None
3340	3341	of	0	None
3341	3342	CYP1A	0	None
3342	3343	enzymes	0	None
3343	3344	,	0	None
3344	3345	which	0	None
3345	3346	are	0	None
3346	3347	highly	0	None
3347	3348	responsible	0	None
3348	3349	for	0	None
3349	3350	metabolic	0	None
3350	3351	activation	0	None
3351	3352	of	0	None
3352	3353	several	0	None
3353	3354	mutagenic	0	None
3354	3355	and	0	None
3355	3356	carcinogenic	0	None
3356	3357	chemicals	0	None
3357	3358	.	0	None

3359	3360	The	0	None
3360	3361	present	0	None
3361	3362	work	0	None
3362	3363	investigated	0	None
3363	3364	whether	0	None
3364	3365	the	0	None
3365	3366	chemoprevention	0	None
3366	3367	by	0	None
3367	3368	DHEA	0	None
3368	3369	was	0	None
3369	3370	due	0	None
3370	3371	to	0	None
3371	3372	diminished	0	None
3372	3373	transcriptional	0	None
3373	3374	activation	0	None
3374	3375	of	0	None
3375	3376	CYP1A	0	None
3376	3377	genes	0	None
3377	3378	or	0	None
3378	3379	to	0	None
3379	3380	the	0	None
3380	3381	post-transcriptional	0	None
3381	3382	modulation	0	None
3382	3383	of	0	None
3383	3384	CYP1A	0	None
3384	3385	expression	0	None
3385	3386	.	0	None

3387	3388	In	0	None
3388	3389	primary	0	None
3389	3390	human	0	None
3390	3391	hepatocytes	0	None
3391	3392	,	0	None
3392	3393	DHEA	0	None
3393	3394	diminished	0	None
3394	3395	the	0	None
3395	3396	increase	0	None
3396	3397	in	0	None
3397	3398	CYP1A	0	None
3398	3399	activities	0	None
3399	3400	(	0	None
3400	3401	7-ethoxyresorufin	0	None
3401	3402	O-dealkylation	0	None
3402	3403	and	0	None
3403	3404	phenacetin	0	None
3404	3405	O-dealkylation	0	None
3405	3406	)	0	None
3406	3407	and	0	None
3407	3408	in	0	None
3408	3409	CYP1A2	0	None
3409	3410	mRNA	0	None
3410	3411	level	0	None
3411	3412	induced	0	None
3412	3413	by	0	None
3413	3414	3-methylcholanthrene	2	CHEMICAL
3414	3415	,	0	None
3415	3416	but	0	None
3416	3417	did	0	None
3417	3418	not	0	None
3418	3419	alter	0	None
3419	3420	the	0	None
3420	3421	amount	0	None
3421	3422	of	0	None
3422	3423	CYP1A1	0	None
3423	3424	and	0	None
3424	3425	CYP1B1	0	None
3425	3426	mRNA	0	None
3426	3427	.	0	None

3428	3429	The	0	None
3429	3431	androgen receptor	1	GENE-Y
3431	3432	seemed	0	None
3432	3433	to	0	None
3433	3434	be	0	None
3434	3435	involved	0	None
3435	3436	in	0	None
3436	3437	DHEA-mediated	0	None
3437	3438	diminishment	0	None
3438	3439	of	0	None
3439	3440	CYP1A2	0	None
3440	3441	induction	0	None
3441	3442	,	0	None
3442	3443	which	0	None
3443	3444	was	0	None
3444	3445	attenuated	0	None
3445	3446	in	0	None
3446	3447	the	0	None
3447	3448	presence	0	None
3448	3449	of	0	None
3449	3450	bicalutamide	2	CHEMICAL
3450	3451	,	0	None
3451	3452	the	0	None
3452	3453	androgen	0	None
3453	3454	receptor	0	None
3454	3455	antagonist	0	None
3455	3456	.	0	None

3457	3458	The	0	None
3458	3459	potential	0	None
3459	3460	role	0	None
3460	3461	of	0	None
3461	3462	the	0	None
3462	3464	glucocorticoid receptor	1	GENE-Y
3464	3465	and	0	None
3465	3467	estrogen receptor	1	GENE-Y
3467	3468	in	0	None
3468	3469	DHEA-mediated	0	None
3469	3470	decrease	0	None
3470	3471	in	0	None
3471	3472	CYP1A2	0	None
3472	3473	induction	0	None
3473	3474	was	0	None
3474	3475	excluded	0	None
3475	3476	.	0	None

3477	3478	The	0	None
3478	3479	developed	0	None
3479	3480	computational	0	None
3480	3481	model	0	None
3481	3482	of	0	None
3482	3483	CYP1A2	0	None
3483	3484	induction	0	None
3484	3485	kinetics	0	None
3485	3486	and	0	None
3486	3487	CYP1A2	0	None
3487	3488	mRNA	0	None
3488	3489	degradation	0	None
3489	3490	proposed	0	None
3490	3491	that	0	None
3491	3492	a	0	None
3492	3493	post-transcriptional	0	None
3493	3494	mechanism	0	None
3494	3495	was	0	None
3495	3496	likely	0	None
3496	3497	to	0	None
3497	3498	be	0	None
3498	3499	the	0	None
3499	3500	primary	0	None
3500	3501	mechanism	0	None
3501	3502	of	0	None
3502	3503	the	0	None
3503	3504	DHEA-mediated	0	None
3504	3505	diminishment	0	None
3505	3506	of	0	None
3506	3507	CYP1A2	0	None
3507	3508	induction	0	None
3508	3509	.	0	None

3510	3511	The	0	None
3511	3512	hypothesis	0	None
3512	3513	was	0	None
3513	3514	confirmed	0	None
3514	3515	by	0	None
3515	3516	the	0	None
3516	3517	results	0	None
3517	3518	of	0	None
3518	3519	actinomycin	0	None
3519	3520	D-chase	0	None
3520	3521	experiments	0	None
3521	3522	in	0	None
3522	3523	MCF-7	0	None
3523	3524	and	0	None
3524	3525	LNCaP	0	None
3525	3526	cells	0	None
3526	3527	,	0	None
3527	3528	displaying	0	None
3528	3529	that	0	None
3529	3530	the	0	None
3530	3531	degradation	0	None
3531	3532	rates	0	None
3532	3533	of	0	None
3533	3534	CYP1A2	0	None
3534	3535	mRNA	0	None
3535	3536	were	0	None
3536	3537	significantly	0	None
3537	3538	higher	0	None
3538	3539	in	0	None
3539	3540	the	0	None
3540	3541	cells	0	None
3541	3542	exposed	0	None
3542	3543	to	0	None
3543	3544	DHEA	0	None
3544	3545	.	0	None

3546	3547	The	0	None
3547	3548	novel	0	None
3548	3549	findings	0	None
3549	3550	on	0	None
3550	3551	DHEA-mediated	0	None
3551	3552	modulation	0	None
3552	3553	of	0	None
3553	3554	CYP1A2	0	None
3554	3555	mRNA	0	None
3555	3556	stability	0	None
3556	3557	may	0	None
3557	3558	account	0	None
3558	3559	for	0	None
3559	3560	the	0	None
3560	3561	beneficial	0	None
3561	3562	effects	0	None
3562	3563	of	0	None
3563	3564	DHEA	0	None
3564	3565	by	0	None
3565	3566	decreasing	0	None
3566	3567	the	0	None
3567	3568	metabolic	0	None
3568	3569	activation	0	None
3569	3570	of	0	None
3570	3571	pro-carcinogenic	0	None
3571	3572	compounds	0	None
3572	3573	.	0	None
3573	3574	Metabolism	0	None
3574	3575	of	0	None
3575	3576	nomifensine	0	None
3576	3577	to	0	None
3577	3578	a	0	None
3578	3579	dihydroisoquinolinium	0	None
3579	3580	ion	0	None
3580	3581	metabolite	0	None
3581	3582	by	0	None
3582	3583	human	0	None
3583	3584	myeloperoxidase	0	None
3584	3585	,	0	None
3585	3587	hemoglobin ,	0	None
3587	3590	monoamine oxidase A	1	GENE-Y
3590	3591	,	0	None
3591	3592	and	0	None
3592	3593	cytochrome	3	GENE-N
3593	3594	P450	0	None
3594	3595	enzymes	0	None
3595	3596	.	0	None
3596	3598	Hydroxysafflor yellow	2	CHEMICAL
3598	3599	a	0	None
3599	3600	inhibits	0	None
3600	3601	lipopolysaccharide-induced	0	None
3601	3602	inflammatory	0	None
3602	3603	signal	0	None
3603	3604	transduction	0	None
3604	3605	in	0	None
3605	3606	human	0	None
3606	3607	alveolar	0	None
3607	3608	epithelial	0	None
3608	3609	A549	0	None
3609	3610	cells	0	None
3610	3611	.	0	None
3611	3612	A	0	None
3612	3613	general	0	None
3613	3614	two-process	0	None
3614	3615	model	0	None
3615	3616	describes	0	None
3616	3617	the	0	None
3617	3618	hydrogen	2	CHEMICAL
3618	3619	exchange	0	None
3619	3620	behavior	0	None
3620	3621	of	0	None
3621	3623	RNase A	1	GENE-Y
3623	3624	in	0	None
3624	3625	unfolding	0	None
3625	3626	conditions	0	None
3626	3627	.	0	None
3627	3628	Selective	0	None
3628	3629	histamine-H1	0	None
3629	3630	receptor	0	None
3630	3631	antagonists	0	None
3631	3632	inhibit	0	None
3632	3633	adenosine	0	None
3633	3634	5'-monophosphate	0	None
3634	3635	(	0	None
3635	3636	AMP	0	None
3636	3637	)	0	None
3637	3638	-induced	0	None
3638	3639	bronchoconstriction	0	None
3639	3640	by	0	None
3640	3641	greater	0	None
3641	3642	than	0	None
3642	3643	80%	0	None
3643	3644	when	0	None
3644	3645	expressed	0	None
3645	3646	as	0	None
3646	3647	a	0	None
3647	3648	percentage	0	None
3648	3649	inhibition	0	None
3649	3650	of	0	None
3650	3651	the	0	None
3651	3652	FEV1	0	None
3652	3653	time-response	0	None
3653	3654	curve	0	None
3654	3655	following	0	None
3655	3656	inhalation	0	None
3656	3657	of	0	None
3657	3658	the	0	None
3658	3659	provocation	0	None
3659	3660	concentration	0	None
3660	3661	of	0	None
3661	3662	AMP	0	None
3662	3663	required	0	None
3663	3664	to	0	None
3664	3665	produce	0	None
3665	3666	a	0	None
3666	3667	20%	0	None
3667	3668	decrease	0	None
3668	3669	in	0	None
3669	3670	FEV1	0	None
3670	3671	from	0	None
3671	3672	baseline	0	None
3672	3673	(	0	None
3673	3674	PC20	0	None
3674	3675	)	0	None
3675	3676	.	0	None

3677	3678	To	0	None
3678	3679	investigate	0	None
3679	3680	this	0	None
3680	3681	further	0	None
3681	3682	we	0	None
3682	3683	have	0	None
3683	3684	determined	0	None
3684	3685	that	0	None
3685	3686	,	0	None
3686	3687	in	0	None
3687	3688	eight	0	None
3688	3689	mild	0	None
3689	3690	atopic	0	None
3690	3691	asthmatic	0	None
3691	3692	subjects	0	None
3692	3693	,	0	None
3693	3694	terfenadine	0	None
3694	3695	(	0	None
3695	3696	180	0	None
3696	3697	mg	2	CHEMICAL
3697	3698	)	0	None
3698	3699	,	0	None
3699	3700	administered	0	None
3700	3701	3	0	None
3701	3702	hr	3	GENE-N
3702	3703	pre-challenge	0	None
3703	3704	,	0	None
3704	3705	increases	0	None
3705	3706	the	0	None
3706	3707	geometric	0	None
3707	3708	mean	0	None
3708	3709	PC20	0	None
3709	3710	for	0	None
3710	3711	histamine	2	CHEMICAL
3711	3712	from	0	None
3712	3713	0	0	None
3713	3714	.	0	None
3714	3715	4	0	None
3715	3716	(	0	None
3716	3717	range	0	None
3717	3718	0	0	None
3718	3719	.	0	None
3719	3720	03-3	0	None
3720	3721	)	0	None
3721	3722	mg	2	CHEMICAL
3722	3723	/	0	None
3723	3724	ml	0	None
3724	3725	after	0	None
3725	3726	placebo	0	None
3726	3727	,	0	None
3727	3728	to	0	None
3728	3729	20	0	None
3729	3730	.	0	None
3730	3731	2	0	None
3731	3732	(	0	None
3732	3733	range	0	None
3733	3734	0	0	None
3734	3735	.	0	None
3735	3736	6-64	0	None
3736	3737	)	0	None
3737	3738	mg	2	CHEMICAL
3738	3739	/	0	None
3739	3740	ml	0	None
3740	3741	following	0	None
3741	3742	active	0	None
3742	3743	treatment	0	None
3743	3744	(	0	None
3744	3745	P	0	None
3745	3746	less	0	None
3746	3747	than	0	None
3747	3748	0	0	None
3748	3749	.	0	None
3749	3750	0001	0	None
3750	3751	)	0	None
3751	3752	.	0	None

3753	3754	For	0	None
3754	3755	AMP	0	None
3755	3756	,	0	None
3756	3757	the	0	None
3757	3758	PC20	0	None
3758	3759	increased	0	None
3759	3760	from	0	None
3760	3761	9	0	None
3761	3762	.	0	None
3762	3763	3	0	None
3763	3764	(	0	None
3764	3765	range	0	None
3765	3766	1	0	None
3766	3767	.	0	None
3767	3768	0-113	0	None
3768	3769	.	0	None
3769	3770	3	0	None
3770	3771	)	0	None
3771	3772	mg	2	CHEMICAL
3772	3773	/	0	None
3773	3774	ml	0	None
3774	3775	after	0	None
3775	3776	placebo	0	None
3776	3777	,	0	None
3777	3778	to	0	None
3778	3779	150	0	None
3779	3780	.	0	None
3780	3781	2	0	None
3781	3782	(	0	None
3782	3783	range	0	None
3783	3784	32	0	None
3784	3785	.	0	None
3785	3786	1-1177	0	None
3786	3787	.	0	None
3787	3788	7	0	None
3788	3789	)	0	None
3789	3790	mg	2	CHEMICAL
3790	3791	/	0	None
3791	3792	ml	0	None
3792	3793	with	0	None
3793	3794	terfenadine	0	None
3794	3795	(	0	None
3795	3796	P	0	None
3796	3797	less	0	None
3797	3798	than	0	None
3798	3799	0	0	None
3799	3800	.	0	None
3800	3801	0001	0	None
3801	3802	)	0	None
3802	3803	.	0	None

3804	3805	This	0	None
3805	3806	16	0	None
3806	3807	.	0	None
3807	3808	2-fold	0	None
3808	3809	(	0	None
3809	3810	range	0	None
3810	3811	,	0	None
3811	3812	5	0	None
3812	3813	.	0	None
3813	3814	5-47	0	None
3814	3815	.	0	None
3815	3816	9	0	None
3816	3817	)	0	None
3817	3818	displacement	0	None
3818	3819	to	0	None
3819	3820	the	0	None
3820	3821	right	0	None
3821	3822	of	0	None
3822	3823	the	0	None
3823	3824	AMP	0	None
3824	3825	concentration-response	0	None
3825	3826	curve	0	None
3826	3827	by	0	None
3827	3828	a	0	None
3828	3829	selective	0	None
3829	3830	histamine-H1	0	None
3830	3831	receptor	0	None
3831	3832	antagonist	0	None
3832	3833	emphasizes	0	None
3833	3834	the	0	None
3834	3835	central	0	None
3835	3836	role	0	None
3836	3837	of	0	None
3837	3838	histamine	2	CHEMICAL
3838	3839	in	0	None
3839	3840	the	0	None
3840	3841	airways	0	None
3841	3842	response	0	None
3842	3843	to	0	None
3843	3844	this	0	None
3844	3845	nucleotide	0	None
3845	3846	.	0	None
3846	3847	This	0	None
3847	3848	study	0	None
3848	3849	determined	0	None
3849	3850	the	0	None
3850	3851	nutritional	0	None
3851	3852	potential	0	None
3852	3853	of	0	None
3853	3854	Thai	0	None
3854	3855	indigenous	0	None
3855	3856	fruits	0	None
3856	3857	in	0	None
3857	3858	terms	0	None
3858	3859	of	0	None
3859	3860	nutrients	0	None
3860	3861	,	0	None
3861	3862	bioactive	0	None
3862	3863	compounds	0	None
3863	3864	,	0	None
3864	3865	and	0	None
3865	3866	antioxidant	0	None
3866	3867	activities	0	None
3867	3868	.	0	None

3869	3870	Three	0	None
3870	3871	indigenous	0	None
3871	3872	fruits	0	None
3872	3873	were	0	None
3873	3874	collected	0	None
3874	3875	at	0	None
3875	3876	two	0	None
3876	3877	conservation	0	None
3877	3878	areas	0	None
3878	3879	in	0	None
3879	3880	Kanchanaburi	0	None
3880	3881	province	0	None
3881	3882	,	0	None
3882	3883	Thailand	0	None
3883	3884	.	0	None

3885	3886	The	0	None
3886	3887	results	0	None
3887	3888	showed	0	None
3888	3889	that	0	None
3889	3890	Phyllanthus	0	None
3890	3891	emblica	0	None
3891	3892	L	0	None
3892	3893	.	0	None

3894	3895	exhibited	0	None
3895	3896	the	0	None
3896	3897	highest	0	None
3897	3898	levels	0	None
3898	3899	of	0	None
3899	3901	vitamin C	2	CHEMICAL
3901	3902	(	0	None
3902	3903	575±452mg	0	None
3903	3904	/	0	None
3904	3905	100g	0	None
3905	3906	)	0	None
3906	3907	,	0	None
3907	3908	total	0	None
3908	3909	phenolics	0	None
3909	3910	(	0	None
3910	3911	TP	1	GENE-Y
3911	3912	)	0	None
3912	3913	(	0	None
3913	3914	3703±1244mGAE	0	None
3914	3915	/	0	None
3915	3916	100g	0	None
3916	3917	)	0	None
3917	3918	,	0	None
3918	3919	and	0	None
3919	3920	antioxidant	0	None
3920	3921	activities	0	None
3921	3922	,	0	None
3922	3923	as	0	None
3923	3924	measured	0	None
3924	3925	by	0	None
3925	3926	DPPH	0	None
3926	3927	,	0	None
3927	3928	FRAP	0	None
3928	3929	and	0	None
3929	3930	ORAC	0	None
3930	3931	assays	0	None
3931	3932	.	0	None

3933	3934	Compared	0	None
3934	3935	to	0	None
3935	3936	the	0	None
3936	3937	other	0	None
3937	3938	two	0	None
3938	3939	fruits	0	None
3939	3940	,	0	None
3940	3941	Antidesma	0	None
3941	3942	velutinosum	0	None
3942	3943	Blume	0	None
3943	3944	contained	0	None
3944	3945	higher	0	None
3945	3946	levels	0	None
3946	3947	of	0	None
3947	3948	most	0	None
3948	3949	nutrients	0	None
3949	3950	and	0	None
3950	3951	dietary	0	None
3951	3952	fibre	0	None
3952	3953	(	0	None
3953	3954	15	0	None
3954	3955	.	0	None
3955	3956	6±5	0	None
3956	3957	.	0	None
3957	3958	9g	0	None
3958	3959	/	0	None
3959	3960	100g	0	None
3960	3961	)	0	None
3961	3962	,	0	None
3962	3963	as	0	None
3963	3964	well	0	None
3964	3965	as	0	None
3965	3966	carotenoids	0	None
3966	3967	(	0	None
3967	3968	335±98μg	0	None
3968	3969	/	0	None
3969	3970	100g	0	None
3970	3971	)	0	None
3971	3972	and	0	None
3972	3973	phytosterols	0	None
3973	3974	(	0	None
3974	3975	22	0	None
3975	3976	.	0	None
3976	3977	1±3	0	None
3977	3978	.	0	None
3978	3979	9mg	0	None
3979	3980	/	0	None
3980	3981	100g	0	None
3981	3982	)	0	None
3982	3983	.	0	None

3984	3985	Spondias	0	None
3985	3986	pinnata	0	None
3986	3987	(	0	None
3987	3988	L	0	None
3988	3989	.	0	None

3990	3991	f	0	None
3991	3992	.	0	None

3993	3994	)	0	None
3994	3995	Kurz	0	None
3995	3996	was	0	None
3996	3997	high	0	None
3997	3998	in	0	None
3998	3999	total	0	None
3999	4000	phenolics	0	None
4000	4001	(	0	None
4001	4002	3178±887mGAE	0	None
4002	4003	/	0	None
4003	4004	100g	0	None
4004	4005	)	0	None
4005	4006	and	0	None
4006	4007	antioxidant	0	None
4007	4008	activity	0	None
4008	4009	.	0	None

4010	4011	Moreover	0	None
4011	4012	,	0	None
4012	4013	high	0	None
4013	4014	correlations	0	None
4014	4015	were	0	None
4015	4016	found	0	None
4016	4017	between	0	None
4017	4018	TP	1	GENE-Y
4018	4019	and	0	None
4019	4020	antioxidant	0	None
4020	4021	activities	0	None
4021	4022	(	0	None
4022	4023	r>0	0	None
4023	4024	.	0	None
4024	4025	9	0	None
4025	4026	)	0	None
4026	4027	.	0	None

4028	4029	These	0	None
4029	4030	Thai	0	None
4030	4031	indigenous	0	None
4031	4032	fruits	0	None
4032	4033	are	0	None
4033	4034	potentially	0	None
4034	4035	good	0	None
4035	4036	sources	0	None
4036	4037	of	0	None
4037	4038	nutrients	0	None
4038	4039	,	0	None
4039	4040	bioactive	0	None
4040	4041	compounds	0	None
4041	4042	,	0	None
4042	4043	and	0	None
4043	4044	antioxidant	0	None
4044	4045	activities	0	None
4045	4046	.	0	None

4047	4048	Conservation	0	None
4048	4049	and	0	None
4049	4050	utilisation	0	None
4050	4051	should	0	None
4051	4052	be	0	None
4052	4053	promoted	0	None
4053	4054	for	0	None
4054	4055	food	0	None
4055	4056	security	0	None
4056	4057	and	0	None
4057	4058	consumption	0	None
4058	4059	as	0	None
4059	4060	part	0	None
4060	4061	of	0	None
4061	4062	a	0	None
4062	4063	healthy	0	None
4063	4064	diet	0	None
4064	4065	.	0	None
4065	4066	We	0	None
4066	4067	report	0	None
4067	4068	the	0	None
4068	4069	cloning	0	None
4069	4070	and	0	None
4070	4071	characterization	0	None
4071	4072	of	0	None
4072	4073	a	0	None
4073	4074	novel	0	None
4074	4076	serotonin receptor	1	GENE-Y
4076	4077	,	0	None
4077	4078	designated	0	None
4078	4079	as	0	None
4079	4080	5-HT7	0	None
4080	4081	,	0	None
4081	4082	which	0	None
4082	4083	is	0	None
4083	4084	coupled	0	None
4084	4085	to	0	None
4085	4086	the	0	None
4086	4087	stimulation	0	None
4087	4088	of	0	None
4088	4090	adenylyl cyclase	3	GENE-N
4090	4091	.	0	None

4092	4093	5-HT7	0	None
4093	4094	mRNA	0	None
4094	4095	is	0	None
4095	4096	expressed	0	None
4096	4097	discretely	0	None
4097	4098	throughout	0	None
4098	4099	the	0	None
4099	4100	CNS	0	None
4100	4101	,	0	None
4101	4102	predominantly	0	None
4102	4103	in	0	None
4103	4104	the	0	None
4104	4105	thalamus	0	None
4105	4106	and	0	None
4106	4107	hypothalamus	0	None
4107	4108	.	0	None

4109	4110	5-HT7	0	None
4110	4111	has	0	None
4111	4112	a	0	None
4112	4113	unique	0	None
4113	4114	pharmacological	0	None
4114	4115	profile	0	None
4115	4116	that	0	None
4116	4117	redefines	0	None
4117	4118	agonist	0	None
4118	4119	and	0	None
4119	4120	antagonist	0	None
4120	4121	classification	0	None
4121	4122	of	0	None
4122	4123	ligands	0	None
4123	4124	previously	0	None
4124	4125	thought	0	None
4125	4126	to	0	None
4126	4127	be	0	None
4127	4128	"selective	0	None
4128	4129	.	0	None

4130	4131	"	0	None
4131	4132	The	0	None
4132	4133	circadian	0	None
4133	4134	phase	0	None
4134	4135	of	0	None
4135	4136	spontaneous	0	None
4136	4137	neuronal	0	None
4137	4138	activity	0	None
4138	4139	of	0	None
4139	4140	the	0	None
4140	4141	rat	0	None
4141	4142	suprachiasmatic	0	None
4142	4143	nucleus	0	None
4143	4144	of	0	None
4144	4145	the	0	None
4145	4146	hypothalamus	0	None
4146	4147	advances	0	None
4147	4148	in	0	None
4148	4149	response	0	None
4149	4150	to	0	None
4150	4151	serotonin	0	None
4151	4152	ligands	0	None
4152	4153	with	0	None
4153	4154	a	0	None
4154	4155	pharmacological	0	None
4155	4156	profile	0	None
4156	4157	consistent	0	None
4157	4158	exclusively	0	None
4158	4159	with	0	None
4159	4160	that	0	None
4160	4161	of	0	None
4161	4162	5-HT7	0	None
4162	4163	.	0	None

4164	4165	These	0	None
4165	4166	findings	0	None
4166	4167	suggest	0	None
4167	4168	a	0	None
4168	4169	physiological	0	None
4169	4170	role	0	None
4170	4171	in	0	None
4171	4172	the	0	None
4172	4173	regulation	0	None
4173	4174	of	0	None
4174	4175	circadian	0	None
4175	4176	rhythms	0	None
4176	4177	for	0	None
4177	4178	one	0	None
4178	4179	subtype	0	None
4179	4180	of	0	None
4180	4181	serotonin	0	None
4181	4182	receptor	0	None
4182	4183	,	0	None
4183	4184	5-HT7	0	None
4184	4185	,	0	None
4185	4186	and	0	None
4186	4187	provide	0	None
4187	4188	a	0	None
4188	4189	pharmacological	0	None
4189	4190	test	0	None
4190	4191	to	0	None
4191	4192	evaluate	0	None
4192	4193	its	0	None
4193	4194	role	0	None
4194	4195	in	0	None
4195	4196	other	0	None
4196	4197	neuronal	0	None
4197	4198	systems	0	None
4198	4199	.	0	None
4199	4200	Axitinib	0	None
4200	4201	in	0	None
4201	4202	metastatic	0	None
4202	4203	renal	0	None
4203	4204	cell	0	None
4204	4205	carcinoma	0	None
4205	4206	:	0	None
4206	4207	results	0	None
4207	4208	of	0	None
4208	4209	a	0	None
4209	4210	pharmacokinetic	0	None
4210	4211	and	0	None
4211	4212	pharmacodynamic	0	None
4212	4213	analysis	0	None
4213	4214	.	0	None
4214	4215	Reconstitution	0	None
4215	4216	into	0	None
4216	4217	liposomes	0	None
4217	4218	of	0	None
4218	4219	the	0	None
4219	4220	glutamine	0	None
4220	4221	/	0	None
4221	4223	amino acid	2	CHEMICAL
4223	4224	transporter	0	None
4224	4225	from	0	None
4225	4226	renal	0	None
4226	4227	cell	0	None
4227	4228	plasma	0	None
4228	4229	membrane	0	None
4229	4230	:	0	None
4230	4231	functional	0	None
4231	4232	characterization	0	None
4232	4233	,	0	None
4233	4234	kinetics	0	None
4234	4235	and	0	None
4235	4236	activation	0	None
4236	4237	by	0	None
4237	4238	nucleotides	0	None
4238	4239	.	0	None
4239	4240	Concentration-effect	0	None
4240	4241	relationship	0	None
4241	4242	of	0	None
4242	4243	the	0	None
4243	4244	positive	0	None
4244	4245	chronotropic	0	None
4245	4246	and	0	None
4246	4247	hypokalaemic	0	None
4247	4248	effects	0	None
4248	4249	of	0	None
4249	4250	fenoterol	2	CHEMICAL
4250	4251	in	0	None
4251	4252	healthy	0	None
4252	4253	women	0	None
4253	4254	of	0	None
4254	4255	childbearing	0	None
4255	4256	age	0	None
4256	4257	.	0	None
4257	4258	Non-enzymatic	0	None
4258	4259	interactions	0	None
4259	4260	of	0	None
4260	4261	glyoxylate	2	CHEMICAL
4261	4262	with	0	None
4262	4263	lysine	0	None
4263	4264	,	0	None
4264	4265	arginine	2	CHEMICAL
4265	4266	,	0	None
4266	4267	and	0	None
4267	4268	glucosamine	0	None
4268	4269	:	0	None
4269	4270	a	0	None
4270	4271	study	0	None
4271	4272	of	0	None
4272	4273	advanced	0	None
4273	4274	non-enzymatic	0	None
4274	4275	glycation	0	None
4275	4276	like	0	None
4276	4277	compounds	0	None
4277	4278	.	0	None
4278	4279	Osteoblasts	0	None
4279	4280	survive	0	None
4280	4281	the	0	None
4281	4283	arsenic trioxide	2	CHEMICAL
4283	4284	treatment	0	None
4284	4285	by	0	None
4285	4286	activation	0	None
4286	4287	of	0	None
4287	4288	ATM-mediated	0	None
4288	4289	pathway	0	None
4289	4290	.	0	None
4290	4291	Cloning	0	None
4291	4292	of	0	None
4292	4293	another	0	None
4293	4294	human	0	None
4294	4296	serotonin receptor	1	GENE-Y
4296	4297	(	0	None
4297	4298	5-HT1F	0	None
4298	4299	)	0	None
4299	4300	:	0	None
4300	4301	a	0	None
4301	4302	fifth	0	None
4302	4303	5-HT1	0	None
4303	4304	receptor	0	None
4304	4305	subtype	0	None
4305	4306	coupled	0	None
4306	4307	to	0	None
4307	4308	the	0	None
4308	4309	inhibition	0	None
4309	4310	of	0	None
4310	4312	adenylate cyclase	3	GENE-N
4312	4313	.	0	None
4313	4314	Organic	0	None
4314	4315	Solvent-Based	0	None
4315	4316	Graphene	0	None
4316	4317	Oxide	0	None
4317	4318	Liquid	0	None
4318	4319	Crystals	0	None
4319	4320	:	0	None
4320	4321	A	0	None
4321	4322	Facile	0	None
4322	4323	Route	0	None
4323	4324	toward	0	None
4324	4325	the	0	None
4325	4326	Next	0	None
4326	4327	Generation	0	None
4327	4328	of	0	None
4328	4329	Self-Assembled	0	None
4329	4330	Layer-by-Layer	0	None
4330	4331	Multifunctional	0	None
4331	4332	3D	0	None
4332	4333	Architectures	0	None
4333	4334	.	0	None
4334	4335	RATIONALE	0	None
4335	4336	:	0	None
4336	4337	A	0	None
4337	4338	common	0	None
4338	4339	polymorphism	0	None
4339	4340	(	0	None
4340	4341	5HTTLPR	3	GENE-N
4341	4342	)	0	None
4342	4343	within	0	None
4343	4344	the	0	None
4344	4345	promoter	0	None
4345	4346	region	0	None
4346	4347	of	0	None
4347	4348	the	0	None
4348	4350	serotonin transporter	1	GENE-Y
4350	4351	gene	0	None
4351	4352	(	0	None
4352	4353	LSC6A4	0	None
4353	4354	)	0	None
4354	4355	has	0	None
4355	4356	been	0	None
4356	4357	shown	0	None
4357	4358	to	0	None
4358	4359	influence	0	None
4359	4360	response	0	None
4360	4361	time	0	None
4361	4362	as	0	None
4362	4363	well	0	None
4363	4364	as	0	None
4364	4365	overall	0	None
4365	4366	response	0	None
4366	4367	to	0	None
4367	4368	selective	0	None
4368	4369	serotonin	0	None
4369	4370	reuptake	0	None
4370	4371	inhibitors	0	None
4371	4372	(	0	None
4372	4373	SSRIs	0	None
4373	4374	)	0	None
4374	4375	in	0	None
4375	4376	subjects	0	None
4376	4377	with	0	None
4377	4378	major	0	None
4378	4379	depressive	0	None
4379	4380	disorder	0	None
4380	4381	.	0	None

4382	4383	We	0	None
4383	4384	hypothesized	0	None
4384	4385	that	0	None
4385	4386	a	0	None
4386	4387	similar	0	None
4387	4388	effect	0	None
4388	4389	in	0	None
4389	4390	response	0	None
4390	4391	time	0	None
4391	4392	to	0	None
4392	4393	sertraline	2	CHEMICAL
4393	4394	would	0	None
4394	4395	be	0	None
4395	4396	observed	0	None
4396	4397	and	0	None
4397	4398	that	0	None
4398	4399	no	0	None
4399	4400	effect	0	None
4400	4401	on	0	None
4401	4402	response	0	None
4402	4403	time	0	None
4403	4404	would	0	None
4404	4405	be	0	None
4405	4406	seen	0	None
4406	4407	in	0	None
4407	4408	a	0	None
4408	4409	placebo	0	None
4409	4410	arm	0	None
4410	4411	.	0	None

4412	4413	OBJECTIVES	0	None
4413	4414	:	0	None
4414	4415	We	0	None
4415	4416	tested	0	None
4416	4417	the	0	None
4417	4418	hypothesis	0	None
4418	4419	that	0	None
4419	4420	subjects	0	None
4420	4421	homozygous	0	None
4421	4422	for	0	None
4422	4423	the	0	None
4423	4424	long	0	None
4424	4425	allele	0	None
4425	4426	at	0	None
4426	4427	the	0	None
4427	4428	5HTTLPR	3	GENE-N
4428	4429	polymorphism	0	None
4429	4430	would	0	None
4430	4431	respond	0	None
4431	4432	more	0	None
4432	4433	rapidly	0	None
4433	4434	to	0	None
4434	4435	sertraline	2	CHEMICAL
4435	4436	than	0	None
4436	4437	subjects	0	None
4437	4438	carrying	0	None
4438	4439	one	0	None
4439	4440	or	0	None
4440	4441	two	0	None
4441	4442	copies	0	None
4442	4443	of	0	None
4443	4444	the	0	None
4444	4445	short	0	None
4445	4446	allele	0	None
4446	4447	.	0	None

4448	4449	METHODS	0	None
4449	4450	:	0	None
4450	4451	HAM-D	0	None
4451	4452	and	0	None
4452	4453	CGI-I	0	None
4453	4454	responses	0	None
4454	4455	to	0	None
4455	4456	sertraline	2	CHEMICAL
4456	4457	and	0	None
4457	4458	placebo	0	None
4458	4459	were	0	None
4459	4460	measured	0	None
4460	4461	weekly	0	None
4461	4462	in	0	None
4462	4463	the	0	None
4463	4464	context	0	None
4464	4465	of	0	None
4465	4466	an	0	None
4466	4467	8-week	0	None
4467	4468	,	0	None
4468	4469	placebo-controlled	0	None
4469	4470	study	0	None
4470	4471	in	0	None
4471	4472	elderly	0	None
4472	4473	depressed	0	None
4473	4474	subjects	0	None
4474	4475	.	0	None

4476	4477	Genotyping	0	None
4477	4478	of	0	None
4478	4479	the	0	None
4479	4480	5HTTLPR	3	GENE-N
4480	4481	polymorphism	0	None
4481	4482	was	0	None
4482	4483	performed	0	None
4483	4484	to	0	None
4484	4485	test	0	None
4485	4486	for	0	None
4486	4487	correlations	0	None
4487	4488	with	0	None
4488	4489	response	0	None
4489	4490	at	0	None
4490	4491	each	0	None
4491	4492	week	0	None
4492	4493	in	0	None
4493	4494	the	0	None
4494	4495	sertraline	2	CHEMICAL
4495	4496	and	0	None
4496	4497	placebo	0	None
4497	4498	groups	0	None
4498	4499	(	0	None
4499	4500	n	0	None
4500	4501	=	0	None
4501	4502	206	0	None
4502	4503	)	0	None
4503	4504	.	0	None

4505	4506	RESULTS	0	None
4506	4507	:	0	None
4507	4508	Subjects	0	None
4508	4509	homozygous	0	None
4509	4510	for	0	None
4510	4511	the	0	None
4511	4512	long	0	None
4512	4513	allele	0	None
4513	4514	of	0	None
4514	4515	5HTTLPR	3	GENE-N
4515	4516	showed	0	None
4516	4517	a	0	None
4517	4518	significant	0	None
4518	4519	increase	0	None
4519	4520	in	0	None
4520	4521	response	0	None
4521	4522	at	0	None
4522	4523	week	0	None
4523	4524	1	0	None
4524	4525	and	0	None
4525	4526	week	0	None
4526	4527	2	0	None
4527	4528	,	0	None
4528	4529	as	0	None
4529	4530	assessed	0	None
4530	4531	by	0	None
4531	4532	the	0	None
4532	4533	CGI-I	0	None
4533	4534	scale	0	None
4534	4535	compared	0	None
4535	4536	with	0	None
4536	4537	subjects	0	None
4537	4538	carrying	0	None
4538	4539	one	0	None
4539	4540	or	0	None
4540	4541	two	0	None
4541	4542	copies	0	None
4542	4543	of	0	None
4543	4544	the	0	None
4544	4545	short	0	None
4545	4546	allele	0	None
4546	4547	(	0	None
4547	4548	P	0	None
4548	4549	=	0	None
4549	4550	0	0	None
4550	4551	.	0	None
4551	4552	01	0	None
4552	4553	at	0	None
4553	4554	both	0	None
4554	4555	weeks	0	None
4555	4556	)	0	None
4556	4557	.	0	None

4558	4559	No	0	None
4559	4560	significant	0	None
4560	4561	difference	0	None
4561	4562	was	0	None
4562	4563	observed	0	None
4563	4564	in	0	None
4564	4565	the	0	None
4565	4566	placebo	0	None
4566	4567	group	0	None
4567	4568	.	0	None

4569	4570	CONCLUSIONS	0	None
4570	4571	:	0	None
4571	4572	These	0	None
4572	4573	results	0	None
4573	4574	suggest	0	None
4574	4575	that	0	None
4575	4576	genetic	0	None
4576	4577	variation	0	None
4577	4578	in	0	None
4578	4579	the	0	None
4579	4581	serotonin transporter	1	GENE-Y
4581	4582	gene	0	None
4582	4583	effects	0	None
4583	4584	the	0	None
4584	4585	response	0	None
4585	4586	time	0	None
4586	4587	to	0	None
4587	4588	sertraline	2	CHEMICAL
4588	4589	and	0	None
4589	4590	provides	0	None
4590	4591	complementing	0	None
4591	4592	evidence	0	None
4592	4593	to	0	None
4593	4594	previous	0	None
4594	4595	reports	0	None
4595	4596	that	0	None
4596	4597	this	0	None
4597	4598	polymorphism	0	None
4598	4599	affects	0	None
4599	4600	response	0	None
4600	4601	time	0	None
4601	4602	to	0	None
4602	4603	other	0	None
4603	4604	SSRIs	0	None
4604	4605	.	0	None
4605	4606	A	0	None
4606	4607	large	0	None
4607	4608	amount	0	None
4608	4609	of	0	None
4609	4610	the	0	None
4610	4611	data	0	None
4611	4612	gathered	0	None
4612	4613	in	0	None
4613	4614	the	0	None
4614	4615	last	0	None
4615	4616	50	0	None
4616	4617	years	0	None
4617	4618	support	0	None
4618	4619	the	0	None
4619	4620	hypothesis	0	None
4620	4621	that	0	None
4621	4622	alterations	0	None
4622	4623	of	0	None
4623	4624	the	0	None
4624	4625	serotonin	0	None
4625	4626	(	0	None
4626	4627	5-HT	0	None
4627	4628	)	0	None
4628	4629	neurotransmission	0	None
4629	4630	play	0	None
4630	4631	a	0	None
4631	4632	crucial	0	None
4632	4633	role	0	None
4633	4634	in	0	None
4634	4635	the	0	None
4635	4636	pathophysiology	0	None
4636	4637	of	0	None
4637	4638	not	0	None
4638	4639	only	0	None
4639	4640	major	0	None
4640	4641	depression	0	None
4641	4642	(	0	None
4642	4643	MD	0	None
4643	4644	)	0	None
4644	4645	,	0	None
4645	4646	but	0	None
4646	4647	also	0	None
4647	4648	of	0	None
4648	4649	different	0	None
4649	4650	neuropsychiatric	0	None
4650	4651	disorders	0	None
4651	4652	.	0	None

4653	4654	Research	0	None
4654	4655	in	0	None
4655	4656	this	0	None
4656	4657	field	0	None
4657	4658	has	0	None
4658	4659	been	0	None
4659	4660	substantially	0	None
4660	4661	promoted	0	None
4661	4662	by	0	None
4662	4663	the	0	None
4663	4664	evidence	0	None
4664	4665	that	0	None
4665	4666	the	0	None
4666	4667	reuptake	0	None
4667	4668	protein	0	None
4668	4669	(	0	None
4669	4670	SERT	0	None
4670	4671	)	0	None
4671	4672	,	0	None
4672	4673	present	0	None
4673	4674	in	0	None
4674	4675	presynaptic	0	None
4675	4676	neurons	0	None
4676	4677	,	0	None
4677	4678	is	0	None
4678	4679	a	0	None
4679	4680	key	0	None
4680	4681	element	0	None
4681	4682	in	0	None
4682	4683	terminating	0	None
4683	4684	the	0	None
4684	4685	activity	0	None
4685	4686	of	0	None
4686	4687	the	0	None
4687	4688	neurotransmitter	0	None
4688	4689	in	0	None
4689	4690	the	0	None
4690	4691	synaptic	0	None
4691	4692	cleft	0	None
4692	4693	.	0	None

4694	4695	For	0	None
4695	4696	this	0	None
4696	4697	reason	0	None
4697	4698	,	0	None
4698	4699	it	0	None
4699	4700	was	0	None
4700	4701	specifically	0	None
4701	4702	targeted	0	None
4702	4703	for	0	None
4703	4704	the	0	None
4704	4705	development	0	None
4705	4706	of	0	None
4706	4707	second-generation	0	None
4707	4708	antidepressants	0	None
4708	4709	,	0	None
4709	4710	in	0	None
4710	4711	particular	0	None
4711	4712	of	0	None
4712	4713	selective	0	None
4713	4714	5-HT	0	None
4714	4715	reuptake	0	None
4715	4716	inhibitors	0	None
4716	4717	(	0	None
4717	4718	SSRIs	0	None
4718	4719	)	0	None
4719	4720	,	0	None
4720	4721	with	0	None
4721	4722	the	0	None
4722	4723	aim	0	None
4723	4724	of	0	None
4724	4725	increasing	0	None
4725	4726	the	0	None
4726	4727	intrasynaptic	0	None
4727	4728	5-HT	0	None
4728	4729	concentrations	0	None
4729	4730	.	0	None

4731	4732	Moreover	0	None
4732	4733	,	0	None
4733	4734	since	0	None
4734	4735	a	0	None
4735	4736	lot	0	None
4736	4737	of	0	None
4737	4738	studies	0	None
4738	4739	showed	0	None
4739	4740	that	0	None
4740	4741	circulating	0	None
4741	4742	platelets	0	None
4742	4743	and	0	None
4743	4744	,	0	None
4744	4745	more	0	None
4745	4746	recently	0	None
4746	4747	,	0	None
4747	4748	lymphocytes	0	None
4748	4749	possess	0	None
4749	4750	functional	0	None
4750	4751	SERT	0	None
4751	4752	proteins	0	None
4752	4753	,	0	None
4753	4754	they	0	None
4754	4755	have	0	None
4755	4756	been	0	None
4756	4757	widely	0	None
4757	4758	used	0	None
4758	4759	as	0	None
4759	4760	peripheral	0	None
4760	4761	mirrors	0	None
4761	4762	of	0	None
4762	4763	the	0	None
4763	4764	same	0	None
4764	4765	structures	0	None
4765	4766	located	0	None
4766	4767	in	0	None
4767	4768	the	0	None
4768	4769	central	0	None
4769	4770	nervous	0	None
4770	4771	system	0	None
4771	4772	.	0	None

4773	4774	The	0	None
4774	4775	presence	0	None
4775	4776	of	0	None
4776	4777	functional	0	None
4777	4778	SERT	0	None
4778	4779	in	0	None
4779	4780	blood	0	None
4780	4781	cells	0	None
4781	4782	suggests	0	None
4782	4783	strict	0	None
4783	4784	relationships	0	None
4784	4785	between	0	None
4785	4786	the	0	None
4786	4787	nervous	0	None
4787	4788	and	0	None
4788	4789	the	0	None
4789	4790	immune	0	None
4790	4791	system	0	None
4791	4792	that	0	None
4792	4793	need	0	None
4793	4794	to	0	None
4794	4795	be	0	None
4795	4796	better	0	None
4796	4797	clarified	0	None
4797	4798	in	0	None
4798	4799	MD	0	None
4799	4800	,	0	None
4800	4801	as	0	None
4801	4802	well	0	None
4802	4803	as	0	None
4803	4804	the	0	None
4804	4805	possibility	0	None
4805	4806	of	0	None
4806	4807	reciprocal	0	None
4807	4808	modulation	0	None
4808	4809	of	0	None
4809	4810	the	0	None
4810	4811	two	0	None
4811	4812	systems	0	None
4812	4813	by	0	None
4813	4814	different	0	None
4814	4815	drugs	0	None
4815	4816	.	0	None

4817	4818	This	0	None
4818	4819	paper	0	None
4819	4820	aims	0	None
4820	4821	to	0	None
4821	4822	review	0	None
4822	4823	briefly	0	None
4823	4824	the	0	None
4824	4825	literature	0	None
4825	4826	on	0	None
4826	4827	the	0	None
4827	4828	5-HT	0	None
4828	4829	hypothesis	0	None
4829	4830	of	0	None
4830	4831	depression	0	None
4831	4832	with	0	None
4832	4833	a	0	None
4833	4834	major	0	None
4834	4835	focus	0	None
4835	4836	on	0	None
4836	4837	the	0	None
4837	4838	possible	0	None
4838	4839	role	0	None
4839	4840	of	0	None
4840	4841	SERT	0	None
4841	4842	in	0	None
4842	4843	this	0	None
4843	4844	disorder	0	None
4844	4845	,	0	None
4845	4846	while	0	None
4846	4847	highlighting	0	None
4847	4848	how	0	None
4848	4849	recent	0	None
4849	4850	data	0	None
4850	4851	are	0	None
4851	4852	more	0	None
4852	4853	oriented	0	None
4853	4854	on	0	None
4854	4855	dimensional	0	None
4855	4856	rather	0	None
4856	4857	than	0	None
4857	4858	nosological	0	None
4858	4859	involvement	0	None
4859	4860	of	0	None
4860	4861	this	0	None
4861	4862	structure	0	None
4862	4863	in	0	None
4863	4864	different	0	None
4864	4865	conditions	0	None
4865	4866	spanning	0	None
4866	4867	from	0	None
4867	4868	normality	0	None
4868	4869	to	0	None
4869	4870	pathology	0	None
4870	4871	.	0	None
4871	4872	Beta-adrenoceptor	3	GENE-N
4872	4873	antagonists	0	None
4873	4874	(	0	None
4874	4875	"beta-blockers"	0	None
4875	4876	)	0	None
4876	4877	are	0	None
4877	4878	one	0	None
4878	4879	of	0	None
4879	4880	the	0	None
4880	4881	most	0	None
4881	4882	widely	0	None
4882	4883	used	0	None
4883	4884	classes	0	None
4884	4885	of	0	None
4885	4886	drugs	0	None
4886	4887	in	0	None
4887	4888	cardiovascular	0	None
4888	4889	medicine	0	None
4889	4890	(	0	None
4890	4891	hypertension	0	None
4891	4892	,	0	None
4892	4893	ischaemic	0	None
4893	4894	heart	0	None
4894	4895	disease	0	None
4895	4896	and	0	None
4896	4897	increasingly	0	None
4897	4898	in	0	None
4898	4899	heart	0	None
4899	4900	failure	0	None
4900	4901	)	0	None
4901	4902	as	0	None
4902	4903	well	0	None
4903	4904	as	0	None
4904	4905	in	0	None
4905	4906	the	0	None
4906	4907	management	0	None
4907	4908	of	0	None
4908	4909	anxiety	0	None
4909	4910	,	0	None
4910	4911	migraine	0	None
4911	4912	and	0	None
4912	4913	glaucoma	0	None
4913	4914	.	0	None

4915	4916	Where	0	None
4916	4917	known	0	None
4917	4918	,	0	None
4918	4919	the	0	None
4919	4920	mode	0	None
4920	4921	of	0	None
4921	4922	action	0	None
4922	4923	in	0	None
4923	4924	cardiovascular	0	None
4924	4925	disease	0	None
4925	4926	is	0	None
4926	4927	from	0	None
4927	4928	antagonism	0	None
4928	4929	of	0	None
4929	4930	endogenous	0	None
4930	4931	catecholamine	0	None
4931	4932	responses	0	None
4932	4933	in	0	None
4933	4934	the	0	None
4934	4935	heart	0	None
4935	4936	(	0	None
4936	4937	mainly	0	None
4937	4938	at	0	None
4938	4939	beta1-adrenoceptors	0	None
4939	4940	)	0	None
4940	4941	,	0	None
4941	4942	while	0	None
4942	4943	the	0	None
4943	4944	worrisome	0	None
4944	4945	side	0	None
4945	4946	effects	0	None
4946	4947	of	0	None
4947	4948	bronchospasm	0	None
4948	4949	result	0	None
4949	4950	from	0	None
4950	4951	airway	0	None
4951	4952	beta2-adrenoceptor	0	None
4952	4953	blockade	0	None
4953	4954	.	0	None

4955	4956	The	0	None
4956	4957	aim	0	None
4957	4958	of	0	None
4958	4959	this	0	None
4959	4960	study	0	None
4960	4961	was	0	None
4961	4962	to	0	None
4962	4963	determine	0	None
4963	4964	the	0	None
4964	4965	selectivity	0	None
4965	4966	of	0	None
4966	4967	beta-antagonists	0	None
4967	4968	for	0	None
4968	4969	the	0	None
4969	4970	human	0	None
4970	4971	beta-adrenoceptor	3	GENE-N
4971	4972	subtypes	0	None
4972	4973	.	0	None

4974	4975	(	0	None
4975	4976	3	0	None
4976	4977	)	0	None
4977	4978	H-CGP	0	None
4978	4979	12177	0	None
4979	4980	whole	0	None
4980	4981	cell-binding	0	None
4981	4982	studies	0	None
4982	4983	were	0	None
4983	4984	undertaken	0	None
4984	4985	in	0	None
4985	4986	CHO	0	None
4986	4987	cell	0	None
4987	4988	lines	0	None
4988	4989	stably	0	None
4989	4990	expressing	0	None
4990	4991	either	0	None
4991	4992	the	0	None
4992	4993	human	0	None
4993	4994	beta1-	0	None
4994	4995	,	0	None
4995	4996	beta2-	0	None
4996	4997	or	0	None
4997	4998	the	0	None
4998	4999	beta3-adrenoceptor	0	None
4999	5000	in	0	None
5000	5001	order	0	None
5001	5002	to	0	None
5002	5003	determine	0	None
5003	5004	the	0	None
5004	5005	affinity	0	None
5005	5006	of	0	None
5006	5007	ligands	0	None
5007	5008	for	0	None
5008	5009	each	0	None
5009	5010	receptor	0	None
5010	5011	subtype	0	None
5011	5012	in	0	None
5012	5013	the	0	None
5013	5014	same	0	None
5014	5015	cell	0	None
5015	5016	background	0	None
5016	5017	.	0	None

5018	5019	In	0	None
5019	5020	this	0	None
5020	5021	study	0	None
5021	5022	,	0	None
5022	5023	the	0	None
5023	5024	selectivity	0	None
5024	5025	of	0	None
5025	5026	well-known	0	None
5026	5027	subtype-selective	0	None
5027	5028	ligands	0	None
5028	5029	was	0	None
5029	5030	clearly	0	None
5030	5031	demonstrated	0	None
5031	5032	:	0	None
5032	5033	thus	0	None
5033	5034	,	0	None
5034	5035	the	0	None
5035	5036	selective	0	None
5036	5037	beta1	0	None
5037	5038	antagonist	0	None
5038	5039	CGP	0	None
5039	5040	20712A	0	None
5040	5041	was	0	None
5041	5042	501-fold	0	None
5042	5043	selective	0	None
5043	5044	over	0	None
5044	5045	beta2	0	None
5045	5046	and	0	None
5046	5047	4169-fold	0	None
5047	5048	selective	0	None
5048	5049	over	0	None
5049	5050	beta3;	0	None
5050	5051	the	0	None
5051	5052	beta2-selective	0	None
5052	5053	antagonist	0	None
5053	5054	ICI	0	None
5054	5055	118551	0	None
5055	5056	was	0	None
5056	5057	550-	0	None
5057	5058	and	0	None
5058	5059	661-fold	0	None
5059	5060	selective	0	None
5060	5061	over	0	None
5061	5062	beta1	0	None
5062	5063	and	0	None
5063	5064	beta3	0	None
5064	5065	,	0	None
5065	5066	respectively	0	None
5066	5067	,	0	None
5067	5068	and	0	None
5068	5069	the	0	None
5069	5070	selective	0	None
5070	5071	beta3	0	None
5071	5072	compound	0	None
5072	5073	CL	0	None
5073	5074	316243	0	None
5074	5075	was	0	None
5075	5076	10-fold	0	None
5076	5077	selective	0	None
5077	5078	over	0	None
5078	5079	beta2	0	None
5079	5080	and	0	None
5080	5081	more	0	None
5081	5082	than	0	None
5082	5083	129-fold	0	None
5083	5084	selective	0	None
5084	5085	over	0	None
5085	5086	beta1	0	None
5086	5087	.	0	None

5088	5089	Those	0	None
5089	5090	beta2-adrenoceptor	0	None
5090	5091	agonists	0	None
5091	5092	used	0	None
5092	5093	clinically	0	None
5093	5094	for	0	None
5094	5095	the	0	None
5095	5096	treatment	0	None
5096	5097	of	0	None
5097	5098	asthma	0	None
5098	5099	and	0	None
5099	5100	COPD	0	None
5100	5101	were	0	None
5101	5102	beta2	0	None
5102	5103	selective	0	None
5103	5104	:	0	None
5104	5105	29-	0	None
5105	5106	,	0	None
5106	5107	61-	0	None
5107	5108	and	0	None
5108	5109	2818-fold	0	None
5109	5110	for	0	None
5110	5111	salbutamol	0	None
5111	5112	,	0	None
5112	5113	terbutaline	0	None
5113	5114	and	0	None
5114	5115	salmeterol	0	None
5115	5116	over	0	None
5116	5117	beta1	0	None
5117	5118	,	0	None
5118	5119	respectively	0	None
5119	5120	.	0	None

5121	5122	There	0	None
5122	5123	was	0	None
5123	5124	little	0	None
5124	5125	difference	0	None
5125	5126	in	0	None
5126	5127	the	0	None
5127	5128	affinity	0	None
5128	5129	of	0	None
5129	5130	these	0	None
5130	5131	ligands	0	None
5131	5132	between	0	None
5132	5133	beta1	0	None
5133	5134	and	0	None
5134	5135	beta3	0	None
5135	5136	adrenoceptors	3	GENE-N
5136	5137	.	0	None

5138	5139	The	0	None
5139	5140	clinically	0	None
5140	5141	used	0	None
5141	5142	beta-antagonists	0	None
5142	5143	studied	0	None
5143	5144	ranged	0	None
5144	5145	from	0	None
5145	5146	bisoprolol	0	None
5146	5147	(	0	None
5147	5148	14-fold	0	None
5148	5149	beta1-selective	0	None
5149	5150	)	0	None
5150	5151	to	0	None
5151	5152	timolol	0	None
5152	5153	(	0	None
5153	5154	26-fold	0	None
5154	5155	beta2-selective	0	None
5155	5156	)	0	None
5156	5157	.	0	None

5158	5159	However	0	None
5159	5160	,	0	None
5160	5161	the	0	None
5161	5162	majority	0	None
5162	5163	showed	0	None
5163	5164	little	0	None
5164	5165	selectivity	0	None
5165	5166	for	0	None
5166	5167	the	0	None
5167	5168	beta1-	0	None
5168	5169	over	0	None
5169	5170	the	0	None
5170	5171	beta2-adrenoceptor	0	None
5171	5172	,	0	None
5172	5173	with	0	None
5173	5174	many	0	None
5174	5175	actually	0	None
5175	5176	being	0	None
5176	5177	more	0	None
5177	5178	beta2-selective	0	None
5178	5179	.	0	None

5180	5181	This	0	None
5181	5182	study	0	None
5182	5183	shows	0	None
5183	5184	that	0	None
5184	5185	the	0	None
5185	5186	beta1	0	None
5186	5187	/	0	None
5187	5188	beta2	0	None
5188	5189	selectivity	0	None
5189	5190	of	0	None
5190	5191	most	0	None
5191	5192	clinically	0	None
5192	5193	used	0	None
5193	5194	beta-blockers	0	None
5194	5195	is	0	None
5195	5196	poor	0	None
5196	5197	in	0	None
5197	5198	intact	0	None
5198	5199	cells	0	None
5199	5200	,	0	None
5200	5201	and	0	None
5201	5202	that	0	None
5202	5203	some	0	None
5203	5204	compounds	0	None
5204	5205	that	0	None
5205	5206	are	0	None
5206	5207	traditionally	0	None
5207	5208	classed	0	None
5208	5209	as	0	None
5209	5210	"beta1-selective"	0	None
5210	5211	actually	0	None
5211	5212	have	0	None
5212	5213	higher	0	None
5213	5214	affinity	0	None
5214	5215	for	0	None
5215	5216	the	0	None
5216	5217	beta2-adrenoceptor	0	None
5217	5218	.	0	None

5219	5220	There	0	None
5220	5221	is	0	None
5221	5222	therefore	0	None
5222	5223	considerable	0	None
5223	5224	potential	0	None
5224	5225	for	0	None
5225	5226	developing	0	None
5226	5227	more	0	None
5227	5228	selective	0	None
5228	5229	beta-antagonists	0	None
5229	5230	for	0	None
5230	5231	clinical	0	None
5231	5232	use	0	None
5232	5233	and	0	None
5233	5234	thereby	0	None
5234	5235	reducing	0	None
5235	5236	the	0	None
5236	5237	side-effect	0	None
5237	5238	profile	0	None
5238	5239	of	0	None
5239	5240	beta-blockers	0	None
5240	5241	.	0	None
5241	5242	Impact	0	None
5242	5243	of	0	None
5243	5244	glucose	0	None
5244	5245	infusion	0	None
5245	5246	on	0	None
5246	5247	the	0	None
5247	5248	structural	0	None
5248	5249	and	0	None
5249	5250	functional	0	None
5250	5251	characteristics	0	None
5251	5252	of	0	None
5252	5253	adipose	0	None
5253	5254	tissue	0	None
5254	5255	and	0	None
5255	5256	on	0	None
5256	5257	hypothalamic	0	None
5257	5258	gene	0	None
5258	5259	expression	0	None
5259	5260	for	0	None
5260	5261	appetite	0	None
5261	5262	regulatory	0	None
5262	5263	neuropeptides	0	None
5263	5264	in	0	None
5264	5265	the	0	None
5265	5266	sheep	0	None
5266	5267	fetus	0	None
5267	5268	during	0	None
5268	5269	late	0	None
5269	5270	gestation	0	None
5270	5271	.	0	None
5271	5272	Buckwheat	0	None
5272	5273	(	0	None
5273	5274	Fagopyrum	0	None
5274	5275	esculentum	0	None
5275	5276	Moench	0	None
5276	5277	)	0	None
5277	5278	groats	0	None
5278	5279	contain	0	None
5279	5280	the	0	None
5280	5281	iminosugar	0	None
5281	5282	D-fagomine	0	None
5282	5283	as	0	None
5283	5284	a	0	None
5284	5285	minor	0	None
5285	5286	component	0	None
5286	5287	that	0	None
5287	5288	might	0	None
5288	5289	contribute	0	None
5289	5290	to	0	None
5290	5291	the	0	None
5291	5292	alleged	0	None
5292	5293	health	0	None
5293	5294	benefits	0	None
5294	5295	of	0	None
5295	5296	this	0	None
5296	5297	pseudo-cereal	0	None
5297	5298	.	0	None

5299	5300	This	0	None
5300	5301	study	0	None
5301	5302	presents	0	None
5302	5303	analysis	0	None
5303	5304	of	0	None
5304	5305	D-fagomine	0	None
5305	5306	in	0	None
5306	5307	buckwheat-based	0	None
5307	5308	foodstuffs	0	None
5308	5309	by	0	None
5309	5310	liquid	0	None
5310	5311	chromatography	0	None
5311	5312	coupled	0	None
5312	5313	to	0	None
5313	5314	mass	0	None
5314	5315	spectrometry	0	None
5315	5316	and	0	None
5316	5317	an	0	None
5317	5318	estimation	0	None
5318	5319	of	0	None
5319	5320	its	0	None
5320	5321	presence	0	None
5321	5322	in	0	None
5322	5323	the	0	None
5323	5324	human	0	None
5324	5325	diet	0	None
5325	5326	based	0	None
5326	5327	on	0	None
5327	5328	a	0	None
5328	5329	published	0	None
5329	5330	population-based	0	None
5330	5331	cross-sectional	0	None
5331	5332	nutrition	0	None
5332	5333	survey	0	None
5333	5334	.	0	None

5335	5336	D-fagomine	0	None
5336	5337	is	0	None
5337	5338	present	0	None
5338	5339	in	0	None
5339	5340	common	0	None
5340	5341	buckwheat-based	0	None
5341	5342	foodstuffs	0	None
5342	5343	in	0	None
5343	5344	amounts	0	None
5344	5345	ranging	0	None
5345	5346	from	0	None
5346	5347	1	0	None
5347	5348	to	0	None
5348	5349	25	0	None
5349	5350	mg	2	CHEMICAL
5350	5351	/	0	None
5351	5352	kg	0	None
5352	5353	or	0	None
5353	5354	mg	2	CHEMICAL
5354	5355	/	0	None
5355	5356	L	0	None
5356	5357	,	0	None
5357	5358	it	0	None
5358	5359	is	0	None
5359	5360	stable	0	None
5360	5361	during	0	None
5361	5362	boiling	0	None
5362	5363	,	0	None
5363	5364	baking	0	None
5364	5365	,	0	None
5365	5366	frying	0	None
5366	5367	and	0	None
5367	5368	fermentation	0	None
5368	5369	,	0	None
5369	5370	and	0	None
5370	5371	it	0	None
5371	5372	is	0	None
5372	5373	biosynthesised	0	None
5373	5374	upon	0	None
5374	5375	sprouting	0	None
5375	5376	.	0	None

5377	5378	The	0	None
5378	5379	estimated	0	None
5379	5380	total	0	None
5380	5381	intake	0	None
5381	5382	of	0	None
5382	5383	D-fagomine	0	None
5383	5384	resulting	0	None
5384	5385	from	0	None
5385	5386	a	0	None
5386	5387	diet	0	None
5387	5388	that	0	None
5388	5389	includes	0	None
5389	5390	such	0	None
5390	5391	foodstuffs	0	None
5391	5392	would	0	None
5392	5393	be	0	None
5393	5394	between	0	None
5394	5395	3	0	None
5395	5396	and	0	None
5396	5397	17	0	None
5397	5398	mg	2	CHEMICAL
5398	5399	per	0	None
5399	5400	day	0	None
5400	5401	(	0	None
5401	5402	mean	0	None
5402	5403	for	0	None
5403	5404	both	0	None
5404	5405	genders;	0	None
5405	5406	range	0	None
5406	5407	from	0	None
5407	5408	P5	0	None
5408	5409	to	0	None
5409	5410	P95	0	None
5410	5411	)	0	None
5411	5412	.	0	None

5413	5414	A	0	None
5414	5415	diet	0	None
5415	5416	rich	0	None
5416	5417	in	0	None
5417	5418	buckwheat	0	None
5418	5419	products	0	None
5419	5420	would	0	None
5420	5421	provide	0	None
5421	5422	a	0	None
5422	5423	daily	0	None
5423	5424	amount	0	None
5424	5425	of	0	None
5425	5426	D-fagomine	0	None
5426	5427	that	0	None
5427	5428	may	0	None
5428	5429	in	0	None
5429	5430	part	0	None
5430	5431	explain	0	None
5431	5432	the	0	None
5432	5433	beneficial	0	None
5433	5434	properties	0	None
5434	5435	traditionally	0	None
5435	5436	attributed	0	None
5436	5437	to	0	None
5437	5438	buckwheat	0	None
5438	5439	consumption	0	None
5439	5440	.	0	None
5440	5441	Predictive	0	None
5441	5442	modeling	0	None
5442	5443	of	0	None
5443	5444	insulin	0	None
5444	5445	release	0	None
5445	5446	profile	0	None
5446	5447	from	0	None
5447	5448	cross-linked	0	None
5448	5449	chitosan	0	None
5449	5450	microspheres	0	None
5450	5451	.	0	None
5451	5452	The	0	None
5452	5453	effects	0	None
5453	5454	of	0	None
5454	5455	pentoxifylline	0	None
5455	5456	on	0	None
5456	5457	the	0	None
5457	5458	myocardial	0	None
5458	5459	inflammation	0	None
5459	5460	and	0	None
5460	5461	ischemia-reperfusion	0	None
5461	5462	injury	0	None
5462	5463	during	0	None
5463	5464	cardiopulmonary	0	None
5464	5465	bypass	0	None
5465	5466	.	0	None
5466	5467	Serine	0	None
5467	5468	hydroxymethyltransferase	0	None
5468	5469	isoforms	0	None
5469	5470	are	0	None
5470	5471	differentially	0	None
5471	5472	inhibited	0	None
5472	5473	by	0	None
5473	5474	leucovorin	0	None
5474	5475	:	0	None
5475	5476	characterization	0	None
5476	5477	and	0	None
5477	5478	comparison	0	None
5478	5479	of	0	None
5479	5480	recombinant	0	None
5480	5481	zebrafish	0	None
5481	5483	serine hydroxymethyltransferases	0	None
5483	5484	.	0	None
5484	5485	Receptors	0	None
5485	5486	for	0	None
5486	5487	prostaglandin	0	None
5487	5488	E	0	None
5488	5489	(	0	None
5489	5490	2	0	None
5490	5491	)	0	None
5491	5492	that	0	None
5492	5493	regulate	0	None
5493	5494	cellular	0	None
5494	5495	immune	0	None
5495	5496	responses	0	None
5496	5497	in	0	None
5497	5498	the	0	None
5498	5499	mouse	0	None
5499	5500	.	0	None
5500	5501	Quercetin	0	None
5501	5502	ameliorate	0	None
5502	5503	insulin	0	None
5503	5504	resistance	0	None
5504	5505	and	0	None
5505	5506	up-regulates	0	None
5506	5507	cellular	0	None
5507	5508	antioxidants	0	None
5508	5509	during	0	None
5509	5511	oleic acid	2	CHEMICAL
5511	5512	induced	0	None
5512	5513	hepatic	0	None
5513	5514	steatosis	0	None
5514	5515	in	0	None
5515	5516	HepG2	0	None
5516	5517	cells	0	None
5517	5518	.	0	None
5518	5519	Polyamines	0	None
5519	5520	,	0	None
5520	5521	androgens	2	CHEMICAL
5521	5522	,	0	None
5522	5523	and	0	None
5523	5524	skeletal	0	None
5524	5525	muscle	0	None
5525	5526	hypertrophy	0	None
5526	5527	.	0	None
5527	5528	Effect	0	None
5528	5529	of	0	None
5529	5530	miR-21	0	None
5530	5531	on	0	None
5531	5532	Renal	0	None
5532	5533	Fibrosis	0	None
5533	5534	by	0	None
5534	5535	Regulating	0	None
5535	5536	MMP-9	0	None
5536	5537	and	0	None
5537	5538	TIMP1	0	None
5538	5539	in	0	None
5539	5540	kk-ay	0	None
5540	5541	Diabetic	0	None
5541	5542	Nephropathy	0	None
5542	5543	Mice	0	None
5543	5544	.	0	None
5544	5545	Pharmacodynamics	0	None
5545	5546	,	0	None
5546	5547	chiral	0	None
5547	5548	pharmacokinetics	0	None
5548	5549	,	0	None
5549	5550	and	0	None
5550	5551	pharmacokinetic-pharmacodynamic	0	None
5551	5552	modeling	0	None
5552	5553	of	0	None
5553	5554	fenoprofen	0	None
5554	5555	in	0	None
5555	5556	patients	0	None
5556	5557	with	0	None
5557	5558	diabetes	0	None
5558	5559	mellitus	0	None
5559	5560	.	0	None
5560	5561	Pharmacodynamic	0	None
5561	5562	characteristics	0	None
5562	5563	of	0	None
5563	5564	lixisenatide	0	None
5564	5565	once	0	None
5565	5566	daily	0	None
5566	5567	versus	0	None
5567	5568	liraglutide	0	None
5568	5569	once	0	None
5569	5570	daily	0	None
5570	5571	in	0	None
5571	5572	patients	0	None
5572	5573	with	0	None
5573	5574	type	0	None
5574	5575	2	0	None
5575	5576	diabetes	0	None
5576	5577	insufficiently	0	None
5577	5578	controlled	0	None
5578	5579	on	0	None
5579	5580	metformin	0	None
5580	5581	.	0	None
5581	5582	OBJECTIVE	0	None
5582	5583	:	0	None
5583	5584	Angiotensin	2	CHEMICAL
5584	5585	II-receptor	0	None
5585	5586	blockers	0	None
5586	5587	are	0	None
5587	5588	an	0	None
5588	5589	established	0	None
5589	5590	class	0	None
5590	5591	of	0	None
5591	5592	antihypertensive	0	None
5592	5593	agents	0	None
5593	5594	,	0	None
5594	5595	but	0	None
5595	5596	the	0	None
5596	5597	differences	0	None
5597	5598	between	0	None
5598	5599	individual	0	None
5599	5600	members	0	None
5600	5601	of	0	None
5601	5602	the	0	None
5602	5603	class	0	None
5603	5604	are	0	None
5604	5605	largely	0	None
5605	5606	unknown	0	None
5606	5607	.	0	None

5608	5609	The	0	None
5609	5610	present	0	None
5610	5611	study	0	None
5611	5612	employed	0	None
5612	5613	an	0	None
5613	5614	animal	0	None
5614	5615	model	0	None
5615	5616	to	0	None
5616	5617	demonstrate	0	None
5617	5618	angiotensin	2	CHEMICAL
5618	5619	II-receptor	0	None
5619	5620	blocker-specific	0	None
5620	5621	effects	0	None
5621	5622	and	0	None
5622	5623	to	0	None
5623	5624	quantify	0	None
5624	5625	these	0	None
5625	5626	differences	0	None
5626	5627	by	0	None
5627	5628	comparing	0	None
5628	5629	two	0	None
5629	5630	common	0	None
5630	5631	agents	0	None
5631	5632	,	0	None
5632	5633	losartan	0	None
5633	5634	and	0	None
5634	5635	valsartan	0	None
5635	5636	.	0	None

5637	5638	METHODS	0	None
5638	5639	:	0	None
5639	5640	We	0	None
5640	5641	measured	0	None
5641	5642	the	0	None
5642	5643	effects	0	None
5643	5644	on	0	None
5644	5645	angiotensin	2	CHEMICAL
5645	5646	II	0	None
5646	5647	AT2-receptor-mediated	0	None
5647	5648	renal	0	None
5648	5649	cGMP	2	CHEMICAL
5649	5650	by	0	None
5650	5651	microdialysis	0	None
5651	5652	in	0	None
5652	5653	the	0	None
5653	5654	outer	0	None
5654	5655	renal	0	None
5655	5656	cortex	0	None
5656	5657	in	0	None
5657	5658	conscious	0	None
5658	5659	normotensive	0	None
5659	5660	,	0	None
5660	5661	sodium-depleted	0	None
5661	5662	,	0	None
5662	5663	4-week-old	0	None
5663	5664	Sprague-Dawley	0	None
5664	5665	rats	0	None
5665	5666	.	0	None

5667	5668	Rats	0	None
5668	5669	(	0	None
5669	5670	n	0	None
5670	5671	=	0	None
5671	5672	8	0	None
5672	5673	)	0	None
5673	5674	were	0	None
5674	5675	given	0	None
5675	5676	equimolar	0	None
5676	5677	and	0	None
5677	5678	equidepressor	0	None
5678	5679	doses	0	None
5679	5680	of	0	None
5680	5681	losartan	0	None
5681	5682	(	0	None
5682	5683	0	0	None
5683	5684	.	0	None
5684	5685	02	0	None
5685	5686	mmol	0	None
5686	5687	/	0	None
5687	5688	kg	0	None
5688	5689	)	0	None
5689	5690	or	0	None
5690	5691	valsartan	0	None
5691	5692	(	0	None
5692	5693	0	0	None
5693	5694	.	0	None
5694	5695	02	0	None
5695	5696	mmol	0	None
5696	5697	/	0	None
5697	5698	kg	0	None
5698	5699	)	0	None
5699	5700	either	0	None
5700	5701	intravenously	0	None
5701	5702	or	0	None
5702	5703	orally	0	None
5703	5704	.	0	None

5705	5706	Time	0	None
5706	5707	was	0	None
5707	5708	allowed	0	None
5708	5709	for	0	None
5709	5710	the	0	None
5710	5711	conversion	0	None
5711	5712	of	0	None
5712	5713	losartan	0	None
5713	5714	into	0	None
5714	5715	its	0	None
5715	5716	active	0	None
5716	5717	metabolite	0	None
5717	5718	,	0	None
5718	5720	EXP 3174	2	CHEMICAL
5720	5721	.	0	None

5722	5723	RESULTS	0	None
5723	5724	:	0	None
5724	5725	Both	0	None
5725	5726	drugs	0	None
5726	5727	had	0	None
5727	5728	equal	0	None
5728	5729	effects	0	None
5729	5730	on	0	None
5730	5731	blood	0	None
5731	5732	pressure	0	None
5732	5733	.	0	None

5734	5735	There	0	None
5735	5736	were	0	None
5736	5737	significantly	0	None
5737	5738	greater	0	None
5738	5739	increases	0	None
5739	5740	in	0	None
5740	5741	cGMP	2	CHEMICAL
5741	5742	levels	0	None
5742	5743	after	0	None
5743	5744	administration	0	None
5744	5745	of	0	None
5745	5746	valsartan	0	None
5746	5747	than	0	None
5747	5748	of	0	None
5748	5749	losartan	0	None
5749	5750	with	0	None
5750	5751	both	0	None
5751	5752	routes	0	None
5752	5753	of	0	None
5753	5754	administration	0	None
5754	5755	.	0	None

5756	5757	Intravenous	0	None
5757	5758	administration	0	None
5758	5759	of	0	None
5759	5760	valsartan	0	None
5760	5761	led	0	None
5761	5762	to	0	None
5762	5763	a	0	None
5763	5764	69	0	None
5764	5765	.	0	None
5765	5766	1%	0	None
5766	5767	increase	0	None
5767	5768	in	0	None
5768	5769	cGMP	2	CHEMICAL
5769	5770	,	0	None
5770	5771	versus	0	None
5771	5772	a	0	None
5772	5773	10	0	None
5773	5774	.	0	None
5774	5775	3%	0	None
5775	5776	increase	0	None
5776	5777	with	0	None
5777	5778	losartan	0	None
5778	5779	.	0	None

5780	5781	Five	0	None
5781	5782	hours	0	None
5782	5783	after	0	None
5783	5784	oral	0	None
5784	5785	administration	0	None
5785	5786	of	0	None
5786	5787	valsartan	0	None
5787	5788	,	0	None
5788	5789	a	0	None
5789	5790	48%	0	None
5790	5791	increase	0	None
5791	5792	in	0	None
5792	5793	cGMP	2	CHEMICAL
5793	5794	was	0	None
5794	5795	observed	0	None
5795	5796	versus	0	None
5796	5797	a	0	None
5797	5798	10	0	None
5798	5799	.	0	None
5799	5800	9%	0	None
5800	5801	increase	0	None
5801	5802	with	0	None
5802	5803	losartan	0	None
5803	5804	.	0	None

5805	5806	The	0	None
5806	5807	increase	0	None
5807	5808	after	0	None
5808	5809	oral	0	None
5809	5810	administration	0	None
5810	5811	of	0	None
5811	5812	valsartan	0	None
5812	5813	was	0	None
5813	5814	sustained	0	None
5814	5815	8	0	None
5815	5816	h	0	None
5816	5817	after	0	None
5817	5818	administration	0	None
5818	5819	,	0	None
5819	5820	whereas	0	None
5820	5821	the	0	None
5821	5822	effect	0	None
5822	5823	of	0	None
5823	5824	losartan	0	None
5824	5825	was	0	None
5825	5826	not	0	None
5826	5827	sustained	0	None
5827	5828	.	0	None

5829	5830	The	0	None
5830	5831	effects	0	None
5831	5832	of	0	None
5832	5833	losartan	0	None
5833	5834	and	0	None
5834	5835	valsartan	0	None
5835	5836	on	0	None
5836	5837	cGMP	2	CHEMICAL
5837	5838	were	0	None
5838	5839	completely	0	None
5839	5840	inhibited	0	None
5840	5841	by	0	None
5841	5842	AT2-receptor	0	None
5842	5843	blockade	0	None
5843	5844	.	0	None

5845	5846	CONCLUSION	0	None
5846	5847	:	0	None
5847	5848	The	0	None
5848	5849	results	0	None
5849	5850	indicate	0	None
5850	5851	that	0	None
5851	5852	AT1-receptor	3	GENE-N
5852	5853	blockade	0	None
5853	5854	with	0	None
5854	5855	valsartan	0	None
5855	5856	influences	0	None
5856	5857	AT2-receptor-mediated	0	None
5857	5858	angiotensin	2	CHEMICAL
5858	5859	II	0	None
5859	5860	responses	0	None
5860	5861	to	0	None
5861	5862	a	0	None
5862	5863	greater	0	None
5863	5864	extent	0	None
5864	5865	than	0	None
5865	5866	with	0	None
5866	5867	losartan	0	None
5867	5868	,	0	None
5868	5869	as	0	None
5869	5870	quantified	0	None
5870	5871	by	0	None
5871	5872	renal	0	None
5872	5873	interstitial	0	None
5873	5874	fluid	0	None
5874	5875	cGMP	2	CHEMICAL
5875	5876	.	0	None
5876	5877	The	0	None
5877	5878	lymphocyte	0	None
5878	5879	function-associated	0	None
5879	5880	antigen	0	None
5880	5881	(	0	None
5881	5882	LFA-1	0	None
5882	5883	)	0	None
5883	5884	belongs	0	None
5884	5885	to	0	None
5885	5886	the	0	None
5886	5887	family	0	None
5887	5888	of	0	None
5888	5889	beta2-integrins	0	None
5889	5890	and	0	None
5890	5891	plays	0	None
5891	5892	an	0	None
5892	5893	important	0	None
5893	5894	role	0	None
5894	5895	in	0	None
5895	5896	T-cell	0	None
5896	5897	activation	0	None
5897	5898	and	0	None
5898	5899	leukocyte	0	None
5899	5900	migration	0	None
5900	5901	to	0	None
5901	5902	sites	0	None
5902	5903	of	0	None
5903	5904	inflammation	0	None
5904	5905	.	0	None

5906	5907	We	0	None
5907	5908	report	0	None
5908	5909	here	0	None
5909	5910	that	0	None
5910	5911	lovastatin	0	None
5911	5912	,	0	None
5912	5913	a	0	None
5913	5914	drug	0	None
5914	5915	clinically	0	None
5915	5916	used	0	None
5916	5917	for	0	None
5917	5918	lowering	0	None
5918	5919	cholesterol	0	None
5919	5920	levels	0	None
5920	5921	,	0	None
5921	5922	inhibits	0	None
5922	5923	the	0	None
5923	5924	interaction	0	None
5924	5925	of	0	None
5925	5926	human	0	None
5926	5927	LFA-1	0	None
5927	5928	with	0	None
5928	5929	its	0	None
5929	5930	counter-receptor	0	None
5930	5931	intercellular	0	None
5931	5932	adhesion	0	None
5932	5933	molecule-1	0	None
5933	5934	.	0	None

5935	5936	Using	0	None
5936	5937	nuclear	0	None
5937	5938	magnetic	0	None
5938	5939	resonance	0	None
5939	5940	spectroscopy	0	None
5940	5941	and	0	None
5941	5942	X-ray	0	None
5942	5943	crystallography	0	None
5943	5944	we	0	None
5944	5945	show	0	None
5945	5946	that	0	None
5946	5947	the	0	None
5947	5948	inhibitor	0	None
5948	5949	binds	0	None
5949	5950	to	0	None
5950	5951	a	0	None
5951	5952	highly	0	None
5952	5953	conserved	0	None
5953	5954	domain	0	None
5954	5955	of	0	None
5955	5956	the	0	None
5956	5957	LFA-1	0	None
5957	5958	alpha-chain	0	None
5958	5959	called	0	None
5959	5960	the	0	None
5960	5961	I-domain	0	None
5961	5962	.	0	None

5963	5964	The	0	None
5964	5965	first	0	None
5965	5966	three-dimensional	0	None
5966	5967	structure	0	None
5967	5968	of	0	None
5968	5969	an	0	None
5969	5970	integrin	0	None
5970	5971	inhibitor	0	None
5971	5972	bound	0	None
5972	5973	to	0	None
5973	5974	its	0	None
5974	5975	receptor	0	None
5975	5976	reveals	0	None
5976	5977	atomic	0	None
5977	5978	details	0	None
5978	5979	for	0	None
5979	5980	a	0	None
5980	5981	hitherto	0	None
5981	5982	unknown	0	None
5982	5983	mode	0	None
5983	5984	of	0	None
5984	5985	LFA-1	0	None
5985	5986	inhibition	0	None
5986	5987	.	0	None

5988	5989	It	0	None
5989	5990	also	0	None
5990	5991	sheds	0	None
5991	5992	light	0	None
5992	5993	into	0	None
5993	5994	possible	0	None
5994	5995	mechanisms	0	None
5995	5996	of	0	None
5996	5997	LFA-1	0	None
5997	5998	mediated	0	None
5998	5999	signalling	0	None
5999	6000	and	0	None
6000	6001	will	0	None
6001	6002	support	0	None
6002	6003	the	0	None
6003	6004	design	0	None
6004	6005	of	0	None
6005	6006	novel	0	None
6006	6007	anti-adhesive	0	None
6007	6008	and	0	None
6008	6009	immunosuppressive	0	None
6009	6010	drugs	0	None
6010	6011	.	0	None
6011	6012	Antidepressants	0	None
6012	6013	suppress	0	None
6013	6014	production	0	None
6014	6015	of	0	None
6015	6016	the	0	None
6016	6017	Th1	0	None
6017	6018	cytokine	0	None
6018	6019	interferon-gamma	0	None
6019	6020	,	0	None
6020	6021	independent	0	None
6021	6022	of	0	None
6022	6023	monoamine	0	None
6023	6024	transporter	0	None
6024	6025	blockade	0	None
6025	6026	.	0	None
6026	6027	GluR5	0	None
6027	6028	kainate	2	CHEMICAL
6028	6029	receptors	0	None
6029	6030	,	0	None
6030	6031	seizures	0	None
6031	6032	,	0	None
6032	6033	and	0	None
6033	6034	the	0	None
6034	6035	amygdala	0	None
6035	6036	.	0	None
6036	6037	INTRODUCTION	0	None
6037	6038	:	0	None
6038	6039	The	0	None
6039	6040	recently	0	None
6040	6041	approved	0	None
6041	6042	angiotensin	2	CHEMICAL
6042	6043	II	0	None
6043	6044	(	0	None
6044	6046	Ang II	2	CHEMICAL
6046	6047	)	0	None
6047	6048	type	0	None
6048	6049	1	0	None
6049	6050	(	0	None
6050	6051	AT1	0	None
6051	6052	)	0	None
6052	6053	receptor	0	None
6053	6054	blocker	0	None
6054	6055	(	0	None
6055	6056	ARB	0	None
6056	6057	)	0	None
6057	6058	azilsartan	0	None
6058	6059	strongly	0	None
6059	6060	reduces	0	None
6060	6061	blood	0	None
6061	6062	pressure	0	None
6062	6063	(	0	None
6063	6064	BP	0	None
6064	6065	)	0	None
6065	6066	in	0	None
6066	6067	patients	0	None
6067	6068	with	0	None
6068	6069	hypertension	0	None
6069	6070	.	0	None

6071	6072	We	0	None
6072	6073	previously	0	None
6073	6074	reported	0	None
6074	6075	that	0	None
6075	6076	azilsartan	0	None
6076	6077	showed	0	None
6077	6078	unique	0	None
6078	6079	binding	0	None
6079	6080	behavior	0	None
6080	6081	to	0	None
6081	6082	the	0	None
6082	6083	AT1	0	None
6083	6084	receptor	0	None
6084	6085	because	0	None
6085	6086	of	0	None
6086	6087	its	0	None
6087	6088	5-oxo-1	0	None
6088	6089	,	0	None
6089	6090	2	0	None
6090	6091	,	0	None
6091	6092	4-oxadiazole	0	None
6092	6093	moiety	0	None
6093	6094	.	0	None

6095	6096	However	0	None
6096	6097	,	0	None
6097	6098	the	0	None
6098	6099	ability	0	None
6099	6100	of	0	None
6100	6101	azilsartan	0	None
6101	6102	to	0	None
6102	6103	block	0	None
6103	6104	Ang	0	None
6104	6105	II-dependent	0	None
6105	6106	AT1	0	None
6106	6107	receptor	0	None
6107	6108	activation	0	None
6108	6109	is	0	None
6109	6110	not	0	None
6110	6111	yet	0	None
6111	6112	clear	0	None
6112	6113	.	0	None

6114	6115	MATERIALS	0	None
6115	6116	AND	0	None
6116	6117	METHODS	0	None
6117	6118	:	0	None
6118	6119	Azilsartan	0	None
6119	6120	and	0	None
6120	6121	a	0	None
6121	6122	derivative	0	None
6122	6123	of	0	None
6123	6124	azilsartan	0	None
6124	6125	(	0	None
6125	6126	azilsartan-7H	0	None
6126	6127	)	0	None
6127	6128	that	0	None
6128	6129	lacks	0	None
6129	6130	a	0	None
6130	6131	carboxyl	0	None
6131	6132	group	0	None
6132	6133	at	0	None
6133	6134	the	0	None
6134	6135	benzimidazole	0	None
6135	6136	ring	0	None
6136	6137	were	0	None
6137	6138	used	0	None
6138	6139	.	0	None

6140	6141	Ang	0	None
6141	6142	II-induced	0	None
6142	6143	inositol	0	None
6143	6144	phosphate	0	None
6144	6145	(	0	None
6145	6146	IP	0	None
6146	6147	)	0	None
6147	6148	production	0	None
6148	6149	and	0	None
6149	6151	extracellular signal-regulated	0	None
6151	6152	kinase	0	None
6152	6153	(	0	None
6153	6154	ERK	0	None
6154	6155	)	0	None
6155	6156	activation	0	None
6156	6157	were	0	None
6157	6158	analyzed	0	None
6158	6159	in	0	None
6159	6160	a	0	None
6160	6161	cell-based	0	None
6161	6162	wash-out	0	None
6162	6163	assay	0	None
6163	6164	.	0	None

6165	6166	RESULTS	0	None
6166	6167	:	0	None
6167	6168	Azilsartan	0	None
6168	6169	,	0	None
6169	6170	but	0	None
6170	6171	not	0	None
6171	6172	azilsartan-7H	0	None
6172	6173	,	0	None
6173	6174	completely	0	None
6174	6175	blocked	0	None
6175	6176	Ang	0	None
6176	6177	II-induced	0	None
6177	6178	IP	0	None
6178	6179	production	0	None
6179	6180	and	0	None
6180	6181	ERK	0	None
6181	6182	activation	0	None
6182	6183	.	0	None

6184	6185	Our	0	None
6185	6186	previous	0	None
6186	6187	report	0	None
6187	6188	demonstrated	0	None
6188	6189	that	0	None
6189	6190	azilsartan	0	None
6190	6191	mainly	0	None
6191	6192	interacts	0	None
6192	6193	with	0	None
6193	6194	Tyr	0	None
6194	6195	(	0	None
6195	6196	113	0	None
6196	6197	)	0	None
6197	6198	,	0	None
6198	6199	Lys	0	None
6199	6200	(	0	None
6200	6201	199	0	None
6201	6202	)	0	None
6202	6203	,	0	None
6203	6204	and	0	None
6204	6205	Gln	0	None
6205	6206	(	0	None
6206	6207	257	0	None
6207	6208	)	0	None
6208	6209	in	0	None
6209	6210	the	0	None
6210	6211	AT1	0	None
6211	6212	receptor	0	None
6212	6213	.	0	None

6214	6215	The	0	None
6215	6216	interactions	0	None
6216	6217	between	0	None
6217	6218	azilsartan	0	None
6218	6219	and	0	None
6219	6220	Tyr	0	None
6220	6221	(	0	None
6221	6222	113	0	None
6222	6223	)	0	None
6223	6224	and	0	None
6224	6225	Gln	0	None
6225	6226	(	0	None
6226	6227	257	0	None
6227	6228	)	0	None
6228	6229	,	0	None
6229	6230	but	0	None
6230	6231	not	0	None
6231	6232	Lys	0	None
6232	6233	(	0	None
6233	6234	199	0	None
6234	6235	)	0	None
6235	6236	,	0	None
6236	6237	were	0	None
6237	6238	critical	0	None
6238	6239	for	0	None
6239	6240	blocking	0	None
6240	6241	Ang	0	None
6241	6242	II-induced	0	None
6242	6243	IP	0	None
6243	6244	production	0	None
6244	6245	and	0	None
6245	6246	ERK	0	None
6246	6247	activation	0	None
6247	6248	after	0	None
6248	6249	wash-out	0	None
6249	6250	.	0	None

6251	6252	CONCLUSIONS	0	None
6252	6253	:	0	None
6253	6254	Although	0	None
6254	6255	our	0	None
6255	6256	findings	0	None
6256	6257	regarding	0	None
6257	6258	the	0	None
6258	6259	molecule-specific	0	None
6259	6260	effects	0	None
6260	6261	of	0	None
6261	6262	azilsartan	0	None
6262	6263	are	0	None
6263	6264	based	0	None
6264	6265	on	0	None
6265	6266	basic	0	None
6266	6267	research	0	None
6267	6268	,	0	None
6268	6269	they	0	None
6269	6270	may	0	None
6270	6271	lead	0	None
6271	6272	to	0	None
6272	6273	an	0	None
6273	6274	exciting	0	None
6274	6275	insight	0	None
6275	6276	into	0	None
6276	6277	the	0	None
6277	6278	mechanism	0	None
6278	6279	of	0	None
6279	6280	azilsartan	0	None
6280	6281	.	0	None
6281	6282	There	0	None
6282	6283	is	0	None
6283	6284	an	0	None
6284	6285	increasing	0	None
6285	6286	body	0	None
6286	6287	of	0	None
6287	6288	evidence	0	None
6288	6289	demonstrating	0	None
6289	6290	that	0	None
6290	6292	growth factor	3	GENE-N
6292	6293	networks	0	None
6293	6294	are	0	None
6294	6295	highly	0	None
6295	6296	interactive	0	None
6296	6297	with	0	None
6297	6298	oestrogen	2	CHEMICAL
6298	6299	receptor	0	None
6299	6300	(	0	None
6300	6301	ER	0	None
6301	6302	)	0	None
6302	6303	signalling	0	None
6303	6304	in	0	None
6304	6305	the	0	None
6305	6306	control	0	None
6306	6307	of	0	None
6307	6308	breast	0	None
6308	6309	cancer	0	None
6309	6310	growth	0	None
6310	6311	.	0	None

6312	6313	As	0	None
6313	6314	such	0	None
6314	6315	,	0	None
6315	6316	tumour	0	None
6316	6317	responses	0	None
6317	6318	to	0	None
6318	6319	anti-	0	None
6319	6320	hormones	2	CHEMICAL
6320	6321	are	0	None
6321	6322	likely	0	None
6322	6323	to	0	None
6323	6324	be	0	None
6324	6325	a	0	None
6325	6326	composite	0	None
6326	6327	of	0	None
6327	6328	the	0	None
6328	6332	ER and growth factor	3	GENE-N
6332	6333	inhibitory	0	None
6333	6334	activity	0	None
6334	6335	of	0	None
6335	6336	these	0	None
6336	6337	agents	0	None
6337	6338	.	0	None

6339	6340	The	0	None
6340	6341	current	0	None
6341	6342	article	0	None
6342	6343	examines	0	None
6343	6344	the	0	None
6344	6345	modulation	0	None
6345	6346	of	0	None
6346	6348	growth factor	3	GENE-N
6348	6349	networks	0	None
6349	6350	during	0	None
6350	6351	endocrine	0	None
6351	6352	response	0	None
6352	6353	,	0	None
6353	6354	and	0	None
6354	6355	presents	0	None
6355	6356	in	0	None
6356	6357	vitro	0	None
6357	6358	and	0	None
6358	6359	clinical	0	None
6359	6360	evidence	0	None
6360	6361	that	0	None
6361	6362	epidermal	0	None
6362	6365	growth factor receptor	3	GENE-N
6365	6366	signalling	0	None
6366	6367	,	0	None
6367	6368	maintained	0	None
6368	6369	in	0	None
6369	6370	either	0	None
6370	6371	an	0	None
6371	6372	ER-dependent	0	None
6372	6373	or	0	None
6373	6374	-independent	0	None
6374	6375	manner	0	None
6375	6376	,	0	None
6376	6377	is	0	None
6377	6378	critical	0	None
6378	6379	to	0	None
6379	6380	anti-	0	None
6380	6381	hormonal-resistant	0	None
6381	6382	breast	0	None
6382	6383	cancer	0	None
6383	6384	cell	0	None
6384	6385	growth	0	None
6385	6386	.	0	None

6387	6388	The	0	None
6388	6389	considerable	0	None
6389	6390	potential	0	None
6390	6391	of	0	None
6391	6392	the	0	None
6392	6393	epidermal	0	None
6393	6394	growth	0	None
6394	6395	factor	0	None
6395	6396	receptor-selective	0	None
6396	6397	tyrosine	2	CHEMICAL
6397	6398	kinase	0	None
6398	6399	inhibitor	0	None
6399	6400	,	0	None
6400	6401	ZD	0	None
6401	6402	1839	0	None
6402	6403	(	0	None
6403	6404	Iressa;	0	None
6404	6405	AstraZeneca	0	None
6405	6406	)	0	None
6406	6407	to	0	None
6407	6408	efficiently	0	None
6408	6409	treat	0	None
6409	6410	,	0	None
6410	6411	and	0	None
6411	6412	perhaps	0	None
6412	6413	even	0	None
6413	6414	prevent	0	None
6414	6415	,	0	None
6415	6416	endocrine-resistant	0	None
6416	6417	breast	0	None
6417	6418	cancer	0	None
6418	6419	is	0	None
6419	6420	highlighted	0	None
6420	6421	.	0	None
6421	6422	The	0	None
6422	6423	long	0	None
6423	6424	QT-related	0	None
6424	6425	arrhythmia	0	None
6425	6426	torsades	0	None
6426	6427	de	0	None
6427	6428	pointes	0	None
6428	6429	(	0	None
6429	6430	TdP	0	None
6430	6431	)	0	None
6431	6432	can	0	None
6432	6433	arise	0	None
6433	6434	with	0	None
6434	6435	mutations	0	None
6435	6436	in	0	None
6436	6437	HERG	1	GENE-Y
6437	6438	and	0	None
6438	6439	during	0	None
6439	6440	treatment	0	None
6440	6441	with	0	None
6441	6442	drugs	0	None
6442	6443	that	0	None
6443	6444	block	0	None
6444	6445	cardiac	0	None
6445	6446	I	0	None
6446	6447	Kr	0	None
6447	6448	,	0	None
6448	6449	the	0	None
6449	6450	current	0	None
6450	6451	encoded	0	None
6451	6452	by	0	None
6452	6453	HERG	1	GENE-Y
6453	6454	.	0	None

6455	6456	Multiple	0	None
6456	6457	test	0	None
6457	6458	systems	0	None
6458	6459	have	0	None
6459	6460	been	0	None
6460	6461	used	0	None
6461	6462	to	0	None
6462	6463	assess	0	None
6463	6464	drug	0	None
6464	6465	block	0	None
6465	6466	of	0	None
6466	6467	I	0	None
6467	6468	Kr	0	None
6468	6469	.	0	None

6470	6471	This	0	None
6471	6472	study	0	None
6472	6473	evaluated	0	None
6473	6474	the	0	None
6474	6475	I	0	None
6475	6476	Kr	0	None
6476	6477	blocking	0	None
6477	6478	potency	0	None
6478	6479	of	0	None
6479	6480	a	0	None
6480	6481	series	0	None
6481	6482	of	0	None
6482	6483	antiarrhythmics	0	None
6483	6484	associated	0	None
6484	6485	with	0	None
6485	6486	a	0	None
6486	6487	range	0	None
6487	6488	of	0	None
6488	6489	clinical	0	None
6489	6490	risks	0	None
6490	6491	of	0	None
6491	6492	TdP	0	None
6492	6493	in	0	None
6493	6494	two	0	None
6494	6495	such	0	None
6495	6496	systems	0	None
6496	6497	:	0	None
6497	6498	mouse	0	None
6498	6499	AT-1	0	None
6499	6500	cells	0	None
6500	6501	(	0	None
6501	6502	in	0	None
6502	6503	which	0	None
6503	6504	I	0	None
6504	6505	Kr	0	None
6505	6506	is	0	None
6506	6507	the	0	None
6507	6508	major	0	None
6508	6509	repolarizing	0	None
6509	6510	current	0	None
6510	6511	)	0	None
6511	6512	and	0	None
6512	6513	Ltk	0	None
6513	6514	cells	0	None
6514	6515	transiently	0	None
6515	6516	transfected	0	None
6516	6517	with	0	None
6517	6518	HERG	1	GENE-Y
6518	6519	(	0	None
6519	6520	n	0	None
6520	6521	=	0	None
6521	6522	4-10	0	None
6522	6523	cells	0	None
6523	6524	per	0	None
6524	6525	drug	0	None
6525	6526	)	0	None
6526	6527	.	0	None

6528	6529	For	0	None
6529	6530	each	0	None
6530	6531	compound	0	None
6531	6532	,	0	None
6532	6533	the	0	None
6533	6534	concentration	0	None
6534	6535	required	0	None
6535	6536	to	0	None
6536	6537	produce	0	None
6537	6538	50%	0	None
6538	6539	block	0	None
6539	6540	of	0	None
6540	6541	I	0	None
6541	6542	Kr	0	None
6542	6543	or	0	None
6543	6544	HERG	1	GENE-Y
6544	6545	tail	0	None
6545	6546	currents	0	None
6546	6547	(	0	None
6547	6548	IC	0	None
6548	6549	50	0	None
6549	6550	)	0	None
6550	6551	was	0	None
6551	6552	determined	0	None
6552	6553	.	0	None

6554	6555	There	0	None
6555	6556	was	0	None
6556	6557	an	0	None
6557	6558	excellent	0	None
6558	6559	correlation	0	None
6559	6560	(	0	None
6560	6561	r	0	None
6561	6562	=	0	None
6562	6563	0	0	None
6563	6564	.	0	None
6564	6565	98	0	None
6565	6566	,	0	None
6566	6567	p	0	None
6567	6568	<	0	None
6568	6569	10	0	None
6569	6570	-5	0	None
6570	6571	)	0	None
6571	6572	between	0	None
6572	6573	values	0	None
6573	6574	obtained	0	None
6574	6575	in	0	None
6575	6576	the	0	None
6576	6577	two	0	None
6577	6578	systems	0	None
6578	6579	.	0	None

6580	6581	However	0	None
6581	6582	,	0	None
6582	6583	the	0	None
6583	6584	relation	0	None
6584	6585	between	0	None
6585	6586	the	0	None
6586	6587	liability	0	None
6587	6588	of	0	None
6588	6589	a	0	None
6589	6590	drug	0	None
6590	6591	to	0	None
6591	6592	cause	0	None
6592	6593	TdP	0	None
6593	6594	appeared	0	None
6594	6595	dissociated	0	None
6595	6596	from	0	None
6596	6597	I	0	None
6597	6598	Kr	0	None
6598	6599	blocking	0	None
6599	6600	potency	0	None
6600	6601	.	0	None

6602	6603	Quinidine	2	CHEMICAL
6603	6604	,	0	None
6604	6605	dofetilide	0	None
6605	6606	,	0	None
6606	6607	ibutilide	0	None
6607	6608	,	0	None
6608	6609	procainamide	0	None
6609	6610	,	0	None
6610	6611	and	0	None
6611	6612	disopyramide	0	None
6612	6613	are	0	None
6613	6614	all	0	None
6614	6615	associated	0	None
6615	6616	with	0	None
6616	6617	TdP	0	None
6617	6618	,	0	None
6618	6619	but	0	None
6619	6620	only	0	None
6620	6621	the	0	None
6621	6622	first	0	None
6622	6623	three	0	None
6623	6624	were	0	None
6624	6625	potent	0	None
6625	6626	blockers	0	None
6626	6627	(	0	None
6627	6628	IC	0	None
6628	6629	50	0	None
6629	6630	<	0	None
6630	6631	or	0	None
6631	6632	=	0	None
6632	6633	1	0	None
6633	6634	microM	0	None
6634	6635	)	0	None
6635	6636	,	0	None
6636	6637	whereas	0	None
6637	6638	procainamide	0	None
6638	6639	and	0	None
6639	6640	disopyramide	0	None
6640	6641	were	0	None
6641	6642	not	0	None
6642	6643	(	0	None
6643	6644	IC	0	None
6644	6645	50	0	None
6645	6646	>	0	None
6646	6647	50	0	None
6647	6648	microM	0	None
6648	6649	)	0	None
6649	6650	.	0	None

6651	6652	Conversely	0	None
6652	6653	,	0	None
6653	6654	verapamil	0	None
6654	6655	and	0	None
6655	6656	amiodarone	0	None
6656	6657	,	0	None
6657	6658	drugs	0	None
6658	6659	not	0	None
6659	6660	associated	0	None
6660	6661	with	0	None
6661	6662	TdP	0	None
6662	6663	,	0	None
6663	6664	were	0	None
6664	6665	also	0	None
6665	6666	blockers	0	None
6666	6667	(	0	None
6667	6668	IC	0	None
6668	6669	50	0	None
6669	6670	<	0	None
6670	6671	or	0	None
6671	6672	=	0	None
6672	6673	1	0	None
6673	6674	microM	0	None
6674	6675	)	0	None
6675	6676	.	0	None

6677	6678	We	0	None
6678	6679	conclude	0	None
6679	6680	that	0	None
6680	6681	I	0	None
6681	6682	Kr	0	None
6682	6683	blocking	0	None
6683	6684	potency	0	None
6684	6685	can	0	None
6685	6686	be	0	None
6686	6687	readily	0	None
6687	6688	assessed	0	None
6688	6689	in	0	None
6689	6690	either	0	None
6690	6691	AT-1	0	None
6691	6692	cells	0	None
6692	6693	or	0	None
6693	6694	systems	0	None
6694	6695	in	0	None
6695	6696	which	0	None
6696	6697	HERG	1	GENE-Y
6697	6698	is	0	None
6698	6699	heterologously	0	None
6699	6700	expressed	0	None
6700	6701	.	0	None

6702	6703	However	0	None
6703	6704	,	0	None
6704	6705	not	0	None
6705	6706	all	0	None
6706	6707	drugs	0	None
6707	6708	causing	0	None
6708	6709	TdP	0	None
6709	6710	are	0	None
6710	6711	potent	0	None
6711	6712	I	0	None
6712	6713	Kr	0	None
6713	6714	blockers	0	None
6714	6715	,	0	None
6715	6716	and	0	None
6716	6717	I	0	None
6717	6718	Kr	0	None
6718	6719	block	0	None
6719	6720	is	0	None
6720	6721	not	0	None
6721	6722	necessarily	0	None
6722	6723	associated	0	None
6723	6724	with	0	None
6724	6725	TdP	0	None
6725	6726	.	0	None

6727	6728	Other	0	None
6728	6729	properties	0	None
6729	6730	of	0	None
6730	6731	these	0	None
6731	6732	drugs	0	None
6732	6733	,	0	None
6733	6734	therefore	0	None
6734	6735	,	0	None
6735	6736	contribute	0	None
6736	6737	to	0	None
6737	6738	their	0	None
6738	6739	propensity	0	None
6739	6740	to	0	None
6740	6741	cause	0	None
6741	6742	TdP	0	None
6742	6743	.	0	None
6743	6744	Limited	0	None
6744	6745	availability	0	None
6745	6746	of	0	None
6746	6747	L-arginine	0	None
6747	6748	increases	0	None
6748	6749	DNA-binding	0	None
6749	6750	activity	0	None
6750	6751	of	0	None
6751	6752	NF-kappaB	3	GENE-N
6752	6753	and	0	None
6753	6754	contributes	0	None
6754	6755	to	0	None
6755	6756	regulation	0	None
6756	6757	of	0	None
6757	6758	iNOS	0	None
6758	6759	expression	0	None
6759	6760	.	0	None
6760	6761	Androgen	0	None
6761	6762	/	0	None
6762	6764	androgen receptor	3	GENE-N
6764	6765	pathway	0	None
6765	6766	regulates	0	None
6766	6767	expression	0	None
6767	6768	of	0	None
6768	6769	the	0	None
6769	6770	genes	0	None
6770	6771	for	0	None
6771	6772	cyclooxygenase-2	0	None
6772	6773	and	0	None
6773	6774	amphiregulin	0	None
6774	6775	in	0	None
6775	6776	periovulatory	0	None
6776	6777	granulosa	0	None
6777	6778	cells	0	None
6778	6779	.	0	None
6779	6780	A	0	None
6780	6781	series	0	None
6781	6782	of	0	None
6782	6783	phosphorylated	0	None
6783	6784	flavonoids	0	None
6784	6785	were	0	None
6785	6786	synthesized	0	None
6786	6787	and	0	None
6787	6788	investigated	0	None
6788	6789	in	0	None
6789	6790	vitro	0	None
6790	6791	as	0	None
6791	6792	inhibitors	0	None
6792	6793	of	0	None
6793	6794	pancreatic	0	None
6794	6795	cholesterol	0	None
6795	6796	esterase	0	None
6796	6797	(	0	None
6797	6798	CEase	0	None
6798	6799	)	0	None
6799	6800	and	0	None
6800	6801	acetylcholinesterase	0	None
6801	6802	(	0	None
6802	6803	AChE	1	GENE-Y
6803	6804	)	0	None
6804	6805	.	0	None

6806	6807	The	0	None
6807	6808	results	0	None
6808	6809	showed	0	None
6809	6810	that	0	None
6810	6811	most	0	None
6811	6812	of	0	None
6812	6813	the	0	None
6813	6814	synthesized	0	None
6814	6815	compounds	0	None
6815	6816	exhibited	0	None
6816	6817	nanomolar	0	None
6817	6818	potency	0	None
6818	6819	against	0	None
6819	6820	CEase	0	None
6820	6821	,	0	None
6821	6822	much	0	None
6822	6823	better	0	None
6823	6824	than	0	None
6824	6825	the	0	None
6825	6826	parent	0	None
6826	6827	flavonoids	0	None
6827	6828	.	0	None

6829	6830	Furthermore	0	None
6830	6831	,	0	None
6831	6832	these	0	None
6832	6833	phosphorylated	0	None
6833	6834	flavonoids	0	None
6834	6835	demonstrated	0	None
6835	6836	good	0	None
6836	6837	to	0	None
6837	6838	high	0	None
6838	6839	selectivity	0	None
6839	6840	for	0	None
6840	6841	CEase	0	None
6841	6842	over	0	None
6842	6843	AChE	1	GENE-Y
6843	6844	,	0	None
6844	6845	which	0	None
6845	6846	only	0	None
6846	6847	showed	0	None
6847	6848	micromolar	0	None
6848	6849	potency	0	None
6849	6850	inhibition	0	None
6850	6851	of	0	None
6851	6852	AChE	1	GENE-Y
6852	6853	.	0	None

6854	6855	The	0	None
6855	6856	most	0	None
6856	6857	selective	0	None
6857	6858	and	0	None
6858	6859	potent	0	None
6859	6860	inhibitor	0	None
6860	6861	of	0	None
6861	6862	CEase	0	None
6862	6863	(	0	None
6863	6864	3e	0	None
6864	6865	)	0	None
6865	6866	had	0	None
6866	6867	IC50	0	None
6867	6868	value	0	None
6868	6869	of	0	None
6869	6870	0	0	None
6870	6871	.	0	None
6871	6872	72	0	None
6872	6873	nM	0	None
6873	6874	and	0	None
6874	6875	11800-fold	0	None
6875	6876	selectivity	0	None
6876	6877	for	0	None
6877	6878	CEase	0	None
6878	6879	over	0	None
6879	6880	AChE	1	GENE-Y
6880	6881	.	0	None

6882	6883	The	0	None
6883	6884	structure-activity	0	None
6884	6885	relationships	0	None
6885	6886	revealed	0	None
6886	6887	that	0	None
6887	6888	the	0	None
6888	6889	free	0	None
6889	6890	hydroxyl	2	CHEMICAL
6890	6891	group	0	None
6891	6892	at	0	None
6892	6893	position	0	None
6893	6894	5	0	None
6894	6895	and	0	None
6895	6896	phosphate	0	None
6896	6897	group	0	None
6897	6898	at	0	None
6898	6899	position	0	None
6899	6900	7	0	None
6900	6901	of	0	None
6901	6902	the	0	None
6902	6903	phosphorylated	0	None
6903	6904	flavonoids	0	None
6904	6905	are	0	None
6905	6906	favorable	0	None
6906	6907	to	0	None
6907	6908	the	0	None
6908	6909	inhibition	0	None
6909	6910	of	0	None
6910	6911	CEase	0	None
6911	6912	.	0	None

6913	6914	The	0	None
6914	6915	inhibition	0	None
6915	6916	mechanism	0	None
6916	6917	and	0	None
6917	6918	kinetic	0	None
6918	6919	characterization	0	None
6919	6920	studies	0	None
6920	6921	indicated	0	None
6921	6922	that	0	None
6922	6923	they	0	None
6923	6924	are	0	None
6924	6925	irreversible	0	None
6925	6926	competitive	0	None
6926	6927	inhibitors	0	None
6927	6928	of	0	None
6928	6929	CEase	0	None
6929	6930	.	0	None
6930	6931	In	0	None
6931	6932	this	0	None
6932	6933	study	0	None
6933	6934	seven	0	None
6934	6935	published	0	None
6935	6936	methods	0	None
6936	6937	of	0	None
6937	6938	extraction	0	None
6938	6939	of	0	None
6939	6940	skin	0	None
6940	6941	free	0	None
6941	6942	and	0	None
6942	6943	bound	0	None
6943	6944	volatile	0	None
6944	6945	compounds	0	None
6945	6946	have	0	None
6946	6947	been	0	None
6947	6948	compared	0	None
6948	6949	.	0	None

6950	6951	The	0	None
6951	6952	free	0	None
6952	6953	and	0	None
6953	6954	bound	0	None
6954	6955	volatiles	0	None
6955	6956	were	0	None
6956	6957	separated	0	None
6957	6958	by	0	None
6958	6959	solid	0	None
6959	6960	phase	0	None
6960	6961	extraction	0	None
6961	6962	(	0	None
6962	6963	SPE	0	None
6963	6964	)	0	None
6964	6965	and	0	None
6965	6966	then	0	None
6966	6967	analysed	0	None
6967	6968	by	0	None
6968	6969	gas	0	None
6969	6970	chromatography	0	None
6970	6971	coupled	0	None
6971	6972	with	0	None
6972	6973	mass	0	None
6973	6974	spectrometry	0	None
6974	6975	(	0	None
6975	6976	GC-MS	0	None
6976	6977	)	0	None
6977	6978	.	0	None

6979	6980	The	0	None
6980	6981	results	0	None
6981	6982	showed	0	None
6982	6983	that	0	None
6983	6984	the	0	None
6984	6985	extraction	0	None
6985	6986	of	0	None
6986	6987	volatile	0	None
6987	6988	compounds	0	None
6988	6989	from	0	None
6989	6990	grapes	0	None
6990	6991	is	0	None
6991	6992	highly	0	None
6992	6993	affected	0	None
6993	6994	by	0	None
6994	6995	extraction	0	None
6995	6996	solution	0	None
6996	6997	features	0	None
6997	6998	.	0	None

6999	7000	The	0	None
7000	7001	solution	0	None
7001	7002	at	0	None
7002	7003	pH	0	None
7003	7004	3	0	None
7004	7005	.	0	None
7005	7006	2	0	None
7006	7007	and	0	None
7007	7008	0%	0	None
7008	7009	ethanol	2	CHEMICAL
7009	7010	resulted	0	None
7010	7011	the	0	None
7011	7012	most	0	None
7012	7013	effective	0	None
7013	7014	as	0	None
7014	7015	it	0	None
7015	7016	led	0	None
7016	7017	to	0	None
7017	7018	the	0	None
7018	7019	extraction	0	None
7019	7020	of	0	None
7020	7021	a	0	None
7021	7022	higher	0	None
7022	7023	number	0	None
7023	7024	and	0	None
7024	7025	amount	0	None
7025	7026	of	0	None
7026	7027	free	0	None
7027	7028	and	0	None
7028	7029	glycosilated	0	None
7029	7030	volatile	0	None
7030	7031	compounds	0	None
7031	7032	.	0	None

7033	7034	The	0	None
7034	7035	selected	0	None
7035	7036	extraction	0	None
7036	7037	method	0	None
7037	7038	of	0	None
7038	7039	grape	0	None
7039	7040	skin	0	None
7040	7041	and	0	None
7041	7042	the	0	None
7042	7043	process	0	None
7043	7044	of	0	None
7044	7045	pulp	0	None
7045	7046	juice	0	None
7046	7047	were	0	None
7047	7048	validated	0	None
7048	7049	for	0	None
7049	7050	quantitative	0	None
7050	7051	determination	0	None
7051	7052	of	0	None
7052	7053	a	0	None
7053	7054	wide	0	None
7054	7055	range	0	None
7055	7056	of	0	None
7056	7057	grape	0	None
7057	7058	aroma	0	None
7058	7059	compounds	0	None
7059	7060	.	0	None

7061	7062	A	0	None
7062	7063	total	0	None
7063	7064	of	0	None
7064	7065	37	0	None
7065	7066	free	0	None
7066	7067	and	0	None
7067	7068	bound	0	None
7068	7069	grape	0	None
7069	7070	aroma	0	None
7070	7071	compounds	0	None
7071	7072	were	0	None
7072	7073	quantified	0	None
7073	7074	by	0	None
7074	7075	GC-MS	0	None
7075	7076	in	0	None
7076	7077	selective	0	None
7077	7078	ion	0	None
7078	7079	monitoring	0	None
7079	7080	modality	0	None
7080	7081	(	0	None
7081	7082	SIM	0	None
7082	7083	)	0	None
7083	7084	.	0	None

7085	7086	Among	0	None
7086	7087	them	0	None
7087	7088	,	0	None
7088	7089	26	0	None
7089	7090	volatile	0	None
7090	7091	compounds	0	None
7091	7092	resulted	0	None
7092	7093	validated	0	None
7093	7094	in	0	None
7094	7095	grape	0	None
7095	7096	skin	0	None
7096	7097	and	0	None
7097	7098	pulp	0	None
7098	7099	juice	0	None
7099	7100	.	0	None
7100	7101	Monoacylglycerol	0	None
7101	7102	lipase	3	GENE-N
7102	7103	inhibition-induced	0	None
7103	7104	changes	0	None
7104	7105	in	0	None
7105	7106	plasma	0	None
7106	7107	corticosterone	0	None
7107	7108	levels	0	None
7108	7109	,	0	None
7109	7110	anxiety	0	None
7110	7111	and	0	None
7111	7112	locomotor	0	None
7112	7113	activity	0	None
7113	7114	in	0	None
7114	7115	male	0	None
7115	7116	CD1	3	GENE-N
7116	7117	mice	0	None
7117	7118	.	0	None
7118	7119	Suppression	0	None
7119	7120	by	0	None
7120	7121	cetirizine	0	None
7121	7122	of	0	None
7122	7123	pleurisy	0	None
7123	7124	triggered	0	None
7124	7125	by	0	None
7125	7126	antigen	0	None
7126	7127	in	0	None
7127	7128	actively	0	None
7128	7129	sensitized	0	None
7129	7130	rats	0	None
7130	7131	.	0	None
7131	7132	Similar	0	None
7132	7133	pyruvate	2	CHEMICAL
7133	7134	kinase	0	None
7134	7135	modifications	0	None
7135	7136	in	0	None
7136	7137	glioblastoma	0	None
7137	7138	cells	0	None
7138	7139	by	0	None
7139	7140	7β-hydroxycholesterol	0	None
7140	7141	and	0	None
7141	7142	glutamine	0	None
7142	7143	withdrawal	0	None
7143	7144	.	0	None
7144	7145	A	0	None
7145	7146	novel	0	None
7146	7147	mechanism	0	None
7147	7148	of	0	None
7148	7149	action	0	None
7149	7150	of	0	None
7150	7151	tetracyclines	2	CHEMICAL
7151	7152	:	0	None
7152	7153	effects	0	None
7153	7154	on	0	None
7154	7157	nitric oxide synthases	3	GENE-N
7157	7158	.	0	None
7158	7159	The	0	None
7159	7160	cDNA	0	None
7160	7161	encoding	0	None
7161	7163	PH-20 hyaluronidase	1	GENE-Y
7163	7164	from	0	None
7164	7165	human	0	None
7165	7166	sperm	0	None
7166	7167	has	0	None
7167	7168	been	0	None
7168	7169	mutated	0	None
7169	7170	at	0	None
7170	7171	five	0	None
7171	7172	positions	0	None
7172	7173	by	0	None
7173	7174	in	0	None
7174	7175	vitro	0	None
7175	7176	mutagenesis	0	None
7176	7177	.	0	None

7178	7179	We	0	None
7179	7180	have	0	None
7180	7181	changed	0	None
7181	7182	three	0	None
7182	7185	acidic amino acids	2	CHEMICAL
7185	7186	and	0	None
7186	7187	two	0	None
7187	7188	arginine	2	CHEMICAL
7188	7189	residues	0	None
7189	7190	that	0	None
7190	7191	are	0	None
7191	7192	conserved	0	None
7192	7193	in	0	None
7193	7194	the	0	None
7194	7195	sequence	0	None
7195	7196	of	0	None
7196	7197	mammalian	0	None
7197	7198	PH-20	1	GENE-Y
7198	7199	polypeptides	0	None
7199	7200	as	0	None
7200	7201	well	0	None
7201	7202	as	0	None
7202	7203	in	0	None
7203	7204	the	0	None
7204	7205	hyaluronidases	0	None
7205	7206	from	0	None
7206	7207	bee	0	None
7207	7208	and	0	None
7208	7209	hornet	0	None
7209	7210	venom	0	None
7210	7211	.	0	None

7212	7213	Of	0	None
7213	7214	the	0	None
7214	7215	former	0	None
7215	7216	,	0	None
7216	7217	the	0	None
7217	7218	mutants	0	None
7218	7219	[	0	None
7219	7220	Gln113	0	None
7220	7221	]	0	None
7221	7222	PH-20	1	GENE-Y
7222	7223	and	0	None
7223	7224	[	0	None
7224	7225	Gln249	0	None
7225	7226	]	0	None
7226	7227	PH-20	1	GENE-Y
7227	7228	had	0	None
7228	7229	no	0	None
7229	7230	detectable	0	None
7230	7231	enzymatic	0	None
7231	7232	activity;	0	None
7232	7233	the	0	None
7233	7234	mutant	0	None
7234	7235	[	0	None
7235	7236	Asn111	0	None
7236	7237	]	0	None
7237	7238	PH-20	1	GENE-Y
7238	7239	had	0	None
7239	7240	about	0	None
7240	7241	3%	0	None
7241	7242	activity	0	None
7242	7243	.	0	None

7244	7245	The	0	None
7245	7246	mutant	0	None
7246	7247	[	0	None
7247	7248	Thr252	0	None
7248	7249	]	0	None
7249	7250	PH-20	1	GENE-Y
7250	7251	was	0	None
7251	7252	also	0	None
7252	7253	inactive	0	None
7253	7254	,	0	None
7254	7255	while	0	None
7255	7256	[	0	None
7256	7257	Gly176	0	None
7257	7258	]	0	None
7258	7259	PH-20	1	GENE-Y
7259	7260	had	0	None
7260	7261	only	0	None
7261	7262	about	0	None
7262	7263	1%	0	None
7263	7264	activity	0	None
7264	7265	.	0	None

7266	7267	This	0	None
7267	7268	indicates	0	None
7268	7269	that	0	None
7269	7270	the	0	None
7270	7271	PH-20	1	GENE-Y
7271	7272	hyaluronidases	0	None
7272	7273	,	0	None
7273	7274	like	0	None
7274	7275	numerous	0	None
7275	7276	enzymes	0	None
7276	7277	that	0	None
7277	7278	hydrolyze	0	None
7278	7279	glycosidic	0	None
7279	7280	bonds	0	None
7280	7281	,	0	None
7281	7282	have	0	None
7282	7283	acidic	0	None
7283	7285	amino acids	2	CHEMICAL
7285	7286	in	0	None
7286	7287	their	0	None
7287	7288	active	0	None
7288	7289	site	0	None
7289	7290	.	0	None

7291	7292	Moreover	0	None
7292	7293	,	0	None
7293	7294	for	0	None
7294	7295	the	0	None
7295	7296	binding	0	None
7296	7297	of	0	None
7297	7298	the	0	None
7298	7299	substrate	0	None
7299	7300	,	0	None
7300	7301	the	0	None
7301	7302	polyanion	0	None
7302	7303	hyaluronan	0	None
7303	7304	,	0	None
7304	7305	arginine	2	CHEMICAL
7305	7306	residues	0	None
7306	7307	appear	0	None
7307	7308	to	0	None
7308	7309	be	0	None
7309	7310	essential	0	None
7310	7311	.	0	None
7311	7312	The	0	None
7312	7313	Interaction	0	None
7313	7314	of	0	None
7314	7315	Adrenomedullin	0	None
7315	7316	and	0	None
7316	7317	Macrophages	0	None
7317	7318	Induces	0	None
7318	7319	Ovarian	0	None
7319	7320	Cancer	0	None
7320	7321	Cell	0	None
7321	7322	Migration	0	None
7322	7323	via	0	None
7323	7324	Activation	0	None
7324	7325	of	0	None
7325	7326	RhoA	0	None
7326	7327	Signaling	0	None
7327	7328	Pathway	0	None
7328	7329	.	0	None
7329	7330	Increased	0	None
7330	7331	levels	0	None
7331	7332	of	0	None
7332	7333	free	0	None
7333	7335	fatty acids	2	CHEMICAL
7335	7336	(	0	None
7336	7337	FFAs	0	None
7337	7338	)	0	None
7338	7339	,	0	None
7339	7340	specifically	0	None
7340	7341	saturated	0	None
7341	7342	free	0	None
7342	7344	fatty acids	2	CHEMICAL
7344	7345	such	0	None
7345	7346	as	0	None
7346	7347	palmitate	0	None
7347	7348	are	0	None
7348	7349	associated	0	None
7349	7350	with	0	None
7350	7351	insulin	0	None
7351	7352	resistance	0	None
7352	7353	of	0	None
7353	7354	muscle	0	None
7354	7355	,	0	None
7355	7356	fat	0	None
7356	7357	and	0	None
7357	7358	liver	0	None
7358	7359	.	0	None

7360	7361	Skeletal	0	None
7361	7362	muscle	0	None
7362	7363	,	0	None
7363	7364	responsible	0	None
7364	7365	for	0	None
7365	7366	up	0	None
7366	7367	to	0	None
7367	7368	80%	0	None
7368	7369	of	0	None
7369	7370	the	0	None
7370	7371	glucose	0	None
7371	7372	disposal	0	None
7372	7373	from	0	None
7373	7374	the	0	None
7374	7375	peripheral	0	None
7375	7376	circulation	0	None
7376	7377	,	0	None
7377	7378	is	0	None
7378	7379	particularly	0	None
7379	7380	vulnerable	0	None
7380	7381	to	0	None
7381	7382	increased	0	None
7382	7383	levels	0	None
7383	7384	of	0	None
7384	7385	saturated	0	None
7385	7386	FFAs	0	None
7386	7387	.	0	None

7388	7389	Rooibos	0	None
7389	7390	(	0	None
7390	7391	Aspalathus	0	None
7391	7392	linearis	0	None
7392	7393	)	0	None
7393	7394	and	0	None
7394	7395	its	0	None
7395	7396	unique	0	None
7396	7397	dihydrochalcone	0	None
7397	7398	C-glucoside	0	None
7398	7399	,	0	None
7399	7400	aspalathin	0	None
7400	7401	,	0	None
7401	7402	shown	0	None
7402	7403	to	0	None
7403	7404	reduce	0	None
7404	7405	hyperglycemia	0	None
7405	7406	in	0	None
7406	7407	diabetic	0	None
7407	7408	rats	0	None
7408	7409	,	0	None
7409	7410	could	0	None
7410	7411	play	0	None
7411	7412	a	0	None
7412	7413	role	0	None
7413	7414	in	0	None
7414	7415	preventing	0	None
7415	7416	or	0	None
7416	7417	ameliorating	0	None
7417	7418	the	0	None
7418	7419	development	0	None
7419	7420	of	0	None
7420	7421	insulin	0	None
7421	7422	resistance	0	None
7422	7423	.	0	None

7424	7425	This	0	None
7425	7426	study	0	None
7426	7427	aims	0	None
7427	7428	to	0	None
7428	7429	establish	0	None
7429	7430	whether	0	None
7430	7431	rooibos	0	None
7431	7432	can	0	None
7432	7433	ameliorate	0	None
7433	7434	experimentally-induced	0	None
7434	7435	insulin-resistance	0	None
7435	7436	in	0	None
7436	7437	C2C12	0	None
7437	7438	skeletal	0	None
7438	7439	muscle	0	None
7439	7440	cells	0	None
7440	7441	.	0	None

7442	7443	Palmitate-induced	0	None
7443	7444	insulin	0	None
7444	7445	resistant	0	None
7445	7446	C2C12	0	None
7446	7447	cells	0	None
7447	7448	were	0	None
7448	7449	treated	0	None
7449	7450	with	0	None
7450	7451	an	0	None
7451	7452	aspalathin-enriched	0	None
7452	7453	green	0	None
7453	7454	(	0	None
7454	7455	unfermented	0	None
7455	7456	)	0	None
7456	7457	rooibos	0	None
7457	7458	extract	0	None
7458	7459	(	0	None
7459	7460	GRE	0	None
7460	7461	)	0	None
7461	7462	,	0	None
7462	7463	previously	0	None
7463	7464	shown	0	None
7464	7465	for	0	None
7465	7466	its	0	None
7466	7467	blood	0	None
7467	7468	glucose	0	None
7468	7469	lowering	0	None
7469	7470	effect	0	None
7470	7471	in	0	None
7471	7472	vitro	0	None
7472	7473	and	0	None
7473	7474	in	0	None
7474	7475	vivo	0	None
7475	7476	or	0	None
7476	7477	an	0	None
7477	7478	aqueous	0	None
7478	7479	extract	0	None
7479	7480	of	0	None
7480	7481	fermented	0	None
7481	7482	rooibos	0	None
7482	7483	(	0	None
7483	7484	FRE	0	None
7484	7485	)	0	None
7485	7486	.	0	None

7487	7488	Glucose	0	None
7488	7489	uptake	0	None
7489	7490	and	0	None
7490	7491	mitochondrial	0	None
7491	7492	activity	0	None
7492	7493	were	0	None
7493	7494	measured	0	None
7494	7495	using	0	None
7495	7496	2-deoxy-	0	None
7496	7497	[	0	None
7497	7498	(	0	None
7498	7499	3	0	None
7499	7500	)	0	None
7500	7501	H	0	None
7501	7502	]	0	None
7502	7503	-d-glucose	0	None
7503	7504	,	0	None
7504	7505	MTT	0	None
7505	7506	and	0	None
7506	7507	ATP	0	None
7507	7508	assays	0	None
7508	7509	,	0	None
7509	7510	respectively	0	None
7510	7511	.	0	None

7512	7513	Expression	0	None
7513	7514	of	0	None
7514	7515	proteins	0	None
7515	7516	relevant	0	None
7516	7517	to	0	None
7517	7518	glucose	0	None
7518	7519	metabolism	0	None
7519	7520	was	0	None
7520	7521	analysed	0	None
7521	7522	by	0	None
7522	7523	Western	0	None
7523	7524	blot	0	None
7524	7525	.	0	None

7526	7527	GRE	0	None
7527	7528	contained	0	None
7528	7529	higher	0	None
7529	7530	levels	0	None
7530	7531	of	0	None
7531	7532	all	0	None
7532	7533	compounds	0	None
7533	7534	,	0	None
7534	7535	except	0	None
7535	7536	the	0	None
7536	7537	enolic	0	None
7537	7538	phenylpyruvic	0	None
7538	7539	acid-2-O-glucoside	0	None
7539	7540	and	0	None
7540	7541	luteolin-7-O-glucoside	0	None
7541	7542	.	0	None

7543	7544	Both	0	None
7544	7545	rooibos	0	None
7545	7546	extracts	0	None
7546	7547	increased	0	None
7547	7548	glucose	0	None
7548	7549	uptake	0	None
7549	7550	,	0	None
7550	7551	mitochondrial	0	None
7551	7552	activity	0	None
7552	7553	and	0	None
7553	7554	ATP	0	None
7554	7555	production	0	None
7555	7556	.	0	None

7557	7558	Compared	0	None
7558	7559	to	0	None
7559	7560	FRE	0	None
7560	7561	,	0	None
7561	7562	GRE	0	None
7562	7563	was	0	None
7563	7564	more	0	None
7564	7565	effective	0	None
7565	7566	at	0	None
7566	7567	increasing	0	None
7567	7568	glucose	0	None
7568	7569	uptake	0	None
7569	7570	and	0	None
7570	7571	ATP	0	None
7571	7572	production	0	None
7572	7573	.	0	None

7574	7575	At	0	None
7575	7576	a	0	None
7576	7577	mechanistic	0	None
7577	7578	level	0	None
7578	7579	both	0	None
7579	7580	extracts	0	None
7580	7581	down-regulated	0	None
7581	7582	PKC	0	None
7582	7583	θ	0	None
7583	7584	activation	0	None
7584	7585	,	0	None
7585	7586	which	0	None
7586	7587	is	0	None
7587	7588	associated	0	None
7588	7589	with	0	None
7589	7590	palmitate-induced	0	None
7590	7591	insulin	0	None
7591	7592	resistance	0	None
7592	7593	.	0	None

7594	7595	Furthermore	0	None
7595	7596	,	0	None
7596	7597	the	0	None
7597	7598	extracts	0	None
7598	7599	increased	0	None
7599	7600	activation	0	None
7600	7601	of	0	None
7601	7602	key	0	None
7602	7603	regulatory	0	None
7603	7604	proteins	0	None
7604	7605	(	0	None
7605	7606	AKT	3	GENE-N
7606	7607	and	0	None
7607	7608	AMPK	0	None
7608	7609	)	0	None
7609	7610	involved	0	None
7610	7611	in	0	None
7611	7612	insulin-dependent	0	None
7612	7613	and	0	None
7613	7614	non-insulin	0	None
7614	7615	regulated	0	None
7615	7616	signalling	0	None
7616	7617	pathways	0	None
7617	7618	.	0	None

7619	7620	Protein	0	None
7620	7621	levels	0	None
7621	7622	of	0	None
7622	7623	the	0	None
7623	7625	glucose transporter	1	GENE-Y
7625	7626	(	0	None
7626	7627	GLUT4	0	None
7627	7628	)	0	None
7628	7629	involved	0	None
7629	7630	in	0	None
7630	7631	glucose	0	None
7631	7632	transport	0	None
7632	7633	via	0	None
7633	7634	these	0	None
7634	7635	two	0	None
7635	7636	pathways	0	None
7636	7637	were	0	None
7637	7638	also	0	None
7638	7639	increased	0	None
7639	7640	.	0	None

7641	7642	This	0	None
7642	7643	in	0	None
7643	7644	vitro	0	None
7644	7645	study	0	None
7645	7646	therefore	0	None
7646	7647	confirms	0	None
7647	7648	that	0	None
7648	7649	rooibos	0	None
7649	7650	can	0	None
7650	7651	ameliorate	0	None
7651	7652	palmitate-induced	0	None
7652	7653	insulin	0	None
7653	7654	resistance	0	None
7654	7655	in	0	None
7655	7656	C2C12	0	None
7656	7657	skeletal	0	None
7657	7658	muscle	0	None
7658	7659	cells	0	None
7659	7660	.	0	None

7661	7662	Inhibition	0	None
7662	7663	of	0	None
7663	7664	PKC	0	None
7664	7665	θ	0	None
7665	7666	activation	0	None
7666	7667	and	0	None
7667	7668	increased	0	None
7668	7669	activation	0	None
7669	7670	of	0	None
7670	7671	AMPK	0	None
7671	7672	and	0	None
7672	7673	AKT	3	GENE-N
7673	7674	offer	0	None
7674	7675	a	0	None
7675	7676	plausible	0	None
7676	7677	mechanistic	0	None
7677	7678	explanation	0	None
7678	7679	for	0	None
7679	7680	this	0	None
7680	7681	ameliorative	0	None
7681	7682	effect	0	None
7682	7683	.	0	None
7683	7684	Inborn	0	None
7684	7685	errors	0	None
7685	7686	in	0	None
7686	7687	the	0	None
7687	7688	metabolism	0	None
7688	7689	of	0	None
7689	7690	glutathione	0	None
7690	7691	.	0	None
7691	7692	Suppression	0	None
7692	7693	of	0	None
7693	7694	adrenal	0	None
7694	7695	function	0	None
7695	7696	by	0	None
7696	7697	low-dose	0	None
7697	7698	prednisone	0	None
7698	7699	:	0	None
7699	7700	assessment	0	None
7700	7701	with	0	None
7701	7702	24-hour	0	None
7702	7703	urinary	0	None
7703	7704	steroid	2	CHEMICAL
7704	7705	hormone	0	None
7705	7706	profiles--a	0	None
7706	7707	review	0	None
7707	7708	of	0	None
7708	7709	five	0	None
7709	7710	cases	0	None
7710	7711	.	0	None
7711	7712	ACTH	0	None
7712	7713	has	0	None
7713	7714	been	0	None
7714	7715	shown	0	None
7715	7716	to	0	None
7716	7717	stimulate	0	None
7717	7718	androgen	0	None
7718	7719	production	0	None
7719	7720	by	0	None
7720	7721	the	0	None
7721	7722	fetal	0	None
7722	7723	/	0	None
7723	7724	neonatal	0	None
7724	7725	mouse	0	None
7725	7726	testis	0	None
7726	7727	through	0	None
7727	7728	the	0	None
7728	7729	melanocortin	0	None
7729	7730	type	0	None
7730	7731	2	0	None
7731	7732	receptor	0	None
7732	7733	(	0	None
7733	7734	MC2R	0	None
7734	7735	)	0	None
7735	7736	.	0	None

7737	7738	This	0	None
7738	7739	study	0	None
7739	7740	was	0	None
7740	7741	designed	0	None
7741	7742	to	0	None
7742	7743	localize	0	None
7743	7744	the	0	None
7744	7745	expression	0	None
7745	7746	of	0	None
7746	7747	MC2R	0	None
7747	7748	in	0	None
7748	7749	the	0	None
7749	7750	neonatal	0	None
7750	7751	mouse	0	None
7751	7752	testis	0	None
7752	7753	and	0	None
7753	7754	characterize	0	None
7754	7755	the	0	None
7755	7756	effects	0	None
7756	7757	of	0	None
7757	7758	ACTH	0	None
7758	7759	on	0	None
7759	7760	testicular	0	None
7760	7761	androgen	0	None
7761	7762	production	0	None
7762	7763	.	0	None

7764	7765	Using	0	None
7765	7766	immunohistochemistry	0	None
7766	7767	,	0	None
7767	7768	MC2R	0	None
7768	7769	was	0	None
7769	7770	localized	0	None
7770	7771	to	0	None
7771	7772	the	0	None
7772	7773	fetal-type	0	None
7773	7774	Leydig	0	None
7774	7775	cell	0	None
7775	7776	population	0	None
7776	7777	of	0	None
7777	7778	the	0	None
7778	7779	neonatal	0	None
7779	7780	testis	0	None
7780	7781	.	0	None

7782	7783	ACTH	0	None
7783	7784	caused	0	None
7784	7785	a	0	None
7785	7786	time-dependent	0	None
7786	7787	increase	0	None
7787	7788	in	0	None
7788	7789	cyclic	0	None
7789	7790	AMP	0	None
7790	7791	(	0	None
7791	7792	cAMP	0	None
7792	7793	)	0	None
7793	7794	and	0	None
7794	7795	testosterone	2	CHEMICAL
7795	7796	production	0	None
7796	7797	by	0	None
7797	7798	isolated	0	None
7798	7799	cells	0	None
7799	7800	with	0	None
7800	7801	an	0	None
7801	7802	increase	0	None
7802	7803	in	0	None
7803	7804	cAMP	0	None
7804	7805	apparent	0	None
7805	7806	in	0	None
7806	7807	<	0	None
7807	7808	3	0	None
7808	7809	min	0	None
7809	7810	.	0	None

7811	7812	There	0	None
7812	7813	was	0	None
7813	7814	no	0	None
7814	7815	additive	0	None
7815	7816	effect	0	None
7816	7817	of	0	None
7817	7818	maximally	0	None
7818	7819	stimulating	0	None
7819	7820	doses	0	None
7820	7821	of	0	None
7821	7822	ACTH	0	None
7822	7823	and	0	None
7823	7824	human	0	None
7824	7825	chorionic	0	None
7825	7826	gonadotropin	0	None
7826	7827	(	0	None
7827	7828	hCG	0	None
7828	7829	)	0	None
7829	7830	.	0	None

7831	7832	Androgen	0	None
7832	7833	production	0	None
7833	7834	in	0	None
7834	7835	response	0	None
7835	7836	to	0	None
7836	7837	ACTH	0	None
7837	7838	and	0	None
7838	7839	hCG	0	None
7839	7840	was	0	None
7840	7841	reduced	0	None
7841	7842	by	0	None
7842	7843	UO126	0	None
7843	7844	and	0	None
7844	7845	dexamethasone	2	CHEMICAL
7845	7846	,	0	None
7846	7847	which	0	None
7847	7848	are	0	None
7848	7849	the	0	None
7849	7850	inhibitors	0	None
7850	7851	of	0	None
7851	7852	ERK1	0	None
7852	7853	/	0	None
7853	7854	2	0	None
7854	7855	and	0	None
7855	7856	phospholipase	0	None
7856	7857	A2	0	None
7857	7858	respectively	0	None
7858	7859	.	0	None

7860	7861	Expression	0	None
7861	7862	of	0	None
7862	7863	mRNA	0	None
7863	7864	encoding	0	None
7864	7865	StAR	0	None
7865	7866	was	0	None
7866	7867	increased	0	None
7867	7868	fourfold	0	None
7868	7869	by	0	None
7869	7870	both	0	None
7870	7871	ACTH	0	None
7871	7872	and	0	None
7872	7873	hCG	0	None
7873	7874	,	0	None
7874	7875	although	0	None
7875	7876	expression	0	None
7876	7877	of	0	None
7877	7878	mRNA	0	None
7878	7879	encoding	0	None
7879	7880	for	0	None
7880	7881	steroidogenic	0	None
7881	7882	enzymes	0	None
7882	7883	was	0	None
7883	7884	not	0	None
7884	7885	markedly	0	None
7885	7886	affected	0	None
7886	7887	.	0	None

7888	7889	The	0	None
7889	7890	potency	0	None
7890	7891	of	0	None
7891	7892	N-terminal	0	None
7892	7893	fragments	0	None
7893	7894	of	0	None
7894	7895	ACTH	0	None
7895	7896	to	0	None
7896	7897	stimulate	0	None
7897	7898	androgen	0	None
7898	7899	production	0	None
7899	7900	was	0	None
7900	7901	similar	0	None
7901	7902	to	0	None
7902	7903	that	0	None
7903	7904	seen	0	None
7904	7905	previously	0	None
7905	7906	in	0	None
7906	7907	the	0	None
7907	7908	adrenal	0	None
7908	7909	.	0	None

7910	7911	Data	0	None
7911	7912	indicate	0	None
7912	7913	that	0	None
7913	7914	both	0	None
7914	7915	LH	0	None
7915	7916	and	0	None
7916	7917	ACTH	0	None
7917	7918	,	0	None
7918	7919	acting	0	None
7919	7920	through	0	None
7920	7921	their	0	None
7921	7922	respective	0	None
7922	7923	receptors	0	None
7923	7924	,	0	None
7924	7925	stimulate	0	None
7925	7926	steroidogenesis	0	None
7926	7927	by	0	None
7927	7928	fetal-type	0	None
7928	7929	Leydig	0	None
7929	7930	cells	0	None
7930	7931	via	0	None
7931	7933	arachidonic acid	2	CHEMICAL
7933	7934	,	0	None
7934	7937	protein kinase A	1	GENE-Y
7937	7938	,	0	None
7938	7939	and	0	None
7939	7940	ERK1	0	None
7940	7941	/	0	None
7941	7942	2	0	None
7942	7943	activation	0	None
7943	7944	of	0	None
7944	7945	StAR	0	None
7945	7946	.	0	None
7946	7947	As	0	None
7947	7948	a	0	None
7948	7949	treatment	0	None
7949	7950	for	0	None
7950	7951	dyslipidemia	0	None
7951	7952	,	0	None
7952	7953	oral	0	None
7953	7954	doses	0	None
7954	7955	of	0	None
7955	7956	1-3	0	None
7956	7957	grams	0	None
7957	7958	of	0	None
7958	7960	nicotinic acid	2	CHEMICAL
7960	7961	per	0	None
7961	7962	day	0	None
7962	7963	lower	0	None
7963	7964	serum	0	None
7964	7965	triglycerides	0	None
7965	7966	,	0	None
7966	7967	raise	0	None
7967	7968	high	0	None
7968	7969	density	0	None
7969	7970	lipoprotein	3	GENE-N
7970	7971	cholesterol	0	None
7971	7972	,	0	None
7972	7973	and	0	None
7973	7974	reduce	0	None
7974	7975	mortality	0	None
7975	7976	from	0	None
7976	7977	coronary	0	None
7977	7978	heart	0	None
7978	7979	disease	0	None
7979	7980	(	0	None
7980	7981	Tavintharan	0	None
7981	7982	,	0	None
7982	7983	S	0	None
7983	7984	.	0	None

7985	7986	,	0	None
7986	7987	and	0	None
7987	7988	Kashyap	0	None
7988	7989	,	0	None
7989	7990	M	0	None
7990	7991	.	0	None

7992	7993	L	0	None
7993	7994	.	0	None

7995	7996	(	0	None
7996	7997	2001	0	None
7997	7998	)	0	None
7998	7999	Curr	0	None
7999	8000	.	0	None

8001	8002	Atheroscler	0	None
8002	8003	.	0	None

8004	8005	Rep	0	None
8005	8006	.	0	None

8007	8008	3	0	None
8008	8009	,	0	None
8009	8010	74-82	0	None
8010	8011	)	0	None
8011	8012	.	0	None

8013	8014	These	0	None
8014	8015	benefits	0	None
8015	8016	likely	0	None
8016	8017	result	0	None
8017	8018	from	0	None
8018	8019	the	0	None
8019	8020	ability	0	None
8020	8021	of	0	None
8021	8023	nicotinic acid	2	CHEMICAL
8023	8024	to	0	None
8024	8025	inhibit	0	None
8025	8026	lipolysis	0	None
8026	8027	in	0	None
8027	8028	adipocytes	0	None
8028	8029	and	0	None
8029	8030	thereby	0	None
8030	8031	reduce	0	None
8031	8032	serum	0	None
8032	8033	non-esterified	0	None
8033	8035	fatty acid	2	CHEMICAL
8035	8036	levels	0	None
8036	8037	(	0	None
8037	8038	Carlson	0	None
8038	8039	,	0	None
8039	8040	L	0	None
8040	8041	.	0	None

8042	8043	A	0	None
8043	8044	.	0	None

8045	8046	(	0	None
8046	8047	1963	0	None
8047	8048	)	0	None
8048	8049	Acta	0	None
8049	8050	Med	0	None
8050	8051	.	0	None

8052	8053	Scand	0	None
8053	8054	.	0	None

8055	8056	173	0	None
8056	8057	,	0	None
8057	8058	719-722	0	None
8058	8059	)	0	None
8059	8060	.	0	None

8061	8062	In	0	None
8062	8063	mice	0	None
8063	8064	,	0	None
8064	8066	nicotinic acid	2	CHEMICAL
8066	8067	inhibits	0	None
8067	8068	lipolysis	0	None
8068	8069	via	0	None
8069	8070	PUMA-G	1	GENE-Y
8070	8071	,	0	None
8071	8072	a	0	None
8072	8073	Gi	0	None
8073	8074	/	0	None
8074	8075	o-coupled	0	None
8075	8076	seven-transmembrane	0	None
8076	8077	receptor	0	None
8077	8078	expressed	0	None
8078	8079	in	0	None
8079	8080	adipocytes	0	None
8080	8081	and	0	None
8081	8082	activated	0	None
8082	8083	macrophages	0	None
8083	8084	(	0	None
8084	8085	Tunaru	0	None
8085	8086	,	0	None
8086	8087	S	0	None
8087	8088	.	0	None

8089	8090	,	0	None
8090	8091	Kero	0	None
8091	8092	,	0	None
8092	8093	J	0	None
8093	8094	.	0	None

8095	8096	,	0	None
8096	8097	Schaub	0	None
8097	8098	,	0	None
8098	8099	A	0	None
8099	8100	.	0	None

8101	8102	,	0	None
8102	8103	Wufka	0	None
8103	8104	,	0	None
8104	8105	C	0	None
8105	8106	.	0	None

8107	8108	,	0	None
8108	8109	Blaukat	0	None
8109	8110	,	0	None
8110	8111	A	0	None
8111	8112	.	0	None

8113	8114	,	0	None
8114	8115	Pfeffer	0	None
8115	8116	,	0	None
8116	8117	K	0	None
8117	8118	.	0	None

8119	8120	,	0	None
8120	8121	and	0	None
8121	8122	Offermanns	0	None
8122	8123	,	0	None
8123	8124	S	0	None
8124	8125	.	0	None

8126	8127	(	0	None
8127	8128	2003	0	None
8128	8129	)	0	None
8129	8130	Nat	0	None
8130	8131	.	0	None

8132	8133	Med	0	None
8133	8134	.	0	None

8135	8136	9	0	None
8136	8137	,	0	None
8137	8138	352-355	0	None
8138	8139	)	0	None
8139	8140	.	0	None

8141	8142	The	0	None
8142	8143	human	0	None
8143	8144	ortholog	0	None
8144	8145	HM74a	0	None
8145	8146	is	0	None
8146	8147	also	0	None
8147	8148	a	0	None
8148	8151	nicotinic acid receptor	1	GENE-Y
8151	8152	and	0	None
8152	8153	likely	0	None
8153	8154	has	0	None
8154	8155	a	0	None
8155	8156	similar	0	None
8156	8157	role	0	None
8157	8158	in	0	None
8158	8159	anti-lipolysis	0	None
8159	8160	.	0	None

8161	8162	Endogenous	0	None
8162	8163	levels	0	None
8163	8164	of	0	None
8164	8166	nicotinic acid	2	CHEMICAL
8166	8167	are	0	None
8167	8168	too	0	None
8168	8169	low	0	None
8169	8170	to	0	None
8170	8171	significantly	0	None
8171	8172	impact	0	None
8172	8173	receptor	0	None
8173	8174	activity	0	None
8174	8175	,	0	None
8175	8176	hence	0	None
8176	8177	the	0	None
8177	8178	natural	0	None
8178	8179	ligands	0	None
8179	8180	(	0	None
8180	8181	s	0	None
8181	8182	)	0	None
8182	8183	of	0	None
8183	8184	HM74a	0	None
8184	8185	/	0	None
8185	8186	PUMA-G	1	GENE-Y
8186	8187	remain	0	None
8187	8188	to	0	None
8188	8189	be	0	None
8189	8190	elucidated	0	None
8190	8191	.	0	None

8192	8193	Here	0	None
8193	8194	we	0	None
8194	8195	show	0	None
8195	8196	that	0	None
8196	8197	the	0	None
8197	8198	fatty	0	None
8198	8199	acid-derived	0	None
8199	8200	ketone	0	None
8200	8201	body	0	None
8201	8202	(	0	None
8202	8203	D	0	None
8203	8204	)	0	None
8204	8205	-beta-hydroxybutyrate	0	None
8205	8206	(	0	None
8206	8207	(	0	None
8207	8208	D	0	None
8208	8209	)	0	None
8209	8210	-beta-OHB	0	None
8210	8211	)	0	None
8211	8212	specifically	0	None
8212	8213	activates	0	None
8213	8214	PUMA-G	1	GENE-Y
8214	8215	/	0	None
8215	8216	HM74a	0	None
8216	8217	at	0	None
8217	8218	concentrations	0	None
8218	8219	observed	0	None
8219	8220	in	0	None
8220	8221	serum	0	None
8221	8222	during	0	None
8222	8223	fasting	0	None
8223	8224	.	0	None

8225	8228	Like nicotinic acid	2	CHEMICAL
8228	8229	,	0	None
8229	8230	(	0	None
8230	8231	D	0	None
8231	8232	)	0	None
8232	8233	-beta-OHB	0	None
8233	8234	inhibits	0	None
8234	8235	mouse	0	None
8235	8236	adipocyte	0	None
8236	8237	lipolysis	0	None
8237	8238	in	0	None
8238	8239	a	0	None
8239	8240	PUMA-G-dependent	0	None
8240	8241	manner	0	None
8241	8242	and	0	None
8242	8243	is	0	None
8243	8244	thus	0	None
8244	8245	the	0	None
8245	8246	first	0	None
8246	8247	endogenous	0	None
8247	8248	ligand	0	None
8248	8249	described	0	None
8249	8250	for	0	None
8250	8251	this	0	None
8251	8252	orphan	0	None
8252	8253	receptor	0	None
8253	8254	.	0	None

8255	8256	These	0	None
8256	8257	findings	0	None
8257	8258	suggests	0	None
8258	8259	a	0	None
8259	8260	homeostatic	0	None
8260	8261	mechanism	0	None
8261	8262	for	0	None
8262	8263	surviving	0	None
8263	8264	starvation	0	None
8264	8265	in	0	None
8265	8266	which	0	None
8266	8267	(	0	None
8267	8268	D	0	None
8268	8269	)	0	None
8269	8270	-beta-OHB	0	None
8270	8271	negatively	0	None
8271	8272	regulates	0	None
8272	8273	its	0	None
8273	8274	own	0	None
8274	8275	production	0	None
8275	8276	,	0	None
8276	8277	thereby	0	None
8277	8278	preventing	0	None
8278	8279	ketoacidosis	0	None
8279	8280	and	0	None
8280	8281	promoting	0	None
8281	8282	efficient	0	None
8282	8283	use	0	None
8283	8284	of	0	None
8284	8285	fat	0	None
8285	8286	stores	0	None
8286	8287	.	0	None
8287	8288	The	0	None
8288	8289	mechanisms	0	None
8289	8290	that	0	None
8290	8291	can	0	None
8291	8292	account	0	None
8292	8293	for	0	None
8293	8294	the	0	None
8294	8295	remarkable	0	None
8295	8296	mammary	0	None
8296	8297	carcinogenicity	0	None
8297	8298	of	0	None
8298	8299	the	0	None
8299	8300	environmental	0	None
8300	8301	pollutant	0	None
8301	8302	6-nitrochrysene	0	None
8302	8303	(	0	None
8303	8304	6-NC	0	None
8304	8305	)	0	None
8305	8306	in	0	None
8306	8307	the	0	None
8307	8308	rat	0	None
8308	8309	remain	0	None
8309	8310	elusive	0	None
8310	8311	.	0	None

8312	8313	In	0	None
8313	8314	our	0	None
8314	8315	previous	0	None
8315	8316	studies	0	None
8316	8317	,	0	None
8317	8318	we	0	None
8318	8319	identified	0	None
8319	8320	several	0	None
8320	8321	6-NC-derived	0	None
8321	8322	DNA	0	None
8322	8323	adducts	0	None
8323	8324	in	0	None
8324	8325	the	0	None
8325	8326	rat	0	None
8326	8327	mammary	0	None
8327	8328	gland;	0	None
8328	8329	one	0	None
8329	8330	major	0	None
8330	8331	adduct	0	None
8331	8332	was	0	None
8332	8333	derived	0	None
8333	8334	from	0	None
8334	8335	(	0	None
8335	8336	±	0	None
8336	8337	)	0	None
8337	8338	-trans-1	0	None
8338	8339	,	0	None
8339	8340	2-dihydroxy-1	0	None
8340	8341	,	0	None
8341	8342	2-dihydro-6-nitrochrysene	0	None
8342	8343	(	0	None
8343	8344	1	0	None
8344	8345	,	0	None
8345	8346	2-DHD-6-NC	0	None
8346	8347	)	0	None
8347	8348	.	0	None

8349	8350	In	0	None
8350	8351	the	0	None
8351	8352	present	0	None
8352	8353	study	0	None
8353	8354	,	0	None
8354	8355	we	0	None
8355	8356	resolved	0	None
8356	8357	the	0	None
8357	8358	racemic	0	None
8358	8359	(	0	None
8359	8360	±	0	None
8360	8361	)	0	None
8361	8362	-1	0	None
8362	8363	,	0	None
8363	8364	2-DHD-6-NC	0	None
8364	8365	into	0	None
8365	8366	(	0	None
8366	8367	-	0	None
8367	8368	)	0	None
8368	8369	-	0	None
8369	8370	[	0	None
8370	8371	R	0	None
8371	8372	,	0	None
8372	8373	R	0	None
8373	8374	]	0	None
8374	8375	-	0	None
8375	8376	and	0	None
8376	8377	(	0	None
8377	8378	+	0	None
8378	8379	)	0	None
8379	8380	-	0	None
8380	8381	[	0	None
8381	8382	S	0	None
8382	8383	,	0	None
8383	8384	S	0	None
8384	8385	]	0	None
8385	8386	-1	0	None
8386	8387	,	0	None
8387	8388	2-DHD-6-NC	0	None
8388	8389	and	0	None
8389	8390	compared	0	None
8390	8391	their	0	None
8391	8392	in	0	None
8392	8393	vivo	0	None
8393	8394	mutagenicity	0	None
8394	8395	and	0	None
8395	8396	carcinogenicity	0	None
8396	8397	in	0	None
8397	8398	the	0	None
8398	8399	mammary	0	None
8399	8400	glands	0	None
8400	8401	of	0	None
8401	8402	female	0	None
8402	8403	transgenic	0	None
8403	8404	(	0	None
8404	8405	BigBlue	0	None
8405	8406	F344	0	None
8406	8407	×	0	None
8407	8408	Sprague-Dawley	0	None
8408	8409	)	0	None
8409	8410	F1	0	None
8410	8411	rats	0	None
8411	8412	harboring	0	None
8412	8413	lacI	0	None
8413	8414	/	0	None
8414	8415	cII	0	None
8415	8416	and	0	None
8416	8417	Sprague-Dawley	0	None
8417	8418	rats	0	None
8418	8419	,	0	None
8419	8420	respectively	0	None
8420	8421	.	0	None

8422	8423	Both	0	None
8423	8424	[	0	None
8424	8425	R	0	None
8425	8426	,	0	None
8426	8427	R	0	None
8427	8428	]	0	None
8428	8429	-	0	None
8429	8430	and	0	None
8430	8431	[	0	None
8431	8432	S	0	None
8432	8433	,	0	None
8433	8434	S	0	None
8434	8435	]	0	None
8435	8436	-isomers	0	None
8436	8437	exerted	0	None
8437	8438	similar	0	None
8438	8439	mutagenicity	0	None
8439	8440	and	0	None
8440	8441	carcinogenicity	0	None
8441	8442	but	0	None
8442	8443	were	0	None
8443	8444	less	0	None
8444	8445	potent	0	None
8445	8446	than	0	None
8446	8447	6-NC	0	None
8447	8448	.	0	None

8449	8450	Additional	0	None
8450	8451	in	0	None
8451	8452	vivo	0	None
8452	8453	and	0	None
8453	8454	in	0	None
8454	8455	vitro	0	None
8455	8456	studies	0	None
8456	8457	were	0	None
8457	8458	then	0	None
8458	8459	performed	0	None
8459	8460	to	0	None
8460	8461	explore	0	None
8461	8462	possible	0	None
8462	8463	mechanisms	0	None
8463	8464	that	0	None
8464	8465	can	0	None
8465	8466	explain	0	None
8466	8467	the	0	None
8467	8468	higher	0	None
8468	8469	potency	0	None
8469	8470	of	0	None
8470	8471	6-NC	0	None
8471	8472	than	0	None
8472	8473	1	0	None
8473	8474	,	0	None
8474	8475	2-DHD-6-NC	0	None
8475	8476	.	0	None

8477	8478	Using	0	None
8478	8479	ELISA	0	None
8479	8480	,	0	None
8480	8481	we	0	None
8481	8482	found	0	None
8482	8483	that	0	None
8483	8484	neither	0	None
8484	8485	6-NC	0	None
8485	8486	nor	0	None
8486	8487	1	0	None
8487	8488	,	0	None
8488	8489	2-DHD-6-NC	0	None
8489	8490	increased	0	None
8490	8491	the	0	None
8491	8492	levels	0	None
8492	8493	of	0	None
8493	8494	several	0	None
8494	8495	inflammatory	0	None
8495	8496	cytokines	3	GENE-N
8496	8497	in	0	None
8497	8498	plasma	0	None
8498	8499	obtained	0	None
8499	8500	from	0	None
8500	8501	rats	0	None
8501	8502	24	0	None
8502	8503	h	0	None
8503	8504	after	0	None
8504	8505	treatment	0	None
8505	8506	.	0	None

8507	8508	In	0	None
8508	8509	MCF-7	0	None
8509	8510	cells	0	None
8510	8511	,	0	None
8511	8512	as	0	None
8512	8513	determined	0	None
8513	8514	by	0	None
8514	8515	immunoblotting	0	None
8515	8516	,	0	None
8516	8517	the	0	None
8517	8518	effects	0	None
8518	8519	of	0	None
8519	8520	6-NC	0	None
8520	8521	and	0	None
8521	8522	1	0	None
8522	8523	,	0	None
8523	8524	2-DHD-6-NC	0	None
8524	8525	on	0	None
8525	8526	protein	0	None
8526	8527	expression	0	None
8527	8528	(	0	None
8528	8529	p53	0	None
8529	8530	,	0	None
8530	8531	Akt	0	None
8531	8532	,	0	None
8532	8533	p38	0	None
8533	8534	,	0	None
8534	8535	JNK	0	None
8535	8536	,	0	None
8536	8537	c-myc	1	GENE-Y
8537	8538	,	0	None
8538	8539	bcl-2	1	GENE-Y
8539	8540	,	0	None
8540	8541	PCNA	0	None
8541	8542	,	0	None
8542	8543	and	0	None
8543	8544	ERβ	0	None
8544	8545	)	0	None
8545	8546	were	0	None
8546	8547	comparable;	0	None
8547	8548	however	0	None
8548	8549	,	0	None
8549	8550	the	0	None
8550	8551	expressions	0	None
8551	8552	of	0	None
8552	8553	AhR	0	None
8553	8554	and	0	None
8554	8555	ERα	0	None
8555	8556	proteins	0	None
8556	8557	were	0	None
8557	8558	decreased	0	None
8558	8559	by	0	None
8559	8560	6-NC	0	None
8560	8561	but	0	None
8561	8562	not	0	None
8562	8563	1	0	None
8563	8564	,	0	None
8564	8565	2-DHD-6-NC	0	None
8565	8566	.	0	None

8567	8568	The	0	None
8568	8569	expression	0	None
8569	8570	of	0	None
8570	8571	both	0	None
8571	8572	receptors	0	None
8572	8573	was	0	None
8573	8574	decreased	0	None
8574	8575	in	0	None
8575	8576	mammary	0	None
8576	8577	tissues	0	None
8577	8578	of	0	None
8578	8579	rats	0	None
8579	8580	treated	0	None
8580	8581	with	0	None
8581	8582	6-NC	0	None
8582	8583	.	0	None

8584	8585	Our	0	None
8585	8586	findings	0	None
8586	8587	suggest	0	None
8587	8588	that	0	None
8588	8589	the	0	None
8589	8590	differential	0	None
8590	8591	effects	0	None
8591	8592	of	0	None
8592	8593	6-NC	0	None
8593	8594	and	0	None
8594	8595	1	0	None
8595	8596	,	0	None
8596	8597	2-DHD-6-NC	0	None
8597	8598	on	0	None
8598	8599	AhR	0	None
8599	8600	and	0	None
8600	8601	ERα	0	None
8601	8602	could	0	None
8602	8603	potentially	0	None
8603	8604	account	0	None
8604	8605	for	0	None
8605	8606	the	0	None
8606	8607	higher	0	None
8607	8608	carcinogenicity	0	None
8608	8609	of	0	None
8609	8610	6-NC	0	None
8610	8611	in	0	None
8611	8612	the	0	None
8612	8613	rat	0	None
8613	8614	mammary	0	None
8614	8615	gland	0	None
8615	8616	.	0	None
8616	8617	Evidence	0	None
8617	8618	for	0	None
8618	8619	a	0	None
8619	8620	role	0	None
8620	8621	of	0	None
8621	8622	dopamine	0	None
8622	8623	and	0	None
8623	8624	serotonin	0	None
8624	8625	in	0	None
8625	8626	the	0	None
8626	8627	control	0	None
8627	8628	of	0	None
8628	8629	ethanol	2	CHEMICAL
8629	8630	intake	0	None
8630	8631	in	0	None
8631	8632	animals	0	None
8632	8633	suggests	0	None
8633	8634	that	0	None
8634	8636	monoamine oxidase	3	GENE-N
8636	8637	(	0	None
8637	8638	MAO	3	GENE-N
8638	8639	)	0	None
8639	8640	inhibitors	0	None
8640	8641	,	0	None
8641	8642	which	0	None
8642	8643	increase	0	None
8643	8644	the	0	None
8644	8645	synaptic	0	None
8645	8646	availability	0	None
8646	8647	of	0	None
8647	8648	serotonin	0	None
8648	8649	and	0	None
8649	8650	dopamine	0	None
8650	8651	by	0	None
8651	8652	blocking	0	None
8652	8653	their	0	None
8653	8654	metabolism	0	None
8654	8655	,	0	None
8655	8656	might	0	None
8656	8657	have	0	None
8657	8658	efficacy	0	None
8658	8659	in	0	None
8659	8660	the	0	None
8660	8661	treatment	0	None
8661	8662	of	0	None
8662	8663	alcohol	2	CHEMICAL
8663	8664	dependence	0	None
8664	8665	.	0	None

8666	8667	The	0	None
8667	8668	aim	0	None
8668	8669	of	0	None
8669	8670	the	0	None
8670	8671	present	0	None
8671	8672	study	0	None
8672	8673	was	0	None
8673	8674	,	0	None
8674	8675	therefore	0	None
8675	8676	,	0	None
8676	8677	to	0	None
8677	8678	evaluate	0	None
8678	8679	several	0	None
8679	8680	MAO	3	GENE-N
8680	8681	inhibitors	0	None
8681	8682	for	0	None
8682	8683	their	0	None
8683	8684	capacity	0	None
8684	8685	to	0	None
8685	8686	affect	0	None
8686	8687	ethanol	2	CHEMICAL
8687	8688	self-administration	0	None
8688	8689	in	0	None
8689	8690	rats	0	None
8690	8691	trained	0	None
8691	8692	to	0	None
8692	8693	self-administer	0	None
8693	8694	ethanol	2	CHEMICAL
8694	8695	(	0	None
8695	8696	10%	0	None
8696	8697	v	0	None
8697	8698	/	0	None
8698	8699	v	0	None
8699	8700	)	0	None
8700	8701	orally	0	None
8701	8702	in	0	None
8702	8703	a	0	None
8703	8704	free-choice	0	None
8704	8705	two-lever	0	None
8705	8706	operant	0	None
8706	8707	task	0	None
8707	8708	.	0	None

8709	8710	The	0	None
8710	8711	nonselective	0	None
8711	8712	and	0	None
8712	8713	irreversible	0	None
8713	8714	MAO	3	GENE-N
8714	8715	inhibitors	0	None
8715	8716	,	0	None
8716	8717	phenelzine	2	CHEMICAL
8717	8718	(	0	None
8718	8719	3-10	0	None
8719	8720	mg	2	CHEMICAL
8720	8721	/	0	None
8721	8722	kg	0	None
8722	8723	)	0	None
8723	8724	,	0	None
8724	8725	tranylcypromine	0	None
8725	8726	(	0	None
8726	8727	1-3	0	None
8727	8728	mg	2	CHEMICAL
8728	8729	/	0	None
8729	8730	kg	0	None
8730	8731	)	0	None
8731	8732	,	0	None
8732	8733	and	0	None
8733	8734	nialamide	0	None
8734	8735	(	0	None
8735	8736	30	0	None
8736	8737	mg	2	CHEMICAL
8737	8738	/	0	None
8738	8739	kg	0	None
8739	8740	)	0	None
8740	8741	,	0	None
8741	8742	decreased	0	None
8742	8743	rates	0	None
8743	8744	of	0	None
8744	8745	responding	0	None
8745	8746	maintained	0	None
8746	8747	by	0	None
8747	8748	ethanol	2	CHEMICAL
8748	8749	reinforcement	0	None
8749	8750	.	0	None

8751	8752	The	0	None
8752	8753	reversible	0	None
8753	8754	MAO-A	0	None
8754	8755	inhibitor	0	None
8755	8756	,	0	None
8756	8757	befloxatone	0	None
8757	8758	(	0	None
8758	8759	0	0	None
8759	8760	.	0	None
8760	8761	3-3	0	None
8761	8762	mg	2	CHEMICAL
8762	8763	/	0	None
8763	8764	kg	0	None
8764	8765	)	0	None
8765	8766	,	0	None
8766	8767	and	0	None
8767	8768	the	0	None
8768	8769	irreversible	0	None
8769	8770	MAO-A	0	None
8770	8771	inhibitor	0	None
8771	8772	,	0	None
8772	8773	clorgyline	0	None
8773	8774	(	0	None
8774	8775	10-30	0	None
8775	8776	mg	2	CHEMICAL
8776	8777	/	0	None
8777	8778	kg	0	None
8778	8779	)	0	None
8779	8780	,	0	None
8780	8781	also	0	None
8781	8782	reduced	0	None
8782	8783	ethanol	2	CHEMICAL
8783	8784	self-administration	0	None
8784	8785	.	0	None

8786	8787	However	0	None
8787	8788	,	0	None
8788	8789	befloxatone-induced	0	None
8789	8790	effects	0	None
8790	8791	leveled	0	None
8791	8792	off	0	None
8792	8793	at	0	None
8793	8794	a	0	None
8794	8795	50%	0	None
8795	8796	decrease	0	None
8796	8797	.	0	None

8798	8799	The	0	None
8799	8800	irreversible	0	None
8800	8801	MAO-B	0	None
8801	8802	inhibitors	0	None
8802	8803	,	0	None
8803	8804	pargyline	0	None
8804	8805	(	0	None
8805	8806	30	0	None
8806	8807	mg	2	CHEMICAL
8807	8808	/	0	None
8808	8809	kg	0	None
8809	8810	)	0	None
8810	8811	and	0	None
8811	8812	l-deprenyl	0	None
8812	8813	(	0	None
8813	8814	3-10	0	None
8814	8815	mg	2	CHEMICAL
8815	8816	/	0	None
8816	8817	kg	0	None
8817	8818	)	0	None
8818	8819	also	0	None
8819	8820	decreased	0	None
8820	8821	responding	0	None
8821	8822	maintained	0	None
8822	8823	by	0	None
8823	8824	ethanol	2	CHEMICAL
8824	8825	reinforcement;	0	None
8825	8826	these	0	None
8826	8827	results	0	None
8827	8828	are	0	None
8828	8829	consistent	0	None
8829	8830	with	0	None
8830	8831	previous	0	None
8831	8832	findings	0	None
8832	8833	that	0	None
8833	8834	both	0	None
8834	8835	drugs	0	None
8835	8836	decreased	0	None
8836	8837	ethanol	2	CHEMICAL
8837	8838	intake	0	None
8838	8839	in	0	None
8839	8840	mice	0	None
8840	8841	.	0	None

8842	8843	In	0	None
8843	8844	conclusion	0	None
8844	8845	,	0	None
8845	8846	the	0	None
8846	8847	present	0	None
8847	8848	results	0	None
8848	8849	showing	0	None
8849	8850	that	0	None
8850	8851	several	0	None
8851	8852	MAO	3	GENE-N
8852	8853	inhibitors	0	None
8853	8854	decreased	0	None
8854	8855	ethanol	2	CHEMICAL
8855	8856	self-administration	0	None
8856	8857	in	0	None
8857	8858	rats	0	None
8858	8859	are	0	None
8859	8860	consistent	0	None
8860	8861	with	0	None
8861	8862	previous	0	None
8862	8863	findings	0	None
8863	8864	that	0	None
8864	8865	synaptic	0	None
8865	8866	levels	0	None
8866	8867	of	0	None
8867	8868	serotonin	0	None
8868	8869	and	0	None
8869	8870	dopamine	0	None
8870	8871	play	0	None
8871	8872	a	0	None
8872	8873	critical	0	None
8873	8874	role	0	None
8874	8875	in	0	None
8875	8876	the	0	None
8876	8877	control	0	None
8877	8878	of	0	None
8878	8879	ethanol	2	CHEMICAL
8879	8880	self-administration	0	None
8880	8881	.	0	None
8881	8882	MLL	0	None
8882	8883	histone	0	None
8883	8884	methylases	0	None
8884	8885	regulate	0	None
8885	8886	expression	0	None
8886	8887	of	0	None
8887	8888	HDLR-SR-B1	0	None
8888	8889	in	0	None
8889	8890	presence	0	None
8890	8891	of	0	None
8891	8892	estrogen	0	None
8892	8893	and	0	None
8893	8894	control	0	None
8894	8895	plasma	0	None
8895	8896	cholesterol	0	None
8896	8897	in	0	None
8897	8898	vivo	0	None
8898	8899	.	0	None
8899	8900	Apomorphine	0	None
8900	8901	induces	0	None
8901	8902	trophic	0	None
8902	8903	factors	0	None
8903	8904	that	0	None
8904	8905	support	0	None
8905	8906	fetal	0	None
8906	8907	rat	0	None
8907	8908	mesencephalic	0	None
8908	8909	dopaminergic	0	None
8909	8910	neurons	0	None
8910	8911	in	0	None
8911	8912	cultures	0	None
8912	8913	.	0	None
8913	8914	A	0	None
8914	8915	series	0	None
8915	8916	of	0	None
8916	8917	5-	0	None
8917	8918	and	0	None
8918	8919	8-methoxypsoralen	0	None
8919	8920	(	0	None
8920	8921	MOP	0	None
8921	8922	)	0	None
8922	8923	analogs	0	None
8923	8924	,	0	None
8924	8925	suitable	0	None
8925	8926	for	0	None
8926	8927	structure-antioxidative	0	None
8927	8928	/	0	None
8928	8929	anti-inflammatory	0	None
8929	8930	activity	0	None
8930	8931	relationship	0	None
8931	8932	studies	0	None
8932	8933	,	0	None
8933	8934	were	0	None
8934	8935	synthesized	0	None
8935	8936	using	0	None
8936	8937	as	0	None
8937	8938	key-reactions	0	None
8938	8939	the	0	None
8939	8940	selective	0	None
8940	8941	monobromination	0	None
8941	8942	of	0	None
8942	8943	MOPs	2	CHEMICAL
8943	8944	with	0	None
8944	8945	N-bromosaccharin	0	None
8945	8946	and	0	None
8946	8947	either	0	None
8947	8948	a	0	None
8948	8949	Heck	0	None
8949	8950	reaction	0	None
8950	8951	or	0	None
8951	8952	a	0	None
8952	8953	Suzuki	0	None
8953	8954	coupling	0	None
8954	8955	or	0	None
8955	8956	a	0	None
8956	8957	Suzuki	0	None
8957	8958	coupling	0	None
8958	8959	followed	0	None
8959	8960	by	0	None
8960	8961	a	0	None
8961	8962	Wittig	0	None
8962	8963	reaction	0	None
8963	8964	to	0	None
8964	8965	install	0	None
8965	8966	side-chains	0	None
8966	8967	of	0	None
8967	8968	the	0	None
8968	8969	acrylate-	0	None
8969	8970	or	0	None
8970	8971	benzoate-	0	None
8971	8972	or	0	None
8972	8973	cinnamate-type	0	None
8973	8974	,	0	None
8974	8975	respectively	0	None
8975	8976	.	0	None

8977	8978	The	0	None
8978	8979	8-MOP	0	None
8979	8980	analogs	0	None
8980	8981	19	0	None
8981	8982	and	0	None
8982	8983	24	0	None
8983	8984	,	0	None
8984	8985	incorporating	0	None
8985	8986	at	0	None
8986	8987	position	0	None
8987	8988	5	0	None
8988	8989	of	0	None
8989	8990	the	0	None
8990	8991	psoralen	0	None
8991	8992	nucleus	0	None
8992	8993	a	0	None
8993	8994	butyl	0	None
8994	8995	acrylate	2	CHEMICAL
8995	8996	or	0	None
8996	8997	a	0	None
8997	8998	tert-butyl	0	None
8998	8999	cinnamate	0	None
8999	9000	moiety	0	None
9000	9001	,	0	None
9001	9002	were	0	None
9002	9003	the	0	None
9003	9004	most	0	None
9004	9005	powerful	0	None
9005	9006	inhibitors	0	None
9006	9007	of	0	None
9007	9009	soybean LOX	3	GENE-N
9009	9010	and	0	None
9010	9011	inhibited	0	None
9011	9012	effectively	0	None
9012	9013	lipid	0	None
9013	9014	peroxidation	0	None
9014	9015	.	0	None

9016	9017	Analog	0	None
9017	9018	19	0	None
9018	9019	was	0	None
9019	9020	a	0	None
9020	9021	more	0	None
9021	9022	potent	0	None
9022	9023	anti-inflammatory	0	None
9023	9024	agent	0	None
9024	9025	than	0	None
9025	9026	the	0	None
9026	9027	reference	0	None
9027	9028	compound	0	None
9028	9029	indomethacin	0	None
9029	9030	and	0	None
9030	9031	of	0	None
9031	9032	comparable	0	None
9032	9033	cytocompatibility	0	None
9033	9034	to	0	None
9034	9035	8-MOP	0	None
9035	9036	whereas	0	None
9036	9037	analog	0	None
9037	9038	24	0	None
9038	9039	was	0	None
9039	9040	a	0	None
9040	9041	weaker	0	None
9041	9042	inhibitor	0	None
9042	9043	of	0	None
9043	9044	inflammation	0	None
9044	9045	than	0	None
9045	9046	indomethacin	0	None
9046	9047	and	0	None
9047	9048	significantly	0	None
9048	9049	more	0	None
9049	9050	cytotoxic	0	None
9050	9051	than	0	None
9051	9052	8-MOP	0	None
9052	9053	.	0	None

9054	9055	The	0	None
9055	9056	results	0	None
9056	9057	of	0	None
9057	9058	the	0	None
9058	9059	biological	0	None
9059	9060	tests	0	None
9060	9061	are	0	None
9061	9062	discussed	0	None
9062	9063	in	0	None
9063	9064	terms	0	None
9064	9065	of	0	None
9065	9066	structural	0	None
9066	9067	characteristics	0	None
9067	9068	.	0	None
9068	9069	1	0	None
9069	9070	.	0	None

9071	9072	The	0	None
9072	9073	aim	0	None
9073	9074	of	0	None
9074	9075	the	0	None
9075	9076	present	0	None
9076	9077	study	0	None
9077	9078	was	0	None
9078	9079	to	0	None
9079	9080	examine	0	None
9080	9081	the	0	None
9081	9082	effects	0	None
9082	9083	of	0	None
9083	9084	chronic	0	None
9084	9085	infusion	0	None
9085	9086	of	0	None
9086	9087	the	0	None
9087	9088	long-acting	0	None
9088	9089	agonist	0	None
9089	9090	salmeterol	0	None
9090	9091	on	0	None
9091	9092	pulmonary	0	None
9092	9093	beta	0	None
9093	9094	(	0	None
9094	9095	2	0	None
9095	9096	)	0	None
9096	9097	-adrenoceptor	0	None
9097	9098	function	0	None
9098	9099	in	0	None
9099	9100	Sprague-Dawley	0	None
9100	9101	rats	0	None
9101	9102	in	0	None
9102	9103	vivo	0	None
9103	9104	and	0	None
9104	9105	to	0	None
9105	9106	elucidate	0	None
9106	9107	the	0	None
9107	9108	molecular	0	None
9108	9109	basis	0	None
9109	9110	of	0	None
9110	9111	any	0	None
9111	9112	altered	0	None
9112	9113	state	0	None
9113	9114	.	0	None

9115	9116	2	0	None
9116	9117	.	0	None

9118	9119	Systemic	0	None
9119	9120	administration	0	None
9120	9121	of	0	None
9121	9122	rats	0	None
9122	9123	with	0	None
9123	9124	salmeterol	0	None
9124	9125	for	0	None
9125	9126	7	0	None
9126	9127	days	0	None
9127	9128	compromised	0	None
9128	9129	the	0	None
9129	9130	ability	0	None
9130	9131	of	0	None
9131	9132	salmeterol	0	None
9132	9133	and	0	None
9133	9134	prostaglandin	0	None
9134	9135	E	0	None
9135	9136	(	0	None
9136	9137	2	0	None
9137	9138	)	0	None
9138	9139	(	0	None
9139	9140	PGE	0	None
9140	9141	(	0	None
9141	9142	2	0	None
9142	9143	)	0	None
9143	9144	)	0	None
9144	9145	,	0	None
9145	9146	given	0	None
9146	9147	acutely	0	None
9147	9148	by	0	None
9148	9149	the	0	None
9149	9150	intravenous	0	None
9150	9151	route	0	None
9151	9152	,	0	None
9152	9153	to	0	None
9153	9154	protect	0	None
9154	9155	against	0	None
9155	9156	ACh-induced	0	None
9156	9157	bronchoconstriction	0	None
9157	9158	when	0	None
9158	9159	compared	0	None
9159	9160	to	0	None
9160	9161	rats	0	None
9161	9162	treated	0	None
9162	9163	identically	0	None
9163	9164	with	0	None
9164	9165	vehicle	0	None
9165	9166	.	0	None

9167	9168	3	0	None
9168	9169	.	0	None

9170	9171	beta	0	None
9171	9172	(	0	None
9172	9173	1	0	None
9173	9174	)	0	None
9174	9175	-	0	None
9175	9176	and	0	None
9176	9177	beta	0	None
9177	9178	(	0	None
9178	9179	2	0	None
9179	9180	)	0	None
9180	9181	-adrenoceptor	0	None
9181	9182	density	0	None
9182	9183	was	0	None
9183	9184	significantly	0	None
9184	9185	reduced	0	None
9185	9186	in	0	None
9186	9187	lung	0	None
9187	9188	membranes	0	None
9188	9189	harvested	0	None
9189	9190	from	0	None
9190	9191	salmeterol-treated	0	None
9191	9192	animals	0	None
9192	9193	,	0	None
9193	9194	which	0	None
9194	9195	was	0	None
9195	9196	associated	0	None
9196	9197	with	0	None
9197	9198	impaired	0	None
9198	9199	salmeterol-	0	None
9199	9200	and	0	None
9200	9201	PGE	0	None
9201	9202	(	0	None
9202	9203	2	0	None
9203	9204	)	0	None
9204	9205	-induced	0	None
9205	9206	cyclic	0	None
9206	9207	AMP	0	None
9207	9208	accumulation	0	None
9208	9209	ex	0	None
9209	9210	vivo	0	None
9210	9211	.	0	None

9212	9213	4	0	None
9213	9214	.	0	None

9215	9216	Three	0	None
9216	9217	variants	0	None
9217	9218	of	0	None
9218	9219	G	0	None
9219	9220	(	0	None
9220	9221	s	0	None
9221	9222	alpha	0	None
9222	9223	)	0	None
9223	9224	that	0	None
9224	9225	migrated	0	None
9225	9226	as	0	None
9226	9227	42	0	None
9227	9228	,	0	None
9228	9229	44	0	None
9229	9230	and	0	None
9230	9231	52	0	None
9231	9232	kDa	0	None
9232	9233	peptides	0	None
9233	9234	on	0	None
9234	9235	SDS	0	None
9235	9236	polyacrylamide	0	None
9236	9237	gels	0	None
9237	9238	were	0	None
9238	9239	detected	0	None
9239	9240	in	0	None
9240	9241	lung	0	None
9241	9242	membranes	0	None
9242	9243	prepared	0	None
9243	9244	from	0	None
9244	9245	both	0	None
9245	9246	groups	0	None
9246	9247	of	0	None
9247	9248	rats	0	None
9248	9249	but	0	None
9249	9250	the	0	None
9250	9251	intensity	0	None
9251	9252	of	0	None
9252	9253	each	0	None
9253	9254	isoform	0	None
9254	9255	was	0	None
9255	9256	markedly	0	None
9256	9257	reduced	0	None
9257	9258	in	0	None
9258	9259	rats	0	None
9259	9260	that	0	None
9260	9261	received	0	None
9261	9262	salmeterol	0	None
9262	9263	.	0	None

9264	9265	5	0	None
9265	9266	.	0	None

9267	9268	The	0	None
9268	9269	activity	0	None
9269	9270	of	0	None
9270	9271	cytosolic	0	None
9271	9272	,	0	None
9272	9273	but	0	None
9273	9274	not	0	None
9274	9275	membrane-associated	0	None
9275	9276	,	0	None
9276	9277	G-protein	3	GENE-N
9277	9278	receptor-coupled	0	None
9278	9279	kinase	0	None
9279	9280	was	0	None
9280	9281	elevated	0	None
9281	9282	in	0	None
9282	9283	the	0	None
9283	9284	lung	0	None
9284	9285	of	0	None
9285	9286	salmeterol-treated	0	None
9286	9287	rats	0	None
9287	9288	when	0	None
9288	9289	compared	0	None
9289	9290	to	0	None
9290	9291	vehicle-treated	0	None
9291	9292	animals	0	None
9292	9293	.	0	None

9294	9295	6	0	None
9295	9296	.	0	None

9297	9298	The	0	None
9298	9299	ability	0	None
9299	9300	of	0	None
9300	9301	salmeterol	0	None
9301	9302	,	0	None
9302	9303	administered	0	None
9303	9304	systemically	0	None
9304	9305	,	0	None
9305	9306	to	0	None
9306	9307	protect	0	None
9307	9308	the	0	None
9308	9309	airways	0	None
9309	9310	of	0	None
9310	9311	untreated	0	None
9311	9312	rats	0	None
9312	9313	against	0	None
9313	9314	ACh-induced	0	None
9314	9315	bronchoconstriction	0	None
9315	9316	was	0	None
9316	9317	short-acting	0	None
9317	9318	(	0	None
9318	9319	t	0	None
9319	9320	(	0	None
9320	9321	off	0	None
9321	9322	)	0	None
9322	9323	approximately	0	None
9323	9324	45	0	None
9324	9325	min	0	None
9325	9326	)	0	None
9326	9327	,	0	None
9327	9328	which	0	None
9328	9329	contrasts	0	None
9329	9330	with	0	None
9330	9331	its	0	None
9331	9332	long-acting	0	None
9332	9333	nature	0	None
9333	9334	when	0	None
9334	9335	given	0	None
9335	9336	to	0	None
9336	9337	asthmatic	0	None
9337	9338	subjects	0	None
9338	9339	by	0	None
9339	9340	inhalation	0	None
9340	9341	.	0	None

9342	9343	7	0	None
9343	9344	.	0	None

9345	9346	These	0	None
9346	9347	results	0	None
9347	9348	indicate	0	None
9348	9349	that	0	None
9349	9350	chronic	0	None
9350	9351	treatment	0	None
9351	9352	of	0	None
9352	9353	rats	0	None
9353	9354	with	0	None
9354	9355	salmeterol	0	None
9355	9356	results	0	None
9356	9357	in	0	None
9357	9358	heterologous	0	None
9358	9359	desensitization	0	None
9359	9360	of	0	None
9360	9361	pulmonary	0	None
9361	9362	G	0	None
9362	9363	(	0	None
9363	9364	s	0	None
9364	9365	)	0	None
9365	9366	-coupled	0	None
9366	9367	receptors	0	None
9367	9368	.	0	None

9369	9370	In	0	None
9370	9371	light	0	None
9371	9372	of	0	None
9372	9373	previous	0	None
9373	9374	data	0	None
9374	9375	obtained	0	None
9375	9376	in	0	None
9376	9377	rats	0	None
9377	9378	treated	0	None
9378	9379	chronically	0	None
9379	9380	with	0	None
9380	9381	salbutamol	0	None
9381	9382	,	0	None
9382	9383	we	0	None
9383	9384	propose	0	None
9384	9385	that	0	None
9385	9386	a	0	None
9386	9387	primary	0	None
9387	9388	mechanism	0	None
9388	9389	responsible	0	None
9389	9390	for	0	None
9390	9391	this	0	None
9391	9392	effect	0	None
9392	9393	is	0	None
9393	9394	a	0	None
9394	9395	reduction	0	None
9395	9396	in	0	None
9396	9397	membrane-associated	0	None
9397	9398	G	0	None
9398	9399	(	0	None
9399	9400	s	0	None
9400	9401	alpha	0	None
9401	9402	)	0	None
9402	9403	.	0	None

9404	9405	The	0	None
9405	9406	short-acting	0	None
9406	9407	nature	0	None
9407	9408	of	0	None
9408	9409	salmeterol	0	None
9409	9410	,	0	None
9410	9411	when	0	None
9411	9412	administered	0	None
9412	9413	systemically	0	None
9413	9414	,	0	None
9414	9415	and	0	None
9415	9416	the	0	None
9416	9417	reduction	0	None
9417	9418	in	0	None
9418	9419	beta-adrenoceptor	3	GENE-N
9419	9420	number	0	None
9420	9421	may	0	None
9421	9422	be	0	None
9422	9423	due	0	None
9423	9424	to	0	None
9424	9425	metabolism	0	None
9425	9426	to	0	None
9426	9427	a	0	None
9427	9428	biologically-active	0	None
9428	9429	,	0	None
9429	9430	short-acting	0	None
9430	9431	and	0	None
9431	9432	non-selective	0	None
9432	9433	beta-adrenoceptor	3	GENE-N
9433	9434	agonist	0	None
9434	9435	.	0	None
9435	9436	Novel	0	None
9436	9437	locus	0	None
9437	9438	including	0	None
9438	9439	FGF21	0	None
9439	9440	is	0	None
9440	9441	associated	0	None
9441	9442	with	0	None
9442	9443	dietary	0	None
9443	9444	macronutrient	0	None
9444	9445	intake	0	None
9445	9446	.	0	None
9446	9447	Few	0	None
9447	9448	studies	0	None
9448	9449	have	0	None
9449	9450	addressed	0	None
9450	9451	the	0	None
9451	9452	delivery	0	None
9452	9453	of	0	None
9453	9454	lipoprotein-derived	0	None
9454	9455	cholesterol	0	None
9455	9456	to	0	None
9456	9457	the	0	None
9457	9458	adrenals	0	None
9458	9459	for	0	None
9459	9460	steroid	2	CHEMICAL
9460	9461	production	0	None
9461	9462	in	0	None
9462	9463	humans	0	None
9463	9464	.	0	None

9465	9466	While	0	None
9466	9467	there	0	None
9467	9468	is	0	None
9468	9469	evidence	0	None
9469	9470	against	0	None
9470	9471	a	0	None
9471	9472	role	0	None
9472	9473	for	0	None
9473	9474	low-density	0	None
9474	9475	lipoprotein	3	GENE-N
9475	9476	(	0	None
9476	9477	LDL	3	GENE-N
9477	9478	)	0	None
9478	9479	,	0	None
9479	9480	it	0	None
9480	9481	is	0	None
9481	9482	unresolved	0	None
9482	9483	whether	0	None
9483	9484	high	0	None
9484	9485	density	0	None
9485	9486	lipoprotein	3	GENE-N
9486	9487	(	0	None
9487	9488	HDL	0	None
9488	9489	)	0	None
9489	9490	contributes	0	None
9490	9491	to	0	None
9491	9492	adrenal	0	None
9492	9493	steroidogenesis	0	None
9493	9494	.	0	None

9495	9496	To	0	None
9496	9497	study	0	None
9497	9498	this	0	None
9498	9499	,	0	None
9499	9500	steroid	2	CHEMICAL
9500	9501	hormone	0	None
9501	9502	profiles	0	None
9502	9503	in	0	None
9503	9504	urine	0	None
9504	9505	were	0	None
9505	9506	assessed	0	None
9506	9507	in	0	None
9507	9508	male	0	None
9508	9509	subjects	0	None
9509	9510	suffering	0	None
9510	9511	from	0	None
9511	9512	functional	0	None
9512	9513	mutations	0	None
9513	9514	in	0	None
9514	9515	ATP	0	None
9515	9516	binding	0	None
9516	9517	cassette	0	None
9517	9518	transporter	0	None
9518	9519	A1	1	GENE-Y
9519	9520	(	0	None
9520	9521	ABCA1	0	None
9521	9522	)	0	None
9522	9523	(	0	None
9523	9524	n	0	None
9524	9525	=	0	None
9525	9526	24	0	None
9526	9527	)	0	None
9527	9528	,	0	None
9528	9529	lecithin	0	None
9529	9530	:	0	None
9530	9531	cholesterol	0	None
9531	9532	acyltransferase	0	None
9532	9533	(	0	None
9533	9534	LCAT	0	None
9534	9535	)	0	None
9535	9536	(	0	None
9536	9537	n	0	None
9537	9538	=	0	None
9538	9539	40	0	None
9539	9540	)	0	None
9540	9541	,	0	None
9541	9542	as	0	None
9542	9543	well	0	None
9543	9544	as	0	None
9544	9545	in	0	None
9545	9546	11	0	None
9546	9547	subjects	0	None
9547	9548	with	0	None
9548	9549	low	0	None
9549	9550	HDL	0	None
9550	9551	cholesterol	0	None
9551	9552	(	0	None
9552	9553	HDL-C	0	None
9553	9554	)	0	None
9554	9555	without	0	None
9555	9556	ABCA1	0	None
9556	9557	/	0	None
9557	9558	LCAT	0	None
9558	9559	mutations	0	None
9559	9560	.	0	None

9561	9562	HDL-C	0	None
9562	9563	levels	0	None
9563	9564	were	0	None
9564	9565	39%	0	None
9565	9566	lower	0	None
9566	9567	in	0	None
9567	9568	the	0	None
9568	9569	ABCA1	0	None
9569	9570	,	0	None
9570	9571	LCAT	0	None
9571	9572	,	0	None
9572	9573	and	0	None
9573	9574	low	0	None
9574	9575	HDL-C	0	None
9575	9576	groups	0	None
9576	9577	compared	0	None
9577	9578	with	0	None
9578	9579	controls	0	None
9579	9580	(	0	None
9580	9581	all	0	None
9581	9582	P	0	None
9582	9583	<	0	None
9583	9584	0	0	None
9584	9585	.	0	None
9585	9586	001	0	None
9586	9587	)	0	None
9587	9588	.	0	None

9589	9590	In	0	None
9590	9591	all	0	None
9591	9592	groups	0	None
9592	9593	with	0	None
9593	9594	low	0	None
9594	9595	HDL-C	0	None
9595	9596	levels	0	None
9596	9597	,	0	None
9597	9598	urinary	0	None
9598	9599	excretion	0	None
9599	9600	of	0	None
9600	9601	17-ketogenic	0	None
9601	9602	steroids	0	None
9602	9603	was	0	None
9603	9604	reduced	0	None
9604	9605	by	0	None
9605	9606	33%	0	None
9606	9607	,	0	None
9607	9608	27%	0	None
9608	9609	,	0	None
9609	9610	and	0	None
9610	9611	32%	0	None
9611	9612	compared	0	None
9612	9613	with	0	None
9613	9614	controls	0	None
9614	9615	(	0	None
9615	9616	all	0	None
9616	9617	P	0	None
9617	9618	<	0	None
9618	9619	0	0	None
9619	9620	.	0	None
9620	9621	04	0	None
9621	9622	)	0	None
9622	9623	.	0	None

9624	9625	In	0	None
9625	9626	seven	0	None
9626	9627	carriers	0	None
9627	9628	of	0	None
9628	9629	either	0	None
9629	9630	type	0	None
9630	9631	of	0	None
9631	9632	mutation	0	None
9632	9633	,	0	None
9633	9634	adrenocorticotropic	0	None
9634	9635	hormone	0	None
9635	9636	(	0	None
9636	9637	ACTH	0	None
9637	9638	)	0	None
9638	9639	stimulation	0	None
9639	9640	did	0	None
9640	9641	not	0	None
9641	9642	reveal	0	None
9642	9643	differences	0	None
9643	9644	from	0	None
9644	9645	normolipidemic	0	None
9645	9646	controls	0	None
9646	9647	.	0	None

9648	9649	In	0	None
9649	9650	conclusion	0	None
9650	9651	,	0	None
9651	9652	this	0	None
9652	9653	study	0	None
9653	9654	shows	0	None
9654	9655	that	0	None
9655	9656	basal	0	None
9656	9657	but	0	None
9657	9658	not	0	None
9658	9659	stimulated	0	None
9659	9660	corticosteroid	2	CHEMICAL
9660	9661	metabolism	0	None
9661	9662	is	0	None
9662	9663	attenuated	0	None
9663	9664	in	0	None
9664	9665	subjects	0	None
9665	9666	with	0	None
9666	9667	low	0	None
9667	9668	HDL-C	0	None
9668	9669	,	0	None
9669	9670	irrespective	0	None
9670	9671	of	0	None
9671	9672	its	0	None
9672	9673	molecular	0	None
9673	9674	origin	0	None
9674	9675	.	0	None

9676	9677	These	0	None
9677	9678	findings	0	None
9678	9679	lend	0	None
9679	9680	support	0	None
9680	9681	to	0	None
9681	9682	a	0	None
9682	9683	role	0	None
9683	9684	for	0	None
9684	9685	HDL	0	None
9685	9686	as	0	None
9686	9687	a	0	None
9687	9688	cholesterol	0	None
9688	9689	donor	0	None
9689	9690	for	0	None
9690	9691	basal	0	None
9691	9692	adrenal	0	None
9692	9693	steroidogenesis	0	None
9693	9694	in	0	None
9694	9695	humans	0	None
9695	9696	.	0	None
9696	9697	Sepracor	0	None
9697	9698	in	0	None
9698	9699	the	0	None
9699	9700	US	0	None
9700	9701	is	0	None
9701	9702	developing	0	None
9702	9703	arformoterol	0	None
9703	9704	[	0	None
9704	9705	R	0	None
9705	9706	,	0	None
9706	9707	R-formoterol	0	None
9707	9708	]	0	None
9708	9709	,	0	None
9709	9710	a	0	None
9710	9711	single	0	None
9711	9712	isomer	0	None
9712	9713	form	0	None
9713	9714	of	0	None
9714	9715	the	0	None
9715	9716	beta	0	None
9716	9717	(	0	None
9717	9718	2	0	None
9718	9719	)	0	None
9719	9720	-adrenoceptor	0	None
9720	9721	agonist	0	None
9721	9722	formoterol	0	None
9722	9723	[	0	None
9723	9724	eformoterol	0	None
9724	9725	]	0	None
9725	9726	.	0	None

9727	9728	This	0	None
9728	9729	isomer	0	None
9729	9730	contains	0	None
9730	9731	two	0	None
9731	9732	chiral	0	None
9732	9733	centres	0	None
9733	9734	and	0	None
9734	9735	is	0	None
9735	9736	being	0	None
9736	9737	developed	0	None
9737	9738	as	0	None
9738	9739	an	0	None
9739	9740	inhaled	0	None
9740	9741	preparation	0	None
9741	9742	for	0	None
9742	9743	the	0	None
9743	9744	treatment	0	None
9744	9745	of	0	None
9745	9746	respiratory	0	None
9746	9747	disorders	0	None
9747	9748	.	0	None

9749	9750	Sepracor	0	None
9750	9751	believes	0	None
9751	9752	that	0	None
9752	9753	arformoterol	0	None
9753	9754	has	0	None
9754	9755	the	0	None
9755	9756	potential	0	None
9756	9757	to	0	None
9757	9758	be	0	None
9758	9759	a	0	None
9759	9760	once-daily	0	None
9760	9761	therapy	0	None
9761	9762	with	0	None
9762	9763	a	0	None
9763	9764	rapid	0	None
9764	9765	onset	0	None
9765	9766	of	0	None
9766	9767	action	0	None
9767	9768	and	0	None
9768	9769	a	0	None
9769	9770	duration	0	None
9770	9771	of	0	None
9771	9772	effect	0	None
9772	9773	exceeding	0	None
9773	9774	12	0	None
9774	9775	hours	0	None
9775	9776	.	0	None

9777	9778	In	0	None
9778	9779	1995	0	None
9779	9780	,	0	None
9780	9781	Sepracor	0	None
9781	9782	acquired	0	None
9782	9783	New	0	None
9783	9784	England	0	None
9784	9785	Pharmaceuticals	0	None
9785	9786	,	0	None
9786	9787	a	0	None
9787	9788	manufacturer	0	None
9788	9789	of	0	None
9789	9790	metered-dose	0	None
9790	9791	and	0	None
9791	9792	dry	0	None
9792	9793	powder	0	None
9793	9794	inhalers	0	None
9794	9795	,	0	None
9795	9796	for	0	None
9796	9797	the	0	None
9797	9798	purpose	0	None
9798	9799	of	0	None
9799	9800	preparing	0	None
9800	9801	formulations	0	None
9801	9802	of	0	None
9802	9803	levosalbutamol	0	None
9803	9804	and	0	None
9804	9805	arformoterol	0	None
9805	9806	.	0	None

9807	9808	Phase	0	None
9808	9809	II	0	None
9809	9810	dose-ranging	0	None
9810	9811	clinical	0	None
9811	9812	studies	0	None
9812	9813	of	0	None
9813	9814	arformoterol	0	None
9814	9815	as	0	None
9815	9816	a	0	None
9816	9817	longer-acting	0	None
9817	9818	,	0	None
9818	9819	complementary	0	None
9819	9820	bronchodilator	0	None
9820	9821	were	0	None
9821	9822	completed	0	None
9822	9823	successfully	0	None
9823	9824	in	0	None
9824	9825	the	0	None
9825	9826	fourth	0	None
9826	9827	quarter	0	None
9827	9828	of	0	None
9828	9829	2000	0	None
9829	9830	.	0	None

9831	9832	Phase	0	None
9832	9833	III	0	None
9833	9834	trials	0	None
9834	9835	of	0	None
9835	9836	arformoterol	0	None
9836	9837	began	0	None
9837	9838	in	0	None
9838	9839	September	0	None
9839	9840	2001	0	None
9840	9841	.	0	None

9842	9843	The	0	None
9843	9844	indications	0	None
9844	9845	for	0	None
9845	9846	the	0	None
9846	9847	drug	0	None
9847	9848	appeared	0	None
9848	9849	to	0	None
9849	9850	be	0	None
9850	9851	asthma	0	None
9851	9852	and	0	None
9852	9853	chronic	0	None
9853	9854	obstructive	0	None
9854	9855	pulmonary	0	None
9855	9856	disease	0	None
9856	9857	(	0	None
9857	9858	COPD	0	None
9858	9859	)	0	None
9859	9860	.	0	None

9861	9862	However	0	None
9862	9863	,	0	None
9863	9864	an	0	None
9864	9865	update	0	None
9865	9866	of	0	None
9866	9867	the	0	None
9867	9868	pharmaceutical	0	None
9868	9869	product	0	None
9869	9870	information	0	None
9870	9871	on	0	None
9871	9872	the	0	None
9872	9873	Sepracor	0	None
9873	9874	website	0	None
9874	9875	in	0	None
9875	9876	September	0	None
9876	9877	2003	0	None
9877	9878	listed	0	None
9878	9879	COPD	0	None
9879	9880	maintenance	0	None
9880	9881	therapy	0	None
9881	9882	as	0	None
9882	9883	the	0	None
9883	9884	only	0	None
9884	9885	indication	0	None
9885	9886	for	0	None
9886	9887	arformoterol	0	None
9887	9888	.	0	None

9889	9890	In	0	None
9890	9891	October	0	None
9891	9892	2002	0	None
9892	9893	,	0	None
9893	9894	Sepracor	0	None
9894	9895	stated	0	None
9895	9896	that	0	None
9896	9897	two	0	None
9897	9898	pivotal	0	None
9898	9899	phase	0	None
9899	9900	III	0	None
9900	9901	studies	0	None
9901	9902	were	0	None
9902	9903	ongoing	0	None
9903	9904	in	0	None
9904	9905	1600	0	None
9905	9906	patients	0	None
9906	9907	.	0	None

9908	9909	Sepracor	0	None
9909	9910	estimates	0	None
9910	9911	that	0	None
9911	9912	its	0	None
9912	9913	NDA	0	None
9913	9914	submission	0	None
9914	9915	for	0	None
9915	9916	arformoterol	0	None
9916	9917	,	0	None
9917	9918	which	0	None
9918	9919	is	0	None
9919	9920	projected	0	None
9920	9921	for	0	None
9921	9922	the	0	None
9922	9923	first	0	None
9923	9924	half	0	None
9924	9925	of	0	None
9925	9926	2004	0	None
9926	9927	,	0	None
9927	9928	will	0	None
9928	9929	include	0	None
9929	9930	approximately	0	None
9930	9931	3000	0	None
9931	9932	adult	0	None
9932	9933	subjects	0	None
9933	9934	.	0	None

9935	9936	Sepracor	0	None
9936	9937	stated	0	None
9937	9938	in	0	None
9938	9939	July	0	None
9939	9940	2003	0	None
9940	9941	that	0	None
9941	9942	it	0	None
9942	9943	had	0	None
9943	9944	completed	0	None
9944	9945	more	0	None
9945	9946	than	0	None
9946	9947	100	0	None
9947	9948	preclinical	0	None
9948	9949	studies	0	None
9949	9950	and	0	None
9950	9951	initiated	0	None
9951	9952	or	0	None
9952	9953	completed	0	None
9953	9954	15	0	None
9954	9955	clinical	0	None
9955	9956	studies	0	None
9956	9957	for	0	None
9957	9958	arformoterol	0	None
9958	9959	inhalation	0	None
9959	9960	solution	0	None
9960	9961	for	0	None
9961	9962	the	0	None
9962	9963	treatment	0	None
9963	9964	of	0	None
9964	9965	bronchospasm	0	None
9965	9966	in	0	None
9966	9967	patients	0	None
9967	9968	with	0	None
9968	9969	COPD	0	None
9969	9970	.	0	None

9971	9972	In	0	None
9972	9973	addition	0	None
9973	9974	,	0	None
9974	9975	Sepracor	0	None
9975	9976	stated	0	None
9976	9977	that	0	None
9977	9978	the	0	None
9978	9979	two	0	None
9979	9980	pivotal	0	None
9980	9981	phase	0	None
9981	9982	III	0	None
9982	9983	studies	0	None
9983	9984	in	0	None
9984	9985	1600	0	None
9985	9986	patients	0	None
9986	9987	were	0	None
9987	9988	still	0	None
9988	9989	progressing	0	None
9989	9990	.	0	None

9991	9992	In	0	None
9992	9993	1995	0	None
9993	9994	,	0	None
9994	9995	European	0	None
9995	9996	patents	0	None
9996	9997	were	0	None
9997	9998	granted	0	None
9998	9999	to	0	None
9999	10000	Sepracor	0	None
10000	10001	for	0	None
10001	10002	the	0	None
10002	10003	use	0	None
10003	10004	of	0	None
10004	10005	arformoterol	0	None
10005	10006	in	0	None
10006	10007	the	0	None
10007	10008	treatment	0	None
10008	10009	of	0	None
10009	10010	asthma	0	None
10010	10011	,	0	None
10011	10012	and	0	None
10012	10013	the	0	None
10013	10014	US	0	None
10014	10015	patent	0	None
10015	10016	application	0	None
10016	10017	was	0	None
10017	10018	pending	0	None
10018	10019	.	0	None
10019	10020	Salicylate	0	None
10020	10021	regulates	0	None
10021	10022	COX-2	0	None
10022	10023	expression	0	None
10023	10024	through	0	None
10024	10025	ERK	0	None
10025	10026	and	0	None
10026	10027	subsequent	0	None
10027	10028	NF-kappaB	3	GENE-N
10028	10029	activation	0	None
10029	10030	in	0	None
10030	10031	osteoblasts	0	None
10031	10032	.	0	None
10032	10033	High	0	None
10033	10034	resolution	0	None
10034	10035	(	0	None
10035	10036	1	0	None
10036	10037	)	0	None
10037	10038	H	0	None
10038	10039	NMR	0	None
10039	10040	spectroscopy	0	None
10040	10041	was	0	None
10041	10042	proposed	0	None
10042	10043	for	0	None
10043	10044	the	0	None
10044	10045	determination	0	None
10045	10046	of	0	None
10046	10047	the	0	None
10047	10049	fatty acid	2	CHEMICAL
10049	10050	chain	0	None
10050	10051	profile	0	None
10051	10052	of	0	None
10052	10053	lipids	0	None
10053	10054	in	0	None
10054	10055	pork	0	None
10055	10056	meat	0	None
10056	10057	products	0	None
10057	10058	during	0	None
10058	10059	ripening	0	None
10059	10060	.	0	None

10061	10062	Two	0	None
10062	10063	typical	0	None
10063	10064	Mediterranean	0	None
10064	10065	PDO	0	None
10065	10066	salami	0	None
10066	10067	produced	0	None
10067	10068	in	0	None
10068	10069	Calabria	0	None
10069	10070	,	0	None
10070	10071	a	0	None
10071	10072	region	0	None
10072	10073	in	0	None
10073	10074	the	0	None
10074	10075	Southern	0	None
10075	10076	Italy	0	None
10076	10077	,	0	None
10077	10078	were	0	None
10078	10079	chosen	0	None
10079	10080	as	0	None
10080	10081	a	0	None
10081	10082	case	0	None
10082	10083	of	0	None
10083	10084	study	0	None
10084	10085	.	0	None

10086	10087	Quantitative	0	None
10087	10088	NMR	0	None
10088	10089	analysis	0	None
10089	10090	provided	0	None
10090	10091	the	0	None
10091	10093	fatty acid	2	CHEMICAL
10093	10094	chain	0	None
10094	10095	profiles	0	None
10095	10096	of	0	None
10096	10097	total	0	None
10097	10098	lipid	0	None
10098	10099	extracts	0	None
10099	10100	.	0	None

10101	10102	The	0	None
10102	10103	transesterification	0	None
10103	10104	of	0	None
10104	10105	total	0	None
10105	10106	lipid	0	None
10106	10107	extracts	0	None
10107	10108	furnished	0	None
10108	10109	FAME	0	None
10109	10110	mixtures	0	None
10110	10111	that	0	None
10111	10112	enabled	0	None
10112	10113	quantitation	0	None
10113	10114	of	0	None
10114	10116	fatty acid	2	CHEMICAL
10116	10117	acyl	0	None
10117	10118	chains	0	None
10118	10119	in	0	None
10119	10120	the	0	None
10120	10121	acylglycerol	0	None
10121	10122	and	0	None
10122	10123	FFA	0	None
10123	10124	portions	0	None
10124	10125	.	0	None

10126	10127	In	0	None
10127	10128	all	0	None
10128	10129	cases	0	None
10129	10130	,	0	None
10130	10131	oleyl	0	None
10131	10132	chains	0	None
10132	10133	were	0	None
10133	10134	predominant	0	None
10134	10135	,	0	None
10135	10136	and	0	None
10136	10137	high	0	None
10137	10138	amounts	0	None
10138	10139	of	0	None
10139	10140	polyunsaturated	0	None
10140	10142	fatty acid	2	CHEMICAL
10142	10143	chains	0	None
10143	10144	were	0	None
10144	10145	observed	0	None
10145	10146	.	0	None

10147	10148	The	0	None
10148	10149	proposed	0	None
10149	10150	spectroscopic	0	None
10150	10151	method	0	None
10151	10152	allowed	0	None
10152	10153	also	0	None
10153	10154	the	0	None
10154	10155	estimation	0	None
10155	10156	of	0	None
10156	10157	the	0	None
10157	10158	most	0	None
10158	10159	important	0	None
10159	10160	nutritional	0	None
10160	10161	parameters	0	None
10161	10162	of	0	None
10162	10163	dry	0	None
10163	10164	fermented	0	None
10164	10165	meat	0	None
10165	10166	products	0	None
10166	10167	.	0	None
10167	10168	Dofetilide	0	None
10168	10169	,	0	None
10169	10170	a	0	None
10170	10171	methanesulfonanilide	0	None
10171	10172	derivative	0	None
10172	10173	,	0	None
10173	10174	is	0	None
10174	10175	a	0	None
10175	10176	potent	0	None
10176	10177	class	0	None
10177	10178	III	0	None
10178	10179	antiarrhythmic	0	None
10179	10180	drug	0	None
10180	10181	.	0	None

10182	10183	Like	0	None
10183	10184	other	0	None
10184	10185	members	0	None
10185	10186	of	0	None
10186	10187	this	0	None
10187	10188	class	0	None
10188	10189	of	0	None
10189	10190	K	0	None
10190	10191	+	0	None
10191	10192	channel	0	None
10192	10193	blockers	0	None
10193	10194	,	0	None
10194	10195	the	0	None
10195	10196	sites	0	None
10196	10197	in	0	None
10197	10198	the	0	None
10198	10199	channel	0	None
10199	10200	to	0	None
10200	10201	which	0	None
10201	10202	the	0	None
10202	10203	drug	0	None
10203	10204	binds	0	None
10204	10205	are	0	None
10205	10206	unknown	0	None
10206	10207	,	0	None
10207	10208	although	0	None
10208	10209	high	0	None
10209	10210	and	0	None
10210	10211	low	0	None
10211	10212	affinity	0	None
10212	10213	binding	0	None
10213	10214	has	0	None
10214	10215	been	0	None
10215	10216	reported	0	None
10216	10217	in	0	None
10217	10218	cardiomyocytes	0	None
10218	10219	.	0	None

10220	10221	The	0	None
10221	10222	most	0	None
10222	10223	sensitive	0	None
10223	10224	K	0	None
10224	10225	+	0	None
10225	10226	channel	0	None
10226	10227	target	0	None
10227	10228	for	0	None
10228	10229	dofetilide	0	None
10229	10230	seems	0	None
10230	10231	to	0	None
10231	10232	be	0	None
10232	10233	IKr	3	GENE-N
10233	10234	,	0	None
10234	10235	the	0	None
10235	10236	rapid	0	None
10236	10237	component	0	None
10237	10238	of	0	None
10238	10239	the	0	None
10239	10240	repolarizing	0	None
10240	10241	delayed	0	None
10241	10242	rectifier	0	None
10242	10243	K	0	None
10243	10244	+	0	None
10244	10245	current	0	None
10245	10246	.	0	None

10247	10248	However	0	None
10248	10249	,	0	None
10249	10250	block	0	None
10250	10251	of	0	None
10251	10252	other	0	None
10252	10253	K	0	None
10253	10254	+	0	None
10254	10255	channels	0	None
10255	10256	occurs	0	None
10256	10257	at	0	None
10257	10258	higher	0	None
10258	10259	concentrations	0	None
10259	10260	and	0	None
10260	10261	is	0	None
10261	10262	of	0	None
10262	10263	special	0	None
10263	10264	interest	0	None
10264	10265	in	0	None
10265	10266	regard	0	None
10266	10267	to	0	None
10267	10268	toxicity	0	None
10268	10269	.	0	None

10270	10271	Recently	0	None
10271	10272	,	0	None
10272	10273	we	0	None
10273	10274	have	0	None
10274	10275	demonstrated	0	None
10275	10276	that	0	None
10276	10277	hIRK	0	None
10277	10278	,	0	None
10278	10279	a	0	None
10279	10280	cloned	0	None
10280	10281	inward	0	None
10281	10282	rectifier	0	None
10282	10283	K	0	None
10283	10284	+	0	None
10284	10285	channel	0	None
10285	10286	(	0	None
10286	10287	IRK	0	None
10287	10288	)	0	None
10288	10289	isolated	0	None
10289	10290	from	0	None
10290	10291	human	0	None
10291	10292	atrium	0	None
10292	10293	and	0	None
10293	10294	expressed	0	None
10294	10295	heterologously	0	None
10295	10296	in	0	None
10296	10297	Xenopus	0	None
10297	10298	oocytes	0	None
10298	10299	,	0	None
10299	10300	is	0	None
10300	10301	blocked	0	None
10301	10302	by	0	None
10302	10303	dofetilide	0	None
10303	10304	.	0	None

10305	10306	We	0	None
10306	10307	report	0	None
10307	10308	the	0	None
10308	10309	localization	0	None
10309	10310	of	0	None
10310	10311	a	0	None
10311	10312	site	0	None
10312	10313	that	0	None
10313	10314	is	0	None
10314	10315	critical	0	None
10315	10316	for	0	None
10316	10317	dofetilide	0	None
10317	10318	block	0	None
10318	10319	in	0	None
10319	10320	hIRK	0	None
10320	10321	.	0	None

10322	10323	We	0	None
10323	10324	used	0	None
10324	10325	chimeric	0	None
10325	10326	constructs	0	None
10326	10327	between	0	None
10327	10328	hIRK	0	None
10328	10329	and	0	None
10329	10330	ROMK1	0	None
10330	10331	,	0	None
10331	10332	a	0	None
10332	10333	related	0	None
10333	10334	inward	0	None
10334	10335	rectifier	0	None
10335	10336	that	0	None
10336	10337	is	0	None
10337	10338	drug	0	None
10338	10339	resistant	0	None
10339	10340	.	0	None

10341	10342	Substitution	0	None
10342	10343	of	0	None
10343	10344	hIRK-M2	0	None
10344	10345	,	0	None
10345	10346	the	0	None
10346	10347	second	0	None
10347	10348	putative	0	None
10348	10349	transmembrane	0	None
10349	10350	spanning	0	None
10350	10351	segment	0	None
10351	10352	of	0	None
10352	10353	IRKs	3	GENE-N
10353	10354	,	0	None
10354	10355	with	0	None
10355	10356	ROMK1-M2	0	None
10356	10357	increased	0	None
10357	10358	unblocking	0	None
10358	10359	of	0	None
10359	10360	dofetilide	0	None
10360	10361	by	0	None
10361	10362	10-20-fold	0	None
10362	10363	in	0	None
10363	10364	hIRK	0	None
10364	10365	.	0	None

10366	10367	Site-directed	0	None
10367	10368	mutagenesis	0	None
10368	10369	further	0	None
10369	10370	pinpointed	0	None
10370	10371	the	0	None
10371	10372	effects	0	None
10372	10373	to	0	None
10373	10374	a	0	None
10374	10375	single	0	None
10375	10376	hydrophobic	0	None
10376	10377	residue	0	None
10377	10378	(	0	None
10378	10379	I177	0	None
10379	10380	)	0	None
10380	10381	in	0	None
10381	10382	M2	0	None
10382	10383	.	0	None

10384	10385	A	0	None
10385	10386	reduction	0	None
10386	10387	in	0	None
10387	10388	hydrophobicity	0	None
10388	10389	by	0	None
10389	10390	the	0	None
10390	10391	point	0	None
10391	10392	mutation	0	None
10392	10393	I177C	0	None
10393	10394	increased	0	None
10394	10395	recovery	0	None
10395	10396	from	0	None
10396	10397	block	0	None
10397	10398	>	0	None
10398	10399	10-fold	0	None
10399	10400	(	0	None
10400	10401	1	0	None
10401	10402	.	0	None
10402	10403	17	0	None
10403	10404	sec	0	None
10404	10405	in	0	None
10405	10406	wild-type	0	None
10406	10407	to	0	None
10407	10408	0	0	None
10408	10409	.	0	None
10409	10410	112	0	None
10410	10411	sec	0	None
10411	10412	at	0	None
10412	10413	-80	0	None
10413	10414	mV	0	None
10414	10415	at	0	None
10415	10416	physiological	0	None
10416	10417	K	0	None
10417	10418	+	0	None
10418	10419	concentrations	0	None
10419	10420	)	0	None
10420	10421	,	0	None
10421	10422	leading	0	None
10422	10423	us	0	None
10423	10424	to	0	None
10424	10425	suggest	0	None
10425	10426	that	0	None
10426	10427	hydrophobic	0	None
10427	10428	interactions	0	None
10428	10429	are	0	None
10429	10430	essential	0	None
10430	10431	for	0	None
10431	10432	dofetilide	0	None
10432	10433	block	0	None
10433	10434	in	0	None
10434	10435	hIRK	0	None
10435	10436	.	0	None

10437	10438	A	0	None
10438	10439	similar	0	None
10439	10440	mechanism	0	None
10440	10441	may	0	None
10441	10442	explain	0	None
10442	10443	dofetilide	0	None
10443	10444	block	0	None
10444	10445	in	0	None
10445	10446	other	0	None
10446	10447	ion	0	None
10447	10448	channels	0	None
10448	10449	,	0	None
10449	10450	including	0	None
10450	10451	IKr	3	GENE-N
10451	10452	.	0	None
10452	10453	Jaceosidin	0	None
10453	10454	,	0	None
10454	10455	isolated	0	None
10455	10456	from	0	None
10456	10457	dietary	0	None
10457	10458	mugwort	0	None
10458	10459	(	0	None
10459	10460	Artemisia	0	None
10460	10461	princeps	0	None
10461	10462	)	0	None
10462	10463	,	0	None
10463	10464	induces	0	None
10464	10465	G2	0	None
10465	10466	/	0	None
10466	10467	M	0	None
10467	10468	cell	0	None
10468	10469	cycle	0	None
10469	10470	arrest	0	None
10470	10471	by	0	None
10471	10472	inactivating	0	None
10472	10473	cdc25C-cdc2	0	None
10473	10474	via	0	None
10474	10475	ATM-Chk1	0	None
10475	10476	/	0	None
10476	10477	2	0	None
10477	10478	activation	0	None
10478	10479	.	0	None
10479	10480	The	0	None
10480	10481	role	0	None
10481	10482	of	0	None
10482	10483	cytochrome	3	GENE-N
10483	10484	P450-dependent	0	None
10484	10485	metabolism	0	None
10485	10486	in	0	None
10486	10487	the	0	None
10487	10488	regulation	0	None
10488	10489	of	0	None
10489	10493	mouse hepatic growth hormone	3	GENE-N
10493	10494	signaling	0	None
10494	10495	components	0	None
10495	10496	and	0	None
10496	10497	target	0	None
10497	10498	genes	0	None
10498	10499	by	0	None
10499	10500	3-methylcholanthrene	2	CHEMICAL
10500	10501	.	0	None
10501	10502	The	0	None
10502	10503	glutamine	0	None
10503	10504	/	0	None
10504	10506	amino acid	2	CHEMICAL
10506	10507	transporter	0	None
10507	10508	was	0	None
10508	10509	solubilized	0	None
10509	10510	from	0	None
10510	10511	rat	0	None
10511	10512	renal	0	None
10512	10513	apical	0	None
10513	10514	plasma	0	None
10514	10515	membrane	0	None
10515	10516	(	0	None
10516	10517	brush-border	0	None
10517	10518	membrane	0	None
10518	10519	)	0	None
10519	10520	with	0	None
10520	10521	C12E8	0	None
10521	10522	and	0	None
10522	10523	reconstituted	0	None
10523	10524	into	0	None
10524	10525	liposomes	0	None
10525	10526	by	0	None
10526	10527	removing	0	None
10527	10528	the	0	None
10528	10529	detergent	0	None
10529	10530	from	0	None
10530	10531	mixed	0	None
10531	10532	micelles	0	None
10532	10533	by	0	None
10533	10534	hydrophobic	0	None
10534	10535	chromatography	0	None
10535	10536	on	0	None
10536	10537	Amberlite	0	None
10537	10538	XAD-4	0	None
10538	10539	.	0	None

10540	10541	The	0	None
10541	10542	reconstitution	0	None
10542	10543	was	0	None
10543	10544	optimised	0	None
10544	10545	with	0	None
10545	10546	respect	0	None
10546	10547	to	0	None
10547	10548	the	0	None
10548	10549	protein	0	None
10549	10550	concentration	0	None
10550	10551	,	0	None
10551	10552	the	0	None
10552	10553	detergent	0	None
10553	10554	/	0	None
10554	10555	phospholipid	0	None
10555	10556	ratio	0	None
10556	10557	and	0	None
10557	10558	the	0	None
10558	10559	number	0	None
10559	10560	of	0	None
10560	10561	passages	0	None
10561	10562	through	0	None
10562	10563	a	0	None
10563	10564	single	0	None
10564	10565	Amberlite	0	None
10565	10566	column	0	None
10566	10567	.	0	None

10568	10569	The	0	None
10569	10570	reconstituted	0	None
10570	10571	glutamine	0	None
10571	10572	/	0	None
10572	10574	amino acid	2	CHEMICAL
10574	10575	transporter	0	None
10575	10576	catalysed	0	None
10576	10577	a	0	None
10577	10578	first-order	0	None
10578	10579	antiport	0	None
10579	10580	reaction	0	None
10580	10581	stimulated	0	None
10581	10582	by	0	None
10582	10583	external	0	None
10583	10584	,	0	None
10584	10585	not	0	None
10585	10586	internal	0	None
10586	10587	,	0	None
10587	10588	Na	0	None
10588	10589	+	0	None
10589	10590	.	0	None

10591	10592	Optimal	0	None
10592	10593	activity	0	None
10593	10594	was	0	None
10594	10595	found	0	None
10595	10596	at	0	None
10596	10597	pH	0	None
10597	10598	7	0	None
10598	10599	.	0	None
10599	10600	0	0	None
10600	10601	.	0	None

10602	10603	The	0	None
10603	10605	sulfhydryl reagents	2	CHEMICAL
10605	10606	HgCl2	0	None
10606	10607	,	0	None
10607	10608	mersalyl	0	None
10608	10609	and	0	None
10609	10610	p-hydroxymercuribenzoate	0	None
10610	10611	and	0	None
10611	10612	the	0	None
10612	10614	amino acids	2	CHEMICAL
10614	10615	alanine	0	None
10615	10616	,	0	None
10616	10617	serine	2	CHEMICAL
10617	10618	,	0	None
10618	10619	threonine	0	None
10619	10620	,	0	None
10620	10621	cysteine	0	None
10621	10622	,	0	None
10622	10623	asparagine	0	None
10623	10624	,	0	None
10624	10625	methionine	2	CHEMICAL
10625	10626	and	0	None
10626	10627	valine	2	CHEMICAL
10627	10628	strongly	0	None
10628	10629	inhibited	0	None
10629	10630	the	0	None
10630	10631	transport	0	None
10631	10632	,	0	None
10632	10633	whereas	0	None
10633	10634	the	0	None
10634	10636	amino acid	2	CHEMICAL
10636	10637	analogue	0	None
10637	10638	methylaminoisobutyrate	0	None
10638	10639	had	0	None
10639	10640	no	0	None
10640	10641	effect	0	None
10641	10642	.	0	None

10643	10644	Glutamine	0	None
10644	10645	,	0	None
10645	10646	alanine	0	None
10646	10647	,	0	None
10647	10648	serine	2	CHEMICAL
10648	10649	,	0	None
10649	10650	asparagine	0	None
10650	10651	,	0	None
10651	10652	threonine	0	None
10652	10653	were	0	None
10653	10654	efficiently	0	None
10654	10655	translocated	0	None
10655	10656	from	0	None
10656	10657	outside	0	None
10657	10658	to	0	None
10658	10659	inside	0	None
10659	10660	and	0	None
10660	10661	from	0	None
10661	10662	inside	0	None
10662	10663	to	0	None
10663	10664	outside	0	None
10664	10665	the	0	None
10665	10666	proteoliposomes	0	None
10666	10667	as	0	None
10667	10668	well	0	None
10668	10669	.	0	None

10670	10671	Cysteine	0	None
10671	10672	and	0	None
10672	10673	valine	2	CHEMICAL
10673	10674	were	0	None
10674	10675	translocated	0	None
10675	10676	preferentially	0	None
10676	10677	from	0	None
10677	10678	outside	0	None
10678	10679	to	0	None
10679	10680	inside	0	None
10680	10681	.	0	None

10682	10683	The	0	None
10683	10684	Km	0	None
10684	10685	for	0	None
10685	10686	glutamine	0	None
10686	10687	on	0	None
10687	10688	the	0	None
10688	10689	external	0	None
10689	10690	and	0	None
10690	10691	internal	0	None
10691	10692	side	0	None
10692	10693	of	0	None
10693	10694	the	0	None
10694	10695	transporter	0	None
10695	10696	was	0	None
10696	10697	0	0	None
10697	10698	.	0	None
10698	10699	47	0	None
10699	10700	and	0	None
10700	10701	11	0	None
10701	10702	mM	0	None
10702	10703	,	0	None
10703	10704	respectively;	0	None
10704	10705	the	0	None
10705	10706	values	0	None
10706	10707	were	0	None
10707	10708	not	0	None
10708	10709	influenced	0	None
10709	10710	by	0	None
10710	10711	the	0	None
10711	10712	type	0	None
10712	10713	of	0	None
10713	10714	the	0	None
10714	10715	counter	0	None
10715	10716	substrate	0	None
10716	10717	.	0	None

10718	10719	The	0	None
10719	10720	transporter	0	None
10720	10721	is	0	None
10721	10722	functionally	0	None
10722	10723	asymmetrical	0	None
10723	10724	and	0	None
10724	10725	it	0	None
10725	10726	is	0	None
10726	10727	unidirectionally	0	None
10727	10728	inserted	0	None
10728	10729	into	0	None
10729	10730	the	0	None
10730	10731	proteoliposomal	0	None
10731	10732	membrane	0	None
10732	10733	with	0	None
10733	10734	an	0	None
10734	10735	orientation	0	None
10735	10736	corresponding	0	None
10736	10737	to	0	None
10737	10738	that	0	None
10738	10739	of	0	None
10739	10740	the	0	None
10740	10741	native	0	None
10741	10742	membrane	0	None
10742	10743	.	0	None

10744	10745	By	0	None
10745	10746	a	0	None
10746	10747	bisubstrate	0	None
10747	10748	kinetic	0	None
10748	10749	analysis	0	None
10749	10750	of	0	None
10750	10751	the	0	None
10751	10752	glutamine	0	None
10752	10753	antiport	0	None
10753	10754	,	0	None
10754	10755	a	0	None
10755	10756	random	0	None
10756	10757	simultaneous	0	None
10757	10758	mechanism	0	None
10758	10759	was	0	None
10759	10760	found	0	None
10760	10761	.	0	None

10762	10763	The	0	None
10763	10764	glutamine	0	None
10764	10765	antiport	0	None
10765	10766	was	0	None
10766	10767	strongly	0	None
10767	10768	stimulated	0	None
10768	10769	by	0	None
10769	10770	internal	0	None
10770	10771	nucleoside	0	None
10771	10772	triphosphates	0	None
10772	10773	and	0	None
10773	10774	,	0	None
10774	10775	to	0	None
10775	10776	a	0	None
10776	10777	lower	0	None
10777	10778	extent	0	None
10778	10779	,	0	None
10779	10780	by	0	None
10780	10781	pyrophoshate	0	None
10781	10782	.	0	None

10783	10784	The	0	None
10784	10785	reconstituted	0	None
10785	10786	glutamine	0	None
10786	10787	/	0	None
10787	10789	amino acid	2	CHEMICAL
10789	10790	transporter	0	None
10790	10791	functionally	0	None
10791	10792	corresponds	0	None
10792	10793	to	0	None
10793	10794	the	0	None
10794	10795	ASCT2	0	None
10795	10796	protein	0	None
10796	10797	.	0	None
10797	10798	Arsenic	2	CHEMICAL
10798	10799	can	0	None
10799	10800	induce	0	None
10800	10801	reactive	0	None
10801	10802	oxygen	0	None
10802	10803	species	0	None
10803	10804	(	0	None
10804	10805	ROS	0	None
10805	10806	)	0	None
10806	10807	leading	0	None
10807	10808	to	0	None
10808	10809	oxidative	0	None
10809	10810	stress	0	None
10810	10811	and	0	None
10811	10812	carcinogenesis	0	None
10812	10813	.	0	None

10814	10815	Bladder	0	None
10815	10816	is	0	None
10816	10817	one	0	None
10817	10818	of	0	None
10818	10819	the	0	None
10819	10820	major	0	None
10820	10821	target	0	None
10821	10822	organs	0	None
10822	10823	of	0	None
10823	10824	arsenic	2	CHEMICAL
10824	10825	,	0	None
10825	10826	and	0	None
10826	10827	cyclooxygenase-2	0	None
10827	10828	(	0	None
10828	10829	COX-2	0	None
10829	10830	)	0	None
10830	10831	may	0	None
10831	10832	play	0	None
10832	10833	an	0	None
10833	10834	important	0	None
10834	10835	role	0	None
10835	10836	in	0	None
10836	10837	arsenic-induced	0	None
10837	10838	bladder	0	None
10838	10839	cancer	0	None
10839	10840	.	0	None

10841	10842	However	0	None
10842	10843	,	0	None
10843	10844	the	0	None
10844	10845	mechanism	0	None
10845	10846	by	0	None
10846	10847	which	0	None
10847	10848	arsenic	2	CHEMICAL
10848	10849	induces	0	None
10849	10850	COX-2	0	None
10850	10851	in	0	None
10851	10852	bladder	0	None
10852	10853	cells	0	None
10853	10854	remains	0	None
10854	10855	unclear	0	None
10855	10856	.	0	None

10857	10858	This	0	None
10858	10859	study	0	None
10859	10860	aimed	0	None
10860	10861	at	0	None
10861	10862	investigating	0	None
10862	10863	arsenic-mediated	0	None
10863	10864	intracellular	0	None
10864	10865	redox	0	None
10865	10866	status	0	None
10866	10867	and	0	None
10867	10868	signaling	0	None
10868	10869	cascades	0	None
10869	10870	leading	0	None
10870	10871	to	0	None
10871	10872	COX-2	0	None
10872	10873	induction	0	None
10873	10874	in	0	None
10874	10875	human	0	None
10875	10876	uroepithelial	0	None
10876	10877	cells	0	None
10877	10878	(	0	None
10878	10879	SV-HUC-1	0	None
10879	10880	)	0	None
10880	10881	.	0	None

10882	10883	SV-HUC-1	0	None
10883	10884	cells	0	None
10884	10885	were	0	None
10885	10886	exposed	0	None
10886	10887	to	0	None
10887	10889	sodium arsenite	2	CHEMICAL
10889	10890	and	0	None
10890	10891	COX-2	0	None
10891	10892	expression	0	None
10892	10893	,	0	None
10893	10896	mitogen-activated protein kinase	3	GENE-N
10896	10897	(	0	None
10897	10898	MAPK	3	GENE-N
10898	10899	)	0	None
10899	10900	phosphorylation	0	None
10900	10901	,	0	None
10901	10902	glutathione	0	None
10902	10903	(	0	None
10903	10904	GSH	0	None
10904	10905	)	0	None
10905	10906	levels	0	None
10906	10907	,	0	None
10907	10908	ROS	0	None
10908	10909	induction	0	None
10909	10910	and	0	None
10910	10911	Nrf2	1	GENE-Y
10911	10912	expression	0	None
10912	10913	were	0	None
10913	10914	quantified	0	None
10914	10915	.	0	None

10916	10917	Our	0	None
10917	10918	results	0	None
10918	10919	demonstrate	0	None
10919	10920	that	0	None
10920	10921	arsenite	2	CHEMICAL
10921	10922	(	0	None
10922	10923	1-10	0	None
10923	10924	μM	0	None
10924	10925	)	0	None
10925	10926	elevates	0	None
10926	10927	COX-2	0	None
10927	10928	expression	0	None
10928	10929	,	0	None
10929	10930	GSH	0	None
10930	10931	levels	0	None
10931	10932	,	0	None
10932	10933	ROS	0	None
10933	10934	and	0	None
10934	10935	Nrf2	1	GENE-Y
10935	10936	expression	0	None
10936	10937	.	0	None

10938	10939	Arsenite	2	CHEMICAL
10939	10940	treatment	0	None
10940	10941	for	0	None
10941	10942	24h	0	None
10942	10943	stimulates	0	None
10943	10944	phosphorylation	0	None
10944	10945	of	0	None
10945	10946	ERK	0	None
10946	10947	and	0	None
10947	10948	p38	0	None
10948	10949	,	0	None
10949	10950	but	0	None
10950	10951	not	0	None
10951	10952	JNK	0	None
10952	10953	in	0	None
10953	10954	SV-HUC-1	0	None
10954	10955	cells	0	None
10955	10956	.	0	None

10957	10958	Induction	0	None
10958	10959	of	0	None
10959	10960	Cox-2	0	None
10960	10961	mRNA	0	None
10961	10962	levels	0	None
10962	10963	by	0	None
10963	10964	arsenite	2	CHEMICAL
10964	10965	was	0	None
10965	10966	attenuated	0	None
10966	10967	by	0	None
10967	10968	inhibitors	0	None
10968	10969	of	0	None
10969	10970	ERK	0	None
10970	10971	,	0	None
10971	10972	p38	0	None
10972	10973	and	0	None
10973	10974	JNK	0	None
10974	10975	.	0	None

10976	10977	Arsenite-induced	0	None
10977	10978	ROS	0	None
10978	10979	generation	0	None
10979	10980	and	0	None
10980	10981	COX-2	0	None
10981	10982	expression	0	None
10982	10983	were	0	None
10983	10984	significantly	0	None
10984	10985	attenuated	0	None
10985	10986	by	0	None
10986	10987	treatment	0	None
10987	10988	with	0	None
10988	10989	melatonin	0	None
10989	10990	(	0	None
10990	10991	a	0	None
10991	10992	ROS	0	None
10992	10993	scavenger	0	None
10993	10994	)	0	None
10994	10995	,	0	None
10995	10996	but	0	None
10996	10997	enhanced	0	None
10997	10998	by	0	None
10998	10999	DL-buthionine-	0	None
10999	11000	(	0	None
11000	11001	S	0	None
11001	11002	,	0	None
11002	11003	R	0	None
11003	11004	)	0	None
11004	11005	-sulfoximine	0	None
11005	11006	(	0	None
11006	11007	BSO	0	None
11007	11008	,	0	None
11008	11009	an	0	None
11009	11010	inhibitor	0	None
11010	11011	of	0	None
11011	11012	gamma-glutamylcysteine	2	CHEMICAL
11012	11013	synthetase	0	None
11013	11014	(	0	None
11014	11015	γ-GCS	0	None
11015	11016	)	0	None
11016	11017	resulting	0	None
11017	11018	in	0	None
11018	11019	lower	0	None
11019	11020	GSH	0	None
11020	11021	and	0	None
11021	11022	increased	0	None
11022	11023	ROS	0	None
11023	11024	levels	0	None
11024	11025	)	0	None
11025	11026	.	0	None

11027	11028	These	0	None
11028	11029	data	0	None
11029	11030	indicate	0	None
11030	11031	that	0	None
11031	11032	arsenite	2	CHEMICAL
11032	11033	promotes	0	None
11033	11034	an	0	None
11034	11035	induction	0	None
11035	11036	of	0	None
11036	11037	ROS	0	None
11037	11038	,	0	None
11038	11039	which	0	None
11039	11040	results	0	None
11040	11041	in	0	None
11041	11042	an	0	None
11042	11043	induction	0	None
11043	11044	of	0	None
11044	11045	COX-2	0	None
11045	11046	expression	0	None
11046	11047	through	0	None
11047	11048	activation	0	None
11048	11049	of	0	None
11049	11050	the	0	None
11050	11051	MAPK	3	GENE-N
11051	11052	pathway	0	None
11052	11053	.	0	None
11053	11054	Due	0	None
11054	11055	to	0	None
11055	11056	the	0	None
11056	11057	increased	0	None
11057	11058	prevalence	0	None
11058	11059	of	0	None
11059	11060	bacterial	0	None
11060	11061	strains	0	None
11061	11062	that	0	None
11062	11063	are	0	None
11063	11064	resistant	0	None
11064	11065	to	0	None
11065	11066	existing	0	None
11066	11067	antibiotics	0	None
11067	11068	,	0	None
11068	11069	there	0	None
11069	11070	is	0	None
11070	11071	an	0	None
11071	11072	urgent	0	None
11072	11073	need	0	None
11073	11074	for	0	None
11074	11075	new	0	None
11075	11076	antibacterial	0	None
11076	11077	strategies	0	None
11077	11078	.	0	None

11079	11080	Bacterial	0	None
11080	11081	glycans	0	None
11081	11082	are	0	None
11082	11083	an	0	None
11083	11084	attractive	0	None
11084	11085	target	0	None
11085	11086	for	0	None
11086	11087	new	0	None
11087	11088	treatments	0	None
11088	11089	,	0	None
11089	11090	as	0	None
11090	11091	they	0	None
11091	11092	are	0	None
11092	11093	frequently	0	None
11093	11094	linked	0	None
11094	11095	to	0	None
11095	11096	pathogenesis	0	None
11096	11097	and	0	None
11097	11098	contain	0	None
11098	11099	distinctive	0	None
11099	11100	structures	0	None
11100	11101	that	0	None
11101	11102	are	0	None
11102	11103	absent	0	None
11103	11104	in	0	None
11104	11105	humans	0	None
11105	11106	.	0	None

11107	11108	We	0	None
11108	11109	set	0	None
11109	11110	out	0	None
11110	11111	to	0	None
11111	11112	develop	0	None
11112	11113	a	0	None
11113	11114	novel	0	None
11114	11115	targeting	0	None
11115	11116	strategy	0	None
11116	11117	based	0	None
11117	11118	on	0	None
11118	11119	surface	0	None
11119	11120	glycans	0	None
11120	11121	present	0	None
11121	11122	on	0	None
11122	11123	the	0	None
11123	11124	gastric	0	None
11124	11125	pathogen	0	None
11125	11126	Helicobacter	0	None
11126	11127	pylori	0	None
11127	11128	(	0	None
11128	11129	Hp	0	None
11129	11130	)	0	None
11130	11131	.	0	None

11132	11133	In	0	None
11133	11134	this	0	None
11134	11135	study	0	None
11135	11136	,	0	None
11136	11137	metabolic	0	None
11137	11138	labeling	0	None
11138	11139	of	0	None
11139	11140	bacterial	0	None
11140	11141	glycans	0	None
11141	11142	with	0	None
11142	11143	an	0	None
11143	11144	azide-containing	0	None
11144	11145	sugar	0	None
11145	11146	allowed	0	None
11146	11147	selective	0	None
11147	11148	delivery	0	None
11148	11149	of	0	None
11149	11150	immune	0	None
11150	11151	stimulants	0	None
11151	11152	to	0	None
11152	11153	azide-covered	0	None
11153	11154	Hp	0	None
11154	11155	.	0	None

11156	11157	We	0	None
11157	11158	established	0	None
11158	11159	that	0	None
11159	11160	Hp's	0	None
11160	11161	surface	0	None
11161	11162	glycans	0	None
11162	11163	are	0	None
11163	11164	labeled	0	None
11164	11165	by	0	None
11165	11166	treatment	0	None
11166	11167	with	0	None
11167	11168	the	0	None
11168	11169	metabolic	0	None
11169	11170	substrate	0	None
11170	11171	peracetylated	0	None
11171	11172	N-azidoacetylglucosamine	0	None
11172	11173	(	0	None
11173	11174	Ac4	0	None
11174	11175	GlcNAz	0	None
11175	11176	)	0	None
11176	11177	.	0	None

11178	11179	By	0	None
11179	11180	contrast	0	None
11180	11181	,	0	None
11181	11182	mammalian	0	None
11182	11183	cells	0	None
11183	11184	treated	0	None
11184	11185	with	0	None
11185	11186	Ac4	0	None
11186	11187	GlcNAz	0	None
11187	11188	exhibited	0	None
11188	11189	no	0	None
11189	11190	incorporation	0	None
11190	11191	of	0	None
11191	11192	the	0	None
11192	11193	chemical	0	None
11193	11194	label	0	None
11194	11195	within	0	None
11195	11196	extracellular	0	None
11196	11197	glycans	0	None
11197	11198	.	0	None

11199	11200	We	0	None
11200	11201	further	0	None
11201	11202	demonstrated	0	None
11202	11203	that	0	None
11203	11204	the	0	None
11204	11205	Staudinger	0	None
11205	11206	ligation	0	None
11206	11207	between	0	None
11207	11208	azides	0	None
11208	11209	and	0	None
11209	11210	phosphines	0	None
11210	11211	proceeds	0	None
11211	11212	under	0	None
11212	11213	acidic	0	None
11213	11214	conditions	0	None
11214	11215	with	0	None
11215	11216	only	0	None
11216	11217	a	0	None
11217	11218	small	0	None
11218	11219	loss	0	None
11219	11220	of	0	None
11220	11221	efficiency	0	None
11221	11222	.	0	None

11223	11224	We	0	None
11224	11225	then	0	None
11225	11226	targeted	0	None
11226	11227	azide-covered	0	None
11227	11228	Hp	0	None
11228	11229	with	0	None
11229	11230	phosphines	0	None
11230	11231	conjugated	0	None
11231	11232	to	0	None
11232	11233	the	0	None
11233	11234	immune	0	None
11234	11235	stimulant	0	None
11235	11236	2	0	None
11236	11237	,	0	None
11237	11238	4-dinitrophenyl	0	None
11238	11239	(	0	None
11239	11240	DNP	0	None
11240	11241	)	0	None
11241	11242	,	0	None
11242	11243	a	0	None
11243	11244	compound	0	None
11244	11245	capable	0	None
11245	11246	of	0	None
11246	11247	directing	0	None
11247	11248	a	0	None
11248	11249	host	0	None
11249	11250	immune	0	None
11250	11251	response	0	None
11251	11252	against	0	None
11252	11253	these	0	None
11253	11254	cells	0	None
11254	11255	.	0	None

11256	11257	Finally	0	None
11257	11258	,	0	None
11258	11259	we	0	None
11259	11260	report	0	None
11260	11261	that	0	None
11261	11262	immune	0	None
11262	11263	effector	0	None
11263	11264	cells	0	None
11264	11265	catalyze	0	None
11265	11266	selective	0	None
11266	11267	damage	0	None
11267	11268	in	0	None
11268	11269	vitro	0	None
11269	11270	to	0	None
11270	11271	DNP-covered	0	None
11271	11272	Hp	0	None
11272	11273	in	0	None
11273	11274	the	0	None
11274	11275	presence	0	None
11275	11276	of	0	None
11276	11277	anti-DNP	0	None
11277	11278	antibodies	0	None
11278	11279	.	0	None

11280	11281	The	0	None
11281	11282	technology	0	None
11282	11283	reported	0	None
11283	11284	herein	0	None
11284	11285	represents	0	None
11285	11286	a	0	None
11286	11287	novel	0	None
11287	11288	strategy	0	None
11288	11289	to	0	None
11289	11290	target	0	None
11290	11291	Hp	0	None
11291	11292	based	0	None
11292	11293	on	0	None
11293	11294	its	0	None
11294	11295	glycans	0	None
11295	11296	.	0	None
11296	11297	Extracellular	0	None
11297	11298	loop	0	None
11298	11299	3	0	None
11299	11300	(	0	None
11300	11301	EL3	0	None
11301	11302	)	0	None
11302	11303	and	0	None
11303	11304	EL3-proximal	0	None
11304	11305	transmembrane	0	None
11305	11306	helix	0	None
11306	11307	7	0	None
11307	11308	of	0	None
11308	11309	the	0	None
11309	11310	mammalian	0	None
11310	11311	type	0	None
11311	11312	I	0	None
11312	11313	and	0	None
11313	11314	type	0	None
11314	11315	II	0	None
11315	11317	gonadotropin-releasing hormone	1	GENE-Y
11317	11318	(	0	None
11318	11319	GnRH	0	None
11319	11320	)	0	None
11320	11321	receptors	0	None
11321	11322	determine	0	None
11322	11323	differential	0	None
11323	11324	ligand	0	None
11324	11325	selectivity	0	None
11325	11326	to	0	None
11326	11327	GnRH-I	0	None
11327	11328	and	0	None
11328	11329	GnRH-II	0	None
11329	11330	.	0	None
11330	11331	Lanthanum	0	None
11331	11332	(	0	None
11332	11333	III	0	None
11333	11334	)	0	None
11334	11335	regulates	0	None
11335	11336	the	0	None
11336	11337	nitrogen	0	None
11337	11338	assimilation	0	None
11338	11339	in	0	None
11339	11340	soybean	0	None
11340	11341	seedlings	0	None
11341	11342	under	0	None
11342	11343	ultraviolet-B	0	None
11343	11344	radiation	0	None
11344	11345	.	0	None
11345	11346	The	0	None
11346	11347	enzyme	0	None
11347	11348	,	0	None
11348	11350	10-formyltetrahydrofolate dehydrogenase	1	GENE-Y
11350	11351	(	0	None
11351	11352	FDH	0	None
11352	11353	)	0	None
11353	11354	,	0	None
11354	11355	converts	0	None
11355	11356	10-formyltetrahydrofolate	2	CHEMICAL
11356	11357	(	0	None
11357	11358	10-formyl-THF	0	None
11358	11359	)	0	None
11359	11360	to	0	None
11360	11361	tetrahydrofolate	2	CHEMICAL
11361	11362	in	0	None
11362	11363	an	0	None
11363	11364	NADP	0	None
11364	11365	(	0	None
11365	11366	+	0	None
11366	11367	)	0	None
11367	11368	-dependent	0	None
11368	11369	dehydrogenase	0	None
11369	11370	reaction	0	None
11370	11371	or	0	None
11371	11372	an	0	None
11372	11373	NADP	0	None
11373	11374	(	0	None
11374	11375	+	0	None
11375	11376	)	0	None
11376	11377	-independent	0	None
11377	11378	hydrolase	0	None
11378	11379	reaction	0	None
11379	11380	.	0	None

11381	11382	The	0	None
11382	11383	hydrolase	0	None
11383	11384	reaction	0	None
11384	11385	occurs	0	None
11385	11386	in	0	None
11386	11387	a	0	None
11387	11388	310-amino	0	None
11388	11389	acid	0	None
11389	11390	long	0	None
11390	11391	amino-terminal	0	None
11391	11392	domain	0	None
11392	11393	of	0	None
11393	11394	FDH	0	None
11394	11395	(	0	None
11395	11396	N	0	None
11396	11397	(	0	None
11397	11398	t	0	None
11398	11399	)	0	None
11399	11400	-FDH	0	None
11400	11401	)	0	None
11401	11402	,	0	None
11402	11403	whereas	0	None
11403	11404	the	0	None
11404	11405	dehydrogenase	0	None
11405	11406	reaction	0	None
11406	11407	requires	0	None
11407	11408	the	0	None
11408	11409	full-length	0	None
11409	11410	enzyme	0	None
11410	11411	.	0	None

11412	11413	The	0	None
11413	11414	amino-terminal	0	None
11414	11415	domain	0	None
11415	11416	of	0	None
11416	11417	FDH	0	None
11417	11418	shares	0	None
11418	11419	some	0	None
11419	11420	sequence	0	None
11420	11421	identity	0	None
11421	11422	with	0	None
11422	11423	several	0	None
11423	11424	other	0	None
11424	11425	enzymes	0	None
11425	11426	utilizing	0	None
11426	11427	10-formyl-THF	0	None
11427	11428	as	0	None
11428	11429	a	0	None
11429	11430	substrate	0	None
11430	11431	.	0	None

11432	11433	These	0	None
11433	11434	enzymes	0	None
11434	11435	have	0	None
11435	11436	two	0	None
11436	11437	strictly	0	None
11437	11438	conserved	0	None
11438	11439	residues	0	None
11439	11440	,	0	None
11440	11441	aspartate	0	None
11441	11442	and	0	None
11442	11443	histidine	2	CHEMICAL
11443	11444	,	0	None
11444	11445	in	0	None
11445	11446	the	0	None
11446	11447	putative	0	None
11447	11448	catalytic	0	None
11448	11449	center	0	None
11449	11450	.	0	None

11451	11452	We	0	None
11452	11453	have	0	None
11453	11454	shown	0	None
11454	11455	recently	0	None
11455	11456	that	0	None
11456	11457	the	0	None
11457	11458	conserved	0	None
11458	11459	aspartate	0	None
11459	11460	is	0	None
11460	11461	involved	0	None
11461	11462	in	0	None
11462	11463	FDH	0	None
11463	11464	catalysis	0	None
11464	11465	.	0	None

11466	11467	In	0	None
11467	11468	the	0	None
11468	11469	present	0	None
11469	11470	work	0	None
11470	11471	we	0	None
11471	11472	studied	0	None
11472	11473	the	0	None
11473	11474	role	0	None
11474	11475	of	0	None
11475	11476	the	0	None
11476	11477	conserved	0	None
11477	11478	histidine	2	CHEMICAL
11478	11479	,	0	None
11479	11480	His	0	None
11480	11481	(	0	None
11481	11482	106	0	None
11482	11483	)	0	None
11483	11484	,	0	None
11484	11485	in	0	None
11485	11486	FDH	0	None
11486	11487	function	0	None
11487	11488	.	0	None

11489	11490	Site-directed	0	None
11490	11491	mutagenesis	0	None
11491	11492	experiments	0	None
11492	11493	showed	0	None
11493	11494	that	0	None
11494	11495	replacement	0	None
11495	11496	of	0	None
11496	11497	the	0	None
11497	11498	histidine	2	CHEMICAL
11498	11499	with	0	None
11499	11500	alanine	0	None
11500	11501	,	0	None
11501	11502	asparagine	0	None
11502	11503	,	0	None
11503	11504	aspartate	0	None
11504	11505	,	0	None
11505	11506	glutamate	0	None
11506	11507	,	0	None
11507	11508	glutamine	0	None
11508	11509	,	0	None
11509	11510	or	0	None
11510	11511	arginine	2	CHEMICAL
11511	11512	in	0	None
11512	11513	N	0	None
11513	11514	(	0	None
11514	11515	t	0	None
11515	11516	)	0	None
11516	11517	-FDH	0	None
11517	11518	resulted	0	None
11518	11519	in	0	None
11519	11520	expression	0	None
11520	11521	of	0	None
11521	11522	insoluble	0	None
11522	11523	proteins	0	None
11523	11524	.	0	None

11525	11526	Replacement	0	None
11526	11527	of	0	None
11527	11528	the	0	None
11528	11529	histidine	2	CHEMICAL
11529	11530	with	0	None
11530	11531	another	0	None
11531	11532	positively	0	None
11532	11533	charged	0	None
11533	11534	residue	0	None
11534	11535	,	0	None
11535	11536	lysine	0	None
11536	11537	,	0	None
11537	11538	produced	0	None
11538	11539	a	0	None
11539	11540	soluble	0	None
11540	11541	mutant	0	None
11541	11542	with	0	None
11542	11543	no	0	None
11543	11544	hydrolase	0	None
11544	11545	activity	0	None
11545	11546	.	0	None

11547	11548	The	0	None
11548	11549	insoluble	0	None
11549	11550	mutants	0	None
11550	11551	refolded	0	None
11551	11552	from	0	None
11552	11553	inclusion	0	None
11553	11554	bodies	0	None
11554	11555	adopted	0	None
11555	11556	a	0	None
11556	11557	conformation	0	None
11557	11558	inherent	0	None
11558	11559	to	0	None
11559	11560	the	0	None
11560	11561	wild-type	0	None
11561	11562	N	0	None
11562	11563	(	0	None
11563	11564	t	0	None
11564	11565	)	0	None
11565	11566	-FDH	0	None
11566	11567	,	0	None
11567	11568	but	0	None
11568	11569	they	0	None
11569	11570	did	0	None
11570	11571	not	0	None
11571	11572	exhibit	0	None
11572	11573	any	0	None
11573	11574	hydrolase	0	None
11574	11575	activity	0	None
11575	11576	.	0	None

11577	11578	Substitution	0	None
11578	11579	of	0	None
11579	11580	alanine	0	None
11580	11581	for	0	None
11581	11582	three	0	None
11582	11583	non-conserved	0	None
11583	11584	histidines	0	None
11584	11585	located	0	None
11585	11586	close	0	None
11586	11587	to	0	None
11587	11588	the	0	None
11588	11589	conserved	0	None
11589	11590	one	0	None
11590	11591	did	0	None
11591	11592	not	0	None
11592	11593	reveal	0	None
11593	11594	any	0	None
11594	11595	significant	0	None
11595	11596	changes	0	None
11596	11597	in	0	None
11597	11598	the	0	None
11598	11599	hydrolase	0	None
11599	11600	activity	0	None
11600	11601	of	0	None
11601	11602	N	0	None
11602	11603	(	0	None
11603	11604	t	0	None
11604	11605	)	0	None
11605	11606	-FDH	0	None
11606	11607	.	0	None

11608	11609	Expressed	0	None
11609	11610	full-length	0	None
11610	11611	FDH	0	None
11611	11612	with	0	None
11612	11613	the	0	None
11613	11614	substitution	0	None
11614	11615	of	0	None
11615	11616	lysine	0	None
11616	11617	for	0	None
11617	11618	the	0	None
11618	11619	His	0	None
11619	11620	(	0	None
11620	11621	106	0	None
11621	11622	)	0	None
11622	11623	completely	0	None
11623	11624	lost	0	None
11624	11625	both	0	None
11625	11626	the	0	None
11626	11627	hydrolase	0	None
11627	11628	and	0	None
11628	11629	dehydrogenase	0	None
11629	11630	activities	0	None
11630	11631	.	0	None

11632	11633	Thus	0	None
11633	11634	,	0	None
11634	11635	our	0	None
11635	11636	study	0	None
11636	11637	showed	0	None
11637	11638	that	0	None
11638	11639	His	0	None
11639	11640	(	0	None
11640	11641	106	0	None
11641	11642	)	0	None
11642	11643	,	0	None
11643	11644	besides	0	None
11644	11645	being	0	None
11645	11646	an	0	None
11646	11647	important	0	None
11647	11648	structural	0	None
11648	11649	residue	0	None
11649	11650	,	0	None
11650	11651	is	0	None
11651	11652	also	0	None
11652	11653	directly	0	None
11653	11654	involved	0	None
11654	11655	in	0	None
11655	11656	both	0	None
11656	11657	the	0	None
11657	11658	hydrolase	0	None
11658	11659	and	0	None
11659	11660	dehydrogenase	0	None
11660	11661	mechanisms	0	None
11661	11662	of	0	None
11662	11663	FDH	0	None
11663	11664	.	0	None

11665	11666	Modeling	0	None
11666	11667	of	0	None
11667	11668	the	0	None
11668	11669	putative	0	None
11669	11670	hydrolase	0	None
11670	11671	catalytic	0	None
11671	11672	center	0	None
11672	11673	/	0	None
11673	11674	folate-binding	0	None
11674	11675	site	0	None
11675	11676	suggested	0	None
11676	11677	that	0	None
11677	11678	the	0	None
11678	11679	catalytic	0	None
11679	11680	residues	0	None
11680	11681	,	0	None
11681	11684	aspartate and histidine	2	CHEMICAL
11684	11685	,	0	None
11685	11686	are	0	None
11686	11687	unlikely	0	None
11687	11688	to	0	None
11688	11689	be	0	None
11689	11690	adjacent	0	None
11690	11691	to	0	None
11691	11692	the	0	None
11692	11693	catalytic	0	None
11693	11694	cysteine	0	None
11694	11695	in	0	None
11695	11696	the	0	None
11696	11698	aldehyde dehydrogenase	3	GENE-N
11698	11699	catalytic	0	None
11699	11700	center	0	None
11700	11701	.	0	None

11702	11703	We	0	None
11703	11704	hypothesize	0	None
11704	11705	that	0	None
11705	11706	10-formyl-THF	0	None
11706	11707	dehydrogenase	0	None
11707	11708	reaction	0	None
11708	11709	is	0	None
11709	11710	not	0	None
11710	11711	an	0	None
11711	11712	independent	0	None
11712	11713	reaction	0	None
11713	11714	but	0	None
11714	11715	is	0	None
11715	11716	a	0	None
11716	11717	combination	0	None
11717	11718	of	0	None
11718	11719	hydrolase	0	None
11719	11720	and	0	None
11720	11722	aldehyde dehydrogenase	3	GENE-N
11722	11723	reactions	0	None
11723	11724	.	0	None
11724	11725	Serine	0	None
11725	11726	(	0	None
11726	11727	Ser	2	CHEMICAL
11727	11728	)	0	None
11728	11729	biosynthesis	0	None
11729	11730	in	0	None
11730	11731	C	0	None
11731	11732	(	0	None
11732	11733	3	0	None
11733	11734	)	0	None
11734	11735	plants	0	None
11735	11736	can	0	None
11736	11737	occur	0	None
11737	11738	via	0	None
11738	11739	several	0	None
11739	11740	pathways	0	None
11740	11741	.	0	None

11742	11743	One	0	None
11743	11744	major	0	None
11744	11745	route	0	None
11745	11746	involves	0	None
11746	11747	the	0	None
11747	11748	tetrahydrofolate	2	CHEMICAL
11748	11749	(	0	None
11749	11750	THF	0	None
11750	11751	)	0	None
11751	11752	-dependent	0	None
11752	11753	activities	0	None
11753	11754	of	0	None
11754	11755	the	0	None
11755	11756	glycine	2	CHEMICAL
11756	11757	decarboxylase	0	None
11757	11758	complex	0	None
11758	11759	(	0	None
11759	11760	GDC	0	None
11760	11761	,	0	None
11761	11762	EC	0	None
11762	11763	2	0	None
11763	11764	.	0	None
11764	11765	1	0	None
11765	11766	.	0	None
11766	11767	1	0	None
11767	11768	.	0	None
11768	11769	10	0	None
11769	11770	)	0	None
11770	11771	and	0	None
11771	11772	serine	2	CHEMICAL
11772	11773	hydroxymethyltransferase	0	None
11773	11774	(	0	None
11774	11775	SHMT	0	None
11775	11776	,	0	None
11776	11777	EC	0	None
11777	11778	2	0	None
11778	11779	.	0	None
11779	11780	1	0	None
11780	11781	.	0	None
11781	11782	2	0	None
11782	11783	.	0	None
11783	11784	1	0	None
11784	11785	)	0	None
11785	11786	with	0	None
11786	11787	glycine	2	CHEMICAL
11787	11788	(	0	None
11788	11789	Gly	2	CHEMICAL
11789	11790	)	0	None
11790	11791	as	0	None
11791	11792	one-carbon	0	None
11792	11793	(	0	None
11793	11794	1-C	0	None
11794	11795	)	0	None
11795	11796	source	0	None
11796	11797	.	0	None

11798	11799	An	0	None
11799	11800	alternative	0	None
11800	11801	THF-dependent	0	None
11801	11802	pathway	0	None
11802	11803	involves	0	None
11803	11804	the	0	None
11804	11805	C1-THF	0	None
11805	11806	synthase	0	None
11806	11807	/	0	None
11807	11808	SHMT	0	None
11808	11809	activities	0	None
11809	11810	with	0	None
11810	11811	formate	0	None
11811	11812	as	0	None
11812	11813	1-C	0	None
11813	11814	source	0	None
11814	11815	.	0	None

11816	11817	Here	0	None
11817	11818	,	0	None
11818	11819	we	0	None
11819	11820	have	0	None
11820	11821	investigated	0	None
11821	11822	aspects	0	None
11822	11823	of	0	None
11823	11824	the	0	None
11824	11825	regulation	0	None
11825	11826	of	0	None
11826	11827	these	0	None
11827	11828	two	0	None
11828	11829	folate-mediated	0	None
11829	11830	pathways	0	None
11830	11831	in	0	None
11831	11832	Arabidopsis	0	None
11832	11833	thaliana	0	None
11833	11834	(	0	None
11834	11835	L	0	None
11835	11836	.	0	None

11837	11838	)	0	None
11838	11839	Heynh	0	None
11839	11840	.	0	None

11841	11842	Columbia	0	None
11842	11843	using	0	None
11843	11844	two	0	None
11844	11845	approaches	0	None
11845	11846	.	0	None

11847	11848	Firstly	0	None
11848	11849	,	0	None
11849	11850	transgenic	0	None
11850	11851	plants	0	None
11851	11852	overexpressing	0	None
11852	11853	formate	0	None
11853	11854	dehydrogenase	0	None
11854	11855	(	0	None
11855	11856	FDH	0	None
11856	11857	,	0	None
11857	11858	EC	0	None
11858	11859	1	0	None
11859	11860	.	0	None
11860	11861	2	0	None
11861	11862	.	0	None
11862	11863	1	0	None
11863	11864	.	0	None
11864	11865	2	0	None
11865	11866	)	0	None
11866	11867	were	0	None
11867	11868	used	0	None
11868	11869	to	0	None
11869	11870	continue	0	None
11870	11871	our	0	None
11871	11872	previous	0	None
11872	11873	studies	0	None
11873	11874	on	0	None
11874	11875	the	0	None
11875	11876	function	0	None
11876	11877	of	0	None
11877	11878	FDH	0	None
11878	11879	in	0	None
11879	11880	formate	0	None
11880	11881	metabolism	0	None
11881	11882	.	0	None

11883	11884	The	0	None
11884	11885	formate	0	None
11885	11886	pool	0	None
11886	11887	size	0	None
11887	11888	was	0	None
11888	11889	approximately	0	None
11889	11890	73	0	None
11890	11891	nmol	0	None
11891	11892	(	0	None
11892	11893	g	0	None
11893	11894	FW	0	None
11894	11895	)	0	None
11895	11896	(	0	None
11896	11897	-1	0	None
11897	11898	)	0	None
11898	11899	in	0	None
11899	11900	wild	0	None
11900	11901	type	0	None
11901	11902	(	0	None
11902	11903	WT	0	None
11903	11904	)	0	None
11904	11905	Arabidopsis	0	None
11905	11906	plants;	0	None
11906	11907	three	0	None
11907	11908	independent	0	None
11908	11909	transgenic	0	None
11909	11910	lines	0	None
11910	11911	had	0	None
11911	11912	similar-sized	0	None
11912	11913	pools	0	None
11913	11914	of	0	None
11914	11915	formate	0	None
11915	11916	.	0	None

11917	11918	Transgenic	0	None
11918	11919	plants	0	None
11919	11920	produced	0	None
11920	11921	more	0	None
11921	11922	(	0	None
11922	11923	13	0	None
11923	11924	)	0	None
11924	11925	CO	0	None
11925	11926	(	0	None
11926	11927	2	0	None
11927	11928	)	0	None
11928	11929	from	0	None
11929	11930	supplied	0	None
11930	11931	[	0	None
11931	11932	(	0	None
11932	11933	13	0	None
11933	11934	)	0	None
11934	11935	C	0	None
11935	11936	]	0	None
11936	11937	formate	0	None
11937	11938	than	0	None
11938	11939	did	0	None
11939	11940	WT	0	None
11940	11941	plants	0	None
11941	11942	but	0	None
11942	11943	were	0	None
11943	11944	not	0	None
11944	11945	significantly	0	None
11945	11946	different	0	None
11946	11947	from	0	None
11947	11948	WT	0	None
11948	11949	plants	0	None
11949	11950	in	0	None
11950	11951	their	0	None
11951	11952	synthesis	0	None
11952	11953	of	0	None
11953	11954	Ser	2	CHEMICAL
11954	11955	.	0	None

11956	11957	We	0	None
11957	11958	concluded	0	None
11958	11959	that	0	None
11959	11960	FDH	0	None
11960	11961	has	0	None
11961	11962	no	0	None
11962	11963	direct	0	None
11963	11964	role	0	None
11964	11965	in	0	None
11965	11966	the	0	None
11966	11967	regulation	0	None
11967	11968	of	0	None
11968	11969	the	0	None
11969	11970	above	0	None
11970	11971	two	0	None
11971	11972	pathways	0	None
11972	11973	of	0	None
11973	11974	Ser	2	CHEMICAL
11974	11975	synthesis;	0	None
11975	11976	the	0	None
11976	11977	breakdown	0	None
11977	11978	of	0	None
11978	11979	formate	0	None
11979	11980	to	0	None
11980	11981	CO	0	None
11981	11982	(	0	None
11982	11983	2	0	None
11983	11984	)	0	None
11984	11985	by	0	None
11985	11986	the	0	None
11986	11987	FDH	0	None
11987	11988	reaction	0	None
11988	11989	is	0	None
11989	11990	the	0	None
11990	11991	primary	0	None
11991	11992	and	0	None
11992	11993	preferred	0	None
11993	11994	fate	0	None
11994	11995	of	0	None
11995	11996	the	0	None
11996	11998	organic acid	2	CHEMICAL
11998	11999	in	0	None
11999	12000	Arabidopsis	0	None
12000	12001	.	0	None

12002	12003	The	0	None
12003	12004	ratio	0	None
12004	12005	between	0	None
12005	12006	the	0	None
12006	12007	GDC	0	None
12007	12008	/	0	None
12008	12009	SHMT	0	None
12009	12010	and	0	None
12010	12011	C1-THF	0	None
12011	12012	synthase	0	None
12012	12013	/	0	None
12013	12014	SHMT	0	None
12014	12015	pathways	0	None
12015	12016	of	0	None
12016	12017	Ser	2	CHEMICAL
12017	12018	synthesis	0	None
12018	12019	from	0	None
12019	12020	[	0	None
12020	12021	alpha-	0	None
12021	12022	(	0	None
12022	12023	13	0	None
12023	12024	)	0	None
12024	12025	C	0	None
12025	12026	]	0	None
12026	12027	Gly	2	CHEMICAL
12027	12028	and	0	None
12028	12029	[	0	None
12029	12030	(	0	None
12030	12031	13	0	None
12031	12032	)	0	None
12032	12033	C	0	None
12033	12034	]	0	None
12034	12035	formate	0	None
12035	12036	,	0	None
12036	12037	respectively	0	None
12037	12038	,	0	None
12038	12039	in	0	None
12039	12040	Arabidopsis	0	None
12040	12041	shoots	0	None
12041	12042	was	0	None
12042	12043	21	0	None
12043	12044	:	0	None
12044	12045	1;	0	None
12045	12046	in	0	None
12046	12047	roots	0	None
12047	12048	,	0	None
12048	12049	9	0	None
12049	12050	:	0	None
12050	12051	1	0	None
12051	12052	.	0	None

12053	12054	In	0	None
12054	12055	shoots	0	None
12055	12056	,	0	None
12056	12057	therefore	0	None
12057	12058	,	0	None
12058	12059	the	0	None
12059	12060	pathway	0	None
12060	12061	from	0	None
12061	12062	formate	0	None
12062	12063	plays	0	None
12063	12064	only	0	None
12064	12065	a	0	None
12065	12066	small	0	None
12066	12067	role	0	None
12067	12068	in	0	None
12068	12069	Ser	2	CHEMICAL
12069	12070	synthesis;	0	None
12070	12071	in	0	None
12071	12072	the	0	None
12072	12073	case	0	None
12073	12074	of	0	None
12074	12075	roots	0	None
12075	12076	,	0	None
12076	12077	results	0	None
12077	12078	indicated	0	None
12078	12079	that	0	None
12079	12080	the	0	None
12080	12081	9	0	None
12081	12082	:	0	None
12082	12083	1	0	None
12083	12084	ratio	0	None
12084	12085	was	0	None
12085	12086	as	0	None
12086	12087	a	0	None
12087	12088	result	0	None
12088	12089	of	0	None
12089	12090	greater	0	None
12090	12091	fluxes	0	None
12091	12092	of	0	None
12092	12093	(	0	None
12093	12094	13	0	None
12094	12095	)	0	None
12095	12096	C	0	None
12096	12097	through	0	None
12097	12098	both	0	None
12098	12099	pathways	0	None
12099	12100	together	0	None
12100	12101	with	0	None
12101	12102	a	0	None
12102	12103	relatively	0	None
12103	12104	higher	0	None
12104	12105	contribution	0	None
12105	12106	from	0	None
12106	12107	the	0	None
12107	12108	C1-THF	0	None
12108	12109	synthase	0	None
12109	12110	/	0	None
12110	12111	SHMT	0	None
12111	12112	route	0	None
12112	12113	than	0	None
12113	12114	in	0	None
12114	12115	shoots	0	None
12115	12116	.	0	None

12117	12118	We	0	None
12118	12119	also	0	None
12119	12120	examined	0	None
12120	12121	the	0	None
12121	12122	synthesis	0	None
12122	12123	of	0	None
12123	12124	Ser	2	CHEMICAL
12124	12125	in	0	None
12125	12126	a	0	None
12126	12127	GDC-deficient	0	None
12127	12128	mutant	0	None
12128	12129	of	0	None
12129	12130	Arabidopsis	0	None
12130	12131	(	0	None
12131	12132	glyD	0	None
12132	12133	)	0	None
12133	12134	where	0	None
12134	12135	the	0	None
12135	12136	GDC	0	None
12136	12137	/	0	None
12137	12138	SHMT	0	None
12138	12139	pathway	0	None
12139	12140	was	0	None
12140	12141	impaired	0	None
12141	12142	.	0	None

12143	12144	Compared	0	None
12144	12145	with	0	None
12145	12146	WT	0	None
12146	12147	,	0	None
12147	12148	glyD	0	None
12148	12149	plants	0	None
12149	12150	accumulated	0	None
12150	12151	5-fold	0	None
12151	12152	more	0	None
12152	12153	Gly	2	CHEMICAL
12153	12154	than	0	None
12154	12155	WT	0	None
12155	12156	after	0	None
12156	12157	supplying	0	None
12157	12158	[	0	None
12158	12159	alpha-	0	None
12159	12160	(	0	None
12160	12161	13	0	None
12161	12162	)	0	None
12162	12163	C	0	None
12163	12164	]	0	None
12164	12165	Gly	2	CHEMICAL
12165	12166	for	0	None
12166	12167	24	0	None
12167	12168	h;	0	None
12168	12169	the	0	None
12169	12170	accumulation	0	None
12170	12171	of	0	None
12171	12172	Ser	2	CHEMICAL
12172	12173	from	0	None
12173	12174	[	0	None
12174	12175	alpha-	0	None
12175	12176	(	0	None
12176	12177	13	0	None
12177	12178	)	0	None
12178	12179	C	0	None
12179	12180	]	0	None
12180	12181	Gly	2	CHEMICAL
12181	12182	was	0	None
12182	12183	reduced	0	None
12183	12184	by	0	None
12184	12185	25%	0	None
12185	12186	in	0	None
12186	12187	the	0	None
12187	12188	same	0	None
12188	12189	time	0	None
12189	12190	period	0	None
12190	12191	.	0	None

12192	12193	On	0	None
12193	12194	the	0	None
12194	12195	other	0	None
12195	12196	hand	0	None
12196	12197	,	0	None
12197	12198	the	0	None
12198	12199	accumulation	0	None
12199	12200	of	0	None
12200	12201	Ser	2	CHEMICAL
12201	12202	through	0	None
12202	12203	the	0	None
12203	12204	C1-THF	0	None
12204	12205	synthase	0	None
12205	12206	/	0	None
12206	12207	SHMT	0	None
12207	12208	pathway	0	None
12208	12209	in	0	None
12209	12210	glyD	0	None
12210	12211	plants	0	None
12211	12212	was	0	None
12212	12213	2	0	None
12213	12214	.	0	None
12214	12215	5-fold	0	None
12215	12216	greater	0	None
12216	12217	than	0	None
12217	12218	that	0	None
12218	12219	in	0	None
12219	12220	WT	0	None
12220	12221	plants	0	None
12221	12222	.	0	None

12223	12224	Our	0	None
12224	12225	experiments	0	None
12225	12226	confirmed	0	None
12226	12227	that	0	None
12227	12228	the	0	None
12228	12229	GDC	0	None
12229	12230	/	0	None
12230	12231	SHMT	0	None
12231	12232	and	0	None
12232	12233	C1-THF	0	None
12233	12234	synthase	0	None
12234	12235	/	0	None
12235	12236	SHMT	0	None
12236	12237	pathways	0	None
12237	12238	normally	0	None
12238	12239	operate	0	None
12239	12240	independently	0	None
12240	12241	in	0	None
12241	12242	Arabidopsis	0	None
12242	12243	plants	0	None
12243	12244	but	0	None
12244	12245	that	0	None
12245	12246	when	0	None
12246	12247	the	0	None
12247	12248	primary	0	None
12248	12249	GDC	0	None
12249	12250	/	0	None
12250	12251	SHMT	0	None
12251	12252	pathway	0	None
12252	12253	is	0	None
12253	12254	impaired	0	None
12254	12255	the	0	None
12255	12256	alternative	0	None
12256	12257	C1-THF	0	None
12257	12258	synthase	0	None
12258	12259	/	0	None
12259	12260	SHMT	0	None
12260	12261	pathway	0	None
12261	12262	can	0	None
12262	12263	partially	0	None
12263	12264	compensate	0	None
12264	12265	for	0	None
12265	12266	deficiencies	0	None
12266	12267	in	0	None
12267	12268	the	0	None
12268	12269	synthesis	0	None
12269	12270	of	0	None
12270	12271	Ser	2	CHEMICAL
12271	12272	.	0	None
12272	12273	Strontium	0	None
12273	12274	stimulates	0	None
12274	12275	cartilage	0	None
12275	12276	matrix	0	None
12276	12277	formation	0	None
12277	12278	in	0	None
12278	12279	vitro	0	None
12279	12280	.	0	None

12281	12282	However	0	None
12282	12283	,	0	None
12283	12284	the	0	None
12284	12285	mechanisms	0	None
12285	12286	governing	0	None
12286	12287	these	0	None
12287	12288	effects	0	None
12288	12289	have	0	None
12289	12290	not	0	None
12290	12291	yet	0	None
12291	12292	been	0	None
12292	12293	extensively	0	None
12293	12294	reported	0	None
12294	12295	.	0	None

12296	12297	In	0	None
12297	12298	this	0	None
12298	12299	study	0	None
12299	12300	,	0	None
12300	12301	chondrocytes	0	None
12301	12302	were	0	None
12302	12303	isolated	0	None
12303	12304	from	0	None
12304	12305	rat	0	None
12305	12306	articular	0	None
12306	12307	cartilage	0	None
12307	12308	by	0	None
12308	12309	enzymatic	0	None
12309	12310	digestion	0	None
12310	12311	and	0	None
12311	12312	cultured	0	None
12312	12313	for	0	None
12313	12314	24-72	0	None
12314	12315	h	0	None
12315	12316	with	0	None
12316	12317	1-5	0	None
12317	12318	mM	0	None
12318	12319	strontium	0	None
12319	12320	.	0	None

12321	12322	We	0	None
12322	12323	investigated	0	None
12323	12324	the	0	None
12324	12325	effects	0	None
12325	12326	of	0	None
12326	12327	different	0	None
12327	12328	concentrations	0	None
12328	12329	of	0	None
12329	12330	strontium	0	None
12330	12331	on	0	None
12331	12332	collagen	3	GENE-N
12332	12333	content	0	None
12333	12334	,	0	None
12334	12335	type	0	None
12335	12336	II	0	None
12336	12337	collagen	3	GENE-N
12337	12338	,	0	None
12338	12341	insulin-like growth factor	3	GENE-N
12341	12342	(	0	None
12342	12343	IGF-1	0	None
12343	12344	)	0	None
12344	12345	and	0	None
12345	12347	matrix metalloproteinase	1	GENE-Y
12347	12348	(	0	None
12348	12349	MMP	2	CHEMICAL
12349	12350	)	0	None
12350	12351	-13	0	None
12351	12352	expression	0	None
12352	12353	in	0	None
12353	12354	rat	0	None
12354	12355	cultured	0	None
12355	12356	articular	0	None
12356	12357	chondrocytes	0	None
12357	12358	in	0	None
12358	12359	vitro	0	None
12359	12360	.	0	None

12361	12362	The	0	None
12362	12363	collagen	3	GENE-N
12363	12364	content	0	None
12364	12365	of	0	None
12365	12366	the	0	None
12366	12367	chondrocytes	0	None
12367	12368	,	0	None
12368	12369	determined	0	None
12369	12370	as	0	None
12370	12371	hydroxyproline	0	None
12371	12372	,	0	None
12372	12373	was	0	None
12373	12374	measured	0	None
12374	12375	by	0	None
12375	12376	a	0	None
12376	12377	colorimetry	0	None
12377	12378	method	0	None
12378	12379	.	0	None

12380	12381	Type	0	None
12381	12382	II	0	None
12382	12383	collagen	3	GENE-N
12383	12384	,	0	None
12384	12385	IGF-1	0	None
12385	12386	,	0	None
12386	12387	and	0	None
12387	12388	MMP-13	0	None
12388	12389	mRNA	0	None
12389	12390	abundance	0	None
12390	12391	and	0	None
12391	12392	protein	0	None
12392	12393	expression	0	None
12393	12394	levels	0	None
12394	12395	were	0	None
12395	12396	determined	0	None
12396	12397	by	0	None
12397	12398	real-time	0	None
12398	12399	polymerase	0	None
12399	12400	chain	0	None
12400	12401	reaction	0	None
12401	12402	(	0	None
12402	12403	real-time	0	None
12403	12404	PCR	0	None
12404	12405	)	0	None
12405	12406	and	0	None
12406	12407	western	0	None
12407	12408	blot	0	None
12408	12409	,	0	None
12409	12410	respectively	0	None
12410	12411	.	0	None

12412	12413	The	0	None
12413	12414	results	0	None
12414	12415	showed	0	None
12415	12416	that	0	None
12416	12417	collagen	3	GENE-N
12417	12418	content	0	None
12418	12419	from	0	None
12419	12420	the	0	None
12420	12421	chondrocytes	0	None
12421	12423	extracellular matrix	1	GENE-Y
12423	12424	increased	0	None
12424	12425	with	0	None
12425	12426	increasing	0	None
12426	12427	strontium	0	None
12427	12428	concentration	0	None
12428	12429	.	0	None

12430	12431	Moreover	0	None
12431	12432	,	0	None
12432	12433	3	0	None
12433	12434	and	0	None
12434	12435	5	0	None
12435	12436	mM	0	None
12436	12437	strontium	0	None
12437	12438	strongly	0	None
12438	12439	stimulated	0	None
12439	12440	protein	0	None
12440	12441	expression	0	None
12441	12442	and	0	None
12442	12443	mRNA	0	None
12443	12444	levels	0	None
12444	12445	of	0	None
12445	12446	type	0	None
12446	12447	II	0	None
12447	12448	collagen	3	GENE-N
12448	12449	and	0	None
12449	12450	IGF-1	0	None
12450	12451	.	0	None

12452	12453	Conversely	0	None
12453	12454	,	0	None
12454	12455	MMP-13	0	None
12455	12456	expression	0	None
12456	12457	in	0	None
12457	12458	chondrocytes	0	None
12458	12459	decreased	0	None
12459	12460	dose-dependently	0	None
12460	12461	with	0	None
12461	12462	increasing	0	None
12462	12463	strontium	0	None
12463	12464	concentration	0	None
12464	12465	.	0	None

12466	12467	These	0	None
12467	12468	results	0	None
12468	12469	should	0	None
12469	12470	provide	0	None
12470	12471	insight	0	None
12471	12472	into	0	None
12472	12473	the	0	None
12473	12474	ability	0	None
12474	12475	of	0	None
12475	12476	strontium	0	None
12476	12477	to	0	None
12477	12478	promote	0	None
12478	12479	chondrocyte	0	None
12479	12480	extracellular	0	None
12480	12481	matrix	0	None
12481	12482	synthesis	0	None
12482	12483	.	0	None

12484	12485	Strontium	0	None
12485	12486	could	0	None
12486	12487	promote	0	None
12487	12488	collagen	3	GENE-N
12488	12489	synthesis	0	None
12489	12490	and	0	None
12490	12491	suppress	0	None
12491	12492	collagen	3	GENE-N
12492	12493	degradation	0	None
12493	12494	via	0	None
12494	12495	the	0	None
12495	12496	repression	0	None
12496	12497	of	0	None
12497	12498	MMP-13	0	None
12498	12499	expression	0	None
12499	12500	.	0	None
12500	12501	Hepatocytes	0	None
12501	12502	display	0	None
12502	12503	a	0	None
12503	12504	compensatory	0	None
12504	12505	survival	0	None
12505	12506	response	0	None
12506	12507	against	0	None
12507	12508	cadmium	2	CHEMICAL
12508	12509	toxicity	0	None
12509	12510	by	0	None
12510	12511	a	0	None
12511	12512	mechanism	0	None
12512	12513	mediated	0	None
12513	12514	by	0	None
12514	12515	EGFR	0	None
12515	12516	and	0	None
12516	12517	Src	0	None
12517	12518	.	0	None
12518	12519	Chronic	0	None
12519	12520	treatment	0	None
12520	12521	with	0	None
12521	12522	myo-inositol	0	None
12522	12523	reduces	0	None
12523	12524	white	0	None
12524	12525	adipose	0	None
12525	12526	tissue	0	None
12526	12527	accretion	0	None
12527	12528	and	0	None
12528	12529	improves	0	None
12529	12530	insulin	0	None
12530	12531	sensitivity	0	None
12531	12532	in	0	None
12532	12533	female	0	None
12533	12534	mice	0	None
12534	12535	.	0	None
12535	12536	Three	0	None
12536	12537	anatase	0	None
12537	12538	titanium	0	None
12538	12539	dioxide	0	None
12539	12540	(	0	None
12540	12541	TiO	0	None
12541	12542	(	0	None
12542	12543	2	0	None
12543	12544	)	0	None
12544	12545	)	0	None
12545	12546	nanoparticles	0	None
12546	12547	(	0	None
12547	12548	NPs	0	None
12548	12549	)	0	None
12549	12550	were	0	None
12550	12551	prepared;	0	None
12551	12552	nanospheres	0	None
12552	12553	(	0	None
12553	12554	NSs	0	None
12554	12555	)	0	None
12555	12556	,	0	None
12556	12557	short	0	None
12557	12558	nanobelts	0	None
12558	12559	(	0	None
12559	12560	NB1	0	None
12560	12561	)	0	None
12561	12562	,	0	None
12562	12563	and	0	None
12563	12564	long	0	None
12564	12565	nanobelts	0	None
12565	12566	(	0	None
12566	12567	NB2	0	None
12567	12568	)	0	None
12568	12569	.	0	None

12570	12571	These	0	None
12571	12572	NPs	0	None
12572	12573	were	0	None
12573	12574	used	0	None
12574	12575	to	0	None
12575	12576	investigate	0	None
12576	12577	the	0	None
12577	12578	effect	0	None
12578	12579	of	0	None
12579	12580	NP	0	None
12580	12581	shape	0	None
12581	12582	and	0	None
12582	12583	length	0	None
12583	12584	on	0	None
12584	12585	lung	0	None
12585	12586	toxicity	0	None
12586	12587	.	0	None

12588	12589	Mice	0	None
12589	12590	were	0	None
12590	12591	exposed	0	None
12591	12592	(	0	None
12592	12593	0-30	0	None
12593	12594	µg	0	None
12594	12595	per	0	None
12595	12596	mouse	0	None
12596	12597	)	0	None
12597	12598	by	0	None
12598	12599	pharyngeal	0	None
12599	12600	aspiration	0	None
12600	12601	and	0	None
12601	12602	pulmonary	0	None
12602	12603	toxicity	0	None
12603	12604	was	0	None
12604	12605	assessed	0	None
12605	12606	over	0	None
12606	12607	a	0	None
12607	12608	112-day	0	None
12608	12609	time	0	None
12609	12610	course	0	None
12610	12611	.	0	None

12612	12613	Whole	0	None
12613	12614	lung	0	None
12614	12615	lavage	0	None
12615	12616	data	0	None
12616	12617	indicated	0	None
12617	12618	that	0	None
12618	12619	NB1-	0	None
12619	12620	and	0	None
12620	12621	NB2-exposed	0	None
12621	12622	mice	0	None
12622	12623	,	0	None
12623	12624	but	0	None
12624	12625	not	0	None
12625	12626	NS-exposed	0	None
12626	12627	mice	0	None
12627	12628	,	0	None
12628	12629	had	0	None
12629	12630	significant	0	None
12630	12631	dose-	0	None
12631	12632	and	0	None
12632	12633	time-dependent	0	None
12633	12634	pulmonary	0	None
12634	12635	inflammation	0	None
12635	12636	and	0	None
12636	12637	damage	0	None
12637	12638	.	0	None

12639	12640	Histopathological	0	None
12640	12641	analyses	0	None
12641	12642	at	0	None
12642	12643	112	0	None
12643	12644	days	0	None
12644	12645	postexposure	0	None
12645	12646	determined	0	None
12646	12647	no	0	None
12647	12648	interstitial	0	None
12648	12649	fibrosis	0	None
12649	12650	in	0	None
12650	12651	any	0	None
12651	12652	NS-exposed	0	None
12652	12653	mice	0	None
12653	12654	,	0	None
12654	12655	an	0	None
12655	12656	increased	0	None
12656	12657	incidence	0	None
12657	12658	in	0	None
12658	12659	30	0	None
12659	12660	µg	0	None
12660	12661	NB1-exposed	0	None
12661	12662	mice	0	None
12662	12663	,	0	None
12663	12664	and	0	None
12664	12665	significant	0	None
12665	12666	interstitial	0	None
12666	12667	fibrosis	0	None
12667	12668	in	0	None
12668	12669	30	0	None
12669	12670	µg	0	None
12670	12671	NB2-exposed	0	None
12671	12672	mice	0	None
12672	12673	.	0	None

12674	12675	At	0	None
12675	12676	112	0	None
12676	12677	days	0	None
12677	12678	postexposure	0	None
12678	12679	,	0	None
12679	12680	lung	0	None
12680	12681	burden	0	None
12681	12682	of	0	None
12682	12683	NS	0	None
12683	12684	was	0	None
12684	12685	decreased	0	None
12685	12686	by	0	None
12686	12687	96	0	None
12687	12688	.	0	None
12688	12689	4%	0	None
12689	12690	and	0	None
12690	12691	NB2	0	None
12691	12692	by	0	None
12692	12693	80	0	None
12693	12694	.	0	None
12694	12695	5%	0	None
12695	12696	from	0	None
12696	12697	initial	0	None
12697	12698	deposition	0	None
12698	12699	levels	0	None
12699	12700	.	0	None

12701	12702	At	0	None
12702	12703	112	0	None
12703	12704	days	0	None
12704	12705	postexposure	0	None
12705	12706	,	0	None
12706	12707	enhanced	0	None
12707	12708	dark	0	None
12708	12709	field	0	None
12709	12710	microscopy	0	None
12710	12711	determined	0	None
12711	12712	that	0	None
12712	12713	alveolar	0	None
12713	12714	macro-	0	None
12714	12715	phages	0	None
12715	12716	were	0	None
12716	12717	the	0	None
12717	12718	dominant	0	None
12718	12719	deposition	0	None
12719	12720	site	0	None
12720	12721	,	0	None
12721	12722	but	0	None
12722	12723	a	0	None
12723	12724	fraction	0	None
12724	12725	of	0	None
12725	12726	NB1	0	None
12726	12727	and	0	None
12727	12728	NB2	0	None
12728	12729	was	0	None
12729	12730	observed	0	None
12730	12731	in	0	None
12731	12732	the	0	None
12732	12733	alveolar	0	None
12733	12734	interstitial	0	None
12734	12735	spaces	0	None
12735	12736	.	0	None

12737	12738	For	0	None
12738	12739	the	0	None
12739	12740	30	0	None
12740	12741	µg	0	None
12741	12742	exposure	0	None
12742	12743	groups	0	None
12743	12744	at	0	None
12744	12745	112	0	None
12745	12746	days	0	None
12746	12747	postexposure	0	None
12747	12748	,	0	None
12748	12749	confocal	0	None
12749	12750	micro-	0	None
12750	12751	scopy	0	None
12751	12752	and	0	None
12752	12753	immunofluorescent	0	None
12753	12754	staining	0	None
12754	12755	demonstrated	0	None
12755	12756	that	0	None
12756	12757	retained	0	None
12757	12758	NB2	0	None
12758	12759	but	0	None
12759	12760	not	0	None
12760	12761	NS	0	None
12761	12762	were	0	None
12762	12763	present	0	None
12763	12764	in	0	None
12764	12765	the	0	None
12765	12766	interstitium	0	None
12766	12767	subjacent	0	None
12767	12768	to	0	None
12768	12769	the	0	None
12769	12770	terminal	0	None
12770	12771	bronchiole	0	None
12771	12772	near	0	None
12772	12773	the	0	None
12773	12774	normal	0	None
12774	12775	location	0	None
12775	12776	of	0	None
12776	12777	the	0	None
12777	12778	smallest	0	None
12778	12779	lymphatic	0	None
12779	12780	capillaries	0	None
12780	12781	in	0	None
12781	12782	the	0	None
12782	12783	lung	0	None
12783	12784	.	0	None

12785	12786	These	0	None
12786	12787	lymphatic	0	None
12787	12788	capillaries	0	None
12788	12789	play	0	None
12789	12790	a	0	None
12790	12791	critical	0	None
12791	12792	role	0	None
12792	12793	in	0	None
12793	12794	particle	0	None
12794	12795	clearance	0	None
12795	12796	,	0	None
12796	12797	and	0	None
12797	12798	the	0	None
12798	12799	accumulation	0	None
12799	12800	of	0	None
12800	12801	NB2	0	None
12801	12802	,	0	None
12802	12803	but	0	None
12803	12804	not	0	None
12804	12805	NS	0	None
12805	12806	,	0	None
12806	12807	suggests	0	None
12807	12808	possible	0	None
12808	12809	impaired	0	None
12809	12810	lymphatic	0	None
12810	12811	clearance	0	None
12811	12812	by	0	None
12812	12813	the	0	None
12813	12814	high	0	None
12814	12815	aspect	0	None
12815	12816	ratio	0	None
12816	12817	particles	0	None
12817	12818	.	0	None

12819	12820	In	0	None
12820	12821	summary	0	None
12821	12822	,	0	None
12822	12823	our	0	None
12823	12824	data	0	None
12824	12825	indicate	0	None
12825	12826	that	0	None
12826	12827	TiO	0	None
12827	12828	(	0	None
12828	12829	2	0	None
12829	12830	)	0	None
12830	12831	NP	0	None
12831	12832	shape	0	None
12832	12833	alters	0	None
12833	12834	pulmonary	0	None
12834	12835	responses	0	None
12835	12836	,	0	None
12836	12837	with	0	None
12837	12838	severity	0	None
12838	12839	of	0	None
12839	12840	responses	0	None
12840	12841	being	0	None
12841	12842	ranked	0	None
12842	12843	as	0	None
12843	12844	NS	0	None
12844	12845	<	0	None
12845	12846	NB1	0	None
12846	12847	<	0	None
12847	12848	NB2	0	None
12848	12849	.	0	None
12849	12850	The	0	None
12850	12851	L1	0	None
12851	12852	stalk	0	None
12852	12853	is	0	None
12853	12854	a	0	None
12854	12855	prominent	0	None
12855	12856	mobile	0	None
12856	12857	element	0	None
12857	12858	of	0	None
12858	12859	the	0	None
12859	12860	large	0	None
12860	12861	ribosomal	0	None
12861	12862	subunit	0	None
12862	12863	.	0	None

12864	12865	We	0	None
12865	12866	explore	0	None
12866	12867	the	0	None
12867	12868	structure	0	None
12868	12869	and	0	None
12869	12870	dynamics	0	None
12870	12871	of	0	None
12871	12872	its	0	None
12872	12873	non-canonical	0	None
12873	12874	rRNA	0	None
12874	12875	elements	0	None
12875	12876	,	0	None
12876	12877	which	0	None
12877	12878	include	0	None
12878	12879	two	0	None
12879	12880	kink-turns	0	None
12880	12881	,	0	None
12881	12882	an	0	None
12882	12883	internal	0	None
12883	12884	loop	0	None
12884	12885	,	0	None
12885	12886	and	0	None
12886	12887	a	0	None
12887	12888	tetraloop	0	None
12888	12889	.	0	None

12890	12891	We	0	None
12891	12892	use	0	None
12892	12893	bioinformatics	0	None
12893	12894	to	0	None
12894	12895	identify	0	None
12895	12896	the	0	None
12896	12897	L1	0	None
12897	12898	stalk	0	None
12898	12899	RNA	0	None
12899	12900	conservation	0	None
12900	12901	patterns	0	None
12901	12902	and	0	None
12902	12903	carry	0	None
12903	12904	out	0	None
12904	12905	over	0	None
12905	12906	11	0	None
12906	12907	.	0	None
12907	12908	5	0	None
12908	12909	μs	0	None
12909	12910	of	0	None
12910	12911	MD	0	None
12911	12912	simulations	0	None
12912	12913	for	0	None
12913	12914	a	0	None
12914	12915	set	0	None
12915	12916	of	0	None
12916	12917	systems	0	None
12917	12918	ranging	0	None
12918	12919	from	0	None
12919	12920	isolated	0	None
12920	12921	RNA	0	None
12921	12922	building	0	None
12922	12923	blocks	0	None
12923	12924	up	0	None
12924	12925	to	0	None
12925	12926	complexes	0	None
12926	12927	of	0	None
12927	12928	L1	0	None
12928	12929	stalk	0	None
12929	12930	rRNA	0	None
12930	12931	with	0	None
12931	12932	the	0	None
12932	12933	L1	0	None
12933	12934	protein	0	None
12934	12935	and	0	None
12935	12936	tRNA	0	None
12936	12937	fragment	0	None
12937	12938	.	0	None

12939	12940	We	0	None
12940	12941	show	0	None
12941	12942	that	0	None
12942	12943	the	0	None
12943	12944	L1	0	None
12944	12945	stalk	0	None
12945	12946	tetraloop	0	None
12946	12947	has	0	None
12947	12948	an	0	None
12948	12949	unusual	0	None
12949	12950	GNNA	0	None
12950	12951	or	0	None
12951	12952	UNNG	0	None
12952	12953	conservation	0	None
12953	12954	pattern	0	None
12954	12955	deviating	0	None
12955	12956	from	0	None
12956	12957	major	0	None
12957	12958	GNRA	0	None
12958	12959	and	0	None
12959	12960	YNMG	0	None
12960	12961	RNA	0	None
12961	12962	tetraloop	0	None
12962	12963	families	0	None
12963	12964	.	0	None

12965	12966	We	0	None
12966	12967	suggest	0	None
12967	12968	that	0	None
12968	12969	this	0	None
12969	12970	deviation	0	None
12970	12971	is	0	None
12971	12972	related	0	None
12972	12973	to	0	None
12973	12974	a	0	None
12974	12975	highly	0	None
12975	12976	conserved	0	None
12976	12977	tertiary	0	None
12977	12978	contact	0	None
12978	12979	within	0	None
12979	12980	the	0	None
12980	12981	L1	0	None
12981	12982	stalk	0	None
12982	12983	.	0	None

12984	12985	The	0	None
12985	12986	available	0	None
12986	12987	X-ray	0	None
12987	12988	structures	0	None
12988	12989	contain	0	None
12989	12990	only	0	None
12990	12991	UCCG	0	None
12991	12992	tetraloops	0	None
12992	12993	which	0	None
12993	12994	in	0	None
12994	12995	addition	0	None
12995	12996	differ	0	None
12996	12997	in	0	None
12997	12998	orientation	0	None
12998	12999	(	0	None
12999	13000	anti	0	None
13000	13001	vs	0	None
13001	13002	syn	0	None
13002	13003	)	0	None
13003	13004	of	0	None
13004	13005	the	0	None
13005	13006	guanine	0	None
13006	13007	.	0	None

13008	13009	Our	0	None
13009	13010	analysis	0	None
13010	13011	suggests	0	None
13011	13012	that	0	None
13012	13013	the	0	None
13013	13014	anti	0	None
13014	13015	orientation	0	None
13015	13016	might	0	None
13016	13017	be	0	None
13017	13018	a	0	None
13018	13019	mis-refinement	0	None
13019	13020	,	0	None
13020	13021	although	0	None
13021	13022	even	0	None
13022	13023	the	0	None
13023	13024	anti	0	None
13024	13025	interaction	0	None
13025	13026	would	0	None
13026	13027	be	0	None
13027	13028	compatible	0	None
13028	13029	with	0	None
13029	13030	the	0	None
13030	13031	sequence	0	None
13031	13032	pattern	0	None
13032	13033	and	0	None
13033	13034	observed	0	None
13034	13035	tertiary	0	None
13035	13036	interaction	0	None
13036	13037	.	0	None

13038	13039	Alternatively	0	None
13039	13040	,	0	None
13040	13041	the	0	None
13041	13042	anti	0	None
13042	13043	conformation	0	None
13043	13044	may	0	None
13044	13045	be	0	None
13045	13046	a	0	None
13046	13047	real	0	None
13047	13048	substate	0	None
13048	13049	whose	0	None
13049	13050	population	0	None
13050	13051	could	0	None
13051	13052	be	0	None
13052	13053	pH-dependent	0	None
13053	13054	,	0	None
13054	13055	since	0	None
13055	13056	the	0	None
13056	13057	guanine	0	None
13057	13058	syn	0	None
13058	13059	orientation	0	None
13059	13060	requires	0	None
13060	13061	protonation	0	None
13061	13062	of	0	None
13062	13063	cytosine	0	None
13063	13064	in	0	None
13064	13065	the	0	None
13065	13066	tertiary	0	None
13066	13067	contact	0	None
13067	13068	.	0	None

13069	13070	In	0	None
13070	13071	absence	0	None
13071	13072	of	0	None
13072	13073	structural	0	None
13073	13074	data	0	None
13074	13075	,	0	None
13075	13076	we	0	None
13076	13077	use	0	None
13077	13078	molecular	0	None
13078	13079	modeling	0	None
13079	13080	to	0	None
13080	13081	explore	0	None
13081	13082	the	0	None
13082	13083	GCCA	0	None
13083	13084	tetraloop	0	None
13084	13085	that	0	None
13085	13086	is	0	None
13086	13087	dominant	0	None
13087	13088	in	0	None
13088	13089	bacteria	0	None
13089	13090	and	0	None
13090	13091	suggest	0	None
13091	13092	that	0	None
13092	13093	the	0	None
13093	13094	GCCA	0	None
13094	13095	tetraloop	0	None
13095	13096	is	0	None
13096	13097	structurally	0	None
13097	13098	similar	0	None
13098	13099	to	0	None
13099	13100	the	0	None
13100	13101	YNMG	0	None
13101	13102	tetraloop	0	None
13102	13103	.	0	None

13104	13105	Kink-turn	0	None
13105	13106	Kt-77	0	None
13106	13107	is	0	None
13107	13108	unusual	0	None
13108	13109	due	0	None
13109	13110	to	0	None
13110	13111	its	0	None
13111	13112	11-nucleotide	0	None
13112	13113	bulge	0	None
13113	13114	.	0	None

13115	13116	The	0	None
13116	13117	simulations	0	None
13117	13118	indicate	0	None
13118	13119	that	0	None
13119	13120	the	0	None
13120	13121	long	0	None
13121	13122	bulge	0	None
13122	13123	is	0	None
13123	13124	a	0	None
13124	13125	stalk-specific	0	None
13125	13126	eight-nucleotide	0	None
13126	13127	insertion	0	None
13127	13128	into	0	None
13128	13129	consensual	0	None
13129	13130	kink-turn	0	None
13130	13131	only	0	None
13131	13132	subtly	0	None
13132	13133	modifying	0	None
13133	13134	its	0	None
13134	13135	structural	0	None
13135	13136	dynamics	0	None
13136	13137	.	0	None

13138	13139	We	0	None
13139	13140	discuss	0	None
13140	13141	a	0	None
13141	13142	possible	0	None
13142	13143	evolutionary	0	None
13143	13144	role	0	None
13144	13145	of	0	None
13145	13147	helix H78	3	GENE-N
13147	13148	and	0	None
13148	13149	a	0	None
13149	13150	mechanism	0	None
13150	13151	of	0	None
13151	13152	L1	0	None
13152	13153	stalk	0	None
13153	13154	interaction	0	None
13154	13155	with	0	None
13155	13156	tRNA	0	None
13156	13157	.	0	None

13158	13159	We	0	None
13159	13160	also	0	None
13160	13161	assess	0	None
13161	13162	the	0	None
13162	13163	simulation	0	None
13163	13164	methodology	0	None
13164	13165	.	0	None

13166	13167	The	0	None
13167	13168	simulations	0	None
13168	13169	provide	0	None
13169	13170	a	0	None
13170	13171	good	0	None
13171	13172	description	0	None
13172	13173	of	0	None
13173	13174	the	0	None
13174	13175	studied	0	None
13175	13176	systems	0	None
13176	13177	with	0	None
13177	13178	the	0	None
13178	13179	latest	0	None
13179	13180	bsc0χOL3	0	None
13180	13181	force	0	None
13181	13182	field	0	None
13182	13183	showing	0	None
13183	13184	improved	0	None
13184	13185	performance	0	None
13185	13186	.	0	None

13187	13188	Still	0	None
13188	13189	,	0	None
13189	13190	even	0	None
13190	13191	bsc0χOL3	0	None
13191	13192	is	0	None
13192	13193	unable	0	None
13193	13194	to	0	None
13194	13195	fully	0	None
13195	13196	stabilize	0	None
13196	13197	an	0	None
13197	13198	essential	0	None
13198	13199	sugar-edge	0	None
13199	13200	H-bond	0	None
13200	13201	between	0	None
13201	13202	the	0	None
13202	13203	bulge	0	None
13203	13204	and	0	None
13204	13205	non-canonical	0	None
13205	13206	stem	0	None
13206	13207	of	0	None
13207	13208	the	0	None
13208	13209	kink-turn	0	None
13209	13210	.	0	None

13211	13212	Inclusion	0	None
13212	13213	of	0	None
13213	13214	Mg	2	CHEMICAL
13214	13215	(	0	None
13215	13216	2	0	None
13216	13217	+	0	None
13217	13218	)	0	None
13218	13219	ions	0	None
13219	13220	may	0	None
13220	13221	deteriorate	0	None
13221	13222	the	0	None
13222	13223	simulations	0	None
13223	13224	.	0	None

13225	13226	On	0	None
13226	13227	the	0	None
13227	13228	other	0	None
13228	13229	hand	0	None
13229	13230	,	0	None
13230	13231	monovalent	0	None
13231	13232	ions	0	None
13232	13233	can	0	None
13233	13234	in	0	None
13234	13235	simulations	0	None
13235	13236	readily	0	None
13236	13237	occupy	0	None
13237	13238	experimental	0	None
13238	13239	Mg	2	CHEMICAL
13239	13240	(	0	None
13240	13241	2	0	None
13241	13242	+	0	None
13242	13243	)	0	None
13243	13244	binding	0	None
13244	13245	sites	0	None
13245	13246	.	0	None
13246	13247	RATIONALE	0	None
13247	13248	:	0	None
13248	13249	Recent	0	None
13249	13250	studies	0	None
13250	13251	provide	0	None
13251	13252	evidence	0	None
13252	13253	for	0	None
13253	13254	reduced	0	None
13254	13255	phosphodiesterase-4B	0	None
13255	13256	(	0	None
13256	13257	PDE4B	0	None
13257	13258	)	0	None
13258	13259	as	0	None
13259	13260	a	0	None
13260	13261	genetic	0	None
13261	13262	susceptibility	0	None
13262	13263	factor	0	None
13263	13264	as	0	None
13264	13265	well	0	None
13265	13266	as	0	None
13266	13267	suggesting	0	None
13267	13268	an	0	None
13268	13269	association	0	None
13269	13270	of	0	None
13270	13271	several	0	None
13271	13272	single	0	None
13272	13273	nucleotide	0	None
13273	13274	polymorphisms	0	None
13274	13275	(	0	None
13275	13276	SNPs	0	None
13276	13277	)	0	None
13277	13278	in	0	None
13278	13279	PDE4B	0	None
13279	13280	that	0	None
13280	13281	are	0	None
13281	13282	associated	0	None
13282	13283	with	0	None
13283	13284	an	0	None
13284	13285	increased	0	None
13285	13286	incidence	0	None
13286	13287	of	0	None
13287	13288	schizophrenia	0	None
13288	13289	.	0	None

13290	13291	OBJECTIVES	0	None
13291	13292	:	0	None
13292	13293	The	0	None
13293	13294	aim	0	None
13294	13295	of	0	None
13295	13296	the	0	None
13296	13297	current	0	None
13297	13298	study	0	None
13298	13299	was	0	None
13299	13300	to	0	None
13300	13301	assess	0	None
13301	13302	the	0	None
13302	13303	activity	0	None
13303	13304	of	0	None
13304	13305	rolipram	0	None
13305	13306	,	0	None
13306	13307	a	0	None
13307	13308	nonsubtype-selective	0	None
13308	13309	PDE4	0	None
13309	13310	inhibitor	0	None
13310	13311	,	0	None
13311	13312	in	0	None
13312	13313	several	0	None
13313	13314	animal	0	None
13314	13315	models	0	None
13315	13316	predictive	0	None
13316	13317	of	0	None
13317	13318	antipsychotic-like	0	None
13318	13319	efficacy	0	None
13319	13320	and	0	None
13320	13321	side-effect	0	None
13321	13322	liability	0	None
13322	13323	and	0	None
13323	13324	to	0	None
13324	13325	use	0	None
13325	13326	PDE4B	0	None
13326	13327	wild-type	0	None
13327	13328	and	0	None
13328	13329	knockout	0	None
13329	13330	mice	0	None
13330	13331	to	0	None
13331	13332	begin	0	None
13332	13333	to	0	None
13333	13334	understand	0	None
13334	13335	the	0	None
13335	13336	subtypes	0	None
13336	13337	involved	0	None
13337	13338	in	0	None
13338	13339	the	0	None
13339	13340	activity	0	None
13340	13341	of	0	None
13341	13342	rolipram	0	None
13342	13343	.	0	None

13344	13345	RESULTS	0	None
13345	13346	:	0	None
13346	13347	In	0	None
13347	13348	rats	0	None
13348	13349	,	0	None
13349	13350	rolipram	0	None
13350	13351	antagonized	0	None
13351	13352	both	0	None
13352	13353	phencyclidine	0	None
13353	13354	hydrochloride-	0	None
13354	13355	and	0	None
13355	13356	D-amphetamine-induced	0	None
13356	13357	hyperactivity	0	None
13357	13358	and	0	None
13358	13359	inhibited	0	None
13359	13360	conditioned	0	None
13360	13361	avoidance	0	None
13361	13362	responding	0	None
13362	13363	(	0	None
13363	13364	CAR	0	None
13364	13365	)	0	None
13365	13366	.	0	None

13367	13368	In	0	None
13368	13369	PDE4B	0	None
13369	13370	wild-type	0	None
13370	13371	mice	0	None
13371	13372	,	0	None
13372	13373	rolipram	0	None
13373	13374	dose-dependently	0	None
13374	13375	suppressed	0	None
13375	13376	CAR	0	None
13376	13377	(	0	None
13377	13378	ED	0	None
13378	13379	(	0	None
13379	13380	50	0	None
13380	13381	)	0	None
13381	13382	=	0	None
13382	13383	2	0	None
13383	13384	.	0	None
13384	13385	4	0	None
13385	13386	mg	2	CHEMICAL
13386	13387	/	0	None
13387	13388	kg	0	None
13388	13389	)	0	None
13389	13390	;	0	None
13390	13391	however	0	None
13391	13392	,	0	None
13392	13393	in	0	None
13393	13394	knockout	0	None
13394	13395	mice	0	None
13395	13396	,	0	None
13396	13397	their	0	None
13397	13398	sensitivity	0	None
13398	13399	to	0	None
13399	13400	rolipram	0	None
13400	13401	at	0	None
13401	13402	the	0	None
13402	13403	higher	0	None
13403	13404	doses	0	None
13404	13405	(	0	None
13405	13406	1	0	None
13406	13407	.	0	None
13407	13408	0	0	None
13408	13409	and	0	None
13409	13410	3	0	None
13410	13411	.	0	None
13411	13412	2	0	None
13412	13413	mg	2	CHEMICAL
13413	13414	/	0	None
13414	13415	kg	0	None
13415	13416	)	0	None
13416	13417	was	0	None
13417	13418	reduced	0	None
13418	13419	,	0	None
13419	13420	resulting	0	None
13420	13421	in	0	None
13421	13422	a	0	None
13422	13423	threefold	0	None
13423	13424	shift	0	None
13424	13425	in	0	None
13425	13426	the	0	None
13426	13427	ED	0	None
13427	13428	(	0	None
13428	13429	50	0	None
13429	13430	)	0	None
13430	13431	(	0	None
13431	13432	7	0	None
13432	13433	.	0	None
13433	13434	3	0	None
13434	13435	mg	2	CHEMICAL
13435	13436	/	0	None
13436	13437	kg	0	None
13437	13438	)	0	None
13438	13439	,	0	None
13439	13440	suggesting	0	None
13440	13441	PDE4B	0	None
13441	13442	is	0	None
13442	13443	involved	0	None
13443	13444	,	0	None
13444	13445	at	0	None
13445	13446	least	0	None
13446	13447	in	0	None
13447	13448	part	0	None
13448	13449	,	0	None
13449	13450	with	0	None
13450	13451	the	0	None
13451	13452	activity	0	None
13452	13453	of	0	None
13453	13454	rolipram	0	None
13454	13455	.	0	None

13456	13457	Only	0	None
13457	13458	the	0	None
13458	13459	highest	0	None
13459	13460	dose	0	None
13460	13461	of	0	None
13461	13462	rolipram	0	None
13462	13463	(	0	None
13463	13464	3	0	None
13464	13465	.	0	None
13465	13466	2	0	None
13466	13467	mg	2	CHEMICAL
13467	13468	/	0	None
13468	13469	kg	0	None
13469	13470	)	0	None
13470	13471	produced	0	None
13471	13472	a	0	None
13472	13473	modest	0	None
13473	13474	but	0	None
13474	13475	significant	0	None
13475	13476	degree	0	None
13476	13477	of	0	None
13477	13478	catalepsy	0	None
13478	13479	.	0	None

13480	13481	CONCLUSIONS	0	None
13481	13482	:	0	None
13482	13483	Rolipram	0	None
13483	13484	has	0	None
13484	13485	a	0	None
13485	13486	pharmacologic	0	None
13486	13487	profile	0	None
13487	13488	similar	0	None
13488	13489	to	0	None
13489	13490	that	0	None
13490	13491	of	0	None
13491	13492	the	0	None
13492	13493	atypical	0	None
13493	13494	antipsychotics	0	None
13494	13495	and	0	None
13495	13496	has	0	None
13496	13497	low	0	None
13497	13498	extrapyramidal	0	None
13498	13499	symptom	0	None
13499	13500	liability	0	None
13500	13501	.	0	None

13502	13503	These	0	None
13503	13504	results	0	None
13504	13505	suggest	0	None
13505	13506	that	0	None
13506	13507	PDE4B	0	None
13507	13508	mediates	0	None
13508	13509	the	0	None
13509	13510	antipsychotic	0	None
13510	13511	effects	0	None
13511	13512	of	0	None
13512	13513	rolipram	0	None
13513	13514	in	0	None
13514	13515	CAR	0	None
13515	13516	and	0	None
13516	13517	that	0	None
13517	13518	the	0	None
13518	13519	PDE4B-regulated	0	None
13519	13522	cyclic adenosine monophosphate	2	CHEMICAL
13522	13523	signaling	0	None
13523	13524	pathway	0	None
13524	13525	may	0	None
13525	13526	play	0	None
13526	13527	a	0	None
13527	13528	role	0	None
13528	13529	in	0	None
13529	13530	the	0	None
13530	13531	pathophysiology	0	None
13531	13532	and	0	None
13532	13533	pharmacotherapy	0	None
13533	13534	of	0	None
13534	13535	psychosis	0	None
13535	13536	.	0	None
13536	13537	Effect	0	None
13537	13538	of	0	None
13538	13539	JTH-601	0	None
13539	13540	,	0	None
13540	13541	a	0	None
13541	13542	novel	0	None
13542	13543	alpha	0	None
13543	13544	(	0	None
13544	13545	1	0	None
13545	13546	)	0	None
13546	13547	-adrenoceptor	0	None
13547	13548	antagonist	0	None
13548	13549	,	0	None
13549	13550	on	0	None
13550	13551	prostate	0	None
13551	13552	function	0	None
13552	13553	in	0	None
13553	13554	dogs	0	None
13554	13555	.	0	None
13555	13556	Storage	0	None
13556	13557	protocols	0	None
13557	13558	of	0	None
13558	13559	vascular	0	None
13559	13560	grafts	0	None
13560	13561	need	0	None
13561	13562	further	0	None
13562	13563	improvement	0	None
13563	13564	against	0	None
13564	13565	ischemia-reperfusion	0	None
13565	13566	(	0	None
13566	13567	IR	0	None
13567	13568	)	0	None
13568	13569	injury	0	None
13569	13570	.	0	None

13571	13572	Hypoxia	0	None
13572	13573	elicits	0	None
13573	13574	a	0	None
13574	13575	variety	0	None
13575	13576	of	0	None
13576	13577	complex	0	None
13577	13578	cellular	0	None
13578	13579	responses	0	None
13579	13580	by	0	None
13580	13581	altering	0	None
13581	13582	the	0	None
13582	13583	activity	0	None
13583	13584	of	0	None
13584	13585	many	0	None
13585	13586	signaling	0	None
13586	13587	pathways	0	None
13587	13588	,	0	None
13588	13589	such	0	None
13589	13590	as	0	None
13590	13591	the	0	None
13591	13592	oxygen-dependent	0	None
13592	13595	prolyl-hyroxylase domain-containing enzyme	1	GENE-Y
13595	13596	(	0	None
13596	13597	PHD	0	None
13597	13598	)	0	None
13598	13599	.	0	None

13600	13601	Reduction	0	None
13601	13602	of	0	None
13602	13603	PHD	0	None
13603	13604	activity	0	None
13604	13605	during	0	None
13605	13606	hypoxia	0	None
13606	13607	leads	0	None
13607	13608	to	0	None
13608	13609	stabilization	0	None
13609	13610	and	0	None
13610	13611	accumulation	0	None
13611	13612	of	0	None
13612	13615	hypoxia inducible factor	1	GENE-Y
13615	13616	(	0	None
13616	13617	HIF	0	None
13617	13618	)	0	None
13618	13619	1α	0	None
13619	13620	.	0	None

13621	13622	We	0	None
13622	13623	examined	0	None
13623	13624	the	0	None
13624	13625	effects	0	None
13625	13626	of	0	None
13626	13627	PHD	0	None
13627	13628	inhibiton	0	None
13628	13629	by	0	None
13629	13630	dimethyloxalylglycine	0	None
13630	13631	on	0	None
13631	13632	the	0	None
13632	13633	vasomotor	0	None
13633	13634	responses	0	None
13634	13635	of	0	None
13635	13636	isolated	0	None
13636	13637	rat	0	None
13637	13638	aorta	0	None
13638	13639	and	0	None
13639	13640	aortic	0	None
13640	13641	vascular	0	None
13641	13642	smooth	0	None
13642	13643	muscle	0	None
13643	13644	cells	0	None
13644	13645	(	0	None
13645	13646	VSMCs	0	None
13646	13647	)	0	None
13647	13648	in	0	None
13648	13649	a	0	None
13649	13650	model	0	None
13650	13651	of	0	None
13651	13652	cold	0	None
13652	13653	ischemia	0	None
13653	13654	/	0	None
13654	13655	warm	0	None
13655	13656	reperfusion	0	None
13656	13657	.	0	None

13658	13659	Aortic	0	None
13659	13660	segments	0	None
13660	13661	underwent	0	None
13661	13662	24	0	None
13662	13663	hours	0	None
13663	13664	of	0	None
13664	13665	cold	0	None
13665	13666	ischemic	0	None
13666	13667	preservation	0	None
13667	13668	in	0	None
13668	13669	saline	0	None
13669	13670	or	0	None
13670	13671	DMOG	0	None
13671	13672	(	0	None
13672	13673	dimethyloxalylglycine	0	None
13673	13674	)	0	None
13674	13675	-supplemented	0	None
13675	13676	saline	0	None
13676	13677	solution	0	None
13677	13678	.	0	None

13679	13680	We	0	None
13680	13681	investigated	0	None
13681	13682	endothelium-dependent	0	None
13682	13683	and	0	None
13683	13684	-independent	0	None
13684	13685	vasorelaxations	0	None
13685	13686	.	0	None

13687	13688	To	0	None
13688	13689	simulate	0	None
13689	13690	IR	0	None
13690	13691	injury	0	None
13691	13692	,	0	None
13692	13693	hypochlorite	0	None
13693	13694	(	0	None
13694	13695	NaOCl	0	None
13695	13696	)	0	None
13696	13697	was	0	None
13697	13698	added	0	None
13698	13699	during	0	None
13699	13700	warm	0	None
13700	13701	reperfusion	0	None
13701	13702	.	0	None

13703	13704	VSMCs	0	None
13704	13705	were	0	None
13705	13706	incubated	0	None
13706	13707	in	0	None
13707	13708	NaCl	0	None
13708	13709	or	0	None
13709	13710	DMOG	0	None
13710	13711	solution	0	None
13711	13712	at	0	None
13712	13713	4°C	0	None
13713	13714	for	0	None
13714	13715	24	0	None
13715	13716	hours	0	None
13716	13717	after	0	None
13717	13718	the	0	None
13718	13719	medium	0	None
13719	13720	was	0	None
13720	13721	changed	0	None
13721	13722	for	0	None
13722	13723	a	0	None
13723	13724	supplied	0	None
13724	13725	standard	0	None
13725	13726	medium	0	None
13726	13727	at	0	None
13727	13728	37°C	0	None
13728	13729	for	0	None
13729	13730	6	0	None
13730	13731	hours	0	None
13731	13732	.	0	None

13733	13734	Apoptosis	0	None
13734	13735	was	0	None
13735	13736	assessed	0	None
13736	13737	using	0	None
13737	13738	the	0	None
13738	13739	TUNEL	0	None
13739	13740	method	0	None
13740	13741	.	0	None

13742	13743	Gene	0	None
13743	13744	expression	0	None
13744	13745	analysis	0	None
13745	13746	was	0	None
13746	13747	performed	0	None
13747	13748	using	0	None
13748	13749	quantitative	0	None
13749	13750	real-time	0	None
13750	13751	polymerase	0	None
13751	13752	chain	0	None
13752	13753	reaction	0	None
13753	13754	.	0	None

13755	13756	Cold	0	None
13756	13757	ischemic	0	None
13757	13758	preservation	0	None
13758	13759	and	0	None
13759	13760	NaOCl	0	None
13760	13761	induced	0	None
13761	13762	severe	0	None
13762	13763	endothelial	0	None
13763	13764	dysfunction	0	None
13764	13765	,	0	None
13765	13766	which	0	None
13766	13767	was	0	None
13767	13768	significantly	0	None
13768	13769	improved	0	None
13769	13770	by	0	None
13770	13771	DMOG	0	None
13771	13772	supplementation	0	None
13772	13773	(	0	None
13773	13774	maximal	0	None
13774	13775	relaxation	0	None
13775	13776	of	0	None
13776	13777	aortic	0	None
13777	13778	segments	0	None
13778	13779	to	0	None
13779	13780	acetylcholine	0	None
13780	13781	:	0	None
13781	13782	control	0	None
13782	13783	95%	0	None
13783	13784	±	0	None
13784	13785	1%	0	None
13785	13786	versus	0	None
13786	13787	NaOCl	0	None
13787	13788	44%	0	None
13788	13789	±	0	None
13789	13790	4%	0	None
13790	13791	versus	0	None
13791	13792	DMOG	0	None
13792	13793	68%	0	None
13793	13794	±	0	None
13794	13795	5%	0	None
13795	13796	)	0	None
13796	13797	.	0	None

13798	13799	Number	0	None
13799	13800	of	0	None
13800	13801	TUNEL-positive	0	None
13801	13802	cell	0	None
13802	13803	nuclei	0	None
13803	13804	was	0	None
13804	13805	significantly	0	None
13805	13806	higher	0	None
13806	13807	in	0	None
13807	13808	the	0	None
13808	13809	NaOCl	0	None
13809	13810	group	0	None
13810	13811	,	0	None
13811	13812	and	0	None
13812	13813	DMOG	0	None
13813	13814	treatment	0	None
13814	13815	significantly	0	None
13815	13816	decreased	0	None
13816	13817	apoptosis	0	None
13817	13818	.	0	None

13819	13820	Inducible	0	None
13820	13821	heme-oxygenase	0	None
13821	13822	1	0	None
13822	13823	mRNA	0	None
13823	13824	expressions	0	None
13824	13825	were	0	None
13825	13826	significantly	0	None
13826	13827	higher	0	None
13827	13828	in	0	None
13828	13829	the	0	None
13829	13830	DMOG	0	None
13830	13831	group	0	None
13831	13832	.	0	None

13833	13834	Pharmacological	0	None
13834	13835	modulation	0	None
13835	13836	of	0	None
13836	13837	oxygen	0	None
13837	13838	sensing	0	None
13838	13839	system	0	None
13839	13840	by	0	None
13840	13841	DMOG	0	None
13841	13842	in	0	None
13842	13843	an	0	None
13843	13844	in	0	None
13844	13845	vitro	0	None
13845	13846	model	0	None
13846	13847	of	0	None
13847	13848	vascular	0	None
13848	13849	IR	0	None
13849	13850	effectively	0	None
13850	13851	preserved	0	None
13851	13852	endothelial	0	None
13852	13853	function	0	None
13853	13854	.	0	None

13855	13856	Inhibition	0	None
13856	13857	of	0	None
13857	13858	PHDs	0	None
13858	13859	could	0	None
13859	13860	therefore	0	None
13860	13861	be	0	None
13861	13862	a	0	None
13862	13863	new	0	None
13863	13864	therapeutic	0	None
13864	13865	avenue	0	None
13865	13866	for	0	None
13866	13867	protecting	0	None
13867	13868	endothelium	0	None
13868	13869	and	0	None
13869	13870	vascular	0	None
13870	13871	muscle	0	None
13871	13872	cells	0	None
13872	13873	against	0	None
13873	13874	IR	0	None
13874	13875	injury	0	None
13875	13876	.	0	None
13876	13877	Using	0	None
13877	13878	a	0	None
13878	13879	fragment-based	0	None
13879	13880	approach	0	None
13880	13881	to	0	None
13881	13882	target	0	None
13882	13883	protein-protein	0	None
13883	13884	interactions	0	None
13884	13885	.	0	None
13885	13887	Salicylic acid	2	CHEMICAL
13887	13888	(	0	None
13888	13889	SA	0	None
13889	13890	)	0	None
13890	13891	,	0	None
13891	13892	an	0	None
13892	13893	endogenous	0	None
13893	13894	signaling	0	None
13894	13895	molecule	0	None
13895	13896	of	0	None
13896	13897	plants	0	None
13897	13898	,	0	None
13898	13899	possesses	0	None
13899	13900	anti-inflammatory	0	None
13900	13901	and	0	None
13901	13902	anti-neoplastic	0	None
13902	13903	actions	0	None
13903	13904	in	0	None
13904	13905	human	0	None
13905	13906	.	0	None

13907	13908	Its	0	None
13908	13909	derivative	0	None
13909	13910	,	0	None
13910	13911	aspirin	2	CHEMICAL
13911	13912	,	0	None
13912	13913	is	0	None
13913	13914	the	0	None
13914	13915	most	0	None
13915	13916	commonly	0	None
13916	13917	used	0	None
13917	13918	anti-inflammatory	0	None
13918	13919	and	0	None
13919	13920	analgesic	0	None
13920	13921	drug	0	None
13921	13922	.	0	None

13923	13924	Aspirin	2	CHEMICAL
13924	13925	and	0	None
13925	13927	sodium salicylate	2	CHEMICAL
13927	13928	(	0	None
13928	13929	salicylates	0	None
13929	13930	)	0	None
13930	13931	have	0	None
13931	13932	been	0	None
13932	13933	reported	0	None
13933	13934	to	0	None
13934	13935	have	0	None
13935	13936	multiple	0	None
13936	13937	pharmacological	0	None
13937	13938	actions	0	None
13938	13939	.	0	None

13940	13941	However	0	None
13941	13942	,	0	None
13942	13943	it	0	None
13943	13944	is	0	None
13944	13945	unclear	0	None
13945	13946	whether	0	None
13946	13947	they	0	None
13947	13948	bind	0	None
13948	13949	to	0	None
13949	13950	a	0	None
13950	13951	cellular	0	None
13951	13952	protein	0	None
13952	13953	.	0	None

13954	13955	Here	0	None
13955	13956	,	0	None
13956	13957	we	0	None
13957	13958	report	0	None
13958	13959	for	0	None
13959	13960	the	0	None
13960	13961	first	0	None
13961	13962	time	0	None
13962	13963	the	0	None
13963	13964	purification	0	None
13964	13965	from	0	None
13965	13966	human	0	None
13966	13967	fibroblasts	0	None
13967	13968	of	0	None
13968	13969	a	0	None
13969	13970	approximately	0	None
13970	13971	78	0	None
13971	13972	kDa	0	None
13972	13973	salicylate	2	CHEMICAL
13973	13974	binding	0	None
13974	13975	protein	0	None
13975	13976	with	0	None
13976	13977	sequence	0	None
13977	13978	identity	0	None
13978	13979	to	0	None
13979	13980	immunoglobulin	0	None
13980	13981	heavy	0	None
13981	13982	chain	0	None
13982	13983	binding	0	None
13983	13984	protein	0	None
13984	13985	(	0	None
13985	13986	BiP	0	None
13986	13987	)	0	None
13987	13988	.	0	None

13989	13990	The	0	None
13990	13991	Kd	0	None
13991	13992	values	0	None
13992	13993	of	0	None
13993	13994	SA	0	None
13994	13995	binding	0	None
13995	13996	to	0	None
13996	13997	crude	0	None
13997	13998	extract	0	None
13998	13999	and	0	None
13999	14000	to	0	None
14000	14001	recombinant	0	None
14001	14002	BiP	0	None
14002	14003	were	0	None
14003	14004	45	0	None
14004	14005	.	0	None
14005	14006	2	0	None
14006	14007	and	0	None
14007	14008	54	0	None
14008	14009	.	0	None
14009	14010	6	0	None
14010	14011	microM	0	None
14011	14012	,	0	None
14012	14013	respectively	0	None
14013	14014	.	0	None

14015	14016	BiP	0	None
14016	14017	is	0	None
14017	14018	a	0	None
14018	14019	chaperone	0	None
14019	14020	protein	0	None
14020	14021	containing	0	None
14021	14022	a	0	None
14022	14023	polypeptide	0	None
14023	14024	binding	0	None
14024	14025	site	0	None
14025	14026	recognizing	0	None
14026	14027	specific	0	None
14027	14028	heptapeptide	0	None
14028	14029	sequence	0	None
14029	14030	and	0	None
14030	14031	an	0	None
14031	14032	ATP	0	None
14032	14033	binding	0	None
14033	14034	site	0	None
14034	14035	.	0	None

14036	14037	A	0	None
14037	14038	heptapeptide	0	None
14038	14039	with	0	None
14039	14040	the	0	None
14040	14041	specific	0	None
14041	14042	sequence	0	None
14042	14043	displaced	0	None
14043	14044	SA	0	None
14044	14045	binding	0	None
14045	14046	in	0	None
14046	14047	a	0	None
14047	14048	concentration-dependent	0	None
14048	14049	manner	0	None
14049	14050	whereas	0	None
14050	14051	a	0	None
14051	14052	control	0	None
14052	14053	heptapeptide	0	None
14053	14054	did	0	None
14054	14055	not	0	None
14055	14056	.	0	None

14057	14058	Salicylates	0	None
14058	14059	inhibited	0	None
14059	14060	ATPase	3	GENE-N
14060	14061	activity	0	None
14061	14062	stimulated	0	None
14062	14063	by	0	None
14063	14064	this	0	None
14064	14065	specific	0	None
14065	14066	heptapeptide	0	None
14066	14067	but	0	None
14067	14068	did	0	None
14068	14069	not	0	None
14069	14070	block	0	None
14070	14071	ATP	0	None
14071	14072	binding	0	None
14072	14073	or	0	None
14073	14074	induce	0	None
14074	14075	BiP	0	None
14075	14076	expression	0	None
14076	14077	.	0	None

14078	14079	These	0	None
14079	14080	results	0	None
14080	14081	indicate	0	None
14081	14082	that	0	None
14082	14083	salicylates	0	None
14083	14084	bind	0	None
14084	14085	specifically	0	None
14085	14086	to	0	None
14086	14087	the	0	None
14087	14088	polypeptide	0	None
14088	14089	binding	0	None
14089	14090	site	0	None
14090	14091	of	0	None
14091	14092	BiP	0	None
14092	14093	in	0	None
14093	14094	human	0	None
14094	14095	cells	0	None
14095	14096	that	0	None
14096	14097	may	0	None
14097	14098	interfere	0	None
14098	14099	with	0	None
14099	14100	folding	0	None
14100	14101	and	0	None
14101	14102	transport	0	None
14102	14103	of	0	None
14103	14104	proteins	0	None
14104	14105	important	0	None
14105	14106	in	0	None
14106	14107	inflammation	0	None
14107	14108	.	0	None
14108	14109	The	0	None
14109	14110	activity	0	None
14110	14111	of	0	None
14111	14112	penicillins	2	CHEMICAL
14112	14113	against	0	None
14113	14114	bacteria	0	None
14114	14115	is	0	None
14115	14116	in	0	None
14116	14117	large	0	None
14117	14118	part	0	None
14118	14119	related	0	None
14119	14120	to	0	None
14120	14121	binding	0	None
14121	14122	to	0	None
14122	14123	specific	0	None
14123	14124	receptor	0	None
14124	14125	proteins	0	None
14125	14126	involved	0	None
14126	14127	in	0	None
14127	14128	cell	0	None
14128	14129	wall	0	None
14129	14130	biosynthesis	0	None
14130	14131	.	0	None

14132	14133	These	0	None
14133	14134	proteins	0	None
14134	14135	have	0	None
14135	14136	been	0	None
14136	14137	designated	0	None
14137	14138	penicillin-binding	0	None
14138	14139	proteins	0	None
14139	14140	.	0	None

14141	14142	They	0	None
14142	14143	can	0	None
14143	14144	be	0	None
14144	14145	separated	0	None
14145	14146	into	0	None
14146	14147	distinct	0	None
14147	14148	entities	0	None
14148	14149	through	0	None
14149	14150	the	0	None
14150	14151	use	0	None
14151	14152	of	0	None
14152	14153	acrylamide	0	None
14153	14154	gel	0	None
14154	14155	electrophoresis	0	None
14155	14156	and	0	None
14156	14157	binding	0	None
14157	14158	of	0	None
14158	14159	radioactive	0	None
14159	14160	14C-labeled	0	None
14160	14162	penicillin G	2	CHEMICAL
14162	14163	.	0	None

14164	14165	Six	0	None
14165	14166	major	0	None
14166	14167	proteins	0	None
14167	14168	have	0	None
14168	14169	been	0	None
14169	14170	defined	0	None
14170	14171	in	0	None
14171	14172	the	0	None
14172	14173	Enterobacteriaceae	0	None
14173	14174	,	0	None
14174	14175	penicillin-binding	0	None
14175	14176	proteins	0	None
14176	14177	1	0	None
14177	14178	to	0	None
14178	14179	6	0	None
14179	14180	.	0	None

14181	14182	Selection	0	None
14182	14183	of	0	None
14183	14184	mutants	0	None
14184	14185	has	0	None
14185	14186	shown	0	None
14186	14187	that	0	None
14187	14188	there	0	None
14188	14189	are	0	None
14189	14190	three	0	None
14190	14191	essential	0	None
14191	14192	proteins	0	None
14192	14193	:	0	None
14193	14194	penicillin-binding	0	None
14194	14195	protein	0	None
14195	14196	1	0	None
14196	14197	,	0	None
14197	14198	which	0	None
14198	14199	is	0	None
14199	14200	divided	0	None
14200	14201	into	0	None
14201	14202	penicillin-binding	0	None
14202	14203	protein	0	None
14203	14204	1Bs	0	None
14204	14205	,	0	None
14205	14206	a	0	None
14206	14207	peptidoglycan	0	None
14207	14208	transpeptidase	0	None
14208	14209	,	0	None
14209	14210	and	0	None
14210	14211	penicillin-binding	0	None
14211	14212	protein	0	None
14212	14213	1A	0	None
14213	14214	,	0	None
14214	14215	which	0	None
14215	14216	acts	0	None
14216	14217	as	0	None
14217	14218	a	0	None
14218	14219	replacement	0	None
14219	14220	for	0	None
14220	14221	penicillin-binding	0	None
14221	14222	protein	0	None
14222	14223	1Bs	0	None
14223	14224	.	0	None

14225	14226	Penicillin-binding	0	None
14226	14227	protein	0	None
14227	14228	2	0	None
14228	14229	is	0	None
14229	14230	a	0	None
14230	14231	murein-elongation	0	None
14231	14232	initiating	0	None
14232	14233	enzyme	0	None
14233	14234	and	0	None
14234	14235	penicillin-binding	0	None
14235	14236	protein	0	None
14236	14237	3	0	None
14237	14238	is	0	None
14238	14239	a	0	None
14239	14240	septal	0	None
14240	14241	murein-synthesizing	0	None
14241	14242	enzyme	0	None
14242	14243	.	0	None

14244	14245	Penicillin-binding	0	None
14245	14246	proteins	0	None
14246	14247	4	0	None
14247	14248	,	0	None
14248	14249	5	0	None
14249	14250	,	0	None
14250	14251	and	0	None
14251	14252	6	0	None
14252	14253	are	0	None
14253	14254	not	0	None
14254	14255	essential	0	None
14255	14256	for	0	None
14256	14257	bacterial	0	None
14257	14258	survival	0	None
14258	14259	.	0	None

14260	14261	Binding	0	None
14261	14262	of	0	None
14262	14263	penicillins	2	CHEMICAL
14263	14264	to	0	None
14264	14265	penicillin-binding	0	None
14265	14266	protein	0	None
14266	14267	1Bs	0	None
14267	14268	produces	0	None
14268	14269	lysis	0	None
14269	14270	,	0	None
14270	14271	binding	0	None
14271	14272	to	0	None
14272	14273	penicillin-binding	0	None
14273	14274	protein	0	None
14274	14275	2	0	None
14275	14276	produces	0	None
14276	14277	round	0	None
14277	14278	cells	0	None
14278	14279	,	0	None
14279	14280	and	0	None
14280	14281	binding	0	None
14281	14282	to	0	None
14282	14283	penicillin-binding	0	None
14283	14284	protein	0	None
14284	14285	3	0	None
14285	14286	produces	0	None
14286	14287	long	0	None
14287	14288	filaments	0	None
14288	14289	.	0	None

14290	14291	Amdinocillin	0	None
14291	14292	is	0	None
14292	14293	a	0	None
14293	14294	beta-amidino	0	None
14294	14295	penicillanic	0	None
14295	14296	acid	0	None
14296	14297	derivative	0	None
14297	14298	that	0	None
14298	14299	binds	0	None
14299	14300	specifically	0	None
14300	14301	to	0	None
14301	14302	penicillin-binding	0	None
14302	14303	protein	0	None
14303	14304	2	0	None
14304	14305	.	0	None

14306	14307	The	0	None
14307	14308	compound	0	None
14308	14309	is	0	None
14309	14310	more	0	None
14310	14311	beta-lactamase	0	None
14311	14312	stable	0	None
14312	14313	than	0	None
14313	14314	ampicillin	2	CHEMICAL
14314	14315	and	0	None
14315	14316	has	0	None
14316	14317	no	0	None
14317	14318	major	0	None
14318	14319	delay	0	None
14319	14320	in	0	None
14320	14321	entry	0	None
14321	14322	into	0	None
14322	14323	the	0	None
14323	14324	periplasmic	0	None
14324	14325	space	0	None
14325	14326	as	0	None
14326	14327	do	0	None
14327	14328	some	0	None
14328	14329	penicillins	2	CHEMICAL
14329	14330	.	0	None

14331	14332	Amdinocillin	0	None
14332	14333	inhibits	0	None
14333	14334	most	0	None
14334	14335	of	0	None
14335	14336	the	0	None
14336	14337	Enterobacteriaceae	0	None
14337	14338	,	0	None
14338	14339	with	0	None
14339	14340	the	0	None
14340	14341	exception	0	None
14341	14342	of	0	None
14342	14343	some	0	None
14343	14344	indole-positive	0	None
14344	14345	Proteus	0	None
14345	14346	species	0	None
14346	14347	,	0	None
14347	14348	but	0	None
14348	14349	it	0	None
14349	14350	does	0	None
14350	14351	not	0	None
14351	14352	inhibit	0	None
14352	14353	gram-positive	0	None
14353	14354	cocci	0	None
14354	14355	or	0	None
14355	14356	Pseudomonas	0	None
14356	14357	aeruginosa	0	None
14357	14358	.	0	None

14359	14360	Amdinocillin	0	None
14360	14361	produces	0	None
14361	14362	spherical	0	None
14362	14363	bacterial	0	None
14363	14364	cells	0	None
14364	14365	that	0	None
14365	14366	eventually	0	None
14366	14367	lyse	0	None
14367	14368	.	0	None

14369	14370	Its	0	None
14370	14371	activity	0	None
14371	14372	in	0	None
14372	14373	vitro	0	None
14373	14374	is	0	None
14374	14375	markedly	0	None
14375	14376	affected	0	None
14376	14377	by	0	None
14377	14378	ionic	0	None
14378	14379	content	0	None
14379	14380	of	0	None
14380	14381	media	0	None
14381	14382	.	0	None

14383	14384	This	0	None
14384	14385	agent	0	None
14385	14386	acts	0	None
14386	14387	synergistically	0	None
14387	14388	with	0	None
14388	14389	many	0	None
14389	14390	penicillins	2	CHEMICAL
14390	14391	,	0	None
14391	14392	such	0	None
14392	14393	as	0	None
14393	14394	ampicillin	2	CHEMICAL
14394	14395	,	0	None
14395	14396	carbenicillin	0	None
14396	14397	,	0	None
14397	14398	and	0	None
14398	14399	the	0	None
14399	14400	like	0	None
14400	14401	,	0	None
14401	14402	and	0	None
14402	14403	with	0	None
14403	14404	cephalosporins	0	None
14404	14405	,	0	None
14405	14406	cefazolin	0	None
14406	14407	,	0	None
14407	14408	cefamandole	0	None
14408	14409	,	0	None
14409	14410	or	0	None
14410	14411	cefoxitin	0	None
14411	14412	to	0	None
14412	14413	inhibit	0	None
14413	14414	gram-negative	0	None
14414	14415	bacilli	0	None
14415	14416	,	0	None
14416	14417	probably	0	None
14417	14418	on	0	None
14418	14419	the	0	None
14419	14420	basis	0	None
14420	14421	of	0	None
14421	14422	binding	0	None
14422	14423	to	0	None
14423	14424	different	0	None
14424	14425	proteins	0	None
14425	14426	needed	0	None
14426	14427	for	0	None
14427	14428	the	0	None
14428	14429	production	0	None
14429	14430	of	0	None
14430	14431	the	0	None
14431	14432	peptidoglycan	0	None
14432	14433	of	0	None
14433	14434	the	0	None
14434	14435	bacterial	0	None
14435	14436	cell	0	None
14436	14437	wall	0	None
14437	14438	.	0	None

14439	14440	Amdinocillin	0	None
14440	14441	possesses	0	None
14441	14442	a	0	None
14442	14443	number	0	None
14443	14444	of	0	None
14444	14445	the	0	None
14445	14446	essentials	0	None
14446	14447	for	0	None
14447	14448	effective	0	None
14448	14449	antimicrobial	0	None
14449	14450	activity	0	None
14450	14451	and	0	None
14451	14452	,	0	None
14452	14453	by	0	None
14453	14454	virtue	0	None
14454	14455	of	0	None
14455	14456	its	0	None
14456	14457	enhancement	0	None
14457	14458	of	0	None
14458	14459	the	0	None
14459	14460	activity	0	None
14460	14461	of	0	None
14461	14462	other	0	None
14462	14463	beta-lactams	0	None
14463	14464	,	0	None
14464	14465	may	0	None
14465	14466	prove	0	None
14466	14467	to	0	None
14467	14468	be	0	None
14468	14469	a	0	None
14469	14470	useful	0	None
14470	14471	agent	0	None
14471	14472	in	0	None
14472	14473	the	0	None
14473	14474	chemotherapy	0	None
14474	14475	of	0	None
14475	14476	certain	0	None
14476	14477	infections	0	None
14477	14478	.	0	None
14478	14479	Relaxin	0	None
14479	14480	is	0	None
14480	14481	a	0	None
14481	14482	polypeptide	0	None
14482	14483	hormone	0	None
14483	14484	involved	0	None
14484	14485	in	0	None
14485	14486	remodeling	0	None
14486	14487	of	0	None
14487	14488	the	0	None
14488	14489	birth	0	None
14489	14490	canal	0	None
14490	14491	during	0	None
14491	14492	parturition	0	None
14492	14493	.	0	None

14494	14495	It	0	None
14495	14496	is	0	None
14496	14497	synthesized	0	None
14497	14498	as	0	None
14498	14499	a	0	None
14499	14500	preprohormone	0	None
14500	14501	precursor	0	None
14501	14502	,	0	None
14502	14503	which	0	None
14503	14504	undergoes	0	None
14504	14505	specific	0	None
14505	14506	processing	0	None
14506	14507	to	0	None
14507	14508	form	0	None
14508	14509	the	0	None
14509	14510	mature	0	None
14510	14511	two-chain	0	None
14511	14512	disulfide-linked	0	None
14512	14513	active	0	None
14513	14514	species	0	None
14514	14515	that	0	None
14515	14516	is	0	None
14516	14517	secreted	0	None
14517	14518	by	0	None
14518	14519	the	0	None
14519	14520	cell	0	None
14520	14521	.	0	None

14522	14523	A	0	None
14523	14524	major	0	None
14524	14525	part	0	None
14525	14526	of	0	None
14526	14527	this	0	None
14527	14528	processing	0	None
14528	14529	requires	0	None
14529	14530	endoproteolytic	0	None
14530	14531	cleavage	0	None
14531	14532	at	0	None
14532	14533	specific	0	None
14533	14534	pairs	0	None
14534	14535	of	0	None
14535	14536	basic	0	None
14536	14538	amino acid	2	CHEMICAL
14538	14539	residues	0	None
14539	14540	,	0	None
14540	14541	an	0	None
14541	14542	event	0	None
14542	14543	necessary	0	None
14543	14544	for	0	None
14544	14545	the	0	None
14545	14546	maturation	0	None
14546	14547	of	0	None
14547	14548	a	0	None
14548	14549	variety	0	None
14549	14550	of	0	None
14550	14551	important	0	None
14551	14552	biologically	0	None
14552	14553	active	0	None
14553	14554	proteins	0	None
14554	14555	,	0	None
14555	14556	such	0	None
14556	14557	as	0	None
14557	14558	insulin	0	None
14558	14559	and	0	None
14559	14560	nerve	0	None
14560	14562	growth factor	3	GENE-N
14562	14563	.	0	None

14564	14565	Human	0	None
14565	14566	type	0	None
14566	14567	2	0	None
14567	14568	preprorelaxin	0	None
14568	14569	was	0	None
14569	14570	coexpressed	0	None
14570	14571	in	0	None
14571	14572	human	0	None
14572	14573	kidney	0	None
14573	14574	293	0	None
14574	14575	cells	0	None
14575	14576	with	0	None
14576	14577	the	0	None
14577	14578	candidate	0	None
14578	14579	prohormone	0	None
14579	14580	convertase-processing	0	None
14580	14581	enzymes	0	None
14581	14582	mPC1	0	None
14582	14583	or	0	None
14583	14584	mPC2	0	None
14584	14585	,	0	None
14585	14586	both	0	None
14586	14587	cloned	0	None
14587	14588	from	0	None
14588	14589	the	0	None
14589	14590	mouse	0	None
14590	14591	pituitary	0	None
14591	14592	tumor	0	None
14592	14593	AtT-20	0	None
14593	14594	cell	0	None
14594	14595	line	0	None
14595	14596	,	0	None
14596	14597	or	0	None
14597	14598	with	0	None
14598	14599	the	0	None
14599	14600	yeast	0	None
14600	14601	kex2	0	None
14601	14602	alpha-mating	0	None
14602	14603	factor-converting	0	None
14603	14604	enzyme	0	None
14604	14605	from	0	None
14605	14606	Saccharomyces	0	None
14606	14607	cerevisiae	0	None
14607	14608	.	0	None

14609	14610	Prorelaxin	0	None
14610	14611	expressed	0	None
14611	14612	alone	0	None
14612	14613	in	0	None
14613	14614	293	0	None
14614	14615	cells	0	None
14615	14616	was	0	None
14616	14617	secreted	0	None
14617	14618	into	0	None
14618	14619	the	0	None
14619	14620	culture	0	None
14620	14621	medium	0	None
14621	14622	unprocessed	0	None
14622	14623	.	0	None

14624	14625	Transient	0	None
14625	14626	coexpression	0	None
14626	14627	with	0	None
14627	14628	mPC1	0	None
14628	14629	or	0	None
14629	14630	kex2	0	None
14630	14631	,	0	None
14631	14632	but	0	None
14632	14633	not	0	None
14633	14634	with	0	None
14634	14635	mPC2	0	None
14635	14636	,	0	None
14636	14637	resulted	0	None
14637	14638	in	0	None
14638	14639	the	0	None
14639	14640	secretion	0	None
14640	14641	of	0	None
14641	14642	a	0	None
14642	14643	low	0	None
14643	14644	mol	0	None
14644	14645	wt	0	None
14645	14646	species	0	None
14646	14647	with	0	None
14647	14648	an	0	None
14648	14649	electrophoretic	0	None
14649	14650	mobility	0	None
14650	14651	very	0	None
14651	14652	similar	0	None
14652	14653	,	0	None
14653	14654	if	0	None
14654	14655	not	0	None
14655	14656	identical	0	None
14656	14657	,	0	None
14657	14658	to	0	None
14658	14659	that	0	None
14659	14660	of	0	None
14660	14661	authentic	0	None
14661	14662	mature	0	None
14662	14663	relaxin	0	None
14663	14664	purified	0	None
14664	14665	from	0	None
14665	14666	human	0	None
14666	14667	placenta	0	None
14667	14668	.	0	None

14669	14670	This	0	None
14670	14671	species	0	None
14671	14672	was	0	None
14672	14673	precipitable	0	None
14673	14674	by	0	None
14674	14675	monoclonal	0	None
14675	14676	antibodies	0	None
14676	14677	specific	0	None
14677	14678	for	0	None
14678	14679	relaxin	0	None
14679	14680	and	0	None
14680	14681	had	0	None
14681	14682	a	0	None
14682	14683	retention	0	None
14683	14684	time	0	None
14684	14685	on	0	None
14685	14686	reverse	0	None
14686	14687	phase	0	None
14687	14688	HPLC	0	None
14688	14689	comparable	0	None
14689	14690	to	0	None
14690	14691	that	0	None
14691	14692	of	0	None
14692	14693	relaxin	0	None
14693	14694	.	0	None

14695	14696	Its	0	None
14696	14697	analysis	0	None
14697	14698	by	0	None
14698	14699	both	0	None
14699	14700	electrospray	0	None
14700	14701	and	0	None
14701	14702	fast	0	None
14702	14703	atom	0	None
14703	14704	bombardment	0	None
14704	14705	mass	0	None
14705	14706	spectrometry	0	None
14706	14707	generated	0	None
14707	14708	mass	0	None
14708	14709	data	0	None
14709	14710	that	0	None
14710	14711	were	0	None
14711	14712	consistent	0	None
14712	14713	only	0	None
14713	14714	with	0	None
14714	14715	mature	0	None
14715	14716	relaxin	0	None
14716	14717	.	0	None

14718	14719	The	0	None
14719	14720	basic	0	None
14720	14721	residues	0	None
14721	14722	required	0	None
14722	14723	for	0	None
14723	14724	mPC1-dependent	0	None
14724	14725	cleavage	0	None
14725	14726	of	0	None
14726	14727	prorelaxin	0	None
14727	14728	are	0	None
14728	14729	defined	0	None
14729	14730	by	0	None
14730	14731	site-directed	0	None
14731	14732	mutagenesis	0	None
14732	14733	.	0	None
14733	14734	BACKGROUND	0	None
14734	14735	:	0	None
14735	14736	The	0	None
14736	14737	risk	0	None
14737	14738	of	0	None
14738	14739	postoperative	0	None
14739	14740	immune	0	None
14740	14741	reaction	0	None
14741	14742	/	0	None
14742	14743	transplant	0	None
14743	14744	rejection	0	None
14744	14745	is	0	None
14745	14746	increased	0	None
14746	14747	in	0	None
14747	14748	the	0	None
14748	14749	presence	0	None
14749	14750	of	0	None
14750	14751	distinct	0	None
14751	14752	risk	0	None
14752	14753	factors	0	None
14753	14754	.	0	None

14755	14756	In	0	None
14756	14757	these	0	None
14757	14758	situations	0	None
14758	14759	,	0	None
14759	14760	the	0	None
14760	14761	use	0	None
14761	14762	of	0	None
14762	14763	established	0	None
14763	14764	immunosuppressive	0	None
14764	14765	agents	0	None
14765	14766	(	0	None
14766	14767	steroids	0	None
14767	14768	,	0	None
14768	14769	cyclosporin	2	CHEMICAL
14769	14770	)	0	None
14770	14771	is	0	None
14771	14772	indicated	0	None
14772	14773	.	0	None

14774	14775	However	0	None
14775	14776	,	0	None
14776	14777	immune	0	None
14777	14778	reactions	0	None
14778	14779	can	0	None
14779	14780	occur	0	None
14780	14781	despite	0	None
14781	14782	this	0	None
14782	14783	therapy	0	None
14783	14784	.	0	None

14785	14786	Basiliximab	0	None
14786	14787	is	0	None
14787	14788	a	0	None
14788	14789	monoclonal	0	None
14789	14790	antibody	0	None
14790	14791	with	0	None
14791	14792	a	0	None
14792	14793	high	0	None
14793	14794	specific	0	None
14794	14795	binding	0	None
14795	14796	affinity	0	None
14796	14797	to	0	None
14797	14798	the	0	None
14798	14799	IL-2	0	None
14799	14800	receptor	0	None
14800	14801	of	0	None
14801	14802	activated	0	None
14802	14803	T-cells	0	None
14803	14804	.	0	None

14805	14806	After	0	None
14806	14807	renal	0	None
14807	14808	transplantation	0	None
14808	14809	,	0	None
14809	14810	the	0	None
14810	14811	combination	0	None
14811	14812	therapy	0	None
14812	14813	with	0	None
14813	14814	basiliximab	0	None
14814	14815	and	0	None
14815	14816	cyclosporin	2	CHEMICAL
14816	14817	reduces	0	None
14817	14818	the	0	None
14818	14819	risk	0	None
14819	14820	of	0	None
14820	14821	acute	0	None
14821	14822	rejection	0	None
14822	14823	by	0	None
14823	14824	30%	0	None
14824	14825	against	0	None
14825	14826	placebo	0	None
14826	14827	.	0	None

14828	14829	The	0	None
14829	14830	aim	0	None
14830	14831	of	0	None
14831	14832	this	0	None
14832	14833	study	0	None
14833	14834	was	0	None
14834	14835	to	0	None
14835	14836	investigate	0	None
14836	14837	the	0	None
14837	14838	effect	0	None
14838	14839	of	0	None
14839	14840	complementary	0	None
14840	14841	immune	0	None
14841	14842	suppression	0	None
14842	14843	with	0	None
14843	14844	the	0	None
14844	14845	IL-2	0	None
14845	14846	synthesis	0	None
14846	14847	inhibitor	0	None
14847	14848	cyclosporin	0	None
14848	14849	and	0	None
14849	14850	the	0	None
14850	14851	IL-2	0	None
14851	14852	receptor	0	None
14852	14853	antagonist	0	None
14853	14854	basiliximab	0	None
14854	14855	on	0	None
14855	14856	the	0	None
14856	14857	incidence	0	None
14857	14858	of	0	None
14858	14859	transplant	0	None
14859	14860	rejection	0	None
14860	14861	after	0	None
14861	14862	high-risk	0	None
14862	14863	keratoplasty	0	None
14863	14864	.	0	None

14865	14866	PATIENTS	0	None
14866	14867	AND	0	None
14867	14868	METHODS	0	None
14868	14869	:	0	None
14869	14870	In	0	None
14870	14871	an	0	None
14871	14872	open	0	None
14872	14873	pilot	0	None
14873	14874	study	0	None
14874	14875	,	0	None
14875	14876	seven	0	None
14876	14877	patients	0	None
14877	14878	with	0	None
14878	14879	high-risk	0	None
14879	14880	keratoplasty	0	None
14880	14881	were	0	None
14881	14882	treated	0	None
14882	14883	with	0	None
14883	14884	basiliximab	0	None
14884	14885	perioperatively	0	None
14885	14886	and	0	None
14886	14888	cyclosporin postoperatively	2	CHEMICAL
14888	14889	.	0	None

14890	14891	All	0	None
14891	14892	patients	0	None
14892	14893	had	0	None
14893	14894	penetrating	0	None
14894	14895	keratoplasty	0	None
14895	14896	with	0	None
14896	14897	a	0	None
14897	14898	non-HLA-matched	0	None
14898	14899	corneal	0	None
14899	14900	graft	0	None
14900	14901	.	0	None

14902	14903	RESULTS	0	None
14903	14904	:	0	None
14904	14905	Seven	0	None
14905	14906	patients	0	None
14906	14907	were	0	None
14907	14908	operated	0	None
14908	14909	on	0	None
14909	14910	from	0	None
14910	14911	12	0	None
14911	14912	/	0	None
14912	14913	98	0	None
14913	14914	through	0	None
14914	14915	12	0	None
14915	14916	/	0	None
14916	14917	99	0	None
14917	14918	with	0	None
14918	14919	a	0	None
14919	14920	corneal	0	None
14920	14921	transplant	0	None
14921	14922	diameter	0	None
14922	14923	between	0	None
14923	14924	7	0	None
14924	14925	.	0	None
14925	14926	1	0	None
14926	14927	and	0	None
14927	14928	9	0	None
14928	14929	.	0	None
14929	14930	5	0	None
14930	14931	mm	0	None
14931	14932	.	0	None

14933	14934	Risk	0	None
14934	14935	factors	0	None
14935	14936	included	0	None
14936	14937	extensive	0	None
14937	14938	corneal	0	None
14938	14939	neovascularization	0	None
14939	14940	in	0	None
14940	14941	all	0	None
14941	14942	patients	0	None
14942	14943	(	0	None
14943	14944	indications	0	None
14944	14945	for	0	None
14945	14946	surgery	0	None
14946	14947	:	0	None
14947	14948	4	0	None
14948	14949	cases	0	None
14949	14950	with	0	None
14950	14951	corneal	0	None
14951	14952	scars	0	None
14952	14953	after	0	None
14953	14954	herpetic	0	None
14954	14955	disease	0	None
14955	14956	,	0	None
14956	14957	2	0	None
14957	14958	cases	0	None
14958	14959	with	0	None
14959	14960	conditions	0	None
14960	14961	after	0	None
14961	14962	alkali	0	None
14962	14963	burns	0	None
14963	14964	,	0	None
14964	14965	1	0	None
14965	14966	case	0	None
14966	14967	with	0	None
14967	14968	corneal	0	None
14968	14969	ulceration	0	None
14969	14970	after	0	None
14970	14971	thermal	0	None
14971	14972	burn	0	None
14972	14973	)	0	None
14973	14974	.	0	None

14975	14976	During	0	None
14976	14977	the	0	None
14977	14978	follow-up	0	None
14978	14979	of	0	None
14979	14980	14-25	0	None
14980	14981	months	0	None
14981	14982	,	0	None
14982	14983	no	0	None
14983	14984	immune	0	None
14984	14985	reaction	0	None
14985	14986	has	0	None
14986	14987	occurred	0	None
14987	14988	,	0	None
14988	14989	and	0	None
14989	14990	all	0	None
14990	14991	transplants	0	None
14991	14992	are	0	None
14992	14993	clear	0	None
14993	14994	.	0	None

14995	14996	The	0	None
14996	14997	mean	0	None
14997	14998	visual	0	None
14998	14999	acuity	0	None
14999	15000	increased	0	None
15000	15001	from	0	None
15001	15002	0	0	None
15002	15003	.	0	None
15003	15004	04	0	None
15004	15005	to	0	None
15005	15006	0	0	None
15006	15007	.	0	None
15007	15008	41	0	None
15008	15009	postoperatively	0	None
15009	15010	.	0	None

15011	15012	DISCUSSION	0	None
15012	15013	:	0	None
15013	15014	The	0	None
15014	15015	preliminary	0	None
15015	15016	data	0	None
15016	15017	on	0	None
15017	15018	a	0	None
15018	15019	combination	0	None
15019	15020	therapy	0	None
15020	15021	with	0	None
15021	15022	basiliximab	0	None
15022	15023	and	0	None
15023	15024	cyclosporin	2	CHEMICAL
15024	15025	are	0	None
15025	15026	promising	0	None
15026	15027	.	0	None

15028	15029	For	0	None
15029	15030	further	0	None
15030	15031	evaluation	0	None
15031	15032	a	0	None
15032	15033	prospective	0	None
15033	15034	multicenter	0	None
15034	15035	study	0	None
15035	15036	is	0	None
15036	15037	planned	0	None
15037	15038	.	0	None
15038	15039	The	0	None
15039	15042	aromatic amino acid	2	CHEMICAL
15042	15043	hydroxylases	0	None
15043	15044	represent	0	None
15044	15045	a	0	None
15045	15046	superfamily	0	None
15046	15047	of	0	None
15047	15048	structurally	0	None
15048	15049	and	0	None
15049	15050	functionally	0	None
15050	15051	closely	0	None
15051	15052	related	0	None
15052	15053	enzymes	0	None
15053	15054	,	0	None
15054	15055	one	0	None
15055	15056	of	0	None
15056	15057	those	0	None
15057	15058	functions	0	None
15058	15059	being	0	None
15059	15060	reversible	0	None
15060	15061	inhibition	0	None
15061	15062	by	0	None
15062	15063	catechol	0	None
15063	15064	derivatives	0	None
15064	15065	.	0	None

15066	15067	Here	0	None
15067	15068	we	0	None
15068	15069	present	0	None
15069	15070	the	0	None
15070	15071	crystal	0	None
15071	15072	structure	0	None
15072	15073	of	0	None
15073	15074	the	0	None
15074	15075	dimeric	0	None
15075	15076	catalytic	0	None
15076	15077	domain	0	None
15077	15078	(	0	None
15078	15079	residues	0	None
15079	15080	117-424	0	None
15080	15081	)	0	None
15081	15082	of	0	None
15082	15084	human phenylalanine	2	CHEMICAL
15084	15085	hydroxylase	0	None
15085	15086	(	0	None
15086	15087	hPheOH	0	None
15087	15088	)	0	None
15088	15089	,	0	None
15089	15090	cocrystallized	0	None
15090	15091	with	0	None
15091	15092	various	0	None
15092	15093	potent	0	None
15093	15094	and	0	None
15094	15095	well-known	0	None
15095	15096	catechol	0	None
15096	15097	inhibitors	0	None
15097	15098	and	0	None
15098	15099	refined	0	None
15099	15100	at	0	None
15100	15101	a	0	None
15101	15102	resolution	0	None
15102	15103	of	0	None
15103	15104	2	0	None
15104	15105	.	0	None
15105	15106	0	0	None
15106	15107	A	0	None
15107	15108	.	0	None

15109	15110	The	0	None
15110	15111	catechols	0	None
15111	15112	bind	0	None
15112	15113	by	0	None
15113	15114	bidentate	0	None
15114	15115	coordination	0	None
15115	15116	to	0	None
15116	15117	each	0	None
15117	15118	iron	0	None
15118	15119	in	0	None
15119	15120	both	0	None
15120	15121	subunits	0	None
15121	15122	of	0	None
15122	15123	the	0	None
15123	15124	dimer	0	None
15124	15125	through	0	None
15125	15126	the	0	None
15126	15127	catechol	0	None
15127	15128	hydroxyl	2	CHEMICAL
15128	15129	groups	0	None
15129	15130	,	0	None
15130	15131	forming	0	None
15131	15132	a	0	None
15132	15133	blue-green	0	None
15133	15134	colored	0	None
15134	15135	ligand-to-metal	0	None
15135	15136	charge-transfer	0	None
15136	15137	complex	0	None
15137	15138	.	0	None

15139	15140	In	0	None
15140	15141	addition	0	None
15141	15142	,	0	None
15142	15143	Glu330	0	None
15143	15144	and	0	None
15144	15145	Tyr325	0	None
15145	15146	are	0	None
15146	15147	identified	0	None
15147	15148	as	0	None
15148	15149	determinant	0	None
15149	15150	residues	0	None
15150	15151	in	0	None
15151	15152	the	0	None
15152	15153	recognition	0	None
15153	15154	of	0	None
15154	15155	the	0	None
15155	15156	inhibitors	0	None
15156	15157	.	0	None

15158	15159	In	0	None
15159	15160	particular	0	None
15160	15161	,	0	None
15161	15162	the	0	None
15162	15163	interaction	0	None
15163	15164	with	0	None
15164	15165	Glu330	0	None
15165	15166	conforms	0	None
15166	15167	to	0	None
15167	15168	the	0	None
15168	15169	structural	0	None
15169	15170	explanation	0	None
15170	15171	for	0	None
15171	15172	the	0	None
15172	15173	pH	0	None
15173	15174	dependence	0	None
15174	15175	of	0	None
15175	15176	catecholamine	0	None
15176	15177	binding	0	None
15177	15178	to	0	None
15178	15179	PheOH	0	None
15179	15180	,	0	None
15180	15181	with	0	None
15181	15182	a	0	None
15182	15183	pKa	0	None
15183	15184	value	0	None
15184	15185	of	0	None
15185	15186	5	0	None
15186	15187	.	0	None
15187	15188	1	0	None
15188	15189	(	0	None
15189	15190	20	0	None
15190	15191	degreesC	0	None
15191	15192	)	0	None
15192	15193	.	0	None

15194	15195	The	0	None
15195	15196	overall	0	None
15196	15197	structure	0	None
15197	15198	of	0	None
15198	15199	the	0	None
15199	15200	catechol-bound	0	None
15200	15201	enzyme	0	None
15201	15202	is	0	None
15202	15203	very	0	None
15203	15204	similar	0	None
15204	15205	to	0	None
15205	15206	that	0	None
15206	15207	of	0	None
15207	15208	the	0	None
15208	15209	uncomplexed	0	None
15209	15210	enzyme	0	None
15210	15211	(	0	None
15211	15212	rms	0	None
15212	15213	difference	0	None
15213	15214	of	0	None
15214	15215	0	0	None
15215	15216	.	0	None
15216	15217	2	0	None
15217	15218	A	0	None
15218	15219	for	0	None
15219	15220	the	0	None
15220	15221	Calpha	0	None
15221	15222	atoms	0	None
15222	15223	)	0	None
15223	15224	.	0	None

15225	15226	Most	0	None
15226	15227	striking	0	None
15227	15228	is	0	None
15228	15229	the	0	None
15229	15230	replacement	0	None
15230	15231	of	0	None
15231	15232	two	0	None
15232	15233	iron-bound	0	None
15233	15234	water	0	None
15234	15235	molecules	0	None
15235	15236	with	0	None
15236	15237	catechol	0	None
15237	15238	hydroxyl	2	CHEMICAL
15238	15239	groups	0	None
15239	15240	.	0	None

15241	15242	This	0	None
15242	15243	change	0	None
15243	15244	is	0	None
15244	15245	consistent	0	None
15245	15246	with	0	None
15246	15247	a	0	None
15247	15248	change	0	None
15248	15249	in	0	None
15249	15250	the	0	None
15250	15251	ligand	0	None
15251	15252	field	0	None
15252	15253	symmetry	0	None
15253	15254	of	0	None
15254	15255	the	0	None
15255	15256	high-spin	0	None
15256	15257	(	0	None
15257	15258	S	0	None
15258	15259	=	0	None
15259	15260	5	0	None
15260	15261	/	0	None
15261	15262	2	0	None
15262	15263	)	0	None
15263	15264	Fe	0	None
15264	15265	(	0	None
15265	15266	III	0	None
15266	15267	)	0	None
15267	15268	from	0	None
15268	15269	a	0	None
15269	15270	rhombic	0	None
15270	15271	to	0	None
15271	15272	a	0	None
15272	15273	nearly	0	None
15273	15274	axial	0	None
15274	15275	ligand	0	None
15275	15276	field	0	None
15276	15277	symmetry	0	None
15277	15278	as	0	None
15278	15279	seen	0	None
15279	15280	upon	0	None
15280	15281	noradrenaline	0	None
15281	15282	binding	0	None
15282	15283	using	0	None
15283	15284	EPR	0	None
15284	15285	spectroscopy	0	None
15285	15286	[	0	None
15286	15287	Martinez	0	None
15287	15288	,	0	None
15288	15289	A	0	None
15289	15290	.	0	None

15291	15292	,	0	None
15292	15293	Andersson	0	None
15293	15294	,	0	None
15294	15295	K	0	None
15295	15296	.	0	None

15297	15298	K	0	None
15298	15299	.	0	None

15300	15301	,	0	None
15301	15302	Haavik	0	None
15302	15303	,	0	None
15303	15304	J	0	None
15304	15305	.	0	None

15306	15307	,	0	None
15307	15308	and	0	None
15308	15309	Flatmark	0	None
15309	15310	,	0	None
15310	15311	T	0	None
15311	15312	.	0	None

15313	15314	(	0	None
15314	15315	1991	0	None
15315	15316	)	0	None
15316	15317	Eur	0	None
15317	15318	.	0	None

15319	15320	J	0	None
15320	15321	.	0	None

15322	15323	Biochem	0	None
15323	15324	.	0	None

15325	15326	198	0	None
15326	15327	,	0	None
15327	15328	675-682	0	None
15328	15329	]	0	None
15329	15330	.	0	None

15331	15332	Crystallographic	0	None
15332	15333	comparison	0	None
15333	15334	with	0	None
15334	15335	the	0	None
15335	15336	structurally	0	None
15336	15337	related	0	None
15337	15338	rat	0	None
15338	15339	tyrosine	2	CHEMICAL
15339	15340	hydroxylase	0	None
15340	15341	binary	0	None
15341	15342	complex	0	None
15342	15343	with	0	None
15343	15344	the	0	None
15344	15345	oxidized	0	None
15345	15346	cofactor	0	None
15346	15347	7	0	None
15347	15348	,	0	None
15348	15349	8-dihydrobiopterin	0	None
15349	15350	revealed	0	None
15350	15351	overlapping	0	None
15351	15352	binding	0	None
15352	15353	sites	0	None
15353	15354	for	0	None
15354	15355	the	0	None
15355	15356	catechols	0	None
15356	15357	and	0	None
15357	15358	the	0	None
15358	15359	cofactor	0	None
15359	15360	,	0	None
15360	15361	compatible	0	None
15361	15362	with	0	None
15362	15363	a	0	None
15363	15364	competitive	0	None
15364	15365	type	0	None
15365	15366	of	0	None
15366	15367	inhibition	0	None
15367	15368	of	0	None
15368	15369	the	0	None
15369	15370	catechols	0	None
15370	15371	versus	0	None
15371	15372	BH4	0	None
15372	15373	.	0	None

15374	15375	The	0	None
15375	15376	comparison	0	None
15376	15377	demonstrates	0	None
15377	15378	some	0	None
15378	15379	structural	0	None
15379	15380	differences	0	None
15380	15381	at	0	None
15381	15382	the	0	None
15382	15383	active	0	None
15383	15384	site	0	None
15384	15385	as	0	None
15385	15386	the	0	None
15386	15387	potential	0	None
15387	15388	basis	0	None
15388	15389	for	0	None
15389	15390	the	0	None
15390	15391	different	0	None
15391	15392	substrate	0	None
15392	15393	specificity	0	None
15393	15394	of	0	None
15394	15395	the	0	None
15395	15396	two	0	None
15396	15397	enzymes	0	None
15397	15398	.	0	None
15398	15399	The	0	None
15399	15400	hypothalamus-pituitary-adrenal-axis	0	None
15400	15401	is	0	None
15401	15402	strongly	0	None
15402	15403	controlled	0	None
15403	15404	by	0	None
15404	15405	the	0	None
15405	15406	endocannabinoid	0	None
15406	15407	system	0	None
15407	15408	.	0	None

15409	15410	The	0	None
15410	15411	specific	0	None
15411	15412	impact	0	None
15412	15413	of	0	None
15413	15414	enhanced	0	None
15414	15415	2-arachidonoylglycerol	0	None
15415	15416	signaling	0	None
15416	15417	on	0	None
15417	15418	corticosterone	0	None
15418	15419	plasma	0	None
15419	15420	levels	0	None
15420	15421	,	0	None
15421	15422	however	0	None
15422	15423	,	0	None
15423	15424	was	0	None
15424	15425	not	0	None
15425	15426	investigated	0	None
15426	15427	so	0	None
15427	15428	far	0	None
15428	15429	.	0	None

15430	15431	Here	0	None
15431	15432	we	0	None
15432	15433	studied	0	None
15433	15434	the	0	None
15434	15435	effects	0	None
15435	15436	of	0	None
15436	15437	the	0	None
15437	15438	recently	0	None
15438	15439	developed	0	None
15439	15440	monoacylglycerol	0	None
15440	15441	lipase	3	GENE-N
15441	15442	inhibitor	0	None
15442	15443	JZL184	0	None
15443	15444	on	0	None
15444	15445	basal	0	None
15445	15446	and	0	None
15446	15447	stress-induced	0	None
15447	15448	corticosterone	0	None
15448	15449	levels	0	None
15449	15450	in	0	None
15450	15451	male	0	None
15451	15452	CD1	3	GENE-N
15452	15453	mice	0	None
15453	15454	,	0	None
15454	15455	and	0	None
15455	15456	found	0	None
15456	15457	that	0	None
15457	15458	this	0	None
15458	15459	compound	0	None
15459	15460	dramatically	0	None
15460	15461	increased	0	None
15461	15462	basal	0	None
15462	15463	levels	0	None
15463	15464	without	0	None
15464	15465	affecting	0	None
15465	15466	stress	0	None
15466	15467	responses	0	None
15467	15468	.	0	None

15469	15470	Since	0	None
15470	15471	acute	0	None
15471	15472	changes	0	None
15472	15473	in	0	None
15473	15474	corticosterone	0	None
15474	15475	levels	0	None
15475	15476	can	0	None
15476	15477	affect	0	None
15477	15478	behavior	0	None
15478	15479	,	0	None
15479	15480	JZL184	0	None
15480	15481	was	0	None
15481	15482	administered	0	None
15482	15483	concurrently	0	None
15483	15484	with	0	None
15484	15485	the	0	None
15485	15486	corticosterone	0	None
15486	15487	synthesis	0	None
15487	15488	inhibitor	0	None
15488	15489	metyrapone	0	None
15489	15490	,	0	None
15490	15491	to	0	None
15491	15492	investigate	0	None
15492	15493	whether	0	None
15493	15494	the	0	None
15494	15495	previously	0	None
15495	15496	shown	0	None
15496	15497	behavioral	0	None
15497	15498	effects	0	None
15498	15499	of	0	None
15499	15500	JZL184	0	None
15500	15501	are	0	None
15501	15502	dependent	0	None
15502	15503	on	0	None
15503	15504	corticosterone	0	None
15504	15505	.	0	None

15506	15507	We	0	None
15507	15508	found	0	None
15508	15509	that	0	None
15509	15510	in	0	None
15510	15511	the	0	None
15511	15512	elevated	0	None
15512	15513	plus-maze	0	None
15513	15514	,	0	None
15514	15515	the	0	None
15515	15516	effects	0	None
15516	15517	of	0	None
15517	15518	JZL184	0	None
15518	15519	on	0	None
15519	15520	"classical"	0	None
15520	15521	anxiety-related	0	None
15521	15522	measures	0	None
15522	15523	were	0	None
15523	15524	abolished	0	None
15524	15525	by	0	None
15525	15526	corticosterone	0	None
15526	15527	synthesis	0	None
15527	15528	blockade	0	None
15528	15529	.	0	None

15530	15531	By	0	None
15531	15532	contrast	0	None
15532	15533	,	0	None
15533	15534	effects	0	None
15534	15535	on	0	None
15535	15536	the	0	None
15536	15537	"ethological"	0	None
15537	15538	measures	0	None
15538	15539	of	0	None
15539	15540	anxiety	0	None
15540	15541	(	0	None
15541	15542	i	0	None
15542	15543	.	0	None

15544	15545	e	0	None
15545	15546	.	0	None

15547	15548	risk	0	None
15548	15549	assessment	0	None
15549	15550	)	0	None
15550	15551	were	0	None
15551	15552	not	0	None
15552	15553	affected	0	None
15553	15554	by	0	None
15554	15555	metyrapone	0	None
15555	15556	.	0	None

15557	15558	In	0	None
15558	15559	the	0	None
15559	15560	open-field	0	None
15560	15561	,	0	None
15561	15562	the	0	None
15562	15563	locomotion-enhancing	0	None
15563	15564	effects	0	None
15564	15565	of	0	None
15565	15566	the	0	None
15566	15567	compound	0	None
15567	15568	were	0	None
15568	15569	not	0	None
15569	15570	changed	0	None
15570	15571	either	0	None
15571	15572	.	0	None

15573	15574	These	0	None
15574	15575	findings	0	None
15575	15576	show	0	None
15576	15577	that	0	None
15577	15578	monoacylglycerol	0	None
15578	15579	lipase	3	GENE-N
15579	15580	inhibition	0	None
15580	15581	dramatically	0	None
15581	15582	increases	0	None
15582	15583	basal	0	None
15583	15584	levels	0	None
15584	15585	of	0	None
15585	15586	corticosterone	0	None
15586	15587	.	0	None

15588	15589	This	0	None
15589	15590	endocrine	0	None
15590	15591	effect	0	None
15591	15592	partly	0	None
15592	15593	affects	0	None
15593	15594	the	0	None
15594	15595	anxiolytic	0	None
15595	15596	,	0	None
15596	15597	but	0	None
15597	15598	not	0	None
15598	15599	the	0	None
15599	15600	locomotion-enhancing	0	None
15600	15601	effects	0	None
15601	15602	of	0	None
15602	15603	monoacylglycerol	0	None
15603	15604	lipase	3	GENE-N
15604	15605	blockade	0	None
15605	15606	.	0	None
15606	15607	Selective	0	None
15607	15608	separation	0	None
15608	15609	of	0	None
15609	15610	similarly	0	None
15610	15611	sized	0	None
15611	15612	proteins	0	None
15612	15613	with	0	None
15613	15614	tunable	0	None
15614	15615	nanoporous	0	None
15615	15616	block	0	None
15616	15617	copolymer	0	None
15617	15618	membranes	0	None
15618	15619	.	0	None
15619	15620	Improvement	0	None
15620	15621	of	0	None
15621	15622	cardiac	0	None
15622	15623	output	0	None
15623	15624	in	0	None
15624	15625	patients	0	None
15625	15626	with	0	None
15626	15627	severe	0	None
15627	15628	heart	0	None
15628	15629	failure	0	None
15629	15630	by	0	None
15630	15631	use	0	None
15631	15632	of	0	None
15632	15633	ACE-inhibitors	0	None
15633	15634	combined	0	None
15634	15635	with	0	None
15635	15636	the	0	None
15636	15637	AT1-antagonist	0	None
15637	15638	eprosartan	0	None
15638	15639	.	0	None
15639	15640	Topical	0	None
15640	15641	vitamin	0	None
15641	15642	D3	0	None
15642	15643	and	0	None
15643	15644	low-calcemic	0	None
15644	15645	analogs	0	None
15645	15646	induce	0	None
15646	15649	thymic stromal lymphopoietin	1	GENE-Y
15649	15650	in	0	None
15650	15651	mouse	0	None
15651	15652	keratinocytes	0	None
15652	15653	and	0	None
15653	15654	trigger	0	None
15654	15655	an	0	None
15655	15656	atopic	0	None
15656	15657	dermatitis	0	None
15657	15658	.	0	None
15658	15659	UNLABELLED	0	None
15659	15660	:	0	None
15660	15661	Escitalopram	0	None
15661	15662	is	0	None
15662	15663	the	0	None
15663	15664	therapeutically	0	None
15664	15665	active	0	None
15665	15666	S-enantiomer	0	None
15666	15667	of	0	None
15667	15668	RS-citalopram	0	None
15668	15669	,	0	None
15669	15670	a	0	None
15670	15671	commonly	0	None
15671	15672	prescribed	0	None
15672	15673	SSRI	0	None
15673	15674	.	0	None

15675	15676	The	0	None
15676	15677	R-enantiomer	0	None
15677	15678	is	0	None
15678	15679	essentially	0	None
15679	15680	pharmacologically	0	None
15680	15681	inactive	0	None
15681	15682	.	0	None

15683	15684	Escitalopram	0	None
15684	15685	10	0	None
15685	15686	or	0	None
15686	15687	20	0	None
15687	15688	mg	2	CHEMICAL
15688	15689	/	0	None
15689	15690	day	0	None
15690	15691	produced	0	None
15691	15692	significantly	0	None
15692	15693	greater	0	None
15693	15694	improvements	0	None
15694	15695	in	0	None
15695	15696	standard	0	None
15696	15697	measurements	0	None
15697	15698	of	0	None
15698	15699	antidepressant	0	None
15699	15700	effect	0	None
15700	15701	(	0	None
15701	15702	Montgomery-Asberg	0	None
15702	15703	Depression	0	None
15703	15704	Rating	0	None
15704	15705	Scale	0	None
15705	15706	[	0	None
15706	15707	MADRS	0	None
15707	15708	]	0	None
15708	15709	,	0	None
15709	15710	Clinical	0	None
15710	15711	Global	0	None
15711	15712	Impressions	0	None
15712	15713	Improvement	0	None
15713	15714	and	0	None
15714	15715	Severity	0	None
15715	15716	scales	0	None
15716	15717	[	0	None
15717	15718	CGI-I	0	None
15718	15719	and	0	None
15719	15720	CGI-S	0	None
15720	15721	]	0	None
15721	15722	and	0	None
15722	15723	Hamilton	0	None
15723	15724	Rating	0	None
15724	15725	Scale	0	None
15725	15726	for	0	None
15726	15727	Depression	0	None
15727	15728	[	0	None
15728	15729	HAM-D	0	None
15729	15730	]	0	None
15730	15731	)	0	None
15731	15732	in	0	None
15732	15733	patients	0	None
15733	15734	with	0	None
15734	15735	major	0	None
15735	15736	depressive	0	None
15736	15737	disorder	0	None
15737	15738	(	0	None
15738	15739	MDD	0	None
15739	15740	)	0	None
15740	15741	than	0	None
15741	15742	placebo	0	None
15742	15743	in	0	None
15743	15744	several	0	None
15744	15745	8-week	0	None
15745	15746	,	0	None
15746	15747	placebo-controlled	0	None
15747	15748	,	0	None
15748	15749	randomised	0	None
15749	15750	,	0	None
15750	15751	double-blind	0	None
15751	15752	,	0	None
15752	15753	multicentre	0	None
15753	15754	studies	0	None
15754	15755	.	0	None

15756	15757	Symptom	0	None
15757	15758	improvement	0	None
15758	15759	was	0	None
15759	15760	rapid	0	None
15760	15761	,	0	None
15761	15762	with	0	None
15762	15763	some	0	None
15763	15764	parameters	0	None
15764	15765	improving	0	None
15765	15766	within	0	None
15766	15767	1-2	0	None
15767	15768	weeks	0	None
15768	15769	of	0	None
15769	15770	starting	0	None
15770	15771	escitalopram	0	None
15771	15772	treatment	0	None
15772	15773	.	0	None

15774	15775	In	0	None
15775	15776	addition	0	None
15776	15777	,	0	None
15777	15778	escitalopram	0	None
15778	15779	showed	0	None
15779	15780	earlier	0	None
15780	15781	and	0	None
15781	15782	clearer	0	None
15782	15783	separation	0	None
15783	15784	from	0	None
15784	15785	placebo	0	None
15785	15786	than	0	None
15786	15787	RS-citalopram	0	None
15787	15788	,	0	None
15788	15789	at	0	None
15789	15790	one-quarter	0	None
15790	15791	to	0	None
15791	15792	half	0	None
15792	15793	the	0	None
15793	15794	dosage	0	None
15794	15795	,	0	None
15795	15796	in	0	None
15796	15797	8-week	0	None
15797	15798	,	0	None
15798	15799	placebo-controlled	0	None
15799	15800	trials;	0	None
15800	15801	had	0	None
15801	15802	significantly	0	None
15802	15803	better	0	None
15803	15804	efficacy	0	None
15804	15805	than	0	None
15805	15806	RS-citalopram	0	None
15806	15807	in	0	None
15807	15808	a	0	None
15808	15809	subgroup	0	None
15809	15810	of	0	None
15810	15811	patients	0	None
15811	15812	with	0	None
15812	15813	moderate	0	None
15813	15814	MDD	0	None
15814	15815	in	0	None
15815	15816	a	0	None
15816	15817	24-week	0	None
15817	15818	trial;	0	None
15818	15819	and	0	None
15819	15820	produced	0	None
15820	15821	sustained	0	None
15821	15822	response	0	None
15822	15823	and	0	None
15823	15824	remission	0	None
15824	15825	significantly	0	None
15825	15826	faster	0	None
15826	15827	than	0	None
15827	15828	venlafaxine	0	None
15828	15829	extended	0	None
15829	15830	release	0	None
15830	15831	in	0	None
15831	15832	patients	0	None
15832	15833	with	0	None
15833	15834	MDD	0	None
15834	15835	.	0	None

15836	15837	Escitalopram	0	None
15837	15838	reduced	0	None
15838	15839	relapse	0	None
15839	15840	rate	0	None
15840	15841	compared	0	None
15841	15842	with	0	None
15842	15843	placebo	0	None
15843	15844	and	0	None
15844	15845	increased	0	None
15845	15846	the	0	None
15846	15847	percentage	0	None
15847	15848	of	0	None
15848	15849	patients	0	None
15849	15850	in	0	None
15850	15851	remission	0	None
15851	15852	in	0	None
15852	15853	long-term	0	None
15853	15854	trials	0	None
15854	15855	(	0	None
15855	15856	up	0	None
15856	15857	to	0	None
15857	15858	52	0	None
15858	15859	weeks	0	None
15859	15860	)	0	None
15860	15861	.	0	None

15862	15863	Consistently	0	None
15863	15864	significant	0	None
15864	15865	improvements	0	None
15865	15866	for	0	None
15866	15867	all	0	None
15867	15868	efficacy	0	None
15868	15869	parameters	0	None
15869	15870	were	0	None
15870	15871	also	0	None
15871	15872	observed	0	None
15872	15873	in	0	None
15873	15874	patients	0	None
15874	15875	with	0	None
15875	15876	generalised	0	None
15876	15877	anxiety	0	None
15877	15878	disorder	0	None
15878	15879	,	0	None
15879	15880	social	0	None
15880	15881	anxiety	0	None
15881	15882	disorder	0	None
15882	15883	and	0	None
15883	15884	panic	0	None
15884	15885	disorder	0	None
15885	15886	treated	0	None
15886	15887	with	0	None
15887	15888	escitalopram	0	None
15888	15889	for	0	None
15889	15890	8-12	0	None
15890	15891	weeks	0	None
15891	15892	in	0	None
15892	15893	individual	0	None
15893	15894	,	0	None
15894	15895	randomised	0	None
15895	15896	,	0	None
15896	15897	placebo-controlled	0	None
15897	15898	,	0	None
15898	15899	double-blind	0	None
15899	15900	investigations	0	None
15900	15901	.	0	None

15902	15903	The	0	None
15903	15904	good	0	None
15904	15905	tolerability	0	None
15905	15906	profile	0	None
15906	15907	of	0	None
15907	15908	escitalopram	0	None
15908	15909	is	0	None
15909	15910	predictable	0	None
15910	15911	and	0	None
15911	15912	similar	0	None
15912	15913	to	0	None
15913	15914	that	0	None
15914	15915	of	0	None
15915	15916	RS-citalopram	0	None
15916	15917	.	0	None

15918	15919	Such	0	None
15919	15920	adverse	0	None
15920	15921	events	0	None
15921	15922	as	0	None
15922	15923	nausea	0	None
15923	15924	,	0	None
15924	15925	ejaculatory	0	None
15925	15926	problems	0	None
15926	15927	,	0	None
15927	15928	diarrhoea	0	None
15928	15929	and	0	None
15929	15930	insomnia	0	None
15930	15931	are	0	None
15931	15932	expected	0	None
15932	15933	but	0	None
15933	15934	,	0	None
15934	15935	with	0	None
15935	15936	the	0	None
15936	15937	exception	0	None
15937	15938	of	0	None
15938	15939	ejaculatory	0	None
15939	15940	problems	0	None
15940	15941	and	0	None
15941	15942	nausea	0	None
15942	15943	,	0	None
15943	15944	which	0	None
15944	15945	is	0	None
15945	15946	mild	0	None
15946	15947	and	0	None
15947	15948	transient	0	None
15948	15949	,	0	None
15949	15950	these	0	None
15950	15951	were	0	None
15951	15952	generally	0	None
15952	15953	no	0	None
15953	15954	more	0	None
15954	15955	frequent	0	None
15955	15956	than	0	None
15956	15957	with	0	None
15957	15958	placebo	0	None
15958	15959	in	0	None
15959	15960	fully	0	None
15960	15961	published	0	None
15961	15962	clinical	0	None
15962	15963	trials	0	None
15963	15964	.	0	None

15965	15966	No	0	None
15966	15967	adverse	0	None
15967	15968	events	0	None
15968	15969	not	0	None
15969	15970	previously	0	None
15970	15971	seen	0	None
15971	15972	in	0	None
15972	15973	acute	0	None
15973	15974	trials	0	None
15974	15975	were	0	None
15975	15976	reported	0	None
15976	15977	with	0	None
15977	15978	long-term	0	None
15978	15979	use	0	None
15979	15980	.	0	None

15981	15982	CONCLUSIONS	0	None
15982	15983	:	0	None
15983	15984	Escitalopram	0	None
15984	15985	,	0	None
15985	15986	the	0	None
15986	15987	S-enantiomer	0	None
15987	15988	of	0	None
15988	15989	RS-citalopram	0	None
15989	15990	,	0	None
15990	15991	is	0	None
15991	15992	a	0	None
15992	15993	highly	0	None
15993	15994	selective	0	None
15994	15995	inhibitor	0	None
15995	15996	for	0	None
15996	15997	the	0	None
15997	15999	serotonin transporter	1	GENE-Y
15999	16000	,	0	None
16000	16001	ameliorates	0	None
16001	16002	depressive	0	None
16002	16003	symptoms	0	None
16003	16004	in	0	None
16004	16005	patients	0	None
16005	16006	with	0	None
16006	16007	MDD	0	None
16007	16008	at	0	None
16008	16009	half	0	None
16009	16010	the	0	None
16010	16011	RS-citalopram	0	None
16011	16012	dosage	0	None
16012	16013	,	0	None
16013	16014	has	0	None
16014	16015	a	0	None
16015	16016	rapid	0	None
16016	16017	onset	0	None
16017	16018	of	0	None
16018	16019	symptom	0	None
16019	16020	improvement	0	None
16020	16021	and	0	None
16021	16022	has	0	None
16022	16023	a	0	None
16023	16024	predictable	0	None
16024	16025	tolerability	0	None
16025	16026	profile	0	None
16026	16027	of	0	None
16027	16028	generally	0	None
16028	16029	mild	0	None
16029	16030	adverse	0	None
16030	16031	events	0	None
16031	16032	.	0	None

16033	16034	Like	0	None
16034	16035	RS-citalopram	0	None
16035	16036	,	0	None
16036	16037	escitalopram	0	None
16037	16038	is	0	None
16038	16039	expected	0	None
16039	16040	to	0	None
16040	16041	have	0	None
16041	16042	a	0	None
16042	16043	low	0	None
16043	16044	propensity	0	None
16044	16045	for	0	None
16045	16046	drug	0	None
16046	16047	interactions	0	None
16047	16048	,	0	None
16048	16049	a	0	None
16049	16050	potential	0	None
16050	16051	benefit	0	None
16051	16052	in	0	None
16052	16053	the	0	None
16053	16054	management	0	None
16054	16055	of	0	None
16055	16056	patients	0	None
16056	16057	with	0	None
16057	16058	comorbidities	0	None
16058	16059	.	0	None

16060	16061	In	0	None
16061	16062	combination	0	None
16062	16063	,	0	None
16063	16064	these	0	None
16064	16065	properties	0	None
16065	16066	place	0	None
16066	16067	escitalopram	0	None
16067	16068	,	0	None
16068	16069	like	0	None
16069	16070	other	0	None
16070	16071	SSRIs	0	None
16071	16072	,	0	None
16072	16073	as	0	None
16073	16074	first-line	0	None
16074	16075	therapy	0	None
16075	16076	in	0	None
16076	16077	patients	0	None
16077	16078	with	0	None
16078	16079	MDD	0	None
16079	16080	.	0	None

16081	16082	Escitalopram	0	None
16082	16083	is	0	None
16083	16084	indicated	0	None
16084	16085	for	0	None
16085	16086	use	0	None
16086	16087	in	0	None
16087	16088	patients	0	None
16088	16089	with	0	None
16089	16090	panic	0	None
16090	16091	disorder	0	None
16091	16092	in	0	None
16092	16093	Europe	0	None
16093	16094	and	0	None
16094	16095	,	0	None
16095	16096	should	0	None
16096	16097	further	0	None
16097	16098	evidence	0	None
16098	16099	confirm	0	None
16099	16100	early	0	None
16100	16101	findings	0	None
16101	16102	that	0	None
16102	16103	escitalopram	0	None
16103	16104	reduces	0	None
16104	16105	anxiety	0	None
16105	16106	,	0	None
16106	16107	the	0	None
16107	16108	drug	0	None
16108	16109	may	0	None
16109	16110	well	0	None
16110	16111	find	0	None
16111	16112	an	0	None
16112	16113	additional	0	None
16113	16114	role	0	None
16114	16115	in	0	None
16115	16116	the	0	None
16116	16117	management	0	None
16117	16118	of	0	None
16118	16119	anxiety	0	None
16119	16120	disorders	0	None
16120	16121	.	0	None
16121	16122	Cofactor	0	None
16122	16123	and	0	None
16123	16124	tryptophan	2	CHEMICAL
16124	16125	accessibility	0	None
16125	16126	and	0	None
16126	16127	unfolding	0	None
16127	16128	of	0	None
16128	16131	brain glutamate decarboxylase	3	GENE-N
16131	16132	.	0	None
16132	16133	Association	0	None
16133	16134	of	0	None
16134	16135	enzyme	0	None
16135	16136	and	0	None
16136	16137	transporter	0	None
16137	16138	genotypes	0	None
16138	16139	with	0	None
16139	16140	the	0	None
16140	16141	pharmacokinetics	0	None
16141	16142	of	0	None
16142	16143	imatinib	0	None
16143	16144	.	0	None
16144	16145	Multiple	0	None
16145	16146	exposure	0	None
16146	16147	to	0	None
16147	16148	theophylline	2	CHEMICAL
16148	16149	,	0	None
16149	16150	a	0	None
16150	16151	phosphodiesterase	3	GENE-N
16151	16152	(	0	None
16152	16153	PDE	0	None
16153	16154	)	0	None
16154	16155	inhibitor	0	None
16155	16156	,	0	None
16156	16157	induces	0	None
16157	16158	acinar	0	None
16158	16159	hypertrophy	0	None
16159	16160	in	0	None
16160	16161	the	0	None
16161	16162	salivary	0	None
16162	16163	gland	0	None
16163	16164	.	0	None

16165	16166	This	0	None
16166	16167	study	0	None
16167	16168	examined	0	None
16168	16169	the	0	None
16169	16170	effect	0	None
16170	16171	of	0	None
16171	16172	theophylline	2	CHEMICAL
16172	16173	on	0	None
16173	16174	the	0	None
16174	16175	gene	0	None
16175	16176	expression	0	None
16176	16177	of	0	None
16177	16178	secretory	0	None
16178	16179	proteins	0	None
16179	16180	and	0	None
16180	16181	phosphodiesterases	0	None
16181	16182	in	0	None
16182	16183	the	0	None
16183	16184	submaxillary	0	None
16184	16185	gland	0	None
16185	16186	.	0	None

16187	16188	Male	0	None
16188	16189	F344	0	None
16189	16190	rats	0	None
16190	16191	received	0	None
16191	16192	saline	0	None
16192	16193	or	0	None
16193	16194	theophylline	2	CHEMICAL
16194	16195	(	0	None
16195	16196	50	0	None
16196	16197	mg	2	CHEMICAL
16197	16198	/	0	None
16198	16199	kg	0	None
16199	16200	)	0	None
16200	16201	intraperitoneally	0	None
16201	16202	for	0	None
16202	16203	4	0	None
16203	16204	days	0	None
16204	16205	.	0	None

16206	16207	The	0	None
16207	16208	gene	0	None
16208	16209	expressions	0	None
16209	16210	for	0	None
16210	16211	the	0	None
16211	16212	secretory	0	None
16212	16213	protein	0	None
16213	16214	,	0	None
16214	16215	cystatin	0	None
16215	16216	S	0	None
16216	16217	(	0	None
16217	16218	CysS	0	None
16218	16219	)	0	None
16219	16220	,	0	None
16220	16221	and	0	None
16221	16222	PDE	0	None
16222	16223	subfamilies	0	None
16223	16224	3A	0	None
16224	16225	and	0	None
16225	16226	4D	0	None
16226	16227	in	0	None
16227	16228	the	0	None
16228	16229	submaxillary	0	None
16229	16230	gland	0	None
16230	16231	were	0	None
16231	16232	quantified	0	None
16232	16233	using	0	None
16233	16234	RT-PCR	0	None
16234	16235	.	0	None

16236	16237	Theophylline	0	None
16237	16238	exposure	0	None
16238	16239	resulted	0	None
16239	16240	in	0	None
16240	16241	a	0	None
16241	16242	sustained	0	None
16242	16243	increase	0	None
16243	16244	in	0	None
16244	16245	mRNA	0	None
16245	16246	expression	0	None
16246	16247	for	0	None
16247	16248	CysS	0	None
16248	16249	and	0	None
16249	16250	PDE3A	0	None
16250	16251	,	0	None
16251	16252	but	0	None
16252	16253	PDE4D	0	None
16253	16254	gene	0	None
16254	16255	expression	0	None
16255	16256	was	0	None
16256	16257	unchanged	0	None
16257	16258	.	0	None

16259	16260	Our	0	None
16260	16261	results	0	None
16261	16262	suggest	0	None
16262	16263	that	0	None
16263	16264	submaxillary	0	None
16264	16265	hypertrophy	0	None
16265	16266	is	0	None
16266	16267	primarily	0	None
16267	16268	caused	0	None
16268	16269	by	0	None
16269	16270	the	0	None
16270	16271	enhanced	0	None
16271	16272	transcription	0	None
16272	16273	of	0	None
16273	16274	CysS	0	None
16274	16275	,	0	None
16275	16276	and	0	None
16276	16277	that	0	None
16277	16278	the	0	None
16278	16279	transcription	0	None
16279	16280	of	0	None
16280	16281	each	0	None
16281	16282	PDE	0	None
16282	16283	subfamily	0	None
16283	16284	gene	0	None
16284	16285	is	0	None
16285	16286	regulated	0	None
16286	16287	differently	0	None
16287	16288	.	0	None
16288	16289	Very	0	None
16289	16290	few	0	None
16290	16291	nonpeptide	0	None
16291	16292	oxytocin	2	CHEMICAL
16292	16293	agonists	0	None
16293	16294	have	0	None
16294	16295	currently	0	None
16295	16296	been	0	None
16296	16297	reported	0	None
16297	16298	,	0	None
16298	16299	and	0	None
16299	16300	none	0	None
16300	16301	of	0	None
16301	16302	them	0	None
16302	16303	seem	0	None
16303	16304	suitable	0	None
16304	16305	for	0	None
16305	16306	the	0	None
16306	16307	in	0	None
16307	16308	vivo	0	None
16308	16309	investigation	0	None
16309	16310	of	0	None
16310	16311	the	0	None
16311	16312	oxytocin	2	CHEMICAL
16312	16313	mediated	0	None
16313	16314	functions	0	None
16314	16315	.	0	None

16316	16317	In	0	None
16317	16318	an	0	None
16318	16319	attempt	0	None
16319	16320	to	0	None
16320	16321	rationalize	0	None
16321	16322	the	0	None
16322	16323	design	0	None
16323	16324	of	0	None
16324	16325	better	0	None
16325	16326	tools	0	None
16326	16327	,	0	None
16327	16328	we	0	None
16328	16329	have	0	None
16329	16330	systematically	0	None
16330	16331	studied	0	None
16331	16332	the	0	None
16332	16333	structural	0	None
16333	16334	determinants	0	None
16334	16335	of	0	None
16335	16336	the	0	None
16336	16337	affinity	0	None
16337	16338	and	0	None
16338	16339	efficacy	0	None
16339	16340	of	0	None
16340	16341	representative	0	None
16341	16342	ligands	0	None
16342	16343	of	0	None
16343	16344	the	0	None
16344	16345	V	0	None
16345	16346	(	0	None
16346	16347	1a	0	None
16347	16348	)	0	None
16348	16349	,	0	None
16349	16350	V	0	None
16350	16351	(	0	None
16351	16352	2	0	None
16352	16353	)	0	None
16353	16354	,	0	None
16354	16355	and	0	None
16355	16356	OT	0	None
16356	16357	receptor	0	None
16357	16358	subtypes	0	None
16358	16359	.	0	None

16360	16361	Despite	0	None
16361	16362	apparently	0	None
16362	16363	obvious	0	None
16363	16364	similarity	0	None
16364	16365	between	0	None
16365	16366	the	0	None
16366	16367	ligand	0	None
16367	16368	structures	0	None
16368	16369	on	0	None
16369	16370	one	0	None
16370	16371	hand	0	None
16371	16372	,	0	None
16372	16373	and	0	None
16373	16374	between	0	None
16374	16375	the	0	None
16375	16376	receptor	0	None
16376	16377	subtypes	0	None
16377	16378	on	0	None
16378	16379	the	0	None
16379	16380	other	0	None
16380	16381	hand	0	None
16381	16382	,	0	None
16382	16383	the	0	None
16383	16384	binding	0	None
16384	16385	affinity	0	None
16385	16386	and	0	None
16386	16387	the	0	None
16387	16388	functional	0	None
16388	16389	activity	0	None
16389	16390	profiles	0	None
16390	16391	of	0	None
16391	16392	truncated	0	None
16392	16393	and	0	None
16393	16394	hybrid	0	None
16394	16395	ligands	0	None
16395	16396	highlight	0	None
16396	16397	the	0	None
16397	16398	subtlety	0	None
16398	16399	of	0	None
16399	16400	ligand-receptor	0	None
16400	16401	interactions	0	None
16401	16402	for	0	None
16402	16403	obtaining	0	None
16403	16404	nonpeptide	0	None
16404	16405	OT	0	None
16405	16406	receptor	0	None
16406	16407	agonists	0	None
16407	16408	.	0	None
16408	16409	Several	0	None
16409	16410	signaling	0	None
16410	16411	pathways	0	None
16411	16412	are	0	None
16412	16413	believed	0	None
16413	16414	to	0	None
16414	16415	be	0	None
16415	16416	involved	0	None
16416	16417	in	0	None
16417	16418	the	0	None
16418	16419	epileptogenic	0	None
16419	16420	process	0	None
16420	16421	that	0	None
16421	16422	triggers	0	None
16422	16423	the	0	None
16423	16424	subsequent	0	None
16424	16425	changes	0	None
16425	16426	in	0	None
16426	16427	the	0	None
16427	16428	brain	0	None
16428	16429	causing	0	None
16429	16430	epilepsy	0	None
16430	16431	.	0	None

16432	16433	The	0	None
16433	16437	mammalian target of rapamycin	1	GENE-Y
16437	16438	(	0	None
16438	16439	mTOR	0	None
16439	16440	)	0	None
16440	16441	is	0	None
16441	16442	a	0	None
16442	16443	serine	2	CHEMICAL
16443	16444	/	0	None
16444	16445	threonine	0	None
16445	16446	kinase	0	None
16446	16447	that	0	None
16447	16448	in	0	None
16448	16449	the	0	None
16449	16450	brain	0	None
16450	16451	,	0	None
16451	16452	regulates	0	None
16452	16453	several	0	None
16453	16454	important	0	None
16454	16455	physiological	0	None
16455	16456	functions	0	None
16456	16457	such	0	None
16457	16458	as	0	None
16458	16459	neuronal	0	None
16459	16460	development	0	None
16460	16461	and	0	None
16461	16462	synaptic	0	None
16462	16463	plasticity	0	None
16463	16464	,	0	None
16464	16465	and	0	None
16465	16466	also	0	None
16466	16467	seems	0	None
16467	16468	to	0	None
16468	16469	be	0	None
16469	16470	involved	0	None
16470	16471	in	0	None
16471	16472	many	0	None
16472	16473	pathologies	0	None
16473	16474	,	0	None
16474	16475	including	0	None
16475	16476	epilepsy	0	None
16476	16477	and	0	None
16477	16478	psychiatric	0	None
16478	16479	disorders	0	None
16479	16480	.	0	None

16481	16482	Previous	0	None
16482	16483	work	0	None
16483	16484	in	0	None
16484	16485	animal	0	None
16485	16486	models	0	None
16486	16487	of	0	None
16487	16488	both	0	None
16488	16489	genetic	0	None
16489	16490	and	0	None
16490	16491	acquired	0	None
16491	16492	generalized	0	None
16492	16493	convulsive	0	None
16493	16494	epilepsies	0	None
16494	16495	,	0	None
16495	16496	has	0	None
16496	16497	suggested	0	None
16497	16498	that	0	None
16498	16499	modulators	0	None
16499	16500	of	0	None
16500	16501	the	0	None
16501	16502	mTOR	0	None
16502	16503	signaling	0	None
16503	16504	pathway	0	None
16504	16505	may	0	None
16505	16506	have	0	None
16506	16507	beneficial	0	None
16507	16508	neuroprotective	0	None
16508	16509	and	0	None
16509	16510	antiepileptogenic	0	None
16510	16511	effects	0	None
16511	16512	.	0	None

16513	16514	Here	0	None
16514	16515	,	0	None
16515	16516	we	0	None
16516	16517	investigated	0	None
16517	16518	for	0	None
16518	16519	the	0	None
16519	16520	first	0	None
16520	16521	time	0	None
16521	16522	,	0	None
16522	16523	the	0	None
16523	16524	effect	0	None
16524	16525	of	0	None
16525	16526	some	0	None
16526	16527	treatment	0	None
16527	16528	schedules	0	None
16528	16529	(	0	None
16529	16530	i	0	None
16530	16531	.	0	None

16532	16533	e	0	None
16533	16534	.	0	None

16535	16536	early	0	None
16536	16537	chronic	0	None
16537	16538	,	0	None
16538	16539	sub-chronic	0	None
16539	16540	and	0	None
16540	16541	acute	0	None
16541	16542	)	0	None
16542	16543	with	0	None
16543	16544	the	0	None
16544	16545	specific	0	None
16545	16546	mTOR	0	None
16546	16547	inhibitor	0	None
16547	16548	rapamycin	3	GENE-N
16548	16549	,	0	None
16549	16550	on	0	None
16550	16551	the	0	None
16551	16552	development	0	None
16552	16553	of	0	None
16553	16554	absence	0	None
16554	16555	seizures	0	None
16555	16556	and	0	None
16556	16557	seizure	0	None
16557	16558	parameters	0	None
16558	16559	as	0	None
16559	16560	well	0	None
16560	16561	as	0	None
16561	16562	depressive-like	0	None
16562	16563	behavior	0	None
16563	16564	in	0	None
16564	16565	WAG	0	None
16565	16566	/	0	None
16566	16567	Rij	0	None
16567	16568	rats	0	None
16568	16569	,	0	None
16569	16570	a	0	None
16570	16571	genetic	0	None
16571	16572	model	0	None
16572	16573	of	0	None
16573	16574	absence	0	None
16574	16575	epilepsy	0	None
16575	16576	,	0	None
16576	16577	epileptogenesis	0	None
16577	16578	and	0	None
16578	16579	mild-depression	0	None
16579	16580	comorbidity	0	None
16580	16581	.	0	None

16582	16583	In	0	None
16583	16584	addition	0	None
16584	16585	,	0	None
16585	16586	we	0	None
16586	16587	studied	0	None
16587	16588	the	0	None
16588	16589	possible	0	None
16589	16590	interaction	0	None
16590	16591	between	0	None
16591	16592	rapamycin	3	GENE-N
16592	16593	treatment	0	None
16593	16594	and	0	None
16594	16595	the	0	None
16595	16596	effects	0	None
16596	16597	of	0	None
16597	16598	bacterial	0	None
16598	16599	lipopolysaccharide	0	None
16599	16600	(	0	None
16600	16601	LPS	0	None
16601	16602	)	0	None
16602	16603	endotoxin	0	None
16603	16604	administration	0	None
16604	16605	,	0	None
16605	16606	which	0	None
16606	16607	is	0	None
16607	16608	known	0	None
16608	16609	to	0	None
16609	16610	aggravate	0	None
16610	16611	absence	0	None
16611	16612	seizures	0	None
16612	16613	through	0	None
16613	16614	generation	0	None
16614	16615	of	0	None
16615	16616	increased	0	None
16616	16617	neuroinflammatory	0	None
16617	16618	responses	0	None
16618	16619	.	0	None

16620	16621	We	0	None
16621	16622	found	0	None
16622	16623	that	0	None
16623	16624	rapamycin	3	GENE-N
16624	16625	(	0	None
16625	16626	early	0	None
16626	16627	chronic	0	None
16627	16628	treatment	0	None
16628	16629	for	0	None
16629	16630	17	0	None
16630	16631	weeks	0	None
16631	16632	,	0	None
16632	16633	starting	0	None
16633	16634	at	0	None
16634	16635	P45	0	None
16635	16636	)	0	None
16636	16637	exhibited	0	None
16637	16638	clear	0	None
16638	16639	antiepileptogenic	0	None
16639	16640	properties	0	None
16640	16641	also	0	None
16641	16642	in	0	None
16642	16643	this	0	None
16643	16644	animal	0	None
16644	16645	epilepsy	0	None
16645	16646	model;	0	None
16646	16647	however	0	None
16647	16648	,	0	None
16648	16649	this	0	None
16649	16650	effect	0	None
16650	16651	was	0	None
16651	16652	accompanied	0	None
16652	16653	by	0	None
16653	16654	unexpected	0	None
16654	16655	prodepressant	0	None
16655	16656	effects	0	None
16656	16657	.	0	None

16658	16659	Both	0	None
16659	16660	acute	0	None
16660	16661	and	0	None
16661	16662	sub-chronic	0	None
16662	16663	(	0	None
16663	16664	7	0	None
16664	16665	day	0	None
16665	16666	)	0	None
16666	16667	treatments	0	None
16667	16668	also	0	None
16668	16669	had	0	None
16669	16670	anti-absence	0	None
16670	16671	properties	0	None
16671	16672	,	0	None
16672	16673	but	0	None
16673	16674	the	0	None
16674	16675	sub-chronic	0	None
16675	16676	treatment	0	None
16676	16677	produced	0	None
16677	16678	contrasting	0	None
16678	16679	antidepressant	0	None
16679	16680	properties	0	None
16680	16681	in	0	None
16681	16682	the	0	None
16682	16683	WAG	0	None
16683	16684	/	0	None
16684	16685	Rij	0	None
16685	16686	rats	0	None
16686	16687	that	0	None
16687	16688	were	0	None
16688	16689	not	0	None
16689	16690	seen	0	None
16690	16691	in	0	None
16691	16692	control	0	None
16692	16693	Wistar	0	None
16693	16694	rats	0	None
16694	16695	.	0	None

16696	16697	The	0	None
16697	16698	rapamycin	3	GENE-N
16698	16699	/	0	None
16699	16700	LPS	0	None
16700	16701	co-administration	0	None
16701	16702	studies	0	None
16702	16703	showed	0	None
16703	16704	that	0	None
16704	16705	rapamycin	3	GENE-N
16705	16706	blocked	0	None
16706	16707	or	0	None
16707	16708	prevented	0	None
16708	16709	the	0	None
16709	16710	LPS-dependent	0	None
16710	16711	increase	0	None
16711	16712	in	0	None
16712	16713	absence	0	None
16713	16714	seizures	0	None
16714	16715	,	0	None
16715	16716	suggesting	0	None
16716	16717	an	0	None
16717	16718	anti-inflammatory-like	0	None
16718	16719	protective	0	None
16719	16720	action	0	None
16720	16721	.	0	None

16722	16723	In	0	None
16723	16724	conclusion	0	None
16724	16725	,	0	None
16725	16726	we	0	None
16726	16727	have	0	None
16727	16728	demonstrated	0	None
16728	16729	a	0	None
16729	16730	novel	0	None
16730	16731	antiepileptogenic	0	None
16731	16732	effect	0	None
16732	16733	of	0	None
16733	16734	rapamycin	3	GENE-N
16734	16735	in	0	None
16735	16736	a	0	None
16736	16737	well-established	0	None
16737	16738	animal	0	None
16738	16739	model	0	None
16739	16740	of	0	None
16740	16741	absence	0	None
16741	16742	epilepsy	0	None
16742	16743	,	0	None
16743	16744	and	0	None
16744	16745	we	0	None
16745	16746	suggest	0	None
16746	16747	that	0	None
16747	16748	this	0	None
16748	16749	effect	0	None
16749	16750	may	0	None
16750	16751	be	0	None
16751	16752	mediated	0	None
16752	16753	by	0	None
16753	16754	the	0	None
16754	16755	inhibition	0	None
16755	16756	of	0	None
16756	16757	inflammatory	0	None
16757	16758	processes	0	None
16758	16759	that	0	None
16759	16760	are	0	None
16760	16761	developed	0	None
16761	16762	in	0	None
16762	16763	the	0	None
16763	16764	brain	0	None
16764	16765	of	0	None
16765	16766	these	0	None
16766	16767	specific	0	None
16767	16768	animals	0	None
16768	16769	during	0	None
16769	16770	epileptogenesis	0	None
16770	16771	and	0	None
16771	16772	during	0	None
16772	16773	seizures	0	None
16773	16774	.	0	None

16775	16776	Our	0	None
16776	16777	experiments	0	None
16777	16778	here	0	None
16778	16779	suggest	0	None
16779	16780	new	0	None
16780	16781	insights	0	None
16781	16782	into	0	None
16782	16783	this	0	None
16783	16784	intriguing	0	None
16784	16785	field	0	None
16785	16786	,	0	None
16786	16787	which	0	None
16787	16788	deserves	0	None
16788	16789	to	0	None
16789	16790	be	0	None
16790	16791	further	0	None
16791	16792	explored	0	None
16792	16793	.	0	None

16794	16795	This	0	None
16795	16796	article	0	None
16796	16797	is	0	None
16797	16798	part	0	None
16798	16799	of	0	None
16799	16800	the	0	None
16800	16801	Special	0	None
16801	16802	Issue	0	None
16802	16803	entitled	0	None
16803	16804	'New	0	None
16804	16805	Targets	0	None
16805	16806	and	0	None
16806	16807	Approaches	0	None
16807	16808	to	0	None
16808	16809	the	0	None
16809	16810	Treatment	0	None
16810	16811	of	0	None
16811	16812	Epilepsy'	0	None
16812	16813	.	0	None
16813	16814	A	0	None
16814	16815	series	0	None
16815	16816	of	0	None
16816	16817	novel	0	None
16817	16818	hybrid	0	None
16818	16819	compounds	0	None
16819	16820	between	0	None
16820	16821	2-benzylbenzofuran	0	None
16821	16822	and	0	None
16822	16823	imidazole	2	CHEMICAL
16823	16824	has	0	None
16824	16825	been	0	None
16825	16826	prepared	0	None
16826	16827	and	0	None
16827	16828	evaluated	0	None
16828	16829	in	0	None
16829	16830	vitro	0	None
16830	16831	against	0	None
16831	16832	a	0	None
16832	16833	panel	0	None
16833	16834	of	0	None
16834	16835	human	0	None
16835	16836	tumor	0	None
16836	16837	cell	0	None
16837	16838	lines	0	None
16838	16839	.	0	None

16840	16841	The	0	None
16841	16842	results	0	None
16842	16843	suggest	0	None
16843	16844	that	0	None
16844	16845	the	0	None
16845	16846	existence	0	None
16846	16847	of	0	None
16847	16848	benzimidazole	0	None
16848	16849	ring	0	None
16849	16850	and	0	None
16850	16851	substitution	0	None
16851	16852	of	0	None
16852	16853	the	0	None
16853	16854	imidazolyl-3-position	0	None
16854	16855	with	0	None
16855	16856	a	0	None
16856	16857	naphthylacyl	0	None
16857	16858	or	0	None
16858	16859	4-methoxyphenacyl	0	None
16859	16860	group	0	None
16860	16861	were	0	None
16861	16862	vital	0	None
16862	16863	for	0	None
16863	16864	modulating	0	None
16864	16865	cytotoxic	0	None
16865	16866	activity	0	None
16866	16867	.	0	None

16868	16869	In	0	None
16869	16870	particular	0	None
16870	16871	,	0	None
16871	16872	hybrid	0	None
16872	16873	compounds	0	None
16873	16874	46	0	None
16874	16875	and	0	None
16875	16876	47	0	None
16876	16877	were	0	None
16877	16878	found	0	None
16878	16879	to	0	None
16879	16880	be	0	None
16880	16881	the	0	None
16881	16882	most	0	None
16882	16883	potent	0	None
16883	16884	derivatives	0	None
16884	16885	against	0	None
16885	16886	5	0	None
16886	16887	strains	0	None
16887	16888	human	0	None
16888	16889	tumor	0	None
16889	16890	cell	0	None
16890	16891	lines	0	None
16891	16892	and	0	None
16892	16893	more	0	None
16893	16894	active	0	None
16894	16895	than	0	None
16895	16896	cisplatin	0	None
16896	16897	(	0	None
16897	16898	DDP	0	None
16898	16899	)	0	None
16899	16900	,	0	None
16900	16901	and	0	None
16901	16902	exhibited	0	None
16902	16903	cytotoxic	0	None
16903	16904	activities	0	None
16904	16905	selectively	0	None
16905	16906	against	0	None
16906	16907	breast	0	None
16907	16908	carcinoma	0	None
16908	16909	(	0	None
16909	16910	MCF-7	0	None
16910	16911	)	0	None
16911	16912	and	0	None
16912	16913	myeloid	0	None
16913	16914	liver	0	None
16914	16915	carcinoma	0	None
16915	16916	(	0	None
16916	16917	SMMC-7721	0	None
16917	16918	)	0	None
16918	16919	,	0	None
16919	16920	respectively	0	None
16920	16921	.	0	None
16921	16922	RNAi	0	None
16922	16923	silencing	0	None
16923	16924	of	0	None
16924	16925	three	0	None
16925	16926	homologues	0	None
16926	16927	of	0	None
16927	16928	S-adenosylmethionine	2	CHEMICAL
16928	16929	decarboxylase	0	None
16929	16930	gene	0	None
16930	16931	in	0	None
16931	16932	tapetal	0	None
16932	16933	tissue	0	None
16933	16934	of	0	None
16934	16935	tomato	0	None
16935	16936	results	0	None
16936	16937	in	0	None
16937	16938	male	0	None
16938	16939	sterility	0	None
16939	16940	.	0	None
16940	16941	Synthesis	0	None
16941	16942	and	0	None
16942	16943	structure-activity	0	None
16943	16944	studies	0	None
16944	16945	of	0	None
16945	16946	benzyl	0	None
16946	16947	ester	0	None
16947	16948	meperidine	0	None
16948	16949	and	0	None
16949	16950	normeperidine	2	CHEMICAL
16950	16951	derivatives	0	None
16951	16952	as	0	None
16952	16953	selective	0	None
16953	16954	serotonin	0	None
16954	16955	transporter	0	None
16955	16956	ligands	0	None
16956	16957	.	0	None
16957	16958	HIV	0	None
16958	16959	entry	0	None
16959	16960	is	0	None
16960	16961	mediated	0	None
16961	16962	by	0	None
16962	16963	the	0	None
16963	16964	envelope	0	None
16964	16965	glycoproteins	3	GENE-N
16965	16966	gp120	0	None
16966	16967	and	0	None
16967	16968	gp41	0	None
16968	16969	.	0	None

16970	16971	The	0	None
16971	16972	gp41	0	None
16972	16973	subunit	0	None
16973	16974	contains	0	None
16974	16975	several	0	None
16975	16976	functional	0	None
16976	16977	domains	0	None
16977	16978	:	0	None
16978	16979	the	0	None
16979	16980	N-terminal	0	None
16980	16981	heptad	0	None
16981	16982	repeat	0	None
16982	16983	(	0	None
16983	16984	NHR	0	None
16984	16985	)	0	None
16985	16986	domains	0	None
16986	16987	fold	0	None
16987	16988	a	0	None
16988	16989	triple	0	None
16989	16990	stranded	0	None
16990	16991	coiled-coil	0	None
16991	16992	forming	0	None
16992	16993	a	0	None
16993	16994	meta-stable	0	None
16994	16995	prefusion	0	None
16995	16996	intermediate	0	None
16996	16997	.	0	None

16998	16999	C-terminal	0	None
16999	17000	heptad	0	None
17000	17001	repeat	0	None
17001	17002	(	0	None
17002	17003	CHR	3	GENE-N
17003	17004	)	0	None
17004	17005	subsequently	0	None
17005	17006	folds	0	None
17006	17007	onto	0	None
17007	17008	the	0	None
17008	17009	hydrophobic	0	None
17009	17010	grooves	0	None
17010	17011	of	0	None
17011	17012	the	0	None
17012	17013	NHR	0	None
17013	17014	coiled-coil	0	None
17014	17015	to	0	None
17015	17016	form	0	None
17016	17017	a	0	None
17017	17018	stable	0	None
17018	17019	6-helix	0	None
17019	17020	bundle	0	None
17020	17021	,	0	None
17021	17022	which	0	None
17022	17023	juxtaposes	0	None
17023	17024	the	0	None
17024	17025	viral	0	None
17025	17026	and	0	None
17026	17027	cellular	0	None
17027	17028	membranes	0	None
17028	17029	for	0	None
17029	17030	fusion	0	None
17030	17031	.	0	None

17032	17033	The	0	None
17033	17034	C34	0	None
17034	17035	which	0	None
17035	17036	has	0	None
17036	17037	34	0	None
17037	17039	amino acid	2	CHEMICAL
17039	17040	residues	0	None
17040	17041	is	0	None
17041	17042	known	0	None
17042	17043	as	0	None
17043	17044	the	0	None
17044	17045	core	0	None
17045	17046	structure	0	None
17046	17047	in	0	None
17047	17048	CHR	0	None
17048	17049	.	0	None

17050	17051	A	0	None
17051	17052	highly	0	None
17052	17053	anti-HIV	0	None
17053	17054	peptide	0	None
17054	17055	inhibitor	0	None
17055	17056	derived	0	None
17056	17057	from	0	None
17057	17058	C34	0	None
17058	17059	was	0	None
17059	17060	designed	0	None
17060	17061	.	0	None

17062	17063	An	0	None
17063	17064	artificial	0	None
17064	17065	salt	0	None
17065	17066	bridge	0	None
17066	17067	was	0	None
17067	17068	added	0	None
17068	17069	in	0	None
17069	17070	the	0	None
17070	17071	6-helical	0	None
17071	17072	bundle	0	None
17072	17073	by	0	None
17073	17074	substitution	0	None
17074	17075	of	0	None
17075	17076	lysine	0	None
17076	17077	for	0	None
17077	17078	Ile646	0	None
17078	17079	.	0	None

17080	17081	With	0	None
17081	17082	a	0	None
17082	17083	cholesterol	0	None
17083	17084	modification	0	None
17084	17085	at	0	None
17085	17086	C-terminal	0	None
17086	17087	,	0	None
17087	17088	the	0	None
17088	17089	inhibitor	0	None
17089	17090	containing	0	None
17090	17091	I646K	0	None
17091	17092	mutation	0	None
17092	17093	represented	0	None
17093	17094	higher	0	None
17094	17095	anti-viral	0	None
17095	17096	activity	0	None
17096	17097	than	0	None
17097	17098	C34-cholesterol	0	None
17098	17099	combination	0	None
17099	17100	without	0	None
17100	17101	mutation	0	None
17101	17102	.	0	None
17102	17103	Cisapride	0	None
17103	17104	,	0	None
17104	17105	a	0	None
17105	17106	gastrointestinal	0	None
17106	17107	prokinetic	0	None
17107	17108	agent	0	None
17108	17109	,	0	None
17109	17110	is	0	None
17110	17111	known	0	None
17111	17112	to	0	None
17112	17113	cause	0	None
17113	17114	long	0	None
17114	17115	Q-T	0	None
17115	17116	syndrome	0	None
17116	17117	and	0	None
17117	17118	ventricular	0	None
17118	17119	arrhythmias	0	None
17119	17120	.	0	None

17121	17122	The	0	None
17122	17123	cellular	0	None
17123	17124	mechanism	0	None
17124	17125	is	0	None
17125	17126	not	0	None
17126	17127	known	0	None
17127	17128	.	0	None

17129	17130	The	0	None
17130	17131	human	0	None
17131	17132	ether-a-go-go-related	0	None
17132	17133	gene	0	None
17133	17134	(	0	None
17134	17135	HERG	1	GENE-Y
17135	17136	)	0	None
17136	17137	,	0	None
17137	17138	which	0	None
17138	17139	encodes	0	None
17139	17140	the	0	None
17140	17141	rapidly	0	None
17141	17142	activating	0	None
17142	17143	delayed	0	None
17143	17144	rectifier	0	None
17144	17145	K	0	None
17145	17146	+	0	None
17146	17147	current	0	None
17147	17148	and	0	None
17148	17149	is	0	None
17149	17150	important	0	None
17150	17151	in	0	None
17151	17152	cardiac	0	None
17152	17153	repolarization	0	None
17153	17154	,	0	None
17154	17155	may	0	None
17155	17156	serve	0	None
17156	17157	as	0	None
17157	17158	a	0	None
17158	17159	target	0	None
17159	17160	for	0	None
17160	17161	the	0	None
17161	17162	action	0	None
17162	17163	of	0	None
17163	17164	cisapride	0	None
17164	17165	.	0	None

17166	17167	We	0	None
17167	17168	tested	0	None
17168	17169	the	0	None
17169	17170	hypothesis	0	None
17170	17171	that	0	None
17171	17172	cisapride	0	None
17172	17173	blocks	0	None
17173	17174	HERG	1	GENE-Y
17174	17175	.	0	None

17176	17177	The	0	None
17177	17178	whole	0	None
17178	17179	cell	0	None
17179	17180	patch-clamp	0	None
17180	17181	recording	0	None
17181	17182	technique	0	None
17182	17183	was	0	None
17183	17184	used	0	None
17184	17185	to	0	None
17185	17186	study	0	None
17186	17187	HERG	1	GENE-Y
17187	17188	channels	0	None
17188	17189	stably	0	None
17189	17190	expressed	0	None
17190	17191	heterologously	0	None
17191	17192	in	0	None
17192	17193	HEK293	0	None
17193	17194	cells	0	None
17194	17195	.	0	None

17196	17197	Under	0	None
17197	17198	voltage-clamp	0	None
17198	17199	conditions	0	None
17199	17200	,	0	None
17200	17201	cisapride	0	None
17201	17202	block	0	None
17202	17203	of	0	None
17203	17204	HERG	1	GENE-Y
17204	17205	is	0	None
17205	17206	dose	0	None
17206	17207	dependent	0	None
17207	17208	with	0	None
17208	17209	a	0	None
17209	17210	half-maximal	0	None
17210	17211	inhibitory	0	None
17211	17212	concentration	0	None
17212	17213	of	0	None
17213	17214	6	0	None
17214	17215	.	0	None
17215	17216	5	0	None
17216	17217	nM	0	None
17217	17218	at	0	None
17218	17219	22	0	None
17219	17220	degrees	0	None
17220	17221	C	0	None
17221	17222	(	0	None
17222	17223	n	0	None
17223	17224	=	0	None
17224	17225	25	0	None
17225	17226	cells	0	None
17226	17227	)	0	None
17227	17228	.	0	None

17229	17230	Currents	0	None
17230	17231	rapidly	0	None
17231	17232	recovered	0	None
17232	17233	with	0	None
17233	17234	drug	0	None
17234	17235	washout	0	None
17235	17236	.	0	None

17237	17238	The	0	None
17238	17239	onset	0	None
17239	17240	of	0	None
17240	17241	block	0	None
17241	17242	by	0	None
17242	17243	cisapride	0	None
17243	17244	required	0	None
17244	17245	channel	0	None
17245	17246	activation	0	None
17246	17247	indicative	0	None
17247	17248	of	0	None
17248	17249	open	0	None
17249	17250	or	0	None
17250	17251	inactivated	0	None
17251	17252	state	0	None
17252	17253	blockage	0	None
17253	17254	.	0	None

17255	17256	Block	0	None
17256	17257	of	0	None
17257	17258	HERG	1	GENE-Y
17258	17259	with	0	None
17259	17260	cisapride	0	None
17260	17261	after	0	None
17261	17262	channel	0	None
17262	17263	activation	0	None
17263	17264	was	0	None
17264	17265	voltage	0	None
17265	17266	dependent	0	None
17266	17267	.	0	None

17268	17269	At	0	None
17269	17270	-20	0	None
17270	17271	mV	0	None
17271	17272	,	0	None
17272	17273	10	0	None
17273	17274	nM	0	None
17274	17275	cisapride	0	None
17275	17276	reduced	0	None
17276	17277	HERG	1	GENE-Y
17277	17278	tail-current	0	None
17278	17279	amplitude	0	None
17279	17280	by	0	None
17280	17281	5%	0	None
17281	17282	,	0	None
17282	17283	whereas	0	None
17283	17284	,	0	None
17284	17285	at	0	None
17285	17286	+	0	None
17286	17287	20	0	None
17287	17288	mV	0	None
17288	17289	,	0	None
17289	17290	the	0	None
17290	17291	tail-current	0	None
17291	17292	amplitude	0	None
17292	17293	was	0	None
17293	17294	reduced	0	None
17294	17295	by	0	None
17295	17296	45%	0	None
17296	17297	(	0	None
17297	17298	n	0	None
17298	17299	=	0	None
17299	17300	4	0	None
17300	17301	cells	0	None
17301	17302	)	0	None
17302	17303	.	0	None

17304	17305	At	0	None
17305	17306	-20	0	None
17306	17307	and	0	None
17307	17308	+	0	None
17308	17309	20	0	None
17309	17310	mV	0	None
17310	17311	,	0	None
17311	17312	100	0	None
17312	17313	nM	0	None
17313	17314	cisapride	0	None
17314	17315	reduced	0	None
17315	17316	tail-current	0	None
17316	17317	amplitude	0	None
17317	17318	by	0	None
17318	17319	66	0	None
17319	17320	and	0	None
17320	17321	90%	0	None
17321	17322	,	0	None
17322	17323	respectively	0	None
17323	17324	.	0	None

17325	17326	We	0	None
17326	17327	conclude	0	None
17327	17328	that	0	None
17328	17329	cisapride	0	None
17329	17330	is	0	None
17330	17331	a	0	None
17331	17332	potent	0	None
17332	17333	blocker	0	None
17333	17334	of	0	None
17334	17335	HERG	1	GENE-Y
17335	17336	channels	0	None
17336	17337	expressed	0	None
17337	17338	in	0	None
17338	17339	HEK293	0	None
17339	17340	cells	0	None
17340	17341	.	0	None

17342	17343	This	0	None
17343	17344	effect	0	None
17344	17345	may	0	None
17345	17346	account	0	None
17346	17347	for	0	None
17347	17348	the	0	None
17348	17349	clinical	0	None
17349	17350	occurrence	0	None
17350	17351	of	0	None
17351	17352	Q-T	0	None
17352	17353	prolongation	0	None
17353	17354	and	0	None
17354	17355	ventricular	0	None
17355	17356	arrhythmias	0	None
17356	17357	observed	0	None
17357	17358	with	0	None
17358	17359	cisapride	0	None
17359	17360	.	0	None
17360	17361	Dominant	0	None
17361	17362	expression	0	None
17362	17363	of	0	None
17363	17364	mRNA	0	None
17364	17365	for	0	None
17365	17366	prostaglandin	0	None
17366	17367	D	0	None
17367	17368	synthase	0	None
17368	17369	in	0	None
17369	17370	leptomeninges	0	None
17370	17371	,	0	None
17371	17372	choroid	0	None
17372	17373	plexus	0	None
17373	17374	,	0	None
17374	17375	and	0	None
17375	17376	oligodendrocytes	0	None
17376	17377	of	0	None
17377	17378	the	0	None
17378	17379	adult	0	None
17379	17380	rat	0	None
17380	17381	brain	0	None
17381	17382	.	0	None
17382	17383	Differential	0	None
17383	17384	regulation	0	None
17384	17385	of	0	None
17385	17386	T-cell	0	None
17386	17387	growth	0	None
17387	17388	by	0	None
17388	17389	IL-2	0	None
17389	17390	and	0	None
17390	17391	IL-15	0	None
17391	17392	.	0	None
17392	17393	Involvement	0	None
17393	17394	of	0	None
17394	17395	UDP-glucuronosyltransferases	0	None
17395	17396	UGT1A9	0	None
17396	17397	and	0	None
17397	17398	UGT2B7	0	None
17398	17399	in	0	None
17399	17400	ethanol	2	CHEMICAL
17400	17401	glucuronidation	0	None
17401	17402	,	0	None
17402	17403	and	0	None
17403	17404	interactions	0	None
17404	17405	with	0	None
17405	17406	common	0	None
17406	17407	drugs	0	None
17407	17408	of	0	None
17408	17409	abuse	0	None
17409	17410	.	0	None
17410	17411	Nonsteroidal	0	None
17411	17412	anti-inflammatory	0	None
17412	17413	agents	0	None
17413	17414	differ	0	None
17414	17415	in	0	None
17415	17416	their	0	None
17416	17417	ability	0	None
17417	17418	to	0	None
17418	17419	suppress	0	None
17419	17420	NF-kappaB	3	GENE-N
17420	17421	activation	0	None
17421	17422	,	0	None
17422	17423	inhibition	0	None
17423	17424	of	0	None
17424	17425	expression	0	None
17425	17426	of	0	None
17426	17427	cyclooxygenase-2	0	None
17427	17428	and	0	None
17428	17430	cyclin D1	1	GENE-Y
17430	17431	,	0	None
17431	17432	and	0	None
17432	17433	abrogation	0	None
17433	17434	of	0	None
17434	17435	tumor	0	None
17435	17436	cell	0	None
17436	17437	proliferation	0	None
17437	17438	.	0	None
17438	17439	Minireview	0	None
17439	17440	:	0	None
17440	17441	the	0	None
17441	17442	AMP-activated	0	None
17442	17443	protein	0	None
17443	17444	kinase	0	None
17444	17445	cascade	0	None
17445	17446	:	0	None
17446	17447	the	0	None
17447	17448	key	0	None
17448	17449	sensor	0	None
17449	17450	of	0	None
17450	17451	cellular	0	None
17451	17452	energy	0	None
17452	17453	status	0	None
17453	17454	.	0	None
17454	17455	Vitamin	0	None
17455	17456	B-6	0	None
17456	17457	deficiency	0	None
17457	17458	suppresses	0	None
17458	17459	the	0	None
17459	17460	hepatic	0	None
17460	17461	transsulfuration	0	None
17461	17462	pathway	0	None
17462	17463	but	0	None
17463	17464	increases	0	None
17464	17465	glutathione	0	None
17465	17466	concentration	0	None
17466	17467	in	0	None
17467	17468	rats	0	None
17468	17469	fed	0	None
17469	17470	AIN-76A	0	None
17470	17471	or	0	None
17471	17472	AIN-93G	0	None
17472	17473	diets	0	None
17473	17474	.	0	None
17474	17475	Perfluorooctanoic	0	None
17475	17476	acid	0	None
17476	17477	(	0	None
17477	17478	PFOA	0	None
17478	17479	)	0	None
17479	17480	is	0	None
17480	17481	in	0	None
17481	17482	use	0	None
17482	17483	for	0	None
17483	17484	the	0	None
17484	17485	production	0	None
17485	17486	of	0	None
17486	17487	fluoropolymers	2	CHEMICAL
17487	17488	(	0	None
17488	17489	PFT	0	None
17489	17490	)	0	None
17490	17491	.	0	None

17492	17493	Due	0	None
17493	17494	to	0	None
17494	17495	its	0	None
17495	17496	toxic	0	None
17496	17497	properties	0	None
17497	17498	it	0	None
17498	17499	was	0	None
17499	17500	proposed	0	None
17500	17501	to	0	None
17501	17502	replace	0	None
17502	17503	the	0	None
17503	17504	substance	0	None
17504	17505	in	0	None
17505	17506	its	0	None
17506	17507	industrial	0	None
17507	17508	applications	0	None
17508	17509	by	0	None
17509	17510	homologous	0	None
17510	17511	compounds	0	None
17511	17512	with	0	None
17512	17513	shorter	0	None
17513	17514	carbon	2	CHEMICAL
17514	17515	chain	0	None
17515	17516	length	0	None
17516	17517	that	0	None
17517	17518	were	0	None
17518	17519	supposed	0	None
17519	17520	to	0	None
17520	17521	be	0	None
17521	17522	less	0	None
17522	17523	toxic	0	None
17523	17524	compared	0	None
17524	17525	to	0	None
17525	17526	PFOA	0	None
17526	17527	,	0	None
17527	17528	however	0	None
17528	17529	,	0	None
17529	17530	the	0	None
17530	17531	smaller	0	None
17531	17532	PFOA	0	None
17532	17533	homologs	0	None
17533	17534	are	0	None
17534	17535	poorly	0	None
17535	17536	characterized	0	None
17536	17537	so	0	None
17537	17538	far	0	None
17538	17539	.	0	None

17540	17541	In	0	None
17541	17542	this	0	None
17542	17543	study	0	None
17543	17544	we	0	None
17544	17545	have	0	None
17545	17546	conducted	0	None
17546	17547	a	0	None
17547	17548	comparative	0	None
17548	17549	analysis	0	None
17549	17550	of	0	None
17550	17551	the	0	None
17551	17552	toxicity	0	None
17552	17553	of	0	None
17553	17554	perfluorinated	0	None
17554	17555	carboxylic	2	CHEMICAL
17555	17556	acids	0	None
17556	17557	(	0	None
17557	17558	PFCA	0	None
17558	17559	)	0	None
17559	17560	with	0	None
17560	17561	a	0	None
17561	17562	carbon	2	CHEMICAL
17562	17563	chain	0	None
17563	17564	length	0	None
17564	17565	ranging	0	None
17565	17566	from	0	None
17566	17567	four	0	None
17567	17568	to	0	None
17568	17569	twelve	0	None
17569	17570	carbon	2	CHEMICAL
17570	17571	atoms	0	None
17571	17572	.	0	None

17573	17574	By	0	None
17574	17575	using	0	None
17575	17576	the	0	None
17576	17577	human	0	None
17577	17578	hepatocarcinoma	0	None
17578	17579	cell	0	None
17579	17580	line	0	None
17580	17581	HepG2	0	None
17581	17582	as	0	None
17582	17583	an	0	None
17583	17584	in	0	None
17584	17585	vitro	0	None
17585	17586	model	0	None
17586	17587	for	0	None
17587	17588	human	0	None
17588	17589	hepatocytes	0	None
17589	17590	we	0	None
17590	17591	could	0	None
17591	17592	show	0	None
17592	17593	a	0	None
17593	17594	positive	0	None
17594	17595	correlation	0	None
17595	17596	between	0	None
17596	17597	the	0	None
17597	17598	carbon	2	CHEMICAL
17598	17599	chain	0	None
17599	17600	length	0	None
17600	17601	of	0	None
17601	17602	the	0	None
17602	17603	respective	0	None
17603	17604	PFCA	0	None
17604	17605	and	0	None
17605	17606	its	0	None
17606	17607	cytotoxicity	0	None
17607	17608	.	0	None

17609	17610	There	0	None
17610	17611	was	0	None
17611	17612	,	0	None
17612	17613	however	0	None
17613	17614	,	0	None
17614	17615	no	0	None
17615	17616	indication	0	None
17616	17617	of	0	None
17617	17618	an	0	None
17618	17619	apoptotic	0	None
17619	17620	mechanism	0	None
17620	17621	for	0	None
17621	17622	cytotoxicity	0	None
17622	17623	.	0	None

17624	17625	All	0	None
17625	17626	PFCA	0	None
17626	17627	under	0	None
17627	17628	investigation	0	None
17628	17629	were	0	None
17629	17630	negative	0	None
17630	17631	in	0	None
17631	17632	two	0	None
17632	17633	independent	0	None
17633	17634	genotoxicity	0	None
17634	17635	assays	0	None
17635	17636	.	0	None

17637	17638	As	0	None
17638	17639	PFOA	0	None
17639	17640	,	0	None
17640	17641	being	0	None
17641	17642	a	0	None
17642	17643	well-known	0	None
17643	17644	peroxisome	0	None
17644	17645	proliferator	0	None
17645	17646	,	0	None
17646	17647	the	0	None
17647	17648	other	0	None
17648	17649	PFCA	0	None
17649	17650	tested	0	None
17650	17651	in	0	None
17651	17652	this	0	None
17652	17653	study	0	None
17653	17654	were	0	None
17654	17655	also	0	None
17655	17656	shown	0	None
17656	17657	to	0	None
17657	17658	activate	0	None
17658	17659	human	0	None
17659	17663	peroxisome proliferator-activated receptor alpha	1	GENE-Y
17663	17664	(	0	None
17664	17665	PPARα	0	None
17665	17666	)	0	None
17666	17667	with	0	None
17667	17668	PFOA	0	None
17668	17669	having	0	None
17669	17670	the	0	None
17670	17671	highest	0	None
17671	17672	potential	0	None
17672	17673	of	0	None
17673	17674	PPARα	0	None
17674	17675	activation	0	None
17675	17676	.	0	None

17677	17678	Moreover	0	None
17678	17679	,	0	None
17679	17680	the	0	None
17680	17681	compounds	0	None
17681	17682	showed	0	None
17682	17683	weak	0	None
17683	17684	potential	0	None
17684	17685	to	0	None
17685	17686	activate	0	None
17686	17687	PPARγ	0	None
17687	17688	and	0	None
17688	17689	hardly	0	None
17689	17690	activated	0	None
17690	17691	PPARδ	0	None
17691	17692	.	0	None

17693	17694	Taken	0	None
17694	17695	together	0	None
17695	17696	,	0	None
17696	17697	the	0	None
17697	17698	in	0	None
17698	17699	vitro	0	None
17699	17700	study	0	None
17700	17701	revealed	0	None
17701	17702	that	0	None
17702	17703	PFCA	0	None
17703	17704	with	0	None
17704	17705	a	0	None
17705	17706	shorter	0	None
17706	17707	carbon	2	CHEMICAL
17707	17708	chain	0	None
17708	17709	length	0	None
17709	17710	seem	0	None
17710	17711	to	0	None
17711	17712	be	0	None
17712	17713	less	0	None
17713	17714	toxic	0	None
17714	17715	than	0	None
17715	17716	PFOA	0	None
17716	17717	.	0	None
17717	17718	Lithium	0	None
17718	17719	modulates	0	None
17719	17720	desensitization	0	None
17720	17721	of	0	None
17721	17722	the	0	None
17722	17724	glutamate receptor	3	GENE-N
17724	17725	subtype	0	None
17725	17726	gluR3	0	None
17726	17727	in	0	None
17727	17728	Xenopus	0	None
17728	17729	oocytes	0	None
17729	17730	.	0	None
17730	17731	In	0	None
17731	17732	response	0	None
17732	17733	to	0	None
17733	17734	intense	0	None
17734	17735	stress	0	None
17735	17736	,	0	None
17736	17737	the	0	None
17737	17738	tumor	0	None
17738	17739	protein	0	None
17739	17740	p53	0	None
17740	17741	(	0	None
17741	17742	p53	0	None
17742	17743	)	0	None
17743	17744	tumor	0	None
17744	17745	suppressor	0	None
17745	17746	rapidly	0	None
17746	17747	mounts	0	None
17747	17748	a	0	None
17748	17749	direct	0	None
17749	17750	mitochondrial	0	None
17750	17751	death	0	None
17751	17752	program	0	None
17752	17753	that	0	None
17753	17754	precedes	0	None
17754	17755	transcription-mediated	0	None
17755	17756	apoptosis	0	None
17756	17757	.	0	None

17758	17759	By	0	None
17759	17760	eliminating	0	None
17760	17761	severely	0	None
17761	17762	damaged	0	None
17762	17763	cells	0	None
17763	17764	,	0	None
17764	17765	this	0	None
17765	17766	pathway	0	None
17766	17767	contributes	0	None
17767	17768	to	0	None
17768	17769	tumor	0	None
17769	17770	suppression	0	None
17770	17771	as	0	None
17771	17772	well	0	None
17772	17773	as	0	None
17773	17774	to	0	None
17774	17775	cancer	0	None
17775	17776	cell	0	None
17776	17777	killing	0	None
17777	17778	induced	0	None
17778	17779	by	0	None
17779	17780	both	0	None
17780	17781	genotoxic	0	None
17781	17782	drugs	0	None
17782	17783	and	0	None
17783	17784	non-genotoxic	0	None
17784	17785	p53-reactivating	0	None
17785	17786	molecules	0	None
17786	17787	.	0	None

17788	17789	Here	0	None
17789	17790	we	0	None
17790	17791	have	0	None
17791	17792	explored	0	None
17792	17793	the	0	None
17793	17794	role	0	None
17794	17795	had	0	None
17795	17796	in	0	None
17796	17797	this	0	None
17797	17798	pathway	0	None
17798	17799	by	0	None
17799	17800	the	0	None
17800	17801	prolyl-isomerase	0	None
17801	17802	Pin1	0	None
17802	17803	(	0	None
17803	17804	peptidylprolyl	0	None
17804	17805	cis	0	None
17805	17806	/	0	None
17806	17807	trans	0	None
17807	17808	isomerase	0	None
17808	17809	,	0	None
17809	17810	NIMA-interacting	0	None
17810	17811	1	0	None
17811	17812	)	0	None
17812	17813	,	0	None
17813	17814	a	0	None
17814	17815	crucial	0	None
17815	17816	transducer	0	None
17816	17817	of	0	None
17817	17818	p53's	0	None
17818	17819	phosphorylation	0	None
17819	17820	into	0	None
17820	17821	conformational	0	None
17821	17822	changes	0	None
17822	17823	unleashing	0	None
17823	17824	its	0	None
17824	17825	pro-apoptotic	0	None
17825	17826	activity	0	None
17826	17827	.	0	None

17828	17829	We	0	None
17829	17830	show	0	None
17830	17831	that	0	None
17831	17832	Pin1	0	None
17832	17833	promotes	0	None
17833	17834	stress-induced	0	None
17834	17835	localization	0	None
17835	17836	of	0	None
17836	17837	p53	0	None
17837	17838	to	0	None
17838	17839	mitochondria	0	None
17839	17840	both	0	None
17840	17841	in	0	None
17841	17842	vitro	0	None
17842	17843	and	0	None
17843	17844	in	0	None
17844	17845	vivo	0	None
17845	17846	.	0	None

17847	17848	In	0	None
17848	17849	particular	0	None
17849	17850	,	0	None
17850	17851	we	0	None
17851	17852	demonstrate	0	None
17852	17853	that	0	None
17853	17854	upon	0	None
17854	17855	stress-induced	0	None
17855	17856	phosphorylation	0	None
17856	17857	of	0	None
17857	17858	p53	0	None
17858	17859	on	0	None
17859	17860	Ser46	0	None
17860	17861	by	0	None
17861	17866	homeodomain interacting protein kinase 2	1	GENE-Y
17866	17867	,	0	None
17867	17868	Pin1	0	None
17868	17869	stimulates	0	None
17869	17870	its	0	None
17870	17871	mitochondrial	0	None
17871	17872	trafficking	0	None
17872	17873	signal	0	None
17873	17874	,	0	None
17874	17875	that	0	None
17875	17876	is	0	None
17876	17877	,	0	None
17877	17878	monoubiquitination	0	None
17878	17879	.	0	None

17880	17881	This	0	None
17881	17882	pathway	0	None
17882	17883	is	0	None
17883	17884	induced	0	None
17884	17885	also	0	None
17885	17886	by	0	None
17886	17887	the	0	None
17887	17888	p53-activating	0	None
17888	17889	molecule	0	None
17889	17890	RITA	0	None
17890	17891	,	0	None
17891	17892	and	0	None
17892	17893	we	0	None
17893	17894	demonstrate	0	None
17894	17895	the	0	None
17895	17896	strong	0	None
17896	17897	requirement	0	None
17897	17898	of	0	None
17898	17899	Pin1	0	None
17899	17900	for	0	None
17900	17901	the	0	None
17901	17902	induction	0	None
17902	17903	of	0	None
17903	17904	mitochondrial	0	None
17904	17905	apoptosis	0	None
17905	17906	by	0	None
17906	17907	this	0	None
17907	17908	compound	0	None
17908	17909	.	0	None

17910	17911	These	0	None
17911	17912	findings	0	None
17912	17913	have	0	None
17913	17914	significant	0	None
17914	17915	implications	0	None
17915	17916	for	0	None
17916	17917	treatment	0	None
17917	17918	of	0	None
17918	17919	p53-expressing	0	None
17919	17920	tumors	0	None
17920	17921	and	0	None
17921	17922	for	0	None
17922	17923	prospective	0	None
17923	17924	use	0	None
17924	17925	of	0	None
17925	17926	p53-activating	0	None
17926	17927	compounds	0	None
17927	17928	in	0	None
17928	17929	clinics	0	None
17929	17930	.	0	None
17930	17931	Bupropion	0	None
17931	17932	occupancy	0	None
17932	17933	of	0	None
17933	17934	the	0	None
17934	17935	dopamine	0	None
17935	17936	transporter	0	None
17936	17937	is	0	None
17937	17938	low	0	None
17938	17939	during	0	None
17939	17940	clinical	0	None
17940	17941	treatment	0	None
17941	17942	.	0	None
17942	17943	Over	0	None
17943	17944	the	0	None
17944	17945	past	0	None
17945	17946	20	0	None
17946	17947	years	0	None
17947	17948	,	0	None
17948	17949	studies	0	None
17949	17950	of	0	None
17950	17952	transient receptor	3	GENE-N
17952	17953	potential	0	None
17953	17954	(	0	None
17954	17955	TRP	0	None
17955	17956	)	0	None
17956	17957	channels	0	None
17957	17958	have	0	None
17958	17959	significantly	0	None
17959	17960	extended	0	None
17960	17961	our	0	None
17961	17962	knowledge	0	None
17962	17963	regarding	0	None
17963	17964	the	0	None
17964	17965	molecular	0	None
17965	17966	basis	0	None
17966	17967	of	0	None
17967	17968	Ca2	0	None
17968	17969	+	0	None
17969	17970	signals	0	None
17970	17971	in	0	None
17971	17972	cardiac	0	None
17972	17973	myocytes	0	None
17973	17974	.	0	None

17975	17976	The	0	None
17976	17977	functional	0	None
17977	17978	significance	0	None
17978	17979	of	0	None
17979	17980	cardiac	0	None
17980	17981	TRP	0	None
17981	17982	channels	0	None
17982	17983	is	0	None
17983	17984	likely	0	None
17984	17985	connected	0	None
17985	17986	to	0	None
17986	17987	the	0	None
17987	17988	alteration	0	None
17988	17989	of	0	None
17989	17990	membrane	0	None
17990	17991	potential	0	None
17991	17992	or	0	None
17992	17993	Ca2	0	None
17993	17994	+	0	None
17994	17995	entry	0	None
17995	17996	into	0	None
17996	17997	a	0	None
17997	17998	noncontractile	0	None
17998	17999	compartment	0	None
17999	18000	,	0	None
18000	18001	where	0	None
18001	18002	gene	0	None
18002	18003	expression	0	None
18003	18004	responsible	0	None
18004	18005	for	0	None
18005	18006	various	0	None
18006	18007	cardiac	0	None
18007	18008	diseases	0	None
18008	18009	is	0	None
18009	18010	induced	0	None
18010	18011	.	0	None

18012	18013	This	0	None
18013	18014	review	0	None
18014	18015	highlights	0	None
18015	18016	some	0	None
18016	18017	aspects	0	None
18017	18018	of	0	None
18018	18019	TRP	0	None
18019	18020	channels	0	None
18020	18021	with	0	None
18021	18022	anticipated	0	None
18022	18023	roles	0	None
18023	18024	in	0	None
18024	18025	cardiac	0	None
18025	18026	disease	0	None
18026	18027	.	0	None

18028	18029	Evidence	0	None
18029	18030	suggests	0	None
18030	18031	that	0	None
18031	18032	(	0	None
18032	18033	a	0	None
18033	18034	)	0	None
18034	18035	increased	0	None
18035	18036	activities	0	None
18036	18037	of	0	None
18037	18038	TRPC1	0	None
18038	18039	,	0	None
18039	18040	TRPC3	0	None
18040	18041	,	0	None
18041	18042	or	0	None
18042	18043	TRPC6	1	GENE-Y
18043	18044	are	0	None
18044	18045	involved	0	None
18045	18046	in	0	None
18046	18047	the	0	None
18047	18048	development	0	None
18048	18049	of	0	None
18049	18050	cardiac	0	None
18050	18051	hypertrophy	0	None
18051	18052	,	0	None
18052	18053	where	0	None
18053	18054	these	0	None
18054	18055	TRPC	0	None
18055	18056	channels	0	None
18056	18057	act	0	None
18057	18058	as	0	None
18058	18059	unique	0	None
18059	18060	sensors	0	None
18060	18061	for	0	None
18061	18062	a	0	None
18062	18063	wide	0	None
18063	18064	range	0	None
18064	18065	of	0	None
18065	18066	hypertrophic	0	None
18066	18067	stimuli	0	None
18067	18068	,	0	None
18068	18069	and	0	None
18069	18070	(	0	None
18070	18071	b	0	None
18071	18072	)	0	None
18072	18073	mutations	0	None
18073	18074	in	0	None
18074	18075	TRPM4	1	GENE-Y
18075	18076	are	0	None
18076	18077	now	0	None
18077	18078	recognized	0	None
18078	18079	as	0	None
18079	18080	causes	0	None
18080	18081	of	0	None
18081	18082	human	0	None
18082	18083	cardiac	0	None
18083	18084	conduction	0	None
18084	18085	disorders	0	None
18085	18086	.	0	None

18087	18088	Ultimately	0	None
18088	18089	,	0	None
18089	18090	TRP	0	None
18090	18091	channels	0	None
18091	18092	may	0	None
18092	18093	become	0	None
18093	18094	novel	0	None
18094	18095	pharmacological	0	None
18095	18096	targets	0	None
18096	18097	in	0	None
18097	18098	the	0	None
18098	18099	treatment	0	None
18099	18100	of	0	None
18100	18101	human	0	None
18101	18102	cardiac	0	None
18102	18103	disease	0	None
18103	18104	.	0	None
18104	18105	Study	0	None
18105	18106	on	0	None
18106	18107	medicinal	0	None
18107	18108	chemistry	0	None
18108	18109	of	0	None
18109	18110	k203	0	None
18110	18111	in	0	None
18111	18112	wistar	0	None
18112	18113	rats	0	None
18113	18114	and	0	None
18114	18115	beagle	0	None
18115	18116	dogs	0	None
18116	18117	.	0	None
18117	18118	The	0	None
18118	18119	voltage-dependent	0	None
18119	18120	M-type	0	None
18120	18121	potassium	0	None
18121	18122	current	0	None
18122	18123	(	0	None
18123	18124	M-current	0	None
18124	18125	)	0	None
18125	18126	plays	0	None
18126	18127	a	0	None
18127	18128	major	0	None
18128	18129	role	0	None
18129	18130	in	0	None
18130	18131	controlling	0	None
18131	18132	brain	0	None
18132	18133	excitability	0	None
18133	18134	by	0	None
18134	18135	stabilizing	0	None
18135	18136	the	0	None
18136	18137	membrane	0	None
18137	18138	potential	0	None
18138	18139	and	0	None
18139	18140	acting	0	None
18140	18141	as	0	None
18141	18142	a	0	None
18142	18143	brake	0	None
18143	18144	for	0	None
18144	18145	neuronal	0	None
18145	18146	firing	0	None
18146	18147	.	0	None

18148	18149	The	0	None
18149	18150	KCNQ2	0	None
18150	18151	/	0	None
18151	18152	Q3	0	None
18152	18153	heteromeric	0	None
18153	18154	channel	0	None
18154	18155	complex	0	None
18155	18156	was	0	None
18156	18157	identified	0	None
18157	18158	as	0	None
18158	18159	the	0	None
18159	18160	molecular	0	None
18160	18161	correlate	0	None
18161	18162	of	0	None
18162	18163	the	0	None
18163	18164	M-current	0	None
18164	18165	.	0	None

18166	18167	Furthermore	0	None
18167	18168	,	0	None
18168	18169	the	0	None
18169	18170	KCNQ2	0	None
18170	18171	and	0	None
18171	18172	KCNQ3	0	None
18172	18173	channel	0	None
18173	18174	alpha	0	None
18174	18175	subunits	0	None
18175	18176	are	0	None
18176	18177	mutated	0	None
18177	18178	in	0	None
18178	18179	families	0	None
18179	18180	with	0	None
18180	18181	benign	0	None
18181	18182	familial	0	None
18182	18183	neonatal	0	None
18183	18184	convulsions	0	None
18184	18185	,	0	None
18185	18186	a	0	None
18186	18187	neonatal	0	None
18187	18188	form	0	None
18188	18189	of	0	None
18189	18190	epilepsy	0	None
18190	18191	.	0	None

18192	18193	Enhancement	0	None
18193	18194	of	0	None
18194	18195	KCNQ2	0	None
18195	18196	/	0	None
18196	18197	Q3	0	None
18197	18198	potassium	0	None
18198	18199	currents	0	None
18199	18200	may	0	None
18200	18201	provide	0	None
18201	18202	an	0	None
18202	18203	important	0	None
18203	18204	target	0	None
18204	18205	for	0	None
18205	18206	antiepileptic	0	None
18206	18207	drug	0	None
18207	18208	development	0	None
18208	18209	.	0	None

18210	18211	Here	0	None
18211	18212	,	0	None
18212	18213	we	0	None
18213	18214	show	0	None
18214	18215	that	0	None
18215	18217	meclofenamic acid	2	CHEMICAL
18217	18218	(	0	None
18218	18219	meclofenamate	2	CHEMICAL
18219	18220	)	0	None
18220	18221	and	0	None
18221	18222	diclofenac	0	None
18222	18223	,	0	None
18223	18224	two	0	None
18224	18225	related	0	None
18225	18226	molecules	0	None
18226	18227	previously	0	None
18227	18228	used	0	None
18228	18229	as	0	None
18229	18230	anti-inflammatory	0	None
18230	18231	drugs	0	None
18231	18232	,	0	None
18232	18233	act	0	None
18233	18234	as	0	None
18234	18235	novel	0	None
18235	18236	KCNQ2	0	None
18236	18237	/	0	None
18237	18238	Q3	0	None
18238	18239	channel	0	None
18239	18240	openers	0	None
18240	18241	.	0	None

18242	18243	Extracellular	0	None
18243	18244	application	0	None
18244	18245	of	0	None
18245	18246	meclofenamate	2	CHEMICAL
18246	18247	(	0	None
18247	18248	EC	0	None
18248	18249	(	0	None
18249	18250	50	0	None
18250	18251	)	0	None
18251	18252	=	0	None
18252	18253	25	0	None
18253	18254	microM	0	None
18254	18255	)	0	None
18255	18256	and	0	None
18256	18257	diclofenac	0	None
18257	18258	(	0	None
18258	18259	EC	0	None
18259	18260	(	0	None
18260	18261	50	0	None
18261	18262	)	0	None
18262	18263	=	0	None
18263	18264	2	0	None
18264	18265	.	0	None
18265	18266	6	0	None
18266	18267	microM	0	None
18267	18268	)	0	None
18268	18269	resulted	0	None
18269	18270	in	0	None
18270	18271	the	0	None
18271	18272	activation	0	None
18272	18273	of	0	None
18273	18274	KCNQ2	0	None
18274	18275	/	0	None
18275	18276	Q3	0	None
18276	18277	K	0	None
18277	18278	(	0	None
18278	18279	+	0	None
18279	18280	)	0	None
18280	18281	currents	0	None
18281	18282	,	0	None
18282	18283	heterologously	0	None
18283	18284	expressed	0	None
18284	18285	in	0	None
18285	18286	Chinese	0	None
18286	18287	hamster	0	None
18287	18288	ovary	0	None
18288	18289	cells	0	None
18289	18290	.	0	None

18291	18292	Both	0	None
18292	18293	openers	0	None
18293	18294	activated	0	None
18294	18295	KCNQ2	0	None
18295	18296	/	0	None
18296	18297	Q3	0	None
18297	18298	channels	0	None
18298	18299	by	0	None
18299	18300	causing	0	None
18300	18301	a	0	None
18301	18302	hyperpolarizing	0	None
18302	18303	shift	0	None
18303	18304	of	0	None
18304	18305	the	0	None
18305	18306	voltage	0	None
18306	18307	activation	0	None
18307	18308	curve	0	None
18308	18309	(	0	None
18309	18310	-23	0	None
18310	18311	and	0	None
18311	18312	-15	0	None
18312	18313	mV	0	None
18313	18314	,	0	None
18314	18315	respectively	0	None
18315	18316	)	0	None
18316	18317	and	0	None
18317	18318	by	0	None
18318	18319	markedly	0	None
18319	18320	slowing	0	None
18320	18321	the	0	None
18321	18322	deactivation	0	None
18322	18323	kinetics	0	None
18323	18324	.	0	None

18325	18326	The	0	None
18326	18327	effects	0	None
18327	18328	of	0	None
18328	18329	the	0	None
18329	18330	drugs	0	None
18330	18331	were	0	None
18331	18332	stronger	0	None
18332	18333	on	0	None
18333	18334	KCNQ2	0	None
18334	18335	than	0	None
18335	18336	on	0	None
18336	18337	KCNQ3	0	None
18337	18338	channel	0	None
18338	18339	alpha	0	None
18339	18340	subunits	0	None
18340	18341	.	0	None

18342	18343	In	0	None
18343	18344	contrast	0	None
18344	18345	,	0	None
18345	18346	they	0	None
18346	18347	did	0	None
18347	18348	not	0	None
18348	18349	enhance	0	None
18349	18350	KCNQ1	1	GENE-Y
18350	18351	K	0	None
18351	18352	(	0	None
18352	18353	+	0	None
18353	18354	)	0	None
18354	18355	currents	0	None
18355	18356	.	0	None

18357	18358	Both	0	None
18358	18359	openers	0	None
18359	18360	increased	0	None
18360	18361	KCNQ2	0	None
18361	18362	/	0	None
18362	18363	Q3	0	None
18363	18364	current	0	None
18364	18365	amplitude	0	None
18365	18366	at	0	None
18366	18367	physiologically	0	None
18367	18368	relevant	0	None
18368	18369	potentials	0	None
18369	18370	and	0	None
18370	18371	led	0	None
18371	18372	to	0	None
18372	18373	hyperpolarization	0	None
18373	18374	of	0	None
18374	18375	the	0	None
18375	18376	resting	0	None
18376	18377	membrane	0	None
18377	18378	potential	0	None
18378	18379	.	0	None

18380	18381	In	0	None
18381	18382	cultured	0	None
18382	18383	cortical	0	None
18383	18384	neurons	0	None
18384	18385	,	0	None
18385	18386	meclofenamate	2	CHEMICAL
18386	18387	and	0	None
18387	18388	diclofenac	0	None
18388	18389	enhanced	0	None
18389	18390	the	0	None
18390	18391	M-current	0	None
18391	18392	and	0	None
18392	18393	reduced	0	None
18393	18394	evoked	0	None
18394	18395	and	0	None
18395	18396	spontaneous	0	None
18396	18397	action	0	None
18397	18398	potentials	0	None
18398	18399	,	0	None
18399	18400	whereas	0	None
18400	18401	in	0	None
18401	18402	vivo	0	None
18402	18403	diclofenac	0	None
18403	18404	exhibited	0	None
18404	18405	an	0	None
18405	18406	anticonvulsant	0	None
18406	18407	activity	0	None
18407	18408	(	0	None
18408	18409	ED	0	None
18409	18410	(	0	None
18410	18411	50	0	None
18411	18412	)	0	None
18412	18413	=	0	None
18413	18414	43	0	None
18414	18415	mg	2	CHEMICAL
18415	18416	/	0	None
18416	18417	kg	0	None
18417	18418	)	0	None
18418	18419	.	0	None

18420	18421	These	0	None
18421	18422	compounds	0	None
18422	18423	potentially	0	None
18423	18424	constitute	0	None
18424	18425	novel	0	None
18425	18426	drug	0	None
18426	18427	templates	0	None
18427	18428	for	0	None
18428	18429	the	0	None
18429	18430	treatment	0	None
18430	18431	of	0	None
18431	18432	neuronal	0	None
18432	18433	hyperexcitability	0	None
18433	18434	including	0	None
18434	18435	epilepsy	0	None
18435	18436	,	0	None
18436	18437	migraine	0	None
18437	18438	,	0	None
18438	18439	or	0	None
18439	18440	neuropathic	0	None
18440	18441	pain	0	None
18441	18442	.	0	None
18442	18443	The	0	None
18443	18444	pharmacological	0	None
18444	18445	treatment	0	None
18445	18446	of	0	None
18446	18447	obesity	0	None
18447	18448	should	0	None
18448	18449	be	0	None
18449	18450	considered	0	None
18450	18451	when	0	None
18451	18452	cannot	0	None
18452	18453	be	0	None
18453	18454	achieved	0	None
18454	18455	a	0	None
18455	18456	10%	0	None
18456	18457	weight	0	None
18457	18458	loss	0	None
18458	18459	with	0	None
18459	18460	diet	0	None
18460	18461	therapy	0	None
18461	18462	and	0	None
18462	18463	physical	0	None
18463	18464	activity	0	None
18464	18465	.	0	None

18466	18467	The	0	None
18467	18468	drugs	0	None
18468	18469	effective	0	None
18469	18470	in	0	None
18470	18471	obesity	0	None
18471	18472	treatment	0	None
18472	18473	may	0	None
18473	18474	act	0	None
18474	18475	by	0	None
18475	18476	different	0	None
18476	18477	mechanisms	0	None
18477	18478	such	0	None
18478	18479	as	0	None
18479	18480	reduction	0	None
18480	18481	in	0	None
18481	18482	food	0	None
18482	18483	intake	0	None
18483	18484	,	0	None
18484	18485	inhibition	0	None
18485	18486	of	0	None
18486	18487	fat	0	None
18487	18488	absorption	0	None
18488	18489	,	0	None
18489	18490	increase	0	None
18490	18491	of	0	None
18491	18492	thermogenesis	0	None
18492	18493	and	0	None
18493	18494	stimulation	0	None
18494	18495	of	0	None
18495	18496	adipocyte	0	None
18496	18497	apoptosis	0	None
18497	18498	.	0	None

18499	18500	At	0	None
18500	18501	present	0	None
18501	18502	,	0	None
18502	18503	we	0	None
18503	18504	only	0	None
18504	18505	have	0	None
18505	18506	two	0	None
18506	18507	marketed	0	None
18507	18508	drugs	0	None
18508	18509	for	0	None
18509	18510	obesity	0	None
18510	18511	treatment	0	None
18511	18512	.	0	None

18513	18514	Sibutramine	0	None
18514	18515	is	0	None
18515	18516	an	0	None
18516	18517	inhibitor	0	None
18517	18518	of	0	None
18518	18519	norepinephrine	2	CHEMICAL
18519	18520	,	0	None
18520	18521	dopamine	0	None
18521	18522	and	0	None
18522	18523	serotonina	0	None
18523	18524	reuptake	0	None
18524	18525	which	0	None
18525	18526	inhibits	0	None
18526	18527	food	0	None
18527	18528	intake	0	None
18528	18529	and	0	None
18529	18530	increases	0	None
18530	18531	thermogenesis	0	None
18531	18532	.	0	None

18533	18534	Sibutramine	0	None
18534	18535	administration	0	None
18535	18536	for	0	None
18536	18537	a	0	None
18537	18538	year	0	None
18538	18539	can	0	None
18539	18540	induce	0	None
18540	18541	a	0	None
18541	18542	weight	0	None
18542	18543	loss	0	None
18543	18544	of	0	None
18544	18545	4-7%	0	None
18545	18546	.	0	None

18547	18548	Its	0	None
18548	18549	main	0	None
18549	18550	side	0	None
18550	18551	effects	0	None
18551	18552	are	0	None
18552	18553	hypertension	0	None
18553	18554	,	0	None
18554	18555	headache	0	None
18555	18556	,	0	None
18556	18557	insomnia	0	None
18557	18558	and	0	None
18558	18559	constipation	0	None
18559	18560	.	0	None

18561	18562	Orlistat	0	None
18562	18563	is	0	None
18563	18564	an	0	None
18564	18565	inhibitor	0	None
18565	18566	of	0	None
18566	18567	pancreatic	0	None
18567	18568	lipase	3	GENE-N
18568	18569	which	0	None
18569	18570	is	0	None
18570	18571	able	0	None
18571	18572	to	0	None
18572	18573	block	0	None
18573	18574	the	0	None
18574	18575	absorption	0	None
18575	18576	of	0	None
18576	18577	30%	0	None
18577	18578	of	0	None
18578	18579	ingested	0	None
18579	18580	fat	0	None
18580	18581	.	0	None

18582	18583	Its	0	None
18583	18584	administration	0	None
18584	18585	induces	0	None
18585	18586	weight	0	None
18586	18587	loss	0	None
18587	18588	and	0	None
18588	18589	reduction	0	None
18589	18590	of	0	None
18590	18591	ulterior	0	None
18591	18592	weight	0	None
18592	18593	regain	0	None
18593	18594	.	0	None

18595	18596	Also	0	None
18596	18597	,	0	None
18597	18598	this	0	None
18598	18599	drug	0	None
18599	18600	improves	0	None
18600	18601	hypertension	0	None
18601	18602	dyslipdaemia	0	None
18602	18603	and	0	None
18603	18604	helps	0	None
18604	18605	to	0	None
18605	18606	prevent	0	None
18606	18607	diabetes	0	None
18607	18608	in	0	None
18608	18609	52%	0	None
18609	18610	of	0	None
18610	18611	cases	0	None
18611	18612	when	0	None
18612	18613	administered	0	None
18613	18614	over	0	None
18614	18615	four	0	None
18615	18616	years	0	None
18616	18617	.	0	None

18618	18619	The	0	None
18619	18620	increase	0	None
18620	18621	in	0	None
18621	18622	frequency	0	None
18622	18623	of	0	None
18623	18624	stools	0	None
18624	18625	and	0	None
18625	18626	interference	0	None
18626	18627	with	0	None
18627	18628	vitamin	0	None
18628	18629	absorption	0	None
18629	18630	are	0	None
18630	18631	its	0	None
18631	18632	main	0	None
18632	18633	side	0	None
18633	18634	effects	0	None
18634	18635	.	0	None

18636	18637	Glucagon-like	0	None
18637	18638	peptide	0	None
18638	18639	1	0	None
18639	18640	,	0	None
18640	18641	which	0	None
18641	18642	increases	0	None
18642	18643	insulin	0	None
18643	18644	sensitivity	0	None
18644	18645	and	0	None
18645	18646	satiety	0	None
18646	18647	,	0	None
18647	18648	adiponectin	1	GENE-Y
18648	18649	and	0	None
18649	18650	PPAR-gamma	0	None
18650	18651	agonists	0	None
18651	18652	which	0	None
18652	18653	reduce	0	None
18653	18654	insulin	0	None
18654	18655	resistance	0	None
18655	18656	and	0	None
18656	18657	modulates	0	None
18657	18658	adipocyte	0	None
18658	18659	generation	0	None
18659	18660	are	0	None
18660	18661	the	0	None
18661	18662	basis	0	None
18662	18663	for	0	None
18663	18664	future	0	None
18664	18665	therapeutic	0	None
18665	18666	approaches	0	None
18666	18667	of	0	None
18667	18668	obesity	0	None
18668	18669	.	0	None

18670	18671	Phosphatase	0	None
18671	18672	inhibitors	0	None
18672	18673	induce	0	None
18673	18674	PPAR-gamma	0	None
18674	18675	phosphorylation	0	None
18675	18676	and	0	None
18676	18677	UCP-1	0	None
18677	18678	expression	0	None
18678	18679	leading	0	None
18679	18680	to	0	None
18680	18681	an	0	None
18681	18682	increase	0	None
18682	18683	in	0	None
18683	18684	thermogenesis	0	None
18684	18685	and	0	None
18685	18686	reduction	0	None
18686	18687	in	0	None
18687	18688	appetite	0	None
18688	18689	.	0	None
18689	18690	In	0	None
18690	18691	the	0	None
18691	18692	present	0	None
18692	18693	study	0	None
18693	18694	,	0	None
18694	18695	our	0	None
18695	18696	aim	0	None
18696	18697	was	0	None
18697	18698	to	0	None
18698	18699	determine	0	None
18699	18700	whether	0	None
18700	18701	intrafetal	0	None
18701	18702	glucose	0	None
18702	18703	infusion	0	None
18703	18704	increases	0	None
18704	18705	fetal	0	None
18705	18706	adiposity	0	None
18706	18707	,	0	None
18707	18708	synthesis	0	None
18708	18709	and	0	None
18709	18710	secretion	0	None
18710	18711	of	0	None
18711	18712	leptin	0	None
18712	18713	and	0	None
18713	18714	regulates	0	None
18714	18715	gene	0	None
18715	18716	expression	0	None
18716	18717	of	0	None
18717	18718	the	0	None
18718	18719	'appetite	0	None
18719	18720	regulatory'	0	None
18720	18721	neuropeptides	0	None
18721	18722	neuropepetide	0	None
18722	18723	Y	0	None
18723	18724	(	0	None
18724	18725	NPY	0	None
18725	18726	)	0	None
18726	18727	,	0	None
18727	18729	agouti-related peptide	1	GENE-Y
18729	18730	(	0	None
18730	18731	AGRP	0	None
18731	18732	)	0	None
18732	18733	,	0	None
18733	18734	pro-opiomelanocortin	0	None
18734	18735	(	0	None
18735	18736	POMC	0	None
18736	18737	)	0	None
18737	18738	and	0	None
18738	18739	cocaine-	0	None
18739	18740	and	0	None
18740	18741	amphetamine-regulated	0	None
18741	18742	transcript	0	None
18742	18743	(	0	None
18743	18744	CART	0	None
18744	18745	)	0	None
18745	18746	and	0	None
18746	18747	receptors	0	None
18747	18748	(	0	None
18748	18750	leptin receptor	1	GENE-Y
18750	18751	(	0	None
18751	18752	OB-Rb	1	GENE-Y
18752	18753	)	0	None
18753	18754	and	0	None
18754	18755	melancortin	0	None
18755	18756	3	0	None
18756	18757	receptor	0	None
18757	18758	(	0	None
18758	18759	MC3R	0	None
18759	18760	)	0	None
18760	18761	)	0	None
18761	18762	within	0	None
18762	18763	the	0	None
18763	18764	fetal	0	None
18764	18765	hypothalamus	0	None
18765	18766	.	0	None

18767	18768	Glucose	0	None
18768	18769	(	0	None
18769	18770	50%	0	None
18770	18771	dextrose	0	None
18771	18772	in	0	None
18772	18773	saline	0	None
18773	18774	)	0	None
18774	18775	or	0	None
18775	18776	saline	0	None
18776	18777	was	0	None
18777	18778	infused	0	None
18778	18779	(	0	None
18779	18780	7	0	None
18780	18781	.	0	None
18781	18782	5	0	None
18782	18783	ml	0	None
18783	18784	h	0	None
18784	18785	(	0	None
18785	18786	-1	0	None
18786	18787	)	0	None
18787	18788	)	0	None
18788	18789	into	0	None
18789	18790	fetal	0	None
18790	18791	sheep	0	None
18791	18792	between	0	None
18792	18793	130	0	None
18793	18794	and	0	None
18794	18795	140	0	None
18795	18796	days	0	None
18796	18797	gestation	0	None
18797	18798	(	0	None
18798	18799	term	0	None
18799	18800	=	0	None
18800	18801	150	0	None
18801	18802	+	0	None
18802	18803	/	0	None
18803	18804	-	0	None
18804	18805	3	0	None
18805	18806	days	0	None
18806	18807	gestation	0	None
18807	18808	)	0	None
18808	18809	.	0	None

18810	18811	Glucose	0	None
18811	18812	infusion	0	None
18812	18813	increased	0	None
18813	18814	circulating	0	None
18814	18815	glucose	0	None
18815	18816	and	0	None
18816	18817	insulin	0	None
18817	18818	concentrations	0	None
18818	18819	,	0	None
18819	18820	mean	0	None
18820	18821	lipid	0	None
18821	18822	locule	0	None
18822	18823	size	0	None
18823	18824	(	0	None
18824	18825	532	0	None
18825	18826	.	0	None
18826	18827	8	0	None
18827	18828	+	0	None
18828	18829	/	0	None
18829	18830	-	0	None
18830	18831	3	0	None
18831	18832	.	0	None
18832	18833	3	0	None
18833	18834	microm2	0	None
18834	18835	versus	0	None
18835	18836	456	0	None
18836	18837	.	0	None
18837	18838	7	0	None
18838	18839	+	0	None
18839	18840	/	0	None
18840	18841	-	0	None
18841	18842	14	0	None
18842	18843	.	0	None
18843	18844	8	0	None
18844	18845	microm2	0	None
18845	18846	)	0	None
18846	18847	and	0	None
18847	18848	total	0	None
18848	18849	unilocular	0	None
18849	18850	fat	0	None
18850	18851	mass	0	None
18851	18852	(	0	None
18852	18853	11	0	None
18853	18854	.	0	None
18854	18855	7	0	None
18855	18856	+	0	None
18856	18857	/	0	None
18857	18858	-	0	None
18858	18859	0	0	None
18859	18860	.	0	None
18860	18861	6	0	None
18861	18862	g	0	None
18862	18863	versus	0	None
18863	18864	8	0	None
18864	18865	.	0	None
18865	18866	9	0	None
18866	18867	+	0	None
18867	18868	/	0	None
18868	18869	-	0	None
18869	18870	0	0	None
18870	18871	.	0	None
18871	18872	6	0	None
18872	18873	g	0	None
18873	18874	)	0	None
18874	18875	of	0	None
18875	18876	the	0	None
18876	18877	perirenal	0	None
18877	18878	fat	0	None
18878	18879	depot	0	None
18879	18880	.	0	None

18881	18882	The	0	None
18882	18883	expression	0	None
18883	18884	of	0	None
18884	18885	OB-Rb	1	GENE-Y
18885	18886	mRNA	0	None
18886	18887	was	0	None
18887	18888	higher	0	None
18888	18889	in	0	None
18889	18890	the	0	None
18890	18891	ventromedial	0	None
18891	18892	nucleus	0	None
18892	18893	compared	0	None
18893	18894	to	0	None
18894	18895	the	0	None
18895	18896	arcuate	0	None
18896	18897	nucleus	0	None
18897	18898	of	0	None
18898	18899	the	0	None
18899	18900	hypothalamus	0	None
18900	18901	in	0	None
18901	18902	both	0	None
18902	18903	glucose	0	None
18903	18904	and	0	None
18904	18905	saline	0	None
18905	18906	infused	0	None
18906	18907	fetuses	0	None
18907	18908	(	0	None
18908	18909	F	0	None
18909	18910	=	0	None
18910	18911	8	0	None
18911	18912	.	0	None
18912	18913	04;	0	None
18913	18914	P	0	None
18914	18915	<	0	None
18915	18916	0	0	None
18916	18917	.	0	None
18917	18918	01	0	None
18918	18919	)	0	None
18919	18920	and	0	None
18920	18921	there	0	None
18921	18922	was	0	None
18922	18923	a	0	None
18923	18924	positive	0	None
18924	18925	correlation	0	None
18925	18926	between	0	None
18926	18927	expression	0	None
18927	18928	of	0	None
18928	18929	OB-Rb	1	GENE-Y
18929	18930	and	0	None
18930	18931	MC3R	0	None
18931	18932	mRNA	0	None
18932	18933	in	0	None
18933	18934	the	0	None
18934	18935	arcuate	0	None
18935	18936	nucleus	0	None
18936	18937	(	0	None
18937	18938	r	0	None
18938	18939	=	0	None
18939	18940	0	0	None
18940	18941	.	0	None
18941	18942	81;	0	None
18942	18943	P	0	None
18943	18944	<	0	None
18944	18945	0	0	None
18945	18946	.	0	None
18946	18947	005	0	None
18947	18948	)	0	None
18948	18949	.	0	None

18950	18951	Glucose	0	None
18951	18952	infusion	0	None
18952	18953	increased	0	None
18953	18954	mRNA	0	None
18954	18955	expression	0	None
18955	18956	for	0	None
18956	18957	POMC	0	None
18957	18958	,	0	None
18958	18959	but	0	None
18959	18960	not	0	None
18960	18961	for	0	None
18961	18962	the	0	None
18962	18964	anorectic neuropeptide	3	GENE-N
18964	18965	CART	0	None
18965	18966	,	0	None
18966	18967	or	0	None
18967	18968	the	0	None
18968	18969	orexigenic	0	None
18969	18970	neuropeptides	0	None
18970	18971	NPY	0	None
18971	18972	and	0	None
18972	18973	AGRP	0	None
18973	18974	,	0	None
18974	18975	in	0	None
18975	18976	the	0	None
18976	18977	arcuate	0	None
18977	18978	nucleus	0	None
18978	18979	of	0	None
18979	18980	the	0	None
18980	18981	fetal	0	None
18981	18982	hypothalamus	0	None
18982	18983	.	0	None

18984	18985	These	0	None
18985	18986	findings	0	None
18986	18987	demonstrate	0	None
18987	18988	that	0	None
18988	18989	increased	0	None
18989	18990	circulating	0	None
18990	18991	glucose	0	None
18991	18992	and	0	None
18992	18993	insulin	0	None
18993	18994	regulate	0	None
18994	18995	gene	0	None
18995	18996	expression	0	None
18996	18997	of	0	None
18997	18998	the	0	None
18998	18999	neuropeptides	0	None
18999	19000	within	0	None
19000	19001	the	0	None
19001	19002	fetal	0	None
19002	19003	hypothalamus	0	None
19003	19004	that	0	None
19004	19005	are	0	None
19005	19006	part	0	None
19006	19007	of	0	None
19007	19008	the	0	None
19008	19009	neural	0	None
19009	19010	network	0	None
19010	19011	regulating	0	None
19011	19012	energy	0	None
19012	19013	balance	0	None
19013	19014	in	0	None
19014	19015	adult	0	None
19015	19016	life	0	None
19016	19017	.	0	None
19017	19018	Pseudohypoaldosteronism	0	None
19018	19019	type	0	None
19019	19020	1	0	None
19020	19021	(	0	None
19021	19022	PHA1	0	None
19022	19023	)	0	None
19023	19024	is	0	None
19024	19025	characterized	0	None
19025	19026	by	0	None
19026	19027	neonatal	0	None
19027	19028	salt	0	None
19028	19029	wasting	0	None
19029	19030	resistant	0	None
19030	19031	to	0	None
19031	19032	mineralocorticoids	0	None
19032	19033	.	0	None

19034	19035	There	0	None
19035	19036	are	0	None
19036	19037	2	0	None
19037	19038	forms	0	None
19038	19039	of	0	None
19039	19040	PHA1	0	None
19040	19041	:	0	None
19041	19042	the	0	None
19042	19043	autosomal	0	None
19043	19044	recessive	0	None
19044	19045	form	0	None
19045	19046	with	0	None
19046	19047	symptoms	0	None
19047	19048	persisting	0	None
19048	19049	into	0	None
19049	19050	adulthood	0	None
19050	19051	,	0	None
19051	19052	caused	0	None
19052	19053	by	0	None
19053	19054	mutations	0	None
19054	19055	in	0	None
19055	19056	the	0	None
19056	19057	amiloride-sensitive	0	None
19057	19058	luminal	0	None
19058	19060	sodium channel	3	GENE-N
19060	19061	,	0	None
19061	19062	and	0	None
19062	19063	the	0	None
19063	19064	autosomal	0	None
19064	19065	dominant	0	None
19065	19066	or	0	None
19066	19067	sporadic	0	None
19067	19068	form	0	None
19068	19069	,	0	None
19069	19070	which	0	None
19070	19071	shows	0	None
19071	19072	milder	0	None
19072	19073	symptoms	0	None
19073	19074	that	0	None
19074	19075	remit	0	None
19075	19076	with	0	None
19076	19077	age	0	None
19077	19078	.	0	None

19079	19080	Mutations	0	None
19080	19081	in	0	None
19081	19082	the	0	None
19082	19083	gene	0	None
19083	19084	encoding	0	None
19084	19085	the	0	None
19085	19086	human	0	None
19086	19088	mineralocorticoid receptor	1	GENE-Y
19088	19089	(	0	None
19089	19090	hMR	0	None
19090	19091	)	0	None
19091	19092	are	0	None
19092	19093	,	0	None
19093	19094	at	0	None
19094	19095	least	0	None
19095	19096	in	0	None
19096	19097	some	0	None
19097	19098	patients	0	None
19098	19099	,	0	None
19099	19100	responsible	0	None
19100	19101	for	0	None
19101	19102	the	0	None
19102	19103	latter	0	None
19103	19104	form	0	None
19104	19105	of	0	None
19105	19106	PHA1	0	None
19106	19107	.	0	None

19108	19109	We	0	None
19109	19110	here	0	None
19110	19111	report	0	None
19111	19112	the	0	None
19112	19113	results	0	None
19113	19114	of	0	None
19114	19115	a	0	None
19115	19116	genetic	0	None
19116	19117	study	0	None
19117	19118	in	0	None
19118	19119	a	0	None
19119	19120	sporadic	0	None
19120	19121	case	0	None
19121	19122	and	0	None
19122	19123	in	0	None
19123	19124	5	0	None
19124	19125	affected	0	None
19125	19126	patients	0	None
19126	19127	from	0	None
19127	19128	2	0	None
19128	19129	families	0	None
19129	19130	with	0	None
19130	19131	autosomal	0	None
19131	19132	dominant	0	None
19132	19133	PHA1	0	None
19133	19134	.	0	None

19135	19136	In	0	None
19136	19137	the	0	None
19137	19138	sporadic	0	None
19138	19139	case	0	None
19139	19140	we	0	None
19140	19141	identified	0	None
19141	19142	a	0	None
19142	19143	new	0	None
19143	19144	frameshift	0	None
19144	19145	mutation	0	None
19145	19146	,	0	None
19146	19147	Ins2871C	0	None
19147	19148	,	0	None
19148	19149	in	0	None
19149	19150	exon	0	None
19150	19151	9	0	None
19151	19152	of	0	None
19152	19153	the	0	None
19153	19154	hMR	0	None
19154	19155	gene	0	None
19155	19156	.	0	None

19157	19158	Family	0	None
19158	19159	members	0	None
19159	19160	were	0	None
19160	19161	asymptomatic	0	None
19161	19162	and	0	None
19162	19163	had	0	None
19163	19164	no	0	None
19164	19165	mutation	0	None
19165	19166	.	0	None

19167	19168	This	0	None
19168	19169	mutation	0	None
19169	19170	is	0	None
19170	19171	the	0	None
19171	19172	first	0	None
19172	19173	described	0	None
19173	19174	in	0	None
19174	19175	exon	0	None
19175	19176	9	0	None
19176	19177	and	0	None
19177	19178	impairs	0	None
19178	19179	the	0	None
19179	19180	last	0	None
19180	19181	27	0	None
19181	19183	amino acids	2	CHEMICAL
19183	19184	of	0	None
19184	19185	the	0	None
19185	19186	hormone-binding	0	None
19186	19187	domain	0	None
19187	19188	.	0	None

19189	19190	In	0	None
19190	19191	2	0	None
19191	19192	kindreds	0	None
19192	19193	with	0	None
19193	19194	autosomal	0	None
19194	19195	dominant	0	None
19195	19196	PHA1	0	None
19196	19197	we	0	None
19197	19198	found	0	None
19198	19199	no	0	None
19199	19200	mutation	0	None
19200	19201	of	0	None
19201	19202	the	0	None
19202	19203	hMR	0	None
19203	19204	gene	0	None
19204	19205	.	0	None

19206	19207	Our	0	None
19207	19208	results	0	None
19208	19209	confirm	0	None
19209	19210	the	0	None
19210	19211	hypothesis	0	None
19211	19212	that	0	None
19212	19213	autosomal	0	None
19213	19214	dominant	0	None
19214	19215	or	0	None
19215	19216	sporadic	0	None
19216	19217	PHA1	0	None
19217	19218	is	0	None
19218	19219	a	0	None
19219	19220	genetically	0	None
19220	19221	heterogeneous	0	None
19221	19222	disease	0	None
19222	19223	involving	0	None
19223	19224	other	0	None
19224	19225	,	0	None
19225	19226	as	0	None
19226	19227	yet	0	None
19227	19228	unidentified	0	None
19228	19229	,	0	None
19229	19230	genes	0	None
19230	19231	.	0	None
19231	19232	Therapeutic	0	None
19232	19233	oral	0	None
19233	19234	anticoagulation	0	None
19234	19235	is	0	None
19235	19236	still	0	None
19236	19237	commonly	0	None
19237	19238	achieved	0	None
19238	19239	by	0	None
19239	19240	administration	0	None
19240	19241	of	0	None
19241	19242	warfarin	2	CHEMICAL
19242	19243	or	0	None
19243	19244	other	0	None
19244	19245	vitamin	0	None
19245	19246	K	0	None
19246	19247	antagonists	0	None
19247	19248	that	0	None
19248	19249	are	0	None
19249	19250	associated	0	None
19250	19251	with	0	None
19251	19252	an	0	None
19252	19253	untoward	0	None
19253	19254	pharmacokinetic	0	None
19254	19255	/	0	None
19255	19256	pharmacodynamic	0	None
19256	19257	(	0	None
19257	19258	PK	0	None
19258	19259	/	0	None
19259	19260	PD	0	None
19260	19261	)	0	None
19261	19262	profile	0	None
19262	19263	leading	0	None
19263	19264	to	0	None
19264	19265	a	0	None
19265	19266	high	0	None
19266	19267	incidence	0	None
19267	19268	of	0	None
19268	19269	bleeding	0	None
19269	19270	complications	0	None
19270	19271	or	0	None
19271	19272	therapeutic	0	None
19272	19273	failure	0	None
19273	19274	.	0	None

19275	19276	Hence	0	None
19276	19277	,	0	None
19277	19278	there	0	None
19278	19279	is	0	None
19279	19280	an	0	None
19280	19281	unmet	0	None
19281	19282	medical	0	None
19282	19283	need	0	None
19283	19284	of	0	None
19284	19285	novel	0	None
19285	19286	easy-to-use	0	None
19286	19287	oral	0	None
19287	19288	anticoagulants	0	None
19288	19289	with	0	None
19289	19290	improved	0	None
19290	19291	efficacy	0	None
19291	19292	and	0	None
19292	19293	safety	0	None
19293	19294	.	0	None

19295	19296	Recent	0	None
19296	19297	developments	0	None
19297	19298	include	0	None
19298	19299	the	0	None
19299	19300	identification	0	None
19300	19301	of	0	None
19301	19302	non-peptidic	0	None
19302	19303	small-molecules	0	None
19303	19304	that	0	None
19304	19305	selectively	0	None
19305	19306	inhibit	0	None
19306	19307	certain	0	None
19307	19309	serine proteases	3	GENE-N
19309	19310	within	0	None
19310	19311	the	0	None
19311	19312	coagulation	0	None
19312	19313	cascade	0	None
19313	19314	.	0	None

19315	19316	Of	0	None
19316	19317	these	0	None
19317	19318	,	0	None
19318	19319	the	0	None
19319	19320	thrombin	0	None
19320	19321	inhibitor	0	None
19321	19322	dabigatran	0	None
19322	19323	and	0	None
19323	19324	factor	0	None
19324	19325	Xa	0	None
19325	19326	inhibitor	0	None
19326	19327	rivaroxaban	0	None
19327	19328	have	0	None
19328	19329	recently	0	None
19329	19330	been	0	None
19330	19331	licensed	0	None
19331	19332	for	0	None
19332	19333	thromboprophylaxis	0	None
19333	19334	after	0	None
19334	19335	orthopaedic	0	None
19335	19336	surgery	0	None
19336	19337	mainly	0	None
19337	19338	in	0	None
19338	19339	Europe	0	None
19339	19340	.	0	None

19341	19342	In	0	None
19342	19343	addition	0	None
19343	19344	,	0	None
19344	19345	the	0	None
19345	19346	factor	0	None
19346	19347	Xa	0	None
19347	19348	inhibitor	0	None
19348	19349	apixaban	2	CHEMICAL
19349	19350	is	0	None
19350	19351	in	0	None
19351	19352	late-stage	0	None
19352	19353	clinical	0	None
19353	19354	development	0	None
19354	19355	.	0	None

19356	19357	Each	0	None
19357	19358	drug	0	None
19358	19359	is	0	None
19359	19360	prescribed	0	None
19360	19361	at	0	None
19361	19362	fixed	0	None
19362	19363	doses	0	None
19363	19364	without	0	None
19364	19365	the	0	None
19365	19366	need	0	None
19366	19367	of	0	None
19367	19368	anticoagulant	0	None
19368	19369	monitoring	0	None
19369	19370	.	0	None

19371	19372	Phase	0	None
19372	19373	III	0	None
19373	19374	trials	0	None
19374	19375	in	0	None
19375	19376	orthopaedic	0	None
19376	19377	patients	0	None
19377	19378	essentially	0	None
19378	19379	resulted	0	None
19379	19380	in	0	None
19380	19381	non-inferior	0	None
19381	19382	efficacy	0	None
19382	19383	of	0	None
19383	19384	dabigatran	0	None
19384	19385	and	0	None
19385	19386	superior	0	None
19386	19387	efficacy	0	None
19387	19388	of	0	None
19388	19389	rivaroxaban	0	None
19389	19390	over	0	None
19390	19391	enoxaparin	0	None
19391	19392	without	0	None
19392	19393	any	0	None
19393	19394	marked	0	None
19394	19395	differences	0	None
19395	19396	of	0	None
19396	19397	drug	0	None
19397	19398	safety	0	None
19398	19399	,	0	None
19399	19400	while	0	None
19400	19401	apixaban	2	CHEMICAL
19401	19402	data	0	None
19402	19403	is	0	None
19403	19404	still	0	None
19404	19405	controversial	0	None
19405	19406	.	0	None

19407	19408	However	0	None
19408	19409	,	0	None
19409	19410	alterations	0	None
19410	19411	of	0	None
19411	19412	rivaroxaban	0	None
19412	19413	and	0	None
19413	19414	apixaban	2	CHEMICAL
19414	19415	pharmacokinetics	0	None
19415	19416	upon	0	None
19416	19417	interactions	0	None
19417	19418	with	0	None
19418	19419	inhibitors	0	None
19419	19420	and	0	None
19420	19421	inducers	0	None
19421	19422	of	0	None
19422	19423	CYP3A4	0	None
19423	19424	or	0	None
19424	19425	P-glycoprotein	3	GENE-N
19425	19426	may	0	None
19426	19427	complicate	0	None
19427	19428	the	0	None
19428	19429	use	0	None
19429	19430	of	0	None
19430	19431	these	0	None
19431	19432	compounds	0	None
19432	19433	in	0	None
19433	19434	daily	0	None
19434	19435	practice	0	None
19435	19436	,	0	None
19436	19437	whereas	0	None
19437	19438	dabigatran	0	None
19438	19439	elimination	0	None
19439	19440	largely	0	None
19440	19441	depends	0	None
19441	19442	on	0	None
19442	19443	renal	0	None
19443	19444	function	0	None
19444	19445	.	0	None

19446	19447	Hence	0	None
19447	19448	,	0	None
19448	19449	this	0	None
19449	19450	review	0	None
19450	19451	reports	0	None
19451	19452	PK	0	None
19452	19453	/	0	None
19453	19454	PD	0	None
19454	19455	,	0	None
19455	19456	efficacy	0	None
19456	19457	and	0	None
19457	19458	safety	0	None
19458	19459	data	0	None
19459	19460	of	0	None
19460	19461	dabigatran	0	None
19461	19462	,	0	None
19462	19463	rivaroxaban	0	None
19463	19464	and	0	None
19464	19465	apixaban	2	CHEMICAL
19465	19466	throughout	0	None
19466	19467	preclinical	0	None
19467	19468	and	0	None
19468	19469	clinical	0	None
19469	19470	development	0	None
19470	19471	.	0	None
19471	19472	Electrical	0	None
19472	19473	Stimuli	0	None
19473	19474	Release	0	None
19474	19475	ATP	0	None
19475	19476	to	0	None
19476	19477	Increase	0	None
19477	19478	GLUT4	0	None
19478	19479	Translocation	0	None
19479	19480	and	0	None
19480	19481	Glucose	0	None
19481	19482	Uptake	0	None
19482	19483	via	0	None
19483	19484	PI3Kγ-Akt-AS160	0	None
19484	19485	in	0	None
19485	19486	Skeletal	0	None
19486	19487	Muscle	0	None
19487	19488	Cells	0	None
19488	19489	.	0	None
19489	19490	Progress	0	None
19490	19491	and	0	None
19491	19492	Developments	0	None
19492	19493	in	0	None
19493	19494	Tau	1	GENE-Y
19494	19495	Aggregation	0	None
19495	19496	Inhibitors	0	None
19496	19497	for	0	None
19497	19498	Alzheimer	0	None
19498	19499	Disease	0	None
19499	19500	.	0	None
19500	19501	It	0	None
19501	19502	has	0	None
19502	19503	been	0	None
19503	19504	recognised	0	None
19504	19505	that	0	None
19505	19506	the	0	None
19506	19507	active	0	None
19507	19508	transport	0	None
19508	19509	of	0	None
19509	19510	L-phenylalanine	0	None
19510	19511	and	0	None
19511	19512	its	0	None
19512	19513	autocrine	0	None
19513	19514	turnover	0	None
19514	19515	to	0	None
19515	19516	L-tyrosine	0	None
19516	19517	via	0	None
19517	19518	phenylalanine	0	None
19518	19519	hydroxylase	0	None
19519	19520	in	0	None
19520	19521	the	0	None
19521	19522	cytosol	0	None
19522	19523	of	0	None
19523	19524	epidermal	0	None
19524	19525	melanocytes	0	None
19525	19526	provides	0	None
19526	19527	the	0	None
19527	19528	majority	0	None
19528	19529	of	0	None
19529	19530	the	0	None
19530	19531	L-tyrosine	0	None
19531	19532	pool	0	None
19532	19533	for	0	None
19533	19534	melanogenesis	0	None
19534	19535	.	0	None

19536	19537	In	0	None
19537	19538	this	0	None
19538	19539	context	0	None
19539	19540	,	0	None
19540	19541	it	0	None
19541	19542	has	0	None
19542	19543	been	0	None
19543	19544	shown	0	None
19544	19545	that	0	None
19545	19546	the	0	None
19546	19547	cofactor	0	None
19547	19548	6	0	None
19548	19549	(	0	None
19549	19550	R	0	None
19550	19551	)	0	None
19551	19552	-L-erythro	0	None
19552	19553	5	0	None
19553	19554	,	0	None
19554	19555	6	0	None
19555	19556	,	0	None
19556	19557	7	0	None
19557	19558	,	0	None
19558	19559	8	0	None
19559	19560	tetrahydrobiopterin	2	CHEMICAL
19560	19561	(	0	None
19561	19562	6BH4	0	None
19562	19563	)	0	None
19563	19564	is	0	None
19564	19565	produced	0	None
19565	19566	de	0	None
19566	19567	novo	0	None
19567	19568	,	0	None
19568	19569	recycled	0	None
19569	19570	and	0	None
19570	19571	regulated	0	None
19571	19572	in	0	None
19572	19573	both	0	None
19573	19574	epidermal	0	None
19574	19575	melanocytes	0	None
19575	19576	and	0	None
19576	19577	keratinocytes	0	None
19577	19578	to	0	None
19578	19579	control	0	None
19579	19580	tyrosine	2	CHEMICAL
19580	19581	hydroxylase	0	None
19581	19582	,	0	None
19582	19583	phenylalanine	0	None
19583	19584	hydroxylase	0	None
19584	19585	and	0	None
19585	19586	tyrosinase	1	GENE-Y
19586	19587	activity	0	None
19587	19588	.	0	None

19589	19590	Inhibition	0	None
19590	19591	of	0	None
19591	19592	the	0	None
19592	19593	enzymes	0	None
19593	19594	by	0	None
19594	19595	excessive	0	None
19595	19596	6BH4	0	None
19596	19597	levels	0	None
19597	19598	is	0	None
19598	19599	reversible	0	None
19599	19600	with	0	None
19600	19601	alpha-MSH	0	None
19601	19602	by	0	None
19602	19603	specific	0	None
19603	19604	complex	0	None
19604	19605	formation	0	None
19605	19606	between	0	None
19606	19607	6BH4	0	None
19607	19608	and	0	None
19608	19609	the	0	None
19609	19610	hormone	0	None
19610	19611	.	0	None

19612	19613	This	0	None
19613	19614	direct	0	None
19614	19615	mechanism	0	None
19615	19616	of	0	None
19616	19617	alpha-MSH	0	None
19617	19618	is	0	None
19618	19619	supported	0	None
19619	19620	by	0	None
19620	19621	the	0	None
19621	19622	presence	0	None
19622	19623	of	0	None
19623	19624	the	0	None
19624	19625	entire	0	None
19625	19626	POMC	0	None
19626	19627	processing	0	None
19627	19628	system	0	None
19628	19629	in	0	None
19629	19630	the	0	None
19630	19631	melanosome	0	None
19631	19632	indicating	0	None
19632	19633	a	0	None
19633	19634	receptor	0	None
19634	19635	independent	0	None
19635	19636	control	0	None
19636	19637	of	0	None
19637	19638	eumelanogenesis	0	None
19638	19639	.	0	None

19640	19641	Finally	0	None
19641	19642	,	0	None
19642	19643	the	0	None
19643	19644	role	0	None
19644	19645	of	0	None
19645	19646	tyrosinase	1	GENE-Y
19646	19647	,	0	None
19647	19648	TRP-1	0	None
19648	19649	and	0	None
19649	19650	TRP2	0	None
19650	19651	is	0	None
19651	19652	discussed	0	None
19652	19653	in	0	None
19653	19654	association	0	None
19654	19655	with	0	None
19655	19656	oxidative	0	None
19656	19657	stress	0	None
19657	19658	specifically	0	None
19658	19659	related	0	None
19659	19660	to	0	None
19660	19661	hydrogen	2	CHEMICAL
19661	19662	peroxide	2	CHEMICAL
19662	19663	.	0	None

19664	19665	These	0	None
19665	19666	recent	0	None
19666	19667	findings	0	None
19667	19668	are	0	None
19668	19669	based	0	None
19669	19670	on	0	None
19670	19671	detailed	0	None
19671	19672	investigations	0	None
19672	19673	of	0	None
19673	19674	the	0	None
19674	19675	depigmentation	0	None
19675	19676	disorder	0	None
19676	19677	vitiligo	0	None
19677	19678	and	0	None
19678	19679	Hermansky-Pudlak	0	None
19679	19680	syndrome	0	None
19680	19681	.	0	None
19681	19682	We	0	None
19682	19683	report	0	None
19683	19684	the	0	None
19684	19685	SAR	0	None
19685	19686	around	0	None
19686	19687	a	0	None
19687	19688	series	0	None
19688	19689	of	0	None
19689	19690	2	0	None
19690	19691	,	0	None
19691	19692	4-diaminopyrimidine-5-carboxamide	0	None
19692	19693	inhibitors	0	None
19693	19694	of	0	None
19694	19695	Sky	0	None
19695	19696	kinase	0	None
19696	19697	.	0	None

19698	19699	2-Aminophenethyl	0	None
19699	19700	analogs	0	None
19700	19701	demonstrate	0	None
19701	19702	excellent	0	None
19702	19703	potency	0	None
19703	19704	but	0	None
19704	19705	moderate	0	None
19705	19706	kinase	0	None
19706	19707	selectivity	0	None
19707	19708	,	0	None
19708	19709	while	0	None
19709	19710	2-aminobenzyl	0	None
19710	19711	analogs	0	None
19711	19712	that	0	None
19712	19713	fill	0	None
19713	19714	the	0	None
19714	19715	Ala571	0	None
19715	19716	subpocket	0	None
19716	19717	exhibit	0	None
19717	19718	good	0	None
19718	19719	inhibition	0	None
19719	19720	activity	0	None
19720	19721	and	0	None
19721	19722	excellent	0	None
19722	19723	kinase	0	None
19723	19724	selectivity	0	None
19724	19725	.	0	None
19725	19726	In	0	None
19726	19727	a	0	None
19727	19728	recent	0	None
19728	19729	study	0	None
19729	19730	it	0	None
19730	19731	has	0	None
19731	19732	been	0	None
19732	19733	shown	0	None
19733	19734	that	0	None
19734	19737	mitochondrial creatine kinase	3	GENE-N
19737	19738	from	0	None
19738	19739	chicken	0	None
19739	19740	brain	0	None
19740	19741	(	0	None
19741	19742	Mia-CK	0	None
19742	19743	)	0	None
19743	19744	and	0	None
19744	19745	heart	0	None
19745	19746	(	0	None
19746	19747	Mib-CK	0	None
19747	19748	)	0	None
19748	19749	are	0	None
19749	19750	two	0	None
19750	19751	distinct	0	None
19751	19752	isoenzymes	0	None
19752	19753	differing	0	None
19753	19754	in	0	None
19754	19755	ten	0	None
19755	19756	out	0	None
19756	19757	of	0	None
19757	19758	the	0	None
19758	19759	thirty	0	None
19759	19760	N-terminal	0	None
19760	19762	amino acids	2	CHEMICAL
19762	19763	(	0	None
19763	19764	Hossle	0	None
19764	19765	,	0	None
19765	19766	J	0	None
19766	19767	.	0	None

19768	19769	P	0	None
19769	19770	.	0	None

19771	19772	,	0	None
19772	19773	Schlegel	0	None
19773	19774	,	0	None
19774	19775	J	0	None
19775	19776	.	0	None

19777	19778	,	0	None
19778	19779	Wegmann	0	None
19779	19780	,	0	None
19780	19781	G	0	None
19781	19782	.	0	None

19783	19784	,	0	None
19784	19785	Wyss	0	None
19785	19786	,	0	None
19786	19787	M	0	None
19787	19788	.	0	None

19789	19790	,	0	None
19790	19791	Bohlen	0	None
19791	19792	,	0	None
19792	19793	P	0	None
19793	19794	.	0	None

19795	19796	,	0	None
19796	19797	Eppenberger	0	None
19797	19798	,	0	None
19798	19799	H	0	None
19799	19800	.	0	None

19801	19802	M	0	None
19802	19803	.	0	None

19804	19805	,	0	None
19805	19806	Wallimann	0	None
19806	19807	,	0	None
19807	19808	T	0	None
19808	19809	.	0	None

19810	19811	,	0	None
19811	19812	and	0	None
19812	19813	Perriard	0	None
19813	19814	J	0	None
19814	19815	.	0	None

19816	19817	C	0	None
19817	19818	.	0	None

19819	19820	(	0	None
19820	19821	1988	0	None
19821	19822	)	0	None
19822	19823	Biochem	0	None
19823	19824	.	0	None

19825	19826	Biophys	0	None
19826	19827	.	0	None

19828	19829	Res	0	None
19829	19830	.	0	None

19831	19832	Commun	0	None
19832	19833	.	0	None

19834	19835	151	0	None
19835	19836	,	0	None
19836	19837	408-416	0	None
19837	19838	)	0	None
19838	19839	.	0	None

19840	19841	The	0	None
19841	19842	present	0	None
19842	19843	article	0	None
19843	19844	describes	0	None
19844	19845	the	0	None
19845	19846	purification	0	None
19846	19847	and	0	None
19847	19848	biophysical	0	None
19848	19849	characterization	0	None
19849	19850	of	0	None
19850	19851	the	0	None
19851	19854	mitochondrial creatine kinase	3	GENE-N
19854	19855	isoenzyme	0	None
19855	19856	from	0	None
19856	19857	chicken	0	None
19857	19858	brain	0	None
19858	19859	(	0	None
19859	19860	Mia-CK	0	None
19860	19861	)	0	None
19861	19862	.	0	None

19863	19864	Gel	0	None
19864	19865	permeation	0	None
19865	19866	chromatography	0	None
19866	19867	,	0	None
19867	19868	direct	0	None
19868	19869	mass	0	None
19869	19870	measurements	0	None
19870	19871	of	0	None
19871	19872	individual	0	None
19872	19873	molecules	0	None
19873	19874	by	0	None
19874	19875	scanning	0	None
19875	19876	transmission	0	None
19876	19877	electron	0	None
19877	19878	microscopy	0	None
19878	19879	,	0	None
19879	19880	and	0	None
19880	19881	analytical	0	None
19881	19882	ultracentrifugation	0	None
19882	19883	confirmed	0	None
19883	19884	the	0	None
19884	19885	existence	0	None
19885	19886	of	0	None
19886	19887	two	0	None
19887	19888	different	0	None
19888	19889	oligomeric	0	None
19889	19890	forms	0	None
19890	19891	,	0	None
19891	19892	dimeric	0	None
19892	19893	and	0	None
19893	19894	octameric	0	None
19894	19895	Mia-CK	0	None
19895	19896	,	0	None
19896	19897	with	0	None
19897	19898	molecular	0	None
19898	19899	masses	0	None
19899	19900	of	0	None
19900	19901	85	0	None
19901	19902	kDa	0	None
19902	19903	and	0	None
19903	19904	306-352	0	None
19904	19905	kDa	0	None
19905	19906	and	0	None
19906	19907	with	0	None
19907	19908	sedimentation	0	None
19908	19909	constants	0	None
19909	19910	of	0	None
19910	19911	4	0	None
19911	19912	.	0	None
19912	19913	9-5	0	None
19913	19914	.	0	None
19914	19915	3	0	None
19915	19916	and	0	None
19916	19917	11	0	None
19917	19918	.	0	None
19918	19919	6-12	0	None
19919	19920	.	0	None
19920	19921	0	0	None
19921	19922	S	0	None
19922	19923	,	0	None
19923	19924	respectively	0	None
19924	19925	.	0	None

19926	19927	In	0	None
19927	19928	addition	0	None
19928	19929	,	0	None
19929	19930	it	0	None
19930	19931	was	0	None
19931	19932	tested	0	None
19932	19933	if	0	None
19933	19934	Mia-	0	None
19934	19935	and	0	None
19935	19936	Mib-CK	0	None
19936	19937	can	0	None
19937	19938	form	0	None
19938	19939	heterodimeric	0	None
19939	19940	and	0	None
19940	19941	heterooctameric	0	None
19941	19942	molecules	0	None
19942	19943	with	0	None
19943	19944	subunits	0	None
19944	19945	of	0	None
19945	19946	other	0	None
19946	19947	CK	0	None
19947	19948	isoenzymes	0	None
19948	19949	.	0	None

19950	19951	By	0	None
19951	19952	denaturation	0	None
19952	19953	in	0	None
19953	19954	urea	2	CHEMICAL
19954	19955	or	0	None
19955	19956	guanidine	0	None
19956	19957	hydrochloride	2	CHEMICAL
19957	19958	and	0	None
19958	19959	subsequent	0	None
19959	19960	renaturation	0	None
19960	19961	,	0	None
19961	19962	MiaMib-CK	0	None
19962	19963	and	0	None
19963	19964	surprisingly	0	None
19964	19965	also	0	None
19965	19966	MiaM-CK	0	None
19966	19967	heterodimers	0	None
19967	19968	could	0	None
19968	19969	be	0	None
19969	19970	generated	0	None
19970	19971	.	0	None

19972	19973	In	0	None
19973	19974	contrast	0	None
19974	19975	,	0	None
19975	19976	no	0	None
19976	19977	heterodimers	0	None
19977	19978	were	0	None
19978	19979	obtained	0	None
19979	19980	between	0	None
19980	19981	Mib-	0	None
19981	19982	and	0	None
19982	19983	M-	0	None
19983	19984	or	0	None
19984	19985	B-CK	0	None
19985	19986	.	0	None

19987	19988	Furthermore	0	None
19988	19989	,	0	None
19989	19990	reoctamerization	0	None
19990	19991	of	0	None
19991	19992	a	0	None
19992	19993	mixture	0	None
19993	19994	of	0	None
19994	19995	Mia-	0	None
19995	19996	and	0	None
19996	19997	Mib-CK	0	None
19997	19998	homodimers	0	None
19998	19999	led	0	None
19999	20000	to	0	None
20000	20001	the	0	None
20001	20002	formation	0	None
20002	20003	of	0	None
20003	20004	MiaMib-CK	0	None
20004	20005	heterooctamers	0	None
20005	20006	.	0	None

20007	20008	In	0	None
20008	20009	these	0	None
20009	20010	heterooctamers	0	None
20010	20011	,	0	None
20011	20012	the	0	None
20012	20013	Mia-	0	None
20013	20014	and	0	None
20014	20015	Mib-CK	0	None
20015	20016	homodimers	0	None
20016	20017	remained	0	None
20017	20018	the	0	None
20018	20019	fundamental	0	None
20019	20020	building	0	None
20020	20021	blocks	0	None
20021	20022	.	0	None

20023	20024	No	0	None
20024	20025	subunit	0	None
20025	20026	exchange	0	None
20026	20027	between	0	None
20027	20028	adjacent	0	None
20028	20029	dimers	0	None
20029	20030	within	0	None
20030	20031	the	0	None
20031	20032	heterooctamer	0	None
20032	20033	could	0	None
20033	20034	be	0	None
20034	20035	observed	0	None
20035	20036	even	0	None
20036	20037	after	0	None
20037	20038	storage	0	None
20038	20039	for	0	None
20039	20040	3	0	None
20040	20041	months	0	None
20041	20042	at	0	None
20042	20043	4	0	None
20043	20044	degrees	0	None
20044	20045	C	0	None
20045	20046	.	0	None

20047	20048	The	0	None
20048	20049	relevance	0	None
20049	20050	of	0	None
20050	20051	these	0	None
20051	20052	data	0	None
20052	20053	on	0	None
20053	20054	the	0	None
20054	20055	structural	0	None
20055	20056	organization	0	None
20056	20057	of	0	None
20057	20058	the	0	None
20058	20059	Mi-CK	0	None
20059	20060	octamer	0	None
20060	20061	and	0	None
20061	20062	on	0	None
20062	20063	the	0	None
20063	20064	physiological	0	None
20064	20065	aspects	0	None
20065	20066	of	0	None
20066	20067	tissue-specific	0	None
20067	20068	isoenzyme	0	None
20068	20069	expression	0	None
20069	20070	are	0	None
20070	20071	discussed	0	None
20071	20072	.	0	None
20072	20073	To	0	None
20073	20074	characterize	0	None
20074	20075	neonatal	0	None
20075	20076	mesenteric	0	None
20076	20077	alpha-adrenoceptor	0	None
20077	20078	populations	0	None
20078	20079	,	0	None
20079	20080	an	0	None
20080	20081	extracorporeal	0	None
20081	20082	perfusion	0	None
20082	20083	circuit	0	None
20083	20084	was	0	None
20084	20085	established	0	None
20085	20086	to	0	None
20086	20087	control	0	None
20087	20088	intestinal	0	None
20088	20089	blood	0	None
20089	20090	flow	0	None
20090	20091	in	0	None
20091	20092	prematurely	0	None
20092	20093	delivered	0	None
20093	20094	(	0	None
20094	20095	by	0	None
20095	20096	cesarean	0	None
20096	20097	section	0	None
20097	20098	at	0	None
20098	20099	90%	0	None
20099	20100	of	0	None
20100	20101	gestational	0	None
20101	20102	age	0	None
20102	20103	)	0	None
20103	20104	piglets	0	None
20104	20105	.	0	None

20106	20107	Activation	0	None
20107	20108	of	0	None
20108	20110	alpha 1-adrenoceptors	1	GENE-Y
20110	20111	was	0	None
20111	20112	documented	0	None
20112	20113	by	0	None
20113	20114	observing	0	None
20114	20115	dose-dependent	0	None
20115	20116	increases	0	None
20116	20117	in	0	None
20117	20118	mesenteric	0	None
20118	20119	perfusion	0	None
20119	20120	pressure	0	None
20120	20121	after	0	None
20121	20122	intramesenteric	0	None
20122	20123	arterial	0	None
20123	20124	injection	0	None
20124	20125	of	0	None
20125	20126	methoxamine;	0	None
20126	20127	alpha	0	None
20127	20128	2-adrenoceptor	0	None
20128	20129	activity	0	None
20129	20130	was	0	None
20130	20131	confirmed	0	None
20131	20132	by	0	None
20132	20133	finding	0	None
20133	20134	similar	0	None
20134	20135	increases	0	None
20135	20136	in	0	None
20136	20137	mesenteric	0	None
20137	20138	perfusion	0	None
20138	20139	pressure	0	None
20139	20140	after	0	None
20140	20141	intramesenteric	0	None
20141	20142	arterial	0	None
20142	20143	injections	0	None
20143	20144	of	0	None
20144	20145	BHT	0	None
20145	20146	933	0	None
20146	20147	.	0	None

20148	20149	Peripheral	0	None
20149	20150	intravenous	0	None
20150	20151	injections	0	None
20151	20152	of	0	None
20152	20153	WB	0	None
20153	20154	4101	0	None
20154	20155	(	0	None
20155	20156	a	0	None
20156	20157	competitive	0	None
20157	20158	alpha	0	None
20158	20159	1A-adrenoceptor	0	None
20159	20160	antagonist	0	None
20160	20161	)	0	None
20161	20162	,	0	None
20162	20163	but	0	None
20163	20164	not	0	None
20164	20165	clorethylclonidine	0	None
20165	20166	(	0	None
20166	20167	CEC	0	None
20167	20168	,	0	None
20168	20169	an	0	None
20169	20170	alpha	0	None
20170	20171	1B-adrenoceptor	0	None
20171	20172	antagonist	0	None
20172	20173	)	0	None
20173	20174	,	0	None
20174	20175	significantly	0	None
20175	20176	blunted	0	None
20176	20177	(	0	None
20177	20178	P	0	None
20178	20179	<	0	None
20179	20180	.	0	None
20180	20181	05	0	None
20181	20182	,	0	None
20182	20183	ANOVA	0	None
20183	20184	)	0	None
20184	20185	the	0	None
20185	20186	mesenteric	0	None
20186	20187	vasoconstrictor	0	None
20187	20188	responses	0	None
20188	20189	to	0	None
20189	20190	methoxamine	0	None
20190	20191	.	0	None

20192	20193	The	0	None
20193	20194	mesenteric	0	None
20194	20195	vasoconstrictor	0	None
20195	20196	response	0	None
20196	20197	to	0	None
20197	20198	BHT	0	None
20198	20199	933	0	None
20199	20200	(	0	None
20200	20201	an	0	None
20201	20202	alpha	0	None
20202	20203	2-adrenoceptor	0	None
20203	20204	agonist	0	None
20204	20205	)	0	None
20205	20206	also	0	None
20206	20207	was	0	None
20207	20208	blunted	0	None
20208	20209	by	0	None
20209	20210	WB	0	None
20210	20211	4101	0	None
20211	20212	,	0	None
20212	20213	but	0	None
20213	20214	not	0	None
20214	20215	by	0	None
20215	20216	CEC	0	None
20216	20217	.	0	None

20218	20219	These	0	None
20219	20220	data	0	None
20220	20221	suggest	0	None
20221	20222	that	0	None
20222	20223	alpha	0	None
20223	20224	1A-	0	None
20224	20225	and	0	None
20225	20226	alpha	0	None
20226	20227	2-adrenoceptors	0	None
20227	20228	can	0	None
20228	20229	be	0	None
20229	20230	activated	0	None
20230	20231	in	0	None
20231	20232	the	0	None
20232	20233	small	0	None
20233	20234	intestinal	0	None
20234	20235	mesentery	0	None
20235	20236	of	0	None
20236	20237	piglets	0	None
20237	20238	well	0	None
20238	20239	before	0	None
20239	20240	they	0	None
20240	20241	reach	0	None
20241	20242	full-term	0	None
20242	20243	maturation	0	None
20243	20244	,	0	None
20244	20245	although	0	None
20245	20246	receptor	0	None
20246	20247	specificity	0	None
20247	20248	has	0	None
20248	20249	not	0	None
20249	20250	been	0	None
20250	20251	fully	0	None
20251	20252	established	0	None
20252	20253	.	0	None
20253	20254	The	0	None
20254	20255	scientific	0	None
20255	20256	rationale	0	None
20256	20257	of	0	None
20257	20258	pharmacologically	0	None
20258	20259	inhibiting	0	None
20259	20262	phosphodiesterase type 5	1	GENE-Y
20262	20263	(	0	None
20263	20264	PDE5	0	None
20264	20265	)	0	None
20265	20266	in	0	None
20266	20267	the	0	None
20267	20268	treatment	0	None
20268	20269	of	0	None
20269	20270	erectile	0	None
20270	20271	dysfunction	0	None
20271	20272	(	0	None
20272	20273	ED	0	None
20273	20274	)	0	None
20274	20275	is	0	None
20275	20276	reviewed	0	None
20276	20277	.	0	None

20278	20279	Published	0	None
20279	20280	literature	0	None
20280	20281	on	0	None
20281	20282	the	0	None
20282	20283	nitric	0	None
20283	20284	oxide-cyclic	0	None
20284	20286	guanosine monophosphate	2	CHEMICAL
20286	20287	(	0	None
20287	20288	cGMP	2	CHEMICAL
20288	20289	)	0	None
20289	20290	pathway	0	None
20290	20291	for	0	None
20291	20292	penile	0	None
20292	20293	erection	0	None
20293	20294	and	0	None
20294	20295	on	0	None
20295	20296	PDE5	0	None
20296	20297	inhibition	0	None
20297	20298	using	0	None
20298	20299	sildenafil	0	None
20299	20300	as	0	None
20300	20301	the	0	None
20301	20302	model	0	None
20302	20303	for	0	None
20303	20304	pharmacologic	0	None
20304	20305	PDE5	0	None
20305	20306	inhibition	0	None
20306	20307	are	0	None
20307	20308	assessed	0	None
20308	20309	.	0	None

20310	20311	The	0	None
20311	20312	key	0	None
20312	20313	second	0	None
20313	20314	messenger	0	None
20314	20315	in	0	None
20315	20316	the	0	None
20316	20317	mediation	0	None
20317	20318	of	0	None
20318	20319	penile	0	None
20319	20320	erection	0	None
20320	20321	is	0	None
20321	20322	cGMP	2	CHEMICAL
20322	20323	.	0	None

20324	20325	PDE5	0	None
20325	20326	is	0	None
20326	20327	the	0	None
20327	20328	predominant	0	None
20328	20329	PDE	0	None
20329	20330	in	0	None
20330	20331	the	0	None
20331	20332	corpus	0	None
20332	20333	cavernosum	0	None
20333	20334	,	0	None
20334	20335	and	0	None
20335	20336	cGMP	2	CHEMICAL
20336	20337	is	0	None
20337	20338	its	0	None
20338	20339	primary	0	None
20339	20340	substrate	0	None
20340	20341	.	0	None

20342	20343	Therefore	0	None
20343	20344	,	0	None
20344	20345	in	0	None
20345	20346	men	0	None
20346	20347	with	0	None
20347	20348	ED	0	None
20348	20349	,	0	None
20349	20350	elevation	0	None
20350	20351	of	0	None
20351	20352	cGMP	2	CHEMICAL
20352	20353	in	0	None
20353	20354	corpus	0	None
20354	20355	cavernosal	0	None
20355	20356	tissue	0	None
20356	20357	via	0	None
20357	20358	selective	0	None
20358	20359	inhibition	0	None
20359	20360	of	0	None
20360	20361	cGMP-specific	0	None
20361	20362	PDE5	0	None
20362	20363	is	0	None
20363	20364	a	0	None
20364	20365	means	0	None
20365	20366	of	0	None
20366	20367	improving	0	None
20367	20368	erectile	0	None
20368	20369	function	0	None
20369	20370	at	0	None
20370	20371	minimal	0	None
20371	20372	risk	0	None
20372	20373	of	0	None
20373	20374	adverse	0	None
20374	20375	events	0	None
20375	20376	.	0	None

20377	20378	This	0	None
20378	20379	approach	0	None
20379	20380	is	0	None
20380	20381	validated	0	None
20381	20382	by	0	None
20382	20383	the	0	None
20383	20384	clinical	0	None
20384	20385	efficacy	0	None
20385	20386	and	0	None
20386	20387	safety	0	None
20387	20388	of	0	None
20388	20389	sildenafil	0	None
20389	20390	,	0	None
20390	20391	the	0	None
20391	20392	pioneering	0	None
20392	20393	drug	0	None
20393	20394	for	0	None
20394	20395	selective	0	None
20395	20396	PDE5	0	None
20396	20397	inhibitor	0	None
20397	20398	therapy	0	None
20398	20399	for	0	None
20399	20400	ED	0	None
20400	20401	.	0	None

20402	20403	Sildenafil	0	None
20403	20404	exhibits	0	None
20404	20405	inhibitory	0	None
20405	20406	potency	0	None
20406	20407	against	0	None
20407	20408	PDE5	0	None
20408	20409	and	0	None
20409	20410	a	0	None
20410	20411	10-fold	0	None
20411	20412	lower	0	None
20412	20413	dose-related	0	None
20413	20414	inhibitory	0	None
20414	20415	potency	0	None
20415	20416	against	0	None
20416	20417	rod	0	None
20417	20418	outer	0	None
20418	20419	segment	0	None
20419	20420	PDE6	3	GENE-N
20420	20421	,	0	None
20421	20422	the	0	None
20422	20423	predominant	0	None
20423	20424	PDE	0	None
20424	20425	in	0	None
20425	20426	the	0	None
20426	20427	phototransduction	0	None
20427	20428	cascade	0	None
20428	20429	in	0	None
20429	20430	rods	0	None
20430	20431	.	0	None

20432	20433	Thus	0	None
20433	20434	,	0	None
20434	20435	its	0	None
20435	20436	pharmacologic	0	None
20436	20437	profile	0	None
20437	20438	is	0	None
20438	20439	predictable	0	None
20439	20440	,	0	None
20440	20441	with	0	None
20441	20442	close	0	None
20442	20443	correlation	0	None
20443	20444	between	0	None
20444	20445	pharmacodynamic	0	None
20445	20446	and	0	None
20446	20447	pharmacokinetic	0	None
20447	20448	properties	0	None
20448	20449	.	0	None

20450	20451	Clinically	0	None
20451	20452	,	0	None
20452	20453	sildenafil	0	None
20453	20454	improves	0	None
20454	20455	erectile	0	None
20455	20456	function	0	None
20456	20457	in	0	None
20457	20458	a	0	None
20458	20459	large	0	None
20459	20460	percentage	0	None
20460	20461	of	0	None
20461	20462	men	0	None
20462	20463	with	0	None
20463	20464	ED	0	None
20464	20465	.	0	None

20466	20467	The	0	None
20467	20468	most	0	None
20468	20469	common	0	None
20469	20470	adverse	0	None
20470	20471	events	0	None
20471	20472	are	0	None
20472	20473	due	0	None
20473	20474	to	0	None
20474	20475	PDE5	0	None
20475	20476	inhibition	0	None
20476	20477	in	0	None
20477	20478	vascular	0	None
20478	20479	and	0	None
20479	20480	visceral	0	None
20480	20481	smooth	0	None
20481	20482	muscle;	0	None
20482	20483	similar	0	None
20483	20484	adverse	0	None
20484	20485	events	0	None
20485	20486	are	0	None
20486	20487	expected	0	None
20487	20488	during	0	None
20488	20489	therapeutic	0	None
20489	20490	use	0	None
20490	20491	of	0	None
20491	20492	all	0	None
20492	20493	PDE5	0	None
20493	20494	inhibitors	0	None
20494	20495	.	0	None

20496	20497	As	0	None
20497	20498	free	0	None
20498	20499	sildenafil	0	None
20499	20500	plasma	0	None
20500	20501	concentrations	0	None
20501	20502	approach	0	None
20502	20503	concentrations	0	None
20503	20504	sufficient	0	None
20504	20505	to	0	None
20505	20506	inhibit	0	None
20506	20507	retinal	2	CHEMICAL
20507	20508	PDE6	3	GENE-N
20508	20509	,	0	None
20509	20510	usually	0	None
20510	20511	at	0	None
20511	20512	higher	0	None
20512	20513	therapeutic	0	None
20513	20514	doses	0	None
20514	20515	,	0	None
20515	20516	transient	0	None
20516	20517	,	0	None
20517	20518	reversible	0	None
20518	20519	visual	0	None
20519	20520	adverse	0	None
20520	20521	events	0	None
20521	20522	can	0	None
20522	20523	occur	0	None
20523	20524	,	0	None
20524	20525	albeit	0	None
20525	20526	infrequently	0	None
20526	20527	.	0	None

20528	20529	Selective	0	None
20529	20530	inhibition	0	None
20530	20531	of	0	None
20531	20532	PDE5	0	None
20532	20533	is	0	None
20533	20534	a	0	None
20534	20535	rational	0	None
20535	20536	therapeutic	0	None
20536	20537	approach	0	None
20537	20538	in	0	None
20538	20539	ED	0	None
20539	20540	,	0	None
20540	20541	as	0	None
20541	20542	proved	0	None
20542	20543	by	0	None
20543	20544	the	0	None
20544	20545	clinical	0	None
20545	20546	success	0	None
20546	20547	of	0	None
20547	20548	sildenafil	0	None
20548	20549	.	0	None
20549	20550	Prostaglandins	0	None
20550	20551	are	0	None
20551	20552	key	0	None
20552	20553	regulators	0	None
20553	20554	of	0	None
20554	20555	ion	0	None
20555	20556	transport	0	None
20556	20557	in	0	None
20557	20558	the	0	None
20558	20559	kidney	0	None
20559	20560	.	0	None

20561	20562	In	0	None
20562	20563	MDCK	0	None
20563	20564	cells	0	None
20564	20565	,	0	None
20565	20566	which	0	None
20566	20567	model	0	None
20567	20568	distal	0	None
20568	20569	tubule	0	None
20569	20570	cells	0	None
20570	20571	,	0	None
20571	20572	the	0	None
20572	20573	transcription	0	None
20573	20574	of	0	None
20574	20575	the	0	None
20575	20576	Na	0	None
20576	20577	,	0	None
20577	20578	K-ATPase	0	None
20578	20579	beta1	0	None
20579	20580	subunit	0	None
20580	20581	is	0	None
20581	20582	regulated	0	None
20582	20583	by	0	None
20583	20584	PGE1	0	None
20584	20585	and	0	None
20585	20586	PGE2	2	CHEMICAL
20586	20587	.	0	None

20588	20589	To	0	None
20589	20590	identify	0	None
20590	20591	the	0	None
20591	20592	EP	0	None
20592	20593	receptors	0	None
20593	20594	that	0	None
20594	20595	mediate	0	None
20595	20596	transcriptional	0	None
20596	20597	regulation	0	None
20597	20598	,	0	None
20598	20599	transient	0	None
20599	20600	transfection	0	None
20600	20601	studies	0	None
20601	20602	are	0	None
20602	20603	conducted	0	None
20603	20604	using	0	None
20604	20605	the	0	None
20605	20606	human	0	None
20606	20607	beta1promoter	0	None
20607	20608	/	0	None
20608	20609	luciferase	0	None
20609	20610	construct	0	None
20610	20611	,	0	None
20611	20612	pHbeta1-1141	0	None
20612	20613	Luc	0	None
20613	20614	.	0	None

20615	20616	The	0	None
20616	20617	involvement	0	None
20617	20618	of	0	None
20618	20619	EP1	1	GENE-Y
20619	20620	and	0	None
20620	20621	EP2	1	GENE-Y
20621	20622	receptors	0	None
20622	20623	is	0	None
20623	20624	indicated	0	None
20624	20625	by	0	None
20625	20626	studies	0	None
20626	20627	with	0	None
20627	20628	the	0	None
20628	20629	EP1	1	GENE-Y
20629	20630	selective	0	None
20630	20631	agonist	0	None
20631	20632	17-phenyl	0	None
20632	20633	trinor	0	None
20633	20634	PGE2	2	CHEMICAL
20634	20635	,	0	None
20635	20636	and	0	None
20636	20637	the	0	None
20637	20638	EP2	1	GENE-Y
20638	20639	selective	0	None
20639	20640	agonist	0	None
20640	20641	butaprost	2	CHEMICAL
20641	20642	(	0	None
20642	20643	which	0	None
20643	20644	stimulate	0	None
20644	20645	)	0	None
20645	20646	,	0	None
20646	20647	as	0	None
20647	20648	well	0	None
20648	20649	as	0	None
20649	20650	by	0	None
20650	20651	studies	0	None
20651	20652	with	0	None
20652	20653	the	0	None
20653	20654	antagonists	0	None
20654	20655	SC-51089	0	None
20655	20656	(	0	None
20656	20657	EP1	1	GENE-Y
20657	20658	specific	0	None
20658	20659	)	0	None
20659	20660	and	0	None
20660	20661	AH	0	None
20661	20662	6809	0	None
20662	20663	(	0	None
20663	20664	EP1	1	GENE-Y
20664	20665	and	0	None
20665	20666	EP2	1	GENE-Y
20666	20667	specific	0	None
20667	20668	)	0	None
20668	20669	.	0	None

20670	20671	Consistent	0	None
20671	20672	with	0	None
20672	20673	the	0	None
20673	20674	involvement	0	None
20674	20675	of	0	None
20675	20676	Gs	0	None
20676	20677	coupled	0	None
20677	20678	EP2	1	GENE-Y
20678	20679	receptors	0	None
20679	20680	,	0	None
20680	20681	is	0	None
20681	20682	that	0	None
20682	20683	the	0	None
20683	20684	PGE1	0	None
20684	20685	stimulation	0	None
20685	20686	is	0	None
20686	20687	inhibited	0	None
20687	20688	by	0	None
20688	20689	the	0	None
20689	20690	PKAI	0	None
20690	20691	expression	0	None
20691	20692	vector	0	None
20692	20693	(	0	None
20693	20694	encoding	0	None
20694	20695	the	0	None
20695	20696	protein	0	None
20696	20697	kinase	0	None
20697	20698	A	0	None
20698	20699	(	0	None
20699	20700	PKA	0	None
20700	20701	)	0	None
20701	20702	inhibitory	0	None
20702	20703	protein	0	None
20703	20704	)	0	None
20704	20705	,	0	None
20705	20706	as	0	None
20706	20707	well	0	None
20707	20708	as	0	None
20708	20709	by	0	None
20709	20710	the	0	None
20710	20711	myristolated	0	None
20711	20712	PKA	0	None
20712	20713	inhibitory	0	None
20713	20714	peptide	0	None
20714	20715	PKI	0	None
20715	20716	.	0	None

20717	20718	In	0	None
20718	20719	addition	0	None
20719	20720	to	0	None
20720	20721	this	0	None
20721	20722	evidence	0	None
20722	20723	(	0	None
20723	20724	for	0	None
20724	20725	the	0	None
20725	20726	involvement	0	None
20726	20727	of	0	None
20727	20728	EP2	1	GENE-Y
20728	20729	receptors	0	None
20729	20730	)	0	None
20730	20731	,	0	None
20731	20732	evidence	0	None
20732	20733	for	0	None
20733	20734	the	0	None
20734	20735	involvement	0	None
20735	20736	of	0	None
20736	20737	EP1	1	GENE-Y
20737	20738	receptors	0	None
20738	20739	in	0	None
20739	20740	the	0	None
20740	20741	PGE1	0	None
20741	20742	mediated	0	None
20742	20743	stimulation	0	None
20743	20744	of	0	None
20744	20745	Na	0	None
20745	20746	,	0	None
20746	20747	K-ATPase	0	None
20747	20748	beta	0	None
20748	20749	subunit	0	None
20749	20750	gene	0	None
20750	20751	transcription	0	None
20751	20752	includes	0	None
20752	20753	the	0	None
20753	20754	stimulatory	0	None
20754	20755	effect	0	None
20755	20756	of	0	None
20756	20757	17-phenyl	0	None
20757	20758	trinor	0	None
20758	20759	PGE2	2	CHEMICAL
20759	20760	,	0	None
20760	20761	as	0	None
20761	20762	well	0	None
20762	20763	as	0	None
20763	20764	the	0	None
20764	20765	inhibitory	0	None
20765	20766	effects	0	None
20766	20767	of	0	None
20767	20768	SC-51089	0	None
20768	20769	.	0	None

20770	20771	Also	0	None
20771	20772	consistent	0	None
20772	20773	with	0	None
20773	20774	the	0	None
20774	20775	involvement	0	None
20775	20776	of	0	None
20776	20777	Gq	0	None
20777	20778	coupled	0	None
20778	20779	EP1	1	GENE-Y
20779	20780	receptors	0	None
20780	20781	,	0	None
20781	20782	the	0	None
20782	20783	PGE1	0	None
20783	20784	stimulation	0	None
20784	20785	is	0	None
20785	20786	inhibited	0	None
20786	20787	by	0	None
20787	20788	the	0	None
20788	20789	PKCI	0	None
20789	20790	vector	0	None
20790	20791	(	0	None
20791	20792	encoding	0	None
20792	20793	the	0	None
20793	20794	PKC	0	None
20794	20795	inhibitory	0	None
20795	20796	domain	0	None
20796	20797	)	0	None
20797	20798	,	0	None
20798	20799	the	0	None
20799	20800	PKC	0	None
20800	20801	inhibitor	0	None
20801	20802	Go	0	None
20802	20803	6976	0	None
20803	20804	,	0	None
20804	20805	thapsigargin	0	None
20805	20806	,	0	None
20806	20807	as	0	None
20807	20808	well	0	None
20808	20809	as	0	None
20809	20810	the	0	None
20810	20811	calmodulin	0	None
20811	20812	antagonists	0	None
20812	20813	W7	0	None
20813	20814	and	0	None
20814	20815	W13	0	None
20815	20816	.	0	None
20816	20817	Effect	0	None
20817	20818	of	0	None
20818	20819	developmental	0	None
20819	20820	dioxin	2	CHEMICAL
20820	20821	exposure	0	None
20821	20822	on	0	None
20822	20823	methylation	0	None
20823	20824	and	0	None
20824	20825	expression	0	None
20825	20826	of	0	None
20826	20827	specific	0	None
20827	20828	imprinted	0	None
20828	20829	genes	0	None
20829	20830	in	0	None
20830	20831	mice	0	None
20831	20832	.	0	None
20832	20833	Emerging	0	None
20833	20834	role	0	None
20834	20835	of	0	None
20835	20836	epidermal	0	None
20836	20839	growth factor receptor	3	GENE-N
20839	20840	inhibition	0	None
20840	20841	in	0	None
20841	20842	therapy	0	None
20842	20843	for	0	None
20843	20844	advanced	0	None
20844	20845	malignancy	0	None
20845	20846	:	0	None
20846	20847	focus	0	None
20847	20848	on	0	None
20848	20849	NSCLC	0	None
20849	20850	.	0	None
20850	20851	We	0	None
20851	20852	determined	0	None
20852	20853	the	0	None
20853	20854	effects	0	None
20854	20855	of	0	None
20855	20856	low-level	0	None
20856	20857	prenatal	0	None
20857	20858	MeHg	0	None
20858	20859	exposure	0	None
20859	20860	on	0	None
20860	20861	neuronal	0	None
20861	20862	migration	0	None
20862	20863	in	0	None
20863	20864	the	0	None
20864	20865	developing	0	None
20865	20866	rat	0	None
20866	20867	cerebral	0	None
20867	20868	cortex	0	None
20868	20869	using	0	None
20869	20870	in	0	None
20870	20871	utero	0	None
20871	20872	electroporation	0	None
20872	20873	.	0	None

20874	20875	We	0	None
20875	20876	used	0	None
20876	20877	offspring	0	None
20877	20878	rats	0	None
20878	20879	born	0	None
20879	20880	to	0	None
20880	20881	dams	0	None
20881	20882	that	0	None
20882	20883	had	0	None
20883	20884	been	0	None
20884	20885	exposed	0	None
20885	20886	to	0	None
20886	20887	saline	0	None
20887	20888	or	0	None
20888	20889	various	0	None
20889	20890	doses	0	None
20890	20891	of	0	None
20891	20892	MeHg	0	None
20892	20893	(	0	None
20893	20894	0	0	None
20894	20895	.	0	None
20895	20896	01	0	None
20896	20897	mg	2	CHEMICAL
20897	20898	/	0	None
20898	20899	kg	0	None
20899	20900	/	0	None
20900	20901	day	0	None
20901	20902	,	0	None
20902	20903	0	0	None
20903	20904	.	0	None
20904	20905	1	0	None
20905	20906	mg	2	CHEMICAL
20906	20907	/	0	None
20907	20908	kg	0	None
20908	20909	/	0	None
20909	20910	day	0	None
20910	20911	,	0	None
20911	20912	and	0	None
20912	20913	1	0	None
20913	20914	mg	2	CHEMICAL
20914	20915	/	0	None
20915	20916	kg	0	None
20916	20917	/	0	None
20917	20918	day	0	None
20918	20919	)	0	None
20919	20920	from	0	None
20920	20921	gestational	0	None
20921	20922	day	0	None
20922	20923	(	0	None
20923	20924	GD	0	None
20924	20925	)	0	None
20925	20926	11-21	0	None
20926	20927	.	0	None

20928	20929	Immunohistochemical	0	None
20929	20930	examination	0	None
20930	20931	of	0	None
20931	20932	the	0	None
20932	20933	brains	0	None
20933	20934	of	0	None
20934	20935	the	0	None
20935	20936	offspring	0	None
20936	20937	was	0	None
20937	20938	conducted	0	None
20938	20939	on	0	None
20939	20940	postnatal	0	None
20940	20941	day	0	None
20941	20942	(	0	None
20942	20943	PND	0	None
20943	20944	)	0	None
20944	20945	0	0	None
20945	20946	,	0	None
20946	20947	PND3	0	None
20947	20948	,	0	None
20948	20949	and	0	None
20949	20950	PND7	0	None
20950	20951	.	0	None

20952	20953	Our	0	None
20953	20954	results	0	None
20954	20955	showed	0	None
20955	20956	that	0	None
20956	20957	prenatal	0	None
20957	20958	exposure	0	None
20958	20959	to	0	None
20959	20960	low	0	None
20960	20961	levels	0	None
20961	20962	of	0	None
20962	20963	MeHg	0	None
20963	20964	(	0	None
20964	20965	0	0	None
20965	20966	.	0	None
20966	20967	1	0	None
20967	20968	mg	2	CHEMICAL
20968	20969	/	0	None
20969	20970	kg	0	None
20970	20971	/	0	None
20971	20972	day	0	None
20972	20973	or	0	None
20973	20974	1	0	None
20974	20975	mg	2	CHEMICAL
20975	20976	/	0	None
20976	20977	kg	0	None
20977	20978	/	0	None
20978	20979	day	0	None
20979	20980	)	0	None
20980	20981	during	0	None
20981	20982	the	0	None
20982	20983	critical	0	None
20983	20984	stage	0	None
20984	20985	in	0	None
20985	20986	neuronal	0	None
20986	20987	migration	0	None
20987	20988	resulted	0	None
20988	20989	in	0	None
20989	20990	migration	0	None
20990	20991	defects	0	None
20991	20992	of	0	None
20992	20993	the	0	None
20993	20994	cerebrocortical	0	None
20994	20995	neurons	0	None
20995	20996	in	0	None
20996	20997	offspring	0	None
20997	20998	rats	0	None
20998	20999	.	0	None

21000	21001	Importantly	0	None
21001	21002	,	0	None
21002	21003	our	0	None
21003	21004	data	0	None
21004	21005	revealed	0	None
21005	21006	that	0	None
21006	21007	the	0	None
21007	21008	abnormal	0	None
21008	21009	neuronal	0	None
21009	21010	distribution	0	None
21010	21011	induced	0	None
21011	21012	by	0	None
21012	21013	MeHg	0	None
21013	21014	was	0	None
21014	21015	not	0	None
21015	21016	caused	0	None
21016	21017	by	0	None
21017	21018	altered	0	None
21018	21019	proliferation	0	None
21019	21020	of	0	None
21020	21021	neural	0	None
21021	21022	progenitor	0	None
21022	21023	cells	0	None
21023	21024	(	0	None
21024	21025	NPCs	0	None
21025	21026	)	0	None
21026	21027	,	0	None
21027	21028	induction	0	None
21028	21029	of	0	None
21029	21030	apoptosis	0	None
21030	21031	of	0	None
21031	21032	NPCs	0	None
21032	21033	and	0	None
21033	21034	/	0	None
21034	21035	or	0	None
21035	21036	newborn	0	None
21036	21037	neurons	0	None
21037	21038	,	0	None
21038	21039	abnormal	0	None
21039	21040	differentiation	0	None
21040	21041	of	0	None
21041	21042	NPCs	0	None
21042	21043	,	0	None
21043	21044	and	0	None
21044	21045	the	0	None
21045	21046	morphological	0	None
21046	21047	changes	0	None
21047	21048	of	0	None
21048	21049	radial	0	None
21049	21050	glial	0	None
21050	21051	scaffold	0	None
21051	21052	,	0	None
21052	21053	indicating	0	None
21053	21054	that	0	None
21054	21055	the	0	None
21055	21056	defective	0	None
21056	21057	neuronal	0	None
21057	21058	positioning	0	None
21058	21059	triggered	0	None
21059	21060	by	0	None
21060	21061	exposure	0	None
21061	21062	to	0	None
21062	21063	low-dose	0	None
21063	21064	of	0	None
21064	21065	MeHg	0	None
21065	21066	is	0	None
21066	21067	due	0	None
21067	21068	to	0	None
21068	21069	the	0	None
21069	21070	impacts	0	None
21070	21071	of	0	None
21071	21072	MeHg	0	None
21072	21073	on	0	None
21073	21074	the	0	None
21074	21075	process	0	None
21075	21076	of	0	None
21076	21077	neuronal	0	None
21077	21078	migration	0	None
21078	21079	itself	0	None
21079	21080	.	0	None

21081	21082	Moreover	0	None
21082	21083	,	0	None
21083	21084	we	0	None
21084	21085	demonstrated	0	None
21085	21086	that	0	None
21086	21087	in	0	None
21087	21088	utero	0	None
21088	21089	exposure	0	None
21089	21090	to	0	None
21090	21091	low-level	0	None
21091	21092	MeHg	0	None
21092	21093	suppresses	0	None
21093	21094	the	0	None
21094	21095	expression	0	None
21095	21096	of	0	None
21096	21097	Rac1	0	None
21097	21098	,	0	None
21098	21099	Cdc42	1	GENE-Y
21099	21100	,	0	None
21100	21101	and	0	None
21101	21102	RhoA	0	None
21102	21103	,	0	None
21103	21104	which	0	None
21104	21105	play	0	None
21105	21106	key	0	None
21106	21107	roles	0	None
21107	21108	in	0	None
21108	21109	the	0	None
21109	21110	migration	0	None
21110	21111	of	0	None
21111	21112	cerebrocortical	0	None
21112	21113	neurons	0	None
21113	21114	during	0	None
21114	21115	the	0	None
21115	21116	early	0	None
21116	21117	stage	0	None
21117	21118	of	0	None
21118	21119	brain	0	None
21119	21120	development	0	None
21120	21121	,	0	None
21121	21122	suggesting	0	None
21122	21123	that	0	None
21123	21124	the	0	None
21124	21125	MeHg-induced	0	None
21125	21126	migratory	0	None
21126	21127	disturbance	0	None
21127	21128	of	0	None
21128	21129	cerebrocortical	0	None
21129	21130	neurons	0	None
21130	21131	is	0	None
21131	21132	likely	0	None
21132	21133	associated	0	None
21133	21134	with	0	None
21134	21135	the	0	None
21135	21136	Rho	0	None
21136	21137	GTPases	0	None
21137	21138	signal	0	None
21138	21139	pathway	0	None
21139	21140	.	0	None

21141	21142	In	0	None
21142	21143	conclusion	0	None
21143	21144	,	0	None
21144	21145	our	0	None
21145	21146	results	0	None
21146	21147	provide	0	None
21147	21148	a	0	None
21148	21149	novel	0	None
21149	21150	perspective	0	None
21150	21151	on	0	None
21151	21152	clarifying	0	None
21152	21153	the	0	None
21153	21154	mechanisms	0	None
21154	21155	underlying	0	None
21155	21156	the	0	None
21156	21157	impairment	0	None
21157	21158	of	0	None
21158	21159	neuronal	0	None
21159	21160	migration	0	None
21160	21161	induced	0	None
21161	21162	by	0	None
21162	21163	MeHg	0	None
21163	21164	.	0	None
21164	21165	BACKGROUND	0	None
21165	21166	:	0	None
21166	21167	Because	0	None
21167	21168	of	0	None
21168	21169	the	0	None
21169	21170	adverse	0	None
21170	21171	characteristics	0	None
21171	21172	associated	0	None
21172	21173	with	0	None
21173	21174	heparin	0	None
21174	21175	,	0	None
21175	21176	direct	0	None
21176	21177	antagonists	0	None
21177	21178	of	0	None
21178	21179	thrombin	0	None
21179	21180	have	0	None
21180	21181	been	0	None
21181	21182	investigated	0	None
21182	21183	as	0	None
21183	21184	anticoagulants	0	None
21184	21185	during	0	None
21185	21186	percutaneous	0	None
21186	21187	coronary	0	None
21187	21188	interventions	0	None
21188	21189	.	0	None

21190	21191	However	0	None
21191	21192	,	0	None
21192	21193	the	0	None
21193	21194	hematologic	0	None
21194	21195	and	0	None
21195	21196	clinical	0	None
21196	21197	interactions	0	None
21197	21198	between	0	None
21198	21199	direct	0	None
21199	21200	thrombin	0	None
21200	21201	antagonists	0	None
21201	21202	and	0	None
21202	21203	inhibitors	0	None
21203	21204	of	0	None
21204	21207	platelet glycoprotein IIb-IIIa	1	GENE-Y
21207	21208	are	0	None
21208	21209	incompletely	0	None
21209	21210	explored	0	None
21210	21211	.	0	None

21212	21213	METHODS	0	None
21213	21214	:	0	None
21214	21215	Forty-two	0	None
21215	21216	patients	0	None
21216	21217	who	0	None
21217	21218	underwent	0	None
21218	21219	elective	0	None
21219	21220	percutaneous	0	None
21220	21221	coronary	0	None
21221	21222	intervention	0	None
21222	21223	were	0	None
21223	21224	randomized	0	None
21224	21225	to	0	None
21225	21226	receive	0	None
21226	21227	a	0	None
21227	21228	bivalirudin	0	None
21228	21229	1	0	None
21229	21230	.	0	None
21230	21231	0	0	None
21231	21232	mg	2	CHEMICAL
21232	21233	/	0	None
21233	21234	kg	0	None
21234	21235	bolus	0	None
21235	21236	followed	0	None
21236	21237	by	0	None
21237	21238	a	0	None
21238	21239	4-hour	0	None
21239	21240	infusion	0	None
21240	21241	at	0	None
21241	21242	2	0	None
21242	21243	.	0	None
21243	21244	5	0	None
21244	21245	mg	2	CHEMICAL
21245	21246	/	0	None
21246	21247	kg	0	None
21247	21248	/	0	None
21248	21249	h;	0	None
21249	21250	a	0	None
21250	21251	bivalirudin	0	None
21251	21252	0	0	None
21252	21253	.	0	None
21253	21254	75	0	None
21254	21255	mg	2	CHEMICAL
21255	21256	/	0	None
21256	21257	kg	0	None
21257	21258	bolus	0	None
21258	21259	followed	0	None
21259	21260	by	0	None
21260	21261	a	0	None
21261	21262	4-hour	0	None
21262	21263	infusion	0	None
21263	21264	at	0	None
21264	21265	1	0	None
21265	21266	.	0	None
21266	21267	75	0	None
21267	21268	mg	2	CHEMICAL
21268	21269	/	0	None
21269	21270	kg;	0	None
21270	21271	or	0	None
21271	21272	a	0	None
21272	21273	heparin	0	None
21273	21274	60	0	None
21274	21275	U	0	None
21275	21276	/	0	None
21276	21277	kg	0	None
21277	21278	bolus	0	None
21278	21279	.	0	None

21280	21281	All	0	None
21281	21282	the	0	None
21282	21283	patients	0	None
21283	21284	also	0	None
21284	21285	received	0	None
21285	21286	eptifibatide	0	None
21286	21287	,	0	None
21287	21288	given	0	None
21288	21289	as	0	None
21289	21290	2	0	None
21290	21291	sequential	0	None
21291	21292	boluses	0	None
21292	21293	of	0	None
21293	21294	180	0	None
21294	21295	microg	0	None
21295	21296	/	0	None
21296	21297	kg	0	None
21297	21298	followed	0	None
21298	21299	by	0	None
21299	21300	a	0	None
21300	21301	2	0	None
21301	21302	microg	0	None
21302	21303	/	0	None
21303	21304	kg	0	None
21304	21305	/	0	None
21305	21306	min	0	None
21306	21307	infusion	0	None
21307	21308	for	0	None
21308	21309	18	0	None
21309	21310	to	0	None
21310	21311	24	0	None
21311	21312	hours	0	None
21312	21313	,	0	None
21313	21314	and	0	None
21314	21315	aspirin	2	CHEMICAL
21315	21316	.	0	None

21317	21318	RESULTS	0	None
21318	21319	:	0	None
21319	21320	After	0	None
21320	21321	the	0	None
21321	21322	bolus	0	None
21322	21323	dose	0	None
21323	21324	of	0	None
21324	21325	the	0	None
21325	21326	study	0	None
21326	21327	drug	0	None
21327	21328	,	0	None
21328	21329	turbidimetric	0	None
21329	21330	platelet	0	None
21330	21331	aggregation	0	None
21331	21332	in	0	None
21332	21333	response	0	None
21333	21334	to	0	None
21334	21335	5	0	None
21335	21336	micromol	0	None
21336	21337	/	0	None
21337	21338	L	0	None
21338	21340	adenosine diphosphate	2	CHEMICAL
21340	21341	increased	0	None
21341	21342	in	0	None
21342	21343	patients	0	None
21343	21344	assigned	0	None
21344	21345	to	0	None
21345	21346	heparin	0	None
21346	21347	but	0	None
21347	21348	not	0	None
21348	21349	those	0	None
21349	21350	assigned	0	None
21350	21351	to	0	None
21351	21352	bivalirudin	0	None
21352	21353	.	0	None

21354	21355	After	0	None
21355	21356	eptifibatide	0	None
21356	21357	,	0	None
21357	21358	platelet	0	None
21358	21359	aggregation	0	None
21359	21360	was	0	None
21360	21361	eliminated	0	None
21361	21362	in	0	None
21362	21363	all	0	None
21363	21364	3	0	None
21364	21365	treatment	0	None
21365	21366	groups	0	None
21366	21367	.	0	None

21368	21369	The	0	None
21369	21370	effect	0	None
21370	21371	of	0	None
21371	21372	heparin	0	None
21372	21373	and	0	None
21373	21374	the	0	None
21374	21375	effects	0	None
21375	21376	of	0	None
21376	21377	both	0	None
21377	21378	bivalirudin	0	None
21378	21379	regimens	0	None
21379	21380	on	0	None
21380	21381	the	0	None
21381	21382	formation	0	None
21382	21383	of	0	None
21383	21384	thrombin	0	None
21384	21385	antithrombin	0	None
21385	21386	complexes	0	None
21386	21387	and	0	None
21387	21388	prothrombin	0	None
21388	21389	fragment	0	None
21389	21390	1	0	None
21390	21391	.	0	None
21391	21392	2	0	None
21392	21393	were	0	None
21393	21394	comparable	0	None
21394	21395	.	0	None

21396	21397	Neither	0	None
21397	21398	agent	0	None
21398	21399	affected	0	None
21399	21400	the	0	None
21400	21401	formation	0	None
21401	21402	of	0	None
21402	21403	platelet-monocyte	0	None
21403	21404	complexes	0	None
21404	21405	or	0	None
21405	21406	expression	0	None
21406	21407	of	0	None
21407	21408	CD	0	None
21408	21409	63	0	None
21409	21410	lysosomal	0	None
21410	21411	antigen	0	None
21411	21412	.	0	None

21413	21414	There	0	None
21414	21415	were	0	None
21415	21416	no	0	None
21416	21417	major	0	None
21417	21418	bleeding	0	None
21418	21419	events	0	None
21419	21420	,	0	None
21420	21421	and	0	None
21421	21422	a	0	None
21422	21423	single	0	None
21423	21424	non-Q-wave	0	None
21424	21425	myocardial	0	None
21425	21426	infarction	0	None
21426	21427	(	0	None
21427	21428	MI	0	None
21428	21429	)	0	None
21429	21430	occurred	0	None
21430	21431	in	0	None
21431	21432	a	0	None
21432	21433	patient	0	None
21433	21434	treated	0	None
21434	21435	with	0	None
21435	21436	bivalirudin	0	None
21436	21437	.	0	None

21438	21439	CONCLUSION	0	None
21439	21440	:	0	None
21440	21441	These	0	None
21441	21442	findings	0	None
21442	21443	show	0	None
21443	21444	the	0	None
21444	21445	feasibility	0	None
21445	21446	of	0	None
21446	21447	combining	0	None
21447	21448	the	0	None
21448	21449	direct	0	None
21449	21450	thrombin	0	None
21450	21451	antagonist	0	None
21451	21452	bivalirudin	0	None
21452	21453	with	0	None
21453	21454	a	0	None
21454	21455	potent	0	None
21455	21456	antagonist	0	None
21456	21457	of	0	None
21457	21460	platelet glycoprotein IIb-IIIa	1	GENE-Y
21460	21461	.	0	None

21462	21463	Clinical	0	None
21463	21464	trials	0	None
21464	21465	are	0	None
21465	21466	needed	0	None
21466	21467	to	0	None
21467	21468	assess	0	None
21468	21469	the	0	None
21469	21470	safety	0	None
21470	21471	and	0	None
21471	21472	efficacy	0	None
21472	21473	of	0	None
21473	21474	this	0	None
21474	21475	combination	0	None
21475	21476	.	0	None
21476	21477	The	0	None
21477	21478	phytochemical	0	None
21478	21479	investigation	0	None
21479	21480	of	0	None
21480	21481	the	0	None
21481	21482	ethylacetate-soluble	0	None
21482	21483	fraction	0	None
21483	21484	of	0	None
21484	21485	Caryopteris	0	None
21485	21486	odorata	0	None
21486	21487	(	0	None
21487	21488	Ham	0	None
21488	21489	.	0	None

21490	21491	ex	0	None
21491	21492	Roxb	0	None
21492	21493	.	0	None

21494	21495	)	0	None
21495	21496	led	0	None
21496	21497	to	0	None
21497	21498	the	0	None
21498	21499	isolation	0	None
21499	21500	of	0	None
21500	21501	four	0	None
21501	21502	new	0	None
21502	21503	iridoid	0	None
21503	21504	glucosides	0	None
21504	21505	(	0	None
21505	21506	1-4	0	None
21506	21507	)	0	None
21507	21508	:	0	None
21508	21509	8-O-trans-cinnamoyl	0	None
21509	21510	caryoptoside	0	None
21510	21511	(	0	None
21511	21512	1	0	None
21512	21513	)	0	None
21513	21514	,	0	None
21514	21515	8-O-trans-cinnamoyl	0	None
21515	21517	shanzhiside methylester	2	CHEMICAL
21517	21518	(	0	None
21518	21519	2	0	None
21519	21520	)	0	None
21520	21521	,	0	None
21521	21522	8-O-trans-cinnamoyl	0	None
21522	21523	mussaenoside	0	None
21523	21524	(	0	None
21524	21525	3	0	None
21525	21526	)	0	None
21526	21527	and	0	None
21527	21528	8-O-cafeoyl	0	None
21528	21529	massenoside	0	None
21529	21530	(	0	None
21530	21531	4	0	None
21531	21532	)	0	None
21532	21533	.	0	None

21534	21535	The	0	None
21535	21536	structures	0	None
21536	21537	of	0	None
21537	21538	these	0	None
21538	21539	compounds	0	None
21539	21540	were	0	None
21540	21541	determined	0	None
21541	21542	by	0	None
21542	21543	FAB-MS	0	None
21543	21544	,	0	None
21544	21545	IR	0	None
21545	21546	,	0	None
21546	21547	1D	0	None
21547	21548	and	0	None
21548	21549	2D-NMR	0	None
21549	21550	spectroscopy	0	None
21550	21551	and	0	None
21551	21552	by	0	None
21552	21553	comparing	0	None
21553	21554	with	0	None
21554	21555	the	0	None
21555	21556	published	0	None
21556	21557	data	0	None
21557	21558	of	0	None
21558	21559	the	0	None
21559	21560	closely	0	None
21560	21561	related	0	None
21561	21562	compounds	0	None
21562	21563	.	0	None

21564	21565	The	0	None
21565	21566	antioxidant	0	None
21566	21567	potential	0	None
21567	21568	of	0	None
21568	21569	the	0	None
21569	21570	isolated	0	None
21570	21571	iridoids	0	None
21571	21572	(	0	None
21572	21573	1-4	0	None
21573	21574	)	0	None
21574	21575	was	0	None
21575	21576	evaluated	0	None
21576	21577	relative	0	None
21577	21578	to	0	None
21578	21579	conventionally	0	None
21579	21580	used	0	None
21580	21581	standards	0	None
21581	21582	and	0	None
21582	21583	these	0	None
21583	21584	molecules	0	None
21584	21585	exhibited	0	None
21585	21586	good	0	None
21586	21587	antioxidant	0	None
21587	21588	potential	0	None
21588	21589	.	0	None

21590	21591	Moreover	0	None
21591	21592	,	0	None
21592	21593	their	0	None
21593	21594	inhibitory	0	None
21594	21595	potential	0	None
21595	21596	was	0	None
21596	21597	also	0	None
21597	21598	screened	0	None
21598	21599	against	0	None
21599	21600	three	0	None
21600	21601	enzymes	0	None
21601	21602	,	0	None
21602	21603	namely	0	None
21603	21604	acetyl	0	None
21604	21605	cholinesterase	1	GENE-Y
21605	21606	,	0	None
21606	21607	butyrylcholinesterase	0	None
21607	21608	and	0	None
21608	21609	lipoxygenase	0	None
21609	21610	.	0	None

21611	21612	These	0	None
21612	21613	iridoid	0	None
21613	21614	glucosides	0	None
21614	21615	were	0	None
21615	21616	found	0	None
21616	21617	to	0	None
21617	21618	be	0	None
21618	21619	inactive	0	None
21619	21620	against	0	None
21620	21621	acetyl	0	None
21621	21622	and	0	None
21622	21623	butyrylcholinesterases	0	None
21623	21624	but	0	None
21624	21625	active	0	None
21625	21626	against	0	None
21626	21627	lipoxygenase	0	None
21627	21628	.	0	None
21628	21629	Reconstitution	0	None
21629	21630	of	0	None
21630	21631	homomeric	0	None
21631	21632	GluA2	0	None
21632	21633	(	0	None
21633	21634	flop	0	None
21634	21635	)	0	None
21635	21636	receptors	0	None
21636	21637	in	0	None
21637	21638	supported	0	None
21638	21639	lipid	0	None
21639	21640	membranes	0	None
21640	21641	:	0	None
21641	21642	functional	0	None
21642	21643	and	0	None
21643	21644	structural	0	None
21644	21645	properties	0	None
21645	21646	.	0	None
21646	21647	Dopamine	0	None
21647	21648	genes	0	None
21648	21649	and	0	None
21649	21650	pathological	0	None
21650	21651	gambling	0	None
21651	21652	in	0	None
21652	21653	discordant	0	None
21653	21654	sib-pairs	0	None
21654	21655	.	0	None
21655	21656	Novel	0	None
21656	21657	analgesic	0	None
21657	21658	/	0	None
21658	21659	anti-inflammatory	0	None
21659	21660	agents	0	None
21660	21661	:	0	None
21661	21662	1	0	None
21662	21663	,	0	None
21663	21664	5-diarylpyrrole	0	None
21664	21665	nitrooxyalkyl	0	None
21665	21666	ethers	0	None
21666	21667	and	0	None
21667	21668	related	0	None
21668	21669	compounds	0	None
21669	21670	as	0	None
21670	21671	cyclooxygenase-2	0	None
21671	21672	inhibiting	0	None
21672	21673	nitric	0	None
21673	21674	oxide	0	None
21674	21675	donors	0	None
21675	21676	.	0	None
21676	21677	Minocycline	2	CHEMICAL
21677	21678	inhibits	0	None
21678	21679	the	0	None
21679	21680	production	0	None
21680	21681	of	0	None
21681	21685	inducible nitric oxide synthase	1	GENE-Y
21685	21686	in	0	None
21686	21687	articular	0	None
21687	21688	chondrocytes	0	None
21688	21689	.	0	None
21689	21690	Interaction	0	None
21690	21691	of	0	None
21691	21692	silymarin	0	None
21692	21693	flavonolignans	2	CHEMICAL
21693	21694	with	0	None
21694	21697	organic anion-transporting polypeptides	3	GENE-N
21697	21698	.	0	None
21698	21699	DNA	0	None
21699	21700	polymerase	0	None
21700	21701	is	0	None
21701	21702	one	0	None
21702	21703	of	0	None
21703	21704	the	0	None
21704	21705	most	0	None
21705	21706	important	0	None
21706	21707	target	0	None
21707	21708	molecules	0	None
21708	21709	of	0	None
21709	21710	antitumor	0	None
21710	21711	agents	0	None
21711	21712	,	0	None
21712	21713	especially	0	None
21713	21714	for	0	None
21714	21715	antimetabolite	0	None
21715	21716	nucleosides	0	None
21716	21717	that	0	None
21717	21718	include	0	None
21718	21719	1-beta-D-arabinofuranosylcytosine	0	None
21719	21720	(	0	None
21720	21721	araC	2	CHEMICAL
21721	21722	)	0	None
21722	21723	and	0	None
21723	21724	2'-deoxy-2'	0	None
21724	21725	,	0	None
21725	21726	2'-difluorocytidine	0	None
21726	21727	(	0	None
21727	21728	gemcitabine	0	None
21728	21729	)	0	None
21729	21730	.	0	None

21731	21732	There	0	None
21732	21733	are	0	None
21733	21734	several	0	None
21734	21735	subtypes	0	None
21735	21736	of	0	None
21736	21739	mammalian DNA polymerases	3	GENE-N
21739	21740	and	0	None
21740	21741	their	0	None
21741	21742	localization	0	None
21742	21743	and	0	None
21743	21744	function	0	None
21744	21745	have	0	None
21745	21746	been	0	None
21746	21747	clarified	0	None
21747	21748	.	0	None

21749	21750	DNA	0	None
21750	21751	polymerase	0	None
21751	21752	alpha	0	None
21752	21753	,	0	None
21753	21754	delta	0	None
21754	21755	and	0	None
21755	21756	epsilon	0	None
21756	21757	have	0	None
21757	21758	been	0	None
21758	21759	implicated	0	None
21759	21760	to	0	None
21760	21761	be	0	None
21761	21762	responsible	0	None
21762	21763	for	0	None
21763	21764	DNA	0	None
21764	21765	replication	0	None
21765	21766	,	0	None
21766	21767	whereas	0	None
21767	21768	DNA	0	None
21768	21769	polymerase	0	None
21769	21770	beta	0	None
21770	21771	,	0	None
21771	21772	delta	0	None
21772	21773	and	0	None
21773	21774	epsilon	0	None
21774	21775	have	0	None
21775	21776	been	0	None
21776	21777	suggested	0	None
21777	21778	to	0	None
21778	21779	work	0	None
21779	21780	in	0	None
21780	21781	DNA	0	None
21781	21782	repair	0	None
21782	21783	.	0	None

21784	21785	DNA	0	None
21785	21786	polymerase	0	None
21786	21787	gamma	0	None
21787	21788	is	0	None
21788	21789	encoded	0	None
21789	21790	in	0	None
21790	21791	the	0	None
21791	21792	nucleus	0	None
21792	21793	but	0	None
21793	21794	localizes	0	None
21794	21795	in	0	None
21795	21796	the	0	None
21796	21797	mitochondria	0	None
21797	21798	,	0	None
21798	21799	and	0	None
21799	21800	is	0	None
21800	21801	responsible	0	None
21801	21802	for	0	None
21802	21803	the	0	None
21803	21804	mitochondrial	0	None
21804	21805	DNA	0	None
21805	21806	replication	0	None
21806	21807	.	0	None

21808	21809	Recently	0	None
21809	21810	,	0	None
21810	21811	several	0	None
21811	21812	antiviral	0	None
21812	21813	nucleoside	0	None
21813	21814	analogs	0	None
21814	21815	were	0	None
21815	21816	reported	0	None
21816	21817	to	0	None
21817	21818	inhibit	0	None
21818	21819	DNA	0	None
21819	21820	polymerase	0	None
21820	21821	gamma	0	None
21821	21822	after	0	None
21822	21823	intracellular	0	None
21823	21824	phosphorylation	0	None
21824	21825	and	0	None
21825	21826	cause	0	None
21826	21827	severe	0	None
21827	21828	chronic	0	None
21828	21829	toxicity	0	None
21829	21830	.	0	None

21831	21832	1-	0	None
21832	21833	(	0	None
21833	21834	2-Deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl	0	None
21834	21835	)	0	None
21835	21836	cytosine	0	None
21836	21837	(	0	None
21837	21838	4'-thio-FAC	0	None
21838	21839	)	0	None
21839	21840	,	0	None
21840	21841	an	0	None
21841	21842	antimetabolite	0	None
21842	21843	similar	0	None
21843	21844	to	0	None
21844	21845	araC	2	CHEMICAL
21845	21846	and	0	None
21846	21847	gemcitabine	0	None
21847	21848	,	0	None
21848	21849	is	0	None
21849	21850	recently	0	None
21850	21851	shown	0	None
21851	21852	by	0	None
21852	21853	us	0	None
21853	21854	to	0	None
21854	21855	be	0	None
21855	21856	a	0	None
21856	21857	very	0	None
21857	21858	promising	0	None
21858	21859	agent	0	None
21859	21860	because	0	None
21860	21861	of	0	None
21861	21862	its	0	None
21862	21863	potent	0	None
21863	21864	antitumor	0	None
21864	21865	activity	0	None
21865	21866	by	0	None
21866	21867	oral	0	None
21867	21868	administration	0	None
21868	21869	to	0	None
21869	21870	mice	0	None
21870	21871	.	0	None

21872	21873	We	0	None
21873	21874	tested	0	None
21874	21875	for	0	None
21875	21876	the	0	None
21876	21877	inhibitory	0	None
21877	21878	activities	0	None
21878	21879	of	0	None
21879	21880	the	0	None
21880	21883	triphosphates of 4'-thio-FAC	2	CHEMICAL
21883	21884	and	0	None
21884	21885	gemcitabine	0	None
21885	21886	against	0	None
21886	21887	DNA	0	None
21887	21888	polymerase	0	None
21888	21889	alpha	0	None
21889	21890	,	0	None
21890	21891	beta	0	None
21891	21892	and	0	None
21892	21893	gamma	0	None
21893	21894	.	0	None

21895	21896	The	0	None
21896	21899	triphosphates of 4'-thio-FAC	2	CHEMICAL
21899	21900	(	0	None
21900	21901	4'-thio-FACTP	0	None
21901	21902	)	0	None
21902	21903	exhibited	0	None
21903	21904	the	0	None
21904	21905	potent	0	None
21905	21906	inhibitory	0	None
21906	21907	action	0	None
21907	21908	against	0	None
21908	21909	DNA	0	None
21909	21910	polymerase	0	None
21910	21911	alpha	0	None
21911	21912	,	0	None
21912	21913	whereas	0	None
21913	21914	it	0	None
21914	21915	showed	0	None
21915	21916	moderate	0	None
21916	21917	inhibition	0	None
21917	21918	against	0	None
21918	21919	DNA	0	None
21919	21920	polymerase	0	None
21920	21921	beta	0	None
21921	21922	and	0	None
21922	21923	little	0	None
21923	21924	inhibition	0	None
21924	21925	against	0	None
21925	21926	DNA	0	None
21926	21927	polymerase	0	None
21927	21928	gamma	0	None
21928	21929	.	0	None

21930	21931	The	0	None
21931	21932	triphosphate	0	None
21932	21933	of	0	None
21933	21934	gemcitabine	0	None
21934	21935	(	0	None
21935	21936	dFdCTP	0	None
21936	21937	)	0	None
21937	21938	did	0	None
21938	21939	not	0	None
21939	21940	show	0	None
21940	21941	potent	0	None
21941	21942	inhibition	0	None
21942	21943	against	0	None
21943	21944	these	0	None
21944	21945	three	0	None
21945	21947	DNA polymerases	3	GENE-N
21947	21948	.	0	None

21949	21950	Thus	0	None
21950	21951	,	0	None
21951	21952	the	0	None
21952	21953	effect	0	None
21953	21954	on	0	None
21954	21955	ribonucleotide	0	None
21955	21956	reductase	0	None
21956	21957	was	0	None
21957	21958	suggested	0	None
21958	21959	to	0	None
21959	21960	be	0	None
21960	21961	more	0	None
21961	21962	responsible	0	None
21962	21963	for	0	None
21963	21964	the	0	None
21964	21965	antitumor	0	None
21965	21966	action	0	None
21966	21967	of	0	None
21967	21968	gemcitabine	0	None
21968	21969	.	0	None

21970	21971	The	0	None
21971	21972	differences	0	None
21972	21973	in	0	None
21973	21974	the	0	None
21974	21975	mechanisms	0	None
21975	21976	of	0	None
21976	21977	action	0	None
21977	21978	against	0	None
21978	21980	DNA polymerases	3	GENE-N
21980	21981	between	0	None
21981	21982	these	0	None
21982	21983	drugs	0	None
21983	21984	and	0	None
21984	21985	other	0	None
21985	21986	nucleosides	0	None
21986	21987	were	0	None
21987	21988	also	0	None
21988	21989	discussed	0	None
21989	21990	.	0	None
21990	21991	OBJECTIVE	0	None
21991	21992	:	0	None
21992	21993	The	0	None
21993	21994	metabolic	0	None
21994	21995	syndrome	0	None
21995	21996	(	0	None
21996	21997	MetS	0	None
21997	21998	)	0	None
21998	21999	is	0	None
21999	22000	an	0	None
22000	22001	increasing	0	None
22001	22002	epidemiologic	0	None
22002	22003	challenge	0	None
22003	22004	and	0	None
22004	22005	cardiovascular	0	None
22005	22006	risk	0	None
22006	22007	factor	0	None
22007	22008	.	0	None

22009	22010	Interleukin-6	0	None
22010	22011	(	0	None
22011	22012	IL-6	0	None
22012	22013	)	0	None
22013	22014	is	0	None
22014	22015	a	0	None
22015	22016	cytokine	0	None
22016	22017	that	0	None
22017	22018	exerts	0	None
22018	22019	its	0	None
22019	22020	biological	0	None
22020	22021	function	0	None
22021	22022	via	0	None
22022	22023	a	0	None
22023	22024	complex	0	None
22024	22025	orchestration	0	None
22025	22026	of	0	None
22026	22027	soluble	0	None
22027	22028	and	0	None
22028	22029	membrane	0	None
22029	22030	bound	0	None
22030	22031	receptors	0	None
22031	22032	.	0	None

22033	22034	We	0	None
22034	22035	have	0	None
22035	22036	investigated	0	None
22036	22037	associations	0	None
22037	22038	between	0	None
22038	22039	IL-6	0	None
22039	22040	and	0	None
22040	22041	its	0	None
22041	22042	soluble	0	None
22042	22043	receptors	0	None
22043	22044	,	0	None
22044	22047	soluble IL-6 receptor	1	GENE-Y
22047	22048	(	0	None
22048	22049	sIL-6r	0	None
22049	22050	)	0	None
22050	22051	and	0	None
22051	22054	soluble glycoprotein 130	1	GENE-Y
22054	22055	(	0	None
22055	22056	sGP130	0	None
22056	22057	)	0	None
22057	22058	and	0	None
22058	22059	the	0	None
22059	22060	metabolic	0	None
22060	22061	syndrome	0	None
22061	22062	.	0	None

22063	22064	Furthermore	0	None
22064	22065	,	0	None
22065	22066	we	0	None
22066	22067	have	0	None
22067	22068	investigated	0	None
22068	22069	possible	0	None
22069	22070	associations	0	None
22070	22071	with	0	None
22071	22072	endothelial	0	None
22072	22073	dysfunction	0	None
22073	22074	and	0	None
22074	22075	arterial	0	None
22075	22076	stiffness	0	None
22076	22077	.	0	None

22078	22079	METHODS	0	None
22079	22080	:	0	None
22080	22081	A	0	None
22081	22082	total	0	None
22082	22083	of	0	None
22083	22084	563	0	None
22084	22085	subjects	0	None
22085	22086	were	0	None
22086	22087	included	0	None
22087	22088	in	0	None
22088	22089	this	0	None
22089	22090	study	0	None
22090	22091	.	0	None

22092	22093	The	0	None
22093	22094	Adult	0	None
22094	22095	Treatment	0	None
22095	22096	Panel	0	None
22096	22097	III	0	None
22097	22098	criteria	0	None
22098	22099	of	0	None
22099	22100	the	0	None
22100	22101	National	0	None
22101	22102	Cholesterol	0	None
22102	22103	Education	0	None
22103	22104	Program	0	None
22104	22105	were	0	None
22105	22106	used	0	None
22106	22107	for	0	None
22107	22108	the	0	None
22108	22109	definition	0	None
22109	22110	of	0	None
22110	22111	MetS	0	None
22111	22112	.	0	None

22113	22114	We	0	None
22114	22115	used	0	None
22115	22116	commercially	0	None
22116	22117	available	0	None
22117	22118	ELISA	0	None
22118	22119	to	0	None
22119	22120	analyse	0	None
22120	22121	circulating	0	None
22121	22122	levels	0	None
22122	22123	of	0	None
22123	22124	the	0	None
22124	22125	markers	0	None
22125	22126	.	0	None

22127	22128	Pulse	0	None
22128	22129	wave	0	None
22129	22130	propagation	0	None
22130	22131	time	0	None
22131	22132	(	0	None
22132	22133	PWP	0	None
22133	22134	)	0	None
22134	22135	was	0	None
22135	22136	determined	0	None
22136	22137	to	0	None
22137	22138	assess	0	None
22138	22139	arterial	0	None
22139	22140	stiffness	0	None
22140	22141	.	0	None

22142	22143	RESULTS	0	None
22143	22144	:	0	None
22144	22145	The	0	None
22145	22146	criteria	0	None
22146	22147	for	0	None
22147	22148	having	0	None
22148	22149	MetS	0	None
22149	22150	were	0	None
22150	22151	filled	0	None
22151	22152	by	0	None
22152	22153	221	0	None
22153	22154	subjects	0	None
22154	22155	.	0	None

22156	22157	sGP130	0	None
22157	22158	,	0	None
22158	22159	sIL-6r	0	None
22159	22160	and	0	None
22160	22161	IL-6	0	None
22161	22162	levels	0	None
22162	22163	were	0	None
22163	22164	elevated	0	None
22164	22165	in	0	None
22165	22166	subjects	0	None
22166	22167	with	0	None
22167	22168	MetS	0	None
22168	22169	(	0	None
22169	22170	p<0	0	None
22170	22171	.	0	None
22171	22172	05	0	None
22172	22173	for	0	None
22173	22174	all	0	None
22174	22175	markers	0	None
22175	22176	)	0	None
22176	22177	,	0	None
22177	22178	and	0	None
22178	22179	are	0	None
22179	22180	associated	0	None
22180	22181	with	0	None
22181	22182	increasing	0	None
22182	22183	components	0	None
22183	22184	of	0	None
22184	22185	MetS	0	None
22185	22186	.	0	None

22187	22188	Particularly	0	None
22188	22189	hypertriglyceridaemia	0	None
22189	22190	,	0	None
22190	22191	hypertension	0	None
22191	22192	and	0	None
22192	22193	fasting	0	None
22193	22194	plasma	0	None
22194	22195	glucose	0	None
22195	22196	(	0	None
22196	22197	FPG	0	None
22197	22198	)	0	None
22198	22199	seem	0	None
22199	22200	to	0	None
22200	22201	carry	0	None
22201	22202	this	0	None
22202	22203	association	0	None
22203	22204	.	0	None

22205	22206	sGP130	0	None
22206	22207	(	0	None
22207	22208	p<0	0	None
22208	22209	.	0	None
22209	22210	01	0	None
22210	22211	)	0	None
22211	22212	,	0	None
22212	22213	IL-6	0	None
22213	22214	(	0	None
22214	22215	p<0	0	None
22215	22216	.	0	None
22216	22217	05	0	None
22217	22218	)	0	None
22218	22219	and	0	None
22219	22220	partially	0	None
22220	22221	sIL-6r	0	None
22221	22222	(	0	None
22222	22223	p<0	0	None
22223	22224	.	0	None
22224	22225	05	0	None
22225	22226	)	0	None
22226	22227	correlated	0	None
22227	22228	with	0	None
22228	22229	markers	0	None
22229	22230	of	0	None
22230	22231	endothelial	0	None
22231	22232	function	0	None
22232	22233	(	0	None
22233	22234	E-selectin	0	None
22234	22235	,	0	None
22235	22236	I-CAM-1	0	None
22236	22237	,	0	None
22237	22238	V-CAM-1	0	None
22238	22239	)	0	None
22239	22240	and	0	None
22240	22241	inversely	0	None
22241	22242	with	0	None
22242	22243	PWP	0	None
22243	22244	after	0	None
22244	22245	adjustment	0	None
22245	22246	for	0	None
22246	22247	relevant	0	None
22247	22248	covariates	0	None
22248	22249	.	0	None

22250	22251	CONCLUSION	0	None
22251	22252	:	0	None
22252	22253	sGP130	0	None
22253	22254	,	0	None
22254	22255	sIL-6r	0	None
22255	22256	and	0	None
22256	22257	IL-6	0	None
22257	22258	were	0	None
22258	22259	significantly	0	None
22259	22260	elevated	0	None
22260	22261	in	0	None
22261	22262	subjects	0	None
22262	22263	with	0	None
22263	22264	MetS	0	None
22264	22265	.	0	None

22266	22267	In	0	None
22267	22268	addition	0	None
22268	22269	,	0	None
22269	22270	sGP130	0	None
22270	22271	,	0	None
22271	22272	IL-6	0	None
22272	22273	and	0	None
22273	22274	partially	0	None
22274	22275	sIL-6r	0	None
22275	22276	were	0	None
22276	22277	associated	0	None
22277	22278	with	0	None
22278	22279	markers	0	None
22279	22280	of	0	None
22280	22281	endothelial	0	None
22281	22282	function	0	None
22282	22283	and	0	None
22283	22284	arterial	0	None
22284	22285	stiffness	0	None
22285	22286	.	0	None

22287	22288	This	0	None
22288	22289	finding	0	None
22289	22290	sheds	0	None
22290	22291	new	0	None
22291	22292	light	0	None
22292	22293	on	0	None
22293	22294	the	0	None
22294	22295	role	0	None
22295	22296	of	0	None
22296	22297	these	0	None
22297	22298	inflammatory	0	None
22298	22299	cytokines	3	GENE-N
22299	22300	in	0	None
22300	22301	subjects	0	None
22301	22302	with	0	None
22302	22303	MetS	0	None
22303	22304	and	0	None
22304	22305	the	0	None
22305	22306	development	0	None
22306	22307	and	0	None
22307	22308	progression	0	None
22308	22309	of	0	None
22309	22310	clinically	0	None
22310	22311	silent	0	None
22311	22312	atherosclerosis	0	None
22312	22313	.	0	None
22313	22314	Methylenetetrahydrofolate	0	None
22314	22315	reductase	0	None
22315	22316	genotype	0	None
22316	22317	,	0	None
22317	22318	vitamin	0	None
22318	22319	B12	0	None
22319	22320	,	0	None
22320	22321	and	0	None
22321	22322	folate	0	None
22322	22323	influence	0	None
22323	22324	plasma	0	None
22324	22325	homocysteine	0	None
22325	22326	in	0	None
22326	22327	hemodialysis	0	None
22327	22328	patients	0	None
22328	22329	.	0	None
22329	22330	Direct	0	None
22330	22331	transcriptional	0	None
22331	22332	regulation	0	None
22332	22333	of	0	None
22333	22338	human hepatic cytochrome P450 3A4	1	GENE-Y
22338	22339	(	0	None
22339	22340	CYP3A4	0	None
22340	22341	)	0	None
22341	22342	by	0	None
22342	22346	peroxisome proliferator-activated receptor alpha	1	GENE-Y
22346	22347	(	0	None
22347	22348	PPARα	0	None
22348	22349	)	0	None
22349	22350	.	0	None
22350	22351	The	0	None
22351	22352	YLR205c	0	None
22352	22353	gene	0	None
22353	22354	of	0	None
22354	22355	Saccharomyces	0	None
22355	22356	cerevisiae	0	None
22356	22357	does	0	None
22357	22358	not	0	None
22358	22359	show	0	None
22359	22360	significant	0	None
22360	22361	sequence	0	None
22361	22362	identity	0	None
22362	22363	to	0	None
22363	22364	any	0	None
22364	22365	known	0	None
22365	22366	gene	0	None
22366	22367	,	0	None
22367	22368	except	0	None
22368	22369	for	0	None
22369	22370	heme	0	None
22370	22371	oxygenase	0	None
22371	22372	(	0	None
22372	22373	22%	0	None
22373	22374	to	0	None
22374	22375	human	0	None
22375	22376	HO-1	0	None
22376	22377	)	0	None
22377	22378	.	0	None

22379	22380	The	0	None
22380	22381	YLR205	0	None
22381	22382	ORF	0	None
22382	22383	was	0	None
22383	22384	cloned	0	None
22384	22385	and	0	None
22385	22386	overexpressed	0	None
22386	22387	in	0	None
22387	22388	both	0	None
22388	22389	Escherichia	0	None
22389	22390	coli	0	None
22390	22391	and	0	None
22391	22392	S	0	None
22392	22393	.	0	None

22394	22395	cerevisiae	0	None
22395	22396	.	0	None

22397	22398	Both	0	None
22398	22399	expression	0	None
22399	22400	systems	0	None
22400	22401	yielded	0	None
22401	22402	proteins	0	None
22402	22403	that	0	None
22403	22404	bound	0	None
22404	22405	heme	0	None
22405	22406	tightly	0	None
22406	22407	.	0	None

22408	22409	The	0	None
22409	22410	isolated	0	None
22410	22411	YLR205c	0	None
22411	22412	protein	0	None
22412	22413	underwent	0	None
22413	22414	reduction	0	None
22414	22415	in	0	None
22415	22416	the	0	None
22416	22417	presence	0	None
22417	22418	of	0	None
22418	22419	either	0	None
22419	22420	NADPH-cytochrome	0	None
22420	22421	P450	0	None
22421	22422	reductase	0	None
22422	22423	or	0	None
22423	22424	NADH-putidaredoxin-putidaredoxin	0	None
22424	22425	reductase	0	None
22425	22426	but	0	None
22426	22427	did	0	None
22427	22428	not	0	None
22428	22429	exhibit	0	None
22429	22430	heme	0	None
22430	22431	oxygenase	0	None
22431	22432	activity	0	None
22432	22433	.	0	None

22434	22435	The	0	None
22435	22436	protein	0	None
22436	22437	exhibited	0	None
22437	22438	modest	0	None
22438	22439	H	0	None
22439	22440	(	0	None
22440	22441	2	0	None
22441	22442	)	0	None
22442	22443	O	0	None
22443	22444	(	0	None
22444	22445	2	0	None
22445	22446	)	0	None
22446	22447	-dependent	0	None
22447	22448	peroxidase	0	None
22448	22449	activities	0	None
22449	22450	with	0	None
22450	22451	guaiacol	0	None
22451	22452	,	0	None
22452	22453	potassium	0	None
22453	22454	iodide	2	CHEMICAL
22454	22455	,	0	None
22455	22456	and	0	None
22456	22457	2	0	None
22457	22458	,	0	None
22458	22459	2	0	None
22459	22460	(	0	None
22460	22461	'	0	None
22461	22462	)	0	None
22462	22463	-azino-bis	0	None
22463	22464	(	0	None
22464	22465	3-ethylbenzothiazoline-6-sulfonic	0	None
22465	22466	acid	0	None
22466	22467	(	0	None
22467	22468	ABTS	0	None
22468	22469	)	0	None
22469	22470	.	0	None

22471	22472	Thus	0	None
22472	22473	,	0	None
22473	22474	YLR205c	0	None
22474	22475	codes	0	None
22475	22476	for	0	None
22476	22477	a	0	None
22477	22478	hemoprotein	0	None
22478	22479	of	0	None
22479	22480	unknown	0	None
22480	22481	physiological	0	None
22481	22482	function	0	None
22482	22483	that	0	None
22483	22484	exhibits	0	None
22484	22485	peroxidase	0	None
22485	22486	activity	0	None
22486	22487	.	0	None
22487	22488	Maqui	0	None
22488	22489	berry	0	None
22489	22490	(	0	None
22490	22491	Aristotelia	0	None
22491	22492	chilensis	0	None
22492	22493	)	0	None
22493	22494	and	0	None
22494	22495	the	0	None
22495	22496	constituent	0	None
22496	22497	delphinidin	0	None
22497	22498	glycoside	0	None
22498	22499	inhibit	0	None
22499	22500	photoreceptor	0	None
22500	22501	cell	0	None
22501	22502	death	0	None
22502	22503	induced	0	None
22503	22504	by	0	None
22504	22505	visible	0	None
22505	22506	light	0	None
22506	22507	.	0	None
22507	22508	A	0	None
22508	22509	low-affinity	0	None
22509	22510	Ca	0	None
22510	22511	(	0	None
22511	22512	2	0	None
22512	22513	+	0	None
22513	22514	)	0	None
22514	22515	/	0	None
22515	22516	H	0	None
22516	22517	(	0	None
22517	22518	+	0	None
22518	22519	)	0	None
22519	22520	-antiport	0	None
22520	22521	was	0	None
22521	22522	described	0	None
22522	22523	in	0	None
22523	22524	the	0	None
22524	22525	membrane	0	None
22525	22526	of	0	None
22526	22527	mammalian	0	None
22527	22528	brain	0	None
22528	22529	synaptic	0	None
22529	22530	vesicles	0	None
22530	22531	.	0	None

22532	22533	Electrophysiological	0	None
22533	22534	studies	0	None
22534	22535	showed	0	None
22535	22536	that	0	None
22536	22537	this	0	None
22537	22538	antiport	0	None
22538	22539	contributes	0	None
22539	22540	to	0	None
22540	22541	the	0	None
22541	22542	extreme	0	None
22542	22543	brevity	0	None
22543	22544	of	0	None
22544	22545	excitation-release	0	None
22545	22546	coupling	0	None
22546	22547	in	0	None
22547	22548	rapid	0	None
22548	22549	synapses	0	None
22549	22550	.	0	None

22551	22552	Synaptotagmin-1	0	None
22552	22553	,	0	None
22553	22554	a	0	None
22554	22555	vesicular	0	None
22555	22556	protein	0	None
22556	22557	interacting	0	None
22557	22558	with	0	None
22558	22559	membranes	0	None
22559	22560	upon	0	None
22560	22561	low-affinity	0	None
22561	22562	Ca	0	None
22562	22563	(	0	None
22563	22564	2	0	None
22564	22565	+	0	None
22565	22566	)	0	None
22566	22567	-binding	0	None
22567	22568	,	0	None
22568	22569	plays	0	None
22569	22570	a	0	None
22570	22571	major	0	None
22571	22572	role	0	None
22572	22573	in	0	None
22573	22574	excitation-release	0	None
22574	22575	coupling	0	None
22575	22576	,	0	None
22576	22577	by	0	None
22577	22578	synchronizing	0	None
22578	22579	calcium	0	None
22579	22580	entry	0	None
22580	22581	with	0	None
22581	22582	fast	0	None
22582	22583	neurotransmitter	0	None
22583	22584	release	0	None
22584	22585	.	0	None

22586	22587	Here	0	None
22587	22588	,	0	None
22588	22589	we	0	None
22589	22590	report	0	None
22590	22591	that	0	None
22591	22592	synaptotagmin-1	0	None
22592	22593	is	0	None
22593	22594	necessary	0	None
22594	22595	for	0	None
22595	22596	expression	0	None
22596	22597	of	0	None
22597	22598	the	0	None
22598	22599	vesicular	0	None
22599	22600	Ca	0	None
22600	22601	(	0	None
22601	22602	2	0	None
22602	22603	+	0	None
22603	22604	)	0	None
22604	22605	/	0	None
22605	22606	H	0	None
22606	22607	(	0	None
22607	22608	+	0	None
22608	22609	)	0	None
22609	22610	-antiport	0	None
22610	22611	.	0	None

22612	22613	We	0	None
22613	22614	measured	0	None
22614	22615	Ca	0	None
22615	22616	(	0	None
22616	22617	2	0	None
22617	22618	+	0	None
22618	22619	)	0	None
22619	22620	/	0	None
22620	22621	H	0	None
22621	22622	(	0	None
22622	22623	+	0	None
22623	22624	)	0	None
22624	22625	-antiport	0	None
22625	22626	activity	0	None
22626	22627	in	0	None
22627	22628	vesicles	0	None
22628	22629	and	0	None
22629	22630	granules	0	None
22630	22631	of	0	None
22631	22632	pheochromocytoma	0	None
22632	22633	PC12	0	None
22633	22634	cells	0	None
22634	22635	by	0	None
22635	22636	three	0	None
22636	22637	methods	0	None
22637	22638	:	0	None
22638	22639	(	0	None
22639	22640	1	0	None
22640	22641	)	0	None
22641	22642	Ca	0	None
22642	22643	(	0	None
22643	22644	2	0	None
22644	22645	+	0	None
22645	22646	)	0	None
22646	22647	-induced	0	None
22647	22648	dissipation	0	None
22648	22649	of	0	None
22649	22650	the	0	None
22650	22651	vesicular	0	None
22651	22652	H	0	None
22652	22653	(	0	None
22653	22654	+	0	None
22654	22655	)	0	None
22655	22656	-gradient;	0	None
22656	22657	(	0	None
22657	22658	2	0	None
22658	22659	)	0	None
22659	22660	bafilomycin-sensitive	0	None
22660	22661	calcium	0	None
22661	22662	accumulation	0	None
22662	22663	and	0	None
22663	22664	(	0	None
22664	22665	3	0	None
22665	22666	)	0	None
22666	22667	pH-jump-induced	0	None
22667	22668	calcium	0	None
22668	22669	accumulation	0	None
22669	22670	.	0	None

22671	22672	The	0	None
22672	22673	results	0	None
22673	22674	were	0	None
22674	22675	congruent	0	None
22675	22676	and	0	None
22676	22677	highly	0	None
22677	22678	significant	0	None
22678	22679	:	0	None
22679	22680	Ca	0	None
22680	22681	(	0	None
22681	22682	2	0	None
22682	22683	+	0	None
22683	22684	)	0	None
22684	22685	/	0	None
22685	22686	H	0	None
22686	22687	(	0	None
22687	22688	+	0	None
22688	22689	)	0	None
22689	22690	-antiport	0	None
22690	22691	activity	0	None
22691	22692	is	0	None
22692	22693	detectable	0	None
22693	22694	only	0	None
22694	22695	in	0	None
22695	22696	acidic	0	None
22696	22697	organelles	0	None
22697	22698	expressing	0	None
22698	22699	functional	0	None
22699	22700	synaptotagmin-1	0	None
22700	22701	.	0	None

22702	22703	In	0	None
22703	22704	contrast	0	None
22704	22705	,	0	None
22705	22706	synaptotagmin-1-deficient	0	None
22706	22707	cells	0	None
22707	22708	-	0	None
22708	22709	and	0	None
22709	22710	cells	0	None
22710	22711	where	0	None
22711	22712	transgenically	0	None
22712	22713	encoded	0	None
22713	22714	synaptotagmin-1	0	None
22714	22715	was	0	None
22715	22716	acutely	0	None
22716	22717	photo-inactivated	0	None
22717	22718	-	0	None
22718	22719	were	0	None
22719	22720	devoid	0	None
22720	22721	of	0	None
22721	22722	any	0	None
22722	22723	Ca	0	None
22723	22724	(	0	None
22724	22725	2	0	None
22725	22726	+	0	None
22726	22727	)	0	None
22727	22728	/	0	None
22728	22729	H	0	None
22729	22730	(	0	None
22730	22731	+	0	None
22731	22732	)	0	None
22732	22733	-antiport	0	None
22733	22734	activity	0	None
22734	22735	.	0	None

22736	22737	Therefore	0	None
22737	22738	,	0	None
22738	22739	in	0	None
22739	22740	addition	0	None
22740	22741	to	0	None
22741	22742	its	0	None
22742	22743	previously	0	None
22743	22744	described	0	None
22744	22745	functions	0	None
22745	22746	,	0	None
22746	22747	synaptotagmin-1	0	None
22747	22748	is	0	None
22748	22749	involved	0	None
22749	22750	in	0	None
22750	22751	a	0	None
22751	22752	rapid	0	None
22752	22753	vesicular	0	None
22753	22754	Ca	0	None
22754	22755	(	0	None
22755	22756	2	0	None
22756	22757	+	0	None
22757	22758	)	0	None
22758	22759	sequestration	0	None
22759	22760	through	0	None
22760	22761	a	0	None
22761	22762	Ca	0	None
22762	22763	(	0	None
22763	22764	2	0	None
22764	22765	+	0	None
22765	22766	)	0	None
22766	22767	/	0	None
22767	22768	H	0	None
22768	22769	(	0	None
22769	22770	+	0	None
22770	22771	)	0	None
22771	22772	antiport	0	None
22772	22773	.	0	None

22774	22775	This	0	None
22775	22776	article	0	None
22776	22777	is	0	None
22777	22778	protected	0	None
22778	22779	by	0	None
22779	22780	copyright	0	None
22780	22781	.	0	None

22782	22783	All	0	None
22783	22784	rights	0	None
22784	22785	reserved	0	None
22785	22786	.	0	None
22786	22787	The	0	None
22787	22788	human	0	None
22788	22789	NADH	2	CHEMICAL
22789	22790	:	0	None
22790	22791	ubiquinone	0	None
22791	22792	oxidoreductase	0	None
22792	22793	NDUFS5	1	GENE-Y
22793	22794	(	0	None
22794	22795	15	0	None
22795	22796	kDa	0	None
22796	22797	)	0	None
22797	22798	subunit	0	None
22798	22799	:	0	None
22799	22800	cDNA	0	None
22800	22801	cloning	0	None
22801	22802	,	0	None
22802	22803	chromosomal	0	None
22803	22804	localization	0	None
22804	22805	,	0	None
22805	22806	tissue	0	None
22806	22807	distribution	0	None
22807	22808	and	0	None
22808	22809	the	0	None
22809	22810	absence	0	None
22810	22811	of	0	None
22811	22812	mutations	0	None
22812	22813	in	0	None
22813	22814	isolated	0	None
22814	22815	complex	0	None
22815	22816	I-deficient	0	None
22816	22817	patients	0	None
22817	22818	.	0	None
22818	22819	Type	0	None
22819	22820	II	0	None
22820	22821	diabetes	0	None
22821	22822	is	0	None
22822	22823	a	0	None
22823	22824	heterogeneous	0	None
22824	22825	disease	0	None
22825	22826	where	0	None
22826	22827	environment	0	None
22827	22828	and	0	None
22828	22829	genetics	0	None
22829	22830	are	0	None
22830	22831	important	0	None
22831	22832	factors	0	None
22832	22833	for	0	None
22833	22834	the	0	None
22834	22835	expression	0	None
22835	22836	of	0	None
22836	22837	the	0	None
22837	22838	disease	0	None
22838	22839	.	0	None

22840	22841	The	0	None
22841	22842	high	0	None
22842	22843	cost	0	None
22843	22844	for	0	None
22844	22845	treating	0	None
22845	22846	complications	0	None
22846	22847	of	0	None
22847	22848	diabetes	0	None
22848	22849	is	0	None
22849	22850	a	0	None
22850	22851	burden	0	None
22851	22852	for	0	None
22852	22853	public	0	None
22853	22854	health	0	None
22854	22855	systems	0	None
22855	22856	and	0	None
22856	22857	governments	0	None
22857	22858	worldwide	0	None
22858	22859	.	0	None

22860	22861	Type	0	None
22861	22862	II	0	None
22862	22863	diabetes	0	None
22863	22864	has	0	None
22864	22865	been	0	None
22865	22866	causing	0	None
22866	22867	debilitation	0	None
22867	22868	worldwide	0	None
22868	22869	for	0	None
22869	22870	many	0	None
22870	22871	decades	0	None
22871	22872	,	0	None
22872	22873	and	0	None
22873	22874	a	0	None
22874	22875	single	0	None
22875	22876	drug	0	None
22876	22877	that	0	None
22877	22878	safely	0	None
22878	22879	treats	0	None
22879	22880	the	0	None
22880	22881	disease	0	None
22881	22882	has	0	None
22882	22883	yet	0	None
22883	22884	to	0	None
22884	22885	be	0	None
22885	22886	discovered	0	None
22886	22887	.	0	None

22888	22889	Sulfonylureas	0	None
22889	22890	,	0	None
22890	22891	biguanides	0	None
22891	22892	,	0	None
22892	22893	alpha-glucosidase	0	None
22893	22894	,	0	None
22894	22895	meglitinides	0	None
22895	22896	,	0	None
22896	22897	DPP-4	0	None
22897	22898	inhibitors	0	None
22898	22899	and	0	None
22899	22900	thiazolidinediones	0	None
22900	22901	are	0	None
22901	22902	among	0	None
22902	22903	the	0	None
22903	22904	classes	0	None
22904	22905	of	0	None
22905	22906	oral	0	None
22906	22907	hypoglycemic	0	None
22907	22908	drugs	0	None
22908	22909	available	0	None
22909	22910	to	0	None
22910	22911	treat	0	None
22911	22912	Type	0	None
22912	22913	II	0	None
22913	22914	diabetes	0	None
22914	22915	,	0	None
22915	22916	but	0	None
22916	22917	concerns	0	None
22917	22918	exist	0	None
22918	22919	regarding	0	None
22919	22920	safety	0	None
22920	22921	and	0	None
22921	22922	efficacy	0	None
22922	22923	of	0	None
22923	22924	these	0	None
22924	22925	drugs	0	None
22925	22926	.	0	None

22927	22928	In	0	None
22928	22929	this	0	None
22929	22930	article	0	None
22930	22931	we	0	None
22931	22932	present	0	None
22932	22933	the	0	None
22933	22934	pros	0	None
22934	22935	and	0	None
22935	22936	cons	0	None
22936	22937	of	0	None
22937	22938	the	0	None
22938	22939	six	0	None
22939	22940	classes	0	None
22940	22941	and	0	None
22941	22942	discuss	0	None
22942	22943	some	0	None
22943	22944	of	0	None
22944	22945	the	0	None
22945	22946	latest	0	None
22946	22947	advances	0	None
22947	22948	towards	0	None
22948	22949	the	0	None
22949	22950	development	0	None
22950	22951	of	0	None
22951	22952	new	0	None
22952	22953	drugs	0	None
22953	22954	for	0	None
22954	22955	the	0	None
22955	22956	treatment	0	None
22956	22957	of	0	None
22957	22958	Type	0	None
22958	22959	II	0	None
22959	22960	diabetes	0	None
22960	22961	.	0	None
22961	22962	Distinct	0	None
22962	22963	pharmacologic	0	None
22963	22964	properties	0	None
22964	22965	of	0	None
22965	22966	neuromuscular	0	None
22966	22967	blocking	0	None
22967	22968	agents	0	None
22968	22969	on	0	None
22969	22970	human	0	None
22970	22971	neuronal	0	None
22971	22972	nicotinic	0	None
22972	22973	acetylcholine	0	None
22973	22974	receptors	0	None
22974	22975	:	0	None
22975	22976	a	0	None
22976	22977	possible	0	None
22977	22978	explanation	0	None
22978	22979	for	0	None
22979	22980	the	0	None
22980	22981	train-of-four	0	None
22981	22982	fade	0	None
22982	22983	.	0	None
22983	22984	In	0	None
22984	22985	this	0	None
22985	22986	study	0	None
22986	22987	,	0	None
22987	22988	we	0	None
22988	22989	investigated	0	None
22989	22990	the	0	None
22990	22991	role	0	None
22991	22992	of	0	None
22992	22993	intercellular	0	None
22993	22994	adhesion	0	None
22994	22995	molecule-2	0	None
22995	22996	(	0	None
22996	22997	ICAM2	0	None
22997	22998	)	0	None
22998	22999	in	0	None
22999	23000	the	0	None
23000	23001	testis	0	None
23001	23002	.	0	None

23003	23004	ICAM2	0	None
23004	23005	is	0	None
23005	23006	a	0	None
23006	23007	cell	0	None
23007	23009	adhesion protein	3	GENE-N
23009	23010	having	0	None
23010	23011	important	0	None
23011	23012	roles	0	None
23012	23013	in	0	None
23013	23014	cell	0	None
23014	23015	migration	0	None
23015	23016	,	0	None
23016	23017	especially	0	None
23017	23018	during	0	None
23018	23019	inflammation	0	None
23019	23020	when	0	None
23020	23021	leukocytes	0	None
23021	23022	cross	0	None
23022	23023	the	0	None
23023	23024	endothelium	0	None
23024	23025	.	0	None

23026	23027	Herein	0	None
23027	23028	,	0	None
23028	23029	we	0	None
23029	23030	showed	0	None
23030	23031	ICAM2	0	None
23031	23032	to	0	None
23032	23033	be	0	None
23033	23034	expressed	0	None
23034	23035	by	0	None
23035	23036	germ	0	None
23036	23037	and	0	None
23037	23038	Sertoli	0	None
23038	23039	cells	0	None
23039	23040	in	0	None
23040	23041	the	0	None
23041	23042	rat	0	None
23042	23043	testis	0	None
23043	23044	.	0	None

23045	23046	When	0	None
23046	23047	a	0	None
23047	23048	monospecific	0	None
23048	23049	antibody	0	None
23049	23050	was	0	None
23050	23051	used	0	None
23051	23052	for	0	None
23052	23053	immunolocalization	0	None
23053	23054	experiments	0	None
23054	23055	,	0	None
23055	23056	ICAM2	0	None
23056	23057	was	0	None
23057	23058	found	0	None
23058	23059	to	0	None
23059	23060	surround	0	None
23060	23061	the	0	None
23061	23062	heads	0	None
23062	23063	of	0	None
23063	23064	elongating	0	None
23064	23065	/	0	None
23065	23066	elongated	0	None
23066	23067	spermatids	0	None
23067	23068	in	0	None
23068	23069	all	0	None
23069	23070	stages	0	None
23070	23071	of	0	None
23071	23072	the	0	None
23072	23073	seminiferous	0	None
23073	23074	epithelial	0	None
23074	23075	cycle	0	None
23075	23076	.	0	None

23077	23078	To	0	None
23078	23079	determine	0	None
23079	23080	whether	0	None
23080	23081	ICAM2	0	None
23081	23082	is	0	None
23082	23083	a	0	None
23083	23084	constituent	0	None
23084	23085	of	0	None
23085	23086	apical	0	None
23086	23087	ectoplasmic	0	None
23087	23088	specialization	0	None
23088	23089	(	0	None
23089	23090	ES	0	None
23090	23091	)	0	None
23091	23092	,	0	None
23092	23093	co-immunoprecipitation	0	None
23093	23094	and	0	None
23094	23095	dual	0	None
23095	23096	immunofluorescence	0	None
23096	23097	staining	0	None
23097	23098	were	0	None
23098	23099	performed	0	None
23099	23100	.	0	None

23101	23102	Interestingly	0	None
23102	23103	,	0	None
23103	23104	ICAM2	0	None
23104	23105	was	0	None
23105	23106	found	0	None
23106	23107	to	0	None
23107	23108	associate	0	None
23108	23109	with	0	None
23109	23110	β1-integrin	0	None
23110	23111	,	0	None
23111	23112	nectin-3	0	None
23112	23113	,	0	None
23113	23114	afadin	0	None
23114	23115	,	0	None
23115	23116	Src	0	None
23116	23117	,	0	None
23117	23118	proline-rich	0	None
23118	23120	tyrosine kinase	3	GENE-N
23120	23121	2	0	None
23121	23122	,	0	None
23122	23124	annexin II	1	GENE-Y
23124	23125	,	0	None
23125	23126	and	0	None
23126	23127	actin	3	GENE-N
23127	23128	.	0	None

23129	23130	Following	0	None
23130	23131	CdCl₂	0	None
23131	23132	treatment	0	None
23132	23133	,	0	None
23133	23134	ICAM2	0	None
23134	23135	was	0	None
23135	23136	found	0	None
23136	23137	to	0	None
23137	23138	be	0	None
23138	23139	upregulated	0	None
23139	23140	during	0	None
23140	23141	restructuring	0	None
23141	23142	of	0	None
23142	23143	the	0	None
23143	23144	seminiferous	0	None
23144	23145	epithelium	0	None
23145	23146	,	0	None
23146	23147	with	0	None
23147	23148	round	0	None
23148	23149	spermatids	0	None
23149	23150	becoming	0	None
23150	23151	increasingly	0	None
23151	23152	immunoreactive	0	None
23152	23153	for	0	None
23153	23154	ICAM2	0	None
23154	23155	by	0	None
23155	23156	6-16	0	None
23156	23157	h	0	None
23157	23158	.	0	None

23159	23160	Interestingly	0	None
23160	23161	,	0	None
23161	23162	there	0	None
23162	23163	was	0	None
23163	23164	a	0	None
23164	23165	loss	0	None
23165	23166	in	0	None
23166	23167	the	0	None
23167	23168	binding	0	None
23168	23169	of	0	None
23169	23170	ICAM2	0	None
23170	23171	to	0	None
23171	23172	actin	3	GENE-N
23172	23173	during	0	None
23173	23174	CdCl₂-induced	0	None
23174	23175	germ	0	None
23175	23176	cell	0	None
23176	23177	loss	0	None
23177	23178	,	0	None
23178	23179	suggesting	0	None
23179	23180	that	0	None
23180	23181	a	0	None
23181	23182	loss	0	None
23182	23183	of	0	None
23183	23184	ICAM2-actin	0	None
23184	23185	interactions	0	None
23185	23186	might	0	None
23186	23187	have	0	None
23187	23188	facilitated	0	None
23188	23189	junction	0	None
23189	23190	restructuring	0	None
23190	23191	.	0	None

23192	23193	Taken	0	None
23193	23194	collectively	0	None
23194	23195	,	0	None
23195	23196	these	0	None
23196	23197	results	0	None
23197	23198	illustrate	0	None
23198	23199	that	0	None
23199	23200	ICAM2	0	None
23200	23201	plays	0	None
23201	23202	an	0	None
23202	23203	important	0	None
23203	23204	role	0	None
23204	23205	in	0	None
23205	23206	apical	0	None
23206	23207	ES	0	None
23207	23208	dynamics	0	None
23208	23209	during	0	None
23209	23210	spermatogenesis	0	None
23210	23211	.	0	None
23211	23212	Over-expression	0	None
23212	23213	of	0	None
23213	23214	cleaved	0	None
23214	23215	cyclin	0	None
23215	23216	E	0	None
23216	23217	in	0	None
23217	23218	breast	0	None
23218	23219	tumors	0	None
23219	23220	is	0	None
23220	23221	closely	0	None
23221	23222	associated	0	None
23222	23223	with	0	None
23223	23224	tumor	0	None
23224	23225	progression	0	None
23225	23226	and	0	None
23226	23227	resistance	0	None
23227	23228	to	0	None
23228	23229	antiestrogens	0	None
23229	23230	.	0	None

23231	23232	17β-Estradiol	0	None
23232	23233	(	0	None
23233	23234	E2	0	None
23234	23235	)	0	None
23235	23236	has	0	None
23236	23237	been	0	None
23237	23238	recently	0	None
23238	23239	shown	0	None
23239	23240	to	0	None
23240	23241	induce	0	None
23241	23242	cyclin	0	None
23242	23243	E	0	None
23243	23244	processing	0	None
23244	23245	in	0	None
23245	23246	breast	0	None
23246	23247	cancer	0	None
23247	23248	cells	0	None
23248	23249	.	0	None

23250	23251	Tamoxifen	0	None
23251	23252	has	0	None
23252	23253	been	0	None
23253	23254	used	0	None
23254	23255	in	0	None
23255	23256	patients	0	None
23256	23257	with	0	None
23257	23258	estrogen-sensitive	0	None
23258	23259	breast	0	None
23259	23260	cancer	0	None
23260	23261	,	0	None
23261	23262	yet	0	None
23262	23263	resistance	0	None
23263	23264	to	0	None
23264	23265	antiestrogens	0	None
23265	23266	and	0	None
23266	23267	recurrence	0	None
23267	23268	will	0	None
23268	23269	appear	0	None
23269	23270	in	0	None
23270	23271	some	0	None
23271	23272	of	0	None
23272	23273	the	0	None
23273	23274	patients	0	None
23274	23275	after	0	None
23275	23276	its	0	None
23276	23277	continued	0	None
23277	23278	use	0	None
23278	23279	.	0	None

23280	23281	We	0	None
23281	23282	therefore	0	None
23282	23283	addressed	0	None
23283	23284	possible	0	None
23284	23285	effects	0	None
23285	23286	of	0	None
23286	23287	tamoxifen	0	None
23287	23288	on	0	None
23288	23289	the	0	None
23289	23290	generation	0	None
23290	23291	of	0	None
23291	23292	cleaved	0	None
23292	23293	cyclin	0	None
23293	23294	E	0	None
23294	23295	and	0	None
23295	23296	its	0	None
23296	23297	signal	0	None
23297	23298	mechanism	0	None
23298	23299	(	0	None
23299	23300	s	0	None
23300	23301	)	0	None
23301	23302	in	0	None
23302	23303	estrogen-responsive	0	None
23303	23304	MCF-7	0	None
23304	23305	breast	0	None
23305	23306	cancer	0	None
23306	23307	cells	0	None
23307	23308	that	0	None
23308	23309	express	0	None
23309	23310	both	0	None
23310	23311	G	0	None
23311	23312	protein-coupled	0	None
23312	23313	protein	0	None
23313	23314	(	0	None
23314	23315	GPR	0	None
23315	23316	)	0	None
23316	23317	30	0	None
23317	23318	and	0	None
23318	23320	estrogen receptor	1	GENE-Y
23320	23321	α	0	None
23321	23322	(	0	None
23322	23323	ERα	0	None
23323	23324	)	0	None
23324	23325	.	0	None

23326	23327	4-Hydroxytamoxifen	0	None
23327	23328	(	0	None
23328	23329	OHT	0	None
23329	23330	,	0	None
23330	23331	tamoxifen's	0	None
23331	23332	active	0	None
23332	23333	form	0	None
23333	23334	)	0	None
23334	23335	failed	0	None
23335	23336	to	0	None
23336	23337	prevent	0	None
23337	23338	E2-induced	0	None
23338	23339	proteolysis	0	None
23339	23340	of	0	None
23340	23341	cyclin	0	None
23341	23342	E	0	None
23342	23343	and	0	None
23343	23344	migration	0	None
23344	23345	,	0	None
23345	23346	but	0	None
23346	23347	rather	0	None
23347	23348	triggered	0	None
23348	23350	cyclin E	1	GENE-Y
23350	23351	cleavage	0	None
23351	23352	coincident	0	None
23352	23353	with	0	None
23353	23354	augmented	0	None
23354	23355	migration	0	None
23355	23356	.	0	None

23357	23358	OHT-induced	0	None
23358	23359	cyclin	0	None
23359	23360	E	0	None
23360	23361	truncation	0	None
23361	23362	also	0	None
23362	23363	occurred	0	None
23363	23364	in	0	None
23364	23365	SK-BR-3	0	None
23365	23366	cells	0	None
23366	23367	that	0	None
23367	23368	express	0	None
23368	23369	GPR30	0	None
23369	23370	and	0	None
23370	23371	lack	0	None
23371	23372	ERα	0	None
23372	23373	,	0	None
23373	23374	but	0	None
23374	23375	not	0	None
23375	23376	in	0	None
23376	23377	MDA-MB-231	0	None
23377	23378	cells	0	None
23378	23379	that	0	None
23379	23380	express	0	None
23380	23381	neither	0	None
23381	23382	GPR30	0	None
23382	23383	nor	0	None
23383	23384	ERα	0	None
23384	23385	.	0	None

23386	23387	G1	0	None
23387	23388	,	0	None
23388	23389	a	0	None
23389	23390	specific	0	None
23390	23391	GPR	0	None
23391	23392	30	0	None
23392	23393	agonist	0	None
23393	23394	,	0	None
23394	23395	caused	0	None
23395	23396	dramatic	0	None
23396	23397	proteolysis	0	None
23397	23398	of	0	None
23398	23399	cyclin	0	None
23399	23400	E	0	None
23400	23401	and	0	None
23401	23402	enhanced	0	None
23402	23403	migration	0	None
23403	23404	.	0	None

23405	23406	Furthermore	0	None
23406	23407	,	0	None
23407	23408	OHT-stimulated	0	None
23408	23409	cleavage	0	None
23409	23410	of	0	None
23410	23411	cyclin	0	None
23411	23412	E	0	None
23412	23413	and	0	None
23413	23414	migration	0	None
23414	23415	were	0	None
23415	23416	tremendously	0	None
23416	23417	attenuated	0	None
23417	23418	by	0	None
23418	23419	G15	0	None
23419	23420	,	0	None
23420	23421	a	0	None
23421	23422	GPR30	0	None
23422	23423	antagonist	0	None
23423	23424	,	0	None
23424	23425	or	0	None
23425	23426	siRNA	0	None
23426	23427	against	0	None
23427	23428	GPR30	0	None
23428	23429	.	0	None

23430	23431	In	0	None
23431	23432	addition	0	None
23432	23433	,	0	None
23433	23434	inhibitors	0	None
23434	23435	for	0	None
23435	23436	EGFR	0	None
23436	23437	or	0	None
23437	23438	ERK1	0	None
23438	23439	/	0	None
23439	23440	2	0	None
23440	23441	remarkably	0	None
23441	23442	suppressed	0	None
23442	23443	OHT-induced	0	None
23443	23444	truncation	0	None
23444	23445	of	0	None
23445	23447	cyclin E	1	GENE-Y
23447	23448	,	0	None
23448	23449	suggesting	0	None
23449	23450	involvement	0	None
23450	23451	of	0	None
23451	23452	EGFR	0	None
23452	23453	signaling	0	None
23453	23454	.	0	None

23455	23456	Collectively	0	None
23456	23457	,	0	None
23457	23458	our	0	None
23458	23459	data	0	None
23459	23460	indicate	0	None
23460	23461	that	0	None
23461	23462	OHT	0	None
23462	23463	contributes	0	None
23463	23464	to	0	None
23464	23465	the	0	None
23465	23466	production	0	None
23466	23467	of	0	None
23467	23468	proteolyzed	0	None
23468	23469	cyclin	0	None
23469	23470	E	0	None
23470	23471	via	0	None
23471	23472	GPR30	0	None
23472	23473	with	0	None
23473	23474	augmented	0	None
23474	23475	migration	0	None
23475	23476	in	0	None
23476	23477	MCF-7	0	None
23477	23478	cells	0	None
23478	23479	.	0	None
23479	23480	The	0	None
23480	23481	effect	0	None
23481	23482	of	0	None
23482	23483	vitamin	0	None
23483	23484	B6	0	None
23484	23485	deficiency	0	None
23485	23486	on	0	None
23486	23488	alanine :	0	None
23488	23489	glyoxylate	2	CHEMICAL
23489	23490	aminotransferase	3	GENE-N
23490	23491	isoenzymes	0	None
23491	23492	in	0	None
23492	23493	rat	0	None
23493	23494	liver	0	None
23494	23495	.	0	None
23495	23496	No	0	None
23496	23497	mutations	0	None
23497	23498	in	0	None
23498	23499	the	0	None
23499	23500	serotonin	0	None
23500	23501	related	0	None
23501	23502	TPH1	0	None
23502	23503	and	0	None
23503	23504	HTR1B	0	None
23504	23505	genes	0	None
23505	23506	in	0	None
23506	23507	patients	0	None
23507	23508	with	0	None
23508	23509	monogenic	0	None
23509	23510	sclerosing	0	None
23510	23511	bone	0	None
23511	23512	disorders	0	None
23512	23513	.	0	None
23513	23514	Nitric	0	None
23514	23515	oxide	0	None
23515	23516	(	0	None
23516	23517	NO	0	None
23517	23518	)	0	None
23518	23519	is	0	None
23519	23520	involved	0	None
23520	23521	in	0	None
23521	23522	many	0	None
23522	23523	physiological	0	None
23523	23524	and	0	None
23524	23525	pathological	0	None
23525	23526	processes	0	None
23526	23527	in	0	None
23527	23528	the	0	None
23528	23529	brain	0	None
23529	23530	.	0	None

23531	23532	NO	0	None
23532	23533	is	0	None
23533	23534	synthesized	0	None
23534	23535	from	0	None
23535	23536	arginine	2	CHEMICAL
23536	23537	by	0	None
23537	23540	nitric oxide synthase	3	GENE-N
23540	23541	(	0	None
23541	23542	NOS	3	GENE-N
23542	23543	)	0	None
23543	23544	,	0	None
23544	23545	and	0	None
23545	23546	the	0	None
23546	23547	citrulline	0	None
23547	23548	generated	0	None
23548	23549	as	0	None
23549	23550	a	0	None
23550	23551	by-product	0	None
23551	23552	can	0	None
23552	23553	be	0	None
23553	23554	recycled	0	None
23554	23555	to	0	None
23555	23556	arginine	2	CHEMICAL
23556	23557	by	0	None
23557	23559	argininosuccinate synthetase	1	GENE-Y
23559	23560	(	0	None
23560	23561	AS	0	None
23561	23562	)	0	None
23562	23563	and	0	None
23563	23564	argininosuccinate	2	CHEMICAL
23564	23565	lyase	0	None
23565	23566	(	0	None
23566	23567	AL	0	None
23567	23568	)	0	None
23568	23569	via	0	None
23569	23570	the	0	None
23570	23571	citrulline-NO	0	None
23571	23572	cycle	0	None
23572	23573	.	0	None

23574	23575	When	0	None
23575	23576	neuronal	0	None
23576	23577	PC12	0	None
23577	23578	cells	0	None
23578	23579	differentiated	0	None
23579	23580	with	0	None
23580	23581	nerve	0	None
23581	23582	growth	0	None
23582	23583	factor	0	None
23583	23584	were	0	None
23584	23585	treated	0	None
23585	23586	with	0	None
23586	23587	interferon-gamma	0	None
23587	23588	(	0	None
23588	23589	IFNgamma	1	GENE-Y
23589	23590	)	0	None
23590	23591	and	0	None
23591	23592	tumor	0	None
23592	23593	necrosis	0	None
23593	23594	factor-alpha	0	None
23594	23595	(	0	None
23595	23596	TNFalpha	0	None
23596	23597	)	0	None
23597	23598	,	0	None
23598	23599	iNOS	0	None
23599	23600	and	0	None
23600	23601	AS	0	None
23601	23602	mRNAs	0	None
23602	23603	and	0	None
23603	23604	proteins	0	None
23604	23605	were	0	None
23605	23606	markedly	0	None
23606	23607	induced	0	None
23607	23608	,	0	None
23608	23609	with	0	None
23609	23610	AL	0	None
23610	23611	mRNA	0	None
23611	23612	and	0	None
23612	23613	protein	0	None
23613	23614	being	0	None
23614	23615	weakly	0	None
23615	23616	induced	0	None
23616	23617	.	0	None

23618	23619	Cationic	0	None
23619	23621	amino acid	2	CHEMICAL
23621	23622	transporter-1	0	None
23622	23623	and	0	None
23623	23624	-2	0	None
23624	23625	were	0	None
23625	23626	not	0	None
23626	23627	induced	0	None
23627	23628	.	0	None

23629	23630	IFNgamma	1	GENE-Y
23630	23631	or	0	None
23631	23632	TNFalpha	0	None
23632	23633	alone	0	None
23633	23634	was	0	None
23634	23635	ineffective	0	None
23635	23636	.	0	None

23637	23638	A	0	None
23638	23639	large	0	None
23639	23640	amount	0	None
23640	23641	of	0	None
23641	23642	NO	0	None
23642	23643	(	0	None
23643	23644	190	0	None
23644	23645	microM	0	None
23645	23646	NO	0	None
23646	23647	(	0	None
23647	23648	2	0	None
23648	23649	)	0	None
23649	23650	(	0	None
23650	23651	-	0	None
23651	23652	)	0	None
23652	23653	plus	0	None
23653	23654	NO	0	None
23654	23655	(	0	None
23655	23656	3	0	None
23656	23657	)	0	None
23657	23658	(	0	None
23658	23659	-	0	None
23659	23660	)	0	None
23660	23661	in	0	None
23661	23662	culture	0	None
23662	23663	medium	0	None
23663	23664	in	0	None
23664	23665	24	0	None
23665	23666	h	0	None
23666	23667	)	0	None
23667	23668	was	0	None
23668	23669	produced	0	None
23669	23670	from	0	None
23670	23671	arginine	2	CHEMICAL
23671	23672	by	0	None
23672	23673	cytokine-stimulated	0	None
23673	23674	cells	0	None
23674	23675	,	0	None
23675	23676	and	0	None
23676	23677	arginine	2	CHEMICAL
23677	23678	could	0	None
23678	23679	be	0	None
23679	23680	replaced	0	None
23680	23681	by	0	None
23681	23682	citrulline	0	None
23682	23683	.	0	None

23684	23685	iNOS	0	None
23685	23686	induction	0	None
23686	23687	and	0	None
23687	23688	NO	0	None
23688	23689	production	0	None
23689	23690	were	0	None
23690	23691	attenuated	0	None
23691	23692	by	0	None
23692	23693	dexamethasone	2	CHEMICAL
23693	23694	and	0	None
23694	23695	dibutyryl	0	None
23695	23696	cAMP	0	None
23696	23697	and	0	None
23697	23698	even	0	None
23698	23699	more	0	None
23699	23700	strongly	0	None
23700	23701	so	0	None
23701	23702	when	0	None
23702	23703	combined	0	None
23703	23704	.	0	None

23705	23706	Therefore	0	None
23706	23707	,	0	None
23707	23708	a	0	None
23708	23709	large	0	None
23709	23710	amount	0	None
23710	23711	of	0	None
23711	23712	NO	0	None
23712	23713	is	0	None
23713	23714	produced	0	None
23714	23715	in	0	None
23715	23716	cytokine-stimulated	0	None
23716	23717	PC12	0	None
23717	23718	cells	0	None
23718	23719	following	0	None
23719	23720	to	0	None
23720	23721	induction	0	None
23721	23722	of	0	None
23722	23723	iNOS	0	None
23723	23724	and	0	None
23724	23725	citrulline-arginine	0	None
23725	23726	recycling	0	None
23726	23727	is	0	None
23727	23728	important	0	None
23728	23729	for	0	None
23729	23730	NO	0	None
23730	23731	production	0	None
23731	23732	.	0	None
23732	23733	Hospitalized	0	None
23733	23734	osteoporotic	0	None
23734	23735	vertebral	0	None
23735	23736	fracture	0	None
23736	23737	increases	0	None
23737	23738	the	0	None
23738	23739	risk	0	None
23739	23740	of	0	None
23740	23741	stroke	0	None
23741	23742	:	0	None
23742	23743	a	0	None
23743	23744	population-based	0	None
23744	23745	cohort	0	None
23745	23746	study	0	None
23746	23747	.	0	None
23747	23748	The	0	None
23748	23750	mineralocorticoid receptor	1	GENE-Y
23750	23751	may	0	None
23751	23752	compensate	0	None
23752	23753	for	0	None
23753	23754	the	0	None
23754	23755	loss	0	None
23755	23756	of	0	None
23756	23757	the	0	None
23757	23759	glucocorticoid receptor	1	GENE-Y
23759	23760	at	0	None
23760	23761	specific	0	None
23761	23762	stages	0	None
23762	23763	of	0	None
23763	23764	mammary	0	None
23764	23765	gland	0	None
23765	23766	development	0	None
23766	23767	.	0	None
23767	23768	Platelet	0	None
23768	23769	activation	0	None
23769	23770	by	0	None
23770	23771	ADP	0	None
23771	23772	and	0	None
23772	23773	ATP	0	None
23773	23774	plays	0	None
23774	23775	a	0	None
23775	23776	crucial	0	None
23776	23777	role	0	None
23777	23778	in	0	None
23778	23779	haemostasis	0	None
23779	23780	and	0	None
23780	23781	thrombosis	0	None
23781	23782	,	0	None
23782	23783	and	0	None
23783	23784	their	0	None
23784	23785	so-called	0	None
23785	23786	P2	0	None
23786	23787	receptors	0	None
23787	23788	are	0	None
23788	23789	potential	0	None
23789	23790	targets	0	None
23790	23791	for	0	None
23791	23792	antithrombotic	0	None
23792	23793	drugs	0	None
23793	23794	.	0	None

23795	23796	The	0	None
23796	23797	ATP-gated	0	None
23797	23798	channel	0	None
23798	23799	P2X1	0	None
23799	23800	and	0	None
23800	23801	the	0	None
23801	23802	2	0	None
23802	23804	G protein-coupled	0	None
23804	23805	P2Y1	1	GENE-Y
23805	23806	and	0	None
23806	23807	P2Y12	1	GENE-Y
23807	23808	ADP	0	None
23808	23809	receptors	0	None
23809	23810	selectively	0	None
23810	23811	contribute	0	None
23811	23812	to	0	None
23812	23813	platelet	0	None
23813	23814	aggregation	0	None
23814	23815	.	0	None

23816	23817	The	0	None
23817	23818	P2Y1	1	GENE-Y
23818	23819	receptor	0	None
23819	23820	is	0	None
23820	23821	responsible	0	None
23821	23822	for	0	None
23822	23823	ADP-induced	0	None
23823	23824	shape	0	None
23824	23825	change	0	None
23825	23826	and	0	None
23826	23827	weak	0	None
23827	23828	and	0	None
23828	23829	transient	0	None
23829	23830	aggregation	0	None
23830	23831	,	0	None
23831	23832	while	0	None
23832	23833	the	0	None
23833	23834	P2Y12	1	GENE-Y
23834	23835	receptor	0	None
23835	23836	is	0	None
23836	23837	responsible	0	None
23837	23838	for	0	None
23838	23839	the	0	None
23839	23840	completion	0	None
23840	23841	and	0	None
23841	23842	amplification	0	None
23842	23843	of	0	None
23843	23844	the	0	None
23844	23845	response	0	None
23845	23846	to	0	None
23846	23847	ADP	0	None
23847	23848	and	0	None
23848	23849	to	0	None
23849	23850	all	0	None
23850	23851	platelet	0	None
23851	23852	agonists	0	None
23852	23853	,	0	None
23853	23854	including	0	None
23854	23855	thromboxane	0	None
23855	23856	A2	0	None
23856	23857	(	0	None
23857	23858	TXA2	0	None
23858	23859	)	0	None
23859	23860	,	0	None
23860	23861	thrombin	0	None
23861	23862	,	0	None
23862	23863	and	0	None
23863	23864	collagen	3	GENE-N
23864	23865	.	0	None

23866	23867	The	0	None
23867	23868	P2X1	0	None
23868	23869	receptor	0	None
23869	23870	is	0	None
23870	23871	involved	0	None
23871	23872	in	0	None
23872	23873	platelet	0	None
23873	23874	shape	0	None
23874	23875	change	0	None
23875	23876	and	0	None
23876	23877	in	0	None
23877	23878	activation	0	None
23878	23879	by	0	None
23879	23880	collagen	3	GENE-N
23880	23881	under	0	None
23881	23882	shear	0	None
23882	23883	conditions	0	None
23883	23884	.	0	None

23885	23886	Due	0	None
23886	23887	to	0	None
23887	23888	its	0	None
23888	23889	central	0	None
23889	23890	role	0	None
23890	23891	in	0	None
23891	23892	the	0	None
23892	23893	formation	0	None
23893	23894	and	0	None
23894	23895	stabilization	0	None
23895	23896	of	0	None
23896	23897	a	0	None
23897	23898	thrombus	0	None
23898	23899	,	0	None
23899	23900	the	0	None
23900	23901	P2Y12	1	GENE-Y
23901	23902	receptor	0	None
23902	23903	is	0	None
23903	23904	a	0	None
23904	23905	well-established	0	None
23905	23906	target	0	None
23906	23907	of	0	None
23907	23908	antithrombotic	0	None
23908	23909	drugs	0	None
23909	23910	like	0	None
23910	23911	ticlopidine	0	None
23911	23912	or	0	None
23912	23913	clopidogrel	0	None
23913	23914	,	0	None
23914	23915	which	0	None
23915	23916	have	0	None
23916	23917	proved	0	None
23917	23918	efficacy	0	None
23918	23919	in	0	None
23919	23920	many	0	None
23920	23921	clinical	0	None
23921	23922	trials	0	None
23922	23923	and	0	None
23923	23924	experimental	0	None
23924	23925	models	0	None
23925	23926	of	0	None
23926	23927	thrombosis	0	None
23927	23928	.	0	None

23929	23930	Competitive	0	None
23930	23931	P2Y12	1	GENE-Y
23931	23932	antagonists	0	None
23932	23933	have	0	None
23933	23934	also	0	None
23934	23935	been	0	None
23935	23936	shown	0	None
23936	23937	to	0	None
23937	23938	be	0	None
23938	23939	effective	0	None
23939	23940	in	0	None
23940	23941	experimental	0	None
23941	23942	thrombosis	0	None
23942	23943	as	0	None
23943	23944	well	0	None
23944	23945	as	0	None
23945	23946	in	0	None
23946	23947	several	0	None
23947	23948	clinical	0	None
23948	23949	trials	0	None
23949	23950	.	0	None

23951	23952	Studies	0	None
23952	23953	in	0	None
23953	23954	P2Y1	1	GENE-Y
23954	23955	and	0	None
23955	23956	P2X1	0	None
23956	23957	knockout	0	None
23957	23958	mice	0	None
23958	23959	and	0	None
23959	23960	experimental	0	None
23960	23961	thrombosis	0	None
23961	23962	models	0	None
23962	23963	using	0	None
23963	23964	selective	0	None
23964	23965	P2Y1	1	GENE-Y
23965	23966	and	0	None
23966	23967	P2X1	0	None
23967	23968	antagonists	0	None
23968	23969	have	0	None
23969	23970	shown	0	None
23970	23971	that	0	None
23971	23972	,	0	None
23972	23973	depending	0	None
23973	23974	on	0	None
23974	23975	the	0	None
23975	23976	conditions	0	None
23976	23977	,	0	None
23977	23978	these	0	None
23978	23979	receptors	0	None
23979	23980	could	0	None
23980	23981	also	0	None
23981	23982	be	0	None
23982	23983	potential	0	None
23983	23984	targets	0	None
23984	23985	for	0	None
23985	23986	new	0	None
23986	23987	antithrombotic	0	None
23987	23988	drugs	0	None
23988	23989	.	0	None
23989	23990	Synaptotagmin	0	None
23990	23991	1	0	None
23991	23992	is	0	None
23992	23993	required	0	None
23993	23994	for	0	None
23994	23995	vesicular	0	None
23995	23996	Ca	0	None
23996	23997	(	0	None
23997	23998	2	0	None
23998	23999	+	0	None
23999	24000	)	0	None
24000	24001	/	0	None
24001	24002	H	0	None
24002	24003	(	0	None
24003	24004	+	0	None
24004	24005	)	0	None
24005	24006	-antiport	0	None
24006	24007	activity	0	None
24007	24008	.	0	None
24008	24009	The	0	None
24009	24010	implementation	0	None
24010	24011	of	0	None
24011	24012	a	0	None
24012	24013	reactive	0	None
24013	24014	functional	0	None
24014	24015	group	0	None
24015	24016	onto	0	None
24016	24017	a	0	None
24017	24018	material	0	None
24018	24019	surface	0	None
24019	24020	is	0	None
24020	24021	of	0	None
24021	24022	great	0	None
24022	24023	importance	0	None
24023	24024	.	0	None

24025	24026	Reactive	0	None
24026	24027	functional	0	None
24027	24028	groups	0	None
24028	24029	(	0	None
24029	24030	e	0	None
24030	24031	.	0	None

24032	24033	g	0	None
24033	24034	.	0	None

24035	24036	,	0	None
24036	24037	an	0	None
24037	24038	amino	0	None
24038	24039	group	0	None
24039	24040	and	0	None
24040	24041	a	0	None
24041	24042	hydroxyl	2	CHEMICAL
24042	24043	group	0	None
24043	24044	)	0	None
24044	24045	are	0	None
24045	24046	usually	0	None
24046	24047	hydrophilic	0	None
24047	24048	,	0	None
24048	24049	which	0	None
24049	24050	makes	0	None
24050	24051	it	0	None
24051	24052	difficult	0	None
24052	24053	to	0	None
24053	24054	display	0	None
24054	24055	them	0	None
24055	24056	on	0	None
24056	24057	a	0	None
24057	24058	dry	0	None
24058	24059	polymer	0	None
24059	24060	surface	0	None
24060	24061	.	0	None

24062	24063	We	0	None
24063	24064	here	0	None
24064	24065	propose	0	None
24065	24066	a	0	None
24066	24067	novel	0	None
24067	24068	method	0	None
24068	24069	for	0	None
24069	24070	displaying	0	None
24070	24071	amino	0	None
24071	24072	groups	0	None
24072	24073	on	0	None
24073	24074	the	0	None
24074	24075	surfaces	0	None
24075	24076	of	0	None
24076	24077	polymeric	0	None
24077	24078	substrates	0	None
24078	24079	through	0	None
24079	24080	dip-coating	0	None
24080	24081	of	0	None
24081	24082	a	0	None
24082	24083	methacrylate-based	0	None
24083	24084	copolymer	0	None
24084	24085	.	0	None

24086	24087	We	0	None
24087	24088	synthesized	0	None
24088	24089	copolymers	0	None
24089	24090	composed	0	None
24090	24091	of	0	None
24091	24092	methyl	0	None
24092	24093	methacrylate	0	None
24093	24094	and	0	None
24094	24095	2-aminoethyl	0	None
24095	24096	methacrylate	0	None
24096	24097	with	0	None
24097	24098	different	0	None
24098	24099	protecting	0	None
24099	24100	groups	0	None
24100	24101	or	0	None
24101	24102	ion-complexes	0	None
24102	24103	on	0	None
24103	24104	their	0	None
24104	24105	amino	0	None
24105	24106	groups	0	None
24106	24107	,	0	None
24107	24108	then	0	None
24108	24109	dip-coated	0	None
24109	24110	the	0	None
24110	24111	copolymers	0	None
24111	24112	onto	0	None
24112	24113	a	0	None
24113	24114	poly	0	None
24114	24115	(	0	None
24115	24116	methyl	0	None
24116	24117	methacrylate	0	None
24117	24118	)	0	None
24118	24119	(	0	None
24119	24120	PMMA	0	None
24120	24121	)	0	None
24121	24122	substrate	0	None
24122	24123	.	0	None

24124	24125	Evaluation	0	None
24125	24126	using	0	None
24126	24127	a	0	None
24127	24128	cleavable	0	None
24128	24129	fluorescent	0	None
24129	24130	compound	0	None
24130	24131	,	0	None
24131	24132	which	0	None
24132	24133	was	0	None
24133	24134	synthesized	0	None
24134	24135	in	0	None
24135	24136	the	0	None
24136	24137	present	0	None
24137	24138	study	0	None
24138	24139	to	0	None
24139	24140	quantify	0	None
24140	24141	a	0	None
24141	24142	small	0	None
24142	24143	amount	0	None
24143	24144	(	0	None
24144	24145	pmol	0	None
24145	24146	/	0	None
24146	24147	cm	0	None
24147	24148	(	0	None
24148	24149	2	0	None
24149	24150	)	0	None
24150	24151	)	0	None
24151	24152	of	0	None
24152	24153	amino	0	None
24153	24154	groups	0	None
24154	24155	on	0	None
24155	24156	a	0	None
24156	24157	solid	0	None
24157	24158	surface	0	None
24158	24159	,	0	None
24159	24160	revealed	0	None
24160	24161	that	0	None
24161	24162	the	0	None
24162	24163	protection	0	None
24163	24164	of	0	None
24164	24165	amino	0	None
24165	24166	groups	0	None
24166	24167	affected	0	None
24167	24168	their	0	None
24168	24169	surface	0	None
24169	24170	segregation	0	None
24170	24171	in	0	None
24171	24172	the	0	None
24172	24173	copolymer	0	None
24173	24174	coating	0	None
24174	24175	.	0	None

24176	24177	p-Toluenesulfonate	0	None
24177	24178	ion-complex	0	None
24178	24179	and	0	None
24179	24180	tert-butoxycarbonyl	0	None
24180	24181	(	0	None
24181	24182	Boc	2	CHEMICAL
24182	24183	)	0	None
24183	24184	protection	0	None
24184	24185	of	0	None
24185	24186	amino	0	None
24186	24187	groups	0	None
24187	24188	were	0	None
24188	24189	found	0	None
24189	24190	to	0	None
24190	24191	effectively	0	None
24191	24192	display	0	None
24192	24193	amino	0	None
24193	24194	groups	0	None
24194	24195	on	0	None
24195	24196	the	0	None
24196	24197	surface	0	None
24197	24198	(	0	None
24198	24199	more	0	None
24199	24200	than	0	None
24200	24201	70	0	None
24201	24202	pmol	0	None
24202	24203	/	0	None
24203	24204	cm	0	None
24204	24205	(	0	None
24205	24206	2	0	None
24206	24207	)	0	None
24207	24208	)	0	None
24208	24209	.	0	None

24210	24211	The	0	None
24211	24212	density	0	None
24212	24213	of	0	None
24213	24214	amino	0	None
24214	24215	groups	0	None
24215	24216	displayed	0	None
24216	24217	on	0	None
24217	24218	a	0	None
24218	24219	surface	0	None
24219	24220	can	0	None
24220	24221	be	0	None
24221	24222	easily	0	None
24222	24223	controlled	0	None
24223	24224	by	0	None
24224	24225	mixing	0	None
24225	24226	the	0	None
24226	24227	copolymer	0	None
24227	24228	and	0	None
24228	24229	PMMA	0	None
24229	24230	before	0	None
24230	24231	dip-coating	0	None
24231	24232	.	0	None

24233	24234	Dip-coating	0	None
24234	24235	of	0	None
24235	24236	the	0	None
24236	24237	copolymer	0	None
24237	24238	with	0	None
24238	24239	Boc	2	CHEMICAL
24239	24240	protection	0	None
24240	24241	on	0	None
24241	24242	various	0	None
24242	24243	polymeric	0	None
24243	24244	substrates	0	None
24244	24245	also	0	None
24245	24246	successfully	0	None
24246	24247	displayed	0	None
24247	24248	amino	0	None
24248	24249	groups	0	None
24249	24250	on	0	None
24250	24251	their	0	None
24251	24252	surfaces	0	None
24252	24253	.	0	None

24254	24255	Finally	0	None
24255	24256	,	0	None
24256	24257	we	0	None
24257	24258	demonstrated	0	None
24258	24259	that	0	None
24259	24260	the	0	None
24260	24261	amino	0	None
24261	24262	groups	0	None
24262	24263	displayed	0	None
24263	24264	can	0	None
24264	24265	be	0	None
24265	24266	utilized	0	None
24266	24267	for	0	None
24267	24268	the	0	None
24268	24269	immobilization	0	None
24269	24270	of	0	None
24270	24271	a	0	None
24271	24272	DNA	0	None
24272	24273	oligonucleotide	0	None
24273	24274	on	0	None
24274	24275	a	0	None
24275	24276	substrate	0	None
24276	24277	surface	0	None
24277	24278	.	0	None
24278	24279	Injection	0	None
24279	24280	of	0	None
24280	24281	ropivacaine	0	None
24281	24282	into	0	None
24282	24283	the	0	None
24283	24284	subarachnoid	0	None
24284	24285	changes	0	None
24285	24286	the	0	None
24286	24287	ultrastructure	0	None
24287	24288	and	0	None
24288	24289	proteome	0	None
24289	24290	of	0	None
24290	24291	the	0	None
24291	24292	rat	0	None
24292	24293	spinal	0	None
24293	24294	cord	0	None
24294	24295	.	0	None
24295	24296	Role	0	None
24296	24297	of	0	None
24297	24298	dehydropeptidase-I	0	None
24298	24299	in	0	None
24299	24300	the	0	None
24300	24301	metabolism	0	None
24301	24302	of	0	None
24302	24303	glutathione	0	None
24303	24304	and	0	None
24304	24305	its	0	None
24305	24306	conjugates	0	None
24306	24307	in	0	None
24307	24308	the	0	None
24308	24309	rat	0	None
24309	24310	kidney	0	None
24310	24311	.	0	None
24311	24312	Exendin-4	0	None
24312	24313	,	0	None
24313	24314	a	0	None
24314	24315	GLP-1	0	None
24315	24316	receptor	0	None
24316	24317	agonist	0	None
24317	24318	,	0	None
24318	24319	prevents	0	None
24319	24320	osteopnia	0	None
24320	24321	by	0	None
24321	24322	promoting	0	None
24322	24323	bone	0	None
24323	24324	formation	0	None
24324	24325	and	0	None
24325	24326	suppressing	0	None
24326	24327	bone	0	None
24327	24328	resorption	0	None
24328	24329	in	0	None
24329	24330	aged	0	None
24330	24331	ovariectomized	0	None
24331	24332	rats	0	None
24332	24333	.	0	None
24333	24337	Polycomb repressive complex 1	3	GENE-N
24337	24338	(	0	None
24338	24339	PRC1	3	GENE-N
24339	24340	)	0	None
24340	24341	catalyzes	0	None
24341	24342	lysine	0	None
24342	24343	119	0	None
24343	24344	monoubiquitylation	0	None
24344	24345	on	0	None
24345	24346	H2A	0	None
24346	24347	(	0	None
24347	24348	H2AK119ub1	0	None
24348	24349	)	0	None
24349	24350	and	0	None
24350	24351	regulates	0	None
24351	24352	pluripotency	0	None
24352	24353	in	0	None
24353	24354	embryonic	0	None
24354	24355	stem	0	None
24355	24356	cells	0	None
24356	24357	(	0	None
24357	24358	ESCs	0	None
24358	24359	)	0	None
24359	24360	.	0	None

24361	24362	However	0	None
24362	24363	,	0	None
24363	24364	the	0	None
24364	24365	mechanisms	0	None
24365	24366	controlling	0	None
24366	24367	the	0	None
24367	24368	binding	0	None
24368	24369	of	0	None
24369	24370	PRC1	3	GENE-N
24370	24371	to	0	None
24371	24372	genomic	0	None
24372	24373	sites	0	None
24373	24374	and	0	None
24374	24375	its	0	None
24375	24376	catalytic	0	None
24376	24377	activity	0	None
24377	24378	are	0	None
24378	24379	poorly	0	None
24379	24380	understood	0	None
24380	24381	.	0	None

24382	24383	Here	0	None
24383	24384	,	0	None
24384	24385	we	0	None
24385	24386	show	0	None
24386	24387	that	0	None
24387	24388	Fbxl10	0	None
24388	24389	interacts	0	None
24389	24390	with	0	None
24390	24391	Ring1B	1	GENE-Y
24391	24392	and	0	None
24392	24393	Nspc1	0	None
24393	24394	,	0	None
24394	24395	forming	0	None
24395	24396	a	0	None
24396	24397	noncanonical	0	None
24397	24398	PRC1	3	GENE-N
24398	24399	that	0	None
24399	24400	is	0	None
24400	24401	required	0	None
24401	24402	for	0	None
24402	24403	H2AK119ub1	0	None
24403	24404	in	0	None
24404	24405	mouse	0	None
24405	24406	ESCs	0	None
24406	24407	.	0	None

24408	24409	Genome-wide	0	None
24409	24410	analyses	0	None
24410	24411	reveal	0	None
24411	24412	that	0	None
24412	24413	Fbxl10	0	None
24413	24414	preferentially	0	None
24414	24415	binds	0	None
24415	24416	to	0	None
24416	24417	CpG	0	None
24417	24418	islands	0	None
24418	24419	and	0	None
24419	24420	colocalizes	0	None
24420	24421	with	0	None
24421	24422	Ring1B	1	GENE-Y
24422	24423	on	0	None
24423	24424	Polycomb	0	None
24424	24425	target	0	None
24425	24426	genes	0	None
24426	24427	.	0	None

24428	24429	Notably	0	None
24429	24430	,	0	None
24430	24431	Fbxl10	0	None
24431	24432	depletion	0	None
24432	24433	causes	0	None
24433	24434	a	0	None
24434	24435	decrease	0	None
24435	24436	in	0	None
24436	24437	Ring1B	1	GENE-Y
24437	24438	binding	0	None
24438	24439	to	0	None
24439	24440	target	0	None
24440	24441	genes	0	None
24441	24442	and	0	None
24442	24443	a	0	None
24443	24444	major	0	None
24444	24445	loss	0	None
24445	24446	of	0	None
24446	24447	H2AK119ub1	0	None
24447	24448	.	0	None

24449	24450	Furthermore	0	None
24450	24451	,	0	None
24451	24452	genetic	0	None
24452	24453	analyses	0	None
24453	24454	demonstrate	0	None
24454	24455	that	0	None
24455	24456	Fbxl10	0	None
24456	24457	DNA	0	None
24457	24458	binding	0	None
24458	24459	capability	0	None
24459	24460	and	0	None
24460	24461	integration	0	None
24461	24462	into	0	None
24462	24463	PRC1	3	GENE-N
24463	24464	are	0	None
24464	24465	required	0	None
24465	24466	for	0	None
24466	24467	H2AK119	0	None
24467	24468	ubiquitylation	0	None
24468	24469	.	0	None

24470	24471	ESCs	0	None
24471	24472	lacking	0	None
24472	24473	Fbxl10	0	None
24473	24474	,	0	None
24474	24475	like	0	None
24475	24476	previously	0	None
24476	24477	characterized	0	None
24477	24478	Polycomb	0	None
24478	24479	mutants	0	None
24479	24480	,	0	None
24480	24481	cannot	0	None
24481	24482	differentiate	0	None
24482	24483	properly	0	None
24483	24484	.	0	None

24485	24486	These	0	None
24486	24487	results	0	None
24487	24488	demonstrate	0	None
24488	24489	that	0	None
24489	24490	Fbxl10	0	None
24490	24491	has	0	None
24491	24492	a	0	None
24492	24493	key	0	None
24493	24494	role	0	None
24494	24495	in	0	None
24495	24496	regulating	0	None
24496	24497	Ring1B	1	GENE-Y
24497	24498	recruitment	0	None
24498	24499	to	0	None
24499	24500	its	0	None
24500	24501	target	0	None
24501	24502	genes	0	None
24502	24503	and	0	None
24503	24504	H2AK119	0	None
24504	24505	ubiquitylation	0	None
24505	24506	in	0	None
24506	24507	ESCs	0	None
24507	24508	.	0	None
24508	24509	Considerable	0	None
24509	24510	evidence	0	None
24510	24511	indicates	0	None
24511	24512	that	0	None
24512	24513	serotonergic	0	None
24513	24514	mechanisms	0	None
24514	24515	,	0	None
24515	24516	particularly	0	None
24516	24517	the	0	None
24517	24519	serotonin transporter	1	GENE-Y
24519	24520	(	0	None
24520	24521	5HTT	0	None
24521	24522	)	0	None
24522	24523	,	0	None
24523	24524	may	0	None
24524	24525	mediate	0	None
24525	24526	central	0	None
24526	24527	effects	0	None
24527	24528	of	0	None
24528	24529	cocaine	2	CHEMICAL
24529	24530	and	0	None
24530	24531	may	0	None
24531	24532	also	0	None
24532	24533	be	0	None
24533	24534	involved	0	None
24534	24535	in	0	None
24535	24536	impulsive	0	None
24536	24537	and	0	None
24537	24538	aggressive	0	None
24538	24539	behavior	0	None
24539	24540	.	0	None

24541	24542	We	0	None
24542	24543	investigated	0	None
24543	24544	whether	0	None
24544	24545	polymorphisms	0	None
24545	24546	in	0	None
24546	24547	the	0	None
24547	24548	5HTT	0	None
24548	24549	gene	0	None
24549	24550	were	0	None
24550	24551	related	0	None
24551	24552	to	0	None
24552	24553	traits	0	None
24553	24554	of	0	None
24554	24555	impulsivity	0	None
24555	24556	,	0	None
24556	24557	sensation	0	None
24557	24558	seeking	0	None
24558	24559	,	0	None
24559	24560	and	0	None
24560	24561	aggression	0	None
24561	24562	among	0	None
24562	24563	cocaine	2	CHEMICAL
24563	24564	abusers	0	None
24564	24565	.	0	None

24566	24567	Standardized	0	None
24567	24568	measures	0	None
24568	24569	of	0	None
24569	24570	these	0	None
24570	24571	personality	0	None
24571	24572	traits	0	None
24572	24573	were	0	None
24573	24574	obtained	0	None
24574	24575	in	0	None
24575	24576	a	0	None
24576	24577	sample	0	None
24577	24578	of	0	None
24578	24579	105	0	None
24579	24580	severely	0	None
24580	24581	affected	0	None
24581	24582	cocaine-dependent	0	None
24582	24583	African-American	0	None
24583	24584	subjects	0	None
24584	24585	and	0	None
24585	24586	44	0	None
24586	24587	African-American	0	None
24587	24588	controls	0	None
24588	24589	.	0	None

24590	24591	Two	0	None
24591	24592	polymorphisms	0	None
24592	24593	of	0	None
24593	24594	the	0	None
24594	24595	5HTT	0	None
24595	24596	gene	0	None
24596	24597	were	0	None
24597	24598	examined	0	None
24598	24599	involving	0	None
24599	24600	the	0	None
24600	24601	5'	0	None
24601	24602	promoter	0	None
24602	24603	(	0	None
24603	24604	5HTTLPR	3	GENE-N
24604	24605	)	0	None
24605	24606	region	0	None
24606	24607	and	0	None
24607	24608	a	0	None
24608	24609	17	0	None
24609	24610	base	0	None
24610	24611	pair	0	None
24611	24612	variable-number-tandem-repeat	3	GENE-N
24612	24613	(	0	None
24613	24614	VNTR	0	None
24614	24615	)	0	None
24615	24616	marker	0	None
24616	24617	among	0	None
24617	24618	cocaine	2	CHEMICAL
24618	24619	patients	0	None
24619	24620	.	0	None

24621	24622	No	0	None
24622	24623	significant	0	None
24623	24624	relationships	0	None
24624	24625	were	0	None
24625	24626	observed	0	None
24626	24627	between	0	None
24627	24628	polymorphic	0	None
24628	24629	variants	0	None
24629	24630	of	0	None
24630	24631	the	0	None
24631	24632	5HTTLPR	3	GENE-N
24632	24633	and	0	None
24633	24634	VNTR	0	None
24634	24635	regions	0	None
24635	24636	and	0	None
24636	24637	scores	0	None
24637	24638	on	0	None
24638	24639	any	0	None
24639	24640	of	0	None
24640	24641	the	0	None
24641	24642	trait	0	None
24642	24643	measures	0	None
24643	24644	.	0	None

24645	24646	Similarly	0	None
24646	24647	,	0	None
24647	24648	demographic	0	None
24648	24649	variables	0	None
24649	24650	and	0	None
24650	24651	measures	0	None
24651	24652	of	0	None
24652	24653	severity	0	None
24653	24654	of	0	None
24654	24655	substance	0	None
24655	24656	use	0	None
24656	24657	and	0	None
24657	24658	depression	0	None
24658	24659	were	0	None
24659	24660	unrelated	0	None
24660	24661	to	0	None
24661	24662	allele	0	None
24662	24663	frequencies	0	None
24663	24664	or	0	None
24664	24665	genotype	0	None
24665	24666	distributions	0	None
24666	24667	of	0	None
24667	24668	the	0	None
24668	24669	variants	0	None
24669	24670	among	0	None
24670	24671	cocaine	2	CHEMICAL
24671	24672	patients	0	None
24672	24673	.	0	None

24674	24675	As	0	None
24675	24676	expected	0	None
24676	24677	,	0	None
24677	24678	cocaine	2	CHEMICAL
24678	24679	patients	0	None
24679	24680	scored	0	None
24680	24681	significantly	0	None
24681	24682	higher	0	None
24682	24683	on	0	None
24683	24684	total	0	None
24684	24685	scores	0	None
24685	24686	of	0	None
24686	24687	impulsivity	0	None
24687	24688	,	0	None
24688	24689	aggression	0	None
24689	24690	,	0	None
24690	24691	and	0	None
24691	24692	sensation	0	None
24692	24693	seeking	0	None
24693	24694	compared	0	None
24694	24695	to	0	None
24695	24696	controls	0	None
24696	24697	.	0	None

24698	24699	The	0	None
24699	24700	findings	0	None
24700	24701	do	0	None
24701	24702	not	0	None
24702	24703	seem	0	None
24703	24704	to	0	None
24704	24705	support	0	None
24705	24706	an	0	None
24706	24707	association	0	None
24707	24708	between	0	None
24708	24709	these	0	None
24709	24710	polymorphisms	0	None
24710	24711	in	0	None
24711	24712	the	0	None
24712	24713	5HTT	0	None
24713	24714	gene	0	None
24714	24715	and	0	None
24715	24716	impulsive-aggressive	0	None
24716	24717	traits	0	None
24717	24718	among	0	None
24718	24719	cocaine-dependent	0	None
24719	24720	African-American	0	None
24720	24721	individuals	0	None
24721	24722	.	0	None
24722	24723	Anti-diabetic	0	None
24723	24724	and	0	None
24724	24725	anti-lipidemic	0	None
24725	24726	effects	0	None
24726	24727	of	0	None
24727	24728	chlorogenic	0	None
24728	24729	acid	0	None
24729	24730	are	0	None
24730	24731	mediated	0	None
24731	24732	by	0	None
24732	24733	ampk	0	None
24733	24734	activation	0	None
24734	24735	.	0	None
24735	24736	E7080	0	None
24736	24737	,	0	None
24737	24738	a	0	None
24738	24739	novel	0	None
24739	24740	inhibitor	0	None
24740	24741	that	0	None
24741	24742	targets	0	None
24742	24743	multiple	0	None
24743	24744	kinases	0	None
24744	24745	,	0	None
24745	24746	has	0	None
24746	24747	potent	0	None
24747	24748	antitumor	0	None
24748	24749	activities	0	None
24749	24750	against	0	None
24750	24751	stem	0	None
24751	24752	cell	0	None
24752	24753	factor	0	None
24753	24754	producing	0	None
24754	24755	human	0	None
24755	24756	small	0	None
24756	24757	cell	0	None
24757	24758	lung	0	None
24758	24759	cancer	0	None
24759	24760	H146	0	None
24760	24761	,	0	None
24761	24762	based	0	None
24762	24763	on	0	None
24763	24764	angiogenesis	0	None
24764	24765	inhibition	0	None
24765	24766	.	0	None
24766	24767	Defective	0	None
24767	24768	DNA	0	None
24768	24769	damage	0	None
24769	24770	response	0	None
24770	24771	and	0	None
24771	24772	repair	0	None
24772	24773	in	0	None
24773	24774	liver	0	None
24774	24775	cells	0	None
24775	24776	expressing	0	None
24776	24777	hepatitis	0	None
24777	24778	B	0	None
24778	24779	virus	0	None
24779	24780	surface	0	None
24780	24781	antigen	0	None
24781	24782	.	0	None
24782	24783	Recent	0	None
24783	24784	evidence	0	None
24784	24785	suggests	0	None
24785	24786	that	0	None
24786	24787	the	0	None
24787	24788	dopamine	0	None
24788	24790	D4 receptor	1	GENE-Y
24790	24791	may	0	None
24791	24792	play	0	None
24792	24793	a	0	None
24793	24794	role	0	None
24794	24795	in	0	None
24795	24796	schizophrenia	0	None
24796	24797	,	0	None
24797	24798	and	0	None
24798	24799	that	0	None
24799	24800	the	0	None
24800	24801	atypical	0	None
24801	24802	properties	0	None
24802	24803	of	0	None
24803	24804	the	0	None
24804	24805	antipsychotic	0	None
24805	24806	clozapine	2	CHEMICAL
24806	24807	may	0	None
24807	24808	be	0	None
24808	24809	attributable	0	None
24809	24810	in	0	None
24810	24811	part	0	None
24811	24812	to	0	None
24812	24813	its	0	None
24813	24814	antagonistic	0	None
24814	24815	actions	0	None
24815	24816	at	0	None
24816	24817	this	0	None
24817	24818	receptor	0	None
24818	24819	.	0	None

24820	24821	In	0	None
24821	24822	the	0	None
24822	24823	present	0	None
24823	24824	study	0	None
24824	24825	,	0	None
24825	24826	clozapine	2	CHEMICAL
24826	24827	and	0	None
24827	24828	three	0	None
24828	24829	other	0	None
24829	24830	compounds	0	None
24830	24831	having	0	None
24831	24834	D4 dopamine receptor	1	GENE-Y
24834	24835	antagonist	0	None
24835	24836	properties	0	None
24836	24837	were	0	None
24837	24838	examined	0	None
24838	24839	for	0	None
24839	24840	their	0	None
24840	24841	effectiveness	0	None
24841	24842	in	0	None
24842	24843	reducing	0	None
24843	24844	losses	0	None
24844	24845	in	0	None
24845	24846	prepulse	0	None
24846	24847	inhibition	0	None
24847	24848	(	0	None
24848	24849	PPI	0	None
24849	24850	)	0	None
24850	24851	induced	0	None
24851	24852	in	0	None
24852	24853	rats	0	None
24853	24854	by	0	None
24854	24855	the	0	None
24855	24856	dopamine	0	None
24856	24857	receptor	0	None
24857	24858	agonist	0	None
24858	24859	apomorphine	0	None
24859	24860	.	0	None

24861	24862	Previously	0	None
24862	24863	,	0	None
24863	24864	activity	0	None
24864	24865	in	0	None
24865	24866	the	0	None
24866	24867	PPI	0	None
24867	24868	model	0	None
24868	24869	has	0	None
24869	24870	been	0	None
24870	24871	shown	0	None
24871	24872	to	0	None
24872	24873	correlate	0	None
24873	24874	highly	0	None
24874	24875	with	0	None
24875	24876	the	0	None
24876	24877	antipsychotic	0	None
24877	24878	potency	0	None
24878	24879	of	0	None
24879	24880	a	0	None
24880	24881	number	0	None
24881	24882	of	0	None
24882	24883	neuroleptics	2	CHEMICAL
24883	24884	.	0	None

24885	24886	As	0	None
24886	24887	previously	0	None
24887	24888	reported	0	None
24888	24889	,	0	None
24889	24890	clozapine	2	CHEMICAL
24890	24891	(	0	None
24891	24892	1-5	0	None
24892	24893	.	0	None
24893	24894	6	0	None
24894	24895	mg	2	CHEMICAL
24895	24896	/	0	None
24896	24897	kg	0	None
24897	24898	)	0	None
24898	24899	significantly	0	None
24899	24900	reduced	0	None
24900	24901	apomorphine-induced	0	None
24901	24902	PPI	0	None
24902	24903	deficits	0	None
24903	24904	.	0	None

24905	24906	The	0	None
24906	24907	three	0	None
24907	24908	D4-selective	0	None
24908	24909	compounds	0	None
24909	24910	,	0	None
24910	24911	CP-293	0	None
24911	24912	,	0	None
24912	24913	019	0	None
24913	24914	(	0	None
24914	24915	5	0	None
24915	24916	.	0	None
24916	24917	6-17	0	None
24917	24918	.	0	None
24918	24919	8	0	None
24919	24920	mg	2	CHEMICAL
24920	24921	/	0	None
24921	24922	kg	0	None
24922	24923	)	0	None
24923	24924	,	0	None
24924	24925	U-101	0	None
24925	24926	,	0	None
24926	24927	387	0	None
24927	24928	(	0	None
24928	24929	3-30	0	None
24929	24930	mg	2	CHEMICAL
24930	24931	/	0	None
24931	24932	kg	0	None
24932	24933	)	0	None
24933	24934	and	0	None
24934	24935	L-745	0	None
24935	24936	,	0	None
24936	24937	870	0	None
24937	24938	(	0	None
24938	24939	1-10	0	None
24939	24940	mg	2	CHEMICAL
24940	24941	/	0	None
24941	24942	kg	0	None
24942	24943	)	0	None
24943	24944	,	0	None
24944	24945	also	0	None
24945	24946	significantly	0	None
24946	24947	blocked	0	None
24947	24948	the	0	None
24948	24949	losses	0	None
24949	24950	in	0	None
24950	24951	PPI	0	None
24951	24952	produced	0	None
24952	24953	by	0	None
24953	24954	apomorphine	0	None
24954	24955	.	0	None

24956	24957	Taken	0	None
24957	24958	together	0	None
24958	24959	,	0	None
24959	24960	these	0	None
24960	24961	results	0	None
24961	24962	suggest	0	None
24962	24963	that	0	None
24963	24964	dopamine	0	None
24964	24965	receptor	0	None
24965	24966	antagonists	0	None
24966	24967	with	0	None
24967	24968	selectivity	0	None
24968	24969	for	0	None
24969	24970	the	0	None
24970	24973	D4 dopamine receptor	1	GENE-Y
24973	24974	subtype	0	None
24974	24975	may	0	None
24975	24976	be	0	None
24976	24977	effective	0	None
24977	24978	in	0	None
24978	24979	the	0	None
24979	24980	treatment	0	None
24980	24981	of	0	None
24981	24982	schizophrenia	0	None
24982	24983	,	0	None
24983	24984	while	0	None
24984	24985	being	0	None
24985	24986	less	0	None
24986	24987	likely	0	None
24987	24988	to	0	None
24988	24989	produce	0	None
24989	24990	dyskinesias	0	None
24990	24991	associated	0	None
24991	24992	with	0	None
24992	24993	D2	0	None
24993	24994	receptor	0	None
24994	24995	antagonists	0	None
24995	24996	.	0	None
24996	24997	Bupropion	0	None
24997	24998	,	0	None
24998	24999	an	0	None
24999	25000	efficacious	0	None
25000	25001	antidepressant	0	None
25001	25002	and	0	None
25002	25003	smoking	0	None
25003	25004	cessation	0	None
25004	25005	agent	0	None
25005	25006	,	0	None
25006	25007	inhibits	0	None
25007	25008	dopamine	0	None
25008	25009	and	0	None
25009	25011	norepinephrine transporters	3	GENE-N
25011	25012	(	0	None
25012	25013	DAT	1	GENE-Y
25013	25014	and	0	None
25014	25015	NET	0	None
25015	25016	,	0	None
25016	25017	respectively	0	None
25017	25018	)	0	None
25018	25019	.	0	None

25020	25021	Recently	0	None
25021	25022	,	0	None
25022	25023	bupropion	0	None
25023	25024	has	0	None
25024	25025	been	0	None
25025	25026	reported	0	None
25026	25027	to	0	None
25027	25028	noncompetitively	0	None
25028	25029	inhibit	0	None
25029	25030	alpha3beta2	0	None
25030	25031	,	0	None
25031	25032	alpha3beta4	0	None
25032	25033	,	0	None
25033	25034	and	0	None
25034	25037	alpha4beta2 nicotinic acetylcholine	0	None
25037	25038	receptors	0	None
25038	25039	(	0	None
25039	25040	nAChRs	0	None
25040	25041	)	0	None
25041	25042	expressed	0	None
25042	25043	in	0	None
25043	25044	Xenopus	0	None
25044	25045	oocytes	0	None
25045	25046	or	0	None
25046	25047	established	0	None
25047	25048	cell	0	None
25048	25049	lines	0	None
25049	25050	.	0	None

25051	25052	The	0	None
25052	25053	present	0	None
25053	25054	study	0	None
25054	25055	evaluated	0	None
25055	25056	bupropion-induced	0	None
25056	25057	inhibition	0	None
25057	25058	of	0	None
25058	25059	native	0	None
25059	25060	alpha3beta2*	0	None
25060	25061	and	0	None
25061	25062	alpha3beta4*	0	None
25062	25063	nAChRs	0	None
25063	25064	using	0	None
25064	25065	functional	0	None
25065	25066	neurotransmitter	0	None
25066	25067	release	0	None
25067	25068	assays	0	None
25068	25069	,	0	None
25069	25070	nicotine-evoked	0	None
25070	25071	[	0	None
25071	25072	(	0	None
25072	25073	3	0	None
25073	25074	)	0	None
25074	25075	H	0	None
25075	25076	]	0	None
25076	25077	overflow	0	None
25077	25078	from	0	None
25078	25079	superfused	0	None
25079	25080	rat	0	None
25080	25081	striatal	0	None
25081	25082	slices	0	None
25082	25083	preloaded	0	None
25083	25084	with	0	None
25084	25085	[	0	None
25085	25086	(	0	None
25086	25087	3	0	None
25087	25088	)	0	None
25088	25089	H	0	None
25089	25090	]	0	None
25090	25091	dopamine	0	None
25091	25092	(	0	None
25092	25093	[	0	None
25093	25094	(	0	None
25094	25095	3	0	None
25095	25096	)	0	None
25096	25097	H	0	None
25097	25098	]	0	None
25098	25099	DA	0	None
25099	25100	)	0	None
25100	25101	,	0	None
25101	25102	and	0	None
25102	25103	nicotine-evoked	0	None
25103	25104	[	0	None
25104	25105	(	0	None
25105	25106	3	0	None
25106	25107	)	0	None
25107	25108	H	0	None
25108	25109	]	0	None
25109	25110	overflow	0	None
25110	25111	from	0	None
25111	25112	hippocampal	0	None
25112	25113	slices	0	None
25113	25114	preloaded	0	None
25114	25115	with	0	None
25115	25116	[	0	None
25116	25117	(	0	None
25117	25118	3	0	None
25118	25119	)	0	None
25119	25120	H	0	None
25120	25121	]	0	None
25121	25122	norepinephrine	2	CHEMICAL
25122	25123	(	0	None
25123	25124	[	0	None
25124	25125	(	0	None
25125	25126	3	0	None
25126	25127	)	0	None
25127	25128	H	0	None
25128	25129	]	0	None
25129	25130	NE	0	None
25130	25131	)	0	None
25131	25132	.	0	None

25133	25134	The	0	None
25134	25135	mechanism	0	None
25135	25136	of	0	None
25136	25137	inhibition	0	None
25137	25138	was	0	None
25138	25139	evaluated	0	None
25139	25140	using	0	None
25140	25141	Schild	0	None
25141	25142	analysis	0	None
25142	25143	.	0	None

25144	25145	To	0	None
25145	25146	eliminate	0	None
25146	25147	the	0	None
25147	25148	interaction	0	None
25148	25149	of	0	None
25149	25150	bupropion	0	None
25150	25151	with	0	None
25151	25152	DAT	1	GENE-Y
25152	25153	or	0	None
25153	25154	NET	0	None
25154	25155	,	0	None
25155	25156	nomifensine	0	None
25156	25157	or	0	None
25157	25158	desipramine	0	None
25158	25159	,	0	None
25159	25160	respectively	0	None
25160	25161	,	0	None
25161	25162	was	0	None
25162	25163	included	0	None
25163	25164	in	0	None
25164	25165	the	0	None
25165	25166	superfusion	0	None
25166	25167	buffer	0	None
25167	25168	.	0	None

25169	25170	A	0	None
25170	25171	high	0	None
25171	25172	bupropion	0	None
25172	25173	concentration	0	None
25173	25174	(	0	None
25174	25175	100	0	None
25175	25176	microM	0	None
25176	25177	)	0	None
25177	25178	elicited	0	None
25178	25179	intrinsic	0	None
25179	25180	activity	0	None
25180	25181	in	0	None
25181	25182	the	0	None
25182	25183	[	0	None
25183	25184	(	0	None
25184	25185	3	0	None
25185	25186	)	0	None
25186	25187	H	0	None
25187	25188	]	0	None
25188	25189	DA	0	None
25189	25190	release	0	None
25190	25191	assay	0	None
25191	25192	.	0	None

25193	25194	However	0	None
25194	25195	,	0	None
25195	25196	none	0	None
25196	25197	of	0	None
25197	25198	the	0	None
25198	25199	concentrations	0	None
25199	25200	(	0	None
25200	25201	1	0	None
25201	25202	nM-100	0	None
25202	25203	microM	0	None
25203	25204	)	0	None
25204	25205	examined	0	None
25205	25206	evoked	0	None
25206	25207	[	0	None
25207	25208	(	0	None
25208	25209	3	0	None
25209	25210	)	0	None
25210	25211	H	0	None
25211	25212	]	0	None
25212	25213	NE	0	None
25213	25214	overflow	0	None
25214	25215	and	0	None
25215	25216	,	0	None
25216	25217	thus	0	None
25217	25218	,	0	None
25218	25219	were	0	None
25219	25220	without	0	None
25220	25221	intrinsic	0	None
25221	25222	activity	0	None
25222	25223	in	0	None
25223	25224	this	0	None
25224	25225	assay	0	None
25225	25226	.	0	None

25227	25228	Moreover	0	None
25228	25229	,	0	None
25229	25230	bupropion	0	None
25230	25231	inhibited	0	None
25231	25232	both	0	None
25232	25233	nicotine-evoked	0	None
25233	25234	[	0	None
25234	25235	(	0	None
25235	25236	3	0	None
25236	25237	)	0	None
25237	25238	H	0	None
25238	25239	]	0	None
25239	25240	DA	0	None
25240	25241	overflow	0	None
25241	25242	(	0	None
25242	25243	IC	0	None
25243	25244	(	0	None
25244	25245	50	0	None
25245	25246	)	0	None
25246	25247	=	0	None
25247	25248	1	0	None
25248	25249	.	0	None
25249	25250	27	0	None
25250	25251	microM	0	None
25251	25252	)	0	None
25252	25253	and	0	None
25253	25254	nicotine-evoked	0	None
25254	25255	[	0	None
25255	25256	(	0	None
25256	25257	3	0	None
25257	25258	)	0	None
25258	25259	H	0	None
25259	25260	]	0	None
25260	25261	NE	0	None
25261	25262	overflow	0	None
25262	25263	(	0	None
25263	25264	IC	0	None
25264	25265	(	0	None
25265	25266	50	0	None
25266	25267	)	0	None
25267	25268	=	0	None
25268	25269	323	0	None
25269	25270	nM	0	None
25270	25271	)	0	None
25271	25272	at	0	None
25272	25273	bupropion	0	None
25273	25274	concentrations	0	None
25274	25275	well	0	None
25275	25276	below	0	None
25276	25277	those	0	None
25277	25278	eliciting	0	None
25278	25279	intrinsic	0	None
25279	25280	activity	0	None
25280	25281	.	0	None

25282	25283	Results	0	None
25283	25284	from	0	None
25284	25285	Schild	0	None
25285	25286	analyses	0	None
25286	25287	suggest	0	None
25287	25288	that	0	None
25288	25289	bupropion	0	None
25289	25290	competitively	0	None
25290	25291	inhibits	0	None
25291	25292	nicotine-evoked	0	None
25292	25293	[	0	None
25293	25294	(	0	None
25294	25295	3	0	None
25295	25296	)	0	None
25296	25297	H	0	None
25297	25298	]	0	None
25298	25299	DA	0	None
25299	25300	overflow	0	None
25300	25301	,	0	None
25301	25302	whereas	0	None
25302	25303	evidence	0	None
25303	25304	for	0	None
25304	25305	receptor	0	None
25305	25306	reserve	0	None
25306	25307	was	0	None
25307	25308	obtained	0	None
25308	25309	upon	0	None
25309	25310	assessment	0	None
25310	25311	of	0	None
25311	25312	bupropion	0	None
25312	25313	inhibition	0	None
25313	25314	of	0	None
25314	25315	nicotine-evoked	0	None
25315	25316	[	0	None
25316	25317	(	0	None
25317	25318	3	0	None
25318	25319	)	0	None
25319	25320	H	0	None
25320	25321	]	0	None
25321	25322	NE	0	None
25322	25323	overflow	0	None
25323	25324	.	0	None

25325	25326	Thus	0	None
25326	25327	,	0	None
25327	25328	bupropion	0	None
25328	25329	acts	0	None
25329	25330	as	0	None
25330	25331	an	0	None
25331	25332	antagonist	0	None
25332	25333	at	0	None
25333	25334	alpha3beta2*	0	None
25334	25335	and	0	None
25335	25336	alpha3beta4*	0	None
25336	25337	nAChRs	0	None
25337	25338	in	0	None
25338	25339	rat	0	None
25339	25340	striatum	0	None
25340	25341	and	0	None
25341	25342	hippocampus	0	None
25342	25343	,	0	None
25343	25344	respectively	0	None
25344	25345	,	0	None
25345	25346	across	0	None
25346	25347	the	0	None
25347	25348	same	0	None
25348	25349	concentration	0	None
25349	25350	range	0	None
25350	25351	that	0	None
25351	25352	inhibits	0	None
25352	25353	DAT	1	GENE-Y
25353	25354	and	0	None
25354	25355	NET	0	None
25355	25356	function	0	None
25356	25357	.	0	None

25358	25359	The	0	None
25359	25360	combination	0	None
25360	25361	of	0	None
25361	25362	nAChR	0	None
25362	25363	and	0	None
25363	25364	transporter	0	None
25364	25365	inhibition	0	None
25365	25366	produced	0	None
25366	25367	by	0	None
25367	25368	bupropion	0	None
25368	25369	may	0	None
25369	25370	contribute	0	None
25370	25371	to	0	None
25371	25372	its	0	None
25372	25373	clinical	0	None
25373	25374	efficacy	0	None
25374	25375	as	0	None
25375	25376	a	0	None
25376	25377	smoking	0	None
25377	25378	cessation	0	None
25378	25379	agent	0	None
25379	25380	.	0	None
25380	25381	Effect	0	None
25381	25382	of	0	None
25382	25383	naloxone	0	None
25383	25384	on	0	None
25384	25385	ischemic	0	None
25385	25386	acute	0	None
25386	25387	kidney	0	None
25387	25388	injury	0	None
25388	25389	in	0	None
25389	25390	the	0	None
25390	25391	mouse	0	None
25391	25392	.	0	None
25392	25393	LPA1-induced	0	None
25393	25394	cytoskeleton	0	None
25394	25395	reorganization	0	None
25395	25396	drives	0	None
25396	25397	fibrosis	0	None
25397	25398	through	0	None
25398	25399	CTGF-dependent	0	None
25399	25400	fibroblast	0	None
25400	25401	proliferation	0	None
25401	25402	.	0	None
25402	25403	Determination	0	None
25403	25404	of	0	None
25404	25405	homocysteine	0	None
25405	25406	levels	0	None
25406	25407	in	0	None
25407	25408	cells	0	None
25408	25409	and	0	None
25409	25410	serum	0	None
25410	25411	is	0	None
25411	25412	important	0	None
25412	25413	because	0	None
25413	25414	high	0	None
25414	25415	homocysteine	0	None
25415	25416	is	0	None
25416	25417	a	0	None
25417	25418	risk	0	None
25418	25419	factor	0	None
25419	25420	for	0	None
25420	25421	cardiovascular	0	None
25421	25422	disease	0	None
25422	25423	.	0	None

25424	25425	The	0	None
25425	25426	currently	0	None
25426	25427	used	0	None
25427	25428	methods	0	None
25428	25429	for	0	None
25429	25430	homocysteine	0	None
25430	25431	analysis	0	None
25431	25432	either	0	None
25432	25433	are	0	None
25433	25434	time	0	None
25434	25435	consuming	0	None
25435	25436	or	0	None
25436	25437	rely	0	None
25437	25438	on	0	None
25438	25439	the	0	None
25439	25440	use	0	None
25440	25441	of	0	None
25441	25442	expensive	0	None
25442	25443	equipment	0	None
25443	25444	.	0	None

25445	25446	Described	0	None
25446	25447	in	0	None
25447	25448	this	0	None
25448	25449	study	0	None
25449	25450	is	0	None
25450	25451	an	0	None
25451	25452	enzymatic	0	None
25452	25453	assay	0	None
25453	25454	that	0	None
25454	25455	determines	0	None
25455	25456	levels	0	None
25456	25457	of	0	None
25457	25458	homocysteine	0	None
25458	25459	in	0	None
25459	25460	multiple	0	None
25460	25461	samples	0	None
25461	25462	in	0	None
25462	25463	less	0	None
25463	25464	than	0	None
25464	25465	30	0	None
25465	25466	min	0	None
25466	25467	at	0	None
25467	25468	levels	0	None
25468	25469	from	0	None
25469	25470	5	0	None
25470	25471	to	0	None
25471	25472	50	0	None
25472	25473	pmol	0	None
25473	25474	using	0	None
25474	25475	only	0	None
25475	25476	a	0	None
25476	25477	spectrophotometer	0	None
25477	25478	.	0	None

25479	25480	The	0	None
25480	25481	reproducibility	0	None
25481	25482	of	0	None
25482	25483	the	0	None
25483	25484	assay	0	None
25484	25485	is	0	None
25485	25486	consistent	0	None
25486	25487	with	0	None
25487	25488	the	0	None
25488	25489	other	0	None
25489	25490	methods	0	None
25490	25491	currently	0	None
25491	25492	used	0	None
25492	25493	.	0	None

25494	25495	A	0	None
25495	25496	second	0	None
25496	25497	assay	0	None
25497	25498	,	0	None
25498	25499	that	0	None
25499	25500	is	0	None
25500	25501	about	0	None
25501	25502	5-fold	0	None
25502	25503	more	0	None
25503	25504	sensitive	0	None
25504	25505	,	0	None
25505	25506	follows	0	None
25506	25507	the	0	None
25507	25508	enzymatic	0	None
25508	25509	catalyzed	0	None
25509	25510	solvent	0	None
25510	25511	exchange	0	None
25511	25512	of	0	None
25512	25513	protons	0	None
25513	25514	on	0	None
25514	25515	glycine	2	CHEMICAL
25515	25516	,	0	None
25516	25517	which	0	None
25517	25518	requires	0	None
25518	25519	a	0	None
25519	25520	scintillation	0	None
25520	25521	counter	0	None
25521	25522	.	0	None

25523	25524	Both	0	None
25524	25525	the	0	None
25525	25526	spectrophotometric	0	None
25526	25527	and	0	None
25527	25528	the	0	None
25528	25529	radiometric	0	None
25529	25530	methods	0	None
25530	25531	are	0	None
25531	25532	based	0	None
25532	25533	on	0	None
25533	25534	the	0	None
25534	25535	conversion	0	None
25535	25536	of	0	None
25536	25537	5-methyltetrahydrofolate	0	None
25537	25538	to	0	None
25538	25539	tetrahydrofolate	2	CHEMICAL
25539	25540	by	0	None
25540	25542	methionine synthase	1	GENE-Y
25542	25543	.	0	None

25544	25545	The	0	None
25545	25546	tetrahydrofolate	2	CHEMICAL
25546	25547	is	0	None
25547	25548	formed	0	None
25548	25549	in	0	None
25549	25550	stoichiometric	0	None
25550	25551	amounts	0	None
25551	25552	to	0	None
25552	25553	the	0	None
25553	25554	homocysteine	0	None
25554	25555	in	0	None
25555	25556	the	0	None
25556	25557	sample	0	None
25557	25558	.	0	None

25559	25560	In	0	None
25560	25561	the	0	None
25561	25562	spectrophotometric	0	None
25562	25563	method	0	None
25563	25564	the	0	None
25564	25565	tetrahydrofolate	2	CHEMICAL
25565	25566	is	0	None
25566	25567	used	0	None
25567	25568	at	0	None
25568	25569	catalytic	0	None
25569	25570	levels	0	None
25570	25571	by	0	None
25571	25572	three	0	None
25572	25573	enzymes	0	None
25573	25574	to	0	None
25574	25575	form	0	None
25575	25576	a	0	None
25576	25577	metabolic	0	None
25577	25578	cycle	0	None
25578	25579	that	0	None
25579	25580	generates	0	None
25580	25581	NADPH	0	None
25581	25582	from	0	None
25582	25583	NADP	0	None
25583	25584	(	0	None
25584	25585	+	0	None
25585	25586	)	0	None
25586	25587	.	0	None

25588	25589	In	0	None
25589	25590	the	0	None
25590	25591	radiometric	0	None
25591	25592	assay	0	None
25592	25593	tetrahydrofolate	2	CHEMICAL
25593	25594	is	0	None
25594	25595	required	0	None
25595	25596	for	0	None
25596	25597	the	0	None
25597	25598	enzymatic	0	None
25598	25599	exchange	0	None
25599	25600	of	0	None
25600	25601	the	0	None
25601	25602	pro	2	CHEMICAL
25602	25603	2S	0	None
25603	25604	proton	0	None
25604	25605	of	0	None
25605	25606	glycine	2	CHEMICAL
25606	25607	with	0	None
25607	25608	solvent	0	None
25608	25609	.	0	None

25610	25611	L-Cysteine	2	CHEMICAL
25611	25612	,	0	None
25612	25613	at	0	None
25613	25614	levels	0	None
25614	25615	more	0	None
25615	25616	than	0	None
25616	25617	30-fold	0	None
25617	25618	higher	0	None
25618	25619	than	0	None
25619	25620	the	0	None
25620	25621	upper	0	None
25621	25622	level	0	None
25622	25623	of	0	None
25623	25624	homocysteine	0	None
25624	25625	used	0	None
25625	25626	in	0	None
25626	25627	these	0	None
25627	25628	assays	0	None
25628	25629	,	0	None
25629	25630	does	0	None
25630	25631	not	0	None
25631	25632	give	0	None
25632	25633	any	0	None
25633	25634	measurable	0	None
25634	25635	response	0	None
25635	25636	.	0	None
25636	25637	Drospirenone	0	None
25637	25638	(	0	None
25638	25639	ZK	0	None
25639	25640	30595;	0	None
25640	25641	6	0	None
25641	25642	beta	0	None
25642	25643	,	0	None
25643	25644	7	0	None
25644	25645	beta	0	None
25645	25646	,	0	None
25646	25647	15	0	None
25647	25648	beta	0	None
25648	25649	,	0	None
25649	25650	16	0	None
25650	25651	beta-dimethylen-3-oxo-17	0	None
25651	25652	alpha-pregn-4-ene-21	0	None
25652	25653	,	0	None
25653	25654	17-carbolactone	0	None
25654	25655	)	0	None
25655	25656	is	0	None
25656	25657	a	0	None
25657	25658	novel	0	None
25658	25659	progestogen	0	None
25659	25660	under	0	None
25660	25661	clinical	0	None
25661	25662	development	0	None
25662	25663	.	0	None

25664	25665	Drospirenone	0	None
25665	25666	is	0	None
25666	25667	characterized	0	None
25667	25668	by	0	None
25668	25669	an	0	None
25669	25670	innovative	0	None
25670	25671	pharmacodynamic	0	None
25671	25672	profile	0	None
25672	25673	which	0	None
25673	25674	is	0	None
25674	25675	very	0	None
25675	25676	closely	0	None
25676	25677	related	0	None
25677	25678	to	0	None
25678	25679	that	0	None
25679	25680	of	0	None
25680	25681	progesterone	2	CHEMICAL
25681	25682	.	0	None

25683	25684	Potential	0	None
25684	25685	applications	0	None
25685	25686	include	0	None
25686	25687	oral	0	None
25687	25688	contraception	0	None
25688	25689	,	0	None
25689	25690	hormone	0	None
25690	25691	replacement	0	None
25691	25692	therapy	0	None
25692	25693	and	0	None
25693	25694	treatment	0	None
25694	25695	of	0	None
25695	25696	hormonal	0	None
25696	25697	disorders	0	None
25697	25698	.	0	None

25699	25700	The	0	None
25700	25701	pharmacological	0	None
25701	25702	properties	0	None
25702	25703	of	0	None
25703	25704	drospirenone	2	CHEMICAL
25704	25705	were	0	None
25705	25706	investigated	0	None
25706	25707	in	0	None
25707	25708	vitro	0	None
25708	25709	by	0	None
25709	25710	receptor	0	None
25710	25711	binding	0	None
25711	25712	and	0	None
25712	25713	transactivation	0	None
25713	25714	experiments	0	None
25714	25715	and	0	None
25715	25716	in	0	None
25716	25717	vivo	0	None
25717	25718	in	0	None
25718	25719	appropriate	0	None
25719	25720	animal	0	None
25720	25721	models	0	None
25721	25722	.	0	None

25723	25724	In	0	None
25724	25725	qualitative	0	None
25725	25726	agreement	0	None
25726	25727	with	0	None
25727	25728	progesterone	2	CHEMICAL
25728	25729	,	0	None
25729	25730	the	0	None
25730	25731	compound	0	None
25731	25732	binds	0	None
25732	25733	strongly	0	None
25733	25734	to	0	None
25734	25735	the	0	None
25735	25736	progesterone	2	CHEMICAL
25736	25737	and	0	None
25737	25738	the	0	None
25738	25740	mineralocorticoid receptor	1	GENE-Y
25740	25741	and	0	None
25741	25742	with	0	None
25742	25743	lower	0	None
25743	25744	affinity	0	None
25744	25745	to	0	None
25745	25746	androgen	0	None
25746	25747	and	0	None
25747	25748	glucocorticoid	0	None
25748	25749	receptors	0	None
25749	25750	.	0	None

25751	25752	There	0	None
25752	25753	is	0	None
25753	25754	no	0	None
25754	25755	detectable	0	None
25755	25756	binding	0	None
25756	25757	to	0	None
25757	25758	the	0	None
25758	25760	estrogen receptor	1	GENE-Y
25760	25761	.	0	None

25762	25763	Steroid	0	None
25763	25764	hormone	0	None
25764	25765	agonistic	0	None
25765	25766	and	0	None
25766	25767	antagonistic	0	None
25767	25768	activities	0	None
25768	25769	of	0	None
25769	25770	progesterone	2	CHEMICAL
25770	25771	and	0	None
25771	25772	drospirenone	2	CHEMICAL
25772	25773	were	0	None
25773	25774	compared	0	None
25774	25775	in	0	None
25775	25776	transactivation	0	None
25776	25777	experiments	0	None
25777	25778	.	0	None

25779	25780	Individual	0	None
25780	25781	steroid	2	CHEMICAL
25781	25782	hormone	0	None
25782	25783	receptors	0	None
25783	25784	were	0	None
25784	25785	artificially	0	None
25785	25786	expressed	0	None
25786	25787	together	0	None
25787	25788	with	0	None
25788	25789	a	0	None
25789	25790	reporter	0	None
25790	25791	gene	0	None
25791	25792	in	0	None
25792	25793	appropriate	0	None
25793	25794	cell	0	None
25794	25795	lines	0	None
25795	25796	.	0	None

25797	25798	Both	0	None
25798	25799	hormones	2	CHEMICAL
25799	25800	were	0	None
25800	25801	unable	0	None
25801	25802	to	0	None
25802	25803	induce	0	None
25803	25804	any	0	None
25804	25805	androgen	0	None
25805	25806	receptor-mediated	0	None
25806	25807	agonistic	0	None
25807	25808	activity	0	None
25808	25809	.	0	None

25810	25811	Rather	0	None
25811	25812	,	0	None
25812	25813	both	0	None
25813	25814	progesterone	2	CHEMICAL
25814	25815	and	0	None
25815	25816	drospirenone	2	CHEMICAL
25816	25817	distinctly	0	None
25817	25818	antagonized	0	None
25818	25819	androgen-stimulated	0	None
25819	25820	transcriptional	0	None
25820	25821	activation	0	None
25821	25822	.	0	None

25823	25824	Likewise	0	None
25824	25825	,	0	None
25825	25826	both	0	None
25826	25827	compounds	0	None
25827	25828	only	0	None
25828	25829	very	0	None
25829	25830	weakly	0	None
25830	25831	activated	0	None
25831	25832	the	0	None
25832	25834	mineralocorticoid receptor	1	GENE-Y
25834	25835	but	0	None
25835	25836	showed	0	None
25836	25837	potent	0	None
25837	25838	aldosterone	0	None
25838	25839	antagonistic	0	None
25839	25840	activity	0	None
25840	25841	.	0	None

25842	25843	Drospirenone	0	None
25843	25844	did	0	None
25844	25845	not	0	None
25845	25846	induce	0	None
25846	25847	glucocorticoid	0	None
25847	25848	receptor-driven	0	None
25848	25849	transactivation	0	None
25849	25850	.	0	None

25851	25852	Progesterone	0	None
25852	25853	was	0	None
25853	25854	a	0	None
25854	25855	weak	0	None
25855	25856	agonist	0	None
25856	25857	in	0	None
25857	25858	this	0	None
25858	25859	respect	0	None
25859	25860	.	0	None

25861	25862	Drospirenone	0	None
25862	25863	exerts	0	None
25863	25864	potent	0	None
25864	25865	progestogenic	0	None
25865	25866	and	0	None
25866	25867	antigonadotropic	0	None
25867	25868	activity	0	None
25868	25869	which	0	None
25869	25870	was	0	None
25870	25871	studied	0	None
25871	25872	in	0	None
25872	25873	various	0	None
25873	25874	animal	0	None
25874	25875	species	0	None
25875	25876	.	0	None

25877	25878	It	0	None
25878	25879	efficiently	0	None
25879	25880	promotes	0	None
25880	25881	the	0	None
25881	25882	maintenance	0	None
25882	25883	of	0	None
25883	25884	pregnancy	0	None
25884	25885	in	0	None
25885	25886	ovariectomized	0	None
25886	25887	rats	0	None
25887	25888	,	0	None
25888	25889	inhibits	0	None
25889	25890	ovulation	0	None
25890	25891	in	0	None
25891	25892	rats	0	None
25892	25893	and	0	None
25893	25894	mice	0	None
25894	25895	and	0	None
25895	25896	stimulates	0	None
25896	25897	endometrial	0	None
25897	25898	transformation	0	None
25898	25899	in	0	None
25899	25900	the	0	None
25900	25901	rabbit	0	None
25901	25902	.	0	None

25903	25904	Furthermore	0	None
25904	25905	,	0	None
25905	25906	drospirenone	2	CHEMICAL
25906	25907	shows	0	None
25907	25908	potent	0	None
25908	25909	antigonadotropic	0	None
25909	25910	,	0	None
25910	25911	i	0	None
25911	25912	.	0	None

25913	25914	e	0	None
25914	25915	.	0	None

25916	25917	,	0	None
25917	25918	testosterone-lowering	0	None
25918	25919	activity	0	None
25919	25920	in	0	None
25920	25921	male	0	None
25921	25922	cynomolgus	0	None
25922	25923	monkeys	0	None
25923	25924	.	0	None

25925	25926	The	0	None
25926	25927	progestogenic	0	None
25927	25928	potency	0	None
25928	25929	of	0	None
25929	25930	drospirenone	2	CHEMICAL
25930	25931	was	0	None
25931	25932	found	0	None
25932	25933	to	0	None
25933	25934	be	0	None
25934	25935	in	0	None
25935	25936	the	0	None
25936	25937	range	0	None
25937	25938	of	0	None
25938	25939	that	0	None
25939	25940	of	0	None
25940	25941	norethisterone	0	None
25941	25942	acetate	0	None
25942	25943	.	0	None

25944	25945	The	0	None
25945	25946	majority	0	None
25946	25947	of	0	None
25947	25948	clinically	0	None
25948	25949	used	0	None
25949	25950	progestogens	0	None
25950	25951	are	0	None
25951	25952	androgenic	0	None
25952	25953	.	0	None

25954	25955	Drospirenone	0	None
25955	25956	,	0	None
25956	25957	like	0	None
25957	25958	progesterone	2	CHEMICAL
25958	25959	,	0	None
25959	25960	has	0	None
25960	25961	no	0	None
25961	25962	androgenic	0	None
25962	25963	but	0	None
25963	25964	rather	0	None
25964	25965	an	0	None
25965	25966	antiandrogenic	0	None
25966	25967	effect	0	None
25967	25968	.	0	None

25969	25970	This	0	None
25970	25971	property	0	None
25971	25972	was	0	None
25972	25973	demonstrated	0	None
25973	25974	in	0	None
25974	25975	castrated	0	None
25975	25976	,	0	None
25976	25977	testosterone	2	CHEMICAL
25977	25978	propionate	0	None
25978	25979	substituted	0	None
25979	25980	male	0	None
25980	25981	rats	0	None
25981	25982	by	0	None
25982	25983	a	0	None
25983	25984	dose-dependent	0	None
25984	25985	inhibition	0	None
25985	25986	of	0	None
25986	25987	accessory	0	None
25987	25988	sex	0	None
25988	25989	organ	0	None
25989	25990	growth	0	None
25990	25991	(	0	None
25991	25992	seminal	0	None
25992	25993	vesicles	0	None
25993	25994	,	0	None
25994	25995	prostate	0	None
25995	25996	)	0	None
25996	25997	.	0	None

25998	25999	In	0	None
25999	26000	this	0	None
26000	26001	model	0	None
26001	26002	,	0	None
26002	26003	the	0	None
26003	26004	potency	0	None
26004	26005	of	0	None
26005	26006	drospirenone	2	CHEMICAL
26006	26007	was	0	None
26007	26008	about	0	None
26008	26009	a	0	None
26009	26010	third	0	None
26010	26011	that	0	None
26011	26012	of	0	None
26012	26013	cyproterone	0	None
26013	26014	acetate	0	None
26014	26015	.	0	None

26016	26017	Drospirenone	0	None
26017	26018	,	0	None
26018	26019	like	0	None
26019	26020	progesterone	2	CHEMICAL
26020	26021	,	0	None
26021	26022	shows	0	None
26022	26023	antimineralocorticoid	0	None
26023	26024	activity	0	None
26024	26025	,	0	None
26025	26026	which	0	None
26026	26027	causes	0	None
26027	26028	moderately	0	None
26028	26029	increased	0	None
26029	26030	sodium	2	CHEMICAL
26030	26031	and	0	None
26031	26032	water	0	None
26032	26033	excretion	0	None
26033	26034	.	0	None

26035	26036	This	0	None
26036	26037	is	0	None
26037	26038	an	0	None
26038	26039	outstanding	0	None
26039	26040	characteristic	0	None
26040	26041	which	0	None
26041	26042	has	0	None
26042	26043	not	0	None
26043	26044	been	0	None
26044	26045	described	0	None
26045	26046	for	0	None
26046	26047	any	0	None
26047	26048	other	0	None
26048	26049	synthetic	0	None
26049	26050	progestogen	0	None
26050	26051	before	0	None
26051	26052	.	0	None

26053	26054	Drospirenone	0	None
26054	26055	is	0	None
26055	26056	eight	0	None
26056	26057	to	0	None
26057	26058	ten	0	None
26058	26059	times	0	None
26059	26060	more	0	None
26060	26061	effective	0	None
26061	26062	in	0	None
26062	26063	this	0	None
26063	26064	respect	0	None
26064	26065	than	0	None
26065	26066	spironolactone	0	None
26066	26067	.	0	None

26068	26069	The	0	None
26069	26070	natriuretic	0	None
26070	26071	effect	0	None
26071	26072	was	0	None
26072	26073	demonstrable	0	None
26073	26074	for	0	None
26074	26075	at	0	None
26075	26076	least	0	None
26076	26077	three	0	None
26077	26078	weeks	0	None
26078	26079	upon	0	None
26079	26080	daily	0	None
26080	26081	treatment	0	None
26081	26082	of	0	None
26082	26083	rats	0	None
26083	26084	with	0	None
26084	26085	a	0	None
26085	26086	dose	0	None
26086	26087	of	0	None
26087	26088	10	0	None
26088	26089	mg	2	CHEMICAL
26089	26090	/	0	None
26090	26091	animal	0	None
26091	26092	.	0	None

26093	26094	Drospirenone	0	None
26094	26095	is	0	None
26095	26096	devoid	0	None
26096	26097	of	0	None
26097	26098	any	0	None
26098	26099	estrogenic	0	None
26099	26100	,	0	None
26100	26101	glucocorticoid	0	None
26101	26102	or	0	None
26102	26103	antiglucocorticoid	0	None
26103	26104	activity	0	None
26104	26105	.	0	None

26106	26107	In	0	None
26107	26108	summary	0	None
26108	26109	,	0	None
26109	26110	drospirenone	2	CHEMICAL
26110	26111	,	0	None
26111	26112	like	0	None
26112	26113	progesterone	2	CHEMICAL
26113	26114	,	0	None
26114	26115	combines	0	None
26115	26116	potent	0	None
26116	26117	progestogenic	0	None
26117	26118	with	0	None
26118	26119	antimineralocorticoid	0	None
26119	26120	and	0	None
26120	26121	antiandrogenic	0	None
26121	26122	activity	0	None
26122	26123	in	0	None
26123	26124	a	0	None
26124	26125	similar	0	None
26125	26126	dose	0	None
26126	26127	range	0	None
26127	26128	.	0	None

26129	26130	(	0	None
26130	26131	ABSTRACT	0	None
26131	26132	TRUNCATED	0	None
26132	26133	AT	0	None
26133	26134	400	0	None
26134	26135	WORDS	0	None
26135	26136	)	0	None
26136	26137	Recently	0	None
26137	26138	,	0	None
26138	26139	we	0	None
26139	26140	described	0	None
26140	26141	the	0	None
26141	26142	aminothiazole	0	None
26142	26143	lead	0	None
26143	26144	(	0	None
26144	26145	4-biphenyl-4-ylthiazol-2-yl	0	None
26145	26146	)	0	None
26146	26147	-	0	None
26147	26148	(	0	None
26148	26149	6-methylpyridin-2-yl	0	None
26149	26150	)	0	None
26150	26151	-amine	0	None
26151	26152	(	0	None
26152	26153	1	0	None
26153	26154	)	0	None
26154	26155	,	0	None
26155	26156	which	0	None
26156	26157	exhibits	0	None
26157	26158	many	0	None
26158	26159	desirable	0	None
26159	26160	properties	0	None
26160	26161	,	0	None
26161	26162	including	0	None
26162	26163	excellent	0	None
26163	26164	stability	0	None
26164	26165	in	0	None
26165	26166	liver	0	None
26166	26167	microsomes	0	None
26167	26168	,	0	None
26168	26169	oral	0	None
26169	26170	bioavailability	0	None
26170	26171	of	0	None
26171	26172	∼40	0	None
26172	26173	%	0	None
26173	26174	,	0	None
26174	26175	and	0	None
26175	26176	high	0	None
26176	26177	exposure	0	None
26177	26178	in	0	None
26178	26179	the	0	None
26179	26180	brains	0	None
26180	26181	of	0	None
26181	26182	mice	0	None
26182	26183	.	0	None

26184	26185	Despite	0	None
26185	26186	its	0	None
26186	26187	good	0	None
26187	26188	pharmacokinetic	0	None
26188	26189	properties	0	None
26189	26190	,	0	None
26190	26191	compound	0	None
26191	26192	1	0	None
26192	26193	exhibited	0	None
26193	26194	only	0	None
26194	26195	modest	0	None
26195	26196	potency	0	None
26196	26197	in	0	None
26197	26198	mouse	0	None
26198	26199	neuroblastoma	0	None
26199	26200	cells	0	None
26200	26201	overexpressing	0	None
26201	26202	the	0	None
26202	26203	disease-causing	0	None
26203	26206	prion protein PrP	1	GENE-Y
26206	26207	(	0	None
26207	26208	Sc	0	None
26208	26209	)	0	None
26209	26210	.	0	None

26211	26212	Accordingly	0	None
26212	26213	,	0	None
26213	26214	we	0	None
26214	26215	sought	0	None
26215	26216	to	0	None
26216	26217	identify	0	None
26217	26218	analogues	0	None
26218	26219	of	0	None
26219	26220	1	0	None
26220	26221	with	0	None
26221	26222	improved	0	None
26222	26223	antiprion	0	None
26223	26224	potency	0	None
26224	26225	in	0	None
26225	26226	ScN2a-cl3	0	None
26226	26227	cells	0	None
26227	26228	while	0	None
26228	26229	retaining	0	None
26229	26230	similar	0	None
26230	26231	or	0	None
26231	26232	superior	0	None
26232	26233	properties	0	None
26233	26234	.	0	None

26235	26236	Herein	0	None
26236	26237	we	0	None
26237	26238	report	0	None
26238	26239	the	0	None
26239	26240	discovery	0	None
26240	26241	of	0	None
26241	26242	improved	0	None
26242	26243	lead	0	None
26243	26244	compounds	0	None
26244	26245	such	0	None
26245	26246	as	0	None
26246	26247	(	0	None
26247	26248	6-methylpyridin-2-yl	0	None
26248	26249	)	0	None
26249	26250	-	0	None
26250	26251	[	0	None
26251	26252	4-	0	None
26252	26253	(	0	None
26253	26254	4-pyridin-3-yl-phenyl	0	None
26254	26255	)	0	None
26255	26256	thiazol-2-yl	0	None
26256	26257	]	0	None
26257	26258	amine	2	CHEMICAL
26258	26259	and	0	None
26259	26260	cyclopropanecarboxylic	0	None
26260	26261	acid	0	None
26261	26262	(	0	None
26262	26263	4-biphenylthiazol-2-yl	0	None
26263	26264	)	0	None
26264	26265	amide	2	CHEMICAL
26265	26266	,	0	None
26266	26267	which	0	None
26267	26268	exhibit	0	None
26268	26269	brain	0	None
26269	26270	exposure	0	None
26270	26271	/	0	None
26271	26272	EC50	0	None
26272	26273	ratios	0	None
26273	26274	at	0	None
26274	26275	least	0	None
26275	26276	tenfold	0	None
26276	26277	greater	0	None
26277	26278	than	0	None
26278	26279	that	0	None
26279	26280	of	0	None
26280	26281	compound	0	None
26281	26282	1	0	None
26282	26283	.	0	None
26283	26284	The	0	None
26284	26285	molecular	0	None
26285	26286	events	0	None
26286	26287	during	0	None
26287	26288	nongenotoxic	0	None
26288	26289	carcinogenesis	0	None
26289	26290	and	0	None
26290	26291	their	0	None
26291	26292	temporal	0	None
26292	26293	order	0	None
26293	26294	are	0	None
26294	26295	poorly	0	None
26295	26296	understood	0	None
26296	26297	but	0	None
26297	26298	thought	0	None
26298	26299	to	0	None
26299	26300	include	0	None
26300	26301	long-lasting	0	None
26301	26302	perturbations	0	None
26302	26303	of	0	None
26303	26304	gene	0	None
26304	26305	expression	0	None
26305	26306	.	0	None

26307	26308	Here	0	None
26308	26309	,	0	None
26309	26310	we	0	None
26310	26311	have	0	None
26311	26312	investigated	0	None
26312	26313	the	0	None
26313	26314	temporal	0	None
26314	26315	sequence	0	None
26315	26316	of	0	None
26316	26317	molecular	0	None
26317	26318	and	0	None
26318	26319	pathological	0	None
26319	26320	perturbations	0	None
26320	26321	at	0	None
26321	26322	early	0	None
26322	26323	stages	0	None
26323	26324	of	0	None
26324	26325	phenobarbital	0	None
26325	26326	(	0	None
26326	26327	PB	2	CHEMICAL
26327	26328	)	0	None
26328	26329	mediated	0	None
26329	26330	liver	0	None
26330	26331	tumor	0	None
26331	26332	promotion	0	None
26332	26333	in	0	None
26333	26334	vivo	0	None
26334	26335	.	0	None

26336	26337	Molecular	0	None
26337	26338	profiling	0	None
26338	26339	(	0	None
26339	26340	mRNA	0	None
26340	26341	,	0	None
26341	26342	microRNA	0	None
26342	26343	[	0	None
26343	26344	miRNA	0	None
26344	26345	]	0	None
26345	26346	,	0	None
26346	26347	DNA	0	None
26347	26348	methylation	0	None
26348	26349	,	0	None
26349	26350	and	0	None
26350	26351	proteins	0	None
26351	26352	)	0	None
26352	26353	of	0	None
26353	26354	mouse	0	None
26354	26355	liver	0	None
26355	26356	during	0	None
26356	26357	13	0	None
26357	26358	weeks	0	None
26358	26359	of	0	None
26359	26360	PB	2	CHEMICAL
26360	26361	treatment	0	None
26361	26362	revealed	0	None
26362	26363	progressive	0	None
26363	26364	increases	0	None
26364	26365	in	0	None
26365	26366	hepatic	0	None
26366	26367	expression	0	None
26367	26368	of	0	None
26368	26369	long	0	None
26369	26370	noncoding	0	None
26370	26371	RNAs	0	None
26371	26372	and	0	None
26372	26373	miRNAs	0	None
26373	26374	originating	0	None
26374	26375	from	0	None
26375	26376	the	0	None
26376	26377	Dlk1-Dio3	0	None
26377	26378	imprinted	0	None
26378	26379	gene	0	None
26379	26380	cluster	0	None
26380	26381	,	0	None
26381	26382	a	0	None
26382	26383	locus	0	None
26383	26384	that	0	None
26384	26385	has	0	None
26385	26386	recently	0	None
26386	26387	been	0	None
26387	26388	associated	0	None
26388	26389	with	0	None
26389	26390	stem	0	None
26390	26391	cell	0	None
26391	26392	pluripotency	0	None
26392	26393	in	0	None
26393	26394	mice	0	None
26394	26395	and	0	None
26395	26396	various	0	None
26396	26397	neoplasms	0	None
26397	26398	in	0	None
26398	26399	humans	0	None
26399	26400	.	0	None

26401	26402	PB	2	CHEMICAL
26402	26403	induction	0	None
26403	26404	of	0	None
26404	26405	the	0	None
26405	26406	Dlk1-Dio3	0	None
26406	26407	cluster	0	None
26407	26408	noncoding	0	None
26408	26409	RNA	0	None
26409	26410	(	0	None
26410	26411	ncRNA	0	None
26411	26412	)	0	None
26412	26413	Meg3	0	None
26413	26414	was	0	None
26414	26415	localized	0	None
26415	26416	to	0	None
26416	26417	glutamine	0	None
26417	26418	synthetase-positive	0	None
26418	26419	hypertrophic	0	None
26419	26420	perivenous	0	None
26420	26421	hepatocytes	0	None
26421	26422	,	0	None
26422	26423	suggesting	0	None
26423	26424	a	0	None
26424	26425	role	0	None
26425	26426	for	0	None
26426	26427	β-catenin	0	None
26427	26428	signaling	0	None
26428	26429	in	0	None
26429	26430	the	0	None
26430	26431	dysregulation	0	None
26431	26432	of	0	None
26432	26433	Dlk1-Dio3	0	None
26433	26434	ncRNAs	0	None
26434	26435	.	0	None

26436	26437	The	0	None
26437	26438	carcinogenic	0	None
26438	26439	relevance	0	None
26439	26440	of	0	None
26440	26441	Dlk1-Dio3	0	None
26441	26442	locus	0	None
26442	26443	ncRNA	0	None
26443	26444	induction	0	None
26444	26445	was	0	None
26445	26446	further	0	None
26446	26447	supported	0	None
26447	26448	by	0	None
26448	26449	in	0	None
26449	26450	vivo	0	None
26450	26451	genetic	0	None
26451	26452	dependence	0	None
26452	26453	on	0	None
26453	26454	constitutive	0	None
26454	26455	androstane	0	None
26455	26456	receptor	0	None
26456	26457	and	0	None
26457	26458	β-catenin	0	None
26458	26459	pathways	0	None
26459	26460	.	0	None

26461	26462	Our	0	None
26462	26463	data	0	None
26463	26464	identify	0	None
26464	26465	Dlk1-Dio3	0	None
26465	26466	ncRNAs	0	None
26466	26467	as	0	None
26467	26468	novel	0	None
26468	26469	candidate	0	None
26469	26470	early	0	None
26470	26471	biomarkers	0	None
26471	26472	for	0	None
26472	26473	mouse	0	None
26473	26474	liver	0	None
26474	26475	tumor	0	None
26475	26476	promotion	0	None
26476	26477	and	0	None
26477	26478	provide	0	None
26478	26479	new	0	None
26479	26480	opportunities	0	None
26480	26481	for	0	None
26481	26482	assessing	0	None
26482	26483	the	0	None
26483	26484	carcinogenic	0	None
26484	26485	potential	0	None
26485	26486	of	0	None
26486	26487	novel	0	None
26487	26488	compounds	0	None
26488	26489	.	0	None
26489	26490	The	0	None
26490	26492	serotonin transporter	1	GENE-Y
26492	26493	polymorphism	0	None
26493	26494	,	0	None
26494	26495	5HTTLPR	3	GENE-N
26495	26496	,	0	None
26496	26497	is	0	None
26497	26498	associated	0	None
26498	26499	with	0	None
26499	26500	a	0	None
26500	26501	faster	0	None
26501	26502	response	0	None
26502	26503	time	0	None
26503	26504	to	0	None
26504	26505	sertraline	2	CHEMICAL
26505	26506	in	0	None
26506	26507	an	0	None
26507	26508	elderly	0	None
26508	26509	population	0	None
26509	26510	with	0	None
26510	26511	major	0	None
26511	26512	depressive	0	None
26512	26513	disorder	0	None
26513	26514	.	0	None
26514	26515	Minocycline	2	CHEMICAL
26515	26516	is	0	None
26516	26517	protective	0	None
26517	26518	in	0	None
26518	26519	models	0	None
26519	26520	of	0	None
26520	26521	transient	0	None
26521	26522	middle	0	None
26522	26523	cerebral	0	None
26523	26524	artery	0	None
26524	26525	occlusion	0	None
26525	26526	(	0	None
26526	26527	MCAO	0	None
26527	26528	)	0	None
26528	26529	.	0	None

26530	26531	We	0	None
26531	26532	studied	0	None
26532	26533	whether	0	None
26533	26534	minocycline	2	CHEMICAL
26534	26535	and	0	None
26535	26536	doxycycline	2	CHEMICAL
26536	26537	,	0	None
26537	26538	another	0	None
26538	26539	tetracycline	2	CHEMICAL
26539	26540	derivative	0	None
26540	26541	,	0	None
26541	26542	provide	0	None
26542	26543	protection	0	None
26543	26544	in	0	None
26544	26545	permanent	0	None
26545	26546	MCAO	0	None
26546	26547	.	0	None

26548	26549	Because	0	None
26549	26550	minocycline	2	CHEMICAL
26550	26551	inhibits	0	None
26551	26552	matrix	0	None
26552	26553	metalloprotease-9	0	None
26553	26554	(	0	None
26554	26555	MMP-9	0	None
26555	26556	)	0	None
26556	26557	,	0	None
26557	26558	we	0	None
26558	26559	also	0	None
26559	26560	compared	0	None
26560	26561	minocycline's	0	None
26561	26562	protective	0	None
26562	26563	effect	0	None
26563	26564	in	0	None
26564	26565	wild	0	None
26565	26566	type	0	None
26566	26567	(	0	None
26567	26568	wt	0	None
26568	26569	)	0	None
26569	26570	and	0	None
26570	26571	MMP-9	0	None
26571	26572	knock-out	0	None
26572	26573	(	0	None
26573	26574	ko	0	None
26574	26575	)	0	None
26575	26576	mice	0	None
26576	26577	.	0	None

26578	26579	Wt	0	None
26579	26580	FVB	0	None
26580	26581	/	0	None
26581	26582	N	0	None
26582	26583	,	0	None
26583	26584	Balb	0	None
26584	26585	/	0	None
26585	26586	C	0	None
26586	26587	,	0	None
26587	26588	and	0	None
26588	26589	two	0	None
26589	26590	lines	0	None
26590	26591	of	0	None
26591	26592	MMP-9	0	None
26592	26593	ko	0	None
26593	26594	and	0	None
26594	26595	their	0	None
26595	26596	wt	0	None
26596	26597	C57Bl	0	None
26597	26598	/	0	None
26598	26599	6	0	None
26599	26600	control	0	None
26600	26601	mice	0	None
26601	26602	were	0	None
26602	26603	subjected	0	None
26603	26604	to	0	None
26604	26605	24-	0	None
26605	26606	or	0	None
26606	26607	72-hour	0	None
26607	26608	permanent	0	None
26608	26609	MCAO	0	None
26609	26610	.	0	None

26611	26612	Drug	0	None
26612	26613	administration	0	None
26613	26614	was	0	None
26614	26615	started	0	None
26615	26616	either	0	None
26616	26617	12	0	None
26617	26618	hours	0	None
26618	26619	before	0	None
26619	26620	or	0	None
26620	26621	2	0	None
26621	26622	hours	0	None
26622	26623	after	0	None
26623	26624	the	0	None
26624	26625	onset	0	None
26625	26626	of	0	None
26626	26627	MCAO	0	None
26627	26628	.	0	None

26629	26630	Infarct	0	None
26630	26631	size	0	None
26631	26632	was	0	None
26632	26633	determined	0	None
26633	26634	by	0	None
26634	26635	triphenyltetrazolium	0	None
26635	26636	staining	0	None
26636	26637	or	0	None
26637	26638	T2-weighted	0	None
26638	26639	MRI	0	None
26639	26640	.	0	None

26641	26642	Zymography	0	None
26642	26643	was	0	None
26643	26644	used	0	None
26644	26645	to	0	None
26645	26646	study	0	None
26646	26647	the	0	None
26647	26648	expression	0	None
26648	26649	of	0	None
26649	26650	MMPs	0	None
26650	26651	.	0	None

26652	26653	In	0	None
26653	26654	wt	0	None
26654	26655	strains	0	None
26655	26656	,	0	None
26656	26657	tetracycline	2	CHEMICAL
26657	26658	treatments	0	None
26658	26659	started	0	None
26659	26660	before	0	None
26660	26661	MCAO	0	None
26661	26662	reduced	0	None
26662	26663	the	0	None
26663	26664	infarct	0	None
26664	26665	size	0	None
26665	26666	by	0	None
26666	26667	25%	0	None
26667	26668	to	0	None
26668	26669	50%	0	None
26669	26670	,	0	None
26670	26671	whereas	0	None
26671	26672	the	0	None
26672	26673	treatment	0	None
26673	26674	started	0	None
26674	26675	after	0	None
26675	26676	MCAO	0	None
26676	26677	was	0	None
26677	26678	not	0	None
26678	26679	protective	0	None
26679	26680	.	0	None

26681	26682	Minocycline	2	CHEMICAL
26682	26683	inhibited	0	None
26683	26684	ischemia-provoked	0	None
26684	26685	pro-MMP-9	0	None
26685	26686	induction	0	None
26686	26687	in	0	None
26687	26688	wt	0	None
26688	26689	mice	0	None
26689	26690	,	0	None
26690	26691	but	0	None
26691	26692	was	0	None
26692	26693	not	0	None
26693	26694	protective	0	None
26694	26695	in	0	None
26695	26696	MMP-9	0	None
26696	26697	ko	0	None
26697	26698	mice	0	None
26698	26699	.	0	None

26700	26701	Pro-MMP-2	0	None
26701	26702	was	0	None
26702	26703	induced	0	None
26703	26704	by	0	None
26704	26705	MCAO	0	None
26705	26706	in	0	None
26706	26707	wt	0	None
26707	26708	and	0	None
26708	26709	MMP-9	0	None
26709	26710	ko	0	None
26710	26711	mice	0	None
26711	26712	.	0	None

26713	26714	MCAO-induced	0	None
26714	26715	pro-MMP-2	0	None
26715	26716	was	0	None
26716	26717	downregulated	0	None
26717	26718	by	0	None
26718	26719	minocycline	2	CHEMICAL
26719	26720	treatment	0	None
26720	26721	in	0	None
26721	26722	wt	0	None
26722	26723	mice	0	None
26723	26724	but	0	None
26724	26725	remained	0	None
26725	26726	in	0	None
26726	26727	MMP-9	0	None
26727	26728	ko	0	None
26728	26729	mice	0	None
26729	26730	at	0	None
26730	26731	the	0	None
26731	26732	same	0	None
26732	26733	level	0	None
26733	26734	as	0	None
26734	26735	in	0	None
26735	26736	saline-treated	0	None
26736	26737	wt	0	None
26737	26738	mice	0	None
26738	26739	.	0	None

26740	26741	Tetracyclines	2	CHEMICAL
26741	26742	are	0	None
26742	26743	protective	0	None
26743	26744	in	0	None
26744	26745	permanent	0	None
26745	26746	MCAO	0	None
26746	26747	when	0	None
26747	26748	the	0	None
26748	26749	treatment	0	None
26749	26750	is	0	None
26750	26751	started	0	None
26751	26752	before	0	None
26752	26753	the	0	None
26753	26754	insult	0	None
26754	26755	.	0	None

26756	26757	Minocycline	2	CHEMICAL
26757	26758	may	0	None
26758	26759	provide	0	None
26759	26760	protection	0	None
26760	26761	by	0	None
26761	26762	interfering	0	None
26762	26763	with	0	None
26763	26764	MMPs	0	None
26764	26765	.	0	None
26765	26766	Differential	0	None
26766	26767	phosphoproteome	0	None
26767	26768	of	0	None
26768	26769	the	0	None
26769	26770	striatum	0	None
26770	26771	from	0	None
26771	26772	pleiotrophin	0	None
26772	26773	knockout	0	None
26773	26774	and	0	None
26774	26775	midkine	0	None
26775	26776	knockout	0	None
26776	26777	mice	0	None
26777	26778	treated	0	None
26778	26779	with	0	None
26779	26780	amphetamine	0	None
26780	26781	:	0	None
26781	26782	Correlations	0	None
26782	26783	with	0	None
26783	26784	amphetamine-induced	0	None
26784	26785	neurotoxicity	0	None
26785	26786	.	0	None
26786	26787	Activation	0	None
26787	26788	of	0	None
26788	26789	β-cell	0	None
26789	26790	EphA5	0	None
26790	26791	receptors	0	None
26791	26792	by	0	None
26792	26793	its	0	None
26793	26794	ligand	0	None
26794	26795	ephrinA5	0	None
26795	26796	from	0	None
26796	26797	adjacent	0	None
26797	26798	β-cells	0	None
26798	26799	has	0	None
26799	26800	been	0	None
26800	26801	reported	0	None
26801	26802	to	0	None
26802	26803	decrease	0	None
26803	26804	insulin	0	None
26804	26805	secretion	0	None
26805	26806	during	0	None
26806	26807	hypoglycemia	0	None
26807	26808	.	0	None

26809	26810	Given	0	None
26810	26811	the	0	None
26811	26812	similarities	0	None
26812	26813	between	0	None
26813	26814	islet	3	GENE-N
26814	26815	and	0	None
26815	26816	ventromedial	0	None
26816	26817	hypothalamus	0	None
26817	26818	(	0	None
26818	26819	VMH	0	None
26819	26820	)	0	None
26820	26821	glucose	0	None
26821	26822	sensing	0	None
26822	26823	,	0	None
26823	26824	we	0	None
26824	26825	tested	0	None
26825	26826	the	0	None
26826	26827	hypothesis	0	None
26827	26828	that	0	None
26828	26829	the	0	None
26829	26830	EphA5	0	None
26830	26831	/	0	None
26831	26832	ephrinA5	0	None
26832	26833	system	0	None
26833	26834	might	0	None
26834	26835	function	0	None
26835	26836	within	0	None
26836	26837	the	0	None
26837	26838	VMH	0	None
26838	26839	during	0	None
26839	26840	hypoglycemia	0	None
26840	26841	to	0	None
26841	26842	stimulate	0	None
26842	26843	counterregulatory	0	None
26843	26844	hormone	0	None
26844	26845	release	0	None
26845	26846	as	0	None
26846	26847	well	0	None
26847	26848	.	0	None

26849	26850	Counterregulatory	0	None
26850	26851	responses	0	None
26851	26852	and	0	None
26852	26853	glutamine	0	None
26853	26854	/	0	None
26854	26855	glutamate	0	None
26855	26856	concentrations	0	None
26856	26857	in	0	None
26857	26858	the	0	None
26858	26859	VMH	0	None
26859	26860	were	0	None
26860	26861	assessed	0	None
26861	26862	during	0	None
26862	26863	a	0	None
26863	26864	hyperinsulinemic-hypoglycemic	0	None
26864	26865	glucose	0	None
26865	26866	clamp	0	None
26866	26867	study	0	None
26867	26868	in	0	None
26868	26869	chronically	0	None
26869	26870	catheterized	0	None
26870	26871	awake	0	None
26871	26872	male	0	None
26872	26873	Sprague-Dawley	0	None
26873	26874	rats	0	None
26874	26875	that	0	None
26875	26876	received	0	None
26876	26877	an	0	None
26877	26878	acute	0	None
26878	26879	VMH	0	None
26879	26880	microinjection	0	None
26880	26881	of	0	None
26881	26882	ephrinA5-Fc	0	None
26882	26883	,	0	None
26883	26884	chronic	0	None
26884	26885	VMH	0	None
26885	26886	knockdown	0	None
26886	26887	,	0	None
26887	26888	or	0	None
26888	26889	overexpression	0	None
26889	26890	of	0	None
26890	26891	ephrinA5	0	None
26891	26892	using	0	None
26892	26893	an	0	None
26893	26894	adenoassociated	0	None
26894	26895	viral	0	None
26895	26896	construct	0	None
26896	26897	.	0	None

26898	26899	Local	0	None
26899	26900	stimulation	0	None
26900	26901	of	0	None
26901	26902	VMH	0	None
26902	26903	EphA5	0	None
26903	26904	receptors	0	None
26904	26905	by	0	None
26905	26906	ephrinA5-Fc	0	None
26906	26907	or	0	None
26907	26908	ephrinA5	0	None
26908	26909	overexpression	0	None
26909	26910	increased	0	None
26910	26911	,	0	None
26911	26912	whereas	0	None
26912	26913	knockdown	0	None
26913	26914	of	0	None
26914	26915	VMH	0	None
26915	26916	ephrinA5	0	None
26916	26917	reduced	0	None
26917	26918	counterregulatory	0	None
26918	26919	responses	0	None
26919	26920	during	0	None
26920	26921	hypoglycemia	0	None
26921	26922	.	0	None

26923	26924	Overexpression	0	None
26924	26925	of	0	None
26925	26926	VMH	0	None
26926	26927	ephrinA5	0	None
26927	26928	transiently	0	None
26928	26929	increased	0	None
26929	26930	local	0	None
26930	26931	glutamate	0	None
26931	26932	concentrations	0	None
26932	26933	,	0	None
26933	26934	whereas	0	None
26934	26935	ephrinA5	0	None
26935	26936	knockdown	0	None
26936	26937	produced	0	None
26937	26938	profound	0	None
26938	26939	suppression	0	None
26939	26940	of	0	None
26940	26941	VMH	0	None
26941	26942	interstitial	0	None
26942	26943	fluid	0	None
26943	26944	glutamine	0	None
26944	26945	concentrations	0	None
26945	26946	in	0	None
26946	26947	the	0	None
26947	26948	basal	0	None
26948	26949	state	0	None
26949	26950	and	0	None
26950	26951	during	0	None
26951	26952	hypoglycemia	0	None
26952	26953	.	0	None

26954	26955	Changes	0	None
26955	26956	in	0	None
26956	26957	ephrinA5	0	None
26957	26958	/	0	None
26958	26959	EphA5	0	None
26959	26960	interactions	0	None
26960	26961	within	0	None
26961	26962	the	0	None
26962	26963	VMH	0	None
26963	26964	,	0	None
26964	26965	a	0	None
26965	26966	key	0	None
26966	26967	brain	0	None
26967	26968	glucose-sensing	0	None
26968	26969	region	0	None
26969	26970	,	0	None
26970	26971	act	0	None
26971	26972	in	0	None
26972	26973	concert	0	None
26973	26974	with	0	None
26974	26975	islets	0	None
26975	26976	to	0	None
26976	26977	restore	0	None
26977	26978	glucose	0	None
26978	26979	homeostasis	0	None
26979	26980	during	0	None
26980	26981	acute	0	None
26981	26982	hypoglycemia	0	None
26982	26983	,	0	None
26983	26984	and	0	None
26984	26985	its	0	None
26985	26986	effect	0	None
26986	26987	on	0	None
26987	26988	counterregulation	0	None
26988	26989	may	0	None
26989	26990	be	0	None
26990	26991	mediated	0	None
26991	26992	by	0	None
26992	26993	changes	0	None
26993	26994	in	0	None
26994	26995	glutamate	0	None
26995	26996	/	0	None
26996	26997	glutamine	0	None
26997	26998	cycling	0	None
26998	26999	.	0	None
26999	27000	Dual	0	None
27000	27001	antithrombotic	0	None
27001	27002	agents	0	None
27002	27003	acting	0	None
27003	27004	as	0	None
27004	27005	anticoagulants	0	None
27005	27006	and	0	None
27006	27007	aggregation	0	None
27007	27008	inhibitors	0	None
27008	27009	could	0	None
27009	27010	have	0	None
27010	27011	substantial	0	None
27011	27012	advantages	0	None
27012	27013	over	0	None
27013	27014	currently	0	None
27014	27015	prescribed	0	None
27015	27016	combinations	0	None
27016	27017	of	0	None
27017	27018	antithrombotic	0	None
27018	27019	drugs	0	None
27019	27020	.	0	None

27021	27022	Herein	0	None
27022	27023	,	0	None
27023	27024	we	0	None
27024	27025	report	0	None
27025	27026	compounds	0	None
27026	27027	with	0	None
27027	27028	moderate	0	None
27028	27029	inhibitory	0	None
27029	27030	activity	0	None
27030	27031	for	0	None
27031	27032	factor	0	None
27032	27033	Xa	0	None
27033	27034	and	0	None
27034	27035	fibrinogen	0	None
27035	27036	GPIIb	0	None
27036	27037	/	0	None
27037	27038	IIIa	0	None
27038	27039	binding	0	None
27039	27040	(	0	None
27040	27041	both	0	None
27041	27042	in	0	None
27042	27043	the	0	None
27043	27044	micromolar	0	None
27044	27045	range	0	None
27045	27046	)	0	None
27046	27047	.	0	None

27048	27049	These	0	None
27049	27050	compounds	0	None
27050	27051	resulted	0	None
27051	27052	from	0	None
27052	27053	our	0	None
27053	27054	efforts	0	None
27054	27055	to	0	None
27055	27056	merge	0	None
27056	27057	the	0	None
27057	27058	pharmacophores	0	None
27058	27059	of	0	None
27059	27060	selective	0	None
27060	27061	factor	0	None
27061	27062	Xa	0	None
27062	27063	inhibitor	0	None
27063	27064	rivaroxaban	0	None
27064	27065	with	0	None
27065	27066	a	0	None
27066	27067	mimic	0	None
27067	27068	of	0	None
27068	27069	the	0	None
27069	27070	Arg-Gly-Asp	0	None
27070	27071	(	0	None
27071	27072	RGD	0	None
27072	27073	)	0	None
27073	27074	sequence	0	None
27074	27075	of	0	None
27075	27076	fibrinogen	0	None
27076	27077	to	0	None
27077	27078	obtain	0	None
27078	27079	designed	0	None
27079	27080	multiple	0	None
27080	27081	ligands	0	None
27081	27082	with	0	None
27082	27083	potential	0	None
27083	27084	antithrombotic	0	None
27084	27085	activity	0	None
27085	27086	.	0	None

27087	27088	Resulting	0	None
27088	27089	from	0	None
27089	27090	this	0	None
27090	27091	study	0	None
27091	27092	,	0	None
27092	27093	a	0	None
27093	27094	structurally	0	None
27094	27095	novel	0	None
27095	27096	class	0	None
27096	27097	of	0	None
27097	27098	submicromolar	0	None
27098	27099	fibrinogen	0	None
27099	27100	GPIIb	0	None
27100	27101	/	0	None
27101	27102	IIIa	0	None
27102	27103	binding	0	None
27103	27104	inhibitor	0	None
27104	27105	bearing	0	None
27105	27106	1	0	None
27106	27107	,	0	None
27107	27108	2	0	None
27108	27109	,	0	None
27109	27110	4-oxadiazol-5	0	None
27110	27111	(	0	None
27111	27112	4H	0	None
27112	27113	)	0	None
27113	27114	-one	0	None
27114	27115	moiety	0	None
27115	27116	is	0	None
27116	27117	also	0	None
27117	27118	described	0	None
27118	27119	.	0	None
27119	27120	Intermittent	0	None
27120	27121	PTH	0	None
27121	27122	is	0	None
27122	27123	the	0	None
27123	27124	major	0	None
27124	27125	anabolic	0	None
27125	27126	therapy	0	None
27126	27127	for	0	None
27127	27128	osteoporosis	0	None
27128	27129	while	0	None
27129	27130	continuous	0	None
27130	27131	PTH	0	None
27131	27132	causes	0	None
27132	27133	bone	0	None
27133	27134	loss	0	None
27134	27135	.	0	None

27136	27137	PTH	0	None
27137	27138	acts	0	None
27138	27139	on	0	None
27139	27140	the	0	None
27140	27141	osteoblast	0	None
27141	27142	(	0	None
27142	27143	OB	0	None
27143	27144	)	0	None
27144	27145	lineage	0	None
27145	27146	to	0	None
27146	27147	regulate	0	None
27147	27148	bone	0	None
27148	27149	resorption	0	None
27149	27150	and	0	None
27150	27151	formation	0	None
27151	27152	.	0	None

27153	27154	PTH	0	None
27154	27155	also	0	None
27155	27156	induces	0	None
27156	27157	cyclooxygenase-2	0	None
27157	27158	(	0	None
27158	27159	COX-2	0	None
27159	27160	)	0	None
27160	27161	,	0	None
27161	27162	producing	0	None
27162	27163	prostaglandin	0	None
27163	27164	E2	0	None
27164	27165	(	0	None
27165	27166	PGE2	2	CHEMICAL
27166	27167	)	0	None
27167	27168	,	0	None
27168	27169	that	0	None
27169	27170	can	0	None
27170	27171	act	0	None
27171	27172	on	0	None
27172	27173	both	0	None
27173	27174	OBs	0	None
27174	27175	and	0	None
27175	27176	osteoclasts	0	None
27176	27177	(	0	None
27177	27178	OCs	0	None
27178	27179	)	0	None
27179	27180	.	0	None

27181	27182	Because	0	None
27182	27183	intermittent	0	None
27183	27184	PTH	0	None
27184	27185	is	0	None
27185	27186	more	0	None
27186	27187	anabolic	0	None
27187	27188	in	0	None
27188	27189	Cox-2	0	None
27189	27190	knockout	0	None
27190	27191	(	0	None
27191	27192	KO	0	None
27192	27193	)	0	None
27193	27194	than	0	None
27194	27195	wild	0	None
27195	27196	type	0	None
27196	27197	(	0	None
27197	27198	WT	0	None
27198	27199	)	0	None
27199	27200	mice	0	None
27200	27201	,	0	None
27201	27202	we	0	None
27202	27203	hypothesized	0	None
27203	27204	COX-2	0	None
27204	27205	might	0	None
27205	27206	contribute	0	None
27206	27207	to	0	None
27207	27208	the	0	None
27208	27209	effects	0	None
27209	27210	of	0	None
27210	27211	continuous	0	None
27211	27212	PTH	0	None
27212	27213	by	0	None
27213	27214	suppressing	0	None
27214	27215	PTH-stimulated	0	None
27215	27216	differentiation	0	None
27216	27217	of	0	None
27217	27218	mesenchymal	0	None
27218	27219	stem	0	None
27219	27220	cells	0	None
27220	27221	into	0	None
27221	27222	OBs	0	None
27222	27223	.	0	None

27224	27225	We	0	None
27225	27226	compared	0	None
27226	27227	effects	0	None
27227	27228	of	0	None
27228	27229	continuous	0	None
27229	27230	PTH	0	None
27230	27231	on	0	None
27231	27232	bone	0	None
27232	27233	marrow	0	None
27233	27234	stromal	0	None
27234	27235	cells	0	None
27235	27236	(	0	None
27236	27237	BMSCs	0	None
27237	27238	)	0	None
27238	27239	and	0	None
27239	27240	primary	0	None
27240	27241	OBs	0	None
27241	27242	(	0	None
27242	27243	POBs	0	None
27243	27244	)	0	None
27244	27245	from	0	None
27245	27246	Cox-2	0	None
27246	27247	KO	0	None
27247	27248	mice	0	None
27248	27249	,	0	None
27249	27250	mice	0	None
27250	27251	with	0	None
27251	27252	deletion	0	None
27252	27253	of	0	None
27253	27254	PGE2	2	CHEMICAL
27254	27255	receptors	0	None
27255	27256	(	0	None
27256	27257	Ptger4	0	None
27257	27258	and	0	None
27258	27259	Ptger2	0	None
27259	27260	KO	0	None
27260	27261	mice	0	None
27261	27262	)	0	None
27262	27263	,	0	None
27263	27264	and	0	None
27264	27265	WT	0	None
27265	27266	controls	0	None
27266	27267	.	0	None

27268	27269	PTH	0	None
27269	27270	increased	0	None
27270	27271	OB	0	None
27271	27272	differentiation	0	None
27272	27273	in	0	None
27273	27274	BMSCs	0	None
27274	27275	only	0	None
27275	27276	in	0	None
27276	27277	the	0	None
27277	27278	absence	0	None
27278	27279	of	0	None
27279	27280	COX-2	0	None
27280	27281	expression	0	None
27281	27282	or	0	None
27282	27283	activity	0	None
27283	27284	.	0	None

27285	27286	In	0	None
27286	27287	the	0	None
27287	27288	absence	0	None
27288	27289	of	0	None
27289	27290	COX-2	0	None
27290	27291	,	0	None
27291	27292	PTH	0	None
27292	27293	stimulated	0	None
27293	27294	differentiation	0	None
27294	27295	if	0	None
27295	27296	added	0	None
27296	27297	during	0	None
27297	27298	the	0	None
27298	27299	first	0	None
27299	27300	week	0	None
27300	27301	of	0	None
27301	27302	culture	0	None
27302	27303	.	0	None

27304	27305	In	0	None
27305	27306	Cox-2	0	None
27306	27307	KO	0	None
27307	27308	BMSCs	0	None
27308	27309	,	0	None
27309	27310	PTH-stimulated	0	None
27310	27311	differentiation	0	None
27311	27312	was	0	None
27312	27313	prevented	0	None
27313	27314	by	0	None
27314	27315	adding	0	None
27315	27316	PGE2	2	CHEMICAL
27316	27317	to	0	None
27317	27318	cultures	0	None
27318	27319	.	0	None

27320	27321	Co-culture	0	None
27321	27322	of	0	None
27322	27323	POBs	0	None
27323	27324	with	0	None
27324	27325	M-CSF-expanded	0	None
27325	27326	bone	0	None
27326	27327	marrow	0	None
27327	27328	macrophages	0	None
27328	27329	(	0	None
27329	27330	BMMs	0	None
27330	27331	)	0	None
27331	27332	showed	0	None
27332	27333	that	0	None
27333	27334	the	0	None
27334	27335	inhibition	0	None
27335	27336	of	0	None
27336	27337	PTH-stimulated	0	None
27337	27338	OB	0	None
27338	27339	differentiation	0	None
27339	27340	required	0	None
27340	27341	not	0	None
27341	27342	only	0	None
27342	27343	COX-2	0	None
27343	27344	or	0	None
27344	27345	PGE2	2	CHEMICAL
27345	27346	but	0	None
27346	27347	also	0	None
27347	27348	BMMs	0	None
27348	27349	.	0	None

27350	27351	Sufficient	0	None
27351	27352	PGE2	2	CHEMICAL
27352	27353	to	0	None
27353	27354	mediate	0	None
27354	27355	the	0	None
27355	27356	inhibitory	0	None
27356	27357	effect	0	None
27357	27358	was	0	None
27358	27359	made	0	None
27359	27360	by	0	None
27360	27361	either	0	None
27361	27362	WT	0	None
27362	27363	POBs	0	None
27363	27364	or	0	None
27364	27365	WT	0	None
27365	27366	BMMs	0	None
27366	27367	.	0	None

27368	27369	The	0	None
27369	27370	inhibitory	0	None
27370	27371	effect	0	None
27371	27372	mediated	0	None
27372	27373	by	0	None
27373	27374	COX-2	0	None
27374	27375	/	0	None
27375	27376	PGE2	2	CHEMICAL
27376	27377	was	0	None
27377	27378	transferred	0	None
27378	27379	by	0	None
27379	27380	conditioned	0	None
27380	27381	media	0	None
27381	27382	from	0	None
27382	27383	RANKL-treated	0	None
27383	27384	BMMs	0	None
27384	27385	and	0	None
27385	27386	could	0	None
27386	27387	be	0	None
27387	27388	blocked	0	None
27388	27389	by	0	None
27389	27390	osteoprotegerin	0	None
27390	27391	,	0	None
27391	27392	which	0	None
27392	27393	interferes	0	None
27393	27394	with	0	None
27394	27395	RANKL	1	GENE-Y
27395	27396	binding	0	None
27396	27397	to	0	None
27397	27398	its	0	None
27398	27399	receptor	0	None
27399	27400	on	0	None
27400	27401	OC	1	GENE-Y
27401	27402	lineage	0	None
27402	27403	cells	0	None
27403	27404	.	0	None

27405	27406	Deletion	0	None
27406	27407	of	0	None
27407	27408	Ptger4	0	None
27408	27409	,	0	None
27409	27410	but	0	None
27410	27411	not	0	None
27411	27412	Ptger2	0	None
27412	27413	,	0	None
27413	27414	in	0	None
27414	27415	BMMs	0	None
27415	27416	prevented	0	None
27416	27417	the	0	None
27417	27418	inhibition	0	None
27418	27419	of	0	None
27419	27420	PTH-stimulated	0	None
27420	27421	OB	0	None
27421	27422	differentiation	0	None
27422	27423	.	0	None

27424	27425	As	0	None
27425	27426	expected	0	None
27426	27427	,	0	None
27427	27428	PGE2	2	CHEMICAL
27428	27429	also	0	None
27429	27430	stimulated	0	None
27430	27431	OB	0	None
27431	27432	differentiation	0	None
27432	27433	,	0	None
27433	27434	but	0	None
27434	27435	when	0	None
27435	27436	given	0	None
27436	27437	in	0	None
27437	27438	combination	0	None
27438	27439	with	0	None
27439	27440	PTH	0	None
27440	27441	,	0	None
27441	27442	the	0	None
27442	27443	stimulatory	0	None
27443	27444	effects	0	None
27444	27445	of	0	None
27445	27446	both	0	None
27446	27447	were	0	None
27447	27448	abrogated	0	None
27448	27449	.	0	None

27450	27451	These	0	None
27451	27452	data	0	None
27452	27453	suggest	0	None
27453	27454	that	0	None
27454	27455	PGE2	2	CHEMICAL
27455	27456	,	0	None
27456	27457	acting	0	None
27457	27458	via	0	None
27458	27459	EP4R	0	None
27459	27460	on	0	None
27460	27461	BMMs	0	None
27461	27462	committed	0	None
27462	27463	to	0	None
27463	27464	the	0	None
27464	27465	OC	1	GENE-Y
27465	27466	lineage	0	None
27466	27467	,	0	None
27467	27468	stimulated	0	None
27468	27469	secretion	0	None
27469	27470	of	0	None
27470	27471	a	0	None
27471	27472	factor	0	None
27472	27473	or	0	None
27473	27474	factors	0	None
27474	27475	that	0	None
27475	27476	acted	0	None
27476	27477	to	0	None
27477	27478	suppress	0	None
27478	27479	PTH-stimulated	0	None
27479	27480	OB	0	None
27480	27481	differentiation	0	None
27481	27482	.	0	None

27483	27484	This	0	None
27484	27485	suppression	0	None
27485	27486	of	0	None
27486	27487	OB	0	None
27487	27488	differentiation	0	None
27488	27489	could	0	None
27489	27490	contribute	0	None
27490	27491	to	0	None
27491	27492	the	0	None
27492	27493	bone	0	None
27493	27494	loss	0	None
27494	27495	seen	0	None
27495	27496	with	0	None
27496	27497	continuous	0	None
27497	27498	PTH	0	None
27498	27499	in	0	None
27499	27500	vivo	0	None
27500	27501	.	0	None
27501	27502	OBJECTIVES	0	None
27502	27503	:	0	None
27503	27504	Significant	0	None
27504	27505	variability	0	None
27505	27506	in	0	None
27506	27507	the	0	None
27507	27508	efficacy	0	None
27508	27509	and	0	None
27509	27510	toxicity	0	None
27510	27511	of	0	None
27511	27512	an	0	None
27512	27513	anticancer	0	None
27513	27514	drug	0	None
27514	27515	is	0	None
27515	27516	observed	0	None
27516	27517	in	0	None
27517	27518	cancer	0	None
27518	27519	patients	0	None
27519	27520	.	0	None

27521	27522	Currently	0	None
27522	27523	,	0	None
27523	27524	there	0	None
27524	27525	are	0	None
27525	27526	no	0	None
27526	27527	standard	0	None
27527	27528	tools	0	None
27528	27529	for	0	None
27529	27530	prediction	0	None
27530	27531	of	0	None
27531	27532	a	0	None
27532	27533	patient's	0	None
27533	27534	tumor	0	None
27534	27535	response	0	None
27535	27536	or	0	None
27536	27537	his	0	None
27537	27538	risk	0	None
27538	27539	of	0	None
27539	27540	adverse	0	None
27540	27541	events	0	None
27541	27542	to	0	None
27542	27543	chemotherapy	0	None
27543	27544	.	0	None

27545	27546	METHODS	0	None
27546	27547	:	0	None
27547	27548	We	0	None
27548	27549	investigate	0	None
27549	27550	an	0	None
27550	27551	association	0	None
27551	27552	between	0	None
27552	27553	polymorphisms	0	None
27553	27554	of	0	None
27554	27555	gemcitabine	0	None
27555	27556	metabolism-related	0	None
27556	27557	genes	0	None
27557	27558	and	0	None
27558	27559	its	0	None
27559	27560	chemosensitivity	0	None
27560	27561	in	0	None
27561	27562	vitro	0	None
27562	27563	using	0	None
27563	27564	62	0	None
27564	27565	human	0	None
27565	27566	cancer	0	None
27566	27567	cell	0	None
27567	27568	lines	0	None
27568	27569	of	0	None
27569	27570	various	0	None
27570	27571	origins	0	None
27571	27572	.	0	None

27573	27574	Polymorphisms	0	None
27574	27575	of	0	None
27575	27576	gemcitabine	0	None
27576	27577	metabolism-related	0	None
27577	27578	genes	0	None
27578	27579	of	0	None
27579	27582	deoxycytidine monophosphate deaminase	1	GENE-Y
27582	27583	(	0	None
27583	27584	DCTD	0	None
27584	27585	)	0	None
27585	27586	,	0	None
27586	27587	deoxycytidine	0	None
27587	27588	kinase	0	None
27588	27589	(	0	None
27589	27590	DCK	0	None
27590	27591	)	0	None
27591	27592	and	0	None
27592	27593	ribonucleotide	0	None
27593	27594	reductase	0	None
27594	27595	M1	0	None
27595	27596	(	0	None
27596	27597	RRM1	0	None
27597	27598	)	0	None
27598	27599	were	0	None
27599	27600	evaluated	0	None
27600	27601	using	0	None
27601	27602	the	0	None
27602	27603	CEQ8000	0	None
27603	27604	Genetic	0	None
27604	27605	analysis	0	None
27605	27606	system	0	None
27606	27607	and	0	None
27607	27608	GeneDoc	0	None
27608	27609	software	0	None
27609	27610	.	0	None

27611	27612	Chemosensitivity	0	None
27612	27613	of	0	None
27613	27614	gemcitabine	0	None
27614	27615	was	0	None
27615	27616	expressed	0	None
27616	27617	as	0	None
27617	27618	an	0	None
27618	27619	IC50	0	None
27619	27620	using	0	None
27620	27621	MTT	0	None
27621	27622	assay	0	None
27622	27623	.	0	None

27624	27625	RESULTS	0	None
27625	27626	:	0	None
27626	27627	The	0	None
27627	27628	frequency	0	None
27628	27629	of	0	None
27629	27630	the	0	None
27630	27631	polymorphisms	0	None
27631	27632	was	0	None
27632	27633	21%	0	None
27633	27634	in	0	None
27634	27635	DCTD	0	None
27635	27636	315T>C	0	None
27636	27637	,	0	None
27637	27638	45	0	None
27638	27639	.	0	None
27639	27640	2%	0	None
27640	27641	in	0	None
27641	27642	RRM1	0	None
27642	27643	1082C>A	0	None
27643	27644	,	0	None
27644	27645	59	0	None
27645	27646	.	0	None
27646	27647	7%	0	None
27647	27648	in	0	None
27648	27649	RRM1	0	None
27649	27650	2455A>G	0	None
27650	27651	,	0	None
27651	27652	and	0	None
27652	27653	79%	0	None
27653	27654	in	0	None
27654	27655	RRM1	0	None
27655	27656	2464G>A	0	None
27656	27657	.	0	None

27658	27659	When	0	None
27659	27660	examining	0	None
27660	27661	the	0	None
27661	27662	association	0	None
27662	27663	between	0	None
27663	27664	these	0	None
27664	27665	polymorphisms	0	None
27665	27666	and	0	None
27666	27667	IC50	0	None
27667	27668	,	0	None
27668	27669	only	0	None
27669	27670	the	0	None
27670	27671	RRM1	0	None
27671	27672	2464G>A	0	None
27672	27673	showed	0	None
27673	27674	the	0	None
27674	27675	tendency	0	None
27675	27676	to	0	None
27676	27677	be	0	None
27677	27678	more	0	None
27678	27679	chemosensitive	0	None
27679	27680	to	0	None
27680	27681	gemcitabine	0	None
27681	27682	(	0	None
27682	27683	P	0	None
27683	27684	=	0	None
27684	27685	0	0	None
27685	27686	.	0	None
27686	27687	011	0	None
27687	27688	)	0	None
27688	27689	,	0	None
27689	27690	and	0	None
27690	27691	haplotypes	0	None
27691	27692	containing	0	None
27692	27693	2464G>A	0	None
27693	27694	polymorphism	0	None
27694	27695	also	0	None
27695	27696	showed	0	None
27696	27697	the	0	None
27697	27698	association	0	None
27698	27699	with	0	None
27699	27700	chemosensitivity	0	None
27700	27701	when	0	None
27701	27702	compared	0	None
27702	27703	to	0	None
27703	27704	wild-type	0	None
27704	27705	RRM1	0	None
27705	27706	(	0	None
27706	27707	G2464G	0	None
27707	27708	)	0	None
27708	27709	.	0	None

27710	27711	We	0	None
27711	27712	could	0	None
27712	27713	not	0	None
27713	27714	see	0	None
27714	27715	the	0	None
27715	27716	significant	0	None
27716	27717	differences	0	None
27717	27718	of	0	None
27718	27719	mRNA	0	None
27719	27720	expression	0	None
27720	27721	level	0	None
27721	27722	with	0	None
27722	27723	real-time	0	None
27723	27724	PCR	0	None
27724	27725	between	0	None
27725	27726	cell	0	None
27726	27727	lines	0	None
27727	27728	according	0	None
27728	27729	to	0	None
27729	27730	G2464A	0	None
27730	27731	polymorphism	0	None
27731	27732	.	0	None

27733	27734	In	0	None
27734	27735	oligonucleotide	0	None
27735	27736	microarray	0	None
27736	27737	73	0	None
27737	27738	GenBank	0	None
27738	27739	Accession	0	None
27739	27740	Number	0	None
27740	27741	(	0	None
27741	27742	69	0	None
27742	27743	genes	0	None
27743	27744	)	0	None
27744	27745	were	0	None
27745	27746	selected	0	None
27746	27747	which	0	None
27747	27748	expressed	0	None
27748	27749	differently	0	None
27749	27750	between	0	None
27750	27751	RRM1	0	None
27751	27752	wild-type	0	None
27752	27753	and	0	None
27753	27754	the	0	None
27754	27755	G2464A	0	None
27755	27756	polymorphism	0	None
27756	27757	.	0	None

27758	27759	CONCLUSIONS	0	None
27759	27760	:	0	None
27760	27761	RRM1	0	None
27761	27762	2464G>A	0	None
27762	27763	polymorphism	0	None
27763	27764	demonstrated	0	None
27764	27765	an	0	None
27765	27766	association	0	None
27766	27767	with	0	None
27767	27768	gemcitabine	0	None
27768	27769	sensitivity	0	None
27769	27770	,	0	None
27770	27771	which	0	None
27771	27772	needs	0	None
27772	27773	functional	0	None
27773	27774	studies	0	None
27774	27775	with	0	None
27775	27776	co-expressing	0	None
27776	27777	genes	0	None
27777	27778	and	0	None
27778	27779	prospective	0	None
27779	27780	clinical	0	None
27780	27781	studies	0	None
27781	27782	for	0	None
27782	27783	the	0	None
27783	27784	clinical	0	None
27784	27785	application	0	None
27785	27786	as	0	None
27786	27787	a	0	None
27787	27788	predictive	0	None
27788	27789	bio-marker	0	None
27789	27790	.	0	None
27790	27791	Supernumerary	0	None
27791	27792	centrosomes	0	None
27792	27793	and	0	None
27793	27794	aneuploidy	0	None
27794	27795	are	0	None
27795	27796	associated	0	None
27796	27797	with	0	None
27797	27798	a	0	None
27798	27799	malignant	0	None
27799	27800	phenotype	0	None
27800	27801	of	0	None
27801	27802	tumor	0	None
27802	27803	cells	0	None
27803	27804	.	0	None

27805	27806	Centrosomal	0	None
27806	27807	clustering	0	None
27807	27808	is	0	None
27808	27809	a	0	None
27809	27810	mechanism	0	None
27810	27811	used	0	None
27811	27812	by	0	None
27812	27813	cancer	0	None
27813	27814	cells	0	None
27814	27815	with	0	None
27815	27816	supernumerary	0	None
27816	27817	centrosomes	0	None
27817	27818	to	0	None
27818	27819	solve	0	None
27819	27820	the	0	None
27820	27821	threatening	0	None
27821	27822	problem	0	None
27822	27823	of	0	None
27823	27824	multipolar	0	None
27824	27825	spindles	0	None
27825	27826	.	0	None

27827	27828	Griseofulvin	0	None
27828	27829	is	0	None
27829	27830	an	0	None
27830	27831	antifungal	0	None
27831	27832	substance	0	None
27832	27833	that	0	None
27833	27834	interferes	0	None
27834	27835	with	0	None
27835	27836	the	0	None
27836	27837	microtubule	0	None
27837	27838	apparatus	0	None
27838	27839	and	0	None
27839	27840	inhibits	0	None
27840	27841	centrosomal	0	None
27841	27842	clustering	0	None
27842	27843	.	0	None

27844	27845	It	0	None
27845	27846	has	0	None
27846	27847	also	0	None
27847	27848	been	0	None
27848	27849	demonstrated	0	None
27849	27850	that	0	None
27850	27851	griseofulvin	0	None
27851	27852	inhibits	0	None
27852	27853	the	0	None
27853	27854	growth	0	None
27854	27855	of	0	None
27855	27856	tumor	0	None
27856	27857	cells	0	None
27857	27858	in	0	None
27858	27859	vitro	0	None
27859	27860	and	0	None
27860	27861	in	0	None
27861	27862	vivo	0	None
27862	27863	.	0	None

27864	27865	However	0	None
27865	27866	,	0	None
27866	27867	it	0	None
27867	27868	is	0	None
27868	27869	not	0	None
27869	27870	yet	0	None
27870	27871	known	0	None
27871	27872	whether	0	None
27872	27873	treatment	0	None
27873	27874	with	0	None
27874	27875	griseofulvin	0	None
27875	27876	inhibits	0	None
27876	27877	growth	0	None
27877	27878	of	0	None
27878	27879	adrenocortical	0	None
27879	27880	tumor	0	None
27880	27881	cells	0	None
27881	27882	.	0	None

27883	27884	We	0	None
27884	27885	studied	0	None
27885	27886	the	0	None
27886	27887	viability	0	None
27887	27888	and	0	None
27888	27889	antiproliferative	0	None
27889	27890	effects	0	None
27890	27891	of	0	None
27891	27892	griseofulvin	0	None
27892	27893	on	0	None
27893	27894	cultured	0	None
27894	27895	NCI-H295R	0	None
27895	27896	adrenocortical	0	None
27896	27897	carcinoma	0	None
27897	27898	cells	0	None
27898	27899	using	0	None
27899	27900	Wst-1-	0	None
27900	27901	,	0	None
27901	27902	BrdUrd-	0	None
27902	27903	,	0	None
27903	27904	and	0	None
27904	27905	[	0	None
27905	27906	3H	0	None
27906	27907	]	0	None
27907	27908	-thymidine	0	None
27908	27909	assays	0	None
27909	27910	.	0	None

27911	27912	For	0	None
27912	27913	the	0	None
27913	27914	detection	0	None
27914	27915	of	0	None
27915	27916	apoptosis	0	None
27916	27917	we	0	None
27917	27918	used	0	None
27918	27919	a	0	None
27919	27920	caspase	3	GENE-N
27920	27921	3	0	None
27921	27922	/	0	None
27922	27923	7	0	None
27923	27924	cleavage	0	None
27924	27925	assay	0	None
27925	27926	and	0	None
27926	27927	light	0	None
27927	27928	microscopy	0	None
27928	27929	techniques	0	None
27929	27930	.	0	None

27931	27932	We	0	None
27932	27933	observed	0	None
27933	27934	that	0	None
27934	27935	incubation	0	None
27935	27936	with	0	None
27936	27937	griseofulvin	0	None
27937	27938	for	0	None
27938	27939	24-48	0	None
27939	27940	h	0	None
27940	27941	leads	0	None
27941	27942	to	0	None
27942	27943	a	0	None
27943	27944	decrease	0	None
27944	27945	in	0	None
27945	27946	the	0	None
27946	27947	viability	0	None
27947	27948	and	0	None
27948	27949	proliferation	0	None
27949	27950	of	0	None
27950	27951	NCI-H295R	0	None
27951	27952	cells	0	None
27952	27953	in	0	None
27953	27954	a	0	None
27954	27955	dose-dependent	0	None
27955	27956	manner	0	None
27956	27957	.	0	None

27958	27959	Significant	0	None
27959	27960	effects	0	None
27960	27961	could	0	None
27961	27962	be	0	None
27962	27963	observed	0	None
27963	27964	after	0	None
27964	27965	incubation	0	None
27965	27966	with	0	None
27966	27967	griseofulvin	0	None
27967	27968	as	0	None
27968	27969	measured	0	None
27969	27970	by	0	None
27970	27971	Wst-1-	0	None
27971	27972	,	0	None
27972	27973	BrdUrd-	0	None
27973	27974	,	0	None
27974	27975	and	0	None
27975	27976	[	0	None
27976	27977	3H	0	None
27977	27978	]	0	None
27978	27979	dT-	0	None
27979	27980	uptake	0	None
27980	27981	assays	0	None
27981	27982	.	0	None

27983	27984	Apoptosis	0	None
27984	27985	of	0	None
27985	27986	NCI-H295R	0	None
27986	27987	cells	0	None
27987	27988	was	0	None
27988	27989	increased	0	None
27989	27990	in	0	None
27990	27991	a	0	None
27991	27992	dose-dependent	0	None
27992	27993	manner	0	None
27993	27994	up	0	None
27994	27995	to	0	None
27995	27996	4	0	None
27996	27997	.	0	None
27997	27998	5-fold	0	None
27998	27999	after	0	None
27999	28000	incubation	0	None
28000	28001	with	0	None
28001	28002	griseofulvin	0	None
28002	28003	40	0	None
28003	28004	μM	0	None
28004	28005	for	0	None
28005	28006	24	0	None
28006	28007	h	0	None
28007	28008	as	0	None
28008	28009	shown	0	None
28009	28010	by	0	None
28010	28011	caspase	3	GENE-N
28011	28012	3	0	None
28012	28013	/	0	None
28013	28014	7	0	None
28014	28015	cleavage	0	None
28015	28016	assay	0	None
28016	28017	and	0	None
28017	28018	light	0	None
28018	28019	microscopy	0	None
28019	28020	.	0	None

28021	28022	With	0	None
28022	28023	regard	0	None
28023	28024	to	0	None
28024	28025	new	0	None
28025	28026	treatment	0	None
28026	28027	strategies	0	None
28027	28028	for	0	None
28028	28029	adrenocortical	0	None
28029	28030	cancer	0	None
28030	28031	,	0	None
28031	28032	griseofulvin	0	None
28032	28033	,	0	None
28033	28034	and	0	None
28034	28035	possibly	0	None
28035	28036	other	0	None
28036	28037	agents	0	None
28037	28038	,	0	None
28038	28039	which	0	None
28039	28040	interfere	0	None
28040	28041	with	0	None
28041	28042	the	0	None
28042	28043	microtubule	0	None
28043	28044	apparatus	0	None
28044	28045	and	0	None
28045	28046	inhibit	0	None
28046	28047	centrosomal	0	None
28047	28048	clustering	0	None
28048	28049	,	0	None
28049	28050	may	0	None
28050	28051	turn	0	None
28051	28052	out	0	None
28052	28053	to	0	None
28053	28054	be	0	None
28054	28055	interesting	0	None
28055	28056	targets	0	None
28056	28057	for	0	None
28057	28058	further	0	None
28058	28059	research	0	None
28059	28060	.	0	None
28060	28061	Traumatic	0	None
28061	28062	brain	0	None
28062	28063	injury	0	None
28063	28064	(	0	None
28064	28065	TBI	0	None
28065	28066	)	0	None
28066	28067	evokes	0	None
28067	28068	an	0	None
28068	28069	intense	0	None
28069	28070	neuroinflammatory	0	None
28070	28071	reaction	0	None
28071	28072	that	0	None
28072	28073	is	0	None
28073	28074	essentially	0	None
28074	28075	mediated	0	None
28075	28076	by	0	None
28076	28077	activated	0	None
28077	28078	microglia	0	None
28078	28079	and	0	None
28079	28080	that	0	None
28080	28081	has	0	None
28081	28082	been	0	None
28082	28083	reported	0	None
28083	28084	to	0	None
28084	28085	act	0	None
28085	28086	as	0	None
28086	28087	a	0	None
28087	28088	secondary	0	None
28088	28089	injury	0	None
28089	28090	mechanism	0	None
28090	28091	that	0	None
28091	28092	further	0	None
28092	28093	promotes	0	None
28093	28094	neuronal	0	None
28094	28095	death	0	None
28095	28096	.	0	None

28097	28098	It	0	None
28098	28099	involves	0	None
28099	28100	the	0	None
28100	28101	excessive	0	None
28101	28102	production	0	None
28102	28103	of	0	None
28103	28104	inflammatory	0	None
28104	28105	cytokines	3	GENE-N
28105	28106	and	0	None
28106	28107	the	0	None
28107	28108	diminution	0	None
28108	28109	of	0	None
28109	28110	neuroprotective	0	None
28110	28111	and	0	None
28111	28112	neurotrophic	0	None
28112	28113	factors	0	None
28113	28114	,	0	None
28114	28115	such	0	None
28115	28116	as	0	None
28116	28117	the	0	None
28117	28118	soluble	0	None
28118	28119	form	0	None
28119	28120	alpha	0	None
28120	28121	of	0	None
28121	28122	the	0	None
28122	28125	amyloid precursor protein	1	GENE-Y
28125	28126	(	0	None
28126	28127	sAPPα	0	None
28127	28128	)	0	None
28128	28129	,	0	None
28129	28130	generated	0	None
28130	28131	by	0	None
28131	28132	the	0	None
28132	28133	activity	0	None
28133	28134	of	0	None
28134	28135	α-secretases	0	None
28135	28136	.	0	None

28137	28138	Hence	0	None
28138	28139	,	0	None
28139	28140	the	0	None
28140	28141	aim	0	None
28141	28142	of	0	None
28142	28143	this	0	None
28143	28144	study	0	None
28144	28145	was	0	None
28145	28146	to	0	None
28146	28147	examine	0	None
28147	28148	the	0	None
28148	28149	effects	0	None
28149	28150	of	0	None
28150	28151	etazolate	0	None
28151	28152	,	0	None
28152	28153	an	0	None
28153	28154	α-secretase	0	None
28154	28155	activator	0	None
28155	28156	,	0	None
28156	28157	on	0	None
28157	28158	acute	0	None
28158	28159	and	0	None
28159	28160	belated	0	None
28160	28161	post-TBI	0	None
28161	28162	consequences	0	None
28162	28163	.	0	None

28164	28165	The	0	None
28165	28166	mouse	0	None
28166	28167	model	0	None
28167	28168	of	0	None
28168	28169	TBI	0	None
28169	28170	by	0	None
28170	28171	mechanical	0	None
28171	28172	percussion	0	None
28172	28173	was	0	None
28173	28174	used	0	None
28174	28175	and	0	None
28175	28176	injured	0	None
28176	28177	mice	0	None
28177	28178	received	0	None
28178	28179	either	0	None
28179	28180	the	0	None
28180	28181	vehicle	0	None
28181	28182	or	0	None
28182	28183	etazolate	0	None
28183	28184	at	0	None
28184	28185	the	0	None
28185	28186	dose	0	None
28186	28187	of	0	None
28187	28188	1	0	None
28188	28189	,	0	None
28189	28190	3	0	None
28190	28191	or	0	None
28191	28192	10	0	None
28192	28193	mg	2	CHEMICAL
28193	28194	/	0	None
28194	28195	kg	0	None
28195	28196	at	0	None
28196	28197	2	0	None
28197	28198	h	0	None
28198	28199	post-TBI	0	None
28199	28200	.	0	None

28201	28202	Neurological	0	None
28202	28203	score	0	None
28203	28204	,	0	None
28204	28205	cerebral	0	None
28205	28206	œdema	0	None
28206	28207	,	0	None
28207	28208	IL-1β	0	None
28208	28209	and	0	None
28209	28210	sAPPα	0	None
28210	28211	levels	0	None
28211	28212	,	0	None
28212	28213	microglial	0	None
28213	28214	activation	0	None
28214	28215	and	0	None
28215	28216	lesion	0	None
28216	28217	size	0	None
28217	28218	were	0	None
28218	28219	evaluated	0	None
28219	28220	from	0	None
28220	28221	6	0	None
28221	28222	to	0	None
28222	28223	24	0	None
28223	28224	h	0	None
28224	28225	post-TBI	0	None
28225	28226	.	0	None

28227	28228	Spontaneous	0	None
28228	28229	locomotor	0	None
28229	28230	activity	0	None
28230	28231	was	0	None
28231	28232	evaluated	0	None
28232	28233	from	0	None
28233	28234	48	0	None
28234	28235	h	0	None
28235	28236	to	0	None
28236	28237	12	0	None
28237	28238	weeks	0	None
28238	28239	post-TBI	0	None
28239	28240	,	0	None
28240	28241	memory	0	None
28241	28242	function	0	None
28242	28243	at	0	None
28243	28244	5	0	None
28244	28245	weeks	0	None
28245	28246	and	0	None
28246	28247	olfactory	0	None
28247	28248	bulb	0	None
28248	28249	lesions	0	None
28249	28250	at	0	None
28250	28251	13	0	None
28251	28252	weeks	0	None
28252	28253	post-TBI	0	None
28253	28254	.	0	None

28255	28256	A	0	None
28256	28257	single	0	None
28257	28258	administration	0	None
28258	28259	of	0	None
28259	28260	etazolate	0	None
28260	28261	exerted	0	None
28261	28262	a	0	None
28262	28263	dose-dependent	0	None
28263	28264	anti-inflammatory	0	None
28264	28265	and	0	None
28265	28266	anti-œdematous	0	None
28266	28267	effect	0	None
28267	28268	accompanied	0	None
28268	28269	by	0	None
28269	28270	lasting	0	None
28270	28271	memory	0	None
28271	28272	improvement	0	None
28272	28273	,	0	None
28273	28274	reduction	0	None
28274	28275	of	0	None
28275	28276	locomotor	0	None
28276	28277	hyperactivity	0	None
28277	28278	and	0	None
28278	28279	olfactory	0	None
28279	28280	bulb	0	None
28280	28281	tissue	0	None
28281	28282	protection	0	None
28282	28283	,	0	None
28283	28284	with	0	None
28284	28285	a	0	None
28285	28286	therapeutic	0	None
28286	28287	window	0	None
28287	28288	of	0	None
28288	28289	at	0	None
28289	28290	least	0	None
28290	28291	2	0	None
28291	28292	h	0	None
28292	28293	.	0	None

28294	28295	These	0	None
28295	28296	effects	0	None
28296	28297	were	0	None
28297	28298	associated	0	None
28298	28299	with	0	None
28299	28300	the	0	None
28300	28301	restoration	0	None
28301	28302	of	0	None
28302	28303	the	0	None
28303	28304	levels	0	None
28304	28305	of	0	None
28305	28306	the	0	None
28306	28307	sAPPα	0	None
28307	28308	protein	0	None
28308	28309	post-TBI	0	None
28309	28310	.	0	None

28311	28312	Taken	0	None
28312	28313	together	0	None
28313	28314	,	0	None
28314	28315	these	0	None
28315	28316	results	0	None
28316	28317	highlight	0	None
28317	28318	for	0	None
28318	28319	the	0	None
28319	28320	first	0	None
28320	28321	time	0	None
28321	28322	the	0	None
28322	28323	therapeutic	0	None
28323	28324	interest	0	None
28324	28325	of	0	None
28325	28326	an	0	None
28326	28327	α-secretase	0	None
28327	28328	activator	0	None
28328	28329	in	0	None
28329	28330	TBI	0	None
28330	28331	.	0	None
28331	28332	Design	0	None
28332	28333	,	0	None
28333	28334	synthesis	0	None
28334	28335	,	0	None
28335	28336	and	0	None
28336	28337	structure-activity	0	None
28337	28338	relationship	0	None
28338	28339	studies	0	None
28339	28340	of	0	None
28340	28341	tryptanthrins	0	None
28341	28342	as	0	None
28342	28343	antitubercular	0	None
28343	28344	agents	0	None
28344	28345	.	0	None
28345	28346	Synthesis	0	None
28346	28347	,	0	None
28347	28348	crystal	0	None
28348	28349	structure	0	None
28349	28350	and	0	None
28350	28351	antidiabetic	0	None
28351	28352	activity	0	None
28352	28353	of	0	None
28353	28354	substituted	0	None
28354	28355	(	0	None
28355	28356	E	0	None
28356	28357	)	0	None
28357	28358	-3-	0	None
28358	28359	(	0	None
28359	28360	Benzo	0	None
28360	28361	[	0	None
28361	28362	d	0	None
28362	28363	]	0	None
28363	28364	thiazol-2-ylamino	0	None
28364	28365	)	0	None
28365	28366	phenylprop-2-en-1-one	0	None
28366	28367	.	0	None
28367	28368	DNA	0	None
28368	28369	damage	0	None
28369	28370	and	0	None
28370	28371	homologous	0	None
28371	28372	recombination	0	None
28372	28373	signaling	0	None
28373	28374	induced	0	None
28374	28375	by	0	None
28375	28376	thymidylate	2	CHEMICAL
28376	28377	deprivation	0	None
28377	28378	.	0	None
28378	28379	The	0	None
28379	28380	human	0	None
28380	28381	multidrug	0	None
28381	28382	and	0	None
28382	28383	toxin	0	None
28383	28384	extrusion	0	None
28384	28385	(	0	None
28385	28386	MATE	0	None
28386	28387	)	0	None
28387	28388	transporter	0	None
28388	28389	1	0	None
28389	28390	contributes	0	None
28390	28391	to	0	None
28391	28392	the	0	None
28392	28393	tissue	0	None
28393	28394	distribution	0	None
28394	28395	and	0	None
28395	28396	excretion	0	None
28396	28397	of	0	None
28397	28398	many	0	None
28398	28399	drugs	0	None
28399	28400	.	0	None

28401	28402	Inhibition	0	None
28402	28403	of	0	None
28403	28404	MATE1	0	None
28404	28405	may	0	None
28405	28406	result	0	None
28406	28407	in	0	None
28407	28408	potential	0	None
28408	28409	drug-drug	0	None
28409	28410	interactions	0	None
28410	28411	(	0	None
28411	28412	DDIs	0	None
28412	28413	)	0	None
28413	28414	and	0	None
28414	28415	alterations	0	None
28415	28416	in	0	None
28416	28417	drug	0	None
28417	28418	exposure	0	None
28418	28419	and	0	None
28419	28420	accumulation	0	None
28420	28421	in	0	None
28421	28422	various	0	None
28422	28423	tissues	0	None
28423	28424	.	0	None

28425	28426	The	0	None
28426	28427	primary	0	None
28427	28428	goals	0	None
28428	28429	of	0	None
28429	28430	this	0	None
28430	28431	project	0	None
28431	28432	were	0	None
28432	28433	to	0	None
28433	28434	identify	0	None
28434	28435	MATE1	0	None
28435	28436	inhibitors	0	None
28436	28437	with	0	None
28437	28438	clinical	0	None
28438	28439	importance	0	None
28439	28440	or	0	None
28440	28441	in	0	None
28441	28442	vitro	0	None
28442	28443	utility	0	None
28443	28444	and	0	None
28444	28445	to	0	None
28445	28446	elucidate	0	None
28446	28447	the	0	None
28447	28448	physicochemical	0	None
28448	28449	properties	0	None
28449	28450	that	0	None
28450	28451	differ	0	None
28451	28452	between	0	None
28452	28453	MATE1	0	None
28453	28454	and	0	None
28454	28455	OCT2	0	None
28455	28456	inhibitors	0	None
28456	28457	.	0	None

28458	28459	Using	0	None
28459	28460	a	0	None
28460	28461	fluorescence	0	None
28461	28462	assay	0	None
28462	28463	of	0	None
28463	28464	ASP	0	None
28464	28465	(	0	None
28465	28466	+	0	None
28466	28467	)	0	None
28467	28468	uptake	0	None
28468	28469	in	0	None
28469	28470	cells	0	None
28470	28471	stably	0	None
28471	28472	expressing	0	None
28472	28473	MATE1	0	None
28473	28474	,	0	None
28474	28475	over	0	None
28475	28476	900	0	None
28476	28477	prescription	0	None
28477	28478	drugs	0	None
28478	28479	were	0	None
28479	28480	screened	0	None
28480	28481	and	0	None
28481	28482	84	0	None
28482	28483	potential	0	None
28483	28484	MATE1	0	None
28484	28485	inhibitors	0	None
28485	28486	were	0	None
28486	28487	found	0	None
28487	28488	.	0	None

28489	28490	We	0	None
28490	28491	identified	0	None
28491	28492	several	0	None
28492	28493	MATE1	0	None
28493	28494	selective	0	None
28494	28495	inhibitors	0	None
28495	28496	including	0	None
28496	28497	four	0	None
28497	28498	FDA-approved	0	None
28498	28499	medications	0	None
28499	28500	that	0	None
28500	28501	may	0	None
28501	28502	be	0	None
28502	28503	clinically	0	None
28503	28504	relevant	0	None
28504	28505	MATE1	0	None
28505	28506	inhibitors	0	None
28506	28507	and	0	None
28507	28508	could	0	None
28508	28509	cause	0	None
28509	28510	a	0	None
28510	28511	clinical	0	None
28511	28512	DDI	0	None
28512	28513	.	0	None

28514	28515	In	0	None
28515	28516	parallel	0	None
28516	28517	,	0	None
28517	28518	a	0	None
28518	28519	QSAR	0	None
28519	28520	model	0	None
28520	28521	identified	0	None
28521	28522	distinct	0	None
28522	28523	molecular	0	None
28523	28524	properties	0	None
28524	28525	of	0	None
28525	28526	MATE1	0	None
28526	28527	versus	0	None
28527	28528	OCT2	0	None
28528	28529	inhibitors	0	None
28529	28530	and	0	None
28530	28531	was	0	None
28531	28532	used	0	None
28532	28533	to	0	None
28533	28534	screen	0	None
28534	28535	the	0	None
28535	28536	DrugBank	0	None
28536	28537	in	0	None
28537	28538	silico	0	None
28538	28539	library	0	None
28539	28540	for	0	None
28540	28541	new	0	None
28541	28542	hits	0	None
28542	28543	in	0	None
28543	28544	a	0	None
28544	28545	larger	0	None
28545	28546	chemical	0	None
28546	28547	space	0	None
28547	28548	.	0	None
28548	28549	Exposure	0	None
28549	28550	to	0	None
28550	28551	chronic	0	None
28551	28552	stress	0	None
28552	28553	during	0	None
28553	28554	developmental	0	None
28554	28555	periods	0	None
28555	28556	is	0	None
28556	28557	a	0	None
28557	28558	risk	0	None
28558	28559	factor	0	None
28559	28560	for	0	None
28560	28561	a	0	None
28561	28562	number	0	None
28562	28563	of	0	None
28563	28564	psychiatric	0	None
28564	28565	disorders	0	None
28565	28566	.	0	None

28567	28568	While	0	None
28568	28569	the	0	None
28569	28570	direct	0	None
28570	28571	effects	0	None
28571	28572	of	0	None
28572	28573	stress	0	None
28573	28574	exposure	0	None
28574	28575	have	0	None
28575	28576	been	0	None
28576	28577	studied	0	None
28577	28578	extensively	0	None
28578	28579	,	0	None
28579	28580	little	0	None
28580	28581	is	0	None
28581	28582	known	0	None
28582	28583	about	0	None
28583	28584	the	0	None
28584	28585	long-lasting	0	None
28585	28586	effects	0	None
28586	28587	and	0	None
28587	28588	the	0	None
28588	28589	interaction	0	None
28589	28590	with	0	None
28590	28591	ageing	0	None
28591	28592	.	0	None

28593	28594	The	0	None
28594	28595	same	0	None
28595	28596	holds	0	None
28596	28597	true	0	None
28597	28598	for	0	None
28598	28599	the	0	None
28599	28600	treatment	0	None
28600	28601	with	0	None
28601	28602	selective	0	None
28602	28603	serotonin	0	None
28603	28604	reuptake	0	None
28604	28605	inhibitors	0	None
28605	28606	(	0	None
28606	28607	SSRIs	0	None
28607	28608	)	0	None
28608	28609	,	0	None
28609	28610	which	0	None
28610	28611	have	0	None
28611	28612	been	0	None
28612	28613	shown	0	None
28613	28614	to	0	None
28614	28615	prevent	0	None
28615	28616	or	0	None
28616	28617	reverse	0	None
28617	28618	some	0	None
28618	28619	stress-induced	0	None
28619	28620	effects	0	None
28620	28621	.	0	None

28622	28623	Here	0	None
28623	28624	,	0	None
28624	28625	we	0	None
28625	28626	studied	0	None
28626	28627	the	0	None
28627	28628	direct	0	None
28628	28629	and	0	None
28629	28630	long-lasting	0	None
28630	28631	impact	0	None
28631	28632	of	0	None
28632	28633	chronic	0	None
28633	28634	social	0	None
28634	28635	stress	0	None
28635	28636	during	0	None
28636	28637	adolescence	0	None
28637	28638	and	0	None
28638	28639	the	0	None
28639	28640	impact	0	None
28640	28641	of	0	None
28641	28642	chronic	0	None
28642	28643	treatment	0	None
28643	28644	with	0	None
28644	28645	the	0	None
28645	28646	SSRI	0	None
28646	28647	paroxetine	2	CHEMICAL
28647	28648	in	0	None
28648	28649	adulthood	0	None
28649	28650	and	0	None
28650	28651	aged	0	None
28651	28652	animals	0	None
28652	28653	.	0	None

28654	28655	Therefore	0	None
28655	28656	,	0	None
28656	28657	male	0	None
28657	28658	CD1	3	GENE-N
28658	28659	mice	0	None
28659	28660	at	0	None
28660	28661	the	0	None
28661	28662	age	0	None
28662	28663	of	0	None
28663	28664	28	0	None
28664	28665	days	0	None
28665	28666	were	0	None
28666	28667	subjected	0	None
28667	28668	to	0	None
28668	28669	7	0	None
28669	28670	weeks	0	None
28670	28671	of	0	None
28671	28672	chronic	0	None
28672	28673	social	0	None
28673	28674	stress	0	None
28674	28675	.	0	None

28676	28677	Treatment	0	None
28677	28678	with	0	None
28678	28679	paroxetine	2	CHEMICAL
28679	28680	was	0	None
28680	28681	performed	0	None
28681	28682	per	0	None
28682	28683	os	0	None
28683	28684	with	0	None
28684	28685	a	0	None
28685	28686	dosage	0	None
28686	28687	of	0	None
28687	28688	20	0	None
28688	28689	mg	2	CHEMICAL
28689	28690	/	0	None
28690	28691	g	0	None
28691	28692	BW	0	None
28692	28693	.	0	None

28694	28695	We	0	None
28695	28696	were	0	None
28696	28697	able	0	None
28697	28698	to	0	None
28698	28699	reverse	0	None
28699	28700	most	0	None
28700	28701	of	0	None
28701	28702	the	0	None
28702	28703	effects	0	None
28703	28704	of	0	None
28704	28705	chronic	0	None
28705	28706	social	0	None
28706	28707	stress	0	None
28707	28708	in	0	None
28708	28709	adult	0	None
28709	28710	mice	0	None
28710	28711	(	0	None
28711	28712	4	0	None
28712	28713	months	0	None
28713	28714	old	0	None
28714	28715	)	0	None
28715	28716	and	0	None
28716	28717	to	0	None
28717	28718	some	0	None
28718	28719	extend	0	None
28719	28720	in	0	None
28720	28721	aged	0	None
28721	28722	animals	0	None
28722	28723	(	0	None
28723	28724	15	0	None
28724	28725	months	0	None
28725	28726	old	0	None
28726	28727	)	0	None
28727	28728	with	0	None
28728	28729	the	0	None
28729	28730	SSRI	0	None
28730	28731	treatment	0	None
28731	28732	.	0	None

28733	28734	Especially	0	None
28734	28735	the	0	None
28735	28736	regulation	0	None
28736	28737	of	0	None
28737	28738	the	0	None
28738	28739	HPA	0	None
28739	28740	axis	0	None
28740	28741	seems	0	None
28741	28742	to	0	None
28742	28743	be	0	None
28743	28744	affected	0	None
28744	28745	in	0	None
28745	28746	aged	0	None
28746	28747	mice	0	None
28747	28748	with	0	None
28748	28749	a	0	None
28749	28750	shift	0	None
28750	28751	to	0	None
28751	28752	the	0	None
28752	28753	use	0	None
28753	28754	of	0	None
28754	28755	vasopressin	1	GENE-Y
28755	28756	.	0	None

28757	28758	Our	0	None
28758	28759	results	0	None
28759	28760	demonstrate	0	None
28760	28761	that	0	None
28761	28762	chronic	0	None
28762	28763	stress	0	None
28763	28764	exposure	0	None
28764	28765	and	0	None
28765	28766	antidepressant	0	None
28766	28767	treatment	0	None
28767	28768	at	0	None
28768	28769	the	0	None
28769	28770	end	0	None
28770	28771	of	0	None
28771	28772	the	0	None
28772	28773	developmental	0	None
28773	28774	period	0	None
28774	28775	can	0	None
28775	28776	have	0	None
28776	28777	a	0	None
28777	28778	significant	0	None
28778	28779	and	0	None
28779	28780	long-lasting	0	None
28780	28781	impact	0	None
28781	28782	,	0	None
28782	28783	highly	0	None
28783	28784	relevant	0	None
28784	28785	for	0	None
28785	28786	healthy	0	None
28786	28787	ageing	0	None
28787	28788	.	0	None
28788	28789	Chronic	0	None
28789	28790	obstructive	0	None
28790	28791	pulmonary	0	None
28791	28792	disease	0	None
28792	28793	(	0	None
28793	28794	COPD	0	None
28794	28795	)	0	None
28795	28796	is	0	None
28796	28797	a	0	None
28797	28798	major	0	None
28798	28799	cause	0	None
28799	28800	of	0	None
28800	28801	morbidity	0	None
28801	28802	and	0	None
28802	28803	mortality	0	None
28803	28804	worldwide	0	None
28804	28805	.	0	None

28806	28807	Oxidative	0	None
28807	28808	stress	0	None
28808	28809	is	0	None
28809	28810	an	0	None
28810	28811	important	0	None
28811	28812	mechanism	0	None
28812	28813	in	0	None
28813	28814	the	0	None
28814	28815	pathogenesis	0	None
28815	28816	of	0	None
28816	28817	this	0	None
28817	28818	disease	0	None
28818	28819	.	0	None

28820	28821	The	0	None
28821	28822	oxidant	0	None
28822	28823	/	0	None
28823	28824	antioxidant	0	None
28824	28825	imbalance	0	None
28825	28826	occurring	0	None
28826	28827	in	0	None
28827	28828	smokers	0	None
28828	28829	and	0	None
28829	28830	patients	0	None
28830	28831	with	0	None
28831	28832	COPD	0	None
28832	28833	is	0	None
28833	28834	well	0	None
28834	28835	established	0	None
28835	28836	.	0	None

28837	28838	Thus	0	None
28838	28839	,	0	None
28839	28840	therapeutic	0	None
28840	28841	strategies	0	None
28841	28842	targeting	0	None
28842	28843	oxidative	0	None
28843	28844	stress	0	None
28844	28845	with	0	None
28845	28846	pharmacological	0	None
28846	28847	antioxidant	0	None
28847	28848	agents	0	None
28848	28849	or	0	None
28849	28850	boosting	0	None
28850	28851	the	0	None
28851	28852	endogenous	0	None
28852	28853	levels	0	None
28853	28854	of	0	None
28854	28855	antioxidants	0	None
28855	28856	is	0	None
28856	28857	likely	0	None
28857	28858	to	0	None
28858	28859	be	0	None
28859	28860	beneficial	0	None
28860	28861	as	0	None
28861	28862	an	0	None
28862	28863	adjunctive	0	None
28863	28864	tool	0	None
28864	28865	in	0	None
28865	28866	the	0	None
28866	28867	treatment	0	None
28867	28868	of	0	None
28868	28869	COPD	0	None
28869	28870	patients	0	None
28870	28871	.	0	None

28872	28873	Thiol	0	None
28873	28874	compounts	0	None
28874	28875	such	0	None
28875	28876	as	0	None
28876	28877	N-acetyl-L-cysteine	0	None
28877	28878	(	0	None
28878	28879	NAC	2	CHEMICAL
28879	28880	)	0	None
28880	28881	,	0	None
28881	28882	carbocysteine	0	None
28882	28883	,	0	None
28883	28884	erdosteine	2	CHEMICAL
28884	28885	,	0	None
28885	28886	and	0	None
28886	28887	fudosteine	0	None
28887	28888	have	0	None
28888	28889	been	0	None
28889	28890	extensively	0	None
28890	28891	studied	0	None
28891	28892	.	0	None

28893	28894	Although	0	None
28894	28895	some	0	None
28895	28896	results	0	None
28896	28897	remain	0	None
28897	28898	controversial	0	None
28898	28899	,	0	None
28899	28900	NAC	2	CHEMICAL
28900	28901	and	0	None
28901	28902	carbocysteine	0	None
28902	28903	seem	0	None
28903	28904	to	0	None
28904	28905	have	0	None
28905	28906	beneficial	0	None
28906	28907	effect	0	None
28907	28908	in	0	None
28908	28909	patients	0	None
28909	28910	not	0	None
28910	28911	receiving	0	None
28911	28912	inhaled	0	None
28912	28913	corticosteroids	0	None
28913	28914	who	0	None
28914	28915	suffer	0	None
28915	28916	from	0	None
28916	28917	frequent	0	None
28917	28918	exacerbations	0	None
28918	28919	.	0	None

28920	28921	In	0	None
28921	28922	addition	0	None
28922	28923	,	0	None
28923	28924	other	0	None
28924	28925	antioxidants	0	None
28925	28926	like	0	None
28926	28927	superoxide	0	None
28927	28928	dismutase	0	None
28928	28929	(	0	None
28929	28930	SOD	1	GENE-Y
28930	28931	)	0	None
28931	28932	mimetics	0	None
28932	28933	and	0	None
28933	28934	nuclear	0	None
28934	28935	factor-erythroid	0	None
28935	28936	2	0	None
28936	28937	related	0	None
28937	28938	factor	0	None
28938	28939	2	0	None
28939	28940	(	0	None
28940	28941	Nrf2	1	GENE-Y
28941	28942	)	0	None
28942	28943	are	0	None
28943	28944	shown	0	None
28944	28945	to	0	None
28945	28946	decrease	0	None
28946	28947	markers	0	None
28947	28948	of	0	None
28948	28949	oxidative	0	None
28949	28950	stress	0	None
28950	28951	in	0	None
28951	28952	patients	0	None
28952	28953	with	0	None
28953	28954	emphysema	0	None
28954	28955	,	0	None
28955	28956	while	0	None
28956	28957	others	0	None
28957	28958	like	0	None
28958	28960	glutathione peroxidase	1	GENE-Y
28960	28961	(	0	None
28961	28962	GPx	0	None
28962	28963	)	0	None
28963	28964	mimetics	0	None
28964	28965	and	0	None
28965	28966	NO	0	None
28966	28967	synthase	0	None
28967	28968	(	0	None
28968	28969	iNOS	0	None
28969	28970	)	0	None
28970	28971	can	0	None
28971	28972	prevent	0	None
28972	28973	both	0	None
28973	28974	inflammation	0	None
28974	28975	and	0	None
28975	28976	oxidative	0	None
28976	28977	stress	0	None
28977	28978	in	0	None
28978	28979	clinical	0	None
28979	28980	trials	0	None
28980	28981	in	0	None
28981	28982	vivo	0	None
28982	28983	(	0	None
28983	28984	or	0	None
28984	28985	in	0	None
28985	28986	mouse	0	None
28986	28987	models	0	None
28987	28988	)	0	None
28988	28989	.	0	None

28990	28991	In	0	None
28991	28992	this	0	None
28992	28993	article	0	None
28993	28994	we	0	None
28994	28995	review	0	None
28995	28996	the	0	None
28996	28997	effectiveness	0	None
28997	28998	of	0	None
28998	28999	various	0	None
28999	29000	antioxidant	0	None
29000	29001	factors	0	None
29001	29002	in	0	None
29002	29003	COPD	0	None
29003	29004	and	0	None
29004	29005	their	0	None
29005	29006	potential	0	None
29006	29007	beneficial	0	None
29007	29008	effect	0	None
29008	29009	in	0	None
29009	29010	the	0	None
29010	29011	treatment	0	None
29011	29012	of	0	None
29012	29013	the	0	None
29013	29014	disease	0	None
29014	29015	.	0	None
29015	29016	Determinants	0	None
29016	29017	of	0	None
29017	29018	specificity	0	None
29018	29019	for	0	None
29019	29020	aflatoxin	0	None
29020	29021	B1-8	0	None
29021	29022	,	0	None
29022	29023	9-epoxide	0	None
29023	29024	in	0	None
29024	29025	alpha-class	0	None
29025	29026	glutathione	0	None
29026	29027	S-transferases	0	None
29027	29028	.	0	None
29028	29029	Structure-based	0	None
29029	29030	design	0	None
29030	29031	of	0	None
29031	29032	aliskiren	0	None
29032	29033	,	0	None
29033	29034	a	0	None
29034	29035	novel	0	None
29035	29036	orally	0	None
29036	29037	effective	0	None
29037	29038	renin	0	None
29038	29039	inhibitor	0	None
29039	29040	.	0	None
29040	29041	RATIONALE	0	None
29041	29042	:	0	None
29042	29043	Social	0	None
29043	29044	defeat	0	None
29044	29045	stress	0	None
29045	29046	induces	0	None
29046	29047	physiological	0	None
29047	29048	and	0	None
29048	29049	behavioral	0	None
29049	29050	symptoms	0	None
29050	29051	,	0	None
29051	29052	including	0	None
29052	29053	anxiety	0	None
29053	29054	,	0	None
29054	29055	anhedonia	0	None
29055	29056	,	0	None
29056	29057	immune	0	None
29057	29058	deficits	0	None
29058	29059	,	0	None
29059	29060	and	0	None
29060	29061	altered	0	None
29061	29062	expression	0	None
29062	29063	of	0	None
29063	29064	key	0	None
29064	29065	brain	0	None
29065	29066	genes	0	None
29066	29067	.	0	None

29068	29069	OBJECTIVES	0	None
29069	29070	:	0	None
29070	29071	The	0	None
29071	29072	present	0	None
29072	29073	study	0	None
29073	29074	investigated	0	None
29074	29075	the	0	None
29075	29076	effects	0	None
29076	29077	of	0	None
29077	29078	social	0	None
29078	29079	defeat	0	None
29079	29080	stress	0	None
29080	29081	on	0	None
29081	29082	the	0	None
29082	29083	behaviors	0	None
29083	29084	and	0	None
29084	29085	expressions	0	None
29085	29086	of	0	None
29086	29087	Chat	0	None
29087	29088	,	0	None
29088	29089	Grp78	0	None
29089	29090	,	0	None
29090	29091	and	0	None
29091	29092	chop	0	None
29092	29093	in	0	None
29093	29094	the	0	None
29094	29095	brains	0	None
29095	29096	of	0	None
29096	29097	adult	0	None
29097	29098	mice	0	None
29098	29099	.	0	None

29100	29101	METHODS	0	None
29101	29102	:	0	None
29102	29103	Adult	0	None
29103	29104	mice	0	None
29104	29105	were	0	None
29105	29106	divided	0	None
29106	29107	into	0	None
29107	29108	susceptible	0	None
29108	29109	and	0	None
29109	29110	unsusceptible	0	None
29110	29111	groups	0	None
29111	29112	after	0	None
29112	29113	10	0	None
29113	29114	days	0	None
29114	29115	of	0	None
29115	29116	social	0	None
29116	29117	defeat	0	None
29117	29118	stress	0	None
29118	29119	.	0	None

29120	29121	In	0	None
29121	29122	experiment	0	None
29122	29123	1	0	None
29123	29124	,	0	None
29124	29125	behavioral	0	None
29125	29126	tests	0	None
29126	29127	were	0	None
29127	29128	conducted	0	None
29128	29129	,	0	None
29129	29130	and	0	None
29130	29131	brains	0	None
29131	29132	were	0	None
29132	29133	processed	0	None
29133	29134	for	0	None
29134	29135	Western	0	None
29135	29136	blotting	0	None
29136	29137	at	0	None
29137	29138	day	0	None
29138	29139	27	0	None
29139	29140	after	0	None
29140	29141	stress	0	None
29141	29142	.	0	None

29143	29144	In	0	None
29144	29145	experiment	0	None
29145	29146	2	0	None
29146	29147	,	0	None
29147	29148	social	0	None
29148	29149	avoidance	0	None
29149	29150	tests	0	None
29150	29151	were	0	None
29151	29152	conducted	0	None
29152	29153	,	0	None
29153	29154	and	0	None
29154	29155	brains	0	None
29155	29156	were	0	None
29156	29157	processed	0	None
29157	29158	for	0	None
29158	29159	Western	0	None
29159	29160	blotting	0	None
29160	29161	at	0	None
29161	29162	day	0	None
29162	29163	12	0	None
29163	29164	after	0	None
29164	29165	stress	0	None
29165	29166	.	0	None

29167	29168	RESULTS	0	None
29168	29169	:	0	None
29169	29170	The	0	None
29170	29171	results	0	None
29171	29172	indicate	0	None
29172	29173	decreased	0	None
29173	29174	and	0	None
29174	29175	increased	0	None
29175	29176	locomotion	0	None
29176	29177	and	0	None
29177	29178	anxiety	0	None
29178	29179	behavior	0	None
29179	29180	in	0	None
29180	29181	all	0	None
29181	29182	defeated	0	None
29182	29183	mice	0	None
29183	29184	.	0	None

29185	29186	Decrease	0	None
29186	29187	in	0	None
29187	29188	social	0	None
29188	29189	interaction	0	None
29189	29190	,	0	None
29190	29191	increased	0	None
29191	29192	immobility	0	None
29192	29193	,	0	None
29193	29194	and	0	None
29194	29195	impaired	0	None
29195	29196	memory	0	None
29196	29197	performance	0	None
29197	29198	were	0	None
29198	29199	only	0	None
29199	29200	observed	0	None
29200	29201	in	0	None
29201	29202	susceptible	0	None
29202	29203	mice	0	None
29203	29204	.	0	None

29205	29206	A	0	None
29206	29207	decrease	0	None
29207	29208	in	0	None
29208	29209	the	0	None
29209	29210	Chat	0	None
29210	29211	level	0	None
29211	29212	at	0	None
29212	29213	days	0	None
29213	29214	12	0	None
29214	29215	and	0	None
29215	29216	27	0	None
29216	29217	was	0	None
29217	29218	noted	0	None
29218	29219	in	0	None
29219	29220	the	0	None
29220	29221	prefrontal	0	None
29221	29222	cortex	0	None
29222	29223	(	0	None
29223	29224	PFC	0	None
29224	29225	)	0	None
29225	29226	,	0	None
29226	29227	amygdala	0	None
29227	29228	(	0	None
29228	29229	Amyg	0	None
29229	29230	)	0	None
29230	29231	,	0	None
29231	29232	and	0	None
29232	29233	dorsal	0	None
29233	29234	hippocampus	0	None
29234	29235	(	0	None
29235	29236	HIP	0	None
29236	29237	)	0	None
29237	29238	in	0	None
29238	29239	defeated	0	None
29239	29240	mice	0	None
29240	29241	.	0	None

29242	29243	The	0	None
29243	29244	expression	0	None
29244	29245	levels	0	None
29245	29246	of	0	None
29246	29247	Grp78	0	None
29247	29248	and	0	None
29248	29249	chop	0	None
29249	29250	measured	0	None
29250	29251	on	0	None
29251	29252	days	0	None
29252	29253	12	0	None
29253	29254	and	0	None
29254	29255	27	0	None
29255	29256	were	0	None
29256	29257	significantly	0	None
29257	29258	greater	0	None
29258	29259	in	0	None
29259	29260	the	0	None
29260	29261	Amyg	0	None
29261	29262	of	0	None
29262	29263	susceptible	0	None
29263	29264	mice	0	None
29264	29265	.	0	None

29266	29267	In	0	None
29267	29268	the	0	None
29268	29269	PFC	0	None
29269	29270	and	0	None
29270	29271	HIP	0	None
29271	29272	,	0	None
29272	29273	defeated	0	None
29273	29274	mice	0	None
29274	29275	displayed	0	None
29275	29276	different	0	None
29276	29277	patterns	0	None
29277	29278	in	0	None
29278	29279	the	0	None
29279	29280	levels	0	None
29280	29281	of	0	None
29281	29282	Grp78	0	None
29282	29283	and	0	None
29283	29284	chop	0	None
29284	29285	expressions	0	None
29285	29286	measured	0	None
29286	29287	on	0	None
29287	29288	days	0	None
29288	29289	12	0	None
29289	29290	and	0	None
29290	29291	27	0	None
29291	29292	.	0	None

29293	29294	CONCLUSIONS	0	None
29294	29295	:	0	None
29295	29296	The	0	None
29296	29297	present	0	None
29297	29298	study	0	None
29298	29299	demonstrated	0	None
29299	29300	that	0	None
29300	29301	chronic	0	None
29301	29302	social	0	None
29302	29303	defeat	0	None
29303	29304	stress	0	None
29304	29305	in	0	None
29305	29306	mice	0	None
29306	29307	produces	0	None
29307	29308	stress-related	0	None
29308	29309	behaviors	0	None
29309	29310	.	0	None

29311	29312	Different	0	None
29312	29313	response	0	None
29313	29314	patterns	0	None
29314	29315	were	0	None
29315	29316	noted	0	None
29316	29317	for	0	None
29317	29318	Grp78	0	None
29318	29319	and	0	None
29319	29320	chop	0	None
29320	29321	expression	0	None
29321	29322	among	0	None
29322	29323	the	0	None
29323	29324	groups	0	None
29324	29325	in	0	None
29325	29326	terms	0	None
29326	29327	of	0	None
29327	29328	brain	0	None
29328	29329	regions	0	None
29329	29330	and	0	None
29330	29331	time-course	0	None
29331	29332	effects	0	None
29332	29333	.	0	None
29333	29335	Vitamin A	2	CHEMICAL
29335	29336	deficiency	0	None
29336	29337	leads	0	None
29337	29338	to	0	None
29338	29339	focal	0	None
29339	29340	metaplasia	0	None
29340	29341	of	0	None
29341	29342	numerous	0	None
29342	29343	epithelial	0	None
29343	29344	tissues	0	None
29344	29345	with	0	None
29345	29346	altered	0	None
29346	29347	differentiation	0	None
29347	29348	from	0	None
29348	29349	columnar	0	None
29349	29350	(	0	None
29350	29351	in	0	None
29351	29352	general	0	None
29352	29353	)	0	None
29353	29354	to	0	None
29354	29355	stratified	0	None
29355	29356	squamous	0	None
29356	29357	cells	0	None
29357	29358	.	0	None

29359	29360	This	0	None
29360	29361	process	0	None
29361	29362	can	0	None
29362	29363	be	0	None
29363	29364	reversed	0	None
29364	29365	with	0	None
29365	29367	vitamin A	2	CHEMICAL
29367	29368	repletion	0	None
29368	29369	.	0	None

29370	29371	Previously	0	None
29371	29372	,	0	None
29372	29373	we	0	None
29373	29374	described	0	None
29374	29375	a	0	None
29375	29376	system	0	None
29376	29377	of	0	None
29377	29379	retinoic acid	2	CHEMICAL
29379	29380	(	0	None
29380	29381	RA	2	CHEMICAL
29381	29382	)	0	None
29382	29383	synthesis	0	None
29383	29384	in	0	None
29384	29385	the	0	None
29385	29386	cycling	0	None
29386	29387	rat	0	None
29387	29388	uterus	0	None
29388	29389	consisting	0	None
29389	29390	of	0	None
29390	29391	cellular	0	None
29391	29392	retinol	2	CHEMICAL
29392	29393	binding	0	None
29393	29394	protein	0	None
29394	29395	(	0	None
29395	29396	Crbp	0	None
29396	29397	)	0	None
29397	29398	,	0	None
29398	29399	epithelial	0	None
29399	29400	retinol	2	CHEMICAL
29400	29401	dehydrogenase	0	None
29401	29402	(	0	None
29402	29403	eRoldh	0	None
29403	29404	)	0	None
29404	29405	,	0	None
29405	29406	retinal	2	CHEMICAL
29406	29407	dehydrogenase	0	None
29407	29408	2	0	None
29408	29409	(	0	None
29409	29410	Aldh1a2	0	None
29410	29411	)	0	None
29411	29412	,	0	None
29412	29413	and	0	None
29413	29414	cellular	0	None
29414	29416	retinoic acid	2	CHEMICAL
29416	29417	binding	0	None
29417	29418	protein	0	None
29418	29419	type	0	None
29419	29420	II	0	None
29420	29421	(	0	None
29421	29422	Crabp2	0	None
29422	29423	)	0	None
29423	29424	.	0	None

29425	29426	Western	0	None
29426	29427	blot	0	None
29427	29428	analysis	0	None
29428	29429	,	0	None
29429	29430	RT-PCR	0	None
29430	29431	,	0	None
29431	29432	and	0	None
29432	29433	immunohistochemistry	0	None
29433	29434	were	0	None
29434	29435	performed	0	None
29435	29436	to	0	None
29436	29437	test	0	None
29437	29438	whether	0	None
29438	29439	this	0	None
29439	29441	retinoic acid	2	CHEMICAL
29441	29442	synthesis	0	None
29442	29443	system	0	None
29443	29444	was	0	None
29444	29445	also	0	None
29445	29446	present	0	None
29446	29447	in	0	None
29447	29448	other	0	None
29448	29450	vitamin A	2	CHEMICAL
29450	29451	sensitive	0	None
29451	29452	tissues	0	None
29452	29453	.	0	None

29454	29455	We	0	None
29455	29456	found	0	None
29456	29457	that	0	None
29457	29458	combinations	0	None
29458	29459	of	0	None
29459	29460	Crbp	0	None
29460	29461	,	0	None
29461	29462	eRoldh	0	None
29462	29463	,	0	None
29463	29464	Aldh1a2	0	None
29464	29465	or	0	None
29465	29466	Aldh1a3	0	None
29466	29467	,	0	None
29467	29468	and	0	None
29468	29469	Crabp2	0	None
29469	29470	were	0	None
29470	29471	present	0	None
29471	29472	in	0	None
29472	29473	all	0	None
29473	29475	vitamin A	2	CHEMICAL
29475	29476	sensitive	0	None
29476	29477	tissues	0	None
29477	29478	examined	0	None
29478	29479	.	0	None

29480	29481	In	0	None
29481	29482	the	0	None
29482	29483	ureter	0	None
29483	29484	,	0	None
29484	29485	while	0	None
29485	29486	eRoldh	0	None
29486	29487	was	0	None
29487	29488	present	0	None
29488	29489	,	0	None
29489	29490	another	0	None
29490	29491	short	0	None
29491	29492	chain	0	None
29492	29494	alcohol dehydrogenase	3	GENE-N
29494	29495	reductase	0	None
29495	29496	(	0	None
29496	29497	possibly	0	None
29497	29498	Roldh	0	None
29498	29499	1	0	None
29499	29500	,	0	None
29500	29501	2	0	None
29501	29502	,	0	None
29502	29503	or	0	None
29503	29504	3	0	None
29504	29505	)	0	None
29505	29506	was	0	None
29506	29507	in	0	None
29507	29508	higher	0	None
29508	29509	concentration	0	None
29509	29510	in	0	None
29510	29511	the	0	None
29511	29512	transitional	0	None
29512	29513	epithelia	0	None
29513	29514	.	0	None

29515	29516	In	0	None
29516	29517	several	0	None
29517	29518	tissues	0	None
29518	29519	,	0	None
29519	29520	Crbp	0	None
29520	29521	,	0	None
29521	29522	Aldh1a2	0	None
29522	29523	,	0	None
29523	29524	and	0	None
29524	29525	/	0	None
29525	29526	or	0	None
29526	29527	Aldh1a3	0	None
29527	29528	localized	0	None
29528	29529	to	0	None
29529	29530	mesenchyme	0	None
29530	29531	and	0	None
29531	29532	/	0	None
29532	29533	or	0	None
29533	29534	epithelial	0	None
29534	29535	cells	0	None
29535	29536	,	0	None
29536	29537	while	0	None
29537	29538	eRoldh	0	None
29538	29539	and	0	None
29539	29540	Crabp2	0	None
29540	29541	were	0	None
29541	29542	expressed	0	None
29542	29543	only	0	None
29543	29544	in	0	None
29544	29545	epithelial	0	None
29545	29546	cells	0	None
29546	29547	.	0	None

29548	29549	This	0	None
29549	29550	suggests	0	None
29550	29551	that	0	None
29551	29552	mesenchymal-epithelial	0	None
29552	29553	interactions	0	None
29553	29554	may	0	None
29554	29555	be	0	None
29555	29556	as	0	None
29556	29557	important	0	None
29557	29558	in	0	None
29558	29559	the	0	None
29559	29560	adult	0	None
29560	29561	as	0	None
29561	29562	they	0	None
29562	29563	are	0	None
29563	29564	during	0	None
29564	29565	development	0	None
29565	29566	and	0	None
29566	29567	that	0	None
29567	29568	local	0	None
29568	29569	synthesis	0	None
29569	29570	of	0	None
29570	29571	RA	2	CHEMICAL
29571	29572	is	0	None
29572	29573	important	0	None
29573	29574	in	0	None
29574	29575	maintenance	0	None
29575	29576	of	0	None
29576	29577	these	0	None
29577	29578	tissues	0	None
29578	29579	.	0	None
29579	29580	The	0	None
29580	29581	toxicity	0	None
29581	29582	of	0	None
29582	29583	the	0	None
29583	29584	N-hydroxy	0	None
29584	29585	and	0	None
29585	29586	6-hydroxy	0	None
29586	29587	metabolites	0	None
29587	29588	of	0	None
29588	29589	3	0	None
29589	29590	,	0	None
29590	29591	4-dichloropropionanilide	0	None
29591	29592	does	0	None
29592	29593	not	0	None
29593	29594	depend	0	None
29594	29595	on	0	None
29595	29596	calcium	0	None
29596	29597	release-activated	0	None
29597	29599	calcium channel	3	GENE-N
29599	29600	inhibition	0	None
29600	29601	.	0	None
29601	29602	Acetaminophen	0	None
29602	29603	(	0	None
29603	29604	APAP	0	None
29604	29605	)	0	None
29605	29606	overdose	0	None
29606	29607	is	0	None
29607	29608	a	0	None
29608	29609	classical	0	None
29609	29610	model	0	None
29610	29611	of	0	None
29611	29612	hepatocellular	0	None
29612	29613	necrosis;	0	None
29613	29614	however	0	None
29614	29615	,	0	None
29615	29616	the	0	None
29616	29617	involvement	0	None
29617	29618	of	0	None
29618	29619	the	0	None
29619	29620	Fas	0	None
29620	29621	receptor	0	None
29621	29622	in	0	None
29622	29623	the	0	None
29623	29624	pathophysiology	0	None
29624	29625	remains	0	None
29625	29626	controversial	0	None
29626	29627	.	0	None

29628	29629	Fas	0	None
29629	29630	receptor-deficient	0	None
29630	29631	(	0	None
29631	29632	lpr	0	None
29632	29633	)	0	None
29633	29634	and	0	None
29634	29635	C57BL	0	None
29635	29636	/	0	None
29636	29637	6	0	None
29637	29638	mice	0	None
29638	29639	were	0	None
29639	29640	treated	0	None
29640	29641	with	0	None
29641	29642	APAP	0	None
29642	29643	to	0	None
29643	29644	compare	0	None
29644	29645	the	0	None
29645	29646	mechanisms	0	None
29646	29647	of	0	None
29647	29648	hepatotoxicity	0	None
29648	29649	.	0	None

29650	29651	Lpr	0	None
29651	29652	mice	0	None
29652	29653	were	0	None
29653	29654	partially	0	None
29654	29655	protected	0	None
29655	29656	against	0	None
29656	29657	APAP	0	None
29657	29658	hepatotoxicity	0	None
29658	29659	as	0	None
29659	29660	indicated	0	None
29660	29661	by	0	None
29661	29662	reduced	0	None
29662	29663	plasma	0	None
29663	29664	ALT	0	None
29664	29665	and	0	None
29665	29666	GDH	0	None
29666	29667	levels	0	None
29667	29668	and	0	None
29668	29669	liver	0	None
29669	29670	necrosis	0	None
29670	29671	.	0	None

29672	29673	Hepatic	0	None
29673	29674	Cyp2e1	0	None
29674	29675	protein	0	None
29675	29676	,	0	None
29676	29677	adduct	0	None
29677	29678	formation	0	None
29678	29679	and	0	None
29679	29680	hepatic	0	None
29680	29681	glutathione	0	None
29681	29682	(	0	None
29682	29683	GSH	0	None
29683	29684	)	0	None
29684	29685	depletion	0	None
29685	29686	were	0	None
29686	29687	similar	0	None
29687	29688	,	0	None
29688	29689	demonstrating	0	None
29689	29690	equivalent	0	None
29690	29691	reactive	0	None
29691	29692	metabolite	0	None
29692	29693	generation	0	None
29693	29694	.	0	None

29695	29696	There	0	None
29696	29697	was	0	None
29697	29698	no	0	None
29698	29699	difference	0	None
29699	29700	in	0	None
29700	29701	cytokine	0	None
29701	29702	formation	0	None
29702	29703	or	0	None
29703	29704	hepatic	0	None
29704	29705	neutrophil	0	None
29705	29706	recruitment	0	None
29706	29707	.	0	None

29708	29709	Interestingly	0	None
29709	29710	,	0	None
29710	29711	hepatic	0	None
29711	29712	GSH	0	None
29712	29713	recovered	0	None
29713	29714	faster	0	None
29714	29715	in	0	None
29715	29716	lpr	0	None
29716	29717	mice	0	None
29717	29718	than	0	None
29718	29719	in	0	None
29719	29720	wild	0	None
29720	29721	type	0	None
29721	29722	animals	0	None
29722	29723	resulting	0	None
29723	29724	in	0	None
29724	29725	enhanced	0	None
29725	29726	detoxification	0	None
29726	29727	of	0	None
29727	29728	reactive	0	None
29728	29729	oxygen	0	None
29729	29730	species	0	None
29730	29731	.	0	None

29732	29733	Driving	0	None
29733	29734	the	0	None
29734	29735	increased	0	None
29735	29736	GSH	0	None
29736	29737	levels	0	None
29737	29738	,	0	None
29738	29739	mRNA	0	None
29739	29740	induction	0	None
29740	29741	and	0	None
29741	29742	protein	0	None
29742	29743	expression	0	None
29743	29744	of	0	None
29744	29745	glutamate-cysteine	0	None
29745	29746	ligase	0	None
29746	29747	(	0	None
29747	29748	gclc	3	GENE-N
29748	29749	)	0	None
29749	29750	were	0	None
29750	29751	higher	0	None
29751	29752	in	0	None
29752	29753	lpr	0	None
29753	29754	mice	0	None
29754	29755	.	0	None

29756	29757	Inducible	0	None
29757	29760	nitric oxide synthase	3	GENE-N
29760	29761	(	0	None
29761	29762	iNOS	0	None
29762	29763	)	0	None
29763	29764	mRNA	0	None
29764	29765	and	0	None
29765	29766	protein	0	None
29766	29767	levels	0	None
29767	29768	at	0	None
29768	29769	6h	0	None
29769	29770	were	0	None
29770	29771	significantly	0	None
29771	29772	lower	0	None
29772	29773	in	0	None
29773	29774	lpr	0	None
29774	29775	mice	0	None
29775	29776	,	0	None
29776	29777	which	0	None
29777	29778	correlated	0	None
29778	29779	with	0	None
29779	29780	reduced	0	None
29780	29781	nitrotyrosine	0	None
29781	29782	staining	0	None
29782	29783	.	0	None

29784	29788	Heat shock protein 70	3	GENE-N
29788	29789	(	0	None
29789	29790	Hsp70	3	GENE-N
29790	29791	)	0	None
29791	29792	mRNA	0	None
29792	29793	levels	0	None
29793	29794	were	0	None
29794	29795	substantially	0	None
29795	29796	higher	0	None
29796	29797	in	0	None
29797	29798	lpr	0	None
29798	29799	mice	0	None
29799	29800	after	0	None
29800	29801	APAP	0	None
29801	29802	.	0	None

29803	29804	Conclusion	0	None
29804	29805	:	0	None
29805	29806	Our	0	None
29806	29807	data	0	None
29807	29808	suggest	0	None
29808	29809	that	0	None
29809	29810	the	0	None
29810	29811	faster	0	None
29811	29812	recovery	0	None
29812	29813	of	0	None
29813	29814	hepatic	0	None
29814	29815	GSH	0	None
29815	29816	levels	0	None
29816	29817	during	0	None
29817	29818	oxidant	0	None
29818	29819	stress	0	None
29819	29820	and	0	None
29820	29821	peroxynitrite	2	CHEMICAL
29821	29822	formation	0	None
29822	29823	,	0	None
29823	29824	reduced	0	None
29824	29825	iNOS	0	None
29825	29826	expression	0	None
29826	29827	and	0	None
29827	29828	enhanced	0	None
29828	29829	induction	0	None
29829	29830	of	0	None
29830	29831	Hsp70	3	GENE-N
29831	29832	attenuated	0	None
29832	29833	the	0	None
29833	29834	susceptibility	0	None
29834	29835	to	0	None
29835	29836	APAP-induced	0	None
29836	29837	cell	0	None
29837	29838	death	0	None
29838	29839	in	0	None
29839	29840	lpr	0	None
29840	29841	mice	0	None
29841	29842	.	0	None
29842	29843	BACKGROUND	0	None
29843	29844	&	0	None
29844	29845	AIMS	0	None
29845	29846	:	0	None
29846	29847	Sensitization	0	None
29847	29848	of	0	None
29848	29849	Kupffer	0	None
29849	29850	cells	0	None
29850	29851	(	0	None
29851	29852	KCs	0	None
29852	29853	)	0	None
29853	29854	to	0	None
29854	29855	lipopolysaccharide	0	None
29855	29856	(	0	None
29856	29857	LPS	0	None
29857	29858	)	0	None
29858	29859	and	0	None
29859	29860	overproduction	0	None
29860	29861	of	0	None
29861	29864	tumor necrosis factor	1	GENE-Y
29864	29865	(	0	None
29865	29866	TNF	1	GENE-Y
29866	29867	)	0	None
29867	29868	alpha	0	None
29868	29869	are	0	None
29869	29870	critical	0	None
29870	29871	for	0	None
29871	29872	progression	0	None
29872	29873	of	0	None
29873	29874	alcoholic	2	CHEMICAL
29874	29875	liver	0	None
29875	29876	injury	0	None
29876	29877	.	0	None

29878	29879	Thalidomide	0	None
29879	29880	has	0	None
29880	29881	been	0	None
29881	29882	shown	0	None
29882	29883	to	0	None
29883	29884	suppress	0	None
29884	29885	TNF-alpha	0	None
29885	29886	production	0	None
29886	29887	from	0	None
29887	29888	macrophages	0	None
29888	29889	.	0	None

29890	29891	Accordingly	0	None
29891	29892	,	0	None
29892	29893	the	0	None
29893	29894	purpose	0	None
29894	29895	of	0	None
29895	29896	this	0	None
29896	29897	study	0	None
29897	29898	was	0	None
29898	29899	to	0	None
29899	29900	determine	0	None
29900	29901	whether	0	None
29901	29902	thalidomide	2	CHEMICAL
29902	29903	could	0	None
29903	29904	prevent	0	None
29904	29905	alcohol-induced	0	None
29905	29906	liver	0	None
29906	29907	injury	0	None
29907	29908	.	0	None

29909	29910	METHODS	0	None
29910	29911	:	0	None
29911	29912	Rats	0	None
29912	29913	were	0	None
29913	29914	given	0	None
29914	29915	ethanol	2	CHEMICAL
29915	29916	(	0	None
29916	29917	5	0	None
29917	29918	g	0	None
29918	29919	/	0	None
29919	29920	kg	0	None
29920	29921	body	0	None
29921	29922	wt	0	None
29922	29923	)	0	None
29923	29924	and	0	None
29924	29925	thalidomide	2	CHEMICAL
29925	29926	(	0	None
29926	29927	5	0	None
29927	29928	mg	2	CHEMICAL
29928	29929	/	0	None
29929	29930	kg	0	None
29930	29931	)	0	None
29931	29932	once	0	None
29932	29933	every	0	None
29933	29934	24	0	None
29934	29935	hours	0	None
29935	29936	intragastrically	0	None
29936	29937	.	0	None

29938	29939	To	0	None
29939	29940	assess	0	None
29940	29941	the	0	None
29941	29942	sensitization	0	None
29942	29943	of	0	None
29943	29944	Kupffer	0	None
29944	29945	cells	0	None
29945	29946	,	0	None
29946	29947	LPS	0	None
29947	29948	(	0	None
29948	29949	5	0	None
29949	29950	mg	2	CHEMICAL
29950	29951	/	0	None
29951	29952	kg	0	None
29952	29953	intravenously	0	None
29953	29954	)	0	None
29954	29955	was	0	None
29955	29956	administered	0	None
29956	29957	and	0	None
29957	29958	liver	0	None
29958	29959	histology	0	None
29959	29960	was	0	None
29960	29961	evaluated	0	None
29961	29962	24	0	None
29962	29963	hours	0	None
29963	29964	later	0	None
29964	29965	.	0	None

29966	29967	KCs	0	None
29967	29968	were	0	None
29968	29969	isolated	0	None
29969	29970	after	0	None
29970	29971	4	0	None
29971	29972	weeks	0	None
29972	29973	of	0	None
29973	29974	ethanol	2	CHEMICAL
29974	29975	treatment	0	None
29975	29976	and	0	None
29976	29977	intracellular	0	None
29977	29978	Ca2	0	None
29978	29979	+	0	None
29979	29980	(	0	None
29980	29981	[	0	None
29981	29982	Ca2	0	None
29982	29983	+	0	None
29983	29984	]	0	None
29984	29985	i	0	None
29985	29986	)	0	None
29986	29987	was	0	None
29987	29988	measured	0	None
29988	29989	using	0	None
29989	29990	fura-2	0	None
29990	29991	,	0	None
29991	29992	whereas	0	None
29992	29993	TNF-alpha	0	None
29993	29994	was	0	None
29994	29995	evaluated	0	None
29995	29996	by	0	None
29996	29997	reverse-transcription	0	None
29997	29998	polymerase	0	None
29998	29999	chain	0	None
29999	30000	reaction	0	None
30000	30001	and	0	None
30001	30002	enzyme-linked	0	None
30002	30003	immunosorbent	0	None
30003	30004	assay	0	None
30004	30005	.	0	None

30006	30007	CD14	0	None
30007	30008	was	0	None
30008	30009	determined	0	None
30009	30010	by	0	None
30010	30011	Western	0	None
30011	30012	and	0	None
30012	30013	fluorescence	0	None
30013	30014	staining	0	None
30014	30015	.	0	None

30016	30017	RESULTS	0	None
30017	30018	:	0	None
30018	30019	Treatment	0	None
30019	30020	with	0	None
30020	30021	ethanol	2	CHEMICAL
30021	30022	for	0	None
30022	30023	8	0	None
30023	30024	weeks	0	None
30024	30025	caused	0	None
30025	30026	marked	0	None
30026	30027	steatosis	0	None
30027	30028	,	0	None
30028	30029	necrosis	0	None
30029	30030	,	0	None
30030	30031	and	0	None
30031	30032	inflammation	0	None
30032	30033	in	0	None
30033	30034	the	0	None
30034	30035	liver	0	None
30035	30036	.	0	None

30037	30038	These	0	None
30038	30039	pathologic	0	None
30039	30040	parameters	0	None
30040	30041	were	0	None
30041	30042	diminished	0	None
30042	30043	markedly	0	None
30043	30044	by	0	None
30044	30045	treatment	0	None
30045	30046	with	0	None
30046	30047	thalidomide	2	CHEMICAL
30047	30048	.	0	None

30049	30050	In	0	None
30050	30051	the	0	None
30051	30052	4-week	0	None
30052	30053	ethanol	2	CHEMICAL
30053	30054	group	0	None
30054	30055	,	0	None
30055	30056	the	0	None
30056	30057	LPS-induced	0	None
30057	30058	liver	0	None
30058	30059	damage	0	None
30059	30060	was	0	None
30060	30061	aggravated	0	None
30061	30062	and	0	None
30062	30063	KCs	0	None
30063	30064	were	0	None
30064	30065	sensitized	0	None
30065	30066	to	0	None
30066	30067	LPS	0	None
30067	30068	.	0	None

30069	30070	Coadministration	0	None
30070	30071	of	0	None
30071	30072	thalidomide	2	CHEMICAL
30072	30073	with	0	None
30073	30074	ethanol	2	CHEMICAL
30074	30075	prevented	0	None
30075	30076	the	0	None
30076	30077	KC	1	GENE-Y
30077	30078	sensitization	0	None
30078	30079	completely	0	None
30079	30080	.	0	None

30081	30082	Furthermore	0	None
30082	30083	,	0	None
30083	30084	thalidomide	2	CHEMICAL
30084	30085	abolished	0	None
30085	30086	the	0	None
30086	30087	LPS-induced	0	None
30087	30088	increase	0	None
30088	30089	in	0	None
30089	30090	CD14	0	None
30090	30091	expression	0	None
30091	30092	and	0	None
30092	30093	[	0	None
30093	30094	Ca2	0	None
30094	30095	+	0	None
30095	30096	]	0	None
30096	30097	i	0	None
30097	30098	elevation	0	None
30098	30099	in	0	None
30099	30100	KCs	0	None
30100	30101	.	0	None

30102	30103	Gut	0	None
30103	30104	permeability	0	None
30104	30105	was	0	None
30105	30106	increased	0	None
30106	30107	about	0	None
30107	30108	10-fold	0	None
30108	30109	after	0	None
30109	30110	4	0	None
30110	30111	weeks	0	None
30111	30112	of	0	None
30112	30113	ethanol	2	CHEMICAL
30113	30114	exposure	0	None
30114	30115	,	0	None
30115	30116	which	0	None
30116	30117	was	0	None
30117	30118	not	0	None
30118	30119	affected	0	None
30119	30120	by	0	None
30120	30121	thalidomide	2	CHEMICAL
30121	30122	.	0	None

30123	30124	Moreover	0	None
30124	30125	,	0	None
30125	30126	thalidomide	2	CHEMICAL
30126	30127	reduced	0	None
30127	30128	the	0	None
30128	30129	LPS-induced	0	None
30129	30130	TNF-alpha	0	None
30130	30131	production	0	None
30131	30132	by	0	None
30132	30133	KCs	0	None
30133	30134	by	0	None
30134	30135	decreasing	0	None
30135	30136	TNF-alpha	0	None
30136	30137	messenger	0	None
30137	30138	RNA	0	None
30138	30139	.	0	None

30140	30141	CONCLUSIONS	0	None
30141	30142	:	0	None
30142	30143	These	0	None
30143	30144	results	0	None
30144	30145	collectively	0	None
30145	30146	indicate	0	None
30146	30147	that	0	None
30147	30148	thalidomide	2	CHEMICAL
30148	30149	prevents	0	None
30149	30150	alcoholic	2	CHEMICAL
30150	30151	liver	0	None
30151	30152	injury	0	None
30152	30153	through	0	None
30153	30154	suppression	0	None
30154	30155	of	0	None
30155	30156	TNF-alpha	0	None
30156	30157	production	0	None
30157	30158	and	0	None
30158	30159	abolishment	0	None
30159	30160	of	0	None
30160	30161	KC	1	GENE-Y
30161	30162	sensitization	0	None
30162	30163	.	0	None
30163	30164	Clinical	0	None
30164	30165	manifestations	0	None
30165	30166	of	0	None
30166	30167	genetic	0	None
30167	30168	defects	0	None
30168	30169	affecting	0	None
30169	30170	gonadotrophins	3	GENE-N
30170	30171	and	0	None
30171	30172	their	0	None
30172	30173	receptors	0	None
30173	30174	.	0	None
30174	30175	A	0	None
30175	30176	series	0	None
30176	30177	of	0	None
30177	30178	3-substituted	0	None
30178	30179	1	0	None
30179	30180	,	0	None
30180	30181	5-diarylpyrroles	0	None
30181	30182	bearing	0	None
30182	30183	a	0	None
30183	30184	nitrooxyalkyl	0	None
30184	30185	side	0	None
30185	30186	chain	0	None
30186	30187	linked	0	None
30187	30188	to	0	None
30188	30189	different	0	None
30189	30190	spacers	0	None
30190	30191	were	0	None
30191	30192	designed	0	None
30192	30193	.	0	None

30194	30195	New	0	None
30195	30196	classes	0	None
30196	30197	of	0	None
30197	30198	pyrrole-derived	0	None
30198	30199	nitrooxyalkyl	0	None
30199	30200	inverse	0	None
30200	30201	esters	0	None
30201	30202	,	0	None
30202	30203	carbonates	0	None
30203	30204	,	0	None
30204	30205	and	0	None
30205	30206	ethers	0	None
30206	30207	(	0	None
30207	30208	7-10	0	None
30208	30209	)	0	None
30209	30210	as	0	None
30210	30211	COX-2	0	None
30211	30212	selective	0	None
30212	30213	inhibitors	0	None
30213	30214	and	0	None
30214	30215	NO	0	None
30215	30216	donors	0	None
30216	30217	were	0	None
30217	30218	synthesized	0	None
30218	30219	and	0	None
30219	30220	are	0	None
30220	30221	herein	0	None
30221	30222	reported	0	None
30222	30223	.	0	None

30224	30225	By	0	None
30225	30226	taking	0	None
30226	30227	into	0	None
30227	30228	account	0	None
30228	30229	the	0	None
30229	30230	metabolic	0	None
30230	30231	conversion	0	None
30231	30232	of	0	None
30232	30233	nitrooxyalkyl	0	None
30233	30234	ethers	0	None
30234	30235	(	0	None
30235	30236	9	0	None
30236	30237	,	0	None
30237	30238	10	0	None
30238	30239	)	0	None
30239	30240	into	0	None
30240	30241	corresponding	0	None
30241	30242	alcohols	0	None
30242	30243	,	0	None
30243	30244	derivatives	0	None
30244	30245	17	0	None
30245	30246	and	0	None
30246	30247	18	0	None
30247	30248	were	0	None
30248	30249	also	0	None
30249	30250	studied	0	None
30250	30251	.	0	None

30252	30253	Nitrooxy	0	None
30253	30254	derivatives	0	None
30254	30255	showed	0	None
30255	30256	NO-dependent	0	None
30256	30257	vasorelaxing	0	None
30257	30258	properties	0	None
30258	30259	,	0	None
30259	30260	while	0	None
30260	30261	most	0	None
30261	30262	of	0	None
30262	30263	the	0	None
30263	30264	compounds	0	None
30264	30265	proved	0	None
30265	30266	to	0	None
30266	30267	be	0	None
30267	30268	very	0	None
30268	30269	potent	0	None
30269	30270	and	0	None
30270	30271	selective	0	None
30271	30272	COX-2	0	None
30272	30273	inhibitors	0	None
30273	30274	in	0	None
30274	30275	in	0	None
30275	30276	vitro	0	None
30276	30277	experimental	0	None
30277	30278	models	0	None
30278	30279	.	0	None

30280	30281	Further	0	None
30281	30282	in	0	None
30282	30283	vivo	0	None
30283	30284	studies	0	None
30284	30285	on	0	None
30285	30286	compounds	0	None
30286	30287	9a	0	None
30287	30288	,	0	None
30288	30289	c	0	None
30289	30290	and	0	None
30290	30291	17a	0	None
30291	30292	highlighted	0	None
30292	30293	good	0	None
30293	30294	anti-inflammatory	0	None
30294	30295	and	0	None
30295	30296	antinociceptive	0	None
30296	30297	activities	0	None
30297	30298	.	0	None

30299	30300	Compound	0	None
30300	30301	9c	0	None
30301	30302	was	0	None
30302	30303	able	0	None
30303	30304	to	0	None
30304	30305	inhibit	0	None
30305	30306	glycosaminoglycan	0	None
30306	30307	(	0	None
30307	30308	GAG	0	None
30308	30309	)	0	None
30309	30310	release	0	None
30310	30311	induced	0	None
30311	30312	by	0	None
30312	30313	interleukin-1β	0	None
30313	30314	(	0	None
30314	30315	IL-1β	0	None
30315	30316	)	0	None
30316	30317	,	0	None
30317	30318	showing	0	None
30318	30319	cartilage	0	None
30319	30320	protective	0	None
30320	30321	properties	0	None
30321	30322	.	0	None

30323	30324	Finally	0	None
30324	30325	,	0	None
30325	30326	molecular	0	None
30326	30327	modeling	0	None
30327	30328	and	0	None
30328	30329	(	0	None
30329	30330	1	0	None
30330	30331	)	0	None
30331	30332	H-	0	None
30332	30333	and	0	None
30333	30334	(	0	None
30334	30335	13	0	None
30335	30336	)	0	None
30336	30337	C-NMR	0	None
30337	30338	studies	0	None
30338	30339	performed	0	None
30339	30340	on	0	None
30340	30341	compounds	0	None
30341	30342	6c	0	None
30342	30343	,	0	None
30343	30344	d	0	None
30344	30345	,	0	None
30345	30346	9c	0	None
30346	30347	,	0	None
30347	30348	and	0	None
30348	30349	10b	0	None
30349	30350	allowed	0	None
30350	30351	the	0	None
30351	30352	right	0	None
30352	30353	conformation	0	None
30353	30354	of	0	None
30354	30355	nitrooxyalkyl	0	None
30355	30356	ester	0	None
30356	30357	and	0	None
30357	30358	ether	0	None
30358	30359	side	0	None
30359	30360	chain	0	None
30360	30361	of	0	None
30361	30362	these	0	None
30362	30363	molecules	0	None
30363	30364	within	0	None
30364	30365	the	0	None
30365	30366	COX-2	0	None
30366	30367	active	0	None
30367	30368	site	0	None
30368	30369	to	0	None
30369	30370	be	0	None
30370	30371	assessed	0	None
30371	30372	.	0	None
30372	30373	Gabapentin	0	None
30373	30374	is	0	None
30374	30375	used	0	None
30375	30376	in	0	None
30376	30377	the	0	None
30377	30378	treatment	0	None
30378	30379	of	0	None
30379	30380	epilepsy	0	None
30380	30381	and	0	None
30381	30382	neuropathic	0	None
30382	30383	pain	0	None
30383	30384	.	0	None

30385	30386	Gabapentin	0	None
30386	30387	has	0	None
30387	30388	high	0	None
30388	30389	and	0	None
30389	30390	saturable	0	None
30390	30391	permeability	0	None
30391	30392	across	0	None
30392	30393	the	0	None
30393	30394	BBB	0	None
30394	30395	,	0	None
30395	30396	but	0	None
30396	30397	no	0	None
30397	30398	mechanistic	0	None
30398	30399	studies	0	None
30399	30400	underpinning	0	None
30400	30401	this	0	None
30401	30402	process	0	None
30402	30403	have	0	None
30403	30404	been	0	None
30404	30405	reported	0	None
30405	30406	.	0	None

30407	30408	The	0	None
30408	30409	aim	0	None
30409	30410	of	0	None
30410	30411	the	0	None
30411	30412	current	0	None
30412	30413	study	0	None
30413	30414	was	0	None
30414	30415	to	0	None
30415	30416	investigate	0	None
30416	30417	the	0	None
30417	30418	transport	0	None
30418	30419	of	0	None
30419	30420	gabapentin	0	None
30420	30421	in	0	None
30421	30422	a	0	None
30422	30423	model	0	None
30423	30424	of	0	None
30424	30425	the	0	None
30425	30426	BBB	0	None
30426	30427	,	0	None
30427	30428	identify	0	None
30428	30429	the	0	None
30429	30430	important	0	None
30430	30431	drug	0	None
30431	30432	transporter	0	None
30432	30433	(	0	None
30433	30434	s	0	None
30434	30435	)	0	None
30435	30436	and	0	None
30436	30437	to	0	None
30437	30438	use	0	None
30438	30439	mathematical	0	None
30439	30440	modelling	0	None
30440	30441	to	0	None
30441	30442	quantify	0	None
30442	30443	the	0	None
30443	30444	processes	0	None
30444	30445	involved	0	None
30445	30446	.	0	None

30447	30448	A	0	None
30448	30449	human	0	None
30449	30450	brain	0	None
30450	30451	endothelial	0	None
30451	30452	cell	0	None
30452	30453	line	0	None
30453	30454	(	0	None
30454	30455	hCMEC	0	None
30455	30456	/	0	None
30456	30457	D3	0	None
30457	30458	)	0	None
30458	30459	was	0	None
30459	30460	utilised	0	None
30460	30461	as	0	None
30461	30462	an	0	None
30462	30463	in-vitro	0	None
30463	30464	model	0	None
30464	30465	of	0	None
30465	30466	the	0	None
30466	30467	BBB	0	None
30467	30468	.	0	None

30469	30470	Uptake	0	None
30470	30471	of	0	None
30471	30472	radiolabeled	0	None
30472	30473	gabapentin	0	None
30473	30474	into	0	None
30474	30475	cells	0	None
30475	30476	in	0	None
30476	30477	the	0	None
30477	30478	presence	0	None
30478	30479	of	0	None
30479	30480	chemical	0	None
30480	30481	inhibitors	0	None
30481	30482	,	0	None
30482	30483	siRNA	0	None
30483	30484	or	0	None
30484	30485	overexpressed	0	None
30485	30486	drug	0	None
30486	30487	transporters	0	None
30487	30488	of	0	None
30488	30489	interest	0	None
30489	30490	was	0	None
30490	30491	investigated	0	None
30491	30492	.	0	None

30493	30494	Gabapentin	0	None
30494	30495	was	0	None
30495	30496	demonstrated	0	None
30496	30497	to	0	None
30497	30498	be	0	None
30498	30499	a	0	None
30499	30500	LAT1	0	None
30500	30501	substrate	0	None
30501	30502	in	0	None
30502	30503	brain	0	None
30503	30504	endothelial	0	None
30504	30505	cells	0	None
30505	30506	(	0	None
30506	30507	LAT1-process;	0	None
30507	30508	Km	0	None
30508	30509	=	0	None
30509	30510	530μM	0	None
30510	30511	and	0	None
30511	30512	Vmax	0	None
30512	30513	=	0	None
30513	30514	7039pmoles	0	None
30514	30515	/	0	None
30515	30516	million	0	None
30516	30517	cells	0	None
30517	30518	/	0	None
30518	30519	min	0	None
30519	30520	versus	0	None
30520	30521	other-processes;	0	None
30521	30522	Km	0	None
30522	30523	=	0	None
30523	30524	923μM	0	None
30524	30525	and	0	None
30525	30526	Vmax	0	None
30526	30527	=	0	None
30527	30528	3656pmoles	0	None
30528	30529	/	0	None
30529	30530	million	0	None
30530	30531	cells	0	None
30531	30532	/	0	None
30532	30533	min	0	None
30533	30534	)	0	None
30534	30535	and	0	None
30535	30536	in	0	None
30536	30537	transfected	0	None
30537	30538	HEK	0	None
30538	30539	293	0	None
30539	30540	LAT1	0	None
30540	30541	cells	0	None
30541	30542	(	0	None
30542	30543	LAT1-process;	0	None
30543	30544	Km	0	None
30544	30545	=	0	None
30545	30546	217μM	0	None
30546	30547	and	0	None
30547	30548	Vmax	0	None
30548	30549	=	0	None
30549	30550	5192pmoles	0	None
30550	30551	/	0	None
30551	30552	million	0	None
30552	30553	cells	0	None
30553	30554	/	0	None
30554	30555	min	0	None
30555	30556	versus	0	None
30556	30557	otherprocesses;	0	None
30557	30558	Km	0	None
30558	30559	=	0	None
30559	30560	1546μM	0	None
30560	30561	and	0	None
30561	30562	Vmax	0	None
30562	30563	=	0	None
30563	30564	3375pmoles	0	None
30564	30565	/	0	None
30565	30566	million	0	None
30566	30567	cells	0	None
30567	30568	/	0	None
30568	30569	min	0	None
30569	30570	)	0	None
30570	30571	.	0	None

30572	30573	At	0	None
30573	30574	physiological	0	None
30574	30575	concentrations	0	None
30575	30576	of	0	None
30576	30577	gabapentin	0	None
30577	30578	,	0	None
30578	30579	LAT1	0	None
30579	30580	mediated	0	None
30580	30581	transport	0	None
30581	30582	was	0	None
30582	30583	3	0	None
30583	30584	or	0	None
30584	30585	~10-fold	0	None
30585	30586	higher	0	None
30586	30587	than	0	None
30587	30588	the	0	None
30588	30589	other	0	None
30589	30590	transport	0	None
30590	30591	processes	0	None
30591	30592	in	0	None
30592	30593	the	0	None
30593	30594	two	0	None
30594	30595	systems	0	None
30595	30596	,	0	None
30596	30597	respectively	0	None
30597	30598	,	0	None
30598	30599	demonstrating	0	None
30599	30600	clear	0	None
30600	30601	selectivity	0	None
30601	30602	for	0	None
30602	30603	gabapentin	0	None
30603	30604	.	0	None

30605	30606	In-silico	0	None
30606	30607	structural	0	None
30607	30608	homology	0	None
30608	30609	modelling	0	None
30609	30610	confirmed	0	None
30610	30611	that	0	None
30611	30612	LAT1	0	None
30612	30613	could	0	None
30613	30614	have	0	None
30614	30615	the	0	None
30615	30616	LeuT	0	None
30616	30617	conserved	0	None
30617	30618	fold	0	None
30618	30619	and	0	None
30619	30620	functions	0	None
30620	30621	by	0	None
30621	30622	the	0	None
30622	30623	alternative	0	None
30623	30624	access	0	None
30624	30625	mechanism	0	None
30625	30626	.	0	None

30627	30628	Mathematical	0	None
30628	30629	modelling	0	None
30629	30630	of	0	None
30630	30631	this	0	None
30631	30632	mechanism	0	None
30632	30633	revealed	0	None
30633	30634	revised	0	None
30634	30635	significance	0	None
30635	30636	of	0	None
30636	30637	Vmax	0	None
30637	30638	and	0	None
30638	30639	Km	0	None
30639	30640	so	0	None
30640	30641	that	0	None
30641	30642	a	0	None
30642	30643	low	0	None
30643	30644	Km	0	None
30644	30645	may	0	None
30645	30646	not	0	None
30646	30647	necessarily	0	None
30647	30648	imply	0	None
30648	30649	a	0	None
30649	30650	high	0	None
30650	30651	affinity	0	None
30651	30652	transport	0	None
30652	30653	process	0	None
30653	30654	.	0	None

30655	30656	Gabapentin	0	None
30656	30657	was	0	None
30657	30658	negative	0	None
30658	30659	for	0	None
30659	30660	OCT	0	None
30660	30661	like	0	None
30661	30662	transport	0	None
30662	30663	and	0	None
30663	30664	LAT2	0	None
30664	30665	activity	0	None
30665	30666	in	0	None
30666	30667	the	0	None
30667	30668	hCMEC	0	None
30668	30669	/	0	None
30669	30670	D3	0	None
30670	30671	and	0	None
30671	30672	OCT1	0	None
30672	30673	transfected	0	None
30673	30674	cells	0	None
30674	30675	.	0	None

30676	30677	Our	0	None
30677	30678	data	0	None
30678	30679	shows	0	None
30679	30680	that	0	None
30680	30681	gabapentin	0	None
30681	30682	is	0	None
30682	30683	a	0	None
30683	30684	substrate	0	None
30684	30685	for	0	None
30685	30686	the	0	None
30686	30687	influx	0	None
30687	30688	transporter	0	None
30688	30689	LAT1	0	None
30689	30690	at	0	None
30690	30691	therapeutic	0	None
30691	30692	concentrations	0	None
30692	30693	.	0	None
30693	30694	Comparison	0	None
30694	30695	of	0	None
30695	30696	the	0	None
30696	30697	novel	0	None
30697	30698	antipsychotic	0	None
30698	30699	ziprasidone	2	CHEMICAL
30699	30700	with	0	None
30700	30701	clozapine	2	CHEMICAL
30701	30702	and	0	None
30702	30703	olanzapine	0	None
30703	30704	:	0	None
30704	30705	inhibition	0	None
30705	30706	of	0	None
30706	30707	dorsal	0	None
30707	30708	raphe	0	None
30708	30709	cell	0	None
30709	30710	firing	0	None
30710	30711	and	0	None
30711	30712	the	0	None
30712	30713	role	0	None
30713	30714	of	0	None
30714	30715	5-HT1A	1	GENE-Y
30715	30716	receptor	0	None
30716	30717	activation	0	None
30717	30718	.	0	None
30718	30720	Retinoic acid	2	CHEMICAL
30720	30721	inhibits	0	None
30721	30722	HIV-1-induced	0	None
30722	30723	podocyte	0	None
30723	30724	proliferation	0	None
30724	30725	through	0	None
30725	30726	the	0	None
30726	30727	cAMP	0	None
30727	30728	pathway	0	None
30728	30729	.	0	None
30729	30730	Several	0	None
30730	30731	members	0	None
30731	30732	of	0	None
30732	30733	a	0	None
30733	30734	new	0	None
30734	30735	family	0	None
30735	30736	of	0	None
30736	30737	non-sugar-type	0	None
30737	30738	α-glycosidase	0	None
30738	30739	inhibitors	0	None
30739	30740	,	0	None
30740	30741	bearing	0	None
30741	30742	a	0	None
30742	30743	5-	0	None
30743	30744	(	0	None
30744	30745	p-toluenesulfonylamino	0	None
30745	30746	)	0	None
30746	30747	phthalimide	0	None
30747	30748	moiety	0	None
30748	30749	and	0	None
30749	30750	various	0	None
30750	30751	substituent	0	None
30751	30752	at	0	None
30752	30753	the	0	None
30753	30754	N2	0	None
30754	30755	position	0	None
30755	30756	,	0	None
30756	30757	were	0	None
30757	30758	synthesized	0	None
30758	30759	and	0	None
30759	30760	their	0	None
30760	30761	activities	0	None
30761	30762	were	0	None
30762	30763	investigated	0	None
30763	30764	.	0	None

30765	30766	The	0	None
30766	30767	newly	0	None
30767	30768	synthesized	0	None
30768	30769	compounds	0	None
30769	30770	displayed	0	None
30770	30771	different	0	None
30771	30772	inhibition	0	None
30772	30773	profile	0	None
30773	30774	towards	0	None
30774	30775	yeast	0	None
30775	30776	α-glycosidase	0	None
30776	30777	and	0	None
30777	30778	rat	0	None
30778	30779	intestinal	0	None
30779	30780	α-glycosidase	0	None
30780	30781	.	0	None

30782	30783	Almost	0	None
30783	30784	all	0	None
30784	30785	the	0	None
30785	30786	compounds	0	None
30786	30787	had	0	None
30787	30788	strong	0	None
30788	30789	inhibitory	0	None
30789	30790	activities	0	None
30790	30791	against	0	None
30791	30792	yeast	0	None
30792	30793	α-glycosidase	0	None
30793	30794	.	0	None

30795	30796	Regarding	0	None
30796	30797	rat	0	None
30797	30798	intestinal	0	None
30798	30799	α-glycosidase	0	None
30799	30800	,	0	None
30800	30801	only	0	None
30801	30802	analogs	0	None
30802	30803	with	0	None
30803	30804	N2-aromatic	0	None
30804	30805	substituents	0	None
30805	30806	displayed	0	None
30806	30807	varying	0	None
30807	30808	degrees	0	None
30808	30809	of	0	None
30809	30810	inhibitory	0	None
30810	30811	activities	0	None
30811	30812	on	0	None
30812	30813	rat	0	None
30813	30814	intestinal	0	None
30814	30815	maltase	0	None
30815	30816	and	0	None
30816	30817	lactase	0	None
30817	30818	and	0	None
30818	30819	nearly	0	None
30819	30820	all	0	None
30820	30821	compounds	0	None
30821	30822	showed	0	None
30822	30823	no	0	None
30823	30824	inhibition	0	None
30824	30825	against	0	None
30825	30826	rat	0	None
30826	30827	intestinal	0	None
30827	30828	α-amylase	0	None
30828	30829	.	0	None

30830	30831	Structure-activity	0	None
30831	30832	relationship	0	None
30832	30833	studies	0	None
30833	30834	indicated	0	None
30834	30835	that	0	None
30835	30836	5-	0	None
30836	30837	(	0	None
30837	30838	p-toluenesulfonylamino	0	None
30838	30839	)	0	None
30839	30840	phthalimide	0	None
30840	30841	moiety	0	None
30841	30842	is	0	None
30842	30843	a	0	None
30843	30844	favorable	0	None
30844	30845	scaffold	0	None
30845	30846	to	0	None
30846	30847	exert	0	None
30847	30848	the	0	None
30848	30849	α-glucosidase	0	None
30849	30850	inhibitory	0	None
30850	30851	activity	0	None
30851	30852	and	0	None
30852	30853	substituents	0	None
30853	30854	at	0	None
30854	30855	the	0	None
30855	30856	N2	0	None
30856	30857	position	0	None
30857	30858	have	0	None
30858	30859	considerable	0	None
30859	30860	influence	0	None
30860	30861	on	0	None
30861	30862	the	0	None
30862	30863	efficacy	0	None
30863	30864	of	0	None
30864	30865	the	0	None
30865	30866	inhibition	0	None
30866	30867	activities	0	None
30867	30868	.	0	None
30868	30869	Repeated	0	None
30869	30870	morphine	0	None
30870	30871	administration	0	None
30871	30872	leads	0	None
30872	30873	to	0	None
30873	30874	molecular	0	None
30874	30875	alterations	0	None
30875	30876	of	0	None
30876	30877	the	0	None
30877	30878	neural	0	None
30878	30879	circuitry	0	None
30879	30880	in	0	None
30880	30881	the	0	None
30881	30882	locus	0	None
30882	30883	coeruleus	0	None
30883	30884	and	0	None
30884	30885	nucleus	0	None
30885	30886	accumbens	0	None
30886	30887	.	0	None

30888	30889	These	0	None
30889	30890	changes	0	None
30890	30891	include	0	None
30891	30892	increased	0	None
30892	30893	activity	0	None
30893	30894	of	0	None
30894	30895	several	0	None
30895	30896	components	0	None
30896	30897	of	0	None
30897	30898	the	0	None
30898	30899	cAMP	0	None
30899	30900	signaling	0	None
30900	30901	pathway	0	None
30901	30902	that	0	None
30902	30903	are	0	None
30903	30904	thought	0	None
30904	30905	to	0	None
30905	30906	be	0	None
30906	30907	associated	0	None
30907	30908	with	0	None
30908	30909	psychological	0	None
30909	30910	and	0	None
30910	30911	somatic	0	None
30911	30912	signs	0	None
30912	30913	of	0	None
30913	30914	opiate	0	None
30914	30915	withdrawal	0	None
30915	30916	.	0	None

30917	30918	The	0	None
30918	30919	neuropeptide	0	None
30919	30920	galanin	0	None
30920	30921	has	0	None
30921	30922	been	0	None
30922	30923	shown	0	None
30923	30924	to	0	None
30924	30925	attenuate	0	None
30925	30926	cAMP	0	None
30926	30927	signaling	0	None
30927	30928	in	0	None
30928	30929	multiple	0	None
30929	30930	cell	0	None
30930	30931	types	0	None
30931	30932	.	0	None

30933	30934	The	0	None
30934	30935	current	0	None
30935	30936	study	0	None
30936	30937	demonstrates	0	None
30937	30938	that	0	None
30938	30939	acute	0	None
30939	30940	galanin	0	None
30940	30941	treatment	0	None
30941	30942	blocks	0	None
30942	30943	the	0	None
30943	30944	consequences	0	None
30944	30945	of	0	None
30945	30946	increased	0	None
30946	30947	cAMP	0	None
30947	30948	signaling	0	None
30948	30949	following	0	None
30949	30950	chronic	0	None
30950	30951	opiate	0	None
30951	30952	administration	0	None
30952	30953	and	0	None
30953	30954	withdrawal	0	None
30954	30955	in	0	None
30955	30956	Cath	0	None
30956	30957	.	0	None

30958	30959	a	0	None
30959	30960	cells	0	None
30960	30961	and	0	None
30961	30962	primary	0	None
30962	30963	cultures	0	None
30963	30964	of	0	None
30964	30965	striatal	0	None
30965	30966	neurons	0	None
30966	30967	as	0	None
30967	30968	measured	0	None
30968	30969	by	0	None
30969	30970	phosphorylation	0	None
30970	30971	of	0	None
30971	30972	the	0	None
30972	30973	transcription	0	None
30973	30974	factor	0	None
30974	30975	cAMP	0	None
30975	30976	regulatory	0	None
30976	30977	element-binding	0	None
30977	30978	protein	0	None
30978	30979	(	0	None
30979	30980	CREB	0	None
30980	30981	)	0	None
30981	30982	.	0	None

30983	30984	In	0	None
30984	30985	addition	0	None
30985	30986	,	0	None
30986	30987	galanin-mediated	0	None
30987	30988	attenuation	0	None
30988	30989	of	0	None
30989	30990	CREB	0	None
30990	30991	phosphorylation	0	None
30991	30992	is	0	None
30992	30993	independent	0	None
30993	30994	of	0	None
30994	30995	galanin-induced	0	None
30995	30997	extracellular signal-regulated	0	None
30997	30998	kinase	0	None
30998	30999	(	0	None
30999	31000	ERK	0	None
31000	31001	)	0	None
31001	31002	1	0	None
31002	31003	/	0	None
31003	31004	2	0	None
31004	31005	phosphorylation	0	None
31005	31006	in	0	None
31006	31007	Cath	0	None
31007	31008	.	0	None

31009	31010	a	0	None
31010	31011	cells	0	None
31011	31012	.	0	None

31013	31014	These	0	None
31014	31015	data	0	None
31015	31016	suggest	0	None
31016	31017	that	0	None
31017	31018	galanin	0	None
31018	31019	receptors	0	None
31019	31020	may	0	None
31020	31021	serve	0	None
31021	31022	as	0	None
31022	31023	an	0	None
31023	31024	additional	0	None
31024	31025	potential	0	None
31025	31026	therapeutic	0	None
31026	31027	target	0	None
31027	31028	for	0	None
31028	31029	the	0	None
31029	31030	treatment	0	None
31030	31031	of	0	None
31031	31032	opiate	0	None
31032	31033	withdrawal	0	None
31033	31034	.	0	None
31034	31035	Prokinetic	0	None
31035	31036	effects	0	None
31036	31037	of	0	None
31037	31038	a	0	None
31038	31039	new	0	None
31039	31040	ghrelin	0	None
31040	31041	receptor	0	None
31041	31042	agonist	0	None
31042	31043	TZP-101	2	CHEMICAL
31043	31044	in	0	None
31044	31045	a	0	None
31045	31046	rat	0	None
31046	31047	model	0	None
31047	31048	of	0	None
31048	31049	postoperative	0	None
31049	31050	ileus	0	None
31050	31051	.	0	None
31051	31052	Our	0	None
31052	31053	previous	0	None
31053	31054	study	0	None
31054	31055	has	0	None
31055	31056	revealed	0	None
31056	31057	that	0	None
31057	31058	dioscin	0	None
31058	31059	,	0	None
31059	31060	a	0	None
31060	31061	compound	0	None
31061	31062	with	0	None
31062	31063	anti-inflammatory	0	None
31063	31064	,	0	None
31064	31065	lipid-lowering	0	None
31065	31066	,	0	None
31066	31067	anticancer	0	None
31067	31068	and	0	None
31068	31069	hepatoprotective	0	None
31069	31070	effects	0	None
31070	31071	,	0	None
31071	31072	may	0	None
31072	31073	induce	0	None
31073	31074	autophagy	0	None
31074	31075	in	0	None
31075	31076	hepatoma	0	None
31076	31077	cells	0	None
31077	31078	.	0	None

31079	31080	Autophagy	0	None
31080	31081	is	0	None
31081	31082	a	0	None
31082	31083	lysosomal	0	None
31083	31084	degradation	0	None
31084	31085	pathway	0	None
31085	31086	that	0	None
31086	31087	is	0	None
31087	31088	essential	0	None
31088	31089	for	0	None
31089	31090	cell	0	None
31090	31091	survival	0	None
31091	31092	and	0	None
31092	31093	tissue	0	None
31093	31094	homeostasis	0	None
31094	31095	.	0	None

31096	31097	In	0	None
31097	31098	this	0	None
31098	31099	study	0	None
31099	31100	,	0	None
31100	31101	the	0	None
31101	31102	role	0	None
31102	31103	of	0	None
31103	31104	autophagy	0	None
31104	31105	and	0	None
31105	31106	related	0	None
31106	31107	signaling	0	None
31107	31108	pathways	0	None
31108	31109	during	0	None
31109	31110	dioscin-induced	0	None
31110	31111	apoptosis	0	None
31111	31112	in	0	None
31112	31113	human	0	None
31113	31114	lung	0	None
31114	31115	cancer	0	None
31115	31116	cells	0	None
31116	31117	was	0	None
31117	31118	investigated	0	None
31118	31119	.	0	None

31120	31121	Results	0	None
31121	31122	from	0	None
31122	31123	4'-6-diamidino-2-phenylindole	0	None
31123	31124	and	0	None
31124	31125	annexin-V	0	None
31125	31126	/	0	None
31126	31127	PI	0	None
31127	31128	double-staining	0	None
31128	31129	assay	0	None
31129	31130	showed	0	None
31130	31131	that	0	None
31131	31132	caspase-3-	0	None
31132	31133	and	0	None
31133	31134	caspase-8-dependent	0	None
31134	31135	,	0	None
31135	31136	and	0	None
31136	31137	dose-dependent	0	None
31137	31138	apoptoses	0	None
31138	31139	were	0	None
31139	31140	detected	0	None
31140	31141	after	0	None
31141	31142	a	0	None
31142	31143	24-h	0	None
31143	31144	dioscin	0	None
31144	31145	treatment	0	None
31145	31146	.	0	None

31147	31148	Meanwhile	0	None
31148	31149	,	0	None
31149	31150	autophagy	0	None
31150	31151	was	0	None
31151	31152	detected	0	None
31152	31153	as	0	None
31153	31154	early	0	None
31154	31155	as	0	None
31155	31156	12	0	None
31156	31157	h	0	None
31157	31158	after	0	None
31158	31159	an	0	None
31159	31160	exposure	0	None
31160	31161	to	0	None
31161	31162	low-dose	0	None
31162	31163	dioscin	0	None
31163	31164	,	0	None
31164	31165	as	0	None
31165	31166	indicated	0	None
31166	31167	by	0	None
31167	31168	an	0	None
31168	31169	up-regulated	0	None
31169	31170	expression	0	None
31170	31171	of	0	None
31171	31172	LC3-II	0	None
31172	31173	and	0	None
31173	31174	beclin-1	0	None
31174	31175	proteins	0	None
31175	31176	.	0	None

31177	31178	Blockade	0	None
31178	31179	of	0	None
31179	31180	autophagy	0	None
31180	31181	with	0	None
31181	31182	bafilomycin	0	None
31182	31183	A1	1	GENE-Y
31183	31184	or	0	None
31184	31185	3-methyladenine	0	None
31185	31186	sensitized	0	None
31186	31187	the	0	None
31187	31188	A549	0	None
31188	31189	and	0	None
31189	31190	H1299	0	None
31190	31191	cells	0	None
31191	31192	to	0	None
31192	31193	apoptosis	0	None
31193	31194	.	0	None

31195	31196	Treatment	0	None
31196	31197	of	0	None
31197	31198	A549	0	None
31198	31199	and	0	None
31199	31200	H1299	0	None
31200	31201	cells	0	None
31201	31202	with	0	None
31202	31203	dioscin	0	None
31203	31204	caused	0	None
31204	31205	a	0	None
31205	31206	dose-dependent	0	None
31206	31207	increase	0	None
31207	31208	in	0	None
31208	31209	ERK1	0	None
31209	31210	/	0	None
31210	31211	2	0	None
31211	31212	and	0	None
31212	31213	JNK1	0	None
31213	31214	/	0	None
31214	31215	2	0	None
31215	31216	activity	0	None
31216	31217	,	0	None
31217	31218	accompanied	0	None
31218	31219	with	0	None
31219	31220	a	0	None
31220	31221	decreased	0	None
31221	31222	PI3K	0	None
31222	31223	expression	0	None
31223	31224	and	0	None
31224	31225	decreased	0	None
31225	31226	phosphorylation	0	None
31226	31227	of	0	None
31227	31228	Akt	0	None
31228	31229	and	0	None
31229	31230	mTOR	0	None
31230	31231	.	0	None

31232	31233	Taken	0	None
31233	31234	together	0	None
31234	31235	,	0	None
31235	31236	this	0	None
31236	31237	study	0	None
31237	31238	demonstrated	0	None
31238	31239	for	0	None
31239	31240	the	0	None
31240	31241	first	0	None
31241	31242	time	0	None
31242	31243	that	0	None
31243	31244	autophagy	0	None
31244	31245	occurred	0	None
31245	31246	earlier	0	None
31246	31247	than	0	None
31247	31248	apoptosis	0	None
31248	31249	during	0	None
31249	31250	dioscin-induced	0	None
31250	31251	human	0	None
31251	31252	lung	0	None
31252	31253	cancer	0	None
31253	31254	cell	0	None
31254	31255	line	0	None
31255	31256	apoptosis	0	None
31256	31257	.	0	None

31258	31259	Dioscin-induced	0	None
31259	31260	autophagy	0	None
31260	31261	via	0	None
31261	31262	ERK1	0	None
31262	31263	/	0	None
31263	31264	2	0	None
31264	31265	and	0	None
31265	31266	JNK1	0	None
31266	31267	/	0	None
31267	31268	2	0	None
31268	31269	pathways	0	None
31269	31270	may	0	None
31270	31271	provide	0	None
31271	31272	a	0	None
31272	31273	protective	0	None
31273	31274	mechanism	0	None
31274	31275	for	0	None
31275	31276	cell	0	None
31276	31277	survival	0	None
31277	31278	against	0	None
31278	31279	dioscin-induced	0	None
31279	31280	apoptosis	0	None
31280	31281	to	0	None
31281	31282	act	0	None
31282	31283	as	0	None
31283	31284	a	0	None
31284	31285	cytoprotective	0	None
31285	31286	reaction	0	None
31286	31287	.	0	None
31287	31288	Bone	0	None
31288	31289	remodeling	0	None
31289	31290	is	0	None
31290	31291	affected	0	None
31291	31292	by	0	None
31292	31293	mechanical	0	None
31293	31294	loading	0	None
31294	31295	and	0	None
31295	31296	inflammatory	0	None
31296	31297	mediators	0	None
31297	31298	,	0	None
31298	31299	including	0	None
31299	31300	chemokines	0	None
31300	31301	.	0	None

31302	31303	The	0	None
31303	31304	chemokine	0	None
31304	31305	(	0	None
31305	31306	C-C	0	None
31306	31307	motif	0	None
31307	31308	)	0	None
31308	31309	ligand	0	None
31309	31310	3	0	None
31310	31311	(	0	None
31311	31312	CCL3	0	None
31312	31313	)	0	None
31313	31314	is	0	None
31314	31315	involved	0	None
31315	31316	in	0	None
31316	31317	bone	0	None
31317	31318	remodeling	0	None
31318	31319	by	0	None
31319	31320	binding	0	None
31320	31321	to	0	None
31321	31322	C-C	0	None
31322	31323	chemokine	0	None
31323	31324	receptors	0	None
31324	31325	1	0	None
31325	31326	and	0	None
31326	31327	5	0	None
31327	31328	(	0	None
31328	31329	CCR1	0	None
31329	31330	and	0	None
31330	31331	CCR5	0	None
31331	31332	)	0	None
31332	31333	expressed	0	None
31333	31334	on	0	None
31334	31335	osteoclasts	0	None
31335	31336	and	0	None
31336	31337	osteoblasts	0	None
31337	31338	.	0	None

31339	31340	Our	0	None
31340	31341	group	0	None
31341	31342	has	0	None
31342	31343	previously	0	None
31343	31344	demonstrated	0	None
31344	31345	that	0	None
31345	31346	CCR5	0	None
31346	31347	down-regulates	0	None
31347	31348	mechanical	0	None
31348	31349	loading-induced	0	None
31349	31350	bone	0	None
31350	31351	resorption	0	None
31351	31352	.	0	None

31353	31354	Thus	0	None
31354	31355	,	0	None
31355	31356	the	0	None
31356	31357	present	0	None
31357	31358	study	0	None
31358	31359	aimed	0	None
31359	31360	to	0	None
31360	31361	investigate	0	None
31361	31362	the	0	None
31362	31363	role	0	None
31363	31364	of	0	None
31364	31365	CCR1	0	None
31365	31366	and	0	None
31366	31367	CCL3	0	None
31367	31368	in	0	None
31368	31369	bone	0	None
31369	31370	remodeling	0	None
31370	31371	induced	0	None
31371	31372	by	0	None
31372	31373	mechanical	0	None
31373	31374	loading	0	None
31374	31375	during	0	None
31375	31376	orthodontic	0	None
31376	31377	tooth	0	None
31377	31378	movement	0	None
31378	31379	in	0	None
31379	31380	mice	0	None
31380	31381	.	0	None

31382	31383	Our	0	None
31383	31384	results	0	None
31384	31385	showed	0	None
31385	31386	that	0	None
31386	31387	bone	0	None
31387	31388	remodeling	0	None
31388	31389	was	0	None
31389	31390	significantly	0	None
31390	31391	decreased	0	None
31391	31392	in	0	None
31392	31393	CCL3	0	None
31393	31394	(	0	None
31394	31395	-	0	None
31395	31396	/	0	None
31396	31397	-	0	None
31397	31398	)	0	None
31398	31399	and	0	None
31399	31400	CCR1	0	None
31400	31401	(	0	None
31401	31402	-	0	None
31402	31403	/	0	None
31403	31404	-	0	None
31404	31405	)	0	None
31405	31406	mice	0	None
31406	31407	and	0	None
31407	31408	in	0	None
31408	31409	animals	0	None
31409	31410	treated	0	None
31410	31411	with	0	None
31411	31412	Met-RANTES	0	None
31412	31413	(	0	None
31413	31414	an	0	None
31414	31415	antagonist	0	None
31415	31416	of	0	None
31416	31417	CCR5	0	None
31417	31418	and	0	None
31418	31419	CCR1	0	None
31419	31420	)	0	None
31420	31421	.	0	None

31422	31423	mRNA	0	None
31423	31424	levels	0	None
31424	31425	of	0	None
31425	31426	receptor	0	None
31426	31427	activator	0	None
31427	31428	of	0	None
31428	31431	nuclear factor kappa-B	3	GENE-N
31431	31432	(	0	None
31432	31433	RANK	1	GENE-Y
31433	31434	)	0	None
31434	31435	,	0	None
31435	31436	its	0	None
31436	31437	ligand	0	None
31437	31438	RANKL	1	GENE-Y
31438	31439	,	0	None
31439	31442	tumor necrosis factor	1	GENE-Y
31442	31443	alpha	0	None
31443	31444	(	0	None
31444	31445	TNF-α	0	None
31445	31446	)	0	None
31446	31447	and	0	None
31447	31448	RANKL	1	GENE-Y
31448	31449	/	0	None
31449	31450	osteoprotegerin	0	None
31450	31451	(	0	None
31451	31452	OPG	0	None
31452	31453	)	0	None
31453	31454	ratio	0	None
31454	31455	were	0	None
31455	31456	diminished	0	None
31456	31457	in	0	None
31457	31458	the	0	None
31458	31459	periodontium	0	None
31459	31460	of	0	None
31460	31461	CCL3	0	None
31461	31462	(	0	None
31462	31463	-	0	None
31463	31464	/	0	None
31464	31465	-	0	None
31465	31466	)	0	None
31466	31467	mice	0	None
31467	31468	and	0	None
31468	31469	in	0	None
31469	31470	the	0	None
31470	31471	group	0	None
31471	31472	treated	0	None
31472	31473	with	0	None
31473	31474	Met-RANTES	0	None
31474	31475	.	0	None

31476	31477	Met-RANTES	0	None
31477	31478	treatment	0	None
31478	31479	also	0	None
31479	31480	reduced	0	None
31480	31481	the	0	None
31481	31482	levels	0	None
31482	31483	of	0	None
31483	31484	cathepsin	0	None
31484	31485	K	0	None
31485	31486	and	0	None
31486	31488	metalloproteinase 13	1	GENE-Y
31488	31489	(	0	None
31489	31490	MMP13	0	None
31490	31491	)	0	None
31491	31492	.	0	None

31493	31494	The	0	None
31494	31495	expression	0	None
31495	31496	of	0	None
31496	31497	the	0	None
31497	31498	osteoblast	0	None
31498	31499	markers	0	None
31499	31500	runt-related	0	None
31500	31503	transcription factor 2	3	GENE-N
31503	31504	(	0	None
31504	31505	RUNX2	0	None
31505	31506	)	0	None
31506	31507	and	0	None
31507	31508	periostin	0	None
31508	31509	was	0	None
31509	31510	decreased	0	None
31510	31511	,	0	None
31511	31512	while	0	None
31512	31513	osteocalcin	0	None
31513	31514	(	0	None
31514	31515	OCN	0	None
31515	31516	)	0	None
31516	31517	was	0	None
31517	31518	augmented	0	None
31518	31519	in	0	None
31519	31520	CCL3	0	None
31520	31521	(	0	None
31521	31522	-	0	None
31522	31523	/	0	None
31523	31524	-	0	None
31524	31525	)	0	None
31525	31526	and	0	None
31526	31527	Met-RANTES-treated	0	None
31527	31528	mice	0	None
31528	31529	.	0	None

31530	31531	Altogether	0	None
31531	31532	,	0	None
31532	31533	these	0	None
31533	31534	findings	0	None
31534	31535	show	0	None
31535	31536	that	0	None
31536	31537	CCR1	0	None
31537	31538	is	0	None
31538	31539	pivotal	0	None
31539	31540	for	0	None
31540	31541	bone	0	None
31541	31542	remodeling	0	None
31542	31543	induced	0	None
31543	31544	by	0	None
31544	31545	mechanical	0	None
31545	31546	loading	0	None
31546	31547	during	0	None
31547	31548	orthodontic	0	None
31548	31549	tooth	0	None
31549	31550	movement	0	None
31550	31551	and	0	None
31551	31552	these	0	None
31552	31553	actions	0	None
31553	31554	depend	0	None
31554	31555	,	0	None
31555	31556	at	0	None
31556	31557	least	0	None
31557	31558	in	0	None
31558	31559	part	0	None
31559	31560	,	0	None
31560	31561	on	0	None
31561	31562	CCL3	0	None
31562	31563	.	0	None
31563	31564	BACKGROUND	0	None
31564	31565	:	0	None
31565	31566	Recent	0	None
31566	31567	epidemiologic	0	None
31567	31568	and	0	None
31568	31569	laboratory	0	None
31569	31570	studies	0	None
31570	31571	have	0	None
31571	31572	suggested	0	None
31572	31573	that	0	None
31573	31574	non-steroidal	0	None
31574	31575	anti-inflammatory	0	None
31575	31576	drugs	0	None
31576	31577	(	0	None
31577	31578	NSAIDs	0	None
31578	31579	)	0	None
31579	31580	may	0	None
31580	31581	reduce	0	None
31581	31582	the	0	None
31582	31583	risk	0	None
31583	31584	of	0	None
31584	31585	breast	0	None
31585	31586	cancer	0	None
31586	31587	through	0	None
31587	31588	inhibition	0	None
31588	31589	of	0	None
31589	31590	cyclooxygenase-2	0	None
31590	31591	(	0	None
31591	31592	COX-2	0	None
31592	31593	)	0	None
31593	31594	.	0	None

31595	31596	METHODS	0	None
31596	31597	:	0	None
31597	31598	We	0	None
31598	31599	conducted	0	None
31599	31600	a	0	None
31600	31601	case-control	0	None
31601	31602	study	0	None
31602	31603	to	0	None
31603	31604	measure	0	None
31604	31605	the	0	None
31605	31606	association	0	None
31606	31607	between	0	None
31607	31608	selective	0	None
31608	31609	cox-2	0	None
31609	31610	inhibitors	0	None
31610	31611	,	0	None
31611	31612	particularly	0	None
31612	31613	celecoxib	2	CHEMICAL
31613	31614	,	0	None
31614	31615	rofecoxib	0	None
31615	31616	,	0	None
31616	31617	valdecoxib	0	None
31617	31618	and	0	None
31618	31619	non-specific	0	None
31619	31620	NSAID	0	None
31620	31621	subgroups	0	None
31621	31622	,	0	None
31622	31623	and	0	None
31623	31624	breast	0	None
31624	31625	cancer	0	None
31625	31626	risk	0	None
31626	31627	.	0	None

31628	31629	Between	0	None
31629	31630	2003	0	None
31630	31631	and	0	None
31631	31632	2006	0	None
31632	31633	,	0	None
31633	31634	a	0	None
31634	31635	total	0	None
31635	31636	of	0	None
31636	31637	18	0	None
31637	31638	,	0	None
31638	31639	368	0	None
31639	31640	incident	0	None
31640	31641	breast	0	None
31641	31642	cancer	0	None
31642	31643	cases	0	None
31643	31644	were	0	None
31644	31645	identified	0	None
31645	31646	in	0	None
31646	31647	the	0	None
31647	31648	Ingenix	0	None
31648	31649	/	0	None
31649	31650	Lab	0	None
31650	31651	Rx	1	GENE-Y
31651	31652	insurance	0	None
31652	31653	database	0	None
31653	31654	,	0	None
31654	31655	which	0	None
31655	31656	contains	0	None
31656	31657	clinical	0	None
31657	31658	encounter	0	None
31658	31659	and	0	None
31659	31660	drug	0	None
31660	31661	prescription	0	None
31661	31662	data	0	None
31662	31663	.	0	None

31664	31665	Four	0	None
31665	31666	controls	0	None
31666	31667	per	0	None
31667	31668	case	0	None
31668	31669	were	0	None
31669	31670	randomly	0	None
31670	31671	selected	0	None
31671	31672	,	0	None
31672	31673	matched	0	None
31673	31674	on	0	None
31674	31675	age	0	None
31675	31676	and	0	None
31676	31677	time	0	None
31677	31678	in	0	None
31678	31679	database	0	None
31679	31680	.	0	None

31681	31682	Odds	0	None
31682	31683	ratios	0	None
31683	31684	(	0	None
31684	31685	OR	0	None
31685	31686	)	0	None
31686	31687	and	0	None
31687	31688	95%	0	None
31688	31689	confidence	0	None
31689	31690	intervals	0	None
31690	31691	(	0	None
31691	31692	CI	0	None
31692	31693	)	0	None
31693	31694	were	0	None
31694	31695	estimated	0	None
31695	31696	using	0	None
31696	31697	conditional	0	None
31697	31698	logistic	0	None
31698	31699	regression	0	None
31699	31700	.	0	None

31701	31702	RESULTS	0	None
31702	31703	:	0	None
31703	31704	Breast	0	None
31704	31705	cancer	0	None
31705	31706	risk	0	None
31706	31707	was	0	None
31707	31708	inversely	0	None
31708	31709	associated	0	None
31709	31710	with	0	None
31710	31711	both	0	None
31711	31712	non-specific	0	None
31712	31713	NSAID	0	None
31713	31714	and	0	None
31714	31715	selective	0	None
31715	31716	COX-2	0	None
31716	31717	inhibitor	0	None
31717	31718	use	0	None
31718	31719	.	0	None

31720	31721	Greater	0	None
31721	31722	than	0	None
31722	31723	12	0	None
31723	31724	months'	0	None
31724	31725	duration	0	None
31725	31726	of	0	None
31726	31727	use	0	None
31727	31728	of	0	None
31728	31729	Celecoxib	0	None
31729	31730	at	0	None
31730	31731	a	0	None
31731	31732	standard	0	None
31732	31733	dose	0	None
31733	31734	(	0	None
31734	31735	200mg	0	None
31735	31736	/	0	None
31736	31737	day	0	None
31737	31738	)	0	None
31738	31739	was	0	None
31739	31740	associated	0	None
31740	31741	with	0	None
31741	31742	a	0	None
31742	31743	16%	0	None
31743	31744	decrease	0	None
31744	31745	in	0	None
31745	31746	breast	0	None
31746	31747	cancer	0	None
31747	31748	risk	0	None
31748	31749	(	0	None
31749	31750	OR	0	None
31750	31751	=	0	None
31751	31752	0	0	None
31752	31753	.	0	None
31753	31754	84	0	None
31754	31755	,	0	None
31755	31756	95%	0	None
31756	31757	CI	0	None
31757	31758	=	0	None
31758	31759	0	0	None
31759	31760	.	0	None
31760	31761	73	0	None
31761	31762	,	0	None
31762	31763	0	0	None
31763	31764	.	0	None
31764	31765	97	0	None
31765	31766	)	0	None
31766	31767	.	0	None

31768	31769	We	0	None
31769	31770	observed	0	None
31770	31771	the	0	None
31771	31772	greatest	0	None
31772	31773	risk	0	None
31773	31774	reduction	0	None
31774	31775	in	0	None
31775	31776	association	0	None
31776	31777	with	0	None
31777	31778	>2	0	None
31778	31779	years	0	None
31779	31780	of	0	None
31780	31781	rofecoxib	0	None
31781	31782	exposure	0	None
31782	31783	(	0	None
31783	31784	OR	0	None
31784	31785	=	0	None
31785	31786	0	0	None
31786	31787	.	0	None
31787	31788	54	0	None
31788	31789	,	0	None
31789	31790	95%	0	None
31790	31791	CI	0	None
31791	31792	=	0	None
31792	31793	0	0	None
31793	31794	.	0	None
31794	31795	37	0	None
31795	31796	,	0	None
31796	31797	0	0	None
31797	31798	.	0	None
31798	31799	80	0	None
31799	31800	)	0	None
31800	31801	.	0	None

31802	31803	Acetaminophen	0	None
31803	31804	,	0	None
31804	31805	a	0	None
31805	31806	compound	0	None
31806	31807	with	0	None
31807	31808	less	0	None
31808	31809	biological	0	None
31809	31810	plausibility	0	None
31810	31811	for	0	None
31811	31812	chemoprevention	0	None
31812	31813	,	0	None
31813	31814	showed	0	None
31814	31815	no	0	None
31815	31816	significant	0	None
31816	31817	association	0	None
31817	31818	with	0	None
31818	31819	the	0	None
31819	31820	risk	0	None
31820	31821	of	0	None
31821	31822	developing	0	None
31822	31823	breast	0	None
31823	31824	cancer	0	None
31824	31825	.	0	None

31826	31827	CONCLUSION	0	None
31827	31828	:	0	None
31828	31829	Consistent	0	None
31829	31830	with	0	None
31830	31831	animal	0	None
31831	31832	models	0	None
31832	31833	and	0	None
31833	31834	laboratory	0	None
31834	31835	investigations	0	None
31835	31836	,	0	None
31836	31837	higher	0	None
31837	31838	doses	0	None
31838	31839	of	0	None
31839	31840	selective	0	None
31840	31841	COX-2	0	None
31841	31842	inhibitors	0	None
31842	31843	were	0	None
31843	31844	more	0	None
31844	31845	protective	0	None
31845	31846	against	0	None
31846	31847	breast	0	None
31847	31848	cancer	0	None
31848	31849	than	0	None
31849	31850	non-specific	0	None
31850	31851	NSAIDs	0	None
31851	31852	.	0	None

31853	31854	With	0	None
31854	31855	exposure	0	None
31855	31856	to	0	None
31856	31857	rofecoxib	0	None
31857	31858	,	0	None
31858	31859	a	0	None
31859	31860	selective	0	None
31860	31861	COX-2	0	None
31861	31862	inhibitor	0	None
31862	31863	,	0	None
31863	31864	breast	0	None
31864	31865	cancer	0	None
31865	31866	risk	0	None
31866	31867	reduction	0	None
31867	31868	was	0	None
31868	31869	appreciable	0	None
31869	31870	(	0	None
31870	31871	46%	0	None
31871	31872	)	0	None
31872	31873	,	0	None
31873	31874	suggesting	0	None
31874	31875	a	0	None
31875	31876	possible	0	None
31876	31877	role	0	None
31877	31878	for	0	None
31878	31879	selective	0	None
31879	31880	COX-2	0	None
31880	31881	inhibitors	0	None
31881	31882	in	0	None
31882	31883	breast	0	None
31883	31884	cancer	0	None
31884	31885	prophylaxis	0	None
31885	31886	.	0	None
31886	31887	Chronic	0	None
31887	31888	arsenic	2	CHEMICAL
31888	31889	ingestion	0	None
31889	31890	predisposes	0	None
31890	31891	to	0	None
31891	31892	vascular	0	None
31892	31893	disease	0	None
31893	31894	,	0	None
31894	31895	but	0	None
31895	31896	underlying	0	None
31896	31897	mechanisms	0	None
31897	31898	are	0	None
31898	31899	poorly	0	None
31899	31900	understood	0	None
31900	31901	.	0	None

31902	31903	In	0	None
31903	31904	the	0	None
31904	31905	present	0	None
31905	31906	study	0	None
31906	31907	we	0	None
31907	31908	have	0	None
31908	31909	analyzed	0	None
31909	31910	the	0	None
31910	31911	effects	0	None
31911	31912	of	0	None
31912	31913	short-term	0	None
31913	31914	arsenite	2	CHEMICAL
31914	31915	exposure	0	None
31915	31916	on	0	None
31916	31917	vascular	0	None
31917	31918	function	0	None
31918	31919	and	0	None
31919	31920	endothelium-dependent	0	None
31920	31921	relaxation	0	None
31921	31922	.	0	None

31923	31924	Endothelium-dependent	0	None
31924	31925	relaxations	0	None
31925	31926	,	0	None
31926	31927	nitric	0	None
31927	31928	oxide	0	None
31928	31929	(	0	None
31929	31930	NO	0	None
31930	31931	)	0	None
31931	31932	and	0	None
31932	31933	endothelium	0	None
31933	31934	derived	0	None
31934	31935	hyperpolarizing	0	None
31935	31936	factor	0	None
31936	31937	(	0	None
31937	31938	EDHF	0	None
31938	31939	)	0	None
31939	31940	-type	0	None
31940	31941	,	0	None
31941	31942	were	0	None
31942	31943	studied	0	None
31943	31944	in	0	None
31944	31945	rabbit	0	None
31945	31946	iliac	0	None
31946	31947	artery	0	None
31947	31948	and	0	None
31948	31949	aortic	0	None
31949	31950	rings	0	None
31950	31951	using	0	None
31951	31952	the	0	None
31952	31953	G	0	None
31953	31954	protein-coupled	0	None
31954	31955	receptor	0	None
31955	31956	agonist	0	None
31956	31957	acetylcholine	0	None
31957	31958	(	0	None
31958	31959	ACh	0	None
31959	31960	)	0	None
31960	31961	and	0	None
31961	31962	by	0	None
31962	31963	cyclopiazonic	0	None
31963	31964	acid	0	None
31964	31965	(	0	None
31965	31966	CPA	0	None
31966	31967	)	0	None
31967	31968	,	0	None
31968	31969	which	0	None
31969	31970	promotes	0	None
31970	31971	store-operated	0	None
31971	31972	Ca	0	None
31972	31973	(	0	None
31973	31974	2	0	None
31974	31975	+	0	None
31975	31976	)	0	None
31976	31977	entry	0	None
31977	31978	by	0	None
31978	31979	inhibiting	0	None
31979	31980	the	0	None
31980	31981	endothelial	0	None
31981	31982	SERCA	0	None
31982	31983	pump	0	None
31983	31984	.	0	None

31985	31986	Production	0	None
31986	31987	of	0	None
31987	31988	reactive	0	None
31988	31989	oxygen	0	None
31989	31990	species	0	None
31990	31991	(	0	None
31991	31992	ROS	0	None
31992	31993	)	0	None
31993	31994	in	0	None
31994	31995	the	0	None
31995	31996	endothelium	0	None
31996	31997	of	0	None
31997	31998	rabbit	0	None
31998	31999	aortic	0	None
31999	32000	valve	0	None
32000	32001	leaflets	0	None
32001	32002	and	0	None
32002	32003	endothelium-denuded	0	None
32003	32004	RIA	0	None
32004	32005	and	0	None
32005	32006	aortic	0	None
32006	32007	rings	0	None
32007	32008	was	0	None
32008	32009	assessed	0	None
32009	32010	by	0	None
32010	32011	imaging	0	None
32011	32012	of	0	None
32012	32013	dihydroethidium	0	None
32013	32014	.	0	None

32015	32016	In	0	None
32016	32017	the	0	None
32017	32018	iliac	0	None
32018	32019	artery	0	None
32019	32020	,	0	None
32020	32021	exposure	0	None
32021	32022	to	0	None
32022	32023	100μM	0	None
32023	32024	arsenite	2	CHEMICAL
32024	32025	for	0	None
32025	32026	30min	0	None
32026	32027	potentiated	0	None
32027	32028	EDHF-type	0	None
32028	32029	relaxations	0	None
32029	32030	evoked	0	None
32030	32031	by	0	None
32031	32032	both	0	None
32032	32033	CPA	0	None
32033	32034	and	0	None
32034	32035	ACh	0	None
32035	32036	.	0	None

32037	32038	Potentiation	0	None
32038	32039	was	0	None
32039	32040	prevented	0	None
32040	32041	by	0	None
32041	32042	catalase	0	None
32042	32043	,	0	None
32043	32044	the	0	None
32044	32045	catalase	0	None
32045	32046	/	0	None
32046	32047	superoxide	0	None
32047	32048	dismutase	0	None
32048	32049	mimetic	0	None
32049	32050	manganese	2	CHEMICAL
32050	32051	porphyrin	2	CHEMICAL
32051	32052	and	0	None
32052	32053	the	0	None
32053	32054	NADPH	0	None
32054	32055	oxidase	0	None
32055	32056	inhibitor	0	None
32056	32057	apocynin	0	None
32057	32058	.	0	None

32059	32060	By	0	None
32060	32061	contrast	0	None
32061	32062	in	0	None
32062	32063	aortic	0	None
32063	32064	rings	0	None
32064	32065	,	0	None
32065	32066	that	0	None
32066	32067	exhibited	0	None
32067	32068	negligible	0	None
32068	32069	EDHF-type	0	None
32069	32070	responses	0	None
32070	32071	,	0	None
32071	32072	endothelium-dependent	0	None
32072	32073	NO-mediated	0	None
32073	32074	relaxations	0	None
32074	32075	evoked	0	None
32075	32076	by	0	None
32076	32077	CPA	0	None
32077	32078	and	0	None
32078	32079	ACh	0	None
32079	32080	were	0	None
32080	32081	unaffected	0	None
32081	32082	by	0	None
32082	32083	arsenite	2	CHEMICAL
32083	32084	.	0	None

32085	32086	Arsenite	2	CHEMICAL
32086	32087	induced	0	None
32087	32088	apocynin-sensitive	0	None
32088	32089	increases	0	None
32089	32090	in	0	None
32090	32091	ROS	0	None
32091	32092	production	0	None
32092	32093	in	0	None
32093	32094	the	0	None
32094	32095	aortic	0	None
32095	32096	valve	0	None
32096	32097	endothelium	0	None
32097	32098	,	0	None
32098	32099	but	0	None
32099	32100	not	0	None
32100	32101	in	0	None
32101	32102	the	0	None
32102	32103	media	0	None
32103	32104	and	0	None
32104	32105	adventitia	0	None
32105	32106	of	0	None
32106	32107	the	0	None
32107	32108	iliac	0	None
32108	32109	artery	0	None
32109	32110	and	0	None
32110	32111	aorta	0	None
32111	32112	.	0	None

32113	32114	Our	0	None
32114	32115	results	0	None
32115	32116	suggest	0	None
32116	32117	that	0	None
32117	32118	arsenite	2	CHEMICAL
32118	32119	can	0	None
32119	32120	potentiate	0	None
32120	32121	EDHF-type	0	None
32121	32122	relaxations	0	None
32122	32123	via	0	None
32123	32124	a	0	None
32124	32125	mechanism	0	None
32125	32126	that	0	None
32126	32127	is	0	None
32127	32128	dependent	0	None
32128	32129	on	0	None
32129	32130	hydrogen	2	CHEMICAL
32130	32131	peroxide	2	CHEMICAL
32131	32132	,	0	None
32132	32133	thus	0	None
32133	32134	demonstrating	0	None
32134	32135	that	0	None
32135	32136	dismutation	0	None
32136	32137	of	0	None
32137	32138	the	0	None
32138	32139	superoxide	0	None
32139	32140	anion	0	None
32140	32141	generated	0	None
32141	32142	by	0	None
32142	32143	NADPH	0	None
32143	32144	oxidase	0	None
32144	32145	can	0	None
32145	32146	potentially	0	None
32146	32147	offset	0	None
32147	32148	loss	0	None
32148	32149	of	0	None
32149	32150	NO	0	None
32150	32151	bioavailability	0	None
32151	32152	under	0	None
32152	32153	conditions	0	None
32153	32154	of	0	None
32154	32155	reduced	0	None
32155	32156	eNOS	0	None
32156	32157	activity	0	None
32157	32158	.	0	None

32159	32160	By	0	None
32160	32161	contrast	0	None
32161	32162	,	0	None
32162	32163	selective	0	None
32163	32164	increases	0	None
32164	32165	in	0	None
32165	32166	endothelial	0	None
32166	32167	ROS	0	None
32167	32168	production	0	None
32168	32169	following	0	None
32169	32170	exposure	0	None
32170	32171	to	0	None
32171	32172	arsenite	2	CHEMICAL
32172	32173	failed	0	None
32173	32174	to	0	None
32174	32175	modify	0	None
32175	32176	relaxations	0	None
32176	32177	mediated	0	None
32177	32178	by	0	None
32178	32179	endogenous	0	None
32179	32180	NO	0	None
32180	32181	.	0	None
32181	32182	This	0	None
32182	32183	study	0	None
32183	32184	aims	0	None
32184	32185	to	0	None
32185	32186	assess	0	None
32186	32187	the	0	None
32187	32188	efficacy	0	None
32188	32189	and	0	None
32189	32190	safety	0	None
32190	32191	of	0	None
32191	32192	Rehmannia	0	None
32192	32193	glutinosa	0	None
32193	32194	acteosides	0	None
32194	32195	used	0	None
32195	32196	in	0	None
32196	32197	combination	0	None
32197	32198	with	0	None
32198	32199	the	0	None
32199	32200	angiotensin	2	CHEMICAL
32200	32201	receptor	0	None
32201	32202	blocker	0	None
32202	32203	irbesartan	0	None
32203	32204	to	0	None
32204	32205	treat	0	None
32205	32206	primary	0	None
32206	32207	chronic	0	None
32207	32208	glomerulonephritis	0	None
32208	32209	.	0	None

32210	32211	A	0	None
32211	32212	total	0	None
32212	32213	of	0	None
32213	32214	479	0	None
32214	32215	patients	0	None
32215	32216	diagnosed	0	None
32216	32217	with	0	None
32217	32218	primary	0	None
32218	32219	chronic	0	None
32219	32220	glomerulonephritis	0	None
32220	32221	were	0	None
32221	32222	recruited	0	None
32222	32223	from	0	None
32223	32224	outpatient	0	None
32224	32225	clinics	0	None
32225	32226	and	0	None
32226	32227	were	0	None
32227	32228	randomly	0	None
32228	32229	assigned	0	None
32229	32230	to	0	None
32230	32231	the	0	None
32231	32232	treatment	0	None
32232	32233	group	0	None
32233	32234	(	0	None
32234	32235	Rehmannia	0	None
32235	32236	glutinosa	0	None
32236	32237	acteosides	0	None
32237	32238	,	0	None
32238	32239	two	0	None
32239	32240	200-mg	0	None
32240	32241	capsules	0	None
32241	32242	,	0	None
32242	32243	bid;	0	None
32243	32244	and	0	None
32244	32245	irbesartan	0	None
32245	32246	,	0	None
32246	32247	one	0	None
32247	32248	150-mg	0	None
32248	32249	tablet	0	None
32249	32250	,	0	None
32250	32251	qd	0	None
32251	32252	)	0	None
32252	32253	or	0	None
32253	32254	the	0	None
32254	32255	control	0	None
32255	32256	group	0	None
32256	32257	(	0	None
32257	32258	irbesartan	0	None
32258	32259	,	0	None
32259	32260	one	0	None
32260	32261	150-mg	0	None
32261	32262	tablet	0	None
32262	32263	,	0	None
32263	32264	qd	0	None
32264	32265	)	0	None
32265	32266	.	0	None

32267	32268	The	0	None
32268	32269	primary	0	None
32269	32270	outcome	0	None
32270	32271	was	0	None
32271	32272	24-h	0	None
32272	32273	urinary	0	None
32273	32274	protein	0	None
32274	32275	.	0	None

32276	32277	Secondary	0	None
32277	32278	outcome	0	None
32278	32279	measures	0	None
32279	32280	included	0	None
32280	32281	blood	0	None
32281	32282	pressure	0	None
32282	32283	,	0	None
32283	32284	estimated	0	None
32284	32285	glomerular	0	None
32285	32286	filtration	0	None
32286	32287	rate	0	None
32287	32288	,	0	None
32288	32289	erythrocyturia	0	None
32289	32290	,	0	None
32290	32291	serum	0	None
32291	32293	alanine aminotransferase	3	GENE-N
32293	32294	,	0	None
32294	32296	aspartate transaminase	3	GENE-N
32296	32297	and	0	None
32297	32298	electrolytes	0	None
32298	32299	.	0	None

32300	32301	After	0	None
32301	32302	8	0	None
32302	32303	weeks	0	None
32303	32304	of	0	None
32304	32305	treatment	0	None
32305	32306	,	0	None
32306	32307	the	0	None
32307	32308	treatment	0	None
32308	32309	group	0	None
32309	32310	showed	0	None
32310	32311	a	0	None
32311	32312	mean	0	None
32312	32313	reduction	0	None
32313	32314	in	0	None
32314	32315	24-h	0	None
32315	32316	proteinuria	0	None
32316	32317	of	0	None
32317	32318	36	0	None
32318	32319	.	0	None
32319	32320	42%	0	None
32320	32321	compared	0	None
32321	32322	to	0	None
32322	32323	baseline	0	None
32323	32324	,	0	None
32324	32325	which	0	None
32325	32326	was	0	None
32326	32327	significantly	0	None
32327	32328	higher	0	None
32328	32329	than	0	None
32329	32330	the	0	None
32330	32331	mean	0	None
32331	32332	reduction	0	None
32332	32333	from	0	None
32333	32334	baseline	0	None
32334	32335	of	0	None
32335	32336	27	0	None
32336	32337	.	0	None
32337	32338	97%	0	None
32338	32339	in	0	None
32339	32340	the	0	None
32340	32341	control	0	None
32341	32342	group	0	None
32342	32343	(	0	None
32343	32344	P	0	None
32344	32345	=	0	None
32345	32346	0	0	None
32346	32347	.	0	None
32347	32348	0278	0	None
32348	32349	)	0	None
32349	32350	.	0	None

32351	32352	Adverse	0	None
32352	32353	drug	0	None
32353	32354	reactions	0	None
32354	32355	occurred	0	None
32355	32356	at	0	None
32356	32357	a	0	None
32357	32358	similarly	0	None
32358	32359	low	0	None
32359	32360	rate	0	None
32360	32361	in	0	None
32361	32362	the	0	None
32362	32363	treatment	0	None
32363	32364	group	0	None
32364	32365	(	0	None
32365	32366	0	0	None
32366	32367	.	0	None
32367	32368	4%	0	None
32368	32369	)	0	None
32369	32370	and	0	None
32370	32371	control	0	None
32371	32372	group	0	None
32372	32373	(	0	None
32373	32374	1	0	None
32374	32375	.	0	None
32375	32376	2%	0	None
32376	32377	,	0	None
32377	32378	P	0	None
32378	32379	=	0	None
32379	32380	0	0	None
32380	32381	.	0	None
32381	32382	3724	0	None
32382	32383	)	0	None
32383	32384	.	0	None

32385	32386	In	0	None
32386	32387	the	0	None
32387	32388	treatment	0	None
32388	32389	of	0	None
32389	32390	chronic	0	None
32390	32391	glomerulonephritis	0	None
32391	32392	,	0	None
32392	32393	the	0	None
32393	32394	combination	0	None
32394	32395	of	0	None
32395	32396	Rehmannia	0	None
32396	32397	glutinosa	0	None
32397	32398	acteosides	0	None
32398	32399	and	0	None
32399	32400	irbesartan	0	None
32400	32401	can	0	None
32401	32402	reduce	0	None
32402	32403	proteinuria	0	None
32403	32404	more	0	None
32404	32405	effectively	0	None
32405	32406	than	0	None
32406	32407	irbesartan	0	None
32407	32408	alone	0	None
32408	32409	.	0	None

32410	32411	Copyright	0	None
32411	32412	©	0	None
32412	32413	2013	0	None
32413	32414	John	0	None
32414	32415	Wiley	0	None
32415	32416	&	0	None
32416	32417	Sons	0	None
32417	32418	,	0	None
32418	32419	Ltd	0	None
32419	32420	.	0	None
32420	32421	Genentech	0	None
32421	32422	and	0	None
32422	32423	ImmunoGen	0	None
32423	32424	are	0	None
32424	32425	collaborating	0	None
32425	32426	on	0	None
32426	32427	the	0	None
32427	32428	development	0	None
32428	32429	of	0	None
32429	32430	trastuzumab	0	None
32430	32431	emtansine	0	None
32431	32432	,	0	None
32432	32433	a	0	None
32433	32434	HER2	0	None
32434	32435	antibody-drug	0	None
32435	32436	conjugate	0	None
32436	32437	that	0	None
32437	32438	comprises	0	None
32438	32439	Genentech's	0	None
32439	32440	trastuzumab	0	None
32440	32441	antibody	0	None
32441	32442	linked	0	None
32442	32443	to	0	None
32443	32444	ImmunoGen's	0	None
32444	32445	anti-mitotic	0	None
32445	32446	agent	0	None
32446	32447	,	0	None
32447	32448	mertansine	2	CHEMICAL
32448	32449	(	0	None
32449	32450	a	0	None
32450	32451	maytansine	0	None
32451	32452	derivative;	0	None
32452	32453	also	0	None
32453	32454	known	0	None
32454	32455	as	0	None
32455	32456	DM1	0	None
32456	32457	)	0	None
32457	32458	.	0	None

32459	32460	The	0	None
32460	32461	conjugate	0	None
32461	32462	combines	0	None
32462	32463	two	0	None
32463	32464	strategies	0	None
32464	32465	:	0	None
32465	32466	the	0	None
32466	32467	anti-HER2	0	None
32467	32468	activity	0	None
32468	32469	of	0	None
32469	32470	trastuzumab	0	None
32470	32471	,	0	None
32471	32472	and	0	None
32472	32473	the	0	None
32473	32474	targeted	0	None
32474	32475	intracellular	0	None
32475	32476	delivery	0	None
32476	32477	of	0	None
32477	32478	mertansine	2	CHEMICAL
32478	32479	,	0	None
32479	32480	a	0	None
32480	32481	tubulin	0	None
32481	32482	polymerisation	0	None
32482	32483	inhibitor	0	None
32483	32484	which	0	None
32484	32485	interferes	0	None
32485	32486	with	0	None
32486	32487	mitosis	0	None
32487	32488	and	0	None
32488	32489	promotes	0	None
32489	32490	apoptosis	0	None
32490	32491	.	0	None

32492	32493	The	0	None
32493	32494	linker	0	None
32494	32495	in	0	None
32495	32496	trastuzumab	0	None
32496	32497	emtansine	0	None
32497	32498	is	0	None
32498	32499	a	0	None
32499	32500	non-reducible	0	None
32500	32501	thioether	2	CHEMICAL
32501	32502	linker	0	None
32502	32503	,	0	None
32503	32504	N-succinimidyl-4-	0	None
32504	32505	(	0	None
32505	32506	N-maleimidomethyl	0	None
32506	32507	)	0	None
32507	32508	cyclohexane-1-carboxylate	0	None
32508	32509	(	0	None
32509	32510	SMCC	0	None
32510	32511	,	0	None
32511	32512	designated	0	None
32512	32513	MCC	0	None
32513	32514	after	0	None
32514	32515	conjugation	0	None
32515	32516	)	0	None
32516	32517	.	0	None

32518	32519	Trastuzumab	0	None
32519	32520	emtansine	0	None
32520	32521	(	0	None
32521	32522	Kadcyla™	0	None
32522	32523	)	0	None
32523	32524	has	0	None
32524	32525	been	0	None
32525	32526	launched	0	None
32526	32527	in	0	None
32527	32528	the	0	None
32528	32529	USA	0	None
32529	32530	as	0	None
32530	32531	second-line	0	None
32531	32532	monotherapy	0	None
32532	32533	for	0	None
32533	32534	HER2-positive	0	None
32534	32535	metastatic	0	None
32535	32536	breast	0	None
32536	32537	cancer	0	None
32537	32538	,	0	None
32538	32539	and	0	None
32539	32540	has	0	None
32540	32541	been	0	None
32541	32542	filed	0	None
32542	32543	for	0	None
32543	32544	approval	0	None
32544	32545	in	0	None
32545	32546	the	0	None
32546	32547	EU	0	None
32547	32548	and	0	None
32548	32549	Japan	0	None
32549	32550	in	0	None
32550	32551	this	0	None
32551	32552	indication	0	None
32552	32553	.	0	None

32554	32555	Trastuzumab	0	None
32555	32556	emtansine	0	None
32556	32557	is	0	None
32557	32558	in	0	None
32558	32559	phase	0	None
32559	32560	III	0	None
32560	32561	development	0	None
32561	32562	as	0	None
32562	32563	first-line	0	None
32563	32564	combination	0	None
32564	32565	therapy	0	None
32565	32566	or	0	None
32566	32567	monotherapy	0	None
32567	32568	for	0	None
32568	32569	metastatic	0	None
32569	32570	HER2-positive	0	None
32570	32571	breast	0	None
32571	32572	cancer	0	None
32572	32573	,	0	None
32573	32574	and	0	None
32574	32575	as	0	None
32575	32576	third-line	0	None
32576	32577	monotherapy	0	None
32577	32578	for	0	None
32578	32579	metastatic	0	None
32579	32580	HER2-positive	0	None
32580	32581	breast	0	None
32581	32582	cancer	0	None
32582	32583	.	0	None

32584	32585	Phase	0	None
32585	32586	II	0	None
32586	32587	development	0	None
32587	32588	is	0	None
32588	32589	underway	0	None
32589	32590	for	0	None
32590	32591	early-stage	0	None
32591	32592	breast	0	None
32592	32593	cancer	0	None
32593	32594	and	0	None
32594	32595	phase	0	None
32595	32596	II	0	None
32596	32597	/	0	None
32597	32598	III	0	None
32598	32599	development	0	None
32599	32600	is	0	None
32600	32601	underway	0	None
32601	32602	in	0	None
32602	32603	patients	0	None
32603	32604	with	0	None
32604	32605	HER2-positive	0	None
32605	32606	gastric	0	None
32606	32607	cancer	0	None
32607	32608	.	0	None

32609	32610	This	0	None
32610	32611	article	0	None
32611	32612	summarizes	0	None
32612	32613	the	0	None
32613	32614	milestones	0	None
32614	32615	in	0	None
32615	32616	the	0	None
32616	32617	development	0	None
32617	32618	of	0	None
32618	32619	trastuzumab	0	None
32619	32620	emtansine	0	None
32620	32621	leading	0	None
32621	32622	to	0	None
32622	32623	this	0	None
32623	32624	first	0	None
32624	32625	approval	0	None
32625	32626	for	0	None
32626	32627	the	0	None
32627	32628	treatment	0	None
32628	32629	of	0	None
32629	32630	patients	0	None
32630	32631	with	0	None
32631	32632	HER2-positive	0	None
32632	32633	,	0	None
32633	32634	metastatic	0	None
32634	32635	breast	0	None
32635	32636	cancer	0	None
32636	32637	who	0	None
32637	32638	previously	0	None
32638	32639	received	0	None
32639	32640	trastuzumab	0	None
32640	32641	and	0	None
32641	32642	a	0	None
32642	32643	taxane	2	CHEMICAL
32643	32644	,	0	None
32644	32645	separately	0	None
32645	32646	or	0	None
32646	32647	in	0	None
32647	32648	combination	0	None
32648	32649	.	0	None
32649	32650	Complexity	0	None
32650	32651	in	0	None
32651	32652	influenza	0	None
32652	32653	virus	0	None
32653	32654	targeted	0	None
32654	32655	drug	0	None
32655	32656	design	0	None
32656	32657	:	0	None
32657	32658	interaction	0	None
32658	32659	with	0	None
32659	32660	human	0	None
32660	32661	sialidases	0	None
32661	32662	.	0	None
32662	32663	Titanium	0	None
32663	32664	dioxide	0	None
32664	32665	nanoparticles	0	None
32665	32666	increase	0	None
32666	32667	inflammatory	0	None
32667	32668	responses	0	None
32668	32669	in	0	None
32669	32670	vascular	0	None
32670	32671	endothelial	0	None
32671	32672	cells	0	None
32672	32673	.	0	None
32673	32674	In	0	None
32674	32675	many	0	None
32675	32676	renal	0	None
32676	32677	diseases	0	None
32677	32678	,	0	None
32678	32682	transforming growth factor β	3	GENE-N
32682	32683	(	0	None
32683	32684	TGFβ	0	None
32684	32685	)	0	None
32685	32686	-stimulated	0	None
32686	32687	canonical	0	None
32687	32688	Smad	3	GENE-N
32688	32689	3	0	None
32689	32690	and	0	None
32690	32691	noncanonical	0	None
32691	32692	mechanistic	0	None
32692	32693	target	0	None
32693	32694	of	0	None
32694	32695	rapamycin	3	GENE-N
32695	32696	(	0	None
32696	32697	mTOR	0	None
32697	32698	)	0	None
32698	32699	promote	0	None
32699	32700	increased	0	None
32700	32701	protein	0	None
32701	32702	synthesis	0	None
32702	32703	and	0	None
32703	32704	mesangial	0	None
32704	32705	cell	0	None
32705	32706	hypertrophy	0	None
32706	32707	.	0	None

32708	32709	The	0	None
32709	32710	cellular	0	None
32710	32711	underpinnings	0	None
32711	32712	involving	0	None
32712	32713	these	0	None
32713	32714	signaling	0	None
32714	32715	molecules	0	None
32715	32716	to	0	None
32716	32717	regulate	0	None
32717	32718	mesangial	0	None
32718	32719	cell	0	None
32719	32720	hypertrophy	0	None
32720	32721	are	0	None
32721	32722	not	0	None
32722	32723	fully	0	None
32723	32724	understood	0	None
32724	32725	.	0	None

32726	32727	Deptor	0	None
32727	32728	has	0	None
32728	32729	recently	0	None
32729	32730	been	0	None
32730	32731	identified	0	None
32731	32732	as	0	None
32732	32733	an	0	None
32733	32734	mTOR	0	None
32734	32735	interacting	0	None
32735	32736	protein	0	None
32736	32737	and	0	None
32737	32738	functions	0	None
32738	32739	as	0	None
32739	32740	an	0	None
32740	32741	endogenous	0	None
32741	32742	inhibitor	0	None
32742	32743	of	0	None
32743	32744	the	0	None
32744	32745	kinase	0	None
32745	32746	activity	0	None
32746	32747	for	0	None
32747	32748	both	0	None
32748	32749	TORC1	0	None
32749	32750	and	0	None
32750	32751	TORC2	0	None
32751	32752	.	0	None

32753	32754	Prolonged	0	None
32754	32755	incubation	0	None
32755	32756	of	0	None
32756	32757	mesangial	0	None
32757	32758	cells	0	None
32758	32759	with	0	None
32759	32760	TGFβ	0	None
32760	32761	reduced	0	None
32761	32762	the	0	None
32762	32763	levels	0	None
32763	32764	of	0	None
32764	32765	deptor	0	None
32765	32766	concomitant	0	None
32766	32767	with	0	None
32767	32768	an	0	None
32768	32769	increase	0	None
32769	32770	in	0	None
32770	32771	TORC1	0	None
32771	32772	and	0	None
32772	32773	TORC2	0	None
32773	32774	activity	0	None
32774	32775	.	0	None

32776	32777	Sustained	0	None
32777	32778	TGFβ	0	None
32778	32779	activation	0	None
32779	32780	was	0	None
32780	32781	required	0	None
32781	32782	to	0	None
32782	32783	inhibit	0	None
32783	32784	association	0	None
32784	32785	of	0	None
32785	32786	deptor	0	None
32786	32787	with	0	None
32787	32788	mTOR	0	None
32788	32789	,	0	None
32789	32790	whereas	0	None
32790	32791	rapid	0	None
32791	32792	activation	0	None
32792	32793	had	0	None
32793	32794	no	0	None
32794	32795	effect	0	None
32795	32796	.	0	None

32797	32798	Using	0	None
32798	32799	the	0	None
32799	32800	mTOR	0	None
32800	32801	inhibitor	0	None
32801	32802	PP242	0	None
32802	32803	,	0	None
32803	32804	we	0	None
32804	32805	found	0	None
32805	32806	that	0	None
32806	32807	TGFβ-induced	0	None
32807	32808	both	0	None
32808	32809	early	0	None
32809	32810	and	0	None
32810	32811	sustained	0	None
32811	32812	activation	0	None
32812	32813	of	0	None
32813	32814	TORC1	0	None
32814	32815	and	0	None
32815	32816	TORC2	0	None
32816	32817	was	0	None
32817	32818	necessary	0	None
32818	32819	for	0	None
32819	32820	deptor	0	None
32820	32821	suppression	0	None
32821	32822	.	0	None

32823	32824	PP242-induced	0	None
32824	32825	reversal	0	None
32825	32826	of	0	None
32826	32827	deptor	0	None
32827	32828	suppression	0	None
32828	32829	by	0	None
32829	32830	TGFβ	0	None
32830	32831	was	0	None
32831	32832	associated	0	None
32832	32833	with	0	None
32833	32834	a	0	None
32834	32835	significant	0	None
32835	32836	inhibition	0	None
32836	32837	of	0	None
32837	32838	TGFβ-stimulated	0	None
32838	32839	protein	0	None
32839	32840	synthesis	0	None
32840	32841	and	0	None
32841	32842	hypertrophy	0	None
32842	32843	.	0	None

32844	32845	Interestingly	0	None
32845	32846	,	0	None
32846	32847	expression	0	None
32847	32848	of	0	None
32848	32849	siRNA	0	None
32849	32850	against	0	None
32850	32851	Smad	3	GENE-N
32851	32852	3	0	None
32852	32853	or	0	None
32853	32854	Smad	3	GENE-N
32854	32855	7	0	None
32855	32856	,	0	None
32856	32857	which	0	None
32857	32858	blocks	0	None
32858	32859	TGFβ	0	None
32859	32860	receptor-specific	0	None
32860	32861	Smad	3	GENE-N
32861	32862	3	0	None
32862	32863	signaling	0	None
32863	32864	,	0	None
32864	32865	prevented	0	None
32865	32866	TGFβ-induced	0	None
32866	32867	suppression	0	None
32867	32868	of	0	None
32868	32869	deptor	0	None
32869	32870	abundance	0	None
32870	32871	and	0	None
32871	32872	TORC1	0	None
32872	32873	/	0	None
32873	32874	2	0	None
32874	32875	activities	0	None
32875	32876	.	0	None

32877	32878	Furthermore	0	None
32878	32879	,	0	None
32879	32880	overexpression	0	None
32880	32881	of	0	None
32881	32882	Smad	3	GENE-N
32882	32883	3	0	None
32883	32884	decreased	0	None
32884	32885	deptor	0	None
32885	32886	expression	0	None
32886	32887	similar	0	None
32887	32888	to	0	None
32888	32889	TGFβ	0	None
32889	32890	stimulation	0	None
32890	32891	concomitant	0	None
32891	32892	with	0	None
32892	32893	increased	0	None
32893	32894	TORC1	0	None
32894	32895	and	0	None
32895	32896	TORC2	0	None
32896	32897	activities	0	None
32897	32898	.	0	None

32899	32900	Finally	0	None
32900	32901	,	0	None
32901	32902	knockdown	0	None
32902	32903	of	0	None
32903	32904	deptor	0	None
32904	32905	reversed	0	None
32905	32906	Smad	3	GENE-N
32906	32907	7-mediated	0	None
32907	32908	inhibition	0	None
32908	32909	of	0	None
32909	32910	protein	0	None
32910	32911	synthesis	0	None
32911	32912	and	0	None
32912	32913	mesangial	0	None
32913	32914	cell	0	None
32914	32915	hypertrophy	0	None
32915	32916	induced	0	None
32916	32917	by	0	None
32917	32918	TGFβ	0	None
32918	32919	.	0	None

32920	32921	These	0	None
32921	32922	data	0	None
32922	32923	reveal	0	None
32923	32924	the	0	None
32924	32925	requirement	0	None
32925	32926	of	0	None
32926	32927	both	0	None
32927	32928	early	0	None
32928	32929	and	0	None
32929	32930	late	0	None
32930	32931	activation	0	None
32931	32932	of	0	None
32932	32933	mTOR	0	None
32933	32934	for	0	None
32934	32935	TGFβ-induced	0	None
32935	32936	protein	0	None
32936	32937	synthesis	0	None
32937	32938	.	0	None

32939	32940	Our	0	None
32940	32941	results	0	None
32941	32942	support	0	None
32942	32943	that	0	None
32943	32944	TGFβ-stimulated	0	None
32944	32945	Smad	3	GENE-N
32945	32946	3	0	None
32946	32947	acts	0	None
32947	32948	as	0	None
32948	32949	a	0	None
32949	32950	key	0	None
32950	32951	node	0	None
32951	32952	to	0	None
32952	32953	instill	0	None
32953	32954	a	0	None
32954	32955	feedback	0	None
32955	32956	loop	0	None
32956	32957	between	0	None
32957	32958	deptor	0	None
32958	32959	down-regulation	0	None
32959	32960	and	0	None
32960	32961	TORC1	0	None
32961	32962	/	0	None
32962	32963	2	0	None
32963	32964	activation	0	None
32964	32965	in	0	None
32965	32966	driving	0	None
32966	32967	mesangial	0	None
32967	32968	cell	0	None
32968	32969	hypertrophy	0	None
32969	32970	.	0	None
32970	32971	Layer-by-layer	0	None
32971	32972	(	0	None
32972	32973	LBL	0	None
32973	32974	)	0	None
32974	32975	assembly	0	None
32975	32976	is	0	None
32976	32977	an	0	None
32977	32978	attractive	0	None
32978	32979	platform	0	None
32979	32980	for	0	None
32980	32981	controlled	0	None
32981	32982	release	0	None
32982	32983	of	0	None
32983	32984	biologics	0	None
32984	32985	given	0	None
32985	32986	its	0	None
32986	32987	mild	0	None
32987	32988	fabrication	0	None
32988	32989	process	0	None
32989	32990	and	0	None
32990	32991	versatility	0	None
32991	32992	in	0	None
32992	32993	coating	0	None
32993	32994	substrates	0	None
32994	32995	of	0	None
32995	32996	any	0	None
32996	32997	shape	0	None
32997	32998	.	0	None

32999	33000	Proteins	0	None
33000	33001	can	0	None
33001	33002	be	0	None
33002	33003	incorporated	0	None
33003	33004	into	0	None
33004	33005	LBL	0	None
33005	33006	coatings	0	None
33006	33007	by	0	None
33007	33008	sequentially	0	None
33008	33009	depositing	0	None
33009	33010	oppositely	0	None
33010	33011	charged	0	None
33011	33012	polyelectrolytes	0	None
33012	33013	,	0	None
33013	33014	which	0	None
33014	33015	self-assemble	0	None
33015	33016	into	0	None
33016	33017	nanoscale	0	None
33017	33018	films	0	None
33018	33019	on	0	None
33019	33020	medical	0	None
33020	33021	devices	0	None
33021	33022	or	0	None
33022	33023	tissue	0	None
33023	33024	engineering	0	None
33024	33025	scaffolds	0	None
33025	33026	.	0	None

33027	33028	However	0	None
33028	33029	,	0	None
33029	33030	previously	0	None
33030	33031	reported	0	None
33031	33032	LBL	0	None
33032	33033	platforms	0	None
33033	33034	often	0	None
33034	33035	require	0	None
33035	33036	the	0	None
33036	33037	use	0	None
33037	33038	of	0	None
33038	33039	a	0	None
33039	33040	few	0	None
33040	33041	hundred	0	None
33041	33042	layers	0	None
33042	33043	to	0	None
33043	33044	avoid	0	None
33044	33045	burst	0	None
33045	33046	release	0	None
33046	33047	,	0	None
33047	33048	which	0	None
33048	33049	hinders	0	None
33049	33050	their	0	None
33050	33051	broad	0	None
33051	33052	translation	0	None
33052	33053	due	0	None
33053	33054	to	0	None
33054	33055	the	0	None
33055	33056	lengthy	0	None
33056	33057	fabrication	0	None
33057	33058	process	0	None
33058	33059	,	0	None
33059	33060	cost	0	None
33060	33061	,	0	None
33061	33062	and	0	None
33062	33063	batch-to-batch	0	None
33063	33064	variability	0	None
33064	33065	.	0	None

33066	33067	Here	0	None
33067	33068	we	0	None
33068	33069	report	0	None
33069	33070	a	0	None
33070	33071	biodegradable	0	None
33071	33072	LBL	0	None
33072	33073	platform	0	None
33073	33074	composed	0	None
33074	33075	of	0	None
33075	33076	only	0	None
33076	33077	10	0	None
33077	33078	layers	0	None
33078	33079	with	0	None
33079	33080	tunable	0	None
33080	33081	protein	0	None
33081	33082	release	0	None
33082	33083	kinetics	0	None
33083	33084	,	0	None
33084	33085	which	0	None
33085	33086	is	0	None
33086	33087	an	0	None
33087	33088	order	0	None
33088	33089	of	0	None
33089	33090	magnitude	0	None
33090	33091	less	0	None
33091	33092	than	0	None
33092	33093	previously	0	None
33093	33094	reported	0	None
33094	33095	LBL	0	None
33095	33096	platforms	0	None
33096	33097	.	0	None

33098	33099	We	0	None
33099	33100	performed	0	None
33100	33101	a	0	None
33101	33102	combinatorial	0	None
33102	33103	study	0	None
33103	33104	to	0	None
33104	33105	examine	0	None
33105	33106	the	0	None
33106	33107	effects	0	None
33107	33108	of	0	None
33108	33109	polymer	0	None
33109	33110	chemistry	0	None
33110	33111	and	0	None
33111	33112	order	0	None
33112	33113	of	0	None
33113	33114	deposition	0	None
33114	33115	of	0	None
33115	33116	poly	0	None
33116	33117	(	0	None
33117	33118	β-amino	0	None
33118	33119	)	0	None
33119	33120	esters	0	None
33120	33121	on	0	None
33121	33122	protein	0	None
33122	33123	release	0	None
33123	33124	kinetics	0	None
33124	33125	under	0	None
33125	33126	81	0	None
33126	33127	LBL	0	None
33127	33128	assembly	0	None
33128	33129	conditions	0	None
33129	33130	.	0	None

33131	33132	Using	0	None
33132	33133	the	0	None
33133	33134	optimal	0	None
33134	33135	"polyelectrolyte	0	None
33135	33136	couples"	0	None
33136	33137	for	0	None
33137	33138	constructing	0	None
33138	33139	the	0	None
33139	33140	LBL	0	None
33140	33141	film	0	None
33141	33142	,	0	None
33142	33143	basic	0	None
33143	33146	fibroblast growth factor	3	GENE-N
33146	33147	(	0	None
33147	33148	bFGF	0	None
33148	33149	)	0	None
33149	33150	was	0	None
33150	33151	released	0	None
33151	33152	gradually	0	None
33152	33153	over	0	None
33153	33154	14	0	None
33154	33155	days	0	None
33155	33156	with	0	None
33156	33157	retained	0	None
33157	33158	biological	0	None
33158	33159	activity	0	None
33159	33160	to	0	None
33160	33161	stimulate	0	None
33161	33162	cell	0	None
33162	33163	proliferation	0	None
33163	33164	.	0	None

33165	33166	The	0	None
33166	33167	method	0	None
33167	33168	reported	0	None
33168	33169	herein	0	None
33169	33170	is	0	None
33170	33171	applicable	0	None
33171	33172	for	0	None
33172	33173	coating	0	None
33173	33174	various	0	None
33174	33175	substrates	0	None
33175	33176	including	0	None
33176	33177	metals	0	None
33177	33178	,	0	None
33178	33179	polymers	0	None
33179	33180	,	0	None
33180	33181	and	0	None
33181	33182	ceramics	0	None
33182	33183	and	0	None
33183	33184	may	0	None
33184	33185	be	0	None
33185	33186	used	0	None
33186	33187	for	0	None
33187	33188	a	0	None
33188	33189	broad	0	None
33189	33190	range	0	None
33190	33191	of	0	None
33191	33192	biomedical	0	None
33192	33193	and	0	None
33193	33194	tissue	0	None
33194	33195	engineering	0	None
33195	33196	applications	0	None
33196	33197	.	0	None
33197	33198	JAK	3	GENE-N
33198	33199	inhibitors	0	None
33199	33200	:	0	None
33200	33201	pharmacology	0	None
33201	33202	and	0	None
33202	33203	clinical	0	None
33203	33204	activity	0	None
33204	33205	in	0	None
33205	33206	chronic	0	None
33206	33207	myeloprolipherative	0	None
33207	33208	neoplasms	0	None
33208	33209	.	0	None
33209	33210	TMPRSS4	0	None
33210	33211	is	0	None
33211	33212	a	0	None
33212	33213	novel	0	None
33213	33214	type	0	None
33214	33215	II	0	None
33215	33216	transmembrane	0	None
33216	33218	serine protease	3	GENE-N
33218	33219	that	0	None
33219	33220	has	0	None
33220	33221	been	0	None
33221	33222	implicated	0	None
33222	33223	in	0	None
33223	33224	the	0	None
33224	33225	invasion	0	None
33225	33226	and	0	None
33226	33227	metastasis	0	None
33227	33228	of	0	None
33228	33229	colon	0	None
33229	33230	cancer	0	None
33230	33231	cells	0	None
33231	33232	.	0	None

33233	33234	In	0	None
33234	33235	this	0	None
33235	33236	study	0	None
33236	33237	,	0	None
33237	33238	a	0	None
33238	33239	novel	0	None
33239	33240	series	0	None
33240	33241	of	0	None
33241	33242	2-hydroxydiarylamide	0	None
33242	33243	derivatives	0	None
33243	33244	were	0	None
33244	33245	synthesized	0	None
33245	33246	and	0	None
33246	33247	evaluated	0	None
33247	33248	for	0	None
33248	33249	inhibiting	0	None
33249	33250	TMPRSS4	0	None
33250	33252	serine protease	1	GENE-Y
33252	33253	activity	0	None
33253	33254	and	0	None
33254	33255	suppressing	0	None
33255	33256	cancer	0	None
33256	33257	cell	0	None
33257	33258	invasion	0	None
33258	33259	.	0	None

33260	33261	These	0	None
33261	33262	derivatives	0	None
33262	33263	demonstrated	0	None
33263	33264	good	0	None
33264	33265	inhibitory	0	None
33265	33266	activity	0	None
33266	33267	against	0	None
33267	33268	TMPRSS4	0	None
33268	33270	serine protease	1	GENE-Y
33270	33271	,	0	None
33271	33272	which	0	None
33272	33273	correlated	0	None
33273	33274	with	0	None
33274	33275	the	0	None
33275	33276	promising	0	None
33276	33277	anti-invasive	0	None
33277	33278	activity	0	None
33278	33279	of	0	None
33279	33280	colon	0	None
33280	33281	cancer	0	None
33281	33282	cells	0	None
33282	33283	overexpressing	0	None
33283	33284	TMPRSS4	0	None
33284	33285	.	0	None
33285	33286	Palmitate	0	None
33286	33287	and	0	None
33287	33288	lipopolysaccharide	0	None
33288	33289	trigger	0	None
33289	33290	synergistic	0	None
33290	33291	ceramide	0	None
33291	33292	production	0	None
33292	33293	in	0	None
33293	33294	primary	0	None
33294	33295	macrophages	0	None
33295	33296	.	0	None
33296	33297	This	0	None
33297	33298	work	0	None
33298	33299	reports	0	None
33299	33300	on	0	None
33300	33301	the	0	None
33301	33302	composition	0	None
33302	33303	and	0	None
33303	33304	bionutritional	0	None
33304	33305	value	0	None
33305	33306	of	0	None
33306	33307	organic	0	None
33307	33308	virgin	0	None
33308	33309	olive	0	None
33309	33310	oil	0	None
33310	33311	from	0	None
33311	33312	the	0	None
33312	33313	Nocellara	0	None
33313	33314	del	0	None
33314	33315	Belice	0	None
33315	33316	variety	0	None
33316	33317	,	0	None
33317	33318	one	0	None
33318	33319	cultivated	0	None
33319	33320	in	0	None
33320	33321	the	0	None
33321	33322	olive	0	None
33322	33323	areas	0	None
33323	33324	of	0	None
33324	33325	the	0	None
33325	33326	Sicily	0	None
33326	33327	region	0	None
33327	33328	,	0	None
33328	33329	Italy	0	None
33329	33330	.	0	None

33331	33332	Destoned	0	None
33332	33333	oils	0	None
33333	33334	obtained	0	None
33334	33335	by	0	None
33335	33336	processing	0	None
33336	33337	olives	0	None
33337	33338	with	0	None
33338	33339	a	0	None
33339	33340	destoning-based	0	None
33340	33341	procedure	0	None
33341	33342	were	0	None
33342	33343	compared	0	None
33343	33344	with	0	None
33344	33345	conventional	0	None
33345	33346	oils	0	None
33346	33347	.	0	None

33348	33349	This	0	None
33349	33350	innovative	0	None
33350	33351	technique	0	None
33351	33352	,	0	None
33352	33353	consisting	0	None
33353	33354	in	0	None
33354	33355	removing	0	None
33355	33356	the	0	None
33356	33357	stone	0	None
33357	33358	from	0	None
33358	33359	fruits	0	None
33359	33360	prior	0	None
33360	33361	to	0	None
33361	33362	processing	0	None
33362	33363	,	0	None
33363	33364	strongly	0	None
33364	33365	enhanced	0	None
33365	33366	the	0	None
33366	33367	already	0	None
33367	33368	high-quality	0	None
33368	33369	level	0	None
33369	33370	of	0	None
33370	33371	the	0	None
33371	33372	conventional	0	None
33372	33373	product	0	None
33373	33374	.	0	None

33375	33376	An	0	None
33376	33377	in-depth	0	None
33377	33378	analytical	0	None
33378	33379	investigation	0	None
33379	33380	from	0	None
33380	33381	2008	0	None
33381	33382	to	0	None
33382	33383	2010	0	None
33383	33384	showed	0	None
33384	33385	how	0	None
33385	33386	this	0	None
33386	33387	innovative	0	None
33387	33388	olive	0	None
33388	33389	extraction	0	None
33389	33390	process	0	None
33390	33391	led	0	None
33391	33392	to	0	None
33392	33393	an	0	None
33393	33394	excellent	0	None
33394	33395	peculiar	0	None
33395	33396	final	0	None
33396	33397	product	0	None
33397	33398	,	0	None
33398	33399	mainly	0	None
33399	33400	attributable	0	None
33400	33401	to	0	None
33401	33402	the	0	None
33402	33403	improved	0	None
33403	33404	biophenol	0	None
33404	33405	and	0	None
33405	33406	volatile	0	None
33406	33407	composition	0	None
33407	33408	,	0	None
33408	33409	as	0	None
33409	33410	well	0	None
33410	33411	as	0	None
33411	33412	higher	0	None
33412	33413	concentrations	0	None
33413	33414	of	0	None
33414	33415	the	0	None
33415	33416	lipophilic	0	None
33416	33417	and	0	None
33417	33418	vitamin	0	None
33418	33419	antioxidants	0	None
33419	33420	(	0	None
33420	33421	tocopherols	0	None
33421	33422	and	0	None
33422	33423	tocotrienols	0	None
33423	33424	)	0	None
33424	33425	.	0	None

33426	33427	It	0	None
33427	33428	had	0	None
33428	33429	higher	0	None
33429	33430	levels	0	None
33430	33431	of	0	None
33431	33432	oleocanthal	0	None
33432	33433	(	0	None
33433	33434	p-HPEA-EDA	0	None
33434	33435	)	0	None
33435	33436	,	0	None
33436	33437	a	0	None
33437	33438	nutraceutical	0	None
33438	33439	compound	0	None
33439	33440	exerting	0	None
33440	33441	actions	0	None
33441	33442	against	0	None
33442	33443	COX1	0	None
33443	33444	and	0	None
33444	33445	COX2	1	GENE-Y
33445	33446	(	0	None
33446	33447	cycloxygenases	0	None
33447	33448	)	0	None
33448	33449	.	0	None

33450	33451	Its	0	None
33451	33452	head-space	0	None
33452	33453	aroma	0	None
33453	33454	displayed	0	None
33454	33455	new	0	None
33455	33456	volatile	0	None
33456	33457	phytomolecules	0	None
33457	33458	and	0	None
33458	33459	also	0	None
33459	33460	had	0	None
33460	33461	higher	0	None
33461	33462	levels	0	None
33462	33463	of	0	None
33463	33464	green	0	None
33464	33465	volatiles	0	None
33465	33466	from	0	None
33466	33467	the	0	None
33467	33468	lipoxygenase	0	None
33468	33469	(	0	None
33469	33470	LOX	0	None
33470	33471	)	0	None
33471	33472	-pathway	0	None
33472	33473	(	0	None
33473	33474	one	0	None
33474	33475	having	0	None
33475	33476	as	0	None
33476	33477	precursors	0	None
33477	33478	the	0	None
33478	33479	polyunsaturated	0	None
33479	33481	fatty acids	2	CHEMICAL
33481	33482	containing	0	None
33482	33483	a	0	None
33483	33484	cis-cis-1	0	None
33484	33485	,	0	None
33485	33486	4-pentadiene	0	None
33486	33487	system	0	None
33487	33488	)	0	None
33488	33489	.	0	None

33490	33491	Among	0	None
33491	33492	the	0	None
33492	33493	other	0	None
33493	33494	bioactives	0	None
33494	33495	,	0	None
33495	33496	we	0	None
33496	33497	highlight	0	None
33497	33498	its	0	None
33498	33499	significant	0	None
33499	33500	levels	0	None
33500	33501	of	0	None
33501	33502	trans-β-carotene	0	None
33502	33503	and	0	None
33503	33504	xanthophylls	0	None
33504	33505	(	0	None
33505	33506	lutein	0	None
33506	33507	,	0	None
33507	33508	violaxanthin	0	None
33508	33509	,	0	None
33509	33510	neoxanthin	0	None
33510	33511	and	0	None
33511	33512	other	0	None
33512	33513	carotenoids	0	None
33513	33514	)	0	None
33514	33515	.	0	None

33516	33517	Its	0	None
33517	33518	enhanced	0	None
33518	33519	nutritional	0	None
33519	33520	value	0	None
33520	33521	was	0	None
33521	33522	also	0	None
33522	33523	attributable	0	None
33523	33524	to	0	None
33524	33525	the	0	None
33525	33526	increased	0	None
33526	33527	intensity	0	None
33527	33528	of	0	None
33528	33529	valuable	0	None
33529	33530	tasting	0	None
33530	33531	notes	0	None
33531	33532	.	0	None
33532	33533	The	0	None
33533	33534	α-hydroxy	0	None
33534	33535	ketones	0	None
33535	33536	are	0	None
33536	33537	used	0	None
33537	33538	as	0	None
33538	33539	building	0	None
33539	33540	blocks	0	None
33540	33541	for	0	None
33541	33542	compounds	0	None
33542	33543	of	0	None
33543	33544	pharmaceutical	0	None
33544	33545	interest	0	None
33545	33546	(	0	None
33546	33547	such	0	None
33547	33548	as	0	None
33548	33549	antidepressants	0	None
33549	33550	,	0	None
33550	33551	HIV-protease	0	None
33551	33552	inhibitors	0	None
33552	33553	and	0	None
33553	33554	antitumorals	0	None
33554	33555	)	0	None
33555	33556	.	0	None

33557	33558	They	0	None
33558	33559	can	0	None
33559	33560	be	0	None
33560	33561	obtained	0	None
33561	33562	by	0	None
33562	33563	the	0	None
33563	33564	action	0	None
33564	33565	of	0	None
33565	33566	enzymes	0	None
33566	33567	or	0	None
33567	33568	whole	0	None
33568	33569	cells	0	None
33569	33570	on	0	None
33570	33571	selected	0	None
33571	33572	substrates	0	None
33572	33573	,	0	None
33573	33574	such	0	None
33574	33575	as	0	None
33575	33576	diketones	0	None
33576	33577	.	0	None

33578	33579	We	0	None
33579	33580	have	0	None
33580	33581	studied	0	None
33581	33582	the	0	None
33582	33583	enantiospecificities	0	None
33583	33584	of	0	None
33584	33585	several	0	None
33585	33586	fungal	0	None
33586	33587	(	0	None
33587	33588	AKR3C1	0	None
33588	33589	,	0	None
33589	33590	AKR5F	0	None
33590	33591	and	0	None
33591	33592	AKR5G	0	None
33592	33593	)	0	None
33593	33594	and	0	None
33594	33595	human	0	None
33595	33596	(	0	None
33596	33597	AKR1B1	0	None
33597	33598	and	0	None
33598	33599	AKR1B10	1	GENE-Y
33599	33600	)	0	None
33600	33602	aldo-keto reductases	3	GENE-N
33602	33603	in	0	None
33603	33604	the	0	None
33604	33605	production	0	None
33605	33606	of	0	None
33606	33607	α-hydroxy	0	None
33607	33608	ketones	0	None
33608	33609	and	0	None
33609	33610	diols	2	CHEMICAL
33610	33611	from	0	None
33611	33612	vicinal	0	None
33612	33613	diketones	0	None
33613	33614	.	0	None

33615	33616	The	0	None
33616	33617	reactions	0	None
33617	33618	have	0	None
33618	33619	been	0	None
33619	33620	carried	0	None
33620	33621	out	0	None
33621	33622	with	0	None
33622	33623	pure	0	None
33623	33624	enzymes	0	None
33624	33625	and	0	None
33625	33626	with	0	None
33626	33627	an	0	None
33627	33628	NADPH-regenerating	0	None
33628	33629	system	0	None
33629	33630	consisting	0	None
33630	33631	of	0	None
33631	33632	glucose-6-phosphate	2	CHEMICAL
33632	33633	and	0	None
33633	33634	glucose-6-phosphate	2	CHEMICAL
33634	33635	dehydrogenase	0	None
33635	33636	.	0	None

33637	33638	To	0	None
33638	33639	ascertain	0	None
33639	33640	the	0	None
33640	33641	regio	0	None
33641	33642	and	0	None
33642	33643	stereoselectivity	0	None
33643	33644	of	0	None
33644	33645	the	0	None
33645	33646	reduction	0	None
33646	33647	reactions	0	None
33647	33648	catalyzed	0	None
33648	33649	by	0	None
33649	33650	the	0	None
33650	33651	AKRs	0	None
33651	33652	,	0	None
33652	33653	we	0	None
33653	33654	have	0	None
33654	33655	separated	0	None
33655	33656	and	0	None
33656	33657	characterized	0	None
33657	33658	the	0	None
33658	33659	reaction	0	None
33659	33660	products	0	None
33660	33661	by	0	None
33661	33662	means	0	None
33662	33663	of	0	None
33663	33664	a	0	None
33664	33665	gas	0	None
33665	33666	chromatograph	0	None
33666	33667	equipped	0	None
33667	33668	with	0	None
33668	33669	a	0	None
33669	33670	chiral	0	None
33670	33671	column	0	None
33671	33672	and	0	None
33672	33673	coupled	0	None
33673	33674	to	0	None
33674	33675	a	0	None
33675	33676	mass	0	None
33676	33677	spectrometer	0	None
33677	33678	as	0	None
33678	33679	a	0	None
33679	33680	detector	0	None
33680	33681	.	0	None

33682	33683	According	0	None
33683	33684	to	0	None
33684	33685	the	0	None
33685	33686	regioselectivity	0	None
33686	33687	and	0	None
33687	33688	stereoselectivity	0	None
33688	33689	,	0	None
33689	33690	the	0	None
33690	33691	AKRs	0	None
33691	33692	studied	0	None
33692	33693	can	0	None
33693	33694	be	0	None
33694	33695	divided	0	None
33695	33696	in	0	None
33696	33697	two	0	None
33697	33698	groups	0	None
33698	33699	:	0	None
33699	33700	one	0	None
33700	33701	of	0	None
33701	33702	them	0	None
33702	33703	showed	0	None
33703	33704	preference	0	None
33704	33705	for	0	None
33705	33706	the	0	None
33706	33707	reduction	0	None
33707	33708	of	0	None
33708	33709	the	0	None
33709	33710	proximal	0	None
33710	33711	keto	0	None
33711	33712	group	0	None
33712	33713	,	0	None
33713	33714	resulting	0	None
33714	33715	in	0	None
33715	33716	the	0	None
33716	33717	S-enantiomer	0	None
33717	33718	of	0	None
33718	33719	the	0	None
33719	33720	corresponding	0	None
33720	33721	α-hydroxy	0	None
33721	33722	ketones	0	None
33722	33723	.	0	None

33724	33725	The	0	None
33725	33726	other	0	None
33726	33727	group	0	None
33727	33728	favored	0	None
33728	33729	the	0	None
33729	33730	reduction	0	None
33730	33731	of	0	None
33731	33732	the	0	None
33732	33733	distal	0	None
33733	33734	keto	0	None
33734	33735	group	0	None
33735	33736	and	0	None
33736	33737	yielded	0	None
33737	33738	the	0	None
33738	33739	corresponding	0	None
33739	33740	R-enantiomer	0	None
33740	33741	.	0	None

33742	33743	Three	0	None
33743	33744	of	0	None
33744	33745	the	0	None
33745	33746	AKRs	0	None
33746	33747	used	0	None
33747	33748	(	0	None
33748	33749	AKR1B1	0	None
33749	33750	,	0	None
33750	33751	AKR1B10	1	GENE-Y
33751	33752	and	0	None
33752	33753	AKR3C1	0	None
33753	33754	)	0	None
33754	33755	could	0	None
33755	33756	produce	0	None
33756	33757	2	0	None
33757	33758	,	0	None
33758	33759	3-butanediol	0	None
33759	33760	from	0	None
33760	33761	acetoin	0	None
33761	33762	.	0	None

33763	33764	We	0	None
33764	33765	have	0	None
33765	33766	explored	0	None
33766	33767	the	0	None
33767	33768	structure	0	None
33768	33769	/	0	None
33769	33770	function	0	None
33770	33771	relationships	0	None
33771	33772	in	0	None
33772	33773	the	0	None
33773	33774	reactivity	0	None
33774	33775	between	0	None
33775	33776	several	0	None
33776	33777	yeast	0	None
33777	33778	and	0	None
33778	33779	human	0	None
33779	33780	AKRs	0	None
33780	33781	and	0	None
33781	33782	various	0	None
33782	33783	diketones	0	None
33783	33784	and	0	None
33784	33785	acetoin	0	None
33785	33786	.	0	None

33787	33788	In	0	None
33788	33789	addition	0	None
33789	33790	,	0	None
33790	33791	we	0	None
33791	33792	have	0	None
33792	33793	demonstrated	0	None
33793	33794	the	0	None
33794	33795	utility	0	None
33795	33796	of	0	None
33796	33797	these	0	None
33797	33798	AKRs	0	None
33798	33799	in	0	None
33799	33800	the	0	None
33800	33801	synthesis	0	None
33801	33802	of	0	None
33802	33803	selected	0	None
33803	33804	α-hydroxy	0	None
33804	33805	ketones	0	None
33805	33806	and	0	None
33806	33807	diols	2	CHEMICAL
33807	33808	.	0	None
33808	33809	Tissues	0	None
33809	33810	distribution	0	None
33810	33811	of	0	None
33811	33812	heavy	0	None
33812	33813	metals	0	None
33813	33814	and	0	None
33814	33815	erythrocytes	0	None
33815	33816	antioxidant	0	None
33816	33817	status	0	None
33817	33818	in	0	None
33818	33819	rats	0	None
33819	33820	exposed	0	None
33820	33821	to	0	None
33821	33822	Nigerian	0	None
33822	33823	bonny	0	None
33823	33824	light	0	None
33824	33825	crude	0	None
33825	33826	oil	0	None
33826	33827	.	0	None
33827	33828	(	0	None
33828	33829	-	0	None
33829	33830	)	0	None
33830	33831	-Galanthamine	0	None
33831	33832	(	0	None
33832	33833	GAL	0	None
33833	33834	)	0	None
33834	33835	,	0	None
33835	33836	an	0	None
33836	33837	alkaloid	0	None
33837	33838	from	0	None
33838	33839	the	0	None
33839	33840	flower	0	None
33840	33841	,	0	None
33841	33842	the	0	None
33842	33843	common	0	None
33843	33844	snowdrop	0	None
33844	33845	(	0	None
33845	33846	Galanthus	0	None
33846	33847	nivalis	0	None
33847	33848	)	0	None
33848	33849	,	0	None
33849	33850	shows	0	None
33850	33851	anticholinesterase	0	None
33851	33852	activity	0	None
33852	33853	.	0	None

33854	33855	This	0	None
33855	33856	property	0	None
33856	33857	has	0	None
33857	33858	made	0	None
33858	33859	GAL	0	None
33859	33860	the	0	None
33860	33861	target	0	None
33861	33862	of	0	None
33862	33863	research	0	None
33863	33864	as	0	None
33864	33865	to	0	None
33865	33866	its	0	None
33866	33867	effectiveness	0	None
33867	33868	in	0	None
33868	33869	the	0	None
33869	33870	treatment	0	None
33870	33871	of	0	None
33871	33872	Alzheimer's	0	None
33872	33873	disease	0	None
33873	33874	.	0	None

33875	33876	We	0	None
33876	33877	have	0	None
33877	33878	solved	0	None
33878	33879	the	0	None
33879	33880	X-ray	0	None
33880	33881	crystal	0	None
33881	33882	structure	0	None
33882	33883	of	0	None
33883	33884	GAL	0	None
33884	33885	bound	0	None
33885	33886	in	0	None
33886	33887	the	0	None
33887	33888	active	0	None
33888	33889	site	0	None
33889	33890	of	0	None
33890	33891	Torpedo	0	None
33891	33892	californica	0	None
33892	33893	acetylcholinesterase	0	None
33893	33894	(	0	None
33894	33895	TcAChE	0	None
33895	33896	)	0	None
33896	33897	to	0	None
33897	33898	2	0	None
33898	33899	.	0	None
33899	33900	3	0	None
33900	33901	A	0	None
33901	33902	resolution	0	None
33902	33903	.	0	None

33904	33905	The	0	None
33905	33906	inhibitor	0	None
33906	33907	binds	0	None
33907	33908	at	0	None
33908	33909	the	0	None
33909	33910	base	0	None
33910	33911	of	0	None
33911	33912	the	0	None
33912	33913	active	0	None
33913	33914	site	0	None
33914	33915	gorge	0	None
33915	33916	of	0	None
33916	33917	TcAChE	0	None
33917	33918	,	0	None
33918	33919	interacting	0	None
33919	33920	with	0	None
33920	33921	both	0	None
33921	33922	the	0	None
33922	33923	choline-binding	0	None
33923	33924	site	0	None
33924	33925	(	0	None
33925	33926	Trp-84	0	None
33926	33927	)	0	None
33927	33928	and	0	None
33928	33929	the	0	None
33929	33930	acyl-binding	0	None
33930	33931	pocket	0	None
33931	33932	(	0	None
33932	33933	Phe-288	0	None
33933	33934	,	0	None
33934	33935	Phe-290	0	None
33935	33936	)	0	None
33936	33937	.	0	None

33938	33939	The	0	None
33939	33941	tertiary amine	2	CHEMICAL
33941	33942	group	0	None
33942	33943	of	0	None
33943	33944	GAL	0	None
33944	33945	does	0	None
33945	33946	not	0	None
33946	33947	interact	0	None
33947	33948	closely	0	None
33948	33949	with	0	None
33949	33950	Trp-84;	0	None
33950	33951	rather	0	None
33951	33952	,	0	None
33952	33953	the	0	None
33953	33954	double	0	None
33954	33955	bond	0	None
33955	33956	of	0	None
33956	33957	its	0	None
33957	33958	cyclohexene	0	None
33958	33959	ring	0	None
33959	33960	stacks	0	None
33960	33961	against	0	None
33961	33962	the	0	None
33962	33963	indole	0	None
33963	33964	ring	0	None
33964	33965	.	0	None

33966	33967	The	0	None
33967	33969	tertiary amine	2	CHEMICAL
33969	33970	appears	0	None
33970	33971	to	0	None
33971	33972	make	0	None
33972	33973	a	0	None
33973	33974	non-conventional	0	None
33974	33975	hydrogen	2	CHEMICAL
33975	33976	bond	0	None
33976	33977	,	0	None
33977	33978	via	0	None
33978	33979	its	0	None
33979	33980	N-methyl	0	None
33980	33981	group	0	None
33981	33982	,	0	None
33982	33983	to	0	None
33983	33984	Asp-72	0	None
33984	33985	,	0	None
33985	33986	near	0	None
33986	33987	the	0	None
33987	33988	top	0	None
33988	33989	of	0	None
33989	33990	the	0	None
33990	33991	gorge	0	None
33991	33992	.	0	None

33993	33994	The	0	None
33994	33995	hydroxyl	2	CHEMICAL
33995	33996	group	0	None
33996	33997	of	0	None
33997	33998	the	0	None
33998	33999	inhibitor	0	None
33999	34000	makes	0	None
34000	34001	a	0	None
34001	34002	strong	0	None
34002	34003	hydrogen	2	CHEMICAL
34003	34004	bond	0	None
34004	34005	(	0	None
34005	34006	2	0	None
34006	34007	.	0	None
34007	34008	7	0	None
34008	34009	A	0	None
34009	34010	)	0	None
34010	34011	with	0	None
34011	34012	Glu-199	0	None
34012	34013	.	0	None

34014	34015	The	0	None
34015	34016	relatively	0	None
34016	34017	tight	0	None
34017	34018	binding	0	None
34018	34019	of	0	None
34019	34020	GAL	0	None
34020	34021	to	0	None
34021	34022	TcAChE	0	None
34022	34023	appears	0	None
34023	34024	to	0	None
34024	34025	arise	0	None
34025	34026	from	0	None
34026	34027	a	0	None
34027	34028	number	0	None
34028	34029	of	0	None
34029	34030	moderate	0	None
34030	34031	to	0	None
34031	34032	weak	0	None
34032	34033	interactions	0	None
34033	34034	with	0	None
34034	34035	the	0	None
34035	34036	protein	0	None
34036	34037	,	0	None
34037	34038	coupled	0	None
34038	34039	to	0	None
34039	34040	a	0	None
34040	34041	low	0	None
34041	34042	entropy	0	None
34042	34043	cost	0	None
34043	34044	for	0	None
34044	34045	binding	0	None
34045	34046	due	0	None
34046	34047	to	0	None
34047	34048	the	0	None
34048	34049	rigid	0	None
34049	34050	nature	0	None
34050	34051	of	0	None
34051	34052	the	0	None
34052	34053	inhibitor	0	None
34053	34054	.	0	None
34054	34056	Perfluorooctane sulfonate	2	CHEMICAL
34056	34057	(	0	None
34057	34058	PFOS	0	None
34058	34059	)	0	None
34059	34060	affects	0	None
34060	34062	hormone receptor	3	GENE-N
34062	34063	activity	0	None
34063	34064	,	0	None
34064	34065	steroidogenesis	0	None
34065	34066	,	0	None
34066	34067	and	0	None
34067	34068	expression	0	None
34068	34069	of	0	None
34069	34070	endocrine-related	0	None
34070	34071	genes	0	None
34071	34072	in	0	None
34072	34073	vitro	0	None
34073	34074	and	0	None
34074	34075	in	0	None
34075	34076	vivo	0	None
34076	34077	.	0	None
34077	34078	Dopamine	0	None
34078	34079	transporter	0	None
34079	34080	gene	0	None
34080	34081	associated	0	None
34081	34082	with	0	None
34082	34083	diminished	0	None
34083	34084	subjective	0	None
34084	34085	response	0	None
34085	34086	to	0	None
34086	34087	amphetamine	0	None
34087	34088	.	0	None
34088	34089	A	0	None
34089	34090	membrane	0	None
34090	34091	vesicle-based	0	None
34091	34092	assay	0	None
34092	34093	to	0	None
34093	34094	enable	0	None
34094	34095	prediction	0	None
34095	34096	of	0	None
34096	34097	human	0	None
34097	34098	biliary	0	None
34098	34099	excretion	0	None
34099	34100	.	0	None
34100	34101	Cholinergic	0	None
34101	34102	fibers	0	None
34102	34103	from	0	None
34103	34104	the	0	None
34104	34105	brainstem	0	None
34105	34106	and	0	None
34106	34107	basal	0	None
34107	34108	forebrain	0	None
34108	34109	innervate	0	None
34109	34110	the	0	None
34110	34111	medial	0	None
34111	34112	prefrontal	0	None
34112	34113	cortex	0	None
34113	34114	(	0	None
34114	34115	mPFC	0	None
34115	34116	)	0	None
34116	34117	modulating	0	None
34117	34118	neuronal	0	None
34118	34119	activity	0	None
34119	34120	and	0	None
34120	34121	synaptic	0	None
34121	34122	plasticity	0	None
34122	34123	responses	0	None
34123	34124	to	0	None
34124	34125	hippocampal	0	None
34125	34126	inputs	0	None
34126	34127	.	0	None

34128	34129	Here	0	None
34129	34130	,	0	None
34130	34131	we	0	None
34131	34132	investigated	0	None
34132	34133	the	0	None
34133	34134	muscarinic	0	None
34134	34135	and	0	None
34135	34136	glutamatergic	0	None
34136	34137	modulation	0	None
34137	34138	of	0	None
34138	34139	long-term	0	None
34139	34140	depression	0	None
34140	34141	(	0	None
34141	34142	LTD	0	None
34142	34143	)	0	None
34143	34144	in	0	None
34144	34145	the	0	None
34145	34146	intact	0	None
34146	34147	projections	0	None
34147	34148	from	0	None
34148	34149	CA1	0	None
34149	34150	to	0	None
34150	34151	mPFC	0	None
34151	34152	in	0	None
34152	34153	vivo	0	None
34153	34154	.	0	None

34155	34156	Cortical-evoked	0	None
34156	34157	responses	0	None
34157	34158	were	0	None
34158	34159	recorded	0	None
34159	34160	in	0	None
34160	34161	urethane-anesthetized	0	None
34161	34162	rats	0	None
34162	34163	for	0	None
34163	34164	30	0	None
34164	34165	min	0	None
34165	34166	during	0	None
34166	34167	baseline	0	None
34167	34168	and	0	None
34168	34169	4	0	None
34169	34170	h	0	None
34170	34171	following	0	None
34171	34172	LTD	0	None
34172	34173	.	0	None

34174	34175	In	0	None
34175	34176	order	0	None
34176	34177	to	0	None
34177	34178	test	0	None
34178	34179	the	0	None
34179	34180	potentiating	0	None
34180	34181	effects	0	None
34181	34182	of	0	None
34182	34183	pilocarpine	0	None
34183	34184	(	0	None
34184	34185	PILO	0	None
34185	34186	)	0	None
34186	34187	,	0	None
34187	34188	independent	0	None
34188	34189	groups	0	None
34189	34190	of	0	None
34190	34191	rats	0	None
34191	34192	received	0	None
34192	34193	either	0	None
34193	34194	a	0	None
34194	34195	microinjection	0	None
34195	34196	of	0	None
34196	34197	PILO	0	None
34197	34198	(	0	None
34198	34199	40	0	None
34199	34200	nmol;	0	None
34200	34201	i	0	None
34201	34202	.	0	None

34203	34204	c	0	None
34204	34205	.	0	None

34206	34207	v	0	None
34207	34208	.	0	None

34209	34210	)	0	None
34210	34211	or	0	None
34211	34212	vehicle	0	None
34212	34213	,	0	None
34213	34214	immediately	0	None
34214	34215	before	0	None
34215	34216	or	0	None
34216	34217	20	0	None
34217	34218	min	0	None
34218	34219	after	0	None
34219	34220	a	0	None
34220	34221	sub-threshold	0	None
34221	34222	LTD	0	None
34222	34223	protocol	0	None
34223	34224	(	0	None
34224	34225	600	0	None
34225	34226	pulses	0	None
34226	34227	,	0	None
34227	34228	1	0	None
34228	34229	Hz;	0	None
34229	34230	LFS600	0	None
34230	34231	)	0	None
34231	34232	.	0	None

34233	34234	Other	0	None
34234	34235	groups	0	None
34235	34236	received	0	None
34236	34237	either	0	None
34237	34238	an	0	None
34238	34239	infusion	0	None
34239	34240	of	0	None
34240	34241	the	0	None
34241	34242	selective	0	None
34242	34243	NMDA	0	None
34243	34244	receptor	0	None
34244	34245	antagonist	0	None
34245	34246	(	0	None
34246	34247	AP7;	0	None
34247	34248	10	0	None
34248	34249	nmol;	0	None
34249	34250	intra-mPFC	0	None
34250	34251	)	0	None
34251	34252	or	0	None
34252	34253	vehicle	0	None
34253	34254	,	0	None
34254	34255	10	0	None
34255	34256	min	0	None
34256	34257	prior	0	None
34257	34258	to	0	None
34258	34259	PILO	0	None
34259	34260	preceding	0	None
34260	34261	LFS600	0	None
34261	34262	,	0	None
34262	34263	or	0	None
34263	34264	prior	0	None
34264	34265	to	0	None
34265	34266	a	0	None
34266	34267	supra-threshold	0	None
34267	34268	LTD	0	None
34268	34269	protocol	0	None
34269	34270	(	0	None
34270	34271	900	0	None
34271	34272	pulses	0	None
34272	34273	,	0	None
34273	34274	1	0	None
34274	34275	Hz;	0	None
34275	34276	LFS900	0	None
34276	34277	)	0	None
34277	34278	.	0	None

34279	34280	Our	0	None
34280	34281	results	0	None
34281	34282	show	0	None
34282	34283	that	0	None
34283	34284	PILO	0	None
34284	34285	converts	0	None
34285	34286	a	0	None
34286	34287	transient	0	None
34287	34288	cortical	0	None
34288	34289	depression	0	None
34289	34290	induced	0	None
34290	34291	by	0	None
34291	34292	LFS600	0	None
34292	34293	into	0	None
34293	34294	a	0	None
34294	34295	robust	0	None
34295	34296	LTD	0	None
34296	34297	,	0	None
34297	34298	stable	0	None
34298	34299	for	0	None
34299	34300	at	0	None
34300	34301	least	0	None
34301	34302	4	0	None
34302	34303	h	0	None
34303	34304	.	0	None

34305	34306	When	0	None
34306	34307	applied	0	None
34307	34308	after	0	None
34308	34309	LFS600	0	None
34309	34310	,	0	None
34310	34311	PILO	0	None
34311	34312	does	0	None
34312	34313	not	0	None
34313	34314	change	0	None
34314	34315	either	0	None
34315	34316	mPFC	0	None
34316	34317	basal	0	None
34317	34318	neurotransmission	0	None
34318	34319	or	0	None
34319	34320	late	0	None
34320	34321	LTD	0	None
34321	34322	.	0	None

34323	34324	Our	0	None
34324	34325	data	0	None
34325	34326	also	0	None
34326	34327	indicate	0	None
34327	34328	that	0	None
34328	34329	NMDA	0	None
34329	34330	receptor	0	None
34330	34331	pre-activation	0	None
34331	34332	is	0	None
34332	34333	essential	0	None
34333	34334	to	0	None
34334	34335	the	0	None
34335	34336	muscarinic	0	None
34336	34337	enhancement	0	None
34337	34338	of	0	None
34338	34339	mPFC	0	None
34339	34340	synaptic	0	None
34340	34341	depression	0	None
34341	34342	,	0	None
34342	34343	since	0	None
34343	34344	AP7	0	None
34344	34345	microinjection	0	None
34345	34346	into	0	None
34346	34347	the	0	None
34347	34348	mPFC	0	None
34348	34349	blocked	0	None
34349	34350	the	0	None
34350	34351	conversion	0	None
34351	34352	of	0	None
34352	34353	transient	0	None
34353	34354	depression	0	None
34354	34355	into	0	None
34355	34356	long-lasting	0	None
34356	34357	LTD	0	None
34357	34358	produced	0	None
34358	34359	by	0	None
34359	34360	PILO	0	None
34360	34361	.	0	None

34362	34363	In	0	None
34363	34364	addition	0	None
34364	34365	,	0	None
34365	34366	AP7	0	None
34366	34367	effectively	0	None
34367	34368	blocked	0	None
34368	34369	the	0	None
34369	34370	long-lasting	0	None
34370	34371	LTD	0	None
34371	34372	induced	0	None
34372	34373	by	0	None
34373	34374	LFS900	0	None
34374	34375	.	0	None

34376	34377	Therefore	0	None
34377	34378	,	0	None
34378	34379	our	0	None
34379	34380	findings	0	None
34380	34381	suggest	0	None
34381	34382	that	0	None
34382	34383	the	0	None
34383	34384	glutamatergic	0	None
34384	34385	co-activation	0	None
34385	34386	of	0	None
34386	34387	prefrontal	0	None
34387	34388	neurons	0	None
34388	34389	is	0	None
34389	34390	important	0	None
34390	34391	for	0	None
34391	34392	the	0	None
34392	34393	effects	0	None
34393	34394	of	0	None
34394	34395	PILO	0	None
34395	34396	on	0	None
34396	34397	mPFC	0	None
34397	34398	synaptic	0	None
34398	34399	depression	0	None
34399	34400	,	0	None
34400	34401	which	0	None
34401	34402	could	0	None
34402	34403	play	0	None
34403	34404	an	0	None
34404	34405	important	0	None
34405	34406	role	0	None
34406	34407	in	0	None
34407	34408	the	0	None
34408	34409	control	0	None
34409	34410	of	0	None
34410	34411	executive	0	None
34411	34412	and	0	None
34412	34413	emotional	0	None
34413	34414	functions	0	None
34414	34415	.	0	None
34415	34416	Cyclooxygenase	0	None
34416	34417	inhibition	0	None
34417	34418	attenuates	0	None
34418	34419	3-nitropropionic	0	None
34419	34420	acid-induced	0	None
34420	34421	neurotoxicity	0	None
34421	34422	in	0	None
34422	34423	rats	0	None
34423	34424	:	0	None
34424	34425	possible	0	None
34425	34426	antioxidant	0	None
34426	34427	mechanisms	0	None
34427	34428	.	0	None
34428	34429	Decrease	0	None
34429	34430	in	0	None
34430	34431	interstitial	0	None
34431	34432	pH	0	None
34432	34433	of	0	None
34433	34434	the	0	None
34434	34435	tumor	0	None
34435	34436	stroma	0	None
34436	34437	and	0	None
34437	34438	over-expression	0	None
34438	34439	of	0	None
34439	34440	low	0	None
34440	34441	density	0	None
34441	34442	lipoprotein	3	GENE-N
34442	34443	(	0	None
34443	34444	LDL	3	GENE-N
34444	34445	)	0	None
34445	34446	receptors	0	None
34446	34447	by	0	None
34447	34448	several	0	None
34448	34449	types	0	None
34449	34450	of	0	None
34450	34451	neoplastic	0	None
34451	34452	cells	0	None
34452	34453	have	0	None
34453	34454	been	0	None
34454	34455	suggested	0	None
34455	34456	to	0	None
34456	34457	be	0	None
34457	34458	important	0	None
34458	34459	determinants	0	None
34459	34460	of	0	None
34460	34461	selective	0	None
34461	34462	retention	0	None
34462	34463	of	0	None
34463	34464	photosensitizers	0	None
34464	34465	by	0	None
34465	34466	proliferative	0	None
34466	34467	tissues	0	None
34467	34468	.	0	None

34469	34470	The	0	None
34470	34471	interactions	0	None
34471	34472	of	0	None
34472	34474	chlorin e6	2	CHEMICAL
34474	34475	(	0	None
34475	34476	Ce6	0	None
34476	34477	)	0	None
34477	34478	,	0	None
34478	34479	a	0	None
34479	34480	photosensitizer	0	None
34480	34481	bearing	0	None
34481	34482	three	0	None
34482	34483	carboxylic	2	CHEMICAL
34483	34484	groups	0	None
34484	34485	,	0	None
34485	34486	with	0	None
34486	34487	plasma	0	None
34487	34488	proteins	0	None
34488	34489	and	0	None
34489	34490	DOPC	0	None
34490	34491	unilamellar	0	None
34491	34492	vesicles	0	None
34492	34493	are	0	None
34493	34494	investigated	0	None
34494	34495	by	0	None
34495	34496	fluorescence	0	None
34496	34497	spectroscopy	0	None
34497	34498	.	0	None

34499	34500	The	0	None
34500	34501	binding	0	None
34501	34502	constant	0	None
34502	34503	to	0	None
34503	34504	liposomes	0	None
34504	34505	,	0	None
34505	34506	with	0	None
34506	34507	reference	0	None
34507	34508	to	0	None
34508	34509	the	0	None
34509	34510	DOPC	0	None
34510	34511	concentration	0	None
34511	34512	,	0	None
34512	34513	is	0	None
34513	34514	6	0	None
34514	34515	x	0	None
34515	34516	10	0	None
34516	34517	(	0	None
34517	34518	3	0	None
34518	34519	)	0	None
34519	34520	M	0	None
34520	34521	(	0	None
34521	34522	-1	0	None
34522	34523	)	0	None
34523	34524	at	0	None
34524	34525	pH	0	None
34525	34526	7	0	None
34526	34527	.	0	None
34527	34528	4	0	None
34528	34529	.	0	None

34530	34531	Binding	0	None
34531	34532	of	0	None
34532	34533	Ce6	0	None
34533	34534	to	0	None
34534	34535	LDL	3	GENE-N
34535	34536	involves	0	None
34536	34537	about	0	None
34537	34538	ten	0	None
34538	34539	high	0	None
34539	34540	affinity	0	None
34540	34541	sites	0	None
34541	34542	close	0	None
34542	34543	to	0	None
34543	34544	the	0	None
34544	34545	apoprotein	0	None
34545	34546	and	0	None
34546	34547	some	0	None
34547	34548	solubilization	0	None
34548	34549	in	0	None
34549	34550	the	0	None
34550	34551	lipid	0	None
34551	34552	compartment	0	None
34552	34553	.	0	None

34554	34555	The	0	None
34555	34556	overall	0	None
34556	34557	association	0	None
34557	34558	constant	0	None
34558	34559	is	0	None
34559	34560	5	0	None
34560	34561	.	0	None
34561	34562	7	0	None
34562	34563	x	0	None
34563	34564	10	0	None
34564	34565	(	0	None
34565	34566	7	0	None
34566	34567	)	0	None
34567	34568	M	0	None
34568	34569	(	0	None
34569	34570	-1	0	None
34570	34571	)	0	None
34571	34572	at	0	None
34572	34573	pH	0	None
34573	34574	7	0	None
34574	34575	.	0	None
34575	34576	4	0	None
34576	34577	.	0	None

34578	34579	Human	0	None
34579	34581	serum albumin	1	GENE-Y
34581	34582	(	0	None
34582	34583	HSA	0	None
34583	34584	)	0	None
34584	34585	is	0	None
34585	34586	the	0	None
34586	34587	major	0	None
34587	34588	carrier	0	None
34588	34589	(	0	None
34589	34590	association	0	None
34590	34591	constant	0	None
34591	34592	1	0	None
34592	34593	.	0	None
34593	34594	8	0	None
34594	34595	x	0	None
34595	34596	10	0	None
34596	34597	(	0	None
34597	34598	8	0	None
34598	34599	)	0	None
34599	34600	M	0	None
34600	34601	(	0	None
34601	34602	-1	0	None
34602	34603	)	0	None
34603	34604	at	0	None
34604	34605	pH	0	None
34605	34606	7	0	None
34606	34607	.	0	None
34607	34608	4	0	None
34608	34609	)	0	None
34609	34610	.	0	None

34611	34612	Whereas	0	None
34612	34613	the	0	None
34613	34614	affinity	0	None
34614	34615	of	0	None
34615	34616	Ce6	0	None
34616	34617	for	0	None
34617	34618	LDL	3	GENE-N
34618	34619	and	0	None
34619	34620	liposomes	0	None
34620	34621	increases	0	None
34621	34622	at	0	None
34622	34623	lower	0	None
34623	34624	pH	0	None
34624	34625	,	0	None
34625	34626	it	0	None
34626	34627	decreases	0	None
34627	34628	for	0	None
34628	34629	albumin	0	None
34629	34630	.	0	None

34631	34632	Between	0	None
34632	34633	pH	0	None
34633	34634	7	0	None
34634	34635	.	0	None
34635	34636	4	0	None
34636	34637	and	0	None
34637	34638	6	0	None
34638	34639	.	0	None
34639	34640	5	0	None
34640	34641	,	0	None
34641	34642	the	0	None
34642	34643	relative	0	None
34643	34644	affinities	0	None
34644	34645	of	0	None
34645	34646	Ce6	0	None
34646	34647	for	0	None
34647	34648	LDL	3	GENE-N
34648	34649	versus	0	None
34649	34650	HSA	0	None
34650	34651	,	0	None
34651	34652	and	0	None
34652	34653	for	0	None
34653	34654	membranes	0	None
34654	34655	versus	0	None
34655	34656	HSA	0	None
34656	34657	,	0	None
34657	34658	are	0	None
34658	34659	multiplied	0	None
34659	34660	by	0	None
34660	34661	4	0	None
34661	34662	.	0	None
34662	34663	6	0	None
34663	34664	and	0	None
34664	34665	3	0	None
34665	34666	.	0	None
34666	34667	5	0	None
34667	34668	,	0	None
34668	34669	respectively	0	None
34669	34670	.	0	None

34671	34672	These	0	None
34672	34673	effects	0	None
34673	34674	are	0	None
34674	34675	likely	0	None
34675	34676	driven	0	None
34676	34677	by	0	None
34677	34678	the	0	None
34678	34679	ionization	0	None
34679	34680	equilibria	0	None
34680	34681	of	0	None
34681	34682	the	0	None
34682	34683	photosensitizer	0	None
34683	34684	carboxylic	2	CHEMICAL
34684	34685	chains	0	None
34685	34686	.	0	None

34687	34688	Then	0	None
34688	34689	,	0	None
34689	34690	the	0	None
34690	34691	cellular	0	None
34691	34692	uptake	0	None
34692	34693	of	0	None
34693	34695	chlorin e6	2	CHEMICAL
34695	34696	may	0	None
34696	34697	be	0	None
34697	34698	facilitated	0	None
34698	34699	by	0	None
34699	34700	its	0	None
34700	34701	pH-mediated	0	None
34701	34702	redistribution	0	None
34702	34703	within	0	None
34703	34704	the	0	None
34704	34705	tumor	0	None
34705	34706	stroma	0	None
34706	34707	.	0	None
34707	34708	Mechanisms	0	None
34708	34709	of	0	None
34709	34710	agonist-induced	0	None
34710	34711	down-regulation	0	None
34711	34712	of	0	None
34712	34713	the	0	None
34713	34716	human kappa-opioid receptor	3	GENE-N
34716	34717	:	0	None
34717	34718	internalization	0	None
34718	34719	is	0	None
34719	34720	required	0	None
34720	34721	for	0	None
34721	34722	down-regulation	0	None
34722	34723	.	0	None
34723	34724	Recent	0	None
34724	34725	studies	0	None
34725	34726	have	0	None
34726	34727	shed	0	None
34727	34728	new	0	None
34728	34729	light	0	None
34729	34730	on	0	None
34730	34731	a	0	None
34731	34732	possible	0	None
34732	34733	link	0	None
34733	34734	between	0	None
34734	34735	the	0	None
34735	34736	innate	0	None
34736	34737	activation	0	None
34737	34738	of	0	None
34738	34739	plasmocytoid	0	None
34739	34740	dendritic	0	None
34740	34741	cells	0	None
34741	34742	and	0	None
34742	34743	marginal	0	None
34743	34744	zone	0	None
34744	34745	B	0	None
34745	34746	cells	0	None
34746	34747	and	0	None
34747	34748	the	0	None
34748	34749	pathogenesis	0	None
34749	34750	of	0	None
34750	34751	systemic	0	None
34751	34752	lupus	0	None
34752	34753	erythematosus	0	None
34753	34754	.	0	None

34755	34756	Animal	0	None
34756	34757	studies	0	None
34757	34758	have	0	None
34758	34759	identified	0	None
34759	34760	that	0	None
34760	34761	this	0	None
34761	34762	response	0	None
34762	34763	requires	0	None
34763	34764	the	0	None
34764	34765	Toll-like	0	None
34765	34766	receptor	0	None
34766	34767	9	0	None
34767	34768	(	0	None
34768	34769	TLR9	0	None
34769	34770	)	0	None
34770	34771	.	0	None

34772	34773	Engagement	0	None
34773	34774	of	0	None
34774	34775	the	0	None
34775	34776	TLR9	0	None
34776	34777	by	0	None
34777	34778	various	0	None
34778	34779	ligands	0	None
34779	34780	,	0	None
34780	34781	including	0	None
34781	34782	non-canonical	0	None
34782	34783	CpG-motifs	0	None
34783	34784	,	0	None
34784	34785	can	0	None
34785	34786	cause	0	None
34786	34787	or	0	None
34787	34788	aggravate	0	None
34788	34789	pathogenic	0	None
34789	34790	autoantibody	0	None
34790	34791	production	0	None
34791	34792	and	0	None
34792	34793	cytokine	0	None
34793	34794	secretion	0	None
34794	34795	in	0	None
34795	34796	lupus	0	None
34796	34797	.	0	None

34798	34799	Attempts	0	None
34799	34800	to	0	None
34800	34801	neutralize	0	None
34801	34802	this	0	None
34802	34803	activity	0	None
34803	34804	either	0	None
34804	34805	by	0	None
34805	34806	blocking	0	None
34806	34807	the	0	None
34807	34808	acidification	0	None
34808	34809	of	0	None
34809	34810	the	0	None
34810	34811	endosomal	0	None
34811	34812	compartment	0	None
34812	34813	with	0	None
34813	34814	chloroquine	0	None
34814	34815	and	0	None
34815	34816	related	0	None
34816	34817	compounds	0	None
34817	34818	,	0	None
34818	34819	or	0	None
34819	34820	by	0	None
34820	34821	preventing	0	None
34821	34822	the	0	None
34822	34823	interaction	0	None
34823	34824	between	0	None
34824	34825	the	0	None
34825	34826	CpG-DNA	0	None
34826	34827	sequences	0	None
34827	34828	and	0	None
34828	34829	TLR9	0	None
34829	34830	using	0	None
34830	34831	inhibitory	0	None
34831	34832	oligonucleotides	0	None
34832	34833	could	0	None
34833	34834	be	0	None
34834	34835	a	0	None
34835	34836	promising	0	None
34836	34837	therapeutic	0	None
34837	34838	option	0	None
34838	34839	for	0	None
34839	34840	lupus	0	None
34840	34841	.	0	None
34841	34842	1	0	None
34842	34843	.	0	None

34844	34845	The	0	None
34845	34846	interactions	0	None
34846	34847	between	0	None
34847	34848	herbal	0	None
34848	34849	dietary	0	None
34849	34850	supplements	0	None
34850	34851	and	0	None
34851	34852	therapeutic	0	None
34852	34853	drugs	0	None
34853	34854	have	0	None
34854	34855	emerged	0	None
34855	34856	as	0	None
34856	34857	an	0	None
34857	34858	important	0	None
34858	34859	issue	0	None
34859	34860	and	0	None
34860	34861	P-glycoprotein	3	GENE-N
34861	34862	(	0	None
34862	34863	P-gp	3	GENE-N
34863	34864	)	0	None
34864	34865	has	0	None
34865	34866	been	0	None
34866	34867	reported	0	None
34867	34868	as	0	None
34868	34869	one	0	None
34869	34870	of	0	None
34870	34871	the	0	None
34871	34872	significant	0	None
34872	34873	factors	0	None
34873	34874	of	0	None
34874	34875	these	0	None
34875	34876	interactions	0	None
34876	34877	.	0	None

34878	34879	2	0	None
34879	34880	.	0	None

34881	34882	The	0	None
34882	34883	objective	0	None
34883	34884	of	0	None
34884	34885	this	0	None
34885	34886	article	0	None
34886	34887	is	0	None
34887	34888	to	0	None
34888	34889	examine	0	None
34889	34890	the	0	None
34890	34891	effects	0	None
34891	34892	of	0	None
34892	34893	single	0	None
34893	34894	and	0	None
34894	34895	repeated	0	None
34895	34896	administrations	0	None
34896	34897	of	0	None
34897	34898	silymarin	0	None
34898	34899	on	0	None
34899	34900	pharmacokinetics	0	None
34900	34901	of	0	None
34901	34902	a	0	None
34902	34903	P-gp	3	GENE-N
34903	34904	substrate	0	None
34904	34905	,	0	None
34905	34906	risperidone	0	None
34906	34907	,	0	None
34907	34908	and	0	None
34908	34909	its	0	None
34909	34910	major	0	None
34910	34911	metabolite	0	None
34911	34912	,	0	None
34912	34913	9-hydroxyrisperidone	0	None
34913	34914	,	0	None
34914	34915	in	0	None
34915	34916	rats	0	None
34916	34917	.	0	None

34918	34919	3	0	None
34919	34920	.	0	None

34921	34922	To	0	None
34922	34923	determine	0	None
34923	34924	the	0	None
34924	34925	plasma	0	None
34925	34926	levels	0	None
34926	34927	of	0	None
34927	34928	risperidone	0	None
34928	34929	and	0	None
34929	34930	9-hydroxyrisperidone	0	None
34930	34931	in	0	None
34931	34932	rats	0	None
34932	34933	,	0	None
34933	34934	a	0	None
34934	34935	HPLC	0	None
34935	34936	method	0	None
34936	34937	was	0	None
34937	34938	developed	0	None
34938	34939	using	0	None
34939	34940	a	0	None
34940	34941	liquid-liquid	0	None
34941	34942	acid	0	None
34942	34943	back	0	None
34943	34944	extraction	0	None
34944	34945	.	0	None

34946	34947	When	0	None
34947	34948	risperidone	0	None
34948	34949	(	0	None
34949	34950	6	0	None
34950	34951	mg	2	CHEMICAL
34951	34952	/	0	None
34952	34953	kg	0	None
34953	34954	)	0	None
34954	34955	was	0	None
34955	34956	co-administered	0	None
34956	34957	with	0	None
34957	34958	silymarin	0	None
34958	34959	(	0	None
34959	34960	40	0	None
34960	34961	mg	2	CHEMICAL
34961	34962	/	0	None
34962	34963	kg	0	None
34963	34964	)	0	None
34964	34965	to	0	None
34965	34966	rats	0	None
34966	34967	orally	0	None
34967	34968	,	0	None
34968	34969	the	0	None
34969	34970	C	0	None
34970	34971	(	0	None
34971	34972	max	0	None
34972	34973	)	0	None
34973	34974	of	0	None
34974	34975	9-hydroxyrisperidone	0	None
34975	34976	was	0	None
34976	34977	significantly	0	None
34977	34978	increased	0	None
34978	34979	to1	0	None
34979	34980	.	0	None
34980	34981	3-fold	0	None
34981	34982	(	0	None
34982	34983	p	0	None
34983	34984	<	0	None
34984	34985	0	0	None
34985	34986	.	0	None
34986	34987	05	0	None
34987	34988	)	0	None
34988	34989	,	0	None
34989	34990	while	0	None
34990	34991	the	0	None
34991	34992	other	0	None
34992	34993	pharmacokinetic	0	None
34993	34994	parameters	0	None
34994	34995	did	0	None
34995	34996	not	0	None
34996	34997	show	0	None
34997	34998	any	0	None
34998	34999	significant	0	None
34999	35000	differences	0	None
35000	35001	.	0	None

35002	35003	Expanding	0	None
35003	35004	the	0	None
35004	35005	experiment	0	None
35005	35006	where	0	None
35006	35007	rats	0	None
35007	35008	were	0	None
35008	35009	repeatedly	0	None
35009	35010	administered	0	None
35010	35011	with	0	None
35011	35012	silymarin	0	None
35012	35013	for	0	None
35013	35014	5	0	None
35014	35015	days	0	None
35015	35016	prior	0	None
35016	35017	to	0	None
35017	35018	giving	0	None
35018	35019	risperidone	0	None
35019	35020	,	0	None
35020	35021	the	0	None
35021	35022	C	0	None
35022	35023	(	0	None
35023	35024	max	0	None
35024	35025	)	0	None
35025	35026	of	0	None
35026	35027	risperidone	0	None
35027	35028	and	0	None
35028	35029	9-hydroxyrisperidone	0	None
35029	35030	were	0	None
35030	35031	significantly	0	None
35031	35032	increased	0	None
35032	35033	to	0	None
35033	35034	2	0	None
35034	35035	.	0	None
35035	35036	4-fold	0	None
35036	35037	(	0	None
35037	35038	p	0	None
35038	35039	<	0	None
35039	35040	0	0	None
35040	35041	.	0	None
35041	35042	001	0	None
35042	35043	)	0	None
35043	35044	and	0	None
35044	35045	1	0	None
35045	35046	.	0	None
35046	35047	7-fold	0	None
35047	35048	(	0	None
35048	35049	p	0	None
35049	35050	<	0	None
35050	35051	0	0	None
35051	35052	.	0	None
35052	35053	001	0	None
35053	35054	)	0	None
35054	35055	,	0	None
35055	35056	respectively	0	None
35056	35057	,	0	None
35057	35058	and	0	None
35058	35059	the	0	None
35059	35060	AUC	0	None
35060	35061	(	0	None
35061	35062	0-t	0	None
35062	35063	)	0	None
35063	35064	,	0	None
35064	35065	as	0	None
35065	35066	well	0	None
35066	35067	to	0	None
35067	35068	1	0	None
35068	35069	.	0	None
35069	35070	7-fold	0	None
35070	35071	(	0	None
35071	35072	p	0	None
35072	35073	<	0	None
35073	35074	0	0	None
35074	35075	.	0	None
35075	35076	05	0	None
35076	35077	)	0	None
35077	35078	and	0	None
35078	35079	2	0	None
35079	35080	.	0	None
35080	35081	1-fold	0	None
35081	35082	(	0	None
35082	35083	p	0	None
35083	35084	<	0	None
35084	35085	0	0	None
35085	35086	.	0	None
35086	35087	01	0	None
35087	35088	)	0	None
35088	35089	,	0	None
35089	35090	respectively	0	None
35090	35091	.	0	None

35092	35093	4	0	None
35093	35094	.	0	None

35095	35096	The	0	None
35096	35097	repeated	0	None
35097	35098	exposures	0	None
35098	35099	of	0	None
35099	35100	silymarin	0	None
35100	35101	,	0	None
35101	35102	compared	0	None
35102	35103	to	0	None
35103	35104	single	0	None
35104	35105	administration	0	None
35105	35106	of	0	None
35106	35107	silymarin	0	None
35107	35108	,	0	None
35108	35109	increased	0	None
35109	35110	oral	0	None
35110	35111	bioavailability	0	None
35111	35112	and	0	None
35112	35113	affected	0	None
35113	35114	the	0	None
35114	35115	pharmacokinetics	0	None
35115	35116	of	0	None
35116	35117	risperidone	0	None
35117	35118	and	0	None
35118	35119	9-hydroxyrisperidone	0	None
35119	35120	,	0	None
35120	35121	by	0	None
35121	35122	inhibiting	0	None
35122	35123	P-gp	3	GENE-N
35123	35124	.	0	None
35124	35125	OBJECTIVES	0	None
35125	35126	:	0	None
35126	35127	Medical	0	None
35127	35128	treatment	0	None
35128	35129	of	0	None
35129	35130	tyrosinemia	0	None
35130	35131	I	0	None
35131	35132	relies	0	None
35132	35133	on	0	None
35133	35134	the	0	None
35134	35135	herbicide	0	None
35135	35136	NTBC	0	None
35136	35137	[	0	None
35137	35138	Orfadin	0	None
35138	35139	2-	0	None
35139	35140	(	0	None
35140	35141	2-nitro-4-trifluoromethylbenzoyl	0	None
35141	35142	)	0	None
35142	35143	-cyclohexane-1	0	None
35143	35144	,	0	None
35144	35145	3-dione	0	None
35145	35146	]	0	None
35146	35147	,	0	None
35147	35148	an	0	None
35148	35149	inhibitor	0	None
35149	35150	of	0	None
35150	35151	plant	0	None
35151	35152	and	0	None
35152	35153	mammalian	0	None
35153	35154	2-oxoacid-utilizing	0	None
35154	35155	dioxygenases	0	None
35155	35156	with	0	None
35156	35157	a	0	None
35157	35158	collective	0	None
35158	35159	catalytic	0	None
35159	35160	cycle	0	None
35160	35161	(	0	None
35161	35162	'HAG'	0	None
35162	35163	mechanism	0	None
35163	35164	)	0	None
35164	35165	.	0	None

35166	35167	We	0	None
35167	35168	hypothesize	0	None
35168	35169	that	0	None
35169	35170	NTBC-treated	0	None
35170	35171	tyrosinemia	0	None
35171	35172	I	0	None
35172	35173	is	0	None
35173	35174	a	0	None
35174	35175	human	0	None
35175	35176	model	0	None
35176	35177	for	0	None
35177	35178	the	0	None
35178	35179	pathogenic	0	None
35179	35180	role	0	None
35180	35181	of	0	None
35181	35182	two	0	None
35182	35183	major	0	None
35183	35184	enzymes	0	None
35184	35185	in	0	None
35185	35186	this	0	None
35186	35187	class	0	None
35187	35188	,	0	None
35188	35189	4-hydroxyphenylpyruvate	0	None
35189	35190	dioxygenase	0	None
35190	35191	(	0	None
35191	35192	4-HPPD;	0	None
35192	35193	EC	0	None
35193	35194	1	0	None
35194	35195	.	0	None
35195	35196	13	0	None
35196	35197	.	0	None
35197	35198	11	0	None
35198	35199	.	0	None
35199	35200	27	0	None
35200	35201	)	0	None
35201	35202	and	0	None
35202	35203	prolyl	0	None
35203	35204	4-hydroxylase	0	None
35204	35205	(	0	None
35205	35206	P4-H;	0	None
35206	35207	E	0	None
35207	35208	.	0	None

35209	35210	C	0	None
35210	35211	.	0	None

35212	35213	1	0	None
35213	35214	.	0	None
35214	35215	14	0	None
35215	35216	.	0	None
35216	35217	11	0	None
35217	35218	.	0	None
35218	35219	2	0	None
35219	35220	)	0	None
35220	35221	,	0	None
35221	35222	essential	0	None
35222	35223	for	0	None
35223	35224	tyrosine	2	CHEMICAL
35224	35225	and	0	None
35225	35226	collagen	3	GENE-N
35226	35227	metabolism	0	None
35227	35228	,	0	None
35228	35229	respectively	0	None
35229	35230	.	0	None

35231	35232	METHODS	0	None
35232	35233	:	0	None
35233	35234	In	0	None
35234	35235	a	0	None
35235	35236	patient	0	None
35236	35237	with	0	None
35237	35238	established	0	None
35238	35239	tyrosinemia	0	None
35239	35240	I	0	None
35240	35241	,	0	None
35241	35242	we	0	None
35242	35243	monitored	0	None
35243	35244	the	0	None
35244	35245	in	0	None
35245	35246	vivo	0	None
35246	35247	activities	0	None
35247	35248	of	0	None
35248	35249	4-HPPD	0	None
35249	35250	and	0	None
35250	35251	P4-H	0	None
35251	35252	via	0	None
35252	35253	five	0	None
35253	35254	biomarkers	0	None
35254	35255	before	0	None
35255	35256	and	0	None
35256	35257	during	0	None
35257	35258	NTBC	0	None
35258	35259	medication	0	None
35259	35260	.	0	None

35261	35262	Hypothesis	0	None
35262	35263	testing	0	None
35263	35264	at	0	None
35264	35265	the	0	None
35265	35266	molecular	0	None
35266	35267	level	0	None
35267	35268	was	0	None
35268	35269	performed	0	None
35269	35270	by	0	None
35270	35271	computational	0	None
35271	35272	modeling	0	None
35272	35273	of	0	None
35273	35274	NTBC	0	None
35274	35275	binding	0	None
35275	35276	to	0	None
35276	35277	the	0	None
35277	35278	crystal	0	None
35278	35279	structure-derived	0	None
35279	35280	active	0	None
35280	35281	site	0	None
35281	35282	of	0	None
35282	35283	4-HPPD	0	None
35283	35284	,	0	None
35284	35285	and	0	None
35285	35286	then	0	None
35286	35287	relating	0	None
35287	35288	these	0	None
35288	35289	findings	0	None
35289	35290	to	0	None
35290	35291	our	0	None
35291	35292	experimental	0	None
35292	35293	results	0	None
35293	35294	and	0	None
35294	35295	to	0	None
35295	35296	known	0	None
35296	35297	P4-H	0	None
35297	35298	data	0	None
35298	35299	.	0	None

35300	35301	RESULTS	0	None
35301	35302	:	0	None
35302	35303	NTBC	0	None
35303	35304	rapidly	0	None
35304	35305	normalized	0	None
35305	35306	the	0	None
35306	35307	biomarkers	0	None
35307	35308	for	0	None
35308	35309	4-HPPD	0	None
35309	35310	activity	0	None
35310	35311	.	0	None

35312	35313	However	0	None
35313	35314	,	0	None
35314	35315	those	0	None
35315	35316	for	0	None
35316	35317	P4-H	0	None
35317	35318	activity	0	None
35318	35319	remained	0	None
35319	35320	uniformly	0	None
35320	35321	elevated	0	None
35321	35322	after	0	None
35322	35323	one	0	None
35323	35324	hundred	0	None
35324	35325	days	0	None
35325	35326	on	0	None
35326	35327	NTBC	0	None
35327	35328	,	0	None
35328	35329	the	0	None
35329	35330	PIIINP	0	None
35330	35331	biomarker	0	None
35331	35332	even	0	None
35332	35333	increasing	0	None
35333	35334	above	0	None
35334	35335	its	0	None
35335	35336	grossly	0	None
35336	35337	abnormal	0	None
35337	35338	,	0	None
35338	35339	initial	0	None
35339	35340	level	0	None
35340	35341	.	0	None

35342	35343	This	0	None
35343	35344	selective	0	None
35344	35345	enzyme	0	None
35345	35346	inhibition	0	None
35346	35347	despite	0	None
35347	35348	a	0	None
35348	35349	collective	0	None
35349	35350	catalytic	0	None
35350	35351	cycle	0	None
35351	35352	is	0	None
35352	35353	attributed	0	None
35353	35354	to	0	None
35354	35355	the	0	None
35355	35356	conformation	0	None
35356	35357	of	0	None
35357	35358	NTBC	0	None
35358	35359	,	0	None
35359	35360	which	0	None
35360	35361	only	0	None
35361	35362	fits	0	None
35362	35363	the	0	None
35363	35364	active	0	None
35364	35365	site	0	None
35365	35366	of	0	None
35366	35367	4-HPPD	0	None
35367	35368	,	0	None
35368	35369	as	0	None
35369	35370	confirmed	0	None
35370	35371	by	0	None
35371	35372	its	0	None
35372	35373	crystal	0	None
35373	35374	structure	0	None
35374	35375	.	0	None

35376	35377	CONCLUSIONS	0	None
35377	35378	:	0	None
35378	35379	Normalization	0	None
35379	35380	of	0	None
35380	35381	hepatic	0	None
35381	35382	collagen	3	GENE-N
35382	35383	formation	0	None
35383	35384	,	0	None
35384	35385	highly	0	None
35385	35386	desirable	0	None
35386	35387	in	0	None
35387	35388	all	0	None
35388	35389	fibrotic	0	None
35389	35390	liver	0	None
35390	35391	diseases	0	None
35391	35392	,	0	None
35392	35393	is	0	None
35393	35394	not	0	None
35394	35395	achieved	0	None
35395	35396	by	0	None
35396	35397	NTBC	0	None
35397	35398	in	0	None
35398	35399	tyrosinemia	0	None
35399	35400	I	0	None
35400	35401	.	0	None

35402	35403	By	0	None
35403	35404	establishing	0	None
35404	35405	the	0	None
35405	35406	molecular	0	None
35406	35407	cause	0	None
35407	35408	for	0	None
35408	35409	this	0	None
35409	35410	failure	0	None
35410	35411	,	0	None
35411	35412	our	0	None
35412	35413	results	0	None
35413	35414	also	0	None
35414	35415	establish	0	None
35415	35416	a	0	None
35416	35417	rational	0	None
35417	35418	approach	0	None
35418	35419	to	0	None
35419	35420	identify	0	None
35420	35421	inhibitors	0	None
35421	35422	that	0	None
35422	35423	achieve	0	None
35423	35424	that	0	None
35424	35425	goal	0	None
35425	35426	,	0	None
35426	35427	either	0	None
35427	35428	by	0	None
35428	35429	joint	0	None
35429	35430	4-HPPD	0	None
35430	35431	/	0	None
35431	35432	P-4H	0	None
35432	35433	inhibition	0	None
35433	35434	,	0	None
35434	35435	or	0	None
35435	35436	by	0	None
35436	35437	inhibition	0	None
35437	35438	of	0	None
35438	35439	only	0	None
35439	35440	P-4H	0	None
35440	35441	.	0	None
35441	35442	Mapping	0	None
35442	35443	the	0	None
35443	35444	block	0	None
35444	35445	of	0	None
35445	35446	a	0	None
35446	35447	cloned	0	None
35447	35448	human	0	None
35448	35449	inward	0	None
35449	35450	rectifier	0	None
35450	35451	potassium	0	None
35451	35452	channel	0	None
35452	35453	by	0	None
35453	35454	dofetilide	0	None
35454	35455	.	0	None
35455	35456	GLP-1	0	None
35456	35457	receptor	0	None
35457	35458	activated	0	None
35458	35459	insulin	0	None
35459	35460	secretion	0	None
35460	35461	from	0	None
35461	35462	pancreatic	0	None
35462	35463	β-cells	0	None
35463	35464	:	0	None
35464	35465	mechanism	0	None
35465	35466	and	0	None
35466	35467	glucose	0	None
35467	35468	dependence	0	None
35468	35469	.	0	None
35469	35470	Benzodiazepines	0	None
35470	35471	(	0	None
35471	35472	BDZs	0	None
35472	35473	)	0	None
35473	35474	depress	0	None
35474	35475	neuronal	0	None
35475	35476	excitability	0	None
35476	35477	via	0	None
35477	35478	positive	0	None
35478	35479	allosteric	0	None
35479	35480	modulation	0	None
35480	35481	of	0	None
35481	35482	inhibitory	0	None
35482	35483	GABA	2	CHEMICAL
35483	35484	(	0	None
35484	35485	A	0	None
35485	35486	)	0	None
35486	35487	receptors	0	None
35487	35488	(	0	None
35488	35489	GABA	2	CHEMICAL
35489	35490	(	0	None
35490	35491	A	0	None
35491	35492	)	0	None
35492	35493	R	0	None
35493	35494	)	0	None
35494	35495	.	0	None

35496	35497	BDZs	0	None
35497	35498	and	0	None
35498	35499	other	0	None
35499	35500	positive	0	None
35500	35501	GABA	2	CHEMICAL
35501	35502	(	0	None
35502	35503	A	0	None
35503	35504	)	0	None
35504	35505	R	0	None
35505	35506	modulators	0	None
35506	35507	,	0	None
35507	35508	including	0	None
35508	35509	barbiturates	0	None
35509	35510	,	0	None
35510	35511	ethanol	2	CHEMICAL
35511	35512	,	0	None
35512	35513	and	0	None
35513	35514	neurosteroids	0	None
35514	35515	,	0	None
35515	35516	can	0	None
35516	35517	also	0	None
35517	35518	inhibit	0	None
35518	35519	L-type	0	None
35519	35520	voltage-gated	0	None
35520	35521	calcium	0	None
35521	35522	channels	0	None
35522	35523	(	0	None
35523	35524	L-VGCCs	0	None
35524	35525	)	0	None
35525	35526	,	0	None
35526	35527	which	0	None
35527	35528	could	0	None
35528	35529	contribute	0	None
35529	35530	to	0	None
35530	35531	reduced	0	None
35531	35532	neuronal	0	None
35532	35533	excitability	0	None
35533	35534	.	0	None

35535	35536	Because	0	None
35536	35537	neuronal	0	None
35537	35538	L-VGCC	0	None
35538	35539	function	0	None
35539	35540	is	0	None
35540	35541	up-regulated	0	None
35541	35542	after	0	None
35542	35543	long-term	0	None
35543	35544	GABA	2	CHEMICAL
35544	35545	(	0	None
35545	35546	A	0	None
35546	35547	)	0	None
35547	35548	R	0	None
35548	35549	modulator	0	None
35549	35550	exposure	0	None
35550	35551	,	0	None
35551	35552	an	0	None
35552	35553	interaction	0	None
35553	35554	with	0	None
35554	35555	L-VGCCs	0	None
35555	35556	may	0	None
35556	35557	also	0	None
35557	35558	play	0	None
35558	35559	a	0	None
35559	35560	role	0	None
35560	35561	in	0	None
35561	35562	physical	0	None
35562	35563	dependence	0	None
35563	35564	.	0	None

35565	35566	The	0	None
35566	35567	current	0	None
35567	35568	studies	0	None
35568	35569	assessed	0	None
35569	35570	the	0	None
35570	35571	effects	0	None
35571	35572	of	0	None
35572	35573	BDZs	0	None
35573	35574	(	0	None
35574	35575	diazepam	0	None
35575	35576	,	0	None
35576	35577	flurazepam	0	None
35577	35578	,	0	None
35578	35579	and	0	None
35579	35580	desalkylflurazepam	0	None
35580	35581	)	0	None
35581	35582	,	0	None
35582	35583	allopregnanolone	2	CHEMICAL
35583	35584	,	0	None
35584	35585	pentobarbital	0	None
35585	35586	,	0	None
35586	35587	and	0	None
35587	35588	ethanol	2	CHEMICAL
35588	35589	on	0	None
35589	35590	whole-cell	0	None
35590	35591	Ba	2	CHEMICAL
35591	35592	(	0	None
35592	35593	2	0	None
35593	35594	+	0	None
35594	35595	)	0	None
35595	35596	currents	0	None
35596	35597	through	0	None
35597	35598	recombinant	0	None
35598	35599	neuronal	0	None
35599	35600	Ca	0	None
35600	35601	(	0	None
35601	35602	v	0	None
35602	35603	)	0	None
35603	35604	1	0	None
35604	35605	.	0	None
35605	35606	2	0	None
35606	35607	and	0	None
35607	35608	Ca	0	None
35608	35609	(	0	None
35609	35610	v	0	None
35610	35611	)	0	None
35611	35612	1	0	None
35612	35613	.	0	None
35613	35614	3	0	None
35614	35615	L-VGCCs	0	None
35615	35616	expressed	0	None
35616	35617	with	0	None
35617	35618	beta	0	None
35618	35619	(	0	None
35619	35620	3	0	None
35620	35621	)	0	None
35621	35622	and	0	None
35622	35623	alpha	0	None
35623	35624	(	0	None
35624	35625	2	0	None
35625	35626	)	0	None
35626	35627	delta-1	0	None
35627	35628	in	0	None
35628	35629	HEK293T	0	None
35629	35630	cells	0	None
35630	35631	.	0	None

35632	35633	Allopregnanolone	2	CHEMICAL
35633	35634	was	0	None
35634	35635	the	0	None
35635	35636	most	0	None
35636	35637	potent	0	None
35637	35638	inhibitor	0	None
35638	35639	(	0	None
35639	35640	IC	0	None
35640	35641	(	0	None
35641	35642	50	0	None
35642	35643	)	0	None
35643	35644	,	0	None
35644	35645	approximately	0	None
35645	35646	10	0	None
35646	35647	muM	0	None
35647	35648	)	0	None
35648	35649	,	0	None
35649	35650	followed	0	None
35650	35651	by	0	None
35651	35652	BDZs	0	None
35652	35653	(	0	None
35653	35654	IC	0	None
35654	35655	(	0	None
35655	35656	50	0	None
35656	35657	)	0	None
35657	35658	,	0	None
35658	35659	approximately	0	None
35659	35660	50	0	None
35660	35661	muM	0	None
35661	35662	)	0	None
35662	35663	,	0	None
35663	35664	pentobarbital	0	None
35664	35665	(	0	None
35665	35666	IC	0	None
35666	35667	(	0	None
35667	35668	50	0	None
35668	35669	)	0	None
35669	35670	,	0	None
35670	35671	0	0	None
35671	35672	.	0	None
35672	35673	3-1	0	None
35673	35674	mM	0	None
35674	35675	)	0	None
35675	35676	,	0	None
35676	35677	and	0	None
35677	35678	ethanol	2	CHEMICAL
35678	35679	(	0	None
35679	35680	IC	0	None
35680	35681	(	0	None
35681	35682	50	0	None
35682	35683	)	0	None
35683	35684	,	0	None
35684	35685	approximately	0	None
35685	35686	300	0	None
35686	35687	mM	0	None
35687	35688	)	0	None
35688	35689	.	0	None

35690	35691	Ca	0	None
35691	35692	(	0	None
35692	35693	v	0	None
35693	35694	)	0	None
35694	35695	1	0	None
35695	35696	.	0	None
35696	35697	3	0	None
35697	35698	channels	0	None
35698	35699	were	0	None
35699	35700	less	0	None
35700	35701	sensitive	0	None
35701	35702	to	0	None
35702	35703	pentobarbital	0	None
35703	35704	inhibition	0	None
35704	35705	than	0	None
35705	35706	Ca	0	None
35706	35707	(	0	None
35707	35708	v	0	None
35708	35709	)	0	None
35709	35710	1	0	None
35710	35711	.	0	None
35711	35712	2	0	None
35712	35713	channels	0	None
35713	35714	,	0	None
35714	35715	similar	0	None
35715	35716	to	0	None
35716	35717	dihydropyridine	0	None
35717	35718	(	0	None
35718	35719	DHP	0	None
35719	35720	)	0	None
35720	35721	L-VGCC	0	None
35721	35722	antagonists	0	None
35722	35723	.	0	None

35724	35725	All	0	None
35725	35726	GABA	2	CHEMICAL
35726	35727	(	0	None
35727	35728	A	0	None
35728	35729	)	0	None
35729	35730	R	0	None
35730	35731	modulators	0	None
35731	35732	induced	0	None
35732	35733	a	0	None
35733	35734	negative	0	None
35734	35735	shift	0	None
35735	35736	in	0	None
35736	35737	the	0	None
35737	35738	steady-state	0	None
35738	35739	inactivation	0	None
35739	35740	curve	0	None
35740	35741	of	0	None
35741	35742	Ca	0	None
35742	35743	(	0	None
35743	35744	v	0	None
35744	35745	)	0	None
35745	35746	1	0	None
35746	35747	.	0	None
35747	35748	3	0	None
35748	35749	channels	0	None
35749	35750	,	0	None
35750	35751	but	0	None
35751	35752	only	0	None
35752	35753	BDZs	0	None
35753	35754	and	0	None
35754	35755	pentobarbital	0	None
35755	35756	induced	0	None
35756	35757	a	0	None
35757	35758	negative	0	None
35758	35759	shift	0	None
35759	35760	in	0	None
35760	35761	Ca	0	None
35761	35762	(	0	None
35762	35763	v	0	None
35763	35764	)	0	None
35764	35765	1	0	None
35765	35766	.	0	None
35766	35767	2	0	None
35767	35768	channel	0	None
35768	35769	inactivation	0	None
35769	35770	.	0	None

35771	35772	Mutation	0	None
35772	35773	of	0	None
35773	35774	the	0	None
35774	35775	high-affinity	0	None
35775	35776	DHP	0	None
35776	35777	binding	0	None
35777	35778	site	0	None
35778	35779	(	0	None
35779	35780	T1039Y	0	None
35780	35781	and	0	None
35781	35782	Q1043M	0	None
35782	35783	)	0	None
35783	35784	in	0	None
35784	35785	Ca	0	None
35785	35786	(	0	None
35786	35787	v	0	None
35787	35788	)	0	None
35788	35789	1	0	None
35789	35790	.	0	None
35790	35791	2	0	None
35791	35792	channels	0	None
35792	35793	reduced	0	None
35793	35794	pentobarbital	0	None
35794	35795	potency	0	None
35795	35796	.	0	None

35797	35798	Despite	0	None
35798	35799	the	0	None
35799	35800	structural	0	None
35800	35801	similarity	0	None
35801	35802	between	0	None
35802	35803	benzothiazepines	0	None
35803	35804	and	0	None
35804	35805	BDZs	0	None
35805	35806	,	0	None
35806	35807	mutation	0	None
35807	35808	of	0	None
35808	35809	an	0	None
35809	35811	amino acid	2	CHEMICAL
35811	35812	important	0	None
35812	35813	for	0	None
35813	35814	diltiazem	0	None
35814	35815	potency	0	None
35815	35816	(	0	None
35816	35817	I1150A	0	None
35817	35818	)	0	None
35818	35819	did	0	None
35819	35820	not	0	None
35820	35821	affect	0	None
35821	35822	diazepam	0	None
35822	35823	potency	0	None
35823	35824	.	0	None

35825	35826	Although	0	None
35826	35827	L-VGCC	0	None
35827	35828	inhibition	0	None
35828	35829	by	0	None
35829	35830	BDZs	0	None
35830	35831	occurred	0	None
35831	35832	at	0	None
35832	35833	concentrations	0	None
35833	35834	that	0	None
35834	35835	are	0	None
35835	35836	possibly	0	None
35836	35837	too	0	None
35837	35838	high	0	None
35838	35839	to	0	None
35839	35840	be	0	None
35840	35841	clinically	0	None
35841	35842	relevant	0	None
35842	35843	and	0	None
35843	35844	is	0	None
35844	35845	not	0	None
35845	35846	likely	0	None
35846	35847	to	0	None
35847	35848	play	0	None
35848	35849	a	0	None
35849	35850	role	0	None
35850	35851	in	0	None
35851	35852	the	0	None
35852	35853	up-regulation	0	None
35853	35854	of	0	None
35854	35855	L-VGCCs	0	None
35855	35856	during	0	None
35856	35857	long-term	0	None
35857	35858	treatment	0	None
35858	35859	,	0	None
35859	35860	pentobarbital	0	None
35860	35861	and	0	None
35861	35862	ethanol	2	CHEMICAL
35862	35863	inhibited	0	None
35863	35864	L-VGCCs	0	None
35864	35865	at	0	None
35865	35866	clinically	0	None
35866	35867	relevant	0	None
35867	35868	concentrations	0	None
35868	35869	.	0	None
35869	35870	1	0	None
35870	35871	.	0	None

35872	35873	The	0	None
35873	35874	aim	0	None
35874	35875	of	0	None
35875	35876	the	0	None
35876	35877	present	0	None
35877	35878	study	0	None
35878	35879	was	0	None
35879	35880	to	0	None
35880	35881	evaluate	0	None
35881	35882	the	0	None
35882	35883	relative	0	None
35883	35884	beta	0	None
35884	35885	1	0	None
35885	35886	/	0	None
35886	35887	beta	0	None
35887	35888	2	0	None
35888	35889	antagonist	0	None
35889	35890	selectivity	0	None
35890	35891	of	0	None
35891	35892	the	0	None
35892	35893	beta-adrenoceptor	3	GENE-N
35893	35894	blocker	0	None
35894	35895	nadolol	0	None
35895	35896	,	0	None
35896	35897	in	0	None
35897	35898	lower	0	None
35898	35899	than	0	None
35899	35900	conventional	0	None
35900	35901	clinical	0	None
35901	35902	doses	0	None
35902	35903	.	0	None

35904	35905	2	0	None
35905	35906	.	0	None

35907	35908	Eight	0	None
35908	35909	normal	0	None
35909	35910	volunteers	0	None
35910	35911	received	0	None
35911	35912	single	0	None
35912	35913	oral	0	None
35913	35914	doses	0	None
35914	35915	of	0	None
35915	35916	either	0	None
35916	35917	placebo	0	None
35917	35918	(	0	None
35918	35919	PL	0	None
35919	35920	)	0	None
35920	35921	,	0	None
35921	35922	nadolol	0	None
35922	35923	5	0	None
35923	35924	mg	2	CHEMICAL
35924	35925	(	0	None
35925	35926	N5	0	None
35926	35927	)	0	None
35927	35928	,	0	None
35928	35929	20	0	None
35929	35930	mg	2	CHEMICAL
35930	35931	(	0	None
35931	35932	N20	0	None
35932	35933	)	0	None
35933	35934	or	0	None
35934	35935	80	0	None
35935	35936	mg	2	CHEMICAL
35936	35937	(	0	None
35937	35938	N80	0	None
35938	35939	)	0	None
35939	35940	in	0	None
35940	35941	a	0	None
35941	35942	single-blind	0	None
35942	35943	,	0	None
35943	35944	randomised	0	None
35944	35945	crossover	0	None
35945	35946	design	0	None
35946	35947	.	0	None

35948	35949	beta	0	None
35949	35950	1-adrenoceptor	0	None
35950	35951	antagonism	0	None
35951	35952	was	0	None
35952	35953	assessed	0	None
35953	35954	by	0	None
35954	35955	attenuation	0	None
35955	35956	of	0	None
35956	35957	exercise	0	None
35957	35958	tachycardia	0	None
35958	35959	,	0	None
35959	35960	and	0	None
35960	35961	beta	0	None
35961	35962	2-adrenoceptor	0	None
35962	35963	blockade	0	None
35963	35964	by	0	None
35964	35965	effects	0	None
35965	35966	on	0	None
35966	35967	salbutamol-induced	0	None
35967	35968	chronotropic	0	None
35968	35969	,	0	None
35969	35970	hypokalaemic	0	None
35970	35971	and	0	None
35971	35972	finger	0	None
35972	35973	tremor	0	None
35973	35974	responses	0	None
35974	35975	.	0	None

35976	35977	The	0	None
35977	35978	relative	0	None
35978	35979	percentage	0	None
35979	35980	attenuation	0	None
35980	35981	of	0	None
35981	35982	beta	0	None
35982	35983	2	0	None
35983	35984	and	0	None
35984	35985	beta	0	None
35985	35986	1-mediated	0	None
35986	35987	responses	0	None
35987	35988	was	0	None
35988	35989	calculated	0	None
35989	35990	and	0	None
35990	35991	expressed	0	None
35991	35992	as	0	None
35992	35993	beta	0	None
35993	35994	2	0	None
35994	35995	:	0	None
35995	35996	beta	0	None
35996	35997	1	0	None
35997	35998	selectivity	0	None
35998	35999	ratios	0	None
35999	36000	.	0	None

36001	36002	3	0	None
36002	36003	.	0	None

36004	36005	Nadolol	0	None
36005	36006	produced	0	None
36006	36007	dose-related	0	None
36007	36008	reductions	0	None
36008	36009	in	0	None
36009	36010	exercise	0	None
36010	36011	tachycardia	0	None
36011	36012	in	0	None
36012	36013	keeping	0	None
36013	36014	with	0	None
36014	36015	increasing	0	None
36015	36016	beta	0	None
36016	36017	1-adrenoceptor	0	None
36017	36018	blockade;	0	None
36018	36019	mean	0	None
36019	36020	%	0	None
36020	36021	reduction	0	None
36021	36022	(	0	None
36022	36023	95%	0	None
36023	36024	CI	0	None
36024	36025	)	0	None
36025	36026	compared	0	None
36026	36027	with	0	None
36027	36028	placebo	0	None
36028	36029	:	0	None
36029	36030	N5	0	None
36030	36031	10	0	None
36031	36032	.	0	None
36032	36033	7	0	None
36033	36034	(	0	None
36034	36035	6	0	None
36035	36036	.	0	None
36036	36037	6	0	None
36037	36038	to	0	None
36038	36039	14	0	None
36039	36040	.	0	None
36040	36041	8	0	None
36041	36042	)	0	None
36042	36043	,	0	None
36043	36044	N20	0	None
36044	36045	21	0	None
36045	36046	.	0	None
36046	36047	4	0	None
36047	36048	(	0	None
36048	36049	17	0	None
36049	36050	.	0	None
36050	36051	3	0	None
36051	36052	to	0	None
36052	36053	25	0	None
36053	36054	.	0	None
36054	36055	4	0	None
36055	36056	)	0	None
36056	36057	,	0	None
36057	36058	N80	0	None
36058	36059	38	0	None
36059	36060	.	0	None
36060	36061	9	0	None
36061	36062	(	0	None
36062	36063	34	0	None
36063	36064	.	0	None
36064	36065	8	0	None
36065	36066	to	0	None
36066	36067	42	0	None
36067	36068	.	0	None
36068	36069	9	0	None
36069	36070	)	0	None
36070	36071	.	0	None

36072	36073	However	0	None
36073	36074	,	0	None
36074	36075	even	0	None
36075	36076	the	0	None
36076	36077	lowest	0	None
36077	36078	dose	0	None
36078	36079	of	0	None
36079	36080	nadolol	0	None
36080	36081	(	0	None
36081	36082	5	0	None
36082	36083	mg	2	CHEMICAL
36083	36084	)	0	None
36084	36085	produced	0	None
36085	36086	almost	0	None
36086	36087	complete	0	None
36087	36088	blunting	0	None
36088	36089	of	0	None
36089	36090	beta	0	None
36090	36091	2-mediated	0	None
36091	36092	effects	0	None
36092	36093	and	0	None
36093	36094	significantly	0	None
36094	36095	increase	0	None
36095	36096	exercise	0	None
36096	36097	hyperkalaemia;	0	None
36097	36098	peak	0	None
36098	36099	exercise	0	None
36099	36100	hyperkalaemia	0	None
36100	36101	(	0	None
36101	36102	mmol	0	None
36102	36103	l-1	0	None
36103	36104	)	0	None
36104	36105	(	0	None
36105	36106	means	0	None
36106	36107	and	0	None
36107	36108	95%	0	None
36108	36109	CI	0	None
36109	36110	)	0	None
36110	36111	:	0	None
36111	36112	PL	0	None
36112	36113	4	0	None
36113	36114	.	0	None
36114	36115	88	0	None
36115	36116	(	0	None
36116	36117	4	0	None
36117	36118	.	0	None
36118	36119	68	0	None
36119	36120	to	0	None
36120	36121	5	0	None
36121	36122	.	0	None
36122	36123	07	0	None
36123	36124	)	0	None
36124	36125	,	0	None
36125	36126	N5	0	None
36126	36127	5	0	None
36127	36128	.	0	None
36128	36129	36	0	None
36129	36130	(	0	None
36130	36131	5	0	None
36131	36132	.	0	None
36132	36133	17	0	None
36133	36134	to	0	None
36134	36135	5	0	None
36135	36136	.	0	None
36136	36137	55	0	None
36137	36138	)	0	None
36138	36139	,	0	None
36139	36140	N20	0	None
36140	36141	5	0	None
36141	36142	.	0	None
36142	36143	48	0	None
36143	36144	(	0	None
36144	36145	5	0	None
36145	36146	.	0	None
36146	36147	28	0	None
36147	36148	to	0	None
36148	36149	5	0	None
36149	36150	.	0	None
36150	36151	67	0	None
36151	36152	)	0	None
36152	36153	,	0	None
36153	36154	N80	0	None
36154	36155	5	0	None
36155	36156	.	0	None
36156	36157	42	0	None
36157	36158	(	0	None
36158	36159	5	0	None
36159	36160	.	0	None
36160	36161	22	0	None
36161	36162	to	0	None
36162	36163	5	0	None
36163	36164	.	0	None
36164	36165	61	0	None
36165	36166	)	0	None
36166	36167	.	0	None

36168	36169	beta	0	None
36169	36170	2	0	None
36170	36171	:	0	None
36171	36172	beta	0	None
36172	36173	1	0	None
36173	36174	selectivity	0	None
36174	36175	ratios	0	None
36175	36176	significantly	0	None
36176	36177	increased	0	None
36177	36178	as	0	None
36178	36179	the	0	None
36179	36180	dose	0	None
36180	36181	of	0	None
36181	36182	nadolol	0	None
36182	36183	was	0	None
36183	36184	reduced	0	None
36184	36185	.	0	None

36186	36187	4	0	None
36187	36188	.	0	None

36189	36190	These	0	None
36190	36191	data	0	None
36191	36192	suggest	0	None
36192	36193	that	0	None
36193	36194	whereas	0	None
36194	36195	in	0	None
36195	36196	the	0	None
36196	36197	clinical	0	None
36197	36198	dose	0	None
36198	36199	range	0	None
36199	36200	nadolol	0	None
36200	36201	behaves	0	None
36201	36202	as	0	None
36202	36203	a	0	None
36203	36204	non-selective	0	None
36204	36205	beta-adrenoceptor	3	GENE-N
36205	36206	antagonist	0	None
36206	36207	,	0	None
36207	36208	as	0	None
36208	36209	the	0	None
36209	36210	dose	0	None
36210	36211	is	0	None
36211	36212	reduced	0	None
36212	36213	this	0	None
36213	36214	drug	0	None
36214	36215	demonstrates	0	None
36215	36216	an	0	None
36216	36217	increasing	0	None
36217	36218	degree	0	None
36218	36219	of	0	None
36219	36220	selectivity	0	None
36220	36221	for	0	None
36221	36222	the	0	None
36222	36223	beta	0	None
36223	36224	2-adrenoceptor	0	None
36224	36225	.	0	None

36226	36227	(	0	None
36227	36228	ABSTRACT	0	None
36228	36229	TRUNCATED	0	None
36229	36230	AT	0	None
36230	36231	250	0	None
36231	36232	WORDS	0	None
36232	36233	)	0	None
36233	36234	The	0	None
36234	36235	aim	0	None
36235	36236	of	0	None
36236	36237	this	0	None
36237	36238	work	0	None
36238	36239	was	0	None
36239	36240	to	0	None
36240	36241	examine	0	None
36241	36242	the	0	None
36242	36243	chemical	0	None
36243	36244	constituents	0	None
36244	36245	and	0	None
36245	36246	antioxidant	0	None
36246	36247	potential	0	None
36247	36248	of	0	None
36248	36249	water-soluble	0	None
36249	36250	fractions	0	None
36250	36251	from	0	None
36251	36252	the	0	None
36252	36253	commonly	0	None
36253	36254	consumed	0	None
36254	36255	vegetable	0	None
36255	36256	,	0	None
36256	36257	Allium	0	None
36257	36258	vineale	0	None
36258	36259	.	0	None

36260	36261	The	0	None
36261	36262	water-soluble	0	None
36262	36263	fraction	0	None
36263	36264	,	0	None
36264	36265	containing	0	None
36265	36266	phenolic	0	None
36266	36267	compounds	0	None
36267	36268	,	0	None
36268	36269	was	0	None
36269	36270	extracted	0	None
36270	36271	with	0	None
36271	36272	ethyl	2	CHEMICAL
36272	36273	acetate	0	None
36273	36274	to	0	None
36274	36275	obtain	0	None
36275	36276	flavonoids	0	None
36276	36277	which	0	None
36277	36278	were	0	None
36278	36279	separated	0	None
36279	36280	and	0	None
36280	36281	purified	0	None
36281	36282	by	0	None
36282	36283	repeated	0	None
36283	36284	column	0	None
36284	36285	chromatography	0	None
36285	36286	over	0	None
36286	36287	Sephadex	0	None
36287	36288	LH-20	0	None
36288	36289	,	0	None
36289	36290	RP	0	None
36290	36291	C18	0	None
36291	36292	and	0	None
36292	36293	silica	0	None
36293	36294	gel	0	None
36294	36295	.	0	None

36296	36297	The	0	None
36297	36298	isolated	0	None
36298	36299	compounds	0	None
36299	36300	were	0	None
36300	36301	identified	0	None
36301	36302	according	0	None
36302	36303	to	0	None
36303	36304	their	0	None
36304	36305	physicochemical	0	None
36305	36306	properties	0	None
36306	36307	and	0	None
36307	36308	spectral	0	None
36308	36309	data	0	None
36309	36310	(	0	None
36310	36311	UV	0	None
36311	36312	,	0	None
36312	36313	HPLC-TOF	0	None
36313	36314	/	0	None
36314	36315	MS	0	None
36315	36316	,	0	None
36316	36317	(	0	None
36317	36318	1	0	None
36318	36319	)	0	None
36319	36320	H	0	None
36320	36321	NMR	0	None
36321	36322	,	0	None
36322	36323	(	0	None
36323	36324	13	0	None
36324	36325	)	0	None
36325	36326	C	0	None
36326	36327	NMR	0	None
36327	36328	and	0	None
36328	36329	2D	0	None
36329	36330	NMR	0	None
36330	36331	)	0	None
36331	36332	.	0	None

36333	36334	Three	0	None
36334	36335	flavonoids	0	None
36335	36336	were	0	None
36336	36337	isolated	0	None
36337	36338	and	0	None
36338	36339	identified	0	None
36339	36340	as	0	None
36340	36341	chrysoeriol-7-O-	0	None
36341	36342	[	0	None
36342	36343	2″-O-E-feruloyl	0	None
36343	36344	]	0	None
36344	36345	-β-d-glucoside	0	None
36345	36346	(	0	None
36346	36347	1	0	None
36347	36348	)	0	None
36348	36349	,	0	None
36349	36350	chrysoeriol	2	CHEMICAL
36350	36351	(	0	None
36351	36352	2	0	None
36352	36353	)	0	None
36353	36354	,	0	None
36354	36355	and	0	None
36355	36356	isorhamnetin-3-β-d-glucoside	0	None
36356	36357	(	0	None
36357	36358	3	0	None
36358	36359	)	0	None
36359	36360	.	0	None

36361	36362	Antioxidant	0	None
36362	36363	studies	0	None
36363	36364	of	0	None
36364	36365	the	0	None
36365	36366	aqueous	0	None
36366	36367	extract	0	None
36367	36368	and	0	None
36368	36369	three	0	None
36369	36370	isolated	0	None
36370	36371	compounds	0	None
36371	36372	,	0	None
36372	36373	1	0	None
36373	36374	,	0	None
36374	36375	2	0	None
36375	36376	,	0	None
36376	36377	3	0	None
36377	36378	,	0	None
36378	36379	were	0	None
36379	36380	undertaken	0	None
36380	36381	and	0	None
36381	36382	they	0	None
36382	36383	were	0	None
36383	36384	found	0	None
36384	36385	to	0	None
36385	36386	have	0	None
36386	36387	significant	0	None
36387	36388	antioxidant	0	None
36388	36389	activity	0	None
36389	36390	.	0	None

36391	36392	Antioxidant	0	None
36392	36393	activities	0	None
36393	36394	were	0	None
36394	36395	evaluated	0	None
36395	36396	for	0	None
36396	36397	total	0	None
36397	36398	antioxidant	0	None
36398	36399	activity	0	None
36399	36400	by	0	None
36400	36401	the	0	None
36401	36402	ferric	0	None
36402	36403	thiocyanate	0	None
36403	36404	method	0	None
36404	36405	,	0	None
36405	36407	ferric ion	2	CHEMICAL
36407	36408	(	0	None
36408	36409	Fe	0	None
36409	36410	(	0	None
36410	36411	3	0	None
36411	36412	+	0	None
36412	36413	)	0	None
36413	36414	)	0	None
36414	36415	reducing	0	None
36415	36416	antioxidant	0	None
36416	36417	power	0	None
36417	36418	assay	0	None
36418	36419	(	0	None
36419	36420	FRAP	0	None
36420	36421	)	0	None
36421	36422	,	0	None
36422	36423	ferrous	0	None
36423	36424	ion	0	None
36424	36425	(	0	None
36425	36426	Fe	0	None
36426	36427	(	0	None
36427	36428	2	0	None
36428	36429	+	0	None
36429	36430	)	0	None
36430	36431	)	0	None
36431	36432	metal	0	None
36432	36433	chelating	0	None
36433	36434	activity	0	None
36434	36435	,	0	None
36435	36436	and	0	None
36436	36437	DPPH	0	None
36437	36438	free	0	None
36438	36439	radical-scavenging	0	None
36439	36440	activity	0	None
36440	36441	.	0	None

36442	36443	The	0	None
36443	36444	water-soluble	0	None
36444	36445	ethyl	2	CHEMICAL
36445	36446	acetate	0	None
36446	36447	and	0	None
36447	36448	methanol	0	None
36448	36449	extraction	0	None
36449	36450	methods	0	None
36450	36451	were	0	None
36451	36452	also	0	None
36452	36453	compared	0	None
36453	36454	using	0	None
36454	36455	HPLC-TOF	0	None
36455	36456	/	0	None
36456	36457	MS	0	None
36457	36458	.	0	None
36458	36459	Tumor-suppressive	0	None
36459	36460	Maspin	0	None
36460	36461	Functions	0	None
36461	36462	as	0	None
36462	36463	a	0	None
36463	36464	Reactive	0	None
36464	36465	Oxygen	0	None
36465	36466	Species	0	None
36466	36467	Scavenger	0	None
36467	36468	:	0	None
36468	36469	IMPORTANCE	0	None
36469	36470	OF	0	None
36470	36471	CYSTEINE	0	None
36471	36472	RESIDUES	0	None
36472	36473	.	0	None
36473	36474	Virus-sized	0	None
36474	36475	particulate	0	None
36475	36476	adjuvants	0	None
36476	36477	such	0	None
36477	36478	as	0	None
36478	36479	ISCOMs	0	None
36479	36480	,	0	None
36480	36481	polystyrene	0	None
36481	36482	nanoparticles	0	None
36482	36483	and	0	None
36483	36484	virus-like	0	None
36484	36485	particles	0	None
36485	36486	have	0	None
36486	36487	been	0	None
36487	36488	shown	0	None
36488	36489	to	0	None
36489	36490	target	0	None
36490	36491	dendritic	0	None
36491	36492	cells	0	None
36492	36493	,	0	None
36493	36494	resulting	0	None
36494	36495	in	0	None
36495	36496	the	0	None
36496	36497	activation	0	None
36497	36498	of	0	None
36498	36499	T	0	None
36499	36500	and	0	None
36500	36501	B	0	None
36501	36502	cells	0	None
36502	36503	in	0	None
36503	36504	vivo	0	None
36504	36505	.	0	None

36506	36507	Using	0	None
36507	36508	an	0	None
36508	36509	ovine	0	None
36509	36510	pseudo-afferent	0	None
36510	36511	lymph	0	None
36511	36512	cannulation	0	None
36512	36513	model	0	None
36513	36514	to	0	None
36514	36515	capture	0	None
36515	36516	APC	0	None
36516	36517	that	0	None
36517	36518	traffic	0	None
36518	36519	from	0	None
36519	36520	the	0	None
36520	36521	site	0	None
36521	36522	of	0	None
36522	36523	injection	0	None
36523	36524	to	0	None
36524	36525	the	0	None
36525	36526	local	0	None
36526	36527	lymph	0	None
36527	36528	node	0	None
36528	36529	,	0	None
36529	36530	we	0	None
36530	36531	show	0	None
36531	36532	that	0	None
36532	36533	40-50nm	0	None
36533	36534	nanoparticles	0	None
36534	36535	are	0	None
36535	36536	taken	0	None
36536	36537	up	0	None
36537	36538	at	0	None
36538	36539	the	0	None
36539	36540	site	0	None
36540	36541	of	0	None
36541	36542	injection	0	None
36542	36543	by	0	None
36543	36544	dendritic	0	None
36544	36545	cells	0	None
36545	36546	(	0	None
36546	36547	DCs	0	None
36547	36548	)	0	None
36548	36549	migrating	0	None
36549	36550	to	0	None
36550	36551	the	0	None
36551	36552	draining	0	None
36552	36553	lymph	0	None
36553	36554	node	0	None
36554	36555	.	0	None

36556	36557	These	0	None
36557	36558	DCs	0	None
36558	36559	can	0	None
36559	36560	express	0	None
36560	36561	CD11c	0	None
36561	36562	,	0	None
36562	36563	CD1b	0	None
36563	36564	,	0	None
36564	36565	CD5	0	None
36565	36566	,	0	None
36566	36567	MHC	0	None
36567	36568	class	0	None
36568	36569	II	0	None
36569	36570	and	0	None
36570	36571	CD8	0	None
36571	36572	.	0	None

36573	36574	Nanoparticles	0	None
36574	36575	transported	0	None
36575	36576	by	0	None
36576	36577	DCs	0	None
36577	36578	migrating	0	None
36578	36579	from	0	None
36579	36580	the	0	None
36580	36581	site	0	None
36581	36582	of	0	None
36582	36583	injection	0	None
36583	36584	to	0	None
36584	36585	the	0	None
36585	36586	local	0	None
36586	36587	lymph	0	None
36587	36588	node	0	None
36588	36589	therefore	0	None
36589	36590	needs	0	None
36590	36591	to	0	None
36591	36592	be	0	None
36592	36593	considered	0	None
36593	36594	as	0	None
36594	36595	a	0	None
36595	36596	new	0	None
36596	36597	mechanism	0	None
36597	36598	underlying	0	None
36598	36599	the	0	None
36599	36600	immunogenicity	0	None
36600	36601	of	0	None
36601	36602	virus-sized	0	None
36602	36603	vaccine	0	None
36603	36604	delivery	0	None
36604	36605	systems	0	None
36605	36606	.	0	None
36606	36607	Novel	0	None
36607	36608	mutations	0	None
36608	36609	of	0	None
36609	36611	androgen receptor	3	GENE-N
36611	36612	:	0	None
36612	36613	a	0	None
36613	36614	possible	0	None
36614	36615	mechanism	0	None
36615	36616	of	0	None
36616	36617	bicalutamide	2	CHEMICAL
36617	36618	withdrawal	0	None
36618	36619	syndrome	0	None
36619	36620	.	0	None
36620	36621	Chemoprevention	0	None
36621	36622	for	0	None
36622	36623	high-risk	0	None
36623	36624	women	0	None
36624	36625	:	0	None
36625	36626	tamoxifen	0	None
36626	36627	and	0	None
36627	36628	beyond	0	None
36628	36629	.	0	None
36629	36630	PURPOSE	0	None
36630	36631	:	0	None
36631	36632	We	0	None
36632	36633	provide	0	None
36633	36634	a	0	None
36634	36635	comprehensive	0	None
36635	36636	overview	0	None
36636	36637	of	0	None
36637	36638	the	0	None
36638	36639	role	0	None
36639	36640	of	0	None
36640	36641	alpha1-adrenergic	0	None
36641	36642	receptors	0	None
36642	36643	(	0	None
36643	36644	alpha1ARs	0	None
36644	36645	)	0	None
36645	36646	as	0	None
36646	36647	critical	0	None
36647	36648	mediators	0	None
36648	36649	of	0	None
36649	36650	lower	0	None
36650	36651	urinary	0	None
36651	36652	tract	0	None
36652	36653	symptoms	0	None
36653	36654	(	0	None
36654	36655	LUTS	0	None
36655	36656	)	0	None
36656	36657	and	0	None
36657	36658	pathophysiology	0	None
36658	36659	in	0	None
36659	36660	benign	0	None
36660	36661	prostatic	0	None
36661	36662	hyperplasia	0	None
36662	36663	(	0	None
36663	36664	BPH	0	None
36664	36665	)	0	None
36665	36666	,	0	None
36666	36667	and	0	None
36667	36668	we	0	None
36668	36669	review	0	None
36669	36670	the	0	None
36670	36671	pharmacological	0	None
36671	36672	antagonists	0	None
36672	36673	of	0	None
36673	36674	alpha1ARs	0	None
36674	36675	.	0	None

36676	36677	MATERIALS	0	None
36677	36678	AND	0	None
36678	36679	METHODS	0	None
36679	36680	:	0	None
36680	36681	A	0	None
36681	36682	review	0	None
36682	36683	was	0	None
36683	36684	performed	0	None
36684	36685	of	0	None
36685	36686	pertinent	0	None
36686	36687	studies	0	None
36687	36688	in	0	None
36688	36689	the	0	None
36689	36690	literature	0	None
36690	36691	relating	0	None
36691	36692	to	0	None
36692	36693	the	0	None
36693	36694	pathophysiology	0	None
36694	36695	of	0	None
36695	36696	LUTS	0	None
36696	36697	and	0	None
36697	36698	BPH	0	None
36698	36699	,	0	None
36699	36700	focusing	0	None
36700	36701	on	0	None
36701	36702	the	0	None
36702	36703	role	0	None
36703	36704	of	0	None
36704	36705	alpha1ARs	0	None
36705	36706	,	0	None
36706	36707	and	0	None
36707	36708	of	0	None
36708	36709	clinical	0	None
36709	36710	trial	0	None
36710	36711	and	0	None
36711	36712	practice	0	None
36712	36713	data	0	None
36713	36714	evaluating	0	None
36714	36715	the	0	None
36715	36716	different	0	None
36716	36717	agents	0	None
36717	36718	that	0	None
36718	36719	inhibit	0	None
36719	36720	these	0	None
36720	36721	receptors	0	None
36721	36722	.	0	None

36723	36724	RESULTS	0	None
36724	36725	:	0	None
36725	36726	Further	0	None
36726	36727	characterization	0	None
36727	36728	of	0	None
36728	36729	the	0	None
36729	36730	alpha1AR	0	None
36730	36731	gene	0	None
36731	36732	family	0	None
36732	36733	indicates	0	None
36733	36734	that	0	None
36734	36735	3	0	None
36735	36736	receptor	0	None
36736	36737	subtypes	0	None
36737	36738	exist	0	None
36738	36739	in	0	None
36739	36740	humans	0	None
36740	36741	.	0	None

36742	36743	Their	0	None
36743	36744	different	0	None
36744	36745	distribution	0	None
36745	36746	between	0	None
36746	36747	urinary	0	None
36747	36748	tract	0	None
36748	36749	and	0	None
36749	36750	cardiovascular	0	None
36750	36751	tissues	0	None
36751	36752	has	0	None
36752	36753	provided	0	None
36753	36754	a	0	None
36754	36755	strategy	0	None
36755	36756	for	0	None
36756	36757	the	0	None
36757	36758	development	0	None
36758	36759	of	0	None
36759	36760	improved	0	None
36760	36761	therapeutic	0	None
36761	36762	agents	0	None
36762	36763	.	0	None

36764	36765	Since	0	None
36765	36766	excessive	0	None
36766	36767	activity	0	None
36767	36768	of	0	None
36768	36769	the	0	None
36769	36770	alpha1aAR	0	None
36770	36771	and	0	None
36771	36772	alpha1dAR	0	None
36772	36773	subtypes	0	None
36773	36774	appears	0	None
36774	36775	to	0	None
36775	36776	be	0	None
36776	36777	a	0	None
36777	36778	common	0	None
36778	36779	feature	0	None
36779	36780	in	0	None
36780	36781	symptomatic	0	None
36781	36782	BPH	0	None
36782	36783	and	0	None
36783	36784	alpha1aARs	0	None
36784	36785	are	0	None
36785	36786	enriched	0	None
36786	36787	in	0	None
36787	36788	prostatic	0	None
36788	36789	tissue	0	None
36789	36790	,	0	None
36790	36791	drugs	0	None
36791	36792	that	0	None
36792	36793	demonstrate	0	None
36793	36794	high	0	None
36794	36795	alpha1aAR	0	None
36795	36796	selectivity	0	None
36796	36797	have	0	None
36797	36798	attracted	0	None
36798	36799	attention	0	None
36799	36800	.	0	None

36801	36802	Tamsulosin	2	CHEMICAL
36802	36803	,	0	None
36803	36804	which	0	None
36804	36805	has	0	None
36805	36806	high	0	None
36806	36807	affinity	0	None
36807	36808	for	0	None
36808	36809	alpha1aAR	0	None
36809	36810	and	0	None
36810	36811	alpha1dAR	0	None
36811	36812	subtypes	0	None
36812	36813	but	0	None
36813	36814	not	0	None
36814	36815	for	0	None
36815	36816	alpha1bAR	0	None
36816	36817	,	0	None
36817	36818	shows	0	None
36818	36819	efficacy	0	None
36819	36820	similar	0	None
36820	36821	to	0	None
36821	36822	the	0	None
36822	36823	nonsubtype	0	None
36823	36824	selective	0	None
36824	36825	agents	0	None
36825	36826	terazosin	0	None
36826	36827	and	0	None
36827	36828	doxazosin	2	CHEMICAL
36828	36829	.	0	None

36830	36831	It	0	None
36831	36832	is	0	None
36832	36833	associated	0	None
36833	36834	with	0	None
36834	36835	fewer	0	None
36835	36836	cardiovascular	0	None
36836	36837	side	0	None
36837	36838	effects	0	None
36838	36839	,	0	None
36839	36840	although	0	None
36840	36841	it	0	None
36841	36842	has	0	None
36842	36843	some	0	None
36843	36844	ejaculatory	0	None
36844	36845	side	0	None
36845	36846	effects	0	None
36846	36847	.	0	None

36848	36849	The	0	None
36849	36850	nonsubtype	0	None
36850	36851	selective	0	None
36851	36852	agent	0	None
36852	36853	alfuzosin	0	None
36853	36854	also	0	None
36854	36855	demonstrates	0	None
36855	36856	efficacy	0	None
36856	36857	and	0	None
36857	36858	offers	0	None
36858	36859	an	0	None
36859	36860	enhanced	0	None
36860	36861	side	0	None
36861	36862	effect	0	None
36862	36863	profile	0	None
36863	36864	,	0	None
36864	36865	particularly	0	None
36865	36866	minimizing	0	None
36866	36867	hypotension	0	None
36867	36868	.	0	None

36869	36870	Other	0	None
36870	36871	agents	0	None
36871	36872	with	0	None
36872	36873	super	0	None
36873	36874	selective	0	None
36874	36875	specificity	0	None
36875	36876	for	0	None
36876	36877	the	0	None
36877	36878	alpha1aAR	0	None
36878	36879	subtype	0	None
36879	36880	are	0	None
36880	36881	under	0	None
36881	36882	investigation	0	None
36882	36883	.	0	None

36884	36885	CONCLUSIONS	0	None
36885	36886	:	0	None
36886	36887	Further	0	None
36887	36888	advances	0	None
36888	36889	in	0	None
36889	36890	the	0	None
36890	36891	treatment	0	None
36891	36892	of	0	None
36892	36893	LUTS	0	None
36893	36894	associated	0	None
36894	36895	with	0	None
36895	36896	BPH	0	None
36896	36897	may	0	None
36897	36898	depend	0	None
36898	36899	not	0	None
36899	36900	only	0	None
36900	36901	on	0	None
36901	36902	receptor	0	None
36902	36903	subtype	0	None
36903	36904	selectivity	0	None
36904	36905	,	0	None
36905	36906	but	0	None
36906	36907	also	0	None
36907	36908	on	0	None
36908	36909	other	0	None
36909	36910	pharmacokinetic	0	None
36910	36911	and	0	None
36911	36912	pharmacodynamic	0	None
36912	36913	factors	0	None
36913	36914	.	0	None
36914	36915	The	0	None
36915	36916	topology	0	None
36916	36917	of	0	None
36917	36918	the	0	None
36918	36919	second	0	None
36919	36920	extracellular	0	None
36920	36921	loop	0	None
36921	36922	(	0	None
36922	36923	ECL2	0	None
36923	36924	)	0	None
36924	36925	and	0	None
36925	36926	its	0	None
36926	36927	interaction	0	None
36927	36928	with	0	None
36928	36929	ligands	0	None
36929	36930	is	0	None
36930	36931	unique	0	None
36931	36932	in	0	None
36932	36933	each	0	None
36933	36934	G	0	None
36934	36935	protein-coupled	0	None
36935	36936	receptor	0	None
36936	36937	.	0	None

36938	36939	When	0	None
36939	36940	the	0	None
36940	36941	orthosteric	0	None
36941	36942	ligand	0	None
36942	36943	pocket	0	None
36943	36944	located	0	None
36944	36945	in	0	None
36945	36946	the	0	None
36946	36947	transmembrane	0	None
36947	36948	(	0	None
36948	36949	TM	0	None
36949	36950	)	0	None
36950	36951	domain	0	None
36951	36952	is	0	None
36952	36953	occupied	0	None
36953	36954	,	0	None
36954	36955	ligand-specific	0	None
36955	36956	conformational	0	None
36956	36957	changes	0	None
36957	36958	occur	0	None
36958	36959	in	0	None
36959	36960	the	0	None
36960	36961	ECL2	0	None
36961	36962	.	0	None

36963	36964	In	0	None
36964	36965	more	0	None
36965	36966	than	0	None
36966	36967	90%	0	None
36967	36968	of	0	None
36968	36969	G	0	None
36969	36970	protein-coupled	0	None
36970	36971	receptors	0	None
36971	36972	,	0	None
36972	36973	ECL2	0	None
36973	36974	is	0	None
36974	36975	tethered	0	None
36975	36976	to	0	None
36976	36977	the	0	None
36977	36978	third	0	None
36978	36979	TM	0	None
36979	36980	helix	0	None
36980	36981	via	0	None
36981	36982	a	0	None
36982	36983	disulfide	0	None
36983	36984	bond	0	None
36984	36985	.	0	None

36986	36987	Therefore	0	None
36987	36988	,	0	None
36988	36989	understanding	0	None
36989	36990	the	0	None
36990	36991	extent	0	None
36991	36992	to	0	None
36992	36993	which	0	None
36993	36994	the	0	None
36994	36995	TM	0	None
36995	36996	domain	0	None
36996	36997	and	0	None
36997	36998	ECL2	0	None
36998	36999	conformations	0	None
36999	37000	are	0	None
37000	37001	coupled	0	None
37001	37002	is	0	None
37002	37003	useful	0	None
37003	37004	.	0	None

37005	37006	To	0	None
37006	37007	investigate	0	None
37007	37008	this	0	None
37008	37009	,	0	None
37009	37010	we	0	None
37010	37011	examined	0	None
37011	37012	conformational	0	None
37012	37013	changes	0	None
37013	37014	in	0	None
37014	37015	ECL2	0	None
37015	37016	of	0	None
37016	37017	the	0	None
37017	37018	angiotensin	2	CHEMICAL
37018	37019	II	0	None
37019	37020	type	0	None
37020	37021	1	0	None
37021	37022	receptor	0	None
37022	37023	(	0	None
37023	37024	AT1R	0	None
37024	37025	)	0	None
37025	37026	by	0	None
37026	37027	introducing	0	None
37027	37028	mutations	0	None
37028	37029	in	0	None
37029	37030	distant	0	None
37030	37031	sites	0	None
37031	37032	that	0	None
37032	37033	alter	0	None
37033	37034	the	0	None
37034	37035	activation	0	None
37035	37036	state	0	None
37036	37037	equilibrium	0	None
37037	37038	of	0	None
37038	37039	the	0	None
37039	37040	AT1R	0	None
37040	37041	.	0	None

37042	37043	Differential	0	None
37043	37044	accessibility	0	None
37044	37045	of	0	None
37045	37046	reporter	0	None
37046	37047	cysteines	0	None
37047	37048	introduced	0	None
37048	37049	at	0	None
37049	37050	four	0	None
37050	37051	conformation-sensitive	0	None
37051	37052	sites	0	None
37052	37053	in	0	None
37053	37054	ECL2	0	None
37054	37055	of	0	None
37055	37056	these	0	None
37056	37057	mutants	0	None
37057	37058	was	0	None
37058	37059	measured	0	None
37059	37060	.	0	None

37061	37062	Binding	0	None
37062	37063	of	0	None
37063	37064	the	0	None
37064	37065	agonist	0	None
37065	37066	angiotensin	2	CHEMICAL
37066	37067	II	0	None
37067	37068	(	0	None
37068	37069	AngII	0	None
37069	37070	)	0	None
37070	37071	and	0	None
37071	37072	inverse	0	None
37072	37073	agonist	0	None
37073	37074	losartan	0	None
37074	37075	in	0	None
37075	37076	wild-type	0	None
37076	37077	AT1R	0	None
37077	37078	changed	0	None
37078	37079	the	0	None
37079	37080	accessibility	0	None
37080	37081	of	0	None
37081	37082	reporter	0	None
37082	37083	cysteines	0	None
37083	37084	,	0	None
37084	37085	and	0	None
37085	37086	the	0	None
37086	37087	pattern	0	None
37087	37088	was	0	None
37088	37089	consistent	0	None
37089	37090	with	0	None
37090	37091	ligand-specific	0	None
37091	37092	"lid"	0	None
37092	37093	conformations	0	None
37093	37094	of	0	None
37094	37095	ECL2	0	None
37095	37096	.	0	None

37097	37098	Without	0	None
37098	37099	agonist	0	None
37099	37100	stimulation	0	None
37100	37101	,	0	None
37101	37102	the	0	None
37102	37103	ECL2	0	None
37103	37104	in	0	None
37104	37105	the	0	None
37105	37106	gain	0	None
37106	37107	of	0	None
37107	37108	function	0	None
37108	37109	mutant	0	None
37109	37110	N111G	0	None
37110	37111	assumed	0	None
37111	37112	a	0	None
37112	37113	lid	0	None
37113	37114	conformation	0	None
37114	37115	similar	0	None
37115	37116	to	0	None
37116	37117	AngII-bound	0	None
37117	37118	wild-type	0	None
37118	37119	AT1R	0	None
37119	37120	.	0	None

37121	37122	In	0	None
37122	37123	the	0	None
37123	37124	presence	0	None
37124	37125	of	0	None
37125	37126	inverse	0	None
37126	37127	agonists	0	None
37127	37128	,	0	None
37128	37129	the	0	None
37129	37130	conformation	0	None
37130	37131	of	0	None
37131	37132	ECL2	0	None
37132	37133	in	0	None
37133	37134	the	0	None
37134	37135	N111G	0	None
37135	37136	mutant	0	None
37136	37137	was	0	None
37137	37138	similar	0	None
37138	37139	to	0	None
37139	37140	the	0	None
37140	37141	inactive	0	None
37141	37142	state	0	None
37142	37143	of	0	None
37143	37144	wild-type	0	None
37144	37145	AT1R	0	None
37145	37146	.	0	None

37147	37148	In	0	None
37148	37149	contrast	0	None
37149	37150	,	0	None
37150	37151	AngII	0	None
37151	37152	did	0	None
37152	37153	not	0	None
37153	37154	induce	0	None
37154	37155	a	0	None
37155	37156	lid	0	None
37156	37157	conformation	0	None
37157	37158	in	0	None
37158	37159	ECL2	0	None
37159	37160	in	0	None
37160	37161	the	0	None
37161	37162	loss	0	None
37162	37163	of	0	None
37163	37164	function	0	None
37164	37165	D281A	0	None
37165	37166	mutant	0	None
37166	37167	,	0	None
37167	37168	which	0	None
37168	37169	is	0	None
37169	37170	consistent	0	None
37170	37171	with	0	None
37171	37172	the	0	None
37172	37173	reduced	0	None
37173	37174	AngII	0	None
37174	37175	binding	0	None
37175	37176	affinity	0	None
37176	37177	in	0	None
37177	37178	this	0	None
37178	37179	mutant	0	None
37179	37180	.	0	None

37181	37182	However	0	None
37182	37183	,	0	None
37183	37184	a	0	None
37184	37185	lid	0	None
37185	37186	conformation	0	None
37186	37187	was	0	None
37187	37188	induced	0	None
37188	37189	by	0	None
37189	37190	[	0	None
37190	37191	Sar	0	None
37191	37192	(	0	None
37192	37193	1	0	None
37193	37194	)	0	None
37194	37195	,	0	None
37195	37196	Gln	0	None
37196	37197	(	0	None
37197	37198	2	0	None
37198	37199	)	0	None
37199	37200	,	0	None
37200	37201	Ile	0	None
37201	37202	(	0	None
37202	37203	8	0	None
37203	37204	)	0	None
37204	37205	]	0	None
37205	37206	AngII	0	None
37206	37207	,	0	None
37207	37208	a	0	None
37208	37209	specific	0	None
37209	37210	analog	0	None
37210	37211	that	0	None
37211	37212	binds	0	None
37212	37213	to	0	None
37213	37214	the	0	None
37214	37215	D281A	0	None
37215	37216	mutant	0	None
37216	37217	with	0	None
37217	37218	better	0	None
37218	37219	affinity	0	None
37219	37220	than	0	None
37220	37221	AngII	0	None
37221	37222	.	0	None

37223	37224	These	0	None
37224	37225	results	0	None
37225	37226	provide	0	None
37226	37227	evidence	0	None
37227	37228	for	0	None
37228	37229	the	0	None
37229	37230	emerging	0	None
37230	37231	paradigm	0	None
37231	37232	of	0	None
37232	37233	domain	0	None
37233	37234	coupling	0	None
37234	37235	facilitated	0	None
37235	37236	by	0	None
37236	37237	long	0	None
37237	37238	range	0	None
37238	37239	interactions	0	None
37239	37240	at	0	None
37240	37241	distant	0	None
37241	37242	sites	0	None
37242	37243	on	0	None
37243	37244	the	0	None
37244	37245	same	0	None
37245	37246	receptor	0	None
37246	37247	.	0	None
37247	37248	Carnosine	2	CHEMICAL
37248	37249	inhibits	0	None
37249	37250	Aβ	0	None
37250	37251	(	0	None
37251	37252	42	0	None
37252	37253	)	0	None
37253	37254	aggregation	0	None
37254	37255	by	0	None
37255	37256	perturbing	0	None
37256	37257	the	0	None
37257	37258	H-bond	0	None
37258	37259	network	0	None
37259	37260	in	0	None
37260	37261	and	0	None
37261	37262	around	0	None
37262	37263	the	0	None
37263	37264	central	0	None
37264	37265	hydrophobic	0	None
37265	37266	cluster	0	None
37266	37267	.	0	None
37267	37268	Microglial	0	None
37268	37269	disruption	0	None
37269	37270	in	0	None
37270	37271	young	0	None
37271	37272	mice	0	None
37272	37273	with	0	None
37273	37274	early	0	None
37274	37275	chronic	0	None
37275	37276	lead	0	None
37276	37277	exposure	0	None
37277	37278	.	0	None
37278	37279	For	0	None
37279	37280	many	0	None
37280	37281	years	0	None
37281	37282	,	0	None
37282	37283	dietary	0	None
37283	37284	arginine	2	CHEMICAL
37284	37285	supplementation	0	None
37285	37286	,	0	None
37286	37287	often	0	None
37287	37288	combined	0	None
37288	37289	with	0	None
37289	37290	other	0	None
37290	37291	substances	0	None
37291	37292	,	0	None
37292	37293	has	0	None
37293	37294	been	0	None
37294	37295	used	0	None
37295	37296	as	0	None
37296	37297	a	0	None
37297	37298	mechanism	0	None
37298	37299	to	0	None
37299	37300	boost	0	None
37300	37301	the	0	None
37301	37302	immune	0	None
37302	37303	system	0	None
37303	37304	.	0	None

37305	37306	Considerable	0	None
37306	37307	controversy	0	None
37307	37308	,	0	None
37308	37309	however	0	None
37309	37310	,	0	None
37310	37311	exists	0	None
37311	37312	as	0	None
37312	37313	to	0	None
37313	37314	the	0	None
37314	37315	benefits	0	None
37315	37316	and	0	None
37316	37317	indications	0	None
37317	37318	of	0	None
37318	37319	dietary	0	None
37319	37320	arginine	2	CHEMICAL
37320	37321	due	0	None
37321	37322	in	0	None
37322	37323	part	0	None
37323	37324	to	0	None
37324	37325	a	0	None
37325	37326	poor	0	None
37326	37327	understanding	0	None
37327	37328	of	0	None
37328	37329	the	0	None
37329	37330	role	0	None
37330	37331	played	0	None
37331	37332	by	0	None
37332	37333	this	0	None
37333	37335	amino acid	2	CHEMICAL
37335	37336	in	0	None
37336	37337	maintaining	0	None
37337	37338	immune	0	None
37338	37339	function	0	None
37339	37340	.	0	None

37341	37342	Emerging	0	None
37342	37343	knowledge	0	None
37343	37344	promises	0	None
37344	37345	to	0	None
37345	37346	clear	0	None
37346	37347	this	0	None
37347	37348	controversy	0	None
37348	37349	and	0	None
37349	37350	allow	0	None
37350	37351	for	0	None
37351	37352	arginine's	0	None
37352	37353	safe	0	None
37353	37354	use	0	None
37354	37355	.	0	None

37356	37357	In	0	None
37357	37358	myeloid	0	None
37358	37359	cells	0	None
37359	37360	,	0	None
37360	37361	arginine	2	CHEMICAL
37361	37362	is	0	None
37362	37363	mainly	0	None
37363	37364	metabolized	0	None
37364	37365	either	0	None
37365	37366	by	0	None
37366	37367	inducible	0	None
37367	37368	nitric	0	None
37368	37369	oxide	0	None
37369	37370	(	0	None
37370	37371	NO	0	None
37371	37372	)	0	None
37372	37373	synthases	0	None
37373	37374	(	0	None
37374	37375	iNOS	0	None
37375	37376	)	0	None
37376	37377	or	0	None
37377	37378	by	0	None
37378	37379	arginase	0	None
37379	37380	1	0	None
37380	37381	,	0	None
37381	37382	enzymes	0	None
37382	37383	that	0	None
37383	37384	are	0	None
37384	37385	stimulated	0	None
37385	37386	by	0	None
37386	37387	T	0	None
37387	37388	helper	0	None
37388	37389	1	0	None
37389	37390	or	0	None
37390	37391	2	0	None
37391	37392	cytokines	3	GENE-N
37392	37393	,	0	None
37393	37394	respectively	0	None
37394	37395	.	0	None

37396	37397	Thus	0	None
37397	37398	,	0	None
37398	37399	activation	0	None
37399	37400	of	0	None
37400	37401	iNOS	0	None
37401	37402	or	0	None
37402	37403	arginase	0	None
37403	37404	(	0	None
37404	37405	or	0	None
37405	37406	both	0	None
37406	37407	)	0	None
37407	37408	reflects	0	None
37408	37409	the	0	None
37409	37410	type	0	None
37410	37411	of	0	None
37411	37412	inflammatory	0	None
37412	37413	response	0	None
37413	37414	in	0	None
37414	37415	a	0	None
37415	37416	specific	0	None
37416	37417	disease	0	None
37417	37418	process	0	None
37418	37419	.	0	None

37420	37421	Myeloid	0	None
37421	37422	suppressor	0	None
37422	37423	cells	0	None
37423	37424	(	0	None
37424	37425	MSC	0	None
37425	37426	)	0	None
37426	37427	expressing	0	None
37427	37428	arginase	0	None
37428	37429	have	0	None
37429	37430	been	0	None
37430	37431	described	0	None
37431	37432	in	0	None
37432	37433	trauma	0	None
37433	37434	(	0	None
37434	37435	in	0	None
37435	37436	both	0	None
37436	37437	mice	0	None
37437	37438	and	0	None
37438	37439	humans	0	None
37439	37440	)	0	None
37440	37441	,	0	None
37441	37442	intra-abdominal	0	None
37442	37443	sepsis	0	None
37443	37444	,	0	None
37444	37445	certain	0	None
37445	37446	infections	0	None
37446	37447	,	0	None
37447	37448	and	0	None
37448	37449	prominently	0	None
37449	37450	,	0	None
37450	37451	cancer	0	None
37451	37452	.	0	None

37453	37454	Myeloid	0	None
37454	37455	cells	0	None
37455	37456	expressing	0	None
37456	37457	arginase	0	None
37457	37458	have	0	None
37458	37459	been	0	None
37459	37460	shown	0	None
37460	37461	to	0	None
37461	37462	accumulate	0	None
37462	37463	in	0	None
37463	37464	patients	0	None
37464	37465	with	0	None
37465	37466	cancer	0	None
37466	37467	.	0	None

37468	37469	Arginase	0	None
37469	37470	1	0	None
37470	37471	expression	0	None
37471	37472	is	0	None
37472	37473	also	0	None
37473	37474	detected	0	None
37474	37475	in	0	None
37475	37476	mononuclear	0	None
37476	37477	cells	0	None
37477	37478	after	0	None
37478	37479	trauma	0	None
37479	37480	or	0	None
37480	37481	surgery	0	None
37481	37482	.	0	None

37483	37484	MSC	0	None
37484	37485	efficiently	0	None
37485	37486	deplete	0	None
37486	37487	arginine	2	CHEMICAL
37487	37488	and	0	None
37488	37489	generate	0	None
37489	37490	ornithine	2	CHEMICAL
37490	37491	.	0	None

37492	37493	Through	0	None
37493	37494	arginine	2	CHEMICAL
37494	37495	depletion	0	None
37495	37496	,	0	None
37496	37497	MSC	0	None
37497	37498	may	0	None
37498	37499	control	0	None
37499	37500	NO	0	None
37500	37501	production	0	None
37501	37502	and	0	None
37502	37503	regulate	0	None
37503	37504	other	0	None
37504	37505	arginine-dependent	0	None
37505	37506	biological	0	None
37506	37507	processes	0	None
37507	37508	.	0	None

37509	37510	Low	0	None
37510	37511	circulating	0	None
37511	37512	arginine	2	CHEMICAL
37512	37513	has	0	None
37513	37514	been	0	None
37514	37515	documented	0	None
37515	37516	in	0	None
37516	37517	trauma	0	None
37517	37518	and	0	None
37518	37519	cancer	0	None
37519	37520	,	0	None
37520	37521	suggesting	0	None
37521	37522	that	0	None
37522	37523	MSC	0	None
37523	37524	may	0	None
37524	37525	exert	0	None
37525	37526	a	0	None
37526	37527	systemic	0	None
37527	37528	effect	0	None
37528	37529	and	0	None
37529	37530	cause	0	None
37530	37531	a	0	None
37531	37532	state	0	None
37532	37533	of	0	None
37533	37534	arginine	2	CHEMICAL
37534	37535	deficiency	0	None
37535	37536	.	0	None

37537	37538	Simultaneously	0	None
37538	37539	,	0	None
37539	37540	T	0	None
37540	37541	lymphocytes	0	None
37541	37542	depend	0	None
37542	37543	on	0	None
37543	37544	arginine	2	CHEMICAL
37544	37545	for	0	None
37545	37546	proliferation	0	None
37546	37547	,	0	None
37547	37548	zeta-chain	0	None
37548	37549	peptide	0	None
37549	37550	and	0	None
37550	37551	T-cell	0	None
37551	37552	receptor	0	None
37552	37553	complex	0	None
37553	37554	expression	0	None
37554	37555	,	0	None
37555	37556	and	0	None
37556	37557	the	0	None
37557	37558	development	0	None
37558	37559	of	0	None
37559	37560	memory	0	None
37560	37561	.	0	None

37562	37563	T-cells	0	None
37563	37564	cocultured	0	None
37564	37565	with	0	None
37565	37566	MSC	0	None
37566	37567	exhibit	0	None
37567	37568	the	0	None
37568	37569	molecular	0	None
37569	37570	and	0	None
37570	37571	functional	0	None
37571	37572	effects	0	None
37572	37573	associated	0	None
37573	37574	with	0	None
37574	37575	arginine	2	CHEMICAL
37575	37576	deficiency	0	None
37576	37577	.	0	None

37578	37579	Not	0	None
37579	37580	surprisingly	0	None
37580	37581	,	0	None
37581	37582	T-cell	0	None
37582	37583	abnormalities	0	None
37583	37584	,	0	None
37584	37585	including	0	None
37585	37586	decreased	0	None
37586	37587	proliferation	0	None
37587	37588	and	0	None
37588	37589	loss	0	None
37589	37590	of	0	None
37590	37591	the	0	None
37591	37592	zeta-chain	0	None
37592	37593	,	0	None
37593	37594	are	0	None
37594	37595	observed	0	None
37595	37596	in	0	None
37596	37597	cancer	0	None
37597	37598	and	0	None
37598	37599	after	0	None
37599	37600	trauma	0	None
37600	37601	.	0	None
37601	37602	Atypical	0	None
37602	37603	teratoid	0	None
37603	37604	/	0	None
37604	37605	rhabdoid	0	None
37605	37606	tumor	0	None
37606	37607	of	0	None
37607	37608	the	0	None
37608	37609	CNS	0	None
37609	37610	:	0	None
37610	37611	cytopathology	0	None
37611	37612	and	0	None
37612	37613	immunohistochemistry	0	None
37613	37614	of	0	None
37614	37615	insulin-like	0	None
37615	37616	growth	0	None
37616	37617	factor-II	0	None
37617	37618	,	0	None
37618	37622	insulin-like growth factor receptor	1	GENE-Y
37622	37623	type	0	None
37623	37624	1	0	None
37624	37625	,	0	None
37625	37626	cathepsin	0	None
37626	37627	D	0	None
37627	37628	,	0	None
37628	37629	and	0	None
37629	37630	Ki-67	0	None
37630	37631	.	0	None
37631	37632	Phenytoin	0	None
37632	37633	and	0	None
37633	37634	carbamazepine	0	None
37634	37635	are	0	None
37635	37636	effective	0	None
37636	37637	and	0	None
37637	37638	inexpensive	0	None
37638	37639	anti-epileptic	0	None
37639	37640	drugs	0	None
37640	37641	(	0	None
37641	37642	AEDs	0	None
37642	37643	)	0	None
37643	37644	.	0	None

37645	37646	As	0	None
37646	37647	with	0	None
37647	37648	many	0	None
37648	37649	AEDs	0	None
37649	37650	,	0	None
37650	37651	a	0	None
37651	37652	broad	0	None
37652	37653	range	0	None
37653	37654	of	0	None
37654	37655	doses	0	None
37655	37656	is	0	None
37656	37657	used	0	None
37657	37658	,	0	None
37658	37659	with	0	None
37659	37660	the	0	None
37660	37661	final	0	None
37661	37662	"maintenance"	0	None
37662	37663	dose	0	None
37663	37664	normally	0	None
37664	37665	determined	0	None
37665	37666	by	0	None
37666	37667	trial	0	None
37667	37668	and	0	None
37668	37669	error	0	None
37669	37670	.	0	None

37671	37672	Although	0	None
37672	37673	many	0	None
37673	37674	genes	0	None
37674	37675	could	0	None
37675	37676	influence	0	None
37676	37677	response	0	None
37677	37678	to	0	None
37678	37679	these	0	None
37679	37680	medicines	0	None
37680	37681	,	0	None
37681	37682	there	0	None
37682	37683	are	0	None
37683	37684	obvious	0	None
37684	37685	candidates	0	None
37685	37686	.	0	None

37687	37688	Both	0	None
37688	37689	drugs	0	None
37689	37690	target	0	None
37690	37691	the	0	None
37691	37692	alpha-subunit	0	None
37692	37693	of	0	None
37693	37694	the	0	None
37694	37696	sodium channel	3	GENE-N
37696	37697	,	0	None
37697	37698	encoded	0	None
37698	37699	by	0	None
37699	37700	the	0	None
37700	37701	SCN	0	None
37701	37702	family	0	None
37702	37703	of	0	None
37703	37704	genes	0	None
37704	37705	.	0	None

37706	37707	Phenytoin	0	None
37707	37708	is	0	None
37708	37709	principally	0	None
37709	37710	metabolized	0	None
37710	37711	by	0	None
37711	37712	CYP2C9	0	None
37712	37713	,	0	None
37713	37714	and	0	None
37714	37715	both	0	None
37715	37716	are	0	None
37716	37717	probable	0	None
37717	37718	substrates	0	None
37718	37719	of	0	None
37719	37720	the	0	None
37720	37721	drug	0	None
37721	37722	transporter	0	None
37722	37723	P-glycoprotein	3	GENE-N
37723	37724	.	0	None

37725	37726	We	0	None
37726	37727	therefore	0	None
37727	37728	assessed	0	None
37728	37729	whether	0	None
37729	37730	variation	0	None
37730	37731	in	0	None
37731	37732	these	0	None
37732	37733	genes	0	None
37733	37734	associates	0	None
37734	37735	with	0	None
37735	37736	the	0	None
37736	37737	clinical	0	None
37737	37738	use	0	None
37738	37739	of	0	None
37739	37740	carbamazepine	0	None
37740	37741	and	0	None
37741	37742	phenytoin	0	None
37742	37743	in	0	None
37743	37744	cohorts	0	None
37744	37745	of	0	None
37745	37746	425	0	None
37746	37747	and	0	None
37747	37748	281	0	None
37748	37749	patients	0	None
37749	37750	,	0	None
37750	37751	respectively	0	None
37751	37752	.	0	None

37753	37754	We	0	None
37754	37755	report	0	None
37755	37756	that	0	None
37756	37757	a	0	None
37757	37758	known	0	None
37758	37759	functional	0	None
37759	37760	polymorphism	0	None
37760	37761	in	0	None
37761	37762	CYP2C9	0	None
37762	37763	is	0	None
37763	37764	highly	0	None
37764	37765	associated	0	None
37765	37766	with	0	None
37766	37767	the	0	None
37767	37768	maximum	0	None
37768	37769	dose	0	None
37769	37770	of	0	None
37770	37771	phenytoin	0	None
37771	37772	(	0	None
37772	37773	P	0	None
37773	37774	=	0	None
37774	37775	0	0	None
37775	37776	.	0	None
37776	37777	0066	0	None
37777	37778	)	0	None
37778	37779	.	0	None

37780	37781	We	0	None
37781	37782	also	0	None
37782	37783	show	0	None
37783	37784	that	0	None
37784	37785	an	0	None
37785	37786	intronic	0	None
37786	37787	polymorphism	0	None
37787	37788	in	0	None
37788	37789	the	0	None
37789	37790	SCN1A	0	None
37790	37791	gene	0	None
37791	37792	shows	0	None
37792	37793	significant	0	None
37793	37794	association	0	None
37794	37795	with	0	None
37795	37796	maximum	0	None
37796	37797	doses	0	None
37797	37798	in	0	None
37798	37799	regular	0	None
37799	37800	usage	0	None
37800	37801	of	0	None
37801	37802	both	0	None
37802	37803	carbamazepine	0	None
37803	37804	and	0	None
37804	37805	phenytoin	0	None
37805	37806	(	0	None
37806	37807	P	0	None
37807	37808	=	0	None
37808	37809	0	0	None
37809	37810	.	0	None
37810	37811	0051	0	None
37811	37812	and	0	None
37812	37813	P	0	None
37813	37814	=	0	None
37814	37815	0	0	None
37815	37816	.	0	None
37816	37817	014	0	None
37817	37818	,	0	None
37818	37819	respectively	0	None
37819	37820	)	0	None
37820	37821	.	0	None

37822	37823	This	0	None
37823	37824	polymorphism	0	None
37824	37825	disrupts	0	None
37825	37826	the	0	None
37826	37827	consensus	0	None
37827	37828	sequence	0	None
37828	37829	of	0	None
37829	37830	the	0	None
37830	37831	5'	0	None
37831	37832	splice	0	None
37832	37833	donor	0	None
37833	37834	site	0	None
37834	37835	of	0	None
37835	37836	a	0	None
37836	37837	highly	0	None
37837	37838	conserved	0	None
37838	37839	alternative	0	None
37839	37840	exon	0	None
37840	37841	(	0	None
37841	37842	5N	0	None
37842	37843	)	0	None
37843	37844	,	0	None
37844	37845	and	0	None
37845	37846	it	0	None
37846	37847	significantly	0	None
37847	37848	affects	0	None
37848	37849	the	0	None
37849	37850	proportions	0	None
37850	37851	of	0	None
37851	37852	the	0	None
37852	37853	alternative	0	None
37853	37854	transcripts	0	None
37854	37855	in	0	None
37855	37856	individuals	0	None
37856	37857	with	0	None
37857	37858	a	0	None
37858	37859	history	0	None
37859	37860	of	0	None
37860	37861	epilepsy	0	None
37861	37862	.	0	None

37863	37864	These	0	None
37864	37865	results	0	None
37865	37866	provide	0	None
37866	37867	evidence	0	None
37867	37868	of	0	None
37868	37869	a	0	None
37869	37870	drug	0	None
37870	37871	target	0	None
37871	37872	polymorphism	0	None
37872	37873	associated	0	None
37873	37874	with	0	None
37874	37875	the	0	None
37875	37876	clinical	0	None
37876	37877	use	0	None
37877	37878	of	0	None
37878	37879	AEDs	0	None
37879	37880	and	0	None
37880	37881	set	0	None
37881	37882	the	0	None
37882	37883	stage	0	None
37883	37884	for	0	None
37884	37885	a	0	None
37885	37886	prospective	0	None
37886	37887	evaluation	0	None
37887	37888	of	0	None
37888	37889	how	0	None
37889	37890	pharmacogenetic	0	None
37890	37891	diagnostics	0	None
37891	37892	can	0	None
37892	37893	be	0	None
37893	37894	used	0	None
37894	37895	to	0	None
37895	37896	improve	0	None
37896	37897	dosing	0	None
37897	37898	decisions	0	None
37898	37899	in	0	None
37899	37900	the	0	None
37900	37901	use	0	None
37901	37902	of	0	None
37902	37903	phenytoin	0	None
37903	37904	and	0	None
37904	37905	carbamazepine	0	None
37905	37906	.	0	None

37907	37908	Although	0	None
37908	37909	the	0	None
37909	37910	case	0	None
37910	37911	made	0	None
37911	37912	here	0	None
37912	37913	is	0	None
37913	37914	compelling	0	None
37914	37915	,	0	None
37915	37916	our	0	None
37916	37917	results	0	None
37917	37918	cannot	0	None
37918	37919	be	0	None
37919	37920	considered	0	None
37920	37921	definitive	0	None
37921	37922	or	0	None
37922	37923	ready	0	None
37923	37924	for	0	None
37924	37925	clinical	0	None
37925	37926	application	0	None
37926	37927	until	0	None
37927	37928	they	0	None
37928	37929	are	0	None
37929	37930	confirmed	0	None
37930	37931	by	0	None
37931	37932	independent	0	None
37932	37933	replication	0	None
37933	37934	.	0	None
37934	37935	An	0	None
37935	37936	optimized	0	None
37936	37937	RAD51	0	None
37937	37938	inhibitor	0	None
37938	37939	that	0	None
37939	37940	disrupts	0	None
37940	37941	homologous	0	None
37941	37942	recombination	0	None
37942	37943	without	0	None
37943	37944	requiring	0	None
37944	37945	Michael	0	None
37945	37946	acceptor	0	None
37946	37947	reactivity	0	None
37947	37948	.	0	None
37948	37949	Selective	0	None
37949	37950	COX-2	0	None
37950	37951	inhibitors	0	None
37951	37952	(	0	None
37952	37953	COXib	0	None
37953	37954	)	0	None
37954	37955	belonging	0	None
37955	37956	to	0	None
37956	37957	the	0	None
37957	37958	class	0	None
37958	37959	of	0	None
37959	37960	diaryl	0	None
37960	37961	heterocycles	0	None
37961	37962	(	0	None
37962	37963	e	0	None
37963	37964	.	0	None

37965	37966	g	0	None
37966	37967	.	0	None

37968	37969	,	0	None
37969	37970	celecoxib	2	CHEMICAL
37970	37971	,	0	None
37971	37972	rofecoxib	0	None
37972	37973	,	0	None
37973	37974	etc	0	None
37974	37975	.	0	None

37976	37977	)	0	None
37977	37978	,	0	None
37978	37979	are	0	None
37979	37980	devoid	0	None
37980	37981	of	0	None
37981	37982	the	0	None
37982	37983	undesirable	0	None
37983	37984	effects	0	None
37984	37985	due	0	None
37985	37986	to	0	None
37986	37987	their	0	None
37987	37988	capacity	0	None
37988	37989	to	0	None
37989	37990	inhibit	0	None
37990	37991	selectively	0	None
37991	37992	inducible	0	None
37992	37993	(	0	None
37993	37994	COX-2	0	None
37994	37995	)	0	None
37995	37996	,	0	None
37996	37997	responsible	0	None
37997	37998	for	0	None
37998	37999	inflammatory	0	None
37999	38000	effects	0	None
38000	38001	but	0	None
38001	38002	not	0	None
38002	38003	constitutive	0	None
38003	38004	cyclooxygenase-1	1	GENE-Y
38004	38005	(	0	None
38005	38006	COX-1	1	GENE-Y
38006	38007	)	0	None
38007	38008	(	0	None
38008	38009	COX	3	GENE-N
38009	38010	)	0	None
38010	38011	;	0	None
38011	38012	responsible	0	None
38012	38013	for	0	None
38013	38014	cytoprotective	0	None
38014	38015	effects	0	None
38015	38016	on	0	None
38016	38017	gastric	0	None
38017	38018	mucosa	0	None
38018	38019	.	0	None

38020	38021	In	0	None
38021	38022	addition	0	None
38022	38023	,	0	None
38023	38024	several	0	None
38024	38025	reports	0	None
38025	38026	have	0	None
38026	38027	identified	0	None
38027	38028	an	0	None
38028	38029	increased	0	None
38029	38030	risk	0	None
38030	38031	of	0	None
38031	38032	cardiovascular	0	None
38032	38033	events	0	None
38033	38034	associated	0	None
38034	38035	with	0	None
38035	38036	the	0	None
38036	38037	use	0	None
38037	38038	of	0	None
38038	38039	COXib	0	None
38039	38040	.	0	None

38041	38042	We	0	None
38042	38043	have	0	None
38043	38044	developed	0	None
38044	38045	a	0	None
38045	38046	new	0	None
38046	38047	series	0	None
38047	38048	of	0	None
38048	38049	anti-inflammatory	0	None
38049	38050	agents	0	None
38050	38051	(	0	None
38051	38052	1	0	None
38052	38053	,	0	None
38053	38054	5-diarylpyrrole-3-alkoxyethyl	0	None
38054	38055	esters	0	None
38055	38056	and	0	None
38056	38057	ethers	0	None
38057	38058	)	0	None
38058	38059	.	0	None

38060	38061	To	0	None
38061	38062	evaluate	0	None
38062	38063	the	0	None
38063	38064	effect	0	None
38064	38065	of	0	None
38065	38066	two	0	None
38066	38067	1	0	None
38067	38068	,	0	None
38068	38069	5-diarylpyrrole-3-alkoxyethyl	0	None
38069	38070	ethers	0	None
38070	38071	,	0	None
38071	38072	VA441	0	None
38072	38073	and	0	None
38073	38074	VA428	0	None
38074	38075	(	0	None
38075	38076	up	0	None
38076	38077	to	0	None
38077	38078	100μM	0	None
38078	38079	)	0	None
38079	38080	,	0	None
38080	38081	respectively	0	None
38081	38082	,	0	None
38082	38083	in	0	None
38083	38084	comparison	0	None
38084	38085	with	0	None
38085	38086	two	0	None
38086	38087	well	0	None
38087	38088	known	0	None
38088	38089	COXib	0	None
38089	38090	,	0	None
38090	38091	celecoxib	2	CHEMICAL
38091	38092	and	0	None
38092	38093	rofecoxib	0	None
38093	38094	,	0	None
38094	38095	on	0	None
38095	38096	HaCaT	0	None
38096	38097	cell	0	None
38097	38098	(	0	None
38098	38099	keratinocytes	0	None
38099	38100	)	0	None
38100	38101	proliferation	0	None
38101	38102	and	0	None
38102	38103	toxicity	0	None
38103	38104	.	0	None

38105	38106	Crucial	0	None
38106	38107	molecules	0	None
38107	38108	in	0	None
38108	38109	cell	0	None
38109	38110	cycle	0	None
38110	38111	progression	0	None
38111	38112	,	0	None
38112	38113	i	0	None
38113	38114	.	0	None

38115	38116	e	0	None
38116	38117	.	0	None

38118	38119	NFκB	0	None
38119	38120	and	0	None
38120	38121	ERK	0	None
38121	38122	as	0	None
38122	38123	targets	0	None
38123	38124	/	0	None
38124	38125	mediators	0	None
38125	38126	and	0	None
38126	38128	cyclin D1	1	GENE-Y
38128	38129	and	0	None
38129	38130	p21	0	None
38130	38131	Cip1	1	GENE-Y
38131	38132	/	0	None
38132	38133	Kip	0	None
38133	38134	as	0	None
38134	38135	final	0	None
38135	38136	effectors	0	None
38136	38137	were	0	None
38137	38138	evaluated	0	None
38138	38139	by	0	None
38139	38140	Western	0	None
38140	38141	blot	0	None
38141	38142	,	0	None
38142	38143	immunohystochemistry	0	None
38143	38144	and	0	None
38144	38145	q-PCR	0	None
38145	38146	analysis	0	None
38146	38147	.	0	None

38148	38149	Both	0	None
38149	38150	compounds	0	None
38150	38151	,	0	None
38151	38152	VA441	0	None
38152	38153	and	0	None
38153	38154	VA428	0	None
38154	38155	,	0	None
38155	38156	showed	0	None
38156	38157	a	0	None
38157	38158	strong	0	None
38158	38159	inhibition	0	None
38159	38160	of	0	None
38160	38161	cell	0	None
38161	38162	proliferation	0	None
38162	38163	,	0	None
38163	38164	and	0	None
38164	38165	did	0	None
38165	38166	not	0	None
38166	38167	exhibit	0	None
38167	38168	cytotoxicity	0	None
38168	38169	.	0	None

38170	38171	The	0	None
38171	38172	anti-proliferative	0	None
38172	38173	effect	0	None
38173	38174	was	0	None
38174	38175	accompanied	0	None
38175	38176	by	0	None
38176	38177	a	0	None
38177	38178	strong	0	None
38178	38179	activation	0	None
38179	38180	of	0	None
38180	38181	ERK	0	None
38181	38182	and	0	None
38182	38183	induction	0	None
38183	38184	of	0	None
38184	38185	the	0	None
38185	38186	cell	0	None
38186	38187	cycle	0	None
38187	38188	inhibitor	0	None
38188	38189	p21	0	None
38189	38190	.	0	None

38191	38192	In	0	None
38192	38193	addition	0	None
38193	38194	,	0	None
38194	38195	there	0	None
38195	38196	was	0	None
38196	38197	a	0	None
38197	38198	clear	0	None
38198	38199	inhibition	0	None
38199	38200	of	0	None
38200	38201	the	0	None
38201	38202	transcription	0	None
38202	38203	factor	0	None
38203	38204	NF-κB	0	None
38204	38205	and	0	None
38205	38206	downregulation	0	None
38206	38207	of	0	None
38207	38209	cyclin D1	1	GENE-Y
38209	38210	,	0	None
38210	38211	with	0	None
38211	38212	enforced	0	None
38212	38213	inhibition	0	None
38213	38214	of	0	None
38214	38215	the	0	None
38215	38216	HaCaT	0	None
38216	38217	cell	0	None
38217	38218	cycle	0	None
38218	38219	progression	0	None
38219	38220	.	0	None

38221	38222	These	0	None
38222	38223	data	0	None
38223	38224	suggest	0	None
38224	38225	that	0	None
38225	38226	compounds	0	None
38226	38227	VA441	0	None
38227	38228	and	0	None
38228	38229	VA428	0	None
38229	38230	,	0	None
38230	38231	along	0	None
38231	38232	with	0	None
38232	38233	their	0	None
38233	38234	role	0	None
38234	38235	in	0	None
38235	38236	inhibiting	0	None
38236	38237	COX-2	0	None
38237	38238	and	0	None
38238	38239	inflammation	0	None
38239	38240	,	0	None
38240	38241	could	0	None
38241	38242	have	0	None
38242	38243	a	0	None
38243	38244	possible	0	None
38244	38245	therapeutic	0	None
38245	38246	(	0	None
38246	38247	topical	0	None
38247	38248	and	0	None
38248	38249	systemic	0	None
38249	38250	)	0	None
38250	38251	use	0	None
38251	38252	against	0	None
38252	38253	skin	0	None
38253	38254	proliferative	0	None
38254	38255	disorders	0	None
38255	38256	,	0	None
38256	38257	such	0	None
38257	38258	as	0	None
38258	38259	psoriasis	0	None
38259	38260	.	0	None
38260	38261	Natural	0	None
38261	38262	(	0	None
38262	38263	all	0	None
38263	38264	trans-retinoic	0	None
38264	38265	acid	0	None
38265	38266	,	0	None
38266	38267	RA	2	CHEMICAL
38267	38268	)	0	None
38268	38269	and	0	None
38269	38270	synthetic	0	None
38270	38271	retinoids	2	CHEMICAL
38271	38272	exhibit	0	None
38272	38273	potent	0	None
38273	38274	anti-proliferative	0	None
38274	38275	,	0	None
38275	38276	normalization	0	None
38276	38277	of	0	None
38277	38278	differentiation	0	None
38278	38279	and	0	None
38279	38280	anti-inflammatory	0	None
38280	38281	activities	0	None
38281	38282	which	0	None
38282	38283	appear	0	None
38283	38284	to	0	None
38284	38285	account	0	None
38285	38286	for	0	None
38286	38287	their	0	None
38287	38288	therapeutic	0	None
38288	38289	effects	0	None
38289	38290	in	0	None
38290	38291	acne	0	None
38291	38292	,	0	None
38292	38293	psoriasis	0	None
38293	38294	,	0	None
38294	38295	photoaging	0	None
38295	38296	,	0	None
38296	38297	precancerous	0	None
38297	38298	lesions	0	None
38298	38299	and	0	None
38299	38300	established	0	None
38300	38301	cancers	0	None
38301	38302	.	0	None

38303	38304	Although	0	None
38304	38305	RA	2	CHEMICAL
38305	38306	has	0	None
38306	38307	shown	0	None
38307	38308	considerable	0	None
38308	38309	promise	0	None
38309	38310	in	0	None
38310	38311	dermatologic	0	None
38311	38312	indications	0	None
38312	38313	,	0	None
38313	38314	certain	0	None
38314	38315	side	0	None
38315	38316	effects	0	None
38316	38317	have	0	None
38317	38318	restricted	0	None
38318	38319	its	0	None
38319	38320	use	0	None
38320	38321	as	0	None
38321	38322	a	0	None
38322	38323	choice	0	None
38323	38324	of	0	None
38324	38325	agent	0	None
38325	38326	for	0	None
38326	38327	chronic	0	None
38327	38328	administration	0	None
38328	38329	.	0	None

38330	38331	Systematic	0	None
38331	38332	synthesis	0	None
38332	38333	of	0	None
38333	38334	receptor-selective	0	None
38334	38335	retinoids	2	CHEMICAL
38335	38336	has	0	None
38336	38337	resulted	0	None
38337	38338	in	0	None
38338	38339	two	0	None
38339	38340	topical	0	None
38340	38341	drugs	0	None
38341	38342	,	0	None
38342	38343	Tazorac	2	CHEMICAL
38343	38344	/	0	None
38344	38345	Zorac	0	None
38345	38346	(	0	None
38346	38347	tazarotene	2	CHEMICAL
38347	38348	)	0	None
38348	38349	and	0	None
38349	38350	Differin	0	None
38350	38351	(	0	None
38351	38352	adapalene	0	None
38352	38353	)	0	None
38353	38354	.	0	None

38355	38356	Tazorac	2	CHEMICAL
38356	38357	is	0	None
38357	38358	indicated	0	None
38358	38359	for	0	None
38359	38360	psoriasis	0	None
38360	38361	and	0	None
38361	38362	acne	0	None
38362	38363	and	0	None
38363	38364	Differin	0	None
38364	38365	gel	0	None
38365	38366	for	0	None
38366	38367	the	0	None
38367	38368	treatment	0	None
38368	38369	of	0	None
38369	38370	acne	0	None
38370	38371	.	0	None

38372	38373	These	0	None
38373	38374	drugs	0	None
38374	38375	bind	0	None
38375	38376	to	0	None
38376	38377	the	0	None
38377	38380	retinoic acid receptor	3	GENE-N
38380	38381	(	0	None
38381	38382	RAR	0	None
38382	38383	)	0	None
38383	38384	family	0	None
38384	38385	members	0	None
38385	38386	.	0	None

38387	38388	Various	0	None
38388	38389	RAR	0	None
38389	38390	subtype-specific	0	None
38390	38391	and	0	None
38391	38392	function-selective	0	None
38392	38393	retinoids	2	CHEMICAL
38393	38394	have	0	None
38394	38395	been	0	None
38395	38396	synthesized	0	None
38396	38397	.	0	None

38398	38399	These	0	None
38399	38400	retinoids	2	CHEMICAL
38400	38401	,	0	None
38401	38402	which	0	None
38402	38403	are	0	None
38403	38404	in	0	None
38404	38405	various	0	None
38405	38406	stages	0	None
38406	38407	of	0	None
38407	38408	pre-clinical	0	None
38408	38409	development	0	None
38409	38410	for	0	None
38410	38411	the	0	None
38411	38412	treatment	0	None
38412	38413	of	0	None
38413	38414	cancers	0	None
38414	38415	,	0	None
38415	38416	psoriasis	0	None
38416	38417	and	0	None
38417	38418	as	0	None
38418	38419	an	0	None
38419	38420	antidote	0	None
38420	38421	to	0	None
38421	38422	Accutane-mediated	0	None
38422	38423	mucocutaneous	0	None
38423	38424	toxicity	0	None
38424	38425	,	0	None
38425	38426	will	0	None
38426	38427	also	0	None
38427	38428	be	0	None
38428	38429	discussed	0	None
38429	38430	in	0	None
38430	38431	this	0	None
38431	38432	review	0	None
38432	38433	.	0	None

38434	38435	Discovery	0	None
38435	38436	of	0	None
38436	38437	another	0	None
38437	38438	retinoid	0	None
38438	38439	receptor	0	None
38439	38440	,	0	None
38440	38441	retinoid	0	None
38441	38442	X	0	None
38442	38443	receptor	0	None
38443	38444	(	0	None
38444	38445	RXR	0	None
38445	38446	)	0	None
38446	38447	,	0	None
38447	38448	revealed	0	None
38448	38449	that	0	None
38449	38450	RXR-specific	0	None
38450	38451	retinoids	2	CHEMICAL
38451	38452	already	0	None
38452	38453	existed	0	None
38453	38454	in	0	None
38454	38455	retinoid	0	None
38455	38456	chemical	0	None
38456	38457	libraries	0	None
38457	38458	.	0	None

38459	38460	Structure	0	None
38460	38461	activity	0	None
38461	38462	relationship	0	None
38462	38463	studies	0	None
38463	38464	based	0	None
38464	38465	upon	0	None
38465	38466	binding	0	None
38466	38467	and	0	None
38467	38468	transactivation	0	None
38468	38469	assays	0	None
38469	38470	led	0	None
38470	38471	to	0	None
38471	38472	the	0	None
38472	38473	synthesis	0	None
38473	38474	of	0	None
38474	38475	RXR-specific	0	None
38475	38476	ligands	0	None
38476	38477	with	0	None
38477	38478	high	0	None
38478	38479	affinities	0	None
38479	38480	for	0	None
38480	38481	RXR	0	None
38481	38482	subtypes	0	None
38482	38483	.	0	None

38484	38485	These	0	None
38485	38486	compounds	0	None
38486	38487	were	0	None
38487	38488	found	0	None
38488	38489	to	0	None
38489	38490	be	0	None
38490	38491	effective	0	None
38491	38492	in	0	None
38492	38493	the	0	None
38493	38494	treatment	0	None
38494	38495	of	0	None
38495	38496	hyperglycemia	0	None
38496	38497	in	0	None
38497	38498	animal	0	None
38498	38499	models	0	None
38499	38500	of	0	None
38500	38501	type	0	None
38501	38502	II	0	None
38502	38503	diabetes	0	None
38503	38504	.	0	None

38505	38506	The	0	None
38506	38507	discovery	0	None
38507	38508	of	0	None
38508	38509	novel	0	None
38509	38510	retinoids	2	CHEMICAL
38510	38511	along	0	None
38511	38512	with	0	None
38512	38513	an	0	None
38513	38514	increased	0	None
38514	38515	understanding	0	None
38515	38516	of	0	None
38516	38517	the	0	None
38517	38518	biological	0	None
38518	38519	functions	0	None
38519	38520	and	0	None
38520	38521	mechanisms	0	None
38521	38522	of	0	None
38522	38523	action	0	None
38523	38524	of	0	None
38524	38525	retinoid	0	None
38525	38526	receptors	0	None
38526	38527	are	0	None
38527	38528	likely	0	None
38528	38529	to	0	None
38529	38530	result	0	None
38530	38531	in	0	None
38531	38532	improved	0	None
38532	38533	treatments	0	None
38533	38534	for	0	None
38534	38535	existing	0	None
38535	38536	responsive	0	None
38536	38537	indications	0	None
38537	38538	and	0	None
38538	38539	identification	0	None
38539	38540	of	0	None
38540	38541	new	0	None
38541	38542	retinoid	0	None
38542	38543	therapeutic	0	None
38543	38544	targets	0	None
38544	38545	.	0	None
38545	38546	Numerous	0	None
38546	38547	studies	0	None
38547	38548	have	0	None
38548	38549	shown	0	None
38549	38550	that	0	None
38550	38551	resveratrol	0	None
38551	38552	(	0	None
38552	38553	RES	0	None
38553	38554	)	0	None
38554	38555	exerts	0	None
38555	38556	anti-inflammatory	0	None
38556	38557	effects	0	None
38557	38558	but	0	None
38558	38559	human	0	None
38559	38560	trials	0	None
38560	38561	evidencing	0	None
38561	38562	these	0	None
38562	38563	effects	0	None
38563	38564	in	0	None
38564	38565	vivo	0	None
38565	38566	are	0	None
38566	38567	limited	0	None
38567	38568	.	0	None

38569	38570	Furthermore	0	None
38570	38571	,	0	None
38571	38572	the	0	None
38572	38573	molecular	0	None
38573	38574	mechanisms	0	None
38574	38575	triggered	0	None
38575	38576	in	0	None
38576	38577	humans	0	None
38577	38578	following	0	None
38578	38579	the	0	None
38579	38580	oral	0	None
38580	38581	intake	0	None
38581	38582	of	0	None
38582	38583	RES	0	None
38583	38584	are	0	None
38584	38585	not	0	None
38585	38586	yet	0	None
38586	38587	understood	0	None
38587	38588	.	0	None

38589	38590	Therefore	0	None
38590	38591	,	0	None
38591	38592	the	0	None
38592	38593	purpose	0	None
38593	38594	of	0	None
38594	38595	this	0	None
38595	38596	study	0	None
38596	38597	was	0	None
38597	38598	to	0	None
38598	38599	investigate	0	None
38599	38600	the	0	None
38600	38601	molecular	0	None
38601	38602	changes	0	None
38602	38603	in	0	None
38603	38604	peripheral	0	None
38604	38605	blood	0	None
38605	38606	mononuclear	0	None
38606	38607	cells	0	None
38607	38608	(	0	None
38608	38609	PBMCs	0	None
38609	38610	)	0	None
38610	38611	associated	0	None
38611	38612	to	0	None
38612	38613	the	0	None
38613	38614	one-year	0	None
38614	38615	daily	0	None
38615	38616	intake	0	None
38616	38617	of	0	None
38617	38618	a	0	None
38618	38619	RES	0	None
38619	38620	enriched	0	None
38620	38621	(	0	None
38621	38622	8mg	0	None
38622	38623	)	0	None
38623	38624	grape	0	None
38624	38625	extract	0	None
38625	38626	(	0	None
38626	38627	GE-RES	0	None
38627	38628	)	0	None
38628	38629	in	0	None
38629	38630	hypertensive	0	None
38630	38631	male	0	None
38631	38632	patients	0	None
38632	38633	with	0	None
38633	38634	type	0	None
38634	38635	2	0	None
38635	38636	diabetes	0	None
38636	38637	mellitus	0	None
38637	38638	(	0	None
38638	38639	T2DM	0	None
38639	38640	)	0	None
38640	38641	.	0	None

38642	38643	We	0	None
38643	38644	used	0	None
38644	38645	microarrays	0	None
38645	38646	and	0	None
38646	38647	RT-PCR	0	None
38647	38648	to	0	None
38648	38649	analyze	0	None
38649	38650	expression	0	None
38650	38651	changes	0	None
38651	38652	in	0	None
38652	38653	genes	0	None
38653	38654	and	0	None
38654	38655	microRNAs	0	None
38655	38656	(	0	None
38656	38657	miRs	0	None
38657	38658	)	0	None
38658	38659	involved	0	None
38659	38660	in	0	None
38660	38661	the	0	None
38661	38662	inflammatory	0	None
38662	38663	response	0	None
38663	38664	modulated	0	None
38664	38665	by	0	None
38665	38666	the	0	None
38666	38667	consumption	0	None
38667	38668	of	0	None
38668	38669	GE-RES	0	None
38669	38670	in	0	None
38670	38671	comparison	0	None
38671	38672	to	0	None
38672	38673	a	0	None
38673	38674	placebo	0	None
38674	38675	and	0	None
38675	38676	GE	0	None
38676	38677	lacking	0	None
38677	38678	RES	0	None
38678	38679	.	0	None

38680	38681	We	0	None
38681	38682	also	0	None
38682	38683	examined	0	None
38683	38684	the	0	None
38684	38685	changes	0	None
38685	38686	in	0	None
38686	38687	several	0	None
38687	38688	serobiochemical	0	None
38688	38689	variables	0	None
38689	38690	,	0	None
38690	38691	inflammatory	0	None
38691	38692	and	0	None
38692	38693	fibrinolytic	0	None
38693	38694	markers	0	None
38694	38695	.	0	None

38696	38697	Our	0	None
38697	38698	results	0	None
38698	38699	showed	0	None
38699	38700	that	0	None
38700	38701	supplementation	0	None
38701	38702	with	0	None
38702	38703	GE	0	None
38703	38704	or	0	None
38704	38705	GE-RES	0	None
38705	38706	did	0	None
38706	38707	not	0	None
38707	38708	affect	0	None
38708	38709	body	0	None
38709	38710	weight	0	None
38710	38711	,	0	None
38711	38712	blood	0	None
38712	38713	pressure	0	None
38713	38714	,	0	None
38714	38715	glucose	0	None
38715	38716	,	0	None
38716	38717	HbA1c	0	None
38717	38718	or	0	None
38718	38719	lipids	0	None
38719	38720	,	0	None
38720	38721	beyond	0	None
38721	38722	the	0	None
38722	38723	values	0	None
38723	38724	regulated	0	None
38724	38725	by	0	None
38725	38726	gold	0	None
38726	38727	standard	0	None
38727	38728	medication	0	None
38728	38729	in	0	None
38729	38730	these	0	None
38730	38731	patients	0	None
38731	38732	.	0	None

38733	38734	We	0	None
38734	38735	did	0	None
38735	38736	not	0	None
38736	38737	find	0	None
38737	38738	either	0	None
38738	38739	any	0	None
38739	38740	significant	0	None
38740	38741	change	0	None
38741	38742	on	0	None
38742	38743	serum	0	None
38743	38744	inflammatory	0	None
38744	38745	markers	0	None
38745	38746	except	0	None
38746	38747	for	0	None
38747	38748	a	0	None
38748	38749	significant	0	None
38749	38750	reduction	0	None
38750	38751	of	0	None
38751	38752	ALP	0	None
38752	38753	and	0	None
38753	38754	IL-6	0	None
38754	38755	levels	0	None
38755	38756	.	0	None

38757	38758	The	0	None
38758	38759	expression	0	None
38759	38760	of	0	None
38760	38761	the	0	None
38761	38762	pro-inflammatory	0	None
38762	38763	cytokines	3	GENE-N
38763	38764	CCL3	0	None
38764	38765	,	0	None
38765	38766	IL-1β	0	None
38766	38767	and	0	None
38767	38768	TNF-α	0	None
38768	38769	was	0	None
38769	38770	significantly	0	None
38770	38771	reduced	0	None
38771	38772	and	0	None
38772	38773	that	0	None
38773	38774	of	0	None
38774	38775	the	0	None
38775	38776	transcriptional	0	None
38776	38777	repressor	0	None
38777	38778	LRRFIP-1	0	None
38778	38779	increased	0	None
38779	38780	in	0	None
38780	38781	PBMCs	0	None
38781	38782	from	0	None
38782	38783	patients	0	None
38783	38784	taking	0	None
38784	38785	the	0	None
38785	38786	GE-RES	0	None
38786	38787	extract	0	None
38787	38788	.	0	None

38789	38790	Also	0	None
38790	38791	,	0	None
38791	38792	a	0	None
38792	38793	group	0	None
38793	38794	of	0	None
38794	38795	miRs	0	None
38795	38796	involved	0	None
38796	38797	in	0	None
38797	38798	the	0	None
38798	38799	regulation	0	None
38799	38800	of	0	None
38800	38801	the	0	None
38801	38802	inflammatory	0	None
38802	38803	response	0	None
38803	38804	:	0	None
38804	38805	miR-21	0	None
38805	38806	,	0	None
38806	38807	miR-181b	0	None
38807	38808	,	0	None
38808	38809	miR-663	0	None
38809	38810	,	0	None
38810	38811	miR-30c2	0	None
38811	38812	,	0	None
38812	38813	miR-155	0	None
38813	38814	and	0	None
38814	38815	miR-34a	0	None
38815	38816	were	0	None
38816	38817	found	0	None
38817	38818	to	0	None
38818	38819	be	0	None
38819	38820	highly	0	None
38820	38821	correlated	0	None
38821	38822	and	0	None
38822	38823	altered	0	None
38823	38824	in	0	None
38824	38825	the	0	None
38825	38826	group	0	None
38826	38827	consuming	0	None
38827	38828	the	0	None
38828	38829	GE-RES	0	None
38829	38830	for	0	None
38830	38831	12	0	None
38831	38832	months	0	None
38832	38833	.	0	None

38834	38835	Our	0	None
38835	38836	results	0	None
38836	38837	provide	0	None
38837	38838	preliminary	0	None
38838	38839	evidence	0	None
38839	38840	that	0	None
38840	38841	long-term	0	None
38841	38842	supplementation	0	None
38842	38843	with	0	None
38843	38844	a	0	None
38844	38845	grape	0	None
38845	38846	extract	0	None
38846	38847	containing	0	None
38847	38848	RES	0	None
38848	38849	downregulates	0	None
38849	38850	the	0	None
38850	38851	expression	0	None
38851	38852	of	0	None
38852	38853	key	0	None
38853	38854	pro-inflammatory	0	None
38854	38855	cytokines	3	GENE-N
38855	38856	with	0	None
38856	38857	the	0	None
38857	38858	involvement	0	None
38858	38859	of	0	None
38859	38860	inflammation-related	0	None
38860	38861	miRs	0	None
38861	38862	in	0	None
38862	38863	circulating	0	None
38863	38864	immune	0	None
38864	38865	cells	0	None
38865	38866	of	0	None
38866	38867	T2DM	0	None
38867	38868	hypertensive	0	None
38868	38869	medicated	0	None
38869	38870	patients	0	None
38870	38871	and	0	None
38871	38872	support	0	None
38872	38873	a	0	None
38873	38874	beneficial	0	None
38874	38875	immunomodulatory	0	None
38875	38876	effect	0	None
38876	38877	in	0	None
38877	38878	these	0	None
38878	38879	patients	0	None
38879	38880	.	0	None
38880	38881	OBJECTIVES	0	None
38881	38882	:	0	None
38882	38883	The	0	None
38883	38884	purpose	0	None
38884	38885	of	0	None
38885	38886	this	0	None
38886	38887	study	0	None
38887	38888	was	0	None
38888	38889	to	0	None
38889	38890	determine	0	None
38890	38891	whether	0	None
38891	38892	continuous	0	None
38892	38893	infusion	0	None
38893	38894	of	0	None
38894	38895	ritodrine	0	None
38895	38896	could	0	None
38896	38897	prevent	0	None
38897	38898	preterm	0	None
38898	38899	delivery	0	None
38899	38900	in	0	None
38900	38901	sheep	0	None
38901	38902	.	0	None

38903	38904	STUDY	0	None
38904	38905	DESIGN	0	None
38905	38906	:	0	None
38906	38907	Sheep	0	None
38907	38908	in	0	None
38908	38909	preterm	0	None
38909	38910	labor	0	None
38910	38911	induced	0	None
38911	38912	by	0	None
38912	38913	RU	0	None
38913	38914	486	0	None
38914	38915	(	0	None
38915	38916	mifepristone	2	CHEMICAL
38916	38917	)	0	None
38917	38918	received	0	None
38918	38919	infusions	0	None
38919	38920	of	0	None
38920	38921	either	0	None
38921	38922	ritodrine	0	None
38922	38923	(	0	None
38923	38924	n	0	None
38924	38925	=	0	None
38925	38926	5	0	None
38926	38927	)	0	None
38927	38928	or	0	None
38928	38929	saline	0	None
38929	38930	solution	0	None
38930	38931	(	0	None
38931	38932	n	0	None
38932	38933	=	0	None
38933	38934	5	0	None
38934	38935	)	0	None
38935	38936	,	0	None
38936	38937	and	0	None
38937	38938	the	0	None
38938	38939	progress	0	None
38939	38940	of	0	None
38940	38941	labor	0	None
38941	38942	was	0	None
38942	38943	monitored	0	None
38943	38944	.	0	None

38945	38946	beta	0	None
38946	38947	2-Adrenergic	0	None
38947	38948	receptor	0	None
38948	38949	density	0	None
38949	38950	and	0	None
38950	38951	function	0	None
38951	38952	(	0	None
38952	38953	agonist-induced	0	None
38953	38956	cyclic adenosine monophosphate	2	CHEMICAL
38956	38957	production	0	None
38957	38958	)	0	None
38958	38959	was	0	None
38959	38960	measured	0	None
38960	38961	in	0	None
38961	38962	myometrial	0	None
38962	38963	samples	0	None
38963	38964	from	0	None
38964	38965	both	0	None
38965	38966	groups	0	None
38966	38967	.	0	None

38968	38969	RESULTS	0	None
38969	38970	:	0	None
38970	38971	Ritodrine	0	None
38971	38972	initially	0	None
38972	38973	inhibited	0	None
38973	38974	labor	0	None
38974	38975	contractions	0	None
38975	38976	.	0	None

38977	38978	This	0	None
38978	38979	inhibition	0	None
38979	38980	was	0	None
38980	38981	only	0	None
38981	38982	maintained	0	None
38982	38983	for	0	None
38983	38984	16	0	None
38984	38985	hours	0	None
38985	38986	,	0	None
38986	38987	after	0	None
38987	38988	which	0	None
38988	38989	both	0	None
38989	38990	the	0	None
38990	38991	amplitude	0	None
38991	38992	and	0	None
38992	38993	frequency	0	None
38993	38994	of	0	None
38994	38995	electromyographic	0	None
38995	38996	bursts	0	None
38996	38997	and	0	None
38997	38998	contractions	0	None
38998	38999	returned	0	None
38999	39000	.	0	None

39001	39002	The	0	None
39002	39003	failure	0	None
39003	39004	of	0	None
39004	39005	the	0	None
39005	39006	myometrium	0	None
39006	39007	to	0	None
39007	39008	respond	0	None
39008	39009	to	0	None
39009	39010	ritodrine	0	None
39010	39011	(	0	None
39011	39012	desensitization	0	None
39012	39013	)	0	None
39013	39014	was	0	None
39014	39015	associated	0	None
39015	39016	with	0	None
39016	39017	significant	0	None
39017	39018	reductions	0	None
39018	39019	in	0	None
39019	39020	agonist-induced	0	None
39020	39023	cyclic adenosine monophosphate	2	CHEMICAL
39023	39024	production	0	None
39024	39025	and	0	None
39025	39026	beta	0	None
39026	39027	2-adrenergic	0	None
39027	39028	receptor	0	None
39028	39029	concentration	0	None
39029	39030	in	0	None
39030	39031	myometrial	0	None
39031	39032	tissue	0	None
39032	39033	collected	0	None
39033	39034	from	0	None
39034	39035	these	0	None
39035	39036	animals	0	None
39036	39037	compared	0	None
39037	39038	with	0	None
39038	39039	the	0	None
39039	39040	saline	0	None
39040	39041	solution-treated	0	None
39041	39042	controls	0	None
39042	39043	.	0	None

39044	39045	CONCLUSIONS	0	None
39045	39046	:	0	None
39046	39047	Continuous	0	None
39047	39048	infusion	0	None
39048	39049	of	0	None
39049	39050	ritodrine	0	None
39050	39051	to	0	None
39051	39052	sheep	0	None
39052	39053	in	0	None
39053	39054	preterm	0	None
39054	39055	labor	0	None
39055	39056	produces	0	None
39056	39057	only	0	None
39057	39058	a	0	None
39058	39059	transient	0	None
39059	39060	inhibition	0	None
39060	39061	of	0	None
39061	39062	contractions	0	None
39062	39063	.	0	None

39064	39065	This	0	None
39065	39066	desensitization	0	None
39066	39067	is	0	None
39067	39068	caused	0	None
39068	39069	by	0	None
39069	39070	a	0	None
39070	39071	down-regulation	0	None
39071	39072	of	0	None
39072	39075	myometrial beta 2-adrenergic	1	GENE-Y
39075	39076	receptors	0	None
39076	39077	.	0	None
39077	39078	Frovatriptan	0	None
39078	39079	succinate	0	None
39079	39080	,	0	None
39080	39081	a	0	None
39081	39082	5-HT1B	0	None
39082	39083	/	0	None
39083	39084	1D	0	None
39084	39085	receptor	0	None
39085	39086	agonist	0	None
39086	39087	for	0	None
39087	39088	migraine	0	None
39088	39089	.	0	None
39089	39090	Synthesis	0	None
39090	39091	and	0	None
39091	39092	Biological	0	None
39092	39093	Evaluation	0	None
39093	39094	of	0	None
39094	39095	Urea	2	CHEMICAL
39095	39096	Derivatives	0	None
39096	39097	as	0	None
39097	39098	Highly	0	None
39098	39099	Potent	0	None
39099	39100	and	0	None
39100	39101	Selective	0	None
39101	39102	Rho	0	None
39102	39103	Kinase	0	None
39103	39104	Inhibitors	0	None
39104	39105	.	0	None
39105	39106	Metabolic	0	None
39106	39107	derangement	0	None
39107	39108	of	0	None
39108	39109	methionine	2	CHEMICAL
39109	39110	and	0	None
39110	39111	folate	0	None
39111	39112	metabolism	0	None
39112	39113	in	0	None
39113	39114	mice	0	None
39114	39115	deficient	0	None
39115	39116	in	0	None
39116	39118	methionine synthase	1	GENE-Y
39118	39119	reductase	0	None
39119	39120	.	0	None
39120	39121	BACKGROUND	0	None
39121	39122	&	0	None
39122	39123	AIMS	0	None
39123	39124	:	0	None
39124	39125	Of	0	None
39125	39126	the	0	None
39126	39127	2	0	None
39127	39128	genes	0	None
39128	39129	(	0	None
39129	39130	MAT1A	0	None
39130	39131	,	0	None
39131	39132	MAT2A	0	None
39132	39133	)	0	None
39133	39134	encoding	0	None
39134	39135	methionine	0	None
39135	39136	adenosyltransferase	0	None
39136	39137	,	0	None
39137	39138	the	0	None
39138	39139	enzyme	0	None
39139	39140	that	0	None
39140	39141	synthesizes	0	None
39141	39142	S-adenosylmethionine	2	CHEMICAL
39142	39143	,	0	None
39143	39144	MAT1A	0	None
39144	39145	,	0	None
39145	39146	is	0	None
39146	39147	expressed	0	None
39147	39148	in	0	None
39148	39149	liver	0	None
39149	39150	,	0	None
39150	39151	whereas	0	None
39151	39152	MAT2A	0	None
39152	39153	is	0	None
39153	39154	expressed	0	None
39154	39155	in	0	None
39155	39156	extrahepatic	0	None
39156	39157	tissues	0	None
39157	39158	.	0	None

39159	39160	In	0	None
39160	39161	liver	0	None
39161	39162	,	0	None
39162	39163	MAT2A	0	None
39163	39164	expression	0	None
39164	39165	associates	0	None
39165	39166	with	0	None
39166	39167	growth	0	None
39167	39168	,	0	None
39168	39169	dedifferentiation	0	None
39169	39170	,	0	None
39170	39171	and	0	None
39171	39172	cancer	0	None
39172	39173	.	0	None

39174	39175	Here	0	None
39175	39176	,	0	None
39176	39177	we	0	None
39177	39178	identified	0	None
39178	39179	the	0	None
39179	39180	beta	0	None
39180	39181	subunit	0	None
39181	39182	as	0	None
39182	39183	a	0	None
39183	39184	regulator	0	None
39184	39185	of	0	None
39185	39186	proliferation	0	None
39186	39187	in	0	None
39187	39188	human	0	None
39188	39189	hepatoma	0	None
39189	39190	cell	0	None
39190	39191	lines	0	None
39191	39192	.	0	None

39193	39194	The	0	None
39194	39195	beta	0	None
39195	39196	subunit	0	None
39196	39197	has	0	None
39197	39198	been	0	None
39198	39199	cloned	0	None
39199	39200	and	0	None
39200	39201	shown	0	None
39201	39202	to	0	None
39202	39203	lower	0	None
39203	39204	the	0	None
39204	39205	K	0	None
39205	39206	(	0	None
39206	39207	m	0	None
39207	39208	)	0	None
39208	39209	of	0	None
39209	39211	methionine adenosyltransferase	0	None
39211	39212	II	0	None
39212	39213	alpha2	0	None
39213	39214	(	0	None
39214	39215	the	0	None
39215	39216	MAT2A	0	None
39216	39217	product	0	None
39217	39218	)	0	None
39218	39219	for	0	None
39219	39220	methionine	2	CHEMICAL
39220	39221	and	0	None
39221	39222	to	0	None
39222	39223	render	0	None
39223	39224	the	0	None
39224	39225	enzyme	0	None
39225	39226	more	0	None
39226	39227	susceptible	0	None
39227	39228	to	0	None
39228	39229	S-adenosylmethionine	2	CHEMICAL
39229	39230	inhibition	0	None
39230	39231	.	0	None

39232	39233	METHODS	0	None
39233	39234	:	0	None
39234	39235	Methionine	0	None
39235	39236	adenosyltransferase	0	None
39236	39237	II	0	None
39237	39238	alpha2	0	None
39238	39239	and	0	None
39239	39240	beta	0	None
39240	39241	subunit	0	None
39241	39242	expression	0	None
39242	39243	was	0	None
39243	39244	analyzed	0	None
39244	39245	in	0	None
39245	39246	human	0	None
39246	39247	and	0	None
39247	39248	rat	0	None
39248	39249	liver	0	None
39249	39250	and	0	None
39250	39251	hepatoma	0	None
39251	39252	cell	0	None
39252	39253	lines	0	None
39253	39254	and	0	None
39254	39255	their	0	None
39255	39256	interaction	0	None
39256	39257	studied	0	None
39257	39258	in	0	None
39258	39259	HuH7	0	None
39259	39260	cells	0	None
39260	39261	.	0	None

39262	39263	beta	0	None
39263	39264	Subunit	0	None
39264	39265	expression	0	None
39265	39266	was	0	None
39266	39267	up-	0	None
39267	39268	and	0	None
39268	39269	down-regulated	0	None
39269	39270	in	0	None
39270	39271	human	0	None
39271	39272	hepatoma	0	None
39272	39273	cell	0	None
39273	39274	lines	0	None
39274	39275	and	0	None
39275	39276	the	0	None
39276	39277	effect	0	None
39277	39278	on	0	None
39278	39279	DNA	0	None
39279	39280	synthesis	0	None
39280	39281	determined	0	None
39281	39282	.	0	None

39283	39284	RESULTS	0	None
39284	39285	:	0	None
39285	39286	We	0	None
39286	39287	found	0	None
39287	39288	that	0	None
39288	39289	beta	0	None
39289	39290	subunit	0	None
39290	39291	is	0	None
39291	39292	expressed	0	None
39292	39293	in	0	None
39293	39294	rat	0	None
39294	39295	extrahepatic	0	None
39295	39296	tissues	0	None
39296	39297	but	0	None
39297	39298	not	0	None
39298	39299	in	0	None
39299	39300	normal	0	None
39300	39301	liver	0	None
39301	39302	.	0	None

39303	39304	In	0	None
39304	39305	human	0	None
39305	39306	liver	0	None
39306	39307	,	0	None
39307	39308	beta	0	None
39308	39309	subunit	0	None
39309	39310	expression	0	None
39310	39311	associates	0	None
39311	39312	with	0	None
39312	39313	cirrhosis	0	None
39313	39314	and	0	None
39314	39315	hepatoma	0	None
39315	39316	.	0	None

39317	39318	beta	0	None
39318	39319	Subunit	0	None
39319	39320	is	0	None
39320	39321	expressed	0	None
39321	39322	in	0	None
39322	39323	most	0	None
39323	39324	(	0	None
39324	39325	HepG2	0	None
39325	39326	,	0	None
39326	39327	PLC	3	GENE-N
39327	39328	,	0	None
39328	39329	and	0	None
39329	39330	Hep3B	0	None
39330	39331	)	0	None
39331	39332	but	0	None
39332	39333	not	0	None
39333	39334	all	0	None
39334	39335	(	0	None
39335	39336	HuH7	0	None
39336	39337	)	0	None
39337	39338	hepatoma	0	None
39338	39339	cell	0	None
39339	39340	lines	0	None
39340	39341	.	0	None

39342	39343	Transfection	0	None
39343	39344	of	0	None
39344	39345	beta	0	None
39345	39346	subunit	0	None
39346	39347	reduced	0	None
39347	39348	S-adenosylmethionine	2	CHEMICAL
39348	39349	content	0	None
39349	39350	and	0	None
39350	39351	stimulated	0	None
39351	39352	DNA	0	None
39352	39353	synthesis	0	None
39353	39354	in	0	None
39354	39355	HuH7	0	None
39355	39356	cells	0	None
39356	39357	,	0	None
39357	39358	whereas	0	None
39358	39359	down-regulation	0	None
39359	39360	of	0	None
39360	39361	beta	0	None
39361	39362	subunit	0	None
39362	39363	expression	0	None
39363	39364	diminished	0	None
39364	39365	DNA	0	None
39365	39366	synthesis	0	None
39366	39367	in	0	None
39367	39368	HepG2	0	None
39368	39369	.	0	None

39370	39371	The	0	None
39371	39372	interaction	0	None
39372	39373	between	0	None
39373	39375	methionine adenosyltransferase	0	None
39375	39376	II	0	None
39376	39377	alpha2	0	None
39377	39378	and	0	None
39378	39379	beta	0	None
39379	39380	subunit	0	None
39380	39381	was	0	None
39381	39382	demonstrated	0	None
39382	39383	in	0	None
39383	39384	HuH7	0	None
39384	39385	cells	0	None
39385	39386	.	0	None

39387	39388	CONCLUSIONS	0	None
39388	39389	:	0	None
39389	39390	Our	0	None
39390	39391	findings	0	None
39391	39392	indicate	0	None
39392	39393	that	0	None
39393	39394	beta	0	None
39394	39395	subunit	0	None
39395	39396	associates	0	None
39396	39397	with	0	None
39397	39398	cirrhosis	0	None
39398	39399	and	0	None
39399	39400	cancer	0	None
39400	39401	providing	0	None
39401	39402	a	0	None
39402	39403	proliferative	0	None
39403	39404	advantage	0	None
39404	39405	in	0	None
39405	39406	hepatoma	0	None
39406	39407	cells	0	None
39407	39408	through	0	None
39408	39409	its	0	None
39409	39410	interaction	0	None
39410	39411	with	0	None
39411	39413	methionine adenosyltransferase	0	None
39413	39414	II	0	None
39414	39415	alpha2	0	None
39415	39416	and	0	None
39416	39417	down-regulation	0	None
39417	39418	of	0	None
39418	39419	S-adenosylmethionine	2	CHEMICAL
39419	39420	levels	0	None
39420	39421	.	0	None
39421	39422	The	0	None
39422	39423	enzymatic	0	None
39423	39424	basis	0	None
39424	39425	for	0	None
39425	39426	the	0	None
39426	39427	metabolism	0	None
39427	39428	and	0	None
39428	39429	inhibitory	0	None
39429	39430	effects	0	None
39430	39431	of	0	None
39431	39432	valproic	0	None
39432	39433	acid	0	None
39433	39434	:	0	None
39434	39435	dehydrogenation	0	None
39435	39436	of	0	None
39436	39437	valproyl-CoA	0	None
39437	39438	by	0	None
39438	39441	2-methyl-branched-chain acyl-CoA dehydrogenase	3	GENE-N
39441	39442	.	0	None
39442	39443	Time-specific	0	None
39443	39444	effects	0	None
39444	39445	of	0	None
39445	39446	perinatal	0	None
39446	39447	glucocorticoid	0	None
39447	39448	treatment	0	None
39448	39449	on	0	None
39449	39450	anterior	0	None
39450	39451	pituitary	0	None
39451	39452	morphology	0	None
39452	39453	,	0	None
39453	39455	annexin 1	1	GENE-Y
39455	39456	expression	0	None
39456	39457	and	0	None
39457	39458	adrenocorticotrophic	0	None
39458	39459	hormone	0	None
39459	39460	secretion	0	None
39460	39461	in	0	None
39461	39462	the	0	None
39462	39463	adult	0	None
39463	39464	female	0	None
39464	39465	rat	0	None
39465	39466	.	0	None
39466	39467	The	0	None
39467	39468	M6P	0	None
39468	39469	(	0	None
39469	39470	mannose	0	None
39470	39471	6-phosphate	0	None
39471	39472	)	0	None
39472	39473	/	0	None
39473	39474	IGF2R	0	None
39474	39475	(	0	None
39475	39480	insulin-like growth factor II receptor	1	GENE-Y
39480	39481	)	0	None
39481	39482	interacts	0	None
39482	39483	with	0	None
39483	39484	a	0	None
39484	39485	variety	0	None
39485	39486	of	0	None
39486	39487	factors	0	None
39487	39488	that	0	None
39488	39489	impinge	0	None
39489	39490	on	0	None
39490	39491	tumour	0	None
39491	39492	invasion	0	None
39492	39493	and	0	None
39493	39494	metastasis	0	None
39494	39495	.	0	None

39496	39497	It	0	None
39497	39498	has	0	None
39498	39499	been	0	None
39499	39500	shown	0	None
39500	39501	that	0	None
39501	39502	expression	0	None
39502	39503	of	0	None
39503	39504	wild-type	0	None
39504	39505	M6P	0	None
39505	39506	/	0	None
39506	39507	IGF2R	0	None
39507	39508	reduces	0	None
39508	39509	the	0	None
39509	39510	tumorigenic	0	None
39510	39511	and	0	None
39511	39512	invasive	0	None
39512	39513	properties	0	None
39513	39514	of	0	None
39514	39515	receptor-deficient	0	None
39515	39516	SCC-VII	0	None
39516	39517	squamous	0	None
39517	39518	cell	0	None
39518	39519	carcinoma	0	None
39519	39520	cells	0	None
39520	39521	.	0	None

39522	39523	We	0	None
39523	39524	have	0	None
39524	39525	now	0	None
39525	39526	used	0	None
39526	39527	mutant	0	None
39527	39528	forms	0	None
39528	39529	of	0	None
39529	39530	M6P	0	None
39530	39531	/	0	None
39531	39532	IGF2R	0	None
39532	39533	to	0	None
39533	39534	assess	0	None
39534	39535	the	0	None
39535	39536	relevance	0	None
39536	39537	of	0	None
39537	39538	the	0	None
39538	39539	different	0	None
39539	39540	ligand-binding	0	None
39540	39541	sites	0	None
39541	39542	of	0	None
39542	39543	the	0	None
39543	39544	receptor	0	None
39544	39545	for	0	None
39545	39546	its	0	None
39546	39547	biological	0	None
39547	39548	activities	0	None
39548	39549	in	0	None
39549	39550	this	0	None
39550	39551	cellular	0	None
39551	39552	system	0	None
39552	39553	.	0	None

39554	39555	The	0	None
39555	39556	results	0	None
39556	39557	of	0	None
39557	39558	the	0	None
39558	39559	present	0	None
39559	39560	study	0	None
39560	39561	demonstrate	0	None
39561	39562	that	0	None
39562	39563	M6P	0	None
39563	39564	/	0	None
39564	39565	IGF2R	0	None
39565	39566	does	0	None
39566	39567	not	0	None
39567	39568	require	0	None
39568	39569	a	0	None
39569	39570	functional	0	None
39570	39571	binding	0	None
39571	39572	site	0	None
39572	39573	for	0	None
39573	39577	insulin-like growth factor II	3	GENE-N
39577	39578	for	0	None
39578	39579	inhibition	0	None
39579	39580	of	0	None
39580	39581	anchorage-independent	0	None
39581	39582	growth	0	None
39582	39583	and	0	None
39583	39584	matrix	0	None
39584	39585	invasion	0	None
39585	39586	by	0	None
39586	39587	SCC-VII	0	None
39587	39588	cells	0	None
39588	39589	.	0	None

39590	39591	In	0	None
39591	39592	contrast	0	None
39592	39593	,	0	None
39593	39594	the	0	None
39594	39595	simultaneous	0	None
39595	39596	mutation	0	None
39596	39597	of	0	None
39597	39598	both	0	None
39598	39599	M6P-binding	0	None
39599	39600	sites	0	None
39600	39601	is	0	None
39601	39602	sufficient	0	None
39602	39603	to	0	None
39603	39604	impair	0	None
39604	39605	all	0	None
39605	39606	cellular	0	None
39606	39607	functions	0	None
39607	39608	of	0	None
39608	39609	the	0	None
39609	39610	receptor	0	None
39610	39611	tested	0	None
39611	39612	.	0	None

39613	39614	These	0	None
39614	39615	findings	0	None
39615	39616	highlight	0	None
39616	39617	that	0	None
39617	39618	the	0	None
39618	39619	interaction	0	None
39619	39620	between	0	None
39620	39621	M6P	0	None
39621	39622	/	0	None
39622	39623	IGF2R	0	None
39623	39624	and	0	None
39624	39625	M6P-modified	0	None
39625	39626	ligands	0	None
39626	39627	is	0	None
39627	39628	not	0	None
39628	39629	only	0	None
39629	39630	important	0	None
39630	39631	for	0	None
39631	39632	intracellular	0	None
39632	39633	accumulation	0	None
39633	39634	of	0	None
39634	39635	lysosomal	0	None
39635	39636	enzymes	0	None
39636	39637	and	0	None
39637	39638	formation	0	None
39638	39639	of	0	None
39639	39640	dense	0	None
39640	39641	lysosomes	0	None
39641	39642	,	0	None
39642	39643	but	0	None
39643	39644	is	0	None
39644	39645	also	0	None
39645	39646	crucial	0	None
39646	39647	for	0	None
39647	39648	the	0	None
39648	39649	ability	0	None
39649	39650	of	0	None
39650	39651	the	0	None
39651	39652	receptor	0	None
39652	39653	to	0	None
39653	39654	suppress	0	None
39654	39655	SCC-VII	0	None
39655	39656	growth	0	None
39656	39657	and	0	None
39657	39658	invasion	0	None
39658	39659	.	0	None

39660	39661	The	0	None
39661	39662	present	0	None
39662	39663	study	0	None
39663	39664	also	0	None
39664	39665	shows	0	None
39665	39666	that	0	None
39666	39667	some	0	None
39667	39668	of	0	None
39668	39669	the	0	None
39669	39670	biological	0	None
39670	39671	activities	0	None
39671	39672	of	0	None
39672	39673	M6P	0	None
39673	39674	/	0	None
39674	39675	IGF2R	0	None
39675	39676	in	0	None
39676	39677	SCC-VII	0	None
39677	39678	cells	0	None
39678	39679	strongly	0	None
39679	39680	depend	0	None
39680	39681	on	0	None
39681	39682	a	0	None
39682	39683	functional	0	None
39683	39684	M6P-binding	0	None
39684	39685	site	0	None
39685	39686	within	0	None
39686	39687	domain	0	None
39687	39688	3	0	None
39688	39689	,	0	None
39689	39690	thus	0	None
39690	39691	providing	0	None
39691	39692	further	0	None
39692	39693	evidence	0	None
39693	39694	for	0	None
39694	39695	the	0	None
39695	39696	non-redundant	0	None
39696	39697	cellular	0	None
39697	39698	functions	0	None
39698	39699	of	0	None
39699	39700	the	0	None
39700	39701	individual	0	None
39701	39702	carbohydrate-binding	0	None
39702	39703	domains	0	None
39703	39704	of	0	None
39704	39705	the	0	None
39705	39706	receptor	0	None
39706	39707	.	0	None
39707	39708	OBJECTIVE	0	None
39708	39709	:	0	None
39709	39710	Tricyclic	0	None
39710	39711	antidepressants	0	None
39711	39712	(	0	None
39712	39713	TCAs	0	None
39713	39714	)	0	None
39714	39715	are	0	None
39715	39716	one	0	None
39716	39717	of	0	None
39717	39718	the	0	None
39718	39719	first-line	0	None
39719	39720	pharmacological	0	None
39720	39721	treatments	0	None
39721	39722	against	0	None
39722	39723	neuropathic	0	None
39723	39724	pain	0	None
39724	39725	.	0	None

39726	39727	TCAs	0	None
39727	39728	increase	0	None
39728	39729	the	0	None
39729	39730	extracellular	0	None
39730	39731	concentrations	0	None
39731	39732	of	0	None
39732	39733	noradrenaline	0	None
39733	39734	and	0	None
39734	39735	serotonin	0	None
39735	39736	by	0	None
39736	39737	blocking	0	None
39737	39738	the	0	None
39738	39739	reuptake	0	None
39739	39740	transporters	0	None
39740	39741	of	0	None
39741	39742	these	0	None
39742	39743	amines	0	None
39743	39744	.	0	None

39745	39746	However	0	None
39746	39747	,	0	None
39747	39748	the	0	None
39748	39749	precise	0	None
39749	39750	downstream	0	None
39750	39751	mechanism	0	None
39751	39752	leading	0	None
39752	39753	to	0	None
39753	39754	the	0	None
39754	39755	therapeutic	0	None
39755	39756	action	0	None
39756	39757	remains	0	None
39757	39758	identified	0	None
39758	39759	.	0	None

39760	39761	In	0	None
39761	39762	this	0	None
39762	39763	work	0	None
39763	39764	,	0	None
39764	39765	we	0	None
39765	39766	evaluated	0	None
39766	39767	the	0	None
39767	39768	role	0	None
39768	39769	of	0	None
39769	39771	adrenergic receptors	3	GENE-N
39771	39772	(	0	None
39772	39773	ARs	0	None
39773	39774	)	0	None
39774	39775	in	0	None
39775	39776	the	0	None
39776	39777	action	0	None
39777	39778	of	0	None
39778	39779	TCAs	0	None
39779	39780	.	0	None

39781	39782	METHODS	0	None
39782	39783	:	0	None
39783	39784	We	0	None
39784	39785	used	0	None
39785	39786	pharmacological	0	None
39786	39787	and	0	None
39787	39788	genetic	0	None
39788	39789	approaches	0	None
39789	39790	in	0	None
39790	39791	mice	0	None
39791	39792	to	0	None
39792	39793	study	0	None
39793	39794	the	0	None
39794	39795	role	0	None
39795	39796	of	0	None
39796	39797	ARs	0	None
39797	39798	in	0	None
39798	39799	the	0	None
39799	39800	antiallodynic	0	None
39800	39801	action	0	None
39801	39802	of	0	None
39802	39803	the	0	None
39803	39804	TCA	0	None
39804	39805	nortriptyline	2	CHEMICAL
39805	39806	.	0	None

39807	39808	Peripheral	0	None
39808	39809	neuropathy	0	None
39809	39810	was	0	None
39810	39811	induced	0	None
39811	39812	by	0	None
39812	39813	the	0	None
39813	39814	insertion	0	None
39814	39815	of	0	None
39815	39816	a	0	None
39816	39817	polyethylene	0	None
39817	39818	cuff	0	None
39818	39819	around	0	None
39819	39820	the	0	None
39820	39821	main	0	None
39821	39822	branch	0	None
39822	39823	of	0	None
39823	39824	the	0	None
39824	39825	sciatic	0	None
39825	39826	nerve	0	None
39826	39827	.	0	None

39828	39829	The	0	None
39829	39830	specific	0	None
39830	39831	role	0	None
39831	39832	of	0	None
39832	39833	beta	0	None
39833	39834	(	0	None
39834	39835	2	0	None
39835	39836	)	0	None
39836	39837	-AR	0	None
39837	39838	was	0	None
39838	39839	evaluated	0	None
39839	39840	by	0	None
39840	39841	studying	0	None
39841	39842	beta	0	None
39842	39843	(	0	None
39843	39844	2	0	None
39844	39845	)	0	None
39845	39846	-AR	0	None
39846	39847	(	0	None
39847	39848	-	0	None
39848	39849	/	0	None
39849	39850	-	0	None
39850	39851	)	0	None
39851	39852	mice	0	None
39852	39853	.	0	None

39854	39855	We	0	None
39855	39856	used	0	None
39856	39857	von	0	None
39857	39858	Frey	0	None
39858	39859	filaments	0	None
39859	39860	to	0	None
39860	39861	assess	0	None
39861	39862	mechanical	0	None
39862	39863	allodynia	0	None
39863	39864	.	0	None

39865	39866	RESULTS	0	None
39866	39867	:	0	None
39867	39868	The	0	None
39868	39869	antiallodynic	0	None
39869	39870	action	0	None
39870	39871	of	0	None
39871	39872	nortriptyline	2	CHEMICAL
39872	39873	was	0	None
39873	39874	not	0	None
39874	39875	affected	0	None
39875	39876	by	0	None
39876	39877	cotreatment	0	None
39877	39878	with	0	None
39878	39879	the	0	None
39879	39880	alpha	0	None
39880	39881	(	0	None
39881	39882	2	0	None
39882	39883	)	0	None
39883	39884	-AR	0	None
39884	39885	antagonist	0	None
39885	39886	yohimbine	0	None
39886	39887	,	0	None
39887	39888	the	0	None
39888	39889	beta	0	None
39889	39890	(	0	None
39890	39891	1	0	None
39891	39892	)	0	None
39892	39893	-AR	0	None
39893	39894	antagonists	0	None
39894	39895	atenolol	0	None
39895	39896	or	0	None
39896	39897	metoprolol	2	CHEMICAL
39897	39898	,	0	None
39898	39899	or	0	None
39899	39900	the	0	None
39900	39901	beta	0	None
39901	39902	(	0	None
39902	39903	3	0	None
39903	39904	)	0	None
39904	39905	-AR	0	None
39905	39906	antagonist	0	None
39906	39908	SR 59230A	2	CHEMICAL
39908	39909	.	0	None

39910	39911	On	0	None
39911	39912	the	0	None
39912	39913	contrary	0	None
39913	39914	,	0	None
39914	39915	the	0	None
39915	39916	beta-AR	0	None
39916	39917	antagonists	0	None
39917	39918	propranolol	0	None
39918	39919	or	0	None
39919	39920	sotalol	0	None
39920	39921	,	0	None
39921	39922	the	0	None
39922	39923	beta	0	None
39923	39924	(	0	None
39924	39925	1	0	None
39925	39926	)	0	None
39926	39927	/	0	None
39927	39928	beta	0	None
39928	39929	(	0	None
39929	39930	2	0	None
39930	39931	)	0	None
39931	39932	-AR	0	None
39932	39933	antagonists	0	None
39933	39934	alprenolol	2	CHEMICAL
39934	39935	or	0	None
39935	39936	pindolol	2	CHEMICAL
39936	39937	,	0	None
39937	39938	or	0	None
39938	39939	the	0	None
39939	39940	specific	0	None
39940	39941	beta	0	None
39941	39942	(	0	None
39942	39943	2	0	None
39943	39944	)	0	None
39944	39945	-AR	0	None
39945	39946	antagonist	0	None
39946	39947	ICI	0	None
39947	39948	118	0	None
39948	39949	,	0	None
39949	39950	551	0	None
39950	39951	blocked	0	None
39951	39952	the	0	None
39952	39953	action	0	None
39953	39954	of	0	None
39954	39955	nortriptyline	2	CHEMICAL
39955	39956	.	0	None

39957	39958	The	0	None
39958	39959	effect	0	None
39959	39960	of	0	None
39960	39961	nortriptyline	2	CHEMICAL
39961	39962	was	0	None
39962	39963	also	0	None
39963	39964	totally	0	None
39964	39965	absent	0	None
39965	39966	in	0	None
39966	39967	beta	0	None
39967	39968	(	0	None
39968	39969	2	0	None
39969	39970	)	0	None
39970	39971	-AR-deficient	0	None
39971	39972	mice	0	None
39972	39973	.	0	None

39974	39975	INTERPRETATION	0	None
39975	39976	:	0	None
39976	39977	Stimulation	0	None
39977	39978	of	0	None
39978	39979	beta	0	None
39979	39980	(	0	None
39980	39981	2	0	None
39981	39982	)	0	None
39982	39983	-AR	0	None
39983	39984	is	0	None
39984	39985	necessary	0	None
39985	39986	for	0	None
39986	39987	nortriptyline	2	CHEMICAL
39987	39988	to	0	None
39988	39989	exert	0	None
39989	39990	its	0	None
39990	39991	antiallodynic	0	None
39991	39992	action	0	None
39992	39993	against	0	None
39993	39994	neuropathic	0	None
39994	39995	pain	0	None
39995	39996	.	0	None

39997	39998	These	0	None
39998	39999	findings	0	None
39999	40000	provide	0	None
40000	40001	new	0	None
40001	40002	insight	0	None
40002	40003	into	0	None
40003	40004	the	0	None
40004	40005	mechanism	0	None
40005	40006	by	0	None
40006	40007	which	0	None
40007	40008	antidepressants	0	None
40008	40009	alleviate	0	None
40009	40010	neuropathic	0	None
40010	40011	pain	0	None
40011	40012	.	0	None

40013	40014	Our	0	None
40014	40015	results	0	None
40015	40016	also	0	None
40016	40017	raise	0	None
40017	40018	the	0	None
40018	40019	question	0	None
40019	40020	of	0	None
40020	40021	a	0	None
40021	40022	potential	0	None
40022	40023	incompatibility	0	None
40023	40024	between	0	None
40024	40025	beta-blockers	0	None
40025	40026	that	0	None
40026	40027	affect	0	None
40027	40028	beta	0	None
40028	40029	(	0	None
40029	40030	2	0	None
40030	40031	)	0	None
40031	40032	-AR	0	None
40032	40033	and	0	None
40033	40034	antidepressant	0	None
40034	40035	drugs	0	None
40035	40036	in	0	None
40036	40037	patients	0	None
40037	40038	treated	0	None
40038	40039	for	0	None
40039	40040	neuropathic	0	None
40040	40041	pain	0	None
40041	40042	.	0	None
40042	40043	Effects	0	None
40043	40044	of	0	None
40044	40045	the	0	None
40045	40046	inhibition	0	None
40046	40047	of	0	None
40047	40048	cyclo-oxygenase	0	None
40048	40049	1	0	None
40049	40050	or	0	None
40050	40051	2	0	None
40051	40052	or	0	None
40052	40053	5-lipoxygenase	1	GENE-Y
40053	40054	on	0	None
40054	40055	the	0	None
40055	40056	activation	0	None
40056	40057	of	0	None
40057	40058	the	0	None
40058	40059	hypothalamic-pituitary-adrenal	0	None
40059	40060	axis	0	None
40060	40061	induced	0	None
40061	40062	by	0	None
40062	40063	interleukin-1beta	0	None
40063	40064	in	0	None
40064	40065	the	0	None
40065	40066	male	0	None
40066	40067	Rat	0	None
40067	40068	.	0	None
40068	40069	Increased	0	None
40069	40070	responsiveness	0	None
40070	40071	of	0	None
40071	40072	rat	0	None
40072	40073	colonic	0	None
40073	40074	splanchnic	0	None
40074	40075	afferents	0	None
40075	40076	to	0	None
40076	40077	5-HT	0	None
40077	40078	after	0	None
40078	40079	inflammation	0	None
40079	40080	and	0	None
40080	40081	recovery	0	None
40081	40082	.	0	None
40082	40083	2-Phenyl-4-piperidinyl-6	0	None
40083	40084	,	0	None
40084	40085	7-dihydrothieno	0	None
40085	40086	[	0	None
40086	40087	3	0	None
40087	40088	,	0	None
40088	40089	4-d	0	None
40089	40090	]	0	None
40090	40091	pyrimidine	2	CHEMICAL
40091	40092	derivative	0	None
40092	40093	(	0	None
40093	40094	2	0	None
40094	40095	)	0	None
40095	40096	was	0	None
40096	40097	found	0	None
40097	40098	to	0	None
40098	40099	be	0	None
40099	40100	a	0	None
40100	40101	new	0	None
40101	40102	PDE4	0	None
40102	40103	inhibitor	0	None
40103	40104	with	0	None
40104	40105	moderate	0	None
40105	40106	PDE4B	0	None
40106	40107	activity	0	None
40107	40108	(	0	None
40108	40109	IC50	0	None
40109	40110	=	0	None
40110	40111	150nM	0	None
40111	40112	)	0	None
40112	40113	.	0	None

40114	40115	A	0	None
40115	40116	number	0	None
40116	40117	of	0	None
40117	40118	derivatives	0	None
40118	40119	with	0	None
40119	40120	a	0	None
40120	40121	variety	0	None
40121	40122	of	0	None
40122	40123	4-amino	0	None
40123	40124	substituents	0	None
40124	40125	and	0	None
40125	40126	fused	0	None
40126	40127	bicyclic	0	None
40127	40128	pyrimidines	0	None
40128	40129	were	0	None
40129	40130	synthesized	0	None
40130	40131	.	0	None

40132	40133	Among	0	None
40133	40134	these	0	None
40134	40135	,	0	None
40135	40136	5	0	None
40136	40137	,	0	None
40137	40138	5-dioxo-7	0	None
40138	40139	,	0	None
40139	40140	8-dihydro-6H-thiopyrano	0	None
40140	40141	[	0	None
40141	40142	3	0	None
40142	40143	,	0	None
40143	40144	2-d	0	None
40144	40145	]	0	None
40145	40146	pyrimidine	2	CHEMICAL
40146	40147	derivative	0	None
40147	40148	(	0	None
40148	40149	18	0	None
40149	40150	)	0	None
40150	40151	showed	0	None
40151	40152	potent	0	None
40152	40153	PDE4B	0	None
40153	40154	inhibitory	0	None
40154	40155	activity	0	None
40155	40156	(	0	None
40156	40157	IC50	0	None
40157	40158	=	0	None
40158	40159	25	0	None
40159	40160	nM	0	None
40160	40161	)	0	None
40161	40162	.	0	None

40163	40164	Finally	0	None
40164	40165	,	0	None
40165	40166	N-propylacetamide	0	None
40166	40167	derivative	0	None
40167	40168	(	0	None
40168	40169	31b	0	None
40169	40170	)	0	None
40170	40171	was	0	None
40171	40172	determined	0	None
40172	40173	as	0	None
40173	40174	a	0	None
40174	40175	potent	0	None
40175	40176	inhibitor	0	None
40176	40177	for	0	None
40177	40178	both	0	None
40178	40179	PDE4B	0	None
40179	40180	(	0	None
40180	40181	IC50	0	None
40181	40182	=	0	None
40182	40183	7	0	None
40183	40184	.	0	None
40184	40185	5nM	0	None
40185	40186	)	0	None
40186	40187	and	0	None
40187	40188	TNF-α	0	None
40188	40189	production	0	None
40189	40190	in	0	None
40190	40191	mouse	0	None
40191	40192	splenocytes	0	None
40192	40193	(	0	None
40193	40194	IC50	0	None
40194	40195	=	0	None
40195	40196	9	0	None
40196	40197	.	0	None
40197	40198	8nM	0	None
40198	40199	)	0	None
40199	40200	and	0	None
40200	40201	showed	0	None
40201	40202	good	0	None
40202	40203	in	0	None
40203	40204	vivo	0	None
40204	40205	anti-inflammatory	0	None
40205	40206	activity	0	None
40206	40207	in	0	None
40207	40208	the	0	None
40208	40209	LPS-induced	0	None
40209	40210	lung	0	None
40210	40211	inflammation	0	None
40211	40212	model	0	None
40212	40213	in	0	None
40213	40214	mice	0	None
40214	40215	(	0	None
40215	40216	ID50	0	None
40216	40217	=	0	None
40217	40218	18mg	0	None
40218	40219	/	0	None
40219	40220	kg	0	None
40220	40221	)	0	None
40221	40222	.	0	None

40223	40224	The	0	None
40224	40225	binding	0	None
40225	40226	mode	0	None
40226	40227	of	0	None
40227	40228	the	0	None
40228	40229	new	0	None
40229	40230	inhibitor	0	None
40230	40231	(	0	None
40231	40232	31e	0	None
40232	40233	)	0	None
40233	40234	in	0	None
40234	40235	the	0	None
40235	40236	catalytic	0	None
40236	40237	site	0	None
40237	40238	of	0	None
40238	40239	PDE4B	0	None
40239	40240	is	0	None
40240	40241	presented	0	None
40241	40242	based	0	None
40242	40243	on	0	None
40243	40244	an	0	None
40244	40245	X-ray	0	None
40245	40246	crystal	0	None
40246	40247	structure	0	None
40247	40248	of	0	None
40248	40249	the	0	None
40249	40250	ligand-enzyme	0	None
40250	40251	complex	0	None
40251	40252	.	0	None
40252	40253	Topiramate	0	None
40253	40254	is	0	None
40254	40255	a	0	None
40255	40256	widely	0	None
40256	40257	used	0	None
40257	40258	antiepileptic	0	None
40258	40259	agent	0	None
40259	40260	whose	0	None
40260	40261	mechanism	0	None
40261	40262	of	0	None
40262	40263	action	0	None
40263	40264	is	0	None
40264	40265	poorly	0	None
40265	40266	understood	0	None
40266	40267	.	0	None

40268	40269	The	0	None
40269	40270	drug	0	None
40270	40271	has	0	None
40271	40272	been	0	None
40272	40273	reported	0	None
40273	40274	to	0	None
40274	40275	interact	0	None
40275	40276	with	0	None
40276	40277	various	0	None
40277	40279	ion channel	3	GENE-N
40279	40280	types	0	None
40280	40281	,	0	None
40281	40282	including	0	None
40282	40283	AMPA	0	None
40283	40284	/	0	None
40284	40285	kainate	2	CHEMICAL
40285	40286	receptors	0	None
40286	40287	.	0	None

40288	40289	In	0	None
40289	40290	whole-cell	0	None
40290	40291	voltage-clamp	0	None
40291	40292	recordings	0	None
40292	40293	from	0	None
40293	40294	principal	0	None
40294	40295	neurons	0	None
40295	40296	of	0	None
40296	40297	the	0	None
40297	40298	rat	0	None
40298	40299	basolateral	0	None
40299	40300	amygdala	0	None
40300	40301	,	0	None
40301	40302	topiramate	0	None
40302	40303	at	0	None
40303	40304	low	0	None
40304	40305	concentrations	0	None
40305	40306	(	0	None
40306	40307	IC50	0	None
40307	40308	,	0	None
40308	40309	approximately	0	None
40309	40310	0	0	None
40310	40311	.	0	None
40311	40312	5	0	None
40312	40313	microm	0	None
40313	40314	)	0	None
40314	40315	selectively	0	None
40315	40316	inhibited	0	None
40316	40317	pharmacologically	0	None
40317	40318	isolated	0	None
40318	40319	excitatory	0	None
40319	40320	synaptic	0	None
40320	40321	currents	0	None
40321	40322	mediated	0	None
40322	40323	by	0	None
40323	40324	kainate	2	CHEMICAL
40324	40325	receptors	0	None
40325	40326	containing	0	None
40326	40327	the	0	None
40327	40328	GluR5	0	None
40328	40329	subunit	0	None
40329	40330	.	0	None

40331	40332	Topiramate	0	None
40332	40333	also	0	None
40333	40334	partially	0	None
40334	40335	depressed	0	None
40335	40336	predominantly	0	None
40336	40337	AMPA-receptor-mediated	0	None
40337	40338	EPSCs	0	None
40338	40339	,	0	None
40339	40340	but	0	None
40340	40341	with	0	None
40341	40342	lower	0	None
40342	40343	efficacy	0	None
40343	40344	.	0	None

40345	40346	Topiramate	0	None
40346	40347	did	0	None
40347	40348	not	0	None
40348	40349	alter	0	None
40349	40350	the	0	None
40350	40351	degree	0	None
40351	40352	of	0	None
40352	40353	facilitation	0	None
40353	40354	in	0	None
40354	40355	paired-pulse	0	None
40355	40356	experiments	0	None
40356	40357	,	0	None
40357	40358	and	0	None
40358	40359	it	0	None
40359	40360	reduced	0	None
40360	40361	the	0	None
40361	40362	amplitude	0	None
40362	40363	of	0	None
40363	40364	miniature	0	None
40364	40365	EPSCs	0	None
40365	40366	without	0	None
40366	40367	affecting	0	None
40367	40368	their	0	None
40368	40369	frequency	0	None
40369	40370	,	0	None
40370	40371	demonstrating	0	None
40371	40372	that	0	None
40372	40373	the	0	None
40373	40374	block	0	None
40374	40375	of	0	None
40375	40376	synaptic	0	None
40376	40377	responses	0	None
40377	40378	occurs	0	None
40378	40379	postsynaptically	0	None
40379	40380	.	0	None

40381	40382	Inhibition	0	None
40382	40383	of	0	None
40383	40384	GluR5	0	None
40384	40385	kainate	2	CHEMICAL
40385	40386	receptors	0	None
40386	40387	could	0	None
40387	40388	represent	0	None
40388	40389	a	0	None
40389	40390	key	0	None
40390	40391	mechanism	0	None
40391	40392	underlying	0	None
40392	40393	the	0	None
40393	40394	anticonvulsant	0	None
40394	40395	activity	0	None
40395	40396	of	0	None
40396	40397	topiramate	0	None
40397	40398	.	0	None

40399	40400	Moreover	0	None
40400	40401	,	0	None
40401	40402	these	0	None
40402	40403	results	0	None
40403	40404	support	0	None
40404	40405	the	0	None
40405	40406	concept	0	None
40406	40407	that	0	None
40407	40408	GluR5	0	None
40408	40409	kainate	2	CHEMICAL
40409	40410	receptors	0	None
40410	40411	represent	0	None
40411	40412	a	0	None
40412	40413	novel	0	None
40413	40414	target	0	None
40414	40415	for	0	None
40415	40416	antiepileptic	0	None
40416	40417	drug	0	None
40417	40418	development	0	None
40418	40419	.	0	None
40419	40420	Antithrombotic	0	None
40420	40421	activity	0	None
40421	40422	of	0	None
40422	40423	a	0	None
40423	40424	newly	0	None
40424	40425	synthesized	0	None
40425	40426	coumarin	0	None
40426	40427	derivative	0	None
40427	40428	3-	0	None
40428	40429	(	0	None
40429	40430	5-hydroxy-2	0	None
40430	40431	,	0	None
40431	40432	2-dimethyl-chroman-6-yl	0	None
40432	40433	)	0	None
40433	40434	-N-{2-	0	None
40434	40435	[	0	None
40435	40436	3-	0	None
40436	40437	(	0	None
40437	40438	5-hydroxy-2	0	None
40438	40439	,	0	None
40439	40440	2-dimethyl-chroman-6-yl	0	None
40440	40441	)	0	None
40441	40442	-propionylamino	0	None
40442	40443	]	0	None
40443	40444	-ethyl}-propionamide	0	None
40444	40445	.	0	None
40445	40446	The	0	None
40446	40447	possibility	0	None
40447	40448	of	0	None
40448	40449	using	0	None
40449	40450	freshwater	0	None
40450	40451	Ulva	0	None
40451	40452	(	0	None
40452	40453	Chlorophyta	0	None
40453	40454	)	0	None
40454	40455	as	0	None
40455	40456	a	0	None
40456	40457	bioaccumulator	0	None
40457	40458	of	0	None
40458	40459	metals	0	None
40459	40460	(	0	None
40460	40461	Co	0	None
40461	40462	,	0	None
40462	40463	Cr	0	None
40463	40464	,	0	None
40464	40465	Cu	2	CHEMICAL
40465	40466	,	0	None
40466	40467	Mn	2	CHEMICAL
40467	40468	and	0	None
40468	40469	Zn	0	None
40469	40470	)	0	None
40470	40471	in	0	None
40471	40472	lake	0	None
40472	40473	and	0	None
40473	40474	river	0	None
40474	40475	water	0	None
40475	40476	was	0	None
40476	40477	examined	0	None
40477	40478	weekly	0	None
40478	40479	in	0	None
40479	40480	the	0	None
40480	40481	summer	0	None
40481	40482	of	0	None
40482	40483	2010	0	None
40483	40484	in	0	None
40484	40485	three	0	None
40485	40486	types	0	None
40486	40487	of	0	None
40487	40488	samples	0	None
40488	40489	:	0	None
40489	40490	the	0	None
40490	40491	water	0	None
40491	40492	,	0	None
40492	40493	the	0	None
40493	40494	sediment	0	None
40494	40495	and	0	None
40495	40496	the	0	None
40496	40497	thalli	0	None
40497	40498	of	0	None
40498	40499	Ulva	0	None
40499	40500	.	0	None

40501	40502	Samples	0	None
40502	40503	of	0	None
40503	40504	freshwater	0	None
40504	40505	Ulva	0	None
40505	40506	were	0	None
40506	40507	collected	0	None
40507	40508	from	0	None
40508	40509	two	0	None
40509	40510	aqueous	0	None
40510	40511	ecosystems	0	None
40511	40512	lie	0	None
40512	40513	250	0	None
40513	40514	km	0	None
40514	40515	away	0	None
40515	40516	from	0	None
40516	40517	the	0	None
40517	40518	basin	0	None
40518	40519	of	0	None
40519	40520	the	0	None
40520	40521	Baltic	0	None
40521	40522	Sea	0	None
40522	40523	and	0	None
40523	40524	53	0	None
40524	40525	km	0	None
40525	40526	from	0	None
40526	40527	each	0	None
40527	40528	other	0	None
40528	40529	.	0	None

40530	40531	A	0	None
40531	40532	flow	0	None
40532	40533	lake	0	None
40533	40534	located	0	None
40534	40535	in	0	None
40535	40536	the	0	None
40536	40537	centre	0	None
40537	40538	of	0	None
40538	40539	the	0	None
40539	40540	big	0	None
40540	40541	city	0	None
40541	40542	was	0	None
40542	40543	the	0	None
40543	40544	first	0	None
40544	40545	water	0	None
40545	40546	reservoir	0	None
40546	40547	(	0	None
40547	40548	ten	0	None
40548	40549	sites	0	None
40549	40550	)	0	None
40550	40551	and	0	None
40551	40552	second	0	None
40552	40553	,	0	None
40553	40554	the	0	None
40554	40555	suburban	0	None
40555	40556	river	0	None
40556	40557	(	0	None
40557	40558	six	0	None
40558	40559	sites	0	None
40559	40560	)	0	None
40560	40561	.	0	None

40562	40563	The	0	None
40563	40564	mean	0	None
40564	40565	metal	0	None
40565	40566	concentrations	0	None
40566	40567	in	0	None
40567	40568	the	0	None
40568	40569	Ulva	0	None
40569	40570	tissue	0	None
40570	40571	from	0	None
40571	40572	the	0	None
40572	40573	river	0	None
40573	40574	and	0	None
40574	40575	the	0	None
40575	40576	lake	0	None
40576	40577	decreased	0	None
40577	40578	in	0	None
40578	40579	the	0	None
40579	40580	following	0	None
40580	40581	order	0	None
40581	40582	:	0	None
40582	40583	Mn	2	CHEMICAL
40583	40584	>	0	None
40584	40585	Zn	0	None
40585	40586	>	0	None
40586	40587	Cr	0	None
40587	40588	>	0	None
40588	40589	Cu	2	CHEMICAL
40589	40590	>	0	None
40590	40591	Co	0	None
40591	40592	and	0	None
40592	40593	Mn	2	CHEMICAL
40593	40594	>	0	None
40594	40595	Cr	0	None
40595	40596	>	0	None
40596	40597	Zn	0	None
40597	40598	>	0	None
40598	40599	Cu	2	CHEMICAL
40599	40600	>	0	None
40600	40601	Co	0	None
40601	40602	,	0	None
40602	40603	respectively	0	None
40603	40604	.	0	None

40605	40606	Moreover	0	None
40606	40607	,	0	None
40607	40608	a	0	None
40608	40609	negative	0	None
40609	40610	and	0	None
40610	40611	statistically	0	None
40611	40612	significant	0	None
40612	40613	correlation	0	None
40613	40614	between	0	None
40614	40615	Mn	2	CHEMICAL
40615	40616	concentrations	0	None
40616	40617	in	0	None
40617	40618	the	0	None
40618	40619	Ulva	0	None
40619	40620	thalli	0	None
40620	40621	and	0	None
40621	40622	the	0	None
40622	40623	river	0	None
40623	40624	water	0	None
40624	40625	was	0	None
40625	40626	observed	0	None
40626	40627	.	0	None

40628	40629	Additionally	0	None
40629	40630	,	0	None
40630	40631	numerous	0	None
40631	40632	correlations	0	None
40632	40633	were	0	None
40633	40634	noted	0	None
40634	40635	between	0	None
40635	40636	the	0	None
40636	40637	different	0	None
40637	40638	concentrations	0	None
40638	40639	of	0	None
40639	40640	metals	0	None
40640	40641	within	0	None
40641	40642	the	0	None
40642	40643	Ulva	0	None
40643	40644	thalli	0	None
40644	40645	,	0	None
40645	40646	in	0	None
40646	40647	the	0	None
40647	40648	water	0	None
40648	40649	and	0	None
40649	40650	in	0	None
40650	40651	the	0	None
40651	40652	sediment	0	None
40652	40653	.	0	None

40654	40655	The	0	None
40655	40656	great	0	None
40656	40657	concentrations	0	None
40657	40658	of	0	None
40658	40659	Mn	2	CHEMICAL
40659	40660	and	0	None
40660	40661	Zn	0	None
40661	40662	and	0	None
40662	40663	the	0	None
40663	40664	smallest	0	None
40664	40665	of	0	None
40665	40666	Co	0	None
40666	40667	were	0	None
40667	40668	found	0	None
40668	40669	in	0	None
40669	40670	thalli	0	None
40670	40671	of	0	None
40671	40672	Ulva	0	None
40672	40673	,	0	None
40673	40674	irrespective	0	None
40674	40675	of	0	None
40675	40676	the	0	None
40676	40677	type	0	None
40677	40678	of	0	None
40678	40679	the	0	None
40679	40680	ecosystem	0	None
40680	40681	from	0	None
40681	40682	which	0	None
40682	40683	samples	0	None
40683	40684	of	0	None
40684	40685	algal	0	None
40685	40686	thalli	0	None
40686	40687	originated	0	None
40687	40688	.	0	None

40689	40690	Freshwater	0	None
40690	40691	Ulva	0	None
40691	40692	populations	0	None
40692	40693	examined	0	None
40693	40694	in	0	None
40694	40695	this	0	None
40695	40696	study	0	None
40696	40697	were	0	None
40697	40698	clearly	0	None
40698	40699	characterized	0	None
40699	40700	a	0	None
40700	40701	dozen	0	None
40701	40702	or	0	None
40702	40703	so	0	None
40703	40704	times	0	None
40704	40705	by	0	None
40705	40706	the	0	None
40706	40707	higher	0	None
40707	40708	Mn	2	CHEMICAL
40708	40709	and	0	None
40709	40710	Cr	0	None
40710	40711	accumulation	0	None
40711	40712	than	0	None
40712	40713	taxa	0	None
40713	40714	from	0	None
40714	40715	that	0	None
40715	40716	genera	0	None
40716	40717	coming	0	None
40717	40718	from	0	None
40718	40719	sea	0	None
40719	40720	ecosystems	0	None
40720	40721	.	0	None

40722	40723	The	0	None
40723	40724	calculated	0	None
40724	40725	bioconcentration	0	None
40725	40726	factor	0	None
40726	40727	confirm	0	None
40727	40728	the	0	None
40728	40729	high	0	None
40729	40730	potential	0	None
40730	40731	for	0	None
40731	40732	freshwater	0	None
40732	40733	Ulva	0	None
40733	40734	to	0	None
40734	40735	be	0	None
40735	40736	a	0	None
40736	40737	bioaccumulator	0	None
40737	40738	of	0	None
40738	40739	trace	0	None
40739	40740	metals	0	None
40740	40741	in	0	None
40741	40742	freshwater	0	None
40742	40743	ecosystems	0	None
40743	40744	.	0	None
40744	40745	The	0	None
40745	40746	phosphoramidate	0	None
40746	40747	nerve	0	None
40747	40748	agent	0	None
40748	40749	tabun	0	None
40749	40750	inhibits	0	None
40750	40751	butyrylcholinesterase	0	None
40751	40752	(	0	None
40752	40753	BChE	0	None
40753	40754	)	0	None
40754	40755	and	0	None
40755	40756	acetylcholinesterase	0	None
40756	40757	by	0	None
40757	40758	making	0	None
40758	40759	a	0	None
40759	40760	covalent	0	None
40760	40761	bond	0	None
40761	40762	on	0	None
40762	40763	the	0	None
40763	40764	active	0	None
40764	40765	site	0	None
40765	40766	serine	2	CHEMICAL
40766	40767	.	0	None

40768	40769	The	0	None
40769	40770	adduct	0	None
40770	40771	loses	0	None
40771	40772	an	0	None
40772	40773	alkyl	0	None
40773	40774	group	0	None
40774	40775	in	0	None
40775	40776	a	0	None
40776	40777	process	0	None
40777	40778	called	0	None
40778	40779	aging	0	None
40779	40780	.	0	None

40781	40782	The	0	None
40782	40783	mechanism	0	None
40783	40784	of	0	None
40784	40785	aging	0	None
40785	40786	of	0	None
40786	40787	the	0	None
40787	40788	tabun	0	None
40788	40789	adduct	0	None
40789	40790	is	0	None
40790	40791	controversial	0	None
40791	40792	.	0	None

40793	40794	Some	0	None
40794	40795	studies	0	None
40795	40796	claim	0	None
40796	40797	that	0	None
40797	40798	aging	0	None
40798	40799	proceeds	0	None
40799	40800	through	0	None
40800	40801	deamination	0	None
40801	40802	,	0	None
40802	40803	whereas	0	None
40803	40804	crystal	0	None
40804	40805	structure	0	None
40805	40806	studies	0	None
40806	40807	show	0	None
40807	40808	aging	0	None
40808	40809	by	0	None
40809	40810	O-dealkylation	0	None
40810	40811	.	0	None

40812	40813	Our	0	None
40813	40814	goal	0	None
40814	40815	was	0	None
40815	40816	to	0	None
40816	40817	develop	0	None
40817	40818	a	0	None
40818	40819	method	0	None
40819	40820	that	0	None
40820	40821	clearly	0	None
40821	40822	distinguishes	0	None
40822	40823	between	0	None
40823	40824	deamination	0	None
40824	40825	and	0	None
40825	40826	O-dealkylation	0	None
40826	40827	.	0	None

40828	40829	We	0	None
40829	40830	began	0	None
40830	40831	by	0	None
40831	40832	studying	0	None
40832	40833	the	0	None
40833	40834	tetraisopropyl	0	None
40834	40835	pyrophosphoramide	0	None
40835	40836	adduct	0	None
40836	40837	of	0	None
40837	40838	BChE	0	None
40838	40839	because	0	None
40839	40840	this	0	None
40840	40841	adduct	0	None
40841	40842	has	0	None
40842	40843	two	0	None
40843	40844	P-N	0	None
40844	40845	bonds	0	None
40845	40846	.	0	None

40847	40848	Mass	0	None
40848	40849	spectra	0	None
40849	40850	showed	0	None
40850	40851	that	0	None
40851	40852	the	0	None
40852	40853	P-N	0	None
40853	40854	bonds	0	None
40854	40855	were	0	None
40855	40856	stable	0	None
40856	40857	during	0	None
40857	40858	trypsin	0	None
40858	40859	digestion	0	None
40859	40860	at	0	None
40860	40861	pH	0	None
40861	40862	8	0	None
40862	40863	but	0	None
40863	40864	were	0	None
40864	40865	cleaved	0	None
40865	40866	during	0	None
40866	40867	pepsin	0	None
40867	40868	digestion	0	None
40868	40869	at	0	None
40869	40870	pH	0	None
40870	40871	2	0	None
40871	40872	.	0	None

40873	40874	The	0	None
40874	40875	P-N	0	None
40875	40876	bond	0	None
40876	40877	in	0	None
40877	40878	tabun	0	None
40878	40879	was	0	None
40879	40880	also	0	None
40880	40881	acid	0	None
40881	40882	labile	0	None
40882	40883	,	0	None
40883	40884	whereas	0	None
40884	40885	the	0	None
40885	40886	P-O	0	None
40886	40887	bond	0	None
40887	40888	was	0	None
40888	40889	stable	0	None
40889	40890	.	0	None

40891	40892	A	0	None
40892	40893	scheme	0	None
40893	40894	to	0	None
40894	40895	distinguish	0	None
40895	40896	aging	0	None
40896	40897	by	0	None
40897	40898	deamination	0	None
40898	40899	from	0	None
40899	40900	aging	0	None
40900	40901	by	0	None
40901	40902	O-dealkylation	0	None
40902	40903	was	0	None
40903	40904	based	0	None
40904	40905	on	0	None
40905	40906	the	0	None
40906	40907	acid	0	None
40907	40908	labile	0	None
40908	40909	P-N	0	None
40909	40910	bond	0	None
40910	40911	.	0	None

40912	40913	BChE	0	None
40913	40914	was	0	None
40914	40915	inhibited	0	None
40915	40916	with	0	None
40916	40917	Sp-	0	None
40917	40918	and	0	None
40918	40919	Rp-tabun	0	None
40919	40920	thiocholine	2	CHEMICAL
40920	40921	nerve	0	None
40921	40922	agent	0	None
40922	40923	model	0	None
40923	40924	compounds	0	None
40924	40925	to	0	None
40925	40926	make	0	None
40926	40927	adducts	0	None
40927	40928	identical	0	None
40928	40929	to	0	None
40929	40930	those	0	None
40930	40931	of	0	None
40931	40932	tabun	0	None
40932	40933	with	0	None
40933	40934	known	0	None
40934	40935	stereochemistry	0	None
40935	40936	.	0	None

40937	40938	After	0	None
40938	40939	aging	0	None
40939	40940	and	0	None
40940	40941	digestion	0	None
40941	40942	with	0	None
40942	40943	pepsin	0	None
40943	40944	at	0	None
40944	40945	pH	0	None
40945	40946	2	0	None
40946	40947	,	0	None
40947	40948	peptide	0	None
40948	40949	FGES198AGAAS	0	None
40949	40950	from	0	None
40950	40951	Sp-tabun	0	None
40951	40952	thiocholine	2	CHEMICAL
40952	40953	had	0	None
40953	40954	a	0	None
40954	40955	mass	0	None
40955	40956	of	0	None
40956	40957	902	0	None
40957	40958	.	0	None
40958	40959	2	0	None
40959	40960	m	0	None
40960	40961	/	0	None
40961	40962	z	0	None
40962	40963	in	0	None
40963	40964	negative	0	None
40964	40965	mode	0	None
40965	40966	,	0	None
40966	40967	indicating	0	None
40967	40968	that	0	None
40968	40969	it	0	None
40969	40970	had	0	None
40970	40971	aged	0	None
40971	40972	by	0	None
40972	40973	deamination	0	None
40973	40974	,	0	None
40974	40975	whereas	0	None
40975	40976	peptide	0	None
40976	40977	FGES198AGAAS	0	None
40977	40978	from	0	None
40978	40979	Rp-tabun	0	None
40979	40980	thiocholine	2	CHEMICAL
40980	40981	had	0	None
40981	40982	a	0	None
40982	40983	mass	0	None
40983	40984	of	0	None
40984	40985	874	0	None
40985	40986	.	0	None
40986	40987	2	0	None
40987	40988	m	0	None
40988	40989	/	0	None
40989	40990	z	0	None
40990	40991	in	0	None
40991	40992	negative	0	None
40992	40993	mode	0	None
40993	40994	,	0	None
40994	40995	indicating	0	None
40995	40996	that	0	None
40996	40997	it	0	None
40997	40998	had	0	None
40998	40999	aged	0	None
40999	41000	by	0	None
41000	41001	O-dealkylation	0	None
41001	41002	.	0	None

41003	41004	BChE	0	None
41004	41005	inhibited	0	None
41005	41006	by	0	None
41006	41007	authentic	0	None
41007	41008	,	0	None
41008	41009	racemic	0	None
41009	41010	tabun	0	None
41010	41011	yielded	0	None
41011	41012	both	0	None
41012	41013	902	0	None
41013	41014	.	0	None
41014	41015	2	0	None
41015	41016	and	0	None
41016	41017	874	0	None
41017	41018	.	0	None
41018	41019	2	0	None
41019	41020	m	0	None
41020	41021	/	0	None
41021	41022	z	0	None
41022	41023	peptides	0	None
41023	41024	,	0	None
41024	41025	indicating	0	None
41025	41026	that	0	None
41026	41027	both	0	None
41027	41028	stereoisomers	0	None
41028	41029	reacted	0	None
41029	41030	with	0	None
41030	41031	BChE	0	None
41031	41032	and	0	None
41032	41033	aged	0	None
41033	41034	either	0	None
41034	41035	by	0	None
41035	41036	deamination	0	None
41036	41037	or	0	None
41037	41038	dealkylation	0	None
41038	41039	.	0	None
41039	41040	Fluoxetine	0	None
41040	41041	,	0	None
41041	41042	as	0	None
41042	41043	a	0	None
41043	41044	serotonin	0	None
41044	41045	re-uptake	0	None
41045	41046	inhibitor	0	None
41046	41047	augments	0	None
41047	41048	serotonin	0	None
41048	41049	concentration	0	None
41049	41050	within	0	None
41050	41051	the	0	None
41051	41052	synapse	0	None
41052	41053	by	0	None
41053	41054	inhibiting	0	None
41054	41055	the	0	None
41055	41057	serotonin transporter	1	GENE-Y
41057	41058	.	0	None

41059	41060	The	0	None
41060	41061	contribution	0	None
41061	41062	of	0	None
41062	41064	amino acids	2	CHEMICAL
41064	41065	has	0	None
41065	41066	also	0	None
41066	41067	been	0	None
41067	41068	shown	0	None
41068	41069	in	0	None
41069	41070	depression	0	None
41070	41071	.	0	None

41072	41073	We	0	None
41073	41074	hypothesized	0	None
41074	41075	that	0	None
41075	41076	fluoxetine	0	None
41076	41077	exerts	0	None
41077	41078	its	0	None
41078	41079	actions	0	None
41079	41080	at	0	None
41080	41081	least	0	None
41081	41082	in	0	None
41082	41083	part	0	None
41083	41084	by	0	None
41084	41085	intervening	0	None
41085	41086	brain	0	None
41086	41087	signaling	0	None
41087	41088	operated	0	None
41088	41089	by	0	None
41089	41091	amino acid	2	CHEMICAL
41091	41092	transmitters	0	None
41092	41093	.	0	None

41094	41095	Therefore	0	None
41095	41096	the	0	None
41096	41097	aim	0	None
41097	41098	of	0	None
41098	41099	this	0	None
41099	41100	study	0	None
41100	41101	is	0	None
41101	41102	to	0	None
41102	41103	supply	0	None
41103	41104	neurochemical	0	None
41104	41105	evidence	0	None
41105	41106	that	0	None
41106	41107	fluoxetine	0	None
41107	41108	produces	0	None
41108	41109	changes	0	None
41109	41110	in	0	None
41110	41112	amino acids	2	CHEMICAL
41112	41113	in	0	None
41113	41114	cerebrospinal	0	None
41114	41115	fluid	0	None
41115	41116	of	0	None
41116	41117	rats	0	None
41117	41118	.	0	None

41119	41120	Sprague-Dawley	0	None
41120	41121	rats	0	None
41121	41122	were	0	None
41122	41123	anesthetized	0	None
41123	41124	and	0	None
41124	41125	concentric	0	None
41125	41126	microdialysis	0	None
41126	41127	probes	0	None
41127	41128	were	0	None
41128	41129	implanted	0	None
41129	41130	stereotaxically	0	None
41130	41131	into	0	None
41131	41132	the	0	None
41132	41133	right	0	None
41133	41134	lateral	0	None
41134	41135	ventricle	0	None
41135	41136	.	0	None

41137	41138	Intraperitoneal	0	None
41138	41139	fluoxetine	0	None
41139	41140	(	0	None
41140	41141	2	0	None
41141	41142	.	0	None
41142	41143	5	0	None
41143	41144	or	0	None
41144	41145	5	0	None
41145	41146	mg	2	CHEMICAL
41146	41147	/	0	None
41147	41148	kg	0	None
41148	41149	)	0	None
41149	41150	or	0	None
41150	41151	physiological	0	None
41151	41152	saline	0	None
41152	41153	was	0	None
41153	41154	administered	0	None
41154	41155	and	0	None
41155	41156	the	0	None
41156	41157	probes	0	None
41157	41158	were	0	None
41158	41159	perfused	0	None
41159	41160	with	0	None
41160	41161	artificial	0	None
41161	41162	cerebrospinal	0	None
41162	41163	fluid	0	None
41163	41164	at	0	None
41164	41165	a	0	None
41165	41166	rate	0	None
41166	41167	of	0	None
41167	41168	1	0	None
41168	41169	mul	0	None
41169	41170	/	0	None
41170	41171	min	0	None
41171	41172	.	0	None

41173	41174	In	0	None
41174	41175	the	0	None
41175	41176	chronic	0	None
41176	41177	fluoxetine	0	None
41177	41178	group	0	None
41178	41179	,	0	None
41179	41180	the	0	None
41180	41181	rats	0	None
41181	41182	were	0	None
41182	41183	treated	0	None
41183	41184	daily	0	None
41184	41185	with	0	None
41185	41186	oral	0	None
41186	41187	fluoxetine	0	None
41187	41188	solution	0	None
41188	41189	or	0	None
41189	41190	inert	0	None
41190	41191	syrup	0	None
41191	41192	for	0	None
41192	41193	3	0	None
41193	41194	weeks	0	None
41194	41195	.	0	None

41196	41197	The	0	None
41197	41198	microdialysis	0	None
41198	41199	probes	0	None
41199	41200	were	0	None
41200	41201	placed	0	None
41201	41202	on	0	None
41202	41203	the	0	None
41203	41204	21st	0	None
41204	41205	day	0	None
41205	41206	and	0	None
41206	41207	perfused	0	None
41207	41208	the	0	None
41208	41209	next	0	None
41209	41210	day	0	None
41210	41211	.	0	None

41212	41213	Fluoxetine	0	None
41213	41214	was	0	None
41214	41215	ineffective	0	None
41215	41216	in	0	None
41216	41217	changing	0	None
41217	41218	the	0	None
41218	41219	cerebrospinal	0	None
41219	41220	fluid	0	None
41220	41221	GABA	2	CHEMICAL
41221	41222	levels	0	None
41222	41223	at	0	None
41223	41224	the	0	None
41224	41225	dose	0	None
41225	41226	of	0	None
41226	41227	2	0	None
41227	41228	.	0	None
41228	41229	5	0	None
41229	41230	mg	2	CHEMICAL
41230	41231	/	0	None
41231	41232	kg	0	None
41232	41233	but	0	None
41233	41234	produced	0	None
41234	41235	a	0	None
41235	41236	significant	0	None
41236	41237	increase	0	None
41237	41238	in	0	None
41238	41239	the	0	None
41239	41240	perfusates	0	None
41240	41241	following	0	None
41241	41242	injection	0	None
41242	41243	of	0	None
41243	41244	5	0	None
41244	41245	mg	2	CHEMICAL
41245	41246	/	0	None
41246	41247	kg	0	None
41247	41248	of	0	None
41248	41249	fluoxetine	0	None
41249	41250	(	0	None
41250	41251	P	0	None
41251	41252	<	0	None
41252	41253	0	0	None
41253	41254	.	0	None
41254	41255	05	0	None
41255	41256	)	0	None
41256	41257	.	0	None

41258	41259	Oral	0	None
41259	41260	fluoxetine	0	None
41260	41261	administration	0	None
41261	41262	(	0	None
41262	41263	5	0	None
41263	41264	mg	2	CHEMICAL
41264	41265	/	0	None
41265	41266	kg	0	None
41266	41267	)	0	None
41267	41268	for	0	None
41268	41269	21	0	None
41269	41270	days	0	None
41270	41271	also	0	None
41271	41272	elevated	0	None
41272	41273	the	0	None
41273	41274	CSF	0	None
41274	41275	GABA	2	CHEMICAL
41275	41276	levels	0	None
41276	41277	by	0	None
41277	41278	approximately	0	None
41278	41279	2-fold	0	None
41279	41280	(	0	None
41280	41281	P	0	None
41281	41282	<	0	None
41282	41283	0	0	None
41283	41284	.	0	None
41284	41285	05	0	None
41285	41286	)	0	None
41286	41287	.	0	None

41288	41289	L	0	None
41289	41290	:	0	None
41290	41291	-glutamic	0	None
41291	41292	acid	0	None
41292	41293	levels	0	None
41293	41294	were	0	None
41294	41295	not	0	None
41295	41296	affected	0	None
41296	41297	in	0	None
41297	41298	all	0	None
41298	41299	groups	0	None
41299	41300	.	0	None

41301	41302	These	0	None
41302	41303	neurochemical	0	None
41303	41304	findings	0	None
41304	41305	show	0	None
41305	41306	that	0	None
41306	41307	fluoxetine	0	None
41307	41308	,	0	None
41308	41309	a	0	None
41309	41310	selective	0	None
41310	41311	serotonin	0	None
41311	41312	re-uptake	0	None
41312	41313	inhibitor	0	None
41313	41314	affects	0	None
41314	41315	brain	0	None
41315	41316	GABA	2	CHEMICAL
41316	41317	levels	0	None
41317	41318	indirectly	0	None
41318	41319	,	0	None
41319	41320	and	0	None
41320	41321	our	0	None
41321	41322	results	0	None
41322	41323	suggest	0	None
41323	41324	that	0	None
41324	41325	acute	0	None
41325	41326	or	0	None
41326	41327	chronic	0	None
41327	41328	effects	0	None
41328	41329	may	0	None
41329	41330	be	0	None
41330	41331	involved	0	None
41331	41332	in	0	None
41332	41333	beneficial	0	None
41333	41334	and	0	None
41334	41335	/	0	None
41335	41336	or	0	None
41336	41337	adverse	0	None
41337	41338	effects	0	None
41338	41339	of	0	None
41339	41340	the	0	None
41340	41341	drug	0	None
41341	41342	.	0	None
41342	41343	1	0	None
41343	41344	.	0	None

41345	41346	Eight	0	None
41346	41347	types	0	None
41347	41348	and	0	None
41348	41349	subtypes	0	None
41349	41350	of	0	None
41350	41351	the	0	None
41351	41352	mouse	0	None
41352	41354	prostanoid receptor	3	GENE-N
41354	41355	,	0	None
41355	41356	the	0	None
41356	41357	prostaglandin	0	None
41357	41358	D	0	None
41358	41359	(	0	None
41359	41360	DP	0	None
41360	41361	)	0	None
41361	41362	receptor	0	None
41362	41363	,	0	None
41363	41364	the	0	None
41364	41365	prostaglandin	0	None
41365	41366	F	0	None
41366	41367	(	0	None
41367	41368	FP	0	None
41368	41369	)	0	None
41369	41370	receptor	0	None
41370	41371	,	0	None
41371	41372	the	0	None
41372	41373	prostaglandin	0	None
41373	41374	I	0	None
41374	41375	(	0	None
41375	41376	IP	0	None
41376	41377	)	0	None
41377	41378	receptor	0	None
41378	41379	,	0	None
41379	41380	the	0	None
41380	41381	thromboxane	0	None
41381	41382	A	0	None
41382	41383	(	0	None
41383	41384	TP	1	GENE-Y
41384	41385	)	0	None
41385	41386	receptor	0	None
41386	41387	and	0	None
41387	41388	the	0	None
41388	41389	EP1	1	GENE-Y
41389	41390	,	0	None
41390	41391	EP2	1	GENE-Y
41391	41392	,	0	None
41392	41393	EP3	0	None
41393	41394	and	0	None
41394	41395	EP4	0	None
41395	41396	subtypes	0	None
41396	41397	of	0	None
41397	41398	the	0	None
41398	41399	prostaglandin	0	None
41399	41400	E	0	None
41400	41401	receptor	0	None
41401	41402	,	0	None
41402	41403	were	0	None
41403	41404	stably	0	None
41404	41405	expressed	0	None
41405	41406	in	0	None
41406	41407	Chinese	0	None
41407	41408	hamster	0	None
41408	41409	ovary	0	None
41409	41410	cells	0	None
41410	41411	.	0	None

41412	41413	Their	0	None
41413	41414	ligand	0	None
41414	41415	binding	0	None
41415	41416	characteristics	0	None
41416	41417	were	0	None
41417	41418	examined	0	None
41418	41419	with	0	None
41419	41420	thirty	0	None
41420	41421	two	0	None
41421	41422	prostanoids	2	CHEMICAL
41422	41423	and	0	None
41423	41424	their	0	None
41424	41425	analogues	0	None
41425	41426	by	0	None
41426	41427	determining	0	None
41427	41428	the	0	None
41428	41429	Ki	0	None
41429	41430	values	0	None
41430	41431	from	0	None
41431	41432	the	0	None
41432	41433	displacement	0	None
41433	41434	curves	0	None
41434	41435	of	0	None
41435	41436	radioligand	0	None
41436	41437	binding	0	None
41437	41438	to	0	None
41438	41439	the	0	None
41439	41440	respective	0	None
41440	41441	receptors	0	None
41441	41442	.	0	None

41443	41444	2	0	None
41444	41445	.	0	None

41446	41447	The	0	None
41447	41448	DP	0	None
41448	41449	,	0	None
41449	41450	IP	0	None
41450	41451	and	0	None
41451	41452	TP	1	GENE-Y
41452	41453	receptors	0	None
41453	41454	showed	0	None
41454	41455	high	0	None
41455	41456	ligand	0	None
41456	41457	binding	0	None
41457	41458	specificity	0	None
41458	41459	and	0	None
41459	41460	only	0	None
41460	41461	bound	0	None
41461	41462	their	0	None
41462	41463	own	0	None
41463	41464	putative	0	None
41464	41465	ligands	0	None
41465	41466	with	0	None
41466	41467	high	0	None
41467	41468	affinity	0	None
41468	41469	such	0	None
41469	41470	as	0	None
41470	41471	PGD2	0	None
41471	41472	,	0	None
41472	41473	BW245C	0	None
41473	41474	and	0	None
41474	41475	BW868C	0	None
41475	41476	for	0	None
41476	41477	DP	0	None
41477	41478	,	0	None
41478	41479	cicaprost	0	None
41479	41480	,	0	None
41480	41481	iloprost	0	None
41481	41482	and	0	None
41482	41483	isocabacyclin	0	None
41483	41484	for	0	None
41484	41485	IP	0	None
41485	41486	,	0	None
41486	41487	and	0	None
41487	41488	S-145	0	None
41488	41489	,	0	None
41489	41490	I-BOP	0	None
41490	41491	and	0	None
41491	41492	GR	0	None
41492	41493	32191	0	None
41493	41494	for	0	None
41494	41495	TP	1	GENE-Y
41495	41496	.	0	None

41497	41498	3	0	None
41498	41499	.	0	None

41500	41501	The	0	None
41501	41502	FP	0	None
41502	41503	receptor	0	None
41503	41504	bound	0	None
41504	41505	PGF2	0	None
41505	41506	alpha	0	None
41506	41507	and	0	None
41507	41508	fluprostenol	0	None
41508	41509	with	0	None
41509	41510	Ki	0	None
41510	41511	values	0	None
41511	41512	of	0	None
41512	41513	3-4	0	None
41513	41514	nM	0	None
41514	41515	.	0	None

41516	41517	In	0	None
41517	41518	addition	0	None
41518	41519	,	0	None
41519	41520	PGD2	0	None
41520	41521	,	0	None
41521	41522	17-phenyl-PGE2	0	None
41522	41523	,	0	None
41523	41524	STA2	0	None
41524	41525	,	0	None
41525	41526	I-BOP	0	None
41526	41527	,	0	None
41527	41528	PGE2	2	CHEMICAL
41528	41529	and	0	None
41529	41530	M&B-28767	0	None
41530	41531	bound	0	None
41531	41532	to	0	None
41532	41533	this	0	None
41533	41534	receptor	0	None
41534	41535	with	0	None
41535	41536	Ki	0	None
41536	41537	values	0	None
41537	41538	less	0	None
41538	41539	than	0	None
41539	41540	100	0	None
41540	41541	nM	0	None
41541	41542	.	0	None

41543	41544	4	0	None
41544	41545	.	0	None

41546	41547	The	0	None
41547	41548	EP1	1	GENE-Y
41548	41549	receptor	0	None
41549	41550	bound	0	None
41550	41551	17-phenyl-PGE2	0	None
41551	41552	,	0	None
41552	41553	sulprostone	0	None
41553	41554	and	0	None
41554	41555	iloprost	0	None
41555	41556	in	0	None
41556	41557	addition	0	None
41557	41558	to	0	None
41558	41559	PGE2	2	CHEMICAL
41559	41560	and	0	None
41560	41561	PGE1	0	None
41561	41562	,	0	None
41562	41563	with	0	None
41563	41564	Ki	0	None
41564	41565	values	0	None
41565	41566	of	0	None
41566	41567	14-36	0	None
41567	41568	nM	0	None
41568	41569	.	0	None

41570	41571	16	0	None
41571	41572	,	0	None
41572	41573	16-dimethyl-PGE2	0	None
41573	41574	and	0	None
41574	41575	two	0	None
41575	41576	putative	0	None
41576	41577	EP1	1	GENE-Y
41577	41578	antagonists	0	None
41578	41579	,	0	None
41579	41580	AH6809	0	None
41580	41581	and	0	None
41581	41582	SC-19220	0	None
41582	41583	,	0	None
41583	41584	did	0	None
41584	41585	not	0	None
41585	41586	show	0	None
41586	41587	any	0	None
41587	41588	significant	0	None
41588	41589	binding	0	None
41589	41590	to	0	None
41590	41591	this	0	None
41591	41592	receptor	0	None
41592	41593	.	0	None

41594	41595	M&B-28767	0	None
41595	41596	,	0	None
41596	41597	a	0	None
41597	41598	putative	0	None
41598	41599	EP3	0	None
41599	41600	agonist	0	None
41600	41601	,	0	None
41601	41602	and	0	None
41602	41603	misoprostol	0	None
41603	41604	,	0	None
41604	41605	a	0	None
41605	41606	putative	0	None
41606	41607	EP2	1	GENE-Y
41607	41608	/	0	None
41608	41609	EP3	0	None
41609	41610	agonist	0	None
41610	41611	,	0	None
41611	41612	also	0	None
41612	41613	bound	0	None
41613	41614	to	0	None
41614	41615	this	0	None
41615	41616	receptor	0	None
41616	41617	with	0	None
41617	41618	Ki	0	None
41618	41619	values	0	None
41619	41620	of	0	None
41620	41621	120	0	None
41621	41622	nM	0	None
41622	41623	.	0	None

41624	41625	5	0	None
41625	41626	.	0	None

41627	41628	The	0	None
41628	41629	EP2	1	GENE-Y
41629	41630	and	0	None
41630	41631	EP4	0	None
41631	41632	receptors	0	None
41632	41633	showed	0	None
41633	41634	similar	0	None
41634	41635	binding	0	None
41635	41636	profiles	0	None
41636	41637	.	0	None

41638	41639	They	0	None
41639	41640	bound	0	None
41640	41641	16	0	None
41641	41642	,	0	None
41642	41643	16-dimethyl	0	None
41643	41644	PGE2	2	CHEMICAL
41644	41645	and	0	None
41645	41646	11-deoxy-PGE1	0	None
41646	41647	in	0	None
41647	41648	addition	0	None
41648	41649	to	0	None
41649	41650	PGE2	2	CHEMICAL
41650	41651	and	0	None
41651	41652	PGE1	0	None
41652	41653	.	0	None

41654	41655	The	0	None
41655	41656	two	0	None
41656	41657	receptors	0	None
41657	41658	were	0	None
41658	41659	discriminated	0	None
41659	41660	by	0	None
41660	41661	butaprost	2	CHEMICAL
41661	41662	,	0	None
41662	41663	AH-13205	0	None
41663	41664	and	0	None
41664	41665	AH-6809	0	None
41665	41666	that	0	None
41666	41667	bound	0	None
41667	41668	to	0	None
41668	41669	the	0	None
41669	41670	EP2	1	GENE-Y
41670	41671	receptor	0	None
41671	41672	but	0	None
41672	41673	not	0	None
41673	41674	to	0	None
41674	41675	the	0	None
41675	41676	EP4	0	None
41676	41677	receptor	0	None
41677	41678	,	0	None
41678	41679	and	0	None
41679	41680	by	0	None
41680	41681	1-OH-PGE1	0	None
41681	41682	that	0	None
41682	41683	bound	0	None
41683	41684	to	0	None
41684	41685	the	0	None
41685	41686	EP4	0	None
41686	41687	but	0	None
41687	41688	not	0	None
41688	41689	to	0	None
41689	41690	the	0	None
41690	41691	EP2	1	GENE-Y
41691	41692	receptor	0	None
41692	41693	.	0	None

41694	41695	6	0	None
41695	41696	.	0	None

41697	41698	The	0	None
41698	41699	EP3	0	None
41699	41700	receptor	0	None
41700	41701	showed	0	None
41701	41702	the	0	None
41702	41703	broadest	0	None
41703	41704	binding	0	None
41704	41705	profile	0	None
41705	41706	,	0	None
41706	41707	and	0	None
41707	41708	bound	0	None
41708	41709	sulprostone	0	None
41709	41710	,	0	None
41710	41711	M&B-28767	0	None
41711	41712	,	0	None
41712	41713	GR63799X	0	None
41713	41714	,	0	None
41714	41715	11-deoxy-PGE1	0	None
41715	41716	,	0	None
41716	41717	16	0	None
41717	41718	,	0	None
41718	41719	16-dimethyl-PGE2	0	None
41719	41720	and	0	None
41720	41721	17-phenyl-PGE2	0	None
41721	41722	,	0	None
41722	41723	in	0	None
41723	41724	addition	0	None
41724	41725	to	0	None
41725	41726	PGE2	2	CHEMICAL
41726	41727	and	0	None
41727	41728	PGE1	0	None
41728	41729	,	0	None
41729	41730	with	0	None
41730	41731	Ki	0	None
41731	41732	values	0	None
41732	41733	of	0	None
41733	41734	0	0	None
41734	41735	.	0	None
41735	41736	6-3	0	None
41736	41737	.	0	None
41737	41738	7	0	None
41738	41739	nM	0	None
41739	41740	.	0	None

41741	41742	In	0	None
41742	41743	addition	0	None
41743	41744	,	0	None
41744	41745	three	0	None
41745	41746	IP	0	None
41746	41747	ligands	0	None
41747	41748	,	0	None
41748	41749	iloprost	0	None
41749	41750	,	0	None
41750	41751	carbacyclin	0	None
41751	41752	and	0	None
41752	41753	isocarbacyclin	0	None
41753	41754	,	0	None
41754	41755	and	0	None
41755	41756	one	0	None
41756	41757	TP	1	GENE-Y
41757	41758	ligand	0	None
41758	41759	,	0	None
41759	41760	STA2	0	None
41760	41761	,	0	None
41761	41762	bound	0	None
41762	41763	to	0	None
41763	41764	this	0	None
41764	41765	receptor	0	None
41765	41766	with	0	None
41766	41767	Ki	0	None
41767	41768	values	0	None
41768	41769	comparable	0	None
41769	41770	to	0	None
41770	41771	the	0	None
41771	41772	Ki	0	None
41772	41773	values	0	None
41773	41774	of	0	None
41774	41775	these	0	None
41775	41776	compounds	0	None
41776	41777	for	0	None
41777	41778	the	0	None
41778	41779	IP	0	None
41779	41780	and	0	None
41780	41781	TP	1	GENE-Y
41781	41782	receptors	0	None
41782	41783	,	0	None
41783	41784	respectively	0	None
41784	41785	.	0	None

41786	41787	7	0	None
41787	41788	.	0	None

41789	41790	8-Epi-PGF2	0	None
41790	41791	alpha	0	None
41791	41792	showed	0	None
41792	41793	only	0	None
41793	41794	weak	0	None
41794	41795	binding	0	None
41795	41796	to	0	None
41796	41797	the	0	None
41797	41798	IP	0	None
41798	41799	,	0	None
41799	41800	TP	1	GENE-Y
41800	41801	,	0	None
41801	41802	FP	0	None
41802	41803	,	0	None
41803	41804	EP2	1	GENE-Y
41804	41805	and	0	None
41805	41806	EP3	0	None
41806	41807	receptor	0	None
41807	41808	at	0	None
41808	41809	10	0	None
41809	41810	microM	0	None
41810	41811	concentration	0	None
41811	41812	.	0	None
41812	41813	[	0	None
41813	41815	Phospholipase D	3	GENE-N
41815	41816	in	0	None
41816	41817	mammalian	0	None
41817	41818	cells	0	None
41818	41819	:	0	None
41819	41820	structure	0	None
41820	41821	,	0	None
41821	41822	properties	0	None
41822	41823	,	0	None
41823	41824	physiological	0	None
41824	41825	and	0	None
41825	41826	pathological	0	None
41826	41827	role	0	None
41827	41828	]	0	None
41828	41829	.	0	None
41829	41830	Structural	0	None
41830	41831	optimization	0	None
41831	41832	of	0	None
41832	41833	2	0	None
41833	41834	,	0	None
41834	41835	5-thiophene	0	None
41835	41836	amides	0	None
41836	41837	as	0	None
41837	41838	highly	0	None
41838	41839	potent	0	None
41839	41840	and	0	None
41840	41841	selective	0	None
41841	41842	17β-hydroxysteroid	0	None
41842	41843	dehydrogenase	0	None
41843	41844	type	0	None
41844	41845	2	0	None
41845	41846	inhibitors	0	None
41846	41847	for	0	None
41847	41848	the	0	None
41848	41849	treatment	0	None
41849	41850	of	0	None
41850	41851	osteoporosis	0	None
41851	41852	.	0	None
41852	41853	DRD2	0	None
41853	41854	promoter	0	None
41854	41855	region	0	None
41855	41856	variation	0	None
41856	41857	as	0	None
41857	41858	a	0	None
41858	41859	predictor	0	None
41859	41860	of	0	None
41860	41861	sustained	0	None
41861	41862	response	0	None
41862	41863	to	0	None
41863	41864	antipsychotic	0	None
41864	41865	medication	0	None
41865	41866	in	0	None
41866	41867	first-episode	0	None
41867	41868	schizophrenia	0	None
41868	41869	patients	0	None
41869	41870	.	0	None
41870	41871	Discriminative	0	None
41871	41872	stimulus	0	None
41872	41873	effects	0	None
41873	41874	of	0	None
41874	41875	esteratic	0	None
41875	41876	local	0	None
41876	41877	anesthetics	0	None
41877	41878	in	0	None
41878	41879	squirrel	0	None
41879	41880	monkeys	0	None
41880	41881	.	0	None
41881	41882	The	0	None
41882	41883	effects	0	None
41883	41884	of	0	None
41884	41885	catecholamines	0	None
41885	41886	on	0	None
41886	41887	ciliary	0	None
41887	41888	motility	0	None
41888	41889	of	0	None
41889	41890	canine	0	None
41890	41891	bronchial	0	None
41891	41892	epithelium	0	None
41892	41893	was	0	None
41893	41894	studied	0	None
41894	41895	by	0	None
41895	41896	a	0	None
41896	41897	photoelectric	0	None
41897	41898	method	0	None
41898	41899	in	0	None
41899	41900	vitro	0	None
41900	41901	.	0	None

41902	41903	Addition	0	None
41903	41904	of	0	None
41904	41905	beta-adrenoceptor	3	GENE-N
41905	41906	agonists	0	None
41906	41907	increased	0	None
41907	41908	ciliary	0	None
41908	41909	beat	0	None
41909	41910	frequency	0	None
41910	41911	,	0	None
41911	41912	a	0	None
41912	41913	rank	1	GENE-Y
41913	41914	order	0	None
41914	41915	of	0	None
41915	41916	potency	0	None
41916	41917	being	0	None
41917	41918	salbutamol	0	None
41918	41919	>	0	None
41919	41920	or	0	None
41920	41921	=	0	None
41921	41923	BRL 37344	2	CHEMICAL
41923	41924	,	0	None
41924	41925	a	0	None
41925	41926	selective	0	None
41926	41927	beta	0	None
41927	41928	3-adrenoceptor	0	None
41928	41929	agonist	0	None
41929	41930	>	0	None
41930	41931	norepinephrine	2	CHEMICAL
41931	41932	.	0	None

41933	41934	The	0	None
41934	41935	response	0	None
41935	41936	to	0	None
41936	41938	BRL 37344	2	CHEMICAL
41938	41939	was	0	None
41939	41940	relatively	0	None
41940	41941	resistant	0	None
41941	41942	to	0	None
41942	41943	the	0	None
41943	41944	blockade	0	None
41944	41945	of	0	None
41945	41950	beta 1- and beta 2-adrenoceptors	3	GENE-N
41950	41951	but	0	None
41951	41952	was	0	None
41952	41953	competitively	0	None
41953	41954	antagonized	0	None
41954	41955	by	0	None
41955	41956	the	0	None
41956	41957	beta	0	None
41957	41958	3-adrenoceptor	0	None
41958	41959	antagonist	0	None
41959	41960	cyanopindolol	0	None
41960	41961	,	0	None
41961	41962	with	0	None
41962	41963	the	0	None
41963	41964	pA2	0	None
41964	41965	value	0	None
41965	41966	being	0	None
41966	41967	lower	0	None
41967	41968	than	0	None
41968	41969	that	0	None
41969	41970	when	0	None
41970	41971	salbutamol	0	None
41971	41972	was	0	None
41972	41973	used	0	None
41973	41974	as	0	None
41974	41975	an	0	None
41975	41976	agonist	0	None
41976	41977	.	0	None

41978	41979	These	0	None
41979	41980	results	0	None
41980	41981	suggest	0	None
41981	41982	that	0	None
41982	41984	beta 3-adrenoceptors	1	GENE-Y
41984	41985	exist	0	None
41985	41986	in	0	None
41986	41987	canine	0	None
41987	41988	bronchial	0	None
41988	41989	epithelium	0	None
41989	41990	and	0	None
41990	41991	that	0	None
41991	41992	stimulation	0	None
41992	41993	of	0	None
41993	41994	this	0	None
41994	41995	receptor	0	None
41995	41996	subtype	0	None
41996	41997	may	0	None
41997	41998	enhance	0	None
41998	41999	ciliary	0	None
41999	42000	motility	0	None
42000	42001	and	0	None
42001	42002	,	0	None
42002	42003	hence	0	None
42003	42004	,	0	None
42004	42005	mucociliary	0	None
42005	42006	transport	0	None
42006	42007	in	0	None
42007	42008	the	0	None
42008	42009	airway	0	None
42009	42010	.	0	None
42010	42011	Losartan	0	None
42011	42012	:	0	None
42012	42013	a	0	None
42013	42014	selective	0	None
42014	42015	angiotensin	2	CHEMICAL
42015	42016	II	0	None
42016	42017	type	0	None
42017	42018	1	0	None
42018	42019	(	0	None
42019	42020	AT1	0	None
42020	42021	)	0	None
42021	42022	receptor	0	None
42022	42023	antagonist	0	None
42023	42024	for	0	None
42024	42025	the	0	None
42025	42026	treatment	0	None
42026	42027	of	0	None
42027	42028	heart	0	None
42028	42029	failure	0	None
42029	42030	.	0	None
42030	42031	A	0	None
42031	42032	consistent	0	None
42032	42033	effect	0	None
42033	42034	of	0	None
42034	42035	repeated	0	None
42035	42036	exposure	0	None
42036	42037	to	0	None
42037	42038	3	0	None
42038	42039	,	0	None
42039	42040	4	0	None
42040	42041	methylenedioxymethamphetamine	0	None
42041	42042	(	0	None
42042	42043	MDMA	0	None
42043	42044	)	0	None
42044	42045	is	0	None
42045	42046	a	0	None
42046	42047	decrease	0	None
42047	42048	in	0	None
42048	42049	the	0	None
42049	42050	tissue	0	None
42050	42051	levels	0	None
42051	42052	of	0	None
42052	42053	serotonin	0	None
42053	42054	(	0	None
42054	42055	5-HT	0	None
42055	42056	)	0	None
42056	42057	.	0	None

42058	42059	A	0	None
42059	42060	variety	0	None
42060	42061	of	0	None
42061	42062	behavioural	0	None
42062	42063	and	0	None
42063	42064	neurochemical	0	None
42064	42065	tests	0	None
42065	42066	were	0	None
42066	42067	conducted	0	None
42067	42068	to	0	None
42068	42069	determine	0	None
42069	42070	whether	0	None
42070	42071	the	0	None
42071	42072	tissue	0	None
42072	42073	deficits	0	None
42073	42074	were	0	None
42074	42075	accompanied	0	None
42075	42076	by	0	None
42076	42077	an	0	None
42077	42078	increased	0	None
42078	42079	sensitivity	0	None
42079	42080	of	0	None
42080	42081	the	0	None
42081	42082	5-HT1a	1	GENE-Y
42082	42083	autoreceptor	0	None
42083	42084	.	0	None

42085	42086	Tests	0	None
42086	42087	were	0	None
42087	42088	conducted	0	None
42088	42089	2	0	None
42089	42090	weeks	0	None
42090	42091	following	0	None
42091	42092	MDMA	0	None
42092	42093	exposure	0	None
42093	42094	(	0	None
42094	42095	four	0	None
42095	42096	injections	0	None
42096	42097	of	0	None
42097	42098	10	0	None
42098	42099	.	0	None
42099	42100	0	0	None
42100	42101	mg	2	CHEMICAL
42101	42102	/	0	None
42102	42103	kg	0	None
42103	42104	,	0	None
42104	42105	IP	0	None
42105	42106	,	0	None
42106	42107	administered	0	None
42107	42108	at	0	None
42108	42109	2-h	0	None
42109	42110	intervals	0	None
42110	42111	in	0	None
42111	42112	a	0	None
42112	42113	single	0	None
42113	42114	day	0	None
42114	42115	)	0	None
42115	42116	.	0	None

42117	42118	The	0	None
42118	42119	response	0	None
42119	42120	to	0	None
42120	42121	the	0	None
42121	42122	5-HT1a	1	GENE-Y
42122	42123	agonist	0	None
42123	42124	,	0	None
42124	42125	8-OHDPAT	0	None
42125	42126	(	0	None
42126	42127	0	0	None
42127	42128	.	0	None
42128	42129	003-0	0	None
42129	42130	.	0	None
42130	42131	5	0	None
42131	42132	mg	2	CHEMICAL
42132	42133	/	0	None
42133	42134	kg	0	None
42134	42135	,	0	None
42135	42136	SC	0	None
42136	42137	)	0	None
42137	42138	,	0	None
42138	42139	was	0	None
42139	42140	assessed	0	None
42140	42141	using	0	None
42141	42142	lower	0	None
42142	42143	lip	0	None
42143	42144	retraction	0	None
42144	42145	(	0	None
42145	42146	LLR	0	None
42146	42147	)	0	None
42147	42148	,	0	None
42148	42149	hypoactivity	0	None
42149	42150	,	0	None
42150	42151	and	0	None
42151	42152	5-hydroxytryptophan	0	None
42152	42153	(	0	None
42153	42154	5-HTP	2	CHEMICAL
42154	42155	)	0	None
42155	42156	accumulation	0	None
42156	42157	following	0	None
42157	42158	decarboxylase	0	None
42158	42159	inhibition	0	None
42159	42160	.	0	None

42161	42162	The	0	None
42162	42163	8-OHDPAT	0	None
42163	42164	produced	0	None
42164	42165	a	0	None
42165	42166	dose-dependent	0	None
42166	42167	increase	0	None
42167	42168	in	0	None
42168	42169	LLR	0	None
42169	42170	and	0	None
42170	42171	hypoactivity	0	None
42171	42172	,	0	None
42172	42173	but	0	None
42173	42174	these	0	None
42174	42175	effects	0	None
42175	42176	were	0	None
42176	42177	comparable	0	None
42177	42178	for	0	None
42178	42179	MDMA	0	None
42179	42180	and	0	None
42180	42181	saline	0	None
42181	42182	pretreated	0	None
42182	42183	groups	0	None
42183	42184	.	0	None

42185	42186	MDMA	0	None
42186	42187	decreased	0	None
42187	42188	tissue	0	None
42188	42189	levels	0	None
42189	42190	of	0	None
42190	42191	5-HT	0	None
42191	42192	and	0	None
42192	42193	the	0	None
42193	42194	accumulation	0	None
42194	42195	of	0	None
42195	42196	5-HTP	2	CHEMICAL
42196	42197	,	0	None
42197	42198	but	0	None
42198	42199	these	0	None
42199	42200	effects	0	None
42200	42201	were	0	None
42201	42202	not	0	None
42202	42203	reflected	0	None
42203	42204	in	0	None
42204	42205	the	0	None
42205	42206	changes	0	None
42206	42207	in	0	None
42207	42208	autoreceptor	0	None
42208	42209	sensitivity	0	None
42209	42210	.	0	None

42211	42212	The	0	None
42212	42213	data	0	None
42213	42214	suggest	0	None
42214	42215	that	0	None
42215	42216	the	0	None
42216	42217	decrease	0	None
42217	42218	in	0	None
42218	42219	tissue	0	None
42219	42220	levels	0	None
42220	42221	of	0	None
42221	42222	5-HT	0	None
42222	42223	produced	0	None
42223	42224	by	0	None
42224	42225	MDMA	0	None
42225	42226	is	0	None
42226	42227	accompanied	0	None
42227	42228	by	0	None
42228	42229	a	0	None
42229	42230	decrease	0	None
42230	42231	in	0	None
42231	42232	tryptophan	2	CHEMICAL
42232	42233	hydroxylase	0	None
42233	42234	activity	0	None
42234	42235	but	0	None
42235	42236	cannot	0	None
42236	42237	be	0	None
42237	42238	explained	0	None
42238	42239	by	0	None
42239	42240	supersensitivity	0	None
42240	42241	of	0	None
42241	42242	the	0	None
42242	42244	5-HT1a autoreceptor	3	GENE-N
42244	42245	.	0	None
42245	42246	BACKGROUND	0	None
42246	42247	:	0	None
42247	42248	Clinical	0	None
42248	42249	trial	0	None
42249	42250	data	0	None
42250	42251	have	0	None
42251	42252	shown	0	None
42252	42253	that	0	None
42253	42254	among	0	None
42254	42255	breast	0	None
42255	42256	cancer	0	None
42256	42257	patients	0	None
42257	42258	who	0	None
42258	42259	were	0	None
42259	42260	disease	0	None
42260	42261	free	0	None
42261	42262	after	0	None
42262	42263	5	0	None
42263	42264	years	0	None
42264	42265	of	0	None
42265	42266	adjuvant	0	None
42266	42267	treatment	0	None
42267	42268	with	0	None
42268	42269	tamoxifen	0	None
42269	42270	,	0	None
42270	42271	further	0	None
42271	42272	extended	0	None
42272	42273	treatment	0	None
42273	42274	with	0	None
42274	42275	the	0	None
42275	42276	nonsteroidal	0	None
42276	42277	aromatase	3	GENE-N
42277	42278	inhibitor	0	None
42278	42279	letrozole	2	CHEMICAL
42279	42280	reduces	0	None
42280	42281	breast	0	None
42281	42282	cancer	0	None
42282	42283	recurrence	0	None
42283	42284	.	0	None

42285	42286	We	0	None
42286	42287	examined	0	None
42287	42288	the	0	None
42288	42289	efficacy	0	None
42289	42290	and	0	None
42290	42291	tolerability	0	None
42291	42292	of	0	None
42292	42293	extended	0	None
42293	42294	adjuvant	0	None
42294	42295	therapy	0	None
42295	42296	with	0	None
42296	42297	another	0	None
42297	42298	aromatase	0	None
42298	42299	inhibitor	0	None
42299	42300	,	0	None
42300	42301	anastrozole	2	CHEMICAL
42301	42302	,	0	None
42302	42303	for	0	None
42303	42304	3	0	None
42304	42305	years	0	None
42305	42306	among	0	None
42306	42307	women	0	None
42307	42308	who	0	None
42308	42309	had	0	None
42309	42310	completed	0	None
42310	42311	5	0	None
42311	42312	years	0	None
42312	42313	of	0	None
42313	42314	adjuvant	0	None
42314	42315	therapy	0	None
42315	42316	.	0	None

42317	42318	METHODS	0	None
42318	42319	:	0	None
42319	42320	Austrian	0	None
42320	42321	Breast	0	None
42321	42322	and	0	None
42322	42323	Colorectal	0	None
42323	42324	Cancer	0	None
42324	42325	Study	0	None
42325	42326	Group	0	None
42326	42327	(	0	None
42327	42328	ABCSG	0	None
42328	42329	)	0	None
42329	42330	Trial	0	None
42330	42331	6a	0	None
42331	42332	is	0	None
42332	42333	an	0	None
42333	42334	extension	0	None
42334	42335	of	0	None
42335	42336	ABCSG	0	None
42336	42337	Trial	0	None
42337	42338	6	0	None
42338	42339	,	0	None
42339	42340	in	0	None
42340	42341	which	0	None
42341	42342	hormone	0	None
42342	42343	receptor-positive	0	None
42343	42344	postmenopausal	0	None
42344	42345	patients	0	None
42345	42346	received	0	None
42346	42347	5	0	None
42347	42348	years	0	None
42348	42349	of	0	None
42349	42350	adjuvant	0	None
42350	42351	tamoxifen	0	None
42351	42352	,	0	None
42352	42353	with	0	None
42353	42354	or	0	None
42354	42355	without	0	None
42355	42356	the	0	None
42356	42357	aromatase	0	None
42357	42358	inhibitor	0	None
42358	42359	aminoglutethimide	0	None
42359	42360	,	0	None
42360	42361	for	0	None
42361	42362	the	0	None
42362	42363	first	0	None
42363	42364	2	0	None
42364	42365	years	0	None
42365	42366	of	0	None
42366	42367	therapy	0	None
42367	42368	.	0	None

42369	42370	For	0	None
42370	42371	ABCSG	0	None
42371	42372	Trial	0	None
42372	42373	6a	0	None
42373	42374	,	0	None
42374	42375	patients	0	None
42375	42376	who	0	None
42376	42377	were	0	None
42377	42378	disease	0	None
42378	42379	free	0	None
42379	42380	at	0	None
42380	42381	the	0	None
42381	42382	end	0	None
42382	42383	of	0	None
42383	42384	Trial	0	None
42384	42385	6	0	None
42385	42386	were	0	None
42386	42387	randomly	0	None
42387	42388	assigned	0	None
42388	42389	to	0	None
42389	42390	receive	0	None
42390	42391	either	0	None
42391	42392	3	0	None
42392	42393	years	0	None
42393	42394	of	0	None
42394	42395	anastrozole	2	CHEMICAL
42395	42396	or	0	None
42396	42397	no	0	None
42397	42398	further	0	None
42398	42399	treatment	0	None
42399	42400	.	0	None

42401	42402	Efficacy	0	None
42402	42403	data	0	None
42403	42404	were	0	None
42404	42405	analyzed	0	None
42405	42406	with	0	None
42406	42407	the	0	None
42407	42408	use	0	None
42408	42409	of	0	None
42409	42410	a	0	None
42410	42411	Cox	0	None
42411	42412	proportional	0	None
42412	42413	hazards	0	None
42413	42414	regression	0	None
42414	42415	model	0	None
42415	42416	with	0	None
42416	42417	two-sided	0	None
42417	42418	P	0	None
42418	42419	values	0	None
42419	42420	and	0	None
42420	42421	Kaplan-Meier	0	None
42421	42422	curves	0	None
42422	42423	,	0	None
42423	42424	and	0	None
42424	42425	tolerability	0	None
42425	42426	data	0	None
42426	42427	were	0	None
42427	42428	estimated	0	None
42428	42429	using	0	None
42429	42430	logistic	0	None
42430	42431	regression	0	None
42431	42432	analysis	0	None
42432	42433	with	0	None
42433	42434	odds	0	None
42434	42435	ratios	0	None
42435	42436	and	0	None
42436	42437	95%	0	None
42437	42438	confidence	0	None
42438	42439	intervals	0	None
42439	42440	(	0	None
42440	42441	CIs	0	None
42441	42442	)	0	None
42442	42443	.	0	None

42444	42445	RESULTS	0	None
42445	42446	:	0	None
42446	42447	ABCSG	0	None
42447	42448	Trial	0	None
42448	42449	6a	0	None
42449	42450	included	0	None
42450	42451	856	0	None
42451	42452	patients	0	None
42452	42453	.	0	None

42454	42455	At	0	None
42455	42456	a	0	None
42456	42457	median	0	None
42457	42458	follow-up	0	None
42458	42459	of	0	None
42459	42460	62	0	None
42460	42461	.	0	None
42461	42462	3	0	None
42462	42463	months	0	None
42463	42464	,	0	None
42464	42465	women	0	None
42465	42466	who	0	None
42466	42467	received	0	None
42467	42468	anastrozole	2	CHEMICAL
42468	42469	(	0	None
42469	42470	n	0	None
42470	42471	=	0	None
42471	42472	387	0	None
42472	42473	)	0	None
42473	42474	had	0	None
42474	42475	a	0	None
42475	42476	statistically	0	None
42476	42477	significantly	0	None
42477	42478	reduced	0	None
42478	42479	risk	0	None
42479	42480	of	0	None
42480	42481	recurrence	0	None
42481	42482	(	0	None
42482	42483	locoregional	0	None
42483	42484	recurrence	0	None
42484	42485	,	0	None
42485	42486	contralateral	0	None
42486	42487	breast	0	None
42487	42488	cancer	0	None
42488	42489	,	0	None
42489	42490	or	0	None
42490	42491	distant	0	None
42491	42492	metastasis	0	None
42492	42493	)	0	None
42493	42494	compared	0	None
42494	42495	with	0	None
42495	42496	women	0	None
42496	42497	who	0	None
42497	42498	received	0	None
42498	42499	no	0	None
42499	42500	further	0	None
42500	42501	treatment	0	None
42501	42502	(	0	None
42502	42503	n	0	None
42503	42504	=	0	None
42504	42505	469;	0	None
42505	42506	hazard	0	None
42506	42507	ratio	0	None
42507	42508	=	0	None
42508	42509	0	0	None
42509	42510	.	0	None
42510	42511	62;	0	None
42511	42512	95%	0	None
42512	42513	CI	0	None
42513	42514	=	0	None
42514	42515	0	0	None
42515	42516	.	0	None
42516	42517	40	0	None
42517	42518	to	0	None
42518	42519	0	0	None
42519	42520	.	0	None
42520	42521	96	0	None
42521	42522	,	0	None
42522	42523	P	0	None
42523	42524	=	0	None
42524	42525	.	0	None
42525	42526	031	0	None
42526	42527	)	0	None
42527	42528	.	0	None

42529	42530	Anastrozole	0	None
42530	42531	was	0	None
42531	42532	well	0	None
42532	42533	tolerated	0	None
42533	42534	,	0	None
42534	42535	and	0	None
42535	42536	no	0	None
42536	42537	unexpected	0	None
42537	42538	adverse	0	None
42538	42539	events	0	None
42539	42540	were	0	None
42540	42541	reported	0	None
42541	42542	.	0	None

42543	42544	CONCLUSIONS	0	None
42544	42545	:	0	None
42545	42546	These	0	None
42546	42547	data	0	None
42547	42548	confirm	0	None
42548	42549	the	0	None
42549	42550	benefit	0	None
42550	42551	of	0	None
42551	42552	extending	0	None
42552	42553	adjuvant	0	None
42553	42554	tamoxifen	0	None
42554	42555	therapy	0	None
42555	42556	beyond	0	None
42556	42557	5	0	None
42557	42558	years	0	None
42558	42559	with	0	None
42559	42560	anastrozole	2	CHEMICAL
42560	42561	compared	0	None
42561	42562	with	0	None
42562	42563	no	0	None
42563	42564	further	0	None
42564	42565	treatment	0	None
42565	42566	.	0	None

42567	42568	Further	0	None
42568	42569	research	0	None
42569	42570	is	0	None
42570	42571	required	0	None
42571	42572	to	0	None
42572	42573	define	0	None
42573	42574	the	0	None
42574	42575	optimum	0	None
42575	42576	length	0	None
42576	42577	of	0	None
42577	42578	extended	0	None
42578	42579	adjuvant	0	None
42579	42580	therapy	0	None
42580	42581	and	0	None
42581	42582	to	0	None
42582	42583	investigate	0	None
42583	42584	the	0	None
42584	42585	possibility	0	None
42585	42586	of	0	None
42586	42587	tailoring	0	None
42587	42588	this	0	None
42588	42589	period	0	None
42589	42590	to	0	None
42590	42591	suit	0	None
42591	42592	different	0	None
42592	42593	disease	0	None
42593	42594	types	0	None
42594	42595	.	0	None
42595	42596	Catalpol	0	None
42596	42597	inhibits	0	None
42597	42598	LPS	0	None
42598	42599	plus	0	None
42599	42600	IFN-γ-induced	0	None
42600	42601	inflammatory	0	None
42601	42602	response	0	None
42602	42603	in	0	None
42603	42604	astrocytes	0	None
42604	42605	primary	0	None
42605	42606	cultures	0	None
42606	42607	.	0	None
42607	42608	OBJECTIVEIn	0	None
42608	42609	adults	0	None
42609	42610	,	0	None
42610	42611	1-h	0	None
42611	42612	glucose	0	None
42612	42613	during	0	None
42613	42614	an	0	None
42614	42615	oral	0	None
42615	42616	glucose	0	None
42616	42617	tolerance	0	None
42617	42618	test	0	None
42618	42619	(	0	None
42619	42620	OGTT	0	None
42620	42621	)	0	None
42621	42622	predicts	0	None
42622	42623	the	0	None
42623	42624	development	0	None
42624	42625	of	0	None
42625	42626	type	0	None
42626	42627	2	0	None
42627	42628	diabetes	0	None
42628	42629	independent	0	None
42629	42630	of	0	None
42630	42631	fasting	0	None
42631	42632	and	0	None
42632	42633	2-h	0	None
42633	42634	glucose	0	None
42634	42635	concentrations	0	None
42635	42636	.	0	None

42637	42638	The	0	None
42638	42639	purpose	0	None
42639	42640	of	0	None
42640	42641	the	0	None
42641	42642	current	0	None
42642	42643	investigation	0	None
42643	42644	was	0	None
42644	42645	to	0	None
42645	42646	examine	0	None
42646	42647	the	0	None
42647	42648	utility	0	None
42648	42649	of	0	None
42649	42650	elevated	0	None
42650	42651	1-h	0	None
42651	42652	glucose	0	None
42652	42653	levels	0	None
42653	42654	to	0	None
42654	42655	prospectively	0	None
42655	42656	predict	0	None
42656	42657	deterioration	0	None
42657	42658	in	0	None
42658	42659	β-cell	0	None
42659	42660	function	0	None
42660	42661	and	0	None
42661	42662	the	0	None
42662	42663	development	0	None
42663	42664	of	0	None
42664	42665	prediabetes	0	None
42665	42666	in	0	None
42666	42667	high-risk	0	None
42667	42668	youth	0	None
42668	42669	.	0	None

42670	42671	RESEARCH	0	None
42671	42672	DESIGN	0	None
42672	42673	AND	0	None
42673	42674	METHODSObese	0	None
42674	42675	Latino	0	None
42675	42676	youth	0	None
42676	42677	with	0	None
42677	42678	a	0	None
42678	42679	family	0	None
42679	42680	history	0	None
42680	42681	of	0	None
42681	42682	type	0	None
42682	42683	2	0	None
42683	42684	diabetes	0	None
42684	42685	(	0	None
42685	42686	133	0	None
42686	42687	male	0	None
42687	42688	and	0	None
42688	42689	100	0	None
42689	42690	female;	0	None
42690	42691	age	0	None
42691	42692	11	0	None
42692	42693	.	0	None
42693	42694	1	0	None
42694	42695	±	0	None
42695	42696	1	0	None
42696	42697	.	0	None
42697	42698	7	0	None
42698	42699	years	0	None
42699	42700	)	0	None
42700	42701	completed	0	None
42701	42702	a	0	None
42702	42703	baseline	0	None
42703	42704	OGTT	0	None
42704	42705	and	0	None
42705	42706	were	0	None
42706	42707	divided	0	None
42707	42708	into	0	None
42708	42709	two	0	None
42709	42710	groups	0	None
42710	42711	based	0	None
42711	42712	upon	0	None
42712	42713	a	0	None
42713	42714	1-h	0	None
42714	42715	glucose	0	None
42715	42716	threshold	0	None
42716	42717	of	0	None
42717	42718	155	0	None
42718	42719	mg	2	CHEMICAL
42719	42720	/	0	None
42720	42721	dL	0	None
42721	42722	(	0	None
42722	42723	<155	0	None
42723	42724	mg	2	CHEMICAL
42724	42725	/	0	None
42725	42726	dL	0	None
42726	42727	,	0	None
42727	42728	n	0	None
42728	42729	=	0	None
42729	42730	151	0	None
42730	42731	,	0	None
42731	42732	or	0	None
42732	42733	≥155	0	None
42733	42734	mg	2	CHEMICAL
42734	42735	/	0	None
42735	42736	dL	0	None
42736	42737	,	0	None
42737	42738	n	0	None
42738	42739	=	0	None
42739	42740	82	0	None
42740	42741	)	0	None
42741	42742	.	0	None

42743	42744	Youth	0	None
42744	42745	were	0	None
42745	42746	followed	0	None
42746	42747	annually	0	None
42747	42748	for	0	None
42748	42749	up	0	None
42749	42750	to	0	None
42750	42751	8	0	None
42751	42752	years	0	None
42752	42753	for	0	None
42753	42754	assessment	0	None
42754	42755	of	0	None
42755	42756	glucose	0	None
42756	42757	tolerance	0	None
42757	42758	,	0	None
42758	42759	body	0	None
42759	42760	composition	0	None
42760	42761	by	0	None
42761	42762	dual-energy	0	None
42762	42763	X-ray	0	None
42763	42764	absorptiometry	0	None
42764	42765	,	0	None
42765	42766	and	0	None
42766	42767	insulin	0	None
42767	42768	sensitivity	0	None
42768	42769	,	0	None
42769	42770	insulin	0	None
42770	42771	secretion	0	None
42771	42772	,	0	None
42772	42773	and	0	None
42773	42774	the	0	None
42774	42775	disposition	0	None
42775	42776	index	0	None
42776	42777	by	0	None
42777	42778	the	0	None
42778	42779	frequently	0	None
42779	42780	sampled	0	None
42780	42781	intravenous	0	None
42781	42782	glucose	0	None
42782	42783	tolerance	0	None
42783	42784	test	0	None
42784	42785	.	0	None

42786	42787	RESULTSOver	0	None
42787	42788	time	0	None
42788	42789	,	0	None
42789	42790	the	0	None
42790	42791	≥155	0	None
42791	42792	mg	2	CHEMICAL
42792	42793	/	0	None
42793	42794	dL	0	None
42794	42795	group	0	None
42795	42796	exhibited	0	None
42796	42797	a	0	None
42797	42798	significantly	0	None
42798	42799	greater	0	None
42799	42800	decline	0	None
42800	42801	in	0	None
42801	42802	β-cell	0	None
42802	42803	function	0	None
42803	42804	compared	0	None
42804	42805	with	0	None
42805	42806	youth	0	None
42806	42807	with	0	None
42807	42808	a	0	None
42808	42809	1-h	0	None
42809	42810	glucose	0	None
42810	42811	<155	0	None
42811	42812	mg	2	CHEMICAL
42812	42813	/	0	None
42813	42814	dL	0	None
42814	42815	(	0	None
42815	42816	β	0	None
42816	42817	=	0	None
42817	42818	-327	0	None
42818	42819	.	0	None
42819	42820	8	0	None
42820	42821	±	0	None
42821	42822	126	0	None
42822	42823	.	0	None
42823	42824	2	0	None
42824	42825	,	0	None
42825	42826	P	0	None
42826	42827	=	0	None
42827	42828	0	0	None
42828	42829	.	0	None
42829	42830	01	0	None
42830	42831	)	0	None
42831	42832	.	0	None

42833	42834	Moreover	0	None
42834	42835	,	0	None
42835	42836	this	0	None
42836	42837	decline	0	None
42837	42838	was	0	None
42838	42839	independent	0	None
42839	42840	of	0	None
42840	42841	fasting	0	None
42841	42842	or	0	None
42842	42843	2-h	0	None
42843	42844	glucose	0	None
42844	42845	and	0	None
42845	42846	body	0	None
42846	42847	composition	0	None
42847	42848	.	0	None

42849	42850	When	0	None
42850	42851	the	0	None
42851	42852	data	0	None
42852	42853	were	0	None
42853	42854	restricted	0	None
42854	42855	to	0	None
42855	42856	only	0	None
42856	42857	participants	0	None
42857	42858	with	0	None
42858	42859	normal	0	None
42859	42860	glucose	0	None
42860	42861	tolerance	0	None
42861	42862	at	0	None
42862	42863	baseline	0	None
42863	42864	,	0	None
42864	42865	a	0	None
42865	42866	1-h	0	None
42866	42867	glucose	0	None
42867	42868	≥155	0	None
42868	42869	mg	2	CHEMICAL
42869	42870	/	0	None
42870	42871	dL	0	None
42871	42872	was	0	None
42872	42873	independently	0	None
42873	42874	associated	0	None
42874	42875	with	0	None
42875	42876	a	0	None
42876	42877	2	0	None
42877	42878	.	0	None
42878	42879	5	0	None
42879	42880	times	0	None
42880	42881	greater	0	None
42881	42882	likelihood	0	None
42882	42883	of	0	None
42883	42884	developing	0	None
42884	42885	prediabetes	0	None
42885	42886	during	0	None
42886	42887	follow-up	0	None
42887	42888	(	0	None
42888	42889	95%	0	None
42889	42890	CI	0	None
42890	42891	1	0	None
42891	42892	.	0	None
42892	42893	6-4	0	None
42893	42894	.	0	None
42894	42895	1	0	None
42895	42896	,	0	None
42896	42897	P	0	None
42897	42898	=	0	None
42898	42899	0	0	None
42899	42900	.	0	None
42900	42901	0001	0	None
42901	42902	)	0	None
42902	42903	.	0	None

42904	42905	CONCLUSIONSThese	0	None
42905	42906	data	0	None
42906	42907	suggest	0	None
42907	42908	that	0	None
42908	42909	a	0	None
42909	42910	1-h	0	None
42910	42911	glucose	0	None
42911	42912	≥155	0	None
42912	42913	mg	2	CHEMICAL
42913	42914	/	0	None
42914	42915	dL	0	None
42915	42916	during	0	None
42916	42917	an	0	None
42917	42918	OGTT	0	None
42918	42919	is	0	None
42919	42920	an	0	None
42920	42921	independent	0	None
42921	42922	predictor	0	None
42922	42923	of	0	None
42923	42924	β-cell	0	None
42924	42925	deterioration	0	None
42925	42926	and	0	None
42926	42927	progression	0	None
42927	42928	to	0	None
42928	42929	prediabetes	0	None
42929	42930	among	0	None
42930	42931	obese	0	None
42931	42932	Latino	0	None
42932	42933	youth	0	None
42933	42934	.	0	None
42934	42935	The	0	None
42935	42936	effect	0	None
42936	42937	of	0	None
42937	42938	a	0	None
42938	42939	21-day	0	None
42939	42940	treatment	0	None
42940	42941	with	0	None
42941	42942	the	0	None
42942	42943	dual	0	None
42943	42944	5-HT	0	None
42944	42945	and	0	None
42945	42946	NE	0	None
42946	42947	reuptake	0	None
42947	42948	blocker	0	None
42948	42949	venlafaxine	0	None
42949	42950	(	0	None
42950	42951	delivered	0	None
42951	42952	s	0	None
42952	42953	.	0	None

42954	42955	c	0	None
42955	42956	.	0	None

42957	42958	by	0	None
42958	42959	osmotic	0	None
42959	42960	minipumps	0	None
42960	42961	)	0	None
42961	42962	was	0	None
42962	42963	assessed	0	None
42963	42964	on	0	None
42964	42965	the	0	None
42965	42966	time	0	None
42966	42967	required	0	None
42967	42968	for	0	None
42968	42969	a	0	None
42969	42970	50%	0	None
42970	42971	recovery	0	None
42971	42972	(	0	None
42972	42973	RT	0	None
42973	42974	(	0	None
42974	42975	50	0	None
42975	42976	)	0	None
42976	42977	)	0	None
42977	42978	of	0	None
42978	42979	the	0	None
42979	42980	firing	0	None
42980	42981	activity	0	None
42981	42982	of	0	None
42982	42983	dorsal	0	None
42983	42984	hippocampus	0	None
42984	42985	CA	1	GENE-Y
42985	42986	(	0	None
42986	42987	3	0	None
42987	42988	)	0	None
42988	42989	pyramidal	0	None
42989	42990	neurons	0	None
42990	42991	from	0	None
42991	42992	the	0	None
42992	42993	suppression	0	None
42993	42994	induced	0	None
42994	42995	by	0	None
42995	42996	microiontophoretic	0	None
42996	42997	applications	0	None
42997	42998	of	0	None
42998	42999	5-HT	0	None
42999	43000	and	0	None
43000	43001	NE	0	None
43001	43002	.	0	None

43003	43004	The	0	None
43004	43005	RT	0	None
43005	43006	(	0	None
43006	43007	50	0	None
43007	43008	)	0	None
43008	43009	values	0	None
43009	43010	for	0	None
43010	43011	5-HT	0	None
43011	43012	were	0	None
43012	43013	increased	0	None
43013	43014	by	0	None
43014	43015	both	0	None
43015	43016	10	0	None
43016	43017	and	0	None
43017	43018	40	0	None
43018	43019	mg	2	CHEMICAL
43019	43020	/	0	None
43020	43021	kg	0	None
43021	43022	/	0	None
43022	43023	day	0	None
43023	43024	regimens	0	None
43024	43025	of	0	None
43025	43026	venlafaxine	0	None
43026	43027	,	0	None
43027	43028	whereas	0	None
43028	43029	those	0	None
43029	43030	for	0	None
43030	43031	NE	0	None
43031	43032	were	0	None
43032	43033	increased	0	None
43033	43034	only	0	None
43034	43035	by	0	None
43035	43036	the	0	None
43036	43037	40	0	None
43037	43038	mg	2	CHEMICAL
43038	43039	/	0	None
43039	43040	kg	0	None
43040	43041	/	0	None
43041	43042	day	0	None
43042	43043	regimen	0	None
43043	43044	,	0	None
43044	43045	indicative	0	None
43045	43046	of	0	None
43046	43047	a	0	None
43047	43048	greater	0	None
43048	43049	potency	0	None
43049	43050	of	0	None
43050	43051	venlafaxine	0	None
43051	43052	in	0	None
43052	43053	blocking	0	None
43053	43054	5-HT	0	None
43054	43055	reuptake	0	None
43055	43056	.	0	None

43057	43058	The	0	None
43058	43059	sensitivity	0	None
43059	43060	of	0	None
43060	43061	the	0	None
43061	43062	postsynaptic	0	None
43062	43063	5-HT	0	None
43063	43064	(	0	None
43064	43065	1A	0	None
43065	43066	)	0	None
43066	43067	and	0	None
43067	43068	alpha	0	None
43068	43069	(	0	None
43069	43070	2	0	None
43070	43071	)	0	None
43071	43072	-adrenergic	0	None
43072	43073	receptors	0	None
43073	43074	was	0	None
43074	43075	altered	0	None
43075	43076	by	0	None
43076	43077	neither	0	None
43077	43078	regimen	0	None
43078	43079	of	0	None
43079	43080	venlafaxine	0	None
43080	43081	.	0	None

43082	43083	Using	0	None
43083	43084	a	0	None
43084	43085	paradigm	0	None
43085	43086	by	0	None
43086	43087	which	0	None
43087	43088	the	0	None
43088	43089	5-HT	0	None
43089	43090	(	0	None
43090	43091	1A	0	None
43091	43092	)	0	None
43092	43093	antagonist	0	None
43093	43094	WAY	0	None
43094	43095	100635	0	None
43095	43096	can	0	None
43096	43097	induce	0	None
43097	43098	a	0	None
43098	43099	disinhibition	0	None
43099	43100	of	0	None
43100	43101	firing	0	None
43101	43102	activity	0	None
43102	43103	of	0	None
43103	43104	CA	1	GENE-Y
43104	43105	(	0	None
43105	43106	3	0	None
43106	43107	)	0	None
43107	43108	pyramidal	0	None
43108	43109	neurons	0	None
43109	43110	,	0	None
43110	43111	it	0	None
43111	43112	was	0	None
43112	43113	demonstrated	0	None
43113	43114	that	0	None
43114	43115	the	0	None
43115	43116	high	0	None
43116	43117	,	0	None
43117	43118	but	0	None
43118	43119	not	0	None
43119	43120	the	0	None
43120	43121	low	0	None
43121	43122	,	0	None
43122	43123	dose	0	None
43123	43124	of	0	None
43124	43125	venlafaxine	0	None
43125	43126	led	0	None
43126	43127	to	0	None
43127	43128	an	0	None
43128	43129	enhanced	0	None
43129	43130	tonic	0	None
43130	43131	activation	0	None
43131	43132	of	0	None
43132	43133	postsynaptic	0	None
43133	43134	5-HT	0	None
43134	43135	(	0	None
43135	43136	1A	0	None
43136	43137	)	0	None
43137	43138	receptors	0	None
43138	43139	in	0	None
43139	43140	the	0	None
43140	43141	dorsal	0	None
43141	43142	hippocampus	0	None
43142	43143	.	0	None

43144	43145	The	0	None
43145	43146	duration	0	None
43146	43147	of	0	None
43147	43148	the	0	None
43148	43149	suppressant	0	None
43149	43150	effect	0	None
43150	43151	of	0	None
43151	43152	the	0	None
43152	43153	firing	0	None
43153	43154	activity	0	None
43154	43155	of	0	None
43155	43156	CA	1	GENE-Y
43156	43157	(	0	None
43157	43158	3	0	None
43158	43159	)	0	None
43159	43160	hippocampus	0	None
43160	43161	pyramidal	0	None
43161	43162	neurons	0	None
43162	43163	produced	0	None
43163	43164	by	0	None
43164	43165	the	0	None
43165	43166	electrical	0	None
43166	43167	stimulation	0	None
43167	43168	of	0	None
43168	43169	the	0	None
43169	43170	ascending	0	None
43170	43171	5-HT	0	None
43171	43172	pathway	0	None
43172	43173	was	0	None
43173	43174	significantly	0	None
43174	43175	reduced	0	None
43175	43176	when	0	None
43176	43177	the	0	None
43177	43178	frequency	0	None
43178	43179	of	0	None
43179	43180	the	0	None
43180	43181	stimulation	0	None
43181	43182	was	0	None
43182	43183	enhanced	0	None
43183	43184	from	0	None
43184	43185	1	0	None
43185	43186	Hz	0	None
43186	43187	to	0	None
43187	43188	5	0	None
43188	43189	Hz	0	None
43189	43190	in	0	None
43190	43191	control	0	None
43191	43192	rats	0	None
43192	43193	and	0	None
43193	43194	in	0	None
43194	43195	rats	0	None
43195	43196	treated	0	None
43196	43197	with	0	None
43197	43198	10	0	None
43198	43199	mg	2	CHEMICAL
43199	43200	/	0	None
43200	43201	kg	0	None
43201	43202	/	0	None
43202	43203	day	0	None
43203	43204	,	0	None
43204	43205	but	0	None
43205	43206	not	0	None
43206	43207	with	0	None
43207	43208	40	0	None
43208	43209	mg	2	CHEMICAL
43209	43210	/	0	None
43210	43211	kg	0	None
43211	43212	/	0	None
43212	43213	day	0	None
43213	43214	of	0	None
43214	43215	venlafaxine	0	None
43215	43216	.	0	None

43217	43218	Hence	0	None
43218	43219	,	0	None
43219	43220	venlafaxine	0	None
43220	43221	induced	0	None
43221	43222	a	0	None
43222	43223	desensitization	0	None
43223	43224	of	0	None
43224	43225	the	0	None
43225	43226	terminal	0	None
43226	43227	5-HT	0	None
43227	43228	(	0	None
43228	43229	1B	0	None
43229	43230	)	0	None
43230	43231	autoreceptor	0	None
43231	43232	only	0	None
43232	43233	at	0	None
43233	43234	the	0	None
43234	43235	high	0	None
43235	43236	dose	0	None
43236	43237	.	0	None

43238	43239	A	0	None
43239	43240	2-day	0	None
43240	43241	treatment	0	None
43241	43242	with	0	None
43242	43243	10	0	None
43243	43244	mg	2	CHEMICAL
43244	43245	/	0	None
43245	43246	kg	0	None
43246	43247	/	0	None
43247	43248	day	0	None
43248	43249	of	0	None
43249	43250	venlafaxine	0	None
43250	43251	induced	0	None
43251	43252	a	0	None
43252	43253	suppression	0	None
43253	43254	of	0	None
43254	43255	the	0	None
43255	43256	firing	0	None
43256	43257	activity	0	None
43257	43258	of	0	None
43258	43259	5-HT	0	None
43259	43260	neurons	0	None
43260	43261	of	0	None
43261	43262	the	0	None
43262	43263	dorsal	0	None
43263	43264	raphe	0	None
43264	43265	.	0	None

43266	43267	The	0	None
43267	43268	firing	0	None
43268	43269	activity	0	None
43269	43270	of	0	None
43270	43271	these	0	None
43271	43272	neurons	0	None
43272	43273	was	0	None
43273	43274	back	0	None
43274	43275	to	0	None
43275	43276	control	0	None
43276	43277	level	0	None
43277	43278	in	0	None
43278	43279	rats	0	None
43279	43280	that	0	None
43280	43281	had	0	None
43281	43282	been	0	None
43282	43283	treated	0	None
43283	43284	for	0	None
43284	43285	21	0	None
43285	43286	days	0	None
43286	43287	with	0	None
43287	43288	the	0	None
43288	43289	same	0	None
43289	43290	dose	0	None
43290	43291	of	0	None
43291	43292	venlafaxine	0	None
43292	43293	.	0	None

43294	43295	The	0	None
43295	43296	suppressant	0	None
43296	43297	effect	0	None
43297	43298	of	0	None
43298	43299	the	0	None
43299	43300	i	0	None
43300	43301	.	0	None

43302	43303	v	0	None
43303	43304	.	0	None

43305	43306	administration	0	None
43306	43307	of	0	None
43307	43308	the	0	None
43308	43309	5-HT	0	None
43309	43310	autoreceptor	0	None
43310	43311	agonist	0	None
43311	43312	LSD	0	None
43312	43313	on	0	None
43313	43314	the	0	None
43314	43315	firing	0	None
43315	43316	activity	0	None
43316	43317	of	0	None
43317	43318	dorsal	0	None
43318	43319	raphe	0	None
43319	43320	5-HT	0	None
43320	43321	neurons	0	None
43321	43322	was	0	None
43322	43323	reduced	0	None
43323	43324	in	0	None
43324	43325	rats	0	None
43325	43326	that	0	None
43326	43327	had	0	None
43327	43328	been	0	None
43328	43329	treated	0	None
43329	43330	for	0	None
43330	43331	21	0	None
43331	43332	days	0	None
43332	43333	with	0	None
43333	43334	10	0	None
43334	43335	mg	2	CHEMICAL
43335	43336	/	0	None
43336	43337	kg	0	None
43337	43338	/	0	None
43338	43339	day	0	None
43339	43340	of	0	None
43340	43341	venlafaxine	0	None
43341	43342	.	0	None

43343	43344	A	0	None
43344	43345	2-day	0	None
43345	43346	treatment	0	None
43346	43347	with	0	None
43347	43348	40	0	None
43348	43349	mg	2	CHEMICAL
43349	43350	/	0	None
43350	43351	kg	0	None
43351	43352	/	0	None
43352	43353	day	0	None
43353	43354	of	0	None
43354	43355	venlafaxine	0	None
43355	43356	,	0	None
43356	43357	unlike	0	None
43357	43358	the	0	None
43358	43359	10	0	None
43359	43360	mg	2	CHEMICAL
43360	43361	/	0	None
43361	43362	kg	0	None
43362	43363	/	0	None
43363	43364	day	0	None
43364	43365	regimen	0	None
43365	43366	,	0	None
43366	43367	induced	0	None
43367	43368	a	0	None
43368	43369	marked	0	None
43369	43370	suppression	0	None
43370	43371	of	0	None
43371	43372	the	0	None
43372	43373	firing	0	None
43373	43374	activity	0	None
43374	43375	of	0	None
43375	43376	locus	0	None
43376	43377	coeruleus	0	None
43377	43378	NE	0	None
43378	43379	neurons	0	None
43379	43380	.	0	None

43381	43382	However	0	None
43382	43383	,	0	None
43383	43384	in	0	None
43384	43385	contrast	0	None
43385	43386	to	0	None
43386	43387	5-HT	0	None
43387	43388	neurons	0	None
43388	43389	,	0	None
43389	43390	NE	0	None
43390	43391	neurons	0	None
43391	43392	did	0	None
43392	43393	not	0	None
43393	43394	recover	0	None
43394	43395	their	0	None
43395	43396	firing	0	None
43396	43397	activity	0	None
43397	43398	after	0	None
43398	43399	a	0	None
43399	43400	21-day	0	None
43400	43401	treatment	0	None
43401	43402	.	0	None

43403	43404	Taken	0	None
43404	43405	together	0	None
43405	43406	,	0	None
43406	43407	the	0	None
43407	43408	results	0	None
43408	43409	from	0	None
43409	43410	this	0	None
43410	43411	study	0	None
43411	43412	indicate	0	None
43412	43413	that	0	None
43413	43414	the	0	None
43414	43415	low	0	None
43415	43416	dose	0	None
43416	43417	of	0	None
43417	43418	venlafaxine	0	None
43418	43419	blocked	0	None
43419	43420	selectively	0	None
43420	43421	the	0	None
43421	43422	reuptake	0	None
43422	43423	of	0	None
43423	43424	5-HT	0	None
43424	43425	,	0	None
43425	43426	whereas	0	None
43426	43427	the	0	None
43427	43428	high	0	None
43428	43429	dose	0	None
43429	43430	blocked	0	None
43430	43431	the	0	None
43431	43432	reuptake	0	None
43432	43433	of	0	None
43433	43434	both	0	None
43434	43435	5-HT	0	None
43435	43436	and	0	None
43436	43437	NE	0	None
43437	43438	.	0	None

43439	43440	Moreover	0	None
43440	43441	,	0	None
43441	43442	an	0	None
43442	43443	enhancement	0	None
43443	43444	of	0	None
43444	43445	serotonergic	0	None
43445	43446	neurotransmission	0	None
43446	43447	by	0	None
43447	43448	venlafaxine	0	None
43448	43449	was	0	None
43449	43450	only	0	None
43450	43451	achieved	0	None
43451	43452	under	0	None
43452	43453	conditions	0	None
43453	43454	whereby	0	None
43454	43455	the	0	None
43455	43456	desensitization	0	None
43456	43457	of	0	None
43457	43458	the	0	None
43458	43459	terminal	0	None
43459	43460	5-HT	0	None
43460	43461	(	0	None
43461	43462	1B	0	None
43462	43463	)	0	None
43463	43464	autoreceptor	0	None
43464	43465	is	0	None
43465	43466	appended	0	None
43466	43467	to	0	None
43467	43468	that	0	None
43468	43469	of	0	None
43469	43470	the	0	None
43470	43471	somatodendritic	0	None
43471	43472	5-HT	0	None
43472	43473	(	0	None
43473	43474	1A	0	None
43474	43475	)	0	None
43475	43476	receptor	0	None
43476	43477	.	0	None
43477	43479	Plant homeodomain	3	GENE-N
43479	43480	(	0	None
43480	43481	PHD	0	None
43481	43482	)	0	None
43482	43483	-type	0	None
43483	43484	zinc	2	CHEMICAL
43484	43485	fingers	0	None
43485	43486	play	0	None
43486	43487	an	0	None
43487	43488	important	0	None
43488	43489	role	0	None
43489	43490	in	0	None
43490	43491	recognizing	0	None
43491	43492	chromatin	0	None
43492	43493	modifications	0	None
43493	43494	and	0	None
43494	43495	recruiting	0	None
43495	43496	regulatory	0	None
43496	43497	proteins	0	None
43497	43498	to	0	None
43498	43499	specific	0	None
43499	43500	genes	0	None
43500	43501	.	0	None

43502	43503	A	0	None
43503	43504	specific	0	None
43504	43505	module	0	None
43505	43506	containing	0	None
43506	43507	a	0	None
43507	43508	conventional	0	None
43508	43509	PHD	0	None
43509	43510	finger	0	None
43510	43511	followed	0	None
43511	43512	by	0	None
43512	43513	an	0	None
43513	43514	extended	0	None
43514	43515	PHD	0	None
43515	43516	finger	0	None
43516	43517	exists	0	None
43517	43518	in	0	None
43518	43519	the	0	None
43519	43521	mammalian AF10	1	GENE-Y
43521	43522	protein	0	None
43522	43523	,	0	None
43523	43524	among	0	None
43524	43525	a	0	None
43525	43526	few	0	None
43526	43527	others	0	None
43527	43528	.	0	None

43529	43530	AF10	1	GENE-Y
43530	43531	has	0	None
43531	43532	mostly	0	None
43532	43533	been	0	None
43533	43534	studied	0	None
43534	43535	in	0	None
43535	43536	the	0	None
43536	43537	context	0	None
43537	43538	of	0	None
43538	43539	the	0	None
43539	43540	leukemic	0	None
43540	43541	MLL-AF10	0	None
43541	43542	fusion	0	None
43542	43543	protein	0	None
43543	43544	,	0	None
43544	43545	which	0	None
43545	43546	lacks	0	None
43546	43547	the	0	None
43547	43548	N-terminal	0	None
43548	43549	PHD	0	None
43549	43550	fingers	0	None
43550	43551	of	0	None
43551	43552	AF10	1	GENE-Y
43552	43553	.	0	None

43554	43555	Although	0	None
43555	43556	this	0	None
43556	43557	domain	0	None
43557	43558	of	0	None
43558	43559	AF10	1	GENE-Y
43559	43560	is	0	None
43560	43561	the	0	None
43561	43562	most	0	None
43562	43563	conserved	0	None
43563	43564	region	0	None
43564	43565	of	0	None
43565	43566	the	0	None
43566	43567	protein	0	None
43567	43568	,	0	None
43568	43569	its	0	None
43569	43570	biological	0	None
43570	43571	significance	0	None
43571	43572	has	0	None
43572	43573	not	0	None
43573	43574	been	0	None
43574	43575	elucidated	0	None
43575	43576	.	0	None

43577	43578	In	0	None
43578	43579	this	0	None
43579	43580	study	0	None
43580	43581	,	0	None
43581	43582	we	0	None
43582	43583	used	0	None
43583	43584	genetic	0	None
43584	43585	and	0	None
43585	43586	biochemical	0	None
43586	43587	approaches	0	None
43587	43588	to	0	None
43588	43589	examine	0	None
43589	43590	the	0	None
43590	43591	PHD1-PHD2	0	None
43591	43592	region	0	None
43592	43593	of	0	None
43593	43594	the	0	None
43594	43595	Caenorhabditis	0	None
43595	43596	elegans	0	None
43596	43597	ortholog	0	None
43597	43598	of	0	None
43598	43599	AF10	1	GENE-Y
43599	43600	,	0	None
43600	43601	zinc	2	CHEMICAL
43601	43602	finger	0	None
43602	43603	protein	0	None
43603	43604	1	0	None
43604	43605	(	0	None
43605	43606	ZFP-1	1	GENE-Y
43606	43607	)	0	None
43607	43608	.	0	None

43609	43610	We	0	None
43610	43611	demonstrate	0	None
43611	43612	that	0	None
43612	43613	the	0	None
43613	43614	PHD1-PHD2	0	None
43614	43615	region	0	None
43615	43616	is	0	None
43616	43617	essential	0	None
43617	43618	for	0	None
43618	43619	viability	0	None
43619	43620	and	0	None
43620	43621	that	0	None
43621	43622	the	0	None
43622	43623	first	0	None
43623	43624	PHD	0	None
43624	43625	finger	0	None
43625	43626	contributes	0	None
43626	43627	to	0	None
43627	43628	the	0	None
43628	43629	preferred	0	None
43629	43630	binding	0	None
43630	43631	of	0	None
43631	43632	PHD1-PHD2	0	None
43632	43633	to	0	None
43633	43634	lysine	0	None
43634	43635	4-methylated	0	None
43635	43636	histone	0	None
43636	43637	H3	0	None
43637	43638	tails	0	None
43638	43639	.	0	None

43640	43641	Moreover	0	None
43641	43642	,	0	None
43642	43643	we	0	None
43643	43644	show	0	None
43644	43645	that	0	None
43645	43646	ZFP-1	1	GENE-Y
43646	43647	localization	0	None
43647	43648	peaks	0	None
43648	43649	overlap	0	None
43649	43650	with	0	None
43650	43651	H3K4	0	None
43651	43652	methylation-enriched	0	None
43652	43653	promoters	0	None
43653	43654	of	0	None
43654	43655	actively	0	None
43655	43656	expressed	0	None
43656	43657	genes	0	None
43657	43658	genomewide	0	None
43658	43659	and	0	None
43659	43660	that	0	None
43660	43661	H3K4	0	None
43661	43662	methylation	0	None
43662	43663	is	0	None
43663	43664	important	0	None
43664	43665	for	0	None
43665	43666	ZFP-1	1	GENE-Y
43666	43667	localization	0	None
43667	43668	to	0	None
43668	43669	promoters	0	None
43669	43670	in	0	None
43670	43671	the	0	None
43671	43672	embryo	0	None
43672	43673	.	0	None

43674	43675	We	0	None
43675	43676	predict	0	None
43676	43677	that	0	None
43677	43678	the	0	None
43678	43679	essential	0	None
43679	43680	biological	0	None
43680	43681	role	0	None
43681	43682	of	0	None
43682	43683	the	0	None
43683	43684	PHD1-PHD2	0	None
43684	43685	module	0	None
43685	43686	of	0	None
43686	43687	ZFP-1	1	GENE-Y
43687	43688	/	0	None
43688	43689	AF10	1	GENE-Y
43689	43690	is	0	None
43690	43691	connected	0	None
43691	43692	to	0	None
43692	43693	the	0	None
43693	43694	regulation	0	None
43694	43695	of	0	None
43695	43696	actively	0	None
43696	43697	expressed	0	None
43697	43698	genes	0	None
43698	43699	during	0	None
43699	43700	early	0	None
43700	43701	development	0	None
43701	43702	.	0	None
43702	43703	HR-MAS	0	None
43703	43704	NMR	0	None
43704	43705	Spectroscopy	0	None
43705	43706	of	0	None
43706	43707	Reconstructed	0	None
43707	43708	Human	0	None
43708	43709	Epidermis	0	None
43709	43710	:	0	None
43710	43711	Potential	0	None
43711	43712	for	0	None
43712	43713	the	0	None
43713	43714	in	0	None
43714	43715	Situ	0	None
43715	43716	Investigation	0	None
43716	43717	of	0	None
43717	43718	the	0	None
43718	43719	Chemical	0	None
43719	43720	Interactions	0	None
43720	43721	between	0	None
43721	43722	Skin	0	None
43722	43723	Allergens	0	None
43723	43724	and	0	None
43724	43725	Nucleophilic	0	None
43725	43726	Amino	0	None
43726	43727	Acids	0	None
43727	43728	.	0	None
43728	43729	Synthesis	0	None
43729	43730	of	0	None
43730	43731	C17-OH-north	0	None
43731	43732	unit	0	None
43732	43733	of	0	None
43733	43734	ritterazine	0	None
43734	43735	G	0	None
43735	43736	via	0	None
43736	43737	"Red-Ox"	0	None
43737	43738	modifications	0	None
43738	43739	of	0	None
43739	43740	hecogenin	0	None
43740	43741	acetate	0	None
43741	43742	.	0	None
43742	43743	In	0	None
43743	43744	this	0	None
43744	43745	study	0	None
43745	43746	,	0	None
43746	43747	the	0	None
43747	43748	in	0	None
43748	43749	vivo	0	None
43749	43750	effects	0	None
43750	43751	of	0	None
43751	43752	a	0	None
43752	43753	purified	0	None
43753	43754	saponin	0	None
43754	43755	mixture	0	None
43755	43756	(	0	None
43756	43757	PSM	0	None
43757	43758	)	0	None
43758	43759	,	0	None
43759	43760	obtained	0	None
43760	43761	from	0	None
43761	43762	Astragalus	0	None
43762	43763	corniculatus	0	None
43763	43764	Bieb	0	None
43764	43765	.	0	None

43766	43767	,	0	None
43767	43768	were	0	None
43768	43769	investigated	0	None
43769	43770	using	0	None
43770	43771	two	0	None
43771	43772	in	0	None
43772	43773	vivo	0	None
43773	43774	hepatotoxicity	0	None
43774	43775	models	0	None
43775	43776	based	0	None
43776	43777	on	0	None
43777	43778	liver	0	None
43778	43779	damage	0	None
43779	43780	caused	0	None
43780	43781	by	0	None
43781	43782	paracetamol	0	None
43782	43783	(	0	None
43783	43784	PC	1	GENE-Y
43784	43785	)	0	None
43785	43786	and	0	None
43786	43787	carbon	2	CHEMICAL
43787	43788	tetrachloride	0	None
43788	43789	(	0	None
43789	43790	CCl4	0	None
43790	43791	)	0	None
43791	43792	.	0	None

43793	43794	The	0	None
43794	43795	effects	0	None
43795	43796	of	0	None
43796	43797	PSM	0	None
43797	43798	were	0	None
43798	43799	compared	0	None
43799	43800	with	0	None
43800	43801	silymarin	0	None
43801	43802	.	0	None

43803	43804	Male	0	None
43804	43805	Wistar	0	None
43805	43806	rats	0	None
43806	43807	were	0	None
43807	43808	challenged	0	None
43808	43809	orally	0	None
43809	43810	with	0	None
43810	43811	20%	0	None
43811	43812	CCl4	0	None
43812	43813	or	0	None
43813	43814	PC	1	GENE-Y
43814	43815	(	0	None
43815	43816	2	0	None
43816	43817	g	0	None
43817	43818	/	0	None
43818	43819	kg	0	None
43819	43820	)	0	None
43820	43821	four	0	None
43821	43822	days	0	None
43822	43823	after	0	None
43823	43824	being	0	None
43824	43825	pre-treated	0	None
43825	43826	with	0	None
43826	43827	PSM	0	None
43827	43828	(	0	None
43828	43829	100	0	None
43829	43830	mg	2	CHEMICAL
43830	43831	/	0	None
43831	43832	kg	0	None
43832	43833	)	0	None
43833	43834	or	0	None
43834	43835	silymarin	0	None
43835	43836	(	0	None
43836	43837	200	0	None
43837	43838	mg	2	CHEMICAL
43838	43839	/	0	None
43839	43840	kg	0	None
43840	43841	)	0	None
43841	43842	.	0	None

43843	43844	A	0	None
43844	43845	significant	0	None
43845	43846	decrease	0	None
43846	43847	of	0	None
43847	43849	aspartate aminotransferase	1	GENE-Y
43849	43850	,	0	None
43850	43852	alanine aminotransferase	1	GENE-Y
43852	43853	,	0	None
43853	43854	lactate	0	None
43854	43855	dehydrogenase	0	None
43855	43856	(	0	None
43856	43857	LDH	0	None
43857	43858	)	0	None
43858	43859	activities	0	None
43859	43860	and	0	None
43860	43861	glutathione	0	None
43861	43862	(	0	None
43862	43863	GSH	0	None
43863	43864	)	0	None
43864	43865	levels	0	None
43865	43866	and	0	None
43866	43867	an	0	None
43867	43868	increase	0	None
43868	43869	of	0	None
43869	43870	malondialdehyde	2	CHEMICAL
43870	43871	(	0	None
43871	43872	MDA	0	None
43872	43873	)	0	None
43873	43874	quantity	0	None
43874	43875	was	0	None
43875	43876	observed	0	None
43876	43877	after	0	None
43877	43878	CCl4	0	None
43878	43879	and	0	None
43879	43880	PC	1	GENE-Y
43880	43881	administration	0	None
43881	43882	alone	0	None
43882	43883	.	0	None

43884	43885	PSM	0	None
43885	43886	pre-treatment	0	None
43886	43887	decreased	0	None
43887	43889	serum transaminases	3	GENE-N
43889	43890	and	0	None
43890	43891	LDH	0	None
43891	43892	activities	0	None
43892	43893	and	0	None
43893	43894	MDA	0	None
43894	43895	levels	0	None
43895	43896	and	0	None
43896	43897	increased	0	None
43897	43898	the	0	None
43898	43899	levels	0	None
43899	43900	of	0	None
43900	43901	cell	0	None
43901	43902	protector	0	None
43902	43903	GSH	0	None
43903	43904	.	0	None

43905	43906	Biotransformation	0	None
43906	43907	phase	0	None
43907	43908	I	0	None
43908	43909	enzymes	0	None
43909	43910	were	0	None
43910	43911	also	0	None
43911	43912	assessed	0	None
43912	43913	in	0	None
43913	43914	both	0	None
43914	43915	models	0	None
43915	43916	.	0	None

43917	43918	In	0	None
43918	43919	the	0	None
43919	43920	CCl4	0	None
43920	43921	hepatotoxicity	0	None
43921	43922	model	0	None
43922	43923	,	0	None
43923	43924	pre-treatment	0	None
43924	43925	with	0	None
43925	43926	PSM	0	None
43926	43927	or	0	None
43927	43928	silymarin	0	None
43928	43929	resulted	0	None
43929	43930	in	0	None
43930	43931	significantly	0	None
43931	43932	increased	0	None
43932	43933	activities	0	None
43933	43934	of	0	None
43934	43935	ethylmorphine-N-demethylase	0	None
43935	43936	and	0	None
43936	43937	aniline	0	None
43937	43938	4-hydroxylase	0	None
43938	43939	activity	0	None
43939	43940	and	0	None
43940	43941	cytochrome	3	GENE-N
43941	43942	P450	0	None
43942	43943	,	0	None
43943	43944	compared	0	None
43944	43945	to	0	None
43945	43946	the	0	None
43946	43947	CCl4	0	None
43947	43948	only	0	None
43948	43949	group	0	None
43949	43950	.	0	None

43951	43952	Neither	0	None
43952	43953	silymarin	0	None
43953	43954	nor	0	None
43954	43955	PSM	0	None
43955	43956	influenced	0	None
43956	43957	PC	1	GENE-Y
43957	43958	biotransformation	0	None
43958	43959	.	0	None

43960	43961	Our	0	None
43961	43962	results	0	None
43962	43963	suggest	0	None
43963	43964	that	0	None
43964	43965	PSM	0	None
43965	43966	,	0	None
43966	43967	obtained	0	None
43967	43968	from	0	None
43968	43969	A	0	None
43969	43970	.	0	None

43971	43972	corniculatus	0	None
43972	43973	,	0	None
43973	43974	Bieb	0	None
43974	43975	.	0	None

43976	43977	showed	0	None
43977	43978	in	0	None
43978	43979	vivo	0	None
43979	43980	hepatoprotective	0	None
43980	43981	and	0	None
43981	43982	antioxidant	0	None
43982	43983	activities	0	None
43983	43984	against	0	None
43984	43985	CCl4	0	None
43985	43986	and	0	None
43986	43987	PC-induced	0	None
43987	43988	liver	0	None
43988	43989	damage	0	None
43989	43990	comparable	0	None
43990	43991	to	0	None
43991	43992	that	0	None
43992	43993	of	0	None
43993	43994	silymarin	0	None
43994	43995	.	0	None

43996	43997	Copyright	0	None
43997	43998	©	0	None
43998	43999	2012	0	None
43999	44000	John	0	None
44000	44001	Wiley	0	None
44001	44002	&	0	None
44002	44003	Sons	0	None
44003	44004	,	0	None
44004	44005	Ltd	0	None
44005	44006	.	0	None
44006	44007	The	0	None
44007	44008	mechanism	0	None
44008	44009	(	0	None
44009	44010	s	0	None
44010	44011	)	0	None
44011	44012	responsible	0	None
44012	44013	for	0	None
44013	44014	arterial	0	None
44014	44015	vasodilation	0	None
44015	44016	observed	0	None
44016	44017	following	0	None
44017	44018	acute	0	None
44018	44019	administration	0	None
44019	44020	of	0	None
44020	44021	racemic	0	None
44021	44022	carvedilol	2	CHEMICAL
44022	44023	,	0	None
44023	44024	a	0	None
44024	44025	novel	0	None
44025	44026	vasodilator	0	None
44026	44027	/	0	None
44027	44028	beta	0	None
44028	44029	adrenoceptor	0	None
44029	44030	antagonist	0	None
44030	44031	,	0	None
44031	44032	has	0	None
44032	44033	been	0	None
44033	44034	investigated	0	None
44034	44035	in	0	None
44035	44036	rats	0	None
44036	44037	.	0	None

44038	44039	In	0	None
44039	44040	conscious	0	None
44040	44041	spontaneously	0	None
44041	44042	hypertensive	0	None
44042	44043	rats	0	None
44043	44044	,	0	None
44044	44045	carvedilol	2	CHEMICAL
44045	44046	(	0	None
44046	44047	0	0	None
44047	44048	.	0	None
44048	44049	03-3	0	None
44049	44050	.	0	None
44050	44051	0	0	None
44051	44052	mg	2	CHEMICAL
44052	44053	/	0	None
44053	44054	kg	0	None
44054	44055	,	0	None
44055	44056	iv	0	None
44056	44057	)	0	None
44057	44058	produced	0	None
44058	44059	a	0	None
44059	44060	dose-dependent	0	None
44060	44061	reduction	0	None
44061	44062	in	0	None
44062	44063	blood	0	None
44063	44064	pressure	0	None
44064	44065	with	0	None
44065	44066	no	0	None
44066	44067	significant	0	None
44067	44068	effect	0	None
44068	44069	on	0	None
44069	44070	heart	0	None
44070	44071	rate	0	None
44071	44072	.	0	None

44073	44074	Because	0	None
44074	44075	cardiac	0	None
44075	44076	output	0	None
44076	44077	was	0	None
44077	44078	relatively	0	None
44078	44079	unaffected	0	None
44079	44080	,	0	None
44080	44081	the	0	None
44081	44082	antihypertensive	0	None
44082	44083	response	0	None
44083	44084	of	0	None
44084	44085	carvedilol	2	CHEMICAL
44085	44086	was	0	None
44086	44087	associated	0	None
44087	44088	with	0	None
44088	44089	a	0	None
44089	44090	dose-dependent	0	None
44090	44091	reduction	0	None
44091	44092	in	0	None
44092	44093	total	0	None
44093	44094	peripheral	0	None
44094	44095	vascular	0	None
44095	44096	resistance	0	None
44096	44097	.	0	None

44098	44099	Submaximal	0	None
44099	44100	antihypertensive	0	None
44100	44101	doses	0	None
44101	44102	of	0	None
44102	44103	carvedilol	2	CHEMICAL
44103	44104	were	0	None
44104	44105	chosen	0	None
44105	44106	for	0	None
44106	44107	mechanism	0	None
44107	44108	of	0	None
44108	44109	action	0	None
44109	44110	studies	0	None
44110	44111	in	0	None
44111	44112	pithed	0	None
44112	44113	rats	0	None
44113	44114	.	0	None

44115	44116	Carvedilol	0	None
44116	44117	(	0	None
44117	44118	0	0	None
44118	44119	.	0	None
44119	44120	3	0	None
44120	44121	mg	2	CHEMICAL
44121	44122	/	0	None
44122	44123	kg	0	None
44123	44124	,	0	None
44124	44125	iv	0	None
44125	44126	)	0	None
44126	44127	produced	0	None
44127	44128	a	0	None
44128	44129	significant	0	None
44129	44130	inhibition	0	None
44130	44131	of	0	None
44131	44132	the	0	None
44132	44135	beta 1 adrenoceptor	3	GENE-N
44135	44136	mediated	0	None
44136	44137	positive	0	None
44137	44138	chronotropic	0	None
44138	44139	response	0	None
44139	44140	to	0	None
44140	44141	isoproterenol	0	None
44141	44142	.	0	None

44143	44144	This	0	None
44144	44145	same	0	None
44145	44146	dose	0	None
44146	44147	of	0	None
44147	44148	carvedilol	2	CHEMICAL
44148	44149	also	0	None
44149	44150	inhibited	0	None
44150	44151	,	0	None
44151	44152	but	0	None
44152	44153	to	0	None
44153	44154	a	0	None
44154	44155	lesser	0	None
44155	44156	degree	0	None
44156	44157	,	0	None
44157	44158	the	0	None
44158	44161	beta 2 adrenoceptor	1	GENE-Y
44161	44162	mediated	0	None
44162	44163	vasodepressor	0	None
44163	44164	response	0	None
44164	44165	to	0	None
44165	44166	salbutamol	0	None
44166	44167	in	0	None
44167	44168	pithed	0	None
44168	44169	rats	0	None
44169	44170	whose	0	None
44170	44171	blood	0	None
44171	44172	pressure	0	None
44172	44173	was	0	None
44173	44174	elevated	0	None
44174	44175	by	0	None
44175	44176	a	0	None
44176	44177	constant	0	None
44177	44178	intravenous	0	None
44178	44179	infusion	0	None
44179	44180	of	0	None
44180	44181	angiotensin	2	CHEMICAL
44181	44182	II	0	None
44182	44183	.	0	None

44184	44185	Thus	0	None
44185	44186	,	0	None
44186	44187	carvedilol	2	CHEMICAL
44187	44188	blocks	0	None
44188	44189	both	0	None
44189	44190	beta	0	None
44190	44191	1	0	None
44191	44192	and	0	None
44192	44195	beta 2 adrenoceptors	3	GENE-N
44195	44196	at	0	None
44196	44197	antihypertensive	0	None
44197	44198	doses	0	None
44198	44199	,	0	None
44199	44200	with	0	None
44200	44201	modest	0	None
44201	44202	selectivity	0	None
44202	44203	being	0	None
44203	44204	observed	0	None
44204	44205	for	0	None
44205	44206	the	0	None
44206	44209	beta 1 adrenoceptor	3	GENE-N
44209	44210	subtype	0	None
44210	44211	.	0	None

44212	44213	Carvedilol	0	None
44213	44214	produced	0	None
44214	44215	significant	0	None
44215	44216	inhibition	0	None
44216	44217	of	0	None
44217	44218	the	0	None
44218	44219	alpha	0	None
44219	44220	1	0	None
44220	44221	adrenoceptor	0	None
44221	44222	mediated	0	None
44222	44223	pressor	0	None
44223	44224	response	0	None
44224	44225	to	0	None
44225	44226	cirazoline	0	None
44226	44227	in	0	None
44227	44228	the	0	None
44228	44229	pithed	0	None
44229	44230	rat	0	None
44230	44231	,	0	None
44231	44232	but	0	None
44232	44233	had	0	None
44233	44234	no	0	None
44234	44235	effect	0	None
44235	44236	on	0	None
44236	44237	the	0	None
44237	44238	alpha	0	None
44238	44239	2	0	None
44239	44240	adrenoceptor	0	None
44240	44241	mediated	0	None
44241	44242	pressor	0	None
44242	44243	response	0	None
44243	44244	to	0	None
44244	44245	B-HT	0	None
44245	44246	933	0	None
44246	44247	,	0	None
44247	44248	suggesting	0	None
44248	44249	that	0	None
44249	44250	carvedilol	2	CHEMICAL
44250	44251	is	0	None
44251	44252	also	0	None
44252	44253	an	0	None
44253	44254	alpha	0	None
44254	44255	1	0	None
44255	44256	adrenoceptor	0	None
44256	44257	antagonist	0	None
44257	44258	at	0	None
44258	44259	antihypertensive	0	None
44259	44260	doses	0	None
44260	44261	.	0	None

44262	44263	Carvedilol	0	None
44263	44264	had	0	None
44264	44265	no	0	None
44265	44266	effect	0	None
44266	44267	on	0	None
44267	44268	the	0	None
44268	44269	pressor	0	None
44269	44270	response	0	None
44270	44271	elicited	0	None
44271	44272	by	0	None
44272	44273	angiotensin	2	CHEMICAL
44273	44274	II	0	None
44274	44275	,	0	None
44275	44276	indicating	0	None
44276	44277	a	0	None
44277	44278	lack	0	None
44278	44279	of	0	None
44279	44280	nonspecific	0	None
44280	44281	vasodilator	0	None
44281	44282	activity	0	None
44282	44283	.	0	None

44284	44285	The	0	None
44285	44286	vasopressor	0	None
44286	44287	response	0	None
44287	44288	to	0	None
44288	44289	the	0	None
44289	44290	calcium	0	None
44290	44291	channel	0	None
44291	44292	activator	0	None
44292	44293	,	0	None
44293	44294	BAY-K-8644	0	None
44294	44295	,	0	None
44295	44296	which	0	None
44296	44297	is	0	None
44297	44298	mediated	0	None
44298	44299	through	0	None
44299	44300	the	0	None
44300	44301	opening	0	None
44301	44302	of	0	None
44302	44303	voltage	0	None
44303	44304	dependent	0	None
44304	44305	calcium	0	None
44305	44306	channels	0	None
44306	44307	and	0	None
44307	44308	the	0	None
44308	44309	subsequent	0	None
44309	44310	translocation	0	None
44310	44311	of	0	None
44311	44312	extracellular	0	None
44312	44313	calcium	0	None
44313	44314	,	0	None
44314	44315	was	0	None
44315	44316	significantly	0	None
44316	44317	inhibited	0	None
44317	44318	by	0	None
44318	44319	carvedilol	2	CHEMICAL
44319	44320	(	0	None
44320	44321	1	0	None
44321	44322	mg	2	CHEMICAL
44322	44323	/	0	None
44323	44324	kg	0	None
44324	44325	,	0	None
44325	44326	iv	0	None
44326	44327	)	0	None
44327	44328	,	0	None
44328	44329	suggesting	0	None
44329	44330	that	0	None
44330	44331	carvedilol	2	CHEMICAL
44331	44332	is	0	None
44332	44333	also	0	None
44333	44334	a	0	None
44334	44335	calcium	0	None
44335	44336	channel	0	None
44336	44337	antagonist	0	None
44337	44338	,	0	None
44338	44339	consistent	0	None
44339	44340	with	0	None
44340	44341	our	0	None
44341	44342	previous	0	None
44342	44343	in	0	None
44343	44344	vitro	0	None
44344	44345	studies	0	None
44345	44346	.	0	None

44347	44348	In	0	None
44348	44349	anesthetized	0	None
44349	44350	spontaneously	0	None
44350	44351	hypertensive	0	None
44351	44352	rats	0	None
44352	44353	,	0	None
44353	44354	the	0	None
44354	44355	antihypertensive	0	None
44355	44356	activity	0	None
44356	44357	of	0	None
44357	44358	carvedilol	2	CHEMICAL
44358	44359	was	0	None
44359	44360	nearly	0	None
44360	44361	abolished	0	None
44361	44362	by	0	None
44362	44363	combined	0	None
44363	44364	pretreatment	0	None
44364	44365	of	0	None
44365	44366	the	0	None
44366	44367	rats	0	None
44367	44368	with	0	None
44368	44369	high	0	None
44369	44370	doses	0	None
44370	44371	of	0	None
44371	44372	the	0	None
44372	44373	alpha	0	None
44373	44374	1	0	None
44374	44375	adrenoceptor	0	None
44375	44376	antagonist	0	None
44376	44377	,	0	None
44377	44378	prazosin	2	CHEMICAL
44378	44379	(	0	None
44379	44380	1	0	None
44380	44381	mg	2	CHEMICAL
44381	44382	/	0	None
44382	44383	kg	0	None
44383	44384	,	0	None
44384	44385	iv	0	None
44385	44386	)	0	None
44386	44387	,	0	None
44387	44388	and	0	None
44388	44389	the	0	None
44389	44390	nonselective	0	None
44390	44391	beta	0	None
44391	44392	adrenoceptor	0	None
44392	44393	antagonist	0	None
44393	44394	,	0	None
44394	44395	propranolol	0	None
44395	44396	(	0	None
44396	44397	3	0	None
44397	44398	mg	2	CHEMICAL
44398	44399	/	0	None
44399	44400	kg	0	None
44400	44401	,	0	None
44401	44402	iv	0	None
44402	44403	)	0	None
44403	44404	,	0	None
44404	44405	suggesting	0	None
44405	44406	that	0	None
44406	44407	the	0	None
44407	44408	majority	0	None
44408	44409	of	0	None
44409	44410	the	0	None
44410	44411	antihypertensive	0	None
44411	44412	response	0	None
44412	44413	produced	0	None
44413	44414	by	0	None
44414	44415	carvedilol	2	CHEMICAL
44415	44416	may	0	None
44416	44417	be	0	None
44417	44418	accounted	0	None
44418	44419	for	0	None
44419	44420	by	0	None
44420	44421	blockade	0	None
44421	44422	of	0	None
44422	44427	beta and alpha 1 adrenoceptors	3	GENE-N
44427	44428	.	0	None

44429	44430	We	0	None
44430	44431	therefore	0	None
44431	44432	conclude	0	None
44432	44433	that	0	None
44433	44434	carvedilol	2	CHEMICAL
44434	44435	,	0	None
44435	44436	at	0	None
44436	44437	antihypertensive	0	None
44437	44438	doses	0	None
44438	44439	,	0	None
44439	44440	is	0	None
44440	44441	an	0	None
44441	44442	antagonist	0	None
44442	44443	of	0	None
44443	44444	beta	0	None
44444	44445	1	0	None
44445	44446	,	0	None
44446	44447	beta	0	None
44447	44448	2	0	None
44448	44449	,	0	None
44449	44450	and	0	None
44450	44451	alpha	0	None
44451	44452	1	0	None
44452	44453	adrenoceptors	3	GENE-N
44453	44454	,	0	None
44454	44455	and	0	None
44455	44456	also	0	None
44456	44457	of	0	None
44457	44458	calcium	0	None
44458	44459	channels	0	None
44459	44460	in	0	None
44460	44461	vascular	0	None
44461	44462	smooth	0	None
44462	44463	muscle	0	None
44463	44464	.	0	None

44465	44466	(	0	None
44466	44467	ABSTRACT	0	None
44467	44468	TRUNCATED	0	None
44468	44469	AT	0	None
44469	44470	400	0	None
44470	44471	WORDS	0	None
44471	44472	)	0	None
44472	44473	Drug-protein	0	None
44473	44474	interactions	0	None
44474	44475	:	0	None
44475	44476	isolation	0	None
44476	44477	and	0	None
44477	44478	characterization	0	None
44478	44479	of	0	None
44479	44480	covalent	0	None
44480	44481	adducts	0	None
44481	44482	of	0	None
44482	44483	phenoxybenzamine	0	None
44483	44484	and	0	None
44484	44485	calmodulin	0	None
44485	44486	.	0	None
44486	44487	Lipoxin	0	None
44487	44488	A4	0	None
44488	44489	(	0	None
44489	44490	LXA4	0	None
44490	44491	)	0	None
44491	44492	has	0	None
44492	44493	been	0	None
44493	44494	described	0	None
44494	44495	as	0	None
44495	44496	an	0	None
44496	44497	anti-inflammatory	0	None
44497	44498	mediator	0	None
44498	44499	,	0	None
44499	44500	which	0	None
44500	44501	exerts	0	None
44501	44502	its	0	None
44502	44503	effects	0	None
44503	44504	through	0	None
44504	44505	the	0	None
44505	44506	formyl	0	None
44506	44507	peptide	0	None
44507	44508	receptor	0	None
44508	44509	FPR2	1	GENE-Y
44509	44510	,	0	None
44510	44511	also	0	None
44511	44512	known	0	None
44512	44513	as	0	None
44513	44514	ALX	0	None
44514	44515	.	0	None

44516	44517	However	0	None
44517	44518	,	0	None
44518	44519	there	0	None
44519	44520	has	0	None
44520	44521	been	0	None
44521	44522	a	0	None
44522	44523	controversy	0	None
44523	44524	whether	0	None
44524	44525	or	0	None
44525	44526	not	0	None
44526	44527	cells	0	None
44527	44528	expressing	0	None
44528	44529	FPR2	1	GENE-Y
44529	44530	/	0	None
44530	44531	ALX	0	None
44531	44532	,	0	None
44532	44533	such	0	None
44533	44534	as	0	None
44534	44535	neutrophils	0	None
44535	44536	,	0	None
44536	44537	respond	0	None
44537	44538	to	0	None
44538	44539	LXA4	0	None
44539	44540	.	0	None

44541	44542	We	0	None
44542	44543	,	0	None
44543	44544	therefore	0	None
44544	44545	,	0	None
44545	44546	systematically	0	None
44546	44547	examined	0	None
44547	44548	the	0	None
44548	44549	ability	0	None
44549	44550	of	0	None
44550	44551	the	0	None
44551	44552	human	0	None
44552	44553	and	0	None
44553	44554	murine	0	None
44554	44555	forms	0	None
44555	44556	of	0	None
44556	44557	the	0	None
44557	44558	receptor	0	None
44558	44559	to	0	None
44559	44560	respond	0	None
44560	44561	to	0	None
44561	44562	LXA4	0	None
44562	44563	.	0	None

44564	44565	We	0	None
44565	44566	show	0	None
44566	44567	that	0	None
44567	44568	both	0	None
44568	44569	receptor	0	None
44569	44570	orthologues	0	None
44570	44571	responded	0	None
44571	44572	to	0	None
44572	44573	the	0	None
44573	44574	FPR2	1	GENE-Y
44574	44575	/	0	None
44575	44576	ALX	0	None
44576	44577	peptide	0	None
44577	44578	agonist	0	None
44578	44579	WKYMVM	0	None
44579	44580	when	0	None
44580	44581	expressed	0	None
44581	44582	heterologously	0	None
44582	44583	.	0	None

44584	44585	In	0	None
44585	44586	contrast	0	None
44586	44587	,	0	None
44587	44588	LXA4	0	None
44588	44589	from	0	None
44589	44590	different	0	None
44590	44591	sources	0	None
44591	44592	neither	0	None
44592	44593	increased	0	None
44593	44594	[	0	None
44594	44595	Ca	0	None
44595	44596	(	0	None
44596	44597	2	0	None
44597	44598	+	0	None
44598	44599	)	0	None
44599	44600	]	0	None
44600	44601	i	0	None
44601	44602	and	0	None
44602	44603	extracellular-signal-regulated	0	None
44603	44604	kinase	0	None
44604	44605	(	0	None
44605	44606	ERK	0	None
44606	44607	)	0	None
44607	44608	phosphorylation	0	None
44608	44609	,	0	None
44609	44610	nor	0	None
44610	44611	did	0	None
44611	44612	it	0	None
44612	44613	induce	0	None
44613	44614	a	0	None
44614	44615	decrease	0	None
44615	44616	in	0	None
44616	44617	cAMP	0	None
44617	44618	levels	0	None
44618	44619	or	0	None
44619	44620	a	0	None
44620	44621	translocation	0	None
44621	44622	of	0	None
44622	44623	β-arrestin	0	None
44623	44624	.	0	None

44625	44626	Also	0	None
44626	44627	,	0	None
44627	44628	several	0	None
44628	44629	LXA4	0	None
44629	44630	analogues	0	None
44630	44631	were	0	None
44631	44632	found	0	None
44632	44633	to	0	None
44633	44634	be	0	None
44634	44635	unable	0	None
44635	44636	to	0	None
44636	44637	signal	0	None
44637	44638	through	0	None
44638	44639	FPR2	1	GENE-Y
44639	44640	/	0	None
44640	44641	ALX	0	None
44641	44642	.	0	None

44643	44644	We	0	None
44644	44645	conclude	0	None
44645	44646	that	0	None
44646	44647	FPR2	1	GENE-Y
44647	44648	/	0	None
44648	44649	ALX	0	None
44649	44650	is	0	None
44650	44651	not	0	None
44651	44652	activated	0	None
44652	44653	by	0	None
44653	44654	LXA4	0	None
44654	44655	and	0	None
44655	44656	that	0	None
44656	44657	the	0	None
44657	44658	molecular	0	None
44658	44659	mechanism	0	None
44659	44660	by	0	None
44660	44661	which	0	None
44661	44662	LXA4	0	None
44662	44663	functions	0	None
44663	44664	still	0	None
44664	44665	needs	0	None
44665	44666	to	0	None
44666	44667	be	0	None
44667	44668	identified	0	None
44668	44669	.	0	None
44669	44670	Non-steroidal	0	None
44670	44671	anti-inflammatory	0	None
44671	44672	drugs	0	None
44672	44673	(	0	None
44673	44674	NSAIDs	0	None
44674	44675	)	0	None
44675	44676	are	0	None
44676	44677	competitive	0	None
44677	44678	inhibitors	0	None
44678	44679	of	0	None
44679	44680	cyclooxygenase	3	GENE-N
44680	44681	(	0	None
44681	44682	COX	3	GENE-N
44682	44683	)	0	None
44683	44684	,	0	None
44684	44685	the	0	None
44685	44686	enzyme	0	None
44686	44687	that	0	None
44687	44688	mediates	0	None
44688	44689	biosynthesis	0	None
44689	44690	of	0	None
44690	44691	prostaglandins	2	CHEMICAL
44691	44692	and	0	None
44692	44693	thromboxanes	0	None
44693	44694	from	0	None
44694	44695	arachidonic	0	None
44695	44696	acid	0	None
44696	44697	.	0	None

44698	44699	There	0	None
44699	44700	are	0	None
44700	44701	at	0	None
44701	44702	least	0	None
44702	44703	two	0	None
44703	44704	different	0	None
44704	44705	isoforms	0	None
44705	44706	of	0	None
44706	44707	the	0	None
44707	44708	enzyme	0	None
44708	44709	known	0	None
44709	44710	as	0	None
44710	44711	COX-1	1	GENE-Y
44711	44712	and	0	None
44712	44713	-2	0	None
44713	44714	.	0	None

44715	44716	Site	0	None
44716	44717	directed	0	None
44717	44718	mutagenesis	0	None
44718	44719	studies	0	None
44719	44720	suggest	0	None
44720	44721	that	0	None
44721	44722	non-selective	0	None
44722	44723	COX	3	GENE-N
44723	44724	inhibitors	0	None
44724	44725	of	0	None
44725	44726	diverse	0	None
44726	44727	chemical	0	None
44727	44728	families	0	None
44728	44729	exhibit	0	None
44729	44730	differential	0	None
44730	44731	binding	0	None
44731	44732	modes	0	None
44732	44733	to	0	None
44733	44734	the	0	None
44734	44735	two	0	None
44735	44736	isozymes	0	None
44736	44737	.	0	None

44738	44739	These	0	None
44739	44740	results	0	None
44740	44741	cannot	0	None
44741	44742	clearly	0	None
44742	44743	be	0	None
44743	44744	explained	0	None
44744	44745	from	0	None
44745	44746	the	0	None
44746	44747	sole	0	None
44747	44748	analysis	0	None
44748	44749	of	0	None
44749	44750	the	0	None
44750	44751	crystal	0	None
44751	44752	structures	0	None
44752	44753	of	0	None
44753	44754	COX	3	GENE-N
44754	44755	available	0	None
44755	44756	from	0	None
44756	44757	X-ray	0	None
44757	44758	diffraction	0	None
44758	44759	studies	0	None
44759	44760	.	0	None

44761	44762	With	0	None
44762	44763	the	0	None
44763	44764	aim	0	None
44764	44765	to	0	None
44765	44766	elucidate	0	None
44766	44767	the	0	None
44767	44768	structural	0	None
44768	44769	features	0	None
44769	44770	governing	0	None
44770	44771	the	0	None
44771	44772	differential	0	None
44772	44773	inhibitory	0	None
44773	44774	binding	0	None
44774	44775	behavior	0	None
44775	44776	of	0	None
44776	44777	these	0	None
44777	44778	inhibitors	0	None
44778	44779	,	0	None
44779	44780	molecular	0	None
44780	44781	modeling	0	None
44781	44782	studies	0	None
44782	44783	were	0	None
44783	44784	undertaken	0	None
44784	44785	to	0	None
44785	44786	generate	0	None
44786	44787	atomic	0	None
44787	44788	models	0	None
44788	44789	compatible	0	None
44789	44790	with	0	None
44790	44791	the	0	None
44791	44792	experimental	0	None
44792	44793	data	0	None
44793	44794	available	0	None
44794	44795	.	0	None

44796	44797	Accordingly	0	None
44797	44798	,	0	None
44798	44799	docking	0	None
44799	44800	of	0	None
44800	44801	different	0	None
44801	44802	COX	3	GENE-N
44802	44803	inhibitors	0	None
44803	44804	,	0	None
44804	44805	including	0	None
44805	44806	selective	0	None
44806	44807	and	0	None
44807	44808	non-selective	0	None
44808	44809	ligands	0	None
44809	44810	:	0	None
44810	44811	rofecoxib	0	None
44811	44812	,	0	None
44812	44813	ketoprofen	0	None
44813	44814	,	0	None
44814	44815	suprofen	0	None
44815	44816	,	0	None
44816	44817	carprofen	0	None
44817	44818	,	0	None
44818	44819	zomepirac	0	None
44819	44820	,	0	None
44820	44821	indomethacin	0	None
44821	44822	,	0	None
44822	44823	diclofenac	0	None
44823	44824	and	0	None
44824	44826	meclofenamic acid	2	CHEMICAL
44826	44827	were	0	None
44827	44828	undertaken	0	None
44828	44829	using	0	None
44829	44830	the	0	None
44830	44831	AMBER	0	None
44831	44832	program	0	None
44832	44833	.	0	None

44834	44835	The	0	None
44835	44836	results	0	None
44836	44837	of	0	None
44837	44838	the	0	None
44838	44839	present	0	None
44839	44840	study	0	None
44840	44841	provide	0	None
44841	44842	new	0	None
44842	44843	insights	0	None
44843	44844	into	0	None
44844	44845	a	0	None
44845	44846	better	0	None
44846	44847	understanding	0	None
44847	44848	of	0	None
44848	44849	the	0	None
44849	44850	differential	0	None
44850	44851	binding	0	None
44851	44852	mode	0	None
44852	44853	of	0	None
44853	44854	diverse	0	None
44854	44855	families	0	None
44855	44856	of	0	None
44856	44857	COX	3	GENE-N
44857	44858	inhibitors	0	None
44858	44859	,	0	None
44859	44860	and	0	None
44860	44861	are	0	None
44861	44862	expected	0	None
44862	44863	to	0	None
44863	44864	contribute	0	None
44864	44865	to	0	None
44865	44866	the	0	None
44866	44867	design	0	None
44867	44868	of	0	None
44868	44869	new	0	None
44869	44870	selective	0	None
44870	44871	compounds	0	None
44871	44872	.	0	None
44872	44873	Neuronal	0	None
44873	44874	nicotinic	0	None
44874	44875	receptors	0	None
44875	44876	are	0	None
44876	44879	ligand-gated ion channels	3	GENE-N
44879	44880	of	0	None
44880	44881	the	0	None
44881	44882	central	0	None
44882	44883	and	0	None
44883	44884	peripheral	0	None
44884	44885	central	0	None
44885	44886	nervous	0	None
44886	44887	system	0	None
44887	44888	that	0	None
44888	44889	regulate	0	None
44889	44890	synaptic	0	None
44890	44891	activity	0	None
44891	44892	from	0	None
44892	44893	both	0	None
44893	44894	pre-	0	None
44894	44895	and	0	None
44895	44896	postsynaptic	0	None
44896	44897	sites	0	None
44897	44898	.	0	None

44899	44900	The	0	None
44900	44901	present	0	None
44901	44902	study	0	None
44902	44903	establishes	0	None
44903	44904	the	0	None
44904	44905	acute	0	None
44905	44906	interaction	0	None
44906	44907	of	0	None
44907	44908	bupropion	0	None
44908	44909	,	0	None
44909	44910	an	0	None
44910	44911	antidepressant	0	None
44911	44912	agent	0	None
44912	44913	that	0	None
44913	44914	is	0	None
44914	44915	also	0	None
44915	44916	effective	0	None
44916	44917	in	0	None
44917	44918	nicotine	0	None
44918	44919	dependence	0	None
44919	44920	,	0	None
44920	44921	with	0	None
44921	44922	nicotine	0	None
44922	44923	and	0	None
44923	44924	nicotinic	0	None
44924	44925	receptors	0	None
44925	44926	using	0	None
44926	44927	different	0	None
44927	44928	in	0	None
44928	44929	vivo	0	None
44929	44930	and	0	None
44930	44931	in	0	None
44931	44932	vitro	0	None
44932	44933	tests	0	None
44933	44934	.	0	None

44935	44936	Bupropion	0	None
44936	44937	was	0	None
44937	44938	found	0	None
44938	44939	to	0	None
44939	44940	block	0	None
44940	44941	nicotine's	0	None
44941	44942	antinociception	0	None
44942	44943	(	0	None
44943	44944	in	0	None
44944	44945	two	0	None
44945	44946	tests	0	None
44946	44947	)	0	None
44947	44948	,	0	None
44948	44949	motor	0	None
44949	44950	effects	0	None
44950	44951	,	0	None
44951	44952	hypothermia	0	None
44952	44953	,	0	None
44953	44954	and	0	None
44954	44955	convulsive	0	None
44955	44956	effects	0	None
44956	44957	with	0	None
44957	44958	different	0	None
44958	44959	potencies	0	None
44959	44960	in	0	None
44960	44961	the	0	None
44961	44962	present	0	None
44962	44963	investigation	0	None
44963	44964	,	0	None
44964	44965	suggesting	0	None
44965	44966	that	0	None
44966	44967	bupropion	0	None
44967	44968	possesses	0	None
44968	44969	some	0	None
44969	44970	selectivity	0	None
44970	44971	for	0	None
44971	44972	neuronal	0	None
44972	44973	nicotinic	0	None
44973	44974	receptors	0	None
44974	44975	underlying	0	None
44975	44976	these	0	None
44976	44977	various	0	None
44977	44978	nicotinic	0	None
44978	44979	effects	0	None
44979	44980	.	0	None

44981	44982	In	0	None
44982	44983	addition	0	None
44983	44984	,	0	None
44984	44985	bupropion	0	None
44985	44986	blocks	0	None
44986	44987	nicotine	0	None
44987	44988	activation	0	None
44988	44989	of	0	None
44989	44990	alpha	0	None
44990	44991	(	0	None
44991	44992	3	0	None
44992	44993	)	0	None
44993	44994	beta	0	None
44994	44995	(	0	None
44995	44996	2	0	None
44996	44997	)	0	None
44997	44998	,	0	None
44998	44999	alpha	0	None
44999	45000	(	0	None
45000	45001	4	0	None
45001	45002	)	0	None
45002	45003	beta	0	None
45003	45004	(	0	None
45004	45005	2	0	None
45005	45006	)	0	None
45006	45007	,	0	None
45007	45008	and	0	None
45008	45009	alpha	0	None
45009	45010	(	0	None
45010	45011	7	0	None
45011	45012	)	0	None
45012	45013	neuronal	0	None
45013	45015	acetylcholine nicotinic	0	None
45015	45016	receptors	0	None
45016	45017	(	0	None
45017	45018	nAChRs	0	None
45018	45019	)	0	None
45019	45020	with	0	None
45020	45021	some	0	None
45021	45022	degree	0	None
45022	45023	of	0	None
45023	45024	selectivity	0	None
45024	45025	.	0	None

45026	45027	It	0	None
45027	45028	was	0	None
45028	45029	approximately	0	None
45029	45030	50	0	None
45030	45031	and	0	None
45031	45032	12	0	None
45032	45033	times	0	None
45033	45034	more	0	None
45034	45035	effective	0	None
45035	45036	in	0	None
45036	45037	blocking	0	None
45037	45038	alpha	0	None
45038	45039	(	0	None
45039	45040	3	0	None
45040	45041	)	0	None
45041	45042	beta	0	None
45042	45043	(	0	None
45043	45044	2	0	None
45044	45045	)	0	None
45045	45046	and	0	None
45046	45047	alpha	0	None
45047	45048	(	0	None
45048	45049	4	0	None
45049	45050	)	0	None
45050	45051	beta	0	None
45051	45052	(	0	None
45052	45053	2	0	None
45053	45054	)	0	None
45054	45055	than	0	None
45055	45056	alpha	0	None
45056	45057	(	0	None
45057	45058	7	0	None
45058	45059	.	0	None

45060	45061	)	0	None
45061	45062	This	0	None
45062	45063	functional	0	None
45063	45064	blockade	0	None
45064	45065	was	0	None
45065	45066	noncompetitive	0	None
45066	45067	,	0	None
45067	45068	because	0	None
45068	45069	it	0	None
45069	45070	was	0	None
45070	45071	insurmountable	0	None
45071	45072	by	0	None
45072	45073	increasing	0	None
45073	45074	concentration	0	None
45074	45075	of	0	None
45075	45076	ACh	0	None
45076	45077	in	0	None
45077	45078	the	0	None
45078	45079	nAChRs	0	None
45079	45080	subtypes	0	None
45080	45081	tested	0	None
45081	45082	.	0	None

45083	45084	Furthermore	0	None
45084	45085	,	0	None
45085	45086	bupropion	0	None
45086	45087	at	0	None
45087	45088	high	0	None
45088	45089	concentration	0	None
45089	45090	failed	0	None
45090	45091	to	0	None
45091	45092	displace	0	None
45092	45093	brain	0	None
45093	45094	[	0	None
45094	45095	(	0	None
45095	45096	3	0	None
45096	45097	)	0	None
45097	45098	H	0	None
45098	45099	]	0	None
45099	45100	nicotine	0	None
45100	45101	binding	0	None
45101	45102	sites	0	None
45102	45103	,	0	None
45103	45104	a	0	None
45104	45105	site	0	None
45105	45106	largely	0	None
45106	45107	composed	0	None
45107	45108	of	0	None
45108	45109	alpha	0	None
45109	45110	(	0	None
45110	45111	4	0	None
45111	45112	)	0	None
45112	45113	beta	0	None
45113	45114	(	0	None
45114	45115	2	0	None
45115	45116	)	0	None
45116	45117	subunit	0	None
45117	45118	combination	0	None
45118	45119	.	0	None

45120	45121	Given	0	None
45121	45122	the	0	None
45122	45123	observation	0	None
45123	45124	that	0	None
45124	45125	bupropion	0	None
45125	45126	inhibition	0	None
45126	45127	of	0	None
45127	45128	alpha	0	None
45128	45129	(	0	None
45129	45130	3	0	None
45130	45131	)	0	None
45131	45132	beta	0	None
45132	45133	(	0	None
45133	45134	2	0	None
45134	45135	)	0	None
45135	45136	and	0	None
45136	45137	alpha	0	None
45137	45138	(	0	None
45138	45139	4	0	None
45139	45140	)	0	None
45140	45141	beta	0	None
45141	45142	(	0	None
45142	45143	2	0	None
45143	45144	)	0	None
45144	45145	receptors	0	None
45145	45146	exhibits	0	None
45146	45147	voltage-independence	0	None
45147	45148	properties	0	None
45148	45149	,	0	None
45149	45150	bupropion	0	None
45150	45151	may	0	None
45151	45152	not	0	None
45152	45153	be	0	None
45153	45154	acting	0	None
45154	45155	as	0	None
45155	45156	an	0	None
45156	45157	open	0	None
45157	45158	channel	0	None
45158	45159	blocker	0	None
45159	45160	.	0	None

45161	45162	These	0	None
45162	45163	effects	0	None
45163	45164	may	0	None
45164	45165	explain	0	None
45165	45166	in	0	None
45166	45167	part	0	None
45167	45168	bupropion's	0	None
45168	45169	efficacy	0	None
45169	45170	in	0	None
45170	45171	nicotine	0	None
45171	45172	dependence	0	None
45172	45173	.	0	None

45174	45175	Our	0	None
45175	45176	present	0	None
45176	45177	findings	0	None
45177	45178	suggest	0	None
45178	45179	that	0	None
45179	45180	functional	0	None
45180	45181	blockade	0	None
45181	45182	of	0	None
45182	45183	neuronal	0	None
45183	45184	nAChRs	0	None
45184	45185	are	0	None
45185	45186	useful	0	None
45186	45187	in	0	None
45187	45188	nicotine	0	None
45188	45189	dependence	0	None
45189	45190	treatment	0	None
45190	45191	.	0	None
45191	45192	Saturable	0	None
45192	45193	active	0	None
45193	45194	efflux	0	None
45194	45195	by	0	None
45195	45196	p-glycoprotein	3	GENE-N
45196	45197	and	0	None
45197	45198	breast	0	None
45198	45199	cancer	0	None
45199	45200	resistance	0	None
45200	45201	protein	0	None
45201	45202	at	0	None
45202	45203	the	0	None
45203	45204	blood-brain	0	None
45204	45205	barrier	0	None
45205	45206	leads	0	None
45206	45207	to	0	None
45207	45208	nonlinear	0	None
45208	45209	distribution	0	None
45209	45210	of	0	None
45210	45211	elacridar	2	CHEMICAL
45211	45212	to	0	None
45212	45213	the	0	None
45213	45214	central	0	None
45214	45215	nervous	0	None
45215	45216	system	0	None
45216	45217	.	0	None
45217	45218	Pharmacodynamic	0	None
45218	45219	profile	0	None
45219	45220	of	0	None
45220	45221	the	0	None
45221	45222	direct	0	None
45222	45223	thrombin	0	None
45223	45224	antagonist	0	None
45224	45225	bivalirudin	0	None
45225	45226	given	0	None
45226	45227	in	0	None
45227	45228	combination	0	None
45228	45229	with	0	None
45229	45230	the	0	None
45230	45231	glycoprotein	0	None
45231	45232	IIb	0	None
45232	45233	/	0	None
45233	45234	IIIa	0	None
45234	45235	antagonist	0	None
45235	45236	eptifibatide	0	None
45236	45237	.	0	None
45237	45238	Systematic	0	None
45238	45239	identification	0	None
45239	45240	of	0	None
45240	45241	functional	0	None
45241	45242	residues	0	None
45242	45243	in	0	None
45243	45244	mammalian	0	None
45244	45245	histone	0	None
45245	45246	H2AX	0	None
45246	45247	.	0	None
45247	45248	2	0	None
45248	45249	,	0	None
45249	45250	3	0	None
45250	45251	,	0	None
45251	45252	7	0	None
45252	45253	,	0	None
45253	45254	8-TCDD	0	None
45254	45255	induces	0	None
45255	45256	neurotoxicity	0	None
45256	45257	and	0	None
45257	45258	neuronal	0	None
45258	45259	apoptosis	0	None
45259	45260	in	0	None
45260	45261	the	0	None
45261	45262	rat	0	None
45262	45263	brain	0	None
45263	45264	cortex	0	None
45264	45265	and	0	None
45265	45266	PC12	0	None
45266	45267	cell	0	None
45267	45268	line	0	None
45268	45269	through	0	None
45269	45270	the	0	None
45270	45271	down-regulation	0	None
45271	45272	of	0	None
45272	45273	the	0	None
45273	45274	Wnt	0	None
45274	45275	/	0	None
45275	45276	β-catenin	0	None
45276	45277	signaling	0	None
45277	45278	pathway	0	None
45278	45279	.	0	None
45279	45280	Marine	0	None
45280	45281	algae	0	None
45281	45282	are	0	None
45282	45283	popular	0	None
45283	45284	and	0	None
45284	45285	abundant	0	None
45285	45286	food	0	None
45286	45287	ingredients	0	None
45287	45288	mainly	0	None
45288	45289	in	0	None
45289	45290	Asian	0	None
45290	45291	countries	0	None
45291	45292	,	0	None
45292	45293	and	0	None
45293	45294	also	0	None
45294	45295	well	0	None
45295	45296	known	0	None
45296	45297	for	0	None
45297	45298	their	0	None
45298	45299	health	0	None
45299	45300	beneficial	0	None
45300	45301	effects	0	None
45301	45302	due	0	None
45302	45303	to	0	None
45303	45304	the	0	None
45304	45305	presence	0	None
45305	45306	of	0	None
45306	45307	biologically	0	None
45307	45308	active	0	None
45308	45309	components	0	None
45309	45310	.	0	None

45311	45312	The	0	None
45312	45313	marine	0	None
45313	45314	algae	0	None
45314	45315	have	0	None
45315	45316	been	0	None
45316	45317	studied	0	None
45317	45318	for	0	None
45318	45319	biologically	0	None
45319	45320	active	0	None
45320	45321	components	0	None
45321	45322	and	0	None
45322	45323	phlorotannins	0	None
45323	45324	,	0	None
45324	45325	marine	0	None
45325	45326	polyphenols	0	None
45326	45327	are	0	None
45327	45328	among	0	None
45328	45329	them	0	None
45329	45330	.	0	None

45331	45332	Among	0	None
45332	45333	marine	0	None
45333	45334	algae	0	None
45334	45335	,	0	None
45335	45336	brown	0	None
45336	45337	algae	0	None
45337	45338	have	0	None
45338	45339	extensively	0	None
45339	45340	studied	0	None
45340	45341	for	0	None
45341	45342	their	0	None
45342	45343	potential	0	None
45343	45344	anti-diabetic	0	None
45344	45345	activities	0	None
45345	45346	.	0	None

45347	45348	Majority	0	None
45348	45349	of	0	None
45349	45350	the	0	None
45350	45351	investigations	0	None
45351	45352	on	0	None
45352	45353	phlorotannins	0	None
45353	45354	derived	0	None
45354	45355	from	0	None
45355	45356	brown	0	None
45356	45357	algae	0	None
45357	45358	have	0	None
45358	45359	exhibited	0	None
45359	45360	their	0	None
45360	45361	various	0	None
45361	45362	anti-diabetic	0	None
45362	45363	mechanisms	0	None
45363	45364	such	0	None
45364	45365	as	0	None
45365	45366	α-glucosidase	0	None
45366	45367	and	0	None
45367	45368	α-amylase	0	None
45368	45369	inhibitory	0	None
45369	45370	effect	0	None
45370	45371	,	0	None
45371	45372	glucose	0	None
45372	45373	uptake	0	None
45373	45374	effect	0	None
45374	45375	in	0	None
45375	45376	skeletal	0	None
45376	45377	muscle	0	None
45377	45378	,	0	None
45378	45379	protein	0	None
45379	45380	tyrosine	2	CHEMICAL
45380	45381	phosphatase	0	None
45381	45382	1B	0	None
45382	45383	(	0	None
45383	45384	PTP	0	None
45384	45385	1B	0	None
45385	45386	)	0	None
45386	45387	enzyme	0	None
45387	45388	inhibition	0	None
45388	45389	,	0	None
45389	45390	improvement	0	None
45390	45391	of	0	None
45391	45392	insulin	0	None
45392	45393	sensitivity	0	None
45393	45394	in	0	None
45394	45395	type	0	None
45395	45396	2	0	None
45396	45397	diabetic	0	None
45397	45398	db	0	None
45398	45399	/	0	None
45399	45400	db	0	None
45400	45401	mice	0	None
45401	45402	,	0	None
45402	45403	and	0	None
45403	45404	protective	0	None
45404	45405	effect	0	None
45405	45406	against	0	None
45406	45407	diabetes	0	None
45407	45408	complication	0	None
45408	45409	.	0	None

45410	45411	In	0	None
45411	45412	this	0	None
45412	45413	review	0	None
45413	45414	,	0	None
45414	45415	we	0	None
45415	45416	have	0	None
45416	45417	made	0	None
45417	45418	an	0	None
45418	45419	attempt	0	None
45419	45420	to	0	None
45420	45421	discuss	0	None
45421	45422	the	0	None
45422	45423	various	0	None
45423	45424	anti-diabetic	0	None
45424	45425	mechanisms	0	None
45425	45426	associated	0	None
45426	45427	with	0	None
45427	45428	phlorotannins	0	None
45428	45429	from	0	None
45429	45430	brown	0	None
45430	45431	algae	0	None
45431	45432	that	0	None
45432	45433	are	0	None
45433	45434	confined	0	None
45434	45435	to	0	None
45435	45436	in	0	None
45436	45437	vitro	0	None
45437	45438	and	0	None
45438	45439	in	0	None
45439	45440	vivo	0	None
45440	45441	.	0	None
45441	45442	Adverse	0	None
45442	45443	respiratory	0	None
45443	45444	reactions	0	None
45444	45445	to	0	None
45445	45446	aspirin	2	CHEMICAL
45446	45447	and	0	None
45447	45448	nonsteroidal	0	None
45448	45449	anti-inflammatory	0	None
45449	45450	drugs	0	None
45450	45451	.	0	None
45451	45452	A	0	None
45452	45453	novel	0	None
45453	45454	class	0	None
45454	45455	of	0	None
45455	45456	3-	0	None
45456	45457	(	0	None
45457	45458	phenoxy-phenyl-methyl	0	None
45458	45459	)	0	None
45459	45460	-pyrrolidines	0	None
45460	45461	as	0	None
45461	45462	potent	0	None
45462	45463	and	0	None
45463	45464	balanced	0	None
45464	45465	norepinephrine	2	CHEMICAL
45465	45466	and	0	None
45466	45467	serotonin	0	None
45467	45468	reuptake	0	None
45468	45469	inhibitors	0	None
45469	45470	:	0	None
45470	45471	synthesis	0	None
45471	45472	and	0	None
45472	45473	structure-activity	0	None
45473	45474	relationships	0	None
45474	45475	.	0	None
45475	45477	Zinc sulphate	2	CHEMICAL
45477	45478	and	0	None
45478	45480	vitamin E	2	CHEMICAL
45480	45481	alleviate	0	None
45481	45482	reproductive	0	None
45482	45483	toxicity	0	None
45483	45484	caused	0	None
45484	45485	by	0	None
45485	45486	aluminium	2	CHEMICAL
45486	45487	sulphate	0	None
45487	45488	in	0	None
45488	45489	male	0	None
45489	45490	albino	0	None
45490	45491	rats	0	None
45491	45492	.	0	None
45492	45493	Effects	0	None
45493	45494	of	0	None
45494	45495	dopamine	0	None
45495	45496	receptor	0	None
45496	45497	agonists	0	None
45497	45498	and	0	None
45498	45499	antagonists	0	None
45499	45500	on	0	None
45500	45501	catecholamine	0	None
45501	45502	release	0	None
45502	45503	in	0	None
45503	45504	bovine	0	None
45504	45505	chromaffin	0	None
45505	45506	cells	0	None
45506	45507	.	0	None
45507	45508	Plasmacytoid	0	None
45508	45509	dendritic	0	None
45509	45510	cells	0	None
45510	45511	produce	0	None
45511	45512	cytokines	3	GENE-N
45512	45513	and	0	None
45513	45514	mature	0	None
45514	45515	in	0	None
45515	45516	response	0	None
45516	45517	to	0	None
45517	45518	the	0	None
45518	45519	TLR7	0	None
45519	45520	agonists	0	None
45520	45521	,	0	None
45521	45522	imiquimod	0	None
45522	45523	and	0	None
45523	45524	resiquimod	2	CHEMICAL
45524	45525	.	0	None
45525	45526	In	0	None
45526	45527	the	0	None
45527	45528	present	0	None
45528	45529	study	0	None
45529	45530	,	0	None
45530	45531	six	0	None
45531	45532	cyanobacteria	0	None
45532	45533	isolates	0	None
45533	45534	were	0	None
45534	45535	evaluated	0	None
45535	45536	for	0	None
45536	45537	the	0	None
45537	45538	PAL	0	None
45538	45539	enzyme	0	None
45539	45540	activity	0	None
45540	45541	,	0	None
45541	45542	and	0	None
45542	45543	their	0	None
45543	45544	methanol	0	None
45544	45545	extracts	0	None
45545	45546	were	0	None
45546	45547	assessed	0	None
45547	45548	for	0	None
45548	45549	the	0	None
45549	45550	total	0	None
45550	45551	phenolic	0	None
45551	45552	amount	0	None
45552	45553	and	0	None
45553	45554	other	0	None
45554	45555	antioxidant	0	None
45555	45556	parameters	0	None
45556	45557	.	0	None

45558	45559	Synechocystis	0	None
45559	45560	sp	0	None
45560	45561	.	0	None

45562	45563	BASO444	0	None
45563	45564	and	0	None
45564	45565	Synechocystis	0	None
45565	45566	sp	0	None
45566	45567	.	0	None

45568	45569	BASO673	0	None
45569	45570	isolates	0	None
45570	45571	with	0	None
45571	45572	high	0	None
45572	45573	levels	0	None
45573	45574	of	0	None
45574	45575	total	0	None
45575	45576	phenols	0	None
45576	45577	(	0	None
45577	45578	66	0	None
45578	45579	.	0	None
45579	45580	0±1	0	None
45580	45581	.	0	None
45581	45582	2μg	0	None
45582	45583	/	0	None
45583	45584	mg	2	CHEMICAL
45584	45585	,	0	None
45585	45586	78	0	None
45586	45587	.	0	None
45587	45588	1±1	0	None
45588	45589	.	0	None
45589	45590	8μg	0	None
45590	45591	/	0	None
45591	45592	mg	2	CHEMICAL
45592	45593	,	0	None
45593	45594	respectively	0	None
45594	45595	)	0	None
45595	45596	also	0	None
45596	45597	showed	0	None
45597	45598	high	0	None
45598	45599	levels	0	None
45599	45600	of	0	None
45600	45601	PAL	0	None
45601	45602	activities	0	None
45602	45603	(	0	None
45603	45604	20	0	None
45604	45605	.	0	None
45605	45606	5±3	0	None
45606	45607	.	0	None
45607	45608	1U	0	None
45608	45609	/	0	None
45609	45610	mg	2	CHEMICAL
45610	45611	protein	0	None
45611	45612	,	0	None
45612	45613	17	0	None
45613	45614	.	0	None
45614	45615	2±2	0	None
45615	45616	.	0	None
45616	45617	3U	0	None
45617	45618	/	0	None
45618	45619	mg	2	CHEMICAL
45619	45620	protein	0	None
45620	45621	,	0	None
45621	45622	respectively	0	None
45622	45623	)	0	None
45623	45624	and	0	None
45624	45625	strong	0	None
45625	45626	antioxidant	0	None
45626	45627	activities	0	None
45627	45628	.	0	None

45629	45630	To	0	None
45630	45631	understand	0	None
45631	45632	the	0	None
45632	45633	effect	0	None
45633	45634	of	0	None
45634	45635	l-phenylalanine	0	None
45635	45636	(	0	None
45636	45637	l-phe	0	None
45637	45638	)	0	None
45638	45639	on	0	None
45639	45640	the	0	None
45640	45641	PAL	0	None
45641	45642	activity	0	None
45642	45643	,	0	None
45643	45644	total	0	None
45644	45645	phenolic	0	None
45645	45646	amount	0	None
45646	45647	,	0	None
45647	45648	and	0	None
45648	45649	phenolic	0	None
45649	45650	constituents	0	None
45650	45651	,	0	None
45651	45652	isolates	0	None
45652	45653	were	0	None
45653	45654	evaluated	0	None
45654	45655	with	0	None
45655	45656	100mg	0	None
45656	45657	/	0	None
45657	45658	l	0	None
45658	45659	l-phe	0	None
45659	45660	.	0	None

45661	45662	While	0	None
45662	45663	PAL	0	None
45663	45664	activities	0	None
45664	45665	exhibited	0	None
45665	45666	no	0	None
45666	45667	significant	0	None
45667	45668	change	0	None
45668	45669	with	0	None
45669	45670	l-phe	0	None
45670	45671	addition	0	None
45671	45672	,	0	None
45672	45673	total	0	None
45673	45674	phenolic	0	None
45674	45675	amount	0	None
45675	45676	of	0	None
45676	45677	the	0	None
45677	45678	isolates	0	None
45678	45679	significantly	0	None
45679	45680	increased	0	None
45680	45681	.	0	None

45682	45683	HPLC	0	None
45683	45684	analysis	0	None
45684	45685	revealed	0	None
45685	45686	gallic	0	None
45686	45687	acid	0	None
45687	45688	,	0	None
45688	45689	trans-cinnamic	0	None
45689	45690	acid	0	None
45690	45691	,	0	None
45691	45693	p-coumaric acid	2	CHEMICAL
45693	45694	,	0	None
45694	45695	and	0	None
45695	45696	ferulic	0	None
45696	45697	acid	0	None
45697	45698	as	0	None
45698	45699	the	0	None
45699	45700	main	0	None
45700	45701	compounds	0	None
45701	45702	.	0	None

45703	45704	Results	0	None
45704	45705	suggested	0	None
45705	45706	that	0	None
45706	45707	the	0	None
45707	45708	two	0	None
45708	45709	isolate	0	None
45709	45710	mights	0	None
45710	45711	be	0	None
45711	45712	an	0	None
45712	45713	important	0	None
45713	45714	source	0	None
45714	45715	for	0	None
45715	45716	the	0	None
45716	45717	l-phe	0	None
45717	45718	inducible	0	None
45718	45719	phenolic	0	None
45719	45720	compounds	0	None
45720	45721	.	0	None
45721	45722	Minocycline	2	CHEMICAL
45722	45723	protects	0	None
45723	45724	against	0	None
45724	45725	permanent	0	None
45725	45726	cerebral	0	None
45726	45727	ischemia	0	None
45727	45728	in	0	None
45728	45729	wild	0	None
45729	45730	type	0	None
45730	45731	but	0	None
45731	45732	not	0	None
45732	45733	in	0	None
45733	45734	matrix	0	None
45734	45735	metalloprotease-9-deficient	0	None
45735	45736	mice	0	None
45736	45737	.	0	None
45737	45738	Several	0	None
45738	45739	types	0	None
45739	45740	of	0	None
45740	45741	human	0	None
45741	45742	tumors	0	None
45742	45743	overexpress	0	None
45743	45744	cyclooxygenase	3	GENE-N
45744	45745	(	0	None
45745	45746	COX	3	GENE-N
45746	45747	)	0	None
45747	45748	-2	0	None
45748	45749	but	0	None
45749	45750	not	0	None
45750	45751	COX-1	1	GENE-Y
45751	45752	,	0	None
45752	45753	and	0	None
45753	45754	gene	0	None
45754	45755	knockout	0	None
45755	45756	transfection	0	None
45756	45757	experiments	0	None
45757	45758	demonstrate	0	None
45758	45759	a	0	None
45759	45760	central	0	None
45760	45761	role	0	None
45761	45762	of	0	None
45762	45763	COX-2	0	None
45763	45764	in	0	None
45764	45765	experimental	0	None
45765	45766	tumorigenesis	0	None
45766	45767	.	0	None

45768	45769	COX-2	0	None
45769	45770	produces	0	None
45770	45771	prostaglandins	2	CHEMICAL
45771	45772	that	0	None
45772	45773	inhibit	0	None
45773	45774	apoptosis	0	None
45774	45775	and	0	None
45775	45776	stimulate	0	None
45776	45777	angiogenesis	0	None
45777	45778	and	0	None
45778	45779	invasiveness	0	None
45779	45780	.	0	None

45781	45782	Selective	0	None
45782	45783	COX-2	0	None
45783	45784	inhibitors	0	None
45784	45785	reduce	0	None
45785	45786	prostaglandin	0	None
45786	45787	synthesis	0	None
45787	45788	,	0	None
45788	45789	restore	0	None
45789	45790	apoptosis	0	None
45790	45791	,	0	None
45791	45792	and	0	None
45792	45793	inhibit	0	None
45793	45794	cancer	0	None
45794	45795	cell	0	None
45795	45796	proliferation	0	None
45796	45797	.	0	None

45798	45799	In	0	None
45799	45800	animal	0	None
45800	45801	studies	0	None
45801	45802	they	0	None
45802	45803	limit	0	None
45803	45804	carcinogen-induced	0	None
45804	45805	tumorigenesis	0	None
45805	45806	.	0	None

45807	45808	In	0	None
45808	45809	contrast	0	None
45809	45810	,	0	None
45810	45811	aspirin-like	0	None
45811	45812	nonselective	0	None
45812	45813	NSAIDs	0	None
45813	45814	such	0	None
45814	45815	as	0	None
45815	45816	sulindac	0	None
45816	45817	and	0	None
45817	45818	indomethacin	0	None
45818	45819	inhibit	0	None
45819	45820	not	0	None
45820	45821	only	0	None
45821	45822	the	0	None
45822	45823	enzymatic	0	None
45823	45824	action	0	None
45824	45825	of	0	None
45825	45826	the	0	None
45826	45827	highly	0	None
45827	45828	inducible	0	None
45828	45829	,	0	None
45829	45830	proinflammatory	0	None
45830	45831	COX-2	0	None
45831	45832	but	0	None
45832	45833	the	0	None
45833	45834	constitutively	0	None
45834	45835	expressed	0	None
45835	45836	,	0	None
45836	45837	cytoprotective	0	None
45837	45838	COX-1	1	GENE-Y
45838	45839	as	0	None
45839	45840	well	0	None
45840	45841	.	0	None

45842	45843	Consequently	0	None
45843	45844	,	0	None
45844	45845	nonselective	0	None
45845	45846	NSAIDs	0	None
45846	45847	can	0	None
45847	45848	cause	0	None
45848	45849	platelet	0	None
45849	45850	dysfunction	0	None
45850	45851	,	0	None
45851	45852	gastrointestinal	0	None
45852	45853	ulceration	0	None
45853	45854	,	0	None
45854	45855	and	0	None
45855	45856	kidney	0	None
45856	45857	damage	0	None
45857	45858	.	0	None

45859	45860	For	0	None
45860	45861	that	0	None
45861	45862	reason	0	None
45862	45863	,	0	None
45863	45864	selective	0	None
45864	45865	inhibition	0	None
45865	45866	of	0	None
45866	45867	COX-2	0	None
45867	45868	to	0	None
45868	45869	treat	0	None
45869	45870	neoplastic	0	None
45870	45871	proliferation	0	None
45871	45872	is	0	None
45872	45873	preferable	0	None
45873	45874	to	0	None
45874	45875	nonselective	0	None
45875	45876	inhibition	0	None
45876	45877	.	0	None

45878	45879	Selective	0	None
45879	45880	COX-2	0	None
45880	45881	inhibitors	0	None
45881	45882	,	0	None
45882	45883	such	0	None
45883	45884	as	0	None
45884	45885	meloxicam	0	None
45885	45886	,	0	None
45886	45887	celecoxib	2	CHEMICAL
45887	45888	(	0	None
45888	45889	SC-58635	2	CHEMICAL
45889	45890	)	0	None
45890	45891	,	0	None
45891	45892	and	0	None
45892	45893	rofecoxib	0	None
45893	45894	(	0	None
45894	45895	MK-0966	2	CHEMICAL
45895	45896	)	0	None
45896	45897	,	0	None
45897	45898	are	0	None
45898	45899	NSAIDs	0	None
45899	45900	that	0	None
45900	45901	have	0	None
45901	45902	been	0	None
45902	45903	modified	0	None
45903	45904	chemically	0	None
45904	45905	to	0	None
45905	45906	preferentially	0	None
45906	45907	inhibit	0	None
45907	45908	COX-2	0	None
45908	45909	but	0	None
45909	45910	not	0	None
45910	45911	COX-1	1	GENE-Y
45911	45912	.	0	None

45913	45914	For	0	None
45914	45915	instance	0	None
45915	45916	,	0	None
45916	45917	meloxicam	0	None
45917	45918	inhibits	0	None
45918	45919	the	0	None
45919	45920	growth	0	None
45920	45921	of	0	None
45921	45922	cultured	0	None
45922	45923	colon	0	None
45923	45924	cancer	0	None
45924	45925	cells	0	None
45925	45926	(	0	None
45926	45927	HCA-7	0	None
45927	45928	and	0	None
45928	45929	Moser-S	0	None
45929	45930	)	0	None
45930	45931	that	0	None
45931	45932	express	0	None
45932	45933	COX-2	0	None
45933	45934	but	0	None
45934	45935	has	0	None
45935	45936	no	0	None
45936	45937	effect	0	None
45937	45938	on	0	None
45938	45939	HCT-116	0	None
45939	45940	tumor	0	None
45940	45941	cells	0	None
45941	45942	that	0	None
45942	45943	do	0	None
45943	45944	not	0	None
45944	45945	express	0	None
45945	45946	COX-2	0	None
45946	45947	.	0	None

45948	45949	NS-398	0	None
45949	45950	induces	0	None
45950	45951	apoptosis	0	None
45951	45952	in	0	None
45952	45953	COX-2	0	None
45953	45954	expressing	0	None
45954	45955	LNCaP	0	None
45955	45956	prostate	0	None
45956	45957	cancer	0	None
45957	45958	cells	0	None
45958	45959	and	0	None
45959	45960	,	0	None
45960	45961	surprisingly	0	None
45961	45962	,	0	None
45962	45963	in	0	None
45963	45964	colon	0	None
45964	45965	cancer	0	None
45965	45966	S	0	None
45966	45967	/	0	None
45967	45968	KS	0	None
45968	45969	cells	0	None
45969	45970	that	0	None
45970	45971	does	0	None
45971	45972	not	0	None
45972	45973	express	0	None
45973	45974	COX-2	0	None
45974	45975	.	0	None

45976	45977	This	0	None
45977	45978	effect	0	None
45978	45979	may	0	None
45979	45980	due	0	None
45980	45981	to	0	None
45981	45982	induction	0	None
45982	45983	of	0	None
45983	45984	apoptosis	0	None
45984	45985	through	0	None
45985	45986	uncoupling	0	None
45986	45987	of	0	None
45987	45988	oxidative	0	None
45988	45989	phosphorylation	0	None
45989	45990	and	0	None
45990	45991	down-regulation	0	None
45991	45992	of	0	None
45992	45993	Bcl-2	1	GENE-Y
45993	45994	,	0	None
45994	45995	as	0	None
45995	45996	has	0	None
45996	45997	been	0	None
45997	45998	demonstrated	0	None
45998	45999	for	0	None
45999	46000	some	0	None
46000	46001	nonselective	0	None
46001	46002	NSAIDs	0	None
46002	46003	,	0	None
46003	46004	for	0	None
46004	46005	instance	0	None
46005	46006	,	0	None
46006	46007	flurbiprofen	0	None
46007	46008	.	0	None

46009	46010	COX-2	0	None
46010	46011	mRNA	0	None
46011	46012	and	0	None
46012	46013	COX-2	0	None
46013	46014	protein	0	None
46014	46015	is	0	None
46015	46016	constitutively	0	None
46016	46017	expressed	0	None
46017	46018	in	0	None
46018	46019	the	0	None
46019	46020	kidney	0	None
46020	46021	,	0	None
46021	46022	brain	0	None
46022	46023	,	0	None
46023	46024	spinal	0	None
46024	46025	cord	0	None
46025	46026	,	0	None
46026	46027	and	0	None
46027	46028	ductus	0	None
46028	46029	deferens	0	None
46029	46030	,	0	None
46030	46031	and	0	None
46031	46032	in	0	None
46032	46033	the	0	None
46033	46034	uterus	0	None
46034	46035	during	0	None
46035	46036	implantation	0	None
46036	46037	.	0	None

46038	46039	In	0	None
46039	46040	addition	0	None
46040	46041	,	0	None
46041	46042	COX-2	0	None
46042	46043	is	0	None
46043	46044	constitutively	0	None
46044	46045	and	0	None
46045	46046	dominantly	0	None
46046	46047	expressed	0	None
46047	46048	in	0	None
46048	46049	the	0	None
46049	46050	pancreatic	0	None
46050	46051	islet	3	GENE-N
46051	46052	cells	0	None
46052	46053	.	0	None

46054	46055	These	0	None
46055	46056	findings	0	None
46056	46057	might	0	None
46057	46058	somewhat	0	None
46058	46059	limit	0	None
46059	46060	the	0	None
46060	46061	use	0	None
46061	46062	of	0	None
46062	46063	presently	0	None
46063	46064	available	0	None
46064	46065	selective	0	None
46065	46066	COX-2	0	None
46066	46067	inhibitors	0	None
46067	46068	in	0	None
46068	46069	cancer	0	None
46069	46070	prevention	0	None
46070	46071	but	0	None
46071	46072	will	0	None
46072	46073	probably	0	None
46073	46074	not	0	None
46074	46075	deter	0	None
46075	46076	their	0	None
46076	46077	successful	0	None
46077	46078	application	0	None
46078	46079	for	0	None
46079	46080	the	0	None
46080	46081	treatment	0	None
46081	46082	of	0	None
46082	46083	human	0	None
46083	46084	cancers	0	None
46084	46085	.	0	None
46085	46086	Role	0	None
46086	46087	of	0	None
46087	46088	nitric	0	None
46088	46089	oxide	0	None
46089	46090	in	0	None
46090	46091	the	0	None
46091	46092	chemistry	0	None
46092	46093	and	0	None
46093	46094	anticancer	0	None
46094	46095	activity	0	None
46095	46096	of	0	None
46096	46097	etoposide	0	None
46097	46098	(	0	None
46098	46099	VP-16	0	None
46099	46100	,	0	None
46100	46101	213	0	None
46101	46102	)	0	None
46102	46103	.	0	None
46103	46104	All	0	None
46104	46105	DNA	0	None
46105	46106	(	0	None
46106	46107	cytosine-5	0	None
46107	46108	)	0	None
46108	46109	-methyltransferases	0	None
46109	46110	contain	0	None
46110	46111	a	0	None
46111	46112	single	0	None
46112	46113	conserved	0	None
46113	46114	cysteine	0	None
46114	46115	.	0	None

46116	46117	It	0	None
46117	46118	has	0	None
46118	46119	been	0	None
46119	46120	proposed	0	None
46120	46121	that	0	None
46121	46122	this	0	None
46122	46123	cysteine	0	None
46123	46124	initiates	0	None
46124	46125	catalysis	0	None
46125	46126	by	0	None
46126	46127	attacking	0	None
46127	46128	the	0	None
46128	46129	C6	0	None
46129	46130	of	0	None
46130	46131	cytosine	0	None
46131	46132	and	0	None
46132	46133	thereby	0	None
46133	46134	activating	0	None
46134	46135	the	0	None
46135	46136	normally	0	None
46136	46137	inert	0	None
46137	46138	C5	0	None
46138	46139	position	0	None
46139	46140	.	0	None

46141	46142	We	0	None
46142	46143	show	0	None
46143	46144	here	0	None
46144	46145	that	0	None
46145	46146	substitutions	0	None
46146	46147	of	0	None
46147	46148	this	0	None
46148	46149	cysteine	0	None
46149	46150	in	0	None
46150	46151	the	0	None
46151	46152	E	0	None
46152	46153	.	0	None

46154	46155	coli	0	None
46155	46156	methylase	0	None
46156	46157	M	0	None
46157	46158	.	0	None

46159	46160	EcoRII	0	None
46160	46161	with	0	None
46161	46162	either	0	None
46162	46163	serine	2	CHEMICAL
46163	46164	or	0	None
46164	46165	tryptophan	2	CHEMICAL
46165	46166	results	0	None
46166	46167	in	0	None
46167	46168	a	0	None
46168	46169	complete	0	None
46169	46170	loss	0	None
46170	46171	of	0	None
46171	46172	ability	0	None
46172	46173	to	0	None
46173	46174	transfer	0	None
46174	46175	methyl	0	None
46175	46176	groups	0	None
46176	46177	to	0	None
46177	46178	DNA	0	None
46178	46179	.	0	None

46180	46181	Interestingly	0	None
46181	46182	,	0	None
46182	46183	mutants	0	None
46183	46184	with	0	None
46184	46185	either	0	None
46185	46186	serine	2	CHEMICAL
46186	46187	or	0	None
46187	46188	glycine	2	CHEMICAL
46188	46189	substitution	0	None
46189	46190	bind	0	None
46190	46191	tightly	0	None
46191	46192	to	0	None
46192	46193	substrate	0	None
46193	46194	DNA	0	None
46194	46195	.	0	None

46196	46197	These	0	None
46197	46198	mutants	0	None
46198	46199	resemble	0	None
46199	46200	the	0	None
46200	46201	wild-type	0	None
46201	46202	enzyme	0	None
46202	46203	in	0	None
46203	46204	that	0	None
46204	46205	their	0	None
46205	46206	binding	0	None
46206	46207	to	0	None
46207	46208	substrate	0	None
46208	46209	is	0	None
46209	46210	not	0	None
46210	46211	eliminated	0	None
46211	46212	by	0	None
46212	46213	the	0	None
46213	46214	presence	0	None
46214	46215	of	0	None
46215	46216	non-specific	0	None
46216	46217	DNA	0	None
46217	46218	in	0	None
46218	46219	the	0	None
46219	46220	reaction	0	None
46220	46221	,	0	None
46221	46222	it	0	None
46222	46223	is	0	None
46223	46224	sensitive	0	None
46224	46225	to	0	None
46225	46226	methylation	0	None
46226	46227	status	0	None
46227	46228	of	0	None
46228	46229	the	0	None
46229	46230	substrate	0	None
46230	46231	and	0	None
46231	46232	is	0	None
46232	46233	stimulated	0	None
46233	46234	by	0	None
46234	46235	an	0	None
46235	46236	analog	0	None
46236	46237	of	0	None
46237	46238	the	0	None
46238	46239	methyl	0	None
46239	46240	donor	0	None
46240	46241	.	0	None

46242	46243	Hence	0	None
46243	46244	the	0	None
46244	46245	conserved	0	None
46245	46246	cysteine	0	None
46246	46247	is	0	None
46247	46248	not	0	None
46248	46249	essential	0	None
46249	46250	for	0	None
46250	46251	the	0	None
46251	46252	specific	0	None
46252	46253	stable	0	None
46253	46254	binding	0	None
46254	46255	of	0	None
46255	46256	the	0	None
46256	46257	enzyme	0	None
46257	46258	to	0	None
46258	46259	its	0	None
46259	46260	substrate	0	None
46260	46261	.	0	None

46262	46263	However	0	None
46263	46264	,	0	None
46264	46265	substitution	0	None
46265	46266	of	0	None
46266	46267	the	0	None
46267	46268	cysteine	0	None
46268	46269	with	0	None
46269	46270	the	0	None
46270	46271	bulkier	0	None
46271	46272	tryptophan	2	CHEMICAL
46272	46273	does	0	None
46273	46274	reduce	0	None
46274	46275	DNA	0	None
46275	46276	binding	0	None
46276	46277	.	0	None

46278	46279	We	0	None
46279	46280	also	0	None
46280	46281	report	0	None
46281	46282	here	0	None
46282	46283	a	0	None
46283	46284	novel	0	None
46284	46285	procedure	0	None
46285	46286	for	0	None
46286	46287	the	0	None
46287	46288	synthesis	0	None
46288	46289	of	0	None
46289	46290	DNA	0	None
46290	46291	containing	0	None
46291	46292	5-fluorocytosine	0	None
46292	46293	.	0	None

46294	46295	Further	0	None
46295	46296	,	0	None
46296	46297	we	0	None
46297	46298	show	0	None
46298	46299	that	0	None
46299	46300	a	0	None
46300	46301	DNA	0	None
46301	46302	substrate	0	None
46302	46303	for	0	None
46303	46304	M	0	None
46304	46305	.	0	None

46306	46307	EcoRII	0	None
46307	46308	in	0	None
46308	46309	which	0	None
46309	46310	the	0	None
46310	46311	target	0	None
46311	46312	cytosine	0	None
46312	46313	is	0	None
46313	46314	replaced	0	None
46314	46315	by	0	None
46315	46316	5-fluorocytosine	0	None
46316	46317	is	0	None
46317	46318	a	0	None
46318	46319	mechanism-based	0	None
46319	46320	inhibitor	0	None
46320	46321	of	0	None
46321	46322	the	0	None
46322	46323	enzyme	0	None
46323	46324	and	0	None
46324	46325	that	0	None
46325	46326	it	0	None
46326	46327	forms	0	None
46327	46328	an	0	None
46328	46329	irreversible	0	None
46329	46330	complex	0	None
46330	46331	with	0	None
46331	46332	the	0	None
46332	46333	enzyme	0	None
46333	46334	.	0	None

46335	46336	As	0	None
46336	46337	expected	0	None
46337	46338	,	0	None
46338	46339	this	0	None
46339	46340	modified	0	None
46340	46341	substrate	0	None
46341	46342	does	0	None
46342	46343	not	0	None
46343	46344	form	0	None
46344	46345	irreversible	0	None
46345	46346	complexes	0	None
46346	46347	with	0	None
46347	46348	the	0	None
46348	46349	mutants	0	None
46349	46350	.	0	None
46350	46351	Effect	0	None
46351	46352	of	0	None
46352	46353	L-arginine-nitric	0	None
46353	46354	oxide	0	None
46354	46355	system	0	None
46355	46356	on	0	None
46356	46357	the	0	None
46357	46358	metabolism	0	None
46358	46359	of	0	None
46359	46360	essential	0	None
46360	46362	fatty acids	2	CHEMICAL
46362	46363	in	0	None
46363	46364	chemical-induced	0	None
46364	46365	diabetes	0	None
46365	46366	mellitus	0	None
46366	46367	.	0	None
46367	46368	Recent	0	None
46368	46369	data	0	None
46369	46370	suggest	0	None
46370	46371	that	0	None
46371	46372	the	0	None
46372	46373	role	0	None
46373	46374	of	0	None
46374	46375	CYP3A4	0	None
46375	46376	in	0	None
46376	46377	imatinib	0	None
46377	46378	metabolism	0	None
46378	46379	is	0	None
46379	46380	smaller	0	None
46380	46381	than	0	None
46381	46382	presumed	0	None
46382	46383	.	0	None

46384	46385	This	0	None
46385	46386	study	0	None
46386	46387	aimed	0	None
46387	46388	to	0	None
46388	46389	evaluate	0	None
46389	46390	the	0	None
46390	46391	quantitative	0	None
46391	46392	importance	0	None
46392	46393	of	0	None
46393	46394	different	0	None
46394	46395	cytochrome	3	GENE-N
46395	46396	P450	0	None
46396	46397	(	0	None
46397	46398	P450	0	None
46398	46399	)	0	None
46399	46400	enzymes	0	None
46400	46401	in	0	None
46401	46402	imatinib	0	None
46402	46403	pharmacokinetics	0	None
46403	46404	.	0	None

46405	46406	First	0	None
46406	46407	,	0	None
46407	46408	the	0	None
46408	46409	metabolism	0	None
46409	46410	of	0	None
46410	46411	imatinib	0	None
46411	46412	was	0	None
46412	46413	investigated	0	None
46413	46414	using	0	None
46414	46415	recombinant	0	None
46415	46416	P450	0	None
46416	46417	enzymes	0	None
46417	46418	and	0	None
46418	46419	human	0	None
46419	46420	liver	0	None
46420	46421	microsomes	0	None
46421	46422	with	0	None
46422	46423	P450	0	None
46423	46424	isoform-selective	0	None
46424	46425	inhibitors	0	None
46425	46426	.	0	None

46427	46428	Thereafter	0	None
46428	46429	,	0	None
46429	46430	an	0	None
46430	46431	in	0	None
46431	46432	silico	0	None
46432	46433	model	0	None
46433	46434	for	0	None
46434	46435	imatinib	0	None
46435	46436	was	0	None
46436	46437	constructed	0	None
46437	46438	to	0	None
46438	46439	perform	0	None
46439	46440	pharmacokinetic	0	None
46440	46441	simulations	0	None
46441	46442	to	0	None
46442	46443	assess	0	None
46443	46444	the	0	None
46444	46445	roles	0	None
46445	46446	of	0	None
46446	46447	P450	0	None
46447	46448	enzymes	0	None
46448	46449	in	0	None
46449	46450	imatinib	0	None
46450	46451	elimination	0	None
46451	46452	at	0	None
46452	46453	clinically	0	None
46453	46454	used	0	None
46454	46455	imatinib	0	None
46455	46456	doses	0	None
46456	46457	.	0	None

46458	46459	In	0	None
46459	46460	vitro	0	None
46460	46461	,	0	None
46461	46462	CYP2C8	0	None
46462	46463	inhibitors	0	None
46463	46464	and	0	None
46464	46465	CYP3A4	0	None
46465	46466	inhibitors	0	None
46466	46467	inhibited	0	None
46467	46468	the	0	None
46468	46469	depletion	0	None
46469	46470	of	0	None
46470	46471	0	0	None
46471	46472	.	0	None
46472	46473	1	0	None
46473	46474	µM	0	None
46474	46475	imatinib	0	None
46475	46476	by	0	None
46476	46477	45	0	None
46477	46478	and	0	None
46478	46479	80%	0	None
46479	46480	,	0	None
46480	46481	respectively	0	None
46481	46482	,	0	None
46482	46483	and	0	None
46483	46484	the	0	None
46484	46485	formation	0	None
46485	46486	of	0	None
46486	46487	the	0	None
46487	46488	main	0	None
46488	46489	metabolite	0	None
46489	46490	of	0	None
46490	46491	imatinib	0	None
46491	46492	,	0	None
46492	46493	N-desmethylimatinib	0	None
46493	46494	,	0	None
46494	46495	by	0	None
46495	46496	>50%	0	None
46496	46497	.	0	None

46498	46499	Likewise	0	None
46499	46500	,	0	None
46500	46501	recombinant	0	None
46501	46502	CYP2C8	0	None
46502	46503	and	0	None
46503	46504	CYP3A4	0	None
46504	46505	metabolized	0	None
46505	46506	imatinib	0	None
46506	46507	extensively	0	None
46507	46508	,	0	None
46508	46509	whereas	0	None
46509	46510	other	0	None
46510	46511	isoforms	0	None
46511	46512	had	0	None
46512	46513	minor	0	None
46513	46514	effect	0	None
46514	46515	on	0	None
46515	46516	imatinib	0	None
46516	46517	concentrations	0	None
46517	46518	.	0	None

46519	46520	In	0	None
46520	46521	the	0	None
46521	46522	beginning	0	None
46522	46523	of	0	None
46523	46524	imatinib	0	None
46524	46525	treatment	0	None
46525	46526	,	0	None
46526	46527	the	0	None
46527	46528	fractions	0	None
46528	46529	of	0	None
46529	46530	its	0	None
46530	46531	hepatic	0	None
46531	46532	clearance	0	None
46532	46533	mediated	0	None
46533	46534	by	0	None
46534	46535	CYP2C8	0	None
46535	46536	and	0	None
46536	46537	CYP3A4	0	None
46537	46538	were	0	None
46538	46539	predicted	0	None
46539	46540	to	0	None
46540	46541	approximate	0	None
46541	46542	40	0	None
46542	46543	and	0	None
46543	46544	60%	0	None
46544	46545	,	0	None
46545	46546	respectively	0	None
46546	46547	.	0	None

46548	46549	During	0	None
46549	46550	long-term	0	None
46550	46551	treatment	0	None
46551	46552	with	0	None
46552	46553	imatinib	0	None
46553	46554	400	0	None
46554	46555	mg	2	CHEMICAL
46555	46556	once	0	None
46556	46557	or	0	None
46557	46558	twice	0	None
46558	46559	daily	0	None
46559	46560	,	0	None
46560	46561	up	0	None
46561	46562	to	0	None
46562	46563	65	0	None
46563	46564	or	0	None
46564	46565	75%	0	None
46565	46566	of	0	None
46566	46567	its	0	None
46567	46568	hepatic	0	None
46568	46569	elimination	0	None
46569	46570	was	0	None
46570	46571	predicted	0	None
46571	46572	to	0	None
46572	46573	occur	0	None
46573	46574	via	0	None
46574	46575	CYP2C8	0	None
46575	46576	,	0	None
46576	46577	and	0	None
46577	46578	only	0	None
46578	46579	about	0	None
46579	46580	35	0	None
46580	46581	or	0	None
46581	46582	25%	0	None
46582	46583	by	0	None
46583	46584	CYP3A4	0	None
46584	46585	,	0	None
46585	46586	due	0	None
46586	46587	to	0	None
46587	46588	dose-	0	None
46588	46589	and	0	None
46589	46590	time-dependent	0	None
46590	46591	autoinactivation	0	None
46591	46592	of	0	None
46592	46593	CYP3A4	0	None
46593	46594	by	0	None
46594	46595	imatinib	0	None
46595	46596	.	0	None

46597	46598	Thus	0	None
46598	46599	,	0	None
46599	46600	although	0	None
46600	46601	CYP2C8	0	None
46601	46602	and	0	None
46602	46603	CYP3A4	0	None
46603	46604	are	0	None
46604	46605	the	0	None
46605	46606	main	0	None
46606	46607	enzymes	0	None
46607	46608	in	0	None
46608	46609	imatinib	0	None
46609	46610	metabolism	0	None
46610	46611	in	0	None
46611	46612	vitro	0	None
46612	46613	,	0	None
46613	46614	in	0	None
46614	46615	silico	0	None
46615	46616	predictions	0	None
46616	46617	indicate	0	None
46617	46618	that	0	None
46618	46619	imatinib	0	None
46619	46620	inhibits	0	None
46620	46621	its	0	None
46621	46622	own	0	None
46622	46623	CYP3A4-mediated	0	None
46623	46624	metabolism	0	None
46624	46625	,	0	None
46625	46626	assigning	0	None
46626	46627	a	0	None
46627	46628	key	0	None
46628	46629	role	0	None
46629	46630	for	0	None
46630	46631	CYP2C8	0	None
46631	46632	.	0	None

46633	46634	During	0	None
46634	46635	multiple	0	None
46635	46636	dosing	0	None
46636	46637	,	0	None
46637	46638	pharmacogenetic	0	None
46638	46639	polymorphisms	0	None
46639	46640	and	0	None
46640	46641	drug	0	None
46641	46642	interactions	0	None
46642	46643	affecting	0	None
46643	46644	CYP2C8	0	None
46644	46645	activity	0	None
46645	46646	may	0	None
46646	46647	cause	0	None
46647	46648	marked	0	None
46648	46649	interindividual	0	None
46649	46650	variation	0	None
46650	46651	in	0	None
46651	46652	the	0	None
46652	46653	exposure	0	None
46653	46654	and	0	None
46654	46655	response	0	None
46655	46656	to	0	None
46656	46657	imatinib	0	None
46657	46658	.	0	None
46658	46659	IGF-I	1	GENE-Y
46659	46660	signaling	0	None
46660	46661	is	0	None
46661	46662	essential	0	None
46662	46663	for	0	None
46663	46664	FSH	0	None
46664	46665	stimulation	0	None
46665	46666	of	0	None
46666	46667	AKT	3	GENE-N
46667	46668	and	0	None
46668	46669	steroidogenic	0	None
46669	46670	genes	0	None
46670	46671	in	0	None
46671	46672	granulosa	0	None
46672	46673	cells	0	None
46673	46674	.	0	None
46674	46675	Effects	0	None
46675	46676	of	0	None
46676	46677	zonisamide	0	None
46677	46678	on	0	None
46678	46679	dopaminergic	0	None
46679	46680	system	0	None
46680	46681	.	0	None
46681	46682	D2	0	None
46682	46683	dopamine	0	None
46683	46684	receptors	0	None
46684	46685	colocalize	0	None
46685	46686	regulator	0	None
46686	46687	of	0	None
46687	46688	G-protein	3	GENE-N
46688	46689	signaling	0	None
46689	46690	9-2	0	None
46690	46691	(	0	None
46691	46692	RGS9-2	0	None
46692	46693	)	0	None
46693	46694	via	0	None
46694	46695	the	0	None
46695	46696	RGS9	0	None
46696	46697	DEP	0	None
46697	46698	domain	0	None
46698	46699	,	0	None
46699	46700	and	0	None
46700	46701	RGS9	0	None
46701	46702	knock-out	0	None
46702	46703	mice	0	None
46703	46704	develop	0	None
46704	46705	dyskinesias	0	None
46705	46706	associated	0	None
46706	46707	with	0	None
46707	46708	dopamine	0	None
46708	46709	pathways	0	None
46709	46710	.	0	None
46710	46711	Aripiprazole	0	None
46711	46712	,	0	None
46712	46713	7-	0	None
46713	46714	[	0	None
46714	46715	4-	0	None
46715	46716	[	0	None
46716	46717	4-	0	None
46717	46718	(	0	None
46718	46719	2	0	None
46719	46720	,	0	None
46720	46721	3-dichlorophenyl	0	None
46721	46722	)	0	None
46722	46723	-1-piperazinyl	0	None
46723	46724	]	0	None
46724	46725	butyloxy	0	None
46725	46726	]	0	None
46726	46727	-3	0	None
46727	46728	,	0	None
46728	46729	4-dihydro-2	0	None
46729	46730	(	0	None
46730	46731	1H	0	None
46731	46732	)	0	None
46732	46733	-quinolinon	0	None
46733	46734	e	0	None
46734	46735	,	0	None
46735	46736	a	0	None
46736	46737	novel	0	None
46737	46738	antipsychotic	0	None
46738	46739	with	0	None
46739	46740	partial	0	None
46740	46741	agonist	0	None
46741	46742	activity	0	None
46742	46743	at	0	None
46743	46744	dopamine	0	None
46744	46745	D2	0	None
46745	46746	receptors	0	None
46746	46747	,	0	None
46747	46748	bound	0	None
46748	46749	with	0	None
46749	46750	high	0	None
46750	46751	affinity	0	None
46751	46752	to	0	None
46752	46753	recombinant	0	None
46753	46754	human	0	None
46754	46755	5-HT	0	None
46755	46756	(	0	None
46756	46757	1A	0	None
46757	46758	)	0	None
46758	46759	receptors	0	None
46759	46760	(	0	None
46760	46761	h5-HT	0	None
46761	46762	(	0	None
46762	46763	1A	0	None
46763	46764	)	0	None
46764	46765	)	0	None
46765	46766	in	0	None
46766	46767	Chinese	0	None
46767	46768	hamster	0	None
46768	46769	ovary	0	None
46769	46770	cell	0	None
46770	46771	membranes	0	None
46771	46772	and	0	None
46772	46773	displayed	0	None
46773	46774	potent	0	None
46774	46775	,	0	None
46775	46776	partial	0	None
46776	46777	agonism	0	None
46777	46778	at	0	None
46778	46779	5-HT	0	None
46779	46780	(	0	None
46780	46781	1A	0	None
46781	46782	)	0	None
46782	46783	receptors	0	None
46783	46784	in	0	None
46784	46785	a	0	None
46785	46786	guanosine-5'-O-	0	None
46786	46787	(	0	None
46787	46788	3-	0	None
46788	46789	[	0	None
46789	46790	(	0	None
46790	46791	35	0	None
46791	46792	)	0	None
46792	46793	S	0	None
46793	46794	]	0	None
46794	46795	thio	0	None
46795	46796	)	0	None
46796	46797	-triphosphate	0	None
46797	46798	(	0	None
46798	46799	[	0	None
46799	46800	(	0	None
46800	46801	35	0	None
46801	46802	)	0	None
46802	46803	S	0	None
46803	46804	]	0	None
46804	46805	GTP	0	None
46805	46806	gamma	0	None
46806	46807	S	0	None
46807	46808	)	0	None
46808	46809	-binding	0	None
46809	46810	assay	0	None
46810	46811	that	0	None
46811	46812	was	0	None
46812	46813	blocked	0	None
46813	46814	completely	0	None
46814	46815	by	0	None
46815	46816	a	0	None
46816	46817	selective	0	None
46817	46818	5-HT	0	None
46818	46819	(	0	None
46819	46820	1A	0	None
46820	46821	)	0	None
46821	46822	receptor	0	None
46822	46823	antagonist	0	None
46823	46824	.	0	None

46825	46826	An	0	None
46826	46827	interaction	0	None
46827	46828	with	0	None
46828	46829	5-HT	0	None
46829	46830	(	0	None
46830	46831	1A	0	None
46831	46832	)	0	None
46832	46833	receptors	0	None
46833	46834	may	0	None
46834	46835	contribute	0	None
46835	46836	to	0	None
46836	46837	the	0	None
46837	46838	overall	0	None
46838	46839	efficacy	0	None
46839	46840	of	0	None
46840	46841	aripiprazole	2	CHEMICAL
46841	46842	against	0	None
46842	46843	symptoms	0	None
46843	46844	of	0	None
46844	46845	schizophrenia	0	None
46845	46846	,	0	None
46846	46847	including	0	None
46847	46848	anxiety	0	None
46848	46849	,	0	None
46849	46850	depression	0	None
46850	46851	,	0	None
46851	46852	cognitive	0	None
46852	46853	and	0	None
46853	46854	negative	0	None
46854	46855	symptoms	0	None
46855	46856	,	0	None
46856	46857	and	0	None
46857	46858	to	0	None
46858	46859	its	0	None
46859	46860	favorable	0	None
46860	46861	side-effect	0	None
46861	46862	profile	0	None
46862	46863	.	0	None

46864	46865	Combined	0	None
46865	46866	with	0	None
46866	46867	previous	0	None
46867	46868	studies	0	None
46868	46869	demonstrating	0	None
46869	46870	the	0	None
46870	46871	potent	0	None
46871	46872	partial	0	None
46872	46873	agonism	0	None
46873	46874	of	0	None
46874	46875	aripiprazole	2	CHEMICAL
46875	46876	at	0	None
46876	46877	dopamine	0	None
46877	46878	D2	0	None
46878	46879	receptors	0	None
46879	46880	,	0	None
46880	46881	this	0	None
46881	46882	study	0	None
46882	46883	suggests	0	None
46883	46884	aripiprazole	2	CHEMICAL
46884	46885	is	0	None
46885	46886	the	0	None
46886	46887	first	0	None
46887	46888	dopamine-serotonin	0	None
46888	46889	system	0	None
46889	46890	stabilizer	0	None
46890	46891	.	0	None
46891	46892	Biosynthetic	0	None
46892	46893	regulation	0	None
46893	46894	and	0	None
46894	46895	intracellular	0	None
46895	46898	transport of phosphatidylserine	2	CHEMICAL
46898	46899	in	0	None
46899	46900	mammalian	0	None
46900	46901	cells	0	None
46901	46902	.	0	None
46902	46903	Prenatal	0	None
46903	46904	exposure	0	None
46904	46905	to	0	None
46905	46906	bisphenol	0	None
46906	46907	A	0	None
46907	46908	impacts	0	None
46908	46909	midbrain	0	None
46909	46910	dopamine	0	None
46910	46911	neurons	0	None
46911	46912	and	0	None
46912	46913	hippocampal	0	None
46913	46914	spine	0	None
46914	46915	synapses	0	None
46915	46916	in	0	None
46916	46917	non-human	0	None
46917	46918	primates	0	None
46918	46919	.	0	None
46919	46920	Normal	0	None
46920	46921	growth	0	None
46921	46922	and	0	None
46922	46923	function	0	None
46923	46924	of	0	None
46924	46925	the	0	None
46925	46926	prostate	0	None
46926	46927	are	0	None
46927	46928	contingent	0	None
46928	46929	on	0	None
46929	46930	the	0	None
46930	46931	reduction	0	None
46931	46932	of	0	None
46932	46933	testosterone	2	CHEMICAL
46933	46934	to	0	None
46934	46935	dihydrotestosterone	0	None
46935	46936	(	0	None
46936	46937	DHT	0	None
46937	46938	)	0	None
46938	46939	by	0	None
46939	46940	5-alpha	0	None
46940	46941	reductase	0	None
46941	46942	(	0	None
46942	46943	5-AR	3	GENE-N
46943	46944	)	0	None
46944	46945	enzymes	0	None
46945	46946	types	0	None
46946	46947	1	0	None
46947	46948	and	0	None
46948	46949	2	0	None
46949	46950	.	0	None

46951	46952	It	0	None
46952	46953	has	0	None
46953	46954	been	0	None
46954	46955	theorized	0	None
46955	46956	that	0	None
46956	46957	an	0	None
46957	46958	overabundance	0	None
46958	46959	of	0	None
46959	46960	DHT	0	None
46960	46961	may	0	None
46961	46962	be	0	None
46962	46963	implicated	0	None
46963	46964	in	0	None
46964	46965	the	0	None
46965	46966	pathogenesis	0	None
46966	46967	of	0	None
46967	46968	both	0	None
46968	46969	benign	0	None
46969	46970	prostatic	0	None
46970	46971	hyperplasia	0	None
46971	46972	(	0	None
46972	46973	BPH	0	None
46973	46974	)	0	None
46974	46975	and	0	None
46975	46976	prostate	0	None
46976	46977	cancer	0	None
46977	46978	.	0	None

46979	46980	Inhibitors	0	None
46980	46981	of	0	None
46981	46982	5-AR	3	GENE-N
46982	46983	such	0	None
46983	46984	as	0	None
46984	46985	dutasteride	2	CHEMICAL
46985	46986	and	0	None
46986	46987	finasteride	2	CHEMICAL
46987	46988	may	0	None
46988	46989	therefore	0	None
46989	46990	have	0	None
46990	46991	an	0	None
46991	46992	important	0	None
46992	46993	role	0	None
46993	46994	in	0	None
46994	46995	the	0	None
46995	46996	prevention	0	None
46996	46997	and	0	None
46997	46998	treatment	0	None
46998	46999	of	0	None
46999	47000	BPH	0	None
47000	47001	and	0	None
47001	47002	prostate	0	None
47002	47003	cancer	0	None
47003	47004	.	0	None

47005	47006	Dutasteride	2	CHEMICAL
47006	47007	provides	0	None
47007	47008	greater	0	None
47008	47009	suppression	0	None
47009	47010	of	0	None
47010	47011	DHT	0	None
47011	47012	than	0	None
47012	47013	finasteride	2	CHEMICAL
47013	47014	,	0	None
47014	47015	thereby	0	None
47015	47016	underlying	0	None
47016	47017	the	0	None
47017	47018	hypothesis	0	None
47018	47019	that	0	None
47019	47020	inhibition	0	None
47020	47021	of	0	None
47021	47022	both	0	None
47022	47023	type	0	None
47023	47024	1	0	None
47024	47025	and	0	None
47025	47026	type	0	None
47026	47027	2	0	None
47027	47028	would	0	None
47028	47029	provide	0	None
47029	47030	correspondingly	0	None
47030	47031	greater	0	None
47031	47032	protection	0	None
47032	47033	than	0	None
47033	47034	inhibition	0	None
47034	47035	of	0	None
47035	47036	type	0	None
47036	47037	2	0	None
47037	47038	alone	0	None
47038	47039	.	0	None

47040	47041	We	0	None
47041	47042	review	0	None
47042	47043	the	0	None
47043	47044	potential	0	None
47044	47045	significance	0	None
47045	47046	of	0	None
47046	47047	the	0	None
47047	47048	5-AR	3	GENE-N
47048	47049	inhibitors	0	None
47049	47050	in	0	None
47050	47051	reducing	0	None
47051	47052	the	0	None
47052	47053	risk	0	None
47053	47054	of	0	None
47054	47055	prostate	0	None
47055	47056	cancer	0	None
47056	47057	according	0	None
47057	47058	to	0	None
47058	47059	the	0	None
47059	47060	basic	0	None
47060	47061	biology	0	None
47061	47062	of	0	None
47062	47063	prostate	0	None
47063	47064	disease	0	None
47064	47065	.	0	None
47065	47066	The	0	None
47066	47067	synthesis	0	None
47067	47068	and	0	None
47068	47069	pharmacological	0	None
47069	47070	evaluation	0	None
47070	47071	of	0	None
47071	47072	new	0	None
47072	47073	water-soluble	0	None
47073	47074	phosphoramidate	0	None
47074	47075	derivatives	0	None
47075	47076	of	0	None
47076	47077	the	0	None
47077	47078	COX-2	0	None
47078	47079	selective	0	None
47079	47080	inhibitor	0	None
47080	47081	cimicoxib	0	None
47081	47082	(	0	None
47082	47083	4	0	None
47083	47084	)	0	None
47084	47085	are	0	None
47085	47086	described	0	None
47086	47087	.	0	None

47088	47089	The	0	None
47089	47090	sulfonylphosphoramidic	0	None
47090	47091	acid	0	None
47091	47092	derivative	0	None
47092	47093	10	0	None
47093	47094	was	0	None
47094	47095	converted	0	None
47095	47096	to	0	None
47096	47097	4	0	None
47097	47098	in	0	None
47098	47099	human	0	None
47099	47100	plasma	0	None
47100	47101	and	0	None
47101	47102	showed	0	None
47102	47103	excellent	0	None
47103	47104	in	0	None
47104	47105	vivo	0	None
47105	47106	activity	0	None
47106	47107	in	0	None
47107	47108	the	0	None
47108	47109	rat	0	None
47109	47110	carrageenan-edema	0	None
47110	47111	test	0	None
47111	47112	.	0	None

47113	47114	Pharmacokinetic	0	None
47114	47115	evaluation	0	None
47115	47116	in	0	None
47116	47117	dogs	0	None
47117	47118	indicated	0	None
47118	47119	that	0	None
47119	47120	10	0	None
47120	47121	behaved	0	None
47121	47122	as	0	None
47122	47123	a	0	None
47123	47124	prodrug	0	None
47124	47125	,	0	None
47125	47126	immediately	0	None
47126	47127	converting	0	None
47127	47128	to	0	None
47128	47129	4	0	None
47129	47130	and	0	None
47130	47131	giving	0	None
47131	47132	an	0	None
47132	47133	identical	0	None
47133	47134	profile	0	None
47134	47135	to	0	None
47135	47136	that	0	None
47136	47137	of	0	None
47137	47138	the	0	None
47138	47139	parent	0	None
47139	47140	compound	0	None
47140	47141	.	0	None

47142	47143	These	0	None
47143	47144	results	0	None
47144	47145	represent	0	None
47145	47146	the	0	None
47146	47147	first	0	None
47147	47148	description	0	None
47148	47149	of	0	None
47149	47150	phosphoramidic	0	None
47150	47151	acids	0	None
47151	47152	as	0	None
47152	47153	prodrugs	0	None
47153	47154	for	0	None
47154	47155	the	0	None
47155	47156	sulfonamido	0	None
47156	47157	group	0	None
47157	47158	.	0	None

47159	47160	Compound	0	None
47160	47161	10	0	None
47161	47162	also	0	None
47162	47163	exhibited	0	None
47163	47164	an	0	None
47164	47165	important	0	None
47165	47166	and	0	None
47166	47167	sustained	0	None
47167	47168	analgesic	0	None
47168	47169	effect	0	None
47169	47170	in	0	None
47170	47171	the	0	None
47171	47172	hyperalgesia	0	None
47172	47173	test	0	None
47173	47174	in	0	None
47174	47175	rats	0	None
47175	47176	and	0	None
47176	47177	a	0	None
47177	47178	high	0	None
47178	47179	aqueous	0	None
47179	47180	solubility	0	None
47180	47181	at	0	None
47181	47182	pH	0	None
47182	47183	higher	0	None
47183	47184	than	0	None
47184	47185	7	0	None
47185	47186	.	0	None

47187	47188	This	0	None
47188	47189	profile	0	None
47189	47190	led	0	None
47190	47191	to	0	None
47191	47192	the	0	None
47192	47193	selection	0	None
47193	47194	of	0	None
47194	47195	10	0	None
47195	47196	(	0	None
47196	47197	UR-14048	0	None
47197	47198	)	0	None
47198	47199	for	0	None
47199	47200	further	0	None
47200	47201	development	0	None
47201	47202	in	0	None
47202	47203	the	0	None
47203	47204	parenteral	0	None
47204	47205	treatment	0	None
47205	47206	of	0	None
47206	47207	acute	0	None
47207	47208	pain	0	None
47208	47209	.	0	None
47209	47210	Suppression	0	None
47210	47211	of	0	None
47211	47212	Src	0	None
47212	47213	/	0	None
47213	47214	ERK	0	None
47214	47215	and	0	None
47215	47216	GSK-3	0	None
47216	47217	/	0	None
47217	47218	β-catenin	0	None
47218	47219	signaling	0	None
47219	47220	by	0	None
47220	47221	pinosylvin	0	None
47221	47222	inhibits	0	None
47222	47223	the	0	None
47223	47224	growth	0	None
47224	47225	of	0	None
47225	47226	human	0	None
47226	47227	colorectal	0	None
47227	47228	cancer	0	None
47228	47229	cells	0	None
47229	47230	.	0	None
47230	47231	Hyperornithinemia	0	None
47231	47232	,	0	None
47232	47233	hyperammonemia	0	None
47233	47234	,	0	None
47234	47235	and	0	None
47235	47236	homocitrullinuria	0	None
47236	47237	(	0	None
47237	47238	HHH	0	None
47238	47239	)	0	None
47239	47240	syndrome	0	None
47240	47241	is	0	None
47241	47242	caused	0	None
47242	47243	by	0	None
47243	47244	mutations	0	None
47244	47245	in	0	None
47245	47246	the	0	None
47246	47247	SLC25A15	0	None
47247	47248	(	0	None
47248	47249	ORNT1	0	None
47249	47250	)	0	None
47250	47251	gene	0	None
47251	47252	encoding	0	None
47252	47253	the	0	None
47253	47254	mitochondrial	0	None
47254	47255	ornithine	2	CHEMICAL
47255	47256	transporter	0	None
47256	47257	,	0	None
47257	47258	but	0	None
47258	47259	the	0	None
47259	47260	mechanism	0	None
47260	47261	of	0	None
47261	47262	pathogenesis	0	None
47262	47263	of	0	None
47263	47264	the	0	None
47264	47265	encephalopathy	0	None
47265	47266	,	0	None
47266	47267	spastic	0	None
47267	47268	paraparesis	0	None
47268	47269	and	0	None
47269	47270	hepatopathy	0	None
47270	47271	remains	0	None
47271	47272	undetermined	0	None
47272	47273	.	0	None

47274	47275	HHH	0	None
47275	47276	syndrome	0	None
47276	47277	was	0	None
47277	47278	diagnosed	0	None
47278	47279	in	0	None
47279	47280	a	0	None
47280	47281	2-year-old	0	None
47281	47282	Palestinian	0	None
47282	47283	boy	0	None
47283	47284	with	0	None
47284	47285	developmental	0	None
47285	47286	delay	0	None
47286	47287	and	0	None
47287	47288	seizures	0	None
47288	47289	,	0	None
47289	47290	and	0	None
47290	47291	subsequently	0	None
47291	47292	in	0	None
47292	47293	his	0	None
47293	47294	13-year-old	0	None
47294	47295	brother	0	None
47295	47296	with	0	None
47296	47297	developmental	0	None
47297	47298	delay	0	None
47298	47299	.	0	None

47300	47301	Direct	0	None
47301	47302	sequencing	0	None
47302	47303	of	0	None
47303	47304	the	0	None
47304	47305	PCR	0	None
47305	47306	products	0	None
47306	47307	of	0	None
47307	47308	SLC25A15	0	None
47308	47309	exon	0	None
47309	47310	amplifications	0	None
47310	47311	revealed	0	None
47311	47312	that	0	None
47312	47313	both	0	None
47313	47314	brothers	0	None
47314	47315	were	0	None
47315	47316	homozygous	0	None
47316	47317	for	0	None
47317	47318	a	0	None
47318	47319	novel	0	None
47319	47320	446G	0	None
47320	47321	deletion	0	None
47321	47322	in	0	None
47322	47323	exon	0	None
47323	47324	3	0	None
47324	47325	as	0	None
47325	47326	well	0	None
47326	47327	as	0	None
47327	47328	for	0	None
47328	47329	a	0	None
47329	47330	760A>T	0	None
47330	47331	(	0	None
47331	47332	I254L	0	None
47332	47333	)	0	None
47333	47334	polymorphism	0	None
47334	47335	in	0	None
47335	47336	exon	0	None
47336	47337	5	0	None
47337	47338	,	0	None
47338	47339	which	0	None
47339	47340	is	0	None
47340	47341	downstream	0	None
47341	47342	of	0	None
47342	47343	a	0	None
47343	47344	premature	0	None
47344	47345	termination	0	None
47345	47346	codon	0	None
47346	47347	produced	0	None
47347	47348	by	0	None
47348	47349	the	0	None
47349	47350	frameshift	0	None
47350	47351	resulting	0	None
47351	47352	from	0	None
47352	47353	the	0	None
47353	47354	446G	0	None
47354	47355	deletion	0	None
47355	47356	.	0	None

47357	47358	The	0	None
47358	47359	index	0	None
47359	47360	patient	0	None
47360	47361	had	0	None
47361	47362	elevated	0	None
47362	47363	liver	0	None
47363	47364	enzymes	0	None
47364	47365	as	0	None
47365	47366	well	0	None
47366	47367	as	0	None
47367	47368	hyperalaninemia	0	None
47368	47369	,	0	None
47369	47370	lactic	0	None
47370	47371	acidemia	0	None
47371	47372	with	0	None
47372	47373	an	0	None
47373	47374	elevated	0	None
47374	47375	lactate	0	None
47375	47376	to	0	None
47376	47377	pyruvate	2	CHEMICAL
47377	47378	ratio	0	None
47378	47379	,	0	None
47379	47380	and	0	None
47380	47381	increased	0	None
47381	47382	urinary	0	None
47382	47383	excretion	0	None
47383	47384	of	0	None
47384	47385	lactate	0	None
47385	47386	,	0	None
47386	47387	glutarate	0	None
47387	47388	and	0	None
47388	47389	Krebs	0	None
47389	47390	cycle	0	None
47390	47391	intermediates	0	None
47391	47392	.	0	None

47393	47394	These	0	None
47394	47395	findings	0	None
47395	47396	are	0	None
47396	47397	indicative	0	None
47397	47398	of	0	None
47398	47399	mitochondrial	0	None
47399	47400	dysfunction	0	None
47400	47401	and	0	None
47401	47402	are	0	None
47402	47403	in	0	None
47403	47404	accordance	0	None
47404	47405	with	0	None
47405	47406	ultrastructural	0	None
47406	47407	studies	0	None
47407	47408	showing	0	None
47408	47409	increased	0	None
47409	47410	numbers	0	None
47410	47411	of	0	None
47411	47412	large	0	None
47412	47413	and	0	None
47413	47414	bizarre	0	None
47414	47415	mitochondria	0	None
47415	47416	in	0	None
47416	47417	liver	0	None
47417	47418	,	0	None
47418	47419	muscle	0	None
47419	47420	,	0	None
47420	47421	leukocytes	0	None
47421	47422	and	0	None
47422	47423	fibroblasts	0	None
47423	47424	of	0	None
47424	47425	some	0	None
47425	47426	HHH	0	None
47426	47427	patients	0	None
47427	47428	.	0	None

47429	47430	Neurologic	0	None
47430	47431	and	0	None
47431	47432	hepatic	0	None
47432	47433	manifestations	0	None
47433	47434	are	0	None
47434	47435	characteristic	0	None
47435	47436	of	0	None
47436	47437	some	0	None
47437	47438	primary	0	None
47438	47439	mitochondrial	0	None
47439	47440	disorders	0	None
47440	47441	.	0	None

47442	47443	Secondary	0	None
47443	47444	mitochondrial	0	None
47444	47445	dysfunction	0	None
47445	47446	may	0	None
47446	47447	contribute	0	None
47447	47448	to	0	None
47448	47449	the	0	None
47449	47450	pathogenesis	0	None
47450	47451	of	0	None
47451	47452	these	0	None
47452	47453	same	0	None
47453	47454	features	0	None
47454	47455	in	0	None
47455	47456	HHH	0	None
47456	47457	syndrome	0	None
47457	47458	.	0	None
47458	47459	Within	0	None
47459	47460	the	0	None
47460	47461	past	0	None
47461	47462	decade	0	None
47462	47463	,	0	None
47463	47464	gonadotrophin-releasing	0	None
47464	47465	hormone	0	None
47465	47466	(	0	None
47466	47467	GnRH	0	None
47467	47468	)	0	None
47468	47469	agonists	0	None
47469	47470	have	0	None
47470	47471	contributed	0	None
47471	47472	greatly	0	None
47472	47473	to	0	None
47473	47474	the	0	None
47474	47475	success	0	None
47475	47476	of	0	None
47476	47477	cycles	0	None
47477	47478	programmed	0	None
47478	47479	for	0	None
47479	47480	in-vitro	0	None
47480	47481	fertilization	0	None
47481	47482	and	0	None
47482	47483	embryo	0	None
47483	47484	transfer	0	None
47484	47485	.	0	None

47486	47487	However	0	None
47487	47488	,	0	None
47488	47489	apart	0	None
47489	47490	from	0	None
47490	47491	a	0	None
47491	47492	preventive	0	None
47492	47493	effect	0	None
47493	47494	on	0	None
47494	47495	the	0	None
47495	47496	luteinizing	0	None
47496	47497	hormone	0	None
47497	47498	(	0	None
47498	47499	LH	0	None
47499	47500	)	0	None
47500	47501	surge	0	None
47501	47502	,	0	None
47502	47503	most	0	None
47503	47504	of	0	None
47504	47505	the	0	None
47505	47506	beneficial	0	None
47506	47507	effects	0	None
47507	47508	of	0	None
47508	47509	these	0	None
47509	47510	molecules	0	None
47510	47511	are	0	None
47511	47512	still	0	None
47512	47513	only	0	None
47513	47514	partly	0	None
47514	47515	known	0	None
47515	47516	.	0	None

47517	47518	A	0	None
47518	47519	precise	0	None
47519	47520	analysis	0	None
47520	47521	of	0	None
47521	47522	regimens	0	None
47522	47523	using	0	None
47523	47524	GnRH	0	None
47524	47525	agonists	0	None
47525	47526	for	0	None
47526	47527	ovarian	0	None
47527	47528	stimulation	0	None
47528	47529	shows	0	None
47529	47530	that	0	None
47530	47531	many	0	None
47531	47532	parameters	0	None
47532	47533	may	0	None
47533	47534	interfere	0	None
47534	47535	with	0	None
47535	47536	the	0	None
47536	47537	outcome	0	None
47537	47538	of	0	None
47538	47539	long-term	0	None
47539	47540	and	0	None
47540	47541	short-term	0	None
47541	47542	protocols	0	None
47542	47543	.	0	None

47544	47545	The	0	None
47545	47546	great	0	None
47546	47547	variability	0	None
47547	47548	between	0	None
47548	47549	these	0	None
47549	47550	protocols	0	None
47550	47551	hampers	0	None
47551	47552	our	0	None
47552	47553	comprehension	0	None
47553	47554	of	0	None
47554	47555	the	0	None
47555	47556	mechanisms	0	None
47556	47557	involved	0	None
47557	47558	in	0	None
47558	47559	the	0	None
47559	47560	overall	0	None
47560	47561	clinical	0	None
47561	47562	improvement	0	None
47562	47563	seen	0	None
47563	47564	with	0	None
47564	47565	this	0	None
47565	47566	therapy	0	None
47566	47567	.	0	None

47568	47569	The	0	None
47569	47570	hypophyseal	0	None
47570	47571	desensitization	0	None
47571	47572	induced	0	None
47572	47573	by	0	None
47573	47574	GnRH	0	None
47574	47575	agonists	0	None
47575	47576	is	0	None
47576	47577	greatly	0	None
47577	47578	dependent	0	None
47578	47579	on	0	None
47579	47580	the	0	None
47580	47581	dose	0	None
47581	47582	and	0	None
47582	47583	duration	0	None
47583	47584	of	0	None
47584	47585	their	0	None
47585	47586	administration	0	None
47586	47587	,	0	None
47587	47588	but	0	None
47588	47589	the	0	None
47589	47590	residual	0	None
47590	47591	gonadotrophin	0	None
47591	47592	secretion	0	None
47592	47593	is	0	None
47593	47594	imperfectly	0	None
47594	47595	estimated	0	None
47595	47596	by	0	None
47596	47597	hormonal	0	None
47597	47598	measurements	0	None
47598	47599	using	0	None
47599	47600	radioimmunometric	0	None
47600	47601	assays	0	None
47601	47602	.	0	None

47603	47604	Moreover	0	None
47604	47605	,	0	None
47605	47606	the	0	None
47606	47607	specific	0	None
47607	47608	role	0	None
47608	47609	of	0	None
47609	47610	GnRH	0	None
47610	47611	agonist-induced	0	None
47611	47612	ovarian	0	None
47612	47613	quiescence	0	None
47613	47614	on	0	None
47614	47615	subsequent	0	None
47615	47616	ovarian	0	None
47616	47617	responsiveness	0	None
47617	47618	to	0	None
47618	47619	gonadotrophins	3	GENE-N
47619	47620	and	0	None
47620	47621	on	0	None
47621	47622	endometrial	0	None
47622	47623	receptivity	0	None
47623	47624	deserves	0	None
47624	47625	further	0	None
47625	47626	investigation	0	None
47626	47627	.	0	None

47628	47629	Finally	0	None
47629	47630	,	0	None
47630	47631	a	0	None
47631	47632	direct	0	None
47632	47633	ovarian	0	None
47633	47634	action	0	None
47634	47635	of	0	None
47635	47636	GnRH	0	None
47636	47637	agonists	0	None
47637	47638	on	0	None
47638	47639	steroidogenesis	0	None
47639	47640	,	0	None
47640	47641	folliculogenesis	0	None
47641	47642	and	0	None
47642	47643	embryo	0	None
47643	47644	quality	0	None
47644	47645	is	0	None
47645	47646	still	0	None
47646	47647	controversial	0	None
47647	47648	in	0	None
47648	47649	humans	0	None
47649	47650	.	0	None

47651	47652	These	0	None
47652	47653	putative	0	None
47653	47654	deleterious	0	None
47654	47655	effects	0	None
47655	47656	of	0	None
47656	47657	GnRH	0	None
47657	47658	agonists	0	None
47658	47659	have	0	None
47659	47660	led	0	None
47660	47661	some	0	None
47661	47662	authors	0	None
47662	47663	to	0	None
47663	47664	recommend	0	None
47664	47665	a	0	None
47665	47666	reduction	0	None
47666	47667	of	0	None
47667	47668	both	0	None
47668	47669	dose	0	None
47669	47670	and	0	None
47670	47671	duration	0	None
47671	47672	of	0	None
47672	47673	GnRH	0	None
47673	47674	agonist	0	None
47674	47675	administration	0	None
47675	47676	for	0	None
47676	47677	women	0	None
47677	47678	identified	0	None
47678	47679	by	0	None
47679	47680	a	0	None
47680	47681	poor	0	None
47681	47682	response	0	None
47682	47683	to	0	None
47683	47684	gonadotrophins	3	GENE-N
47684	47685	.	0	None

47686	47687	Using	0	None
47687	47688	this	0	None
47688	47689	approach	0	None
47689	47690	,	0	None
47690	47691	a	0	None
47691	47692	few	0	None
47692	47693	reports	0	None
47693	47694	have	0	None
47694	47695	recently	0	None
47695	47696	shown	0	None
47696	47697	some	0	None
47697	47698	clinical	0	None
47698	47699	advantages	0	None
47699	47700	for	0	None
47700	47701	ovarian	0	None
47701	47702	responsiveness	0	None
47702	47703	but	0	None
47703	47704	no	0	None
47704	47705	convincing	0	None
47705	47706	evidence	0	None
47706	47707	for	0	None
47707	47708	any	0	None
47708	47709	improvement	0	None
47709	47710	in	0	None
47710	47711	pregnancy	0	None
47711	47712	rate	0	None
47712	47713	.	0	None

47714	47715	It	0	None
47715	47716	thus	0	None
47716	47717	appears	0	None
47717	47718	that	0	None
47718	47719	the	0	None
47719	47720	overall	0	None
47720	47721	impact	0	None
47721	47722	of	0	None
47722	47723	GnRH	0	None
47723	47724	agonists	0	None
47724	47725	on	0	None
47725	47726	reproductive	0	None
47726	47727	function	0	None
47727	47728	is	0	None
47728	47729	still	0	None
47729	47730	partly	0	None
47730	47731	misunderstood	0	None
47731	47732	.	0	None
47732	47733	Rapid	0	None
47733	47734	cortical	0	None
47734	47735	bone	0	None
47735	47736	loss	0	None
47736	47737	in	0	None
47737	47738	patients	0	None
47738	47739	with	0	None
47739	47740	chronic	0	None
47740	47741	kidney	0	None
47741	47742	disease	0	None
47742	47743	.	0	None
47743	47744	Sesamin	0	None
47744	47745	(	0	None
47745	47746	a	0	None
47746	47747	non-fat	0	None
47747	47748	portion	0	None
47748	47749	of	0	None
47749	47750	sesame	0	None
47750	47751	seed	0	None
47751	47752	oil	0	None
47752	47753	)	0	None
47753	47754	inhibits	0	None
47754	47755	delta-5	0	None
47755	47756	desaturase	0	None
47756	47757	activity	0	None
47757	47758	resulting	0	None
47758	47759	in	0	None
47759	47760	an	0	None
47760	47761	accumulation	0	None
47761	47762	of	0	None
47762	47763	dihomo-gamma-linolenic	0	None
47763	47764	acid	0	None
47764	47765	(	0	None
47765	47766	DGLA	0	None
47766	47767	)	0	None
47767	47768	which	0	None
47768	47769	can	0	None
47769	47770	displace	0	None
47770	47771	arachidonic	0	None
47771	47772	acid	0	None
47772	47773	(	0	None
47773	47774	AA	0	None
47774	47775	)	0	None
47775	47776	and	0	None
47776	47777	decrease	0	None
47777	47778	the	0	None
47778	47779	formation	0	None
47779	47780	of	0	None
47780	47781	pro-inflammatory	0	None
47781	47782	mediators	0	None
47782	47783	.	0	None

47784	47785	We	0	None
47785	47786	investigated	0	None
47786	47787	the	0	None
47787	47788	effects	0	None
47788	47789	of	0	None
47789	47790	consumption	0	None
47790	47791	of	0	None
47791	47792	diets	0	None
47792	47793	containing	0	None
47793	47794	0	0	None
47794	47795	.	0	None
47795	47796	25wt%	0	None
47796	47797	sesamin	0	None
47797	47798	and	0	None
47798	47799	15	0	None
47799	47800	wt%	0	None
47800	47801	safflower	0	None
47801	47802	oil	0	None
47802	47803	(	0	None
47803	47804	SO	0	None
47804	47805	)	0	None
47805	47806	(	0	None
47806	47807	providing	0	None
47807	47808	12%	0	None
47808	47809	of	0	None
47809	47810	the	0	None
47810	47811	added	0	None
47811	47812	fat	0	None
47812	47813	as	0	None
47813	47814	linoleic	0	None
47814	47815	acid	0	None
47815	47816	)	0	None
47816	47817	or	0	None
47817	47818	a	0	None
47818	47819	15	0	None
47819	47820	wt%	0	None
47820	47821	2	0	None
47821	47822	:	0	None
47822	47823	1	0	None
47823	47824	mixture	0	None
47824	47825	of	0	None
47825	47826	linseed	0	None
47826	47827	oil	0	None
47827	47828	and	0	None
47828	47829	SO	0	None
47829	47830	(	0	None
47830	47831	LOSO	0	None
47831	47832	)	0	None
47832	47833	(	0	None
47833	47834	providing	0	None
47834	47835	6%	0	None
47835	47836	alpha-linolenic	0	None
47836	47837	acid	0	None
47837	47838	and	0	None
47838	47839	6%	0	None
47839	47840	linoleic	0	None
47840	47841	acid	0	None
47841	47842	)	0	None
47842	47843	for	0	None
47843	47844	3	0	None
47844	47845	weeks	0	None
47845	47846	on	0	None
47846	47847	the	0	None
47847	47848	liver	0	None
47848	47849	membrane	0	None
47849	47851	fatty acid	2	CHEMICAL
47851	47852	composition	0	None
47852	47853	and	0	None
47853	47854	on	0	None
47854	47855	the	0	None
47855	47856	production	0	None
47856	47857	of	0	None
47857	47858	prostaglandin	0	None
47858	47859	(	0	None
47859	47860	PG	0	None
47860	47861	)	0	None
47861	47862	E2	0	None
47862	47863	,	0	None
47863	47864	TNF-alpha	0	None
47864	47865	,	0	None
47865	47866	IL-6	0	None
47866	47867	and	0	None
47867	47868	IL10	0	None
47868	47869	in	0	None
47869	47870	mice	0	None
47870	47871	.	0	None

47872	47873	Consumption	0	None
47873	47874	of	0	None
47874	47875	sesamin-supplemented	0	None
47875	47876	SO	0	None
47876	47877	and	0	None
47877	47878	LOSO	0	None
47878	47879	diets	0	None
47879	47880	resulted	0	None
47880	47881	in	0	None
47881	47882	a	0	None
47882	47883	significant	0	None
47883	47884	increase	0	None
47884	47885	in	0	None
47885	47886	the	0	None
47886	47887	levels	0	None
47887	47888	of	0	None
47888	47889	20	0	None
47889	47890	:	0	None
47890	47891	3omega6	0	None
47891	47892	(	0	None
47892	47893	DGLA	0	None
47893	47894	)	0	None
47894	47895	,	0	None
47895	47896	suggesting	0	None
47896	47897	that	0	None
47897	47898	sesamin	0	None
47898	47899	inhibited	0	None
47899	47900	delta-5	0	None
47900	47901	desaturation	0	None
47901	47902	of	0	None
47902	47905	omega6 fatty acids	2	CHEMICAL
47905	47906	.	0	None

47907	47908	In	0	None
47908	47909	animals	0	None
47909	47910	fed	0	None
47910	47911	LOSO	0	None
47911	47912	diets	0	None
47912	47913	,	0	None
47913	47914	the	0	None
47914	47915	levels	0	None
47915	47916	of	0	None
47916	47917	alpha-linolenic	0	None
47917	47918	acid	0	None
47918	47919	,	0	None
47919	47921	eicosapentaenoic acid	2	CHEMICAL
47921	47922	(	0	None
47922	47923	EPA	0	None
47923	47924	)	0	None
47924	47925	and	0	None
47925	47926	of	0	None
47926	47927	docosahexaenoic	0	None
47927	47928	acid	0	None
47928	47929	(	0	None
47929	47930	DHA	0	None
47930	47931	)	0	None
47931	47932	were	0	None
47932	47933	elevated	0	None
47933	47934	with	0	None
47934	47935	a	0	None
47935	47936	concomitant	0	None
47936	47937	decrease	0	None
47937	47938	of	0	None
47938	47940	arachidonic acid	2	CHEMICAL
47940	47941	(	0	None
47941	47942	AA	0	None
47942	47943	)	0	None
47943	47944	in	0	None
47944	47945	the	0	None
47945	47946	liver	0	None
47946	47947	membrane	0	None
47947	47948	phospholipids	0	None
47948	47949	.	0	None

47950	47951	Further	0	None
47951	47952	,	0	None
47952	47953	in	0	None
47953	47954	animals	0	None
47954	47955	fed	0	None
47955	47956	LOSO	0	None
47956	47957	diets	0	None
47957	47958	with	0	None
47958	47959	or	0	None
47959	47960	without	0	None
47960	47961	sesamin	0	None
47961	47962	,	0	None
47962	47963	an	0	None
47963	47964	increase	0	None
47964	47965	in	0	None
47965	47966	the	0	None
47966	47967	circulating	0	None
47967	47968	levels	0	None
47968	47969	of	0	None
47969	47970	TNF-alpha	0	None
47970	47971	was	0	None
47971	47972	associated	0	None
47972	47973	with	0	None
47973	47974	a	0	None
47974	47975	concomitant	0	None
47975	47976	decrease	0	None
47976	47977	in	0	None
47977	47978	PGE2	2	CHEMICAL
47978	47979	.	0	None

47980	47981	Despite	0	None
47981	47982	a	0	None
47982	47983	lack	0	None
47983	47984	of	0	None
47984	47985	differences	0	None
47985	47986	in	0	None
47986	47987	the	0	None
47987	47988	levels	0	None
47988	47989	of	0	None
47989	47990	AA	0	None
47990	47991	,	0	None
47991	47992	the	0	None
47992	47993	PGE2	2	CHEMICAL
47993	47994	levels	0	None
47994	47995	were	0	None
47995	47996	significantly	0	None
47996	47997	lower	0	None
47997	47998	in	0	None
47998	47999	mice	0	None
47999	48000	fed	0	None
48000	48001	sesamin-supplemented	0	None
48001	48002	SO	0	None
48002	48003	compared	0	None
48003	48004	to	0	None
48004	48005	those	0	None
48005	48006	fed	0	None
48006	48007	SO	0	None
48007	48008	alone	0	None
48008	48009	.	0	None

48010	48011	Thus	0	None
48011	48012	,	0	None
48012	48013	these	0	None
48013	48014	data	0	None
48014	48015	suggest	0	None
48015	48016	that	0	None
48016	48017	irrespective	0	None
48017	48018	of	0	None
48018	48019	the	0	None
48019	48020	availability	0	None
48020	48021	of	0	None
48021	48022	a	0	None
48022	48023	specific	0	None
48023	48025	fatty acid	2	CHEMICAL
48025	48026	as	0	None
48026	48027	a	0	None
48027	48028	substrate	0	None
48028	48029	,	0	None
48029	48030	through	0	None
48030	48031	regulating	0	None
48031	48032	the	0	None
48032	48033	PGE2	2	CHEMICAL
48033	48034	synthesis	0	None
48034	48035	,	0	None
48035	48036	the	0	None
48036	48037	production	0	None
48037	48038	of	0	None
48038	48039	TNF-alpha	0	None
48039	48040	could	0	None
48040	48041	be	0	None
48041	48042	modulated	0	None
48042	48043	.	0	None
48043	48044	Inhibitory	0	None
48044	48045	effect	0	None
48045	48046	of	0	None
48046	48047	dihydroartemisinin	0	None
48047	48048	against	0	None
48048	48049	phorbol	0	None
48049	48050	ester-induced	0	None
48050	48051	cyclooxygenase-2	0	None
48051	48052	expression	0	None
48052	48053	in	0	None
48053	48054	macrophages	0	None
48054	48055	.	0	None
48055	48056	Proximal	0	None
48056	48057	tubule	0	None
48057	48058	cells	0	None
48058	48059	extract	0	None
48059	48060	dicarboxylates	0	None
48060	48061	from	0	None
48061	48062	filtrate	0	None
48062	48063	and	0	None
48063	48064	blood	0	None
48064	48065	,	0	None
48065	48066	using	0	None
48066	48067	cotransporters	0	None
48067	48068	located	0	None
48068	48069	in	0	None
48069	48070	the	0	None
48070	48071	brush	0	None
48071	48072	border	0	None
48072	48073	[	0	None
48073	48075	sodium dicarboxylate	2	CHEMICAL
48075	48076	cotransporter	0	None
48076	48077	(	0	None
48077	48078	NaDC-1	0	None
48078	48079	)	0	None
48079	48080	]	0	None
48080	48081	and	0	None
48081	48082	basolateral	0	None
48082	48083	cell	0	None
48083	48084	membrane	0	None
48084	48085	(	0	None
48085	48086	NaDC-3	0	None
48086	48087	)	0	None
48087	48088	.	0	None

48089	48090	We	0	None
48090	48091	expressed	0	None
48091	48092	the	0	None
48092	48093	human	0	None
48093	48094	NaDC-3	0	None
48094	48095	(	0	None
48095	48096	hNaDC-3	0	None
48096	48097	)	0	None
48097	48098	in	0	None
48098	48099	Xenopus	0	None
48099	48100	laevis	0	None
48100	48101	oocytes	0	None
48101	48102	and	0	None
48102	48103	characterized	0	None
48103	48104	it	0	None
48104	48105	by	0	None
48105	48106	the	0	None
48106	48107	two-electrode	0	None
48107	48108	voltage-clamp	0	None
48108	48109	technique	0	None
48109	48110	.	0	None

48111	48112	At	0	None
48112	48113	-60	0	None
48113	48114	mV	0	None
48114	48115	,	0	None
48115	48116	succinate	0	None
48116	48117	(	0	None
48117	48118	4	0	None
48118	48119	carbons	0	None
48119	48120	)	0	None
48120	48121	and	0	None
48121	48122	glutarate	0	None
48122	48123	(	0	None
48123	48124	5	0	None
48124	48125	carbons	0	None
48125	48126	)	0	None
48126	48127	generated	0	None
48127	48128	inward	0	None
48128	48129	currents	0	None
48129	48130	due	0	None
48130	48131	to	0	None
48131	48132	translocation	0	None
48132	48133	of	0	None
48133	48134	three	0	None
48134	48135	sodium	2	CHEMICAL
48135	48136	ions	0	None
48136	48137	and	0	None
48137	48138	one	0	None
48138	48139	divalent	0	None
48139	48140	dicarboxylate	2	CHEMICAL
48140	48141	,	0	None
48141	48142	whereas	0	None
48142	48143	oxalate	2	CHEMICAL
48143	48144	(	0	None
48144	48145	2	0	None
48145	48146	carbons	0	None
48146	48147	)	0	None
48147	48148	and	0	None
48148	48149	malonate	0	None
48149	48150	(	0	None
48150	48151	3	0	None
48151	48152	carbons	0	None
48152	48153	)	0	None
48153	48154	did	0	None
48154	48155	not	0	None
48155	48156	.	0	None

48157	48158	The	0	None
48158	48159	cis-dicarboxylate	0	None
48159	48160	maleate	0	None
48160	48161	produced	0	None
48161	48162	currents	0	None
48162	48163	smaller	0	None
48163	48164	in	0	None
48164	48165	magnitude	0	None
48165	48166	,	0	None
48166	48167	whereas	0	None
48167	48168	the	0	None
48168	48169	trans-dicarboxylate	0	None
48169	48170	fumarate	0	None
48170	48171	generated	0	None
48171	48172	currents	0	None
48172	48173	similar	0	None
48173	48174	to	0	None
48174	48175	succinate	0	None
48175	48176	.	0	None

48177	48178	The	0	None
48178	48179	substituted	0	None
48179	48180	succinate	0	None
48180	48181	derivatives	0	None
48181	48182	,	0	None
48182	48183	malate	0	None
48183	48184	,	0	None
48184	48185	2	0	None
48185	48186	,	0	None
48186	48187	2-	0	None
48187	48188	and	0	None
48188	48189	2	0	None
48189	48190	,	0	None
48190	48191	3-dimethylsuccinate	0	None
48191	48192	,	0	None
48192	48193	and	0	None
48193	48194	2	0	None
48194	48195	,	0	None
48195	48196	3-dimercaptosuccinate	0	None
48196	48197	elicited	0	None
48197	48198	inward	0	None
48198	48199	currents	0	None
48199	48200	,	0	None
48200	48201	whereas	0	None
48201	48202	aspartate	0	None
48202	48203	and	0	None
48203	48204	guanidinosuccinate	0	None
48204	48205	showed	0	None
48205	48206	hardly	0	None
48206	48207	detectable	0	None
48207	48208	currents	0	None
48208	48209	.	0	None

48210	48211	The	0	None
48211	48212	C-5	0	None
48212	48213	dicarboxylates	0	None
48213	48214	glutarate	0	None
48214	48215	and	0	None
48215	48216	alpha-ketoglutarate	0	None
48216	48217	produced	0	None
48217	48218	larger	0	None
48218	48219	currents	0	None
48219	48220	than	0	None
48220	48221	succinate;	0	None
48221	48222	glutamate	0	None
48222	48223	and	0	None
48223	48224	folate	0	None
48224	48225	failed	0	None
48225	48226	to	0	None
48226	48227	cause	0	None
48227	48228	inward	0	None
48228	48229	currents	0	None
48229	48230	.	0	None

48231	48232	Kinetic	0	None
48232	48233	analysis	0	None
48233	48234	revealed	0	None
48234	48235	,	0	None
48235	48236	at	0	None
48236	48237	-60	0	None
48237	48238	mV	0	None
48238	48239	,	0	None
48239	48240	K	0	None
48240	48241	(	0	None
48241	48242	0	0	None
48242	48243	.	0	None
48243	48244	5	0	None
48244	48245	)	0	None
48245	48246	values	0	None
48246	48247	of	0	None
48247	48248	25	0	None
48248	48249	+	0	None
48249	48250	/	0	None
48250	48251	-	0	None
48251	48252	12	0	None
48252	48253	microM	0	None
48253	48254	for	0	None
48254	48255	succinate	0	None
48255	48256	and	0	None
48256	48257	45	0	None
48257	48258	+	0	None
48258	48259	/	0	None
48259	48260	-	0	None
48260	48261	13	0	None
48261	48262	microM	0	None
48262	48263	for	0	None
48263	48264	alpha-ketoglutarate	0	None
48264	48265	,	0	None
48265	48266	values	0	None
48266	48267	close	0	None
48267	48268	to	0	None
48268	48269	the	0	None
48269	48270	plasma	0	None
48270	48271	concentration	0	None
48271	48272	of	0	None
48272	48273	these	0	None
48273	48274	compounds	0	None
48274	48275	.	0	None

48276	48277	For	0	None
48277	48278	both	0	None
48278	48279	compounds	0	None
48279	48280	,	0	None
48280	48281	the	0	None
48281	48282	K	0	None
48282	48283	(	0	None
48283	48284	0	0	None
48284	48285	.	0	None
48285	48286	5	0	None
48286	48287	)	0	None
48287	48288	was	0	None
48288	48289	independent	0	None
48289	48290	of	0	None
48290	48291	voltage	0	None
48291	48292	,	0	None
48292	48293	whereas	0	None
48293	48294	the	0	None
48294	48295	maximal	0	None
48295	48296	current	0	None
48296	48297	increased	0	None
48297	48298	with	0	None
48298	48299	hyperpolarization	0	None
48299	48300	.	0	None

48301	48302	As	0	None
48302	48303	opposed	0	None
48303	48304	to	0	None
48304	48305	the	0	None
48305	48306	rat	0	None
48306	48307	and	0	None
48307	48308	flounder	0	None
48308	48309	orthologs	0	None
48309	48310	,	0	None
48310	48311	hNaDC-3	0	None
48311	48312	was	0	None
48312	48313	hardly	0	None
48313	48314	inhibited	0	None
48314	48315	by	0	None
48315	48316	lithium	0	None
48316	48317	concentrations	0	None
48317	48318	up	0	None
48318	48319	to	0	None
48319	48320	5	0	None
48320	48321	mM	0	None
48321	48322	.	0	None

48323	48324	In	0	None
48324	48325	the	0	None
48325	48326	absence	0	None
48326	48327	of	0	None
48327	48328	sodium	2	CHEMICAL
48328	48329	,	0	None
48329	48330	however	0	None
48330	48331	,	0	None
48331	48332	lithium	0	None
48332	48333	can	0	None
48333	48334	mediate	0	None
48334	48335	succinate-dependent	0	None
48335	48336	currents	0	None
48336	48337	.	0	None

48338	48339	The	0	None
48339	48340	narrow	0	None
48340	48341	substrate	0	None
48341	48342	specificity	0	None
48342	48343	prevents	0	None
48343	48344	interaction	0	None
48344	48345	of	0	None
48345	48346	drugs	0	None
48346	48347	with	0	None
48347	48348	dicarboxylate-like	0	None
48348	48349	structure	0	None
48349	48350	with	0	None
48350	48351	hNaDC-3	0	None
48351	48352	and	0	None
48352	48353	ensures	0	None
48353	48354	sufficient	0	None
48354	48355	support	0	None
48355	48356	of	0	None
48356	48357	the	0	None
48357	48358	proximal	0	None
48358	48359	tubule	0	None
48359	48360	cells	0	None
48360	48361	with	0	None
48361	48362	alpha-ketoglutarate	0	None
48362	48363	for	0	None
48363	48364	anion	0	None
48364	48365	secretion	0	None
48365	48366	via	0	None
48366	48369	organic anion transporter	3	GENE-N
48369	48370	1	0	None
48370	48371	or	0	None
48371	48372	3	0	None
48372	48373	.	0	None
48373	48374	Phenformin	0	None
48374	48375	has	0	None
48375	48376	a	0	None
48376	48377	direct	0	None
48377	48378	inhibitory	0	None
48378	48379	effect	0	None
48379	48380	on	0	None
48380	48381	the	0	None
48381	48384	ATP-sensitive potassium channel	3	GENE-N
48384	48385	.	0	None
48385	48386	Changes	0	None
48386	48387	in	0	None
48387	48388	intestinal	0	None
48388	48389	permeability	0	None
48389	48390	and	0	None
48390	48391	lactose	0	None
48391	48392	hydrolysis	0	None
48392	48393	have	0	None
48393	48394	been	0	None
48394	48395	investigated	0	None
48395	48396	in	0	None
48396	48397	three	0	None
48397	48398	adults	0	None
48398	48399	and	0	None
48399	48400	fifteen	0	None
48400	48401	infants	0	None
48401	48402	with	0	None
48402	48403	acute	0	None
48403	48404	rotaviral	0	None
48404	48405	gastroenteritis	0	None
48405	48406	by	0	None
48406	48407	differential	0	None
48407	48408	sugar	0	None
48408	48409	absorption	0	None
48409	48410	.	0	None

48411	48412	The	0	None
48412	48413	method	0	None
48413	48414	involves	0	None
48414	48415	chromatographic	0	None
48415	48416	measurement	0	None
48416	48417	of	0	None
48417	48418	urinary	0	None
48418	48419	lactose	0	None
48419	48420	,	0	None
48420	48421	lactulose	0	None
48421	48422	and	0	None
48422	48423	L-rhamnose	0	None
48423	48424	excretion	0	None
48424	48425	following	0	None
48425	48426	combined	0	None
48426	48427	ingestion	0	None
48427	48428	in	0	None
48428	48429	an	0	None
48429	48430	iso-osmolar	0	None
48430	48431	test	0	None
48431	48432	solution	0	None
48432	48433	.	0	None

48434	48435	All	0	None
48435	48436	patients	0	None
48436	48437	had	0	None
48437	48438	abnormal	0	None
48438	48439	intestinal	0	None
48439	48440	permeability	0	None
48440	48441	indicated	0	None
48441	48442	by	0	None
48442	48443	raised	0	None
48443	48444	urine	0	None
48444	48445	lactulose	0	None
48445	48446	/	0	None
48446	48447	L-rhamnose	0	None
48447	48448	excretion	0	None
48448	48449	,	0	None
48449	48450	ratio	0	None
48450	48451	of	0	None
48451	48452	percentages	0	None
48452	48453	recovered	0	None
48453	48454	in	0	None
48454	48455	5	0	None
48455	48456	h	0	None
48456	48457	,	0	None
48457	48458	of	0	None
48458	48459	0	0	None
48459	48460	.	0	None
48460	48461	462	0	None
48461	48462	(	0	None
48462	48463	0	0	None
48463	48464	.	0	None
48464	48465	100-1	0	None
48465	48466	.	0	None
48466	48467	227	0	None
48467	48468	)	0	None
48468	48469	mean	0	None
48469	48470	and	0	None
48470	48471	range	0	None
48471	48472	,	0	None
48472	48473	compared	0	None
48473	48474	with	0	None
48474	48475	0	0	None
48475	48476	.	0	None
48476	48477	027	0	None
48477	48478	(	0	None
48478	48479	0	0	None
48479	48480	.	0	None
48480	48481	008-0	0	None
48481	48482	.	0	None
48482	48483	052	0	None
48483	48484	)	0	None
48484	48485	for	0	None
48485	48486	healthy	0	None
48486	48487	controls	0	None
48487	48488	(	0	None
48488	48489	P	0	None
48489	48490	less	0	None
48490	48491	than	0	None
48491	48492	0	0	None
48492	48493	.	0	None
48493	48494	001	0	None
48494	48495	)	0	None
48495	48496	.	0	None

48497	48498	Ten	0	None
48498	48499	patients	0	None
48499	48500	also	0	None
48500	48501	had	0	None
48501	48502	urinary	0	None
48502	48503	lactose	0	None
48503	48504	/	0	None
48504	48505	lactulose	0	None
48505	48506	excretion	0	None
48506	48507	ratios	0	None
48507	48508	raised	0	None
48508	48509	above	0	None
48509	48510	the	0	None
48510	48511	normal	0	None
48511	48512	range	0	None
48512	48513	(	0	None
48513	48514	0	0	None
48514	48515	.	0	None
48515	48516	014-0	0	None
48516	48517	.	0	None
48517	48518	41	0	None
48518	48519	,	0	None
48519	48520	mean	0	None
48520	48521	0	0	None
48521	48522	.	0	None
48522	48523	258	0	None
48523	48524	)	0	None
48524	48525	during	0	None
48525	48526	their	0	None
48526	48527	acute	0	None
48527	48528	illness	0	None
48528	48529	,	0	None
48529	48530	indicating	0	None
48530	48531	impaired	0	None
48531	48532	intestinal	0	None
48532	48533	lactose	0	None
48533	48534	hydrolysis	0	None
48534	48535	.	0	None

48536	48537	Both	0	None
48537	48538	indices	0	None
48538	48539	had	0	None
48539	48540	become	0	None
48540	48541	normal	0	None
48541	48542	4	0	None
48542	48543	weeks	0	None
48543	48544	after	0	None
48544	48545	the	0	None
48545	48546	acute	0	None
48546	48547	illness	0	None
48547	48548	,	0	None
48548	48549	serial	0	None
48549	48550	investigation	0	None
48550	48551	of	0	None
48551	48552	five	0	None
48552	48553	patients	0	None
48553	48554	showing	0	None
48554	48555	that	0	None
48555	48556	improvement	0	None
48556	48557	was	0	None
48557	48558	complete	0	None
48558	48559	much	0	None
48559	48560	earlier	0	None
48560	48561	.	0	None

48562	48563	Except	0	None
48563	48564	for	0	None
48564	48565	the	0	None
48565	48566	short	0	None
48566	48567	duration	0	None
48567	48568	these	0	None
48568	48569	changes	0	None
48569	48570	are	0	None
48570	48571	similar	0	None
48571	48572	to	0	None
48572	48573	those	0	None
48573	48574	associated	0	None
48574	48575	with	0	None
48575	48576	villous	0	None
48576	48577	atrophy	0	None
48577	48578	in	0	None
48578	48579	coeliac	0	None
48579	48580	disease	0	None
48580	48581	.	0	None

48582	48583	The	0	None
48583	48584	test	0	None
48584	48585	procedure	0	None
48585	48586	was	0	None
48586	48587	verified	0	None
48587	48588	with	0	None
48588	48589	respect	0	None
48589	48590	to	0	None
48590	48591	intestinal	0	None
48591	48592	lactose	0	None
48592	48593	hydrolysis	0	None
48593	48594	by	0	None
48594	48595	demonstrating	0	None
48595	48596	a	0	None
48596	48597	linear	0	None
48597	48598	relationship	0	None
48598	48599	between	0	None
48599	48600	lactose	0	None
48600	48601	/	0	None
48601	48602	lactulose	0	None
48602	48603	excretion	0	None
48603	48604	and	0	None
48604	48605	log	0	None
48605	48606	jejunal	0	None
48606	48607	mucosal	0	None
48607	48608	lactase	0	None
48608	48609	activity	0	None
48609	48610	by	0	None
48610	48611	in	0	None
48611	48612	vitro	0	None
48612	48613	assay	0	None
48613	48614	(	0	None
48614	48615	R2	0	None
48615	48616	=	0	None
48616	48617	0	0	None
48617	48618	.	0	None
48618	48619	95	0	None
48619	48620	)	0	None
48620	48621	in	0	None
48621	48622	a	0	None
48622	48623	further	0	None
48623	48624	group	0	None
48624	48625	of	0	None
48625	48626	subjects	0	None
48626	48627	.	0	None

48628	48629	Differential	0	None
48629	48630	lactose	0	None
48630	48631	/	0	None
48631	48632	lactulose	0	None
48632	48633	/	0	None
48633	48634	L-rhamnose	0	None
48634	48635	absorption	0	None
48635	48636	provides	0	None
48636	48637	a	0	None
48637	48638	non-invasive	0	None
48638	48639	and	0	None
48639	48640	sensitive	0	None
48640	48641	index	0	None
48641	48642	of	0	None
48642	48643	small	0	None
48643	48644	intestinal	0	None
48644	48645	integrity	0	None
48645	48646	of	0	None
48646	48647	value	0	None
48647	48648	for	0	None
48648	48649	the	0	None
48649	48650	interpretation	0	None
48650	48651	of	0	None
48651	48652	prolonged	0	None
48652	48653	or	0	None
48653	48654	otherwise	0	None
48654	48655	complicated	0	None
48655	48656	enteritis	0	None
48656	48657	and	0	None
48657	48658	the	0	None
48658	48659	distinction	0	None
48659	48660	of	0	None
48660	48661	primary	0	None
48661	48662	secondary	0	None
48662	48663	intestinal	0	None
48663	48664	lactase	0	None
48664	48665	deficiency	0	None
48665	48666	.	0	None
48666	48667	The	0	None
48667	48668	human	0	None
48668	48669	telomeric	0	None
48669	48670	protein	0	None
48670	48671	TRF2	0	None
48671	48672	is	0	None
48672	48673	required	0	None
48673	48674	to	0	None
48674	48675	protect	0	None
48675	48676	chromosome	0	None
48676	48677	ends	0	None
48677	48678	by	0	None
48678	48679	facilitating	0	None
48679	48680	their	0	None
48680	48681	organization	0	None
48681	48682	into	0	None
48682	48683	the	0	None
48683	48684	protective	0	None
48684	48685	capping	0	None
48685	48686	structure	0	None
48686	48687	.	0	None

48688	48689	Post-translational	0	None
48689	48690	modifications	0	None
48690	48691	of	0	None
48691	48692	TRF2	0	None
48692	48693	such	0	None
48693	48694	as	0	None
48694	48695	phosphorylation	0	None
48695	48696	,	0	None
48696	48697	ubiquitination	0	None
48697	48698	,	0	None
48698	48699	SUMOylation	0	None
48699	48700	,	0	None
48700	48701	methylation	0	None
48701	48702	and	0	None
48702	48703	poly	0	None
48703	48704	(	0	None
48704	48705	ADP-ribosyl	0	None
48705	48706	)	0	None
48706	48707	ation	0	None
48707	48708	have	0	None
48708	48709	been	0	None
48709	48710	shown	0	None
48710	48711	to	0	None
48711	48712	play	0	None
48712	48713	important	0	None
48713	48714	roles	0	None
48714	48715	in	0	None
48715	48716	telomere	0	None
48716	48717	function	0	None
48717	48718	.	0	None

48719	48720	Here	0	None
48720	48721	we	0	None
48721	48722	show	0	None
48722	48723	that	0	None
48723	48724	TRF2	0	None
48724	48725	specifically	0	None
48725	48726	interacts	0	None
48726	48727	with	0	None
48727	48728	the	0	None
48728	48729	histone	0	None
48729	48730	acetyltransferase	0	None
48730	48731	p300	1	GENE-Y
48731	48732	,	0	None
48732	48733	and	0	None
48733	48734	that	0	None
48734	48735	p300	1	GENE-Y
48735	48736	acetylates	0	None
48736	48737	the	0	None
48737	48738	lysine	0	None
48738	48739	residue	0	None
48739	48740	at	0	None
48740	48741	position	0	None
48741	48742	293	0	None
48742	48743	of	0	None
48743	48744	TRF2	0	None
48744	48745	.	0	None

48746	48747	We	0	None
48747	48748	also	0	None
48748	48749	report	0	None
48749	48750	that	0	None
48750	48751	p300-mediated	0	None
48751	48752	acetylation	0	None
48752	48753	stabilizes	0	None
48753	48754	the	0	None
48754	48755	TRF2	0	None
48755	48756	protein	0	None
48756	48757	by	0	None
48757	48758	inhibiting	0	None
48758	48759	its	0	None
48759	48760	ubiquitin-dependent	0	None
48760	48761	proteolysis	0	None
48761	48762	and	0	None
48762	48763	is	0	None
48763	48764	required	0	None
48764	48765	for	0	None
48765	48766	efficient	0	None
48766	48767	telomere	0	None
48767	48768	binding	0	None
48768	48769	of	0	None
48769	48770	TRF2	0	None
48770	48771	.	0	None

48772	48773	Furthermore	0	None
48773	48774	,	0	None
48774	48775	overexpression	0	None
48775	48776	of	0	None
48776	48777	the	0	None
48777	48778	acetylation-deficient	0	None
48778	48779	mutant	0	None
48779	48780	,	0	None
48780	48781	K293R	0	None
48781	48782	,	0	None
48782	48783	induces	0	None
48783	48784	DNA-damage	0	None
48784	48785	response	0	None
48785	48786	foci	0	None
48786	48787	at	0	None
48787	48788	telomeres	0	None
48788	48789	,	0	None
48789	48790	thereby	0	None
48790	48791	leading	0	None
48791	48792	to	0	None
48792	48793	induction	0	None
48793	48794	of	0	None
48794	48795	impaired	0	None
48795	48796	cell	0	None
48796	48797	growth	0	None
48797	48798	,	0	None
48798	48799	cellular	0	None
48799	48800	senescence	0	None
48800	48801	and	0	None
48801	48802	altered	0	None
48802	48803	cell	0	None
48803	48804	cycle	0	None
48804	48805	distribution	0	None
48805	48806	.	0	None

48807	48808	A	0	None
48808	48809	small	0	None
48809	48810	but	0	None
48810	48811	significant	0	None
48811	48812	number	0	None
48812	48813	of	0	None
48813	48814	metaphase	0	None
48814	48815	chromosomes	0	None
48815	48816	show	0	None
48816	48817	no	0	None
48817	48818	telomeric	0	None
48818	48819	signals	0	None
48819	48820	at	0	None
48820	48821	chromatid	0	None
48821	48822	ends	0	None
48822	48823	,	0	None
48823	48824	suggesting	0	None
48824	48825	an	0	None
48825	48826	aberrant	0	None
48826	48827	telomere	0	None
48827	48828	structure	0	None
48828	48829	.	0	None

48830	48831	These	0	None
48831	48832	findings	0	None
48832	48833	demonstrate	0	None
48833	48834	that	0	None
48834	48835	acetylation	0	None
48835	48836	of	0	None
48836	48837	TRF2	0	None
48837	48838	by	0	None
48838	48839	p300	1	GENE-Y
48839	48840	plays	0	None
48840	48841	a	0	None
48841	48842	crucial	0	None
48842	48843	role	0	None
48843	48844	in	0	None
48844	48845	the	0	None
48845	48846	maintenance	0	None
48846	48847	of	0	None
48847	48848	functional	0	None
48848	48849	telomeres	0	None
48849	48850	as	0	None
48850	48851	well	0	None
48851	48852	as	0	None
48852	48853	in	0	None
48853	48854	the	0	None
48854	48855	regulation	0	None
48855	48856	of	0	None
48856	48857	the	0	None
48857	48858	telomere-associated	0	None
48858	48859	DNA-damage	0	None
48859	48860	response	0	None
48860	48861	,	0	None
48861	48862	thus	0	None
48862	48863	providing	0	None
48863	48864	a	0	None
48864	48865	new	0	None
48865	48866	route	0	None
48866	48867	for	0	None
48867	48868	modulating	0	None
48868	48869	telomere	0	None
48869	48870	protection	0	None
48870	48871	function	0	None
48871	48872	.	0	None
48872	48873	OBJECTIVE	0	None
48873	48874	:	0	None
48874	48875	To	0	None
48875	48876	determine	0	None
48876	48877	the	0	None
48877	48878	type	0	None
48878	48879	of	0	None
48879	48880	mutation	0	None
48880	48881	in	0	None
48881	48882	a	0	None
48882	48883	patient	0	None
48883	48884	with	0	None
48884	48885	clinical	0	None
48885	48886	diagnosis	0	None
48886	48887	of	0	None
48887	48888	suspected	0	None
48888	48889	APRT	1	GENE-Y
48889	48890	deficiency	0	None
48890	48891	.	0	None

48892	48893	DESIGN	0	None
48893	48894	AND	0	None
48894	48895	METHODS	0	None
48895	48896	:	0	None
48896	48897	A	0	None
48897	48898	51-year-old	0	None
48898	48899	male	0	None
48899	48900	patient	0	None
48900	48901	,	0	None
48901	48902	with	0	None
48902	48903	a	0	None
48903	48904	clinical	0	None
48904	48905	history	0	None
48905	48906	of	0	None
48906	48907	two	0	None
48907	48908	prior	0	None
48908	48909	episodes	0	None
48909	48910	of	0	None
48910	48911	renal	0	None
48911	48912	colic	0	None
48912	48913	with	0	None
48913	48914	urinary	0	None
48914	48915	stone	0	None
48915	48916	excretion	0	None
48916	48917	(	0	None
48917	48918	reported	0	None
48918	48919	as	0	None
48919	48920	uric	0	None
48920	48921	acid	0	None
48921	48922	stones	0	None
48922	48923	in	0	None
48923	48924	the	0	None
48924	48925	first	0	None
48925	48926	episode	0	None
48926	48927	and	0	None
48927	48928	as	0	None
48928	48929	calcium	0	None
48929	48930	oxalate	2	CHEMICAL
48930	48931	stones	0	None
48931	48932	in	0	None
48932	48933	the	0	None
48933	48934	second	0	None
48934	48935	)	0	None
48935	48936	,	0	None
48936	48937	was	0	None
48937	48938	admitted	0	None
48938	48939	to	0	None
48939	48940	the	0	None
48940	48941	hospital	0	None
48941	48942	with	0	None
48942	48943	severe	0	None
48943	48944	non-oliguric	0	None
48944	48945	renal	0	None
48945	48946	failure	0	None
48946	48947	(	0	None
48947	48948	1	0	None
48948	48949	.	0	None
48949	48950	06	0	None
48950	48951	mmol	0	None
48951	48952	/	0	None
48952	48953	L	0	None
48953	48954	serum	0	None
48954	48955	creatinine	0	None
48955	48956	)	0	None
48956	48957	,	0	None
48957	48958	severe	0	None
48958	48959	hyponatremia	0	None
48959	48960	(	0	None
48960	48961	114	0	None
48961	48962	mmol	0	None
48962	48963	/	0	None
48963	48964	L	0	None
48964	48965	Na	0	None
48965	48966	(	0	None
48966	48967	+	0	None
48967	48968	)	0	None
48968	48969	)	0	None
48969	48970	,	0	None
48970	48971	metabolic	0	None
48971	48972	acidosis	0	None
48972	48973	(	0	None
48973	48974	14	0	None
48974	48975	mmol	0	None
48975	48976	/	0	None
48976	48977	L	0	None
48977	48978	HCO	0	None
48978	48979	(	0	None
48979	48980	3	0	None
48980	48981	)	0	None
48981	48982	(	0	None
48982	48983	-	0	None
48983	48984	)	0	None
48984	48985	)	0	None
48985	48986	and	0	None
48986	48987	uricemia	0	None
48987	48988	in	0	None
48988	48989	the	0	None
48989	48990	normal	0	None
48990	48991	range	0	None
48991	48992	.	0	None

48993	48994	Abnormalities	0	None
48994	48995	at	0	None
48995	48996	renal	0	None
48996	48997	scan	0	None
48997	48998	and	0	None
48998	48999	persistency	0	None
48999	49000	of	0	None
49000	49001	severe	0	None
49001	49002	renal	0	None
49002	49003	failure	0	None
49003	49004	required	0	None
49004	49005	to	0	None
49005	49006	start	0	None
49006	49007	haemodialysis	0	None
49007	49008	.	0	None

49009	49010	Results	0	None
49010	49011	of	0	None
49011	49012	renal	0	None
49012	49013	biopsy	0	None
49013	49014	prompted	0	None
49014	49015	us	0	None
49015	49016	to	0	None
49016	49017	undertake	0	None
49017	49018	a	0	None
49018	49019	biochemical	0	None
49019	49020	and	0	None
49020	49021	molecular	0	None
49021	49022	biological	0	None
49022	49023	evaluation	0	None
49023	49024	of	0	None
49024	49025	the	0	None
49025	49026	patient	0	None
49026	49027	for	0	None
49027	49028	suspected	0	None
49028	49030	adenine phosphoribosyltransferase	1	GENE-Y
49030	49031	(	0	None
49031	49032	APRT	1	GENE-Y
49032	49033	)	0	None
49033	49034	deficiency	0	None
49034	49035	.	0	None

49036	49037	RESULTS	0	None
49037	49038	:	0	None
49038	49039	HPLC	0	None
49039	49040	analysis	0	None
49040	49041	of	0	None
49041	49042	serum	0	None
49042	49043	and	0	None
49043	49044	urine	0	None
49044	49045	,	0	None
49045	49046	for	0	None
49046	49047	determining	0	None
49047	49048	purine	0	None
49048	49049	derivative	0	None
49049	49050	profile	0	None
49050	49051	,	0	None
49051	49052	showed	0	None
49052	49053	the	0	None
49053	49054	pathological	0	None
49054	49055	presence	0	None
49055	49056	of	0	None
49056	49057	adenine	2	CHEMICAL
49057	49058	in	0	None
49058	49059	both	0	None
49059	49060	biological	0	None
49060	49061	fluids	0	None
49061	49062	(	0	None
49062	49063	3	0	None
49063	49064	.	0	None
49064	49065	57	0	None
49065	49066	micromol	0	None
49066	49067	/	0	None
49067	49068	L	0	None
49068	49069	and	0	None
49069	49070	7	0	None
49070	49071	.	0	None
49071	49072	11	0	None
49072	49073	micromol	0	None
49073	49074	/	0	None
49074	49075	mmol	0	None
49075	49076	creatinine	0	None
49076	49077	in	0	None
49077	49078	serum	0	None
49078	49079	and	0	None
49079	49080	urine	0	None
49080	49081	,	0	None
49081	49082	respectively;	0	None
49082	49083	not	0	None
49083	49084	detectable	0	None
49084	49085	in	0	None
49085	49086	both	0	None
49086	49087	fluids	0	None
49087	49088	in	0	None
49088	49089	healthy	0	None
49089	49090	controls	0	None
49090	49091	)	0	None
49091	49092	.	0	None

49093	49094	APRT	1	GENE-Y
49094	49095	assay	0	None
49095	49096	in	0	None
49096	49097	a	0	None
49097	49098	sample	0	None
49098	49099	of	0	None
49099	49100	patient	0	None
49100	49101	hemolysate	0	None
49101	49102	showed	0	None
49102	49103	no	0	None
49103	49104	detectable	0	None
49104	49105	activity	0	None
49105	49106	of	0	None
49106	49107	the	0	None
49107	49108	enzyme	0	None
49108	49109	(	0	None
49109	49110	25	0	None
49110	49111	.	0	None
49111	49112	56	0	None
49112	49113	+	0	None
49113	49114	/	0	None
49114	49115	-9	0	None
49115	49116	.	0	None
49116	49117	55	0	None
49117	49118	U	0	None
49118	49119	/	0	None
49119	49120	L	0	None
49120	49121	red	0	None
49121	49122	blood	0	None
49122	49123	cells	0	None
49123	49124	in	0	None
49124	49125	control	0	None
49125	49126	healthy	0	None
49126	49127	subjects	0	None
49127	49128	)	0	None
49128	49129	.	0	None

49130	49131	Molecular	0	None
49131	49132	biological	0	None
49132	49133	analysis	0	None
49133	49134	of	0	None
49134	49135	the	0	None
49135	49136	amplified	0	None
49136	49137	APRT	1	GENE-Y
49137	49138	gene	0	None
49138	49139	revealed	0	None
49139	49140	that	0	None
49140	49141	the	0	None
49141	49142	patient	0	None
49142	49143	harboured	0	None
49143	49144	in	0	None
49144	49145	exon	0	None
49145	49146	3	0	None
49146	49147	a	0	None
49147	49148	homozygous	0	None
49148	49149	254	0	None
49149	49150	bp	0	None
49150	49151	deletion-8	0	None
49151	49152	bp	0	None
49152	49153	insertion	0	None
49153	49154	,	0	None
49154	49155	previously	0	None
49155	49156	described	0	None
49156	49157	only	0	None
49157	49158	once	0	None
49158	49159	in	0	None
49159	49160	a	0	None
49160	49161	compound	0	None
49161	49162	heterozygote	0	None
49162	49163	.	0	None

49164	49165	Analysis	0	None
49165	49166	of	0	None
49166	49167	the	0	None
49167	49168	patient	0	None
49168	49169	family	0	None
49169	49170	showed	0	None
49170	49171	that	0	None
49171	49172	heterozygotes	0	None
49172	49173	for	0	None
49173	49174	this	0	None
49174	49175	APRT	1	GENE-Y
49175	49176	gene	0	None
49176	49177	mutation	0	None
49177	49178	,	0	None
49178	49179	in	0	None
49179	49180	spite	0	None
49180	49181	of	0	None
49181	49182	a	0	None
49182	49183	69%	0	None
49183	49184	lower	0	None
49184	49185	APRT	1	GENE-Y
49185	49186	enzymatic	0	None
49186	49187	activity	0	None
49187	49188	than	0	None
49188	49189	that	0	None
49189	49190	of	0	None
49190	49191	healthy	0	None
49191	49192	subjects	0	None
49192	49193	,	0	None
49193	49194	had	0	None
49194	49195	no	0	None
49195	49196	detectable	0	None
49196	49197	adenine	2	CHEMICAL
49197	49198	concentrations	0	None
49198	49199	in	0	None
49199	49200	both	0	None
49200	49201	serum	0	None
49201	49202	and	0	None
49202	49203	urine	0	None
49203	49204	.	0	None

49205	49206	CONCLUSIONS	0	None
49206	49207	:	0	None
49207	49208	Results	0	None
49208	49209	of	0	None
49209	49210	the	0	None
49210	49211	first	0	None
49211	49212	patient	0	None
49212	49213	harbouring	0	None
49213	49214	the	0	None
49214	49215	homozygous	0	None
49215	49216	254	0	None
49216	49217	bp	0	None
49217	49218	deletion-8	0	None
49218	49219	bp	0	None
49219	49220	insertion	0	None
49220	49221	of	0	None
49221	49222	the	0	None
49222	49223	APRT	1	GENE-Y
49223	49224	gene	0	None
49224	49225	strongly	0	None
49225	49226	indicated	0	None
49226	49227	that	0	None
49227	49228	definitive	0	None
49228	49229	diagnosis	0	None
49229	49230	of	0	None
49230	49231	APRT	1	GENE-Y
49231	49232	deficiency	0	None
49232	49233	(	0	None
49233	49234	often	0	None
49234	49235	under	0	None
49235	49236	or	0	None
49236	49237	misdiagnosed	0	None
49237	49238	)	0	None
49238	49239	would	0	None
49239	49240	require	0	None
49240	49241	a	0	None
49241	49242	combined	0	None
49242	49243	clinical	0	None
49243	49244	,	0	None
49244	49245	biochemical	0	None
49245	49246	and	0	None
49246	49247	molecular	0	None
49247	49248	biological	0	None
49248	49249	evaluation	0	None
49249	49250	.	0	None
49250	49251	Polyethylenimine	0	None
49251	49252	(	0	None
49252	49253	PEI	0	None
49253	49254	)	0	None
49254	49255	is	0	None
49255	49256	one	0	None
49256	49257	of	0	None
49257	49258	the	0	None
49258	49259	most	0	None
49259	49260	broadly	0	None
49260	49261	used	0	None
49261	49262	polycations	0	None
49262	49263	for	0	None
49263	49264	gene	0	None
49264	49265	delivery	0	None
49265	49266	due	0	None
49266	49267	to	0	None
49267	49268	its	0	None
49268	49269	high	0	None
49269	49270	transfection	0	None
49270	49271	efficiency	0	None
49271	49272	and	0	None
49272	49273	commercial	0	None
49273	49274	availability	0	None
49274	49275	but	0	None
49275	49276	materials	0	None
49276	49277	are	0	None
49277	49278	cytotoxic	0	None
49278	49279	and	0	None
49279	49280	often	0	None
49280	49281	polydisperse	0	None
49281	49282	.	0	None

49283	49284	The	0	None
49284	49285	goal	0	None
49285	49286	of	0	None
49286	49287	current	0	None
49287	49288	work	0	None
49288	49289	is	0	None
49289	49290	to	0	None
49290	49291	develop	0	None
49291	49292	an	0	None
49292	49293	alternative	0	None
49293	49294	family	0	None
49294	49295	of	0	None
49295	49296	polycations	0	None
49296	49297	based	0	None
49297	49298	on	0	None
49298	49299	controlled	0	None
49299	49300	living	0	None
49300	49301	radical	0	None
49301	49302	polymerization	0	None
49302	49303	(	0	None
49303	49304	CLRP	0	None
49304	49305	)	0	None
49305	49306	and	0	None
49306	49307	to	0	None
49307	49308	optimize	0	None
49308	49309	the	0	None
49309	49310	polymer	0	None
49310	49311	structure	0	None
49311	49312	for	0	None
49312	49313	efficient	0	None
49313	49314	gene	0	None
49314	49315	delivery	0	None
49315	49316	.	0	None

49317	49318	In	0	None
49318	49319	this	0	None
49319	49320	study	0	None
49320	49321	,	0	None
49321	49322	well-defined	0	None
49322	49323	poly	0	None
49323	49324	(	0	None
49324	49325	glycidyl	0	None
49325	49326	methacrylate	0	None
49326	49327	)	0	None
49327	49328	(	0	None
49328	49329	P	0	None
49329	49330	(	0	None
49330	49331	GMA	0	None
49331	49332	)	0	None
49332	49333	)	0	None
49333	49334	homopolymers	0	None
49334	49335	were	0	None
49335	49336	synthesized	0	None
49336	49337	using	0	None
49337	49338	reversible	0	None
49338	49339	addition-fragmentation	0	None
49339	49340	chain	0	None
49340	49341	transfer	0	None
49341	49342	(	0	None
49342	49343	RAFT	0	None
49343	49344	)	0	None
49344	49345	polymerization	0	None
49345	49346	followed	0	None
49346	49347	by	0	None
49347	49348	decoration	0	None
49348	49349	using	0	None
49349	49350	three	0	None
49350	49351	different	0	None
49351	49352	types	0	None
49352	49353	of	0	None
49353	49354	oligoamines	0	None
49354	49355	,	0	None
49355	49356	i	0	None
49356	49357	.	0	None

49358	49359	e	0	None
49359	49360	.	0	None

49361	49362	,	0	None
49362	49363	tetraethylenepentamine	0	None
49363	49364	(	0	None
49364	49365	TEPA	0	None
49365	49366	)	0	None
49366	49367	,	0	None
49367	49368	pentaethylenehexamine	0	None
49368	49369	(	0	None
49369	49370	PEHA	0	None
49370	49371	)	0	None
49371	49372	,	0	None
49372	49373	and	0	None
49373	49374	tris	0	None
49374	49375	(	0	None
49375	49376	2-aminoethyl	0	None
49376	49377	)	0	None
49377	49378	amine	2	CHEMICAL
49378	49379	(	0	None
49379	49380	TREN	0	None
49380	49381	)	0	None
49381	49382	,	0	None
49382	49383	respectively	0	None
49383	49384	,	0	None
49384	49385	to	0	None
49385	49386	generate	0	None
49386	49387	various	0	None
49387	49388	P	0	None
49388	49389	(	0	None
49389	49390	GMA-oligoamine	0	None
49390	49391	)	0	None
49391	49392	homopolycations	0	None
49392	49393	.	0	None

49394	49395	The	0	None
49395	49396	effect	0	None
49396	49397	of	0	None
49397	49398	P	0	None
49398	49399	(	0	None
49399	49400	GMA	0	None
49400	49401	)	0	None
49401	49402	backbone	0	None
49402	49403	length	0	None
49403	49404	and	0	None
49404	49405	structure	0	None
49405	49406	of	0	None
49406	49407	oligoamine	0	None
49407	49408	on	0	None
49408	49409	gene	0	None
49409	49410	transfer	0	None
49410	49411	efficiency	0	None
49411	49412	was	0	None
49412	49413	then	0	None
49413	49414	determined	0	None
49414	49415	.	0	None

49416	49417	The	0	None
49417	49418	optimal	0	None
49418	49419	polymer	0	None
49419	49420	,	0	None
49420	49421	P	0	None
49421	49422	(	0	None
49422	49423	GMA-TEPA	0	None
49423	49424	)	0	None
49424	49425	(	0	None
49425	49426	50	0	None
49426	49427	)	0	None
49427	49428	,	0	None
49428	49429	provided	0	None
49429	49430	comparable	0	None
49430	49431	transfection	0	None
49431	49432	efficiency	0	None
49432	49433	but	0	None
49433	49434	lower	0	None
49434	49435	cytotoxicity	0	None
49435	49436	than	0	None
49436	49437	PEI	0	None
49437	49438	.	0	None

49439	49440	P	0	None
49440	49441	(	0	None
49441	49442	GMA-TEPA	0	None
49442	49443	)	0	None
49443	49444	(	0	None
49444	49445	50	0	None
49445	49446	)	0	None
49446	49447	was	0	None
49447	49448	then	0	None
49448	49449	used	0	None
49449	49450	as	0	None
49450	49451	the	0	None
49451	49452	cationic	0	None
49452	49453	block	0	None
49453	49454	in	0	None
49454	49455	diblock	0	None
49455	49456	copolymers	0	None
49456	49457	containing	0	None
49457	49458	hydrophilic	0	None
49458	49459	N-	0	None
49459	49460	(	0	None
49460	49461	2-hydroxypropyl	0	None
49461	49462	)	0	None
49462	49463	methacrylamide	0	None
49463	49464	(	0	None
49464	49465	HPMA	2	CHEMICAL
49465	49466	)	0	None
49466	49467	and	0	None
49467	49468	oligo	0	None
49468	49469	(	0	None
49469	49470	ethylene	0	None
49470	49471	glycol	0	None
49471	49472	)	0	None
49472	49473	monomethyl	0	None
49473	49474	ether	0	None
49474	49475	methacrylate	0	None
49475	49476	(	0	None
49476	49477	OEGMA	0	None
49477	49478	)	0	None
49478	49479	.	0	None

49480	49481	Polyplexes	0	None
49481	49482	of	0	None
49482	49483	block	0	None
49483	49484	copolymers	0	None
49484	49485	were	0	None
49485	49486	stable	0	None
49486	49487	against	0	None
49487	49488	aggregation	0	None
49488	49489	in	0	None
49489	49490	physiological	0	None
49490	49491	salt	0	None
49491	49492	condition	0	None
49492	49493	and	0	None
49493	49494	in	0	None
49494	49495	Opti-MEM	0	None
49495	49496	due	0	None
49496	49497	to	0	None
49497	49498	the	0	None
49498	49499	shielding	0	None
49499	49500	effect	0	None
49500	49501	of	0	None
49501	49502	P	0	None
49502	49503	(	0	None
49503	49504	HPMA	2	CHEMICAL
49504	49505	)	0	None
49505	49506	and	0	None
49506	49507	P	0	None
49507	49508	(	0	None
49508	49509	OEGMA	0	None
49509	49510	)	0	None
49510	49511	.	0	None

49512	49513	However	0	None
49513	49514	,	0	None
49514	49515	the	0	None
49515	49516	presence	0	None
49516	49517	of	0	None
49517	49518	the	0	None
49518	49519	HPMA	2	CHEMICAL
49519	49520	/	0	None
49520	49521	OEGMA	0	None
49521	49522	block	0	None
49522	49523	significantly	0	None
49523	49524	decreased	0	None
49524	49525	the	0	None
49525	49526	transfection	0	None
49526	49527	efficacy	0	None
49527	49528	of	0	None
49528	49529	P	0	None
49529	49530	(	0	None
49530	49531	GMA-TEPA	0	None
49531	49532	)	0	None
49532	49533	(	0	None
49533	49534	50	0	None
49534	49535	)	0	None
49535	49536	homopolycation	0	None
49536	49537	.	0	None

49538	49539	To	0	None
49539	49540	compensate	0	None
49540	49541	for	0	None
49541	49542	reduced	0	None
49542	49543	cell	0	None
49543	49544	uptake	0	None
49544	49545	caused	0	None
49545	49546	by	0	None
49546	49547	the	0	None
49547	49548	hydrophilic	0	None
49548	49549	shell	0	None
49549	49550	of	0	None
49550	49551	polyplex	0	None
49551	49552	,	0	None
49552	49553	the	0	None
49553	49554	integrin-binding	0	None
49554	49555	peptide	0	None
49555	49556	,	0	None
49556	49557	RGD	0	None
49557	49558	,	0	None
49558	49559	was	0	None
49559	49560	conjugated	0	None
49560	49561	to	0	None
49561	49562	the	0	None
49562	49563	hydrophilic	0	None
49563	49564	chain	0	None
49564	49565	end	0	None
49565	49566	of	0	None
49566	49567	P	0	None
49567	49568	(	0	None
49568	49569	OEGMA	0	None
49569	49570	)	0	None
49570	49571	(	0	None
49571	49572	15	0	None
49572	49573	)	0	None
49573	49574	-b-P	0	None
49574	49575	(	0	None
49575	49576	GMA-TEPA	0	None
49576	49577	)	0	None
49577	49578	(	0	None
49578	49579	50	0	None
49579	49580	)	0	None
49580	49581	copolymer	0	None
49581	49582	by	0	None
49582	49583	Michael-type	0	None
49583	49584	addition	0	None
49584	49585	reaction	0	None
49585	49586	.	0	None

49587	49588	At	0	None
49588	49589	low	0	None
49589	49590	polymer	0	None
49590	49591	to	0	None
49591	49592	DNA	0	None
49592	49593	ratios	0	None
49593	49594	,	0	None
49594	49595	the	0	None
49595	49596	RGD-functionalized	0	None
49596	49597	polymer	0	None
49597	49598	showed	0	None
49598	49599	increased	0	None
49599	49600	gene	0	None
49600	49601	delivery	0	None
49601	49602	efficiency	0	None
49602	49603	to	0	None
49603	49604	HeLa	0	None
49604	49605	cells	0	None
49605	49606	compared	0	None
49606	49607	to	0	None
49607	49608	analogous	0	None
49608	49609	polymers	0	None
49609	49610	lacking	0	None
49610	49611	RGD	0	None
49611	49612	.	0	None
49612	49613	Differential	0	None
49613	49614	interaction	0	None
49614	49615	of	0	None
49615	49616	glimepiride	0	None
49616	49617	and	0	None
49617	49618	glibenclamide	0	None
49618	49619	with	0	None
49619	49620	the	0	None
49620	49621	beta-cell	0	None
49621	49622	sulfonylurea	2	CHEMICAL
49622	49623	receptor	0	None
49623	49624	.	0	None

49625	49626	I	0	None
49626	49627	.	0	None

49628	49629	Binding	0	None
49629	49630	characteristics	0	None
49630	49631	.	0	None
49631	49632	Alkaloid	0	None
49632	49633	homoharringtonine	0	None
49633	49634	inhibits	0	None
49634	49635	polypeptide	0	None
49635	49636	chain	0	None
49636	49637	elongation	0	None
49637	49638	on	0	None
49638	49639	human	0	None
49639	49640	ribosomes	0	None
49640	49641	on	0	None
49641	49642	the	0	None
49642	49643	step	0	None
49643	49644	of	0	None
49644	49645	peptide	0	None
49645	49646	bond	0	None
49646	49647	formation	0	None
49647	49648	.	0	None
49648	49649	Tocopherols	0	None
49649	49650	and	0	None
49650	49651	tocotrienols	0	None
49651	49652	represent	0	None
49652	49653	the	0	None
49653	49654	two	0	None
49654	49655	subclasses	0	None
49655	49656	within	0	None
49656	49657	the	0	None
49657	49659	vitamin E	2	CHEMICAL
49659	49660	family	0	None
49660	49661	of	0	None
49661	49662	compounds	0	None
49662	49663	.	0	None

49664	49665	However	0	None
49665	49666	,	0	None
49666	49667	tocotrienols	0	None
49667	49668	are	0	None
49668	49669	significantly	0	None
49669	49670	more	0	None
49670	49671	potent	0	None
49671	49672	than	0	None
49672	49673	tocopherols	0	None
49673	49674	in	0	None
49674	49675	suppressing	0	None
49675	49676	epidermal	0	None
49676	49678	growth factor	3	GENE-N
49678	49679	(	0	None
49679	49680	EGF	0	None
49680	49681	)	0	None
49681	49682	-dependent	0	None
49682	49683	normal	0	None
49683	49684	mammary	0	None
49684	49685	epithelial	0	None
49685	49686	cell	0	None
49686	49687	growth	0	None
49687	49688	.	0	None

49689	49690	EGF	0	None
49690	49691	is	0	None
49691	49692	a	0	None
49692	49693	potent	0	None
49693	49694	mitogen	0	None
49694	49695	for	0	None
49695	49696	normal	0	None
49696	49697	mammary	0	None
49697	49698	epithelial	0	None
49698	49699	cells	0	None
49699	49700	and	0	None
49700	49701	an	0	None
49701	49702	initial	0	None
49702	49703	event	0	None
49703	49704	in	0	None
49704	49705	EGF-receptor	0	None
49705	49706	mitogenic-signalling	0	None
49706	49707	is	0	None
49707	49708	protein	0	None
49708	49709	kinase	0	None
49709	49710	C	0	None
49710	49711	(	0	None
49711	49712	PKC	0	None
49712	49713	)	0	None
49713	49714	activation	0	None
49714	49715	.	0	None

49716	49717	Studies	0	None
49717	49718	were	0	None
49718	49719	conducted	0	None
49719	49720	to	0	None
49720	49721	determine	0	None
49721	49722	if	0	None
49722	49723	the	0	None
49723	49724	antiproliferative	0	None
49724	49725	effects	0	None
49725	49726	of	0	None
49726	49727	specific	0	None
49727	49728	tocopherol	0	None
49728	49729	and	0	None
49729	49730	tocotrienol	0	None
49730	49731	isoforms	0	None
49731	49732	are	0	None
49732	49733	associated	0	None
49733	49734	with	0	None
49734	49735	a	0	None
49735	49736	reduction	0	None
49736	49737	in	0	None
49737	49738	EGF-receptor	0	None
49738	49739	mitogenic	0	None
49739	49740	signalling	0	None
49740	49741	and	0	None
49741	49742	/	0	None
49742	49743	or	0	None
49743	49744	PKC	0	None
49744	49745	activation	0	None
49745	49746	.	0	None

49747	49748	Normal	0	None
49748	49749	mammary	0	None
49749	49750	epithelial	0	None
49750	49751	cells	0	None
49751	49752	isolated	0	None
49752	49753	from	0	None
49753	49754	midpregnant	0	None
49754	49755	BALB	0	None
49755	49756	/	0	None
49756	49757	c	0	None
49757	49758	mice	0	None
49758	49759	were	0	None
49759	49760	grown	0	None
49760	49761	in	0	None
49761	49762	primary	0	None
49762	49763	culture	0	None
49763	49764	,	0	None
49764	49765	and	0	None
49765	49766	maintained	0	None
49766	49767	on	0	None
49767	49768	serum-free	0	None
49768	49769	media	0	None
49769	49770	containing	0	None
49770	49771	10	0	None
49771	49772	ng	0	None
49772	49773	/	0	None
49773	49774	mL	0	None
49774	49775	EGF	0	None
49775	49776	as	0	None
49776	49777	a	0	None
49777	49778	mitogen	0	None
49778	49779	,	0	None
49779	49780	and	0	None
49780	49781	treated	0	None
49781	49782	with	0	None
49782	49783	various	0	None
49783	49784	doses	0	None
49784	49785	(	0	None
49785	49786	0-250	0	None
49786	49787	microm	0	None
49787	49788	)	0	None
49788	49789	of	0	None
49789	49790	alpha-	0	None
49790	49791	,	0	None
49791	49792	gamma-	0	None
49792	49793	,	0	None
49793	49794	or	0	None
49794	49795	delta-tocopherol	0	None
49795	49796	or	0	None
49796	49797	alpha-	0	None
49797	49798	,	0	None
49798	49799	gamma-	0	None
49799	49800	,	0	None
49800	49801	or	0	None
49801	49802	delta-tocotrienol	0	None
49802	49803	.	0	None

49804	49805	Treatment	0	None
49805	49806	with	0	None
49806	49807	growth	0	None
49807	49808	inhibitory	0	None
49808	49809	doses	0	None
49809	49810	of	0	None
49810	49811	delta-tocopherol	0	None
49811	49812	(	0	None
49812	49813	100	0	None
49813	49814	microm	0	None
49814	49815	)	0	None
49815	49816	,	0	None
49816	49817	alpha-tocotrienol	0	None
49817	49818	(	0	None
49818	49819	50	0	None
49819	49820	microm	0	None
49820	49821	)	0	None
49821	49822	,	0	None
49822	49823	or	0	None
49823	49824	gamma-	0	None
49824	49825	or	0	None
49825	49826	delta-tocotrienol	0	None
49826	49827	(	0	None
49827	49828	10	0	None
49828	49829	microm	0	None
49829	49830	)	0	None
49830	49831	did	0	None
49831	49832	not	0	None
49832	49833	affect	0	None
49833	49834	EGF-receptor	0	None
49834	49835	levels	0	None
49835	49836	,	0	None
49836	49837	EGF-induced	0	None
49837	49838	EGF-receptor	0	None
49838	49839	tyrosine	2	CHEMICAL
49839	49840	kinase	0	None
49840	49841	activity	0	None
49841	49842	,	0	None
49842	49843	or	0	None
49843	49844	total	0	None
49844	49845	intracellular	0	None
49845	49846	levels	0	None
49846	49847	of	0	None
49847	49848	PKC	0	None
49848	49849	(	0	None
49849	49850	alpha	0	None
49850	49851	)	0	None
49851	49852	.	0	None

49853	49854	However	0	None
49854	49855	,	0	None
49855	49856	these	0	None
49856	49857	treatments	0	None
49857	49858	were	0	None
49858	49859	found	0	None
49859	49860	to	0	None
49860	49861	inhibit	0	None
49861	49862	EGF-induced	0	None
49862	49863	PKC	0	None
49863	49864	(	0	None
49864	49865	alpha	0	None
49865	49866	)	0	None
49866	49867	activation	0	None
49867	49868	as	0	None
49868	49869	determined	0	None
49869	49870	by	0	None
49870	49871	its	0	None
49871	49872	translocation	0	None
49872	49873	from	0	None
49873	49874	the	0	None
49874	49875	cytosolic	0	None
49875	49876	to	0	None
49876	49877	membrane	0	None
49877	49878	fraction	0	None
49878	49879	.	0	None

49880	49881	Treatment	0	None
49881	49882	with	0	None
49882	49883	250	0	None
49883	49884	microm	0	None
49884	49885	alpha-	0	None
49885	49886	or	0	None
49886	49887	gamma-tocopherol	0	None
49887	49888	had	0	None
49888	49889	no	0	None
49889	49890	affect	0	None
49890	49891	on	0	None
49891	49892	EGF-receptor	0	None
49892	49893	mitogenic	0	None
49893	49894	signalling	0	None
49894	49895	or	0	None
49895	49896	cell	0	None
49896	49897	growth	0	None
49897	49898	.	0	None

49899	49900	These	0	None
49900	49901	findings	0	None
49901	49902	demonstrate	0	None
49902	49903	that	0	None
49903	49904	the	0	None
49904	49905	inhibitory	0	None
49905	49906	effects	0	None
49906	49907	of	0	None
49907	49908	specific	0	None
49908	49909	tocopherol	0	None
49909	49910	and	0	None
49910	49911	tocotrienol	0	None
49911	49912	isoforms	0	None
49912	49913	on	0	None
49913	49914	EGF-dependent	0	None
49914	49915	normal	0	None
49915	49916	mammary	0	None
49916	49917	epithelial	0	None
49917	49918	cell	0	None
49918	49919	mitogenesis	0	None
49919	49920	occurs	0	None
49920	49921	downstream	0	None
49921	49922	from	0	None
49922	49923	the	0	None
49923	49924	EGF-receptor	0	None
49924	49925	and	0	None
49925	49926	appears	0	None
49926	49927	to	0	None
49927	49928	be	0	None
49928	49929	mediated	0	None
49929	49930	,	0	None
49930	49931	at	0	None
49931	49932	least	0	None
49932	49933	in	0	None
49933	49934	part	0	None
49934	49935	,	0	None
49935	49936	by	0	None
49936	49937	a	0	None
49937	49938	reduction	0	None
49938	49939	in	0	None
49939	49940	PKC	0	None
49940	49941	(	0	None
49941	49942	alpha	0	None
49942	49943	)	0	None
49943	49944	activation	0	None
49944	49945	.	0	None
49945	49946	RATIONALE	0	None
49946	49947	:	0	None
49947	49948	Induction	0	None
49948	49949	of	0	None
49949	49951	heme oxygenase-1	1	GENE-Y
49951	49952	(	0	None
49952	49953	HO-1	0	None
49953	49954	)	0	None
49954	49955	protects	0	None
49955	49956	the	0	None
49956	49957	liver	0	None
49957	49958	against	0	None
49958	49959	reperfusion	0	None
49959	49960	injury	0	None
49960	49961	after	0	None
49961	49962	hemorrhagic	0	None
49962	49963	shock	0	None
49963	49964	.	0	None

49965	49966	Previous	0	None
49966	49967	data	0	None
49967	49968	suggest	0	None
49968	49969	that	0	None
49969	49970	the	0	None
49970	49971	beta	0	None
49971	49972	(	0	None
49972	49973	1	0	None
49973	49974	)	0	None
49974	49975	-adrenoceptor	0	None
49975	49976	agonist	0	None
49976	49977	dobutamine	2	CHEMICAL
49977	49978	induces	0	None
49978	49979	HO-1	0	None
49979	49980	in	0	None
49980	49981	hepatocytes	0	None
49981	49982	.	0	None

49983	49984	OBJECTIVES	0	None
49984	49985	:	0	None
49985	49986	To	0	None
49986	49987	investigate	0	None
49987	49988	the	0	None
49988	49989	functional	0	None
49989	49990	significance	0	None
49990	49991	of	0	None
49991	49992	dobutamine	2	CHEMICAL
49992	49993	pretreatment	0	None
49993	49994	for	0	None
49994	49995	liver	0	None
49995	49996	function	0	None
49996	49997	after	0	None
49997	49998	hemorrhagic	0	None
49998	49999	shock	0	None
49999	50000	in	0	None
50000	50001	vivo	0	None
50001	50002	.	0	None

50003	50004	METHODS	0	None
50004	50005	:	0	None
50005	50006	Anesthetized	0	None
50006	50007	rats	0	None
50007	50008	received	0	None
50008	50009	either	0	None
50009	50010	Ringer's	0	None
50010	50011	(	0	None
50011	50012	Vehicle	0	None
50012	50013	/	0	None
50013	50014	Shock	0	None
50014	50015	)	0	None
50015	50016	,	0	None
50016	50017	10	0	None
50017	50018	microg	0	None
50018	50019	/	0	None
50019	50020	kg	0	None
50020	50021	/	0	None
50021	50022	min	0	None
50022	50023	of	0	None
50023	50024	the	0	None
50024	50025	beta	0	None
50025	50026	(	0	None
50026	50027	1	0	None
50027	50028	)	0	None
50028	50029	-adrenoceptor	0	None
50029	50030	agonist	0	None
50030	50031	dobutamine	2	CHEMICAL
50031	50032	(	0	None
50032	50033	Dob	0	None
50033	50034	/	0	None
50034	50035	Shock	0	None
50035	50036	)	0	None
50036	50037	,	0	None
50037	50038	or	0	None
50038	50039	10	0	None
50039	50040	microg	0	None
50040	50041	/	0	None
50041	50042	kg	0	None
50042	50043	/	0	None
50043	50044	min	0	None
50044	50045	dobutamine	2	CHEMICAL
50045	50046	and	0	None
50046	50047	500	0	None
50047	50048	microg	0	None
50048	50049	/	0	None
50049	50050	kg	0	None
50050	50051	/	0	None
50051	50052	min	0	None
50052	50053	of	0	None
50053	50054	the	0	None
50054	50055	beta	0	None
50055	50056	(	0	None
50056	50057	1	0	None
50057	50058	)	0	None
50058	50059	-adrenoceptor	0	None
50059	50060	antagonist	0	None
50060	50061	esmolol	0	None
50061	50062	(	0	None
50062	50063	Dob	0	None
50063	50064	/	0	None
50064	50065	Esmolol	0	None
50065	50066	/	0	None
50066	50067	Shock	0	None
50067	50068	)	0	None
50068	50069	for	0	None
50069	50070	6	0	None
50070	50071	h	0	None
50071	50072	.	0	None

50073	50074	Hemorrhagic	0	None
50074	50075	shock	0	None
50075	50076	was	0	None
50076	50077	induced	0	None
50077	50078	thereafter	0	None
50078	50079	(	0	None
50079	50080	mean	0	None
50080	50081	arterial	0	None
50081	50082	pressure	0	None
50082	50083	,	0	None
50083	50084	35	0	None
50084	50085	mm	0	None
50085	50086	Hg	0	None
50086	50087	for	0	None
50087	50088	90	0	None
50088	50089	min	0	None
50089	50090	)	0	None
50090	50091	.	0	None

50092	50093	Animals	0	None
50093	50094	were	0	None
50094	50095	resuscitated	0	None
50095	50096	with	0	None
50096	50097	shed	0	None
50097	50098	blood	0	None
50098	50099	and	0	None
50099	50100	Ringer's	0	None
50100	50101	.	0	None

50102	50103	In	0	None
50103	50104	addition	0	None
50104	50105	,	0	None
50105	50106	the	0	None
50106	50107	HO	0	None
50107	50108	pathway	0	None
50108	50109	was	0	None
50109	50110	blocked	0	None
50110	50111	after	0	None
50111	50112	dobutamine	2	CHEMICAL
50112	50113	pretreatment	0	None
50113	50114	with	0	None
50114	50115	10	0	None
50115	50116	micromol	0	None
50116	50117	/	0	None
50117	50118	kg	0	None
50118	50119	tin-mesoporphyrin-IX	0	None
50119	50120	(	0	None
50120	50121	Dob	0	None
50121	50122	/	0	None
50122	50123	SnMP	0	None
50123	50124	/	0	None
50124	50125	Shock	0	None
50125	50126	)	0	None
50126	50127	or	0	None
50127	50128	animals	0	None
50128	50129	received	0	None
50129	50130	100	0	None
50130	50131	mg	2	CHEMICAL
50131	50132	/	0	None
50132	50133	kg	0	None
50133	50134	of	0	None
50134	50135	the	0	None
50135	50136	carbon	2	CHEMICAL
50136	50137	monoxide	0	None
50137	50138	donor	0	None
50138	50139	dichloromethane	2	CHEMICAL
50139	50140	(	0	None
50140	50141	DCM	2	CHEMICAL
50141	50142	/	0	None
50142	50143	Shock	0	None
50143	50144	)	0	None
50144	50145	.	0	None

50146	50147	MEASUREMENTS	0	None
50147	50148	:	0	None
50148	50149	Hepatocellular	0	None
50149	50150	metabolism	0	None
50150	50151	and	0	None
50151	50152	liver	0	None
50152	50153	blood	0	None
50153	50154	flow	0	None
50154	50155	were	0	None
50155	50156	measured	0	None
50156	50157	by	0	None
50157	50158	plasma	0	None
50158	50159	disappearance	0	None
50159	50160	rate	0	None
50160	50161	of	0	None
50161	50162	indocyanine	0	None
50162	50163	green	0	None
50163	50164	(	0	None
50164	50165	PDR	0	None
50165	50166	(	0	None
50166	50167	ICG	0	None
50167	50168	)	0	None
50168	50169	)	0	None
50169	50170	as	0	None
50170	50171	a	0	None
50171	50172	sensitive	0	None
50172	50173	marker	0	None
50173	50174	of	0	None
50174	50175	liver	0	None
50175	50176	function	0	None
50176	50177	.	0	None

50178	50179	MAIN	0	None
50179	50180	RESULTS	0	None
50180	50181	:	0	None
50181	50182	Pretreatment	0	None
50182	50183	with	0	None
50183	50184	dobutamine	2	CHEMICAL
50184	50185	induced	0	None
50185	50186	HO-1	0	None
50186	50187	in	0	None
50187	50188	pericentral	0	None
50188	50189	hepatocytes	0	None
50189	50190	and	0	None
50190	50191	improved	0	None
50191	50192	PDR	0	None
50192	50193	(	0	None
50193	50194	ICG	0	None
50194	50195	)	0	None
50195	50196	(	0	None
50196	50197	Vehicle	0	None
50197	50198	/	0	None
50198	50199	Shock	0	None
50199	50200	:	0	None
50200	50201	11	0	None
50201	50202	.	0	None
50202	50203	7	0	None
50203	50204	+	0	None
50204	50205	/	0	None
50205	50206	-	0	None
50206	50207	8	0	None
50207	50208	.	0	None
50208	50209	12%	0	None
50209	50210	/	0	None
50210	50211	min	0	None
50211	50212	vs	0	None
50212	50213	.	0	None

50214	50215	Dob	0	None
50215	50216	/	0	None
50216	50217	Shock	0	None
50217	50218	:	0	None
50218	50219	19	0	None
50219	50220	.	0	None
50220	50221	7	0	None
50221	50222	+	0	None
50222	50223	/	0	None
50223	50224	-	0	None
50224	50225	2	0	None
50225	50226	.	0	None
50226	50227	46%	0	None
50227	50228	/	0	None
50228	50229	min	0	None
50229	50230	,	0	None
50230	50231	p	0	None
50231	50232	=	0	None
50232	50233	0	0	None
50233	50234	.	0	None
50234	50235	006	0	None
50235	50236	)	0	None
50236	50237	.	0	None

50238	50239	Blockade	0	None
50239	50240	of	0	None
50240	50241	the	0	None
50241	50242	HO	0	None
50242	50243	pathway	0	None
50243	50244	after	0	None
50244	50245	preconditioning	0	None
50245	50246	and	0	None
50246	50247	the	0	None
50247	50248	combined	0	None
50248	50249	pretreatment	0	None
50249	50250	with	0	None
50250	50251	dobutamine	2	CHEMICAL
50251	50252	and	0	None
50252	50253	esmolol	0	None
50253	50254	decreased	0	None
50254	50255	PDR	0	None
50255	50256	(	0	None
50256	50257	ICG	0	None
50257	50258	)	0	None
50258	50259	(	0	None
50259	50260	Dob	0	None
50260	50261	/	0	None
50261	50262	SnMP	0	None
50262	50263	/	0	None
50263	50264	Shock	0	None
50264	50265	:	0	None
50265	50266	12	0	None
50266	50267	.	0	None
50267	50268	6	0	None
50268	50269	+	0	None
50269	50270	/	0	None
50270	50271	-	0	None
50271	50272	4	0	None
50272	50273	.	0	None
50273	50274	24%	0	None
50274	50275	/	0	None
50275	50276	min	0	None
50276	50277	,	0	None
50277	50278	p	0	None
50278	50279	=	0	None
50279	50280	0	0	None
50280	50281	.	0	None
50281	50282	011;	0	None
50282	50283	Dob	0	None
50283	50284	/	0	None
50284	50285	Esmolol	0	None
50285	50286	/	0	None
50286	50287	Shock	0	None
50287	50288	:	0	None
50288	50289	10	0	None
50289	50290	.	0	None
50290	50291	2	0	None
50291	50292	+	0	None
50292	50293	/	0	None
50293	50294	-	0	None
50294	50295	4	0	None
50295	50296	.	0	None
50296	50297	34%	0	None
50297	50298	/	0	None
50298	50299	min	0	None
50299	50300	,	0	None
50300	50301	p	0	None
50301	50302	=	0	None
50302	50303	0	0	None
50303	50304	.	0	None
50304	50305	008	0	None
50305	50306	)	0	None
50306	50307	.	0	None

50308	50309	Pretreatment	0	None
50309	50310	with	0	None
50310	50311	a	0	None
50311	50312	carbon	2	CHEMICAL
50312	50313	monoxide	0	None
50313	50314	donor	0	None
50314	50315	improved	0	None
50315	50316	PDR	0	None
50316	50317	(	0	None
50317	50318	ICG	0	None
50318	50319	)	0	None
50319	50320	(	0	None
50320	50321	DCM	2	CHEMICAL
50321	50322	/	0	None
50322	50323	Shock	0	None
50323	50324	:	0	None
50324	50325	18	0	None
50325	50326	+	0	None
50326	50327	/	0	None
50327	50328	-	0	None
50328	50329	3	0	None
50329	50330	.	0	None
50330	50331	19%	0	None
50331	50332	/	0	None
50332	50333	min	0	None
50333	50334	,	0	None
50334	50335	p	0	None
50335	50336	=	0	None
50336	50337	0	0	None
50337	50338	.	0	None
50338	50339	022	0	None
50339	50340	)	0	None
50340	50341	compared	0	None
50341	50342	with	0	None
50342	50343	Vehicle	0	None
50343	50344	/	0	None
50344	50345	Shock	0	None
50345	50346	.	0	None

50347	50348	CONCLUSIONS	0	None
50348	50349	:	0	None
50349	50350	These	0	None
50350	50351	results	0	None
50351	50352	suggest	0	None
50352	50353	a	0	None
50353	50354	beta	0	None
50354	50355	(	0	None
50355	50356	1	0	None
50356	50357	)	0	None
50357	50358	-adrenoceptor-dependent	0	None
50358	50359	hepatic	0	None
50359	50360	up-regulation	0	None
50360	50361	of	0	None
50361	50362	HO-1	0	None
50362	50363	and	0	None
50363	50364	a	0	None
50364	50365	better	0	None
50365	50366	maintained	0	None
50366	50367	hepatocellular	0	None
50367	50368	function	0	None
50368	50369	after	0	None
50369	50370	hemorrhagic	0	None
50370	50371	shock	0	None
50371	50372	in	0	None
50372	50373	animals	0	None
50373	50374	pretreated	0	None
50374	50375	with	0	None
50375	50376	dobutamine	2	CHEMICAL
50376	50377	.	0	None

50378	50379	The	0	None
50379	50380	improved	0	None
50380	50381	hepatocellular	0	None
50381	50382	function	0	None
50382	50383	may	0	None
50383	50384	be	0	None
50384	50385	in	0	None
50385	50386	part	0	None
50386	50387	mediated	0	None
50387	50388	by	0	None
50388	50389	carbon	2	CHEMICAL
50389	50390	monoxide	0	None
50390	50391	because	0	None
50391	50392	of	0	None
50392	50393	up-regulation	0	None
50393	50394	of	0	None
50394	50395	HO-1	0	None
50395	50396	.	0	None

50397	50398	Pretreatment	0	None
50398	50399	with	0	None
50399	50400	dobutamine	2	CHEMICAL
50400	50401	might	0	None
50401	50402	be	0	None
50402	50403	a	0	None
50403	50404	potential	0	None
50404	50405	means	0	None
50405	50406	of	0	None
50406	50407	pharmacologic	0	None
50407	50408	preconditioning	0	None
50408	50409	before	0	None
50409	50410	ischemia-reperfusion	0	None
50410	50411	of	0	None
50411	50412	the	0	None
50412	50413	liver	0	None
50413	50414	.	0	None
50414	50415	β-Galactosidase	0	None
50415	50416	(	0	None
50416	50417	lacZ	0	None
50417	50418	)	0	None
50418	50419	has	0	None
50419	50420	bifunctional	0	None
50420	50421	activity	0	None
50421	50422	.	0	None

50423	50424	It	0	None
50424	50425	hydrolyzes	0	None
50425	50426	lactose	0	None
50426	50427	to	0	None
50427	50428	galactose	2	CHEMICAL
50428	50429	and	0	None
50429	50430	glucose	0	None
50430	50431	and	0	None
50431	50432	catalyzes	0	None
50432	50433	the	0	None
50433	50434	intramolecular	0	None
50434	50435	isomerization	0	None
50435	50436	of	0	None
50436	50437	lactose	0	None
50437	50438	to	0	None
50438	50439	allolactose	0	None
50439	50440	,	0	None
50440	50441	the	0	None
50441	50442	lac	0	None
50442	50443	operon	0	None
50443	50444	inducer	0	None
50444	50445	.	0	None

50446	50447	β-Galactosidase	0	None
50447	50448	promotes	0	None
50448	50449	the	0	None
50449	50450	isomerization	0	None
50450	50451	by	0	None
50451	50452	means	0	None
50452	50453	of	0	None
50453	50454	an	0	None
50454	50455	acceptor	0	None
50455	50456	site	0	None
50456	50457	that	0	None
50457	50458	binds	0	None
50458	50459	glucose	0	None
50459	50460	after	0	None
50460	50461	its	0	None
50461	50462	cleavage	0	None
50462	50463	from	0	None
50463	50464	lactose	0	None
50464	50465	and	0	None
50465	50466	thus	0	None
50466	50467	delays	0	None
50467	50468	its	0	None
50468	50469	exit	0	None
50469	50470	from	0	None
50470	50471	the	0	None
50471	50472	site	0	None
50472	50473	.	0	None

50474	50475	However	0	None
50475	50476	,	0	None
50476	50477	because	0	None
50477	50478	of	0	None
50478	50479	its	0	None
50479	50480	relatively	0	None
50480	50481	low	0	None
50481	50482	affinity	0	None
50482	50483	for	0	None
50483	50484	glucose	0	None
50484	50485	,	0	None
50485	50486	details	0	None
50486	50487	of	0	None
50487	50488	this	0	None
50488	50489	site	0	None
50489	50490	have	0	None
50490	50491	remained	0	None
50491	50492	elusive	0	None
50492	50493	.	0	None

50494	50495	We	0	None
50495	50496	present	0	None
50496	50497	structural	0	None
50497	50498	data	0	None
50498	50499	mapping	0	None
50499	50500	the	0	None
50500	50501	glucose	0	None
50501	50502	site	0	None
50502	50503	based	0	None
50503	50504	on	0	None
50504	50505	a	0	None
50505	50506	substituted	0	None
50506	50507	enzyme	0	None
50507	50508	(	0	None
50508	50509	G794A-β-galactosidase	0	None
50509	50510	)	0	None
50510	50511	that	0	None
50511	50512	traps	0	None
50512	50513	allolactose	0	None
50513	50514	.	0	None

50515	50516	Various	0	None
50516	50517	lines	0	None
50517	50518	of	0	None
50518	50519	evidence	0	None
50519	50520	indicate	0	None
50520	50521	that	0	None
50521	50522	the	0	None
50522	50523	glucose	0	None
50523	50524	of	0	None
50524	50525	the	0	None
50525	50526	trapped	0	None
50526	50527	allolactose	0	None
50527	50528	is	0	None
50528	50529	in	0	None
50529	50530	the	0	None
50530	50531	acceptor	0	None
50531	50532	position	0	None
50532	50533	.	0	None

50534	50535	The	0	None
50535	50536	evidence	0	None
50536	50537	includes	0	None
50537	50538	structures	0	None
50538	50539	with	0	None
50539	50540	Bis-Tris	0	None
50540	50541	(	0	None
50541	50542	2	0	None
50542	50543	,	0	None
50543	50544	2-bis	0	None
50544	50545	(	0	None
50545	50546	hydroxymethyl	0	None
50546	50547	)	0	None
50547	50548	-2	0	None
50548	50549	,	0	None
50549	50550	2'	0	None
50550	50551	,	0	None
50551	50552	2″-nitrilotriethanol	0	None
50552	50553	)	0	None
50553	50554	and	0	None
50554	50555	l-ribose	0	None
50555	50556	in	0	None
50556	50557	the	0	None
50557	50558	site	0	None
50558	50559	and	0	None
50559	50560	kinetic	0	None
50560	50561	binding	0	None
50561	50562	studies	0	None
50562	50563	with	0	None
50563	50564	substituted	0	None
50564	50565	β-galactosidases	0	None
50565	50566	.	0	None

50567	50568	The	0	None
50568	50569	site	0	None
50569	50570	is	0	None
50570	50571	composed	0	None
50571	50572	of	0	None
50572	50573	Asn-102	0	None
50573	50574	,	0	None
50574	50575	His-418	0	None
50575	50576	,	0	None
50576	50577	Lys-517	0	None
50577	50578	,	0	None
50578	50579	Ser-796	0	None
50579	50580	,	0	None
50580	50581	Glu-797	0	None
50581	50582	,	0	None
50582	50583	and	0	None
50583	50584	Trp-999	0	None
50584	50585	.	0	None

50586	50587	Ser-796	0	None
50587	50588	and	0	None
50588	50589	Glu-797	0	None
50589	50590	are	0	None
50590	50591	part	0	None
50591	50592	of	0	None
50592	50593	a	0	None
50593	50594	loop	0	None
50594	50595	(	0	None
50595	50596	residues	0	None
50596	50597	795-803	0	None
50597	50598	)	0	None
50598	50599	that	0	None
50599	50600	closes	0	None
50600	50601	over	0	None
50601	50602	the	0	None
50602	50603	active	0	None
50603	50604	site	0	None
50604	50605	.	0	None

50606	50607	This	0	None
50607	50608	loop	0	None
50608	50609	appears	0	None
50609	50610	essential	0	None
50610	50611	for	0	None
50611	50612	the	0	None
50612	50613	bifunctional	0	None
50613	50614	nature	0	None
50614	50615	of	0	None
50615	50616	the	0	None
50616	50617	enzyme	0	None
50617	50618	because	0	None
50618	50619	it	0	None
50619	50620	helps	0	None
50620	50621	form	0	None
50621	50622	the	0	None
50622	50623	glucose	0	None
50623	50625	binding site	0	None
50625	50626	.	0	None

50627	50628	In	0	None
50628	50629	addition	0	None
50629	50630	,	0	None
50630	50631	because	0	None
50631	50632	the	0	None
50632	50633	loop	0	None
50633	50634	is	0	None
50634	50635	mobile	0	None
50635	50636	,	0	None
50636	50637	glucose	0	None
50637	50638	binding	0	None
50638	50639	is	0	None
50639	50640	transient	0	None
50640	50641	,	0	None
50641	50642	allowing	0	None
50642	50643	the	0	None
50643	50644	release	0	None
50644	50645	of	0	None
50645	50646	some	0	None
50646	50647	glucose	0	None
50647	50648	.	0	None

50649	50650	Bioinformatics	0	None
50650	50651	studies	0	None
50651	50652	showed	0	None
50652	50653	that	0	None
50653	50654	the	0	None
50654	50655	residues	0	None
50655	50656	important	0	None
50656	50657	for	0	None
50657	50658	interacting	0	None
50658	50659	with	0	None
50659	50660	glucose	0	None
50660	50661	are	0	None
50661	50662	only	0	None
50662	50663	conserved	0	None
50663	50664	in	0	None
50664	50665	a	0	None
50665	50666	subset	0	None
50666	50667	of	0	None
50667	50668	related	0	None
50668	50669	enzymes	0	None
50669	50670	.	0	None

50671	50672	Thus	0	None
50672	50673	,	0	None
50673	50674	intramolecular	0	None
50674	50675	isomerization	0	None
50675	50676	is	0	None
50676	50677	not	0	None
50677	50678	a	0	None
50678	50679	universal	0	None
50679	50680	feature	0	None
50680	50681	of	0	None
50681	50682	β-galactosidases	0	None
50682	50683	.	0	None

50684	50685	Genomic	0	None
50685	50686	analyses	0	None
50686	50687	indicated	0	None
50687	50688	that	0	None
50688	50689	lac	0	None
50689	50690	repressors	0	None
50690	50691	were	0	None
50691	50692	co-selected	0	None
50692	50693	only	0	None
50693	50694	within	0	None
50694	50695	the	0	None
50695	50696	conserved	0	None
50696	50697	subset	0	None
50697	50698	.	0	None

50699	50700	This	0	None
50700	50701	shows	0	None
50701	50702	that	0	None
50702	50703	the	0	None
50703	50704	glucose	0	None
50704	50706	binding site	3	GENE-N
50706	50707	of	0	None
50707	50708	β-galactosidase	0	None
50708	50709	played	0	None
50709	50710	an	0	None
50710	50711	important	0	None
50711	50712	role	0	None
50712	50713	in	0	None
50713	50714	lac	0	None
50714	50715	operon	0	None
50715	50716	evolution	0	None
50716	50717	.	0	None
50717	50718	Design	0	None
50718	50719	and	0	None
50719	50720	synthesis	0	None
50720	50721	of	0	None
50721	50722	2-substituted	0	None
50722	50723	benzoxazoles	0	None
50723	50724	as	0	None
50724	50725	novel	0	None
50725	50726	PTP1B	0	None
50726	50727	inhibitors	0	None
50727	50728	.	0	None
50728	50729	SU11248	0	None
50729	50730	is	0	None
50730	50731	a	0	None
50731	50732	novel	0	None
50732	50733	FLT3	0	None
50733	50734	tyrosine	2	CHEMICAL
50734	50735	kinase	0	None
50735	50736	inhibitor	0	None
50736	50737	with	0	None
50737	50738	potent	0	None
50738	50739	activity	0	None
50739	50740	in	0	None
50740	50741	vitro	0	None
50741	50742	and	0	None
50742	50743	in	0	None
50743	50744	vivo	0	None
50744	50745	.	0	None
50745	50746	Allopurinol	0	None
50746	50747	is	0	None
50747	50748	an	0	None
50748	50749	inhibitor	0	None
50749	50750	of	0	None
50750	50751	xanthine	0	None
50751	50752	oxidoreductase	0	None
50752	50753	(	0	None
50753	50754	XOR	0	None
50754	50755	)	0	None
50755	50756	and	0	None
50756	50757	inhibits	0	None
50757	50758	the	0	None
50758	50759	generation	0	None
50759	50760	of	0	None
50760	50761	uric	0	None
50761	50762	acid	0	None
50762	50763	(	0	None
50763	50764	UA	0	None
50764	50765	)	0	None
50765	50766	as	0	None
50766	50767	the	0	None
50767	50768	final	0	None
50768	50769	product	0	None
50769	50770	of	0	None
50770	50771	purine	0	None
50771	50772	catabolism	0	None
50772	50773	,	0	None
50773	50774	as	0	None
50774	50775	well	0	None
50775	50776	as	0	None
50776	50777	the	0	None
50777	50778	resulting	0	None
50778	50779	generation	0	None
50779	50780	of	0	None
50780	50781	superoxide	0	None
50781	50782	(	0	None
50782	50783	O2	2	CHEMICAL
50783	50784	(	0	None
50784	50785	-	0	None
50785	50786	)	0	None
50786	50787	)	0	None
50787	50788	,	0	None
50788	50789	in	0	None
50789	50790	humans	0	None
50790	50791	.	0	None

50792	50793	Elevation	0	None
50793	50794	of	0	None
50794	50795	the	0	None
50795	50796	serum	0	None
50796	50797	UA	0	None
50797	50798	(	0	None
50798	50799	SUA	0	None
50799	50800	)	0	None
50800	50801	level	0	None
50801	50802	,	0	None
50802	50803	referred	0	None
50803	50804	to	0	None
50804	50805	as	0	None
50805	50806	hyperuricemia	0	None
50806	50807	(	0	None
50807	50808	HU	0	None
50808	50809	)	0	None
50809	50810	,	0	None
50810	50811	eventually	0	None
50811	50812	leads	0	None
50812	50813	to	0	None
50813	50814	gout	0	None
50814	50815	and	0	None
50815	50816	allopurinol	0	None
50816	50817	has	0	None
50817	50818	been	0	None
50818	50819	used	0	None
50819	50820	for	0	None
50820	50821	the	0	None
50821	50822	treatment	0	None
50822	50823	of	0	None
50823	50824	HU	0	None
50824	50825	and	0	None
50825	50826	gout	0	None
50826	50827	.	0	None

50828	50829	Studies	0	None
50829	50830	have	0	None
50830	50831	revealed	0	None
50831	50832	the	0	None
50832	50833	role	0	None
50833	50834	of	0	None
50834	50835	elevated	0	None
50835	50836	SUA	0	None
50836	50837	levels	0	None
50837	50838	and	0	None
50838	50839	the	0	None
50839	50840	associated	0	None
50840	50841	oxidative	0	None
50841	50842	stress	0	None
50842	50843	(	0	None
50843	50844	OS	0	None
50844	50845	)	0	None
50845	50846	in	0	None
50846	50847	a	0	None
50847	50848	broad	0	None
50848	50849	spectrum	0	None
50849	50850	of	0	None
50850	50851	pathological	0	None
50851	50852	conditions	0	None
50852	50853	and	0	None
50853	50854	it	0	None
50854	50855	is	0	None
50855	50856	anticipated	0	None
50856	50857	that	0	None
50857	50858	these	0	None
50858	50859	findings	0	None
50859	50860	would	0	None
50860	50861	also	0	None
50861	50862	expand	0	None
50862	50863	the	0	None
50863	50864	use	0	None
50864	50865	of	0	None
50865	50866	allopurinol	0	None
50866	50867	as	0	None
50867	50868	a	0	None
50868	50869	therapeutic	0	None
50869	50870	drug	0	None
50870	50871	.	0	None

50872	50873	This	0	None
50873	50874	article	0	None
50874	50875	presents	0	None
50875	50876	a	0	None
50876	50877	review	0	None
50877	50878	of	0	None
50878	50879	reports	0	None
50879	50880	,	0	None
50880	50881	mainly	0	None
50881	50882	of	0	None
50882	50883	recent	0	None
50883	50884	studies	0	None
50884	50885	,	0	None
50885	50886	on	0	None
50886	50887	the	0	None
50887	50888	efficacy	0	None
50888	50889	of	0	None
50889	50890	allopurinol	0	None
50890	50891	in	0	None
50891	50892	various	0	None
50892	50893	diseases	0	None
50893	50894	and	0	None
50894	50895	explores	0	None
50895	50896	novel	0	None
50896	50897	potential	0	None
50897	50898	uses	0	None
50898	50899	of	0	None
50899	50900	the	0	None
50900	50901	drug	0	None
50901	50902	.	0	None

50903	50904	Important	0	None
50904	50905	novel	0	None
50905	50906	and	0	None
50906	50907	potential	0	None
50907	50908	uses	0	None
50908	50909	of	0	None
50909	50910	great	0	None
50910	50911	interest	0	None
50911	50912	include	0	None
50912	50913	metabolic	0	None
50913	50914	syndrome	0	None
50914	50915	(	0	None
50915	50916	MetS	0	None
50916	50917	)	0	None
50917	50918	and	0	None
50918	50919	related	0	None
50919	50920	disorders	0	None
50920	50921	,	0	None
50921	50922	chronic	0	None
50922	50923	kidney	0	None
50923	50924	disease	0	None
50924	50925	(	0	None
50925	50926	CKD	0	None
50926	50927	)	0	None
50927	50928	,	0	None
50928	50929	nonalcoholic	0	None
50929	50930	fatty	0	None
50930	50931	liver	0	None
50931	50932	disease	0	None
50932	50933	(	0	None
50933	50934	NAFLD	0	None
50934	50935	)	0	None
50935	50936	and	0	None
50936	50937	nonalcoholic	0	None
50937	50938	steatohepatitis	0	None
50938	50939	(	0	None
50939	50940	NASH	0	None
50940	50941	)	0	None
50941	50942	.	0	None

50943	50944	Ischemia-reperfusion	0	None
50944	50945	injury	0	None
50945	50946	and	0	None
50946	50947	mucositis	0	None
50947	50948	,	0	None
50948	50949	encountered	0	None
50949	50950	as	0	None
50950	50951	adverse	0	None
50951	50952	effects	0	None
50952	50953	of	0	None
50953	50954	cancer	0	None
50954	50955	treatment	0	None
50955	50956	,	0	None
50956	50957	have	0	None
50957	50958	also	0	None
50958	50959	been	0	None
50959	50960	under	0	None
50960	50961	investigation	0	None
50961	50962	as	0	None
50962	50963	potential	0	None
50963	50964	targets	0	None
50964	50965	for	0	None
50965	50966	allopurinol	0	None
50966	50967	.	0	None
50967	50968	Endosulfan	0	None
50968	50969	(	0	None
50969	50970	ES	0	None
50970	50971	)	0	None
50971	50972	,	0	None
50972	50973	a	0	None
50973	50974	persistent	0	None
50974	50975	organochlorine	0	None
50975	50976	pesticide	0	None
50976	50977	,	0	None
50977	50978	is	0	None
50978	50979	widely	0	None
50979	50980	used	0	None
50980	50981	despite	0	None
50981	50982	its	0	None
50982	50983	toxicity	0	None
50983	50984	to	0	None
50984	50985	non-target	0	None
50985	50986	animals	0	None
50986	50987	.	0	None

50988	50989	Upon	0	None
50989	50990	reaching	0	None
50990	50991	water	0	None
50991	50992	bodies	0	None
50992	50993	,	0	None
50993	50994	ES	0	None
50994	50995	can	0	None
50995	50996	cause	0	None
50996	50997	negative	0	None
50997	50998	effects	0	None
50998	50999	on	0	None
50999	51000	aquatic	0	None
51000	51001	animals	0	None
51001	51002	,	0	None
51002	51003	including	0	None
51003	51004	disruption	0	None
51004	51005	of	0	None
51005	51006	hormonal	0	None
51006	51007	systems	0	None
51007	51008	.	0	None

51009	51010	However	0	None
51010	51011	,	0	None
51011	51012	the	0	None
51012	51013	action	0	None
51013	51014	of	0	None
51014	51015	ES	0	None
51015	51016	on	0	None
51016	51017	fish	0	None
51017	51018	reproductive	0	None
51018	51019	axis	0	None
51019	51020	has	0	None
51020	51021	been	0	None
51021	51022	hardly	0	None
51022	51023	studied	0	None
51023	51024	thus	0	None
51024	51025	far	0	None
51025	51026	.	0	None

51027	51028	The	0	None
51028	51029	aim	0	None
51029	51030	of	0	None
51030	51031	the	0	None
51031	51032	present	0	None
51032	51033	work	0	None
51033	51034	was	0	None
51034	51035	to	0	None
51035	51036	assess	0	None
51036	51037	the	0	None
51037	51038	endocrine	0	None
51038	51039	disruptive	0	None
51039	51040	potential	0	None
51040	51041	of	0	None
51041	51042	endosulfan	0	None
51042	51043	on	0	None
51043	51044	the	0	None
51044	51045	pituitary	0	None
51045	51046	gonadotropins	0	None
51046	51047	levels	0	None
51047	51048	and	0	None
51048	51049	on	0	None
51049	51050	the	0	None
51050	51051	testes	0	None
51051	51052	function	0	None
51052	51053	due	0	None
51053	51054	to	0	None
51054	51055	ES	0	None
51055	51056	in	0	None
51056	51057	the	0	None
51057	51058	South	0	None
51058	51059	American	0	None
51059	51060	freshwater	0	None
51060	51061	fish	0	None
51061	51062	Cichlasoma	0	None
51062	51063	dimerus	0	None
51063	51064	,	0	None
51064	51065	using	0	None
51065	51066	in	0	None
51066	51067	vitro	0	None
51067	51068	and	0	None
51068	51069	in	0	None
51069	51070	vivo	0	None
51070	51071	approaches	0	None
51071	51072	.	0	None

51073	51074	In	0	None
51074	51075	vitro	0	None
51075	51076	experiments	0	None
51076	51077	showed	0	None
51077	51078	that	0	None
51078	51079	ES	0	None
51079	51080	inhibited	0	None
51080	51081	the	0	None
51081	51082	LH-stimulated	0	None
51082	51083	steroidogenesis	0	None
51083	51084	in	0	None
51084	51085	gonads;	0	None
51085	51086	no	0	None
51086	51087	change	0	None
51087	51088	was	0	None
51088	51089	observed	0	None
51089	51090	in	0	None
51090	51091	gonadotropins	0	None
51091	51092	release	0	None
51092	51093	from	0	None
51093	51094	pituitaries	0	None
51094	51095	in	0	None
51095	51096	culture	0	None
51096	51097	.	0	None

51098	51099	Laboratory	0	None
51099	51100	waterborne	0	None
51100	51101	ES	0	None
51101	51102	(	0	None
51102	51103	0	0	None
51103	51104	.	0	None
51104	51105	1	0	None
51105	51106	,	0	None
51106	51107	0	0	None
51107	51108	.	0	None
51108	51109	3	0	None
51109	51110	and	0	None
51110	51111	1	0	None
51111	51112	μg	0	None
51112	51113	/	0	None
51113	51114	L	0	None
51114	51115	)	0	None
51115	51116	exposure	0	None
51116	51117	for	0	None
51117	51118	two	0	None
51118	51119	months	0	None
51119	51120	caused	0	None
51120	51121	decrease	0	None
51121	51122	in	0	None
51122	51123	βFSH	0	None
51123	51124	pituitary	0	None
51124	51125	content	0	None
51125	51126	and	0	None
51126	51127	γGT	0	None
51127	51128	activity	0	None
51128	51129	in	0	None
51129	51130	the	0	None
51130	51131	testes	0	None
51131	51132	(	0	None
51132	51133	Sertoli	0	None
51133	51134	cell	0	None
51134	51135	function	0	None
51135	51136	marker	0	None
51136	51137	)	0	None
51137	51138	.	0	None

51139	51140	Testicular	0	None
51140	51141	histology	0	None
51141	51142	revealed	0	None
51142	51143	pathologies	0	None
51143	51144	such	0	None
51144	51145	as	0	None
51145	51146	scarce	0	None
51146	51147	intermediate	0	None
51147	51148	stages	0	None
51148	51149	of	0	None
51149	51150	spermatogenesis	0	None
51150	51151	,	0	None
51151	51152	release	0	None
51152	51153	of	0	None
51153	51154	immature	0	None
51154	51155	germ	0	None
51155	51156	cells	0	None
51156	51157	into	0	None
51157	51158	the	0	None
51158	51159	lobular	0	None
51159	51160	lumen	0	None
51160	51161	,	0	None
51161	51162	presence	0	None
51162	51163	of	0	None
51163	51164	foam	0	None
51164	51165	cells	0	None
51165	51166	and	0	None
51166	51167	interstitial	0	None
51167	51168	fibrosis	0	None
51168	51169	.	0	None

51170	51171	As	0	None
51171	51172	FSH	0	None
51172	51173	and	0	None
51173	51174	FSH-mediated	0	None
51174	51175	steroidogenesis	0	None
51175	51176	regulate	0	None
51176	51177	spermatogenesis	0	None
51177	51178	and	0	None
51178	51179	Sertoli	0	None
51179	51180	cell	0	None
51180	51181	function	0	None
51181	51182	,	0	None
51182	51183	the	0	None
51183	51184	effect	0	None
51184	51185	of	0	None
51185	51186	ES	0	None
51186	51187	on	0	None
51187	51188	FSH	0	None
51188	51189	could	0	None
51189	51190	be	0	None
51190	51191	responsible	0	None
51191	51192	for	0	None
51192	51193	the	0	None
51193	51194	morphological	0	None
51194	51195	alterations	0	None
51195	51196	observed	0	None
51196	51197	in	0	None
51197	51198	testes	0	None
51198	51199	.	0	None

51200	51201	In	0	None
51201	51202	vitro	0	None
51202	51203	,	0	None
51203	51204	ES	0	None
51204	51205	disrupted	0	None
51205	51206	steroidogenesis	0	None
51206	51207	in	0	None
51207	51208	gonads	0	None
51208	51209	,	0	None
51209	51210	therefore	0	None
51210	51211	similar	0	None
51211	51212	effects	0	None
51212	51213	in	0	None
51213	51214	vivo	0	None
51214	51215	cannot	0	None
51215	51216	be	0	None
51216	51217	ruled	0	None
51217	51218	out	0	None
51218	51219	.	0	None

51220	51221	Based	0	None
51221	51222	on	0	None
51222	51223	this	0	None
51223	51224	evidence	0	None
51224	51225	,	0	None
51225	51226	ES	0	None
51226	51227	exhibits	0	None
51227	51228	an	0	None
51228	51229	endocrine	0	None
51229	51230	disruptive	0	None
51230	51231	action	0	None
51231	51232	on	0	None
51232	51233	the	0	None
51233	51234	reproductive	0	None
51234	51235	axis	0	None
51235	51236	of	0	None
51236	51237	C	0	None
51237	51238	.	0	None

51239	51240	dimerus	0	None
51240	51241	,	0	None
51241	51242	causing	0	None
51242	51243	disruption	0	None
51243	51244	at	0	None
51244	51245	the	0	None
51245	51246	pituitary	0	None
51246	51247	and	0	None
51247	51248	/	0	None
51248	51249	or	0	None
51249	51250	at	0	None
51250	51251	the	0	None
51251	51252	gonad	0	None
51252	51253	level	0	None
51253	51254	.	0	None

51255	51256	These	0	None
51256	51257	effects	0	None
51257	51258	could	0	None
51258	51259	acquire	0	None
51259	51260	ecological	0	None
51260	51261	significance	0	None
51261	51262	under	0	None
51262	51263	prolonged	0	None
51263	51264	exposure	0	None
51264	51265	to	0	None
51265	51266	the	0	None
51266	51267	pesticide	0	None
51267	51268	in	0	None
51268	51269	nature	0	None
51269	51270	.	0	None
51270	51271	A	0	None
51271	51272	"clickable"	0	None
51272	51273	MTX	0	None
51273	51274	reagent	0	None
51274	51275	as	0	None
51275	51276	a	0	None
51276	51277	practical	0	None
51277	51278	tool	0	None
51278	51279	for	0	None
51279	51280	profiling	0	None
51280	51281	small-molecule-intracellular	0	None
51281	51282	target	0	None
51282	51283	interactions	0	None
51283	51284	via	0	None
51284	51285	MASPIT	0	None
51285	51286	.	0	None
51286	51287	Pseudohypoaldosteronism	0	None
51287	51288	type	0	None
51288	51289	1	0	None
51289	51290	(	0	None
51290	51291	PHA1	0	None
51291	51292	)	0	None
51292	51293	,	0	None
51293	51294	a	0	None
51294	51295	rare	0	None
51295	51296	disorder	0	None
51296	51297	of	0	None
51297	51298	infancy	0	None
51298	51299	,	0	None
51299	51300	presents	0	None
51300	51301	with	0	None
51301	51302	potential	0	None
51302	51303	life-threatening	0	None
51303	51304	salt	0	None
51304	51305	wasting	0	None
51305	51306	and	0	None
51306	51307	failure	0	None
51307	51308	to	0	None
51308	51309	thrive	0	None
51309	51310	.	0	None

51311	51312	Thus	0	None
51312	51313	far	0	None
51313	51314	,	0	None
51314	51315	PHA1	0	None
51315	51316	has	0	None
51316	51317	been	0	None
51317	51318	attributed	0	None
51318	51319	to	0	None
51319	51320	mutations	0	None
51320	51321	affecting	0	None
51321	51322	the	0	None
51322	51324	mineralocorticoid receptor	1	GENE-Y
51324	51325	or	0	None
51325	51326	any	0	None
51326	51327	of	0	None
51327	51328	the	0	None
51328	51329	three	0	None
51329	51330	subunits	0	None
51330	51331	assembling	0	None
51331	51332	the	0	None
51332	51333	amiloride-sensitive	0	None
51333	51334	epithelial	0	None
51334	51336	sodium channel	3	GENE-N
51336	51337	(	0	None
51337	51338	ENaC	0	None
51338	51339	)	0	None
51339	51340	.	0	None

51341	51342	However	0	None
51342	51343	,	0	None
51343	51344	a	0	None
51344	51345	lot	0	None
51345	51346	of	0	None
51346	51347	patients	0	None
51347	51348	with	0	None
51348	51349	a	0	None
51349	51350	phenotype	0	None
51350	51351	resembling	0	None
51351	51352	PHA1	0	None
51352	51353	,	0	None
51353	51354	show	0	None
51354	51355	no	0	None
51355	51356	defects	0	None
51356	51357	in	0	None
51357	51358	these	0	None
51358	51359	proteins	0	None
51359	51360	,	0	None
51360	51361	making	0	None
51361	51362	it	0	None
51362	51363	likely	0	None
51363	51364	that	0	None
51364	51365	further	0	None
51365	51366	genes	0	None
51366	51367	are	0	None
51367	51368	involved	0	None
51368	51369	in	0	None
51369	51370	the	0	None
51370	51371	aetiology	0	None
51371	51372	of	0	None
51372	51373	this	0	None
51373	51374	disease	0	None
51374	51375	.	0	None

51376	51377	Recent	0	None
51377	51378	studies	0	None
51378	51379	have	0	None
51379	51380	elucidated	0	None
51380	51381	additional	0	None
51381	51382	participants	0	None
51382	51383	(	0	None
51383	51384	alpha-spectrin	0	None
51384	51385	and	0	None
51385	51386	members	0	None
51386	51387	of	0	None
51387	51388	the	0	None
51388	51389	families	0	None
51389	51390	of	0	None
51390	51391	transmembrane	0	None
51391	51393	serine proteases	3	GENE-N
51393	51394	,	0	None
51394	51395	ubiquitin-protein	0	None
51395	51396	ligases	0	None
51396	51397	,	0	None
51397	51398	and	0	None
51398	51399	serum-	0	None
51399	51400	and	0	None
51400	51401	glucocorticoid-regulated	0	None
51401	51402	kinases	0	None
51402	51403	,	0	None
51403	51404	respectively	0	None
51404	51405	)	0	None
51405	51406	regulating	0	None
51406	51407	and	0	None
51407	51408	/	0	None
51408	51409	or	0	None
51409	51410	interacting	0	None
51410	51411	in	0	None
51411	51412	the	0	None
51412	51413	complex	0	None
51413	51414	pathway	0	None
51414	51415	of	0	None
51415	51416	sodium	2	CHEMICAL
51416	51417	retention	0	None
51417	51418	in	0	None
51418	51419	the	0	None
51419	51420	amiloride-sensitive	0	None
51420	51421	distal	0	None
51421	51422	nephron	0	None
51422	51423	.	0	None

51424	51425	This	0	None
51425	51426	led	0	None
51426	51427	us	0	None
51427	51428	to	0	None
51428	51429	investigate	0	None
51429	51430	whether	0	None
51430	51431	PHA1	0	None
51431	51432	can	0	None
51432	51433	also	0	None
51433	51434	be	0	None
51434	51435	associated	0	None
51435	51436	with	0	None
51436	51437	mutations	0	None
51437	51438	in	0	None
51438	51439	some	0	None
51439	51440	of	0	None
51440	51441	these	0	None
51441	51442	genes	0	None
51442	51443	.	0	None

51444	51445	Our	0	None
51445	51446	data	0	None
51446	51447	suggest	0	None
51447	51448	that	0	None
51448	51449	at	0	None
51449	51450	least	0	None
51450	51451	the	0	None
51451	51452	prostasin	0	None
51452	51453	gene	0	None
51453	51454	might	0	None
51454	51455	be	0	None
51455	51456	excluded	0	None
51456	51457	as	0	None
51457	51458	a	0	None
51458	51459	causative	0	None
51459	51460	locus	0	None
51460	51461	.	0	None
51461	51462	Recent	0	None
51462	51463	observations	0	None
51463	51464	point	0	None
51464	51465	to	0	None
51465	51466	the	0	None
51466	51467	role	0	None
51467	51468	played	0	None
51468	51469	by	0	None
51469	51470	Zn2	0	None
51470	51471	+	0	None
51471	51472	as	0	None
51472	51473	an	0	None
51473	51474	inducer	0	None
51474	51475	of	0	None
51475	51476	neuronal	0	None
51476	51477	death	0	None
51477	51478	.	0	None

51479	51480	Two	0	None
51480	51481	Zn2	0	None
51481	51482	+	0	None
51482	51483	targets	0	None
51483	51484	have	0	None
51484	51485	been	0	None
51485	51486	identified	0	None
51486	51487	that	0	None
51487	51488	result	0	None
51488	51489	in	0	None
51489	51490	inhibition	0	None
51490	51491	of	0	None
51491	51492	mitochondrial	0	None
51492	51493	respiration	0	None
51493	51494	:	0	None
51494	51495	the	0	None
51495	51496	bc1	0	None
51496	51497	center	0	None
51497	51498	and	0	None
51498	51499	,	0	None
51499	51500	more	0	None
51500	51501	recently	0	None
51501	51502	,	0	None
51502	51503	alpha-ketoglutarate	0	None
51503	51504	dehydrogenase	0	None
51504	51505	.	0	None

51506	51507	Zn2	0	None
51507	51508	+	0	None
51508	51509	is	0	None
51509	51510	also	0	None
51510	51511	a	0	None
51511	51512	mediator	0	None
51512	51513	of	0	None
51513	51514	oxidative	0	None
51514	51515	stress	0	None
51515	51516	,	0	None
51516	51517	leading	0	None
51517	51518	to	0	None
51518	51519	mitochondrial	0	None
51519	51520	failure	0	None
51520	51521	,	0	None
51521	51522	release	0	None
51522	51523	of	0	None
51523	51524	apoptotic	0	None
51524	51525	peptides	0	None
51525	51526	,	0	None
51526	51527	and	0	None
51527	51528	neuronal	0	None
51528	51529	death	0	None
51529	51530	.	0	None

51531	51532	We	0	None
51532	51533	now	0	None
51533	51534	present	0	None
51534	51535	evidence	0	None
51535	51536	,	0	None
51536	51537	by	0	None
51537	51538	means	0	None
51538	51539	of	0	None
51539	51540	direct	0	None
51540	51541	biochemical	0	None
51541	51542	assays	0	None
51542	51543	,	0	None
51543	51544	that	0	None
51544	51545	Zn2	0	None
51545	51546	+	0	None
51546	51547	is	0	None
51547	51548	imported	0	None
51548	51549	through	0	None
51549	51550	the	0	None
51550	51551	Ca2	0	None
51551	51552	+	0	None
51552	51553	uniporter	0	None
51553	51554	and	0	None
51554	51555	directly	0	None
51555	51556	targets	0	None
51556	51557	major	0	None
51557	51558	enzymes	0	None
51558	51559	of	0	None
51559	51560	energy	0	None
51560	51561	production	0	None
51561	51562	(	0	None
51562	51564	lipoamide dehydrogenase	1	GENE-Y
51564	51565	)	0	None
51565	51566	and	0	None
51566	51567	antioxidant	0	None
51567	51568	defense	0	None
51568	51569	(	0	None
51569	51570	thioredoxin	1	GENE-Y
51570	51571	reductase	0	None
51571	51572	and	0	None
51572	51574	glutathione reductase	1	GENE-Y
51574	51575	)	0	None
51575	51576	.	0	None

51577	51578	We	0	None
51578	51579	demonstrate	0	None
51579	51580	the	0	None
51580	51581	following	0	None
51581	51582	.	0	None

51583	51584	(	0	None
51584	51585	a	0	None
51585	51586	)	0	None
51586	51587	These	0	None
51587	51588	matrix	0	None
51588	51589	enzymes	0	None
51589	51590	are	0	None
51590	51591	rapidly	0	None
51591	51592	inhibited	0	None
51592	51593	by	0	None
51593	51594	application	0	None
51594	51595	of	0	None
51595	51596	Zn2	0	None
51596	51597	+	0	None
51597	51598	to	0	None
51598	51599	intact	0	None
51599	51600	mitochondria	0	None
51600	51601	.	0	None

51602	51603	(	0	None
51603	51604	b	0	None
51604	51605	)	0	None
51605	51606	Delayed	0	None
51606	51607	treatment	0	None
51607	51608	with	0	None
51608	51609	membrane-impermeable	0	None
51609	51610	chelators	0	None
51610	51611	has	0	None
51611	51612	no	0	None
51612	51613	effect	0	None
51613	51614	,	0	None
51614	51615	indicating	0	None
51615	51616	rapid	0	None
51616	51617	transport	0	None
51617	51618	of	0	None
51618	51619	biologically	0	None
51619	51620	relevant	0	None
51620	51621	quantities	0	None
51621	51622	of	0	None
51622	51623	Zn2	0	None
51623	51624	+	0	None
51624	51625	into	0	None
51625	51626	the	0	None
51626	51627	matrix	0	None
51627	51628	.	0	None

51629	51630	(	0	None
51630	51631	c	0	None
51631	51632	)	0	None
51632	51633	Membrane-permeable	0	None
51633	51634	chelators	0	None
51634	51635	stop	0	None
51635	51636	but	0	None
51636	51637	do	0	None
51637	51638	not	0	None
51638	51639	reverse	0	None
51639	51640	enzyme	0	None
51640	51641	inactivation	0	None
51641	51642	.	0	None

51643	51644	(	0	None
51644	51645	d	0	None
51645	51646	)	0	None
51646	51647	Enzyme	0	None
51647	51648	inhibition	0	None
51648	51649	is	0	None
51649	51650	rapid	0	None
51650	51651	and	0	None
51651	51652	irreversible	0	None
51652	51653	and	0	None
51653	51654	precedes	0	None
51654	51655	the	0	None
51655	51656	major	0	None
51656	51657	changes	0	None
51657	51658	associated	0	None
51658	51659	with	0	None
51659	51660	the	0	None
51660	51661	mitochondrial	0	None
51661	51662	permeability	0	None
51662	51663	transition	0	None
51663	51664	(	0	None
51664	51665	MPT	0	None
51665	51666	)	0	None
51666	51667	.	0	None

51668	51669	(	0	None
51669	51670	e	0	None
51670	51671	)	0	None
51671	51672	The	0	None
51672	51673	extent	0	None
51673	51674	and	0	None
51674	51675	rate	0	None
51675	51676	of	0	None
51676	51677	enzyme	0	None
51677	51678	inactivation	0	None
51678	51679	linearly	0	None
51679	51680	correlates	0	None
51680	51681	with	0	None
51681	51682	the	0	None
51682	51683	MPT	0	None
51683	51684	onset	0	None
51684	51685	and	0	None
51685	51686	propagation	0	None
51686	51687	.	0	None

51688	51689	(	0	None
51689	51690	f	0	None
51690	51691	)	0	None
51691	51692	The	0	None
51692	51693	Ca2	0	None
51693	51694	+	0	None
51694	51695	uniporter	0	None
51695	51696	blocker	0	None
51696	51697	,	0	None
51697	51698	Ruthenium	0	None
51698	51699	Red	0	None
51699	51700	,	0	None
51700	51701	protects	0	None
51701	51702	enzyme	0	None
51702	51703	activities	0	None
51703	51704	and	0	None
51704	51705	delays	0	None
51705	51706	pore	0	None
51706	51707	opening	0	None
51707	51708	up	0	None
51708	51709	to	0	None
51709	51710	2	0	None
51710	51711	microm	0	None
51711	51712	Zn2	0	None
51712	51713	+	0	None
51713	51714	.	0	None

51715	51716	An	0	None
51716	51717	additional	0	None
51717	51718	,	0	None
51718	51719	unidentified	0	None
51719	51720	import	0	None
51720	51721	route	0	None
51721	51722	functions	0	None
51722	51723	at	0	None
51723	51724	higher	0	None
51724	51725	Zn2	0	None
51725	51726	+	0	None
51726	51727	concentrations	0	None
51727	51728	.	0	None

51729	51730	(	0	None
51730	51731	g	0	None
51731	51732	)	0	None
51732	51733	No	0	None
51733	51734	enzyme	0	None
51734	51735	inactivation	0	None
51735	51736	is	0	None
51736	51737	observed	0	None
51737	51738	for	0	None
51738	51739	Ca2	0	None
51739	51740	+	0	None
51740	51741	-induced	0	None
51741	51742	MPT	0	None
51742	51743	.	0	None

51744	51745	These	0	None
51745	51746	observations	0	None
51746	51747	strongly	0	None
51747	51748	suggest	0	None
51748	51749	that	0	None
51749	51750	,	0	None
51750	51751	unlike	0	None
51751	51752	Ca2	0	None
51752	51753	+	0	None
51753	51754	,	0	None
51754	51755	exogenous	0	None
51755	51756	Zn2	0	None
51756	51757	+	0	None
51757	51758	interferes	0	None
51758	51759	with	0	None
51759	51760	mitochondrial	0	None
51760	51761	NADH	2	CHEMICAL
51761	51762	production	0	None
51762	51763	and	0	None
51763	51764	directly	0	None
51764	51765	alters	0	None
51765	51766	redox	0	None
51766	51767	protection	0	None
51767	51768	in	0	None
51768	51769	the	0	None
51769	51770	matrix	0	None
51770	51771	,	0	None
51771	51772	contributing	0	None
51772	51773	to	0	None
51773	51774	mitochondrial	0	None
51774	51775	dysfunction	0	None
51775	51776	.	0	None

51777	51778	Inactivation	0	None
51778	51779	of	0	None
51779	51780	these	0	None
51780	51781	enzymes	0	None
51781	51782	by	0	None
51782	51783	Zn2	0	None
51783	51784	+	0	None
51784	51785	is	0	None
51785	51786	irreversible	0	None
51786	51787	,	0	None
51787	51788	and	0	None
51788	51789	thus	0	None
51789	51790	only	0	None
51790	51791	their	0	None
51791	51792	de	0	None
51792	51793	novo	0	None
51793	51794	synthesis	0	None
51794	51795	can	0	None
51795	51796	restore	0	None
51796	51797	function	0	None
51797	51798	,	0	None
51798	51799	which	0	None
51799	51800	may	0	None
51800	51801	underlie	0	None
51801	51802	persistent	0	None
51802	51803	loss	0	None
51803	51804	of	0	None
51804	51805	oxidative	0	None
51805	51806	carbohydrate	0	None
51806	51807	metabolism	0	None
51807	51808	following	0	None
51808	51809	transient	0	None
51809	51810	ischemia	0	None
51810	51811	.	0	None
51811	51813	Fatty acid	2	CHEMICAL
51813	51814	biosynthesis	0	None
51814	51815	is	0	None
51815	51816	an	0	None
51816	51817	emerging	0	None
51817	51818	target	0	None
51818	51819	for	0	None
51819	51820	the	0	None
51820	51821	development	0	None
51821	51822	of	0	None
51822	51823	novel	0	None
51823	51824	antibacterial	0	None
51824	51825	chemotherapeutics	0	None
51825	51826	.	0	None

51827	51828	The	0	None
51828	51829	dissociated	0	None
51829	51830	bacterial	0	None
51830	51831	system	0	None
51831	51832	is	0	None
51832	51833	substantially	0	None
51833	51834	different	0	None
51834	51835	from	0	None
51835	51836	the	0	None
51836	51837	large	0	None
51837	51838	,	0	None
51838	51839	multifunctional	0	None
51839	51840	protein	0	None
51840	51841	of	0	None
51841	51842	mammals	0	None
51842	51843	,	0	None
51843	51844	and	0	None
51844	51845	many	0	None
51845	51846	possibilities	0	None
51846	51847	exist	0	None
51847	51848	for	0	None
51848	51849	type-selective	0	None
51849	51850	drugs	0	None
51850	51851	.	0	None

51852	51853	Several	0	None
51853	51854	compounds	0	None
51854	51855	,	0	None
51855	51856	both	0	None
51856	51857	synthetic	0	None
51857	51858	and	0	None
51858	51859	natural	0	None
51859	51860	,	0	None
51860	51861	target	0	None
51861	51862	bacterial	0	None
51862	51864	fatty acid	2	CHEMICAL
51864	51865	synthesis	0	None
51865	51866	.	0	None

51867	51868	Three	0	None
51868	51869	compounds	0	None
51869	51870	target	0	None
51870	51871	the	0	None
51871	51872	FabI	0	None
51872	51873	enoyl-ACP	0	None
51873	51874	reductase	0	None
51874	51875	step;	0	None
51875	51876	isoniazid	0	None
51876	51877	,	0	None
51877	51878	a	0	None
51878	51879	clinically	0	None
51879	51880	used	0	None
51880	51881	antituberculosis	0	None
51881	51882	drug	0	None
51882	51883	,	0	None
51883	51884	triclosan	0	None
51884	51885	,	0	None
51885	51886	a	0	None
51886	51887	widely	0	None
51887	51888	used	0	None
51888	51889	consumer	0	None
51889	51890	antimicrobial	0	None
51890	51891	,	0	None
51891	51892	and	0	None
51892	51893	diazaborines	0	None
51893	51894	.	0	None

51895	51896	In	0	None
51896	51897	addition	0	None
51897	51898	,	0	None
51898	51899	cerulenin	0	None
51899	51900	and	0	None
51900	51901	thiolactomycin	0	None
51901	51902	,	0	None
51902	51903	two	0	None
51903	51904	fungal	0	None
51904	51905	products	0	None
51905	51906	,	0	None
51906	51907	inhibit	0	None
51907	51908	the	0	None
51908	51909	FabH	0	None
51909	51910	,	0	None
51910	51911	FabB	0	None
51911	51912	and	0	None
51912	51913	FabF	0	None
51913	51914	condensation	0	None
51914	51915	enzymes	0	None
51915	51916	.	0	None

51917	51918	Finally	0	None
51918	51919	,	0	None
51919	51920	the	0	None
51920	51921	synthetic	0	None
51921	51922	reaction	0	None
51922	51923	intermediates	0	None
51923	51924	BP1	0	None
51924	51925	and	0	None
51925	51926	decynoyl-	0	None
51926	51927	N-acetyl	0	None
51927	51928	cysteamine	0	None
51928	51929	inhibit	0	None
51929	51930	the	0	None
51930	51931	acetyl-CoA	0	None
51931	51932	carboxylase	0	None
51932	51933	and	0	None
51933	51934	dehydratase	3	GENE-N
51934	51935	isomerase	0	None
51935	51936	steps	0	None
51936	51937	,	0	None
51937	51938	respectively	0	None
51938	51939	.	0	None

51940	51941	The	0	None
51941	51942	mechanisms	0	None
51942	51943	of	0	None
51943	51944	action	0	None
51944	51945	of	0	None
51945	51946	these	0	None
51946	51947	compounds	0	None
51947	51948	,	0	None
51948	51949	as	0	None
51949	51950	well	0	None
51950	51951	as	0	None
51951	51952	the	0	None
51952	51953	potential	0	None
51953	51954	development	0	None
51954	51955	of	0	None
51955	51956	new	0	None
51956	51957	drugs	0	None
51957	51958	targeted	0	None
51958	51959	against	0	None
51959	51960	this	0	None
51960	51961	pathway	0	None
51961	51962	,	0	None
51962	51963	are	0	None
51963	51964	discussed	0	None
51964	51965	.	0	None
51965	51966	Atherogenesis	0	None
51966	51967	in	0	None
51967	51968	the	0	None
51968	51969	vasculature	0	None
51969	51970	is	0	None
51970	51971	accelerated	0	None
51971	51972	by	0	None
51972	51973	changes	0	None
51973	51974	in	0	None
51974	51975	the	0	None
51975	51976	dynamic	0	None
51976	51977	equilibrium	0	None
51977	51978	between	0	None
51978	51979	endogenous	0	None
51979	51980	tissue	0	None
51980	51981	plasminogen	0	None
51981	51982	activator	0	None
51982	51983	and	0	None
51983	51986	plasminogen activator inhibitor-1	1	GENE-Y
51986	51987	(	0	None
51987	51988	PAI-1	1	GENE-Y
51988	51989	)	0	None
51989	51990	.	0	None

51991	51992	Increased	0	None
51992	51993	expression	0	None
51993	51994	of	0	None
51994	51995	PAI-1	1	GENE-Y
51995	51996	,	0	None
51996	51997	decreased	0	None
51997	51998	expression	0	None
51998	51999	of	0	None
51999	52000	tissue	0	None
52000	52001	plasminogen	0	None
52001	52002	activator	0	None
52002	52003	,	0	None
52003	52004	or	0	None
52004	52005	both	0	None
52005	52006	can	0	None
52006	52007	lead	0	None
52007	52008	to	0	None
52008	52009	decreased	0	None
52009	52010	fibrinolytic	0	None
52010	52011	activity	0	None
52011	52012	and	0	None
52012	52013	predispose	0	None
52013	52014	to	0	None
52014	52015	thrombosis	0	None
52015	52016	.	0	None

52017	52018	Increased	0	None
52018	52019	concentrations	0	None
52019	52020	of	0	None
52020	52021	insulin	0	None
52021	52022	(	0	None
52022	52023	and	0	None
52023	52024	proinsulin	1	GENE-Y
52024	52025	)	0	None
52025	52026	in	0	None
52026	52027	the	0	None
52027	52028	plasma	0	None
52028	52029	increase	0	None
52029	52030	plasma	0	None
52030	52031	PAI-1	1	GENE-Y
52031	52032	,	0	None
52032	52033	although	0	None
52033	52034	the	0	None
52034	52035	mechanisms	0	None
52035	52036	of	0	None
52036	52037	this	0	None
52037	52038	effect	0	None
52038	52039	are	0	None
52039	52040	not	0	None
52040	52041	known	0	None
52041	52042	.	0	None

52043	52044	In	0	None
52044	52045	addition	0	None
52045	52046	,	0	None
52046	52047	it	0	None
52047	52048	has	0	None
52048	52049	been	0	None
52049	52050	observed	0	None
52050	52051	that	0	None
52051	52052	basal	0	None
52052	52053	fibrinolytic	0	None
52053	52054	activity	0	None
52054	52055	is	0	None
52055	52056	decreased	0	None
52056	52057	in	0	None
52057	52058	patients	0	None
52058	52059	with	0	None
52059	52060	type	0	None
52060	52061	2	0	None
52061	52062	diabetes;	0	None
52062	52063	this	0	None
52063	52064	may	0	None
52064	52065	accelerate	0	None
52065	52066	atherosclerosis	0	None
52066	52067	by	0	None
52067	52068	exposing	0	None
52068	52069	vascular	0	None
52069	52070	luminal	0	None
52070	52071	wall	0	None
52071	52072	surfaces	0	None
52072	52073	to	0	None
52073	52074	persistent	0	None
52074	52075	and	0	None
52075	52076	recurrent	0	None
52076	52077	thrombi	0	None
52077	52078	.	0	None

52079	52080	Abnormalities	0	None
52080	52081	in	0	None
52081	52082	the	0	None
52082	52083	vessel	0	None
52083	52084	wall	0	None
52084	52085	appear	0	None
52085	52086	to	0	None
52086	52087	contribute	0	None
52087	52088	to	0	None
52088	52089	the	0	None
52089	52090	increased	0	None
52090	52091	risk	0	None
52091	52092	.	0	None

52093	52094	There	0	None
52094	52095	is	0	None
52095	52096	also	0	None
52096	52097	evidence	0	None
52097	52098	that	0	None
52098	52099	PAI-1	1	GENE-Y
52099	52100	content	0	None
52100	52101	is	0	None
52101	52102	increased	0	None
52102	52103	in	0	None
52103	52104	atherosclerotic	0	None
52104	52105	lesions	0	None
52105	52106	of	0	None
52106	52107	patients	0	None
52107	52108	with	0	None
52108	52109	type	0	None
52109	52110	2	0	None
52110	52111	diabetes	0	None
52111	52112	,	0	None
52112	52113	suggesting	0	None
52113	52114	that	0	None
52114	52115	interventions	0	None
52115	52116	to	0	None
52116	52117	reduce	0	None
52117	52118	insulin	0	None
52118	52119	resistance	0	None
52119	52120	and	0	None
52120	52121	improve	0	None
52121	52122	glycemic	0	None
52122	52123	control	0	None
52123	52124	may	0	None
52124	52125	improve	0	None
52125	52126	the	0	None
52126	52127	fibrinolytic	0	None
52127	52128	response	0	None
52128	52129	.	0	None

52130	52131	Clinical	0	None
52131	52132	studies	0	None
52132	52133	in	0	None
52133	52134	patients	0	None
52134	52135	with	0	None
52135	52136	polycystic	0	None
52136	52137	ovary	0	None
52137	52138	syndrome	0	None
52138	52139	(	0	None
52139	52140	characterized	0	None
52140	52141	by	0	None
52141	52142	insulin	0	None
52142	52143	resistance	0	None
52143	52144	,	0	None
52144	52145	hyperinsulinemia	0	None
52145	52146	,	0	None
52146	52147	ovarian	0	None
52147	52148	androgen	0	None
52148	52149	overproduction	0	None
52149	52150	,	0	None
52150	52151	and	0	None
52151	52152	impaired	0	None
52152	52153	fibrinolytic	0	None
52153	52154	capacity	0	None
52154	52155	)	0	None
52155	52156	demonstrated	0	None
52156	52157	that	0	None
52157	52158	treatment	0	None
52158	52159	with	0	None
52159	52160	troglitazone	0	None
52160	52161	,	0	None
52161	52162	an	0	None
52162	52163	insulin-sensitizing	0	None
52163	52164	agent	0	None
52164	52165	,	0	None
52165	52166	can	0	None
52166	52167	markedly	0	None
52167	52168	reduce	0	None
52168	52169	blood	0	None
52169	52170	levels	0	None
52170	52171	of	0	None
52171	52172	PAI-1	1	GENE-Y
52172	52173	.	0	None

52174	52175	There	0	None
52175	52176	is	0	None
52176	52177	also	0	None
52177	52178	clinical	0	None
52178	52179	evidence	0	None
52179	52180	that	0	None
52180	52181	these	0	None
52181	52182	agents	0	None
52182	52183	may	0	None
52183	52184	contribute	0	None
52184	52185	to	0	None
52185	52186	regression	0	None
52186	52187	of	0	None
52187	52188	intimal	0	None
52188	52189	medial	0	None
52189	52190	thickness	0	None
52190	52191	in	0	None
52191	52192	patients	0	None
52192	52193	with	0	None
52193	52194	type	0	None
52194	52195	2	0	None
52195	52196	diabetes	0	None
52196	52197	,	0	None
52197	52198	providing	0	None
52198	52199	further	0	None
52199	52200	indication	0	None
52200	52201	that	0	None
52201	52202	antidiabetic	0	None
52202	52203	interventions	0	None
52203	52204	may	0	None
52204	52205	help	0	None
52205	52206	inhibit	0	None
52206	52207	the	0	None
52207	52208	progression	0	None
52208	52209	of	0	None
52209	52210	early	0	None
52210	52211	atherosclerotic	0	None
52211	52212	lesions	0	None
52212	52213	.	0	None
52213	52214	Triethylenetetramine	0	None
52214	52215	(	0	None
52215	52216	TETA;	0	None
52216	52217	Syprine;	0	None
52217	52218	Merck	0	None
52218	52219	Rahway	0	None
52219	52220	,	0	None
52220	52221	NJ	0	None
52221	52222	)	0	None
52222	52223	,	0	None
52223	52224	a	0	None
52224	52225	drug	0	None
52225	52226	for	0	None
52226	52227	Wilson's	0	None
52227	52228	disease	0	None
52228	52229	,	0	None
52229	52230	is	0	None
52230	52231	a	0	None
52231	52232	copper	0	None
52232	52233	chelator	0	None
52233	52234	and	0	None
52234	52235	a	0	None
52235	52236	charge-deficient	0	None
52236	52237	analog	0	None
52237	52238	of	0	None
52238	52239	polyamine	0	None
52239	52240	spermidine	0	None
52240	52241	.	0	None

52242	52243	We	0	None
52243	52244	recently	0	None
52244	52245	showed	0	None
52245	52246	that	0	None
52246	52247	TETA	0	None
52247	52248	is	0	None
52248	52249	metabolized	0	None
52249	52250	in	0	None
52250	52251	vitro	0	None
52251	52252	by	0	None
52252	52253	polyamine	0	None
52253	52254	catabolic	0	None
52254	52255	enzyme	0	None
52255	52256	spermidine	0	None
52256	52257	/	0	None
52257	52258	spermine-N	0	None
52258	52259	(	0	None
52259	52260	1	0	None
52260	52261	)	0	None
52261	52262	-acetyltransferase	0	None
52262	52263	(	0	None
52263	52264	SSAT1	0	None
52264	52265	)	0	None
52265	52266	and	0	None
52266	52267	by	0	None
52267	52268	thialysine	0	None
52268	52269	acetyltransferase	0	None
52269	52270	(	0	None
52270	52271	SSAT2	0	None
52271	52272	)	0	None
52272	52273	to	0	None
52273	52274	its	0	None
52274	52275	monoacetylated	0	None
52275	52276	derivative	0	None
52276	52277	(	0	None
52277	52278	MAT	3	GENE-N
52278	52279	)	0	None
52279	52280	.	0	None

52281	52282	The	0	None
52282	52283	acetylation	0	None
52283	52284	of	0	None
52284	52285	TETA	0	None
52285	52286	is	0	None
52286	52287	increased	0	None
52287	52288	in	0	None
52288	52289	SSAT1-overexpressing	0	None
52289	52290	mice	0	None
52290	52291	compared	0	None
52291	52292	with	0	None
52292	52293	wild-type	0	None
52293	52294	mice	0	None
52294	52295	.	0	None

52296	52297	However	0	None
52297	52298	,	0	None
52298	52299	SSAT1-deficient	0	None
52299	52300	mice	0	None
52300	52301	metabolize	0	None
52301	52302	TETA	0	None
52302	52303	at	0	None
52303	52304	the	0	None
52304	52305	same	0	None
52305	52306	rate	0	None
52306	52307	as	0	None
52307	52308	the	0	None
52308	52309	wild-type	0	None
52309	52310	mice	0	None
52310	52311	,	0	None
52311	52312	indicating	0	None
52312	52313	the	0	None
52313	52314	existence	0	None
52314	52315	of	0	None
52315	52316	another	0	None
52316	52317	N-acetylase	0	None
52317	52318	respons	0	None
52318	52319	2ible	0	None
52319	52320	for	0	None
52320	52321	its	0	None
52321	52322	metabolism	0	None
52322	52323	in	0	None
52323	52324	mice	0	None
52324	52325	.	0	None

52326	52327	Here	0	None
52327	52328	,	0	None
52328	52329	we	0	None
52329	52330	show	0	None
52330	52331	that	0	None
52331	52332	siRNA-mediated	0	None
52332	52333	knockdown	0	None
52333	52334	of	0	None
52334	52335	SSAT2	0	None
52335	52336	in	0	None
52336	52337	HEPG2	0	None
52337	52338	cells	0	None
52338	52339	and	0	None
52339	52340	in	0	None
52340	52341	primary	0	None
52341	52342	hepatocytes	0	None
52342	52343	from	0	None
52343	52344	the	0	None
52344	52345	SSAT1-deficient	0	None
52345	52346	or	0	None
52346	52347	wild-type	0	None
52347	52348	mice	0	None
52348	52349	reduced	0	None
52349	52350	the	0	None
52350	52351	metabolism	0	None
52351	52352	of	0	None
52352	52353	TETA	0	None
52353	52354	to	0	None
52354	52355	MAT	3	GENE-N
52355	52356	.	0	None

52357	52358	By	0	None
52358	52359	contrast	0	None
52359	52360	,	0	None
52360	52361	1	0	None
52361	52362	,	0	None
52362	52363	12-diamino-3	0	None
52363	52364	,	0	None
52364	52365	6	0	None
52365	52366	,	0	None
52366	52367	9-triazadodecane	0	None
52367	52368	(	0	None
52368	52369	SpmTrien	0	None
52369	52370	)	0	None
52370	52371	,	0	None
52371	52372	a	0	None
52372	52373	charge-deficient	0	None
52373	52374	spermine	0	None
52374	52375	analog	0	None
52375	52376	,	0	None
52376	52377	was	0	None
52377	52378	an	0	None
52378	52379	extremely	0	None
52379	52380	poor	0	None
52380	52381	substrate	0	None
52381	52382	of	0	None
52382	52383	human	0	None
52383	52384	recombinant	0	None
52384	52385	SSAT2	0	None
52385	52386	and	0	None
52386	52387	was	0	None
52387	52388	metabolized	0	None
52388	52389	by	0	None
52389	52390	SSAT1	0	None
52390	52391	in	0	None
52391	52392	HEPG2	0	None
52392	52393	cells	0	None
52393	52394	and	0	None
52394	52395	in	0	None
52395	52396	wild-type	0	None
52396	52397	primary	0	None
52397	52398	hepatocytes	0	None
52398	52399	.	0	None

52400	52401	Thus	0	None
52401	52402	,	0	None
52402	52403	despite	0	None
52403	52404	the	0	None
52404	52405	similar	0	None
52405	52406	structures	0	None
52406	52407	of	0	None
52407	52408	TETA	0	None
52408	52409	and	0	None
52409	52410	SpmTrien	0	None
52410	52411	,	0	None
52411	52412	SSAT2	0	None
52412	52413	is	0	None
52413	52414	the	0	None
52414	52415	main	0	None
52415	52416	acetylator	0	None
52416	52417	of	0	None
52417	52418	TETA	0	None
52418	52419	,	0	None
52419	52420	whereas	0	None
52420	52421	SpmTrien	0	None
52421	52422	is	0	None
52422	52423	primarily	0	None
52423	52424	acetylated	0	None
52424	52425	by	0	None
52425	52426	SSAT1	0	None
52426	52427	.	0	None
52427	52428	A	0	None
52428	52429	substantial	0	None
52429	52430	proportion	0	None
52430	52431	of	0	None
52431	52432	women	0	None
52432	52433	with	0	None
52433	52434	the	0	None
52434	52435	polycystic	0	None
52435	52436	ovary	0	None
52436	52437	syndrome	0	None
52437	52438	(	0	None
52438	52439	PCOS	0	None
52439	52440	)	0	None
52440	52441	are	0	None
52441	52442	obese	0	None
52442	52443	and	0	None
52443	52444	obesity	0	None
52444	52445	is	0	None
52445	52446	considered	0	None
52446	52447	as	0	None
52447	52448	a	0	None
52448	52449	prothrombotic	0	None
52449	52450	state	0	None
52450	52451	.	0	None

52452	52453	Platelet-derived	0	None
52453	52454	microparticles	0	None
52454	52455	(	0	None
52455	52456	PMPs	0	None
52456	52457	)	0	None
52457	52458	might	0	None
52458	52459	be	0	None
52459	52460	implicated	0	None
52460	52461	in	0	None
52461	52462	the	0	None
52462	52463	activation	0	None
52463	52464	of	0	None
52464	52465	the	0	None
52465	52466	coagulation	0	None
52466	52467	cascade	0	None
52467	52468	.	0	None

52469	52470	We	0	None
52470	52471	aimed	0	None
52471	52472	to	0	None
52472	52473	assess	0	None
52473	52474	plasma	0	None
52474	52475	PMPs	0	None
52475	52476	in	0	None
52476	52477	overweight	0	None
52477	52478	/	0	None
52478	52479	obese	0	None
52479	52480	women	0	None
52480	52481	with	0	None
52481	52482	PCOS	0	None
52482	52483	.	0	None

52484	52485	We	0	None
52485	52486	measured	0	None
52486	52487	plasma	0	None
52487	52488	PMPs	0	None
52488	52489	and	0	None
52489	52490	determined	0	None
52490	52491	anthropometric	0	None
52491	52492	,	0	None
52492	52493	metabolic	0	None
52493	52494	,	0	None
52494	52495	hormonal	0	None
52495	52496	and	0	None
52496	52497	ultrasonographic	0	None
52497	52498	features	0	None
52498	52499	of	0	None
52499	52500	PCOS	0	None
52500	52501	in	0	None
52501	52502	67	0	None
52502	52503	overweight	0	None
52503	52504	/	0	None
52504	52505	obese	0	None
52505	52506	women	0	None
52506	52507	with	0	None
52507	52508	PCOS	0	None
52508	52509	(	0	None
52509	52510	with	0	None
52510	52511	body	0	None
52511	52512	mass	0	None
52512	52513	index	0	None
52513	52514	[	0	None
52514	52515	BMI	0	None
52515	52516	]	0	None
52516	52517	>25	0	None
52517	52518	.	0	None
52518	52519	0	0	None
52519	52520	kg	0	None
52520	52521	/	0	None
52521	52522	m	0	None
52522	52523	(	0	None
52523	52524	2	0	None
52524	52525	)	0	None
52525	52526	)	0	None
52526	52527	and	0	None
52527	52528	in	0	None
52528	52529	21	0	None
52529	52530	BMI-matched	0	None
52530	52531	healthy	0	None
52531	52532	women	0	None
52532	52533	.	0	None

52534	52535	Circulating	0	None
52535	52536	androgens	2	CHEMICAL
52536	52537	and	0	None
52537	52538	markers	0	None
52538	52539	of	0	None
52539	52540	insulin	0	None
52540	52541	resistance	0	None
52541	52542	(	0	None
52542	52543	IR	0	None
52543	52544	)	0	None
52544	52545	were	0	None
52545	52546	higher	0	None
52546	52547	in	0	None
52547	52548	women	0	None
52548	52549	with	0	None
52549	52550	PCOS	0	None
52550	52551	than	0	None
52551	52552	in	0	None
52552	52553	controls	0	None
52553	52554	.	0	None

52555	52556	Plasma	0	None
52556	52557	PMPs	0	None
52557	52558	were	0	None
52558	52559	also	0	None
52559	52560	higher	0	None
52560	52561	in	0	None
52561	52562	women	0	None
52562	52563	with	0	None
52563	52564	PCOS	0	None
52564	52565	than	0	None
52565	52566	in	0	None
52566	52567	controls	0	None
52567	52568	(	0	None
52568	52569	p	0	None
52569	52570	=	0	None
52570	52571	0	0	None
52571	52572	.	0	None
52572	52573	046	0	None
52573	52574	)	0	None
52574	52575	.	0	None

52576	52577	In	0	None
52577	52578	women	0	None
52578	52579	with	0	None
52579	52580	PCOS	0	None
52580	52581	,	0	None
52581	52582	plasma	0	None
52582	52583	PMPs	0	None
52583	52584	correlated	0	None
52584	52585	with	0	None
52585	52586	the	0	None
52586	52587	mean	0	None
52587	52588	number	0	None
52588	52589	of	0	None
52589	52590	follicles	0	None
52590	52591	in	0	None
52591	52592	the	0	None
52592	52593	ovaries	0	None
52593	52594	(	0	None
52594	52595	r	0	None
52595	52596	=	0	None
52596	52597	0	0	None
52597	52598	.	0	None
52598	52599	343;	0	None
52599	52600	p	0	None
52600	52601	=	0	None
52601	52602	0	0	None
52602	52603	.	0	None
52603	52604	006	0	None
52604	52605	)	0	None
52605	52606	.	0	None

52607	52608	In	0	None
52608	52609	controls	0	None
52609	52610	,	0	None
52610	52611	plasma	0	None
52611	52612	PMPs	0	None
52612	52613	did	0	None
52613	52614	not	0	None
52614	52615	correlate	0	None
52615	52616	with	0	None
52616	52617	any	0	None
52617	52618	of	0	None
52618	52619	the	0	None
52619	52620	studied	0	None
52620	52621	parameters	0	None
52621	52622	.	0	None

52623	52624	In	0	None
52624	52625	conclusion	0	None
52625	52626	,	0	None
52626	52627	plasma	0	None
52627	52628	PMPs	0	None
52628	52629	are	0	None
52629	52630	elevated	0	None
52630	52631	in	0	None
52631	52632	overweight	0	None
52632	52633	/	0	None
52633	52634	obese	0	None
52634	52635	women	0	None
52635	52636	with	0	None
52636	52637	PCOS	0	None
52637	52638	compared	0	None
52638	52639	with	0	None
52639	52640	BMI-matched	0	None
52640	52641	controls	0	None
52641	52642	.	0	None

52643	52644	The	0	None
52644	52645	cause	0	None
52645	52646	of	0	None
52646	52647	this	0	None
52647	52648	increase	0	None
52648	52649	is	0	None
52649	52650	unclear	0	None
52650	52651	but	0	None
52651	52652	both	0	None
52652	52653	IR	0	None
52653	52654	and	0	None
52654	52655	hyperandrogenemia	0	None
52655	52656	might	0	None
52656	52657	be	0	None
52657	52658	implicated	0	None
52658	52659	.	0	None

52660	52661	More	0	None
52661	52662	studies	0	None
52662	52663	are	0	None
52663	52664	required	0	None
52664	52665	to	0	None
52665	52666	elucidate	0	None
52666	52667	the	0	None
52667	52668	pathogenesis	0	None
52668	52669	of	0	None
52669	52670	the	0	None
52670	52671	elevation	0	None
52671	52672	of	0	None
52672	52673	PMPs	0	None
52673	52674	in	0	None
52674	52675	PCOS	0	None
52675	52676	and	0	None
52676	52677	to	0	None
52677	52678	assess	0	None
52678	52679	its	0	None
52679	52680	implications	0	None
52680	52681	on	0	None
52681	52682	the	0	None
52682	52683	cardiovascular	0	None
52683	52684	risk	0	None
52684	52685	of	0	None
52685	52686	these	0	None
52686	52687	patients	0	None
52687	52688	.	0	None
52688	52689	Effects	0	None
52689	52690	of	0	None
52690	52691	felodipine	2	CHEMICAL
52691	52692	(	0	None
52692	52693	a	0	None
52693	52694	dihydropyridine	0	None
52694	52695	calcium	0	None
52695	52696	channel	0	None
52696	52697	blocker	0	None
52697	52698	)	0	None
52698	52699	and	0	None
52699	52700	analogues	0	None
52700	52701	on	0	None
52701	52702	calmodulin-dependent	0	None
52702	52703	enzymes	0	None
52703	52704	.	0	None
52704	52705	DCPIB	0	None
52705	52706	,	0	None
52706	52707	the	0	None
52707	52708	proposed	0	None
52708	52709	selective	0	None
52709	52710	blocker	0	None
52710	52711	of	0	None
52711	52712	volume-regulated	0	None
52712	52713	anion	0	None
52713	52714	channels	0	None
52714	52715	,	0	None
52715	52716	inhibits	0	None
52716	52717	several	0	None
52717	52718	glutamate	0	None
52718	52719	transport	0	None
52719	52720	pathways	0	None
52720	52721	in	0	None
52721	52722	glial	0	None
52722	52723	cells	0	None
52723	52724	.	0	None
52724	52725	Functional	0	None
52725	52726	evidence	0	None
52726	52727	that	0	None
52727	52728	gastroprotection	0	None
52728	52729	can	0	None
52729	52730	be	0	None
52730	52731	induced	0	None
52731	52732	by	0	None
52732	52733	activation	0	None
52733	52734	of	0	None
52734	52735	central	0	None
52735	52736	alpha	0	None
52736	52737	(	0	None
52737	52738	2B	0	None
52738	52739	)	0	None
52739	52740	-adrenoceptor	0	None
52740	52741	subtypes	0	None
52741	52742	in	0	None
52742	52743	the	0	None
52743	52744	rat	0	None
52744	52745	.	0	None
52745	52746	Role	0	None
52746	52747	of	0	None
52747	52748	acetylcholinesterase	0	None
52748	52749	(	0	None
52749	52750	AChE	1	GENE-Y
52750	52751	)	0	None
52751	52752	secreted	0	None
52752	52753	by	0	None
52753	52754	parasitic	0	None
52754	52755	nematodes	0	None
52755	52756	on	0	None
52756	52757	the	0	None
52757	52758	growth	0	None
52758	52759	of	0	None
52759	52760	the	0	None
52760	52761	cell	0	None
52761	52762	line	0	None
52762	52763	from	0	None
52763	52764	epithelial	0	None
52764	52765	origin	0	None
52765	52766	HT29-D4	0	None
52766	52767	.	0	None
52767	52768	The	0	None
52768	52769	impact	0	None
52769	52770	of	0	None
52770	52771	the	0	None
52771	52772	synthetic	0	None
52772	52773	glucocorticoid	0	None
52773	52774	prednisone	0	None
52774	52775	on	0	None
52775	52776	adrenal	0	None
52776	52777	steroid	2	CHEMICAL
52777	52778	hormone	0	None
52778	52779	production	0	None
52779	52780	was	0	None
52780	52781	examined	0	None
52781	52782	using	0	None
52782	52783	24-hour	0	None
52783	52784	urinary	0	None
52784	52785	steroid	2	CHEMICAL
52785	52786	hormone	0	None
52786	52787	profiling	0	None
52787	52788	.	0	None

52789	52790	Five	0	None
52790	52791	women	0	None
52791	52792	,	0	None
52792	52793	who	0	None
52793	52794	were	0	None
52794	52795	chronically	0	None
52795	52796	taking	0	None
52796	52797	low-dose	0	None
52797	52798	prednisone	0	None
52798	52799	,	0	None
52799	52800	were	0	None
52800	52801	tested	0	None
52801	52802	,	0	None
52802	52803	and	0	None
52803	52804	the	0	None
52804	52805	relevant	0	None
52805	52806	literature	0	None
52806	52807	was	0	None
52807	52808	reviewed	0	None
52808	52809	.	0	None

52810	52811	As	0	None
52811	52812	expected	0	None
52812	52813	,	0	None
52813	52814	adrenal	0	None
52814	52815	glucocorticoid	0	None
52815	52816	production	0	None
52816	52817	,	0	None
52817	52818	measured	0	None
52818	52819	by	0	None
52819	52820	urinary	0	None
52820	52821	terminal	0	None
52821	52822	cortisol	2	CHEMICAL
52822	52823	and	0	None
52823	52824	cortisone	0	None
52824	52825	metabolites	0	None
52825	52826	,	0	None
52826	52827	was	0	None
52827	52828	markedly	0	None
52828	52829	suppressed	0	None
52829	52830	compared	0	None
52830	52831	to	0	None
52831	52832	reference	0	None
52832	52833	range	0	None
52833	52834	values	0	None
52834	52835	(	0	None
52835	52836	p	0	None
52836	52837	=	0	None
52837	52838	0	0	None
52838	52839	.	0	None
52839	52840	03	0	None
52840	52841	)	0	None
52841	52842	.	0	None

52843	52844	Urinary	0	None
52844	52845	cortisol	2	CHEMICAL
52845	52846	and	0	None
52846	52847	cortisone	0	None
52847	52848	,	0	None
52848	52849	reflecting	0	None
52849	52850	circulating	0	None
52850	52851	glucocorticoids	0	None
52851	52852	,	0	None
52852	52853	were	0	None
52853	52854	decreased	0	None
52854	52855	to	0	None
52855	52856	a	0	None
52856	52857	lesser	0	None
52857	52858	extent	0	None
52858	52859	than	0	None
52859	52860	their	0	None
52860	52861	terminal	0	None
52861	52862	metabolites	0	None
52862	52863	.	0	None

52864	52865	Urinary	0	None
52865	52866	dehydroepiandrosterone	0	None
52866	52867	(	0	None
52867	52868	DHEA	0	None
52868	52869	)	0	None
52869	52870	excretion	0	None
52870	52871	was	0	None
52871	52872	dramatically	0	None
52872	52873	suppressed	0	None
52873	52874	(	0	None
52874	52875	p	0	None
52875	52876	=	0	None
52876	52877	0	0	None
52877	52878	.	0	None
52878	52879	03	0	None
52879	52880	)	0	None
52880	52881	,	0	None
52881	52882	while	0	None
52882	52883	the	0	None
52883	52884	downstream	0	None
52884	52885	androgen	0	None
52885	52886	metabolites	0	None
52886	52887	androsterone	0	None
52887	52888	and	0	None
52888	52889	etiocholanolone	0	None
52889	52890	were	0	None
52890	52891	suppressed	0	None
52891	52892	to	0	None
52892	52893	a	0	None
52893	52894	lesser	0	None
52894	52895	extent	0	None
52895	52896	.	0	None

52897	52898	Aldosterone	0	None
52898	52899	and	0	None
52899	52900	tetrahydrocorticosterone	0	None
52900	52901	production	0	None
52901	52902	demonstrated	0	None
52902	52903	modest	0	None
52903	52904	suppression	0	None
52904	52905	after	0	None
52905	52906	prednisone	0	None
52906	52907	administration	0	None
52907	52908	,	0	None
52908	52909	but	0	None
52909	52910	allo-tetrahydrocorticosterone	0	None
52910	52911	,	0	None
52911	52912	which	0	None
52912	52913	is	0	None
52913	52914	highly	0	None
52914	52915	sensitive	0	None
52915	52916	to	0	None
52916	52917	adrenocorticotropic	0	None
52917	52918	hormone	0	None
52918	52919	(	0	None
52919	52920	ACTH	0	None
52920	52921	)	0	None
52921	52922	secretion	0	None
52922	52923	,	0	None
52923	52924	was	0	None
52924	52925	suppressed	0	None
52925	52926	to	0	None
52926	52927	a	0	None
52927	52928	greater	0	None
52928	52929	extent	0	None
52929	52930	.	0	None

52931	52932	Prednisone	0	None
52932	52933	administration	0	None
52933	52934	results	0	None
52934	52935	in	0	None
52935	52936	a	0	None
52936	52937	decrease	0	None
52937	52938	in	0	None
52938	52939	ACTH	0	None
52939	52940	secretion	0	None
52940	52941	by	0	None
52941	52942	the	0	None
52942	52943	anterior	0	None
52943	52944	pituitary	0	None
52944	52945	,	0	None
52945	52946	suppressing	0	None
52946	52947	synthesis	0	None
52947	52948	of	0	None
52948	52949	glucocorticoids	0	None
52949	52950	,	0	None
52950	52951	DHEA	0	None
52951	52952	,	0	None
52952	52953	and	0	None
52953	52954	DHEA	0	None
52954	52955	metabolites	0	None
52955	52956	.	0	None

52957	52958	Decreased	0	None
52958	52959	glucocorticoid	0	None
52959	52960	synthesis	0	None
52960	52961	is	0	None
52961	52962	adaptive	0	None
52962	52963	,	0	None
52963	52964	because	0	None
52964	52965	prednisone	0	None
52965	52966	is	0	None
52966	52967	active	0	None
52967	52968	at	0	None
52968	52969	the	0	None
52969	52971	glucocorticoid receptor	1	GENE-Y
52971	52972	,	0	None
52972	52973	but	0	None
52973	52974	suppression	0	None
52974	52975	of	0	None
52975	52976	DHEA	0	None
52976	52977	synthesis	0	None
52977	52978	is	0	None
52978	52979	not	0	None
52979	52980	mitigated	0	None
52980	52981	by	0	None
52981	52982	prednisone	0	None
52982	52983	.	0	None

52984	52985	DHEA	0	None
52985	52986	is	0	None
52986	52987	an	0	None
52987	52988	important	0	None
52988	52989	sex	0	None
52989	52990	hormone	0	None
52990	52991	precursor	0	None
52991	52992	,	0	None
52992	52993	neurosteroid	0	None
52993	52994	,	0	None
52994	52995	and	0	None
52995	52996	endocrine	0	None
52996	52997	and	0	None
52997	52998	immune	0	None
52998	52999	modulator;	0	None
52999	53000	therefore	0	None
53000	53001	,	0	None
53001	53002	DHEA	0	None
53002	53003	depletion	0	None
53003	53004	may	0	None
53004	53005	have	0	None
53005	53006	significant	0	None
53006	53007	adverse	0	None
53007	53008	consequences	0	None
53008	53009	in	0	None
53009	53010	terms	0	None
53010	53011	of	0	None
53011	53012	sex	0	None
53012	53013	hormone	0	None
53013	53014	production	0	None
53014	53015	,	0	None
53015	53016	bone	0	None
53016	53017	health	0	None
53017	53018	,	0	None
53018	53019	endocrine	0	None
53019	53020	and	0	None
53020	53021	immune	0	None
53021	53022	system	0	None
53022	53023	function	0	None
53023	53024	,	0	None
53024	53025	and	0	None
53025	53026	neuropsychiatric	0	None
53026	53027	status	0	None
53027	53028	.	0	None

53029	53030	Studies	0	None
53030	53031	of	0	None
53031	53032	DHEA	0	None
53032	53033	replacement	0	None
53033	53034	in	0	None
53034	53035	patients	0	None
53035	53036	taking	0	None
53036	53037	prednisone	0	None
53037	53038	for	0	None
53038	53039	lupus	0	None
53039	53040	demonstrate	0	None
53040	53041	amelioration	0	None
53041	53042	of	0	None
53042	53043	some	0	None
53043	53044	of	0	None
53044	53045	these	0	None
53045	53046	adverse	0	None
53046	53047	effects	0	None
53047	53048	.	0	None
53048	53049	Graphene	0	None
53049	53050	oxide	0	None
53050	53051	nanoribbons	0	None
53051	53052	(	0	None
53052	53053	GONRs	0	None
53053	53054	)	0	None
53054	53055	and	0	None
53055	53056	chemically	0	None
53056	53057	reduced	0	None
53057	53058	graphene	0	None
53058	53059	nanoribbons	0	None
53059	53060	(	0	None
53060	53061	crGNRs	0	None
53061	53062	)	0	None
53062	53063	were	0	None
53063	53064	dispersed	0	None
53064	53065	at	0	None
53065	53066	high	0	None
53066	53067	concentrations	0	None
53067	53068	in	0	None
53068	53069	chlorosulfonic	0	None
53069	53070	acid	0	None
53070	53071	to	0	None
53071	53072	form	0	None
53072	53073	anisotropic	0	None
53073	53074	liquid	0	None
53074	53075	crystal	0	None
53075	53076	phases	0	None
53076	53077	.	0	None

53078	53079	The	0	None
53079	53080	liquid	0	None
53080	53081	crystal	0	None
53081	53082	solutions	0	None
53082	53083	were	0	None
53083	53084	spun	0	None
53084	53085	directly	0	None
53085	53086	into	0	None
53086	53087	hundreds	0	None
53087	53088	of	0	None
53088	53089	meters	0	None
53089	53090	of	0	None
53090	53091	continuous	0	None
53091	53092	macroscopic	0	None
53092	53093	fibers	0	None
53093	53094	.	0	None

53095	53096	The	0	None
53096	53097	relationship	0	None
53097	53098	of	0	None
53098	53099	fiber	0	None
53099	53100	morphology	0	None
53100	53101	to	0	None
53101	53102	coagulation	0	None
53102	53103	bath	0	None
53103	53104	conditions	0	None
53104	53105	was	0	None
53105	53106	studied	0	None
53106	53107	.	0	None

53108	53109	The	0	None
53109	53110	effects	0	None
53110	53111	of	0	None
53111	53112	colloid	0	None
53112	53113	concentration	0	None
53113	53114	,	0	None
53114	53115	annealing	0	None
53115	53116	temperature	0	None
53116	53117	,	0	None
53117	53118	spinning	0	None
53118	53119	air	0	None
53119	53120	gap	0	None
53120	53121	,	0	None
53121	53122	and	0	None
53122	53123	pretension	0	None
53123	53124	during	0	None
53124	53125	annealing	0	None
53125	53126	on	0	None
53126	53127	the	0	None
53127	53128	fibers'	0	None
53128	53129	performance	0	None
53129	53130	were	0	None
53130	53131	also	0	None
53131	53132	investigated	0	None
53132	53133	.	0	None

53134	53135	Heat	0	None
53135	53136	treatment	0	None
53136	53137	of	0	None
53137	53138	the	0	None
53138	53139	as-spun	0	None
53139	53140	GONR	0	None
53140	53141	fibers	0	None
53141	53142	at	0	None
53142	53143	1500	0	None
53143	53144	°C	0	None
53144	53145	produced	0	None
53145	53146	thermally	0	None
53146	53147	reduced	0	None
53147	53148	graphene	0	None
53148	53149	nanoribbon	0	None
53149	53150	(	0	None
53150	53151	trGNR	0	None
53151	53152	)	0	None
53152	53153	fibers	0	None
53153	53154	with	0	None
53154	53155	a	0	None
53155	53156	tensile	0	None
53156	53157	strength	0	None
53157	53158	of	0	None
53158	53159	378	0	None
53159	53160	MPa	0	None
53160	53161	,	0	None
53161	53162	Young's	0	None
53162	53163	modulus	0	None
53163	53164	of	0	None
53164	53165	36	0	None
53165	53166	.	0	None
53166	53167	2	0	None
53167	53168	GPa	0	None
53168	53169	,	0	None
53169	53170	and	0	None
53170	53171	electrical	0	None
53171	53172	conductivity	0	None
53172	53173	of	0	None
53173	53174	285	0	None
53174	53175	S	0	None
53175	53176	/	0	None
53176	53177	cm	0	None
53177	53178	,	0	None
53178	53179	which	0	None
53179	53180	is	0	None
53180	53181	considerably	0	None
53181	53182	higher	0	None
53182	53183	than	0	None
53183	53184	that	0	None
53184	53185	in	0	None
53185	53186	other	0	None
53186	53187	reported	0	None
53187	53188	graphene-derived	0	None
53188	53189	fibers	0	None
53189	53190	.	0	None

53191	53192	This	0	None
53192	53193	better	0	None
53193	53194	trGNR	0	None
53194	53195	fiber	0	None
53195	53196	performance	0	None
53196	53197	was	0	None
53197	53198	due	0	None
53198	53199	to	0	None
53199	53200	the	0	None
53200	53201	air	0	None
53201	53202	gap	0	None
53202	53203	spinning	0	None
53203	53204	and	0	None
53204	53205	annealing	0	None
53205	53206	with	0	None
53206	53207	pretension	0	None
53207	53208	that	0	None
53208	53209	produced	0	None
53209	53210	higher	0	None
53210	53211	molecular	0	None
53211	53212	alignment	0	None
53212	53213	within	0	None
53213	53214	the	0	None
53214	53215	fibers	0	None
53215	53216	,	0	None
53216	53217	as	0	None
53217	53218	determined	0	None
53218	53219	by	0	None
53219	53220	X-ray	0	None
53220	53221	diffraction	0	None
53221	53222	and	0	None
53222	53223	scanning	0	None
53223	53224	electron	0	None
53224	53225	microscopy	0	None
53225	53226	.	0	None

53227	53228	The	0	None
53228	53229	specific	0	None
53229	53230	modulus	0	None
53230	53231	of	0	None
53231	53232	trGNR	0	None
53232	53233	fibers	0	None
53233	53234	is	0	None
53234	53235	higher	0	None
53235	53236	than	0	None
53236	53237	that	0	None
53237	53238	of	0	None
53238	53239	the	0	None
53239	53240	commercial	0	None
53240	53241	general	0	None
53241	53242	purpose	0	None
53242	53243	carbon	2	CHEMICAL
53243	53244	fibers	0	None
53244	53245	and	0	None
53245	53246	commonly	0	None
53246	53247	used	0	None
53247	53248	metals	0	None
53248	53249	such	0	None
53249	53250	as	0	None
53250	53251	Al	2	CHEMICAL
53251	53252	,	0	None
53252	53253	Cu	2	CHEMICAL
53253	53254	,	0	None
53254	53255	and	0	None
53255	53256	steel	0	None
53256	53257	.	0	None

53258	53259	The	0	None
53259	53260	properties	0	None
53260	53261	of	0	None
53261	53262	trGNR	0	None
53262	53263	fibers	0	None
53263	53264	can	0	None
53264	53265	be	0	None
53265	53266	further	0	None
53266	53267	improved	0	None
53267	53268	by	0	None
53268	53269	optimizing	0	None
53269	53270	the	0	None
53270	53271	spinning	0	None
53271	53272	conditions	0	None
53272	53273	with	0	None
53273	53274	higher	0	None
53274	53275	draw	0	None
53275	53276	ratio	0	None
53276	53277	,	0	None
53277	53278	annealing	0	None
53278	53279	conditions	0	None
53279	53280	with	0	None
53280	53281	higher	0	None
53281	53282	pretensions	0	None
53282	53283	,	0	None
53283	53284	and	0	None
53284	53285	using	0	None
53285	53286	longer	0	None
53286	53287	flake	0	None
53287	53288	GONRs	0	None
53288	53289	.	0	None

53290	53291	This	0	None
53291	53292	technique	0	None
53292	53293	is	0	None
53293	53294	a	0	None
53294	53295	new	0	None
53295	53296	high-carbon-yield	0	None
53296	53297	approach	0	None
53297	53298	to	0	None
53298	53299	make	0	None
53299	53300	the	0	None
53300	53301	next	0	None
53301	53302	generation	0	None
53302	53303	carbon	2	CHEMICAL
53303	53304	fibers	0	None
53304	53305	based	0	None
53305	53306	on	0	None
53306	53307	solution-based	0	None
53307	53308	liquid	0	None
53308	53309	crystal	0	None
53309	53310	phase	0	None
53310	53311	spinning	0	None
53311	53312	.	0	None
53312	53313	Active	0	None
53313	53314	Hexose	0	None
53314	53315	Correlated	0	None
53315	53316	Compound	0	None
53316	53317	(	0	None
53317	53318	AHCC	0	None
53318	53319	)	0	None
53319	53320	is	0	None
53320	53321	an	0	None
53321	53322	immunostimulatory	0	None
53322	53323	nutritional	0	None
53323	53324	supplement	0	None
53324	53325	.	0	None

53326	53327	AHCC	0	None
53327	53328	effects	0	None
53328	53329	and	0	None
53329	53330	mechanism	0	None
53330	53331	of	0	None
53331	53332	action	0	None
53332	53333	on	0	None
53333	53334	intestinal	0	None
53334	53335	epithelial	0	None
53335	53336	cells	0	None
53336	53337	or	0	None
53337	53338	monocytes	0	None
53338	53339	are	0	None
53339	53340	poorly	0	None
53340	53341	described	0	None
53341	53342	.	0	None

53343	53344	AHCC	0	None
53344	53345	was	0	None
53345	53346	added	0	None
53346	53347	to	0	None
53347	53348	the	0	None
53348	53349	culture	0	None
53349	53350	medium	0	None
53350	53351	of	0	None
53351	53352	intestinal	0	None
53352	53353	epithelial	0	None
53353	53354	cells	0	None
53354	53355	(	0	None
53355	53356	IEC18	0	None
53356	53357	and	0	None
53357	53358	HT29	0	None
53358	53359	cells	0	None
53359	53360	)	0	None
53360	53361	and	0	None
53361	53362	monocytes	0	None
53362	53363	(	0	None
53363	53364	THP-1	0	None
53364	53365	cells	0	None
53365	53366	)	0	None
53366	53367	and	0	None
53367	53368	assessed	0	None
53368	53369	the	0	None
53369	53370	secretion	0	None
53370	53371	of	0	None
53371	53372	proinflammatory	0	None
53372	53373	cytokines	3	GENE-N
53373	53374	by	0	None
53374	53375	ELISA	0	None
53375	53376	.	0	None

53377	53378	Inhibitors	0	None
53378	53379	of	0	None
53379	53380	NFκB	0	None
53380	53381	and	0	None
53381	53382	MAPKs	0	None
53382	53383	were	0	None
53383	53384	used	0	None
53384	53385	to	0	None
53385	53386	study	0	None
53386	53387	signal	0	None
53387	53388	transduction	0	None
53388	53389	pathways	0	None
53389	53390	while	0	None
53390	53391	TLR4	0	None
53391	53392	and	0	None
53392	53393	MyD88	0	None
53393	53394	were	0	None
53394	53395	silenced	0	None
53395	53396	in	0	None
53396	53397	IEC18	0	None
53397	53398	cells	0	None
53398	53399	using	0	None
53399	53400	shRNA	0	None
53400	53401	.	0	None

53402	53403	It	0	None
53403	53404	was	0	None
53404	53405	found	0	None
53405	53406	that	0	None
53406	53407	AHCC	0	None
53407	53408	induced	0	None
53408	53409	GROα	0	None
53409	53410	and	0	None
53410	53411	MCP1	0	None
53411	53412	secretion	0	None
53412	53413	in	0	None
53413	53414	IEC18	0	None
53414	53415	and	0	None
53415	53416	IL-8	1	GENE-Y
53416	53417	in	0	None
53417	53418	HT29	0	None
53418	53419	cells	0	None
53419	53420	.	0	None

53421	53422	These	0	None
53422	53423	effects	0	None
53423	53424	depended	0	None
53424	53425	on	0	None
53425	53426	NFκB	0	None
53426	53427	activation	0	None
53427	53428	,	0	None
53428	53429	and	0	None
53429	53430	partly	0	None
53430	53431	on	0	None
53431	53432	MAPKs	0	None
53432	53433	activation	0	None
53433	53434	and	0	None
53434	53435	on	0	None
53435	53436	the	0	None
53436	53437	presence	0	None
53437	53438	of	0	None
53438	53439	MyD88	0	None
53439	53440	and	0	None
53440	53441	TLR4	0	None
53441	53442	.	0	None

53443	53444	In	0	None
53444	53445	THP-1	0	None
53445	53446	cells	0	None
53446	53447	AHCC	0	None
53447	53448	evoked	0	None
53448	53449	IL-8	1	GENE-Y
53449	53450	,	0	None
53450	53451	IL-1β	0	None
53451	53452	and	0	None
53452	53453	TNF-α	0	None
53453	53454	secretion	0	None
53454	53455	.	0	None

53456	53457	The	0	None
53457	53458	induction	0	None
53458	53459	of	0	None
53459	53460	IL-8	1	GENE-Y
53460	53461	depended	0	None
53461	53462	on	0	None
53462	53463	JNK	0	None
53463	53464	and	0	None
53464	53465	NFκB	0	None
53465	53466	activation	0	None
53466	53467	.	0	None

53468	53469	Therefore	0	None
53469	53470	,	0	None
53470	53471	AHCC	0	None
53471	53472	exerts	0	None
53472	53473	immunostimulatory	0	None
53473	53474	effects	0	None
53474	53475	on	0	None
53475	53476	intestinal	0	None
53476	53477	epithelial	0	None
53477	53478	cells	0	None
53478	53479	and	0	None
53479	53480	monocytes	0	None
53480	53481	involving	0	None
53481	53482	TLR4	0	None
53482	53483	/	0	None
53483	53484	MyD88	0	None
53484	53485	and	0	None
53485	53486	NFκB	0	None
53486	53487	/	0	None
53487	53488	MAPK	3	GENE-N
53488	53489	signal	0	None
53489	53490	transduction	0	None
53490	53491	pathways	0	None
53491	53492	.	0	None
53492	53493	The	0	None
53493	53494	cellular	0	None
53494	53495	action	0	None
53495	53496	of	0	None
53496	53498	steroid hormones	2	CHEMICAL
53498	53499	is	0	None
53499	53500	mediated	0	None
53500	53501	by	0	None
53501	53502	specific	0	None
53502	53503	receptors	0	None
53503	53504	.	0	None

53505	53506	Recently	0	None
53506	53507	,	0	None
53507	53508	two	0	None
53508	53509	different	0	None
53509	53510	estrogen	0	None
53510	53511	receptors	0	None
53511	53512	(	0	None
53512	53513	ER	0	None
53513	53514	)	0	None
53514	53515	,	0	None
53515	53516	alpha	0	None
53516	53517	and	0	None
53517	53518	beta	0	None
53518	53519	,	0	None
53519	53520	have	0	None
53520	53521	been	0	None
53521	53522	cloned	0	None
53522	53523	with	0	None
53523	53524	a	0	None
53524	53525	specific	0	None
53525	53526	tissue	0	None
53526	53527	distribution	0	None
53527	53528	.	0	None

53529	53530	Active	0	None
53530	53531	estrogen	0	None
53531	53532	as	0	None
53532	53533	well	0	None
53533	53534	as	0	None
53534	53535	active	0	None
53535	53536	progestin	0	None
53536	53537	are	0	None
53537	53538	compounds	0	None
53538	53539	of	0	None
53539	53540	oral	0	None
53540	53541	hormonal	0	None
53541	53542	contraceptives	0	None
53542	53543	and	0	None
53543	53544	hormone	0	None
53544	53545	replacement	0	None
53545	53546	therapy	0	None
53546	53547	.	0	None

53548	53549	To	0	None
53549	53550	examine	0	None
53550	53551	the	0	None
53551	53552	regulation	0	None
53552	53553	of	0	None
53553	53554	ER-alpha	0	None
53554	53555	and	0	None
53555	53556	-beta	0	None
53556	53557	activities	0	None
53557	53558	after	0	None
53558	53559	treatment	0	None
53559	53560	with	0	None
53560	53561	synthetic	0	None
53561	53562	progestins	2	CHEMICAL
53562	53563	and	0	None
53563	53564	synthetic	0	None
53564	53565	and	0	None
53565	53566	natural	0	None
53566	53567	estrogens	2	CHEMICAL
53567	53568	,	0	None
53568	53569	COS	0	None
53569	53570	7	0	None
53570	53571	cells	0	None
53571	53572	were	0	None
53572	53573	transfected	0	None
53573	53574	with	0	None
53574	53575	the	0	None
53575	53576	vector	0	None
53576	53577	expressing	0	None
53577	53578	ER-alpha	0	None
53578	53579	and	0	None
53579	53580	-beta	0	None
53580	53581	in	0	None
53581	53582	combination	0	None
53582	53583	with	0	None
53583	53584	a	0	None
53584	53585	luciferase	0	None
53585	53586	reporter	0	None
53586	53587	vector	0	None
53587	53588	.	0	None

53589	53590	ER-alpha	0	None
53590	53591	activity	0	None
53591	53592	was	0	None
53592	53593	upregulated	0	None
53593	53594	in	0	None
53594	53595	the	0	None
53595	53596	presence	0	None
53596	53597	of	0	None
53597	53598	synthetic	0	None
53598	53599	progestins	2	CHEMICAL
53599	53600	in	0	None
53600	53601	a	0	None
53601	53602	dose-dependent	0	None
53602	53603	manner	0	None
53603	53604	.	0	None

53605	53606	Norethisterone	0	None
53606	53607	,	0	None
53607	53608	norethynodrel	0	None
53608	53609	and	0	None
53609	53610	desogestrel	0	None
53610	53611	proved	0	None
53611	53612	to	0	None
53612	53613	be	0	None
53613	53614	the	0	None
53614	53615	most	0	None
53615	53616	potent	0	None
53616	53617	stimulatory	0	None
53617	53618	agents	0	None
53618	53619	of	0	None
53619	53620	ER-alpha	0	None
53620	53621	expression	0	None
53621	53622	.	0	None

53623	53624	On	0	None
53624	53625	the	0	None
53625	53626	other	0	None
53626	53627	hand	0	None
53627	53628	,	0	None
53628	53629	not	0	None
53629	53630	all	0	None
53630	53631	progestins	2	CHEMICAL
53631	53632	exhibited	0	None
53632	53633	a	0	None
53633	53634	stimulatory	0	None
53634	53635	action	0	None
53635	53636	on	0	None
53636	53637	ER-beta	0	None
53637	53638	activity	0	None
53638	53639	.	0	None

53640	53641	Only	0	None
53641	53642	norgestrel	0	None
53642	53643	,	0	None
53643	53644	levonorgestrel	0	None
53644	53645	,	0	None
53645	53646	norethynodrel	0	None
53646	53647	and	0	None
53647	53648	norethisterone	0	None
53648	53649	induced	0	None
53649	53650	ER-beta-activating	0	None
53650	53651	functions	0	None
53651	53652	in	0	None
53652	53653	a	0	None
53653	53654	dose-dependent	0	None
53654	53655	manner	0	None
53655	53656	.	0	None

53657	53658	Luciferase	0	None
53658	53659	activity	0	None
53659	53660	due	0	None
53660	53661	to	0	None
53661	53662	estrogen	0	None
53662	53663	stimulation	0	None
53663	53664	served	0	None
53664	53665	as	0	None
53665	53666	a	0	None
53666	53667	positive	0	None
53667	53668	control	0	None
53668	53669	.	0	None

53670	53671	Our	0	None
53671	53672	results	0	None
53672	53673	indicate	0	None
53673	53674	that	0	None
53674	53675	progestins	2	CHEMICAL
53675	53676	have	0	None
53676	53677	different	0	None
53677	53678	effects	0	None
53678	53679	on	0	None
53679	53680	the	0	None
53680	53681	activities	0	None
53681	53682	of	0	None
53682	53683	ER-alpha	0	None
53683	53684	and	0	None
53684	53685	-beta	0	None
53685	53686	.	0	None
53686	53687	Characterization	0	None
53687	53688	of	0	None
53688	53689	cytosolic	0	None
53689	53691	glutathione peroxidase	1	GENE-Y
53691	53692	and	0	None
53692	53693	phospholipid-hydroperoxide	0	None
53693	53694	glutathione	0	None
53694	53695	peroxidase	0	None
53695	53696	genes	0	None
53696	53697	in	0	None
53697	53698	rainbow	0	None
53698	53699	trout	0	None
53699	53700	(	0	None
53700	53701	Oncorhynchus	0	None
53701	53702	mykiss	0	None
53702	53703	)	0	None
53703	53704	and	0	None
53704	53705	their	0	None
53705	53706	modulation	0	None
53706	53707	by	0	None
53707	53708	in	0	None
53708	53709	vitro	0	None
53709	53710	selenium	0	None
53710	53711	exposure	0	None
53711	53712	.	0	None
53712	53713	beta-Adrenoceptor	0	None
53713	53714	binding	0	None
53714	53715	of	0	None
53715	53716	cardioselective	0	None
53716	53717	drugs	0	None
53717	53718	to	0	None
53718	53719	intact	0	None
53719	53720	ventricular	0	None
53720	53721	myocytes	0	None
53721	53722	was	0	None
53722	53723	performed	0	None
53723	53724	using	0	None
53724	53725	[	0	None
53725	53726	3H	0	None
53726	53727	]	0	None
53727	53728	CGP-12177	0	None
53728	53729	,	0	None
53729	53730	a	0	None
53730	53731	hydrophilic	0	None
53731	53732	non-beta	0	None
53732	53733	1	0	None
53733	53734	/	0	None
53734	53735	beta	0	None
53735	53736	2-selective	0	None
53736	53737	antagonist	0	None
53737	53738	radioligand	0	None
53738	53739	.	0	None

53740	53741	The	0	None
53741	53742	beta-adrenoceptor	3	GENE-N
53742	53743	density	0	None
53743	53744	on	0	None
53744	53745	the	0	None
53745	53746	intact	0	None
53746	53747	cardiomyocytes	0	None
53747	53748	was	0	None
53748	53749	about	0	None
53749	53750	2	0	None
53750	53751	x	0	None
53751	53752	10	0	None
53752	53753	(	0	None
53753	53754	5	0	None
53754	53755	)	0	None
53755	53756	molecules	0	None
53756	53757	/	0	None
53757	53758	cell	0	None
53758	53759	.	0	None

53760	53761	The	0	None
53761	53762	beta	0	None
53762	53763	1-selective	0	None
53763	53764	antagonists	0	None
53764	53765	H-I	0	None
53765	53766	42	0	None
53766	53767	BS	0	None
53767	53768	and	0	None
53768	53769	HX-CH	0	None
53769	53770	44	0	None
53770	53771	BS	0	None
53771	53772	competed	0	None
53772	53773	for	0	None
53773	53774	[	0	None
53774	53775	3H	0	None
53775	53776	]	0	None
53776	53777	CGP-12177	0	None
53777	53778	binding	0	None
53778	53779	sites	0	None
53779	53780	on	0	None
53780	53781	the	0	None
53781	53782	ventricular	0	None
53782	53783	myocytes	0	None
53783	53784	in	0	None
53784	53785	an	0	None
53785	53786	essentially	0	None
53786	53787	monophasic	0	None
53787	53788	manner	0	None
53788	53789	with	0	None
53789	53790	Ki	0	None
53790	53791	=	0	None
53791	53792	72	0	None
53792	53793	.	0	None
53793	53794	6	0	None
53794	53795	nM	0	None
53795	53796	and	0	None
53796	53797	Ki	0	None
53797	53798	=	0	None
53798	53799	76	0	None
53799	53800	.	0	None
53800	53801	7	0	None
53801	53802	nM	0	None
53802	53803	,	0	None
53803	53804	respectively	0	None
53804	53805	.	0	None

53806	53807	This	0	None
53807	53808	is	0	None
53808	53809	in	0	None
53809	53810	contrast	0	None
53810	53811	to	0	None
53811	53812	the	0	None
53812	53813	results	0	None
53813	53814	of	0	None
53814	53815	binding	0	None
53815	53816	data	0	None
53816	53817	from	0	None
53817	53818	heart	0	None
53818	53819	membranes	0	None
53819	53820	,	0	None
53820	53821	where	0	None
53821	53822	these	0	None
53822	53823	beta	0	None
53823	53824	1-antagonists	0	None
53824	53825	bind	0	None
53825	53826	in	0	None
53826	53827	a	0	None
53827	53828	biphasic	0	None
53828	53829	manner	0	None
53829	53830	with	0	None
53830	53831	about	0	None
53831	53832	30%	0	None
53832	53833	of	0	None
53833	53834	an	0	None
53834	53835	additional	0	None
53835	53836	low	0	None
53836	53837	affinity	0	None
53837	53838	site	0	None
53838	53839	,	0	None
53839	53840	presumably	0	None
53840	53841	corresponding	0	None
53841	53842	to	0	None
53842	53843	the	0	None
53843	53844	beta	0	None
53844	53845	2-adrenoceptor	0	None
53845	53846	.	0	None

53847	53848	The	0	None
53848	53849	beta	0	None
53849	53850	1-selective	0	None
53850	53851	antagonist	0	None
53851	53852	bisoprolol	0	None
53852	53853	revealed	0	None
53853	53854	two	0	None
53854	53855	binding	0	None
53855	53856	sites	0	None
53856	53857	at	0	None
53857	53858	the	0	None
53858	53859	heart	0	None
53859	53860	membranes	0	None
53860	53861	and	0	None
53861	53862	at	0	None
53862	53863	the	0	None
53863	53864	myocytes	0	None
53864	53865	as	0	None
53865	53866	well	0	None
53866	53867	with	0	None
53867	53868	Ki	0	None
53868	53869	(	0	None
53869	53870	1	0	None
53870	53871	)	0	None
53871	53872	=	0	None
53872	53873	34	0	None
53873	53874	.	0	None
53874	53875	2	0	None
53875	53876	and	0	None
53876	53877	20	0	None
53877	53878	.	0	None
53878	53879	0	0	None
53879	53880	nM	0	None
53880	53881	and	0	None
53881	53882	Ki	0	None
53882	53883	(	0	None
53883	53884	2	0	None
53884	53885	)	0	None
53885	53886	=	0	None
53886	53887	3	0	None
53887	53888	,	0	None
53888	53889	014	0	None
53889	53890	and	0	None
53890	53891	918	0	None
53891	53892	nM	0	None
53892	53893	,	0	None
53893	53894	respectively	0	None
53894	53895	.	0	None

53896	53897	Our	0	None
53897	53898	results	0	None
53898	53899	suggest	0	None
53899	53900	that	0	None
53900	53901	viable	0	None
53901	53902	adult	0	None
53902	53903	rat	0	None
53903	53904	ventricular	0	None
53904	53905	myocytes	0	None
53905	53906	may	0	None
53906	53907	contain	0	None
53907	53908	two	0	None
53908	53909	beta	0	None
53909	53910	1-adrenoceptor	0	None
53910	53911	binding	0	None
53911	53912	sites	0	None
53912	53913	exhibiting	0	None
53913	53914	different	0	None
53914	53915	affinities	0	None
53915	53916	for	0	None
53916	53917	bisoprolol	0	None
53917	53918	,	0	None
53918	53919	whereas	0	None
53919	53921	beta 2-adrenergic	1	GENE-Y
53921	53922	receptors	0	None
53922	53923	are	0	None
53923	53924	completely	0	None
53924	53925	absent	0	None
53925	53926	.	0	None
53926	53927	P21-activated	0	None
53927	53928	kinase	0	None
53928	53929	4	0	None
53929	53930	(	0	None
53930	53931	PAK4	0	None
53931	53932	)	0	None
53932	53933	is	0	None
53933	53934	required	0	None
53934	53935	for	0	None
53935	53936	metaphase	0	None
53936	53937	spindle	0	None
53937	53938	positioning	0	None
53938	53939	and	0	None
53939	53940	anchoring	0	None
53940	53941	.	0	None
53941	53942	BACKGROUND	0	None
53942	53943	:	0	None
53943	53944	Sunitinib	0	None
53944	53945	malate	0	None
53945	53946	(	0	None
53946	53947	SUTENT	0	None
53947	53948	)	0	None
53948	53949	is	0	None
53949	53950	an	0	None
53950	53951	oral	0	None
53951	53952	,	0	None
53952	53953	multitargeted	0	None
53953	53954	tyrosine	2	CHEMICAL
53954	53955	kinase	0	None
53955	53956	inhibitor	0	None
53956	53957	,	0	None
53957	53958	approved	0	None
53958	53959	multinationally	0	None
53959	53960	for	0	None
53960	53961	the	0	None
53961	53962	treatment	0	None
53962	53963	of	0	None
53963	53964	advanced	0	None
53964	53965	RCC	0	None
53965	53966	and	0	None
53966	53967	of	0	None
53967	53968	imatinib-resistant	0	None
53968	53969	or	0	None
53969	53970	-	0	None
53970	53971	intolerant	0	None
53971	53972	GIST	0	None
53972	53973	.	0	None

53974	53975	The	0	None
53975	53976	purpose	0	None
53976	53977	of	0	None
53977	53978	this	0	None
53978	53979	study	0	None
53979	53980	was	0	None
53980	53981	to	0	None
53981	53982	explore	0	None
53982	53983	potential	0	None
53983	53984	biomarkers	0	None
53984	53985	of	0	None
53985	53986	sunitinib	0	None
53986	53987	pharmacological	0	None
53987	53988	activity	0	None
53988	53989	via	0	None
53989	53990	serial	0	None
53990	53991	assessment	0	None
53991	53992	of	0	None
53992	53993	plasma	0	None
53993	53994	levels	0	None
53994	53995	of	0	None
53995	53996	four	0	None
53996	53997	soluble	0	None
53997	53998	proteins	0	None
53998	53999	from	0	None
53999	54000	patients	0	None
54000	54001	in	0	None
54001	54002	a	0	None
54002	54003	phase	0	None
54003	54004	II	0	None
54004	54005	study	0	None
54005	54006	of	0	None
54006	54007	advanced	0	None
54007	54008	RCC	0	None
54008	54009	:	0	None
54009	54010	VEGF	0	None
54010	54011	,	0	None
54011	54012	soluble	0	None
54012	54013	VEGFR-2	0	None
54013	54014	(	0	None
54014	54015	sVEGFR-2	0	None
54015	54016	)	0	None
54016	54017	,	0	None
54017	54020	placenta growth factor	1	GENE-Y
54020	54021	(	0	None
54021	54022	PlGF	0	None
54022	54023	)	0	None
54023	54024	,	0	None
54024	54025	and	0	None
54025	54026	a	0	None
54026	54027	novel	0	None
54027	54028	soluble	0	None
54028	54029	variant	0	None
54029	54030	of	0	None
54030	54031	VEGFR-3	0	None
54031	54032	(	0	None
54032	54033	sVEGFR-3	0	None
54033	54034	)	0	None
54034	54035	.	0	None

54036	54037	METHODS	0	None
54037	54038	:	0	None
54038	54039	Sunitinib	0	None
54039	54040	was	0	None
54040	54041	administered	0	None
54041	54042	at	0	None
54042	54043	50	0	None
54043	54044	mg	2	CHEMICAL
54044	54045	/	0	None
54045	54046	day	0	None
54046	54047	on	0	None
54047	54048	a	0	None
54048	54049	4	0	None
54049	54050	/	0	None
54050	54051	2	0	None
54051	54052	schedule	0	None
54052	54053	(	0	None
54053	54054	4	0	None
54054	54055	weeks	0	None
54055	54056	on	0	None
54056	54057	treatment	0	None
54057	54058	,	0	None
54058	54059	2	0	None
54059	54060	weeks	0	None
54060	54061	off	0	None
54061	54062	treatment	0	None
54062	54063	)	0	None
54063	54064	to	0	None
54064	54065	63	0	None
54065	54066	patients	0	None
54066	54067	with	0	None
54067	54068	metastatic	0	None
54068	54069	RCC	0	None
54069	54070	after	0	None
54070	54071	failure	0	None
54071	54072	of	0	None
54072	54073	first-line	0	None
54073	54074	cytokine	0	None
54074	54075	therapy	0	None
54075	54076	.	0	None

54077	54078	Predose	0	None
54078	54079	plasma	0	None
54079	54080	samples	0	None
54080	54081	were	0	None
54081	54082	collected	0	None
54082	54083	on	0	None
54083	54084	days	0	None
54084	54085	1	0	None
54085	54086	and	0	None
54086	54087	28	0	None
54087	54088	of	0	None
54088	54089	each	0	None
54089	54090	cycle	0	None
54090	54091	and	0	None
54091	54092	analyzed	0	None
54092	54093	via	0	None
54093	54094	ELISA	0	None
54094	54095	.	0	None

54096	54097	RESULTS	0	None
54097	54098	:	0	None
54098	54099	At	0	None
54099	54100	the	0	None
54100	54101	end	0	None
54101	54102	of	0	None
54102	54103	cycle	0	None
54103	54104	1	0	None
54104	54105	,	0	None
54105	54106	VEGF	0	None
54106	54107	and	0	None
54107	54108	PlGF	0	None
54108	54109	levels	0	None
54109	54110	increased	0	None
54110	54111	>3-fold	0	None
54111	54112	(	0	None
54112	54113	relative	0	None
54113	54114	to	0	None
54114	54115	baseline	0	None
54115	54116	)	0	None
54116	54117	in	0	None
54117	54118	24	0	None
54118	54119	/	0	None
54119	54120	54	0	None
54120	54121	(	0	None
54121	54122	44%	0	None
54122	54123	)	0	None
54123	54124	and	0	None
54124	54125	22	0	None
54125	54126	/	0	None
54126	54127	55	0	None
54127	54128	(	0	None
54128	54129	40%	0	None
54129	54130	)	0	None
54130	54131	cases	0	None
54131	54132	,	0	None
54132	54133	respectively	0	None
54133	54134	(	0	None
54134	54135	P	0	None
54135	54136	<	0	None
54136	54137	0	0	None
54137	54138	.	0	None
54138	54139	001	0	None
54139	54140	)	0	None
54140	54141	.	0	None

54142	54143	sVEGFR-2	0	None
54143	54144	levels	0	None
54144	54145	decreased	0	None
54145	54146	>or	0	None
54146	54147	=	0	None
54147	54148	30%	0	None
54148	54149	in	0	None
54149	54150	50	0	None
54150	54151	/	0	None
54151	54152	55	0	None
54152	54153	(	0	None
54153	54154	91%	0	None
54154	54155	)	0	None
54155	54156	cases	0	None
54156	54157	and	0	None
54157	54158	>or	0	None
54158	54159	=	0	None
54159	54160	20%	0	None
54160	54161	in	0	None
54161	54162	all	0	None
54162	54163	cases	0	None
54163	54164	(	0	None
54164	54165	P	0	None
54165	54166	<	0	None
54166	54167	0	0	None
54167	54168	.	0	None
54168	54169	001	0	None
54169	54170	)	0	None
54170	54171	during	0	None
54171	54172	cycle	0	None
54172	54173	1	0	None
54173	54174	,	0	None
54174	54175	while	0	None
54175	54176	sVEGFR-3	0	None
54176	54177	levels	0	None
54177	54178	were	0	None
54178	54179	decreased	0	None
54179	54180	>or	0	None
54180	54181	=	0	None
54181	54182	30%	0	None
54182	54183	in	0	None
54183	54184	48	0	None
54184	54185	of	0	None
54185	54186	55	0	None
54186	54187	cases	0	None
54187	54188	(	0	None
54188	54189	87%	0	None
54189	54190	)	0	None
54190	54191	,	0	None
54191	54192	and	0	None
54192	54193	>or	0	None
54193	54194	=	0	None
54194	54195	20%	0	None
54195	54196	in	0	None
54196	54197	all	0	None
54197	54198	but	0	None
54198	54199	2	0	None
54199	54200	cases	0	None
54200	54201	.	0	None

54202	54203	These	0	None
54203	54204	levels	0	None
54204	54205	tended	0	None
54205	54206	to	0	None
54206	54207	return	0	None
54207	54208	to	0	None
54208	54209	near-baseline	0	None
54209	54210	after	0	None
54210	54211	2	0	None
54211	54212	weeks	0	None
54212	54213	off	0	None
54213	54214	treatment	0	None
54214	54215	,	0	None
54215	54216	indicating	0	None
54216	54217	that	0	None
54217	54218	these	0	None
54218	54219	effects	0	None
54219	54220	were	0	None
54220	54221	dependent	0	None
54221	54222	on	0	None
54222	54223	drug	0	None
54223	54224	exposure	0	None
54224	54225	.	0	None

54226	54227	Overall	0	None
54227	54228	,	0	None
54228	54229	significantly	0	None
54229	54230	larger	0	None
54230	54231	changes	0	None
54231	54232	in	0	None
54232	54233	VEGF	0	None
54233	54234	,	0	None
54234	54235	sVEGFR-2	0	None
54235	54236	,	0	None
54236	54237	and	0	None
54237	54238	sVEGFR-3	0	None
54238	54239	levels	0	None
54239	54240	were	0	None
54240	54241	observed	0	None
54241	54242	in	0	None
54242	54243	patients	0	None
54243	54244	exhibiting	0	None
54244	54245	objective	0	None
54245	54246	tumor	0	None
54246	54247	response	0	None
54247	54248	compared	0	None
54248	54249	with	0	None
54249	54250	those	0	None
54250	54251	exhibiting	0	None
54251	54252	stable	0	None
54252	54253	disease	0	None
54253	54254	or	0	None
54254	54255	disease	0	None
54255	54256	progression	0	None
54256	54257	(	0	None
54257	54258	P	0	None
54258	54259	<	0	None
54259	54260	0	0	None
54260	54261	.	0	None
54261	54262	05	0	None
54262	54263	for	0	None
54263	54264	each	0	None
54264	54265	analyte;	0	None
54265	54266	analysis	0	None
54266	54267	not	0	None
54267	54268	done	0	None
54268	54269	for	0	None
54269	54270	PlGF	0	None
54270	54271	)	0	None
54271	54272	.	0	None

54273	54274	CONCLUSION	0	None
54274	54275	:	0	None
54275	54276	Sunitinib	0	None
54276	54277	treatment	0	None
54277	54278	in	0	None
54278	54279	advanced	0	None
54279	54280	RCC	0	None
54280	54281	patients	0	None
54281	54282	leads	0	None
54282	54283	to	0	None
54283	54284	modulation	0	None
54284	54285	of	0	None
54285	54286	plasma	0	None
54286	54287	levels	0	None
54287	54288	of	0	None
54288	54289	circulating	0	None
54289	54290	proteins	0	None
54290	54291	involved	0	None
54291	54292	in	0	None
54292	54293	VEGF	0	None
54293	54294	signaling	0	None
54294	54295	,	0	None
54295	54296	including	0	None
54296	54297	soluble	0	None
54297	54298	forms	0	None
54298	54299	of	0	None
54299	54300	two	0	None
54300	54301	VEGF	0	None
54301	54302	receptors	0	None
54302	54303	.	0	None

54304	54305	This	0	None
54305	54306	panel	0	None
54306	54307	of	0	None
54307	54308	proteins	0	None
54308	54309	may	0	None
54309	54310	be	0	None
54310	54311	of	0	None
54311	54312	value	0	None
54312	54313	as	0	None
54313	54314	biomarkers	0	None
54314	54315	of	0	None
54315	54316	the	0	None
54316	54317	pharmacological	0	None
54317	54318	and	0	None
54318	54319	clinical	0	None
54319	54320	activity	0	None
54320	54321	of	0	None
54321	54322	sunitinib	0	None
54322	54323	in	0	None
54323	54324	RCC	0	None
54324	54325	,	0	None
54325	54326	and	0	None
54326	54327	of	0	None
54327	54328	angiogenic	0	None
54328	54329	processes	0	None
54329	54330	in	0	None
54330	54331	cancer	0	None
54331	54332	and	0	None
54332	54333	other	0	None
54333	54334	diseases	0	None
54334	54335	.	0	None
54335	54336	We	0	None
54336	54337	previously	0	None
54337	54338	characterized	0	None
54338	54339	1-ethyl-2-benzimidazolinone	0	None
54339	54340	(	0	None
54340	54341	1-EBIO	0	None
54341	54342	)	0	None
54342	54343	,	0	None
54343	54344	as	0	None
54344	54345	well	0	None
54345	54346	as	0	None
54346	54347	the	0	None
54347	54348	clinically	0	None
54348	54349	useful	0	None
54349	54350	benzoxazoles	0	None
54350	54351	,	0	None
54351	54352	chlorzoxazone	0	None
54352	54353	(	0	None
54353	54354	CZ	0	None
54354	54355	)	0	None
54355	54356	,	0	None
54356	54357	and	0	None
54357	54358	zoxazolamine	0	None
54358	54359	(	0	None
54359	54360	ZOX	0	None
54360	54361	)	0	None
54361	54362	,	0	None
54362	54363	as	0	None
54363	54364	pharmacological	0	None
54364	54365	activators	0	None
54365	54366	of	0	None
54366	54367	the	0	None
54367	54368	intermediate-conductance	0	None
54368	54369	Ca	0	None
54369	54370	(	0	None
54370	54371	2	0	None
54371	54372	+	0	None
54372	54373	)	0	None
54373	54374	-activated	0	None
54374	54375	K	0	None
54375	54376	(	0	None
54376	54377	+	0	None
54377	54378	)	0	None
54378	54379	channel	0	None
54379	54380	,	0	None
54380	54381	hIK1	0	None
54381	54382	.	0	None

54383	54384	The	0	None
54384	54385	mechanism	0	None
54385	54386	of	0	None
54386	54387	activation	0	None
54387	54388	of	0	None
54388	54389	hIK1	0	None
54389	54390	,	0	None
54390	54391	as	0	None
54391	54392	well	0	None
54392	54393	as	0	None
54393	54394	the	0	None
54394	54395	highly	0	None
54395	54396	homologous	0	None
54396	54397	small-conductance	0	None
54397	54398	,	0	None
54398	54399	Ca	0	None
54399	54400	(	0	None
54400	54401	2	0	None
54401	54402	+	0	None
54402	54403	)	0	None
54403	54404	-dependent	0	None
54404	54405	K	0	None
54405	54406	(	0	None
54406	54407	+	0	None
54407	54408	)	0	None
54408	54409	channel	0	None
54409	54410	,	0	None
54410	54411	rSK2	0	None
54411	54412	,	0	None
54412	54413	was	0	None
54413	54414	determined	0	None
54414	54415	following	0	None
54415	54416	heterologous	0	None
54416	54417	expression	0	None
54417	54418	in	0	None
54418	54419	Xenopus	0	None
54419	54420	oocytes	0	None
54420	54421	using	0	None
54421	54422	two-electrode	0	None
54422	54423	voltage	0	None
54423	54424	clamp	0	None
54424	54425	(	0	None
54425	54426	TEVC	0	None
54426	54427	)	0	None
54427	54428	and	0	None
54428	54429	excised	0	None
54429	54430	,	0	None
54430	54431	inside-out	0	None
54431	54432	patch-clamp	0	None
54432	54433	techniques	0	None
54433	54434	.	0	None

54435	54436	1-EBIO	0	None
54436	54437	,	0	None
54437	54438	CZ	0	None
54438	54439	,	0	None
54439	54440	and	0	None
54440	54441	ZOX	0	None
54441	54442	activated	0	None
54442	54443	both	0	None
54443	54444	hIK1	0	None
54444	54445	and	0	None
54445	54446	rSK2	0	None
54446	54447	in	0	None
54447	54448	TEVC	0	None
54448	54449	and	0	None
54449	54450	excised	0	None
54450	54451	inside-out	0	None
54451	54452	patch-clamp	0	None
54452	54453	experiments	0	None
54453	54454	.	0	None

54455	54456	In	0	None
54456	54457	excised	0	None
54457	54458	,	0	None
54458	54459	inside-out	0	None
54459	54460	patches	0	None
54460	54461	,	0	None
54461	54462	1-EBIO	0	None
54462	54463	and	0	None
54463	54464	CZ	0	None
54464	54465	induced	0	None
54465	54466	a	0	None
54466	54467	concentration-dependent	0	None
54467	54468	activation	0	None
54468	54469	of	0	None
54469	54470	hIK1	0	None
54470	54471	,	0	None
54471	54472	with	0	None
54472	54473	half-maximal	0	None
54473	54474	(	0	None
54474	54475	K	0	None
54475	54476	(	0	None
54476	54477	1	0	None
54477	54478	/	0	None
54478	54479	2	0	None
54479	54480	)	0	None
54480	54481	)	0	None
54481	54482	values	0	None
54482	54483	of	0	None
54483	54484	84	0	None
54484	54485	microM	0	None
54485	54486	and	0	None
54486	54487	98	0	None
54487	54488	microM	0	None
54488	54489	,	0	None
54489	54490	respectively	0	None
54490	54491	.	0	None

54492	54493	Similarly	0	None
54493	54494	,	0	None
54494	54495	CZ	0	None
54495	54496	activated	0	None
54496	54497	rSK2	0	None
54497	54498	with	0	None
54498	54499	a	0	None
54499	54500	K	0	None
54500	54501	(	0	None
54501	54502	1	0	None
54502	54503	/	0	None
54503	54504	2	0	None
54504	54505	)	0	None
54505	54506	of	0	None
54506	54507	87	0	None
54507	54508	microM	0	None
54508	54509	.	0	None

54510	54511	In	0	None
54511	54512	the	0	None
54512	54513	absence	0	None
54513	54514	of	0	None
54514	54515	CZ	0	None
54515	54516	,	0	None
54516	54517	the	0	None
54517	54518	Ca	0	None
54518	54519	(	0	None
54519	54520	2	0	None
54520	54521	+	0	None
54521	54522	)	0	None
54522	54523	-dependent	0	None
54523	54524	activation	0	None
54524	54525	of	0	None
54525	54526	hIK1	0	None
54526	54527	was	0	None
54527	54528	best	0	None
54528	54529	fit	0	None
54529	54530	with	0	None
54530	54531	a	0	None
54531	54532	K	0	None
54532	54533	(	0	None
54533	54534	1	0	None
54534	54535	/	0	None
54535	54536	2	0	None
54536	54537	)	0	None
54537	54538	of	0	None
54538	54539	700	0	None
54539	54540	nM	0	None
54540	54541	and	0	None
54541	54542	a	0	None
54542	54543	Hill	0	None
54543	54544	coefficient	0	None
54544	54545	(	0	None
54545	54546	n	0	None
54546	54547	)	0	None
54547	54548	of	0	None
54548	54549	2	0	None
54549	54550	.	0	None
54550	54551	0	0	None
54551	54552	.	0	None

54553	54554	rSK2	0	None
54554	54555	was	0	None
54555	54556	activated	0	None
54556	54557	by	0	None
54557	54558	Ca	0	None
54558	54559	(	0	None
54559	54560	2	0	None
54560	54561	+	0	None
54561	54562	)	0	None
54562	54563	with	0	None
54563	54564	a	0	None
54564	54565	K	0	None
54565	54566	(	0	None
54566	54567	1	0	None
54567	54568	/	0	None
54568	54569	2	0	None
54569	54570	)	0	None
54570	54571	of	0	None
54571	54572	700	0	None
54572	54573	nM	0	None
54573	54574	and	0	None
54574	54575	an	0	None
54575	54576	n	0	None
54576	54577	of	0	None
54577	54578	2	0	None
54578	54579	.	0	None
54579	54580	5	0	None
54580	54581	.	0	None

54582	54583	Addition	0	None
54583	54584	of	0	None
54584	54585	CZ	0	None
54585	54586	had	0	None
54586	54587	no	0	None
54587	54588	effect	0	None
54588	54589	on	0	None
54589	54590	either	0	None
54590	54591	the	0	None
54591	54592	K	0	None
54592	54593	(	0	None
54593	54594	1	0	None
54594	54595	/	0	None
54595	54596	2	0	None
54596	54597	)	0	None
54597	54598	or	0	None
54598	54599	n	0	None
54599	54600	for	0	None
54600	54601	Ca	0	None
54601	54602	(	0	None
54602	54603	2	0	None
54603	54604	+	0	None
54604	54605	)	0	None
54605	54606	-dependent	0	None
54606	54607	activation	0	None
54607	54608	of	0	None
54608	54609	either	0	None
54609	54610	hIK1	0	None
54610	54611	or	0	None
54611	54612	rSK2	0	None
54612	54613	.	0	None

54614	54615	Rather	0	None
54615	54616	,	0	None
54616	54617	CZ	0	None
54617	54618	increased	0	None
54618	54619	channel	0	None
54619	54620	activity	0	None
54620	54621	at	0	None
54621	54622	all	0	None
54622	54623	Ca	0	None
54623	54624	(	0	None
54624	54625	2	0	None
54625	54626	+	0	None
54626	54627	)	0	None
54627	54628	concentrations	0	None
54628	54629	(	0	None
54629	54630	V	0	None
54630	54631	(	0	None
54631	54632	max	0	None
54632	54633	)	0	None
54633	54634	)	0	None
54634	54635	.	0	None

54636	54637	Event-duration	0	None
54637	54638	analysis	0	None
54638	54639	revealed	0	None
54639	54640	hIK1	0	None
54640	54641	was	0	None
54641	54642	minimally	0	None
54642	54643	described	0	None
54643	54644	by	0	None
54644	54645	two	0	None
54645	54646	open	0	None
54646	54647	and	0	None
54647	54648	three	0	None
54648	54649	closed	0	None
54649	54650	times	0	None
54650	54651	.	0	None

54652	54653	Activation	0	None
54653	54654	by	0	None
54654	54655	1-EBIO	0	None
54655	54656	had	0	None
54656	54657	no	0	None
54657	54658	effect	0	None
54658	54659	on	0	None
54659	54660	tau	1	GENE-Y
54660	54661	(	0	None
54661	54662	o1	0	None
54662	54663	)	0	None
54663	54664	,	0	None
54664	54665	tau	1	GENE-Y
54665	54666	(	0	None
54666	54667	o2	1	GENE-Y
54667	54668	)	0	None
54668	54669	,	0	None
54669	54670	or	0	None
54670	54671	tau	1	GENE-Y
54671	54672	(	0	None
54672	54673	c1	0	None
54673	54674	)	0	None
54674	54675	,	0	None
54675	54676	whereas	0	None
54676	54677	tau	1	GENE-Y
54677	54678	(	0	None
54678	54679	c2	0	None
54679	54680	)	0	None
54680	54681	and	0	None
54681	54682	tau	1	GENE-Y
54682	54683	(	0	None
54683	54684	c3	0	None
54684	54685	)	0	None
54685	54686	were	0	None
54686	54687	reduced	0	None
54687	54688	from	0	None
54688	54689	9	0	None
54689	54690	.	0	None
54690	54691	0	0	None
54691	54692	and	0	None
54692	54693	92	0	None
54693	54694	.	0	None
54694	54695	6	0	None
54695	54696	ms	0	None
54696	54697	to	0	None
54697	54698	5	0	None
54698	54699	.	0	None
54699	54700	0	0	None
54700	54701	and	0	None
54701	54702	44	0	None
54702	54703	.	0	None
54703	54704	1	0	None
54704	54705	ms	0	None
54705	54706	,	0	None
54706	54707	respectively	0	None
54707	54708	.	0	None

54709	54710	In	0	None
54710	54711	conclusion	0	None
54711	54712	,	0	None
54712	54713	we	0	None
54713	54714	define	0	None
54714	54715	1-EBIO	0	None
54715	54716	,	0	None
54716	54717	CZ	0	None
54717	54718	,	0	None
54718	54719	and	0	None
54719	54720	ZOX	0	None
54720	54721	as	0	None
54721	54722	the	0	None
54722	54723	first	0	None
54723	54724	known	0	None
54724	54725	activators	0	None
54725	54726	of	0	None
54726	54727	hIK1	0	None
54727	54728	and	0	None
54728	54729	rSK2	0	None
54729	54730	.	0	None

54731	54732	Openers	0	None
54732	54733	of	0	None
54733	54734	IK	0	None
54734	54735	and	0	None
54735	54736	SK	0	None
54736	54737	channels	0	None
54737	54738	may	0	None
54738	54739	be	0	None
54739	54740	therapeutically	0	None
54740	54741	beneficial	0	None
54741	54742	in	0	None
54742	54743	cystic	0	None
54743	54744	fibrosis	0	None
54744	54745	and	0	None
54745	54746	vascular	0	None
54746	54747	diseases	0	None
54747	54748	.	0	None
54748	54749	Abstract	0	None
54749	54750	We	0	None
54750	54751	performed	0	None
54751	54752	this	0	None
54752	54753	study	0	None
54753	54754	to	0	None
54754	54755	investigate	0	None
54755	54756	the	0	None
54756	54757	effect	0	None
54757	54758	of	0	None
54758	54759	ketorolac	0	None
54759	54760	(	0	None
54760	54761	a	0	None
54761	54762	non-steroidal	0	None
54762	54763	anti-inflammatory	0	None
54763	54764	drug	0	None
54764	54765	)	0	None
54765	54766	administration	0	None
54766	54767	around	0	None
54767	54768	ovarian	0	None
54768	54769	stimulation	0	None
54769	54770	on	0	None
54770	54771	in	0	None
54771	54772	vivo	0	None
54772	54773	and	0	None
54773	54774	in	0	None
54774	54775	vitro	0	None
54775	54776	fertilization	0	None
54776	54777	process	0	None
54777	54778	.	0	None

54779	54780	Sixty-four	0	None
54780	54781	female	0	None
54781	54782	mice	0	None
54782	54783	(	0	None
54783	54784	ICR	0	None
54784	54785	)	0	None
54785	54786	were	0	None
54786	54787	injected	0	None
54787	54788	with	0	None
54788	54789	ketorolac	0	None
54789	54790	(	0	None
54790	54791	0	0	None
54791	54792	,	0	None
54792	54793	7	0	None
54793	54794	.	0	None
54794	54795	5	0	None
54795	54796	,	0	None
54796	54797	15	0	None
54797	54798	and	0	None
54798	54799	30	0	None
54799	54800	µg	0	None
54800	54801	/	0	None
54801	54802	d	0	None
54802	54803	)	0	None
54803	54804	for	0	None
54804	54805	3	0	None
54805	54806	d	0	None
54806	54807	starting	0	None
54807	54808	from	0	None
54808	54809	the	0	None
54809	54810	day	0	None
54810	54811	of	0	None
54811	54812	eCG	0	None
54812	54813	treatment	0	None
54813	54814	.	0	None

54815	54816	In	0	None
54816	54817	experiment	0	None
54817	54818	1	0	None
54818	54819	,	0	None
54819	54820	41	0	None
54820	54821	mice	0	None
54821	54822	were	0	None
54822	54823	triggered	0	None
54823	54824	by	0	None
54824	54825	hCG	0	None
54825	54826	and	0	None
54826	54827	then	0	None
54827	54828	mated;	0	None
54828	54829	two-cell	0	None
54829	54830	embryos	0	None
54830	54831	were	0	None
54831	54832	obtained	0	None
54832	54833	and	0	None
54833	54834	in	0	None
54834	54835	vitro	0	None
54835	54836	development	0	None
54836	54837	up	0	None
54837	54838	to	0	None
54838	54839	blastocyst	0	None
54839	54840	was	0	None
54840	54841	observed	0	None
54841	54842	.	0	None

54843	54844	In	0	None
54844	54845	experiment	0	None
54845	54846	2	0	None
54846	54847	,	0	None
54847	54848	23	0	None
54848	54849	mice	0	None
54849	54850	were	0	None
54850	54851	triggered	0	None
54851	54852	by	0	None
54852	54853	hCG	0	None
54853	54854	and	0	None
54854	54855	mature	0	None
54855	54856	oocytes	0	None
54856	54857	were	0	None
54857	54858	collected;	0	None
54858	54859	in	0	None
54859	54860	vitro	0	None
54860	54861	fertilization	0	None
54861	54862	rate	0	None
54862	54863	and	0	None
54863	54864	subsequent	0	None
54864	54865	embryo	0	None
54865	54866	development	0	None
54866	54867	up	0	None
54867	54868	to	0	None
54868	54869	blastocyst	0	None
54869	54870	was	0	None
54870	54871	recorded	0	None
54871	54872	.	0	None

54873	54874	In	0	None
54874	54875	experiment	0	None
54875	54876	1	0	None
54876	54877	,	0	None
54877	54878	the	0	None
54878	54879	blastocyst-forming	0	None
54879	54880	rates	0	None
54880	54881	per	0	None
54881	54882	in	0	None
54882	54883	vivo	0	None
54883	54884	fertilized	0	None
54884	54885	two-cell	0	None
54885	54886	embryo	0	None
54886	54887	showed	0	None
54887	54888	an	0	None
54888	54889	inverse	0	None
54889	54890	relationship	0	None
54890	54891	with	0	None
54891	54892	a	0	None
54892	54893	dosage	0	None
54893	54894	of	0	None
54894	54895	ketorolac	0	None
54895	54896	(	0	None
54896	54897	97	0	None
54897	54898	.	0	None
54898	54899	6%	0	None
54899	54900	,	0	None
54900	54901	64	0	None
54901	54902	.	0	None
54902	54903	2%	0	None
54903	54904	,	0	None
54904	54905	35	0	None
54905	54906	.	0	None
54906	54907	4%	0	None
54907	54908	and	0	None
54908	54909	25	0	None
54909	54910	.	0	None
54910	54911	9%	0	None
54911	54912	)	0	None
54912	54913	.	0	None

54914	54915	In	0	None
54915	54916	experiment	0	None
54916	54917	2	0	None
54917	54918	,	0	None
54918	54919	degenerated	0	None
54919	54920	oocytes	0	None
54920	54921	were	0	None
54921	54922	frequently	0	None
54922	54923	observed	0	None
54923	54924	in	0	None
54924	54925	a	0	None
54925	54926	dose-dependent	0	None
54926	54927	manner	0	None
54927	54928	(	0	None
54928	54929	4	0	None
54929	54930	.	0	None
54930	54931	3%	0	None
54931	54932	,	0	None
54932	54933	22	0	None
54933	54934	.	0	None
54934	54935	9%	0	None
54935	54936	,	0	None
54936	54937	22	0	None
54937	54938	.	0	None
54938	54939	4%	0	None
54939	54940	and	0	None
54940	54941	75	0	None
54941	54942	.	0	None
54942	54943	0%	0	None
54943	54944	)	0	None
54944	54945	.	0	None

54946	54947	Lower	0	None
54947	54948	fertilization	0	None
54948	54949	rates	0	None
54949	54950	were	0	None
54950	54951	noted	0	None
54951	54952	in	0	None
54952	54953	all	0	None
54953	54954	the	0	None
54954	54955	three	0	None
54955	54956	ketorolac-treating	0	None
54956	54957	groups;	0	None
54957	54958	blastocyst-forming	0	None
54958	54959	rate	0	None
54959	54960	was	0	None
54960	54961	significantly	0	None
54961	54962	lower	0	None
54962	54963	in	0	None
54963	54964	30-µg-treating	0	None
54964	54965	group	0	None
54965	54966	when	0	None
54966	54967	compared	0	None
54967	54968	with	0	None
54968	54969	the	0	None
54969	54970	control	0	None
54970	54971	group	0	None
54971	54972	.	0	None

54973	54974	Administration	0	None
54974	54975	of	0	None
54975	54976	ketorolac	0	None
54976	54977	around	0	None
54977	54978	ovarian	0	None
54978	54979	stimulation	0	None
54979	54980	significantly	0	None
54980	54981	affects	0	None
54981	54982	the	0	None
54982	54983	development	0	None
54983	54984	of	0	None
54984	54985	in	0	None
54985	54986	vivo	0	None
54986	54987	fertilized	0	None
54987	54988	embryo	0	None
54988	54989	in	0	None
54989	54990	a	0	None
54990	54991	dose-dependent	0	None
54991	54992	manner	0	None
54992	54993	.	0	None

54994	54995	High-dose	0	None
54995	54996	ketorolac	0	None
54996	54997	could	0	None
54997	54998	result	0	None
54998	54999	in	0	None
54999	55000	a	0	None
55000	55001	poor	0	None
55001	55002	oocyte	0	None
55002	55003	quality	0	None
55003	55004	and	0	None
55004	55005	decreased	0	None
55005	55006	embryo	0	None
55006	55007	developmental	0	None
55007	55008	competence	0	None
55008	55009	.	0	None
55009	55010	Functional	0	None
55010	55011	characteristics	0	None
55011	55012	of	0	None
55012	55013	H	0	None
55013	55014	+	0	None
55014	55015	-dependent	0	None
55015	55016	nicotinate	0	None
55016	55017	transport	0	None
55017	55018	in	0	None
55018	55019	primary	0	None
55019	55020	cultures	0	None
55020	55021	of	0	None
55021	55022	astrocytes	0	None
55022	55023	from	0	None
55023	55024	rat	0	None
55024	55025	cerebral	0	None
55025	55026	cortex	0	None
55026	55027	.	0	None
55027	55028	Model	0	None
55028	55029	for	0	None
55029	55030	a	0	None
55030	55031	factor	0	None
55031	55032	IX	0	None
55032	55033	activation	0	None
55033	55034	complex	0	None
55034	55035	on	0	None
55035	55036	blood	0	None
55036	55037	platelets	0	None
55037	55038	:	0	None
55038	55039	dimeric	0	None
55039	55040	conformation	0	None
55040	55041	of	0	None
55041	55042	factor	0	None
55042	55043	XIa	0	None
55043	55044	is	0	None
55044	55045	essential	0	None
55045	55046	.	0	None
55046	55047	Import	0	None
55047	55048	of	0	None
55048	55049	acylcarnitine	0	None
55049	55050	into	0	None
55050	55051	mitochondrial	0	None
55051	55052	matrix	0	None
55052	55053	through	0	None
55053	55054	carnitine	2	CHEMICAL
55054	55055	/	0	None
55055	55056	acylcarnitine-translocase	0	None
55056	55057	(	0	None
55057	55058	CACT	0	None
55058	55059	)	0	None
55059	55060	is	0	None
55060	55061	fundamental	0	None
55061	55062	for	0	None
55062	55063	lipid	0	None
55063	55064	catabolism	0	None
55064	55065	.	0	None

55066	55067	To	0	None
55067	55068	probe	0	None
55068	55069	the	0	None
55069	55070	effect	0	None
55070	55071	of	0	None
55071	55072	CACT	0	None
55072	55073	down-expression	0	None
55073	55074	on	0	None
55074	55075	lipid	0	None
55075	55076	metabolism	0	None
55076	55077	in	0	None
55077	55078	muscle	0	None
55078	55079	,	0	None
55079	55080	human	0	None
55080	55081	myocytes	0	None
55081	55082	were	0	None
55082	55083	stably	0	None
55083	55084	transfected	0	None
55084	55085	with	0	None
55085	55086	CACT-antisense	0	None
55086	55087	construct	0	None
55087	55088	.	0	None

55089	55090	In	0	None
55090	55091	presence	0	None
55091	55092	of	0	None
55092	55093	low	0	None
55093	55094	concentration	0	None
55094	55095	of	0	None
55095	55096	palmitate	0	None
55096	55097	,	0	None
55097	55098	transfected	0	None
55098	55099	cells	0	None
55099	55100	showed	0	None
55100	55101	decreased	0	None
55101	55102	palmitate	0	None
55102	55103	oxidation	0	None
55103	55104	and	0	None
55104	55105	acetyl-carnitine	0	None
55105	55106	content	0	None
55106	55107	,	0	None
55107	55108	increased	0	None
55108	55109	palmitoyl-carnitine	0	None
55109	55110	level	0	None
55110	55111	,	0	None
55111	55112	and	0	None
55112	55113	reduced	0	None
55113	55114	insulin-dependent	0	None
55114	55115	decrease	0	None
55115	55116	of	0	None
55116	55119	fatty acylcarnitine-to-fatty acyl-CoA	2	CHEMICAL
55119	55120	ratio	0	None
55120	55121	.	0	None

55122	55123	The	0	None
55123	55124	augmented	0	None
55124	55125	palmitoyl-carnitine	0	None
55125	55126	synthesis	0	None
55126	55127	,	0	None
55127	55128	also	0	None
55128	55129	in	0	None
55129	55130	the	0	None
55130	55131	presence	0	None
55131	55132	of	0	None
55132	55133	insulin	0	None
55133	55134	,	0	None
55134	55135	could	0	None
55135	55136	be	0	None
55136	55137	related	0	None
55137	55138	to	0	None
55138	55139	an	0	None
55139	55140	altered	0	None
55140	55141	regulation	0	None
55141	55142	of	0	None
55142	55143	carnitine-palmitoyl-transferase	0	None
55143	55144	1	0	None
55144	55145	(	0	None
55145	55147	CPT 1	1	GENE-Y
55147	55148	)	0	None
55148	55149	by	0	None
55149	55150	malonyl-CoA	0	None
55150	55151	,	0	None
55151	55152	whose	0	None
55152	55153	synthesis	0	None
55153	55154	is	0	None
55154	55155	dependent	0	None
55155	55156	by	0	None
55156	55157	the	0	None
55157	55158	availability	0	None
55158	55159	of	0	None
55159	55160	cytosolic	0	None
55160	55161	acetyl-groups	0	None
55161	55162	.	0	None

55163	55164	Indeed	0	None
55164	55165	,	0	None
55165	55166	all	0	None
55166	55167	the	0	None
55167	55168	described	0	None
55168	55169	effects	0	None
55169	55170	were	0	None
55170	55171	completely	0	None
55171	55172	overcome	0	None
55172	55173	by	0	None
55173	55174	CACT	0	None
55174	55175	neo-expression	0	None
55175	55176	by	0	None
55176	55177	recombinant	0	None
55177	55178	adenovirus	0	None
55178	55179	vector	0	None
55179	55180	or	0	None
55180	55181	by	0	None
55181	55182	addition	0	None
55182	55183	of	0	None
55183	55184	acetyl-carnitine	0	None
55184	55185	to	0	None
55185	55186	cultures	0	None
55186	55187	.	0	None

55188	55189	Acetyl-carnitine	0	None
55189	55190	effect	0	None
55190	55191	was	0	None
55191	55192	related	0	None
55192	55193	to	0	None
55193	55194	an	0	None
55194	55195	increase	0	None
55195	55196	of	0	None
55196	55197	malonyl-CoA	0	None
55197	55198	and	0	None
55198	55199	was	0	None
55199	55200	abolished	0	None
55200	55201	by	0	None
55201	55202	down-expression	0	None
55202	55203	,	0	None
55203	55204	via	0	None
55204	55205	antisense	0	None
55205	55206	RNA	0	None
55206	55207	strategy	0	None
55207	55208	,	0	None
55208	55209	of	0	None
55209	55210	acetyl-CoA	0	None
55210	55211	carboxylase-beta	0	None
55211	55212	,	0	None
55212	55213	the	0	None
55213	55214	mitochondrial	0	None
55214	55215	membrane	0	None
55215	55216	enzyme	0	None
55216	55217	involved	0	None
55217	55218	in	0	None
55218	55219	the	0	None
55219	55220	direct	0	None
55220	55222	CPT 1	1	GENE-Y
55222	55223	inhibition	0	None
55223	55224	via	0	None
55224	55225	malonyl-CoA	0	None
55225	55226	synthesis	0	None
55226	55227	.	0	None

55228	55229	Thus	0	None
55229	55230	,	0	None
55230	55231	in	0	None
55231	55232	our	0	None
55232	55233	experimental	0	None
55233	55234	model	0	None
55234	55235	the	0	None
55235	55236	modulation	0	None
55236	55237	of	0	None
55237	55238	CACT	0	None
55238	55239	expression	0	None
55239	55240	has	0	None
55240	55241	consequences	0	None
55241	55242	for	0	None
55242	55244	CPT 1	1	GENE-Y
55244	55245	activity	0	None
55245	55246	,	0	None
55246	55247	while	0	None
55247	55248	the	0	None
55248	55249	biologic	0	None
55249	55250	effects	0	None
55250	55251	of	0	None
55251	55252	acetyl-carnitine	0	None
55252	55253	are	0	None
55253	55254	not	0	None
55254	55255	associated	0	None
55255	55256	with	0	None
55256	55257	a	0	None
55257	55258	generic	0	None
55258	55259	supply	0	None
55259	55260	of	0	None
55260	55261	energy	0	None
55261	55262	compounds	0	None
55262	55263	but	0	None
55263	55264	to	0	None
55264	55265	the	0	None
55265	55266	anaplerotic	0	None
55266	55267	property	0	None
55267	55268	of	0	None
55268	55269	the	0	None
55269	55270	molecule	0	None
55270	55271	.	0	None
55271	55272	Three-finger	0	None
55272	55273	toxins	0	None
55273	55274	,	0	None
55274	55275	a	0	None
55275	55276	deadly	0	None
55276	55277	weapon	0	None
55277	55278	of	0	None
55278	55279	elapid	0	None
55279	55280	venom--milestones	0	None
55280	55281	of	0	None
55281	55282	discovery	0	None
55282	55283	.	0	None
55283	55284	The	0	None
55284	55285	molecular	0	None
55285	55286	bases	0	None
55286	55287	for	0	None
55287	55289	phosphodiesterase 5	3	GENE-N
55289	55290	(	0	None
55290	55291	PDE5	0	None
55291	55292	)	0	None
55292	55293	catalytic-site	0	None
55293	55294	affinity	0	None
55294	55295	for	0	None
55295	55298	cyclic guanosine monophosphate	2	CHEMICAL
55298	55299	(	0	None
55299	55300	cGMP	2	CHEMICAL
55300	55301	)	0	None
55301	55302	and	0	None
55302	55303	potency	0	None
55303	55304	of	0	None
55304	55305	inhibitors	0	None
55305	55306	are	0	None
55306	55307	poorly	0	None
55307	55308	understood	0	None
55308	55309	.	0	None

55310	55311	Cocrystal	0	None
55311	55312	structures	0	None
55312	55313	of	0	None
55313	55314	PDE5	0	None
55314	55315	catalytic	0	None
55315	55316	(	0	None
55316	55317	C	0	None
55317	55318	)	0	None
55318	55319	domain	0	None
55319	55320	with	0	None
55320	55321	inhibitors	0	None
55321	55322	reveal	0	None
55322	55323	a	0	None
55323	55324	hydrogen	2	CHEMICAL
55324	55325	bond	0	None
55325	55326	and	0	None
55326	55327	hydrophobic	0	None
55327	55328	interactions	0	None
55328	55329	with	0	None
55329	55330	Tyr-612	0	None
55330	55331	,	0	None
55331	55332	hydrogen	2	CHEMICAL
55332	55333	bonds	0	None
55333	55334	with	0	None
55334	55335	Gln-817	0	None
55335	55336	,	0	None
55336	55337	a	0	None
55337	55338	hydrophobic	0	None
55338	55339	clamp	0	None
55339	55340	formed	0	None
55340	55341	by	0	None
55341	55342	Phe-820	0	None
55342	55343	and	0	None
55343	55344	Val-782	0	None
55344	55345	,	0	None
55345	55346	and	0	None
55346	55347	contacts	0	None
55347	55348	with	0	None
55348	55349	His-613	0	None
55349	55350	,	0	None
55350	55351	Leu-765	0	None
55351	55352	,	0	None
55352	55353	and	0	None
55353	55354	Phe-786	0	None
55354	55355	[	0	None
55355	55356	Sung	0	None
55356	55357	et	0	None
55357	55358	al	0	None
55358	55359	.	0	None

55360	55361	(	0	None
55361	55362	2003	0	None
55362	55363	)	0	None
55363	55364	Nature	0	None
55364	55365	425	0	None
55365	55366	,	0	None
55366	55367	98-102;	0	None
55367	55368	Huai	0	None
55368	55369	et	0	None
55369	55370	al	0	None
55370	55371	.	0	None

55372	55373	(	0	None
55373	55374	2004	0	None
55374	55375	)	0	None
55375	55376	J	0	None
55376	55377	.	0	None

55378	55379	Biol	0	None
55379	55380	.	0	None

55381	55382	Chem	0	None
55382	55383	.	0	None

55384	55385	279	0	None
55385	55386	,	0	None
55386	55387	13095-13101	0	None
55387	55388	]	0	None
55388	55389	.	0	None

55390	55391	Present	0	None
55391	55392	results	0	None
55392	55393	of	0	None
55393	55394	point	0	None
55394	55395	mutations	0	None
55395	55396	of	0	None
55396	55397	full-length	0	None
55397	55398	PDE5	0	None
55398	55399	showed	0	None
55399	55400	that	0	None
55400	55401	maximum	0	None
55401	55402	catalysis	0	None
55402	55403	was	0	None
55403	55404	decreased	0	None
55404	55405	2650-fold	0	None
55405	55406	in	0	None
55406	55407	H613A	0	None
55407	55408	and	0	None
55408	55409	55-fold	0	None
55409	55410	in	0	None
55410	55411	F820A	0	None
55411	55412	.	0	None

55413	55414	Catalytic-site	0	None
55414	55415	affinities	0	None
55415	55416	for	0	None
55416	55417	cGMP	2	CHEMICAL
55417	55418	,	0	None
55418	55419	vardenafil	0	None
55419	55420	,	0	None
55420	55421	sildenafil	0	None
55421	55422	,	0	None
55422	55423	tadalafil	0	None
55423	55424	,	0	None
55424	55425	or	0	None
55425	55426	3-isobutyl-1-methylxanthine	0	None
55426	55427	(	0	None
55427	55428	IBMX	0	None
55428	55429	)	0	None
55429	55430	were	0	None
55430	55431	respectively	0	None
55431	55432	weakened	0	None
55432	55433	14-	0	None
55433	55434	,	0	None
55434	55435	123-	0	None
55435	55436	,	0	None
55436	55437	30-	0	None
55437	55438	,	0	None
55438	55439	51-	0	None
55439	55440	,	0	None
55440	55441	and	0	None
55441	55442	43-fold	0	None
55442	55443	for	0	None
55443	55444	Y612A;	0	None
55444	55445	63-	0	None
55445	55446	,	0	None
55446	55447	511-	0	None
55447	55448	,	0	None
55448	55449	43-	0	None
55449	55450	,	0	None
55450	55451	95-	0	None
55451	55452	and	0	None
55452	55453	61-fold	0	None
55453	55454	for	0	None
55454	55455	Q817A;	0	None
55455	55456	and	0	None
55456	55457	59-	0	None
55457	55458	,	0	None
55458	55459	448-	0	None
55459	55460	,	0	None
55460	55461	71-	0	None
55461	55462	,	0	None
55462	55463	137-	0	None
55463	55464	,	0	None
55464	55465	and	0	None
55465	55466	93-fold	0	None
55466	55467	for	0	None
55467	55468	F820A	0	None
55468	55469	.	0	None

55470	55471	The	0	None
55471	55472	data	0	None
55472	55473	indicate	0	None
55473	55474	that	0	None
55474	55475	these	0	None
55475	55476	three	0	None
55476	55478	amino acids	2	CHEMICAL
55478	55479	are	0	None
55479	55480	major	0	None
55480	55481	determinants	0	None
55481	55482	of	0	None
55482	55483	affinity	0	None
55483	55484	for	0	None
55484	55485	cGMP	2	CHEMICAL
55485	55486	and	0	None
55486	55487	potency	0	None
55487	55488	of	0	None
55488	55489	selective	0	None
55489	55490	and	0	None
55490	55491	nonselective	0	None
55491	55492	inhibitors	0	None
55492	55493	,	0	None
55493	55494	and	0	None
55494	55495	that	0	None
55495	55496	higher	0	None
55496	55497	vardenafil	0	None
55497	55498	potency	0	None
55498	55499	over	0	None
55499	55500	sildenafil	0	None
55500	55501	and	0	None
55501	55502	tadalafil	0	None
55502	55503	results	0	None
55503	55504	from	0	None
55504	55505	stronger	0	None
55505	55506	contacts	0	None
55506	55507	with	0	None
55507	55508	Tyr-612	0	None
55508	55509	,	0	None
55509	55510	Gln-817	0	None
55510	55511	,	0	None
55511	55512	and	0	None
55512	55513	Phe-820	0	None
55513	55514	.	0	None

55515	55516	Affinity	0	None
55516	55517	of	0	None
55517	55518	V782A	0	None
55518	55519	for	0	None
55519	55520	cGMP	2	CHEMICAL
55520	55521	,	0	None
55521	55522	vardenafil	0	None
55522	55523	,	0	None
55523	55524	sildenafil	0	None
55524	55525	,	0	None
55525	55526	tadalafil	0	None
55526	55527	,	0	None
55527	55528	or	0	None
55528	55529	IBMX	0	None
55529	55530	was	0	None
55530	55531	reduced	0	None
55531	55532	5	0	None
55532	55533	.	0	None
55533	55534	5-	0	None
55534	55535	,	0	None
55535	55536	23-	0	None
55536	55537	,	0	None
55537	55538	10-	0	None
55538	55539	,	0	None
55539	55540	3-	0	None
55540	55541	,	0	None
55541	55542	and	0	None
55542	55543	12-fold	0	None
55543	55544	,	0	None
55544	55545	respectively	0	None
55545	55546	.	0	None

55547	55548	Change	0	None
55548	55549	in	0	None
55549	55550	affinity	0	None
55550	55551	for	0	None
55551	55552	cGMP	2	CHEMICAL
55552	55553	,	0	None
55553	55554	vardenafil	0	None
55554	55555	,	0	None
55555	55556	sildenafil	0	None
55556	55557	,	0	None
55557	55558	or	0	None
55558	55559	IBMX	0	None
55559	55560	in	0	None
55560	55561	Y612F	0	None
55561	55562	,	0	None
55562	55563	H613A	0	None
55563	55564	,	0	None
55564	55565	L765A	0	None
55565	55566	,	0	None
55566	55567	or	0	None
55567	55568	F786A	0	None
55568	55569	was	0	None
55569	55570	less	0	None
55570	55571	,	0	None
55571	55572	but	0	None
55572	55573	affinity	0	None
55573	55574	of	0	None
55574	55575	H613A	0	None
55575	55576	or	0	None
55576	55577	F786A	0	None
55577	55578	for	0	None
55578	55579	tadalafil	0	None
55579	55580	was	0	None
55580	55581	weakened	0	None
55581	55582	37-	0	None
55582	55583	and	0	None
55583	55584	17-fold	0	None
55584	55585	,	0	None
55585	55586	respectively	0	None
55586	55587	.	0	None

55588	55589	The	0	None
55589	55590	results	0	None
55590	55591	quantify	0	None
55591	55592	the	0	None
55592	55593	role	0	None
55593	55594	of	0	None
55594	55595	PDE5	0	None
55595	55596	catalytic-site	0	None
55596	55597	residues	0	None
55597	55598	for	0	None
55598	55599	cGMP	2	CHEMICAL
55599	55600	and	0	None
55600	55601	inhibitors	0	None
55601	55602	,	0	None
55602	55603	indicate	0	None
55603	55604	that	0	None
55604	55605	Tyr-612	0	None
55605	55606	,	0	None
55606	55607	Gln-817	0	None
55607	55608	,	0	None
55608	55609	and	0	None
55609	55610	Phe-820	0	None
55610	55611	are	0	None
55611	55612	the	0	None
55612	55613	most	0	None
55613	55614	important	0	None
55614	55615	cGMP	2	CHEMICAL
55615	55616	or	0	None
55616	55617	inhibitor	0	None
55617	55618	contacts	0	None
55618	55619	studied	0	None
55619	55620	,	0	None
55620	55621	and	0	None
55621	55622	identify	0	None
55622	55623	residues	0	None
55623	55624	that	0	None
55624	55625	contribute	0	None
55625	55626	to	0	None
55626	55627	selectivity	0	None
55627	55628	among	0	None
55628	55629	different	0	None
55629	55630	classes	0	None
55630	55631	of	0	None
55631	55632	inhibitors	0	None
55632	55633	.	0	None
55633	55634	Folate	0	None
55634	55635	Conjugation	0	None
55635	55636	to	0	None
55636	55637	Polymeric	0	None
55637	55638	Micelles	0	None
55638	55639	via	0	None
55639	55640	Boronic	0	None
55640	55641	Acid	0	None
55641	55642	Ester	0	None
55642	55643	to	0	None
55643	55644	Deliver	0	None
55644	55645	Platinum	0	None
55645	55646	Drugs	0	None
55646	55647	to	0	None
55647	55648	Ovarian	0	None
55648	55649	Cancer	0	None
55649	55650	Cell	0	None
55650	55651	Lines	0	None
55651	55652	.	0	None
55652	55653	Phosphodiesterase	0	None
55653	55654	type	0	None
55654	55655	5	0	None
55655	55656	as	0	None
55656	55657	a	0	None
55657	55658	pharmacologic	0	None
55658	55659	target	0	None
55659	55660	in	0	None
55660	55661	erectile	0	None
55661	55662	dysfunction	0	None
55662	55663	.	0	None
55663	55664	Extracts	0	None
55664	55665	of	0	None
55665	55666	Scutellaria	0	None
55666	55667	baicalensis	0	None
55667	55668	reduced	0	None
55668	55669	body	0	None
55669	55670	weight	0	None
55670	55671	and	0	None
55671	55672	blood	0	None
55672	55673	triglyceride	0	None
55673	55674	in	0	None
55674	55675	db	0	None
55675	55676	/	0	None
55676	55677	db	0	None
55677	55678	Mice	0	None
55678	55679	.	0	None
55679	55680	A	0	None
55680	55681	series	0	None
55681	55682	of	0	None
55682	55683	imidazopyridazines	0	None
55683	55684	which	0	None
55684	55685	are	0	None
55685	55686	potent	0	None
55686	55687	inhibitors	0	None
55687	55688	of	0	None
55688	55689	Plasmodium	0	None
55689	55690	falciparum	0	None
55690	55691	calcium-dependent	0	None
55691	55694	protein kinase 1	3	GENE-N
55694	55695	(	0	None
55695	55696	PfCDPK1	0	None
55696	55697	)	0	None
55697	55698	was	0	None
55698	55699	identified	0	None
55699	55700	from	0	None
55700	55701	a	0	None
55701	55702	high-throughput	0	None
55702	55703	screen	0	None
55703	55704	against	0	None
55704	55705	the	0	None
55705	55706	isolated	0	None
55706	55707	enzyme	0	None
55707	55708	.	0	None

55709	55710	Subsequent	0	None
55710	55711	exploration	0	None
55711	55712	of	0	None
55712	55713	the	0	None
55713	55714	SAR	0	None
55714	55715	and	0	None
55715	55716	optimisation	0	None
55716	55717	has	0	None
55717	55718	yielded	0	None
55718	55719	leading	0	None
55719	55720	members	0	None
55720	55721	which	0	None
55721	55722	show	0	None
55722	55723	promising	0	None
55723	55724	in	0	None
55724	55725	vitro	0	None
55725	55726	anti-parasite	0	None
55726	55727	activity	0	None
55727	55728	along	0	None
55728	55729	with	0	None
55729	55730	good	0	None
55730	55731	in	0	None
55731	55732	vitro	0	None
55732	55733	ADME	0	None
55733	55734	and	0	None
55734	55735	selectivity	0	None
55735	55736	against	0	None
55736	55737	human	0	None
55737	55738	kinases	0	None
55738	55739	.	0	None

55740	55741	Initial	0	None
55741	55742	in	0	None
55742	55743	vivo	0	None
55743	55744	testing	0	None
55744	55745	has	0	None
55745	55746	revealed	0	None
55746	55747	good	0	None
55747	55748	oral	0	None
55748	55749	bioavailability	0	None
55749	55750	in	0	None
55750	55751	a	0	None
55751	55752	mouse	0	None
55752	55753	PK	0	None
55753	55754	study	0	None
55754	55755	and	0	None
55755	55756	modest	0	None
55756	55757	in	0	None
55757	55758	vivo	0	None
55758	55759	efficacy	0	None
55759	55760	in	0	None
55760	55761	a	0	None
55761	55762	Plasmodium	0	None
55762	55763	berghei	0	None
55763	55764	mouse	0	None
55764	55765	model	0	None
55765	55766	of	0	None
55766	55767	malaria	0	None
55767	55768	.	0	None
55768	55769	A	0	None
55769	55770	series	0	None
55770	55771	of	0	None
55771	55772	substituted	0	None
55772	55773	ortho-carboranylphenoxyacetanilides	0	None
55773	55774	were	0	None
55774	55775	synthesized	0	None
55775	55776	and	0	None
55776	55777	evaluated	0	None
55777	55778	for	0	None
55778	55779	their	0	None
55779	55780	ability	0	None
55780	55781	to	0	None
55781	55782	inhibit	0	None
55782	55783	hypoxia-induced	0	None
55783	55784	HIF-1	3	GENE-N
55784	55785	transcriptional	0	None
55785	55786	activity	0	None
55786	55787	using	0	None
55787	55788	a	0	None
55788	55789	cell-based	0	None
55789	55790	reporter	0	None
55790	55791	assay	0	None
55791	55792	in	0	None
55792	55793	HeLa	0	None
55793	55794	cells	0	None
55794	55795	expressing	0	None
55795	55796	the	0	None
55796	55797	HRE-dependent	0	None
55797	55798	firefly	0	None
55798	55799	luciferase	0	None
55799	55800	reporter	0	None
55800	55801	construct	0	None
55801	55802	(	0	None
55802	55803	HRE-Luc	0	None
55803	55804	)	0	None
55804	55805	and	0	None
55805	55806	constitutively	0	None
55806	55807	expressing	0	None
55807	55808	CMV-driven	0	None
55808	55809	Renilla	0	None
55809	55810	luciferase	0	None
55810	55811	reporter	0	None
55811	55812	,	0	None
55812	55813	and	0	None
55813	55814	their	0	None
55814	55815	ability	0	None
55815	55816	to	0	None
55816	55817	inhibit	0	None
55817	55818	cell	0	None
55818	55819	growth	0	None
55819	55820	(	0	None
55820	55821	GI	0	None
55821	55822	(	0	None
55822	55823	50	0	None
55823	55824	)	0	None
55824	55825	)	0	None
55825	55826	using	0	None
55826	55827	the	0	None
55827	55828	MTT	0	None
55828	55829	assay	0	None
55829	55830	.	0	None

55831	55832	Among	0	None
55832	55833	the	0	None
55833	55834	compounds	0	None
55834	55835	synthesized	0	None
55835	55836	,	0	None
55836	55837	1g	0	None
55837	55838	and	0	None
55838	55839	1l	0	None
55839	55840	showed	0	None
55840	55841	significant	0	None
55841	55842	inhibition	0	None
55842	55843	of	0	None
55843	55844	hypoxia-induced	0	None
55844	55845	HIF-1	3	GENE-N
55845	55846	transcriptional	0	None
55846	55847	activity	0	None
55847	55848	(	0	None
55848	55849	IC	0	None
55849	55850	(	0	None
55850	55851	50	0	None
55851	55852	)	0	None
55852	55853	:	0	None
55853	55854	1	0	None
55854	55855	.	0	None
55855	55856	9	0	None
55856	55857	±	0	None
55857	55858	0	0	None
55858	55859	.	0	None
55859	55860	4	0	None
55860	55861	and	0	None
55861	55862	1	0	None
55862	55863	.	0	None
55863	55864	4	0	None
55864	55865	±	0	None
55865	55866	0	0	None
55866	55867	.	0	None
55867	55868	2	0	None
55868	55869	μM	0	None
55869	55870	,	0	None
55870	55871	respectively	0	None
55871	55872	)	0	None
55872	55873	.	0	None

55874	55875	Both	0	None
55875	55876	compounds	0	None
55876	55877	suppressed	0	None
55877	55878	HIF-1α	0	None
55878	55879	accumulation	0	None
55879	55880	in	0	None
55880	55881	a	0	None
55881	55882	concentration-dependent	0	None
55882	55883	manner	0	None
55883	55884	.	0	None

55885	55886	The	0	None
55886	55887	porcine	0	None
55887	55888	heart	0	None
55888	55889	malate	0	None
55889	55890	dehydrogenase	0	None
55890	55891	(	0	None
55891	55892	MDH	3	GENE-N
55892	55893	)	0	None
55893	55894	refolding	0	None
55894	55895	assay	0	None
55895	55896	revealed	0	None
55896	55897	that	0	None
55897	55898	compound	0	None
55898	55899	1l	0	None
55899	55900	inhibited	0	None
55900	55901	human	0	None
55901	55902	Hsp60	0	None
55902	55903	chaperone	0	None
55903	55904	activity	0	None
55904	55905	(	0	None
55905	55906	IC	0	None
55906	55907	(	0	None
55907	55908	50	0	None
55908	55909	)	0	None
55909	55910	:	0	None
55910	55911	6	0	None
55911	55912	.	0	None
55912	55913	80	0	None
55913	55914	±	0	None
55914	55915	0	0	None
55915	55916	.	0	None
55916	55917	25	0	None
55917	55918	μM	0	None
55918	55919	)	0	None
55919	55920	and	0	None
55920	55921	this	0	None
55921	55922	inhibition	0	None
55922	55923	activity	0	None
55923	55924	was	0	None
55924	55925	higher	0	None
55925	55926	than	0	None
55926	55927	that	0	None
55927	55928	of	0	None
55928	55929	ETB	0	None
55929	55930	(	0	None
55930	55931	IC	0	None
55931	55932	(	0	None
55932	55933	50	0	None
55933	55934	)	0	None
55934	55935	:	0	None
55935	55936	10	0	None
55936	55937	.	0	None
55937	55938	9	0	None
55938	55939	±	0	None
55939	55940	0	0	None
55940	55941	.	0	None
55941	55942	63	0	None
55942	55943	μM	0	None
55943	55944	)	0	None
55944	55945	.	0	None
55945	55946	Desipramine	0	None
55946	55947	administration	0	None
55947	55948	in	0	None
55948	55949	the	0	None
55949	55950	olfactory	0	None
55950	55951	bulbectomized	0	None
55951	55952	rat	0	None
55952	55953	:	0	None
55953	55954	changes	0	None
55954	55955	in	0	None
55955	55956	brain	0	None
55956	55957	beta-adrenoceptor	3	GENE-N
55957	55958	and	0	None
55958	55959	5-HT2A	0	None
55959	55960	binding	0	None
55960	55961	sites	0	None
55961	55962	and	0	None
55962	55963	their	0	None
55963	55964	relationship	0	None
55964	55965	to	0	None
55965	55966	behaviour	0	None
55966	55967	.	0	None
55967	55968	Inhibition	0	None
55968	55969	of	0	None
55969	55970	vascular	0	None
55970	55971	endothelial	0	None
55971	55972	growth	0	None
55972	55973	factor-A	0	None
55973	55974	(	0	None
55974	55975	VEGF	0	None
55975	55976	)	0	None
55976	55977	signaling	0	None
55977	55978	is	0	None
55978	55979	a	0	None
55979	55980	promising	0	None
55980	55981	therapeutic	0	None
55981	55982	approach	0	None
55982	55983	that	0	None
55983	55984	aims	0	None
55984	55985	to	0	None
55985	55986	stabilize	0	None
55986	55987	the	0	None
55987	55988	progression	0	None
55988	55989	of	0	None
55989	55990	solid	0	None
55990	55991	malignancies	0	None
55991	55992	by	0	None
55992	55993	abrogating	0	None
55993	55994	tumor-induced	0	None
55994	55995	angiogenesis	0	None
55995	55996	.	0	None

55997	55998	This	0	None
55998	55999	may	0	None
55999	56000	be	0	None
56000	56001	accomplished	0	None
56001	56002	by	0	None
56002	56003	inhibiting	0	None
56003	56004	the	0	None
56004	56005	kinase	0	None
56005	56006	activity	0	None
56006	56007	of	0	None
56007	56008	VEGF	0	None
56008	56009	receptor-2	0	None
56009	56010	(	0	None
56010	56011	KDR	0	None
56011	56012	)	0	None
56012	56013	,	0	None
56013	56014	which	0	None
56014	56015	has	0	None
56015	56016	a	0	None
56016	56017	key	0	None
56017	56018	role	0	None
56018	56019	in	0	None
56019	56020	mediating	0	None
56020	56021	VEGF-induced	0	None
56021	56022	responses	0	None
56022	56023	.	0	None

56024	56025	The	0	None
56025	56026	novel	0	None
56026	56027	indole-ether	0	None
56027	56028	quinazoline	0	None
56028	56029	AZD2171	2	CHEMICAL
56029	56030	is	0	None
56030	56031	a	0	None
56031	56032	highly	0	None
56032	56033	potent	0	None
56033	56034	(	0	None
56034	56035	IC50	0	None
56035	56036	<	0	None
56036	56037	1	0	None
56037	56038	nmol	0	None
56038	56039	/	0	None
56039	56040	L	0	None
56040	56041	)	0	None
56041	56042	ATP-competitive	0	None
56042	56043	inhibitor	0	None
56043	56044	of	0	None
56044	56045	recombinant	0	None
56045	56046	KDR	0	None
56046	56047	tyrosine	2	CHEMICAL
56047	56048	kinase	0	None
56048	56049	in	0	None
56049	56050	vitro	0	None
56050	56051	.	0	None

56052	56053	Concordant	0	None
56053	56054	with	0	None
56054	56055	this	0	None
56055	56056	activity	0	None
56056	56057	,	0	None
56057	56058	in	0	None
56058	56059	human	0	None
56059	56060	umbilical	0	None
56060	56061	vein	0	None
56061	56062	endothelial	0	None
56062	56063	cells	0	None
56063	56064	,	0	None
56064	56065	AZD2171	2	CHEMICAL
56065	56066	inhibited	0	None
56066	56067	VEGF-stimulated	0	None
56067	56068	proliferation	0	None
56068	56069	and	0	None
56069	56070	KDR	0	None
56070	56071	phosphorylation	0	None
56071	56072	with	0	None
56072	56073	IC50	0	None
56073	56074	values	0	None
56074	56075	of	0	None
56075	56076	0	0	None
56076	56077	.	0	None
56077	56078	4	0	None
56078	56079	and	0	None
56079	56080	0	0	None
56080	56081	.	0	None
56081	56082	5	0	None
56082	56083	nmol	0	None
56083	56084	/	0	None
56084	56085	L	0	None
56085	56086	,	0	None
56086	56087	respectively	0	None
56087	56088	.	0	None

56089	56090	In	0	None
56090	56091	a	0	None
56091	56092	fibroblast	0	None
56092	56093	/	0	None
56093	56094	endothelial	0	None
56094	56095	cell	0	None
56095	56096	coculture	0	None
56096	56097	model	0	None
56097	56098	of	0	None
56098	56099	vessel	0	None
56099	56100	sprouting	0	None
56100	56101	,	0	None
56101	56102	AZD2171	2	CHEMICAL
56102	56103	also	0	None
56103	56104	reduced	0	None
56104	56105	vessel	0	None
56105	56106	area	0	None
56106	56107	,	0	None
56107	56108	length	0	None
56108	56109	,	0	None
56109	56110	and	0	None
56110	56111	branching	0	None
56111	56112	at	0	None
56112	56113	subnanomolar	0	None
56113	56114	concentrations	0	None
56114	56115	.	0	None

56116	56117	Once-daily	0	None
56117	56118	oral	0	None
56118	56119	administration	0	None
56119	56120	of	0	None
56120	56121	AZD2171	2	CHEMICAL
56121	56122	ablated	0	None
56122	56123	experimental	0	None
56123	56124	(	0	None
56124	56125	VEGF-induced	0	None
56125	56126	)	0	None
56126	56127	angiogenesis	0	None
56127	56128	in	0	None
56128	56129	vivo	0	None
56129	56130	and	0	None
56130	56131	inhibited	0	None
56131	56132	endochondral	0	None
56132	56133	ossification	0	None
56133	56134	in	0	None
56134	56135	bone	0	None
56135	56136	or	0	None
56136	56137	corpora	0	None
56137	56138	luteal	0	None
56138	56139	development	0	None
56139	56140	in	0	None
56140	56141	ovary;	0	None
56141	56142	physiologic	0	None
56142	56143	processes	0	None
56143	56144	that	0	None
56144	56145	are	0	None
56145	56146	highly	0	None
56146	56147	dependent	0	None
56147	56148	upon	0	None
56148	56149	neovascularization	0	None
56149	56150	.	0	None

56151	56152	The	0	None
56152	56153	growth	0	None
56153	56154	of	0	None
56154	56155	established	0	None
56155	56156	human	0	None
56156	56157	tumor	0	None
56157	56158	xenografts	0	None
56158	56159	(	0	None
56159	56160	colon	0	None
56160	56161	,	0	None
56161	56162	lung	0	None
56162	56163	,	0	None
56163	56164	prostate	0	None
56164	56165	,	0	None
56165	56166	breast	0	None
56166	56167	,	0	None
56167	56168	and	0	None
56168	56169	ovary	0	None
56169	56170	)	0	None
56170	56171	in	0	None
56171	56172	athymic	0	None
56172	56173	mice	0	None
56173	56174	was	0	None
56174	56175	inhibited	0	None
56175	56176	dose-dependently	0	None
56176	56177	by	0	None
56177	56178	AZD2171	2	CHEMICAL
56178	56179	,	0	None
56179	56180	with	0	None
56180	56181	chronic	0	None
56181	56182	administration	0	None
56182	56183	of	0	None
56183	56184	1	0	None
56184	56185	.	0	None
56185	56186	5	0	None
56186	56187	mg	2	CHEMICAL
56187	56188	per	0	None
56188	56189	kg	0	None
56189	56190	per	0	None
56190	56191	day	0	None
56191	56192	producing	0	None
56192	56193	statistically	0	None
56193	56194	significant	0	None
56194	56195	inhibition	0	None
56195	56196	in	0	None
56196	56197	all	0	None
56197	56198	models	0	None
56198	56199	.	0	None

56200	56201	A	0	None
56201	56202	histologic	0	None
56202	56203	analysis	0	None
56203	56204	of	0	None
56204	56205	Calu-6	0	None
56205	56206	lung	0	None
56206	56207	tumors	0	None
56207	56208	treated	0	None
56208	56209	with	0	None
56209	56210	AZD2171	2	CHEMICAL
56210	56211	revealed	0	None
56211	56212	a	0	None
56212	56213	reduction	0	None
56213	56214	in	0	None
56214	56215	microvessel	0	None
56215	56216	density	0	None
56216	56217	within	0	None
56217	56218	52	0	None
56218	56219	hours	0	None
56219	56220	that	0	None
56220	56221	became	0	None
56221	56222	progressively	0	None
56222	56223	greater	0	None
56223	56224	with	0	None
56224	56225	the	0	None
56225	56226	duration	0	None
56226	56227	of	0	None
56227	56228	treatment	0	None
56228	56229	.	0	None

56230	56231	These	0	None
56231	56232	changes	0	None
56232	56233	are	0	None
56233	56234	indicative	0	None
56234	56235	of	0	None
56235	56236	vascular	0	None
56236	56237	regression	0	None
56237	56238	within	0	None
56238	56239	tumors	0	None
56239	56240	.	0	None

56241	56242	Collectively	0	None
56242	56243	,	0	None
56243	56244	the	0	None
56244	56245	data	0	None
56245	56246	obtained	0	None
56246	56247	with	0	None
56247	56248	AZD2171	2	CHEMICAL
56248	56249	are	0	None
56249	56250	consistent	0	None
56250	56251	with	0	None
56251	56252	potent	0	None
56252	56253	inhibition	0	None
56253	56254	of	0	None
56254	56255	VEGF	0	None
56255	56256	signaling	0	None
56256	56257	,	0	None
56257	56258	angiogenesis	0	None
56258	56259	,	0	None
56259	56260	neovascular	0	None
56260	56261	survival	0	None
56261	56262	,	0	None
56262	56263	and	0	None
56263	56264	tumor	0	None
56264	56265	growth	0	None
56265	56266	.	0	None

56267	56268	AZD2171	2	CHEMICAL
56268	56269	is	0	None
56269	56270	being	0	None
56270	56271	developed	0	None
56271	56272	clinically	0	None
56272	56273	as	0	None
56273	56274	a	0	None
56274	56275	once-daily	0	None
56275	56276	oral	0	None
56276	56277	therapy	0	None
56277	56278	for	0	None
56278	56279	the	0	None
56279	56280	treatment	0	None
56280	56281	of	0	None
56281	56282	cancer	0	None
56282	56283	.	0	None
56283	56284	The	0	None
56284	56285	role	0	None
56285	56286	of	0	None
56286	56287	platelet	0	None
56287	56288	/	0	None
56288	56289	lymphocyte	0	None
56289	56291	serotonin transporter	1	GENE-Y
56291	56292	in	0	None
56292	56293	depression	0	None
56293	56294	and	0	None
56294	56295	beyond	0	None
56295	56296	.	0	None
56296	56297	Murine	0	None
56297	56298	prostaglandin	0	None
56298	56299	endoperoxide	0	None
56299	56300	(	0	None
56300	56301	PGH	0	None
56301	56302	)	0	None
56302	56303	synthase-1	0	None
56303	56304	and	0	None
56304	56305	PGH	0	None
56305	56306	synthase-2	0	None
56306	56307	expressed	0	None
56307	56308	in	0	None
56308	56309	cos-1	0	None
56309	56310	cells	0	None
56310	56311	were	0	None
56311	56312	found	0	None
56312	56313	to	0	None
56313	56314	be	0	None
56314	56315	differentially	0	None
56315	56316	sensitive	0	None
56316	56317	to	0	None
56317	56318	inhibition	0	None
56318	56319	by	0	None
56319	56320	common	0	None
56320	56321	nonsteroidal	0	None
56321	56322	anti-inflammatory	0	None
56322	56323	drugs	0	None
56323	56324	(	0	None
56324	56325	NSAIDs	0	None
56325	56326	)	0	None
56326	56327	.	0	None

56328	56329	Aspirin	2	CHEMICAL
56329	56330	completely	0	None
56330	56331	inhibited	0	None
56331	56332	bis-oxygenation	0	None
56332	56333	of	0	None
56333	56334	arachidonate	0	None
56334	56335	by	0	None
56335	56336	PGH	0	None
56336	56337	synthase-1;	0	None
56337	56338	in	0	None
56338	56339	contrast	0	None
56339	56340	,	0	None
56340	56341	aspirin-treated	0	None
56341	56342	PGH	0	None
56342	56343	synthase-2	0	None
56343	56344	metabolized	0	None
56344	56345	arachidonate	0	None
56345	56346	primarily	0	None
56346	56347	to	0	None
56347	56348	15-hydroxyeicosatetraenoic	0	None
56348	56349	acid	0	None
56349	56350	(	0	None
56350	56351	15-HETE	0	None
56351	56352	)	0	None
56352	56353	instead	0	None
56353	56354	of	0	None
56354	56355	PGH2	0	None
56355	56356	.	0	None

56357	56358	ID50	0	None
56358	56359	values	0	None
56359	56360	were	0	None
56360	56361	determined	0	None
56361	56362	for	0	None
56362	56363	a	0	None
56363	56364	panel	0	None
56364	56365	of	0	None
56365	56366	common	0	None
56366	56367	NSAIDs	0	None
56367	56368	by	0	None
56368	56369	measuring	0	None
56369	56370	instantaneous	0	None
56370	56371	inhibition	0	None
56371	56372	of	0	None
56372	56373	cyclooxygenase	3	GENE-N
56373	56374	activity	0	None
56374	56375	using	0	None
56375	56376	an	0	None
56376	56377	oxygen	0	None
56377	56378	electrode	0	None
56378	56379	.	0	None

56380	56381	Among	0	None
56381	56382	common	0	None
56382	56383	NSAIDs	0	None
56383	56384	tested	0	None
56384	56385	,	0	None
56385	56386	indomethacin	0	None
56386	56387	,	0	None
56387	56388	sulindac	0	None
56388	56389	sulfide	2	CHEMICAL
56389	56390	,	0	None
56390	56391	and	0	None
56391	56392	piroxicam	2	CHEMICAL
56392	56393	preferentially	0	None
56393	56394	inhibited	0	None
56394	56395	PGH	0	None
56395	56396	synthase-1;	0	None
56396	56397	ibuprofen	2	CHEMICAL
56397	56398	,	0	None
56398	56399	flurbiprofen	0	None
56399	56400	,	0	None
56400	56401	and	0	None
56401	56402	meclofenamate	2	CHEMICAL
56402	56403	inhibited	0	None
56403	56404	both	0	None
56404	56405	enzymes	0	None
56405	56406	with	0	None
56406	56407	comparable	0	None
56407	56408	potencies;	0	None
56408	56409	and	0	None
56409	56410	6-methoxy-2-naphthylacetic	0	None
56410	56411	acid	0	None
56411	56412	preferentially	0	None
56412	56413	inhibited	0	None
56413	56414	PGH	0	None
56414	56415	synthase-2	0	None
56415	56416	.	0	None

56417	56418	These	0	None
56418	56419	results	0	None
56419	56420	demonstrate	0	None
56420	56421	that	0	None
56421	56422	the	0	None
56422	56423	two	0	None
56423	56424	PGH	0	None
56424	56425	synthases	0	None
56425	56426	are	0	None
56426	56427	pharmacologically	0	None
56427	56428	distinct	0	None
56428	56429	and	0	None
56429	56430	indicate	0	None
56430	56431	that	0	None
56431	56432	it	0	None
56432	56433	may	0	None
56433	56434	be	0	None
56434	56435	possible	0	None
56435	56436	to	0	None
56436	56437	develop	0	None
56437	56438	isozyme-specific	0	None
56438	56439	cyclooxygenase	3	GENE-N
56439	56440	inhibitors	0	None
56440	56441	useful	0	None
56441	56442	both	0	None
56442	56443	for	0	None
56443	56444	anti-inflammatory	0	None
56444	56445	therapy	0	None
56445	56446	and	0	None
56446	56447	for	0	None
56447	56448	delineating	0	None
56448	56449	between	0	None
56449	56450	the	0	None
56450	56451	biological	0	None
56451	56452	roles	0	None
56452	56453	of	0	None
56453	56454	the	0	None
56454	56455	PGH	0	None
56455	56456	synthase	0	None
56456	56457	isozymes	0	None
56457	56458	.	0	None
56458	56459	The	0	None
56459	56460	cardiomyocyte	0	None
56460	56461	apoptosis	0	None
56461	56462	plays	0	None
56462	56463	a	0	None
56463	56464	critical	0	None
56464	56465	role	0	None
56465	56466	in	0	None
56466	56467	the	0	None
56467	56468	development	0	None
56468	56469	of	0	None
56469	56470	myocardial	0	None
56470	56471	injury	0	None
56471	56472	after	0	None
56472	56473	ischemia	0	None
56473	56474	and	0	None
56474	56475	reperfusion	0	None
56475	56476	.	0	None

56477	56478	Thus	0	None
56478	56479	,	0	None
56479	56480	alteration	0	None
56480	56481	of	0	None
56481	56482	the	0	None
56482	56483	major	0	None
56483	56484	apoptosis-regulatory	0	None
56484	56485	factors	0	None
56485	56486	during	0	None
56486	56487	myocardial	0	None
56487	56488	ischemia-reperfusion	0	None
56488	56489	is	0	None
56489	56490	expected	0	None
56490	56491	to	0	None
56491	56492	have	0	None
56492	56493	favorable	0	None
56493	56494	cardioprotective	0	None
56494	56495	effects	0	None
56495	56496	.	0	None

56497	56498	Herein	0	None
56498	56499	,	0	None
56499	56500	we	0	None
56500	56501	report	0	None
56501	56502	ischemic-reperfused	0	None
56502	56503	myocardial	0	None
56503	56504	infarction	0	None
56504	56505	(	0	None
56505	56506	MI	0	None
56506	56507	)	0	None
56507	56508	repair	0	None
56508	56509	with	0	None
56509	56510	siRNA	0	None
56510	56511	against	0	None
56511	56512	Src	0	None
56512	56513	homology	0	None
56513	56514	region	0	None
56514	56515	2	0	None
56515	56516	domain-containing	0	None
56516	56518	tyrosine phosphatase-1	3	GENE-N
56518	56519	(	0	None
56519	56520	SHP-1	0	None
56520	56521	)	0	None
56521	56522	,	0	None
56522	56523	which	0	None
56523	56524	is	0	None
56524	56525	known	0	None
56525	56526	as	0	None
56526	56527	a	0	None
56527	56528	key	0	None
56528	56529	factor	0	None
56529	56530	involved	0	None
56530	56531	in	0	None
56531	56532	regulating	0	None
56532	56533	the	0	None
56533	56534	progress	0	None
56534	56535	of	0	None
56535	56536	apoptosis	0	None
56536	56537	in	0	None
56537	56538	many	0	None
56538	56539	cell	0	None
56539	56540	types	0	None
56540	56541	.	0	None

56542	56543	A	0	None
56543	56544	low	0	None
56544	56545	molecular	0	None
56545	56546	weight	0	None
56546	56547	polyethyleneimine	0	None
56547	56548	modified	0	None
56548	56549	with	0	None
56549	56550	deoxycholic	0	None
56550	56551	acid	0	None
56551	56552	(	0	None
56552	56553	PEI1	0	None
56553	56554	.	0	None
56554	56555	8-DA	0	None
56555	56556	)	0	None
56556	56557	-based	0	None
56557	56558	delivery	0	None
56558	56559	strategy	0	None
56559	56560	was	0	None
56560	56561	suggested	0	None
56561	56562	for	0	None
56562	56563	the	0	None
56563	56564	cardiac	0	None
56564	56565	application	0	None
56565	56566	of	0	None
56566	56567	SHP-1	0	None
56567	56568	siRNA	0	None
56568	56569	to	0	None
56569	56570	overcome	0	None
56570	56571	the	0	None
56571	56572	poor	0	None
56572	56573	gene	0	None
56573	56574	delivery	0	None
56574	56575	efficiency	0	None
56575	56576	to	0	None
56576	56577	myocardium	0	None
56577	56578	due	0	None
56578	56579	to	0	None
56579	56580	the	0	None
56580	56581	highly	0	None
56581	56582	charged	0	None
56582	56583	structures	0	None
56583	56584	of	0	None
56584	56585	the	0	None
56585	56586	compact	0	None
56586	56587	cardiac	0	None
56587	56588	muscles	0	None
56588	56589	.	0	None

56590	56591	The	0	None
56591	56592	PEI1	0	None
56592	56593	.	0	None
56593	56594	8-DA	0	None
56594	56595	conjugates	0	None
56595	56596	formed	0	None
56596	56597	stable	0	None
56597	56598	nanocomplexes	0	None
56598	56599	with	0	None
56599	56600	SHP-1	0	None
56600	56601	siRNA	0	None
56601	56602	via	0	None
56602	56603	electrostatic	0	None
56603	56604	and	0	None
56604	56605	hydrophobic	0	None
56605	56606	interactions	0	None
56606	56607	.	0	None

56608	56609	The	0	None
56609	56610	PEI1	0	None
56610	56611	.	0	None
56611	56612	8-DA	0	None
56612	56613	/	0	None
56613	56614	SHP-1	0	None
56614	56615	siRNA	0	None
56615	56616	polyplexes	0	None
56616	56617	effectively	0	None
56617	56618	silenced	0	None
56618	56619	SHP-1	0	None
56619	56620	gene	0	None
56620	56621	expression	0	None
56621	56622	in	0	None
56622	56623	cardiomyocytes	0	None
56623	56624	,	0	None
56624	56625	leading	0	None
56625	56626	to	0	None
56626	56627	a	0	None
56627	56628	significant	0	None
56628	56629	inhibition	0	None
56629	56630	of	0	None
56630	56631	cardiomyocyte	0	None
56631	56632	apoptosis	0	None
56632	56633	under	0	None
56633	56634	hypoxia	0	None
56634	56635	.	0	None

56636	56637	In	0	None
56637	56638	comparison	0	None
56638	56639	to	0	None
56639	56640	conventional	0	None
56640	56641	gene	0	None
56641	56642	carriers	0	None
56642	56643	,	0	None
56643	56644	relatively	0	None
56644	56645	large	0	None
56645	56646	amounts	0	None
56646	56647	of	0	None
56647	56648	siRNA	0	None
56648	56649	molecules	0	None
56649	56650	remained	0	None
56650	56651	after	0	None
56651	56652	treatment	0	None
56652	56653	with	0	None
56653	56654	the	0	None
56654	56655	PEI1	0	None
56655	56656	.	0	None
56656	56657	8-DA	0	None
56657	56658	/	0	None
56658	56659	SHP-1	0	None
56659	56660	siRNA	0	None
56660	56661	polyplexes	0	None
56661	56662	.	0	None

56663	56664	Cardiac	0	None
56664	56665	administration	0	None
56665	56666	of	0	None
56666	56667	the	0	None
56667	56668	PEI1	0	None
56668	56669	.	0	None
56669	56670	8-DA	0	None
56670	56671	/	0	None
56671	56672	SHP-1	0	None
56672	56673	siRNA	0	None
56673	56674	polyplexes	0	None
56674	56675	resulted	0	None
56675	56676	in	0	None
56676	56677	substantial	0	None
56677	56678	improvement	0	None
56678	56679	in	0	None
56679	56680	SHP-1	0	None
56680	56681	gene	0	None
56681	56682	silencing	0	None
56682	56683	,	0	None
56683	56684	which	0	None
56684	56685	can	0	None
56685	56686	be	0	None
56686	56687	explained	0	None
56687	56688	by	0	None
56688	56689	the	0	None
56689	56690	enhancement	0	None
56690	56691	of	0	None
56691	56692	cardiac	0	None
56692	56693	delivery	0	None
56693	56694	efficiency	0	None
56694	56695	of	0	None
56695	56696	the	0	None
56696	56697	PEI1	0	None
56697	56698	.	0	None
56698	56699	8-DA	0	None
56699	56700	conjugates	0	None
56700	56701	.	0	None

56702	56703	In	0	None
56703	56704	addition	0	None
56704	56705	,	0	None
56705	56706	in	0	None
56706	56707	vivo	0	None
56707	56708	treatment	0	None
56708	56709	with	0	None
56709	56710	the	0	None
56710	56711	PEI1	0	None
56711	56712	.	0	None
56712	56713	8-DA	0	None
56713	56714	/	0	None
56714	56715	SHP-1	0	None
56715	56716	siRNA	0	None
56716	56717	polyplexes	0	None
56717	56718	induced	0	None
56718	56719	a	0	None
56719	56720	highly	0	None
56720	56721	significant	0	None
56721	56722	reduction	0	None
56722	56723	in	0	None
56723	56724	myocardial	0	None
56724	56725	apoptosis	0	None
56725	56726	and	0	None
56726	56727	infarct	0	None
56727	56728	size	0	None
56728	56729	in	0	None
56729	56730	rat	0	None
56730	56731	MI	0	None
56731	56732	models	0	None
56732	56733	.	0	None

56734	56735	These	0	None
56735	56736	results	0	None
56736	56737	demonstrate	0	None
56737	56738	that	0	None
56738	56739	the	0	None
56739	56740	PEI1	0	None
56740	56741	.	0	None
56741	56742	8-DA	0	None
56742	56743	/	0	None
56743	56744	SHP-1	0	None
56744	56745	siRNA	0	None
56745	56746	polyplex	0	None
56746	56747	formulation	0	None
56747	56748	is	0	None
56748	56749	a	0	None
56749	56750	useful	0	None
56750	56751	system	0	None
56751	56752	for	0	None
56752	56753	efficient	0	None
56753	56754	gene	0	None
56754	56755	delivery	0	None
56755	56756	into	0	None
56756	56757	the	0	None
56757	56758	compact	0	None
56758	56759	myocardium	0	None
56759	56760	that	0	None
56760	56761	provides	0	None
56761	56762	a	0	None
56762	56763	fundamental	0	None
56763	56764	advantage	0	None
56764	56765	in	0	None
56765	56766	treating	0	None
56766	56767	ischemic-reperfused	0	None
56767	56768	MI	0	None
56768	56769	.	0	None
56769	56770	A	0	None
56770	56771	simple	0	None
56771	56772	in	0	None
56772	56773	vitro	0	None
56773	56774	test	0	None
56774	56775	system	0	None
56775	56776	based	0	None
56776	56777	on	0	None
56777	56778	the	0	None
56778	56779	use	0	None
56779	56780	of	0	None
56780	56781	peroxide-eliminating	0	None
56781	56782	oxidoreductases	0	None
56782	56783	(	0	None
56783	56785	glutathione reductase	1	GENE-Y
56785	56786	,	0	None
56786	56788	glutathione peroxidase	1	GENE-Y
56788	56789	)	0	None
56789	56790	is	0	None
56790	56791	described	0	None
56791	56792	.	0	None

56793	56794	The	0	None
56794	56795	system	0	None
56795	56796	allows	0	None
56796	56797	detection	0	None
56797	56798	of	0	None
56798	56799	antioxidant	0	None
56799	56800	properties	0	None
56800	56801	of	0	None
56801	56802	aqueous	0	None
56802	56803	extracts	0	None
56803	56804	from	0	None
56804	56805	raw	0	None
56805	56806	medicinal	0	None
56806	56807	plants	0	None
56807	56808	.	0	None

56809	56810	The	0	None
56810	56811	system	0	None
56811	56812	was	0	None
56812	56813	used	0	None
56813	56814	for	0	None
56814	56815	testing	0	None
56815	56816	water	0	None
56816	56817	extract	0	None
56817	56818	of	0	None
56818	56819	Baikalskii-6	0	None
56819	56820	tea	0	None
56820	56821	.	0	None

56822	56823	Antioxidant	0	None
56823	56824	and	0	None
56824	56825	,	0	None
56825	56826	presumably	0	None
56826	56827	,	0	None
56827	56828	adaptogenic	0	None
56828	56829	activity	0	None
56829	56830	of	0	None
56830	56831	this	0	None
56831	56832	tea	0	None
56832	56833	was	0	None
56833	56834	detected	0	None
56834	56835	.	0	None

56836	56837	In	0	None
56837	56838	addition	0	None
56838	56839	to	0	None
56839	56840	activation	0	None
56840	56841	of	0	None
56841	56843	glutathione reductase	1	GENE-Y
56843	56844	and	0	None
56844	56846	glutathione peroxidase	1	GENE-Y
56846	56847	,	0	None
56847	56848	the	0	None
56848	56849	preparation	0	None
56849	56850	inhibits	0	None
56850	56851	erythrocyte	0	None
56851	56852	catalase	0	None
56852	56853	and	0	None
56853	56854	therefore	0	None
56854	56855	should	0	None
56855	56856	not	0	None
56856	56857	be	0	None
56857	56858	used	0	None
56858	56859	for	0	None
56859	56860	detection	0	None
56860	56861	of	0	None
56861	56862	antioxidant	0	None
56862	56863	activity	0	None
56863	56864	in	0	None
56864	56865	in	0	None
56865	56866	vitro	0	None
56866	56867	screening	0	None
56867	56868	tests	0	None
56868	56869	.	0	None
56869	56870	Role	0	None
56870	56871	of	0	None
56871	56872	Asp104	0	None
56872	56873	in	0	None
56873	56874	the	0	None
56874	56875	SHV	0	None
56875	56876	beta-lactamase	0	None
56876	56877	.	0	None
56877	56878	A	0	None
56878	56879	method	0	None
56879	56880	has	0	None
56880	56881	been	0	None
56881	56882	developed	0	None
56882	56883	for	0	None
56883	56884	the	0	None
56884	56885	measurement	0	None
56885	56886	of	0	None
56886	56887	transport	0	None
56887	56888	activities	0	None
56888	56889	in	0	None
56889	56890	membrane	0	None
56890	56891	vesicles	0	None
56891	56892	obtained	0	None
56892	56893	from	0	None
56893	56894	Sf9	0	None
56894	56895	cells	0	None
56895	56896	for	0	None
56896	56897	3β-hydroxy-Δ	0	None
56897	56898	(	0	None
56898	56899	5	0	None
56899	56900	)	0	None
56900	56901	-bile	0	None
56901	56902	acids	0	None
56902	56903	by	0	None
56903	56904	high-performance	0	None
56904	56905	liquid	0	None
56905	56906	chromatography-electrospray	0	None
56906	56907	ionization-tandem	0	None
56907	56908	mass	0	None
56908	56909	spectrometry	0	None
56909	56910	.	0	None

56911	56912	Calibration	0	None
56912	56913	curves	0	None
56913	56914	for	0	None
56914	56915	the	0	None
56915	56917	bile acids	2	CHEMICAL
56917	56918	were	0	None
56918	56919	linear	0	None
56919	56920	over	0	None
56920	56921	the	0	None
56921	56922	range	0	None
56922	56923	of	0	None
56923	56924	10	0	None
56924	56925	to	0	None
56925	56926	2000	0	None
56926	56927	pmol	0	None
56927	56928	/	0	None
56928	56929	mL	0	None
56929	56930	,	0	None
56930	56931	and	0	None
56931	56932	the	0	None
56932	56933	detection	0	None
56933	56934	limit	0	None
56934	56935	was	0	None
56935	56936	less	0	None
56936	56937	than	0	None
56937	56938	1	0	None
56938	56939	pmol	0	None
56939	56940	/	0	None
56940	56941	mL	0	None
56941	56942	for	0	None
56942	56943	3β-hydroxy-Δ	0	None
56943	56944	(	0	None
56944	56945	5	0	None
56945	56946	)	0	None
56946	56947	-bile	0	None
56947	56948	acids	0	None
56948	56949	using	0	None
56949	56950	selected	0	None
56950	56951	reaction	0	None
56951	56952	monitoring	0	None
56952	56953	analysis	0	None
56953	56954	.	0	None

56955	56956	The	0	None
56956	56957	analytical	0	None
56957	56958	method	0	None
56958	56959	was	0	None
56959	56960	applied	0	None
56960	56961	to	0	None
56961	56962	measurements	0	None
56962	56963	of	0	None
56963	56964	transport	0	None
56964	56965	activities	0	None
56965	56966	in	0	None
56966	56967	membrane	0	None
56967	56968	vesicles	0	None
56968	56969	obtained	0	None
56969	56970	from	0	None
56970	56973	human multidrug resistance-associated	1	GENE-Y
56973	56974	protein	0	None
56974	56975	2-	0	None
56975	56976	,	0	None
56976	56977	3-	0	None
56977	56978	,	0	None
56978	56979	and	0	None
56979	56984	human bile salt export pump-expressing	0	None
56984	56985	Sf9	0	None
56985	56986	cells	0	None
56986	56987	for	0	None
56987	56988	conjugated	0	None
56988	56989	3β-hydroxy-Δ	0	None
56989	56990	(	0	None
56990	56991	5	0	None
56991	56992	)	0	None
56992	56993	-bile	0	None
56993	56994	acids	0	None
56994	56995	.	0	None

56996	56997	The	0	None
56997	56998	present	0	None
56998	56999	study	0	None
56999	57000	demonstrated	0	None
57000	57001	that	0	None
57001	57004	human multidrug resistance-associated	1	GENE-Y
57004	57005	protein	0	None
57005	57006	3	0	None
57006	57007	vesicles	0	None
57007	57008	accepted	0	None
57008	57009	conjugated	0	None
57009	57010	3β-hydroxy-Δ	0	None
57010	57011	(	0	None
57011	57012	5	0	None
57012	57013	)	0	None
57013	57014	-bile	0	None
57014	57015	acids	0	None
57015	57016	along	0	None
57016	57017	with	0	None
57017	57018	common	0	None
57018	57020	bile acids	2	CHEMICAL
57020	57021	such	0	None
57021	57022	as	0	None
57022	57023	glycocholic	0	None
57023	57024	acid	0	None
57024	57025	and	0	None
57025	57026	taurolithocholic	0	None
57026	57027	acid	0	None
57027	57028	3-sulfate	0	None
57028	57029	.	0	None
57029	57030	A	0	None
57030	57031	positive	0	None
57031	57032	association	0	None
57032	57033	between	0	None
57033	57034	air	0	None
57034	57035	pollution	0	None
57035	57036	exposure	0	None
57036	57037	and	0	None
57037	57038	increased	0	None
57038	57039	human	0	None
57039	57040	risk	0	None
57040	57041	of	0	None
57041	57042	chronic	0	None
57042	57043	heart	0	None
57043	57044	disease	0	None
57044	57045	progression	0	None
57045	57046	is	0	None
57046	57047	well	0	None
57047	57048	established	0	None
57048	57049	.	0	None

57050	57051	In	0	None
57051	57052	the	0	None
57052	57053	current	0	None
57053	57054	study	0	None
57054	57055	,	0	None
57055	57056	we	0	None
57056	57057	test	0	None
57057	57058	two	0	None
57058	57059	hypotheses	0	None
57059	57060	:	0	None
57060	57061	(	0	None
57061	57062	1	0	None
57062	57063	)	0	None
57063	57064	the	0	None
57064	57065	cardiac	0	None
57065	57066	compensatory	0	None
57066	57067	changes	0	None
57067	57068	in	0	None
57068	57069	response	0	None
57069	57070	to	0	None
57070	57071	air	0	None
57071	57072	pollution	0	None
57072	57073	are	0	None
57073	57074	dependent	0	None
57074	57075	on	0	None
57075	57076	its	0	None
57076	57077	composition	0	None
57077	57078	and	0	None
57078	57079	(	0	None
57079	57080	2	0	None
57080	57081	)	0	None
57081	57082	specific	0	None
57082	57083	cardiac	0	None
57083	57084	adaptations	0	None
57084	57085	are	0	None
57085	57086	regulated	0	None
57086	57087	by	0	None
57087	57090	atrial natriuretic peptide	1	GENE-Y
57090	57091	(	0	None
57091	57092	ANP	0	None
57092	57093	)	0	None
57093	57094	.	0	None

57095	57096	We	0	None
57096	57097	address	0	None
57097	57098	these	0	None
57098	57099	hypotheses	0	None
57099	57100	by	0	None
57100	57101	initially	0	None
57101	57102	examining	0	None
57102	57103	the	0	None
57103	57104	exposure	0	None
57104	57105	effects	0	None
57105	57106	of	0	None
57106	57107	ozone	0	None
57107	57108	(	0	None
57108	57109	O	0	None
57109	57110	(	0	None
57110	57111	3	0	None
57111	57112	)	0	None
57112	57113	)	0	None
57113	57114	and	0	None
57114	57115	/	0	None
57115	57116	or	0	None
57116	57117	particulate	0	None
57117	57118	matter	0	None
57118	57119	(	0	None
57119	57120	PM	0	None
57120	57121	)	0	None
57121	57122	on	0	None
57122	57123	cardiac	0	None
57123	57124	function	0	None
57124	57125	in	0	None
57125	57126	C57Bl	0	None
57126	57127	/	0	None
57127	57128	6J	0	None
57128	57129	(	0	None
57129	57130	B6	0	None
57130	57131	)	0	None
57131	57132	mice	0	None
57132	57133	.	0	None

57134	57135	Subsequently	0	None
57135	57136	,	0	None
57136	57137	the	0	None
57137	57138	results	0	None
57138	57139	are	0	None
57139	57140	compared	0	None
57140	57141	with	0	None
57141	57142	cardiac	0	None
57142	57143	functional	0	None
57143	57144	changes	0	None
57144	57145	to	0	None
57145	57146	the	0	None
57146	57147	same	0	None
57147	57148	exposures	0	None
57148	57149	in	0	None
57149	57150	Nppa	0	None
57150	57151	(	0	None
57151	57152	the	0	None
57152	57153	precursor	0	None
57153	57154	gene	0	None
57154	57155	for	0	None
57155	57156	ANP	0	None
57156	57157	)	0	None
57157	57158	knockout	0	None
57158	57159	(	0	None
57159	57160	KO	0	None
57160	57161	)	0	None
57161	57162	mice	0	None
57162	57163	.	0	None

57164	57165	Separate	0	None
57165	57166	groups	0	None
57166	57167	of	0	None
57167	57168	mice	0	None
57168	57169	underwent	0	None
57169	57170	3	0	None
57170	57171	consecutive	0	None
57171	57172	days	0	None
57172	57173	of	0	None
57173	57174	the	0	None
57174	57175	same	0	None
57175	57176	exposure	0	None
57176	57177	sequence	0	None
57177	57178	for	0	None
57178	57179	3h	0	None
57179	57180	each	0	None
57180	57181	consisting	0	None
57181	57182	of	0	None
57182	57183	the	0	None
57183	57184	following	0	None
57184	57185	:	0	None
57185	57186	(	0	None
57186	57187	1	0	None
57187	57188	)	0	None
57188	57189	6h	0	None
57189	57190	of	0	None
57190	57191	filtered	0	None
57191	57192	air	0	None
57192	57193	(	0	None
57193	57194	FAFA	0	None
57194	57195	)	0	None
57195	57196	,	0	None
57196	57197	(	0	None
57197	57198	2	0	None
57198	57199	)	0	None
57199	57200	O	0	None
57200	57201	(	0	None
57201	57202	3	0	None
57202	57203	)	0	None
57203	57204	then	0	None
57204	57205	FA	0	None
57205	57206	(	0	None
57206	57207	O	0	None
57207	57208	(	0	None
57208	57209	3	0	None
57209	57210	)	0	None
57210	57211	FA	0	None
57211	57212	)	0	None
57212	57213	,	0	None
57213	57214	(	0	None
57214	57215	3	0	None
57215	57216	)	0	None
57216	57217	FA	0	None
57217	57218	then	0	None
57218	57219	carbon	2	CHEMICAL
57219	57220	black	0	None
57220	57221	(	0	None
57221	57222	FACB	0	None
57222	57223	)	0	None
57223	57224	,	0	None
57224	57225	or	0	None
57225	57226	(	0	None
57226	57227	4	0	None
57227	57228	)	0	None
57228	57229	O	0	None
57229	57230	(	0	None
57230	57231	3	0	None
57231	57232	)	0	None
57232	57233	then	0	None
57233	57234	CB	2	CHEMICAL
57234	57235	.	0	None

57236	57237	Cardiac	0	None
57237	57238	function	0	None
57238	57239	was	0	None
57239	57240	assessed	0	None
57240	57241	using	0	None
57241	57242	a	0	None
57242	57243	conductance	0	None
57243	57244	catheter	0	None
57244	57245	to	0	None
57245	57246	generate	0	None
57246	57247	cardiac	0	None
57247	57248	pressure-volume	0	None
57248	57249	loops	0	None
57249	57250	8-10h	0	None
57250	57251	following	0	None
57251	57252	each	0	None
57252	57253	exposure	0	None
57253	57254	sequence	0	None
57254	57255	.	0	None

57256	57257	As	0	None
57257	57258	compared	0	None
57258	57259	with	0	None
57259	57260	FAFA	0	None
57260	57261	,	0	None
57261	57262	each	0	None
57262	57263	sequence	0	None
57263	57264	led	0	None
57264	57265	to	0	None
57265	57266	a	0	None
57266	57267	substantial	0	None
57267	57268	drop	0	None
57268	57269	(	0	None
57269	57270	as	0	None
57270	57271	much	0	None
57271	57272	as	0	None
57272	57273	33%	0	None
57273	57274	)	0	None
57274	57275	in	0	None
57275	57276	stroke	0	None
57276	57277	volume	0	None
57277	57278	and	0	None
57278	57279	cardiac	0	None
57279	57280	output	0	None
57280	57281	.	0	None

57282	57283	However	0	None
57283	57284	,	0	None
57284	57285	these	0	None
57285	57286	losses	0	None
57286	57287	of	0	None
57287	57288	cardiac	0	None
57288	57289	function	0	None
57289	57290	occurred	0	None
57290	57291	by	0	None
57291	57292	different	0	None
57292	57293	compensatory	0	None
57293	57294	mechanisms	0	None
57294	57295	dependent	0	None
57295	57296	on	0	None
57296	57297	the	0	None
57297	57298	pollutant	0	None
57298	57299	composition	0	None
57299	57300	.	0	None

57301	57302	For	0	None
57302	57303	example	0	None
57303	57304	,	0	None
57304	57305	O	0	None
57305	57306	(	0	None
57306	57307	3	0	None
57307	57308	)	0	None
57308	57309	FA	0	None
57309	57310	exposure	0	None
57310	57311	led	0	None
57311	57312	to	0	None
57312	57313	reductions	0	None
57313	57314	in	0	None
57314	57315	both	0	None
57315	57316	end-systolic	0	None
57316	57317	and	0	None
57317	57318	end-diastolic	0	None
57318	57319	left	0	None
57319	57320	ventricular	0	None
57320	57321	(	0	None
57321	57322	LV	0	None
57322	57323	)	0	None
57323	57324	volumes	0	None
57324	57325	,	0	None
57325	57326	whereas	0	None
57326	57327	FACB	0	None
57327	57328	exposure	0	None
57328	57329	led	0	None
57329	57330	an	0	None
57330	57331	increase	0	None
57331	57332	in	0	None
57332	57333	end-diastolic	0	None
57333	57334	LV	0	None
57334	57335	volume	0	None
57335	57336	.	0	None

57337	57338	These	0	None
57338	57339	same	0	None
57339	57340	cardiac	0	None
57340	57341	compensatory	0	None
57341	57342	changes	0	None
57342	57343	were	0	None
57343	57344	largely	0	None
57344	57345	abolished	0	None
57345	57346	in	0	None
57346	57347	Nppa	0	None
57347	57348	KO	0	None
57348	57349	mice	0	None
57349	57350	following	0	None
57350	57351	O	0	None
57351	57352	(	0	None
57352	57353	3	0	None
57353	57354	)	0	None
57354	57355	FA	0	None
57355	57356	or	0	None
57356	57357	FACB	0	None
57357	57358	exposure	0	None
57358	57359	.	0	None

57360	57361	These	0	None
57361	57362	results	0	None
57362	57363	suggest	0	None
57363	57364	that	0	None
57364	57365	cardiac	0	None
57365	57366	functional	0	None
57366	57367	changes	0	None
57367	57368	in	0	None
57368	57369	response	0	None
57369	57370	to	0	None
57370	57371	air	0	None
57371	57372	pollution	0	None
57372	57373	exposure	0	None
57373	57374	are	0	None
57374	57375	strongly	0	None
57375	57376	dependent	0	None
57376	57377	on	0	None
57377	57378	the	0	None
57378	57379	pollutant	0	None
57379	57380	constituents	0	None
57380	57381	,	0	None
57381	57382	especially	0	None
57382	57383	related	0	None
57383	57384	to	0	None
57384	57385	O	0	None
57385	57386	(	0	None
57386	57387	3	0	None
57387	57388	)	0	None
57388	57389	and	0	None
57389	57390	/	0	None
57390	57391	or	0	None
57391	57392	PM	0	None
57392	57393	.	0	None

57394	57395	Furthermore	0	None
57395	57396	,	0	None
57396	57397	ANP	0	None
57397	57398	regulation	0	None
57398	57399	appears	0	None
57399	57400	to	0	None
57400	57401	be	0	None
57401	57402	crucial	0	None
57402	57403	to	0	None
57403	57404	these	0	None
57404	57405	cardiac	0	None
57405	57406	compensatory	0	None
57406	57407	mechanisms	0	None
57407	57408	induced	0	None
57408	57409	by	0	None
57409	57410	air	0	None
57410	57411	pollution	0	None
57411	57412	.	0	None
57412	57413	Understanding	0	None
57413	57414	the	0	None
57414	57415	molecular	0	None
57415	57416	evolution	0	None
57416	57417	of	0	None
57417	57418	genes	0	None
57418	57419	that	0	None
57419	57420	underlie	0	None
57420	57421	intraspecific	0	None
57421	57422	polymorphisms	0	None
57422	57423	can	0	None
57423	57424	provide	0	None
57424	57425	insights	0	None
57425	57426	into	0	None
57426	57427	the	0	None
57427	57428	process	0	None
57428	57429	of	0	None
57429	57430	adaptive	0	None
57430	57431	evolution	0	None
57431	57432	.	0	None

57433	57434	For	0	None
57434	57435	adaptive	0	None
57435	57436	polymorphisms	0	None
57436	57437	characterized	0	None
57437	57438	by	0	None
57438	57439	gene	0	None
57439	57440	presence	0	None
57440	57441	/	0	None
57441	57442	absence	0	None
57442	57443	(	0	None
57443	57444	P	0	None
57444	57445	/	0	None
57445	57446	A	0	None
57446	57447	)	0	None
57447	57448	variation	0	None
57448	57449	,	0	None
57449	57450	underlying	0	None
57450	57451	loci	0	None
57451	57452	commonly	0	None
57452	57453	show	0	None
57453	57454	signatures	0	None
57454	57455	of	0	None
57455	57456	long-term	0	None
57456	57457	balancing	0	None
57457	57458	selection	0	None
57458	57459	,	0	None
57459	57460	with	0	None
57460	57461	gene-presence	0	None
57461	57462	and	0	None
57462	57463	gene-absence	0	None
57463	57464	alleles	0	None
57464	57465	maintained	0	None
57465	57466	as	0	None
57466	57467	two	0	None
57467	57468	divergent	0	None
57468	57469	lineages	0	None
57469	57470	.	0	None

57471	57472	We	0	None
57472	57473	examined	0	None
57473	57474	the	0	None
57474	57475	molecular	0	None
57475	57476	evolution	0	None
57476	57477	of	0	None
57477	57478	two	0	None
57478	57479	unlinked	0	None
57479	57480	P	0	None
57480	57481	/	0	None
57481	57482	A	0	None
57482	57483	polymorphisms	0	None
57483	57484	that	0	None
57484	57485	underlie	0	None
57485	57486	a	0	None
57486	57487	well-documented	0	None
57487	57488	adaptive	0	None
57488	57489	polymorphism	0	None
57489	57490	for	0	None
57490	57491	cyanogenesis	0	None
57491	57492	(	0	None
57492	57493	hydrogen	2	CHEMICAL
57493	57494	cyanide	0	None
57494	57495	release	0	None
57495	57496	with	0	None
57496	57497	tissue	0	None
57497	57498	damage	0	None
57498	57499	)	0	None
57499	57500	in	0	None
57500	57501	white	0	None
57501	57502	clover	0	None
57502	57503	.	0	None

57504	57505	Both	0	None
57505	57506	cyanogenic	0	None
57506	57507	and	0	None
57507	57508	acyanogenic	0	None
57508	57509	plants	0	None
57509	57510	occur	0	None
57510	57511	in	0	None
57511	57512	this	0	None
57512	57513	species	0	None
57513	57514	,	0	None
57514	57515	and	0	None
57515	57516	the	0	None
57516	57517	ecological	0	None
57517	57518	forces	0	None
57518	57519	that	0	None
57519	57520	maintain	0	None
57520	57521	this	0	None
57521	57522	chemical	0	None
57522	57523	defence	0	None
57523	57524	polymorphism	0	None
57524	57525	have	0	None
57525	57526	been	0	None
57526	57527	studied	0	None
57527	57528	for	0	None
57528	57529	several	0	None
57529	57530	decades	0	None
57530	57531	.	0	None

57532	57533	Using	0	None
57533	57534	a	0	None
57534	57535	sample	0	None
57535	57536	of	0	None
57536	57537	65	0	None
57537	57538	plants	0	None
57538	57539	,	0	None
57539	57540	we	0	None
57540	57541	investigated	0	None
57541	57542	the	0	None
57542	57543	molecular	0	None
57543	57544	evolution	0	None
57544	57545	of	0	None
57545	57546	sequences	0	None
57546	57547	flanking	0	None
57547	57548	the	0	None
57548	57549	two	0	None
57549	57550	underlying	0	None
57550	57551	cyanogenesis	0	None
57551	57552	genes	0	None
57552	57553	:	0	None
57553	57554	Ac	0	None
57554	57555	/	0	None
57555	57556	ac	3	GENE-N
57556	57557	(	0	None
57557	57558	controlling	0	None
57558	57559	the	0	None
57559	57560	presence	0	None
57560	57561	/	0	None
57561	57562	absence	0	None
57562	57563	of	0	None
57563	57564	cyanogenic	0	None
57564	57565	glucosides	0	None
57565	57566	)	0	None
57566	57567	and	0	None
57567	57568	Li	0	None
57568	57569	/	0	None
57569	57570	li	0	None
57570	57571	(	0	None
57571	57572	controlling	0	None
57572	57573	the	0	None
57573	57574	presence	0	None
57574	57575	/	0	None
57575	57576	absence	0	None
57576	57577	of	0	None
57577	57578	their	0	None
57578	57579	hydrolysing	0	None
57579	57580	enzyme	0	None
57580	57581	,	0	None
57581	57582	linamarase	3	GENE-N
57582	57583	)	0	None
57583	57584	.	0	None

57585	57586	A	0	None
57586	57587	combination	0	None
57587	57588	of	0	None
57588	57589	genome	0	None
57589	57590	walking	0	None
57590	57591	,	0	None
57591	57592	PCR	0	None
57592	57593	assays	0	None
57593	57594	,	0	None
57594	57595	DNA	0	None
57595	57596	sequence	0	None
57596	57597	analysis	0	None
57597	57598	and	0	None
57598	57599	Southern	0	None
57599	57600	blotting	0	None
57600	57601	was	0	None
57601	57602	used	0	None
57602	57603	to	0	None
57603	57604	test	0	None
57604	57605	whether	0	None
57605	57606	these	0	None
57606	57607	adaptive	0	None
57607	57608	P	0	None
57608	57609	/	0	None
57609	57610	A	0	None
57610	57611	polymorphisms	0	None
57611	57612	show	0	None
57612	57613	evidence	0	None
57613	57614	of	0	None
57614	57615	long-term	0	None
57615	57616	balancing	0	None
57616	57617	selection	0	None
57617	57618	,	0	None
57618	57619	or	0	None
57619	57620	whether	0	None
57620	57621	gene-absence	0	None
57621	57622	alleles	0	None
57622	57623	have	0	None
57623	57624	evolved	0	None
57624	57625	repeatedly	0	None
57625	57626	through	0	None
57626	57627	independent	0	None
57627	57628	deletion	0	None
57628	57629	events	0	None
57629	57630	.	0	None

57631	57632	For	0	None
57632	57633	both	0	None
57633	57634	loci	0	None
57634	57635	,	0	None
57635	57636	we	0	None
57636	57637	detect	0	None
57637	57638	no	0	None
57638	57639	signatures	0	None
57639	57640	of	0	None
57640	57641	balancing	0	None
57641	57642	selection	0	None
57642	57643	in	0	None
57643	57644	the	0	None
57644	57645	closest	0	None
57645	57646	flanking	0	None
57646	57647	genomic	0	None
57647	57648	sequences	0	None
57648	57649	.	0	None

57650	57651	Instead	0	None
57651	57652	,	0	None
57652	57653	we	0	None
57653	57654	find	0	None
57654	57655	evidence	0	None
57655	57656	for	0	None
57656	57657	variation	0	None
57657	57658	in	0	None
57658	57659	the	0	None
57659	57660	size	0	None
57660	57661	of	0	None
57661	57662	the	0	None
57662	57663	deletions	0	None
57663	57664	characterizing	0	None
57664	57665	gene-absence	0	None
57665	57666	alleles	0	None
57666	57667	.	0	None

57668	57669	These	0	None
57669	57670	observations	0	None
57670	57671	strongly	0	None
57671	57672	suggest	0	None
57672	57673	that	0	None
57673	57674	both	0	None
57674	57675	of	0	None
57675	57676	these	0	None
57676	57677	polymorphisms	0	None
57677	57678	have	0	None
57678	57679	been	0	None
57679	57680	evolving	0	None
57680	57681	through	0	None
57681	57682	recurrent	0	None
57682	57683	gene	0	None
57683	57684	deletions	0	None
57684	57685	over	0	None
57685	57686	time	0	None
57686	57687	.	0	None

57688	57689	We	0	None
57689	57690	discuss	0	None
57690	57691	the	0	None
57691	57692	genetic	0	None
57692	57693	mechanisms	0	None
57693	57694	that	0	None
57694	57695	could	0	None
57695	57696	account	0	None
57696	57697	for	0	None
57697	57698	this	0	None
57698	57699	surprising	0	None
57699	57700	pattern	0	None
57700	57701	and	0	None
57701	57702	the	0	None
57702	57703	implications	0	None
57703	57704	of	0	None
57704	57705	these	0	None
57705	57706	findings	0	None
57706	57707	for	0	None
57707	57708	mechanisms	0	None
57708	57709	of	0	None
57709	57710	rapid	0	None
57710	57711	adaptive	0	None
57711	57712	evolution	0	None
57712	57713	in	0	None
57713	57714	white	0	None
57714	57715	clover	0	None
57715	57716	.	0	None
57716	57717	Preparation	0	None
57717	57718	of	0	None
57718	57719	functionalized	0	None
57719	57720	alkynyl	2	CHEMICAL
57720	57721	magnetic	0	None
57721	57722	microspheres	0	None
57722	57723	for	0	None
57723	57724	the	0	None
57724	57725	selective	0	None
57725	57726	enrichment	0	None
57726	57727	of	0	None
57727	57728	cell	0	None
57728	57729	glycoproteins	3	GENE-N
57729	57730	based	0	None
57730	57731	on	0	None
57731	57732	click	0	None
57732	57733	chemistry	0	None
57733	57734	.	0	None
57734	57736	Serotonin transporter	1	GENE-Y
57736	57737	gene	0	None
57737	57738	regulatory	0	None
57738	57739	region	0	None
57739	57740	polymorphism	0	None
57740	57741	(	0	None
57741	57742	5-HTTLPR	1	GENE-Y
57742	57743	)	0	None
57743	57744	,	0	None
57744	57745	[	0	None
57745	57746	3H	0	None
57746	57747	]	0	None
57747	57748	paroxetine	2	CHEMICAL
57748	57749	binding	0	None
57749	57750	in	0	None
57750	57751	healthy	0	None
57751	57752	control	0	None
57752	57753	subjects	0	None
57753	57754	and	0	None
57754	57755	alcohol-dependent	0	None
57755	57756	patients	0	None
57756	57757	and	0	None
57757	57758	their	0	None
57758	57759	relationships	0	None
57759	57760	to	0	None
57760	57761	impulsivity	0	None
57761	57762	.	0	None
57762	57763	Binding	0	None
57763	57764	of	0	None
57764	57765	Diverse	0	None
57765	57766	Environmental	0	None
57766	57767	Chemicals	0	None
57767	57768	with	0	None
57768	57769	Human	0	None
57769	57770	Cytochromes	0	None
57770	57771	P450	0	None
57771	57772	2A13	0	None
57772	57773	,	0	None
57773	57774	2A6	0	None
57774	57775	,	0	None
57775	57776	and	0	None
57776	57777	1B1	0	None
57777	57778	and	0	None
57778	57779	Enzyme	0	None
57779	57780	Inhibition	0	None
57780	57781	.	0	None
57781	57782	Effects	0	None
57782	57783	of	0	None
57783	57784	Crataegus	0	None
57784	57785	microphylla	0	None
57785	57786	on	0	None
57786	57787	vascular	0	None
57787	57788	dysfunction	0	None
57788	57789	in	0	None
57789	57790	streptozotocin-induced	0	None
57790	57791	diabetic	0	None
57791	57792	rats	0	None
57792	57793	.	0	None
57793	57794	Lipid	0	None
57794	57795	raft	0	None
57795	57796	modulation	0	None
57796	57797	by	0	None
57797	57798	Rp1	0	None
57798	57799	reverses	0	None
57799	57800	multidrug	0	None
57800	57801	resistance	0	None
57801	57802	via	0	None
57802	57803	inactivating	0	None
57803	57804	MDR-1	0	None
57804	57805	and	0	None
57805	57806	Src	0	None
57806	57807	inhibition	0	None
57807	57808	.	0	None
57808	57809	Triptans	0	None
57809	57810	are	0	None
57810	57811	commonly	0	None
57811	57812	used	0	None
57812	57813	anti-migraine	0	None
57813	57814	drugs	0	None
57814	57815	and	0	None
57815	57816	show	0	None
57816	57817	agonist	0	None
57817	57818	action	0	None
57818	57819	mainly	0	None
57819	57820	at	0	None
57820	57821	serotonin	0	None
57821	57822	5-HT	0	None
57822	57823	(	0	None
57823	57824	1B	0	None
57824	57825	/	0	None
57825	57826	1D	0	None
57826	57827	/	0	None
57827	57828	1F	0	None
57828	57829	)	0	None
57829	57830	receptors	0	None
57830	57831	.	0	None

57832	57833	It	0	None
57833	57834	is	0	None
57834	57835	not	0	None
57835	57836	known	0	None
57836	57837	whether	0	None
57837	57838	frequent	0	None
57838	57839	or	0	None
57839	57840	long-term	0	None
57840	57841	treatment	0	None
57841	57842	with	0	None
57842	57843	these	0	None
57843	57844	drugs	0	None
57844	57845	would	0	None
57845	57846	alter	0	None
57846	57847	5-HT	0	None
57847	57848	receptor	0	None
57848	57849	function	0	None
57849	57850	.	0	None

57851	57852	We	0	None
57852	57853	investigated	0	None
57853	57854	the	0	None
57854	57855	effects	0	None
57855	57856	of	0	None
57856	57857	protracted	0	None
57857	57858	(	0	None
57858	57859	14-18	0	None
57859	57860	days	0	None
57860	57861	)	0	None
57861	57862	sumatriptan	2	CHEMICAL
57862	57863	and	0	None
57863	57864	zolmitriptan	2	CHEMICAL
57864	57865	treatment	0	None
57865	57866	in	0	None
57866	57867	rats	0	None
57867	57868	on	0	None
57868	57869	5-HT	0	None
57869	57870	(	0	None
57870	57871	1	0	None
57871	57872	)	0	None
57872	57873	receptor	0	None
57873	57874	mRNA	0	None
57874	57875	expression	0	None
57875	57876	and	0	None
57876	57877	function	0	None
57877	57878	in	0	None
57878	57879	tissues	0	None
57879	57880	related	0	None
57880	57881	to	0	None
57881	57882	migraine	0	None
57882	57883	pathophysiology	0	None
57883	57884	.	0	None

57885	57886	RT-PCR	0	None
57886	57887	analysis	0	None
57887	57888	revealed	0	None
57888	57889	that	0	None
57889	57890	5-HT	0	None
57890	57891	(	0	None
57891	57892	1B	0	None
57892	57893	/	0	None
57893	57894	1D	0	None
57894	57895	/	0	None
57895	57896	1F	0	None
57896	57897	)	0	None
57897	57898	receptor	0	None
57898	57899	mRNA	0	None
57899	57900	was	0	None
57900	57901	reduced	0	None
57901	57902	in	0	None
57902	57903	the	0	None
57903	57904	trigeminal	0	None
57904	57905	ganglion	0	None
57905	57906	after	0	None
57906	57907	treatment	0	None
57907	57908	with	0	None
57908	57909	either	0	None
57909	57910	triptan	2	CHEMICAL
57910	57911	(	0	None
57911	57912	reduction	0	None
57912	57913	by	0	None
57913	57914	:	0	None
57914	57915	sumatriptan	2	CHEMICAL
57915	57916	39%	0	None
57916	57917	and	0	None
57917	57918	zolmitriptan	2	CHEMICAL
57918	57919	61%	0	None
57919	57920	for	0	None
57920	57921	5-HT	0	None
57921	57922	(	0	None
57922	57923	1B	0	None
57923	57924	)	0	None
57924	57925	;	0	None
57925	57926	60%vs	0	None
57926	57927	41%	0	None
57927	57928	for	0	None
57928	57929	5-HT	0	None
57929	57930	(	0	None
57930	57931	1D	0	None
57931	57932	)	0	None
57932	57933	;	0	None
57933	57934	32%vs	0	None
57934	57935	68%	0	None
57935	57936	for	0	None
57936	57937	5-HT	0	None
57937	57938	(	0	None
57938	57939	1F	0	None
57939	57940	)	0	None
57940	57941	)	0	None
57941	57942	.	0	None

57943	57944	Sumatriptan	2	CHEMICAL
57944	57945	attenuated	0	None
57945	57946	5-HT	0	None
57946	57947	(	0	None
57947	57948	1D	0	None
57948	57949	)	0	None
57949	57950	receptor	0	None
57950	57951	mRNA	0	None
57951	57952	by	0	None
57952	57953	49%	0	None
57953	57954	in	0	None
57954	57955	the	0	None
57955	57956	basilar	0	None
57956	57957	artery	0	None
57957	57958	,	0	None
57958	57959	whereas	0	None
57959	57960	zolmitriptan	2	CHEMICAL
57960	57961	reduced	0	None
57961	57962	5-HT	0	None
57962	57963	(	0	None
57963	57964	1B	0	None
57964	57965	)	0	None
57965	57966	mRNA	0	None
57966	57967	in	0	None
57967	57968	this	0	None
57968	57969	tissue	0	None
57969	57970	by	0	None
57970	57971	70%	0	None
57971	57972	.	0	None

57973	57974	No	0	None
57974	57975	change	0	None
57975	57976	in	0	None
57976	57977	5-HT	0	None
57977	57978	(	0	None
57978	57979	1	0	None
57979	57980	)	0	None
57980	57981	receptor	0	None
57981	57982	mRNA	0	None
57982	57983	expression	0	None
57983	57984	was	0	None
57984	57985	observed	0	None
57985	57986	in	0	None
57986	57987	coronary	0	None
57987	57988	artery	0	None
57988	57989	and	0	None
57989	57990	dura	0	None
57990	57991	mater	0	None
57991	57992	.	0	None

57993	57994	Chronic	0	None
57994	57995	triptan	2	CHEMICAL
57995	57996	treatment	0	None
57996	57997	had	0	None
57997	57998	no	0	None
57998	57999	effect	0	None
57999	58000	in	0	None
58000	58001	two	0	None
58001	58002	functional	0	None
58002	58003	assays	0	None
58003	58004	[	0	None
58004	58005	sumatriptan	2	CHEMICAL
58005	58006	mediated	0	None
58006	58007	inhibition	0	None
58007	58008	(	0	None
58008	58009	50	0	None
58009	58010	mg	2	CHEMICAL
58010	58011	/	0	None
58011	58012	kg	0	None
58012	58013	,	0	None
58013	58014	i	0	None
58014	58015	.	0	None

58016	58017	p	0	None
58017	58018	.	0	None

58019	58020	)	0	None
58020	58021	of	0	None
58021	58022	electrically	0	None
58022	58023	induced	0	None
58023	58024	plasma	0	None
58024	58025	protein	0	None
58025	58026	extravasation	0	None
58026	58027	in	0	None
58027	58028	dura	0	None
58028	58029	mater	0	None
58029	58030	and	0	None
58030	58031	5-nonyloxytryptamine-stimulated	0	None
58031	58032	[	0	None
58032	58033	(	0	None
58033	58034	35	0	None
58034	58035	)	0	None
58035	58036	S	0	None
58036	58037	]	0	None
58037	58038	guanosine-5'-O-	0	None
58038	58039	(	0	None
58039	58040	3-thio	0	None
58040	58041	)	0	None
58041	58042	triphosphate	0	None
58042	58043	binding	0	None
58043	58044	in	0	None
58044	58045	substantia	0	None
58045	58046	nigra	0	None
58046	58047	]	0	None
58047	58048	.	0	None

58049	58050	Furthermore	0	None
58050	58051	,	0	None
58051	58052	vasoconstriction	0	None
58052	58053	to	0	None
58053	58054	5-HT	0	None
58054	58055	in	0	None
58055	58056	isolated	0	None
58056	58057	basilar	0	None
58057	58058	artery	0	None
58058	58059	was	0	None
58059	58060	not	0	None
58060	58061	affected	0	None
58061	58062	by	0	None
58062	58063	chronic	0	None
58063	58064	triptan	2	CHEMICAL
58064	58065	treatment	0	None
58065	58066	,	0	None
58066	58067	while	0	None
58067	58068	it	0	None
58068	58069	was	0	None
58069	58070	slightly	0	None
58070	58071	reduced	0	None
58071	58072	in	0	None
58072	58073	coronary	0	None
58073	58074	artery	0	None
58074	58075	.	0	None

58076	58077	We	0	None
58077	58078	conclude	0	None
58078	58079	that	0	None
58079	58080	,	0	None
58080	58081	although	0	None
58081	58082	our	0	None
58082	58083	treatment	0	None
58083	58084	protocol	0	None
58084	58085	altered	0	None
58085	58086	mRNA	0	None
58086	58087	receptor	0	None
58087	58088	expression	0	None
58088	58089	in	0	None
58089	58090	several	0	None
58090	58091	tissues	0	None
58091	58092	relevant	0	None
58092	58093	to	0	None
58093	58094	migraine	0	None
58094	58095	pathophysiology	0	None
58095	58096	,	0	None
58096	58097	it	0	None
58097	58098	did	0	None
58098	58099	not	0	None
58099	58100	attenuate	0	None
58100	58101	5-HT	0	None
58101	58102	(	0	None
58102	58103	1	0	None
58103	58104	)	0	None
58104	58105	receptor-dependent	0	None
58105	58106	functions	0	None
58106	58107	in	0	None
58107	58108	rats	0	None
58108	58109	.	0	None
58109	58110	Although	0	None
58110	58111	osteoclasts	0	None
58111	58112	incorporate	0	None
58112	58113	bisphosphonates	2	CHEMICAL
58113	58114	during	0	None
58114	58115	bone	0	None
58115	58116	resorption	0	None
58116	58117	,	0	None
58117	58118	the	0	None
58118	58119	mechanism	0	None
58119	58120	of	0	None
58120	58121	this	0	None
58121	58122	incorporation	0	None
58122	58123	by	0	None
58123	58124	osteoclasts	0	None
58124	58125	is	0	None
58125	58126	not	0	None
58126	58127	known	0	None
58127	58128	.	0	None

58129	58130	We	0	None
58130	58131	previously	0	None
58131	58132	reported	0	None
58132	58133	that	0	None
58133	58134	bisphosphonates	2	CHEMICAL
58134	58135	disrupt	0	None
58135	58136	the	0	None
58136	58137	actin	3	GENE-N
58137	58138	rings	0	None
58138	58139	(	0	None
58139	58140	clear	0	None
58140	58141	zones	0	None
58141	58142	)	0	None
58142	58143	formed	0	None
58143	58144	in	0	None
58144	58145	normal	0	None
58145	58146	osteoclasts	0	None
58146	58147	,	0	None
58147	58148	but	0	None
58148	58149	did	0	None
58149	58150	not	0	None
58150	58151	disrupt	0	None
58151	58152	actin	3	GENE-N
58152	58153	rings	0	None
58153	58154	in	0	None
58154	58155	osteoclasts	0	None
58155	58156	derived	0	None
58156	58157	from	0	None
58157	58158	osteosclerotic	0	None
58158	58159	oc	0	None
58159	58160	/	0	None
58160	58161	oc	0	None
58161	58162	mice	0	None
58162	58163	,	0	None
58163	58164	which	0	None
58164	58165	have	0	None
58165	58166	a	0	None
58166	58167	defect	0	None
58167	58168	in	0	None
58168	58169	the	0	None
58169	58170	gene	0	None
58170	58171	encoding	0	None
58171	58172	vacuolar	0	None
58172	58173	H	0	None
58173	58174	(	0	None
58174	58175	+	0	None
58175	58176	)	0	None
58176	58177	-ATPase	0	None
58177	58178	(	0	None
58178	58179	V-ATPase	3	GENE-N
58179	58180	)	0	None
58180	58181	.	0	None

58182	58183	The	0	None
58183	58184	present	0	None
58184	58185	study	0	None
58185	58186	showed	0	None
58186	58187	that	0	None
58187	58188	V-ATPase	3	GENE-N
58188	58189	is	0	None
58189	58190	directly	0	None
58190	58191	involved	0	None
58191	58192	in	0	None
58192	58193	the	0	None
58193	58194	incorporation	0	None
58194	58195	of	0	None
58195	58196	risedronate	0	None
58196	58197	,	0	None
58197	58198	a	0	None
58198	58199	nitrogen	0	None
58199	58200	containing	0	None
58200	58201	bisphosphonate	0	None
58201	58202	,	0	None
58202	58203	into	0	None
58203	58204	osteoclasts	0	None
58204	58205	.	0	None

58206	58207	Treatment	0	None
58207	58208	of	0	None
58208	58209	osteoclasts	0	None
58209	58210	with	0	None
58210	58211	risedronate	0	None
58211	58212	disrupted	0	None
58212	58213	actin	3	GENE-N
58213	58214	rings	0	None
58214	58215	and	0	None
58215	58216	inhibited	0	None
58216	58217	pit	0	None
58217	58218	formation	0	None
58218	58219	by	0	None
58219	58220	osteoclasts	0	None
58220	58221	on	0	None
58221	58222	dentine	0	None
58222	58223	slices	0	None
58223	58224	.	0	None

58225	58226	Bafilomycin	0	None
58226	58227	A	0	None
58227	58228	(	0	None
58228	58229	1	0	None
58229	58230	)	0	None
58230	58231	,	0	None
58231	58232	a	0	None
58232	58233	V-ATPase	3	GENE-N
58233	58234	inhibitor	0	None
58234	58235	,	0	None
58235	58236	inhibited	0	None
58236	58237	the	0	None
58237	58238	pit-forming	0	None
58238	58239	activity	0	None
58239	58240	of	0	None
58240	58241	osteoclasts	0	None
58241	58242	but	0	None
58242	58243	did	0	None
58243	58244	not	0	None
58244	58245	disrupt	0	None
58245	58246	actin	3	GENE-N
58246	58247	rings	0	None
58247	58248	.	0	None

58249	58250	Risedronate	0	None
58250	58251	failed	0	None
58251	58252	to	0	None
58252	58253	disrupt	0	None
58253	58254	actin	3	GENE-N
58254	58255	rings	0	None
58255	58256	in	0	None
58256	58257	the	0	None
58257	58258	presence	0	None
58258	58259	of	0	None
58259	58260	bafilomycin	0	None
58260	58261	A	0	None
58261	58262	(	0	None
58262	58263	1	0	None
58263	58264	)	0	None
58264	58265	.	0	None

58266	58267	E-64	0	None
58267	58268	,	0	None
58268	58269	a	0	None
58269	58270	lysosomal	0	None
58270	58271	cysteine	0	None
58271	58272	proteinase	0	None
58272	58273	inhibitor	0	None
58273	58274	,	0	None
58274	58275	showed	0	None
58275	58276	no	0	None
58276	58277	inhibitory	0	None
58277	58278	effect	0	None
58278	58279	on	0	None
58279	58280	the	0	None
58280	58281	demineralization	0	None
58281	58282	of	0	None
58282	58283	dentine	0	None
58283	58284	by	0	None
58284	58285	osteoclasts	0	None
58285	58286	but	0	None
58286	58287	inhibited	0	None
58287	58288	the	0	None
58288	58289	digestion	0	None
58289	58290	of	0	None
58290	58291	dentine	0	None
58291	58292	matrix	0	None
58292	58293	proteins	0	None
58293	58294	without	0	None
58294	58295	disrupting	0	None
58295	58296	actin	3	GENE-N
58296	58297	rings	0	None
58297	58298	.	0	None

58299	58300	Risedronate	0	None
58300	58301	disrupted	0	None
58301	58302	actin	3	GENE-N
58302	58303	rings	0	None
58303	58304	even	0	None
58304	58305	in	0	None
58305	58306	the	0	None
58306	58307	presence	0	None
58307	58308	of	0	None
58308	58309	E-64	0	None
58309	58310	.	0	None

58311	58312	Treatment	0	None
58312	58313	of	0	None
58313	58314	osteoclasts	0	None
58314	58315	placed	0	None
58315	58316	on	0	None
58316	58317	plastic	0	None
58317	58318	plates	0	None
58318	58319	with	0	None
58319	58320	risedronate	0	None
58320	58321	also	0	None
58321	58322	disrupted	0	None
58322	58323	actin	3	GENE-N
58323	58324	rings	0	None
58324	58325	.	0	None

58326	58327	Bafilomycin	0	None
58327	58328	A	0	None
58328	58329	(	0	None
58329	58330	1	0	None
58330	58331	)	0	None
58331	58332	but	0	None
58332	58333	not	0	None
58333	58334	E64	0	None
58334	58335	prevented	0	None
58335	58336	the	0	None
58336	58337	disruption	0	None
58337	58338	of	0	None
58338	58339	actin	3	GENE-N
58339	58340	rings	0	None
58340	58341	in	0	None
58341	58342	osteoclasts	0	None
58342	58343	treated	0	None
58343	58344	with	0	None
58344	58345	risedronate	0	None
58345	58346	on	0	None
58346	58347	plastic	0	None
58347	58348	plates	0	None
58348	58349	.	0	None

58350	58351	Inhibition	0	None
58351	58352	of	0	None
58352	58353	V-ATPase	3	GENE-N
58353	58354	with	0	None
58354	58355	bafilomycin	0	None
58355	58356	A	0	None
58356	58357	(	0	None
58357	58358	1	0	None
58358	58359	)	0	None
58359	58360	also	0	None
58360	58361	prevented	0	None
58361	58362	disruption	0	None
58362	58363	of	0	None
58363	58364	actin	3	GENE-N
58364	58365	rings	0	None
58365	58366	by	0	None
58366	58367	etidronate	0	None
58367	58368	,	0	None
58368	58369	a	0	None
58369	58370	non-nitrogen-containing	0	None
58370	58371	bisphosphonate	0	None
58371	58372	.	0	None

58373	58374	These	0	None
58374	58375	results	0	None
58375	58376	suggest	0	None
58376	58377	that	0	None
58377	58378	V-ATPase	3	GENE-N
58378	58379	induced	0	None
58379	58380	acidification	0	None
58380	58381	beneath	0	None
58381	58382	the	0	None
58382	58383	ruffled	0	None
58383	58384	borders	0	None
58384	58385	of	0	None
58385	58386	osteoclasts	0	None
58386	58387	and	0	None
58387	58388	subsequent	0	None
58388	58389	bone	0	None
58389	58390	demineralization	0	None
58390	58391	triggers	0	None
58391	58392	the	0	None
58392	58393	incorporation	0	None
58393	58394	of	0	None
58394	58395	both	0	None
58395	58396	nitrogen-containing	0	None
58396	58397	and	0	None
58397	58398	non-nitrogen-containing	0	None
58398	58399	bisphosphonates	2	CHEMICAL
58399	58400	into	0	None
58400	58401	osteoclasts	0	None
58401	58402	.	0	None
58402	58403	The	0	None
58403	58404	expression	0	None
58404	58405	and	0	None
58405	58406	activity	0	None
58406	58407	of	0	None
58407	58408	Fatty	0	None
58408	58409	Acid	0	None
58409	58410	Synthase	0	None
58410	58411	(	0	None
58411	58412	FASN;	0	None
58412	58413	the	0	None
58413	58414	sole	0	None
58414	58415	enzyme	0	None
58415	58416	capable	0	None
58416	58417	of	0	None
58417	58418	the	0	None
58418	58419	reductive	0	None
58419	58420	de	0	None
58420	58421	novo	0	None
58421	58422	synthesis	0	None
58422	58423	of	0	None
58423	58424	long-chain	0	None
58424	58426	fatty acids	2	CHEMICAL
58426	58427	from	0	None
58427	58428	acetyl-CoA	0	None
58428	58429	,	0	None
58429	58430	malonyl-CoA	0	None
58430	58431	,	0	None
58431	58432	and	0	None
58432	58433	nicotinamide	0	None
58433	58434	adenine	2	CHEMICAL
58434	58435	dinucleotide	0	None
58435	58436	phosphate	0	None
58436	58437	-NADPH-	0	None
58437	58438	)	0	None
58438	58439	is	0	None
58439	58440	extremely	0	None
58440	58441	low	0	None
58441	58442	in	0	None
58442	58443	nearly	0	None
58443	58444	all	0	None
58444	58445	nonmalignant	0	None
58445	58446	adult	0	None
58446	58447	tissues	0	None
58447	58448	,	0	None
58448	58449	whereas	0	None
58449	58450	it	0	None
58450	58451	is	0	None
58451	58452	significantly	0	None
58452	58453	up-regulated	0	None
58453	58454	or	0	None
58454	58455	activated	0	None
58455	58456	in	0	None
58456	58457	many	0	None
58457	58458	cancer	0	None
58458	58459	types	0	None
58459	58460	,	0	None
58460	58461	thus	0	None
58461	58462	creating	0	None
58462	58463	the	0	None
58463	58464	potential	0	None
58464	58465	for	0	None
58465	58466	a	0	None
58466	58467	large	0	None
58467	58468	therapeutic	0	None
58468	58469	index	0	None
58469	58470	.	0	None

58471	58472	Since	0	None
58472	58473	the	0	None
58473	58474	pioneering	0	None
58474	58475	observation	0	None
58475	58476	that	0	None
58476	58477	inhibition	0	None
58477	58478	of	0	None
58478	58479	FASN	0	None
58479	58480	activity	0	None
58480	58481	by	0	None
58481	58482	the	0	None
58482	58483	mycotoxin	0	None
58483	58484	cerulenin	0	None
58484	58485	preferentially	0	None
58485	58486	kills	0	None
58486	58487	cancer	0	None
58487	58488	cells	0	None
58488	58489	and	0	None
58489	58490	retards	0	None
58490	58491	the	0	None
58491	58492	growth	0	None
58492	58493	of	0	None
58493	58494	tumors	0	None
58494	58495	in	0	None
58495	58496	xenografts	0	None
58496	58497	models	0	None
58497	58498	,	0	None
58498	58499	numerous	0	None
58499	58500	in	0	None
58500	58501	vitro	0	None
58501	58502	and	0	None
58502	58503	in	0	None
58503	58504	vivo	0	None
58504	58505	studies	0	None
58505	58506	have	0	None
58506	58507	confirmed	0	None
58507	58508	the	0	None
58508	58509	potential	0	None
58509	58510	of	0	None
58510	58511	FASN	0	None
58511	58512	as	0	None
58512	58513	a	0	None
58513	58514	target	0	None
58514	58515	for	0	None
58515	58516	antineoplastic	0	None
58516	58517	intervention	0	None
58517	58518	.	0	None

58519	58520	Other	0	None
58520	58521	FASN	0	None
58521	58522	inhibitors	0	None
58522	58523	such	0	None
58523	58524	as	0	None
58524	58525	the	0	None
58525	58526	cerulenin	0	None
58526	58527	derivative	0	None
58527	58528	C75	0	None
58528	58529	,	0	None
58529	58530	the	0	None
58530	58531	beta-lactone	0	None
58531	58532	orlistat	0	None
58532	58533	,	0	None
58533	58534	the	0	None
58534	58535	green	0	None
58535	58536	tea	0	None
58536	58537	polyphenol	0	None
58537	58538	epigallocatechin-3-gallate	0	None
58538	58539	(	0	None
58539	58540	EGCG	2	CHEMICAL
58540	58541	)	0	None
58541	58542	and	0	None
58542	58543	other	0	None
58543	58544	naturally	0	None
58544	58545	occurring	0	None
58545	58546	flavonoids	0	None
58546	58547	(	0	None
58547	58548	i	0	None
58548	58549	.	0	None

58550	58551	e	0	None
58551	58552	.	0	None

58553	58554	,	0	None
58554	58555	luteolin	2	CHEMICAL
58555	58556	,	0	None
58556	58557	quercetin	0	None
58557	58558	,	0	None
58558	58559	and	0	None
58559	58560	kaempferol	0	None
58560	58561	)	0	None
58561	58562	,	0	None
58562	58563	as	0	None
58563	58564	well	0	None
58564	58565	as	0	None
58565	58566	the	0	None
58566	58567	antibiotic	0	None
58567	58568	triclosan	0	None
58568	58569	,	0	None
58569	58570	have	0	None
58570	58571	been	0	None
58571	58572	identified	0	None
58572	58573	and	0	None
58573	58574	have	0	None
58574	58575	been	0	None
58575	58576	shown	0	None
58576	58577	to	0	None
58577	58578	limit	0	None
58578	58579	cancer	0	None
58579	58580	cell	0	None
58580	58581	growth	0	None
58581	58582	by	0	None
58582	58583	inducing	0	None
58583	58584	apoptotic	0	None
58584	58585	cell	0	None
58585	58586	death	0	None
58586	58587	.	0	None

58588	58589	Though	0	None
58589	58590	the	0	None
58590	58591	exact	0	None
58591	58592	mode	0	None
58592	58593	of	0	None
58593	58594	action	0	None
58594	58595	of	0	None
58595	58596	these	0	None
58596	58597	FASN	0	None
58597	58598	inhibitors	0	None
58598	58599	is	0	None
58599	58600	under	0	None
58600	58601	discussion	0	None
58601	58602	,	0	None
58602	58603	it	0	None
58603	58604	has	0	None
58604	58605	been	0	None
58605	58606	revealed	0	None
58606	58607	that	0	None
58607	58608	depletion	0	None
58608	58609	of	0	None
58609	58610	end-product	0	None
58610	58612	fatty acids	2	CHEMICAL
58612	58613	,	0	None
58613	58614	toxic	0	None
58614	58615	intracellular	0	None
58615	58616	accumulation	0	None
58616	58617	of	0	None
58617	58618	supra-physiological	0	None
58618	58619	concentrations	0	None
58619	58620	of	0	None
58620	58621	the	0	None
58621	58622	FASN	0	None
58622	58623	substrate	0	None
58623	58624	malonyl-CoA	0	None
58624	58625	and	0	None
58625	58626	/	0	None
58626	58627	or	0	None
58627	58628	limited	0	None
58628	58629	membrane	0	None
58629	58630	synthesis	0	None
58630	58631	and	0	None
58631	58632	/	0	None
58632	58633	or	0	None
58633	58634	functioning	0	None
58634	58635	by	0	None
58635	58636	altered	0	None
58636	58637	production	0	None
58637	58638	of	0	None
58638	58639	phospholipids	0	None
58639	58640	partitioning	0	None
58640	58641	into	0	None
58641	58642	detergent-resistant	0	None
58642	58643	membrane	0	None
58643	58644	microdomains	0	None
58644	58645	(	0	None
58645	58646	lipid	0	None
58646	58647	raft-aggregates	0	None
58647	58648	)	0	None
58648	58649	,	0	None
58649	58650	can	0	None
58650	58651	explain	0	None
58651	58652	,	0	None
58652	58653	at	0	None
58653	58654	least	0	None
58654	58655	in	0	None
58655	58656	part	0	None
58656	58657	,	0	None
58657	58658	the	0	None
58658	58659	cytostatic	0	None
58659	58660	,	0	None
58660	58661	cytotoxic	0	None
58661	58662	as	0	None
58662	58663	well	0	None
58663	58664	as	0	None
58664	58665	the	0	None
58665	58666	apoptotic	0	None
58666	58667	effects	0	None
58667	58668	occurring	0	None
58668	58669	upon	0	None
58669	58670	pharmacological	0	None
58670	58671	inhibition	0	None
58671	58672	of	0	None
58672	58673	FASN	0	None
58673	58674	activity	0	None
58674	58675	in	0	None
58675	58676	cancer	0	None
58676	58677	cells	0	None
58677	58678	.	0	None

58679	58680	Moreover	0	None
58680	58681	,	0	None
58681	58682	several	0	None
58682	58683	cancer-associated	0	None
58683	58684	molecular	0	None
58684	58685	features	0	None
58685	58686	including	0	None
58686	58687	nonfunctioning	0	None
58687	58688	p53	0	None
58688	58689	,	0	None
58689	58690	overexpression	0	None
58690	58691	of	0	None
58691	58692	the	0	None
58692	58693	Her-2	0	None
58693	58694	/	0	None
58694	58695	neu	1	GENE-Y
58695	58696	(	0	None
58696	58697	erbB-2	0	None
58697	58698	)	0	None
58698	58699	oncogene	0	None
58699	58700	,	0	None
58700	58701	and	0	None
58701	58702	hyperactivation	0	None
58702	58703	of	0	None
58703	58704	the	0	None
58704	58705	PI-3'K	0	None
58705	58706	down-stream	0	None
58706	58707	effector	0	None
58707	58708	protein	0	None
58708	58709	kinase	0	None
58709	58710	B	0	None
58710	58711	(	0	None
58711	58712	AKT	3	GENE-N
58712	58713	)	0	None
58713	58714	,	0	None
58714	58715	appear	0	None
58715	58716	to	0	None
58716	58717	determine	0	None
58717	58718	an	0	None
58718	58719	exacerbated	0	None
58719	58720	sensitivity	0	None
58720	58721	to	0	None
58721	58722	FASN	0	None
58722	58723	inhibition-induced	0	None
58723	58724	cancer	0	None
58724	58725	cell	0	None
58725	58726	death	0	None
58726	58727	.	0	None

58728	58729	Although	0	None
58729	58730	few	0	None
58730	58731	of	0	None
58731	58732	these	0	None
58732	58733	inhibitors	0	None
58733	58734	are	0	None
58734	58735	expected	0	None
58735	58736	to	0	None
58736	58737	be	0	None
58737	58738	"exclusively"	0	None
58738	58739	selective	0	None
58739	58740	for	0	None
58740	58741	FASN	0	None
58741	58742	,	0	None
58742	58743	the	0	None
58743	58744	potential	0	None
58744	58745	of	0	None
58745	58746	FASN	0	None
58746	58747	as	0	None
58747	58748	a	0	None
58748	58749	target	0	None
58749	58750	for	0	None
58750	58751	antineoplastic	0	None
58751	58752	intervention	0	None
58752	58753	has	0	None
58753	58754	eventually	0	None
58754	58755	been	0	None
58755	58756	confirmed	0	None
58756	58757	by	0	None
58757	58758	RNA	0	None
58758	58759	interference	0	None
58759	58760	(	0	None
58760	58761	RNAi	0	None
58761	58762	)	0	None
58762	58763	-knockdown	0	None
58763	58764	of	0	None
58764	58765	FASN	0	None
58765	58766	.	0	None

58767	58768	Certainly	0	None
58768	58769	,	0	None
58769	58770	future	0	None
58770	58771	studies	0	None
58771	58772	should	0	None
58772	58773	definitely	0	None
58773	58774	elucidate	0	None
58774	58775	the	0	None
58775	58776	ultimate	0	None
58776	58777	biochemical	0	None
58777	58778	link	0	None
58778	58779	between	0	None
58779	58780	FASN	0	None
58780	58781	inhibition	0	None
58781	58782	and	0	None
58782	58783	cancer	0	None
58783	58784	cell	0	None
58784	58785	death	0	None
58785	58786	.	0	None

58787	58788	Although	0	None
58788	58789	the	0	None
58789	58790	combination	0	None
58790	58791	of	0	None
58791	58792	FASN	0	None
58792	58793	structural	0	None
58793	58794	complexity	0	None
58794	58795	and	0	None
58795	58796	until	0	None
58796	58797	recently	0	None
58797	58798	the	0	None
58798	58799	lack	0	None
58799	58800	of	0	None
58800	58801	X-ray	0	None
58801	58802	crystallography	0	None
58802	58803	data	0	None
58803	58804	of	0	None
58804	58805	mammalian	0	None
58805	58806	FASN	0	None
58806	58807	created	0	None
58807	58808	a	0	None
58808	58809	significant	0	None
58809	58810	challenge	0	None
58810	58811	in	0	None
58811	58812	the	0	None
58812	58813	exploitation	0	None
58813	58814	of	0	None
58814	58815	FASN	0	None
58815	58816	as	0	None
58816	58817	a	0	None
58817	58818	valuable	0	None
58818	58819	target	0	None
58819	58820	for	0	None
58820	58821	drug	0	None
58821	58822	development	0	None
58822	58823	,	0	None
58823	58824	it	0	None
58824	58825	is	0	None
58825	58826	hoped	0	None
58826	58827	that	0	None
58827	58828	the	0	None
58828	58829	improvement	0	None
58829	58830	in	0	None
58830	58831	the	0	None
58831	58832	selectivity	0	None
58832	58833	and	0	None
58833	58834	potency	0	None
58834	58835	of	0	None
58835	58836	forthcoming	0	None
58836	58837	novel	0	None
58837	58838	FASN-targeted	0	None
58838	58839	small	0	None
58839	58840	molecule	0	None
58840	58841	inhibitors	0	None
58841	58842	by	0	None
58842	58843	taking	0	None
58843	58844	advantage	0	None
58844	58845	,	0	None
58845	58846	for	0	None
58846	58847	instance	0	None
58847	58848	,	0	None
58848	58849	of	0	None
58849	58850	the	0	None
58850	58851	recent	0	None
58851	58852	4	0	None
58852	58853	.	0	None
58853	58854	5	0	None
58854	58855	A	0	None
58855	58856	resolution	0	None
58856	58857	X-ray	0	None
58857	58858	crystallographic	0	None
58858	58859	map	0	None
58859	58860	of	0	None
58860	58861	mammalian	0	None
58861	58862	FASN	0	None
58862	58863	,	0	None
58863	58864	will	0	None
58864	58865	direct	0	None
58865	58866	the	0	None
58866	58867	foundation	0	None
58867	58868	of	0	None
58868	58869	a	0	None
58869	58870	new	0	None
58870	58871	family	0	None
58871	58872	of	0	None
58872	58873	chemotherapeutic	0	None
58873	58874	agents	0	None
58874	58875	in	0	None
58875	58876	cancer	0	None
58876	58877	history	0	None
58877	58878	.	0	None
58878	58879	Full	0	None
58879	58880	agonists	0	None
58880	58881	to	0	None
58881	58882	the	0	None
58882	58883	peroxisome	0	None
58883	58884	proliferator-activated	0	None
58884	58885	receptor	0	None
58885	58886	(	0	None
58886	58887	PPAR	0	None
58887	58888	)	0	None
58888	58889	γ	0	None
58889	58890	,	0	None
58890	58891	such	0	None
58891	58892	as	0	None
58892	58893	Rosiglitazone	0	None
58893	58894	,	0	None
58894	58895	have	0	None
58895	58896	been	0	None
58896	58897	associated	0	None
58897	58898	with	0	None
58898	58899	a	0	None
58899	58900	series	0	None
58900	58901	of	0	None
58901	58902	undesired	0	None
58902	58903	side	0	None
58903	58904	effects	0	None
58904	58905	,	0	None
58905	58906	such	0	None
58906	58907	as	0	None
58907	58908	weight	0	None
58908	58909	gain	0	None
58909	58910	,	0	None
58910	58911	fluid	0	None
58911	58912	retention	0	None
58912	58913	,	0	None
58913	58914	cardiac	0	None
58914	58915	hypertrophy	0	None
58915	58916	,	0	None
58916	58917	and	0	None
58917	58918	hepatotoxicity	0	None
58918	58919	.	0	None

58920	58921	Nevertheless	0	None
58921	58922	,	0	None
58922	58923	PPARγ	0	None
58923	58924	is	0	None
58924	58925	involved	0	None
58925	58926	in	0	None
58926	58927	the	0	None
58927	58928	expression	0	None
58928	58929	of	0	None
58929	58930	genes	0	None
58930	58931	that	0	None
58931	58932	control	0	None
58932	58933	glucose	0	None
58933	58934	and	0	None
58934	58935	lipid	0	None
58935	58936	metabolism	0	None
58936	58937	and	0	None
58937	58938	is	0	None
58938	58939	an	0	None
58939	58940	important	0	None
58940	58941	target	0	None
58941	58942	for	0	None
58942	58943	drugs	0	None
58943	58944	against	0	None
58944	58945	type	0	None
58945	58946	2	0	None
58946	58947	diabetes	0	None
58947	58948	,	0	None
58948	58949	dyslipidemia	0	None
58949	58950	,	0	None
58950	58951	atherosclerosis	0	None
58951	58952	,	0	None
58952	58953	and	0	None
58953	58954	cardiovascular	0	None
58954	58955	disease	0	None
58955	58956	.	0	None

58957	58958	In	0	None
58958	58959	an	0	None
58959	58960	effort	0	None
58960	58961	to	0	None
58961	58962	identify	0	None
58962	58963	novel	0	None
58963	58964	PPARγ	0	None
58964	58965	ligands	0	None
58965	58966	with	0	None
58966	58967	an	0	None
58967	58968	improved	0	None
58968	58969	pharmacological	0	None
58969	58970	profile	0	None
58970	58971	,	0	None
58971	58972	emphasis	0	None
58972	58973	has	0	None
58973	58974	shifted	0	None
58974	58975	to	0	None
58975	58976	selective	0	None
58976	58977	ligands	0	None
58977	58978	with	0	None
58978	58979	partial	0	None
58979	58980	agonist	0	None
58980	58981	binding	0	None
58981	58982	properties	0	None
58982	58983	.	0	None

58984	58985	Toward	0	None
58985	58986	this	0	None
58986	58987	end	0	None
58987	58988	we	0	None
58988	58989	applied	0	None
58989	58990	an	0	None
58990	58991	integrated	0	None
58991	58992	in	0	None
58992	58993	silico	0	None
58993	58994	/	0	None
58994	58995	in	0	None
58995	58996	vitro	0	None
58996	58997	workflow	0	None
58997	58998	,	0	None
58998	58999	based	0	None
58999	59000	on	0	None
59000	59001	pharmacophore-	0	None
59001	59002	and	0	None
59002	59003	structure-based	0	None
59003	59004	virtual	0	None
59004	59005	screening	0	None
59005	59006	of	0	None
59006	59007	the	0	None
59007	59008	ZINC	2	CHEMICAL
59008	59009	library	0	None
59009	59010	,	0	None
59010	59011	coupled	0	None
59011	59012	with	0	None
59012	59013	competitive	0	None
59013	59014	binding	0	None
59014	59015	and	0	None
59015	59016	transactivation	0	None
59016	59017	assays	0	None
59017	59018	,	0	None
59018	59019	and	0	None
59019	59020	adipocyte	0	None
59020	59021	differentiation	0	None
59021	59022	and	0	None
59022	59023	gene	0	None
59023	59024	expression	0	None
59024	59025	studies	0	None
59025	59026	.	0	None

59027	59028	Hit	0	None
59028	59029	compound	0	None
59029	59030	9	0	None
59030	59031	was	0	None
59031	59032	identified	0	None
59032	59033	as	0	None
59033	59034	the	0	None
59034	59035	most	0	None
59035	59036	potent	0	None
59036	59037	ligand	0	None
59037	59038	(	0	None
59038	59039	IC50	0	None
59039	59040	=	0	None
59040	59041	0	0	None
59041	59042	.	0	None
59042	59043	3	0	None
59043	59044	μM	0	None
59044	59045	)	0	None
59045	59046	and	0	None
59046	59047	a	0	None
59047	59048	relatively	0	None
59048	59049	poor	0	None
59049	59050	inducer	0	None
59050	59051	of	0	None
59051	59052	adipocyte	0	None
59052	59053	differentiation	0	None
59053	59054	.	0	None

59055	59056	The	0	None
59056	59057	binding	0	None
59057	59058	mode	0	None
59058	59059	of	0	None
59059	59060	compound	0	None
59060	59061	9	0	None
59061	59062	was	0	None
59062	59063	confirmed	0	None
59063	59064	by	0	None
59064	59065	molecular	0	None
59065	59066	dynamics	0	None
59066	59067	simulation	0	None
59067	59068	,	0	None
59068	59069	and	0	None
59069	59070	the	0	None
59070	59071	calculated	0	None
59071	59072	free	0	None
59072	59073	energy	0	None
59073	59074	of	0	None
59074	59075	binding	0	None
59075	59076	was	0	None
59076	59077	-8	0	None
59077	59078	.	0	None
59078	59079	4	0	None
59079	59080	kcal	0	None
59080	59081	/	0	None
59081	59082	mol	0	None
59082	59083	.	0	None

59084	59085	A	0	None
59085	59086	novel	0	None
59086	59087	functional	0	None
59087	59088	group	0	None
59088	59089	,	0	None
59089	59090	the	0	None
59090	59091	carbonitrile	0	None
59091	59092	group	0	None
59092	59093	,	0	None
59093	59094	was	0	None
59094	59095	identified	0	None
59095	59096	to	0	None
59096	59097	be	0	None
59097	59098	a	0	None
59098	59099	key	0	None
59099	59100	substituent	0	None
59100	59101	in	0	None
59101	59102	the	0	None
59102	59103	ligand-protein	0	None
59103	59104	interactions	0	None
59104	59105	.	0	None

59106	59107	Further	0	None
59107	59108	studies	0	None
59108	59109	on	0	None
59109	59110	the	0	None
59110	59111	transcriptional	0	None
59111	59112	regulation	0	None
59112	59113	properties	0	None
59113	59114	of	0	None
59114	59115	compound	0	None
59115	59116	9	0	None
59116	59117	revealed	0	None
59117	59118	a	0	None
59118	59119	gene	0	None
59119	59120	regulatory	0	None
59120	59121	profile	0	None
59121	59122	that	0	None
59122	59123	was	0	None
59123	59124	to	0	None
59124	59125	a	0	None
59125	59126	large	0	None
59126	59127	extent	0	None
59127	59128	unique	0	None
59128	59129	,	0	None
59129	59130	however	0	None
59130	59131	functionally	0	None
59131	59132	closer	0	None
59132	59133	to	0	None
59133	59134	that	0	None
59134	59135	of	0	None
59135	59136	a	0	None
59136	59137	partial	0	None
59137	59138	agonist	0	None
59138	59139	.	0	None
59139	59140	Externalization	0	None
59140	59141	of	0	None
59141	59142	phosphatidylserine	2	CHEMICAL
59142	59143	during	0	None
59143	59144	apoptosis	0	None
59144	59145	does	0	None
59145	59146	not	0	None
59146	59147	specifically	0	None
59147	59148	require	0	None
59148	59149	either	0	None
59149	59150	isoform	0	None
59150	59151	of	0	None
59151	59152	phosphatidylserine	2	CHEMICAL
59152	59153	synthase	0	None
59153	59154	.	0	None
59154	59155	The	0	None
59155	59156	propeptides	0	None
59156	59157	of	0	None
59157	59158	VEGF-D	1	GENE-Y
59158	59159	determine	0	None
59159	59160	heparin	0	None
59160	59161	binding	0	None
59161	59162	,	0	None
59162	59163	receptor	0	None
59163	59164	heterodimerization	0	None
59164	59165	,	0	None
59165	59166	and	0	None
59166	59167	effects	0	None
59167	59168	on	0	None
59168	59169	tumor	0	None
59169	59170	biology	0	None
59170	59171	.	0	None
59171	59172	Ginseng	0	None
59172	59173	has	0	None
59173	59174	shown	0	None
59174	59175	an	0	None
59175	59176	efficacy	0	None
59176	59177	in	0	None
59177	59178	preventing	0	None
59178	59179	and	0	None
59179	59180	managing	0	None
59180	59181	various	0	None
59181	59182	health	0	None
59182	59183	conditions	0	None
59183	59184	.	0	None

59185	59186	This	0	None
59186	59187	study	0	None
59187	59188	aimed	0	None
59188	59189	to	0	None
59189	59190	evaluate	0	None
59190	59191	the	0	None
59191	59192	effect	0	None
59192	59193	of	0	None
59193	59194	the	0	None
59194	59195	fermented	0	None
59195	59196	ginseng	0	None
59196	59197	extract	0	None
59197	59198	(	0	None
59198	59199	FGE	0	None
59199	59200	)	0	None
59200	59201	in	0	None
59201	59202	type	0	None
59202	59203	2	0	None
59203	59204	diabetes	0	None
59204	59205	mellitus	0	None
59205	59206	murine	0	None
59206	59207	model	0	None
59207	59208	.	0	None

59209	59210	FGE	0	None
59210	59211	was	0	None
59211	59212	provided	0	None
59212	59213	to	0	None
59213	59214	male	0	None
59214	59215	C57BL	0	None
59215	59216	/	0	None
59216	59217	ksJ-db	0	None
59217	59218	/	0	None
59218	59219	db	0	None
59219	59220	mice	0	None
59220	59221	for	0	None
59221	59222	8	0	None
59222	59223	weeks	0	None
59223	59224	at	0	None
59224	59225	0	0	None
59225	59226	.	0	None
59226	59227	1%	0	None
59227	59228	(	0	None
59228	59229	w	0	None
59229	59230	/	0	None
59230	59231	w	0	None
59231	59232	)	0	None
59232	59233	dose	0	None
59233	59234	in	0	None
59234	59235	contrast	0	None
59235	59236	to	0	None
59236	59237	water	0	None
59237	59238	for	0	None
59238	59239	the	0	None
59239	59240	control	0	None
59240	59241	group	0	None
59241	59242	.	0	None

59243	59244	Potential	0	None
59244	59245	anti-diabetic	0	None
59245	59246	mechanisms	0	None
59246	59247	were	0	None
59247	59248	investigated	0	None
59248	59249	with	0	None
59249	59250	blood	0	None
59250	59251	glucose	0	None
59251	59252	,	0	None
59252	59254	serum insulin	1	GENE-Y
59254	59255	,	0	None
59255	59256	serum	0	None
59256	59257	adiponectin	1	GENE-Y
59257	59258	,	0	None
59258	59260	hemoglobin A1c	1	GENE-Y
59260	59261	(	0	None
59261	59262	HbA1c	0	None
59262	59263	)	0	None
59263	59264	,	0	None
59264	59265	glucose	0	None
59265	59266	tolerance	0	None
59266	59267	,	0	None
59267	59268	insulin	0	None
59268	59269	secretion	0	None
59269	59270	assay	0	None
59270	59271	,	0	None
59271	59272	quantitative	0	None
59272	59273	real-time	0	None
59273	59274	polymerase	0	None
59274	59275	chain	0	None
59275	59276	reaction	0	None
59276	59277	,	0	None
59277	59278	and	0	None
59278	59279	hematoxylin-eosin	0	None
59279	59280	staining	0	None
59280	59281	.	0	None

59282	59283	Compared	0	None
59283	59284	with	0	None
59284	59285	the	0	None
59285	59286	control	0	None
59286	59287	group	0	None
59287	59288	,	0	None
59288	59289	the	0	None
59289	59290	FGE	0	None
59290	59291	group	0	None
59291	59292	had	0	None
59292	59293	lower	0	None
59293	59294	levels	0	None
59294	59295	of	0	None
59295	59296	blood	0	None
59296	59297	glucose	0	None
59297	59298	after	0	None
59298	59299	6	0	None
59299	59300	and	0	None
59300	59301	9	0	None
59301	59302	h	0	None
59302	59303	fasting	0	None
59303	59304	,	0	None
59304	59305	HbA1c	0	None
59305	59306	,	0	None
59306	59307	and	0	None
59307	59308	the	0	None
59308	59309	area	0	None
59309	59310	under	0	None
59310	59311	the	0	None
59311	59312	curve	0	None
59312	59313	in	0	None
59313	59314	an	0	None
59314	59315	oral	0	None
59315	59316	glucose	0	None
59316	59317	tolerance	0	None
59317	59318	test	0	None
59318	59319	and	0	None
59319	59320	higher	0	None
59320	59321	levels	0	None
59321	59322	of	0	None
59322	59323	adiponectin	1	GENE-Y
59323	59324	and	0	None
59324	59326	serum insulin	1	GENE-Y
59326	59327	(	0	None
59327	59328	p	0	None
59328	59329	<	0	None
59329	59330	0	0	None
59330	59331	.	0	None
59331	59332	05	0	None
59332	59333	)	0	None
59333	59334	.	0	None

59335	59336	The	0	None
59336	59337	FGE	0	None
59337	59338	group	0	None
59338	59339	had	0	None
59339	59340	higher	0	None
59340	59341	levels	0	None
59341	59342	of	0	None
59342	59343	peroxisome	0	None
59343	59344	proliferator-activated	0	None
59344	59345	receptor	0	None
59345	59346	gamma	0	None
59346	59347	2	0	None
59347	59348	and	0	None
59348	59350	glucose transporter	1	GENE-Y
59350	59351	protein	0	None
59351	59352	2	0	None
59352	59353	mRNAs	0	None
59353	59354	,	0	None
59354	59355	a	0	None
59355	59356	lower	0	None
59356	59357	level	0	None
59357	59358	of	0	None
59358	59359	tumor	0	None
59359	59360	necrosis	0	None
59360	59361	factor-α	0	None
59361	59362	(	0	None
59362	59363	TNF-α	0	None
59363	59364	)	0	None
59364	59365	(	0	None
59365	59366	p	0	None
59366	59367	<	0	None
59367	59368	0	0	None
59368	59369	.	0	None
59369	59370	05	0	None
59370	59371	)	0	None
59371	59372	,	0	None
59372	59373	and	0	None
59373	59374	less	0	None
59374	59375	lymphocytes	0	None
59375	59376	in	0	None
59376	59377	pancreas	0	None
59377	59378	than	0	None
59378	59379	the	0	None
59379	59380	control	0	None
59380	59381	group	0	None
59381	59382	had	0	None
59382	59383	.	0	None

59384	59385	The	0	None
59385	59386	FGE	0	None
59386	59387	exerted	0	None
59387	59388	anti-diabetic	0	None
59388	59389	effects	0	None
59389	59390	in	0	None
59390	59391	type	0	None
59391	59392	2	0	None
59392	59393	diabetic	0	None
59393	59394	mice	0	None
59394	59395	.	0	None
59395	59396	Fragment-based	0	None
59396	59397	drug	0	None
59397	59398	design	0	None
59398	59399	and	0	None
59399	59400	identification	0	None
59400	59401	of	0	None
59401	59402	HJC0123	0	None
59402	59403	,	0	None
59403	59404	a	0	None
59404	59405	novel	0	None
59405	59406	orally	0	None
59406	59407	bioavailable	0	None
59407	59408	STAT3	1	GENE-Y
59408	59409	inhibitor	0	None
59409	59410	for	0	None
59410	59411	cancer	0	None
59411	59412	therapy	0	None
59412	59413	.	0	None
59413	59414	Low-operating-voltage	0	None
59414	59415	flexible	0	None
59415	59416	organic	0	None
59416	59417	thin-film	0	None
59417	59418	transistors	0	None
59418	59419	with	0	None
59419	59420	high	0	None
59420	59421	thermal	0	None
59421	59422	stability	0	None
59422	59423	using	0	None
59423	59424	DPh-DNTT	0	None
59424	59425	and	0	None
59425	59426	SAM	0	None
59426	59427	gate	0	None
59427	59428	dielectrics	0	None
59428	59429	are	0	None
59429	59430	reported	0	None
59430	59431	.	0	None

59432	59433	The	0	None
59433	59434	mobility	0	None
59434	59435	of	0	None
59435	59436	the	0	None
59436	59437	transistors	0	None
59437	59438	are	0	None
59438	59439	decreased	0	None
59439	59440	by	0	None
59440	59441	23%	0	None
59441	59442	after	0	None
59442	59443	heating	0	None
59443	59444	to	0	None
59444	59445	250	0	None
59445	59446	°C	0	None
59446	59447	for	0	None
59447	59448	30	0	None
59448	59449	min	0	None
59449	59450	.	0	None

59451	59452	Furthermore	0	None
59452	59453	,	0	None
59453	59454	flexible	0	None
59454	59455	organic	0	None
59455	59456	pseudo-CMOS	0	None
59456	59457	inverter	0	None
59457	59458	circuits	0	None
59458	59459	,	0	None
59459	59460	which	0	None
59460	59461	are	0	None
59461	59462	functional	0	None
59462	59463	after	0	None
59463	59464	heating	0	None
59464	59465	to	0	None
59465	59466	200	0	None
59466	59467	°C	0	None
59467	59468	.	0	None
59468	59469	Histidine	2	CHEMICAL
59469	59470	triad	0	None
59470	59471	nucleotide	0	None
59471	59473	binding proteins	3	GENE-N
59473	59474	(	0	None
59474	59475	Hints	0	None
59475	59476	)	0	None
59476	59477	are	0	None
59477	59478	the	0	None
59478	59479	most	0	None
59479	59480	ancient	0	None
59480	59481	members	0	None
59481	59482	of	0	None
59482	59483	the	0	None
59483	59484	histidine	2	CHEMICAL
59484	59485	triad	0	None
59485	59486	protein	0	None
59486	59487	superfamily	0	None
59487	59488	of	0	None
59488	59489	nucleotidyltransferases	0	None
59489	59490	and	0	None
59490	59491	hydrolyases	0	None
59491	59492	.	0	None

59493	59494	Protein-protein	0	None
59494	59495	interaction	0	None
59495	59496	studies	0	None
59496	59497	have	0	None
59497	59498	found	0	None
59498	59499	that	0	None
59499	59500	complexes	0	None
59500	59501	of	0	None
59501	59502	the	0	None
59502	59503	transcription	0	None
59503	59504	factors	0	None
59504	59505	MITF	0	None
59505	59506	or	0	None
59506	59507	USF2	0	None
59507	59508	and	0	None
59508	59509	lysyl-tRNA	0	None
59509	59510	synthetase	0	None
59510	59511	(	0	None
59511	59512	LysRS	1	GENE-Y
59512	59513	)	0	None
59513	59514	are	0	None
59514	59515	associated	0	None
59515	59516	with	0	None
59516	59517	human	0	None
59517	59518	Hint1	0	None
59518	59519	.	0	None

59520	59521	Therefore	0	None
59521	59522	,	0	None
59522	59523	we	0	None
59523	59524	hypothesized	0	None
59524	59525	that	0	None
59525	59526	lysyl-AMP	0	None
59526	59527	or	0	None
59527	59528	the	0	None
59528	59529	LysRS	1	GENE-Y
59529	59530	.	0	None

59531	59532	lysyl-AMP	0	None
59532	59533	may	0	None
59533	59534	be	0	None
59534	59535	a	0	None
59535	59536	native	0	None
59536	59537	substrate	0	None
59537	59538	for	0	None
59538	59539	Hints	0	None
59539	59540	.	0	None

59541	59542	To	0	None
59542	59543	explore	0	None
59543	59544	the	0	None
59544	59545	biochemical	0	None
59545	59546	relationship	0	None
59546	59547	between	0	None
59547	59548	Hint1	0	None
59548	59549	and	0	None
59549	59550	LysRS	1	GENE-Y
59550	59551	,	0	None
59551	59552	a	0	None
59552	59553	series	0	None
59553	59554	of	0	None
59554	59555	catalytic	0	None
59555	59556	radiolabeling	0	None
59556	59557	,	0	None
59557	59558	mutagenesis	0	None
59558	59559	,	0	None
59559	59560	and	0	None
59560	59561	kinetic	0	None
59561	59562	experiments	0	None
59562	59563	was	0	None
59563	59564	conducted	0	None
59564	59565	with	0	None
59565	59566	purified	0	None
59566	59567	LysRSs	0	None
59567	59568	and	0	None
59568	59569	Hints	0	None
59569	59570	from	0	None
59570	59571	human	0	None
59571	59572	and	0	None
59572	59573	Escherichia	0	None
59573	59574	coli	0	None
59574	59575	.	0	None

59576	59577	After	0	None
59577	59578	incubation	0	None
59578	59579	of	0	None
59579	59580	the	0	None
59580	59581	E	0	None
59581	59582	.	0	None

59583	59584	coli	0	None
59584	59585	or	0	None
59585	59586	human	0	None
59586	59587	LysRS	1	GENE-Y
59587	59588	with	0	None
59588	59589	Hints	0	None
59589	59590	and	0	None
59590	59591	[	0	None
59591	59592	alpha-	0	None
59592	59593	(	0	None
59593	59594	32	0	None
59594	59595	)	0	None
59595	59596	P	0	None
59596	59597	]	0	None
59597	59598	ATP	0	None
59598	59599	,	0	None
59599	59600	but	0	None
59600	59601	not	0	None
59601	59602	[	0	None
59602	59603	alpha-	0	None
59603	59604	(	0	None
59604	59605	32	0	None
59605	59606	)	0	None
59606	59607	P	0	None
59607	59608	]	0	None
59608	59609	GTP	0	None
59609	59610	,	0	None
59610	59611	(	0	None
59611	59612	32	0	None
59612	59613	)	0	None
59613	59614	P-labeled	0	None
59614	59615	Hints	0	None
59615	59616	were	0	None
59616	59617	observed	0	None
59617	59618	.	0	None

59619	59620	By	0	None
59620	59621	varying	0	None
59621	59622	time	0	None
59622	59623	and	0	None
59623	59624	the	0	None
59624	59625	concentrations	0	None
59625	59626	of	0	None
59626	59627	lysine	0	None
59627	59628	,	0	None
59628	59629	Mg	2	CHEMICAL
59629	59630	(	0	None
59630	59631	2	0	None
59631	59632	+	0	None
59632	59633	)	0	None
59633	59634	,	0	None
59634	59635	or	0	None
59635	59636	LysRS	1	GENE-Y
59636	59637	,	0	None
59637	59638	the	0	None
59638	59639	adenylation	0	None
59639	59640	of	0	None
59640	59641	Hint	0	None
59641	59642	was	0	None
59642	59643	found	0	None
59643	59644	to	0	None
59644	59645	be	0	None
59645	59646	dependent	0	None
59646	59647	on	0	None
59647	59648	the	0	None
59648	59649	formation	0	None
59649	59650	of	0	None
59650	59651	lysyl-AMP	0	None
59651	59652	.	0	None

59653	59654	Site-directed	0	None
59654	59655	mutagenesis	0	None
59655	59656	studies	0	None
59656	59657	of	0	None
59657	59658	the	0	None
59658	59659	active	0	None
59659	59660	site	0	None
59660	59661	histidine	2	CHEMICAL
59661	59662	triad	0	None
59662	59663	revealed	0	None
59663	59664	that	0	None
59664	59665	Hint	0	None
59665	59666	labeling	0	None
59666	59667	could	0	None
59667	59668	be	0	None
59668	59669	abolished	0	None
59669	59670	by	0	None
59670	59671	substitution	0	None
59671	59672	of	0	None
59672	59673	either	0	None
59673	59674	His-101	0	None
59674	59675	of	0	None
59675	59676	E	0	None
59676	59677	.	0	None

59678	59679	coli	0	None
59679	59680	hinT	0	None
59680	59681	or	0	None
59681	59682	His-112	0	None
59682	59683	of	0	None
59683	59684	human	0	None
59684	59685	Hint1	0	None
59685	59686	by	0	None
59686	59687	either	0	None
59687	59688	alanine	0	None
59688	59689	or	0	None
59689	59690	glycine	2	CHEMICAL
59690	59691	.	0	None

59692	59693	Ap	0	None
59693	59694	(	0	None
59694	59695	4	0	None
59695	59696	)	0	None
59696	59697	A	0	None
59697	59698	,	0	None
59698	59699	believed	0	None
59699	59700	to	0	None
59700	59701	be	0	None
59701	59702	synthesized	0	None
59702	59703	by	0	None
59703	59704	LysRS	1	GENE-Y
59704	59705	in	0	None
59705	59706	vivo	0	None
59706	59707	,	0	None
59707	59708	and	0	None
59708	59709	Zn	0	None
59709	59710	(	0	None
59710	59711	2	0	None
59711	59712	+	0	None
59712	59713	)	0	None
59713	59714	were	0	None
59714	59715	shown	0	None
59715	59716	to	0	None
59716	59717	inhibit	0	None
59717	59718	the	0	None
59718	59719	formation	0	None
59719	59720	of	0	None
59720	59721	Hint-AMP	0	None
59721	59722	with	0	None
59722	59723	an	0	None
59723	59724	IC	0	None
59724	59725	(	0	None
59725	59726	50	0	None
59726	59727	)	0	None
59727	59728	value	0	None
59728	59729	in	0	None
59729	59730	the	0	None
59730	59731	low	0	None
59731	59732	micromolar	0	None
59732	59733	range	0	None
59733	59734	.	0	None

59735	59736	Consistent	0	None
59736	59737	with	0	None
59737	59738	pyrophosphate	0	None
59738	59739	being	0	None
59739	59740	an	0	None
59740	59741	inhibitor	0	None
59741	59742	for	0	None
59742	59743	aminoacyl-tRNA	0	None
59743	59744	synthetase	0	None
59744	59745	,	0	None
59745	59746	incubations	0	None
59746	59747	in	0	None
59747	59748	the	0	None
59748	59749	presence	0	None
59749	59750	of	0	None
59750	59751	pyrophosphatase	0	None
59751	59752	resulted	0	None
59752	59753	in	0	None
59753	59754	enhanced	0	None
59754	59755	formation	0	None
59755	59756	of	0	None
59756	59757	Hint-AMP	0	None
59757	59758	.	0	None

59759	59760	These	0	None
59760	59761	results	0	None
59761	59762	demonstrate	0	None
59762	59763	that	0	None
59763	59764	the	0	None
59764	59765	lysyl-AMP	0	None
59765	59766	intermediate	0	None
59766	59767	formed	0	None
59767	59768	by	0	None
59768	59769	LysRS	1	GENE-Y
59769	59770	is	0	None
59770	59771	a	0	None
59771	59772	natural	0	None
59772	59773	substrate	0	None
59773	59774	for	0	None
59774	59775	Hints	0	None
59775	59776	and	0	None
59776	59777	suggests	0	None
59777	59778	a	0	None
59778	59779	potential	0	None
59779	59780	highly	0	None
59780	59781	conserved	0	None
59781	59782	regulatory	0	None
59782	59783	role	0	None
59783	59784	for	0	None
59784	59785	Hints	0	None
59785	59786	on	0	None
59786	59787	LysRS	1	GENE-Y
59787	59788	and	0	None
59788	59789	possibly	0	None
59789	59790	other	0	None
59790	59791	aminoacyl-tRNA	0	None
59791	59792	synthetases	0	None
59792	59793	.	0	None
59793	59794	BACKGROUND	0	None
59794	59795	:	0	None
59795	59796	Voltage-gated	0	None
59796	59797	sodium	2	CHEMICAL
59797	59798	channels	0	None
59798	59799	dysregulation	0	None
59799	59800	is	0	None
59800	59801	important	0	None
59801	59802	for	0	None
59802	59803	hyperexcitability	0	None
59803	59804	leading	0	None
59804	59805	to	0	None
59805	59806	pain	0	None
59806	59807	persistence	0	None
59807	59808	.	0	None

59809	59810	Sodium	2	CHEMICAL
59810	59811	channel	0	None
59811	59812	blockers	0	None
59812	59813	currently	0	None
59813	59814	used	0	None
59814	59815	to	0	None
59815	59816	treat	0	None
59816	59817	neuropathic	0	None
59817	59818	pain	0	None
59818	59819	are	0	None
59819	59820	poorly	0	None
59820	59821	tolerated	0	None
59821	59822	.	0	None

59823	59824	Getting	0	None
59824	59825	new	0	None
59825	59826	molecules	0	None
59826	59827	to	0	None
59827	59828	clinical	0	None
59828	59829	use	0	None
59829	59830	is	0	None
59830	59831	laborious	0	None
59831	59832	.	0	None

59833	59834	We	0	None
59834	59835	here	0	None
59835	59836	propose	0	None
59836	59837	a	0	None
59837	59838	drug	0	None
59838	59839	already	0	None
59839	59840	marketed	0	None
59840	59841	as	0	None
59841	59842	anticonvulsant	0	None
59842	59843	,	0	None
59843	59844	rufinamide	0	None
59844	59845	.	0	None

59846	59847	METHODS	0	None
59847	59848	:	0	None
59848	59849	We	0	None
59849	59850	compared	0	None
59850	59851	the	0	None
59851	59852	behavioral	0	None
59852	59853	effect	0	None
59853	59854	of	0	None
59854	59855	rufinamide	0	None
59855	59856	to	0	None
59856	59857	amitriptyline	2	CHEMICAL
59857	59858	using	0	None
59858	59859	the	0	None
59859	59860	Spared	0	None
59860	59861	Nerve	0	None
59861	59862	Injury	0	None
59862	59863	neuropathic	0	None
59863	59864	pain	0	None
59864	59865	model	0	None
59865	59866	in	0	None
59866	59867	mice	0	None
59867	59868	.	0	None

59869	59870	We	0	None
59870	59871	compared	0	None
59871	59872	the	0	None
59872	59873	effect	0	None
59873	59874	of	0	None
59874	59875	rufinamide	0	None
59875	59876	on	0	None
59876	59877	sodium	2	CHEMICAL
59877	59878	currents	0	None
59878	59879	using	0	None
59879	59880	in	0	None
59880	59881	vitro	0	None
59881	59882	patch	0	None
59882	59883	clamp	0	None
59883	59884	in	0	None
59884	59885	cells	0	None
59885	59886	expressing	0	None
59886	59887	the	0	None
59887	59888	voltage-gated	0	None
59888	59890	sodium channel	3	GENE-N
59890	59891	Nav1	0	None
59891	59892	.	0	None
59892	59893	7	0	None
59893	59894	isoform	0	None
59894	59895	and	0	None
59895	59896	on	0	None
59896	59897	dissociated	0	None
59897	59898	dorsal	0	None
59898	59899	root	0	None
59899	59900	ganglion	0	None
59900	59901	neurons	0	None
59901	59902	to	0	None
59902	59903	amitriptyline	2	CHEMICAL
59903	59904	and	0	None
59904	59905	mexiletine	0	None
59905	59906	.	0	None

59907	59908	RESULTS	0	None
59908	59909	:	0	None
59909	59910	In	0	None
59910	59911	naive	0	None
59911	59912	mice	0	None
59912	59913	,	0	None
59913	59914	amitriptyline	2	CHEMICAL
59914	59915	(	0	None
59915	59916	20	0	None
59916	59917	mg	2	CHEMICAL
59917	59918	/	0	None
59918	59919	kg	0	None
59919	59920	)	0	None
59920	59921	increased	0	None
59921	59922	withdrawal	0	None
59922	59923	threshold	0	None
59923	59924	to	0	None
59924	59925	mechanical	0	None
59925	59926	stimulation	0	None
59926	59927	from	0	None
59927	59928	1	0	None
59928	59929	.	0	None
59929	59930	3	0	None
59930	59931	(	0	None
59931	59932	0	0	None
59932	59933	.	0	None
59933	59934	6-1	0	None
59934	59935	.	0	None
59935	59936	9	0	None
59936	59937	)	0	None
59937	59938	(	0	None
59938	59939	median	0	None
59939	59940	[	0	None
59940	59941	95%	0	None
59941	59942	CI	0	None
59942	59943	]	0	None
59943	59944	)	0	None
59944	59945	to	0	None
59945	59946	2	0	None
59946	59947	.	0	None
59947	59948	3	0	None
59948	59949	g	0	None
59949	59950	(	0	None
59950	59951	2	0	None
59951	59952	.	0	None
59952	59953	2-2	0	None
59953	59954	.	0	None
59954	59955	5	0	None
59955	59956	)	0	None
59956	59957	and	0	None
59957	59958	latency	0	None
59958	59959	of	0	None
59959	59960	withdrawal	0	None
59960	59961	to	0	None
59961	59962	heat	0	None
59962	59963	stimulation	0	None
59963	59964	from	0	None
59964	59965	13	0	None
59965	59966	.	0	None
59966	59967	1	0	None
59967	59968	(	0	None
59968	59969	10	0	None
59969	59970	.	0	None
59970	59971	4-15	0	None
59971	59972	.	0	None
59972	59973	5	0	None
59973	59974	)	0	None
59974	59975	to	0	None
59975	59976	30	0	None
59976	59977	.	0	None
59977	59978	0	0	None
59978	59979	s	0	None
59979	59980	(	0	None
59980	59981	21	0	None
59981	59982	.	0	None
59982	59983	8-31	0	None
59983	59984	.	0	None
59984	59985	9	0	None
59985	59986	)	0	None
59986	59987	,	0	None
59987	59988	whereas	0	None
59988	59989	rufinamide	0	None
59989	59990	had	0	None
59990	59991	no	0	None
59991	59992	effect	0	None
59992	59993	.	0	None

59994	59995	Rufinamide	0	None
59995	59996	and	0	None
59996	59997	amitriptyline	2	CHEMICAL
59997	59998	alleviated	0	None
59998	59999	injury-induced	0	None
59999	60000	mechanical	0	None
60000	60001	allodynia	0	None
60001	60002	for	0	None
60002	60003	4	0	None
60003	60004	h	0	None
60004	60005	(	0	None
60005	60006	maximal	0	None
60006	60007	effect	0	None
60007	60008	:	0	None
60008	60009	0	0	None
60009	60010	.	0	None
60010	60011	10	0	None
60011	60012	+	0	None
60012	60013	/	0	None
60013	60014	-	0	None
60014	60015	0	0	None
60015	60016	.	0	None
60016	60017	03	0	None
60017	60018	g	0	None
60018	60019	(	0	None
60019	60020	mean	0	None
60020	60021	+	0	None
60021	60022	/	0	None
60022	60023	-	0	None
60023	60024	SD	0	None
60024	60025	)	0	None
60025	60026	to	0	None
60026	60027	1	0	None
60027	60028	.	0	None
60028	60029	99	0	None
60029	60030	+	0	None
60030	60031	/	0	None
60031	60032	-	0	None
60032	60033	0	0	None
60033	60034	.	0	None
60034	60035	26	0	None
60035	60036	g	0	None
60036	60037	for	0	None
60037	60038	rufinamide	0	None
60038	60039	and	0	None
60039	60040	0	0	None
60040	60041	.	0	None
60041	60042	25	0	None
60042	60043	+	0	None
60043	60044	/	0	None
60044	60045	-	0	None
60045	60046	0	0	None
60046	60047	.	0	None
60047	60048	22	0	None
60048	60049	g	0	None
60049	60050	to	0	None
60050	60051	1	0	None
60051	60052	.	0	None
60052	60053	92	0	None
60053	60054	+	0	None
60054	60055	/	0	None
60055	60056	-	0	None
60056	60057	0	0	None
60057	60058	.	0	None
60058	60059	85	0	None
60059	60060	g	0	None
60060	60061	for	0	None
60061	60062	amitriptyline	2	CHEMICAL
60062	60063	)	0	None
60063	60064	.	0	None

60065	60066	All	0	None
60066	60067	drugs	0	None
60067	60068	reduced	0	None
60068	60069	peak	0	None
60069	60070	current	0	None
60070	60071	and	0	None
60071	60072	stabilized	0	None
60072	60073	the	0	None
60073	60074	inactivated	0	None
60074	60075	state	0	None
60075	60076	of	0	None
60076	60077	voltage-gated	0	None
60077	60079	sodium channel	3	GENE-N
60079	60080	Nav1	0	None
60080	60081	.	0	None
60081	60082	7	0	None
60082	60083	,	0	None
60083	60084	with	0	None
60084	60085	similar	0	None
60085	60086	effects	0	None
60086	60087	in	0	None
60087	60088	dorsal	0	None
60088	60089	root	0	None
60089	60090	ganglion	0	None
60090	60091	neurons	0	None
60091	60092	.	0	None

60093	60094	CONCLUSIONS	0	None
60094	60095	:	0	None
60095	60096	At	0	None
60096	60097	doses	0	None
60097	60098	alleviating	0	None
60098	60099	neuropathic	0	None
60099	60100	pain	0	None
60100	60101	,	0	None
60101	60102	amitriptyline	2	CHEMICAL
60102	60103	showed	0	None
60103	60104	alteration	0	None
60104	60105	of	0	None
60105	60106	behavioral	0	None
60106	60107	response	0	None
60107	60108	possibly	0	None
60108	60109	related	0	None
60109	60110	to	0	None
60110	60111	either	0	None
60111	60112	alteration	0	None
60112	60113	of	0	None
60113	60114	basal	0	None
60114	60115	pain	0	None
60115	60116	sensitivity	0	None
60116	60117	or	0	None
60117	60118	sedative	0	None
60118	60119	effect	0	None
60119	60120	or	0	None
60120	60121	both	0	None
60121	60122	.	0	None

60123	60124	Side-effects	0	None
60124	60125	and	0	None
60125	60126	drug	0	None
60126	60127	tolerance	0	None
60127	60128	/	0	None
60128	60129	compliance	0	None
60129	60130	are	0	None
60130	60131	major	0	None
60131	60132	problems	0	None
60132	60133	with	0	None
60133	60134	drugs	0	None
60134	60135	such	0	None
60135	60136	as	0	None
60136	60137	amitriptyline	2	CHEMICAL
60137	60138	.	0	None

60139	60140	Rufinamide	0	None
60140	60141	seems	0	None
60141	60142	to	0	None
60142	60143	have	0	None
60143	60144	a	0	None
60144	60145	better	0	None
60145	60146	tolerability	0	None
60146	60147	profile	0	None
60147	60148	and	0	None
60148	60149	could	0	None
60149	60150	be	0	None
60150	60151	a	0	None
60151	60152	new	0	None
60152	60153	alternative	0	None
60153	60154	to	0	None
60154	60155	explore	0	None
60155	60156	for	0	None
60156	60157	the	0	None
60157	60158	treatment	0	None
60158	60159	of	0	None
60159	60160	neuropathic	0	None
60160	60161	pain	0	None
60161	60162	.	0	None
60162	60163	Nutrients	0	None
60163	60164	and	0	None
60164	60165	bioactive	0	None
60165	60166	compounds	0	None
60166	60167	of	0	None
60167	60168	Thai	0	None
60168	60169	indigenous	0	None
60169	60170	fruits	0	None
60170	60171	.	0	None
60171	60172	Epigenetic	0	None
60172	60173	Regulation	0	None
60173	60174	Is	0	None
60174	60175	a	0	None
60175	60176	Crucial	0	None
60176	60177	Factor	0	None
60177	60178	in	0	None
60178	60179	the	0	None
60179	60180	Repression	0	None
60180	60181	of	0	None
60181	60182	UGT1A1	0	None
60182	60183	Expression	0	None
60183	60184	in	0	None
60184	60185	the	0	None
60185	60186	Human	0	None
60186	60187	Kidney	0	None
60187	60188	.	0	None
60188	60189	A	0	None
60189	60190	cDNA	0	None
60190	60191	encoding	0	None
60191	60192	the	0	None
60192	60193	mouse	0	None
60193	60194	carbonic	0	None
60194	60195	anhydrase	0	None
60195	60196	V	0	None
60196	60197	gene	0	None
60197	60198	was	0	None
60198	60199	isolated	0	None
60199	60200	by	0	None
60200	60201	reverse	0	None
60201	60202	transcription	0	None
60202	60203	and	0	None
60203	60204	polymerase	0	None
60204	60205	chain	0	None
60205	60206	reaction	0	None
60206	60207	from	0	None
60207	60208	BALB	0	None
60208	60209	/	0	None
60209	60210	c	0	None
60210	60211	mouse	0	None
60211	60212	liver	0	None
60212	60213	mRNA	0	None
60213	60214	.	0	None

60215	60216	Vectors	0	None
60216	60217	containing	0	None
60217	60218	the	0	None
60218	60219	full	0	None
60219	60220	coding	0	None
60220	60221	sequence	0	None
60221	60222	as	0	None
60222	60223	well	0	None
60223	60224	as	0	None
60224	60225	two	0	None
60225	60226	different	0	None
60226	60227	NH2-terminal	0	None
60227	60228	truncated	0	None
60228	60229	genes	0	None
60229	60230	expressed	0	None
60230	60231	enzymatically	0	None
60231	60232	active	0	None
60232	60233	protein	0	None
60233	60234	in	0	None
60234	60235	Escherichia	0	None
60235	60236	coli	0	None
60236	60237	.	0	None

60238	60239	The	0	None
60239	60240	carbonic	0	None
60240	60241	anhydrase	0	None
60241	60242	V	0	None
60242	60243	produced	0	None
60243	60244	by	0	None
60244	60245	a	0	None
60245	60246	vector	0	None
60246	60247	containing	0	None
60247	60248	the	0	None
60248	60249	full	0	None
60249	60250	coding	0	None
60250	60251	sequence	0	None
60251	60252	,	0	None
60252	60253	which	0	None
60253	60254	includes	0	None
60254	60255	a	0	None
60255	60256	possible	0	None
60256	60257	NH2-terminal	0	None
60257	60258	mitochondrial	0	None
60258	60259	targeting	0	None
60259	60260	signal	0	None
60260	60261	,	0	None
60261	60262	was	0	None
60262	60263	proteolytically	0	None
60263	60264	processed	0	None
60264	60265	by	0	None
60265	60266	E	0	None
60266	60267	.	0	None

60268	60269	coli	0	None
60269	60270	and	0	None
60270	60271	contained	0	None
60271	60272	several	0	None
60272	60273	amino-terminal	0	None
60273	60274	ends	0	None
60274	60275	.	0	None

60276	60277	The	0	None
60277	60278	two	0	None
60278	60279	NH2-terminal	0	None
60279	60280	truncated	0	None
60280	60281	vectors	0	None
60281	60282	deleted	0	None
60282	60283	,	0	None
60283	60284	respectively	0	None
60284	60285	,	0	None
60285	60286	1	0	None
60286	60287	)	0	None
60287	60288	the	0	None
60288	60289	29-amino	0	None
60289	60290	acid	0	None
60290	60291	putative	0	None
60291	60292	targeting	0	None
60292	60293	sequence	0	None
60293	60294	and	0	None
60294	60295	2	0	None
60295	60296	)	0	None
60296	60297	51	0	None
60297	60299	amino acids	2	CHEMICAL
60299	60300	,	0	None
60300	60301	yielding	0	None
60301	60302	a	0	None
60302	60303	protein	0	None
60303	60304	equivalent	0	None
60304	60305	to	0	None
60305	60306	a	0	None
60306	60307	carbonic	0	None
60307	60308	anhydrase	0	None
60308	60309	(	0	None
60309	60310	CA	1	GENE-Y
60310	60311	)	0	None
60311	60312	V	0	None
60312	60313	isolated	0	None
60313	60314	from	0	None
60314	60315	mouse	0	None
60315	60316	liver	0	None
60316	60317	mitochondria;	0	None
60317	60318	and	0	None
60318	60319	both	0	None
60319	60320	vectors	0	None
60320	60321	produced	0	None
60321	60322	homogeneous	0	None
60322	60323	protein	0	None
60323	60324	fractions	0	None
60324	60325	.	0	None

60326	60327	These	0	None
60327	60328	latter	0	None
60328	60329	two	0	None
60329	60330	forms	0	None
60330	60331	of	0	None
60331	60332	CA	1	GENE-Y
60332	60333	V	0	None
60333	60334	had	0	None
60334	60335	identical	0	None
60335	60336	steady-state	0	None
60336	60337	constants	0	None
60337	60338	for	0	None
60338	60339	the	0	None
60339	60340	hydration	0	None
60340	60341	of	0	None
60341	60342	CO2	0	None
60342	60343	,	0	None
60343	60344	with	0	None
60344	60345	maximal	0	None
60345	60346	values	0	None
60346	60347	of	0	None
60347	60348	kcat	0	None
60348	60349	/	0	None
60349	60350	Km	0	None
60350	60351	at	0	None
60351	60352	3	0	None
60352	60353	x	0	None
60353	60354	10	0	None
60354	60355	(	0	None
60355	60356	7	0	None
60356	60357	)	0	None
60357	60358	M-1	0	None
60358	60359	s-1	0	None
60359	60360	and	0	None
60360	60361	kcat	0	None
60361	60362	at	0	None
60362	60363	3	0	None
60363	60364	x	0	None
60364	60365	10	0	None
60365	60366	(	0	None
60366	60367	5	0	None
60367	60368	)	0	None
60368	60369	s-1	0	None
60369	60370	with	0	None
60370	60371	an	0	None
60371	60372	apparent	0	None
60372	60373	pKa	0	None
60373	60374	for	0	None
60374	60375	catalysis	0	None
60375	60376	of	0	None
60376	60377	7	0	None
60377	60378	.	0	None
60378	60379	4	0	None
60379	60380	determined	0	None
60380	60381	from	0	None
60381	60382	kcat	0	None
60382	60383	/	0	None
60383	60384	Km	0	None
60384	60385	.	0	None

60386	60387	In	0	None
60387	60388	catalytic	0	None
60388	60389	properties	0	None
60389	60390	,	0	None
60390	60391	mouse	0	None
60391	60392	CA	1	GENE-Y
60392	60393	V	0	None
60393	60394	is	0	None
60394	60395	closest	0	None
60395	60396	to	0	None
60396	60397	CA	1	GENE-Y
60397	60398	I;	0	None
60398	60399	however	0	None
60399	60400	,	0	None
60400	60401	in	0	None
60401	60402	inhibition	0	None
60402	60403	by	0	None
60403	60404	acetazolamide	0	None
60404	60405	,	0	None
60405	60406	ethoxzolamide	0	None
60406	60407	,	0	None
60407	60408	and	0	None
60408	60409	cyanate	0	None
60409	60410	,	0	None
60410	60411	CA	1	GENE-Y
60411	60412	V	0	None
60412	60413	is	0	None
60413	60414	very	0	None
60414	60415	similar	0	None
60415	60416	to	0	None
60416	60418	CA II	1	GENE-Y
60418	60419	.	0	None

60420	60421	Mouse	0	None
60421	60422	CA	1	GENE-Y
60422	60423	V	0	None
60423	60424	has	0	None
60424	60425	a	0	None
60425	60426	tyrosine	2	CHEMICAL
60426	60427	at	0	None
60427	60428	position	0	None
60428	60429	64	0	None
60429	60430	,	0	None
60430	60431	where	0	None
60431	60432	the	0	None
60432	60433	highly	0	None
60433	60434	active	0	None
60434	60435	isozyme	0	None
60435	60436	II	0	None
60436	60437	has	0	None
60437	60438	histidine	2	CHEMICAL
60438	60439	serving	0	None
60439	60440	as	0	None
60440	60441	a	0	None
60441	60442	proton	0	None
60442	60443	shuttle	0	None
60443	60444	in	0	None
60444	60445	the	0	None
60445	60446	catalytic	0	None
60446	60447	pathway	0	None
60447	60448	.	0	None

60449	60450	Investigation	0	None
60450	60451	of	0	None
60451	60452	a	0	None
60452	60453	site-specific	0	None
60453	60454	mutant	0	None
60454	60455	of	0	None
60455	60456	CA	1	GENE-Y
60456	60457	V	0	None
60457	60458	containing	0	None
60458	60459	the	0	None
60459	60460	replacement	0	None
60460	60461	Tyr64-->His	0	None
60461	60462	showed	0	None
60462	60463	that	0	None
60463	60464	the	0	None
60464	60465	unique	0	None
60465	60466	kinetic	0	None
60466	60467	properties	0	None
60467	60468	of	0	None
60468	60469	CA	1	GENE-Y
60469	60470	V	0	None
60470	60471	are	0	None
60471	60472	not	0	None
60472	60473	due	0	None
60473	60474	to	0	None
60474	60475	the	0	None
60475	60476	presence	0	None
60476	60477	of	0	None
60477	60478	tyrosine	2	CHEMICAL
60478	60479	at	0	None
60479	60480	position	0	None
60480	60481	64	0	None
60481	60482	.	0	None
60482	60483	An	0	None
60483	60484	overview	0	None
60484	60485	of	0	None
60485	60486	transcriptional	0	None
60486	60487	regulation	0	None
60487	60488	in	0	None
60488	60489	response	0	None
60489	60490	to	0	None
60490	60491	toxicological	0	None
60491	60492	insult	0	None
60492	60493	.	0	None
60493	60494	Novel	0	None
60494	60495	N-indolylmethyl	0	None
60495	60496	substituted	0	None
60496	60497	spiroindoline-3	0	None
60497	60498	,	0	None
60498	60499	2'-quinazolines	0	None
60499	60500	were	0	None
60500	60501	designed	0	None
60501	60502	as	0	None
60502	60503	potential	0	None
60503	60504	inhibitiors	0	None
60504	60505	of	0	None
60505	60506	SIRT1	0	None
60506	60507	.	0	None

60508	60509	These	0	None
60509	60510	compounds	0	None
60510	60511	were	0	None
60511	60512	synthesized	0	None
60512	60513	in	0	None
60513	60514	good	0	None
60514	60515	yields	0	None
60515	60516	by	0	None
60516	60517	using	0	None
60517	60518	Pd	0	None
60518	60519	/	0	None
60519	60520	C-Cu	0	None
60520	60521	mediated	0	None
60521	60522	coupling-cyclization	0	None
60522	60523	strategy	0	None
60523	60524	as	0	None
60524	60525	a	0	None
60525	60526	key	0	None
60526	60527	step	0	None
60527	60528	involving	0	None
60528	60529	the	0	None
60529	60530	reaction	0	None
60530	60531	of	0	None
60531	60532	1-	0	None
60532	60533	(	0	None
60533	60534	prop-2-ynyl	0	None
60534	60535	)	0	None
60535	60536	-1'H-spiro	0	None
60536	60537	[	0	None
60537	60538	indoline-3	0	None
60538	60539	,	0	None
60539	60540	2'-quinazoline	0	None
60540	60541	]	0	None
60541	60542	-2	0	None
60542	60543	,	0	None
60543	60544	4'	0	None
60544	60545	(	0	None
60545	60546	3'H	0	None
60546	60547	)	0	None
60547	60548	-dione	0	None
60548	60549	with	0	None
60549	60550	2-iodoanilides	0	None
60550	60551	.	0	None

60552	60553	Some	0	None
60553	60554	of	0	None
60554	60555	the	0	None
60555	60556	compounds	0	None
60556	60557	synthesized	0	None
60557	60558	have	0	None
60558	60559	shown	0	None
60559	60560	encouraging	0	None
60560	60561	inhibition	0	None
60561	60562	of	0	None
60562	60563	Sir	0	None
60563	60564	2	0	None
60564	60565	protein	0	None
60565	60566	(	0	None
60566	60567	a	0	None
60567	60568	yeast	0	None
60568	60569	homologue	0	None
60569	60570	of	0	None
60570	60571	mammalian	0	None
60571	60572	SIRT1	0	None
60572	60573	)	0	None
60573	60574	in	0	None
60574	60575	vitro	0	None
60575	60576	and	0	None
60576	60577	three	0	None
60577	60578	of	0	None
60578	60579	them	0	None
60579	60580	showed	0	None
60580	60581	dose	0	None
60581	60582	dependent	0	None
60582	60583	inhibition	0	None
60583	60584	of	0	None
60584	60585	Sir	0	None
60585	60586	2	0	None
60586	60587	.	0	None

60588	60589	The	0	None
60589	60590	docking	0	None
60590	60591	results	0	None
60591	60592	suggested	0	None
60592	60593	that	0	None
60593	60594	the	0	None
60594	60595	benzene	0	None
60595	60596	ring	0	None
60596	60597	of	0	None
60597	60598	1	0	None
60598	60599	,	0	None
60599	60600	2	0	None
60600	60601	,	0	None
60601	60602	3	0	None
60602	60603	,	0	None
60603	60604	4-tetrahydroquinazolin	0	None
60604	60605	ring	0	None
60605	60606	system	0	None
60606	60607	of	0	None
60607	60608	these	0	None
60608	60609	molecules	0	None
60609	60610	occupied	0	None
60610	60611	the	0	None
60611	60612	deep	0	None
60612	60613	hydrophobic	0	None
60613	60614	pocket	0	None
60614	60615	of	0	None
60615	60616	the	0	None
60616	60617	protein	0	None
60617	60618	and	0	None
60618	60619	one	0	None
60619	60620	of	0	None
60620	60621	the	0	None
60621	60622	NH	0	None
60622	60623	along	0	None
60623	60624	with	0	None
60624	60625	the	0	None
60625	60626	sulfonyl	0	None
60626	60627	group	0	None
60627	60628	participated	0	None
60628	60629	in	0	None
60629	60630	strong	0	None
60630	60631	H-bonding	0	None
60631	60632	interaction	0	None
60632	60633	with	0	None
60633	60634	the	0	None
60634	60636	amino acid	2	CHEMICAL
60636	60637	residues	0	None
60637	60638	.	0	None
60638	60639	This	0	None
60639	60640	study	0	None
60640	60641	aims	0	None
60641	60642	to	0	None
60642	60643	investigate	0	None
60643	60644	potential	0	None
60644	60645	diabetic	0	None
60645	60646	retinopathy	0	None
60646	60647	(	0	None
60647	60648	DR	0	None
60648	60649	)	0	None
60649	60650	risk	0	None
60650	60651	factors	0	None
60651	60652	by	0	None
60652	60653	evaluating	0	None
60653	60654	the	0	None
60654	60655	circulating	0	None
60655	60656	levels	0	None
60656	60657	of	0	None
60657	60658	pentosidine	0	None
60658	60659	,	0	None
60659	60660	soluble	0	None
60660	60661	receptor	0	None
60661	60662	for	0	None
60662	60663	advanced	0	None
60663	60664	glycation	0	None
60664	60665	end-product	0	None
60665	60666	(	0	None
60666	60667	sRAGE	0	None
60667	60668	)	0	None
60668	60669	,	0	None
60669	60670	advanced	0	None
60670	60671	oxidation	0	None
60671	60672	protein	0	None
60672	60673	product	0	None
60673	60674	(	0	None
60674	60675	AOPP	0	None
60675	60676	)	0	None
60676	60677	as	0	None
60677	60678	well	0	None
60678	60679	as	0	None
60679	60681	glutathione peroxidase	1	GENE-Y
60681	60682	(	0	None
60682	60683	GPx	0	None
60683	60684	)	0	None
60684	60685	and	0	None
60685	60686	superoxide	0	None
60686	60687	dismutase	0	None
60687	60688	(	0	None
60688	60689	SOD	1	GENE-Y
60689	60690	)	0	None
60690	60691	activities	0	None
60691	60692	in	0	None
60692	60693	DR	0	None
60693	60694	patients	0	None
60694	60695	.	0	None

60696	60697	A	0	None
60697	60698	total	0	None
60698	60699	of	0	None
60699	60700	235	0	None
60700	60701	healthy	0	None
60701	60702	controls	0	None
60702	60703	,	0	None
60703	60704	171	0	None
60704	60705	type	0	None
60705	60706	2	0	None
60706	60707	diabetic	0	None
60707	60708	without	0	None
60708	60709	retinopathy	0	None
60709	60710	(	0	None
60710	60711	DNR	0	None
60711	60712	)	0	None
60712	60713	and	0	None
60713	60714	200	0	None
60714	60715	diabetic	0	None
60715	60716	retinopathy	0	None
60716	60717	(	0	None
60717	60718	DR	0	None
60718	60719	)	0	None
60719	60720	patients	0	None
60720	60721	were	0	None
60721	60722	recruited	0	None
60722	60723	.	0	None

60724	60725	Plasma	0	None
60725	60726	was	0	None
60726	60727	extracted	0	None
60727	60728	for	0	None
60728	60729	the	0	None
60729	60730	estimation	0	None
60730	60731	of	0	None
60731	60732	pentosidine	0	None
60732	60733	,	0	None
60733	60734	sRAGE	0	None
60734	60735	,	0	None
60735	60736	AOPP	0	None
60736	60737	levels	0	None
60737	60738	and	0	None
60738	60739	GPx	0	None
60739	60740	activity	0	None
60740	60741	whereas	0	None
60741	60742	peripheral	0	None
60742	60743	blood	0	None
60743	60744	mononuclear	0	None
60744	60745	cells	0	None
60745	60746	were	0	None
60746	60747	disrupted	0	None
60747	60748	for	0	None
60748	60749	SOD	1	GENE-Y
60749	60750	activity	0	None
60750	60751	measurement	0	None
60751	60752	.	0	None

60753	60754	DNR	0	None
60754	60755	and	0	None
60755	60756	DR	0	None
60756	60757	patients	0	None
60757	60758	showed	0	None
60758	60759	significantly	0	None
60759	60760	higher	0	None
60760	60761	levels	0	None
60761	60762	of	0	None
60762	60763	plasma	0	None
60763	60764	pentosidine	0	None
60764	60765	,	0	None
60765	60766	sRAGE	0	None
60766	60767	and	0	None
60767	60768	AOPP	0	None
60768	60769	but	0	None
60769	60770	lower	0	None
60770	60771	GPx	0	None
60771	60772	and	0	None
60772	60773	SOD	1	GENE-Y
60773	60774	activities	0	None
60774	60775	when	0	None
60775	60776	compared	0	None
60776	60777	to	0	None
60777	60778	healthy	0	None
60778	60779	controls	0	None
60779	60780	.	0	None

60781	60782	The	0	None
60782	60783	sRAGE	0	None
60783	60784	/	0	None
60784	60785	pentosidine	0	None
60785	60786	ratio	0	None
60786	60787	in	0	None
60787	60788	DR	0	None
60788	60789	patients	0	None
60789	60790	was	0	None
60790	60791	significantly	0	None
60791	60792	lower	0	None
60792	60793	than	0	None
60793	60794	the	0	None
60794	60795	ratio	0	None
60795	60796	detected	0	None
60796	60797	in	0	None
60797	60798	DNR	0	None
60798	60799	patients	0	None
60799	60800	.	0	None

60801	60802	Proliferative	0	None
60802	60803	DR	0	None
60803	60804	patients	0	None
60804	60805	had	0	None
60805	60806	significantly	0	None
60806	60807	higher	0	None
60807	60808	levels	0	None
60808	60809	of	0	None
60809	60810	plasma	0	None
60810	60811	pentosidine	0	None
60811	60812	,	0	None
60812	60813	sRAGE	0	None
60813	60814	,	0	None
60814	60815	AOPP	0	None
60815	60816	and	0	None
60816	60817	sRAGE	0	None
60817	60818	/	0	None
60818	60819	pentosidine	0	None
60819	60820	ratio	0	None
60820	60821	than	0	None
60821	60822	non-proliferative	0	None
60822	60823	DR	0	None
60823	60824	patients	0	None
60824	60825	.	0	None

60826	60827	High	0	None
60827	60828	HbA1c	0	None
60828	60829	level	0	None
60829	60830	,	0	None
60830	60831	long	0	None
60831	60832	duration	0	None
60832	60833	of	0	None
60833	60834	diabetes	0	None
60834	60835	and	0	None
60835	60836	low	0	None
60836	60837	sRAGE	0	None
60837	60838	/	0	None
60838	60839	pentosidine	0	None
60839	60840	ratio	0	None
60840	60841	were	0	None
60841	60842	determined	0	None
60842	60843	as	0	None
60843	60844	the	0	None
60844	60845	risk	0	None
60845	60846	factors	0	None
60846	60847	for	0	None
60847	60848	DR	0	None
60848	60849	.	0	None

60850	60851	This	0	None
60851	60852	study	0	None
60852	60853	suggests	0	None
60853	60854	that	0	None
60854	60855	sRAGE	0	None
60855	60856	/	0	None
60856	60857	pentosidine	0	None
60857	60858	ratio	0	None
60858	60859	could	0	None
60859	60860	serve	0	None
60860	60861	as	0	None
60861	60862	a	0	None
60862	60863	risk	0	None
60863	60864	factor	0	None
60864	60865	determinant	0	None
60865	60866	for	0	None
60866	60867	type	0	None
60867	60868	2	0	None
60868	60869	DR	0	None
60869	60870	as	0	None
60870	60871	it	0	None
60871	60872	has	0	None
60872	60873	a	0	None
60873	60874	positive	0	None
60874	60875	correlation	0	None
60875	60876	with	0	None
60876	60877	the	0	None
60877	60878	severity	0	None
60878	60879	of	0	None
60879	60880	DR	0	None
60880	60881	.	0	None
60881	60882	[	0	None
60882	60883	Effects	0	None
60883	60884	of	0	None
60884	60885	thrombolysis	0	None
60885	60886	and	0	None
60886	60887	anticoagulation	0	None
60887	60888	on	0	None
60888	60889	the	0	None
60889	60890	functions	0	None
60890	60891	of	0	None
60891	60892	vascular	0	None
60892	60893	endothelial	0	None
60893	60894	cells	0	None
60894	60895	and	0	None
60895	60896	coagulation	0	None
60896	60897	and	0	None
60897	60898	fibrinolysis	0	None
60898	60899	in	0	None
60899	60900	patients	0	None
60900	60901	with	0	None
60901	60902	pulmonary	0	None
60902	60903	thromboembolism	0	None
60903	60904	]	0	None
60904	60905	.	0	None
60905	60906	The	0	None
60906	60907	prostaglandin	0	None
60907	60908	F	0	None
60908	60909	(	0	None
60909	60910	2alpha	0	None
60910	60911	)	0	None
60911	60912	receptor	0	None
60912	60913	(	0	None
60913	60914	PTGFR	0	None
60914	60915	)	0	None
60915	60916	is	0	None
60916	60917	believed	0	None
60917	60918	to	0	None
60918	60919	play	0	None
60919	60920	a	0	None
60920	60921	role	0	None
60921	60922	in	0	None
60922	60923	the	0	None
60923	60924	process	0	None
60924	60925	of	0	None
60925	60926	parturition	0	None
60926	60927	.	0	None

60928	60929	The	0	None
60929	60930	main	0	None
60930	60931	support	0	None
60931	60932	for	0	None
60932	60933	this	0	None
60933	60934	comes	0	None
60934	60935	from	0	None
60935	60936	animal	0	None
60936	60937	studies;	0	None
60937	60938	however	0	None
60938	60939	,	0	None
60939	60940	in	0	None
60940	60941	humans	0	None
60941	60942	,	0	None
60942	60943	the	0	None
60943	60944	evidence	0	None
60944	60945	is	0	None
60945	60946	less	0	None
60946	60947	clear	0	None
60947	60948	.	0	None

60949	60950	The	0	None
60950	60951	gene	0	None
60951	60952	coding	0	None
60952	60953	for	0	None
60953	60954	PTGFR	0	None
60954	60955	may	0	None
60955	60956	be	0	None
60956	60957	subject	0	None
60957	60958	to	0	None
60958	60959	alternative	0	None
60959	60960	splicing	0	None
60960	60961	to	0	None
60961	60962	generate	0	None
60962	60963	alternate	0	None
60963	60964	variants	0	None
60964	60965	with	0	None
60965	60966	different	0	None
60966	60967	signalling	0	None
60967	60968	pathways	0	None
60968	60969	.	0	None

60970	60971	We	0	None
60971	60972	have	0	None
60972	60973	determined	0	None
60973	60974	regional	0	None
60974	60975	(	0	None
60975	60976	upper	0	None
60976	60977	versus	0	None
60977	60978	lower	0	None
60978	60979	segment	0	None
60979	60980	)	0	None
60980	60981	and	0	None
60981	60982	labour-associated	0	None
60982	60983	expression	0	None
60983	60984	of	0	None
60984	60985	PTGFR	0	None
60985	60986	mRNA	0	None
60986	60987	and	0	None
60987	60988	a	0	None
60988	60989	recently	0	None
60989	60990	identified	0	None
60990	60991	splice	0	None
60991	60992	variant	0	None
60992	60993	of	0	None
60993	60994	PTGFR	0	None
60994	60995	in	0	None
60995	60996	human	0	None
60996	60997	myometrium	0	None
60997	60998	and	0	None
60998	60999	decidua	0	None
60999	61000	.	0	None

61001	61002	We	0	None
61002	61003	also	0	None
61003	61004	examined	0	None
61004	61005	the	0	None
61005	61006	effect	0	None
61006	61007	of	0	None
61007	61008	the	0	None
61008	61009	inflammatory	0	None
61009	61010	cytokine	0	None
61010	61011	interleukin-1beta	0	None
61011	61012	(	0	None
61012	61013	IL-1beta	0	None
61013	61014	)	0	None
61014	61015	on	0	None
61015	61016	PTGFR	0	None
61016	61017	mRNA	0	None
61017	61018	expression	0	None
61018	61019	in	0	None
61019	61020	a	0	None
61020	61021	model	0	None
61021	61022	of	0	None
61022	61023	cultured	0	None
61023	61024	human	0	None
61024	61025	myometrial	0	None
61025	61026	smooth	0	None
61026	61027	muscle	0	None
61027	61028	cells	0	None
61028	61029	.	0	None

61030	61031	We	0	None
61031	61032	identified	0	None
61032	61033	a	0	None
61033	61034	PTGFR	0	None
61034	61035	transcript	0	None
61035	61036	variant	0	None
61036	61037	2	0	None
61037	61038	(	0	None
61038	61039	PTGFR-v2	0	None
61039	61040	)	0	None
61040	61041	generated	0	None
61041	61042	by	0	None
61042	61043	alternate	0	None
61043	61044	splicing	0	None
61044	61045	in	0	None
61045	61046	human	0	None
61046	61047	myometrium	0	None
61047	61048	and	0	None
61048	61049	decidua	0	None
61049	61050	.	0	None

61051	61052	The	0	None
61052	61053	PTGFR-v2	0	None
61053	61054	contains	0	None
61054	61055	an	0	None
61055	61056	additional	0	None
61056	61057	71	0	None
61057	61058	base	0	None
61058	61059	pair	0	None
61059	61060	exon	0	None
61060	61061	,	0	None
61061	61062	which	0	None
61062	61063	results	0	None
61063	61064	in	0	None
61064	61065	a	0	None
61065	61066	truncated	0	None
61066	61067	protein	0	None
61067	61068	at	0	None
61068	61069	297	0	None
61069	61071	amino acids	2	CHEMICAL
61071	61072	compared	0	None
61072	61073	with	0	None
61073	61074	the	0	None
61074	61075	PTGFR	0	None
61075	61076	transcript	0	None
61076	61077	variant	0	None
61077	61078	1	0	None
61078	61079	(	0	None
61079	61080	PTGFR-v1	0	None
61080	61081	)	0	None
61081	61082	at	0	None
61082	61083	359	0	None
61083	61085	amino acids	2	CHEMICAL
61085	61086	.	0	None

61087	61088	In	0	None
61088	61089	contrast	0	None
61089	61090	to	0	None
61090	61091	our	0	None
61091	61092	hypothesis	0	None
61092	61093	,	0	None
61093	61094	we	0	None
61094	61095	demonstrate	0	None
61095	61096	that	0	None
61096	61097	PTGFR-v1	0	None
61097	61098	and	0	None
61098	61099	PTGFR-v2	0	None
61099	61100	mRNA	0	None
61100	61101	expression	0	None
61101	61102	is	0	None
61102	61103	not	0	None
61103	61104	significantly	0	None
61104	61105	higher	0	None
61105	61106	in	0	None
61106	61107	upper	0	None
61107	61108	segment	0	None
61108	61109	compared	0	None
61109	61110	with	0	None
61110	61111	lower	0	None
61111	61112	segment	0	None
61112	61113	paired	0	None
61113	61114	samples	0	None
61114	61115	.	0	None

61116	61117	We	0	None
61117	61118	also	0	None
61118	61119	show	0	None
61119	61120	a	0	None
61120	61121	labour-associated	0	None
61121	61122	decrease	0	None
61122	61123	in	0	None
61123	61124	PTGFR-v1	0	None
61124	61125	and	0	None
61125	61126	PTGFR-v2	0	None
61126	61127	mRNA	0	None
61127	61128	expression	0	None
61128	61129	in	0	None
61129	61130	lower	0	None
61130	61131	segment	0	None
61131	61132	myometrial	0	None
61132	61133	samples	0	None
61133	61134	.	0	None

61135	61136	IL-1beta-stimulated	0	None
61136	61137	mRNA	0	None
61137	61138	expression	0	None
61138	61139	of	0	None
61139	61140	both	0	None
61140	61141	PTGFR	0	None
61141	61142	variants	0	None
61142	61143	in	0	None
61143	61144	a	0	None
61144	61145	distinct	0	None
61145	61146	time-dependent	0	None
61146	61147	manner	0	None
61147	61148	in	0	None
61148	61149	myometrial	0	None
61149	61150	cell	0	None
61150	61151	cultures	0	None
61151	61152	.	0	None

61153	61154	We	0	None
61154	61155	suggest	0	None
61155	61156	that	0	None
61156	61157	the	0	None
61157	61158	role	0	None
61158	61159	of	0	None
61159	61160	the	0	None
61160	61161	PTGFR	0	None
61161	61162	in	0	None
61162	61163	the	0	None
61163	61164	human	0	None
61164	61165	uterus	0	None
61165	61166	requires	0	None
61166	61167	further	0	None
61167	61168	validation	0	None
61168	61169	prior	0	None
61169	61170	to	0	None
61170	61171	pursuing	0	None
61171	61172	it	0	None
61172	61173	as	0	None
61173	61174	a	0	None
61174	61175	target	0	None
61175	61176	for	0	None
61176	61177	the	0	None
61177	61178	treatment	0	None
61178	61179	of	0	None
61179	61180	preterm	0	None
61180	61181	labour	0	None
61181	61182	.	0	None

61183	61184	In	0	None
61184	61185	addition	0	None
61185	61186	,	0	None
61186	61187	the	0	None
61187	61188	presence	0	None
61188	61189	of	0	None
61189	61190	distinct	0	None
61190	61191	variants	0	None
61191	61192	suggests	0	None
61192	61193	further	0	None
61193	61194	levels	0	None
61194	61195	of	0	None
61195	61196	gene	0	None
61196	61197	regulation	0	None
61197	61198	within	0	None
61198	61199	the	0	None
61199	61200	pregnant	0	None
61200	61201	uterus	0	None
61201	61202	.	0	None
61202	61203	OBJECTIVE	0	None
61203	61204	:	0	None
61204	61205	The	0	None
61205	61206	activity	0	None
61206	61207	of	0	None
61207	61208	the	0	None
61208	61209	antitumoral	0	None
61209	61210	agent	0	None
61210	61211	bexarotene	0	None
61211	61212	(	0	None
61212	61213	Targretin	0	None
61213	61214	,	0	None
61214	61215	Bexarotene	0	None
61215	61216	)	0	None
61216	61217	depends	0	None
61217	61218	on	0	None
61218	61219	its	0	None
61219	61220	binding	0	None
61220	61221	to	0	None
61221	61222	the	0	None
61222	61223	nuclear	0	None
61223	61225	retinoid-X receptor	3	GENE-N
61225	61226	(	0	None
61226	61227	RXR	0	None
61227	61228	)	0	None
61228	61229	and	0	None
61229	61230	subsequent	0	None
61230	61231	transcriptional	0	None
61231	61232	regulation	0	None
61232	61233	of	0	None
61233	61234	target	0	None
61234	61235	genes	0	None
61235	61236	.	0	None

61237	61238	Through	0	None
61238	61239	RXR	0	None
61239	61240	activation	0	None
61240	61241	,	0	None
61241	61242	bexarotene	0	None
61242	61243	may	0	None
61243	61244	modulate	0	None
61244	61245	numerous	0	None
61245	61246	metabolic	0	None
61246	61247	pathways	0	None
61247	61248	involved	0	None
61248	61249	in	0	None
61249	61250	atherosclerosis	0	None
61250	61251	.	0	None

61252	61253	Here	0	None
61253	61254	,	0	None
61254	61255	we	0	None
61255	61256	investigated	0	None
61256	61257	the	0	None
61257	61258	effect	0	None
61258	61259	of	0	None
61259	61260	bexarotene	0	None
61260	61261	on	0	None
61261	61262	atherosclerosis	0	None
61262	61263	progression	0	None
61263	61264	in	0	None
61264	61265	a	0	None
61265	61266	dyslipidemic	0	None
61266	61267	murine	0	None
61267	61268	model	0	None
61268	61269	,	0	None
61269	61270	the	0	None
61270	61271	human	0	None
61271	61272	apolipoprotein	0	None
61272	61273	E2	0	None
61273	61274	knockin	0	None
61274	61275	mouse	0	None
61275	61276	,	0	None
61276	61277	that	0	None
61277	61278	develops	0	None
61278	61279	essentially	0	None
61279	61280	macrophage-laden	0	None
61280	61281	lesions	0	None
61281	61282	.	0	None

61283	61284	METHODS	0	None
61284	61285	AND	0	None
61285	61286	RESULTS	0	None
61286	61287	:	0	None
61287	61288	Atherosclerotic	0	None
61288	61289	lesions	0	None
61289	61290	together	0	None
61290	61291	with	0	None
61291	61292	different	0	None
61292	61293	metabolic	0	None
61293	61294	pathways	0	None
61294	61295	involved	0	None
61295	61296	in	0	None
61296	61297	atherosclerosis	0	None
61297	61298	were	0	None
61298	61299	investigated	0	None
61299	61300	in	0	None
61300	61301	mice	0	None
61301	61302	treated	0	None
61302	61303	or	0	None
61303	61304	not	0	None
61304	61305	with	0	None
61305	61306	bexarotene	0	None
61306	61307	.	0	None

61308	61309	Bexarotene	0	None
61309	61310	protects	0	None
61310	61311	from	0	None
61311	61312	atherosclerosis	0	None
61312	61313	development	0	None
61313	61314	in	0	None
61314	61315	mice	0	None
61315	61316	,	0	None
61316	61317	at	0	None
61317	61318	least	0	None
61318	61319	in	0	None
61319	61320	part	0	None
61320	61321	by	0	None
61321	61322	improving	0	None
61322	61323	the	0	None
61323	61324	circulating	0	None
61324	61325	cholesterol	0	None
61325	61326	distribution	0	None
61326	61327	profile	0	None
61327	61328	likely	0	None
61328	61329	via	0	None
61329	61330	a	0	None
61330	61331	marked	0	None
61331	61332	decrease	0	None
61332	61333	of	0	None
61333	61334	dietary	0	None
61334	61335	cholesterol	0	None
61335	61336	absorption	0	None
61336	61337	caused	0	None
61337	61338	by	0	None
61338	61339	modulation	0	None
61339	61340	of	0	None
61340	61341	intestinal	0	None
61341	61342	expression	0	None
61342	61343	of	0	None
61343	61344	genes	0	None
61344	61345	recently	0	None
61345	61346	identified	0	None
61346	61347	as	0	None
61347	61348	major	0	None
61348	61349	players	0	None
61349	61350	in	0	None
61350	61351	this	0	None
61351	61352	process	0	None
61352	61353	,	0	None
61353	61354	Niemann-Pick-C1-Like1	0	None
61354	61355	(	0	None
61355	61356	NPC1L1	0	None
61356	61357	)	0	None
61357	61358	and	0	None
61358	61359	CD13	0	None
61359	61360	.	0	None

61361	61362	This	0	None
61362	61363	atheroprotection	0	None
61363	61364	appears	0	None
61364	61365	despite	0	None
61365	61366	a	0	None
61366	61367	strong	0	None
61367	61368	hypertriglyceridemia	0	None
61368	61369	.	0	None

61370	61371	Moreover	0	None
61371	61372	,	0	None
61372	61373	bexarotene	0	None
61373	61374	treatment	0	None
61374	61375	only	0	None
61375	61376	modestly	0	None
61376	61377	modulates	0	None
61377	61378	inflammatory	0	None
61378	61379	gene	0	None
61379	61380	expression	0	None
61380	61381	in	0	None
61381	61382	the	0	None
61382	61383	vascular	0	None
61383	61384	wall	0	None
61384	61385	,	0	None
61385	61386	but	0	None
61386	61387	markedly	0	None
61387	61388	enhanced	0	None
61388	61389	the	0	None
61389	61390	capacity	0	None
61390	61391	of	0	None
61391	61392	macrophages	0	None
61392	61393	to	0	None
61393	61394	efflux	0	None
61394	61395	cellular	0	None
61395	61396	lipids	0	None
61396	61397	.	0	None

61398	61399	CONCLUSIONS	0	None
61399	61400	:	0	None
61400	61401	These	0	None
61401	61402	data	0	None
61402	61403	provide	0	None
61403	61404	evidence	0	None
61404	61405	of	0	None
61405	61406	a	0	None
61406	61407	favorable	0	None
61407	61408	pharmacological	0	None
61408	61409	effect	0	None
61409	61410	of	0	None
61410	61411	bexarotene	0	None
61411	61412	on	0	None
61412	61413	atherosclerosis	0	None
61413	61414	despite	0	None
61414	61415	the	0	None
61415	61416	induction	0	None
61416	61417	of	0	None
61417	61418	hypertriglyceridemia	0	None
61418	61419	,	0	None
61419	61420	likely	0	None
61420	61421	via	0	None
61421	61422	a	0	None
61422	61423	beneficial	0	None
61423	61424	action	0	None
61424	61425	on	0	None
61425	61426	intestinal	0	None
61426	61427	absorption	0	None
61427	61428	and	0	None
61428	61429	macrophage	0	None
61429	61430	efflux	0	None
61430	61431	.	0	None
61431	61432	GABA-induced	0	None
61432	61433	currents	0	None
61433	61434	have	0	None
61434	61435	been	0	None
61435	61436	characterized	0	None
61436	61437	in	0	None
61437	61438	isolated	0	None
61438	61439	horizontal	0	None
61439	61440	cells	0	None
61440	61441	from	0	None
61441	61442	lower	0	None
61442	61443	vertebrates	0	None
61443	61444	but	0	None
61444	61445	not	0	None
61445	61446	in	0	None
61446	61447	mammalian	0	None
61447	61448	horizontal	0	None
61448	61449	cells	0	None
61449	61450	.	0	None

61451	61452	Therefore	0	None
61452	61453	horizontal	0	None
61453	61454	cells	0	None
61454	61455	were	0	None
61455	61456	isolated	0	None
61456	61457	after	0	None
61457	61458	enzymatical	0	None
61458	61459	and	0	None
61459	61460	mechanical	0	None
61460	61461	dissociation	0	None
61461	61462	of	0	None
61462	61463	the	0	None
61463	61464	adult	0	None
61464	61465	mouse	0	None
61465	61466	retina	0	None
61466	61467	and	0	None
61467	61468	visually	0	None
61468	61469	identified	0	None
61469	61470	.	0	None

61471	61472	We	0	None
61472	61473	recorded	0	None
61473	61474	from	0	None
61474	61475	horizontal	0	None
61475	61476	cell	0	None
61476	61477	bodies	0	None
61477	61478	using	0	None
61478	61479	the	0	None
61479	61480	whole	0	None
61480	61481	cell	0	None
61481	61482	and	0	None
61482	61483	outside-out	0	None
61483	61484	configuration	0	None
61484	61485	of	0	None
61485	61486	the	0	None
61486	61487	patch-clamp	0	None
61487	61488	technique	0	None
61488	61489	.	0	None

61490	61491	Extracellular	0	None
61491	61492	application	0	None
61492	61493	of	0	None
61493	61494	GABA	2	CHEMICAL
61494	61495	induced	0	None
61495	61496	inward	0	None
61496	61497	currents	0	None
61497	61498	carried	0	None
61498	61499	by	0	None
61499	61500	chloride	0	None
61500	61501	ions	0	None
61501	61502	.	0	None

61503	61504	GABA-evoked	0	None
61504	61505	currents	0	None
61505	61506	were	0	None
61506	61507	completely	0	None
61507	61508	and	0	None
61508	61509	reversibly	0	None
61509	61510	blocked	0	None
61510	61511	by	0	None
61511	61512	the	0	None
61512	61513	competitive	0	None
61513	61514	GABAA	3	GENE-N
61514	61515	receptor	0	None
61515	61516	antagonist	0	None
61516	61517	bicuculline	2	CHEMICAL
61517	61518	(	0	None
61518	61519	IC50	0	None
61519	61520	=	0	None
61520	61521	1	0	None
61521	61522	.	0	None
61522	61523	7	0	None
61523	61524	microM	0	None
61524	61525	)	0	None
61525	61526	,	0	None
61526	61527	indicating	0	None
61527	61528	expression	0	None
61528	61529	of	0	None
61529	61530	GABAA	3	GENE-N
61530	61531	but	0	None
61531	61532	not	0	None
61532	61533	GABAC	0	None
61533	61534	receptors	0	None
61534	61535	.	0	None

61536	61537	Their	0	None
61537	61538	affinity	0	None
61538	61539	for	0	None
61539	61540	GABA	2	CHEMICAL
61540	61541	was	0	None
61541	61542	moderate	0	None
61542	61543	(	0	None
61543	61544	EC50	0	None
61544	61545	=	0	None
61545	61546	30	0	None
61546	61547	microM	0	None
61547	61548	)	0	None
61548	61549	,	0	None
61549	61550	and	0	None
61550	61551	the	0	None
61551	61552	Hill	0	None
61552	61553	coefficient	0	None
61553	61554	was	0	None
61554	61555	1	0	None
61555	61556	.	0	None
61556	61557	3	0	None
61557	61558	,	0	None
61558	61559	corresponding	0	None
61559	61560	to	0	None
61560	61561	two	0	None
61561	61562	GABA	2	CHEMICAL
61562	61563	binding	0	None
61563	61564	sites	0	None
61564	61565	.	0	None

61566	61567	GABA	2	CHEMICAL
61567	61568	responses	0	None
61568	61569	were	0	None
61569	61570	partially	0	None
61570	61571	reduced	0	None
61571	61572	by	0	None
61572	61573	picrotoxin	2	CHEMICAL
61573	61574	with	0	None
61574	61575	differential	0	None
61575	61576	effects	0	None
61576	61577	on	0	None
61577	61578	peak	0	None
61578	61579	and	0	None
61579	61580	steady-state	0	None
61580	61581	current	0	None
61581	61582	values	0	None
61582	61583	.	0	None

61584	61585	Zinc	2	CHEMICAL
61585	61586	blocked	0	None
61586	61587	the	0	None
61587	61588	GABA	2	CHEMICAL
61588	61589	response	0	None
61589	61590	with	0	None
61590	61591	an	0	None
61591	61592	IC50	0	None
61592	61593	value	0	None
61593	61594	of	0	None
61594	61595	7	0	None
61595	61596	.	0	None
61596	61597	3	0	None
61597	61598	microM	0	None
61598	61599	in	0	None
61599	61600	a	0	None
61600	61601	noncompetitive	0	None
61601	61602	manner	0	None
61602	61603	.	0	None

61604	61605	Furthermore	0	None
61605	61606	,	0	None
61606	61607	GABA	2	CHEMICAL
61607	61608	receptors	0	None
61608	61609	of	0	None
61609	61610	horizontal	0	None
61610	61611	cells	0	None
61611	61612	were	0	None
61612	61613	modulated	0	None
61613	61614	by	0	None
61614	61615	extracellular	0	None
61615	61616	application	0	None
61616	61617	of	0	None
61617	61618	diazepam	0	None
61618	61619	,	0	None
61619	61620	zolpidem	0	None
61620	61621	,	0	None
61621	61622	methyl	0	None
61622	61623	6	0	None
61623	61624	,	0	None
61624	61625	7-dimethoxy-4-ethyl-beta-carboxylate	0	None
61625	61626	,	0	None
61626	61627	pentobarbital	0	None
61627	61628	,	0	None
61628	61629	and	0	None
61629	61630	alphaxalone	0	None
61630	61631	,	0	None
61631	61632	thus	0	None
61632	61633	showing	0	None
61633	61634	typical	0	None
61634	61635	pharmacological	0	None
61635	61636	properties	0	None
61636	61637	of	0	None
61637	61638	CNS	0	None
61638	61639	GABAA	3	GENE-N
61639	61640	receptors	0	None
61640	61641	.	0	None

61642	61643	GABA-evoked	0	None
61643	61644	single-channel	0	None
61644	61645	currents	0	None
61645	61646	were	0	None
61646	61647	characterized	0	None
61647	61648	by	0	None
61648	61649	a	0	None
61649	61650	main	0	None
61650	61651	conductance	0	None
61651	61652	state	0	None
61652	61653	of	0	None
61653	61654	29	0	None
61654	61655	.	0	None
61655	61656	8	0	None
61656	61657	pS	0	None
61657	61658	and	0	None
61658	61659	two	0	None
61659	61660	subconductance	0	None
61660	61661	states	0	None
61661	61662	(	0	None
61662	61663	20	0	None
61663	61664	.	0	None
61664	61665	2	0	None
61665	61666	and	0	None
61666	61667	10	0	None
61667	61668	.	0	None
61668	61669	8	0	None
61669	61670	pS	0	None
61670	61671	,	0	None
61671	61672	respectively	0	None
61672	61673	)	0	None
61673	61674	.	0	None

61675	61676	Kinetic	0	None
61676	61677	analysis	0	None
61677	61678	of	0	None
61678	61679	single-channel	0	None
61679	61680	events	0	None
61680	61681	within	0	None
61681	61682	bursts	0	None
61682	61683	revealed	0	None
61683	61684	similar	0	None
61684	61685	mean	0	None
61685	61686	open	0	None
61686	61687	and	0	None
61687	61688	closed	0	None
61688	61689	times	0	None
61689	61690	for	0	None
61690	61691	the	0	None
61691	61692	main	0	None
61692	61693	conductance	0	None
61693	61694	and	0	None
61694	61695	the	0	None
61695	61696	20	0	None
61696	61697	.	0	None
61697	61698	2-pS	0	None
61698	61699	subconductance	0	None
61699	61700	state	0	None
61700	61701	,	0	None
61701	61702	resulting	0	None
61702	61703	in	0	None
61703	61704	open	0	None
61704	61705	probabilities	0	None
61705	61706	of	0	None
61706	61707	44	0	None
61707	61708	.	0	None
61708	61709	6	0	None
61709	61710	and	0	None
61710	61711	42	0	None
61711	61712	.	0	None
61712	61713	7%	0	None
61713	61714	,	0	None
61714	61715	respectively	0	None
61715	61716	.	0	None

61717	61718	The	0	None
61718	61719	ratio	0	None
61719	61720	of	0	None
61720	61721	open	0	None
61721	61722	to	0	None
61722	61723	closed	0	None
61723	61724	times	0	None
61724	61725	,	0	None
61725	61726	however	0	None
61726	61727	,	0	None
61727	61728	was	0	None
61728	61729	significantly	0	None
61729	61730	different	0	None
61730	61731	for	0	None
61731	61732	the	0	None
61732	61733	10	0	None
61733	61734	.	0	None
61734	61735	8-pS	0	None
61735	61736	subconductance	0	None
61736	61737	state	0	None
61737	61738	with	0	None
61738	61739	an	0	None
61739	61740	open	0	None
61740	61741	probability	0	None
61741	61742	of	0	None
61742	61743	57	0	None
61743	61744	.	0	None
61744	61745	2%	0	None
61745	61746	.	0	None
61746	61747	Catecholamine	0	None
61747	61748	mimetic	0	None
61748	61749	EDTA-bis	0	None
61749	61750	(	0	None
61750	61751	tyramide	0	None
61751	61752	)	0	None
61752	61753	was	0	None
61753	61754	synthesized	0	None
61754	61755	and	0	None
61755	61756	characterized	0	None
61756	61757	by	0	None
61757	61758	various	0	None
61758	61759	spectroscopic	0	None
61759	61760	techniques	0	None
61760	61761	(	0	None
61761	61762	NMR	0	None
61762	61763	,	0	None
61763	61764	Mass	0	None
61764	61765	spectroscopy	0	None
61765	61766	)	0	None
61766	61767	and	0	None
61767	61768	λem	0	None
61768	61769	310	0	None
61769	61770	nm	0	None
61770	61771	for	0	None
61771	61772	the	0	None
61772	61773	excitation	0	None
61773	61774	at	0	None
61774	61775	270	0	None
61775	61776	nm	0	None
61776	61777	.	0	None

61778	61779	Molecular	0	None
61779	61780	docking	0	None
61780	61781	studies	0	None
61781	61782	were	0	None
61782	61783	performed	0	None
61783	61784	with	0	None
61784	61785	Human	0	None
61785	61787	Serum Albumin	1	GENE-Y
61787	61788	(	0	None
61788	61789	HSA	0	None
61789	61790	:	0	None
61790	61791	PDB	0	None
61791	61792	1E78	0	None
61792	61793	)	0	None
61793	61794	,	0	None
61794	61795	showing	0	None
61795	61796	binding	0	None
61796	61797	pattern	0	None
61797	61798	with	0	None
61798	61800	amino acid	2	CHEMICAL
61800	61801	residues	0	None
61801	61802	Arg218	0	None
61802	61803	,	0	None
61803	61804	Arg222	0	None
61804	61805	and	0	None
61805	61806	Lys444	0	None
61806	61807	,	0	None
61807	61808	identifies	0	None
61808	61809	the	0	None
61809	61810	ligand-HSA	0	None
61810	61811	interaction	0	None
61811	61812	for	0	None
61812	61813	the	0	None
61813	61814	transportation	0	None
61814	61815	affinity	0	None
61815	61816	of	0	None
61816	61817	the	0	None
61817	61818	ligand	0	None
61818	61819	at	0	None
61819	61820	the	0	None
61820	61821	specific	0	None
61821	61822	site	0	None
61822	61823	of	0	None
61823	61824	the	0	None
61824	61825	target	0	None
61825	61826	.	0	None

61827	61828	Subsequently	0	None
61828	61829	binding	0	None
61829	61830	study	0	None
61830	61831	with	0	None
61831	61832	HSA	0	None
61832	61833	at	0	None
61833	61834	λex	0	None
61834	61835	=	0	None
61835	61836	350	0	None
61836	61837	nm	0	None
61837	61838	found	0	None
61838	61839	to	0	None
61839	61840	be	0	None
61840	61841	5	0	None
61841	61842	.	0	None
61842	61843	847x10	0	None
61843	61844	(	0	None
61844	61845	4	0	None
61845	61846	)	0	None
61846	61847	M	0	None
61847	61848	(	0	None
61848	61849	-1	0	None
61849	61850	)	0	None
61850	61851	shows	0	None
61851	61852	effective	0	None
61852	61853	quenching	0	None
61853	61854	effect	0	None
61854	61855	.	0	None

61856	61857	Additionally	0	None
61857	61858	to	0	None
61858	61859	go	0	None
61859	61860	more	0	None
61860	61861	insight	0	None
61861	61862	AChE	1	GENE-Y
61862	61863	binding	0	None
61863	61864	affinity	0	None
61864	61865	was	0	None
61865	61866	investigated	0	None
61866	61867	,	0	None
61867	61868	which	0	None
61868	61869	shows	0	None
61869	61870	90%	0	None
61870	61871	binding	0	None
61871	61872	affinity	0	None
61872	61873	for	0	None
61873	61874	the	0	None
61874	61875	10	0	None
61875	61876	mM	0	None
61876	61877	concentration	0	None
61877	61878	.	0	None

61879	61880	IC50	0	None
61880	61881	value	0	None
61881	61882	was	0	None
61882	61883	was	0	None
61883	61884	found	0	None
61884	61885	18	0	None
61885	61886	.	0	None
61886	61887	60	0	None
61887	61888	μM	0	None
61888	61889	for	0	None
61889	61890	MAO-B	0	None
61890	61891	inhibition	0	None
61891	61892	.	0	None

61893	61894	Finally	0	None
61894	61895	,	0	None
61895	61896	EDTA-bis	0	None
61896	61897	(	0	None
61897	61898	tyramide	0	None
61898	61899	)	0	None
61899	61900	labeled	0	None
61900	61901	with	0	None
61901	61902	(	0	None
61902	61903	99m	0	None
61903	61904	)	0	None
61904	61905	Tc	0	None
61905	61906	to	0	None
61906	61907	investigate	0	None
61907	61908	its	0	None
61908	61909	in-vivo	0	None
61909	61910	radiopharmaceutical	0	None
61910	61911	efficiency	0	None
61911	61912	,	0	None
61912	61913	having	0	None
61913	61914	97%	0	None
61914	61915	binding	0	None
61915	61916	affinity	0	None
61916	61917	with	0	None
61917	61918	98%	0	None
61918	61919	radiochemical	0	None
61919	61920	purity	0	None
61920	61921	.	0	None

61922	61923	In-vivo	0	None
61923	61924	studies	0	None
61924	61925	were	0	None
61925	61926	carried	0	None
61926	61927	out	0	None
61927	61928	for	0	None
61928	61929	(	0	None
61929	61930	99m	0	None
61930	61931	)	0	None
61931	61932	Tc-	0	None
61932	61933	EDTA-bis	0	None
61933	61934	(	0	None
61934	61935	tyramide	0	None
61935	61936	)	0	None
61936	61937	included	0	None
61937	61938	blood	0	None
61938	61939	kinetics	0	None
61939	61940	showed	0	None
61940	61941	a	0	None
61941	61942	quick	0	None
61942	61943	wash	0	None
61943	61944	out	0	None
61944	61945	from	0	None
61945	61946	the	0	None
61946	61947	circulation	0	None
61947	61948	via	0	None
61948	61949	renal	0	None
61949	61950	route	0	None
61950	61951	and	0	None
61951	61952	biodistribution	0	None
61952	61953	revealed	0	None
61953	61954	that	0	None
61954	61955	maximum%ID	0	None
61955	61956	/	0	None
61956	61957	g	0	None
61957	61958	was	0	None
61958	61959	found	0	None
61959	61960	in	0	None
61960	61961	kidney	0	None
61961	61962	at	0	None
61962	61963	1h	0	None
61963	61964	and	0	None
61964	61965	its	0	None
61965	61966	scintigraphy	0	None
61966	61967	image	0	None
61967	61968	shows	0	None
61968	61969	3	0	None
61969	61970	.	0	None
61970	61971	96%	0	None
61971	61972	brain	0	None
61972	61973	uptake	0	None
61973	61974	with	0	None
61974	61975	respect	0	None
61975	61976	to	0	None
61976	61977	whole	0	None
61977	61978	body	0	None
61978	61979	.	0	None

61980	61981	This	0	None
61981	61982	article	0	None
61982	61983	is	0	None
61983	61984	protected	0	None
61984	61985	by	0	None
61985	61986	copyright	0	None
61986	61987	.	0	None

61988	61989	All	0	None
61989	61990	rights	0	None
61990	61991	reserved	0	None
61991	61992	.	0	None
61992	61993	Pyridinium	0	None
61993	61994	oximes	0	None
61994	61995	as	0	None
61995	61996	cholinesterase	1	GENE-Y
61996	61997	reactivators	0	None
61997	61998	.	0	None

61999	62000	Structure-activity	0	None
62000	62001	relationship	0	None
62001	62002	and	0	None
62002	62003	efficacy	0	None
62003	62004	in	0	None
62004	62005	the	0	None
62005	62006	treatment	0	None
62006	62007	of	0	None
62007	62008	poisoning	0	None
62008	62009	with	0	None
62009	62010	organophosphorus	0	None
62010	62011	compounds	0	None
62011	62012	.	0	None
62012	62013	Thymidylate	2	CHEMICAL
62013	62014	kinase	0	None
62014	62015	(	0	None
62015	62016	TMPK	0	None
62016	62017	)	0	None
62017	62018	is	0	None
62018	62019	a	0	None
62019	62020	key	0	None
62020	62021	enzyme	0	None
62021	62022	for	0	None
62022	62023	pyrimidine	2	CHEMICAL
62023	62024	synthesis	0	None
62024	62025	that	0	None
62025	62026	catalyzes	0	None
62026	62027	the	0	None
62027	62028	phosphorylation	0	None
62028	62029	of	0	None
62029	62031	thymidine 5'-monophosphate	2	CHEMICAL
62031	62032	(	0	None
62032	62033	dTMP	0	None
62033	62034	)	0	None
62034	62035	in	0	None
62035	62036	the	0	None
62036	62037	presence	0	None
62037	62038	of	0	None
62038	62039	ATP	0	None
62039	62040	and	0	None
62040	62041	Mg	2	CHEMICAL
62041	62042	(	0	None
62042	62043	2	0	None
62043	62044	+	0	None
62044	62045	)	0	None
62045	62046	to	0	None
62046	62047	form	0	None
62047	62049	thymidine 5'-diphosphate	2	CHEMICAL
62049	62050	(	0	None
62050	62051	dTDP	0	None
62051	62052	)	0	None
62052	62053	,	0	None
62053	62054	which	0	None
62054	62055	is	0	None
62055	62056	then	0	None
62056	62057	converted	0	None
62057	62058	to	0	None
62058	62060	thymidine 5'-triphosphate	0	None
62060	62061	(	0	None
62061	62062	dTTP	0	None
62062	62063	)	0	None
62063	62064	by	0	None
62064	62065	nucleoside-diphosphate	0	None
62065	62066	kinase	0	None
62066	62067	(	0	None
62067	62068	NDK	0	None
62068	62069	)	0	None
62069	62070	.	0	None

62071	62072	TMPK	0	None
62072	62073	has	0	None
62073	62074	an	0	None
62074	62075	important	0	None
62075	62076	function	0	None
62076	62077	in	0	None
62077	62078	cell	0	None
62078	62079	proliferation	0	None
62079	62080	and	0	None
62080	62081	its	0	None
62081	62082	enzyme	0	None
62082	62083	kinetics	0	None
62083	62084	and	0	None
62084	62085	related	0	None
62085	62086	structures	0	None
62086	62087	have	0	None
62087	62088	been	0	None
62088	62089	determined	0	None
62089	62090	in	0	None
62090	62091	various	0	None
62091	62092	organisms	0	None
62092	62093	.	0	None

62094	62095	TMPK	0	None
62095	62096	is	0	None
62096	62097	well	0	None
62097	62098	recognized	0	None
62098	62099	as	0	None
62099	62100	a	0	None
62100	62101	potential	0	None
62101	62102	drug	0	None
62102	62103	target	0	None
62103	62104	,	0	None
62104	62105	with	0	None
62105	62106	the	0	None
62106	62107	most	0	None
62107	62108	notable	0	None
62108	62109	function	0	None
62109	62110	being	0	None
62110	62111	in	0	None
62111	62112	the	0	None
62112	62113	activation	0	None
62113	62114	of	0	None
62114	62115	anti-HIV	0	None
62115	62116	nucleoside	0	None
62116	62117	prodrugs	0	None
62117	62118	.	0	None

62119	62120	Recent	0	None
62120	62121	studies	0	None
62121	62122	have	0	None
62122	62123	shown	0	None
62123	62124	that	0	None
62124	62125	TMPK	0	None
62125	62126	is	0	None
62126	62127	a	0	None
62127	62128	validated	0	None
62128	62129	target	0	None
62129	62130	for	0	None
62130	62131	antibiotic	0	None
62131	62132	development	0	None
62132	62133	against	0	None
62133	62134	gram-positive	0	None
62134	62135	bacterium	0	None
62135	62136	of	0	None
62136	62137	Staphylococcus	0	None
62137	62138	aureus	0	None
62138	62139	.	0	None

62140	62141	In	0	None
62141	62142	addition	0	None
62142	62143	,	0	None
62143	62144	inhibition	0	None
62144	62145	of	0	None
62145	62146	human	0	None
62146	62147	TMPK	0	None
62147	62148	increases	0	None
62148	62149	the	0	None
62149	62150	potential	0	None
62150	62151	of	0	None
62151	62152	anticancer	0	None
62152	62153	agent	0	None
62153	62154	doxorubicin	2	CHEMICAL
62154	62155	toward	0	None
62155	62156	colon	0	None
62156	62157	cancer	0	None
62157	62158	cells	0	None
62158	62159	regardless	0	None
62159	62160	of	0	None
62160	62161	p53	0	None
62161	62162	status	0	None
62162	62163	.	0	None

62164	62165	Following	0	None
62165	62166	the	0	None
62166	62167	rapid	0	None
62167	62168	expanding	0	None
62168	62169	knowledge	0	None
62169	62170	on	0	None
62170	62171	TMPKs	0	None
62171	62172	and	0	None
62172	62173	the	0	None
62173	62174	rising	0	None
62174	62175	interests	0	None
62175	62176	in	0	None
62176	62177	TMPKs	0	None
62177	62178	as	0	None
62178	62179	a	0	None
62179	62180	drug	0	None
62180	62181	target	0	None
62181	62182	,	0	None
62182	62183	in	0	None
62183	62184	this	0	None
62184	62185	review	0	None
62185	62186	we	0	None
62186	62187	try	0	None
62187	62188	to	0	None
62188	62189	describe	0	None
62189	62190	current	0	None
62190	62191	research	0	None
62191	62192	on	0	None
62192	62193	TMPKs	0	None
62193	62194	in	0	None
62194	62195	various	0	None
62195	62196	organisms	0	None
62196	62197	of	0	None
62197	62198	eukaryotes	0	None
62198	62199	,	0	None
62199	62200	prokaryotes	0	None
62200	62201	and	0	None
62201	62202	viruses	0	None
62202	62203	and	0	None
62203	62204	to	0	None
62204	62205	provide	0	None
62205	62206	information	0	None
62206	62207	for	0	None
62207	62208	designing	0	None
62208	62209	new	0	None
62209	62210	potential	0	None
62210	62211	inhibitors	0	None
62211	62212	against	0	None
62212	62213	TMPKs	0	None
62213	62214	.	0	None
62214	62215	Alteration	0	None
62215	62216	of	0	None
62216	62217	α-tocopherol-associated	0	None
62217	62218	protein	0	None
62218	62219	(	0	None
62219	62220	TAP	0	None
62220	62221	)	0	None
62221	62222	expression	0	None
62222	62223	in	0	None
62223	62224	human	0	None
62224	62225	breast	0	None
62225	62226	epithelial	0	None
62226	62227	cells	0	None
62227	62228	during	0	None
62228	62229	breast	0	None
62229	62230	cancer	0	None
62230	62231	development	0	None
62231	62232	.	0	None
62232	62233	D4	1	GENE-Y
62233	62235	dopamine receptor	1	GENE-Y
62235	62236	binding	0	None
62236	62237	affinity	0	None
62237	62238	does	0	None
62238	62239	not	0	None
62239	62240	distinguish	0	None
62240	62241	between	0	None
62241	62242	typical	0	None
62242	62243	and	0	None
62243	62244	atypical	0	None
62244	62245	antipsychotic	0	None
62245	62246	drugs	0	None
62246	62247	.	0	None
62247	62248	We	0	None
62248	62249	investigated	0	None
62249	62250	the	0	None
62250	62251	effects	0	None
62251	62252	of	0	None
62252	62253	resveratrol	0	None
62253	62254	on	0	None
62254	62255	rat	0	None
62255	62256	portal	0	None
62256	62257	vein	0	None
62257	62258	(	0	None
62258	62259	RPV	0	None
62259	62260	)	0	None
62260	62261	contractility	0	None
62261	62262	without	0	None
62262	62263	endothelium	0	None
62263	62264	.	0	None

62265	62266	Contractions	0	None
62266	62267	were	0	None
62267	62268	produced	0	None
62268	62269	by	0	None
62269	62270	electrical	0	None
62270	62271	field	0	None
62271	62272	stimulation	0	None
62272	62273	of	0	None
62273	62274	perivascular	0	None
62274	62275	nerves	0	None
62275	62276	(	0	None
62276	62277	EFS	0	None
62277	62278	)	0	None
62278	62279	,	0	None
62279	62280	norepinephrine	2	CHEMICAL
62280	62281	(	0	None
62281	62282	NE	0	None
62282	62283	)	0	None
62283	62284	,	0	None
62284	62285	adenosine	0	None
62285	62286	5'-triphosphate	0	None
62286	62287	(	0	None
62287	62288	ATP	0	None
62288	62289	)	0	None
62289	62290	,	0	None
62290	62291	high	0	None
62291	62292	K	0	None
62292	62293	(	0	None
62293	62294	+	0	None
62294	62295	)	0	None
62295	62296	solution	0	None
62296	62297	and	0	None
62297	62298	by	0	None
62298	62299	calcium	0	None
62299	62300	chloride	0	None
62300	62301	(	0	None
62301	62302	CaCl	0	None
62302	62303	(	0	None
62303	62304	2	0	None
62304	62305	)	0	None
62305	62306	)	0	None
62306	62307	in	0	None
62307	62308	Ca	0	None
62308	62309	(	0	None
62309	62310	2	0	None
62310	62311	+	0	None
62311	62312	)	0	None
62312	62313	-free	0	None
62313	62314	and	0	None
62314	62315	high	0	None
62315	62316	K	0	None
62316	62317	(	0	None
62317	62318	+	0	None
62318	62319	)	0	None
62319	62320	,	0	None
62320	62321	Ca	0	None
62321	62322	(	0	None
62322	62323	2	0	None
62323	62324	+	0	None
62324	62325	)	0	None
62325	62326	-free	0	None
62326	62327	solution	0	None
62327	62328	.	0	None

62329	62330	The	0	None
62330	62331	EFS-evoked	0	None
62331	62332	contractions	0	None
62332	62333	were	0	None
62333	62334	more	0	None
62334	62335	sensitive	0	None
62335	62336	to	0	None
62336	62337	resveratrol	0	None
62337	62338	and	0	None
62338	62339	to	0	None
62339	62340	NS1619-selective	0	None
62340	62341	openers	0	None
62341	62342	of	0	None
62342	62343	big	0	None
62343	62344	calcium-sensitive	0	None
62344	62345	(	0	None
62345	62346	BK	0	None
62346	62347	(	0	None
62347	62348	Ca	0	None
62348	62349	)	0	None
62349	62350	)	0	None
62350	62351	channels	0	None
62351	62352	,	0	None
62352	62353	than	0	None
62353	62354	NE-evoked	0	None
62354	62355	contractions	0	None
62355	62356	.	0	None

62357	62358	Effects	0	None
62358	62359	of	0	None
62359	62360	resveratrol	0	None
62360	62361	on	0	None
62361	62362	the	0	None
62362	62363	ATP-evoked	0	None
62363	62364	contractions	0	None
62364	62365	were	0	None
62365	62366	weak	0	None
62366	62367	.	0	None

62368	62369	Blockers	0	None
62369	62370	of	0	None
62370	62371	BK	0	None
62371	62372	(	0	None
62372	62373	Ca	0	None
62373	62374	)	0	None
62374	62375	channels	0	None
62375	62376	partly	0	None
62376	62377	inhibited	0	None
62377	62378	the	0	None
62378	62379	effect	0	None
62379	62380	of	0	None
62380	62381	resveratrol	0	None
62381	62382	only	0	None
62382	62383	in	0	None
62383	62384	EFS-contracted	0	None
62384	62385	preparations	0	None
62385	62386	.	0	None

62387	62388	Western	0	None
62388	62389	blotting	0	None
62389	62390	showed	0	None
62390	62391	that	0	None
62391	62392	RPV	0	None
62392	62393	expressed	0	None
62393	62394	K	0	None
62394	62395	(	0	None
62395	62396	Ca	0	None
62396	62397	)	0	None
62397	62398	1	0	None
62398	62399	.	0	None
62399	62400	1	0	None
62400	62401	protein	0	None
62401	62402	.	0	None

62403	62404	Inhibitors	0	None
62404	62405	of	0	None
62405	62406	ATP-	0	None
62406	62407	and	0	None
62407	62408	voltage-sensitive	0	None
62408	62409	K	0	None
62409	62410	(	0	None
62410	62411	+	0	None
62411	62412	)	0	None
62412	62413	channels	0	None
62413	62414	did	0	None
62414	62415	not	0	None
62415	62416	modify	0	None
62416	62417	the	0	None
62417	62418	effects	0	None
62418	62419	of	0	None
62419	62420	resveratrol	0	None
62420	62421	.	0	None

62422	62423	None	0	None
62423	62424	of	0	None
62424	62425	the	0	None
62425	62426	antagonists	0	None
62426	62427	of	0	None
62427	62428	K	0	None
62428	62429	(	0	None
62429	62430	+	0	None
62430	62431	)	0	None
62431	62432	channels	0	None
62432	62433	affected	0	None
62433	62434	the	0	None
62434	62435	resveratrol	0	None
62435	62436	inhibition	0	None
62436	62437	of	0	None
62437	62438	NE-evoked	0	None
62438	62439	contractions	0	None
62439	62440	and	0	None
62440	62441	effect	0	None
62441	62442	of	0	None
62442	62443	high	0	None
62443	62444	concentrations	0	None
62444	62445	of	0	None
62445	62446	resveratrol	0	None
62446	62447	on	0	None
62447	62448	the	0	None
62448	62449	EFS-evoked	0	None
62449	62450	contractions	0	None
62450	62451	.	0	None

62452	62453	Resveratrol	0	None
62453	62454	more	0	None
62454	62455	potently	0	None
62455	62456	inhibited	0	None
62456	62457	CaCl	0	None
62457	62458	(	0	None
62458	62459	2	0	None
62459	62460	)	0	None
62460	62461	than	0	None
62461	62462	potassium	0	None
62462	62463	chloride	0	None
62463	62464	contractions	0	None
62464	62465	of	0	None
62465	62466	RPV	0	None
62466	62467	.	0	None

62468	62469	Thus	0	None
62469	62470	,	0	None
62470	62471	BK	0	None
62471	62472	(	0	None
62472	62473	Ca	0	None
62473	62474	)	0	None
62474	62475	channels	0	None
62475	62476	partly	0	None
62476	62477	mediate	0	None
62477	62478	the	0	None
62478	62479	inhibitory	0	None
62479	62480	effect	0	None
62480	62481	of	0	None
62481	62482	resveratrol	0	None
62482	62483	on	0	None
62483	62484	the	0	None
62484	62485	neurogenic	0	None
62485	62486	contractions	0	None
62486	62487	of	0	None
62487	62488	RPV	0	None
62488	62489	.	0	None

62490	62491	The	0	None
62491	62492	smooth	0	None
62492	62493	muscle	0	None
62493	62494	Ca	0	None
62494	62495	(	0	None
62495	62496	2	0	None
62496	62497	+	0	None
62497	62498	)	0	None
62498	62499	channels	0	None
62499	62500	and	0	None
62500	62501	/	0	None
62501	62502	or	0	None
62502	62503	Ca	0	None
62503	62504	(	0	None
62504	62505	2	0	None
62505	62506	+	0	None
62506	62507	)	0	None
62507	62508	mobilizing	0	None
62508	62509	through	0	None
62509	62510	cells	0	None
62510	62511	might	0	None
62511	62512	be	0	None
62512	62513	involved	0	None
62513	62514	in	0	None
62514	62515	the	0	None
62515	62516	effects	0	None
62516	62517	of	0	None
62517	62518	resveratrol	0	None
62518	62519	on	0	None
62519	62520	the	0	None
62520	62521	contractility	0	None
62521	62522	of	0	None
62522	62523	RPV	0	None
62523	62524	.	0	None

62525	62526	Our	0	None
62526	62527	results	0	None
62527	62528	are	0	None
62528	62529	important	0	None
62529	62530	for	0	None
62530	62531	better	0	None
62531	62532	understanding	0	None
62532	62533	the	0	None
62533	62534	impact	0	None
62534	62535	of	0	None
62535	62536	resveratrol	0	None
62536	62537	on	0	None
62537	62538	the	0	None
62538	62539	portal	0	None
62539	62540	circulation	0	None
62540	62541	.	0	None

62542	62543	Copyright	0	None
62543	62544	©	0	None
62544	62545	2013	0	None
62545	62546	John	0	None
62546	62547	Wiley	0	None
62547	62548	&	0	None
62548	62549	Sons	0	None
62549	62550	,	0	None
62550	62551	Ltd	0	None
62551	62552	.	0	None
62552	62553	OAT1	1	GENE-Y
62553	62554	and	0	None
62554	62555	OAT3	0	None
62555	62556	:	0	None
62556	62557	targets	0	None
62557	62558	of	0	None
62558	62559	drug-drug	0	None
62559	62560	interaction	0	None
62560	62561	between	0	None
62561	62562	entecavir	2	CHEMICAL
62562	62563	and	0	None
62563	62564	JBP485	0	None
62564	62565	.	0	None
62565	62566	β-Cell	0	None
62566	62567	lipotoxicity	0	None
62567	62568	is	0	None
62568	62569	thought	0	None
62569	62570	to	0	None
62570	62571	play	0	None
62571	62572	an	0	None
62572	62573	important	0	None
62573	62574	role	0	None
62574	62575	in	0	None
62575	62576	the	0	None
62576	62577	development	0	None
62577	62578	of	0	None
62578	62579	type	0	None
62579	62580	2	0	None
62580	62581	diabetes	0	None
62581	62582	.	0	None

62583	62584	However	0	None
62584	62585	,	0	None
62585	62586	no	0	None
62586	62587	study	0	None
62587	62588	has	0	None
62588	62589	examined	0	None
62589	62590	its	0	None
62590	62591	role	0	None
62591	62592	in	0	None
62592	62593	type	0	None
62593	62594	1	0	None
62594	62595	diabetes	0	None
62595	62596	,	0	None
62596	62597	which	0	None
62597	62598	could	0	None
62598	62599	be	0	None
62599	62600	clinically	0	None
62600	62601	relevant	0	None
62601	62602	for	0	None
62602	62603	slow-onset	0	None
62603	62604	type	0	None
62604	62605	1	0	None
62605	62606	diabetes	0	None
62606	62607	.	0	None

62608	62609	Reports	0	None
62609	62610	of	0	None
62610	62611	enhanced	0	None
62611	62612	cytokine	0	None
62612	62613	toxicity	0	None
62613	62614	in	0	None
62614	62615	fat-laden	0	None
62615	62616	islets	0	None
62616	62617	are	0	None
62617	62618	consistent	0	None
62618	62619	with	0	None
62619	62620	the	0	None
62620	62621	hypothesis	0	None
62621	62622	that	0	None
62622	62623	lipid	0	None
62623	62624	and	0	None
62624	62625	cytokine	0	None
62625	62626	toxicity	0	None
62626	62627	may	0	None
62627	62628	be	0	None
62628	62629	synergistic	0	None
62629	62630	.	0	None

62631	62632	Thus	0	None
62632	62633	,	0	None
62633	62634	β-cell	0	None
62634	62635	lipotoxicity	0	None
62635	62636	could	0	None
62636	62637	be	0	None
62637	62638	enhanced	0	None
62638	62639	in	0	None
62639	62640	models	0	None
62640	62641	of	0	None
62641	62642	autoimmune	0	None
62642	62643	diabetes	0	None
62643	62644	.	0	None

62645	62646	To	0	None
62646	62647	determine	0	None
62647	62648	this	0	None
62648	62649	,	0	None
62649	62650	we	0	None
62650	62651	examined	0	None
62651	62652	the	0	None
62652	62653	effects	0	None
62653	62654	of	0	None
62654	62655	prolonged	0	None
62655	62656	free	0	None
62656	62658	fatty acids	2	CHEMICAL
62658	62659	elevation	0	None
62659	62660	on	0	None
62660	62661	β-cell	0	None
62661	62662	secretory	0	None
62662	62663	function	0	None
62663	62664	in	0	None
62664	62665	the	0	None
62665	62666	prediabetic	0	None
62666	62667	diabetes-prone	0	None
62667	62668	BioBreeding	0	None
62668	62669	(	0	None
62669	62670	dp-BB	0	None
62670	62671	)	0	None
62671	62672	rat	0	None
62672	62673	,	0	None
62673	62674	its	0	None
62674	62675	diabetes-resistant	0	None
62675	62676	BioBreeding	0	None
62676	62677	(	0	None
62677	62678	dr-BB	0	None
62678	62679	)	0	None
62679	62680	control	0	None
62680	62681	,	0	None
62681	62682	and	0	None
62682	62683	normal	0	None
62683	62684	Wistar-Furth	0	None
62684	62685	(	0	None
62685	62686	WF	0	None
62686	62687	)	0	None
62687	62688	rats	0	None
62688	62689	.	0	None

62690	62691	Rats	0	None
62691	62692	received	0	None
62692	62693	a	0	None
62693	62694	48-h	0	None
62694	62695	iv	0	None
62695	62696	infusion	0	None
62696	62697	of	0	None
62697	62698	saline	0	None
62698	62699	or	0	None
62699	62700	Intralipid	0	None
62700	62701	plus	0	None
62701	62702	heparin	0	None
62702	62703	(	0	None
62703	62704	IH	0	None
62704	62705	)	0	None
62705	62706	(	0	None
62706	62707	to	0	None
62707	62708	elevate	0	None
62708	62709	free	0	None
62709	62711	fatty acid	2	CHEMICAL
62711	62712	levels	0	None
62712	62713	~2-fold	0	None
62713	62714	)	0	None
62714	62715	followed	0	None
62715	62716	by	0	None
62716	62717	hyperglycemic	0	None
62717	62718	clamp	0	None
62718	62719	or	0	None
62719	62720	islet	3	GENE-N
62720	62721	secretion	0	None
62721	62722	studies	0	None
62722	62723	ex	0	None
62723	62724	vivo	0	None
62724	62725	.	0	None

62726	62727	IH	0	None
62727	62728	significantly	0	None
62728	62729	decreased	0	None
62729	62730	β-cell	0	None
62730	62731	function	0	None
62731	62732	,	0	None
62732	62733	assessed	0	None
62733	62734	both	0	None
62734	62735	by	0	None
62735	62736	the	0	None
62736	62737	disposition	0	None
62737	62738	index	0	None
62738	62739	(	0	None
62739	62740	insulin	0	None
62740	62741	secretion	0	None
62741	62742	corrected	0	None
62742	62743	for	0	None
62743	62744	IH-induced	0	None
62744	62745	insulin	0	None
62745	62746	resistance	0	None
62746	62747	)	0	None
62747	62748	and	0	None
62748	62749	in	0	None
62749	62750	isolated	0	None
62750	62751	islets	0	None
62751	62752	,	0	None
62752	62753	in	0	None
62753	62754	dp-BB	0	None
62754	62755	,	0	None
62755	62756	but	0	None
62756	62757	not	0	None
62757	62758	in	0	None
62758	62759	dr-BB	0	None
62759	62760	or	0	None
62760	62761	WF	0	None
62761	62762	,	0	None
62762	62763	rats	0	None
62763	62764	,	0	None
62764	62765	and	0	None
62765	62766	the	0	None
62766	62767	effect	0	None
62767	62768	of	0	None
62768	62769	IH	0	None
62769	62770	was	0	None
62770	62771	inhibited	0	None
62771	62772	by	0	None
62772	62773	the	0	None
62773	62774	antioxidant	0	None
62774	62775	N-acetylcysteine	0	None
62775	62776	.	0	None

62777	62778	Furthermore	0	None
62778	62779	,	0	None
62779	62780	IH	0	None
62780	62781	significantly	0	None
62781	62782	increased	0	None
62782	62783	islet	3	GENE-N
62783	62784	cytokine	0	None
62784	62785	mRNA	0	None
62785	62786	and	0	None
62786	62787	plasma	0	None
62787	62788	cytokine	0	None
62788	62789	levels	0	None
62789	62790	(	0	None
62790	62791	monocyte	0	None
62791	62792	chemoattractant	0	None
62792	62793	protein-1	0	None
62793	62794	and	0	None
62794	62795	IL-10	0	None
62795	62796	)	0	None
62796	62797	in	0	None
62797	62798	dp-BB	0	None
62798	62799	,	0	None
62799	62800	but	0	None
62800	62801	not	0	None
62801	62802	in	0	None
62802	62803	dr-BB	0	None
62803	62804	or	0	None
62804	62805	WF	0	None
62805	62806	,	0	None
62806	62807	rats	0	None
62807	62808	.	0	None

62809	62810	All	0	None
62810	62811	dp-BB	0	None
62811	62812	rats	0	None
62812	62813	had	0	None
62813	62814	mononuclear	0	None
62814	62815	infiltration	0	None
62815	62816	of	0	None
62816	62817	islets	0	None
62817	62818	,	0	None
62818	62819	which	0	None
62819	62820	was	0	None
62820	62821	absent	0	None
62821	62822	in	0	None
62822	62823	dr-BB	0	None
62823	62824	and	0	None
62824	62825	WF	0	None
62825	62826	rats	0	None
62826	62827	.	0	None

62828	62829	In	0	None
62829	62830	conclusion	0	None
62830	62831	,	0	None
62831	62832	the	0	None
62832	62833	presence	0	None
62833	62834	of	0	None
62834	62835	insulitis	0	None
62835	62836	was	0	None
62836	62837	permissive	0	None
62837	62838	for	0	None
62838	62839	IH-induced	0	None
62839	62840	β-cell	0	None
62840	62841	dysfunction	0	None
62841	62842	in	0	None
62842	62843	the	0	None
62843	62844	BB	0	None
62844	62845	rat	0	None
62845	62846	,	0	None
62846	62847	which	0	None
62847	62848	suggests	0	None
62848	62849	a	0	None
62849	62850	link	0	None
62850	62851	between	0	None
62851	62852	β-cell	0	None
62852	62853	lipotoxicity	0	None
62853	62854	and	0	None
62854	62855	islet	3	GENE-N
62855	62856	inflammation	0	None
62856	62857	.	0	None
62857	62858	Low	0	None
62858	62859	levels	0	None
62859	62860	of	0	None
62860	62861	serotonin	0	None
62861	62862	may	0	None
62862	62863	reduce	0	None
62863	62864	the	0	None
62864	62865	density	0	None
62865	62866	of	0	None
62866	62867	the	0	None
62867	62869	serotonin transporter	1	GENE-Y
62869	62870	(	0	None
62870	62871	SERT	0	None
62871	62872	)	0	None
62872	62873	by	0	None
62873	62874	either	0	None
62874	62875	increasing	0	None
62875	62876	trafficking	0	None
62876	62877	or	0	None
62877	62878	reducing	0	None
62878	62879	synthesis;	0	None
62879	62880	a	0	None
62880	62881	"neuroadaptive	0	None
62881	62882	response"	0	None
62882	62883	.	0	None

62884	62885	To	0	None
62885	62886	determine	0	None
62886	62887	whether	0	None
62887	62888	3	0	None
62888	62889	,	0	None
62889	62890	4-methylenedioxymethamphetamine	0	None
62890	62891	(	0	None
62891	62892	MDMA	0	None
62892	62893	)	0	None
62893	62894	-induced	0	None
62894	62895	reductions	0	None
62895	62896	in	0	None
62896	62897	SERT	0	None
62897	62898	density	0	None
62898	62899	could	0	None
62899	62900	be	0	None
62900	62901	related	0	None
62901	62902	to	0	None
62902	62903	such	0	None
62903	62904	a	0	None
62904	62905	mechanism	0	None
62905	62906	,	0	None
62906	62907	p-chlorophenylalanine	0	None
62907	62908	or	0	None
62908	62909	MDMA	0	None
62909	62910	was	0	None
62910	62911	administered	0	None
62911	62912	to	0	None
62912	62913	rats	0	None
62913	62914	,	0	None
62914	62915	and	0	None
62915	62916	brain	0	None
62916	62917	serotonin	0	None
62917	62918	and	0	None
62918	62919	SERT	0	None
62919	62920	density	0	None
62920	62921	were	0	None
62921	62922	measured	0	None
62922	62923	.	0	None

62924	62925	As	0	None
62925	62926	expected	0	None
62926	62927	,	0	None
62927	62928	both	0	None
62928	62929	treatments	0	None
62929	62930	led	0	None
62930	62931	to	0	None
62931	62932	serotonin	0	None
62932	62933	depletion	0	None
62933	62934	1	0	None
62934	62935	,	0	None
62935	62936	7	0	None
62936	62937	and	0	None
62937	62938	14	0	None
62938	62939	days	0	None
62939	62940	later	0	None
62940	62941	.	0	None

62942	62943	However	0	None
62943	62944	,	0	None
62944	62945	only	0	None
62945	62946	MDMA	0	None
62946	62947	reduced	0	None
62947	62948	SERT	0	None
62948	62949	density	0	None
62949	62950	.	0	None

62951	62952	This	0	None
62952	62953	observation	0	None
62953	62954	suggests	0	None
62954	62955	that	0	None
62955	62956	MDMA-induced	0	None
62956	62957	reductions	0	None
62957	62958	in	0	None
62958	62959	SERT	0	None
62959	62960	density	0	None
62960	62961	do	0	None
62961	62962	not	0	None
62962	62963	represent	0	None
62963	62964	neuroadaptive	0	None
62964	62965	responses	0	None
62965	62966	to	0	None
62966	62967	decreased	0	None
62967	62968	levels	0	None
62968	62969	of	0	None
62969	62970	brain	0	None
62970	62971	serotonin	0	None
62971	62972	,	0	None
62972	62973	but	0	None
62973	62974	may	0	None
62974	62975	occur	0	None
62975	62976	in	0	None
62976	62977	response	0	None
62977	62978	to	0	None
62978	62979	some	0	None
62979	62980	other	0	None
62980	62981	stimulus	0	None
62981	62982	or	0	None
62982	62983	to	0	None
62983	62984	the	0	None
62984	62985	neurotoxic	0	None
62985	62986	effects	0	None
62986	62987	of	0	None
62987	62988	MDMA	0	None
62988	62989	.	0	None
62989	62990	Hibiscus	0	None
62990	62991	sabdariffa	0	None
62991	62992	L	0	None
62992	62993	.	0	None

62994	62995	in	0	None
62995	62996	the	0	None
62996	62997	treatment	0	None
62997	62998	of	0	None
62998	62999	hypertension	0	None
62999	63000	and	0	None
63000	63001	hyperlipidemia	0	None
63001	63002	:	0	None
63002	63003	a	0	None
63003	63004	comprehensive	0	None
63004	63005	review	0	None
63005	63006	of	0	None
63006	63007	animal	0	None
63007	63008	and	0	None
63008	63009	human	0	None
63009	63010	studies	0	None
63010	63011	.	0	None
63011	63012	The	0	None
63012	63013	Drosophila	0	None
63013	63014	fat	0	None
63014	63015	body	0	None
63015	63016	is	0	None
63016	63017	a	0	None
63017	63018	liver-	0	None
63018	63019	and	0	None
63019	63020	adipose-like	0	None
63020	63021	tissue	0	None
63021	63022	that	0	None
63022	63023	stores	0	None
63023	63024	fat	0	None
63024	63025	and	0	None
63025	63026	serves	0	None
63026	63027	as	0	None
63027	63028	a	0	None
63028	63029	detoxifying	0	None
63029	63030	and	0	None
63030	63031	immune	0	None
63031	63032	responsive	0	None
63032	63033	organ	0	None
63033	63034	.	0	None

63035	63036	We	0	None
63036	63037	have	0	None
63037	63038	previously	0	None
63038	63039	shown	0	None
63039	63040	that	0	None
63040	63041	a	0	None
63041	63042	high	0	None
63042	63043	sugar	0	None
63043	63044	diet	0	None
63044	63045	leads	0	None
63045	63046	to	0	None
63046	63047	elevated	0	None
63047	63048	hemolymph	0	None
63048	63049	glucose	0	None
63049	63050	and	0	None
63050	63051	systemic	0	None
63051	63052	insulin	0	None
63052	63053	resistance	0	None
63053	63054	in	0	None
63054	63055	developing	0	None
63055	63056	larvae	0	None
63056	63057	and	0	None
63057	63058	adults	0	None
63058	63059	.	0	None

63060	63061	Here	0	None
63061	63062	,	0	None
63062	63063	we	0	None
63063	63064	used	0	None
63064	63065	stable	0	None
63065	63066	isotope	0	None
63066	63067	tracer	0	None
63067	63068	feeding	0	None
63068	63069	to	0	None
63069	63070	demonstrate	0	None
63070	63071	that	0	None
63071	63072	rearing	0	None
63072	63073	larvae	0	None
63073	63074	on	0	None
63074	63075	high	0	None
63075	63076	sugar	0	None
63076	63077	diets	0	None
63077	63078	impaired	0	None
63078	63079	the	0	None
63079	63080	synthesis	0	None
63080	63081	of	0	None
63081	63082	esterified	0	None
63082	63084	fatty acids	2	CHEMICAL
63084	63085	from	0	None
63085	63086	dietary	0	None
63086	63087	glucose	0	None
63087	63088	.	0	None

63089	63090	Fat	0	None
63090	63091	body	0	None
63091	63092	lipid	0	None
63092	63093	profiling	0	None
63093	63094	revealed	0	None
63094	63095	changes	0	None
63095	63096	in	0	None
63096	63097	both	0	None
63097	63098	carbon	2	CHEMICAL
63098	63099	chain	0	None
63099	63100	length	0	None
63100	63101	and	0	None
63101	63102	degree	0	None
63102	63103	of	0	None
63103	63104	unsaturation	0	None
63104	63105	of	0	None
63105	63107	fatty acid	2	CHEMICAL
63107	63108	substituents	0	None
63108	63109	,	0	None
63109	63110	particularly	0	None
63110	63111	in	0	None
63111	63112	stored	0	None
63112	63113	triglycerides	0	None
63113	63114	.	0	None

63115	63116	We	0	None
63116	63117	tested	0	None
63117	63118	the	0	None
63118	63119	role	0	None
63119	63120	of	0	None
63120	63121	the	0	None
63121	63122	fat	0	None
63122	63123	body	0	None
63123	63124	in	0	None
63124	63125	larval	0	None
63125	63126	tolerance	0	None
63126	63127	of	0	None
63127	63128	caloric	0	None
63128	63129	excess	0	None
63129	63130	.	0	None

63131	63132	Our	0	None
63132	63133	experiments	0	None
63133	63134	demonstrated	0	None
63134	63135	that	0	None
63135	63136	lipogenesis	0	None
63136	63137	was	0	None
63137	63138	necessary	0	None
63138	63139	for	0	None
63139	63140	animals	0	None
63140	63141	to	0	None
63141	63142	tolerate	0	None
63142	63143	high	0	None
63143	63144	sugar	0	None
63144	63145	feeding	0	None
63145	63146	as	0	None
63146	63147	tissue-specific	0	None
63147	63148	loss	0	None
63148	63149	of	0	None
63149	63150	orthologs	0	None
63150	63151	of	0	None
63151	63152	carbohydrate	0	None
63152	63153	response	0	None
63153	63154	element-binding	0	None
63154	63155	protein	0	None
63155	63156	or	0	None
63156	63157	stearoyl-CoA	0	None
63157	63158	desaturase	0	None
63158	63159	1	0	None
63159	63160	resulted	0	None
63160	63161	in	0	None
63161	63162	lethality	0	None
63162	63163	on	0	None
63163	63164	high	0	None
63164	63165	sugar	0	None
63165	63166	diets	0	None
63166	63167	.	0	None

63168	63169	By	0	None
63169	63170	contrast	0	None
63170	63171	,	0	None
63171	63172	increasing	0	None
63172	63173	the	0	None
63173	63174	fat	0	None
63174	63175	content	0	None
63175	63176	of	0	None
63176	63177	the	0	None
63177	63178	fat	0	None
63178	63179	body	0	None
63179	63180	by	0	None
63180	63181	knockdown	0	None
63181	63182	of	0	None
63182	63183	king-tubby	0	None
63183	63184	was	0	None
63184	63185	associated	0	None
63185	63186	with	0	None
63186	63187	reduced	0	None
63187	63188	hyperglycemia	0	None
63188	63189	and	0	None
63189	63190	improved	0	None
63190	63191	growth	0	None
63191	63192	and	0	None
63192	63193	tolerance	0	None
63193	63194	of	0	None
63194	63195	high	0	None
63195	63196	sugar	0	None
63196	63197	diets	0	None
63197	63198	.	0	None

63199	63200	Our	0	None
63200	63201	work	0	None
63201	63202	supports	0	None
63202	63203	a	0	None
63203	63204	critical	0	None
63204	63205	role	0	None
63205	63206	for	0	None
63206	63207	the	0	None
63207	63208	fat	0	None
63208	63209	body	0	None
63209	63210	and	0	None
63210	63211	the	0	None
63211	63212	Drosophila	0	None
63212	63213	carbohydrate	0	None
63213	63214	response	0	None
63214	63215	element-binding	0	None
63215	63216	protein	0	None
63216	63217	ortholog	0	None
63217	63218	in	0	None
63218	63219	metabolic	0	None
63219	63220	homeostasis	0	None
63220	63221	in	0	None
63221	63222	Drosophila	0	None
63222	63223	.	0	None
63223	63224	Activating	0	None
63224	63225	internal	0	None
63225	63226	tandem	0	None
63226	63227	duplication	0	None
63227	63228	(	0	None
63228	63229	ITD	0	None
63229	63230	)	0	None
63230	63231	insertions	0	None
63231	63232	in	0	None
63232	63233	the	0	None
63233	63234	juxtamembrane	0	None
63234	63235	domain	0	None
63235	63236	of	0	None
63236	63237	the	0	None
63237	63238	FLT3	0	None
63238	63239	tyrosine	2	CHEMICAL
63239	63240	kinase	0	None
63240	63241	are	0	None
63241	63242	found	0	None
63242	63243	in	0	None
63243	63244	about	0	None
63244	63245	one	0	None
63245	63246	fourth	0	None
63246	63247	of	0	None
63247	63248	patients	0	None
63248	63249	with	0	None
63249	63250	acute	0	None
63250	63251	myeloid	0	None
63251	63252	leukemia	0	None
63252	63253	and	0	None
63253	63254	have	0	None
63254	63255	been	0	None
63255	63256	shown	0	None
63256	63257	to	0	None
63257	63258	be	0	None
63258	63259	an	0	None
63259	63260	independent	0	None
63260	63261	negative	0	None
63261	63262	prognostic	0	None
63262	63263	factor	0	None
63263	63264	for	0	None
63264	63265	survival	0	None
63265	63266	.	0	None

63267	63268	We	0	None
63268	63269	show	0	None
63269	63270	that	0	None
63270	63271	sorafenib	0	None
63271	63272	(	0	None
63272	63273	BAY	0	None
63273	63274	43-9006	0	None
63274	63275	,	0	None
63275	63276	Nexavar	0	None
63276	63277	)	0	None
63277	63278	potently	0	None
63278	63279	inhibits	0	None
63279	63280	FLT3	0	None
63280	63281	enzymatic	0	None
63281	63282	and	0	None
63282	63283	signaling	0	None
63283	63284	activities	0	None
63284	63285	.	0	None

63286	63287	In	0	None
63287	63288	HEK293	0	None
63288	63289	cells	0	None
63289	63290	stably	0	None
63290	63291	transfected	0	None
63291	63292	with	0	None
63292	63293	FLT3-WT	0	None
63293	63294	or	0	None
63294	63295	FLT3-ITD	0	None
63295	63296	,	0	None
63296	63297	sorafenib	0	None
63297	63298	blocked	0	None
63298	63299	basal	0	None
63299	63300	and	0	None
63300	63301	ligand	0	None
63301	63302	dependent	0	None
63302	63303	FLT3-mediated	0	None
63303	63304	tyrosine	2	CHEMICAL
63304	63305	autophosphorylation	0	None
63305	63306	as	0	None
63306	63307	well	0	None
63307	63308	as	0	None
63308	63310	extracellular signal-regulated	0	None
63310	63311	kinase1	0	None
63311	63312	/	0	None
63312	63313	2	0	None
63313	63314	and	0	None
63314	63315	Stat5	0	None
63315	63316	phosphorylation	0	None
63316	63317	.	0	None

63318	63319	In	0	None
63319	63320	leukemia	0	None
63320	63321	cell	0	None
63321	63322	lines	0	None
63322	63323	MV4-11	0	None
63323	63324	and	0	None
63324	63325	EOL-1	0	None
63325	63326	,	0	None
63326	63327	sorafenib	0	None
63327	63328	treatment	0	None
63328	63329	resulted	0	None
63329	63330	in	0	None
63330	63331	decreased	0	None
63331	63332	cell	0	None
63332	63333	proliferation	0	None
63333	63334	and	0	None
63334	63335	inhibition	0	None
63335	63336	of	0	None
63336	63337	FLT3	0	None
63337	63338	signaling	0	None
63338	63339	.	0	None

63340	63341	The	0	None
63341	63342	growth	0	None
63342	63343	of	0	None
63343	63344	the	0	None
63344	63345	FLT3-independent	0	None
63345	63346	RS4-11	0	None
63346	63347	cell	0	None
63347	63348	line	0	None
63348	63349	was	0	None
63349	63350	only	0	None
63350	63351	weakly	0	None
63351	63352	inhibited	0	None
63352	63353	by	0	None
63353	63354	sorafenib	0	None
63354	63355	.	0	None

63356	63357	Cell	0	None
63357	63358	cycle	0	None
63358	63359	arrest	0	None
63359	63360	and	0	None
63360	63361	induction	0	None
63361	63362	of	0	None
63362	63363	apoptosis	0	None
63363	63364	were	0	None
63364	63365	observed	0	None
63365	63366	upon	0	None
63366	63367	treatment	0	None
63367	63368	with	0	None
63368	63369	sorafenib	0	None
63369	63370	in	0	None
63370	63371	MV4-11	0	None
63371	63372	and	0	None
63372	63373	EOL-1	0	None
63373	63374	cells	0	None
63374	63375	.	0	None

63376	63377	The	0	None
63377	63378	antitumor	0	None
63378	63379	efficacy	0	None
63379	63380	of	0	None
63380	63381	sorafenib	0	None
63381	63382	was	0	None
63382	63383	evaluated	0	None
63383	63384	against	0	None
63384	63385	the	0	None
63385	63386	MV4-11	0	None
63386	63387	leukemia	0	None
63387	63388	grown	0	None
63388	63389	subcutaneously	0	None
63389	63390	in	0	None
63390	63391	NCr	0	None
63391	63392	nu	0	None
63392	63393	/	0	None
63393	63394	nu	0	None
63394	63395	mice	0	None
63395	63396	.	0	None

63397	63398	Doses	0	None
63398	63399	of	0	None
63399	63400	3	0	None
63400	63401	and	0	None
63401	63402	10	0	None
63402	63403	mg	2	CHEMICAL
63403	63404	/	0	None
63404	63405	kg	0	None
63405	63406	administered	0	None
63406	63407	orally	0	None
63407	63408	for	0	None
63408	63409	14	0	None
63409	63410	days	0	None
63410	63411	resulted	0	None
63411	63412	in	0	None
63412	63413	six	0	None
63413	63414	and	0	None
63414	63415	nine	0	None
63415	63416	out	0	None
63416	63417	of	0	None
63417	63418	10	0	None
63418	63419	animals	0	None
63419	63420	with	0	None
63420	63421	complete	0	None
63421	63422	responses	0	None
63422	63423	,	0	None
63423	63424	respectively	0	None
63424	63425	.	0	None

63426	63427	The	0	None
63427	63428	demonstration	0	None
63428	63429	that	0	None
63429	63430	sorafenib	0	None
63430	63431	exhibits	0	None
63431	63432	potent	0	None
63432	63433	target	0	None
63433	63434	inhibition	0	None
63434	63435	and	0	None
63435	63436	efficacy	0	None
63436	63437	in	0	None
63437	63438	FLT3-driven	0	None
63438	63439	models	0	None
63439	63440	suggests	0	None
63440	63441	that	0	None
63441	63442	this	0	None
63442	63443	compound	0	None
63443	63444	may	0	None
63444	63445	have	0	None
63445	63446	a	0	None
63446	63447	therapeutic	0	None
63447	63448	benefit	0	None
63448	63449	for	0	None
63449	63450	patients	0	None
63450	63451	with	0	None
63451	63452	FLT3-driven	0	None
63452	63453	leukemias	0	None
63453	63454	.	0	None
63454	63455	Molecular	0	None
63455	63456	recognition	0	None
63456	63457	of	0	None
63457	63458	histidine	2	CHEMICAL
63458	63459	tRNA	0	None
63459	63460	by	0	None
63460	63461	histidyl-tRNA	0	None
63461	63462	synthetase	0	None
63462	63463	from	0	None
63463	63464	hyperthermophilic	0	None
63464	63465	archaeon	0	None
63465	63466	,	0	None
63466	63467	Aeropyrum	0	None
63467	63468	pernix	0	None
63468	63469	K1	0	None
63469	63470	.	0	None
63470	63471	BACKGROUND	0	None
63471	63472	:	0	None
63472	63473	Inhibitors	0	None
63473	63474	of	0	None
63474	63475	monoamine	0	None
63475	63476	oxidase	0	None
63476	63477	(	0	None
63477	63478	MAO	3	GENE-N
63478	63479	)	0	None
63479	63480	with	0	None
63480	63481	selectivity	0	None
63481	63482	and	0	None
63482	63483	specificity	0	None
63483	63484	for	0	None
63484	63485	MAO	3	GENE-N
63485	63486	type	0	None
63486	63487	B	0	None
63487	63488	(	0	None
63488	63489	MAO-B	0	None
63489	63490	)	0	None
63490	63491	prolong	0	None
63491	63492	the	0	None
63492	63493	duration	0	None
63493	63494	of	0	None
63494	63495	action	0	None
63495	63496	of	0	None
63496	63497	both	0	None
63497	63498	endogenously	0	None
63498	63499	and	0	None
63499	63500	exogenously	0	None
63500	63501	derived	0	None
63501	63502	dopamine	0	None
63502	63503	.	0	None

63504	63505	Rasagiline	0	None
63505	63506	[	0	None
63506	63507	N-propargyl-l	0	None
63507	63508	(	0	None
63508	63509	R	0	None
63509	63510	)	0	None
63510	63511	-aminoindan	0	None
63511	63512	]	0	None
63512	63513	is	0	None
63513	63514	a	0	None
63514	63515	second-generation	0	None
63515	63516	propargylamine	0	None
63516	63517	pharmacophore	0	None
63517	63518	that	0	None
63518	63519	selectively	0	None
63519	63520	and	0	None
63520	63521	irreversibly	0	None
63521	63522	inhibits	0	None
63522	63523	brain	0	None
63523	63524	MAO-B	0	None
63524	63525	and	0	None
63525	63526	is	0	None
63526	63527	specifically	0	None
63527	63528	designed	0	None
63528	63529	for	0	None
63529	63530	the	0	None
63530	63531	treatment	0	None
63531	63532	of	0	None
63532	63533	Parkinson's	0	None
63533	63534	disease	0	None
63534	63535	(	0	None
63535	63536	PD	0	None
63536	63537	)	0	None
63537	63538	.	0	None

63539	63540	OBJECTIVE	0	None
63540	63541	:	0	None
63541	63542	The	0	None
63542	63543	aim	0	None
63543	63544	of	0	None
63544	63545	this	0	None
63545	63546	study	0	None
63546	63547	was	0	None
63547	63548	to	0	None
63548	63549	review	0	None
63549	63550	the	0	None
63550	63551	pharmacology	0	None
63551	63552	,	0	None
63552	63553	tolerability	0	None
63553	63554	,	0	None
63554	63555	and	0	None
63555	63556	clinical	0	None
63556	63557	efficacy	0	None
63557	63558	of	0	None
63558	63559	rasagiline	0	None
63559	63560	in	0	None
63560	63561	the	0	None
63561	63562	treatment	0	None
63562	63563	of	0	None
63563	63564	PD	0	None
63564	63565	.	0	None

63566	63567	METHODS	0	None
63567	63568	:	0	None
63568	63569	MEDLINE	0	None
63569	63570	(	0	None
63570	63571	1966-April	0	None
63571	63572	2007	0	None
63572	63573	)	0	None
63573	63574	,	0	None
63574	63575	the	0	None
63575	63576	Cochrane	0	None
63576	63577	Database	0	None
63577	63578	of	0	None
63578	63579	Systematic	0	None
63579	63580	Reviews	0	None
63580	63581	,	0	None
63581	63582	and	0	None
63582	63583	International	0	None
63583	63584	Pharmaceutical	0	None
63584	63585	Abstracts	0	None
63585	63586	(	0	None
63586	63587	1970-April	0	None
63587	63588	2007	0	None
63588	63589	)	0	None
63589	63590	were	0	None
63590	63591	searched	0	None
63591	63592	for	0	None
63592	63593	original	0	None
63593	63594	research	0	None
63594	63595	and	0	None
63595	63596	review	0	None
63596	63597	articles	0	None
63597	63598	published	0	None
63598	63599	in	0	None
63599	63600	English	0	None
63600	63601	.	0	None

63602	63603	The	0	None
63603	63604	search	0	None
63604	63605	terms	0	None
63605	63606	were	0	None
63606	63607	monoamine	0	None
63607	63608	oxidase	0	None
63608	63609	,	0	None
63609	63610	neuroprotection	0	None
63610	63611	,	0	None
63611	63612	Parkinson	0	None
63612	63613	disease	0	None
63613	63614	,	0	None
63614	63615	propargylamine	0	None
63615	63616	,	0	None
63616	63617	rasagiline	0	None
63617	63618	,	0	None
63618	63619	and	0	None
63619	63620	selegiline	0	None
63620	63621	.	0	None

63622	63623	The	0	None
63623	63624	reference	0	None
63624	63625	lists	0	None
63625	63626	of	0	None
63626	63627	articles	0	None
63627	63628	were	0	None
63628	63629	also	0	None
63629	63630	consulted	0	None
63630	63631	,	0	None
63631	63632	as	0	None
63632	63633	was	0	None
63633	63634	information	0	None
63634	63635	provided	0	None
63635	63636	by	0	None
63636	63637	the	0	None
63637	63638	manufacturer	0	None
63638	63639	of	0	None
63639	63640	rasagiline	0	None
63640	63641	.	0	None

63642	63643	RESULTS	0	None
63643	63644	:	0	None
63644	63645	Data	0	None
63645	63646	from	0	None
63646	63647	63	0	None
63647	63648	clinical	0	None
63648	63649	and	0	None
63649	63650	laboratory	0	None
63650	63651	studies	0	None
63651	63652	were	0	None
63652	63653	analyzed	0	None
63653	63654	.	0	None

63655	63656	Based	0	None
63656	63657	on	0	None
63657	63658	the	0	None
63658	63659	results	0	None
63659	63660	from	0	None
63660	63661	those	0	None
63661	63662	studies	0	None
63662	63663	,	0	None
63663	63664	we	0	None
63664	63665	concluded	0	None
63665	63666	that	0	None
63666	63667	rasagiline	0	None
63667	63668	PO	0	None
63668	63669	QD	0	None
63669	63670	,	0	None
63670	63671	at	0	None
63671	63672	the	0	None
63672	63673	therapeutic	0	None
63673	63674	dosage	0	None
63674	63675	range	0	None
63675	63676	of	0	None
63676	63677	0	0	None
63677	63678	.	0	None
63678	63679	5	0	None
63679	63680	to	0	None
63680	63681	1	0	None
63681	63682	rag	0	None
63682	63683	/	0	None
63683	63684	d	0	None
63684	63685	,	0	None
63685	63686	is	0	None
63686	63687	effective	0	None
63687	63688	and	0	None
63688	63689	well	0	None
63689	63690	tolerated	0	None
63690	63691	and	0	None
63691	63692	completely	0	None
63692	63693	,	0	None
63693	63694	selectively	0	None
63694	63695	,	0	None
63695	63696	and	0	None
63696	63697	specifically	0	None
63697	63698	inhibited	0	None
63698	63699	MAO-B	0	None
63699	63700	.	0	None

63701	63702	Pharmacologically	0	None
63702	63703	,	0	None
63703	63704	rasagiline	0	None
63704	63705	was	0	None
63705	63706	found	0	None
63706	63707	to	0	None
63707	63708	be	0	None
63708	63709	<	0	None
63709	63710	or	0	None
63710	63711	=	0	None
63711	63712	10-fold	0	None
63712	63713	more	0	None
63713	63714	potent	0	None
63714	63715	than	0	None
63715	63716	selegiline	0	None
63716	63717	and	0	None
63717	63718	was	0	None
63718	63719	not	0	None
63719	63720	metabolized	0	None
63720	63721	to	0	None
63721	63722	amphetamine	0	None
63722	63723	derivatives	0	None
63723	63724	.	0	None

63725	63726	Rasagiline	0	None
63726	63727	was	0	None
63727	63728	effective	0	None
63728	63729	both	0	None
63729	63730	as	0	None
63730	63731	monotherapy	0	None
63731	63732	in	0	None
63732	63733	early	0	None
63733	63734	PD	0	None
63734	63735	and	0	None
63735	63736	as	0	None
63736	63737	adjunctive	0	None
63737	63738	treatment	0	None
63738	63739	in	0	None
63739	63740	patients	0	None
63740	63741	with	0	None
63741	63742	advancing	0	None
63742	63743	PD	0	None
63743	63744	and	0	None
63744	63745	motor	0	None
63745	63746	fluctuations	0	None
63746	63747	.	0	None

63748	63749	As	0	None
63749	63750	monotherapy	0	None
63750	63751	,	0	None
63751	63752	rasagiline	0	None
63752	63753	provided	0	None
63753	63754	modest	0	None
63754	63755	yet	0	None
63755	63756	clinically	0	None
63756	63757	meaningful	0	None
63757	63758	benefit	0	None
63758	63759	.	0	None

63760	63761	A	0	None
63761	63762	randomized	0	None
63762	63763	,	0	None
63763	63764	double-blind	0	None
63764	63765	,	0	None
63765	63766	placebo-controlled	0	None
63766	63767	study	0	None
63767	63768	found	0	None
63768	63769	that	0	None
63769	63770	,	0	None
63770	63771	after	0	None
63771	63772	26	0	None
63772	63773	weeks	0	None
63773	63774	of	0	None
63774	63775	treatment	0	None
63775	63776	,	0	None
63776	63777	the	0	None
63777	63778	adjusted	0	None
63778	63779	effect	0	None
63779	63780	size	0	None
63780	63781	for	0	None
63781	63782	total	0	None
63782	63783	Unified	0	None
63783	63784	Parkinson's	0	None
63784	63785	Disease	0	None
63785	63786	Rating	0	None
63786	63787	Scale	0	None
63787	63788	score	0	None
63788	63789	was	0	None
63789	63790	-4	0	None
63790	63791	.	0	None
63791	63792	20	0	None
63792	63793	(	0	None
63793	63794	95%	0	None
63794	63795	CI	0	None
63795	63796	,	0	None
63796	63797	-5	0	None
63797	63798	.	0	None
63798	63799	66	0	None
63799	63800	to	0	None
63800	63801	-2	0	None
63801	63802	.	0	None
63802	63803	73	0	None
63803	63804	)	0	None
63804	63805	for	0	None
63805	63806	rasagiline	0	None
63806	63807	1	0	None
63807	63808	mg	2	CHEMICAL
63808	63809	/	0	None
63809	63810	d	0	None
63810	63811	versus	0	None
63811	63812	placebo	0	None
63812	63813	(	0	None
63813	63814	P	0	None
63814	63815	<	0	None
63815	63816	0	0	None
63816	63817	.	0	None
63817	63818	001	0	None
63818	63819	)	0	None
63819	63820	.	0	None

63821	63822	Preliminary	0	None
63822	63823	long-term	0	None
63823	63824	data	0	None
63824	63825	from	0	None
63825	63826	an	0	None
63826	63827	open-label	0	None
63827	63828	study	0	None
63828	63829	suggest	0	None
63829	63830	a	0	None
63830	63831	sustained	0	None
63831	63832	therapeutic	0	None
63832	63833	advantage	0	None
63833	63834	when	0	None
63834	63835	rasagiline	0	None
63835	63836	is	0	None
63836	63837	initiated	0	None
63837	63838	early	0	None
63838	63839	(	0	None
63839	63840	before	0	None
63840	63841	the	0	None
63841	63842	need	0	None
63842	63843	for	0	None
63843	63844	dopaminergic	0	None
63844	63845	agents	0	None
63845	63846	)	0	None
63846	63847	rather	0	None
63847	63848	than	0	None
63848	63849	later	0	None
63849	63850	.	0	None

63851	63852	In	0	None
63852	63853	patients	0	None
63853	63854	with	0	None
63854	63855	more	0	None
63855	63856	advanced	0	None
63856	63857	disease	0	None
63857	63858	who	0	None
63858	63859	received	0	None
63859	63860	treatment	0	None
63860	63861	with	0	None
63861	63862	dopaminergic	0	None
63862	63863	agents	0	None
63863	63864	,	0	None
63864	63865	rasagiline	0	None
63865	63866	and	0	None
63866	63867	entacapone	0	None
63867	63868	were	0	None
63868	63869	associated	0	None
63869	63870	with	0	None
63870	63871	reductions	0	None
63871	63872	of	0	None
63872	63873	"off"	0	None
63873	63874	time	0	None
63874	63875	significantly	0	None
63875	63876	greater	0	None
63876	63877	than	0	None
63877	63878	placebo	0	None
63878	63879	(	0	None
63879	63880	-1	0	None
63880	63881	.	0	None
63881	63882	18	0	None
63882	63883	and	0	None
63883	63884	-1	0	None
63884	63885	.	0	None
63885	63886	2	0	None
63886	63887	vs	0	None
63887	63888	0	0	None
63888	63889	.	0	None
63889	63890	4	0	None
63890	63891	hour;	0	None
63891	63892	both	0	None
63892	63893	,	0	None
63893	63894	P	0	None
63894	63895	<	0	None
63895	63896	or	0	None
63896	63897	=	0	None
63897	63898	0	0	None
63898	63899	.	0	None
63899	63900	001	0	None
63900	63901	)	0	None
63901	63902	.	0	None

63903	63904	Rasagiline	0	None
63904	63905	was	0	None
63905	63906	well	0	None
63906	63907	tolerated	0	None
63907	63908	in	0	None
63908	63909	younger	0	None
63909	63910	(	0	None
63910	63911	aged	0	None
63911	63912	<;70	0	None
63912	63913	years	0	None
63913	63914	)	0	None
63914	63915	and	0	None
63915	63916	older	0	None
63916	63917	(	0	None
63917	63918	aged	0	None
63918	63919	>	0	None
63919	63920	or	0	None
63920	63921	=	0	None
63921	63922	70	0	None
63922	63923	years	0	None
63923	63924	)	0	None
63924	63925	patients	0	None
63925	63926	with	0	None
63926	63927	early	0	None
63927	63928	or	0	None
63928	63929	advanced	0	None
63929	63930	PD	0	None
63930	63931	.	0	None

63932	63933	Pharmacologically	0	None
63933	63934	,	0	None
63934	63935	rasagiline	0	None
63935	63936	has	0	None
63936	63937	the	0	None
63937	63938	potential	0	None
63938	63939	to	0	None
63939	63940	augment	0	None
63940	63941	the	0	None
63941	63942	vasopressor	0	None
63942	63943	effects	0	None
63943	63944	of	0	None
63944	63945	diet-derived	0	None
63945	63946	tyramine	0	None
63946	63947	(	0	None
63947	63948	ie	0	None
63948	63949	,	0	None
63949	63950	the	0	None
63950	63951	"cheese	0	None
63951	63952	reaction"	0	None
63952	63953	)	0	None
63953	63954	.	0	None

63955	63956	However	0	None
63956	63957	,	0	None
63957	63958	clinical	0	None
63958	63959	challenge	0	None
63959	63960	studies	0	None
63960	63961	of	0	None
63961	63962	tyramine	0	None
63962	63963	have	0	None
63963	63964	found	0	None
63964	63965	this	0	None
63965	63966	unlikely	0	None
63966	63967	to	0	None
63967	63968	occur	0	None
63968	63969	even	0	None
63969	63970	with	0	None
63970	63971	ingestion	0	None
63971	63972	of	0	None
63972	63973	supraphysiologic	0	None
63973	63974	amounts	0	None
63974	63975	of	0	None
63975	63976	tyramine	0	None
63976	63977	.	0	None

63978	63979	In	0	None
63979	63980	experimental	0	None
63980	63981	models	0	None
63981	63982	,	0	None
63982	63983	rasagiline	0	None
63983	63984	has	0	None
63984	63985	been	0	None
63985	63986	found	0	None
63986	63987	to	0	None
63987	63988	have	0	None
63988	63989	neuroprotective	0	None
63989	63990	properties	0	None
63990	63991	that	0	None
63991	63992	may	0	None
63992	63993	be	0	None
63993	63994	independent	0	None
63994	63995	of	0	None
63995	63996	MAO-B	0	None
63996	63997	inhibition	0	None
63997	63998	.	0	None

63999	64000	CONCLUSIONS	0	None
64000	64001	:	0	None
64001	64002	Based	0	None
64002	64003	on	0	None
64003	64004	this	0	None
64004	64005	review	0	None
64005	64006	,	0	None
64006	64007	rasagiline	0	None
64007	64008	has	0	None
64008	64009	been	0	None
64009	64010	found	0	None
64010	64011	to	0	None
64011	64012	be	0	None
64012	64013	well	0	None
64013	64014	tolerated	0	None
64014	64015	and	0	None
64015	64016	effective	0	None
64016	64017	in	0	None
64017	64018	the	0	None
64018	64019	treatment	0	None
64019	64020	of	0	None
64020	64021	early	0	None
64021	64022	PD	0	None
64022	64023	and	0	None
64023	64024	as	0	None
64024	64025	adjunctive	0	None
64025	64026	treatment	0	None
64026	64027	in	0	None
64027	64028	motor	0	None
64028	64029	fluctuations	0	None
64029	64030	.	0	None

64031	64032	Whether	0	None
64032	64033	rasagiline	0	None
64033	64034	is	0	None
64034	64035	associated	0	None
64035	64036	with	0	None
64036	64037	clinically	0	None
64037	64038	significant	0	None
64038	64039	neuroprotection	0	None
64039	64040	(	0	None
64040	64041	ie	0	None
64041	64042	,	0	None
64042	64043	disease	0	None
64043	64044	modification	0	None
64044	64045	)	0	None
64045	64046	in	0	None
64046	64047	PD	0	None
64047	64048	is	0	None
64048	64049	the	0	None
64049	64050	subject	0	None
64050	64051	of	0	None
64051	64052	ongoing	0	None
64052	64053	clinical	0	None
64053	64054	trials	0	None
64054	64055	.	0	None
64055	64056	Trichostatin	0	None
64056	64057	A	0	None
64057	64058	(	0	None
64058	64059	TSA	0	None
64059	64060	)	0	None
64060	64061	has	0	None
64061	64062	been	0	None
64062	64063	shown	0	None
64063	64064	to	0	None
64064	64065	prevent	0	None
64065	64066	fibrosis	0	None
64066	64067	in	0	None
64067	64068	vitro	0	None
64068	64069	and	0	None
64069	64070	in	0	None
64070	64071	vivo	0	None
64071	64072	.	0	None

64073	64074	The	0	None
64074	64075	present	0	None
64075	64076	study	0	None
64076	64077	aimed	0	None
64077	64078	at	0	None
64078	64079	investigating	0	None
64079	64080	the	0	None
64080	64081	role	0	None
64081	64082	of	0	None
64082	64083	reactive	0	None
64083	64084	oxygen	0	None
64084	64085	species	0	None
64085	64086	(	0	None
64086	64087	ROS	0	None
64087	64088	)	0	None
64088	64089	scavenging	0	None
64089	64090	by	0	None
64090	64091	TSA	0	None
64091	64092	on	0	None
64092	64093	transforming	0	None
64093	64094	growth	0	None
64094	64095	factor-β	0	None
64095	64096	(	0	None
64096	64097	TGF-β	0	None
64097	64098	)	0	None
64098	64099	-induced	0	None
64099	64100	myofibroblast	0	None
64100	64101	differentiation	0	None
64101	64102	of	0	None
64102	64103	corneal	0	None
64103	64104	fibroblasts	0	None
64104	64105	in	0	None
64105	64106	vitro	0	None
64106	64107	.	0	None

64108	64109	Human	0	None
64109	64110	immortalized	0	None
64110	64111	corneal	0	None
64111	64112	fibroblasts	0	None
64112	64113	were	0	None
64113	64114	treated	0	None
64114	64115	with	0	None
64115	64116	TGF-β	0	None
64116	64117	in	0	None
64117	64118	the	0	None
64118	64119	presence	0	None
64119	64120	of	0	None
64120	64121	TSA	0	None
64121	64122	,	0	None
64122	64123	the	0	None
64123	64124	NAD	0	None
64124	64125	(	0	None
64125	64126	P	0	None
64126	64127	)	0	None
64127	64128	H	0	None
64128	64129	oxidase	0	None
64129	64130	inhibitor	0	None
64130	64131	diphenyleneiodonium	0	None
64131	64132	(	0	None
64132	64133	DPI	0	None
64133	64134	)	0	None
64134	64135	,	0	None
64135	64136	the	0	None
64136	64137	antioxidant	0	None
64137	64138	N-acetyl-cysteine	0	None
64138	64139	(	0	None
64139	64140	NAC	2	CHEMICAL
64140	64141	)	0	None
64141	64142	,	0	None
64142	64143	the	0	None
64143	64144	NF-E2-related	0	None
64144	64145	factor	0	None
64145	64146	2-antioxidant	0	None
64146	64147	response	0	None
64147	64148	element	0	None
64148	64149	(	0	None
64149	64150	Nrf2-ARE	0	None
64150	64151	)	0	None
64151	64152	activator	0	None
64152	64153	sulforaphane	0	None
64153	64154	,	0	None
64154	64155	or	0	None
64155	64156	small	0	None
64156	64157	interfering	0	None
64157	64158	RNA	0	None
64158	64159	.	0	None

64160	64161	Myofibroblast	0	None
64161	64162	differentiation	0	None
64162	64163	was	0	None
64163	64164	assessed	0	None
64164	64165	by	0	None
64165	64166	α-smooth	0	None
64166	64167	muscle	0	None
64167	64168	actin	3	GENE-N
64168	64169	(	0	None
64169	64170	α-SMA	0	None
64170	64171	)	0	None
64171	64172	expression	0	None
64172	64173	,	0	None
64173	64174	F-actin	0	None
64174	64175	bundle	0	None
64175	64176	formation	0	None
64176	64177	,	0	None
64177	64178	and	0	None
64178	64179	collagen	3	GENE-N
64179	64180	gel	0	None
64180	64181	contraction	0	None
64181	64182	.	0	None

64183	64184	ROS	0	None
64184	64185	,	0	None
64185	64186	H	0	None
64186	64187	(	0	None
64187	64188	2	0	None
64188	64189	)	0	None
64189	64190	O	0	None
64190	64191	(	0	None
64191	64192	2	0	None
64192	64193	)	0	None
64193	64194	,	0	None
64194	64195	intracellular	0	None
64195	64196	glutathione	0	None
64196	64197	(	0	None
64197	64198	GSH	0	None
64198	64199	)	0	None
64199	64200	level	0	None
64200	64201	,	0	None
64201	64202	cellular	0	None
64202	64203	total	0	None
64203	64204	antioxidant	0	None
64204	64205	capacity	0	None
64205	64206	,	0	None
64206	64207	and	0	None
64207	64208	the	0	None
64208	64209	activation	0	None
64209	64210	of	0	None
64210	64211	Nrf2-ARE	0	None
64211	64212	signaling	0	None
64212	64213	were	0	None
64213	64214	determined	0	None
64214	64215	with	0	None
64215	64216	various	0	None
64216	64217	assays	0	None
64217	64218	.	0	None

64219	64220	Treatment	0	None
64220	64221	with	0	None
64221	64222	TSA	0	None
64222	64223	and	0	None
64223	64224	the	0	None
64224	64225	Nrf2-ARE	0	None
64225	64226	activator	0	None
64226	64227	resulted	0	None
64227	64228	in	0	None
64228	64229	increased	0	None
64229	64230	inhibition	0	None
64230	64231	of	0	None
64231	64232	the	0	None
64232	64233	TGF-β-induced	0	None
64233	64234	myofibroblast	0	None
64234	64235	differentiation	0	None
64235	64236	as	0	None
64236	64237	compared	0	None
64237	64238	with	0	None
64238	64239	treatment	0	None
64239	64240	with	0	None
64240	64241	DPI	0	None
64241	64242	or	0	None
64242	64243	NAC	2	CHEMICAL
64243	64244	.	0	None

64245	64246	Furthermore	0	None
64246	64247	,	0	None
64247	64248	TSA	0	None
64248	64249	also	0	None
64249	64250	decreased	0	None
64250	64251	cellular	0	None
64251	64252	ROS	0	None
64252	64253	and	0	None
64253	64254	H	0	None
64254	64255	(	0	None
64255	64256	2	0	None
64256	64257	)	0	None
64257	64258	O	0	None
64258	64259	(	0	None
64259	64260	2	0	None
64260	64261	)	0	None
64261	64262	accumulation	0	None
64262	64263	induced	0	None
64263	64264	by	0	None
64264	64265	TGF-β	0	None
64265	64266	,	0	None
64266	64267	whereas	0	None
64267	64268	it	0	None
64268	64269	elevated	0	None
64269	64270	intracellular	0	None
64270	64271	GSH	0	None
64271	64272	level	0	None
64272	64273	and	0	None
64273	64274	cellular	0	None
64274	64275	total	0	None
64275	64276	antioxidant	0	None
64276	64277	capacity	0	None
64277	64278	.	0	None

64279	64280	In	0	None
64280	64281	addition	0	None
64281	64282	,	0	None
64282	64283	TSA	0	None
64283	64284	induced	0	None
64284	64285	Nrf2	1	GENE-Y
64285	64286	nuclear	0	None
64286	64287	translocation	0	None
64287	64288	and	0	None
64288	64289	up-regulated	0	None
64289	64290	the	0	None
64290	64291	expression	0	None
64291	64292	of	0	None
64292	64293	Nrf2-ARE	0	None
64293	64294	downstream	0	None
64294	64295	antioxidant	0	None
64295	64296	genes	0	None
64296	64297	,	0	None
64297	64298	whereas	0	None
64298	64299	Nrf2	1	GENE-Y
64299	64300	knockdown	0	None
64300	64301	by	0	None
64301	64302	RNA	0	None
64302	64303	interference	0	None
64303	64304	blocked	0	None
64304	64305	the	0	None
64305	64306	inhibition	0	None
64306	64307	of	0	None
64307	64308	TSA	0	None
64308	64309	on	0	None
64309	64310	myofibroblast	0	None
64310	64311	differentiation	0	None
64311	64312	.	0	None

64313	64314	In	0	None
64314	64315	conclusion	0	None
64315	64316	,	0	None
64316	64317	this	0	None
64317	64318	study	0	None
64318	64319	provides	0	None
64319	64320	the	0	None
64320	64321	first	0	None
64321	64322	evidence	0	None
64322	64323	implicating	0	None
64323	64324	that	0	None
64324	64325	TSA	0	None
64325	64326	inhibits	0	None
64326	64327	TGF-β-induced	0	None
64327	64328	ROS	0	None
64328	64329	accumulation	0	None
64329	64330	and	0	None
64330	64331	myofibroblast	0	None
64331	64332	differentiation	0	None
64332	64333	via	0	None
64333	64334	enhanced	0	None
64334	64335	Nrf2-ARE	0	None
64335	64336	signaling	0	None
64336	64337	.	0	None
64337	64338	Desipramine	0	None
64338	64339	treatment	0	None
64339	64340	decreases	0	None
64340	64341	3H-nisoxetine	0	None
64341	64342	binding	0	None
64342	64343	and	0	None
64343	64345	norepinephrine transporter	3	GENE-N
64345	64346	mRNA	0	None
64346	64347	in	0	None
64347	64348	SK-N-SHSY5Y	0	None
64348	64349	cells	0	None
64349	64350	.	0	None
64350	64351	Glycine	2	CHEMICAL
64351	64352	and	0	None
64352	64353	gamma-aminobutyric	0	None
64353	64354	acid	0	None
64354	64355	(	0	None
64355	64356	GABA	2	CHEMICAL
64356	64357	)	0	None
64357	64358	are	0	None
64358	64359	the	0	None
64359	64360	major	0	None
64360	64361	inhibitory	0	None
64361	64362	neurotransmitters	0	None
64362	64363	in	0	None
64363	64364	the	0	None
64364	64365	retina	0	None
64365	64366	.	0	None

64367	64368	Approximately	0	None
64368	64369	half	0	None
64369	64370	of	0	None
64370	64371	the	0	None
64371	64372	amacrine	0	None
64372	64373	cells	0	None
64373	64374	release	0	None
64374	64375	glycine	2	CHEMICAL
64375	64376	at	0	None
64376	64377	their	0	None
64377	64378	synapses	0	None
64378	64379	with	0	None
64379	64380	bipolar	0	None
64380	64381	,	0	None
64381	64382	other	0	None
64382	64383	amacrine	0	None
64383	64384	,	0	None
64384	64385	and	0	None
64385	64386	ganglion	0	None
64386	64387	cells	0	None
64387	64388	.	0	None

64389	64390	Whereas	0	None
64390	64391	the	0	None
64391	64392	retinal	2	CHEMICAL
64392	64393	distributions	0	None
64393	64394	of	0	None
64394	64395	glycine	2	CHEMICAL
64395	64396	receptor	0	None
64396	64397	(	0	None
64397	64398	GlyR	0	None
64398	64399	)	0	None
64399	64400	subunits	0	None
64400	64401	alpha1	0	None
64401	64402	,	0	None
64402	64403	alpha2	0	None
64403	64404	,	0	None
64404	64405	and	0	None
64405	64406	alpha3	0	None
64406	64407	have	0	None
64407	64408	been	0	None
64408	64409	mapped	0	None
64409	64410	,	0	None
64410	64411	the	0	None
64411	64412	role	0	None
64412	64413	of	0	None
64413	64414	the	0	None
64414	64415	alpha4	0	None
64415	64416	subunit	0	None
64416	64417	in	0	None
64417	64418	retinal	2	CHEMICAL
64418	64419	circuitry	0	None
64419	64420	remains	0	None
64420	64421	unclear	0	None
64421	64422	.	0	None

64423	64424	A	0	None
64424	64425	rabbit	0	None
64425	64426	polyclonal	0	None
64426	64427	antiserum	0	None
64427	64428	was	0	None
64428	64429	raised	0	None
64429	64430	against	0	None
64430	64431	a	0	None
64431	64432	peptide	0	None
64432	64433	that	0	None
64433	64434	comprises	0	None
64434	64435	the	0	None
64435	64436	C-terminal	0	None
64436	64437	14	0	None
64437	64439	amino acids	2	CHEMICAL
64439	64440	of	0	None
64440	64441	the	0	None
64441	64442	mouse	0	None
64442	64443	GlyR	0	None
64443	64444	alpha4	0	None
64444	64445	subunit	0	None
64445	64446	.	0	None

64447	64448	Using	0	None
64448	64449	immunocytochemistry	0	None
64449	64450	,	0	None
64450	64451	we	0	None
64451	64452	localized	0	None
64452	64453	the	0	None
64453	64454	alpha4	0	None
64454	64455	subunit	0	None
64455	64456	in	0	None
64456	64457	the	0	None
64457	64458	inner	0	None
64458	64459	plexiform	0	None
64459	64460	layer	0	None
64460	64461	(	0	None
64461	64462	IPL	0	None
64462	64463	)	0	None
64463	64464	in	0	None
64464	64465	brightly	0	None
64465	64466	fluorescent	0	None
64466	64467	puncta	0	None
64467	64468	,	0	None
64468	64469	which	0	None
64469	64470	represent	0	None
64470	64471	postsynaptically	0	None
64471	64472	clustered	0	None
64472	64473	GlyRs	3	GENE-N
64473	64474	.	0	None

64475	64476	This	0	None
64476	64477	was	0	None
64477	64478	shown	0	None
64478	64479	by	0	None
64479	64480	double-labeling	0	None
64480	64481	sections	0	None
64481	64482	for	0	None
64482	64483	GlyR	0	None
64483	64484	alpha4	0	None
64484	64485	and	0	None
64485	64486	synaptic	0	None
64486	64487	markers	0	None
64487	64488	(	0	None
64488	64489	bassoon	0	None
64489	64490	,	0	None
64490	64491	gephyrin	0	None
64491	64492	)	0	None
64492	64493	.	0	None

64494	64495	Double-labeling	0	None
64495	64496	sections	0	None
64496	64497	for	0	None
64497	64498	GlyR	0	None
64498	64499	alpha4	0	None
64499	64500	and	0	None
64500	64501	the	0	None
64501	64502	other	0	None
64502	64503	GlyR	0	None
64503	64504	alpha	0	None
64504	64505	subunits	0	None
64505	64506	shows	0	None
64506	64507	that	0	None
64507	64508	they	0	None
64508	64509	are	0	None
64509	64510	mostly	0	None
64510	64511	clustered	0	None
64511	64512	at	0	None
64512	64513	different	0	None
64513	64514	synapses;	0	None
64514	64515	however	0	None
64515	64516	,	0	None
64516	64517	approximately	0	None
64517	64518	30%	0	None
64518	64519	of	0	None
64519	64520	the	0	None
64520	64521	alpha4-containing	0	None
64521	64522	synapses	0	None
64522	64523	also	0	None
64523	64524	express	0	None
64524	64525	the	0	None
64525	64526	alpha2	0	None
64526	64527	subunit	0	None
64527	64528	.	0	None

64529	64530	We	0	None
64530	64531	also	0	None
64531	64532	studied	0	None
64532	64533	the	0	None
64533	64534	pre-	0	None
64534	64535	and	0	None
64535	64536	postsynaptic	0	None
64536	64537	partners	0	None
64537	64538	at	0	None
64538	64539	GlyR	0	None
64539	64540	alpha4-containing	0	None
64540	64541	synapses	0	None
64541	64542	and	0	None
64542	64543	found	0	None
64543	64544	that	0	None
64544	64545	displaced	0	None
64545	64546	(	0	None
64546	64547	ON-	0	None
64547	64548	)	0	None
64548	64549	cholinergic	0	None
64549	64550	amacrine	0	None
64550	64551	cells	0	None
64551	64552	prominently	0	None
64552	64553	expressed	0	None
64553	64554	the	0	None
64554	64555	alpha4	0	None
64555	64556	subunit	0	None
64556	64557	.	0	None

64558	64559	The	0	None
64559	64560	density	0	None
64560	64561	of	0	None
64561	64562	GlyR	0	None
64562	64563	alpha4-expressing	0	None
64563	64564	synapses	0	None
64564	64565	in	0	None
64565	64566	wildtype	0	None
64566	64567	,	0	None
64567	64568	Glra1	1	GENE-Y
64568	64569	(	0	None
64569	64570	ot	0	None
64570	64571	/	0	None
64571	64572	ot	0	None
64572	64573	)	0	None
64573	64574	,	0	None
64574	64575	and	0	None
64575	64576	Glra3	1	GENE-Y
64576	64577	(	0	None
64577	64578	-	0	None
64578	64579	/	0	None
64579	64580	-	0	None
64580	64581	)	0	None
64581	64582	mouse	0	None
64582	64583	retinas	0	None
64583	64584	did	0	None
64584	64585	not	0	None
64585	64586	differ	0	None
64586	64587	significantly	0	None
64587	64588	.	0	None

64589	64590	Thus	0	None
64590	64591	,	0	None
64591	64592	there	0	None
64592	64593	is	0	None
64593	64594	no	0	None
64594	64595	apparent	0	None
64595	64596	compensation	0	None
64596	64597	of	0	None
64597	64598	the	0	None
64598	64599	loss	0	None
64599	64600	of	0	None
64600	64601	alpha1	0	None
64601	64602	or	0	None
64602	64603	alpha3	0	None
64603	64604	subunits	0	None
64604	64605	by	0	None
64605	64606	an	0	None
64606	64607	upregulation	0	None
64607	64608	of	0	None
64608	64609	alpha4	0	None
64609	64610	subunit	0	None
64610	64611	gene	0	None
64611	64612	expression;	0	None
64612	64613	however	0	None
64613	64614	,	0	None
64614	64615	the	0	None
64615	64616	alpha2	0	None
64616	64617	subunit	0	None
64617	64618	is	0	None
64618	64619	moderately	0	None
64619	64620	upregulated	0	None
64620	64621	.	0	None
64621	64622	PURPOSE	0	None
64622	64623	:	0	None
64623	64624	Talampanel	0	None
64624	64625	(	0	None
64625	64626	LY300164	0	None
64626	64627	)	0	None
64627	64628	,	0	None
64628	64629	a	0	None
64629	64630	potent	0	None
64630	64631	and	0	None
64631	64632	selective	0	None
64632	64633	alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate	0	None
64633	64634	(	0	None
64634	64635	AMPA	0	None
64635	64636	)	0	None
64636	64637	-receptor	0	None
64637	64638	antagonist	0	None
64638	64639	,	0	None
64639	64640	is	0	None
64640	64641	a	0	None
64641	64642	potential	0	None
64642	64643	new	0	None
64643	64644	antiepileptic	0	None
64644	64645	drug	0	None
64645	64646	(	0	None
64646	64647	AED	0	None
64647	64648	)	0	None
64648	64649	.	0	None

64650	64651	This	0	None
64651	64652	study	0	None
64652	64653	examines	0	None
64653	64654	the	0	None
64654	64655	single-	0	None
64655	64656	and	0	None
64656	64657	multiple-dose	0	None
64657	64658	pharmacokinetics	0	None
64658	64659	,	0	None
64659	64660	safety	0	None
64660	64661	,	0	None
64661	64662	and	0	None
64662	64663	tolerability	0	None
64663	64664	of	0	None
64664	64665	talampanel	0	None
64665	64666	in	0	None
64666	64667	patients	0	None
64667	64668	with	0	None
64668	64669	intractable	0	None
64669	64670	epilepsy	0	None
64670	64671	and	0	None
64671	64672	assesses	0	None
64672	64673	the	0	None
64673	64674	potential	0	None
64674	64675	for	0	None
64675	64676	pharmacokinetic	0	None
64676	64677	interaction	0	None
64677	64678	.	0	None

64679	64680	METHODS	0	None
64680	64681	:	0	None
64681	64682	Eleven	0	None
64682	64683	of	0	None
64683	64684	14	0	None
64684	64685	patients	0	None
64685	64686	entered	0	None
64686	64687	into	0	None
64687	64688	the	0	None
64688	64689	study	0	None
64689	64690	completed	0	None
64690	64691	.	0	None

64692	64693	Fourteen	0	None
64693	64694	patients	0	None
64694	64695	were	0	None
64695	64696	evaluated	0	None
64696	64697	for	0	None
64697	64698	safety	0	None
64698	64699	,	0	None
64699	64700	13	0	None
64700	64701	patients	0	None
64701	64702	were	0	None
64702	64703	used	0	None
64703	64704	in	0	None
64704	64705	the	0	None
64705	64706	single-dose	0	None
64706	64707	,	0	None
64707	64708	and	0	None
64708	64709	11	0	None
64709	64710	patients	0	None
64710	64711	in	0	None
64711	64712	the	0	None
64712	64713	multiple-dose	0	None
64713	64714	pharmacokinetic	0	None
64714	64715	analysis	0	None
64715	64716	.	0	None

64717	64718	Each	0	None
64718	64719	patient	0	None
64719	64720	initially	0	None
64720	64721	received	0	None
64721	64722	a	0	None
64722	64723	single	0	None
64723	64724	35-mg	0	None
64724	64725	dose	0	None
64725	64726	of	0	None
64726	64727	talampanel	0	None
64727	64728	followed	0	None
64728	64729	by	0	None
64729	64730	the	0	None
64730	64731	measurement	0	None
64731	64732	of	0	None
64732	64733	pharmacokinetic	0	None
64733	64734	profiles	0	None
64734	64735	.	0	None

64736	64737	A	0	None
64737	64738	21-day	0	None
64738	64739	t	0	None
64739	64740	.	0	None

64741	64742	i	0	None
64742	64743	.	0	None

64744	64745	d	0	None
64745	64746	.	0	None

64747	64748	dosing	0	None
64748	64749	regimen	0	None
64749	64750	was	0	None
64750	64751	then	0	None
64751	64752	determined	0	None
64752	64753	for	0	None
64753	64754	each	0	None
64754	64755	patient	0	None
64755	64756	based	0	None
64756	64757	on	0	None
64757	64758	his	0	None
64758	64759	or	0	None
64759	64760	her	0	None
64760	64761	initial	0	None
64761	64762	pharmacokinetic	0	None
64762	64763	profile	0	None
64763	64764	.	0	None

64765	64766	Adverse	0	None
64766	64767	events	0	None
64767	64768	were	0	None
64768	64769	recorded	0	None
64769	64770	by	0	None
64770	64771	patients	0	None
64771	64772	or	0	None
64772	64773	their	0	None
64773	64774	carers	0	None
64774	64775	.	0	None

64776	64777	RESULTS	0	None
64777	64778	:	0	None
64778	64779	After	0	None
64779	64780	oral	0	None
64780	64781	ingestion	0	None
64781	64782	,	0	None
64782	64783	talampanel	0	None
64783	64784	was	0	None
64784	64785	rapidly	0	None
64785	64786	absorbed	0	None
64786	64787	,	0	None
64787	64788	with	0	None
64788	64789	maximal	0	None
64789	64790	plasma	0	None
64790	64791	concentrations	0	None
64791	64792	achieved	0	None
64792	64793	within	0	None
64793	64794	1-3	0	None
64794	64795	h	0	None
64795	64796	.	0	None

64797	64798	Talampanel	0	None
64798	64799	concentrations	0	None
64799	64800	in	0	None
64800	64801	patients	0	None
64801	64802	taking	0	None
64802	64803	enzyme-inducing	0	None
64803	64804	AEDs	0	None
64804	64805	were	0	None
64805	64806	50%	0	None
64806	64807	lower	0	None
64807	64808	than	0	None
64808	64809	those	0	None
64809	64810	seen	0	None
64810	64811	in	0	None
64811	64812	healthy	0	None
64812	64813	volunteers	0	None
64813	64814	.	0	None

64815	64816	Mean	0	None
64816	64817	talampanel	0	None
64817	64818	t1	0	None
64818	64819	/	0	None
64819	64820	2	0	None
64820	64821	values	0	None
64821	64822	were	0	None
64822	64823	3	0	None
64823	64824	.	0	None
64824	64825	0	0	None
64825	64826	h	0	None
64826	64827	compared	0	None
64827	64828	with	0	None
64828	64829	4	0	None
64829	64830	.	0	None
64830	64831	2	0	None
64831	64832	h	0	None
64832	64833	in	0	None
64833	64834	healthy	0	None
64834	64835	volunteers	0	None
64835	64836	.	0	None

64837	64838	After	0	None
64838	64839	multiple-dose	0	None
64839	64840	and	0	None
64840	64841	steady-state	0	None
64841	64842	,	0	None
64842	64843	talampanel	0	None
64843	64844	t1	0	None
64844	64845	/	0	None
64845	64846	2	0	None
64846	64847	values	0	None
64847	64848	were	0	None
64848	64849	increased	0	None
64849	64850	to	0	None
64850	64851	5	0	None
64851	64852	.	0	None
64852	64853	6	0	None
64853	64854	h	0	None
64854	64855	Talampanel	0	None
64855	64856	and	0	None
64856	64857	valproic	0	None
64857	64858	acid	0	None
64858	64859	(	0	None
64859	64860	VPA	0	None
64860	64861	)	0	None
64861	64862	appear	0	None
64862	64863	to	0	None
64863	64864	inhibit	0	None
64864	64865	each	0	None
64865	64866	other's	0	None
64866	64867	metabolism	0	None
64867	64868	mutually	0	None
64868	64869	.	0	None

64870	64871	Talampanel	0	None
64871	64872	had	0	None
64872	64873	no	0	None
64873	64874	effect	0	None
64874	64875	on	0	None
64875	64876	plasma	0	None
64876	64877	concentrations	0	None
64877	64878	of	0	None
64878	64879	other	0	None
64879	64880	AEDs	0	None
64880	64881	.	0	None

64882	64883	Multiple-dose	0	None
64883	64884	talampanel	0	None
64884	64885	administration	0	None
64885	64886	was	0	None
64886	64887	associated	0	None
64887	64888	with	0	None
64888	64889	nonlinear	0	None
64889	64890	pharmacokinetics	0	None
64890	64891	.	0	None

64892	64893	No	0	None
64893	64894	serious	0	None
64894	64895	adverse	0	None
64895	64896	events	0	None
64896	64897	were	0	None
64897	64898	reported;	0	None
64898	64899	the	0	None
64899	64900	most	0	None
64900	64901	frequently	0	None
64901	64902	reported	0	None
64902	64903	being	0	None
64903	64904	dizziness	0	None
64904	64905	,	0	None
64905	64906	ataxia	0	None
64906	64907	,	0	None
64907	64908	drowsiness	0	None
64908	64909	,	0	None
64909	64910	and	0	None
64910	64911	headaches	0	None
64911	64912	CONCLUSIONS	0	None
64912	64913	:	0	None
64913	64914	Talampanel	0	None
64914	64915	dosing	0	None
64915	64916	strategies	0	None
64916	64917	may	0	None
64917	64918	be	0	None
64918	64919	reliant	0	None
64919	64920	on	0	None
64920	64921	concomitant	0	None
64921	64922	AED	0	None
64922	64923	medication	0	None
64923	64924	,	0	None
64924	64925	as	0	None
64925	64926	enzyme-inducing	0	None
64926	64927	AEDs	0	None
64927	64928	enhance	0	None
64928	64929	,	0	None
64929	64930	whereas	0	None
64930	64931	VPA	0	None
64931	64932	inhibits	0	None
64932	64933	its	0	None
64933	64934	metabolism	0	None
64934	64935	.	0	None

64936	64937	Talampanel	0	None
64937	64938	was	0	None
64938	64939	well	0	None
64939	64940	tolerated	0	None
64940	64941	,	0	None
64941	64942	although	0	None
64942	64943	adverse	0	None
64943	64944	events	0	None
64944	64945	occurred	0	None
64945	64946	at	0	None
64946	64947	lower	0	None
64947	64948	doses	0	None
64948	64949	compared	0	None
64949	64950	with	0	None
64950	64951	those	0	None
64951	64952	in	0	None
64952	64953	healthy	0	None
64953	64954	subjects	0	None
64954	64955	,	0	None
64955	64956	probably	0	None
64956	64957	because	0	None
64957	64958	of	0	None
64958	64959	the	0	None
64959	64960	additive	0	None
64960	64961	effect	0	None
64961	64962	of	0	None
64962	64963	concomitant	0	None
64963	64964	AEDs	0	None
64964	64965	.	0	None
64965	64966	Silent	0	None
64966	64967	information	0	None
64967	64968	regulator	0	None
64968	64969	2	0	None
64969	64970	(	0	None
64970	64971	Sir2	0	None
64971	64972	)	0	None
64972	64973	enzymes	0	None
64973	64974	or	0	None
64974	64975	sirtuins	0	None
64975	64976	are	0	None
64976	64977	a	0	None
64977	64978	family	0	None
64978	64979	of	0	None
64979	64980	evolutionarily	0	None
64980	64981	conserved	0	None
64981	64984	intracellular protein deacetylases	3	GENE-N
64984	64985	that	0	None
64985	64986	can	0	None
64986	64987	catalyze	0	None
64987	64988	the	0	None
64988	64989	acetyl	0	None
64989	64990	group	0	None
64990	64991	removal	0	None
64991	64992	from	0	None
64992	64993	the	0	None
64993	64994	specific	0	None
64994	64995	Nε-acetyl-lysine	0	None
64995	64996	(	0	None
64996	64997	AcK	0	None
64997	64998	)	0	None
64998	64999	side	0	None
64999	65000	chains	0	None
65000	65001	on	0	None
65001	65002	a	0	None
65002	65003	variety	0	None
65003	65004	of	0	None
65004	65005	proteins	0	None
65005	65006	from	0	None
65006	65007	all	0	None
65007	65008	kingdoms	0	None
65008	65009	of	0	None
65009	65010	life	0	None
65010	65011	.	0	None

65012	65013	Yeast	0	None
65013	65014	Sir2	0	None
65014	65015	was	0	None
65015	65016	the	0	None
65016	65017	first	0	None
65017	65018	sirtuin	3	GENE-N
65018	65019	identified	0	None
65019	65020	,	0	None
65020	65021	and	0	None
65021	65022	so	0	None
65022	65023	far	0	None
65023	65024	seven	0	None
65024	65025	sirtuins	0	None
65025	65026	(	0	None
65026	65027	i	0	None
65027	65028	.	0	None

65029	65030	e	0	None
65030	65031	.	0	None

65032	65033	SIRT1-7	0	None
65033	65034	)	0	None
65034	65035	have	0	None
65035	65036	been	0	None
65036	65037	found	0	None
65037	65038	in	0	None
65038	65039	mammals	0	None
65039	65040	including	0	None
65040	65041	humans	0	None
65041	65042	.	0	None

65043	65044	The	0	None
65044	65045	sirtuin-catalyzed	0	None
65045	65046	deacetylation	0	None
65046	65047	reaction	0	None
65047	65048	has	0	None
65048	65049	captured	0	None
65049	65050	tremendous	0	None
65050	65051	interest	0	None
65051	65052	during	0	None
65052	65053	the	0	None
65053	65054	past	0	None
65054	65055	a	0	None
65055	65056	few	0	None
65056	65057	years	0	None
65057	65058	because	0	None
65058	65059	of	0	None
65059	65060	(	0	None
65060	65061	i	0	None
65061	65062	)	0	None
65062	65063	its	0	None
65063	65064	increasingly	0	None
65064	65065	demonstrated	0	None
65065	65066	importance	0	None
65066	65067	in	0	None
65067	65068	many	0	None
65068	65069	crucial	0	None
65069	65070	biological	0	None
65070	65071	processes	0	None
65071	65072	such	0	None
65072	65073	as	0	None
65073	65074	gene	0	None
65074	65075	transcription	0	None
65075	65076	,	0	None
65076	65077	metabolism	0	None
65077	65078	,	0	None
65078	65079	and	0	None
65079	65080	aging	0	None
65080	65081	,	0	None
65081	65082	and	0	None
65082	65083	thus	0	None
65083	65084	its	0	None
65084	65085	therapeutic	0	None
65085	65086	potential	0	None
65086	65087	for	0	None
65087	65088	metabolic	0	None
65088	65089	and	0	None
65089	65090	age-related	0	None
65090	65091	diseases	0	None
65091	65092	and	0	None
65092	65093	cancer	0	None
65093	65094	,	0	None
65094	65095	and	0	None
65095	65096	(	0	None
65096	65097	ii	0	None
65097	65098	)	0	None
65098	65099	its	0	None
65099	65100	unique	0	None
65100	65101	deacetylation	0	None
65101	65102	chemistry	0	None
65102	65103	.	0	None

65104	65105	Specifically	0	None
65105	65106	,	0	None
65106	65107	the	0	None
65107	65108	sirtuin-catalyzed	0	None
65108	65109	AcK	0	None
65109	65110	side	0	None
65110	65111	chain	0	None
65111	65112	deacetylation	0	None
65112	65113	is	0	None
65113	65114	not	0	None
65114	65115	merely	0	None
65115	65116	an	0	None
65116	65117	amide	2	CHEMICAL
65117	65118	hydrolysis	0	None
65118	65119	reaction	0	None
65119	65120	,	0	None
65120	65121	instead	0	None
65121	65122	is	0	None
65122	65123	coupled	0	None
65123	65124	to	0	None
65124	65125	the	0	None
65125	65126	nicotinamide	0	None
65126	65127	cleavage	0	None
65127	65128	from	0	None
65128	65131	β-nicotinamide adenine dinucleotide	2	CHEMICAL
65131	65132	(	0	None
65132	65133	β-NAD	0	None
65133	65134	+	0	None
65134	65135	or	0	None
65135	65136	NAD	0	None
65136	65137	+	0	None
65137	65138	)	0	None
65138	65139	with	0	None
65139	65140	the	0	None
65140	65141	generation	0	None
65141	65142	of	0	None
65142	65143	three	0	None
65143	65144	enzymatic	0	None
65144	65145	products	0	None
65145	65146	,	0	None
65146	65147	i	0	None
65147	65148	.	0	None

65149	65150	e	0	None
65150	65151	.	0	None

65152	65153	the	0	None
65153	65154	deacetylated	0	None
65154	65155	protein	0	None
65155	65156	species	0	None
65156	65157	,	0	None
65157	65158	nicotinamide	0	None
65158	65159	,	0	None
65159	65160	and	0	None
65160	65161	2'-O-acetyl-ADP-ribose	0	None
65161	65162	(	0	None
65162	65163	2'-O-AADPR	0	None
65163	65164	)	0	None
65164	65165	.	0	None

65166	65167	Here	0	None
65167	65168	the	0	None
65168	65169	author	0	None
65169	65170	would	0	None
65170	65171	like	0	None
65171	65172	to	0	None
65172	65173	review	0	None
65173	65174	the	0	None
65174	65175	past	0	None
65175	65176	endeavors	0	None
65176	65177	on	0	None
65177	65178	developing	0	None
65178	65179	mechanism-based	0	None
65179	65180	sirtuin	3	GENE-N
65180	65181	modulators	0	None
65181	65182	(	0	None
65182	65183	inhibitors	0	None
65183	65184	and	0	None
65184	65185	activators	0	None
65185	65186	)	0	None
65186	65187	.	0	None

65188	65189	The	0	None
65189	65190	first	0	None
65190	65191	part	0	None
65191	65192	of	0	None
65192	65193	this	0	None
65193	65194	article	0	None
65194	65195	will	0	None
65195	65196	provide	0	None
65196	65197	an	0	None
65197	65198	updated	0	None
65198	65199	mechanistic	0	None
65199	65200	picture	0	None
65200	65201	of	0	None
65201	65202	the	0	None
65202	65203	sirtuin-catalyzed	0	None
65203	65204	deacetylation	0	None
65204	65205	reaction	0	None
65205	65206	.	0	None

65207	65208	The	0	None
65208	65209	second	0	None
65209	65210	part	0	None
65210	65211	will	0	None
65211	65212	be	0	None
65212	65213	focused	0	None
65213	65214	on	0	None
65214	65215	how	0	None
65215	65216	the	0	None
65216	65217	mechanistic	0	None
65217	65218	knowledge	0	None
65218	65219	has	0	None
65219	65220	been	0	None
65220	65221	exploited	0	None
65221	65222	for	0	None
65222	65223	the	0	None
65223	65224	design	0	None
65224	65225	of	0	None
65225	65226	effective	0	None
65226	65227	sirtuin	3	GENE-N
65227	65228	modulators	0	None
65228	65229	.	0	None
65229	65230	Identification	0	None
65230	65231	of	0	None
65231	65232	a	0	None
65232	65234	nuclear receptor	3	GENE-N
65234	65235	for	0	None
65235	65237	bile acids	2	CHEMICAL
65237	65238	.	0	None
65238	65239	Levels	0	None
65239	65240	of	0	None
65240	65241	ATP	0	None
65241	65242	and	0	None
65242	65243	other	0	None
65243	65244	nucleotides	0	None
65244	65245	increased	0	None
65245	65246	in	0	None
65246	65247	wounded	0	None
65247	65248	potato	0	None
65248	65249	tuber	0	None
65249	65250	slices	0	None
65250	65251	,	0	None
65251	65252	maintained	0	None
65252	65253	on	0	None
65253	65254	moist	0	None
65254	65255	paper	0	None
65255	65256	for	0	None
65256	65257	24	0	None
65257	65258	h	0	None
65258	65259	after	0	None
65259	65260	preparation	0	None
65260	65261	.	0	None

65262	65263	The	0	None
65263	65264	relative	0	None
65264	65265	expression	0	None
65265	65266	intensity	0	None
65266	65267	of	0	None
65267	65268	genes	0	None
65268	65269	encoding	0	None
65269	65270	adenosine	0	None
65270	65271	kinase	0	None
65271	65272	(	0	None
65272	65273	AK	0	None
65273	65274	)	0	None
65274	65275	and	0	None
65275	65277	adenine phosphoribosyltransferase	1	GENE-Y
65277	65278	(	0	None
65278	65279	APRT	1	GENE-Y
65279	65280	)	0	None
65280	65281	in	0	None
65281	65282	wounded	0	None
65282	65283	slices	0	None
65283	65284	was	0	None
65284	65285	greater	0	None
65285	65286	than	0	None
65286	65287	the	0	None
65287	65288	intensity	0	None
65288	65289	of	0	None
65289	65290	genes	0	None
65290	65291	of	0	None
65291	65292	the	0	None
65292	65293	de	0	None
65293	65294	novo	0	None
65294	65295	pathway	0	None
65295	65296	,	0	None
65296	65297	glycineamide	0	None
65297	65298	ribonucleotide	0	None
65298	65299	formyltransferase	0	None
65299	65300	(	0	None
65300	65301	GART	0	None
65301	65302	)	0	None
65302	65303	and	0	None
65303	65304	5-aminoimidazole	0	None
65304	65305	ribonucleotide	0	None
65305	65306	synthetase	0	None
65306	65307	(	0	None
65307	65308	AIRS	0	None
65308	65309	)	0	None
65309	65310	.	0	None

65311	65312	In	0	None
65312	65313	vitro	0	None
65313	65314	activities	0	None
65314	65315	of	0	None
65315	65316	adenosine	0	None
65316	65317	kinase	0	None
65317	65318	(	0	None
65318	65319	ATP	0	None
65319	65320	:	0	None
65320	65321	adenosine	0	None
65321	65322	5'-phosphotransferase;	0	None
65322	65323	EC	0	None
65323	65324	2	0	None
65324	65325	.	0	None
65325	65326	7	0	None
65326	65327	.	0	None
65327	65328	1	0	None
65328	65329	.	0	None
65329	65330	20	0	None
65330	65331	)	0	None
65331	65332	and	0	None
65332	65334	adenine phosphoribosyltransferase	1	GENE-Y
65334	65335	(	0	None
65335	65336	AMP	0	None
65336	65337	:	0	None
65337	65338	pyrophosphate	0	None
65338	65339	phospho-d-ribosyltransferase;	0	None
65339	65340	EC	0	None
65340	65341	2	0	None
65341	65342	.	0	None
65342	65343	4	0	None
65343	65344	.	0	None
65344	65345	2	0	None
65345	65346	.	0	None
65346	65347	7	0	None
65347	65348	)	0	None
65348	65349	increased	0	None
65349	65350	during	0	None
65350	65351	wounding	0	None
65351	65352	.	0	None

65353	65355	Adenosine nucleosidase	3	GENE-N
65355	65356	(	0	None
65356	65357	adenosine	0	None
65357	65358	ribohydrolase;	0	None
65358	65359	EC	0	None
65359	65360	3	0	None
65360	65361	.	0	None
65361	65362	2	0	None
65362	65363	.	0	None
65363	65364	2	0	None
65364	65365	.	0	None
65365	65366	7	0	None
65366	65367	)	0	None
65367	65368	activity	0	None
65368	65369	was	0	None
65369	65370	negligible	0	None
65370	65371	in	0	None
65371	65372	freshly	0	None
65372	65373	prepared	0	None
65373	65374	slices	0	None
65374	65375	,	0	None
65375	65376	but	0	None
65376	65377	its	0	None
65377	65378	activity	0	None
65378	65379	is	0	None
65379	65380	dramatically	0	None
65380	65381	enhanced	0	None
65381	65382	in	0	None
65382	65383	wounded	0	None
65383	65384	slices	0	None
65384	65385	.	0	None

65386	65387	In	0	None
65387	65388	situ	0	None
65388	65389	adenosine	0	None
65389	65390	salvage	0	None
65390	65391	activity	0	None
65391	65392	,	0	None
65392	65393	estimated	0	None
65393	65394	from	0	None
65394	65395	the	0	None
65395	65396	incorporation	0	None
65396	65397	of	0	None
65397	65398	radioactivity	0	None
65398	65399	from	0	None
65399	65400	exogenously	0	None
65400	65401	supplied	0	None
65401	65402	[	0	None
65402	65403	8-	0	None
65403	65404	(	0	None
65404	65405	14	0	None
65405	65406	)	0	None
65406	65407	C	0	None
65407	65408	]	0	None
65408	65409	adenosine	0	None
65409	65410	into	0	None
65410	65411	nucleotides	0	None
65411	65412	and	0	None
65412	65413	RNA	0	None
65413	65414	,	0	None
65414	65415	increased	0	None
65415	65416	more	0	None
65416	65417	than	0	None
65417	65418	five	0	None
65418	65419	times	0	None
65419	65420	in	0	None
65420	65421	the	0	None
65421	65422	wounded	0	None
65422	65423	slices	0	None
65423	65424	.	0	None

65425	65426	These	0	None
65426	65427	results	0	None
65427	65428	strongly	0	None
65428	65429	suggest	0	None
65429	65430	that	0	None
65430	65431	greater	0	None
65431	65432	expression	0	None
65432	65433	of	0	None
65433	65434	the	0	None
65434	65435	genes	0	None
65435	65436	encoding	0	None
65436	65437	enzymes	0	None
65437	65438	of	0	None
65438	65439	adenosine	0	None
65439	65440	salvage	0	None
65440	65441	during	0	None
65441	65442	wounding	0	None
65442	65443	is	0	None
65443	65444	closely	0	None
65444	65445	related	0	None
65445	65446	to	0	None
65446	65447	the	0	None
65447	65448	increased	0	None
65448	65449	supply	0	None
65449	65450	of	0	None
65450	65451	adenine	2	CHEMICAL
65451	65452	nucleotides	0	None
65452	65453	in	0	None
65453	65454	the	0	None
65454	65455	wounded	0	None
65455	65456	slices	0	None
65456	65457	.	0	None
65457	65458	In	0	None
65458	65459	this	0	None
65459	65460	study	0	None
65460	65461	,	0	None
65461	65462	we	0	None
65462	65463	investigated	0	None
65463	65464	the	0	None
65464	65465	alterations	0	None
65465	65466	of	0	None
65466	65467	the	0	None
65467	65468	redox	0	None
65468	65469	balance	0	None
65469	65470	induced	0	None
65470	65471	by	0	None
65471	65472	the	0	None
65472	65473	lipid	0	None
65473	65474	fraction	0	None
65474	65475	of	0	None
65475	65476	oxLDL	0	None
65476	65477	in	0	None
65477	65478	Caco-2	0	None
65478	65479	intestinal	0	None
65479	65480	cells	0	None
65480	65481	,	0	None
65481	65482	and	0	None
65482	65483	the	0	None
65483	65484	effects	0	None
65484	65485	of	0	None
65485	65486	tyrosol	0	None
65486	65487	and	0	None
65487	65488	protocatechuic	0	None
65488	65489	acid	0	None
65489	65490	,	0	None
65490	65491	two	0	None
65491	65492	dietary	0	None
65492	65493	phenolic	0	None
65493	65494	compounds	0	None
65494	65495	.	0	None

65496	65497	We	0	None
65497	65498	found	0	None
65498	65499	that	0	None
65499	65500	oxidized	0	None
65500	65501	lipids	0	None
65501	65502	extracted	0	None
65502	65503	from	0	None
65503	65504	oxLDL	0	None
65504	65505	(	0	None
65505	65506	LipE	0	None
65506	65507	)	0	None
65507	65508	induced	0	None
65508	65509	oxidative	0	None
65509	65510	stress	0	None
65510	65511	by	0	None
65511	65512	determining	0	None
65512	65513	,	0	None
65513	65514	6	0	None
65514	65515	h	0	None
65515	65516	after	0	None
65516	65517	treatment	0	None
65517	65518	,	0	None
65518	65519	ROS	0	None
65519	65520	overproduction	0	None
65520	65521	(	0	None
65521	65522	about	0	None
65522	65523	a	0	None
65523	65524	100%	0	None
65524	65525	and	0	None
65525	65526	a	0	None
65526	65527	43%	0	None
65527	65528	increase	0	None
65528	65529	of	0	None
65529	65530	O*2	0	None
65530	65531	and	0	None
65531	65532	H2O2	0	None
65532	65533	production	0	None
65533	65534	,	0	None
65534	65535	respectively	0	None
65535	65536	,	0	None
65536	65537	P<	0	None
65537	65538	.	0	None
65538	65539	05	0	None
65539	65540	:	0	None
65540	65541	LipE	0	None
65541	65542	vs	0	None
65542	65543	.	0	None

65544	65545	control	0	None
65545	65546	)	0	None
65546	65547	and	0	None
65547	65548	,	0	None
65548	65549	12	0	None
65549	65550	h	0	None
65550	65551	after	0	None
65551	65552	treatment	0	None
65552	65553	,	0	None
65553	65554	GSH	0	None
65554	65555	depletion	0	None
65555	65556	(	0	None
65556	65557	about	0	None
65557	65558	a	0	None
65558	65559	26%	0	None
65559	65560	decrease	0	None
65560	65561	,	0	None
65561	65562	P<	0	None
65562	65563	.	0	None
65563	65564	05	0	None
65564	65565	:	0	None
65565	65566	LipE	0	None
65566	65567	vs	0	None
65567	65568	.	0	None

65569	65570	control	0	None
65570	65571	)	0	None
65571	65572	,	0	None
65572	65573	and	0	None
65573	65574	by	0	None
65574	65575	impairing	0	None
65575	65576	the	0	None
65576	65577	activities	0	None
65577	65578	of	0	None
65578	65579	superoxide	0	None
65579	65580	dismutase	0	None
65580	65581	,	0	None
65581	65582	catalase	0	None
65582	65583	and	0	None
65583	65585	glutathione peroxidase	1	GENE-Y
65585	65586	.	0	None

65587	65588	In	0	None
65588	65589	response	0	None
65589	65590	to	0	None
65590	65591	the	0	None
65591	65592	induced	0	None
65592	65593	oxidative	0	None
65593	65594	stress	0	None
65594	65595	,	0	None
65595	65596	we	0	None
65596	65597	observed	0	None
65597	65598	significant	0	None
65598	65599	overexpression	0	None
65599	65600	of	0	None
65600	65602	glutathione peroxidase	1	GENE-Y
65602	65603	(	0	None
65603	65604	6	0	None
65604	65605	h	0	None
65605	65606	after	0	None
65606	65607	treatment	0	None
65607	65608	:	0	None
65608	65609	P<	0	None
65609	65610	.	0	None
65610	65611	05	0	None
65611	65612	)	0	None
65612	65613	,	0	None
65613	65615	glutathione reductase	1	GENE-Y
65615	65616	and	0	None
65616	65617	gamma-glutamylcysteine	2	CHEMICAL
65617	65618	synthetase	0	None
65618	65619	(	0	None
65619	65620	12	0	None
65620	65621	h	0	None
65621	65622	after	0	None
65622	65623	treatment	0	None
65623	65624	:	0	None
65624	65625	P<	0	None
65625	65626	.	0	None
65626	65627	05	0	None
65627	65628	)	0	None
65628	65629	.	0	None

65630	65631	Notably	0	None
65631	65632	,	0	None
65632	65633	when	0	None
65633	65634	GSH	0	None
65634	65635	depletion	0	None
65635	65636	occurred	0	None
65636	65637	,	0	None
65637	65638	p66Shc	0	None
65638	65639	protein	0	None
65639	65640	expression	0	None
65640	65641	increased	0	None
65641	65642	by	0	None
65642	65643	about	0	None
65643	65644	300%	0	None
65644	65645	with	0	None
65645	65646	respect	0	None
65646	65647	to	0	None
65647	65648	control	0	None
65648	65649	(	0	None
65649	65650	P<	0	None
65650	65651	.	0	None
65651	65652	001;	0	None
65652	65653	LipE	0	None
65653	65654	vs	0	None
65654	65655	.	0	None

65656	65657	control	0	None
65657	65658	)	0	None
65658	65659	.	0	None

65660	65661	These	0	None
65661	65662	effects	0	None
65662	65663	were	0	None
65663	65664	fully	0	None
65664	65665	counteracted	0	None
65665	65666	by	0	None
65666	65667	dietary	0	None
65667	65668	phenolics	0	None
65668	65669	which	0	None
65669	65670	inhibited	0	None
65670	65671	ROS	0	None
65671	65672	overproduction	0	None
65672	65673	and	0	None
65673	65674	GSH	0	None
65674	65675	consumption	0	None
65675	65676	,	0	None
65676	65677	rendered	0	None
65677	65678	the	0	None
65678	65679	reactive	0	None
65679	65680	transcription	0	None
65680	65681	of	0	None
65681	65682	glutathione-associated	0	None
65682	65683	enzymes	0	None
65683	65684	unnecessary	0	None
65684	65685	and	0	None
65685	65686	blocked	0	None
65686	65687	the	0	None
65687	65688	intracellular	0	None
65688	65689	signals	0	None
65689	65690	leading	0	None
65690	65691	to	0	None
65691	65692	the	0	None
65692	65693	overexpression	0	None
65693	65694	and	0	None
65694	65695	rearrangement	0	None
65695	65696	of	0	None
65696	65697	p66Shc	0	None
65697	65698	signalling	0	None
65698	65699	molecule	0	None
65699	65700	.	0	None

65701	65702	Altogether	0	None
65702	65703	,	0	None
65703	65704	these	0	None
65704	65705	results	0	None
65705	65706	suggest	0	None
65706	65707	that	0	None
65707	65708	the	0	None
65708	65709	impairment	0	None
65709	65710	of	0	None
65710	65711	the	0	None
65711	65712	antioxidant	0	None
65712	65713	system	0	None
65713	65714	hijacks	0	None
65714	65715	intestinal	0	None
65715	65716	cells	0	None
65716	65717	towards	0	None
65717	65718	an	0	None
65718	65719	apoptotic-prone	0	None
65719	65720	phenotype	0	None
65720	65721	via	0	None
65721	65722	the	0	None
65722	65723	activation	0	None
65723	65724	of	0	None
65724	65725	p66Shc	0	None
65725	65726	molecule	0	None
65726	65727	.	0	None

65728	65729	They	0	None
65729	65730	also	0	None
65730	65731	propose	0	None
65731	65732	a	0	None
65732	65733	reappraisal	0	None
65733	65734	of	0	None
65734	65735	dietary	0	None
65735	65736	polyphenols	0	None
65736	65737	as	0	None
65737	65738	intestinal	0	None
65738	65739	protecting	0	None
65739	65740	agents	0	None
65740	65741	,	0	None
65741	65742	indicating	0	None
65742	65743	the	0	None
65743	65744	antiapoptotic	0	None
65744	65745	effect	0	None
65745	65746	as	0	None
65746	65747	a	0	None
65747	65748	further	0	None
65748	65749	mechanism	0	None
65749	65750	of	0	None
65750	65751	action	0	None
65751	65752	of	0	None
65752	65753	these	0	None
65753	65754	antioxidant	0	None
65754	65755	compounds	0	None
65755	65756	.	0	None
65756	65757	Puerarin	2	CHEMICAL
65757	65758	stimulates	0	None
65758	65759	proliferation	0	None
65759	65760	and	0	None
65760	65761	differentiation	0	None
65761	65762	and	0	None
65762	65763	protects	0	None
65763	65764	against	0	None
65764	65765	cell	0	None
65765	65766	death	0	None
65766	65767	in	0	None
65767	65768	human	0	None
65768	65769	osteoblastic	0	None
65769	65770	MG-63	0	None
65770	65771	cells	0	None
65771	65772	via	0	None
65772	65773	ER-dependent	0	None
65773	65774	MEK	0	None
65774	65775	/	0	None
65775	65776	ERK	0	None
65776	65777	and	0	None
65777	65778	PI3K	0	None
65778	65779	/	0	None
65779	65780	Akt	0	None
65780	65781	activation	0	None
65781	65782	.	0	None
65782	65783	3-Amido	0	None
65783	65784	pyrrolopyrazine	0	None
65784	65785	JAK	0	None
65785	65786	kinase	0	None
65786	65787	inhibitors	0	None
65787	65788	:	0	None
65788	65789	development	0	None
65789	65790	of	0	None
65790	65791	a	0	None
65791	65792	JAK3	0	None
65792	65793	vs	0	None
65793	65794	JAK1	0	None
65794	65795	selective	0	None
65795	65796	inhibitor	0	None
65796	65797	and	0	None
65797	65798	evaluation	0	None
65798	65799	in	0	None
65799	65800	cellular	0	None
65800	65801	and	0	None
65801	65802	in	0	None
65802	65803	vivo	0	None
65803	65804	models	0	None
65804	65805	.	0	None
65805	65806	Tailorable	0	None
65806	65807	cell	0	None
65807	65808	culture	0	None
65808	65809	platforms	0	None
65809	65810	from	0	None
65810	65811	enzymatically	0	None
65811	65812	cross-linked	0	None
65812	65813	multifunctional	0	None
65813	65814	poly	0	None
65814	65815	(	0	None
65815	65817	ethylene glycol	2	CHEMICAL
65817	65818	)	0	None
65818	65819	-based	0	None
65819	65820	hydrogels	0	None
65820	65821	.	0	None
65821	65822	Discovery	0	None
65822	65823	of	0	None
65823	65824	oxysterol-derived	0	None
65824	65825	pharmacological	0	None
65825	65826	chaperones	0	None
65826	65827	for	0	None
65827	65828	NPC1	0	None
65828	65829	:	0	None
65829	65830	implication	0	None
65830	65831	for	0	None
65831	65832	the	0	None
65832	65833	existence	0	None
65833	65834	of	0	None
65834	65835	second	0	None
65835	65836	sterol-binding	0	None
65836	65837	site	0	None
65837	65838	.	0	None
65838	65839	Role	0	None
65839	65840	of	0	None
65840	65841	metabotropic	0	None
65841	65843	glutamate receptor	3	GENE-N
65843	65844	1	0	None
65844	65845	in	0	None
65845	65846	the	0	None
65846	65847	basolateral	0	None
65847	65848	amygdala-driven	0	None
65848	65849	prefrontal	0	None
65849	65850	cortical	0	None
65850	65851	deactivation	0	None
65851	65852	in	0	None
65852	65853	inflammatory	0	None
65853	65854	pain	0	None
65854	65855	in	0	None
65855	65856	the	0	None
65856	65857	rat	0	None
65857	65858	.	0	None
65858	65859	The	0	None
65859	65860	biological	0	None
65860	65861	effects	0	None
65861	65862	of	0	None
65862	65863	dose-dependent	0	None
65863	65864	inhibition	0	None
65864	65865	of	0	None
65865	65866	renin	0	None
65866	65867	have	0	None
65867	65868	rarely	0	None
65868	65869	been	0	None
65869	65870	extensively	0	None
65870	65871	studied	0	None
65871	65872	after	0	None
65872	65873	oral	0	None
65873	65874	(	0	None
65874	65875	p	0	None
65875	65876	.	0	None

65877	65878	o	0	None
65878	65879	.	0	None

65880	65881	)	0	None
65881	65882	dosing	0	None
65882	65883	in	0	None
65883	65884	humans	0	None
65884	65885	.	0	None

65886	65887	We	0	None
65887	65888	studied	0	None
65888	65889	remikiren	0	None
65889	65890	(	0	None
65890	65891	Ro42-4892	0	None
65891	65892	)	0	None
65892	65893	,	0	None
65893	65894	a	0	None
65894	65895	selective	0	None
65895	65896	renin	0	None
65896	65897	inhibitor	0	None
65897	65898	,	0	None
65898	65899	in	0	None
65899	65900	normal	0	None
65900	65901	volunteers	0	None
65901	65902	after	0	None
65902	65903	activation	0	None
65903	65904	of	0	None
65904	65905	the	0	None
65905	65906	renin-angiotensin	0	None
65906	65907	system	0	None
65907	65908	(	0	None
65908	65909	RAS	3	GENE-N
65909	65910	)	0	None
65910	65911	based	0	None
65911	65912	on	0	None
65912	65913	salt	0	None
65913	65914	depletion	0	None
65914	65915	.	0	None

65916	65917	Twelve	0	None
65917	65918	normal	0	None
65918	65919	men	0	None
65919	65920	(	0	None
65920	65921	28	0	None
65921	65922	+	0	None
65922	65923	/	0	None
65923	65924	-	0	None
65924	65925	9	0	None
65925	65926	years	0	None
65926	65927	,	0	None
65927	65928	77	0	None
65928	65929	+	0	None
65929	65930	/	0	None
65930	65931	-	0	None
65931	65932	10	0	None
65932	65933	kg	0	None
65933	65934	)	0	None
65934	65935	,	0	None
65935	65936	comprising	0	None
65936	65937	three	0	None
65937	65938	consecutive	0	None
65938	65939	dose	0	None
65939	65940	panels	0	None
65940	65941	of	0	None
65941	65942	4	0	None
65942	65943	subjects	0	None
65943	65944	,	0	None
65944	65945	received	0	None
65945	65946	four	0	None
65946	65947	treatments	0	None
65947	65948	,	0	None
65948	65949	double-blind	0	None
65949	65950	and	0	None
65950	65951	randomised	0	None
65951	65952	2	0	None
65952	65953	weeks	0	None
65953	65954	apart	0	None
65954	65955	:	0	None
65955	65956	panel	0	None
65956	65957	I	0	None
65957	65958	,	0	None
65958	65959	placebo	0	None
65959	65960	(	0	None
65960	65961	P	0	None
65961	65962	)	0	None
65962	65963	,	0	None
65963	65964	or	0	None
65964	65965	30	0	None
65965	65966	,	0	None
65966	65967	100	0	None
65967	65968	,	0	None
65968	65969	and	0	None
65969	65970	300	0	None
65970	65971	mg	2	CHEMICAL
65971	65972	,	0	None
65972	65973	remikiren;	0	None
65973	65974	panel	0	None
65974	65975	II	0	None
65975	65976	,	0	None
65976	65977	placebo	0	None
65977	65978	or	0	None
65978	65979	300	0	None
65979	65980	,	0	None
65980	65981	600	0	None
65981	65982	mg	2	CHEMICAL
65982	65983	,	0	None
65983	65984	1	0	None
65984	65985	,	0	None
65985	65986	000;	0	None
65986	65987	panel	0	None
65987	65988	III	0	None
65988	65989	,	0	None
65989	65990	placebo	0	None
65990	65991	or	0	None
65991	65992	30	0	None
65992	65993	,	0	None
65993	65994	600	0	None
65994	65995	,	0	None
65995	65996	and	0	None
65996	65997	1	0	None
65997	65998	,	0	None
65998	65999	000	0	None
65999	66000	mg	2	CHEMICAL
66000	66001	.	0	None

66002	66003	The	0	None
66003	66004	RAS	3	GENE-N
66004	66005	was	0	None
66005	66006	activated	0	None
66006	66007	by	0	None
66007	66008	40	0	None
66008	66009	mmol	0	None
66009	66010	/	0	None
66010	66011	day	0	None
66011	66012	sodium	2	CHEMICAL
66012	66013	diet	0	None
66013	66014	plus	0	None
66014	66015	frusemide	0	None
66015	66016	(	0	None
66016	66017	40	0	None
66017	66018	mg	2	CHEMICAL
66018	66019	BDS	0	None
66019	66020	)	0	None
66020	66021	,	0	None
66021	66022	for	0	None
66022	66023	3	0	None
66023	66024	days	0	None
66024	66025	before	0	None
66025	66026	each	0	None
66026	66027	study	0	None
66027	66028	day	0	None
66028	66029	.	0	None

66030	66031	Data	0	None
66031	66032	(	0	None
66032	66033	mean	0	None
66033	66034	+	0	None
66034	66035	/	0	None
66035	66036	-	0	None
66036	66037	SD	0	None
66037	66038	)	0	None
66038	66039	were	0	None
66039	66040	examined	0	None
66040	66041	by	0	None
66041	66042	repeated-measures	0	None
66042	66043	analysis	0	None
66043	66044	of	0	None
66044	66045	variance	0	None
66045	66046	(	0	None
66046	66047	ANOVA	0	None
66047	66048	)	0	None
66048	66049	.	0	None

66050	66051	RAS	3	GENE-N
66051	66052	activation	0	None
66052	66053	was	0	None
66053	66054	confirmed	0	None
66054	66055	by	0	None
66055	66056	24-h	0	None
66056	66057	urinary	0	None
66057	66058	sodium	2	CHEMICAL
66058	66059	excretion	0	None
66059	66060	(	0	None
66060	66061	screen	0	None
66061	66062	,	0	None
66062	66063	142	0	None
66063	66064	+	0	None
66064	66065	/	0	None
66065	66066	-	0	None
66066	66067	74	0	None
66067	66068	mmol	0	None
66068	66069	/	0	None
66069	66070	24	0	None
66070	66071	h;	0	None
66071	66072	prestudy	0	None
66072	66073	,	0	None
66073	66074	66	0	None
66074	66075	+	0	None
66075	66076	/	0	None
66076	66077	-	0	None
66077	66078	33	0	None
66078	66079	,	0	None
66079	66080	59	0	None
66080	66081	+	0	None
66081	66082	/	0	None
66082	66083	-	0	None
66083	66084	41	0	None
66084	66085	,	0	None
66085	66086	78	0	None
66086	66087	+	0	None
66087	66088	/	0	None
66088	66089	-	0	None
66089	66090	4	0	None
66090	66091	,	0	None
66091	66092	73	0	None
66092	66093	+	0	None
66093	66094	/	0	None
66094	66095	-	0	None
66095	66096	30	0	None
66096	66097	mmol	0	None
66097	66098	/	0	None
66098	66099	24	0	None
66099	66100	h	0	None
66100	66101	)	0	None
66101	66102	and	0	None
66102	66103	increase	0	None
66103	66104	in	0	None
66104	66105	plasma	0	None
66105	66106	renin	0	None
66106	66107	activity	0	None
66107	66108	(	0	None
66108	66109	PRA	0	None
66109	66110	)	0	None
66110	66111	(	0	None
66111	66112	screen	0	None
66112	66113	,	0	None
66113	66114	0	0	None
66114	66115	.	0	None
66115	66116	8	0	None
66116	66117	+	0	None
66117	66118	/	0	None
66118	66119	-	0	None
66119	66120	0	0	None
66120	66121	.	0	None
66121	66122	3	0	None
66122	66123	ng	0	None
66123	66124	AI	0	None
66124	66125	/	0	None
66125	66126	ml	0	None
66126	66127	/	0	None
66127	66128	h;	0	None
66128	66129	before	0	None
66129	66130	dosing	0	None
66130	66131	,	0	None
66131	66132	P	0	None
66132	66133	,	0	None
66133	66134	6	0	None
66134	66135	.	0	None
66135	66136	5	0	None
66136	66137	+	0	None
66137	66138	/	0	None
66138	66139	-	0	None
66139	66140	3	0	None
66140	66141	.	0	None
66141	66142	1;	0	None
66142	66143	30	0	None
66143	66144	mg	2	CHEMICAL
66144	66145	,	0	None
66145	66146	8	0	None
66146	66147	.	0	None
66147	66148	2	0	None
66148	66149	+	0	None
66149	66150	/	0	None
66150	66151	-	0	None
66151	66152	3;	0	None
66152	66153	100	0	None
66153	66154	mg	2	CHEMICAL
66154	66155	,	0	None
66155	66156	9	0	None
66156	66157	.	0	None
66157	66158	4	0	None
66158	66159	+	0	None
66159	66160	/	0	None
66160	66161	-	0	None
66161	66162	5	0	None
66162	66163	.	0	None
66163	66164	7;	0	None
66164	66165	300	0	None
66165	66166	mg	2	CHEMICAL
66166	66167	,	0	None
66167	66168	6	0	None
66168	66169	.	0	None
66169	66170	5	0	None
66170	66171	+	0	None
66171	66172	/	0	None
66172	66173	-	0	None
66173	66174	2	0	None
66174	66175	.	0	None
66175	66176	4;	0	None
66176	66177	600	0	None
66177	66178	mg	2	CHEMICAL
66178	66179	,	0	None
66179	66180	5	0	None
66180	66181	.	0	None
66181	66182	2	0	None
66182	66183	+	0	None
66183	66184	/	0	None
66184	66185	-	0	None
66185	66186	2;	0	None
66186	66187	1	0	None
66187	66188	,	0	None
66188	66189	000	0	None
66189	66190	mg	2	CHEMICAL
66190	66191	,	0	None
66191	66192	6	0	None
66192	66193	.	0	None
66193	66194	2	0	None
66194	66195	+	0	None
66195	66196	/	0	None
66196	66197	-	0	None
66197	66198	4	0	None
66198	66199	.	0	None
66199	66200	4	0	None
66200	66201	ng	0	None
66201	66202	AI	0	None
66202	66203	/	0	None
66203	66204	ml	0	None
66204	66205	/	0	None
66205	66206	h	0	None
66206	66207	)	0	None
66207	66208	.	0	None

66209	66210	(	0	None
66210	66211	ABSTRACT	0	None
66211	66212	TRUNCATED	0	None
66212	66213	AT	0	None
66213	66214	250	0	None
66214	66215	WORDS	0	None
66215	66216	)	0	None
66216	66217	This	0	None
66217	66218	study	0	None
66218	66219	was	0	None
66219	66220	designed	0	None
66220	66221	to	0	None
66221	66222	evaluate	0	None
66222	66223	the	0	None
66223	66224	effectiveness	0	None
66224	66225	of	0	None
66225	66226	crocin	0	None
66226	66227	,	0	None
66227	66228	main	0	None
66228	66229	component	0	None
66229	66230	of	0	None
66230	66231	Crocus	0	None
66231	66232	sativus	0	None
66232	66233	L	0	None
66233	66234	.	0	None

66235	66236	(	0	None
66236	66237	Saffron	0	None
66237	66238	)	0	None
66238	66239	against	0	None
66239	66240	subchronic	0	None
66240	66241	diazinon	0	None
66241	66242	(	0	None
66242	66243	DZN	0	None
66243	66244	)	0	None
66244	66245	induced	0	None
66245	66246	cardiotoxicity	0	None
66246	66247	in	0	None
66247	66248	rats	0	None
66248	66249	.	0	None

66250	66251	METHODS	0	None
66251	66252	:	0	None
66252	66253	Rats	0	None
66253	66254	were	0	None
66254	66255	divided	0	None
66255	66256	into	0	None
66256	66257	7	0	None
66257	66258	groups;	0	None
66258	66259	control	0	None
66259	66260	(	0	None
66260	66261	corn	0	None
66261	66262	oil	0	None
66262	66263	,	0	None
66263	66264	gavage	0	None
66264	66265	)	0	None
66265	66266	,	0	None
66266	66267	DZN	0	None
66267	66268	(	0	None
66268	66269	15mg	0	None
66269	66270	/	0	None
66270	66271	kg	0	None
66271	66272	/	0	None
66272	66273	day	0	None
66273	66274	,	0	None
66274	66275	gavage	0	None
66275	66276	,	0	None
66276	66277	)	0	None
66277	66278	,	0	None
66278	66279	crocin	0	None
66279	66280	(	0	None
66280	66281	12	0	None
66281	66282	.	0	None
66282	66283	5	0	None
66283	66284	,	0	None
66284	66285	25	0	None
66285	66286	or	0	None
66286	66287	50mg	0	None
66287	66288	/	0	None
66288	66289	kg	0	None
66289	66290	/	0	None
66290	66291	day	0	None
66291	66292	,	0	None
66292	66293	i	0	None
66293	66294	.	0	None

66295	66296	p	0	None
66296	66297	)	0	None
66297	66298	plus	0	None
66298	66299	DZN	0	None
66299	66300	,	0	None
66300	66302	vitamin E	2	CHEMICAL
66302	66303	(	0	None
66303	66304	200IU	0	None
66304	66305	/	0	None
66305	66306	kg	0	None
66306	66307	,	0	None
66307	66308	i	0	None
66308	66309	.	0	None

66310	66311	p	0	None
66311	66312	,	0	None
66312	66313	three	0	None
66313	66314	times	0	None
66314	66315	per	0	None
66315	66316	week	0	None
66316	66317	)	0	None
66317	66318	plus	0	None
66318	66319	DZN	0	None
66319	66320	and	0	None
66320	66321	crocin	0	None
66321	66322	(	0	None
66322	66323	50mg	0	None
66323	66324	/	0	None
66324	66325	kg	0	None
66325	66326	/	0	None
66326	66327	day	0	None
66327	66328	,	0	None
66328	66329	i	0	None
66329	66330	.	0	None

66331	66332	p	0	None
66332	66333	)	0	None
66333	66334	groups	0	None
66334	66335	.	0	None

66336	66337	Treatments	0	None
66337	66338	were	0	None
66338	66339	continued	0	None
66339	66340	for	0	None
66340	66341	4weeks	0	None
66341	66342	.	0	None

66343	66344	Creatine	0	None
66344	66345	phosphokinase	0	None
66345	66346	MB	0	None
66346	66347	(	0	None
66347	66348	CK-MB	0	None
66348	66349	)	0	None
66349	66350	,	0	None
66350	66351	malondealdehyde	0	None
66351	66352	(	0	None
66352	66353	MDA	0	None
66353	66354	)	0	None
66354	66355	and	0	None
66355	66356	glutathione	0	None
66356	66357	(	0	None
66357	66358	GSH	0	None
66358	66359	)	0	None
66359	66360	levels	0	None
66360	66361	were	0	None
66361	66362	evaluated	0	None
66362	66363	in	0	None
66363	66364	heart	0	None
66364	66365	tissue	0	None
66365	66366	at	0	None
66366	66367	the	0	None
66367	66368	end	0	None
66368	66369	of	0	None
66369	66370	treatments	0	None
66370	66371	.	0	None

66372	66373	Levels	0	None
66373	66374	of	0	None
66374	66375	apoptotic	0	None
66375	66376	proteins	0	None
66376	66377	(	0	None
66377	66378	Bax	0	None
66378	66379	,	0	None
66379	66380	Bcl2	0	None
66380	66381	,	0	None
66381	66382	caspase	3	GENE-N
66382	66383	3	0	None
66383	66384	)	0	None
66384	66385	and	0	None
66385	66386	cytosolic	0	None
66386	66387	cytochrome	3	GENE-N
66387	66388	c	0	None
66388	66389	were	0	None
66389	66390	analyzed	0	None
66390	66391	by	0	None
66391	66392	Western	0	None
66392	66393	blotting	0	None
66393	66394	.	0	None

66395	66396	Transcript	0	None
66396	66397	levels	0	None
66397	66398	of	0	None
66398	66399	Bax	0	None
66399	66400	and	0	None
66400	66401	Bcl2	0	None
66401	66402	were	0	None
66402	66403	also	0	None
66403	66404	determined	0	None
66404	66405	using	0	None
66405	66406	qRT	0	None
66406	66407	PCR	0	None
66407	66408	.	0	None

66409	66410	RESULTS	0	None
66410	66411	:	0	None
66411	66412	DZN	0	None
66412	66413	induced	0	None
66413	66414	histophatological	0	None
66414	66415	damages	0	None
66415	66416	and	0	None
66416	66417	elevated	0	None
66417	66418	the	0	None
66418	66419	level	0	None
66419	66420	of	0	None
66420	66421	cardiac	0	None
66421	66422	marker	0	None
66422	66423	CK-MB	0	None
66423	66424	.	0	None

66425	66426	These	0	None
66426	66427	effects	0	None
66427	66428	were	0	None
66428	66429	associated	0	None
66429	66430	with	0	None
66430	66431	increased	0	None
66431	66432	MDA	0	None
66432	66433	level	0	None
66433	66434	,	0	None
66434	66435	lower	0	None
66435	66436	level	0	None
66436	66437	of	0	None
66437	66438	reduced	0	None
66438	66439	GSH	0	None
66439	66440	and	0	None
66440	66441	induction	0	None
66441	66442	of	0	None
66442	66443	apoptosis	0	None
66443	66444	through	0	None
66444	66445	elevation	0	None
66445	66446	of	0	None
66446	66447	Bax	0	None
66447	66448	/	0	None
66448	66449	Bcl2	0	None
66449	66450	ratio	0	None
66450	66451	(	0	None
66451	66452	both	0	None
66452	66453	protein	0	None
66453	66454	and	0	None
66454	66455	mRNA	0	None
66455	66456	levels	0	None
66456	66457	)	0	None
66457	66458	,	0	None
66458	66459	cytochrome	3	GENE-N
66459	66460	c	0	None
66460	66461	release	0	None
66461	66462	to	0	None
66462	66463	the	0	None
66463	66464	cytosol	0	None
66464	66465	and	0	None
66465	66466	activation	0	None
66466	66467	caspase	3	GENE-N
66467	66468	3	0	None
66468	66469	in	0	None
66469	66470	cardiac	0	None
66470	66471	tissue	0	None
66471	66472	.	0	None

66473	66474	Crocin	0	None
66474	66475	(	0	None
66475	66476	25	0	None
66476	66477	and	0	None
66477	66478	50mg	0	None
66478	66479	/	0	None
66479	66480	kg	0	None
66480	66481	)	0	None
66481	66482	or	0	None
66482	66484	vitamin E	2	CHEMICAL
66484	66485	improved	0	None
66485	66486	histopathological	0	None
66486	66487	damages	0	None
66487	66488	,	0	None
66488	66489	decreased	0	None
66489	66490	MDA	0	None
66490	66491	and	0	None
66491	66492	CK-MB	0	None
66492	66493	,	0	None
66493	66494	increased	0	None
66494	66495	GSH	0	None
66495	66496	content	0	None
66496	66497	and	0	None
66497	66498	attenuated	0	None
66498	66499	the	0	None
66499	66500	increase	0	None
66500	66501	of	0	None
66501	66502	Bax	0	None
66502	66503	/	0	None
66503	66504	Bcl2	0	None
66504	66505	ratio	0	None
66505	66506	,	0	None
66506	66507	activation	0	None
66507	66508	of	0	None
66508	66509	caspase	3	GENE-N
66509	66510	3	0	None
66510	66511	and	0	None
66511	66512	release	0	None
66512	66513	of	0	None
66513	66514	cytochrome	3	GENE-N
66514	66515	c	0	None
66515	66516	to	0	None
66516	66517	the	0	None
66517	66518	cytosol	0	None
66518	66519	induced	0	None
66519	66520	by	0	None
66520	66521	DZN	0	None
66521	66522	.	0	None

66523	66524	In	0	None
66524	66525	summary	0	None
66525	66526	,	0	None
66526	66527	DZN	0	None
66527	66528	induced	0	None
66528	66529	mitochondrial-mediated	0	None
66529	66530	apoptosis	0	None
66530	66531	in	0	None
66531	66532	heart	0	None
66532	66533	tissue	0	None
66533	66534	of	0	None
66534	66535	rat	0	None
66535	66536	following	0	None
66536	66537	subchronic	0	None
66537	66538	exposure	0	None
66538	66539	.	0	None

66540	66541	Crocin	0	None
66541	66542	,	0	None
66542	66543	as	0	None
66543	66544	an	0	None
66544	66545	antioxidant	0	None
66545	66546	,	0	None
66546	66547	showed	0	None
66547	66548	protective	0	None
66548	66549	effects	0	None
66549	66550	against	0	None
66550	66551	DZN	0	None
66551	66552	cardiotoxicity	0	None
66552	66553	by	0	None
66553	66554	reducing	0	None
66554	66555	lipid	0	None
66555	66556	peroxidation	0	None
66556	66557	and	0	None
66557	66558	alleviating	0	None
66558	66559	apoptosis	0	None
66559	66560	.	0	None
66560	66561	The	0	None
66561	66562	present	0	None
66562	66563	study	0	None
66563	66564	investigates	0	None
66564	66565	enzyme	0	None
66565	66566	activities	0	None
66566	66567	of	0	None
66567	66568	the	0	None
66568	66569	urea	2	CHEMICAL
66569	66570	cycle	0	None
66570	66571	,	0	None
66571	66572	transamidinase	0	None
66572	66573	and	0	None
66573	66574	ornithine-proline	0	None
66574	66575	inter-conversion	0	None
66575	66576	in	0	None
66576	66577	the	0	None
66577	66578	hypertrophied	0	None
66578	66579	kidney	0	None
66579	66580	after	0	None
66580	66581	unilateral	0	None
66581	66582	nephrectomy	0	None
66582	66583	in	0	None
66583	66584	mice	0	None
66584	66585	.	0	None

66586	66587	Surgical	0	None
66587	66588	removal	0	None
66588	66589	of	0	None
66589	66590	the	0	None
66590	66591	left	0	None
66591	66592	kidney	0	None
66592	66593	in	0	None
66593	66594	mice	0	None
66594	66595	led	0	None
66595	66596	to	0	None
66596	66597	compensatory	0	None
66597	66598	enlargement	0	None
66598	66599	of	0	None
66599	66600	the	0	None
66600	66601	right	0	None
66601	66602	kidney	0	None
66602	66603	after	0	None
66603	66604	1	0	None
66604	66605	and	0	None
66605	66606	14	0	None
66606	66607	days	0	None
66607	66608	.	0	None

66609	66610	This	0	None
66610	66611	renal	0	None
66611	66612	growth	0	None
66612	66613	was	0	None
66613	66614	associated	0	None
66614	66615	with	0	None
66615	66616	an	0	None
66616	66617	increase	0	None
66617	66618	in	0	None
66618	66619	glomerular	0	None
66619	66620	volume	0	None
66620	66621	(	0	None
66621	66622	but	0	None
66622	66623	not	0	None
66623	66624	number	0	None
66624	66625	)	0	None
66625	66626	and	0	None
66626	66627	enlargement	0	None
66627	66628	of	0	None
66628	66629	the	0	None
66629	66630	proximal	0	None
66630	66631	convoluted	0	None
66631	66632	tubules	0	None
66632	66633	.	0	None

66634	66635	The	0	None
66635	66636	total	0	None
66636	66637	renal	0	None
66637	66638	protein	0	None
66638	66639	content	0	None
66639	66640	increased	0	None
66640	66641	in	0	None
66641	66642	proportion	0	None
66642	66643	to	0	None
66643	66644	the	0	None
66644	66645	increase	0	None
66645	66646	in	0	None
66646	66647	kidney	0	None
66647	66648	weight	0	None
66648	66649	,	0	None
66649	66650	but	0	None
66650	66651	the	0	None
66651	66652	protein	0	None
66652	66653	per	0	None
66653	66654	gram	0	None
66654	66655	weight	0	None
66655	66656	of	0	None
66656	66657	kidney	0	None
66657	66658	did	0	None
66658	66659	not	0	None
66659	66660	change	0	None
66660	66661	.	0	None

66662	66663	The	0	None
66663	66664	specific	0	None
66664	66665	activity	0	None
66665	66666	of	0	None
66666	66667	only	0	None
66667	66668	ornithine	2	CHEMICAL
66668	66669	aminotransferase	3	GENE-N
66669	66670	(	0	None
66670	66671	OAT	0	None
66671	66672	)	0	None
66672	66673	,	0	None
66673	66674	the	0	None
66674	66675	rate-limiting	0	None
66675	66676	enzyme	0	None
66676	66677	in	0	None
66677	66678	the	0	None
66678	66679	conversion	0	None
66679	66680	of	0	None
66680	66681	ornithine	2	CHEMICAL
66681	66682	to	0	None
66682	66683	proline	0	None
66683	66684	,	0	None
66684	66685	increased	0	None
66685	66686	in	0	None
66686	66687	2	0	None
66687	66688	weeks	0	None
66688	66689	of	0	None
66689	66690	hypertrophy	0	None
66690	66691	.	0	None

66692	66693	The	0	None
66693	66694	specific	0	None
66694	66695	activity	0	None
66695	66696	of	0	None
66696	66697	all	0	None
66697	66698	other	0	None
66698	66699	enzymes	0	None
66699	66700	was	0	None
66700	66701	unchanged	0	None
66701	66702	.	0	None

66703	66704	However	0	None
66704	66705	,	0	None
66705	66706	the	0	None
66706	66707	total	0	None
66707	66708	enzyme	0	None
66708	66709	activity	0	None
66709	66710	per	0	None
66710	66711	kidney	0	None
66711	66712	of	0	None
66712	66713	all	0	None
66713	66714	the	0	None
66714	66715	enzymes	0	None
66715	66716	,	0	None
66716	66717	without	0	None
66717	66718	exception	0	None
66718	66719	,	0	None
66719	66720	was	0	None
66720	66721	elevated	0	None
66721	66722	in	0	None
66722	66723	the	0	None
66723	66724	hypertrophied	0	None
66724	66725	kidney	0	None
66725	66726	.	0	None

66727	66728	While	0	None
66728	66729	the	0	None
66729	66730	increase	0	None
66730	66731	in	0	None
66731	66732	total	0	None
66732	66733	OAT	0	None
66733	66734	activity	0	None
66734	66735	was	0	None
66735	66736	much	0	None
66736	66737	more	0	None
66737	66738	than	0	None
66738	66739	the	0	None
66739	66740	increase	0	None
66740	66741	in	0	None
66741	66742	kidney	0	None
66742	66743	weight	0	None
66743	66744	,	0	None
66744	66745	all	0	None
66745	66746	other	0	None
66746	66747	enzymes	0	None
66747	66748	increased	0	None
66748	66749	more	0	None
66749	66750	or	0	None
66750	66751	less	0	None
66751	66752	in	0	None
66752	66753	proportion	0	None
66753	66754	to	0	None
66754	66755	the	0	None
66755	66756	increase	0	None
66756	66757	in	0	None
66757	66758	renal	0	None
66758	66759	mass	0	None
66759	66760	.	0	None

66761	66762	The	0	None
66762	66763	results	0	None
66763	66764	suggest	0	None
66764	66765	that	0	None
66765	66766	compensation	0	None
66766	66767	in	0	None
66767	66768	OAT	0	None
66768	66769	activity	0	None
66769	66770	to	0	None
66770	66771	chronic	0	None
66771	66772	reduction	0	None
66772	66773	in	0	None
66773	66774	renal	0	None
66774	66775	mass	0	None
66775	66776	was	0	None
66776	66777	complete	0	None
66777	66778	,	0	None
66778	66779	but	0	None
66779	66780	only	0	None
66780	66781	partial	0	None
66781	66782	in	0	None
66782	66783	the	0	None
66783	66784	case	0	None
66784	66785	of	0	None
66785	66786	other	0	None
66786	66787	enzymes	0	None
66787	66788	.	0	None
66788	66789	Ethanol	2	CHEMICAL
66789	66790	extract	0	None
66790	66791	of	0	None
66791	66792	Adiantum	0	None
66792	66793	capillus-veneris	0	None
66793	66794	L	0	None
66794	66795	.	0	None

66796	66797	suppresses	0	None
66797	66798	the	0	None
66798	66799	production	0	None
66799	66800	of	0	None
66800	66801	inflammatory	0	None
66801	66802	mediators	0	None
66802	66803	by	0	None
66803	66804	inhibiting	0	None
66804	66805	NF-κB	0	None
66805	66806	activation	0	None
66806	66807	.	0	None
66807	66808	Fungicide	0	None
66808	66809	prochloraz	0	None
66809	66810	and	0	None
66810	66811	environmental	0	None
66811	66812	pollutant	0	None
66812	66813	dioxin	2	CHEMICAL
66813	66814	induce	0	None
66814	66815	the	0	None
66815	66816	ABCG2	1	GENE-Y
66816	66817	transporter	0	None
66817	66818	in	0	None
66818	66819	bovine	0	None
66819	66820	mammary	0	None
66820	66821	epithelial	0	None
66821	66822	cells	0	None
66822	66823	by	0	None
66823	66824	the	0	None
66824	66825	arylhydrocarbon	0	None
66825	66826	receptor	0	None
66826	66827	signaling	0	None
66827	66828	pathway	0	None
66828	66829	.	0	None
66829	66830	In	0	None
66830	66831	the	0	None
66831	66832	present	0	None
66832	66833	investigation	0	None
66833	66834	,	0	None
66834	66835	16	0	None
66835	66836	new	0	None
66836	66837	rotundic	0	None
66837	66838	acid	0	None
66838	66839	(	0	None
66839	66840	RA	2	CHEMICAL
66840	66841	)	0	None
66841	66842	derivatives	0	None
66842	66843	modified	0	None
66843	66844	at	0	None
66844	66845	the	0	None
66845	66846	C-3	0	None
66846	66847	,	0	None
66847	66848	C-23	0	None
66848	66849	and	0	None
66849	66850	C-28	0	None
66850	66851	positions	0	None
66851	66852	were	0	None
66852	66853	synthesized	0	None
66853	66854	.	0	None

66855	66856	The	0	None
66856	66857	cytotoxicities	0	None
66857	66858	of	0	None
66858	66859	the	0	None
66859	66860	derivatives	0	None
66860	66861	were	0	None
66861	66862	evaluated	0	None
66862	66863	against	0	None
66863	66864	HeLa	0	None
66864	66865	,	0	None
66865	66866	A375	0	None
66866	66867	,	0	None
66867	66868	HepG2	0	None
66868	66869	,	0	None
66869	66870	SPC-A1	0	None
66870	66871	and	0	None
66871	66872	NCI-H446	0	None
66872	66873	human	0	None
66873	66874	tumor	0	None
66874	66875	cell	0	None
66875	66876	lines	0	None
66876	66877	by	0	None
66877	66878	MTT	0	None
66878	66879	assay	0	None
66879	66880	.	0	None

66881	66882	Among	0	None
66882	66883	these	0	None
66883	66884	derivatives	0	None
66884	66885	,	0	None
66885	66886	compounds	0	None
66886	66887	4-7	0	None
66887	66888	exhibited	0	None
66888	66889	stronger	0	None
66889	66890	cell	0	None
66890	66891	growth	0	None
66891	66892	inhibitory	0	None
66892	66893	than	0	None
66893	66894	RA	2	CHEMICAL
66894	66895	and	0	None
66895	66896	compound	0	None
66896	66897	4	0	None
66897	66898	was	0	None
66898	66899	found	0	None
66899	66900	to	0	None
66900	66901	be	0	None
66901	66902	the	0	None
66902	66903	best	0	None
66903	66904	inhibition	0	None
66904	66905	activity	0	None
66905	66906	on	0	None
66906	66907	five	0	None
66907	66908	human	0	None
66908	66909	tumor	0	None
66909	66910	cell	0	None
66910	66911	lines	0	None
66911	66912	with	0	None
66912	66913	IC50	0	None
66913	66914	<10μM	0	None
66914	66915	.	0	None

66916	66917	The	0	None
66917	66918	apoptosis	0	None
66918	66919	mechanism	0	None
66919	66920	of	0	None
66920	66921	compound	0	None
66921	66922	4	0	None
66922	66923	in	0	None
66923	66924	HeLa	0	None
66924	66925	cells	0	None
66925	66926	was	0	None
66926	66927	investigated	0	None
66927	66928	by	0	None
66928	66929	western	0	None
66929	66930	blot	0	None
66930	66931	analysis	0	None
66931	66932	.	0	None

66933	66934	The	0	None
66934	66935	results	0	None
66935	66936	indicated	0	None
66936	66937	that	0	None
66937	66938	compound	0	None
66938	66939	4	0	None
66939	66940	could	0	None
66940	66941	induce	0	None
66941	66942	apoptosis	0	None
66942	66943	through	0	None
66943	66944	increasing	0	None
66944	66945	protein	0	None
66945	66946	expression	0	None
66946	66947	of	0	None
66947	66948	cleaved	0	None
66948	66949	caspase-3	1	GENE-Y
66949	66950	and	0	None
66950	66951	Bax	0	None
66951	66952	,	0	None
66952	66953	and	0	None
66953	66954	decreasing	0	None
66954	66955	protein	0	None
66955	66956	expression	0	None
66956	66957	of	0	None
66957	66958	Bcl-2	1	GENE-Y
66958	66959	.	0	None

66960	66961	In	0	None
66961	66962	summary	0	None
66962	66963	,	0	None
66963	66964	the	0	None
66964	66965	present	0	None
66965	66966	work	0	None
66966	66967	suggests	0	None
66967	66968	that	0	None
66968	66969	compound	0	None
66969	66970	4	0	None
66970	66971	might	0	None
66971	66972	serve	0	None
66972	66973	as	0	None
66973	66974	an	0	None
66974	66975	effective	0	None
66975	66976	chemotherapeutic	0	None
66976	66977	candidate	0	None
66977	66978	.	0	None
66978	66980	Arsenic trioxide	2	CHEMICAL
66980	66981	(	0	None
66981	66982	ATO	0	None
66982	66983	)	0	None
66983	66984	is	0	None
66984	66985	widely	0	None
66985	66986	used	0	None
66986	66987	in	0	None
66987	66988	tumor	0	None
66988	66989	treatment	0	None
66989	66990	,	0	None
66990	66991	but	0	None
66991	66992	excessive	0	None
66992	66993	arsenic	2	CHEMICAL
66993	66994	exposure	0	None
66994	66995	can	0	None
66995	66996	have	0	None
66996	66997	adverse	0	None
66997	66998	effects	0	None
66998	66999	.	0	None

67000	67001	We	0	None
67001	67002	recently	0	None
67002	67003	found	0	None
67003	67004	that	0	None
67004	67005	,	0	None
67005	67006	in	0	None
67006	67007	primary	0	None
67007	67008	osteoblasts	0	None
67008	67009	,	0	None
67009	67010	ATO	0	None
67010	67011	produces	0	None
67011	67012	oxidative	0	None
67012	67013	stress	0	None
67013	67014	and	0	None
67014	67015	causes	0	None
67015	67016	DNA	0	None
67016	67017	tailing	0	None
67017	67018	,	0	None
67018	67019	but	0	None
67019	67020	does	0	None
67020	67021	not	0	None
67021	67022	induce	0	None
67022	67023	apoptosis	0	None
67023	67024	.	0	None

67025	67026	We	0	None
67026	67027	further	0	None
67027	67028	examined	0	None
67028	67029	the	0	None
67029	67030	signaling	0	None
67030	67031	pathway	0	None
67031	67032	by	0	None
67032	67033	which	0	None
67033	67034	osteoblasts	0	None
67034	67035	survive	0	None
67035	67036	ATO	0	None
67036	67037	treatment	0	None
67037	67038	,	0	None
67038	67039	and	0	None
67039	67040	found	0	None
67040	67041	that	0	None
67041	67042	they	0	None
67042	67043	were	0	None
67043	67044	arrested	0	None
67044	67045	at	0	None
67045	67046	G2	0	None
67046	67047	/	0	None
67047	67048	M	0	None
67048	67049	phase	0	None
67049	67050	of	0	None
67050	67051	the	0	None
67051	67052	cell	0	None
67052	67053	cycle	0	None
67053	67054	at	0	None
67054	67055	30h	0	None
67055	67056	and	0	None
67056	67057	overrode	0	None
67057	67058	the	0	None
67058	67059	G2	0	None
67059	67060	/	0	None
67060	67061	M	0	None
67061	67062	boundary	0	None
67062	67063	at	0	None
67063	67064	48h	0	None
67064	67065	.	0	None

67066	67067	After	0	None
67067	67068	treatment	0	None
67068	67069	for	0	None
67069	67070	30h	0	None
67070	67071	,	0	None
67071	67072	there	0	None
67072	67073	was	0	None
67073	67074	increased	0	None
67074	67075	Cdc2	0	None
67075	67076	phosphorylation	0	None
67076	67077	and	0	None
67077	67078	expression	0	None
67078	67079	of	0	None
67079	67080	Wee1	1	GENE-Y
67080	67081	,	0	None
67081	67082	a	0	None
67082	67083	Cdc2	0	None
67083	67084	kinase	0	None
67084	67085	,	0	None
67085	67086	and	0	None
67086	67087	expression	0	None
67087	67088	of	0	None
67088	67089	the	0	None
67089	67090	cell	0	None
67090	67091	cycle	0	None
67091	67092	inhibitor	0	None
67092	67093	,	0	None
67093	67094	p21	0	None
67094	67095	(	0	None
67095	67096	waf1	1	GENE-Y
67096	67097	/	0	None
67097	67098	cip1	1	GENE-Y
67098	67099	)	0	None
67099	67100	,	0	None
67100	67101	which	0	None
67101	67102	interacts	0	None
67102	67103	with	0	None
67103	67104	Cdc2	0	None
67104	67105	.	0	None

67106	67107	Furthermore	0	None
67107	67108	,	0	None
67108	67109	levels	0	None
67109	67110	of	0	None
67110	67111	the	0	None
67111	67112	phosphatase	0	None
67112	67113	Cdc25C	0	None
67113	67114	,	0	None
67114	67115	which	0	None
67115	67116	activates	0	None
67116	67117	Cdc2	0	None
67117	67118	,	0	None
67118	67119	were	0	None
67119	67120	decreased	0	None
67120	67121	,	0	None
67121	67122	while	0	None
67122	67123	the	0	None
67123	67124	ratio	0	None
67124	67125	of	0	None
67125	67126	its	0	None
67126	67127	phosphorylated	0	None
67127	67128	/	0	None
67128	67129	inactivated	0	None
67129	67130	form	0	None
67130	67131	to	0	None
67131	67132	the	0	None
67132	67133	total	0	None
67133	67134	amount	0	None
67134	67135	was	0	None
67135	67136	increased	0	None
67136	67137	.	0	None

67138	67139	Moreover	0	None
67139	67140	,	0	None
67140	67141	phosphorylation	0	None
67141	67142	/	0	None
67142	67143	activation	0	None
67143	67144	of	0	None
67144	67145	the	0	None
67145	67146	checkpoint	0	None
67146	67147	kinases	0	None
67147	67148	Chk1	0	None
67148	67149	,	0	None
67149	67150	Chk2	0	None
67150	67151	and	0	None
67151	67152	p53	0	None
67152	67153	levels	0	None
67153	67154	were	0	None
67154	67155	increased	0	None
67155	67156	,	0	None
67156	67157	as	0	None
67157	67158	were	0	None
67158	67159	levels	0	None
67159	67160	of	0	None
67160	67161	activated	0	None
67161	67162	ATM	0	None
67162	67163	and	0	None
67163	67164	γ-H2AX	0	None
67164	67165	.	0	None

67166	67167	The	0	None
67167	67168	cell	0	None
67168	67169	viability	0	None
67169	67170	was	0	None
67170	67171	decreased	0	None
67171	67172	as	0	None
67172	67173	an	0	None
67173	67174	ATM	0	None
67174	67175	inhibitor	0	None
67175	67176	was	0	None
67176	67177	added	0	None
67177	67178	.	0	None

67179	67180	Additionally	0	None
67180	67181	,	0	None
67181	67182	these	0	None
67182	67183	effects	0	None
67183	67184	of	0	None
67184	67185	ATO	0	None
67185	67186	on	0	None
67186	67187	γ-H2AX	0	None
67187	67188	,	0	None
67188	67189	Chk1	0	None
67189	67190	,	0	None
67190	67191	Chk2	0	None
67191	67192	,	0	None
67192	67193	p53	0	None
67193	67194	,	0	None
67194	67195	and	0	None
67195	67196	p21	0	None
67196	67197	(	0	None
67197	67198	waf1	1	GENE-Y
67198	67199	/	0	None
67199	67200	cip1	1	GENE-Y
67200	67201	)	0	None
67201	67202	were	0	None
67202	67203	reduced	0	None
67203	67204	by	0	None
67204	67205	an	0	None
67205	67206	ATM	0	None
67206	67207	inhibitor	0	None
67207	67208	.	0	None

67209	67210	These	0	None
67210	67211	findings	0	None
67211	67212	suggest	0	None
67212	67213	that	0	None
67213	67214	G2	0	None
67214	67215	/	0	None
67215	67216	M	0	None
67216	67217	phase	0	None
67217	67218	arrest	0	None
67218	67219	of	0	None
67219	67220	osteoblasts	0	None
67220	67221	is	0	None
67221	67222	mediated	0	None
67222	67223	by	0	None
67223	67224	Chk1	0	None
67224	67225	/	0	None
67225	67226	Chk2	0	None
67226	67227	activation	0	None
67227	67228	via	0	None
67228	67229	an	0	None
67229	67230	ATM-dependent	0	None
67230	67231	pathway	0	None
67231	67232	by	0	None
67232	67233	which	0	None
67233	67234	osteoblasts	0	None
67234	67235	survive	0	None
67235	67236	.	0	None
67236	67237	Prototypic	0	None
67237	67238	G	0	None
67238	67239	protein-coupled	0	None
67239	67240	receptor	0	None
67240	67241	for	0	None
67241	67242	the	0	None
67242	67243	intestinotrophic	0	None
67243	67244	factor	0	None
67244	67245	glucagon-like	0	None
67245	67246	peptide	0	None
67246	67247	2	0	None
67247	67248	.	0	None
67248	67249	Benzodiazepine	0	None
67249	67250	receptor	0	None
67250	67251	binding	0	None
67251	67252	of	0	None
67252	67253	triazolobenzodiazepines	0	None
67253	67254	in	0	None
67254	67255	vivo	0	None
67255	67256	:	0	None
67256	67257	increased	0	None
67257	67258	receptor	0	None
67258	67259	number	0	None
67259	67260	with	0	None
67260	67261	low-dose	0	None
67261	67262	alprazolam	2	CHEMICAL
67262	67263	.	0	None
67263	67264	Arsenic	2	CHEMICAL
67264	67265	geochemistry	0	None
67265	67266	in	0	None
67266	67267	a	0	None
67267	67268	biostimulated	0	None
67268	67269	aquifer	0	None
67269	67270	:	0	None
67270	67271	An	0	None
67271	67272	aqueous	0	None
67272	67273	speciation	0	None
67273	67274	study	0	None
67274	67275	.	0	None
67275	67276	Persistent	0	None
67276	67277	hyperglycemia	0	None
67277	67278	is	0	None
67278	67279	associated	0	None
67279	67280	with	0	None
67280	67281	chronic	0	None
67281	67282	oxidative	0	None
67282	67283	stress	0	None
67283	67284	which	0	None
67284	67285	contributes	0	None
67285	67286	to	0	None
67286	67287	the	0	None
67287	67288	development	0	None
67288	67289	and	0	None
67289	67290	progression	0	None
67290	67291	of	0	None
67291	67292	diabetes-associated	0	None
67292	67293	complications	0	None
67293	67294	.	0	None

67295	67296	The	0	None
67296	67297	sensitivity	0	None
67297	67298	of	0	None
67298	67299	pancreatic	0	None
67299	67300	β-cells	0	None
67300	67301	to	0	None
67301	67302	oxidative	0	None
67302	67303	stress	0	None
67303	67304	has	0	None
67304	67305	been	0	None
67305	67306	attributed	0	None
67306	67307	to	0	None
67307	67308	their	0	None
67308	67309	low	0	None
67309	67310	content	0	None
67310	67311	of	0	None
67311	67312	antioxidants	0	None
67312	67313	compared	0	None
67313	67314	with	0	None
67314	67315	other	0	None
67315	67316	tissues	0	None
67316	67317	.	0	None

67318	67319	Bioactive	0	None
67319	67320	compounds	0	None
67320	67321	with	0	None
67321	67322	potent	0	None
67322	67323	antidiabetic	0	None
67323	67324	properties	0	None
67324	67325	have	0	None
67325	67326	been	0	None
67326	67327	shown	0	None
67327	67328	to	0	None
67328	67329	ameliorate	0	None
67329	67330	hyperglycemia	0	None
67330	67331	mediated	0	None
67331	67332	oxidative	0	None
67332	67333	stress	0	None
67333	67334	.	0	None

67335	67336	Recently	0	None
67336	67337	,	0	None
67337	67338	we	0	None
67338	67339	have	0	None
67339	67340	reported	0	None
67340	67341	that	0	None
67341	67342	oral	0	None
67342	67343	administration	0	None
67343	67344	of	0	None
67344	67345	fisetin	0	None
67345	67346	(	0	None
67346	67347	10	0	None
67347	67348	mg	2	CHEMICAL
67348	67349	/	0	None
67349	67350	Kg	0	None
67350	67351	b	0	None
67351	67352	.	0	None

67353	67354	w	0	None
67354	67355	.	0	None

67356	67357	)	0	None
67357	67358	,	0	None
67358	67359	a	0	None
67359	67360	bioflavonoid	0	None
67360	67361	found	0	None
67361	67362	to	0	None
67362	67363	be	0	None
67363	67364	present	0	None
67364	67365	in	0	None
67365	67366	strawberries	0	None
67366	67367	,	0	None
67367	67368	persimmon	0	None
67368	67369	,	0	None
67369	67370	to	0	None
67370	67371	STZ-induced	0	None
67371	67372	experimental	0	None
67372	67373	diabetic	0	None
67373	67374	rats	0	None
67374	67375	significantly	0	None
67375	67376	improved	0	None
67376	67377	normoglycemia	0	None
67377	67378	.	0	None

67379	67380	The	0	None
67380	67381	present	0	None
67381	67382	study	0	None
67382	67383	was	0	None
67383	67384	aimed	0	None
67384	67385	to	0	None
67385	67386	evaluate	0	None
67386	67387	the	0	None
67387	67388	antioxidant	0	None
67388	67389	potential	0	None
67389	67390	of	0	None
67390	67391	fisetin	0	None
67391	67392	in	0	None
67392	67393	both	0	None
67393	67394	in	0	None
67394	67395	vitro	0	None
67395	67396	and	0	None
67396	67397	in	0	None
67397	67398	vivo	0	None
67398	67399	.	0	None

67400	67401	Diabetes	0	None
67401	67402	was	0	None
67402	67403	induced	0	None
67403	67404	by	0	None
67404	67405	single	0	None
67405	67406	intraperitoneal	0	None
67406	67407	injection	0	None
67407	67408	of	0	None
67408	67409	streptozotocin	2	CHEMICAL
67409	67410	(	0	None
67410	67411	50	0	None
67411	67412	mg	2	CHEMICAL
67412	67413	/	0	None
67413	67414	kg	0	None
67414	67415	body	0	None
67415	67416	weight	0	None
67416	67417	)	0	None
67417	67418	.	0	None

67419	67420	Fisetin	0	None
67420	67421	was	0	None
67421	67422	administered	0	None
67422	67423	orally	0	None
67423	67424	for	0	None
67424	67425	30	0	None
67425	67426	days	0	None
67426	67427	.	0	None

67428	67429	At	0	None
67429	67430	the	0	None
67430	67431	end	0	None
67431	67432	of	0	None
67432	67433	the	0	None
67433	67434	study	0	None
67434	67435	,	0	None
67435	67436	all	0	None
67436	67437	animals	0	None
67437	67438	were	0	None
67438	67439	killed	0	None
67439	67440	.	0	None

67441	67442	Blood	0	None
67442	67443	samples	0	None
67443	67444	were	0	None
67444	67445	collected	0	None
67445	67446	for	0	None
67446	67447	the	0	None
67447	67448	biochemical	0	None
67448	67449	estimations	0	None
67449	67450	.	0	None

67451	67452	The	0	None
67452	67453	antioxidant	0	None
67453	67454	status	0	None
67454	67455	was	0	None
67455	67456	evaluated	0	None
67456	67457	.	0	None

67458	67459	Histological	0	None
67459	67460	examinations	0	None
67460	67461	were	0	None
67461	67462	performed	0	None
67462	67463	on	0	None
67463	67464	pancreatic	0	None
67464	67465	tissues	0	None
67465	67466	.	0	None

67467	67468	Fisetin	0	None
67468	67469	treatment	0	None
67469	67470	showed	0	None
67470	67471	a	0	None
67471	67472	significant	0	None
67472	67473	decline	0	None
67473	67474	in	0	None
67474	67475	the	0	None
67475	67476	levels	0	None
67476	67477	of	0	None
67477	67478	blood	0	None
67478	67479	glucose	0	None
67479	67480	,	0	None
67480	67481	glycosylated	0	None
67481	67482	hemoglobin	0	None
67482	67483	(	0	None
67483	67484	HbA1c	0	None
67484	67485	)	0	None
67485	67486	,	0	None
67486	67487	NF-kB	0	None
67487	67488	p65	0	None
67488	67489	unit	0	None
67489	67490	(	0	None
67490	67491	in	0	None
67491	67492	pancreas	0	None
67492	67493	)	0	None
67493	67494	and	0	None
67494	67495	IL-1β	0	None
67495	67496	(	0	None
67496	67497	plasma	0	None
67497	67498	)	0	None
67498	67499	,	0	None
67499	67500	serum	0	None
67500	67501	nitric	0	None
67501	67502	oxide	0	None
67502	67503	(	0	None
67503	67504	NO	0	None
67504	67505	)	0	None
67505	67506	with	0	None
67506	67507	an	0	None
67507	67508	elevation	0	None
67508	67509	in	0	None
67509	67510	plasma	0	None
67510	67511	insulin	0	None
67511	67512	.	0	None

67513	67514	The	0	None
67514	67515	treatment	0	None
67515	67516	also	0	None
67516	67517	improved	0	None
67517	67518	the	0	None
67518	67519	antioxidant	0	None
67519	67520	status	0	None
67520	67521	in	0	None
67521	67522	pancreas	0	None
67522	67523	as	0	None
67523	67524	well	0	None
67524	67525	as	0	None
67525	67526	plasma	0	None
67526	67527	of	0	None
67527	67528	diabetic	0	None
67528	67529	rats	0	None
67529	67530	indicating	0	None
67530	67531	the	0	None
67531	67532	antioxidant	0	None
67532	67533	potential	0	None
67533	67534	of	0	None
67534	67535	fisetin	0	None
67535	67536	.	0	None

67537	67538	In	0	None
67538	67539	addition	0	None
67539	67540	,	0	None
67540	67541	the	0	None
67541	67542	results	0	None
67542	67543	of	0	None
67543	67544	DPPH	0	None
67544	67545	and	0	None
67545	67546	ABTS	0	None
67546	67547	assays	0	None
67547	67548	substantiate	0	None
67548	67549	the	0	None
67549	67550	free	0	None
67550	67551	radical	0	None
67551	67552	scavenging	0	None
67552	67553	activity	0	None
67553	67554	of	0	None
67554	67555	fisetin	0	None
67555	67556	.	0	None

67557	67558	Histological	0	None
67558	67559	studies	0	None
67559	67560	of	0	None
67560	67561	the	0	None
67561	67562	pancreas	0	None
67562	67563	also	0	None
67563	67564	evidenced	0	None
67564	67565	the	0	None
67565	67566	tissue	0	None
67566	67567	protective	0	None
67567	67568	nature	0	None
67568	67569	of	0	None
67569	67570	fisetin	0	None
67570	67571	.	0	None

67572	67573	It	0	None
67573	67574	is	0	None
67574	67575	concluded	0	None
67575	67576	that	0	None
67576	67577	,	0	None
67577	67578	fisetin	0	None
67578	67579	possesses	0	None
67579	67580	antioxidant	0	None
67580	67581	and	0	None
67581	67582	anti-inflammatory	0	None
67582	67583	property	0	None
67583	67584	and	0	None
67584	67585	may	0	None
67585	67586	be	0	None
67586	67587	considered	0	None
67587	67588	as	0	None
67588	67589	an	0	None
67589	67590	adjunct	0	None
67590	67591	for	0	None
67591	67592	the	0	None
67592	67593	treatment	0	None
67593	67594	of	0	None
67594	67595	diabetes	0	None
67595	67596	.	0	None
67596	67597	The	0	None
67597	67598	serotonin	0	None
67598	67599	(	0	None
67599	67600	5-HT	0	None
67600	67601	)	0	None
67601	67602	receptors	0	None
67602	67603	of	0	None
67603	67604	type	0	None
67604	67605	6	0	None
67605	67606	(	0	None
67606	67607	5-HT6	0	None
67607	67608	)	0	None
67608	67609	are	0	None
67609	67610	quite	0	None
67610	67611	different	0	None
67611	67612	from	0	None
67612	67613	all	0	None
67613	67614	other	0	None
67614	67615	5-HT	0	None
67615	67616	receptors	0	None
67616	67617	,	0	None
67617	67618	as	0	None
67618	67619	they	0	None
67619	67620	include	0	None
67620	67621	a	0	None
67621	67622	short	0	None
67622	67623	third	0	None
67623	67624	cytoplasmatic	0	None
67624	67625	loop	0	None
67625	67626	and	0	None
67626	67627	a	0	None
67627	67628	long	0	None
67628	67629	C-terminal	0	None
67629	67630	tail	0	None
67630	67631	,	0	None
67631	67632	and	0	None
67632	67633	one	0	None
67633	67634	intron	0	None
67634	67635	located	0	None
67635	67636	in	0	None
67636	67637	the	0	None
67637	67638	middle	0	None
67638	67639	of	0	None
67639	67640	the	0	None
67640	67641	third	0	None
67641	67642	cytoplasmatic	0	None
67642	67643	loop	0	None
67643	67644	.	0	None

67645	67646	A	0	None
67646	67647	lot	0	None
67647	67648	of	0	None
67648	67649	controversies	0	None
67649	67650	still	0	None
67650	67651	exist	0	None
67651	67652	regarding	0	None
67652	67653	their	0	None
67653	67654	binding	0	None
67654	67655	affinity	0	None
67655	67656	,	0	None
67656	67657	effects	0	None
67657	67658	of	0	None
67658	67659	5-HT6	0	None
67659	67660	ligands	0	None
67660	67661	on	0	None
67661	67662	brain	0	None
67662	67663	catecholamines	0	None
67663	67664	,	0	None
67664	67665	behavioral	0	None
67665	67666	syndromes	0	None
67666	67667	regulated	0	None
67667	67668	by	0	None
67668	67669	them	0	None
67669	67670	,	0	None
67670	67671	and	0	None
67671	67672	brain	0	None
67672	67673	distribution	0	None
67673	67674	.	0	None

67675	67676	In	0	None
67676	67677	spite	0	None
67677	67678	of	0	None
67678	67679	the	0	None
67679	67680	lack	0	None
67680	67681	of	0	None
67681	67682	information	0	None
67682	67683	on	0	None
67683	67684	metabolic	0	None
67684	67685	pattern	0	None
67685	67686	of	0	None
67686	67687	the	0	None
67687	67688	various	0	None
67688	67689	compounds	0	None
67689	67690	,	0	None
67690	67691	some	0	None
67691	67692	of	0	None
67692	67693	5-HT6	0	None
67693	67694	receptor	0	None
67694	67695	ligands	0	None
67695	67696	entered	0	None
67696	67697	the	0	None
67697	67698	clinical	0	None
67698	67699	development	0	None
67699	67700	as	0	None
67700	67701	potential	0	None
67701	67702	anti-dementia	0	None
67702	67703	,	0	None
67703	67704	antipsychotic	0	None
67704	67705	,	0	None
67705	67706	antidepressant	0	None
67706	67707	and	0	None
67707	67708	anti-obese	0	None
67708	67709	drugs	0	None
67709	67710	.	0	None

67711	67712	The	0	None
67712	67713	present	0	None
67713	67714	paper	0	None
67714	67715	is	0	None
67715	67716	a	0	None
67716	67717	comprehensive	0	None
67717	67718	review	0	None
67718	67719	on	0	None
67719	67720	the	0	None
67720	67721	state	0	None
67721	67722	of	0	None
67722	67723	art	0	None
67723	67724	of	0	None
67724	67725	the	0	None
67725	67726	5-HT6	0	None
67726	67727	receptors	0	None
67727	67728	,	0	None
67728	67729	while	0	None
67729	67730	highlighting	0	None
67730	67731	the	0	None
67731	67732	potential	0	None
67732	67733	clinical	0	None
67733	67734	applications	0	None
67734	67735	of	0	None
67735	67736	5-HT6	0	None
67736	67737	receptor	0	None
67737	67738	agonists	0	None
67738	67739	/	0	None
67739	67740	antagonists	0	None
67740	67741	.	0	None
67741	67742	A	0	None
67742	67743	series	0	None
67743	67744	of	0	None
67744	67745	compounds	0	None
67745	67746	based	0	None
67746	67747	on	0	None
67747	67748	a	0	None
67748	67749	4-phenyl-2-phenylaminopyridine	0	None
67749	67750	scaffold	0	None
67750	67751	that	0	None
67751	67752	are	0	None
67752	67753	potent	0	None
67753	67754	and	0	None
67754	67755	selective	0	None
67755	67756	inhibitors	0	None
67756	67757	of	0	None
67757	67758	Traf2-	0	None
67758	67759	and	0	None
67759	67760	Nck-interacting	0	None
67760	67761	kinase	0	None
67761	67762	(	0	None
67762	67763	TNIK	0	None
67763	67764	)	0	None
67764	67765	activity	0	None
67765	67766	are	0	None
67766	67767	described	0	None
67767	67768	.	0	None

67769	67770	These	0	None
67770	67771	compounds	0	None
67771	67772	were	0	None
67772	67773	used	0	None
67773	67774	as	0	None
67774	67775	tools	0	None
67775	67776	to	0	None
67776	67777	test	0	None
67777	67778	the	0	None
67778	67779	importance	0	None
67779	67780	of	0	None
67780	67781	TNIK	0	None
67781	67782	kinase	0	None
67782	67783	activity	0	None
67783	67784	in	0	None
67784	67785	signaling	0	None
67785	67786	and	0	None
67786	67787	proliferation	0	None
67787	67788	in	0	None
67788	67789	Wnt-activated	0	None
67789	67790	colorectal	0	None
67790	67791	cancer	0	None
67791	67792	cells	0	None
67792	67793	.	0	None

67794	67795	The	0	None
67795	67796	results	0	None
67796	67797	indicate	0	None
67797	67798	that	0	None
67798	67799	pharmacological	0	None
67799	67800	inhibition	0	None
67800	67801	of	0	None
67801	67802	TNIK	0	None
67802	67803	kinase	0	None
67803	67804	activity	0	None
67804	67805	has	0	None
67805	67806	minimal	0	None
67806	67807	effects	0	None
67807	67808	on	0	None
67808	67809	either	0	None
67809	67810	Wnt	0	None
67810	67811	/	0	None
67811	67812	TCF4	0	None
67812	67813	/	0	None
67813	67814	β-catenin-driven	0	None
67814	67815	transcription	0	None
67815	67816	or	0	None
67816	67817	viability	0	None
67817	67818	.	0	None

67819	67820	The	0	None
67820	67821	findings	0	None
67821	67822	suggest	0	None
67822	67823	that	0	None
67823	67824	the	0	None
67824	67825	kinase	0	None
67825	67826	activity	0	None
67826	67827	of	0	None
67827	67828	TNIK	0	None
67828	67829	may	0	None
67829	67830	be	0	None
67830	67831	less	0	None
67831	67832	important	0	None
67832	67833	to	0	None
67833	67834	Wnt	0	None
67834	67835	signaling	0	None
67835	67836	than	0	None
67836	67837	other	0	None
67837	67838	aspects	0	None
67838	67839	of	0	None
67839	67840	TNIK	0	None
67840	67841	function	0	None
67841	67842	,	0	None
67842	67843	such	0	None
67843	67844	as	0	None
67844	67845	its	0	None
67845	67846	putative	0	None
67846	67847	role	0	None
67847	67848	in	0	None
67848	67849	stabilizing	0	None
67849	67850	the	0	None
67850	67851	TCF4	0	None
67851	67852	/	0	None
67852	67853	β-catenin	0	None
67853	67854	transcriptional	0	None
67854	67855	complex	0	None
67855	67856	.	0	None
67856	67857	A	0	None
67857	67858	series	0	None
67858	67859	of	0	None
67859	67860	N-substituted	0	None
67860	67861	lobelane	0	None
67861	67862	analogues	0	None
67862	67863	was	0	None
67863	67864	synthesized	0	None
67864	67865	and	0	None
67865	67866	evaluated	0	None
67866	67867	for	0	None
67867	67868	their	0	None
67868	67869	[	0	None
67869	67870	(	0	None
67870	67871	3	0	None
67871	67872	)	0	None
67872	67873	H	0	None
67873	67874	]	0	None
67874	67875	dihydrotetrabenazine	0	None
67875	67876	binding	0	None
67876	67877	affinity	0	None
67877	67878	at	0	None
67878	67879	the	0	None
67879	67880	vesicular	0	None
67880	67881	monoamine	0	None
67881	67882	transporter	0	None
67882	67883	and	0	None
67883	67884	for	0	None
67884	67885	their	0	None
67885	67886	inhibition	0	None
67886	67887	of	0	None
67887	67888	vesicular	0	None
67888	67889	[	0	None
67889	67890	(	0	None
67890	67891	3	0	None
67891	67892	)	0	None
67892	67893	H	0	None
67893	67894	]	0	None
67894	67895	dopamine	0	None
67895	67896	uptake	0	None
67896	67897	.	0	None

67898	67899	Compound	0	None
67899	67900	19a	0	None
67900	67901	,	0	None
67901	67902	which	0	None
67902	67903	contains	0	None
67903	67904	an	0	None
67904	67905	N-1	0	None
67905	67906	,	0	None
67906	67907	2	0	None
67907	67908	(	0	None
67908	67909	R	0	None
67909	67910	)	0	None
67910	67911	-dihydroxypropyl	0	None
67911	67912	group	0	None
67912	67913	,	0	None
67913	67914	had	0	None
67914	67915	been	0	None
67915	67916	identified	0	None
67916	67917	as	0	None
67917	67918	a	0	None
67918	67919	potential	0	None
67919	67920	clinical	0	None
67920	67921	candidate	0	None
67921	67922	for	0	None
67922	67923	the	0	None
67923	67924	treatment	0	None
67924	67925	of	0	None
67925	67926	methamphetamine	0	None
67926	67927	abuse	0	None
67927	67928	.	0	None
67928	67929	[	0	None
67929	67930	Proliferation	0	None
67930	67931	inhibition	0	None
67931	67932	effect	0	None
67932	67933	of	0	None
67933	67934	indomethacin	0	None
67934	67935	on	0	None
67935	67936	CML	0	None
67936	67937	cells	0	None
67937	67938	associated	0	None
67938	67939	with	0	None
67939	67940	down-regulation	0	None
67940	67941	of	0	None
67941	67942	phosphorylated	0	None
67942	67943	STAT1	0	None
67943	67944	/	0	None
67944	67945	STAT5	0	None
67945	67946	and	0	None
67946	67947	inhibition	0	None
67947	67948	of	0	None
67948	67949	COX-2	0	None
67949	67950	expression	0	None
67950	67951	]	0	None
67951	67952	.	0	None
67952	67953	Recent	0	None
67953	67954	findings	0	None
67954	67955	have	0	None
67955	67956	implicated	0	None
67956	67957	the	0	None
67957	67958	5-hydroxytryptamine	0	None
67958	67959	2B	0	None
67959	67960	(	0	None
67960	67961	5-HT2B	1	GENE-Y
67961	67962	)	0	None
67962	67964	serotonin receptor	1	GENE-Y
67964	67965	in	0	None
67965	67966	mediating	0	None
67966	67967	the	0	None
67967	67968	heart	0	None
67968	67969	valve	0	None
67969	67970	fibroplasia	0	None
67970	67971	[	0	None
67971	67972	valvular	0	None
67972	67973	heart	0	None
67973	67974	disease	0	None
67974	67975	(	0	None
67975	67976	VHD	0	None
67976	67977	)	0	None
67977	67978	]	0	None
67978	67979	and	0	None
67979	67980	primary	0	None
67980	67981	pulmonary	0	None
67981	67982	hypertension	0	None
67982	67983	observed	0	None
67983	67984	in	0	None
67984	67985	patients	0	None
67985	67986	taking	0	None
67986	67987	the	0	None
67987	67988	now-banned	0	None
67988	67989	appetite	0	None
67989	67990	suppressant	0	None
67990	67991	fenfluramine	0	None
67991	67992	(	0	None
67992	67993	Pondimin	0	None
67993	67994	,	0	None
67994	67995	Redux	0	None
67995	67996	)	0	None
67996	67997	.	0	None

67998	67999	Via	0	None
67999	68000	large-scale	0	None
68000	68001	,	0	None
68001	68002	random	0	None
68002	68003	screening	0	None
68003	68004	of	0	None
68004	68005	a	0	None
68005	68006	portion	0	None
68006	68007	of	0	None
68007	68008	the	0	None
68008	68009	receptorome	0	None
68009	68010	,	0	None
68010	68011	we	0	None
68011	68012	have	0	None
68012	68013	discovered	0	None
68013	68014	that	0	None
68014	68015	the	0	None
68015	68016	amphetamine	0	None
68016	68017	derivative	0	None
68017	68018	3	0	None
68018	68019	,	0	None
68019	68020	4-methylenedioxymethamphetamine	0	None
68020	68021	(	0	None
68021	68022	MDMA	0	None
68022	68023	,	0	None
68023	68024	"Ecstasy"	0	None
68024	68025	)	0	None
68025	68026	and	0	None
68026	68027	its	0	None
68027	68028	N-demethylated	0	None
68028	68029	metabolite	0	None
68029	68030	3	0	None
68030	68031	,	0	None
68031	68032	4-methylenedioxyamphetamine	0	None
68032	68033	(	0	None
68033	68034	MDA	0	None
68034	68035	)	0	None
68035	68036	each	0	None
68036	68037	preferentially	0	None
68037	68038	bind	0	None
68038	68039	to	0	None
68039	68040	and	0	None
68040	68041	activate	0	None
68041	68042	human	0	None
68042	68043	recombinant	0	None
68043	68044	5-HT2B	1	GENE-Y
68044	68045	receptors	0	None
68045	68046	.	0	None

68047	68048	We	0	None
68048	68049	also	0	None
68049	68050	demonstrate	0	None
68050	68051	that	0	None
68051	68052	MDMA	0	None
68052	68053	and	0	None
68053	68054	MDA	0	None
68054	68055	,	0	None
68055	68056	like	0	None
68056	68057	fenfluramine	0	None
68057	68058	and	0	None
68058	68059	its	0	None
68059	68060	N-deethylated	0	None
68060	68061	metabolite	0	None
68061	68062	norfenfluramine	2	CHEMICAL
68062	68063	,	0	None
68063	68064	elicit	0	None
68064	68065	prolonged	0	None
68065	68066	mitogenic	0	None
68066	68067	responses	0	None
68067	68068	in	0	None
68068	68069	human	0	None
68069	68070	valvular	0	None
68070	68071	interstitial	0	None
68071	68072	cells	0	None
68072	68073	via	0	None
68073	68074	activation	0	None
68074	68075	of	0	None
68075	68076	5-HT2B	1	GENE-Y
68076	68077	receptors	0	None
68077	68078	.	0	None

68079	68080	We	0	None
68080	68081	also	0	None
68081	68082	report	0	None
68082	68083	that	0	None
68083	68084	pergolide	2	CHEMICAL
68084	68085	and	0	None
68085	68086	dihydroergotamine	0	None
68086	68087	,	0	None
68087	68088	two	0	None
68088	68089	drugs	0	None
68089	68090	recently	0	None
68090	68091	demonstrated	0	None
68091	68092	to	0	None
68092	68093	induce	0	None
68093	68094	VHD	0	None
68094	68095	in	0	None
68095	68096	humans	0	None
68096	68097	,	0	None
68097	68098	potently	0	None
68098	68099	activate	0	None
68099	68100	5-HT2B	1	GENE-Y
68100	68101	receptors	0	None
68101	68102	,	0	None
68102	68103	thus	0	None
68103	68104	validating	0	None
68104	68105	this	0	None
68105	68106	assay	0	None
68106	68107	system	0	None
68107	68108	for	0	None
68108	68109	its	0	None
68109	68110	ability	0	None
68110	68111	to	0	None
68111	68112	predict	0	None
68112	68113	medications	0	None
68113	68114	that	0	None
68114	68115	might	0	None
68115	68116	induce	0	None
68116	68117	VHD	0	None
68117	68118	.	0	None

68119	68120	Our	0	None
68120	68121	discovery	0	None
68121	68122	that	0	None
68122	68123	MDMA	0	None
68123	68124	and	0	None
68124	68125	a	0	None
68125	68126	major	0	None
68126	68127	metabolite	0	None
68127	68128	,	0	None
68128	68129	MDA	0	None
68129	68130	,	0	None
68130	68131	induce	0	None
68131	68132	prolonged	0	None
68132	68133	mitogenic	0	None
68133	68134	responses	0	None
68134	68135	in	0	None
68135	68136	vitro	0	None
68136	68137	similar	0	None
68137	68138	to	0	None
68138	68139	those	0	None
68139	68140	induced	0	None
68140	68141	by	0	None
68141	68142	fenfluramine	0	None
68142	68143	and	0	None
68143	68144	norfenfluramine	2	CHEMICAL
68144	68145	in	0	None
68145	68146	vivo	0	None
68146	68147	(	0	None
68147	68148	i	0	None
68148	68149	.	0	None

68150	68151	e	0	None
68151	68152	.	0	None

68153	68154	,	0	None
68154	68155	valvular	0	None
68155	68156	interstitial	0	None
68156	68157	cell	0	None
68157	68158	fibroplasia	0	None
68158	68159	)	0	None
68159	68160	predict	0	None
68160	68161	that	0	None
68161	68162	long-term	0	None
68162	68163	MDMA	0	None
68163	68164	use	0	None
68164	68165	could	0	None
68165	68166	lead	0	None
68166	68167	to	0	None
68167	68168	the	0	None
68168	68169	development	0	None
68169	68170	of	0	None
68170	68171	fenfluramine-like	0	None
68171	68172	VHD	0	None
68172	68173	.	0	None

68174	68175	Because	0	None
68175	68176	of	0	None
68176	68177	the	0	None
68177	68178	widespread	0	None
68178	68179	abuse	0	None
68179	68180	of	0	None
68180	68181	MDMA	0	None
68181	68182	,	0	None
68182	68183	these	0	None
68183	68184	findings	0	None
68184	68185	have	0	None
68185	68186	major	0	None
68186	68187	public	0	None
68187	68188	health	0	None
68188	68189	implications	0	None
68189	68190	.	0	None

68191	68192	These	0	None
68192	68193	findings	0	None
68193	68194	also	0	None
68194	68195	underscore	0	None
68195	68196	the	0	None
68196	68197	necessity	0	None
68197	68198	of	0	None
68198	68199	screening	0	None
68199	68200	current	0	None
68200	68201	and	0	None
68201	68202	future	0	None
68202	68203	drugs	0	None
68203	68204	at	0	None
68204	68205	h5-HT2B	0	None
68205	68206	receptors	0	None
68206	68207	for	0	None
68207	68208	agonist	0	None
68208	68209	actions	0	None
68209	68210	before	0	None
68210	68211	their	0	None
68211	68212	use	0	None
68212	68213	in	0	None
68213	68214	humans	0	None
68214	68215	.	0	None
68215	68216	Chemical	0	None
68216	68217	characterization	0	None
68217	68218	of	0	None
68218	68219	chicken	0	None
68219	68220	and	0	None
68220	68221	rat	0	None
68221	68222	lipoprotein	3	GENE-N
68222	68223	lipase	3	GENE-N
68223	68224	(	0	None
68224	68225	LPL	0	None
68225	68226	)	0	None
68226	68227	was	0	None
68227	68228	carried	0	None
68228	68229	out	0	None
68229	68230	following	0	None
68230	68231	purification	0	None
68231	68232	of	0	None
68232	68233	LPL	0	None
68233	68234	.	0	None

68235	68236	Molecular	0	None
68236	68237	weight	0	None
68237	68238	and	0	None
68238	68239	isoelectric	0	None
68239	68240	point	0	None
68240	68241	of	0	None
68241	68242	both	0	None
68242	68243	purified	0	None
68243	68244	enzymes	0	None
68244	68245	were	0	None
68245	68246	determined	0	None
68246	68247	to	0	None
68247	68248	be	0	None
68248	68249	60	0	None
68249	68250	KDa	0	None
68250	68251	and	0	None
68251	68252	pH	0	None
68252	68253	4	0	None
68253	68254	,	0	None
68254	68255	while	0	None
68255	68256	optimum	0	None
68256	68257	temperature	0	None
68257	68258	and	0	None
68258	68259	pH	0	None
68259	68260	to	0	None
68260	68261	yield	0	None
68261	68262	the	0	None
68262	68263	maximal	0	None
68263	68264	activity	0	None
68264	68265	were	0	None
68265	68266	about	0	None
68266	68267	37	0	None
68267	68268	degrees	0	None
68268	68269	C	0	None
68269	68270	and	0	None
68270	68271	pH	0	None
68271	68272	8	0	None
68272	68273	.	0	None
68273	68274	5	0	None
68274	68275	.	0	None

68276	68277	Metallic	0	None
68277	68278	ions	0	None
68278	68279	,	0	None
68279	68280	NaCl	0	None
68280	68281	and	0	None
68281	68282	protamine	3	GENE-N
68282	68283	sulfate	2	CHEMICAL
68283	68284	reduced	0	None
68284	68285	,	0	None
68285	68286	and	0	None
68286	68287	heparin	0	None
68287	68288	increased	0	None
68288	68289	,	0	None
68289	68290	both	0	None
68290	68291	LPL	0	None
68291	68292	activities	0	None
68292	68293	.	0	None

68294	68295	Michaelis	0	None
68295	68296	constants	0	None
68296	68297	for	0	None
68297	68298	LPLs	0	None
68298	68299	determined	0	None
68299	68300	with	0	None
68300	68301	triolein	0	None
68301	68302	emulsion	0	None
68302	68303	as	0	None
68303	68304	the	0	None
68304	68305	substrate	0	None
68305	68306	were	0	None
68306	68307	0	0	None
68307	68308	.	0	None
68308	68309	98	0	None
68309	68310	and	0	None
68310	68311	1	0	None
68311	68312	.	0	None
68312	68313	57	0	None
68313	68314	,	0	None
68314	68315	and	0	None
68315	68316	those	0	None
68316	68317	of	0	None
68317	68318	Vmax	0	None
68318	68319	were	0	None
68319	68320	379	0	None
68320	68321	.	0	None
68321	68322	2	0	None
68322	68323	and	0	None
68323	68324	181	0	None
68324	68325	.	0	None
68325	68326	3	0	None
68326	68327	,	0	None
68327	68328	in	0	None
68328	68329	chickens	0	None
68329	68330	and	0	None
68330	68331	rats	0	None
68331	68332	,	0	None
68332	68333	respectively	0	None
68333	68334	.	0	None

68335	68336	Triton	0	None
68336	68337	WR-1339	0	None
68337	68338	caused	0	None
68338	68339	mixed-type	0	None
68339	68340	inhibition	0	None
68340	68341	in	0	None
68341	68342	rat	0	None
68342	68343	,	0	None
68343	68344	but	0	None
68344	68345	inhibited	0	None
68345	68346	chicken	0	None
68346	68347	LPL	0	None
68347	68348	noncompetitively	0	None
68348	68349	.	0	None

68350	68351	In	0	None
68351	68352	LPLs	0	None
68352	68353	of	0	None
68353	68354	chickens	0	None
68354	68355	and	0	None
68355	68356	rats	0	None
68356	68357	,	0	None
68357	68358	values	0	None
68358	68359	of	0	None
68359	68360	Ki	0	None
68360	68361	were	0	None
68361	68362	66	0	None
68362	68363	.	0	None
68363	68364	7	0	None
68364	68365	and	0	None
68365	68366	36	0	None
68366	68367	.	0	None
68367	68368	4	0	None
68368	68369	with	0	None
68369	68370	triolein	0	None
68370	68371	emulsion	0	None
68371	68372	as	0	None
68372	68373	the	0	None
68373	68374	substrate	0	None
68374	68375	,	0	None
68375	68376	and	0	None
68376	68377	832	0	None
68377	68378	.	0	None
68378	68379	4	0	None
68379	68380	and	0	None
68380	68381	66	0	None
68381	68382	.	0	None
68382	68383	0	0	None
68383	68384	with	0	None
68384	68385	respective	0	None
68385	68386	VLDL	0	None
68386	68387	as	0	None
68387	68388	the	0	None
68388	68389	substrate	0	None
68389	68390	.	0	None

68391	68392	These	0	None
68392	68393	results	0	None
68393	68394	show	0	None
68394	68395	species	0	None
68395	68396	difference	0	None
68396	68397	between	0	None
68397	68398	chickens	0	None
68398	68399	and	0	None
68399	68400	rats	0	None
68400	68401	in	0	None
68401	68402	the	0	None
68402	68403	affinity	0	None
68403	68404	to	0	None
68404	68405	lipoproteins	3	GENE-N
68405	68406	of	0	None
68406	68407	LPL	0	None
68407	68408	and	0	None
68408	68409	inhibition	0	None
68409	68410	of	0	None
68410	68411	LPL	0	None
68411	68412	by	0	None
68412	68413	Triton	0	None
68413	68414	WR-1339	0	None
68414	68415	.	0	None
68415	68417	Nuclear factor-κB	3	GENE-N
68417	68418	(	0	None
68418	68419	NF-κB	0	None
68419	68420	)	0	None
68420	68421	is	0	None
68421	68422	a	0	None
68422	68423	transcription	0	None
68423	68424	factor	0	None
68424	68425	that	0	None
68425	68426	mediates	0	None
68426	68427	the	0	None
68427	68428	inducible	0	None
68428	68429	expression	0	None
68429	68430	of	0	None
68430	68431	a	0	None
68431	68432	variety	0	None
68432	68433	of	0	None
68433	68434	genes	0	None
68434	68435	involved	0	None
68435	68436	in	0	None
68436	68437	immune	0	None
68437	68438	and	0	None
68438	68439	inflammatory	0	None
68439	68440	responses	0	None
68440	68441	.	0	None

68442	68443	NF-κB	0	None
68443	68444	activation	0	None
68444	68445	induces	0	None
68445	68446	numerous	0	None
68446	68447	proinflammatory	0	None
68447	68448	gene	0	None
68448	68449	products	0	None
68449	68450	including	0	None
68450	68451	cytokines	3	GENE-N
68451	68452	,	0	None
68452	68453	cyclooxygenase-2	0	None
68453	68454	(	0	None
68454	68455	COX-2	0	None
68455	68456	)	0	None
68456	68457	,	0	None
68457	68458	and	0	None
68458	68462	inducible nitric oxide synthase	1	GENE-Y
68462	68463	(	0	None
68463	68464	iNOS	0	None
68464	68465	)	0	None
68465	68466	.	0	None

68467	68468	The	0	None
68468	68469	divalent	0	None
68469	68470	heavy	0	None
68470	68471	metal	0	None
68471	68472	mercury	0	None
68472	68473	has	0	None
68473	68474	been	0	None
68474	68475	used	0	None
68475	68476	for	0	None
68476	68477	thousands	0	None
68477	68478	of	0	None
68478	68479	years	0	None
68479	68480	.	0	None

68481	68482	Although	0	None
68482	68483	mercury	0	None
68483	68484	is	0	None
68484	68485	clearly	0	None
68485	68486	toxic	0	None
68486	68487	to	0	None
68487	68488	most	0	None
68488	68489	mammalian	0	None
68489	68490	organ	0	None
68490	68491	systems	0	None
68491	68492	,	0	None
68492	68493	especially	0	None
68493	68494	the	0	None
68494	68495	immune	0	None
68495	68496	system	0	None
68496	68497	,	0	None
68497	68498	exposure	0	None
68498	68499	has	0	None
68499	68500	still	0	None
68500	68501	increased	0	None
68501	68502	in	0	None
68502	68503	some	0	None
68503	68504	areas	0	None
68504	68505	of	0	None
68505	68506	the	0	None
68506	68507	world	0	None
68507	68508	.	0	None

68509	68510	However	0	None
68510	68511	,	0	None
68511	68512	the	0	None
68512	68513	underlying	0	None
68513	68514	toxic	0	None
68514	68515	mechanism	0	None
68515	68516	is	0	None
68516	68517	not	0	None
68517	68518	clearly	0	None
68518	68519	identified	0	None
68519	68520	.	0	None

68521	68522	Here	0	None
68522	68523	,	0	None
68523	68524	we	0	None
68524	68525	report	0	None
68525	68526	biochemical	0	None
68526	68527	evidence	0	None
68527	68528	that	0	None
68528	68529	mercury	0	None
68529	68530	alone	0	None
68530	68531	induces	0	None
68531	68532	NF-κB	0	None
68532	68533	activation	0	None
68533	68534	,	0	None
68534	68535	resulting	0	None
68535	68536	in	0	None
68536	68537	the	0	None
68537	68538	induced	0	None
68538	68539	expression	0	None
68539	68540	of	0	None
68540	68541	COX-2	0	None
68541	68542	and	0	None
68542	68543	iNOS	0	None
68543	68544	.	0	None

68545	68546	The	0	None
68546	68547	results	0	None
68547	68548	suggest	0	None
68548	68549	that	0	None
68549	68550	mercury	0	None
68550	68551	can	0	None
68551	68552	induce	0	None
68552	68553	inflammatory	0	None
68553	68554	diseases	0	None
68554	68555	by	0	None
68555	68556	lowering	0	None
68556	68557	host	0	None
68557	68558	defense	0	None
68558	68559	.	0	None
68559	68560	We	0	None
68560	68561	investigated	0	None
68561	68562	the	0	None
68562	68563	effects	0	None
68563	68564	of	0	None
68564	68568	transforming growth factor alpha	1	GENE-Y
68568	68569	(	0	None
68569	68570	TGF-alpha	0	None
68570	68571	)	0	None
68571	68572	on	0	None
68572	68573	DNA	0	None
68573	68574	synthesis	0	None
68574	68575	and	0	None
68575	68576	proliferation	0	None
68576	68577	in	0	None
68577	68578	primary	0	None
68578	68579	cultures	0	None
68579	68580	of	0	None
68580	68581	adult	0	None
68581	68582	rat	0	None
68582	68583	hepatocytes	0	None
68583	68584	and	0	None
68584	68585	examined	0	None
68585	68586	the	0	None
68586	68587	influence	0	None
68587	68588	of	0	None
68588	68589	alpha	0	None
68589	68590	and	0	None
68590	68591	beta	0	None
68591	68592	adrenoceptor	0	None
68592	68593	agonists	0	None
68593	68594	on	0	None
68594	68595	the	0	None
68595	68596	TGF-alpha-induced	0	None
68596	68597	responses	0	None
68597	68598	.	0	None

68599	68600	TGF-alpha	0	None
68600	68601	(	0	None
68601	68602	1	0	None
68602	68603	.	0	None
68603	68604	0	0	None
68604	68605	ng	0	None
68605	68606	/	0	None
68606	68607	ml	0	None
68607	68608	)	0	None
68608	68609	produced	0	None
68609	68610	a	0	None
68610	68611	4	0	None
68611	68612	.	0	None
68612	68613	1-fold	0	None
68613	68614	elevation	0	None
68614	68615	of	0	None
68615	68616	DNA	0	None
68616	68617	synthesis	0	None
68617	68618	during	0	None
68618	68619	3	0	None
68619	68620	h	0	None
68620	68621	of	0	None
68621	68622	culture	0	None
68622	68623	and	0	None
68623	68624	a	0	None
68624	68625	1	0	None
68625	68626	.	0	None
68626	68627	2-fold	0	None
68627	68628	increase	0	None
68628	68629	in	0	None
68629	68630	the	0	None
68630	68631	nucleus	0	None
68631	68632	number	0	None
68632	68633	(	0	None
68633	68634	proliferation	0	None
68634	68635	)	0	None
68635	68636	during	0	None
68636	68637	4	0	None
68637	68638	h	0	None
68638	68639	of	0	None
68639	68640	culture	0	None
68640	68641	at	0	None
68641	68642	a	0	None
68642	68643	cell	0	None
68643	68644	density	0	None
68644	68645	of	0	None
68645	68646	3	0	None
68646	68647	.	0	None
68647	68648	3	0	None
68648	68649	x	0	None
68649	68650	10	0	None
68650	68651	(	0	None
68651	68652	4	0	None
68652	68653	)	0	None
68653	68654	cells	0	None
68654	68655	/	0	None
68655	68656	cm	0	None
68656	68657	(	0	None
68657	68658	2	0	None
68658	68659	)	0	None
68659	68660	.	0	None

68661	68662	The	0	None
68662	68663	TGF-alpha-induced	0	None
68663	68664	hepatocyte	0	None
68664	68665	DNA	0	None
68665	68666	synthesis	0	None
68666	68667	and	0	None
68667	68668	proliferation	0	None
68668	68669	were	0	None
68669	68670	dose-dependent	0	None
68670	68671	at	0	None
68671	68672	EC	0	None
68672	68673	(	0	None
68673	68674	50	0	None
68674	68675	)	0	None
68675	68676	values	0	None
68676	68677	of	0	None
68677	68678	0	0	None
68678	68679	.	0	None
68679	68680	36	0	None
68680	68681	ng	0	None
68681	68682	/	0	None
68682	68683	ml	0	None
68683	68684	and	0	None
68684	68685	0	0	None
68685	68686	.	0	None
68686	68687	45	0	None
68687	68688	ng	0	None
68688	68689	/	0	None
68689	68690	ml	0	None
68690	68691	,	0	None
68691	68692	respectively	0	None
68692	68693	.	0	None

68694	68695	Hepatocyte	0	None
68695	68696	DNA	0	None
68696	68697	synthesis	0	None
68697	68698	and	0	None
68698	68699	proliferation	0	None
68699	68700	induced	0	None
68700	68701	by	0	None
68701	68702	1	0	None
68702	68703	.	0	None
68703	68704	0	0	None
68704	68705	ng	0	None
68705	68706	/	0	None
68706	68707	ml	0	None
68707	68708	TGF-alpha	0	None
68708	68709	did	0	None
68709	68710	not	0	None
68710	68711	reduce	0	None
68711	68712	even	0	None
68712	68713	at	0	None
68713	68714	higher	0	None
68714	68715	initial	0	None
68715	68716	plating	0	None
68716	68717	densities	0	None
68717	68718	(	0	None
68718	68719	5	0	None
68719	68720	.	0	None
68720	68721	0	0	None
68721	68722	x	0	None
68722	68723	10	0	None
68723	68724	(	0	None
68724	68725	4	0	None
68725	68726	)	0	None
68726	68727	and	0	None
68727	68728	1	0	None
68728	68729	.	0	None
68729	68730	0	0	None
68730	68731	x	0	None
68731	68732	10	0	None
68732	68733	(	0	None
68733	68734	5	0	None
68734	68735	)	0	None
68735	68736	cells	0	None
68736	68737	/	0	None
68737	68738	cm	0	None
68738	68739	(	0	None
68739	68740	2	0	None
68740	68741	)	0	None
68741	68742	)	0	None
68742	68743	.	0	None

68744	68745	Increasing	0	None
68745	68746	concentrations	0	None
68746	68747	of	0	None
68747	68748	the	0	None
68748	68749	beta	0	None
68749	68750	(	0	None
68750	68751	2	0	None
68751	68752	)	0	None
68752	68753	adrenoceptor	0	None
68753	68754	agonist	0	None
68754	68755	metaproterenol	0	None
68755	68756	(	0	None
68756	68757	10	0	None
68757	68758	(	0	None
68758	68759	-7	0	None
68759	68760	)	0	None
68760	68761	-10	0	None
68761	68762	(	0	None
68762	68763	-6	0	None
68763	68764	)	0	None
68764	68765	M	0	None
68765	68766	)	0	None
68766	68767	markedly	0	None
68767	68768	reduced	0	None
68768	68769	the	0	None
68769	68770	proliferative	0	None
68770	68771	effects	0	None
68771	68772	of	0	None
68772	68773	TGF-alpha	0	None
68773	68774	,	0	None
68774	68775	whereas	0	None
68775	68776	those	0	None
68776	68777	of	0	None
68777	68778	the	0	None
68778	68779	alpha	0	None
68779	68780	(	0	None
68780	68781	2	0	None
68781	68782	)	0	None
68782	68783	adrenoceptor	0	None
68783	68784	agonist	0	None
68784	68785	5-bromo-6-	0	None
68785	68786	[	0	None
68786	68787	2-imidazolin-2-yl-amino	0	None
68787	68788	]	0	None
68788	68789	-quinoxaline	0	None
68789	68790	(	0	None
68790	68791	UK-14304;	0	None
68791	68792	10	0	None
68792	68793	(	0	None
68793	68794	-6	0	None
68794	68795	)	0	None
68795	68796	-10	0	None
68796	68797	(	0	None
68797	68798	-5	0	None
68798	68799	)	0	None
68799	68800	M	0	None
68800	68801	)	0	None
68801	68802	and	0	None
68802	68803	the	0	None
68803	68804	alpha	0	None
68804	68805	(	0	None
68805	68806	1	0	None
68806	68807	)	0	None
68807	68808	adrenoceptor	0	None
68808	68809	agonist	0	None
68809	68810	phenylephrine	0	None
68810	68811	(	0	None
68811	68812	10	0	None
68812	68813	(	0	None
68813	68814	-7	0	None
68814	68815	)	0	None
68815	68816	-10	0	None
68816	68817	(	0	None
68817	68818	-6	0	None
68818	68819	)	0	None
68819	68820	M	0	None
68820	68821	)	0	None
68821	68822	significantly	0	None
68822	68823	potentiated	0	None
68823	68824	the	0	None
68824	68825	TGF-alpha	0	None
68825	68826	action	0	None
68826	68827	.	0	None

68828	68829	The	0	None
68829	68830	proliferative	0	None
68830	68831	effects	0	None
68831	68832	of	0	None
68832	68833	TGF-alpha	0	None
68833	68834	(	0	None
68834	68835	1	0	None
68835	68836	.	0	None
68836	68837	0	0	None
68837	68838	ng	0	None
68838	68839	/	0	None
68839	68840	ml	0	None
68840	68841	)	0	None
68841	68842	were	0	None
68842	68843	not	0	None
68843	68844	affected	0	None
68844	68845	significantly	0	None
68845	68846	by	0	None
68846	68847	a	0	None
68847	68848	monoclonal	0	None
68848	68849	antiepidermal	0	None
68849	68852	growth factor receptor	3	GENE-N
68852	68853	antibody	0	None
68853	68854	(	0	None
68854	68855	1-100	0	None
68855	68856	ng	0	None
68856	68857	/	0	None
68857	68858	ml	0	None
68858	68859	)	0	None
68859	68860	and	0	None
68860	68861	were	0	None
68861	68862	almost	0	None
68862	68863	completely	0	None
68863	68864	blocked	0	None
68864	68865	by	0	None
68865	68866	specific	0	None
68866	68867	inhibitors	0	None
68867	68868	of	0	None
68868	68869	signal	0	None
68869	68870	transducers	0	None
68870	68871	such	0	None
68871	68872	as	0	None
68872	68873	genistein	0	None
68873	68874	(	0	None
68874	68875	10	0	None
68875	68876	(	0	None
68876	68877	-5	0	None
68877	68878	)	0	None
68878	68879	M	0	None
68879	68880	)	0	None
68880	68881	,	0	None
68881	68882	1-6	0	None
68882	68883	[	0	None
68883	68884	[	0	None
68884	68885	17beta-3methoxyestra-1	0	None
68885	68886	,	0	None
68886	68887	3	0	None
68887	68888	,	0	None
68888	68889	5	0	None
68889	68890	(	0	None
68890	68891	10	0	None
68891	68892	)	0	None
68892	68893	-trien-17-yl	0	None
68893	68894	]	0	None
68894	68895	amino	0	None
68895	68896	]	0	None
68896	68897	hexyl	0	None
68897	68898	]	0	None
68898	68899	-1H-pyrrol2	0	None
68899	68900	,	0	None
68900	68901	5-dione	0	None
68901	68902	(	0	None
68902	68903	U-73122;	0	None
68903	68904	0	0	None
68904	68905	(	0	None
68905	68906	-5	0	None
68906	68907	)	0	None
68907	68908	M	0	None
68908	68909	)	0	None
68909	68910	,	0	None
68910	68911	wortmannin	0	None
68911	68912	(	0	None
68912	68913	5	0	None
68913	68914	x	0	None
68914	68915	10	0	None
68915	68916	(	0	None
68916	68917	-7	0	None
68917	68918	)	0	None
68918	68919	M	0	None
68919	68920	)	0	None
68920	68921	,	0	None
68921	68922	sphingosine	0	None
68922	68923	(	0	None
68923	68924	5	0	None
68924	68925	x	0	None
68925	68926	10	0	None
68926	68927	(	0	None
68927	68928	-6	0	None
68928	68929	)	0	None
68929	68930	M	0	None
68930	68931	)	0	None
68931	68932	,	0	None
68932	68933	2'-amino-3'-methoxyflavone	0	None
68933	68934	(	0	None
68934	68935	PD98059;	0	None
68935	68936	5	0	None
68936	68937	x	0	None
68937	68938	10	0	None
68938	68939	(	0	None
68939	68940	-5	0	None
68940	68941	)	0	None
68941	68942	M	0	None
68942	68943	)	0	None
68943	68944	,	0	None
68944	68945	and	0	None
68945	68946	rapamycin	3	GENE-N
68946	68947	(	0	None
68947	68948	10	0	None
68948	68949	ng	0	None
68949	68950	/	0	None
68950	68951	ml	0	None
68951	68952	)	0	None
68952	68953	.	0	None

68954	68955	These	0	None
68955	68956	results	0	None
68956	68957	suggest	0	None
68957	68958	that	0	None
68958	68959	among	0	None
68959	68960	the	0	None
68960	68961	elements	0	None
68961	68962	that	0	None
68962	68963	link	0	None
68963	68964	signals	0	None
68964	68965	of	0	None
68965	68966	cell	0	None
68966	68967	surface	0	None
68967	68968	receptor	0	None
68968	68969	to	0	None
68969	68970	the	0	None
68970	68971	nucleus	0	None
68971	68972	,	0	None
68972	68973	the	0	None
68973	68974	proliferative	0	None
68974	68975	action	0	None
68975	68976	of	0	None
68976	68977	TGF-alpha	0	None
68977	68978	is	0	None
68978	68979	mediated	0	None
68979	68980	,	0	None
68980	68981	at	0	None
68981	68982	least	0	None
68982	68983	,	0	None
68983	68984	by	0	None
68984	68985	tyrosine	2	CHEMICAL
68985	68986	kinase	0	None
68986	68987	,	0	None
68987	68988	phospholipase	0	None
68988	68989	C	0	None
68989	68990	,	0	None
68990	68991	phosphatidylinositol	2	CHEMICAL
68991	68992	3-kinase	0	None
68992	68993	,	0	None
68993	68994	protein	0	None
68994	68996	kinase C	0	None
68996	68997	,	0	None
68997	69000	mitogen-activated protein kinase	3	GENE-N
69000	69001	kinase	0	None
69001	69002	,	0	None
69002	69003	and	0	None
69003	69004	ribosomal	0	None
69004	69005	protein	0	None
69005	69006	p70	0	None
69006	69007	S6	0	None
69007	69008	kinase	0	None
69008	69009	.	0	None
69009	69010	Oncolytic	0	None
69010	69011	activity	0	None
69011	69012	and	0	None
69012	69013	mechanism	0	None
69013	69014	of	0	None
69014	69015	action	0	None
69015	69016	of	0	None
69016	69017	a	0	None
69017	69018	novel	0	None
69018	69019	L-cysteine	0	None
69019	69020	derivative	0	None
69020	69021	,	0	None
69021	69022	L-cysteine	0	None
69022	69023	,	0	None
69023	69024	ethyl	2	CHEMICAL
69024	69025	ester	0	None
69025	69026	,	0	None
69026	69027	S-	0	None
69027	69028	(	0	None
69028	69029	N-methylcarbamate	0	None
69029	69030	)	0	None
69030	69031	monohydrochloride	0	None
69031	69032	.	0	None
69032	69033	[	0	None
69033	69034	Acetylsalicylic	0	None
69034	69035	acid	0	None
69035	69036	resistance--clinical	0	None
69036	69037	diagnosis	0	None
69037	69038	with	0	None
69038	69039	unclear	0	None
69039	69040	mechanism	0	None
69040	69041	]	0	None
69041	69042	.	0	None
69042	69043	In	0	None
69043	69044	recent	0	None
69044	69045	years	0	None
69045	69046	the	0	None
69046	69047	use	0	None
69047	69048	of	0	None
69048	69049	the	0	None
69049	69050	opioid	0	None
69050	69051	oxycodone	0	None
69051	69052	has	0	None
69052	69053	increased	0	None
69053	69054	markedly	0	None
69054	69055	and	0	None
69055	69056	replacing	0	None
69056	69057	morphine	0	None
69057	69058	as	0	None
69058	69059	the	0	None
69059	69060	first-line	0	None
69060	69061	choice	0	None
69061	69062	of	0	None
69062	69063	opioid	0	None
69063	69064	in	0	None
69064	69065	several	0	None
69065	69066	countries	0	None
69066	69067	.	0	None

69068	69069	There	0	None
69069	69070	are	0	None
69070	69071	formulations	0	None
69071	69072	for	0	None
69072	69073	oral	0	None
69073	69074	immediate	0	None
69074	69075	,	0	None
69075	69076	oral	0	None
69076	69077	extended	0	None
69077	69078	release	0	None
69078	69079	and	0	None
69079	69080	intravenous	0	None
69080	69081	use	0	None
69081	69082	.	0	None

69083	69084	The	0	None
69084	69085	bioavailability	0	None
69085	69086	is	0	None
69086	69087	higher	0	None
69087	69088	than	0	None
69088	69089	for	0	None
69089	69090	morphine	0	None
69090	69091	and	0	None
69091	69092	less	0	None
69092	69093	variable	0	None
69093	69094	.	0	None

69095	69096	Oxycodone	0	None
69096	69097	is	0	None
69097	69098	primarily	0	None
69098	69099	metabolized	0	None
69099	69100	in	0	None
69100	69101	the	0	None
69101	69102	liver	0	None
69102	69103	by	0	None
69103	69104	the	0	None
69104	69105	cytochrome	3	GENE-N
69105	69106	P450	0	None
69106	69107	(	0	None
69107	69108	CYP	0	None
69108	69109	)	0	None
69109	69110	enzymes	0	None
69110	69111	with	0	None
69111	69112	CYP3A	0	None
69112	69113	as	0	None
69113	69114	the	0	None
69114	69115	major	0	None
69115	69116	metabolic	0	None
69116	69117	pathway	0	None
69117	69118	and	0	None
69118	69119	CYP2D6	0	None
69119	69120	as	0	None
69120	69121	the	0	None
69121	69122	minor	0	None
69122	69123	metabolic	0	None
69123	69124	pathway	0	None
69124	69125	to	0	None
69125	69126	noroxycodone	0	None
69126	69127	,	0	None
69127	69128	oxymorphone	0	None
69128	69129	and	0	None
69129	69130	noroxymorphone	0	None
69130	69131	.	0	None

69132	69133	Oxycodone	0	None
69133	69134	exerts	0	None
69134	69135	its	0	None
69135	69136	analgesic	0	None
69136	69137	effect	0	None
69137	69138	via	0	None
69138	69139	the	0	None
69139	69140	µ-opioid	0	None
69140	69141	receptor	0	None
69141	69142	.	0	None

69143	69144	The	0	None
69144	69145	metabolism	0	None
69145	69146	of	0	None
69146	69147	CYP2D6	0	None
69147	69148	substrates	0	None
69148	69149	varies	0	None
69149	69150	to	0	None
69150	69151	a	0	None
69151	69152	large	0	None
69152	69153	degree	0	None
69153	69154	between	0	None
69154	69155	individuals	0	None
69155	69156	as	0	None
69156	69157	a	0	None
69157	69158	result	0	None
69158	69159	of	0	None
69159	69160	allele	0	None
69160	69161	functionality	0	None
69161	69162	.	0	None

69163	69164	Poor	0	None
69164	69165	metabolizers	0	None
69165	69166	(	0	None
69166	69167	PM	0	None
69167	69168	)	0	None
69168	69169	have	0	None
69169	69170	two	0	None
69170	69171	non-functional	0	None
69171	69172	alleles	0	None
69172	69173	,	0	None
69173	69174	extensive	0	None
69174	69175	metabolizers	0	None
69175	69176	(	0	None
69176	69177	EM	0	None
69177	69178	)	0	None
69178	69179	are	0	None
69179	69180	homozygous	0	None
69180	69181	with	0	None
69181	69182	two	0	None
69182	69183	functional	0	None
69183	69184	alleles	0	None
69184	69185	or	0	None
69185	69186	heterozygous	0	None
69186	69187	with	0	None
69187	69188	one	0	None
69188	69189	functional	0	None
69189	69190	allele	0	None
69190	69191	and	0	None
69191	69192	ultrarapid	0	None
69192	69193	metabolizers	0	None
69193	69194	(	0	None
69194	69195	UM	0	None
69195	69196	)	0	None
69196	69197	have	0	None
69197	69198	more	0	None
69198	69199	than	0	None
69199	69200	two	0	None
69200	69201	functional	0	None
69201	69202	alleles	0	None
69202	69203	.	0	None

69204	69205	There	0	None
69205	69206	are	0	None
69206	69207	pronounced	0	None
69207	69208	interethnic	0	None
69208	69209	differences	0	None
69209	69210	in	0	None
69210	69211	the	0	None
69211	69212	allele	0	None
69212	69213	distribution	0	None
69213	69214	.	0	None

69215	69216	On	0	None
69216	69217	the	0	None
69217	69218	basis	0	None
69218	69219	of	0	None
69219	69220	studies	0	None
69220	69221	performed	0	None
69221	69222	thus	0	None
69222	69223	far	0	None
69223	69224	,	0	None
69224	69225	oxycodone	0	None
69225	69226	concentrations	0	None
69226	69227	in	0	None
69227	69228	comparison	0	None
69228	69229	with	0	None
69229	69230	EM	0	None
69230	69231	are	0	None
69231	69232	similar	0	None
69232	69233	in	0	None
69233	69234	PM	0	None
69234	69235	and	0	None
69235	69236	reduced	0	None
69236	69237	in	0	None
69237	69238	UM	0	None
69238	69239	.	0	None

69240	69241	The	0	None
69241	69242	pharmacokinetics	0	None
69242	69243	in	0	None
69243	69244	UM	0	None
69244	69245	are	0	None
69245	69246	insufficiently	0	None
69246	69247	investigated	0	None
69247	69248	.	0	None

69249	69250	Simultaneous	0	None
69250	69251	inhibition	0	None
69251	69252	of	0	None
69252	69253	both	0	None
69253	69254	CYP3A	0	None
69254	69255	and	0	None
69255	69256	CYP2D6	0	None
69256	69257	results	0	None
69257	69258	in	0	None
69258	69259	increased	0	None
69259	69260	oxycodone	0	None
69260	69261	concentrations	0	None
69261	69262	and	0	None
69262	69263	such	0	None
69263	69264	a	0	None
69264	69265	combination	0	None
69265	69266	should	0	None
69266	69267	be	0	None
69267	69268	avoided	0	None
69268	69269	.	0	None

69270	69271	A	0	None
69271	69272	similar	0	None
69272	69273	effect	0	None
69273	69274	is	0	None
69274	69275	to	0	None
69275	69276	be	0	None
69276	69277	expected	0	None
69277	69278	with	0	None
69278	69279	use	0	None
69279	69280	of	0	None
69280	69281	a	0	None
69281	69282	CYP3A	0	None
69282	69283	inhibitor	0	None
69283	69284	in	0	None
69284	69285	CYP2D6	0	None
69285	69286	PM	0	None
69286	69287	.	0	None

69288	69289	Concomitant	0	None
69289	69290	use	0	None
69290	69291	of	0	None
69291	69292	enzyme	0	None
69292	69293	inducers	0	None
69293	69294	such	0	None
69294	69295	as	0	None
69295	69296	rifampicin	2	CHEMICAL
69296	69297	,	0	None
69297	69298	St	0	None
69298	69299	John's	0	None
69299	69300	wort	0	None
69300	69301	and	0	None
69301	69302	carbamazepine	0	None
69302	69303	should	0	None
69303	69304	be	0	None
69304	69305	avoided	0	None
69305	69306	because	0	None
69306	69307	of	0	None
69307	69308	the	0	None
69308	69309	risk	0	None
69309	69310	of	0	None
69310	69311	subtherapeutic	0	None
69311	69312	concentrations	0	None
69312	69313	of	0	None
69313	69314	oxycodone	0	None
69314	69315	.	0	None

69316	69317	When	0	None
69317	69318	the	0	None
69318	69319	dosage	0	None
69319	69320	of	0	None
69320	69321	morphine	0	None
69321	69322	may	0	None
69322	69323	result	0	None
69323	69324	in	0	None
69324	69325	unpredictable	0	None
69325	69326	bioavailability	0	None
69326	69327	,	0	None
69327	69328	like	0	None
69328	69329	in	0	None
69329	69330	patients	0	None
69330	69331	with	0	None
69331	69332	severe	0	None
69332	69333	hepatic	0	None
69333	69334	cirrhosis	0	None
69334	69335	,	0	None
69335	69336	oxycodone	0	None
69336	69337	might	0	None
69337	69338	be	0	None
69338	69339	beneficial	0	None
69339	69340	because	0	None
69340	69341	it	0	None
69341	69342	has	0	None
69342	69343	higher	0	None
69343	69344	and	0	None
69344	69345	less	0	None
69345	69346	variability	0	None
69346	69347	in	0	None
69347	69348	bioavailability	0	None
69348	69349	between	0	None
69349	69350	patients	0	None
69350	69351	than	0	None
69351	69352	morphine	0	None
69352	69353	.	0	None
69353	69354	5-aminosalicylic	0	None
69354	69355	acid	0	None
69355	69356	(	0	None
69356	69357	5-ASA	2	CHEMICAL
69357	69358	)	0	None
69358	69359	preparations	0	None
69359	69360	(	0	None
69360	69361	eg	0	None
69361	69362	,	0	None
69362	69363	mesalazine	2	CHEMICAL
69363	69364	,	0	None
69364	69365	mesalamine	0	None
69365	69366	)	0	None
69366	69367	are	0	None
69367	69368	well-established	0	None
69368	69369	preparations	0	None
69369	69370	used	0	None
69370	69371	in	0	None
69371	69372	the	0	None
69372	69373	management	0	None
69373	69374	of	0	None
69374	69375	inflammatory	0	None
69375	69376	bowel	0	None
69376	69377	disease	0	None
69377	69378	.	0	None

69379	69380	These	0	None
69380	69381	drugs	0	None
69381	69382	are	0	None
69382	69383	most	0	None
69383	69384	useful	0	None
69384	69385	for	0	None
69385	69386	the	0	None
69386	69387	treatment	0	None
69387	69388	of	0	None
69388	69389	mild	0	None
69389	69390	to	0	None
69390	69391	moderate	0	None
69391	69392	flares	0	None
69392	69393	of	0	None
69393	69394	ulcerative	0	None
69394	69395	colitis	0	None
69395	69396	and	0	None
69396	69397	,	0	None
69397	69398	especially	0	None
69398	69399	,	0	None
69399	69400	for	0	None
69400	69401	maintenance	0	None
69401	69402	of	0	None
69402	69403	remission	0	None
69403	69404	.	0	None

69405	69406	Although	0	None
69406	69407	most	0	None
69407	69408	gastroenterologists	0	None
69408	69409	are	0	None
69409	69410	very	0	None
69410	69411	familiar	0	None
69411	69412	with	0	None
69412	69413	these	0	None
69413	69414	drugs	0	None
69414	69415	,	0	None
69415	69416	the	0	None
69416	69417	interest	0	None
69417	69418	in	0	None
69418	69419	these	0	None
69419	69420	drugs	0	None
69420	69421	has	0	None
69421	69422	undergone	0	None
69422	69423	a	0	None
69423	69424	resurgence	0	None
69424	69425	,	0	None
69425	69426	with	0	None
69426	69427	new	0	None
69427	69428	preparations	0	None
69428	69429	offering	0	None
69429	69430	convenience	0	None
69430	69431	and	0	None
69431	69432	high	0	None
69432	69433	dosage	0	None
69433	69434	,	0	None
69434	69435	while	0	None
69435	69436	preserving	0	None
69436	69437	their	0	None
69437	69438	customary	0	None
69438	69439	safety	0	None
69439	69440	.	0	None

69441	69442	New	0	None
69442	69443	dosage	0	None
69443	69444	regimens	0	None
69444	69445	are	0	None
69445	69446	likely	0	None
69446	69447	to	0	None
69447	69448	become	0	None
69448	69449	standard	0	None
69449	69450	practice	0	None
69450	69451	in	0	None
69451	69452	the	0	None
69452	69453	near	0	None
69453	69454	future	0	None
69454	69455	.	0	None

69456	69457	There	0	None
69457	69458	is	0	None
69458	69459	also	0	None
69459	69460	considerable	0	None
69460	69461	interest	0	None
69461	69462	in	0	None
69462	69463	chemoprevention	0	None
69463	69464	of	0	None
69464	69465	colorectal	0	None
69465	69466	cancer	0	None
69466	69467	in	0	None
69467	69468	the	0	None
69468	69469	context	0	None
69469	69470	of	0	None
69470	69471	inflammatory	0	None
69471	69472	bowel	0	None
69472	69473	disease	0	None
69473	69474	,	0	None
69474	69475	and	0	None
69475	69476	the	0	None
69476	69477	role	0	None
69477	69478	of	0	None
69478	69479	long-term	0	None
69479	69480	maintenance	0	None
69480	69481	therapy	0	None
69481	69482	with	0	None
69482	69483	5-ASAs	0	None
69483	69484	in	0	None
69484	69485	achieving	0	None
69485	69486	such	0	None
69486	69487	chemoprevention	0	None
69487	69488	.	0	None

69489	69490	A	0	None
69490	69491	mechanism	0	None
69491	69492	of	0	None
69492	69493	action	0	None
69493	69494	for	0	None
69494	69495	such	0	None
69495	69496	chemoprevention	0	None
69496	69497	has	0	None
69497	69498	been	0	None
69498	69499	provided	0	None
69499	69500	by	0	None
69500	69501	the	0	None
69501	69502	agonism	0	None
69502	69503	of	0	None
69503	69504	the	0	None
69504	69505	peroxisome	0	None
69505	69506	proliferator-activated	0	None
69506	69507	receptor-gamma	0	None
69507	69508	by	0	None
69508	69509	5-ASA	2	CHEMICAL
69509	69510	,	0	None
69510	69511	which	0	None
69511	69512	unifies	0	None
69512	69513	its	0	None
69513	69514	efficacy	0	None
69514	69515	as	0	None
69515	69516	an	0	None
69516	69517	anti-inflammatory	0	None
69517	69518	and	0	None
69518	69519	chemopreventive	0	None
69519	69520	agent	0	None
69520	69521	.	0	None

69522	69523	In	0	None
69523	69524	the	0	None
69524	69525	future	0	None
69525	69526	,	0	None
69526	69527	even	0	None
69527	69528	more	0	None
69528	69529	effective	0	None
69529	69530	agents	0	None
69530	69531	based	0	None
69531	69532	on	0	None
69532	69533	5-ASA	2	CHEMICAL
69533	69534	are	0	None
69534	69535	expected	0	None
69535	69536	,	0	None
69536	69537	based	0	None
69537	69538	on	0	None
69538	69539	more	0	None
69539	69540	powerful	0	None
69540	69541	agonism	0	None
69541	69542	of	0	None
69542	69543	peroxisome	0	None
69543	69544	proliferator-activated	0	None
69544	69545	receptor-gamma;	0	None
69545	69546	5-ASA	2	CHEMICAL
69546	69547	preparations	0	None
69547	69548	have	0	None
69548	69549	become	0	None
69549	69550	'trendy'	0	None
69550	69551	again	0	None
69551	69552	.	0	None
69552	69553	Interleukin	0	None
69553	69554	2	0	None
69554	69555	toxin	0	None
69555	69556	:	0	None
69556	69557	a	0	None
69557	69558	step	0	None
69558	69559	toward	0	None
69559	69560	selective	0	None
69560	69561	immunomodulation	0	None
69561	69562	.	0	None
69562	69563	Hepatic	0	None
69563	69564	very-low-density	0	None
69564	69565	lipoprotein	3	GENE-N
69565	69566	and	0	None
69566	69567	apolipoprotein	0	None
69567	69568	B	0	None
69568	69569	production	0	None
69569	69570	are	0	None
69570	69571	increased	0	None
69571	69572	following	0	None
69572	69573	in	0	None
69573	69574	vivo	0	None
69574	69575	induction	0	None
69575	69576	of	0	None
69576	69577	betaine-homocysteine	0	None
69577	69578	S-methyltransferase	0	None
69578	69579	.	0	None
69579	69580	Versatile	0	None
69580	69581	conjugation	0	None
69581	69582	of	0	None
69582	69583	octreotide	0	None
69583	69584	to	0	None
69584	69585	dendrimers	0	None
69585	69586	by	0	None
69586	69587	cycloaddition	0	None
69587	69588	(	0	None
69588	69589	"click"	0	None
69589	69590	)	0	None
69590	69591	chemistry	0	None
69591	69592	to	0	None
69592	69593	yield	0	None
69593	69594	high-affinity	0	None
69594	69595	multivalent	0	None
69595	69596	cyclic	0	None
69596	69597	Peptide	0	None
69597	69598	dendrimers	0	None
69598	69599	.	0	None
69599	69600	The	0	None
69600	69601	feasibility	0	None
69601	69602	of	0	None
69602	69603	administering	0	None
69603	69604	a	0	None
69604	69605	relatively	0	None
69605	69606	high	0	None
69606	69607	dose	0	None
69607	69608	of	0	None
69608	69609	the	0	None
69609	69610	gonadotrophin-releasing	0	None
69610	69611	hormone	0	None
69611	69612	(	0	None
69612	69613	GnRH	0	None
69613	69614	)	0	None
69614	69615	antagonist	0	None
69615	69616	ganirelix	0	None
69616	69617	by	0	None
69617	69618	means	0	None
69618	69619	of	0	None
69619	69620	a	0	None
69620	69621	needle-free	0	None
69621	69622	injection	0	None
69622	69623	device	0	None
69623	69624	,	0	None
69624	69625	which	0	None
69625	69626	could	0	None
69626	69627	be	0	None
69627	69628	useful	0	None
69628	69629	in	0	None
69629	69630	the	0	None
69630	69631	long-term	0	None
69631	69632	treatment	0	None
69632	69633	of	0	None
69633	69634	sex-steroid-dependent	0	None
69634	69635	disorders	0	None
69635	69636	,	0	None
69636	69637	was	0	None
69637	69638	evaluated	0	None
69638	69639	in	0	None
69639	69640	a	0	None
69640	69641	randomized	0	None
69641	69642	,	0	None
69642	69643	crossover	0	None
69643	69644	study	0	None
69644	69645	in	0	None
69645	69646	16	0	None
69646	69647	healthy	0	None
69647	69648	females	0	None
69648	69649	.	0	None

69650	69651	Local	0	None
69651	69652	tolerance	0	None
69652	69653	and	0	None
69653	69654	pharmacokinetics	0	None
69654	69655	of	0	None
69655	69656	ganirelix	0	None
69656	69657	administered	0	None
69657	69658	by	0	None
69658	69659	MediJector	0	None
69659	69660	versus	0	None
69660	69661	conventional	0	None
69661	69662	needle	0	None
69662	69663	injections	0	None
69663	69664	were	0	None
69664	69665	compared	0	None
69665	69666	.	0	None

69667	69668	Additionally	0	None
69668	69669	,	0	None
69669	69670	the	0	None
69670	69671	pharmacodynamic	0	None
69671	69672	effect	0	None
69672	69673	was	0	None
69673	69674	evaluated	0	None
69674	69675	.	0	None

69676	69677	Two	0	None
69677	69678	milligrams	0	None
69678	69679	of	0	None
69679	69680	ganirelix	0	None
69680	69681	was	0	None
69681	69682	administered	0	None
69682	69683	s	0	None
69683	69684	.	0	None

69685	69686	c	0	None
69686	69687	.	0	None

69688	69689	once	0	None
69689	69690	daily	0	None
69690	69691	for	0	None
69691	69692	7	0	None
69692	69693	days	0	None
69693	69694	by	0	None
69694	69695	Medi-Jector	0	None
69695	69696	or	0	None
69696	69697	conventional	0	None
69697	69698	needle	0	None
69698	69699	in	0	None
69699	69700	a	0	None
69700	69701	randomized	0	None
69701	69702	sequence	0	None
69702	69703	,	0	None
69703	69704	without	0	None
69704	69705	a	0	None
69705	69706	washout	0	None
69706	69707	period	0	None
69707	69708	.	0	None

69709	69710	No	0	None
69710	69711	apparent	0	None
69711	69712	differences	0	None
69712	69713	in	0	None
69713	69714	local	0	None
69714	69715	tolerance	0	None
69715	69716	were	0	None
69716	69717	observed	0	None
69717	69718	.	0	None

69719	69720	Most	0	None
69720	69721	injections	0	None
69721	69722	(	0	None
69722	69723	87	0	None
69723	69724	.	0	None
69724	69725	5%	0	None
69725	69726	)	0	None
69726	69727	gave	0	None
69727	69728	either	0	None
69728	69729	no	0	None
69729	69730	or	0	None
69730	69731	only	0	None
69731	69732	a	0	None
69732	69733	mild	0	None
69733	69734	reaction	0	None
69734	69735	.	0	None

69736	69737	Of	0	None
69737	69738	the	0	None
69738	69739	moderate	0	None
69739	69740	reactions	0	None
69740	69741	,	0	None
69741	69742	swelling	0	None
69742	69743	and	0	None
69743	69744	redness	0	None
69744	69745	were	0	None
69745	69746	reported	0	None
69746	69747	most	0	None
69747	69748	frequently	0	None
69748	69749	(	0	None
69749	69750	overall	0	None
69750	69751	4	0	None
69751	69752	.	0	None
69752	69753	9	0	None
69753	69754	and	0	None
69754	69755	8	0	None
69755	69756	.	0	None
69756	69757	5%	0	None
69757	69758	per	0	None
69758	69759	injection	0	None
69759	69760	,	0	None
69760	69761	respectively	0	None
69761	69762	)	0	None
69762	69763	.	0	None

69764	69765	Administration	0	None
69765	69766	by	0	None
69766	69767	Medi-Jector	0	None
69767	69768	was	0	None
69768	69769	bioequivalent	0	None
69769	69770	to	0	None
69770	69771	conventional	0	None
69771	69772	needle	0	None
69772	69773	injection	0	None
69773	69774	with	0	None
69774	69775	respect	0	None
69775	69776	to	0	None
69776	69777	the	0	None
69777	69778	peak	0	None
69778	69779	concentration	0	None
69779	69780	and	0	None
69780	69781	area	0	None
69781	69782	under	0	None
69782	69783	the	0	None
69783	69784	curve	0	None
69784	69785	.	0	None

69786	69787	A	0	None
69787	69788	profound	0	None
69788	69789	suppression	0	None
69789	69790	of	0	None
69790	69791	luteinizing	0	None
69791	69792	hormone	0	None
69792	69793	and	0	None
69793	69794	follicle	0	None
69794	69795	stimulating	0	None
69795	69796	hormone	0	None
69796	69797	was	0	None
69797	69798	observed	0	None
69798	69799	.	0	None

69800	69801	Serum	0	None
69801	69802	oestradiol	0	None
69802	69803	and	0	None
69803	69804	progesterone	2	CHEMICAL
69804	69805	concentrations	0	None
69805	69806	were	0	None
69806	69807	relatively	0	None
69807	69808	low	0	None
69808	69809	prior	0	None
69809	69810	to	0	None
69810	69811	treatment	0	None
69811	69812	and	0	None
69812	69813	remained	0	None
69813	69814	low	0	None
69814	69815	during	0	None
69815	69816	the	0	None
69816	69817	entire	0	None
69817	69818	study	0	None
69818	69819	period	0	None
69819	69820	.	0	None

69821	69822	In	0	None
69822	69823	conclusion	0	None
69823	69824	,	0	None
69824	69825	administration	0	None
69825	69826	of	0	None
69826	69827	a	0	None
69827	69828	relatively	0	None
69828	69829	high	0	None
69829	69830	dose	0	None
69830	69831	of	0	None
69831	69832	ganirelix	0	None
69832	69833	by	0	None
69833	69834	Medi-Jector	0	None
69834	69835	might	0	None
69835	69836	be	0	None
69836	69837	useful	0	None
69837	69838	for	0	None
69838	69839	long-term	0	None
69839	69840	treatment	0	None
69840	69841	of	0	None
69841	69842	sex-steroid	0	None
69842	69843	dependent	0	None
69843	69844	disorders	0	None
69844	69845	.	0	None
69845	69846	In	0	None
69846	69847	order	0	None
69847	69848	for	0	None
69848	69849	a	0	None
69849	69850	protein	0	None
69850	69851	to	0	None
69851	69852	elicit	0	None
69852	69853	a	0	None
69853	69854	systemic	0	None
69854	69855	allergic	0	None
69855	69856	response	0	None
69856	69857	it	0	None
69857	69858	must	0	None
69858	69859	reach	0	None
69859	69860	the	0	None
69860	69861	circulatory	0	None
69861	69862	system	0	None
69862	69863	through	0	None
69863	69864	the	0	None
69864	69865	intestinal	0	None
69865	69866	mucosa	0	None
69866	69867	as	0	None
69867	69868	a	0	None
69868	69869	sufficiently	0	None
69869	69870	large	0	None
69870	69871	fragment	0	None
69871	69872	with	0	None
69872	69873	adequate	0	None
69873	69874	structural	0	None
69874	69875	integrity	0	None
69875	69876	.	0	None

69877	69878	Sunflower	0	None
69878	69879	LTP	1	GENE-Y
69879	69880	and	0	None
69880	69881	2S	0	None
69881	69882	albumins	0	None
69882	69883	(	0	None
69883	69884	SFA8	0	None
69884	69885	and	0	None
69885	69886	three	0	None
69886	69887	mixed	0	None
69887	69888	fractions	0	None
69888	69889	of	0	None
69889	69890	Alb1	0	None
69890	69891	and	0	None
69891	69892	Alb2	0	None
69892	69893	)	0	None
69893	69894	were	0	None
69894	69895	digested	0	None
69895	69896	in	0	None
69896	69897	simulated	0	None
69897	69898	gastric	0	None
69898	69899	fluid	0	None
69899	69900	(	0	None
69900	69901	SGF	0	None
69901	69902	)	0	None
69902	69903	for	0	None
69903	69904	2h	0	None
69904	69905	and	0	None
69905	69906	the	0	None
69906	69907	conditions	0	None
69907	69908	were	0	None
69908	69909	then	0	None
69909	69910	changed	0	None
69910	69911	to	0	None
69911	69912	mimic	0	None
69912	69913	the	0	None
69913	69914	intestinal	0	None
69914	69915	environment	0	None
69915	69916	for	0	None
69916	69917	a	0	None
69917	69918	further	0	None
69918	69919	2h	0	None
69919	69920	digestion	0	None
69920	69921	.	0	None

69922	69923	The	0	None
69923	69924	effects	0	None
69924	69925	of	0	None
69925	69926	phosphatidylcholine	0	None
69926	69927	(	0	None
69927	69928	PC	1	GENE-Y
69928	69929	)	0	None
69929	69930	and	0	None
69930	69931	emulsification	0	None
69931	69932	on	0	None
69932	69933	the	0	None
69933	69934	digestibility	0	None
69934	69935	of	0	None
69935	69936	the	0	None
69936	69937	proteins	0	None
69937	69938	were	0	None
69938	69939	investigated	0	None
69939	69940	.	0	None

69941	69942	PC	1	GENE-Y
69942	69943	protected	0	None
69943	69944	all	0	None
69944	69945	of	0	None
69945	69946	the	0	None
69946	69947	proteins	0	None
69947	69948	studied	0	None
69948	69949	against	0	None
69949	69950	both	0	None
69950	69951	gastric	0	None
69951	69952	and	0	None
69952	69953	intestinal	0	None
69953	69954	digestive	0	None
69954	69955	enzymes	0	None
69955	69956	but	0	None
69956	69957	to	0	None
69957	69958	different	0	None
69958	69959	extents	0	None
69959	69960	.	0	None

69961	69962	Emulsification	0	None
69962	69963	of	0	None
69963	69964	SFA8	0	None
69964	69965	resulted	0	None
69965	69966	in	0	None
69966	69967	strong	0	None
69967	69968	protection	0	None
69968	69969	against	0	None
69969	69970	digestion	0	None
69970	69971	,	0	None
69971	69972	which	0	None
69972	69973	was	0	None
69973	69974	further	0	None
69974	69975	enhanced	0	None
69975	69976	by	0	None
69976	69977	the	0	None
69977	69978	presence	0	None
69978	69979	of	0	None
69979	69980	PC	1	GENE-Y
69980	69981	in	0	None
69981	69982	the	0	None
69982	69983	SGF	0	None
69983	69984	.	0	None

69985	69986	These	0	None
69986	69987	results	0	None
69987	69988	highlight	0	None
69988	69989	the	0	None
69989	69990	importance	0	None
69990	69991	of	0	None
69991	69992	considering	0	None
69992	69993	real	0	None
69993	69994	food	0	None
69994	69995	structures	0	None
69995	69996	such	0	None
69996	69997	as	0	None
69997	69998	emulsified	0	None
69998	69999	systems	0	None
69999	70000	and	0	None
70000	70001	also	0	None
70001	70002	the	0	None
70002	70003	gastrointestinal	0	None
70003	70004	environment	0	None
70004	70005	that	0	None
70005	70006	proteins	0	None
70006	70007	are	0	None
70007	70008	exposed	0	None
70008	70009	to	0	None
70009	70010	once	0	None
70010	70011	consumed	0	None
70011	70012	when	0	None
70012	70013	assessing	0	None
70013	70014	allergenicity	0	None
70014	70015	.	0	None
70015	70016	Fluorescent	0	None
70016	70017	sensing	0	None
70017	70018	layer	0	None
70018	70019	for	0	None
70019	70020	the	0	None
70020	70021	determination	0	None
70021	70022	of	0	None
70022	70023	L-malic	0	None
70023	70024	acid	0	None
70024	70025	in	0	None
70025	70026	wine	0	None
70026	70027	.	0	None
70027	70028	Over	0	None
70028	70029	expression	0	None
70029	70030	of	0	None
70030	70031	lipoxygenase	0	None
70031	70032	(	0	None
70032	70033	LOX	0	None
70033	70034	)	0	None
70034	70035	and	0	None
70035	70036	urease	3	GENE-N
70036	70037	has	0	None
70037	70038	already	0	None
70038	70039	contributed	0	None
70039	70040	to	0	None
70040	70041	the	0	None
70041	70042	pathology	0	None
70042	70043	of	0	None
70043	70044	different	0	None
70044	70045	human	0	None
70045	70046	disease	0	None
70046	70047	.	0	None

70048	70049	Targeting	0	None
70049	70050	the	0	None
70050	70051	inhibition	0	None
70051	70052	of	0	None
70052	70053	these	0	None
70053	70054	enzymes	0	None
70054	70055	has	0	None
70055	70056	proved	0	None
70056	70057	great	0	None
70057	70058	clinical	0	None
70058	70059	utility	0	None
70059	70060	.	0	None

70061	70062	The	0	None
70062	70063	aim	0	None
70063	70064	of	0	None
70064	70065	the	0	None
70065	70066	present	0	None
70066	70067	study	0	None
70067	70068	was	0	None
70068	70069	to	0	None
70069	70070	scrutinised	0	None
70070	70071	the	0	None
70071	70072	inhibitory	0	None
70072	70073	profile	0	None
70073	70074	of	0	None
70074	70075	the	0	None
70075	70076	aerial	0	None
70076	70077	parts	0	None
70077	70078	of	0	None
70078	70079	the	0	None
70079	70080	Polygonatum	0	None
70080	70081	verticillatum	0	None
70081	70082	enzyme	0	None
70082	70083	against	0	None
70083	70084	LOX	0	None
70084	70085	,	0	None
70085	70086	urease	3	GENE-N
70086	70087	,	0	None
70087	70088	acetylcholinesterase	0	None
70088	70089	(	0	None
70089	70090	AChE	1	GENE-Y
70090	70091	)	0	None
70091	70092	and	0	None
70092	70093	butyrylcholinesterase	0	None
70093	70094	(	0	None
70094	70095	BChE	0	None
70095	70096	)	0	None
70096	70097	using	0	None
70097	70098	standard	0	None
70098	70099	experimental	0	None
70099	70100	protocols	0	None
70100	70101	.	0	None

70102	70103	When	0	None
70103	70104	checked	0	None
70104	70105	against	0	None
70105	70106	lipoxygenase	0	None
70106	70107	,	0	None
70107	70108	the	0	None
70108	70109	extracts	0	None
70109	70110	revealed	0	None
70110	70111	significant	0	None
70111	70112	attenuation	0	None
70112	70113	.	0	None

70114	70115	Of	0	None
70115	70116	the	0	None
70116	70117	tested	0	None
70117	70118	extracts	0	None
70118	70119	,	0	None
70119	70120	the	0	None
70120	70121	ethyl	2	CHEMICAL
70121	70122	acetate	0	None
70122	70123	fraction	0	None
70123	70124	was	0	None
70124	70125	the	0	None
70125	70126	most	0	None
70126	70127	potent	0	None
70127	70128	(	0	None
70128	70129	half-maximal	0	None
70129	70130	inhibitory	0	None
70130	70131	concentration	0	None
70131	70132	(	0	None
70132	70133	IC50	0	None
70133	70134	)	0	None
70134	70135	:	0	None
70135	70136	97	0	None
70136	70137	µg	0	None
70137	70138	/	0	None
70138	70139	mL	0	None
70139	70140	)	0	None
70140	70141	followed	0	None
70141	70142	by	0	None
70142	70143	aqueous	0	None
70143	70144	fraction	0	None
70144	70145	IC50	0	None
70145	70146	:	0	None
70146	70147	109	0	None
70147	70148	µg	0	None
70148	70149	/	0	None
70149	70150	mL	0	None
70150	70151	)	0	None
70151	70152	.	0	None

70153	70154	Regarding	0	None
70154	70155	urease	3	GENE-N
70155	70156	inhibition	0	None
70156	70157	,	0	None
70157	70158	n-butanol	0	None
70158	70159	was	0	None
70159	70160	the	0	None
70160	70161	most	0	None
70161	70162	potent	0	None
70162	70163	fraction	0	None
70163	70164	(	0	None
70164	70165	IC50	0	None
70165	70166	:	0	None
70166	70167	97	0	None
70167	70168	µg	0	None
70168	70169	/	0	None
70169	70170	mL	0	None
70170	70171	)	0	None
70171	70172	.	0	None

70173	70174	However	0	None
70174	70175	,	0	None
70175	70176	the	0	None
70176	70177	extracts	0	None
70177	70178	did	0	None
70178	70179	not	0	None
70179	70180	show	0	None
70180	70181	significant	0	None
70181	70182	inhibition	0	None
70182	70183	on	0	None
70183	70184	AChE	1	GENE-Y
70184	70185	and	0	None
70185	70186	BChE	0	None
70186	70187	.	0	None

70188	70189	In	0	None
70189	70190	the	0	None
70190	70191	preliminary	0	None
70191	70192	phytochemical	0	None
70192	70193	tests	0	None
70193	70194	,	0	None
70194	70195	the	0	None
70195	70196	aerial	0	None
70196	70197	parts	0	None
70197	70198	of	0	None
70198	70199	the	0	None
70199	70200	plant	0	None
70200	70201	showed	0	None
70201	70202	the	0	None
70202	70203	presence	0	None
70203	70204	of	0	None
70204	70205	saponins	0	None
70205	70206	,	0	None
70206	70207	alkaloids	0	None
70207	70208	,	0	None
70208	70209	flavonoids	0	None
70209	70210	,	0	None
70210	70211	phenols	0	None
70211	70212	,	0	None
70212	70213	tannins	0	None
70213	70214	and	0	None
70214	70215	terpenoids	0	None
70215	70216	.	0	None

70217	70218	The	0	None
70218	70219	current	0	None
70219	70220	findings	0	None
70220	70221	could	0	None
70221	70222	be	0	None
70222	70223	attributed	0	None
70223	70224	to	0	None
70224	70225	these	0	None
70225	70226	groups	0	None
70226	70227	of	0	None
70227	70228	compounds	0	None
70228	70229	.	0	None
70229	70230	Serotonin	0	None
70230	70231	1A	0	None
70231	70232	receptor	0	None
70232	70233	(	0	None
70233	70234	5-HT	0	None
70234	70235	(	0	None
70235	70236	1A	0	None
70236	70237	)	0	None
70237	70238	R	0	None
70238	70239	)	0	None
70239	70240	agonists	0	None
70240	70241	have	0	None
70241	70242	emerged	0	None
70242	70243	as	0	None
70243	70244	valuable	0	None
70244	70245	supplements	0	None
70245	70246	to	0	None
70246	70247	l-DOPA	0	None
70247	70248	therapy	0	None
70248	70249	,	0	None
70249	70250	demonstrating	0	None
70250	70251	that	0	None
70251	70252	they	0	None
70252	70253	can	0	None
70253	70254	decrease	0	None
70254	70255	side	0	None
70255	70256	effects	0	None
70256	70257	and	0	None
70257	70258	enhance	0	None
70258	70259	motor	0	None
70259	70260	function	0	None
70260	70261	in	0	None
70261	70262	animal	0	None
70262	70263	models	0	None
70263	70264	of	0	None
70264	70265	Parkinson's	0	None
70265	70266	disease	0	None
70266	70267	(	0	None
70267	70268	PD	0	None
70268	70269	)	0	None
70269	70270	and	0	None
70270	70271	human	0	None
70271	70272	PD	0	None
70272	70273	patients	0	None
70273	70274	.	0	None

70275	70276	The	0	None
70276	70277	precise	0	None
70277	70278	mechanism	0	None
70278	70279	by	0	None
70279	70280	which	0	None
70280	70281	these	0	None
70281	70282	receptors	0	None
70282	70283	act	0	None
70283	70284	remains	0	None
70284	70285	unknown	0	None
70285	70286	and	0	None
70286	70287	there	0	None
70287	70288	is	0	None
70288	70289	limited	0	None
70289	70290	information	0	None
70290	70291	on	0	None
70291	70292	how	0	None
70292	70293	5-HT	0	None
70293	70294	(	0	None
70294	70295	1A	0	None
70295	70296	)	0	None
70296	70297	R	0	None
70297	70298	stimulation	0	None
70298	70299	impacts	0	None
70299	70300	striatal	0	None
70300	70301	dopamine	0	None
70301	70302	(	0	None
70302	70303	DA	0	None
70303	70304	)	0	None
70304	70305	D1	1	GENE-Y
70305	70306	receptor	0	None
70306	70307	(	0	None
70307	70308	D1R	0	None
70308	70309	)	0	None
70309	70310	and	0	None
70310	70311	D2	0	None
70311	70312	receptor	0	None
70312	70313	(	0	None
70313	70314	D2R	0	None
70314	70315	)	0	None
70315	70316	function	0	None
70316	70317	.	0	None

70318	70319	The	0	None
70319	70320	current	0	None
70320	70321	study	0	None
70321	70322	examined	0	None
70322	70323	the	0	None
70323	70324	effects	0	None
70324	70325	of	0	None
70325	70326	5-HT	0	None
70326	70327	(	0	None
70327	70328	1A	0	None
70328	70329	)	0	None
70329	70330	R	0	None
70330	70331	stimulation	0	None
70331	70332	on	0	None
70332	70333	DA	0	None
70333	70334	receptor-mediated	0	None
70334	70335	behaviors	0	None
70335	70336	.	0	None

70337	70338	Male	0	None
70338	70339	Sprague-Dawley	0	None
70339	70340	rats	0	None
70340	70341	were	0	None
70341	70342	rendered	0	None
70342	70343	hemiparkinsonian	0	None
70343	70344	by	0	None
70344	70345	unilateral	0	None
70345	70346	6-OHDA	0	None
70346	70347	lesions	0	None
70347	70348	and	0	None
70348	70349	primed	0	None
70349	70350	with	0	None
70350	70351	the	0	None
70351	70352	D1R	0	None
70352	70353	agonist	0	None
70353	70354	SKF81297	0	None
70354	70355	(	0	None
70355	70356	0	0	None
70356	70357	.	0	None
70357	70358	8	0	None
70358	70359	mg	2	CHEMICAL
70359	70360	/	0	None
70360	70361	kg	0	None
70361	70362	,	0	None
70362	70363	i	0	None
70363	70364	.	0	None

70365	70366	p	0	None
70366	70367	.	0	None

70368	70369	)	0	None
70369	70370	in	0	None
70370	70371	order	0	None
70371	70372	to	0	None
70372	70373	sensitize	0	None
70373	70374	DA	0	None
70374	70375	receptors	0	None
70375	70376	.	0	None

70377	70378	Using	0	None
70378	70379	a	0	None
70379	70380	randomized	0	None
70380	70381	within	0	None
70381	70382	subjects	0	None
70382	70383	design	0	None
70383	70384	,	0	None
70384	70385	rats	0	None
70385	70386	received	0	None
70386	70387	a	0	None
70387	70388	first	0	None
70388	70389	injection	0	None
70389	70390	of	0	None
70390	70391	:	0	None
70391	70392	Vehicle	0	None
70392	70393	(	0	None
70393	70394	dH	0	None
70394	70395	(	0	None
70395	70396	2	0	None
70396	70397	)	0	None
70397	70398	O	0	None
70398	70399	)	0	None
70399	70400	or	0	None
70400	70401	the	0	None
70401	70402	5-HT	0	None
70402	70403	(	0	None
70403	70404	1A	0	None
70404	70405	)	0	None
70405	70406	R	0	None
70406	70407	agonist	0	None
70407	70408	+	0	None
70408	70409	/	0	None
70409	70410	-8-OH-DPAT	0	None
70410	70411	(	0	None
70411	70412	0	0	None
70412	70413	.	0	None
70413	70414	1	0	None
70414	70415	or	0	None
70415	70416	1	0	None
70416	70417	.	0	None
70417	70418	0	0	None
70418	70419	mg	2	CHEMICAL
70419	70420	/	0	None
70420	70421	kg	0	None
70421	70422	,	0	None
70422	70423	i	0	None
70423	70424	.	0	None

70425	70426	p	0	None
70426	70427	.	0	None

70428	70429	)	0	None
70429	70430	,	0	None
70430	70431	followed	0	None
70431	70432	by	0	None
70432	70433	a	0	None
70433	70434	second	0	None
70434	70435	injection	0	None
70435	70436	of	0	None
70436	70437	:	0	None
70437	70438	Vehicle	0	None
70438	70439	(	0	None
70439	70440	dimethyl	0	None
70440	70441	sulfoxide	0	None
70441	70442	)	0	None
70442	70443	,	0	None
70443	70444	the	0	None
70444	70445	D1R	0	None
70445	70446	agonist	0	None
70446	70447	SKF81297	0	None
70447	70448	(	0	None
70448	70449	0	0	None
70449	70450	.	0	None
70450	70451	8	0	None
70451	70452	mg	2	CHEMICAL
70452	70453	/	0	None
70453	70454	kg	0	None
70454	70455	,	0	None
70455	70456	i	0	None
70456	70457	.	0	None

70458	70459	p	0	None
70459	70460	.	0	None

70461	70462	)	0	None
70462	70463	,	0	None
70463	70464	the	0	None
70464	70465	D2R	0	None
70465	70466	agonist	0	None
70466	70467	quinpirole	0	None
70467	70468	(	0	None
70468	70469	0	0	None
70469	70470	.	0	None
70470	70471	2	0	None
70471	70472	mg	2	CHEMICAL
70472	70473	/	0	None
70473	70474	kg	0	None
70474	70475	,	0	None
70475	70476	i	0	None
70476	70477	.	0	None

70478	70479	p	0	None
70479	70480	.	0	None

70481	70482	)	0	None
70482	70483	,	0	None
70483	70484	or	0	None
70484	70485	l-DOPA	0	None
70485	70486	(	0	None
70486	70487	12	0	None
70487	70488	mg	2	CHEMICAL
70488	70489	/	0	None
70489	70490	kg	0	None
70490	70491	+	0	None
70491	70492	benserazide	0	None
70492	70493	,	0	None
70493	70494	15	0	None
70494	70495	mg	2	CHEMICAL
70495	70496	/	0	None
70496	70497	kg	0	None
70497	70498	,	0	None
70498	70499	i	0	None
70499	70500	.	0	None

70501	70502	p	0	None
70502	70503	.	0	None

70504	70505	)	0	None
70505	70506	.	0	None

70507	70508	On	0	None
70508	70509	test	0	None
70509	70510	days	0	None
70510	70511	,	0	None
70511	70512	rats	0	None
70512	70513	were	0	None
70513	70514	monitored	0	None
70514	70515	over	0	None
70515	70516	a	0	None
70516	70517	2-h	0	None
70517	70518	period	0	None
70518	70519	immediately	0	None
70519	70520	following	0	None
70520	70521	the	0	None
70521	70522	second	0	None
70522	70523	injection	0	None
70523	70524	for	0	None
70524	70525	abnormal	0	None
70525	70526	involuntary	0	None
70526	70527	movements	0	None
70527	70528	(	0	None
70528	70529	AIMs	0	None
70529	70530	)	0	None
70530	70531	,	0	None
70531	70532	analogous	0	None
70532	70533	to	0	None
70533	70534	dyskinesia	0	None
70534	70535	observed	0	None
70535	70536	in	0	None
70536	70537	PD	0	None
70537	70538	patients	0	None
70538	70539	,	0	None
70539	70540	and	0	None
70540	70541	contralateral	0	None
70541	70542	rotations	0	None
70542	70543	.	0	None

70544	70545	The	0	None
70545	70546	present	0	None
70546	70547	findings	0	None
70547	70548	indicate	0	None
70548	70549	that	0	None
70549	70550	5-HT	0	None
70550	70551	(	0	None
70551	70552	1A	0	None
70552	70553	)	0	None
70553	70554	R	0	None
70554	70555	stimulation	0	None
70555	70556	reduces	0	None
70556	70557	AIMs	0	None
70557	70558	induced	0	None
70558	70559	by	0	None
70559	70560	D1R	0	None
70560	70561	,	0	None
70561	70562	D2R	0	None
70562	70563	and	0	None
70563	70564	l-DOPA	0	None
70564	70565	administration	0	None
70565	70566	while	0	None
70566	70567	its	0	None
70567	70568	effects	0	None
70568	70569	on	0	None
70569	70570	DA	0	None
70570	70571	agonist-induced	0	None
70571	70572	rotations	0	None
70572	70573	were	0	None
70573	70574	receptor-dependent	0	None
70574	70575	,	0	None
70575	70576	suggesting	0	None
70576	70577	that	0	None
70577	70578	direct	0	None
70578	70579	5-HT	0	None
70579	70580	(	0	None
70580	70581	1A	0	None
70581	70582	)	0	None
70582	70583	R	0	None
70583	70584	and	0	None
70584	70585	DA	0	None
70585	70586	receptor	0	None
70586	70587	interactions	0	None
70587	70588	may	0	None
70588	70589	contribute	0	None
70589	70590	to	0	None
70590	70591	the	0	None
70591	70592	unique	0	None
70592	70593	profile	0	None
70593	70594	of	0	None
70594	70595	5-HT	0	None
70595	70596	(	0	None
70596	70597	1A	0	None
70597	70598	)	0	None
70598	70599	R	0	None
70599	70600	agonists	0	None
70600	70601	for	0	None
70601	70602	the	0	None
70602	70603	improvement	0	None
70603	70604	of	0	None
70604	70605	PD	0	None
70605	70606	treatment	0	None
70606	70607	.	0	None
70607	70608	Ebastine	0	None
70608	70609	is	0	None
70609	70610	a	0	None
70610	70611	long-acting	0	None
70611	70612	nonsedating	0	None
70612	70613	second	0	None
70613	70614	generation	0	None
70614	70617	histamine H1 receptor	1	GENE-Y
70617	70618	antagonist	0	None
70618	70619	which	0	None
70619	70620	binds	0	None
70620	70621	preferentially	0	None
70621	70622	to	0	None
70622	70623	peripheral	0	None
70623	70625	H1 receptors	3	GENE-N
70625	70626	in	0	None
70626	70627	vivo	0	None
70627	70628	.	0	None

70629	70630	It	0	None
70630	70631	has	0	None
70631	70632	shown	0	None
70632	70633	antihistamine	2	CHEMICAL
70633	70634	and	0	None
70634	70635	antiallergic	0	None
70635	70636	activity	0	None
70636	70637	in	0	None
70637	70638	healthy	0	None
70638	70639	volunteers	0	None
70639	70640	and	0	None
70640	70641	patients	0	None
70641	70642	with	0	None
70642	70643	allergies	0	None
70643	70644	,	0	None
70644	70645	and	0	None
70645	70646	protected	0	None
70646	70647	against	0	None
70647	70648	histamine-induced	0	None
70648	70649	bronchoconstriction	0	None
70649	70650	in	0	None
70650	70651	patients	0	None
70651	70652	with	0	None
70652	70653	asthma	0	None
70653	70654	.	0	None

70655	70656	Significant	0	None
70656	70657	symptom	0	None
70657	70658	improvement	0	None
70658	70659	is	0	None
70659	70660	observed	0	None
70660	70661	in	0	None
70661	70662	patients	0	None
70662	70663	with	0	None
70663	70664	seasonal	0	None
70664	70665	or	0	None
70665	70666	perennial	0	None
70666	70667	allergic	0	None
70667	70668	rhinitis	0	None
70668	70669	or	0	None
70669	70670	chronic	0	None
70670	70671	idiopathic	0	None
70671	70672	urticaria	0	None
70672	70673	following	0	None
70673	70674	administration	0	None
70674	70675	of	0	None
70675	70676	ebastine	0	None
70676	70677	10	0	None
70677	70678	mg	2	CHEMICAL
70678	70679	/	0	None
70679	70680	day	0	None
70680	70681	,	0	None
70681	70682	or	0	None
70682	70683	20	0	None
70683	70684	mg	2	CHEMICAL
70684	70685	/	0	None
70685	70686	day	0	None
70686	70687	in	0	None
70687	70688	severe	0	None
70688	70689	rhinitis	0	None
70689	70690	.	0	None

70691	70692	In	0	None
70692	70693	clinical	0	None
70693	70694	trials	0	None
70694	70695	,	0	None
70695	70696	the	0	None
70696	70697	efficacy	0	None
70697	70698	of	0	None
70698	70699	ebastine	0	None
70699	70700	10	0	None
70700	70701	or	0	None
70701	70702	20	0	None
70702	70703	mg	2	CHEMICAL
70703	70704	/	0	None
70704	70705	day	0	None
70705	70706	was	0	None
70706	70707	generally	0	None
70707	70708	similar	0	None
70708	70709	to	0	None
70709	70710	standard	0	None
70710	70711	dosages	0	None
70711	70712	of	0	None
70712	70713	terfenadine	0	None
70713	70714	,	0	None
70714	70715	cetirizine	0	None
70715	70716	,	0	None
70716	70717	astemizole	0	None
70717	70718	and	0	None
70718	70719	loratadine	0	None
70719	70720	in	0	None
70720	70721	patients	0	None
70721	70722	with	0	None
70722	70723	seasonal	0	None
70723	70724	allergic	0	None
70724	70725	rhinitis	0	None
70725	70726	,	0	None
70726	70727	astemizole	0	None
70727	70728	,	0	None
70728	70729	terfenadine	0	None
70729	70730	and	0	None
70730	70731	ketotifen	0	None
70731	70732	in	0	None
70732	70733	patients	0	None
70733	70734	with	0	None
70734	70735	chronic	0	None
70735	70736	idiopathic	0	None
70736	70737	urticaria	0	None
70737	70738	,	0	None
70738	70739	and	0	None
70739	70740	ketotifen	0	None
70740	70741	,	0	None
70741	70742	terfenadine	0	None
70742	70743	,	0	None
70743	70744	chlorpheniramine	0	None
70744	70745	and	0	None
70745	70746	mequitazine	0	None
70746	70747	in	0	None
70747	70748	patients	0	None
70748	70749	with	0	None
70749	70750	perennial	0	None
70750	70751	allergic	0	None
70751	70752	rhinitis	0	None
70752	70753	.	0	None

70754	70755	The	0	None
70755	70756	most	0	None
70756	70757	frequent	0	None
70757	70758	adverse	0	None
70758	70759	events	0	None
70759	70760	reported	0	None
70760	70761	during	0	None
70761	70762	ebastine	0	None
70762	70763	therapy	0	None
70763	70764	are	0	None
70764	70765	drowsiness	0	None
70765	70766	,	0	None
70766	70767	headache	0	None
70767	70768	and	0	None
70768	70769	dry	0	None
70769	70770	mouth	0	None
70770	70771	,	0	None
70771	70772	the	0	None
70772	70773	incidence	0	None
70773	70774	being	0	None
70774	70775	similar	0	None
70775	70776	to	0	None
70776	70777	that	0	None
70777	70778	reported	0	None
70778	70779	in	0	None
70779	70780	placebo	0	None
70780	70781	recipients	0	None
70781	70782	.	0	None

70783	70784	Serious	0	None
70784	70785	adverse	0	None
70785	70786	cardiac	0	None
70786	70787	events	0	None
70787	70788	,	0	None
70788	70789	observed	0	None
70789	70790	on	0	None
70790	70791	rare	0	None
70791	70792	occasions	0	None
70792	70793	with	0	None
70793	70794	some	0	None
70794	70795	other	0	None
70795	70798	histamine H1 receptor	1	GENE-Y
70798	70799	antagonists	0	None
70799	70800	,	0	None
70800	70801	have	0	None
70801	70802	not	0	None
70802	70803	been	0	None
70803	70804	reported	0	None
70804	70805	with	0	None
70805	70806	ebastine	0	None
70806	70807	,	0	None
70807	70808	and	0	None
70808	70809	there	0	None
70809	70810	has	0	None
70810	70811	been	0	None
70811	70812	no	0	None
70812	70813	evidence	0	None
70813	70814	of	0	None
70814	70815	QTc	0	None
70815	70816	interval	0	None
70816	70817	prolongation	0	None
70817	70818	related	0	None
70818	70819	to	0	None
70819	70820	ebastine	0	None
70820	70821	therapy	0	None
70821	70822	.	0	None

70823	70824	Thus	0	None
70824	70825	,	0	None
70825	70826	once-daily	0	None
70826	70827	ebastine	0	None
70827	70828	offers	0	None
70828	70829	an	0	None
70829	70830	effective	0	None
70830	70831	and	0	None
70831	70832	well-tolerated	0	None
70832	70833	alternative	0	None
70833	70834	to	0	None
70834	70835	other	0	None
70835	70836	second	0	None
70836	70837	generation	0	None
70837	70838	antihistamines	0	None
70838	70839	in	0	None
70839	70840	current	0	None
70840	70841	use	0	None
70841	70842	for	0	None
70842	70843	the	0	None
70843	70844	first-line	0	None
70844	70845	treatment	0	None
70845	70846	of	0	None
70846	70847	seasonal	0	None
70847	70848	and	0	None
70848	70849	perennial	0	None
70849	70850	allergic	0	None
70850	70851	rhinitis	0	None
70851	70852	and	0	None
70852	70853	chronic	0	None
70853	70854	idiopathic	0	None
70854	70855	urticaria	0	None
70855	70856	.	0	None
70856	70857	Nonalcoholic	0	None
70857	70858	fatty	0	None
70858	70859	liver	0	None
70859	70860	disease	0	None
70860	70861	:	0	None
70861	70862	current	0	None
70862	70863	issues	0	None
70863	70864	and	0	None
70864	70865	novel	0	None
70865	70866	treatment	0	None
70866	70867	approaches	0	None
70867	70868	.	0	None
70868	70869	2-Amino-3-	0	None
70869	70870	[	0	None
70870	70871	3-hydroxy-5-	0	None
70871	70872	(	0	None
70872	70873	2-thiazolyl	0	None
70873	70874	)	0	None
70874	70875	-4-isoxazolyl	0	None
70875	70876	]	0	None
70876	70877	propionic	0	None
70877	70878	acid	0	None
70878	70879	(	0	None
70879	70880	1	0	None
70880	70881	)	0	None
70881	70882	is	0	None
70882	70883	a	0	None
70883	70884	potent	0	None
70884	70885	AMPA	0	None
70885	70886	receptor	0	None
70886	70887	agonist	0	None
70887	70888	with	0	None
70888	70889	moderate	0	None
70889	70890	affinity	0	None
70890	70891	for	0	None
70891	70892	native	0	None
70892	70894	kainic acid	2	CHEMICAL
70894	70895	(	0	None
70895	70896	KA	0	None
70896	70897	)	0	None
70897	70898	receptors	0	None
70898	70899	,	0	None
70899	70900	whereas	0	None
70900	70901	(	0	None
70901	70902	S	0	None
70902	70903	)	0	None
70903	70904	-E-4-	0	None
70904	70905	(	0	None
70905	70906	2	0	None
70906	70907	,	0	None
70907	70908	2-dimethylpropylidene	0	None
70908	70909	)	0	None
70909	70911	glutamic acid	2	CHEMICAL
70911	70912	(	0	None
70912	70913	3	0	None
70913	70914	)	0	None
70914	70915	show	0	None
70915	70916	high	0	None
70916	70917	affinity	0	None
70917	70918	for	0	None
70918	70919	the	0	None
70919	70920	GluR5	0	None
70920	70921	subtype	0	None
70921	70922	of	0	None
70922	70923	KA	0	None
70923	70924	receptors	0	None
70924	70925	and	0	None
70925	70926	much	0	None
70926	70927	lower	0	None
70927	70928	affinity	0	None
70928	70929	for	0	None
70929	70930	the	0	None
70930	70931	GluR2	1	GENE-Y
70931	70932	subtype	0	None
70932	70933	of	0	None
70933	70934	AMPA	0	None
70934	70935	receptors	0	None
70935	70936	.	0	None

70937	70938	As	0	None
70938	70939	an	0	None
70939	70940	attempt	0	None
70940	70941	to	0	None
70941	70942	develop	0	None
70942	70943	new	0	None
70943	70944	pharmacological	0	None
70944	70945	tools	0	None
70945	70946	for	0	None
70946	70947	studies	0	None
70947	70948	of	0	None
70948	70949	GluR5	0	None
70949	70950	receptors	0	None
70950	70951	,	0	None
70951	70952	(	0	None
70952	70953	S	0	None
70953	70954	)	0	None
70954	70955	-E-4-	0	None
70955	70956	(	0	None
70956	70957	2-thiazolylmethylene	0	None
70957	70958	)	0	None
70958	70960	glutamic acid	2	CHEMICAL
70960	70961	(	0	None
70961	70962	4a	0	None
70962	70963	)	0	None
70963	70964	was	0	None
70964	70965	designed	0	None
70965	70966	as	0	None
70966	70967	a	0	None
70967	70968	structural	0	None
70968	70969	hybrid	0	None
70969	70970	between	0	None
70970	70971	1	0	None
70971	70972	and	0	None
70972	70973	3	0	None
70973	70974	.	0	None

70975	70976	4a	0	None
70976	70977	was	0	None
70977	70978	shown	0	None
70978	70979	to	0	None
70979	70980	be	0	None
70980	70981	a	0	None
70981	70982	potent	0	None
70982	70983	GluR5	0	None
70983	70984	agonist	0	None
70984	70985	and	0	None
70985	70986	a	0	None
70986	70987	high	0	None
70987	70988	affinity	0	None
70988	70989	ligand	0	None
70989	70990	and	0	None
70990	70991	to	0	None
70991	70992	indiscriminately	0	None
70992	70993	bind	0	None
70993	70994	to	0	None
70994	70995	the	0	None
70995	70996	AMPA	0	None
70996	70997	receptor	0	None
70997	70998	subtypes	0	None
70998	70999	GluR1-4	0	None
70999	71000	with	0	None
71000	71001	lower	0	None
71001	71002	affinities	0	None
71002	71003	.	0	None

71004	71005	Compounds	0	None
71005	71006	4b-h	0	None
71006	71007	,	0	None
71007	71008	in	0	None
71008	71009	which	0	None
71009	71010	the	0	None
71010	71011	2-thiazolyl	0	None
71011	71012	substituent	0	None
71012	71013	of	0	None
71013	71014	4a	0	None
71014	71015	was	0	None
71015	71016	replaced	0	None
71016	71017	by	0	None
71017	71018	other	0	None
71018	71019	heterocyclic	0	None
71019	71020	rings	0	None
71020	71021	,	0	None
71021	71022	which	0	None
71022	71023	have	0	None
71023	71024	previously	0	None
71024	71025	been	0	None
71025	71026	incorporated	0	None
71026	71027	as	0	None
71027	71028	5-substituents	0	None
71028	71029	in	0	None
71029	71030	AMPA	0	None
71030	71031	analogues	0	None
71031	71032	,	0	None
71032	71033	as	0	None
71033	71034	exemplified	0	None
71034	71035	by	0	None
71035	71036	1	0	None
71036	71037	were	0	None
71037	71038	also	0	None
71038	71039	synthesized	0	None
71039	71040	.	0	None

71041	71042	Compounds	0	None
71042	71043	4b-h	0	None
71043	71044	were	0	None
71044	71045	either	0	None
71045	71046	inactive	0	None
71046	71047	(	0	None
71047	71048	4e	0	None
71048	71049	,	0	None
71049	71050	f	0	None
71050	71051	)	0	None
71051	71052	or	0	None
71052	71053	weaker	0	None
71053	71054	than	0	None
71054	71055	4a	0	None
71055	71056	as	0	None
71056	71057	affinity	0	None
71057	71058	ligands	0	None
71058	71059	for	0	None
71059	71060	GluR1-4	0	None
71060	71061	and	0	None
71061	71062	GluR5	0	None
71062	71063	with	0	None
71063	71064	relative	0	None
71064	71065	potencies	0	None
71065	71066	comparable	0	None
71066	71067	with	0	None
71067	71068	those	0	None
71068	71069	of	0	None
71069	71070	the	0	None
71070	71071	corresponding	0	None
71071	71072	AMPA	0	None
71072	71073	analogues	0	None
71073	71074	as	0	None
71074	71075	AMPA	0	None
71075	71076	receptor	0	None
71076	71077	agonists	0	None
71077	71078	.	0	None

71079	71080	Compounds	0	None
71080	71081	4a-h	0	None
71081	71082	may	0	None
71082	71083	be	0	None
71083	71084	useful	0	None
71084	71085	tools	0	None
71085	71086	for	0	None
71086	71087	the	0	None
71087	71088	progressing	0	None
71088	71089	pharmacophore	0	None
71089	71090	mapping	0	None
71090	71091	of	0	None
71091	71092	the	0	None
71092	71093	GluR5	0	None
71093	71094	agonist	0	None
71094	71095	binding	0	None
71095	71096	site	0	None
71096	71097	.	0	None
71097	71098	Treatment-related	0	None
71098	71099	osteoporosis	0	None
71099	71100	in	0	None
71100	71101	men	0	None
71101	71102	with	0	None
71102	71103	prostate	0	None
71103	71104	cancer	0	None
71104	71105	.	0	None
71105	71106	A	0	None
71106	71107	novel	0	None
71107	71108	series	0	None
71108	71109	of	0	None
71109	71110	substituted	0	None
71110	71111	(	0	None
71111	71112	E	0	None
71112	71113	)	0	None
71113	71114	-3-	0	None
71114	71115	(	0	None
71115	71116	Benzo	0	None
71116	71117	[	0	None
71117	71118	d	0	None
71118	71119	]	0	None
71119	71120	thiazol-2-ylamino	0	None
71120	71121	)	0	None
71121	71122	phenylprop-2-en-1-onewere	0	None
71122	71123	synthesized	0	None
71123	71124	starting	0	None
71124	71125	from	0	None
71125	71126	2-aminobenzothiazole	0	None
71126	71127	and	0	None
71127	71128	1-aryl-3	0	None
71128	71129	,	0	None
71129	71130	3-bis-	0	None
71130	71131	(	0	None
71131	71132	methylsulfanyl	0	None
71132	71133	)	0	None
71133	71134	-2-propen-1-onesin	0	None
71134	71135	the	0	None
71135	71136	presence	0	None
71136	71137	of	0	None
71137	71138	a	0	None
71138	71139	catalytic	0	None
71139	71140	amount	0	None
71140	71141	of	0	None
71141	71142	sodium	2	CHEMICAL
71142	71143	hydride	0	None
71143	71144	in	0	None
71144	71145	THF	0	None
71145	71146	.	0	None

71147	71148	The	0	None
71148	71149	synthesised	0	None
71149	71150	compounds'	0	None
71150	71151	structures	0	None
71151	71152	were	0	None
71152	71153	confirmed	0	None
71153	71154	by	0	None
71154	71155	IR	0	None
71155	71156	,	0	None
71156	71157	Mass	0	None
71157	71158	spectrometry	0	None
71158	71159	,	0	None
71159	71160	(	0	None
71160	71161	1	0	None
71161	71162	)	0	None
71162	71163	H	0	None
71163	71164	NMR	0	None
71164	71165	,	0	None
71165	71166	(	0	None
71166	71167	13	0	None
71167	71168	)	0	None
71168	71169	C	0	None
71169	71170	NMR	0	None
71170	71171	and	0	None
71171	71172	HRMS	0	None
71172	71173	spectral	0	None
71173	71174	data	0	None
71174	71175	.	0	None

71176	71177	These	0	None
71177	71178	compounds	0	None
71178	71179	were	0	None
71179	71180	evaluated	0	None
71180	71181	for	0	None
71181	71182	their	0	None
71182	71183	antidiabetic	0	None
71183	71184	activity	0	None
71184	71185	,	0	None
71185	71186	and	0	None
71186	71187	most	0	None
71187	71188	of	0	None
71188	71189	the	0	None
71189	71190	derivatives	0	None
71190	71191	of	0	None
71191	71192	(	0	None
71192	71193	E	0	None
71193	71194	)	0	None
71194	71195	-3-	0	None
71195	71196	(	0	None
71196	71197	Benzo	0	None
71197	71198	[	0	None
71198	71199	d	0	None
71199	71200	]	0	None
71200	71201	thiazol-2-ylamino	0	None
71201	71202	)	0	None
71202	71203	phenylprop-2-en-1-one	0	None
71203	71204	displayed	0	None
71204	71205	significant	0	None
71205	71206	antidiabetic	0	None
71206	71207	activity	0	None
71207	71208	.	0	None
71208	71209	Effects	0	None
71209	71210	of	0	None
71210	71211	DMSA-coated	0	None
71211	71212	Fe3O4	2	CHEMICAL
71212	71213	nanoparticles	0	None
71213	71214	on	0	None
71214	71215	the	0	None
71215	71216	transcription	0	None
71216	71217	of	0	None
71217	71218	genes	0	None
71218	71219	related	0	None
71219	71220	to	0	None
71220	71221	iron	0	None
71221	71222	and	0	None
71222	71223	osmosis	0	None
71223	71224	homeostasis	0	None
71224	71225	.	0	None
71225	71226	Toxic	0	None
71226	71227	,	0	None
71227	71228	halogenated	0	None
71228	71229	cysteine	0	None
71229	71230	S-conjugates	0	None
71230	71231	and	0	None
71231	71232	targeting	0	None
71232	71233	of	0	None
71233	71234	mitochondrial	0	None
71234	71235	enzymes	0	None
71235	71236	of	0	None
71236	71237	energy	0	None
71237	71238	metabolism	0	None
71238	71239	.	0	None
71239	71240	The	0	None
71240	71241	purpose	0	None
71241	71242	of	0	None
71242	71243	this	0	None
71243	71244	transverse	0	None
71244	71245	prospective	0	None
71245	71246	study	0	None
71246	71247	was	0	None
71247	71248	to	0	None
71248	71249	determine	0	None
71249	71250	blood	0	None
71250	71251	nutritional	0	None
71251	71252	,	0	None
71252	71253	immunity	0	None
71253	71254	and	0	None
71254	71255	inflammatory	0	None
71255	71256	proteins	0	None
71256	71257	change	0	None
71257	71258	in	0	None
71258	71260	vitamin A	2	CHEMICAL
71260	71261	deficiency	0	None
71261	71262	in	0	None
71262	71263	children	0	None
71263	71264	of	0	None
71264	71265	school-age	0	None
71265	71266	(	0	None
71266	71267	262	0	None
71267	71268	children	0	None
71268	71269	,	0	None
71269	71270	aged	0	None
71270	71271	7	0	None
71271	71272	to	0	None
71272	71273	15	0	None
71273	71274	years	0	None
71274	71275	)	0	None
71275	71276	.	0	None

71277	71278	Blood	0	None
71278	71280	vitamin A	2	CHEMICAL
71280	71281	has	0	None
71281	71282	been	0	None
71282	71283	determined	0	None
71283	71284	by	0	None
71284	71285	HPLC	0	None
71285	71286	with	0	None
71286	71287	UV	0	None
71287	71288	detection	0	None
71288	71289	.	0	None

71290	71291	Proteins	0	None
71291	71292	have	0	None
71292	71293	been	0	None
71293	71294	measured	0	None
71294	71295	by	0	None
71295	71296	radial	0	None
71296	71297	immunodiffusion	0	None
71297	71298	according	0	None
71298	71299	to	0	None
71299	71300	Mancini	0	None
71300	71301	.	0	None

71302	71303	Results	0	None
71303	71304	showed	0	None
71304	71305	that	0	None
71305	71306	96	0	None
71306	71307	children	0	None
71307	71308	(	0	None
71308	71309	36	0	None
71309	71310	.	0	None
71310	71311	6%	0	None
71311	71312	)	0	None
71312	71313	presented	0	None
71313	71314	a	0	None
71314	71316	vitamin A	2	CHEMICAL
71316	71317	deficiency	0	None
71317	71318	(	0	None
71318	71320	vitamin A	2	CHEMICAL
71320	71321	<	0	None
71321	71322	200	0	None
71322	71323	microg	0	None
71323	71324	/	0	None
71324	71325	L	0	None
71325	71326	with	0	None
71326	71327	a	0	None
71327	71328	retinol	2	CHEMICAL
71328	71329	binding	0	None
71329	71330	protein	0	None
71330	71331	/	0	None
71331	71332	transthyretin	0	None
71332	71333	molar	0	None
71333	71334	ratio	0	None
71334	71335	=	0	None
71335	71336	0	0	None
71336	71337	.	0	None
71337	71338	29	0	None
71338	71339	+	0	None
71339	71340	/	0	None
71340	71341	-	0	None
71341	71342	0	0	None
71342	71343	.	0	None
71343	71344	06	0	None
71344	71345	)	0	None
71345	71346	while	0	None
71346	71347	166	0	None
71347	71348	(	0	None
71348	71349	63	0	None
71349	71350	.	0	None
71350	71351	3%	0	None
71351	71352	)	0	None
71352	71353	children	0	None
71353	71354	presented	0	None
71354	71355	normal	0	None
71355	71356	blood	0	None
71356	71357	concentrations	0	None
71357	71358	of	0	None
71358	71360	vitamin A	2	CHEMICAL
71360	71361	(	0	None
71361	71363	vitamin A	2	CHEMICAL
71363	71364	>	0	None
71364	71365	or	0	None
71365	71366	=	0	None
71366	71367	200	0	None
71367	71368	microg	0	None
71368	71369	/	0	None
71369	71370	L	0	None
71370	71371	with	0	None
71371	71372	a	0	None
71372	71373	Retinol	2	CHEMICAL
71373	71374	Binding	0	None
71374	71375	Protein	0	None
71375	71376	/	0	None
71376	71377	Transthyretin	0	None
71377	71378	molar	0	None
71378	71379	ratio	0	None
71379	71380	=	0	None
71380	71381	0	0	None
71381	71382	.	0	None
71382	71383	40	0	None
71383	71384	+	0	None
71384	71385	/	0	None
71385	71386	-	0	None
71386	71387	0	0	None
71387	71388	.	0	None
71388	71389	08	0	None
71389	71390	)	0	None
71390	71391	.	0	None

71392	71393	This	0	None
71393	71394	study	0	None
71394	71395	showed	0	None
71395	71396	that	0	None
71396	71397	the	0	None
71397	71398	retinol	2	CHEMICAL
71398	71399	binding	0	None
71399	71400	protein	0	None
71400	71401	and	0	None
71401	71402	the	0	None
71402	71403	immunoglobulin	0	None
71403	71404	A	0	None
71404	71405	are	0	None
71405	71406	lower	0	None
71406	71407	in	0	None
71407	71408	children	0	None
71408	71409	with	0	None
71409	71411	vitamin A	2	CHEMICAL
71411	71412	deficiency	0	None
71412	71413	.	0	None

71414	71415	On	0	None
71415	71416	the	0	None
71416	71417	other	0	None
71417	71418	hand	0	None
71418	71419	,	0	None
71419	71420	an	0	None
71420	71421	isolated	0	None
71421	71422	increase	0	None
71422	71423	of	0	None
71423	71426	alpha-1 glycoprotein acid	1	GENE-Y
71426	71427	has	0	None
71427	71428	been	0	None
71428	71429	observed	0	None
71429	71430	in	0	None
71430	71431	boys	0	None
71431	71432	with	0	None
71432	71434	vitamin A	2	CHEMICAL
71434	71435	deficiency	0	None
71435	71436	.	0	None

71437	71438	The	0	None
71438	71440	vitamin A	2	CHEMICAL
71440	71441	deficiency	0	None
71441	71442	observed	0	None
71442	71443	in	0	None
71443	71444	this	0	None
71444	71445	survey	0	None
71445	71446	is	0	None
71446	71447	due	0	None
71447	71448	to	0	None
71448	71449	a	0	None
71449	71450	micronutrients	0	None
71450	71451	deficiency	0	None
71451	71452	in	0	None
71452	71453	the	0	None
71453	71454	diet	0	None
71454	71455	which	0	None
71455	71456	is	0	None
71456	71457	essentially	0	None
71457	71458	based	0	None
71458	71459	on	0	None
71459	71460	glucides	0	None
71460	71461	.	0	None

71462	71463	The	0	None
71463	71464	positive	0	None
71464	71465	correlation	0	None
71465	71466	between	0	None
71466	71468	vitamin A	2	CHEMICAL
71468	71469	and	0	None
71469	71470	immunoglobulin	0	None
71470	71471	A	0	None
71471	71472	concentrations	0	None
71472	71473	might	0	None
71473	71474	be	0	None
71474	71475	the	0	None
71475	71476	result	0	None
71476	71477	of	0	None
71477	71478	the	0	None
71478	71479	vitamin	0	None
71479	71480	A	0	None
71480	71481	inductive	0	None
71481	71482	effect	0	None
71482	71483	during	0	None
71483	71484	immunoglobulins	0	None
71484	71485	A	0	None
71485	71486	synthesis	0	None
71486	71487	.	0	None

71488	71489	The	0	None
71489	71490	isolated	0	None
71490	71491	increasing	0	None
71491	71492	of	0	None
71492	71495	alpha-1 glycoprotein acid	1	GENE-Y
71495	71496	in	0	None
71496	71497	boys	0	None
71497	71498	with	0	None
71498	71500	vitamin A	2	CHEMICAL
71500	71501	deficiency	0	None
71501	71502	has	0	None
71502	71503	been	0	None
71503	71504	assigned	0	None
71504	71505	to	0	None
71505	71506	the	0	None
71506	71507	ecosensitiveness	0	None
71507	71508	of	0	None
71508	71509	the	0	None
71509	71510	unfavourable	0	None
71510	71511	environment	0	None
71511	71512	.	0	None

71513	71514	We	0	None
71514	71515	therefore	0	None
71515	71516	concluded	0	None
71516	71517	that	0	None
71517	71518	,	0	None
71518	71519	in	0	None
71519	71520	Ivorian	0	None
71520	71521	primary-school-aged	0	None
71521	71522	children	0	None
71522	71523	with	0	None
71523	71525	vitamin A	2	CHEMICAL
71525	71526	deficiency	0	None
71526	71527	,	0	None
71527	71528	nutritional	0	None
71528	71529	,	0	None
71529	71530	immunity	0	None
71530	71531	and	0	None
71531	71532	inflammatory	0	None
71532	71533	proteins	0	None
71533	71534	which	0	None
71534	71535	are	0	None
71535	71536	modified	0	None
71536	71537	are	0	None
71537	71538	respectively	0	None
71538	71539	retinol	2	CHEMICAL
71539	71540	binding	0	None
71540	71541	protein	0	None
71541	71542	,	0	None
71542	71543	immunoglobulin	0	None
71543	71544	A	0	None
71544	71545	and	0	None
71545	71546	alpha-1	0	None
71546	71547	glycoprotein	0	None
71547	71548	acid	0	None
71548	71549	.	0	None
71549	71550	Phenylalanine	0	None
71550	71551	hydroxylase	0	None
71551	71552	,	0	None
71552	71553	tyrosine	2	CHEMICAL
71553	71554	hydroxylase	0	None
71554	71555	,	0	None
71555	71556	and	0	None
71556	71557	tryptophan	2	CHEMICAL
71557	71558	hydroxylase	0	None
71558	71559	constitute	0	None
71559	71560	a	0	None
71560	71561	small	0	None
71561	71562	family	0	None
71562	71563	of	0	None
71563	71564	monooxygenases	0	None
71564	71565	that	0	None
71565	71566	utilize	0	None
71566	71567	tetrahydropterins	0	None
71567	71568	as	0	None
71568	71569	substrates	0	None
71569	71570	.	0	None

71571	71572	When	0	None
71572	71573	from	0	None
71573	71574	eukaryotic	0	None
71574	71575	sources	0	None
71575	71576	,	0	None
71576	71577	these	0	None
71577	71578	enzymes	0	None
71578	71579	are	0	None
71579	71580	composed	0	None
71580	71581	of	0	None
71581	71582	a	0	None
71582	71583	homologous	0	None
71583	71584	catalytic	0	None
71584	71585	domain	0	None
71585	71586	to	0	None
71586	71587	which	0	None
71587	71588	are	0	None
71588	71589	attached	0	None
71589	71590	discrete	0	None
71590	71591	N-terminal	0	None
71591	71592	regulatory	0	None
71592	71593	domains	0	None
71593	71594	and	0	None
71594	71595	short	0	None
71595	71596	C-terminal	0	None
71596	71597	tetramerization	0	None
71597	71598	domains	0	None
71598	71599	,	0	None
71599	71600	whereas	0	None
71600	71601	the	0	None
71601	71602	bacterial	0	None
71602	71603	enzymes	0	None
71603	71604	lack	0	None
71604	71605	the	0	None
71605	71606	N-terminal	0	None
71606	71607	and	0	None
71607	71608	C-terminal	0	None
71608	71609	domains	0	None
71609	71610	.	0	None

71611	71612	Each	0	None
71612	71613	enzyme	0	None
71613	71614	contains	0	None
71614	71615	a	0	None
71615	71616	single	0	None
71616	71617	ferrous	0	None
71617	71618	iron	0	None
71618	71619	atom	0	None
71619	71620	bound	0	None
71620	71621	to	0	None
71621	71622	two	0	None
71622	71623	histidines	0	None
71623	71624	and	0	None
71624	71625	a	0	None
71625	71626	glutamate	0	None
71626	71627	.	0	None

71628	71629	Recent	0	None
71629	71630	mechanistic	0	None
71630	71631	studies	0	None
71631	71632	have	0	None
71632	71633	begun	0	None
71633	71634	to	0	None
71634	71635	provide	0	None
71635	71636	insights	0	None
71636	71637	into	0	None
71637	71638	the	0	None
71638	71639	mechanisms	0	None
71639	71640	of	0	None
71640	71641	oxygen	0	None
71641	71642	activation	0	None
71642	71643	and	0	None
71643	71644	hydroxylation	0	None
71644	71645	.	0	None

71646	71647	Although	0	None
71647	71648	the	0	None
71648	71649	hydroxylating	0	None
71649	71650	intermediate	0	None
71650	71651	in	0	None
71651	71652	these	0	None
71652	71653	enzymes	0	None
71653	71654	has	0	None
71654	71655	not	0	None
71655	71656	been	0	None
71656	71657	identified	0	None
71657	71658	,	0	None
71658	71659	the	0	None
71659	71660	iron	0	None
71660	71661	is	0	None
71661	71662	likely	0	None
71662	71663	to	0	None
71663	71664	be	0	None
71664	71665	involved	0	None
71665	71666	.	0	None

71667	71668	Reversible	0	None
71668	71669	phosphorylation	0	None
71669	71670	of	0	None
71670	71671	serine	2	CHEMICAL
71671	71672	residues	0	None
71672	71673	in	0	None
71673	71674	the	0	None
71674	71675	regulatory	0	None
71675	71676	domains	0	None
71676	71677	affects	0	None
71677	71678	the	0	None
71678	71679	activities	0	None
71679	71680	of	0	None
71680	71681	all	0	None
71681	71682	three	0	None
71682	71683	enzymes	0	None
71683	71684	.	0	None

71685	71686	In	0	None
71686	71687	addition	0	None
71687	71688	,	0	None
71688	71689	phenylalanine	0	None
71689	71690	hydroxylase	0	None
71690	71691	is	0	None
71691	71692	allosterically	0	None
71692	71693	regulated	0	None
71693	71694	by	0	None
71694	71695	its	0	None
71695	71696	substrates	0	None
71696	71697	,	0	None
71697	71698	phenylalanine	0	None
71698	71699	and	0	None
71699	71700	tetrahydrobiopterin	2	CHEMICAL
71700	71701	.	0	None
71701	71702	Syzygium	0	None
71702	71703	aqueum	0	None
71703	71704	leaf	0	None
71704	71705	extract	0	None
71705	71706	and	0	None
71706	71707	its	0	None
71707	71708	bioactive	0	None
71708	71709	compounds	0	None
71709	71710	enhances	0	None
71710	71711	pre-adipocyte	0	None
71711	71712	differentiation	0	None
71712	71713	and	0	None
71713	71714	2-NBDG	0	None
71714	71715	uptake	0	None
71715	71716	in	0	None
71716	71717	3T3-L1	0	None
71717	71718	cells	0	None
71718	71719	.	0	None
71719	71720	OBJECTIVE	0	None
71720	71721	:	0	None
71721	71722	Ziprasidone	2	CHEMICAL
71722	71723	is	0	None
71723	71724	an	0	None
71724	71725	atypical	0	None
71725	71726	antipsychotic	0	None
71726	71727	drug	0	None
71727	71728	that	0	None
71728	71729	shows	0	None
71729	71730	a	0	None
71730	71731	higher	0	None
71731	71732	affinity	0	None
71732	71733	for	0	None
71733	71734	serotonin	0	None
71734	71735	5-HT	0	None
71735	71736	(	0	None
71736	71737	2	0	None
71737	71738	)	0	None
71738	71739	receptors	0	None
71739	71740	compared	0	None
71740	71741	with	0	None
71741	71742	dopamine	0	None
71742	71743	D	0	None
71743	71744	(	0	None
71744	71745	2	0	None
71745	71746	)	0	None
71746	71747	receptors	0	None
71747	71748	in	0	None
71748	71749	vitro	0	None
71749	71750	.	0	None

71751	71752	The	0	None
71752	71753	affinity	0	None
71753	71754	of	0	None
71754	71755	ziprasidone	2	CHEMICAL
71755	71756	for	0	None
71756	71757	these	0	None
71757	71758	receptors	0	None
71758	71759	in	0	None
71759	71760	vivo	0	None
71760	71761	in	0	None
71761	71762	patients	0	None
71762	71763	was	0	None
71763	71764	examined	0	None
71764	71765	in	0	None
71765	71766	a	0	None
71766	71767	positron	0	None
71767	71768	emission	0	None
71768	71769	tomography	0	None
71769	71770	(	0	None
71770	71771	PET	0	None
71771	71772	)	0	None
71772	71773	study	0	None
71773	71774	.	0	None

71775	71776	METHOD	0	None
71776	71777	:	0	None
71777	71778	The	0	None
71778	71779	authors	0	None
71779	71780	conducted	0	None
71780	71781	a	0	None
71781	71782	PET	0	None
71782	71783	study	0	None
71783	71784	to	0	None
71784	71785	evaluate	0	None
71785	71786	D	0	None
71786	71787	(	0	None
71787	71788	2	0	None
71788	71789	)	0	None
71789	71790	occupancy	0	None
71790	71791	(	0	None
71791	71792	using	0	None
71792	71793	[	0	None
71793	71794	(	0	None
71794	71795	11	0	None
71795	71796	)	0	None
71796	71797	C	0	None
71797	71798	]	0	None
71798	71799	raclopride	0	None
71799	71800	)	0	None
71800	71801	and	0	None
71801	71802	5-HT	0	None
71802	71803	(	0	None
71803	71804	2	0	None
71804	71805	)	0	None
71805	71806	occupancy	0	None
71806	71807	(	0	None
71807	71808	using	0	None
71808	71809	[	0	None
71809	71810	(	0	None
71810	71811	18	0	None
71811	71812	)	0	None
71812	71813	F	0	None
71813	71814	]	0	None
71814	71815	setoperone	0	None
71815	71816	)	0	None
71816	71817	in	0	None
71817	71818	brain	0	None
71818	71819	regions	0	None
71819	71820	of	0	None
71820	71821	interest	0	None
71821	71822	in	0	None
71822	71823	16	0	None
71823	71824	patients	0	None
71824	71825	with	0	None
71825	71826	schizophrenia	0	None
71826	71827	or	0	None
71827	71828	schizoaffective	0	None
71828	71829	disorder	0	None
71829	71830	randomly	0	None
71830	71831	assigned	0	None
71831	71832	to	0	None
71832	71833	receive	0	None
71833	71834	40	0	None
71834	71835	,	0	None
71835	71836	80	0	None
71836	71837	,	0	None
71837	71838	120	0	None
71838	71839	,	0	None
71839	71840	or	0	None
71840	71841	160	0	None
71841	71842	mg	2	CHEMICAL
71842	71843	/	0	None
71843	71844	day	0	None
71844	71845	of	0	None
71845	71846	ziprasidone	2	CHEMICAL
71846	71847	,	0	None
71847	71848	which	0	None
71848	71849	reflected	0	None
71849	71850	the	0	None
71850	71851	recommended	0	None
71851	71852	dose	0	None
71852	71853	range	0	None
71853	71854	.	0	None

71855	71856	PET	0	None
71856	71857	scanning	0	None
71857	71858	was	0	None
71858	71859	done	0	None
71859	71860	after	0	None
71860	71861	3	0	None
71861	71862	weeks	0	None
71862	71863	of	0	None
71863	71864	administration	0	None
71864	71865	and	0	None
71865	71866	at	0	None
71866	71867	trough	0	None
71867	71868	plasma	0	None
71868	71869	levels	0	None
71869	71870	,	0	None
71870	71871	i	0	None
71871	71872	.	0	None

71873	71874	e	0	None
71874	71875	.	0	None

71876	71877	,	0	None
71877	71878	12-16	0	None
71878	71879	hours	0	None
71879	71880	after	0	None
71880	71881	the	0	None
71881	71882	last	0	None
71882	71883	dose	0	None
71883	71884	.	0	None

71885	71886	RESULTS	0	None
71886	71887	:	0	None
71887	71888	The	0	None
71888	71889	mean	0	None
71889	71890	5-HT	0	None
71890	71891	(	0	None
71891	71892	2	0	None
71892	71893	)	0	None
71893	71894	receptor	0	None
71894	71895	occupancy	0	None
71895	71896	was	0	None
71896	71897	significantly	0	None
71897	71898	higher	0	None
71898	71899	than	0	None
71899	71900	the	0	None
71900	71901	mean	0	None
71901	71902	D	0	None
71902	71903	(	0	None
71903	71904	2	0	None
71904	71905	)	0	None
71905	71906	receptor	0	None
71906	71907	occupancy	0	None
71907	71908	(	0	None
71908	71909	mean	0	None
71909	71910	=	0	None
71910	71911	76%	0	None
71911	71912	,	0	None
71912	71913	SD	0	None
71913	71914	=	0	None
71914	71915	15%	0	None
71915	71916	,	0	None
71916	71917	and	0	None
71917	71918	mean	0	None
71918	71919	=	0	None
71919	71920	56%	0	None
71920	71921	,	0	None
71921	71922	SD	0	None
71922	71923	=	0	None
71923	71924	18%	0	None
71924	71925	,	0	None
71925	71926	respectively	0	None
71926	71927	)	0	None
71927	71928	.	0	None

71929	71930	The	0	None
71930	71931	estimated	0	None
71931	71932	plasma	0	None
71932	71933	ziprasidone	2	CHEMICAL
71933	71934	concentration	0	None
71934	71935	associated	0	None
71935	71936	with	0	None
71936	71937	50%	0	None
71937	71938	maximal	0	None
71938	71939	5-HT	0	None
71939	71940	(	0	None
71940	71941	2	0	None
71941	71942	)	0	None
71942	71943	receptor	0	None
71943	71944	occupancy	0	None
71944	71945	was	0	None
71945	71946	almost	0	None
71946	71947	four	0	None
71947	71948	times	0	None
71948	71949	lower	0	None
71949	71950	than	0	None
71950	71951	that	0	None
71951	71952	for	0	None
71952	71953	D	0	None
71953	71954	(	0	None
71954	71955	2	0	None
71955	71956	)	0	None
71956	71957	receptor	0	None
71957	71958	occupancy	0	None
71958	71959	.	0	None

71960	71961	CONCLUSIONS	0	None
71961	71962	:	0	None
71962	71963	These	0	None
71963	71964	data	0	None
71964	71965	affirm	0	None
71965	71966	that	0	None
71966	71967	ziprasidone	2	CHEMICAL
71967	71968	is	0	None
71968	71969	similar	0	None
71969	71970	to	0	None
71970	71971	other	0	None
71971	71972	novel	0	None
71972	71973	antipsychotics	0	None
71973	71974	in	0	None
71974	71975	having	0	None
71975	71976	greater	0	None
71976	71977	5-HT	0	None
71977	71978	(	0	None
71978	71979	2	0	None
71979	71980	)	0	None
71980	71981	than	0	None
71981	71982	D	0	None
71982	71983	(	0	None
71983	71984	2	0	None
71984	71985	)	0	None
71985	71986	receptor	0	None
71986	71987	occupancy	0	None
71987	71988	at	0	None
71988	71989	therapeutic	0	None
71989	71990	doses	0	None
71990	71991	and	0	None
71991	71992	suggest	0	None
71992	71993	that	0	None
71993	71994	the	0	None
71994	71995	optimal	0	None
71995	71996	effective	0	None
71996	71997	dose	0	None
71997	71998	of	0	None
71998	71999	ziprasidone	2	CHEMICAL
71999	72000	is	0	None
72000	72001	closer	0	None
72001	72002	to	0	None
72002	72003	120	0	None
72003	72004	mg	2	CHEMICAL
72004	72005	/	0	None
72005	72006	day	0	None
72006	72007	than	0	None
72007	72008	to	0	None
72008	72009	the	0	None
72009	72010	lower	0	None
72010	72011	doses	0	None
72011	72012	suggested	0	None
72012	72013	by	0	None
72013	72014	previous	0	None
72014	72015	PET	0	None
72015	72016	studies	0	None
72016	72017	.	0	None

72018	72019	The	0	None
72019	72020	relatively	0	None
72020	72021	high	0	None
72021	72022	D	0	None
72022	72023	(	0	None
72023	72024	2	0	None
72024	72025	)	0	None
72025	72026	receptor	0	None
72026	72027	occupancy	0	None
72027	72028	,	0	None
72028	72029	even	0	None
72029	72030	at	0	None
72030	72031	trough	0	None
72031	72032	plasma	0	None
72032	72033	levels	0	None
72033	72034	,	0	None
72034	72035	suggests	0	None
72035	72036	that	0	None
72036	72037	ziprasidone	2	CHEMICAL
72037	72038	is	0	None
72038	72039	more	0	None
72039	72040	similar	0	None
72040	72041	to	0	None
72041	72042	risperidone	0	None
72042	72043	and	0	None
72043	72044	olanzapine	0	None
72044	72045	in	0	None
72045	72046	receptor	0	None
72046	72047	occupancy	0	None
72047	72048	profile	0	None
72048	72049	than	0	None
72049	72050	to	0	None
72050	72051	clozapine	2	CHEMICAL
72051	72052	and	0	None
72052	72053	quetiapine	0	None
72053	72054	.	0	None

72055	72056	Since	0	None
72056	72057	ziprasidone	2	CHEMICAL
72057	72058	plasma	0	None
72058	72059	levels	0	None
72059	72060	show	0	None
72060	72061	significant	0	None
72061	72062	(	0	None
72062	72063	more	0	None
72063	72064	than	0	None
72064	72065	twofold	0	None
72065	72066	)	0	None
72066	72067	variation	0	None
72067	72068	within	0	None
72068	72069	a	0	None
72069	72070	single	0	None
72070	72071	dose	0	None
72071	72072	cycle	0	None
72072	72073	,	0	None
72073	72074	studies	0	None
72074	72075	that	0	None
72075	72076	are	0	None
72076	72077	aimed	0	None
72077	72078	at	0	None
72078	72079	peak	0	None
72079	72080	plasma	0	None
72080	72081	levels	0	None
72081	72082	(	0	None
72082	72083	6	0	None
72083	72084	hours	0	None
72084	72085	after	0	None
72085	72086	the	0	None
72086	72087	last	0	None
72087	72088	dose	0	None
72088	72089	)	0	None
72089	72090	and	0	None
72090	72091	that	0	None
72091	72092	examine	0	None
72092	72093	extrastriatal	0	None
72093	72094	regions	0	None
72094	72095	are	0	None
72095	72096	required	0	None
72096	72097	to	0	None
72097	72098	fully	0	None
72098	72099	characterize	0	None
72099	72100	the	0	None
72100	72101	in	0	None
72101	72102	vivo	0	None
72102	72103	occupancy	0	None
72103	72104	profile	0	None
72104	72105	of	0	None
72105	72106	ziprasidone	2	CHEMICAL
72106	72107	.	0	None
72107	72108	Inspired	0	None
72108	72109	by	0	None
72109	72110	the	0	None
72110	72111	water-enhanced	0	None
72111	72112	mechanical	0	None
72112	72113	gradient	0	None
72113	72114	character	0	None
72114	72115	of	0	None
72115	72116	the	0	None
72116	72117	squid	0	None
72117	72118	beak	0	None
72118	72119	,	0	None
72119	72120	we	0	None
72120	72121	herein	0	None
72121	72122	report	0	None
72122	72123	a	0	None
72123	72124	nanocomposite	0	None
72124	72125	that	0	None
72125	72126	mimics	0	None
72126	72127	both	0	None
72127	72128	the	0	None
72128	72129	architecture	0	None
72129	72130	and	0	None
72130	72131	properties	0	None
72131	72132	of	0	None
72132	72133	this	0	None
72133	72134	interesting	0	None
72134	72135	natural	0	None
72135	72136	material	0	None
72136	72137	.	0	None

72138	72139	Similar	0	None
72139	72140	to	0	None
72140	72141	the	0	None
72141	72142	squid	0	None
72142	72143	beak	0	None
72143	72144	,	0	None
72144	72145	we	0	None
72145	72146	have	0	None
72146	72147	developed	0	None
72147	72148	nanocomposites	0	None
72148	72149	where	0	None
72149	72150	the	0	None
72150	72151	degree	0	None
72151	72152	of	0	None
72152	72153	cross-linking	0	None
72153	72154	is	0	None
72154	72155	controlled	0	None
72155	72156	along	0	None
72156	72157	the	0	None
72157	72158	length	0	None
72158	72159	of	0	None
72159	72160	the	0	None
72160	72161	film	0	None
72161	72162	.	0	None

72163	72164	In	0	None
72164	72165	this	0	None
72165	72166	study	0	None
72166	72167	,	0	None
72167	72168	we	0	None
72168	72169	utilized	0	None
72169	72170	tunicate	0	None
72170	72171	cellulose	0	None
72171	72172	nanocrystals	0	None
72172	72173	as	0	None
72173	72174	the	0	None
72174	72175	nanofiller	0	None
72175	72176	that	0	None
72176	72177	are	0	None
72177	72178	functionalized	0	None
72178	72179	with	0	None
72179	72180	allyl	0	None
72180	72181	moieties	0	None
72181	72182	.	0	None

72183	72184	Using	0	None
72184	72185	photoinduced	0	None
72185	72186	thiol-ene	0	None
72186	72187	chemistry	0	None
72187	72188	,	0	None
72188	72189	we	0	None
72189	72190	have	0	None
72190	72191	been	0	None
72191	72192	able	0	None
72192	72193	to	0	None
72193	72194	cross-link	0	None
72194	72195	the	0	None
72195	72196	CNC	0	None
72196	72197	nanofiller	0	None
72197	72198	.	0	None

72199	72200	In	0	None
72200	72201	the	0	None
72201	72202	dry	0	None
72202	72203	state	0	None
72203	72204	where	0	None
72204	72205	strong	0	None
72205	72206	CNC	0	None
72206	72207	interactions	0	None
72207	72208	can	0	None
72208	72209	occur	0	None
72209	72210	,	0	None
72210	72211	only	0	None
72211	72212	a	0	None
72212	72213	small	0	None
72213	72214	mechanical	0	None
72214	72215	contrast	0	None
72215	72216	is	0	None
72216	72217	observed	0	None
72217	72218	between	0	None
72218	72219	the	0	None
72219	72220	cross-linked	0	None
72220	72221	and	0	None
72221	72222	uncross-linked	0	None
72222	72223	samples	0	None
72223	72224	.	0	None

72225	72226	However	0	None
72226	72227	,	0	None
72227	72228	when	0	None
72228	72229	the	0	None
72229	72230	films	0	None
72230	72231	are	0	None
72231	72232	exposed	0	None
72232	72233	to	0	None
72233	72234	water	0	None
72234	72235	,	0	None
72235	72236	which	0	None
72236	72237	"switches	0	None
72237	72238	off"	0	None
72238	72239	the	0	None
72239	72240	noncovalent	0	None
72240	72241	CNC	0	None
72241	72242	interactions	0	None
72242	72243	,	0	None
72243	72244	a	0	None
72244	72245	significant	0	None
72245	72246	mechanical	0	None
72246	72247	contrast	0	None
72247	72248	is	0	None
72248	72249	observed	0	None
72249	72250	between	0	None
72250	72251	the	0	None
72251	72252	same	0	None
72252	72253	films	0	None
72253	72254	.	0	None

72255	72256	For	0	None
72256	72257	example	0	None
72257	72258	,	0	None
72258	72259	at	0	None
72259	72260	20	0	None
72260	72261	wt	0	None
72261	72262	%	0	None
72262	72263	CNC	0	None
72263	72264	(	0	None
72264	72265	in	0	None
72265	72266	the	0	None
72266	72267	dry	0	None
72267	72268	film	0	None
72268	72269	)	0	None
72269	72270	,	0	None
72270	72271	an	0	None
72271	72272	increase	0	None
72272	72273	in	0	None
72273	72274	wet	0	None
72274	72275	modulus	0	None
72275	72276	from	0	None
72276	72277	60	0	None
72277	72278	to	0	None
72278	72279	300	0	None
72279	72280	MPa	0	None
72280	72281	(	0	None
72281	72282	∼500%	0	None
72282	72283	increase	0	None
72283	72284	)	0	None
72284	72285	is	0	None
72285	72286	observed	0	None
72286	72287	after	0	None
72287	72288	photoirradiation	0	None
72288	72289	.	0	None

72290	72291	Furthermore	0	None
72291	72292	,	0	None
72292	72293	we	0	None
72293	72294	show	0	None
72294	72295	that	0	None
72295	72296	the	0	None
72296	72297	wet	0	None
72297	72298	modulus	0	None
72298	72299	can	0	None
72299	72300	be	0	None
72300	72301	controlled	0	None
72301	72302	by	0	None
72302	72303	altering	0	None
72303	72304	the	0	None
72304	72305	UV	0	None
72305	72306	exposure	0	None
72306	72307	time	0	None
72307	72308	which	0	None
72308	72309	allows	0	None
72309	72310	access	0	None
72310	72311	to	0	None
72311	72312	mechanical	0	None
72312	72313	gradient	0	None
72313	72314	films	0	None
72314	72315	.	0	None
72315	72316	Recent	0	None
72316	72317	work	0	None
72317	72318	has	0	None
72318	72319	revealed	0	None
72319	72320	cAMP-dependent	0	None
72320	72321	phosphorylation	0	None
72321	72322	of	0	None
72322	72323	the	0	None
72323	72324	18-kDa	0	None
72324	72325	IP	0	None
72325	72326	subunit	0	None
72326	72327	of	0	None
72327	72328	the	0	None
72328	72330	mammalian complex	0	None
72330	72331	I	0	None
72331	72332	of	0	None
72332	72333	the	0	None
72333	72334	respiratory	0	None
72334	72335	chain	0	None
72335	72336	,	0	None
72336	72337	encoded	0	None
72337	72338	by	0	None
72338	72339	the	0	None
72339	72340	nuclear	0	None
72340	72341	NDUFS4	0	None
72341	72342	gene	0	None
72342	72343	(	0	None
72343	72344	chromosome	0	None
72344	72345	5	0	None
72345	72346	)	0	None
72346	72347	.	0	None

72348	72349	Phosphorylation	0	None
72349	72350	of	0	None
72350	72351	this	0	None
72351	72352	protein	0	None
72352	72353	has	0	None
72353	72354	been	0	None
72354	72355	shown	0	None
72355	72356	to	0	None
72356	72357	take	0	None
72357	72358	place	0	None
72358	72359	in	0	None
72359	72360	fibroblast	0	None
72360	72361	cultures	0	None
72361	72362	in	0	None
72362	72363	vivo	0	None
72363	72364	,	0	None
72364	72365	as	0	None
72365	72366	well	0	None
72366	72367	as	0	None
72367	72368	in	0	None
72368	72369	isolated	0	None
72369	72370	mitochondria	0	None
72370	72371	,	0	None
72371	72372	which	0	None
72372	72373	in	0	None
72373	72374	addition	0	None
72374	72375	to	0	None
72375	72376	the	0	None
72376	72377	cytosol	0	None
72377	72378	also	0	None
72378	72379	contain	0	None
72379	72380	,	0	None
72380	72381	in	0	None
72381	72382	the	0	None
72382	72383	inner-membrane	0	None
72383	72384	matrix	0	None
72384	72385	fraction	0	None
72385	72386	,	0	None
72386	72387	a	0	None
72387	72388	cAMP-dependent	0	None
72388	72390	protein kinase	3	GENE-N
72390	72391	.	0	None

72392	72393	Mitochondria	0	None
72393	72394	appear	0	None
72394	72395	to	0	None
72395	72396	have	0	None
72396	72397	a	0	None
72397	72398	Ca2	0	None
72398	72399	+	0	None
72399	72400	-inhibited	0	None
72400	72401	phosphatase	0	None
72401	72402	,	0	None
72402	72403	which	0	None
72403	72404	dephosphorylates	0	None
72404	72405	the	0	None
72405	72406	18-kDa	0	None
72406	72407	phosphoprotein	0	None
72407	72408	.	0	None

72409	72410	In	0	None
72410	72411	fibroblast	0	None
72411	72412	and	0	None
72412	72413	myoblast	0	None
72413	72414	cultures	0	None
72414	72415	cAMP-dependent	0	None
72415	72416	phosphorylation	0	None
72416	72417	of	0	None
72417	72418	the	0	None
72418	72419	18-kDa	0	None
72419	72420	protein	0	None
72420	72421	is	0	None
72421	72422	associated	0	None
72422	72423	with	0	None
72423	72424	potent	0	None
72424	72425	stimulation	0	None
72425	72426	of	0	None
72426	72427	complex	0	None
72427	72428	I	0	None
72428	72429	and	0	None
72429	72430	overall	0	None
72430	72431	respiratory	0	None
72431	72432	activity	0	None
72432	72433	with	0	None
72433	72434	NAD-linked	0	None
72434	72435	substrates	0	None
72435	72436	.	0	None

72437	72438	Mutations	0	None
72438	72439	in	0	None
72439	72440	the	0	None
72440	72442	human NDUFS4	3	GENE-N
72442	72443	gene	0	None
72443	72444	have	0	None
72444	72445	been	0	None
72445	72446	found	0	None
72446	72447	,	0	None
72447	72448	which	0	None
72448	72449	in	0	None
72449	72450	the	0	None
72450	72451	homozygous	0	None
72451	72452	state	0	None
72452	72453	are	0	None
72453	72454	associated	0	None
72454	72455	with	0	None
72455	72456	deficiency	0	None
72456	72457	of	0	None
72457	72458	complex	0	None
72458	72459	I	0	None
72459	72460	and	0	None
72460	72461	fatal	0	None
72461	72462	neurological	0	None
72462	72463	syndrome	0	None
72463	72464	.	0	None

72465	72466	In	0	None
72466	72467	one	0	None
72467	72468	case	0	None
72468	72469	consisting	0	None
72469	72470	of	0	None
72470	72471	a	0	None
72471	72472	5	0	None
72472	72473	bp	0	None
72473	72474	duplication	0	None
72474	72475	,	0	None
72475	72476	which	0	None
72476	72477	destroyed	0	None
72477	72478	the	0	None
72478	72479	phosphorylation	0	None
72479	72480	site	0	None
72480	72481	,	0	None
72481	72482	cAMP-dependent	0	None
72482	72483	activation	0	None
72483	72484	of	0	None
72484	72485	complex	0	None
72485	72486	I	0	None
72486	72487	was	0	None
72487	72488	abolished	0	None
72488	72489	in	0	None
72489	72490	the	0	None
72490	72491	patient's	0	None
72491	72492	fibroblast	0	None
72492	72493	cultures	0	None
72493	72494	.	0	None

72495	72496	In	0	None
72496	72497	another	0	None
72497	72498	case	0	None
72498	72499	consisting	0	None
72499	72500	of	0	None
72500	72501	a	0	None
72501	72502	nonsense	0	None
72502	72503	mutation	0	None
72503	72504	,	0	None
72504	72505	leading	0	None
72505	72506	to	0	None
72506	72507	termination	0	None
72507	72508	of	0	None
72508	72509	the	0	None
72509	72510	protein	0	None
72510	72511	after	0	None
72511	72512	only	0	None
72512	72513	14	0	None
72513	72514	residues	0	None
72514	72515	of	0	None
72515	72516	the	0	None
72516	72517	putative	0	None
72517	72518	mitochondria	0	None
72518	72519	targeting	0	None
72519	72520	peptide	0	None
72520	72521	,	0	None
72521	72522	a	0	None
72522	72523	defect	0	None
72523	72524	in	0	None
72524	72525	the	0	None
72525	72526	assembly	0	None
72526	72527	of	0	None
72527	72528	complex	0	None
72528	72529	I	0	None
72529	72530	was	0	None
72530	72531	found	0	None
72531	72532	in	0	None
72532	72533	fibroblast	0	None
72533	72534	cultures	0	None
72534	72535	.	0	None
72535	72536	The	0	None
72536	72537	TGF-β	0	None
72537	72538	signaling	0	None
72538	72539	pathway	0	None
72539	72540	is	0	None
72540	72541	involved	0	None
72541	72542	with	0	None
72542	72543	multiple	0	None
72543	72544	processes	0	None
72544	72545	in	0	None
72545	72546	the	0	None
72546	72547	mammalian	0	None
72547	72548	ovary	0	None
72548	72549	,	0	None
72549	72550	including	0	None
72550	72551	primordial	0	None
72551	72552	follicle	0	None
72552	72553	formation	0	None
72553	72554	,	0	None
72554	72555	granulosa	0	None
72555	72556	cell	0	None
72556	72557	(	0	None
72557	72558	GC	0	None
72558	72559	)	0	None
72559	72560	proliferation	0	None
72560	72561	,	0	None
72561	72562	follicle	0	None
72562	72563	atresia	0	None
72563	72564	,	0	None
72564	72565	ovulation	0	None
72565	72566	,	0	None
72566	72567	and	0	None
72567	72568	feedback	0	None
72568	72569	regulation	0	None
72569	72570	between	0	None
72570	72571	the	0	None
72571	72572	pituitary	0	None
72572	72573	and	0	None
72573	72574	ovary	0	None
72574	72575	.	0	None

72576	72577	The	0	None
72577	72578	transcriptional	0	None
72578	72579	factor	0	None
72579	72580	SMAD4	1	GENE-Y
72580	72581	is	0	None
72581	72582	the	0	None
72582	72583	central	0	None
72583	72584	component	0	None
72584	72585	of	0	None
72585	72586	the	0	None
72586	72587	canonical	0	None
72587	72588	TGF-β	0	None
72588	72589	signaling	0	None
72589	72590	pathway	0	None
72590	72591	.	0	None

72592	72593	Smad4	1	GENE-Y
72593	72594	knockout	0	None
72594	72595	using	0	None
72595	72596	Amhr2-Cre	0	None
72596	72597	,	0	None
72597	72598	which	0	None
72598	72599	is	0	None
72599	72600	expressed	0	None
72600	72601	in	0	None
72601	72602	GCs	0	None
72602	72603	of	0	None
72603	72604	immature	0	None
72604	72605	developing	0	None
72605	72606	follicles	0	None
72606	72607	,	0	None
72607	72608	causes	0	None
72608	72609	premature	0	None
72609	72610	luteinization	0	None
72610	72611	.	0	None

72612	72613	In	0	None
72613	72614	this	0	None
72614	72615	study	0	None
72615	72616	,	0	None
72616	72617	we	0	None
72617	72618	specifically	0	None
72618	72619	depleted	0	None
72619	72620	Smad4	1	GENE-Y
72620	72621	in	0	None
72621	72622	GCs	0	None
72622	72623	of	0	None
72623	72624	preovulatory	0	None
72624	72625	follicles	0	None
72625	72626	using	0	None
72626	72627	Cyp19-Cre	0	None
72627	72628	mice	0	None
72628	72629	.	0	None

72630	72631	As	0	None
72631	72632	different	0	None
72632	72633	from	0	None
72633	72634	results	0	None
72634	72635	with	0	None
72635	72636	Smad4	1	GENE-Y
72636	72637	(	0	None
72637	72638	fl	0	None
72638	72639	/	0	None
72639	72640	fl	0	None
72640	72641	)	0	None
72641	72642	;Amhr2-Cre	0	None
72642	72643	mice	0	None
72643	72644	,	0	None
72644	72645	Smad4	1	GENE-Y
72645	72646	depletion	0	None
72646	72647	in	0	None
72647	72648	preovulatory	0	None
72648	72649	follicles	0	None
72649	72650	did	0	None
72650	72651	not	0	None
72651	72652	cause	0	None
72652	72653	premature	0	None
72653	72654	luteinization	0	None
72654	72655	or	0	None
72655	72656	suppress	0	None
72656	72657	GC	0	None
72657	72658	proliferation;	0	None
72658	72659	rather	0	None
72659	72660	,	0	None
72660	72661	it	0	None
72661	72662	increased	0	None
72662	72663	follicle	0	None
72663	72664	atresia	0	None
72664	72665	.	0	None

72666	72667	In	0	None
72667	72668	addition	0	None
72668	72669	,	0	None
72669	72670	Nppc	0	None
72670	72671	and	0	None
72671	72672	Npr2	0	None
72672	72673	expressions	0	None
72673	72674	were	0	None
72674	72675	reduced	0	None
72675	72676	by	0	None
72676	72677	Smad4	1	GENE-Y
72677	72678	depletion;	0	None
72678	72679	thus	0	None
72679	72680	,	0	None
72680	72681	their	0	None
72681	72682	effect	0	None
72682	72683	of	0	None
72683	72684	maintaining	0	None
72684	72685	oocyte	0	None
72685	72686	meiotic	0	None
72686	72687	arrest	0	None
72687	72688	was	0	None
72688	72689	weakened	0	None
72689	72690	in	0	None
72690	72691	Smad4	1	GENE-Y
72691	72692	conditional	0	None
72692	72693	knockout	0	None
72693	72694	mice	0	None
72694	72695	.	0	None

72696	72697	Smad4	1	GENE-Y
72697	72698	(	0	None
72698	72699	fl	0	None
72699	72700	/	0	None
72700	72701	fl	0	None
72701	72702	)	0	None
72702	72703	;Cyp19-Cre	0	None
72703	72704	female	0	None
72704	72705	mice	0	None
72705	72706	were	0	None
72706	72707	subfertile	0	None
72707	72708	and	0	None
72708	72709	had	0	None
72709	72710	irregular	0	None
72710	72711	estrous	0	None
72711	72712	cycles	0	None
72712	72713	and	0	None
72713	72714	ovulation	0	None
72714	72715	defects	0	None
72715	72716	.	0	None

72717	72718	Smad4	1	GENE-Y
72718	72719	knockout	0	None
72719	72720	also	0	None
72720	72721	blocked	0	None
72721	72722	luteinizing	0	None
72722	72723	hormone	0	None
72723	72724	(	0	None
72724	72725	LH	0	None
72725	72726	)	0	None
72726	72727	-induced	0	None
72727	72728	cumulus	0	None
72728	72729	expansion	0	None
72729	72730	and	0	None
72730	72731	follicle	0	None
72731	72732	rupture	0	None
72732	72733	,	0	None
72733	72734	but	0	None
72734	72735	not	0	None
72735	72736	oocyte	0	None
72736	72737	meiotic	0	None
72737	72738	resumption	0	None
72738	72739	.	0	None

72740	72741	Our	0	None
72741	72742	results	0	None
72742	72743	also	0	None
72743	72744	indicated	0	None
72744	72745	that	0	None
72745	72746	SMAD4	1	GENE-Y
72746	72747	was	0	None
72747	72748	required	0	None
72748	72749	for	0	None
72749	72750	LH-stimulated	0	None
72750	72751	activation	0	None
72751	72752	of	0	None
72752	72753	ERK1	0	None
72753	72754	/	0	None
72754	72755	2	0	None
72755	72756	and	0	None
72756	72757	the	0	None
72757	72758	expressions	0	None
72758	72759	of	0	None
72759	72760	ovulation-related	0	None
72760	72761	genes	0	None
72761	72762	.	0	None

72763	72764	The	0	None
72764	72765	defects	0	None
72765	72766	arising	0	None
72766	72767	from	0	None
72767	72768	SMAD4	1	GENE-Y
72768	72769	depletion	0	None
72769	72770	could	0	None
72770	72771	not	0	None
72771	72772	be	0	None
72772	72773	rescued	0	None
72773	72774	by	0	None
72774	72775	intra-ovarian	0	None
72775	72776	mediators	0	None
72776	72777	of	0	None
72777	72778	LH	0	None
72778	72779	actions	0	None
72779	72780	,	0	None
72780	72781	such	0	None
72781	72782	as	0	None
72782	72783	EGF-like	0	None
72783	72784	factors	0	None
72784	72785	and	0	None
72785	72786	prostaglandin	0	None
72786	72787	E2	0	None
72787	72788	.	0	None

72789	72790	Furthermore	0	None
72790	72791	,	0	None
72791	72792	corpus	0	None
72792	72793	lutea	0	None
72793	72794	did	0	None
72794	72795	not	0	None
72795	72796	form	0	None
72796	72797	in	0	None
72797	72798	Smad4	1	GENE-Y
72798	72799	(	0	None
72799	72800	fl	0	None
72800	72801	/	0	None
72801	72802	fl	0	None
72802	72803	)	0	None
72803	72804	;Cyp19-Cre	0	None
72804	72805	female	0	None
72805	72806	mice	0	None
72806	72807	,	0	None
72807	72808	indicating	0	None
72808	72809	that	0	None
72809	72810	SMAD4	1	GENE-Y
72810	72811	was	0	None
72811	72812	crucial	0	None
72812	72813	for	0	None
72813	72814	GCs	0	None
72814	72815	terminal	0	None
72815	72816	differentiation	0	None
72816	72817	.	0	None

72818	72819	Thus	0	None
72819	72820	,	0	None
72820	72821	by	0	None
72821	72822	characterizing	0	None
72822	72823	the	0	None
72823	72824	ovarian	0	None
72824	72825	phenotypes	0	None
72825	72826	of	0	None
72826	72827	preovulatory	0	None
72827	72828	follicle-specific	0	None
72828	72829	Smad4	1	GENE-Y
72829	72830	knockout	0	None
72830	72831	mice	0	None
72831	72832	,	0	None
72832	72833	we	0	None
72833	72834	identified	0	None
72834	72835	the	0	None
72835	72836	developmental	0	None
72836	72837	stage-specific	0	None
72837	72838	functions	0	None
72838	72839	of	0	None
72839	72840	the	0	None
72840	72841	canonical	0	None
72841	72842	TGF-β	1	GENE-Y
72842	72843	signaling	0	None
72843	72844	pathway	0	None
72844	72845	in	0	None
72845	72846	ovulation	0	None
72846	72847	and	0	None
72847	72848	luteinization	0	None
72848	72849	.	0	None
72849	72850	Effects	0	None
72850	72851	of	0	None
72851	72852	biotin	0	None
72852	72853	supplementation	0	None
72853	72854	in	0	None
72854	72855	the	0	None
72855	72856	diet	0	None
72856	72857	on	0	None
72857	72858	insulin	0	None
72858	72859	secretion	0	None
72859	72860	,	0	None
72860	72861	islet	3	GENE-N
72861	72862	gene	0	None
72862	72863	expression	0	None
72863	72864	,	0	None
72864	72865	glucose	0	None
72865	72866	homeostasis	0	None
72866	72867	and	0	None
72867	72868	beta-cell	0	None
72868	72869	proportion	0	None
72869	72870	.	0	None
72870	72871	We	0	None
72871	72872	have	0	None
72872	72873	demonstrated	0	None
72873	72874	that	0	None
72874	72875	the	0	None
72875	72876	complementary	0	None
72876	72877	combination	0	None
72877	72878	of	0	None
72878	72879	grazing	0	None
72879	72880	incidence	0	None
72880	72881	X-ray	0	None
72881	72882	fluorescence	0	None
72882	72883	(	0	None
72883	72884	GIXF	0	None
72884	72885	)	0	None
72885	72886	with	0	None
72886	72887	specular	0	None
72887	72888	X-ray	0	None
72888	72889	reflectivity	0	None
72889	72890	(	0	None
72890	72891	XRR	0	None
72891	72892	)	0	None
72892	72893	can	0	None
72893	72894	be	0	None
72894	72895	used	0	None
72895	72896	to	0	None
72896	72897	quantitatively	0	None
72897	72898	determine	0	None
72898	72899	the	0	None
72899	72900	density	0	None
72900	72901	profiles	0	None
72901	72902	of	0	None
72902	72903	Ni	0	None
72903	72904	(	0	None
72904	72905	2	0	None
72905	72906	)	0	None
72906	72907	(	0	None
72907	72908	+	0	None
72908	72909	)	0	None
72909	72910	ions	0	None
72910	72911	complexed	0	None
72911	72912	with	0	None
72912	72913	chelator	0	None
72913	72914	headgroups	0	None
72914	72915	as	0	None
72915	72916	well	0	None
72916	72917	as	0	None
72917	72918	S	0	None
72918	72919	atoms	0	None
72919	72920	in	0	None
72920	72921	recombinant	0	None
72921	72922	proteins	0	None
72922	72923	anchored	0	None
72923	72924	to	0	None
72924	72925	lipid	0	None
72925	72926	monolayers	0	None
72926	72927	at	0	None
72927	72928	the	0	None
72928	72929	air	0	None
72929	72930	/	0	None
72930	72931	water	0	None
72931	72932	interface	0	None
72932	72933	.	0	None

72934	72935	First	0	None
72935	72936	,	0	None
72936	72937	we	0	None
72937	72938	prepared	0	None
72938	72939	phospholipid	0	None
72939	72940	monolayers	0	None
72940	72941	incorporating	0	None
72941	72942	chelator	0	None
72942	72943	lipid	0	None
72943	72944	anchors	0	None
72944	72945	at	0	None
72945	72946	different	0	None
72946	72947	molar	0	None
72947	72948	fractions	0	None
72948	72949	at	0	None
72949	72950	the	0	None
72950	72951	air	0	None
72951	72952	/	0	None
72952	72953	water	0	None
72953	72954	interface	0	None
72954	72955	.	0	None

72956	72957	The	0	None
72957	72958	fine-structures	0	None
72958	72959	perpendicular	0	None
72959	72960	to	0	None
72960	72961	the	0	None
72961	72962	global	0	None
72962	72963	plane	0	None
72963	72964	of	0	None
72964	72965	monolayers	0	None
72965	72966	were	0	None
72966	72967	characterized	0	None
72967	72968	by	0	None
72968	72969	XRR	0	None
72969	72970	in	0	None
72970	72971	the	0	None
72971	72972	presence	0	None
72972	72973	of	0	None
72973	72974	Ni	0	None
72974	72975	(	0	None
72975	72976	2	0	None
72976	72977	)	0	None
72977	72978	(	0	None
72978	72979	+	0	None
72979	72980	)	0	None
72980	72981	ions	0	None
72981	72982	,	0	None
72982	72983	yielding	0	None
72983	72984	the	0	None
72984	72985	thickness	0	None
72985	72986	,	0	None
72986	72987	roughness	0	None
72987	72988	,	0	None
72988	72989	and	0	None
72989	72990	electron	0	None
72990	72991	density	0	None
72991	72992	of	0	None
72992	72993	the	0	None
72993	72994	stratified	0	None
72994	72995	lipid	0	None
72995	72996	monolayers	0	None
72996	72997	.	0	None

72998	72999	X-ray	0	None
72999	73000	fluorescence	0	None
73000	73001	intensities	0	None
73001	73002	from	0	None
73002	73003	Ni	0	None
73003	73004	Kα	0	None
73004	73005	core	0	None
73005	73006	levels	0	None
73006	73007	recorded	0	None
73007	73008	at	0	None
73008	73009	the	0	None
73009	73010	incidence	0	None
73010	73011	angles	0	None
73011	73012	below	0	None
73012	73013	and	0	None
73013	73014	above	0	None
73014	73015	the	0	None
73015	73016	critical	0	None
73016	73017	angle	0	None
73017	73018	of	0	None
73018	73019	total	0	None
73019	73020	reflection	0	None
73020	73021	allow	0	None
73021	73022	for	0	None
73022	73023	the	0	None
73023	73024	determination	0	None
73024	73025	of	0	None
73025	73026	the	0	None
73026	73027	position	0	None
73027	73028	and	0	None
73028	73029	lateral	0	None
73029	73030	density	0	None
73030	73031	of	0	None
73031	73032	Ni	0	None
73032	73033	(	0	None
73033	73034	2	0	None
73034	73035	)	0	None
73035	73036	(	0	None
73036	73037	+	0	None
73037	73038	)	0	None
73038	73039	ions	0	None
73039	73040	associated	0	None
73040	73041	with	0	None
73041	73042	chelator	0	None
73042	73043	headgroups	0	None
73043	73044	with	0	None
73044	73045	a	0	None
73045	73046	high	0	None
73046	73047	spatial	0	None
73047	73048	accuracy	0	None
73048	73049	(	0	None
73049	73050	±5	0	None
73050	73051	Å	0	None
73051	73052	)	0	None
73052	73053	.	0	None

73054	73055	The	0	None
73055	73056	coupling	0	None
73056	73057	of	0	None
73057	73058	histidine-tagged	0	None
73058	73061	Xenopus cadherin 11	1	GENE-Y
73061	73062	(	0	None
73062	73063	Xcad-11	0	None
73063	73064	)	0	None
73064	73065	can	0	None
73065	73066	also	0	None
73066	73067	be	0	None
73067	73068	identified	0	None
73068	73069	by	0	None
73069	73070	changes	0	None
73070	73071	in	0	None
73071	73072	the	0	None
73072	73073	fines-structures	0	None
73073	73074	using	0	None
73074	73075	XRR	0	None
73075	73076	.	0	None

73077	73078	Although	0	None
73078	73079	fluorescence	0	None
73079	73080	intensities	0	None
73080	73081	from	0	None
73081	73082	S	0	None
73082	73083	Kα	0	None
73083	73084	level	0	None
73084	73085	were	0	None
73085	73086	much	0	None
73086	73087	weaker	0	None
73087	73088	than	0	None
73088	73089	Ni	0	None
73089	73090	Kα	0	None
73090	73091	signals	0	None
73091	73092	,	0	None
73092	73093	we	0	None
73093	73094	could	0	None
73094	73095	detect	0	None
73095	73096	the	0	None
73096	73097	location	0	None
73097	73098	of	0	None
73098	73099	S	0	None
73099	73100	atoms	0	None
73100	73101	in	0	None
73101	73102	recombinant	0	None
73102	73103	Xcad-11	0	None
73103	73104	proteins	0	None
73104	73105	.	0	None
73105	73106	Tris	0	None
73106	73107	(	0	None
73107	73108	1-chloro-2-propyl	0	None
73108	73109	)	0	None
73109	73110	phosphate	0	None
73110	73111	(	0	None
73111	73112	TCPP	0	None
73112	73113	)	0	None
73113	73114	and	0	None
73114	73115	tris	0	None
73115	73116	(	0	None
73116	73117	1	0	None
73117	73118	,	0	None
73118	73119	3-dichloro-2-propyl	0	None
73119	73120	)	0	None
73120	73121	phosphate	0	None
73121	73122	(	0	None
73122	73123	TDCPP	0	None
73123	73124	)	0	None
73124	73125	are	0	None
73125	73126	organic	0	None
73126	73127	flame	0	None
73127	73128	retardants	0	None
73128	73129	detected	0	None
73129	73130	in	0	None
73130	73131	the	0	None
73131	73132	environment	0	None
73132	73133	and	0	None
73133	73134	biota	0	None
73134	73135	for	0	None
73135	73136	which	0	None
73136	73137	toxicological	0	None
73137	73138	data	0	None
73138	73139	for	0	None
73139	73140	avian	0	None
73140	73141	species	0	None
73141	73142	are	0	None
73142	73143	limited	0	None
73143	73144	.	0	None

73145	73146	In	0	None
73146	73147	this	0	None
73147	73148	study	0	None
73148	73149	,	0	None
73149	73150	domestic	0	None
73150	73151	chicken	0	None
73151	73152	eggs	0	None
73152	73153	were	0	None
73153	73154	injected	0	None
73154	73155	with	0	None
73155	73156	TCPP	0	None
73156	73157	or	0	None
73157	73158	TDCPP	0	None
73158	73159	(	0	None
73159	73160	maximum	0	None
73160	73161	dose	0	None
73161	73162	=	0	None
73162	73163	51600	0	None
73163	73164	and	0	None
73164	73165	45000	0	None
73165	73166	ng	0	None
73166	73167	/	0	None
73167	73168	g	0	None
73168	73169	egg	0	None
73169	73170	,	0	None
73170	73171	respectively	0	None
73171	73172	)	0	None
73172	73173	to	0	None
73173	73174	determine	0	None
73174	73175	dose-dependent	0	None
73175	73176	effects	0	None
73176	73177	on	0	None
73177	73178	pipping	0	None
73178	73179	success	0	None
73179	73180	,	0	None
73180	73181	development	0	None
73181	73182	,	0	None
73182	73183	hepatic	0	None
73183	73184	messenger	0	None
73184	73185	RNA	0	None
73185	73186	(	0	None
73186	73187	mRNA	0	None
73187	73188	)	0	None
73188	73189	expression	0	None
73189	73190	levels	0	None
73190	73191	of	0	None
73191	73192	genes	0	None
73192	73193	associated	0	None
73193	73194	with	0	None
73194	73195	xenobiotic	0	None
73195	73196	metabolism	0	None
73196	73197	and	0	None
73197	73198	the	0	None
73198	73199	thyroid	0	None
73199	73200	hormone	0	None
73200	73201	(	0	None
73201	73202	TH	0	None
73202	73203	)	0	None
73203	73204	pathway	0	None
73204	73205	,	0	None
73205	73206	and	0	None
73206	73207	TH	0	None
73207	73208	levels	0	None
73208	73209	following	0	None
73209	73210	20-22	0	None
73210	73211	days	0	None
73211	73212	of	0	None
73212	73213	incubation	0	None
73213	73214	.	0	None

73215	73216	Neither	0	None
73216	73217	compound	0	None
73217	73218	reduced	0	None
73218	73219	pipping	0	None
73219	73220	success;	0	None
73220	73221	however	0	None
73221	73222	,	0	None
73222	73223	TCPP	0	None
73223	73224	significantly	0	None
73224	73225	delayed	0	None
73225	73226	pipping	0	None
73226	73227	at	0	None
73227	73228	9240	0	None
73228	73229	and	0	None
73229	73230	51600	0	None
73230	73231	ng	0	None
73231	73232	/	0	None
73232	73233	g	0	None
73233	73234	and	0	None
73234	73235	reduced	0	None
73235	73236	tarsus	0	None
73236	73237	length	0	None
73237	73238	at	0	None
73238	73239	51600	0	None
73239	73240	ng	0	None
73240	73241	/	0	None
73241	73242	g	0	None
73242	73243	.	0	None

73244	73245	TDCPP	0	None
73245	73246	exposure	0	None
73246	73247	resulted	0	None
73247	73248	in	0	None
73248	73249	significant	0	None
73249	73250	decreases	0	None
73250	73251	in	0	None
73251	73252	head	0	None
73252	73253	plus	0	None
73253	73254	bill	0	None
73254	73255	length	0	None
73255	73256	,	0	None
73256	73257	embryo	0	None
73257	73258	mass	0	None
73258	73259	and	0	None
73259	73260	gallbladder	0	None
73260	73261	size	0	None
73261	73262	at	0	None
73262	73263	45000	0	None
73263	73264	ng	0	None
73264	73265	/	0	None
73265	73266	g	0	None
73266	73267	and	0	None
73267	73268	reduced	0	None
73268	73269	plasma	0	None
73269	73270	free	0	None
73270	73271	T4	0	None
73271	73272	levels	0	None
73272	73273	at	0	None
73273	73274	7640	0	None
73274	73275	ng	0	None
73275	73276	/	0	None
73276	73277	g	0	None
73277	73278	.	0	None

73279	73280	Type	0	None
73280	73281	I	0	None
73281	73282	deiodinase	0	None
73282	73283	,	0	None
73283	73284	liver	0	None
73284	73285	fatty-acid	0	None
73285	73286	binding	0	None
73286	73287	protein	0	None
73287	73288	and	0	None
73288	73289	cytochrome	3	GENE-N
73289	73290	P450	0	None
73290	73291	(	0	None
73291	73292	CYP	0	None
73292	73293	)	0	None
73293	73294	3A37	0	None
73294	73295	mRNA	0	None
73295	73296	levels	0	None
73296	73297	were	0	None
73297	73298	significantly	0	None
73298	73299	induced	0	None
73299	73300	by	0	None
73300	73301	TCPP	0	None
73301	73302	,	0	None
73302	73303	while	0	None
73303	73304	TDCPP	0	None
73304	73305	induced	0	None
73305	73306	CYP3A37	0	None
73306	73307	and	0	None
73307	73308	CYP2H1	0	None
73308	73309	.	0	None

73310	73311	Chemical	0	None
73311	73312	analysis	0	None
73312	73313	of	0	None
73313	73314	egg	0	None
73314	73315	contents	0	None
73315	73316	at	0	None
73316	73317	incubation	0	None
73317	73318	days	0	None
73318	73319	0	0	None
73319	73320	,	0	None
73320	73321	5	0	None
73321	73322	,	0	None
73322	73323	11	0	None
73323	73324	,	0	None
73324	73325	18	0	None
73325	73326	,	0	None
73326	73327	and	0	None
73327	73328	19	0	None
73328	73329	revealed	0	None
73329	73330	that	0	None
73330	73331	>92%	0	None
73331	73332	of	0	None
73332	73333	the	0	None
73333	73334	injected	0	None
73334	73335	TCPP	0	None
73335	73336	or	0	None
73336	73337	TDCPP	0	None
73337	73338	concentration	0	None
73338	73339	was	0	None
73339	73340	detectable	0	None
73340	73341	up	0	None
73341	73342	to	0	None
73342	73343	day	0	None
73343	73344	5;	0	None
73344	73345	however	0	None
73345	73346	,	0	None
73346	73347	<1%	0	None
73347	73348	was	0	None
73348	73349	detected	0	None
73349	73350	by	0	None
73350	73351	day	0	None
73351	73352	19	0	None
73352	73353	.	0	None

73354	73355	The	0	None
73355	73356	observed	0	None
73356	73357	phenotypic	0	None
73357	73358	responses	0	None
73358	73359	to	0	None
73359	73360	TCPP	0	None
73360	73361	and	0	None
73361	73362	TDCPP	0	None
73362	73363	exposure	0	None
73363	73364	may	0	None
73364	73365	be	0	None
73365	73366	associated	0	None
73366	73367	with	0	None
73367	73368	disruption	0	None
73368	73369	of	0	None
73369	73370	the	0	None
73370	73371	TH-axis	0	None
73371	73372	,	0	None
73372	73373	which	0	None
73373	73374	is	0	None
73374	73375	critical	0	None
73375	73376	for	0	None
73376	73377	normal	0	None
73377	73378	growth	0	None
73378	73379	and	0	None
73379	73380	development	0	None
73380	73381	in	0	None
73381	73382	birds	0	None
73382	73383	.	0	None

73384	73385	The	0	None
73385	73386	effects	0	None
73386	73387	of	0	None
73387	73388	TDCPP	0	None
73388	73389	on	0	None
73389	73390	the	0	None
73390	73391	gallbladder	0	None
73391	73392	indicate	0	None
73392	73393	that	0	None
73393	73394	the	0	None
73394	73395	disturbance	0	None
73395	73396	of	0	None
73396	73397	lipid	0	None
73397	73398	metabolism	0	None
73398	73399	is	0	None
73399	73400	a	0	None
73400	73401	likely	0	None
73401	73402	target	0	None
73402	73403	in	0	None
73403	73404	its	0	None
73404	73405	mechanism	0	None
73405	73406	of	0	None
73406	73407	toxicity	0	None
73407	73408	.	0	None
73408	73409	Anti-Ulcerative	0	None
73409	73410	Colitis	0	None
73410	73411	Activity	0	None
73411	73412	of	0	None
73412	73413	Compounds	0	None
73413	73414	from	0	None
73414	73415	Euphorbia	0	None
73415	73416	granuleta	0	None
73416	73417	Forssk	0	None
73417	73418	.	0	None
73418	73419	Selective	0	None
73419	73420	inhibition	0	None
73420	73421	of	0	None
73421	73422	cyclooxygenase	3	GENE-N
73422	73423	2	0	None
73423	73424	spares	0	None
73424	73425	renal	0	None
73425	73426	function	0	None
73426	73427	and	0	None
73427	73428	prostaglandin	0	None
73428	73429	synthesis	0	None
73429	73430	in	0	None
73430	73431	cirrhotic	0	None
73431	73432	rats	0	None
73432	73433	with	0	None
73433	73434	ascites	0	None
73434	73435	.	0	None
73435	73436	Over	0	None
73436	73437	the	0	None
73437	73438	last	0	None
73438	73439	years	0	None
73439	73440	,	0	None
73440	73441	considerable	0	None
73441	73442	progress	0	None
73442	73443	has	0	None
73443	73444	been	0	None
73444	73445	made	0	None
73445	73446	for	0	None
73446	73447	the	0	None
73447	73448	identification	0	None
73448	73449	and	0	None
73449	73450	characterization	0	None
73450	73451	of	0	None
73451	73452	drug	0	None
73452	73453	transporters	0	None
73453	73454	,	0	None
73454	73455	and	0	None
73455	73456	several	0	None
73456	73457	modeling	0	None
73457	73458	studies	0	None
73458	73459	have	0	None
73459	73460	been	0	None
73460	73461	undertaken	0	None
73461	73462	to	0	None
73462	73463	predict	0	None
73463	73464	their	0	None
73464	73465	effects	0	None
73465	73466	on	0	None
73466	73467	ADME	0	None
73467	73468	profiling	0	None
73468	73469	.	0	None

73470	73471	Thus	0	None
73471	73472	,	0	None
73472	73473	this	0	None
73473	73474	study	0	None
73474	73475	was	0	None
73475	73476	focused	0	None
73476	73477	on	0	None
73477	73478	the	0	None
73478	73479	peptide	0	None
73479	73480	transporter	0	None
73480	73481	hPepT2	0	None
73481	73482	,	0	None
73482	73483	which	0	None
73483	73484	influences	0	None
73484	73485	the	0	None
73485	73486	regional	0	None
73486	73487	pharmacokinetics	0	None
73487	73488	in	0	None
73488	73489	brain	0	None
73489	73490	,	0	None
73490	73491	the	0	None
73491	73492	reabsorption	0	None
73492	73493	from	0	None
73493	73494	renal	0	None
73494	73495	tubular	0	None
73495	73496	fluid	0	None
73496	73497	and	0	None
73497	73498	the	0	None
73498	73499	pulmonary	0	None
73499	73500	delivery	0	None
73500	73501	.	0	None

73502	73503	A	0	None
73503	73504	reliable	0	None
73504	73505	model	0	None
73505	73506	for	0	None
73506	73507	hPepT2	0	None
73507	73508	was	0	None
73508	73509	generated	0	None
73509	73510	by	0	None
73510	73511	fragments	0	None
73511	73512	based	0	None
73512	73513	on	0	None
73513	73514	the	0	None
73514	73515	resolved	0	None
73515	73516	structure	0	None
73516	73517	of	0	None
73517	73518	the	0	None
73518	73519	homologue	0	None
73519	73520	lactose	0	None
73520	73521	permease	0	None
73521	73522	LacY	0	None
73522	73523	and	0	None
73523	73524	the	0	None
73524	73525	structure	0	None
73525	73526	is	0	None
73526	73527	made	0	None
73527	73528	available	0	None
73528	73529	as	0	None
73529	73530	Supplementary	0	None
73530	73531	data	0	None
73531	73532	.	0	None

73533	73534	The	0	None
73534	73535	interaction	0	None
73535	73536	capacities	0	None
73536	73537	of	0	None
73537	73538	such	0	None
73538	73539	a	0	None
73539	73540	model	0	None
73540	73541	were	0	None
73541	73542	explored	0	None
73542	73543	by	0	None
73543	73544	docking	0	None
73544	73545	a	0	None
73545	73546	set	0	None
73546	73547	of	0	None
73547	73548	75	0	None
73548	73549	known	0	None
73549	73550	ligands	0	None
73550	73551	.	0	None

73552	73553	Docking	0	None
73553	73554	results	0	None
73554	73555	underlined	0	None
73555	73556	the	0	None
73556	73557	predilection	0	None
73557	73558	of	0	None
73558	73559	hPepT2	0	None
73559	73560	for	0	None
73560	73561	highly	0	None
73561	73562	hydrophobic	0	None
73562	73563	ligands	0	None
73563	73564	and	0	None
73564	73565	the	0	None
73565	73566	key	0	None
73566	73567	role	0	None
73567	73568	of	0	None
73568	73569	ionic	0	None
73569	73570	interactions	0	None
73570	73571	elicited	0	None
73571	73572	by	0	None
73572	73573	both	0	None
73573	73574	charged	0	None
73574	73575	termini	0	None
73575	73576	.	0	None

73577	73578	The	0	None
73578	73579	docking	0	None
73579	73580	results	0	None
73580	73581	were	0	None
73581	73582	further	0	None
73582	73583	verified	0	None
73583	73584	developing	0	None
73584	73585	a	0	None
73585	73586	pharmacophore	0	None
73586	73587	model	0	None
73587	73588	which	0	None
73588	73589	clarified	0	None
73589	73590	the	0	None
73590	73591	key	0	None
73591	73592	features	0	None
73592	73593	required	0	None
73593	73594	for	0	None
73594	73595	an	0	None
73595	73596	optimal	0	None
73596	73597	hPepT2	0	None
73597	73598	affinity	0	None
73598	73599	and	0	None
73599	73600	confirmed	0	None
73600	73601	the	0	None
73601	73602	main	0	None
73602	73603	factors	0	None
73603	73604	governing	0	None
73604	73605	the	0	None
73605	73606	hPepT2	0	None
73606	73607	/	0	None
73607	73608	hPepT1	0	None
73608	73609	selectivity	0	None
73609	73610	.	0	None

73611	73612	The	0	None
73612	73613	soundness	0	None
73613	73614	of	0	None
73614	73615	the	0	None
73615	73616	docking	0	None
73616	73617	results	0	None
73617	73618	and	0	None
73618	73619	the	0	None
73619	73620	agreement	0	None
73620	73621	with	0	None
73621	73622	the	0	None
73622	73623	pharmacophore	0	None
73623	73624	mapping	0	None
73624	73625	afford	0	None
73625	73626	an	0	None
73626	73627	encouraging	0	None
73627	73628	validation	0	None
73628	73629	for	0	None
73629	73630	the	0	None
73630	73631	proposed	0	None
73631	73632	hPepT2	0	None
73632	73633	model	0	None
73633	73634	and	0	None
73634	73635	suggest	0	None
73635	73636	that	0	None
73636	73637	it	0	None
73637	73638	can	0	None
73638	73639	be	0	None
73639	73640	conveniently	0	None
73640	73641	exploited	0	None
73641	73642	to	0	None
73642	73643	design	0	None
73643	73644	peptide-like	0	None
73644	73645	molecules	0	None
73645	73646	with	0	None
73646	73647	an	0	None
73647	73648	improved	0	None
73648	73649	affinity	0	None
73649	73650	for	0	None
73650	73651	this	0	None
73651	73652	transporter	0	None
73652	73653	.	0	None
73653	73654	Cellular	0	None
73654	73655	assessment	0	None
73655	73656	of	0	None
73656	73657	the	0	None
73657	73658	extract	0	None
73658	73659	of	0	None
73659	73660	bambangan	0	None
73660	73661	(	0	None
73661	73662	Mangifera	0	None
73662	73663	pajang	0	None
73663	73664	)	0	None
73664	73665	as	0	None
73665	73666	a	0	None
73666	73667	potential	0	None
73667	73668	cytoprotective	0	None
73668	73669	agent	0	None
73669	73670	for	0	None
73670	73671	the	0	None
73671	73672	human	0	None
73672	73673	hepatocellular	0	None
73673	73674	HepG2	0	None
73674	73675	cell	0	None
73675	73676	line	0	None
73676	73677	.	0	None
73677	73678	Aldosterone	0	None
73678	73679	induces	0	None
73679	73680	elastin	1	GENE-Y
73680	73681	production	0	None
73681	73682	in	0	None
73682	73683	cardiac	0	None
73683	73684	fibroblasts	0	None
73684	73685	through	0	None
73685	73686	activation	0	None
73686	73687	of	0	None
73687	73690	insulin-like growth factor-I	1	GENE-Y
73690	73691	receptors	0	None
73691	73692	in	0	None
73692	73693	a	0	None
73693	73694	mineralocorticoid	0	None
73694	73695	receptor-independent	0	None
73695	73696	manner	0	None
73696	73697	.	0	None
73697	73698	Candesartan	0	None
73698	73699	is	0	None
73699	73700	an	0	None
73700	73701	angiotensin	2	CHEMICAL
73701	73702	II	0	None
73702	73703	type	0	None
73703	73704	1	0	None
73704	73705	receptor	0	None
73705	73706	blocker	0	None
73706	73707	(	0	None
73707	73708	ARB	0	None
73708	73709	)	0	None
73709	73710	that	0	None
73710	73711	has	0	None
73711	73712	been	0	None
73712	73713	to	0	None
73713	73714	shown	0	None
73714	73715	to	0	None
73715	73716	limit	0	None
73716	73717	ischemic	0	None
73717	73718	stroke	0	None
73718	73719	and	0	None
73719	73720	improve	0	None
73720	73721	stroke	0	None
73721	73722	outcome	0	None
73722	73723	.	0	None

73724	73725	In	0	None
73725	73726	experimental	0	None
73726	73727	stroke	0	None
73727	73728	,	0	None
73728	73729	candesartan	0	None
73729	73730	induces	0	None
73730	73731	a	0	None
73731	73732	proangiogenic	0	None
73732	73733	effect	0	None
73733	73734	that	0	None
73734	73735	is	0	None
73735	73736	partly	0	None
73736	73737	attributable	0	None
73737	73738	to	0	None
73738	73742	vascular endothelial growth factor	1	GENE-Y
73742	73743	.	0	None

73744	73747	Brain-derived neurotrophic factor	1	GENE-Y
73747	73748	(	0	None
73748	73749	BDNF	1	GENE-Y
73749	73750	)	0	None
73750	73751	is	0	None
73751	73752	a	0	None
73752	73753	member	0	None
73753	73754	of	0	None
73754	73755	the	0	None
73755	73756	neurotrophin	0	None
73756	73757	family	0	None
73757	73758	that	0	None
73758	73759	has	0	None
73759	73760	been	0	None
73760	73761	reported	0	None
73761	73762	to	0	None
73762	73763	have	0	None
73763	73764	angiogenic	0	None
73764	73765	effects	0	None
73765	73766	and	0	None
73766	73767	play	0	None
73767	73768	an	0	None
73768	73769	important	0	None
73769	73770	role	0	None
73770	73771	in	0	None
73771	73772	recovery	0	None
73772	73773	after	0	None
73773	73774	stroke	0	None
73774	73775	.	0	None

73776	73777	The	0	None
73777	73778	purpose	0	None
73778	73779	of	0	None
73779	73780	this	0	None
73780	73781	investigation	0	None
73781	73782	was	0	None
73782	73783	to	0	None
73783	73784	determine	0	None
73784	73785	the	0	None
73785	73786	role	0	None
73786	73787	of	0	None
73787	73788	BDNF	1	GENE-Y
73788	73789	in	0	None
73789	73790	the	0	None
73790	73791	proangiogenic	0	None
73791	73792	effect	0	None
73792	73793	of	0	None
73793	73794	candesartan	0	None
73794	73795	in	0	None
73795	73796	the	0	None
73796	73797	brain	0	None
73797	73798	under	0	None
73798	73799	hypertensive	0	None
73799	73800	conditions	0	None
73800	73801	.	0	None

73802	73803	Accordingly	0	None
73803	73804	,	0	None
73804	73805	spontaneously	0	None
73805	73806	hypertensive	0	None
73806	73807	rats	0	None
73807	73808	were	0	None
73808	73809	treated	0	None
73809	73810	with	0	None
73810	73811	candesartan	0	None
73811	73812	,	0	None
73812	73813	and	0	None
73813	73814	brain	0	None
73814	73815	tissue	0	None
73815	73816	samples	0	None
73816	73817	were	0	None
73817	73818	collected	0	None
73818	73819	for	0	None
73819	73820	quantification	0	None
73820	73821	of	0	None
73821	73822	BDNF	1	GENE-Y
73822	73823	expression	0	None
73823	73824	.	0	None

73825	73826	In	0	None
73826	73827	addition	0	None
73827	73828	,	0	None
73828	73829	human	0	None
73829	73830	cerebromicrovascular	0	None
73830	73831	endothelial	0	None
73831	73832	cells	0	None
73832	73833	were	0	None
73833	73834	treated	0	None
73834	73835	with	0	None
73835	73836	either	0	None
73836	73837	low-dose	0	None
73837	73838	(	0	None
73838	73839	1	0	None
73839	73840	ƒM	0	None
73840	73841	)	0	None
73841	73842	or	0	None
73842	73843	high-dose	0	None
73843	73844	(	0	None
73844	73845	1	0	None
73845	73846	µM	0	None
73846	73847	)	0	None
73847	73848	angiotensin	2	CHEMICAL
73848	73849	II	0	None
73849	73850	alone	0	None
73850	73851	or	0	None
73851	73852	in	0	None
73852	73853	combination	0	None
73853	73854	with	0	None
73854	73855	candesartan	0	None
73855	73856	(	0	None
73856	73857	0	0	None
73857	73858	.	0	None
73858	73859	16	0	None
73859	73860	µM	0	None
73860	73861	)	0	None
73861	73862	to	0	None
73862	73863	assess	0	None
73863	73864	the	0	None
73864	73865	effect	0	None
73865	73866	of	0	None
73866	73867	candesartan	0	None
73867	73868	treatment	0	None
73868	73869	and	0	None
73869	73870	BDNF	1	GENE-Y
73870	73871	involvement	0	None
73871	73872	in	0	None
73872	73873	the	0	None
73873	73874	behavior	0	None
73874	73875	of	0	None
73875	73876	endothelial	0	None
73876	73877	cells	0	None
73877	73878	.	0	None

73879	73880	Candesartan	0	None
73880	73881	significantly	0	None
73881	73882	increased	0	None
73882	73883	the	0	None
73883	73884	expression	0	None
73884	73885	of	0	None
73885	73886	BDNF	1	GENE-Y
73886	73887	in	0	None
73887	73888	the	0	None
73888	73889	SHR	0	None
73889	73890	(	0	None
73890	73891	P	0	None
73891	73892	<	0	None
73892	73893	0	0	None
73893	73894	.	0	None
73894	73895	05	0	None
73895	73896	)	0	None
73896	73897	.	0	None

73898	73899	In	0	None
73899	73900	addition	0	None
73900	73901	,	0	None
73901	73902	candesartan	0	None
73902	73903	reversed	0	None
73903	73904	the	0	None
73904	73905	antiangiogenic	0	None
73905	73906	effect	0	None
73906	73907	of	0	None
73907	73908	the	0	None
73908	73909	1-µM	0	None
73909	73910	dose	0	None
73910	73911	of	0	None
73911	73912	AngII	0	None
73912	73913	(	0	None
73913	73914	P	0	None
73914	73915	=	0	None
73915	73916	0	0	None
73916	73917	.	0	None
73917	73918	0001	0	None
73918	73919	)	0	None
73919	73920	.	0	None

73921	73922	The	0	None
73922	73923	observed	0	None
73923	73924	effects	0	None
73924	73925	of	0	None
73925	73926	candesartan	0	None
73926	73927	were	0	None
73927	73928	ablated	0	None
73928	73929	by	0	None
73929	73930	neutralizing	0	None
73930	73931	the	0	None
73931	73932	effects	0	None
73932	73933	of	0	None
73933	73934	BDNF	1	GENE-Y
73934	73935	.	0	None

73936	73937	Treatment	0	None
73937	73938	with	0	None
73938	73939	the	0	None
73939	73940	AT2	0	None
73940	73941	antagonist	0	None
73941	73942	PD-123319	2	CHEMICAL
73942	73943	significantly	0	None
73943	73944	reduced	0	None
73944	73945	tube-like	0	None
73945	73946	formation	0	None
73946	73947	in	0	None
73947	73948	endothelial	0	None
73948	73949	cells	0	None
73949	73950	.	0	None

73951	73952	AT2	0	None
73952	73953	stimulation	0	None
73953	73954	induced	0	None
73954	73955	the	0	None
73955	73956	BDNF	1	GENE-Y
73956	73957	expression	0	None
73957	73958	and	0	None
73958	73959	migration	0	None
73959	73960	(	0	None
73960	73961	P	0	None
73961	73962	<	0	None
73962	73963	0	0	None
73963	73964	.	0	None
73964	73965	05	0	None
73965	73966	)	0	None
73966	73967	.	0	None

73968	73969	In	0	None
73969	73970	conclusion	0	None
73970	73971	,	0	None
73971	73972	candesartan	0	None
73972	73973	exerts	0	None
73973	73974	a	0	None
73974	73975	proangiogenic	0	None
73975	73976	effect	0	None
73976	73977	on	0	None
73977	73978	brain	0	None
73978	73979	microvascular	0	None
73979	73980	endothelial	0	None
73980	73981	cells	0	None
73981	73982	treated	0	None
73982	73983	with	0	None
73983	73984	angiotensin	2	CHEMICAL
73984	73985	II	0	None
73985	73986	.	0	None

73987	73988	This	0	None
73988	73989	response	0	None
73989	73990	is	0	None
73990	73991	attributable	0	None
73991	73992	to	0	None
73992	73993	increased	0	None
73993	73994	BDNF	1	GENE-Y
73994	73995	expression	0	None
73995	73996	and	0	None
73996	73997	is	0	None
73997	73998	mediated	0	None
73998	73999	through	0	None
73999	74000	stimulation	0	None
74000	74001	of	0	None
74001	74002	the	0	None
74002	74004	AT2 receptor	1	GENE-Y
74004	74005	.	0	None
74005	74006	First-Line	0	None
74006	74007	Management	0	None
74007	74008	of	0	None
74008	74009	EGFR-Mutated	0	None
74009	74010	Advanced	0	None
74010	74011	Lung	0	None
74011	74012	Adenocarcinoma	0	None
74012	74013	:	0	None
74013	74014	Recent	0	None
74014	74015	Developments	0	None
74015	74016	.	0	None
74016	74017	Pathophysiological	0	None
74017	74018	roles	0	None
74018	74019	of	0	None
74019	74021	aldo-keto reductases	3	GENE-N
74021	74022	(	0	None
74022	74023	AKR1C1	0	None
74023	74024	and	0	None
74024	74025	AKR1C3	1	GENE-Y
74025	74026	)	0	None
74026	74027	in	0	None
74027	74028	development	0	None
74028	74029	of	0	None
74029	74030	cisplatin	0	None
74030	74031	resistance	0	None
74031	74032	in	0	None
74032	74033	human	0	None
74033	74034	colon	0	None
74034	74035	cancers	0	None
74035	74036	.	0	None
74036	74037	Posttranslational	0	None
74037	74038	modification	0	None
74038	74039	of	0	None
74039	74040	the	0	None
74040	74041	neural	0	None
74041	74042	cell	0	None
74042	74043	adhesion	0	None
74043	74044	molecule	0	None
74044	74045	(	0	None
74045	74046	NCAM	0	None
74046	74047	)	0	None
74047	74048	by	0	None
74048	74049	polysialic	0	None
74049	74050	acid	0	None
74050	74051	(	0	None
74051	74052	polySia	0	None
74052	74053	)	0	None
74053	74054	is	0	None
74054	74055	well	0	None
74055	74056	studied	0	None
74056	74057	in	0	None
74057	74058	the	0	None
74058	74059	nervous	0	None
74059	74060	system	0	None
74060	74061	and	0	None
74061	74062	described	0	None
74062	74063	as	0	None
74063	74064	a	0	None
74064	74065	dynamic	0	None
74065	74066	modulator	0	None
74066	74067	of	0	None
74067	74068	plastic	0	None
74068	74069	processes	0	None
74069	74070	like	0	None
74070	74071	precursor	0	None
74071	74072	cell	0	None
74072	74073	migration	0	None
74073	74074	,	0	None
74074	74075	axon	0	None
74075	74076	fasciculation	0	None
74076	74077	,	0	None
74077	74078	and	0	None
74078	74079	synaptic	0	None
74079	74080	plasticity	0	None
74080	74081	.	0	None

74082	74083	Here	0	None
74083	74084	,	0	None
74084	74085	we	0	None
74085	74086	describe	0	None
74086	74087	a	0	None
74087	74088	novel	0	None
74088	74089	function	0	None
74089	74090	of	0	None
74090	74091	polysialylated	0	None
74091	74092	NCAM	0	None
74092	74093	(	0	None
74093	74094	polySia-NCAM	0	None
74094	74095	)	0	None
74095	74096	in	0	None
74096	74097	innate	0	None
74097	74098	immunity	0	None
74098	74099	of	0	None
74099	74100	the	0	None
74100	74101	lung	0	None
74101	74102	.	0	None

74103	74104	In	0	None
74104	74105	mature	0	None
74105	74106	lung	0	None
74106	74107	tissue	0	None
74107	74108	of	0	None
74108	74109	healthy	0	None
74109	74110	donors	0	None
74110	74111	,	0	None
74111	74112	polySia	0	None
74112	74113	was	0	None
74113	74114	exclusively	0	None
74114	74115	attached	0	None
74115	74116	to	0	None
74116	74117	the	0	None
74117	74118	transmembrane	0	None
74118	74119	isoform	0	None
74119	74120	NCAM-140	0	None
74120	74121	and	0	None
74121	74122	located	0	None
74122	74123	to	0	None
74123	74124	intracellular	0	None
74124	74125	compartments	0	None
74125	74126	of	0	None
74126	74127	epithelial	0	None
74127	74128	cells	0	None
74128	74129	.	0	None

74130	74131	In	0	None
74131	74132	patients	0	None
74132	74133	with	0	None
74133	74134	chronic	0	None
74134	74135	obstructive	0	None
74135	74136	pulmonary	0	None
74136	74137	disease	0	None
74137	74138	,	0	None
74138	74139	however	0	None
74139	74140	,	0	None
74140	74141	increased	0	None
74141	74142	polySia	0	None
74142	74143	levels	0	None
74143	74144	and	0	None
74144	74145	processing	0	None
74145	74146	of	0	None
74146	74147	the	0	None
74147	74148	NCAM	0	None
74148	74149	carrier	0	None
74149	74150	were	0	None
74150	74151	observed	0	None
74151	74152	.	0	None

74153	74154	Processing	0	None
74154	74155	of	0	None
74155	74156	polysialylated	0	None
74156	74157	NCAM	0	None
74157	74158	was	0	None
74158	74159	reproduced	0	None
74159	74160	in	0	None
74160	74161	a	0	None
74161	74162	mouse	0	None
74162	74163	model	0	None
74163	74164	by	0	None
74164	74165	bleomycin	0	None
74165	74166	administration	0	None
74166	74167	leading	0	None
74167	74168	to	0	None
74168	74169	an	0	None
74169	74170	activation	0	None
74170	74171	of	0	None
74171	74172	the	0	None
74172	74173	inflammasome	0	None
74173	74174	and	0	None
74174	74175	secretion	0	None
74175	74176	of	0	None
74176	74177	interleukin	1	GENE-Y
74177	74178	(	0	None
74178	74179	IL	0	None
74179	74180	)	0	None
74180	74181	-1β	0	None
74181	74182	.	0	None

74183	74184	As	0	None
74184	74185	shown	0	None
74185	74186	in	0	None
74186	74187	a	0	None
74187	74188	cell	0	None
74188	74189	culture	0	None
74189	74190	model	0	None
74190	74191	,	0	None
74191	74192	polySia-NCAM-140	0	None
74192	74193	was	0	None
74193	74194	kept	0	None
74194	74195	in	0	None
74195	74196	the	0	None
74196	74197	late	0	None
74197	74198	trans-Golgi	0	None
74198	74199	apparatus	0	None
74199	74200	of	0	None
74200	74201	lung	0	None
74201	74202	epithelial	0	None
74202	74203	cells	0	None
74203	74204	and	0	None
74204	74205	stimulation	0	None
74205	74206	by	0	None
74206	74207	IL-1β	0	None
74207	74208	or	0	None
74208	74209	lipopolysaccharide	0	None
74209	74210	induced	0	None
74210	74211	metalloprotease-mediated	0	None
74211	74212	ectodomain	0	None
74212	74213	shedding	0	None
74213	74214	,	0	None
74214	74215	resulting	0	None
74215	74216	in	0	None
74216	74217	the	0	None
74217	74218	secretion	0	None
74218	74219	of	0	None
74219	74220	soluble	0	None
74220	74221	polySia-NCAM	0	None
74221	74222	.	0	None

74223	74224	Interestingly	0	None
74224	74225	,	0	None
74225	74226	polySia	0	None
74226	74227	chains	0	None
74227	74228	of	0	None
74228	74229	secreted	0	None
74229	74230	NCAM	0	None
74230	74231	neutralized	0	None
74231	74232	the	0	None
74232	74233	cytotoxic	0	None
74233	74234	activity	0	None
74234	74235	of	0	None
74235	74236	extracellular	0	None
74236	74237	histones	0	None
74237	74238	as	0	None
74238	74239	well	0	None
74239	74240	as	0	None
74240	74241	DNA	0	None
74241	74242	/	0	None
74242	74243	histone-network-containing	0	None
74243	74244	"neutrophil	0	None
74244	74245	extracellular	0	None
74245	74246	traps"	0	None
74246	74247	,	0	None
74247	74248	which	0	None
74248	74249	are	0	None
74249	74250	formed	0	None
74250	74251	during	0	None
74251	74252	invasion	0	None
74252	74253	of	0	None
74253	74254	microorganisms	0	None
74254	74255	.	0	None

74256	74257	Thus	0	None
74257	74258	,	0	None
74258	74259	shedding	0	None
74259	74260	of	0	None
74260	74261	polySia-NCAM	0	None
74261	74262	by	0	None
74262	74263	lung	0	None
74263	74264	epithelial	0	None
74264	74265	cells	0	None
74265	74266	may	0	None
74266	74267	provide	0	None
74267	74268	a	0	None
74268	74269	host-protective	0	None
74269	74270	mechanism	0	None
74270	74271	to	0	None
74271	74272	reduce	0	None
74272	74273	tissue	0	None
74273	74274	damage	0	None
74274	74275	during	0	None
74275	74276	inflammatory	0	None
74276	74277	processes	0	None
74277	74278	.	0	None
74278	74279	RATIONALE	0	None
74279	74280	:	0	None
74280	74281	Prepulse	0	None
74281	74282	inhibition	0	None
74282	74283	(	0	None
74283	74284	PPI	0	None
74284	74285	)	0	None
74285	74286	is	0	None
74286	74287	an	0	None
74287	74288	operational	0	None
74288	74289	measure	0	None
74289	74290	of	0	None
74290	74291	sensorimotor	0	None
74291	74292	gating	0	None
74292	74293	that	0	None
74293	74294	is	0	None
74294	74295	deficient	0	None
74295	74296	in	0	None
74296	74297	schizophrenia	0	None
74297	74298	patients	0	None
74298	74299	.	0	None

74300	74301	In	0	None
74301	74302	rats	0	None
74302	74303	,	0	None
74303	74304	PPI	0	None
74304	74305	deficits	0	None
74305	74306	induced	0	None
74306	74307	by	0	None
74307	74308	dopamine	0	None
74308	74309	(	0	None
74309	74310	DA	0	None
74310	74311	)	0	None
74311	74312	agonists	0	None
74312	74313	are	0	None
74313	74314	reversed	0	None
74314	74315	by	0	None
74315	74316	antipsychotics	0	None
74316	74317	.	0	None

74318	74319	Inhibition	0	None
74319	74320	of	0	None
74320	74321	the	0	None
74321	74322	striatum-rich	0	None
74322	74323	phosphodiesterase	3	GENE-N
74323	74324	(	0	None
74324	74325	PDE	0	None
74325	74326	)	0	None
74326	74327	10A	0	None
74327	74328	may	0	None
74328	74329	represent	0	None
74329	74330	a	0	None
74330	74331	novel	0	None
74331	74332	antipsychotic	0	None
74332	74333	mechanism	0	None
74333	74334	.	0	None

74335	74336	Previous	0	None
74336	74337	studies	0	None
74337	74338	were	0	None
74338	74339	controversial	0	None
74339	74340	,	0	None
74340	74341	showing	0	None
74341	74342	antipsychotic-like	0	None
74342	74343	profiles	0	None
74343	74344	in	0	None
74344	74345	measures	0	None
74345	74346	of	0	None
74346	74347	PPI	0	None
74347	74348	for	0	None
74348	74349	the	0	None
74349	74350	preferential	0	None
74350	74351	PDE10A	0	None
74351	74352	inhibitor	0	None
74352	74353	papaverine	0	None
74353	74354	(	0	None
74354	74355	PAP	0	None
74355	74356	)	0	None
74356	74357	but	0	None
74357	74358	not	0	None
74358	74359	the	0	None
74359	74360	novel	0	None
74360	74361	PDE10A	0	None
74361	74362	inhibitor	0	None
74362	74363	TP-10	0	None
74363	74364	.	0	None

74365	74366	OBJECTIVE	0	None
74366	74367	:	0	None
74367	74368	The	0	None
74368	74369	aim	0	None
74369	74370	of	0	None
74370	74371	the	0	None
74371	74372	study	0	None
74372	74373	was	0	None
74373	74374	to	0	None
74374	74375	evaluate	0	None
74375	74376	the	0	None
74376	74377	antipsychotic	0	None
74377	74378	profile	0	None
74378	74379	of	0	None
74379	74380	PAP	0	None
74380	74381	in	0	None
74381	74382	rats	0	None
74382	74383	using	0	None
74383	74384	PPI	0	None
74384	74385	.	0	None

74386	74387	MATERIALS	0	None
74387	74388	AND	0	None
74388	74389	METHODS	0	None
74389	74390	:	0	None
74390	74391	PPI	0	None
74391	74392	deficits	0	None
74392	74393	were	0	None
74393	74394	induced	0	None
74394	74395	in	0	None
74395	74396	rats	0	None
74396	74397	by	0	None
74397	74398	apomorphine	0	None
74398	74399	(	0	None
74399	74400	APO;	0	None
74400	74401	0	0	None
74401	74402	.	0	None
74402	74403	1	0	None
74403	74404	,	0	None
74404	74405	0	0	None
74405	74406	.	0	None
74406	74407	5	0	None
74407	74408	mg	2	CHEMICAL
74408	74409	/	0	None
74409	74410	kg	0	None
74410	74411	)	0	None
74411	74412	or	0	None
74412	74413	D	0	None
74413	74414	:	0	None
74414	74415	-amphetamine	0	None
74415	74416	(	0	None
74416	74417	AMPH;	0	None
74417	74418	4	0	None
74418	74419	mg	2	CHEMICAL
74419	74420	/	0	None
74420	74421	kg	0	None
74421	74422	)	0	None
74422	74423	.	0	None

74424	74425	PAP	0	None
74425	74426	(	0	None
74426	74427	3	0	None
74427	74428	,	0	None
74428	74429	10	0	None
74429	74430	,	0	None
74430	74431	30	0	None
74431	74432	mg	2	CHEMICAL
74432	74433	/	0	None
74433	74434	kg	0	None
74434	74435	)	0	None
74435	74436	or	0	None
74436	74437	haloperidol	2	CHEMICAL
74437	74438	(	0	None
74438	74439	HAL;	0	None
74439	74440	0	0	None
74440	74441	.	0	None
74441	74442	1	0	None
74442	74443	mg	2	CHEMICAL
74443	74444	/	0	None
74444	74445	kg	0	None
74445	74446	)	0	None
74446	74447	was	0	None
74447	74448	tested	0	None
74448	74449	against	0	None
74449	74450	these	0	None
74450	74451	agonists	0	None
74451	74452	in	0	None
74452	74453	Sprague-Dawley	0	None
74453	74454	(	0	None
74454	74455	SD	0	None
74455	74456	)	0	None
74456	74457	or	0	None
74457	74458	Wistar	0	None
74458	74459	(	0	None
74459	74460	WI	0	None
74460	74461	)	0	None
74461	74462	rats	0	None
74462	74463	.	0	None

74464	74465	Prepulse	0	None
74465	74466	intervals	0	None
74466	74467	ranged	0	None
74467	74468	from	0	None
74468	74469	10	0	None
74469	74470	to	0	None
74470	74471	120	0	None
74471	74472	ms	0	None
74472	74473	.	0	None

74474	74475	Further	0	None
74475	74476	tests	0	None
74476	74477	evaluated	0	None
74477	74478	the	0	None
74478	74479	effects	0	None
74479	74480	of	0	None
74480	74481	PAP	0	None
74481	74482	on	0	None
74482	74483	spontaneous	0	None
74483	74484	locomotion	0	None
74484	74485	,	0	None
74485	74486	AMPH	0	None
74486	74487	(	0	None
74487	74488	1	0	None
74488	74489	mg	2	CHEMICAL
74489	74490	/	0	None
74490	74491	kg	0	None
74491	74492	)	0	None
74492	74493	-induced	0	None
74493	74494	hyperlocomotion	0	None
74494	74495	,	0	None
74495	74496	and	0	None
74496	74497	core	0	None
74497	74498	body	0	None
74498	74499	temperature	0	None
74499	74500	(	0	None
74500	74501	T	0	None
74501	74502	degrees	0	None
74502	74503	)	0	None
74503	74504	.	0	None

74505	74506	RESULTS	0	None
74506	74507	:	0	None
74507	74508	HAL	0	None
74508	74509	reversed	0	None
74509	74510	APO-induced	0	None
74510	74511	PPI	0	None
74511	74512	deficits	0	None
74512	74513	but	0	None
74513	74514	PAP	0	None
74514	74515	failed	0	None
74515	74516	to	0	None
74516	74517	reverse	0	None
74517	74518	APO-	0	None
74518	74519	and	0	None
74519	74520	AMPH-induced	0	None
74520	74521	PPI	0	None
74521	74522	deficits	0	None
74522	74523	at	0	None
74523	74524	all	0	None
74524	74525	doses	0	None
74525	74526	,	0	None
74526	74527	strains	0	None
74527	74528	,	0	None
74528	74529	pretreatment	0	None
74529	74530	times	0	None
74530	74531	,	0	None
74531	74532	and	0	None
74532	74533	prepulse	0	None
74533	74534	intervals	0	None
74534	74535	.	0	None

74536	74537	PAP	0	None
74537	74538	(	0	None
74538	74539	30	0	None
74539	74540	mg	2	CHEMICAL
74540	74541	/	0	None
74541	74542	kg	0	None
74542	74543	)	0	None
74543	74544	significantly	0	None
74544	74545	reduced	0	None
74545	74546	AMPH	0	None
74546	74547	hyperlocomotion	0	None
74547	74548	in	0	None
74548	74549	SD	0	None
74549	74550	rats	0	None
74550	74551	,	0	None
74551	74552	and	0	None
74552	74553	a	0	None
74553	74554	similar	0	None
74554	74555	pattern	0	None
74555	74556	was	0	None
74556	74557	detected	0	None
74557	74558	in	0	None
74558	74559	WI	0	None
74559	74560	rats	0	None
74560	74561	.	0	None

74562	74563	This	0	None
74563	74564	PAP	0	None
74564	74565	dose	0	None
74565	74566	also	0	None
74566	74567	strongly	0	None
74567	74568	reduced	0	None
74568	74569	spontaneous	0	None
74569	74570	locomotion	0	None
74570	74571	and	0	None
74571	74572	T	0	None
74572	74573	degrees	0	None
74573	74574	in	0	None
74574	74575	SD	0	None
74575	74576	rats	0	None
74576	74577	.	0	None

74578	74579	CONCLUSION	0	None
74579	74580	:	0	None
74580	74581	Our	0	None
74581	74582	study	0	None
74582	74583	does	0	None
74583	74584	not	0	None
74584	74585	support	0	None
74585	74586	an	0	None
74586	74587	antipsychotic-like	0	None
74587	74588	profile	0	None
74588	74589	of	0	None
74589	74590	PAP	0	None
74590	74591	in	0	None
74591	74592	dopaminergic	0	None
74592	74593	PPI	0	None
74593	74594	models	0	None
74594	74595	.	0	None
74595	74596	Norepinephrine	0	None
74596	74597	(	0	None
74597	74598	10	0	None
74598	74599	microM	0	None
74599	74600	)	0	None
74600	74601	,	0	None
74601	74602	methoxamine	0	None
74602	74603	(	0	None
74603	74604	100	0	None
74604	74605	microM	0	None
74605	74606	)	0	None
74606	74607	and	0	None
74607	74608	clonidine	0	None
74608	74609	(	0	None
74609	74610	100	0	None
74610	74611	microM	0	None
74611	74612	)	0	None
74612	74613	with	0	None
74613	74614	guanosine	0	None
74614	74615	5'-triphosphate	0	None
74615	74616	(	0	None
74616	74617	GTP	0	None
74617	74618	,	0	None
74618	74619	50	0	None
74619	74620	microM	0	None
74620	74621	)	0	None
74621	74622	or	0	None
74622	74623	guanosine	0	None
74623	74624	5'-O-	0	None
74624	74625	(	0	None
74625	74626	3-thiotriphosphate	0	None
74626	74627	)	0	None
74627	74628	(	0	None
74628	74629	GTP	0	None
74629	74630	gamma-S	0	None
74630	74631	,	0	None
74631	74632	10	0	None
74632	74633	microM	0	None
74633	74634	)	0	None
74634	74635	all	0	None
74635	74636	significantly	0	None
74636	74637	enhanced	0	None
74637	74638	the	0	None
74638	74639	contraction	0	None
74639	74640	induced	0	None
74640	74641	by	0	None
74641	74642	0	0	None
74642	74643	.	0	None
74643	74644	3	0	None
74644	74645	microM	0	None
74645	74646	Ca2	0	None
74646	74647	+	0	None
74647	74648	(	0	None
74648	74649	pCa6	0	None
74649	74650	.	0	None
74650	74651	5	0	None
74651	74652	)	0	None
74652	74653	in	0	None
74653	74654	beta-escin-skinned	0	None
74654	74655	smooth	0	None
74655	74656	muscle	0	None
74656	74657	of	0	None
74657	74658	rabbit	0	None
74658	74659	thoracic	0	None
74659	74660	aorta	0	None
74660	74661	.	0	None

74662	74663	The	0	None
74663	74664	enhancement	0	None
74664	74665	of	0	None
74665	74666	Ca2	0	None
74666	74667	+	0	None
74667	74668	contraction	0	None
74668	74669	produced	0	None
74669	74670	by	0	None
74670	74671	norepinephrine	2	CHEMICAL
74671	74672	was	0	None
74672	74673	greater	0	None
74673	74674	than	0	None
74674	74675	that	0	None
74675	74676	produced	0	None
74676	74677	by	0	None
74677	74678	methoxamine	0	None
74678	74679	or	0	None
74679	74680	clonidine	0	None
74680	74681	.	0	None

74682	74683	In	0	None
74683	74684	beta-escin-skinned	0	None
74684	74685	strips	0	None
74685	74686	of	0	None
74686	74687	chloroethylclonidine-pretreated	0	None
74687	74688	smooth	0	None
74688	74689	muscle	0	None
74689	74690	,	0	None
74690	74691	the	0	None
74691	74692	enhancement	0	None
74692	74693	of	0	None
74693	74694	Ca2	0	None
74694	74695	+	0	None
74695	74696	contraction	0	None
74696	74697	produced	0	None
74697	74698	by	0	None
74698	74699	norepinephrine	2	CHEMICAL
74699	74700	was	0	None
74700	74701	significantly	0	None
74701	74702	decreased	0	None
74702	74703	,	0	None
74703	74704	whereas	0	None
74704	74705	the	0	None
74705	74706	amplitude	0	None
74706	74707	was	0	None
74707	74708	the	0	None
74708	74709	same	0	None
74709	74710	as	0	None
74710	74711	that	0	None
74711	74712	produced	0	None
74712	74713	by	0	None
74713	74714	methoxamine	0	None
74714	74715	or	0	None
74715	74716	clonidine;	0	None
74716	74717	this	0	None
74717	74718	enhancement	0	None
74718	74719	was	0	None
74719	74720	inhibited	0	None
74720	74721	by	0	None
74721	74722	the	0	None
74722	74723	selective	0	None
74723	74724	alpha	0	None
74724	74725	1A-adrenoceptor	0	None
74725	74726	antagonist	0	None
74726	74727	WB	0	None
74727	74728	4101	0	None
74728	74729	(	0	None
74729	74730	100	0	None
74730	74731	nM	0	None
74731	74732	)	0	None
74732	74733	.	0	None

74734	74735	The	0	None
74735	74736	enhancement	0	None
74736	74737	of	0	None
74737	74738	Ca2	0	None
74738	74739	+	0	None
74739	74740	contraction	0	None
74740	74741	produced	0	None
74741	74742	by	0	None
74742	74743	methoxamine	0	None
74743	74744	and	0	None
74744	74745	clonidine	0	None
74745	74746	was	0	None
74746	74747	not	0	None
74747	74748	affected	0	None
74748	74749	by	0	None
74749	74750	chloroethylclonidine	0	None
74750	74751	pretreatment	0	None
74751	74752	.	0	None

74753	74754	The	0	None
74754	74755	effects	0	None
74755	74756	of	0	None
74756	74757	methoxamine	0	None
74757	74758	,	0	None
74758	74759	clonidine	0	None
74759	74760	and	0	None
74760	74761	norepinephrine	2	CHEMICAL
74761	74762	in	0	None
74762	74763	the	0	None
74763	74764	chloroethylclonidine-pretreated	0	None
74764	74765	tissue	0	None
74765	74766	were	0	None
74766	74767	all	0	None
74767	74768	inhibited	0	None
74768	74769	by	0	None
74769	74770	guanosine	0	None
74770	74771	5'-O-	0	None
74771	74772	(	0	None
74772	74773	2-thiodiphosphate	0	None
74773	74774	)	0	None
74774	74775	(	0	None
74775	74776	GDP	0	None
74776	74777	beta-S	0	None
74777	74778	,	0	None
74778	74779	1	0	None
74779	74780	mM	0	None
74780	74781	)	0	None
74781	74782	and	0	None
74782	74783	1-	0	None
74783	74784	(	0	None
74784	74785	5-isoquinolinylsulfonyl	0	None
74785	74786	)	0	None
74786	74787	-methylpiperazine	0	None
74787	74788	(	0	None
74788	74789	H-7	0	None
74789	74790	,	0	None
74790	74791	20	0	None
74791	74792	microM	0	None
74792	74793	)	0	None
74793	74794	.	0	None

74795	74796	Furthermore	0	None
74796	74797	,	0	None
74797	74798	the	0	None
74798	74799	phosphorylation	0	None
74799	74800	of	0	None
74800	74801	myosin	0	None
74801	74802	light	0	None
74802	74803	chain	0	None
74803	74804	produced	0	None
74804	74805	by	0	None
74805	74806	norepinephrine	2	CHEMICAL
74806	74807	was	0	None
74807	74808	greater	0	None
74808	74809	than	0	None
74809	74810	that	0	None
74810	74811	produced	0	None
74811	74812	by	0	None
74812	74813	clonidine	0	None
74813	74814	.	0	None

74815	74816	These	0	None
74816	74817	results	0	None
74817	74818	suggest	0	None
74818	74819	that	0	None
74819	74820	both	0	None
74820	74821	alpha	0	None
74821	74822	1-adrenoceptor	0	None
74822	74823	subtypes	0	None
74823	74824	(	0	None
74824	74825	alpha	0	None
74825	74826	1A	0	None
74826	74827	and	0	None
74827	74828	alpha	0	None
74828	74829	1B	0	None
74829	74830	)	0	None
74830	74831	increase	0	None
74831	74832	the	0	None
74832	74833	Ca2	0	None
74833	74834	+	0	None
74834	74835	sensitivity	0	None
74835	74836	of	0	None
74836	74837	contractile	0	None
74837	74838	elements	0	None
74838	74839	,	0	None
74839	74840	and	0	None
74840	74841	that	0	None
74841	74842	the	0	None
74842	74843	Ca2	0	None
74843	74844	+	0	None
74844	74845	sensitization	0	None
74845	74846	produced	0	None
74846	74847	by	0	None
74847	74848	alpha	0	None
74848	74849	1A-subtype	0	None
74849	74850	receptors	0	None
74850	74851	is	0	None
74851	74852	mediated	0	None
74852	74853	through	0	None
74853	74854	G-protein	3	GENE-N
74854	74855	and	0	None
74855	74858	protein kinase C	3	GENE-N
74858	74859	,	0	None
74859	74860	and	0	None
74860	74861	plays	0	None
74861	74862	an	0	None
74862	74863	important	0	None
74863	74864	role	0	None
74864	74865	in	0	None
74865	74866	contraction	0	None
74866	74867	of	0	None
74867	74868	smooth	0	None
74868	74869	muscle	0	None
74869	74870	of	0	None
74870	74871	rabbit	0	None
74871	74872	thoracic	0	None
74872	74873	aorta	0	None
74873	74874	.	0	None
74874	74875	Although	0	None
74875	74876	agonist	0	None
74876	74877	binding	0	None
74877	74878	in	0	None
74878	74879	adrenergic	0	None
74879	74880	receptors	0	None
74880	74881	is	0	None
74881	74882	fairly	0	None
74882	74883	well	0	None
74883	74884	understood	0	None
74884	74885	and	0	None
74885	74886	involves	0	None
74886	74887	residues	0	None
74887	74888	located	0	None
74888	74889	in	0	None
74889	74890	transmembrane	0	None
74890	74891	domains	0	None
74891	74892	3	0	None
74892	74893	through	0	None
74893	74894	6	0	None
74894	74895	,	0	None
74895	74896	there	0	None
74896	74897	are	0	None
74897	74898	few	0	None
74898	74899	residues	0	None
74899	74900	reported	0	None
74900	74901	that	0	None
74901	74902	are	0	None
74902	74903	involved	0	None
74903	74904	in	0	None
74904	74905	antagonist	0	None
74905	74906	binding	0	None
74906	74907	.	0	None

74908	74909	In	0	None
74909	74910	fact	0	None
74910	74911	,	0	None
74911	74912	a	0	None
74912	74913	major	0	None
74913	74914	docking	0	None
74914	74915	site	0	None
74915	74916	for	0	None
74916	74917	antagonists	0	None
74917	74918	has	0	None
74918	74919	never	0	None
74919	74920	been	0	None
74920	74921	reported	0	None
74921	74922	in	0	None
74922	74923	any	0	None
74923	74924	G-protein	3	GENE-N
74924	74925	coupled	0	None
74925	74926	receptor	0	None
74926	74927	.	0	None

74928	74929	It	0	None
74929	74930	has	0	None
74930	74931	been	0	None
74931	74932	speculated	0	None
74932	74933	that	0	None
74933	74934	antagonist	0	None
74934	74935	binding	0	None
74935	74936	is	0	None
74936	74937	quite	0	None
74937	74938	diverse	0	None
74938	74939	depending	0	None
74939	74940	upon	0	None
74940	74941	the	0	None
74941	74942	chemical	0	None
74942	74943	structure	0	None
74943	74944	of	0	None
74944	74945	the	0	None
74945	74946	antagonist	0	None
74946	74947	,	0	None
74947	74948	which	0	None
74948	74949	can	0	None
74949	74950	be	0	None
74950	74951	quite	0	None
74951	74952	different	0	None
74952	74953	from	0	None
74953	74954	agonists	0	None
74954	74955	.	0	None

74956	74957	We	0	None
74957	74958	now	0	None
74958	74959	report	0	None
74959	74960	the	0	None
74960	74961	identification	0	None
74961	74962	of	0	None
74962	74963	two	0	None
74963	74964	phenylalanine	0	None
74964	74965	residues	0	None
74965	74966	in	0	None
74966	74967	transmembrane	0	None
74967	74968	domain	0	None
74968	74969	7	0	None
74969	74970	of	0	None
74970	74971	the	0	None
74971	74972	alpha	0	None
74972	74973	(	0	None
74973	74974	1a	0	None
74974	74975	)	0	None
74975	74976	-adrenergic	0	None
74976	74977	receptor	0	None
74977	74978	(	0	None
74978	74979	Phe-312	0	None
74979	74980	and	0	None
74980	74981	Phe-308	0	None
74981	74982	)	0	None
74982	74983	that	0	None
74983	74984	are	0	None
74984	74985	a	0	None
74985	74986	major	0	None
74986	74987	site	0	None
74987	74988	of	0	None
74988	74989	antagonist	0	None
74989	74990	affinity	0	None
74990	74991	.	0	None

74992	74993	Mutation	0	None
74993	74994	of	0	None
74994	74995	either	0	None
74995	74996	Phe-308	0	None
74996	74997	or	0	None
74997	74998	Phe-312	0	None
74998	74999	resulted	0	None
74999	75000	in	0	None
75000	75001	significant	0	None
75001	75002	losses	0	None
75002	75003	of	0	None
75003	75004	affinity	0	None
75004	75005	(	0	None
75005	75006	4-1200-fold	0	None
75006	75007	)	0	None
75007	75008	for	0	None
75008	75009	the	0	None
75009	75010	antagonists	0	None
75010	75011	prazosin	2	CHEMICAL
75011	75012	,	0	None
75012	75013	WB4101	0	None
75013	75014	,	0	None
75014	75015	BMY7378	0	None
75015	75016	,	0	None
75016	75017	(	0	None
75017	75018	+	0	None
75018	75019	)	0	None
75019	75020	niguldipine	0	None
75020	75021	,	0	None
75021	75022	and	0	None
75022	75023	5-methylurapidil	2	CHEMICAL
75023	75024	,	0	None
75024	75025	with	0	None
75025	75026	no	0	None
75026	75027	changes	0	None
75027	75028	in	0	None
75028	75029	affinity	0	None
75029	75030	for	0	None
75030	75031	phenethylamine-type	0	None
75031	75032	agonists	0	None
75032	75033	such	0	None
75033	75034	as	0	None
75034	75035	epinephrine	0	None
75035	75036	,	0	None
75036	75037	methoxamine	0	None
75037	75038	,	0	None
75038	75039	or	0	None
75039	75040	phenylephrine	0	None
75040	75041	.	0	None

75042	75043	Interestingly	0	None
75043	75044	,	0	None
75044	75045	both	0	None
75045	75046	residues	0	None
75046	75047	are	0	None
75047	75048	involved	0	None
75048	75049	in	0	None
75049	75050	the	0	None
75050	75051	binding	0	None
75051	75052	of	0	None
75052	75053	all	0	None
75053	75054	imidazoline-type	0	None
75054	75055	agonists	0	None
75055	75056	such	0	None
75056	75057	as	0	None
75057	75058	oxymetazoline	2	CHEMICAL
75058	75059	,	0	None
75059	75060	cirazoline	0	None
75060	75061	,	0	None
75061	75062	and	0	None
75062	75063	clonidine	0	None
75063	75064	,	0	None
75064	75065	confirming	0	None
75065	75066	previous	0	None
75066	75067	evidence	0	None
75067	75068	that	0	None
75068	75069	this	0	None
75069	75070	class	0	None
75070	75071	of	0	None
75071	75072	ligand	0	None
75072	75073	binds	0	None
75073	75074	differently	0	None
75074	75075	than	0	None
75075	75076	phenethylamine-type	0	None
75076	75077	agonists	0	None
75077	75078	and	0	None
75078	75079	may	0	None
75079	75080	be	0	None
75080	75081	more	0	None
75081	75082	antagonist-like	0	None
75082	75083	,	0	None
75083	75084	which	0	None
75084	75085	may	0	None
75085	75086	explain	0	None
75086	75087	their	0	None
75087	75088	partial	0	None
75088	75089	agonist	0	None
75089	75090	properties	0	None
75090	75091	.	0	None

75092	75093	In	0	None
75093	75094	modeling	0	None
75094	75095	these	0	None
75095	75096	interactions	0	None
75096	75097	with	0	None
75097	75098	previous	0	None
75098	75099	mutagenesis	0	None
75099	75100	studies	0	None
75100	75101	and	0	None
75101	75102	using	0	None
75102	75103	the	0	None
75103	75104	current	0	None
75104	75105	backbone	0	None
75105	75106	structure	0	None
75106	75107	of	0	None
75107	75108	rhodopsin	0	None
75108	75109	,	0	None
75109	75110	we	0	None
75110	75111	conclude	0	None
75111	75112	that	0	None
75112	75113	antagonist	0	None
75113	75114	binding	0	None
75114	75115	is	0	None
75115	75116	docked	0	None
75116	75117	higher	0	None
75117	75118	in	0	None
75118	75119	the	0	None
75119	75120	pocket	0	None
75120	75121	closer	0	None
75121	75122	to	0	None
75122	75123	the	0	None
75123	75124	extracellular	0	None
75124	75125	surface	0	None
75125	75126	than	0	None
75126	75127	agonist	0	None
75127	75128	binding	0	None
75128	75129	and	0	None
75129	75130	appears	0	None
75130	75131	skewed	0	None
75131	75132	toward	0	None
75132	75133	transmembrane	0	None
75133	75134	domain	0	None
75134	75135	7	0	None
75135	75136	.	0	None
75136	75137	BACKGROUND	0	None
75137	75138	:	0	None
75138	75139	(	0	None
75139	75140	+	0	None
75140	75141	/	0	None
75141	75142	-	0	None
75142	75143	)	0	None
75143	75144	-Modafinil	0	None
75144	75145	has	0	None
75145	75146	piqued	0	None
75146	75147	interest	0	None
75147	75148	as	0	None
75148	75149	a	0	None
75149	75150	treatment	0	None
75150	75151	for	0	None
75151	75152	attention-deficit	0	None
75152	75153	/	0	None
75153	75154	hyperactivity	0	None
75154	75155	disorder	0	None
75155	75156	and	0	None
75156	75157	stimulant	0	None
75157	75158	dependence	0	None
75158	75159	.	0	None

75160	75161	The	0	None
75161	75162	R-enantiomer	0	None
75162	75163	of	0	None
75163	75164	modafinil	2	CHEMICAL
75164	75165	might	0	None
75165	75166	have	0	None
75166	75167	unique	0	None
75167	75168	pharmacological	0	None
75168	75169	properties	0	None
75169	75170	that	0	None
75170	75171	should	0	None
75171	75172	be	0	None
75172	75173	further	0	None
75173	75174	investigated	0	None
75174	75175	.	0	None

75176	75177	METHODS	0	None
75177	75178	:	0	None
75178	75179	(	0	None
75179	75180	+	0	None
75180	75181	/	0	None
75181	75182	-	0	None
75182	75183	)	0	None
75183	75184	-Modafinil	0	None
75184	75185	and	0	None
75185	75186	its	0	None
75186	75187	R-	0	None
75187	75188	(	0	None
75188	75189	-	0	None
75189	75190	)	0	None
75190	75191	-	0	None
75191	75192	and	0	None
75192	75193	S-	0	None
75193	75194	(	0	None
75194	75195	+	0	None
75195	75196	)	0	None
75196	75197	-enantiomers	0	None
75197	75198	were	0	None
75198	75199	synthesized	0	None
75199	75200	and	0	None
75200	75201	tested	0	None
75201	75202	for	0	None
75202	75203	inhibition	0	None
75203	75204	of	0	None
75204	75205	[	0	None
75205	75206	(	0	None
75206	75207	3	0	None
75207	75208	)	0	None
75208	75209	H	0	None
75209	75210	]	0	None
75210	75211	dopamine	0	None
75211	75212	(	0	None
75212	75213	DA	0	None
75213	75214	)	0	None
75214	75215	uptake	0	None
75215	75216	and	0	None
75216	75217	[	0	None
75217	75218	(	0	None
75218	75219	3	0	None
75219	75220	)	0	None
75220	75221	H	0	None
75221	75222	]	0	None
75222	75223	WIN	0	None
75223	75224	35428	0	None
75224	75225	binding	0	None
75225	75226	in	0	None
75226	75229	human dopamine transporter	1	GENE-Y
75229	75230	(	0	None
75230	75231	DAT	1	GENE-Y
75231	75232	)	0	None
75232	75233	wild-type	0	None
75233	75234	and	0	None
75234	75235	mutants	0	None
75235	75236	with	0	None
75236	75237	altered	0	None
75237	75238	conformational	0	None
75238	75239	equilibria	0	None
75239	75240	.	0	None

75241	75242	Data	0	None
75242	75243	were	0	None
75243	75244	compared	0	None
75244	75245	with	0	None
75245	75246	cocaine	2	CHEMICAL
75246	75247	and	0	None
75247	75248	the	0	None
75248	75249	atypical	0	None
75249	75250	DA	0	None
75250	75251	uptake	0	None
75251	75252	inhibitor	0	None
75252	75253	,	0	None
75253	75254	JHW	0	None
75254	75255	007	0	None
75255	75256	.	0	None

75257	75258	R-	0	None
75258	75259	and	0	None
75259	75260	S-modafinil	0	None
75260	75261	were	0	None
75261	75262	also	0	None
75262	75263	evaluated	0	None
75263	75264	in	0	None
75264	75265	microdialysis	0	None
75265	75266	studies	0	None
75266	75267	in	0	None
75267	75268	the	0	None
75268	75269	mouse	0	None
75269	75270	nucleus	0	None
75270	75271	accumbens	0	None
75271	75272	shell	0	None
75272	75273	and	0	None
75273	75274	in	0	None
75274	75275	a	0	None
75275	75276	cocaine	2	CHEMICAL
75276	75277	discrimination	0	None
75277	75278	procedure	0	None
75278	75279	.	0	None

75280	75281	RESULTS	0	None
75281	75282	:	0	None
75282	75283	(	0	None
75283	75284	+	0	None
75284	75285	/	0	None
75285	75286	-	0	None
75286	75287	)	0	None
75287	75288	-	0	None
75288	75289	,	0	None
75289	75290	R-	0	None
75290	75291	,	0	None
75291	75292	and	0	None
75292	75293	S-modafinil	0	None
75293	75294	bind	0	None
75294	75295	to	0	None
75295	75296	the	0	None
75296	75297	DAT	1	GENE-Y
75297	75298	and	0	None
75298	75299	inhibit	0	None
75299	75300	DA	0	None
75300	75301	uptake	0	None
75301	75302	less	0	None
75302	75303	potently	0	None
75303	75304	than	0	None
75304	75305	cocaine	2	CHEMICAL
75305	75306	,	0	None
75306	75307	with	0	None
75307	75308	R-modafinil	0	None
75308	75309	having	0	None
75309	75310	approximately	0	None
75310	75311	threefold	0	None
75311	75312	higher	0	None
75312	75313	affinity	0	None
75313	75314	than	0	None
75314	75315	its	0	None
75315	75316	S-enantiomer	0	None
75316	75317	.	0	None

75318	75319	Molecular	0	None
75319	75320	docking	0	None
75320	75321	studies	0	None
75321	75322	revealed	0	None
75322	75323	subtle	0	None
75323	75324	differences	0	None
75324	75325	in	0	None
75325	75326	binding	0	None
75326	75327	modes	0	None
75327	75328	for	0	None
75328	75329	the	0	None
75329	75330	enantiomers	0	None
75330	75331	.	0	None

75332	75333	R-modafinil	0	None
75333	75334	was	0	None
75334	75335	significantly	0	None
75335	75336	less	0	None
75336	75337	potent	0	None
75337	75338	in	0	None
75338	75339	the	0	None
75339	75340	DAT	1	GENE-Y
75340	75341	Y156F	0	None
75341	75342	mutant	0	None
75342	75343	compared	0	None
75343	75344	with	0	None
75344	75345	wild-type	0	None
75345	75346	DAT	1	GENE-Y
75346	75347	,	0	None
75347	75348	whereas	0	None
75348	75349	S-modafinil	0	None
75349	75350	was	0	None
75350	75351	affected	0	None
75351	75352	less	0	None
75352	75353	.	0	None

75354	75355	Studies	0	None
75355	75356	with	0	None
75356	75357	the	0	None
75357	75358	Y335A	0	None
75358	75359	DAT	1	GENE-Y
75359	75360	mutant	0	None
75360	75361	showed	0	None
75361	75362	that	0	None
75362	75363	the	0	None
75363	75364	R-	0	None
75364	75365	and	0	None
75365	75366	S-enantiomers	0	None
75366	75367	tolerated	0	None
75367	75368	the	0	None
75368	75369	inward-facing	0	None
75369	75370	conformation	0	None
75370	75371	better	0	None
75371	75372	than	0	None
75372	75373	cocaine	2	CHEMICAL
75373	75374	,	0	None
75374	75375	which	0	None
75375	75376	was	0	None
75376	75377	further	0	None
75377	75378	supported	0	None
75378	75379	by	0	None
75379	75380	[	0	None
75380	75381	2-	0	None
75381	75382	(	0	None
75382	75383	trimethylammonium	0	None
75383	75384	)	0	None
75384	75385	ethyl	2	CHEMICAL
75385	75386	]	0	None
75386	75387	-methanethiosulfonate	0	None
75387	75388	reactivity	0	None
75388	75389	on	0	None
75389	75390	the	0	None
75390	75391	DAT	1	GENE-Y
75391	75392	E2C	0	None
75392	75393	I159C	0	None
75393	75394	.	0	None

75395	75396	Microdialysis	0	None
75396	75397	studies	0	None
75397	75398	demonstrated	0	None
75398	75399	that	0	None
75399	75400	both	0	None
75400	75401	R-	0	None
75401	75402	and	0	None
75402	75403	S-modafinil	0	None
75403	75404	produced	0	None
75404	75405	increases	0	None
75405	75406	in	0	None
75406	75407	extracellular	0	None
75407	75408	DA	0	None
75408	75409	concentrations	0	None
75409	75410	in	0	None
75410	75411	the	0	None
75411	75412	nucleus	0	None
75412	75413	accumbens	0	None
75413	75414	shell	0	None
75414	75415	less	0	None
75415	75416	efficaciously	0	None
75416	75417	than	0	None
75417	75418	cocaine	2	CHEMICAL
75418	75419	and	0	None
75419	75420	with	0	None
75420	75421	a	0	None
75421	75422	longer	0	None
75422	75423	duration	0	None
75423	75424	of	0	None
75424	75425	action	0	None
75425	75426	.	0	None

75427	75428	Both	0	None
75428	75429	enantiomers	0	None
75429	75430	fully	0	None
75430	75431	substituted	0	None
75431	75432	in	0	None
75432	75433	mice	0	None
75433	75434	trained	0	None
75434	75435	to	0	None
75435	75436	discriminate	0	None
75436	75437	cocaine	2	CHEMICAL
75437	75438	from	0	None
75438	75439	saline	0	None
75439	75440	.	0	None

75441	75442	CONCLUSIONS	0	None
75442	75443	:	0	None
75443	75444	R-modafinil	0	None
75444	75445	displays	0	None
75445	75446	an	0	None
75446	75447	in	0	None
75447	75448	vitro	0	None
75448	75449	profile	0	None
75449	75450	different	0	None
75450	75451	from	0	None
75451	75452	cocaine	2	CHEMICAL
75452	75453	.	0	None

75454	75455	Future	0	None
75455	75456	trials	0	None
75456	75457	with	0	None
75457	75458	R-modafinil	0	None
75458	75459	as	0	None
75459	75460	a	0	None
75460	75461	substitute	0	None
75461	75462	therapy	0	None
75462	75463	with	0	None
75463	75464	the	0	None
75464	75465	potential	0	None
75465	75466	benefit	0	None
75466	75467	of	0	None
75467	75468	cognitive	0	None
75468	75469	enhancement	0	None
75469	75470	for	0	None
75470	75471	psychostimulant	0	None
75471	75472	addiction	0	None
75472	75473	are	0	None
75473	75474	warranted	0	None
75474	75475	.	0	None
75475	75476	Cinobufagin	0	None
75476	75477	,	0	None
75477	75478	a	0	None
75478	75479	major	0	None
75479	75480	component	0	None
75480	75481	of	0	None
75481	75482	cinobufacini	0	None
75482	75483	(	0	None
75483	75484	huachansu	0	None
75484	75485	)	0	None
75485	75486	,	0	None
75486	75487	is	0	None
75487	75488	an	0	None
75488	75489	important	0	None
75489	75490	cardenolidal	0	None
75490	75491	steroid	2	CHEMICAL
75491	75492	.	0	None

75493	75494	Several	0	None
75494	75495	studies	0	None
75495	75496	have	0	None
75496	75497	suggested	0	None
75497	75498	that	0	None
75498	75499	cinobufagin	0	None
75499	75500	has	0	None
75500	75501	potent	0	None
75501	75502	anti-cancer	0	None
75502	75503	effects	0	None
75503	75504	.	0	None

75505	75506	The	0	None
75506	75507	present	0	None
75507	75508	study	0	None
75508	75509	examines	0	None
75509	75510	the	0	None
75510	75511	apoptosis-inducing	0	None
75511	75512	activity	0	None
75512	75513	and	0	None
75513	75514	the	0	None
75514	75515	underlying	0	None
75515	75516	mechanism	0	None
75516	75517	of	0	None
75517	75518	action	0	None
75518	75519	of	0	None
75519	75520	cinobufagin	0	None
75520	75521	in	0	None
75521	75522	osteosarcoma	0	None
75522	75523	(	0	None
75523	75524	OS	0	None
75524	75525	)	0	None
75525	75526	cells	0	None
75526	75527	.	0	None

75528	75529	Our	0	None
75529	75530	results	0	None
75530	75531	showed	0	None
75531	75532	that	0	None
75532	75533	cinobufagin	0	None
75533	75534	potently	0	None
75534	75535	inhibited	0	None
75535	75536	the	0	None
75536	75537	proliferation	0	None
75537	75538	of	0	None
75538	75539	U2OS	0	None
75539	75540	,	0	None
75540	75541	MG63	0	None
75541	75542	and	0	None
75542	75543	SaOS-2	0	None
75543	75544	cells	0	None
75544	75545	.	0	None

75546	75547	Significant	0	None
75547	75548	increases	0	None
75548	75549	in	0	None
75549	75550	G2	0	None
75550	75551	/	0	None
75551	75552	M	0	None
75552	75553	cell-cycle	0	None
75553	75554	arrest	0	None
75554	75555	and	0	None
75555	75556	apoptosis	0	None
75556	75557	in	0	None
75557	75558	OS	0	None
75558	75559	cells	0	None
75559	75560	were	0	None
75560	75561	also	0	None
75561	75562	observed	0	None
75562	75563	.	0	None

75564	75565	The	0	None
75565	75566	expression	0	None
75566	75567	levels	0	None
75567	75568	of	0	None
75568	75569	several	0	None
75569	75570	apoptotic	0	None
75570	75571	proteins	0	None
75571	75572	were	0	None
75572	75573	assessed	0	None
75573	75574	after	0	None
75574	75575	cinobufagin	0	None
75575	75576	treatment	0	None
75576	75577	in	0	None
75577	75578	U2OS	0	None
75578	75579	cells	0	None
75579	75580	.	0	None

75581	75582	Among	0	None
75582	75583	them	0	None
75583	75584	,	0	None
75584	75585	xIAP	0	None
75585	75586	,	0	None
75586	75587	cIAP-1	0	None
75587	75588	,	0	None
75588	75589	survivin	3	GENE-N
75589	75590	and	0	None
75590	75591	Bcl-2	1	GENE-Y
75591	75592	levels	0	None
75592	75593	decreased	0	None
75593	75594	remarkably	0	None
75594	75595	,	0	None
75595	75596	while	0	None
75596	75597	the	0	None
75597	75598	levels	0	None
75598	75599	of	0	None
75599	75600	Bax	0	None
75600	75601	and	0	None
75601	75602	cleaved-PARP	0	None
75602	75603	increased	0	None
75603	75604	.	0	None

75605	75606	Furthermore	0	None
75606	75607	,	0	None
75607	75608	we	0	None
75608	75609	validated	0	None
75609	75610	the	0	None
75610	75611	inhibition	0	None
75611	75612	of	0	None
75612	75613	GSK-3β	0	None
75613	75614	/	0	None
75614	75615	NF-κB	0	None
75615	75616	signaling	0	None
75616	75617	following	0	None
75617	75618	cinobufagin	0	None
75618	75619	treatment	0	None
75619	75620	.	0	None

75621	75622	Western	0	None
75622	75623	blots	0	None
75623	75624	showed	0	None
75624	75625	a	0	None
75625	75626	decrease	0	None
75626	75627	in	0	None
75627	75628	nuclear	0	None
75628	75629	p65	0	None
75629	75630	protein	0	None
75630	75631	expression	0	None
75631	75632	after	0	None
75632	75633	exposure	0	None
75633	75634	to	0	None
75634	75635	different	0	None
75635	75636	concentrations	0	None
75636	75637	of	0	None
75637	75638	cinobufagin	0	None
75638	75639	,	0	None
75639	75640	while	0	None
75640	75641	the	0	None
75641	75642	phosphorylation	0	None
75642	75643	of	0	None
75643	75644	GSK-3β	0	None
75644	75645	was	0	None
75645	75646	simultaneously	0	None
75646	75647	increased	0	None
75647	75648	.	0	None

75649	75650	Transduction	0	None
75650	75651	with	0	None
75651	75652	constitutively	0	None
75652	75653	active	0	None
75653	75654	forms	0	None
75654	75655	of	0	None
75655	75656	GSK-3β	0	None
75656	75657	could	0	None
75657	75658	protect	0	None
75658	75659	against	0	None
75659	75660	the	0	None
75660	75661	downregulation	0	None
75661	75662	of	0	None
75662	75663	p65	0	None
75663	75664	and	0	None
75664	75665	upregulation	0	None
75665	75666	of	0	None
75666	75667	cleaved-PARP	0	None
75667	75668	that	0	None
75668	75669	are	0	None
75669	75670	induced	0	None
75670	75671	by	0	None
75671	75672	cinobufagin	0	None
75672	75673	treatment	0	None
75673	75674	.	0	None

75675	75676	However	0	None
75676	75677	,	0	None
75677	75678	combined	0	None
75678	75679	treatment	0	None
75679	75680	with	0	None
75680	75681	cinobufagin	0	None
75681	75682	and	0	None
75682	75683	SB216367	0	None
75683	75684	resulted	0	None
75684	75685	in	0	None
75685	75686	a	0	None
75686	75687	significant	0	None
75687	75688	reduction	0	None
75688	75689	in	0	None
75689	75690	p65	0	None
75690	75691	and	0	None
75691	75692	an	0	None
75692	75693	increase	0	None
75693	75694	in	0	None
75694	75695	cleaved-PARP	0	None
75695	75696	in	0	None
75696	75697	U2OS	0	None
75697	75698	cells	0	None
75698	75699	.	0	None

75700	75701	Altogether	0	None
75701	75702	,	0	None
75702	75703	these	0	None
75703	75704	results	0	None
75704	75705	show	0	None
75705	75706	that	0	None
75706	75707	cinobufagin	0	None
75707	75708	is	0	None
75708	75709	a	0	None
75709	75710	promising	0	None
75710	75711	agent	0	None
75711	75712	for	0	None
75712	75713	the	0	None
75713	75714	treatment	0	None
75714	75715	of	0	None
75715	75716	OS	0	None
75716	75717	.	0	None

75718	75719	These	0	None
75719	75720	studies	0	None
75720	75721	are	0	None
75721	75722	the	0	None
75722	75723	first	0	None
75723	75724	to	0	None
75724	75725	reveal	0	None
75725	75726	the	0	None
75726	75727	involvement	0	None
75727	75728	of	0	None
75728	75729	the	0	None
75729	75730	GSK-3β	0	None
75730	75731	/	0	None
75731	75732	NF-κB	0	None
75732	75733	pathway	0	None
75733	75734	in	0	None
75734	75735	cinobufagin-induced	0	None
75735	75736	apoptosis	0	None
75736	75737	.	0	None
75737	75738	Exploring	0	None
75738	75739	the	0	None
75739	75740	Interplay	0	None
75740	75741	Between	0	None
75741	75742	Ligand	0	None
75742	75743	Derivatisation	0	None
75743	75744	and	0	None
75744	75745	Cation	0	None
75745	75746	Type	0	None
75746	75747	in	0	None
75747	75748	the	0	None
75748	75749	Assembly	0	None
75749	75750	of	0	None
75750	75751	Hybrid	0	None
75751	75752	Polyoxometalate	0	None
75752	75753	Mn-Andersons	0	None
75753	75754	.	0	None
75754	75755	BACKGROUND	0	None
75755	75756	AND	0	None
75756	75757	RATIONALE	0	None
75757	75758	:	0	None
75758	75759	We	0	None
75759	75760	previously	0	None
75760	75761	found	0	None
75761	75762	that	0	None
75762	75763	the	0	None
75763	75764	intronic	0	None
75764	75766	norepinephrine transporter	3	GENE-N
75766	75767	gene	0	None
75767	75768	(	0	None
75768	75769	SLC6A2	0	None
75769	75770	)	0	None
75770	75771	polymorphism	0	None
75771	75772	rs36017	0	None
75772	75773	modulates	0	None
75773	75774	feelings	0	None
75774	75775	of	0	None
75775	75776	elation	0	None
75776	75777	after	0	None
75777	75778	administration	0	None
75778	75779	of	0	None
75779	75780	20	0	None
75780	75781	mg	2	CHEMICAL
75781	75782	D-amphetamine	0	None
75782	75783	in	0	None
75783	75784	healthy	0	None
75784	75785	volunteers	0	None
75785	75786	.	0	None

75787	75788	OBJECTIVES	0	None
75788	75789	:	0	None
75789	75790	In	0	None
75790	75791	this	0	None
75791	75792	study	0	None
75792	75793	,	0	None
75793	75794	we	0	None
75794	75795	further	0	None
75795	75796	investigated	0	None
75796	75797	the	0	None
75797	75798	association	0	None
75798	75799	between	0	None
75799	75800	D-amphetamine	0	None
75800	75801	response	0	None
75801	75802	and	0	None
75802	75803	11	0	None
75803	75804	SLC6A2	0	None
75804	75805	single-nucleotide	0	None
75805	75806	polymorphisms	0	None
75806	75807	(	0	None
75807	75808	SNPs	0	None
75808	75809	)	0	None
75809	75810	,	0	None
75810	75811	including	0	None
75811	75812	rs36017	0	None
75812	75813	,	0	None
75813	75814	in	0	None
75814	75815	an	0	None
75815	75816	extended	0	None
75816	75817	sample	0	None
75817	75818	of	0	None
75818	75819	Caucasian	0	None
75819	75820	young	0	None
75820	75821	adults	0	None
75821	75822	.	0	None

75823	75824	METHODS	0	None
75824	75825	:	0	None
75825	75826	One	0	None
75826	75827	hundred	0	None
75827	75828	fifty-nine	0	None
75828	75829	healthy	0	None
75829	75830	volunteers	0	None
75830	75831	participated	0	None
75831	75832	in	0	None
75832	75833	a	0	None
75833	75834	three-session	0	None
75834	75835	double-blind	0	None
75835	75836	crossover	0	None
75836	75837	design	0	None
75837	75838	receiving	0	None
75838	75839	either	0	None
75839	75840	placebo	0	None
75840	75841	or	0	None
75841	75842	oral	0	None
75842	75843	D-amphetamine	0	None
75843	75844	(	0	None
75844	75845	10	0	None
75845	75846	and	0	None
75846	75847	20	0	None
75847	75848	mg	2	CHEMICAL
75848	75849	)	0	None
75849	75850	.	0	None

75851	75852	Based	0	None
75852	75853	on	0	None
75853	75854	our	0	None
75854	75855	previous	0	None
75855	75856	results	0	None
75856	75857	,	0	None
75857	75858	we	0	None
75858	75859	examined	0	None
75859	75860	the	0	None
75860	75861	associations	0	None
75861	75862	between	0	None
75862	75863	levels	0	None
75863	75864	of	0	None
75864	75865	self-reported	0	None
75865	75866	elation	0	None
75866	75867	and	0	None
75867	75868	vigor	0	None
75868	75869	after	0	None
75869	75870	D-amphetamine	0	None
75870	75871	administration	0	None
75871	75872	and	0	None
75872	75873	SNPs	0	None
75873	75874	and	0	None
75874	75875	SNP	0	None
75875	75876	haplotypes	0	None
75876	75877	in	0	None
75877	75878	SLC6A2	0	None
75878	75879	.	0	None

75880	75881	RESULTS	0	None
75881	75882	:	0	None
75882	75883	Consistent	0	None
75883	75884	with	0	None
75884	75885	our	0	None
75885	75886	previous	0	None
75886	75887	findings	0	None
75887	75888	,	0	None
75888	75889	SNPs	0	None
75889	75890	rs36017	0	None
75890	75891	and	0	None
75891	75892	rs1861647	0	None
75892	75893	were	0	None
75893	75894	associated	0	None
75894	75895	with	0	None
75895	75896	significantly	0	None
75896	75897	higher	0	None
75897	75898	ratings	0	None
75898	75899	of	0	None
75899	75900	elation	0	None
75900	75901	and	0	None
75901	75902	vigor	0	None
75902	75903	after	0	None
75903	75904	20	0	None
75904	75905	mg	2	CHEMICAL
75905	75906	Damphetamine	0	None
75906	75907	.	0	None

75908	75909	Ratings	0	None
75909	75910	of	0	None
75910	75911	vigor	0	None
75911	75912	after	0	None
75912	75913	20	0	None
75913	75914	mg	2	CHEMICAL
75914	75915	D-amphetamine	0	None
75915	75916	were	0	None
75916	75917	also	0	None
75917	75918	associated	0	None
75918	75919	with	0	None
75919	75920	a	0	None
75920	75921	two-SNP	0	None
75921	75922	haplotype	0	None
75922	75923	formed	0	None
75923	75924	with	0	None
75924	75925	rs1861647	0	None
75925	75926	and	0	None
75926	75927	rs5569	0	None
75927	75928	and	0	None
75928	75929	a	0	None
75929	75930	three-SNP	0	None
75930	75931	haplotype	0	None
75931	75932	formed	0	None
75932	75933	with	0	None
75933	75934	rs36017	0	None
75934	75935	,	0	None
75935	75936	rs10521329	0	None
75936	75937	,	0	None
75937	75938	and	0	None
75938	75939	rs3785155	0	None
75939	75940	.	0	None

75941	75942	CONCLUSIONS	0	None
75942	75943	:	0	None
75943	75944	These	0	None
75944	75945	results	0	None
75945	75946	provide	0	None
75946	75947	further	0	None
75947	75948	evidence	0	None
75948	75949	that	0	None
75949	75950	genetic	0	None
75950	75951	variants	0	None
75951	75952	in	0	None
75952	75953	the	0	None
75953	75954	SLC6A2	0	None
75954	75955	gene	0	None
75955	75956	are	0	None
75956	75957	involved	0	None
75957	75958	in	0	None
75958	75959	acute	0	None
75959	75960	response	0	None
75960	75961	to	0	None
75961	75962	D-amphetamine	0	None
75962	75963	,	0	None
75963	75964	which	0	None
75964	75965	may	0	None
75965	75966	influence	0	None
75966	75967	progression	0	None
75967	75968	to	0	None
75968	75969	amphetamine	0	None
75969	75970	abuse	0	None
75970	75971	.	0	None

75972	75973	Identifying	0	None
75973	75974	sources	0	None
75974	75975	of	0	None
75975	75976	variation	0	None
75976	75977	in	0	None
75977	75978	acute	0	None
75978	75979	drug	0	None
75979	75980	responses	0	None
75980	75981	could	0	None
75981	75982	lead	0	None
75982	75983	to	0	None
75983	75984	better	0	None
75984	75985	prevention	0	None
75985	75986	and	0	None
75986	75987	treatment	0	None
75987	75988	of	0	None
75988	75989	psychostimulant	0	None
75989	75990	abuse	0	None
75990	75991	and	0	None
75991	75992	may	0	None
75992	75993	be	0	None
75993	75994	valuable	0	None
75994	75995	in	0	None
75995	75996	the	0	None
75996	75997	therapeutic	0	None
75997	75998	use	0	None
75998	75999	of	0	None
75999	76000	stimulants	0	None
76000	76001	.	0	None
76001	76002	Effects	0	None
76002	76003	of	0	None
76003	76004	the	0	None
76004	76005	serine	2	CHEMICAL
76005	76006	/	0	None
76006	76007	threonine	0	None
76007	76008	kinase	0	None
76008	76009	SGK1	0	None
76009	76010	on	0	None
76010	76011	the	0	None
76011	76012	epithelial	0	None
76012	76013	Na	0	None
76013	76014	(	0	None
76014	76015	+	0	None
76015	76016	)	0	None
76016	76017	channel	0	None
76017	76018	(	0	None
76018	76019	ENaC	0	None
76019	76020	)	0	None
76020	76021	and	0	None
76021	76022	CFTR	0	None
76022	76023	:	0	None
76023	76024	implications	0	None
76024	76025	for	0	None
76025	76026	cystic	0	None
76026	76027	fibrosis	0	None
76027	76028	.	0	None
76028	76029	In	0	None
76029	76030	the	0	None
76030	76031	present	0	None
76031	76032	study	0	None
76032	76033	,	0	None
76033	76034	age-related	0	None
76034	76035	changes	0	None
76035	76036	of	0	None
76036	76037	pyridoxal	2	CHEMICAL
76037	76038	5'-phosphate	0	None
76038	76039	(	0	None
76039	76040	PLP	0	None
76040	76041	)	0	None
76041	76042	synthesizing	0	None
76042	76043	enzymes	0	None
76043	76044	,	0	None
76044	76045	pyridoxal	2	CHEMICAL
76045	76046	kinase	0	None
76046	76047	(	0	None
76047	76048	PLK	0	None
76048	76049	)	0	None
76049	76050	and	0	None
76050	76051	pyridoxine	0	None
76051	76052	5'-phosphate	0	None
76052	76053	oxidase	0	None
76053	76054	(	0	None
76054	76055	PNPO	0	None
76055	76056	)	0	None
76056	76057	,	0	None
76057	76058	their	0	None
76058	76059	protein	0	None
76059	76060	contents	0	None
76060	76061	and	0	None
76061	76062	activities	0	None
76062	76063	were	0	None
76063	76064	examined	0	None
76064	76065	in	0	None
76065	76066	the	0	None
76066	76067	gerbil	0	None
76067	76068	hippocampus	0	None
76068	76069	proper	0	None
76069	76070	.	0	None

76071	76072	Significant	0	None
76072	76073	age-dependent	0	None
76073	76074	changes	0	None
76074	76075	in	0	None
76075	76076	PLK	0	None
76076	76077	and	0	None
76077	76078	PNPO	0	None
76078	76079	immunoreactivities	0	None
76079	76080	were	0	None
76080	76081	found	0	None
76081	76082	in	0	None
76082	76083	the	0	None
76083	76084	CA1	0	None
76084	76085	region	0	None
76085	76086	,	0	None
76086	76087	but	0	None
76087	76088	not	0	None
76088	76089	in	0	None
76089	76090	the	0	None
76090	76091	CA2	0	None
76091	76092	/	0	None
76092	76093	3	0	None
76093	76094	region	0	None
76094	76095	.	0	None

76096	76097	In	0	None
76097	76098	the	0	None
76098	76099	postnatal	0	None
76099	76100	month	0	None
76100	76101	1	0	None
76101	76102	(	0	None
76102	76103	PM	0	None
76103	76104	1	0	None
76104	76105	)	0	None
76105	76106	group	0	None
76106	76107	,	0	None
76107	76108	PLK	0	None
76108	76109	and	0	None
76109	76110	PNPO	0	None
76110	76111	immunoreactivities	0	None
76111	76112	were	0	None
76112	76113	detected	0	None
76113	76114	mainly	0	None
76114	76115	in	0	None
76115	76116	the	0	None
76116	76117	stratum	0	None
76117	76118	pyramidale	0	None
76118	76119	of	0	None
76119	76120	the	0	None
76120	76121	CA1	0	None
76121	76122	region	0	None
76122	76123	.	0	None

76124	76125	PLK	0	None
76125	76126	and	0	None
76126	76127	PNPO	0	None
76127	76128	immunoreactivities	0	None
76128	76129	and	0	None
76129	76130	their	0	None
76130	76131	protein	0	None
76131	76132	contents	0	None
76132	76133	were	0	None
76133	76134	highest	0	None
76134	76135	in	0	None
76135	76136	the	0	None
76136	76137	PM	0	None
76137	76138	6	0	None
76138	76139	group	0	None
76139	76140	,	0	None
76140	76141	showing	0	None
76141	76142	that	0	None
76142	76143	many	0	None
76143	76144	CA1	0	None
76144	76145	pyramidal	0	None
76145	76146	cells	0	None
76146	76147	had	0	None
76147	76148	strong	0	None
76148	76149	PLK	0	None
76149	76150	and	0	None
76150	76151	PNPO	0	None
76151	76152	immunoreactivities	0	None
76152	76153	.	0	None

76154	76155	Thereafter	0	None
76155	76156	,	0	None
76156	76157	PLK	0	None
76157	76158	and	0	None
76158	76159	PNPO	0	None
76159	76160	immunoreactivities	0	None
76160	76161	started	0	None
76161	76162	to	0	None
76162	76163	decrease	0	None
76163	76164	and	0	None
76164	76165	were	0	None
76165	76166	very	0	None
76166	76167	low	0	None
76167	76168	at	0	None
76168	76169	PM	0	None
76169	76170	24	0	None
76170	76171	.	0	None

76172	76173	Alterations	0	None
76173	76174	in	0	None
76174	76175	the	0	None
76175	76176	change	0	None
76176	76177	patterns	0	None
76177	76178	in	0	None
76178	76179	protein	0	None
76179	76180	contents	0	None
76180	76181	and	0	None
76181	76182	total	0	None
76182	76183	activities	0	None
76183	76184	of	0	None
76184	76185	PLK	0	None
76185	76186	and	0	None
76186	76187	PNPO	0	None
76187	76188	corresponded	0	None
76188	76189	to	0	None
76189	76190	the	0	None
76190	76191	immunohistochemical	0	None
76191	76192	data	0	None
76192	76193	,	0	None
76193	76194	but	0	None
76194	76195	their	0	None
76195	76196	specific	0	None
76196	76197	activities	0	None
76197	76198	were	0	None
76198	76199	not	0	None
76199	76200	altered	0	None
76200	76201	in	0	None
76201	76202	any	0	None
76202	76203	experimental	0	None
76203	76204	group	0	None
76204	76205	.	0	None

76206	76207	Based	0	None
76207	76208	on	0	None
76208	76209	double	0	None
76209	76210	immunofluorescence	0	None
76210	76211	study	0	None
76211	76212	,	0	None
76212	76213	PLK	0	None
76213	76214	and	0	None
76214	76215	PNPO	0	None
76215	76216	immunoreactive	0	None
76216	76217	cells	0	None
76217	76218	in	0	None
76218	76219	the	0	None
76219	76220	strata	0	None
76220	76221	oriens	0	None
76221	76222	and	0	None
76222	76223	radiatum	0	None
76223	76224	were	0	None
76224	76225	identified	0	None
76225	76226	as	0	None
76226	76227	GABAergic	0	None
76227	76228	cells	0	None
76228	76229	.	0	None

76230	76231	Therefore	0	None
76231	76232	,	0	None
76232	76233	decreases	0	None
76233	76234	of	0	None
76234	76235	PLK	0	None
76235	76236	and	0	None
76236	76237	PNPO	0	None
76237	76238	in	0	None
76238	76239	the	0	None
76239	76240	hippocampal	0	None
76240	76241	CA1	0	None
76241	76242	region	0	None
76242	76243	of	0	None
76243	76244	aged	0	None
76244	76245	brains	0	None
76245	76246	may	0	None
76246	76247	be	0	None
76247	76248	involved	0	None
76248	76249	in	0	None
76249	76250	aging	0	None
76250	76251	processes	0	None
76251	76252	related	0	None
76252	76253	with	0	None
76253	76254	gamma-aminobutyric	0	None
76254	76255	acid	0	None
76255	76256	(	0	None
76256	76257	GABA	2	CHEMICAL
76257	76258	)	0	None
76258	76259	function	0	None
76259	76260	.	0	None
76260	76261	Ergovaline	0	None
76261	76262	binding	0	None
76262	76263	and	0	None
76263	76264	activation	0	None
76264	76265	of	0	None
76265	76266	D2	0	None
76266	76267	dopamine	0	None
76267	76268	receptors	0	None
76268	76269	in	0	None
76269	76270	GH4ZR7	0	None
76270	76271	cells	0	None
76271	76272	.	0	None
76272	76273	Cyclooxygenase	0	None
76273	76274	isozymes	0	None
76274	76275	(	0	None
76275	76276	COX-1	1	GENE-Y
76276	76277	and	0	None
76277	76278	COX-2	0	None
76278	76279	)	0	None
76279	76280	are	0	None
76280	76281	found	0	None
76281	76282	to	0	None
76282	76283	be	0	None
76283	76284	constitutively	0	None
76284	76285	expressed	0	None
76285	76286	in	0	None
76286	76287	brain	0	None
76287	76288	,	0	None
76288	76289	with	0	None
76289	76290	neuronal	0	None
76290	76291	expression	0	None
76291	76292	of	0	None
76292	76293	COX-2	0	None
76293	76294	being	0	None
76294	76295	rapidly	0	None
76295	76296	induced	0	None
76296	76297	after	0	None
76297	76298	numerous	0	None
76298	76299	insults	0	None
76299	76300	,	0	None
76300	76301	including	0	None
76301	76302	cerebral	0	None
76302	76303	ischemia	0	None
76303	76304	.	0	None

76305	76306	Because	0	None
76306	76307	overactivation	0	None
76307	76308	of	0	None
76308	76309	N-methyl-D-aspartate	0	None
76309	76310	(	0	None
76310	76311	NMDA	0	None
76311	76312	)	0	None
76312	76313	receptors	0	None
76313	76314	has	0	None
76314	76315	been	0	None
76315	76316	implicated	0	None
76316	76317	in	0	None
76317	76318	the	0	None
76318	76319	cell	0	None
76319	76320	loss	0	None
76320	76321	associated	0	None
76321	76322	with	0	None
76322	76323	ischemia	0	None
76323	76324	,	0	None
76324	76325	we	0	None
76325	76326	characterized	0	None
76326	76327	the	0	None
76327	76328	expression	0	None
76328	76329	of	0	None
76329	76330	the	0	None
76330	76331	COX	3	GENE-N
76331	76332	isozymes	0	None
76332	76333	in	0	None
76333	76334	murine	0	None
76334	76335	mixed	0	None
76335	76336	cortical	0	None
76336	76337	cell	0	None
76337	76338	cultures	0	None
76338	76339	and	0	None
76339	76340	used	0	None
76340	76341	isozyme-selective	0	None
76341	76342	inhibitors	0	None
76342	76343	to	0	None
76343	76344	determine	0	None
76344	76345	their	0	None
76345	76346	relative	0	None
76346	76347	contribution	0	None
76347	76348	to	0	None
76348	76349	NMDA	0	None
76349	76350	receptor-stimulated	0	None
76350	76351	prostaglandin	0	None
76351	76352	(	0	None
76352	76353	PG	0	None
76353	76354	)	0	None
76354	76355	production	0	None
76355	76356	and	0	None
76356	76357	excitotoxic	0	None
76357	76358	neuronal	0	None
76358	76359	cell	0	None
76359	76360	death	0	None
76360	76361	.	0	None

76362	76363	Immunocytochemical	0	None
76363	76364	analysis	0	None
76364	76365	of	0	None
76365	76366	mixed	0	None
76366	76367	cortical	0	None
76367	76368	cell	0	None
76368	76369	cultures	0	None
76369	76370	revealed	0	None
76370	76371	that	0	None
76371	76372	COX-2	0	None
76372	76373	expression	0	None
76373	76374	was	0	None
76374	76375	restricted	0	None
76375	76376	to	0	None
76376	76377	neurons	0	None
76377	76378	,	0	None
76378	76379	whereas	0	None
76379	76380	COX-1	1	GENE-Y
76380	76381	was	0	None
76381	76382	expressed	0	None
76382	76383	in	0	None
76383	76384	both	0	None
76384	76385	neurons	0	None
76385	76386	and	0	None
76386	76387	astrocytes	0	None
76387	76388	.	0	None

76389	76390	Brief	0	None
76390	76391	exposure	0	None
76391	76392	to	0	None
76392	76393	NMDA	0	None
76393	76394	(	0	None
76394	76395	5	0	None
76395	76396	min;	0	None
76396	76397	100	0	None
76397	76398	microM	0	None
76398	76399	)	0	None
76399	76400	elicited	0	None
76400	76401	a	0	None
76401	76402	time-dependent	0	None
76402	76403	accumulation	0	None
76403	76404	of	0	None
76404	76405	PGs	2	CHEMICAL
76405	76406	in	0	None
76406	76407	the	0	None
76407	76408	culture	0	None
76408	76409	medium	0	None
76409	76410	that	0	None
76410	76411	preceded	0	None
76411	76412	neuronal	0	None
76412	76413	cell	0	None
76413	76414	death	0	None
76414	76415	and	0	None
76415	76416	correlated	0	None
76416	76417	with	0	None
76417	76418	the	0	None
76418	76419	induction	0	None
76419	76420	of	0	None
76420	76421	COX-2	0	None
76421	76422	mRNA	0	None
76422	76423	.	0	None

76424	76425	COX-1	1	GENE-Y
76425	76426	expression	0	None
76426	76427	remained	0	None
76427	76428	unchanged	0	None
76428	76429	.	0	None

76430	76431	Flurbiprofen	0	None
76431	76432	,	0	None
76432	76433	a	0	None
76433	76434	nonselective	0	None
76434	76435	COX-1	1	GENE-Y
76435	76436	/	0	None
76436	76437	COX-2	0	None
76437	76438	inhibitor	0	None
76438	76439	,	0	None
76439	76440	blocked	0	None
76440	76441	NMDA-stimulated	0	None
76441	76442	PG	0	None
76442	76443	production	0	None
76443	76444	and	0	None
76444	76445	attenuated	0	None
76445	76446	neuronal	0	None
76446	76447	death	0	None
76447	76448	in	0	None
76448	76449	a	0	None
76449	76450	concentration-dependent	0	None
76450	76451	manner	0	None
76451	76452	.	0	None

76453	76454	Similar	0	None
76454	76455	results	0	None
76455	76456	were	0	None
76456	76457	obtained	0	None
76457	76458	with	0	None
76458	76459	the	0	None
76459	76460	specific	0	None
76460	76461	COX-2	0	None
76461	76462	inhibitor	0	None
76462	76463	NS-398	0	None
76463	76464	(	0	None
76464	76465	10-30	0	None
76465	76466	microM	0	None
76466	76467	)	0	None
76467	76468	but	0	None
76468	76469	not	0	None
76469	76470	with	0	None
76470	76471	the	0	None
76471	76472	selective	0	None
76472	76473	COX-1	1	GENE-Y
76473	76474	inhibitor	0	None
76474	76475	valeryl	0	None
76475	76476	salicylate	2	CHEMICAL
76476	76477	(	0	None
76477	76478	10-300	0	None
76478	76479	microM	0	None
76479	76480	)	0	None
76480	76481	.	0	None

76482	76483	Inhibition	0	None
76483	76484	of	0	None
76484	76485	total	0	None
76485	76486	constitutive	0	None
76486	76487	COX	3	GENE-N
76487	76488	activity	0	None
76488	76489	with	0	None
76489	76490	aspirin	2	CHEMICAL
76490	76491	(	0	None
76491	76492	100	0	None
76492	76493	microM	0	None
76493	76494	,	0	None
76494	76495	1	0	None
76495	76496	.	0	None
76496	76497	5	0	None
76497	76498	h	0	None
76498	76499	)	0	None
76499	76500	before	0	None
76500	76501	NMDA	0	None
76501	76502	exposure	0	None
76502	76503	did	0	None
76503	76504	not	0	None
76504	76505	prevent	0	None
76505	76506	subsequent	0	None
76506	76507	NMDA-mediated	0	None
76507	76508	neuronal	0	None
76508	76509	cell	0	None
76509	76510	death	0	None
76510	76511	.	0	None

76512	76513	However	0	None
76513	76514	,	0	None
76514	76515	neuronal	0	None
76515	76516	injury	0	None
76516	76517	in	0	None
76517	76518	aspirin-pretreated	0	None
76518	76519	cultures	0	None
76519	76520	was	0	None
76520	76521	attenuated	0	None
76521	76522	by	0	None
76522	76523	flurbiprofen	0	None
76523	76524	administration	0	None
76524	76525	after	0	None
76525	76526	NMDA	0	None
76526	76527	exposure	0	None
76527	76528	.	0	None

76529	76530	Finally	0	None
76530	76531	,	0	None
76531	76532	the	0	None
76532	76533	protection	0	None
76533	76534	afforded	0	None
76534	76535	by	0	None
76535	76536	COX-2	0	None
76536	76537	inhibition	0	None
76537	76538	was	0	None
76538	76539	specific	0	None
76539	76540	for	0	None
76540	76541	NMDA	0	None
76541	76542	because	0	None
76542	76543	neither	0	None
76543	76544	flurbiprofen	0	None
76544	76545	nor	0	None
76545	76546	NS-398	0	None
76546	76547	protected	0	None
76547	76548	neurons	0	None
76548	76549	against	0	None
76549	76550	kainate-mediated	0	None
76550	76551	neurotoxicity	0	None
76551	76552	.	0	None

76553	76554	Together	0	None
76554	76555	,	0	None
76555	76556	these	0	None
76556	76557	results	0	None
76557	76558	support	0	None
76558	76559	the	0	None
76559	76560	conclusion	0	None
76560	76561	that	0	None
76561	76562	newly	0	None
76562	76563	synthesized	0	None
76563	76564	COX-2	0	None
76564	76565	protein	0	None
76565	76566	contributes	0	None
76566	76567	to	0	None
76567	76568	NMDA-induced	0	None
76568	76569	neuronal	0	None
76569	76570	injury	0	None
76570	76571	.	0	None
76571	76572	Excess	0	None
76572	76573	activation	0	None
76573	76574	of	0	None
76574	76575	glutamatergic	0	None
76575	76576	neurotransmission	0	None
76576	76577	in	0	None
76577	76578	the	0	None
76578	76579	cerebral	0	None
76579	76580	cortex	0	None
76580	76581	following	0	None
76581	76582	ethanol	2	CHEMICAL
76582	76583	withdrawal	0	None
76583	76584	is	0	None
76584	76585	considered	0	None
76585	76586	to	0	None
76586	76587	contribute	0	None
76587	76588	to	0	None
76588	76589	significant	0	None
76589	76590	behavioural	0	None
76590	76591	disturbances	0	None
76591	76592	,	0	None
76592	76593	and	0	None
76593	76594	to	0	None
76594	76595	alcohol	2	CHEMICAL
76595	76596	craving	0	None
76596	76597	.	0	None

76598	76599	Astrocytes	0	None
76599	76600	may	0	None
76600	76601	play	0	None
76601	76602	a	0	None
76602	76603	role	0	None
76603	76604	in	0	None
76604	76605	these	0	None
76605	76606	manifestations	0	None
76606	76607	because	0	None
76607	76608	astrocytes	0	None
76608	76609	are	0	None
76609	76610	essential	0	None
76610	76611	in	0	None
76611	76612	the	0	None
76612	76613	regulation	0	None
76613	76614	of	0	None
76614	76615	released	0	None
76615	76616	glutamate	0	None
76616	76617	and	0	None
76617	76618	its	0	None
76618	76619	conversion	0	None
76619	76620	to	0	None
76620	76621	glutamine	0	None
76621	76622	through	0	None
76622	76623	the	0	None
76623	76624	enzyme	0	None
76624	76625	glutamine	0	None
76625	76626	synthetase	0	None
76626	76627	(	0	None
76627	76628	GS	0	None
76628	76629	)	0	None
76629	76630	.	0	None

76631	76632	However	0	None
76632	76633	,	0	None
76633	76634	it	0	None
76634	76635	is	0	None
76635	76636	unclear	0	None
76636	76637	if	0	None
76637	76638	withdrawal	0	None
76638	76639	from	0	None
76639	76640	free-choice	0	None
76640	76641	ethanol	2	CHEMICAL
76641	76642	drinking	0	None
76642	76643	causes	0	None
76643	76644	changes	0	None
76644	76645	in	0	None
76645	76646	the	0	None
76646	76647	numbers	0	None
76647	76648	of	0	None
76648	76649	astrocytes	0	None
76649	76650	expressing	0	None
76650	76651	GS	0	None
76651	76652	or	0	None
76652	76653	the	0	None
76653	76654	cytoskeletal	0	None
76654	76655	protein	0	None
76655	76656	of	0	None
76656	76657	astrocytes	0	None
76657	76658	glial	0	None
76658	76659	fibrillary	0	None
76659	76660	acidic	0	None
76660	76661	protein	0	None
76661	76662	(	0	None
76662	76663	GFAP	0	None
76663	76664	)	0	None
76664	76665	.	0	None

76666	76667	Alcohol-preferring	0	None
76667	76668	(	0	None
76668	76669	P	0	None
76669	76670	)	0	None
76670	76671	rats	0	None
76671	76672	exposed	0	None
76672	76673	to	0	None
76673	76674	free-choice	0	None
76674	76675	ethanol	2	CHEMICAL
76675	76676	drinking	0	None
76676	76677	were	0	None
76677	76678	either	0	None
76678	76679	maintained	0	None
76679	76680	without	0	None
76680	76681	forced	0	None
76681	76682	interruption	0	None
76682	76683	of	0	None
76683	76684	ethanol	2	CHEMICAL
76684	76685	drinking	0	None
76685	76686	,	0	None
76686	76687	subjected	0	None
76687	76688	to	0	None
76688	76689	a	0	None
76689	76690	3-day	0	None
76690	76691	withdrawal	0	None
76691	76692	period	0	None
76692	76693	at	0	None
76693	76694	the	0	None
76694	76695	end	0	None
76695	76696	of	0	None
76696	76697	2	0	None
76697	76698	months	0	None
76698	76699	,	0	None
76699	76700	or	0	None
76700	76701	subjected	0	None
76701	76702	to	0	None
76702	76703	three	0	None
76703	76704	3-day	0	None
76704	76705	withdrawal	0	None
76705	76706	periods	0	None
76706	76707	along	0	None
76707	76708	6	0	None
76708	76709	months	0	None
76709	76710	.	0	None

76711	76712	At	0	None
76712	76713	2	0	None
76713	76714	months	0	None
76714	76715	,	0	None
76715	76716	P	0	None
76716	76717	rats	0	None
76717	76718	were	0	None
76718	76719	also	0	None
76719	76720	compared	0	None
76720	76721	with	0	None
76721	76722	alcohol-naive	0	None
76722	76723	alcohol	2	CHEMICAL
76723	76724	non-preferring	0	None
76724	76725	rats	0	None
76725	76726	(	0	None
76726	76727	NP	0	None
76727	76728	)	0	None
76728	76729	rats	0	None
76729	76730	.	0	None

76731	76732	Packing	0	None
76732	76733	density	0	None
76733	76734	of	0	None
76734	76735	GS	0	None
76735	76736	and	0	None
76736	76737	GFAP-immunoreactive	0	None
76737	76738	(	0	None
76738	76739	IR	0	None
76739	76740	)	0	None
76740	76741	astrocytes	0	None
76741	76742	was	0	None
76742	76743	measured	0	None
76743	76744	in	0	None
76744	76745	sections	0	None
76745	76746	from	0	None
76746	76747	the	0	None
76747	76748	prelimbic	0	None
76748	76749	cortex	0	None
76749	76750	(	0	None
76750	76751	PLC	3	GENE-N
76751	76752	)	0	None
76752	76753	using	0	None
76753	76754	the	0	None
76754	76755	optical	0	None
76755	76756	disector	0	None
76756	76757	probe	0	None
76757	76758	.	0	None

76759	76760	An	0	None
76760	76761	alcohol	2	CHEMICAL
76761	76762	deprivation	0	None
76762	76763	effect	0	None
76763	76764	was	0	None
76764	76765	observed	0	None
76765	76766	in	0	None
76766	76767	P	0	None
76767	76768	rats	0	None
76768	76769	with	0	None
76769	76770	withdrawals	0	None
76770	76771	during	0	None
76771	76772	a	0	None
76772	76773	6-month	0	None
76773	76774	ethanol	2	CHEMICAL
76774	76775	drinking	0	None
76775	76776	period	0	None
76776	76777	.	0	None

76778	76779	Ethanol	2	CHEMICAL
76779	76780	withdrawal	0	None
76780	76781	significantly	0	None
76781	76782	increased	0	None
76782	76783	the	0	None
76783	76784	packing	0	None
76784	76785	density	0	None
76785	76786	of	0	None
76786	76787	GS-	0	None
76787	76788	and	0	None
76788	76789	GFAP-IR	0	None
76789	76790	astrocytes	0	None
76790	76791	in	0	None
76791	76792	the	0	None
76792	76793	PLC	3	GENE-N
76793	76794	of	0	None
76794	76795	P	0	None
76795	76796	rats	0	None
76796	76797	as	0	None
76797	76798	compared	0	None
76798	76799	with	0	None
76799	76800	P	0	None
76800	76801	rats	0	None
76801	76802	with	0	None
76802	76803	continuous	0	None
76803	76804	access	0	None
76804	76805	to	0	None
76805	76806	ethanol	2	CHEMICAL
76806	76807	.	0	None

76808	76809	In	0	None
76809	76810	addition	0	None
76810	76811	,	0	None
76811	76812	there	0	None
76812	76813	was	0	None
76813	76814	a	0	None
76814	76815	positive	0	None
76815	76816	correlation	0	None
76816	76817	between	0	None
76817	76818	the	0	None
76818	76819	pre-withdrawal	0	None
76819	76820	ethanol	2	CHEMICAL
76820	76821	consumption	0	None
76821	76822	and	0	None
76822	76823	the	0	None
76823	76824	packing	0	None
76824	76825	density	0	None
76825	76826	of	0	None
76826	76827	GS-IR	0	None
76827	76828	astrocytes	0	None
76828	76829	.	0	None

76830	76831	The	0	None
76831	76832	present	0	None
76832	76833	results	0	None
76833	76834	suggest	0	None
76834	76835	the	0	None
76835	76836	involvement	0	None
76836	76837	of	0	None
76837	76838	astrocytes	0	None
76838	76839	in	0	None
76839	76840	the	0	None
76840	76841	regulation	0	None
76841	76842	of	0	None
76842	76843	the	0	None
76843	76844	glutamatergic	0	None
76844	76845	activation	0	None
76845	76846	associated	0	None
76846	76847	with	0	None
76847	76848	withdrawal	0	None
76848	76849	from	0	None
76849	76850	free-choice	0	None
76850	76851	ethanol	2	CHEMICAL
76851	76852	consumption	0	None
76852	76853	and	0	None
76853	76854	point	0	None
76854	76855	to	0	None
76855	76856	differential	0	None
76856	76857	adaptations	0	None
76857	76858	of	0	None
76858	76859	GS	0	None
76859	76860	and	0	None
76860	76861	GFAP	0	None
76861	76862	to	0	None
76862	76863	prolonged	0	None
76863	76864	alcohol	2	CHEMICAL
76864	76865	drinking	0	None
76865	76866	in	0	None
76866	76867	the	0	None
76867	76868	PLC	3	GENE-N
76868	76869	of	0	None
76869	76870	P	0	None
76870	76871	rats	0	None
76871	76872	.	0	None
76872	76873	Novel	0	None
76873	76874	pentablock	0	None
76874	76875	copolymer	0	None
76875	76876	(	0	None
76876	76877	PLA-PCL-PEG-PCL-PLA	0	None
76877	76878	)	0	None
76878	76879	based	0	None
76879	76880	nanoparticles	0	None
76880	76881	for	0	None
76881	76882	controlled	0	None
76882	76883	drug	0	None
76883	76884	delivery	0	None
76884	76885	:	0	None
76885	76886	Effect	0	None
76886	76887	of	0	None
76887	76888	copolymer	0	None
76888	76889	compositions	0	None
76889	76890	on	0	None
76890	76891	the	0	None
76891	76892	crystallinity	0	None
76892	76893	of	0	None
76893	76894	copolymers	0	None
76894	76895	and	0	None
76895	76896	in	0	None
76896	76897	vitro	0	None
76897	76898	drug	0	None
76898	76899	release	0	None
76899	76900	profile	0	None
76900	76901	from	0	None
76901	76902	nanoparticles	0	None
76902	76903	.	0	None
76903	76904	Botulinum	0	None
76904	76905	toxin	0	None
76905	76906	type	0	None
76906	76907	A	0	None
76907	76908	(	0	None
76908	76909	BoNT	3	GENE-N
76909	76910	/	0	None
76910	76911	A	0	None
76911	76912	)	0	None
76912	76913	produced	0	None
76913	76914	by	0	None
76914	76915	Clostridium	0	None
76915	76916	botulinum	0	None
76916	76917	inhibits	0	None
76917	76918	Ca2	0	None
76918	76919	+	0	None
76919	76920	-dependent	0	None
76920	76921	acetylcholine	0	None
76921	76922	(	0	None
76922	76923	ACh	0	None
76923	76924	)	0	None
76924	76925	release	0	None
76925	76926	(	0	None
76926	76927	neuroexocytosis	0	None
76927	76928	)	0	None
76928	76929	at	0	None
76929	76930	peripheral	0	None
76930	76931	neuromuscular	0	None
76931	76932	junctions	0	None
76932	76933	,	0	None
76933	76934	sometimes	0	None
76934	76935	causing	0	None
76935	76936	neuromuscular	0	None
76936	76937	paralysis	0	None
76937	76938	.	0	None

76939	76940	This	0	None
76940	76941	inhibitory	0	None
76941	76942	effect	0	None
76942	76943	is	0	None
76943	76944	attributed	0	None
76944	76945	to	0	None
76945	76946	its	0	None
76946	76947	metalloprotease	0	None
76947	76948	activity	0	None
76948	76949	to	0	None
76949	76950	cleave	0	None
76950	76951	the	0	None
76951	76952	25-kDa	0	None
76952	76953	synaptosomal-associated	0	None
76953	76954	protein	0	None
76954	76955	,	0	None
76955	76956	which	0	None
76956	76957	is	0	None
76957	76958	essential	0	None
76958	76959	for	0	None
76959	76960	the	0	None
76960	76961	exocytotic	0	None
76961	76962	machinery	0	None
76962	76963	.	0	None

76964	76965	However	0	None
76965	76966	,	0	None
76966	76967	deletion	0	None
76967	76968	of	0	None
76968	76969	this	0	None
76969	76970	protein	0	None
76970	76971	does	0	None
76971	76972	not	0	None
76972	76973	result	0	None
76973	76974	in	0	None
76974	76975	a	0	None
76975	76976	complete	0	None
76976	76977	block	0	None
76977	76978	of	0	None
76978	76979	neuroexocytosis	0	None
76979	76980	,	0	None
76980	76981	suggesting	0	None
76981	76982	that	0	None
76982	76983	botulinum-mediated	0	None
76983	76984	inhibition	0	None
76984	76985	may	0	None
76985	76986	occur	0	None
76986	76987	via	0	None
76987	76988	another	0	None
76988	76989	mechanism	0	None
76989	76990	.	0	None

76991	76992	Rho	0	None
76992	76993	GTPases	0	None
76993	76994	,	0	None
76994	76995	a	0	None
76995	76996	class	0	None
76996	76997	of	0	None
76997	76998	small	0	None
76998	76999	GTP-binding	0	None
76999	77000	proteins	0	None
77000	77001	(	0	None
77001	77002	G	0	None
77002	77003	proteins	0	None
77003	77004	)	0	None
77004	77005	,	0	None
77005	77006	control	0	None
77006	77007	actin	3	GENE-N
77007	77008	cytoskeletal	0	None
77008	77009	organization	0	None
77009	77010	,	0	None
77010	77011	thereby	0	None
77011	77012	regulating	0	None
77012	77013	a	0	None
77013	77014	variety	0	None
77014	77015	of	0	None
77015	77016	cellular	0	None
77016	77017	functions	0	None
77017	77018	in	0	None
77018	77019	various	0	None
77019	77020	cells	0	None
77020	77021	,	0	None
77021	77022	including	0	None
77022	77023	neuronal	0	None
77023	77024	cells	0	None
77024	77025	.	0	None

77026	77027	We	0	None
77027	77028	have	0	None
77028	77029	shown	0	None
77029	77030	that	0	None
77030	77031	the	0	None
77031	77032	G	0	None
77032	77033	protein	0	None
77033	77034	activator	0	None
77034	77035	lysophosphatidic	0	None
77035	77036	acid	0	None
77036	77037	(	0	None
77037	77038	LPA	0	None
77038	77039	)	0	None
77039	77040	triggered	0	None
77040	77041	actin	3	GENE-N
77041	77042	reorganization	0	None
77042	77043	followed	0	None
77043	77044	by	0	None
77044	77045	Ca2	0	None
77045	77046	+	0	None
77046	77047	-dependent	0	None
77047	77048	ACh	0	None
77048	77049	release	0	None
77049	77050	in	0	None
77050	77051	nerve	0	None
77051	77052	growth	0	None
77052	77053	factor-treated	0	None
77053	77054	PC12	0	None
77054	77055	cells	0	None
77055	77056	and	0	None
77056	77057	that	0	None
77057	77058	BoNT	3	GENE-N
77058	77059	/	0	None
77059	77060	A	0	None
77060	77061	blocked	0	None
77061	77062	both	0	None
77062	77063	events	0	None
77063	77064	through	0	None
77064	77065	degradation	0	None
77065	77066	of	0	None
77066	77067	RhoB	0	None
77067	77068	by	0	None
77068	77069	the	0	None
77069	77070	proteasome	3	GENE-N
77070	77071	.	0	None

77072	77073	Overexpression	0	None
77073	77074	of	0	None
77074	77075	wild-type	0	None
77075	77076	RhoB	0	None
77076	77077	caused	0	None
77077	77078	actin	3	GENE-N
77078	77079	reorganization	0	None
77079	77080	and	0	None
77080	77081	enhanced	0	None
77081	77082	the	0	None
77082	77083	release	0	None
77083	77084	of	0	None
77084	77085	ACh	0	None
77085	77086	by	0	None
77086	77087	LPA	0	None
77087	77088	to	0	None
77088	77089	overcome	0	None
77089	77090	toxin's	0	None
77090	77091	inhibitory	0	None
77091	77092	effect	0	None
77092	77093	on	0	None
77093	77094	actin	3	GENE-N
77094	77095	reorganization	0	None
77095	77096	/	0	None
77096	77097	exocytosis	0	None
77097	77098	stimulated	0	None
77098	77099	by	0	None
77099	77100	LPA	0	None
77100	77101	,	0	None
77101	77102	whereas	0	None
77102	77103	overexpression	0	None
77103	77104	of	0	None
77104	77105	a	0	None
77105	77106	dominant	0	None
77106	77107	negative	0	None
77107	77108	RhoB	0	None
77108	77109	inhibited	0	None
77109	77110	ACh	0	None
77110	77111	release	0	None
77111	77112	,	0	None
77112	77113	regardless	0	None
77113	77114	of	0	None
77114	77115	LPA	0	None
77115	77116	and	0	None
77116	77117	/	0	None
77117	77118	or	0	None
77118	77119	toxin	0	None
77119	77120	treatment	0	None
77120	77121	.	0	None

77122	77123	Finally	0	None
77123	77124	,	0	None
77124	77125	a	0	None
77125	77126	knockdown	0	None
77126	77127	of	0	None
77127	77128	the	0	None
77128	77129	RhoB	0	None
77129	77130	gene	0	None
77130	77131	via	0	None
77131	77132	sequence-specific	0	None
77132	77133	,	0	None
77133	77134	post-transcriptional	0	None
77134	77135	gene	0	None
77135	77136	silencing	0	None
77136	77137	reduced	0	None
77137	77138	RhoB	0	None
77138	77139	expression	0	None
77139	77140	in	0	None
77140	77141	PC12	0	None
77141	77142	cells	0	None
77142	77143	,	0	None
77143	77144	resulting	0	None
77144	77145	in	0	None
77145	77146	total	0	None
77146	77147	inhibition	0	None
77147	77148	of	0	None
77148	77149	both	0	None
77149	77150	actin	3	GENE-N
77150	77151	reorganization	0	None
77151	77152	and	0	None
77152	77153	ACh	0	None
77153	77154	release	0	None
77154	77155	induced	0	None
77155	77156	by	0	None
77156	77157	LPA	0	None
77157	77158	.	0	None

77159	77160	We	0	None
77160	77161	conclude	0	None
77161	77162	that	0	None
77162	77163	the	0	None
77163	77164	RhoB	0	None
77164	77165	signaling	0	None
77165	77166	pathway	0	None
77166	77167	regulates	0	None
77167	77168	ACh	0	None
77168	77169	release	0	None
77169	77170	via	0	None
77170	77171	actin	3	GENE-N
77171	77172	cytoskeletal	0	None
77172	77173	reorganization	0	None
77173	77174	and	0	None
77174	77175	that	0	None
77175	77176	botulinum	0	None
77176	77177	toxin	0	None
77177	77178	inhibits	0	None
77178	77179	neuroexocytosis	0	None
77179	77180	by	0	None
77180	77181	targeting	0	None
77181	77182	RhoB	0	None
77182	77183	pathway	0	None
77183	77184	.	0	None
77184	77185	Insulin-	0	None
77185	77186	and	0	None
77186	77187	glucagon-like	0	None
77187	77188	peptide-1-induced	0	None
77188	77189	changes	0	None
77189	77190	in	0	None
77190	77191	heart	0	None
77191	77192	rate	0	None
77192	77193	and	0	None
77193	77194	vagosympathetic	0	None
77194	77195	activity	0	None
77195	77196	:	0	None
77196	77197	why	0	None
77197	77198	they	0	None
77198	77199	matter	0	None
77199	77200	.	0	None
77200	77201	Expression	0	None
77201	77202	and	0	None
77202	77203	1	0	None
77203	77204	,	0	None
77204	77205	4-dihydropyridine-binding	0	None
77205	77206	properties	0	None
77206	77207	of	0	None
77207	77208	brain	0	None
77208	77211	L-type calcium channel	3	GENE-N
77211	77212	isoforms	0	None
77212	77213	.	0	None
77213	77214	Gastrodin	0	None
77214	77215	attenuation	0	None
77215	77216	of	0	None
77216	77217	the	0	None
77217	77218	inflammatory	0	None
77218	77219	response	0	None
77219	77220	in	0	None
77220	77221	H9c2	0	None
77221	77222	cardiomyocytes	0	None
77222	77223	involves	0	None
77223	77224	inhibition	0	None
77224	77225	of	0	None
77225	77226	NF-κB	0	None
77226	77227	and	0	None
77227	77228	MAPKs	0	None
77228	77229	activation	0	None
77229	77230	via	0	None
77230	77231	the	0	None
77231	77232	phosphatidylinositol	2	CHEMICAL
77232	77233	3-kinase	0	None
77233	77234	signaling	0	None
77234	77235	.	0	None
77235	77236	Chalcogenopyrylium	0	None
77236	77237	Dyes	0	None
77237	77238	as	0	None
77238	77239	Differential	0	None
77239	77240	Modulators	0	None
77240	77241	of	0	None
77241	77242	Organic	0	None
77242	77243	Anion	0	None
77243	77244	Transport	0	None
77244	77245	by	0	None
77245	77246	MRP1	0	None
77246	77247	,	0	None
77247	77248	MRP2	1	GENE-Y
77248	77249	and	0	None
77249	77250	MRP4	0	None
77250	77251	.	0	None
77251	77252	Olopatadine	0	None
77252	77253	hydrochloride	2	CHEMICAL
77253	77254	(	0	None
77254	77255	olopatadine	0	None
77255	77256	)	0	None
77256	77257	is	0	None
77257	77258	an	0	None
77258	77259	antiallergic	0	None
77259	77260	drug	0	None
77260	77261	with	0	None
77261	77262	histamine	2	CHEMICAL
77262	77263	H	0	None
77263	77264	(	0	None
77264	77265	1	0	None
77265	77266	)	0	None
77266	77267	receptor	0	None
77267	77268	antagonistic	0	None
77268	77269	activity	0	None
77269	77270	.	0	None

77271	77272	Recently	0	None
77272	77273	,	0	None
77273	77274	olopatadine	0	None
77274	77275	has	0	None
77275	77276	been	0	None
77276	77277	shown	0	None
77277	77278	to	0	None
77278	77279	bind	0	None
77279	77280	to	0	None
77280	77281	S100A12	0	None
77281	77282	which	0	None
77282	77283	is	0	None
77283	77284	a	0	None
77284	77285	member	0	None
77285	77286	of	0	None
77286	77287	the	0	None
77287	77288	S100	0	None
77288	77289	family	0	None
77289	77290	of	0	None
77290	77291	calcium-binding	0	None
77291	77292	proteins	0	None
77292	77293	,	0	None
77293	77294	and	0	None
77294	77295	exerts	0	None
77295	77296	multiple	0	None
77296	77297	proinflammatory	0	None
77297	77298	activities	0	None
77298	77299	including	0	None
77299	77300	chemotaxis	0	None
77300	77301	for	0	None
77301	77302	monocytes	0	None
77302	77303	and	0	None
77303	77304	neutrophils	0	None
77304	77305	.	0	None

77306	77307	In	0	None
77307	77308	this	0	None
77308	77309	study	0	None
77309	77310	,	0	None
77310	77311	we	0	None
77311	77312	examined	0	None
77312	77313	the	0	None
77313	77314	possibility	0	None
77314	77315	that	0	None
77315	77316	the	0	None
77316	77317	interaction	0	None
77317	77318	of	0	None
77318	77319	olopatadine	0	None
77319	77320	with	0	None
77320	77321	S100A12	0	None
77321	77322	inhibits	0	None
77322	77323	the	0	None
77323	77324	proinflammatory	0	None
77324	77325	effects	0	None
77325	77326	of	0	None
77326	77327	S100A12	0	None
77327	77328	.	0	None

77329	77330	Pretreatment	0	None
77330	77331	of	0	None
77331	77332	olopatadine	0	None
77332	77333	with	0	None
77333	77334	S100A12	0	None
77334	77335	reduced	0	None
77335	77336	migration	0	None
77336	77337	of	0	None
77337	77338	THP-1	0	None
77338	77339	,	0	None
77339	77340	a	0	None
77340	77341	monocyte	0	None
77341	77342	cell	0	None
77342	77343	line	0	None
77343	77344	,	0	None
77344	77345	induced	0	None
77345	77346	by	0	None
77346	77347	S100A12	0	None
77347	77348	alone	0	None
77348	77349	,	0	None
77349	77350	but	0	None
77350	77351	did	0	None
77351	77352	not	0	None
77352	77353	affect	0	None
77353	77354	recombinant	0	None
77354	77355	human	0	None
77355	77356	regulated	0	None
77356	77357	upon	0	None
77357	77358	activation	0	None
77358	77359	,	0	None
77359	77360	normal	0	None
77360	77361	T	0	None
77361	77362	cell	0	None
77362	77363	expressed	0	None
77363	77364	and	0	None
77364	77365	secreted	0	None
77365	77366	(	0	None
77366	77367	RANTES	1	GENE-Y
77367	77368	)	0	None
77368	77369	-induced	0	None
77369	77370	migration	0	None
77370	77371	.	0	None

77372	77373	Amlexanox	0	None
77373	77374	,	0	None
77374	77375	which	0	None
77375	77376	also	0	None
77376	77377	binds	0	None
77377	77378	to	0	None
77378	77379	S100A12	0	None
77379	77380	,	0	None
77380	77381	inhibited	0	None
77381	77382	the	0	None
77382	77383	THP-1	0	None
77383	77384	migration	0	None
77384	77385	induced	0	None
77385	77386	by	0	None
77386	77387	S100A12	0	None
77387	77388	.	0	None

77389	77390	However	0	None
77390	77391	,	0	None
77391	77392	ketotifen	0	None
77392	77393	,	0	None
77393	77394	another	0	None
77394	77395	histamine	2	CHEMICAL
77395	77396	H	0	None
77396	77397	(	0	None
77397	77398	1	0	None
77398	77399	)	0	None
77399	77400	receptor	0	None
77400	77401	antagonist	0	None
77401	77402	,	0	None
77402	77403	had	0	None
77403	77404	little	0	None
77404	77405	effect	0	None
77405	77406	on	0	None
77406	77407	the	0	None
77407	77408	activity	0	None
77408	77409	of	0	None
77409	77410	S100A12	0	None
77410	77411	.	0	None

77412	77413	These	0	None
77413	77414	results	0	None
77414	77415	suggest	0	None
77415	77416	that	0	None
77416	77417	olopatadine	0	None
77417	77418	has	0	None
77418	77419	a	0	None
77419	77420	new	0	None
77420	77421	mechanism	0	None
77421	77422	of	0	None
77422	77423	action	0	None
77423	77424	,	0	None
77424	77425	that	0	None
77425	77426	is	0	None
77426	77427	,	0	None
77427	77428	suppression	0	None
77428	77429	of	0	None
77429	77430	the	0	None
77430	77431	function	0	None
77431	77432	of	0	None
77432	77433	S100A12	0	None
77433	77434	,	0	None
77434	77435	in	0	None
77435	77436	addition	0	None
77436	77437	to	0	None
77437	77438	histamine	2	CHEMICAL
77438	77439	H	0	None
77439	77440	(	0	None
77440	77441	1	0	None
77441	77442	)	0	None
77442	77443	receptor	0	None
77443	77444	antagonistic	0	None
77444	77445	activity	0	None
77445	77446	.	0	None
77446	77447	Current	0	None
77447	77448	and	0	None
77448	77449	future	0	None
77449	77450	prospects	0	None
77450	77451	for	0	None
77451	77452	anticoagulant	0	None
77452	77453	therapy	0	None
77453	77454	:	0	None
77454	77455	inhibitors	0	None
77455	77456	of	0	None
77456	77457	factor	0	None
77457	77458	Xa	0	None
77458	77459	and	0	None
77459	77461	factor IIa	1	GENE-Y
77461	77462	.	0	None
77462	77463	Neuromuscular	0	None
77463	77464	blocking	0	None
77464	77465	drugs	0	None
77465	77466	produce	0	None
77466	77467	muscle	0	None
77467	77468	weakness	0	None
77468	77469	by	0	None
77469	77470	interaction	0	None
77470	77471	with	0	None
77471	77472	nicotinic-acetylcholine	0	None
77472	77473	receptors	0	None
77473	77474	.	0	None

77475	77476	Cardiovascular	0	None
77476	77477	side	0	None
77477	77478	effects	0	None
77478	77479	have	0	None
77479	77480	been	0	None
77480	77481	reported	0	None
77481	77482	.	0	None

77483	77484	In	0	None
77484	77485	this	0	None
77485	77486	study	0	None
77486	77487	the	0	None
77487	77488	neuromuscular	0	None
77488	77489	blocking	0	None
77489	77490	drug	0	None
77490	77491	vecuronium	0	None
77491	77492	and	0	None
77492	77493	the	0	None
77493	77494	controls	0	None
77494	77495	gallamine	2	CHEMICAL
77495	77496	and	0	None
77496	77497	pancuronium	0	None
77497	77498	slowed	0	None
77498	77499	the	0	None
77499	77500	rate	0	None
77500	77501	of	0	None
77501	77502	atropine	2	CHEMICAL
77502	77503	induced	0	None
77503	77504	[	0	None
77504	77505	(	0	None
77505	77506	3	0	None
77506	77507	)	0	None
77507	77508	H	0	None
77508	77509	]	0	None
77509	77510	N-methylscopolamine	0	None
77510	77511	dissociation	0	None
77511	77512	from	0	None
77512	77513	Chinese	0	None
77513	77514	hamster	0	None
77514	77515	ovary	0	None
77515	77516	cells	0	None
77516	77517	expressing	0	None
77517	77518	recombinant	0	None
77518	77519	human	0	None
77519	77520	muscarinic	0	None
77520	77521	M2	0	None
77521	77522	receptors	0	None
77522	77523	K	0	None
77523	77524	(	0	None
77524	77525	off	0	None
77525	77526	)	0	None
77526	77527	values	0	None
77527	77528	min	0	None
77528	77529	(	0	None
77529	77530	-1	0	None
77530	77531	)	0	None
77531	77532	;	0	None
77532	77533	vecuronium	0	None
77533	77534	(	0	None
77534	77535	125	0	None
77535	77536	nM	0	None
77536	77537	)	0	None
77537	77538	,	0	None
77538	77539	atropine	2	CHEMICAL
77539	77540	0	0	None
77540	77541	.	0	None
77541	77542	45	0	None
77542	77543	+	0	None
77543	77544	/	0	None
77544	77545	-0	0	None
77545	77546	.	0	None
77546	77547	07	0	None
77547	77548	+	0	None
77548	77549	blocker	0	None
77549	77550	0	0	None
77550	77551	.	0	None
77551	77552	04	0	None
77552	77553	+	0	None
77553	77554	/	0	None
77554	77555	-0	0	None
77555	77556	.	0	None
77556	77557	02;	0	None
77557	77558	gallamine	2	CHEMICAL
77558	77559	(	0	None
77559	77560	21	0	None
77560	77561	nM	0	None
77561	77562	)	0	None
77562	77563	,	0	None
77563	77564	atropine	2	CHEMICAL
77564	77565	0	0	None
77565	77566	.	0	None
77566	77567	42	0	None
77567	77568	+	0	None
77568	77569	/	0	None
77569	77570	-0	0	None
77570	77571	.	0	None
77571	77572	05	0	None
77572	77573	+	0	None
77573	77574	blocker	0	None
77574	77575	0	0	None
77575	77576	.	0	None
77576	77577	15	0	None
77577	77578	+	0	None
77578	77579	/	0	None
77579	77580	-0	0	None
77580	77581	.	0	None
77581	77582	04;	0	None
77582	77583	pancuronium	0	None
77583	77584	(	0	None
77584	77585	21	0	None
77585	77586	nM	0	None
77586	77587	)	0	None
77587	77588	,	0	None
77588	77589	atropine	2	CHEMICAL
77589	77590	0	0	None
77590	77591	.	0	None
77591	77592	36	0	None
77592	77593	+	0	None
77593	77594	/	0	None
77594	77595	-0	0	None
77595	77596	.	0	None
77596	77597	03	0	None
77597	77598	+	0	None
77598	77599	blocker	0	None
77599	77600	0	0	None
77600	77601	.	0	None
77601	77602	03	0	None
77602	77603	+	0	None
77603	77604	/	0	None
77604	77605	-0	0	None
77605	77606	.	0	None
77606	77607	01	0	None
77607	77608	)	0	None
77608	77609	.	0	None

77610	77611	These	0	None
77611	77612	data	0	None
77612	77613	indicate	0	None
77613	77614	that	0	None
77614	77615	vecuronium	0	None
77615	77616	,	0	None
77616	77617	gallamine	2	CHEMICAL
77617	77618	and	0	None
77618	77619	pancuronium	0	None
77619	77620	interact	0	None
77620	77621	with	0	None
77621	77622	an	0	None
77622	77623	allosteric	0	None
77623	77624	site	0	None
77624	77625	on	0	None
77625	77626	the	0	None
77626	77627	muscarinic	0	None
77627	77629	M2 receptor	1	GENE-Y
77629	77630	(	0	None
77630	77631	located	0	None
77631	77632	on	0	None
77632	77633	the	0	None
77633	77634	heart	0	None
77634	77635	)	0	None
77635	77636	and	0	None
77636	77637	this	0	None
77637	77638	may	0	None
77638	77639	explain	0	None
77639	77640	some	0	None
77640	77641	of	0	None
77641	77642	their	0	None
77642	77643	cardiac	0	None
77643	77644	side	0	None
77644	77645	effects	0	None
77645	77646	.	0	None
77646	77647	Bimodal	0	None
77647	77648	occurrence	0	None
77648	77649	of	0	None
77649	77650	aspartoacylase	1	GENE-Y
77650	77651	in	0	None
77651	77652	myelin	0	None
77652	77653	and	0	None
77653	77654	cytosol	0	None
77654	77655	of	0	None
77655	77656	brain	0	None
77656	77657	.	0	None
77657	77658	A	0	None
77658	77659	noncatalytic	0	None
77659	77660	tetrahydrofolate	2	CHEMICAL
77660	77661	tight	0	None
77661	77662	binding	0	None
77662	77663	site	0	None
77663	77664	is	0	None
77664	77665	on	0	None
77665	77666	the	0	None
77666	77667	small	0	None
77667	77668	domain	0	None
77668	77669	of	0	None
77669	77671	10-formyltetrahydrofolate dehydrogenase	1	GENE-Y
77671	77672	.	0	None
77672	77673	Multifunctional	0	None
77673	77674	targets	0	None
77674	77675	of	0	None
77675	77676	dietary	0	None
77676	77677	polyphenols	0	None
77677	77678	in	0	None
77678	77679	disease	0	None
77679	77680	:	0	None
77680	77681	a	0	None
77681	77682	case	0	None
77682	77683	for	0	None
77683	77684	the	0	None
77684	77685	chemokine	0	None
77685	77686	network	0	None
77686	77687	and	0	None
77687	77688	energy	0	None
77688	77689	metabolism	0	None
77689	77690	.	0	None
77690	77691	Cocaine	0	None
77691	77692	modulates	0	None
77692	77693	serum	0	None
77693	77694	levels	0	None
77694	77695	of	0	None
77695	77696	progesterone	2	CHEMICAL
77696	77697	in	0	None
77697	77698	intact	0	None
77698	77699	female	0	None
77699	77700	and	0	None
77700	77701	male	0	None
77701	77702	rats	0	None
77702	77703	,	0	None
77703	77704	as	0	None
77704	77705	well	0	None
77705	77706	as	0	None
77706	77707	in	0	None
77707	77708	pregnant	0	None
77708	77709	dams	0	None
77709	77710	,	0	None
77710	77711	and	0	None
77711	77712	progesterone	2	CHEMICAL
77712	77713	decreases	0	None
77713	77714	or	0	None
77714	77715	attenuates	0	None
77715	77716	cocaine-induced	0	None
77716	77717	behavioral	0	None
77717	77718	and	0	None
77718	77719	reward	0	None
77719	77720	responses	0	None
77720	77721	.	0	None

77722	77723	It	0	None
77723	77724	has	0	None
77724	77725	been	0	None
77725	77726	postulated	0	None
77726	77727	that	0	None
77727	77728	cocaine's	0	None
77728	77729	modulation	0	None
77729	77730	of	0	None
77730	77731	serum	0	None
77731	77732	progesterone	2	CHEMICAL
77732	77733	levels	0	None
77733	77734	may	0	None
77734	77735	in	0	None
77735	77736	turn	0	None
77736	77737	alter	0	None
77737	77739	progesterone receptor	1	GENE-Y
77739	77740	activity	0	None
77740	77741	,	0	None
77741	77742	thereby	0	None
77742	77743	contributing	0	None
77743	77744	to	0	None
77744	77745	cocaine-induced	0	None
77745	77746	alterations	0	None
77746	77747	of	0	None
77747	77748	neuronal	0	None
77748	77749	functions	0	None
77749	77750	and	0	None
77750	77751	genomic	0	None
77751	77752	regulations	0	None
77752	77753	.	0	None

77754	77755	To	0	None
77755	77756	test	0	None
77756	77757	this	0	None
77757	77758	hypothesis	0	None
77758	77759	,	0	None
77759	77760	intact	0	None
77760	77761	male	0	None
77761	77762	rats	0	None
77762	77763	received	0	None
77763	77764	acute	0	None
77764	77765	injections	0	None
77765	77766	of	0	None
77766	77767	saline	0	None
77767	77768	or	0	None
77768	77769	cocaine	2	CHEMICAL
77769	77770	(	0	None
77770	77771	15	0	None
77771	77772	or	0	None
77772	77773	30	0	None
77773	77774	mg	2	CHEMICAL
77774	77775	/	0	None
77775	77776	kg	0	None
77776	77777	,	0	None
77777	77778	dissolved	0	None
77778	77779	in	0	None
77779	77780	0	0	None
77780	77781	.	0	None
77781	77782	9%	0	None
77782	77783	saline	0	None
77783	77784	,	0	None
77784	77785	intraperitoneal	0	None
77785	77786	)	0	None
77786	77787	.	0	None

77788	77789	Progesterone	0	None
77789	77790	serum	0	None
77790	77791	levels	0	None
77791	77792	,	0	None
77792	77794	progesterone receptor	1	GENE-Y
77794	77795	(	0	None
77795	77796	PR	0	None
77796	77797	)	0	None
77797	77798	protein	0	None
77798	77799	levels	0	None
77799	77800	,	0	None
77800	77801	and	0	None
77801	77802	PR-DNA	0	None
77802	77803	binding	0	None
77803	77804	complexes	0	None
77804	77805	were	0	None
77805	77806	measured	0	None
77806	77807	in	0	None
77807	77808	the	0	None
77808	77809	striatum	0	None
77809	77810	by	0	None
77810	77811	radioimmunoassay	0	None
77811	77812	,	0	None
77812	77813	Western	0	None
77813	77814	blot	0	None
77814	77815	,	0	None
77815	77816	and	0	None
77816	77817	gel	0	None
77817	77818	shift	0	None
77818	77819	analyses	0	None
77819	77820	,	0	None
77820	77821	respectively	0	None
77821	77822	.	0	None

77823	77824	After	0	None
77824	77825	injection	0	None
77825	77826	of	0	None
77826	77827	15	0	None
77827	77828	mg	2	CHEMICAL
77828	77829	/	0	None
77829	77830	kg	0	None
77830	77831	of	0	None
77831	77832	cocaine	2	CHEMICAL
77832	77833	,	0	None
77833	77834	induction	0	None
77834	77835	of	0	None
77835	77836	progesterone	2	CHEMICAL
77836	77837	serum	0	None
77837	77838	levels	0	None
77838	77839	was	0	None
77839	77840	closely	0	None
77840	77841	followed	0	None
77841	77842	by	0	None
77842	77843	an	0	None
77843	77844	increase	0	None
77844	77845	in	0	None
77845	77846	receptor	0	None
77846	77847	protein	0	None
77847	77848	levels	0	None
77848	77849	and	0	None
77849	77850	DNA	0	None
77850	77851	binding	0	None
77851	77852	complexes	0	None
77852	77853	.	0	None

77854	77855	After	0	None
77855	77856	injection	0	None
77856	77857	of	0	None
77857	77858	30	0	None
77858	77859	mg	2	CHEMICAL
77859	77860	/	0	None
77860	77861	kg	0	None
77861	77862	of	0	None
77862	77863	cocaine	2	CHEMICAL
77863	77864	,	0	None
77864	77865	similar	0	None
77865	77866	effects	0	None
77866	77867	were	0	None
77867	77868	observed	0	None
77868	77869	along	0	None
77869	77870	with	0	None
77870	77871	an	0	None
77871	77872	attenuation	0	None
77872	77873	of	0	None
77873	77874	receptor	0	None
77874	77875	protein	0	None
77875	77876	levels	0	None
77876	77877	and	0	None
77877	77878	DNA	0	None
77878	77879	binding	0	None
77879	77880	complexes	0	None
77880	77881	at	0	None
77881	77882	60	0	None
77882	77883	min	0	None
77883	77884	.	0	None

77885	77886	Our	0	None
77886	77887	results	0	None
77887	77888	suggest	0	None
77888	77889	that	0	None
77889	77890	activation	0	None
77890	77891	of	0	None
77891	77892	progesterone	2	CHEMICAL
77892	77893	receptors	0	None
77893	77894	may	0	None
77894	77895	be	0	None
77895	77896	a	0	None
77896	77897	mechanism	0	None
77897	77898	by	0	None
77898	77899	which	0	None
77899	77900	cocaine	2	CHEMICAL
77900	77901	mediates	0	None
77901	77902	behavior	0	None
77902	77903	through	0	None
77903	77904	molecular	0	None
77904	77905	alterations	0	None
77905	77906	in	0	None
77906	77907	the	0	None
77907	77908	central	0	None
77908	77909	nervous	0	None
77909	77910	system	0	None
77910	77911	.	0	None
77911	77912	The	0	None
77912	77913	high	0	None
77913	77914	potential	0	None
77914	77915	of	0	None
77915	77916	quinazolinone	0	None
77916	77917	containing	0	None
77917	77918	natural	0	None
77918	77919	products	0	None
77919	77920	and	0	None
77920	77921	their	0	None
77921	77922	derivatives	0	None
77922	77923	in	0	None
77923	77924	medicinal	0	None
77924	77925	chemistry	0	None
77925	77926	led	0	None
77926	77927	us	0	None
77927	77928	to	0	None
77928	77929	discover	0	None
77929	77930	four	0	None
77930	77931	novel	0	None
77931	77932	series	0	None
77932	77933	of	0	None
77933	77934	53	0	None
77934	77935	compounds	0	None
77935	77936	of	0	None
77936	77937	quinazolinone	0	None
77937	77938	based	0	None
77938	77939	on	0	None
77939	77940	the	0	None
77940	77941	concept	0	None
77941	77942	of	0	None
77942	77943	molecular	0	None
77943	77944	hybridization	0	None
77944	77945	.	0	None

77946	77947	Most	0	None
77947	77948	of	0	None
77948	77949	the	0	None
77949	77950	synthesized	0	None
77950	77951	analogues	0	None
77951	77952	exhibited	0	None
77952	77953	potent	0	None
77953	77954	leishmanicidal	0	None
77954	77955	activity	0	None
77955	77956	against	0	None
77956	77957	intracellular	0	None
77957	77958	amastigotes	0	None
77958	77959	(	0	None
77959	77960	IC50	0	None
77960	77961	from	0	None
77961	77962	0	0	None
77962	77963	.	0	None
77963	77964	65	0	None
77964	77965	±	0	None
77965	77966	0	0	None
77966	77967	.	0	None
77967	77968	2	0	None
77968	77969	to	0	None
77969	77970	7	0	None
77970	77971	.	0	None
77971	77972	76	0	None
77972	77973	±	0	None
77973	77974	2	0	None
77974	77975	.	0	None
77975	77976	1	0	None
77976	77977	μM	0	None
77977	77978	)	0	None
77978	77979	as	0	None
77979	77980	compared	0	None
77980	77981	to	0	None
77981	77982	miltefosine	0	None
77982	77983	(	0	None
77983	77984	IC50	0	None
77984	77985	=	0	None
77985	77986	8	0	None
77986	77987	.	0	None
77987	77988	4	0	None
77988	77989	±	0	None
77989	77990	2	0	None
77990	77991	.	0	None
77991	77992	1	0	None
77992	77993	μM	0	None
77993	77994	)	0	None
77994	77995	and	0	None
77995	77996	nontoxic	0	None
77996	77997	toward	0	None
77997	77998	the	0	None
77998	77999	J-774A	0	None
77999	78000	.	0	None
78000	78001	1	0	None
78001	78002	cell	0	None
78002	78003	line	0	None
78003	78004	and	0	None
78004	78005	Vero	0	None
78005	78006	cells	0	None
78006	78007	.	0	None

78008	78009	Moreover	0	None
78009	78010	,	0	None
78010	78011	activation	0	None
78011	78012	of	0	None
78012	78013	Th1	0	None
78013	78014	type	0	None
78014	78015	and	0	None
78015	78016	suppression	0	None
78016	78017	of	0	None
78017	78018	Th2	0	None
78018	78019	type	0	None
78019	78020	immune	0	None
78020	78021	responses	0	None
78021	78022	and	0	None
78022	78023	induction	0	None
78023	78024	in	0	None
78024	78025	nitric	0	None
78025	78026	oxide	0	None
78026	78027	generation	0	None
78027	78028	proved	0	None
78028	78029	that	0	None
78029	78030	8a	0	None
78030	78031	and	0	None
78031	78032	8g	0	None
78032	78033	induce	0	None
78033	78034	murine	0	None
78034	78035	macrophages	0	None
78035	78036	to	0	None
78036	78037	prevent	0	None
78037	78038	survival	0	None
78038	78039	of	0	None
78039	78040	parasites	0	None
78040	78041	.	0	None

78042	78043	Compounds	0	None
78043	78044	8a	0	None
78044	78045	and	0	None
78045	78046	8g	0	None
78046	78047	exhibited	0	None
78047	78048	significant	0	None
78048	78049	in	0	None
78049	78050	vivo	0	None
78050	78051	inhibition	0	None
78051	78052	of	0	None
78052	78053	parasite	0	None
78053	78054	73	0	None
78054	78055	.	0	None
78055	78056	15	0	None
78056	78057	±	0	None
78057	78058	12	0	None
78058	78059	.	0	None
78059	78060	69%	0	None
78060	78061	and	0	None
78061	78062	80	0	None
78062	78063	.	0	None
78063	78064	93	0	None
78064	78065	±	0	None
78065	78066	10	0	None
78066	78067	.	0	None
78067	78068	50%	0	None
78068	78069	against	0	None
78069	78070	Leishmania	0	None
78070	78071	donovani	0	None
78071	78072	/	0	None
78072	78073	hamster	0	None
78073	78074	model	0	None
78074	78075	.	0	None

78076	78077	Our	0	None
78077	78078	results	0	None
78078	78079	indicate	0	None
78079	78080	that	0	None
78080	78081	compounds	0	None
78081	78082	8a	0	None
78082	78083	,	0	None
78083	78084	8g	0	None
78084	78085	,	0	None
78085	78086	and	0	None
78086	78087	9f	0	None
78087	78088	represent	0	None
78088	78089	a	0	None
78089	78090	new	0	None
78090	78091	structural	0	None
78091	78092	lead	0	None
78092	78093	for	0	None
78093	78094	this	0	None
78094	78095	serious	0	None
78095	78096	and	0	None
78096	78097	neglected	0	None
78097	78098	disease	0	None
78098	78099	.	0	None
78099	78100	The	0	None
78100	78101	options	0	None
78101	78102	for	0	None
78102	78103	migraine	0	None
78103	78104	treatment	0	None
78104	78105	have	0	None
78105	78106	increased	0	None
78106	78107	in	0	None
78107	78108	the	0	None
78108	78109	recent	0	None
78109	78110	years	0	None
78110	78111	and	0	None
78111	78112	will	0	None
78112	78113	expand	0	None
78113	78114	in	0	None
78114	78115	the	0	None
78115	78116	near	0	None
78116	78117	future	0	None
78117	78118	.	0	None

78119	78120	In	0	None
78120	78121	this	0	None
78121	78122	work	0	None
78122	78123	both	0	None
78123	78124	recent	0	None
78124	78125	and	0	None
78125	78126	future	0	None
78126	78127	options	0	None
78127	78128	for	0	None
78128	78129	migraine	0	None
78129	78130	treatment	0	None
78130	78131	are	0	None
78131	78132	critically	0	None
78132	78133	reviewed	0	None
78133	78134	.	0	None

78135	78136	Firstly	0	None
78136	78137	the	0	None
78137	78138	late	0	None
78138	78139	advances	0	None
78139	78140	in	0	None
78140	78141	the	0	None
78141	78142	symptomatic	0	None
78142	78143	treatment	0	None
78143	78144	of	0	None
78144	78145	migraine	0	None
78145	78146	,	0	None
78146	78147	including	0	None
78147	78148	the	0	None
78148	78149	new	0	None
78149	78150	5-HT1B	0	None
78150	78151	/	0	None
78151	78152	D	0	None
78152	78153	agonists	0	None
78153	78154	"triptans"	0	None
78154	78155	appeared	0	None
78155	78156	after	0	None
78156	78157	sumatriptan	2	CHEMICAL
78157	78158	,	0	None
78158	78159	are	0	None
78159	78160	reviewed	0	None
78160	78161	.	0	None

78162	78163	Possible	0	None
78163	78164	alternative	0	None
78164	78165	,	0	None
78165	78166	such	0	None
78166	78167	as	0	None
78167	78168	selective	0	None
78168	78169	5-HT1D	1	GENE-Y
78169	78170	and	0	None
78170	78171	5-HT1F	0	None
78171	78172	agonists	0	None
78172	78173	,	0	None
78173	78174	are	0	None
78174	78175	also	0	None
78175	78176	discussed	0	None
78176	78177	.	0	None

78178	78179	In	0	None
78179	78180	the	0	None
78180	78181	second	0	None
78181	78182	part	0	None
78182	78183	of	0	None
78183	78184	this	0	None
78184	78185	manuscript	0	None
78185	78186	the	0	None
78186	78187	new	0	None
78187	78188	,	0	None
78188	78189	possible	0	None
78189	78190	options	0	None
78190	78191	for	0	None
78191	78192	the	0	None
78192	78193	preventive	0	None
78193	78194	treatment	0	None
78194	78195	of	0	None
78195	78196	migraine	0	None
78196	78197	comprising	0	None
78197	78198	"antiepileptics"	0	None
78198	78199	,	0	None
78199	78200	such	0	None
78200	78201	as	0	None
78201	78202	valproic	0	None
78202	78203	acid	0	None
78203	78204	,	0	None
78204	78205	gabapentin	0	None
78205	78206	and	0	None
78206	78207	topiramate	0	None
78207	78208	,	0	None
78208	78209	calcium-antagonists	0	None
78209	78210	,	0	None
78210	78211	such	0	None
78211	78212	as	0	None
78212	78213	cyclandelate	0	None
78213	78214	and	0	None
78214	78215	dotarizin	0	None
78215	78216	,	0	None
78216	78217	and	0	None
78217	78218	a	0	None
78218	78219	miscellany	0	None
78219	78220	,	0	None
78220	78221	including	0	None
78221	78222	riboflavin	0	None
78222	78223	,	0	None
78223	78224	are	0	None
78224	78225	analysed	0	None
78225	78226	.	0	None

78227	78228	Finally	0	None
78228	78229	,	0	None
78229	78230	possible	0	None
78230	78231	compounds	0	None
78231	78232	for	0	None
78232	78233	the	0	None
78233	78234	future	0	None
78234	78235	,	0	None
78235	78236	such	0	None
78236	78237	as	0	None
78237	78238	the	0	None
78238	78239	selective	0	None
78239	78240	inhibitors	0	None
78240	78241	of	0	None
78241	78242	neurokinin	0	None
78242	78243	receptors	0	None
78243	78244	or	0	None
78244	78245	drugs	0	None
78245	78246	acting	0	None
78246	78247	upon	0	None
78247	78248	neuronal	0	None
78248	78249	calcium	0	None
78249	78250	channels	0	None
78250	78251	,	0	None
78251	78252	are	0	None
78252	78253	commented	0	None
78253	78254	.	0	None

78255	78256	From	0	None
78256	78257	this	0	None
78257	78258	review	0	None
78258	78259	we	0	None
78259	78260	conclude	0	None
78260	78261	that	0	None
78261	78262	while	0	None
78262	78263	there	0	None
78263	78264	have	0	None
78264	78265	been	0	None
78265	78266	relevant	0	None
78266	78267	advances	0	None
78267	78268	in	0	None
78268	78269	the	0	None
78269	78270	symptomatic	0	None
78270	78271	treatment	0	None
78271	78272	of	0	None
78272	78273	migraine	0	None
78273	78274	,	0	None
78274	78275	there	0	None
78275	78276	is	0	None
78276	78277	a	0	None
78277	78278	need	0	None
78278	78279	for	0	None
78279	78280	the	0	None
78280	78281	development	0	None
78281	78282	of	0	None
78282	78283	better	0	None
78283	78284	preventive	0	None
78284	78285	compounds	0	None
78285	78286	.	0	None
78286	78288	Adenylosuccinate synthetase	3	GENE-N
78288	78289	(	0	None
78289	78290	AdSS	0	None
78290	78291	)	0	None
78291	78292	catalyses	0	None
78292	78293	the	0	None
78293	78294	Mg	2	CHEMICAL
78294	78295	(	0	None
78295	78296	2	0	None
78296	78297	+	0	None
78297	78298	)	0	None
78298	78299	dependent	0	None
78299	78300	formation	0	None
78300	78301	of	0	None
78301	78302	adenylosuccinate	0	None
78302	78303	from	0	None
78303	78304	IMP	0	None
78304	78305	and	0	None
78305	78306	aspartate	0	None
78306	78307	,	0	None
78307	78308	the	0	None
78308	78309	reaction	0	None
78309	78310	being	0	None
78310	78311	driven	0	None
78311	78312	by	0	None
78312	78313	the	0	None
78313	78314	hydrolysis	0	None
78314	78315	of	0	None
78315	78316	GTP	0	None
78316	78317	to	0	None
78317	78318	GDP	0	None
78318	78319	.	0	None

78320	78321	All	0	None
78321	78322	characterized	0	None
78322	78323	AdSS	0	None
78323	78324	thus	0	None
78324	78325	far	0	None
78325	78326	exhibit	0	None
78326	78327	a	0	None
78327	78328	random	0	None
78328	78329	kinetic	0	None
78329	78330	mechanism	0	None
78330	78331	.	0	None

78332	78333	We	0	None
78333	78334	present	0	None
78334	78335	here	0	None
78335	78336	kinetic	0	None
78336	78337	evidence	0	None
78337	78338	that	0	None
78338	78339	unlike	0	None
78339	78340	all	0	None
78340	78341	other	0	None
78341	78342	AdSS	0	None
78342	78343	,	0	None
78343	78344	Plasmodium	0	None
78344	78345	falciparum	0	None
78345	78346	AdSS	0	None
78346	78347	(	0	None
78347	78348	PfAdSS	0	None
78348	78349	)	0	None
78349	78350	has	0	None
78350	78351	ordered	0	None
78351	78352	substrate	0	None
78352	78353	binding	0	None
78353	78354	.	0	None

78355	78356	Inhibition	0	None
78356	78357	studies	0	None
78357	78358	show	0	None
78358	78359	that	0	None
78359	78360	binding	0	None
78360	78361	of	0	None
78361	78362	GTP	0	None
78362	78363	requires	0	None
78363	78364	IMP	0	None
78364	78365	binding	0	None
78365	78366	while	0	None
78366	78367	aspartate	0	None
78367	78368	binds	0	None
78368	78369	to	0	None
78369	78370	the	0	None
78370	78371	enzyme-IMP-GTP	0	None
78371	78372	complex	0	None
78372	78373	.	0	None

78374	78375	A	0	None
78375	78376	structural	0	None
78376	78377	basis	0	None
78377	78378	for	0	None
78378	78379	this	0	None
78379	78380	difference	0	None
78380	78381	in	0	None
78381	78382	mechanism	0	None
78382	78383	is	0	None
78383	78384	presented	0	None
78384	78385	.	0	None

78386	78387	Kinetically	0	None
78387	78388	,	0	None
78388	78389	PfAdSS	0	None
78389	78390	is	0	None
78390	78391	closer	0	None
78391	78392	to	0	None
78392	78393	the	0	None
78393	78394	mouse	0	None
78394	78395	acidic	0	None
78395	78396	isozyme	0	None
78396	78397	rather	0	None
78397	78398	than	0	None
78398	78399	to	0	None
78399	78400	the	0	None
78400	78401	mouse	0	None
78401	78402	basic	0	None
78402	78403	isozyme	0	None
78403	78404	.	0	None

78405	78406	The	0	None
78406	78409	mouse acidic isozyme	3	GENE-N
78409	78410	is	0	None
78410	78411	thought	0	None
78411	78412	to	0	None
78412	78413	play	0	None
78413	78414	a	0	None
78414	78415	role	0	None
78415	78416	in	0	None
78416	78417	the	0	None
78417	78418	purine	0	None
78418	78419	nucleotide	0	None
78419	78420	biosynthetic	0	None
78420	78421	pathway	0	None
78421	78422	.	0	None

78423	78424	Regulation	0	None
78424	78425	of	0	None
78425	78426	PfAdSS	0	None
78426	78427	in	0	None
78427	78428	vivo	0	None
78428	78429	can	0	None
78429	78430	therefore	0	None
78430	78431	,	0	None
78431	78432	be	0	None
78432	78433	expected	0	None
78433	78434	to	0	None
78434	78435	be	0	None
78435	78436	similar	0	None
78436	78437	to	0	None
78437	78438	the	0	None
78438	78441	mouse acidic isozyme	3	GENE-N
78441	78442	,	0	None
78442	78443	in	0	None
78443	78444	agreement	0	None
78444	78445	with	0	None
78445	78446	the	0	None
78446	78447	role	0	None
78447	78448	of	0	None
78448	78449	PfAdSS	0	None
78449	78450	as	0	None
78450	78451	the	0	None
78451	78452	only	0	None
78452	78453	pathway	0	None
78453	78454	for	0	None
78454	78455	the	0	None
78455	78456	synthesis	0	None
78456	78457	of	0	None
78457	78458	adenine	2	CHEMICAL
78458	78459	nucleotides	0	None
78459	78460	in	0	None
78460	78461	the	0	None
78461	78462	parasite	0	None
78462	78463	.	0	None

78464	78465	However	0	None
78465	78466	,	0	None
78466	78467	PfAdSS	0	None
78467	78468	differs	0	None
78468	78469	from	0	None
78469	78470	both	0	None
78470	78471	the	0	None
78471	78472	mammalian	0	None
78472	78473	homologs	0	None
78473	78474	in	0	None
78474	78475	that	0	None
78475	78476	fructose-1	0	None
78476	78477	,	0	None
78477	78478	6-bisphosphate	0	None
78478	78479	,	0	None
78479	78480	a	0	None
78480	78481	potent	0	None
78481	78482	inhibitor	0	None
78482	78483	of	0	None
78483	78484	the	0	None
78484	78485	mammalian	0	None
78485	78486	enzyme	0	None
78486	78487	,	0	None
78487	78488	is	0	None
78488	78489	an	0	None
78489	78490	activator	0	None
78490	78491	of	0	None
78491	78492	PfAdSS	0	None
78492	78493	.	0	None

78494	78495	The	0	None
78495	78496	differences	0	None
78496	78497	highlighted	0	None
78497	78498	here	0	None
78498	78499	are	0	None
78499	78500	promising	0	None
78500	78501	in	0	None
78501	78502	terms	0	None
78502	78503	of	0	None
78503	78504	species-specific	0	None
78504	78505	drug	0	None
78505	78506	design	0	None
78506	78507	,	0	None
78507	78508	targeting	0	None
78508	78509	this	0	None
78509	78510	essential	0	None
78510	78511	enzyme	0	None
78511	78512	in	0	None
78512	78513	the	0	None
78513	78514	parasite	0	None
78514	78515	.	0	None
78515	78516	Electronic	0	None
78516	78517	transitions	0	None
78517	78518	of	0	None
78518	78519	protonated	0	None
78519	78520	and	0	None
78520	78521	deprotonated	0	None
78521	78523	amino acids	2	CHEMICAL
78523	78524	in	0	None
78524	78525	aqueous	0	None
78525	78526	solution	0	None
78526	78527	in	0	None
78527	78528	the	0	None
78528	78529	region	0	None
78529	78530	145-300	0	None
78530	78531	nm	0	None
78531	78532	studied	0	None
78532	78533	by	0	None
78533	78534	attenuated	0	None
78534	78535	total	0	None
78535	78536	reflection	0	None
78536	78537	far-ultraviolet	0	None
78537	78538	spectroscopy	0	None
78538	78539	.	0	None
78539	78541	Progesterone receptor	1	GENE-Y
78541	78542	(	0	None
78542	78543	PR	0	None
78543	78544	)	0	None
78544	78545	plays	0	None
78545	78546	a	0	None
78546	78547	key	0	None
78547	78548	role	0	None
78548	78549	in	0	None
78549	78550	reproductive	0	None
78550	78551	functions	0	None
78551	78552	,	0	None
78552	78553	and	0	None
78553	78554	compounds	0	None
78554	78555	that	0	None
78555	78556	inhibit	0	None
78556	78557	progesterone	2	CHEMICAL
78557	78558	action	0	None
78558	78559	(	0	None
78559	78560	antiprogestins	0	None
78560	78561	)	0	None
78561	78562	have	0	None
78562	78563	potential	0	None
78563	78564	use	0	None
78564	78565	in	0	None
78565	78566	the	0	None
78566	78567	treatment	0	None
78567	78568	of	0	None
78568	78569	estrogen-	0	None
78569	78570	and	0	None
78570	78571	progesterone-dependent	0	None
78571	78572	diseases	0	None
78572	78573	,	0	None
78573	78574	including	0	None
78574	78575	uterine	0	None
78575	78576	leiomyomas	0	None
78576	78577	and	0	None
78577	78578	breast	0	None
78578	78579	cancer	0	None
78579	78580	.	0	None

78581	78582	In	0	None
78582	78583	the	0	None
78583	78584	present	0	None
78584	78585	study	0	None
78585	78586	,	0	None
78586	78587	we	0	None
78587	78588	chemically	0	None
78588	78589	synthesized	0	None
78589	78590	novel	0	None
78590	78591	17-fluorinated	0	None
78591	78592	steroids	0	None
78592	78593	and	0	None
78593	78594	evaluated	0	None
78594	78595	the	0	None
78595	78596	cytotoxicity	0	None
78596	78597	profiles	0	None
78597	78598	of	0	None
78598	78599	these	0	None
78599	78600	compounds	0	None
78600	78601	in	0	None
78601	78602	T47D	0	None
78602	78603	breast	0	None
78603	78604	cancer	0	None
78604	78605	cells	0	None
78605	78606	compared	0	None
78606	78607	to	0	None
78607	78608	the	0	None
78608	78609	activity	0	None
78609	78610	of	0	None
78610	78611	known	0	None
78611	78612	antiprogestins	0	None
78612	78613	,	0	None
78613	78614	including	0	None
78614	78615	ZK230	0	None
78615	78616	211	0	None
78616	78617	,	0	None
78617	78618	RU-486	0	None
78618	78619	,	0	None
78619	78620	CDB2914	0	None
78620	78621	,	0	None
78621	78622	CDB4124	0	None
78622	78623	and	0	None
78623	78624	ORG33628	0	None
78624	78625	.	0	None

78626	78627	We	0	None
78627	78628	analyzed	0	None
78628	78629	in	0	None
78629	78630	vitro	0	None
78630	78631	receptor-binding	0	None
78631	78632	assays	0	None
78632	78633	and	0	None
78633	78634	PR-transactivation	0	None
78634	78635	assays	0	None
78635	78636	to	0	None
78636	78637	establish	0	None
78637	78638	the	0	None
78638	78639	antiprogestational	0	None
78639	78640	activity	0	None
78640	78641	of	0	None
78641	78642	these	0	None
78642	78643	molecules	0	None
78643	78644	.	0	None

78645	78646	The	0	None
78646	78647	representative	0	None
78647	78648	antiprogestin	0	None
78648	78649	EC304	0	None
78649	78650	was	0	None
78650	78651	found	0	None
78651	78652	to	0	None
78652	78653	inhibit	0	None
78653	78654	in	0	None
78654	78655	vitro	0	None
78655	78656	tumorigenicity	0	None
78656	78657	in	0	None
78657	78658	a	0	None
78658	78659	dose-dependent	0	None
78659	78660	fashion	0	None
78660	78661	in	0	None
78661	78662	T47D	0	None
78662	78663	cells	0	None
78663	78664	by	0	None
78664	78665	a	0	None
78665	78666	colony	0	None
78666	78667	formation	0	None
78667	78668	assay	0	None
78668	78669	at	0	None
78669	78670	1	0	None
78670	78671	and	0	None
78671	78672	10nM	0	None
78672	78673	concentrations	0	None
78673	78674	.	0	None

78675	78676	The	0	None
78676	78677	potent	0	None
78677	78678	in	0	None
78678	78679	vivo	0	None
78679	78680	antiprogestational	0	None
78680	78681	activity	0	None
78681	78682	of	0	None
78682	78683	EC304	0	None
78683	78684	was	0	None
78684	78685	also	0	None
78685	78686	demonstrated	0	None
78686	78687	in	0	None
78687	78688	an	0	None
78688	78689	antinidation	0	None
78689	78690	assay	0	None
78690	78691	for	0	None
78691	78692	the	0	None
78692	78693	interruption	0	None
78693	78694	of	0	None
78694	78695	early	0	None
78695	78696	pregnancy	0	None
78696	78697	in	0	None
78697	78698	rats	0	None
78698	78699	.	0	None

78700	78701	The	0	None
78701	78702	strong	0	None
78702	78703	antiprogestational	0	None
78703	78704	activity	0	None
78704	78705	and	0	None
78705	78706	absence	0	None
78706	78707	of	0	None
78707	78708	antiglucocorticoid	0	None
78708	78709	activity	0	None
78709	78710	in	0	None
78710	78711	EC	0	None
78711	78712	compounds	0	None
78712	78713	may	0	None
78713	78714	demonstrate	0	None
78714	78715	their	0	None
78715	78716	utility	0	None
78716	78717	in	0	None
78717	78718	the	0	None
78718	78719	treatment	0	None
78719	78720	of	0	None
78720	78721	leiomyoma	0	None
78721	78722	,	0	None
78722	78723	endometriosis	0	None
78723	78724	and	0	None
78724	78725	breast	0	None
78725	78726	cancer	0	None
78726	78727	.	0	None
78727	78728	Permanent	0	None
78728	78729	Neonatal	0	None
78729	78730	Diabetes	0	None
78730	78731	in	0	None
78731	78732	INSC94Y	0	None
78732	78733	Transgenic	0	None
78733	78734	Pigs	0	None
78734	78735	.	0	None
78735	78736	Theoretical	0	None
78736	78737	Characterization	0	None
78737	78738	of	0	None
78738	78739	Galanin	0	None
78739	78740	Receptor	0	None
78740	78741	Type	0	None
78741	78742	3	0	None
78742	78743	(	0	None
78743	78744	Gal3	0	None
78744	78745	)	0	None
78745	78746	and	0	None
78746	78747	Its	0	None
78747	78748	Interaction	0	None
78748	78749	with	0	None
78749	78750	Agonist	0	None
78750	78751	(	0	None
78751	78752	GALANIN	0	None
78752	78753	)	0	None
78753	78754	and	0	None
78754	78755	Antagonists	0	None
78755	78756	(	0	None
78756	78757	SNAP	0	None
78757	78758	37889	0	None
78758	78759	and	0	None
78759	78760	SNAP	0	None
78760	78761	398299	0	None
78761	78762	)	0	None
78762	78763	:	0	None
78763	78764	An	0	None
78764	78765	In	0	None
78765	78766	Silico	0	None
78766	78767	Analysis	0	None
78767	78768	.	0	None
78768	78769	Cocaine-	0	None
78769	78770	and	0	None
78770	78771	amphetamine-regulated	0	None
78771	78772	transcript	0	None
78772	78773	(	0	None
78773	78774	CART	0	None
78774	78775	)	0	None
78775	78776	is	0	None
78776	78777	widely	0	None
78777	78778	expressed	0	None
78778	78779	in	0	None
78779	78780	the	0	None
78780	78781	rat	0	None
78781	78782	central	0	None
78782	78783	nervous	0	None
78783	78784	system	0	None
78784	78785	,	0	None
78785	78786	notably	0	None
78786	78787	in	0	None
78787	78788	areas	0	None
78788	78789	involved	0	None
78789	78790	in	0	None
78790	78791	control	0	None
78791	78792	of	0	None
78792	78793	autonomic	0	None
78793	78794	and	0	None
78794	78795	neuroendocrine	0	None
78795	78796	functions	0	None
78796	78797	.	0	None

78798	78799	The	0	None
78799	78800	aim	0	None
78800	78801	of	0	None
78801	78802	this	0	None
78802	78803	study	0	None
78803	78804	was	0	None
78804	78805	to	0	None
78805	78806	evaluate	0	None
78806	78807	the	0	None
78807	78808	effects	0	None
78808	78809	of	0	None
78809	78810	CART	0	None
78810	78811	peptide	0	None
78811	78812	fragment	0	None
78812	78813	55-102	0	None
78813	78814	,	0	None
78814	78815	referred	0	None
78815	78816	to	0	None
78816	78817	herein	0	None
78817	78818	as	0	None
78818	78819	CARTp	0	None
78819	78820	,	0	None
78820	78821	by	0	None
78821	78822	intrathecal	0	None
78822	78823	injection	0	None
78823	78824	on	0	None
78824	78825	blood	0	None
78825	78826	pressure	0	None
78826	78827	(	0	None
78827	78828	BP	0	None
78828	78829	)	0	None
78829	78830	and	0	None
78830	78831	heart	0	None
78831	78832	rate	0	None
78832	78833	(	0	None
78833	78834	HR	3	GENE-N
78834	78835	)	0	None
78835	78836	before	0	None
78836	78837	and	0	None
78837	78838	after	0	None
78838	78839	intrathecal	0	None
78839	78840	glutamate	0	None
78840	78841	in	0	None
78841	78842	urethane-anesthetized	0	None
78842	78843	male	0	None
78843	78844	Sprague-Dawley	0	None
78844	78845	rats	0	None
78845	78846	.	0	None

78847	78848	CARTp	0	None
78848	78849	(	0	None
78849	78850	0	0	None
78850	78851	.	0	None
78851	78852	1-10	0	None
78852	78853	nmol	0	None
78853	78854	)	0	None
78854	78855	administered	0	None
78855	78856	intrathecally	0	None
78856	78857	caused	0	None
78857	78858	no	0	None
78858	78859	or	0	None
78859	78860	a	0	None
78860	78861	small	0	None
78861	78862	,	0	None
78862	78863	statistically	0	None
78863	78864	insignificant	0	None
78864	78865	increase	0	None
78865	78866	of	0	None
78866	78867	blood	0	None
78867	78868	pressure	0	None
78868	78869	and	0	None
78869	78870	heart	0	None
78870	78871	rate	0	None
78871	78872	,	0	None
78872	78873	except	0	None
78873	78874	at	0	None
78874	78875	the	0	None
78875	78876	concentration	0	None
78876	78877	of	0	None
78877	78878	10	0	None
78878	78879	nmol	0	None
78879	78880	,	0	None
78880	78881	which	0	None
78881	78882	caused	0	None
78882	78883	a	0	None
78883	78884	significant	0	None
78884	78885	increase	0	None
78885	78886	of	0	None
78886	78887	blood	0	None
78887	78888	pressure	0	None
78888	78889	and	0	None
78889	78890	heart	0	None
78890	78891	rate	0	None
78891	78892	.	0	None

78893	78894	Intrathecal	0	None
78894	78895	glutamate	0	None
78895	78896	(	0	None
78896	78897	0	0	None
78897	78898	.	0	None
78898	78899	1-10	0	None
78899	78900	nmol	0	None
78900	78901	)	0	None
78901	78902	produced	0	None
78902	78903	a	0	None
78903	78904	dose-dependent	0	None
78904	78905	increase	0	None
78905	78906	in	0	None
78906	78907	arterial	0	None
78907	78908	pressure	0	None
78908	78909	and	0	None
78909	78910	heart	0	None
78910	78911	rate	0	None
78911	78912	.	0	None

78913	78914	Pretreatment	0	None
78914	78915	with	0	None
78915	78916	CARTp	0	None
78916	78917	dose-dependently	0	None
78917	78918	potentiated	0	None
78918	78919	the	0	None
78919	78920	pressor	0	None
78920	78921	effects	0	None
78921	78922	of	0	None
78922	78923	glutamate	0	None
78923	78924	(	0	None
78924	78925	1	0	None
78925	78926	nmol	0	None
78926	78927	)	0	None
78927	78928	,	0	None
78928	78929	which	0	None
78929	78930	by	0	None
78930	78931	itself	0	None
78931	78932	elicited	0	None
78932	78933	a	0	None
78933	78934	moderate	0	None
78934	78935	increase	0	None
78935	78936	of	0	None
78936	78937	blood	0	None
78937	78938	pressure	0	None
78938	78939	and	0	None
78939	78940	heart	0	None
78940	78941	rate	0	None
78941	78942	.	0	None

78943	78944	Further	0	None
78944	78945	,	0	None
78945	78946	CARTp	0	None
78946	78947	significantly	0	None
78947	78948	potentiated	0	None
78948	78949	the	0	None
78949	78950	tachycardic	0	None
78950	78951	effect	0	None
78951	78952	of	0	None
78952	78953	glutamate	0	None
78953	78954	at	0	None
78954	78955	1	0	None
78955	78956	and	0	None
78956	78957	5	0	None
78957	78958	nmol	0	None
78958	78959	,	0	None
78959	78960	but	0	None
78960	78961	attenuated	0	None
78961	78962	the	0	None
78962	78963	response	0	None
78963	78964	at	0	None
78964	78965	10	0	None
78965	78966	nmol	0	None
78966	78967	.	0	None

78968	78969	The	0	None
78969	78970	effect	0	None
78970	78971	of	0	None
78971	78972	CARTp	0	None
78972	78973	was	0	None
78973	78974	long-lasting	0	None
78974	78975	,	0	None
78975	78976	as	0	None
78976	78977	it	0	None
78977	78978	enhanced	0	None
78978	78979	glutamatergic	0	None
78979	78980	responses	0	None
78980	78981	up	0	None
78981	78982	to	0	None
78982	78983	90	0	None
78983	78984	min	0	None
78984	78985	after	0	None
78985	78986	administration	0	None
78986	78987	.	0	None

78988	78989	Prior	0	None
78989	78990	injection	0	None
78990	78991	of	0	None
78991	78992	CARTp	0	None
78992	78993	antiserum	0	None
78993	78994	(	0	None
78994	78995	1	0	None
78995	78996	:	0	None
78996	78997	500	0	None
78997	78998	)	0	None
78998	78999	but	0	None
78999	79000	not	0	None
79000	79001	normal	0	None
79001	79002	rabbit	0	None
79002	79003	serum	0	None
79003	79004	nullified	0	None
79004	79005	the	0	None
79005	79006	potentiating	0	None
79006	79007	effect	0	None
79007	79008	of	0	None
79008	79009	CARTp	0	None
79009	79010	on	0	None
79010	79011	glutamatergic	0	None
79011	79012	responses	0	None
79012	79013	.	0	None

79014	79015	The	0	None
79015	79016	result	0	None
79016	79017	suggests	0	None
79017	79018	that	0	None
79018	79019	CARTp	0	None
79019	79020	,	0	None
79020	79021	whose	0	None
79021	79022	immunoreactivity	0	None
79022	79023	is	0	None
79023	79024	detectable	0	None
79024	79025	in	0	None
79025	79026	sympathetic	0	None
79026	79027	preganglionic	0	None
79027	79028	neurons	0	None
79028	79029	as	0	None
79029	79030	well	0	None
79030	79031	as	0	None
79031	79032	in	0	None
79032	79033	fibers	0	None
79033	79034	projecting	0	None
79034	79035	into	0	None
79035	79036	the	0	None
79036	79037	intermediolateral	0	None
79037	79038	cell	0	None
79038	79039	column	0	None
79039	79040	,	0	None
79040	79041	augments	0	None
79041	79042	spinal	0	None
79042	79043	sympathetic	0	None
79043	79044	outflow	0	None
79044	79045	elicited	0	None
79045	79046	by	0	None
79046	79047	glutamate	0	None
79047	79048	at	0	None
79048	79049	lower	0	None
79049	79050	concentrations	0	None
79050	79051	and	0	None
79051	79052	may	0	None
79052	79053	directly	0	None
79053	79054	excite	0	None
79054	79055	neurons	0	None
79055	79056	in	0	None
79056	79057	the	0	None
79057	79058	intermediolateral	0	None
79058	79059	cell	0	None
79059	79060	column	0	None
79060	79061	at	0	None
79061	79062	higher	0	None
79062	79063	concentrations	0	None
79063	79064	.	0	None
79064	79065	3-Methylcholanthrene	2	CHEMICAL
79065	79066	(	0	None
79066	79067	MC	0	None
79067	79068	)	0	None
79068	79069	is	0	None
79069	79070	a	0	None
79070	79071	readily	0	None
79071	79072	metabolized	0	None
79072	79073	aryl	0	None
79073	79074	hydrocarbon	0	None
79074	79075	receptor	0	None
79075	79076	(	0	None
79076	79077	AHR	0	None
79077	79078	)	0	None
79078	79079	agonist	0	None
79079	79080	.	0	None

79081	79082	MC	0	None
79082	79083	disrupts	0	None
79083	79084	expression	0	None
79084	79085	of	0	None
79085	79086	mouse	0	None
79086	79087	hepatic	0	None
79087	79088	growth	0	None
79088	79089	hormone	0	None
79089	79090	(	0	None
79090	79091	GH	0	None
79091	79092	)	0	None
79092	79093	signaling	0	None
79093	79094	components	0	None
79094	79095	and	0	None
79095	79096	suppresses	0	None
79096	79097	cytochrome	3	GENE-N
79097	79098	P450	0	None
79098	79099	2D9	0	None
79099	79100	(	0	None
79100	79101	Cyp2d9	0	None
79101	79102	)	0	None
79102	79103	,	0	None
79103	79104	a	0	None
79104	79105	male-specific	0	None
79105	79106	gene	0	None
79106	79107	controlled	0	None
79107	79108	by	0	None
79108	79109	pulsatile	0	None
79109	79110	GH	0	None
79110	79111	via	0	None
79111	79112	signal	0	None
79112	79113	transducer	0	None
79113	79114	and	0	None
79114	79115	activator	0	None
79115	79116	of	0	None
79116	79117	transcription	0	None
79117	79118	5b	0	None
79118	79119	(	0	None
79119	79120	STAT5b	0	None
79120	79121	)	0	None
79121	79122	.	0	None

79123	79124	To	0	None
79124	79125	determine	0	None
79125	79126	if	0	None
79126	79127	these	0	None
79127	79128	effects	0	None
79128	79129	of	0	None
79129	79130	MC	0	None
79130	79131	depend	0	None
79131	79132	on	0	None
79132	79133	hepatic	0	None
79133	79134	microsomal	0	None
79134	79135	P450-mediated	0	None
79135	79136	activity	0	None
79136	79137	,	0	None
79137	79138	we	0	None
79138	79139	examined	0	None
79139	79140	biologic	0	None
79140	79141	responses	0	None
79141	79142	to	0	None
79142	79143	MC	0	None
79143	79144	treatment	0	None
79144	79145	in	0	None
79145	79146	liver	0	None
79146	79147	Cpr-null	0	None
79147	79148	(	0	None
79148	79149	LCN	0	None
79149	79150	)	0	None
79150	79151	mice	0	None
79151	79152	with	0	None
79152	79153	hepatocyte-specific	0	None
79153	79154	conditional	0	None
79154	79155	deletion	0	None
79155	79156	of	0	None
79156	79157	NADPH-cytochrome	0	None
79157	79158	P450	0	None
79158	79159	oxidoreductase	0	None
79159	79160	(	0	None
79160	79161	POR	0	None
79161	79162	)	0	None
79162	79163	.	0	None

79164	79165	MC	0	None
79165	79166	caused	0	None
79166	79167	mild	0	None
79167	79168	induction	0	None
79168	79169	of	0	None
79169	79170	Por	0	None
79170	79171	and	0	None
79171	79172	a	0	None
79172	79173	hepatic	0	None
79173	79174	inflammatory	0	None
79174	79175	marker	0	None
79175	79176	in	0	None
79176	79177	wild-type	0	None
79177	79178	mice	0	None
79178	79179	,	0	None
79179	79180	whereas	0	None
79180	79181	MC	0	None
79181	79182	caused	0	None
79182	79183	strong	0	None
79183	79184	induction	0	None
79184	79185	of	0	None
79185	79186	AHR	0	None
79186	79187	target	0	None
79187	79188	genes	0	None
79188	79189	,	0	None
79189	79190	Cyp1a1	0	None
79190	79191	,	0	None
79191	79192	Cyp1a2	0	None
79192	79193	,	0	None
79193	79194	and	0	None
79194	79195	Cyp1b1	0	None
79195	79196	in	0	None
79196	79197	wild-type	0	None
79197	79198	and	0	None
79198	79199	LCN	0	None
79199	79200	mice	0	None
79200	79201	.	0	None

79202	79203	Two	0	None
79203	79204	mouse	0	None
79204	79205	hepatic	0	None
79205	79206	STAT5b	0	None
79206	79207	target	0	None
79207	79208	genes	0	None
79208	79209	,	0	None
79209	79210	Cyp2d9	0	None
79210	79211	and	0	None
79211	79212	major	0	None
79212	79213	urinary	0	None
79213	79214	protein	0	None
79214	79215	2	0	None
79215	79216	(	0	None
79216	79217	Mup2	0	None
79217	79218	)	0	None
79218	79219	,	0	None
79219	79220	were	0	None
79220	79221	suppressed	0	None
79221	79222	by	0	None
79222	79223	MC	0	None
79223	79224	in	0	None
79224	79225	wild-type	0	None
79225	79226	mice	0	None
79226	79227	,	0	None
79227	79228	and	0	None
79228	79229	the	0	None
79229	79230	CYP2D9	0	None
79230	79231	mRNA	0	None
79231	79232	response	0	None
79232	79233	was	0	None
79233	79234	maintained	0	None
79234	79235	in	0	None
79235	79236	LCN	0	None
79236	79237	mice	0	None
79237	79238	.	0	None

79239	79240	In	0	None
79240	79241	wild-type	0	None
79241	79242	mice	0	None
79242	79243	only	0	None
79243	79244	,	0	None
79244	79245	MC	0	None
79245	79246	decreased	0	None
79246	79247	hepatic	0	None
79247	79249	GH receptor	1	GENE-Y
79249	79250	(	0	None
79250	79251	GHR	1	GENE-Y
79251	79252	)	0	None
79252	79253	mRNA	0	None
79253	79254	but	0	None
79254	79255	increased	0	None
79255	79256	GHR	1	GENE-Y
79256	79257	protein	0	None
79257	79258	levels	0	None
79258	79259	.	0	None

79260	79261	There	0	None
79261	79262	was	0	None
79262	79263	an	0	None
79263	79264	apparent	0	None
79264	79265	impairment	0	None
79265	79266	of	0	None
79266	79267	STAT5	0	None
79267	79268	phosphorylation	0	None
79268	79269	by	0	None
79269	79270	MC	0	None
79270	79271	in	0	None
79271	79272	wild-type	0	None
79272	79273	and	0	None
79273	79274	LCN	0	None
79274	79275	mice	0	None
79275	79276	,	0	None
79276	79277	but	0	None
79277	79278	large	0	None
79278	79279	interanimal	0	None
79279	79280	variation	0	None
79280	79281	prevented	0	None
79281	79282	achievement	0	None
79282	79283	of	0	None
79283	79284	statistical	0	None
79284	79285	significance	0	None
79285	79286	.	0	None

79287	79288	In	0	None
79288	79289	vehicle-treated	0	None
79289	79290	mice	0	None
79290	79291	,	0	None
79291	79292	basal	0	None
79292	79293	levels	0	None
79293	79294	of	0	None
79294	79295	MUP2	0	None
79295	79296	mRNA	0	None
79296	79297	,	0	None
79297	79298	GHR	1	GENE-Y
79298	79299	mRNA	0	None
79299	79300	,	0	None
79300	79301	GHR	1	GENE-Y
79301	79302	protein	0	None
79302	79303	,	0	None
79303	79304	and	0	None
79304	79305	the	0	None
79305	79306	activation	0	None
79306	79307	status	0	None
79307	79308	of	0	None
79308	79310	extracellular signal-regulated	0	None
79310	79311	kinase	0	None
79311	79312	2	0	None
79312	79313	and	0	None
79313	79314	Akt	0	None
79314	79315	were	0	None
79315	79316	influenced	0	None
79316	79317	by	0	None
79317	79318	hepatic	0	None
79318	79319	Por	0	None
79319	79320	genetic	0	None
79320	79321	status	0	None
79321	79322	.	0	None

79323	79324	These	0	None
79324	79325	results	0	None
79325	79326	indicate	0	None
79326	79327	that	0	None
79327	79328	the	0	None
79328	79329	effects	0	None
79329	79330	of	0	None
79330	79331	MC	0	None
79331	79332	on	0	None
79332	79333	hepatic	0	None
79333	79334	GH	0	None
79334	79335	signaling	0	None
79335	79336	components	0	None
79336	79337	and	0	None
79337	79338	target	0	None
79338	79339	genes	0	None
79339	79340	are	0	None
79340	79341	complex	0	None
79341	79342	,	0	None
79342	79343	involving	0	None
79343	79344	aspects	0	None
79344	79345	that	0	None
79345	79346	are	0	None
79346	79347	both	0	None
79347	79348	dependent	0	None
79348	79349	and	0	None
79349	79350	independent	0	None
79350	79351	of	0	None
79351	79352	hepatic	0	None
79352	79353	microsomal	0	None
79353	79354	P450-mediated	0	None
79354	79355	activity	0	None
79355	79356	.	0	None
79356	79357	24R	0	None
79357	79358	,	0	None
79358	79359	25-	0	None
79359	79360	(	0	None
79360	79361	OH	0	None
79361	79362	)	0	None
79362	79363	(	0	None
79363	79364	2	0	None
79364	79365	)	0	None
79365	79366	D	0	None
79366	79367	(	0	None
79367	79368	3	0	None
79368	79369	)	0	None
79369	79370	mediates	0	None
79370	79371	its	0	None
79371	79372	membrane	0	None
79372	79373	receptor-dependent	0	None
79373	79374	effects	0	None
79374	79375	on	0	None
79375	79376	protein	0	None
79376	79377	kinase	0	None
79377	79378	C	0	None
79378	79379	and	0	None
79379	79381	alkaline phosphatase	3	GENE-N
79381	79382	via	0	None
79382	79383	phospholipase	0	None
79383	79384	A	0	None
79384	79385	(	0	None
79385	79386	2	0	None
79386	79387	)	0	None
79387	79388	and	0	None
79388	79389	cyclooxygenase-1	1	GENE-Y
79389	79390	but	0	None
79390	79391	not	0	None
79391	79392	cyclooxygenase-2	0	None
79392	79393	in	0	None
79393	79394	growth	0	None
79394	79395	plate	0	None
79395	79396	chondrocytes	0	None
79396	79397	.	0	None
79397	79398	Novel	0	None
79398	79399	signaling	0	None
79399	79400	pathways	0	None
79400	79401	promote	0	None
79401	79402	a	0	None
79402	79403	paracrine	0	None
79403	79404	wave	0	None
79404	79405	of	0	None
79405	79406	prostacyclin-induced	0	None
79406	79407	vascular	0	None
79407	79408	smooth	0	None
79408	79409	muscle	0	None
79409	79410	differentiation	0	None
79410	79411	.	0	None
79411	79412	Krüppel-like	0	None
79412	79413	Factor	0	None
79413	79414	3	0	None
79414	79415	(	0	None
79415	79416	KLF3	0	None
79416	79417	)	0	None
79417	79418	is	0	None
79418	79419	a	0	None
79419	79420	transcriptional	0	None
79420	79421	regulator	0	None
79421	79422	that	0	None
79422	79423	we	0	None
79423	79424	have	0	None
79424	79425	shown	0	None
79425	79426	to	0	None
79426	79427	be	0	None
79427	79428	involved	0	None
79428	79429	in	0	None
79429	79430	the	0	None
79430	79431	regulation	0	None
79431	79432	of	0	None
79432	79433	adipogenesis	0	None
79433	79434	in	0	None
79434	79435	vitro	0	None
79435	79436	.	0	None

79437	79438	Here	0	None
79438	79439	we	0	None
79439	79440	report	0	None
79440	79441	that	0	None
79441	79442	KLF3	0	None
79442	79443	null	0	None
79443	79444	mice	0	None
79444	79445	are	0	None
79445	79446	lean	0	None
79446	79447	and	0	None
79447	79448	protected	0	None
79448	79449	from	0	None
79449	79450	diet-induced	0	None
79450	79451	obesity	0	None
79451	79452	and	0	None
79452	79453	glucose	0	None
79453	79454	intolerance	0	None
79454	79455	.	0	None

79456	79457	On	0	None
79457	79458	a	0	None
79458	79459	chow	0	None
79459	79460	diet	0	None
79460	79461	,	0	None
79461	79462	plasma	0	None
79462	79463	levels	0	None
79463	79464	of	0	None
79464	79465	leptin	0	None
79465	79466	are	0	None
79466	79467	decreased	0	None
79467	79468	,	0	None
79468	79469	and	0	None
79469	79470	adiponectin	1	GENE-Y
79470	79471	is	0	None
79471	79472	increased	0	None
79472	79473	.	0	None

79474	79475	Despite	0	None
79475	79476	significant	0	None
79476	79477	reductions	0	None
79477	79478	in	0	None
79478	79479	body	0	None
79479	79480	weight	0	None
79480	79481	and	0	None
79481	79482	adiposity	0	None
79482	79483	,	0	None
79483	79484	wildtype	0	None
79484	79485	and	0	None
79485	79486	knockout	0	None
79486	79487	animals	0	None
79487	79488	show	0	None
79488	79489	equivalent	0	None
79489	79490	energy	0	None
79490	79491	intake	0	None
79491	79492	,	0	None
79492	79493	expenditure	0	None
79493	79494	and	0	None
79494	79495	excretion	0	None
79495	79496	.	0	None

79497	79498	To	0	None
79498	79499	investigate	0	None
79499	79500	the	0	None
79500	79501	molecular	0	None
79501	79502	events	0	None
79502	79503	underlying	0	None
79503	79504	these	0	None
79504	79505	observations	0	None
79505	79506	,	0	None
79506	79507	we	0	None
79507	79508	used	0	None
79508	79509	microarray	0	None
79509	79510	analysis	0	None
79510	79511	to	0	None
79511	79512	compare	0	None
79512	79513	gene	0	None
79513	79514	expression	0	None
79514	79515	in	0	None
79515	79516	Klf3	0	None
79516	79517	(	0	None
79517	79518	+	0	None
79518	79519	/	0	None
79519	79520	+	0	None
79520	79521	)	0	None
79521	79522	and	0	None
79522	79523	Klf3	0	None
79523	79524	(	0	None
79524	79525	-	0	None
79525	79526	/	0	None
79526	79527	-	0	None
79527	79528	)	0	None
79528	79529	tissues	0	None
79529	79530	.	0	None

79531	79532	We	0	None
79532	79533	found	0	None
79533	79534	that	0	None
79534	79535	mRNA	0	None
79535	79536	expression	0	None
79536	79537	of	0	None
79537	79538	Fam132a	0	None
79538	79539	,	0	None
79539	79540	which	0	None
79540	79541	encodes	0	None
79541	79542	a	0	None
79542	79543	newly	0	None
79543	79544	identified	0	None
79544	79545	insulin-sensitizing	0	None
79545	79546	adipokine	0	None
79546	79547	,	0	None
79547	79548	adipolin	0	None
79548	79549	,	0	None
79549	79550	is	0	None
79550	79551	significantly	0	None
79551	79552	upregulated	0	None
79552	79553	in	0	None
79553	79554	the	0	None
79554	79555	absence	0	None
79555	79556	of	0	None
79556	79557	KLF3	0	None
79557	79558	.	0	None

79559	79560	We	0	None
79560	79561	confirmed	0	None
79561	79562	that	0	None
79562	79563	KLF3	0	None
79563	79564	binds	0	None
79564	79565	the	0	None
79565	79566	Fam132a	0	None
79566	79567	promoter	0	None
79567	79568	in	0	None
79568	79569	vitro	0	None
79569	79570	and	0	None
79570	79571	in	0	None
79571	79572	vivo	0	None
79572	79573	and	0	None
79573	79574	that	0	None
79574	79575	this	0	None
79575	79576	leads	0	None
79576	79577	to	0	None
79577	79578	repression	0	None
79578	79579	of	0	None
79579	79580	promoter	0	None
79580	79581	activity	0	None
79581	79582	.	0	None

79583	79584	Further	0	None
79584	79585	,	0	None
79585	79586	plasma	0	None
79586	79587	adipolin	0	None
79587	79588	levels	0	None
79588	79589	were	0	None
79589	79590	significantly	0	None
79590	79591	increased	0	None
79591	79592	in	0	None
79592	79593	Klf3	0	None
79593	79594	(	0	None
79594	79595	-	0	None
79595	79596	/	0	None
79596	79597	-	0	None
79597	79598	)	0	None
79598	79599	mice	0	None
79599	79600	compared	0	None
79600	79601	to	0	None
79601	79602	wild-type	0	None
79602	79603	littermates	0	None
79603	79604	.	0	None

79605	79606	Boosting	0	None
79606	79607	levels	0	None
79607	79608	of	0	None
79608	79609	adipolin	0	None
79609	79610	via	0	None
79610	79611	targeting	0	None
79611	79612	of	0	None
79612	79613	KLF3	0	None
79613	79614	offers	0	None
79614	79615	a	0	None
79615	79616	novel	0	None
79616	79617	potential	0	None
79617	79618	therapeutic	0	None
79618	79619	strategy	0	None
79619	79620	for	0	None
79620	79621	the	0	None
79621	79622	treatment	0	None
79622	79623	of	0	None
79623	79624	insulin	0	None
79624	79625	resistance	0	None
79625	79626	.	0	None
79626	79627	At	0	None
79627	79628	present	0	None
79628	79629	the	0	None
79629	79630	only	0	None
79630	79631	FDA-approved	0	None
79631	79632	therapy	0	None
79632	79633	for	0	None
79633	79634	Alzheimer's	0	None
79634	79635	disease	0	None
79635	79636	involves	0	None
79636	79637	the	0	None
79637	79638	administration	0	None
79638	79639	of	0	None
79639	79640	acetylcholinesterase	0	None
79640	79641	inhibitors	0	None
79641	79642	,	0	None
79642	79643	to	0	None
79643	79644	alleviate	0	None
79644	79645	the	0	None
79645	79646	cholinergic	0	None
79646	79647	deficit	0	None
79647	79648	associated	0	None
79648	79649	with	0	None
79649	79650	this	0	None
79650	79651	disease	0	None
79651	79652	.	0	None

79653	79654	However	0	None
79654	79655	,	0	None
79655	79656	none	0	None
79656	79657	of	0	None
79657	79658	the	0	None
79658	79659	approved	0	None
79659	79660	drugs	0	None
79660	79661	is	0	None
79661	79662	ideal	0	None
79662	79663	in	0	None
79663	79664	efficacy	0	None
79664	79665	or	0	None
79665	79666	tolerability	0	None
79666	79667	.	0	None

79668	79669	One	0	None
79669	79670	possible	0	None
79670	79671	strategy	0	None
79671	79672	to	0	None
79672	79673	improve	0	None
79673	79674	selectivity	0	None
79674	79675	and	0	None
79675	79676	potency	0	None
79676	79677	is	0	None
79677	79678	to	0	None
79678	79679	design	0	None
79679	79680	drugs	0	None
79680	79681	that	0	None
79681	79682	can	0	None
79682	79683	simultaneously	0	None
79683	79684	bind	0	None
79684	79685	to	0	None
79685	79686	the	0	None
79686	79687	catalytic	0	None
79687	79688	and	0	None
79688	79689	peripheral	0	None
79689	79690	anionic	0	None
79690	79691	sites	0	None
79691	79692	of	0	None
79692	79693	AChE	1	GENE-Y
79693	79694	.	0	None

79695	79696	In	0	None
79696	79697	this	0	None
79697	79698	review	0	None
79698	79699	we	0	None
79699	79700	will	0	None
79700	79701	describe	0	None
79701	79702	the	0	None
79702	79703	development	0	None
79703	79704	of	0	None
79704	79705	dimeric	0	None
79705	79706	AChE	1	GENE-Y
79706	79707	inhibitors	0	None
79707	79708	,	0	None
79708	79709	from	0	None
79709	79710	the	0	None
79710	79711	early	0	None
79711	79712	observations	0	None
79712	79713	of	0	None
79713	79714	high	0	None
79714	79715	inhibition	0	None
79715	79716	potency	0	None
79716	79717	by	0	None
79717	79718	bis-quaternary	0	None
79718	79719	inhibitors	0	None
79719	79720	,	0	None
79720	79721	to	0	None
79721	79722	the	0	None
79722	79723	structure-based	0	None
79723	79724	design	0	None
79724	79725	of	0	None
79725	79726	dimers	0	None
79726	79727	based	0	None
79727	79728	on	0	None
79728	79729	tacrine	0	None
79729	79730	,	0	None
79730	79731	huperzine	0	None
79731	79732	A	0	None
79732	79733	,	0	None
79733	79734	galanthamine	0	None
79734	79735	,	0	None
79735	79736	and	0	None
79736	79737	polyamines	0	None
79737	79738	.	0	None
79738	79739	Human	0	None
79739	79740	polymerase	0	None
79740	79741	kappa	0	None
79741	79742	uses	0	None
79742	79743	a	0	None
79743	79744	template-slippage	0	None
79744	79745	deletion	0	None
79745	79746	mechanism	0	None
79746	79747	,	0	None
79747	79748	but	0	None
79748	79749	can	0	None
79749	79750	realign	0	None
79750	79751	the	0	None
79751	79752	slipped	0	None
79752	79753	strands	0	None
79753	79754	to	0	None
79754	79755	favour	0	None
79755	79756	base	0	None
79756	79757	substitution	0	None
79757	79758	mutations	0	None
79758	79759	over	0	None
79759	79760	deletions	0	None
79760	79761	.	0	None
79761	79762	Eosinophilic	0	None
79762	79763	oesophagitis	0	None
79763	79764	:	0	None
79764	79765	a	0	None
79765	79766	common	0	None
79766	79767	cause	0	None
79767	79768	of	0	None
79768	79769	dysphagia	0	None
79769	79770	in	0	None
79770	79771	young	0	None
79771	79772	The	0	None
79772	79773	anticonvulsant	0	None
79773	79774	activity	0	None
79774	79775	of	0	None
79775	79776	inhibitors	0	None
79776	79777	of	0	None
79777	79779	monoamine oxidase	3	GENE-N
79779	79780	(	0	None
79780	79781	MAO	3	GENE-N
79781	79782	)	0	None
79782	79783	was	0	None
79783	79784	reported	0	None
79784	79785	early	0	None
79785	79786	after	0	None
79786	79787	the	0	None
79787	79788	development	0	None
79788	79789	of	0	None
79789	79790	irreversible	0	None
79790	79791	MAO	3	GENE-N
79791	79792	inhibitors	0	None
79792	79793	such	0	None
79793	79794	as	0	None
79794	79795	tranylcypromine	0	None
79795	79796	,	0	None
79796	79797	but	0	None
79797	79798	was	0	None
79798	79799	never	0	None
79799	79800	clinically	0	None
79800	79801	used	0	None
79801	79802	because	0	None
79802	79803	of	0	None
79803	79804	the	0	None
79804	79805	adverse	0	None
79805	79806	effects	0	None
79806	79807	of	0	None
79807	79808	these	0	None
79808	79809	compounds	0	None
79809	79810	.	0	None

79811	79812	The	0	None
79812	79813	more	0	None
79813	79814	recently	0	None
79814	79815	developed	0	None
79815	79816	reversible	0	None
79816	79817	MAO	3	GENE-N
79817	79818	inhibitors	0	None
79818	79819	with	0	None
79819	79820	selectivity	0	None
79820	79821	for	0	None
79821	79822	either	0	None
79822	79823	the	0	None
79823	79824	MAO-A	0	None
79824	79825	or	0	None
79825	79826	MAO-B	0	None
79826	79827	isoenzyme	0	None
79827	79828	forms	0	None
79828	79829	have	0	None
79829	79830	not	0	None
79830	79831	been	0	None
79831	79832	studied	0	None
79832	79833	extensively	0	None
79833	79834	in	0	None
79834	79835	animal	0	None
79835	79836	models	0	None
79836	79837	of	0	None
79837	79838	epilepsy	0	None
79838	79839	,	0	None
79839	79840	so	0	None
79840	79841	it	0	None
79841	79842	is	0	None
79842	79843	not	0	None
79843	79844	known	0	None
79844	79845	which	0	None
79845	79846	type	0	None
79846	79847	of	0	None
79847	79848	MAO	3	GENE-N
79848	79849	inhibitor	0	None
79849	79850	is	0	None
79850	79851	particularly	0	None
79851	79852	effective	0	None
79852	79853	in	0	None
79853	79854	this	0	None
79854	79855	respect	0	None
79855	79856	.	0	None

79857	79858	We	0	None
79858	79859	compared	0	None
79859	79860	the	0	None
79860	79861	following	0	None
79861	79862	drugs	0	None
79862	79863	in	0	None
79863	79864	the	0	None
79864	79865	kindling	0	None
79865	79866	model	0	None
79866	79867	of	0	None
79867	79868	epilepsy	0	None
79868	79869	:	0	None
79869	79870	1	0	None
79870	79871	)	0	None
79871	79872	L-deprenyl	0	None
79872	79873	(	0	None
79873	79874	selegiline	0	None
79874	79875	)	0	None
79875	79876	,	0	None
79876	79877	i	0	None
79877	79878	.	0	None

79879	79880	e	0	None
79880	79881	.	0	None

79882	79883	,	0	None
79883	79884	an	0	None
79884	79885	irreversible	0	None
79885	79886	inhibitor	0	None
79886	79887	of	0	None
79887	79888	MAO-B	0	None
79888	79889	,	0	None
79889	79890	which	0	None
79890	79891	,	0	None
79891	79892	however	0	None
79892	79893	,	0	None
79893	79894	also	0	None
79894	79895	inhibits	0	None
79895	79896	MAO-A	0	None
79896	79897	at	0	None
79897	79898	higher	0	None
79898	79899	doses	0	None
79899	79900	,	0	None
79900	79901	2	0	None
79901	79902	)	0	None
79902	79903	the	0	None
79903	79904	novel	0	None
79904	79905	reversible	0	None
79905	79906	MAO-B	0	None
79906	79907	inhibitor	0	None
79907	79908	LU	0	None
79908	79909	53439	0	None
79909	79910	(	0	None
79910	79911	3	0	None
79911	79912	,	0	None
79912	79913	4-dimethyl-7-	0	None
79913	79914	(	0	None
79914	79915	2-isopropyl-1	0	None
79915	79916	,	0	None
79916	79917	3	0	None
79917	79918	,	0	None
79918	79919	4-thiadiazol-5-yl	0	None
79919	79920	)	0	None
79920	79921	-methoxy-coumarin	0	None
79921	79922	)	0	None
79922	79923	,	0	None
79923	79924	which	0	None
79924	79925	is	0	None
79925	79926	much	0	None
79926	79927	more	0	None
79927	79928	selective	0	None
79928	79929	for	0	None
79929	79930	MAO-B	0	None
79930	79931	than	0	None
79931	79932	L-deprenyl	0	None
79932	79933	,	0	None
79933	79934	3	0	None
79934	79935	)	0	None
79935	79936	the	0	None
79936	79937	novel	0	None
79937	79938	reversible	0	None
79938	79939	and	0	None
79939	79940	highly	0	None
79940	79941	selective	0	None
79941	79942	MAO-A	0	None
79942	79943	inhibitor	0	None
79943	79944	LU	0	None
79944	79945	43839	0	None
79945	79946	(	0	None
79946	79947	esuprone;	0	None
79947	79948	7-hydroxy-3	0	None
79948	79949	,	0	None
79949	79950	4-dimethylcoumarin	0	None
79950	79951	ethanesulfonate	0	None
79951	79952	)	0	None
79952	79953	,	0	None
79953	79954	and	0	None
79954	79955	4	0	None
79955	79956	)	0	None
79956	79957	the	0	None
79957	79958	irreversible	0	None
79958	79959	nonselective	0	None
79959	79960	MAO	3	GENE-N
79960	79961	inhibitor	0	None
79961	79962	tranylcypromine	0	None
79962	79963	.	0	None

79964	79965	Esuprone	0	None
79965	79966	proved	0	None
79966	79967	to	0	None
79967	79968	be	0	None
79968	79969	an	0	None
79969	79970	effective	0	None
79970	79971	anticonvulsant	0	None
79971	79972	in	0	None
79972	79973	the	0	None
79973	79974	kindling	0	None
79974	79975	model	0	None
79975	79976	with	0	None
79976	79977	a	0	None
79977	79978	similar	0	None
79978	79979	potency	0	None
79979	79980	as	0	None
79980	79981	L-deprenyl	0	None
79981	79982	.	0	None

79983	79984	In	0	None
79984	79985	contrast	0	None
79985	79986	to	0	None
79986	79987	esuprone	0	None
79987	79988	and	0	None
79988	79989	L-deprenyl	0	None
79989	79990	,	0	None
79990	79991	the	0	None
79991	79992	selective	0	None
79992	79993	MAO-B	0	None
79993	79994	inhibitor	0	None
79994	79995	LU	0	None
79995	79996	53439	0	None
79996	79997	was	0	None
79997	79998	not	0	None
79998	79999	effective	0	None
79999	80000	in	0	None
80000	80001	the	0	None
80001	80002	kindling	0	None
80002	80003	model;	0	None
80003	80004	this	0	None
80004	80005	substantiates	0	None
80005	80006	the	0	None
80006	80007	previous	0	None
80007	80008	notion	0	None
80008	80009	that	0	None
80009	80010	the	0	None
80010	80011	anticonvulsant	0	None
80011	80012	activity	0	None
80012	80013	of	0	None
80013	80014	L-deprenyl	0	None
80014	80015	is	0	None
80015	80016	not	0	None
80016	80017	related	0	None
80017	80018	to	0	None
80018	80019	MAO-B	0	None
80019	80020	inhibition	0	None
80020	80021	,	0	None
80021	80022	but	0	None
80022	80023	to	0	None
80023	80024	other	0	None
80024	80025	effects	0	None
80025	80026	of	0	None
80026	80027	this	0	None
80027	80028	drug	0	None
80028	80029	,	0	None
80029	80030	such	0	None
80030	80031	as	0	None
80031	80032	inhibition	0	None
80032	80033	of	0	None
80033	80034	MAO-A	0	None
80034	80035	.	0	None

80036	80037	Drugs	0	None
80037	80038	inhibiting	0	None
80038	80039	both	0	None
80039	80040	MAO-A	0	None
80040	80041	and	0	None
80041	80042	MAO-B	0	None
80042	80043	to	0	None
80043	80044	a	0	None
80044	80045	similar	0	None
80045	80046	extent	0	None
80046	80047	(	0	None
80047	80048	tranylcypromine	0	None
80048	80049	)	0	None
80049	80050	or	0	None
80050	80051	combinations	0	None
80051	80052	of	0	None
80052	80053	selective	0	None
80053	80054	MAO-A	0	None
80054	80055	and	0	None
80055	80056	MAO-B	0	None
80056	80057	inhibitors	0	None
80057	80058	(	0	None
80058	80059	esuprone	0	None
80059	80060	plus	0	None
80060	80061	LU	0	None
80061	80062	53439	0	None
80062	80063	)	0	None
80063	80064	had	0	None
80064	80065	no	0	None
80065	80066	advantage	0	None
80066	80067	over	0	None
80067	80068	MAO-A	0	None
80068	80069	inhibition	0	None
80069	80070	alone	0	None
80070	80071	,	0	None
80071	80072	but	0	None
80072	80073	were	0	None
80073	80074	less	0	None
80074	80075	well	0	None
80075	80076	tolerated	0	None
80076	80077	.	0	None

80078	80079	The	0	None
80079	80080	data	0	None
80080	80081	thus	0	None
80081	80082	suggest	0	None
80082	80083	that	0	None
80083	80084	selective	0	None
80084	80085	MAO-A	0	None
80085	80086	inhibitors	0	None
80086	80087	such	0	None
80087	80088	as	0	None
80088	80089	esuprone	0	None
80089	80090	may	0	None
80090	80091	be	0	None
80091	80092	an	0	None
80092	80093	interesting	0	None
80093	80094	new	0	None
80094	80095	approach	0	None
80095	80096	for	0	None
80096	80097	the	0	None
80097	80098	treatment	0	None
80098	80099	of	0	None
80099	80100	epilepsy	0	None
80100	80101	.	0	None
80101	80102	Cyprodinil	0	None
80102	80103	as	0	None
80103	80104	an	0	None
80104	80105	activator	0	None
80105	80106	of	0	None
80106	80107	aryl	0	None
80107	80108	hydrocarbon	0	None
80108	80109	receptor	0	None
80109	80110	.	0	None
80110	80111	1	0	None
80111	80112	.	0	None

80113	80114	The	0	None
80114	80115	effects	0	None
80115	80116	of	0	None
80116	80117	10	0	None
80117	80118	mg	2	CHEMICAL
80118	80119	(	0	None
80119	80120	+	0	None
80120	80121	)	0	None
80121	80122	-	0	None
80122	80123	and	0	None
80123	80124	(	0	None
80124	80125	-	0	None
80125	80126	)	0	None
80126	80127	-chlorpheniramine	0	None
80127	80128	and	0	None
80128	80129	5	0	None
80129	80130	mg	2	CHEMICAL
80130	80131	(	0	None
80131	80132	+	0	None
80132	80133	)	0	None
80133	80134	-	0	None
80134	80135	and	0	None
80135	80136	(	0	None
80136	80137	-	0	None
80137	80138	)	0	None
80138	80139	-dimethindene	0	None
80139	80140	on	0	None
80140	80141	daytime	0	None
80141	80142	sleep	0	None
80142	80143	latencies	0	None
80143	80144	,	0	None
80144	80145	digit	0	None
80145	80146	symbol	0	None
80146	80147	substitution	0	None
80147	80148	and	0	None
80148	80149	subjective	0	None
80149	80150	assessments	0	None
80150	80151	of	0	None
80151	80152	mood	0	None
80152	80153	and	0	None
80153	80154	well-being	0	None
80154	80155	were	0	None
80155	80156	studied	0	None
80156	80157	in	0	None
80157	80158	6	0	None
80158	80159	healthy	0	None
80159	80160	young	0	None
80160	80161	adult	0	None
80161	80162	humans	0	None
80162	80163	.	0	None

80164	80165	Each	0	None
80165	80166	subject	0	None
80166	80167	also	0	None
80167	80168	took	0	None
80168	80169	5	0	None
80169	80170	mg	2	CHEMICAL
80170	80171	triprolidine	2	CHEMICAL
80171	80172	hydrochloride	2	CHEMICAL
80172	80173	as	0	None
80173	80174	an	0	None
80174	80175	active	0	None
80175	80176	control	0	None
80176	80177	and	0	None
80177	80178	two	0	None
80178	80179	placebos	0	None
80179	80180	.	0	None

80181	80182	2	0	None
80182	80183	.	0	None

80184	80185	Daytime	0	None
80185	80186	sleep	0	None
80186	80187	latencies	0	None
80187	80188	were	0	None
80188	80189	reduced	0	None
80189	80190	with	0	None
80190	80191	triprolidine	2	CHEMICAL
80191	80192	,	0	None
80192	80193	(	0	None
80193	80194	+	0	None
80194	80195	)	0	None
80195	80196	-chlorpheniramine	0	None
80196	80197	and	0	None
80197	80198	(	0	None
80198	80199	-	0	None
80199	80200	)	0	None
80200	80201	-dimethindene	0	None
80201	80202	,	0	None
80202	80203	and	0	None
80203	80204	subjects	0	None
80204	80205	also	0	None
80205	80206	reported	0	None
80206	80207	that	0	None
80207	80208	they	0	None
80208	80209	felt	0	None
80209	80210	more	0	None
80210	80211	sleepy	0	None
80211	80212	after	0	None
80212	80213	(	0	None
80213	80214	+	0	None
80214	80215	)	0	None
80215	80216	-chlorpheniramine	0	None
80216	80217	and	0	None
80217	80218	(	0	None
80218	80219	-	0	None
80219	80220	)	0	None
80220	80221	-dimethindene	0	None
80221	80222	.	0	None

80223	80224	Performance	0	None
80224	80225	on	0	None
80225	80226	digit	0	None
80226	80227	symbol	0	None
80227	80228	substitution	0	None
80228	80229	was	0	None
80229	80230	impaired	0	None
80230	80231	with	0	None
80231	80232	(	0	None
80232	80233	+	0	None
80233	80234	)	0	None
80234	80235	-chlorpheniramine	0	None
80235	80236	.	0	None

80237	80238	3	0	None
80238	80239	.	0	None

80240	80241	Changes	0	None
80241	80242	in	0	None
80242	80243	measures	0	None
80243	80244	with	0	None
80244	80245	(	0	None
80245	80246	-	0	None
80246	80247	)	0	None
80247	80248	-chlorpheniramine	0	None
80248	80249	and	0	None
80249	80250	(	0	None
80250	80251	+	0	None
80251	80252	)	0	None
80252	80253	-dimethindene	0	None
80253	80254	were	0	None
80254	80255	not	0	None
80255	80256	different	0	None
80256	80257	from	0	None
80257	80258	changes	0	None
80258	80259	with	0	None
80259	80260	placebo	0	None
80260	80261	.	0	None

80262	80263	4	0	None
80263	80264	.	0	None

80265	80266	In	0	None
80266	80267	the	0	None
80267	80268	present	0	None
80268	80269	study	0	None
80269	80270	,	0	None
80270	80271	changes	0	None
80271	80272	in	0	None
80272	80273	measures	0	None
80273	80274	of	0	None
80274	80275	drowsiness	0	None
80275	80276	and	0	None
80276	80277	performance	0	None
80277	80278	were	0	None
80278	80279	limited	0	None
80279	80280	to	0	None
80280	80281	the	0	None
80281	80282	enantiomers	0	None
80282	80283	with	0	None
80283	80284	high	0	None
80284	80285	affinity	0	None
80285	80286	for	0	None
80286	80287	the	0	None
80287	80288	histamine	2	CHEMICAL
80288	80289	H1-receptor	0	None
80289	80290	.	0	None

80291	80292	These	0	None
80292	80293	findings	0	None
80293	80294	strongly	0	None
80294	80295	suggest	0	None
80295	80296	that	0	None
80296	80297	sedation	0	None
80297	80298	can	0	None
80298	80299	arise	0	None
80299	80300	from	0	None
80300	80301	H1-receptor	0	None
80301	80302	antagonism	0	None
80302	80303	alone	0	None
80303	80304	,	0	None
80304	80305	and	0	None
80305	80306	provide	0	None
80306	80307	further	0	None
80307	80308	support	0	None
80308	80309	for	0	None
80309	80310	the	0	None
80310	80311	belief	0	None
80311	80312	that	0	None
80312	80313	the	0	None
80313	80314	histaminergic	0	None
80314	80315	system	0	None
80315	80316	is	0	None
80316	80317	concerned	0	None
80317	80318	with	0	None
80318	80319	the	0	None
80319	80320	regulation	0	None
80320	80321	of	0	None
80321	80322	alertness	0	None
80322	80323	in	0	None
80323	80324	man	0	None
80324	80325	.	0	None
80325	80326	ERP	0	None
80326	80327	evidence	0	None
80327	80328	suggests	0	None
80328	80329	executive	0	None
80329	80330	dysfunction	0	None
80330	80331	in	0	None
80331	80332	ecstasy	0	None
80332	80333	polydrug	0	None
80333	80334	users	0	None
80334	80335	.	0	None
80335	80336	The	0	None
80336	80337	comparative	0	None
80337	80338	formation	0	None
80338	80339	of	0	None
80339	80340	the	0	None
80340	80342	heterocyclic aromatic	2	CHEMICAL
80342	80343	amine	2	CHEMICAL
80343	80344	2-amino-1-methyl-6-phenylimidazo	0	None
80344	80345	[	0	None
80345	80346	4	0	None
80346	80347	,	0	None
80347	80348	5-b	0	None
80348	80349	]	0	None
80349	80350	pyridine	0	None
80350	80351	(	0	None
80351	80352	PhIP	0	None
80352	80353	)	0	None
80353	80354	in	0	None
80354	80355	both	0	None
80355	80356	creatinine	0	None
80356	80357	/	0	None
80357	80358	phenylalanine	0	None
80358	80359	(	0	None
80359	80360	CRN	0	None
80360	80361	/	0	None
80361	80362	Phe	0	None
80362	80363	)	0	None
80363	80364	and	0	None
80364	80365	creatinine	0	None
80365	80366	/	0	None
80366	80367	phenylalanine	0	None
80367	80368	/	0	None
80368	80369	4-oxo-2-nonenal	0	None
80369	80370	(	0	None
80370	80371	CRN	0	None
80371	80372	/	0	None
80372	80373	Phe	0	None
80373	80374	/	0	None
80374	80375	ON	0	None
80375	80376	)	0	None
80376	80377	systems	0	None
80377	80378	was	0	None
80378	80379	studied	0	None
80379	80380	to	0	None
80380	80381	analyse	0	None
80381	80382	the	0	None
80382	80383	ability	0	None
80383	80384	of	0	None
80384	80385	lipid-derived	0	None
80385	80386	reactive	0	None
80386	80387	carbonyls	2	CHEMICAL
80387	80388	to	0	None
80388	80389	promote	0	None
80389	80390	PhIP	0	None
80390	80391	formation	0	None
80391	80392	.	0	None

80393	80394	Although	0	None
80394	80395	PhIP	0	None
80395	80396	was	0	None
80396	80397	produced	0	None
80397	80398	to	0	None
80398	80399	some	0	None
80399	80400	extent	0	None
80400	80401	in	0	None
80401	80402	the	0	None
80402	80403	CRN	0	None
80403	80404	/	0	None
80404	80405	Phe	0	None
80405	80406	system	0	None
80406	80407	,	0	None
80407	80408	the	0	None
80408	80409	presence	0	None
80409	80410	of	0	None
80410	80411	the	0	None
80411	80412	oxidized	0	None
80412	80413	lipid	0	None
80413	80414	increased	0	None
80414	80415	considerably	0	None
80415	80416	the	0	None
80416	80417	amount	0	None
80417	80418	of	0	None
80418	80419	PhIP	0	None
80419	80420	produced	0	None
80420	80421	.	0	None

80422	80423	This	0	None
80423	80424	increase	0	None
80424	80425	seemed	0	None
80425	80426	to	0	None
80426	80427	be	0	None
80427	80428	a	0	None
80428	80429	consequence	0	None
80429	80430	of	0	None
80430	80431	the	0	None
80431	80432	decrease	0	None
80432	80433	in	0	None
80433	80434	the	0	None
80434	80435	E	0	None
80435	80436	(	0	None
80436	80437	a	0	None
80437	80438	)	0	None
80438	80439	of	0	None
80439	80440	the	0	None
80440	80441	reaction	0	None
80441	80442	when	0	None
80442	80443	the	0	None
80443	80444	lipid	0	None
80444	80445	was	0	None
80445	80446	present	0	None
80446	80447	,	0	None
80447	80448	which	0	None
80448	80449	diminished	0	None
80449	80450	from	0	None
80450	80451	112	0	None
80451	80452	.	0	None
80452	80453	9	0	None
80453	80454	to	0	None
80454	80455	80	0	None
80455	80456	.	0	None
80456	80457	9	0	None
80457	80458	kJ	0	None
80458	80459	/	0	None
80459	80460	mol	0	None
80460	80461	.	0	None

80462	80463	On	0	None
80463	80464	the	0	None
80464	80465	other	0	None
80465	80466	hand	0	None
80466	80467	,	0	None
80467	80468	the	0	None
80468	80469	addition	0	None
80469	80470	of	0	None
80470	80471	the	0	None
80471	80472	lipid	0	None
80472	80473	did	0	None
80473	80474	not	0	None
80474	80475	seem	0	None
80475	80476	to	0	None
80476	80477	produce	0	None
80477	80478	PhIP	0	None
80478	80479	by	0	None
80479	80480	an	0	None
80480	80481	alternative	0	None
80481	80482	mechanism	0	None
80482	80483	because	0	None
80483	80484	PhIP	0	None
80484	80485	was	0	None
80485	80486	formed	0	None
80486	80487	analogously	0	None
80487	80488	in	0	None
80488	80489	both	0	None
80489	80490	CRN	0	None
80490	80491	/	0	None
80491	80492	Phe	0	None
80492	80493	and	0	None
80493	80494	CRN	0	None
80494	80495	/	0	None
80495	80496	Phe	0	None
80496	80497	/	0	None
80497	80498	ON	0	None
80498	80499	systems	0	None
80499	80500	as	0	None
80500	80501	a	0	None
80501	80502	function	0	None
80502	80503	of	0	None
80503	80504	pH	0	None
80504	80505	,	0	None
80505	80506	creatinine	0	None
80506	80507	concentration	0	None
80507	80508	,	0	None
80508	80509	phenylalanine	0	None
80509	80510	concentration	0	None
80510	80511	,	0	None
80511	80512	time	0	None
80512	80513	,	0	None
80513	80514	temperature	0	None
80514	80515	,	0	None
80515	80516	oxygen	0	None
80516	80517	concentration	0	None
80517	80518	in	0	None
80518	80519	the	0	None
80519	80520	reaction	0	None
80520	80521	atmosphere	0	None
80521	80522	,	0	None
80522	80523	and	0	None
80523	80524	the	0	None
80524	80525	addition	0	None
80525	80526	of	0	None
80526	80527	different	0	None
80527	80528	amounts	0	None
80528	80529	of	0	None
80529	80530	ammonia	0	None
80530	80531	.	0	None

80532	80533	All	0	None
80533	80534	these	0	None
80534	80535	results	0	None
80535	80536	suggest	0	None
80536	80537	that	0	None
80537	80538	the	0	None
80538	80539	ability	0	None
80539	80540	of	0	None
80540	80541	lipid	0	None
80541	80542	oxidation	0	None
80542	80543	products	0	None
80543	80544	to	0	None
80544	80545	produce	0	None
80545	80546	PhIP	0	None
80546	80547	is	0	None
80547	80548	related	0	None
80548	80549	to	0	None
80549	80550	their	0	None
80550	80551	capacity	0	None
80551	80552	to	0	None
80552	80553	induce	0	None
80553	80554	the	0	None
80554	80555	Strecker	0	None
80555	80556	degradation	0	None
80556	80557	of	0	None
80557	80558	phenylalanine	0	None
80558	80559	to	0	None
80559	80560	phenylacetaldehyde	0	None
80560	80561	.	0	None

80562	80563	Therefore	0	None
80563	80564	,	0	None
80564	80565	any	0	None
80565	80566	other	0	None
80566	80567	reactive	0	None
80567	80568	carbonyl	0	None
80568	80569	compound	0	None
80569	80570	that	0	None
80570	80571	can	0	None
80571	80572	produce	0	None
80572	80573	the	0	None
80573	80574	Strecker	0	None
80574	80575	degradation	0	None
80575	80576	of	0	None
80576	80577	phenylalanine	0	None
80577	80578	should	0	None
80578	80579	also	0	None
80579	80580	be	0	None
80580	80581	considered	0	None
80581	80582	as	0	None
80582	80583	a	0	None
80583	80584	potential	0	None
80584	80585	inducer	0	None
80585	80586	of	0	None
80586	80587	PhIP	0	None
80587	80588	formation	0	None
80588	80589	under	0	None
80589	80590	appropriate	0	None
80590	80591	conditions	0	None
80591	80592	.	0	None
80592	80594	Adenylosuccinate synthetase	1	GENE-Y
80594	80595	(	0	None
80595	80596	AdSS	0	None
80596	80597	)	0	None
80597	80598	catalyses	0	None
80598	80599	the	0	None
80599	80600	Mg	2	CHEMICAL
80600	80601	(	0	None
80601	80602	2	0	None
80602	80603	+	0	None
80603	80604	)	0	None
80604	80605	dependent	0	None
80605	80606	formation	0	None
80606	80607	of	0	None
80607	80608	adenylosuccinate	0	None
80608	80609	from	0	None
80609	80610	IMP	0	None
80610	80611	and	0	None
80611	80612	aspartate	0	None
80612	80613	,	0	None
80613	80614	the	0	None
80614	80615	reaction	0	None
80615	80616	being	0	None
80616	80617	driven	0	None
80617	80618	by	0	None
80618	80619	the	0	None
80619	80620	hydrolysis	0	None
80620	80621	of	0	None
80621	80622	GTP	0	None
80622	80623	to	0	None
80623	80624	GDP	0	None
80624	80625	.	0	None

80626	80627	All	0	None
80627	80628	characterized	0	None
80628	80629	AdSS	0	None
80629	80630	thus	0	None
80630	80631	far	0	None
80631	80632	exhibit	0	None
80632	80633	a	0	None
80633	80634	random	0	None
80634	80635	kinetic	0	None
80635	80636	mechanism	0	None
80636	80637	.	0	None

80638	80639	We	0	None
80639	80640	present	0	None
80640	80641	here	0	None
80641	80642	kinetic	0	None
80642	80643	evidence	0	None
80643	80644	that	0	None
80644	80645	unlike	0	None
80645	80646	all	0	None
80646	80647	other	0	None
80647	80648	AdSS	0	None
80648	80649	,	0	None
80649	80650	Plasmodium	0	None
80650	80651	falciparum	0	None
80651	80652	AdSS	0	None
80652	80653	(	0	None
80653	80654	PfAdSS	0	None
80654	80655	)	0	None
80655	80656	has	0	None
80656	80657	ordered	0	None
80657	80658	substrate	0	None
80658	80659	binding	0	None
80659	80660	.	0	None

80661	80662	Inhibition	0	None
80662	80663	studies	0	None
80663	80664	show	0	None
80664	80665	that	0	None
80665	80666	binding	0	None
80666	80667	of	0	None
80667	80668	GTP	0	None
80668	80669	requires	0	None
80669	80670	IMP	0	None
80670	80671	binding	0	None
80671	80672	while	0	None
80672	80673	aspartate	0	None
80673	80674	binds	0	None
80674	80675	to	0	None
80675	80676	the	0	None
80676	80677	enzyme-IMP-GTP	0	None
80677	80678	complex	0	None
80678	80679	.	0	None

80680	80681	A	0	None
80681	80682	structural	0	None
80682	80683	basis	0	None
80683	80684	for	0	None
80684	80685	this	0	None
80685	80686	difference	0	None
80686	80687	in	0	None
80687	80688	mechanism	0	None
80688	80689	is	0	None
80689	80690	presented	0	None
80690	80691	.	0	None

80692	80693	Kinetically	0	None
80693	80694	,	0	None
80694	80695	PfAdSS	0	None
80695	80696	is	0	None
80696	80697	closer	0	None
80697	80698	to	0	None
80698	80699	the	0	None
80699	80700	mouse	0	None
80700	80701	acidic	0	None
80701	80702	isozyme	0	None
80702	80703	rather	0	None
80703	80704	than	0	None
80704	80705	to	0	None
80705	80706	the	0	None
80706	80707	mouse	0	None
80707	80708	basic	0	None
80708	80709	isozyme	0	None
80709	80710	.	0	None

80711	80712	The	0	None
80712	80715	mouse acidic isozyme	3	GENE-N
80715	80716	is	0	None
80716	80717	thought	0	None
80717	80718	to	0	None
80718	80719	play	0	None
80719	80720	a	0	None
80720	80721	role	0	None
80721	80722	in	0	None
80722	80723	the	0	None
80723	80724	purine	0	None
80724	80725	nucleotide	0	None
80725	80726	biosynthetic	0	None
80726	80727	pathway	0	None
80727	80728	.	0	None

80729	80730	Regulation	0	None
80730	80731	of	0	None
80731	80732	PfAdSS	0	None
80732	80733	in	0	None
80733	80734	vivo	0	None
80734	80735	can	0	None
80735	80736	therefore	0	None
80736	80737	,	0	None
80737	80738	be	0	None
80738	80739	expected	0	None
80739	80740	to	0	None
80740	80741	be	0	None
80741	80742	similar	0	None
80742	80743	to	0	None
80743	80744	the	0	None
80744	80747	mouse acidic isozyme	3	GENE-N
80747	80748	,	0	None
80748	80749	in	0	None
80749	80750	agreement	0	None
80750	80751	with	0	None
80751	80752	the	0	None
80752	80753	role	0	None
80753	80754	of	0	None
80754	80755	PfAdSS	0	None
80755	80756	as	0	None
80756	80757	the	0	None
80757	80758	only	0	None
80758	80759	pathway	0	None
80759	80760	for	0	None
80760	80761	the	0	None
80761	80762	synthesis	0	None
80762	80763	of	0	None
80763	80764	adenine	2	CHEMICAL
80764	80765	nucleotides	0	None
80765	80766	in	0	None
80766	80767	the	0	None
80767	80768	parasite	0	None
80768	80769	.	0	None

80770	80771	However	0	None
80771	80772	,	0	None
80772	80773	PfAdSS	0	None
80773	80774	differs	0	None
80774	80775	from	0	None
80775	80776	both	0	None
80776	80777	the	0	None
80777	80778	mammalian	0	None
80778	80779	homologs	0	None
80779	80780	in	0	None
80780	80781	that	0	None
80781	80782	fructose-1	0	None
80782	80783	,	0	None
80783	80784	6-bisphosphate	0	None
80784	80785	,	0	None
80785	80786	a	0	None
80786	80787	potent	0	None
80787	80788	inhibitor	0	None
80788	80789	of	0	None
80789	80790	the	0	None
80790	80791	mammalian	0	None
80791	80792	enzyme	0	None
80792	80793	,	0	None
80793	80794	is	0	None
80794	80795	an	0	None
80795	80796	activator	0	None
80796	80797	of	0	None
80797	80798	PfAdSS	0	None
80798	80799	.	0	None

80800	80801	The	0	None
80801	80802	differences	0	None
80802	80803	highlighted	0	None
80803	80804	here	0	None
80804	80805	are	0	None
80805	80806	promising	0	None
80806	80807	in	0	None
80807	80808	terms	0	None
80808	80809	of	0	None
80809	80810	species-specific	0	None
80810	80811	drug	0	None
80811	80812	design	0	None
80812	80813	,	0	None
80813	80814	targeting	0	None
80814	80815	this	0	None
80815	80816	essential	0	None
80816	80817	enzyme	0	None
80817	80818	in	0	None
80818	80819	the	0	None
80819	80820	parasite	0	None
80820	80821	.	0	None
80821	80822	QT	0	None
80822	80823	prolongation	0	None
80823	80824	,	0	None
80824	80825	a	0	None
80825	80826	risk	0	None
80826	80827	factor	0	None
80827	80828	for	0	None
80828	80829	arrhythmias	0	None
80829	80830	,	0	None
80830	80831	can	0	None
80831	80832	result	0	None
80832	80833	from	0	None
80833	80834	genetic	0	None
80834	80835	variants	0	None
80835	80836	in	0	None
80836	80837	one	0	None
80837	80838	(	0	None
80838	80839	or	0	None
80839	80840	more	0	None
80840	80841	)	0	None
80841	80842	of	0	None
80842	80843	the	0	None
80843	80844	genes	0	None
80844	80845	governing	0	None
80845	80846	cardiac	0	None
80846	80847	repolarization	0	None
80847	80848	as	0	None
80848	80849	well	0	None
80849	80850	as	0	None
80850	80851	intake	0	None
80851	80852	of	0	None
80852	80853	drugs	0	None
80853	80854	known	0	None
80854	80855	to	0	None
80855	80856	affect	0	None
80856	80857	a	0	None
80857	80858	cardiac	0	None
80858	80859	K	0	None
80859	80860	(	0	None
80860	80861	+	0	None
80861	80862	)	0	None
80862	80863	channel	0	None
80863	80864	encoded	0	None
80864	80865	by	0	None
80865	80866	human	0	None
80866	80867	ether-a-go-go-related	0	None
80867	80868	gene	0	None
80868	80869	(	0	None
80869	80870	HERG	1	GENE-Y
80870	80871	)	0	None
80871	80872	.	0	None

80873	80874	In	0	None
80874	80875	this	0	None
80875	80876	paper	0	None
80876	80877	,	0	None
80877	80878	we	0	None
80878	80879	will	0	None
80879	80880	report	0	None
80880	80881	a	0	None
80881	80882	case	0	None
80882	80883	of	0	None
80883	80884	drug-induced	0	None
80884	80885	long	0	None
80885	80886	QT	0	None
80886	80887	syndrome	0	None
80887	80888	associated	0	None
80888	80889	with	0	None
80889	80890	an	0	None
80890	80891	H	0	None
80891	80892	(	0	None
80892	80893	1	0	None
80893	80894	)	0	None
80894	80895	-receptor	0	None
80895	80896	antagonist	0	None
80896	80897	,	0	None
80897	80898	hydroxyzine	0	None
80898	80899	,	0	None
80899	80900	in	0	None
80900	80901	which	0	None
80901	80902	a	0	None
80902	80903	mutation	0	None
80903	80904	was	0	None
80904	80905	identified	0	None
80905	80906	in	0	None
80906	80907	the	0	None
80907	80908	HERG	1	GENE-Y
80908	80909	gene	0	None
80909	80910	.	0	None

80911	80912	After	0	None
80912	80913	taking	0	None
80913	80914	75	0	None
80914	80915	mg	2	CHEMICAL
80915	80916	of	0	None
80916	80917	hydroxyzine	0	None
80917	80918	for	0	None
80918	80919	several	0	None
80919	80920	days	0	None
80920	80921	,	0	None
80921	80922	a	0	None
80922	80923	34-year-old	0	None
80923	80924	female	0	None
80924	80925	began	0	None
80925	80926	to	0	None
80926	80927	experience	0	None
80927	80928	repetitive	0	None
80928	80929	syncope	0	None
80929	80930	.	0	None

80931	80932	The	0	None
80932	80933	deleterious	0	None
80933	80934	effect	0	None
80934	80935	of	0	None
80935	80936	hydroxyzine	0	None
80936	80937	was	0	None
80937	80938	suspected	0	None
80938	80939	because	0	None
80939	80940	QTc	0	None
80940	80941	interval	0	None
80941	80942	shortened	0	None
80942	80943	from	0	None
80943	80944	630	0	None
80944	80945	to	0	None
80945	80946	464	0	None
80946	80947	ms	0	None
80947	80948	after	0	None
80948	80949	cessation	0	None
80949	80950	of	0	None
80950	80951	the	0	None
80951	80952	drug	0	None
80952	80953	.	0	None

80954	80955	Later	0	None
80955	80956	on	0	None
80956	80957	,	0	None
80957	80958	the	0	None
80958	80959	patient	0	None
80959	80960	was	0	None
80960	80961	found	0	None
80961	80962	to	0	None
80962	80963	harbor	0	None
80963	80964	an	0	None
80964	80965	A614V-HERG	0	None
80965	80966	mutation	0	None
80966	80967	.	0	None

80968	80969	By	0	None
80969	80970	using	0	None
80970	80971	the	0	None
80971	80972	patch-clamp	0	None
80972	80973	technique	0	None
80973	80974	in	0	None
80974	80975	the	0	None
80975	80976	heterologous	0	None
80976	80977	expression	0	None
80977	80978	system	0	None
80978	80979	,	0	None
80979	80980	we	0	None
80980	80981	examined	0	None
80981	80982	the	0	None
80982	80983	functional	0	None
80983	80984	outcome	0	None
80984	80985	of	0	None
80985	80986	the	0	None
80986	80987	A614V	3	GENE-N
80987	80988	mutation	0	None
80988	80989	and	0	None
80989	80990	confirmed	0	None
80990	80991	a	0	None
80991	80992	dominant-negative	0	None
80992	80993	effect	0	None
80993	80994	on	0	None
80994	80995	HERG	1	GENE-Y
80995	80996	expression	0	None
80996	80997	.	0	None

80998	80999	Hydroxyzine	0	None
80999	81000	concentration-dependently	0	None
81000	81001	inhibited	0	None
81001	81002	both	0	None
81002	81003	wild-type	0	None
81003	81004	(	0	None
81004	81005	WT	0	None
81005	81006	)	0	None
81006	81007	and	0	None
81007	81008	WT	0	None
81008	81009	/	0	None
81009	81010	A614V-HERG	0	None
81010	81011	K	0	None
81011	81012	(	0	None
81012	81013	+	0	None
81013	81014	)	0	None
81014	81015	currents	0	None
81015	81016	.	0	None

81017	81018	Half-maximum	0	None
81018	81019	block	0	None
81019	81020	concentrations	0	None
81020	81021	of	0	None
81021	81022	WT	0	None
81022	81023	and	0	None
81023	81024	WT	0	None
81024	81025	/	0	None
81025	81026	A614V-HERG	0	None
81026	81027	K	0	None
81027	81028	(	0	None
81028	81029	+	0	None
81029	81030	)	0	None
81030	81031	currents	0	None
81031	81032	were	0	None
81032	81033	0	0	None
81033	81034	.	0	None
81034	81035	62	0	None
81035	81036	and	0	None
81036	81037	0	0	None
81037	81038	.	0	None
81038	81039	52	0	None
81039	81040	microM	0	None
81040	81041	,	0	None
81041	81042	respectively	0	None
81042	81043	.	0	None

81044	81045	Thus	0	None
81045	81046	,	0	None
81046	81047	accidental	0	None
81047	81048	combination	0	None
81048	81049	of	0	None
81049	81050	genetic	0	None
81050	81051	mutation	0	None
81051	81052	and	0	None
81052	81053	intake	0	None
81053	81054	of	0	None
81054	81055	hydroxyzine	0	None
81055	81056	appeared	0	None
81056	81057	to	0	None
81057	81058	have	0	None
81058	81059	led	0	None
81059	81060	to	0	None
81060	81061	a	0	None
81061	81062	severe	0	None
81062	81063	phenotype	0	None
81063	81064	,	0	None
81064	81065	probably	0	None
81065	81066	,	0	None
81066	81067	syncope	0	None
81067	81068	due	0	None
81068	81069	to	0	None
81069	81070	torsade	0	None
81070	81071	de	0	None
81071	81072	pointes	0	None
81072	81073	.	0	None
81073	81074	An	0	None
81074	81075	extract	0	None
81075	81076	procedure	0	None
81076	81077	for	0	None
81077	81078	studying	0	None
81078	81079	the	0	None
81079	81080	free	0	None
81080	81081	and	0	None
81081	81082	glycosilated	0	None
81082	81083	aroma	0	None
81083	81084	compounds	0	None
81084	81085	in	0	None
81085	81086	grapes	0	None
81086	81087	.	0	None
81087	81088	The	0	None
81088	81089	GABA	2	CHEMICAL
81089	81090	A	0	None
81090	81091	receptor	0	None
81091	81092	subunits	0	None
81092	81093	heterologously	0	None
81093	81094	expressed	0	None
81094	81095	in	0	None
81095	81096	Xenopus	0	None
81096	81097	oocytes	0	None
81097	81098	.	0	None
81098	81099	Optimization	0	None
81099	81100	of	0	None
81100	81101	Non-ATP	0	None
81101	81102	Competitive	0	None
81102	81103	CDK	0	None
81103	81104	/	0	None
81104	81105	Cyclin	0	None
81105	81106	Groove	0	None
81106	81107	Inhibitors	0	None
81107	81108	through	0	None
81108	81109	REPLACE-Mediated	0	None
81109	81110	Fragment	0	None
81110	81111	Assembly	0	None
81111	81112	.	0	None
81112	81113	Polybrominated	0	None
81113	81114	diphenyl	0	None
81114	81115	ethers	0	None
81115	81116	(	0	None
81116	81117	PBDEs	0	None
81117	81118	)	0	None
81118	81119	were	0	None
81119	81120	widely	0	None
81120	81121	used	0	None
81121	81122	flame	0	None
81122	81123	retardants	0	None
81123	81124	that	0	None
81124	81125	have	0	None
81125	81126	become	0	None
81126	81127	persistent	0	None
81127	81128	environmental	0	None
81128	81129	pollutants	0	None
81129	81130	.	0	None

81131	81132	In	0	None
81132	81133	the	0	None
81133	81134	present	0	None
81134	81135	study	0	None
81135	81136	,	0	None
81136	81137	we	0	None
81137	81138	investigated	0	None
81138	81139	the	0	None
81139	81140	in	0	None
81140	81141	vitro	0	None
81141	81142	oxidative	0	None
81142	81143	metabolism	0	None
81143	81144	of	0	None
81144	81145	2	0	None
81145	81146	,	0	None
81146	81147	2'	0	None
81147	81148	,	0	None
81148	81149	4	0	None
81149	81150	,	0	None
81150	81151	4'-tetrabromodiphenyl	0	None
81151	81152	ether	0	None
81152	81153	(	0	None
81153	81154	BDE-47	0	None
81154	81155	)	0	None
81155	81156	,	0	None
81156	81157	a	0	None
81157	81158	major	0	None
81158	81159	PBDE	0	None
81159	81160	detected	0	None
81160	81161	in	0	None
81161	81162	human	0	None
81162	81163	tissue	0	None
81163	81164	and	0	None
81164	81165	environmental	0	None
81165	81166	samples	0	None
81166	81167	.	0	None

81168	81169	Biotransformation	0	None
81169	81170	of	0	None
81170	81171	BDE-47	0	None
81171	81172	by	0	None
81172	81173	pooled	0	None
81173	81174	and	0	None
81174	81175	individual	0	None
81175	81176	human	0	None
81176	81177	liver	0	None
81177	81178	microsomes	0	None
81178	81179	and	0	None
81179	81180	by	0	None
81180	81181	human	0	None
81181	81182	recombinant	0	None
81182	81183	cytochrome	3	GENE-N
81183	81184	P450	0	None
81184	81185	(	0	None
81185	81186	P450	0	None
81186	81187	)	0	None
81187	81188	enzymes	0	None
81188	81189	was	0	None
81189	81190	assessed	0	None
81190	81191	using	0	None
81191	81192	a	0	None
81192	81193	liquid	0	None
81193	81194	chromatography	0	None
81194	81195	/	0	None
81195	81196	tandem	0	None
81196	81197	mass	0	None
81197	81198	spectrometry-based	0	None
81198	81199	method	0	None
81199	81200	.	0	None

81201	81202	Of	0	None
81202	81203	the	0	None
81203	81204	nine	0	None
81204	81205	hydroxylated	0	None
81205	81206	metabolites	0	None
81206	81207	of	0	None
81207	81208	BDE-47	0	None
81208	81209	produced	0	None
81209	81210	by	0	None
81210	81211	human	0	None
81211	81212	liver	0	None
81212	81213	microsomes	0	None
81213	81214	,	0	None
81214	81215	seven	0	None
81215	81216	metabolites	0	None
81216	81217	were	0	None
81217	81218	identified	0	None
81218	81219	using	0	None
81219	81220	authentic	0	None
81220	81221	standards	0	None
81221	81222	.	0	None

81223	81224	A	0	None
81224	81225	monohydroxy-tetrabrominated	0	None
81225	81226	and	0	None
81226	81227	a	0	None
81227	81228	dihydroxy-tetrabrominated	0	None
81228	81229	metabolite	0	None
81229	81230	remain	0	None
81230	81231	unidentified	0	None
81231	81232	.	0	None

81233	81234	Kinetic	0	None
81234	81235	analysis	0	None
81235	81236	of	0	None
81236	81237	the	0	None
81237	81238	rates	0	None
81238	81239	of	0	None
81239	81240	metabolite	0	None
81240	81241	formation	0	None
81241	81242	revealed	0	None
81242	81243	that	0	None
81243	81244	the	0	None
81244	81245	major	0	None
81245	81246	metabolites	0	None
81246	81247	were	0	None
81247	81248	5-hydroxy-2	0	None
81248	81249	,	0	None
81249	81250	2'	0	None
81250	81251	,	0	None
81251	81252	4	0	None
81252	81253	,	0	None
81253	81254	4'-tetrabromodiphenyl	0	None
81254	81255	ether	0	None
81255	81256	(	0	None
81256	81257	5-OH-BDE-47	0	None
81257	81258	)	0	None
81258	81259	,	0	None
81259	81260	6-hydroxy-2	0	None
81260	81261	,	0	None
81261	81262	2'	0	None
81262	81263	,	0	None
81263	81264	4	0	None
81264	81265	,	0	None
81265	81266	4'-tetrabromodiphenyl	0	None
81266	81267	ether	0	None
81267	81268	(	0	None
81268	81269	6-OH-BDE-47	2	CHEMICAL
81269	81270	)	0	None
81270	81271	,	0	None
81271	81272	and	0	None
81272	81273	possibly	0	None
81273	81274	the	0	None
81274	81275	unidentified	0	None
81275	81276	monohydroxy-tetrabrominated	0	None
81276	81277	metabolite	0	None
81277	81278	.	0	None

81279	81280	Among	0	None
81280	81281	the	0	None
81281	81282	human	0	None
81282	81283	recombinant	0	None
81283	81284	P450	0	None
81284	81285	enzymes	0	None
81285	81286	tested	0	None
81286	81287	,	0	None
81287	81288	P450	0	None
81288	81289	2B6	0	None
81289	81290	was	0	None
81290	81291	the	0	None
81291	81292	most	0	None
81292	81293	active	0	None
81293	81294	enzyme	0	None
81294	81295	in	0	None
81295	81296	the	0	None
81296	81297	formation	0	None
81297	81298	of	0	None
81298	81299	the	0	None
81299	81300	hydroxylated	0	None
81300	81301	metabolites	0	None
81301	81302	of	0	None
81302	81303	BDE-47	0	None
81303	81304	.	0	None

81305	81306	Moreover	0	None
81306	81307	,	0	None
81307	81308	the	0	None
81308	81309	formation	0	None
81309	81310	of	0	None
81310	81311	all	0	None
81311	81312	metabolites	0	None
81312	81313	of	0	None
81313	81314	BDE-47	0	None
81314	81315	by	0	None
81315	81316	pooled	0	None
81316	81317	human	0	None
81317	81318	liver	0	None
81318	81319	microsomes	0	None
81319	81320	was	0	None
81320	81321	inhibited	0	None
81321	81322	by	0	None
81322	81323	a	0	None
81323	81324	P450	0	None
81324	81325	2B6-specific	0	None
81325	81326	antibody	0	None
81326	81327	and	0	None
81327	81328	was	0	None
81328	81329	highly	0	None
81329	81330	correlated	0	None
81330	81331	with	0	None
81331	81332	P450	0	None
81332	81333	2B6-mediated	0	None
81333	81334	activity	0	None
81334	81335	in	0	None
81335	81336	single	0	None
81336	81337	donor	0	None
81337	81338	liver	0	None
81338	81339	microsomes	0	None
81339	81340	indicating	0	None
81340	81341	that	0	None
81341	81342	P450	0	None
81342	81343	2B6	0	None
81343	81344	was	0	None
81344	81345	the	0	None
81345	81346	major	0	None
81346	81347	P450	0	None
81347	81348	responsible	0	None
81348	81349	for	0	None
81349	81350	the	0	None
81350	81351	biotransformation	0	None
81351	81352	of	0	None
81352	81353	BDE-47	0	None
81353	81354	.	0	None

81355	81356	Additional	0	None
81356	81357	experiments	0	None
81357	81358	involving	0	None
81358	81359	the	0	None
81359	81360	incubation	0	None
81360	81361	of	0	None
81361	81362	liver	0	None
81362	81363	microsomes	0	None
81363	81364	with	0	None
81364	81365	individual	0	None
81365	81366	monohydroxy-tetrabrominated	0	None
81366	81367	metabolites	0	None
81367	81368	in	0	None
81368	81369	place	0	None
81369	81370	of	0	None
81370	81371	BDE-47	0	None
81371	81372	demonstrated	0	None
81372	81373	that	0	None
81373	81374	2	0	None
81374	81375	,	0	None
81375	81376	4-dibromophenol	0	None
81376	81377	was	0	None
81377	81378	a	0	None
81378	81379	product	0	None
81379	81380	of	0	None
81380	81381	BDE-47	0	None
81381	81382	and	0	None
81382	81383	several	0	None
81383	81384	primary	0	None
81384	81385	metabolites	0	None
81385	81386	,	0	None
81386	81387	but	0	None
81387	81388	the	0	None
81388	81389	dihydroxy-tetrabrominated	0	None
81389	81390	metabolite	0	None
81390	81391	was	0	None
81391	81392	not	0	None
81392	81393	formed	0	None
81393	81394	by	0	None
81394	81395	sequential	0	None
81395	81396	hydroxylation	0	None
81396	81397	of	0	None
81397	81398	any	0	None
81398	81399	of	0	None
81399	81400	the	0	None
81400	81401	monohydroxy-tetrabrominated	0	None
81401	81402	metabolites	0	None
81402	81403	tested	0	None
81403	81404	.	0	None

81405	81406	The	0	None
81406	81407	present	0	None
81407	81408	study	0	None
81408	81409	provides	0	None
81409	81410	a	0	None
81410	81411	comprehensive	0	None
81411	81412	characterization	0	None
81412	81413	of	0	None
81413	81414	the	0	None
81414	81415	oxidative	0	None
81415	81416	metabolism	0	None
81416	81417	of	0	None
81417	81418	BDE-47	0	None
81418	81419	by	0	None
81419	81420	human	0	None
81420	81421	liver	0	None
81421	81422	microsomes	0	None
81422	81423	and	0	None
81423	81424	P450	0	None
81424	81425	2B6	0	None
81425	81426	.	0	None
81426	81427	Species-specific	0	None
81427	81428	differences	0	None
81428	81429	in	0	None
81429	81430	the	0	None
81430	81432	glucocorticoid receptor	1	GENE-Y
81432	81433	transactivation	0	None
81433	81434	function	0	None
81434	81435	upon	0	None
81435	81436	binding	0	None
81436	81437	with	0	None
81437	81438	betamethasone-esters	0	None
81438	81439	.	0	None
81439	81440	Characterization	0	None
81440	81441	of	0	None
81441	81442	the	0	None
81442	81443	substrate	0	None
81443	81444	mimic	0	None
81444	81445	bound	0	None
81445	81446	to	0	None
81446	81447	engineered	0	None
81447	81449	prostacyclin synthase	1	GENE-Y
81449	81450	in	0	None
81450	81451	solution	0	None
81451	81452	using	0	None
81452	81453	high-resolution	0	None
81453	81454	NMR	0	None
81454	81455	spectroscopy	0	None
81455	81456	and	0	None
81456	81457	mutagenesis	0	None
81457	81458	:	0	None
81458	81459	implication	0	None
81459	81460	of	0	None
81460	81461	the	0	None
81461	81462	molecular	0	None
81462	81463	mechanism	0	None
81463	81464	in	0	None
81464	81465	biosynthesis	0	None
81465	81466	of	0	None
81466	81467	prostacyclin	2	CHEMICAL
81467	81468	.	0	None
81468	81469	The	0	None
81469	81470	functions	0	None
81470	81471	of	0	None
81471	81472	microRNAs	0	None
81472	81473	(	0	None
81473	81474	miRNAs	0	None
81474	81475	)	0	None
81475	81476	as	0	None
81476	81477	either	0	None
81477	81478	oncogenes	0	None
81478	81479	or	0	None
81479	81480	tumor	0	None
81480	81481	suppressors	0	None
81481	81482	in	0	None
81482	81483	regulating	0	None
81483	81484	cancer-related	0	None
81484	81485	events	0	None
81485	81486	have	0	None
81486	81487	been	0	None
81487	81488	established	0	None
81488	81489	.	0	None

81490	81491	We	0	None
81491	81492	analyzed	0	None
81492	81493	the	0	None
81493	81494	alterations	0	None
81494	81495	in	0	None
81495	81496	the	0	None
81496	81497	miRNA	0	None
81497	81498	expression	0	None
81498	81499	profile	0	None
81499	81500	of	0	None
81500	81501	the	0	None
81501	81502	glioma	0	None
81502	81503	cell	0	None
81503	81504	line	0	None
81504	81505	U-251	0	None
81505	81506	caused	0	None
81506	81507	by	0	None
81507	81508	ionizing	0	None
81508	81509	radiation	0	None
81509	81510	(	0	None
81510	81511	IR	0	None
81511	81512	)	0	None
81512	81513	by	0	None
81513	81514	using	0	None
81514	81515	an	0	None
81515	81516	miRNA	0	None
81516	81517	array	0	None
81517	81518	and	0	None
81518	81519	identified	0	None
81519	81520	several	0	None
81520	81521	miRNAs	0	None
81521	81522	whose	0	None
81522	81523	expression	0	None
81523	81524	was	0	None
81524	81525	significantly	0	None
81525	81526	affected	0	None
81526	81527	by	0	None
81527	81528	IR	0	None
81528	81529	.	0	None

81530	81531	Among	0	None
81531	81532	the	0	None
81532	81533	IR-responsive	0	None
81533	81534	miRNAs	0	None
81534	81535	,	0	None
81535	81536	we	0	None
81536	81537	further	0	None
81537	81538	examined	0	None
81538	81539	the	0	None
81539	81540	function	0	None
81540	81541	of	0	None
81541	81542	miR-193a-3p	0	None
81542	81543	,	0	None
81543	81544	which	0	None
81544	81545	exhibited	0	None
81545	81546	the	0	None
81546	81547	most	0	None
81547	81548	significant	0	None
81548	81549	growth-inhibiting	0	None
81549	81550	effect	0	None
81550	81551	.	0	None

81552	81553	miR-193a-3p	0	None
81553	81554	was	0	None
81554	81555	observed	0	None
81555	81556	to	0	None
81556	81557	induce	0	None
81557	81558	apoptosis	0	None
81558	81559	in	0	None
81559	81560	both	0	None
81560	81561	U-251	0	None
81561	81562	and	0	None
81562	81563	HeLa	0	None
81563	81564	cells	0	None
81564	81565	.	0	None

81566	81567	We	0	None
81567	81568	also	0	None
81568	81569	demonstrated	0	None
81569	81570	that	0	None
81570	81571	miR-193a-3p	0	None
81571	81572	induces	0	None
81572	81573	the	0	None
81573	81574	accumulation	0	None
81574	81575	of	0	None
81575	81576	intracellular	0	None
81576	81577	reactive	0	None
81577	81578	oxygen	0	None
81578	81579	species	0	None
81579	81580	(	0	None
81580	81581	ROS	0	None
81581	81582	)	0	None
81582	81583	and	0	None
81583	81584	DNA	0	None
81584	81585	damage	0	None
81585	81586	as	0	None
81586	81587	determined	0	None
81587	81588	by	0	None
81588	81589	the	0	None
81589	81590	level	0	None
81590	81591	of	0	None
81591	81592	γH2AX	0	None
81592	81593	and	0	None
81593	81594	by	0	None
81594	81595	performing	0	None
81595	81596	the	0	None
81596	81597	comet	0	None
81597	81598	assay	0	None
81598	81599	.	0	None

81600	81601	The	0	None
81601	81602	induction	0	None
81602	81603	of	0	None
81603	81604	both	0	None
81604	81605	apoptosis	0	None
81605	81606	and	0	None
81606	81607	DNA	0	None
81607	81608	damage	0	None
81608	81609	by	0	None
81609	81610	miR-193a-3p	0	None
81610	81611	was	0	None
81611	81612	blocked	0	None
81612	81613	by	0	None
81613	81614	antioxidant	0	None
81614	81615	treatment	0	None
81615	81616	,	0	None
81616	81617	indicating	0	None
81617	81618	the	0	None
81618	81619	crucial	0	None
81619	81620	role	0	None
81620	81621	of	0	None
81621	81622	ROS	0	None
81622	81623	in	0	None
81623	81624	the	0	None
81624	81625	action	0	None
81625	81626	of	0	None
81626	81627	miR-193a-3p	0	None
81627	81628	.	0	None

81629	81630	Among	0	None
81630	81631	the	0	None
81631	81632	putative	0	None
81632	81633	target	0	None
81633	81634	proteins	0	None
81634	81635	,	0	None
81635	81636	the	0	None
81636	81637	expression	0	None
81637	81638	of	0	None
81638	81639	Mcl-1	1	GENE-Y
81639	81640	,	0	None
81640	81641	an	0	None
81641	81642	anti-apoptotic	0	None
81642	81643	Bcl-2	1	GENE-Y
81643	81644	family	0	None
81644	81645	member	0	None
81645	81646	,	0	None
81646	81647	decreased	0	None
81647	81648	because	0	None
81648	81649	of	0	None
81649	81650	miR-193a-3p	0	None
81650	81651	transfection	0	None
81651	81652	.	0	None

81653	81654	A	0	None
81654	81655	reporter	0	None
81655	81656	assay	0	None
81656	81657	using	0	None
81657	81658	a	0	None
81658	81659	luciferase	0	None
81659	81660	construct	0	None
81660	81661	containing	0	None
81661	81662	the	0	None
81662	81663	3'-untranslated	0	None
81663	81664	region	0	None
81664	81665	of	0	None
81665	81666	Mcl-1	1	GENE-Y
81666	81667	confirmed	0	None
81667	81668	that	0	None
81668	81669	Mcl-1	1	GENE-Y
81669	81670	is	0	None
81670	81671	a	0	None
81671	81672	direct	0	None
81672	81673	target	0	None
81673	81674	of	0	None
81674	81675	miR-193a-3p	0	None
81675	81676	.	0	None

81677	81678	Down-regulation	0	None
81678	81679	of	0	None
81679	81680	Mcl-1	1	GENE-Y
81680	81681	by	0	None
81681	81682	siRNA	0	None
81682	81683	transfection	0	None
81683	81684	closely	0	None
81684	81685	mimicked	0	None
81685	81686	the	0	None
81686	81687	outcome	0	None
81687	81688	of	0	None
81688	81689	miR-193a-3p	0	None
81689	81690	transfection	0	None
81690	81691	showing	0	None
81691	81692	increased	0	None
81692	81693	ROS	0	None
81693	81694	,	0	None
81694	81695	DNA	0	None
81695	81696	damage	0	None
81696	81697	,	0	None
81697	81698	cytochrome	3	GENE-N
81698	81699	c	0	None
81699	81700	release	0	None
81700	81701	,	0	None
81701	81702	and	0	None
81702	81703	apoptosis	0	None
81703	81704	.	0	None

81705	81706	Ectopic	0	None
81706	81707	expression	0	None
81707	81708	of	0	None
81708	81709	Mcl-1	1	GENE-Y
81709	81710	suppressed	0	None
81710	81711	the	0	None
81711	81712	pro-apoptotic	0	None
81712	81713	action	0	None
81713	81714	of	0	None
81714	81715	miR-193a-3p	0	None
81715	81716	,	0	None
81716	81717	suggesting	0	None
81717	81718	that	0	None
81718	81719	Mcl-1	1	GENE-Y
81719	81720	depletion	0	None
81720	81721	is	0	None
81721	81722	critical	0	None
81722	81723	for	0	None
81723	81724	miR-193a-3p	0	None
81724	81725	induced	0	None
81725	81726	apoptosis	0	None
81726	81727	.	0	None

81728	81729	Collectively	0	None
81729	81730	,	0	None
81730	81731	our	0	None
81731	81732	results	0	None
81732	81733	suggest	0	None
81733	81734	a	0	None
81734	81735	novel	0	None
81735	81736	function	0	None
81736	81737	for	0	None
81737	81738	miR-193a-3p	0	None
81738	81739	and	0	None
81739	81740	its	0	None
81740	81741	potential	0	None
81741	81742	application	0	None
81742	81743	in	0	None
81743	81744	cancer	0	None
81744	81745	therapy	0	None
81745	81746	.	0	None
81746	81747	Binding	0	None
81747	81748	of	0	None
81748	81749	factor	0	None
81749	81750	Xa	0	None
81750	81751	to	0	None
81751	81752	human	0	None
81752	81753	umbilical	0	None
81753	81754	vein	0	None
81754	81755	endothelial	0	None
81755	81756	cells	0	None
81756	81757	(	0	None
81757	81758	HUVEC	0	None
81758	81759	)	0	None
81759	81760	is	0	None
81760	81761	contributed	0	None
81761	81762	by	0	None
81762	81763	effector	0	None
81763	81764	cell	0	None
81764	81765	protease	3	GENE-N
81765	81766	receptor-1	0	None
81766	81767	(	0	None
81767	81768	EPR-1	0	None
81768	81769	)	0	None
81769	81770	.	0	None

81771	81772	The	0	None
81772	81773	structural	0	None
81773	81774	requirements	0	None
81774	81775	of	0	None
81775	81776	this	0	None
81776	81777	recognition	0	None
81777	81778	were	0	None
81778	81779	investigated	0	None
81779	81780	.	0	None

81781	81782	Factor	0	None
81782	81783	Xa	0	None
81783	81784	or	0	None
81784	81785	catalytically	0	None
81785	81786	inactive	0	None
81786	81787	5-dimethylaminonaphthalene-1sulfonyl	0	None
81787	81788	(	0	None
81788	81789	dansyl	0	None
81789	81790	)	0	None
81790	81791	Glu-Gly-Arg-	0	None
81791	81792	(	0	None
81792	81793	DEGR	0	None
81793	81794	)	0	None
81794	81795	-chloromethylketone-factor	0	None
81795	81796	Xa	0	None
81796	81797	bound	0	None
81797	81798	indistinguishably	0	None
81798	81799	to	0	None
81799	81800	HUVEC	0	None
81800	81801	and	0	None
81801	81802	EPR-1	0	None
81802	81803	transfectants	0	None
81803	81804	,	0	None
81804	81805	and	0	None
81805	81806	inhibited	0	None
81806	81807	equally	0	None
81807	81808	well	0	None
81808	81809	the	0	None
81809	81810	binding	0	None
81810	81811	of	0	None
81811	81812	125I-factor	0	None
81812	81813	Xa	0	None
81813	81814	to	0	None
81814	81815	these	0	None
81815	81816	cells	0	None
81816	81817	.	0	None

81818	81819	Similarly	0	None
81819	81820	,	0	None
81820	81821	factor	0	None
81821	81822	Xa	0	None
81822	81823	active	0	None
81823	81824	site	0	None
81824	81825	inhibitors	0	None
81825	81826	TAP	0	None
81826	81827	or	0	None
81827	81828	NAP5	0	None
81828	81829	did	0	None
81829	81830	not	0	None
81830	81831	reduce	0	None
81831	81832	ligand	0	None
81832	81833	binding	0	None
81833	81834	to	0	None
81834	81835	EPR-1	0	None
81835	81836	.	0	None

81837	81838	A	0	None
81838	81839	factor	0	None
81839	81840	X	0	None
81840	81841	peptide	0	None
81841	81842	duplicating	0	None
81842	81843	the	0	None
81843	81844	inter-EGF	0	None
81844	81845	sequence	0	None
81845	81846	Leu83-Phe84-Thr85-Arg86-Lys87-Leu88-	0	None
81846	81847	(	0	None
81847	81848	Gly	2	CHEMICAL
81848	81849	)	0	None
81849	81850	inhibited	0	None
81850	81851	factor	0	None
81851	81852	V	0	None
81852	81853	/	0	None
81853	81854	Va-independent	0	None
81854	81855	prothrombin	0	None
81855	81856	activation	0	None
81856	81857	by	0	None
81857	81858	HUVEC	0	None
81858	81859	and	0	None
81859	81860	blocked	0	None
81860	81861	binding	0	None
81861	81862	of	0	None
81862	81863	125I-factor	0	None
81863	81864	Xa	0	None
81864	81865	to	0	None
81865	81866	these	0	None
81866	81867	cells	0	None
81867	81868	in	0	None
81868	81869	a	0	None
81869	81870	dose-dependent	0	None
81870	81871	manner	0	None
81871	81872	(	0	None
81872	81873	IC50	0	None
81873	81874	approximately	0	None
81874	81875	20-40	0	None
81875	81876	microM	0	None
81876	81877	)	0	None
81877	81878	.	0	None

81879	81880	In	0	None
81880	81881	contrast	0	None
81881	81882	,	0	None
81882	81883	none	0	None
81883	81884	of	0	None
81884	81885	the	0	None
81885	81886	other	0	None
81886	81887	factor	0	None
81887	81888	X	0	None
81888	81889	peptides	0	None
81889	81890	tested	0	None
81890	81891	or	0	None
81891	81892	a	0	None
81892	81893	control	0	None
81893	81894	peptide	0	None
81894	81895	with	0	None
81895	81896	the	0	None
81896	81897	inter-EGF	0	None
81897	81898	sequence	0	None
81898	81899	in	0	None
81899	81900	scrambled	0	None
81900	81901	order	0	None
81901	81902	was	0	None
81902	81903	effective	0	None
81903	81904	.	0	None

81905	81906	A	0	None
81906	81907	recombinant	0	None
81907	81908	chimeric	0	None
81908	81909	molecule	0	None
81909	81910	expressing	0	None
81910	81911	the	0	None
81911	81912	factor	0	None
81912	81913	X	0	None
81913	81914	sequence	0	None
81914	81915	Leu83-Leu88	0	None
81915	81916	within	0	None
81916	81917	a	0	None
81917	81918	factor	0	None
81918	81919	IX	0	None
81919	81920	backbone	0	None
81920	81921	inhibited	0	None
81921	81922	binding	0	None
81922	81923	of	0	None
81923	81924	125I-factor	0	None
81924	81925	Xa	0	None
81925	81926	to	0	None
81926	81927	HUVEC	0	None
81927	81928	and	0	None
81928	81929	EPR-1	0	None
81929	81930	transfectants	0	None
81930	81931	in	0	None
81931	81932	a	0	None
81932	81933	dose-dependent	0	None
81933	81934	fashion	0	None
81934	81935	,	0	None
81935	81936	while	0	None
81936	81937	recombinant	0	None
81937	81938	factor	0	None
81938	81939	IX	0	None
81939	81940	or	0	None
81940	81941	plasma	0	None
81941	81942	IXa	0	None
81942	81943	had	0	None
81943	81944	no	0	None
81944	81945	effect	0	None
81945	81946	.	0	None

81947	81948	An	0	None
81948	81949	antibody	0	None
81949	81950	generated	0	None
81950	81951	against	0	None
81951	81952	the	0	None
81952	81953	factor	0	None
81953	81954	X	0	None
81954	81955	peptide	0	None
81955	81956	83-88	0	None
81956	81957	,	0	None
81957	81958	and	0	None
81958	81959	designated	0	None
81959	81960	JC15	0	None
81960	81961	,	0	None
81961	81962	inhibited	0	None
81962	81963	125I-factor	0	None
81963	81964	Xa	0	None
81964	81965	binding	0	None
81965	81966	to	0	None
81966	81967	HUVEC	0	None
81967	81968	.	0	None

81969	81970	The	0	None
81970	81971	JC15	0	None
81971	81972	antibody	0	None
81972	81973	bound	0	None
81973	81974	to	0	None
81974	81975	factor	0	None
81975	81976	Xa	0	None
81976	81977	and	0	None
81977	81978	the	0	None
81978	81979	recombinant	0	None
81979	81980	IX	0	None
81980	81981	/	0	None
81981	81982	X83-88	0	None
81982	81983	chimera	0	None
81983	81984	in	0	None
81984	81985	a	0	None
81985	81986	concentration	0	None
81986	81987	dependent	0	None
81987	81988	manner	0	None
81988	81989	,	0	None
81989	81990	while	0	None
81990	81991	no	0	None
81991	81992	specific	0	None
81992	81993	reactivity	0	None
81993	81994	with	0	None
81994	81995	factors	0	None
81995	81996	X	0	None
81996	81997	or	0	None
81997	81998	IXa	0	None
81998	81999	was	0	None
81999	82000	observed	0	None
82000	82001	.	0	None

82002	82003	Furthermore	0	None
82003	82004	,	0	None
82004	82005	binding	0	None
82005	82006	of	0	None
82006	82007	125I-factor	0	None
82007	82008	Xa	0	None
82008	82009	to	0	None
82009	82010	immobilized	0	None
82010	82011	JC15	0	None
82011	82012	was	0	None
82012	82013	inhibited	0	None
82013	82014	by	0	None
82014	82015	molar	0	None
82015	82016	excess	0	None
82016	82017	of	0	None
82017	82018	unlabeled	0	None
82018	82019	factor	0	None
82019	82020	Xa	0	None
82020	82021	,	0	None
82021	82022	but	0	None
82022	82023	not	0	None
82023	82024	by	0	None
82024	82025	comparable	0	None
82025	82026	concentrations	0	None
82026	82027	of	0	None
82027	82028	factors	0	None
82028	82029	X	0	None
82029	82030	or	0	None
82030	82031	IXa	0	None
82031	82032	.	0	None

82033	82034	These	0	None
82034	82035	findings	0	None
82035	82036	identify	0	None
82036	82037	the	0	None
82037	82038	inter-EGF	0	None
82038	82039	sequence	0	None
82039	82040	Leu83-Leu88	0	None
82040	82041	in	0	None
82041	82042	factor	0	None
82042	82043	Xa	0	None
82043	82044	as	0	None
82044	82045	a	0	None
82045	82046	novel	0	None
82046	82047	recognition	0	None
82047	82048	site	0	None
82048	82049	for	0	None
82049	82050	EPR-1	0	None
82050	82051	,	0	None
82051	82052	and	0	None
82052	82053	suggest	0	None
82053	82054	its	0	None
82054	82055	potential	0	None
82055	82056	role	0	None
82056	82057	as	0	None
82057	82058	a	0	None
82058	82059	protease	3	GENE-N
82059	82060	activation-dependent	0	None
82060	82061	neo-epitope	0	None
82061	82062	.	0	None

82063	82064	This	0	None
82064	82065	interacting	0	None
82065	82066	motif	0	None
82066	82067	may	0	None
82067	82068	help	0	None
82068	82069	elucidate	0	None
82069	82070	the	0	None
82070	82071	contribution	0	None
82071	82072	of	0	None
82072	82073	factor	0	None
82073	82074	Xa	0	None
82074	82075	to	0	None
82075	82076	cellular	0	None
82076	82077	assembly	0	None
82077	82078	of	0	None
82078	82079	coagulation	0	None
82079	82080	and	0	None
82080	82081	vascular	0	None
82081	82082	injury	0	None
82082	82083	.	0	None
82083	82084	Demonstration	0	None
82084	82085	of	0	None
82085	82086	histamine	2	CHEMICAL
82086	82087	receptors	0	None
82087	82088	on	0	None
82088	82089	human	0	None
82089	82090	platelets	0	None
82090	82091	by	0	None
82091	82092	flow	0	None
82092	82093	cytometry	0	None
82093	82094	.	0	None
82094	82095	Nerve	0	None
82095	82096	Terminal	0	None
82096	82097	GABAA	3	GENE-N
82097	82098	Receptors	0	None
82098	82099	Activate	0	None
82099	82100	Ca2	0	None
82100	82101	+	0	None
82101	82102	/	0	None
82102	82103	Calmodulin-dependent	0	None
82103	82104	Signaling	0	None
82104	82105	to	0	None
82105	82106	Inhibit	0	None
82106	82107	Voltage-gated	0	None
82107	82108	Ca2	0	None
82108	82109	+	0	None
82109	82110	Influx	0	None
82110	82111	and	0	None
82111	82112	Glutamate	0	None
82112	82113	Release	0	None
82113	82114	.	0	None
82114	82115	Mechanisms	0	None
82115	82116	of	0	None
82116	82117	Pharmacokinetic	0	None
82117	82118	Enhancement	0	None
82118	82119	Between	0	None
82119	82120	Ritonavir	0	None
82120	82121	and	0	None
82121	82122	Saquinavir;	0	None
82122	82123	Micro	0	None
82123	82124	/	0	None
82124	82125	Small	0	None
82125	82126	Dosing	0	None
82126	82127	Tests	0	None
82127	82128	Using	0	None
82128	82129	Midazolam	0	None
82129	82130	(	0	None
82130	82131	CYP3A4	0	None
82131	82132	)	0	None
82132	82133	,	0	None
82133	82134	Fexofenadine	2	CHEMICAL
82134	82135	(	0	None
82135	82136	p-Glycoprotein	0	None
82136	82137	)	0	None
82137	82138	,	0	None
82138	82139	and	0	None
82139	82140	Pravastatin	2	CHEMICAL
82140	82141	(	0	None
82141	82142	OATP1B1	0	None
82142	82143	)	0	None
82143	82144	as	0	None
82144	82145	Probe	0	None
82145	82146	Drugs	0	None
82146	82147	.	0	None
82147	82148	Herbicidal	0	None
82148	82149	inhibitors	0	None
82149	82150	of	0	None
82150	82152	amino acid	2	CHEMICAL
82152	82153	biosynthesis	0	None
82153	82154	and	0	None
82154	82155	herbicide-tolerant	0	None
82155	82156	crops	0	None
82156	82157	.	0	None
82157	82158	Anti-inflammatory	0	None
82158	82159	effects	0	None
82159	82160	of	0	None
82160	82161	a	0	None
82161	82162	special	0	None
82162	82163	carbohydrate-whey	0	None
82163	82164	protein	0	None
82164	82165	cake	0	None
82165	82166	after	0	None
82166	82167	exhaustive	0	None
82167	82168	cycling	0	None
82168	82169	in	0	None
82169	82170	humans	0	None
82170	82171	.	0	None
82171	82172	Alteration	0	None
82172	82173	of	0	None
82173	82174	gastric	0	None
82174	82175	functions	0	None
82175	82176	and	0	None
82176	82177	candidate	0	None
82177	82178	genes	0	None
82178	82179	associated	0	None
82179	82180	with	0	None
82180	82181	weight	0	None
82181	82182	reduction	0	None
82182	82183	in	0	None
82183	82184	response	0	None
82184	82185	to	0	None
82185	82186	sibutramine	0	None
82186	82187	.	0	None
82187	82188	Antioxidant	0	None
82188	82189	capacity	0	None
82189	82190	,	0	None
82190	82191	polyphenolic	2	CHEMICAL
82191	82192	content	0	None
82192	82193	and	0	None
82193	82194	tandem	0	None
82194	82195	HPLC-DAD-ESI	0	None
82195	82196	/	0	None
82196	82197	MS	0	None
82197	82198	profiling	0	None
82198	82199	of	0	None
82199	82200	phenolic	0	None
82200	82201	compounds	0	None
82201	82202	from	0	None
82202	82203	the	0	None
82203	82204	South	0	None
82204	82205	American	0	None
82205	82206	berries	0	None
82206	82207	Luma	0	None
82207	82208	apiculata	0	None
82208	82209	and	0	None
82209	82210	L	0	None
82210	82211	.	0	None

82212	82213	chequén	0	None
82213	82214	.	0	None
82214	82215	Characterization	0	None
82215	82216	of	0	None
82216	82218	efflux transporters	3	GENE-N
82218	82219	involved	0	None
82219	82220	in	0	None
82220	82221	distribution	0	None
82221	82222	and	0	None
82222	82223	disposition	0	None
82223	82224	of	0	None
82224	82225	apixaban	2	CHEMICAL
82225	82226	.	0	None
82226	82227	NLRP3	0	None
82227	82228	inflammasome	0	None
82228	82229	has	0	None
82229	82230	been	0	None
82230	82231	reported	0	None
82231	82232	to	0	None
82232	82233	be	0	None
82233	82234	associated	0	None
82234	82235	with	0	None
82235	82236	various	0	None
82236	82237	kinds	0	None
82237	82238	of	0	None
82238	82239	immunological	0	None
82239	82240	diseases	0	None
82240	82241	including	0	None
82241	82242	colitis	0	None
82242	82243	.	0	None

82244	82245	However	0	None
82245	82246	,	0	None
82246	82247	there	0	None
82247	82248	are	0	None
82248	82249	few	0	None
82249	82250	drug	0	None
82250	82251	candidates	0	None
82251	82252	targeting	0	None
82252	82253	inflammasomes	0	None
82253	82254	for	0	None
82254	82255	the	0	None
82255	82256	treatment	0	None
82256	82257	of	0	None
82257	82258	colitis	0	None
82258	82259	.	0	None

82260	82261	In	0	None
82261	82262	the	0	None
82262	82263	present	0	None
82263	82264	study	0	None
82264	82265	,	0	None
82265	82266	we	0	None
82266	82267	aimed	0	None
82267	82268	at	0	None
82268	82269	examining	0	None
82269	82270	the	0	None
82270	82271	effect	0	None
82271	82272	of	0	None
82272	82273	1-ethyl-5-methyl-2-phenyl-1H-benzo	0	None
82273	82274	[	0	None
82274	82275	d	0	None
82275	82276	]	0	None
82276	82277	imidazole	2	CHEMICAL
82277	82278	,	0	None
82278	82279	a	0	None
82279	82280	synthetic	0	None
82280	82281	small	0	None
82281	82282	molecular	0	None
82282	82283	compound	0	None
82283	82284	also	0	None
82284	82285	named	0	None
82285	82286	Fc11a-2	0	None
82286	82287	,	0	None
82287	82288	for	0	None
82288	82289	the	0	None
82289	82290	treatment	0	None
82290	82291	of	0	None
82291	82292	dextran	0	None
82292	82293	sulfate	2	CHEMICAL
82293	82294	sodium	2	CHEMICAL
82294	82295	(	0	None
82295	82296	DSS	0	None
82296	82297	)	0	None
82297	82298	-induced	0	None
82298	82299	experimental	0	None
82299	82300	colitis	0	None
82300	82301	in	0	None
82301	82302	mice	0	None
82302	82303	via	0	None
82303	82304	targeting	0	None
82304	82305	NLRP3	0	None
82305	82306	inflammasome	0	None
82306	82307	.	0	None

82308	82309	Treatment	0	None
82309	82310	with	0	None
82310	82311	Fc11a-2	0	None
82311	82312	dose-dependently	0	None
82312	82313	attenuated	0	None
82313	82314	the	0	None
82314	82315	loss	0	None
82315	82316	of	0	None
82316	82317	body	0	None
82317	82318	weight	0	None
82318	82319	and	0	None
82319	82320	shortening	0	None
82320	82321	of	0	None
82321	82322	colon	0	None
82322	82323	length	0	None
82323	82324	induced	0	None
82324	82325	by	0	None
82325	82326	DSS	0	None
82326	82327	.	0	None

82328	82329	In	0	None
82329	82330	addition	0	None
82330	82331	,	0	None
82331	82332	the	0	None
82332	82333	disease	0	None
82333	82334	activity	0	None
82334	82335	index	0	None
82335	82336	,	0	None
82336	82337	histopathologic	0	None
82337	82338	scores	0	None
82338	82339	and	0	None
82339	82340	myeloperoxidase	0	None
82340	82341	activity	0	None
82341	82342	were	0	None
82342	82343	also	0	None
82343	82344	significantly	0	None
82344	82345	reduced	0	None
82345	82346	by	0	None
82346	82347	Fc11a-2	0	None
82347	82348	treatment	0	None
82348	82349	.	0	None

82350	82351	Moreover	0	None
82351	82352	,	0	None
82352	82353	protein	0	None
82353	82354	and	0	None
82354	82355	mRNA	0	None
82355	82356	levels	0	None
82356	82357	of	0	None
82357	82358	DSS-induced	0	None
82358	82359	proinflammatory	0	None
82359	82360	cytokines	3	GENE-N
82360	82361	in	0	None
82361	82362	colon	0	None
82362	82363	,	0	None
82363	82364	including	0	None
82364	82365	TNF-α	0	None
82365	82366	,	0	None
82366	82367	IL-1β	0	None
82367	82368	,	0	None
82368	82369	IL-18	0	None
82369	82370	,	0	None
82370	82371	IL-17A	0	None
82371	82372	and	0	None
82372	82373	IFN-γ	0	None
82373	82374	,	0	None
82374	82375	were	0	None
82375	82376	markedly	0	None
82376	82377	suppressed	0	None
82377	82378	by	0	None
82378	82379	Fc11a-2	0	None
82379	82380	.	0	None

82381	82382	Furthermore	0	None
82382	82383	,	0	None
82383	82384	a	0	None
82384	82385	decreased	0	None
82385	82386	CD11c	0	None
82386	82387	(	0	None
82387	82388	+	0	None
82388	82389	)	0	None
82389	82390	macrophage	0	None
82390	82391	infiltration	0	None
82391	82392	in	0	None
82392	82393	colons	0	None
82393	82394	and	0	None
82394	82395	inactivation	0	None
82395	82396	of	0	None
82396	82397	caspase-1	1	GENE-Y
82397	82398	in	0	None
82398	82399	peritoneal	0	None
82399	82400	macrophages	0	None
82400	82401	were	0	None
82401	82402	detected	0	None
82402	82403	in	0	None
82403	82404	Fc11a-2-treated	0	None
82404	82405	mice	0	None
82405	82406	.	0	None

82407	82408	The	0	None
82408	82409	mechanism	0	None
82409	82410	of	0	None
82410	82411	action	0	None
82411	82412	of	0	None
82412	82413	Fc11a-2	0	None
82413	82414	was	0	None
82414	82415	related	0	None
82415	82416	to	0	None
82416	82417	the	0	None
82417	82418	inhibition	0	None
82418	82419	of	0	None
82419	82420	the	0	None
82420	82421	cleavage	0	None
82421	82422	of	0	None
82422	82423	pro-caspase-1	0	None
82423	82424	,	0	None
82424	82425	pro-IL-1β	0	None
82425	82426	and	0	None
82426	82427	pro-IL-18	0	None
82427	82428	which	0	None
82428	82429	in	0	None
82429	82430	turn	0	None
82430	82431	suppressed	0	None
82431	82432	the	0	None
82432	82433	activation	0	None
82433	82434	of	0	None
82434	82435	NLRP3	0	None
82435	82436	inflammasome	0	None
82436	82437	.	0	None

82438	82439	Taken	0	None
82439	82440	together	0	None
82440	82441	,	0	None
82441	82442	our	0	None
82442	82443	results	0	None
82443	82444	demonstrate	0	None
82444	82445	the	0	None
82445	82446	ability	0	None
82446	82447	of	0	None
82447	82448	Fc11a-2	0	None
82448	82449	to	0	None
82449	82450	inhibit	0	None
82450	82451	NLRP3	0	None
82451	82452	inflammasome	0	None
82452	82453	activation	0	None
82453	82454	and	0	None
82454	82455	its	0	None
82455	82456	potential	0	None
82456	82457	use	0	None
82457	82458	in	0	None
82458	82459	the	0	None
82459	82460	treatment	0	None
82460	82461	of	0	None
82461	82462	inflammatory	0	None
82462	82463	bowel	0	None
82463	82464	diseases	0	None
82464	82465	.	0	None
82465	82466	Abstract	0	None
82466	82467	Context	0	None
82467	82468	:	0	None
82468	82469	Near-Infrared	0	None
82469	82470	(	0	None
82470	82471	NIR	0	None
82471	82472	)	0	None
82472	82473	spectroscopy	0	None
82473	82474	is	0	None
82474	82475	an	0	None
82475	82476	important	0	None
82476	82477	component	0	None
82477	82478	of	0	None
82478	82479	a	0	None
82479	82480	Process	0	None
82480	82481	Analytical	0	None
82481	82482	Technology	0	None
82482	82483	(	0	None
82483	82484	PAT	0	None
82484	82485	)	0	None
82485	82486	toolbox	0	None
82486	82487	and	0	None
82487	82488	is	0	None
82488	82489	a	0	None
82489	82490	key	0	None
82490	82491	technology	0	None
82491	82492	for	0	None
82492	82493	enabling	0	None
82493	82494	the	0	None
82494	82495	rapid	0	None
82495	82496	analysis	0	None
82496	82497	of	0	None
82497	82498	pharmaceutical	0	None
82498	82499	tablets	0	None
82499	82500	.	0	None

82501	82502	Objective	0	None
82502	82503	:	0	None
82503	82504	The	0	None
82504	82505	aim	0	None
82505	82506	of	0	None
82506	82507	this	0	None
82507	82508	research	0	None
82508	82509	work	0	None
82509	82510	was	0	None
82510	82511	to	0	None
82511	82512	develop	0	None
82512	82513	and	0	None
82513	82514	validate	0	None
82514	82515	NIR-chemometric	0	None
82515	82516	methods	0	None
82516	82517	not	0	None
82517	82518	only	0	None
82518	82519	for	0	None
82519	82520	the	0	None
82520	82521	determination	0	None
82521	82522	of	0	None
82522	82523	active	0	None
82523	82524	pharmaceutical	0	None
82524	82525	ingredients	0	None
82525	82526	content	0	None
82526	82527	but	0	None
82527	82528	also	0	None
82528	82529	pharmaceutical	0	None
82529	82530	properties	0	None
82530	82531	(	0	None
82531	82532	crushing	0	None
82532	82533	strength	0	None
82533	82534	,	0	None
82534	82535	disintegration	0	None
82535	82536	time	0	None
82536	82537	)	0	None
82537	82538	of	0	None
82538	82539	meloxicam	0	None
82539	82540	tablets	0	None
82540	82541	.	0	None

82542	82543	Materials	0	None
82543	82544	and	0	None
82544	82545	methods	0	None
82545	82546	:	0	None
82546	82547	The	0	None
82547	82548	development	0	None
82548	82549	of	0	None
82549	82550	the	0	None
82550	82551	method	0	None
82551	82552	for	0	None
82552	82553	active	0	None
82553	82554	content	0	None
82554	82555	assay	0	None
82555	82556	was	0	None
82556	82557	performed	0	None
82557	82558	on	0	None
82558	82559	samples	0	None
82559	82560	corresponding	0	None
82560	82561	to	0	None
82561	82562	80%	0	None
82562	82563	,	0	None
82563	82564	90%	0	None
82564	82565	,	0	None
82565	82566	100%	0	None
82566	82567	,	0	None
82567	82568	110%	0	None
82568	82569	and	0	None
82569	82570	120%	0	None
82570	82571	of	0	None
82571	82572	meloxicam	0	None
82572	82573	content	0	None
82573	82574	and	0	None
82574	82575	the	0	None
82575	82576	development	0	None
82576	82577	of	0	None
82577	82578	the	0	None
82578	82579	methods	0	None
82579	82580	for	0	None
82580	82581	pharmaceutical	0	None
82581	82582	characterization	0	None
82582	82583	was	0	None
82583	82584	performed	0	None
82584	82585	on	0	None
82585	82586	samples	0	None
82586	82587	prepared	0	None
82587	82588	at	0	None
82588	82589	seven	0	None
82589	82590	different	0	None
82590	82591	compression	0	None
82591	82592	forces	0	None
82592	82593	(	0	None
82593	82594	ranging	0	None
82594	82595	from	0	None
82595	82596	7	0	None
82596	82597	to	0	None
82597	82598	45	0	None
82598	82599	kN	0	None
82599	82600	)	0	None
82600	82601	using	0	None
82601	82602	NIR	0	None
82602	82603	transmission	0	None
82603	82604	spectra	0	None
82604	82605	of	0	None
82605	82606	intact	0	None
82606	82607	tablets	0	None
82607	82608	and	0	None
82608	82609	PLS	0	None
82609	82610	as	0	None
82610	82611	a	0	None
82611	82612	regression	0	None
82612	82613	method	0	None
82613	82614	.	0	None

82615	82616	Results	0	None
82616	82617	:	0	None
82617	82618	The	0	None
82618	82619	results	0	None
82619	82620	show	0	None
82620	82621	that	0	None
82621	82622	the	0	None
82622	82623	developed	0	None
82623	82624	methods	0	None
82624	82625	have	0	None
82625	82626	good	0	None
82626	82627	trueness	0	None
82627	82628	,	0	None
82628	82629	precision	0	None
82629	82630	and	0	None
82630	82631	accuracy	0	None
82631	82632	and	0	None
82632	82633	are	0	None
82633	82634	appropriate	0	None
82634	82635	for	0	None
82635	82636	direct	0	None
82636	82637	active	0	None
82637	82638	content	0	None
82638	82639	assay	0	None
82639	82640	in	0	None
82640	82641	tablets	0	None
82641	82642	(	0	None
82642	82643	ranging	0	None
82643	82644	from	0	None
82644	82645	12	0	None
82645	82646	to	0	None
82646	82647	18	0	None
82647	82648	mg	2	CHEMICAL
82648	82649	/	0	None
82649	82650	tablet	0	None
82650	82651	)	0	None
82651	82652	and	0	None
82652	82653	also	0	None
82653	82654	for	0	None
82654	82655	predicting	0	None
82655	82656	crushing	0	None
82656	82657	strength	0	None
82657	82658	and	0	None
82658	82659	disintegration	0	None
82659	82660	time	0	None
82660	82661	of	0	None
82661	82662	intact	0	None
82662	82663	meloxicam	0	None
82663	82664	tablets	0	None
82664	82665	.	0	None

82666	82667	Discussion	0	None
82667	82668	:	0	None
82668	82669	The	0	None
82669	82670	comparative	0	None
82670	82671	data	0	None
82671	82672	show	0	None
82672	82673	that	0	None
82673	82674	the	0	None
82674	82675	proposed	0	None
82675	82676	methods	0	None
82676	82677	are	0	None
82677	82678	in	0	None
82678	82679	good	0	None
82679	82680	agreement	0	None
82680	82681	with	0	None
82681	82682	the	0	None
82682	82683	reference	0	None
82683	82684	methods	0	None
82684	82685	currently	0	None
82685	82686	used	0	None
82686	82687	for	0	None
82687	82688	the	0	None
82688	82689	characterization	0	None
82689	82690	of	0	None
82690	82691	meloxicam	0	None
82691	82692	tablets	0	None
82692	82693	(	0	None
82693	82694	HPLC-UV	0	None
82694	82695	methods	0	None
82695	82696	for	0	None
82696	82697	the	0	None
82697	82698	assay	0	None
82698	82699	and	0	None
82699	82700	European	0	None
82700	82701	Pharmacopeia	0	None
82701	82702	methods	0	None
82702	82703	for	0	None
82703	82704	determining	0	None
82704	82705	the	0	None
82705	82706	crushing	0	None
82706	82707	strength	0	None
82707	82708	and	0	None
82708	82709	disintegration	0	None
82709	82710	time	0	None
82710	82711	)	0	None
82711	82712	.	0	None

82713	82714	Conclusion	0	None
82714	82715	:	0	None
82715	82716	The	0	None
82716	82717	results	0	None
82717	82718	show	0	None
82718	82719	the	0	None
82719	82720	possibility	0	None
82720	82721	to	0	None
82721	82722	predict	0	None
82722	82723	both	0	None
82723	82724	chemical	0	None
82724	82725	properties	0	None
82725	82726	(	0	None
82726	82727	active	0	None
82727	82728	content	0	None
82728	82729	)	0	None
82729	82730	and	0	None
82730	82731	physical	0	None
82731	82732	/	0	None
82732	82733	pharmaceutical	0	None
82733	82734	properties	0	None
82734	82735	(	0	None
82735	82736	crushing	0	None
82736	82737	strength	0	None
82737	82738	and	0	None
82738	82739	disintegration	0	None
82739	82740	time	0	None
82740	82741	)	0	None
82741	82742	directly	0	None
82742	82743	,	0	None
82743	82744	without	0	None
82744	82745	any	0	None
82745	82746	sample	0	None
82746	82747	preparation	0	None
82747	82748	,	0	None
82748	82749	from	0	None
82749	82750	the	0	None
82750	82751	same	0	None
82751	82752	NIR	0	None
82752	82753	transmission	0	None
82753	82754	spectrum	0	None
82754	82755	of	0	None
82755	82756	meloxicam	0	None
82756	82757	tablets	0	None
82757	82758	.	0	None
82758	82759	The	0	None
82759	82760	aryl	0	None
82760	82761	hydrocarbon	0	None
82761	82762	receptor	0	None
82762	82763	is	0	None
82763	82764	a	0	None
82764	82765	member	0	None
82765	82766	of	0	None
82766	82767	the	0	None
82767	82768	basic-helix-loop-helix	0	None
82768	82769	family	0	None
82769	82770	of	0	None
82770	82771	transcription	0	None
82771	82772	factors	0	None
82772	82773	.	0	None

82774	82775	AhR	0	None
82775	82776	mediates	0	None
82776	82777	the	0	None
82777	82778	biochemical	0	None
82778	82779	and	0	None
82779	82780	toxic	0	None
82780	82781	effects	0	None
82781	82782	of	0	None
82782	82783	a	0	None
82783	82784	number	0	None
82784	82785	of	0	None
82785	82787	polyaromatic hydrocarbons	2	CHEMICAL
82787	82788	such	0	None
82788	82789	as	0	None
82789	82790	2	0	None
82790	82791	,	0	None
82791	82792	3	0	None
82792	82793	,	0	None
82793	82794	7	0	None
82794	82795	,	0	None
82795	82796	8	0	None
82796	82797	,	0	None
82797	82798	-tetrachloro-dibenzo-p-dioxin	0	None
82798	82799	(	0	None
82799	82800	TCDD	0	None
82800	82801	)	0	None
82801	82802	.	0	None

82803	82804	AhR	0	None
82804	82805	is	0	None
82805	82806	widely	0	None
82806	82807	known	0	None
82807	82808	for	0	None
82808	82809	regulating	0	None
82809	82810	the	0	None
82810	82811	transcription	0	None
82811	82812	of	0	None
82812	82813	drug	0	None
82813	82814	metabolizing	0	None
82814	82815	enzymes	0	None
82815	82816	involved	0	None
82816	82817	in	0	None
82817	82818	the	0	None
82818	82819	xenobiotic	0	None
82819	82820	metabolism	0	None
82820	82821	of	0	None
82821	82822	carcinogens	0	None
82822	82823	and	0	None
82823	82824	therapeutic	0	None
82824	82825	agents	0	None
82825	82826	,	0	None
82826	82827	such	0	None
82827	82828	as	0	None
82828	82829	cytochrome	3	GENE-N
82829	82830	P450-1B1	0	None
82830	82831	(	0	None
82831	82832	CYP1B1	0	None
82832	82833	)	0	None
82833	82834	.	0	None

82835	82836	Additionally	0	None
82836	82837	,	0	None
82837	82838	AhR	0	None
82838	82839	has	0	None
82839	82840	also	0	None
82840	82841	been	0	None
82841	82842	reported	0	None
82842	82843	to	0	None
82843	82844	interact	0	None
82844	82845	with	0	None
82845	82846	multiple	0	None
82846	82847	signaling	0	None
82847	82848	pathways	0	None
82848	82849	during	0	None
82849	82850	prostate	0	None
82850	82851	development	0	None
82851	82852	.	0	None

82853	82854	Here	0	None
82854	82855	we	0	None
82855	82856	investigate	0	None
82856	82857	the	0	None
82857	82858	effect	0	None
82858	82859	of	0	None
82859	82860	sustained	0	None
82860	82861	AhR	0	None
82861	82862	signaling	0	None
82862	82863	on	0	None
82863	82865	androgen receptor	3	GENE-N
82865	82866	function	0	None
82866	82867	in	0	None
82867	82868	prostate	0	None
82868	82869	cancer	0	None
82869	82870	cells	0	None
82870	82871	.	0	None

82872	82873	Immunoblot	0	None
82873	82874	analysis	0	None
82874	82875	shows	0	None
82875	82876	that	0	None
82876	82877	AhR	0	None
82877	82878	expression	0	None
82878	82879	is	0	None
82879	82880	increased	0	None
82880	82881	in	0	None
82881	82882	androgen	0	None
82882	82883	independent	0	None
82883	82884	(	0	None
82884	82885	C4-2	0	None
82885	82886	)	0	None
82886	82887	prostate	0	None
82887	82888	cancer	0	None
82888	82889	cells	0	None
82889	82890	when	0	None
82890	82891	compared	0	None
82891	82892	to	0	None
82892	82893	androgen	0	None
82893	82894	sensitive	0	None
82894	82895	(	0	None
82895	82896	LNCaP	0	None
82896	82897	)	0	None
82897	82898	cells	0	None
82898	82899	.	0	None

82900	82901	RT-PCR	0	None
82901	82902	studies	0	None
82902	82903	revealed	0	None
82903	82904	constitutive	0	None
82904	82905	AhR	0	None
82905	82906	signaling	0	None
82906	82907	in	0	None
82907	82908	C4-2	0	None
82908	82909	cells	0	None
82909	82910	without	0	None
82910	82911	the	0	None
82911	82912	ligand	0	None
82912	82913	induced	0	None
82913	82914	activation	0	None
82914	82915	required	0	None
82915	82916	in	0	None
82916	82917	LNCaP	0	None
82917	82918	cells	0	None
82918	82919	.	0	None

82920	82921	A	0	None
82921	82922	reduction	0	None
82922	82923	of	0	None
82923	82924	AhR	0	None
82924	82925	activity	0	None
82925	82926	by	0	None
82926	82927	short	0	None
82927	82928	RNA	0	None
82928	82929	mediated	0	None
82929	82930	silencing	0	None
82930	82931	in	0	None
82931	82932	C4-2	0	None
82932	82933	cells	0	None
82933	82934	reduced	0	None
82934	82935	expression	0	None
82935	82936	of	0	None
82936	82937	both	0	None
82937	82938	AhR	0	None
82938	82939	and	0	None
82939	82940	androgen	0	None
82940	82941	responsive	0	None
82941	82942	genes	0	None
82942	82943	.	0	None

82944	82945	The	0	None
82945	82946	decrease	0	None
82946	82947	in	0	None
82947	82948	androgen	0	None
82948	82949	responsive	0	None
82949	82950	genes	0	None
82950	82951	correlates	0	None
82951	82952	to	0	None
82952	82953	a	0	None
82953	82954	decrease	0	None
82954	82955	in	0	None
82955	82956	phosphorylated	0	None
82956	82958	androgen receptor	1	GENE-Y
82958	82959	and	0	None
82959	82961	androgen receptor	1	GENE-Y
82961	82962	expression	0	None
82962	82963	in	0	None
82963	82964	the	0	None
82964	82965	nucleus	0	None
82965	82966	.	0	None

82967	82968	Furthermore	0	None
82968	82969	,	0	None
82969	82970	the	0	None
82970	82971	forced	0	None
82971	82972	decrease	0	None
82972	82973	in	0	None
82973	82974	AhR	0	None
82974	82975	expression	0	None
82975	82976	resulted	0	None
82976	82977	in	0	None
82977	82978	a	0	None
82978	82979	50%	0	None
82979	82980	decline	0	None
82980	82981	in	0	None
82981	82982	the	0	None
82982	82983	growth	0	None
82983	82984	rate	0	None
82984	82985	of	0	None
82985	82986	C4-2	0	None
82986	82987	cells	0	None
82987	82988	.	0	None

82989	82990	These	0	None
82990	82991	data	0	None
82991	82992	indicates	0	None
82992	82993	that	0	None
82993	82994	AhR	0	None
82994	82995	is	0	None
82995	82996	required	0	None
82996	82997	to	0	None
82997	82998	maintain	0	None
82998	82999	hormone	0	None
82999	83000	independent	0	None
83000	83001	signaling	0	None
83001	83002	and	0	None
83002	83003	growth	0	None
83003	83004	by	0	None
83004	83005	the	0	None
83005	83007	androgen receptor	1	GENE-Y
83007	83008	in	0	None
83008	83009	C4-2	0	None
83009	83010	cells	0	None
83010	83011	.	0	None

83012	83013	Collectively	0	None
83013	83014	,	0	None
83014	83015	these	0	None
83015	83016	data	0	None
83016	83017	provide	0	None
83017	83018	evidence	0	None
83018	83019	of	0	None
83019	83020	a	0	None
83020	83021	direct	0	None
83021	83022	role	0	None
83022	83023	for	0	None
83023	83024	AhR	0	None
83024	83025	in	0	None
83025	83026	androgen	0	None
83026	83027	independent	0	None
83027	83028	signaling	0	None
83028	83029	and	0	None
83029	83030	provides	0	None
83030	83031	insight	0	None
83031	83032	into	0	None
83032	83033	the	0	None
83033	83034	molecular	0	None
83034	83035	mechanisms	0	None
83035	83036	responsible	0	None
83036	83037	for	0	None
83037	83038	sustained	0	None
83038	83040	androgen receptor	3	GENE-N
83040	83041	signaling	0	None
83041	83042	in	0	None
83042	83043	hormone	0	None
83043	83044	refractory	0	None
83044	83045	prostate	0	None
83045	83046	cancer	0	None
83046	83047	.	0	None
83047	83048	Claudin-3	0	None
83048	83049	and	0	None
83049	83050	claudin-4	0	None
83050	83051	regulate	0	None
83051	83052	sensitivity	0	None
83052	83053	to	0	None
83053	83054	cisplatin	0	None
83054	83055	by	0	None
83055	83056	controlling	0	None
83056	83057	expression	0	None
83057	83058	of	0	None
83058	83059	the	0	None
83059	83060	copper	0	None
83060	83061	and	0	None
83061	83062	cisplatin	0	None
83062	83063	influx	0	None
83063	83064	transporter	0	None
83064	83065	CTR1	0	None
83065	83066	.	0	None
83066	83067	Juglone	0	None
83067	83068	,	0	None
83068	83069	isolated	0	None
83069	83070	from	0	None
83070	83071	Juglans	0	None
83071	83072	mandshurica	0	None
83072	83073	Maxim	0	None
83073	83074	,	0	None
83074	83075	induces	0	None
83075	83076	apoptosis	0	None
83076	83077	via	0	None
83077	83078	down-regulation	0	None
83078	83079	of	0	None
83079	83080	AR	0	None
83080	83081	expression	0	None
83081	83082	in	0	None
83082	83083	human	0	None
83083	83084	prostate	0	None
83084	83085	cancer	0	None
83085	83086	LNCaP	0	None
83086	83087	cells	0	None
83087	83088	.	0	None
83088	83089	A	0	None
83089	83090	convective	0	None
83090	83091	replica-exchange	0	None
83091	83092	method	0	None
83092	83093	for	0	None
83093	83094	sampling	0	None
83094	83095	new	0	None
83095	83096	energy	0	None
83096	83097	basins	0	None
83097	83098	.	0	None
83098	83099	Comparative	0	None
83099	83100	efficacy	0	None
83100	83101	and	0	None
83101	83102	safety	0	None
83102	83103	of	0	None
83103	83104	the	0	None
83104	83105	novel	0	None
83105	83106	oral	0	None
83106	83107	anticoagulants	0	None
83107	83108	dabigatran	0	None
83108	83109	,	0	None
83109	83110	rivaroxaban	0	None
83110	83111	and	0	None
83111	83112	apixaban	2	CHEMICAL
83112	83113	in	0	None
83113	83114	preclinical	0	None
83114	83115	and	0	None
83115	83116	clinical	0	None
83116	83117	development	0	None
83117	83118	.	0	None
83118	83119	The	0	None
83119	83120	tricyclic	0	None
83120	83121	antidepressant	0	None
83121	83122	clomipramine	2	CHEMICAL
83122	83123	increases	0	None
83123	83124	plasma	0	None
83124	83125	glucose	0	None
83125	83126	levels	0	None
83126	83127	of	0	None
83127	83128	mice	0	None
83128	83129	.	0	None
83129	83130	OBJECTIVE	0	None
83130	83131	:	0	None
83131	83132	The	0	None
83132	83133	following	0	None
83133	83134	study	0	None
83134	83135	was	0	None
83135	83136	performed	0	None
83136	83137	to	0	None
83137	83138	evaluate	0	None
83138	83139	the	0	None
83139	83140	importance	0	None
83140	83141	of	0	None
83141	83142	phosphodiesterases	0	None
83142	83143	3A	0	None
83143	83144	(	0	None
83144	83145	PDE3A	0	None
83145	83146	)	0	None
83146	83147	and	0	None
83147	83148	5A	0	None
83148	83149	(	0	None
83149	83150	PDE5A	0	None
83150	83151	)	0	None
83151	83152	for	0	None
83152	83153	the	0	None
83153	83154	regulation	0	None
83154	83155	of	0	None
83155	83156	penile	0	None
83156	83157	smooth	0	None
83157	83158	muscle	0	None
83158	83159	tone	0	None
83159	83160	.	0	None

83161	83162	Furthermore	0	None
83162	83163	,	0	None
83163	83164	indications	0	None
83164	83165	of	0	None
83165	83166	side	0	None
83166	83167	effects	0	None
83167	83168	of	0	None
83168	83169	specific	0	None
83169	83170	inhibitors	0	None
83170	83171	in	0	None
83171	83172	certain	0	None
83172	83173	tissues	0	None
83173	83174	as	0	None
83174	83175	well	0	None
83175	83176	as	0	None
83176	83177	of	0	None
83177	83178	a	0	None
83178	83179	possible	0	None
83179	83180	relation	0	None
83180	83181	between	0	None
83181	83182	the	0	None
83182	83183	level	0	None
83183	83184	of	0	None
83184	83185	PDE3A	0	None
83185	83186	and	0	None
83186	83187	PDE5A	0	None
83187	83188	gene	0	None
83188	83189	expression	0	None
83189	83190	and	0	None
83190	83191	erectile	0	None
83191	83192	dysfunction	0	None
83192	83193	should	0	None
83193	83194	have	0	None
83194	83195	been	0	None
83195	83196	deduced	0	None
83196	83197	from	0	None
83197	83198	the	0	None
83198	83199	results	0	None
83199	83200	obtained	0	None
83200	83201	.	0	None

83202	83203	METHODS	0	None
83203	83204	:	0	None
83204	83205	Total	0	None
83205	83206	ribonucleic	0	None
83206	83207	acid	0	None
83207	83208	was	0	None
83208	83209	isolated	0	None
83209	83210	from	0	None
83210	83211	different	0	None
83211	83212	human	0	None
83212	83213	tissues	0	None
83213	83214	(	0	None
83214	83215	urogenital	0	None
83215	83216	tract	0	None
83216	83217	,	0	None
83217	83218	gastrointestinal	0	None
83218	83219	tract	0	None
83219	83220	,	0	None
83220	83221	cardiovascular	0	None
83221	83222	system	0	None
83222	83223	and	0	None
83223	83224	central	0	None
83224	83225	nervous	0	None
83225	83226	system	0	None
83226	83227	)	0	None
83227	83228	and	0	None
83228	83229	subjected	0	None
83229	83230	to	0	None
83230	83231	RTPCR	0	None
83231	83232	analysis	0	None
83232	83233	and	0	None
83233	83234	Northern	0	None
83234	83235	blotting	0	None
83235	83236	using	0	None
83236	83237	primers	0	None
83237	83238	and	0	None
83238	83239	probes	0	None
83239	83240	specific	0	None
83240	83241	for	0	None
83241	83242	PDE3A	0	None
83242	83243	and	0	None
83243	83244	PDE5A	0	None
83244	83245	.	0	None

83246	83247	RESULTS	0	None
83247	83248	:	0	None
83248	83249	As	0	None
83249	83250	shown	0	None
83250	83251	by	0	None
83251	83252	RT-PCR	0	None
83252	83253	and	0	None
83253	83254	Northern	0	None
83254	83255	blotting	0	None
83255	83256	,	0	None
83256	83257	PDE3A	0	None
83257	83258	and	0	None
83258	83259	PDE5A	0	None
83259	83260	mRNAs	0	None
83260	83261	exhibit	0	None
83261	83262	a	0	None
83262	83263	distinct	0	None
83263	83264	distribution	0	None
83264	83265	throughout	0	None
83265	83266	the	0	None
83266	83267	tissues	0	None
83267	83268	examined	0	None
83268	83269	but	0	None
83269	83270	were	0	None
83270	83271	2-fold	0	None
83271	83272	higher	0	None
83272	83273	in	0	None
83273	83274	cavernous	0	None
83274	83275	tissue	0	None
83275	83276	than	0	None
83276	83277	in	0	None
83277	83278	all	0	None
83278	83279	other	0	None
83279	83280	tissues	0	None
83280	83281	investigated	0	None
83281	83282	.	0	None

83283	83284	However	0	None
83284	83285	,	0	None
83285	83286	there	0	None
83286	83287	were	0	None
83287	83288	no	0	None
83288	83289	significant	0	None
83289	83290	differences	0	None
83290	83291	in	0	None
83291	83292	the	0	None
83292	83293	levels	0	None
83293	83294	of	0	None
83294	83295	gene	0	None
83295	83296	expression	0	None
83296	83297	between	0	None
83297	83298	the	0	None
83298	83299	two	0	None
83299	83300	subgroups	0	None
83300	83301	of	0	None
83301	83302	patients	0	None
83302	83303	.	0	None

83304	83305	CONCLUSIONS	0	None
83305	83306	:	0	None
83306	83307	Very	0	None
83307	83308	high	0	None
83308	83309	expression	0	None
83309	83310	levels	0	None
83310	83311	of	0	None
83311	83312	PDE3A	0	None
83312	83313	and	0	None
83313	83314	PDE5A	0	None
83314	83315	in	0	None
83315	83316	human	0	None
83316	83317	cavernous	0	None
83317	83318	tissue	0	None
83318	83319	underscore	0	None
83319	83320	the	0	None
83320	83321	physiological	0	None
83321	83322	importance	0	None
83322	83323	of	0	None
83323	83324	these	0	None
83324	83325	enzymes	0	None
83325	83326	for	0	None
83326	83327	the	0	None
83327	83328	regulation	0	None
83328	83329	of	0	None
83329	83330	penile	0	None
83330	83331	erection	0	None
83331	83332	,	0	None
83332	83333	emphasizing	0	None
83333	83334	their	0	None
83334	83335	therapeutical	0	None
83335	83336	and	0	None
83336	83337	pharmacological	0	None
83337	83338	relevance	0	None
83338	83339	.	0	None

83340	83341	The	0	None
83341	83342	distribution	0	None
83342	83343	pattern	0	None
83343	83344	of	0	None
83344	83345	the	0	None
83345	83346	mRNA	0	None
83346	83347	for	0	None
83347	83348	the	0	None
83348	83349	isoenzymes	0	None
83349	83350	PDE3A	0	None
83350	83351	and	0	None
83351	83352	PDE5A	0	None
83352	83353	may	0	None
83353	83354	explain	0	None
83354	83355	the	0	None
83355	83356	pharmacological	0	None
83356	83357	effects	0	None
83357	83358	as	0	None
83358	83359	well	0	None
83359	83360	as	0	None
83360	83361	the	0	None
83361	83362	side	0	None
83362	83363	effects	0	None
83363	83364	of	0	None
83364	83365	milrinone	2	CHEMICAL
83365	83366	and	0	None
83366	83367	sidenafil	0	None
83367	83368	.	0	None
83368	83369	Alpha	0	None
83369	83370	2u-globulin	0	None
83370	83371	mediated	0	None
83371	83372	hyaline	0	None
83372	83373	droplet	0	None
83373	83374	nephropathy	0	None
83374	83375	(	0	None
83375	83376	HDN	0	None
83376	83377	)	0	None
83377	83378	is	0	None
83378	83379	a	0	None
83379	83380	male	0	None
83380	83381	rat	0	None
83381	83382	specific	0	None
83382	83383	lesion	0	None
83383	83384	induced	0	None
83384	83385	when	0	None
83385	83386	a	0	None
83386	83387	compound	0	None
83387	83388	or	0	None
83388	83389	metabolite	0	None
83389	83390	binds	0	None
83390	83391	to	0	None
83391	83393	alpha 2u-globulin	1	GENE-Y
83393	83394	.	0	None

83395	83396	The	0	None
83396	83397	objective	0	None
83397	83398	of	0	None
83398	83399	this	0	None
83399	83400	study	0	None
83400	83401	was	0	None
83401	83402	to	0	None
83402	83403	investigate	0	None
83403	83404	if	0	None
83404	83405	the	0	None
83405	83406	newer	0	None
83406	83407	and	0	None
83407	83408	more	0	None
83408	83409	sensitive	0	None
83409	83410	renal	0	None
83410	83411	biomarkers	0	None
83411	83412	would	0	None
83412	83413	be	0	None
83413	83414	altered	0	None
83414	83415	with	0	None
83415	83416	HDN	0	None
83416	83417	as	0	None
83417	83418	well	0	None
83418	83419	as	0	None
83419	83420	be	0	None
83420	83421	able	0	None
83421	83422	to	0	None
83422	83423	distinguish	0	None
83423	83424	between	0	None
83424	83425	HDN	0	None
83425	83426	and	0	None
83426	83427	oxidative	0	None
83427	83428	stress-induced	0	None
83428	83429	kidney	0	None
83429	83430	injury	0	None
83430	83431	.	0	None

83432	83433	Rats	0	None
83433	83434	were	0	None
83434	83435	dosed	0	None
83435	83436	orally	0	None
83436	83437	for	0	None
83437	83438	7	0	None
83438	83439	days	0	None
83439	83440	to	0	None
83440	83441	determine	0	None
83441	83442	(	0	None
83442	83443	1	0	None
83443	83444	)	0	None
83444	83445	if	0	None
83445	83446	HDN	0	None
83446	83447	(	0	None
83447	83448	induced	0	None
83448	83449	by	0	None
83449	83450	2-propanol	0	None
83450	83451	or	0	None
83451	83452	D-limonene	0	None
83452	83453	)	0	None
83453	83454	altered	0	None
83454	83455	the	0	None
83455	83456	newer	0	None
83456	83457	renal	0	None
83457	83458	biomarkers	0	None
83458	83459	and	0	None
83459	83460	not	0	None
83460	83461	BUN	0	None
83461	83462	or	0	None
83462	83463	creatinine	0	None
83463	83464	,	0	None
83464	83465	(	0	None
83465	83466	2	0	None
83466	83467	)	0	None
83467	83468	if	0	None
83468	83469	renal	0	None
83469	83470	biomarkers	0	None
83470	83471	could	0	None
83471	83472	distinguish	0	None
83472	83473	between	0	None
83473	83474	HDN	0	None
83474	83475	and	0	None
83475	83476	oxidative	0	None
83476	83477	stress-induced	0	None
83477	83478	kidney	0	None
83478	83479	injury	0	None
83479	83480	(	0	None
83480	83481	induced	0	None
83481	83482	by	0	None
83482	83483	potassium	0	None
83483	83484	bromate	0	None
83484	83485	)	0	None
83485	83486	,	0	None
83486	83487	(	0	None
83487	83488	3	0	None
83488	83489	)	0	None
83489	83490	sensitivity	0	None
83490	83491	of	0	None
83491	83492	HDN-induced	0	None
83492	83493	renal	0	None
83493	83494	biomarker	0	None
83494	83495	changes	0	None
83495	83496	relative	0	None
83496	83497	to	0	None
83497	83498	D-limonene	0	None
83498	83499	dose	0	None
83499	83500	,	0	None
83500	83501	and	0	None
83501	83502	(	0	None
83502	83503	4	0	None
83503	83504	)	0	None
83504	83505	reversibility	0	None
83505	83506	of	0	None
83506	83507	HDN	0	None
83507	83508	and	0	None
83508	83509	renal	0	None
83509	83510	biomarkers	0	None
83510	83511	,	0	None
83511	83512	using	0	None
83512	83513	vehicle	0	None
83513	83514	or	0	None
83514	83515	300	0	None
83515	83516	mg	2	CHEMICAL
83516	83517	/	0	None
83517	83518	kg	0	None
83518	83519	/	0	None
83519	83520	day	0	None
83520	83521	D-limonene	0	None
83521	83522	with	0	None
83522	83523	7	0	None
83523	83524	days	0	None
83524	83525	of	0	None
83525	83526	dosing	0	None
83526	83527	and	0	None
83527	83528	necropsies	0	None
83528	83529	scheduled	0	None
83529	83530	over	0	None
83530	83531	the	0	None
83531	83532	period	0	None
83532	83533	of	0	None
83533	83534	Days	0	None
83534	83535	8-85	0	None
83535	83536	.	0	None

83537	83538	HDN-induced	0	None
83538	83539	renal	0	None
83539	83540	biomarker	0	None
83540	83541	changes	0	None
83541	83542	in	0	None
83542	83543	male	0	None
83543	83544	rats	0	None
83544	83545	were	0	None
83545	83546	potentially	0	None
83546	83547	compound	0	None
83547	83548	specific	0	None
83548	83549	:	0	None
83549	83550	(	0	None
83550	83551	1	0	None
83551	83552	)	0	None
83552	83553	2-propanol	0	None
83553	83554	induced	0	None
83554	83555	mild	0	None
83555	83556	HDN	0	None
83556	83557	without	0	None
83557	83558	increased	0	None
83558	83559	renal	0	None
83559	83560	biomarkers	0	None
83560	83561	,	0	None
83561	83562	(	0	None
83562	83563	2	0	None
83563	83564	)	0	None
83564	83565	potassium	0	None
83565	83566	bromate	0	None
83566	83567	induced	0	None
83567	83568	moderate	0	None
83568	83569	HDN	0	None
83569	83570	with	0	None
83570	83571	increased	0	None
83571	83572	clusterin	1	GENE-Y
83572	83573	,	0	None
83573	83574	and	0	None
83574	83575	(	0	None
83575	83576	3	0	None
83576	83577	)	0	None
83577	83578	D-limonene	0	None
83578	83579	induced	0	None
83579	83580	marked	0	None
83580	83581	HDN	0	None
83581	83582	with	0	None
83582	83583	increased	0	None
83583	83584	αGST	0	None
83584	83585	,	0	None
83585	83586	μGST	0	None
83586	83587	and	0	None
83587	83588	albumin	0	None
83588	83589	.	0	None

83590	83591	Administration	0	None
83591	83592	of	0	None
83592	83593	potassium	0	None
83593	83594	bromate	0	None
83594	83595	did	0	None
83595	83596	not	0	None
83596	83597	result	0	None
83597	83598	in	0	None
83598	83599	oxidative	0	None
83599	83600	stress-induced	0	None
83600	83601	kidney	0	None
83601	83602	injury	0	None
83602	83603	,	0	None
83603	83604	based	0	None
83604	83605	on	0	None
83605	83606	histopathology	0	None
83606	83607	and	0	None
83607	83608	renal	0	None
83608	83609	biomarkers	0	None
83609	83610	creatinine	0	None
83610	83611	and	0	None
83611	83612	BUN	0	None
83612	83613	.	0	None

83614	83615	The	0	None
83615	83616	compound	0	None
83616	83617	D-limonene	0	None
83617	83618	induced	0	None
83618	83619	a	0	None
83619	83620	dose	0	None
83620	83621	dependent	0	None
83621	83622	increase	0	None
83622	83623	in	0	None
83623	83624	HDN	0	None
83624	83625	severity	0	None
83625	83626	and	0	None
83626	83627	renal	0	None
83627	83628	biomarker	0	None
83628	83629	changes	0	None
83629	83630	without	0	None
83630	83631	altering	0	None
83631	83632	BUN	0	None
83632	83633	,	0	None
83633	83634	creatinine	0	None
83634	83635	or	0	None
83635	83636	NAG	0	None
83636	83637	:	0	None
83637	83638	(	0	None
83638	83639	1	0	None
83639	83640	)	0	None
83640	83641	minimal	0	None
83641	83642	induction	0	None
83642	83643	of	0	None
83643	83644	HDN	0	None
83644	83645	and	0	None
83645	83646	no	0	None
83646	83647	altered	0	None
83647	83648	biomarkers	0	None
83648	83649	at	0	None
83649	83650	10	0	None
83650	83651	mg	2	CHEMICAL
83651	83652	/	0	None
83652	83653	kg	0	None
83653	83654	/	0	None
83654	83655	day	0	None
83655	83656	,	0	None
83656	83657	(	0	None
83657	83658	2	0	None
83658	83659	)	0	None
83659	83660	mild	0	None
83660	83661	induction	0	None
83661	83662	of	0	None
83662	83663	HDN	0	None
83663	83664	with	0	None
83664	83665	increased	0	None
83665	83666	αGST	0	None
83666	83667	and	0	None
83667	83668	μGST	0	None
83668	83669	at	0	None
83669	83670	50	0	None
83670	83671	mg	2	CHEMICAL
83671	83672	/	0	None
83672	83673	kg	0	None
83673	83674	/	0	None
83674	83675	day	0	None
83675	83676	and	0	None
83676	83677	(	0	None
83677	83678	3	0	None
83678	83679	)	0	None
83679	83680	marked	0	None
83680	83681	induction	0	None
83681	83682	of	0	None
83682	83683	HDN	0	None
83683	83684	with	0	None
83684	83685	increased	0	None
83685	83686	αGST	0	None
83686	83687	,	0	None
83687	83688	μGST	0	None
83688	83689	and	0	None
83689	83690	albumin	0	None
83690	83691	at	0	None
83691	83692	300	0	None
83692	83693	mg	2	CHEMICAL
83693	83694	/	0	None
83694	83695	kg	0	None
83695	83696	/	0	None
83696	83697	day	0	None
83697	83698	.	0	None

83699	83700	HDN	0	None
83700	83701	induced	0	None
83701	83702	by	0	None
83702	83703	D-limonene	0	None
83703	83704	was	0	None
83704	83705	reversible	0	None
83705	83706	,	0	None
83706	83707	but	0	None
83707	83708	with	0	None
83708	83709	a	0	None
83709	83710	variable	0	None
83710	83711	renal	0	None
83711	83712	biomarker	0	None
83712	83713	pattern	0	None
83713	83714	over	0	None
83714	83715	time	0	None
83715	83716	:	0	None
83716	83717	Day	0	None
83717	83718	8	0	None
83718	83719	there	0	None
83719	83720	was	0	None
83720	83721	increased	0	None
83721	83722	αGST	0	None
83722	83723	,	0	None
83723	83724	μGST	0	None
83724	83725	and	0	None
83725	83726	albumin;	0	None
83726	83727	on	0	None
83727	83728	Day	0	None
83728	83729	15	0	None
83729	83730	increased	0	None
83730	83731	clusterin	1	GENE-Y
83731	83732	,	0	None
83732	83733	albumin	0	None
83733	83734	and	0	None
83734	83735	Kim-1	0	None
83735	83736	.	0	None

83737	83738	In	0	None
83738	83739	summary	0	None
83739	83740	,	0	None
83740	83741	HDN	0	None
83741	83742	altered	0	None
83742	83743	the	0	None
83743	83744	newer	0	None
83744	83745	and	0	None
83745	83746	more	0	None
83746	83747	sensitive	0	None
83747	83748	renal	0	None
83748	83749	biomarkers	0	None
83749	83750	in	0	None
83750	83751	a	0	None
83751	83752	time	0	None
83752	83753	and	0	None
83753	83754	possibly	0	None
83754	83755	compound	0	None
83755	83756	dependent	0	None
83756	83757	manner	0	None
83757	83758	.	0	None
83758	83759	Late-onset	0	None
83759	83760	cobalamin-C	0	None
83760	83761	disorder	0	None
83761	83762	:	0	None
83762	83763	a	0	None
83763	83764	challenging	0	None
83764	83765	diagnosis	0	None
83765	83766	.	0	None
83766	83767	Pemetrexed	2	CHEMICAL
83767	83768	in	0	None
83768	83769	pancreatic	0	None
83769	83770	cancer	0	None
83770	83771	.	0	None
83771	83772	Thiazinotrienomycin	0	None
83772	83773	B	0	None
83773	83774	(	0	None
83774	83775	TT-B	0	None
83775	83776	)	0	None
83776	83777	,	0	None
83777	83778	an	0	None
83778	83779	ansamycin	0	None
83779	83780	isolated	0	None
83780	83781	from	0	None
83781	83782	fermentation	0	None
83782	83783	broths	0	None
83783	83784	of	0	None
83784	83785	Streptomyces	0	None
83785	83786	sp	0	None
83786	83787	.	0	None

83788	83789	MJ672-m3	0	None
83789	83790	,	0	None
83790	83791	inhibited	0	None
83791	83792	the	0	None
83792	83793	growth	0	None
83793	83794	in	0	None
83794	83795	vitro	0	None
83795	83796	of	0	None
83796	83797	human	0	None
83797	83798	stomach	0	None
83798	83799	tumor	0	None
83799	83800	SC-6	0	None
83800	83801	cells	0	None
83801	83802	over	0	None
83802	83803	10	0	None
83803	83804	times	0	None
83804	83805	more	0	None
83805	83806	strongly	0	None
83806	83807	than	0	None
83807	83808	the	0	None
83808	83809	growth	0	None
83809	83810	of	0	None
83810	83811	other	0	None
83811	83812	human	0	None
83812	83813	tumor	0	None
83813	83814	cells	0	None
83814	83815	,	0	None
83815	83816	such	0	None
83816	83817	as	0	None
83817	83818	HeLa	0	None
83818	83819	(	0	None
83819	83820	cervix	0	None
83820	83821	)	0	None
83821	83822	,	0	None
83822	83823	T24	0	None
83823	83824	(	0	None
83824	83825	bladder	0	None
83825	83826	)	0	None
83826	83827	and	0	None
83827	83828	LX-1	0	None
83828	83829	(	0	None
83829	83830	lung	0	None
83830	83831	)	0	None
83831	83832	.	0	None

83833	83834	The	0	None
83834	83835	extent	0	None
83835	83836	of	0	None
83836	83837	growth	0	None
83837	83838	inhibition	0	None
83838	83839	by	0	None
83839	83840	TT-B	0	None
83840	83841	of	0	None
83841	83842	SC-6	0	None
83842	83843	,	0	None
83843	83844	but	0	None
83844	83845	not	0	None
83845	83846	of	0	None
83846	83847	LX-1	0	None
83847	83848	nor	0	None
83848	83849	T24	0	None
83849	83850	,	0	None
83850	83851	was	0	None
83851	83852	lowered	0	None
83852	83853	in	0	None
83853	83854	a	0	None
83854	83855	competitive	0	None
83855	83856	manner	0	None
83856	83857	by	0	None
83857	83858	raising	0	None
83858	83859	serum	0	None
83859	83860	concentrations	0	None
83860	83861	in	0	None
83861	83862	the	0	None
83862	83863	culture	0	None
83863	83864	medium	0	None
83864	83865	.	0	None

83866	83867	TT-B	0	None
83867	83868	inhibited	0	None
83868	83869	the	0	None
83869	83870	cell	0	None
83870	83871	cycle	0	None
83871	83872	progression	0	None
83872	83873	of	0	None
83873	83874	SC-6	0	None
83874	83875	at	0	None
83875	83876	an	0	None
83876	83877	early	0	None
83877	83878	stage	0	None
83878	83879	of	0	None
83879	83880	the	0	None
83880	83881	progression	0	None
83881	83882	from	0	None
83882	83883	G0	0	None
83883	83884	/	0	None
83884	83885	G1	0	None
83885	83886	to	0	None
83886	83887	S	0	None
83887	83888	.	0	None

83889	83890	The	0	None
83890	83891	inhibition	0	None
83891	83892	was	0	None
83892	83893	again	0	None
83893	83894	competitive	0	None
83894	83895	with	0	None
83895	83896	serum	0	None
83896	83897	concentrations	0	None
83897	83898	in	0	None
83898	83899	the	0	None
83899	83900	culture	0	None
83900	83901	medium	0	None
83901	83902	.	0	None

83903	83904	No	0	None
83904	83905	direct	0	None
83905	83906	inhibition	0	None
83906	83907	of	0	None
83907	83908	DNA	0	None
83908	83909	synthesis	0	None
83909	83910	was	0	None
83910	83911	observed	0	None
83911	83912	at	0	None
83912	83913	the	0	None
83913	83914	concentration	0	None
83914	83915	range	0	None
83915	83916	which	0	None
83916	83917	caused	0	None
83917	83918	the	0	None
83918	83919	cell	0	None
83919	83920	cycle	0	None
83920	83921	arrest	0	None
83921	83922	.	0	None

83923	83924	TT-B	0	None
83924	83925	and	0	None
83925	83926	anti-epidermal	0	None
83926	83929	growth factor receptor	3	GENE-N
83929	83930	(	0	None
83930	83931	anti-EGFR	0	None
83931	83932	)	0	None
83932	83933	were	0	None
83933	83934	antagonistic	0	None
83934	83935	to	0	None
83935	83936	each	0	None
83936	83937	other	0	None
83937	83938	in	0	None
83938	83939	inhibiting	0	None
83939	83940	the	0	None
83940	83941	cell	0	None
83941	83942	cycle	0	None
83942	83943	progression	0	None
83943	83944	of	0	None
83944	83945	SC-6	0	None
83945	83946	from	0	None
83946	83947	G0	0	None
83947	83948	/	0	None
83948	83949	G1	0	None
83949	83950	to	0	None
83950	83951	S	0	None
83951	83952	,	0	None
83952	83953	suggesting	0	None
83953	83954	that	0	None
83954	83955	the	0	None
83955	83956	two	0	None
83956	83957	compounds	0	None
83957	83958	share	0	None
83958	83959	the	0	None
83959	83960	same	0	None
83960	83961	target	0	None
83961	83962	,	0	None
83962	83963	EGFR	0	None
83963	83964	.	0	None

83965	83966	The	0	None
83966	83967	kinase	0	None
83967	83968	activity	0	None
83968	83969	of	0	None
83969	83970	EGFR	0	None
83970	83971	was	0	None
83971	83972	little	0	None
83972	83973	inhibited	0	None
83973	83974	by	0	None
83974	83975	TT-B	0	None
83975	83976	in	0	None
83976	83977	a	0	None
83977	83978	cell-free	0	None
83978	83979	system	0	None
83979	83980	.	0	None
83980	83981	Abstract	0	None
83981	83982	1	0	None
83982	83983	.	0	None

83984	83985	IPI-926	0	None
83985	83986	is	0	None
83986	83987	a	0	None
83987	83988	novel	0	None
83988	83989	semisynthetic	0	None
83989	83990	cyclopamine	0	None
83990	83991	derivative	0	None
83991	83992	that	0	None
83992	83993	is	0	None
83993	83994	a	0	None
83994	83995	potent	0	None
83995	83996	and	0	None
83996	83997	selective	0	None
83997	83998	Smoothened	1	GENE-Y
83998	83999	inhibitor	0	None
83999	84000	that	0	None
84000	84001	blocks	0	None
84001	84002	the	0	None
84002	84003	hedgehog	0	None
84003	84004	signal	0	None
84004	84005	transduction	0	None
84005	84006	pathway	0	None
84006	84007	.	0	None

84008	84009	2	0	None
84009	84010	.	0	None

84011	84012	The	0	None
84012	84013	in	0	None
84013	84014	vivo	0	None
84014	84015	clearance	0	None
84015	84016	of	0	None
84016	84017	IPI-926	0	None
84017	84018	is	0	None
84018	84019	low	0	None
84019	84020	in	0	None
84020	84021	mouse	0	None
84021	84022	and	0	None
84022	84023	dog	0	None
84023	84024	and	0	None
84024	84025	moderate	0	None
84025	84026	in	0	None
84026	84027	monkey	0	None
84027	84028	.	0	None

84029	84030	The	0	None
84030	84031	volume	0	None
84031	84032	of	0	None
84032	84033	distribution	0	None
84033	84034	is	0	None
84034	84035	high	0	None
84035	84036	across	0	None
84036	84037	species	0	None
84037	84038	.	0	None

84039	84040	Oral	0	None
84040	84041	bioavailability	0	None
84041	84042	ranges	0	None
84042	84043	from	0	None
84043	84044	moderate	0	None
84044	84045	in	0	None
84045	84046	monkey	0	None
84046	84047	to	0	None
84047	84048	high	0	None
84048	84049	in	0	None
84049	84050	mouse	0	None
84050	84051	and	0	None
84051	84052	dog	0	None
84052	84053	.	0	None

84054	84055	Predicted	0	None
84055	84056	human	0	None
84056	84057	clearance	0	None
84057	84058	using	0	None
84058	84059	simple	0	None
84059	84060	allometry	0	None
84060	84061	is	0	None
84061	84062	low	0	None
84062	84063	(	0	None
84063	84064	24	0	None
84064	84065	L	0	None
84065	84066	h	0	None
84066	84067	(	0	None
84067	84068	-1	0	None
84068	84069	)	0	None
84069	84070	)	0	None
84070	84071	,	0	None
84071	84072	predicted	0	None
84072	84073	volume	0	None
84073	84074	of	0	None
84074	84075	distribution	0	None
84075	84076	is	0	None
84076	84077	high	0	None
84077	84078	(	0	None
84078	84079	469	0	None
84079	84080	L	0	None
84080	84081	)	0	None
84081	84082	and	0	None
84082	84083	predicted	0	None
84083	84084	half-life	0	None
84084	84085	is	0	None
84085	84086	long	0	None
84086	84087	(	0	None
84087	84088	20	0	None
84088	84089	h	0	None
84089	84090	)	0	None
84090	84091	.	0	None

84092	84093	3	0	None
84093	84094	.	0	None

84095	84096	IPI-926	0	None
84096	84097	is	0	None
84097	84098	highly	0	None
84098	84099	bound	0	None
84099	84100	to	0	None
84100	84101	plasma	0	None
84101	84102	proteins	0	None
84102	84103	and	0	None
84103	84104	has	0	None
84104	84105	minimal	0	None
84105	84106	interaction	0	None
84106	84107	with	0	None
84107	84108	human	0	None
84108	84109	α-1-acid	0	None
84109	84110	glycoprotein	0	None
84110	84111	.	0	None

84112	84113	4	0	None
84113	84114	.	0	None

84115	84116	In	0	None
84116	84117	vitro	0	None
84117	84118	metabolic	0	None
84118	84119	stability	0	None
84119	84120	ranges	0	None
84120	84121	from	0	None
84121	84122	stable	0	None
84122	84123	to	0	None
84123	84124	moderately	0	None
84124	84125	stable	0	None
84125	84126	.	0	None

84127	84128	Twelve	0	None
84128	84129	oxidative	0	None
84129	84130	metabolites	0	None
84130	84131	were	0	None
84131	84132	detected	0	None
84132	84133	in	0	None
84133	84134	mouse	0	None
84134	84135	,	0	None
84135	84136	rat	0	None
84136	84137	,	0	None
84137	84138	dog	0	None
84138	84139	,	0	None
84139	84140	monkey	0	None
84140	84141	and	0	None
84141	84142	human	0	None
84142	84143	liver	0	None
84143	84144	microsome	0	None
84144	84145	incubations	0	None
84145	84146	and	0	None
84146	84147	none	0	None
84147	84148	were	0	None
84148	84149	unique	0	None
84149	84150	to	0	None
84150	84151	human	0	None
84151	84152	.	0	None

84153	84154	5	0	None
84154	84155	.	0	None

84156	84157	IPI-926	0	None
84157	84158	is	0	None
84158	84159	not	0	None
84159	84160	a	0	None
84160	84161	potent	0	None
84161	84162	reversible	0	None
84162	84163	inhibitor	0	None
84163	84164	of	0	None
84164	84165	CYP1A2	0	None
84165	84166	,	0	None
84166	84167	2C8	0	None
84167	84168	,	0	None
84168	84169	2C9	0	None
84169	84170	or	0	None
84170	84171	3A4	0	None
84171	84172	(	0	None
84172	84173	testosterone	2	CHEMICAL
84173	84174	)	0	None
84174	84175	.	0	None

84176	84177	IPI-926	0	None
84177	84178	is	0	None
84178	84179	a	0	None
84179	84180	moderate	0	None
84180	84181	inhibitor	0	None
84181	84182	of	0	None
84182	84183	CYP2C19	0	None
84183	84184	,	0	None
84184	84185	2D6	0	None
84185	84186	and	0	None
84186	84187	3A4	0	None
84187	84188	(	0	None
84188	84189	midazolam	0	None
84189	84190	)	0	None
84190	84191	with	0	None
84191	84192	KI	0	None
84192	84193	values	0	None
84193	84194	of	0	None
84194	84195	19	0	None
84195	84196	,	0	None
84196	84197	16	0	None
84197	84198	and	0	None
84198	84199	4	0	None
84199	84200	.	0	None
84200	84201	5	0	None
84201	84202	µM	0	None
84202	84203	,	0	None
84203	84204	respectively	0	None
84204	84205	.	0	None

84206	84207	IPI-926	0	None
84207	84208	is	0	None
84208	84209	both	0	None
84209	84210	a	0	None
84210	84211	substrate	0	None
84211	84212	and	0	None
84212	84213	inhibitor	0	None
84213	84214	(	0	None
84214	84215	IC50	0	None
84215	84216	=	0	None
84216	84217	1	0	None
84217	84218	.	0	None
84218	84219	9	0	None
84219	84220	µM	0	None
84220	84221	)	0	None
84221	84222	of	0	None
84222	84223	P-glycoprotein	3	GENE-N
84223	84224	.	0	None

84225	84226	6	0	None
84226	84227	.	0	None

84228	84229	In	0	None
84229	84230	summary	0	None
84230	84231	,	0	None
84231	84232	IPI-926	0	None
84232	84233	has	0	None
84233	84234	desirable	0	None
84234	84235	pre-clinical	0	None
84235	84236	absorption	0	None
84236	84237	,	0	None
84237	84238	distribution	0	None
84238	84239	,	0	None
84239	84240	metabolism	0	None
84240	84241	and	0	None
84241	84242	excretion	0	None
84242	84243	properties	0	None
84243	84244	.	0	None
84244	84245	Palbinone	0	None
84245	84246	from	0	None
84246	84247	Paeonia	0	None
84247	84248	suffruticosa	0	None
84248	84249	Protects	0	None
84249	84250	Hepatic	0	None
84250	84251	Cells	0	None
84251	84252	via	0	None
84252	84253	Up-regulation	0	None
84253	84254	of	0	None
84254	84256	Heme Oxygenase-1	1	GENE-Y
84256	84257	.	0	None
84257	84258	Group	0	None
84258	84259	III	0	None
84259	84260	metabotropic	0	None
84260	84261	glutamate	0	None
84261	84262	(	0	None
84262	84263	mGlu	0	None
84263	84264	)	0	None
84264	84265	receptors	0	None
84265	84266	are	0	None
84266	84267	localized	0	None
84267	84268	in	0	None
84268	84269	presynaptic	0	None
84269	84270	terminals	0	None
84270	84271	within	0	None
84271	84272	basal	0	None
84272	84273	ganglia	0	None
84273	84274	(	0	None
84274	84275	BG	0	None
84275	84276	)	0	None
84276	84277	circuitry	0	None
84277	84278	that	0	None
84278	84279	become	0	None
84279	84280	hyperactive	0	None
84280	84281	due	0	None
84281	84282	to	0	None
84282	84283	dopamine	0	None
84283	84284	depletion	0	None
84284	84285	in	0	None
84285	84286	Parkinson's	0	None
84286	84287	disease	0	None
84287	84288	(	0	None
84288	84289	PD	0	None
84289	84290	)	0	None
84290	84291	.	0	None

84292	84293	For	0	None
84293	84294	this	0	None
84294	84295	reason	0	None
84295	84296	,	0	None
84296	84297	group	0	None
84297	84298	III	0	None
84298	84299	mGlu	0	None
84299	84300	receptors	0	None
84300	84301	,	0	None
84301	84302	in	0	None
84302	84303	particular	0	None
84303	84304	mGlu4	0	None
84304	84305	,	0	None
84305	84306	have	0	None
84306	84307	been	0	None
84307	84308	considered	0	None
84308	84309	as	0	None
84309	84310	key	0	None
84310	84311	strategic	0	None
84311	84312	targets	0	None
84312	84313	for	0	None
84313	84314	non-dopaminergic	0	None
84314	84315	pharmacological	0	None
84315	84316	treatments	0	None
84316	84317	aimed	0	None
84317	84318	at	0	None
84318	84319	modulating	0	None
84319	84320	these	0	None
84320	84321	synapses	0	None
84321	84322	,	0	None
84322	84323	without	0	None
84323	84324	producing	0	None
84324	84325	the	0	None
84325	84326	well	0	None
84326	84327	known	0	None
84327	84328	side-effects	0	None
84328	84329	of	0	None
84329	84330	l-DOPA	0	None
84330	84331	,	0	None
84331	84332	in	0	None
84332	84333	particular	0	None
84333	84334	the	0	None
84334	84335	highly	0	None
84335	84336	disabling	0	None
84336	84337	l-DOPA-induced	0	None
84337	84338	dyskinesia	0	None
84338	84339	(	0	None
84339	84340	LID	0	None
84340	84341	)	0	None
84341	84342	.	0	None

84343	84344	Herein	0	None
84344	84345	we	0	None
84345	84346	add	0	None
84346	84347	physiological	0	None
84347	84348	and	0	None
84348	84349	functional	0	None
84349	84350	support	0	None
84350	84351	to	0	None
84351	84352	this	0	None
84352	84353	hypothesis	0	None
84353	84354	using	0	None
84354	84356	Lu AF21934	2	CHEMICAL
84356	84357	,	0	None
84357	84358	a	0	None
84358	84359	novel	0	None
84359	84360	selective	0	None
84360	84361	and	0	None
84361	84362	brain-penetrant	0	None
84362	84363	mGlu4	0	None
84363	84364	receptor	0	None
84364	84365	positive	0	None
84365	84366	allosteric	0	None
84366	84367	modulator	0	None
84367	84368	(	0	None
84368	84369	PAM	0	None
84369	84370	)	0	None
84370	84371	tool	0	None
84371	84372	compound	0	None
84372	84373	.	0	None

84374	84375	By	0	None
84375	84376	in	0	None
84376	84377	vitro	0	None
84377	84378	electrophysiological	0	None
84378	84379	recordings	0	None
84379	84380	we	0	None
84380	84381	demonstrate	0	None
84381	84382	that	0	None
84382	84384	Lu AF21934	2	CHEMICAL
84384	84385	inhibits	0	None
84385	84386	corticostriatal	0	None
84386	84387	synaptic	0	None
84387	84388	transmission	0	None
84388	84389	and	0	None
84389	84390	enhances	0	None
84390	84391	the	0	None
84391	84392	effect	0	None
84392	84393	of	0	None
84393	84394	the	0	None
84394	84395	orthosteric	0	None
84395	84396	mGlu4	0	None
84396	84397	receptor-preferred	0	None
84397	84398	agonist	0	None
84398	84399	LSP1-2111	0	None
84399	84400	.	0	None

84401	84402	In	0	None
84402	84403	naïve	0	None
84403	84404	rats	0	None
84404	84405	,	0	None
84405	84407	Lu AF21934	2	CHEMICAL
84407	84408	dose-dependently	0	None
84408	84409	(	0	None
84409	84410	10	0	None
84410	84411	and	0	None
84411	84412	30	0	None
84412	84413	mg	2	CHEMICAL
84413	84414	/	0	None
84414	84415	kg	0	None
84415	84416	)	0	None
84416	84417	alleviated	0	None
84417	84418	haloperidol-induced	0	None
84418	84419	catalepsy	0	None
84419	84420	.	0	None

84421	84422	In	0	None
84422	84423	hemiparkinsonian	0	None
84423	84424	rats	0	None
84424	84425	(	0	None
84425	84426	unilateral	0	None
84426	84427	6-hydroxydopamine	0	None
84427	84428	lesion	0	None
84428	84429	of	0	None
84429	84430	the	0	None
84430	84431	substantia	0	None
84431	84432	nigra	0	None
84432	84433	pars	0	None
84433	84434	compacta	0	None
84434	84435	)	0	None
84435	84436	,	0	None
84436	84438	Lu AF21934	2	CHEMICAL
84438	84439	alone	0	None
84439	84440	did	0	None
84440	84441	not	0	None
84441	84442	affect	0	None
84442	84443	akinesia	0	None
84443	84444	at	0	None
84444	84445	the	0	None
84445	84446	doses	0	None
84446	84447	tested	0	None
84447	84448	(	0	None
84448	84449	10	0	None
84449	84450	and	0	None
84450	84451	30	0	None
84451	84452	mg	2	CHEMICAL
84452	84453	/	0	None
84453	84454	kg	0	None
84454	84455	)	0	None
84455	84456	.	0	None

84457	84458	However	0	None
84458	84459	,	0	None
84459	84460	when	0	None
84460	84462	Lu AF21934	2	CHEMICAL
84462	84463	was	0	None
84463	84464	combined	0	None
84464	84465	with	0	None
84465	84466	sub-threshold	0	None
84466	84467	doses	0	None
84467	84468	of	0	None
84468	84469	l-DOPA	0	None
84469	84470	(	0	None
84470	84471	1	0	None
84471	84472	and	0	None
84472	84473	5	0	None
84473	84474	mg	2	CHEMICAL
84474	84475	/	0	None
84475	84476	kg	0	None
84476	84477	)	0	None
84477	84478	,	0	None
84478	84479	it	0	None
84479	84480	acted	0	None
84480	84481	synergistically	0	None
84481	84482	in	0	None
84482	84483	alleviating	0	None
84483	84484	akinesia	0	None
84484	84485	in	0	None
84485	84486	a	0	None
84486	84487	dose-dependent	0	None
84487	84488	manner	0	None
84488	84489	and	0	None
84489	84490	,	0	None
84490	84491	notably	0	None
84491	84492	,	0	None
84492	84493	also	0	None
84493	84494	reduced	0	None
84494	84495	the	0	None
84495	84496	incidence	0	None
84496	84497	of	0	None
84497	84498	LID	0	None
84498	84499	but	0	None
84499	84500	not	0	None
84500	84501	its	0	None
84501	84502	severity	0	None
84502	84503	.	0	None

84504	84505	Interestingly	0	None
84505	84506	,	0	None
84506	84507	these	0	None
84507	84508	effects	0	None
84508	84509	occurred	0	None
84509	84510	at	0	None
84510	84512	Lu AF21934	2	CHEMICAL
84512	84513	brain	0	None
84513	84514	free	0	None
84514	84515	concentrations	0	None
84515	84516	that	0	None
84516	84517	showed	0	None
84517	84518	functional	0	None
84518	84519	activity	0	None
84519	84520	in	0	None
84520	84521	in	0	None
84521	84522	vitro	0	None
84522	84523	screens	0	None
84523	84524	(	0	None
84524	84525	calcium	0	None
84525	84526	flux	0	None
84526	84527	and	0	None
84527	84528	electrophysiology	0	None
84528	84529	assays	0	None
84529	84530	)	0	None
84530	84531	.	0	None

84532	84533	These	0	None
84533	84534	results	0	None
84534	84535	support	0	None
84535	84536	the	0	None
84536	84537	potential	0	None
84537	84538	for	0	None
84538	84539	antiparkinsonian	0	None
84539	84540	clinical	0	None
84540	84541	use	0	None
84541	84542	of	0	None
84542	84543	a	0	None
84543	84544	combined	0	None
84544	84545	treatment	0	None
84545	84546	consisting	0	None
84546	84547	in	0	None
84547	84548	l-DOPA	0	None
84548	84549	and	0	None
84549	84550	a	0	None
84550	84551	mGlu4	0	None
84551	84552	receptor	0	None
84552	84553	PAM	0	None
84553	84554	to	0	None
84554	84555	reduce	0	None
84555	84556	efficacious	0	None
84556	84557	l-DOPA	0	None
84557	84558	doses	0	None
84558	84559	(	0	None
84559	84560	generally	0	None
84560	84561	known	0	None
84561	84562	as	0	None
84562	84563	l-DOPA	0	None
84563	84564	sparing	0	None
84564	84565	)	0	None
84565	84566	,	0	None
84566	84567	while	0	None
84567	84568	maintaining	0	None
84568	84569	the	0	None
84569	84570	same	0	None
84570	84571	benefit	0	None
84571	84572	on	0	None
84572	84573	PD	0	None
84573	84574	motor	0	None
84574	84575	troubles	0	None
84575	84576	,	0	None
84576	84577	and	0	None
84577	84578	at	0	None
84578	84579	the	0	None
84579	84580	same	0	None
84580	84581	time	0	None
84581	84582	minimizing	0	None
84582	84583	the	0	None
84583	84584	development	0	None
84584	84585	of	0	None
84585	84586	LID	0	None
84586	84587	.	0	None

84588	84589	This	0	None
84589	84590	article	0	None
84590	84591	is	0	None
84591	84592	part	0	None
84592	84593	of	0	None
84593	84594	a	0	None
84594	84595	Special	0	None
84595	84596	Issue	0	None
84596	84597	entitled	0	None
84597	84598	'Metabotropic	0	None
84598	84599	Glutamate	0	None
84599	84600	Receptors'	0	None
84600	84601	.	0	None
84601	84602	The	0	None
84602	84603	putative	0	None
84603	84604	JAK-STAT	0	None
84604	84605	inhibitor	0	None
84605	84606	AG490	0	None
84606	84607	exacerbates	0	None
84607	84608	LPS-fever	0	None
84608	84609	,	0	None
84609	84610	reduces	0	None
84610	84611	sickness	0	None
84611	84612	behavior	0	None
84612	84613	,	0	None
84613	84614	and	0	None
84614	84615	alters	0	None
84615	84616	the	0	None
84616	84617	expression	0	None
84617	84618	of	0	None
84618	84619	pro-	0	None
84619	84620	and	0	None
84620	84621	anti-inflammatory	0	None
84621	84622	genes	0	None
84622	84623	in	0	None
84623	84624	the	0	None
84624	84625	rat	0	None
84625	84626	brain	0	None
84626	84627	.	0	None
84627	84628	3-Methylglutaconic	0	None
84628	84629	aciduria-lessons	0	None
84629	84630	from	0	None
84630	84631	50	0	None
84631	84632	genes	0	None
84632	84633	and	0	None
84633	84634	977	0	None
84634	84635	patients	0	None
84635	84636	.	0	None
84636	84637	Medulloblastoma	0	None
84637	84638	(	0	None
84638	84639	MB	0	None
84639	84640	)	0	None
84640	84641	is	0	None
84641	84642	the	0	None
84642	84643	most	0	None
84643	84644	common	0	None
84644	84645	malignant	0	None
84645	84646	neuroepithelial	0	None
84646	84647	tumor	0	None
84647	84648	of	0	None
84648	84649	childhood	0	None
84649	84650	.	0	None

84651	84652	The	0	None
84652	84655	DNA topoisomerase II	1	GENE-Y
84655	84656	(	0	None
84656	84658	Topo II	1	GENE-Y
84658	84659	)	0	None
84659	84660	inhibitor	0	None
84660	84661	etoposide	0	None
84661	84662	has	0	None
84662	84663	been	0	None
84663	84664	widely	0	None
84664	84665	used	0	None
84665	84666	for	0	None
84666	84667	the	0	None
84667	84668	treatment	0	None
84668	84669	of	0	None
84669	84670	MBs;	0	None
84670	84671	however	0	None
84671	84672	,	0	None
84672	84673	it	0	None
84673	84674	remains	0	None
84674	84675	unknown	0	None
84675	84676	whether	0	None
84676	84677	MB	0	None
84677	84678	cells	0	None
84678	84679	are	0	None
84679	84680	more	0	None
84680	84681	sensitive	0	None
84681	84682	to	0	None
84682	84683	etoposide	0	None
84683	84684	than	0	None
84684	84685	other	0	None
84685	84686	malignant	0	None
84686	84687	neuroepithelial	0	None
84687	84688	tumor	0	None
84688	84689	cells	0	None
84689	84690	.	0	None

84691	84692	In	0	None
84692	84693	this	0	None
84693	84694	study	0	None
84694	84695	,	0	None
84695	84696	we	0	None
84696	84697	tested	0	None
84697	84698	the	0	None
84698	84699	chemosensitivities	0	None
84699	84700	of	0	None
84700	84701	malignant	0	None
84701	84702	neuroepithelial	0	None
84702	84703	tumors	0	None
84703	84704	(	0	None
84704	84705	26	0	None
84705	84706	glioblastomas	0	None
84706	84707	,	0	None
84707	84708	9	0	None
84708	84709	anaplastic	0	None
84709	84710	astrocytomas	0	None
84710	84711	,	0	None
84711	84712	and	0	None
84712	84713	5	0	None
84713	84714	MBs	0	None
84714	84715	)	0	None
84715	84716	to	0	None
84716	84717	etoposide	0	None
84717	84718	and	0	None
84718	84719	vincristine	0	None
84719	84720	using	0	None
84720	84721	the	0	None
84721	84722	succinate	0	None
84722	84723	dehydrogenase	0	None
84723	84724	inhibition	0	None
84724	84725	test	0	None
84725	84726	and	0	None
84726	84727	found	0	None
84727	84728	that	0	None
84728	84729	MB	0	None
84729	84730	cells	0	None
84730	84731	are	0	None
84731	84732	more	0	None
84732	84733	sensitive	0	None
84733	84734	to	0	None
84734	84735	etoposide	0	None
84735	84736	and	0	None
84736	84737	more	0	None
84737	84738	resistant	0	None
84738	84739	to	0	None
84739	84740	vincristine	0	None
84740	84741	than	0	None
84741	84742	other	0	None
84742	84743	tumor	0	None
84743	84744	cells	0	None
84744	84745	.	0	None

84746	84747	We	0	None
84747	84748	performed	0	None
84748	84749	quantitative	0	None
84749	84750	reverse-transcription	0	None
84750	84751	polymerase	0	None
84751	84752	chain	0	None
84752	84753	reaction	0	None
84753	84754	to	0	None
84754	84755	evaluate	0	None
84755	84756	the	0	None
84756	84757	expression	0	None
84757	84758	of	0	None
84758	84759	genes	0	None
84759	84760	related	0	None
84760	84761	to	0	None
84761	84762	etoposide	0	None
84762	84763	sensitivity	0	None
84763	84764	,	0	None
84764	84765	and	0	None
84765	84766	found	0	None
84766	84767	co-overexpression	0	None
84767	84768	of	0	None
84768	84771	DNA topoisomerase II	1	GENE-Y
84771	84772	(	0	None
84772	84774	Topo II	1	GENE-Y
84774	84775	)	0	None
84775	84776	alpha	0	None
84776	84777	and	0	None
84777	84778	beta	0	None
84778	84779	mRNA	0	None
84779	84780	in	0	None
84780	84781	MBs	0	None
84781	84782	.	0	None

84783	84784	In	0	None
84784	84785	addition	0	None
84785	84786	,	0	None
84786	84787	the	0	None
84787	84788	levels	0	None
84788	84789	of	0	None
84789	84791	Topo IIalpha	1	GENE-Y
84791	84792	and	0	None
84792	84793	beta	0	None
84793	84794	mRNA	0	None
84794	84795	in	0	None
84795	84796	these	0	None
84796	84797	tumors	0	None
84797	84798	correlated	0	None
84798	84799	with	0	None
84799	84800	etoposide	0	None
84800	84801	sensitivity	0	None
84801	84802	.	0	None

84803	84804	Immunohistochemical	0	None
84804	84805	studies	0	None
84805	84806	using	0	None
84806	84807	surgical	0	None
84807	84808	samples	0	None
84808	84809	of	0	None
84809	84810	these	0	None
84810	84811	tumors	0	None
84811	84812	demonstrated	0	None
84812	84813	that	0	None
84813	84814	the	0	None
84814	84815	percentages	0	None
84815	84816	of	0	None
84816	84818	Topo IIalpha	1	GENE-Y
84818	84819	immunopositive	0	None
84819	84820	cells	0	None
84820	84821	(	0	None
84821	84823	Topo IIalpha	1	GENE-Y
84823	84824	labeling	0	None
84824	84825	index	0	None
84825	84826	)	0	None
84826	84827	correlated	0	None
84827	84828	with	0	None
84828	84829	those	0	None
84829	84830	of	0	None
84830	84831	Ki-67	0	None
84831	84832	immunopositive	0	None
84832	84833	cells	0	None
84833	84834	(	0	None
84834	84835	MIB-1	0	None
84835	84836	labeling	0	None
84836	84837	index	0	None
84837	84838	)	0	None
84838	84839	;	0	None
84839	84840	however	0	None
84840	84841	,	0	None
84841	84842	neither	0	None
84842	84843	the	0	None
84843	84845	Topo IIalpha	1	GENE-Y
84845	84846	nor	0	None
84846	84847	the	0	None
84847	84848	MIB-1	0	None
84848	84849	labeling	0	None
84849	84850	index	0	None
84850	84851	correlated	0	None
84851	84852	with	0	None
84852	84853	the	0	None
84853	84854	levels	0	None
84854	84855	of	0	None
84855	84857	Topo IIalpha	1	GENE-Y
84857	84858	mRNA	0	None
84858	84859	or	0	None
84859	84860	etoposide	0	None
84860	84861	sensitivity	0	None
84861	84862	.	0	None

84863	84864	Based	0	None
84864	84865	on	0	None
84865	84866	these	0	None
84866	84867	observations	0	None
84867	84868	,	0	None
84868	84870	Topo IIalpha	1	GENE-Y
84870	84871	and	0	None
84871	84872	beta	0	None
84872	84873	mRNA	0	None
84873	84874	expression	0	None
84874	84875	,	0	None
84875	84876	but	0	None
84876	84877	not	0	None
84877	84878	the	0	None
84878	84880	Topo IIalpha	1	GENE-Y
84880	84881	labeling	0	None
84881	84882	index	0	None
84882	84883	,	0	None
84883	84884	might	0	None
84884	84885	be	0	None
84885	84886	a	0	None
84886	84887	useful	0	None
84887	84888	marker	0	None
84888	84889	for	0	None
84889	84890	sensitivity	0	None
84890	84891	to	0	None
84891	84892	etoposide	0	None
84892	84893	in	0	None
84893	84894	human	0	None
84894	84895	malignant	0	None
84895	84896	neuroepithelial	0	None
84896	84897	tumors	0	None
84897	84898	.	0	None
84898	84899	The	0	None
84899	84900	detailed	0	None
84900	84901	molecular	0	None
84901	84902	mechanism	0	None
84902	84903	of	0	None
84903	84904	action	0	None
84904	84905	of	0	None
84905	84906	second-generation	0	None
84906	84907	BCR-ABL	0	None
84907	84908	tyrosine	2	CHEMICAL
84908	84909	kinase	0	None
84909	84910	inhibitors	0	None
84910	84911	,	0	None
84911	84912	including	0	None
84912	84913	perturbed	0	None
84913	84914	targets	0	None
84914	84915	and	0	None
84915	84916	pathways	0	None
84916	84917	,	0	None
84917	84918	should	0	None
84918	84919	contribute	0	None
84919	84920	to	0	None
84920	84921	rationalized	0	None
84921	84922	therapy	0	None
84922	84923	in	0	None
84923	84924	chronic	0	None
84924	84925	myeloid	0	None
84925	84926	leukemia	0	None
84926	84927	(	0	None
84927	84928	CML	0	None
84928	84929	)	0	None
84929	84930	or	0	None
84930	84931	in	0	None
84931	84932	other	0	None
84932	84933	affected	0	None
84933	84934	diseases	0	None
84934	84935	.	0	None

84936	84937	Here	0	None
84937	84938	,	0	None
84938	84939	we	0	None
84939	84940	characterized	0	None
84940	84941	the	0	None
84941	84942	target	0	None
84942	84943	profile	0	None
84943	84944	of	0	None
84944	84945	the	0	None
84945	84946	dual	0	None
84946	84947	SRC	0	None
84947	84948	/	0	None
84948	84949	ABL	1	GENE-Y
84949	84950	inhibitor	0	None
84950	84951	bosutinib	2	CHEMICAL
84951	84952	employing	0	None
84952	84953	a	0	None
84953	84954	two-tiered	0	None
84954	84955	approach	0	None
84955	84956	using	0	None
84956	84957	chemical	0	None
84957	84958	proteomics	0	None
84958	84959	to	0	None
84959	84960	identify	0	None
84960	84961	natural	0	None
84961	84962	binders	0	None
84962	84963	in	0	None
84963	84964	whole	0	None
84964	84965	cell	0	None
84965	84966	lysates	0	None
84966	84967	of	0	None
84967	84968	primary	0	None
84968	84969	CML	0	None
84969	84970	and	0	None
84970	84971	K562	0	None
84971	84972	cells	0	None
84972	84973	in	0	None
84973	84974	parallel	0	None
84974	84975	to	0	None
84975	84976	in	0	None
84976	84977	vitro	0	None
84977	84978	kinase	0	None
84978	84979	assays	0	None
84979	84980	against	0	None
84980	84981	a	0	None
84981	84982	large	0	None
84982	84983	recombinant	0	None
84983	84984	kinase	0	None
84984	84985	panel	0	None
84985	84986	.	0	None

84987	84988	The	0	None
84988	84989	combined	0	None
84989	84990	strategy	0	None
84990	84991	resulted	0	None
84991	84992	in	0	None
84992	84993	a	0	None
84993	84994	global	0	None
84994	84995	survey	0	None
84995	84996	of	0	None
84996	84997	bosutinib	2	CHEMICAL
84997	84998	targets	0	None
84998	84999	comprised	0	None
84999	85000	of	0	None
85000	85001	over	0	None
85001	85002	45	0	None
85002	85003	novel	0	None
85003	85004	tyrosine	2	CHEMICAL
85004	85005	and	0	None
85005	85006	serine	2	CHEMICAL
85006	85007	/	0	None
85007	85008	threonine	0	None
85008	85009	kinases	0	None
85009	85010	.	0	None

85011	85012	We	0	None
85012	85013	have	0	None
85013	85014	found	0	None
85014	85015	clear	0	None
85015	85016	differences	0	None
85016	85017	in	0	None
85017	85018	the	0	None
85018	85019	target	0	None
85019	85020	patterns	0	None
85020	85021	of	0	None
85021	85022	bosutinib	2	CHEMICAL
85022	85023	in	0	None
85023	85024	primary	0	None
85024	85025	CML	0	None
85025	85026	cells	0	None
85026	85027	versus	0	None
85027	85028	the	0	None
85028	85029	K562	0	None
85029	85030	cell	0	None
85030	85031	line	0	None
85031	85032	.	0	None

85033	85034	A	0	None
85034	85035	comparison	0	None
85035	85036	of	0	None
85036	85037	bosutinib	2	CHEMICAL
85037	85038	with	0	None
85038	85039	dasatinib	0	None
85039	85040	across	0	None
85040	85041	the	0	None
85041	85042	whole	0	None
85042	85043	kinase	0	None
85043	85044	panel	0	None
85044	85045	revealed	0	None
85045	85046	overlapping	0	None
85046	85047	,	0	None
85047	85048	but	0	None
85048	85049	distinct	0	None
85049	85050	,	0	None
85050	85051	inhibition	0	None
85051	85052	profiles	0	None
85052	85053	.	0	None

85054	85055	Common	0	None
85055	85056	among	0	None
85056	85057	those	0	None
85057	85058	were	0	None
85058	85059	the	0	None
85059	85060	SRC	0	None
85060	85061	,	0	None
85061	85062	ABL	1	GENE-Y
85062	85063	and	0	None
85063	85064	TEC	0	None
85064	85065	family	0	None
85065	85066	kinases	0	None
85066	85067	.	0	None

85068	85069	Bosutinib	2	CHEMICAL
85069	85070	did	0	None
85070	85071	not	0	None
85071	85072	inhibit	0	None
85072	85073	KIT	0	None
85073	85074	or	0	None
85074	85075	platelet-derived	0	None
85075	85078	growth factor receptor	3	GENE-N
85078	85079	,	0	None
85079	85080	but	0	None
85080	85081	prominently	0	None
85081	85082	targeted	0	None
85082	85083	the	0	None
85083	85084	apoptosis-linked	0	None
85084	85085	STE20	0	None
85085	85086	kinases	0	None
85086	85087	.	0	None

85088	85089	Although	0	None
85089	85090	in	0	None
85090	85091	vivo	0	None
85091	85092	bosutinib	2	CHEMICAL
85092	85093	is	0	None
85093	85094	inactive	0	None
85094	85095	against	0	None
85095	85096	ABL	1	GENE-Y
85096	85097	T315I	0	None
85097	85098	,	0	None
85098	85099	we	0	None
85099	85100	found	0	None
85100	85101	this	0	None
85101	85102	clinically	0	None
85102	85103	important	0	None
85103	85104	mutant	0	None
85104	85105	to	0	None
85105	85106	be	0	None
85106	85107	enzymatically	0	None
85107	85108	inhibited	0	None
85108	85109	in	0	None
85109	85110	the	0	None
85110	85111	mid-nanomolar	0	None
85111	85112	range	0	None
85112	85113	.	0	None

85114	85115	Finally	0	None
85115	85116	,	0	None
85116	85117	bosutinib	2	CHEMICAL
85117	85118	is	0	None
85118	85119	the	0	None
85119	85120	first	0	None
85120	85121	kinase	0	None
85121	85122	inhibitor	0	None
85122	85123	shown	0	None
85123	85124	to	0	None
85124	85125	target	0	None
85125	85126	CAMK2G	0	None
85126	85127	,	0	None
85127	85128	recently	0	None
85128	85129	implicated	0	None
85129	85130	in	0	None
85130	85131	myeloid	0	None
85131	85132	leukemia	0	None
85132	85133	cell	0	None
85133	85134	proliferation	0	None
85134	85135	.	0	None
85135	85136	Reabsorption	0	None
85136	85137	of	0	None
85137	85139	amino acids	2	CHEMICAL
85139	85140	is	0	None
85140	85141	an	0	None
85141	85142	important	0	None
85142	85143	function	0	None
85143	85144	of	0	None
85144	85145	the	0	None
85145	85146	renal	0	None
85146	85147	proximal	0	None
85147	85148	tubule	0	None
85148	85149	.	0	None

85150	85151	pH-dependent	0	None
85151	85153	amino acid	2	CHEMICAL
85153	85154	transport	0	None
85154	85155	has	0	None
85155	85156	been	0	None
85156	85157	measured	0	None
85157	85158	previously	0	None
85158	85159	using	0	None
85159	85160	rabbit	0	None
85160	85161	renal	0	None
85161	85162	brush-border	0	None
85162	85163	membrane	0	None
85163	85164	vesicles	0	None
85164	85165	(	0	None
85165	85166	BBMV	0	None
85166	85167	)	0	None
85167	85168	.	0	None

85169	85170	The	0	None
85170	85171	purpose	0	None
85171	85172	of	0	None
85172	85173	this	0	None
85173	85174	investigation	0	None
85174	85175	was	0	None
85175	85176	to	0	None
85176	85177	determine	0	None
85177	85178	whether	0	None
85178	85179	this	0	None
85179	85180	pH-dependent	0	None
85180	85181	uptake	0	None
85181	85182	represents	0	None
85182	85183	H	0	None
85183	85184	(	0	None
85184	85185	+	0	None
85185	85186	)	0	None
85186	85187	/	0	None
85187	85189	amino acid	2	CHEMICAL
85189	85190	cotransport	0	None
85190	85191	via	0	None
85191	85192	a	0	None
85192	85193	PAT1-like	0	None
85193	85194	transport	0	None
85194	85195	system	0	None
85195	85196	.	0	None

85197	85198	The	0	None
85198	85200	rabbit PAT1	1	GENE-Y
85200	85201	cDNA	0	None
85201	85202	was	0	None
85202	85203	isolated	0	None
85203	85204	(	0	None
85204	85205	2296bp	0	None
85205	85206	including	0	None
85206	85207	both	0	None
85207	85208	5'	0	None
85208	85209	and	0	None
85209	85210	3'	0	None
85210	85211	untranslated	0	None
85211	85212	regions	0	None
85212	85213	and	0	None
85213	85214	poly	0	None
85214	85215	(	0	None
85215	85216	A	0	None
85216	85217	)	0	None
85217	85218	tail	0	None
85218	85219	)	0	None
85219	85220	and	0	None
85220	85221	the	0	None
85221	85222	open	0	None
85222	85223	reading	0	None
85223	85224	frame	0	None
85224	85225	codes	0	None
85225	85226	for	0	None
85226	85227	a	0	None
85227	85228	protein	0	None
85228	85229	of	0	None
85229	85230	475	0	None
85230	85232	amino acids	2	CHEMICAL
85232	85233	(	0	None
85233	85234	92%	0	None
85234	85235	identity	0	None
85235	85236	to	0	None
85236	85237	human	0	None
85237	85238	PAT1	1	GENE-Y
85238	85239	)	0	None
85239	85240	.	0	None

85241	85242	Rabbit	0	None
85242	85243	PAT1	1	GENE-Y
85243	85244	mRNA	0	None
85244	85245	was	0	None
85245	85246	found	0	None
85246	85247	in	0	None
85247	85248	all	0	None
85248	85249	tissues	0	None
85249	85250	investigated	0	None
85250	85251	including	0	None
85251	85252	kidney	0	None
85252	85253	.	0	None

85254	85255	When	0	None
85255	85256	expressed	0	None
85256	85257	heterologously	0	None
85257	85258	in	0	None
85258	85259	a	0	None
85259	85260	mammalian	0	None
85260	85261	cell	0	None
85261	85262	line	0	None
85262	85263	,	0	None
85263	85265	rabbit PAT1	1	GENE-Y
85265	85266	mediates	0	None
85266	85267	pH-dependent	0	None
85267	85268	,	0	None
85268	85269	Na	0	None
85269	85270	(	0	None
85270	85271	+	0	None
85271	85272	)	0	None
85272	85273	-independent	0	None
85273	85274	uptake	0	None
85274	85275	of	0	None
85275	85276	proline	0	None
85276	85277	,	0	None
85277	85278	glycine	2	CHEMICAL
85278	85279	,	0	None
85279	85280	l-alanine	0	None
85280	85281	and	0	None
85281	85282	alpha-	0	None
85282	85283	(	0	None
85283	85284	methylamino	0	None
85284	85285	)	0	None
85285	85286	isobutyric	0	None
85286	85287	acid	0	None
85287	85288	.	0	None

85289	85290	Proline	0	None
85290	85291	uptake	0	None
85291	85292	was	0	None
85292	85293	maximal	0	None
85293	85294	at	0	None
85294	85295	pH	0	None
85295	85296	5	0	None
85296	85297	.	0	None
85297	85298	0	0	None
85298	85299	(	0	None
85299	85300	K	0	None
85300	85301	(	0	None
85301	85302	m	0	None
85302	85303	)	0	None
85303	85304	2	0	None
85304	85305	.	0	None
85305	85306	2	0	None
85306	85307	+	0	None
85307	85308	/	0	None
85308	85309	-0	0	None
85309	85310	.	0	None
85310	85311	7	0	None
85311	85312	mM	0	None
85312	85313	)	0	None
85313	85314	.	0	None

85315	85316	A	0	None
85316	85317	transport	0	None
85317	85318	system	0	None
85318	85319	with	0	None
85319	85320	identical	0	None
85320	85321	characteristics	0	None
85321	85322	(	0	None
85322	85323	ion	0	None
85323	85324	dependency	0	None
85324	85325	,	0	None
85325	85326	substrate	0	None
85326	85327	specificity	0	None
85327	85328	)	0	None
85328	85329	was	0	None
85329	85330	detected	0	None
85330	85331	in	0	None
85331	85332	rabbit	0	None
85332	85333	renal	0	None
85333	85334	BBMV	0	None
85334	85335	where	0	None
85335	85336	an	0	None
85336	85337	overshoot	0	None
85337	85338	was	0	None
85338	85339	observed	0	None
85339	85340	in	0	None
85340	85341	the	0	None
85341	85342	absence	0	None
85342	85343	of	0	None
85343	85344	Na	0	None
85344	85345	+	0	None
85345	85346	but	0	None
85346	85347	in	0	None
85347	85348	the	0	None
85348	85349	presence	0	None
85349	85350	of	0	None
85350	85351	an	0	None
85351	85352	inwardly	0	None
85352	85353	directed	0	None
85353	85354	H	0	None
85354	85355	+	0	None
85355	85356	gradient	0	None
85356	85357	.	0	None

85358	85359	In	0	None
85359	85360	the	0	None
85360	85361	presence	0	None
85361	85362	of	0	None
85362	85363	Na	0	None
85363	85364	+	0	None
85364	85365	and	0	None
85365	85366	under	0	None
85366	85367	conditions	0	None
85367	85368	in	0	None
85368	85369	which	0	None
85369	85370	PAT1	1	GENE-Y
85370	85371	transport	0	None
85371	85372	function	0	None
85372	85373	was	0	None
85373	85374	suppressed	0	None
85374	85375	,	0	None
85375	85376	a	0	None
85376	85377	second	0	None
85377	85378	proline	0	None
85378	85379	uptake	0	None
85379	85380	system	0	None
85380	85381	was	0	None
85381	85382	detected	0	None
85382	85383	that	0	None
85383	85384	exhibited	0	None
85384	85385	functional	0	None
85385	85386	characteristics	0	None
85386	85387	similar	0	None
85387	85388	to	0	None
85388	85389	those	0	None
85389	85390	of	0	None
85390	85391	the	0	None
85391	85392	IMINO	0	None
85392	85393	system	0	None
85393	85394	.	0	None

85395	85396	The	0	None
85396	85397	functional	0	None
85397	85398	characteristics	0	None
85398	85399	of	0	None
85399	85401	rabbit PAT1	1	GENE-Y
85401	85402	in	0	None
85402	85403	either	0	None
85403	85404	mammalian	0	None
85404	85405	cells	0	None
85405	85406	or	0	None
85406	85407	renal	0	None
85407	85408	BBMV	0	None
85408	85409	suggest	0	None
85409	85410	that	0	None
85410	85411	PAT1	1	GENE-Y
85411	85412	is	0	None
85412	85413	the	0	None
85413	85414	low-affinity	0	None
85414	85415	transporter	0	None
85415	85416	of	0	None
85416	85417	proline	0	None
85417	85418	,	0	None
85418	85419	glycine	2	CHEMICAL
85419	85420	and	0	None
85420	85421	hydroxyproline	0	None
85421	85422	believed	0	None
85422	85423	to	0	None
85423	85424	be	0	None
85424	85425	defective	0	None
85425	85426	in	0	None
85426	85427	patients	0	None
85427	85428	with	0	None
85428	85429	iminoglycinuria	0	None
85429	85430	.	0	None
85430	85431	The	0	None
85431	85432	aim	0	None
85432	85433	of	0	None
85433	85434	this	0	None
85434	85435	work	0	None
85435	85436	was	0	None
85436	85437	to	0	None
85437	85438	develop	0	None
85438	85439	by	0	None
85439	85440	means	0	None
85440	85441	of	0	None
85441	85442	co-extrusion	0	None
85442	85443	a	0	None
85443	85444	multilayered	0	None
85444	85445	dosage	0	None
85445	85446	form	0	None
85446	85447	characterized	0	None
85447	85448	by	0	None
85448	85449	a	0	None
85449	85450	dual	0	None
85450	85451	release	0	None
85451	85452	profile	0	None
85452	85453	of	0	None
85453	85454	the	0	None
85454	85455	same	0	None
85455	85456	drug	0	None
85456	85457	.	0	None

85458	85459	Co-extrudates	0	None
85459	85460	consisted	0	None
85460	85461	of	0	None
85461	85462	two	0	None
85462	85463	concentric	0	None
85463	85464	polymer	0	None
85464	85465	matrices	0	None
85465	85466	:	0	None
85466	85467	a	0	None
85467	85468	core	0	None
85468	85469	having	0	None
85469	85470	a	0	None
85470	85471	lipophilic	0	None
85471	85472	character	0	None
85472	85473	and	0	None
85473	85474	a	0	None
85474	85475	coat	0	None
85475	85476	with	0	None
85476	85477	a	0	None
85477	85478	hydrophilic	0	None
85478	85479	character	0	None
85479	85480	.	0	None

85481	85482	Diclofenac	0	None
85482	85483	sodium	2	CHEMICAL
85483	85484	(	0	None
85484	85485	DS	0	None
85485	85486	)	0	None
85486	85487	was	0	None
85487	85488	incorporated	0	None
85488	85489	as	0	None
85489	85490	model	0	None
85490	85491	drug	0	None
85491	85492	in	0	None
85492	85493	both	0	None
85493	85494	layers	0	None
85494	85495	.	0	None

85496	85497	Several	0	None
85497	85498	polymers	0	None
85498	85499	were	0	None
85499	85500	screened	0	None
85500	85501	on	0	None
85501	85502	the	0	None
85502	85503	basis	0	None
85503	85504	of	0	None
85504	85505	their	0	None
85505	85506	processability	0	None
85506	85507	via	0	None
85507	85508	hot	0	None
85508	85509	melt	0	None
85509	85510	extrusion	0	None
85510	85511	(	0	None
85511	85512	HME	0	None
85512	85513	)	0	None
85513	85514	and	0	None
85514	85515	in	0	None
85515	85516	vitro	0	None
85516	85517	drug	0	None
85517	85518	release	0	None
85518	85519	.	0	None

85520	85521	Polymer	0	None
85521	85522	combinations	0	None
85522	85523	with	0	None
85523	85524	suitable	0	None
85524	85525	properties	0	None
85525	85526	(	0	None
85526	85527	i	0	None
85527	85528	.	0	None

85529	85530	e	0	None
85530	85531	.	0	None

85532	85533	,	0	None
85533	85534	similar	0	None
85534	85535	extrusion	0	None
85535	85536	temperature	0	None
85536	85537	,	0	None
85537	85538	appropriate	0	None
85538	85539	drug	0	None
85539	85540	release	0	None
85540	85541	profile	0	None
85541	85542	)	0	None
85542	85543	were	0	None
85543	85544	processed	0	None
85544	85545	via	0	None
85545	85546	co-extrusion	0	None
85546	85547	.	0	None

85548	85549	(	0	None
85549	85550	Co-	0	None
85550	85551	)	0	None
85551	85552	extruded	0	None
85552	85553	samples	0	None
85553	85554	were	0	None
85554	85555	characterized	0	None
85555	85556	in	0	None
85556	85557	terms	0	None
85557	85558	of	0	None
85558	85559	solid	0	None
85559	85560	state	0	None
85560	85561	(	0	None
85561	85562	XRD	0	None
85562	85563	,	0	None
85563	85564	SEM	0	None
85564	85565	)	0	None
85565	85566	,	0	None
85566	85567	in	0	None
85567	85568	vitro	0	None
85568	85569	drug	0	None
85569	85570	release	0	None
85570	85571	,	0	None
85571	85572	core	0	None
85572	85573	/	0	None
85573	85574	coat	0	None
85574	85575	adhesion	0	None
85575	85576	,	0	None
85576	85577	and	0	None
85577	85578	bioavailability	0	None
85578	85579	.	0	None

85580	85581	Based	0	None
85581	85582	on	0	None
85582	85583	the	0	None
85583	85584	polymer	0	None
85584	85585	screening	0	None
85585	85586	,	0	None
85586	85587	two	0	None
85587	85588	polymer	0	None
85588	85589	combinations	0	None
85589	85590	were	0	None
85590	85591	selected	0	None
85591	85592	for	0	None
85592	85593	co-extrusion	0	None
85593	85594	:	0	None
85594	85595	ethylcellulose	0	None
85595	85596	(	0	None
85596	85597	core	0	None
85597	85598	)	0	None
85598	85599	combined	0	None
85599	85600	with	0	None
85600	85601	Soluplus®	0	None
85601	85602	(	0	None
85602	85603	coat	0	None
85603	85604	)	0	None
85604	85605	and	0	None
85605	85606	polycaprolactone	0	None
85606	85607	(	0	None
85607	85608	core	0	None
85608	85609	)	0	None
85609	85610	with	0	None
85610	85611	PEO	2	CHEMICAL
85611	85612	(	0	None
85612	85613	coat	0	None
85613	85614	)	0	None
85614	85615	.	0	None

85616	85617	These	0	None
85617	85618	combinations	0	None
85618	85619	were	0	None
85619	85620	successfully	0	None
85620	85621	co-extruded	0	None
85621	85622	.	0	None

85623	85624	XRD	0	None
85624	85625	revealed	0	None
85625	85626	that	0	None
85626	85627	DS	0	None
85627	85628	remained	0	None
85628	85629	crystalline	0	None
85629	85630	during	0	None
85630	85631	extrusion	0	None
85631	85632	in	0	None
85632	85633	ethylcellulose	0	None
85633	85634	,	0	None
85634	85635	Soluplus®	0	None
85635	85636	,	0	None
85636	85637	polycaprolactone	0	None
85637	85638	,	0	None
85638	85639	and	0	None
85639	85640	PEO	2	CHEMICAL
85640	85641	.	0	None

85642	85643	The	0	None
85643	85644	polycaprolactone	0	None
85644	85645	/	0	None
85645	85646	PEO	2	CHEMICAL
85646	85647	combination	0	None
85647	85648	could	0	None
85648	85649	be	0	None
85649	85650	processed	0	None
85650	85651	at	0	None
85651	85652	a	0	None
85652	85653	lower	0	None
85653	85654	temperature	0	None
85654	85655	(	0	None
85655	85656	70°C	0	None
85656	85657	)	0	None
85657	85658	,	0	None
85658	85659	vs	0	None
85659	85660	.	0	None

85661	85662	140°C	0	None
85662	85663	for	0	None
85663	85664	ethylcellulose	0	None
85664	85665	/	0	None
85665	85666	Soluplus®	0	None
85666	85667	.	0	None

85668	85669	The	0	None
85669	85670	maximum	0	None
85670	85671	drug	0	None
85671	85672	load	0	None
85672	85673	in	0	None
85673	85674	core	0	None
85674	85675	and	0	None
85675	85676	coat	0	None
85676	85677	depended	0	None
85677	85678	on	0	None
85678	85679	the	0	None
85679	85680	extrusion	0	None
85680	85681	temperature	0	None
85681	85682	and	0	None
85682	85683	the	0	None
85683	85684	die	0	None
85684	85685	dimensions	0	None
85685	85686	,	0	None
85686	85687	while	0	None
85687	85688	adhesion	0	None
85688	85689	between	0	None
85689	85690	core	0	None
85690	85691	and	0	None
85691	85692	coat	0	None
85692	85693	was	0	None
85693	85694	mainly	0	None
85694	85695	determined	0	None
85695	85696	by	0	None
85696	85697	the	0	None
85697	85698	drug	0	None
85698	85699	load	0	None
85699	85700	and	0	None
85700	85701	by	0	None
85701	85702	the	0	None
85702	85703	extrusion	0	None
85703	85704	temperature	0	None
85704	85705	.	0	None

85706	85707	In	0	None
85707	85708	vitro	0	None
85708	85709	drug	0	None
85709	85710	release	0	None
85710	85711	from	0	None
85711	85712	the	0	None
85712	85713	co-extruded	0	None
85713	85714	formulations	0	None
85714	85715	was	0	None
85715	85716	reflected	0	None
85716	85717	in	0	None
85717	85718	the	0	None
85718	85719	in	0	None
85719	85720	vivo	0	None
85720	85721	behavior	0	None
85721	85722	:	0	None
85722	85723	formulations	0	None
85723	85724	with	0	None
85724	85725	a	0	None
85725	85726	higher	0	None
85726	85727	DS	0	None
85727	85728	content	0	None
85728	85729	in	0	None
85729	85730	the	0	None
85730	85731	coat	0	None
85731	85732	(	0	None
85732	85733	i	0	None
85733	85734	.	0	None

85735	85736	e	0	None
85736	85737	.	0	None

85738	85739	,	0	None
85739	85740	faster	0	None
85740	85741	drug	0	None
85741	85742	release	0	None
85742	85743	)	0	None
85743	85744	resulted	0	None
85744	85745	in	0	None
85745	85746	higher	0	None
85746	85747	Cmax	0	None
85747	85748	and	0	None
85748	85749	higher	0	None
85749	85750	AUC	0	None
85750	85751	values	0	None
85751	85752	.	0	None

85753	85754	Co-extrusion	0	None
85754	85755	is	0	None
85755	85756	a	0	None
85756	85757	viable	0	None
85757	85758	method	0	None
85758	85759	to	0	None
85759	85760	produce	0	None
85760	85761	in	0	None
85761	85762	a	0	None
85762	85763	single	0	None
85763	85764	step	0	None
85764	85765	a	0	None
85765	85766	multilayer	0	None
85766	85767	dosage	0	None
85767	85768	form	0	None
85768	85769	with	0	None
85769	85770	dual	0	None
85770	85771	drug	0	None
85771	85772	release	0	None
85772	85773	.	0	None
85773	85774	Steatotic	0	None
85774	85775	grafts	0	None
85775	85776	are	0	None
85776	85777	excluded	0	None
85777	85778	for	0	None
85778	85779	use	0	None
85779	85780	in	0	None
85780	85781	partial	0	None
85781	85782	liver	0	None
85782	85783	transplantation	0	None
85783	85784	(	0	None
85784	85785	LT	0	None
85785	85786	)	0	None
85786	85787	because	0	None
85787	85788	of	0	None
85788	85789	the	0	None
85789	85790	increased	0	None
85790	85791	risk	0	None
85791	85792	of	0	None
85792	85793	primary	0	None
85793	85794	nonfunction	0	None
85794	85795	.	0	None

85796	85797	This	0	None
85797	85798	study	0	None
85798	85799	investigated	0	None
85799	85800	the	0	None
85800	85801	effects	0	None
85801	85802	of	0	None
85802	85803	suramin	2	CHEMICAL
85803	85804	,	0	None
85804	85805	a	0	None
85805	85806	polysulfonated	0	None
85806	85807	naphthylurea	0	None
85807	85808	,	0	None
85808	85809	on	0	None
85809	85810	the	0	None
85810	85811	outcome	0	None
85811	85812	of	0	None
85812	85813	steatotic	0	None
85813	85814	partial	0	None
85814	85815	LT	0	None
85815	85816	.	0	None

85817	85818	Rat	0	None
85818	85819	livers	0	None
85819	85820	were	0	None
85820	85821	harvested	0	None
85821	85822	after	0	None
85822	85823	acute	0	None
85823	85824	ethanol	2	CHEMICAL
85824	85825	treatment	0	None
85825	85826	(	0	None
85826	85827	6	0	None
85827	85828	g	0	None
85828	85829	/	0	None
85829	85830	kg	0	None
85830	85831	,	0	None
85831	85832	intragastric	0	None
85832	85833	administration	0	None
85833	85834	)	0	None
85834	85835	,	0	None
85835	85836	reduced	0	None
85836	85837	in	0	None
85837	85838	size	0	None
85838	85839	to	0	None
85839	85840	≈	0	None
85840	85841	1	0	None
85841	85842	/	0	None
85842	85843	3	0	None
85843	85844	,	0	None
85844	85845	and	0	None
85845	85846	transplanted	0	None
85846	85847	.	0	None

85848	85849	Serum	0	None
85849	85851	alanine aminotransferase	3	GENE-N
85851	85852	(	0	None
85852	85853	ALT	0	None
85853	85854	)	0	None
85854	85855	and	0	None
85855	85856	total	0	None
85856	85857	bilirubin	2	CHEMICAL
85857	85858	levels	0	None
85858	85859	as	0	None
85859	85860	well	0	None
85860	85861	as	0	None
85861	85862	hepatic	0	None
85862	85863	necrosis	0	None
85863	85864	and	0	None
85864	85865	apoptosis	0	None
85865	85866	were	0	None
85866	85867	significantly	0	None
85867	85868	higher	0	None
85868	85869	after	0	None
85869	85870	transplantation	0	None
85870	85871	of	0	None
85871	85872	fatty	0	None
85872	85873	partial	0	None
85873	85874	grafts	0	None
85874	85875	(	0	None
85875	85876	FPG	0	None
85876	85877	)	0	None
85877	85878	than	0	None
85878	85879	lean	0	None
85879	85880	partial	0	None
85880	85881	grafts	0	None
85881	85882	(	0	None
85882	85883	LPG	0	None
85883	85884	)	0	None
85884	85885	.	0	None

85886	85887	Suramin	2	CHEMICAL
85887	85888	(	0	None
85888	85889	5	0	None
85889	85890	mg	2	CHEMICAL
85890	85891	/	0	None
85891	85892	kg	0	None
85892	85893	,	0	None
85893	85894	i	0	None
85894	85895	.	0	None

85896	85897	p	0	None
85897	85898	.	0	None

85899	85900	)	0	None
85900	85901	decreased	0	None
85901	85902	ALT	0	None
85902	85903	by	0	None
85903	85904	≈	0	None
85904	85905	60%	0	None
85905	85906	,	0	None
85906	85907	hyperbilirubinemia	0	None
85907	85908	by	0	None
85908	85909	75%	0	None
85909	85910	,	0	None
85910	85911	necrosis	0	None
85911	85912	by	0	None
85912	85913	83%	0	None
85913	85914	,	0	None
85914	85915	and	0	None
85915	85916	apoptosis	0	None
85916	85917	by	0	None
85917	85918	70%	0	None
85918	85919	after	0	None
85919	85920	FPG	0	None
85920	85921	transplantation	0	None
85921	85922	.	0	None

85923	85924	Hepatic	0	None
85924	85925	cellular	0	None
85925	85926	5-bromo-2'-deoxyuridine	0	None
85926	85927	(	0	None
85927	85928	BrdU	2	CHEMICAL
85928	85929	)	0	None
85929	85930	incorporation	0	None
85930	85931	increased	0	None
85931	85932	to	0	None
85932	85933	28%	0	None
85933	85934	in	0	None
85934	85935	LPG	0	None
85935	85936	but	0	None
85936	85937	was	0	None
85937	85938	only	0	None
85938	85939	2%	0	None
85939	85940	in	0	None
85940	85941	FPG	0	None
85941	85942	at	0	None
85942	85943	48	0	None
85943	85944	hours	0	None
85944	85945	,	0	None
85945	85946	and	0	None
85946	85947	the	0	None
85947	85948	mitotic	0	None
85948	85949	index	0	None
85949	85950	increased	0	None
85950	85951	to	0	None
85951	85952	7%	0	None
85952	85953	in	0	None
85953	85954	LPG	0	None
85954	85955	but	0	None
85955	85956	was	0	None
85956	85957	only	0	None
85957	85958	0	0	None
85958	85959	.	0	None
85959	85960	2%	0	None
85960	85961	in	0	None
85961	85962	FPG	0	None
85962	85963	,	0	None
85963	85964	indicating	0	None
85964	85965	suppressed	0	None
85965	85966	regeneration	0	None
85966	85967	in	0	None
85967	85968	FPG	0	None
85968	85969	.	0	None

85970	85971	Suramin	2	CHEMICAL
85971	85972	increased	0	None
85972	85973	BrdU	2	CHEMICAL
85973	85974	incorporation	0	None
85974	85975	and	0	None
85975	85976	the	0	None
85976	85977	mitotic	0	None
85977	85978	index	0	None
85978	85979	to	0	None
85979	85980	43%	0	None
85980	85981	and	0	None
85981	85982	9%	0	None
85982	85983	,	0	None
85983	85984	respectively	0	None
85984	85985	,	0	None
85985	85986	in	0	None
85986	85987	FPG	0	None
85987	85988	.	0	None

85989	85990	All	0	None
85990	85991	FPG	0	None
85991	85992	recipients	0	None
85992	85993	died	0	None
85993	85994	within	0	None
85994	85995	5	0	None
85995	85996	days	0	None
85996	85997	.	0	None

85998	85999	Suramin	2	CHEMICAL
85999	86000	recovered	0	None
86000	86001	survival	0	None
86001	86002	of	0	None
86002	86003	FPG	0	None
86003	86004	to	0	None
86004	86005	62%	0	None
86005	86006	.	0	None

86007	86008	Tumor	0	None
86008	86009	necrosis	0	None
86009	86010	factor-α	0	None
86010	86011	(	0	None
86011	86012	TNF-α	0	None
86012	86013	)	0	None
86013	86014	mRNA	0	None
86014	86015	was	0	None
86015	86016	2	0	None
86016	86017	.	0	None
86017	86018	2-fold	0	None
86018	86019	higher	0	None
86019	86020	in	0	None
86020	86021	FPG	0	None
86021	86022	than	0	None
86022	86023	in	0	None
86023	86024	LPG	0	None
86024	86025	and	0	None
86025	86026	was	0	None
86026	86027	associated	0	None
86027	86028	with	0	None
86028	86029	activation	0	None
86029	86030	of	0	None
86030	86031	caspase-8	0	None
86031	86032	and	0	None
86032	86033	caspase-3	1	GENE-Y
86033	86034	in	0	None
86034	86035	FPG	0	None
86035	86036	.	0	None

86037	86038	Suramin	2	CHEMICAL
86038	86039	decreased	0	None
86039	86040	TNF-α	0	None
86040	86041	and	0	None
86041	86042	caspase	3	GENE-N
86042	86043	activation	0	None
86043	86044	in	0	None
86044	86045	FPG	0	None
86045	86046	.	0	None

86047	86048	Transforming	0	None
86048	86049	growth	0	None
86049	86050	factor-β	0	None
86050	86051	(	0	None
86051	86052	TGF-β	0	None
86052	86053	)	0	None
86053	86054	,	0	None
86054	86055	phospho-Smad2	0	None
86055	86056	/	0	None
86056	86057	3	0	None
86057	86058	and	0	None
86058	86059	p21Cip1	0	None
86059	86060	were	0	None
86060	86061	significantly	0	None
86061	86062	higher	0	None
86062	86063	in	0	None
86063	86064	FPG	0	None
86064	86065	than	0	None
86065	86066	in	0	None
86066	86067	LPG	0	None
86067	86068	and	0	None
86068	86069	suramin	2	CHEMICAL
86069	86070	blocked	0	None
86070	86071	TGF-β	0	None
86071	86072	formation	0	None
86072	86073	and	0	None
86073	86074	its	0	None
86074	86075	down-stream	0	None
86075	86076	signaling	0	None
86076	86077	pathway	0	None
86077	86078	.	0	None

86079	86080	Taken	0	None
86080	86081	together	0	None
86081	86082	,	0	None
86082	86083	suramin	2	CHEMICAL
86083	86084	improves	0	None
86084	86085	the	0	None
86085	86086	outcome	0	None
86086	86087	of	0	None
86087	86088	FPG	0	None
86088	86089	transplantation	0	None
86089	86090	,	0	None
86090	86091	most	0	None
86091	86092	likely	0	None
86092	86093	by	0	None
86093	86094	inhibition	0	None
86094	86095	of	0	None
86095	86096	TNF-α	0	None
86096	86097	and	0	None
86097	86098	TGF-β	0	None
86098	86099	formation	0	None
86099	86100	.	0	None
86100	86101	It	0	None
86101	86102	has	0	None
86102	86103	recently	0	None
86103	86104	been	0	None
86104	86105	shown	0	None
86105	86106	that	0	None
86106	86107	high-fat	0	None
86107	86108	diets	0	None
86108	86109	induce	0	None
86109	86110	the	0	None
86110	86111	expression	0	None
86111	86112	of	0	None
86112	86113	peroxisome	0	None
86113	86114	proliferator-activated	0	None
86114	86115	receptor	0	None
86115	86116	(	0	None
86116	86117	PPAR	0	None
86117	86118	)	0	None
86118	86119	with	0	None
86119	86120	a	0	None
86120	86121	concomitant	0	None
86121	86122	decrease	0	None
86122	86123	in	0	None
86123	86124	expression	0	None
86124	86125	of	0	None
86125	86127	retinoic acid	2	CHEMICAL
86127	86128	(	0	None
86128	86129	RAR	0	None
86129	86130	)	0	None
86130	86131	and	0	None
86131	86132	triiodothyronine	0	None
86132	86133	(	0	None
86133	86134	TR	0	None
86134	86135	)	0	None
86135	86136	receptors	0	None
86136	86137	in	0	None
86137	86138	rat	0	None
86138	86139	liver	0	None
86139	86140	.	0	None

86141	86142	The	0	None
86142	86143	authors	0	None
86143	86144	have	0	None
86144	86145	suggested	0	None
86145	86146	that	0	None
86146	86147	PPAR	0	None
86147	86148	activation	0	None
86148	86149	may	0	None
86149	86150	be	0	None
86150	86151	responsible	0	None
86151	86152	for	0	None
86152	86153	these	0	None
86153	86154	modifications	0	None
86154	86155	in	0	None
86155	86157	nuclear receptor	3	GENE-N
86157	86158	expression	0	None
86158	86159	.	0	None

86160	86161	With	0	None
86161	86162	the	0	None
86162	86163	aim	0	None
86163	86164	of	0	None
86164	86165	gaining	0	None
86165	86166	further	0	None
86166	86167	insight	0	None
86167	86168	into	0	None
86168	86169	a	0	None
86169	86170	possible	0	None
86170	86171	relationship	0	None
86171	86172	between	0	None
86172	86173	the	0	None
86173	86174	patterns	0	None
86174	86175	of	0	None
86175	86176	expression	0	None
86176	86177	of	0	None
86177	86178	these	0	None
86178	86179	receptors	0	None
86179	86180	,	0	None
86180	86181	we	0	None
86181	86182	have	0	None
86182	86183	examined	0	None
86183	86184	,	0	None
86184	86185	using	0	None
86185	86186	a	0	None
86186	86187	pharmacological	0	None
86187	86188	model	0	None
86188	86189	,	0	None
86189	86190	the	0	None
86190	86191	effect	0	None
86191	86192	of	0	None
86192	86193	a	0	None
86193	86194	strong	0	None
86194	86195	and	0	None
86195	86196	specific	0	None
86196	86197	PPAR	0	None
86197	86198	activation	0	None
86198	86199	induced	0	None
86199	86200	by	0	None
86200	86201	bezafibrate	0	None
86201	86202	,	0	None
86202	86203	a	0	None
86203	86204	peroxisome	0	None
86204	86205	proliferator	0	None
86205	86206	agent	0	None
86206	86207	.	0	None

86208	86209	Activation	0	None
86209	86210	of	0	None
86210	86211	PPAR	0	None
86211	86212	was	0	None
86212	86213	evaluated	0	None
86213	86214	by	0	None
86214	86215	quantifying	0	None
86215	86216	PPAR	0	None
86216	86217	alpha	0	None
86217	86218	mRNA	0	None
86218	86219	and	0	None
86219	86221	acyl-CoA oxidase	3	GENE-N
86221	86222	mRNA	0	None
86222	86223	.	0	None

86224	86225	The	0	None
86225	86226	expression	0	None
86226	86227	of	0	None
86227	86228	RAR	0	None
86228	86229	and	0	None
86229	86230	TR	0	None
86230	86231	was	0	None
86231	86232	determined	0	None
86232	86233	by	0	None
86233	86234	assaying	0	None
86234	86235	the	0	None
86235	86236	binding	0	None
86236	86237	properties	0	None
86237	86238	of	0	None
86238	86239	these	0	None
86239	86241	nuclear receptors	3	GENE-N
86241	86242	and	0	None
86242	86243	by	0	None
86243	86244	quantifying	0	None
86244	86245	the	0	None
86245	86246	mRNA	0	None
86246	86247	level	0	None
86247	86248	of	0	None
86248	86250	RAR beta	1	GENE-Y
86250	86251	and	0	None
86251	86252	TR	0	None
86252	86253	alpha1	0	None
86253	86254	,	0	None
86254	86255	beta1	0	None
86255	86256	isoforms	0	None
86256	86257	.	0	None

86258	86259	After	0	None
86259	86260	a	0	None
86260	86261	10	0	None
86261	86262	day	0	None
86262	86263	treatment	0	None
86263	86264	of	0	None
86264	86265	young	0	None
86265	86266	rats	0	None
86266	86267	,	0	None
86267	86268	induction	0	None
86268	86269	of	0	None
86269	86270	PPAR	0	None
86270	86271	(	0	None
86271	86272	PPAR	0	None
86272	86273	alpha	0	None
86273	86274	mRNA	0	None
86274	86275	was	0	None
86275	86276	increased	0	None
86276	86277	by	0	None
86277	86278	40%	0	None
86278	86279	[	0	None
86279	86280	P<	0	None
86280	86281	0	0	None
86281	86282	.	0	None
86282	86283	05	0	None
86283	86284	and	0	None
86284	86285	acyl-CoA	0	None
86285	86286	oxidase	0	None
86286	86287	mRNA	0	None
86287	86288	by	0	None
86288	86289	411%	0	None
86289	86290	[	0	None
86290	86291	P<0	0	None
86291	86292	.	0	None
86292	86293	001	0	None
86293	86294	]	0	None
86294	86295	)	0	None
86295	86296	and	0	None
86296	86297	a	0	None
86297	86298	concomitant	0	None
86298	86299	decrease	0	None
86299	86300	of	0	None
86300	86301	RAR	0	None
86301	86302	and	0	None
86302	86303	TR	0	None
86303	86304	expression	0	None
86304	86305	(	0	None
86305	86306	Maximal	0	None
86306	86307	Binding	0	None
86307	86308	Capacity	0	None
86308	86309	was	0	None
86309	86310	decreased	0	None
86310	86311	by	0	None
86311	86312	21	0	None
86312	86313	and	0	None
86313	86314	26%	0	None
86314	86315	,	0	None
86315	86316	respectively	0	None
86316	86317	[	0	None
86317	86318	P<0	0	None
86318	86319	.	0	None
86319	86320	05	0	None
86320	86321	]	0	None
86321	86322	)	0	None
86322	86323	in	0	None
86323	86324	the	0	None
86324	86325	liver	0	None
86325	86326	was	0	None
86326	86327	observed	0	None
86327	86328	.	0	None

86329	86330	RXR	0	None
86330	86331	alpha	0	None
86331	86332	mRNA	0	None
86332	86333	expression	0	None
86333	86334	was	0	None
86334	86335	unchanged	0	None
86335	86336	by	0	None
86336	86337	treatment	0	None
86337	86338	.	0	None

86339	86340	Cross-talk	0	None
86340	86341	between	0	None
86341	86342	RAR	0	None
86342	86343	,	0	None
86343	86344	TR	0	None
86344	86345	and	0	None
86345	86346	PPAR	0	None
86346	86347	signalling	0	None
86347	86348	pathways	0	None
86348	86349	may	0	None
86349	86350	be	0	None
86350	86351	implicated	0	None
86351	86352	in	0	None
86352	86353	the	0	None
86353	86354	new	0	None
86354	86355	patterns	0	None
86355	86356	of	0	None
86356	86358	nuclear receptor	3	GENE-N
86358	86359	expression	0	None
86359	86360	observed	0	None
86360	86361	.	0	None

86362	86363	The	0	None
86363	86364	decreased	0	None
86364	86365	expression	0	None
86365	86366	of	0	None
86366	86367	RAR	0	None
86367	86368	and	0	None
86368	86369	TR	0	None
86369	86370	reported	0	None
86370	86371	here	0	None
86371	86372	could	0	None
86372	86373	provide	0	None
86373	86374	a	0	None
86374	86375	novel	0	None
86375	86376	element	0	None
86376	86377	for	0	None
86377	86378	the	0	None
86378	86379	understanding	0	None
86379	86380	of	0	None
86380	86381	the	0	None
86381	86382	link	0	None
86382	86383	between	0	None
86383	86384	PPAR	0	None
86384	86385	and	0	None
86385	86386	tumorigenesis	0	None
86386	86387	in	0	None
86387	86388	rat	0	None
86388	86389	liver	0	None
86389	86390	.	0	None
86390	86391	In	0	None
86391	86392	this	0	None
86392	86393	study	0	None
86393	86394	,	0	None
86394	86395	we	0	None
86395	86396	investigated	0	None
86396	86397	the	0	None
86397	86398	effect	0	None
86398	86399	of	0	None
86399	86400	dexamethasone	2	CHEMICAL
86400	86401	on	0	None
86401	86402	the	0	None
86402	86403	synthesis	0	None
86403	86404	of	0	None
86404	86405	steroidogenic	0	None
86405	86406	acute	0	None
86406	86407	regulatory	0	None
86407	86408	protein	0	None
86408	86409	(	0	None
86409	86410	StAR	0	None
86410	86411	)	0	None
86411	86412	and	0	None
86412	86413	the	0	None
86413	86414	expression	0	None
86414	86415	of	0	None
86415	86416	DAX-1	0	None
86416	86417	(	0	None
86417	86418	dosage	0	None
86418	86419	sensitive	0	None
86419	86420	sex	0	None
86420	86421	reversal	0	None
86421	86422	adrenal	0	None
86422	86423	hypoplasia	0	None
86423	86424	congenita	0	None
86424	86425	critical	0	None
86425	86426	region	0	None
86426	86427	on	0	None
86427	86428	the	0	None
86428	86429	X	0	None
86429	86430	chromosome	0	None
86430	86431	,	0	None
86431	86432	gene	0	None
86432	86433	1	0	None
86433	86434	)	0	None
86434	86435	and	0	None
86435	86436	SF-1	1	GENE-Y
86436	86437	(	0	None
86437	86438	steroidogenic	0	None
86438	86439	factor-1	0	None
86439	86440	)	0	None
86440	86441	in	0	None
86441	86442	vivo	0	None
86442	86443	.	0	None

86444	86445	Male	0	None
86445	86446	rats	0	None
86446	86447	were	0	None
86447	86448	treated	0	None
86448	86449	with	0	None
86449	86450	dexamethasone	2	CHEMICAL
86450	86451	(	0	None
86451	86452	0	0	None
86452	86453	.	0	None
86453	86454	4	0	None
86454	86455	and	0	None
86455	86456	4	0	None
86456	86457	mg	2	CHEMICAL
86457	86458	/	0	None
86458	86459	kg	0	None
86459	86460	body	0	None
86460	86461	wt	0	None
86461	86462	per	0	None
86462	86463	day	0	None
86463	86464	)	0	None
86464	86465	by	0	None
86465	86466	intraperitoneal	0	None
86466	86467	injections	0	None
86467	86468	using	0	None
86468	86469	phosphate-buffered	0	None
86469	86470	saline	0	None
86470	86471	as	0	None
86471	86472	the	0	None
86472	86473	vehicle	0	None
86473	86474	for	0	None
86474	86475	7	0	None
86475	86476	d	0	None
86476	86477	.	0	None

86478	86479	At	0	None
86479	86480	the	0	None
86480	86481	end	0	None
86481	86482	of	0	None
86482	86483	7	0	None
86483	86484	d	0	None
86484	86485	,	0	None
86485	86486	serum	0	None
86486	86487	testosterone	2	CHEMICAL
86487	86488	levels	0	None
86488	86489	were	0	None
86489	86490	decreased	0	None
86490	86491	.	0	None

86492	86493	Response	0	None
86493	86494	to	0	None
86494	86495	luteinizing	0	None
86495	86496	hormone	0	None
86496	86497	(	0	None
86497	86498	LH	0	None
86498	86499	)	0	None
86499	86500	and	0	None
86500	86501	8-bromo-cyclic-AMP	0	None
86501	86502	(	0	None
86502	86503	8-Br-cAMP	0	None
86503	86504	)	0	None
86504	86505	in	0	None
86505	86506	vitro	0	None
86506	86507	was	0	None
86507	86508	reduced	0	None
86508	86509	in	0	None
86509	86510	testicular	0	None
86510	86511	cells	0	None
86511	86512	isolated	0	None
86512	86513	from	0	None
86513	86514	dexamethasone-treated	0	None
86514	86515	rat	0	None
86515	86516	testes	0	None
86516	86517	.	0	None

86518	86519	Dexamethasone	2	CHEMICAL
86519	86520	decreased	0	None
86520	86521	LH-stimulated	0	None
86521	86522	cAMP	0	None
86522	86523	production	0	None
86523	86524	.	0	None

86525	86526	The	0	None
86526	86527	conversion	0	None
86527	86528	of	0	None
86528	86529	22	0	None
86529	86530	(	0	None
86530	86531	R	0	None
86531	86532	)	0	None
86532	86533	-hydroxycholesterol	0	None
86533	86534	,	0	None
86534	86535	pregnenolone	2	CHEMICAL
86535	86536	,	0	None
86536	86537	17-hydroxypregnenolone	0	None
86537	86538	,	0	None
86538	86539	dehydroepiandrosterone	0	None
86539	86540	,	0	None
86540	86541	and	0	None
86541	86542	androstenedione	0	None
86542	86543	to	0	None
86543	86544	testosterone	2	CHEMICAL
86544	86545	was	0	None
86545	86546	not	0	None
86546	86547	affected	0	None
86547	86548	by	0	None
86548	86549	dexamethasone	2	CHEMICAL
86549	86550	.	0	None

86551	86552	Dexamethasone	2	CHEMICAL
86552	86553	increased	0	None
86553	86554	DAX-1	0	None
86554	86555	expression	0	None
86555	86556	and	0	None
86556	86557	concordantly	0	None
86557	86558	decreased	0	None
86558	86559	StAR	0	None
86559	86560	protein	0	None
86560	86561	and	0	None
86561	86562	mRNA	0	None
86562	86563	in	0	None
86563	86564	testicular	0	None
86564	86565	cells	0	None
86565	86566	.	0	None

86567	86568	The	0	None
86568	86569	increase	0	None
86569	86570	in	0	None
86570	86571	DAX-1	0	None
86571	86572	protein	0	None
86572	86573	corresponded	0	None
86573	86574	to	0	None
86574	86575	a	0	None
86575	86576	57%	0	None
86576	86577	reduction	0	None
86577	86578	in	0	None
86578	86579	StAR	0	None
86579	86580	mRNA	0	None
86580	86581	levels	0	None
86581	86582	concomitant	0	None
86582	86583	with	0	None
86583	86584	a	0	None
86584	86585	79%	0	None
86585	86586	reduction	0	None
86586	86587	in	0	None
86587	86588	serum	0	None
86588	86589	testosterone	2	CHEMICAL
86589	86590	levels	0	None
86590	86591	.	0	None

86592	86593	Dexamethasone	2	CHEMICAL
86593	86594	had	0	None
86594	86595	no	0	None
86595	86596	effect	0	None
86596	86597	on	0	None
86597	86598	the	0	None
86598	86599	level	0	None
86599	86600	of	0	None
86600	86601	SF-1	1	GENE-Y
86601	86602	,	0	None
86602	86603	but	0	None
86603	86604	increased	0	None
86604	86605	the	0	None
86605	86606	amount	0	None
86606	86607	of	0	None
86607	86608	complexed	0	None
86608	86609	DAX-1-SF-1	0	None
86609	86610	.	0	None

86611	86612	Dexamethasone	2	CHEMICAL
86612	86613	in	0	None
86613	86614	vitro	0	None
86614	86615	suppressed	0	None
86615	86616	StAR	0	None
86616	86617	promoter	0	None
86617	86618	activity	0	None
86618	86619	when	0	None
86619	86620	an	0	None
86620	86621	increasing	0	None
86621	86622	amount	0	None
86622	86623	of	0	None
86623	86624	DAX-1	0	None
86624	86625	cDNA	0	None
86625	86626	was	0	None
86626	86627	transfected	0	None
86627	86628	.	0	None

86629	86630	These	0	None
86630	86631	results	0	None
86631	86632	demonstrate	0	None
86632	86633	that	0	None
86633	86634	dexamethasone	2	CHEMICAL
86634	86635	increases	0	None
86635	86636	expression	0	None
86636	86637	of	0	None
86637	86638	DAX-1	0	None
86638	86639	,	0	None
86639	86640	which	0	None
86640	86641	results	0	None
86641	86642	in	0	None
86642	86643	increased	0	None
86643	86644	amounts	0	None
86644	86645	of	0	None
86645	86646	complexed	0	None
86646	86647	DAX-1-SF-1	0	None
86647	86648	,	0	None
86648	86649	in	0	None
86649	86650	the	0	None
86650	86651	absence	0	None
86651	86652	of	0	None
86652	86653	any	0	None
86653	86654	change	0	None
86654	86655	in	0	None
86655	86656	the	0	None
86656	86657	expression	0	None
86657	86658	of	0	None
86658	86659	SF-1	1	GENE-Y
86659	86660	.	0	None

86661	86662	These	0	None
86662	86663	observations	0	None
86663	86664	strongly	0	None
86664	86665	support	0	None
86665	86666	the	0	None
86666	86667	concept	0	None
86667	86668	that	0	None
86668	86669	dexamethasone	2	CHEMICAL
86669	86670	suppresses	0	None
86670	86671	rat	0	None
86671	86672	testicular	0	None
86672	86673	testosterone	2	CHEMICAL
86673	86674	production	0	None
86674	86675	,	0	None
86675	86676	at	0	None
86676	86677	least	0	None
86677	86678	in	0	None
86678	86679	part	0	None
86679	86680	,	0	None
86680	86681	by	0	None
86681	86682	increasing	0	None
86682	86683	the	0	None
86683	86684	amount	0	None
86684	86685	of	0	None
86685	86686	complexed	0	None
86686	86687	DAX-1-SF-1	0	None
86687	86688	in	0	None
86688	86689	these	0	None
86689	86690	cells	0	None
86690	86691	,	0	None
86691	86692	which	0	None
86692	86693	leads	0	None
86693	86694	directly	0	None
86694	86695	to	0	None
86695	86696	decreased	0	None
86696	86697	availability	0	None
86697	86698	of	0	None
86698	86699	free	0	None
86699	86700	SF-1	1	GENE-Y
86700	86701	and	0	None
86701	86702	,	0	None
86702	86703	therefore	0	None
86703	86704	,	0	None
86704	86705	decreased	0	None
86705	86706	activation	0	None
86706	86707	of	0	None
86707	86708	transcription	0	None
86708	86709	of	0	None
86709	86710	the	0	None
86710	86711	rat	0	None
86711	86712	StAR	0	None
86712	86713	gene	0	None
86713	86714	.	0	None
86714	86715	A	0	None
86715	86716	series	0	None
86716	86717	of	0	None
86717	86718	phenolic	0	None
86718	86719	acids	0	None
86719	86720	and	0	None
86720	86721	phenol	0	None
86721	86722	natural	0	None
86722	86723	products	0	None
86723	86724	,	0	None
86724	86725	such	0	None
86725	86726	as	0	None
86726	86727	p-hydroxybenzoic	0	None
86727	86728	acid	0	None
86728	86729	,	0	None
86729	86731	p-coumaric acid	2	CHEMICAL
86731	86732	,	0	None
86732	86733	caffeic	0	None
86733	86734	acid	0	None
86734	86735	,	0	None
86735	86736	ferulic	0	None
86736	86737	acid	0	None
86737	86738	,	0	None
86738	86739	gallic	0	None
86739	86740	acid	0	None
86740	86741	,	0	None
86741	86742	syringic	0	None
86742	86743	acid	0	None
86743	86744	,	0	None
86744	86745	quercetin	0	None
86745	86746	,	0	None
86746	86747	and	0	None
86747	86749	ellagic acid	2	CHEMICAL
86749	86750	,	0	None
86750	86751	were	0	None
86751	86752	investigated	0	None
86752	86753	for	0	None
86753	86754	their	0	None
86754	86755	inhibitory	0	None
86755	86756	effects	0	None
86756	86757	against	0	None
86757	86758	the	0	None
86758	86759	metalloenzyme	0	None
86759	86760	carbonic	0	None
86760	86761	anhydrase	0	None
86761	86762	(	0	None
86762	86763	CA	1	GENE-Y
86763	86764	,	0	None
86764	86765	EC	0	None
86765	86766	4	0	None
86766	86767	.	0	None
86767	86768	2	0	None
86768	86769	.	0	None
86769	86770	1	0	None
86770	86771	.	0	None
86771	86772	1	0	None
86772	86773	)	0	None
86773	86774	.	0	None

86775	86776	All	0	None
86776	86777	mammalian	0	None
86777	86778	isozymes	0	None
86778	86779	of	0	None
86779	86780	human	0	None
86780	86781	(	0	None
86781	86782	h	0	None
86782	86783	)	0	None
86783	86784	or	0	None
86784	86785	murine	0	None
86785	86786	(	0	None
86786	86787	m	0	None
86787	86788	)	0	None
86788	86789	origin	0	None
86789	86790	hCA	0	None
86790	86791	I-hCA	0	None
86791	86792	XII	0	None
86792	86793	,	0	None
86793	86794	mCA	0	None
86794	86795	XIII	0	None
86795	86796	and	0	None
86796	86797	hCA	0	None
86797	86798	XIV	0	None
86798	86799	were	0	None
86799	86800	inhibited	0	None
86800	86801	in	0	None
86801	86802	the	0	None
86802	86803	low	0	None
86803	86804	micromolar	0	None
86804	86805	or	0	None
86805	86806	submicromolar	0	None
86806	86807	range	0	None
86807	86808	by	0	None
86808	86809	these	0	None
86809	86810	(	0	None
86810	86811	poly	0	None
86811	86812	)	0	None
86812	86813	phenols	0	None
86813	86814	(	0	None
86814	86815	K	0	None
86815	86816	(	0	None
86816	86817	I	0	None
86817	86818	)	0	None
86818	86819	s	0	None
86819	86820	in	0	None
86820	86821	the	0	None
86821	86822	range	0	None
86822	86823	of	0	None
86823	86824	0	0	None
86824	86825	.	0	None
86825	86826	87-7	0	None
86826	86827	.	0	None
86827	86828	79	0	None
86828	86829	microM	0	None
86829	86830	)	0	None
86830	86831	.	0	None

86832	86833	p-Hydroxybenzoic	0	None
86833	86834	acid	0	None
86834	86835	was	0	None
86835	86836	the	0	None
86836	86837	best	0	None
86837	86838	inhibitor	0	None
86838	86839	of	0	None
86839	86840	all	0	None
86840	86841	isozymes	0	None
86841	86842	(	0	None
86842	86843	K	0	None
86843	86844	(	0	None
86844	86845	I	0	None
86845	86846	)	0	None
86846	86847	s	0	None
86847	86848	of	0	None
86848	86849	0	0	None
86849	86850	.	0	None
86850	86851	87-35	0	None
86851	86852	.	0	None
86852	86853	4	0	None
86853	86854	microM	0	None
86854	86855	)	0	None
86855	86856	and	0	None
86856	86857	the	0	None
86857	86858	different	0	None
86858	86859	isozymes	0	None
86859	86860	showed	0	None
86860	86861	very	0	None
86861	86862	variable	0	None
86862	86863	inhibition	0	None
86863	86864	profiles	0	None
86864	86865	with	0	None
86865	86866	these	0	None
86866	86867	derivatives	0	None
86867	86868	.	0	None

86869	86870	Phenols	0	None
86870	86871	like	0	None
86871	86872	the	0	None
86872	86873	ones	0	None
86873	86874	investigated	0	None
86874	86875	here	0	None
86875	86876	possess	0	None
86876	86877	a	0	None
86877	86878	CA	1	GENE-Y
86878	86879	inhibition	0	None
86879	86880	mechanism	0	None
86880	86881	distinct	0	None
86881	86882	of	0	None
86882	86883	that	0	None
86883	86884	of	0	None
86884	86885	the	0	None
86885	86886	sulfonamides	0	None
86886	86887	/	0	None
86887	86888	sulfamates	2	CHEMICAL
86888	86889	used	0	None
86889	86890	clinically	0	None
86890	86891	or	0	None
86891	86892	the	0	None
86892	86893	coumarins	2	CHEMICAL
86893	86894	.	0	None

86895	86896	Unlike	0	None
86896	86897	the	0	None
86897	86898	sulfonamides	0	None
86898	86899	,	0	None
86899	86900	which	0	None
86900	86901	bind	0	None
86901	86902	to	0	None
86902	86903	the	0	None
86903	86904	catalytic	0	None
86904	86905	zinc	2	CHEMICAL
86905	86906	ion	2	CHEMICAL
86906	86907	,	0	None
86907	86908	phenols	0	None
86908	86909	are	0	None
86909	86910	anchored	0	None
86910	86911	at	0	None
86911	86912	the	0	None
86912	86913	Zn	0	None
86913	86914	(	0	None
86914	86915	II	0	None
86915	86916	)	0	None
86916	86917	-coordinated	0	None
86917	86918	water	0	None
86918	86919	molecule	0	None
86919	86920	and	0	None
86920	86921	bind	0	None
86921	86922	more	0	None
86922	86923	externally	0	None
86923	86924	within	0	None
86924	86925	the	0	None
86925	86926	active	0	None
86926	86927	site	0	None
86927	86928	cavity	0	None
86928	86929	,	0	None
86929	86930	making	0	None
86930	86931	contacts	0	None
86931	86932	with	0	None
86932	86933	various	0	None
86933	86935	amino acid	2	CHEMICAL
86935	86936	residues	0	None
86936	86937	.	0	None

86938	86939	As	0	None
86939	86940	this	0	None
86940	86941	is	0	None
86941	86942	the	0	None
86942	86943	region	0	None
86943	86944	with	0	None
86944	86945	the	0	None
86945	86946	highest	0	None
86946	86947	variability	0	None
86947	86948	between	0	None
86948	86949	the	0	None
86949	86950	many	0	None
86950	86951	CA	1	GENE-Y
86951	86952	isozymes	0	None
86952	86953	found	0	None
86953	86954	in	0	None
86954	86955	mammals	0	None
86955	86956	,	0	None
86956	86957	this	0	None
86957	86958	class	0	None
86958	86959	of	0	None
86959	86960	compounds	0	None
86960	86961	may	0	None
86961	86962	lead	0	None
86962	86963	to	0	None
86963	86964	isoform-selective	0	None
86964	86965	inhibitors	0	None
86965	86966	targeting	0	None
86966	86967	just	0	None
86967	86968	one	0	None
86968	86969	or	0	None
86969	86970	few	0	None
86970	86971	of	0	None
86971	86972	the	0	None
86972	86973	medicinally	0	None
86973	86974	relevant	0	None
86974	86975	CAs	0	None
86975	86976	.	0	None
86976	86977	Enzymatic	0	None
86977	86978	characterization	0	None
86978	86979	of	0	None
86979	86980	a	0	None
86980	86981	recombinant	0	None
86981	86982	isoform	0	None
86982	86983	hybrid	0	None
86983	86984	of	0	None
86984	86987	glutamic acid decarboxylase	3	GENE-N
86987	86988	(	0	None
86988	86989	rGAD67	0	None
86989	86990	/	0	None
86990	86991	65	0	None
86991	86992	)	0	None
86992	86993	expressed	0	None
86993	86994	in	0	None
86994	86995	yeast	0	None
86995	86996	.	0	None
86996	86997	We	0	None
86997	86998	have	0	None
86998	86999	investigated	0	None
86999	87000	the	0	None
87000	87001	effects	0	None
87001	87002	of	0	None
87002	87003	volatile	0	None
87003	87004	anaesthetics	0	None
87004	87005	on	0	None
87005	87006	electron	0	None
87006	87007	transport	0	None
87007	87008	chain	0	None
87008	87009	activity	0	None
87009	87010	in	0	None
87010	87011	the	0	None
87011	87012	mammalian	0	None
87012	87013	heart	0	None
87013	87014	.	0	None

87015	87016	Halothane	0	None
87016	87017	,	0	None
87017	87018	isoflurane	0	None
87018	87019	and	0	None
87019	87020	sevoflurane	0	None
87020	87021	reversibly	0	None
87021	87022	increased	0	None
87022	87023	NADH	2	CHEMICAL
87023	87024	fluorescence	0	None
87024	87025	(	0	None
87025	87026	autofluorescence	0	None
87026	87027	)	0	None
87027	87028	in	0	None
87028	87029	intact	0	None
87029	87030	ventricular	0	None
87030	87031	myocytes	0	None
87031	87032	of	0	None
87032	87033	guinea-pig	0	None
87033	87034	,	0	None
87034	87035	suggesting	0	None
87035	87036	that	0	None
87036	87037	NADH	2	CHEMICAL
87037	87038	oxidation	0	None
87038	87039	was	0	None
87039	87040	impaired	0	None
87040	87041	.	0	None

87042	87043	Using	0	None
87043	87044	pig	0	None
87044	87045	heart	0	None
87045	87046	submitochondrial	0	None
87046	87047	particles	0	None
87047	87048	we	0	None
87048	87049	found	0	None
87049	87050	that	0	None
87050	87051	the	0	None
87051	87052	anaesthetics	0	None
87052	87053	dose-dependently	0	None
87053	87054	inhibited	0	None
87054	87055	NADH	2	CHEMICAL
87055	87056	oxidation	0	None
87056	87057	in	0	None
87057	87058	the	0	None
87058	87059	order	0	None
87059	87060	:	0	None
87060	87061	halothane	0	None
87061	87062	>	0	None
87062	87063	isoflurane	0	None
87063	87064	=	0	None
87064	87065	sevoflurane	0	None
87065	87066	.	0	None

87067	87068	Succinate	0	None
87068	87069	oxidation	0	None
87069	87070	was	0	None
87070	87071	unaffected	0	None
87071	87072	by	0	None
87072	87073	either	0	None
87073	87074	isoflurane	0	None
87074	87075	or	0	None
87075	87076	sevoflurane	0	None
87076	87077	,	0	None
87077	87078	indicating	0	None
87078	87079	that	0	None
87079	87080	these	0	None
87080	87081	agents	0	None
87081	87082	selectively	0	None
87082	87083	inhibit	0	None
87083	87084	complex	0	None
87084	87085	I	0	None
87085	87086	(	0	None
87086	87087	NADH	2	CHEMICAL
87087	87088	:	0	None
87088	87089	ubiquinone	0	None
87089	87090	oxidoreductase	0	None
87090	87091	)	0	None
87091	87092	.	0	None

87093	87094	In	0	None
87094	87095	addition	0	None
87095	87096	to	0	None
87096	87097	inhibiting	0	None
87097	87098	NADH	2	CHEMICAL
87098	87099	oxidation	0	None
87099	87100	,	0	None
87100	87101	halothane	0	None
87101	87102	also	0	None
87102	87103	inhibited	0	None
87103	87104	succinate	0	None
87104	87105	oxidation	0	None
87105	87106	(	0	None
87106	87107	and	0	None
87107	87108	succinate	0	None
87108	87109	dehydrogenase	0	None
87109	87110	)	0	None
87110	87111	,	0	None
87111	87112	albeit	0	None
87112	87113	to	0	None
87113	87114	a	0	None
87114	87115	lesser	0	None
87115	87116	extent	0	None
87116	87117	.	0	None

87118	87119	To	0	None
87119	87120	test	0	None
87120	87121	the	0	None
87121	87122	hypothesis	0	None
87122	87123	that	0	None
87123	87124	complex	0	None
87124	87125	I	0	None
87125	87126	is	0	None
87126	87127	a	0	None
87127	87128	target	0	None
87128	87129	of	0	None
87129	87130	volatile	0	None
87130	87131	anaesthetics	0	None
87131	87132	,	0	None
87132	87133	we	0	None
87133	87134	examined	0	None
87134	87135	the	0	None
87135	87136	effects	0	None
87136	87137	of	0	None
87137	87138	these	0	None
87138	87139	agents	0	None
87139	87140	on	0	None
87140	87141	NADH	2	CHEMICAL
87141	87142	:	0	None
87142	87143	ubiquinone	0	None
87143	87144	oxidoreductase	0	None
87144	87145	(	0	None
87145	87146	EC	0	None
87146	87147	1	0	None
87147	87148	.	0	None
87148	87149	6	0	None
87149	87150	.	0	None
87150	87151	99	0	None
87151	87152	.	0	None
87152	87153	3	0	None
87153	87154	)	0	None
87154	87155	activity	0	None
87155	87156	using	0	None
87156	87157	the	0	None
87157	87158	ubiquinone	0	None
87158	87159	analogue	0	None
87159	87160	DBQ	0	None
87160	87161	(	0	None
87161	87162	decylubiquinone	0	None
87162	87163	)	0	None
87163	87164	as	0	None
87164	87165	substrate	0	None
87165	87166	.	0	None

87167	87168	Halothane	0	None
87168	87169	,	0	None
87169	87170	isoflurane	0	None
87170	87171	and	0	None
87171	87172	sevoflurane	0	None
87172	87173	dose-dependently	0	None
87173	87174	inhibited	0	None
87174	87175	NADH	2	CHEMICAL
87175	87176	:	0	None
87176	87177	DBQ	0	None
87177	87178	oxidoreductase	0	None
87178	87179	activity	0	None
87179	87180	.	0	None

87181	87182	Unlike	0	None
87182	87183	the	0	None
87183	87184	classical	0	None
87184	87185	inhibitor	0	None
87185	87186	rotenone	0	None
87186	87187	,	0	None
87187	87188	none	0	None
87188	87189	of	0	None
87189	87190	the	0	None
87190	87191	anaesthetics	0	None
87191	87192	completely	0	None
87192	87193	inhibited	0	None
87193	87194	enzyme	0	None
87194	87195	activity	0	None
87195	87196	at	0	None
87196	87197	high	0	None
87197	87198	concentration	0	None
87198	87199	,	0	None
87199	87200	suggesting	0	None
87200	87201	that	0	None
87201	87202	these	0	None
87202	87203	agents	0	None
87203	87204	bind	0	None
87204	87205	weakly	0	None
87205	87206	to	0	None
87206	87207	the	0	None
87207	87208	'hydrophobic	0	None
87208	87209	inhibitory	0	None
87209	87210	site'	0	None
87210	87211	of	0	None
87211	87212	complex	0	None
87212	87213	I	0	None
87213	87214	.	0	None

87215	87216	In	0	None
87216	87217	conclusion	0	None
87217	87218	,	0	None
87218	87219	halothane	0	None
87219	87220	,	0	None
87220	87221	isoflurane	0	None
87221	87222	and	0	None
87222	87223	sevoflurane	0	None
87223	87224	inhibit	0	None
87224	87225	complex	0	None
87225	87226	I	0	None
87226	87227	(	0	None
87227	87228	NADH	2	CHEMICAL
87228	87229	:	0	None
87229	87230	ubiquinone	0	None
87230	87231	oxidoreductase	0	None
87231	87232	)	0	None
87232	87233	of	0	None
87233	87234	the	0	None
87234	87235	electron	0	None
87235	87236	transport	0	None
87236	87237	chain	0	None
87237	87238	.	0	None

87239	87240	At	0	None
87240	87241	concentrations	0	None
87241	87242	of	0	None
87242	87243	approximately	0	None
87243	87244	2	0	None
87244	87245	MAC	0	None
87245	87246	(	0	None
87246	87247	minimal	0	None
87247	87248	alveolar	0	None
87248	87249	concentration	0	None
87249	87250	)	0	None
87250	87251	,	0	None
87251	87252	the	0	None
87252	87253	activity	0	None
87253	87254	of	0	None
87254	87255	NADH	2	CHEMICAL
87255	87256	:	0	None
87256	87257	ubiquinone	0	None
87257	87258	oxidoreductase	0	None
87258	87259	was	0	None
87259	87260	reduced	0	None
87260	87261	by	0	None
87261	87262	about	0	None
87262	87263	20	0	None
87263	87264	%	0	None
87264	87265	in	0	None
87265	87266	the	0	None
87266	87267	presence	0	None
87267	87268	of	0	None
87268	87269	halothane	0	None
87269	87270	or	0	None
87270	87271	isoflurane	0	None
87271	87272	,	0	None
87272	87273	and	0	None
87273	87274	by	0	None
87274	87275	about	0	None
87275	87276	10	0	None
87276	87277	%	0	None
87277	87278	in	0	None
87278	87279	the	0	None
87279	87280	presence	0	None
87280	87281	of	0	None
87281	87282	sevoflurane	0	None
87282	87283	.	0	None

87284	87285	These	0	None
87285	87286	inhibitory	0	None
87286	87287	effects	0	None
87287	87288	are	0	None
87288	87289	unlikely	0	None
87289	87290	to	0	None
87290	87291	compromise	0	None
87291	87292	cardiac	0	None
87292	87293	performance	0	None
87293	87294	at	0	None
87294	87295	usual	0	None
87295	87296	clinical	0	None
87296	87297	concentrations	0	None
87297	87298	,	0	None
87298	87299	but	0	None
87299	87300	may	0	None
87300	87301	contribute	0	None
87301	87302	to	0	None
87302	87303	the	0	None
87303	87304	mechanism	0	None
87304	87305	by	0	None
87305	87306	which	0	None
87306	87307	volatile	0	None
87307	87308	anaesthetics	0	None
87308	87309	induce	0	None
87309	87310	pharmacological	0	None
87310	87311	preconditioning	0	None
87311	87312	.	0	None
87312	87313	ETHNOPHARMACOLOGICAL	0	None
87313	87314	RELEVANCE	0	None
87314	87315	:	0	None
87315	87316	Licorice	0	None
87316	87317	(	0	None
87317	87318	Glycyrrhiza	0	None
87318	87319	uralensis	0	None
87319	87320	Fisch	0	None
87320	87321	.	0	None

87322	87323	,	0	None
87323	87324	Leguminosae	0	None
87324	87325	)	0	None
87325	87326	has	0	None
87326	87327	been	0	None
87327	87328	used	0	None
87328	87329	in	0	None
87329	87330	herbal	0	None
87330	87331	medicine	0	None
87331	87332	and	0	None
87332	87333	food	0	None
87333	87334	supplement	0	None
87334	87335	worldwide	0	None
87335	87336	for	0	None
87336	87337	centuries	0	None
87337	87338	.	0	None

87339	87340	Licorice	0	None
87340	87341	is	0	None
87341	87342	a	0	None
87342	87343	common	0	None
87343	87344	ingredient	0	None
87344	87345	of	0	None
87345	87346	several	0	None
87346	87347	prescriptions	0	None
87347	87348	of	0	None
87348	87349	traditional	0	None
87349	87350	Chinese	0	None
87350	87351	medicine	0	None
87351	87352	which	0	None
87352	87353	have	0	None
87353	87354	been	0	None
87354	87355	proved	0	None
87355	87356	to	0	None
87356	87357	inhibit	0	None
87357	87358	infection	0	None
87358	87359	of	0	None
87359	87360	human	0	None
87360	87361	respiratory	0	None
87361	87362	syncytial	0	None
87362	87363	virus	0	None
87363	87364	(	0	None
87364	87365	HRSV	0	None
87365	87366	)	0	None
87366	87367	.	0	None

87368	87369	There	0	None
87369	87370	are	0	None
87370	87371	two	0	None
87371	87372	preparations	0	None
87372	87373	of	0	None
87373	87374	licorice	0	None
87374	87375	,	0	None
87375	87376	Radix	0	None
87376	87377	Glycyrrhizae	0	None
87377	87378	and	0	None
87378	87379	Radix	0	None
87379	87380	Glycyrrhizae	0	None
87380	87381	Preparata	0	None
87381	87382	.	0	None

87383	87384	However	0	None
87384	87385	,	0	None
87385	87386	it	0	None
87386	87387	is	0	None
87387	87388	unknown	0	None
87388	87389	whether	0	None
87389	87390	licorice	0	None
87390	87391	or	0	None
87391	87392	which	0	None
87392	87393	preparation	0	None
87393	87394	of	0	None
87394	87395	licorice	0	None
87395	87396	is	0	None
87396	87397	effective	0	None
87397	87398	against	0	None
87398	87399	HRSV	0	None
87399	87400	,	0	None
87400	87401	nor	0	None
87401	87402	is	0	None
87402	87403	its	0	None
87403	87404	active	0	None
87404	87405	constituent	0	None
87405	87406	.	0	None

87407	87408	AIM	0	None
87408	87409	OF	0	None
87409	87410	THE	0	None
87410	87411	STUDY	0	None
87411	87412	:	0	None
87412	87413	We	0	None
87413	87414	tested	0	None
87414	87415	the	0	None
87415	87416	hypothesis	0	None
87416	87417	that	0	None
87417	87418	Radix	0	None
87418	87419	Glycyrrhizae	0	None
87419	87420	can	0	None
87420	87421	effectively	0	None
87421	87422	decrease	0	None
87422	87423	HRSV-induced	0	None
87423	87424	plaque	0	None
87424	87425	formation	0	None
87425	87426	in	0	None
87426	87427	respiratory	0	None
87427	87428	mucosal	0	None
87428	87429	cell	0	None
87429	87430	lines	0	None
87430	87431	.	0	None

87432	87433	We	0	None
87433	87434	also	0	None
87434	87435	tried	0	None
87435	87436	to	0	None
87436	87437	find	0	None
87437	87438	out	0	None
87438	87439	the	0	None
87439	87440	active	0	None
87440	87441	constituent	0	None
87441	87442	.	0	None

87443	87444	MATERIALS	0	None
87444	87445	AND	0	None
87445	87446	METHODS	0	None
87446	87447	:	0	None
87447	87448	Anti-HRSV	0	None
87448	87449	activities	0	None
87449	87450	of	0	None
87450	87451	hot	0	None
87451	87452	water	0	None
87452	87453	extracts	0	None
87453	87454	of	0	None
87454	87455	preparations	0	None
87455	87456	of	0	None
87456	87457	licorice	0	None
87457	87458	,	0	None
87458	87459	glycyrrhizin	0	None
87459	87460	and	0	None
87460	87461	18β-glycyrrhetinic	0	None
87461	87462	acid	0	None
87462	87463	(	0	None
87463	87464	18β-GA	0	None
87464	87465	)	0	None
87465	87466	,	0	None
87466	87467	the	0	None
87467	87468	active	0	None
87468	87469	constituents	0	None
87469	87470	of	0	None
87470	87471	licorice	0	None
87471	87472	,	0	None
87472	87473	were	0	None
87473	87474	examined	0	None
87474	87475	by	0	None
87475	87476	plaque	0	None
87476	87477	reduction	0	None
87477	87478	assay	0	None
87478	87479	in	0	None
87479	87480	both	0	None
87480	87481	human	0	None
87481	87482	upper	0	None
87482	87483	(	0	None
87483	87484	HEp-2	0	None
87484	87485	)	0	None
87485	87486	and	0	None
87486	87487	low	0	None
87487	87488	(	0	None
87488	87489	A549	0	None
87489	87490	)	0	None
87490	87491	respiratory	0	None
87491	87492	tract	0	None
87492	87493	cell	0	None
87493	87494	lines	0	None
87494	87495	.	0	None

87496	87497	Abilities	0	None
87497	87498	of	0	None
87498	87499	crude	0	None
87499	87500	licorice	0	None
87500	87501	to	0	None
87501	87502	inhibit	0	None
87502	87503	viral	0	None
87503	87504	replication	0	None
87504	87505	and	0	None
87505	87506	to	0	None
87506	87507	stimulate	0	None
87507	87508	IFN-β	0	None
87508	87509	were	0	None
87509	87510	evaluated	0	None
87510	87511	by	0	None
87511	87512	reverse	0	None
87512	87513	transcription	0	None
87513	87514	polymerase	0	None
87514	87515	chain	0	None
87515	87516	reaction	0	None
87516	87517	(	0	None
87517	87518	RT-PCR	0	None
87518	87519	)	0	None
87519	87520	and	0	None
87520	87521	enzyme-linked	0	None
87521	87522	immunosorbent	0	None
87522	87523	assay	0	None
87523	87524	(	0	None
87524	87525	ELISA	0	None
87525	87526	)	0	None
87526	87527	,	0	None
87527	87528	respectively	0	None
87528	87529	.	0	None

87530	87531	RESULTS	0	None
87531	87532	:	0	None
87532	87533	Radix	0	None
87533	87534	Glycyrrhizae	0	None
87534	87535	and	0	None
87535	87536	Radix	0	None
87536	87537	Glycyrrhizae	0	None
87537	87538	Preparata	0	None
87538	87539	dose-dependently	0	None
87539	87540	inhibited	0	None
87540	87541	HRSV-induced	0	None
87541	87542	plaque	0	None
87542	87543	formation	0	None
87543	87544	in	0	None
87544	87545	both	0	None
87545	87546	HEp-2	0	None
87546	87547	and	0	None
87547	87548	A549	0	None
87548	87549	cell	0	None
87549	87550	lines	0	None
87550	87551	(	0	None
87551	87552	p<0	0	None
87552	87553	.	0	None
87553	87554	0001	0	None
87554	87555	)	0	None
87555	87556	.	0	None

87557	87558	The	0	None
87558	87559	effect	0	None
87559	87560	of	0	None
87560	87561	Radix	0	None
87561	87562	Glycyrrhizae	0	None
87562	87563	was	0	None
87563	87564	better	0	None
87564	87565	than	0	None
87565	87566	that	0	None
87566	87567	of	0	None
87567	87568	Radix	0	None
87568	87569	Glycyrrhizae	0	None
87569	87570	Preparata	0	None
87570	87571	on	0	None
87571	87572	HEp-2	0	None
87572	87573	cells	0	None
87573	87574	.	0	None

87575	87576	However	0	None
87576	87577	,	0	None
87577	87578	there	0	None
87578	87579	was	0	None
87579	87580	no	0	None
87580	87581	difference	0	None
87581	87582	of	0	None
87582	87583	their	0	None
87583	87584	anti-HRSV	0	None
87584	87585	effects	0	None
87585	87586	on	0	None
87586	87587	A549	0	None
87587	87588	cells	0	None
87588	87589	.	0	None

87590	87591	Besides	0	None
87591	87592	,	0	None
87592	87593	glycyrrhizin	0	None
87593	87594	was	0	None
87594	87595	ineffective	0	None
87595	87596	at	0	None
87596	87597	all	0	None
87597	87598	.	0	None

87599	87600	Nevertheless	0	None
87600	87601	,	0	None
87601	87602	18β-GA	0	None
87602	87603	showed	0	None
87603	87604	a	0	None
87604	87605	potent	0	None
87605	87606	anti-HRSV	0	None
87606	87607	activity	0	None
87607	87608	.	0	None

87609	87610	Radix	0	None
87610	87611	Glycyrrhizae	0	None
87611	87612	was	0	None
87612	87613	more	0	None
87613	87614	effective	0	None
87614	87615	when	0	None
87615	87616	given	0	None
87616	87617	before	0	None
87617	87618	viral	0	None
87618	87619	inoculation	0	None
87619	87620	(	0	None
87620	87621	p<0	0	None
87621	87622	.	0	None
87622	87623	0001	0	None
87623	87624	)	0	None
87624	87625	which	0	None
87625	87626	may	0	None
87626	87627	be	0	None
87627	87628	due	0	None
87628	87629	to	0	None
87629	87630	its	0	None
87630	87631	inhibition	0	None
87631	87632	of	0	None
87632	87633	viral	0	None
87633	87634	attachment	0	None
87634	87635	on	0	None
87635	87636	(	0	None
87636	87637	p<0	0	None
87637	87638	.	0	None
87638	87639	0001	0	None
87639	87640	)	0	None
87640	87641	and	0	None
87641	87642	penetration	0	None
87642	87643	(	0	None
87643	87644	p<0	0	None
87644	87645	.	0	None
87645	87646	0001	0	None
87646	87647	)	0	None
87647	87648	into	0	None
87648	87649	the	0	None
87649	87650	host	0	None
87650	87651	cells	0	None
87651	87652	.	0	None

87653	87654	The	0	None
87654	87655	anti-HRSV	0	None
87655	87656	activity	0	None
87656	87657	of	0	None
87657	87658	Radix	0	None
87658	87659	Glycyrrhizae	0	None
87659	87660	was	0	None
87660	87661	further	0	None
87661	87662	confirmed	0	None
87662	87663	by	0	None
87663	87664	RT-PCR	0	None
87664	87665	and	0	None
87665	87666	qRT-PCR	0	None
87666	87667	.	0	None

87668	87669	300μg	0	None
87669	87670	/	0	None
87670	87671	ml	0	None
87671	87672	Radix	0	None
87672	87673	Glycyrrhizae	0	None
87673	87674	markedly	0	None
87674	87675	decreased	0	None
87675	87676	the	0	None
87676	87677	viral	0	None
87677	87678	amounts	0	None
87678	87679	within	0	None
87679	87680	the	0	None
87680	87681	cells	0	None
87681	87682	and	0	None
87682	87683	in	0	None
87683	87684	the	0	None
87684	87685	suspension	0	None
87685	87686	.	0	None

87687	87688	Radix	0	None
87688	87689	Glycyrrhizae	0	None
87689	87690	might	0	None
87690	87691	further	0	None
87691	87692	stimulate	0	None
87692	87693	mucosal	0	None
87693	87694	cells	0	None
87694	87695	to	0	None
87695	87696	secrete	0	None
87696	87697	IFN-β	0	None
87697	87698	to	0	None
87698	87699	counteract	0	None
87699	87700	viral	0	None
87700	87701	infection	0	None
87701	87702	.	0	None

87703	87704	CONCLUSIONS	0	None
87704	87705	:	0	None
87705	87706	Both	0	None
87706	87707	Radix	0	None
87707	87708	Glycyrrhizae	0	None
87708	87709	and	0	None
87709	87710	Radix	0	None
87710	87711	Glycyrrhizae	0	None
87711	87712	Preparata	0	None
87712	87713	are	0	None
87713	87714	effective	0	None
87714	87715	against	0	None
87715	87716	HRSV	0	None
87716	87717	infection	0	None
87717	87718	on	0	None
87718	87719	airway	0	None
87719	87720	epithelial	0	None
87720	87721	cells	0	None
87721	87722	.	0	None

87723	87724	Radix	0	None
87724	87725	Glycyrrhizae	0	None
87725	87726	inhibited	0	None
87726	87727	HRSV	0	None
87727	87728	mainly	0	None
87728	87729	by	0	None
87729	87730	preventing	0	None
87730	87731	viral	0	None
87731	87732	attachment	0	None
87732	87733	,	0	None
87733	87734	internalization	0	None
87734	87735	,	0	None
87735	87736	and	0	None
87736	87737	by	0	None
87737	87738	stimulating	0	None
87738	87739	IFN	0	None
87739	87740	secretion	0	None
87740	87741	.	0	None

87742	87743	18β-GA	0	None
87743	87744	may	0	None
87744	87745	be	0	None
87745	87746	one	0	None
87746	87747	of	0	None
87747	87748	its	0	None
87748	87749	active	0	None
87749	87750	constituents	0	None
87750	87751	.	0	None
87751	87752	Felbamate	0	None
87752	87753	block	0	None
87753	87754	of	0	None
87754	87755	recombinant	0	None
87755	87756	N-methyl-D-aspartate	0	None
87756	87757	receptors	0	None
87757	87758	:	0	None
87758	87759	selectivity	0	None
87759	87760	for	0	None
87760	87761	the	0	None
87761	87762	NR2B	0	None
87762	87763	subunit	0	None
87763	87764	.	0	None
87764	87765	Rivastigmine	0	None
87765	87766	for	0	None
87766	87767	Alzheimer's	0	None
87767	87768	disease	0	None
87768	87769	.	0	None
87769	87770	Promoter	0	None
87770	87771	polymorphisms	0	None
87771	87772	regulating	0	None
87772	87773	corticotrophin-releasing	0	None
87773	87774	hormone	0	None
87774	87775	transcription	0	None
87775	87776	in	0	None
87776	87777	vitro	0	None
87777	87778	.	0	None
87778	87779	Nucleos	0	None
87779	87780	(	0	None
87780	87781	t	0	None
87781	87782	)	0	None
87782	87783	ide	0	None
87783	87784	analogues	0	None
87784	87785	have	0	None
87785	87786	proven	0	None
87786	87787	useful	0	None
87787	87788	in	0	None
87788	87789	the	0	None
87789	87790	treatment	0	None
87790	87791	of	0	None
87791	87792	viral	0	None
87792	87793	infections	0	None
87793	87794	.	0	None

87795	87796	Ribavirin	0	None
87796	87797	is	0	None
87797	87798	a	0	None
87798	87799	nucleoside	0	None
87799	87800	,	0	None
87800	87801	guanosine	0	None
87801	87802	analogue	0	None
87802	87803	,	0	None
87803	87804	whose	0	None
87804	87805	mechanisms	0	None
87805	87806	of	0	None
87806	87807	action	0	None
87807	87808	include	0	None
87808	87809	inhibition	0	None
87809	87810	of	0	None
87810	87813	inosine monophosphate dehydrogenase	3	GENE-N
87813	87814	(	0	None
87814	87815	IMPDH	0	None
87815	87816	)	0	None
87816	87817	,	0	None
87817	87818	which	0	None
87818	87819	is	0	None
87819	87820	the	0	None
87820	87821	key	0	None
87821	87822	step	0	None
87822	87823	in	0	None
87823	87824	de	0	None
87824	87825	novo	0	None
87825	87826	guanine	0	None
87826	87827	synthesis	0	None
87827	87828	,	0	None
87828	87829	a	0	None
87829	87830	requirement	0	None
87830	87831	for	0	None
87831	87832	viral	0	None
87832	87833	replication	0	None
87833	87834	.	0	None

87835	87836	In	0	None
87836	87837	combination	0	None
87837	87838	with	0	None
87838	87840	pegylated interferon	0	None
87840	87841	alfa	0	None
87841	87842	,	0	None
87842	87843	ribavirin	0	None
87843	87844	is	0	None
87844	87845	the	0	None
87845	87846	standard	0	None
87846	87847	of	0	None
87847	87848	care	0	None
87848	87849	for	0	None
87849	87850	the	0	None
87850	87851	treatment	0	None
87851	87852	of	0	None
87852	87853	chronic	0	None
87853	87854	hepatitis	0	None
87854	87855	C	0	None
87855	87856	today	0	None
87856	87857	.	0	None

87858	87859	However	0	None
87859	87860	,	0	None
87860	87861	the	0	None
87861	87862	medication	0	None
87862	87863	is	0	None
87863	87864	associated	0	None
87864	87865	with	0	None
87865	87866	significant	0	None
87866	87867	haemolytic	0	None
87867	87868	anaemia	0	None
87868	87869	,	0	None
87869	87870	which	0	None
87870	87871	may	0	None
87871	87872	require	0	None
87872	87873	dose	0	None
87873	87874	reduction	0	None
87874	87875	,	0	None
87875	87876	discontinuation	0	None
87876	87877	or	0	None
87877	87878	treatment	0	None
87878	87879	with	0	None
87879	87880	recombinant	0	None
87880	87881	human	0	None
87881	87882	erythropoietin	0	None
87882	87883	.	0	None

87884	87885	Dose	0	None
87885	87886	reduction	0	None
87886	87887	also	0	None
87887	87888	appears	0	None
87888	87889	to	0	None
87889	87890	decrease	0	None
87890	87891	sustained	0	None
87891	87892	viral	0	None
87892	87893	clearance	0	None
87893	87894	rates	0	None
87894	87895	.	0	None

87896	87897	Newer	0	None
87897	87898	IMPDH	0	None
87898	87899	inhibitors	0	None
87899	87900	are	0	None
87900	87901	in	0	None
87901	87902	various	0	None
87902	87903	stages	0	None
87903	87904	of	0	None
87904	87905	development	0	None
87905	87906	.	0	None

87907	87908	Viramidine	0	None
87908	87909	,	0	None
87909	87910	a	0	None
87910	87911	liver-targeting	0	None
87911	87912	prodrug	0	None
87912	87913	of	0	None
87913	87914	ribavirin	0	None
87914	87915	,	0	None
87915	87916	has	0	None
87916	87917	demonstrated	0	None
87917	87918	significant	0	None
87918	87919	antiviral	0	None
87919	87920	activity	0	None
87920	87921	and	0	None
87921	87922	erythrocyte-sparing	0	None
87922	87923	properties	0	None
87923	87924	.	0	None

87925	87926	It	0	None
87926	87927	is	0	None
87927	87928	currently	0	None
87928	87929	in	0	None
87929	87930	Phase	0	None
87930	87931	3	0	None
87931	87932	trials	0	None
87932	87933	.	0	None

87934	87935	Clinical	0	None
87935	87936	trials	0	None
87936	87937	of	0	None
87937	87938	merimepodib	0	None
87938	87939	,	0	None
87939	87940	another	0	None
87940	87941	investigational	0	None
87941	87942	IMPDH	0	None
87942	87943	inhibitor	0	None
87943	87944	,	0	None
87944	87945	have	0	None
87945	87946	completed	0	None
87946	87947	enrolment	0	None
87947	87948	for	0	None
87948	87949	a	0	None
87949	87950	Phase	0	None
87950	87951	2b	0	None
87951	87952	study	0	None
87952	87953	as	0	None
87953	87954	a	0	None
87954	87955	third	0	None
87955	87956	medication	0	None
87956	87957	for	0	None
87957	87958	administration	0	None
87958	87959	with	0	None
87959	87960	pegylated	0	None
87960	87961	interferon	0	None
87961	87962	plus	0	None
87962	87963	ribavirin	0	None
87963	87964	.	0	None

87965	87966	Although	0	None
87966	87967	other	0	None
87967	87968	IMDPH	0	None
87968	87969	inhibitors	0	None
87969	87970	also	0	None
87970	87971	have	0	None
87971	87972	antiviral	0	None
87972	87973	activity	0	None
87973	87974	,	0	None
87974	87975	these	0	None
87975	87976	medications	0	None
87976	87977	appear	0	None
87977	87978	best	0	None
87978	87979	suited	0	None
87979	87980	as	0	None
87980	87981	immunosuppressive	0	None
87981	87982	medications	0	None
87982	87983	at	0	None
87983	87984	this	0	None
87984	87985	time	0	None
87985	87986	.	0	None
87986	87987	Minor	0	None
87987	87988	Compensatory	0	None
87988	87989	Changes	0	None
87989	87990	in	0	None
87990	87991	SAGE	0	None
87991	87992	Mdr1a	1	GENE-Y
87992	87993	(	0	None
87993	87994	P-gp	3	GENE-N
87994	87995	)	0	None
87995	87996	,	0	None
87996	87997	Bcrp	0	None
87997	87998	,	0	None
87998	87999	and	0	None
87999	88000	Mrp2	0	None
88000	88001	Knockout	0	None
88001	88002	Rats	0	None
88002	88003	do	0	None
88003	88004	not	0	None
88004	88005	Detract	0	None
88005	88006	from	0	None
88006	88007	their	0	None
88007	88008	General	0	None
88008	88009	Utility	0	None
88009	88010	in	0	None
88010	88011	the	0	None
88011	88012	Study	0	None
88012	88013	of	0	None
88013	88014	Transporter-mediated	0	None
88014	88015	Pharmacokinetics	0	None
88015	88016	.	0	None
88016	88017	Thymidylate	2	CHEMICAL
88017	88018	kinase	0	None
88018	88019	:	0	None
88019	88020	an	0	None
88020	88021	old	0	None
88021	88022	topic	0	None
88022	88023	brings	0	None
88023	88024	new	0	None
88024	88025	perspectives	0	None
88025	88026	.	0	None
88026	88027	Biosynthesis	0	None
88027	88028	of	0	None
88028	88029	highly	0	None
88029	88030	enriched	0	None
88030	88031	(	0	None
88031	88032	13	0	None
88032	88033	)	0	None
88033	88034	C-lycopene	0	None
88034	88035	for	0	None
88035	88036	human	0	None
88036	88037	metabolic	0	None
88037	88038	studies	0	None
88038	88039	using	0	None
88039	88040	repeated	0	None
88040	88041	batch	0	None
88041	88042	tomato	0	None
88042	88043	cell	0	None
88043	88044	culturing	0	None
88044	88045	with	0	None
88045	88046	(	0	None
88046	88047	13	0	None
88047	88048	)	0	None
88048	88049	C-glucose	0	None
88049	88050	.	0	None
88050	88051	Localization	0	None
88051	88052	of	0	None
88052	88053	the	0	None
88053	88055	ammonium transporter	3	GENE-N
88055	88056	proteins	0	None
88056	88057	RhBG	0	None
88057	88058	and	0	None
88058	88059	RhCG	1	GENE-Y
88059	88060	in	0	None
88060	88061	mouse	0	None
88061	88062	kidney	0	None
88062	88063	.	0	None
88063	88064	Antidepressant-like	0	None
88064	88065	effect	0	None
88065	88066	of	0	None
88066	88068	oleanolic acid	2	CHEMICAL
88068	88069	in	0	None
88069	88070	mice	0	None
88070	88071	exposed	0	None
88071	88072	to	0	None
88072	88073	the	0	None
88073	88074	repeated	0	None
88074	88075	forced	0	None
88075	88076	swimming	0	None
88076	88077	test	0	None
88077	88078	.	0	None
88078	88079	9-Methoxycamptothecin	0	None
88079	88080	(	0	None
88080	88081	MCPT	0	None
88081	88082	)	0	None
88082	88083	has	0	None
88083	88084	been	0	None
88084	88085	recently	0	None
88085	88086	reported	0	None
88086	88087	to	0	None
88087	88088	have	0	None
88088	88089	a	0	None
88089	88090	strong	0	None
88090	88091	anticancer	0	None
88091	88092	activity	0	None
88092	88093	.	0	None

88094	88095	However	0	None
88095	88096	,	0	None
88096	88097	its	0	None
88097	88098	detailed	0	None
88098	88099	mechanism	0	None
88099	88100	of	0	None
88100	88101	action	0	None
88101	88102	in	0	None
88102	88103	human	0	None
88103	88104	cancer	0	None
88104	88105	cells	0	None
88105	88106	has	0	None
88106	88107	not	0	None
88107	88108	been	0	None
88108	88109	well	0	None
88109	88110	clarified	0	None
88110	88111	.	0	None

88112	88113	The	0	None
88113	88114	results	0	None
88114	88115	showed	0	None
88115	88116	that	0	None
88116	88117	MCPT	0	None
88117	88118	induced	0	None
88118	88119	cytotoxicity	0	None
88119	88120	in	0	None
88120	88121	seven	0	None
88121	88122	human	0	None
88122	88123	cancer	0	None
88123	88124	cell	0	None
88124	88125	lines	0	None
88125	88126	in	0	None
88126	88127	a	0	None
88127	88128	dose	0	None
88128	88129	dependent	0	None
88129	88130	manner	0	None
88130	88131	after	0	None
88131	88132	72h	0	None
88132	88133	,	0	None
88133	88134	with	0	None
88134	88135	A2780	0	None
88135	88136	and	0	None
88136	88137	Hela	0	None
88137	88138	cell	0	None
88138	88139	lines	0	None
88139	88140	more	0	None
88140	88141	sensitive	0	None
88141	88142	,	0	None
88142	88143	so	0	None
88143	88144	the	0	None
88144	88145	two	0	None
88145	88146	cell	0	None
88146	88147	lines	0	None
88147	88148	were	0	None
88148	88149	chosen	0	None
88149	88150	to	0	None
88150	88151	do	0	None
88151	88152	further	0	None
88152	88153	studies	0	None
88153	88154	.	0	None

88155	88156	MCPT	0	None
88156	88157	induced	0	None
88157	88158	strong	0	None
88158	88159	G2	0	None
88159	88160	/	0	None
88160	88161	M	0	None
88161	88162	arrest	0	None
88162	88163	in	0	None
88163	88164	both	0	None
88164	88165	A2780	0	None
88165	88166	cells	0	None
88166	88167	and	0	None
88167	88168	Hela	0	None
88168	88169	cells	0	None
88169	88170	after	0	None
88170	88171	24h	0	None
88171	88172	,	0	None
88172	88173	following	0	None
88173	88174	by	0	None
88174	88175	substantial	0	None
88175	88176	sub-G1	0	None
88176	88177	arrest	0	None
88177	88178	(	0	None
88178	88179	indicating	0	None
88179	88180	apoptosis	0	None
88180	88181	)	0	None
88181	88182	.	0	None

88183	88184	The	0	None
88184	88185	apoptosis	0	None
88185	88186	was	0	None
88186	88187	verified	0	None
88187	88188	by	0	None
88188	88189	staining	0	None
88189	88190	with	0	None
88190	88191	Annexin	0	None
88191	88192	V-FITC	0	None
88192	88193	and	0	None
88193	88194	propidium	0	None
88194	88195	iodide	2	CHEMICAL
88195	88196	.	0	None

88197	88198	ROS	0	None
88198	88199	generation	0	None
88199	88200	increased	0	None
88200	88201	significantly	0	None
88201	88202	in	0	None
88202	88203	MCPT-induced	0	None
88203	88204	apoptosis	0	None
88204	88205	.	0	None

88206	88207	Meanwhile	0	None
88207	88208	,	0	None
88208	88209	the	0	None
88209	88210	apoptosis	0	None
88210	88211	appeared	0	None
88211	88212	to	0	None
88212	88213	be	0	None
88213	88214	dependent	0	None
88214	88215	on	0	None
88215	88216	caspase-3	1	GENE-Y
88216	88217	,	0	None
88217	88218	-8	0	None
88218	88219	and	0	None
88219	88220	-9	0	None
88220	88221	in	0	None
88221	88222	A2780	0	None
88222	88223	cells	0	None
88223	88224	,	0	None
88224	88225	and	0	None
88225	88226	caspase-3	1	GENE-Y
88226	88227	in	0	None
88227	88228	Hela	0	None
88228	88229	cells	0	None
88229	88230	.	0	None

88231	88232	In	0	None
88232	88233	addition	0	None
88233	88234	,	0	None
88234	88235	MCPT	0	None
88235	88236	induced	0	None
88236	88237	up-regulation	0	None
88237	88238	expression	0	None
88238	88239	of	0	None
88239	88240	most	0	None
88240	88241	of	0	None
88241	88242	seventeen	0	None
88242	88243	genes	0	None
88243	88244	in	0	None
88244	88245	both	0	None
88245	88246	cell	0	None
88246	88247	lines	0	None
88247	88248	.	0	None

88249	88250	Western	0	None
88250	88251	blot	0	None
88251	88252	verified	0	None
88252	88253	that	0	None
88253	88254	changes	0	None
88254	88255	of	0	None
88255	88256	TNFα	0	None
88256	88257	,	0	None
88257	88258	Fas	0	None
88258	88259	,	0	None
88259	88260	P53	0	None
88260	88261	and	0	None
88261	88262	P27	0	None
88262	88263	protein	0	None
88263	88264	level	0	None
88264	88265	were	0	None
88265	88266	consistent	0	None
88266	88267	with	0	None
88267	88268	their	0	None
88268	88269	gene	0	None
88269	88270	expression	0	None
88270	88271	changes	0	None
88271	88272	.	0	None

88273	88274	Taken	0	None
88274	88275	together	0	None
88275	88276	,	0	None
88276	88277	MCPT	0	None
88277	88278	plays	0	None
88278	88279	an	0	None
88279	88280	important	0	None
88280	88281	role	0	None
88281	88282	in	0	None
88282	88283	tumor	0	None
88283	88284	growth	0	None
88284	88285	suppression	0	None
88285	88286	by	0	None
88286	88287	inducing	0	None
88287	88288	apoptosis	0	None
88288	88289	in	0	None
88289	88290	both	0	None
88290	88291	cell	0	None
88291	88292	lines	0	None
88292	88293	via	0	None
88293	88294	extrinsic	0	None
88294	88295	and	0	None
88295	88296	intrinsic	0	None
88296	88297	apoptotic	0	None
88297	88298	pathways	0	None
88298	88299	,	0	None
88299	88300	and	0	None
88300	88301	has	0	None
88301	88302	the	0	None
88302	88303	potential	0	None
88303	88304	to	0	None
88304	88305	be	0	None
88305	88306	developed	0	None
88306	88307	into	0	None
88307	88308	an	0	None
88308	88309	antitumor	0	None
88309	88310	agent	0	None
88310	88311	.	0	None
88311	88312	A	0	None
88312	88313	series	0	None
88313	88314	of	0	None
88314	88315	GPR119	0	None
88315	88316	agonists	0	None
88316	88317	based	0	None
88317	88318	on	0	None
88318	88319	a	0	None
88319	88320	2	0	None
88320	88321	,	0	None
88321	88322	6-diazatricyclo	0	None
88322	88323	[	0	None
88323	88324	3	0	None
88324	88325	.	0	None
88325	88326	3	0	None
88326	88327	.	0	None
88327	88328	1	0	None
88328	88329	.	0	None
88329	88330	1∼3	0	None
88330	88331	,	0	None
88331	88332	7∼	0	None
88332	88333	]	0	None
88333	88334	decane	0	None
88334	88335	ring	0	None
88335	88336	system	0	None
88336	88337	is	0	None
88337	88338	described	0	None
88338	88339	.	0	None

88340	88341	Also	0	None
88341	88342	provided	0	None
88342	88343	is	0	None
88343	88344	a	0	None
88344	88345	detailed	0	None
88345	88346	account	0	None
88346	88347	of	0	None
88347	88348	the	0	None
88348	88349	development	0	None
88349	88350	of	0	None
88350	88351	a	0	None
88351	88352	multigram	0	None
88352	88353	scale	0	None
88353	88354	synthesis	0	None
88354	88355	of	0	None
88355	88356	the	0	None
88356	88357	diazatricyclic	0	None
88357	88358	ring	0	None
88358	88359	system	0	None
88359	88360	,	0	None
88360	88361	which	0	None
88361	88362	was	0	None
88362	88363	achieved	0	None
88363	88364	using	0	None
88364	88365	a	0	None
88365	88366	Hofmann-Löffler-Freytag	0	None
88366	88367	reaction	0	None
88367	88368	as	0	None
88368	88369	the	0	None
88369	88370	key	0	None
88370	88371	step	0	None
88371	88372	.	0	None

88373	88374	The	0	None
88374	88375	basis	0	None
88375	88376	for	0	None
88376	88377	the	0	None
88377	88378	use	0	None
88378	88379	of	0	None
88379	88380	this	0	None
88380	88381	complex	0	None
88381	88382	framework	0	None
88382	88383	lies	0	None
88383	88384	in	0	None
88384	88385	an	0	None
88385	88386	attempt	0	None
88386	88387	to	0	None
88387	88388	constrain	0	None
88388	88389	one	0	None
88389	88390	end	0	None
88390	88391	of	0	None
88391	88392	the	0	None
88392	88393	molecule	0	None
88393	88394	in	0	None
88394	88395	the	0	None
88395	88396	"agonist	0	None
88396	88397	conformation"	0	None
88397	88398	as	0	None
88398	88399	was	0	None
88399	88400	previously	0	None
88400	88401	described	0	None
88401	88402	for	0	None
88402	88403	3-oxa-7-aza-bicyclo	0	None
88403	88404	[	0	None
88404	88405	3	0	None
88405	88406	.	0	None
88406	88407	3	0	None
88407	88408	.	0	None
88408	88409	1	0	None
88409	88410	]	0	None
88410	88411	nonanes	0	None
88411	88412	.	0	None

88413	88414	Optimization	0	None
88414	88415	of	0	None
88415	88416	carbamate	0	None
88416	88417	analogues	0	None
88417	88418	of	0	None
88418	88419	the	0	None
88419	88420	diazatricylic	0	None
88420	88421	compounds	0	None
88421	88422	led	0	None
88422	88423	to	0	None
88423	88424	the	0	None
88424	88425	identification	0	None
88425	88426	of	0	None
88426	88427	32i	0	None
88427	88428	as	0	None
88428	88429	a	0	None
88429	88430	potent	0	None
88430	88431	agonist	0	None
88431	88432	of	0	None
88432	88433	the	0	None
88433	88434	GPR119	0	None
88434	88435	receptor	0	None
88435	88436	with	0	None
88436	88437	low	0	None
88437	88438	unbound	0	None
88438	88439	human	0	None
88439	88440	liver	0	None
88440	88441	microsomal	0	None
88441	88442	clearance	0	None
88442	88443	.	0	None

88444	88445	The	0	None
88445	88446	use	0	None
88446	88447	of	0	None
88447	88448	an	0	None
88448	88449	agonist	0	None
88449	88450	response	0	None
88450	88451	weighted	0	None
88451	88452	ligand	0	None
88452	88453	lipophilic	0	None
88453	88454	efficiency	0	None
88454	88455	(	0	None
88455	88456	LLE	0	None
88456	88457	)	0	None
88457	88458	termed	0	None
88458	88459	AgLLE	0	None
88459	88460	is	0	None
88460	88461	discussed	0	None
88461	88462	along	0	None
88462	88463	with	0	None
88463	88464	the	0	None
88464	88465	issues	0	None
88465	88466	of	0	None
88466	88467	applying	0	None
88467	88468	efficiency	0	None
88468	88469	measures	0	None
88469	88470	to	0	None
88470	88471	agonist	0	None
88471	88472	programs	0	None
88472	88473	.	0	None

88474	88475	Ultimately	0	None
88475	88476	,	0	None
88476	88477	solubility	0	None
88477	88478	limited	0	None
88478	88479	absorption	0	None
88479	88480	and	0	None
88480	88481	poor	0	None
88481	88482	exposure	0	None
88482	88483	reduced	0	None
88483	88484	further	0	None
88484	88485	interest	0	None
88485	88486	in	0	None
88486	88487	these	0	None
88487	88488	molecules	0	None
88488	88489	.	0	None
88489	88490	The	0	None
88490	88491	purpose	0	None
88491	88492	of	0	None
88492	88493	this	0	None
88493	88494	investigation	0	None
88494	88495	was	0	None
88495	88496	to	0	None
88496	88497	design	0	None
88497	88498	novel	0	None
88498	88499	pentablock	0	None
88499	88500	copolymers	0	None
88500	88501	(	0	None
88501	88502	polylatide-polycaprolactone-polyethylene	0	None
88502	88503	glycol-	0	None
88503	88504	polycaprolactone-polylatide	0	None
88504	88505	)	0	None
88505	88506	(	0	None
88506	88507	PLA-PCL-PEG-PCL-PLA	0	None
88507	88508	)	0	None
88508	88509	to	0	None
88509	88510	prepare	0	None
88510	88511	nanoparticle	0	None
88511	88512	formulations	0	None
88512	88513	which	0	None
88513	88514	provide	0	None
88514	88515	continuous	0	None
88515	88516	delivery	0	None
88516	88517	of	0	None
88517	88518	steroids	0	None
88518	88519	over	0	None
88519	88520	a	0	None
88520	88521	longer	0	None
88521	88522	duration	0	None
88522	88523	with	0	None
88523	88524	minimal	0	None
88524	88525	burst	0	None
88525	88526	effect	0	None
88526	88527	.	0	None

88528	88529	Another	0	None
88529	88530	purpose	0	None
88530	88531	was	0	None
88531	88532	to	0	None
88532	88533	evaluate	0	None
88533	88534	the	0	None
88534	88535	effect	0	None
88535	88536	of	0	None
88536	88537	poly	0	None
88537	88538	(	0	None
88538	88539	L-lactide	0	None
88539	88540	)	0	None
88540	88541	(	0	None
88541	88542	PLLA	0	None
88542	88543	)	0	None
88543	88544	or	0	None
88544	88545	poly	0	None
88545	88546	(	0	None
88546	88547	D	0	None
88547	88548	,	0	None
88548	88549	L-lactide	0	None
88549	88550	)	0	None
88550	88551	(	0	None
88551	88552	PDLLA	0	None
88552	88553	)	0	None
88553	88554	incorporation	0	None
88554	88555	on	0	None
88555	88556	crystallinity	0	None
88556	88557	of	0	None
88557	88558	pentablock	0	None
88558	88559	copolymers	0	None
88559	88560	and	0	None
88560	88561	in	0	None
88561	88562	vitro	0	None
88562	88563	release	0	None
88563	88564	profile	0	None
88564	88565	of	0	None
88565	88567	triamcinolone acetonide	2	CHEMICAL
88567	88568	(	0	None
88568	88569	selected	0	None
88569	88570	as	0	None
88570	88571	model	0	None
88571	88572	drug	0	None
88572	88573	)	0	None
88573	88574	from	0	None
88574	88575	nanoparticles	0	None
88575	88576	.	0	None

88577	88578	PLA-PCL-PEG-PCL-PLA	0	None
88578	88579	copolymers	0	None
88579	88580	with	0	None
88580	88581	different	0	None
88581	88582	block	0	None
88582	88583	ratio	0	None
88583	88584	of	0	None
88584	88585	PCL	0	None
88585	88586	/	0	None
88586	88587	PLA	0	None
88587	88588	segment	0	None
88588	88589	were	0	None
88589	88590	synthesized	0	None
88590	88591	.	0	None

88592	88593	Release	0	None
88593	88594	of	0	None
88594	88596	triamcinolone acetonide	2	CHEMICAL
88596	88597	from	0	None
88597	88598	nanoparticles	0	None
88598	88599	was	0	None
88599	88600	significantly	0	None
88600	88601	affected	0	None
88601	88602	by	0	None
88602	88603	crystallinity	0	None
88603	88604	of	0	None
88604	88605	the	0	None
88605	88606	copolymers	0	None
88606	88607	.	0	None

88608	88609	Burst	0	None
88609	88610	release	0	None
88610	88611	of	0	None
88611	88613	triamcinolone acetonide	2	CHEMICAL
88613	88614	from	0	None
88614	88615	nanoparticles	0	None
88615	88616	was	0	None
88616	88617	significantly	0	None
88617	88618	minimized	0	None
88618	88619	with	0	None
88619	88620	incorporation	0	None
88620	88621	of	0	None
88621	88622	proper	0	None
88622	88623	ratio	0	None
88623	88624	of	0	None
88624	88625	PDLLA	0	None
88625	88626	in	0	None
88626	88627	the	0	None
88627	88628	existing	0	None
88628	88629	triblock	0	None
88629	88630	(	0	None
88630	88631	PCL-PEG-PCL	0	None
88631	88632	)	0	None
88632	88633	copolymer	0	None
88633	88634	.	0	None

88635	88636	Moreover	0	None
88636	88637	,	0	None
88637	88638	pentablock	0	None
88638	88639	copolymer	0	None
88639	88640	based	0	None
88640	88641	nanoparticles	0	None
88641	88642	exhibited	0	None
88642	88643	continuous	0	None
88643	88644	release	0	None
88644	88645	of	0	None
88645	88647	triamcinolone acetonide	2	CHEMICAL
88647	88648	.	0	None

88649	88650	Pentablock	0	None
88650	88651	copolymer	0	None
88651	88652	based	0	None
88652	88653	nanoparticles	0	None
88653	88654	can	0	None
88654	88655	be	0	None
88655	88656	utilized	0	None
88656	88657	to	0	None
88657	88658	achieve	0	None
88658	88659	continuous	0	None
88659	88660	near	0	None
88660	88661	zero-order	0	None
88661	88662	delivery	0	None
88662	88663	of	0	None
88663	88664	corticosteroids	0	None
88664	88665	from	0	None
88665	88666	nanoparticles	0	None
88666	88667	without	0	None
88667	88668	any	0	None
88668	88669	burst	0	None
88669	88670	effect	0	None
88670	88671	.	0	None
88671	88672	Genome-wide	0	None
88672	88673	screen	0	None
88673	88674	for	0	None
88674	88675	modulation	0	None
88675	88676	of	0	None
88676	88677	hepatic	0	None
88677	88678	apolipoprotein	0	None
88678	88679	A-I	0	None
88679	88680	(	0	None
88680	88681	ApoA-I	0	None
88681	88682	)	0	None
88682	88683	secretion	0	None
88683	88684	.	0	None
88684	88685	Neurochemical	0	None
88685	88686	effects	0	None
88686	88687	of	0	None
88687	88688	the	0	None
88688	88689	monoamine	0	None
88689	88690	oxidase	0	None
88690	88691	inhibitor	0	None
88691	88692	phenelzine	2	CHEMICAL
88692	88693	on	0	None
88693	88694	brain	0	None
88694	88695	GABA	2	CHEMICAL
88695	88696	and	0	None
88696	88697	alanine	0	None
88697	88698	:	0	None
88698	88699	A	0	None
88699	88700	comparison	0	None
88700	88701	with	0	None
88701	88702	vigabatrin	0	None
88702	88703	.	0	None
88703	88706	DNA topoisomerase IIalpha	1	GENE-Y
88706	88707	(	0	None
88707	88708	TOP2A	0	None
88708	88709	)	0	None
88709	88710	inhibitors	0	None
88710	88711	up-regulate	0	None
88711	88713	fatty acid	2	CHEMICAL
88713	88714	synthase	0	None
88714	88715	gene	0	None
88715	88716	expression	0	None
88716	88717	in	0	None
88717	88718	SK-Br3	0	None
88718	88719	breast	0	None
88719	88720	cancer	0	None
88720	88721	cells	0	None
88721	88722	:	0	None
88722	88723	in	0	None
88723	88724	vitro	0	None
88724	88725	evidence	0	None
88725	88726	for	0	None
88726	88727	a	0	None
88727	88728	'functional	0	None
88728	88729	amplicon'	0	None
88729	88730	involving	0	None
88730	88731	FAS	0	None
88731	88732	,	0	None
88732	88733	Her-2	0	None
88733	88734	/	0	None
88734	88735	neu	1	GENE-Y
88735	88736	and	0	None
88736	88737	TOP2A	0	None
88737	88738	genes	0	None
88738	88739	.	0	None
88739	88740	Estrogens	0	None
88740	88741	,	0	None
88741	88742	and	0	None
88742	88743	particularly	0	None
88743	88744	glucuronides	0	None
88744	88745	such	0	None
88745	88746	as	0	None
88746	88747	ethinylestradiol	0	None
88747	88748	(	0	None
88748	88749	EE	0	None
88749	88750	)	0	None
88750	88751	,	0	None
88751	88752	have	0	None
88752	88753	been	0	None
88753	88754	shown	0	None
88754	88755	to	0	None
88755	88756	cause	0	None
88756	88757	cholestasis	0	None
88757	88758	in	0	None
88758	88759	animal	0	None
88759	88760	studies	0	None
88760	88761	,	0	None
88761	88762	by	0	None
88762	88763	reducing	0	None
88763	88765	bile acid	2	CHEMICAL
88765	88766	uptake	0	None
88766	88767	by	0	None
88767	88768	hepatocytes	0	None
88768	88769	.	0	None

88770	88771	The	0	None
88771	88772	aim	0	None
88772	88773	of	0	None
88773	88774	the	0	None
88774	88775	present	0	None
88775	88776	article	0	None
88776	88777	was	0	None
88777	88778	to	0	None
88778	88779	investigate	0	None
88779	88780	anticholestatic	0	None
88780	88781	activity	0	None
88781	88782	of	0	None
88782	88783	resveratrol	0	None
88783	88784	(	0	None
88784	88785	RES	0	None
88785	88786	)	0	None
88786	88787	against	0	None
88787	88788	liver	0	None
88788	88789	cholestasis	0	None
88789	88790	induced	0	None
88790	88791	by	0	None
88791	88792	EE	0	None
88792	88793	in	0	None
88793	88794	adult	0	None
88794	88795	female	0	None
88795	88796	rats	0	None
88796	88797	.	0	None

88798	88799	The	0	None
88799	88800	daily	0	None
88800	88801	oral	0	None
88801	88802	administration	0	None
88802	88803	of	0	None
88803	88804	the	0	None
88804	88805	RES	0	None
88805	88806	at	0	None
88806	88807	a	0	None
88807	88808	concentration	0	None
88808	88809	of	0	None
88809	88810	25	0	None
88810	88811	mg	2	CHEMICAL
88811	88812	/	0	None
88812	88813	kg	0	None
88813	88814	body	0	None
88814	88815	weight	0	None
88815	88816	for	0	None
88816	88817	15	0	None
88817	88818	days	0	None
88818	88819	to	0	None
88819	88820	rats	0	None
88820	88821	treated	0	None
88821	88822	with	0	None
88822	88823	EE	0	None
88823	88824	(	0	None
88824	88825	100	0	None
88825	88826	μg	0	None
88826	88827	/	0	None
88827	88828	kg	0	None
88828	88829	body	0	None
88829	88830	weight	0	None
88830	88831	for	0	None
88831	88832	5	0	None
88832	88833	days	0	None
88833	88834	)	0	None
88834	88835	resulted	0	None
88835	88836	in	0	None
88836	88837	a	0	None
88837	88838	significant	0	None
88838	88839	protection	0	None
88839	88840	against	0	None
88840	88841	EE-induced	0	None
88841	88842	decrease	0	None
88842	88843	in	0	None
88843	88844	both	0	None
88844	88845	serum	0	None
88845	88846	cholesterol	0	None
88846	88847	and	0	None
88847	88849	bile acid	2	CHEMICAL
88849	88850	levels	0	None
88850	88851	as	0	None
88851	88852	well	0	None
88852	88853	as	0	None
88853	88854	against	0	None
88854	88855	an	0	None
88855	88856	increase	0	None
88856	88857	of	0	None
88857	88858	serum	0	None
88858	88859	bilirubin	2	CHEMICAL
88859	88860	concentration	0	None
88860	88861	.	0	None

88862	88863	The	0	None
88863	88864	treatment	0	None
88864	88865	also	0	None
88865	88866	resulted	0	None
88866	88867	in	0	None
88867	88868	a	0	None
88868	88869	significant	0	None
88869	88870	increase	0	None
88870	88871	in	0	None
88871	88872	hepatic	0	None
88872	88873	superoxide	0	None
88873	88874	dismutase	0	None
88874	88875	,	0	None
88875	88877	glutathione peroxidase	1	GENE-Y
88877	88878	,	0	None
88878	88880	glutathione reductase	1	GENE-Y
88880	88881	,	0	None
88881	88882	and	0	None
88882	88883	catalase	0	None
88883	88884	activities	0	None
88884	88885	as	0	None
88885	88886	well	0	None
88886	88887	as	0	None
88887	88888	hepatic	0	None
88888	88889	protein-bound	0	None
88889	88890	and	0	None
88890	88891	nonprotein	0	None
88891	88892	sulfhydryl	2	CHEMICAL
88892	88893	groups	0	None
88893	88894	.	0	None

88895	88896	RES	0	None
88896	88897	inhibited	0	None
88897	88900	serum alkaline phosphatase	1	GENE-Y
88900	88901	,	0	None
88901	88903	alanine aminotransferase	3	GENE-N
88903	88904	,	0	None
88904	88905	pi-glutathione-S-transferase	0	None
88905	88906	,	0	None
88906	88907	gamma-glutamyl	0	None
88907	88908	transpeptidase	0	None
88908	88909	,	0	None
88909	88910	and	0	None
88910	88911	alpha-glutathione-S-transferase	0	None
88911	88912	activities	0	None
88912	88913	,	0	None
88913	88914	as	0	None
88914	88915	well	0	None
88915	88916	as	0	None
88916	88917	reduced	0	None
88917	88918	serum	0	None
88918	88919	tumor	0	None
88919	88920	necrosis	0	None
88920	88921	factor-alpha	0	None
88921	88922	,	0	None
88922	88923	nitric	0	None
88923	88924	oxide	0	None
88924	88925	,	0	None
88925	88926	and	0	None
88926	88927	hepatic	0	None
88927	88928	malondialdehyde	2	CHEMICAL
88928	88929	as	0	None
88929	88930	compared	0	None
88930	88931	to	0	None
88931	88932	EE-treated	0	None
88932	88933	rats	0	None
88933	88934	.	0	None

88935	88936	The	0	None
88936	88937	results	0	None
88937	88938	clearly	0	None
88938	88939	suggest	0	None
88939	88940	that	0	None
88940	88941	RES	0	None
88941	88942	has	0	None
88942	88943	a	0	None
88943	88944	powerful	0	None
88944	88945	prophylactic	0	None
88945	88946	action	0	None
88946	88947	in	0	None
88947	88948	cholestasis	0	None
88948	88949	induced	0	None
88949	88950	by	0	None
88950	88951	EE	0	None
88951	88952	.	0	None

88953	88954	Taken	0	None
88954	88955	together	0	None
88955	88956	,	0	None
88956	88957	RES	0	None
88957	88958	has	0	None
88958	88959	potential	0	None
88959	88960	as	0	None
88960	88961	a	0	None
88961	88962	preventive	0	None
88962	88963	and	0	None
88963	88964	therapeutic	0	None
88964	88965	agent	0	None
88965	88966	for	0	None
88966	88967	cholestasis	0	None
88967	88968	and	0	None
88968	88969	deserves	0	None
88969	88970	clinical	0	None
88970	88971	trial	0	None
88971	88972	in	0	None
88972	88973	the	0	None
88973	88974	near	0	None
88974	88975	future	0	None
88975	88976	as	0	None
88976	88977	an	0	None
88977	88978	adjuvant	0	None
88978	88979	therapy	0	None
88979	88980	in	0	None
88980	88981	women	0	None
88981	88982	treated	0	None
88982	88983	with	0	None
88983	88984	estrogen	0	None
88984	88985	.	0	None
88985	88986	Deduced	0	None
88986	88988	amino acid	2	CHEMICAL
88988	88989	sequence	0	None
88989	88990	from	0	None
88990	88991	the	0	None
88991	88992	bovine	0	None
88992	88993	oxytocin-neurophysin	0	None
88993	88994	I	0	None
88994	88995	precursor	0	None
88995	88996	cDNA	0	None
88996	88997	.	0	None
88997	88998	Ghrelin	0	None
88998	88999	is	0	None
88999	89000	a	0	None
89000	89001	stomach-derived	0	None
89001	89002	orexigenic	0	None
89002	89003	peptide	0	None
89003	89004	.	0	None

89005	89006	The	0	None
89006	89007	goal	0	None
89007	89008	of	0	None
89008	89009	the	0	None
89009	89010	study	0	None
89010	89011	was	0	None
89011	89012	to	0	None
89012	89013	investigate	0	None
89013	89014	the	0	None
89014	89015	roles	0	None
89015	89016	of	0	None
89016	89017	mu	0	None
89017	89018	and	0	None
89018	89019	kappa	0	None
89019	89021	opioid receptors	3	GENE-N
89021	89022	in	0	None
89022	89023	systemic	0	None
89023	89024	ghrelin-mediated	0	None
89024	89025	regulation	0	None
89025	89026	of	0	None
89026	89027	the	0	None
89027	89028	mesolimbic	0	None
89028	89029	dopamine	0	None
89029	89030	system	0	None
89030	89031	.	0	None

89032	89033	To	0	None
89033	89034	evaluate	0	None
89034	89035	the	0	None
89035	89036	interaction	0	None
89036	89037	of	0	None
89037	89038	systemic	0	None
89038	89039	ghrelin	0	None
89039	89040	with	0	None
89040	89041	values	0	None
89041	89042	of	0	None
89042	89043	food	0	None
89043	89044	reward	0	None
89044	89045	,	0	None
89045	89046	rats	0	None
89046	89047	were	0	None
89047	89048	exposed	0	None
89048	89049	to	0	None
89049	89050	food	0	None
89050	89051	removal	0	None
89051	89052	,	0	None
89052	89053	regular	0	None
89053	89054	food	0	None
89054	89055	or	0	None
89055	89056	palatable	0	None
89056	89057	food	0	None
89057	89058	after	0	None
89058	89059	systemic	0	None
89059	89060	ghrelin	0	None
89060	89061	administration	0	None
89061	89062	.	0	None

89063	89064	Extracellular	0	None
89064	89065	dopamine	0	None
89065	89066	levels	0	None
89066	89067	were	0	None
89067	89068	quantified	0	None
89068	89069	in	0	None
89069	89070	the	0	None
89070	89071	nucleus	0	None
89071	89072	accumbens	0	None
89072	89073	(	0	None
89073	89074	NAc	0	None
89074	89075	)	0	None
89075	89076	and	0	None
89076	89077	receptor-specific	0	None
89077	89078	compounds	0	None
89078	89079	were	0	None
89079	89080	infused	0	None
89080	89081	into	0	None
89081	89082	the	0	None
89082	89083	ventral	0	None
89083	89084	tegmental	0	None
89084	89085	area	0	None
89085	89086	(	0	None
89086	89087	VTA	0	None
89087	89088	)	0	None
89088	89089	using	0	None
89089	89090	dual-probe	0	None
89090	89091	microdialysis	0	None
89091	89092	.	0	None

89093	89094	Consumption	0	None
89094	89095	of	0	None
89095	89096	regular	0	None
89096	89097	or	0	None
89097	89098	palatable	0	None
89098	89099	food	0	None
89099	89100	without	0	None
89100	89101	systemic	0	None
89101	89102	ghrelin	0	None
89102	89103	administration	0	None
89103	89104	induced	0	None
89104	89105	an	0	None
89105	89106	increase	0	None
89106	89107	in	0	None
89107	89108	dopamine	0	None
89108	89109	levels	0	None
89109	89110	in	0	None
89110	89111	the	0	None
89111	89112	NAc	0	None
89112	89113	via	0	None
89113	89114	activation	0	None
89114	89115	of	0	None
89115	89116	mu	0	None
89116	89118	opioid receptors	3	GENE-N
89118	89119	in	0	None
89119	89120	the	0	None
89120	89121	VTA	0	None
89121	89122	.	0	None

89123	89124	Systemic	0	None
89124	89125	ghrelin	0	None
89125	89126	administration	0	None
89126	89127	(	0	None
89127	89128	3	0	None
89128	89129	nmol	0	None
89129	89130	,	0	None
89130	89131	i	0	None
89131	89132	.	0	None

89133	89134	v	0	None
89134	89135	.	0	None

89136	89137	)	0	None
89137	89138	followed	0	None
89138	89139	by	0	None
89139	89140	no	0	None
89140	89141	food	0	None
89141	89142	induced	0	None
89142	89143	a	0	None
89143	89144	decrease	0	None
89144	89145	in	0	None
89145	89146	dopamine	0	None
89146	89147	levels	0	None
89147	89148	via	0	None
89148	89149	activation	0	None
89149	89150	of	0	None
89150	89151	kappa	0	None
89151	89153	opioid receptors	3	GENE-N
89153	89154	in	0	None
89154	89155	the	0	None
89155	89156	VTA	0	None
89156	89157	.	0	None

89158	89159	Systemic	0	None
89159	89160	ghrelin	0	None
89160	89161	administration	0	None
89161	89162	followed	0	None
89162	89163	by	0	None
89163	89164	consumption	0	None
89164	89165	of	0	None
89165	89166	regular	0	None
89166	89167	food	0	None
89167	89168	induced	0	None
89168	89169	an	0	None
89169	89170	increase	0	None
89170	89171	in	0	None
89171	89172	dopamine	0	None
89172	89173	levels	0	None
89173	89174	via	0	None
89174	89175	preferential	0	None
89175	89176	activation	0	None
89176	89177	of	0	None
89177	89178	mu	0	None
89178	89180	opioid receptors	3	GENE-N
89180	89181	,	0	None
89181	89182	whereas	0	None
89182	89183	systemic	0	None
89183	89184	ghrelin	0	None
89184	89185	administration	0	None
89185	89186	followed	0	None
89186	89187	by	0	None
89187	89188	consumption	0	None
89188	89189	of	0	None
89189	89190	palatable	0	None
89190	89191	food	0	None
89191	89192	suppressed	0	None
89192	89193	the	0	None
89193	89194	increase	0	None
89194	89195	in	0	None
89195	89196	dopamine	0	None
89196	89197	levels	0	None
89197	89198	via	0	None
89198	89199	preferential	0	None
89199	89200	activation	0	None
89200	89201	of	0	None
89201	89202	kappa	0	None
89202	89204	opioid receptors	3	GENE-N
89204	89205	.	0	None

89206	89207	Thus	0	None
89207	89208	,	0	None
89208	89209	natural	0	None
89209	89210	food	0	None
89210	89211	reward	0	None
89211	89212	and	0	None
89212	89213	systemic	0	None
89213	89214	ghrelin	0	None
89214	89215	activate	0	None
89215	89216	mu	0	None
89216	89217	and	0	None
89217	89220	kappa opioid receptor	3	GENE-N
89220	89221	pathways	0	None
89221	89222	in	0	None
89222	89223	the	0	None
89223	89224	VTA	0	None
89224	89225	,	0	None
89225	89226	respectively	0	None
89226	89227	,	0	None
89227	89228	resulting	0	None
89228	89229	in	0	None
89229	89230	opposite	0	None
89230	89231	influences	0	None
89231	89232	on	0	None
89232	89233	dopamine	0	None
89233	89234	release	0	None
89234	89235	in	0	None
89235	89236	the	0	None
89236	89237	NAc	0	None
89237	89238	.	0	None

89239	89240	Furthermore	0	None
89240	89241	,	0	None
89241	89242	systemic	0	None
89242	89243	ghrelin	0	None
89243	89244	induces	0	None
89244	89245	switching	0	None
89245	89246	of	0	None
89246	89247	the	0	None
89247	89248	dominant	0	None
89248	89250	opioid receptor	3	GENE-N
89250	89251	pathway	0	None
89251	89252	for	0	None
89252	89253	highly	0	None
89253	89254	rewarding	0	None
89254	89255	food	0	None
89255	89256	from	0	None
89256	89257	mu	0	None
89257	89258	to	0	None
89258	89259	kappa	0	None
89259	89260	,	0	None
89260	89261	resulting	0	None
89261	89262	in	0	None
89262	89263	suppression	0	None
89263	89264	of	0	None
89264	89265	the	0	None
89265	89266	mesolimbic	0	None
89266	89267	dopamine	0	None
89267	89268	system	0	None
89268	89269	.	0	None

89270	89271	These	0	None
89271	89272	novel	0	None
89272	89273	findings	0	None
89273	89274	might	0	None
89274	89275	provide	0	None
89275	89276	insights	0	None
89276	89277	into	0	None
89277	89278	the	0	None
89278	89279	neural	0	None
89279	89280	pathways	0	None
89280	89281	involved	0	None
89281	89282	in	0	None
89282	89283	eating	0	None
89283	89284	disorders	0	None
89284	89285	.	0	None
89285	89286	Liver	0	None
89286	89287	X	0	None
89287	89288	receptors	0	None
89288	89289	:	0	None
89289	89290	Emerging	0	None
89290	89291	therapeutic	0	None
89291	89292	targets	0	None
89292	89293	for	0	None
89293	89294	Alzheimer's	0	None
89294	89295	disease	0	None
89295	89296	.	0	None
89296	89297	Anti-diabetic	0	None
89297	89298	Activity	0	None
89298	89299	of	0	None
89299	89300	Swertiamarin	0	None
89300	89301	is	0	None
89301	89302	due	0	None
89302	89303	to	0	None
89303	89304	an	0	None
89304	89305	Active	0	None
89305	89306	Metabolite	0	None
89306	89307	,	0	None
89307	89308	Gentianine	0	None
89308	89309	,	0	None
89309	89310	that	0	None
89310	89311	Upregulates	0	None
89311	89312	PPAR-γ	0	None
89312	89313	Gene	0	None
89313	89314	Expression	0	None
89314	89315	in	0	None
89315	89316	3T3-L1	0	None
89316	89317	cells	0	None
89317	89318	.	0	None
89318	89320	Serotonin transporter	1	GENE-Y
89320	89321	function	0	None
89321	89322	in	0	None
89322	89323	vivo	0	None
89323	89324	:	0	None
89324	89325	assessment	0	None
89325	89326	by	0	None
89326	89327	chronoamperometry	0	None
89327	89328	.	0	None
89328	89329	Distinct	0	None
89329	89330	patterns	0	None
89330	89331	of	0	None
89331	89332	mutations	0	None
89332	89333	occurring	0	None
89333	89334	in	0	None
89334	89335	de	0	None
89335	89336	novo	0	None
89336	89337	AML	0	None
89337	89338	versus	0	None
89338	89339	AML	0	None
89339	89340	arising	0	None
89340	89341	in	0	None
89341	89342	the	0	None
89342	89343	setting	0	None
89343	89344	of	0	None
89344	89345	severe	0	None
89345	89346	congenital	0	None
89346	89347	neutropenia	0	None
89347	89348	.	0	None
89348	89349	UNLABELLED	0	None
89349	89350	:	0	None
89350	89351	Long	0	None
89351	89352	standing	0	None
89352	89353	confusion	0	None
89353	89354	exists	0	None
89354	89355	in	0	None
89355	89356	the	0	None
89356	89357	terminology	0	None
89357	89358	of	0	None
89358	89359	hypokalaemic	0	None
89359	89360	salt-losing	0	None
89360	89361	tubulopathies	0	None
89361	89362	(	0	None
89362	89363	SLTs	0	None
89363	89364	)	0	None
89364	89365	.	0	None

89366	89367	SLTs	0	None
89367	89368	are	0	None
89368	89369	autosomal	0	None
89369	89370	recessively	0	None
89370	89371	transmitted	0	None
89371	89372	and	0	None
89372	89373	characterized	0	None
89373	89374	by	0	None
89374	89375	normotensive	0	None
89375	89376	secondary	0	None
89376	89377	hyperreninism	0	None
89377	89378	/	0	None
89378	89379	hyperaldosteronism	0	None
89379	89380	with	0	None
89380	89381	hypokalaemic	0	None
89381	89382	metabolic	0	None
89382	89383	alkalosis	0	None
89383	89384	.	0	None

89385	89386	Historically	0	None
89386	89387	,	0	None
89387	89388	four	0	None
89388	89389	phenotypical	0	None
89389	89390	variants	0	None
89390	89391	have	0	None
89391	89392	been	0	None
89392	89393	described	0	None
89393	89394	:	0	None
89394	89395	(	0	None
89395	89396	1	0	None
89396	89397	)	0	None
89397	89398	the	0	None
89398	89399	(	0	None
89399	89400	classic	0	None
89400	89401	)	0	None
89401	89402	Bartter	0	None
89402	89403	syndrome	0	None
89403	89404	(	0	None
89404	89405	cBS	0	None
89405	89406	)	0	None
89406	89407	,	0	None
89407	89408	(	0	None
89408	89409	2	0	None
89409	89410	)	0	None
89410	89411	the	0	None
89411	89412	hypomagnesaemic	0	None
89412	89413	hypocalciuric	0	None
89413	89414	Gitelman	0	None
89414	89415	syndrome	0	None
89415	89416	(	0	None
89416	89417	GS	0	None
89417	89418	)	0	None
89418	89419	,	0	None
89419	89420	(	0	None
89420	89421	3	0	None
89421	89422	)	0	None
89422	89423	the	0	None
89423	89424	hypercalciuric	0	None
89424	89425	hyperprostaglandin-E-syndrome	0	None
89425	89426	(	0	None
89426	89427	HPS	0	None
89427	89428	)	0	None
89428	89429	or	0	None
89429	89430	antenatal	0	None
89430	89431	Bartter	0	None
89431	89432	syndrome	0	None
89432	89433	(	0	None
89433	89434	aBS	0	None
89434	89435	)	0	None
89435	89436	and	0	None
89436	89437	(	0	None
89437	89438	4	0	None
89438	89439	)	0	None
89439	89440	the	0	None
89440	89441	hyperprostaglandin-E-syndrome	0	None
89441	89442	with	0	None
89442	89443	sensorineural	0	None
89443	89444	deafness	0	None
89444	89445	(	0	None
89445	89446	HPS	0	None
89446	89447	+	0	None
89447	89448	SND	0	None
89448	89449	)	0	None
89449	89450	.	0	None

89451	89452	The	0	None
89452	89453	latter	0	None
89453	89454	two	0	None
89454	89455	syndromes	0	None
89455	89456	are	0	None
89456	89457	the	0	None
89457	89458	most	0	None
89458	89459	severe	0	None
89459	89460	variants	0	None
89460	89461	with	0	None
89461	89462	antenatal	0	None
89462	89463	manifestation	0	None
89463	89464	with	0	None
89464	89465	polyhydramnios	0	None
89465	89466	and	0	None
89466	89467	life-threatening	0	None
89467	89468	course	0	None
89468	89469	of	0	None
89469	89470	salt-	0	None
89470	89471	and	0	None
89471	89472	water-loss	0	None
89472	89473	.	0	None

89474	89475	Defects	0	None
89475	89476	in	0	None
89476	89477	five	0	None
89477	89478	renal	0	None
89478	89479	membrane	0	None
89479	89480	proteins	0	None
89480	89481	involved	0	None
89481	89482	in	0	None
89482	89483	electrolyte	0	None
89483	89484	reabsorption	0	None
89484	89485	have	0	None
89485	89486	been	0	None
89486	89487	identified	0	None
89487	89488	:	0	None
89488	89489	In	0	None
89489	89490	HPS-patients	0	None
89490	89491	mutations	0	None
89491	89492	in	0	None
89492	89493	(	0	None
89493	89494	1	0	None
89494	89495	)	0	None
89495	89496	either	0	None
89496	89497	the	0	None
89497	89498	furosemide-sensitive	0	None
89498	89499	sodium-potassium-chloride	0	None
89499	89500	cotransporter	0	None
89500	89501	NKCC2	0	None
89501	89502	,	0	None
89502	89503	or	0	None
89503	89504	(	0	None
89504	89505	2	0	None
89505	89506	)	0	None
89506	89507	in	0	None
89507	89508	the	0	None
89508	89509	potassium	0	None
89509	89510	channel	0	None
89510	89511	ROMK	3	GENE-N
89511	89512	have	0	None
89512	89513	been	0	None
89513	89514	identified	0	None
89514	89515	,	0	None
89515	89516	and	0	None
89516	89517	(	0	None
89517	89518	3	0	None
89518	89519	)	0	None
89519	89520	HPS	0	None
89520	89521	+	0	None
89521	89522	SND	0	None
89522	89523	is	0	None
89523	89524	caused	0	None
89524	89525	by	0	None
89525	89526	mutations	0	None
89526	89527	in	0	None
89527	89528	the	0	None
89528	89529	beta-subunit	0	None
89529	89530	of	0	None
89530	89531	the	0	None
89531	89532	chloride	0	None
89532	89533	channels	0	None
89533	89534	ClC-Kb	0	None
89534	89535	and	0	None
89535	89536	-Ka	0	None
89536	89537	(	0	None
89537	89538	named	0	None
89538	89539	barttin	0	None
89539	89540	)	0	None
89540	89541	,	0	None
89541	89542	all	0	None
89542	89543	mimicking	0	None
89543	89544	the	0	None
89544	89545	major	0	None
89545	89546	pharmacological	0	None
89546	89547	effects	0	None
89547	89548	of	0	None
89548	89549	furosemide	0	None
89549	89550	with	0	None
89550	89551	minor	0	None
89551	89552	potassium-wasting	0	None
89552	89553	in	0	None
89553	89554	ROMK-patients	0	None
89554	89555	as	0	None
89555	89556	seen	0	None
89556	89557	in	0	None
89557	89558	patients	0	None
89558	89559	treated	0	None
89559	89560	with	0	None
89560	89561	simultaneous	0	None
89561	89562	furosemide	0	None
89562	89563	and	0	None
89563	89564	amiloride	0	None
89564	89565	,	0	None
89565	89566	and	0	None
89566	89567	minor	0	None
89567	89568	calcium-wasting	0	None
89568	89569	in	0	None
89569	89570	Barttin-patients	0	None
89570	89571	resembling	0	None
89571	89572	the	0	None
89572	89573	combination	0	None
89573	89574	of	0	None
89574	89575	furosemide	0	None
89575	89576	and	0	None
89576	89577	thiazides	0	None
89577	89578	.	0	None

89579	89580	(	0	None
89580	89581	4	0	None
89581	89582	)	0	None
89582	89583	cBS	0	None
89583	89584	is	0	None
89584	89585	caused	0	None
89585	89586	by	0	None
89586	89587	mutations	0	None
89587	89588	in	0	None
89588	89589	the	0	None
89589	89591	chloride channel	3	GENE-N
89591	89592	ClC-Kb	0	None
89592	89593	with	0	None
89593	89594	similar	0	None
89594	89595	clinical	0	None
89595	89596	characteristics	0	None
89596	89597	as	0	None
89597	89598	seen	0	None
89598	89599	under	0	None
89599	89600	combination	0	None
89600	89601	of	0	None
89601	89602	thiazides	0	None
89602	89603	and	0	None
89603	89604	furosemide	0	None
89604	89605	,	0	None
89605	89606	(	0	None
89606	89607	5	0	None
89607	89608	)	0	None
89608	89609	GS	0	None
89609	89610	is	0	None
89610	89611	caused	0	None
89611	89612	by	0	None
89612	89613	mutations	0	None
89613	89614	in	0	None
89614	89615	the	0	None
89615	89616	thiazide-sensitive	0	None
89616	89617	sodium-chloride	0	None
89617	89618	cotransporter	0	None
89618	89619	NCCT	0	None
89619	89620	resembling	0	None
89620	89621	the	0	None
89621	89622	effect	0	None
89622	89623	of	0	None
89623	89624	long-term	0	None
89624	89625	thiazide	0	None
89625	89626	administration	0	None
89626	89627	.	0	None

89628	89629	CONCLUSION	0	None
89629	89630	:	0	None
89630	89631	The	0	None
89631	89632	combination	0	None
89632	89633	of	0	None
89633	89634	pharmacology	0	None
89634	89635	and	0	None
89635	89636	genetics	0	None
89636	89637	suggests	0	None
89637	89638	a	0	None
89638	89639	new	0	None
89639	89640	terminology	0	None
89640	89641	for	0	None
89641	89642	the	0	None
89642	89643	above	0	None
89643	89644	described	0	None
89644	89645	SLTs	0	None
89645	89646	:	0	None
89646	89647	Furosemide-like-SLT	0	None
89647	89648	for	0	None
89648	89649	HPS	0	None
89649	89650	caused	0	None
89650	89651	by	0	None
89651	89652	NKCC2-mutations	0	None
89652	89653	,	0	None
89653	89654	furosemide	0	None
89654	89655	/	0	None
89655	89656	amiloride-like-SLT	0	None
89656	89657	for	0	None
89657	89658	HPS	0	None
89658	89659	caused	0	None
89659	89660	by	0	None
89660	89661	ROMK-mutations	0	None
89661	89662	,	0	None
89662	89663	furosemide	0	None
89663	89664	/	0	None
89664	89665	thiazide-like-SLT	0	None
89665	89666	for	0	None
89666	89667	HPS	0	None
89667	89668	+	0	None
89668	89669	SND	0	None
89669	89670	,	0	None
89670	89671	thiazide	0	None
89671	89672	/	0	None
89672	89673	furosemide-like-SLT	0	None
89673	89674	for	0	None
89674	89675	cBS	0	None
89675	89676	,	0	None
89676	89677	and	0	None
89677	89678	thiazide-like-SLT	0	None
89678	89679	for	0	None
89679	89680	GS	0	None
89680	89681	.	0	None
89681	89683	Vitamin A	2	CHEMICAL
89683	89684	or	0	None
89684	89685	retinol	2	CHEMICAL
89685	89686	is	0	None
89686	89687	arguably	0	None
89687	89688	the	0	None
89688	89689	most	0	None
89689	89690	multifunctional	0	None
89690	89691	vitamin	0	None
89691	89692	in	0	None
89692	89693	the	0	None
89693	89694	human	0	None
89694	89695	body	0	None
89695	89696	as	0	None
89696	89697	it	0	None
89697	89698	is	0	None
89698	89699	essential	0	None
89699	89700	from	0	None
89700	89701	embryogenesis	0	None
89701	89702	to	0	None
89702	89703	adulthood	0	None
89703	89704	.	0	None

89705	89706	The	0	None
89706	89707	pleiotropic	0	None
89707	89708	effects	0	None
89708	89709	of	0	None
89709	89711	vitamin A	2	CHEMICAL
89711	89712	are	0	None
89712	89713	exerted	0	None
89713	89714	mainly	0	None
89714	89715	by	0	None
89715	89716	one	0	None
89716	89717	active	0	None
89717	89718	metabolite	0	None
89718	89719	,	0	None
89719	89720	all-trans	0	None
89720	89722	retinoic acid	2	CHEMICAL
89722	89723	(	0	None
89723	89724	atRA	0	None
89724	89725	)	0	None
89725	89726	,	0	None
89726	89727	which	0	None
89727	89728	regulates	0	None
89728	89729	the	0	None
89729	89730	expression	0	None
89730	89731	of	0	None
89731	89732	a	0	None
89732	89733	battery	0	None
89733	89734	of	0	None
89734	89735	target	0	None
89735	89736	genes	0	None
89736	89737	through	0	None
89737	89738	several	0	None
89738	89739	families	0	None
89739	89740	of	0	None
89740	89742	nuclear receptors	3	GENE-N
89742	89743	(	0	None
89743	89744	RARs	0	None
89744	89745	,	0	None
89745	89746	RXRs	0	None
89746	89747	and	0	None
89747	89748	PPARβ	0	None
89748	89749	/	0	None
89749	89750	δ	0	None
89750	89751	)	0	None
89751	89752	,	0	None
89752	89753	polymorphic	0	None
89753	89755	retinoic acid	2	CHEMICAL
89755	89756	(	0	None
89756	89757	RA	2	CHEMICAL
89757	89758	)	0	None
89758	89759	response	0	None
89759	89760	elements	0	None
89760	89761	and	0	None
89761	89762	multiple	0	None
89762	89763	coregulators	0	None
89763	89764	.	0	None

89765	89766	It	0	None
89766	89767	also	0	None
89767	89768	involves	0	None
89768	89769	extra	0	None
89769	89770	nuclear	0	None
89770	89771	and	0	None
89771	89772	non-transcriptional	0	None
89772	89773	effects	0	None
89773	89774	such	0	None
89774	89775	as	0	None
89775	89776	the	0	None
89776	89777	activation	0	None
89777	89778	of	0	None
89778	89779	kinase	0	None
89779	89780	cascades	0	None
89780	89781	,	0	None
89781	89782	which	0	None
89782	89783	are	0	None
89783	89784	integrated	0	None
89784	89785	in	0	None
89785	89786	the	0	None
89786	89787	nucleus	0	None
89787	89788	via	0	None
89788	89789	the	0	None
89789	89790	phosphorylation	0	None
89790	89791	of	0	None
89791	89792	several	0	None
89792	89793	actors	0	None
89793	89794	of	0	None
89794	89795	RA	2	CHEMICAL
89795	89796	signaling	0	None
89796	89797	.	0	None

89798	89799	However	0	None
89799	89800	,	0	None
89800	89802	vitamin A	2	CHEMICAL
89802	89803	itself	0	None
89803	89804	proved	0	None
89804	89805	recently	0	None
89805	89806	to	0	None
89806	89807	be	0	None
89807	89808	active	0	None
89808	89809	and	0	None
89809	89810	RARs	0	None
89810	89811	to	0	None
89811	89812	be	0	None
89812	89813	present	0	None
89813	89814	in	0	None
89814	89815	the	0	None
89815	89816	cytosol	0	None
89816	89817	to	0	None
89817	89818	regulate	0	None
89818	89819	translation	0	None
89819	89820	and	0	None
89820	89821	cell	0	None
89821	89822	plasticity	0	None
89822	89823	.	0	None

89824	89825	All	0	None
89825	89826	these	0	None
89826	89827	new	0	None
89827	89828	concepts	0	None
89828	89829	expand	0	None
89829	89830	the	0	None
89830	89831	scope	0	None
89831	89832	of	0	None
89832	89833	the	0	None
89833	89834	biologic	0	None
89834	89835	functions	0	None
89835	89836	of	0	None
89836	89838	vitamin A	2	CHEMICAL
89838	89839	and	0	None
89839	89840	RA	2	CHEMICAL
89840	89841	.	0	None
89841	89842	Using	0	None
89842	89843	the	0	None
89843	89844	alpha	0	None
89844	89845	1-adrenoceptor	0	None
89845	89846	subtype-selective	0	None
89846	89847	antagonists	0	None
89847	89848	chlorethylclonidine	0	None
89848	89849	(	0	None
89849	89850	CEC	0	None
89850	89851	)	0	None
89851	89852	,	0	None
89852	89853	WB4101	0	None
89853	89854	,	0	None
89854	89855	and	0	None
89855	89856	5-methyl-urapidil	0	None
89856	89857	,	0	None
89857	89858	we	0	None
89858	89859	have	0	None
89859	89860	examined	0	None
89860	89861	the	0	None
89861	89862	possible	0	None
89862	89863	heterogeneity	0	None
89863	89864	in	0	None
89864	89865	the	0	None
89865	89866	alpha	0	None
89866	89867	1-adrenoceptor	0	None
89867	89868	populations	0	None
89868	89869	in	0	None
89869	89870	rabbit	0	None
89870	89871	aorta	0	None
89871	89872	.	0	None

89873	89874	The	0	None
89874	89875	alpha	0	None
89875	89876	1-adrenoceptor	0	None
89876	89877	alkylating	0	None
89877	89878	agent	0	None
89878	89879	CEC	0	None
89879	89880	selectively	0	None
89880	89881	inhibited	0	None
89881	89882	the	0	None
89882	89883	phasic	0	None
89883	89884	component	0	None
89884	89885	of	0	None
89885	89886	the	0	None
89886	89887	norepinephrine-induced	0	None
89887	89888	contractile	0	None
89888	89889	response	0	None
89889	89890	,	0	None
89890	89891	with	0	None
89891	89892	little	0	None
89892	89893	effect	0	None
89893	89894	on	0	None
89894	89895	the	0	None
89895	89896	tonic	0	None
89896	89897	component	0	None
89897	89898	.	0	None

89899	89900	The	0	None
89900	89901	alpha	0	None
89901	89902	1-adrenoceptor	0	None
89902	89903	occupancy-response	0	None
89903	89904	relationship	0	None
89904	89905	defined	0	None
89905	89906	by	0	None
89906	89907	the	0	None
89907	89908	phenoxybenzamine	0	None
89908	89909	inactivation	0	None
89909	89910	method	0	None
89910	89911	was	0	None
89911	89912	rectangular	0	None
89912	89913	hyperbolic	0	None
89913	89914	for	0	None
89914	89915	the	0	None
89915	89916	tonic	0	None
89916	89917	response	0	None
89917	89918	,	0	None
89918	89919	whereas	0	None
89919	89920	that	0	None
89920	89921	for	0	None
89921	89922	the	0	None
89922	89923	phasic	0	None
89923	89924	response	0	None
89924	89925	was	0	None
89925	89926	linear	0	None
89926	89927	,	0	None
89927	89928	indicating	0	None
89928	89929	the	0	None
89929	89930	different	0	None
89930	89931	degree	0	None
89931	89932	of	0	None
89932	89933	receptor	0	None
89933	89934	reserve	0	None
89934	89935	for	0	None
89935	89936	the	0	None
89936	89937	two	0	None
89937	89938	responses	0	None
89938	89939	.	0	None

89940	89941	Radioligand	0	None
89941	89942	binding	0	None
89942	89943	studies	0	None
89943	89944	with	0	None
89944	89945	the	0	None
89945	89946	nonselective	0	None
89946	89947	alpha	0	None
89947	89948	1-adrenoceptor	0	None
89948	89949	antagonist	0	None
89949	89950	radioligand	0	None
89950	89951	125I-BE2254	0	None
89951	89952	showed	0	None
89952	89953	that	0	None
89953	89954	73-87%	0	None
89954	89955	of	0	None
89955	89956	the	0	None
89956	89957	binding	0	None
89957	89958	sites	0	None
89958	89959	in	0	None
89959	89960	rabbit	0	None
89960	89961	aorta	0	None
89961	89962	are	0	None
89962	89963	CEC	0	None
89963	89964	sensitive	0	None
89964	89965	and	0	None
89965	89966	they	0	None
89966	89967	are	0	None
89967	89968	predominantly	0	None
89968	89969	low	0	None
89969	89970	affinity	0	None
89970	89971	sites	0	None
89971	89972	both	0	None
89972	89973	for	0	None
89973	89974	WB4101	0	None
89974	89975	(	0	None
89975	89976	pKd	0	None
89976	89977	=	0	None
89977	89978	8	0	None
89978	89979	.	0	None
89979	89980	1	0	None
89980	89981	)	0	None
89981	89982	and	0	None
89982	89983	for	0	None
89983	89984	5-methylurapidil	2	CHEMICAL
89984	89985	(	0	None
89985	89986	pKd	0	None
89986	89987	=	0	None
89987	89988	7	0	None
89988	89989	.	0	None
89989	89990	1	0	None
89990	89991	)	0	None
89991	89992	.	0	None

89993	89994	Moreover	0	None
89994	89995	,	0	None
89995	89996	alpha	0	None
89996	89997	1-adrenoceptor-mediated	0	None
89997	89998	phosphatidylinositol	2	CHEMICAL
89998	89999	(	0	None
89999	90000	PI	0	None
90000	90001	)	0	None
90001	90002	hydrolysis	0	None
90002	90003	was	0	None
90003	90004	CEC	0	None
90004	90005	sensitive	0	None
90005	90006	,	0	None
90006	90007	and	0	None
90007	90008	fractional	0	None
90008	90009	inactivation	0	None
90009	90010	of	0	None
90010	90011	alpha	0	None
90011	90012	1	0	None
90012	90013	receptors	0	None
90013	90014	with	0	None
90014	90015	CEC	0	None
90015	90016	showed	0	None
90016	90017	equivalent	0	None
90017	90018	increments	0	None
90018	90019	in	0	None
90019	90020	the	0	None
90020	90021	reduction	0	None
90021	90022	of	0	None
90022	90023	PI	0	None
90023	90024	hydrolysis	0	None
90024	90025	and	0	None
90025	90026	phasic	0	None
90026	90027	contractile	0	None
90027	90028	response	0	None
90028	90029	,	0	None
90029	90030	suggesting	0	None
90030	90031	that	0	None
90031	90032	both	0	None
90032	90033	responses	0	None
90033	90034	are	0	None
90034	90035	linearly	0	None
90035	90036	related	0	None
90036	90037	to	0	None
90037	90038	the	0	None
90038	90039	CEC-sensitive	0	None
90039	90040	receptor	0	None
90040	90041	sites	0	None
90041	90042	.	0	None

90043	90044	The	0	None
90044	90045	Schild	0	None
90045	90046	plots	0	None
90046	90047	for	0	None
90047	90048	the	0	None
90048	90049	competitive	0	None
90049	90050	antagonists	0	None
90050	90051	WB4101	0	None
90051	90052	and	0	None
90052	90053	5-methyl-urapidil	0	None
90053	90054	against	0	None
90054	90055	alpha	0	None
90055	90056	1a-adrenoceptor-selective	0	None
90056	90057	agonist	0	None
90057	90058	methoxamine-induced	0	None
90058	90059	contraction	0	None
90059	90060	were	0	None
90060	90061	linear	0	None
90061	90062	and	0	None
90062	90063	had	0	None
90063	90064	slopes	0	None
90064	90065	not	0	None
90065	90066	significantly	0	None
90066	90067	different	0	None
90067	90068	from	0	None
90068	90069	unity	0	None
90069	90070	,	0	None
90070	90071	with	0	None
90071	90072	a	0	None
90072	90073	pA2	0	None
90073	90074	of	0	None
90074	90075	9	0	None
90075	90076	.	0	None
90076	90077	07	0	None
90077	90078	+	0	None
90078	90079	/	0	None
90079	90080	-	0	None
90080	90081	0	0	None
90081	90082	.	0	None
90082	90083	07	0	None
90083	90084	(	0	None
90084	90085	n	0	None
90085	90086	=	0	None
90086	90087	5	0	None
90087	90088	)	0	None
90088	90089	for	0	None
90089	90090	WB4101	0	None
90090	90091	and	0	None
90091	90092	9	0	None
90092	90093	.	0	None
90093	90094	09	0	None
90094	90095	+	0	None
90095	90096	/	0	None
90096	90097	-	0	None
90097	90098	0	0	None
90098	90099	.	0	None
90099	90100	05	0	None
90100	90101	(	0	None
90101	90102	n	0	None
90102	90103	=	0	None
90103	90104	3	0	None
90104	90105	)	0	None
90105	90106	for	0	None
90106	90107	5-methyl-urapidil	0	None
90107	90108	.	0	None

90109	90110	However	0	None
90110	90111	,	0	None
90111	90112	the	0	None
90112	90113	Schilod	0	None
90113	90114	plots	0	None
90114	90115	for	0	None
90115	90116	these	0	None
90116	90117	antagonists	0	None
90117	90118	against	0	None
90118	90119	norepinephrine	2	CHEMICAL
90119	90120	were	0	None
90120	90121	curvilinear	0	None
90121	90122	.	0	None

90123	90124	Computer-assisted	0	None
90124	90125	analysis	0	None
90125	90126	of	0	None
90126	90127	these	0	None
90127	90128	curvilinear	0	None
90128	90129	Schild	0	None
90129	90130	plots	0	None
90130	90131	in	0	None
90131	90132	a	0	None
90132	90133	two-receptor	0	None
90133	90134	system	0	None
90134	90135	indicated	0	None
90135	90136	that	0	None
90136	90137	alpha	0	None
90137	90138	1-adrenoceptor	0	None
90138	90139	populations	0	None
90139	90140	responsible	0	None
90140	90141	for	0	None
90141	90142	the	0	None
90142	90143	constrictive	0	None
90143	90144	response	0	None
90144	90145	are	0	None
90145	90146	predominantly	0	None
90146	90147	(	0	None
90147	90148	approximately	0	None
90148	90149	80-90%	0	None
90149	90150	)	0	None
90150	90151	low	0	None
90151	90152	affinity	0	None
90152	90153	sites	0	None
90153	90154	for	0	None
90154	90155	the	0	None
90155	90156	two	0	None
90156	90157	antagonists	0	None
90157	90158	(	0	None
90158	90159	pKd	0	None
90159	90160	approximately	0	None
90160	90161	8	0	None
90161	90162	.	0	None
90162	90163	1	0	None
90163	90164	for	0	None
90164	90165	WB4101	0	None
90165	90166	and	0	None
90166	90167	pKd	0	None
90167	90168	approximately	0	None
90168	90169	7	0	None
90169	90170	.	0	None
90170	90171	1	0	None
90171	90172	for	0	None
90172	90173	5-methyl-urapidil	0	None
90173	90174	)	0	None
90174	90175	and	0	None
90175	90176	a	0	None
90176	90177	small	0	None
90177	90178	population	0	None
90178	90179	(	0	None
90179	90180	approximately	0	None
90180	90181	10-20%	0	None
90181	90182	)	0	None
90182	90183	are	0	None
90183	90184	high	0	None
90184	90185	affinity	0	None
90185	90186	sites	0	None
90186	90187	(	0	None
90187	90188	pKd	0	None
90188	90189	approximately	0	None
90189	90190	9	0	None
90190	90191	.	0	None
90191	90192	1	0	None
90192	90193	for	0	None
90193	90194	both	0	None
90194	90195	WB4101	0	None
90195	90196	and	0	None
90196	90197	5-methyl-urapidil	0	None
90197	90198	)	0	None
90198	90199	,	0	None
90199	90200	which	0	None
90200	90201	was	0	None
90201	90202	in	0	None
90202	90203	good	0	None
90203	90204	agreement	0	None
90204	90205	with	0	None
90205	90206	radioligand	0	None
90206	90207	binding	0	None
90207	90208	studies	0	None
90208	90209	.	0	None

90210	90211	(	0	None
90211	90212	ABSTRACT	0	None
90212	90213	TRUNCATED	0	None
90213	90214	AT	0	None
90214	90215	400	0	None
90215	90216	WORDS	0	None
90216	90217	)	0	None
90217	90218	UNLABELLED	0	None
90218	90219	:	0	None
90219	90220	Trifluorothymidine	0	None
90220	90221	(	0	None
90221	90222	TFT	0	None
90222	90223	)	0	None
90223	90224	can	0	None
90224	90225	be	0	None
90225	90226	phosphorylated	0	None
90226	90227	by	0	None
90227	90229	thymidine kinase	1	GENE-Y
90229	90230	(	0	None
90230	90231	TK	1	GENE-Y
90231	90232	)	0	None
90232	90233	to	0	None
90233	90234	TFTMP	0	None
90234	90235	which	0	None
90235	90236	can	0	None
90236	90237	inhibit	0	None
90237	90238	thymidylate	2	CHEMICAL
90238	90239	synthase	0	None
90239	90240	(	0	None
90240	90241	TS	0	None
90241	90242	)	0	None
90242	90243	,	0	None
90243	90244	resulting	0	None
90244	90245	in	0	None
90245	90246	depletion	0	None
90246	90247	of	0	None
90247	90248	thymidine	2	CHEMICAL
90248	90249	nucleotides	0	None
90249	90250	.	0	None

90251	90252	TFT	0	None
90252	90253	can	0	None
90253	90254	be	0	None
90254	90255	degraded	0	None
90255	90256	by	0	None
90256	90258	thymidine phosphorylase	1	GENE-Y
90258	90259	(	0	None
90259	90260	TP	1	GENE-Y
90260	90261	)	0	None
90261	90262	which	0	None
90262	90263	can	0	None
90263	90264	be	0	None
90264	90265	inhibited	0	None
90265	90266	by	0	None
90266	90268	thymidine phosphorylase	1	GENE-Y
90268	90269	inhibitor	0	None
90269	90270	(	0	None
90270	90271	TPI	0	None
90271	90272	)	0	None
90272	90273	.	0	None

90274	90275	Using	0	None
90275	90276	the	0	None
90276	90277	TS	0	None
90277	90278	in	0	None
90278	90279	situ	0	None
90279	90280	Inhibition	0	None
90280	90281	Assay	0	None
90281	90282	(	0	None
90282	90283	TSIA	0	None
90283	90284	)	0	None
90284	90285	FM3A	0	None
90285	90286	breast	0	None
90286	90287	cancer	0	None
90287	90288	cells	0	None
90288	90289	were	0	None
90289	90290	exposed	0	None
90290	90291	4	0	None
90291	90292	h	0	None
90292	90293	or	0	None
90293	90294	24	0	None
90294	90295	h	0	None
90295	90296	to	0	None
90296	90297	TFT	0	None
90297	90298	and	0	None
90298	90299	5-Fluorouracil	0	None
90299	90300	(	0	None
90300	90301	5FU	0	None
90301	90302	)	0	None
90302	90303	.	0	None

90304	90305	TS	0	None
90305	90306	activity	0	None
90306	90307	reduced	0	None
90307	90308	to	0	None
90308	90309	9%	0	None
90309	90310	(	0	None
90310	90311	0	0	None
90311	90312	.	0	None
90312	90313	1	0	None
90313	90314	microM	0	None
90314	90315	TFT	0	None
90315	90316	)	0	None
90316	90317	and	0	None
90317	90318	58%	0	None
90318	90319	(	0	None
90319	90320	1	0	None
90320	90321	microM	0	None
90321	90322	5FU	0	None
90322	90323	)	0	None
90323	90324	after	0	None
90324	90325	4	0	None
90325	90326	h	0	None
90326	90327	exposure	0	None
90327	90328	and	0	None
90328	90329	to	0	None
90329	90330	6%	0	None
90330	90331	(	0	None
90331	90332	TFT	0	None
90332	90333	)	0	None
90333	90334	and	0	None
90334	90335	21%	0	None
90335	90336	(	0	None
90336	90337	5FU	0	None
90337	90338	)	0	None
90338	90339	after	0	None
90339	90340	24	0	None
90340	90341	h	0	None
90341	90342	exposure	0	None
90342	90343	.	0	None

90344	90345	TPI	0	None
90345	90346	did	0	None
90346	90347	not	0	None
90347	90348	affect	0	None
90348	90349	TS	0	None
90349	90350	inhibition	0	None
90350	90351	by	0	None
90351	90352	TFT	0	None
90352	90353	.	0	None

90354	90355	FM3A	0	None
90355	90356	cells	0	None
90356	90357	lacking	0	None
90357	90358	TK	1	GENE-Y
90358	90359	or	0	None
90359	90360	TS	0	None
90360	90361	activity	0	None
90361	90362	(	0	None
90362	90363	FM3A	0	None
90363	90364	/	0	None
90364	90365	TK-	0	None
90365	90366	)	0	None
90366	90367	were	0	None
90367	90368	far	0	None
90368	90369	less	0	None
90369	90370	sensitive	0	None
90370	90371	to	0	None
90371	90372	TFT	0	None
90372	90373	compared	0	None
90373	90374	to	0	None
90374	90375	FM3A	0	None
90375	90376	cells	0	None
90376	90377	.	0	None

90378	90379	CONCLUSION	0	None
90379	90380	:	0	None
90380	90381	TFT	0	None
90381	90382	can	0	None
90382	90383	be	0	None
90383	90384	taken	0	None
90384	90385	up	0	None
90385	90386	and	0	None
90386	90387	activated	0	None
90387	90388	very	0	None
90388	90389	rapidly	0	None
90389	90390	by	0	None
90390	90391	FM3A	0	None
90391	90392	cancer	0	None
90392	90393	cells	0	None
90393	90394	,	0	None
90394	90395	probably	0	None
90395	90396	due	0	None
90396	90397	to	0	None
90397	90398	favourable	0	None
90398	90399	TK	1	GENE-Y
90399	90400	enzyme	0	None
90400	90401	properties	0	None
90401	90402	,	0	None
90402	90403	and	0	None
90403	90404	TPI	0	None
90404	90405	did	0	None
90405	90406	not	0	None
90406	90407	influence	0	None
90407	90408	this	0	None
90408	90409	.	0	None
90409	90411	Follicle-stimulating hormone	3	GENE-N
90411	90412	(	0	None
90412	90413	FSH	0	None
90413	90414	)	0	None
90414	90415	,	0	None
90415	90416	a	0	None
90416	90417	dimeric	0	None
90417	90418	glycoprotein	0	None
90418	90419	synthesized	0	None
90419	90420	in	0	None
90420	90421	the	0	None
90421	90422	anterior	0	None
90422	90423	pituitary	0	None
90423	90424	gland	0	None
90424	90425	,	0	None
90425	90426	is	0	None
90426	90427	important	0	None
90427	90428	for	0	None
90428	90429	the	0	None
90429	90430	production	0	None
90430	90431	of	0	None
90431	90432	sex	0	None
90432	90433	steroids	0	None
90433	90434	and	0	None
90434	90435	gametes	0	None
90435	90436	.	0	None

90437	90438	FSH-beta	0	None
90438	90439	(	0	None
90439	90440	FSH	0	None
90440	90441	beta	0	None
90441	90442	)	0	None
90442	90443	and	0	None
90443	90444	FSH	0	None
90444	90445	receptor	0	None
90445	90446	(	0	None
90446	90447	FSHR	0	None
90447	90448	)	0	None
90448	90449	knockout	0	None
90449	90450	mice	0	None
90450	90451	display	0	None
90451	90452	impaired	0	None
90452	90453	ovarian	0	None
90453	90454	follicular	0	None
90454	90455	development	0	None
90455	90456	and	0	None
90456	90457	infertility	0	None
90457	90458	in	0	None
90458	90459	females	0	None
90459	90460	and	0	None
90460	90461	small	0	None
90461	90462	testes	0	None
90462	90463	,	0	None
90463	90464	oligospermia	0	None
90464	90465	,	0	None
90465	90466	and	0	None
90466	90467	fertility	0	None
90467	90468	in	0	None
90468	90469	males	0	None
90469	90470	.	0	None

90471	90472	Humans	0	None
90472	90473	with	0	None
90473	90475	FSH beta	1	GENE-Y
90475	90476	gene	0	None
90476	90477	mutations	0	None
90477	90478	tend	0	None
90478	90479	to	0	None
90479	90480	have	0	None
90480	90481	a	0	None
90481	90482	more	0	None
90482	90483	severe	0	None
90483	90484	phenotype	0	None
90484	90485	than	0	None
90485	90486	those	0	None
90486	90487	with	0	None
90487	90488	FSHR	0	None
90488	90489	gene	0	None
90489	90490	mutations	0	None
90490	90491	,	0	None
90491	90492	although	0	None
90492	90493	infertility	0	None
90493	90494	and	0	None
90494	90495	varying	0	None
90495	90496	degrees	0	None
90496	90497	of	0	None
90497	90498	impaired	0	None
90498	90499	sex	0	None
90499	90500	steroid	2	CHEMICAL
90500	90501	production	0	None
90501	90502	occur	0	None
90502	90503	in	0	None
90503	90504	both	0	None
90504	90505	types	0	None
90505	90506	of	0	None
90506	90507	mutations	0	None
90507	90508	.	0	None

90509	90510	Data	0	None
90510	90511	from	0	None
90511	90512	human	0	None
90512	90513	and	0	None
90513	90514	mouse	0	None
90514	90515	mutations	0	None
90515	90516	in	0	None
90516	90517	the	0	None
90517	90518	FSH	0	None
90518	90519	beta	0	None
90519	90520	and	0	None
90520	90521	FSHR	0	None
90521	90522	genes	0	None
90522	90523	suggest	0	None
90523	90524	that	0	None
90524	90525	FSH	0	None
90525	90526	is	0	None
90526	90527	necessary	0	None
90527	90528	for	0	None
90528	90529	normal	0	None
90529	90530	pubertal	0	None
90530	90531	development	0	None
90531	90532	and	0	None
90532	90533	fertility	0	None
90533	90534	in	0	None
90534	90535	males	0	None
90535	90536	and	0	None
90536	90537	females	0	None
90537	90538	.	0	None
90538	90539	The	0	None
90539	90540	ATP	0	None
90540	90541	required	0	None
90541	90542	for	0	None
90542	90543	potentiation	0	None
90543	90544	of	0	None
90544	90545	skeletal	0	None
90545	90546	muscle	0	None
90546	90547	contraction	0	None
90547	90548	is	0	None
90548	90549	released	0	None
90549	90550	via	0	None
90550	90551	pannexin	3	GENE-N
90551	90552	hemichannels	0	None
90552	90553	.	0	None
90553	90554	Wide-ranging	0	None
90554	90555	exploration	0	None
90555	90556	of	0	None
90556	90557	analogues	0	None
90557	90558	of	0	None
90558	90559	an	0	None
90559	90560	ATP-competitive	0	None
90560	90561	pyrrolopyrimidine	0	None
90561	90562	inhibitor	0	None
90562	90563	of	0	None
90563	90564	Akt	0	None
90564	90565	led	0	None
90565	90566	to	0	None
90566	90567	the	0	None
90567	90568	discovery	0	None
90568	90569	of	0	None
90569	90570	clinical	0	None
90570	90571	candidate	0	None
90571	90572	AZD5363	0	None
90572	90573	,	0	None
90573	90574	which	0	None
90574	90575	showed	0	None
90575	90576	increased	0	None
90576	90577	potency	0	None
90577	90578	,	0	None
90578	90579	reduced	0	None
90579	90580	hERG	1	GENE-Y
90580	90581	affinity	0	None
90581	90582	,	0	None
90582	90583	and	0	None
90583	90584	higher	0	None
90584	90585	selectivity	0	None
90585	90586	against	0	None
90586	90587	the	0	None
90587	90588	closely	0	None
90588	90589	related	0	None
90589	90590	AGC	0	None
90590	90591	kinase	0	None
90591	90592	ROCK	0	None
90592	90593	.	0	None

90594	90595	This	0	None
90595	90596	compound	0	None
90596	90597	demonstrated	0	None
90597	90598	good	0	None
90598	90599	preclinical	0	None
90599	90600	drug	0	None
90600	90601	metabolism	0	None
90601	90602	and	0	None
90602	90603	pharmacokinetics	0	None
90603	90604	(	0	None
90604	90605	DMPK	0	None
90605	90606	)	0	None
90606	90607	properties	0	None
90607	90608	and	0	None
90608	90609	,	0	None
90609	90610	after	0	None
90610	90611	oral	0	None
90611	90612	dosing	0	None
90612	90613	,	0	None
90613	90614	showed	0	None
90614	90615	pharmacodynamic	0	None
90615	90616	knockdown	0	None
90616	90617	of	0	None
90617	90618	phosphorylation	0	None
90618	90619	of	0	None
90619	90620	Akt	0	None
90620	90621	and	0	None
90621	90622	downstream	0	None
90622	90623	biomarkers	0	None
90623	90624	in	0	None
90624	90625	vivo	0	None
90625	90626	,	0	None
90626	90627	and	0	None
90627	90628	inhibition	0	None
90628	90629	of	0	None
90629	90630	tumor	0	None
90630	90631	growth	0	None
90631	90632	in	0	None
90632	90633	a	0	None
90633	90634	breast	0	None
90634	90635	cancer	0	None
90635	90636	xenograft	0	None
90636	90637	model	0	None
90637	90638	.	0	None
90638	90639	Neurotrophins	0	None
90639	90640	,	0	None
90640	90641	the	0	None
90641	90642	cognate	0	None
90642	90643	ligands	0	None
90643	90644	for	0	None
90644	90645	the	0	None
90645	90646	Trk	0	None
90646	90647	receptors	0	None
90647	90648	,	0	None
90648	90649	are	0	None
90649	90650	homodimers	0	None
90650	90651	and	0	None
90651	90652	induce	0	None
90652	90653	Trk	0	None
90653	90654	dimerization	0	None
90654	90655	through	0	None
90655	90656	a	0	None
90656	90657	symmetric	0	None
90657	90658	bivalent	0	None
90658	90659	mechanism	0	None
90659	90660	.	0	None

90661	90662	We	0	None
90662	90663	report	0	None
90663	90664	here	0	None
90664	90665	that	0	None
90665	90666	amitriptyline	2	CHEMICAL
90666	90667	,	0	None
90667	90668	an	0	None
90668	90669	antidepressant	0	None
90669	90670	drug	0	None
90670	90671	,	0	None
90671	90672	directly	0	None
90672	90673	binds	0	None
90673	90674	TrkA	0	None
90674	90675	and	0	None
90675	90676	TrkB	1	GENE-Y
90676	90677	and	0	None
90677	90678	triggers	0	None
90678	90679	their	0	None
90679	90680	dimerization	0	None
90680	90681	and	0	None
90681	90682	activation	0	None
90682	90683	.	0	None

90684	90685	Amitriptyline	2	CHEMICAL
90685	90686	,	0	None
90686	90687	but	0	None
90687	90688	not	0	None
90688	90689	any	0	None
90689	90690	other	0	None
90690	90691	tricyclic	0	None
90691	90692	or	0	None
90692	90693	selective	0	None
90693	90694	serotonin	0	None
90694	90695	reuptake	0	None
90695	90696	inhibitor	0	None
90696	90697	antidepressants	0	None
90697	90698	,	0	None
90698	90699	promotes	0	None
90699	90700	TrkA	0	None
90700	90701	autophosphorylation	0	None
90701	90702	in	0	None
90702	90703	primary	0	None
90703	90704	neurons	0	None
90704	90705	and	0	None
90705	90706	induces	0	None
90706	90707	neurite	0	None
90707	90708	outgrowth	0	None
90708	90709	in	0	None
90709	90710	PC12	0	None
90710	90711	cells	0	None
90711	90712	.	0	None

90713	90714	Amitriptyline	2	CHEMICAL
90714	90715	binds	0	None
90715	90716	the	0	None
90716	90718	extracellular domain	3	GENE-N
90718	90719	of	0	None
90719	90720	both	0	None
90720	90721	TrkA	0	None
90721	90722	and	0	None
90722	90723	TrkB	1	GENE-Y
90723	90724	and	0	None
90724	90725	promotes	0	None
90725	90726	TrkA-TrkB	0	None
90726	90727	receptor	0	None
90727	90728	heterodimerization	0	None
90728	90729	.	0	None

90730	90731	Truncation	0	None
90731	90732	of	0	None
90732	90733	amitriptyline	2	CHEMICAL
90733	90735	binding motif	3	GENE-N
90735	90736	on	0	None
90736	90737	TrkA	0	None
90737	90738	abrogates	0	None
90738	90739	the	0	None
90739	90740	receptor	0	None
90740	90741	dimerization	0	None
90741	90742	by	0	None
90742	90743	amitriptyline	2	CHEMICAL
90743	90744	.	0	None

90745	90746	Administration	0	None
90746	90747	of	0	None
90747	90748	amitriptyline	2	CHEMICAL
90748	90749	to	0	None
90749	90750	mice	0	None
90750	90751	activates	0	None
90751	90752	both	0	None
90752	90753	receptors	0	None
90753	90754	and	0	None
90754	90755	significantly	0	None
90755	90756	reduces	0	None
90756	90757	kainic	0	None
90757	90758	acid-triggered	0	None
90758	90759	neuronal	0	None
90759	90760	cell	0	None
90760	90761	death	0	None
90761	90762	.	0	None

90763	90764	Inhibition	0	None
90764	90765	of	0	None
90765	90766	TrkA	0	None
90766	90767	,	0	None
90767	90768	but	0	None
90768	90769	not	0	None
90769	90770	TrkB	1	GENE-Y
90770	90771	,	0	None
90771	90772	abolishes	0	None
90772	90773	amitriptyline's	0	None
90773	90774	neuroprotective	0	None
90774	90775	effect	0	None
90775	90776	without	0	None
90776	90777	impairing	0	None
90777	90778	its	0	None
90778	90779	antidepressant	0	None
90779	90780	activity	0	None
90780	90781	.	0	None

90782	90783	Thus	0	None
90783	90784	,	0	None
90784	90785	amitriptyline	2	CHEMICAL
90785	90786	acts	0	None
90786	90787	as	0	None
90787	90788	a	0	None
90788	90789	TrkA	0	None
90789	90790	and	0	None
90790	90791	TrkB	1	GENE-Y
90791	90792	agonist	0	None
90792	90793	and	0	None
90793	90794	possesses	0	None
90794	90795	marked	0	None
90795	90796	neurotrophic	0	None
90796	90797	activity	0	None
90797	90798	.	0	None
90798	90799	Polybrominated	0	None
90799	90800	diphenyl	0	None
90800	90801	ethers	0	None
90801	90802	(	0	None
90802	90803	PBDEs	0	None
90803	90804	)	0	None
90804	90805	were	0	None
90805	90806	widely	0	None
90806	90807	used	0	None
90807	90808	flame	0	None
90808	90809	retardants	0	None
90809	90810	that	0	None
90810	90811	have	0	None
90811	90812	become	0	None
90812	90813	persistent	0	None
90813	90814	environmental	0	None
90814	90815	pollutants	0	None
90815	90816	.	0	None

90817	90818	In	0	None
90818	90819	the	0	None
90819	90820	present	0	None
90820	90821	study	0	None
90821	90822	,	0	None
90822	90823	we	0	None
90823	90824	investigated	0	None
90824	90825	the	0	None
90825	90826	in	0	None
90826	90827	vitro	0	None
90827	90828	oxidative	0	None
90828	90829	metabolism	0	None
90829	90830	of	0	None
90830	90831	2	0	None
90831	90832	,	0	None
90832	90833	2'	0	None
90833	90834	,	0	None
90834	90835	4	0	None
90835	90836	,	0	None
90836	90837	4'-tetrabromodiphenyl	0	None
90837	90838	ether	0	None
90838	90839	(	0	None
90839	90840	BDE-47	0	None
90840	90841	)	0	None
90841	90842	,	0	None
90842	90843	a	0	None
90843	90844	major	0	None
90844	90845	PBDE	0	None
90845	90846	detected	0	None
90846	90847	in	0	None
90847	90848	human	0	None
90848	90849	tissue	0	None
90849	90850	and	0	None
90850	90851	environmental	0	None
90851	90852	samples	0	None
90852	90853	.	0	None

90854	90855	Biotransformation	0	None
90855	90856	of	0	None
90856	90857	BDE-47	0	None
90857	90858	by	0	None
90858	90859	pooled	0	None
90859	90860	and	0	None
90860	90861	individual	0	None
90861	90862	human	0	None
90862	90863	liver	0	None
90863	90864	microsomes	0	None
90864	90865	and	0	None
90865	90866	by	0	None
90866	90867	human	0	None
90867	90868	recombinant	0	None
90868	90869	cytochrome	3	GENE-N
90869	90870	P450	0	None
90870	90871	(	0	None
90871	90872	P450	0	None
90872	90873	)	0	None
90873	90874	enzymes	0	None
90874	90875	was	0	None
90875	90876	assessed	0	None
90876	90877	using	0	None
90877	90878	a	0	None
90878	90879	liquid	0	None
90879	90880	chromatography	0	None
90880	90881	/	0	None
90881	90882	tandem	0	None
90882	90883	mass	0	None
90883	90884	spectrometry-based	0	None
90884	90885	method	0	None
90885	90886	.	0	None

90887	90888	Of	0	None
90888	90889	the	0	None
90889	90890	nine	0	None
90890	90891	hydroxylated	0	None
90891	90892	metabolites	0	None
90892	90893	of	0	None
90893	90894	BDE-47	0	None
90894	90895	produced	0	None
90895	90896	by	0	None
90896	90897	human	0	None
90897	90898	liver	0	None
90898	90899	microsomes	0	None
90899	90900	,	0	None
90900	90901	seven	0	None
90901	90902	metabolites	0	None
90902	90903	were	0	None
90903	90904	identified	0	None
90904	90905	using	0	None
90905	90906	authentic	0	None
90906	90907	standards	0	None
90907	90908	.	0	None

90909	90910	A	0	None
90910	90911	monohydroxy-tetrabrominated	0	None
90911	90912	and	0	None
90912	90913	a	0	None
90913	90914	dihydroxy-tetrabrominated	0	None
90914	90915	metabolite	0	None
90915	90916	remain	0	None
90916	90917	unidentified	0	None
90917	90918	.	0	None

90919	90920	Kinetic	0	None
90920	90921	analysis	0	None
90921	90922	of	0	None
90922	90923	the	0	None
90923	90924	rates	0	None
90924	90925	of	0	None
90925	90926	metabolite	0	None
90926	90927	formation	0	None
90927	90928	revealed	0	None
90928	90929	that	0	None
90929	90930	the	0	None
90930	90931	major	0	None
90931	90932	metabolites	0	None
90932	90933	were	0	None
90933	90934	5-hydroxy-2	0	None
90934	90935	,	0	None
90935	90936	2'	0	None
90936	90937	,	0	None
90937	90938	4	0	None
90938	90939	,	0	None
90939	90940	4'-tetrabromodiphenyl	0	None
90940	90941	ether	0	None
90941	90942	(	0	None
90942	90943	5-OH-BDE-47	0	None
90943	90944	)	0	None
90944	90945	,	0	None
90945	90946	6-hydroxy-2	0	None
90946	90947	,	0	None
90947	90948	2'	0	None
90948	90949	,	0	None
90949	90950	4	0	None
90950	90951	,	0	None
90951	90952	4'-tetrabromodiphenyl	0	None
90952	90953	ether	0	None
90953	90954	(	0	None
90954	90955	6-OH-BDE-47	2	CHEMICAL
90955	90956	)	0	None
90956	90957	,	0	None
90957	90958	and	0	None
90958	90959	possibly	0	None
90959	90960	the	0	None
90960	90961	unidentified	0	None
90961	90962	monohydroxy-tetrabrominated	0	None
90962	90963	metabolite	0	None
90963	90964	.	0	None

90965	90966	Among	0	None
90966	90967	the	0	None
90967	90968	human	0	None
90968	90969	recombinant	0	None
90969	90970	P450	0	None
90970	90971	enzymes	0	None
90971	90972	tested	0	None
90972	90973	,	0	None
90973	90974	P450	0	None
90974	90975	2B6	0	None
90975	90976	was	0	None
90976	90977	the	0	None
90977	90978	most	0	None
90978	90979	active	0	None
90979	90980	enzyme	0	None
90980	90981	in	0	None
90981	90982	the	0	None
90982	90983	formation	0	None
90983	90984	of	0	None
90984	90985	the	0	None
90985	90986	hydroxylated	0	None
90986	90987	metabolites	0	None
90987	90988	of	0	None
90988	90989	BDE-47	0	None
90989	90990	.	0	None

90991	90992	Moreover	0	None
90992	90993	,	0	None
90993	90994	the	0	None
90994	90995	formation	0	None
90995	90996	of	0	None
90996	90997	all	0	None
90997	90998	metabolites	0	None
90998	90999	of	0	None
90999	91000	BDE-47	0	None
91000	91001	by	0	None
91001	91002	pooled	0	None
91002	91003	human	0	None
91003	91004	liver	0	None
91004	91005	microsomes	0	None
91005	91006	was	0	None
91006	91007	inhibited	0	None
91007	91008	by	0	None
91008	91009	a	0	None
91009	91010	P450	0	None
91010	91011	2B6-specific	0	None
91011	91012	antibody	0	None
91012	91013	and	0	None
91013	91014	was	0	None
91014	91015	highly	0	None
91015	91016	correlated	0	None
91016	91017	with	0	None
91017	91018	P450	0	None
91018	91019	2B6-mediated	0	None
91019	91020	activity	0	None
91020	91021	in	0	None
91021	91022	single	0	None
91022	91023	donor	0	None
91023	91024	liver	0	None
91024	91025	microsomes	0	None
91025	91026	indicating	0	None
91026	91027	that	0	None
91027	91028	P450	0	None
91028	91029	2B6	0	None
91029	91030	was	0	None
91030	91031	the	0	None
91031	91032	major	0	None
91032	91033	P450	0	None
91033	91034	responsible	0	None
91034	91035	for	0	None
91035	91036	the	0	None
91036	91037	biotransformation	0	None
91037	91038	of	0	None
91038	91039	BDE-47	0	None
91039	91040	.	0	None

91041	91042	Additional	0	None
91042	91043	experiments	0	None
91043	91044	involving	0	None
91044	91045	the	0	None
91045	91046	incubation	0	None
91046	91047	of	0	None
91047	91048	liver	0	None
91048	91049	microsomes	0	None
91049	91050	with	0	None
91050	91051	individual	0	None
91051	91052	monohydroxy-tetrabrominated	0	None
91052	91053	metabolites	0	None
91053	91054	in	0	None
91054	91055	place	0	None
91055	91056	of	0	None
91056	91057	BDE-47	0	None
91057	91058	demonstrated	0	None
91058	91059	that	0	None
91059	91060	2	0	None
91060	91061	,	0	None
91061	91062	4-dibromophenol	0	None
91062	91063	was	0	None
91063	91064	a	0	None
91064	91065	product	0	None
91065	91066	of	0	None
91066	91067	BDE-47	0	None
91067	91068	and	0	None
91068	91069	several	0	None
91069	91070	primary	0	None
91070	91071	metabolites	0	None
91071	91072	,	0	None
91072	91073	but	0	None
91073	91074	the	0	None
91074	91075	dihydroxy-tetrabrominated	0	None
91075	91076	metabolite	0	None
91076	91077	was	0	None
91077	91078	not	0	None
91078	91079	formed	0	None
91079	91080	by	0	None
91080	91081	sequential	0	None
91081	91082	hydroxylation	0	None
91082	91083	of	0	None
91083	91084	any	0	None
91084	91085	of	0	None
91085	91086	the	0	None
91086	91087	monohydroxy-tetrabrominated	0	None
91087	91088	metabolites	0	None
91088	91089	tested	0	None
91089	91090	.	0	None

91091	91092	The	0	None
91092	91093	present	0	None
91093	91094	study	0	None
91094	91095	provides	0	None
91095	91096	a	0	None
91096	91097	comprehensive	0	None
91097	91098	characterization	0	None
91098	91099	of	0	None
91099	91100	the	0	None
91100	91101	oxidative	0	None
91101	91102	metabolism	0	None
91102	91103	of	0	None
91103	91104	BDE-47	0	None
91104	91105	by	0	None
91105	91106	human	0	None
91106	91107	liver	0	None
91107	91108	microsomes	0	None
91108	91109	and	0	None
91109	91110	P450	0	None
91110	91111	2B6	0	None
91111	91112	.	0	None
91112	91113	ETHNOPHARMACOLOGICAL	0	None
91113	91114	RELEVANCE	0	None
91114	91115	:	0	None
91115	91116	Cyperi	0	None
91116	91117	Rhizoma	0	None
91117	91118	has	0	None
91118	91119	commonly	0	None
91119	91120	been	0	None
91120	91121	used	0	None
91121	91122	for	0	None
91122	91123	the	0	None
91123	91124	treatment	0	None
91124	91125	of	0	None
91125	91126	gynecological	0	None
91126	91127	and	0	None
91127	91128	neuropsychiatric	0	None
91128	91129	disorders	0	None
91129	91130	in	0	None
91130	91131	traditional	0	None
91131	91132	medicine	0	None
91132	91133	.	0	None

91134	91135	The	0	None
91135	91136	aim	0	None
91136	91137	of	0	None
91137	91138	this	0	None
91138	91139	study	0	None
91139	91140	was	0	None
91140	91141	to	0	None
91141	91142	evaluate	0	None
91142	91143	the	0	None
91143	91144	estrogenic	0	None
91144	91145	properties	0	None
91145	91146	and	0	None
91146	91147	neuroprotective	0	None
91147	91148	effects	0	None
91148	91149	of	0	None
91149	91150	Cyperi	0	None
91150	91151	Rhizoma	0	None
91151	91152	under	0	None
91152	91153	estrogen-deprived	0	None
91153	91154	condition	0	None
91154	91155	in	0	None
91155	91156	female	0	None
91156	91157	mice	0	None
91157	91158	.	0	None

91159	91160	MATERIALS	0	None
91160	91161	AND	0	None
91161	91162	METHODS	0	None
91162	91163	:	0	None
91163	91164	To	0	None
91164	91165	determine	0	None
91165	91166	the	0	None
91166	91167	estrogen-like	0	None
91167	91168	effect	0	None
91168	91169	of	0	None
91169	91170	Cyperi	0	None
91170	91171	Rhizoma	0	None
91171	91172	extract	0	None
91172	91173	(	0	None
91173	91174	CRE	0	None
91174	91175	)	0	None
91175	91176	,	0	None
91176	91177	we	0	None
91177	91178	measured	0	None
91178	91179	luciferase	0	None
91179	91180	expression	0	None
91180	91181	after	0	None
91181	91182	transfection	0	None
91182	91183	of	0	None
91183	91184	a	0	None
91184	91185	promoter	0	None
91185	91186	construct	0	None
91186	91187	containing	0	None
91187	91188	an	0	None
91188	91189	estrogen	0	None
91189	91190	response	0	None
91190	91191	element	0	None
91191	91192	(	0	None
91192	91193	ERE	0	None
91193	91194	)	0	None
91194	91195	and	0	None
91195	91196	treatment	0	None
91196	91197	of	0	None
91197	91198	CRE	0	None
91198	91199	.	0	None

91200	91201	To	0	None
91201	91202	evaluate	0	None
91202	91203	the	0	None
91203	91204	neuroprotective	0	None
91204	91205	effect	0	None
91205	91206	of	0	None
91206	91207	CRE	0	None
91207	91208	,	0	None
91208	91209	we	0	None
91209	91210	measured	0	None
91210	91211	striatal	0	None
91211	91212	dopamine	0	None
91212	91213	,	0	None
91213	91214	movement	0	None
91214	91215	ability	0	None
91215	91216	,	0	None
91216	91217	tyrosine	2	CHEMICAL
91217	91218	hydroxylase	0	None
91218	91219	(	0	None
91219	91220	TH	0	None
91220	91221	)	0	None
91221	91222	immunoreactivity	0	None
91222	91223	,	0	None
91223	91224	and	0	None
91224	91225	apoptosis-related	0	None
91225	91226	protein	0	None
91226	91227	expression	0	None
91227	91228	levels	0	None
91228	91229	after	0	None
91229	91230	treatment	0	None
91230	91231	of	0	None
91231	91232	CRE	0	None
91232	91233	either	0	None
91233	91234	with	0	None
91234	91235	or	0	None
91235	91236	without	0	None
91236	91237	1-methyl-4-phenyl-1	0	None
91237	91238	,	0	None
91238	91239	2	0	None
91239	91240	,	0	None
91240	91241	3	0	None
91241	91242	,	0	None
91242	91243	6-tetrahydropyridine	0	None
91243	91244	(	0	None
91244	91245	MPTP	0	None
91245	91246	)	0	None
91246	91247	in	0	None
91247	91248	ovariectomized	0	None
91248	91249	female	0	None
91249	91250	mice	0	None
91250	91251	.	0	None

91252	91253	RESULTS	0	None
91253	91254	:	0	None
91254	91255	CRE	0	None
91255	91256	significantly	0	None
91256	91257	induced	0	None
91257	91258	the	0	None
91258	91259	luciferase	0	None
91259	91260	expression	0	None
91260	91261	driven	0	None
91261	91262	by	0	None
91262	91263	an	0	None
91263	91264	ERE	0	None
91264	91265	in	0	None
91265	91266	PC12	0	None
91266	91267	cells	0	None
91267	91268	,	0	None
91268	91269	a	0	None
91269	91270	dopaminergic	0	None
91270	91271	cell	0	None
91271	91272	line	0	None
91272	91273	,	0	None
91273	91274	in	0	None
91274	91275	a	0	None
91275	91276	dose-dependent	0	None
91276	91277	manner	0	None
91277	91278	.	0	None

91279	91280	In	0	None
91280	91281	mice	0	None
91281	91282	,	0	None
91282	91283	MPTP	0	None
91283	91284	significantly	0	None
91284	91285	decreased	0	None
91285	91286	the	0	None
91286	91287	levels	0	None
91287	91288	of	0	None
91288	91289	dopamine	0	None
91289	91290	in	0	None
91290	91291	the	0	None
91291	91292	striatum	0	None
91292	91293	and	0	None
91293	91294	behavior	0	None
91294	91295	performance;	0	None
91295	91296	in	0	None
91296	91297	contrast	0	None
91297	91298	,	0	None
91298	91299	both	0	None
91299	91300	CRE	0	None
91300	91301	and	0	None
91301	91302	17β-estradiol	0	None
91302	91303	benzoate	0	None
91303	91304	(	0	None
91304	91305	EB	0	None
91305	91306	)	0	None
91306	91307	recovered	0	None
91307	91308	these	0	None
91308	91309	parameters	0	None
91309	91310	to	0	None
91310	91311	normal	0	None
91311	91312	levels	0	None
91312	91313	.	0	None

91314	91315	CRE	0	None
91315	91316	and	0	None
91316	91317	EB	0	None
91317	91318	treatment	0	None
91318	91319	also	0	None
91319	91320	recovered	0	None
91320	91321	TH	0	None
91321	91322	immunopositive	0	None
91322	91323	fibers	0	None
91323	91324	and	0	None
91324	91325	cells	0	None
91325	91326	,	0	None
91326	91327	respectively	0	None
91327	91328	,	0	None
91328	91329	from	0	None
91329	91330	MPTP	0	None
91330	91331	toxicity	0	None
91331	91332	.	0	None

91333	91334	Additionally	0	None
91334	91335	,	0	None
91335	91336	MPTP	0	None
91336	91337	significantly	0	None
91337	91338	down-regulated	0	None
91338	91339	Bcl-2	1	GENE-Y
91339	91340	expression	0	None
91340	91341	in	0	None
91341	91342	the	0	None
91342	91343	mitochondria	0	None
91343	91344	of	0	None
91344	91345	dopaminergic	0	None
91345	91346	cells	0	None
91346	91347	in	0	None
91347	91348	the	0	None
91348	91349	SN	0	None
91349	91350	,	0	None
91350	91351	followed	0	None
91351	91352	by	0	None
91352	91353	an	0	None
91353	91354	increase	0	None
91354	91355	in	0	None
91355	91356	Bax	0	None
91356	91357	expression	0	None
91357	91358	,	0	None
91358	91359	cytochrome	3	GENE-N
91359	91360	C	0	None
91360	91361	translocation	0	None
91361	91362	to	0	None
91362	91363	the	0	None
91363	91364	cytosol	0	None
91364	91365	,	0	None
91365	91366	andcleaved-caspase-3	0	None
91366	91367	expression	0	None
91367	91368	,	0	None
91368	91369	whereas	0	None
91369	91370	these	0	None
91370	91371	were	0	None
91371	91372	inhibited	0	None
91372	91373	by	0	None
91373	91374	CRE	0	None
91374	91375	or	0	None
91375	91376	EB	0	None
91376	91377	treatment	0	None
91377	91378	.	0	None

91379	91380	CONCLUSIONS	0	None
91380	91381	:	0	None
91381	91382	These	0	None
91382	91383	findings	0	None
91383	91384	provide	0	None
91384	91385	the	0	None
91385	91386	first	0	None
91386	91387	evidence	0	None
91387	91388	that	0	None
91388	91389	CRE	0	None
91389	91390	has	0	None
91390	91391	estrogen-like	0	None
91391	91392	and	0	None
91392	91393	neuroprotective	0	None
91393	91394	effects	0	None
91394	91395	on	0	None
91395	91396	dopaminergic	0	None
91396	91397	neurons	0	None
91397	91398	in	0	None
91398	91399	estrogen-deprived	0	None
91399	91400	mice	0	None
91400	91401	treated	0	None
91401	91402	with	0	None
91402	91403	MPTP-toxin	0	None
91403	91404	.	0	None
91404	91406	Serotonin transporters	3	GENE-N
91406	91407	(	0	None
91407	91408	SERT	0	None
91408	91409	)	0	None
91409	91410	play	0	None
91410	91411	an	0	None
91411	91412	essential	0	None
91412	91413	role	0	None
91413	91414	in	0	None
91414	91415	the	0	None
91415	91416	termination	0	None
91416	91417	and	0	None
91417	91418	regulation	0	None
91418	91419	of	0	None
91419	91420	serotonin	0	None
91420	91421	signaling	0	None
91421	91422	in	0	None
91422	91423	the	0	None
91423	91424	brain	0	None
91424	91425	.	0	None

91426	91427	SERT	0	None
91427	91428	is	0	None
91428	91429	also	0	None
91429	91430	the	0	None
91430	91431	target	0	None
91431	91432	of	0	None
91432	91433	antidepressants	0	None
91433	91434	and	0	None
91434	91435	psychostimulants	0	None
91435	91436	.	0	None

91437	91438	Molecules	0	None
91438	91439	with	0	None
91439	91440	novel	0	None
91440	91441	activities	0	None
91441	91442	and	0	None
91442	91443	modes	0	None
91443	91444	of	0	None
91444	91445	interaction	0	None
91445	91446	with	0	None
91446	91447	regard	0	None
91447	91448	to	0	None
91448	91449	SERT	0	None
91449	91450	function	0	None
91450	91451	are	0	None
91451	91452	of	0	None
91452	91453	great	0	None
91453	91454	scientific	0	None
91454	91455	and	0	None
91455	91456	clinical	0	None
91456	91457	interest	0	None
91457	91458	.	0	None

91459	91460	We	0	None
91460	91461	explored	0	None
91461	91462	structural	0	None
91462	91463	regions	0	None
91463	91464	outside	0	None
91464	91465	the	0	None
91465	91466	putative	0	None
91466	91467	serotonin	0	None
91467	91468	translocation	0	None
91468	91469	pathway	0	None
91469	91470	to	0	None
91470	91471	identify	0	None
91471	91472	potential	0	None
91472	91473	binding	0	None
91473	91474	sites	0	None
91474	91475	for	0	None
91475	91476	allosteric	0	None
91476	91477	transporter	0	None
91477	91478	modulators	0	None
91478	91479	(	0	None
91479	91480	ATMs	0	None
91480	91481	)	0	None
91481	91482	.	0	None

91483	91484	Mutational	0	None
91484	91485	studies	0	None
91485	91486	revealed	0	None
91486	91487	a	0	None
91487	91488	pocket	0	None
91488	91489	of	0	None
91489	91491	amino acids	2	CHEMICAL
91491	91492	outside	0	None
91492	91493	the	0	None
91493	91494	orthosteric	0	None
91494	91495	substrate	0	None
91495	91496	binding	0	None
91496	91497	sites	0	None
91497	91498	located	0	None
91498	91499	in	0	None
91499	91500	the	0	None
91500	91501	interface	0	None
91501	91502	between	0	None
91502	91504	extracellular loops	3	GENE-N
91504	91505	1	0	None
91505	91506	and	0	None
91506	91507	3	0	None
91507	91508	that	0	None
91508	91509	when	0	None
91509	91510	mutated	0	None
91510	91511	affect	0	None
91511	91512	transporter	0	None
91512	91513	function	0	None
91513	91514	.	0	None

91515	91516	Using	0	None
91516	91517	the	0	None
91517	91518	structure	0	None
91518	91519	of	0	None
91519	91520	the	0	None
91520	91521	bacterial	0	None
91521	91522	transporter	0	None
91522	91523	homologue	0	None
91523	91524	leucine	0	None
91524	91525	transporter	0	None
91525	91526	as	0	None
91526	91527	a	0	None
91527	91528	template	0	None
91528	91529	,	0	None
91529	91530	we	0	None
91530	91531	developed	0	None
91531	91532	a	0	None
91532	91533	structural	0	None
91533	91534	model	0	None
91534	91535	of	0	None
91535	91536	SERT	0	None
91536	91537	.	0	None

91538	91539	We	0	None
91539	91540	performed	0	None
91540	91541	molecular	0	None
91541	91542	dynamics	0	None
91542	91543	simulations	0	None
91543	91544	to	0	None
91544	91545	further	0	None
91545	91546	characterize	0	None
91546	91547	the	0	None
91547	91548	allosteric	0	None
91548	91549	pocket	0	None
91549	91550	that	0	None
91550	91551	was	0	None
91551	91552	identified	0	None
91552	91553	by	0	None
91553	91554	site-directed	0	None
91554	91555	mutagenesis	0	None
91555	91556	studies	0	None
91556	91557	and	0	None
91557	91558	employed	0	None
91558	91559	this	0	None
91559	91560	pocket	0	None
91560	91561	in	0	None
91561	91562	a	0	None
91562	91563	virtual	0	None
91563	91564	screen	0	None
91564	91565	for	0	None
91565	91566	small-molecule	0	None
91566	91567	modulators	0	None
91567	91568	of	0	None
91568	91569	SERT	0	None
91569	91570	function	0	None
91570	91571	.	0	None

91572	91573	In	0	None
91573	91574	functional	0	None
91574	91575	transport	0	None
91575	91576	assays	0	None
91576	91577	,	0	None
91577	91578	we	0	None
91578	91579	found	0	None
91579	91580	that	0	None
91580	91581	one	0	None
91581	91582	of	0	None
91582	91583	the	0	None
91583	91584	identified	0	None
91584	91585	molecules	0	None
91585	91586	,	0	None
91586	91587	ATM7	0	None
91587	91588	,	0	None
91588	91589	increased	0	None
91589	91590	the	0	None
91590	91591	reuptake	0	None
91591	91592	of	0	None
91592	91593	serotonin	0	None
91593	91594	,	0	None
91594	91595	possibly	0	None
91595	91596	by	0	None
91596	91597	facilitating	0	None
91597	91598	the	0	None
91598	91599	interaction	0	None
91599	91600	of	0	None
91600	91601	serotonin	0	None
91601	91602	with	0	None
91602	91603	transport-ready	0	None
91603	91604	conformations	0	None
91604	91605	of	0	None
91605	91606	SERT	0	None
91606	91607	when	0	None
91607	91608	concentrations	0	None
91608	91609	of	0	None
91609	91610	serotonin	0	None
91610	91611	were	0	None
91611	91612	low	0	None
91612	91613	and	0	None
91613	91614	rate	0	None
91614	91615	limiting	0	None
91615	91616	.	0	None

91617	91618	In	0	None
91618	91619	addition	0	None
91619	91620	,	0	None
91620	91621	ATM7	0	None
91621	91622	potentiates	0	None
91622	91623	3	0	None
91623	91624	,	0	None
91624	91625	4-methylenedioxy-N-methylamphetamine	0	None
91625	91626	(	0	None
91626	91627	MDMA	0	None
91627	91628	,	0	None
91628	91629	"Ecstasy"	0	None
91629	91630	)	0	None
91630	91631	-induced	0	None
91631	91632	reversed	0	None
91632	91633	transport	0	None
91633	91634	by	0	None
91634	91635	SERT	0	None
91635	91636	.	0	None

91637	91638	Taking	0	None
91638	91639	advantage	0	None
91639	91640	of	0	None
91640	91641	a	0	None
91641	91642	conformationally	0	None
91642	91643	sensitive	0	None
91643	91644	residue	0	None
91644	91645	in	0	None
91645	91646	transmembrane	0	None
91646	91647	domain	0	None
91647	91648	6	0	None
91648	91649	,	0	None
91649	91650	we	0	None
91650	91651	demonstrate	0	None
91651	91652	that	0	None
91652	91653	ATM7	0	None
91653	91654	mechanistically	0	None
91654	91655	stabilizes	0	None
91655	91656	an	0	None
91656	91657	outward-facing	0	None
91657	91658	conformation	0	None
91658	91659	of	0	None
91659	91660	SERT	0	None
91660	91661	.	0	None

91662	91663	Taken	0	None
91663	91664	together	0	None
91664	91665	these	0	None
91665	91666	observations	0	None
91666	91667	demonstrate	0	None
91667	91668	that	0	None
91668	91669	ATM7	0	None
91669	91670	acts	0	None
91670	91671	through	0	None
91671	91672	a	0	None
91672	91673	novel	0	None
91673	91674	mechanism	0	None
91674	91675	that	0	None
91675	91676	involves	0	None
91676	91677	allosteric	0	None
91677	91678	modulation	0	None
91678	91679	of	0	None
91679	91680	SERT	0	None
91680	91681	function	0	None
91681	91682	.	0	None
91682	91683	RIF1	0	None
91683	91684	is	0	None
91684	91685	essential	0	None
91685	91686	for	0	None
91686	91687	53BP1-dependent	0	None
91687	91688	nonhomologous	0	None
91688	91689	end	0	None
91689	91690	joining	0	None
91690	91691	and	0	None
91691	91692	suppression	0	None
91692	91693	of	0	None
91693	91694	DNA	0	None
91694	91695	double-strand	0	None
91695	91696	break	0	None
91696	91697	resection	0	None
91697	91698	.	0	None
91698	91699	Derivatives	0	None
91699	91700	of	0	None
91700	91701	5-	0	None
91701	91702	(	0	None
91702	91703	dipentylamino	0	None
91703	91704	)	0	None
91704	91705	-5-oxo-pentanoic	0	None
91705	91706	acid	0	None
91706	91707	are	0	None
91707	91708	a	0	None
91708	91709	new	0	None
91709	91710	class	0	None
91710	91711	of	0	None
91711	91712	non-peptide	0	None
91712	91713	cholecystokinin	0	None
91713	91714	(	0	None
91714	91715	CCK	0	None
91715	91716	)	0	None
91716	91717	antagonists	0	None
91717	91718	.	0	None

91719	91720	The	0	None
91720	91721	most	0	None
91721	91722	potent	0	None
91722	91723	compound	0	None
91723	91724	,	0	None
91724	91725	D	0	None
91725	91726	,	0	None
91726	91727	L-4-	0	None
91727	91728	(	0	None
91728	91729	3	0	None
91729	91730	,	0	None
91730	91731	4-dichlorobenzoylamino	0	None
91731	91732	)	0	None
91732	91733	-5-	0	None
91733	91734	(	0	None
91734	91735	dipentylamino	0	None
91735	91736	)	0	None
91736	91737	-5-oxo-pen	0	None
91737	91738	tanoic	0	None
91738	91739	acid	0	None
91739	91740	(	0	None
91740	91741	lorglumide	0	None
91741	91742	,	0	None
91742	91743	CR	2	CHEMICAL
91743	91744	1409	0	None
91744	91745	)	0	None
91745	91746	,	0	None
91746	91747	has	0	None
91747	91748	a	0	None
91748	91749	great	0	None
91749	91750	affinity	0	None
91750	91751	for	0	None
91751	91752	the	0	None
91752	91753	pancreatic	0	None
91753	91754	CCK	0	None
91754	91755	receptors	0	None
91755	91756	and	0	None
91756	91757	is	0	None
91757	91758	a	0	None
91758	91759	competitive	0	None
91759	91760	,	0	None
91760	91761	specific	0	None
91761	91762	and	0	None
91762	91763	potent	0	None
91763	91764	CCK	0	None
91764	91765	antagonist	0	None
91765	91766	on	0	None
91766	91767	the	0	None
91767	91768	smooth	0	None
91768	91769	muscles	0	None
91769	91770	of	0	None
91770	91771	the	0	None
91771	91772	gall	0	None
91772	91773	bladder	0	None
91773	91774	and	0	None
91774	91775	ileum	0	None
91775	91776	of	0	None
91776	91777	the	0	None
91777	91778	guinea	0	None
91778	91779	pig	0	None
91779	91780	and	0	None
91780	91781	on	0	None
91781	91782	the	0	None
91782	91783	CCK-induced	0	None
91783	91784	amylase	0	None
91784	91785	secretion	0	None
91785	91786	of	0	None
91786	91787	isolated	0	None
91787	91788	pancreatic	0	None
91788	91789	acini	0	None
91789	91790	.	0	None

91791	91792	In	0	None
91792	91793	vivo	0	None
91793	91794	lorglumide	0	None
91794	91795	antagonizes	0	None
91795	91796	the	0	None
91796	91797	contraction	0	None
91797	91798	of	0	None
91798	91799	the	0	None
91799	91800	gall	0	None
91800	91801	bladder	0	None
91801	91802	of	0	None
91802	91803	the	0	None
91803	91804	guinea	0	None
91804	91805	pig	0	None
91805	91806	and	0	None
91806	91807	of	0	None
91807	91808	the	0	None
91808	91809	dog	0	None
91809	91810	provoked	0	None
91810	91811	by	0	None
91811	91812	i	0	None
91812	91813	.	0	None

91814	91815	v	0	None
91815	91816	.	0	None

91817	91818	CCK-8	1	GENE-Y
91818	91819	or	0	None
91819	91820	ceruletide	0	None
91820	91821	(	0	None
91821	91822	caerulein	0	None
91822	91823	)	0	None
91823	91824	.	0	None

91825	91826	It	0	None
91826	91827	antagonizes	0	None
91827	91828	the	0	None
91828	91829	satiety	0	None
91829	91830	effect	0	None
91830	91831	of	0	None
91831	91832	CCK-8	1	GENE-Y
91832	91833	in	0	None
91833	91834	the	0	None
91834	91835	rat	0	None
91835	91836	and	0	None
91836	91837	is	0	None
91837	91838	protective	0	None
91838	91839	against	0	None
91839	91840	ceruletide-	0	None
91840	91841	,	0	None
91841	91842	taurocholate-	0	None
91842	91843	and	0	None
91843	91844	diet-induced	0	None
91844	91845	pancreatitis	0	None
91845	91846	.	0	None

91847	91848	Lorglumide	0	None
91848	91849	is	0	None
91849	91850	therefore	0	None
91850	91851	a	0	None
91851	91852	useful	0	None
91852	91853	pharmacological	0	None
91853	91854	tool	0	None
91854	91855	to	0	None
91855	91856	study	0	None
91856	91857	the	0	None
91857	91858	functions	0	None
91858	91859	of	0	None
91859	91860	CCK	0	None
91860	91861	.	0	None

91862	91863	For	0	None
91863	91864	its	0	None
91864	91865	pharmacological	0	None
91865	91866	properties	0	None
91866	91867	,	0	None
91867	91868	its	0	None
91868	91869	relatively	0	None
91869	91870	low	0	None
91870	91871	toxicity	0	None
91871	91872	and	0	None
91872	91873	because	0	None
91873	91874	it	0	None
91874	91875	is	0	None
91875	91876	active	0	None
91876	91877	also	0	None
91877	91878	after	0	None
91878	91879	oral	0	None
91879	91880	administration	0	None
91880	91881	,	0	None
91881	91882	lorglumide	0	None
91882	91883	is	0	None
91883	91884	a	0	None
91884	91885	candidate	0	None
91885	91886	for	0	None
91886	91887	diagnostic	0	None
91887	91888	or	0	None
91888	91889	therapeutic	0	None
91889	91890	use	0	None
91890	91891	in	0	None
91891	91892	man	0	None
91892	91893	when	0	None
91893	91894	an	0	None
91894	91895	involvement	0	None
91895	91896	of	0	None
91896	91897	CCK	0	None
91897	91898	is	0	None
91898	91899	suspected	0	None
91899	91900	.	0	None
91900	91901	Alkyl	0	None
91901	91902	substituted	0	None
91902	91903	2'-benzoylpyridine	0	None
91903	91904	thiosemicarbazone	0	None
91904	91905	chelators	0	None
91905	91906	with	0	None
91906	91907	potent	0	None
91907	91908	and	0	None
91908	91909	selective	0	None
91909	91910	anti-neoplastic	0	None
91910	91911	activity	0	None
91911	91912	:	0	None
91912	91913	novel	0	None
91913	91914	ligands	0	None
91914	91915	that	0	None
91915	91916	limit	0	None
91916	91917	methemoglobin	0	None
91917	91918	formation	0	None
91918	91919	.	0	None
91919	91920	Cysteamine-induced	0	None
91920	91921	reduction	0	None
91921	91922	in	0	None
91922	91923	gastrointestinal	0	None
91923	91924	somatostatin	0	None
91924	91925	:	0	None
91925	91926	evidence	0	None
91926	91927	for	0	None
91927	91928	a	0	None
91928	91929	region-specific	0	None
91929	91930	loss	0	None
91930	91931	in	0	None
91931	91932	immunoreactivity	0	None
91932	91933	.	0	None
91933	91934	Inhibition	0	None
91934	91935	of	0	None
91935	91940	human alcohol and aldehyde dehydrogenases	3	GENE-N
91940	91941	by	0	None
91941	91942	cimetidine	0	None
91942	91943	and	0	None
91943	91944	assessment	0	None
91944	91945	of	0	None
91945	91946	its	0	None
91946	91947	effects	0	None
91947	91948	on	0	None
91948	91949	ethanol	2	CHEMICAL
91949	91950	metabolism	0	None
91950	91951	.	0	None
91951	91952	Presence	0	None
91952	91953	of	0	None
91953	91956	cyclic nucleotide phosphodiesterases	3	GENE-N
91956	91957	PDE1A	0	None
91957	91958	,	0	None
91958	91959	existing	0	None
91959	91960	as	0	None
91960	91961	a	0	None
91961	91962	stable	0	None
91962	91963	complex	0	None
91963	91964	with	0	None
91964	91965	calmodulin	0	None
91965	91966	,	0	None
91966	91967	and	0	None
91967	91968	PDE3A	0	None
91968	91969	in	0	None
91969	91970	human	0	None
91970	91971	spermatozoa	0	None
91971	91972	.	0	None
91972	91973	Trim24-repressed	0	None
91973	91974	VL30	0	None
91974	91975	retrotransposons	0	None
91975	91976	regulate	0	None
91976	91977	gene	0	None
91977	91978	expression	0	None
91978	91979	by	0	None
91979	91980	producing	0	None
91980	91981	noncoding	0	None
91981	91982	RNA	0	None
91982	91983	.	0	None
91983	91984	Effects	0	None
91984	91985	of	0	None
91985	91986	the	0	None
91986	91987	herbal	0	None
91987	91988	medicine	0	None
91988	91989	composition	0	None
91989	91990	"Saiko-ka-ryukotsu-borei-To"	0	None
91990	91991	on	0	None
91991	91992	the	0	None
91992	91993	function	0	None
91993	91994	of	0	None
91994	91995	endothelial	0	None
91995	91996	progenitor	0	None
91996	91997	cells	0	None
91997	91998	in	0	None
91998	91999	hypertensive	0	None
91999	92000	rats	0	None
92000	92001	.	0	None
92001	92002	Cisplatin-induced	0	None
92002	92003	nephrotoxicity	0	None
92003	92004	is	0	None
92004	92005	an	0	None
92005	92006	important	0	None
92006	92007	limiting	0	None
92007	92008	factor	0	None
92008	92009	for	0	None
92009	92010	cisplatin	0	None
92010	92011	use	0	None
92011	92012	.	0	None

92013	92014	Tumor	0	None
92014	92015	necrosis	0	None
92015	92016	factor-α	0	None
92016	92017	(	0	None
92017	92018	TNF-α	0	None
92018	92019	)	0	None
92019	92020	is	0	None
92020	92021	known	0	None
92021	92022	to	0	None
92022	92023	contribute	0	None
92023	92024	to	0	None
92024	92025	cisplatin-induced	0	None
92025	92026	nephrotoxicity	0	None
92026	92027	by	0	None
92027	92028	inducing	0	None
92028	92029	an	0	None
92029	92030	inflammatory	0	None
92030	92031	process	0	None
92031	92032	aggravating	0	None
92032	92033	the	0	None
92033	92034	primary	0	None
92034	92035	injury	0	None
92035	92036	,	0	None
92036	92037	thereby	0	None
92037	92038	resulting	0	None
92038	92039	in	0	None
92039	92040	acute	0	None
92040	92041	kidney	0	None
92041	92042	injury	0	None
92042	92043	(	0	None
92043	92044	AKI	0	None
92044	92045	)	0	None
92045	92046	.	0	None

92047	92048	The	0	None
92048	92049	present	0	None
92049	92050	study	0	None
92050	92051	investigates	0	None
92051	92052	the	0	None
92052	92053	pathways	0	None
92053	92054	synergistically	0	None
92054	92055	activated	0	None
92055	92056	by	0	None
92056	92057	cisplatin	0	None
92057	92058	and	0	None
92058	92059	TNF-α	0	None
92059	92060	responsible	0	None
92060	92061	for	0	None
92061	92062	TNF-α-enhanced	0	None
92062	92063	cisplatin-induced	0	None
92063	92064	renal	0	None
92064	92065	cell	0	None
92065	92066	injury	0	None
92066	92067	.	0	None

92068	92069	To	0	None
92069	92070	do	0	None
92070	92071	so	0	None
92071	92072	,	0	None
92072	92073	immortalized	0	None
92073	92074	renal	0	None
92074	92075	proximal	0	None
92075	92076	tubular	0	None
92076	92077	epithelial	0	None
92077	92078	cells	0	None
92078	92079	(	0	None
92079	92080	IM-PTECs	0	None
92080	92081	)	0	None
92081	92082	were	0	None
92082	92083	co-treated	0	None
92083	92084	with	0	None
92084	92085	TNF-α	0	None
92085	92086	and	0	None
92086	92087	cisplatin	0	None
92087	92088	.	0	None

92089	92090	Under	0	None
92090	92091	these	0	None
92091	92092	conditions	0	None
92092	92093	,	0	None
92093	92094	cisplatin	0	None
92094	92095	induced	0	None
92095	92096	dose-dependent	0	None
92096	92097	apoptosis	0	None
92097	92098	in	0	None
92098	92099	IM-PTECs	0	None
92099	92100	,	0	None
92100	92101	which	0	None
92101	92102	was	0	None
92102	92103	significantly	0	None
92103	92104	enhanced	0	None
92104	92105	by	0	None
92105	92106	TNF-α	0	None
92106	92107	.	0	None

92108	92109	Transcriptomic	0	None
92109	92110	analysis	0	None
92110	92111	revealed	0	None
92111	92112	that	0	None
92112	92113	cisplatin	0	None
92113	92114	inhibited	0	None
92114	92115	the	0	None
92115	92116	typical	0	None
92116	92117	TNF-α	0	None
92117	92118	response	0	None
92118	92119	and	0	None
92119	92120	cisplatin	0	None
92120	92121	/	0	None
92121	92122	TNF-α	0	None
92122	92123	treatment	0	None
92123	92124	up-regulated	0	None
92124	92125	cell	0	None
92125	92126	death	0	None
92126	92127	pathways	0	None
92127	92128	while	0	None
92128	92129	it	0	None
92129	92130	down-regulated	0	None
92130	92131	survival	0	None
92131	92132	pathways	0	None
92132	92133	compared	0	None
92133	92134	to	0	None
92134	92135	cisplatin	0	None
92135	92136	alone	0	None
92136	92137	.	0	None

92138	92139	In	0	None
92139	92140	concordance	0	None
92140	92141	,	0	None
92141	92142	the	0	None
92142	92143	gene	0	None
92143	92144	expression	0	None
92144	92145	levels	0	None
92145	92146	of	0	None
92146	92147	kidney	0	None
92147	92148	injury	0	None
92148	92149	markers	0	None
92149	92150	combined	0	None
92150	92151	with	0	None
92151	92152	activation	0	None
92152	92153	of	0	None
92153	92154	specific	0	None
92154	92155	inflammatory	0	None
92155	92156	mediators	0	None
92156	92157	were	0	None
92157	92158	enhanced	0	None
92158	92159	by	0	None
92159	92160	cisplatin	0	None
92160	92161	/	0	None
92161	92162	TNF-α	0	None
92162	92163	treatment	0	None
92163	92164	,	0	None
92164	92165	resembling	0	None
92165	92166	the	0	None
92166	92167	in	0	None
92167	92168	vivo	0	None
92168	92169	cisplatin-induced	0	None
92169	92170	nephrotoxicity	0	None
92170	92171	response	0	None
92171	92172	.	0	None

92173	92174	Furthermore	0	None
92174	92175	,	0	None
92175	92176	combined	0	None
92176	92177	cisplatin	0	None
92177	92178	/	0	None
92178	92179	TNF-α	0	None
92179	92180	treatment	0	None
92180	92181	inhibited	0	None
92181	92182	NF-κB	0	None
92182	92183	nuclear	0	None
92183	92184	translocation	0	None
92184	92185	and	0	None
92185	92186	NF-κB-mediated	0	None
92186	92187	gene	0	None
92187	92188	transcription	0	None
92188	92189	leading	0	None
92189	92190	to	0	None
92190	92191	enhanced	0	None
92191	92192	and	0	None
92192	92193	prolonged	0	None
92193	92194	JNK	0	None
92194	92195	and	0	None
92195	92196	c-Jun	1	GENE-Y
92196	92197	phosphorylation	0	None
92197	92198	.	0	None

92199	92200	JNK	0	None
92200	92201	sustained	0	None
92201	92202	activation	0	None
92202	92203	further	0	None
92203	92204	inhibited	0	None
92204	92205	NF-κB	0	None
92205	92206	signaling	0	None
92206	92207	via	0	None
92207	92208	a	0	None
92208	92209	feedback	0	None
92209	92210	loop	0	None
92210	92211	mechanism	0	None
92211	92212	.	0	None

92213	92214	This	0	None
92214	92215	led	0	None
92215	92216	to	0	None
92216	92217	an	0	None
92217	92218	alteration	0	None
92218	92219	in	0	None
92219	92220	the	0	None
92220	92221	transcription	0	None
92221	92222	of	0	None
92222	92223	the	0	None
92223	92224	NF-κB-induced	0	None
92224	92225	anti-apoptotic	0	None
92225	92226	genes	0	None
92226	92227	c-IAP2	0	None
92227	92228	,	0	None
92228	92229	Bcl-XL	0	None
92229	92230	,	0	None
92230	92231	Bruce	0	None
92231	92232	and	0	None
92232	92233	Bcl2	0	None
92233	92234	and	0	None
92234	92235	pro-apoptotic	0	None
92235	92236	genes	0	None
92236	92237	Bfk	0	None
92237	92238	and	0	None
92238	92239	Xaf1	0	None
92239	92240	and	0	None
92240	92241	consequently	0	None
92241	92242	to	0	None
92242	92243	sensitization	0	None
92243	92244	of	0	None
92244	92245	the	0	None
92245	92246	IM-PTECs	0	None
92246	92247	toward	0	None
92247	92248	cisplatin	0	None
92248	92249	/	0	None
92249	92250	TNF-α-induced	0	None
92250	92251	toxicity	0	None
92251	92252	.	0	None

92253	92254	In	0	None
92254	92255	conclusion	0	None
92255	92256	,	0	None
92256	92257	our	0	None
92257	92258	findings	0	None
92258	92259	support	0	None
92259	92260	a	0	None
92260	92261	model	0	None
92261	92262	whereby	0	None
92262	92263	renal	0	None
92263	92264	cells	0	None
92264	92265	exposed	0	None
92265	92266	to	0	None
92266	92267	both	0	None
92267	92268	cisplatin	0	None
92268	92269	and	0	None
92269	92270	TNF-α	0	None
92270	92271	switch	0	None
92271	92272	into	0	None
92272	92273	a	0	None
92273	92274	more	0	None
92274	92275	pro-apoptotic	0	None
92275	92276	and	0	None
92276	92277	inflammatory	0	None
92277	92278	program	0	None
92278	92279	by	0	None
92279	92280	altering	0	None
92280	92281	their	0	None
92281	92282	NF-κB	0	None
92282	92283	/	0	None
92283	92284	JNK	0	None
92284	92285	/	0	None
92285	92286	c-Jun	1	GENE-Y
92286	92287	balance	0	None
92287	92288	.	0	None
92288	92289	Inhibition	0	None
92289	92290	of	0	None
92290	92291	ATM	0	None
92291	92292	and	0	None
92292	92293	ATR	1	GENE-Y
92293	92294	kinase	0	None
92294	92295	activities	0	None
92295	92296	by	0	None
92296	92297	the	0	None
92297	92298	radiosensitizing	0	None
92298	92299	agent	0	None
92299	92300	,	0	None
92300	92301	caffeine	0	None
92301	92302	.	0	None
92302	92303	Potential	0	None
92303	92304	of	0	None
92304	92305	endogenous	0	None
92305	92308	estrogen receptor beta	1	GENE-Y
92308	92309	to	0	None
92309	92310	influence	0	None
92310	92311	the	0	None
92311	92312	selective	0	None
92312	92313	ER	0	None
92313	92314	modulator	0	None
92314	92315	ERbeta	0	None
92315	92316	complex	0	None
92316	92317	.	0	None
92317	92318	Contribution	0	None
92318	92319	of	0	None
92319	92320	Leydig	0	None
92320	92321	and	0	None
92321	92322	Sertoli	0	None
92322	92323	cells	0	None
92323	92324	to	0	None
92324	92325	testosterone	2	CHEMICAL
92325	92326	production	0	None
92326	92327	in	0	None
92327	92328	mouse	0	None
92328	92329	fetal	0	None
92329	92330	testes	0	None
92330	92331	.	0	None
92331	92332	OBJECTIVE	0	None
92332	92333	:	0	None
92333	92334	ADP	0	None
92334	92335	plays	0	None
92335	92336	an	0	None
92336	92337	important	0	None
92337	92338	role	0	None
92338	92339	in	0	None
92339	92340	platelet	0	None
92340	92341	aggregation	0	None
92341	92342	by	0	None
92342	92343	activating	0	None
92343	92344	P2Y12	1	GENE-Y
92344	92345	receptors	0	None
92345	92346	.	0	None

92347	92348	We	0	None
92348	92349	assessed	0	None
92349	92350	the	0	None
92350	92351	hypothesis	0	None
92351	92352	that	0	None
92352	92353	P2Y12	1	GENE-Y
92353	92354	receptors	0	None
92354	92355	are	0	None
92355	92356	expressed	0	None
92356	92357	in	0	None
92357	92358	vascular	0	None
92358	92359	smooth	0	None
92359	92360	muscle	0	None
92360	92361	cells	0	None
92361	92362	(	0	None
92362	92363	VSMC	0	None
92363	92364	)	0	None
92364	92365	.	0	None

92366	92367	METHODS	0	None
92367	92368	AND	0	None
92368	92369	RESULTS	0	None
92369	92370	:	0	None
92370	92371	P2Y12	1	GENE-Y
92371	92372	receptor	0	None
92372	92373	mRNA	0	None
92373	92374	was	0	None
92374	92375	found	0	None
92375	92376	to	0	None
92376	92377	have	0	None
92377	92378	a	0	None
92378	92379	high	0	None
92379	92380	expression	0	None
92380	92381	among	0	None
92381	92382	the	0	None
92382	92383	P2	0	None
92383	92384	receptors	0	None
92384	92385	in	0	None
92385	92386	human	0	None
92386	92387	VSMC	0	None
92387	92388	,	0	None
92388	92389	significantly	0	None
92389	92390	higher	0	None
92390	92391	than	0	None
92391	92392	the	0	None
92392	92393	other	0	None
92393	92394	2	0	None
92394	92395	ADP	0	None
92395	92396	receptors	0	None
92396	92397	(	0	None
92397	92398	P2Y1	1	GENE-Y
92398	92399	and	0	None
92399	92400	P2Y13	0	None
92400	92401	,	0	None
92401	92402	real-time	0	None
92402	92403	polymerase	0	None
92403	92404	chain	0	None
92404	92405	reaction	0	None
92405	92406	)	0	None
92406	92407	.	0	None

92408	92409	Western	0	None
92409	92410	blots	0	None
92410	92411	gave	0	None
92411	92412	a	0	None
92412	92413	band	0	None
92413	92414	of	0	None
92414	92415	50	0	None
92415	92416	kD	0	None
92416	92417	,	0	None
92417	92418	similar	0	None
92418	92419	to	0	None
92419	92420	that	0	None
92420	92421	in	0	None
92421	92422	platelets	0	None
92422	92423	.	0	None

92424	92425	To	0	None
92425	92426	unmask	0	None
92426	92427	a	0	None
92427	92428	P2Y12	1	GENE-Y
92428	92429	receptor-mediated	0	None
92429	92430	vasoconstriction	0	None
92430	92431	by	0	None
92431	92432	simulating	0	None
92432	92433	the	0	None
92433	92434	in	0	None
92434	92435	vivo	0	None
92435	92436	situation	0	None
92436	92437	,	0	None
92437	92438	vessels	0	None
92438	92439	were	0	None
92439	92440	precontracted	0	None
92440	92441	to	0	None
92441	92442	a	0	None
92442	92443	submaximal	0	None
92443	92444	level	0	None
92444	92445	.	0	None

92446	92447	2-MeSADP	0	None
92447	92448	stimulated	0	None
92448	92449	contractions	0	None
92449	92450	in	0	None
92450	92451	vessel	0	None
92451	92452	segments	0	None
92452	92453	from	0	None
92453	92454	internal	0	None
92454	92455	mammary	0	None
92455	92456	artery	0	None
92456	92457	(	0	None
92457	92458	IM	0	None
92458	92459	)	0	None
92459	92460	,	0	None
92460	92461	IM	0	None
92461	92462	branches	0	None
92462	92463	and	0	None
92463	92464	small	0	None
92464	92465	veins	0	None
92465	92466	(	0	None
92466	92467	Emax	0	None
92467	92468	=	0	None
92468	92469	15	0	None
92469	92470	+	0	None
92470	92471	/	0	None
92471	92472	-6%	0	None
92472	92473	of	0	None
92473	92474	60	0	None
92474	92475	mmol	0	None
92475	92476	/	0	None
92476	92477	L	0	None
92477	92478	K	0	None
92478	92479	+	0	None
92479	92480	contraction	0	None
92480	92481	,	0	None
92481	92482	pEC50	0	None
92482	92483	=	0	None
92483	92484	5	0	None
92484	92485	.	0	None
92485	92486	6	0	None
92486	92487	+	0	None
92487	92488	/	0	None
92488	92489	-0	0	None
92489	92490	.	0	None
92490	92491	6	0	None
92491	92492	,	0	None
92492	92493	Emax	0	None
92493	92494	=	0	None
92494	92495	21	0	None
92495	92496	+	0	None
92496	92497	/	0	None
92497	92498	-1%	0	None
92498	92499	,	0	None
92499	92500	pEC50	0	None
92500	92501	=	0	None
92501	92502	6	0	None
92502	92503	.	0	None
92503	92504	8	0	None
92504	92505	+	0	None
92505	92506	/	0	None
92506	92507	-0	0	None
92507	92508	.	0	None
92508	92509	1	0	None
92509	92510	,	0	None
92510	92511	and	0	None
92511	92512	Emax	0	None
92512	92513	=	0	None
92513	92514	48	0	None
92514	92515	+	0	None
92515	92516	/	0	None
92516	92517	-9%	0	None
92517	92518	,	0	None
92518	92519	pEC50	0	None
92519	92520	=	0	None
92520	92521	6	0	None
92521	92522	.	0	None
92522	92523	6	0	None
92523	92524	+	0	None
92524	92525	/	0	None
92525	92526	-0	0	None
92526	92527	.	0	None
92527	92528	4	0	None
92528	92529	)	0	None
92529	92530	.	0	None

92531	92532	The	0	None
92532	92533	selective	0	None
92533	92534	P2Y12	1	GENE-Y
92534	92535	antagonist	0	None
92535	92536	AR-C67085	0	None
92536	92537	blocked	0	None
92537	92538	2-MeSADP	0	None
92538	92539	contractions	0	None
92539	92540	.	0	None

92541	92542	The	0	None
92542	92543	contraction	0	None
92543	92544	was	0	None
92544	92545	not	0	None
92545	92546	reduced	0	None
92546	92547	in	0	None
92547	92548	patients	0	None
92548	92549	using	0	None
92549	92550	clopidogrel	0	None
92550	92551	,	0	None
92551	92552	a	0	None
92552	92553	drug	0	None
92553	92554	inhibiting	0	None
92554	92555	ADP-induced	0	None
92555	92556	platelet	0	None
92556	92557	aggregation	0	None
92557	92558	by	0	None
92558	92559	blocking	0	None
92559	92560	the	0	None
92560	92561	P2Y12	1	GENE-Y
92561	92562	receptor	0	None
92562	92563	.	0	None

92564	92565	This	0	None
92565	92566	may	0	None
92566	92567	be	0	None
92567	92568	explained	0	None
92568	92569	by	0	None
92569	92570	the	0	None
92570	92571	high	0	None
92571	92572	instability	0	None
92572	92573	of	0	None
92573	92574	the	0	None
92574	92575	active	0	None
92575	92576	clopidogrel	0	None
92576	92577	metabolite	0	None
92577	92578	that	0	None
92578	92579	never	0	None
92579	92580	reaches	0	None
92580	92581	the	0	None
92581	92582	systemic	0	None
92582	92583	circulation	0	None
92583	92584	.	0	None

92585	92586	CONCLUSIONS	0	None
92586	92587	:	0	None
92587	92588	ADP	0	None
92588	92589	acting	0	None
92589	92590	on	0	None
92590	92591	P2Y12	1	GENE-Y
92591	92592	receptors	0	None
92592	92593	not	0	None
92593	92594	only	0	None
92594	92595	is	0	None
92595	92596	important	0	None
92596	92597	for	0	None
92597	92598	platelet	0	None
92598	92599	activation	0	None
92599	92600	but	0	None
92600	92601	also	0	None
92601	92602	stimulates	0	None
92602	92603	vasoconstriction	0	None
92603	92604	.	0	None

92605	92606	Stable	0	None
92606	92607	drugs	0	None
92607	92608	with	0	None
92608	92609	antagonistic	0	None
92609	92610	effects	0	None
92610	92611	on	0	None
92611	92612	P2Y12	1	GENE-Y
92612	92613	receptors	0	None
92613	92614	,	0	None
92614	92615	affecting	0	None
92615	92616	both	0	None
92616	92617	platelets	0	None
92617	92618	and	0	None
92618	92619	VSMC	0	None
92619	92620	,	0	None
92620	92621	could	0	None
92621	92622	be	0	None
92622	92623	of	0	None
92623	92624	double	0	None
92624	92625	therapeutic	0	None
92625	92626	benefit	0	None
92626	92627	in	0	None
92627	92628	their	0	None
92628	92629	prevention	0	None
92629	92630	of	0	None
92630	92631	both	0	None
92631	92632	thrombosis	0	None
92632	92633	and	0	None
92633	92634	vasospasm	0	None
92634	92635	.	0	None
92635	92636	Tadalafil	0	None
92636	92637	(	0	None
92637	92638	Cialis	0	None
92638	92639	)	0	None
92639	92640	for	0	None
92640	92641	men	0	None
92641	92642	with	0	None
92642	92643	erectile	0	None
92643	92644	dysfunction	0	None
92644	92645	.	0	None
92645	92647	Human CYP3A	3	GENE-N
92647	92648	is	0	None
92648	92649	the	0	None
92649	92650	most	0	None
92650	92651	abundant	0	None
92651	92652	P450	0	None
92652	92653	isozyme	0	None
92653	92654	present	0	None
92654	92655	in	0	None
92655	92656	the	0	None
92656	92657	human	0	None
92657	92658	liver	0	None
92658	92659	and	0	None
92659	92660	small	0	None
92660	92661	intestine	0	None
92661	92662	,	0	None
92662	92663	and	0	None
92663	92664	metabolizes	0	None
92664	92665	around	0	None
92665	92666	50%	0	None
92666	92667	of	0	None
92667	92668	medical	0	None
92668	92669	drugs	0	None
92669	92670	on	0	None
92670	92671	the	0	None
92671	92672	market	0	None
92672	92673	.	0	None

92674	92675	The	0	None
92675	92677	human CYP3A	3	GENE-N
92677	92678	subfamily	0	None
92678	92679	comprises	0	None
92679	92680	four	0	None
92680	92681	members	0	None
92681	92682	(	0	None
92682	92683	CYP3A4	0	None
92683	92684	,	0	None
92684	92685	CYP3A5	0	None
92685	92686	,	0	None
92686	92687	CYP3A7	0	None
92687	92688	,	0	None
92688	92689	CYP3A43	1	GENE-Y
92689	92690	)	0	None
92690	92691	encoded	0	None
92691	92692	on	0	None
92692	92693	human	0	None
92693	92694	chromosome	0	None
92694	92695	7	0	None
92695	92696	.	0	None

92697	92698	However	0	None
92698	92699	,	0	None
92699	92700	transgenic	0	None
92700	92701	mouse	0	None
92701	92702	lines	0	None
92702	92703	carrying	0	None
92703	92704	the	0	None
92704	92705	entire	0	None
92705	92706	human	0	None
92706	92707	CYP3A	0	None
92707	92708	cluster	0	None
92708	92709	have	0	None
92709	92710	not	0	None
92710	92711	been	0	None
92711	92712	constructed	0	None
92712	92713	because	0	None
92713	92714	of	0	None
92714	92715	limitations	0	None
92715	92716	in	0	None
92716	92717	conventional	0	None
92717	92718	cloning	0	None
92718	92719	techniques	0	None
92719	92720	.	0	None

92721	92722	Here	0	None
92722	92723	,	0	None
92723	92724	we	0	None
92724	92725	show	0	None
92725	92726	that	0	None
92726	92727	the	0	None
92727	92728	introduction	0	None
92728	92729	of	0	None
92729	92730	a	0	None
92730	92731	human	0	None
92731	92732	artificial	0	None
92732	92733	chromosome	0	None
92733	92734	(	0	None
92734	92735	HAC	0	None
92735	92736	)	0	None
92736	92737	containing	0	None
92737	92738	the	0	None
92738	92739	entire	0	None
92739	92740	genomic	0	None
92740	92742	human CYP3A	3	GENE-N
92742	92743	locus	0	None
92743	92744	recapitulates	0	None
92744	92745	tissue-	0	None
92745	92746	and	0	None
92746	92747	stage-specific	0	None
92747	92748	expression	0	None
92748	92749	of	0	None
92749	92751	human CYP3A	3	GENE-N
92751	92752	genes	0	None
92752	92753	and	0	None
92753	92754	xenobiotic	0	None
92754	92755	metabolism	0	None
92755	92756	in	0	None
92756	92757	mice	0	None
92757	92758	.	0	None

92759	92760	About	0	None
92760	92761	700	0	None
92761	92762	kb	0	None
92762	92763	of	0	None
92763	92764	the	0	None
92764	92765	entire	0	None
92765	92766	CYP3A	0	None
92766	92767	genomic	0	None
92767	92768	segment	0	None
92768	92769	was	0	None
92769	92770	cloned	0	None
92770	92771	into	0	None
92771	92772	a	0	None
92772	92773	HAC	0	None
92773	92774	(	0	None
92774	92775	CYP3A-HAC	0	None
92775	92776	)	0	None
92776	92777	,	0	None
92777	92778	and	0	None
92778	92779	trans-chromosomic	0	None
92779	92780	(	0	None
92780	92781	Tc	0	None
92781	92782	)	0	None
92782	92783	mice	0	None
92783	92784	carrying	0	None
92784	92785	a	0	None
92785	92786	single	0	None
92786	92787	copy	0	None
92787	92788	of	0	None
92788	92789	germline-transmittable	0	None
92789	92790	CYP3A-HAC	0	None
92790	92791	were	0	None
92791	92792	generated	0	None
92792	92793	via	0	None
92793	92794	a	0	None
92794	92795	chromosome-engineering	0	None
92795	92796	technique	0	None
92796	92797	.	0	None

92798	92799	The	0	None
92799	92800	tissue-	0	None
92800	92801	and	0	None
92801	92802	stage-specific	0	None
92802	92803	expression	0	None
92803	92804	profiles	0	None
92804	92805	of	0	None
92805	92806	CYP3A	0	None
92806	92807	genes	0	None
92807	92808	were	0	None
92808	92809	consistent	0	None
92809	92810	with	0	None
92810	92811	those	0	None
92811	92812	seen	0	None
92812	92813	in	0	None
92813	92814	humans	0	None
92814	92815	.	0	None

92816	92817	We	0	None
92817	92818	further	0	None
92818	92819	generated	0	None
92819	92820	mice	0	None
92820	92821	carrying	0	None
92821	92822	the	0	None
92822	92823	CYP3A-HAC	0	None
92823	92824	in	0	None
92824	92825	the	0	None
92825	92826	background	0	None
92826	92827	homozygous	0	None
92827	92828	for	0	None
92828	92829	targeted	0	None
92829	92830	deletion	0	None
92830	92831	of	0	None
92831	92832	most	0	None
92832	92833	endogenous	0	None
92833	92834	Cyp3a	0	None
92834	92835	genes	0	None
92835	92836	.	0	None

92837	92838	In	0	None
92838	92839	this	0	None
92839	92840	mouse	0	None
92840	92841	strain	0	None
92841	92842	with	0	None
92842	92843	'fully	0	None
92843	92844	humanized'	0	None
92844	92845	CYP3A	0	None
92845	92846	genes	0	None
92846	92847	,	0	None
92847	92848	the	0	None
92848	92849	kinetics	0	None
92849	92850	of	0	None
92850	92851	triazolam	0	None
92851	92852	metabolism	0	None
92852	92853	,	0	None
92853	92854	CYP3A-mediated	0	None
92854	92855	mechanism-based	0	None
92855	92856	inactivation	0	None
92856	92857	effects	0	None
92857	92858	and	0	None
92858	92859	formation	0	None
92859	92860	of	0	None
92860	92861	fetal-specific	0	None
92861	92862	metabolites	0	None
92862	92863	of	0	None
92863	92864	dehydroepiandrosterone	0	None
92864	92865	observed	0	None
92865	92866	in	0	None
92866	92867	humans	0	None
92867	92868	were	0	None
92868	92869	well	0	None
92869	92870	reproduced	0	None
92870	92871	.	0	None

92872	92873	Thus	0	None
92873	92874	,	0	None
92874	92875	these	0	None
92875	92876	mice	0	None
92876	92877	are	0	None
92877	92878	likely	0	None
92878	92879	to	0	None
92879	92880	be	0	None
92880	92881	valuable	0	None
92881	92882	in	0	None
92882	92883	evaluating	0	None
92883	92884	novel	0	None
92884	92885	drugs	0	None
92885	92886	metabolized	0	None
92886	92887	by	0	None
92887	92888	CYP3A	0	None
92888	92889	enzymes	0	None
92889	92890	and	0	None
92890	92891	in	0	None
92891	92892	studying	0	None
92892	92893	the	0	None
92893	92894	regulation	0	None
92894	92895	of	0	None
92895	92897	human CYP3A	3	GENE-N
92897	92898	gene	0	None
92898	92899	expression	0	None
92899	92900	.	0	None

92901	92902	Furthermore	0	None
92902	92903	,	0	None
92903	92904	this	0	None
92904	92905	system	0	None
92905	92906	can	0	None
92906	92907	also	0	None
92907	92908	be	0	None
92908	92909	used	0	None
92909	92910	for	0	None
92910	92911	generating	0	None
92911	92912	Tc	0	None
92912	92913	mice	0	None
92913	92914	carrying	0	None
92914	92915	other	0	None
92915	92916	human	0	None
92916	92917	metabolic	0	None
92917	92918	genes	0	None
92918	92919	.	0	None
92919	92920	Neural	0	None
92920	92921	stem	0	None
92921	92922	/	0	None
92922	92923	progenitor	0	None
92923	92924	cells	0	None
92924	92925	display	0	None
92925	92926	a	0	None
92926	92927	low	0	None
92927	92928	requirement	0	None
92928	92929	for	0	None
92929	92930	oxidative	0	None
92930	92931	metabolism	0	None
92931	92932	independent	0	None
92932	92933	of	0	None
92933	92934	hypoxia	0	None
92934	92935	inducible	0	None
92935	92936	factor-1alpha	0	None
92936	92937	expression	0	None
92937	92938	.	0	None
92938	92939	Helicobacter	0	None
92939	92940	pylori	0	None
92940	92941	induces	0	None
92941	92942	macrophage	0	None
92942	92943	apoptosis	0	None
92943	92944	by	0	None
92944	92945	activation	0	None
92945	92946	of	0	None
92946	92947	arginase	0	None
92947	92948	II	0	None
92948	92949	.	0	None
92949	92951	Adenylosuccinate synthetase	1	GENE-Y
92951	92952	(	0	None
92952	92953	AdSS	0	None
92953	92954	)	0	None
92954	92955	catalyzes	0	None
92955	92956	the	0	None
92956	92957	Mg2	0	None
92957	92958	+	0	None
92958	92959	dependent	0	None
92959	92960	condensation	0	None
92960	92961	of	0	None
92961	92962	a	0	None
92962	92963	molecule	0	None
92963	92964	of	0	None
92964	92965	IMP	0	None
92965	92966	with	0	None
92966	92967	aspartate	0	None
92967	92968	to	0	None
92968	92969	form	0	None
92969	92970	adenylosuccinate	0	None
92970	92971	,	0	None
92971	92972	in	0	None
92972	92973	a	0	None
92973	92974	reaction	0	None
92974	92975	driven	0	None
92975	92976	by	0	None
92976	92977	the	0	None
92977	92978	hydrolysis	0	None
92978	92979	of	0	None
92979	92980	GTP	0	None
92980	92981	to	0	None
92981	92982	GDP	0	None
92982	92983	.	0	None

92984	92985	AdSS	0	None
92985	92986	from	0	None
92986	92987	the	0	None
92987	92988	thermophilic	0	None
92988	92989	archaea	0	None
92989	92990	,	0	None
92990	92991	Methanocaldococcus	0	None
92991	92992	jannaschii	0	None
92992	92993	(	0	None
92993	92994	MjAdSS	0	None
92994	92995	)	0	None
92995	92996	is	0	None
92996	92997	345	0	None
92997	92999	amino acids	2	CHEMICAL
92999	93000	long	0	None
93000	93001	against	0	None
93001	93002	an	0	None
93002	93003	average	0	None
93003	93004	length	0	None
93004	93005	of	0	None
93005	93006	430-457	0	None
93006	93008	amino acids	2	CHEMICAL
93008	93009	for	0	None
93009	93010	most	0	None
93010	93011	mesophilic	0	None
93011	93012	AdSS	0	None
93012	93013	.	0	None

93014	93015	This	0	None
93015	93016	short	0	None
93016	93017	AdSS	0	None
93017	93018	has	0	None
93018	93019	two	0	None
93019	93020	large	0	None
93020	93021	deletions	0	None
93021	93022	that	0	None
93022	93023	map	0	None
93023	93024	to	0	None
93024	93025	the	0	None
93025	93026	middle	0	None
93026	93027	and	0	None
93027	93028	C-terminus	0	None
93028	93029	of	0	None
93029	93030	the	0	None
93030	93031	protein	0	None
93031	93032	.	0	None

93033	93034	This	0	None
93034	93035	article	0	None
93035	93036	discusses	0	None
93036	93037	the	0	None
93037	93038	detailed	0	None
93038	93039	kinetic	0	None
93039	93040	characterization	0	None
93040	93041	of	0	None
93041	93042	MjAdSS	0	None
93042	93043	.	0	None

93044	93045	Initial	0	None
93045	93046	velocity	0	None
93046	93047	and	0	None
93047	93048	product	0	None
93048	93049	inhibition	0	None
93049	93050	studies	0	None
93050	93051	,	0	None
93051	93052	carried	0	None
93052	93053	out	0	None
93053	93054	at	0	None
93054	93055	70	0	None
93055	93056	degrees	0	None
93056	93057	C	0	None
93057	93058	,	0	None
93058	93059	suggest	0	None
93059	93060	a	0	None
93060	93061	rapid	0	None
93061	93062	equilibrium	0	None
93062	93063	random	0	None
93063	93064	AB	0	None
93064	93065	steady-state	0	None
93065	93066	ordered	0	None
93066	93067	C	0	None
93067	93068	kinetic	0	None
93068	93069	mechanism	0	None
93069	93070	for	0	None
93070	93071	the	0	None
93071	93072	MjAdSS	0	None
93072	93073	catalyzed	0	None
93073	93074	reaction	0	None
93074	93075	.	0	None

93076	93077	AdSS	0	None
93077	93078	are	0	None
93078	93079	known	0	None
93079	93080	to	0	None
93080	93081	exhibit	0	None
93081	93082	monomer-dimer	0	None
93082	93083	equilibrium	0	None
93083	93084	with	0	None
93084	93085	the	0	None
93085	93086	dimer	0	None
93086	93087	being	0	None
93087	93088	implicated	0	None
93088	93089	in	0	None
93089	93090	catalysis	0	None
93090	93091	.	0	None

93092	93093	In	0	None
93093	93094	contrast	0	None
93094	93095	,	0	None
93095	93096	our	0	None
93096	93097	studies	0	None
93097	93098	show	0	None
93098	93099	that	0	None
93099	93100	MjAdSS	0	None
93100	93101	is	0	None
93101	93102	an	0	None
93102	93103	equilibrium	0	None
93103	93104	mixture	0	None
93104	93105	of	0	None
93105	93106	dimers	0	None
93106	93107	and	0	None
93107	93108	tetramers	0	None
93108	93109	with	0	None
93109	93110	the	0	None
93110	93111	tetramer	0	None
93111	93112	being	0	None
93112	93113	the	0	None
93113	93114	catalytically	0	None
93114	93115	active	0	None
93115	93116	form	0	None
93116	93117	.	0	None

93118	93119	The	0	None
93119	93120	tetramer	0	None
93120	93121	dissociates	0	None
93121	93122	into	0	None
93122	93123	dimers	0	None
93123	93124	with	0	None
93124	93125	a	0	None
93125	93126	minor	0	None
93126	93127	increase	0	None
93127	93128	in	0	None
93128	93129	ionic	0	None
93129	93130	strength	0	None
93130	93131	of	0	None
93131	93132	the	0	None
93132	93133	buffer	0	None
93133	93134	,	0	None
93134	93135	while	0	None
93135	93136	the	0	None
93136	93137	dimer	0	None
93137	93138	is	0	None
93138	93139	extremely	0	None
93139	93140	stable	0	None
93140	93141	and	0	None
93141	93142	does	0	None
93142	93143	not	0	None
93143	93144	dissociate	0	None
93144	93145	even	0	None
93145	93146	at	0	None
93146	93147	1	0	None
93147	93148	.	0	None
93148	93149	2	0	None
93149	93150	M	0	None
93150	93151	NaCl	0	None
93151	93152	.	0	None

93153	93154	Phosphate	0	None
93154	93155	,	0	None
93155	93156	a	0	None
93156	93157	product	0	None
93157	93158	of	0	None
93158	93159	the	0	None
93159	93160	reaction	0	None
93160	93161	,	0	None
93161	93162	was	0	None
93162	93163	found	0	None
93163	93164	to	0	None
93164	93165	be	0	None
93165	93166	a	0	None
93166	93167	potent	0	None
93167	93168	inhibitor	0	None
93168	93169	of	0	None
93169	93170	MjAdSS	0	None
93170	93171	showing	0	None
93171	93172	biphasic	0	None
93172	93173	inhibition	0	None
93173	93174	of	0	None
93174	93175	enzyme	0	None
93175	93176	activity	0	None
93176	93177	.	0	None

93178	93179	The	0	None
93179	93180	inhibition	0	None
93180	93181	was	0	None
93181	93182	competitive	0	None
93182	93183	with	0	None
93183	93184	IMP	0	None
93184	93185	and	0	None
93185	93186	noncompetitive	0	None
93186	93187	with	0	None
93187	93188	GTP	0	None
93188	93189	.	0	None

93190	93191	MjAdSS	0	None
93191	93192	,	0	None
93192	93193	like	0	None
93193	93194	the	0	None
93194	93195	mouse	0	None
93195	93197	acidic isozyme	3	GENE-N
93197	93198	,	0	None
93198	93199	exhibits	0	None
93199	93200	substrate	0	None
93200	93201	inhibition	0	None
93201	93202	,	0	None
93202	93203	with	0	None
93203	93204	IMP	0	None
93204	93205	inhibiting	0	None
93205	93206	enzyme	0	None
93206	93207	activity	0	None
93207	93208	at	0	None
93208	93209	subsaturating	0	None
93209	93210	GTP	0	None
93210	93211	concentrations	0	None
93211	93212	.	0	None

93213	93214	Regulation	0	None
93214	93215	of	0	None
93215	93216	enzyme	0	None
93216	93217	activity	0	None
93217	93218	by	0	None
93218	93219	the	0	None
93219	93220	glycolytic	0	None
93220	93221	intermediate	0	None
93221	93222	,	0	None
93222	93223	fructose	2	CHEMICAL
93223	93224	1	0	None
93224	93225	,	0	None
93225	93226	6	0	None
93226	93227	bisphosphate	0	None
93227	93228	,	0	None
93228	93229	was	0	None
93229	93230	also	0	None
93230	93231	observed	0	None
93231	93232	with	0	None
93232	93233	the	0	None
93233	93234	inhibition	0	None
93234	93235	being	0	None
93235	93236	competitive	0	None
93236	93237	with	0	None
93237	93238	IMP	0	None
93238	93239	and	0	None
93239	93240	noncompetitive	0	None
93240	93241	against	0	None
93241	93242	GTP	0	None
93242	93243	.	0	None
93243	93244	Sorafenib	0	None
93244	93245	:	0	None
93245	93246	recent	0	None
93246	93247	update	0	None
93247	93248	on	0	None
93248	93249	activity	0	None
93249	93250	as	0	None
93250	93251	a	0	None
93251	93252	single	0	None
93252	93253	agent	0	None
93253	93254	and	0	None
93254	93255	in	0	None
93255	93256	combination	0	None
93256	93257	with	0	None
93257	93258	interferon-alpha2	1	GENE-Y
93258	93259	in	0	None
93259	93260	patients	0	None
93260	93261	with	0	None
93261	93262	advanced-stage	0	None
93262	93263	renal	0	None
93263	93264	cell	0	None
93264	93265	carcinoma	0	None
93265	93266	.	0	None
93266	93267	PPARgamma	0	None
93267	93268	controls	0	None
93268	93269	CD1d	0	None
93269	93270	expression	0	None
93270	93271	by	0	None
93271	93272	turning	0	None
93272	93273	on	0	None
93273	93275	retinoic acid	2	CHEMICAL
93275	93276	synthesis	0	None
93276	93277	in	0	None
93277	93278	developing	0	None
93278	93279	human	0	None
93279	93280	dendritic	0	None
93280	93281	cells	0	None
93281	93282	.	0	None
93282	93283	Hydrogen	2	CHEMICAL
93283	93284	sulfide	2	CHEMICAL
93284	93285	increases	0	None
93285	93286	nitric	0	None
93286	93287	oxide	0	None
93287	93288	production	0	None
93288	93289	with	0	None
93289	93290	calcium-dependent	0	None
93290	93291	activation	0	None
93291	93292	of	0	None
93292	93296	endothelial nitric oxide synthase	1	GENE-Y
93296	93297	in	0	None
93297	93298	endothelial	0	None
93298	93299	cells	0	None
93299	93300	.	0	None
93300	93301	KCC	3	GENE-N
93301	93302	isoforms	0	None
93302	93303	in	0	None
93303	93304	a	0	None
93304	93305	human	0	None
93305	93306	lens	0	None
93306	93307	epithelial	0	None
93307	93308	cell	0	None
93308	93309	line	0	None
93309	93310	(	0	None
93310	93311	B3	0	None
93311	93312	)	0	None
93312	93313	and	0	None
93313	93314	lens	0	None
93314	93315	tissue	0	None
93315	93316	extracts	0	None
93316	93317	.	0	None
93317	93318	The	0	None
93318	93319	medial	0	None
93319	93320	prefrontal	0	None
93320	93321	cortex	0	None
93321	93322	(	0	None
93322	93323	mPFC	0	None
93323	93324	)	0	None
93324	93325	has	0	None
93325	93326	been	0	None
93326	93327	implicated	0	None
93327	93328	in	0	None
93328	93329	modulating	0	None
93329	93330	anxiety	0	None
93330	93331	.	0	None

93332	93333	However	0	None
93333	93334	,	0	None
93334	93335	it	0	None
93335	93336	is	0	None
93336	93337	unknown	0	None
93337	93338	whether	0	None
93338	93339	excitatory	0	None
93339	93340	or	0	None
93340	93341	inhibitory	0	None
93341	93342	neurotransmission	0	None
93342	93343	in	0	None
93343	93344	the	0	None
93344	93345	infralimbic	0	None
93345	93346	(	0	None
93346	93347	IL	0	None
93347	93348	)	0	None
93348	93349	subregion	0	None
93349	93350	of	0	None
93350	93351	the	0	None
93351	93352	mPFC	0	None
93352	93353	underlies	0	None
93353	93354	the	0	None
93354	93355	pathology	0	None
93355	93356	of	0	None
93356	93357	anxiety-related	0	None
93357	93358	behavior	0	None
93358	93359	.	0	None

93360	93361	To	0	None
93361	93362	address	0	None
93362	93363	this	0	None
93363	93364	issue	0	None
93364	93365	,	0	None
93365	93366	we	0	None
93366	93367	infused	0	None
93367	93368	the	0	None
93368	93369	GABAA	3	GENE-N
93369	93370	receptor	0	None
93370	93371	(	0	None
93371	93372	GABAAR	0	None
93372	93373	)	0	None
93373	93374	antagonist	0	None
93374	93375	bicuculline	2	CHEMICAL
93375	93376	to	0	None
93376	93377	temporarily	0	None
93377	93378	activate	0	None
93378	93379	the	0	None
93379	93380	IL	0	None
93380	93381	cortex	0	None
93381	93382	.	0	None

93383	93384	IL	0	None
93384	93385	cortex	0	None
93385	93386	activation	0	None
93386	93387	decreased	0	None
93387	93388	the	0	None
93388	93389	time	0	None
93389	93390	spent	0	None
93390	93391	in	0	None
93391	93392	the	0	None
93392	93393	center	0	None
93393	93394	area	0	None
93394	93395	in	0	None
93395	93396	the	0	None
93396	93397	open	0	None
93397	93398	field	0	None
93398	93399	test	0	None
93399	93400	,	0	None
93400	93401	decreased	0	None
93401	93402	exploration	0	None
93402	93403	of	0	None
93403	93404	the	0	None
93404	93405	open-arms	0	None
93405	93406	in	0	None
93406	93407	the	0	None
93407	93408	elevated	0	None
93408	93409	plus	0	None
93409	93410	maze	0	None
93410	93411	test	0	None
93411	93412	,	0	None
93412	93413	and	0	None
93413	93414	increased	0	None
93414	93415	the	0	None
93415	93416	latency	0	None
93416	93417	to	0	None
93417	93418	bite	0	None
93418	93419	food	0	None
93419	93420	in	0	None
93420	93421	the	0	None
93421	93422	novelty-suppressed	0	None
93422	93423	feeding	0	None
93423	93424	test	0	None
93424	93425	.	0	None

93426	93427	These	0	None
93427	93428	findings	0	None
93428	93429	substantiate	0	None
93429	93430	the	0	None
93430	93431	GABAergic	0	None
93431	93432	system's	0	None
93432	93433	role	0	None
93433	93434	in	0	None
93434	93435	anxiety-related	0	None
93435	93436	behaviors	0	None
93436	93437	.	0	None

93438	93439	IL	0	None
93439	93440	cortex	0	None
93440	93441	inactivation	0	None
93441	93442	with	0	None
93442	93443	the	0	None
93443	93444	AMPA	0	None
93444	93445	receptor	0	None
93445	93446	(	0	None
93446	93447	AMPAR	0	None
93447	93448	)	0	None
93448	93449	antagonist	0	None
93449	93450	CNQX	0	None
93450	93451	produced	0	None
93451	93452	opposite	0	None
93452	93453	,	0	None
93453	93454	anxiolytic	0	None
93454	93455	effects	0	None
93455	93456	.	0	None

93457	93458	However	0	None
93458	93459	,	0	None
93459	93460	infusion	0	None
93460	93461	of	0	None
93461	93462	the	0	None
93462	93463	NMDA	0	None
93463	93464	receptor	0	None
93464	93465	(	0	None
93465	93466	NMDAR	3	GENE-N
93466	93467	)	0	None
93467	93468	antagonist	0	None
93468	93469	AP5	0	None
93469	93470	into	0	None
93470	93471	the	0	None
93471	93472	IL	0	None
93472	93473	cortex	0	None
93473	93474	had	0	None
93474	93475	no	0	None
93475	93476	significant	0	None
93476	93477	effect	0	None
93477	93478	.	0	None

93479	93480	Additionally	0	None
93480	93481	,	0	None
93481	93482	we	0	None
93482	93483	did	0	None
93483	93484	not	0	None
93484	93485	observe	0	None
93485	93486	motor	0	None
93486	93487	activity	0	None
93487	93488	deficits	0	None
93488	93489	or	0	None
93489	93490	appetite	0	None
93490	93491	deficits	0	None
93491	93492	following	0	None
93492	93493	inhibition	0	None
93493	93494	of	0	None
93494	93495	GABAergic	0	None
93495	93496	or	0	None
93496	93497	glutamatergic	0	None
93497	93498	neurotransmission	0	None
93498	93499	.	0	None

93500	93501	Interestingly	0	None
93501	93502	,	0	None
93502	93503	we	0	None
93503	93504	found	0	None
93504	93505	parallel	0	None
93505	93506	and	0	None
93506	93507	corresponding	0	None
93507	93508	electrophysiological	0	None
93508	93509	changes	0	None
93509	93510	in	0	None
93510	93511	anxious	0	None
93511	93512	mice;	0	None
93512	93513	compared	0	None
93513	93514	to	0	None
93514	93515	mice	0	None
93515	93516	with	0	None
93516	93517	relatively	0	None
93517	93518	low	0	None
93518	93519	anxiety	0	None
93519	93520	,	0	None
93520	93521	the	0	None
93521	93522	relatively	0	None
93522	93523	high	0	None
93523	93524	anxiety	0	None
93524	93525	mice	0	None
93525	93526	exhibited	0	None
93526	93527	smaller	0	None
93527	93528	evoked	0	None
93528	93529	inhibitory	0	None
93529	93530	postsynaptic	0	None
93530	93531	currents	0	None
93531	93532	(	0	None
93532	93533	eIPSCs	0	None
93533	93534	)	0	None
93534	93535	and	0	None
93535	93536	larger	0	None
93536	93537	AMPA-mediated	0	None
93537	93538	evoked	0	None
93538	93539	excitatory	0	None
93539	93540	postsynaptic	0	None
93540	93541	currents	0	None
93541	93542	(	0	None
93542	93543	eEPSCs	0	None
93543	93544	)	0	None
93544	93545	in	0	None
93545	93546	pyramidal	0	None
93546	93547	neurons	0	None
93547	93548	in	0	None
93548	93549	the	0	None
93549	93550	IL	0	None
93550	93551	cortex	0	None
93551	93552	.	0	None

93553	93554	The	0	None
93554	93555	changes	0	None
93555	93556	of	0	None
93556	93557	eIPSCs	0	None
93557	93558	and	0	None
93558	93559	eEPSCs	0	None
93559	93560	were	0	None
93560	93561	due	0	None
93561	93562	to	0	None
93562	93563	presynaptic	0	None
93563	93564	mechanisms	0	None
93564	93565	.	0	None

93566	93567	Our	0	None
93567	93568	results	0	None
93568	93569	suggest	0	None
93569	93570	that	0	None
93570	93571	imbalances	0	None
93571	93572	of	0	None
93572	93573	neurotransmission	0	None
93573	93574	in	0	None
93574	93575	the	0	None
93575	93576	IL	0	None
93576	93577	cortex	0	None
93577	93578	may	0	None
93578	93579	cause	0	None
93579	93580	a	0	None
93580	93581	net	0	None
93581	93582	increase	0	None
93582	93583	in	0	None
93583	93584	excitatory	0	None
93584	93585	inputs	0	None
93585	93586	onto	0	None
93586	93587	pyramidal	0	None
93587	93588	neurons	0	None
93588	93589	,	0	None
93589	93590	which	0	None
93590	93591	may	0	None
93591	93592	underlie	0	None
93592	93593	the	0	None
93593	93594	pathogenic	0	None
93594	93595	mechanism	0	None
93595	93596	of	0	None
93596	93597	anxiety	0	None
93597	93598	disorders	0	None
93598	93599	.	0	None
93599	93601	Factor VIII	1	GENE-Y
93601	93602	(	0	None
93602	93603	FVIII	0	None
93603	93604	)	0	None
93604	93605	and	0	None
93605	93606	factor	0	None
93606	93607	V	0	None
93607	93608	(	0	None
93608	93609	FV	0	None
93609	93610	)	0	None
93610	93611	are	0	None
93611	93612	homologous	0	None
93612	93613	coagulation	0	None
93613	93614	cofactors	0	None
93614	93615	sharing	0	None
93615	93616	a	0	None
93616	93617	similar	0	None
93617	93618	domain	0	None
93618	93619	organization	0	None
93619	93620	(	0	None
93620	93621	A1-A2-B-A3-C1-C2	0	None
93621	93622	)	0	None
93622	93623	and	0	None
93623	93624	are	0	None
93624	93625	both	0	None
93625	93626	extensively	0	None
93626	93627	glycosylated	0	None
93627	93628	within	0	None
93628	93629	their	0	None
93629	93630	B-domains	0	None
93630	93631	.	0	None

93632	93633	In	0	None
93633	93634	mammalian	0	None
93634	93635	cell	0	None
93635	93636	expression	0	None
93636	93637	systems	0	None
93637	93638	,	0	None
93638	93639	compared	0	None
93639	93640	with	0	None
93640	93641	FV	0	None
93641	93642	,	0	None
93642	93643	the	0	None
93643	93644	FVIII	0	None
93644	93645	primary	0	None
93645	93646	translation	0	None
93646	93647	product	0	None
93647	93648	is	0	None
93648	93649	inefficiently	0	None
93649	93650	transported	0	None
93650	93651	out	0	None
93651	93652	of	0	None
93652	93653	the	0	None
93653	93654	endoplasmic	0	None
93654	93655	reticulum	0	None
93655	93656	.	0	None

93657	93658	Here	0	None
93658	93659	we	0	None
93659	93660	show	0	None
93660	93661	that	0	None
93661	93662	FVIII	0	None
93662	93663	is	0	None
93663	93664	degraded	0	None
93664	93665	within	0	None
93665	93666	the	0	None
93666	93667	cell	0	None
93667	93668	by	0	None
93668	93669	a	0	None
93669	93670	lactacystin-inhibitable	0	None
93670	93671	pathway	0	None
93671	93672	,	0	None
93672	93673	implicating	0	None
93673	93674	the	0	None
93674	93675	cytosolic	0	None
93675	93676	20	0	None
93676	93677	S	0	None
93677	93678	proteasome	3	GENE-N
93678	93679	machinery	0	None
93679	93680	.	0	None

93681	93682	Protein	0	None
93682	93683	chaperones	0	None
93683	93684	calnexin	0	None
93684	93685	(	0	None
93685	93686	CNX	0	None
93686	93687	)	0	None
93687	93688	and	0	None
93688	93689	calreticulin	0	None
93689	93690	(	0	None
93690	93691	CRT	0	None
93691	93692	)	0	None
93692	93693	preferentially	0	None
93693	93694	interact	0	None
93694	93695	with	0	None
93695	93696	glycoproteins	3	GENE-N
93696	93697	containing	0	None
93697	93698	monoglucosylated	0	None
93698	93699	N-linked	0	None
93699	93700	oligosaccharides	0	None
93700	93701	and	0	None
93701	93702	are	0	None
93702	93703	proposed	0	None
93703	93704	to	0	None
93704	93705	traffic	0	None
93705	93706	proteins	0	None
93706	93707	through	0	None
93707	93708	degradative	0	None
93708	93709	and	0	None
93709	93710	/	0	None
93710	93711	or	0	None
93711	93712	secretory	0	None
93712	93713	pathways	0	None
93713	93714	.	0	None

93715	93716	Utilizing	0	None
93716	93717	co-immunoprecipitation	0	None
93717	93718	assays	0	None
93718	93719	,	0	None
93719	93720	intracellular	0	None
93720	93721	FVIII	0	None
93721	93722	was	0	None
93722	93723	detected	0	None
93723	93724	in	0	None
93724	93725	association	0	None
93725	93726	with	0	None
93726	93727	CNX	0	None
93727	93728	maximally	0	None
93728	93729	within	0	None
93729	93730	30	0	None
93730	93731	min	0	None
93731	93732	to	0	None
93732	93733	1	0	None
93733	93734	h	0	None
93734	93735	following	0	None
93735	93736	synthesis	0	None
93736	93737	,	0	None
93737	93738	whereas	0	None
93738	93739	FV	0	None
93739	93740	could	0	None
93740	93741	not	0	None
93741	93742	be	0	None
93742	93743	detected	0	None
93743	93744	in	0	None
93744	93745	association	0	None
93745	93746	with	0	None
93746	93747	CNX	0	None
93747	93748	.	0	None

93749	93750	In	0	None
93750	93751	contrast	0	None
93751	93752	,	0	None
93752	93753	both	0	None
93753	93754	FVIII	0	None
93754	93755	and	0	None
93755	93756	FV	0	None
93756	93757	displayed	0	None
93757	93758	interaction	0	None
93758	93759	with	0	None
93759	93760	CRT	0	None
93760	93761	during	0	None
93761	93762	transit	0	None
93762	93763	through	0	None
93763	93764	the	0	None
93764	93765	secretory	0	None
93765	93766	pathway	0	None
93766	93767	.	0	None

93768	93769	B-domain	0	None
93769	93770	deleted	0	None
93770	93771	FVIII	0	None
93771	93772	significantly	0	None
93772	93773	reduced	0	None
93773	93774	the	0	None
93774	93775	CNX	0	None
93775	93776	and	0	None
93776	93777	CRT	0	None
93777	93778	interaction	0	None
93778	93779	,	0	None
93779	93780	indicating	0	None
93780	93781	the	0	None
93781	93782	B-domain	0	None
93782	93783	may	0	None
93783	93784	represent	0	None
93784	93785	a	0	None
93785	93786	primary	0	None
93786	93787	CNX	0	None
93787	93788	and	0	None
93788	93789	CRT	0	None
93789	93790	interaction	0	None
93790	93791	site	0	None
93791	93792	.	0	None

93793	93794	In	0	None
93794	93795	the	0	None
93795	93796	presence	0	None
93796	93797	of	0	None
93797	93798	inhibitors	0	None
93798	93799	of	0	None
93799	93800	glucose	0	None
93800	93801	trimming	0	None
93801	93802	,	0	None
93802	93803	the	0	None
93803	93804	interactions	0	None
93804	93805	of	0	None
93805	93806	FVIII	0	None
93806	93807	with	0	None
93807	93808	CNX	0	None
93808	93809	,	0	None
93809	93810	and	0	None
93810	93811	of	0	None
93811	93812	FVIII	0	None
93812	93813	and	0	None
93813	93814	FV	0	None
93814	93815	with	0	None
93815	93816	CRT	0	None
93816	93817	,	0	None
93817	93818	were	0	None
93818	93819	significantly	0	None
93819	93820	reduced	0	None
93820	93821	whereas	0	None
93821	93822	the	0	None
93822	93823	secretion	0	None
93823	93824	of	0	None
93824	93825	FVIII	0	None
93825	93826	,	0	None
93826	93827	and	0	None
93827	93828	not	0	None
93828	93829	FV	0	None
93829	93830	,	0	None
93830	93831	was	0	None
93831	93832	inhibited	0	None
93832	93833	.	0	None

93834	93835	In	0	None
93835	93836	addition	0	None
93836	93837	,	0	None
93837	93838	transfection	0	None
93838	93839	in	0	None
93839	93840	a	0	None
93840	93841	glucosidase	0	None
93841	93842	I-deficient	0	None
93842	93843	Chinese	0	None
93843	93844	hamster	0	None
93844	93845	ovary	0	None
93845	93846	cell	0	None
93846	93847	line	0	None
93847	93848	(	0	None
93848	93849	Lec23	0	None
93849	93850	)	0	None
93850	93851	demonstrated	0	None
93851	93852	that	0	None
93852	93853	both	0	None
93853	93854	degradation	0	None
93854	93855	and	0	None
93855	93856	secretion	0	None
93856	93857	of	0	None
93857	93858	FVIII	0	None
93858	93859	were	0	None
93859	93860	inhibited	0	None
93860	93861	,	0	None
93861	93862	with	0	None
93862	93863	little	0	None
93863	93864	effect	0	None
93864	93865	on	0	None
93865	93866	the	0	None
93866	93867	secretion	0	None
93867	93868	of	0	None
93868	93869	FV	0	None
93869	93870	.	0	None

93871	93872	These	0	None
93872	93873	results	0	None
93873	93874	support	0	None
93874	93875	that	0	None
93875	93876	CNX	0	None
93876	93877	and	0	None
93877	93878	CRT	0	None
93878	93879	binding	0	None
93879	93880	,	0	None
93880	93881	mediated	0	None
93881	93882	at	0	None
93882	93883	least	0	None
93883	93884	in	0	None
93884	93885	part	0	None
93885	93886	by	0	None
93886	93887	the	0	None
93887	93888	B-domain	0	None
93888	93889	of	0	None
93889	93890	FVIII	0	None
93890	93891	,	0	None
93891	93892	is	0	None
93892	93893	required	0	None
93893	93894	for	0	None
93894	93895	efficient	0	None
93895	93896	FVIII	0	None
93896	93897	degradation	0	None
93897	93898	and	0	None
93898	93899	secretion	0	None
93899	93900	.	0	None

93901	93902	In	0	None
93902	93903	contrast	0	None
93903	93904	,	0	None
93904	93905	FV	0	None
93905	93906	does	0	None
93906	93907	not	0	None
93907	93908	require	0	None
93908	93909	CNX	0	None
93909	93910	interaction	0	None
93910	93911	for	0	None
93911	93912	efficient	0	None
93912	93913	secretion	0	None
93913	93914	.	0	None

93915	93916	The	0	None
93916	93917	results	0	None
93917	93918	suggest	0	None
93918	93919	a	0	None
93919	93920	unique	0	None
93920	93921	requirement	0	None
93921	93922	for	0	None
93922	93923	carbohydrate	0	None
93923	93924	processing	0	None
93924	93925	and	0	None
93925	93926	molecular	0	None
93926	93927	chaperone	0	None
93927	93928	interactions	0	None
93928	93929	that	0	None
93929	93930	may	0	None
93930	93931	limit	0	None
93931	93932	the	0	None
93932	93933	productive	0	None
93933	93934	secretion	0	None
93934	93935	of	0	None
93935	93936	FVIII	0	None
93936	93937	.	0	None
93937	93938	Cis-silencing	0	None
93938	93939	of	0	None
93939	93940	PIP5K1B	0	None
93940	93941	evidenced	0	None
93941	93942	in	0	None
93942	93943	Friedreich's	0	None
93943	93944	ataxia	0	None
93944	93945	patient	0	None
93945	93946	cells	0	None
93946	93947	results	0	None
93947	93948	in	0	None
93948	93949	cytoskeleton	0	None
93949	93950	anomalies	0	None
93950	93951	.	0	None
93951	93952	Combined	0	None
93952	93953	targeting	0	None
93953	93954	of	0	None
93954	93955	FGFR2	0	None
93955	93956	and	0	None
93956	93957	mTOR	0	None
93957	93958	by	0	None
93958	93959	ponatinib	2	CHEMICAL
93959	93960	and	0	None
93960	93961	ridaforolimus	0	None
93961	93962	results	0	None
93962	93963	in	0	None
93963	93964	synergistic	0	None
93964	93965	antitumor	0	None
93965	93966	activity	0	None
93966	93967	in	0	None
93967	93968	FGFR2	0	None
93968	93969	mutant	0	None
93969	93970	endometrial	0	None
93970	93971	cancer	0	None
93971	93972	models	0	None
93972	93973	.	0	None
93973	93974	Growth	0	None
93974	93975	factor	0	None
93975	93976	receptor-bound	0	None
93976	93977	protein	0	None
93977	93978	10	0	None
93978	93979	(	0	None
93979	93980	Grb10	0	None
93980	93981	)	0	None
93981	93982	is	0	None
93982	93983	a	0	None
93983	93984	Src	0	None
93984	93985	homology	0	None
93985	93986	2	0	None
93986	93987	(	0	None
93987	93988	SH2	0	None
93988	93989	)	0	None
93989	93990	domain-containing	0	None
93990	93991	protein	0	None
93991	93992	and	0	None
93992	93993	one	0	None
93993	93994	of	0	None
93994	93995	the	0	None
93995	93996	binding	0	None
93996	93997	partners	0	None
93997	93998	for	0	None
93998	93999	several	0	None
93999	94000	trans-membrane	0	None
94000	94001	tyrosine-kinase	0	None
94001	94002	receptors	0	None
94002	94003	,	0	None
94003	94004	including	0	None
94004	94005	insulin	0	None
94005	94006	receptor	0	None
94006	94007	(	0	None
94007	94008	IR	0	None
94008	94009	)	0	None
94009	94010	and	0	None
94010	94011	insulin-like	0	None
94011	94012	growth	0	None
94012	94013	factor-1	0	None
94013	94014	receptor	0	None
94014	94015	(	0	None
94015	94016	IGF1-R	0	None
94016	94017	)	0	None
94017	94018	.	0	None

94019	94020	The	0	None
94020	94021	hippocampus	0	None
94021	94022	,	0	None
94022	94023	which	0	None
94023	94024	is	0	None
94024	94025	critical	0	None
94025	94026	for	0	None
94026	94027	cognitive	0	None
94027	94028	functions	0	None
94028	94029	,	0	None
94029	94030	is	0	None
94030	94031	one	0	None
94031	94032	of	0	None
94032	94033	the	0	None
94033	94034	main	0	None
94034	94035	distribution	0	None
94035	94036	areas	0	None
94036	94037	of	0	None
94037	94038	Grb10	0	None
94038	94039	in	0	None
94039	94040	the	0	None
94040	94041	central	0	None
94041	94042	nervous	0	None
94042	94043	system	0	None
94043	94044	.	0	None

94045	94046	In	0	None
94046	94047	recent	0	None
94047	94048	years	0	None
94048	94049	,	0	None
94049	94050	diabetic	0	None
94050	94051	encephalopathy	0	None
94051	94052	has	0	None
94052	94053	been	0	None
94053	94054	defined	0	None
94054	94055	as	0	None
94055	94056	a	0	None
94056	94057	third	0	None
94057	94058	type	0	None
94058	94059	of	0	None
94059	94060	diabetes	0	None
94060	94061	and	0	None
94061	94062	the	0	None
94062	94063	IGF1-IR	0	None
94063	94064	pathway	0	None
94064	94065	has	0	None
94065	94066	been	0	None
94066	94067	shown	0	None
94067	94068	to	0	None
94068	94069	be	0	None
94069	94070	critical	0	None
94070	94071	for	0	None
94071	94072	the	0	None
94072	94073	neuropathogenic	0	None
94073	94074	process	0	None
94074	94075	of	0	None
94075	94076	cognitive	0	None
94076	94077	disorder	0	None
94077	94078	in	0	None
94078	94079	diabetes	0	None
94079	94080	.	0	None

94081	94082	However	0	None
94082	94083	,	0	None
94083	94084	the	0	None
94084	94085	role	0	None
94085	94086	of	0	None
94086	94087	endogenous	0	None
94087	94088	Grb10	0	None
94088	94089	in	0	None
94089	94090	regulating	0	None
94090	94091	the	0	None
94091	94092	IGF1-IR	0	None
94092	94093	pathway	0	None
94093	94094	and	0	None
94094	94095	neurobehavioral	0	None
94095	94096	changes	0	None
94096	94097	is	0	None
94097	94098	not	0	None
94098	94099	explicit	0	None
94099	94100	.	0	None

94101	94102	The	0	None
94102	94103	objective	0	None
94103	94104	of	0	None
94104	94105	this	0	None
94105	94106	study	0	None
94106	94107	was	0	None
94107	94108	to	0	None
94108	94109	determine	0	None
94109	94110	the	0	None
94110	94111	in	0	None
94111	94112	vivo	0	None
94112	94113	function	0	None
94113	94114	of	0	None
94114	94115	endogenous	0	None
94115	94116	Grb10	0	None
94116	94117	in	0	None
94117	94118	diabetic	0	None
94118	94119	encephalopathy	0	None
94119	94120	and	0	None
94120	94121	the	0	None
94121	94122	underlying	0	None
94122	94123	mechanisms	0	None
94123	94124	.	0	None

94125	94126	Using	0	None
94126	94127	stereotaxic	0	None
94127	94128	surgical	0	None
94128	94129	techniques	0	None
94129	94130	and	0	None
94130	94131	lentiviral	0	None
94131	94132	vectors	0	None
94132	94133	expressing	0	None
94133	94134	specific	0	None
94134	94135	short	0	None
94135	94136	hairpin	0	None
94136	94137	RNA	0	None
94137	94138	(	0	None
94138	94139	shRNA	0	None
94139	94140	)	0	None
94140	94141	,	0	None
94141	94142	we	0	None
94142	94143	could	0	None
94143	94144	steadily	0	None
94144	94145	knock	0	None
94145	94146	down	0	None
94146	94147	Grb10	0	None
94147	94148	expression	0	None
94148	94149	in	0	None
94149	94150	the	0	None
94150	94151	hippocampus	0	None
94151	94152	.	0	None

94153	94154	More	0	None
94154	94155	importantly	0	None
94155	94156	,	0	None
94156	94157	we	0	None
94157	94158	demonstrated	0	None
94158	94159	that	0	None
94159	94160	hippocampus-specific	0	None
94160	94161	modulation	0	None
94161	94162	of	0	None
94162	94163	Grb10	0	None
94163	94164	protein	0	None
94164	94165	levels	0	None
94165	94166	led	0	None
94166	94167	to	0	None
94167	94168	a	0	None
94168	94169	prominent	0	None
94169	94170	remission	0	None
94170	94171	of	0	None
94171	94172	cognitive	0	None
94172	94173	disorder	0	None
94173	94174	,	0	None
94174	94175	including	0	None
94175	94176	improvements	0	None
94176	94177	in	0	None
94177	94178	both	0	None
94178	94179	ultrastructural	0	None
94179	94180	pathology	0	None
94180	94181	and	0	None
94181	94182	abnormal	0	None
94182	94183	neurobehavioural	0	None
94183	94184	changes	0	None
94184	94185	.	0	None

94186	94187	Our	0	None
94187	94188	findings	0	None
94188	94189	indicate	0	None
94189	94190	that	0	None
94190	94191	endogenous	0	None
94191	94192	overexpression	0	None
94192	94193	of	0	None
94193	94194	Grb10	0	None
94194	94195	functions	0	None
94195	94196	as	0	None
94196	94197	a	0	None
94197	94198	suppressor	0	None
94198	94199	of	0	None
94199	94200	the	0	None
94200	94201	IGF1-IR	0	None
94201	94202	pathway	0	None
94202	94203	,	0	None
94203	94204	which	0	None
94204	94205	may	0	None
94205	94206	represent	0	None
94206	94207	an	0	None
94207	94208	important	0	None
94208	94209	mechanism	0	None
94209	94210	that	0	None
94210	94211	regulates	0	None
94211	94212	cognitive	0	None
94212	94213	disorder	0	None
94213	94214	in	0	None
94214	94215	diabetes	0	None
94215	94216	.	0	None

94217	94218	This	0	None
94218	94219	article	0	None
94219	94220	is	0	None
94220	94221	protected	0	None
94221	94222	by	0	None
94222	94223	copyright	0	None
94223	94224	.	0	None

94225	94226	All	0	None
94226	94227	rights	0	None
94227	94228	reserved	0	None
94228	94229	.	0	None
94229	94230	Salidroside	0	None
94230	94231	attenuates	0	None
94231	94232	myocardial	0	None
94232	94233	ischemia-reperfusion	0	None
94233	94234	injury	0	None
94234	94235	via	0	None
94235	94236	PI3K	0	None
94236	94237	/	0	None
94237	94238	Akt	0	None
94238	94239	signaling	0	None
94239	94240	pathway	0	None
94240	94241	.	0	None
94241	94242	Identification	0	None
94242	94243	of	0	None
94243	94244	nuclear	0	None
94244	94245	factor-κB	0	None
94245	94246	sites	0	None
94246	94247	in	0	None
94247	94248	the	0	None
94248	94249	Slc2a4	0	None
94249	94250	gene	0	None
94250	94251	promoter	0	None
94251	94252	.	0	None
94252	94253	Many	0	None
94253	94254	members	0	None
94254	94255	of	0	None
94255	94256	the	0	None
94256	94257	nudix	0	None
94257	94258	hydrolase	0	None
94258	94259	family	0	None
94259	94260	exhibit	0	None
94260	94261	considerable	0	None
94261	94262	substrate	0	None
94262	94263	multispecificity	0	None
94263	94264	and	0	None
94264	94265	ambiguity	0	None
94265	94266	,	0	None
94266	94267	which	0	None
94267	94268	raises	0	None
94268	94269	significant	0	None
94269	94270	issues	0	None
94270	94271	when	0	None
94271	94272	assessing	0	None
94272	94273	their	0	None
94273	94274	functions	0	None
94274	94275	in	0	None
94275	94276	vivo	0	None
94276	94277	and	0	None
94277	94278	gives	0	None
94278	94279	rise	0	None
94279	94280	to	0	None
94280	94281	errors	0	None
94281	94282	in	0	None
94282	94283	database	0	None
94283	94284	annotation	0	None
94284	94285	.	0	None

94286	94287	Several	0	None
94287	94288	display	0	None
94288	94289	low	0	None
94289	94290	antimutator	0	None
94290	94291	activity	0	None
94291	94292	when	0	None
94292	94293	expressed	0	None
94293	94294	in	0	None
94294	94295	bacterial	0	None
94295	94296	tester	0	None
94296	94297	strains	0	None
94297	94298	as	0	None
94298	94299	well	0	None
94299	94300	as	0	None
94300	94301	some	0	None
94301	94302	degree	0	None
94302	94303	of	0	None
94303	94304	activity	0	None
94304	94305	in	0	None
94305	94306	vitro	0	None
94306	94307	towards	0	None
94307	94308	mutagenic	0	None
94308	94309	,	0	None
94309	94310	oxidized	0	None
94310	94311	nucleotides	0	None
94311	94312	such	0	None
94312	94313	as	0	None
94313	94314	8-oxo-dGTP	2	CHEMICAL
94314	94315	.	0	None

94316	94317	However	0	None
94317	94318	,	0	None
94318	94319	many	0	None
94319	94320	of	0	None
94320	94321	these	0	None
94321	94322	show	0	None
94322	94323	greater	0	None
94323	94324	activity	0	None
94324	94325	towards	0	None
94325	94326	other	0	None
94326	94327	nucleotides	0	None
94327	94328	such	0	None
94328	94329	as	0	None
94329	94330	ADP-ribose	0	None
94330	94331	or	0	None
94331	94332	diadenosine	0	None
94332	94333	tetraphosphate	0	None
94333	94334	(	0	None
94334	94335	Ap	0	None
94335	94336	(	0	None
94336	94337	4	0	None
94337	94338	)	0	None
94338	94339	A	0	None
94339	94340	)	0	None
94340	94341	.	0	None

94342	94343	The	0	None
94343	94344	antimutator	0	None
94344	94345	activities	0	None
94345	94346	have	0	None
94346	94347	tended	0	None
94347	94348	to	0	None
94348	94349	gain	0	None
94349	94350	prominence	0	None
94350	94351	in	0	None
94351	94352	the	0	None
94352	94353	literature	0	None
94353	94354	,	0	None
94354	94355	whereas	0	None
94355	94356	they	0	None
94356	94357	may	0	None
94357	94358	in	0	None
94358	94359	fact	0	None
94359	94360	represent	0	None
94360	94361	the	0	None
94361	94362	residual	0	None
94362	94363	activity	0	None
94363	94364	of	0	None
94364	94365	an	0	None
94365	94366	ancestral	0	None
94366	94367	antimutator	0	None
94367	94368	enzyme	0	None
94368	94369	that	0	None
94369	94370	has	0	None
94370	94371	become	0	None
94371	94372	secondary	0	None
94372	94373	to	0	None
94373	94374	the	0	None
94374	94375	more	0	None
94375	94376	recently	0	None
94376	94377	evolved	0	None
94377	94378	major	0	None
94378	94379	activity	0	None
94379	94380	after	0	None
94380	94381	gene	0	None
94381	94382	duplication	0	None
94382	94383	.	0	None

94384	94385	Whether	0	None
94385	94386	any	0	None
94386	94387	meaningful	0	None
94387	94388	antimutagenic	0	None
94388	94389	function	0	None
94389	94390	has	0	None
94390	94391	also	0	None
94391	94392	been	0	None
94392	94393	retained	0	None
94393	94394	in	0	None
94394	94395	vivo	0	None
94395	94396	requires	0	None
94396	94397	very	0	None
94397	94398	careful	0	None
94398	94399	assessment	0	None
94399	94400	.	0	None

94401	94402	Then	0	None
94402	94403	again	0	None
94403	94404	,	0	None
94404	94405	other	0	None
94405	94406	examples	0	None
94406	94407	of	0	None
94407	94408	substrate	0	None
94408	94409	ambiguity	0	None
94409	94410	may	0	None
94410	94411	indicate	0	None
94411	94412	as	0	None
94412	94413	yet	0	None
94413	94414	unexplored	0	None
94414	94415	regulatory	0	None
94415	94416	systems	0	None
94416	94417	.	0	None

94418	94419	For	0	None
94419	94420	example	0	None
94420	94421	,	0	None
94421	94422	bacterial	0	None
94422	94423	Ap	0	None
94423	94424	(	0	None
94424	94425	4	0	None
94425	94426	)	0	None
94426	94427	A	0	None
94427	94428	hydrolases	3	GENE-N
94428	94429	also	0	None
94429	94430	efficiently	0	None
94430	94431	remove	0	None
94431	94432	pyrophosphate	0	None
94432	94433	from	0	None
94433	94434	the	0	None
94434	94435	5'	0	None
94435	94436	termini	0	None
94436	94437	of	0	None
94437	94438	mRNAs	0	None
94438	94439	,	0	None
94439	94440	suggesting	0	None
94440	94441	a	0	None
94441	94442	potential	0	None
94442	94443	role	0	None
94443	94444	for	0	None
94444	94445	Ap	0	None
94445	94446	(	0	None
94446	94447	4	0	None
94447	94448	)	0	None
94448	94449	A	0	None
94449	94450	in	0	None
94450	94451	the	0	None
94451	94452	control	0	None
94452	94453	of	0	None
94453	94454	bacterial	0	None
94454	94455	mRNA	0	None
94455	94456	turnover	0	None
94456	94457	,	0	None
94457	94458	while	0	None
94458	94459	the	0	None
94459	94460	ability	0	None
94460	94461	of	0	None
94461	94462	some	0	None
94462	94463	eukaryotic	0	None
94463	94464	mRNA	0	None
94464	94465	decapping	0	None
94465	94466	enzymes	0	None
94466	94467	to	0	None
94467	94468	degrade	0	None
94468	94469	IDP	0	None
94469	94470	and	0	None
94470	94471	dIDP	0	None
94471	94472	or	0	None
94472	94473	diphosphoinositol	0	None
94473	94474	polyphosphates	0	None
94474	94475	(	0	None
94475	94476	DIPs	0	None
94476	94477	)	0	None
94477	94478	may	0	None
94478	94479	also	0	None
94479	94480	be	0	None
94480	94481	indicative	0	None
94481	94482	of	0	None
94482	94483	new	0	None
94483	94484	regulatory	0	None
94484	94485	networks	0	None
94485	94486	in	0	None
94486	94487	RNA	0	None
94487	94488	metabolism	0	None
94488	94489	.	0	None

94490	94491	DIP	0	None
94491	94492	phosphohydrolases	0	None
94492	94493	also	0	None
94493	94494	degrade	0	None
94494	94495	diadenosine	0	None
94495	94496	polyphosphates	0	None
94496	94497	and	0	None
94497	94498	inorganic	0	None
94498	94499	polyphosphates	0	None
94499	94500	,	0	None
94500	94501	suggesting	0	None
94501	94502	further	0	None
94502	94503	avenues	0	None
94503	94504	for	0	None
94504	94505	investigation	0	None
94505	94506	.	0	None

94507	94508	This	0	None
94508	94509	article	0	None
94509	94510	uses	0	None
94510	94511	these	0	None
94511	94512	and	0	None
94512	94513	other	0	None
94513	94514	examples	0	None
94514	94515	to	0	None
94515	94516	highlight	0	None
94516	94517	the	0	None
94517	94518	need	0	None
94518	94519	for	0	None
94519	94520	a	0	None
94520	94521	greater	0	None
94521	94522	awareness	0	None
94522	94523	of	0	None
94523	94524	the	0	None
94524	94525	possible	0	None
94525	94526	significance	0	None
94526	94527	of	0	None
94527	94528	substrate	0	None
94528	94529	ambiguity	0	None
94529	94530	among	0	None
94530	94531	the	0	None
94531	94532	nudix	0	None
94532	94533	hydrolases	3	GENE-N
94533	94534	as	0	None
94534	94535	well	0	None
94535	94536	as	0	None
94536	94537	the	0	None
94537	94538	need	0	None
94538	94539	to	0	None
94539	94540	exert	0	None
94540	94541	caution	0	None
94541	94542	when	0	None
94542	94543	interpreting	0	None
94543	94544	incomplete	0	None
94544	94545	analyses	0	None
94545	94546	.	0	None
94546	94547	Spatial	0	None
94547	94548	memory	0	None
94548	94549	deficits	0	None
94549	94550	in	0	None
94550	94551	maternal	0	None
94551	94552	iron	0	None
94552	94553	deficiency	0	None
94553	94554	paradigms	0	None
94554	94555	are	0	None
94555	94556	associated	0	None
94556	94557	with	0	None
94557	94558	altered	0	None
94558	94559	glucocorticoid	0	None
94559	94560	levels	0	None
94560	94561	.	0	None
94561	94562	The	0	None
94562	94563	anticholinesterase	0	None
94563	94564	effects	0	None
94564	94565	of	0	None
94565	94566	bis	0	None
94566	94567	(	0	None
94567	94568	7	0	None
94568	94569	)	0	None
94569	94570	-tacrine	0	None
94570	94571	were	0	None
94571	94572	compared	0	None
94572	94573	with	0	None
94573	94574	tacrine	0	None
94574	94575	in	0	None
94575	94576	vitro	0	None
94576	94577	and	0	None
94577	94578	in	0	None
94578	94579	vivo	0	None
94579	94580	.	0	None

94581	94582	Based	0	None
94582	94583	on	0	None
94583	94584	IC50	0	None
94584	94585	ratios	0	None
94585	94586	,	0	None
94586	94587	the	0	None
94587	94588	dimeric	0	None
94588	94589	analog	0	None
94589	94590	bis	0	None
94590	94591	(	0	None
94591	94592	7	0	None
94592	94593	)	0	None
94593	94594	-tacrine	0	None
94594	94595	was	0	None
94595	94596	,	0	None
94596	94597	in	0	None
94597	94598	a	0	None
94598	94599	reversible	0	None
94599	94600	manner	0	None
94600	94601	,	0	None
94601	94602	up	0	None
94602	94603	to	0	None
94603	94604	150-fold	0	None
94604	94605	more	0	None
94605	94606	potent	0	None
94606	94607	and	0	None
94607	94608	250-fold	0	None
94608	94609	more	0	None
94609	94610	selective	0	None
94610	94611	than	0	None
94611	94612	tacrine	0	None
94612	94613	for	0	None
94613	94614	acetylcholinesterase	0	None
94614	94615	(	0	None
94615	94616	AChE	1	GENE-Y
94616	94617	)	0	None
94617	94618	over	0	None
94618	94619	butyrylcholinesterase	0	None
94619	94620	(	0	None
94620	94621	BChE	0	None
94621	94622	)	0	None
94622	94623	.	0	None

94624	94625	Following	0	None
94625	94626	a	0	None
94626	94627	single	0	None
94627	94628	oral	0	None
94628	94629	administration	0	None
94629	94630	,	0	None
94630	94631	both	0	None
94631	94632	bis	0	None
94632	94633	(	0	None
94633	94634	7	0	None
94634	94635	)	0	None
94635	94636	-tacrine	0	None
94636	94637	and	0	None
94637	94638	tacrine	0	None
94638	94639	produced	0	None
94639	94640	dose-dependent	0	None
94640	94641	inhibitions	0	None
94641	94642	of	0	None
94642	94643	AChE	1	GENE-Y
94643	94644	in	0	None
94644	94645	rat	0	None
94645	94646	brain	0	None
94646	94647	,	0	None
94647	94648	but	0	None
94648	94649	bis	0	None
94649	94650	(	0	None
94650	94651	7	0	None
94651	94652	)	0	None
94652	94653	-tacrine	0	None
94653	94654	exhibited	0	None
94654	94655	higher	0	None
94655	94656	efficacy	0	None
94656	94657	and	0	None
94657	94658	AChE	1	GENE-Y
94658	94659	/	0	None
94659	94660	BChE	0	None
94660	94661	selectivity	0	None
94661	94662	than	0	None
94662	94663	tacrine	0	None
94663	94664	.	0	None

94665	94666	The	0	None
94666	94667	anti-AChE	0	None
94667	94668	efficacy	0	None
94668	94669	of	0	None
94669	94670	bis	0	None
94670	94671	(	0	None
94671	94672	7	0	None
94672	94673	)	0	None
94673	94674	-tacrine	0	None
94674	94675	was	0	None
94675	94676	quite	0	None
94676	94677	similar	0	None
94677	94678	following	0	None
94678	94679	an	0	None
94679	94680	oral	0	None
94680	94681	or	0	None
94681	94682	i	0	None
94682	94683	.	0	None

94684	94685	p	0	None
94685	94686	.	0	None

94687	94688	administration	0	None
94688	94689	,	0	None
94689	94690	but	0	None
94690	94691	tacrine	0	None
94691	94692	showed	0	None
94692	94693	much	0	None
94693	94694	lower	0	None
94694	94695	efficacy	0	None
94695	94696	when	0	None
94696	94697	administered	0	None
94697	94698	orally	0	None
94698	94699	than	0	None
94699	94700	when	0	None
94700	94701	given	0	None
94701	94702	i	0	None
94702	94703	.	0	None

94704	94705	p	0	None
94705	94706	.	0	None

94707	94708	These	0	None
94708	94709	findings	0	None
94709	94710	suggest	0	None
94710	94711	bis	0	None
94711	94712	(	0	None
94712	94713	7	0	None
94713	94714	)	0	None
94714	94715	-tacrine	0	None
94715	94716	,	0	None
94716	94717	a	0	None
94717	94718	highly	0	None
94718	94719	potent	0	None
94719	94720	and	0	None
94720	94721	selective	0	None
94721	94722	inhibitor	0	None
94722	94723	of	0	None
94723	94724	AChE	1	GENE-Y
94724	94725	,	0	None
94725	94726	can	0	None
94726	94727	probably	0	None
94727	94728	be	0	None
94728	94729	used	0	None
94729	94730	as	0	None
94730	94731	an	0	None
94731	94732	improved	0	None
94732	94733	drug	0	None
94733	94734	in	0	None
94734	94735	the	0	None
94735	94736	palliative	0	None
94736	94737	treatment	0	None
94737	94738	of	0	None
94738	94739	AD	0	None
94739	94740	.	0	None
94740	94741	A	0	None
94741	94742	comparison	0	None
94742	94743	of	0	None
94743	94744	the	0	None
94744	94745	signalling	0	None
94745	94746	properties	0	None
94746	94747	of	0	None
94747	94748	two	0	None
94748	94749	tyramine	0	None
94749	94750	receptors	0	None
94750	94751	from	0	None
94751	94752	Drosophila	0	None
94752	94753	.	0	None
94753	94754	1	0	None
94754	94755	.	0	None

94756	94757	The	0	None
94757	94758	affinities	0	None
94758	94759	of	0	None
94759	94760	a	0	None
94760	94761	number	0	None
94761	94762	of	0	None
94762	94763	alpha	0	None
94763	94764	1-adrenoceptor	0	None
94764	94765	antagonists	0	None
94765	94766	were	0	None
94766	94767	determined	0	None
94767	94768	by	0	None
94768	94769	displacement	0	None
94769	94770	of	0	None
94770	94771	[	0	None
94771	94772	3H	0	None
94772	94773	]	0	None
94773	94774	-prazosin	0	None
94774	94775	binding	0	None
94775	94776	from	0	None
94776	94777	cloned	0	None
94777	94778	human	0	None
94778	94780	alpha 1A-adrenoceptors	1	GENE-Y
94780	94781	(	0	None
94781	94782	previously	0	None
94782	94783	designated	0	None
94783	94784	cloned	0	None
94784	94785	alpha	0	None
94785	94786	1c	0	None
94786	94787	subtype	0	None
94787	94788	)	0	None
94788	94789	,	0	None
94789	94790	alpha	0	None
94790	94791	1B	0	None
94791	94792	alpha	0	None
94792	94793	1D	0	None
94793	94794	and	0	None
94794	94795	rat	0	None
94795	94796	alpha	0	None
94796	94797	1D-adrenoceptors	0	None
94797	94798	,	0	None
94798	94799	stably	0	None
94799	94800	expressed	0	None
94800	94801	in	0	None
94801	94802	rat-1	0	None
94802	94803	fibroblasts	0	None
94803	94804	.	0	None

94805	94806	Functional	0	None
94806	94807	affinity	0	None
94807	94808	estimates	0	None
94808	94809	for	0	None
94809	94810	these	0	None
94810	94811	compounds	0	None
94811	94812	were	0	None
94812	94813	also	0	None
94813	94814	determined	0	None
94814	94815	from	0	None
94815	94816	noradrenaline-mediated	0	None
94816	94817	contractions	0	None
94817	94818	of	0	None
94818	94819	rat	0	None
94819	94820	aorta	0	None
94820	94821	.	0	None

94822	94823	2	0	None
94823	94824	.	0	None

94825	94827	BMY 7378	2	CHEMICAL
94827	94828	displayed	0	None
94828	94829	high	0	None
94829	94830	affinity	0	None
94830	94831	for	0	None
94831	94832	cloned	0	None
94832	94833	human	0	None
94833	94834	alpha	0	None
94834	94835	1D-adrenoceptors	0	None
94835	94836	(	0	None
94836	94837	pKi	0	None
94837	94838	=	0	None
94838	94839	8	0	None
94839	94840	.	0	None
94840	94841	2	0	None
94841	94842	+	0	None
94842	94843	/	0	None
94843	94844	-	0	None
94844	94845	0	0	None
94845	94846	.	0	None
94846	94847	10	0	None
94847	94848	)	0	None
94848	94849	and	0	None
94849	94850	was	0	None
94850	94851	selective	0	None
94851	94852	over	0	None
94852	94853	alpha	0	None
94853	94854	1A	0	None
94854	94855	(	0	None
94855	94856	pKi	0	None
94856	94857	=	0	None
94857	94858	6	0	None
94858	94859	.	0	None
94859	94860	2	0	None
94860	94861	+	0	None
94861	94862	/	0	None
94862	94863	-	0	None
94863	94864	0	0	None
94864	94865	.	0	None
94865	94866	10	0	None
94866	94867	)	0	None
94867	94868	and	0	None
94868	94869	alpha	0	None
94869	94870	1B	0	None
94870	94871	subtypes	0	None
94871	94872	(	0	None
94872	94873	6	0	None
94873	94874	.	0	None
94874	94875	7	0	None
94875	94876	+	0	None
94876	94877	/	0	None
94877	94878	-	0	None
94878	94879	0	0	None
94879	94880	.	0	None
94880	94881	11	0	None
94881	94882	)	0	None
94882	94883	.	0	None

94884	94885	WB	0	None
94885	94886	4101	0	None
94886	94887	,	0	None
94887	94888	benoxathian	0	None
94888	94889	and	0	None
94889	94890	phentolamine	0	None
94890	94891	displayed	0	None
94891	94892	high	0	None
94892	94893	affinity	0	None
94893	94894	for	0	None
94894	94895	alpha	0	None
94895	94896	1A	0	None
94896	94897	and	0	None
94897	94898	alpha	0	None
94898	94899	1D	0	None
94899	94900	adrenoceptors	3	GENE-N
94900	94901	compared	0	None
94901	94902	to	0	None
94902	94903	the	0	None
94903	94904	alpha	0	None
94904	94905	1B	0	None
94905	94906	subtype	0	None
94906	94907	.	0	None

94908	94909	Spiperone	0	None
94909	94910	displayed	0	None
94910	94911	high	0	None
94911	94912	affinity	0	None
94912	94913	and	0	None
94913	94914	selectivity	0	None
94914	94915	for	0	None
94915	94916	alpha	0	None
94916	94917	1B	0	None
94917	94918	adrenoceptors	3	GENE-N
94918	94919	(	0	None
94919	94920	pKi	0	None
94920	94921	8	0	None
94921	94922	.	0	None
94922	94923	8	0	None
94923	94924	+	0	None
94924	94925	/	0	None
94925	94926	-	0	None
94926	94927	0	0	None
94927	94928	.	0	None
94928	94929	16	0	None
94929	94930	)	0	None
94930	94931	.	0	None

94932	94933	5-Methyl-urapidil	0	None
94933	94934	was	0	None
94934	94935	selective	0	None
94935	94936	for	0	None
94936	94937	cloned	0	None
94937	94938	alpha	0	None
94938	94939	1A	0	None
94939	94940	adrenoceptors	3	GENE-N
94940	94941	.	0	None

94942	94943	3	0	None
94943	94944	.	0	None

94945	94946	Comparative	0	None
94946	94947	binding	0	None
94947	94948	affinities	0	None
94948	94949	(	0	None
94949	94950	pKi	0	None
94950	94951	)	0	None
94951	94952	for	0	None
94952	94953	compounds	0	None
94953	94954	at	0	None
94954	94955	cloned	0	None
94955	94956	human	0	None
94956	94957	and	0	None
94957	94958	rat1D	0	None
94958	94959	adrenoceptors	3	GENE-N
94959	94960	were	0	None
94960	94961	almost	0	None
94961	94962	identical	0	None
94962	94963	(	0	None
94963	94964	r	0	None
94964	94965	=	0	None
94965	94966	0	0	None
94966	94967	.	0	None
94967	94968	99	0	None
94968	94969	,	0	None
94969	94970	slope	0	None
94970	94971	=	0	None
94971	94972	1	0	None
94972	94973	.	0	None
94973	94974	08	0	None
94974	94975	)	0	None
94975	94976	.	0	None

94977	94978	4	0	None
94978	94979	.	0	None

94980	94981	Prazosin	0	None
94981	94982	,	0	None
94982	94983	doxazosin	2	CHEMICAL
94983	94984	and	0	None
94984	94985	5-methyl-urapidil	0	None
94985	94986	were	0	None
94986	94987	potent	0	None
94987	94988	,	0	None
94988	94989	competitive	0	None
94989	94990	antagonists	0	None
94990	94991	of	0	None
94991	94992	noradrenaline-mediated	0	None
94992	94993	contractions	0	None
94993	94994	of	0	None
94994	94995	rat	0	None
94995	94996	aorta	0	None
94996	94997	(	0	None
94997	94998	pA2	0	None
94998	94999	values	0	None
94999	95000	of	0	None
95000	95001	9	0	None
95001	95002	.	0	None
95002	95003	8	0	None
95003	95004	,	0	None
95004	95005	8	0	None
95005	95006	.	0	None
95006	95007	8	0	None
95007	95008	and	0	None
95008	95009	7	0	None
95009	95010	.	0	None
95010	95011	8	0	None
95011	95012	respectively	0	None
95012	95013	)	0	None
95013	95014	.	0	None

95015	95016	The	0	None
95016	95017	selective	0	None
95017	95018	alpha	0	None
95018	95019	1D	0	None
95019	95020	antagonist	0	None
95020	95022	BMY 7378	2	CHEMICAL
95022	95023	was	0	None
95023	95024	also	0	None
95024	95025	a	0	None
95025	95026	potent	0	None
95026	95027	antagonist	0	None
95027	95028	on	0	None
95028	95029	rat	0	None
95029	95030	aorta	0	None
95030	95031	(	0	None
95031	95032	pKB	0	None
95032	95033	=	0	None
95033	95034	8	0	None
95034	95035	.	0	None
95035	95036	3	0	None
95036	95037	+	0	None
95037	95038	/	0	None
95038	95039	-	0	None
95039	95040	0	0	None
95040	95041	.	0	None
95041	95042	1	0	None
95042	95043	)	0	None
95043	95044	but	0	None
95044	95045	the	0	None
95045	95046	interaction	0	None
95046	95047	of	0	None
95047	95048	this	0	None
95048	95049	compound	0	None
95049	95050	was	0	None
95050	95051	not	0	None
95051	95052	consistent	0	None
95052	95053	with	0	None
95053	95054	competitive	0	None
95054	95055	antagonism	0	None
95055	95056	at	0	None
95056	95057	a	0	None
95057	95058	single	0	None
95058	95059	population	0	None
95059	95060	of	0	None
95060	95061	receptors	0	None
95061	95062	.	0	None

95063	95064	5	0	None
95064	95065	.	0	None

95066	95067	Functional	0	None
95067	95068	affinities	0	None
95068	95069	for	0	None
95069	95070	compounds	0	None
95070	95071	determined	0	None
95071	95072	against	0	None
95072	95073	noradrenaline-mediated	0	None
95073	95074	contractions	0	None
95074	95075	of	0	None
95075	95076	rat	0	None
95076	95077	aorta	0	None
95077	95078	correlated	0	None
95078	95079	well	0	None
95079	95080	with	0	None
95080	95081	binding	0	None
95081	95082	affinities	0	None
95082	95083	at	0	None
95083	95084	cloned	0	None
95084	95085	alpha	0	None
95085	95086	1D-adrenoceptors	0	None
95086	95087	(	0	None
95087	95088	r	0	None
95088	95089	=	0	None
95089	95090	0	0	None
95090	95091	.	0	None
95091	95092	96	0	None
95092	95093	)	0	None
95093	95094	,	0	None
95094	95095	but	0	None
95095	95096	not	0	None
95096	95097	with	0	None
95097	95098	alpha	0	None
95098	95099	1A	0	None
95099	95100	(	0	None
95100	95101	r	0	None
95101	95102	=	0	None
95102	95103	0	0	None
95103	95104	.	0	None
95104	95105	61	0	None
95105	95106	)	0	None
95106	95107	or	0	None
95107	95108	alpha	0	None
95108	95109	1B	0	None
95109	95110	(	0	None
95110	95111	r	0	None
95111	95112	=	0	None
95112	95113	0	0	None
95113	95114	.	0	None
95114	95115	46	0	None
95115	95116	)	0	None
95116	95117	subtypes	0	None
95117	95118	.	0	None

95119	95120	6	0	None
95120	95121	.	0	None

95122	95123	Noradrenaline-mediated	0	None
95123	95124	contractions	0	None
95124	95125	of	0	None
95125	95126	rat	0	None
95126	95127	aorta	0	None
95127	95128	were	0	None
95128	95129	sensitive	0	None
95129	95130	to	0	None
95130	95131	the	0	None
95131	95132	alkylating	0	None
95132	95133	effects	0	None
95133	95134	of	0	None
95134	95135	chlorethylclonidine	0	None
95135	95136	(	0	None
95136	95137	CEC	0	None
95137	95138	)	0	None
95138	95139	.	0	None

95140	95141	CEC	0	None
95141	95142	(	0	None
95142	95143	10	0	None
95143	95144	microM	0	None
95144	95145	)	0	None
95145	95146	caused	0	None
95146	95147	a	0	None
95147	95148	small	0	None
95148	95149	rightward	0	None
95149	95150	shift	0	None
95150	95151	in	0	None
95151	95152	the	0	None
95152	95153	noradrenaline	0	None
95153	95154	concentration-response	0	None
95154	95155	curve	0	None
95155	95156	.	0	None

95157	95158	CEC	0	None
95158	95159	at	0	None
95159	95160	100	0	None
95160	95161	microM	0	None
95161	95162	caused	0	None
95162	95163	a	0	None
95163	95164	further	0	None
95164	95165	shift	0	None
95165	95166	and	0	None
95166	95167	suppression	0	None
95167	95168	of	0	None
95168	95169	the	0	None
95169	95170	maximum	0	None
95170	95171	response	0	None
95171	95172	to	0	None
95172	95173	noradrenaline	0	None
95173	95174	.	0	None
95174	95175	7	0	None
95175	95176	.	0	None

95177	95178	The	0	None
95178	95179	results	0	None
95179	95180	of	0	None
95180	95181	this	0	None
95181	95182	study	0	None
95182	95183	suggest	0	None
95183	95184	that	0	None
95184	95185	noradrenaline	0	None
95185	95186	predominantly	0	None
95186	95187	,	0	None
95187	95188	but	0	None
95188	95189	not	0	None
95189	95190	exclusively	0	None
95190	95191	,	0	None
95191	95192	mediates	0	None
95192	95193	contraction	0	None
95193	95194	of	0	None
95194	95195	rat	0	None
95195	95196	aorta	0	None
95196	95197	through	0	None
95197	95198	the	0	None
95198	95199	activation	0	None
95199	95200	of	0	None
95200	95201	an	0	None
95201	95202	alphalD-adrenoceptor	0	None
95202	95203	.	0	None
95203	95204	Thiazolidinediones	0	None
95204	95205	(	0	None
95205	95206	TZDs	0	None
95206	95207	)	0	None
95207	95208	affect	0	None
95208	95209	osteoblast	0	None
95209	95210	viability	0	None
95210	95211	and	0	None
95211	95212	biomarkers	0	None
95212	95213	independently	0	None
95213	95214	of	0	None
95214	95215	the	0	None
95215	95216	TZD	0	None
95216	95217	effects	0	None
95217	95218	on	0	None
95218	95219	aromatase	0	None
95219	95220	.	0	None
95220	95221	Tissue-type	0	None
95221	95222	plasminogen	0	None
95222	95223	activator	0	None
95223	95224	(	0	None
95224	95225	tPA	0	None
95225	95226	)	0	None
95226	95227	,	0	None
95227	95228	a	0	None
95228	95230	serine protease	1	GENE-Y
95230	95231	well	0	None
95231	95232	known	0	None
95232	95233	for	0	None
95233	95234	generating	0	None
95234	95235	plasmin	0	None
95235	95236	,	0	None
95236	95237	has	0	None
95237	95238	been	0	None
95238	95239	demonstrated	0	None
95239	95240	to	0	None
95240	95241	induce	0	None
95241	95243	matrix metalloproteinase-9	1	GENE-Y
95243	95244	(	0	None
95244	95245	MMP-9	0	None
95245	95246	)	0	None
95246	95247	gene	0	None
95247	95248	expression	0	None
95248	95249	and	0	None
95249	95250	protein	0	None
95250	95251	secretion	0	None
95251	95252	in	0	None
95252	95253	renal	0	None
95253	95254	interstitial	0	None
95254	95255	fibroblasts	0	None
95255	95256	.	0	None

95257	95258	However	0	None
95258	95259	,	0	None
95259	95260	exactly	0	None
95260	95261	how	0	None
95261	95262	tPA	0	None
95262	95263	transduces	0	None
95263	95264	its	0	None
95264	95265	signal	0	None
95265	95266	into	0	None
95266	95267	the	0	None
95267	95268	nucleus	0	None
95268	95269	to	0	None
95269	95270	control	0	None
95270	95271	gene	0	None
95271	95272	expression	0	None
95272	95273	is	0	None
95273	95274	unknown	0	None
95274	95275	.	0	None

95276	95277	This	0	None
95277	95278	study	0	None
95278	95279	investigated	0	None
95279	95280	the	0	None
95280	95281	mechanism	0	None
95281	95282	by	0	None
95282	95283	which	0	None
95283	95284	tPA	0	None
95284	95285	induces	0	None
95285	95286	MMP-9	0	None
95286	95287	gene	0	None
95287	95288	expression	0	None
95288	95289	.	0	None

95290	95291	Both	0	None
95291	95292	wild-type	0	None
95292	95293	and	0	None
95293	95294	non-enzymatic	0	None
95294	95295	mutant	0	None
95295	95296	tPA	0	None
95296	95297	were	0	None
95297	95298	found	0	None
95298	95299	to	0	None
95299	95300	induce	0	None
95300	95301	MMP-9	0	None
95301	95302	expression	0	None
95302	95303	in	0	None
95303	95304	rat	0	None
95304	95305	kidney	0	None
95305	95306	interstitial	0	None
95306	95307	fibroblasts	0	None
95307	95308	(	0	None
95308	95309	NRK-49F	0	None
95309	95310	)	0	None
95310	95311	,	0	None
95311	95312	indicating	0	None
95312	95313	that	0	None
95313	95314	the	0	None
95314	95315	actions	0	None
95315	95316	of	0	None
95316	95317	tPA	0	None
95317	95318	are	0	None
95318	95319	independent	0	None
95319	95320	of	0	None
95320	95321	its	0	None
95321	95322	proteolytic	0	None
95322	95323	activity	0	None
95323	95324	.	0	None

95325	95326	tPA	0	None
95326	95327	bound	0	None
95327	95328	to	0	None
95328	95329	the	0	None
95329	95330	low	0	None
95330	95331	density	0	None
95331	95332	lipoprotein	3	GENE-N
95332	95333	receptor-related	0	None
95333	95334	protein-1	0	None
95334	95335	(	0	None
95335	95336	LRP-1	0	None
95336	95337	)	0	None
95337	95338	in	0	None
95338	95339	NRK-49F	0	None
95339	95340	cells	0	None
95340	95341	,	0	None
95341	95342	and	0	None
95342	95343	this	0	None
95343	95344	binding	0	None
95344	95345	was	0	None
95345	95346	competitively	0	None
95346	95347	abrogated	0	None
95347	95348	by	0	None
95348	95349	the	0	None
95349	95350	LRP-1	0	None
95350	95351	antagonist	0	None
95351	95352	,	0	None
95352	95353	the	0	None
95353	95354	receptor-associated	0	None
95354	95355	protein	0	None
95355	95356	.	0	None

95357	95358	In	0	None
95358	95359	mouse	0	None
95359	95360	embryonic	0	None
95360	95361	fibroblasts	0	None
95361	95362	(	0	None
95362	95363	PEA-13	0	None
95363	95364	)	0	None
95364	95365	lacking	0	None
95365	95366	LRP-1	0	None
95366	95367	,	0	None
95367	95368	tPA	0	None
95368	95369	failed	0	None
95369	95370	to	0	None
95370	95371	induce	0	None
95371	95372	MMP-9	0	None
95372	95373	expression	0	None
95373	95374	.	0	None

95375	95376	Furthermore	0	None
95376	95377	,	0	None
95377	95378	tPA	0	None
95378	95379	induced	0	None
95379	95380	rapid	0	None
95380	95381	tyrosine	2	CHEMICAL
95381	95382	phosphorylation	0	None
95382	95383	on	0	None
95383	95384	the	0	None
95384	95385	beta	0	None
95385	95386	subunit	0	None
95386	95387	of	0	None
95387	95388	LRP-1	0	None
95388	95389	,	0	None
95389	95390	which	0	None
95390	95391	was	0	None
95391	95392	followed	0	None
95392	95393	by	0	None
95393	95394	the	0	None
95394	95395	activation	0	None
95395	95396	of	0	None
95396	95397	Mek1	0	None
95397	95398	and	0	None
95398	95399	its	0	None
95399	95400	downstream	0	None
95400	95401	Erk-1	0	None
95401	95402	and	0	None
95402	95403	-2	0	None
95403	95404	.	0	None

95405	95406	Blockade	0	None
95406	95407	of	0	None
95407	95408	Erk-1	0	None
95408	95409	/	0	None
95409	95410	2	0	None
95410	95411	activation	0	None
95411	95412	by	0	None
95412	95413	the	0	None
95413	95414	Mek1	0	None
95414	95415	inhibitor	0	None
95415	95416	abolished	0	None
95416	95417	MMP-9	0	None
95417	95418	induction	0	None
95418	95419	by	0	None
95419	95420	tPA	0	None
95420	95421	in	0	None
95421	95422	NRK-49F	0	None
95422	95423	cells	0	None
95423	95424	.	0	None

95425	95426	Conversely	0	None
95426	95427	,	0	None
95427	95428	overexpression	0	None
95428	95429	of	0	None
95429	95430	constitutively	0	None
95430	95431	activated	0	None
95431	95432	Mek1	0	None
95432	95433	induced	0	None
95433	95434	Erk-1	0	None
95434	95435	/	0	None
95435	95436	2	0	None
95436	95437	phosphorylation	0	None
95437	95438	and	0	None
95438	95439	MMP-9	0	None
95439	95440	expression	0	None
95440	95441	.	0	None

95442	95443	In	0	None
95443	95444	mouse	0	None
95444	95445	obstructed	0	None
95445	95446	kidney	0	None
95446	95447	,	0	None
95447	95448	tPA	0	None
95448	95449	,	0	None
95449	95450	LRP-1	0	None
95450	95451	,	0	None
95451	95452	and	0	None
95452	95453	MMP-9	0	None
95453	95454	were	0	None
95454	95455	concomitantly	0	None
95455	95456	induced	0	None
95456	95457	in	0	None
95457	95458	the	0	None
95458	95459	renal	0	None
95459	95460	interstitium	0	None
95460	95461	.	0	None

95462	95463	Collectively	0	None
95463	95464	,	0	None
95464	95465	these	0	None
95465	95466	results	0	None
95466	95467	suggest	0	None
95467	95468	that	0	None
95468	95469	besides	0	None
95469	95470	its	0	None
95470	95471	classical	0	None
95471	95472	proteolytic	0	None
95472	95473	activity	0	None
95473	95474	,	0	None
95474	95475	tPA	0	None
95475	95476	acts	0	None
95476	95477	as	0	None
95477	95478	a	0	None
95478	95479	cytokine	0	None
95479	95480	that	0	None
95480	95481	binds	0	None
95481	95482	to	0	None
95482	95483	the	0	None
95483	95484	cell	0	None
95484	95485	membrane	0	None
95485	95486	receptor	0	None
95486	95487	LRP-1	0	None
95487	95488	,	0	None
95488	95489	induces	0	None
95489	95490	its	0	None
95490	95491	tyrosine	2	CHEMICAL
95491	95492	phosphorylation	0	None
95492	95493	,	0	None
95493	95494	and	0	None
95494	95495	triggers	0	None
95495	95496	intracellular	0	None
95496	95497	signal	0	None
95497	95498	transduction	0	None
95498	95499	,	0	None
95499	95500	thereby	0	None
95500	95501	inducing	0	None
95501	95502	specific	0	None
95502	95503	gene	0	None
95503	95504	expression	0	None
95504	95505	in	0	None
95505	95506	renal	0	None
95506	95507	interstitial	0	None
95507	95508	fibroblasts	0	None
95508	95509	.	0	None
95509	95510	Tyrosinase	0	None
95510	95511	inhibitors	0	None
95511	95512	from	0	None
95512	95513	Rhododendron	0	None
95513	95514	collettianum	0	None
95514	95515	and	0	None
95515	95516	their	0	None
95516	95517	structure-activity	0	None
95517	95518	relationship	0	None
95518	95519	(	0	None
95519	95520	SAR	0	None
95520	95521	)	0	None
95521	95522	studies	0	None
95522	95523	.	0	None
95523	95524	mTOR	0	None
95524	95525	Regulates	0	None
95525	95526	Nox4-Mediated	0	None
95526	95527	Podocyte	0	None
95527	95528	Depletion	0	None
95528	95529	in	0	None
95529	95530	Diabetic	0	None
95530	95531	Renal	0	None
95531	95532	Injury	0	None
95532	95533	.	0	None
95533	95534	Leydig	0	None
95534	95535	cell	0	None
95535	95536	hyperplasia	0	None
95536	95537	and	0	None
95537	95538	Leydig	0	None
95538	95539	cell	0	None
95539	95540	tumours	0	None
95540	95541	of	0	None
95541	95542	the	0	None
95542	95543	ovary	0	None
95543	95544	are	0	None
95544	95545	rare	0	None
95545	95546	.	0	None

95547	95548	We	0	None
95548	95549	present	0	None
95549	95550	two	0	None
95550	95551	cases	0	None
95551	95552	in	0	None
95552	95553	which	0	None
95553	95554	patients	0	None
95554	95555	had	0	None
95555	95556	increased	0	None
95556	95557	blood	0	None
95557	95558	levels	0	None
95558	95559	of	0	None
95559	95560	testosterone	2	CHEMICAL
95560	95561	and	0	None
95561	95562	frank	0	None
95562	95563	hirsutism	0	None
95563	95564	.	0	None

95565	95566	Imaging	0	None
95566	95567	showed	0	None
95567	95568	minimal	0	None
95568	95569	abnormalities	0	None
95569	95570	.	0	None

95571	95572	After	0	None
95572	95573	adrenal	0	None
95573	95574	disease	0	None
95574	95575	had	0	None
95575	95576	been	0	None
95576	95577	ruled	0	None
95577	95578	out	0	None
95578	95579	,	0	None
95579	95580	they	0	None
95580	95581	underwent	0	None
95581	95582	a	0	None
95582	95583	bilateral	0	None
95583	95584	oophorectomy	0	None
95584	95585	.	0	None

95586	95587	One	0	None
95587	95588	case	0	None
95588	95589	showed	0	None
95589	95590	a	0	None
95590	95591	Leydig	0	None
95591	95592	cell	0	None
95592	95593	hyperplasia	0	None
95593	95594	,	0	None
95594	95595	the	0	None
95595	95596	other	0	None
95596	95597	a	0	None
95597	95598	Leydig	0	None
95598	95599	cell	0	None
95599	95600	tumour	0	None
95600	95601	.	0	None

95602	95603	An	0	None
95603	95604	androgen	0	None
95604	95605	producing	0	None
95605	95606	tumour	0	None
95606	95607	should	0	None
95607	95608	be	0	None
95608	95609	excluded	0	None
95609	95610	in	0	None
95610	95611	every	0	None
95611	95612	woman	0	None
95612	95613	with	0	None
95613	95614	evidence	0	None
95614	95615	of	0	None
95615	95616	hirsutism	0	None
95616	95617	or	0	None
95617	95618	frank	0	None
95618	95619	virilization	0	None
95619	95620	and	0	None
95620	95621	markedly	0	None
95621	95622	elevated	0	None
95622	95623	testosterone	2	CHEMICAL
95623	95624	levels	0	None
95624	95625	.	0	None

95626	95627	Adrenal	0	None
95627	95628	disease	0	None
95628	95629	with	0	None
95629	95630	androgen	0	None
95630	95631	hypersecretion	0	None
95631	95632	can	0	None
95632	95633	be	0	None
95633	95634	suspected	0	None
95634	95635	by	0	None
95635	95636	detailed	0	None
95636	95637	clinical	0	None
95637	95638	,	0	None
95638	95639	laboratory	0	None
95639	95640	and	0	None
95640	95641	radiologic	0	None
95641	95642	imaging	0	None
95642	95643	.	0	None

95644	95645	Although	0	None
95645	95646	DHEAS	2	CHEMICAL
95646	95647	has	0	None
95647	95648	a	0	None
95648	95649	good	0	None
95649	95650	sensitivity	0	None
95650	95651	in	0	None
95651	95652	the	0	None
95652	95653	detection	0	None
95653	95654	of	0	None
95654	95655	adrenal	0	None
95655	95656	origin	0	None
95656	95657	of	0	None
95657	95658	hyperandrogenism	0	None
95658	95659	(	0	None
95659	95660	and	0	None
95660	95661	hence	0	None
95661	95662	a	0	None
95662	95663	good	0	None
95663	95664	negative	0	None
95664	95665	predictive	0	None
95665	95666	value	0	None
95666	95667	)	0	None
95667	95668	it	0	None
95668	95669	is	0	None
95669	95670	not	0	None
95670	95671	specific	0	None
95671	95672	(	0	None
95672	95673	specificity	0	None
95673	95674	ranging	0	None
95674	95675	from	0	None
95675	95676	85	0	None
95676	95677	to	0	None
95677	95678	98%	0	None
95678	95679	)	0	None
95679	95680	.	0	None

95681	95682	Imaging	0	None
95682	95683	of	0	None
95683	95684	the	0	None
95684	95685	ovaries	0	None
95685	95686	can	0	None
95686	95687	be	0	None
95687	95688	helpful	0	None
95688	95689	but	0	None
95689	95690	does	0	None
95690	95691	not	0	None
95691	95692	rule	0	None
95692	95693	out	0	None
95693	95694	ovarian	0	None
95694	95695	disease	0	None
95695	95696	if	0	None
95696	95697	normal	0	None
95697	95698	.	0	None

95699	95700	Indeed	0	None
95700	95701	,	0	None
95701	95702	diffuse	0	None
95702	95703	stromal	0	None
95703	95704	Leydig	0	None
95704	95705	cell	0	None
95705	95706	hyperplasia	0	None
95706	95707	and	0	None
95707	95708	Leydig	0	None
95708	95709	cell	0	None
95709	95710	tumours	0	None
95710	95711	(	0	None
95711	95712	usually	0	None
95712	95713	small	0	None
95713	95714	)	0	None
95714	95715	may	0	None
95715	95716	escape	0	None
95716	95717	imaging	0	None
95717	95718	and	0	None
95718	95719	in	0	None
95719	95720	some	0	None
95720	95721	cases	0	None
95721	95722	diagnosis	0	None
95722	95723	can	0	None
95723	95724	only	0	None
95724	95725	be	0	None
95725	95726	made	0	None
95726	95727	on	0	None
95727	95728	pathology	0	None
95728	95729	.	0	None

95730	95731	As	0	None
95731	95732	these	0	None
95732	95733	clinical	0	None
95733	95734	entities	0	None
95734	95735	represent	0	None
95735	95736	a	0	None
95736	95737	diagnostic	0	None
95737	95738	and	0	None
95738	95739	therapeutic	0	None
95739	95740	challenge	0	None
95740	95741	,	0	None
95741	95742	oophorectomy	0	None
95742	95743	should	0	None
95743	95744	be	0	None
95744	95745	considered	0	None
95745	95746	in	0	None
95746	95747	postmenopausal	0	None
95747	95748	women	0	None
95748	95749	with	0	None
95749	95750	hirsutism	0	None
95750	95751	and	0	None
95751	95752	elevated	0	None
95752	95753	testosterone	2	CHEMICAL
95753	95754	levels	0	None
95754	95755	,	0	None
95755	95756	after	0	None
95756	95757	the	0	None
95757	95758	exclusion	0	None
95758	95759	of	0	None
95759	95760	adrenal	0	None
95760	95761	causes	0	None
95761	95762	.	0	None

95763	95764	The	0	None
95764	95765	procedure	0	None
95765	95766	is	0	None
95766	95767	relatively	0	None
95767	95768	safe	0	None
95768	95769	and	0	None
95769	95770	effective	0	None
95770	95771	.	0	None

95772	95773	Follow-up	0	None
95773	95774	remains	0	None
95774	95775	indicated	0	None
95775	95776	.	0	None
95776	95777	Components	0	None
95777	95778	of	0	None
95778	95779	the	0	None
95779	95780	Interleukin-6	0	None
95780	95781	transsignalling	0	None
95781	95782	system	0	None
95782	95783	are	0	None
95783	95784	associated	0	None
95784	95785	with	0	None
95785	95786	the	0	None
95786	95787	metabolic	0	None
95787	95788	syndrome	0	None
95788	95789	,	0	None
95789	95790	endothelial	0	None
95790	95791	dysfunction	0	None
95791	95792	and	0	None
95792	95793	arterial	0	None
95793	95794	stiffness	0	None
95794	95795	.	0	None
95795	95796	Pharmacological	0	None
95796	95797	therapy	0	None
95797	95798	of	0	None
95798	95799	Cushing's	0	None
95799	95800	syndrome	0	None
95800	95801	:	0	None
95801	95802	drugs	0	None
95802	95803	and	0	None
95803	95804	indications	0	None
95804	95805	.	0	None
95805	95806	Mutations	0	None
95806	95807	in	0	None
95807	95808	the	0	None
95808	95809	alanine-glyoxylate	0	None
95809	95811	amino transferase	1	GENE-Y
95811	95812	gene	0	None
95812	95813	(	0	None
95813	95814	AGXT	0	None
95814	95815	)	0	None
95815	95816	are	0	None
95816	95817	responsible	0	None
95817	95818	for	0	None
95818	95819	primary	0	None
95819	95820	hyperoxaluria	0	None
95820	95821	type	0	None
95821	95822	I	0	None
95822	95823	,	0	None
95823	95824	a	0	None
95824	95825	rare	0	None
95825	95826	disease	0	None
95826	95827	characterized	0	None
95827	95828	by	0	None
95828	95829	excessive	0	None
95829	95830	hepatic	0	None
95830	95831	oxalate	2	CHEMICAL
95831	95832	production	0	None
95832	95833	that	0	None
95833	95834	leads	0	None
95834	95835	to	0	None
95835	95836	renal	0	None
95836	95837	failure	0	None
95837	95838	.	0	None

95839	95840	We	0	None
95840	95841	generated	0	None
95841	95842	a	0	None
95842	95843	null	0	None
95843	95844	mutant	0	None
95844	95845	mouse	0	None
95845	95846	by	0	None
95846	95847	targeted	0	None
95847	95848	mutagenesis	0	None
95848	95849	of	0	None
95849	95850	the	0	None
95850	95851	homologous	0	None
95851	95852	gene	0	None
95852	95853	,	0	None
95853	95854	Agxt	0	None
95854	95855	,	0	None
95855	95856	in	0	None
95856	95857	embryonic	0	None
95857	95858	stem	0	None
95858	95859	cells	0	None
95859	95860	.	0	None

95861	95862	Mutant	0	None
95862	95863	mice	0	None
95863	95864	developed	0	None
95864	95865	normally	0	None
95865	95866	,	0	None
95866	95867	and	0	None
95867	95868	they	0	None
95868	95869	exhibited	0	None
95869	95870	hyperoxaluria	0	None
95870	95871	and	0	None
95871	95872	crystalluria	0	None
95872	95873	.	0	None

95874	95875	Approximately	0	None
95875	95876	half	0	None
95876	95877	of	0	None
95877	95878	the	0	None
95878	95879	male	0	None
95879	95880	mice	0	None
95880	95881	in	0	None
95881	95882	mixed	0	None
95882	95883	genetic	0	None
95883	95884	background	0	None
95884	95885	developed	0	None
95885	95886	calcium	0	None
95886	95887	oxalate	2	CHEMICAL
95887	95888	urinary	0	None
95888	95889	stones	0	None
95889	95890	.	0	None

95891	95892	Severe	0	None
95892	95893	nephrocalcinosis	0	None
95893	95894	and	0	None
95894	95895	renal	0	None
95895	95896	failure	0	None
95896	95897	developed	0	None
95897	95898	after	0	None
95898	95899	enhancement	0	None
95899	95900	of	0	None
95900	95901	oxalate	2	CHEMICAL
95901	95902	production	0	None
95902	95903	by	0	None
95903	95905	ethylene glycol	2	CHEMICAL
95905	95906	administration	0	None
95906	95907	.	0	None

95908	95909	Hepatic	0	None
95909	95910	expression	0	None
95910	95911	of	0	None
95911	95912	human	0	None
95912	95913	AGT1	0	None
95913	95914	,	0	None
95914	95915	the	0	None
95915	95916	protein	0	None
95916	95917	encoded	0	None
95917	95918	by	0	None
95918	95919	AGXT	0	None
95919	95920	,	0	None
95920	95921	by	0	None
95921	95922	adenoviral	0	None
95922	95923	vector-mediated	0	None
95923	95924	gene	0	None
95924	95925	transfer	0	None
95925	95926	in	0	None
95926	95927	Agxt	0	None
95927	95928	(	0	None
95928	95929	-	0	None
95929	95930	/	0	None
95930	95931	-	0	None
95931	95932	)	0	None
95932	95933	mice	0	None
95933	95934	normalized	0	None
95934	95935	urinary	0	None
95935	95936	oxalate	2	CHEMICAL
95936	95937	excretion	0	None
95937	95938	and	0	None
95938	95939	prevented	0	None
95939	95940	oxalate	2	CHEMICAL
95940	95941	crystalluria	0	None
95941	95942	.	0	None

95943	95944	Subcellular	0	None
95944	95945	fractionation	0	None
95945	95946	and	0	None
95946	95947	immunofluorescence	0	None
95947	95948	studies	0	None
95948	95949	revealed	0	None
95949	95950	that	0	None
95950	95951	,	0	None
95951	95952	as	0	None
95952	95953	in	0	None
95953	95954	the	0	None
95954	95955	human	0	None
95955	95956	liver	0	None
95956	95957	,	0	None
95957	95958	the	0	None
95958	95959	expressed	0	None
95959	95960	wild-type	0	None
95960	95961	human	0	None
95961	95962	AGT1	0	None
95962	95963	was	0	None
95963	95964	predominantly	0	None
95964	95965	localized	0	None
95965	95966	in	0	None
95966	95967	mouse	0	None
95967	95968	hepatocellular	0	None
95968	95969	peroxisomes	0	None
95969	95970	,	0	None
95970	95971	whereas	0	None
95971	95972	the	0	None
95972	95973	most	0	None
95973	95974	common	0	None
95974	95975	mutant	0	None
95975	95976	form	0	None
95976	95977	of	0	None
95977	95978	AGT1	0	None
95978	95979	(	0	None
95979	95980	G170R	0	None
95980	95981	)	0	None
95981	95982	was	0	None
95982	95983	localized	0	None
95983	95984	predominantly	0	None
95984	95985	in	0	None
95985	95986	the	0	None
95986	95987	mitochondria	0	None
95987	95988	.	0	None
95988	95989	Due	0	None
95989	95990	to	0	None
95990	95991	its	0	None
95991	95992	production	0	None
95992	95993	of	0	None
95993	95994	potent	0	None
95994	95995	antimicrobial	0	None
95995	95996	oxidants	0	None
95996	95997	including	0	None
95997	95998	hypochlorous	0	None
95998	95999	acid	0	None
95999	96000	,	0	None
96000	96001	human	0	None
96001	96002	myeloperoxidase	0	None
96002	96003	(	0	None
96003	96004	MPO	0	None
96004	96005	)	0	None
96005	96006	plays	0	None
96006	96007	a	0	None
96007	96008	critical	0	None
96008	96009	role	0	None
96009	96010	in	0	None
96010	96011	innate	0	None
96011	96012	immunity	0	None
96012	96013	and	0	None
96013	96014	inflammatory	0	None
96014	96015	diseases	0	None
96015	96016	.	0	None

96017	96018	Thus	0	None
96018	96019	MPO	0	None
96019	96020	is	0	None
96020	96021	an	0	None
96021	96022	attractive	0	None
96022	96023	target	0	None
96023	96024	in	0	None
96024	96025	drug	0	None
96025	96026	design	0	None
96026	96027	.	0	None

96028	96029	(	0	None
96029	96030	Aminoalkyl	0	None
96030	96031	)	0	None
96031	96032	fluoroindole	0	None
96032	96033	derivatives	0	None
96033	96034	were	0	None
96034	96035	detected	0	None
96035	96036	to	0	None
96036	96037	be	0	None
96037	96038	very	0	None
96038	96039	potent	0	None
96039	96040	MPO	0	None
96040	96041	inhibitors;	0	None
96041	96042	however	0	None
96042	96043	,	0	None
96043	96044	they	0	None
96044	96045	also	0	None
96045	96046	promote	0	None
96046	96047	inhibition	0	None
96047	96048	of	0	None
96048	96049	the	0	None
96049	96052	serotonin reuptake transporter	1	GENE-Y
96052	96053	(	0	None
96053	96054	SERT	0	None
96054	96055	)	0	None
96055	96056	at	0	None
96056	96057	the	0	None
96057	96058	same	0	None
96058	96059	concentration	0	None
96059	96060	range	0	None
96060	96061	.	0	None

96062	96063	Via	0	None
96063	96064	structure-based	0	None
96064	96065	drug	0	None
96065	96066	design	0	None
96066	96067	,	0	None
96067	96068	a	0	None
96068	96069	new	0	None
96069	96070	series	0	None
96070	96071	of	0	None
96071	96072	MPO	0	None
96072	96073	inhibitors	0	None
96073	96074	derived	0	None
96074	96075	from	0	None
96075	96076	3-alkylindole	0	None
96076	96077	were	0	None
96077	96078	synthesized	0	None
96078	96079	and	0	None
96079	96080	their	0	None
96080	96081	effects	0	None
96081	96082	were	0	None
96082	96083	assessed	0	None
96083	96084	on	0	None
96084	96085	MPO-mediated	0	None
96085	96086	taurine	0	None
96086	96087	chlorination	0	None
96087	96088	and	0	None
96088	96089	low-density	0	None
96089	96090	lipoprotein	3	GENE-N
96090	96091	oxidation	0	None
96091	96092	as	0	None
96092	96093	well	0	None
96093	96094	as	0	None
96094	96095	on	0	None
96095	96096	inhibition	0	None
96096	96097	of	0	None
96097	96098	SERT	0	None
96098	96099	.	0	None

96100	96101	The	0	None
96101	96102	fluoroindole	0	None
96102	96103	compound	0	None
96103	96104	with	0	None
96104	96105	three	0	None
96105	96106	carbons	0	None
96106	96107	in	0	None
96107	96108	the	0	None
96108	96109	side	0	None
96109	96110	chain	0	None
96110	96111	and	0	None
96111	96112	one	0	None
96112	96113	amide	2	CHEMICAL
96113	96114	group	0	None
96114	96115	exhibited	0	None
96115	96116	a	0	None
96116	96117	selectivity	0	None
96117	96118	index	0	None
96118	96119	of	0	None
96119	96120	35	0	None
96120	96121	(	0	None
96121	96122	Ki	0	None
96122	96123	/	0	None
96123	96124	IC50	0	None
96124	96125	)	0	None
96125	96126	with	0	None
96126	96127	high	0	None
96127	96128	inhibition	0	None
96128	96129	of	0	None
96129	96130	MPO	0	None
96130	96131	activity	0	None
96131	96132	(	0	None
96132	96133	IC50	0	None
96133	96134	=	0	None
96134	96135	18	0	None
96135	96136	nM	0	None
96136	96137	)	0	None
96137	96138	,	0	None
96138	96139	whereas	0	None
96139	96140	its	0	None
96140	96141	effect	0	None
96141	96142	on	0	None
96142	96143	SERT	0	None
96143	96144	was	0	None
96144	96145	in	0	None
96145	96146	the	0	None
96146	96147	micromolar	0	None
96147	96148	range	0	None
96148	96149	.	0	None

96150	96151	Structure-function	0	None
96151	96152	relationships	0	None
96152	96153	,	0	None
96153	96154	mechanism	0	None
96154	96155	of	0	None
96155	96156	action	0	None
96156	96157	,	0	None
96157	96158	and	0	None
96158	96159	safety	0	None
96159	96160	of	0	None
96160	96161	the	0	None
96161	96162	molecule	0	None
96162	96163	are	0	None
96163	96164	discussed	0	None
96164	96165	.	0	None
96165	96166	X-chromosomal	0	None
96166	96167	dystonia	0	None
96167	96168	parkinsonism	0	None
96168	96169	syndrome	0	None
96169	96170	(	0	None
96170	96171	XDP	0	None
96171	96172	,	0	None
96172	96173	'lubag'	0	None
96173	96174	)	0	None
96174	96175	is	0	None
96175	96176	associated	0	None
96176	96177	with	0	None
96177	96178	sequence	0	None
96178	96179	changes	0	None
96179	96180	within	0	None
96180	96181	the	0	None
96181	96182	TAF1	0	None
96182	96183	/	0	None
96183	96184	DYT3	0	None
96184	96185	multiple	0	None
96185	96186	transcript	0	None
96186	96187	system	0	None
96187	96188	.	0	None

96189	96190	Although	0	None
96190	96191	most	0	None
96191	96192	sequence	0	None
96192	96193	changes	0	None
96193	96194	are	0	None
96194	96195	intronic	0	None
96195	96196	,	0	None
96196	96197	one	0	None
96197	96198	,	0	None
96198	96199	disease-specific	0	None
96199	96200	single-nucleotide	0	None
96200	96201	change	0	None
96201	96202	3	0	None
96202	96203	(	0	None
96203	96204	DSC3	0	None
96204	96205	)	0	None
96205	96206	,	0	None
96206	96207	is	0	None
96207	96208	located	0	None
96208	96209	within	0	None
96209	96210	an	0	None
96210	96211	exon	0	None
96211	96212	(	0	None
96212	96213	d4	1	GENE-Y
96213	96214	)	0	None
96214	96215	.	0	None

96216	96217	Transcribed	0	None
96217	96218	exon	0	None
96218	96219	d4	1	GENE-Y
96219	96220	occurs	0	None
96220	96221	as	0	None
96221	96222	part	0	None
96222	96223	of	0	None
96223	96224	multiple	0	None
96224	96225	splice	0	None
96225	96226	variants	0	None
96226	96227	.	0	None

96228	96229	These	0	None
96229	96230	variants	0	None
96230	96231	include	0	None
96231	96232	exons	0	None
96232	96233	d3	0	None
96233	96234	and	0	None
96234	96235	d4	1	GENE-Y
96235	96236	spliced	0	None
96236	96237	to	0	None
96237	96238	exons	0	None
96238	96239	of	0	None
96239	96240	TAF1	0	None
96240	96241	,	0	None
96241	96242	and	0	None
96242	96243	an	0	None
96243	96244	independent	0	None
96244	96245	transcript	0	None
96245	96246	composed	0	None
96246	96247	of	0	None
96247	96248	exons	0	None
96248	96249	d2-d4	0	None
96249	96250	.	0	None

96251	96252	Location	0	None
96252	96253	of	0	None
96253	96254	DSC3	0	None
96254	96255	in	0	None
96255	96256	exon	0	None
96256	96257	d4	1	GENE-Y
96257	96258	and	0	None
96258	96259	utilization	0	None
96259	96260	of	0	None
96260	96261	this	0	None
96261	96262	exon	0	None
96262	96263	in	0	None
96263	96264	multiple	0	None
96264	96265	splice	0	None
96265	96266	variants	0	None
96266	96267	suggest	0	None
96267	96268	an	0	None
96268	96269	important	0	None
96269	96270	role	0	None
96270	96271	of	0	None
96271	96272	DSC3	0	None
96272	96273	in	0	None
96273	96274	the	0	None
96274	96275	XDP	0	None
96275	96276	pathogenesis	0	None
96276	96277	.	0	None

96278	96279	To	0	None
96279	96280	test	0	None
96280	96281	this	0	None
96281	96282	hypothesis	0	None
96282	96283	,	0	None
96283	96284	we	0	None
96284	96285	transfected	0	None
96285	96286	neuroblastoma	0	None
96286	96287	cells	0	None
96287	96288	with	0	None
96288	96289	four	0	None
96289	96290	expression	0	None
96290	96291	constructs	0	None
96291	96292	,	0	None
96292	96293	including	0	None
96293	96294	exons	0	None
96294	96295	d2-d4	0	None
96295	96296	[	0	None
96296	96297	d2-d4	0	None
96297	96298	/	0	None
96298	96299	wild-type	0	None
96299	96300	(	0	None
96300	96301	wt	0	None
96301	96302	)	0	None
96302	96303	and	0	None
96303	96304	d2-d4	0	None
96304	96305	/	0	None
96305	96306	DSC3	0	None
96306	96307	]	0	None
96307	96308	and	0	None
96308	96309	d3-d4	0	None
96309	96310	(	0	None
96310	96311	d3-d4	0	None
96311	96312	/	0	None
96312	96313	wt	0	None
96313	96314	and	0	None
96314	96315	d3-d4	0	None
96315	96316	/	0	None
96316	96317	DSC3	0	None
96317	96318	)	0	None
96318	96319	.	0	None

96320	96321	Expression	0	None
96321	96322	profiling	0	None
96322	96323	revealed	0	None
96323	96324	a	0	None
96324	96325	dramatic	0	None
96325	96326	effect	0	None
96326	96327	of	0	None
96327	96328	DSC3	0	None
96328	96329	on	0	None
96329	96330	overall	0	None
96330	96331	gene	0	None
96331	96332	expression	0	None
96332	96333	.	0	None

96334	96335	Three	0	None
96335	96336	hundred	0	None
96336	96337	and	0	None
96337	96338	sixty-two	0	None
96338	96339	genes	0	None
96339	96340	differed	0	None
96340	96341	between	0	None
96341	96342	cells	0	None
96342	96343	containing	0	None
96343	96344	d2-d4	0	None
96344	96345	/	0	None
96345	96346	wt	0	None
96346	96347	and	0	None
96347	96348	d2-d4	0	None
96348	96349	/	0	None
96349	96350	DSC3	0	None
96350	96351	.	0	None

96352	96353	Annotation	0	None
96353	96354	clustering	0	None
96354	96355	revealed	0	None
96355	96356	enrichment	0	None
96356	96357	of	0	None
96357	96358	genes	0	None
96358	96359	related	0	None
96359	96360	to	0	None
96360	96361	vesicular	0	None
96361	96362	transport	0	None
96362	96363	,	0	None
96363	96364	dopamine	0	None
96364	96365	metabolism	0	None
96365	96366	,	0	None
96366	96367	synapse	0	None
96367	96368	function	0	None
96368	96369	,	0	None
96369	96370	Ca	0	None
96370	96371	(	0	None
96371	96372	2	0	None
96372	96373	+	0	None
96373	96374	)	0	None
96374	96375	metabolism	0	None
96375	96376	and	0	None
96376	96377	oxidative	0	None
96377	96378	stress	0	None
96378	96379	.	0	None

96380	96381	Two	0	None
96381	96382	hundred	0	None
96382	96383	and	0	None
96383	96384	eleven	0	None
96384	96385	genes	0	None
96385	96386	were	0	None
96386	96387	differentially	0	None
96387	96388	expressed	0	None
96388	96389	in	0	None
96389	96390	d3-d4	0	None
96390	96391	/	0	None
96391	96392	wt	0	None
96392	96393	versus	0	None
96393	96394	d3-d4	0	None
96394	96395	/	0	None
96395	96396	DSC3	0	None
96396	96397	.	0	None

96398	96399	Annotation	0	None
96399	96400	clustering	0	None
96400	96401	highlighted	0	None
96401	96402	genes	0	None
96402	96403	in	0	None
96403	96404	signal	0	None
96404	96405	transduction	0	None
96405	96406	and	0	None
96406	96407	cell-cell	0	None
96407	96408	interaction	0	None
96408	96409	.	0	None

96410	96411	The	0	None
96411	96412	data	0	None
96412	96413	show	0	None
96413	96414	an	0	None
96414	96415	important	0	None
96415	96416	role	0	None
96416	96417	of	0	None
96417	96418	physiologically	0	None
96418	96419	occurring	0	None
96419	96420	transcript	0	None
96420	96421	d2-d4	0	None
96421	96422	in	0	None
96422	96423	normal	0	None
96423	96424	brain	0	None
96424	96425	function	0	None
96425	96426	.	0	None

96427	96428	Interference	0	None
96428	96429	with	0	None
96429	96430	this	0	None
96430	96431	role	0	None
96431	96432	by	0	None
96432	96433	DSC3	0	None
96433	96434	is	0	None
96434	96435	a	0	None
96435	96436	likely	0	None
96436	96437	pathological	0	None
96437	96438	mechanism	0	None
96438	96439	in	0	None
96439	96440	XDP	0	None
96440	96441	.	0	None

96442	96443	Disturbance	0	None
96443	96444	of	0	None
96444	96445	dopamine	0	None
96445	96446	function	0	None
96446	96447	and	0	None
96447	96448	of	0	None
96448	96449	Ca	0	None
96449	96450	(	0	None
96450	96451	2	0	None
96451	96452	+	0	None
96452	96453	)	0	None
96453	96454	metabolism	0	None
96454	96455	can	0	None
96455	96456	explain	0	None
96456	96457	abnormal	0	None
96457	96458	movement;	0	None
96458	96459	loss	0	None
96459	96460	of	0	None
96460	96461	protection	0	None
96461	96462	against	0	None
96462	96463	reactive	0	None
96463	96464	oxygen	0	None
96464	96465	species	0	None
96465	96466	may	0	None
96466	96467	account	0	None
96467	96468	for	0	None
96468	96469	the	0	None
96469	96470	neurodegenerative	0	None
96470	96471	changes	0	None
96471	96472	in	0	None
96472	96473	XDP	0	None
96473	96474	.	0	None

96475	96476	Although	0	None
96476	96477	d3-d4	0	None
96477	96478	also	0	None
96478	96479	affect	0	None
96479	96480	genes	0	None
96480	96481	potentially	0	None
96481	96482	related	0	None
96482	96483	to	0	None
96483	96484	neurodegenerative	0	None
96484	96485	processes	0	None
96485	96486	,	0	None
96486	96487	their	0	None
96487	96488	physiologic	0	None
96488	96489	role	0	None
96489	96490	as	0	None
96490	96491	splice	0	None
96491	96492	variants	0	None
96492	96493	of	0	None
96493	96494	TAF1	0	None
96494	96495	awaits	0	None
96495	96496	further	0	None
96496	96497	exploration	0	None
96497	96498	.	0	None
96498	96499	Hypoxia-response	0	None
96499	96500	element	0	None
96500	96501	(	0	None
96501	96502	HRE	0	None
96502	96503	)	0	None
96503	96504	-directed	0	None
96504	96505	transcriptional	0	None
96505	96506	regulation	0	None
96506	96507	of	0	None
96507	96508	the	0	None
96508	96509	rat	0	None
96509	96511	lysyl oxidase	3	GENE-N
96511	96512	gene	0	None
96512	96513	in	0	None
96513	96514	response	0	None
96514	96515	to	0	None
96515	96516	cobalt	0	None
96516	96517	and	0	None
96517	96518	cadmium	2	CHEMICAL
96518	96519	.	0	None
96519	96520	Lead	0	None
96520	96521	is	0	None
96521	96522	a	0	None
96522	96523	heavy	0	None
96523	96524	metal	0	None
96524	96525	widely	0	None
96525	96526	distributed	0	None
96526	96527	in	0	None
96527	96528	the	0	None
96528	96529	environment	0	None
96529	96530	.	0	None

96531	96532	Lead	0	None
96532	96533	is	0	None
96533	96534	a	0	None
96534	96535	ubiquitous	0	None
96535	96536	environmental	0	None
96536	96537	toxin	0	None
96537	96538	that	0	None
96538	96539	is	0	None
96539	96540	capable	0	None
96540	96541	of	0	None
96541	96542	causing	0	None
96542	96543	numerous	0	None
96543	96544	acute	0	None
96544	96545	and	0	None
96545	96546	chronic	0	None
96546	96547	illnesses	0	None
96547	96548	.	0	None

96549	96550	Human	0	None
96550	96551	and	0	None
96551	96552	animal	0	None
96552	96553	exposure	0	None
96553	96554	demonstrates	0	None
96554	96555	that	0	None
96555	96556	lead	0	None
96556	96557	is	0	None
96557	96558	nephrotoxic	0	None
96558	96559	.	0	None

96560	96561	However	0	None
96561	96562	,	0	None
96562	96563	attempts	0	None
96563	96564	to	0	None
96564	96565	reduce	0	None
96565	96566	lead-induced	0	None
96566	96567	nephrotoxicity	0	None
96567	96568	were	0	None
96568	96569	not	0	None
96569	96570	found	0	None
96570	96571	suitable	0	None
96571	96572	for	0	None
96572	96573	clinical	0	None
96573	96574	use	0	None
96574	96575	.	0	None

96576	96577	Recently	0	None
96577	96578	,	0	None
96578	96579	flaxseed	0	None
96579	96580	oil	0	None
96580	96581	(	0	None
96581	96582	FXO	0	None
96582	96583	)	0	None
96583	96584	,	0	None
96584	96585	a	0	None
96585	96586	rich	0	None
96586	96587	source	0	None
96587	96588	of	0	None
96588	96589	ω-3	0	None
96589	96591	fatty acids	2	CHEMICAL
96591	96592	and	0	None
96592	96593	lignans	0	None
96593	96594	,	0	None
96594	96595	has	0	None
96595	96596	been	0	None
96596	96597	shown	0	None
96597	96598	to	0	None
96598	96599	prevent	0	None
96599	96600	/	0	None
96600	96601	reduce	0	None
96601	96602	the	0	None
96602	96603	progression	0	None
96603	96604	of	0	None
96604	96605	certain	0	None
96605	96606	types	0	None
96606	96607	of	0	None
96607	96608	cardiovascular	0	None
96608	96609	and	0	None
96609	96610	renal	0	None
96610	96611	disorders	0	None
96611	96612	.	0	None

96613	96614	In	0	None
96614	96615	view	0	None
96615	96616	of	0	None
96616	96617	this	0	None
96617	96618	,	0	None
96618	96619	the	0	None
96619	96620	present	0	None
96620	96621	study	0	None
96621	96622	investigates	0	None
96622	96623	the	0	None
96623	96624	protective	0	None
96624	96625	effect	0	None
96625	96626	of	0	None
96626	96627	FXO	0	None
96627	96628	on	0	None
96628	96629	lead	0	None
96629	96630	acetate	0	None
96630	96631	(	0	None
96631	96632	PbAc	0	None
96632	96633	)	0	None
96633	96634	-induced	0	None
96634	96635	renal	0	None
96635	96636	damage	0	None
96636	96637	.	0	None

96638	96639	Rats	0	None
96639	96640	were	0	None
96640	96641	pre-fed	0	None
96641	96642	normal	0	None
96642	96643	diet	0	None
96643	96644	and	0	None
96644	96645	the	0	None
96645	96646	diet	0	None
96646	96647	rich	0	None
96647	96648	in	0	None
96648	96649	FXO	0	None
96649	96650	for	0	None
96650	96651	14	0	None
96651	96652	days	0	None
96652	96653	,	0	None
96653	96654	and	0	None
96654	96655	then	0	None
96655	96656	,	0	None
96656	96657	four	0	None
96657	96658	doses	0	None
96658	96659	of	0	None
96659	96660	lead	0	None
96660	96661	acetate	0	None
96661	96662	(	0	None
96662	96663	25	0	None
96663	96664	mg	2	CHEMICAL
96664	96665	/	0	None
96665	96666	kg	0	None
96666	96667	body	0	None
96667	96668	weight	0	None
96668	96669	)	0	None
96669	96670	were	0	None
96670	96671	administered	0	None
96671	96672	intraperitoneally	0	None
96672	96673	while	0	None
96673	96674	still	0	None
96674	96675	on	0	None
96675	96676	diet	0	None
96676	96677	.	0	None

96678	96679	Various	0	None
96679	96680	serum	0	None
96680	96681	parameters	0	None
96681	96682	,	0	None
96682	96683	enzymes	0	None
96683	96684	of	0	None
96684	96685	carbohydrate	0	None
96685	96686	metabolism	0	None
96686	96687	,	0	None
96687	96688	brush	0	None
96688	96689	border	0	None
96689	96690	membrane	0	None
96690	96691	(	0	None
96691	96692	BBM	0	None
96692	96693	)	0	None
96693	96694	,	0	None
96694	96695	and	0	None
96695	96696	oxidative	0	None
96696	96697	stress	0	None
96697	96698	were	0	None
96698	96699	analyzed	0	None
96699	96700	in	0	None
96700	96701	rat	0	None
96701	96702	kidney	0	None
96702	96703	.	0	None

96704	96705	PbAc	0	None
96705	96706	nephrotoxicity	0	None
96706	96707	was	0	None
96707	96708	characterized	0	None
96708	96709	by	0	None
96709	96710	increased	0	None
96710	96711	serum	0	None
96711	96712	creatinine	0	None
96712	96713	and	0	None
96713	96714	blood	0	None
96714	96715	urea	2	CHEMICAL
96715	96716	nitrogen	0	None
96716	96717	.	0	None

96718	96719	PbAc	0	None
96719	96720	increased	0	None
96720	96721	the	0	None
96721	96722	activities	0	None
96722	96723	of	0	None
96723	96724	lactate	0	None
96724	96725	dehydrogenase	0	None
96725	96726	and	0	None
96726	96727	NADP-malic	0	None
96727	96728	enzyme	0	None
96728	96729	,	0	None
96729	96730	whereas	0	None
96730	96731	it	0	None
96731	96732	decreased	0	None
96732	96733	malate	0	None
96733	96734	and	0	None
96734	96735	glucose-6-phosphate	2	CHEMICAL
96735	96736	dehydrogenase	0	None
96736	96737	,	0	None
96737	96738	glucose-6-phosphatase	0	None
96738	96739	,	0	None
96739	96740	fructose-1	0	None
96740	96741	,	0	None
96741	96742	6-bisphosphatase	0	None
96742	96743	,	0	None
96743	96744	and	0	None
96744	96745	BBM	0	None
96745	96746	enzyme	0	None
96746	96747	activities	0	None
96747	96748	.	0	None

96749	96750	PbAc	0	None
96750	96751	caused	0	None
96751	96752	oxidant	0	None
96752	96753	/	0	None
96753	96754	antioxidant	0	None
96754	96755	imbalances	0	None
96755	96756	as	0	None
96756	96757	reflected	0	None
96757	96758	by	0	None
96758	96759	increased	0	None
96759	96760	lipid	0	None
96760	96761	peroxidation	0	None
96761	96762	and	0	None
96762	96763	decreased	0	None
96763	96764	activities	0	None
96764	96765	of	0	None
96765	96766	superoxide	0	None
96766	96767	dismutase	0	None
96767	96768	,	0	None
96768	96770	glutathione peroxidase	1	GENE-Y
96770	96771	,	0	None
96771	96772	and	0	None
96772	96773	catalase	0	None
96773	96774	.	0	None

96775	96776	In	0	None
96776	96777	contrast	0	None
96777	96778	,	0	None
96778	96779	FXO	0	None
96779	96780	alone	0	None
96780	96781	enhanced	0	None
96781	96782	the	0	None
96782	96783	enzyme	0	None
96783	96784	activities	0	None
96784	96785	of	0	None
96785	96786	carbohydrate	0	None
96786	96787	metabolism	0	None
96787	96788	,	0	None
96788	96789	BBM	0	None
96789	96790	,	0	None
96790	96791	and	0	None
96791	96792	antioxidant	0	None
96792	96793	defense	0	None
96793	96794	system	0	None
96794	96795	.	0	None

96796	96797	FXO	0	None
96797	96798	feeding	0	None
96798	96799	to	0	None
96799	96800	PbAc-treated	0	None
96800	96801	rats	0	None
96801	96802	markedly	0	None
96802	96803	enhanced	0	None
96803	96804	resistance	0	None
96804	96805	to	0	None
96805	96806	PbAc-elicited	0	None
96806	96807	deleterious	0	None
96807	96808	effects	0	None
96808	96809	.	0	None

96810	96811	In	0	None
96811	96812	conclusion	0	None
96812	96813	,	0	None
96813	96814	dietary	0	None
96814	96815	FXO	0	None
96815	96816	supplementation	0	None
96816	96817	ameliorated	0	None
96817	96818	PbAc-induced	0	None
96818	96819	specific	0	None
96819	96820	metabolic	0	None
96820	96821	alterations	0	None
96821	96822	and	0	None
96822	96823	oxidative	0	None
96823	96824	damage	0	None
96824	96825	by	0	None
96825	96826	empowering	0	None
96826	96827	antioxidant	0	None
96827	96828	defense	0	None
96828	96829	mechanism	0	None
96829	96830	and	0	None
96830	96831	improving	0	None
96831	96832	BBM	0	None
96832	96833	integrity	0	None
96833	96834	and	0	None
96834	96835	energy	0	None
96835	96836	metabolism	0	None
96836	96837	.	0	None
96837	96838	[	0	None
96838	96839	The	0	None
96839	96840	relation	0	None
96840	96841	between	0	None
96841	96842	metabolism	0	None
96842	96843	of	0	None
96843	96844	biopterin	0	None
96844	96845	and	0	None
96845	96846	dystonia-parkinsonism	0	None
96846	96847	]	0	None
96847	96848	.	0	None
96848	96849	In	0	None
96849	96850	this	0	None
96850	96851	study	0	None
96851	96852	,	0	None
96852	96853	the	0	None
96853	96854	stabilization	0	None
96854	96855	effects	0	None
96855	96856	of	0	None
96856	96857	three	0	None
96857	96858	polymers	0	None
96858	96859	on	0	None
96859	96860	four	0	None
96860	96861	model	0	None
96861	96862	drugs	0	None
96862	96863	(	0	None
96863	96864	felodipine	2	CHEMICAL
96864	96865	,	0	None
96865	96866	fenofibrate	0	None
96866	96867	,	0	None
96867	96868	carbamazepine	0	None
96868	96869	,	0	None
96869	96870	and	0	None
96870	96871	celecoxib	2	CHEMICAL
96871	96872	)	0	None
96872	96873	under	0	None
96873	96874	saturated	0	None
96874	96875	humidity	0	None
96875	96876	were	0	None
96876	96877	investigated	0	None
96877	96878	.	0	None

96879	96880	Three	0	None
96880	96881	different	0	None
96881	96882	types	0	None
96882	96883	of	0	None
96883	96884	thin	0	None
96884	96885	films	0	None
96885	96886	(	0	None
96886	96887	solid	0	None
96887	96888	dispersions	0	None
96888	96889	,	0	None
96889	96890	drug	0	None
96890	96891	films	0	None
96891	96892	with	0	None
96892	96893	a	0	None
96893	96894	polymer	0	None
96894	96895	film	0	None
96895	96896	coating	0	None
96896	96897	and	0	None
96897	96898	drug	0	None
96898	96899	films	0	None
96899	96900	laid	0	None
96900	96901	on	0	None
96901	96902	top	0	None
96902	96903	of	0	None
96903	96904	polymer	0	None
96904	96905	coated	0	None
96905	96906	surfaces	0	None
96906	96907	)	0	None
96907	96908	were	0	None
96908	96909	prepared	0	None
96909	96910	and	0	None
96910	96911	compared	0	None
96911	96912	with	0	None
96912	96913	films	0	None
96913	96914	containing	0	None
96914	96915	the	0	None
96915	96916	drug	0	None
96916	96917	alone	0	None
96917	96918	.	0	None

96919	96920	ATR-FTIR	0	None
96920	96921	spectroscopy	0	None
96921	96922	,	0	None
96922	96923	polarised	0	None
96923	96924	light	0	None
96924	96925	microscopy	0	None
96925	96926	(	0	None
96926	96927	PLM	3	GENE-N
96927	96928	)	0	None
96928	96929	,	0	None
96929	96930	scanning	0	None
96930	96931	electron	0	None
96931	96932	microscopy	0	None
96932	96933	(	0	None
96933	96934	SEM	0	None
96934	96935	)	0	None
96935	96936	and	0	None
96936	96937	nano-thermal	0	None
96937	96938	analysis	0	None
96938	96939	(	0	None
96939	96940	nano-TA	0	None
96940	96941	)	0	None
96941	96942	were	0	None
96942	96943	performed	0	None
96943	96944	on	0	None
96944	96945	the	0	None
96945	96946	model	0	None
96946	96947	systems	0	None
96947	96948	after	0	None
96948	96949	storage	0	None
96949	96950	under	0	None
96950	96951	saturated	0	None
96951	96952	humidity	0	None
96952	96953	.	0	None

96954	96955	The	0	None
96955	96956	recrystallisation	0	None
96956	96957	tendency	0	None
96957	96958	of	0	None
96958	96959	the	0	None
96959	96960	drug	0	None
96960	96961	in	0	None
96961	96962	the	0	None
96962	96963	drug	0	None
96963	96964	containing	0	None
96964	96965	thin	0	None
96965	96966	films	0	None
96966	96967	was	0	None
96967	96968	found	0	None
96968	96969	to	0	None
96969	96970	be	0	None
96970	96971	strongly	0	None
96971	96972	related	0	None
96972	96973	to	0	None
96973	96974	the	0	None
96974	96975	intrinsic	0	None
96975	96976	crystallization	0	None
96976	96977	tendency	0	None
96977	96978	of	0	None
96978	96979	the	0	None
96979	96980	drug	0	None
96980	96981	film	0	None
96981	96982	alone	0	None
96982	96983	and	0	None
96983	96984	the	0	None
96984	96985	strength	0	None
96985	96986	of	0	None
96986	96987	drug-polymer	0	None
96987	96988	interactions	0	None
96988	96989	.	0	None

96990	96991	Additionally	0	None
96991	96992	,	0	None
96992	96993	under	0	None
96993	96994	high	0	None
96994	96995	humidity	0	None
96995	96996	,	0	None
96996	96997	the	0	None
96997	96998	glass	0	None
96998	96999	transition	0	None
96999	97000	temperature	0	None
97000	97001	of	0	None
97001	97002	the	0	None
97002	97003	polymer	0	None
97003	97004	is	0	None
97004	97005	no	0	None
97005	97006	longer	0	None
97006	97007	an	0	None
97007	97008	indicator	0	None
97008	97009	of	0	None
97009	97010	its	0	None
97010	97011	drug	0	None
97011	97012	stabilization	0	None
97012	97013	capability	0	None
97013	97014	.	0	None

97015	97016	Instead	0	None
97016	97017	,	0	None
97017	97018	it	0	None
97018	97019	is	0	None
97019	97020	the	0	None
97020	97021	hygroscobicity	0	None
97021	97022	of	0	None
97022	97023	the	0	None
97023	97024	polymer	0	None
97024	97025	that	0	None
97025	97026	appears	0	None
97026	97027	to	0	None
97027	97028	be	0	None
97028	97029	the	0	None
97029	97030	most	0	None
97030	97031	important	0	None
97031	97032	parameter	0	None
97032	97033	.	0	None

97034	97035	Amongst	0	None
97035	97036	the	0	None
97036	97037	polymers	0	None
97037	97038	tested	0	None
97038	97039	in	0	None
97039	97040	this	0	None
97040	97041	study	0	None
97041	97042	,	0	None
97042	97043	EUDRAGIT	2	CHEMICAL
97043	97044	E	0	None
97044	97045	PO	0	None
97045	97046	was	0	None
97046	97047	found	0	None
97047	97048	to	0	None
97048	97049	have	0	None
97049	97050	the	0	None
97050	97051	greatest	0	None
97051	97052	inhibitory	0	None
97052	97053	effect	0	None
97053	97054	on	0	None
97054	97055	crystallization	0	None
97055	97056	,	0	None
97056	97057	whilst	0	None
97057	97058	PVP	0	None
97058	97059	K30	0	None
97059	97060	was	0	None
97060	97061	found	0	None
97061	97062	to	0	None
97062	97063	have	0	None
97063	97064	the	0	None
97064	97065	least	0	None
97065	97066	protective	0	None
97066	97067	effect;	0	None
97067	97068	presumably	0	None
97068	97069	because	0	None
97069	97070	of	0	None
97070	97071	its	0	None
97071	97072	hygroscopic	0	None
97072	97073	nature	0	None
97073	97074	.	0	None
97074	97075	6-Hydroxydopamine	0	None
97075	97076	(	0	None
97076	97077	6-OHDA	0	None
97077	97078	)	0	None
97078	97079	is	0	None
97079	97080	a	0	None
97080	97081	neurotoxin	0	None
97081	97082	that	0	None
97082	97083	generates	0	None
97083	97084	an	0	None
97084	97085	experimental	0	None
97085	97086	model	0	None
97086	97087	of	0	None
97087	97088	Parkinson's	0	None
97088	97089	disease	0	None
97089	97090	in	0	None
97090	97091	rodents	0	None
97091	97092	and	0	None
97092	97093	is	0	None
97093	97094	commonly	0	None
97094	97095	employed	0	None
97095	97096	to	0	None
97096	97097	induce	0	None
97097	97098	a	0	None
97098	97099	lesion	0	None
97099	97100	in	0	None
97100	97101	dopaminergic	0	None
97101	97102	pathways	0	None
97102	97103	.	0	None

97104	97105	The	0	None
97105	97106	characterization	0	None
97106	97107	of	0	None
97107	97108	those	0	None
97108	97109	molecular	0	None
97109	97110	mechanisms	0	None
97110	97111	linked	0	None
97111	97112	to	0	None
97112	97113	6-OHDA-induced	0	None
97113	97114	early	0	None
97114	97115	toxicity	0	None
97115	97116	is	0	None
97116	97117	needed	0	None
97117	97118	to	0	None
97118	97119	better	0	None
97119	97120	understand	0	None
97120	97121	the	0	None
97121	97122	cellular	0	None
97122	97123	events	0	None
97123	97124	further	0	None
97124	97125	leading	0	None
97125	97126	to	0	None
97126	97127	neurodegeneration	0	None
97127	97128	.	0	None

97129	97130	The	0	None
97130	97131	present	0	None
97131	97132	work	0	None
97132	97133	explored	0	None
97133	97134	how	0	None
97134	97135	6-OHDA	0	None
97135	97136	triggers	0	None
97136	97137	early	0	None
97137	97138	downstream	0	None
97138	97139	signaling	0	None
97139	97140	pathways	0	None
97140	97141	that	0	None
97141	97142	activate	0	None
97142	97143	neurotoxicity	0	None
97143	97144	in	0	None
97144	97145	the	0	None
97145	97146	rat	0	None
97146	97147	striatum	0	None
97147	97148	.	0	None

97149	97150	Mitochondrial	0	None
97150	97151	function	0	None
97151	97152	,	0	None
97152	97153	caspases-dependent	0	None
97153	97154	apoptosis	0	None
97154	97155	,	0	None
97155	97156	kinases	0	None
97156	97157	signaling	0	None
97157	97158	(	0	None
97158	97159	Akt	0	None
97159	97160	,	0	None
97160	97161	ERK	0	None
97161	97162	1	0	None
97162	97163	/	0	None
97163	97164	2	0	None
97164	97165	,	0	None
97165	97166	SAP	0	None
97166	97167	/	0	None
97167	97168	JNK	0	None
97168	97169	and	0	None
97169	97170	p38	0	None
97170	97171	)	0	None
97171	97172	and	0	None
97172	97173	crosstalk	0	None
97173	97174	between	0	None
97174	97178	nuclear factor kappa B	3	GENE-N
97178	97179	(	0	None
97179	97180	NF-κB	0	None
97180	97181	)	0	None
97181	97182	and	0	None
97182	97183	nuclear	0	None
97183	97184	factor-erythroid-2-related	0	None
97184	97185	factor	0	None
97185	97186	2	0	None
97186	97187	(	0	None
97187	97188	Nrf2	1	GENE-Y
97188	97189	)	0	None
97189	97190	were	0	None
97190	97191	evaluated	0	None
97191	97192	at	0	None
97192	97193	early	0	None
97193	97194	times	0	None
97194	97195	post-lesion	0	None
97195	97196	.	0	None

97197	97198	We	0	None
97198	97199	found	0	None
97199	97200	that	0	None
97200	97201	6-OHDA	0	None
97201	97202	initiates	0	None
97202	97203	cell	0	None
97203	97204	damage	0	None
97204	97205	via	0	None
97205	97206	mitochondrial	0	None
97206	97207	complex	0	None
97207	97208	I	0	None
97208	97209	inhibition	0	None
97209	97210	,	0	None
97210	97211	cytochrome	3	GENE-N
97211	97212	c	0	None
97212	97213	and	0	None
97213	97214	apoptosis-inducing	0	None
97214	97215	factor	0	None
97215	97216	(	0	None
97216	97217	AIF	1	GENE-Y
97217	97218	)	0	None
97218	97219	release	0	None
97219	97220	,	0	None
97220	97221	as	0	None
97221	97222	well	0	None
97222	97223	as	0	None
97223	97224	activation	0	None
97224	97225	of	0	None
97225	97229	caspases 9 and 3	3	GENE-N
97229	97230	to	0	None
97230	97231	induce	0	None
97231	97232	apoptosis	0	None
97232	97233	,	0	None
97233	97234	kinase	0	None
97234	97235	signaling	0	None
97235	97236	modulation	0	None
97236	97237	and	0	None
97237	97238	NF-κB-mediated	0	None
97238	97239	inflammatory	0	None
97239	97240	responses	0	None
97240	97241	,	0	None
97241	97242	accompanied	0	None
97242	97243	by	0	None
97243	97244	inhibition	0	None
97244	97245	of	0	None
97245	97246	antioxidant	0	None
97246	97247	systems	0	None
97247	97248	regulated	0	None
97248	97249	by	0	None
97249	97250	the	0	None
97250	97251	Nrf2	1	GENE-Y
97251	97252	pathway	0	None
97252	97253	.	0	None

97254	97255	Our	0	None
97255	97256	results	0	None
97256	97257	suggest	0	None
97257	97258	that	0	None
97258	97259	kinases	0	None
97259	97260	SAP	0	None
97260	97261	/	0	None
97261	97262	JNK	0	None
97262	97263	and	0	None
97263	97264	p38	0	None
97264	97265	up-regulation	0	None
97265	97266	may	0	None
97266	97267	play	0	None
97267	97268	a	0	None
97268	97269	role	0	None
97269	97270	in	0	None
97270	97271	the	0	None
97271	97272	early	0	None
97272	97273	stages	0	None
97273	97274	of	0	None
97274	97275	6-OHDA	0	None
97275	97276	toxicity	0	None
97276	97277	to	0	None
97277	97278	trigger	0	None
97278	97279	intrinsic	0	None
97279	97280	pathways	0	None
97280	97281	for	0	None
97281	97282	apoptosis	0	None
97282	97283	and	0	None
97283	97284	enhanced	0	None
97284	97285	NF-κB	0	None
97285	97286	activation	0	None
97286	97287	.	0	None

97288	97289	In	0	None
97289	97290	turn	0	None
97290	97291	,	0	None
97291	97292	these	0	None
97292	97293	cellular	0	None
97293	97294	events	0	None
97294	97295	inhibit	0	None
97295	97296	the	0	None
97296	97297	activation	0	None
97297	97298	of	0	None
97298	97299	cytoprotective	0	None
97299	97300	mechanisms	0	None
97300	97301	,	0	None
97301	97302	thereby	0	None
97302	97303	leading	0	None
97303	97304	to	0	None
97304	97305	a	0	None
97305	97306	condition	0	None
97306	97307	of	0	None
97307	97308	general	0	None
97308	97309	damage	0	None
97309	97310	.	0	None
97310	97311	The	0	None
97311	97312	effects	0	None
97312	97313	of	0	None
97313	97314	mitiglinide	0	None
97314	97315	(	0	None
97315	97316	KAD-1229	0	None
97316	97317	)	0	None
97317	97318	,	0	None
97318	97319	a	0	None
97319	97320	new	0	None
97320	97321	anti-diabetic	0	None
97321	97322	drug	0	None
97322	97323	,	0	None
97323	97324	on	0	None
97324	97325	ATP-sensitive	0	None
97325	97326	K	0	None
97326	97327	+	0	None
97327	97328	channels	0	None
97328	97329	and	0	None
97329	97330	insulin	0	None
97330	97331	secretion	0	None
97331	97332	:	0	None
97332	97333	comparison	0	None
97333	97334	with	0	None
97334	97335	the	0	None
97335	97336	sulfonylureas	2	CHEMICAL
97336	97337	and	0	None
97337	97338	nateglinide	0	None
97338	97339	.	0	None
97339	97340	Androgen	0	None
97340	97341	receptors	0	None
97341	97342	are	0	None
97342	97343	present	0	None
97343	97344	in	0	None
97344	97345	numerous	0	None
97345	97346	tissues	0	None
97346	97347	throughout	0	None
97347	97348	the	0	None
97348	97349	female	0	None
97349	97350	body	0	None
97350	97351	,	0	None
97351	97352	and	0	None
97352	97353	knowledge	0	None
97353	97354	of	0	None
97354	97355	the	0	None
97355	97356	specific	0	None
97356	97357	actions	0	None
97357	97358	of	0	None
97358	97359	androgens	2	CHEMICAL
97359	97360	at	0	None
97360	97361	different	0	None
97361	97362	sites	0	None
97362	97363	is	0	None
97363	97364	increasing	0	None
97364	97365	,	0	None
97365	97366	along	0	None
97366	97367	with	0	None
97367	97368	the	0	None
97368	97369	understanding	0	None
97369	97370	of	0	None
97370	97371	their	0	None
97371	97372	contribution	0	None
97372	97373	to	0	None
97373	97374	various	0	None
97374	97375	pathophysiological	0	None
97375	97376	states	0	None
97376	97377	.	0	None

97378	97379	This	0	None
97379	97380	article	0	None
97380	97381	reviews	0	None
97381	97382	the	0	None
97382	97383	physiology	0	None
97383	97384	of	0	None
97384	97385	androgens	2	CHEMICAL
97385	97386	(	0	None
97386	97387	testosterone	2	CHEMICAL
97387	97388	and	0	None
97388	97389	dihydrotestosterone	0	None
97389	97390	)	0	None
97390	97391	and	0	None
97391	97392	immediate	0	None
97392	97393	androgen	0	None
97393	97394	precursors	0	None
97394	97395	(	0	None
97395	97396	dehydroepiandrosterone	0	None
97396	97397	[	0	None
97397	97398	DHEA	0	None
97398	97399	]	0	None
97399	97400	,	0	None
97400	97402	dehydroepiandrosterone sulfate	2	CHEMICAL
97402	97403	[	0	None
97403	97404	DHEAS	2	CHEMICAL
97404	97405	]	0	None
97405	97406	,	0	None
97406	97407	and	0	None
97407	97408	androstenedione	0	None
97408	97409	)	0	None
97409	97410	,	0	None
97410	97411	with	0	None
97411	97412	specific	0	None
97412	97413	reference	0	None
97413	97414	to	0	None
97414	97415	the	0	None
97415	97417	androgen receptor	1	GENE-Y
97417	97418	,	0	None
97418	97419	production	0	None
97419	97420	and	0	None
97420	97421	metabolism	0	None
97421	97422	of	0	None
97422	97423	C-	0	None
97423	97424	(	0	None
97424	97425	19	0	None
97425	97426	)	0	None
97426	97427	steroids	0	None
97427	97428	,	0	None
97428	97429	circulating	0	None
97429	97430	androgen	0	None
97430	97431	concentrations	0	None
97431	97432	,	0	None
97432	97433	and	0	None
97433	97434	androgen	0	None
97434	97435	actions	0	None
97435	97436	.	0	None

97437	97438	In	0	None
97438	97439	addition	0	None
97439	97440	,	0	None
97440	97441	the	0	None
97441	97442	evidence	0	None
97442	97443	for	0	None
97443	97444	physiological	0	None
97444	97445	modulation	0	None
97445	97446	of	0	None
97446	97447	androgens	2	CHEMICAL
97447	97448	including	0	None
97448	97449	circadian	0	None
97449	97450	variation	0	None
97450	97451	,	0	None
97451	97452	cyclical	0	None
97452	97453	variation	0	None
97453	97454	,	0	None
97454	97455	age	0	None
97455	97456	,	0	None
97456	97457	and	0	None
97457	97458	natural	0	None
97458	97459	menopause	0	None
97459	97460	is	0	None
97460	97461	reviewed	0	None
97461	97462	.	0	None
97462	97463	Tetrahydrobiopterin	2	CHEMICAL
97463	97464	[	0	None
97464	97465	(	0	None
97465	97466	6R	0	None
97466	97467	)	0	None
97467	97468	-5	0	None
97468	97469	,	0	None
97469	97470	6	0	None
97470	97471	,	0	None
97471	97472	7	0	None
97472	97473	,	0	None
97473	97474	8-tetrahydro-L-biopterin	0	None
97474	97475	,	0	None
97475	97476	H	0	None
97476	97477	(	0	None
97477	97478	4	0	None
97478	97479	)	0	None
97479	97480	biopterin	0	None
97480	97481	]	0	None
97481	97482	is	0	None
97482	97483	one	0	None
97483	97484	of	0	None
97484	97485	several	0	None
97485	97486	cofactors	0	None
97486	97487	of	0	None
97487	97488	nitric	0	None
97488	97489	oxide	0	None
97489	97490	synthases	0	None
97490	97491	(	0	None
97491	97492	EC	0	None
97492	97493	1	0	None
97493	97494	.	0	None
97494	97495	14	0	None
97495	97496	.	0	None
97496	97497	13	0	None
97497	97498	.	0	None
97498	97499	39	0	None
97499	97500	)	0	None
97500	97501	.	0	None

97502	97503	Here	0	None
97503	97504	we	0	None
97504	97505	compared	0	None
97505	97506	the	0	None
97506	97507	action	0	None
97507	97508	of	0	None
97508	97509	N	0	None
97509	97510	(	0	None
97510	97511	5	0	None
97511	97512	)	0	None
97512	97513	-substituted	0	None
97513	97514	derivatives	0	None
97514	97515	on	0	None
97515	97516	recombinant	0	None
97516	97521	rat neuronal nitric oxide synthase	1	GENE-Y
97521	97522	with	0	None
97522	97523	their	0	None
97523	97524	effects	0	None
97524	97525	on	0	None
97525	97526	dihydropteridine	2	CHEMICAL
97526	97527	reductase	0	None
97527	97528	(	0	None
97528	97529	EC	0	None
97529	97530	1	0	None
97530	97531	.	0	None
97531	97532	6	0	None
97532	97533	.	0	None
97533	97534	99	0	None
97534	97535	.	0	None
97535	97536	7	0	None
97536	97537	)	0	None
97537	97538	and	0	None
97538	97539	phenylalanine	0	None
97539	97540	hydroxylase	0	None
97540	97541	(	0	None
97541	97542	EC	0	None
97542	97543	1	0	None
97543	97544	.	0	None
97544	97545	14	0	None
97545	97546	.	0	None
97546	97547	16	0	None
97547	97548	.	0	None
97548	97549	1	0	None
97549	97550	)	0	None
97550	97551	,	0	None
97551	97552	the	0	None
97552	97553	well-studied	0	None
97553	97554	classical	0	None
97554	97555	H	0	None
97555	97556	(	0	None
97556	97557	4	0	None
97557	97558	)	0	None
97558	97559	biopterin-dependent	0	None
97559	97560	reactions	0	None
97560	97561	.	0	None

97562	97563	H	0	None
97563	97564	(	0	None
97564	97565	4	0	None
97565	97566	)	0	None
97566	97567	biopterin	0	None
97567	97568	substituted	0	None
97568	97569	at	0	None
97569	97570	N	0	None
97570	97571	(	0	None
97571	97572	5	0	None
97572	97573	)	0	None
97573	97574	with	0	None
97574	97575	methyl	0	None
97575	97576	,	0	None
97576	97577	hydroxymethyl	0	None
97577	97578	,	0	None
97578	97579	formyl	0	None
97579	97580	and	0	None
97580	97581	acetyl	0	None
97581	97582	groups	0	None
97582	97583	were	0	None
97583	97584	used	0	None
97584	97585	.	0	None

97586	97587	Substitution	0	None
97587	97588	at	0	None
97588	97589	N	0	None
97589	97590	(	0	None
97590	97591	5	0	None
97591	97592	)	0	None
97592	97593	occurs	0	None
97593	97594	at	0	None
97594	97595	a	0	None
97595	97596	position	0	None
97596	97597	critical	0	None
97597	97598	to	0	None
97598	97599	the	0	None
97599	97600	redox	0	None
97600	97601	cycle	0	None
97601	97602	of	0	None
97602	97603	the	0	None
97603	97604	cofactor	0	None
97604	97605	in	0	None
97605	97606	phenylalanine	0	None
97606	97607	hydroxylase	0	None
97607	97608	/	0	None
97608	97609	dihydropteridine	2	CHEMICAL
97609	97610	reductase	0	None
97610	97611	.	0	None

97612	97613	We	0	None
97613	97614	also	0	None
97614	97615	included	0	None
97615	97616	N	0	None
97616	97617	(	0	None
97617	97618	2	0	None
97618	97619	)	0	None
97619	97620	'-methyl	0	None
97620	97621	H	0	None
97621	97622	(	0	None
97622	97623	4	0	None
97623	97624	)	0	None
97624	97625	biopterin	0	None
97625	97626	,	0	None
97626	97627	a	0	None
97627	97628	derivative	0	None
97628	97629	substituted	0	None
97629	97630	at	0	None
97630	97631	a	0	None
97631	97632	position	0	None
97632	97633	not	0	None
97633	97634	directly	0	None
97634	97635	involved	0	None
97635	97636	in	0	None
97636	97637	redox	0	None
97637	97638	cycling	0	None
97638	97639	,	0	None
97639	97640	as	0	None
97640	97641	a	0	None
97641	97642	control	0	None
97642	97643	.	0	None

97644	97645	As	0	None
97645	97646	compared	0	None
97646	97647	with	0	None
97647	97648	N	0	None
97648	97649	(	0	None
97649	97650	5	0	None
97650	97651	)	0	None
97651	97652	-methyl	0	None
97652	97653	H	0	None
97653	97654	(	0	None
97654	97655	4	0	None
97655	97656	)	0	None
97656	97657	biopterin	0	None
97657	97658	,	0	None
97658	97659	N	0	None
97659	97660	(	0	None
97660	97661	5	0	None
97661	97662	)	0	None
97662	97663	-formyl	0	None
97663	97664	H	0	None
97664	97665	(	0	None
97665	97666	4	0	None
97666	97667	)	0	None
97667	97668	biopterin	0	None
97668	97669	bound	0	None
97669	97670	with	0	None
97670	97671	twice	0	None
97671	97672	the	0	None
97672	97673	capacity	0	None
97673	97674	but	0	None
97674	97675	stimulated	0	None
97675	97678	nitric oxide synthase	3	GENE-N
97678	97679	to	0	None
97679	97680	a	0	None
97680	97681	lesser	0	None
97681	97682	extent	0	None
97682	97683	.	0	None

97684	97685	Depending	0	None
97685	97686	on	0	None
97686	97687	the	0	None
97687	97688	substituent	0	None
97688	97689	used	0	None
97689	97690	,	0	None
97690	97691	N	0	None
97691	97692	(	0	None
97692	97693	5	0	None
97693	97694	)	0	None
97694	97695	-substituted	0	None
97695	97696	derivatives	0	None
97696	97697	were	0	None
97697	97698	redox-active	0	None
97698	97699	:	0	None
97699	97700	N	0	None
97700	97701	(	0	None
97701	97702	5	0	None
97702	97703	)	0	None
97703	97704	-methyl-	0	None
97704	97705	and	0	None
97705	97706	N	0	None
97706	97707	(	0	None
97707	97708	5	0	None
97708	97709	)	0	None
97709	97710	-hydroxyl	0	None
97710	97711	methyl	0	None
97711	97712	H	0	None
97712	97713	(	0	None
97713	97714	4	0	None
97714	97715	)	0	None
97715	97716	biopterin	0	None
97716	97717	,	0	None
97717	97718	but	0	None
97718	97719	not	0	None
97719	97720	N	0	None
97720	97721	(	0	None
97721	97722	5	0	None
97722	97723	)	0	None
97723	97724	-formyl-	0	None
97724	97725	and	0	None
97725	97726	N	0	None
97726	97727	(	0	None
97727	97728	5	0	None
97728	97729	)	0	None
97729	97730	-acetyl	0	None
97730	97731	H	0	None
97731	97732	(	0	None
97732	97733	4	0	None
97733	97734	)	0	None
97734	97735	biopterin	0	None
97735	97736	,	0	None
97736	97737	reduced	0	None
97737	97738	2	0	None
97738	97739	,	0	None
97739	97740	6-dichlorophenol	0	None
97740	97741	indophenol	0	None
97741	97742	.	0	None

97743	97744	N	0	None
97744	97745	(	0	None
97745	97746	5	0	None
97746	97747	)	0	None
97747	97748	-Substituted	0	None
97748	97749	H	0	None
97749	97750	(	0	None
97750	97751	4	0	None
97751	97752	)	0	None
97752	97753	biopterin	0	None
97753	97754	derivatives	0	None
97754	97755	were	0	None
97755	97756	not	0	None
97756	97757	oxidized	0	None
97757	97758	to	0	None
97758	97759	products	0	None
97759	97760	serving	0	None
97760	97761	as	0	None
97761	97762	substrates	0	None
97762	97763	for	0	None
97763	97764	dihydropteridine	2	CHEMICAL
97764	97765	reductase	0	None
97765	97766	and	0	None
97766	97767	,	0	None
97767	97768	depending	0	None
97768	97769	on	0	None
97769	97770	the	0	None
97770	97771	substituent	0	None
97771	97772	,	0	None
97772	97773	were	0	None
97773	97774	competitive	0	None
97774	97775	inhibitors	0	None
97775	97776	of	0	None
97776	97777	phenylalanine	2	CHEMICAL
97777	97778	hydroxylase	0	None
97778	97779	:	0	None
97779	97780	N	0	None
97780	97781	(	0	None
97781	97782	5	0	None
97782	97783	)	0	None
97783	97784	-methyl-	0	None
97784	97785	and	0	None
97785	97786	N	0	None
97786	97787	(	0	None
97787	97788	5	0	None
97788	97789	)	0	None
97789	97790	-hydroxymethyl	0	None
97790	97791	H	0	None
97791	97792	(	0	None
97792	97793	4	0	None
97793	97794	)	0	None
97794	97795	biopterin	0	None
97795	97796	inhibited	0	None
97796	97797	phenylalanine	0	None
97797	97798	hydroxylase	0	None
97798	97799	,	0	None
97799	97800	whereas	0	None
97800	97801	N	0	None
97801	97802	(	0	None
97802	97803	5	0	None
97803	97804	)	0	None
97804	97805	-formyl-	0	None
97805	97806	and	0	None
97806	97807	N	0	None
97807	97808	(	0	None
97808	97809	5	0	None
97809	97810	)	0	None
97810	97811	-acetyl	0	None
97811	97812	H	0	None
97812	97813	(	0	None
97813	97814	4	0	None
97814	97815	)	0	None
97815	97816	biopterin	0	None
97816	97817	had	0	None
97817	97818	no	0	None
97818	97819	effect	0	None
97819	97820	.	0	None

97821	97822	Our	0	None
97822	97823	data	0	None
97823	97824	demonstrate	0	None
97824	97825	differences	0	None
97825	97826	in	0	None
97826	97827	the	0	None
97827	97828	mechanism	0	None
97828	97829	of	0	None
97829	97830	stimulation	0	None
97830	97831	of	0	None
97831	97832	phenylalanine	0	None
97832	97833	hydroxylase	0	None
97833	97834	and	0	None
97834	97837	nitric oxide synthase	3	GENE-N
97837	97838	by	0	None
97838	97839	H	0	None
97839	97840	(	0	None
97840	97841	4	0	None
97841	97842	)	0	None
97842	97843	biopterin	0	None
97843	97844	.	0	None

97845	97846	They	0	None
97846	97847	are	0	None
97847	97848	compatible	0	None
97848	97849	with	0	None
97849	97850	a	0	None
97850	97851	novel	0	None
97851	97852	,	0	None
97852	97853	non-classical	0	None
97853	97854	,	0	None
97854	97855	redox-active	0	None
97855	97856	contribution	0	None
97856	97857	of	0	None
97857	97858	H	0	None
97858	97859	(	0	None
97859	97860	4	0	None
97860	97861	)	0	None
97861	97862	biopterin	0	None
97862	97863	to	0	None
97863	97864	the	0	None
97864	97865	catalysis	0	None
97865	97866	of	0	None
97866	97867	the	0	None
97867	97870	nitric oxide synthase	3	GENE-N
97870	97871	reaction	0	None
97871	97872	.	0	None
97872	97873	Safrole-2'	0	None
97873	97874	,	0	None
97874	97875	3'-oxide	0	None
97875	97876	induces	0	None
97876	97877	atherosclerotic	0	None
97877	97878	plaque	0	None
97878	97879	vulnerability	0	None
97879	97880	in	0	None
97880	97881	apolipoprotein	0	None
97881	97882	E-knockout	0	None
97882	97883	mice	0	None
97883	97884	.	0	None
97884	97885	Pharmacological	0	None
97885	97886	and	0	None
97886	97887	genetic	0	None
97887	97888	evidence	0	None
97888	97889	for	0	None
97889	97890	pre-	0	None
97890	97891	and	0	None
97891	97892	postsynaptic	0	None
97892	97893	D2	0	None
97893	97894	receptor	0	None
97894	97895	involvement	0	None
97895	97896	in	0	None
97896	97897	motor	0	None
97897	97898	responses	0	None
97898	97899	to	0	None
97899	97900	nociceptin	0	None
97900	97901	/	0	None
97901	97902	orphanin	0	None
97902	97903	FQ	0	None
97903	97904	receptor	0	None
97904	97905	ligands	0	None
97905	97906	.	0	None
97906	97907	In	0	None
97907	97908	the	0	None
97908	97909	present	0	None
97909	97910	study	0	None
97910	97911	,	0	None
97911	97912	we	0	None
97912	97913	investigated	0	None
97913	97914	the	0	None
97914	97915	effect	0	None
97915	97916	of	0	None
97916	97917	fenoterol-induced	0	None
97917	97918	constitutive	0	None
97918	97919	beta	0	None
97919	97920	(	0	None
97920	97921	2	0	None
97921	97922	)	0	None
97922	97923	-adrenoceptor	0	None
97923	97924	activity	0	None
97924	97925	on	0	None
97925	97926	muscarinic	0	None
97926	97927	receptor	0	None
97927	97928	agonist-	0	None
97928	97929	and	0	None
97929	97930	histamine-induced	0	None
97930	97931	bovine	0	None
97931	97932	tracheal	0	None
97932	97933	smooth	0	None
97933	97934	muscle	0	None
97934	97935	contractions	0	None
97935	97936	.	0	None

97937	97938	Bovine	0	None
97938	97939	tracheal	0	None
97939	97940	smooth	0	None
97940	97941	muscle	0	None
97941	97942	strips	0	None
97942	97943	were	0	None
97943	97944	incubated	0	None
97944	97945	with	0	None
97945	97946	10	0	None
97946	97947	microM	0	None
97947	97948	fenoterol	2	CHEMICAL
97948	97949	or	0	None
97949	97950	vehicle	0	None
97950	97951	for	0	None
97951	97952	various	0	None
97952	97953	periods	0	None
97953	97954	of	0	None
97954	97955	time	0	None
97955	97956	(	0	None
97956	97957	5	0	None
97957	97958	,	0	None
97958	97959	30	0	None
97959	97960	min	0	None
97960	97961	,	0	None
97961	97962	18	0	None
97962	97963	h	0	None
97963	97964	)	0	None
97964	97965	at	0	None
97965	97966	37	0	None
97966	97967	degrees	0	None
97967	97968	C	0	None
97968	97969	.	0	None

97970	97971	After	0	None
97971	97972	extensive	0	None
97972	97973	washout	0	None
97973	97974	(	0	None
97974	97975	3	0	None
97975	97976	h	0	None
97976	97977	,	0	None
97977	97978	37	0	None
97978	97979	degrees	0	None
97979	97980	C	0	None
97980	97981	)	0	None
97981	97982	,	0	None
97982	97983	isometric	0	None
97983	97984	contractions	0	None
97984	97985	were	0	None
97985	97986	measured	0	None
97986	97987	to	0	None
97987	97988	the	0	None
97988	97989	full	0	None
97989	97990	muscarinic	0	None
97990	97991	receptor	0	None
97991	97992	agonist	0	None
97992	97993	methacholine	0	None
97993	97994	,	0	None
97994	97995	the	0	None
97995	97996	partial	0	None
97996	97997	muscarinic	0	None
97997	97998	receptor	0	None
97998	97999	agonist	0	None
97999	98000	4-	0	None
98000	98001	(	0	None
98001	98002	m-chlorophenyl-carbamoyloxy	0	None
98002	98003	)	0	None
98003	98004	-2-butynyltrimethylammonium	0	None
98004	98005	(	0	None
98005	98006	McN-A-343	0	None
98006	98007	)	0	None
98007	98008	and	0	None
98008	98009	histamine	2	CHEMICAL
98009	98010	.	0	None

98011	98012	Fenoterol	2	CHEMICAL
98012	98013	treatment	0	None
98013	98014	significantly	0	None
98014	98015	reduced	0	None
98015	98016	the	0	None
98016	98017	sensitivity	0	None
98017	98018	(	0	None
98018	98019	pEC	0	None
98019	98020	(	0	None
98020	98021	50	0	None
98021	98022	)	0	None
98022	98023	)	0	None
98023	98024	to	0	None
98024	98025	methacholine	0	None
98025	98026	in	0	None
98026	98027	a	0	None
98027	98028	time-dependent	0	None
98028	98029	manner	0	None
98029	98030	,	0	None
98030	98031	without	0	None
98031	98032	affecting	0	None
98032	98033	maximal	0	None
98033	98034	contraction	0	None
98034	98035	(	0	None
98035	98036	E	0	None
98036	98037	(	0	None
98037	98038	max	0	None
98038	98039	)	0	None
98039	98040	)	0	None
98040	98041	.	0	None

98042	98043	Fenoterol	2	CHEMICAL
98043	98044	treatment	0	None
98044	98045	similarly	0	None
98045	98046	reduced	0	None
98046	98047	the	0	None
98047	98048	pEC	0	None
98048	98049	(	0	None
98049	98050	50	0	None
98050	98051	)	0	None
98051	98052	of	0	None
98052	98053	McN-A-343	0	None
98053	98054	and	0	None
98054	98055	histamine;	0	None
98055	98056	however	0	None
98056	98057	,	0	None
98057	98058	E	0	None
98058	98059	(	0	None
98059	98060	max	0	None
98060	98061	)	0	None
98061	98062	values	0	None
98062	98063	were	0	None
98063	98064	also	0	None
98064	98065	reduced	0	None
98065	98066	,	0	None
98066	98067	to	0	None
98067	98068	approximately	0	None
98068	98069	70%	0	None
98069	98070	of	0	None
98070	98071	control	0	None
98071	98072	after	0	None
98072	98073	18-h	0	None
98073	98074	treatment	0	None
98074	98075	.	0	None

98076	98077	The	0	None
98077	98078	inverse	0	None
98078	98079	agonist	0	None
98079	98080	timolol	0	None
98080	98081	,	0	None
98081	98082	having	0	None
98082	98083	no	0	None
98083	98084	effect	0	None
98084	98085	on	0	None
98085	98086	control	0	None
98086	98087	preparations	0	None
98087	98088	,	0	None
98088	98089	consistently	0	None
98089	98090	restored	0	None
98090	98091	the	0	None
98091	98092	reduced	0	None
98092	98093	pEC	0	None
98093	98094	(	0	None
98094	98095	50	0	None
98095	98096	)	0	None
98096	98097	and	0	None
98097	98098	E	0	None
98098	98099	(	0	None
98099	98100	max	0	None
98100	98101	)	0	None
98101	98102	values	0	None
98102	98103	of	0	None
98103	98104	the	0	None
98104	98105	contractile	0	None
98105	98106	agonists	0	None
98106	98107	.	0	None

98108	98109	Remarkably	0	None
98109	98110	,	0	None
98110	98111	in	0	None
98111	98112	the	0	None
98112	98113	presence	0	None
98113	98114	of	0	None
98114	98115	timolol	0	None
98115	98116	the	0	None
98116	98117	pEC	0	None
98117	98118	(	0	None
98118	98119	50	0	None
98119	98120	)	0	None
98120	98121	values	0	None
98121	98122	of	0	None
98122	98123	McN-A-343	0	None
98123	98124	and	0	None
98124	98125	histamine	2	CHEMICAL
98125	98126	in	0	None
98126	98127	fenoterol-treated	0	None
98127	98128	airways	0	None
98128	98129	were	0	None
98129	98130	significantly	0	None
98130	98131	enhanced	0	None
98131	98132	compared	0	None
98132	98133	to	0	None
98133	98134	controls	0	None
98134	98135	.	0	None

98136	98137	In	0	None
98137	98138	conclusion	0	None
98138	98139	,	0	None
98139	98140	fenoterol-induced	0	None
98140	98141	constitutive	0	None
98141	98142	beta	0	None
98142	98143	(	0	None
98143	98144	2	0	None
98144	98145	)	0	None
98145	98146	-adrenoceptor	0	None
98146	98147	activity	0	None
98147	98148	reduces	0	None
98148	98149	muscarinic	0	None
98149	98150	receptor	0	None
98150	98151	agonist-	0	None
98151	98152	and	0	None
98152	98153	histamine-induced	0	None
98153	98154	contractions	0	None
98154	98155	of	0	None
98155	98156	bovine	0	None
98156	98157	tracheal	0	None
98157	98158	smooth	0	None
98158	98159	muscle	0	None
98159	98160	,	0	None
98160	98161	which	0	None
98161	98162	can	0	None
98162	98163	be	0	None
98163	98164	reversed	0	None
98164	98165	by	0	None
98165	98166	the	0	None
98166	98167	inverse	0	None
98167	98168	agonist	0	None
98168	98169	timolol	0	None
98169	98170	.	0	None

98171	98172	Moreover	0	None
98172	98173	,	0	None
98173	98174	after	0	None
98174	98175	beta	0	None
98175	98176	(	0	None
98176	98177	2	0	None
98177	98178	)	0	None
98178	98179	-adrenoceptor	0	None
98179	98180	agonist	0	None
98180	98181	treatment	0	None
98181	98182	,	0	None
98182	98183	inverse	0	None
98183	98184	agonism	0	None
98184	98185	by	0	None
98185	98186	beta-adrenoceptor	3	GENE-N
98186	98187	antagonists	0	None
98187	98188	may	0	None
98188	98189	cause	0	None
98189	98190	enhanced	0	None
98190	98191	airway	0	None
98191	98192	reactivity	0	None
98192	98193	to	0	None
98193	98194	contractile	0	None
98194	98195	mediators	0	None
98195	98196	.	0	None
98196	98197	Activation	0	None
98197	98198	of	0	None
98198	98199	beta2-	0	None
98199	98200	and	0	None
98200	98201	beta3-adrenergic	0	None
98201	98202	receptors	0	None
98202	98203	increases	0	None
98203	98204	brain	0	None
98204	98205	tryptophan	2	CHEMICAL
98205	98206	.	0	None
98206	98207	Enhanced	0	None
98207	98208	beta	0	None
98208	98209	cell	0	None
98209	98210	function	0	None
98210	98211	and	0	None
98211	98212	anti-inflammatory	0	None
98212	98213	effect	0	None
98213	98214	after	0	None
98214	98215	chronic	0	None
98215	98216	treatment	0	None
98216	98217	with	0	None
98217	98218	the	0	None
98218	98220	dipeptidyl peptidase-4	1	GENE-Y
98220	98221	inhibitor	0	None
98221	98222	vildagliptin	0	None
98222	98223	in	0	None
98223	98224	an	0	None
98224	98225	advanced-aged	0	None
98225	98226	diet-induced	0	None
98226	98227	obesity	0	None
98227	98228	mouse	0	None
98228	98229	model	0	None
98229	98230	.	0	None
98230	98231	3-Hydroxypyridin-2-thione	0	None
98231	98232	as	0	None
98232	98233	Novel	0	None
98233	98234	Zinc	2	CHEMICAL
98234	98235	Binding	0	None
98235	98236	Group	0	None
98236	98237	for	0	None
98237	98238	Selective	0	None
98238	98239	Histone	0	None
98239	98240	Deacetylase	0	None
98240	98241	Inhibition	0	None
98241	98242	.	0	None
98242	98243	We	0	None
98243	98244	obtained	0	None
98244	98245	a	0	None
98245	98246	full-length	0	None
98246	98247	cDNA	0	None
98247	98248	based	0	None
98248	98249	on	0	None
98249	98250	a	0	None
98250	98251	sequence	0	None
98251	98252	deposited	0	None
98252	98253	in	0	None
98253	98254	GenBank	0	None
98254	98255	(	0	None
98255	98256	accession	0	None
98256	98257	No	0	None
98257	98258	.	0	None

98259	98260	AB045133	0	None
98260	98261	)	0	None
98261	98262	,	0	None
98262	98263	annotated	0	None
98263	98264	as	0	None
98264	98265	rabbit	0	None
98265	98266	peroxisomal	0	None
98266	98267	NADP	0	None
98267	98268	(	0	None
98268	98269	H	0	None
98269	98270	)	0	None
98270	98271	-dependent	0	None
98271	98272	retinol	2	CHEMICAL
98272	98273	dehydrogenase-reductase	0	None
98273	98274	(	0	None
98274	98275	NDRD	0	None
98275	98276	)	0	None
98276	98277	.	0	None

98278	98279	The	0	None
98279	98280	rabbit	0	None
98280	98281	NDRD	0	None
98281	98282	gene	0	None
98282	98283	,	0	None
98283	98284	like	0	None
98284	98285	its	0	None
98285	98286	mouse	0	None
98286	98287	and	0	None
98287	98288	human	0	None
98288	98289	homologs	0	None
98289	98290	,	0	None
98290	98291	harbors	0	None
98291	98292	2	0	None
98292	98293	initiation	0	None
98293	98294	sites	0	None
98294	98295	,	0	None
98295	98296	one	0	None
98296	98297	of	0	None
98297	98298	which	0	None
98298	98299	theoretically	0	None
98299	98300	encodes	0	None
98300	98301	a	0	None
98301	98302	29	0	None
98302	98303	.	0	None
98303	98304	6	0	None
98304	98305	kDa	0	None
98305	98306	protein	0	None
98306	98307	with	0	None
98307	98308	279	0	None
98308	98310	amino acids	2	CHEMICAL
98310	98311	,	0	None
98311	98312	and	0	None
98312	98313	the	0	None
98313	98314	other	0	None
98314	98315	encodes	0	None
98315	98316	a	0	None
98316	98317	27	0	None
98317	98318	.	0	None
98318	98319	4	0	None
98319	98320	kDa	0	None
98320	98321	protein	0	None
98321	98322	with	0	None
98322	98323	260	0	None
98323	98325	amino acids	2	CHEMICAL
98325	98326	.	0	None

98327	98328	The	0	None
98328	98329	purification	0	None
98329	98330	of	0	None
98330	98331	a	0	None
98331	98332	rabbit	0	None
98332	98333	cytosolic	0	None
98333	98334	retinol	2	CHEMICAL
98334	98335	oxidoreductase	0	None
98335	98336	with	0	None
98336	98337	a	0	None
98337	98338	subunit	0	None
98338	98339	molecular	0	None
98339	98340	mass	0	None
98340	98341	of	0	None
98341	98342	34	0	None
98342	98343	kDa	0	None
98343	98344	and	0	None
98344	98345	an	0	None
98345	98346	N	0	None
98346	98347	terminus	0	None
98347	98348	that	0	None
98348	98349	is	0	None
98349	98350	not	0	None
98350	98351	completely	0	None
98351	98352	identical	0	None
98352	98353	to	0	None
98353	98354	that	0	None
98354	98355	of	0	None
98355	98356	NDRD	0	None
98356	98357	,	0	None
98357	98358	has	0	None
98358	98359	been	0	None
98359	98360	reported	0	None
98360	98361	.	0	None

98362	98363	An	0	None
98363	98364	enzyme	0	None
98364	98365	responsible	0	None
98365	98366	for	0	None
98366	98367	the	0	None
98367	98368	all-trans	0	None
98368	98369	retinal	2	CHEMICAL
98369	98370	reductase	0	None
98370	98371	activity	0	None
98371	98372	in	0	None
98372	98373	the	0	None
98373	98374	liver	0	None
98374	98375	cytosol	0	None
98375	98376	of	0	None
98376	98377	New	0	None
98377	98378	Zealand	0	None
98378	98379	white	0	None
98379	98380	rabbit	0	None
98380	98381	was	0	None
98381	98382	purified	0	None
98382	98383	to	0	None
98383	98384	homogeneity	0	None
98384	98385	using	0	None
98385	98386	differential	0	None
98386	98387	centrifugation	0	None
98387	98388	and	0	None
98388	98389	successive	0	None
98389	98390	chromatographic	0	None
98390	98391	analyses	0	None
98391	98392	.	0	None

98393	98394	The	0	None
98394	98395	subunit	0	None
98395	98396	molecular	0	None
98396	98397	mass	0	None
98397	98398	of	0	None
98398	98399	the	0	None
98399	98400	purified	0	None
98400	98401	enzyme	0	None
98401	98402	,	0	None
98402	98403	revealed	0	None
98403	98404	by	0	None
98404	98405	SDS-PAGE	0	None
98405	98406	,	0	None
98406	98407	was	0	None
98407	98408	approximately	0	None
98408	98409	27	0	None
98409	98410	kDa	0	None
98410	98411	.	0	None

98412	98413	The	0	None
98413	98414	intact	0	None
98414	98415	molecular	0	None
98415	98416	mass	0	None
98416	98417	,	0	None
98417	98418	measured	0	None
98418	98419	by	0	None
98419	98420	MALDI-TOF	0	None
98420	98421	mass	0	None
98421	98422	spectrometry	0	None
98422	98423	,	0	None
98423	98424	was	0	None
98424	98425	27	0	None
98425	98426	.	0	None
98426	98427	368	0	None
98427	98428	kDa	0	None
98428	98429	.	0	None

98430	98431	The	0	None
98431	98432	60	0	None
98432	98433	kDa	0	None
98433	98434	relative	0	None
98434	98435	mobility	0	None
98435	98436	observed	0	None
98436	98437	in	0	None
98437	98438	size-exclusion	0	None
98438	98439	chromatography	0	None
98439	98440	indicates	0	None
98440	98441	that	0	None
98441	98442	the	0	None
98442	98443	native	0	None
98443	98444	protein	0	None
98444	98445	probably	0	None
98445	98446	exists	0	None
98446	98447	as	0	None
98447	98448	a	0	None
98448	98449	dimer	0	None
98449	98450	.	0	None

98451	98452	The	0	None
98452	98453	purified	0	None
98453	98454	enzyme	0	None
98454	98455	was	0	None
98455	98456	positively	0	None
98456	98457	confirmed	0	None
98457	98458	to	0	None
98458	98459	be	0	None
98459	98460	the	0	None
98460	98461	product	0	None
98461	98462	of	0	None
98462	98463	NDRD	0	None
98463	98464	by	0	None
98464	98465	peptide	0	None
98465	98466	mass	0	None
98466	98467	fingerprinting	0	None
98467	98468	,	0	None
98468	98469	tandem	0	None
98469	98470	mass	0	None
98470	98471	spectrometry	0	None
98471	98472	,	0	None
98472	98473	and	0	None
98473	98474	N-terminal	0	None
98474	98475	sequencing	0	None
98475	98476	.	0	None

98477	98478	Taken	0	None
98478	98479	together	0	None
98479	98480	,	0	None
98480	98481	the	0	None
98481	98482	results	0	None
98482	98483	suggested	0	None
98483	98484	that	0	None
98484	98485	the	0	None
98485	98486	native	0	None
98486	98487	protein	0	None
98487	98488	is	0	None
98488	98489	truncated	0	None
98489	98490	at	0	None
98490	98491	the	0	None
98491	98492	N	0	None
98492	98493	terminus	0	None
98493	98494	.	0	None
98494	98495	Apolipoprotein	0	None
98495	98496	E3	0	None
98496	98497	(	0	None
98497	98498	apoE3	0	None
98498	98499	)	0	None
98499	98500	safeguards	0	None
98500	98501	pig	0	None
98501	98502	proximal	0	None
98502	98503	tubular	0	None
98503	98504	LLC-PK1	0	None
98504	98505	cells	0	None
98505	98506	against	0	None
98506	98507	reduction	0	None
98507	98508	in	0	None
98508	98509	SGLT1	0	None
98509	98510	activity	0	None
98510	98511	induced	0	None
98511	98512	by	0	None
98512	98513	gentamicin	0	None
98513	98514	C	0	None
98514	98515	.	0	None
98515	98516	Integrated	0	None
98516	98517	chemical	0	None
98517	98518	and	0	None
98518	98519	biological	0	None
98519	98520	analysis	0	None
98520	98521	to	0	None
98521	98522	explain	0	None
98522	98523	estrogenic	0	None
98523	98524	potency	0	None
98524	98525	in	0	None
98525	98526	bile	0	None
98526	98527	extracts	0	None
98527	98528	of	0	None
98528	98529	red	0	None
98529	98530	mullet	0	None
98530	98531	(	0	None
98531	98532	Mullus	0	None
98532	98533	barbatus	0	None
98533	98534	)	0	None
98534	98535	.	0	None
98535	98536	Dietary	0	None
98536	98537	alpha-linolenic	0	None
98537	98538	acid	0	None
98538	98539	increases	0	None
98539	98540	TNF-alpha	0	None
98540	98541	,	0	None
98541	98542	and	0	None
98542	98543	decreases	0	None
98543	98544	IL-6	0	None
98544	98545	,	0	None
98545	98546	IL-10	0	None
98546	98547	in	0	None
98547	98548	response	0	None
98548	98549	to	0	None
98549	98550	LPS	0	None
98550	98551	:	0	None
98551	98552	effects	0	None
98552	98553	of	0	None
98553	98554	sesamin	0	None
98554	98555	on	0	None
98555	98556	the	0	None
98556	98557	delta-5	0	None
98557	98558	desaturation	0	None
98558	98559	of	0	None
98559	98564	omega6 and omega3 fatty acids	2	CHEMICAL
98564	98565	in	0	None
98565	98566	mice	0	None
98566	98567	.	0	None
98567	98568	Gliomas	0	None
98568	98569	are	0	None
98569	98570	primary	0	None
98570	98571	brain	0	None
98571	98572	tumors	0	None
98572	98573	with	0	None
98573	98574	a	0	None
98574	98575	complex	0	None
98575	98576	biology	0	None
98576	98577	characterized	0	None
98577	98578	by	0	None
98578	98579	antigenic	0	None
98579	98580	and	0	None
98580	98581	genomic	0	None
98581	98582	heterogeneity	0	None
98582	98583	and	0	None
98583	98584	a	0	None
98584	98585	propensity	0	None
98585	98586	for	0	None
98586	98587	invasion	0	None
98587	98588	into	0	None
98588	98589	normal	0	None
98589	98590	brain	0	None
98590	98591	tissue	0	None
98591	98592	.	0	None

98593	98594	High	0	None
98594	98595	grade	0	None
98595	98596	glioma	0	None
98596	98597	cells	0	None
98597	98598	possess	0	None
98598	98599	a	0	None
98599	98600	voltage-independent	0	None
98600	98601	,	0	None
98601	98602	amiloride-inhibitable	0	None
98602	98603	,	0	None
98603	98604	inward	0	None
98604	98605	Na	0	None
98605	98606	+	0	None
98606	98607	current	0	None
98607	98608	.	0	None

98609	98610	This	0	None
98610	98611	current	0	None
98611	98612	does	0	None
98612	98613	not	0	None
98613	98614	exist	0	None
98614	98615	in	0	None
98615	98616	normal	0	None
98616	98617	astrocytes	0	None
98617	98618	or	0	None
98618	98619	low	0	None
98619	98620	grade	0	None
98620	98621	tumor	0	None
98621	98622	cells	0	None
98622	98623	.	0	None

98624	98625	Inhibition	0	None
98625	98626	of	0	None
98626	98627	this	0	None
98627	98628	conductance	0	None
98628	98629	decreases	0	None
98629	98630	glioma	0	None
98630	98631	growth	0	None
98631	98632	and	0	None
98632	98633	cell	0	None
98633	98634	migration	0	None
98634	98635	making	0	None
98635	98636	it	0	None
98636	98637	a	0	None
98637	98638	potential	0	None
98638	98639	therapeutic	0	None
98639	98640	target	0	None
98640	98641	.	0	None

98642	98643	Our	0	None
98643	98644	previous	0	None
98644	98645	results	0	None
98645	98646	have	0	None
98646	98647	shown	0	None
98647	98648	that	0	None
98648	98649	the	0	None
98649	98652	acid-sensing ion channels	3	GENE-N
98652	98653	(	0	None
98653	98654	ASICs	0	None
98654	98655	)	0	None
98655	98656	,	0	None
98656	98657	members	0	None
98657	98658	of	0	None
98658	98659	the	0	None
98659	98660	epithelial	0	None
98660	98661	Na	0	None
98661	98662	+	0	None
98662	98663	channel	0	None
98663	98664	(	0	None
98664	98665	ENaC	0	None
98665	98666	)	0	None
98666	98667	/	0	None
98667	98668	degenerin	0	None
98668	98669	(	0	None
98669	98670	DEG	0	None
98670	98671	)	0	None
98671	98672	family	0	None
98672	98673	of	0	None
98673	98674	ion	0	None
98674	98675	channels	0	None
98675	98676	are	0	None
98676	98677	part	0	None
98677	98678	of	0	None
98678	98679	this	0	None
98679	98680	current	0	None
98680	98681	pathway	0	None
98681	98682	.	0	None

98683	98684	We	0	None
98684	98685	hypothesized	0	None
98685	98686	that	0	None
98686	98687	one	0	None
98687	98688	member	0	None
98688	98689	of	0	None
98689	98690	the	0	None
98690	98691	ENaC	0	None
98691	98692	/	0	None
98692	98693	DEG	0	None
98693	98694	family	0	None
98694	98695	,	0	None
98695	98696	ASIC2	0	None
98696	98697	,	0	None
98697	98698	is	0	None
98698	98699	retained	0	None
98699	98700	intracellularly	0	None
98700	98701	and	0	None
98701	98702	that	0	None
98702	98703	it	0	None
98703	98704	is	0	None
98704	98705	the	0	None
98705	98706	lack	0	None
98706	98707	of	0	None
98707	98708	functional	0	None
98708	98709	expression	0	None
98709	98710	of	0	None
98710	98711	ASIC2	0	None
98711	98712	at	0	None
98712	98713	the	0	None
98713	98714	cell	0	None
98714	98715	surface	0	None
98715	98716	that	0	None
98716	98717	results	0	None
98717	98718	in	0	None
98718	98719	hyperactivity	0	None
98719	98720	of	0	None
98720	98721	this	0	None
98721	98722	conductance	0	None
98722	98723	in	0	None
98723	98724	high	0	None
98724	98725	grade	0	None
98725	98726	gliomas	0	None
98726	98727	.	0	None

98728	98729	In	0	None
98729	98730	this	0	None
98730	98731	study	0	None
98731	98732	we	0	None
98732	98733	show	0	None
98733	98734	that	0	None
98734	98735	the	0	None
98735	98736	chemical	0	None
98736	98737	chaperone	0	None
98737	98738	,	0	None
98738	98739	glycerol	0	None
98739	98740	,	0	None
98740	98741	and	0	None
98741	98742	the	0	None
98742	98743	transcriptional	0	None
98743	98744	regulator	0	None
98744	98745	,	0	None
98745	98746	sodium	2	CHEMICAL
98746	98747	4-phenylbutyrate	0	None
98747	98748	,	0	None
98748	98749	inhibit	0	None
98749	98750	the	0	None
98750	98751	constitutively	0	None
98751	98752	activated	0	None
98752	98753	inward	0	None
98753	98754	current	0	None
98754	98755	and	0	None
98755	98756	reduce	0	None
98756	98757	cell	0	None
98757	98758	growth	0	None
98758	98759	and	0	None
98759	98760	migration	0	None
98760	98761	in	0	None
98761	98762	glioblastoma	0	None
98762	98763	multiforme	0	None
98763	98764	.	0	None

98765	98766	The	0	None
98766	98767	results	0	None
98767	98768	suggest	0	None
98768	98769	that	0	None
98769	98770	these	0	None
98770	98771	compounds	0	None
98771	98772	induce	0	None
98772	98773	the	0	None
98773	98774	movement	0	None
98774	98775	of	0	None
98775	98776	ASIC2	0	None
98776	98777	to	0	None
98777	98778	the	0	None
98778	98779	plasma	0	None
98779	98780	membrane	0	None
98780	98781	,	0	None
98781	98782	and	0	None
98782	98783	once	0	None
98783	98784	there	0	None
98784	98785	,	0	None
98785	98786	the	0	None
98786	98787	basally	0	None
98787	98788	active	0	None
98788	98789	inward	0	None
98789	98790	current	0	None
98790	98791	characteristic	0	None
98791	98792	of	0	None
98792	98793	glioma	0	None
98793	98794	cells	0	None
98794	98795	is	0	None
98795	98796	abolished	0	None
98796	98797	by	0	None
98797	98798	inherent	0	None
98798	98799	negative	0	None
98799	98800	regulatory	0	None
98800	98801	mechanisms	0	None
98801	98802	.	0	None

98803	98804	This	0	None
98804	98805	in	0	None
98805	98806	turn	0	None
98806	98807	compromises	0	None
98807	98808	the	0	None
98808	98809	ability	0	None
98809	98810	of	0	None
98810	98811	the	0	None
98811	98812	glioma	0	None
98812	98813	cell	0	None
98813	98814	to	0	None
98814	98815	migrate	0	None
98815	98816	and	0	None
98816	98817	proliferate	0	None
98817	98818	.	0	None

98819	98820	These	0	None
98820	98821	results	0	None
98821	98822	support	0	None
98822	98823	the	0	None
98823	98824	hypothesis	0	None
98824	98825	that	0	None
98825	98826	the	0	None
98826	98827	conductance	0	None
98827	98828	pathway	0	None
98828	98829	in	0	None
98829	98830	high	0	None
98830	98831	grade	0	None
98831	98832	glioma	0	None
98832	98833	cells	0	None
98833	98834	is	0	None
98834	98835	comprised	0	None
98835	98836	of	0	None
98836	98837	ENaC	0	None
98837	98838	/	0	None
98838	98839	DEG	0	None
98839	98840	subunits	0	None
98840	98841	and	0	None
98841	98842	that	0	None
98842	98843	abolishing	0	None
98843	98844	this	0	None
98844	98845	channel	0	None
98845	98846	activity	0	None
98846	98847	promotes	0	None
98847	98848	a	0	None
98848	98849	reversion	0	None
98849	98850	of	0	None
98850	98851	a	0	None
98851	98852	high	0	None
98852	98853	grade	0	None
98853	98854	glioma	0	None
98854	98855	cell	0	None
98855	98856	to	0	None
98856	98857	a	0	None
98857	98858	phenotype	0	None
98858	98859	resembling	0	None
98859	98860	that	0	None
98860	98861	of	0	None
98861	98862	normal	0	None
98862	98863	astrocytes	0	None
98863	98864	.	0	None
98864	98865	Assignment	0	None
98865	98866	of	0	None
98866	98867	anabolic-androgenic	0	None
98867	98868	and	0	None
98868	98869	antiandrogenic	0	None
98869	98870	properties	0	None
98870	98871	to	0	None
98871	98872	some	0	None
98872	98873	chlorine-substituted	0	None
98873	98874	steroids	0	None
98874	98875	on	0	None
98875	98876	the	0	None
98876	98877	basis	0	None
98877	98878	of	0	None
98878	98879	their	0	None
98879	98880	binding	0	None
98880	98881	characteristics	0	None
98881	98882	to	0	None
98882	98883	the	0	None
98883	98885	androgen receptor	3	GENE-N
98885	98886	of	0	None
98886	98887	the	0	None
98887	98888	rat	0	None
98888	98889	seminal	0	None
98889	98890	vesicle	0	None
98890	98891	.	0	None
98891	98892	Alzheimer's	0	None
98892	98893	disease	0	None
98893	98894	(	0	None
98894	98895	AD	0	None
98895	98896	)	0	None
98896	98897	is	0	None
98897	98898	a	0	None
98898	98899	progressive	0	None
98899	98900	neurodegenerative	0	None
98900	98901	disorder	0	None
98901	98902	that	0	None
98902	98903	is	0	None
98903	98904	characterized	0	None
98904	98905	by	0	None
98905	98906	progressive	0	None
98906	98907	loss	0	None
98907	98908	of	0	None
98908	98909	memory	0	None
98909	98910	and	0	None
98910	98911	cognitive	0	None
98911	98912	impairment	0	None
98912	98913	.	0	None

98914	98915	Aggregation	0	None
98915	98916	of	0	None
98916	98917	amyloid-β	0	None
98917	98918	(	0	None
98918	98919	Aβ	0	None
98919	98920	)	0	None
98920	98921	peptides	0	None
98921	98922	is	0	None
98922	98923	the	0	None
98923	98924	crucial	0	None
98924	98925	factor	0	None
98925	98926	in	0	None
98926	98927	the	0	None
98927	98928	onset	0	None
98928	98929	of	0	None
98929	98930	AD	0	None
98930	98931	.	0	None

98932	98933	The	0	None
98933	98934	toxic	0	None
98934	98935	Aβ	0	None
98935	98936	peptides	0	None
98936	98937	Aβ40	0	None
98937	98938	and	0	None
98938	98939	Aβ42	0	None
98939	98940	are	0	None
98940	98941	produced	0	None
98941	98942	from	0	None
98942	98943	the	0	None
98943	98944	Aβ	0	None
98944	98945	precursor	0	None
98945	98946	protein	0	None
98946	98947	(	0	None
98947	98948	APP	0	None
98948	98949	)	0	None
98949	98950	,	0	None
98950	98951	a	0	None
98951	98952	transmembrane	0	None
98952	98953	protein	0	None
98953	98954	which	0	None
98954	98955	is	0	None
98955	98956	folded	0	None
98956	98957	and	0	None
98957	98958	modified	0	None
98958	98959	in	0	None
98959	98960	endoplasmic	0	None
98960	98961	reticulum	0	None
98961	98962	(	0	None
98962	98963	ER	0	None
98963	98964	)	0	None
98964	98965	.	0	None

98966	98967	ER	0	None
98967	98968	is	0	None
98968	98969	the	0	None
98969	98970	main	0	None
98970	98971	organelle	0	None
98971	98972	for	0	None
98972	98973	the	0	None
98973	98974	synthesis	0	None
98974	98975	and	0	None
98975	98976	processing	0	None
98976	98977	of	0	None
98977	98978	nearly	0	None
98978	98979	all	0	None
98979	98980	proteins	0	None
98980	98981	as	0	None
98981	98982	well	0	None
98982	98983	as	0	None
98983	98984	the	0	None
98984	98985	main	0	None
98985	98986	cellular	0	None
98986	98987	source	0	None
98987	98988	of	0	None
98988	98989	Ca2	0	None
98989	98990	+	0	None
98990	98991	.	0	None

98992	98993	Under	0	None
98993	98994	stress	0	None
98994	98995	conditions	0	None
98995	98996	,	0	None
98996	98997	three	0	None
98997	98998	main	0	None
98998	98999	ER	0	None
98999	99000	pathways	0	None
99000	99001	including	0	None
99001	99002	inositol-requiring	0	None
99002	99003	enzyme	0	None
99003	99004	1	0	None
99004	99005	,	0	None
99005	99010	protein kinase RNA-like ER kinase	1	GENE-Y
99010	99011	,	0	None
99011	99012	and	0	None
99012	99016	activating transcription factor 6	1	GENE-Y
99016	99017	become	0	None
99017	99018	activated	0	None
99018	99019	causing	0	None
99019	99020	the	0	None
99020	99021	accumulation	0	None
99021	99022	of	0	None
99022	99023	unfolded	0	None
99023	99024	or	0	None
99024	99025	misfolded	0	None
99025	99026	proteins	0	None
99026	99027	within	0	None
99027	99028	ER	0	None
99028	99029	lumen	0	None
99029	99030	.	0	None

99031	99032	These	0	None
99032	99033	pathways	0	None
99033	99034	manage	0	None
99034	99035	the	0	None
99035	99036	stress	0	None
99036	99037	by	0	None
99037	99038	regulating	0	None
99038	99039	the	0	None
99039	99040	expression	0	None
99040	99041	of	0	None
99041	99042	chaperones	0	None
99042	99043	and	0	None
99043	99044	enzymes	0	None
99044	99045	involved	0	None
99045	99046	in	0	None
99046	99047	protein	0	None
99047	99048	folding	0	None
99048	99049	.	0	None

99050	99051	Several	0	None
99051	99052	studies	0	None
99052	99053	have	0	None
99053	99054	reported	0	None
99054	99055	the	0	None
99055	99056	dysfunction	0	None
99056	99057	of	0	None
99057	99058	these	0	None
99058	99059	stress-sensing	0	None
99059	99060	pathways	0	None
99060	99061	in	0	None
99061	99062	pathological	0	None
99062	99063	conditions	0	None
99063	99064	,	0	None
99064	99065	including	0	None
99065	99066	neurodegenerative	0	None
99066	99067	diseases	0	None
99067	99068	.	0	None

99069	99070	Recent	0	None
99070	99071	studies	0	None
99071	99072	have	0	None
99072	99073	proposed	0	None
99073	99074	that	0	None
99074	99075	neuronal	0	None
99075	99076	death	0	None
99076	99077	in	0	None
99077	99078	AD	0	None
99078	99079	arises	0	None
99079	99080	from	0	None
99080	99081	dysfunction	0	None
99081	99082	of	0	None
99082	99083	the	0	None
99083	99084	ER	0	None
99084	99085	.	0	None

99086	99087	Here	0	None
99087	99088	,	0	None
99088	99089	we	0	None
99089	99090	will	0	None
99090	99091	review	0	None
99091	99092	recent	0	None
99092	99093	research	0	None
99093	99094	findings	0	None
99094	99095	on	0	None
99095	99096	the	0	None
99096	99097	interaction	0	None
99097	99098	between	0	None
99098	99099	ER	0	None
99099	99100	and	0	None
99100	99101	mitochondria	0	None
99101	99102	,	0	None
99102	99103	and	0	None
99103	99104	its	0	None
99104	99105	effect	0	None
99105	99106	on	0	None
99106	99107	apoptotic	0	None
99107	99108	pathways	0	None
99108	99109	.	0	None

99110	99111	We	0	None
99111	99112	further	0	None
99112	99113	provide	0	None
99113	99114	insights	0	None
99114	99115	into	0	None
99115	99116	studies	0	None
99116	99117	which	0	None
99117	99118	suggest	0	None
99118	99119	the	0	None
99119	99120	role	0	None
99120	99121	of	0	None
99121	99122	ER	0	None
99122	99123	in	0	None
99123	99124	animal	0	None
99124	99125	and	0	None
99125	99126	/	0	None
99126	99127	or	0	None
99127	99128	cellular	0	None
99128	99129	models	0	None
99129	99130	of	0	None
99130	99131	AD	0	None
99131	99132	.	0	None

99133	99134	Therapeutic	0	None
99134	99135	strategies	0	None
99135	99136	that	0	None
99136	99137	modulate	0	None
99137	99138	ER	0	None
99138	99139	could	0	None
99139	99140	represent	0	None
99140	99141	a	0	None
99141	99142	promising	0	None
99142	99143	approach	0	None
99143	99144	for	0	None
99144	99145	prevention	0	None
99145	99146	or	0	None
99146	99147	treatment	0	None
99147	99148	of	0	None
99148	99149	AD	0	None
99149	99150	.	0	None
99150	99151	Fat	0	None
99151	99152	infiltration	0	None
99152	99153	within	0	None
99153	99154	muscle	0	None
99154	99155	is	0	None
99155	99156	one	0	None
99156	99157	of	0	None
99157	99158	a	0	None
99158	99159	number	0	None
99159	99160	of	0	None
99160	99161	features	0	None
99161	99162	of	0	None
99162	99164	vitamin D	2	CHEMICAL
99164	99165	deficiency	0	None
99165	99166	,	0	None
99166	99167	which	0	None
99167	99168	leads	0	None
99168	99169	to	0	None
99169	99170	a	0	None
99170	99171	decline	0	None
99171	99172	in	0	None
99172	99173	muscle	0	None
99173	99174	functionality	0	None
99174	99175	.	0	None

99176	99177	The	0	None
99177	99178	origin	0	None
99178	99179	of	0	None
99179	99180	this	0	None
99180	99181	fat	0	None
99181	99182	is	0	None
99182	99183	unclear	0	None
99183	99184	,	0	None
99184	99185	but	0	None
99185	99186	one	0	None
99186	99187	possibility	0	None
99187	99188	is	0	None
99188	99189	that	0	None
99189	99190	it	0	None
99190	99191	forms	0	None
99191	99192	from	0	None
99192	99193	myogenic	0	None
99193	99194	precursor	0	None
99194	99195	cells	0	None
99195	99196	present	0	None
99196	99197	in	0	None
99197	99198	the	0	None
99198	99199	muscle	0	None
99199	99200	,	0	None
99200	99201	which	0	None
99201	99202	transdifferentiate	0	None
99202	99203	into	0	None
99203	99204	mature	0	None
99204	99205	adipocytes	0	None
99205	99206	.	0	None

99207	99208	The	0	None
99208	99209	current	0	None
99209	99210	study	0	None
99210	99211	examined	0	None
99211	99212	the	0	None
99212	99213	effect	0	None
99213	99214	of	0	None
99214	99215	the	0	None
99215	99216	active	0	None
99216	99217	form	0	None
99217	99218	of	0	None
99218	99220	vitamin D₃	2	CHEMICAL
99220	99221	,	0	None
99221	99222	1	0	None
99222	99223	,	0	None
99223	99224	25-dihydroxyvitamin	0	None
99224	99225	D₃	0	None
99225	99226	(	0	None
99226	99227	1	0	None
99227	99228	,	0	None
99228	99229	25	0	None
99229	99230	(	0	None
99230	99231	OH	0	None
99231	99232	)	0	None
99232	99233	₂D₃	0	None
99233	99234	)	0	None
99234	99235	,	0	None
99235	99236	on	0	None
99236	99237	the	0	None
99237	99238	capacity	0	None
99238	99239	of	0	None
99239	99240	the	0	None
99240	99241	C2C12	0	None
99241	99242	muscle	0	None
99242	99243	cell	0	None
99243	99244	line	0	None
99244	99245	to	0	None
99245	99246	differentiate	0	None
99246	99247	towards	0	None
99247	99248	the	0	None
99248	99249	myogenic	0	None
99249	99250	and	0	None
99250	99251	adipogenic	0	None
99251	99252	lineages	0	None
99252	99253	.	0	None

99254	99255	Cells	0	None
99255	99256	were	0	None
99256	99257	cultured	0	None
99257	99258	in	0	None
99258	99259	myogenic	0	None
99259	99260	or	0	None
99260	99261	adipogenic	0	None
99261	99262	differentiation	0	None
99262	99263	media	0	None
99263	99264	containing	0	None
99264	99265	increasing	0	None
99265	99266	concentrations	0	None
99266	99267	(	0	None
99267	99268	0	0	None
99268	99269	,	0	None
99269	99270	10⁻¹³	0	None
99270	99271	,	0	None
99271	99272	10⁻¹¹	0	None
99272	99273	,	0	None
99273	99274	10⁻⁹	0	None
99274	99275	,	0	None
99275	99276	10⁻⁷	0	None
99276	99277	or	0	None
99277	99278	10⁻⁵	0	None
99278	99279	M	0	None
99279	99280	)	0	None
99280	99281	of	0	None
99281	99282	1	0	None
99282	99283	,	0	None
99283	99284	25	0	None
99284	99285	(	0	None
99285	99286	OH	0	None
99286	99287	)	0	None
99287	99288	₂D₃	0	None
99288	99289	for	0	None
99289	99290	up	0	None
99290	99291	to	0	None
99291	99292	6	0	None
99292	99293	days	0	None
99293	99294	and	0	None
99294	99295	markers	0	None
99295	99296	of	0	None
99296	99297	muscle	0	None
99297	99298	and	0	None
99298	99299	fat	0	None
99299	99300	development	0	None
99300	99301	measured	0	None
99301	99302	.	0	None

99303	99304	Mature	0	None
99304	99305	myofibres	0	None
99305	99306	were	0	None
99306	99307	formed	0	None
99307	99308	in	0	None
99308	99309	both	0	None
99309	99310	adipogenic	0	None
99310	99311	and	0	None
99311	99312	myogenic	0	None
99312	99313	media	0	None
99313	99314	,	0	None
99314	99315	but	0	None
99315	99316	fat	0	None
99316	99317	droplets	0	None
99317	99318	were	0	None
99318	99319	only	0	None
99319	99320	observed	0	None
99320	99321	in	0	None
99321	99322	adipogenic	0	None
99322	99323	media	0	None
99323	99324	.	0	None

99325	99326	Relative	0	None
99326	99327	to	0	None
99327	99328	controls	0	None
99328	99329	,	0	None
99329	99330	low	0	None
99330	99331	physiological	0	None
99331	99332	concentrations	0	None
99332	99333	(	0	None
99333	99334	10⁻¹³	0	None
99334	99335	and	0	None
99335	99336	10⁻¹¹	0	None
99336	99337	M	0	None
99337	99338	)	0	None
99338	99339	of	0	None
99339	99340	1	0	None
99340	99341	,	0	None
99341	99342	25	0	None
99342	99343	(	0	None
99343	99344	OH	0	None
99344	99345	)	0	None
99345	99346	₂D3	0	None
99346	99347	increased	0	None
99347	99348	fat	0	None
99348	99349	droplet	0	None
99349	99350	accumulation	0	None
99350	99351	,	0	None
99351	99352	whereas	0	None
99352	99353	high	0	None
99353	99354	physiological	0	None
99354	99355	(	0	None
99355	99356	10⁻⁹	0	None
99356	99357	M	0	None
99357	99358	)	0	None
99358	99359	and	0	None
99359	99360	supraphysiological	0	None
99360	99361	concentrations	0	None
99361	99362	(	0	None
99362	99363	≥10⁻⁷	0	None
99363	99364	M	0	None
99364	99365	)	0	None
99365	99366	inhibited	0	None
99366	99367	fat	0	None
99367	99368	accumulation	0	None
99368	99369	.	0	None

99370	99371	This	0	None
99371	99372	increased	0	None
99372	99373	accumulation	0	None
99373	99374	of	0	None
99374	99375	fat	0	None
99375	99376	with	0	None
99376	99377	low	0	None
99377	99378	physiological	0	None
99378	99379	concentrations	0	None
99379	99380	(	0	None
99380	99381	10⁻¹³	0	None
99381	99382	and	0	None
99382	99383	10⁻¹¹	0	None
99383	99384	M	0	None
99384	99385	)	0	None
99385	99386	was	0	None
99386	99387	associated	0	None
99387	99388	with	0	None
99388	99389	a	0	None
99389	99390	sequential	0	None
99390	99391	up-regulation	0	None
99391	99392	of	0	None
99392	99393	PPARγ2	0	None
99393	99394	(	0	None
99394	99395	PPARG	0	None
99395	99396	)	0	None
99396	99397	and	0	None
99397	99398	FABP4	1	GENE-Y
99398	99399	mRNA	0	None
99399	99400	,	0	None
99400	99401	indicating	0	None
99401	99402	formation	0	None
99402	99403	of	0	None
99403	99404	adipocytes	0	None
99404	99405	,	0	None
99405	99406	whereas	0	None
99406	99407	higher	0	None
99407	99408	concentrations	0	None
99408	99409	(	0	None
99409	99410	≥10⁻⁹	0	None
99410	99411	M	0	None
99411	99412	)	0	None
99412	99413	reduced	0	None
99413	99414	all	0	None
99414	99415	these	0	None
99415	99416	effects	0	None
99416	99417	,	0	None
99417	99418	and	0	None
99418	99419	the	0	None
99419	99420	highest	0	None
99420	99421	concentration	0	None
99421	99422	(	0	None
99422	99423	10⁻⁵	0	None
99423	99424	M	0	None
99424	99425	)	0	None
99425	99426	appeared	0	None
99426	99427	to	0	None
99427	99428	have	0	None
99428	99429	toxic	0	None
99429	99430	effects	0	None
99430	99431	.	0	None

99432	99433	This	0	None
99433	99434	is	0	None
99434	99435	the	0	None
99435	99436	first	0	None
99436	99437	study	0	None
99437	99438	to	0	None
99438	99439	demonstrate	0	None
99439	99440	dose-dependent	0	None
99440	99441	effects	0	None
99441	99442	of	0	None
99442	99443	1	0	None
99443	99444	,	0	None
99444	99445	25	0	None
99445	99446	(	0	None
99446	99447	OH	0	None
99447	99448	)	0	None
99448	99449	₂D₃	0	None
99449	99450	on	0	None
99450	99451	the	0	None
99451	99452	transdifferentiation	0	None
99452	99453	of	0	None
99453	99454	muscle	0	None
99454	99455	cells	0	None
99455	99456	into	0	None
99456	99457	adipose	0	None
99457	99458	cells	0	None
99458	99459	.	0	None

99460	99461	Low	0	None
99461	99462	physiological	0	None
99462	99463	concentrations	0	None
99463	99464	(	0	None
99464	99465	possibly	0	None
99465	99466	mimicking	0	None
99466	99467	a	0	None
99467	99468	deficient	0	None
99468	99469	state	0	None
99469	99470	)	0	None
99470	99471	induced	0	None
99471	99472	adipogenesis	0	None
99472	99473	,	0	None
99473	99474	whereas	0	None
99474	99475	higher	0	None
99475	99476	(	0	None
99476	99477	physiological	0	None
99477	99478	and	0	None
99478	99479	supraphysiological	0	None
99479	99480	)	0	None
99480	99481	concentrations	0	None
99481	99482	attenuated	0	None
99482	99483	this	0	None
99483	99484	effect	0	None
99484	99485	.	0	None
99485	99487	Vitamin E	2	CHEMICAL
99487	99488	(	0	None
99488	99489	alpha-tocopherol	0	None
99489	99490	)	0	None
99490	99491	is	0	None
99491	99492	an	0	None
99492	99493	essential	0	None
99493	99494	fat-soluble	0	None
99494	99495	nutrient	0	None
99495	99496	with	0	None
99496	99497	antioxidant	0	None
99497	99498	properties	0	None
99498	99499	.	0	None

99500	99501	alpha-Tocopherol	0	None
99501	99502	transfer	0	None
99502	99503	protein	0	None
99503	99504	(	0	None
99504	99505	alpha-TTP	0	None
99505	99506	)	0	None
99506	99507	,	0	None
99507	99508	the	0	None
99508	99509	product	0	None
99509	99510	of	0	None
99510	99511	the	0	None
99511	99512	gene	0	None
99512	99513	responsible	0	None
99513	99514	for	0	None
99514	99515	familial	0	None
99515	99516	isolated	0	None
99516	99518	vitamin E	2	CHEMICAL
99518	99519	deficiency	0	None
99519	99520	,	0	None
99520	99521	plays	0	None
99521	99522	an	0	None
99522	99523	important	0	None
99523	99524	role	0	None
99524	99525	in	0	None
99525	99526	maintaining	0	None
99526	99527	the	0	None
99527	99528	plasma	0	None
99528	99529	alpha-tocopherol	0	None
99529	99530	level	0	None
99530	99531	by	0	None
99531	99532	mediating	0	None
99532	99533	the	0	None
99533	99534	secretion	0	None
99534	99535	of	0	None
99535	99536	alpha-tocopherol	0	None
99536	99537	by	0	None
99537	99538	the	0	None
99538	99539	liver	0	None
99539	99540	.	0	None

99541	99542	However	0	None
99542	99543	,	0	None
99543	99544	the	0	None
99544	99545	mechanisms	0	None
99545	99546	underlying	0	None
99546	99547	hepatic	0	None
99547	99548	alpha-tocopherol	0	None
99548	99549	secretion	0	None
99549	99550	are	0	None
99550	99551	not	0	None
99551	99552	fully	0	None
99552	99553	understood	0	None
99553	99554	.	0	None

99555	99556	This	0	None
99556	99557	study	0	None
99557	99558	was	0	None
99558	99559	undertaken	0	None
99559	99560	to	0	None
99560	99561	elucidate	0	None
99561	99562	the	0	None
99562	99563	mechanism	0	None
99563	99564	of	0	None
99564	99565	alpha-tocopherol	0	None
99565	99566	re-efflux	0	None
99566	99567	from	0	None
99567	99568	hepatocytes	0	None
99568	99569	,	0	None
99569	99570	the	0	None
99570	99571	cells	0	None
99571	99572	that	0	None
99572	99573	have	0	None
99573	99574	the	0	None
99574	99575	most	0	None
99575	99576	important	0	None
99576	99577	role	0	None
99577	99578	in	0	None
99578	99579	regulating	0	None
99579	99580	plasma-alpha-tocopherol	0	None
99580	99581	concentrations	0	None
99581	99582	.	0	None

99583	99584	From	0	None
99584	99585	in	0	None
99585	99586	vitro	0	None
99586	99587	experiments	0	None
99587	99588	using	0	None
99588	99589	[	0	None
99589	99590	(	0	None
99590	99591	3	0	None
99591	99592	)	0	None
99592	99593	H	0	None
99593	99594	]	0	None
99594	99595	alpha-tocopheryl	0	None
99595	99596	acetate	0	None
99596	99597	and	0	None
99597	99598	McARH7777	0	None
99598	99599	cells	0	None
99599	99600	that	0	None
99600	99601	stably	0	None
99601	99602	express	0	None
99602	99603	alpha-tocopherol	0	None
99603	99604	transfer	0	None
99604	99605	protein	0	None
99605	99606	(	0	None
99606	99607	alpha-TTP	0	None
99607	99608	)	0	None
99608	99609	,	0	None
99609	99610	the	0	None
99610	99611	following	0	None
99611	99612	results	0	None
99612	99613	were	0	None
99613	99614	obtained	0	None
99614	99615	.	0	None

99616	99617	First	0	None
99617	99618	,	0	None
99618	99619	addition	0	None
99619	99620	of	0	None
99620	99621	apolipoprotein	0	None
99621	99622	A-I	0	None
99622	99623	(	0	None
99623	99624	apoA-I	0	None
99624	99625	)	0	None
99625	99626	,	0	None
99626	99627	a	0	None
99627	99628	direct	0	None
99628	99629	acceptor	0	None
99629	99630	of	0	None
99630	99631	the	0	None
99631	99632	ATP-binding	0	None
99632	99633	cassette	0	None
99633	99634	transporter	0	None
99634	99635	A1	1	GENE-Y
99635	99636	(	0	None
99636	99637	ABCA1	0	None
99637	99638	)	0	None
99638	99639	-secreted	0	None
99639	99640	lipids	0	None
99640	99641	,	0	None
99641	99642	increased	0	None
99642	99643	alpha-tocopherol	0	None
99643	99644	secretion	0	None
99644	99645	in	0	None
99645	99646	a	0	None
99646	99647	dose-dependent	0	None
99647	99648	manner	0	None
99648	99649	.	0	None

99650	99651	Second	0	None
99651	99652	,	0	None
99652	99653	probucol	2	CHEMICAL
99653	99654	,	0	None
99654	99655	an	0	None
99655	99656	antiatherogenic	0	None
99656	99657	compound	0	None
99657	99658	reported	0	None
99658	99659	to	0	None
99659	99660	be	0	None
99660	99661	an	0	None
99661	99662	inactivator	0	None
99662	99663	of	0	None
99663	99664	ABCA1	0	None
99664	99665	reduced	0	None
99665	99666	hepatic	0	None
99666	99667	alpha-tocopherol	0	None
99667	99668	secretion	0	None
99668	99669	.	0	None

99670	99671	Third	0	None
99671	99672	,	0	None
99672	99673	ABCA1-RNAi	0	None
99673	99674	suppressed	0	None
99674	99675	hepatic	0	None
99675	99676	alpha-tocopherol	0	None
99676	99677	secretion	0	None
99677	99678	.	0	None

99679	99680	In	0	None
99680	99681	a	0	None
99681	99682	mouse	0	None
99682	99683	in	0	None
99683	99684	vivo	0	None
99684	99685	experiment	0	None
99685	99686	,	0	None
99686	99687	addition	0	None
99687	99688	of	0	None
99688	99689	1%	0	None
99689	99690	probucol	2	CHEMICAL
99690	99691	to	0	None
99691	99692	the	0	None
99692	99693	diet	0	None
99693	99694	decreased	0	None
99694	99695	plasma	0	None
99695	99696	alpha-tocopherol	0	None
99696	99697	concentrations	0	None
99697	99698	.	0	None

99699	99700	These	0	None
99700	99701	results	0	None
99701	99702	strongly	0	None
99702	99703	suggest	0	None
99703	99704	that	0	None
99704	99705	ABCA1	0	None
99705	99706	is	0	None
99706	99707	substantially	0	None
99707	99708	involved	0	None
99708	99709	in	0	None
99709	99710	hepatic	0	None
99710	99711	alpha-tocopherol	0	None
99711	99712	secretion	0	None
99712	99713	.	0	None
99713	99714	2-Amino-1-methyl-6-phenylimidazo	0	None
99714	99715	[	0	None
99715	99716	4	0	None
99716	99717	,	0	None
99717	99718	5-b	0	None
99718	99719	]	0	None
99719	99720	pyridine	0	None
99720	99721	(	0	None
99721	99722	PhIP	0	None
99722	99723	)	0	None
99723	99724	is	0	None
99724	99725	one	0	None
99725	99726	of	0	None
99726	99727	the	0	None
99727	99728	most	0	None
99728	99729	abundant	0	None
99729	99730	heterocyclic	0	None
99730	99731	amines	0	None
99731	99732	(	0	None
99732	99733	HCAs	0	None
99733	99734	)	0	None
99734	99735	generated	0	None
99735	99736	from	0	None
99736	99737	overcooking	0	None
99737	99738	meat	0	None
99738	99739	at	0	None
99739	99740	high	0	None
99740	99741	temperatures	0	None
99741	99742	.	0	None

99743	99744	To	0	None
99744	99745	understand	0	None
99745	99746	the	0	None
99746	99747	possible	0	None
99747	99748	mechanism	0	None
99748	99749	of	0	None
99749	99750	PhIP-associated	0	None
99750	99751	stomach	0	None
99751	99752	cancer	0	None
99752	99753	,	0	None
99753	99754	the	0	None
99754	99755	effects	0	None
99755	99756	of	0	None
99756	99757	PhIP	0	None
99757	99758	on	0	None
99758	99759	morphology	0	None
99759	99760	,	0	None
99760	99761	oxidative	0	None
99761	99762	stress	0	None
99762	99763	,	0	None
99763	99764	gene	0	None
99764	99765	expression	0	None
99765	99766	of	0	None
99766	99767	c-fos	1	GENE-Y
99767	99768	,	0	None
99768	99769	c-jun	1	GENE-Y
99769	99770	and	0	None
99770	99771	p16	0	None
99771	99772	in	0	None
99772	99773	rat	0	None
99773	99774	stomachs	0	None
99774	99775	were	0	None
99775	99776	investigated	0	None
99776	99777	.	0	None

99778	99779	The	0	None
99779	99780	results	0	None
99780	99781	showed	0	None
99781	99782	that	0	None
99782	99783	(	0	None
99783	99784	1	0	None
99784	99785	)	0	None
99785	99786	15mg	0	None
99786	99787	/	0	None
99787	99788	kg	0	None
99788	99789	body	0	None
99789	99790	weight	0	None
99790	99791	PhIP	0	None
99791	99792	induced	0	None
99792	99793	obvious	0	None
99793	99794	histopathological	0	None
99794	99795	changes	0	None
99795	99796	in	0	None
99796	99797	gastric	0	None
99797	99798	mucosa;	0	None
99798	99799	(	0	None
99799	99800	2	0	None
99800	99801	)	0	None
99801	99802	PhIP	0	None
99802	99803	(	0	None
99803	99804	10	0	None
99804	99805	and	0	None
99805	99806	/	0	None
99806	99807	or	0	None
99807	99808	15mg	0	None
99808	99809	/	0	None
99809	99810	kg	0	None
99810	99811	)	0	None
99811	99812	significantly	0	None
99812	99813	decreased	0	None
99813	99814	superoxide	0	None
99814	99815	dismutase	0	None
99815	99816	(	0	None
99816	99817	SOD	1	GENE-Y
99817	99818	)	0	None
99818	99819	and	0	None
99819	99820	glutathioneperoxidase	0	None
99820	99821	(	0	None
99821	99822	GPx	0	None
99822	99823	)	0	None
99823	99824	activities	0	None
99824	99825	,	0	None
99825	99826	while	0	None
99826	99827	increased	0	None
99827	99828	catalase	0	None
99828	99829	(	0	None
99829	99830	CAT	0	None
99830	99831	)	0	None
99831	99832	activity	0	None
99832	99833	compared	0	None
99833	99834	with	0	None
99834	99835	the	0	None
99835	99836	control	0	None
99836	99837	.	0	None

99838	99839	With	0	None
99839	99840	the	0	None
99840	99841	elevated	0	None
99841	99842	doses	0	None
99842	99843	of	0	None
99843	99844	PhIP	0	None
99844	99845	,	0	None
99845	99846	malondialdehyde	2	CHEMICAL
99846	99847	(	0	None
99847	99848	MDA	0	None
99848	99849	)	0	None
99849	99850	contents	0	None
99850	99851	,	0	None
99851	99852	protein	0	None
99852	99853	carbonyl	0	None
99853	99854	(	0	None
99854	99855	PCO	0	None
99855	99856	)	0	None
99856	99857	contents	0	None
99857	99858	and	0	None
99858	99859	DNA-protein	0	None
99859	99860	crosslinks	0	None
99860	99861	(	0	None
99861	99862	DPC	0	None
99862	99863	)	0	None
99863	99864	coefficients	0	None
99864	99865	were	0	None
99865	99866	significantly	0	None
99866	99867	raised	0	None
99867	99868	in	0	None
99868	99869	a	0	None
99869	99870	dose-dependent	0	None
99870	99871	manner;	0	None
99871	99872	(	0	None
99872	99873	3	0	None
99873	99874	)	0	None
99874	99875	PhIP	0	None
99875	99876	at	0	None
99876	99877	the	0	None
99877	99878	doses	0	None
99878	99879	of	0	None
99879	99880	10mg	0	None
99880	99881	/	0	None
99881	99882	kg	0	None
99882	99883	and	0	None
99883	99884	/	0	None
99884	99885	or	0	None
99885	99886	15mg	0	None
99886	99887	/	0	None
99887	99888	kg	0	None
99888	99889	significantly	0	None
99889	99890	inhibited	0	None
99890	99891	p16	0	None
99891	99892	mRNA	0	None
99892	99893	and	0	None
99893	99894	protein	0	None
99894	99895	expression	0	None
99895	99896	,	0	None
99896	99897	whereas	0	None
99897	99898	enhanced	0	None
99898	99899	c-fos	1	GENE-Y
99899	99900	and	0	None
99900	99901	c-jun	1	GENE-Y
99901	99902	expression	0	None
99902	99903	relative	0	None
99903	99904	to	0	None
99904	99905	control	0	None
99905	99906	.	0	None

99907	99908	The	0	None
99908	99909	data	0	None
99909	99910	indicated	0	None
99910	99911	that	0	None
99911	99912	PhIP	0	None
99912	99913	could	0	None
99913	99914	cause	0	None
99914	99915	stomach	0	None
99915	99916	injury	0	None
99916	99917	,	0	None
99917	99918	oxidative	0	None
99918	99919	stress	0	None
99919	99920	in	0	None
99920	99921	rat	0	None
99921	99922	stomachs	0	None
99922	99923	as	0	None
99923	99924	well	0	None
99924	99925	as	0	None
99925	99926	the	0	None
99926	99927	activation	0	None
99927	99928	of	0	None
99928	99929	c-fos	1	GENE-Y
99929	99930	and	0	None
99930	99931	c-jun	1	GENE-Y
99931	99932	and	0	None
99932	99933	inactivation	0	None
99933	99934	of	0	None
99934	99935	p16	0	None
99935	99936	,	0	None
99936	99937	which	0	None
99937	99938	may	0	None
99938	99939	play	0	None
99939	99940	a	0	None
99940	99941	role	0	None
99941	99942	in	0	None
99942	99943	the	0	None
99943	99944	pathogenesis	0	None
99944	99945	of	0	None
99945	99946	PhIP-associated	0	None
99946	99947	stomach	0	None
99947	99948	cancer	0	None
99948	99949	.	0	None
99949	99950	In	0	None
99950	99951	vitro	0	None
99951	99952	antiprogestational	0	None
99952	99953	/	0	None
99953	99954	antiglucocorticoid	0	None
99954	99955	activity	0	None
99955	99956	and	0	None
99956	99957	progestin	0	None
99957	99958	and	0	None
99958	99960	glucocorticoid receptor	1	GENE-Y
99960	99961	binding	0	None
99961	99962	of	0	None
99962	99963	the	0	None
99963	99964	putative	0	None
99964	99965	metabolites	0	None
99965	99966	and	0	None
99966	99967	synthetic	0	None
99967	99968	derivatives	0	None
99968	99969	of	0	None
99969	99970	CDB-2914	0	None
99970	99971	,	0	None
99971	99972	CDB-4124	0	None
99972	99973	,	0	None
99973	99974	and	0	None
99974	99975	mifepristone	2	CHEMICAL
99975	99976	.	0	None
99976	99977	Non-targeted	0	None
99977	99978	metabolomic	0	None
99978	99979	approach	0	None
99979	99980	reveals	0	None
99980	99981	urinary	0	None
99981	99982	metabolites	0	None
99982	99983	linked	0	None
99983	99984	to	0	None
99984	99985	steroid	2	CHEMICAL
99985	99986	biosynthesis	0	None
99986	99987	pathway	0	None
99987	99988	after	0	None
99988	99989	ingestion	0	None
99989	99990	of	0	None
99990	99991	citrus	0	None
99991	99992	juice	0	None
99992	99993	.	0	None
99993	99994	Based	0	None
99994	99995	on	0	None
99995	99996	detailed	0	None
99996	99997	,	0	None
99997	99998	high	0	None
99998	99999	level	0	None
99999	100000	ab	0	None
100000	100001	initio	0	None
100001	100002	calculations	0	None
100002	100003	on	0	None
100003	100004	a	0	None
100004	100005	number	0	None
100005	100006	of	0	None
100006	100007	halogenated	0	None
100007	100008	compounds	0	None
100008	100009	of	0	None
100009	100010	second	0	None
100010	100011	row	0	None
100011	100012	,	0	None
100012	100013	late	0	None
100013	100014	p-block	0	None
100014	100015	elements	0	None
100015	100016	,	0	None
100016	100017	the	0	None
100017	100018	SFn	0	None
100018	100019	,	0	None
100019	100020	ClFn	0	None
100020	100021	,	0	None
100021	100022	PFn	0	None
100022	100023	,	0	None
100023	100024	SCln	0	None
100024	100025	,	0	None
100025	100026	and	0	None
100026	100027	SFnCl	0	None
100027	100028	families	0	None
100028	100029	,	0	None
100029	100030	we	0	None
100030	100031	found	0	None
100031	100032	that	0	None
100032	100033	a	0	None
100033	100034	new	0	None
100034	100035	type	0	None
100035	100036	of	0	None
100036	100037	bond	0	None
100037	100038	-	0	None
100038	100039	the	0	None
100039	100040	recoupled	0	None
100040	100041	pair	0	None
100041	100042	bond	0	None
100042	100043	-	0	None
100043	100044	accounts	0	None
100044	100045	for	0	None
100045	100046	the	0	None
100046	100047	ability	0	None
100047	100048	of	0	None
100048	100049	these	0	None
100049	100050	elements	0	None
100050	100051	to	0	None
100051	100052	form	0	None
100052	100053	hypervalent	0	None
100053	100054	,	0	None
100054	100055	or	0	None
100055	100056	hypercoordinated	0	None
100056	100057	,	0	None
100057	100058	compounds	0	None
100058	100059	.	0	None

100060	100061	Hypervalent	0	None
100061	100062	molecules	0	None
100062	100063	are	0	None
100063	100064	formed	0	None
100064	100065	when	0	None
100065	100066	it	0	None
100066	100067	is	0	None
100067	100068	energetically	0	None
100068	100069	favorable	0	None
100069	100070	for	0	None
100070	100071	the	0	None
100071	100072	electrons	0	None
100072	100073	in	0	None
100073	100074	a	0	None
100074	100075	lone	0	None
100075	100076	pair	0	None
100076	100077	orbital	0	None
100077	100078	to	0	None
100078	100079	be	0	None
100079	100080	recoupled	0	None
100080	100081	,	0	None
100081	100082	allowing	0	None
100082	100083	each	0	None
100083	100084	of	0	None
100084	100085	the	0	None
100085	100086	electrons	0	None
100086	100087	to	0	None
100087	100088	form	0	None
100088	100089	chemical	0	None
100089	100090	bonds	0	None
100090	100091	with	0	None
100091	100092	ligands	0	None
100092	100093	.	0	None

100094	100095	In	0	None
100095	100096	this	0	None
100096	100097	paper	0	None
100097	100098	,	0	None
100098	100099	we	0	None
100099	100100	characterize	0	None
100100	100101	the	0	None
100101	100102	structures	0	None
100102	100103	and	0	None
100103	100104	energetics	0	None
100104	100105	of	0	None
100105	100106	the	0	None
100106	100107	ground	0	None
100107	100108	and	0	None
100108	100109	low-lying	0	None
100109	100110	excited	0	None
100110	100111	states	0	None
100111	100112	of	0	None
100112	100113	the	0	None
100113	100114	ClFn	0	None
100114	100115	(	0	None
100115	100116	+	0	None
100116	100117	)	0	None
100117	100118	(	0	None
100118	100119	n	0	None
100119	100120	=	0	None
100120	100121	1-6	0	None
100121	100122	)	0	None
100122	100123	ions	0	None
100123	100124	,	0	None
100124	100125	using	0	None
100125	100126	high	0	None
100126	100127	level	0	None
100127	100128	ab	0	None
100128	100129	initio	0	None
100129	100130	methods	0	None
100130	100131	[	0	None
100131	100132	MRCI	0	None
100132	100133	,	0	None
100133	100134	CCSD	0	None
100134	100135	(	0	None
100135	100136	T	0	None
100136	100137	)	0	None
100137	100138	/	0	None
100138	100139	RCCSD	0	None
100139	100140	(	0	None
100140	100141	T	0	None
100141	100142	)	0	None
100142	100143	]	0	None
100143	100144	with	0	None
100144	100145	large	0	None
100145	100146	correlation	0	None
100146	100147	consistent	0	None
100147	100148	basis	0	None
100148	100149	sets	0	None
100149	100150	.	0	None

100151	100152	We	0	None
100152	100153	computed	0	None
100153	100154	a	0	None
100154	100155	number	0	None
100155	100156	of	0	None
100156	100157	quantities	0	None
100157	100158	,	0	None
100158	100159	including	0	None
100159	100160	ClFn	0	None
100160	100161	(	0	None
100161	100162	+	0	None
100162	100163	)	0	None
100163	100164	structures	0	None
100164	100165	,	0	None
100165	100166	bond	0	None
100166	100167	dissociation	0	None
100167	100168	energies	0	None
100168	100169	and	0	None
100169	100170	ClFn	0	None
100170	100171	ionization	0	None
100171	100172	energies	0	None
100172	100173	,	0	None
100173	100174	and	0	None
100174	100175	compare	0	None
100175	100176	our	0	None
100176	100177	results	0	None
100177	100178	with	0	None
100178	100179	the	0	None
100179	100180	available	0	None
100180	100181	experimental	0	None
100181	100182	data	0	None
100182	100183	.	0	None

100184	100185	Both	0	None
100185	100186	the	0	None
100186	100187	bond	0	None
100187	100188	dissociation	0	None
100188	100189	energies	0	None
100189	100190	and	0	None
100190	100191	ionization	0	None
100191	100192	energies	0	None
100192	100193	oscillate	0	None
100193	100194	,	0	None
100194	100195	variations	0	None
100195	100196	that	0	None
100196	100197	are	0	None
100197	100198	readily	0	None
100198	100199	explained	0	None
100199	100200	using	0	None
100200	100201	the	0	None
100201	100202	recoupled	0	None
100202	100203	pair	0	None
100203	100204	bonding	0	None
100204	100205	model	0	None
100205	100206	.	0	None

100207	100208	Comparisons	0	None
100208	100209	are	0	None
100209	100210	drawn	0	None
100210	100211	between	0	None
100211	100212	the	0	None
100212	100213	ClFn	0	None
100213	100214	(	0	None
100214	100215	+	0	None
100215	100216	)	0	None
100216	100217	cations	0	None
100217	100218	and	0	None
100218	100219	their	0	None
100219	100220	counterparts	0	None
100220	100221	in	0	None
100221	100222	the	0	None
100222	100223	isoelectronic	0	None
100223	100224	SFn	0	None
100224	100225	series	0	None
100225	100226	,	0	None
100226	100227	which	0	None
100227	100228	possess	0	None
100228	100229	many	0	None
100229	100230	similarities	0	None
100230	100231	.	0	None

100232	100233	We	0	None
100233	100234	found	0	None
100234	100235	two	0	None
100235	100236	significant	0	None
100236	100237	differences	0	None
100237	100238	between	0	None
100238	100239	the	0	None
100239	100240	ClFn	0	None
100240	100241	(	0	None
100241	100242	+	0	None
100242	100243	)	0	None
100243	100244	and	0	None
100244	100245	SFn	0	None
100245	100246	series	0	None
100246	100247	:	0	None
100247	100248	(	0	None
100248	100249	i	0	None
100249	100250	)	0	None
100250	100251	the	0	None
100251	100252	bond	0	None
100252	100253	dissociation	0	None
100253	100254	energies	0	None
100254	100255	of	0	None
100255	100256	ClFn	0	None
100256	100257	(	0	None
100257	100258	+	0	None
100258	100259	)	0	None
100259	100260	are	0	None
100260	100261	much	0	None
100261	100262	weaker	0	None
100262	100263	than	0	None
100263	100264	those	0	None
100264	100265	of	0	None
100265	100266	the	0	None
100266	100267	corresponding	0	None
100267	100268	SFn	0	None
100268	100269	species	0	None
100269	100270	,	0	None
100270	100271	and	0	None
100271	100272	(	0	None
100272	100273	ii	0	None
100273	100274	)	0	None
100274	100275	there	0	None
100275	100276	is	0	None
100276	100277	no	0	None
100277	100278	stable	0	None
100278	100279	(	0	None
100279	100280	3	0	None
100280	100281	)	0	None
100281	100282	A2	0	None
100282	100283	state	0	None
100283	100284	in	0	None
100284	100285	ClF2	0	None
100285	100286	(	0	None
100286	100287	+	0	None
100287	100288	)	0	None
100288	100289	corresponding	0	None
100289	100290	to	0	None
100290	100291	the	0	None
100291	100292	stable	0	None
100292	100293	state	0	None
100293	100294	found	0	None
100294	100295	in	0	None
100295	100296	SF2	0	None
100296	100297	.	0	None

100298	100299	Examination	0	None
100299	100300	of	0	None
100300	100301	the	0	None
100301	100302	Mulliken	0	None
100302	100303	populations	0	None
100303	100304	at	0	None
100304	100305	the	0	None
100305	100306	HF	0	None
100306	100307	/	0	None
100307	100308	AVTZ	0	None
100308	100309	level	0	None
100309	100310	for	0	None
100310	100311	ClFn	0	None
100311	100312	(	0	None
100312	100313	+	0	None
100313	100314	)	0	None
100314	100315	and	0	None
100315	100316	SFn	0	None
100316	100317	species	0	None
100317	100318	predicts	0	None
100318	100319	that	0	None
100319	100320	the	0	None
100320	100321	F	0	None
100321	100322	atom	0	None
100322	100323	in	0	None
100323	100324	the	0	None
100324	100325	axial	0	None
100325	100326	(	0	None
100326	100327	recoupled	0	None
100327	100328	pair	0	None
100328	100329	bonding	0	None
100329	100330	)	0	None
100330	100331	position	0	None
100331	100332	is	0	None
100332	100333	more	0	None
100333	100334	highly	0	None
100334	100335	charged	0	None
100335	100336	than	0	None
100336	100337	the	0	None
100337	100338	F	0	None
100338	100339	atom	0	None
100339	100340	in	0	None
100340	100341	the	0	None
100341	100342	equatorial	0	None
100342	100343	(	0	None
100343	100344	covalent	0	None
100344	100345	bonding	0	None
100345	100346	)	0	None
100346	100347	position;	0	None
100347	100348	there	0	None
100348	100349	is	0	None
100349	100350	also	0	None
100350	100351	less	0	None
100351	100352	change	0	None
100352	100353	transfer	0	None
100353	100354	to	0	None
100354	100355	the	0	None
100355	100356	F	0	None
100356	100357	atoms	0	None
100357	100358	in	0	None
100358	100359	ClFn	0	None
100359	100360	(	0	None
100360	100361	+	0	None
100361	100362	)	0	None
100362	100363	than	0	None
100363	100364	in	0	None
100364	100365	SFn	0	None
100365	100366	.	0	None

100367	100368	The	0	None
100368	100369	positive	0	None
100369	100370	charge	0	None
100370	100371	on	0	None
100371	100372	Cl	0	None
100372	100373	(	0	None
100373	100374	+	0	None
100374	100375	)	0	None
100375	100376	makes	0	None
100376	100377	it	0	None
100377	100378	more	0	None
100378	100379	difficult	0	None
100379	100380	for	0	None
100380	100381	an	0	None
100381	100382	F	0	None
100382	100383	atom	0	None
100383	100384	to	0	None
100384	100385	attract	0	None
100385	100386	electrons	0	None
100386	100387	from	0	None
100387	100388	Cl	0	None
100388	100389	(	0	None
100389	100390	+	0	None
100390	100391	)	0	None
100391	100392	than	0	None
100392	100393	from	0	None
100393	100394	S	0	None
100394	100395	and	0	None
100395	100396	correspondingly	0	None
100396	100397	less	0	None
100397	100398	favorable	0	None
100398	100399	to	0	None
100399	100400	recouple	0	None
100400	100401	the	0	None
100401	100402	electrons	0	None
100402	100403	in	0	None
100403	100404	the	0	None
100404	100405	lone	0	None
100405	100406	pair	0	None
100406	100407	orbitals	0	None
100407	100408	in	0	None
100408	100409	the	0	None
100409	100410	ClFn	0	None
100410	100411	(	0	None
100411	100412	+	0	None
100412	100413	)	0	None
100413	100414	species	0	None
100414	100415	.	0	None
100415	100416	Cooperation	0	None
100416	100417	of	0	None
100417	100418	the	0	None
100418	100419	conserved	0	None
100419	100420	aspartate	0	None
100420	100421	439	0	None
100421	100422	and	0	None
100422	100423	bound	0	None
100423	100425	amino acid	2	CHEMICAL
100425	100426	substrate	0	None
100426	100427	is	0	None
100427	100428	important	0	None
100428	100429	for	0	None
100429	100430	high-affinity	0	None
100430	100431	Na	0	None
100431	100432	+	0	None
100432	100433	binding	0	None
100433	100434	to	0	None
100434	100435	the	0	None
100435	100437	glutamate transporter	3	GENE-N
100437	100438	EAAC1	0	None
100438	100439	.	0	None
100439	100440	Using	0	None
100440	100441	chimeric	0	None
100441	100442	mice	0	None
100442	100443	with	0	None
100443	100444	humanized	0	None
100444	100445	livers	0	None
100445	100446	to	0	None
100446	100447	predict	0	None
100447	100448	human	0	None
100448	100449	drug	0	None
100449	100450	metabolism	0	None
100450	100451	and	0	None
100451	100452	a	0	None
100452	100453	drug-drug	0	None
100453	100454	interaction	0	None
100454	100455	.	0	None
100455	100456	The	0	None
100456	100457	role	0	None
100457	100458	of	0	None
100458	100459	adenosine	0	None
100459	100460	receptors	0	None
100460	100461	in	0	None
100461	100462	regulating	0	None
100462	100463	production	0	None
100463	100464	of	0	None
100464	100465	tumour	0	None
100465	100466	necrosis	0	None
100466	100467	factor-alpha	0	None
100467	100468	and	0	None
100468	100469	chemokines	0	None
100469	100470	by	0	None
100470	100471	human	0	None
100471	100472	lung	0	None
100472	100473	macrophages	0	None
100473	100474	.	0	None
100474	100475	Anion	0	None
100475	100476	inhibition	0	None
100476	100477	studies	0	None
100477	100478	of	0	None
100478	100479	the	0	None
100479	100480	α-carbonic	0	None
100480	100481	anhydrase	0	None
100481	100482	from	0	None
100482	100483	the	0	None
100483	100484	pathogenic	0	None
100484	100485	bacterium	0	None
100485	100486	Vibrio	0	None
100486	100487	cholerae	0	None
100487	100488	.	0	None
100488	100489	In	0	None
100489	100490	the	0	None
100490	100491	last	0	None
100491	100492	couple	0	None
100492	100493	of	0	None
100493	100494	decades	0	None
100494	100495	fungal	0	None
100495	100496	infections	0	None
100496	100497	have	0	None
100497	100498	become	0	None
100498	100499	a	0	None
100499	100500	significant	0	None
100500	100501	clinical	0	None
100501	100502	problem	0	None
100502	100503	.	0	None

100504	100505	A	0	None
100505	100506	major	0	None
100506	100507	interest	0	None
100507	100508	into	0	None
100508	100509	fungal	0	None
100509	100510	steroid	2	CHEMICAL
100510	100511	action	0	None
100511	100512	has	0	None
100512	100513	been	0	None
100513	100514	provoked	0	None
100514	100515	since	0	None
100515	100516	research	0	None
100516	100517	has	0	None
100517	100518	proven	0	None
100518	100519	that	0	None
100519	100521	steroid hormones	2	CHEMICAL
100521	100522	are	0	None
100522	100523	toxic	0	None
100523	100524	to	0	None
100524	100525	fungi	0	None
100525	100526	and	0	None
100526	100527	affect	0	None
100527	100528	the	0	None
100528	100529	host	0	None
100529	100530	/	0	None
100530	100531	fungus	0	None
100531	100532	relationship	0	None
100532	100533	.	0	None

100534	100535	Steroid	0	None
100535	100536	hormones	2	CHEMICAL
100536	100537	were	0	None
100537	100538	found	0	None
100538	100539	to	0	None
100539	100540	differ	0	None
100540	100541	in	0	None
100541	100542	their	0	None
100542	100543	antifungal	0	None
100543	100544	activity	0	None
100544	100545	in	0	None
100545	100546	ascomycetous	0	None
100546	100547	fungi	0	None
100547	100548	Hortaea	0	None
100548	100549	werneckii	0	None
100549	100550	,	0	None
100550	100551	Saccharomyces	0	None
100551	100552	cerevisiae	0	None
100552	100553	and	0	None
100553	100554	Aspergillus	0	None
100554	100555	oryzae	0	None
100555	100556	.	0	None

100557	100558	Dehydroepiandrosterone	0	None
100558	100559	was	0	None
100559	100560	shown	0	None
100560	100561	to	0	None
100561	100562	be	0	None
100562	100563	the	0	None
100563	100564	strongest	0	None
100564	100565	inhibitor	0	None
100565	100566	of	0	None
100566	100567	growth	0	None
100567	100568	in	0	None
100568	100569	all	0	None
100569	100570	three	0	None
100570	100571	varieties	0	None
100571	100572	of	0	None
100572	100573	fungi	0	None
100573	100574	followed	0	None
100574	100575	by	0	None
100575	100576	androstenedione	0	None
100576	100577	and	0	None
100577	100578	testosterone	2	CHEMICAL
100578	100579	.	0	None

100580	100581	For	0	None
100581	100582	their	0	None
100582	100583	protection	0	None
100583	100584	,	0	None
100584	100585	fungi	0	None
100585	100586	use	0	None
100586	100587	several	0	None
100587	100588	mechanisms	0	None
100588	100589	to	0	None
100589	100590	lower	0	None
100590	100591	the	0	None
100591	100592	toxic	0	None
100592	100593	effects	0	None
100593	100594	of	0	None
100594	100595	steroids	0	None
100595	100596	.	0	None

100597	100598	The	0	None
100598	100599	efficiency	0	None
100599	100600	of	0	None
100600	100601	biotransformation	0	None
100601	100602	in	0	None
100602	100603	detoxification	0	None
100603	100604	depended	0	None
100604	100605	on	0	None
100605	100606	the	0	None
100606	100607	microorganism	0	None
100607	100608	and	0	None
100608	100609	steroid	2	CHEMICAL
100609	100610	substrate	0	None
100610	100611	used	0	None
100611	100612	.	0	None

100613	100614	Biotransformation	0	None
100614	100615	was	0	None
100615	100616	a	0	None
100616	100617	relatively	0	None
100617	100618	slow	0	None
100618	100619	process	0	None
100619	100620	as	0	None
100620	100621	it	0	None
100621	100622	also	0	None
100622	100623	depended	0	None
100623	100624	on	0	None
100624	100625	the	0	None
100625	100626	growth	0	None
100626	100627	phase	0	None
100627	100628	of	0	None
100628	100629	the	0	None
100629	100630	fungus	0	None
100630	100631	.	0	None

100632	100633	In	0	None
100633	100634	addition	0	None
100634	100635	to	0	None
100635	100636	biotransformation	0	None
100636	100637	,	0	None
100637	100638	steroid	2	CHEMICAL
100638	100639	extrusion	0	None
100639	100640	out	0	None
100640	100641	of	0	None
100641	100642	the	0	None
100642	100643	cells	0	None
100643	100644	contributed	0	None
100644	100645	to	0	None
100645	100646	the	0	None
100646	100647	lowering	0	None
100647	100648	of	0	None
100648	100649	the	0	None
100649	100650	active	0	None
100650	100651	intracellular	0	None
100651	100652	steroid	2	CHEMICAL
100652	100653	concentration	0	None
100653	100654	.	0	None

100655	100656	Plasma	0	None
100656	100657	membrane	0	None
100657	100658	Pdr5	0	None
100658	100659	transporter	0	None
100659	100660	was	0	None
100660	100661	found	0	None
100661	100662	to	0	None
100662	100663	be	0	None
100663	100664	the	0	None
100664	100665	most	0	None
100665	100666	effective	0	None
100666	100667	,	0	None
100667	100668	followed	0	None
100668	100669	by	0	None
100669	100670	Snq2	0	None
100670	100671	transporter	0	None
100671	100672	and	0	None
100672	100673	vacuolar	0	None
100673	100674	transporters	0	None
100674	100675	Ybt1	0	None
100675	100676	and	0	None
100676	100677	Ycf1	0	None
100677	100678	.	0	None

100679	100680	Proteins	0	None
100680	100681	Aus1	0	None
100681	100682	and	0	None
100682	100683	Dan1	0	None
100683	100684	were	0	None
100684	100685	not	0	None
100685	100686	found	0	None
100686	100687	to	0	None
100687	100688	be	0	None
100688	100689	involved	0	None
100689	100690	in	0	None
100690	100691	steroid	2	CHEMICAL
100691	100692	import	0	None
100692	100693	.	0	None

100694	100695	The	0	None
100695	100696	research	0	None
100696	100697	of	0	None
100697	100698	possible	0	None
100698	100699	targets	0	None
100699	100700	of	0	None
100700	100701	steroid	2	CHEMICAL
100701	100702	hormone	0	None
100702	100703	action	0	None
100703	100704	in	0	None
100704	100705	fungi	0	None
100705	100706	suggests	0	None
100706	100707	that	0	None
100707	100709	steroid hormones	2	CHEMICAL
100709	100710	inhibit	0	None
100710	100711	ergosterol	0	None
100711	100712	biosynthesis	0	None
100712	100713	in	0	None
100713	100714	S	0	None
100714	100715	.	0	None

100716	100717	cerevisiae	0	None
100717	100718	and	0	None
100718	100719	H	0	None
100719	100720	.	0	None

100721	100722	werneckii	0	None
100722	100723	.	0	None

100724	100725	Results	0	None
100725	100726	of	0	None
100726	100727	this	0	None
100727	100728	inhibition	0	None
100728	100729	caused	0	None
100729	100730	changes	0	None
100730	100731	in	0	None
100731	100732	the	0	None
100732	100733	sterol	2	CHEMICAL
100733	100734	content	0	None
100734	100735	of	0	None
100735	100736	the	0	None
100736	100737	cellular	0	None
100737	100738	membrane	0	None
100738	100739	.	0	None

100740	100741	The	0	None
100741	100742	presence	0	None
100742	100743	of	0	None
100743	100745	steroid hormones	2	CHEMICAL
100745	100746	most	0	None
100746	100747	probably	0	None
100747	100748	causes	0	None
100748	100749	the	0	None
100749	100750	degradation	0	None
100750	100751	of	0	None
100751	100752	the	0	None
100752	100753	Tat2	0	None
100753	100754	permease	0	None
100754	100755	and	0	None
100755	100756	impairment	0	None
100756	100757	of	0	None
100757	100758	tryptophan	2	CHEMICAL
100758	100759	import	0	None
100759	100760	.	0	None
100760	100761	Effect	0	None
100761	100762	of	0	None
100762	100763	serum	0	None
100763	100764	withdrawal	0	None
100764	100765	on	0	None
100765	100766	the	0	None
100766	100767	contribution	0	None
100767	100768	of	0	None
100768	100769	L-type	0	None
100769	100770	calcium	0	None
100770	100771	channels	0	None
100771	100772	(	0	None
100772	100773	CaV1	0	None
100773	100774	.	0	None
100774	100775	2	0	None
100775	100776	)	0	None
100776	100777	to	0	None
100777	100778	intracellular	0	None
100778	100779	Ca2	0	None
100779	100780	+	0	None
100780	100781	responses	0	None
100781	100782	and	0	None
100782	100783	chemotaxis	0	None
100783	100784	in	0	None
100784	100785	cultured	0	None
100785	100786	human	0	None
100786	100787	vascular	0	None
100787	100788	smooth	0	None
100788	100789	muscle	0	None
100789	100790	cells	0	None
100790	100791	.	0	None
100791	100792	Catalytic	0	None
100792	100793	mechanism	0	None
100793	100794	of	0	None
100794	100795	guanidinoacetate	0	None
100795	100796	methyltransferase	0	None
100796	100797	:	0	None
100797	100798	crystal	0	None
100798	100799	structures	0	None
100799	100800	of	0	None
100800	100801	guanidinoacetate	0	None
100801	100802	methyltransferase	0	None
100802	100803	ternary	0	None
100803	100804	complexes	0	None
100804	100805	.	0	None
100805	100806	Mesenchymal	0	None
100806	100807	stem	0	None
100807	100808	cells	0	None
100808	100809	(	0	None
100809	100810	MSC	0	None
100810	100811	)	0	None
100811	100812	have	0	None
100812	100813	shown	0	None
100813	100814	considerable	0	None
100814	100815	promise	0	None
100815	100816	for	0	None
100816	100817	the	0	None
100817	100818	regeneration	0	None
100818	100819	and	0	None
100819	100820	repair	0	None
100820	100821	of	0	None
100821	100822	damaged	0	None
100822	100823	tissue	0	None
100823	100824	.	0	None

100825	100826	However	0	None
100826	100827	,	0	None
100827	100828	the	0	None
100828	100829	electrophysiological	0	None
100829	100830	properties	0	None
100830	100831	of	0	None
100831	100832	K	0	None
100832	100833	+	0	None
100833	100834	channels	0	None
100834	100835	in	0	None
100835	100836	MSC	0	None
100836	100837	are	0	None
100837	100838	not	0	None
100838	100839	well	0	None
100839	100840	established	0	None
100840	100841	and	0	None
100841	100842	little	0	None
100842	100843	is	0	None
100843	100844	known	0	None
100844	100845	about	0	None
100845	100846	the	0	None
100846	100847	role	0	None
100847	100848	of	0	None
100848	100849	K	0	None
100849	100850	+	0	None
100850	100851	channels	0	None
100851	100852	in	0	None
100852	100853	the	0	None
100853	100854	regulation	0	None
100854	100855	of	0	None
100855	100856	MSC	0	None
100856	100857	proliferation	0	None
100857	100858	.	0	None

100859	100860	We	0	None
100860	100861	detected	0	None
100861	100862	three	0	None
100862	100863	distinct	0	None
100863	100864	outward	0	None
100864	100865	currents	0	None
100865	100866	in	0	None
100866	100867	MSC	0	None
100867	100868	:	0	None
100868	100869	(	0	None
100869	100870	i	0	None
100870	100871	)	0	None
100871	100872	a	0	None
100872	100873	delayed	0	None
100873	100874	rectifier	0	None
100874	100875	current	0	None
100875	100876	(	0	None
100876	100877	IK	0	None
100877	100878	(	0	None
100878	100879	DR	0	None
100879	100880	)	0	None
100880	100881	)	0	None
100881	100882	;	0	None
100882	100883	(	0	None
100883	100884	ii	0	None
100884	100885	)	0	None
100885	100886	a	0	None
100886	100887	Ca2	0	None
100887	100888	+	0	None
100888	100889	-activated	0	None
100889	100890	K	0	None
100890	100891	+	0	None
100891	100892	current	0	None
100892	100893	(	0	None
100893	100894	IK	0	None
100894	100895	(	0	None
100895	100896	Ca	0	None
100896	100897	)	0	None
100897	100898	)	0	None
100898	100899	;	0	None
100899	100900	and	0	None
100900	100901	(	0	None
100901	100902	iii	0	None
100902	100903	)	0	None
100903	100904	a	0	None
100904	100905	transient	0	None
100905	100906	outward	0	None
100906	100907	K	0	None
100907	100908	+	0	None
100908	100909	current	0	None
100909	100910	(	0	None
100910	100911	Ito	0	None
100911	100912	)	0	None
100912	100913	.	0	None

100914	100915	All	0	None
100915	100916	three	0	None
100916	100917	were	0	None
100917	100918	present	0	None
100918	100919	either	0	None
100919	100920	alone	0	None
100920	100921	or	0	None
100921	100922	in	0	None
100922	100923	combination	0	None
100923	100924	in	0	None
100924	100925	almost	0	None
100925	100926	all	0	None
100926	100927	cells	0	None
100927	100928	(	0	None
100928	100929	90%	0	None
100929	100930	)	0	None
100930	100931	investigated	0	None
100931	100932	.	0	None

100933	100934	However	0	None
100934	100935	,	0	None
100935	100936	10%	0	None
100936	100937	of	0	None
100937	100938	cells	0	None
100938	100939	did	0	None
100939	100940	not	0	None
100940	100941	express	0	None
100941	100942	a	0	None
100942	100943	functional	0	None
100943	100944	current	0	None
100944	100945	within	0	None
100945	100946	physiological	0	None
100946	100947	potentials	0	None
100947	100948	.	0	None

100949	100950	Reverse	0	None
100950	100951	transcription-polymerase	0	None
100951	100952	chain	0	None
100952	100953	reaction	0	None
100953	100954	was	0	None
100954	100955	used	0	None
100955	100956	to	0	None
100956	100957	identify	0	None
100957	100958	mRNA	0	None
100958	100959	associated	0	None
100959	100960	with	0	None
100960	100961	functional	0	None
100961	100962	ionic	0	None
100962	100963	currents	0	None
100963	100964	.	0	None

100965	100966	Kv1	0	None
100966	100967	.	0	None
100967	100968	2	0	None
100968	100969	and	0	None
100969	100970	Kv2	0	None
100970	100971	.	0	None
100971	100972	1	0	None
100972	100973	were	0	None
100973	100974	associated	0	None
100974	100975	with	0	None
100975	100976	IK	0	None
100976	100977	(	0	None
100977	100978	DR	0	None
100978	100979	)	0	None
100979	100980	;	0	None
100980	100981	Slo	0	None
100981	100982	and	0	None
100982	100983	KCNN4	0	None
100983	100984	were	0	None
100984	100985	associated	0	None
100985	100986	with	0	None
100986	100987	IK	0	None
100987	100988	(	0	None
100988	100989	Ca	0	None
100989	100990	)	0	None
100990	100991	;	0	None
100991	100992	and	0	None
100992	100993	Kv1	0	None
100993	100994	.	0	None
100994	100995	4	0	None
100995	100996	and	0	None
100996	100997	Kv4	0	None
100997	100998	.	0	None
100998	100999	3	0	None
100999	101000	were	0	None
101000	101001	associated	0	None
101001	101002	with	0	None
101002	101003	Ito	0	None
101003	101004	.	0	None

101005	101006	The	0	None
101006	101007	Kv	0	None
101007	101008	channel	0	None
101008	101009	blockers	0	None
101009	101010	amiodarone	0	None
101010	101011	,	0	None
101011	101012	tetraethylammonium	0	None
101012	101013	and	0	None
101013	101014	verapamil	0	None
101014	101015	,	0	None
101015	101016	as	0	None
101016	101017	well	0	None
101017	101018	as	0	None
101018	101019	increased	0	None
101019	101020	extracellular	0	None
101020	101021	K	0	None
101021	101022	+	0	None
101022	101023	levels	0	None
101023	101024	,	0	None
101024	101025	inhibited	0	None
101025	101026	proliferation	0	None
101026	101027	of	0	None
101027	101028	cultured	0	None
101028	101029	MSC	0	None
101029	101030	.	0	None

101031	101032	In	0	None
101032	101033	MSC	0	None
101033	101034	treated	0	None
101034	101035	with	0	None
101035	101036	Kv	0	None
101036	101037	channel	0	None
101037	101038	blockers	0	None
101038	101039	or	0	None
101039	101040	an	0	None
101040	101041	increased	0	None
101041	101042	extracellular	0	None
101042	101043	concentration	0	None
101043	101044	of	0	None
101044	101045	K	0	None
101045	101046	+	0	None
101046	101047	,	0	None
101047	101048	the	0	None
101048	101049	proportion	0	None
101049	101050	of	0	None
101050	101051	cells	0	None
101051	101052	in	0	None
101052	101053	the	0	None
101053	101054	S	0	None
101054	101055	phase	0	None
101055	101056	decreased	0	None
101056	101057	significantly	0	None
101057	101058	and	0	None
101058	101059	the	0	None
101059	101060	proportion	0	None
101060	101061	of	0	None
101061	101062	cells	0	None
101062	101063	in	0	None
101063	101064	the	0	None
101064	101065	G	0	None
101065	101066	(	0	None
101066	101067	0	0	None
101067	101068	)	0	None
101068	101069	/	0	None
101069	101070	G	0	None
101070	101071	(	0	None
101071	101072	1	0	None
101072	101073	)	0	None
101073	101074	phase	0	None
101074	101075	tended	0	None
101075	101076	to	0	None
101076	101077	increase	0	None
101077	101078	,	0	None
101078	101079	indicating	0	None
101079	101080	that	0	None
101080	101081	the	0	None
101081	101082	cells	0	None
101082	101083	were	0	None
101083	101084	prevented	0	None
101084	101085	from	0	None
101085	101086	entering	0	None
101086	101087	the	0	None
101087	101088	S	0	None
101088	101089	phase	0	None
101089	101090	of	0	None
101090	101091	the	0	None
101091	101092	cell	0	None
101092	101093	cycle	0	None
101093	101094	.	0	None

101095	101096	Our	0	None
101096	101097	findings	0	None
101097	101098	suggest	0	None
101098	101099	that	0	None
101099	101100	rat	0	None
101100	101101	MSC	0	None
101101	101102	heterogeneously	0	None
101102	101103	express	0	None
101103	101104	distinct	0	None
101104	101105	types	0	None
101105	101106	of	0	None
101106	101107	K	0	None
101107	101108	+	0	None
101108	101109	current	0	None
101109	101110	,	0	None
101110	101111	of	0	None
101111	101112	which	0	None
101112	101113	the	0	None
101113	101114	voltage-gated	0	None
101114	101115	IK	0	None
101115	101116	(	0	None
101116	101117	DR	0	None
101117	101118	)	0	None
101118	101119	-like	0	None
101119	101120	K	0	None
101120	101121	+	0	None
101121	101122	current	0	None
101122	101123	is	0	None
101123	101124	most	0	None
101124	101125	common	0	None
101125	101126	.	0	None

101127	101128	Kv	0	None
101128	101129	channel	0	None
101129	101130	activity	0	None
101130	101131	modulates	0	None
101131	101132	the	0	None
101132	101133	progression	0	None
101133	101134	of	0	None
101134	101135	the	0	None
101135	101136	cell	0	None
101136	101137	cycle	0	None
101137	101138	,	0	None
101138	101139	affecting	0	None
101139	101140	the	0	None
101140	101141	proliferation	0	None
101141	101142	of	0	None
101142	101143	MSC	0	None
101143	101144	.	0	None
101144	101145	The	0	None
101145	101146	chemoattractant	0	None
101146	101147	receptor-homologous	0	None
101147	101148	molecule	0	None
101148	101149	expressed	0	None
101149	101150	on	0	None
101150	101151	Th2	0	None
101151	101152	cells	0	None
101152	101153	(	0	None
101153	101154	CRTH2	0	None
101154	101155	)	0	None
101155	101156	receptor	0	None
101156	101157	,	0	None
101157	101158	a	0	None
101158	101159	G	0	None
101159	101160	protein-coupled	0	None
101160	101161	receptor	0	None
101161	101162	that	0	None
101162	101163	mediates	0	None
101163	101164	chemotaxis	0	None
101164	101165	of	0	None
101165	101166	inflammatory	0	None
101166	101167	cells	0	None
101167	101168	in	0	None
101168	101169	response	0	None
101169	101170	to	0	None
101170	101171	prostaglandin	0	None
101171	101172	D2	0	None
101172	101173	(	0	None
101173	101174	PGD2	0	None
101174	101175	)	0	None
101175	101176	,	0	None
101176	101177	is	0	None
101177	101178	hypothesized	0	None
101178	101179	to	0	None
101179	101180	play	0	None
101180	101181	a	0	None
101181	101182	role	0	None
101182	101183	in	0	None
101183	101184	Th2-mediated	0	None
101184	101185	allergic	0	None
101185	101186	disease	0	None
101186	101187	.	0	None

101188	101189	In	0	None
101189	101190	addition	0	None
101190	101191	to	0	None
101191	101192	PGD2	0	None
101192	101193	,	0	None
101193	101194	CRTH2	0	None
101194	101195	can	0	None
101195	101196	be	0	None
101196	101197	activated	0	None
101197	101198	by	0	None
101198	101199	indomethacin	0	None
101199	101200	,	0	None
101200	101201	a	0	None
101201	101202	nonselective	0	None
101202	101203	cyclooxygenase	3	GENE-N
101203	101204	inhibitor	0	None
101204	101205	and	0	None
101205	101206	widely	0	None
101206	101207	used	0	None
101207	101208	nonsteroidal	0	None
101208	101209	anti-inflammatory	0	None
101209	101210	drug	0	None
101210	101211	(	0	None
101211	101212	NSAID	0	None
101212	101213	)	0	None
101213	101214	.	0	None

101215	101216	To	0	None
101216	101217	evaluate	0	None
101217	101218	the	0	None
101218	101219	structural	0	None
101219	101220	features	0	None
101220	101221	that	0	None
101221	101222	confer	0	None
101222	101223	CRTH2	0	None
101223	101224	binding	0	None
101224	101225	selectivity	0	None
101225	101226	,	0	None
101226	101227	structure-activity	0	None
101227	101228	relationship	0	None
101228	101229	analysis	0	None
101229	101230	of	0	None
101230	101231	arylacetic	0	None
101231	101232	acid	0	None
101232	101233	class	0	None
101233	101234	NSAIDs	0	None
101234	101235	as	0	None
101235	101236	CRTH2	0	None
101236	101237	receptor	0	None
101237	101238	ligands	0	None
101238	101239	was	0	None
101239	101240	performed	0	None
101240	101241	.	0	None

101242	101243	Indomethacin	0	None
101243	101244	,	0	None
101244	101245	sulindac	0	None
101245	101246	sulfide	2	CHEMICAL
101246	101247	,	0	None
101247	101248	and	0	None
101248	101249	zomepirac	0	None
101249	101250	displaced	0	None
101250	101251	[	0	None
101251	101252	3H	0	None
101252	101253	]	0	None
101253	101254	PGD2	0	None
101254	101255	binding	0	None
101255	101256	at	0	None
101256	101257	the	0	None
101257	101258	mouse	0	None
101258	101259	CRTH2	0	None
101259	101260	receptor	0	None
101260	101261	(	0	None
101261	101262	mCRTH2	0	None
101262	101263	)	0	None
101263	101264	with	0	None
101264	101265	comparable	0	None
101265	101266	affinity	0	None
101266	101267	(	0	None
101267	101268	Ki	0	None
101268	101269	=	0	None
101269	101270	1	0	None
101270	101271	.	0	None
101271	101272	5	0	None
101272	101273	+	0	None
101273	101274	/	0	None
101274	101275	-	0	None
101275	101276	0	0	None
101276	101277	.	0	None
101277	101278	1	0	None
101278	101279	,	0	None
101279	101280	2	0	None
101280	101281	.	0	None
101281	101282	5	0	None
101282	101283	+	0	None
101283	101284	/	0	None
101284	101285	-	0	None
101285	101286	0	0	None
101286	101287	.	0	None
101287	101288	4	0	None
101288	101289	,	0	None
101289	101290	and	0	None
101290	101291	3	0	None
101291	101292	.	0	None
101292	101293	3	0	None
101293	101294	+	0	None
101294	101295	/	0	None
101295	101296	-	0	None
101296	101297	0	0	None
101297	101298	.	0	None
101298	101299	3	0	None
101299	101300	microM	0	None
101300	101301	,	0	None
101301	101302	respectively	0	None
101302	101303	)	0	None
101303	101304	.	0	None

101305	101306	The	0	None
101306	101307	indomethacin	0	None
101307	101308	metabolite	0	None
101308	101309	5'-O-desmethyl	0	None
101309	101310	indomethacin	0	None
101310	101311	(	0	None
101311	101312	5'-DMI	0	None
101312	101313	)	0	None
101313	101314	possessed	0	None
101314	101315	binding	0	None
101315	101316	affinity	0	None
101316	101317	similar	0	None
101317	101318	to	0	None
101318	101319	indomethacin;	0	None
101319	101320	however	0	None
101320	101321	,	0	None
101321	101322	elimination	0	None
101322	101323	of	0	None
101323	101324	the	0	None
101324	101325	2-methyl	0	None
101325	101326	substituent	0	None
101326	101327	on	0	None
101327	101328	the	0	None
101328	101329	indole	0	None
101329	101330	ring	0	None
101330	101331	resulted	0	None
101331	101332	in	0	None
101332	101333	a	0	None
101333	101334	10-fold	0	None
101334	101335	decrease	0	None
101335	101336	in	0	None
101336	101337	binding	0	None
101337	101338	affinity	0	None
101338	101339	.	0	None

101340	101341	No	0	None
101341	101342	binding	0	None
101342	101343	was	0	None
101343	101344	detected	0	None
101344	101345	for	0	None
101345	101348	indole acetic acid	2	CHEMICAL
101348	101349	and	0	None
101349	101350	indole	0	None
101350	101351	derivatives	0	None
101351	101352	such	0	None
101352	101353	as	0	None
101353	101354	tryptophan	2	CHEMICAL
101354	101355	,	0	None
101355	101356	serotonin	0	None
101356	101357	,	0	None
101357	101358	and	0	None
101358	101359	5-hydroxy	0	None
101359	101360	indole	0	None
101360	101362	acetic acid	2	CHEMICAL
101362	101363	,	0	None
101363	101364	demonstrating	0	None
101364	101365	the	0	None
101365	101366	importance	0	None
101366	101367	of	0	None
101367	101368	the	0	None
101368	101369	N-acyl	0	None
101369	101370	moiety	0	None
101370	101371	of	0	None
101371	101372	indomethacin	0	None
101372	101373	.	0	None

101374	101375	Neutral	0	None
101375	101376	derivatives	0	None
101376	101377	of	0	None
101377	101378	indomethacin	0	None
101378	101379	also	0	None
101379	101380	failed	0	None
101380	101381	to	0	None
101381	101382	bind	0	None
101382	101383	to	0	None
101383	101384	mCRTH2	0	None
101384	101385	,	0	None
101385	101386	suggesting	0	None
101386	101387	that	0	None
101387	101388	the	0	None
101388	101389	negatively	0	None
101389	101390	charged	0	None
101390	101391	carboxylate	0	None
101391	101392	moiety	0	None
101392	101393	participates	0	None
101393	101394	in	0	None
101394	101395	a	0	None
101395	101396	key	0	None
101396	101397	ligand-receptor	0	None
101397	101398	interaction	0	None
101398	101399	.	0	None

101400	101401	Despite	0	None
101401	101402	similar	0	None
101402	101403	binding	0	None
101403	101404	affinities	0	None
101404	101405	,	0	None
101405	101406	NSAID-type	0	None
101406	101407	mCRTH2	0	None
101407	101408	ligands	0	None
101408	101409	exhibited	0	None
101409	101410	variable	0	None
101410	101411	potencies	0	None
101411	101412	as	0	None
101412	101413	mCRTH2	0	None
101413	101414	agonists	0	None
101414	101415	.	0	None

101416	101417	Sulindac	0	None
101417	101418	sulfide	2	CHEMICAL
101418	101419	and	0	None
101419	101420	5'-DMI	0	None
101420	101421	inhibited	0	None
101421	101422	intracellular	0	None
101422	101423	cyclic	0	None
101423	101424	AMP	0	None
101424	101425	(	0	None
101425	101426	[	0	None
101426	101427	cAMP	0	None
101427	101428	]	0	None
101428	101429	i	0	None
101429	101430	)	0	None
101430	101431	generation	0	None
101431	101432	and	0	None
101432	101433	stimulated	0	None
101433	101434	cell	0	None
101434	101435	migration	0	None
101435	101436	comparable	0	None
101436	101437	with	0	None
101437	101438	indomethacin	0	None
101438	101439	.	0	None

101440	101441	In	0	None
101441	101442	contrast	0	None
101442	101443	,	0	None
101443	101444	zomepirac	0	None
101444	101445	did	0	None
101445	101446	not	0	None
101446	101447	inhibit	0	None
101447	101448	[	0	None
101448	101449	cAMP	0	None
101449	101450	]	0	None
101450	101451	i	0	None
101451	101452	generation	0	None
101452	101453	or	0	None
101453	101454	stimulate	0	None
101454	101455	cell	0	None
101455	101456	migration	0	None
101456	101457	but	0	None
101457	101458	weakly	0	None
101458	101459	antagonized	0	None
101459	101460	the	0	None
101460	101461	effects	0	None
101461	101462	of	0	None
101462	101463	indomethacin	0	None
101463	101464	on	0	None
101464	101465	[	0	None
101465	101466	cAMP	0	None
101466	101467	]	0	None
101467	101468	i	0	None
101468	101469	.	0	None

101470	101471	Together	0	None
101471	101472	,	0	None
101472	101473	these	0	None
101473	101474	results	0	None
101474	101475	reveal	0	None
101475	101476	structural	0	None
101476	101477	features	0	None
101477	101478	of	0	None
101478	101479	arylacetic	0	None
101479	101480	acid	0	None
101480	101481	NSAIDs	0	None
101481	101482	that	0	None
101482	101483	may	0	None
101483	101484	be	0	None
101484	101485	exploited	0	None
101485	101486	for	0	None
101486	101487	the	0	None
101487	101488	development	0	None
101488	101489	of	0	None
101489	101490	selective	0	None
101490	101491	CRTH2	0	None
101491	101492	ligands	0	None
101492	101493	.	0	None
101493	101494	A	0	None
101494	101495	study	0	None
101495	101496	of	0	None
101496	101497	parabens	2	CHEMICAL
101497	101498	and	0	None
101498	101499	bisphenol	0	None
101499	101500	A	0	None
101500	101501	in	0	None
101501	101502	surface	0	None
101502	101503	water	0	None
101503	101504	and	0	None
101504	101505	fish	0	None
101505	101506	brain	0	None
101506	101507	tissue	0	None
101507	101508	from	0	None
101508	101509	the	0	None
101509	101510	Greater	0	None
101510	101511	Pittsburgh	0	None
101511	101512	Area	0	None
101512	101513	.	0	None
101513	101514	Synthesis	0	None
101514	101515	and	0	None
101515	101516	micellar	0	None
101516	101517	mimic	0	None
101517	101518	properties	0	None
101518	101519	of	0	None
101519	101521	bile acid	2	CHEMICAL
101521	101522	trimers	0	None
101522	101523	.	0	None
101523	101524	Antitumor	0	None
101524	101525	agents	0	None
101525	101526	,	0	None
101526	101527	130	0	None
101527	101528	,	0	None
101528	101529	Novel	0	None
101529	101530	4	0	None
101530	101531	beta-arylamino	0	None
101531	101532	derivatives	0	None
101532	101533	of	0	None
101533	101534	3'	0	None
101534	101535	,	0	None
101535	101536	4'-didemethoxy-3'	0	None
101536	101537	,	0	None
101537	101538	4'-dioxo-4-deoxypodophyllotoxin	0	None
101538	101539	as	0	None
101539	101540	potent	0	None
101540	101541	inhibitors	0	None
101541	101542	of	0	None
101542	101546	human DNA topoisomerase II	1	GENE-Y
101546	101547	.	0	None
101547	101548	Multiple	0	None
101548	101549	protective	0	None
101549	101550	effects	0	None
101550	101551	of	0	None
101551	101552	melatonin	0	None
101552	101553	against	0	None
101553	101554	maternal	0	None
101554	101555	cholestasis-induced	0	None
101555	101556	oxidative	0	None
101556	101557	stress	0	None
101557	101558	and	0	None
101558	101559	apoptosis	0	None
101559	101560	in	0	None
101560	101561	the	0	None
101561	101562	rat	0	None
101562	101563	fetal	0	None
101563	101564	liver-placenta-maternal	0	None
101564	101565	liver	0	None
101565	101566	trio	0	None
101566	101567	.	0	None
101567	101568	Recent	0	None
101568	101569	studies	0	None
101569	101570	have	0	None
101570	101571	indicated	0	None
101571	101572	that	0	None
101572	101573	the	0	None
101573	101574	basic	0	None
101574	101575	residues	0	None
101575	101576	Arg	0	None
101576	101577	(	0	None
101577	101578	93	0	None
101578	101579	)	0	None
101579	101580	,	0	None
101580	101581	Lys	0	None
101581	101582	(	0	None
101582	101583	96	0	None
101583	101584	)	0	None
101584	101585	,	0	None
101585	101586	Arg	0	None
101586	101587	(	0	None
101587	101588	125	0	None
101588	101589	)	0	None
101589	101590	,	0	None
101590	101591	Arg	0	None
101591	101592	(	0	None
101592	101593	165	0	None
101593	101594	)	0	None
101594	101595	,	0	None
101595	101596	Lys	0	None
101596	101597	(	0	None
101597	101598	169	0	None
101598	101599	)	0	None
101599	101600	,	0	None
101600	101601	Lys	0	None
101601	101602	(	0	None
101602	101603	236	0	None
101603	101604	)	0	None
101604	101605	,	0	None
101605	101606	and	0	None
101606	101607	Arg	0	None
101607	101608	(	0	None
101608	101609	240	0	None
101609	101610	)	0	None
101610	101611	(	0	None
101611	101612	chymotrypsin	0	None
101612	101613	numbering	0	None
101613	101614	)	0	None
101614	101615	constitute	0	None
101615	101616	an	0	None
101616	101617	exosite	0	None
101617	101618	in	0	None
101618	101619	the	0	None
101619	101620	catalytic	0	None
101620	101621	domain	0	None
101621	101622	of	0	None
101622	101623	factor	0	None
101623	101624	Xa	0	None
101624	101625	that	0	None
101625	101626	can	0	None
101626	101627	effectively	0	None
101627	101628	bind	0	None
101628	101629	heparin	0	None
101629	101630	only	0	None
101630	101631	if	0	None
101631	101632	the	0	None
101632	101633	acidic	0	None
101633	101634	N-terminal	0	None
101634	101635	Gla	0	None
101635	101636	domain	0	None
101636	101637	of	0	None
101637	101638	the	0	None
101638	101639	proteinase	0	None
101639	101640	was	0	None
101640	101641	neutralized	0	None
101641	101642	by	0	None
101642	101643	physiological	0	None
101643	101644	levels	0	None
101644	101645	of	0	None
101645	101646	calcium	0	None
101646	101647	.	0	None

101648	101649	Binding	0	None
101649	101650	of	0	None
101650	101651	a	0	None
101651	101652	full-length	0	None
101652	101653	heparin	0	None
101653	101654	chain	0	None
101654	101655	to	0	None
101655	101656	this	0	None
101656	101657	site	0	None
101657	101658	of	0	None
101658	101659	factor	0	None
101659	101660	Xa	0	None
101660	101661	in	0	None
101661	101662	the	0	None
101662	101663	presence	0	None
101663	101664	of	0	None
101664	101665	calcium	0	None
101665	101666	makes	0	None
101666	101667	a	0	None
101667	101668	significant	0	None
101668	101669	contribution	0	None
101669	101670	to	0	None
101670	101671	acceleration	0	None
101671	101672	of	0	None
101672	101673	the	0	None
101673	101674	proteinase	0	None
101674	101675	inhibition	0	None
101675	101676	by	0	None
101676	101677	antithrombin	0	None
101677	101678	through	0	None
101678	101679	a	0	None
101679	101680	ternary	0	None
101680	101681	complex	0	None
101681	101682	bridging	0	None
101682	101683	or	0	None
101683	101684	template	0	None
101684	101685	mechanism	0	None
101685	101686	.	0	None

101687	101688	Moreover	0	None
101688	101689	,	0	None
101689	101690	certain	0	None
101690	101691	basic	0	None
101691	101692	residues	0	None
101692	101693	of	0	None
101693	101694	this	0	None
101694	101695	site	0	None
101695	101696	,	0	None
101696	101697	particularly	0	None
101697	101698	Arg	0	None
101698	101699	(	0	None
101699	101700	165	0	None
101700	101701	)	0	None
101701	101702	and	0	None
101702	101703	Lys	0	None
101703	101704	(	0	None
101704	101705	169	0	None
101705	101706	)	0	None
101706	101707	,	0	None
101707	101708	play	0	None
101708	101709	a	0	None
101709	101710	key	0	None
101710	101711	role	0	None
101711	101712	in	0	None
101712	101713	factor	0	None
101713	101714	Va	0	None
101714	101715	and	0	None
101715	101716	/	0	None
101716	101717	or	0	None
101717	101718	prothrombin	0	None
101718	101719	recognition	0	None
101719	101720	by	0	None
101720	101721	factor	0	None
101721	101722	Xa	0	None
101722	101723	in	0	None
101723	101724	the	0	None
101724	101725	prothrombinase	0	None
101725	101726	complex	0	None
101726	101727	.	0	None

101728	101729	This	0	None
101729	101730	article	0	None
101730	101731	reviews	0	None
101731	101732	recent	0	None
101732	101733	structural	0	None
101733	101734	,	0	None
101734	101735	mutagenesis	0	None
101735	101736	and	0	None
101736	101737	kinetic	0	None
101737	101738	data	0	None
101738	101739	that	0	None
101739	101740	lead	0	None
101740	101741	to	0	None
101741	101742	identification	0	None
101742	101743	of	0	None
101743	101744	this	0	None
101744	101745	exosite	0	None
101745	101746	and	0	None
101746	101747	discusses	0	None
101747	101748	how	0	None
101748	101749	the	0	None
101749	101750	binding	0	None
101750	101751	of	0	None
101751	101752	protein	0	None
101752	101753	or	0	None
101753	101754	polysaccharide	0	None
101754	101755	cofactors	0	None
101755	101756	to	0	None
101756	101757	this	0	None
101757	101758	site	0	None
101758	101759	of	0	None
101759	101760	factor	0	None
101760	101761	Xa	0	None
101761	101762	can	0	None
101762	101763	modulate	0	None
101763	101764	the	0	None
101764	101765	specificity	0	None
101765	101766	and	0	None
101766	101767	physiological	0	None
101767	101768	function	0	None
101768	101769	of	0	None
101769	101770	this	0	None
101770	101771	key	0	None
101771	101772	coagulant	0	None
101772	101773	enzyme	0	None
101773	101774	in	0	None
101774	101775	plasma	0	None
101775	101776	.	0	None
101776	101777	Small	0	None
101777	101778	molecule	0	None
101778	101779	chloropyramine	0	None
101779	101780	hydrochloride	2	CHEMICAL
101780	101781	(	0	None
101781	101782	C4	0	None
101782	101783	)	0	None
101783	101784	targets	0	None
101784	101785	the	0	None
101785	101786	binding	0	None
101786	101787	site	0	None
101787	101788	of	0	None
101788	101789	focal	0	None
101789	101790	adhesion	0	None
101790	101791	kinase	0	None
101791	101792	and	0	None
101792	101796	vascular endothelial growth factor	1	GENE-Y
101796	101797	receptor	0	None
101797	101798	3	0	None
101798	101799	and	0	None
101799	101800	suppresses	0	None
101800	101801	breast	0	None
101801	101802	cancer	0	None
101802	101803	growth	0	None
101803	101804	in	0	None
101804	101805	vivo	0	None
101805	101806	.	0	None
101806	101807	Inflammatory	0	None
101807	101808	bowel	0	None
101808	101809	disease	0	None
101809	101810	is	0	None
101810	101811	an	0	None
101811	101812	urgent	0	None
101812	101813	public	0	None
101813	101814	health	0	None
101814	101815	problem	0	None
101815	101816	with	0	None
101816	101817	a	0	None
101817	101818	high	0	None
101818	101819	incidence	0	None
101819	101820	in	0	None
101820	101821	developed	0	None
101821	101822	countries	0	None
101822	101823	.	0	None

101824	101825	Alterations	0	None
101825	101826	of	0	None
101826	101827	lifestyle	0	None
101827	101828	or	0	None
101828	101829	dietary	0	None
101829	101830	interventions	0	None
101830	101831	may	0	None
101831	101832	attenuate	0	None
101832	101833	the	0	None
101833	101834	disease	0	None
101834	101835	progression	0	None
101835	101836	and	0	None
101836	101837	increase	0	None
101837	101838	the	0	None
101838	101839	efficacy	0	None
101839	101840	of	0	None
101840	101841	current	0	None
101841	101842	therapies	0	None
101842	101843	.	0	None

101844	101845	Here	0	None
101845	101846	we	0	None
101846	101847	tested	0	None
101847	101848	the	0	None
101848	101849	effect	0	None
101849	101850	of	0	None
101850	101851	chronic	0	None
101851	101852	supplementation	0	None
101852	101853	with	0	None
101853	101854	a	0	None
101854	101855	mineral	0	None
101855	101856	extract	0	None
101856	101857	from	0	None
101857	101858	red	0	None
101858	101859	marine	0	None
101859	101860	algae	0	None
101860	101861	-	0	None
101861	101862	rich	0	None
101862	101863	in	0	None
101863	101864	calcium	0	None
101864	101865	(	0	None
101865	101866	34%	0	None
101866	101867	)	0	None
101867	101868	,	0	None
101868	101869	magnesium	0	None
101869	101870	,	0	None
101870	101871	phosphorus	0	None
101871	101872	,	0	None
101872	101873	selenium	0	None
101873	101874	and	0	None
101874	101875	other	0	None
101875	101876	trace	0	None
101876	101877	minerals	0	None
101877	101878	-	0	None
101878	101879	in	0	None
101879	101880	a	0	None
101880	101881	clinically	0	None
101881	101882	relevant	0	None
101882	101883	model	0	None
101883	101884	of	0	None
101884	101885	spontaneous	0	None
101885	101886	enterocolitis	0	None
101886	101887	,	0	None
101887	101888	interleukin	1	GENE-Y
101888	101889	(	0	None
101889	101890	IL	0	None
101890	101891	)	0	None
101891	101892	-10	0	None
101892	101893	(	0	None
101893	101894	-	0	None
101894	101895	/	0	None
101895	101896	-	0	None
101896	101897	)	0	None
101897	101898	mice	0	None
101898	101899	.	0	None

101900	101901	The	0	None
101901	101902	mineral	0	None
101902	101903	extract	0	None
101903	101904	was	0	None
101904	101905	administered	0	None
101905	101906	in	0	None
101906	101907	the	0	None
101907	101908	drinking	0	None
101908	101909	water	0	None
101909	101910	of	0	None
101910	101911	Il10	0	None
101911	101912	(	0	None
101912	101913	-	0	None
101913	101914	/	0	None
101914	101915	-	0	None
101915	101916	)	0	None
101916	101917	mice	0	None
101917	101918	on	0	None
101918	101919	C57BL	0	None
101919	101920	/	0	None
101920	101921	6	0	None
101921	101922	J	0	None
101922	101923	and	0	None
101923	101924	BALB	0	None
101924	101925	/	0	None
101925	101926	c	0	None
101926	101927	strain	0	None
101927	101928	backgrounds	0	None
101928	101929	for	0	None
101929	101930	25	0	None
101930	101931	weeks	0	None
101931	101932	commencing	0	None
101932	101933	from	0	None
101933	101934	3	0	None
101934	101935	to	0	None
101935	101936	4	0	None
101936	101937	weeks	0	None
101937	101938	of	0	None
101938	101939	age	0	None
101939	101940	.	0	None

101941	101942	The	0	None
101942	101943	mineral	0	None
101943	101944	extract	0	None
101944	101945	ameliorated	0	None
101945	101946	the	0	None
101946	101947	spontaneous	0	None
101947	101948	development	0	None
101948	101949	of	0	None
101949	101950	colitis	0	None
101950	101951	and	0	None
101951	101952	severity	0	None
101952	101953	of	0	None
101953	101954	disease	0	None
101954	101955	in	0	None
101955	101956	Il10	0	None
101956	101957	(	0	None
101957	101958	-	0	None
101958	101959	/	0	None
101959	101960	-	0	None
101960	101961	)	0	None
101961	101962	mice	0	None
101962	101963	on	0	None
101963	101964	a	0	None
101964	101965	C57BL	0	None
101965	101966	/	0	None
101966	101967	6	0	None
101967	101968	J	0	None
101968	101969	background	0	None
101969	101970	.	0	None

101971	101972	Mineral	0	None
101972	101973	extract-treated	0	None
101973	101974	Il10	0	None
101974	101975	(	0	None
101975	101976	-	0	None
101976	101977	/	0	None
101977	101978	-	0	None
101978	101979	)	0	None
101979	101980	C57BL	0	None
101980	101981	/	0	None
101981	101982	6	0	None
101982	101983	J	0	None
101983	101984	strain	0	None
101984	101985	mice	0	None
101985	101986	had	0	None
101986	101987	significantly	0	None
101987	101988	reduced	0	None
101988	101989	mortality	0	None
101989	101990	,	0	None
101990	101991	circulating	0	None
101991	101992	levels	0	None
101992	101993	of	0	None
101993	101996	serum Amyloid A	1	GENE-Y
101996	101997	and	0	None
101997	101998	reduced	0	None
101998	101999	colonic	0	None
101999	102000	tissue	0	None
102000	102001	damage	0	None
102001	102002	.	0	None

102003	102004	In	0	None
102004	102005	contrast	0	None
102005	102006	,	0	None
102006	102007	comparable	0	None
102007	102008	treatment	0	None
102008	102009	of	0	None
102009	102010	Il10	0	None
102010	102011	(	0	None
102011	102012	-	0	None
102012	102013	/	0	None
102013	102014	-	0	None
102014	102015	)	0	None
102015	102016	mice	0	None
102016	102017	on	0	None
102017	102018	a	0	None
102018	102019	BALB	0	None
102019	102020	/	0	None
102020	102021	c	0	None
102021	102022	background	0	None
102022	102023	with	0	None
102023	102024	the	0	None
102024	102025	mineral	0	None
102025	102026	extract	0	None
102026	102027	did	0	None
102027	102028	not	0	None
102028	102029	alter	0	None
102029	102030	the	0	None
102030	102031	course	0	None
102031	102032	of	0	None
102032	102033	colitis	0	None
102033	102034	.	0	None

102035	102036	These	0	None
102036	102037	data	0	None
102037	102038	demonstrate	0	None
102038	102039	that	0	None
102039	102040	chronic	0	None
102040	102041	supplementation	0	None
102041	102042	with	0	None
102042	102043	a	0	None
102043	102044	natural	0	None
102044	102045	mineral	0	None
102045	102046	extract	0	None
102046	102047	selectively	0	None
102047	102048	ameliorates	0	None
102048	102049	spontaneous	0	None
102049	102050	mild-moderate	0	None
102050	102051	colitis	0	None
102051	102052	in	0	None
102052	102053	Il10	0	None
102053	102054	(	0	None
102054	102055	-	0	None
102055	102056	/	0	None
102056	102057	-	0	None
102057	102058	)	0	None
102058	102059	mice	0	None
102059	102060	on	0	None
102060	102061	a	0	None
102061	102062	C57BL	0	None
102062	102063	/	0	None
102063	102064	6	0	None
102064	102065	J	0	None
102065	102066	,	0	None
102066	102067	but	0	None
102067	102068	does	0	None
102068	102069	not	0	None
102069	102070	attenuate	0	None
102070	102071	more	0	None
102071	102072	moderate-severe	0	None
102072	102073	colitis	0	None
102073	102074	in	0	None
102074	102075	BALB	0	None
102075	102076	/	0	None
102076	102077	c	0	None
102077	102078	strain	0	None
102078	102079	animals	0	None
102079	102080	.	0	None

102081	102082	Copyright	0	None
102082	102083	©	0	None
102083	102084	2013	0	None
102084	102085	John	0	None
102085	102086	Wiley	0	None
102086	102087	&	0	None
102087	102088	Sons	0	None
102088	102089	,	0	None
102089	102090	Ltd	0	None
102090	102091	.	0	None
102091	102094	Mammalian cysteine dioxygenase	1	GENE-Y
102094	102095	(	0	None
102095	102096	CDO	0	None
102096	102097	)	0	None
102097	102098	is	0	None
102098	102099	a	0	None
102099	102100	non-heme	0	None
102100	102101	iron	0	None
102101	102102	metalloenzyme	0	None
102102	102103	that	0	None
102103	102104	catalyzes	0	None
102104	102105	the	0	None
102105	102106	first	0	None
102106	102107	committed	0	None
102107	102108	step	0	None
102108	102109	in	0	None
102109	102110	oxidative	0	None
102110	102111	cysteine	0	None
102111	102112	catabolism	0	None
102112	102113	.	0	None

102114	102115	The	0	None
102115	102116	active	0	None
102116	102117	site	0	None
102117	102118	coordination	0	None
102118	102119	of	0	None
102119	102120	CDO	0	None
102120	102121	comprises	0	None
102121	102122	a	0	None
102122	102123	mononuclear	0	None
102123	102124	iron	0	None
102124	102125	ligated	0	None
102125	102126	by	0	None
102126	102127	the	0	None
102127	102128	Nepsilon	0	None
102128	102129	atoms	0	None
102129	102130	of	0	None
102130	102131	three	0	None
102131	102132	protein-derived	0	None
102132	102133	histidines	0	None
102133	102134	,	0	None
102134	102135	thus	0	None
102135	102136	representing	0	None
102136	102137	a	0	None
102137	102138	new	0	None
102138	102139	variant	0	None
102139	102140	on	0	None
102140	102141	the	0	None
102141	102142	2-histidine-1-carboxylate	2	CHEMICAL
102142	102143	(	0	None
102143	102144	2H1C	0	None
102144	102145	)	0	None
102145	102146	facial	0	None
102146	102147	triad	0	None
102147	102148	motif	0	None
102148	102149	.	0	None

102150	102151	Nitric	0	None
102151	102152	oxide	0	None
102152	102153	was	0	None
102153	102154	used	0	None
102154	102155	as	0	None
102155	102156	a	0	None
102156	102157	spectroscopic	0	None
102157	102158	probe	0	None
102158	102159	in	0	None
102159	102160	investigating	0	None
102160	102161	the	0	None
102161	102162	order	0	None
102162	102163	of	0	None
102163	102164	substrate-O2	0	None
102164	102165	binding	0	None
102165	102166	by	0	None
102166	102167	EPR	0	None
102167	102168	spectroscopy	0	None
102168	102169	.	0	None

102170	102171	In	0	None
102171	102172	these	0	None
102172	102173	experiments	0	None
102173	102174	,	0	None
102174	102175	CDO	0	None
102175	102176	exhibits	0	None
102176	102177	an	0	None
102177	102178	ordered	0	None
102178	102179	binding	0	None
102179	102180	of	0	None
102180	102181	l-cysteine	2	CHEMICAL
102181	102182	prior	0	None
102182	102183	to	0	None
102183	102184	NO	0	None
102184	102185	(	0	None
102185	102186	and	0	None
102186	102187	presumably	0	None
102187	102188	O2	2	CHEMICAL
102188	102189	)	0	None
102189	102190	similar	0	None
102190	102191	to	0	None
102191	102192	that	0	None
102192	102193	observed	0	None
102193	102194	for	0	None
102194	102195	the	0	None
102195	102201	2H1C class of non-heme iron enzymes	3	GENE-N
102201	102202	.	0	None

102203	102204	Moreover	0	None
102204	102205	,	0	None
102205	102206	the	0	None
102206	102207	CDO	0	None
102207	102208	active	0	None
102208	102209	site	0	None
102209	102210	is	0	None
102210	102211	essentially	0	None
102211	102212	unreactive	0	None
102212	102213	toward	0	None
102213	102214	NO	0	None
102214	102215	in	0	None
102215	102216	the	0	None
102216	102217	absence	0	None
102217	102218	of	0	None
102218	102219	substrate	0	None
102219	102220	,	0	None
102220	102221	suggesting	0	None
102221	102222	an	0	None
102222	102223	obligate	0	None
102223	102224	ordered	0	None
102224	102225	binding	0	None
102225	102226	of	0	None
102226	102227	l-cysteine	2	CHEMICAL
102227	102228	prior	0	None
102228	102229	to	0	None
102229	102230	NO	0	None
102230	102231	.	0	None

102232	102233	Typically	0	None
102233	102234	,	0	None
102234	102235	addition	0	None
102235	102236	of	0	None
102236	102237	NO	0	None
102237	102238	to	0	None
102238	102239	a	0	None
102239	102240	mononuclear	0	None
102240	102241	non-heme	0	None
102241	102242	iron	0	None
102242	102243	center	0	None
102243	102244	results	0	None
102244	102245	in	0	None
102245	102246	the	0	None
102246	102247	formation	0	None
102247	102248	of	0	None
102248	102249	an	0	None
102249	102250	{FeNO}7	0	None
102250	102251	(	0	None
102251	102252	S	0	None
102252	102253	=	0	None
102253	102254	3	0	None
102254	102255	/	0	None
102255	102256	2	0	None
102256	102257	)	0	None
102257	102258	species	0	None
102258	102259	characterized	0	None
102259	102260	by	0	None
102260	102261	an	0	None
102261	102262	axial	0	None
102262	102263	EPR	0	None
102263	102264	spectrum	0	None
102264	102265	with	0	None
102265	102266	gx	0	None
102266	102267	,	0	None
102267	102268	gy	0	None
102268	102269	,	0	None
102269	102270	and	0	None
102270	102271	gz	0	None
102271	102272	values	0	None
102272	102273	of	0	None
102273	102274	approximately	0	None
102274	102275	4	0	None
102275	102276	,	0	None
102276	102277	approximately	0	None
102277	102278	4	0	None
102278	102279	,	0	None
102279	102280	and	0	None
102280	102281	approximately	0	None
102281	102282	2	0	None
102282	102283	,	0	None
102283	102284	respectively	0	None
102284	102285	.	0	None

102286	102287	However	0	None
102287	102288	,	0	None
102288	102289	upon	0	None
102289	102290	addition	0	None
102290	102291	of	0	None
102291	102292	NO	0	None
102292	102293	to	0	None
102293	102294	CDO	0	None
102294	102295	in	0	None
102295	102296	the	0	None
102296	102297	presence	0	None
102297	102298	of	0	None
102298	102299	substrate	0	None
102299	102300	l-cysteine	2	CHEMICAL
102300	102301	,	0	None
102301	102302	a	0	None
102302	102303	low-spin	0	None
102303	102304	{FeNO}7	0	None
102304	102305	(	0	None
102305	102306	S	0	None
102306	102307	=	0	None
102307	102308	1	0	None
102308	102309	/	0	None
102309	102310	2	0	None
102310	102311	)	0	None
102311	102312	signal	0	None
102312	102313	that	0	None
102313	102314	accounts	0	None
102314	102315	for	0	None
102315	102316	approximately	0	None
102316	102317	85%	0	None
102317	102318	of	0	None
102318	102319	the	0	None
102319	102320	iron	0	None
102320	102321	within	0	None
102321	102322	the	0	None
102322	102323	enzyme	0	None
102323	102324	develops	0	None
102324	102325	.	0	None

102326	102327	Similar	0	None
102327	102328	{FeNO}7	0	None
102328	102329	(	0	None
102329	102330	S	0	None
102330	102331	=	0	None
102331	102332	1	0	None
102332	102333	/	0	None
102333	102334	2	0	None
102334	102335	)	0	None
102335	102336	EPR	0	None
102336	102337	signals	0	None
102337	102338	have	0	None
102338	102339	been	0	None
102339	102340	observed	0	None
102340	102341	for	0	None
102341	102342	a	0	None
102342	102343	variety	0	None
102343	102344	of	0	None
102344	102345	octahedral	0	None
102345	102346	mononuclear	0	None
102346	102347	iron-nitrosyl	0	None
102347	102348	synthetic	0	None
102348	102349	complexes;	0	None
102349	102350	however	0	None
102350	102351	,	0	None
102351	102352	this	0	None
102352	102353	type	0	None
102353	102354	of	0	None
102354	102355	iron-nitrosyl	0	None
102355	102356	species	0	None
102356	102357	is	0	None
102357	102358	not	0	None
102358	102359	commonly	0	None
102359	102360	observed	0	None
102360	102361	for	0	None
102361	102362	non-heme	0	None
102362	102363	iron	0	None
102363	102364	enzymes	0	None
102364	102365	.	0	None

102366	102367	Substitution	0	None
102367	102368	of	0	None
102368	102369	l-cysteine	2	CHEMICAL
102369	102370	with	0	None
102370	102371	isosteric	0	None
102371	102372	substrate	0	None
102372	102373	analogues	0	None
102373	102374	cysteamine	0	None
102374	102375	,	0	None
102375	102376	3-mercaptopropionic	0	None
102376	102377	acid	0	None
102377	102378	,	0	None
102378	102379	and	0	None
102379	102380	propane	0	None
102380	102381	thiol	0	None
102381	102382	did	0	None
102382	102383	not	0	None
102383	102384	produce	0	None
102384	102385	any	0	None
102385	102386	analogous	0	None
102386	102387	{FeNO}7	0	None
102387	102388	signals	0	None
102388	102389	(	0	None
102389	102390	S	0	None
102390	102391	=	0	None
102391	102392	1	0	None
102392	102393	/	0	None
102393	102394	2	0	None
102394	102395	or	0	None
102395	102396	3	0	None
102396	102397	/	0	None
102397	102398	2	0	None
102398	102399	)	0	None
102399	102400	,	0	None
102400	102401	thus	0	None
102401	102402	reflecting	0	None
102402	102403	the	0	None
102403	102404	high	0	None
102404	102405	substrate	0	None
102405	102406	specificity	0	None
102406	102407	of	0	None
102407	102408	the	0	None
102408	102409	enzyme	0	None
102409	102410	observed	0	None
102410	102411	by	0	None
102411	102412	a	0	None
102412	102413	number	0	None
102413	102414	of	0	None
102414	102415	researchers	0	None
102415	102416	.	0	None

102417	102418	The	0	None
102418	102419	unusual	0	None
102419	102420	{FeNO}7	0	None
102420	102421	(	0	None
102421	102422	S	0	None
102422	102423	=	0	None
102423	102424	1	0	None
102424	102425	/	0	None
102425	102426	2	0	None
102426	102427	)	0	None
102427	102428	electronic	0	None
102428	102429	configuration	0	None
102429	102430	adopted	0	None
102430	102431	by	0	None
102431	102432	the	0	None
102432	102433	substrate-bound	0	None
102433	102434	iron-nitrosyl	0	None
102434	102435	CDO	0	None
102435	102436	(	0	None
102436	102437	termed	0	None
102437	102438	{ES-NO}7	0	None
102438	102439	)	0	None
102439	102440	is	0	None
102440	102441	a	0	None
102441	102442	result	0	None
102442	102443	of	0	None
102443	102444	the	0	None
102444	102445	bidentate	0	None
102445	102446	thiol	0	None
102446	102447	/	0	None
102447	102448	amine	2	CHEMICAL
102448	102449	coordination	0	None
102449	102450	of	0	None
102450	102451	l-cysteine	2	CHEMICAL
102451	102452	in	0	None
102452	102453	the	0	None
102453	102454	NO-bound	0	None
102454	102455	CDO	0	None
102455	102456	active	0	None
102456	102457	site	0	None
102457	102458	.	0	None

102459	102460	DFT	0	None
102460	102461	computations	0	None
102461	102462	were	0	None
102462	102463	performed	0	None
102463	102464	to	0	None
102464	102465	further	0	None
102465	102466	characterize	0	None
102466	102467	this	0	None
102467	102468	species	0	None
102468	102469	.	0	None

102470	102471	The	0	None
102471	102472	DFT-predicted	0	None
102472	102473	geometric	0	None
102473	102474	parameters	0	None
102474	102475	for	0	None
102475	102476	{ES-NO}7	0	None
102476	102477	are	0	None
102477	102478	in	0	None
102478	102479	good	0	None
102479	102480	agreement	0	None
102480	102481	with	0	None
102481	102482	the	0	None
102482	102483	crystallographically	0	None
102483	102484	determined	0	None
102484	102485	substrate-bound	0	None
102485	102486	active	0	None
102486	102487	site	0	None
102487	102488	configuration	0	None
102488	102489	of	0	None
102489	102490	CDO	0	None
102490	102491	and	0	None
102491	102492	are	0	None
102492	102493	consistent	0	None
102493	102494	with	0	None
102494	102495	known	0	None
102495	102496	iron-nitrosyl	0	None
102496	102497	model	0	None
102497	102498	complexes	0	None
102498	102499	.	0	None

102500	102501	Moreover	0	None
102501	102502	,	0	None
102502	102503	the	0	None
102503	102504	computed	0	None
102504	102505	EPR	0	None
102505	102506	parameters	0	None
102506	102507	(	0	None
102507	102508	g	0	None
102508	102509	and	0	None
102509	102510	A	0	None
102510	102511	values	0	None
102511	102512	)	0	None
102512	102513	are	0	None
102513	102514	in	0	None
102514	102515	excellent	0	None
102515	102516	agreement	0	None
102516	102517	with	0	None
102517	102518	experimental	0	None
102518	102519	results	0	None
102519	102520	for	0	None
102520	102521	this	0	None
102521	102522	CDO	0	None
102522	102523	species	0	None
102523	102524	and	0	None
102524	102525	those	0	None
102525	102526	obtained	0	None
102526	102527	from	0	None
102527	102528	comparable	0	None
102528	102529	synthetic	0	None
102529	102530	{FeNO}7	0	None
102530	102531	(	0	None
102531	102532	S	0	None
102532	102533	=	0	None
102533	102534	1	0	None
102534	102535	/	0	None
102535	102536	2	0	None
102536	102537	)	0	None
102537	102538	iron-nitrosyl	0	None
102538	102539	complexes	0	None
102539	102540	.	0	None
102540	102541	CD74	0	None
102541	102542	is	0	None
102542	102543	a	0	None
102543	102544	type	0	None
102544	102545	II	0	None
102545	102546	transmembrane	0	None
102546	102547	protein	0	None
102547	102548	that	0	None
102548	102549	can	0	None
102549	102550	act	0	None
102550	102551	as	0	None
102551	102552	a	0	None
102552	102553	receptor	0	None
102553	102554	for	0	None
102554	102558	macrophage migration inhibitory factor	1	GENE-Y
102558	102559	(	0	None
102559	102560	MIF	0	None
102560	102561	)	0	None
102561	102562	and	0	None
102562	102563	plays	0	None
102563	102564	a	0	None
102564	102565	role	0	None
102565	102566	in	0	None
102566	102567	MIF-regulated	0	None
102567	102568	responses	0	None
102568	102569	.	0	None

102570	102571	We	0	None
102571	102572	reported	0	None
102572	102573	that	0	None
102573	102574	MIF	0	None
102574	102575	inhibited	0	None
102575	102576	osteoclast	0	None
102576	102577	formation	0	None
102577	102578	and	0	None
102578	102579	MIF	0	None
102579	102580	knockout	0	None
102580	102581	(	0	None
102581	102582	KO	0	None
102582	102583	)	0	None
102583	102584	mice	0	None
102584	102585	had	0	None
102585	102586	decreased	0	None
102586	102587	bone	0	None
102587	102588	mass	0	None
102588	102589	.	0	None

102590	102591	We	0	None
102591	102592	therefore	0	None
102592	102593	examined	0	None
102593	102594	if	0	None
102594	102595	CD74	0	None
102595	102596	was	0	None
102596	102597	involved	0	None
102597	102598	in	0	None
102598	102599	the	0	None
102599	102600	ability	0	None
102600	102601	of	0	None
102601	102602	MIF	0	None
102602	102603	to	0	None
102603	102604	alter	0	None
102604	102605	osteoclastogenesis	0	None
102605	102606	in	0	None
102606	102607	cultured	0	None
102607	102608	bone	0	None
102608	102609	marrow	0	None
102609	102610	(	0	None
102610	102611	BM	0	None
102611	102612	)	0	None
102612	102613	from	0	None
102613	102614	wild-type	0	None
102614	102615	(	0	None
102615	102616	WT	0	None
102616	102617	)	0	None
102617	102618	and	0	None
102618	102619	CD74-deficient	0	None
102619	102620	(	0	None
102620	102621	KO	0	None
102621	102622	)	0	None
102622	102623	male	0	None
102623	102624	mice	0	None
102624	102625	.	0	None

102626	102627	We	0	None
102627	102628	also	0	None
102628	102629	measured	0	None
102629	102630	the	0	None
102630	102631	bone	0	None
102631	102632	phenotype	0	None
102632	102633	of	0	None
102633	102634	CD74	0	None
102634	102635	KO	0	None
102635	102636	male	0	None
102636	102637	mice	0	None
102637	102638	.	0	None

102639	102640	Bone	0	None
102640	102641	mass	0	None
102641	102642	in	0	None
102642	102643	the	0	None
102643	102644	femur	0	None
102644	102645	of	0	None
102645	102646	8-week-old	0	None
102646	102647	mice	0	None
102647	102648	was	0	None
102648	102649	measured	0	None
102649	102650	by	0	None
102650	102651	micro-computed	0	None
102651	102652	tomography	0	None
102652	102653	and	0	None
102653	102654	histomorphometry	0	None
102654	102655	.	0	None

102656	102657	Bone	0	None
102657	102658	marrow	0	None
102658	102659	cells	0	None
102659	102660	from	0	None
102660	102661	CD74	0	None
102661	102662	KO	0	None
102662	102663	mice	0	None
102663	102664	formed	0	None
102664	102665	15%	0	None
102665	102666	more	0	None
102666	102667	osteoclast-like	0	None
102667	102668	cells	0	None
102668	102669	(	0	None
102669	102670	OCLs	0	None
102670	102671	)	0	None
102671	102672	with	0	None
102672	102673	macrophage	0	None
102673	102674	colony-stimulating	0	None
102674	102675	factor	0	None
102675	102676	(	0	None
102676	102677	M-CSF	0	None
102677	102678	)	0	None
102678	102679	and	0	None
102679	102680	receptor	0	None
102680	102681	activator	0	None
102681	102682	of	0	None
102682	102683	NF-κB	0	None
102683	102684	ligand	0	None
102684	102685	(	0	None
102685	102686	RANKL	1	GENE-Y
102686	102687	)	0	None
102687	102688	(	0	None
102688	102689	both	0	None
102689	102690	at	0	None
102690	102691	30	0	None
102691	102692	ng	0	None
102692	102693	/	0	None
102693	102694	mL	0	None
102694	102695	)	0	None
102695	102696	compared	0	None
102696	102697	to	0	None
102697	102698	WT	0	None
102698	102699	.	0	None

102700	102701	Addition	0	None
102701	102702	of	0	None
102702	102703	MIF	0	None
102703	102704	to	0	None
102704	102705	WT	0	None
102705	102706	cultures	0	None
102706	102707	inhibited	0	None
102707	102708	OCL	0	None
102708	102709	formation	0	None
102709	102710	by	0	None
102710	102711	16%	0	None
102711	102712	but	0	None
102712	102713	had	0	None
102713	102714	no	0	None
102714	102715	effect	0	None
102715	102716	on	0	None
102716	102717	CD74KO	0	None
102717	102718	cultures	0	None
102718	102719	.	0	None

102720	102721	The	0	None
102721	102722	number	0	None
102722	102723	of	0	None
102723	102724	colony	0	None
102724	102725	forming	0	None
102725	102726	unit	0	None
102726	102727	granulocyte-macrophage	0	None
102727	102728	(	0	None
102728	102729	CFU-GM	0	None
102729	102730	)	0	None
102730	102731	in	0	None
102731	102732	the	0	None
102732	102733	bone	0	None
102733	102734	marrow	0	None
102734	102735	of	0	None
102735	102736	CD74	0	None
102736	102737	KO	0	None
102737	102738	mice	0	None
102738	102739	was	0	None
102739	102740	26%	0	None
102740	102741	greater	0	None
102741	102742	than	0	None
102742	102743	in	0	None
102743	102744	WT	0	None
102744	102745	controls	0	None
102745	102746	.	0	None

102747	102748	Trabecular	0	None
102748	102749	bone	0	None
102749	102750	volume	0	None
102750	102751	(	0	None
102751	102752	TBV	0	None
102752	102753	)	0	None
102753	102754	in	0	None
102754	102755	the	0	None
102755	102756	femurs	0	None
102756	102757	of	0	None
102757	102758	CD74	0	None
102758	102759	KO	0	None
102759	102760	male	0	None
102760	102761	mice	0	None
102761	102762	was	0	None
102762	102763	decreased	0	None
102763	102764	by	0	None
102764	102765	26%	0	None
102765	102766	compared	0	None
102766	102767	to	0	None
102767	102768	WT	0	None
102768	102769	.	0	None

102770	102771	In	0	None
102771	102772	addition	0	None
102772	102773	,	0	None
102773	102774	cortical	0	None
102774	102775	area	0	None
102775	102776	and	0	None
102776	102777	thickness	0	None
102777	102778	were	0	None
102778	102779	decreased	0	None
102779	102780	by	0	None
102780	102781	14%	0	None
102781	102782	and	0	None
102782	102783	11%	0	None
102783	102784	,	0	None
102784	102785	respectively	0	None
102785	102786	.	0	None

102787	102788	Histomorphometric	0	None
102788	102789	analysis	0	None
102789	102790	demonstrated	0	None
102790	102791	that	0	None
102791	102792	tartrate-resistant	0	None
102792	102793	acid	0	None
102793	102794	phosphatase	0	None
102794	102795	(	0	None
102795	102796	TRAP	0	None
102796	102797	)	0	None
102797	102798	(	0	None
102798	102799	+	0	None
102799	102800	)	0	None
102800	102801	osteoclast	0	None
102801	102802	number	0	None
102802	102803	and	0	None
102803	102804	area	0	None
102804	102805	were	0	None
102805	102806	significantly	0	None
102806	102807	increased	0	None
102807	102808	in	0	None
102808	102809	CD74	0	None
102809	102810	KO	0	None
102810	102811	by	0	None
102811	102812	35%	0	None
102812	102813	and	0	None
102813	102814	43%	0	None
102814	102815	,	0	None
102815	102816	respectively	0	None
102816	102817	compared	0	None
102817	102818	to	0	None
102818	102819	WT	0	None
102819	102820	.	0	None

102821	102822	Finally	0	None
102822	102823	,	0	None
102823	102824	we	0	None
102824	102825	examined	0	None
102825	102826	the	0	None
102826	102827	effect	0	None
102827	102828	of	0	None
102828	102829	MIF	0	None
102829	102830	on	0	None
102830	102831	RANKL-induced-signaling	0	None
102831	102832	pathways	0	None
102832	102833	in	0	None
102833	102834	bone	0	None
102834	102835	marrow	0	None
102835	102836	macrophage	0	None
102836	102837	(	0	None
102837	102838	BMM	0	None
102838	102839	)	0	None
102839	102840	cultures	0	None
102840	102841	.	0	None

102842	102843	MIF	0	None
102843	102844	treatment	0	None
102844	102845	decreased	0	None
102845	102846	RANKL-induced	0	None
102846	102848	nuclear factor	3	GENE-N
102848	102849	of	0	None
102849	102850	activated	0	None
102850	102851	T	0	None
102851	102852	cells	0	None
102852	102853	,	0	None
102853	102854	cytoplasmic	0	None
102854	102855	1	0	None
102855	102856	(	0	None
102856	102857	NFATc1	0	None
102857	102858	)	0	None
102858	102859	and	0	None
102859	102860	c-Fos	1	GENE-Y
102860	102861	protein	0	None
102861	102862	in	0	None
102862	102863	BMM	0	None
102863	102864	cultures	0	None
102864	102865	by	0	None
102865	102866	70%	0	None
102866	102867	and	0	None
102867	102868	41%	0	None
102868	102869	,	0	None
102869	102870	respectively	0	None
102870	102871	.	0	None

102872	102873	Our	0	None
102873	102874	data	0	None
102874	102875	demonstrate	0	None
102875	102876	that	0	None
102876	102877	CD74	0	None
102877	102878	is	0	None
102878	102879	required	0	None
102879	102880	for	0	None
102880	102881	MIF	0	None
102881	102882	to	0	None
102882	102883	affect	0	None
102883	102884	in	0	None
102884	102885	vitro	0	None
102885	102886	osteoclastogenesis	0	None
102886	102887	.	0	None

102888	102889	Further	0	None
102889	102890	,	0	None
102890	102891	the	0	None
102891	102892	bone	0	None
102892	102893	phenotype	0	None
102893	102894	of	0	None
102894	102895	CD74	0	None
102895	102896	KO	0	None
102896	102897	mice	0	None
102897	102898	is	0	None
102898	102899	similar	0	None
102899	102900	to	0	None
102900	102901	that	0	None
102901	102902	of	0	None
102902	102903	MIF	0	None
102903	102904	KO	0	None
102904	102905	mice	0	None
102905	102906	.	0	None

102907	102908	MIF	0	None
102908	102909	treatment	0	None
102909	102910	of	0	None
102910	102911	WT	0	None
102911	102912	cultures	0	None
102912	102913	suppressed	0	None
102913	102914	RANKL-induced	0	None
102914	102915	activator	0	None
102915	102916	protein	0	None
102916	102917	1	0	None
102917	102918	(	0	None
102918	102919	AP-1	0	None
102919	102920	)	0	None
102920	102921	expression	0	None
102921	102922	,	0	None
102922	102923	which	0	None
102923	102924	resulted	0	None
102924	102925	in	0	None
102925	102926	decreased	0	None
102926	102927	osteoclast	0	None
102927	102928	differentiation	0	None
102928	102929	in	0	None
102929	102930	vitro	0	None
102930	102931	.	0	None

102932	102933	We	0	None
102933	102934	propose	0	None
102934	102935	that	0	None
102935	102936	CD74	0	None
102936	102937	plays	0	None
102937	102938	a	0	None
102938	102939	critical	0	None
102939	102940	role	0	None
102940	102941	in	0	None
102941	102942	the	0	None
102942	102943	MIF	0	None
102943	102944	inhibition	0	None
102944	102945	of	0	None
102945	102946	osteoclastogenesis	0	None
102946	102947	.	0	None
102947	102948	BACKGROUND	0	None
102948	102949	:	0	None
102949	102950	The	0	None
102950	102951	purpose	0	None
102951	102952	of	0	None
102952	102953	this	0	None
102953	102954	study	0	None
102954	102955	was	0	None
102955	102956	to	0	None
102956	102957	examine	0	None
102957	102958	the	0	None
102958	102959	utility	0	None
102959	102960	of	0	None
102960	102961	remnant	0	None
102961	102962	uptake	0	None
102962	102963	on	0	None
102963	102964	postoperative	0	None
102964	102965	radioiodine	0	None
102965	102966	scans	0	None
102966	102967	as	0	None
102967	102968	an	0	None
102968	102969	oncologic	0	None
102969	102970	indicator	0	None
102970	102971	after	0	None
102971	102972	thyroidectomy	0	None
102972	102973	for	0	None
102973	102974	differentiated	0	None
102974	102975	thyroid	0	None
102975	102976	cancer	0	None
102976	102977	(	0	None
102977	102978	DTC	0	None
102978	102979	)	0	None
102979	102980	.	0	None

102981	102982	METHODS	0	None
102982	102983	:	0	None
102983	102984	We	0	None
102984	102985	conducted	0	None
102985	102986	a	0	None
102986	102987	retrospective	0	None
102987	102988	review	0	None
102988	102989	of	0	None
102989	102990	patients	0	None
102990	102991	undergoing	0	None
102991	102992	total	0	None
102992	102993	thyroidectomy	0	None
102993	102994	for	0	None
102994	102995	DTC	0	None
102995	102996	and	0	None
102996	102997	subsequent	0	None
102997	102998	radioactive	0	None
102998	102999	iodine	0	None
102999	103000	(	0	None
103000	103001	RAI	2	CHEMICAL
103001	103002	)	0	None
103002	103003	treatment	0	None
103003	103004	.	0	None

103005	103006	Of	0	None
103006	103007	the	0	None
103007	103008	eight	0	None
103008	103009	surgeons	0	None
103009	103010	included	0	None
103010	103011	,	0	None
103011	103012	three	0	None
103012	103013	were	0	None
103013	103014	considered	0	None
103014	103015	high	0	None
103015	103016	volume	0	None
103016	103017	,	0	None
103017	103018	performing	0	None
103018	103019	at	0	None
103019	103020	least	0	None
103020	103021	20	0	None
103021	103022	thyroidectomies	0	None
103022	103023	per	0	None
103023	103024	year	0	None
103024	103025	.	0	None

103026	103027	Patients	0	None
103027	103028	with	0	None
103028	103029	distant	0	None
103029	103030	metastases	0	None
103030	103031	at	0	None
103031	103032	diagnosis	0	None
103032	103033	or	0	None
103033	103034	poorly	0	None
103034	103035	differentiated	0	None
103035	103036	variants	0	None
103036	103037	were	0	None
103037	103038	excluded	0	None
103038	103039	.	0	None

103040	103041	To	0	None
103041	103042	control	0	None
103042	103043	for	0	None
103043	103044	the	0	None
103044	103045	effect	0	None
103045	103046	of	0	None
103046	103047	varying	0	None
103047	103048	RAI	2	CHEMICAL
103048	103049	doses	0	None
103049	103050	,	0	None
103050	103051	the	0	None
103051	103052	remnant	0	None
103052	103053	uptake	0	None
103053	103054	was	0	None
103054	103055	analyzed	0	None
103055	103056	as	0	None
103056	103057	a	0	None
103057	103058	ratio	0	None
103058	103059	of	0	None
103059	103060	the	0	None
103060	103061	percentage	0	None
103061	103062	uptake	0	None
103062	103063	to	0	None
103063	103064	the	0	None
103064	103065	dose	0	None
103065	103066	received	0	None
103066	103067	(	0	None
103067	103068	uptake	0	None
103068	103069	to	0	None
103069	103070	dose	0	None
103070	103071	ratio	0	None
103071	103072	,	0	None
103072	103073	UDR	0	None
103073	103074	)	0	None
103074	103075	.	0	None

103076	103077	Multivariate	0	None
103077	103078	logistic	0	None
103078	103079	regression	0	None
103079	103080	was	0	None
103080	103081	used	0	None
103081	103082	to	0	None
103082	103083	determine	0	None
103083	103084	the	0	None
103084	103085	influence	0	None
103085	103086	of	0	None
103086	103087	UDR	0	None
103087	103088	on	0	None
103088	103089	recurrence	0	None
103089	103090	.	0	None

103091	103092	RESULTS	0	None
103092	103093	:	0	None
103093	103094	Of	0	None
103094	103095	the	0	None
103095	103096	223	0	None
103096	103097	patients	0	None
103097	103098	who	0	None
103098	103099	met	0	None
103099	103100	inclusion	0	None
103100	103101	criteria	0	None
103101	103102	,	0	None
103102	103103	21	0	None
103103	103104	patients	0	None
103104	103105	(	0	None
103105	103106	9	0	None
103106	103107	.	0	None
103107	103108	42%	0	None
103108	103109	)	0	None
103109	103110	experienced	0	None
103110	103111	a	0	None
103111	103112	recurrence	0	None
103112	103113	.	0	None

103114	103115	Those	0	None
103115	103116	who	0	None
103116	103117	recurred	0	None
103117	103118	had	0	None
103118	103119	a	0	None
103119	103120	ten-fold	0	None
103120	103121	higher	0	None
103121	103122	UDR	0	None
103122	103123	compared	0	None
103123	103124	to	0	None
103124	103125	those	0	None
103125	103126	who	0	None
103126	103127	did	0	None
103127	103128	not	0	None
103128	103129	recur	0	None
103129	103130	(	0	None
103130	103131	0	0	None
103131	103132	.	0	None
103132	103133	030	0	None
103133	103134	vs	0	None
103134	103135	.	0	None

103136	103137	0	0	None
103137	103138	.	0	None
103138	103139	003	0	None
103139	103140	,	0	None
103140	103141	p	0	None
103141	103142	=	0	None
103142	103143	0	0	None
103143	103144	.	0	None
103144	103145	001	0	None
103145	103146	)	0	None
103146	103147	.	0	None

103148	103149	Similarly	0	None
103149	103150	,	0	None
103150	103151	patients	0	None
103151	103152	with	0	None
103152	103153	increasing	0	None
103153	103154	postoperative	0	None
103154	103155	thyroglobulin	0	None
103155	103156	measurements	0	None
103156	103157	(	0	None
103157	103158	0	0	None
103158	103159	.	0	None
103159	103160	339	0	None
103160	103161	vs	0	None
103161	103162	.	0	None

103163	103164	0	0	None
103164	103165	.	0	None
103165	103166	003	0	None
103166	103167	,	0	None
103167	103168	p<0	0	None
103168	103169	.	0	None
103169	103170	001	0	None
103170	103171	)	0	None
103171	103172	also	0	None
103172	103173	had	0	None
103173	103174	significantly	0	None
103174	103175	greater	0	None
103175	103176	UDRs	0	None
103176	103177	compared	0	None
103177	103178	to	0	None
103178	103179	those	0	None
103179	103180	with	0	None
103180	103181	stable	0	None
103181	103182	thyroglobulin	0	None
103182	103183	.	0	None

103184	103185	The	0	None
103185	103186	UDRs	0	None
103186	103187	of	0	None
103187	103188	high	0	None
103188	103189	volume	0	None
103189	103190	surgeons	0	None
103190	103191	were	0	None
103191	103192	significantly	0	None
103192	103193	smaller	0	None
103193	103194	than	0	None
103194	103195	low	0	None
103195	103196	volume	0	None
103196	103197	surgeons	0	None
103197	103198	(	0	None
103198	103199	0	0	None
103199	103200	.	0	None
103200	103201	003	0	None
103201	103202	vs	0	None
103202	103203	.	0	None

103204	103205	0	0	None
103205	103206	.	0	None
103206	103207	025	0	None
103207	103208	,	0	None
103208	103209	p	0	None
103209	103210	=	0	None
103210	103211	0	0	None
103211	103212	.	0	None
103212	103213	002	0	None
103213	103214	)	0	None
103214	103215	.	0	None

103216	103217	When	0	None
103217	103218	combined	0	None
103218	103219	with	0	None
103219	103220	other	0	None
103220	103221	known	0	None
103221	103222	predictors	0	None
103222	103223	for	0	None
103223	103224	recurrence	0	None
103224	103225	,	0	None
103225	103226	UDR	0	None
103226	103227	(	0	None
103227	103228	OR	0	None
103228	103229	3	0	None
103229	103230	.	0	None
103230	103231	71	0	None
103231	103232	,	0	None
103232	103233	C	0	None
103233	103234	.	0	None

103235	103236	I	0	None
103236	103237	1	0	None
103237	103238	.	0	None
103238	103239	05	0	None
103239	103240	-	0	None
103240	103241	13	0	None
103241	103242	.	0	None
103242	103243	10	0	None
103243	103244	,	0	None
103244	103245	p	0	None
103245	103246	=	0	None
103246	103247	0	0	None
103247	103248	.	0	None
103248	103249	041	0	None
103249	103250	)	0	None
103250	103251	was	0	None
103251	103252	significantly	0	None
103252	103253	associated	0	None
103253	103254	with	0	None
103254	103255	recurrence	0	None
103255	103256	.	0	None

103257	103258	High	0	None
103258	103259	volume	0	None
103259	103260	surgeons	0	None
103260	103261	maintained	0	None
103261	103262	a	0	None
103262	103263	low	0	None
103263	103264	level	0	None
103264	103265	of	0	None
103265	103266	permanent	0	None
103266	103267	complications	0	None
103267	103268	across	0	None
103268	103269	all	0	None
103269	103270	UDRs	0	None
103270	103271	whereas	0	None
103271	103272	low	0	None
103272	103273	volume	0	None
103273	103274	surgeons	0	None
103274	103275	had	0	None
103275	103276	greater	0	None
103276	103277	permanent	0	None
103277	103278	complications	0	None
103278	103279	associated	0	None
103279	103280	with	0	None
103280	103281	higher	0	None
103281	103282	uptake	0	None
103282	103283	.	0	None
103283	103284	Dehydroepiandrosterone	0	None
103284	103285	post-transcriptionally	0	None
103285	103286	modifies	0	None
103286	103287	CYP1A2	0	None
103287	103288	induction	0	None
103288	103289	involving	0	None
103289	103291	androgen receptor	3	GENE-N
103291	103292	.	0	None
103292	103293	Thyroid	0	None
103293	103294	cancers	0	None
103294	103295	arising	0	None
103295	103296	from	0	None
103296	103297	a	0	None
103297	103298	thyroglossal	0	None
103298	103299	duct	0	None
103299	103300	cyst	0	None
103300	103301	(	0	None
103301	103302	TGDC	0	None
103302	103303	)	0	None
103303	103304	are	0	None
103304	103305	rarely	0	None
103305	103306	reported	0	None
103306	103307	.	0	None

103308	103309	No	0	None
103309	103310	clear	0	None
103310	103311	consensus	0	None
103311	103312	exists	0	None
103312	103313	regarding	0	None
103313	103314	optimal	0	None
103314	103315	management	0	None
103315	103316	.	0	None

103317	103318	In	0	None
103318	103319	this	0	None
103319	103320	light	0	None
103320	103321	,	0	None
103321	103322	TGDC	0	None
103322	103323	carcinomas	0	None
103323	103324	recently	0	None
103324	103325	treated	0	None
103325	103326	at	0	None
103326	103327	Asan	0	None
103327	103328	Medical	0	None
103328	103329	Center	0	None
103329	103330	,	0	None
103330	103331	as	0	None
103331	103332	well	0	None
103332	103333	as	0	None
103333	103334	previously	0	None
103334	103335	reported	0	None
103335	103336	cases	0	None
103336	103337	in	0	None
103337	103338	the	0	None
103338	103339	literature	0	None
103339	103340	,	0	None
103340	103341	were	0	None
103341	103342	reviewed	0	None
103342	103343	.	0	None

103344	103345	There	0	None
103345	103346	were	0	None
103346	103347	ten	0	None
103347	103348	patients	0	None
103348	103349	who	0	None
103349	103350	were	0	None
103350	103351	diagnosed	0	None
103351	103352	with	0	None
103352	103353	TGDC	0	None
103353	103354	carcinoma	0	None
103354	103355	at	0	None
103355	103356	our	0	None
103356	103357	institution	0	None
103357	103358	.	0	None

103359	103360	All	0	None
103360	103361	patients	0	None
103361	103362	underwent	0	None
103362	103363	pre-operative	0	None
103363	103364	fine-needle	0	None
103364	103365	aspiration	0	None
103365	103366	biopsy	0	None
103366	103367	(	0	None
103367	103368	FNAB	0	None
103368	103369	)	0	None
103369	103370	.	0	None

103371	103372	Nine	0	None
103372	103373	patients	0	None
103373	103374	were	0	None
103374	103375	suspected	0	None
103375	103376	of	0	None
103376	103377	having	0	None
103377	103378	papillary	0	None
103378	103379	carcinoma	0	None
103379	103380	following	0	None
103380	103381	cytology	0	None
103381	103382	.	0	None

103383	103384	The	0	None
103384	103385	Sistrunk	0	None
103385	103386	operation	0	None
103386	103387	(	0	None
103387	103388	SO	0	None
103388	103389	)	0	None
103389	103390	was	0	None
103390	103391	performed	0	None
103391	103392	in	0	None
103392	103393	four	0	None
103393	103394	patients	0	None
103394	103395	,	0	None
103395	103396	SO	0	None
103396	103397	with	0	None
103397	103398	total	0	None
103398	103399	thyroidectomy	0	None
103399	103400	(	0	None
103400	103401	SO	0	None
103401	103402	/	0	None
103402	103403	TT	0	None
103403	103404	)	0	None
103404	103405	was	0	None
103405	103406	performed	0	None
103406	103407	in	0	None
103407	103408	three	0	None
103408	103409	patients	0	None
103409	103410	,	0	None
103410	103411	and	0	None
103411	103412	SO	0	None
103412	103413	/	0	None
103413	103414	TT	0	None
103414	103415	with	0	None
103415	103416	neck	0	None
103416	103417	dissection	0	None
103417	103418	was	0	None
103418	103419	performed	0	None
103419	103420	in	0	None
103420	103421	three	0	None
103421	103422	patients	0	None
103422	103423	.	0	None

103424	103425	Six	0	None
103425	103426	patients	0	None
103426	103427	who	0	None
103427	103428	received	0	None
103428	103429	total	0	None
103429	103430	thyroidectomy	0	None
103430	103431	underwent	0	None
103431	103432	radioactive	0	None
103432	103433	iodine	0	None
103433	103434	(	0	None
103434	103435	RAI	2	CHEMICAL
103435	103436	)	0	None
103436	103437	therapy	0	None
103437	103438	and	0	None
103438	103439	T4	0	None
103439	103440	suppression	0	None
103440	103441	.	0	None

103442	103443	With	0	None
103443	103444	a	0	None
103444	103445	median	0	None
103445	103446	follow-up	0	None
103446	103447	period	0	None
103447	103448	of	0	None
103448	103449	28	0	None
103449	103450	.	0	None
103450	103451	5	0	None
103451	103452	months	0	None
103452	103453	,	0	None
103453	103454	two	0	None
103454	103455	patients	0	None
103455	103456	showed	0	None
103456	103457	recurrence	0	None
103457	103458	and	0	None
103458	103459	one	0	None
103459	103460	of	0	None
103460	103461	them	0	None
103461	103462	died	0	None
103462	103463	of	0	None
103463	103464	the	0	None
103464	103465	disease	0	None
103465	103466	.	0	None

103467	103468	We	0	None
103468	103469	analyzed	0	None
103469	103470	163	0	None
103470	103471	cases	0	None
103471	103472	from	0	None
103472	103473	1990	0	None
103473	103474	to	0	None
103474	103475	2012	0	None
103475	103476	with	0	None
103476	103477	three	0	None
103477	103478	or	0	None
103478	103479	more	0	None
103479	103480	cases	0	None
103480	103481	TGDC	0	None
103481	103482	carcinoma	0	None
103482	103483	,	0	None
103483	103484	including	0	None
103484	103485	the	0	None
103485	103486	present	0	None
103486	103487	study	0	None
103487	103488	.	0	None

103489	103490	Among	0	None
103490	103491	48	0	None
103491	103492	patients	0	None
103492	103493	who	0	None
103493	103494	underwent	0	None
103494	103495	FNAB	0	None
103495	103496	,	0	None
103496	103497	75%	0	None
103497	103498	had	0	None
103498	103499	papillary	0	None
103499	103500	thyroid	0	None
103500	103501	carcinoma	0	None
103501	103502	(	0	None
103502	103503	PTC	1	GENE-Y
103503	103504	)	0	None
103504	103505	.	0	None

103506	103507	SO	0	None
103507	103508	,	0	None
103508	103509	SO	0	None
103509	103510	/	0	None
103510	103511	TT	0	None
103511	103512	,	0	None
103512	103513	or	0	None
103513	103514	SO	0	None
103514	103515	/	0	None
103515	103516	TT	0	None
103516	103517	with	0	None
103517	103518	neck	0	None
103518	103519	dissection	0	None
103519	103520	was	0	None
103520	103521	performed	0	None
103521	103522	in	0	None
103522	103523	27%	0	None
103523	103524	,	0	None
103524	103525	41%	0	None
103525	103526	,	0	None
103526	103527	and	0	None
103527	103528	32%	0	None
103528	103529	of	0	None
103529	103530	patients	0	None
103530	103531	,	0	None
103531	103532	respectively	0	None
103532	103533	.	0	None

103534	103535	Among	0	None
103535	103536	119	0	None
103536	103537	patients	0	None
103537	103538	who	0	None
103538	103539	received	0	None
103539	103540	total	0	None
103540	103541	thyroidectomy	0	None
103541	103542	,	0	None
103542	103543	36%	0	None
103543	103544	had	0	None
103544	103545	concomitant	0	None
103545	103546	PTC	1	GENE-Y
103546	103547	in	0	None
103547	103548	the	0	None
103548	103549	thyroid	0	None
103549	103550	.	0	None

103551	103552	Among	0	None
103552	103553	52	0	None
103553	103554	patients	0	None
103554	103555	who	0	None
103555	103556	received	0	None
103556	103557	neck	0	None
103557	103558	dissection	0	None
103558	103559	,	0	None
103559	103560	69%	0	None
103560	103561	had	0	None
103561	103562	cervical	0	None
103562	103563	nodal	0	None
103563	103564	involvement	0	None
103564	103565	.	0	None

103566	103567	The	0	None
103567	103568	results	0	None
103568	103569	of	0	None
103569	103570	our	0	None
103570	103571	review	0	None
103571	103572	suggest	0	None
103572	103573	that	0	None
103573	103574	when	0	None
103574	103575	TGDC	0	None
103575	103576	carcinoma	0	None
103576	103577	is	0	None
103577	103578	suspected	0	None
103578	103579	,	0	None
103579	103580	ultrasonography	0	None
103580	103581	and	0	None
103581	103582	,	0	None
103582	103583	if	0	None
103583	103584	necessary	0	None
103584	103585	,	0	None
103585	103586	FNAB	0	None
103586	103587	should	0	None
103587	103588	be	0	None
103588	103589	performed	0	None
103589	103590	.	0	None

103591	103592	If	0	None
103592	103593	these	0	None
103593	103594	tests	0	None
103594	103595	reveal	0	None
103595	103596	a	0	None
103596	103597	suspected	0	None
103597	103598	lesion	0	None
103598	103599	in	0	None
103599	103600	the	0	None
103600	103601	thyroid	0	None
103601	103602	or	0	None
103602	103603	lymph	0	None
103603	103604	node	0	None
103604	103605	,	0	None
103605	103606	SO	0	None
103606	103607	/	0	None
103607	103608	TT	0	None
103608	103609	and	0	None
103609	103610	lymph	0	None
103610	103611	node	0	None
103611	103612	dissection	0	None
103612	103613	should	0	None
103613	103614	be	0	None
103614	103615	performed	0	None
103615	103616	.	0	None
103616	103617	Arsenic	2	CHEMICAL
103617	103618	is	0	None
103618	103619	one	0	None
103619	103620	of	0	None
103620	103621	the	0	None
103621	103622	most	0	None
103622	103623	hazardous	0	None
103623	103624	substances	0	None
103624	103625	in	0	None
103625	103626	the	0	None
103626	103627	environment	0	None
103627	103628	known	0	None
103628	103629	to	0	None
103629	103630	cause	0	None
103630	103631	toxicity	0	None
103631	103632	in	0	None
103632	103633	multiple	0	None
103633	103634	organs	0	None
103634	103635	.	0	None

103636	103637	Cell	0	None
103637	103638	adhesion	0	None
103638	103639	,	0	None
103639	103640	morphological	0	None
103640	103641	alterations	0	None
103641	103642	,	0	None
103642	103643	cell	0	None
103643	103644	proliferation	0	None
103644	103645	,	0	None
103645	103646	terminal	0	None
103646	103647	deoxyuridine	0	None
103647	103648	triphosphate	0	None
103648	103649	nick-end	0	None
103649	103650	labeling	0	None
103650	103651	(	0	None
103651	103652	TUNEL	0	None
103652	103653	)	0	None
103653	103654	and	0	None
103654	103655	caspase-3	1	GENE-Y
103655	103656	/	0	None
103656	103657	CPP32	0	None
103657	103658	fluorometric	0	None
103658	103659	protease	3	GENE-N
103659	103660	assay	0	None
103660	103661	were	0	None
103661	103662	important	0	None
103662	103663	biomarkers	0	None
103663	103664	to	0	None
103664	103665	assess	0	None
103665	103666	apoptosis	0	None
103666	103667	in	0	None
103667	103668	cells	0	None
103668	103669	.	0	None

103670	103671	This	0	None
103671	103672	study	0	None
103672	103673	aimed	0	None
103673	103674	to	0	None
103674	103675	evaluate	0	None
103675	103676	arsenic-induced	0	None
103676	103677	apoptosis	0	None
103677	103678	in	0	None
103678	103679	the	0	None
103679	103680	hepatocytes	0	None
103680	103681	of	0	None
103681	103682	rat	0	None
103682	103683	and	0	None
103683	103684	its	0	None
103684	103685	protective	0	None
103685	103686	efficacy	0	None
103686	103687	with	0	None
103687	103688	coadministration	0	None
103688	103689	of	0	None
103689	103691	ascorbic acid	2	CHEMICAL
103691	103692	(	0	None
103692	103693	AA	0	None
103693	103694	)	0	None
103694	103695	and	0	None
103695	103696	Pleurotus	0	None
103696	103697	florida	0	None
103697	103698	lectin	0	None
103698	103699	(	0	None
103699	103700	PFL	0	None
103700	103701	)	0	None
103701	103702	individually	0	None
103702	103703	.	0	None

103704	103705	Results	0	None
103705	103706	of	0	None
103706	103707	the	0	None
103707	103708	present	0	None
103708	103709	study	0	None
103709	103710	also	0	None
103710	103711	showed	0	None
103711	103712	that	0	None
103712	103713	arsenic	2	CHEMICAL
103713	103714	caused	0	None
103714	103715	cytotoxicity	0	None
103715	103716	by	0	None
103716	103717	elevating	0	None
103717	103718	morphological	0	None
103718	103719	alterations	0	None
103719	103720	,	0	None
103720	103721	TUNEL-positive	0	None
103721	103722	nuclei	0	None
103722	103723	,	0	None
103723	103724	caspase-3	1	GENE-Y
103724	103725	activity	0	None
103725	103726	and	0	None
103726	103727	DNA	0	None
103727	103728	damage	0	None
103728	103729	and	0	None
103729	103730	reducing	0	None
103730	103731	cell	0	None
103731	103732	adhesion	0	None
103732	103733	and	0	None
103733	103734	cell	0	None
103734	103735	proliferation	0	None
103735	103736	in	0	None
103736	103737	a	0	None
103737	103738	time-dependent	0	None
103738	103739	manner	0	None
103739	103740	.	0	None

103741	103742	The	0	None
103742	103743	apoptosis	0	None
103743	103744	in	0	None
103744	103745	hepatocytes	0	None
103745	103746	was	0	None
103746	103747	reverted	0	None
103747	103748	to	0	None
103748	103749	normal	0	None
103749	103750	value	0	None
103750	103751	after	0	None
103751	103752	coadministration	0	None
103752	103753	of	0	None
103753	103754	mushroom	0	None
103754	103755	lectin	0	None
103755	103756	in	0	None
103756	103757	arsenic-exposed	0	None
103757	103758	rat	0	None
103758	103759	.	0	None

103760	103761	The	0	None
103761	103762	study	0	None
103762	103763	provided	0	None
103763	103764	significant	0	None
103764	103765	evidence	0	None
103765	103766	that	0	None
103766	103767	PFL	0	None
103767	103768	has	0	None
103768	103769	antiapoptotic	0	None
103769	103770	property	0	None
103770	103771	against	0	None
103771	103772	arsenic-induced	0	None
103772	103773	toxicity	0	None
103773	103774	.	0	None

103775	103776	The	0	None
103776	103777	beneficial	0	None
103777	103778	effect	0	None
103778	103779	of	0	None
103779	103780	PFL	0	None
103780	103781	was	0	None
103781	103782	proportional	0	None
103782	103783	to	0	None
103783	103784	its	0	None
103784	103785	duration	0	None
103785	103786	of	0	None
103786	103787	exposure	0	None
103787	103788	.	0	None

103789	103790	Retard	0	None
103790	103791	activities	0	None
103791	103792	of	0	None
103792	103793	superoxide	0	None
103793	103794	dismutase	0	None
103794	103795	and	0	None
103795	103796	catalase	0	None
103796	103797	,	0	None
103797	103798	enhanced	0	None
103798	103799	lipid	0	None
103799	103800	peroxidation	0	None
103800	103801	as	0	None
103801	103802	well	0	None
103802	103803	as	0	None
103803	103804	protein	0	None
103804	103805	carbonyl	0	None
103805	103806	in	0	None
103806	103807	erythrocytes	0	None
103807	103808	caused	0	None
103808	103809	by	0	None
103809	103810	arsenic	2	CHEMICAL
103810	103811	could	0	None
103811	103812	also	0	None
103812	103813	be	0	None
103813	103814	maintained	0	None
103814	103815	toward	0	None
103815	103816	normalcy	0	None
103816	103817	by	0	None
103817	103818	supplementation	0	None
103818	103819	of	0	None
103819	103820	AA	0	None
103820	103821	and	0	None
103821	103822	PFL	0	None
103822	103823	.	0	None

103824	103825	These	0	None
103825	103826	antioxidative	0	None
103826	103827	effects	0	None
103827	103828	were	0	None
103828	103829	exhibited	0	None
103829	103830	in	0	None
103830	103831	a	0	None
103831	103832	time-dependant	0	None
103832	103833	manner	0	None
103833	103834	.	0	None

103835	103836	In	0	None
103836	103837	rat	0	None
103837	103838	,	0	None
103838	103839	treatment	0	None
103839	103840	with	0	None
103840	103841	AA	0	None
103841	103842	and	0	None
103842	103843	PFL	0	None
103843	103844	prevented	0	None
103844	103845	alteration	0	None
103845	103846	of	0	None
103846	103847	plasma	0	None
103847	103848	enzyme	0	None
103848	103849	activities	0	None
103849	103850	caused	0	None
103850	103851	by	0	None
103851	103852	arsenic	2	CHEMICAL
103852	103853	.	0	None

103854	103855	The	0	None
103855	103856	results	0	None
103856	103857	concluded	0	None
103857	103858	that	0	None
103858	103859	treatment	0	None
103859	103860	with	0	None
103860	103861	PFL	0	None
103861	103862	has	0	None
103862	103863	significant	0	None
103863	103864	role	0	None
103864	103865	in	0	None
103865	103866	protecting	0	None
103866	103867	animals	0	None
103867	103868	from	0	None
103868	103869	arsenic-induced	0	None
103869	103870	erythrocytic	0	None
103870	103871	damage	0	None
103871	103872	.	0	None

103873	103874	This	0	None
103874	103875	finding	0	None
103875	103876	might	0	None
103876	103877	be	0	None
103877	103878	of	0	None
103878	103879	therapeutic	0	None
103879	103880	benefit	0	None
103880	103881	in	0	None
103881	103882	people	0	None
103882	103883	suffering	0	None
103883	103884	from	0	None
103884	103885	chronic	0	None
103885	103886	exposure	0	None
103886	103887	to	0	None
103887	103888	arsenic	2	CHEMICAL
103888	103889	from	0	None
103889	103890	natural	0	None
103890	103891	sources	0	None
103891	103892	,	0	None
103892	103893	a	0	None
103893	103894	global	0	None
103894	103895	problem	0	None
103895	103896	especially	0	None
103896	103897	relevant	0	None
103897	103898	to	0	None
103898	103899	millions	0	None
103899	103900	of	0	None
103900	103901	people	0	None
103901	103902	on	0	None
103902	103903	the	0	None
103903	103904	Indian	0	None
103904	103905	subcontinent	0	None
103905	103906	.	0	None
103906	103907	Humans	0	None
103907	103908	are	0	None
103908	103909	commonly	0	None
103909	103910	exposed	0	None
103910	103911	to	0	None
103911	103912	nicotine	0	None
103912	103913	,	0	None
103913	103914	one	0	None
103914	103915	of	0	None
103915	103916	the	0	None
103916	103917	most	0	None
103917	103918	important	0	None
103918	103919	lifestyle	0	None
103919	103920	chemicals	0	None
103920	103921	.	0	None

103922	103923	The	0	None
103923	103924	occurrence	0	None
103924	103925	of	0	None
103925	103926	high	0	None
103926	103927	levels	0	None
103927	103928	of	0	None
103928	103929	arsenic	2	CHEMICAL
103929	103930	in	0	None
103930	103931	the	0	None
103931	103932	groundwater	0	None
103932	103933	of	0	None
103933	103934	the	0	None
103934	103935	southeast	0	None
103935	103936	region	0	None
103936	103937	of	0	None
103937	103938	Asia	0	None
103938	103939	has	0	None
103939	103940	received	0	None
103940	103941	much	0	None
103941	103942	attention	0	None
103942	103943	in	0	None
103943	103944	the	0	None
103944	103945	past	0	None
103945	103946	decade	0	None
103946	103947	and	0	None
103947	103948	has	0	None
103948	103949	become	0	None
103949	103950	a	0	None
103950	103951	global	0	None
103951	103952	health	0	None
103952	103953	concern	0	None
103953	103954	.	0	None

103955	103956	Predominant	0	None
103956	103957	occurrence	0	None
103957	103958	of	0	None
103958	103959	both	0	None
103959	103960	these	0	None
103960	103961	chemicals	0	None
103961	103962	and	0	None
103962	103963	ease	0	None
103963	103964	of	0	None
103964	103965	their	0	None
103965	103966	human	0	None
103966	103967	exposure	0	None
103967	103968	led	0	None
103968	103969	us	0	None
103969	103970	to	0	None
103970	103971	investigate	0	None
103971	103972	the	0	None
103972	103973	effect	0	None
103973	103974	of	0	None
103974	103975	nicotine	0	None
103975	103976	,	0	None
103976	103977	a	0	None
103977	103978	major	0	None
103978	103979	tobacco	0	None
103979	103980	alkaloid	0	None
103980	103981	,	0	None
103981	103982	on	0	None
103982	103983	arsenic	2	CHEMICAL
103983	103984	toxicity	0	None
103984	103985	.	0	None

103986	103987	Adult	0	None
103987	103988	male	0	None
103988	103989	rats	0	None
103989	103990	were	0	None
103990	103991	pre-exposed	0	None
103991	103992	to	0	None
103992	103993	two	0	None
103993	103994	different	0	None
103994	103995	doses	0	None
103995	103996	of	0	None
103996	103997	nicotine	0	None
103997	103998	(	0	None
103998	103999	0	0	None
103999	104000	.	0	None
104000	104001	75	0	None
104001	104002	and	0	None
104002	104003	3	0	None
104003	104004	mg	2	CHEMICAL
104004	104005	/	0	None
104005	104006	kg	0	None
104006	104007	,	0	None
104007	104008	intraperitoneally	0	None
104008	104009	)	0	None
104009	104010	for	0	None
104010	104011	7	0	None
104011	104012	days	0	None
104012	104013	followed	0	None
104013	104014	by	0	None
104014	104015	30	0	None
104015	104016	days	0	None
104016	104017	of	0	None
104017	104018	arsenic	2	CHEMICAL
104018	104019	exposure	0	None
104019	104020	(	0	None
104020	104021	50	0	None
104021	104022	ppm	0	None
104022	104024	sodium arsenite	2	CHEMICAL
104024	104025	in	0	None
104025	104026	drinking	0	None
104026	104027	water	0	None
104027	104028	)	0	None
104028	104029	.	0	None

104030	104031	Nicotine	0	None
104031	104032	pre-exposure	0	None
104032	104033	resulted	0	None
104033	104034	in	0	None
104034	104035	an	0	None
104035	104036	increased	0	None
104036	104037	brain	0	None
104037	104038	arsenic	2	CHEMICAL
104038	104039	accumulation	0	None
104039	104040	and	0	None
104040	104041	a	0	None
104041	104042	decreased	0	None
104042	104043	liver	0	None
104043	104044	arsenic	2	CHEMICAL
104044	104045	concentration	0	None
104045	104046	.	0	None

104047	104048	Arsenic	2	CHEMICAL
104048	104049	also	0	None
104049	104050	caused	0	None
104050	104051	a	0	None
104051	104052	significant	0	None
104052	104053	oxidative	0	None
104053	104054	stress	0	None
104054	104055	in	0	None
104055	104056	the	0	None
104056	104057	blood	0	None
104057	104058	,	0	None
104058	104059	brain	0	None
104059	104060	and	0	None
104060	104061	liver	0	None
104061	104062	of	0	None
104062	104063	the	0	None
104063	104064	exposed	0	None
104064	104065	rats	0	None
104065	104066	.	0	None

104067	104068	Glutathione-S-transferase	0	None
104068	104069	,	0	None
104069	104070	a	0	None
104070	104071	phase	0	None
104071	104072	II	0	None
104072	104073	enzyme	0	None
104073	104074	,	0	None
104074	104075	was	0	None
104075	104076	inhibited	0	None
104076	104077	by	0	None
104077	104078	both	0	None
104078	104079	arsenic	2	CHEMICAL
104079	104080	and	0	None
104080	104081	nicotine	0	None
104081	104082	but	0	None
104082	104083	no	0	None
104083	104084	such	0	None
104084	104085	inhibition	0	None
104085	104086	was	0	None
104086	104087	noted	0	None
104087	104088	in	0	None
104088	104089	arsenic-treated	0	None
104089	104090	animals	0	None
104090	104091	pre-exposed	0	None
104091	104092	to	0	None
104092	104093	nicotine	0	None
104093	104094	.	0	None

104095	104096	Upon	0	None
104096	104097	nicotine	0	None
104097	104098	pre-exposure	0	None
104098	104099	,	0	None
104099	104100	brain	0	None
104100	104101	acetylcholinesterase	0	None
104101	104102	increased	0	None
104102	104103	,	0	None
104103	104104	while	0	None
104104	104106	monoamine oxidase	3	GENE-N
104106	104107	(	0	None
104107	104108	MAO	3	GENE-N
104108	104109	)	0	None
104109	104110	decreased	0	None
104110	104111	.	0	None

104112	104113	The	0	None
104113	104114	toxic	0	None
104114	104115	effects	0	None
104115	104116	of	0	None
104116	104117	MAO	3	GENE-N
104117	104118	significantly	0	None
104118	104119	attenuated	0	None
104119	104120	with	0	None
104120	104121	nicotine	0	None
104121	104122	pre-exposure	0	None
104122	104123	.	0	None

104124	104125	The	0	None
104125	104126	present	0	None
104126	104127	study	0	None
104127	104128	suggests	0	None
104128	104129	that	0	None
104129	104130	nicotine	0	None
104130	104131	may	0	None
104131	104132	not	0	None
104132	104133	be	0	None
104133	104134	the	0	None
104134	104135	major	0	None
104135	104136	contributing	0	None
104136	104137	factor	0	None
104137	104138	for	0	None
104138	104139	the	0	None
104139	104140	previously	0	None
104140	104141	reported	0	None
104141	104142	synergistic	0	None
104142	104143	toxic	0	None
104143	104144	interaction	0	None
104144	104145	between	0	None
104145	104146	tobacco	0	None
104146	104147	and	0	None
104147	104148	arsenic	2	CHEMICAL
104148	104149	.	0	None

104150	104151	Nicotine	0	None
104151	104152	pre-exposure	0	None
104152	104153	in	0	None
104153	104154	arsenic-exposed	0	None
104154	104155	animals	0	None
104155	104156	revealed	0	None
104156	104157	interesting	0	None
104157	104158	toxicokinetics	0	None
104158	104159	and	0	None
104159	104160	oxidative	0	None
104160	104161	stress	0	None
104161	104162	modulating	0	None
104162	104163	interactions	0	None
104163	104164	in	0	None
104164	104165	the	0	None
104165	104166	brain	0	None
104166	104167	and	0	None
104167	104168	liver	0	None
104168	104169	of	0	None
104169	104170	rats	0	None
104170	104171	,	0	None
104171	104172	which	0	None
104172	104173	requires	0	None
104173	104174	further	0	None
104174	104175	exploration	0	None
104175	104176	.	0	None
104176	104177	Acetylcholinesterase	0	None
104177	104178	(	0	None
104178	104179	AChE	1	GENE-Y
104179	104180	)	0	None
104180	104181	at	0	None
104181	104182	the	0	None
104182	104183	neuromuscular	0	None
104183	104184	junction	0	None
104184	104185	(	0	None
104185	104186	NMJ	0	None
104186	104187	)	0	None
104187	104188	is	0	None
104188	104189	anchored	0	None
104189	104190	to	0	None
104190	104191	the	0	None
104191	104192	synaptic	0	None
104192	104193	basal	0	None
104193	104194	lamina	0	None
104194	104195	via	0	None
104195	104196	a	0	None
104196	104197	triple	0	None
104197	104198	helical	0	None
104198	104199	collagen	3	GENE-N
104199	104200	Q	0	None
104200	104201	(	0	None
104201	104202	ColQ	0	None
104202	104203	)	0	None
104203	104204	in	0	None
104204	104205	the	0	None
104205	104206	form	0	None
104206	104207	of	0	None
104207	104208	asymmetric	0	None
104208	104209	AChE	1	GENE-Y
104209	104210	(	0	None
104210	104211	AChE	1	GENE-Y
104211	104212	/	0	None
104212	104213	ColQ	0	None
104213	104214	)	0	None
104214	104215	.	0	None

104216	104217	The	0	None
104217	104218	C-terminal	0	None
104218	104219	domain	0	None
104219	104220	of	0	None
104220	104221	ColQ	0	None
104221	104222	binds	0	None
104222	104223	to	0	None
104223	104224	MuSK	0	None
104224	104225	,	0	None
104225	104226	the	0	None
104226	104227	muscle-specific	0	None
104227	104230	receptor tyrosine kinase	3	GENE-N
104230	104231	,	0	None
104231	104232	that	0	None
104232	104233	mediates	0	None
104233	104234	a	0	None
104234	104235	signal	0	None
104235	104236	for	0	None
104236	104238	acetylcholine receptor	3	GENE-N
104238	104239	(	0	None
104239	104240	AChR	0	None
104240	104241	)	0	None
104241	104242	clustering	0	None
104242	104243	at	0	None
104243	104244	the	0	None
104244	104245	NMJ	0	None
104245	104246	.	0	None

104247	104248	ColQ	0	None
104248	104249	also	0	None
104249	104250	binds	0	None
104250	104251	to	0	None
104251	104252	heparan	0	None
104252	104253	sulfate	2	CHEMICAL
104253	104254	proteoglycans	0	None
104254	104255	including	0	None
104255	104256	perlecan	0	None
104256	104257	.	0	None

104258	104259	Congenital	0	None
104259	104260	defects	0	None
104260	104261	of	0	None
104261	104262	ColQ	0	None
104262	104263	cause	0	None
104263	104264	endplate	0	None
104264	104265	AChE	1	GENE-Y
104265	104266	deficiency	0	None
104266	104267	.	0	None

104268	104269	A	0	None
104269	104270	single	0	None
104270	104271	intravenous	0	None
104271	104272	administration	0	None
104272	104273	of	0	None
104273	104274	adeno-associated	0	None
104274	104275	virus	0	None
104275	104276	serotype	0	None
104276	104277	8	0	None
104277	104278	(	0	None
104278	104279	AAV8	0	None
104279	104280	)	0	None
104280	104281	-COLQ	0	None
104281	104282	to	0	None
104282	104283	Colq-	0	None
104283	104284	/	0	None
104284	104285	-	0	None
104285	104286	mice	0	None
104286	104287	rescued	0	None
104287	104288	motor	0	None
104288	104289	functions	0	None
104289	104290	,	0	None
104290	104291	synaptic	0	None
104291	104292	transmission	0	None
104292	104293	,	0	None
104293	104294	and	0	None
104294	104295	the	0	None
104295	104296	ultrastructure	0	None
104296	104297	of	0	None
104297	104298	NMJ	0	None
104298	104299	.	0	None

104300	104301	We	0	None
104301	104302	also	0	None
104302	104303	injected	0	None
104303	104304	AAV1-COLQ-IRES-EGFP	0	None
104304	104305	to	0	None
104305	104306	the	0	None
104306	104307	left	0	None
104307	104308	tibialis	0	None
104308	104309	anterior	0	None
104309	104310	and	0	None
104310	104311	observed	0	None
104311	104312	colocalization	0	None
104312	104313	of	0	None
104313	104314	AChE	1	GENE-Y
104314	104315	/	0	None
104315	104316	ColQ	0	None
104316	104317	at	0	None
104317	104318	all	0	None
104318	104319	the	0	None
104319	104320	examined	0	None
104320	104321	NMJs	0	None
104321	104322	of	0	None
104322	104323	the	0	None
104323	104324	non-injected	0	None
104324	104325	limbs	0	None
104325	104326	.	0	None

104327	104328	Additionally	0	None
104328	104329	,	0	None
104329	104330	injection	0	None
104330	104331	of	0	None
104331	104332	purified	0	None
104332	104333	recombinant	0	None
104333	104334	AChE	1	GENE-Y
104334	104335	/	0	None
104335	104336	ColQ	0	None
104336	104337	protein	0	None
104337	104338	complex	0	None
104338	104339	into	0	None
104339	104340	gluteus	0	None
104340	104341	maximus	0	None
104341	104342	accumulated	0	None
104342	104343	AChE	1	GENE-Y
104343	104344	in	0	None
104344	104345	non-injected	0	None
104345	104346	forelimbs	0	None
104346	104347	.	0	None

104348	104349	These	0	None
104349	104350	observations	0	None
104350	104351	suggest	0	None
104351	104352	that	0	None
104352	104353	the	0	None
104353	104354	tissue-targeting	0	None
104354	104355	signal	0	None
104355	104356	of	0	None
104356	104357	ColQ	0	None
104357	104358	can	0	None
104358	104359	be	0	None
104359	104360	exploited	0	None
104360	104361	to	0	None
104361	104362	specifically	0	None
104362	104363	deliver	0	None
104363	104364	the	0	None
104364	104365	transgene	0	None
104365	104366	product	0	None
104366	104367	to	0	None
104367	104368	the	0	None
104368	104369	target	0	None
104369	104370	tissue	0	None
104370	104371	.	0	None

104372	104373	MuSK	0	None
104373	104374	antibody-positive	0	None
104374	104375	myasthenia	0	None
104375	104376	gravis	0	None
104376	104377	(	0	None
104377	104378	MG	2	CHEMICAL
104378	104379	)	0	None
104379	104380	accounts	0	None
104380	104381	for	0	None
104381	104382	5-15%	0	None
104382	104383	of	0	None
104383	104384	autoimmune	0	None
104384	104385	MG	2	CHEMICAL
104385	104386	.	0	None

104387	104388	As	0	None
104388	104389	AChR	0	None
104389	104390	deficiency	0	None
104390	104391	is	0	None
104391	104392	typically	0	None
104392	104393	mild	0	None
104393	104394	and	0	None
104394	104395	as	0	None
104395	104396	cholinesterase	1	GENE-Y
104396	104397	inhibitors	0	None
104397	104398	are	0	None
104398	104399	generally	0	None
104399	104400	ineffective	0	None
104400	104401	or	0	None
104401	104402	worsen	0	None
104402	104403	myasthenic	0	None
104403	104404	symptoms	0	None
104404	104405	,	0	None
104405	104406	we	0	None
104406	104407	asked	0	None
104407	104408	if	0	None
104408	104409	the	0	None
104409	104410	patient's	0	None
104410	104411	MuSK-IgG	0	None
104411	104412	interferes	0	None
104412	104413	with	0	None
104413	104414	binding	0	None
104414	104415	of	0	None
104415	104416	ColQ	0	None
104416	104417	to	0	None
104417	104418	MuSK	0	None
104418	104419	.	0	None

104420	104421	In	0	None
104421	104422	vitro	0	None
104422	104423	overlay	0	None
104423	104424	of	0	None
104424	104425	AChE	1	GENE-Y
104425	104426	/	0	None
104426	104427	ColQ	0	None
104427	104428	to	0	None
104428	104429	muscle	0	None
104429	104430	sections	0	None
104430	104431	of	0	None
104431	104432	Colq-	0	None
104432	104433	/	0	None
104433	104434	-	0	None
104434	104435	mice	0	None
104435	104436	revealed	0	None
104436	104437	that	0	None
104437	104438	MuSK-IgG	0	None
104438	104439	blocks	0	None
104439	104440	binding	0	None
104440	104441	of	0	None
104441	104442	ColQ	0	None
104442	104443	to	0	None
104443	104444	the	0	None
104444	104445	NMJ	0	None
104445	104446	.	0	None

104447	104448	In	0	None
104448	104449	vitro	0	None
104449	104450	plate-binding	0	None
104450	104451	of	0	None
104451	104452	MuSK	0	None
104452	104453	to	0	None
104453	104454	ColQ	0	None
104454	104455	disclosed	0	None
104455	104456	that	0	None
104456	104457	MuSK-IgG	0	None
104457	104458	exerts	0	None
104458	104459	a	0	None
104459	104460	dose-dependent	0	None
104460	104461	block	0	None
104461	104462	of	0	None
104462	104463	MuSK-ColQ	0	None
104463	104464	interaction	0	None
104464	104465	.	0	None

104466	104467	In	0	None
104467	104468	addition	0	None
104468	104469	,	0	None
104469	104470	passive	0	None
104470	104471	transfer	0	None
104471	104472	of	0	None
104472	104473	MuSK-IgG	0	None
104473	104474	to	0	None
104474	104475	mice	0	None
104475	104476	reduced	0	None
104476	104477	the	0	None
104477	104478	size	0	None
104478	104479	and	0	None
104479	104480	density	0	None
104480	104481	of	0	None
104481	104482	ColQ	0	None
104482	104483	to	0	None
104483	104484	∼10%	0	None
104484	104485	of	0	None
104485	104486	controls	0	None
104486	104487	and	0	None
104487	104488	had	0	None
104488	104489	a	0	None
104489	104490	lesser	0	None
104490	104491	effect	0	None
104491	104492	on	0	None
104492	104493	the	0	None
104493	104494	sizes	0	None
104494	104495	and	0	None
104495	104496	densities	0	None
104496	104497	of	0	None
104497	104498	AChR	0	None
104498	104499	and	0	None
104499	104500	MuSK	0	None
104500	104501	.	0	None

104502	104503	Elucidation	0	None
104503	104504	of	0	None
104504	104505	molecular	0	None
104505	104506	mechanisms	0	None
104506	104507	of	0	None
104507	104508	specific	0	None
104508	104509	binding	0	None
104509	104510	of	0	None
104510	104511	ColQ	0	None
104511	104512	to	0	None
104512	104513	the	0	None
104513	104514	NMJ	0	None
104514	104515	enabled	0	None
104515	104516	us	0	None
104516	104517	to	0	None
104517	104518	ameliorate	0	None
104518	104519	devastating	0	None
104519	104520	myasthenic	0	None
104520	104521	symptoms	0	None
104521	104522	of	0	None
104522	104523	Colq-	0	None
104523	104524	/	0	None
104524	104525	-	0	None
104525	104526	mice	0	None
104526	104527	and	0	None
104527	104528	to	0	None
104528	104529	reveal	0	None
104529	104530	bases	0	None
104530	104531	of	0	None
104531	104532	anti-MuSK	0	None
104532	104533	MG	2	CHEMICAL
104533	104534	.	0	None
104534	104535	Introduction	0	None
104535	104536	:	0	None
104536	104537	The	0	None
104537	104538	pharmacological	0	None
104538	104539	profile	0	None
104539	104540	of	0	None
104540	104541	eprosartan--implications	0	None
104541	104542	for	0	None
104542	104543	cerebrovascular	0	None
104543	104544	and	0	None
104544	104545	cardiovascular	0	None
104545	104546	risk	0	None
104546	104547	reduction	0	None
104547	104548	.	0	None
104548	104549	Mechanistic	0	None
104549	104550	Aspects	0	None
104550	104551	of	0	None
104551	104552	hSOD1	0	None
104552	104553	Maturation	0	None
104553	104554	from	0	None
104554	104555	the	0	None
104555	104556	Solution	0	None
104556	104557	Structure	0	None
104557	104558	of	0	None
104558	104559	Cu	2	CHEMICAL
104559	104560	(	0	None
104560	104561	I	0	None
104561	104562	)	0	None
104562	104563	-Loaded	0	None
104563	104564	hCCS	1	GENE-Y
104564	104565	Domain	0	None
104565	104566	1	0	None
104566	104567	and	0	None
104567	104568	Analysis	0	None
104568	104569	of	0	None
104569	104570	Disulfide-Free	0	None
104570	104571	hSOD1	0	None
104571	104572	Mutants	0	None
104572	104573	.	0	None
104573	104574	Serum	0	None
104574	104575	carvedilol	2	CHEMICAL
104575	104576	concentration	0	None
104576	104577	and	0	None
104577	104578	its	0	None
104578	104579	relation	0	None
104579	104580	to	0	None
104580	104581	change	0	None
104581	104582	in	0	None
104582	104583	plasma	0	None
104583	104586	brain natriuretic peptide	1	GENE-Y
104586	104587	level	0	None
104587	104588	in	0	None
104588	104589	the	0	None
104589	104590	treatment	0	None
104590	104591	of	0	None
104591	104592	heart	0	None
104592	104593	failure	0	None
104593	104594	:	0	None
104594	104595	a	0	None
104595	104596	preliminary	0	None
104596	104597	study	0	None
104597	104598	.	0	None
104598	104599	It	0	None
104599	104600	was	0	None
104600	104601	investigated	0	None
104601	104602	whether	0	None
104602	104603	ethanol	2	CHEMICAL
104603	104604	(	0	None
104604	104605	Et	0	None
104605	104606	)	0	None
104606	104607	modifies	0	None
104607	104608	the	0	None
104608	104609	damaging	0	None
104609	104610	impact	0	None
104610	104611	of	0	None
104611	104612	lead	0	None
104612	104613	(	0	None
104613	104614	Pb	2	CHEMICAL
104614	104615	)	0	None
104615	104616	on	0	None
104616	104617	bone	0	None
104617	104618	metabolism	0	None
104618	104619	in	0	None
104619	104620	a	0	None
104620	104621	rat	0	None
104621	104622	model	0	None
104622	104623	reflecting	0	None
104623	104624	excessive	0	None
104624	104625	alcohol	2	CHEMICAL
104625	104626	consumption	0	None
104626	104627	by	0	None
104627	104628	humans	0	None
104628	104629	exposed	0	None
104629	104630	to	0	None
104630	104631	relatively	0	None
104631	104632	high	0	None
104632	104633	levels	0	None
104633	104634	of	0	None
104634	104635	this	0	None
104635	104636	metal	0	None
104636	104637	.	0	None

104638	104639	For	0	None
104639	104640	this	0	None
104640	104641	purpose	0	None
104641	104642	,	0	None
104642	104643	markers	0	None
104643	104644	of	0	None
104644	104645	bone	0	None
104645	104646	formation	0	None
104646	104647	(	0	None
104647	104648	osteocalcin	0	None
104648	104649	,	0	None
104649	104650	procollagen	0	None
104650	104651	I	0	None
104651	104652	,	0	None
104652	104653	osteoprotegerin	0	None
104653	104654	,	0	None
104654	104656	alkaline phosphatase	3	GENE-N
104656	104657	)	0	None
104657	104658	and	0	None
104658	104659	resorption	0	None
104659	104660	(	0	None
104660	104661	telopeptides	0	None
104661	104662	of	0	None
104662	104663	collagen	3	GENE-N
104663	104664	I	0	None
104664	104665	,	0	None
104665	104666	soluble	0	None
104666	104667	receptor	0	None
104667	104668	activator	0	None
104668	104669	of	0	None
104669	104670	nuclear	0	None
104670	104671	factor-κB	0	None
104671	104672	ligand	0	None
104672	104673	)	0	None
104673	104674	,	0	None
104674	104675	calciotropic	0	None
104675	104676	hormones	2	CHEMICAL
104676	104677	(	0	None
104677	104678	parathormone	1	GENE-Y
104678	104679	,	0	None
104679	104680	calcitonin	0	None
104680	104681	,	0	None
104681	104683	25-hydroxyvitamin D	2	CHEMICAL
104683	104684	and	0	None
104684	104685	1	0	None
104685	104686	,	0	None
104686	104687	25-dihydroxyvitamin	0	None
104687	104688	D	0	None
104688	104689	)	0	None
104689	104690	in	0	None
104690	104691	the	0	None
104691	104692	serum	0	None
104692	104693	,	0	None
104693	104694	and	0	None
104694	104695	the	0	None
104695	104696	femur	0	None
104696	104697	content	0	None
104697	104698	of	0	None
104698	104699	mineral	0	None
104699	104700	(	0	None
104700	104701	including	0	None
104701	104702	calcium	0	None
104702	104703	-	0	None
104703	104704	Ca	0	None
104704	104705	and	0	None
104705	104706	inorganic	0	None
104706	104707	phosphorus	0	None
104707	104708	-	0	None
104708	104709	Pi	0	None
104709	104710	)	0	None
104710	104711	and	0	None
104711	104712	organic	0	None
104712	104713	components	0	None
104713	104714	were	0	None
104714	104715	estimated	0	None
104715	104716	in	0	None
104716	104717	the	0	None
104717	104718	rats	0	None
104718	104719	exposed	0	None
104719	104720	to	0	None
104720	104721	500mg	0	None
104721	104722	Pb	2	CHEMICAL
104722	104723	/	0	None
104723	104724	l	0	None
104724	104725	(	0	None
104725	104726	in	0	None
104726	104727	drinking	0	None
104727	104728	water	0	None
104728	104729	)	0	None
104729	104730	or	0	None
104730	104731	/	0	None
104731	104732	and	0	None
104732	104733	Et	0	None
104733	104734	(	0	None
104734	104735	5g	0	None
104735	104736	/	0	None
104736	104737	kg	0	None
104737	104738	b	0	None
104738	104739	.	0	None

104740	104741	wt	0	None
104741	104742	.	0	None

104743	104744	/	0	None
104744	104745	24h	0	None
104745	104746	,	0	None
104746	104747	by	0	None
104747	104748	oral	0	None
104748	104749	gavage	0	None
104749	104750	)	0	None
104750	104751	for	0	None
104751	104752	12weeks	0	None
104752	104753	.	0	None

104754	104755	Moreover	0	None
104755	104756	,	0	None
104756	104757	Ca	0	None
104757	104758	and	0	None
104758	104759	Pi	0	None
104759	104760	in	0	None
104760	104761	the	0	None
104761	104762	serum	0	None
104762	104763	and	0	None
104763	104764	urine	0	None
104764	104765	,	0	None
104765	104767	alkaline phosphatase	3	GENE-N
104767	104768	in	0	None
104768	104769	the	0	None
104769	104770	bone	0	None
104770	104771	tissue	0	None
104771	104772	and	0	None
104772	104773	Pb	2	CHEMICAL
104773	104774	in	0	None
104774	104775	the	0	None
104775	104776	blood	0	None
104776	104777	and	0	None
104777	104778	femur	0	None
104778	104779	were	0	None
104779	104780	determined	0	None
104780	104781	.	0	None

104782	104783	The	0	None
104783	104784	exposure	0	None
104784	104785	to	0	None
104785	104786	Pb	2	CHEMICAL
104786	104787	or	0	None
104787	104788	/	0	None
104788	104789	and	0	None
104789	104790	Et	0	None
104790	104791	decreased	0	None
104791	104792	bone	0	None
104792	104793	formation	0	None
104793	104794	and	0	None
104794	104795	increased	0	None
104795	104796	its	0	None
104796	104797	resorption	0	None
104797	104798	resulting	0	None
104798	104799	in	0	None
104799	104800	the	0	None
104800	104801	bone	0	None
104801	104802	demineralization	0	None
104802	104803	.	0	None

104804	104805	These	0	None
104805	104806	effects	0	None
104806	104807	were	0	None
104807	104808	accompanied	0	None
104808	104809	by	0	None
104809	104810	destroying	0	None
104810	104811	the	0	None
104811	104812	hormonal	0	None
104812	104813	regulation	0	None
104813	104814	of	0	None
104814	104815	mineral	0	None
104815	104816	metabolism	0	None
104816	104817	,	0	None
104817	104818	and	0	None
104818	104819	Ca	0	None
104819	104820	and	0	None
104820	104821	Pi	0	None
104821	104822	imbalance	0	None
104822	104823	.	0	None

104824	104825	The	0	None
104825	104826	co-exposure	0	None
104826	104827	to	0	None
104827	104828	Pb	2	CHEMICAL
104828	104829	and	0	None
104829	104830	Et-induced	0	None
104830	104831	disorders	0	None
104831	104832	in	0	None
104832	104833	bone	0	None
104833	104834	metabolism	0	None
104834	104835	were	0	None
104835	104836	more	0	None
104836	104837	advanced	0	None
104837	104838	than	0	None
104838	104839	those	0	None
104839	104840	caused	0	None
104840	104841	by	0	None
104841	104842	Pb	2	CHEMICAL
104842	104843	alone	0	None
104843	104844	.	0	None

104845	104846	Et	0	None
104846	104847	co-administration	0	None
104847	104848	increased	0	None
104848	104849	Pb	2	CHEMICAL
104849	104850	concentration	0	None
104850	104851	in	0	None
104851	104852	the	0	None
104852	104853	blood	0	None
104853	104854	and	0	None
104854	104855	decreased	0	None
104855	104856	its	0	None
104856	104857	accumulation	0	None
104857	104858	in	0	None
104858	104859	the	0	None
104859	104860	bone	0	None
104860	104861	.	0	None

104862	104863	This	0	None
104863	104864	paper	0	None
104864	104865	is	0	None
104865	104866	the	0	None
104866	104867	first	0	None
104867	104868	report	0	None
104868	104869	providing	0	None
104869	104870	evidence	0	None
104870	104871	that	0	None
104871	104872	consumption	0	None
104872	104873	of	0	None
104873	104874	Et	0	None
104874	104875	under	0	None
104875	104876	exposure	0	None
104876	104877	to	0	None
104877	104878	Pb	2	CHEMICAL
104878	104879	intensifies	0	None
104879	104880	disorders	0	None
104880	104881	in	0	None
104881	104882	bone	0	None
104882	104883	metabolism	0	None
104883	104884	and	0	None
104884	104885	that	0	None
104885	104886	destroying	0	None
104886	104887	of	0	None
104887	104888	the	0	None
104888	104889	receptor	0	None
104889	104890	activator	0	None
104890	104891	nuclear	0	None
104891	104892	factor-κB	0	None
104892	104893	(	0	None
104893	104894	RANK	1	GENE-Y
104894	104895	)	0	None
104895	104896	/	0	None
104896	104897	RANK	1	GENE-Y
104897	104898	ligand	0	None
104898	104899	/	0	None
104899	104900	osteoprotegerin	0	None
104900	104901	system	0	None
104901	104902	is	0	None
104902	104903	involved	0	None
104903	104904	in	0	None
104904	104905	the	0	None
104905	104906	mechanisms	0	None
104906	104907	of	0	None
104907	104908	interactive	0	None
104908	104909	action	0	None
104909	104910	of	0	None
104910	104911	these	0	None
104911	104912	xenobiotics	0	None
104912	104913	on	0	None
104913	104914	the	0	None
104914	104915	skeleton	0	None
104915	104916	.	0	None

104917	104918	The	0	None
104918	104919	modifying	0	None
104919	104920	impact	0	None
104920	104921	of	0	None
104921	104922	Et	0	None
104922	104923	may	0	None
104923	104924	be	0	None
104924	104925	an	0	None
104925	104926	effect	0	None
104926	104927	of	0	None
104927	104928	its	0	None
104928	104929	independent	0	None
104929	104930	osteotropic	0	None
104930	104931	action	0	None
104931	104932	and	0	None
104932	104933	interaction	0	None
104933	104934	with	0	None
104934	104935	Pb	2	CHEMICAL
104935	104936	.	0	None

104937	104938	Based	0	None
104938	104939	on	0	None
104939	104940	the	0	None
104940	104941	results	0	None
104941	104942	it	0	None
104942	104943	can	0	None
104943	104944	be	0	None
104944	104945	concluded	0	None
104945	104946	that	0	None
104946	104947	alcohol	2	CHEMICAL
104947	104948	abuse	0	None
104948	104949	by	0	None
104949	104950	subjects	0	None
104950	104951	excessively	0	None
104951	104952	exposed	0	None
104952	104953	to	0	None
104953	104954	Pb	2	CHEMICAL
104954	104955	considerably	0	None
104955	104956	increases	0	None
104956	104957	the	0	None
104957	104958	risk	0	None
104958	104959	of	0	None
104959	104960	bone	0	None
104960	104961	damage	0	None
104961	104962	.	0	None
104962	104963	Mutations	0	None
104963	104964	in	0	None
104964	104965	the	0	None
104965	104966	insulin	0	None
104966	104967	(	0	None
104967	104968	INS	0	None
104968	104969	)	0	None
104969	104970	gene	0	None
104970	104971	may	0	None
104971	104972	cause	0	None
104972	104973	permanent	0	None
104973	104974	neonatal	0	None
104974	104975	diabetes	0	None
104975	104976	mellitus	0	None
104976	104977	(	0	None
104977	104978	PNDM	0	None
104978	104979	)	0	None
104979	104980	.	0	None

104981	104982	Ins2	0	None
104982	104983	mutant	0	None
104983	104984	mouse	0	None
104984	104985	models	0	None
104985	104986	provided	0	None
104986	104987	important	0	None
104987	104988	insights	0	None
104988	104989	into	0	None
104989	104990	the	0	None
104990	104991	disease	0	None
104991	104992	mechanisms	0	None
104992	104993	of	0	None
104993	104994	PNDM	0	None
104994	104995	but	0	None
104995	104996	have	0	None
104996	104997	limitations	0	None
104997	104998	for	0	None
104998	104999	translational	0	None
104999	105000	research	0	None
105000	105001	.	0	None

105002	105003	To	0	None
105003	105004	establish	0	None
105004	105005	a	0	None
105005	105006	large	0	None
105006	105007	animal	0	None
105007	105008	model	0	None
105008	105009	of	0	None
105009	105010	PNDM	0	None
105010	105011	,	0	None
105011	105012	we	0	None
105012	105013	generated	0	None
105013	105014	INS	0	None
105014	105015	(	0	None
105015	105016	C94Y	0	None
105016	105017	)	0	None
105017	105018	transgenic	0	None
105018	105019	pigs	0	None
105019	105020	.	0	None

105021	105022	A	0	None
105022	105023	line	0	None
105023	105024	expressing	0	None
105024	105025	high	0	None
105025	105026	levels	0	None
105026	105027	of	0	None
105027	105028	INS	0	None
105028	105029	(	0	None
105029	105030	C94Y	0	None
105030	105031	)	0	None
105031	105032	mRNA	0	None
105032	105033	(	0	None
105033	105034	70-86%	0	None
105034	105035	of	0	None
105035	105036	wild-type	0	None
105036	105037	INS	0	None
105037	105038	transcripts	0	None
105038	105039	)	0	None
105039	105040	exhibited	0	None
105040	105041	elevated	0	None
105041	105042	blood	0	None
105042	105043	glucose	0	None
105043	105044	soon	0	None
105044	105045	after	0	None
105045	105046	birth	0	None
105046	105047	but	0	None
105047	105048	unaltered	0	None
105048	105049	β-cell	0	None
105049	105050	mass	0	None
105050	105051	at	0	None
105051	105052	the	0	None
105052	105053	age	0	None
105053	105054	of	0	None
105054	105055	8	0	None
105055	105056	days	0	None
105056	105057	.	0	None

105058	105059	At	0	None
105059	105060	4	0	None
105060	105061	.	0	None
105061	105062	5	0	None
105062	105063	months	0	None
105063	105064	,	0	None
105064	105065	INS	0	None
105065	105066	(	0	None
105066	105067	C94Y	0	None
105067	105068	)	0	None
105068	105069	transgenic	0	None
105069	105070	pigs	0	None
105070	105071	exhibited	0	None
105071	105072	41%	0	None
105072	105073	reduced	0	None
105073	105074	body	0	None
105074	105075	weight	0	None
105075	105076	,	0	None
105076	105077	72%	0	None
105077	105078	decreased	0	None
105078	105079	β-cell	0	None
105079	105080	mass	0	None
105080	105081	(	0	None
105081	105082	-53%	0	None
105082	105083	relative	0	None
105083	105084	to	0	None
105084	105085	body	0	None
105085	105086	weight	0	None
105086	105087	)	0	None
105087	105088	,	0	None
105088	105089	and	0	None
105089	105090	60%	0	None
105090	105091	lower	0	None
105091	105093	fasting insulin	1	GENE-Y
105093	105094	levels	0	None
105094	105095	compared	0	None
105095	105096	with	0	None
105096	105097	littermate	0	None
105097	105098	controls	0	None
105098	105099	.	0	None

105100	105101	β-cells	0	None
105101	105102	of	0	None
105102	105103	INS	0	None
105103	105104	(	0	None
105104	105105	C94Y	0	None
105105	105106	)	0	None
105106	105107	transgenic	0	None
105107	105108	pigs	0	None
105108	105109	showed	0	None
105109	105110	a	0	None
105110	105111	marked	0	None
105111	105112	reduction	0	None
105112	105113	of	0	None
105113	105114	insulin	0	None
105114	105115	secretory	0	None
105115	105116	granules	0	None
105116	105117	and	0	None
105117	105118	severe	0	None
105118	105119	dilation	0	None
105119	105120	of	0	None
105120	105121	the	0	None
105121	105122	endoplasmic	0	None
105122	105123	reticulum	0	None
105123	105124	.	0	None

105125	105126	Cataract	0	None
105126	105127	development	0	None
105127	105128	was	0	None
105128	105129	already	0	None
105129	105130	visible	0	None
105130	105131	in	0	None
105131	105132	8-day-old	0	None
105132	105133	INS	0	None
105133	105134	(	0	None
105134	105135	C94Y	0	None
105135	105136	)	0	None
105136	105137	transgenic	0	None
105137	105138	pigs	0	None
105138	105139	and	0	None
105139	105140	became	0	None
105140	105141	more	0	None
105141	105142	severe	0	None
105142	105143	with	0	None
105143	105144	increasing	0	None
105144	105145	age	0	None
105145	105146	.	0	None

105147	105148	Diabetes-associated	0	None
105148	105149	pathological	0	None
105149	105150	alterations	0	None
105150	105151	of	0	None
105151	105152	kidney	0	None
105152	105153	and	0	None
105153	105154	nervous	0	None
105154	105155	tissue	0	None
105155	105156	were	0	None
105156	105157	not	0	None
105157	105158	detected	0	None
105158	105159	during	0	None
105159	105160	the	0	None
105160	105161	observation	0	None
105161	105162	period	0	None
105162	105163	of	0	None
105163	105164	1	0	None
105164	105165	year	0	None
105165	105166	.	0	None

105167	105168	The	0	None
105168	105169	stable	0	None
105169	105170	diabetic	0	None
105170	105171	phenotype	0	None
105171	105172	and	0	None
105172	105173	its	0	None
105173	105174	rescue	0	None
105174	105175	by	0	None
105175	105176	insulin	0	None
105176	105177	treatment	0	None
105177	105178	make	0	None
105178	105179	the	0	None
105179	105180	INS	0	None
105180	105181	(	0	None
105181	105182	C94Y	0	None
105182	105183	)	0	None
105183	105184	transgenic	0	None
105184	105185	pig	0	None
105185	105186	an	0	None
105186	105187	attractive	0	None
105187	105188	model	0	None
105188	105189	for	0	None
105189	105190	insulin	0	None
105190	105191	supplementation	0	None
105191	105192	and	0	None
105192	105193	islet	3	GENE-N
105193	105194	transplantation	0	None
105194	105195	trials	0	None
105195	105196	,	0	None
105196	105197	and	0	None
105197	105198	for	0	None
105198	105199	studying	0	None
105199	105200	developmental	0	None
105200	105201	consequences	0	None
105201	105202	of	0	None
105202	105203	maternal	0	None
105203	105204	diabetes	0	None
105204	105205	mellitus	0	None
105205	105206	.	0	None
105206	105207	Sorafenib	0	None
105207	105208	inhibits	0	None
105208	105209	the	0	None
105209	105210	angiogenesis	0	None
105210	105211	and	0	None
105211	105212	growth	0	None
105212	105213	of	0	None
105213	105214	orthotopic	0	None
105214	105215	anaplastic	0	None
105215	105216	thyroid	0	None
105216	105217	carcinoma	0	None
105217	105218	xenografts	0	None
105218	105219	in	0	None
105219	105220	nude	0	None
105220	105221	mice	0	None
105221	105222	.	0	None
105222	105223	The	0	None
105223	105224	present	0	None
105224	105225	study	0	None
105225	105226	was	0	None
105226	105227	to	0	None
105227	105228	evaluate	0	None
105228	105229	the	0	None
105229	105230	cholesterol-lowering	0	None
105230	105231	effect	0	None
105231	105232	of	0	None
105232	105233	two	0	None
105233	105234	novel	0	None
105234	105235	plant	0	None
105235	105236	stanol	0	None
105236	105237	derivatives	0	None
105237	105238	and	0	None
105238	105239	its	0	None
105239	105240	potential	0	None
105240	105241	molecular	0	None
105241	105242	mechanism	0	None
105242	105243	in	0	None
105243	105244	hyper-cholesterol	0	None
105244	105245	mice	0	None
105245	105246	induced	0	None
105246	105247	by	0	None
105247	105248	a	0	None
105248	105249	high-cholesterol	0	None
105249	105250	diet	0	None
105250	105251	.	0	None

105252	105253	Results	0	None
105253	105254	showed	0	None
105254	105255	that	0	None
105255	105256	oral	0	None
105256	105257	administration	0	None
105257	105258	of	0	None
105258	105259	plant	0	None
105259	105260	stanyl	0	None
105260	105261	hemisuccinate	0	None
105261	105262	(	0	None
105262	105263	2×	0	None
105263	105264	,	0	None
105264	105265	5×	0	None
105265	105266	)	0	None
105266	105267	and	0	None
105267	105268	plant	0	None
105268	105269	stanyl	0	None
105269	105270	sorbitol	0	None
105270	105271	succinate	0	None
105271	105272	(	0	None
105272	105273	2×	0	None
105273	105274	,	0	None
105274	105275	5×	0	None
105275	105276	)	0	None
105276	105277	effectively	0	None
105277	105278	attenuated	0	None
105278	105279	the	0	None
105279	105280	serum	0	None
105280	105281	total	0	None
105281	105282	cholesterol	0	None
105282	105283	and	0	None
105283	105284	low	0	None
105284	105285	density	0	None
105285	105286	lipoprotein	3	GENE-N
105286	105287	cholesterol	0	None
105287	105288	levels	0	None
105288	105289	,	0	None
105289	105290	while	0	None
105290	105291	had	0	None
105291	105292	no	0	None
105292	105293	effect	0	None
105293	105294	on	0	None
105294	105295	the	0	None
105295	105296	serum	0	None
105296	105297	triacylglycerol	0	None
105297	105298	and	0	None
105298	105299	high	0	None
105299	105300	density	0	None
105300	105301	lipoprotein	3	GENE-N
105301	105302	cholesterol	0	None
105302	105303	.	0	None

105304	105305	And	0	None
105305	105306	plant	0	None
105306	105307	stanol	0	None
105307	105308	derivatives	0	None
105308	105309	decreased	0	None
105309	105310	liver	0	None
105310	105311	cholesterol	0	None
105311	105312	concentration	0	None
105312	105313	and	0	None
105313	105314	increased	0	None
105314	105315	faecal	0	None
105315	105316	cholesterol	0	None
105316	105317	output	0	None
105317	105318	.	0	None

105319	105320	Meanwhile	0	None
105320	105321	,	0	None
105321	105322	both	0	None
105322	105323	plant	0	None
105323	105324	stanyl	0	None
105324	105325	hemisuccinate	0	None
105325	105326	and	0	None
105326	105327	plant	0	None
105327	105328	stanyl	0	None
105328	105329	sorbitol	0	None
105329	105330	succinate	2	CHEMICAL
105330	105331	could	0	None
105331	105332	remarkably	0	None
105332	105333	promote	0	None
105333	105334	liver	0	None
105334	105335	X	0	None
105335	105336	receptor	0	None
105336	105337	alpha	0	None
105337	105338	(	0	None
105338	105339	LXRα	0	None
105339	105340	)	0	None
105340	105341	expression	0	None
105341	105342	,	0	None
105342	105343	and	0	None
105343	105344	increased	0	None
105344	105345	cholesterol	0	None
105345	105346	7α-hydroxylase	0	None
105346	105347	(	0	None
105347	105348	CYP7A1	0	None
105348	105349	)	0	None
105349	105350	expression	0	None
105350	105351	and	0	None
105351	105352	faecal	0	None
105352	105353	total	0	None
105353	105355	bile acid	2	CHEMICAL
105355	105356	output	0	None
105356	105357	to	0	None
105357	105358	varying	0	None
105358	105359	degrees	0	None
105359	105360	.	0	None

105361	105362	These	0	None
105362	105363	results	0	None
105363	105364	suggested	0	None
105364	105365	two	0	None
105365	105366	novel	0	None
105366	105367	plant	0	None
105367	105368	stanol	0	None
105368	105369	derivatives	0	None
105369	105370	possessed	0	None
105370	105371	hypocholesterolemic	0	None
105371	105372	effect	0	None
105372	105373	,	0	None
105373	105374	and	0	None
105374	105375	the	0	None
105375	105376	cholesterol-lowering	0	None
105376	105377	action	0	None
105377	105378	of	0	None
105378	105379	plant	0	None
105379	105380	stanol	0	None
105380	105381	derivatives	0	None
105381	105382	may	0	None
105382	105383	be	0	None
105383	105384	through	0	None
105384	105385	activating	0	None
105385	105386	the	0	None
105386	105387	potential	0	None
105387	105388	LXRα-CYP7A1-bile	0	None
105388	105389	acid	0	None
105389	105390	excretion	0	None
105390	105391	pathway	0	None
105391	105392	.	0	None
105392	105393	Molecular	0	None
105393	105394	cloning	0	None
105394	105395	and	0	None
105395	105396	expression	0	None
105396	105397	of	0	None
105397	105398	the	0	None
105398	105399	rat	0	None
105399	105400	EAAT4	0	None
105400	105402	glutamate transporter	3	GENE-N
105402	105403	subtype	0	None
105403	105404	.	0	None
105404	105405	Gastric	0	None
105405	105406	mucin	0	None
105406	105407	secretion	0	None
105407	105408	in	0	None
105408	105409	response	0	None
105409	105410	to	0	None
105410	105411	beta-adrenergic	0	None
105411	105412	G	0	None
105412	105413	protein-coupled	0	None
105413	105414	receptor	0	None
105414	105415	activation	0	None
105415	105416	is	0	None
105416	105417	mediated	0	None
105417	105418	by	0	None
105418	105419	SRC	0	None
105419	105420	kinase-dependent	0	None
105420	105421	epidermal	0	None
105421	105424	growth factor receptor	3	GENE-N
105424	105425	transactivation	0	None
105425	105426	.	0	None
105426	105427	An	0	None
105427	105428	intestinal	0	None
105428	105429	immune	0	None
105429	105430	system	0	None
105430	105431	modulating	0	None
105431	105432	polysaccharide	0	None
105432	105433	(	0	None
105433	105434	CUI-3IIb-3-2	0	None
105434	105435	,	0	None
105435	105436	18kDa	0	None
105436	105437	)	0	None
105437	105438	was	0	None
105438	105439	purified	0	None
105439	105440	from	0	None
105440	105441	Citrus	0	None
105441	105442	unshiu	0	None
105442	105443	peel	0	None
105443	105444	.	0	None

105445	105446	CUI-3IIb-3-2	0	None
105446	105447	mainly	0	None
105447	105448	comprised	0	None
105448	105449	GalA	0	None
105449	105450	,	0	None
105450	105451	GlcA	0	None
105451	105452	,	0	None
105452	105453	Ara	0	None
105453	105454	,	0	None
105454	105455	Gal	0	None
105455	105456	and	0	None
105456	105457	Rha	0	None
105457	105458	,	0	None
105458	105459	and	0	None
105459	105460	it	0	None
105460	105461	consisted	0	None
105461	105462	of	0	None
105462	105463	4-linked	0	None
105463	105464	GalA	0	None
105464	105465	,	0	None
105465	105466	terminal	0	None
105466	105467	Araf	0	None
105467	105468	,	0	None
105468	105469	4-	0	None
105469	105470	or	0	None
105470	105471	5-linked	0	None
105471	105472	/	0	None
105472	105473	3	0	None
105473	105474	,	0	None
105474	105475	4-	0	None
105475	105476	or	0	None
105476	105477	3	0	None
105477	105478	,	0	None
105478	105479	5-branched	0	None
105479	105480	Ara	0	None
105480	105481	,	0	None
105481	105482	terminal	0	None
105482	105483	Gal	0	None
105483	105484	,	0	None
105484	105485	and	0	None
105485	105486	2-linked	0	None
105486	105487	/	0	None
105487	105488	2	0	None
105488	105489	,	0	None
105489	105490	4-branched	0	None
105490	105491	Rha	0	None
105491	105492	.	0	None

105493	105494	After	0	None
105494	105495	CUI-3IIb-3-2	0	None
105495	105496	digestion	0	None
105496	105497	by	0	None
105497	105498	endo-α-d-	0	None
105498	105499	(	0	None
105499	105500	1→4	0	None
105500	105501	)	0	None
105501	105502	-polygalacturonase	0	None
105502	105503	,	0	None
105503	105504	its	0	None
105504	105505	hydrolysate	0	None
105505	105506	was	0	None
105506	105507	fractionated	0	None
105507	105508	into	0	None
105508	105509	PG-1	0	None
105509	105510	and	0	None
105510	105511	PG-2	0	None
105511	105512	.	0	None

105513	105514	Methylation	0	None
105514	105515	analyses	0	None
105515	105516	of	0	None
105516	105517	PG-1	0	None
105517	105518	and	0	None
105518	105519	PG-2	0	None
105519	105520	using	0	None
105520	105521	base-catalysed	0	None
105521	105522	β-elimination	0	None
105522	105523	suggested	0	None
105523	105524	that	0	None
105524	105525	CUI-3IIb-3-2	0	None
105525	105526	be	0	None
105526	105527	assumed	0	None
105527	105528	as	0	None
105528	105529	pectic-type	0	None
105529	105530	polysaccharide	0	None
105530	105531	.	0	None

105532	105533	Since	0	None
105533	105534	the	0	None
105534	105535	activities	0	None
105535	105536	of	0	None
105536	105537	PG-1	0	None
105537	105538	and	0	None
105538	105539	PG-2	0	None
105539	105540	were	0	None
105540	105541	potently	0	None
105541	105542	decreased	0	None
105542	105543	,	0	None
105543	105544	the	0	None
105544	105545	whole	0	None
105545	105546	polysaccharide	0	None
105546	105547	structure	0	None
105547	105548	of	0	None
105548	105549	CUI-3IIb-3-2	0	None
105549	105550	would	0	None
105550	105551	be	0	None
105551	105552	essential	0	None
105552	105553	to	0	None
105553	105554	maintain	0	None
105554	105555	the	0	None
105555	105556	activity	0	None
105556	105557	.	0	None

105558	105559	Meanwhile	0	None
105559	105560	,	0	None
105560	105561	when	0	None
105561	105562	CUI-3IIb	0	None
105562	105563	was	0	None
105563	105564	orally	0	None
105564	105565	administered	0	None
105565	105566	in	0	None
105566	105567	mice	0	None
105567	105568	,	0	None
105568	105569	bone	0	None
105569	105570	marrow	0	None
105570	105571	cell	0	None
105571	105572	proliferation	0	None
105572	105573	and	0	None
105573	105574	GM-CSF	0	None
105574	105575	/	0	None
105575	105576	IL-6	0	None
105576	105577	production	0	None
105577	105578	from	0	None
105578	105579	Peyer's	0	None
105579	105580	patch	0	None
105580	105581	cell	0	None
105581	105582	were	0	None
105582	105583	significantly	0	None
105583	105584	higher	0	None
105584	105585	(	0	None
105585	105586	1	0	None
105586	105587	.	0	None
105587	105588	76-	0	None
105588	105589	and	0	None
105589	105590	2	0	None
105590	105591	.	0	None
105591	105592	03	0	None
105592	105593	/	0	None
105593	105594	2	0	None
105594	105595	.	0	None
105595	105596	51-fold	0	None
105596	105597	,	0	None
105597	105598	respectively	0	None
105598	105599	)	0	None
105599	105600	than	0	None
105600	105601	a	0	None
105601	105602	saline	0	None
105602	105603	.	0	None

105604	105605	Therefore	0	None
105605	105606	,	0	None
105606	105607	a	0	None
105607	105608	pectic-type	0	None
105608	105609	polysaccharide	0	None
105609	105610	from	0	None
105610	105611	citrus	0	None
105611	105612	peel	0	None
105612	105613	could	0	None
105613	105614	stimulate	0	None
105614	105615	Peyer's	0	None
105615	105616	patches	0	None
105616	105617	and	0	None
105617	105618	produce	0	None
105618	105619	hematopoietic	0	None
105619	105620	growth	0	None
105620	105621	factors	0	None
105621	105622	resulted	0	None
105622	105623	in	0	None
105623	105624	bone	0	None
105624	105625	marrow	0	None
105625	105626	cell	0	None
105626	105627	proliferation	0	None
105627	105628	.	0	None
105628	105629	The	0	None
105629	105630	insulin	0	None
105630	105631	/	0	None
105631	105632	IGF-1	0	None
105632	105633	pathway	0	None
105633	105634	controls	0	None
105634	105635	a	0	None
105635	105636	number	0	None
105636	105637	of	0	None
105637	105638	physiological	0	None
105638	105639	processes	0	None
105639	105640	in	0	None
105640	105641	the	0	None
105641	105642	nematode	0	None
105642	105643	worm	0	None
105643	105644	Caenorhabditis	0	None
105644	105645	elegans	0	None
105645	105646	,	0	None
105646	105647	including	0	None
105647	105648	development	0	None
105648	105649	,	0	None
105649	105650	aging	0	None
105650	105651	and	0	None
105651	105652	stress	0	None
105652	105653	response	0	None
105653	105654	.	0	None

105655	105656	We	0	None
105656	105657	previously	0	None
105657	105658	found	0	None
105658	105659	that	0	None
105659	105660	the	0	None
105660	105661	Akt	0	None
105661	105662	/	0	None
105662	105663	PKB	0	None
105663	105664	ortholog	0	None
105664	105665	AKT-1	0	None
105665	105666	dampens	0	None
105666	105667	the	0	None
105667	105668	apoptotic	0	None
105668	105669	response	0	None
105669	105670	to	0	None
105670	105671	genotoxic	0	None
105671	105672	stress	0	None
105672	105673	in	0	None
105673	105674	the	0	None
105674	105675	germline	0	None
105675	105676	by	0	None
105676	105677	negatively	0	None
105677	105678	regulating	0	None
105678	105679	the	0	None
105679	105680	p53-like	0	None
105680	105683	transcription factor CEP-1	3	GENE-N
105683	105684	.	0	None

105685	105686	Here	0	None
105686	105687	,	0	None
105687	105688	we	0	None
105688	105689	report	0	None
105689	105690	unexpected	0	None
105690	105691	rearrangements	0	None
105691	105692	to	0	None
105692	105693	the	0	None
105693	105694	insulin	0	None
105694	105695	/	0	None
105695	105696	IGF-1	0	None
105696	105697	pathway	0	None
105697	105698	,	0	None
105698	105699	whereby	0	None
105699	105700	the	0	None
105700	105702	insulin-like receptor	1	GENE-Y
105702	105703	DAF-2	0	None
105703	105704	and	0	None
105704	105705	3-phosphoinositide-dependent	0	None
105705	105706	protein	0	None
105706	105707	kinase	0	None
105707	105708	PDK-1	0	None
105708	105709	oppose	0	None
105709	105710	AKT-1	0	None
105710	105711	to	0	None
105711	105712	promote	0	None
105712	105713	DNA	0	None
105713	105714	damage-induced	0	None
105714	105715	apoptosis	0	None
105715	105716	.	0	None

105717	105718	While	0	None
105718	105719	DNA	0	None
105719	105720	damage	0	None
105720	105721	does	0	None
105721	105722	not	0	None
105722	105723	affect	0	None
105723	105724	phosphorylation	0	None
105724	105725	at	0	None
105725	105726	the	0	None
105726	105727	PDK-1	0	None
105727	105728	site	0	None
105728	105729	Thr350	0	None
105729	105730	/	0	None
105730	105731	Thr308	0	None
105731	105732	of	0	None
105732	105733	AKT-1	0	None
105733	105734	,	0	None
105734	105735	it	0	None
105735	105736	increased	0	None
105736	105737	phosphorylation	0	None
105737	105738	at	0	None
105738	105739	Ser517	0	None
105739	105740	/	0	None
105740	105741	Ser473	0	None
105741	105742	.	0	None

105743	105744	Although	0	None
105744	105745	ablation	0	None
105745	105746	of	0	None
105746	105747	daf-2	0	None
105747	105748	or	0	None
105748	105749	pdk-1	0	None
105749	105750	completely	0	None
105750	105751	suppressed	0	None
105751	105752	akt-1-dependent	0	None
105752	105753	apoptosis	0	None
105753	105754	,	0	None
105754	105755	the	0	None
105755	105756	transcriptional	0	None
105756	105757	activation	0	None
105757	105758	of	0	None
105758	105759	CEP-1	0	None
105759	105760	was	0	None
105760	105761	unaffected	0	None
105761	105762	,	0	None
105762	105763	suggesting	0	None
105763	105764	that	0	None
105764	105765	daf-2	0	None
105765	105766	and	0	None
105766	105767	pdk-1	0	None
105767	105768	act	0	None
105768	105769	independently	0	None
105769	105770	or	0	None
105770	105771	downstream	0	None
105771	105772	of	0	None
105772	105773	cep-1	0	None
105773	105774	and	0	None
105774	105775	akt-1	0	None
105775	105776	.	0	None

105777	105778	Ablation	0	None
105778	105779	of	0	None
105779	105780	the	0	None
105780	105781	akt-1	0	None
105781	105782	paralog	0	None
105782	105783	akt-2	0	None
105783	105784	or	0	None
105784	105785	the	0	None
105785	105786	downstream	0	None
105786	105787	target	0	None
105787	105788	of	0	None
105788	105789	the	0	None
105789	105790	insulin	0	None
105790	105791	/	0	None
105791	105792	IGF-1	0	None
105792	105793	pathway	0	None
105793	105794	daf-16	0	None
105794	105795	(	0	None
105795	105796	a	0	None
105796	105797	FOXO	0	None
105797	105799	transcription factor	0	None
105799	105800	)	0	None
105800	105801	restored	0	None
105801	105802	sensitivity	0	None
105802	105803	to	0	None
105803	105804	damage-induced	0	None
105804	105805	apoptosis	0	None
105805	105806	in	0	None
105806	105807	daf-2	0	None
105807	105808	and	0	None
105808	105809	pdk-1	0	None
105809	105810	mutants	0	None
105810	105811	.	0	None

105812	105813	In	0	None
105813	105814	addition	0	None
105814	105815	,	0	None
105815	105816	daf-2	0	None
105816	105817	and	0	None
105817	105818	pdk-1	0	None
105818	105819	mutants	0	None
105819	105820	have	0	None
105820	105821	reduced	0	None
105821	105822	levels	0	None
105822	105823	of	0	None
105823	105824	phospho-MPK-1	0	None
105824	105825	/	0	None
105825	105826	ERK	0	None
105826	105827	in	0	None
105827	105828	their	0	None
105828	105829	germ	0	None
105829	105830	cells	0	None
105830	105831	,	0	None
105831	105832	indicating	0	None
105832	105833	that	0	None
105833	105834	the	0	None
105834	105835	insulin	0	None
105835	105836	/	0	None
105836	105837	IGF-1	0	None
105837	105838	pathway	0	None
105838	105839	promotes	0	None
105839	105840	Ras	3	GENE-N
105840	105841	signaling	0	None
105841	105842	in	0	None
105842	105843	the	0	None
105843	105844	germline	0	None
105844	105845	.	0	None

105846	105847	Ablation	0	None
105847	105848	of	0	None
105848	105849	the	0	None
105849	105850	Ras	3	GENE-N
105850	105851	effector	0	None
105851	105852	gla-3	0	None
105852	105853	,	0	None
105853	105854	a	0	None
105854	105855	negative	0	None
105855	105856	regulator	0	None
105856	105857	of	0	None
105857	105858	mpk-1	0	None
105858	105859	,	0	None
105859	105860	restored	0	None
105860	105861	sensitivity	0	None
105861	105862	to	0	None
105862	105863	apoptosis	0	None
105863	105864	in	0	None
105864	105865	daf-2	0	None
105865	105866	mutants	0	None
105866	105867	,	0	None
105867	105868	suggesting	0	None
105868	105869	that	0	None
105869	105870	gla-3	0	None
105870	105871	acts	0	None
105871	105872	downstream	0	None
105872	105873	of	0	None
105873	105874	daf-2	0	None
105874	105875	.	0	None

105876	105877	In	0	None
105877	105878	addition	0	None
105878	105879	,	0	None
105879	105880	the	0	None
105880	105881	hypersensitivity	0	None
105881	105882	of	0	None
105882	105883	let-60	0	None
105883	105884	/	0	None
105884	105885	Ras	3	GENE-N
105885	105886	gain-of-function	0	None
105886	105887	mutants	0	None
105887	105888	to	0	None
105888	105889	damage-induced	0	None
105889	105890	apoptosis	0	None
105890	105891	was	0	None
105891	105892	suppressed	0	None
105892	105893	to	0	None
105893	105894	wild-type	0	None
105894	105895	levels	0	None
105895	105896	by	0	None
105896	105897	ablation	0	None
105897	105898	of	0	None
105898	105899	daf-2	0	None
105899	105900	.	0	None

105901	105902	Thus	0	None
105902	105903	,	0	None
105903	105904	insulin	0	None
105904	105905	/	0	None
105905	105906	IGF-1	0	None
105906	105907	signaling	0	None
105907	105908	selectively	0	None
105908	105909	engages	0	None
105909	105910	AKT-2	0	None
105910	105911	/	0	None
105911	105912	DAF-16	0	None
105912	105913	to	0	None
105913	105914	promote	0	None
105914	105915	DNA	0	None
105915	105916	damage-induced	0	None
105916	105917	germ	0	None
105917	105918	cell	0	None
105918	105919	apoptosis	0	None
105919	105920	downstream	0	None
105920	105921	of	0	None
105921	105922	CEP-1	0	None
105922	105923	through	0	None
105923	105924	the	0	None
105924	105925	Ras	3	GENE-N
105925	105926	pathway	0	None
105926	105927	.	0	None
105927	105928	Inhibition	0	None
105928	105929	of	0	None
105929	105930	cardiac	0	None
105930	105931	voltage-gated	0	None
105931	105933	sodium channels	3	GENE-N
105933	105934	by	0	None
105934	105935	grape	0	None
105935	105936	polyphenols	0	None
105936	105937	.	0	None
105937	105939	GnRH I	1	GENE-Y
105939	105940	regulates	0	None
105940	105941	reproduction	0	None
105941	105942	.	0	None

105943	105944	A	0	None
105944	105945	second	0	None
105945	105946	form	0	None
105946	105947	,	0	None
105947	105948	designated	0	None
105948	105950	GnRH II	2	CHEMICAL
105950	105951	,	0	None
105951	105952	selectively	0	None
105952	105953	binds	0	None
105953	105954	type	0	None
105954	105955	II	0	None
105955	105956	GnRH	0	None
105956	105957	receptors	0	None
105957	105958	.	0	None

105959	105961	Amino acids	2	CHEMICAL
105961	105962	of	0	None
105962	105963	the	0	None
105963	105964	type	0	None
105964	105967	I GnRH receptor	1	GENE-Y
105967	105968	required	0	None
105968	105969	for	0	None
105969	105970	binding	0	None
105970	105971	of	0	None
105971	105973	GnRH I	1	GENE-Y
105973	105974	(	0	None
105974	105975	Asp2	0	None
105975	105976	.	0	None
105976	105977	61	0	None
105977	105978	(	0	None
105978	105979	98	0	None
105979	105980	)	0	None
105980	105981	,	0	None
105981	105982	Asn2	0	None
105982	105983	.	0	None
105983	105984	65	0	None
105984	105985	(	0	None
105985	105986	102	0	None
105986	105987	)	0	None
105987	105988	,	0	None
105988	105989	and	0	None
105989	105990	Lys3	0	None
105990	105991	.	0	None
105991	105992	32	0	None
105992	105993	(	0	None
105993	105994	121	0	None
105994	105995	)	0	None
105995	105996	)	0	None
105996	105997	are	0	None
105997	105998	conserved	0	None
105998	105999	in	0	None
105999	106000	the	0	None
106000	106001	type	0	None
106001	106002	II	0	None
106002	106003	GnRH	0	None
106003	106004	receptor	0	None
106004	106005	,	0	None
106005	106006	but	0	None
106006	106007	their	0	None
106007	106008	roles	0	None
106008	106009	in	0	None
106009	106010	receptor	0	None
106010	106011	function	0	None
106011	106012	are	0	None
106012	106013	unknown	0	None
106013	106014	.	0	None

106015	106016	We	0	None
106016	106017	have	0	None
106017	106018	delineated	0	None
106018	106019	their	0	None
106019	106020	functions	0	None
106020	106021	using	0	None
106021	106022	mutagenesis	0	None
106022	106023	,	0	None
106023	106024	signaling	0	None
106024	106025	and	0	None
106025	106026	binding	0	None
106026	106027	assays	0	None
106027	106028	,	0	None
106028	106029	immunoblotting	0	None
106029	106030	,	0	None
106030	106031	and	0	None
106031	106032	computational	0	None
106032	106033	modeling	0	None
106033	106034	.	0	None

106035	106036	Mutating	0	None
106036	106037	Asp2	0	None
106037	106038	.	0	None
106038	106039	61	0	None
106039	106040	(	0	None
106040	106041	97	0	None
106041	106042	)	0	None
106042	106043	to	0	None
106043	106044	Glu	2	CHEMICAL
106044	106045	or	0	None
106045	106046	Ala	0	None
106046	106047	,	0	None
106047	106048	Asn2	0	None
106048	106049	.	0	None
106049	106050	65	0	None
106050	106051	(	0	None
106051	106052	101	0	None
106052	106053	)	0	None
106053	106054	to	0	None
106054	106055	Ala	0	None
106055	106056	,	0	None
106056	106057	or	0	None
106057	106058	Lys3	0	None
106058	106059	.	0	None
106059	106060	32	0	None
106060	106061	(	0	None
106061	106062	120	0	None
106062	106063	)	0	None
106063	106064	to	0	None
106064	106065	Gln	0	None
106065	106066	decreased	0	None
106066	106067	potency	0	None
106067	106068	of	0	None
106068	106069	GnRH	0	None
106069	106070	II-stimulated	0	None
106070	106071	inositol	0	None
106071	106072	phosphate	0	None
106072	106073	production	0	None
106073	106074	.	0	None

106075	106076	Consistent	0	None
106076	106077	with	0	None
106077	106078	proposed	0	None
106078	106079	roles	0	None
106079	106080	in	0	None
106080	106081	ligand	0	None
106081	106082	recognition	0	None
106082	106083	,	0	None
106083	106084	mutations	0	None
106084	106085	eliminated	0	None
106085	106086	measurable	0	None
106086	106087	binding	0	None
106087	106088	of	0	None
106088	106090	GnRH II	2	CHEMICAL
106090	106091	,	0	None
106091	106092	whereas	0	None
106092	106093	expression	0	None
106093	106094	of	0	None
106094	106095	mutant	0	None
106095	106096	receptors	0	None
106096	106097	was	0	None
106097	106098	not	0	None
106098	106099	decreased	0	None
106099	106100	.	0	None

106101	106102	In	0	None
106102	106103	detailed	0	None
106103	106104	analysis	0	None
106104	106105	of	0	None
106105	106106	how	0	None
106106	106107	these	0	None
106107	106108	residues	0	None
106108	106109	affect	0	None
106109	106110	ligand-dependent	0	None
106110	106111	signaling	0	None
106111	106112	,	0	None
106112	106113	[	0	None
106113	106114	Trp2	0	None
106114	106115	]	0	None
106115	106116	-GnRH	0	None
106116	106117	I	0	None
106117	106118	showed	0	None
106118	106119	lesser	0	None
106119	106120	decreases	0	None
106120	106121	in	0	None
106121	106122	potency	0	None
106122	106123	than	0	None
106123	106125	GnRH I	1	GENE-Y
106125	106126	at	0	None
106126	106127	the	0	None
106127	106128	Asp2	0	None
106128	106129	.	0	None
106129	106130	61	0	None
106130	106131	(	0	None
106131	106132	97	0	None
106132	106133	)	0	None
106133	106134	Glu	2	CHEMICAL
106134	106135	mutant	0	None
106135	106136	.	0	None

106137	106138	In	0	None
106138	106139	contrast	0	None
106139	106140	,	0	None
106140	106141	[	0	None
106141	106142	Trp2	0	None
106142	106143	]	0	None
106143	106144	-GnRH	0	None
106144	106145	II	0	None
106145	106146	showed	0	None
106146	106147	the	0	None
106147	106148	same	0	None
106148	106149	loss	0	None
106149	106150	of	0	None
106150	106151	potency	0	None
106151	106152	as	0	None
106152	106154	GnRH II	2	CHEMICAL
106154	106155	at	0	None
106155	106156	this	0	None
106156	106157	mutant	0	None
106157	106158	.	0	None

106159	106160	This	0	None
106160	106161	suggests	0	None
106161	106162	that	0	None
106162	106163	Asp2	0	None
106163	106164	.	0	None
106164	106165	61	0	None
106165	106166	(	0	None
106166	106167	97	0	None
106167	106168	)	0	None
106168	106169	contributes	0	None
106169	106170	to	0	None
106170	106171	recognition	0	None
106171	106172	of	0	None
106172	106173	His2	2	CHEMICAL
106173	106174	of	0	None
106174	106176	GnRH I	1	GENE-Y
106176	106177	,	0	None
106177	106178	but	0	None
106178	106179	not	0	None
106179	106180	of	0	None
106180	106182	GnRH II	2	CHEMICAL
106182	106183	.	0	None

106184	106186	GnRH II	2	CHEMICAL
106186	106187	showed	0	None
106187	106188	a	0	None
106188	106189	large	0	None
106189	106190	decrease	0	None
106190	106191	in	0	None
106191	106192	potency	0	None
106192	106193	at	0	None
106193	106194	the	0	None
106194	106195	Asn2	0	None
106195	106196	.	0	None
106196	106197	65	0	None
106197	106198	(	0	None
106198	106199	101	0	None
106199	106200	)	0	None
106200	106201	Ala	0	None
106201	106202	mutant	0	None
106202	106203	compared	0	None
106203	106204	with	0	None
106204	106205	analogs	0	None
106205	106206	lacking	0	None
106206	106207	the	0	None
106207	106208	CO	0	None
106208	106209	group	0	None
106209	106210	of	0	None
106210	106211	Gly10NH2	0	None
106211	106212	.	0	None

106213	106214	This	0	None
106214	106215	suggests	0	None
106215	106216	that	0	None
106216	106217	Asn2	0	None
106217	106218	.	0	None
106218	106219	65	0	None
106219	106220	(	0	None
106220	106221	101	0	None
106221	106222	)	0	None
106222	106223	recognizes	0	None
106223	106224	Gly10NH2	0	None
106224	106225	of	0	None
106225	106227	GnRH II	2	CHEMICAL
106227	106228	.	0	None

106229	106230	GnRH	0	None
106230	106231	agonists	0	None
106231	106232	showed	0	None
106232	106233	large	0	None
106233	106234	decreases	0	None
106234	106235	in	0	None
106235	106236	potency	0	None
106236	106237	at	0	None
106237	106238	the	0	None
106238	106239	Lys3	0	None
106239	106240	.	0	None
106240	106241	32	0	None
106241	106242	(	0	None
106242	106243	120	0	None
106243	106244	)	0	None
106244	106245	Gln	0	None
106245	106246	mutant	0	None
106246	106247	,	0	None
106247	106248	but	0	None
106248	106249	antagonist	0	None
106249	106250	activity	0	None
106250	106251	was	0	None
106251	106252	unaffected	0	None
106252	106253	.	0	None

106254	106255	This	0	None
106255	106256	suggests	0	None
106256	106257	that	0	None
106257	106258	Lys3	0	None
106258	106259	.	0	None
106259	106260	32	0	None
106260	106261	(	0	None
106261	106262	120	0	None
106262	106263	)	0	None
106263	106264	recognizes	0	None
106264	106265	agonists	0	None
106265	106266	,	0	None
106266	106267	but	0	None
106267	106268	not	0	None
106268	106269	antagonists	0	None
106269	106270	,	0	None
106270	106271	as	0	None
106271	106272	in	0	None
106272	106273	the	0	None
106273	106274	type	0	None
106274	106275	I	0	None
106275	106276	receptor	0	None
106276	106277	.	0	None

106278	106279	These	0	None
106279	106280	data	0	None
106280	106281	indicate	0	None
106281	106282	that	0	None
106282	106283	roles	0	None
106283	106284	of	0	None
106284	106285	conserved	0	None
106285	106286	residues	0	None
106286	106287	are	0	None
106287	106288	similar	0	None
106288	106289	,	0	None
106289	106290	but	0	None
106290	106291	not	0	None
106291	106292	identical	0	None
106292	106293	,	0	None
106293	106294	in	0	None
106294	106295	the	0	None
106295	106296	type	0	None
106296	106297	I	0	None
106297	106298	and	0	None
106298	106299	II	0	None
106299	106300	GnRH	0	None
106300	106301	receptors	0	None
106301	106302	.	0	None
106302	106306	Beta 1- and beta	1	GENE-Y
106306	106307	2-adrenoceptor	0	None
106307	106308	binding	0	None
106308	106309	and	0	None
106309	106310	functional	0	None
106310	106311	response	0	None
106311	106312	in	0	None
106312	106313	right	0	None
106313	106314	and	0	None
106314	106315	left	0	None
106315	106316	atria	0	None
106316	106317	of	0	None
106317	106318	rat	0	None
106318	106319	heart	0	None
106319	106320	.	0	None
106320	106321	Exenatide	0	None
106321	106322	,	0	None
106322	106323	the	0	None
106323	106324	active	0	None
106324	106325	ingredient	0	None
106325	106326	of	0	None
106326	106327	BYETTA	0	None
106327	106328	(	0	None
106328	106329	exenatide	0	None
106329	106330	injection	0	None
106330	106331	)	0	None
106331	106332	,	0	None
106332	106333	is	0	None
106333	106334	an	0	None
106334	106335	incretin	0	None
106335	106336	mimetic	0	None
106336	106337	that	0	None
106337	106338	has	0	None
106338	106339	been	0	None
106339	106340	developed	0	None
106340	106341	for	0	None
106341	106342	the	0	None
106342	106343	treatment	0	None
106343	106344	of	0	None
106344	106345	patients	0	None
106345	106346	with	0	None
106346	106347	type	0	None
106347	106348	2	0	None
106348	106349	diabetes	0	None
106349	106350	.	0	None

106351	106352	Exenatide	0	None
106352	106353	binds	0	None
106353	106354	to	0	None
106354	106355	and	0	None
106355	106356	activates	0	None
106356	106357	the	0	None
106357	106358	known	0	None
106358	106359	GLP-1	0	None
106359	106360	receptor	0	None
106360	106361	with	0	None
106361	106362	a	0	None
106362	106363	potency	0	None
106363	106364	comparable	0	None
106364	106365	to	0	None
106365	106366	that	0	None
106366	106367	of	0	None
106367	106368	the	0	None
106368	106369	mammalian	0	None
106369	106370	incretin	0	None
106370	106371	GLP-1	0	None
106371	106372	(	0	None
106372	106373	7-36	0	None
106373	106374	)	0	None
106374	106375	,	0	None
106375	106376	thereby	0	None
106376	106377	acting	0	None
106377	106378	as	0	None
106378	106379	a	0	None
106379	106380	glucoregulatory	0	None
106380	106381	agent	0	None
106381	106382	.	0	None

106383	106384	AC3174	0	None
106384	106385	is	0	None
106385	106386	an	0	None
106386	106387	analog	0	None
106387	106388	of	0	None
106388	106389	exenatide	0	None
106389	106390	with	0	None
106390	106391	leucine	0	None
106391	106392	substituted	0	None
106392	106393	for	0	None
106393	106394	methionine	2	CHEMICAL
106394	106395	at	0	None
106395	106396	position	0	None
106396	106397	14	0	None
106397	106398	,	0	None
106398	106399	[	0	None
106399	106400	Leu	0	None
106400	106401	(	0	None
106401	106402	14	0	None
106402	106403	)	0	None
106403	106404	]	0	None
106404	106405	exendin-4	0	None
106405	106406	.	0	None

106407	106408	The	0	None
106408	106409	purpose	0	None
106409	106410	of	0	None
106410	106411	these	0	None
106411	106412	studies	0	None
106412	106413	was	0	None
106413	106414	to	0	None
106414	106415	evaluate	0	None
106415	106416	the	0	None
106416	106417	glucoregulatory	0	None
106417	106418	activity	0	None
106418	106419	and	0	None
106419	106420	pharmacokinetics	0	None
106420	106421	of	0	None
106421	106422	AC3174	0	None
106422	106423	.	0	None

106424	106425	In	0	None
106425	106426	RINm5f	0	None
106426	106427	cell	0	None
106427	106428	membranes	0	None
106428	106429	,	0	None
106429	106430	the	0	None
106430	106431	potency	0	None
106431	106432	of	0	None
106432	106433	AC3174	0	None
106433	106434	for	0	None
106434	106435	the	0	None
106435	106436	displacement	0	None
106436	106437	of	0	None
106437	106438	[	0	None
106438	106439	(	0	None
106439	106440	125	0	None
106440	106441	)	0	None
106441	106442	I	0	None
106442	106443	]	0	None
106443	106444	GLP-1	0	None
106444	106445	and	0	None
106445	106446	activation	0	None
106446	106447	of	0	None
106447	106449	adenylate cyclase	3	GENE-N
106449	106450	was	0	None
106450	106451	similar	0	None
106451	106452	to	0	None
106452	106453	that	0	None
106453	106454	of	0	None
106454	106455	exenatide	0	None
106455	106456	and	0	None
106456	106457	GLP-1	0	None
106457	106458	.	0	None

106459	106460	In	0	None
106460	106461	vivo	0	None
106461	106462	,	0	None
106462	106463	AC3174	0	None
106463	106464	,	0	None
106464	106465	administered	0	None
106465	106466	as	0	None
106466	106467	a	0	None
106467	106468	single	0	None
106468	106469	IP	0	None
106469	106470	injection	0	None
106470	106471	,	0	None
106471	106472	significantly	0	None
106472	106473	decreased	0	None
106473	106474	plasma	0	None
106474	106475	glucose	0	None
106475	106476	concentration	0	None
106476	106477	and	0	None
106477	106478	glucose	0	None
106478	106479	excursion	0	None
106479	106480	following	0	None
106480	106481	the	0	None
106481	106482	administration	0	None
106482	106483	of	0	None
106483	106484	an	0	None
106484	106485	oral	0	None
106485	106486	glucose	0	None
106486	106487	challenge	0	None
106487	106488	in	0	None
106488	106489	both	0	None
106489	106490	non-diabetic	0	None
106490	106491	(	0	None
106491	106492	C57BL	0	None
106492	106493	/	0	None
106493	106494	6	0	None
106494	106495	)	0	None
106495	106496	and	0	None
106496	106497	diabetic	0	None
106497	106498	db	0	None
106498	106499	/	0	None
106499	106500	db	0	None
106500	106501	mice	0	None
106501	106502	(	0	None
106502	106503	P<0	0	None
106503	106504	.	0	None
106504	106505	05	0	None
106505	106506	vs	0	None
106506	106507	.	0	None

106508	106509	vehicle-treated	0	None
106509	106510	)	0	None
106510	106511	.	0	None

106512	106513	The	0	None
106513	106514	magnitude	0	None
106514	106515	of	0	None
106515	106516	glucose	0	None
106516	106517	lowering	0	None
106517	106518	of	0	None
106518	106519	AC3174	0	None
106519	106520	was	0	None
106520	106521	comparable	0	None
106521	106522	to	0	None
106522	106523	exenatide	0	None
106523	106524	.	0	None

106525	106526	The	0	None
106526	106527	ED	0	None
106527	106528	(	0	None
106528	106529	50	0	None
106529	106530	)	0	None
106530	106531	values	0	None
106531	106532	of	0	None
106532	106533	AC3174	0	None
106533	106534	for	0	None
106534	106535	glucose	0	None
106535	106536	lowering	0	None
106536	106537	(	0	None
106537	106538	60	0	None
106538	106539	minute	0	None
106539	106540	post-dose	0	None
106540	106541	)	0	None
106541	106542	were	0	None
106542	106543	1	0	None
106543	106544	.	0	None
106544	106545	2	0	None
106545	106546	microg	0	None
106546	106547	/	0	None
106547	106548	kg	0	None
106548	106549	in	0	None
106549	106550	db	0	None
106550	106551	/	0	None
106551	106552	db	0	None
106552	106553	mice	0	None
106553	106554	and	0	None
106554	106555	1	0	None
106555	106556	.	0	None
106556	106557	3	0	None
106557	106558	microg	0	None
106558	106559	/	0	None
106559	106560	kg	0	None
106560	106561	in	0	None
106561	106562	C57BL	0	None
106562	106563	/	0	None
106563	106564	6	0	None
106564	106565	mice	0	None
106565	106566	.	0	None

106567	106568	AC3174	0	None
106568	106569	has	0	None
106569	106570	insulinotropic	0	None
106570	106571	activity	0	None
106571	106572	in	0	None
106572	106573	vivo	0	None
106573	106574	.	0	None

106575	106576	Administration	0	None
106576	106577	of	0	None
106577	106578	AC3174	0	None
106578	106579	resulted	0	None
106579	106580	in	0	None
106580	106581	a	0	None
106581	106582	4-fold	0	None
106582	106583	increase	0	None
106583	106584	in	0	None
106584	106585	insulin	0	None
106585	106586	concentrations	0	None
106586	106587	in	0	None
106587	106588	normal	0	None
106588	106589	mice	0	None
106589	106590	following	0	None
106590	106591	an	0	None
106591	106592	IP	0	None
106592	106593	glucose	0	None
106593	106594	challenge	0	None
106594	106595	.	0	None

106596	106597	AC3174	0	None
106597	106598	was	0	None
106598	106599	also	0	None
106599	106600	shown	0	None
106600	106601	to	0	None
106601	106602	inhibit	0	None
106602	106603	food	0	None
106603	106604	intake	0	None
106604	106605	and	0	None
106605	106606	decrease	0	None
106606	106607	gastric	0	None
106607	106608	emptying	0	None
106608	106609	in	0	None
106609	106610	rodent	0	None
106610	106611	models	0	None
106611	106612	.	0	None

106613	106614	AC3174	0	None
106614	106615	was	0	None
106615	106616	stable	0	None
106616	106617	in	0	None
106617	106618	human	0	None
106618	106619	plasma	0	None
106619	106620	(	0	None
106620	106621	>90%	0	None
106621	106622	of	0	None
106622	106623	parent	0	None
106623	106624	peptide	0	None
106624	106625	was	0	None
106625	106626	present	0	None
106626	106627	after	0	None
106627	106628	5	0	None
106628	106629	h	0	None
106629	106630	of	0	None
106630	106631	incubation	0	None
106631	106632	)	0	None
106632	106633	.	0	None

106634	106635	In	0	None
106635	106636	rats	0	None
106636	106637	,	0	None
106637	106638	the	0	None
106638	106639	in	0	None
106639	106640	vivo	0	None
106640	106641	half-life	0	None
106641	106642	of	0	None
106642	106643	AC3174	0	None
106643	106644	was	0	None
106644	106645	42-43	0	None
106645	106646	min	0	None
106646	106647	following	0	None
106647	106648	SC	0	None
106648	106649	administration	0	None
106649	106650	.	0	None

106651	106652	In	0	None
106652	106653	summary	0	None
106653	106654	,	0	None
106654	106655	AC3174	0	None
106655	106656	is	0	None
106656	106657	an	0	None
106657	106658	analog	0	None
106658	106659	of	0	None
106659	106660	exenatide	0	None
106660	106661	that	0	None
106661	106662	binds	0	None
106662	106663	to	0	None
106663	106664	the	0	None
106664	106665	GLP-1	0	None
106665	106666	receptor	0	None
106666	106667	in	0	None
106667	106668	vitro	0	None
106668	106669	and	0	None
106669	106670	shares	0	None
106670	106671	many	0	None
106671	106672	of	0	None
106672	106673	the	0	None
106673	106674	biological	0	None
106674	106675	and	0	None
106675	106676	glucoregulatory	0	None
106676	106677	activities	0	None
106677	106678	of	0	None
106678	106679	exenatide	0	None
106679	106680	and	0	None
106680	106681	GLP-1	0	None
106681	106682	in	0	None
106682	106683	vivo	0	None
106683	106684	.	0	None
106684	106685	Considering	0	None
106685	106686	the	0	None
106686	106687	prevalence	0	None
106687	106688	of	0	None
106688	106689	cardiovascular	0	None
106689	106690	disease	0	None
106690	106691	in	0	None
106691	106692	public	0	None
106692	106693	health	0	None
106693	106694	and	0	None
106694	106695	the	0	None
106695	106696	limited	0	None
106696	106697	validated	0	None
106697	106698	therapeutic	0	None
106698	106699	options	0	None
106699	106700	,	0	None
106700	106701	this	0	None
106701	106702	study	0	None
106702	106703	aimed	0	None
106703	106704	to	0	None
106704	106705	find	0	None
106705	106706	novel	0	None
106706	106707	compounds	0	None
106707	106708	targeting	0	None
106708	106709	the	0	None
106709	106710	angiotensin	2	CHEMICAL
106710	106711	II	0	None
106711	106712	type	0	None
106712	106713	1	0	None
106713	106714	receptor	0	None
106714	106715	,	0	None
106715	106716	accepted	0	None
106716	106717	as	0	None
106717	106718	a	0	None
106718	106719	therapeutic	0	None
106719	106720	target	0	None
106720	106721	in	0	None
106721	106722	cardiovascular	0	None
106722	106723	disease	0	None
106723	106724	.	0	None

106725	106726	A	0	None
106726	106727	small	0	None
106727	106728	library	0	None
106728	106729	consisting	0	None
106729	106730	of	0	None
106730	106731	89	0	None
106731	106732	compounds	0	None
106732	106733	from	0	None
106733	106734	39	0	None
106734	106735	Chinese	0	None
106735	106736	herbs	0	None
106736	106737	was	0	None
106737	106738	profiled	0	None
106738	106739	using	0	None
106739	106740	a	0	None
106740	106741	cell-based	0	None
106741	106742	calcium	0	None
106742	106743	mobilization	0	None
106743	106744	assay	0	None
106744	106745	which	0	None
106745	106746	was	0	None
106746	106747	developed	0	None
106747	106748	and	0	None
106748	106749	characterized	0	None
106749	106750	for	0	None
106750	106751	high-throughput	0	None
106751	106752	screening	0	None
106752	106753	.	0	None

106754	106755	[	0	None
106755	106756	6	0	None
106756	106757	]	0	None
106757	106758	-Gingerol	0	None
106758	106759	derived	0	None
106759	106760	from	0	None
106760	106761	Zingiber	0	None
106761	106762	officinale	0	None
106762	106763	Roscoe	0	None
106763	106764	(	0	None
106764	106765	ginger	0	None
106765	106766	)	0	None
106766	106767	was	0	None
106767	106768	identified	0	None
106768	106769	as	0	None
106769	106770	a	0	None
106770	106771	novel	0	None
106771	106772	angiotensin	2	CHEMICAL
106772	106773	II	0	None
106773	106774	type	0	None
106774	106775	1	0	None
106775	106776	receptor	0	None
106776	106777	antagonist	0	None
106777	106778	,	0	None
106778	106779	with	0	None
106779	106780	an	0	None
106780	106781	IC50	0	None
106781	106782	value	0	None
106782	106783	of	0	None
106783	106784	8	0	None
106784	106785	.	0	None
106785	106786	173	0	None
106786	106787	µM	0	None
106787	106788	.	0	None

106789	106790	The	0	None
106790	106791	hit	0	None
106791	106792	was	0	None
106792	106793	further	0	None
106793	106794	tested	0	None
106794	106795	by	0	None
106795	106796	a	0	None
106796	106797	specificity	0	None
106797	106798	assay	0	None
106798	106799	indicating	0	None
106799	106800	that	0	None
106800	106801	it	0	None
106801	106802	had	0	None
106802	106803	no	0	None
106803	106804	antagonistic	0	None
106804	106805	effects	0	None
106805	106806	on	0	None
106806	106807	other	0	None
106807	106808	evaluated	0	None
106808	106809	GPCRs	0	None
106809	106810	,	0	None
106810	106811	such	0	None
106811	106812	as	0	None
106812	106813	endothelin	0	None
106813	106814	receptors	0	None
106814	106815	.	0	None

106816	106817	The	0	None
106817	106818	major	0	None
106818	106819	ingredient	0	None
106819	106820	of	0	None
106820	106821	ginger	0	None
106821	106822	,	0	None
106822	106823	[	0	None
106823	106824	6	0	None
106824	106825	]	0	None
106825	106826	-gingerol	0	None
106826	106827	,	0	None
106827	106828	could	0	None
106828	106829	inhibit	0	None
106829	106830	angiotensin	2	CHEMICAL
106830	106831	II	0	None
106831	106832	type	0	None
106832	106833	1	0	None
106833	106834	receptor	0	None
106834	106835	activation	0	None
106835	106836	,	0	None
106836	106837	which	0	None
106837	106838	partially	0	None
106838	106839	clarified	0	None
106839	106840	the	0	None
106840	106841	mechanism	0	None
106841	106842	of	0	None
106842	106843	ginger	0	None
106843	106844	regulating	0	None
106844	106845	blood	0	None
106845	106846	pressure	0	None
106846	106847	and	0	None
106847	106848	strengthening	0	None
106848	106849	heart	0	None
106849	106850	in	0	None
106850	106851	the	0	None
106851	106852	cardiovascular	0	None
106852	106853	system	0	None
106853	106854	.	0	None
106854	106855	P21-activated	0	None
106855	106856	protein	0	None
106856	106857	kinase	0	None
106857	106858	1	0	None
106858	106859	(	0	None
106859	106860	Pak1	0	None
106860	106861	)	0	None
106861	106862	mediates	0	None
106862	106863	the	0	None
106863	106864	cross	0	None
106864	106865	talk	0	None
106865	106866	between	0	None
106866	106867	insulin	0	None
106867	106868	and	0	None
106868	106869	β-catenin	0	None
106869	106870	on	0	None
106870	106871	proglucagon	0	None
106871	106872	gene	0	None
106872	106873	expression	0	None
106873	106874	and	0	None
106874	106875	its	0	None
106875	106876	ablation	0	None
106876	106877	affects	0	None
106877	106878	glucose	0	None
106878	106879	homeostasis	0	None
106879	106880	in	0	None
106880	106881	male	0	None
106881	106882	C57BL	0	None
106882	106883	/	0	None
106883	106884	6	0	None
106884	106885	mice	0	None
106885	106886	.	0	None
106886	106887	Evaluation	0	None
106887	106888	of	0	None
106888	106889	histamine	2	CHEMICAL
106889	106890	H1-	0	None
106890	106891	,	0	None
106891	106892	H2-	0	None
106892	106893	,	0	None
106893	106894	and	0	None
106894	106895	H3-receptor	0	None
106895	106896	ligands	0	None
106896	106897	at	0	None
106897	106898	the	0	None
106898	106899	human	0	None
106899	106902	histamine H4 receptor	1	GENE-Y
106902	106903	:	0	None
106903	106904	identification	0	None
106904	106905	of	0	None
106905	106906	4-methylhistamine	2	CHEMICAL
106906	106907	as	0	None
106907	106908	the	0	None
106908	106909	first	0	None
106909	106910	potent	0	None
106910	106911	and	0	None
106911	106912	selective	0	None
106912	106913	H4	0	None
106913	106914	receptor	0	None
106914	106915	agonist	0	None
106915	106916	.	0	None
106916	106917	Intracerebroventricular	0	None
106917	106918	administration	0	None
106918	106919	of	0	None
106919	106920	SMS	0	None
106920	106921	201-995	0	None
106921	106922	(	0	None
106922	106923	5	0	None
106923	106924	micrograms	0	None
106924	106925	/	0	None
106925	106926	rat	0	None
106926	106927	)	0	None
106927	106928	,	0	None
106928	106929	a	0	None
106929	106930	somatostatin	0	None
106930	106931	analogue	0	None
106931	106932	,	0	None
106932	106933	induced	0	None
106933	106934	barrel	0	None
106934	106935	rotation	0	None
106935	106936	in	0	None
106936	106937	rats	0	None
106937	106938	.	0	None

106939	106940	Pretreatment	0	None
106940	106941	with	0	None
106941	106942	ceruletide	0	None
106942	106943	(	0	None
106943	106944	40	0	None
106944	106945	micrograms	0	None
106945	106946	/	0	None
106946	106947	100	0	None
106947	106948	g	0	None
106948	106949	b	0	None
106949	106950	.	0	None

106951	106952	wt	0	None
106952	106953	.	0	None

106954	106955	,	0	None
106955	106956	IP	0	None
106956	106957	)	0	None
106957	106958	3	0	None
106958	106959	days	0	None
106959	106960	or	0	None
106960	106961	7	0	None
106961	106962	days	0	None
106962	106963	prior	0	None
106963	106964	to	0	None
106964	106965	the	0	None
106965	106966	injection	0	None
106966	106967	of	0	None
106967	106968	SMS	0	None
106968	106969	201-995	0	None
106969	106970	significantly	0	None
106970	106971	inhibited	0	None
106971	106972	the	0	None
106972	106973	response	0	None
106973	106974	rate	0	None
106974	106975	of	0	None
106975	106976	barrel	0	None
106976	106977	rotation	0	None
106977	106978	induced	0	None
106978	106979	by	0	None
106979	106980	SMS	0	None
106980	106981	201-995	0	None
106981	106982	,	0	None
106982	106983	but	0	None
106983	106984	not	0	None
106984	106985	that	0	None
106985	106986	induced	0	None
106986	106987	by	0	None
106987	106988	arginine-vasopressin	0	None
106988	106989	(	0	None
106989	106990	1	0	None
106990	106991	microgram	0	None
106991	106992	/	0	None
106992	106993	rat	0	None
106993	106994	,	0	None
106994	106995	ICV	0	None
106995	106996	)	0	None
106996	106997	.	0	None

106998	106999	The	0	None
106999	107000	suppressive	0	None
107000	107001	effect	0	None
107001	107002	of	0	None
107002	107003	ceruletide	0	None
107003	107004	on	0	None
107004	107005	barrel	0	None
107005	107006	rotation	0	None
107006	107007	could	0	None
107007	107008	be	0	None
107008	107009	partially	0	None
107009	107010	countered	0	None
107010	107011	by	0	None
107011	107012	MK-329	0	None
107012	107013	,	0	None
107013	107014	a	0	None
107014	107015	selective	0	None
107015	107016	peripheral	0	None
107016	107017	CCK	0	None
107017	107018	(	0	None
107018	107019	CCK-A	0	None
107019	107020	)	0	None
107020	107021	receptor	0	None
107021	107022	antagonist	0	None
107022	107023	.	0	None

107024	107025	Desulfated	0	None
107025	107026	cerulein	0	None
107026	107027	did	0	None
107027	107028	not	0	None
107028	107029	affect	0	None
107029	107030	the	0	None
107030	107031	barrel	0	None
107031	107032	rotation	0	None
107032	107033	induced	0	None
107033	107034	by	0	None
107034	107035	SMS	0	None
107035	107036	201-995	0	None
107036	107037	.	0	None

107038	107039	These	0	None
107039	107040	findings	0	None
107040	107041	suggest	0	None
107041	107042	that	0	None
107042	107043	ceruletide	0	None
107043	107044	specifically	0	None
107044	107045	suppresses	0	None
107045	107046	the	0	None
107046	107047	barrel	0	None
107047	107048	rotation	0	None
107048	107049	evoked	0	None
107049	107050	by	0	None
107050	107051	SMS	0	None
107051	107052	201-995	0	None
107052	107053	in	0	None
107053	107054	a	0	None
107054	107055	long-lasting	0	None
107055	107056	manner	0	None
107056	107057	possibly	0	None
107057	107058	acting	0	None
107058	107059	through	0	None
107059	107060	CCK-A	0	None
107060	107061	receptor	0	None
107061	107062	.	0	None
107062	107063	Lysyl	0	None
107063	107064	oxidase	0	None
107064	107065	(	0	None
107065	107066	LO	0	None
107066	107067	)	0	None
107067	107068	catalyzes	0	None
107068	107069	crosslink	0	None
107069	107070	of	0	None
107070	107071	collagen	3	GENE-N
107071	107072	,	0	None
107072	107073	elastin	1	GENE-Y
107073	107074	,	0	None
107074	107075	and	0	None
107075	107076	histone	0	None
107076	107077	H1	0	None
107077	107078	,	0	None
107078	107079	stabilizing	0	None
107079	107080	the	0	None
107080	107081	extracellular	0	None
107081	107082	matrix	0	None
107082	107083	and	0	None
107083	107084	cell	0	None
107084	107085	nucleus	0	None
107085	107086	.	0	None

107087	107088	This	0	None
107088	107089	enzyme	0	None
107089	107090	displays	0	None
107090	107091	dual	0	None
107091	107092	functions	0	None
107092	107093	for	0	None
107093	107094	tumorigenesis	0	None
107094	107095	,	0	None
107095	107096	i	0	None
107096	107097	.	0	None

107098	107099	e	0	None
107099	107100	.	0	None

107101	107102	,	0	None
107102	107103	as	0	None
107103	107104	a	0	None
107104	107105	tumor	0	None
107105	107106	suppressor	0	None
107106	107107	inactivating	0	None
107107	107108	the	0	None
107108	107109	ras	0	None
107109	107110	oncogene	0	None
107110	107111	and	0	None
107111	107112	as	0	None
107112	107113	a	0	None
107113	107115	tumor promoter	3	GENE-N
107115	107116	enhancing	0	None
107116	107117	malignant	0	None
107117	107118	cell	0	None
107118	107119	metastasis	0	None
107119	107120	.	0	None

107121	107122	To	0	None
107122	107123	elucidate	0	None
107123	107124	LO	0	None
107124	107125	transcriptional	0	None
107125	107126	regulation	0	None
107126	107127	,	0	None
107127	107128	we	0	None
107128	107129	have	0	None
107129	107130	cloned	0	None
107130	107131	the	0	None
107131	107132	804	0	None
107132	107133	base	0	None
107133	107134	pair	0	None
107134	107135	region	0	None
107135	107136	upstream	0	None
107136	107137	of	0	None
107137	107138	the	0	None
107138	107139	translation	0	None
107139	107140	start	0	None
107140	107141	site	0	None
107141	107142	(	0	None
107142	107143	ATG	0	None
107143	107144	)	0	None
107144	107145	of	0	None
107145	107146	the	0	None
107146	107147	rat	0	None
107147	107148	LO	0	None
107148	107149	gene	0	None
107149	107150	with	0	None
107150	107151	the	0	None
107151	107152	maximal	0	None
107152	107153	promoter	0	None
107153	107154	activity	0	None
107154	107155	.	0	None

107156	107157	Computer	0	None
107157	107158	analysis	0	None
107158	107159	indicated	0	None
107159	107160	that	0	None
107160	107161	at	0	None
107161	107162	least	0	None
107162	107163	four	0	None
107163	107164	hypoxia-response	0	None
107164	107165	element	0	None
107165	107166	(	0	None
107166	107167	HRE	0	None
107167	107168	)	0	None
107168	107169	consensuses	0	None
107169	107170	(	0	None
107170	107171	5'-ACGTG-3'	0	None
107171	107172	)	0	None
107172	107173	exist	0	None
107173	107174	in	0	None
107174	107175	the	0	None
107175	107176	cloned	0	None
107176	107177	LO	0	None
107177	107178	promoter	0	None
107178	107179	.	0	None

107180	107181	Treatment	0	None
107181	107182	of	0	None
107182	107183	rat	0	None
107183	107184	lung	0	None
107184	107185	fibroblasts	0	None
107185	107186	(	0	None
107186	107187	RFL6	0	None
107187	107188	)	0	None
107188	107189	with	0	None
107189	107190	CoCl2	0	None
107190	107191	(	0	None
107191	107192	Co	0	None
107192	107193	,	0	None
107193	107194	10-100	0	None
107194	107195	μM	0	None
107195	107196	)	0	None
107196	107197	,	0	None
107197	107198	a	0	None
107198	107199	chemical	0	None
107199	107200	hypoxia	0	None
107200	107201	reagent	0	None
107201	107202	,	0	None
107202	107203	enhanced	0	None
107203	107204	LO	0	None
107204	107205	mRNA	0	None
107205	107206	expression	0	None
107206	107207	and	0	None
107207	107208	promoter	0	None
107208	107209	activities	0	None
107209	107210	.	0	None

107211	107212	Overexpression	0	None
107212	107213	of	0	None
107213	107214	LO	0	None
107214	107215	was	0	None
107215	107216	associated	0	None
107216	107217	with	0	None
107217	107218	upregulation	0	None
107218	107219	of	0	None
107219	107220	hypoxia-inducible	0	None
107220	107221	factor	0	None
107221	107222	(	0	None
107222	107223	HIF	0	None
107223	107224	)	0	None
107224	107225	-1α	0	None
107225	107226	at	0	None
107226	107227	mRNA	0	None
107227	107228	levels	0	None
107228	107229	in	0	None
107229	107230	cobalt	0	None
107230	107231	(	0	None
107231	107232	Co	0	None
107232	107233	)	0	None
107233	107234	-treated	0	None
107234	107235	cells	0	None
107235	107236	.	0	None

107237	107238	Thus	0	None
107238	107239	,	0	None
107239	107240	LO	0	None
107240	107241	is	0	None
107241	107242	a	0	None
107242	107243	hypoxia-responsive	0	None
107243	107244	gene	0	None
107244	107245	.	0	None

107246	107247	Dominant	0	None
107247	107248	negative-HIF-1α	0	None
107248	107249	inhibited	0	None
107249	107250	LO	0	None
107250	107251	promoter	0	None
107251	107252	activities	0	None
107252	107253	stimulated	0	None
107253	107254	by	0	None
107254	107255	Co	0	None
107255	107256	.	0	None

107257	107258	Electrophoretic	0	None
107258	107259	mobility	0	None
107259	107260	shift	0	None
107260	107261	,	0	None
107261	107262	oligonucleotide	0	None
107262	107263	competition	0	None
107263	107264	,	0	None
107264	107265	and	0	None
107265	107266	in	0	None
107266	107267	vitro	0	None
107267	107268	translated	0	None
107268	107269	HIF-1α	0	None
107269	107270	binding	0	None
107270	107271	assays	0	None
107271	107272	indicated	0	None
107272	107273	that	0	None
107273	107274	only	0	None
107274	107275	one	0	None
107275	107276	HRE	0	None
107276	107277	mapped	0	None
107277	107278	at	0	None
107278	107279	-387	0	None
107279	107280	/	0	None
107280	107281	-383	0	None
107281	107282	relative	0	None
107282	107283	to	0	None
107283	107284	ATG	0	None
107284	107285	was	0	None
107285	107286	functionally	0	None
107286	107287	active	0	None
107287	107288	among	0	None
107288	107289	four	0	None
107289	107290	consensuses	0	None
107290	107291	.	0	None

107292	107293	Site-directed	0	None
107293	107294	mutation	0	None
107294	107295	of	0	None
107295	107296	this	0	None
107296	107297	HRE	0	None
107297	107298	significantly	0	None
107298	107299	diminished	0	None
107299	107300	the	0	None
107300	107301	Co-induced	0	None
107301	107302	and	0	None
107302	107303	LO	0	None
107303	107304	promoter-directed	0	None
107304	107305	expression	0	None
107305	107306	of	0	None
107306	107307	the	0	None
107307	107308	reporter	0	None
107308	107309	gene	0	None
107309	107310	.	0	None

107311	107312	Cadmium	2	CHEMICAL
107312	107313	(	0	None
107313	107314	Cd	0	None
107314	107315	)	0	None
107315	107316	,	0	None
107316	107317	an	0	None
107317	107318	inducer	0	None
107318	107319	of	0	None
107319	107320	reactive	0	None
107320	107321	oxygen	0	None
107321	107322	species	0	None
107322	107323	,	0	None
107323	107324	inhibited	0	None
107324	107325	HIF-1α	0	None
107325	107326	mRNA	0	None
107326	107327	expression	0	None
107327	107328	and	0	None
107328	107329	HIF-1α	0	None
107329	107330	binding	0	None
107330	107331	to	0	None
107331	107332	the	0	None
107332	107333	LO	0	None
107333	107334	gene	0	None
107334	107335	in	0	None
107335	107336	Co-treated	0	None
107336	107337	cells	0	None
107337	107338	as	0	None
107338	107339	revealed	0	None
107339	107340	by	0	None
107340	107341	RT-PCR	0	None
107341	107342	and	0	None
107342	107343	ChIP	0	None
107343	107344	assays	0	None
107344	107345	,	0	None
107345	107346	respectively	0	None
107346	107347	.	0	None

107348	107349	Thus	0	None
107349	107350	,	0	None
107350	107351	modulation	0	None
107351	107352	of	0	None
107352	107353	the	0	None
107353	107354	HRE	0	None
107354	107355	activity	0	None
107355	107356	by	0	None
107356	107357	Co	0	None
107357	107358	and	0	None
107358	107359	Cd	0	None
107359	107360	plays	0	None
107360	107361	a	0	None
107361	107362	critical	0	None
107362	107363	role	0	None
107363	107364	in	0	None
107364	107365	LO	0	None
107365	107366	gene	0	None
107366	107367	transactivation	0	None
107367	107368	.	0	None
107368	107369	Characterization	0	None
107369	107370	of	0	None
107370	107371	insulin-like	0	None
107371	107372	growth	0	None
107372	107373	factor-binding	0	None
107373	107374	protein-related	0	None
107374	107375	proteins	0	None
107375	107376	(	0	None
107376	107377	IGFBP-rPs	0	None
107377	107378	)	0	None
107378	107379	1	0	None
107379	107380	,	0	None
107380	107381	2	0	None
107381	107382	,	0	None
107382	107383	and	0	None
107383	107384	3	0	None
107384	107385	in	0	None
107385	107386	human	0	None
107386	107387	prostate	0	None
107387	107388	epithelial	0	None
107388	107389	cells	0	None
107389	107390	:	0	None
107390	107391	potential	0	None
107391	107392	roles	0	None
107392	107393	for	0	None
107393	107394	IGFBP-rP1	0	None
107394	107395	and	0	None
107395	107396	2	0	None
107396	107397	in	0	None
107397	107398	senescence	0	None
107398	107399	of	0	None
107399	107400	the	0	None
107400	107401	prostatic	0	None
107401	107402	epithelium	0	None
107402	107403	.	0	None
107403	107404	Does	0	None
107404	107405	the	0	None
107405	107406	expression	0	None
107406	107407	of	0	None
107407	107408	c-kit	0	None
107408	107409	(	0	None
107409	107410	CD117	0	None
107410	107411	)	0	None
107411	107412	in	0	None
107412	107413	neuroendocrine	0	None
107413	107414	tumors	0	None
107414	107415	represent	0	None
107415	107416	a	0	None
107416	107417	target	0	None
107417	107418	for	0	None
107418	107419	Aim	0	None
107419	107420	:	0	None
107420	107421	A	0	None
107421	107422	number	0	None
107422	107423	of	0	None
107423	107424	studies	0	None
107424	107425	have	0	None
107425	107426	demonstrated	0	None
107426	107427	that	0	None
107427	107428	ABCB1	0	None
107428	107429	and	0	None
107429	107430	BCRP	0	None
107430	107431	(	0	None
107431	107432	ABCG2	1	GENE-Y
107432	107433	)	0	None
107433	107434	actively	0	None
107434	107435	transport	0	None
107435	107436	Aβ	0	None
107436	107437	.	0	None

107438	107439	We	0	None
107439	107440	aimed	0	None
107440	107441	to	0	None
107441	107442	investigate	0	None
107442	107443	the	0	None
107443	107444	association	0	None
107444	107445	of	0	None
107445	107446	genetic	0	None
107446	107447	variants	0	None
107447	107448	of	0	None
107448	107449	selected	0	None
107449	107450	multidrug	0	None
107450	107451	transporters	0	None
107451	107452	with	0	None
107452	107453	Alzheimer's	0	None
107453	107454	disease	0	None
107454	107455	(	0	None
107455	107456	AD	0	None
107456	107457	)	0	None
107457	107458	in	0	None
107458	107459	histopathologically	0	None
107459	107460	confirmed	0	None
107460	107461	AD	0	None
107461	107462	cases	0	None
107462	107463	and	0	None
107463	107464	controls	0	None
107464	107465	.	0	None

107466	107467	Materials	0	None
107467	107468	&	0	None
107468	107469	methods	0	None
107469	107470	:	0	None
107470	107471	DNA	0	None
107471	107472	from	0	None
107472	107473	brain	0	None
107473	107474	tissue	0	None
107474	107475	of	0	None
107475	107476	71	0	None
107476	107477	AD	0	None
107477	107478	cases	0	None
107478	107479	with	0	None
107479	107480	Consortium	0	None
107480	107481	to	0	None
107481	107482	Establish	0	None
107482	107483	a	0	None
107483	107484	Registry	0	None
107484	107485	for	0	None
107485	107486	Alzheimer's	0	None
107486	107487	Disease	0	None
107487	107488	(	0	None
107488	107489	CERAD	0	None
107489	107490	)	0	None
107490	107491	neuropathological	0	None
107491	107492	stages	0	None
107492	107493	B	0	None
107493	107494	/	0	None
107494	107495	C	0	None
107495	107496	and	0	None
107496	107497	81	0	None
107497	107498	controls	0	None
107498	107499	was	0	None
107499	107500	genotyped	0	None
107500	107501	for	0	None
107501	107502	selected	0	None
107502	107503	variants	0	None
107503	107504	in	0	None
107504	107505	ABCA1	0	None
107505	107506	,	0	None
107506	107507	ABCA7	0	None
107507	107508	,	0	None
107508	107509	ABCB1	0	None
107509	107510	,	0	None
107510	107511	ABCC2	0	None
107511	107512	and	0	None
107512	107513	ABCG2	1	GENE-Y
107513	107514	.	0	None

107515	107516	In	0	None
107516	107517	addition	0	None
107517	107518	,	0	None
107518	107519	the	0	None
107519	107520	APOE4	0	None
107520	107521	status	0	None
107521	107522	was	0	None
107522	107523	analyzed	0	None
107523	107524	.	0	None

107525	107526	Results	0	None
107526	107527	:	0	None
107527	107528	The	0	None
107528	107529	novel	0	None
107529	107530	ABCA7	0	None
107530	107531	SNP	0	None
107531	107532	,	0	None
107532	107533	rs3752246	0	None
107533	107534	,	0	None
107534	107535	tended	0	None
107535	107536	to	0	None
107536	107537	be	0	None
107537	107538	associated	0	None
107538	107539	with	0	None
107539	107540	AD	0	None
107540	107541	in	0	None
107541	107542	our	0	None
107542	107543	study	0	None
107543	107544	.	0	None

107545	107546	Variants	0	None
107546	107547	in	0	None
107547	107548	ABCB1	0	None
107548	107549	were	0	None
107549	107550	significantly	0	None
107550	107551	less	0	None
107551	107552	frequent	0	None
107552	107553	in	0	None
107553	107554	AD	0	None
107554	107555	cases	0	None
107555	107556	older	0	None
107556	107557	than	0	None
107557	107558	65	0	None
107558	107559	years	0	None
107559	107560	of	0	None
107560	107561	age	0	None
107561	107562	and	0	None
107562	107563	among	0	None
107563	107564	females	0	None
107564	107565	.	0	None

107566	107567	This	0	None
107567	107568	association	0	None
107568	107569	of	0	None
107569	107570	ABCB1	0	None
107570	107571	2677G>T	0	None
107571	107572	(	0	None
107572	107573	rs2032582	0	None
107573	107574	)	0	None
107574	107575	was	0	None
107575	107576	more	0	None
107576	107577	pronounced	0	None
107577	107578	in	0	None
107578	107579	APOE4-negative	0	None
107579	107580	cases	0	None
107580	107581	(	0	None
107581	107582	p	0	None
107582	107583	=	0	None
107583	107584	0	0	None
107584	107585	.	0	None
107585	107586	005	0	None
107586	107587	)	0	None
107587	107588	.	0	None

107589	107590	However	0	None
107590	107591	,	0	None
107591	107592	only	0	None
107592	107593	ABCC2	0	None
107593	107594	3972C>T	0	None
107594	107595	(	0	None
107595	107596	rs3740066	0	None
107596	107597	)	0	None
107597	107598	was	0	None
107598	107599	significantly	0	None
107599	107600	associated	0	None
107600	107601	with	0	None
107601	107602	AD	0	None
107602	107603	risk	0	None
107603	107604	after	0	None
107604	107605	logistic	0	None
107605	107606	regression	0	None
107606	107607	analysis	0	None
107607	107608	including	0	None
107608	107609	all	0	None
107609	107610	variants	0	None
107610	107611	.	0	None

107612	107613	Other	0	None
107613	107614	transporters	0	None
107614	107615	showed	0	None
107615	107616	a	0	None
107616	107617	lack	0	None
107617	107618	of	0	None
107618	107619	association	0	None
107619	107620	.	0	None

107621	107622	Conclusion	0	None
107622	107623	:	0	None
107623	107624	Our	0	None
107624	107625	results	0	None
107625	107626	support	0	None
107626	107627	the	0	None
107627	107628	hypothesis	0	None
107628	107629	that	0	None
107629	107630	ABCB1	0	None
107630	107631	and	0	None
107631	107632	possibly	0	None
107632	107633	other	0	None
107633	107634	ABC-transporters	0	None
107634	107635	are	0	None
107635	107636	involved	0	None
107636	107637	in	0	None
107637	107638	the	0	None
107638	107639	process	0	None
107639	107640	of	0	None
107640	107641	Aβ	0	None
107641	107642	accumulation	0	None
107642	107643	in	0	None
107643	107644	the	0	None
107644	107645	aging	0	None
107645	107646	brain	0	None
107646	107647	and	0	None
107647	107648	may	0	None
107648	107649	modulate	0	None
107649	107650	the	0	None
107650	107651	risk	0	None
107651	107652	for	0	None
107652	107653	AD	0	None
107653	107654	in	0	None
107654	107655	an	0	None
107655	107656	allele-specific	0	None
107656	107657	manner	0	None
107657	107658	,	0	None
107658	107659	and	0	None
107659	107660	thus	0	None
107660	107661	might	0	None
107661	107662	represent	0	None
107662	107663	a	0	None
107663	107664	new	0	None
107664	107665	target	0	None
107665	107666	for	0	None
107666	107667	prevention	0	None
107667	107668	and	0	None
107668	107669	treatment	0	None
107669	107670	of	0	None
107670	107671	AD	0	None
107671	107672	.	0	None

107673	107674	Original	0	None
107674	107675	submitted	0	None
107675	107676	8	0	None
107676	107677	October	0	None
107677	107678	2012;	0	None
107678	107679	Revision	0	None
107679	107680	submitted	0	None
107680	107681	22	0	None
107681	107682	January	0	None
107682	107683	2013	0	None
107683	107684	.	0	None
107684	107685	β-Ionone	0	None
107685	107686	is	0	None
107686	107687	an	0	None
107687	107688	end	0	None
107688	107689	ring	0	None
107689	107690	analog	0	None
107690	107691	of	0	None
107691	107692	β-carotenoid	0	None
107692	107693	which	0	None
107693	107694	has	0	None
107694	107695	been	0	None
107695	107696	shown	0	None
107696	107697	to	0	None
107697	107698	possess	0	None
107698	107699	potent	0	None
107699	107700	anti-proliferative	0	None
107700	107701	activity	0	None
107701	107702	both	0	None
107702	107703	in	0	None
107703	107704	vitro	0	None
107704	107705	and	0	None
107705	107706	in	0	None
107706	107707	vivo	0	None
107707	107708	.	0	None

107709	107710	To	0	None
107710	107711	investigate	0	None
107711	107712	the	0	None
107712	107713	possible	0	None
107713	107714	inhibitory	0	None
107714	107715	effects	0	None
107715	107716	of	0	None
107716	107717	β-ionone	0	None
107717	107718	,	0	None
107718	107719	we	0	None
107719	107720	studied	0	None
107720	107721	cell	0	None
107721	107722	growth	0	None
107722	107723	characteristics	0	None
107723	107724	,	0	None
107724	107725	DNA	0	None
107725	107726	synthesis	0	None
107726	107727	,	0	None
107727	107728	cell	0	None
107728	107729	cycle	0	None
107729	107730	progression	0	None
107730	107731	,	0	None
107731	107732	as	0	None
107732	107733	well	0	None
107733	107734	as	0	None
107734	107737	mitogen-activated protein kinases	3	GENE-N
107737	107738	(	0	None
107738	107739	MAPKs	0	None
107739	107740	)	0	None
107740	107741	pathways	0	None
107741	107742	in	0	None
107742	107743	the	0	None
107743	107744	human	0	None
107744	107745	gastric	0	None
107745	107746	adenocarcinoma	0	None
107746	107747	cancer	0	None
107747	107748	cell	0	None
107748	107749	line	0	None
107749	107750	(	0	None
107750	107751	SGC-7901	0	None
107751	107752	)	0	None
107752	107753	.	0	None

107754	107755	Our	0	None
107755	107756	results	0	None
107756	107757	show	0	None
107757	107758	that	0	None
107758	107759	cell	0	None
107759	107760	growth	0	None
107760	107761	and	0	None
107761	107762	DNA	0	None
107762	107763	synthesis	0	None
107763	107764	were	0	None
107764	107765	inhibited	0	None
107765	107766	,	0	None
107766	107767	and	0	None
107767	107768	the	0	None
107768	107769	cell	0	None
107769	107770	cycle	0	None
107770	107771	was	0	None
107771	107772	arrested	0	None
107772	107773	at	0	None
107773	107774	the	0	None
107774	107775	G0	0	None
107775	107776	/	0	None
107776	107777	G1	0	None
107777	107778	phase	0	None
107778	107779	in	0	None
107779	107780	a	0	None
107780	107781	dose-dependent	0	None
107781	107782	manner	0	None
107782	107783	in	0	None
107783	107784	cells	0	None
107784	107785	treated	0	None
107785	107786	with	0	None
107786	107787	β-ionone	0	None
107787	107788	(	0	None
107788	107789	25	0	None
107789	107790	,	0	None
107790	107791	50	0	None
107791	107792	,	0	None
107792	107793	100	0	None
107793	107794	and	0	None
107794	107795	200	0	None
107795	107796	μmol	0	None
107796	107797	/	0	None
107797	107798	L	0	None
107798	107799	)	0	None
107799	107800	for	0	None
107800	107801	24	0	None
107801	107802	h	0	None
107802	107803	.	0	None

107804	107805	We	0	None
107805	107806	found	0	None
107806	107807	that	0	None
107807	107808	the	0	None
107808	107809	β-ionone	0	None
107809	107810	significantly	0	None
107810	107811	decreased	0	None
107811	107812	the	0	None
107812	107814	extracellular signal-regulated	0	None
107814	107815	kinase	0	None
107815	107816	protein	0	None
107816	107817	expression	0	None
107817	107818	and	0	None
107818	107819	significantly	0	None
107819	107820	increased	0	None
107820	107821	the	0	None
107821	107822	levels	0	None
107822	107823	of	0	None
107823	107824	p38	0	None
107824	107825	and	0	None
107825	107826	Jun-amino-terminal	0	None
107826	107827	kinase	0	None
107827	107828	protein	0	None
107828	107829	expression	0	None
107829	107830	(	0	None
107830	107831	P	0	None
107831	107832	<	0	None
107832	107833	0	0	None
107833	107834	.	0	None
107834	107835	01	0	None
107835	107836	)	0	None
107836	107837	.	0	None

107838	107839	β-Ionone	0	None
107839	107840	also	0	None
107840	107841	inhibited	0	None
107841	107844	cell cycle-related proteins	3	GENE-N
107844	107845	of	0	None
107845	107846	Cdk4	0	None
107846	107847	,	0	None
107847	107848	Cyclin	0	None
107848	107849	B1	0	None
107849	107850	,	0	None
107850	107851	D1	1	GENE-Y
107851	107852	and	0	None
107852	107853	increased	0	None
107853	107854	p27	0	None
107854	107855	protein	0	None
107855	107856	expression	0	None
107856	107857	in	0	None
107857	107858	SGC-7901	0	None
107858	107859	cells	0	None
107859	107860	.	0	None

107861	107862	These	0	None
107862	107863	results	0	None
107863	107864	suggested	0	None
107864	107865	that	0	None
107865	107866	the	0	None
107866	107867	cell	0	None
107867	107868	cycle	0	None
107868	107869	arrest	0	None
107869	107870	observed	0	None
107870	107871	may	0	None
107871	107872	be	0	None
107872	107873	regulated	0	None
107873	107874	through	0	None
107874	107875	a	0	None
107875	107876	MAPK	3	GENE-N
107876	107877	pathway	0	None
107877	107878	by	0	None
107878	107879	transcriptional	0	None
107879	107880	down-regulation	0	None
107880	107881	of	0	None
107881	107882	cell	0	None
107882	107883	cycle	0	None
107883	107884	proteins	0	None
107884	107885	.	0	None

107886	107887	These	0	None
107887	107888	results	0	None
107888	107889	demonstrate	0	None
107889	107890	potent	0	None
107890	107891	ability	0	None
107891	107892	of	0	None
107892	107893	β-ionone	0	None
107893	107894	to	0	None
107894	107895	arrest	0	None
107895	107896	cell	0	None
107896	107897	cycle	0	None
107897	107898	of	0	None
107898	107899	SGC-7901	0	None
107899	107900	cells	0	None
107900	107901	and	0	None
107901	107902	decrease	0	None
107902	107903	proliferation	0	None
107903	107904	.	0	None
107904	107905	Herein	0	None
107905	107906	a	0	None
107906	107907	library	0	None
107907	107908	of	0	None
107908	107909	hybrid	0	None
107909	107910	Mn-Anderson	0	None
107910	107911	polyoxometalates	0	None
107911	107912	anions	0	None
107912	107913	are	0	None
107913	107914	presented	0	None
107914	107915	:	0	None
107915	107916	1	0	None
107916	107917	,	0	None
107917	107918	[	0	None
107918	107919	(	0	None
107919	107920	MnMo	0	None
107920	107921	(	0	None
107921	107922	6	0	None
107922	107923	)	0	None
107923	107924	O	0	None
107924	107925	(	0	None
107925	107926	18	0	None
107926	107927	)	0	None
107927	107928	)	0	None
107928	107929	(	0	None
107929	107930	(	0	None
107930	107931	OCH	0	None
107931	107932	(	0	None
107932	107933	2	0	None
107933	107934	)	0	None
107934	107935	)	0	None
107935	107936	(	0	None
107936	107937	3	0	None
107937	107938	)	0	None
107938	107939	-C-	0	None
107939	107940	(	0	None
107940	107941	CH	0	None
107941	107942	(	0	None
107942	107943	2	0	None
107943	107944	)	0	None
107944	107945	)	0	None
107945	107946	(	0	None
107946	107947	7	0	None
107947	107948	)	0	None
107948	107949	CHCH	0	None
107949	107950	(	0	None
107950	107951	2	0	None
107951	107952	)	0	None
107952	107953	)	0	None
107953	107954	(	0	None
107954	107955	2	0	None
107955	107956	)	0	None
107956	107957	]	0	None
107957	107958	(	0	None
107958	107959	3-	0	None
107959	107960	)	0	None
107960	107961	;	0	None
107961	107962	compound	0	None
107962	107963	2	0	None
107963	107964	,	0	None
107964	107965	[	0	None
107965	107966	(	0	None
107966	107967	MnMo	0	None
107967	107968	(	0	None
107968	107969	6	0	None
107969	107970	)	0	None
107970	107971	O	0	None
107971	107972	(	0	None
107972	107973	18	0	None
107973	107974	)	0	None
107974	107975	)	0	None
107975	107976	(	0	None
107976	107977	(	0	None
107977	107978	OCH	0	None
107978	107979	(	0	None
107979	107980	2	0	None
107980	107981	)	0	None
107981	107982	)	0	None
107982	107983	(	0	None
107983	107984	3	0	None
107984	107985	)	0	None
107985	107986	C-NHCH	0	None
107986	107987	(	0	None
107987	107988	2	0	None
107988	107989	)	0	None
107989	107990	C	0	None
107990	107991	(	0	None
107991	107992	16	0	None
107992	107993	)	0	None
107993	107994	H	0	None
107994	107995	(	0	None
107995	107996	9	0	None
107996	107997	)	0	None
107997	107998	)	0	None
107998	107999	(	0	None
107999	108000	2	0	None
108000	108001	)	0	None
108001	108002	]	0	None
108002	108003	(	0	None
108003	108004	3-	0	None
108004	108005	)	0	None
108005	108006	;	0	None
108006	108007	compound	0	None
108007	108008	3	0	None
108008	108009	,	0	None
108009	108010	[	0	None
108010	108011	(	0	None
108011	108012	MnMo	0	None
108012	108013	(	0	None
108013	108014	6	0	None
108014	108015	)	0	None
108015	108016	O	0	None
108016	108017	(	0	None
108017	108018	18	0	None
108018	108019	)	0	None
108019	108020	)	0	None
108020	108021	(	0	None
108021	108022	(	0	None
108022	108023	OCH	0	None
108023	108024	(	0	None
108024	108025	2	0	None
108025	108026	)	0	None
108026	108027	)	0	None
108027	108028	(	0	None
108028	108029	3	0	None
108029	108030	)	0	None
108030	108031	C-	0	None
108031	108032	(	0	None
108032	108033	CH	0	None
108033	108034	(	0	None
108034	108035	2	0	None
108035	108036	)	0	None
108036	108037	)	0	None
108037	108038	(	0	None
108038	108039	7	0	None
108039	108040	)	0	None
108040	108041	CHCH	0	None
108041	108042	(	0	None
108042	108043	2	0	None
108043	108044	)	0	None
108044	108045	)	0	None
108045	108046	(	0	None
108046	108047	1	0	None
108047	108048	)	0	None
108048	108049	(	0	None
108049	108050	(	0	None
108050	108051	OCH	0	None
108051	108052	(	0	None
108052	108053	2	0	None
108053	108054	)	0	None
108054	108055	)	0	None
108055	108056	(	0	None
108056	108057	3	0	None
108057	108058	)	0	None
108058	108059	C-NHCH	0	None
108059	108060	(	0	None
108060	108061	2	0	None
108061	108062	)	0	None
108062	108063	C	0	None
108063	108064	(	0	None
108064	108065	16	0	None
108065	108066	)	0	None
108066	108067	H	0	None
108067	108068	(	0	None
108068	108069	9	0	None
108069	108070	)	0	None
108070	108071	)	0	None
108071	108072	(	0	None
108072	108073	1	0	None
108073	108074	)	0	None
108074	108075	]	0	None
108075	108076	(	0	None
108076	108077	3-	0	None
108077	108078	)	0	None
108078	108079	;	0	None
108079	108080	compound	0	None
108080	108081	4	0	None
108081	108082	,	0	None
108082	108083	[	0	None
108083	108084	(	0	None
108084	108085	MnMo	0	None
108085	108086	(	0	None
108086	108087	6	0	None
108087	108088	)	0	None
108088	108089	O	0	None
108089	108090	(	0	None
108090	108091	18	0	None
108091	108092	)	0	None
108092	108093	)	0	None
108093	108094	(	0	None
108094	108095	(	0	None
108095	108096	OCH	0	None
108096	108097	(	0	None
108097	108098	2	0	None
108098	108099	)	0	None
108099	108100	)	0	None
108100	108101	(	0	None
108101	108102	3	0	None
108102	108103	)	0	None
108103	108104	C-NHC	0	None
108104	108105	(	0	None
108105	108106	O	0	None
108106	108107	)	0	None
108107	108108	CH	0	None
108108	108109	(	0	None
108109	108110	2	0	None
108110	108111	)	0	None
108111	108112	CHCH	0	None
108112	108113	(	0	None
108113	108114	2	0	None
108114	108115	)	0	None
108115	108116	)	0	None
108116	108117	(	0	None
108117	108118	2	0	None
108118	108119	)	0	None
108119	108120	]	0	None
108120	108121	(	0	None
108121	108122	3-	0	None
108122	108123	)	0	None
108123	108124	and	0	None
108124	108125	compounds	0	None
108125	108126	5-9	0	None
108126	108127	,	0	None
108127	108128	[	0	None
108128	108129	(	0	None
108129	108130	MnMo	0	None
108130	108131	(	0	None
108131	108132	6	0	None
108132	108133	)	0	None
108133	108134	O	0	None
108134	108135	(	0	None
108135	108136	18	0	None
108136	108137	)	0	None
108137	108138	)	0	None
108138	108139	(	0	None
108139	108140	(	0	None
108140	108141	OCH	0	None
108141	108142	(	0	None
108142	108143	2	0	None
108143	108144	)	0	None
108144	108145	)	0	None
108145	108146	(	0	None
108146	108147	3	0	None
108147	108148	)	0	None
108148	108149	C-NHC	0	None
108149	108150	(	0	None
108150	108151	O	0	None
108151	108152	)	0	None
108152	108153	(	0	None
108153	108154	CH	0	None
108154	108155	(	0	None
108155	108156	2	0	None
108156	108157	)	0	None
108157	108158	)	0	None
108158	108159	(	0	None
108159	108160	x	0	None
108160	108161	)	0	None
108161	108162	CH	0	None
108162	108163	(	0	None
108163	108164	3	0	None
108164	108165	)	0	None
108165	108166	)	0	None
108166	108167	(	0	None
108167	108168	2	0	None
108168	108169	)	0	None
108169	108170	]	0	None
108170	108171	)	0	None
108171	108172	,	0	None
108172	108173	where	0	None
108173	108174	x	0	None
108174	108175	=	0	None
108175	108176	4	0	None
108176	108177	,	0	None
108177	108178	10	0	None
108178	108179	,	0	None
108179	108180	12	0	None
108180	108181	,	0	None
108181	108182	14	0	None
108182	108183	,	0	None
108183	108184	and	0	None
108184	108185	18	0	None
108185	108186	respectively	0	None
108186	108187	.	0	None

108188	108189	The	0	None
108189	108190	compounds	0	None
108190	108191	resulting	0	None
108191	108192	from	0	None
108192	108193	the	0	None
108193	108194	cation	0	None
108194	108195	exchange	0	None
108195	108196	of	0	None
108196	108197	the	0	None
108197	108198	anions	0	None
108198	108199	1-9	0	None
108199	108200	to	0	None
108200	108201	give	0	None
108201	108202	TBA	0	None
108202	108203	(	0	None
108203	108204	a	0	None
108204	108205	)	0	None
108205	108206	and	0	None
108206	108207	DMDOA	0	None
108207	108208	(	0	None
108208	108209	b	0	None
108209	108210	)	0	None
108210	108211	salts	0	None
108211	108212	,	0	None
108212	108213	and	0	None
108213	108214	additionally	0	None
108214	108215	for	0	None
108215	108216	compounds	0	None
108216	108217	1	0	None
108217	108218	,	0	None
108218	108219	2	0	None
108219	108220	and	0	None
108220	108221	3	0	None
108221	108222	,	0	None
108222	108223	tetraphenylphosphonium	0	None
108223	108224	(	0	None
108224	108225	PPh	0	None
108225	108226	(	0	None
108226	108227	4	0	None
108227	108228	)	0	None
108228	108229	)	0	None
108229	108230	(	0	None
108230	108231	c	0	None
108231	108232	)	0	None
108232	108233	salts	0	None
108233	108234	,	0	None
108234	108235	are	0	None
108235	108236	explored	0	None
108236	108237	at	0	None
108237	108238	the	0	None
108238	108239	air	0	None
108239	108240	/	0	None
108240	108241	water	0	None
108241	108242	interface	0	None
108242	108243	using	0	None
108243	108244	scanning	0	None
108244	108245	force	0	None
108245	108246	microscopy	0	None
108246	108247	,	0	None
108247	108248	showing	0	None
108248	108249	a	0	None
108249	108250	range	0	None
108250	108251	of	0	None
108251	108252	architectures	0	None
108252	108253	including	0	None
108253	108254	hexagonal	0	None
108254	108255	structures	0	None
108255	108256	,	0	None
108256	108257	nanofibers	0	None
108257	108258	and	0	None
108258	108259	other	0	None
108259	108260	supramolecular	0	None
108260	108261	forms	0	None
108261	108262	.	0	None

108263	108264	Additionally	0	None
108264	108265	the	0	None
108265	108266	solid-state	0	None
108266	108267	structures	0	None
108267	108268	for	0	None
108268	108269	compounds	0	None
108269	108270	1c	0	None
108270	108271	,	0	None
108271	108272	2c	0	None
108272	108273	,	0	None
108273	108274	4a	0	None
108274	108275	,	0	None
108275	108276	6a	0	None
108276	108277	,	0	None
108277	108278	9a	0	None
108278	108279	,	0	None
108279	108280	are	0	None
108280	108281	presented	0	None
108281	108282	for	0	None
108282	108283	the	0	None
108283	108284	first	0	None
108284	108285	time	0	None
108285	108286	and	0	None
108286	108287	these	0	None
108287	108288	investigations	0	None
108288	108289	demonstrate	0	None
108289	108290	the	0	None
108290	108291	delicate	0	None
108291	108292	interplay	0	None
108292	108293	between	0	None
108293	108294	the	0	None
108294	108295	structure	0	None
108295	108296	of	0	None
108296	108297	the	0	None
108297	108298	covalently	0	None
108298	108299	derivatised	0	None
108299	108300	hybrid	0	None
108300	108301	organo-clusters	0	None
108301	108302	as	0	None
108302	108303	well	0	None
108303	108304	as	0	None
108304	108305	the	0	None
108305	108306	ion-exchange	0	None
108306	108307	cation	0	None
108307	108308	types	0	None
108308	108309	.	0	None
108309	108310	Species-specific	0	None
108310	108311	pharmacological	0	None
108311	108312	properties	0	None
108312	108313	of	0	None
108313	108314	human	0	None
108314	108315	alpha	0	None
108315	108316	(	0	None
108316	108317	2A	0	None
108317	108318	)	0	None
108318	108319	-adrenoceptors	0	None
108319	108320	.	0	None
108320	108321	HRG1	1	GENE-Y
108321	108322	is	0	None
108322	108323	essential	0	None
108323	108324	for	0	None
108324	108325	heme	0	None
108325	108326	transport	0	None
108326	108327	from	0	None
108327	108328	the	0	None
108328	108329	phagolysosome	0	None
108329	108330	of	0	None
108330	108331	macrophages	0	None
108331	108332	during	0	None
108332	108333	erythrophagocytosis	0	None
108333	108334	.	0	None
108334	108335	The	0	None
108335	108336	selective	0	None
108336	108337	SYK	3	GENE-N
108337	108338	inhibitor	0	None
108338	108339	P505-15	0	None
108339	108340	(	0	None
108340	108341	PRT062607	0	None
108341	108342	)	0	None
108342	108343	inhibits	0	None
108343	108344	B	0	None
108344	108345	cell	0	None
108345	108346	signaling	0	None
108346	108347	and	0	None
108347	108348	function	0	None
108348	108349	in	0	None
108349	108350	vitro	0	None
108350	108351	and	0	None
108351	108352	in	0	None
108352	108353	vivo	0	None
108353	108354	and	0	None
108354	108355	augments	0	None
108355	108356	the	0	None
108356	108357	activity	0	None
108357	108358	of	0	None
108358	108359	fludarabine	0	None
108359	108360	in	0	None
108360	108361	chronic	0	None
108361	108362	lymphocytic	0	None
108362	108363	leukemia	0	None
108363	108364	.	0	None
108364	108365	Heparin-binding	0	None
108365	108366	exosite	0	None
108366	108367	of	0	None
108367	108368	factor	0	None
108368	108369	Xa	0	None
108369	108370	.	0	None
108370	108371	Cell	0	None
108371	108372	penetrating	0	None
108372	108373	peptide	0	None
108373	108374	tethered	0	None
108374	108375	bi-ligand	0	None
108375	108376	liposomes	0	None
108376	108377	for	0	None
108377	108378	delivery	0	None
108378	108379	to	0	None
108379	108380	brain	0	None
108380	108381	in	0	None
108381	108382	vivo	0	None
108382	108383	:	0	None
108383	108384	Biodistribution	0	None
108384	108385	and	0	None
108385	108386	transfection	0	None
108386	108387	.	0	None
108387	108388	Reversal	0	None
108388	108389	of	0	None
108389	108390	P-glycoprotein-mediated	0	None
108390	108391	multidrug	0	None
108391	108392	resistance	0	None
108392	108393	is	0	None
108393	108394	induced	0	None
108394	108395	by	0	None
108395	108396	mollugin	2	CHEMICAL
108396	108397	in	0	None
108397	108398	MCF-7	0	None
108398	108399	/	0	None
108399	108400	adriamycin	2	CHEMICAL
108400	108401	cells	0	None
108401	108402	.	0	None
108402	108404	Aurora kinases	3	GENE-N
108404	108405	play	0	None
108405	108406	an	0	None
108406	108407	essential	0	None
108407	108408	role	0	None
108408	108409	in	0	None
108409	108410	mitotic	0	None
108410	108411	progression	0	None
108411	108412	and	0	None
108412	108413	are	0	None
108413	108414	potentially	0	None
108414	108415	druggable	0	None
108415	108416	targets	0	None
108416	108417	in	0	None
108417	108418	cancer	0	None
108418	108419	therapy	0	None
108419	108420	.	0	None

108421	108422	We	0	None
108422	108423	identified	0	None
108423	108424	benzo	0	None
108424	108425	[	0	None
108425	108426	e	0	None
108426	108427	]	0	None
108427	108428	pyridoindoles	0	None
108428	108429	(	0	None
108429	108430	BePI	0	None
108430	108431	)	0	None
108431	108432	as	0	None
108432	108433	powerful	0	None
108433	108434	aurora	0	None
108434	108435	kinase	0	None
108435	108436	inhibitors	0	None
108436	108437	.	0	None

108438	108439	Their	0	None
108439	108440	efficiency	0	None
108440	108441	was	0	None
108441	108442	demonstrated	0	None
108442	108443	both	0	None
108443	108444	in	0	None
108444	108445	enzymatic	0	None
108445	108446	inhibition	0	None
108446	108447	studies	0	None
108447	108448	and	0	None
108448	108449	in	0	None
108449	108450	cell	0	None
108450	108451	culture	0	None
108451	108452	assays	0	None
108452	108453	.	0	None

108454	108455	New	0	None
108455	108456	BePI	0	None
108456	108457	molecules	0	None
108457	108458	were	0	None
108458	108459	synthesized	0	None
108459	108460	,	0	None
108460	108461	and	0	None
108461	108462	a	0	None
108462	108463	structure-activity	0	None
108463	108464	relationship	0	None
108464	108465	study	0	None
108465	108466	was	0	None
108466	108467	conducted	0	None
108467	108468	with	0	None
108468	108469	the	0	None
108469	108470	aim	0	None
108470	108471	of	0	None
108471	108472	improving	0	None
108472	108473	the	0	None
108473	108474	activity	0	None
108474	108475	and	0	None
108475	108476	solubility	0	None
108476	108477	of	0	None
108477	108478	the	0	None
108478	108479	lead	0	None
108479	108480	compound	0	None
108480	108481	.	0	None

108482	108483	Tetracyclic	2	CHEMICAL
108483	108484	BePI	0	None
108484	108485	derivatives	0	None
108485	108486	are	0	None
108486	108487	characterized	0	None
108487	108488	by	0	None
108488	108489	a	0	None
108489	108490	particular	0	None
108490	108491	curved	0	None
108491	108492	shape	0	None
108492	108493	,	0	None
108493	108494	and	0	None
108494	108495	the	0	None
108495	108496	presence	0	None
108496	108497	of	0	None
108497	108498	an	0	None
108498	108499	oxo	0	None
108499	108500	group	0	None
108500	108501	on	0	None
108501	108502	the	0	None
108502	108503	pyridine	0	None
108503	108504	ring	0	None
108504	108505	was	0	None
108505	108506	found	0	None
108506	108507	to	0	None
108507	108508	be	0	None
108508	108509	required	0	None
108509	108510	for	0	None
108510	108513	aurora kinase B	3	GENE-N
108513	108514	inhibition	0	None
108514	108515	.	0	None

108516	108517	New	0	None
108517	108518	hydrosoluble	0	None
108518	108519	benzo	0	None
108519	108520	[	0	None
108520	108521	e	0	None
108521	108522	]	0	None
108522	108523	pyridoindolones	0	None
108523	108524	were	0	None
108524	108525	subsequently	0	None
108525	108526	designed	0	None
108526	108527	,	0	None
108527	108528	and	0	None
108528	108529	their	0	None
108529	108530	efficacy	0	None
108530	108531	was	0	None
108531	108532	tested	0	None
108532	108533	by	0	None
108533	108534	a	0	None
108534	108535	combination	0	None
108535	108536	of	0	None
108536	108537	cell-cycle	0	None
108537	108538	analysis	0	None
108538	108539	and	0	None
108539	108540	time-lapse	0	None
108540	108541	experiments	0	None
108541	108542	in	0	None
108542	108543	live	0	None
108543	108544	cells	0	None
108544	108545	.	0	None

108546	108547	The	0	None
108547	108548	most	0	None
108548	108549	active	0	None
108549	108550	BePI	0	None
108550	108551	derivative	0	None
108551	108552	,	0	None
108552	108553	13	0	None
108553	108554	b	0	None
108554	108555	,	0	None
108555	108556	inhibited	0	None
108556	108557	the	0	None
108557	108558	cell	0	None
108558	108559	cycle	0	None
108559	108560	,	0	None
108560	108561	drove	0	None
108561	108562	cells	0	None
108562	108563	to	0	None
108563	108564	polyploidy	0	None
108564	108565	,	0	None
108565	108566	and	0	None
108566	108567	eventually	0	None
108567	108568	induced	0	None
108568	108569	apoptosis	0	None
108569	108570	.	0	None

108571	108572	It	0	None
108572	108573	exhibited	0	None
108573	108574	high	0	None
108574	108575	antiproliferative	0	None
108575	108576	activity	0	None
108576	108577	in	0	None
108577	108578	HeLa	0	None
108578	108579	cells	0	None
108579	108580	with	0	None
108580	108581	an	0	None
108581	108582	IC	0	None
108582	108583	(	0	None
108583	108584	50	0	None
108584	108585	)	0	None
108585	108586	value	0	None
108586	108587	of	0	None
108587	108588	63	0	None
108588	108589	nM	0	None
108589	108590	.	0	None

108591	108592	Relative	0	None
108592	108593	to	0	None
108593	108594	compounds	0	None
108594	108595	tested	0	None
108595	108596	in	0	None
108596	108597	clinical	0	None
108597	108598	trials	0	None
108598	108599	,	0	None
108599	108600	this	0	None
108600	108601	antiproliferative	0	None
108601	108602	potency	0	None
108602	108603	places	0	None
108603	108604	13	0	None
108604	108605	b	0	None
108605	108606	among	0	None
108606	108607	the	0	None
108607	108608	top	0	None
108608	108609	10	0	None
108609	108610	aurora	0	None
108610	108611	kinase	0	None
108611	108612	inhibitors	0	None
108612	108613	.	0	None

108614	108615	Our	0	None
108615	108616	results	0	None
108616	108617	justify	0	None
108617	108618	further	0	None
108618	108619	in	0	None
108619	108620	vivo	0	None
108620	108621	evaluation	0	None
108621	108622	in	0	None
108622	108623	preclinical	0	None
108623	108624	animal	0	None
108624	108625	models	0	None
108625	108626	of	0	None
108626	108627	cancer	0	None
108627	108628	.	0	None
108628	108629	TGIF	0	None
108629	108630	inhibits	0	None
108630	108631	retinoid	0	None
108631	108632	signaling	0	None
108632	108633	.	0	None
108633	108634	Modulation	0	None
108634	108635	of	0	None
108635	108639	epidermal growth factor receptor	3	GENE-N
108639	108640	in	0	None
108640	108641	endocrine-resistant	0	None
108641	108642	,	0	None
108642	108643	oestrogen	2	CHEMICAL
108643	108644	receptor-positive	0	None
108644	108645	breast	0	None
108645	108646	cancer	0	None
108646	108647	.	0	None
108647	108648	Cotrimoxazole	0	None
108648	108649	,	0	None
108649	108650	an	0	None
108650	108651	association	0	None
108651	108652	of	0	None
108652	108653	trimethoprim	2	CHEMICAL
108653	108654	and	0	None
108654	108655	sulfamethoxazole	0	None
108655	108656	,	0	None
108656	108657	and	0	None
108657	108658	dapsone	0	None
108658	108659	,	0	None
108659	108660	are	0	None
108660	108661	mainstays	0	None
108661	108662	for	0	None
108662	108663	the	0	None
108663	108664	prophylaxis	0	None
108664	108665	and	0	None
108665	108666	treatment	0	None
108666	108667	of	0	None
108667	108668	Pneumocystis	0	None
108668	108669	pneumonia	0	None
108669	108670	(	0	None
108670	108671	PcP	0	None
108671	108672	)	0	None
108672	108673	.	0	None

108674	108675	The	0	None
108675	108676	inability	0	None
108676	108677	to	0	None
108677	108678	culture	0	None
108678	108679	Pneumocystis	0	None
108679	108680	prevents	0	None
108680	108681	routine	0	None
108681	108682	susceptibility	0	None
108682	108683	testing	0	None
108683	108684	and	0	None
108684	108685	detection	0	None
108685	108686	of	0	None
108686	108687	drug	0	None
108687	108688	resistance	0	None
108688	108689	.	0	None

108690	108691	Instead	0	None
108691	108692	,	0	None
108692	108693	molecular	0	None
108693	108694	techniques	0	None
108694	108695	have	0	None
108695	108696	been	0	None
108696	108697	used	0	None
108697	108698	to	0	None
108698	108699	detect	0	None
108699	108700	Pneumocystis	0	None
108700	108701	jiroveci	0	None
108701	108702	dihydropteroate	0	None
108702	108703	synthase	0	None
108703	108704	(	0	None
108704	108705	DHPS	0	None
108705	108706	)	0	None
108706	108707	mutations	0	None
108707	108708	that	0	None
108708	108709	cause	0	None
108709	108710	sulfa	0	None
108710	108711	resistance	0	None
108711	108712	in	0	None
108712	108713	other	0	None
108713	108714	microorganisms	0	None
108714	108715	.	0	None

108716	108717	The	0	None
108717	108718	most	0	None
108718	108719	frequent	0	None
108719	108720	DHPS	0	None
108720	108721	mutations	0	None
108721	108722	occur	0	None
108722	108723	at	0	None
108723	108724	nucleotide	0	None
108724	108725	positions	0	None
108725	108726	165	0	None
108726	108727	and	0	None
108727	108728	171	0	None
108728	108729	,	0	None
108729	108730	which	0	None
108730	108731	lead	0	None
108731	108732	to	0	None
108732	108733	an	0	None
108733	108735	amino acid	2	CHEMICAL
108735	108736	change	0	None
108736	108737	at	0	None
108737	108738	positions	0	None
108738	108739	55	0	None
108739	108740	and	0	None
108740	108741	57	0	None
108741	108742	.	0	None

108743	108744	Several	0	None
108744	108745	studies	0	None
108745	108746	suggest	0	None
108746	108747	that	0	None
108747	108748	these	0	None
108748	108749	mutations	0	None
108749	108750	are	0	None
108750	108751	associated	0	None
108751	108752	with	0	None
108752	108753	the	0	None
108753	108754	failure	0	None
108754	108755	of	0	None
108755	108756	chemoprophylaxis	0	None
108756	108757	for	0	None
108757	108758	PcP	0	None
108758	108759	.	0	None

108760	108761	The	0	None
108761	108762	aim	0	None
108762	108763	was	0	None
108763	108764	to	0	None
108764	108765	establish	0	None
108765	108766	the	0	None
108766	108767	frequency	0	None
108767	108768	and	0	None
108768	108769	characteristics	0	None
108769	108770	of	0	None
108770	108771	P	0	None
108771	108772	jiroveci	0	None
108772	108773	DHPS	0	None
108773	108774	mutations	0	None
108774	108775	among	0	None
108775	108776	colonized	0	None
108776	108777	individuals	0	None
108777	108778	and	0	None
108778	108779	PcP	0	None
108779	108780	patients	0	None
108780	108781	from	0	None
108781	108782	Spain	0	None
108782	108783	.	0	None

108784	108785	A	0	None
108785	108786	total	0	None
108786	108787	of	0	None
108787	108788	50	0	None
108788	108789	colonized	0	None
108789	108790	individuals	0	None
108790	108791	and	0	None
108791	108792	25	0	None
108792	108793	PcP	0	None
108793	108794	patients	0	None
108794	108795	were	0	None
108795	108796	studied	0	None
108796	108797	.	0	None

108798	108799	DHPS	0	None
108799	108800	polymorphisms	0	None
108800	108801	were	0	None
108801	108802	identified	0	None
108802	108803	by	0	None
108803	108804	restriction	0	None
108804	108805	fragment	0	None
108805	108806	length	0	None
108806	108807	polymorphism	0	None
108807	108808	assay	0	None
108808	108809	.	0	None

108810	108811	The	0	None
108811	108812	analysis	0	None
108812	108813	provided	0	None
108813	108814	a	0	None
108814	108815	rate	0	None
108815	108816	of	0	None
108816	108817	28%	0	None
108817	108818	of	0	None
108818	108819	DHPS	0	None
108819	108820	gene	0	None
108820	108821	mutations	0	None
108821	108822	in	0	None
108822	108823	our	0	None
108823	108824	population	0	None
108824	108825	,	0	None
108825	108826	with	0	None
108826	108827	the	0	None
108827	108828	presence	0	None
108828	108829	of	0	None
108829	108830	all	0	None
108830	108831	possible	0	None
108831	108832	polymorphisms	0	None
108832	108833	described	0	None
108833	108834	.	0	None

108835	108836	The	0	None
108836	108837	presence	0	None
108837	108838	of	0	None
108838	108839	mutations	0	None
108839	108840	was	0	None
108840	108841	higher	0	None
108841	108842	in	0	None
108842	108843	PcP	0	None
108843	108844	patients	0	None
108844	108845	than	0	None
108845	108846	in	0	None
108846	108847	colonized	0	None
108847	108848	subjects	0	None
108848	108849	(	0	None
108849	108850	40%	0	None
108850	108851	vs	0	None
108851	108852	22%	0	None
108852	108853	)	0	None
108853	108854	,	0	None
108854	108855	probably	0	None
108855	108856	because	0	None
108856	108857	of	0	None
108857	108858	the	0	None
108858	108859	chemoprophylaxis	0	None
108859	108860	used	0	None
108860	108861	in	0	None
108861	108862	PcP	0	None
108862	108863	patients	0	None
108863	108864	.	0	None

108865	108866	The	0	None
108866	108867	comparison	0	None
108867	108868	between	0	None
108868	108869	patients	0	None
108869	108870	with	0	None
108870	108871	and	0	None
108871	108872	without	0	None
108872	108873	DHPS	0	None
108873	108874	mutations	0	None
108874	108875	did	0	None
108875	108876	not	0	None
108876	108877	show	0	None
108877	108878	statistical	0	None
108878	108879	differences	0	None
108879	108880	due	0	None
108880	108881	to	0	None
108881	108882	age	0	None
108882	108883	,	0	None
108883	108884	sex	0	None
108884	108885	,	0	None
108885	108886	steroid	2	CHEMICAL
108886	108887	use	0	None
108887	108888	,	0	None
108888	108889	sulfa	0	None
108889	108890	drug	0	None
108890	108891	exposure	0	None
108891	108892	,	0	None
108892	108893	or	0	None
108893	108894	smoking	0	None
108894	108895	.	0	None

108896	108897	A	0	None
108897	108898	high	0	None
108898	108899	rate	0	None
108899	108900	of	0	None
108900	108901	DHPS	0	None
108901	108902	mutations	0	None
108902	108903	in	0	None
108903	108904	our	0	None
108904	108905	area	0	None
108905	108906	of	0	None
108906	108907	Spain	0	None
108907	108908	,	0	None
108908	108909	not	0	None
108909	108910	only	0	None
108910	108911	confined	0	None
108911	108912	to	0	None
108912	108913	patients	0	None
108913	108914	previously	0	None
108914	108915	exposed	0	None
108915	108916	to	0	None
108916	108917	sulfa	0	None
108917	108918	drugs	0	None
108918	108919	,	0	None
108919	108920	is	0	None
108920	108921	shown	0	None
108921	108922	in	0	None
108922	108923	this	0	None
108923	108924	study	0	None
108924	108925	.	0	None

108926	108927	As	0	None
108927	108928	well	0	None
108928	108929	as	0	None
108929	108930	PcP	0	None
108930	108931	patients	0	None
108931	108932	,	0	None
108932	108933	colonized	0	None
108933	108934	individuals	0	None
108934	108935	who	0	None
108935	108936	harbor	0	None
108936	108937	P	0	None
108937	108938	jiroveci	0	None
108938	108939	strains	0	None
108939	108940	with	0	None
108940	108941	DHPS	0	None
108941	108942	mutations	0	None
108942	108943	could	0	None
108943	108944	play	0	None
108944	108945	a	0	None
108945	108946	major	0	None
108946	108947	role	0	None
108947	108948	in	0	None
108948	108949	the	0	None
108949	108950	transmission	0	None
108950	108951	cycle	0	None
108951	108952	of	0	None
108952	108953	these	0	None
108953	108954	mutations	0	None
108954	108955	,	0	None
108955	108956	representing	0	None
108956	108957	a	0	None
108957	108958	reservoir	0	None
108958	108959	and	0	None
108959	108960	source	0	None
108960	108961	of	0	None
108961	108962	infection	0	None
108962	108963	for	0	None
108963	108964	susceptible	0	None
108964	108965	individuals	0	None
108965	108966	.	0	None

108967	108968	Further	0	None
108968	108969	research	0	None
108969	108970	is	0	None
108970	108971	thus	0	None
108971	108972	warranted	0	None
108972	108973	to	0	None
108973	108974	assess	0	None
108974	108975	the	0	None
108975	108976	true	0	None
108976	108977	scope	0	None
108977	108978	of	0	None
108978	108979	the	0	None
108979	108980	problem	0	None
108980	108981	and	0	None
108981	108982	to	0	None
108982	108983	design	0	None
108983	108984	rational	0	None
108984	108985	preventive	0	None
108985	108986	strategies	0	None
108986	108987	.	0	None
108987	108988	The	0	None
108988	108989	ATP-sensitive	0	None
108989	108990	potassium	0	None
108990	108991	(	0	None
108991	108992	KATP	0	None
108992	108993	)	0	None
108993	108994	channels	0	None
108994	108995	in	0	None
108995	108996	pancreatic	0	None
108996	108997	beta	0	None
108997	108998	cells	0	None
108998	108999	are	0	None
108999	109000	critical	0	None
109000	109001	in	0	None
109001	109002	the	0	None
109002	109003	regulation	0	None
109003	109004	of	0	None
109004	109005	glucose-induced	0	None
109005	109006	insulin	0	None
109006	109007	secretion	0	None
109007	109008	.	0	None

109009	109010	Although	0	None
109010	109011	electrophysiological	0	None
109011	109012	studies	0	None
109012	109013	provide	0	None
109013	109014	clues	0	None
109014	109015	to	0	None
109015	109016	the	0	None
109016	109017	complex	0	None
109017	109018	control	0	None
109018	109019	of	0	None
109019	109020	KATP	0	None
109020	109021	channels	0	None
109021	109022	by	0	None
109022	109023	ATP	0	None
109023	109024	,	0	None
109024	109025	MgADP	0	None
109025	109026	,	0	None
109026	109027	and	0	None
109027	109028	pharmacological	0	None
109028	109029	agents	0	None
109029	109030	,	0	None
109030	109031	the	0	None
109031	109032	molecular	0	None
109032	109033	mechanism	0	None
109033	109034	of	0	None
109034	109035	KATP-channel	0	None
109035	109036	regulation	0	None
109036	109037	remains	0	None
109037	109038	unclear	0	None
109038	109039	.	0	None

109040	109041	The	0	None
109041	109042	KATP	0	None
109042	109043	channel	0	None
109043	109044	is	0	None
109044	109045	a	0	None
109045	109046	heterooligomeric	0	None
109046	109047	complex	0	None
109047	109048	of	0	None
109048	109049	SUR1	0	None
109049	109050	subunits	0	None
109050	109051	of	0	None
109051	109052	the	0	None
109052	109053	ATP-binding-cassette	0	None
109053	109054	superfamily	0	None
109054	109055	with	0	None
109055	109056	two	0	None
109056	109057	nucleotide-binding	0	None
109057	109058	folds	0	None
109058	109059	(	0	None
109059	109060	NBF1	3	GENE-N
109060	109061	and	0	None
109061	109062	NBF2	3	GENE-N
109062	109063	)	0	None
109063	109064	and	0	None
109064	109065	the	0	None
109065	109066	pore-forming	0	None
109066	109067	Kir6	0	None
109067	109068	.	0	None
109068	109069	2	0	None
109069	109070	subunits	0	None
109070	109071	.	0	None

109072	109073	Here	0	None
109073	109074	,	0	None
109074	109075	we	0	None
109075	109076	report	0	None
109076	109077	that	0	None
109077	109078	MgATP	0	None
109078	109079	and	0	None
109079	109080	MgADP	0	None
109080	109081	,	0	None
109081	109082	but	0	None
109082	109083	not	0	None
109083	109084	the	0	None
109084	109085	Mg	2	CHEMICAL
109085	109086	salt	0	None
109086	109087	of	0	None
109087	109088	gamma-thio-ATP	2	CHEMICAL
109088	109089	,	0	None
109089	109090	stabilize	0	None
109090	109091	the	0	None
109091	109092	binding	0	None
109092	109093	of	0	None
109093	109094	prebound	0	None
109094	109095	8-azido-	0	None
109095	109096	[	0	None
109096	109097	alpha-32P	0	None
109097	109098	]	0	None
109098	109099	ATP	0	None
109099	109100	to	0	None
109100	109101	SUR1	0	None
109101	109102	.	0	None

109103	109104	Mutation	0	None
109104	109105	in	0	None
109105	109106	the	0	None
109106	109111	Walker A and B motifs	3	GENE-N
109111	109112	of	0	None
109112	109113	NBF2	3	GENE-N
109113	109114	of	0	None
109114	109115	SUR1	0	None
109115	109116	abolished	0	None
109116	109117	this	0	None
109117	109118	stabilizing	0	None
109118	109119	effect	0	None
109119	109120	of	0	None
109120	109121	MgADP	0	None
109121	109122	.	0	None

109123	109124	These	0	None
109124	109125	results	0	None
109125	109126	suggest	0	None
109126	109127	that	0	None
109127	109128	SUR1	0	None
109128	109129	binds	0	None
109129	109130	8-azido-ATP	0	None
109130	109131	strongly	0	None
109131	109132	at	0	None
109132	109133	NBF1	3	GENE-N
109133	109134	and	0	None
109134	109135	that	0	None
109135	109136	MgADP	0	None
109136	109137	,	0	None
109137	109138	either	0	None
109138	109139	by	0	None
109139	109140	direct	0	None
109140	109141	binding	0	None
109141	109142	to	0	None
109142	109143	NBF2	3	GENE-N
109143	109144	or	0	None
109144	109145	by	0	None
109145	109146	hydrolysis	0	None
109146	109147	of	0	None
109147	109148	bound	0	None
109148	109149	MgATP	0	None
109149	109150	at	0	None
109150	109151	NBF2	3	GENE-N
109151	109152	,	0	None
109152	109153	stabilizes	0	None
109153	109154	prebound	0	None
109154	109155	8-azido-ATP	0	None
109155	109156	binding	0	None
109156	109157	at	0	None
109157	109158	NBF1	3	GENE-N
109158	109159	.	0	None

109160	109161	The	0	None
109161	109162	sulfonylurea	2	CHEMICAL
109162	109163	glibenclamide	0	None
109163	109164	caused	0	None
109164	109165	release	0	None
109165	109166	of	0	None
109166	109167	prebound	0	None
109167	109168	8-azido-	0	None
109168	109169	[	0	None
109169	109170	alpha-32P	0	None
109170	109171	]	0	None
109171	109172	ATP	0	None
109172	109173	from	0	None
109173	109174	SUR1	0	None
109174	109175	in	0	None
109175	109176	the	0	None
109176	109177	presence	0	None
109177	109178	of	0	None
109178	109179	MgADP	0	None
109179	109180	or	0	None
109180	109181	MgATP	0	None
109181	109182	in	0	None
109182	109183	a	0	None
109183	109184	concentration-dependent	0	None
109184	109185	manner	0	None
109185	109186	.	0	None

109187	109188	This	0	None
109188	109189	direct	0	None
109189	109190	biochemical	0	None
109190	109191	evidence	0	None
109191	109192	of	0	None
109192	109193	cooperative	0	None
109193	109194	interaction	0	None
109194	109195	in	0	None
109195	109196	nucleotide	0	None
109196	109197	binding	0	None
109197	109198	of	0	None
109198	109199	the	0	None
109199	109200	two	0	None
109200	109201	NBFs	0	None
109201	109202	of	0	None
109202	109203	SUR1	0	None
109203	109204	suggests	0	None
109204	109205	that	0	None
109205	109206	glibenclamide	0	None
109206	109207	both	0	None
109207	109208	blocks	0	None
109208	109209	this	0	None
109209	109210	cooperative	0	None
109210	109211	binding	0	None
109211	109212	of	0	None
109212	109213	ATP	0	None
109213	109214	and	0	None
109214	109215	MgADP	0	None
109215	109216	and	0	None
109216	109217	,	0	None
109217	109218	in	0	None
109218	109219	cooperation	0	None
109219	109220	with	0	None
109220	109221	the	0	None
109221	109222	MgADP	0	None
109222	109223	bound	0	None
109223	109224	at	0	None
109224	109225	NBF2	3	GENE-N
109225	109226	,	0	None
109226	109227	causes	0	None
109227	109228	ATP	0	None
109228	109229	to	0	None
109229	109230	be	0	None
109230	109231	released	0	None
109231	109232	from	0	None
109232	109233	NBF1	3	GENE-N
109233	109234	.	0	None
109234	109235	OBJECTIVETo	0	None
109235	109236	assess	0	None
109236	109237	glucose-lowering	0	None
109237	109238	mechanisms	0	None
109238	109239	of	0	None
109239	109240	sitagliptin	2	CHEMICAL
109240	109241	(	0	None
109241	109242	S	0	None
109242	109243	)	0	None
109243	109244	,	0	None
109244	109245	metformin	0	None
109245	109246	(	0	None
109246	109247	M	0	None
109247	109248	)	0	None
109248	109249	,	0	None
109249	109250	and	0	None
109250	109251	the	0	None
109251	109252	two	0	None
109252	109253	combined	0	None
109253	109254	(	0	None
109254	109255	M	0	None
109255	109256	+	0	None
109256	109257	S	0	None
109257	109258	)	0	None
109258	109259	.	0	None

109260	109261	RESEARCH	0	None
109261	109262	DESIGN	0	None
109262	109263	AND	0	None
109263	109264	METHODSWe	0	None
109264	109265	randomized	0	None
109265	109266	16	0	None
109266	109267	patients	0	None
109267	109268	with	0	None
109268	109269	type	0	None
109269	109270	2	0	None
109270	109271	diabetes	0	None
109271	109272	mellitus	0	None
109272	109273	(	0	None
109273	109274	T2DM	0	None
109274	109275	)	0	None
109275	109276	to	0	None
109276	109277	four	0	None
109277	109278	6-week	0	None
109278	109279	treatments	0	None
109279	109280	with	0	None
109280	109281	placebo	0	None
109281	109282	(	0	None
109282	109283	P	0	None
109283	109284	)	0	None
109284	109285	,	0	None
109285	109286	M	0	None
109286	109287	,	0	None
109287	109288	S	0	None
109288	109289	,	0	None
109289	109290	and	0	None
109290	109291	M	0	None
109291	109292	+	0	None
109292	109293	S	0	None
109293	109294	.	0	None

109295	109296	After	0	None
109296	109297	each	0	None
109297	109298	period	0	None
109298	109299	,	0	None
109299	109300	subjects	0	None
109300	109301	received	0	None
109301	109302	a	0	None
109302	109303	6-h	0	None
109303	109304	meal	0	None
109304	109305	tolerance	0	None
109305	109306	test	0	None
109306	109307	(	0	None
109307	109308	MTT	0	None
109308	109309	)	0	None
109309	109310	with	0	None
109310	109311	[	0	None
109311	109312	(	0	None
109312	109313	14	0	None
109313	109314	)	0	None
109314	109315	C	0	None
109315	109316	]	0	None
109316	109317	glucose	0	None
109317	109318	to	0	None
109318	109319	calculate	0	None
109319	109320	glucose	0	None
109320	109321	kinetics	0	None
109321	109322	.	0	None

109323	109324	Fasting	0	None
109324	109325	plasma	0	None
109325	109326	glucose	0	None
109326	109327	(	0	None
109327	109328	FPG	0	None
109328	109329	)	0	None
109329	109330	,	0	None
109330	109331	fasting	0	None
109331	109332	plasma	0	None
109332	109333	insulin	0	None
109333	109334	,	0	None
109334	109335	C-peptide	0	None
109335	109336	(	0	None
109336	109337	insulin	0	None
109337	109338	secretory	0	None
109338	109339	rate	0	None
109339	109340	[	0	None
109340	109341	ISR	0	None
109341	109342	]	0	None
109342	109343	)	0	None
109343	109344	,	0	None
109344	109345	fasting	0	None
109345	109346	plasma	0	None
109346	109347	glucagon	1	GENE-Y
109347	109348	,	0	None
109348	109349	and	0	None
109349	109350	bioactive	0	None
109350	109351	glucagon-like	0	None
109351	109352	peptide	0	None
109352	109353	(	0	None
109353	109354	GLP-1	0	None
109354	109355	)	0	None
109355	109356	and	0	None
109356	109357	gastrointestinal	0	None
109357	109358	insulinotropic	0	None
109358	109359	peptide	0	None
109359	109360	(	0	None
109360	109361	GIP	0	None
109361	109362	)	0	None
109362	109363	was	0	None
109363	109364	measured	0	None
109364	109365	.	0	None

109366	109367	RESULTSFPG	0	None
109367	109368	decreased	0	None
109368	109369	from	0	None
109369	109370	P	0	None
109370	109371	,	0	None
109371	109372	160	0	None
109372	109373	±	0	None
109373	109374	4	0	None
109374	109375	to	0	None
109375	109376	M	0	None
109376	109377	,	0	None
109377	109378	150	0	None
109378	109379	±	0	None
109379	109380	4;	0	None
109380	109381	S	0	None
109381	109382	,	0	None
109382	109383	154	0	None
109383	109384	±	0	None
109384	109385	4;	0	None
109385	109386	and	0	None
109386	109387	M	0	None
109387	109388	+	0	None
109388	109389	S	0	None
109389	109390	,	0	None
109390	109391	125	0	None
109391	109392	±	0	None
109392	109393	3	0	None
109393	109394	mg	2	CHEMICAL
109394	109395	/	0	None
109395	109396	dL	0	None
109396	109397	.	0	None

109398	109399	Mean	0	None
109399	109400	post-MTT	0	None
109400	109401	PG	0	None
109401	109402	decreased	0	None
109402	109403	from	0	None
109403	109404	P	0	None
109404	109405	,	0	None
109405	109406	207	0	None
109406	109407	±	0	None
109407	109408	5	0	None
109408	109409	to	0	None
109409	109410	M	0	None
109410	109411	,	0	None
109411	109412	191	0	None
109412	109413	±	0	None
109413	109414	4;	0	None
109414	109415	S	0	None
109415	109416	,	0	None
109416	109417	195	0	None
109417	109418	±	0	None
109418	109419	4;	0	None
109419	109420	and	0	None
109420	109421	M	0	None
109421	109422	+	0	None
109422	109423	S	0	None
109423	109424	,	0	None
109424	109425	161	0	None
109425	109426	±	0	None
109426	109427	3	0	None
109427	109428	mg	2	CHEMICAL
109428	109429	/	0	None
109429	109430	dL	0	None
109430	109431	(	0	None
109431	109432	P	0	None
109432	109433	<	0	None
109433	109434	0	0	None
109434	109435	.	0	None
109435	109436	01	0	None
109436	109437	]	0	None
109437	109438	.	0	None

109439	109440	The	0	None
109440	109441	increase	0	None
109441	109442	in	0	None
109442	109443	mean	0	None
109443	109444	post-MTT	0	None
109444	109445	plasma	0	None
109445	109446	insulin	0	None
109446	109447	and	0	None
109447	109448	in	0	None
109448	109449	ISR	0	None
109449	109450	was	0	None
109450	109451	similar	0	None
109451	109452	in	0	None
109452	109453	P	0	None
109453	109454	,	0	None
109454	109455	M	0	None
109455	109456	,	0	None
109456	109457	and	0	None
109457	109458	S	0	None
109458	109459	and	0	None
109459	109460	slightly	0	None
109460	109461	greater	0	None
109461	109462	in	0	None
109462	109463	M	0	None
109463	109464	+	0	None
109464	109465	S	0	None
109465	109466	.	0	None

109467	109468	Fasting	0	None
109468	109469	plasma	0	None
109469	109470	glucagon	1	GENE-Y
109470	109471	was	0	None
109471	109472	equal	0	None
109472	109473	(	0	None
109473	109474	∼65-75	0	None
109474	109475	pg	0	None
109475	109476	/	0	None
109476	109477	mL	0	None
109477	109478	)	0	None
109478	109479	with	0	None
109479	109480	all	0	None
109480	109481	treatments	0	None
109481	109482	,	0	None
109482	109483	but	0	None
109483	109484	there	0	None
109484	109485	was	0	None
109485	109486	a	0	None
109486	109487	significant	0	None
109487	109488	drop	0	None
109488	109489	during	0	None
109489	109490	the	0	None
109490	109491	initial	0	None
109491	109492	120	0	None
109492	109493	min	0	None
109493	109494	with	0	None
109494	109495	S	0	None
109495	109496	24%	0	None
109496	109497	and	0	None
109497	109498	M	0	None
109498	109499	+	0	None
109499	109500	S	0	None
109500	109501	34%	0	None
109501	109502	(	0	None
109502	109503	both	0	None
109503	109504	P	0	None
109504	109505	<	0	None
109505	109506	0	0	None
109506	109507	.	0	None
109507	109508	05	0	None
109508	109509	)	0	None
109509	109510	vs	0	None
109510	109511	.	0	None

109512	109513	P	0	None
109513	109514	17%	0	None
109514	109515	and	0	None
109515	109516	M	0	None
109516	109517	16%	0	None
109517	109518	.	0	None

109519	109520	Fasting	0	None
109520	109521	and	0	None
109521	109522	mean	0	None
109522	109523	post-MTT	0	None
109523	109524	plasma	0	None
109524	109525	bioactive	0	None
109525	109526	GLP-1	0	None
109526	109527	were	0	None
109527	109528	higher	0	None
109528	109529	(	0	None
109529	109530	P	0	None
109530	109531	<	0	None
109531	109532	0	0	None
109532	109533	.	0	None
109533	109534	01	0	None
109534	109535	)	0	None
109535	109536	after	0	None
109536	109537	S	0	None
109537	109538	and	0	None
109538	109539	M	0	None
109539	109540	+	0	None
109540	109541	S	0	None
109541	109542	vs	0	None
109542	109543	.	0	None

109544	109545	M	0	None
109545	109546	and	0	None
109546	109547	P	0	None
109547	109548	.	0	None

109549	109550	Basal	0	None
109550	109551	endogenous	0	None
109551	109552	glucose	0	None
109552	109553	production	0	None
109553	109554	(	0	None
109554	109555	EGP	0	None
109555	109556	)	0	None
109556	109557	fell	0	None
109557	109558	from	0	None
109558	109559	P	0	None
109559	109560	2	0	None
109560	109561	.	0	None
109561	109562	0	0	None
109562	109563	±	0	None
109563	109564	0	0	None
109564	109565	.	0	None
109565	109566	1	0	None
109566	109567	to	0	None
109567	109568	S	0	None
109568	109569	1	0	None
109569	109570	.	0	None
109570	109571	8	0	None
109571	109572	±	0	None
109572	109573	0	0	None
109573	109574	.	0	None
109574	109575	1	0	None
109575	109576	mg	2	CHEMICAL
109576	109577	/	0	None
109577	109578	kg	0	None
109578	109579	⋅	0	None
109579	109580	min	0	None
109580	109581	,	0	None
109581	109582	M	0	None
109582	109583	1	0	None
109583	109584	.	0	None
109584	109585	8	0	None
109585	109586	±	0	None
109586	109587	0	0	None
109587	109588	.	0	None
109588	109589	2	0	None
109589	109590	mg	2	CHEMICAL
109590	109591	/	0	None
109591	109592	kg	0	None
109592	109593	⋅	0	None
109593	109594	min	0	None
109594	109595	[	0	None
109595	109596	both	0	None
109596	109597	P	0	None
109597	109598	<	0	None
109598	109599	0	0	None
109599	109600	.	0	None
109600	109601	05	0	None
109601	109602	vs	0	None
109602	109603	.	0	None

109604	109605	P	0	None
109605	109606	)	0	None
109606	109607	,	0	None
109607	109608	and	0	None
109608	109609	M	0	None
109609	109610	+	0	None
109610	109611	S	0	None
109611	109612	1	0	None
109612	109613	.	0	None
109613	109614	5	0	None
109614	109615	±	0	None
109615	109616	0	0	None
109616	109617	.	0	None
109617	109618	1	0	None
109618	109619	mg	2	CHEMICAL
109619	109620	/	0	None
109620	109621	kg	0	None
109621	109622	⋅	0	None
109622	109623	min	0	None
109623	109624	(	0	None
109624	109625	P	0	None
109625	109626	<	0	None
109626	109627	0	0	None
109627	109628	.	0	None
109628	109629	01	0	None
109629	109630	vs	0	None
109630	109631	.	0	None

109632	109633	P	0	None
109633	109634	)	0	None
109634	109635	.	0	None

109636	109637	Although	0	None
109637	109638	the	0	None
109638	109639	EGP	0	None
109639	109640	slope	0	None
109640	109641	of	0	None
109641	109642	decline	0	None
109642	109643	was	0	None
109643	109644	faster	0	None
109644	109645	in	0	None
109645	109646	M	0	None
109646	109647	and	0	None
109647	109648	M	0	None
109648	109649	+	0	None
109649	109650	S	0	None
109650	109651	vs	0	None
109651	109652	.	0	None

109653	109654	S	0	None
109654	109655	,	0	None
109655	109656	all	0	None
109656	109657	had	0	None
109657	109658	comparable	0	None
109658	109659	greater	0	None
109659	109660	post-MTT	0	None
109660	109661	EGP	0	None
109661	109662	inhibition	0	None
109662	109663	vs	0	None
109663	109664	.	0	None

109665	109666	P	0	None
109666	109667	(	0	None
109667	109668	P	0	None
109668	109669	<	0	None
109669	109670	0	0	None
109670	109671	.	0	None
109671	109672	05	0	None
109672	109673	)	0	None
109673	109674	.	0	None

109675	109676	CONCLUSIONSM	0	None
109676	109677	+	0	None
109677	109678	S	0	None
109678	109679	combined	0	None
109679	109680	produce	0	None
109680	109681	additive	0	None
109681	109682	effects	0	None
109682	109683	to	0	None
109683	109684	1	0	None
109684	109685	)	0	None
109685	109686	reduce	0	None
109686	109687	FPG	0	None
109687	109688	and	0	None
109688	109689	postmeal	0	None
109689	109690	PG	0	None
109690	109691	,	0	None
109691	109692	2	0	None
109692	109693	)	0	None
109693	109694	augment	0	None
109694	109695	GLP-1	0	None
109695	109696	secretion	0	None
109696	109697	and	0	None
109697	109698	β-cell	0	None
109698	109699	function	0	None
109699	109700	,	0	None
109700	109701	3	0	None
109701	109702	)	0	None
109702	109703	decrease	0	None
109703	109704	plasma	0	None
109704	109705	glucagon	1	GENE-Y
109705	109706	,	0	None
109706	109707	and	0	None
109707	109708	4	0	None
109708	109709	)	0	None
109709	109710	inhibit	0	None
109710	109711	fasting	0	None
109711	109712	and	0	None
109712	109713	postmeal	0	None
109713	109714	EGP	0	None
109714	109715	compared	0	None
109715	109716	with	0	None
109716	109717	M	0	None
109717	109718	or	0	None
109718	109719	S	0	None
109719	109720	monotherapy	0	None
109720	109721	.	0	None
109721	109722	Circulating	0	None
109722	109723	protein	0	None
109723	109724	biomarkers	0	None
109724	109725	of	0	None
109725	109726	pharmacodynamic	0	None
109726	109727	activity	0	None
109727	109728	of	0	None
109728	109729	sunitinib	0	None
109729	109730	in	0	None
109730	109731	patients	0	None
109731	109732	with	0	None
109732	109733	metastatic	0	None
109733	109734	renal	0	None
109734	109735	cell	0	None
109735	109736	carcinoma	0	None
109736	109737	:	0	None
109737	109738	modulation	0	None
109738	109739	of	0	None
109739	109740	VEGF	0	None
109740	109741	and	0	None
109741	109742	VEGF-related	0	None
109742	109743	proteins	0	None
109743	109744	.	0	None
109744	109745	Molecular	0	None
109745	109746	identification	0	None
109746	109747	of	0	None
109747	109748	high	0	None
109748	109749	and	0	None
109749	109750	low	0	None
109750	109751	affinity	0	None
109751	109752	receptors	0	None
109752	109753	for	0	None
109753	109755	nicotinic acid	2	CHEMICAL
109755	109756	.	0	None
109756	109757	Conformation	0	None
109757	109758	Guides	0	None
109758	109759	Molecular	0	None
109759	109760	Efficacy	0	None
109760	109761	in	0	None
109761	109762	Docking	0	None
109762	109763	Screens	0	None
109763	109764	of	0	None
109764	109765	Activated	0	None
109765	109766	β-2	0	None
109766	109767	Adrenergic	0	None
109767	109768	G	0	None
109768	109769	Protein	0	None
109769	109770	Coupled	0	None
109770	109771	Receptor	0	None
109771	109772	.	0	None
109772	109773	It	0	None
109773	109774	is	0	None
109774	109775	well	0	None
109775	109776	known	0	None
109776	109777	that	0	None
109777	109778	UVB	0	None
109778	109779	(	0	None
109779	109780	290-320	0	None
109780	109781	nm	0	None
109781	109782	)	0	None
109782	109783	induces	0	None
109783	109784	inflammation	0	None
109784	109785	in	0	None
109785	109786	skin	0	None
109786	109787	by	0	None
109787	109788	the	0	None
109788	109789	transcription	0	None
109789	109790	and	0	None
109790	109791	release	0	None
109791	109792	of	0	None
109792	109793	cytokines	3	GENE-N
109793	109794	and	0	None
109794	109795	chemokines	0	None
109795	109796	from	0	None
109796	109797	skin	0	None
109797	109798	keratinocytes	0	None
109798	109799	.	0	None

109800	109801	In	0	None
109801	109802	addition	0	None
109802	109803	,	0	None
109803	109804	it	0	None
109804	109805	is	0	None
109805	109806	considered	0	None
109806	109807	that	0	None
109807	109808	intracellular	0	None
109808	109809	reactive	0	None
109809	109810	oxygen	0	None
109810	109811	species	0	None
109811	109812	(	0	None
109812	109813	ROS	0	None
109813	109814	)	0	None
109814	109815	plays	0	None
109815	109816	an	0	None
109816	109817	important	0	None
109817	109818	role	0	None
109818	109819	in	0	None
109819	109820	UVB-induced	0	None
109820	109821	inflammatory	0	None
109821	109822	response	0	None
109822	109823	in	0	None
109823	109824	the	0	None
109824	109825	skin	0	None
109825	109826	.	0	None

109827	109828	Therefore	0	None
109828	109829	,	0	None
109829	109830	we	0	None
109830	109831	investigated	0	None
109831	109832	the	0	None
109832	109833	effect	0	None
109833	109834	of	0	None
109834	109836	vitamin C	2	CHEMICAL
109836	109837	,	0	None
109837	109838	a	0	None
109838	109839	potent	0	None
109839	109840	antioxidant	0	None
109840	109841	,	0	None
109841	109842	on	0	None
109842	109843	the	0	None
109843	109844	regulation	0	None
109844	109845	of	0	None
109845	109846	UVB-induced	0	None
109846	109847	skin	0	None
109847	109848	inflammation	0	None
109848	109849	via	0	None
109849	109850	the	0	None
109850	109851	modulation	0	None
109851	109852	of	0	None
109852	109853	chemokines	0	None
109853	109854	production	0	None
109854	109855	.	0	None

109856	109857	Vitamin	0	None
109857	109858	C	0	None
109858	109859	uptake	0	None
109859	109860	into	0	None
109860	109861	keratinocytes	0	None
109861	109862	is	0	None
109862	109863	increased	0	None
109863	109864	by	0	None
109864	109865	UVB	0	None
109865	109866	irradiation	0	None
109866	109867	in	0	None
109867	109868	a	0	None
109868	109869	time-	0	None
109869	109870	and	0	None
109870	109871	dose-dependent	0	None
109871	109872	manner	0	None
109872	109873	through	0	None
109873	109874	the	0	None
109874	109875	translocation	0	None
109875	109876	of	0	None
109876	109877	sodium-dependent	0	None
109877	109878	vitamin	0	None
109878	109879	C	0	None
109879	109880	transporter-1	0	None
109880	109881	(	0	None
109881	109882	SVCT-1	0	None
109882	109883	)	0	None
109883	109884	,	0	None
109884	109885	a	0	None
109885	109886	vitamin	0	None
109886	109887	C-specific	0	None
109887	109888	transporter	0	None
109888	109889	,	0	None
109889	109890	from	0	None
109890	109891	the	0	None
109891	109892	cytosol	0	None
109892	109893	to	0	None
109893	109894	the	0	None
109894	109895	membrane	0	None
109895	109896	.	0	None

109897	109898	To	0	None
109898	109899	evaluate	0	None
109899	109900	the	0	None
109900	109901	effect	0	None
109901	109902	of	0	None
109902	109904	vitamin C	2	CHEMICAL
109904	109905	on	0	None
109905	109906	the	0	None
109906	109907	chemokine	0	None
109907	109908	mRNA	0	None
109908	109909	expression	0	None
109909	109910	,	0	None
109910	109911	we	0	None
109911	109912	performed	0	None
109912	109913	RNase	0	None
109913	109914	protection	0	None
109914	109915	assay	0	None
109915	109916	.	0	None

109917	109918	As	0	None
109918	109919	a	0	None
109919	109920	result	0	None
109920	109921	,	0	None
109921	109922	there	0	None
109922	109923	was	0	None
109923	109924	a	0	None
109924	109925	remarkable	0	None
109925	109926	change	0	None
109926	109927	in	0	None
109927	109928	chemokine	0	None
109928	109929	mRNA	0	None
109929	109930	expression	0	None
109930	109931	,	0	None
109931	109932	especially	0	None
109932	109933	IL-8	1	GENE-Y
109933	109934	and	0	None
109934	109935	monocyte	0	None
109935	109936	chemoattractant	0	None
109936	109937	protein	0	None
109937	109938	(	0	None
109938	109939	MCP	0	None
109939	109940	)	0	None
109940	109941	-1	0	None
109941	109942	expression	0	None
109942	109943	.	0	None

109944	109945	In	0	None
109945	109946	addition	0	None
109946	109947	,	0	None
109947	109948	increased	0	None
109948	109949	IL-8	1	GENE-Y
109949	109950	and	0	None
109950	109951	MCP-1	0	None
109951	109952	mRNA	0	None
109952	109953	expressions	0	None
109953	109954	were	0	None
109954	109955	suppressed	0	None
109955	109956	by	0	None
109956	109957	vitamin	0	None
109957	109958	C	0	None
109958	109959	treatment	0	None
109959	109960	.	0	None

109961	109962	We	0	None
109962	109963	also	0	None
109963	109964	confirmed	0	None
109964	109965	the	0	None
109965	109966	results	0	None
109966	109967	of	0	None
109967	109968	protein	0	None
109968	109969	levels	0	None
109969	109970	measured	0	None
109970	109971	by	0	None
109971	109972	ELISA	0	None
109972	109973	.	0	None

109974	109975	Taken	0	None
109975	109976	together	0	None
109976	109977	,	0	None
109977	109979	vitamin C	2	CHEMICAL
109979	109980	uptake	0	None
109980	109981	is	0	None
109981	109982	increased	0	None
109982	109983	in	0	None
109983	109984	UVB-irradiated	0	None
109984	109985	keratinocytes	0	None
109985	109986	through	0	None
109986	109987	the	0	None
109987	109988	translocation	0	None
109988	109989	of	0	None
109989	109990	SVCT-1	0	None
109990	109991	and	0	None
109991	109992	regulates	0	None
109992	109993	inflammatory	0	None
109993	109994	response	0	None
109994	109995	in	0	None
109995	109996	the	0	None
109996	109997	skin	0	None
109997	109998	via	0	None
109998	109999	the	0	None
109999	110000	downregulation	0	None
110000	110001	of	0	None
110001	110002	IL-8	1	GENE-Y
110002	110003	and	0	None
110003	110004	MCP-1	0	None
110004	110005	production	0	None
110005	110006	.	0	None
110006	110007	The	0	None
110007	110008	use	0	None
110008	110009	of	0	None
110009	110010	leflunomide	0	None
110010	110011	in	0	None
110011	110012	the	0	None
110012	110013	treatment	0	None
110013	110014	of	0	None
110014	110015	rheumatoid	0	None
110015	110016	arthritis	0	None
110016	110017	:	0	None
110017	110018	an	0	None
110018	110019	experimental	0	None
110019	110020	and	0	None
110020	110021	clinical	0	None
110021	110022	review	0	None
110022	110023	.	0	None
110023	110024	We	0	None
110024	110025	investigated	0	None
110025	110026	the	0	None
110026	110027	basis	0	None
110027	110028	for	0	None
110028	110029	the	0	None
110029	110030	difference	0	None
110030	110031	in	0	None
110031	110032	the	0	None
110032	110033	cardiotonic	0	None
110033	110034	effects	0	None
110034	110035	of	0	None
110035	110036	the	0	None
110036	110037	PDE3	0	None
110037	110038	inhibitors	0	None
110038	110039	cilostazol	2	CHEMICAL
110039	110040	and	0	None
110040	110041	milrinone	2	CHEMICAL
110041	110042	in	0	None
110042	110043	the	0	None
110043	110044	rabbit	0	None
110044	110045	heart	0	None
110045	110046	.	0	None

110047	110048	Cilostazol	2	CHEMICAL
110048	110049	displayed	0	None
110049	110050	greater	0	None
110050	110051	selectivity	0	None
110051	110052	than	0	None
110052	110053	milrinone	2	CHEMICAL
110053	110054	for	0	None
110054	110055	inhibition	0	None
110055	110056	of	0	None
110056	110057	cAMP-PDE	0	None
110057	110058	activity	0	None
110058	110059	in	0	None
110059	110060	microsomal	0	None
110060	110061	vs	0	None
110061	110062	cytosolic	0	None
110062	110063	fractions	0	None
110063	110064	from	0	None
110064	110065	rabbit	0	None
110065	110066	heart	0	None
110066	110067	.	0	None

110068	110069	This	0	None
110069	110070	difference	0	None
110070	110071	was	0	None
110071	110072	due	0	None
110072	110073	to	0	None
110073	110074	the	0	None
110074	110075	inhibition	0	None
110075	110076	of	0	None
110076	110077	significantly	0	None
110077	110078	less	0	None
110078	110079	cytosolic	0	None
110079	110080	cAMP-PDE	0	None
110080	110081	activity	0	None
110081	110082	by	0	None
110082	110083	cilostazol	2	CHEMICAL
110083	110084	compared	0	None
110084	110085	to	0	None
110085	110086	milrinone	2	CHEMICAL
110086	110087	.	0	None

110088	110089	A	0	None
110089	110090	combination	0	None
110090	110091	of	0	None
110091	110092	cilostazol	2	CHEMICAL
110092	110093	(	0	None
110093	110094	>15	0	None
110094	110095	microM	0	None
110095	110096	)	0	None
110096	110097	and	0	None
110097	110098	the	0	None
110098	110099	PDE4	0	None
110099	110100	selective	0	None
110100	110101	inhibitor	0	None
110101	110102	,	0	None
110102	110103	rolipram	0	None
110103	110104	(	0	None
110104	110105	5	0	None
110105	110106	microM	0	None
110106	110107	)	0	None
110107	110108	,	0	None
110108	110109	inhibited	0	None
110109	110110	levels	0	None
110110	110111	of	0	None
110111	110112	cytosolic	0	None
110112	110113	cAMP-PDE	0	None
110113	110114	activity	0	None
110114	110115	similar	0	None
110115	110116	to	0	None
110116	110117	those	0	None
110117	110118	inhibited	0	None
110118	110119	by	0	None
110119	110120	milrinone	2	CHEMICAL
110120	110121	on	0	None
110121	110122	its	0	None
110122	110123	own	0	None
110123	110124	.	0	None

110125	110126	This	0	None
110126	110127	suggested	0	None
110127	110128	that	0	None
110128	110129	milrinone	2	CHEMICAL
110129	110130	inhibited	0	None
110130	110131	PDE4	0	None
110131	110132	in	0	None
110132	110133	addition	0	None
110133	110134	to	0	None
110134	110135	PDE3	0	None
110135	110136	activity	0	None
110136	110137	.	0	None

110138	110139	In	0	None
110139	110140	isolated	0	None
110140	110141	rabbit	0	None
110141	110142	cardiomyocytes	0	None
110142	110143	,	0	None
110143	110144	milrinone	2	CHEMICAL
110144	110145	(	0	None
110145	110146	>10	0	None
110146	110147	microM	0	None
110147	110148	)	0	None
110148	110149	caused	0	None
110149	110150	greater	0	None
110150	110151	elevations	0	None
110151	110152	in	0	None
110152	110153	intracellular	0	None
110153	110154	cAMP	0	None
110154	110155	and	0	None
110155	110156	calcium	0	None
110156	110157	than	0	None
110157	110158	cilostazol	2	CHEMICAL
110158	110159	.	0	None

110160	110161	In	0	None
110161	110162	the	0	None
110162	110163	presence	0	None
110163	110164	of	0	None
110164	110165	rolipram	0	None
110165	110166	,	0	None
110166	110167	however	0	None
110167	110168	,	0	None
110168	110169	the	0	None
110169	110170	cAMP	0	None
110170	110171	and	0	None
110171	110172	calcium	0	None
110172	110173	elevating	0	None
110173	110174	effects	0	None
110174	110175	of	0	None
110175	110176	cilostazol	2	CHEMICAL
110176	110177	and	0	None
110177	110178	milrinone	2	CHEMICAL
110178	110179	were	0	None
110179	110180	similar	0	None
110180	110181	.	0	None

110182	110183	Therefore	0	None
110183	110184	,	0	None
110184	110185	in	0	None
110185	110186	rabbit	0	None
110186	110187	heart	0	None
110187	110188	,	0	None
110188	110189	partial	0	None
110189	110190	inhibition	0	None
110190	110191	of	0	None
110191	110192	PDE4	0	None
110192	110193	by	0	None
110193	110194	milrinone	2	CHEMICAL
110194	110195	contributed	0	None
110195	110196	to	0	None
110196	110197	greater	0	None
110197	110198	increases	0	None
110198	110199	in	0	None
110199	110200	cardiomyocyte	0	None
110200	110201	cAMP	0	None
110201	110202	and	0	None
110202	110203	calcium	0	None
110203	110204	levels	0	None
110204	110205	than	0	None
110205	110206	cilostazol	2	CHEMICAL
110206	110207	.	0	None

110208	110209	PDE4	0	None
110209	110210	activity	0	None
110210	110211	in	0	None
110211	110212	failing	0	None
110212	110213	human	0	None
110213	110214	heart	0	None
110214	110215	was	0	None
110215	110216	lower	0	None
110216	110217	than	0	None
110217	110218	in	0	None
110218	110219	rabbit	0	None
110219	110220	heart	0	None
110220	110221	and	0	None
110221	110222	there	0	None
110222	110223	was	0	None
110223	110224	no	0	None
110224	110225	significant	0	None
110225	110226	difference	0	None
110226	110227	in	0	None
110227	110228	the	0	None
110228	110229	inhibition	0	None
110229	110230	of	0	None
110230	110231	human	0	None
110231	110232	cytosolic	0	None
110232	110233	cAMP-PDE	0	None
110233	110234	by	0	None
110234	110235	cilostazol	2	CHEMICAL
110235	110236	and	0	None
110236	110237	milrinone	2	CHEMICAL
110237	110238	.	0	None

110239	110240	Our	0	None
110240	110241	results	0	None
110241	110242	suggest	0	None
110242	110243	that	0	None
110243	110244	in	0	None
110244	110245	normal	0	None
110245	110246	rabbit	0	None
110246	110247	heart	0	None
110247	110248	inhibition	0	None
110248	110249	of	0	None
110249	110250	PDE4	0	None
110250	110251	by	0	None
110251	110252	milrinone	2	CHEMICAL
110252	110253	may	0	None
110253	110254	partly	0	None
110254	110255	contribute	0	None
110255	110256	to	0	None
110256	110257	the	0	None
110257	110258	greater	0	None
110258	110259	cardiotonic	0	None
110259	110260	effect	0	None
110260	110261	of	0	None
110261	110262	milrinone	2	CHEMICAL
110262	110263	when	0	None
110263	110264	compared	0	None
110264	110265	to	0	None
110265	110266	cilostazol	2	CHEMICAL
110266	110267	.	0	None

110268	110269	However	0	None
110269	110270	,	0	None
110270	110271	the	0	None
110271	110272	lower	0	None
110272	110273	level	0	None
110273	110274	of	0	None
110274	110275	PDE4	0	None
110275	110276	activity	0	None
110276	110277	in	0	None
110277	110278	failing	0	None
110278	110279	human	0	None
110279	110280	heart	0	None
110280	110281	suggests	0	None
110281	110282	that	0	None
110282	110283	factors	0	None
110283	110284	other	0	None
110284	110285	than	0	None
110285	110286	inhibition	0	None
110286	110287	of	0	None
110287	110288	PDE4	0	None
110288	110289	by	0	None
110289	110290	milrinone	2	CHEMICAL
110290	110291	may	0	None
110291	110292	contribute	0	None
110292	110293	to	0	None
110293	110294	differences	0	None
110294	110295	in	0	None
110295	110296	cardiotonic	0	None
110296	110297	action	0	None
110297	110298	when	0	None
110298	110299	compared	0	None
110299	110300	to	0	None
110300	110301	cilostazol	2	CHEMICAL
110301	110302	.	0	None
110302	110303	Highly	0	None
110303	110304	oriented	0	None
110304	110305	pyrolytic	0	None
110305	110306	graphite	0	None
110306	110307	characterized	0	None
110307	110308	by	0	None
110308	110309	a	0	None
110309	110310	low	0	None
110310	110311	misorientation	0	None
110311	110312	of	0	None
110312	110313	crystallites	0	None
110313	110314	is	0	None
110314	110315	fluorinated	0	None
110315	110316	using	0	None
110316	110317	a	0	None
110317	110318	gaseous	0	None
110318	110319	mixture	0	None
110319	110320	of	0	None
110320	110321	BrF	0	None
110321	110322	(	0	None
110322	110323	3	0	None
110323	110324	)	0	None
110324	110325	with	0	None
110325	110326	Br	0	None
110326	110327	(	0	None
110327	110328	2	0	None
110328	110329	)	0	None
110329	110330	at	0	None
110330	110331	room	0	None
110331	110332	temperature	0	None
110332	110333	.	0	None

110334	110335	The	0	None
110335	110336	golden-colored	0	None
110336	110337	product	0	None
110337	110338	,	0	None
110338	110339	easily	0	None
110339	110340	delaminating	0	None
110340	110341	into	0	None
110341	110342	micrometer-size	0	None
110342	110343	transparent	0	None
110343	110344	flakes	0	None
110344	110345	,	0	None
110345	110346	is	0	None
110346	110347	an	0	None
110347	110348	intercalation	0	None
110348	110349	compound	0	None
110349	110350	where	0	None
110350	110351	Br	0	None
110351	110352	(	0	None
110352	110353	2	0	None
110353	110354	)	0	None
110354	110355	molecules	0	None
110355	110356	are	0	None
110356	110357	hosted	0	None
110357	110358	between	0	None
110358	110359	fluorinated	0	None
110359	110360	graphene	0	None
110360	110361	layers	0	None
110361	110362	of	0	None
110362	110363	approximate	0	None
110363	110364	C	0	None
110364	110365	(	0	None
110365	110366	2	0	None
110366	110367	)	0	None
110367	110368	F	0	None
110368	110369	composition	0	None
110369	110370	.	0	None

110371	110372	To	0	None
110372	110373	unravel	0	None
110373	110374	the	0	None
110374	110375	chemical	0	None
110375	110376	bonding	0	None
110376	110377	in	0	None
110377	110378	semifluorinated	0	None
110378	110379	graphite	0	None
110379	110380	,	0	None
110380	110381	we	0	None
110381	110382	apply	0	None
110382	110383	angle-resolved	0	None
110383	110384	near-edge	0	None
110384	110385	X-ray	0	None
110385	110386	absorption	0	None
110386	110387	fine	0	None
110387	110388	structure	0	None
110388	110389	(	0	None
110389	110390	NEXAFS	0	None
110390	110391	)	0	None
110391	110392	spectroscopy	0	None
110392	110393	and	0	None
110393	110394	quantum-chemical	0	None
110394	110395	modeling	0	None
110395	110396	.	0	None

110397	110398	The	0	None
110398	110399	strong	0	None
110399	110400	angular	0	None
110400	110401	dependence	0	None
110401	110402	of	0	None
110402	110403	the	0	None
110403	110404	CK	0	None
110404	110405	and	0	None
110405	110406	FK	0	None
110406	110407	edge	0	None
110407	110408	NEXAFS	0	None
110408	110409	spectra	0	None
110409	110410	on	0	None
110410	110411	the	0	None
110411	110412	incident	0	None
110412	110413	radiation	0	None
110413	110414	indicates	0	None
110414	110415	that	0	None
110415	110416	room-temperature-produced	0	None
110416	110417	graphite	0	None
110417	110418	fluoride	0	None
110418	110419	is	0	None
110419	110420	a	0	None
110420	110421	highly	0	None
110421	110422	anisotropic	0	None
110422	110423	material	0	None
110423	110424	,	0	None
110424	110425	where	0	None
110425	110426	half	0	None
110426	110427	of	0	None
110427	110428	the	0	None
110428	110429	carbon	2	CHEMICAL
110429	110430	atoms	0	None
110430	110431	are	0	None
110431	110432	covalently	0	None
110432	110433	bonded	0	None
110433	110434	with	0	None
110434	110435	fluorine	0	None
110435	110436	,	0	None
110436	110437	while	0	None
110437	110438	the	0	None
110438	110439	rest	0	None
110439	110440	of	0	None
110440	110441	the	0	None
110441	110442	carbon	2	CHEMICAL
110442	110443	atoms	0	None
110443	110444	preserve	0	None
110444	110445	π	0	None
110445	110446	electrons	0	None
110446	110447	.	0	None

110448	110449	Comparison	0	None
110449	110450	of	0	None
110450	110451	the	0	None
110451	110452	experimental	0	None
110452	110453	CK	0	None
110453	110454	edge	0	None
110454	110455	spectrum	0	None
110455	110456	with	0	None
110456	110457	theoretical	0	None
110457	110458	spectra	0	None
110458	110459	plotted	0	None
110459	110460	for	0	None
110460	110461	C	0	None
110461	110462	(	0	None
110462	110463	2	0	None
110463	110464	)	0	None
110464	110465	F	0	None
110465	110466	models	0	None
110466	110467	reveals	0	None
110467	110468	that	0	None
110468	110469	fluorine	0	None
110469	110470	atoms	0	None
110470	110471	are	0	None
110471	110472	more	0	None
110472	110473	likely	0	None
110473	110474	to	0	None
110474	110475	form	0	None
110475	110476	chains	0	None
110476	110477	.	0	None

110478	110479	This	0	None
110479	110480	conclusion	0	None
110480	110481	agrees	0	None
110481	110482	with	0	None
110482	110483	the	0	None
110483	110484	atomic	0	None
110484	110485	force	0	None
110485	110486	microscopy	0	None
110486	110487	observation	0	None
110487	110488	of	0	None
110488	110489	a	0	None
110489	110490	chain-like	0	None
110490	110491	pattern	0	None
110491	110492	on	0	None
110492	110493	the	0	None
110493	110494	surface	0	None
110494	110495	of	0	None
110495	110496	graphite	0	None
110496	110497	fluoride	0	None
110497	110498	layers	0	None
110498	110499	.	0	None
110499	110500	The	0	None
110500	110501	active	0	None
110501	110502	metabolite	0	None
110502	110503	of	0	None
110503	110504	Clopidogrel	0	None
110504	110505	disrupts	0	None
110505	110506	P2Y12	1	GENE-Y
110506	110507	receptor	0	None
110507	110508	oligomers	0	None
110508	110509	and	0	None
110509	110510	partitions	0	None
110510	110511	them	0	None
110511	110512	out	0	None
110512	110513	of	0	None
110513	110514	lipid	0	None
110514	110515	rafts	0	None
110515	110516	.	0	None
110516	110517	Antihypertensive	0	None
110517	110518	and	0	None
110518	110519	metabolic	0	None
110519	110520	effects	0	None
110520	110521	of	0	None
110521	110522	high-dose	0	None
110522	110523	olmesartan	0	None
110523	110524	and	0	None
110524	110525	telmisartan	0	None
110525	110526	in	0	None
110526	110527	type	0	None
110527	110528	2	0	None
110528	110529	diabetes	0	None
110529	110530	patients	0	None
110530	110531	with	0	None
110531	110532	hypertension	0	None
110532	110533	.	0	None
110533	110534	Thionamides	0	None
110534	110535	,	0	None
110535	110536	inhibitors	0	None
110536	110537	of	0	None
110537	110538	the	0	None
110538	110539	thyroid	0	None
110539	110540	peroxidase-mediated	0	None
110540	110541	iodination	0	None
110541	110542	,	0	None
110542	110543	are	0	None
110543	110544	clinically	0	None
110544	110545	used	0	None
110545	110546	in	0	None
110546	110547	the	0	None
110547	110548	treatment	0	None
110548	110549	of	0	None
110549	110550	hyperthyroidism	0	None
110550	110551	.	0	None

110552	110553	However	0	None
110553	110554	,	0	None
110554	110555	the	0	None
110555	110556	use	0	None
110556	110557	of	0	None
110557	110558	antithyroid	0	None
110558	110559	drugs	0	None
110559	110560	is	0	None
110560	110561	associated	0	None
110561	110562	with	0	None
110562	110563	immunomodulatory	0	None
110563	110564	effects	0	None
110564	110565	,	0	None
110565	110566	and	0	None
110566	110567	recent	0	None
110567	110568	studies	0	None
110568	110569	with	0	None
110569	110571	thionamide-related heterocyclic	0	None
110571	110572	thioderivates	0	None
110572	110573	demonstrated	0	None
110573	110574	direct	0	None
110574	110575	anti-inflammatory	0	None
110575	110576	and	0	None
110576	110577	immunosuppressive	0	None
110577	110578	properties	0	None
110578	110579	.	0	None

110580	110581	Using	0	None
110581	110582	primary	0	None
110582	110583	human	0	None
110583	110584	T-lymphocytes	0	None
110584	110585	,	0	None
110585	110586	we	0	None
110586	110587	show	0	None
110587	110588	that	0	None
110588	110589	the	0	None
110589	110590	heterocyclic	0	None
110590	110591	thionamides	0	None
110591	110592	carbimazole	0	None
110592	110593	and	0	None
110593	110594	propylthiouracil	0	None
110594	110595	inhibit	0	None
110595	110596	synthesis	0	None
110596	110597	of	0	None
110597	110598	the	0	None
110598	110599	proinflammatory	0	None
110599	110600	cytokines	3	GENE-N
110600	110603	tumor necrosis factor	1	GENE-Y
110603	110604	(	0	None
110604	110605	TNF	1	GENE-Y
110605	110606	)	0	None
110606	110607	alpha	0	None
110607	110608	and	0	None
110608	110609	interferon	0	None
110609	110610	(	0	None
110610	110611	IFN	0	None
110611	110612	)	0	None
110612	110613	gamma	0	None
110613	110614	.	0	None

110615	110616	In	0	None
110616	110617	addition	0	None
110617	110618	,	0	None
110618	110619	DNA	0	None
110619	110620	binding	0	None
110620	110621	of	0	None
110621	110623	nuclear factor	3	GENE-N
110623	110624	(	0	None
110624	110625	NF	0	None
110625	110626	)	0	None
110626	110627	-kappaB	0	None
110627	110628	,	0	None
110628	110629	a	0	None
110629	110630	proinflammatory	0	None
110630	110631	transcription	0	None
110631	110632	factor	0	None
110632	110633	that	0	None
110633	110634	regulates	0	None
110634	110635	both	0	None
110635	110636	TNFalpha	0	None
110636	110637	and	0	None
110637	110638	IFNgamma	1	GENE-Y
110638	110639	synthesis	0	None
110639	110640	,	0	None
110640	110641	and	0	None
110641	110642	NF-kappaB-dependent	0	None
110642	110643	reporter	0	None
110643	110644	gene	0	None
110644	110645	expression	0	None
110645	110646	were	0	None
110646	110647	reduced	0	None
110647	110648	.	0	None

110649	110650	Abrogation	0	None
110650	110651	of	0	None
110651	110652	NF-kappaB	3	GENE-N
110652	110653	activity	0	None
110653	110654	was	0	None
110654	110655	accompanied	0	None
110655	110656	by	0	None
110656	110657	reduced	0	None
110657	110658	phosphorylation	0	None
110658	110659	and	0	None
110659	110660	proteolytic	0	None
110660	110661	degradation	0	None
110661	110662	of	0	None
110662	110663	inhibitor	0	None
110663	110664	of	0	None
110664	110665	kappaB	0	None
110665	110666	(	0	None
110666	110667	IkappaB	0	None
110667	110668	)	0	None
110668	110669	alpha	0	None
110669	110670	,	0	None
110670	110671	the	0	None
110671	110672	inhibitory	0	None
110672	110673	subunit	0	None
110673	110674	of	0	None
110674	110675	the	0	None
110675	110676	NF-kappaB	3	GENE-N
110676	110677	complex	0	None
110677	110678	.	0	None

110679	110680	Carbimazole	0	None
110680	110681	inhibited	0	None
110681	110682	NF-kappaB	3	GENE-N
110682	110683	via	0	None
110683	110684	the	0	None
110684	110685	small	0	None
110685	110686	GTPase	0	None
110686	110687	Rac-1	0	None
110687	110688	,	0	None
110688	110689	whereas	0	None
110689	110690	propylthiouracil	0	None
110690	110691	inhibited	0	None
110691	110692	the	0	None
110692	110693	phosphorylation	0	None
110693	110694	of	0	None
110694	110695	IkappaBalpha	0	None
110695	110696	by	0	None
110696	110697	its	0	None
110697	110698	kinase	0	None
110698	110699	inhibitor	0	None
110699	110700	of	0	None
110700	110701	kappaB	0	None
110701	110702	kinase	0	None
110702	110703	alpha	0	None
110703	110704	.	0	None

110705	110706	Methimazole	0	None
110706	110707	had	0	None
110707	110708	no	0	None
110708	110709	effect	0	None
110709	110710	on	0	None
110710	110711	NF-kappaB	3	GENE-N
110711	110712	induction	0	None
110712	110713	,	0	None
110713	110714	demonstrating	0	None
110714	110715	that	0	None
110715	110716	drug	0	None
110716	110717	potency	0	None
110717	110718	correlated	0	None
110718	110719	with	0	None
110719	110720	the	0	None
110720	110721	chemical	0	None
110721	110722	reactivity	0	None
110722	110723	of	0	None
110723	110724	the	0	None
110724	110725	thionamide-associated	0	None
110725	110726	sulfur	2	CHEMICAL
110726	110727	group	0	None
110727	110728	.	0	None

110729	110730	Taken	0	None
110730	110731	together	0	None
110731	110732	,	0	None
110732	110733	our	0	None
110733	110734	data	0	None
110734	110735	demonstrate	0	None
110735	110736	that	0	None
110736	110737	thioureylenes	0	None
110737	110738	with	0	None
110738	110739	a	0	None
110739	110740	common	0	None
110740	110741	,	0	None
110741	110742	heterocyclic	0	None
110742	110743	structure	0	None
110743	110744	inhibit	0	None
110744	110745	inflammation	0	None
110745	110746	and	0	None
110746	110747	immune	0	None
110747	110748	function	0	None
110748	110749	via	0	None
110749	110750	the	0	None
110750	110751	NF-kappaB	3	GENE-N
110751	110752	pathway	0	None
110752	110753	.	0	None

110754	110755	Our	0	None
110755	110756	results	0	None
110756	110757	may	0	None
110757	110758	explain	0	None
110758	110759	the	0	None
110759	110760	observed	0	None
110760	110761	remission	0	None
110761	110762	of	0	None
110762	110763	proinflammatory	0	None
110763	110764	diseases	0	None
110764	110765	upon	0	None
110765	110766	antithyroid	0	None
110766	110767	therapy	0	None
110767	110768	in	0	None
110768	110769	hyperthyroid	0	None
110769	110770	patients	0	None
110770	110771	.	0	None

110772	110773	The	0	None
110773	110774	use	0	None
110774	110775	of	0	None
110775	110776	related	0	None
110776	110777	thioureylenes	0	None
110777	110778	may	0	None
110778	110779	provide	0	None
110779	110780	a	0	None
110780	110781	new	0	None
110781	110782	therapeutic	0	None
110782	110783	basis	0	None
110783	110784	for	0	None
110784	110785	the	0	None
110785	110786	development	0	None
110786	110787	and	0	None
110787	110788	application	0	None
110788	110789	of	0	None
110789	110790	anti-inflammatory	0	None
110790	110791	compounds	0	None
110791	110792	.	0	None
110792	110793	Chemical	0	None
110793	110794	constituents	0	None
110794	110795	of	0	None
110795	110796	Euphorbia	0	None
110796	110797	hyberna	0	None
110797	110798	L	0	None
110798	110799	.	0	None

110800	110801	(	0	None
110801	110802	Euphorbiaceae	0	None
110802	110803	)	0	None
110803	110804	.	0	None
110804	110805	Reduced	0	None
110805	110806	amplitude	0	None
110806	110807	of	0	None
110807	110808	the	0	None
110808	110809	cortical	0	None
110809	110810	P300	1	GENE-Y
110810	110811	event-related	0	None
110811	110812	potential	0	None
110812	110813	(	0	None
110813	110814	ERP	0	None
110814	110815	)	0	None
110815	110816	component	0	None
110816	110817	during	0	None
110817	110818	response	0	None
110818	110819	inhibition	0	None
110819	110820	is	0	None
110820	110821	associated	0	None
110821	110822	with	0	None
110822	110823	vulnerability	0	None
110823	110824	to	0	None
110824	110825	alcohol	2	CHEMICAL
110825	110826	use	0	None
110826	110827	disorders	0	None
110827	110828	.	0	None

110829	110830	In	0	None
110830	110831	the	0	None
110831	110832	current	0	None
110832	110833	study	0	None
110833	110834	,	0	None
110834	110835	we	0	None
110835	110836	investigated	0	None
110836	110837	the	0	None
110837	110838	effect	0	None
110838	110839	of	0	None
110839	110840	an	0	None
110840	110841	experimental	0	None
110841	110842	manipulation	0	None
110842	110843	of	0	None
110843	110844	response	0	None
110844	110845	conflict	0	None
110845	110846	on	0	None
110846	110847	the	0	None
110847	110848	amplitude	0	None
110848	110849	of	0	None
110849	110850	the	0	None
110850	110851	P300	1	GENE-Y
110851	110852	component	0	None
110852	110853	during	0	None
110853	110854	response	0	None
110854	110855	inhibition	0	None
110855	110856	,	0	None
110856	110857	and	0	None
110857	110858	examined	0	None
110858	110859	whether	0	None
110859	110860	individual	0	None
110860	110861	differences	0	None
110861	110862	in	0	None
110862	110863	the	0	None
110863	110864	amplitude	0	None
110864	110865	of	0	None
110865	110866	this	0	None
110866	110867	P300	1	GENE-Y
110867	110868	component	0	None
110868	110869	would	0	None
110869	110870	predict	0	None
110870	110871	voluntary	0	None
110871	110872	ad-lib	0	None
110872	110873	alcohol	2	CHEMICAL
110873	110874	consumption	0	None
110874	110875	,	0	None
110875	110876	in	0	None
110876	110877	social	0	None
110877	110878	drinkers	0	None
110878	110879	.	0	None

110880	110881	Using	0	None
110881	110882	a	0	None
110882	110883	repeated	0	None
110883	110884	measures	0	None
110884	110885	design	0	None
110885	110886	,	0	None
110886	110887	16	0	None
110887	110888	participants	0	None
110888	110889	performed	0	None
110889	110890	a	0	None
110890	110891	stop-signal	0	None
110891	110892	task	0	None
110892	110893	after	0	None
110893	110894	receiving	0	None
110894	110895	instructions	0	None
110895	110896	that	0	None
110896	110897	either	0	None
110897	110898	emphasised	0	None
110898	110899	or	0	None
110899	110900	de-emphasised	0	None
110900	110901	response	0	None
110901	110902	conflict	0	None
110902	110903	while	0	None
110903	110904	their	0	None
110904	110905	electroencephalogram	0	None
110905	110906	(	0	None
110906	110907	EEG	0	None
110907	110908	)	0	None
110908	110909	was	0	None
110909	110910	concurrently	0	None
110910	110911	recorded	0	None
110911	110912	,	0	None
110912	110913	before	0	None
110913	110914	their	0	None
110914	110915	ad-lib	0	None
110915	110916	drinking	0	None
110916	110917	was	0	None
110917	110918	assessed	0	None
110918	110919	.	0	None

110920	110921	Results	0	None
110921	110922	revealed	0	None
110922	110923	that	0	None
110923	110924	task	0	None
110924	110925	instructions	0	None
110925	110926	had	0	None
110926	110927	the	0	None
110927	110928	predicted	0	None
110928	110929	effects	0	None
110929	110930	on	0	None
110930	110931	behavioural	0	None
110931	110932	indices	0	None
110932	110933	of	0	None
110933	110934	response	0	None
110934	110935	inhibition	0	None
110935	110936	and	0	None
110936	110937	the	0	None
110937	110938	associated	0	None
110938	110939	P300	1	GENE-Y
110939	110940	components	0	None
110940	110941	.	0	None

110942	110943	Most	0	None
110943	110944	importantly	0	None
110944	110945	,	0	None
110945	110946	individual	0	None
110946	110947	differences	0	None
110947	110948	in	0	None
110948	110949	the	0	None
110949	110950	amplitude	0	None
110950	110951	of	0	None
110951	110952	P300	1	GENE-Y
110952	110953	subcomponents	0	None
110953	110954	during	0	None
110954	110955	response	0	None
110955	110956	inhibition	0	None
110956	110957	were	0	None
110957	110958	negatively	0	None
110958	110959	correlated	0	None
110959	110960	with	0	None
110960	110961	ad-lib	0	None
110961	110962	alcohol	2	CHEMICAL
110962	110963	consumption	0	None
110963	110964	.	0	None

110965	110966	Results	0	None
110966	110967	provide	0	None
110967	110968	the	0	None
110968	110969	first	0	None
110969	110970	experimental	0	None
110970	110971	support	0	None
110971	110972	for	0	None
110972	110973	theoretical	0	None
110973	110974	models	0	None
110974	110975	that	0	None
110975	110976	posit	0	None
110976	110977	that	0	None
110977	110978	reduced	0	None
110978	110979	amplitude	0	None
110979	110980	of	0	None
110980	110981	the	0	None
110981	110982	P300	1	GENE-Y
110982	110983	during	0	None
110983	110984	response	0	None
110984	110985	inhibition	0	None
110985	110986	is	0	None
110986	110987	associated	0	None
110987	110988	with	0	None
110988	110989	alcohol-seeking	0	None
110989	110990	behaviour	0	None
110990	110991	in	0	None
110991	110992	humans	0	None
110992	110993	.	0	None
110993	110994	Maturation	0	None
110994	110995	of	0	None
110995	110996	neuromuscular	0	None
110996	110997	transmission	0	None
110997	110998	during	0	None
110998	110999	early	0	None
110999	111000	development	0	None
111000	111001	in	0	None
111001	111002	zebrafish	0	None
111002	111003	.	0	None
111003	111004	Male	0	None
111004	111005	and	0	None
111005	111006	female	0	None
111006	111007	Sprague-Dawley	0	None
111007	111008	rats	0	None
111008	111009	were	0	None
111009	111010	administered	0	None
111010	111011	quinpirole	0	None
111011	111012	(	0	None
111012	111013	1	0	None
111013	111014	mg	2	CHEMICAL
111014	111015	/	0	None
111015	111016	kg	0	None
111016	111017	,	0	None
111017	111018	i	0	None
111018	111019	.	0	None

111020	111021	p	0	None
111021	111022	.	0	None

111023	111024	)	0	None
111024	111025	or	0	None
111025	111026	saline	0	None
111026	111027	once	0	None
111027	111028	daily	0	None
111028	111029	from	0	None
111029	111030	postnatal	0	None
111030	111031	day	0	None
111031	111032	(	0	None
111032	111033	P	0	None
111033	111034	)	0	None
111034	111035	1	0	None
111035	111036	to	0	None
111036	111037	P21	0	None
111037	111038	.	0	None

111039	111040	This	0	None
111040	111041	drug	0	None
111041	111042	treatment	0	None
111042	111043	has	0	None
111043	111044	been	0	None
111044	111045	shown	0	None
111045	111046	to	0	None
111046	111047	produce	0	None
111047	111048	long-term	0	None
111048	111049	priming	0	None
111049	111050	of	0	None
111050	111051	the	0	None
111051	111052	D2	0	None
111052	111053	receptor	0	None
111053	111054	.	0	None

111055	111056	Beginning	0	None
111056	111057	on	0	None
111057	111058	P62	0	None
111058	111059	,	0	None
111059	111060	rats	0	None
111060	111061	were	0	None
111061	111062	administered	0	None
111062	111063	the	0	None
111063	111064	atypical	0	None
111064	111065	antipsychotic	0	None
111065	111066	olanzapine	0	None
111066	111067	(	0	None
111067	111068	2	0	None
111068	111069	.	0	None
111069	111070	5	0	None
111070	111071	mg	2	CHEMICAL
111071	111072	/	0	None
111072	111073	kg	0	None
111073	111074	)	0	None
111074	111075	or	0	None
111075	111076	saline	0	None
111076	111077	twice	0	None
111077	111078	daily	0	None
111078	111079	(	0	None
111079	111080	i	0	None
111080	111081	.	0	None

111082	111083	p	0	None
111083	111084	.	0	None

111085	111086	)	0	None
111086	111087	for	0	None
111087	111088	28	0	None
111088	111089	days	0	None
111089	111090	.	0	None

111091	111092	One	0	None
111092	111093	day	0	None
111093	111094	after	0	None
111094	111095	olanzapine	0	None
111095	111096	treatment	0	None
111096	111097	ceased	0	None
111097	111098	,	0	None
111098	111099	rats	0	None
111099	111100	were	0	None
111100	111101	tested	0	None
111101	111102	on	0	None
111102	111103	the	0	None
111103	111104	place	0	None
111104	111105	and	0	None
111105	111106	match-to-place	0	None
111106	111107	versions	0	None
111107	111108	of	0	None
111108	111109	the	0	None
111109	111110	Morris	0	None
111110	111111	water	0	None
111111	111112	maze	0	None
111112	111113	(	0	None
111113	111114	MWM	0	None
111114	111115	)	0	None
111115	111116	for	0	None
111116	111117	seven	0	None
111117	111118	consecutive	0	None
111118	111119	days	0	None
111119	111120	.	0	None

111121	111122	Dopamine	0	None
111122	111123	D2	0	None
111123	111124	receptor	0	None
111124	111125	priming	0	None
111125	111126	was	0	None
111126	111127	verified	0	None
111127	111128	through	0	None
111128	111129	a	0	None
111129	111130	yawning	0	None
111130	111131	behavioural	0	None
111131	111132	test	0	None
111132	111133	,	0	None
111133	111134	a	0	None
111134	111135	D2	0	None
111135	111136	receptor-mediated	0	None
111136	111137	event	0	None
111137	111138	,	0	None
111138	111139	before	0	None
111139	111140	olanzapine	0	None
111140	111141	was	0	None
111141	111142	administered	0	None
111142	111143	as	0	None
111143	111144	well	0	None
111144	111145	as	0	None
111145	111146	after	0	None
111146	111147	olanzapine	0	None
111147	111148	treatment	0	None
111148	111149	and	0	None
111149	111150	behavioural	0	None
111150	111151	testing	0	None
111151	111152	were	0	None
111152	111153	complete	0	None
111153	111154	.	0	None

111155	111156	Results	0	None
111156	111157	showed	0	None
111157	111158	that	0	None
111158	111159	neonatal	0	None
111159	111160	quinpirole	0	None
111160	111161	treatment	0	None
111161	111162	induced	0	None
111162	111163	D2	0	None
111163	111164	priming	0	None
111164	111165	that	0	None
111165	111166	was	0	None
111166	111167	eliminated	0	None
111167	111168	by	0	None
111168	111169	olanzapine	0	None
111169	111170	treatment	0	None
111170	111171	.	0	None

111172	111173	On	0	None
111173	111174	the	0	None
111174	111175	MWM	0	None
111175	111176	place	0	None
111176	111177	version	0	None
111177	111178	,	0	None
111178	111179	D2-primed	0	None
111179	111180	rats	0	None
111180	111181	demonstrated	0	None
111181	111182	a	0	None
111182	111183	significant	0	None
111183	111184	impairment	0	None
111184	111185	that	0	None
111185	111186	was	0	None
111186	111187	eliminated	0	None
111187	111188	by	0	None
111188	111189	olanzapine	0	None
111189	111190	treatment	0	None
111190	111191	,	0	None
111191	111192	but	0	None
111192	111193	olanzapine	0	None
111193	111194	treatment	0	None
111194	111195	to	0	None
111195	111196	animals	0	None
111196	111197	neonatally	0	None
111197	111198	treated	0	None
111198	111199	with	0	None
111199	111200	saline	0	None
111200	111201	produced	0	None
111201	111202	a	0	None
111202	111203	significant	0	None
111203	111204	deficit	0	None
111204	111205	on	0	None
111205	111206	the	0	None
111206	111207	place	0	None
111207	111208	version	0	None
111208	111209	of	0	None
111209	111210	the	0	None
111210	111211	MWM	0	None
111211	111212	.	0	None

111213	111214	There	0	None
111214	111215	were	0	None
111215	111216	no	0	None
111216	111217	significant	0	None
111217	111218	deficits	0	None
111218	111219	on	0	None
111219	111220	the	0	None
111220	111221	match-to-place	0	None
111221	111222	version	0	None
111222	111223	.	0	None

111224	111225	Brain	0	None
111225	111226	tissue	0	None
111226	111227	analyses	0	None
111227	111228	revealed	0	None
111228	111229	that	0	None
111229	111230	neonatal	0	None
111230	111231	quinpirole	0	None
111231	111232	treatment	0	None
111232	111233	produced	0	None
111233	111234	a	0	None
111234	111235	significant	0	None
111235	111236	decrease	0	None
111236	111237	in	0	None
111237	111238	hippocampal	0	None
111238	111239	NGF	0	None
111239	111240	,	0	None
111240	111241	BDNF	1	GENE-Y
111241	111242	and	0	None
111242	111243	ChAT	0	None
111243	111244	that	0	None
111244	111245	was	0	None
111245	111246	eliminated	0	None
111246	111247	by	0	None
111247	111248	olanzapine	0	None
111248	111249	treatment	0	None
111249	111250	.	0	None

111251	111252	Neonatal	0	None
111252	111253	quinpirole	0	None
111253	111254	treatment	0	None
111254	111255	produced	0	None
111255	111256	a	0	None
111256	111257	significant	0	None
111257	111258	decrease	0	None
111258	111259	in	0	None
111259	111260	BDNF	1	GENE-Y
111260	111261	and	0	None
111261	111262	ChAT	0	None
111262	111263	in	0	None
111263	111264	the	0	None
111264	111265	frontal	0	None
111265	111266	cortex	0	None
111266	111267	that	0	None
111267	111268	was	0	None
111268	111269	unaffected	0	None
111269	111270	by	0	None
111270	111271	olanzapine	0	None
111271	111272	treatment	0	None
111272	111273	.	0	None

111274	111275	These	0	None
111275	111276	results	0	None
111276	111277	show	0	None
111277	111278	that	0	None
111278	111279	olanzapine	0	None
111279	111280	eliminates	0	None
111280	111281	D2	0	None
111281	111282	receptor	0	None
111282	111283	priming	0	None
111283	111284	and	0	None
111284	111285	cognitive	0	None
111285	111286	impairment	0	None
111286	111287	and	0	None
111287	111288	also	0	None
111288	111289	alleviates	0	None
111289	111290	decreases	0	None
111290	111291	in	0	None
111291	111292	neurotrophins	0	None
111292	111293	and	0	None
111293	111294	acetylcholinergic	0	None
111294	111295	markers	0	None
111295	111296	produced	0	None
111296	111297	by	0	None
111297	111298	D2	0	None
111298	111299	priming	0	None
111299	111300	in	0	None
111300	111301	the	0	None
111301	111302	hippocampus	0	None
111302	111303	.	0	None
111303	111304	Cigarette	0	None
111304	111305	smoking	0	None
111305	111306	causes	0	None
111306	111307	cellular	0	None
111307	111308	oxidative	0	None
111308	111309	stress	0	None
111309	111310	resulting	0	None
111310	111311	in	0	None
111311	111312	inflammatory	0	None
111312	111313	diseases	0	None
111313	111314	of	0	None
111314	111315	lung	0	None
111315	111316	wherein	0	None
111316	111317	transcription	0	None
111317	111318	factor	0	None
111318	111319	NF-κB	0	None
111319	111320	plays	0	None
111320	111321	an	0	None
111321	111322	important	0	None
111322	111323	role	0	None
111323	111324	.	0	None

111325	111326	It	0	None
111326	111327	is	0	None
111327	111328	possible	0	None
111328	111329	that	0	None
111329	111331	vitamin C	2	CHEMICAL
111331	111332	,	0	None
111332	111333	an	0	None
111333	111334	antioxidant	0	None
111334	111335	,	0	None
111335	111336	may	0	None
111336	111337	prevent	0	None
111337	111338	cigarette	0	None
111338	111339	smoke	0	None
111339	111340	(	0	None
111340	111341	CS	0	None
111341	111342	)	0	None
111342	111343	-induced	0	None
111343	111344	NF-κB	0	None
111344	111345	activation	0	None
111345	111346	that	0	None
111346	111347	involves	0	None
111347	111348	degradation	0	None
111348	111349	of	0	None
111349	111350	I-κBε	0	None
111350	111351	and	0	None
111351	111352	nuclear	0	None
111352	111353	translocation	0	None
111353	111354	of	0	None
111354	111355	c-Rel	0	None
111355	111356	/	0	None
111356	111357	p50	0	None
111357	111358	in	0	None
111358	111359	alveolar	0	None
111359	111360	epithelial	0	None
111360	111361	cells	0	None
111361	111362	.	0	None

111363	111364	Therefore	0	None
111364	111365	,	0	None
111365	111366	to	0	None
111366	111367	examine	0	None
111367	111368	the	0	None
111368	111369	hypothesis	0	None
111369	111370	,	0	None
111370	111371	we	0	None
111371	111372	verified	0	None
111372	111373	the	0	None
111373	111374	effect	0	None
111374	111375	of	0	None
111375	111377	vitamin C	2	CHEMICAL
111377	111378	on	0	None
111378	111379	CS-induced	0	None
111379	111380	expression	0	None
111380	111381	of	0	None
111381	111382	NF-κB	0	None
111382	111383	driven	0	None
111383	111384	luciferase	0	None
111384	111385	reporter	0	None
111385	111386	and	0	None
111386	111387	NF-κB	0	None
111387	111388	binding	0	None
111388	111389	at	0	None
111389	111390	its	0	None
111390	111391	target	0	None
111391	111392	DNA	0	None
111392	111393	by	0	None
111393	111394	EMSA	0	None
111394	111395	in	0	None
111395	111396	alveolar	0	None
111396	111397	epithelial	0	None
111397	111398	A549	0	None
111398	111399	cells	0	None
111399	111400	.	0	None

111401	111402	We	0	None
111402	111403	also	0	None
111403	111404	examined	0	None
111404	111405	the	0	None
111405	111406	level	0	None
111406	111407	of	0	None
111407	111408	I-κBε	0	None
111408	111409	and	0	None
111409	111410	sub-cellular	0	None
111410	111411	distribution	0	None
111411	111412	of	0	None
111412	111413	c-Rel	0	None
111413	111414	by	0	None
111414	111415	western	0	None
111415	111416	blotting	0	None
111416	111417	and	0	None
111417	111418	immunofluorescence	0	None
111418	111419	respectively	0	None
111419	111420	in	0	None
111420	111421	CSE-treated	0	None
111421	111422	A549	0	None
111422	111423	cells	0	None
111423	111424	with	0	None
111424	111425	or	0	None
111425	111426	without	0	None
111426	111427	vitamin	0	None
111427	111428	C	0	None
111428	111429	pretreatment	0	None
111429	111430	.	0	None

111431	111432	We	0	None
111432	111433	observed	0	None
111433	111434	a	0	None
111434	111435	significant	0	None
111435	111436	reduction	0	None
111436	111437	in	0	None
111437	111438	CSE	0	None
111438	111439	induced	0	None
111439	111440	luciferase	0	None
111440	111441	expression	0	None
111441	111442	,	0	None
111442	111443	NF-κB	0	None
111443	111444	DNA	0	None
111444	111445	binding	0	None
111445	111446	,	0	None
111446	111447	I-κBε	0	None
111447	111448	degradation	0	None
111448	111449	and	0	None
111449	111450	c-Rel	0	None
111450	111451	nuclear	0	None
111451	111452	translocation	0	None
111452	111453	in	0	None
111453	111454	cells	0	None
111454	111455	pretreated	0	None
111455	111456	with	0	None
111456	111458	vitamin C	2	CHEMICAL
111458	111459	.	0	None

111460	111461	To	0	None
111461	111462	further	0	None
111462	111463	validate	0	None
111463	111464	the	0	None
111464	111465	result	0	None
111465	111466	,	0	None
111466	111467	we	0	None
111467	111468	examined	0	None
111468	111469	sub-cellular	0	None
111469	111470	distribution	0	None
111470	111471	of	0	None
111471	111472	c-Rel	0	None
111472	111473	in	0	None
111473	111474	lungs	0	None
111474	111475	of	0	None
111475	111476	CS-exposed	0	None
111476	111477	guinea	0	None
111477	111478	pigs	0	None
111478	111479	treated	0	None
111479	111480	or	0	None
111480	111481	untreated	0	None
111481	111482	with	0	None
111482	111484	vitamin C	2	CHEMICAL
111484	111485	.	0	None

111486	111487	Result	0	None
111487	111488	showed	0	None
111488	111489	that	0	None
111489	111491	vitamin C	2	CHEMICAL
111491	111492	treatment	0	None
111492	111493	resulted	0	None
111493	111494	in	0	None
111494	111495	markedly	0	None
111495	111496	reduced	0	None
111496	111497	c-Rel	0	None
111497	111498	nuclear	0	None
111498	111499	translocation	0	None
111499	111500	.	0	None

111501	111502	All	0	None
111502	111503	these	0	None
111503	111504	results	0	None
111504	111505	demonstrate	0	None
111505	111506	that	0	None
111506	111508	vitamin C	2	CHEMICAL
111508	111509	prevents	0	None
111509	111510	CS	0	None
111510	111511	(	0	None
111511	111512	E	0	None
111512	111513	)	0	None
111513	111514	-induced	0	None
111514	111515	NF-κB	0	None
111515	111516	activation	0	None
111516	111517	and	0	None
111517	111518	thus	0	None
111518	111519	it	0	None
111519	111520	could	0	None
111520	111521	be	0	None
111521	111522	used	0	None
111522	111523	for	0	None
111523	111524	the	0	None
111524	111525	prevention	0	None
111525	111526	of	0	None
111526	111527	CS-induced	0	None
111527	111528	inflammatory	0	None
111528	111529	diseases	0	None
111529	111530	.	0	None
111530	111531	Phillyrin	0	None
111531	111532	attenuates	0	None
111532	111533	high	0	None
111533	111534	glucose-induced	0	None
111534	111535	lipid	0	None
111535	111536	accumulation	0	None
111536	111537	in	0	None
111537	111538	human	0	None
111538	111539	HepG2	0	None
111539	111540	hepatocytes	0	None
111540	111541	through	0	None
111541	111542	the	0	None
111542	111543	activation	0	None
111543	111544	of	0	None
111544	111545	LKB1	0	None
111545	111546	/	0	None
111546	111547	AMP-activated	0	None
111547	111548	protein	0	None
111548	111549	kinase-dependent	0	None
111549	111550	signalling	0	None
111550	111551	.	0	None
111551	111552	[	0	None
111552	111553	Heteologous	0	None
111553	111554	expression	0	None
111554	111555	of	0	None
111555	111556	Mortierella	0	None
111556	111557	isabellina	0	None
111557	111558	delta6	0	None
111558	111559	-fatty	0	None
111559	111560	acid	0	None
111560	111561	desaturase	0	None
111561	111562	gene	0	None
111562	111563	in	0	None
111563	111564	soybean	0	None
111564	111565	]	0	None
111565	111566	.	0	None
111566	111567	Carbonic	0	None
111567	111568	anhydrase	0	None
111568	111569	inhibitors	0	None
111569	111570	.	0	None

111571	111572	Inhibition	0	None
111572	111573	of	0	None
111573	111574	mammalian	0	None
111574	111575	isoforms	0	None
111575	111576	I-XIV	0	None
111576	111577	with	0	None
111577	111578	a	0	None
111578	111579	series	0	None
111579	111580	of	0	None
111580	111581	natural	0	None
111581	111582	product	0	None
111582	111583	polyphenols	0	None
111583	111584	and	0	None
111584	111585	phenolic	0	None
111585	111586	acids	0	None
111586	111587	.	0	None
111587	111588	The	0	None
111588	111589	increased	0	None
111589	111590	number	0	None
111590	111591	of	0	None
111591	111592	Leydig	0	None
111592	111593	cells	0	None
111593	111594	by	0	None
111594	111595	di	0	None
111595	111596	(	0	None
111596	111597	2-ethylhexyl	0	None
111597	111598	)	0	None
111598	111599	phthalate	0	None
111599	111600	comes	0	None
111600	111601	from	0	None
111601	111602	the	0	None
111602	111603	differentiation	0	None
111603	111604	of	0	None
111604	111605	stem	0	None
111605	111606	cells	0	None
111606	111607	into	0	None
111607	111608	Leydig	0	None
111608	111609	cell	0	None
111609	111610	lineage	0	None
111610	111611	in	0	None
111611	111612	the	0	None
111612	111613	adult	0	None
111613	111614	rat	0	None
111614	111615	testis	0	None
111615	111616	.	0	None
111616	111617	Development	0	None
111617	111618	of	0	None
111618	111619	hypoxia-inducible	0	None
111619	111620	factor	0	None
111620	111621	(	0	None
111621	111622	HIF	0	None
111622	111623	)	0	None
111623	111624	-1α	0	None
111624	111625	inhibitors	0	None
111625	111626	:	0	None
111626	111627	effect	0	None
111627	111628	of	0	None
111628	111629	ortho-carborane	0	None
111629	111630	substituents	0	None
111630	111631	on	0	None
111631	111632	HIF	0	None
111632	111633	transcriptional	0	None
111633	111634	activity	0	None
111634	111635	under	0	None
111635	111636	hypoxia	0	None
111636	111637	.	0	None
111637	111638	Effects	0	None
111638	111639	of	0	None
111639	111640	labor	0	None
111640	111641	and	0	None
111641	111642	delivery	0	None
111642	111643	on	0	None
111643	111644	fibrinolysis	0	None
111644	111645	.	0	None
111645	111646	Blockade	0	None
111646	111647	of	0	None
111647	111648	LTC4	0	None
111648	111649	synthesis	0	None
111649	111650	caused	0	None
111650	111651	by	0	None
111651	111652	additive	0	None
111652	111653	inhibition	0	None
111653	111654	of	0	None
111654	111655	gIV-PLA2	0	None
111655	111656	phosphorylation	0	None
111656	111657	:	0	None
111657	111658	Effect	0	None
111658	111659	of	0	None
111659	111660	salmeterol	0	None
111660	111661	and	0	None
111661	111662	PDE4	0	None
111662	111663	inhibition	0	None
111663	111664	in	0	None
111664	111665	human	0	None
111665	111666	eosinophils	0	None
111666	111667	.	0	None
111667	111668	To	0	None
111668	111669	evaluate	0	None
111669	111670	the	0	None
111670	111671	cytokine	0	None
111671	111672	balance	0	None
111672	111673	and	0	None
111673	111674	enzymatic	0	None
111674	111675	alterations	0	None
111675	111676	induced	0	None
111676	111677	by	0	None
111677	111678	environmental	0	None
111678	111679	pesticide	0	None
111679	111680	exposure	0	None
111680	111681	during	0	None
111681	111682	pregnancy	0	None
111682	111683	,	0	None
111683	111684	this	0	None
111684	111685	transversal	0	None
111685	111686	study	0	None
111686	111687	explored	0	None
111687	111688	placentas	0	None
111688	111689	derived	0	None
111689	111690	from	0	None
111690	111691	non-exposed	0	None
111691	111692	women	0	None
111692	111693	(	0	None
111693	111694	control	0	None
111694	111695	group-CG	0	None
111695	111696	)	0	None
111696	111697	,	0	None
111697	111698	and	0	None
111698	111699	from	0	None
111699	111700	women	0	None
111700	111701	living	0	None
111701	111702	in	0	None
111702	111703	a	0	None
111703	111704	rural	0	None
111704	111705	area	0	None
111705	111706	(	0	None
111706	111707	rural	0	None
111707	111708	group-RG	0	None
111708	111709	)	0	None
111709	111710	,	0	None
111710	111711	collected	0	None
111711	111712	during	0	None
111712	111713	intensive	0	None
111713	111714	organophosphate	2	CHEMICAL
111714	111715	(	0	None
111715	111716	OP	0	None
111716	111717	)	0	None
111717	111718	pesticide	0	None
111718	111719	spraying	0	None
111719	111720	season	0	None
111720	111721	(	0	None
111721	111722	RG-SS	0	None
111722	111723	)	0	None
111723	111724	and	0	None
111724	111725	during	0	None
111725	111726	non-spraying	0	None
111726	111727	season	0	None
111727	111728	(	0	None
111728	111729	RG-NSS	0	None
111729	111730	)	0	None
111730	111731	.	0	None

111732	111733	The	0	None
111733	111734	exposure	0	None
111734	111735	biomarkers	0	None
111735	111736	blood	0	None
111736	111737	cholinesterase	1	GENE-Y
111737	111738	and	0	None
111738	111739	placental	0	None
111739	111740	carboxylesterase	3	GENE-N
111740	111741	(	0	None
111741	111742	CaE	0	None
111742	111743	)	0	None
111743	111744	were	0	None
111744	111745	significantly	0	None
111745	111746	decreased	0	None
111746	111747	in	0	None
111747	111748	RG-SS	0	None
111748	111749	.	0	None

111750	111751	Among	0	None
111751	111752	the	0	None
111752	111753	cytokines	3	GENE-N
111753	111754	studied	0	None
111754	111755	IL-8	1	GENE-Y
111755	111756	,	0	None
111756	111757	IL-6	0	None
111757	111758	,	0	None
111758	111759	TNFα	0	None
111759	111760	,	0	None
111760	111761	IL-10	0	None
111761	111762	,	0	None
111762	111763	TGFβ	0	None
111763	111764	and	0	None
111764	111765	IL-13	0	None
111765	111766	,	0	None
111766	111767	the	0	None
111767	111768	expression	0	None
111768	111769	frequency	0	None
111769	111770	of	0	None
111770	111771	IL-13	0	None
111771	111772	increased	0	None
111772	111773	in	0	None
111773	111774	RG-SS	0	None
111774	111775	.	0	None

111776	111777	Arginase	0	None
111777	111778	and	0	None
111778	111779	ornithine	2	CHEMICAL
111779	111780	decarboxylase	0	None
111780	111781	(	0	None
111781	111782	ODC	1	GENE-Y
111782	111783	)	0	None
111783	111784	enzymes	0	None
111784	111785	were	0	None
111785	111786	induced	0	None
111786	111787	in	0	None
111787	111788	syncytiotrophoblast	0	None
111788	111789	and	0	None
111789	111790	endothelial	0	None
111790	111791	cells	0	None
111791	111792	.	0	None

111793	111794	Interestingly	0	None
111794	111795	,	0	None
111795	111796	the	0	None
111796	111797	decrease	0	None
111797	111798	in	0	None
111798	111799	CaE	0	None
111799	111800	activity	0	None
111800	111801	was	0	None
111801	111802	associated	0	None
111802	111803	with	0	None
111803	111804	arginase	0	None
111804	111805	and	0	None
111805	111806	ODC	1	GENE-Y
111806	111807	activity	0	None
111807	111808	induction	0	None
111808	111809	.	0	None

111810	111811	These	0	None
111811	111812	findings	0	None
111812	111813	suggest	0	None
111813	111814	that	0	None
111814	111815	environmental	0	None
111815	111816	pesticide	0	None
111816	111817	exposure	0	None
111817	111818	impacts	0	None
111818	111819	the	0	None
111819	111820	placenta	0	None
111820	111821	by	0	None
111821	111822	increasing	0	None
111822	111823	the	0	None
111823	111824	expression	0	None
111824	111825	frequency	0	None
111825	111826	of	0	None
111826	111827	the	0	None
111827	111828	anti-inflammatory	0	None
111828	111829	cytokine	0	None
111829	111830	IL-13	0	None
111830	111831	,	0	None
111831	111832	which	0	None
111832	111833	may	0	None
111833	111834	be	0	None
111834	111835	related	0	None
111835	111836	to	0	None
111836	111837	the	0	None
111837	111838	up-regulation	0	None
111838	111839	of	0	None
111839	111840	enzymes	0	None
111840	111841	implicated	0	None
111841	111842	in	0	None
111842	111843	tissue	0	None
111843	111844	repair	0	None
111844	111845	.	0	None
111845	111846	3D	0	None
111846	111847	ligand-based	0	None
111847	111848	virtual	0	None
111848	111849	screening	0	None
111849	111850	was	0	None
111850	111851	employed	0	None
111851	111852	to	0	None
111852	111853	identify	0	None
111853	111854	novel	0	None
111854	111855	scaffolds	0	None
111855	111856	for	0	None
111856	111857	cannabinoid	2	CHEMICAL
111857	111858	receptor	0	None
111858	111859	ligand	0	None
111859	111860	development	0	None
111860	111861	.	0	None

111862	111863	A	0	None
111863	111864	total	0	None
111864	111865	of	0	None
111865	111866	112	0	None
111866	111867	compounds	0	None
111867	111868	with	0	None
111868	111869	diverse	0	None
111869	111870	structures	0	None
111870	111871	were	0	None
111871	111872	purchased	0	None
111872	111873	from	0	None
111873	111874	commercial	0	None
111874	111875	vendors	0	None
111875	111876	.	0	None

111877	111878	12	0	None
111878	111879	CB1	0	None
111879	111880	receptor	0	None
111880	111881	antagonists	0	None
111881	111882	/	0	None
111882	111883	inverse	0	None
111883	111884	agonists	0	None
111884	111885	and	0	None
111885	111886	10	0	None
111886	111887	CB2	0	None
111887	111888	receptor	0	None
111888	111889	agonists	0	None
111889	111890	were	0	None
111890	111891	identified	0	None
111891	111892	in	0	None
111892	111893	vitro	0	None
111893	111894	.	0	None

111895	111896	One	0	None
111896	111897	of	0	None
111897	111898	the	0	None
111898	111899	CB2	0	None
111899	111900	agonists	0	None
111900	111901	,	0	None
111901	111902	N-cyclopentyl-4-ethoxy-6-	0	None
111902	111903	(	0	None
111903	111904	4-methylpiperidin-1-yl	0	None
111904	111905	)	0	None
111905	111906	-1	0	None
111906	111907	,	0	None
111907	111908	3	0	None
111908	111909	,	0	None
111909	111910	5-triazin-2-amine	0	None
111910	111911	(	0	None
111911	111912	19	0	None
111912	111913	,	0	None
111913	111914	-logEC	0	None
111914	111915	(	0	None
111915	111916	50	0	None
111916	111917	)	0	None
111917	111918	=	0	None
111918	111919	7	0	None
111919	111920	.	0	None
111920	111921	5	0	None
111921	111922	,	0	None
111922	111923	E	0	None
111923	111924	(	0	None
111924	111925	max	0	None
111925	111926	)	0	None
111926	111927	=	0	None
111927	111928	255%	0	None
111928	111929	)	0	None
111929	111930	was	0	None
111930	111931	selected	0	None
111931	111932	for	0	None
111932	111933	further	0	None
111933	111934	development	0	None
111934	111935	.	0	None

111936	111937	As	0	None
111937	111938	far	0	None
111938	111939	as	0	None
111939	111940	we	0	None
111940	111941	are	0	None
111941	111942	aware	0	None
111942	111943	,	0	None
111943	111944	the	0	None
111944	111945	compound's	0	None
111945	111946	1	0	None
111946	111947	,	0	None
111947	111948	3	0	None
111948	111949	,	0	None
111949	111950	5-triazine	0	None
111950	111951	scaffold	0	None
111951	111952	represents	0	None
111952	111953	a	0	None
111953	111954	new	0	None
111954	111955	core	0	None
111955	111956	structure	0	None
111956	111957	for	0	None
111957	111958	CB2	0	None
111958	111959	agonists	0	None
111959	111960	.	0	None

111961	111962	A	0	None
111962	111963	library	0	None
111963	111964	of	0	None
111964	111965	fifty-seven	0	None
111965	111966	2	0	None
111966	111967	,	0	None
111967	111968	4	0	None
111968	111969	,	0	None
111969	111970	6-trisubstituted-1	0	None
111970	111971	,	0	None
111971	111972	3	0	None
111972	111973	,	0	None
111973	111974	5-triazines	0	None
111974	111975	was	0	None
111975	111976	created	0	None
111976	111977	to	0	None
111977	111978	clarify	0	None
111978	111979	the	0	None
111979	111980	structure-activity	0	None
111980	111981	relationship	0	None
111981	111982	study	0	None
111982	111983	of	0	None
111983	111984	the	0	None
111984	111985	analogs	0	None
111985	111986	.	0	None
111986	111987	We	0	None
111987	111988	have	0	None
111988	111989	previously	0	None
111989	111990	reported	0	None
111990	111991	that	0	None
111991	111992	NADPH	0	None
111992	111993	oxidase	0	None
111993	111994	2	0	None
111994	111995	(	0	None
111995	111996	Nox2	0	None
111996	111997	)	0	None
111997	111998	is	0	None
111998	111999	up-regulated	0	None
111999	112000	in	0	None
112000	112001	spinal	0	None
112001	112002	cord	0	None
112002	112003	microglia	0	None
112003	112004	after	0	None
112004	112005	spinal	0	None
112005	112006	nerve	0	None
112006	112007	injury	0	None
112007	112008	,	0	None
112008	112009	demonstrating	0	None
112009	112010	that	0	None
112010	112011	it	0	None
112011	112012	is	0	None
112012	112013	critical	0	None
112013	112014	for	0	None
112014	112015	microglia	0	None
112015	112016	activation	0	None
112016	112017	and	0	None
112017	112018	subsequent	0	None
112018	112019	pain	0	None
112019	112020	hypersensitivity	0	None
112020	112021	.	0	None

112022	112023	However	0	None
112023	112024	,	0	None
112024	112025	the	0	None
112025	112026	mechanisms	0	None
112026	112027	and	0	None
112027	112028	molecules	0	None
112028	112029	involved	0	None
112029	112030	in	0	None
112030	112031	Nox2	0	None
112031	112032	induction	0	None
112032	112033	have	0	None
112033	112034	not	0	None
112034	112035	been	0	None
112035	112036	elucidated	0	None
112036	112037	.	0	None

112038	112039	Previous	0	None
112039	112040	studies	0	None
112040	112041	have	0	None
112041	112042	shown	0	None
112042	112043	that	0	None
112043	112044	Toll-like	0	None
112044	112045	receptors	0	None
112045	112046	(	0	None
112046	112047	TLRs	0	None
112047	112048	)	0	None
112048	112049	are	0	None
112049	112050	involved	0	None
112050	112051	in	0	None
112051	112052	nerve	0	None
112052	112053	injury-induced	0	None
112053	112054	spinal	0	None
112054	112055	cord	0	None
112055	112056	microglia	0	None
112056	112057	activation	0	None
112057	112058	.	0	None

112059	112060	In	0	None
112060	112061	this	0	None
112061	112062	study	0	None
112062	112063	,	0	None
112063	112064	we	0	None
112064	112065	investigated	0	None
112065	112066	the	0	None
112066	112067	role	0	None
112067	112068	of	0	None
112068	112069	TLR	0	None
112069	112070	in	0	None
112070	112071	Nox2	0	None
112071	112072	expression	0	None
112072	112073	in	0	None
112073	112074	spinal	0	None
112074	112075	cord	0	None
112075	112076	microglia	0	None
112076	112077	after	0	None
112077	112078	peripheral	0	None
112078	112079	nerve	0	None
112079	112080	injury	0	None
112080	112081	.	0	None

112082	112083	Studies	0	None
112083	112084	using	0	None
112084	112085	TLR	0	None
112085	112086	knock-out	0	None
112086	112087	mice	0	None
112087	112088	have	0	None
112088	112089	shown	0	None
112089	112090	that	0	None
112090	112091	nerve	0	None
112091	112092	injury-induced	0	None
112092	112093	microglial	0	None
112093	112094	Nox2	0	None
112094	112095	up-regulation	0	None
112095	112096	is	0	None
112096	112097	abrogated	0	None
112097	112098	in	0	None
112098	112099	TLR2	0	None
112099	112100	but	0	None
112100	112101	not	0	None
112101	112102	in	0	None
112102	112103	TLR3	0	None
112103	112104	or	0	None
112104	112105	-4	0	None
112105	112106	knock-out	0	None
112106	112107	mice	0	None
112107	112108	.	0	None

112109	112110	Intrathecal	0	None
112110	112111	injection	0	None
112111	112112	of	0	None
112112	112113	lipoteichoic	0	None
112113	112114	acid	0	None
112114	112115	,	0	None
112115	112116	a	0	None
112116	112117	TLR2	0	None
112117	112118	agonist	0	None
112118	112119	,	0	None
112119	112120	induced	0	None
112120	112121	Nox2	0	None
112121	112122	expression	0	None
112122	112123	in	0	None
112123	112124	spinal	0	None
112124	112125	cord	0	None
112125	112126	microglia	0	None
112126	112127	both	0	None
112127	112128	at	0	None
112128	112129	the	0	None
112129	112130	mRNA	0	None
112130	112131	and	0	None
112131	112132	protein	0	None
112132	112133	levels	0	None
112133	112134	.	0	None

112135	112136	Similarly	0	None
112136	112137	,	0	None
112137	112138	lipoteichoic	0	None
112138	112139	acid	0	None
112139	112140	stimulation	0	None
112140	112141	induced	0	None
112141	112142	Nox2	0	None
112142	112143	expression	0	None
112143	112144	and	0	None
112144	112145	reactive	0	None
112145	112146	oxygen	0	None
112146	112147	species	0	None
112147	112148	production	0	None
112148	112149	in	0	None
112149	112150	primary	0	None
112150	112151	spinal	0	None
112151	112152	cord	0	None
112152	112153	glial	0	None
112153	112154	cells	0	None
112154	112155	in	0	None
112155	112156	vitro	0	None
112156	112157	.	0	None

112158	112159	Studies	0	None
112159	112160	on	0	None
112160	112161	intracellular	0	None
112161	112162	signaling	0	None
112162	112163	pathways	0	None
112163	112164	indicate	0	None
112164	112165	that	0	None
112165	112166	NF-κB	0	None
112166	112167	and	0	None
112167	112168	p38	0	None
112168	112169	MAP	0	None
112169	112170	kinase	0	None
112170	112171	activation	0	None
112171	112172	is	0	None
112172	112173	required	0	None
112173	112174	for	0	None
112174	112175	TLR2-induced	0	None
112175	112176	Nox2	0	None
112176	112177	expression	0	None
112177	112178	in	0	None
112178	112179	glial	0	None
112179	112180	cells	0	None
112180	112181	.	0	None

112182	112183	Conclusively	0	None
112183	112184	,	0	None
112184	112185	our	0	None
112185	112186	data	0	None
112186	112187	show	0	None
112187	112188	that	0	None
112188	112189	TLR2	0	None
112189	112190	mediates	0	None
112190	112191	nerve	0	None
112191	112192	injury-induced	0	None
112192	112193	Nox2	0	None
112193	112194	gene	0	None
112194	112195	expression	0	None
112195	112196	in	0	None
112196	112197	spinal	0	None
112197	112198	cord	0	None
112198	112199	microglia	0	None
112199	112200	via	0	None
112200	112201	NF-κB	0	None
112201	112202	and	0	None
112202	112203	p38	0	None
112203	112204	activation	0	None
112204	112205	and	0	None
112205	112206	thereby	0	None
112206	112207	may	0	None
112207	112208	contribute	0	None
112208	112209	to	0	None
112209	112210	spinal	0	None
112210	112211	cord	0	None
112211	112212	microglia	0	None
112212	112213	activation	0	None
112213	112214	.	0	None
112214	112215	Substrates	0	None
112215	112216	of	0	None
112216	112217	IAP	0	None
112217	112218	ubiquitin	0	None
112218	112219	ligases	0	None
112219	112220	identified	0	None
112220	112221	with	0	None
112221	112222	a	0	None
112222	112223	designed	0	None
112223	112224	orthogonal	0	None
112224	112225	E3	0	None
112225	112226	ligase	0	None
112226	112227	,	0	None
112227	112228	the	0	None
112228	112229	NEDDylator	0	None
112229	112230	.	0	None
112230	112231	A	0	None
112231	112232	dose-ranging	0	None
112232	112233	study	0	None
112233	112234	was	0	None
112234	112235	performed	0	None
112235	112236	to	0	None
112236	112237	compare	0	None
112237	112238	the	0	None
112238	112239	beta	0	None
112239	112240	1-adrenoceptor	0	None
112240	112241	selectivity	0	None
112241	112242	of	0	None
112242	112243	bisoprolol	0	None
112243	112244	with	0	None
112244	112245	that	0	None
112245	112246	of	0	None
112246	112247	atenolol	0	None
112247	112248	and	0	None
112248	112249	nadolol	0	None
112249	112250	.	0	None

112251	112252	Seven	0	None
112252	112253	normal	0	None
112253	112254	subjects	0	None
112254	112255	(	0	None
112255	112256	mean	0	None
112256	112257	age	0	None
112257	112258	26	0	None
112258	112259	y	0	None
112259	112260	)	0	None
112260	112261	were	0	None
112261	112262	given	0	None
112262	112263	single	0	None
112263	112264	oral	0	None
112264	112265	doses	0	None
112265	112266	of	0	None
112266	112267	bisoprolol	0	None
112267	112268	5	0	None
112268	112269	mg	2	CHEMICAL
112269	112270	(	0	None
112270	112271	B5	0	None
112271	112272	)	0	None
112272	112273	,	0	None
112273	112274	10	0	None
112274	112275	mg	2	CHEMICAL
112275	112276	(	0	None
112276	112277	B10	0	None
112277	112278	)	0	None
112278	112279	,	0	None
112279	112280	20	0	None
112280	112281	mg	2	CHEMICAL
112281	112282	(	0	None
112282	112283	B20	0	None
112283	112284	)	0	None
112284	112285	;	0	None
112285	112286	atenolol	0	None
112286	112287	50	0	None
112287	112288	mg	2	CHEMICAL
112288	112289	(	0	None
112289	112290	A50	0	None
112290	112291	)	0	None
112291	112292	,	0	None
112292	112293	100	0	None
112293	112294	mg	2	CHEMICAL
112294	112295	(	0	None
112295	112296	A100	0	None
112296	112297	)	0	None
112297	112298	;	0	None
112298	112299	nadolol	0	None
112299	112300	40	0	None
112300	112301	mg	2	CHEMICAL
112301	112302	(	0	None
112302	112303	N40	0	None
112303	112304	)	0	None
112304	112305	;	0	None
112305	112306	and	0	None
112306	112307	placebo	0	None
112307	112308	(	0	None
112308	112309	PL	0	None
112309	112310	)	0	None
112310	112311	,	0	None
112311	112312	in	0	None
112312	112313	a	0	None
112313	112314	single	0	None
112314	112315	blind	0	None
112315	112316	randomised	0	None
112316	112317	cross-over	0	None
112317	112318	design	0	None
112318	112319	.	0	None

112320	112321	Beta	0	None
112321	112322	2-adrenoceptor	0	None
112322	112323	responses	0	None
112323	112324	were	0	None
112324	112325	assessed	0	None
112325	112326	by	0	None
112326	112327	attenuation	0	None
112327	112328	of	0	None
112328	112329	finger	0	None
112329	112330	tremor	0	None
112330	112331	and	0	None
112331	112332	cardiovascular	0	None
112332	112333	responses	0	None
112333	112334	to	0	None
112334	112335	graded	0	None
112335	112336	isoprenaline	2	CHEMICAL
112336	112337	infusions	0	None
112337	112338	.	0	None

112339	112340	Dose-response	0	None
112340	112341	curves	0	None
112341	112342	were	0	None
112342	112343	constructed	0	None
112343	112344	,	0	None
112344	112345	and	0	None
112345	112346	doses	0	None
112346	112347	of	0	None
112347	112348	isoprenaline	2	CHEMICAL
112348	112349	required	0	None
112349	112350	to	0	None
112350	112351	increase	0	None
112351	112352	finger	0	None
112352	112353	tremor	0	None
112353	112354	by	0	None
112354	112355	100%	0	None
112355	112356	(	0	None
112356	112357	IT100	0	None
112357	112358	)	0	None
112358	112359	,	0	None
112359	112360	heart	0	None
112360	112361	rate	0	None
112361	112362	by	0	None
112362	112363	25	0	None
112363	112364	beats	0	None
112364	112365	/	0	None
112365	112366	min	0	None
112366	112367	(	0	None
112367	112368	IH25	0	None
112368	112369	)	0	None
112369	112370	,	0	None
112370	112371	SBP	0	None
112371	112372	by	0	None
112372	112373	25	0	None
112373	112374	mmHg	0	None
112374	112375	(	0	None
112375	112376	IS25	0	None
112376	112377	)	0	None
112377	112378	,	0	None
112378	112379	cardiac	0	None
112379	112380	output	0	None
112380	112381	by	0	None
112381	112382	35%	0	None
112382	112383	(	0	None
112383	112384	IC35	0	None
112384	112385	)	0	None
112385	112386	,	0	None
112386	112387	and	0	None
112387	112388	decrease	0	None
112388	112389	DBP	0	None
112389	112390	by	0	None
112390	112391	10	0	None
112391	112392	mmHg	0	None
112392	112393	(	0	None
112393	112394	ID10	0	None
112394	112395	)	0	None
112395	112396	,	0	None
112396	112397	after	0	None
112397	112398	each	0	None
112398	112399	treatment	0	None
112399	112400	were	0	None
112400	112401	calculated	0	None
112401	112402	.	0	None

112403	112404	These	0	None
112404	112405	indices	0	None
112405	112406	were	0	None
112406	112407	compared	0	None
112407	112408	with	0	None
112408	112409	placebo	0	None
112409	112410	response	0	None
112410	112411	and	0	None
112411	112412	expressed	0	None
112412	112413	as	0	None
112413	112414	dose-ratios	0	None
112414	112415	.	0	None

112416	112417	Exercise	0	None
112417	112418	heart	0	None
112418	112419	rate	0	None
112419	112420	(	0	None
112420	112421	EHR	0	None
112421	112422	)	0	None
112422	112423	was	0	None
112423	112424	used	0	None
112424	112425	to	0	None
112425	112426	assess	0	None
112426	112427	beta	0	None
112427	112428	1-adrenoceptor	0	None
112428	112429	blockade	0	None
112429	112430	.	0	None

112431	112432	There	0	None
112432	112433	were	0	None
112433	112434	dose-related	0	None
112434	112435	increases	0	None
112435	112436	in	0	None
112436	112437	plasma	0	None
112437	112438	concentrations	0	None
112438	112439	of	0	None
112439	112440	bisoprolol	0	None
112440	112441	and	0	None
112441	112442	atenolol	0	None
112442	112443	.	0	None

112444	112445	Reduction	0	None
112445	112446	of	0	None
112446	112447	EHR	0	None
112447	112448	was	0	None
112448	112449	significantly	0	None
112449	112450	less	0	None
112450	112451	with	0	None
112451	112452	B5	0	None
112452	112453	(	0	None
112453	112454	16	0	None
112454	112455	.	0	None
112455	112456	8%	0	None
112456	112457	)	0	None
112457	112458	in	0	None
112458	112459	comparison	0	None
112459	112460	with	0	None
112460	112461	all	0	None
112461	112462	other	0	None
112462	112463	treatments	0	None
112463	112464	:	0	None
112464	112465	B10	0	None
112465	112466	21	0	None
112466	112467	.	0	None
112467	112468	9%	0	None
112468	112469	,	0	None
112469	112470	B20	0	None
112470	112471	23	0	None
112471	112472	.	0	None
112472	112473	1%;	0	None
112473	112474	A50	0	None
112474	112475	22	0	None
112475	112476	.	0	None
112476	112477	5%	0	None
112477	112478	,	0	None
112478	112479	A100	0	None
112479	112480	22	0	None
112480	112481	.	0	None
112481	112482	6%;	0	None
112482	112483	N40	0	None
112483	112484	22	0	None
112484	112485	.	0	None
112485	112486	9%	0	None
112486	112487	.	0	None

112488	112489	There	0	None
112489	112490	were	0	None
112490	112491	small	0	None
112491	112492	but	0	None
112492	112493	significant	0	None
112493	112494	reductions	0	None
112494	112495	in	0	None
112495	112496	isoprenaline-induced	0	None
112496	112497	tachycardia	0	None
112497	112498	with	0	None
112498	112499	bisoprolol	0	None
112499	112500	and	0	None
112500	112501	atenolol	0	None
112501	112502	,	0	None
112502	112503	although	0	None
112503	112504	mean	0	None
112504	112505	dose-ratios	0	None
112505	112506	were	0	None
112506	112507	considerably	0	None
112507	112508	less	0	None
112508	112509	in	0	None
112509	112510	comparison	0	None
112510	112511	with	0	None
112511	112512	N40	0	None
112512	112513	(	0	None
112513	112514	IH25	0	None
112514	112515	dose-ratios	0	None
112515	112516	)	0	None
112516	112517	:	0	None
112517	112518	B5	0	None
112518	112519	2	0	None
112519	112520	.	0	None
112520	112521	55	0	None
112521	112522	,	0	None
112522	112523	B10	0	None
112523	112524	3	0	None
112524	112525	.	0	None
112525	112526	18	0	None
112526	112527	,	0	None
112527	112528	B20	0	None
112528	112529	3	0	None
112529	112530	.	0	None
112530	112531	93	0	None
112531	112532	,	0	None
112532	112533	A50	0	None
112533	112534	2	0	None
112534	112535	.	0	None
112535	112536	91	0	None
112536	112537	,	0	None
112537	112538	A100	0	None
112538	112539	4	0	None
112539	112540	.	0	None
112540	112541	89	0	None
112541	112542	,	0	None
112542	112543	N40	0	None
112543	112544	17	0	None
112544	112545	.	0	None
112545	112546	23	0	None
112546	112547	.	0	None

112548	112549	There	0	None
112549	112550	were	0	None
112550	112551	similar	0	None
112551	112552	patterns	0	None
112552	112553	for	0	None
112553	112554	the	0	None
112554	112555	other	0	None
112555	112556	isoprenaline	2	CHEMICAL
112556	112557	responses	0	None
112557	112558	.	0	None

112559	112560	These	0	None
112560	112561	results	0	None
112561	112562	show	0	None
112562	112563	that	0	None
112563	112564	conventional	0	None
112564	112565	doses	0	None
112565	112566	of	0	None
112566	112567	bisoprolol	0	None
112567	112568	(	0	None
112568	112569	10	0	None
112569	112570	mg	2	CHEMICAL
112570	112571	)	0	None
112571	112572	and	0	None
112572	112573	atenolol	0	None
112573	112574	(	0	None
112574	112575	50	0	None
112575	112576	mg	2	CHEMICAL
112576	112577	)	0	None
112577	112578	produced	0	None
112578	112579	equal	0	None
112579	112580	antagonism	0	None
112580	112581	of	0	None
112581	112586	beta 1 and beta 2-adrenoceptors	3	GENE-N
112586	112587	,	0	None
112587	112588	and	0	None
112588	112589	therefore	0	None
112589	112590	possess	0	None
112590	112591	equal	0	None
112591	112592	degrees	0	None
112592	112593	of	0	None
112593	112594	beta	0	None
112594	112595	1-adrenoceptor	0	None
112595	112596	selectivity	0	None
112596	112597	.	0	None

112598	112599	(	0	None
112599	112600	ABSTRACT	0	None
112600	112601	TRUNCATED	0	None
112601	112602	AT	0	None
112602	112603	250	0	None
112603	112604	WORDS	0	None
112604	112605	)	0	None
112605	112606	Hypertrophic	0	None
112606	112607	effect	0	None
112607	112608	of	0	None
112608	112609	selective	0	None
112609	112610	beta	0	None
112610	112611	(	0	None
112611	112612	1	0	None
112612	112613	)	0	None
112613	112614	-adrenoceptor	0	None
112614	112615	stimulation	0	None
112615	112616	on	0	None
112616	112617	ventricular	0	None
112617	112618	cardiomyocytes	0	None
112618	112619	from	0	None
112619	112620	adult	0	None
112620	112621	rat	0	None
112621	112622	.	0	None
112622	112623	Regulation	0	None
112623	112624	of	0	None
112624	112625	adenosine	0	None
112625	112626	levels	0	None
112626	112627	during	0	None
112627	112628	cerebral	0	None
112628	112629	ischemia	0	None
112629	112630	.	0	None
112630	112631	Cyclooxygenase	0	None
112631	112632	and	0	None
112632	112633	5-lipoxygenase	1	GENE-Y
112633	112634	inhibitors	0	None
112634	112635	protect	0	None
112635	112636	against	0	None
112636	112637	mononuclear	0	None
112637	112638	phagocyte	0	None
112638	112639	neurotoxicity	0	None
112639	112640	.	0	None
112640	112641	The	0	None
112641	112644	L-type calcium channel	3	GENE-N
112644	112645	(	0	None
112645	112646	LTCC	0	None
112646	112647	)	0	None
112647	112648	isoforms	0	None
112648	112649	Ca	0	None
112649	112650	(	0	None
112650	112651	v	0	None
112651	112652	)	0	None
112652	112653	1	0	None
112653	112654	.	0	None
112654	112655	2	0	None
112655	112656	and	0	None
112656	112657	Ca	0	None
112657	112658	(	0	None
112658	112659	v	0	None
112659	112660	)	0	None
112660	112661	1	0	None
112661	112662	.	0	None
112662	112663	3	0	None
112663	112664	display	0	None
112664	112665	similar	0	None
112665	112666	1	0	None
112666	112667	,	0	None
112667	112668	4-dihydropyridine	0	None
112668	112669	(	0	None
112669	112670	DHP	0	None
112670	112671	)	0	None
112671	112672	binding	0	None
112672	112673	properties	0	None
112673	112674	and	0	None
112674	112675	are	0	None
112675	112676	both	0	None
112676	112677	expressed	0	None
112677	112678	in	0	None
112678	112679	mammalian	0	None
112679	112680	brain	0	None
112680	112681	.	0	None

112682	112683	Recent	0	None
112683	112684	work	0	None
112684	112685	implicates	0	None
112685	112686	Ca	0	None
112686	112687	(	0	None
112687	112688	v	0	None
112688	112689	)	0	None
112689	112690	1	0	None
112690	112691	.	0	None
112691	112692	3	0	None
112692	112693	channels	0	None
112693	112694	as	0	None
112694	112695	interesting	0	None
112695	112696	drug	0	None
112696	112697	targets	0	None
112697	112698	,	0	None
112698	112699	but	0	None
112699	112700	no	0	None
112700	112701	isoform-selective	0	None
112701	112702	modulators	0	None
112702	112703	exist	0	None
112703	112704	.	0	None

112705	112706	It	0	None
112706	112707	is	0	None
112707	112708	also	0	None
112708	112709	unknown	0	None
112709	112710	to	0	None
112710	112711	what	0	None
112711	112712	extent	0	None
112712	112713	Ca	0	None
112713	112714	(	0	None
112714	112715	v	0	None
112715	112716	)	0	None
112716	112717	1	0	None
112717	112718	.	0	None
112718	112719	1	0	None
112719	112720	and	0	None
112720	112721	Ca	0	None
112721	112722	(	0	None
112722	112723	v	0	None
112723	112724	)	0	None
112724	112725	1	0	None
112725	112726	.	0	None
112726	112727	4	0	None
112727	112728	contribute	0	None
112728	112729	to	0	None
112729	112730	L-type-specific	0	None
112730	112731	DHP	0	None
112731	112732	binding	0	None
112732	112733	activity	0	None
112733	112734	in	0	None
112734	112735	brain	0	None
112735	112736	.	0	None

112737	112738	To	0	None
112738	112739	address	0	None
112739	112740	this	0	None
112740	112741	question	0	None
112741	112742	and	0	None
112742	112743	to	0	None
112743	112744	determine	0	None
112744	112745	whether	0	None
112745	112746	DHPs	0	None
112746	112747	can	0	None
112747	112748	discriminate	0	None
112748	112749	between	0	None
112749	112750	Ca	0	None
112750	112751	(	0	None
112751	112752	v	0	None
112752	112753	)	0	None
112753	112754	1	0	None
112754	112755	.	0	None
112755	112756	2	0	None
112756	112757	and	0	None
112757	112758	Ca	0	None
112758	112759	(	0	None
112759	112760	v	0	None
112760	112761	)	0	None
112761	112762	1	0	None
112762	112763	.	0	None
112763	112764	3	0	None
112764	112765	binding	0	None
112765	112766	pockets	0	None
112766	112767	,	0	None
112767	112768	we	0	None
112768	112769	combined	0	None
112769	112770	radioreceptor	0	None
112770	112771	assays	0	None
112771	112772	and	0	None
112772	112773	quantitative	0	None
112773	112774	polymerase	0	None
112774	112775	chain	0	None
112775	112776	reaction	0	None
112776	112777	(	0	None
112777	112778	qPCR	0	None
112778	112779	)	0	None
112779	112780	.	0	None

112781	112782	We	0	None
112782	112783	bred	0	None
112783	112784	double	0	None
112784	112785	mutants	0	None
112785	112786	(	0	None
112786	112787	Ca	0	None
112787	112788	(	0	None
112788	112789	v	0	None
112789	112790	)	0	None
112790	112791	-DM	0	None
112791	112792	)	0	None
112792	112793	from	0	None
112793	112794	mice	0	None
112794	112795	expressing	0	None
112795	112796	mutant	0	None
112796	112797	Ca	0	None
112797	112798	(	0	None
112798	112799	v	0	None
112799	112800	)	0	None
112800	112801	1	0	None
112801	112802	.	0	None
112802	112803	2	0	None
112803	112804	channels	0	None
112804	112805	[	0	None
112805	112806	Ca	0	None
112806	112807	(	0	None
112807	112808	v	0	None
112808	112809	)	0	None
112809	112810	1	0	None
112810	112811	.	0	None
112811	112812	2DHP	0	None
112812	112813	(	0	None
112813	112814	-	0	None
112814	112815	/	0	None
112815	112816	-	0	None
112816	112817	)	0	None
112817	112818	]	0	None
112818	112819	lacking	0	None
112819	112820	high	0	None
112820	112821	affinity	0	None
112821	112822	for	0	None
112822	112823	DHPs	0	None
112823	112824	and	0	None
112824	112825	from	0	None
112825	112826	Ca	0	None
112826	112827	(	0	None
112827	112828	v	0	None
112828	112829	)	0	None
112829	112830	1	0	None
112830	112831	.	0	None
112831	112832	3	0	None
112832	112833	knockouts	0	None
112833	112834	[	0	None
112834	112835	Ca	0	None
112835	112836	(	0	None
112836	112837	v	0	None
112837	112838	)	0	None
112838	112839	1	0	None
112839	112840	.	0	None
112840	112841	3	0	None
112841	112842	(	0	None
112842	112843	-	0	None
112843	112844	/	0	None
112844	112845	-	0	None
112845	112846	)	0	None
112846	112847	]	0	None
112847	112848	.	0	None

112849	112850	(	0	None
112850	112851	+	0	None
112851	112852	)	0	None
112852	112853	-	0	None
112853	112854	[	0	None
112854	112855	(	0	None
112855	112856	3	0	None
112856	112857	)	0	None
112857	112858	H	0	None
112858	112859	]	0	None
112859	112860	isradipine	0	None
112860	112861	binding	0	None
112861	112862	to	0	None
112862	112863	Ca	0	None
112863	112864	(	0	None
112864	112865	v	0	None
112865	112866	)	0	None
112866	112867	1	0	None
112867	112868	.	0	None
112868	112869	2DHP	0	None
112869	112870	(	0	None
112870	112871	-	0	None
112871	112872	/	0	None
112872	112873	-	0	None
112873	112874	)	0	None
112874	112875	and	0	None
112875	112876	Ca	0	None
112876	112877	(	0	None
112877	112878	v	0	None
112878	112879	)	0	None
112879	112880	-DM	0	None
112880	112881	brains	0	None
112881	112882	was	0	None
112882	112883	reduced	0	None
112883	112884	to	0	None
112884	112885	15	0	None
112885	112886	.	0	None
112886	112887	1	0	None
112887	112888	and	0	None
112888	112889	4	0	None
112889	112890	.	0	None
112890	112891	4%	0	None
112891	112892	of	0	None
112892	112893	wild	0	None
112893	112894	type	0	None
112894	112895	,	0	None
112895	112896	respectively	0	None
112896	112897	,	0	None
112897	112898	indicating	0	None
112898	112899	that	0	None
112899	112900	Ca	0	None
112900	112901	(	0	None
112901	112902	v	0	None
112902	112903	)	0	None
112903	112904	1	0	None
112904	112905	.	0	None
112905	112906	3	0	None
112906	112907	accounts	0	None
112907	112908	for	0	None
112908	112909	10	0	None
112909	112910	.	0	None
112910	112911	7%	0	None
112911	112912	of	0	None
112912	112913	brain	0	None
112913	112914	LTCCs	0	None
112914	112915	.	0	None

112916	112917	qPCR	0	None
112917	112918	revealed	0	None
112918	112919	that	0	None
112919	112920	Ca	0	None
112920	112921	(	0	None
112921	112922	v	0	None
112922	112923	)	0	None
112923	112924	1	0	None
112924	112925	.	0	None
112925	112926	1	0	None
112926	112927	and	0	None
112927	112928	Ca	0	None
112928	112929	(	0	None
112929	112930	v	0	None
112930	112931	)	0	None
112931	112932	1	0	None
112932	112933	.	0	None
112933	112934	4	0	None
112934	112935	alpha	0	None
112935	112936	(	0	None
112936	112937	1	0	None
112937	112938	)	0	None
112938	112939	subunits	0	None
112939	112940	comprised	0	None
112940	112941	0	0	None
112941	112942	.	0	None
112942	112943	08%	0	None
112943	112944	of	0	None
112944	112945	the	0	None
112945	112946	LTCC	0	None
112946	112947	transcripts	0	None
112947	112948	in	0	None
112948	112949	mouse	0	None
112949	112950	whole	0	None
112950	112951	brain	0	None
112951	112952	,	0	None
112952	112953	suggesting	0	None
112953	112954	that	0	None
112954	112955	they	0	None
112955	112956	cannot	0	None
112956	112957	account	0	None
112957	112958	for	0	None
112958	112959	the	0	None
112959	112960	residual	0	None
112960	112961	binding	0	None
112961	112962	.	0	None

112963	112964	Instead	0	None
112964	112965	,	0	None
112965	112966	this	0	None
112966	112967	could	0	None
112967	112968	be	0	None
112968	112969	explained	0	None
112969	112970	by	0	None
112970	112971	low-affinity	0	None
112971	112972	binding	0	None
112972	112973	(	0	None
112973	112974	127-fold	0	None
112974	112975	K	0	None
112975	112976	(	0	None
112976	112977	d	0	None
112977	112978	)	0	None
112978	112979	increase	0	None
112979	112980	)	0	None
112980	112981	to	0	None
112981	112982	the	0	None
112982	112983	mutated	0	None
112983	112984	Ca	0	None
112984	112985	(	0	None
112985	112986	v	0	None
112986	112987	)	0	None
112987	112988	1	0	None
112988	112989	.	0	None
112989	112990	2	0	None
112990	112991	channels	0	None
112991	112992	.	0	None

112993	112994	Inhibition	0	None
112994	112995	of	0	None
112995	112996	(	0	None
112996	112997	+	0	None
112997	112998	)	0	None
112998	112999	-	0	None
112999	113000	[	0	None
113000	113001	(	0	None
113001	113002	3	0	None
113002	113003	)	0	None
113003	113004	H	0	None
113004	113005	]	0	None
113005	113006	isradipine	0	None
113006	113007	binding	0	None
113007	113008	to	0	None
113008	113009	Ca	0	None
113009	113010	(	0	None
113010	113011	v	0	None
113011	113012	)	0	None
113012	113013	1	0	None
113013	113014	.	0	None
113014	113015	2DHP	0	None
113015	113016	(	0	None
113016	113017	-	0	None
113017	113018	/	0	None
113018	113019	-	0	None
113019	113020	)	0	None
113020	113021	(	0	None
113021	113022	predominantly	0	None
113022	113023	Ca	0	None
113023	113024	(	0	None
113024	113025	v	0	None
113025	113026	)	0	None
113026	113027	1	0	None
113027	113028	.	0	None
113028	113029	3	0	None
113029	113030	)	0	None
113030	113031	and	0	None
113031	113032	wild-type	0	None
113032	113033	(	0	None
113033	113034	predominantly	0	None
113034	113035	Ca	0	None
113035	113036	(	0	None
113036	113037	v	0	None
113037	113038	)	0	None
113038	113039	1	0	None
113039	113040	.	0	None
113040	113041	2	0	None
113041	113042	)	0	None
113042	113043	brain	0	None
113043	113044	membranes	0	None
113044	113045	by	0	None
113045	113046	unlabeled	0	None
113046	113047	DHPs	0	None
113047	113048	revealed	0	None
113048	113049	a	0	None
113049	113050	3-	0	None
113050	113051	to	0	None
113051	113052	4-fold	0	None
113052	113053	selectivity	0	None
113053	113054	of	0	None
113054	113055	nitrendipine	2	CHEMICAL
113055	113056	and	0	None
113056	113057	nifedipine	0	None
113057	113058	for	0	None
113058	113059	the	0	None
113059	113060	Ca	0	None
113060	113061	(	0	None
113061	113062	v	0	None
113062	113063	)	0	None
113063	113064	1	0	None
113064	113065	.	0	None
113065	113066	2	0	None
113066	113067	binding	0	None
113067	113068	pocket	0	None
113068	113069	,	0	None
113069	113070	a	0	None
113070	113071	finding	0	None
113071	113072	further	0	None
113072	113073	confirmed	0	None
113073	113074	with	0	None
113074	113075	heterologously	0	None
113075	113076	expressed	0	None
113076	113077	channels	0	None
113077	113078	.	0	None

113079	113080	This	0	None
113080	113081	suggests	0	None
113081	113082	that	0	None
113082	113083	small	0	None
113083	113084	differences	0	None
113084	113085	in	0	None
113085	113086	their	0	None
113086	113087	binding	0	None
113087	113088	pockets	0	None
113088	113089	may	0	None
113089	113090	allow	0	None
113090	113091	development	0	None
113091	113092	of	0	None
113092	113093	isoform-selective	0	None
113093	113094	modulators	0	None
113094	113095	for	0	None
113095	113096	LTCCs	0	None
113096	113097	and	0	None
113097	113098	that	0	None
113098	113099	,	0	None
113099	113100	because	0	None
113100	113101	of	0	None
113101	113102	their	0	None
113102	113103	very	0	None
113103	113104	low	0	None
113104	113105	expression	0	None
113105	113106	,	0	None
113106	113107	Ca	0	None
113107	113108	(	0	None
113108	113109	v	0	None
113109	113110	)	0	None
113110	113111	1	0	None
113111	113112	.	0	None
113112	113113	1	0	None
113113	113114	and	0	None
113114	113115	Ca	0	None
113115	113116	(	0	None
113116	113117	v	0	None
113117	113118	)	0	None
113118	113119	1	0	None
113119	113120	.	0	None
113120	113121	4	0	None
113121	113122	are	0	None
113122	113123	unlikely	0	None
113123	113124	to	0	None
113124	113125	serve	0	None
113125	113126	as	0	None
113126	113127	drug	0	None
113127	113128	targets	0	None
113128	113129	to	0	None
113129	113130	treat	0	None
113130	113131	CNS	0	None
113131	113132	diseases	0	None
113132	113133	.	0	None
113133	113134	PURPOSE	0	None
113134	113135	:	0	None
113135	113136	To	0	None
113136	113137	determine	0	None
113137	113138	whether	0	None
113138	113139	the	0	None
113139	113140	temperature-sensitive	0	None
113140	113141	rat	0	None
113141	113142	retinal	2	CHEMICAL
113142	113143	pigment	0	None
113143	113144	epithelial	0	None
113144	113145	cell	0	None
113145	113146	line	0	None
113146	113147	(	0	None
113147	113148	RPE-J	0	None
113148	113149	)	0	None
113149	113150	express	0	None
113150	113151	mRNA	0	None
113151	113152	transcripts	0	None
113152	113153	for	0	None
113153	113154	apolipoprotein	0	None
113154	113155	(	0	None
113155	113156	apo	3	GENE-N
113156	113157	)	0	None
113157	113158	and	0	None
113158	113159	microsomal	0	None
113159	113160	triglyceride	0	None
113160	113161	transfer	0	None
113161	113162	protein	0	None
113162	113163	(	0	None
113163	113164	MTP	0	None
113164	113165	)	0	None
113165	113166	and	0	None
113166	113167	whether	0	None
113167	113168	it	0	None
113168	113169	can	0	None
113169	113170	synthesize	0	None
113170	113171	and	0	None
113171	113172	secrete	0	None
113172	113173	neutral	0	None
113173	113174	lipids	0	None
113174	113175	.	0	None

113176	113177	METHODS	0	None
113177	113178	:	0	None
113178	113179	RPE-J	0	None
113179	113180	cells	0	None
113180	113181	were	0	None
113181	113182	cultured	0	None
113182	113183	in	0	None
113183	113184	plastic	0	None
113184	113185	tissue	0	None
113185	113186	culture	0	None
113186	113187	flasks	0	None
113187	113188	and	0	None
113188	113189	on	0	None
113189	113190	Transwell	0	None
113190	113191	filters	0	None
113191	113192	.	0	None

113193	113194	RT-PCR	0	None
113194	113195	was	0	None
113195	113196	used	0	None
113196	113197	to	0	None
113197	113198	check	0	None
113198	113199	mRNA	0	None
113199	113200	expression	0	None
113200	113201	.	0	None

113202	113203	Phagocytosis	0	None
113203	113204	was	0	None
113204	113205	checked	0	None
113205	113206	by	0	None
113206	113207	adding	0	None
113207	113208	FITC-labeled	0	None
113208	113209	beads	0	None
113209	113210	and	0	None
113210	113211	measuring	0	None
113211	113212	the	0	None
113212	113213	intensity	0	None
113213	113214	of	0	None
113214	113215	the	0	None
113215	113216	fluorescence	0	None
113216	113217	.	0	None

113218	113219	Lipids	0	None
113219	113220	were	0	None
113220	113221	extracted	0	None
113221	113222	from	0	None
113222	113223	cultured	0	None
113223	113224	cells	0	None
113224	113225	that	0	None
113225	113226	were	0	None
113226	113227	fed	0	None
113227	113228	photoreceptor	0	None
113228	113229	outer	0	None
113229	113230	segments	0	None
113230	113231	(	0	None
113231	113232	OS	0	None
113232	113233	)	0	None
113233	113234	for	0	None
113234	113235	24h;	0	None
113235	113236	thin	0	None
113236	113237	layer	0	None
113237	113238	chromatography	0	None
113238	113239	and	0	None
113239	113240	enzymatic	0	None
113240	113241	fluorimetry	0	None
113241	113242	were	0	None
113242	113243	used	0	None
113243	113244	to	0	None
113244	113245	assay	0	None
113245	113246	lipid	0	None
113246	113247	content	0	None
113247	113248	.	0	None

113249	113250	Cells	0	None
113250	113251	were	0	None
113251	113252	supplemented	0	None
113252	113253	with	0	None
113253	113254	[	0	None
113254	113255	3H	0	None
113255	113256	]	0	None
113256	113257	-oleate	0	None
113257	113258	(	0	None
113258	113259	5000	0	None
113259	113260	dpm	0	None
113260	113261	/	0	None
113261	113262	nmole	0	None
113262	113263	)	0	None
113263	113264	bound	0	None
113264	113265	to	0	None
113265	113266	1	0	None
113266	113267	.	0	None
113267	113268	5%	0	None
113268	113270	fatty acid	2	CHEMICAL
113270	113271	free	0	None
113271	113274	bovine serum albumin	1	GENE-Y
113274	113275	in	0	None
113275	113276	order	0	None
113276	113277	to	0	None
113277	113278	permit	0	None
113278	113279	detection	0	None
113279	113280	of	0	None
113280	113281	the	0	None
113281	113282	new	0	None
113282	113283	synthesis	0	None
113283	113284	and	0	None
113284	113285	secretion	0	None
113285	113286	of	0	None
113286	113287	neutral	0	None
113287	113288	lipids	0	None
113288	113289	.	0	None

113290	113291	RESULTS	0	None
113291	113292	:	0	None
113292	113293	RPE-J	0	None
113293	113294	cells	0	None
113294	113295	express	0	None
113295	113296	mRNA	0	None
113296	113297	for	0	None
113297	113298	apoA-I	0	None
113298	113299	,	0	None
113299	113300	apoA-II	0	None
113300	113301	,	0	None
113301	113302	apoB	0	None
113302	113303	,	0	None
113303	113304	apoC-I	0	None
113304	113305	,	0	None
113305	113306	II	0	None
113306	113307	,	0	None
113307	113308	III	0	None
113308	113309	,	0	None
113309	113310	and	0	None
113310	113312	apo E	3	GENE-N
113312	113313	,	0	None
113313	113314	as	0	None
113314	113315	well	0	None
113315	113316	as	0	None
113316	113317	MTP	0	None
113317	113318	.	0	None

113319	113320	RPE-J	0	None
113320	113321	cells	0	None
113321	113322	can	0	None
113322	113323	phagocytose	0	None
113323	113324	OS	0	None
113324	113325	and	0	None
113325	113326	beads	0	None
113326	113327	.	0	None

113328	113329	OS-fed	0	None
113329	113330	RPE-J	0	None
113330	113331	cells	0	None
113331	113332	,	0	None
113332	113333	relative	0	None
113333	113334	to	0	None
113334	113335	untreated	0	None
113335	113336	cells	0	None
113336	113337	,	0	None
113337	113338	have	0	None
113338	113339	5	0	None
113339	113340	.	0	None
113340	113341	8	0	None
113341	113342	times	0	None
113342	113343	more	0	None
113343	113344	triglyceride	0	None
113344	113345	,	0	None
113345	113346	2	0	None
113346	113347	.	0	None
113347	113348	6	0	None
113348	113349	times	0	None
113349	113350	more	0	None
113350	113351	phospholipid	0	None
113351	113352	,	0	None
113352	113353	1	0	None
113353	113354	.	0	None
113354	113355	5	0	None
113355	113356	times	0	None
113356	113357	more	0	None
113357	113358	unesterified	0	None
113358	113359	cholesterol	0	None
113359	113360	,	0	None
113360	113361	and	0	None
113361	113362	0	0	None
113362	113363	.	0	None
113363	113364	3	0	None
113364	113365	times	0	None
113365	113366	more	0	None
113366	113367	esterified	0	None
113367	113368	cholesterol	0	None
113368	113369	.	0	None

113370	113371	Radiolabeled	0	None
113371	113372	neutral	0	None
113372	113373	lipid	0	None
113373	113374	is	0	None
113374	113375	detected	0	None
113375	113376	in	0	None
113376	113377	cells	0	None
113377	113378	and	0	None
113378	113379	medium	0	None
113379	113380	.	0	None

113381	113382	All	0	None
113382	113383	lipids	0	None
113383	113384	increase	0	None
113384	113385	in	0	None
113385	113386	cells	0	None
113386	113387	with	0	None
113387	113388	time	0	None
113388	113389	but	0	None
113389	113390	only	0	None
113390	113391	phospholipid	0	None
113391	113392	increases	0	None
113392	113393	in	0	None
113393	113394	the	0	None
113394	113395	medium	0	None
113395	113396	with	0	None
113396	113397	time	0	None
113397	113398	.	0	None

113399	113400	CONCLUSIONS	0	None
113400	113401	:	0	None
113401	113402	RPE	0	None
113402	113403	cells	0	None
113403	113404	express	0	None
113404	113405	genes	0	None
113405	113406	encoding	0	None
113406	113407	apolipoproteins	0	None
113407	113408	and	0	None
113408	113409	MTP	0	None
113409	113410	.	0	None

113411	113412	Following	0	None
113412	113413	the	0	None
113413	113414	ingestion	0	None
113414	113415	of	0	None
113415	113416	OS	0	None
113416	113417	,	0	None
113417	113418	RPE-J	0	None
113418	113419	cells	0	None
113419	113420	contain	0	None
113420	113421	abundant	0	None
113421	113422	lipid	0	None
113422	113423	.	0	None

113424	113425	Following	0	None
113425	113426	the	0	None
113426	113427	ingestion	0	None
113427	113428	of	0	None
113428	113429	long-chain	0	None
113429	113431	fatty acids	2	CHEMICAL
113431	113432	,	0	None
113432	113433	RPE-J	0	None
113433	113434	cells	0	None
113434	113435	can	0	None
113435	113436	synthesize	0	None
113436	113437	neutral	0	None
113437	113438	lipids	0	None
113438	113439	.	0	None

113440	113441	Future	0	None
113441	113442	experiments	0	None
113442	113443	will	0	None
113443	113444	determine	0	None
113444	113445	if	0	None
113445	113446	RPE-J	0	None
113446	113447	cells	0	None
113447	113448	secrete	0	None
113448	113449	lipoprotein	3	GENE-N
113449	113450	particles	0	None
113450	113451	containing	0	None
113451	113452	these	0	None
113452	113453	proteins	0	None
113453	113454	.	0	None
113454	113455	Human	0	None
113455	113456	follistatin	0	None
113456	113457	is	0	None
113457	113458	a	0	None
113458	113459	regulatory	0	None
113459	113460	glycoprotein	0	None
113460	113461	with	0	None
113461	113462	widespread	0	None
113462	113463	biologic	0	None
113463	113464	functions	0	None
113464	113465	,	0	None
113465	113466	including	0	None
113466	113467	antiinflammatory	0	None
113467	113468	activities	0	None
113468	113469	,	0	None
113469	113470	wound-healing	0	None
113470	113471	properties	0	None
113471	113472	,	0	None
113472	113473	and	0	None
113473	113474	muscle-stimulating	0	None
113474	113475	effects	0	None
113475	113476	.	0	None

113477	113478	The	0	None
113478	113479	role	0	None
113479	113480	of	0	None
113480	113481	follistatin	0	None
113481	113482	in	0	None
113482	113483	a	0	None
113483	113484	wide	0	None
113484	113485	range	0	None
113485	113486	of	0	None
113486	113487	biologic	0	None
113487	113488	activities	0	None
113488	113489	shows	0	None
113489	113490	promise	0	None
113490	113491	for	0	None
113491	113492	potential	0	None
113492	113493	clinical	0	None
113493	113494	application	0	None
113494	113495	,	0	None
113495	113496	which	0	None
113496	113497	has	0	None
113497	113498	prompted	0	None
113498	113499	considerable	0	None
113499	113500	interest	0	None
113500	113501	in	0	None
113501	113502	the	0	None
113502	113503	investigation	0	None
113503	113504	of	0	None
113504	113505	the	0	None
113505	113506	protein	0	None
113506	113507	as	0	None
113507	113508	a	0	None
113508	113509	potential	0	None
113509	113510	disease-modifying	0	None
113510	113511	agent	0	None
113511	113512	.	0	None

113513	113514	In	0	None
113514	113515	spite	0	None
113515	113516	of	0	None
113516	113517	this	0	None
113517	113518	potential	0	None
113518	113519	,	0	None
113519	113520	the	0	None
113520	113521	development	0	None
113521	113522	of	0	None
113522	113523	follistatin	0	None
113523	113524	as	0	None
113524	113525	a	0	None
113525	113526	broad	0	None
113526	113527	use	0	None
113527	113528	biotherapeutic	0	None
113528	113529	has	0	None
113529	113530	been	0	None
113530	113531	severely	0	None
113531	113532	hindered	0	None
113532	113533	by	0	None
113533	113534	a	0	None
113534	113535	poor	0	None
113535	113536	understanding	0	None
113536	113537	and	0	None
113537	113538	characterization	0	None
113538	113539	of	0	None
113539	113540	its	0	None
113540	113541	pharmacokinetic	0	None
113541	113542	/	0	None
113542	113543	pharmacodynamic	0	None
113543	113544	(	0	None
113544	113545	PK	0	None
113545	113546	/	0	None
113546	113547	PD	0	None
113547	113548	)	0	None
113548	113549	relationships	0	None
113549	113550	.	0	None

113551	113552	Therefore	0	None
113552	113553	,	0	None
113553	113554	to	0	None
113554	113555	better	0	None
113555	113556	define	0	None
113556	113557	these	0	None
113557	113558	relationships	0	None
113558	113559	,	0	None
113559	113560	we	0	None
113560	113561	performed	0	None
113561	113562	in-depth	0	None
113562	113563	analyses	0	None
113563	113564	of	0	None
113564	113565	the	0	None
113565	113566	PK	0	None
113566	113567	/	0	None
113567	113568	PD	0	None
113568	113569	relationships	0	None
113569	113570	of	0	None
113570	113571	native	0	None
113571	113572	follistatin-315	0	None
113572	113573	(	0	None
113573	113574	FST315	0	None
113574	113575	)	0	None
113575	113576	.	0	None

113577	113578	Our	0	None
113578	113579	data	0	None
113579	113580	indicate	0	None
113580	113581	that	0	None
113581	113582	the	0	None
113582	113583	intrinsic	0	None
113583	113584	PK	0	None
113584	113585	/	0	None
113585	113586	PD	0	None
113586	113587	properties	0	None
113587	113588	of	0	None
113588	113589	native	0	None
113589	113590	FST315	0	None
113590	113591	are	0	None
113591	113592	poorly	0	None
113592	113593	suited	0	None
113593	113594	for	0	None
113594	113595	acting	0	None
113595	113596	as	0	None
113596	113597	a	0	None
113597	113598	parentally	0	None
113598	113599	administered	0	None
113599	113600	biotherapeutic	0	None
113600	113601	with	0	None
113601	113602	broad	0	None
113602	113603	systemic	0	None
113603	113604	effects	0	None
113604	113605	.	0	None

113606	113607	Here	0	None
113607	113608	,	0	None
113608	113609	we	0	None
113609	113610	leveraged	0	None
113610	113611	protein	0	None
113611	113612	engineering	0	None
113612	113613	to	0	None
113613	113614	modify	0	None
113614	113615	the	0	None
113615	113616	PK	0	None
113616	113617	characteristics	0	None
113617	113618	of	0	None
113618	113619	the	0	None
113619	113620	native	0	None
113620	113621	molecule	0	None
113621	113622	by	0	None
113622	113623	fusing	0	None
113623	113624	FST315	0	None
113624	113625	to	0	None
113625	113626	a	0	None
113626	113627	murine	0	None
113627	113628	IgG	0	None
113628	113629	(	0	None
113629	113630	1	0	None
113630	113631	)	0	None
113631	113632	Fc	0	None
113632	113633	and	0	None
113633	113634	removing	0	None
113634	113635	the	0	None
113635	113636	intrinsic	0	None
113636	113637	heparan	0	None
113637	113638	sulfate-binding	0	None
113638	113639	activity	0	None
113639	113640	of	0	None
113640	113641	follistatin	0	None
113641	113642	.	0	None

113643	113644	The	0	None
113644	113645	engineered	0	None
113645	113646	variant	0	None
113646	113647	molecule	0	None
113647	113648	had	0	None
113648	113649	~100-	0	None
113649	113650	and	0	None
113650	113651	~1600-fold	0	None
113651	113652	improvements	0	None
113652	113653	in	0	None
113653	113654	terminal	0	None
113654	113655	half-life	0	None
113655	113656	and	0	None
113656	113657	exposure	0	None
113657	113658	,	0	None
113658	113659	respectively	0	None
113659	113660	.	0	None

113661	113662	In	0	None
113662	113663	contrast	0	None
113663	113664	to	0	None
113664	113665	the	0	None
113665	113666	native	0	None
113666	113667	FST315	0	None
113667	113668	,	0	None
113668	113669	the	0	None
113669	113670	variant	0	None
113670	113671	showed	0	None
113671	113672	a	0	None
113672	113673	robust	0	None
113673	113674	,	0	None
113674	113675	dose-dependent	0	None
113675	113676	pharmacological	0	None
113676	113677	effect	0	None
113677	113678	when	0	None
113678	113679	administered	0	None
113679	113680	subcutaneously	0	None
113680	113681	on	0	None
113681	113682	a	0	None
113682	113683	weekly	0	None
113683	113684	basis	0	None
113684	113685	in	0	None
113685	113686	mouse	0	None
113686	113687	models	0	None
113687	113688	of	0	None
113688	113689	muscle	0	None
113689	113690	atrophy	0	None
113690	113691	and	0	None
113691	113692	degeneration	0	None
113692	113693	.	0	None

113694	113695	These	0	None
113695	113696	studies	0	None
113696	113697	highlight	0	None
113697	113698	the	0	None
113698	113699	underappreciated	0	None
113699	113700	and	0	None
113700	113701	critical	0	None
113701	113702	relationship	0	None
113702	113703	between	0	None
113703	113704	optimizing	0	None
113704	113705	multiple	0	None
113705	113706	physical	0	None
113706	113707	and	0	None
113707	113708	chemical	0	None
113708	113709	properties	0	None
113709	113710	of	0	None
113710	113711	follistatin	0	None
113711	113712	on	0	None
113712	113713	its	0	None
113713	113714	overall	0	None
113714	113715	PK	0	None
113715	113716	/	0	None
113716	113717	PD	0	None
113717	113718	profile	0	None
113718	113719	.	0	None

113720	113721	Moreover	0	None
113721	113722	,	0	None
113722	113723	our	0	None
113723	113724	findings	0	None
113724	113725	provide	0	None
113725	113726	the	0	None
113726	113727	first	0	None
113727	113728	documented	0	None
113728	113729	strategy	0	None
113729	113730	toward	0	None
113730	113731	the	0	None
113731	113732	development	0	None
113732	113733	of	0	None
113733	113734	a	0	None
113734	113735	follistatin	0	None
113735	113736	therapeutic	0	None
113736	113737	with	0	None
113737	113738	potential	0	None
113738	113739	use	0	None
113739	113740	in	0	None
113740	113741	patients	0	None
113741	113742	affected	0	None
113742	113743	with	0	None
113743	113744	skeletal	0	None
113744	113745	muscle	0	None
113745	113746	diseases	0	None
113746	113747	.	0	None
113747	113748	The	0	None
113748	113749	V600E	0	None
113749	113750	BRAF	0	None
113750	113751	kinase	0	None
113751	113752	mutation	0	None
113752	113753	,	0	None
113753	113754	which	0	None
113754	113755	activates	0	None
113755	113756	the	0	None
113756	113757	downstream	0	None
113757	113758	MAPK	3	GENE-N
113758	113759	signaling	0	None
113759	113760	pathway	0	None
113760	113761	,	0	None
113761	113762	commonly	0	None
113762	113763	occurs	0	None
113763	113764	in	0	None
113764	113765	about	0	None
113765	113766	8%	0	None
113766	113767	of	0	None
113767	113768	all	0	None
113768	113769	human	0	None
113769	113770	malignancies	0	None
113770	113771	and	0	None
113771	113772	about	0	None
113772	113773	50%	0	None
113773	113774	of	0	None
113774	113775	all	0	None
113775	113776	melanomas	0	None
113776	113777	.	0	None

113778	113779	In	0	None
113779	113780	this	0	None
113780	113781	study	0	None
113781	113782	,	0	None
113782	113783	we	0	None
113783	113784	employed	0	None
113784	113785	virtual	0	None
113785	113786	screening	0	None
113786	113787	and	0	None
113787	113788	chemical	0	None
113788	113789	synthesis	0	None
113789	113790	to	0	None
113790	113791	identify	0	None
113791	113792	a	0	None
113792	113793	series	0	None
113793	113794	of	0	None
113794	113795	N-	0	None
113795	113796	(	0	None
113796	113797	thiophen-2-yl	0	None
113797	113798	)	0	None
113798	113799	benzamide	0	None
113799	113800	derivatives	0	None
113800	113801	as	0	None
113801	113802	potent	0	None
113802	113803	BRAF	0	None
113803	113804	(	0	None
113804	113805	V600E	0	None
113805	113806	)	0	None
113806	113807	inhibitors	0	None
113807	113808	.	0	None

113809	113810	Structure-activity	0	None
113810	113811	relationship	0	None
113811	113812	studies	0	None
113812	113813	of	0	None
113813	113814	these	0	None
113814	113815	derivatives	0	None
113815	113816	revealed	0	None
113816	113817	that	0	None
113817	113818	compounds	0	None
113818	113819	b40	0	None
113819	113820	and	0	None
113820	113821	b47	0	None
113821	113822	are	0	None
113822	113823	the	0	None
113823	113824	two	0	None
113824	113825	most	0	None
113825	113826	potent	0	None
113826	113827	BRAF	0	None
113827	113828	(	0	None
113828	113829	V600E	0	None
113829	113830	)	0	None
113830	113831	inhibitors	0	None
113831	113832	in	0	None
113832	113833	this	0	None
113833	113834	series	0	None
113834	113835	.	0	None
113835	113836	Sphingolipids	0	None
113836	113837	are	0	None
113837	113838	well	0	None
113838	113839	established	0	None
113839	113840	effectors	0	None
113840	113841	of	0	None
113841	113842	signal	0	None
113842	113843	transduction	0	None
113843	113844	downstream	0	None
113844	113845	of	0	None
113845	113846	the	0	None
113846	113849	tumor necrosis factor	1	GENE-Y
113849	113850	(	0	None
113850	113851	TNF	1	GENE-Y
113851	113852	)	0	None
113852	113853	receptor	0	None
113853	113854	.	0	None

113855	113856	In	0	None
113856	113857	a	0	None
113857	113858	previous	0	None
113858	113859	study	0	None
113859	113860	,	0	None
113860	113861	we	0	None
113861	113862	showed	0	None
113862	113863	that	0	None
113863	113864	the	0	None
113864	113866	sphingosine kinase	3	GENE-N
113866	113867	/	0	None
113867	113869	sphingosine 1-phosphate	2	CHEMICAL
113869	113870	(	0	None
113870	113871	S1P	0	None
113871	113872	)	0	None
113872	113873	pathway	0	None
113873	113874	couples	0	None
113874	113875	TNF	1	GENE-Y
113875	113876	receptor	0	None
113876	113877	to	0	None
113877	113878	induction	0	None
113878	113879	of	0	None
113879	113880	the	0	None
113880	113881	cyclooxygenase	3	GENE-N
113881	113882	2	0	None
113882	113883	gene	0	None
113883	113884	and	0	None
113884	113885	prostaglandin	0	None
113885	113886	synthesis	0	None
113886	113887	(	0	None
113887	113888	Pettus	0	None
113888	113889	,	0	None
113889	113890	B	0	None
113890	113891	.	0	None

113892	113893	J	0	None
113893	113894	.	0	None

113895	113896	,	0	None
113896	113897	Bielawski	0	None
113897	113898	,	0	None
113898	113899	J	0	None
113899	113900	.	0	None

113901	113902	,	0	None
113902	113903	Porcelli	0	None
113903	113904	,	0	None
113904	113905	A	0	None
113905	113906	.	0	None

113907	113908	M	0	None
113908	113909	.	0	None

113910	113911	,	0	None
113911	113912	Reames	0	None
113912	113913	,	0	None
113913	113914	D	0	None
113914	113915	.	0	None

113916	113917	L	0	None
113917	113918	.	0	None

113919	113920	,	0	None
113920	113921	Johnson	0	None
113921	113922	,	0	None
113922	113923	K	0	None
113923	113924	.	0	None

113925	113926	R	0	None
113926	113927	.	0	None

113928	113929	,	0	None
113929	113930	Morrow	0	None
113930	113931	,	0	None
113931	113932	J	0	None
113932	113933	.	0	None

113934	113935	,	0	None
113935	113936	Chalfant	0	None
113936	113937	,	0	None
113937	113938	C	0	None
113938	113939	.	0	None

113940	113941	E	0	None
113941	113942	.	0	None

113943	113944	,	0	None
113944	113945	Obeid	0	None
113945	113946	,	0	None
113946	113947	L	0	None
113947	113948	.	0	None

113949	113950	M	0	None
113950	113951	.	0	None

113952	113953	,	0	None
113953	113954	and	0	None
113954	113955	Hannun	0	None
113955	113956	,	0	None
113956	113957	Y	0	None
113957	113958	.	0	None

113959	113960	A	0	None
113960	113961	.	0	None

113962	113963	(	0	None
113963	113964	2003	0	None
113964	113965	)	0	None
113965	113966	FASEB	0	None
113966	113967	J	0	None
113967	113968	.	0	None

113969	113970	17	0	None
113970	113971	,	0	None
113971	113972	1411-1421	0	None
113972	113973	)	0	None
113973	113974	.	0	None

113975	113976	In	0	None
113976	113977	this	0	None
113977	113978	study	0	None
113978	113979	,	0	None
113979	113980	the	0	None
113980	113981	requirement	0	None
113981	113982	for	0	None
113982	113984	acid sphingomyelinase	1	GENE-Y
113984	113985	and	0	None
113985	113986	sphingomyelin	0	None
113986	113987	metabolites	0	None
113987	113988	in	0	None
113988	113989	the	0	None
113989	113990	TNFalpha	0	None
113990	113991	/	0	None
113991	113992	prostaglandin	0	None
113992	113993	E	0	None
113993	113994	(	0	None
113994	113995	2	0	None
113995	113996	)	0	None
113996	113997	(	0	None
113997	113998	PGE	0	None
113998	113999	(	0	None
113999	114000	2	0	None
114000	114001	)	0	None
114001	114002	)	0	None
114002	114003	pathway	0	None
114003	114004	was	0	None
114004	114005	investigated	0	None
114005	114006	.	0	None

114007	114008	The	0	None
114008	114009	amphiphilic	0	None
114009	114010	compound	0	None
114010	114011	desipramine	0	None
114011	114012	,	0	None
114012	114013	a	0	None
114013	114014	frequently	0	None
114014	114015	employed	0	None
114015	114016	inhibitor	0	None
114016	114017	of	0	None
114017	114019	acid sphingomyelinase	1	GENE-Y
114019	114020	(	0	None
114020	114021	ASMase	0	None
114021	114022	)	0	None
114022	114023	,	0	None
114023	114024	blocked	0	None
114024	114025	PGE	0	None
114025	114026	(	0	None
114026	114027	2	0	None
114027	114028	)	0	None
114028	114029	production	0	None
114029	114030	.	0	None

114031	114032	However	0	None
114032	114033	,	0	None
114033	114034	the	0	None
114034	114035	action	0	None
114035	114036	of	0	None
114036	114037	desipramine	0	None
114037	114038	was	0	None
114038	114039	independent	0	None
114039	114040	of	0	None
114040	114041	its	0	None
114041	114042	action	0	None
114042	114043	on	0	None
114043	114044	ASMase	0	None
114044	114045	,	0	None
114045	114046	since	0	None
114046	114047	neither	0	None
114047	114048	genetic	0	None
114048	114049	loss	0	None
114049	114050	of	0	None
114050	114051	ASMase	0	None
114051	114052	(	0	None
114052	114053	Niemann-Pick	0	None
114053	114054	fibroblasts	0	None
114054	114055	)	0	None
114055	114056	nor	0	None
114056	114057	knockdown	0	None
114057	114058	of	0	None
114058	114059	ASMase	0	None
114059	114060	using	0	None
114060	114061	RNA	0	None
114061	114062	interference	0	None
114062	114063	affected	0	None
114063	114064	TNFalpha-induced	0	None
114064	114065	PGE	0	None
114065	114066	(	0	None
114066	114067	2	0	None
114067	114068	)	0	None
114068	114069	synthesis	0	None
114069	114070	.	0	None

114071	114072	Further	0	None
114072	114073	investigations	0	None
114073	114074	revealed	0	None
114074	114075	that	0	None
114075	114076	desipramine	0	None
114076	114077	down-regulated	0	None
114077	114078	acid	0	None
114078	114079	ceramidase	0	None
114079	114080	(	0	None
114080	114081	AC	3	GENE-N
114081	114082	)	0	None
114082	114083	,	0	None
114083	114084	but	0	None
114084	114085	not	0	None
114085	114087	sphingosine kinase	3	GENE-N
114087	114088	,	0	None
114088	114089	at	0	None
114089	114090	the	0	None
114090	114091	protein	0	None
114091	114092	level	0	None
114092	114093	.	0	None

114094	114095	This	0	None
114095	114096	resulted	0	None
114096	114097	in	0	None
114097	114098	a	0	None
114098	114099	time-dependent	0	None
114099	114100	drop	0	None
114100	114101	in	0	None
114101	114102	sphingosine	0	None
114102	114103	and	0	None
114103	114104	S1P	0	None
114104	114105	levels	0	None
114105	114106	.	0	None

114107	114108	Moreover	0	None
114108	114109	,	0	None
114109	114110	exogenous	0	None
114110	114111	administration	0	None
114111	114112	of	0	None
114112	114113	either	0	None
114113	114114	sphingosine	0	None
114114	114115	or	0	None
114115	114116	S1P	0	None
114116	114117	rescued	0	None
114117	114118	PGE	0	None
114118	114119	(	0	None
114119	114120	2	0	None
114120	114121	)	0	None
114121	114122	biosynthesis	0	None
114122	114123	after	0	None
114123	114124	desipramine	0	None
114124	114125	treatment	0	None
114125	114126	.	0	None

114127	114128	Interestingly	0	None
114128	114129	,	0	None
114129	114130	knockdown	0	None
114130	114131	of	0	None
114131	114132	endogenous	0	None
114132	114133	AC	3	GENE-N
114133	114134	by	0	None
114134	114135	RNA	0	None
114135	114136	interference	0	None
114136	114137	attenuated	0	None
114137	114138	cyclooxygenase	3	GENE-N
114138	114139	2	0	None
114139	114140	induction	0	None
114140	114141	by	0	None
114141	114142	TNFalpha	0	None
114142	114143	and	0	None
114143	114144	subsequent	0	None
114144	114145	PGE	0	None
114145	114146	(	0	None
114146	114147	2	0	None
114147	114148	)	0	None
114148	114149	biosynthesis	0	None
114149	114150	.	0	None

114151	114152	Taken	0	None
114152	114153	together	0	None
114153	114154	,	0	None
114154	114155	these	0	None
114155	114156	results	0	None
114156	114157	define	0	None
114157	114158	a	0	None
114158	114159	novel	0	None
114159	114160	role	0	None
114160	114161	for	0	None
114161	114162	AC	3	GENE-N
114162	114163	in	0	None
114163	114164	the	0	None
114164	114165	TNFalpha	0	None
114165	114166	/	0	None
114166	114167	PGE	0	None
114167	114168	(	0	None
114168	114169	2	0	None
114169	114170	)	0	None
114170	114171	pathway	0	None
114171	114172	.	0	None

114173	114174	In	0	None
114174	114175	addition	0	None
114175	114176	,	0	None
114176	114177	the	0	None
114177	114178	results	0	None
114178	114179	of	0	None
114179	114180	this	0	None
114180	114181	study	0	None
114181	114182	warrant	0	None
114182	114183	careful	0	None
114183	114184	reconsideration	0	None
114184	114185	of	0	None
114185	114186	desipramine	0	None
114186	114187	as	0	None
114187	114188	a	0	None
114188	114189	specific	0	None
114189	114190	inhibitor	0	None
114190	114191	for	0	None
114191	114192	ASMase	0	None
114192	114193	.	0	None
114193	114194	The	0	None
114194	114195	effects	0	None
114195	114196	of	0	None
114196	114197	aluminium	2	CHEMICAL
114197	114198	lactate	0	None
114198	114199	(	0	None
114199	114200	Al-lactate	0	None
114200	114201	)	0	None
114201	114202	on	0	None
114202	114203	the	0	None
114203	114204	rat	0	None
114204	114205	cerebral	0	None
114205	114206	synaptosome	0	None
114206	114207	integral	0	None
114207	114208	proteins	0	None
114208	114209	adenosinetriphosphatase	0	None
114209	114210	(	0	None
114210	114211	ATPase	3	GENE-N
114211	114212	)	0	None
114212	114213	and	0	None
114213	114214	acetylcholinesterase	0	None
114214	114215	(	0	None
114215	114216	AChE	1	GENE-Y
114216	114217	)	0	None
114217	114218	were	0	None
114218	114219	studied	0	None
114219	114220	in	0	None
114220	114221	vitro	0	None
114221	114222	and	0	None
114222	114223	in	0	None
114223	114224	vivo	0	None
114224	114225	.	0	None

114226	114227	Coexposure	0	None
114227	114228	with	0	None
114228	114229	ethanol	2	CHEMICAL
114229	114230	(	0	None
114230	114231	EtOH	0	None
114231	114232	)	0	None
114232	114233	was	0	None
114233	114234	studied	0	None
114234	114235	in	0	None
114235	114236	both	0	None
114236	114237	situations	0	None
114237	114238	.	0	None

114239	114240	Isolation	0	None
114240	114241	of	0	None
114241	114242	synaptosomes	0	None
114242	114243	was	0	None
114243	114244	carried	0	None
114244	114245	out	0	None
114245	114246	using	0	None
114246	114247	isoosmotic	0	None
114247	114248	Percoll	0	None
114248	114249	gradients	0	None
114249	114250	.	0	None

114251	114252	In	0	None
114252	114253	in	0	None
114253	114254	vitro	0	None
114254	114255	experiments	0	None
114255	114256	,	0	None
114256	114257	the	0	None
114257	114258	synaptosomes	0	None
114258	114259	were	0	None
114259	114260	exposed	0	None
114260	114261	to	0	None
114261	114262	different	0	None
114262	114263	concentrations	0	None
114263	114264	of	0	None
114264	114265	Al-lactate	0	None
114265	114266	in	0	None
114266	114267	the	0	None
114267	114268	incubation	0	None
114268	114269	mixture	0	None
114269	114270	.	0	None

114271	114272	Al-lactate	0	None
114272	114273	caused	0	None
114273	114274	decreases	0	None
114274	114275	in	0	None
114275	114276	total	0	None
114276	114277	ATPase	3	GENE-N
114277	114278	and	0	None
114278	114279	AChE	1	GENE-Y
114279	114280	activities	0	None
114280	114281	concentration	0	None
114281	114282	dependently	0	None
114282	114283	.	0	None

114284	114285	The	0	None
114285	114286	decrease	0	None
114286	114287	in	0	None
114287	114288	ATP	0	None
114288	114289	activity	0	None
114289	114290	started	0	None
114290	114291	at	0	None
114291	114292	0	0	None
114292	114293	.	0	None
114293	114294	2	0	None
114294	114295	mM	0	None
114295	114296	concentration	0	None
114296	114297	,	0	None
114297	114298	and	0	None
114298	114299	concentration	0	None
114299	114300	for	0	None
114300	114301	the	0	None
114301	114302	50%	0	None
114302	114303	decrease	0	None
114303	114304	of	0	None
114304	114305	the	0	None
114305	114306	enzyme	0	None
114306	114307	activity	0	None
114307	114308	(	0	None
114308	114309	EC50	0	None
114309	114310	)	0	None
114310	114311	was	0	None
114311	114312	1	0	None
114312	114313	.	0	None
114313	114314	1	0	None
114314	114315	mM	0	None
114315	114316	.	0	None

114317	114318	The	0	None
114318	114319	decrease	0	None
114319	114320	in	0	None
114320	114321	AChE	1	GENE-Y
114321	114322	activity	0	None
114322	114323	started	0	None
114323	114324	at	0	None
114324	114325	5-10	0	None
114325	114326	mM	0	None
114326	114327	concentration	0	None
114327	114328	,	0	None
114328	114329	and	0	None
114329	114330	the	0	None
114330	114331	EC50	0	None
114331	114332	value	0	None
114332	114333	was	0	None
114333	114334	15	0	None
114334	114335	.	0	None
114335	114336	8	0	None
114336	114337	mM	0	None
114337	114338	.	0	None

114339	114340	Coexposure	0	None
114340	114341	with	0	None
114341	114342	ethanol	2	CHEMICAL
114342	114343	(	0	None
114343	114344	2	0	None
114344	114345	mM	0	None
114345	114346	)	0	None
114346	114347	increased	0	None
114347	114348	the	0	None
114348	114349	EC50	0	None
114349	114350	values	0	None
114350	114351	similarly	0	None
114351	114352	in	0	None
114352	114353	both	0	None
114353	114354	cases	0	None
114354	114355	.	0	None

114356	114357	After	0	None
114357	114358	90-day	0	None
114358	114359	oral	0	None
114359	114360	exposure	0	None
114360	114361	of	0	None
114361	114362	rats	0	None
114362	114363	to	0	None
114363	114364	Al-lactate	0	None
114364	114365	(	0	None
114365	114366	91	0	None
114366	114367	.	0	None
114367	114368	8	0	None
114368	114369	mg	2	CHEMICAL
114369	114370	/	0	None
114370	114371	kg	0	None
114371	114372	/	0	None
114372	114373	day	0	None
114373	114374	)	0	None
114374	114375	,	0	None
114375	114376	the	0	None
114376	114377	serum	0	None
114377	114378	aluminium	2	CHEMICAL
114378	114379	level	0	None
114379	114380	was	0	None
114380	114381	0	0	None
114381	114382	.	0	None
114382	114383	9-1	0	None
114383	114384	.	0	None
114384	114385	3	0	None
114385	114386	ptM	0	None
114386	114387	/	0	None
114387	114388	l	0	None
114388	114389	.	0	None

114390	114391	Coexposure	0	None
114391	114392	with	0	None
114392	114393	EtOH	0	None
114393	114394	(	0	None
114394	114395	3	0	None
114395	114396	.	0	None
114396	114397	0	0	None
114397	114398	g	0	None
114398	114399	/	0	None
114399	114400	kg	0	None
114400	114401	/	0	None
114401	114402	day	0	None
114402	114403	)	0	None
114403	114404	did	0	None
114404	114405	not	0	None
114405	114406	significantly	0	None
114406	114407	increase	0	None
114407	114408	the	0	None
114408	114409	blood	0	None
114409	114410	Al	2	CHEMICAL
114410	114411	(	0	None
114411	114412	0	0	None
114412	114413	.	0	None
114413	114414	7	0	None
114414	114415	2	0	None
114415	114416	.	0	None
114416	114417	2	0	None
114417	114418	pM	0	None
114418	114419	/	0	None
114419	114420	l	0	None
114420	114421	)	0	None
114421	114422	.	0	None

114423	114424	Aluminium	2	CHEMICAL
114424	114425	exposure	0	None
114425	114426	caused	0	None
114426	114427	a	0	None
114427	114428	decrease	0	None
114428	114429	in	0	None
114429	114430	the	0	None
114430	114431	blood	0	None
114431	114432	EtOH	0	None
114432	114433	concentration	0	None
114433	114434	(	0	None
114434	114435	0	0	None
114435	114436	.	0	None
114436	114437	6	0	None
114437	114438	mM	0	None
114438	114439	/	0	None
114439	114440	1	0	None
114440	114441	)	0	None
114441	114442	compared	0	None
114442	114443	with	0	None
114443	114444	blood	0	None
114444	114445	EtOH	0	None
114445	114446	(	0	None
114446	114447	12	0	None
114447	114448	.	0	None
114448	114449	3	0	None
114449	114450	mM	0	None
114450	114451	/	0	None
114451	114452	1	0	None
114452	114453	)	0	None
114453	114454	in	0	None
114454	114455	the	0	None
114455	114456	rats	0	None
114456	114457	exposed	0	None
114457	114458	to	0	None
114458	114459	ethanol	2	CHEMICAL
114459	114460	only	0	None
114460	114461	.	0	None

114462	114463	In	0	None
114463	114464	the	0	None
114464	114465	rats	0	None
114465	114466	studied	0	None
114466	114467	2	0	None
114467	114468	weeks	0	None
114468	114469	after	0	None
114469	114470	the	0	None
114470	114471	Al	2	CHEMICAL
114471	114472	exposure	0	None
114472	114473	,	0	None
114473	114474	the	0	None
114474	114475	activities	0	None
114475	114476	of	0	None
114476	114477	ATPase	3	GENE-N
114477	114478	and	0	None
114478	114479	AChE	1	GENE-Y
114479	114480	were	0	None
114480	114481	significantly	0	None
114481	114482	lower	0	None
114482	114483	than	0	None
114483	114484	in	0	None
114484	114485	the	0	None
114485	114486	rats	0	None
114486	114487	studied	0	None
114487	114488	immediately	0	None
114488	114489	after	0	None
114489	114490	the	0	None
114490	114491	exposure	0	None
114491	114492	.	0	None

114493	114494	Correspondingly	0	None
114494	114495	,	0	None
114495	114496	a	0	None
114496	114497	significant	0	None
114497	114498	decrease	0	None
114498	114499	in	0	None
114499	114500	AChE	1	GENE-Y
114500	114501	activity	0	None
114501	114502	was	0	None
114502	114503	found	0	None
114503	114504	in	0	None
114504	114505	Al	2	CHEMICAL
114505	114506	and	0	None
114506	114507	EtOH-exposed	0	None
114507	114508	rats	0	None
114508	114509	,	0	None
114509	114510	but	0	None
114510	114511	in	0	None
114511	114512	the	0	None
114512	114513	control	0	None
114513	114514	rats	0	None
114514	114515	there	0	None
114515	114516	were	0	None
114516	114517	no	0	None
114517	114518	differences	0	None
114518	114519	between	0	None
114519	114520	the	0	None
114520	114521	study	0	None
114521	114522	groups	0	None
114522	114523	.	0	None

114524	114525	Immediately	0	None
114525	114526	after	0	None
114526	114527	the	0	None
114527	114528	90-day	0	None
114528	114529	dosing	0	None
114529	114530	,	0	None
114530	114531	the	0	None
114531	114532	exposed	0	None
114532	114533	rats	0	None
114533	114534	did	0	None
114534	114535	not	0	None
114535	114536	differ	0	None
114536	114537	significantly	0	None
114537	114538	from	0	None
114538	114539	the	0	None
114539	114540	control	0	None
114540	114541	rats	0	None
114541	114542	.	0	None

114543	114544	Based	0	None
114544	114545	on	0	None
114545	114546	the	0	None
114546	114547	in	0	None
114547	114548	vitro	0	None
114548	114549	results	0	None
114549	114550	,	0	None
114550	114551	the	0	None
114551	114552	neural	0	None
114552	114553	membrane	0	None
114553	114554	integral	0	None
114554	114555	proteins	0	None
114555	114556	ATPase	3	GENE-N
114556	114557	and	0	None
114557	114558	AChE	1	GENE-Y
114558	114559	may	0	None
114559	114560	be	0	None
114560	114561	considered	0	None
114561	114562	as	0	None
114562	114563	targets	0	None
114563	114564	for	0	None
114564	114565	the	0	None
114565	114566	effects	0	None
114566	114567	of	0	None
114567	114568	aluminium	2	CHEMICAL
114568	114569	and	0	None
114569	114570	ethanol	2	CHEMICAL
114570	114571	.	0	None

114572	114573	Ninety-day	0	None
114573	114574	in	0	None
114574	114575	vivo	0	None
114575	114576	exposure	0	None
114576	114577	of	0	None
114577	114578	rats	0	None
114578	114579	to	0	None
114579	114580	aluminium	2	CHEMICAL
114580	114581	caused	0	None
114581	114582	decrease	0	None
114582	114583	in	0	None
114583	114584	ATPase	3	GENE-N
114584	114585	and	0	None
114585	114586	AChE	1	GENE-Y
114586	114587	activities	0	None
114587	114588	,	0	None
114588	114589	detectable	0	None
114589	114590	2	0	None
114590	114591	weeks	0	None
114591	114592	after	0	None
114592	114593	the	0	None
114593	114594	exposure	0	None
114594	114595	.	0	None
114595	114596	The	0	None
114596	114597	neurospecific	0	None
114597	114598	cholesterol	0	None
114598	114599	24-hydroxylase	0	None
114599	114600	converts	0	None
114600	114601	excess	0	None
114601	114602	brain	0	None
114602	114603	cholesterol	0	None
114603	114604	into	0	None
114604	114605	24S-hydroxycholesterol	0	None
114605	114606	(	0	None
114606	114607	24OHC	0	None
114607	114608	)	0	None
114608	114609	which	0	None
114609	114610	,	0	None
114610	114611	via	0	None
114611	114612	the	0	None
114612	114613	liver	0	None
114613	114614	X	0	None
114614	114615	receptor	0	None
114615	114616	(	0	None
114616	114617	LXR	0	None
114617	114618	)	0	None
114618	114619	,	0	None
114619	114620	can	0	None
114620	114621	increase	0	None
114621	114622	the	0	None
114622	114623	expression	0	None
114623	114624	and	0	None
114624	114625	synthesis	0	None
114625	114626	of	0	None
114626	114627	astrocyte	0	None
114627	114628	ApoE	0	None
114628	114629	.	0	None

114630	114631	24OHC	0	None
114631	114632	effluxes	0	None
114632	114633	directly	0	None
114633	114634	from	0	None
114634	114635	brain	0	None
114635	114636	into	0	None
114636	114637	plasma	0	None
114637	114638	where	0	None
114638	114639	it	0	None
114639	114640	is	0	None
114640	114641	considered	0	None
114641	114642	an	0	None
114642	114643	indicator	0	None
114643	114644	of	0	None
114644	114645	brain	0	None
114645	114646	cholesterol	0	None
114646	114647	turnover	0	None
114647	114648	.	0	None

114649	114650	It	0	None
114650	114651	is	0	None
114651	114652	reduced	0	None
114652	114653	in	0	None
114653	114654	neurodegenerative	0	None
114654	114655	disease	0	None
114655	114656	states	0	None
114656	114657	proportionally	0	None
114657	114658	to	0	None
114658	114659	the	0	None
114659	114660	severity	0	None
114660	114661	of	0	None
114661	114662	disease	0	None
114662	114663	and	0	None
114663	114664	the	0	None
114664	114665	degree	0	None
114665	114666	of	0	None
114666	114667	brain	0	None
114667	114668	atrophy	0	None
114668	114669	.	0	None

114670	114671	In	0	None
114671	114672	the	0	None
114672	114673	early	0	None
114673	114674	phases	0	None
114674	114675	of	0	None
114675	114676	active	0	None
114676	114677	disease	0	None
114677	114678	,	0	None
114678	114679	a	0	None
114679	114680	higher	0	None
114680	114681	rate	0	None
114681	114682	of	0	None
114682	114683	turnover	0	None
114683	114684	may	0	None
114684	114685	result	0	None
114685	114686	in	0	None
114686	114687	transitory	0	None
114687	114688	increases	0	None
114688	114689	in	0	None
114689	114690	plasma	0	None
114690	114691	24OHC	0	None
114691	114692	.	0	None

114693	114694	Less	0	None
114694	114695	than	0	None
114695	114696	1%	0	None
114696	114697	of	0	None
114697	114698	the	0	None
114698	114699	total	0	None
114699	114700	brain	0	None
114700	114701	excretion	0	None
114701	114702	of	0	None
114702	114703	24OHC	0	None
114703	114704	occurs	0	None
114704	114705	via	0	None
114705	114706	the	0	None
114706	114707	cerebrospinal	0	None
114707	114708	fluid	0	None
114708	114709	(	0	None
114709	114710	CSF	0	None
114710	114711	)	0	None
114711	114712	whereas	0	None
114712	114713	almost	0	None
114713	114714	all	0	None
114714	114715	27-hydroxycholesterol	0	None
114715	114716	(	0	None
114716	114717	27OHC	0	None
114717	114718	)	0	None
114718	114719	excretion	0	None
114719	114720	is	0	None
114720	114721	dependent	0	None
114721	114722	on	0	None
114722	114723	the	0	None
114723	114724	function	0	None
114724	114725	of	0	None
114725	114726	the	0	None
114726	114727	blood-cerebrospinal	0	None
114727	114728	fluid	0	None
114728	114729	barrier	0	None
114729	114730	.	0	None

114731	114732	Iincreased	0	None
114732	114733	CSF	0	None
114733	114734	oxysterols	0	None
114734	114735	were	0	None
114735	114736	found	0	None
114736	114737	in	0	None
114737	114738	patients	0	None
114738	114739	with	0	None
114739	114740	neurodegenerative	0	None
114740	114741	and	0	None
114741	114742	neuroinflammatory	0	None
114742	114743	diseases	0	None
114743	114744	in	0	None
114744	114745	the	0	None
114745	114746	presence	0	None
114746	114747	of	0	None
114747	114748	barrier	0	None
114748	114749	dysfunction	0	None
114749	114750	.	0	None

114751	114752	In	0	None
114752	114753	neurodegeneration	0	None
114753	114754	,	0	None
114754	114755	free	0	None
114755	114756	cholesterol	0	None
114756	114757	released	0	None
114757	114758	from	0	None
114758	114759	dying	0	None
114759	114760	cells	0	None
114760	114761	may	0	None
114761	114762	engulf	0	None
114762	114763	neurons	0	None
114763	114764	.	0	None

114765	114766	Cholesterol	0	None
114766	114767	also	0	None
114767	114768	increases	0	None
114768	114769	Amyloid	0	None
114769	114770	β	0	None
114770	114771	(	0	None
114771	114772	Aβ	0	None
114772	114773	)	0	None
114773	114774	deposition	0	None
114774	114775	and	0	None
114775	114776	tau	1	GENE-Y
114776	114777	pathology	0	None
114777	114778	.	0	None

114779	114780	ApoE	0	None
114780	114781	,	0	None
114781	114782	24OHC	0	None
114782	114783	,	0	None
114783	114784	tau	1	GENE-Y
114784	114785	and	0	None
114785	114786	soluble	0	None
114786	114787	APP	0	None
114787	114788	were	0	None
114788	114789	correlated	0	None
114789	114790	in	0	None
114790	114791	Alzheimer	0	None
114791	114792	disease	0	None
114792	114793	(	0	None
114793	114794	AD	0	None
114794	114795	)	0	None
114795	114796	samples	0	None
114796	114797	.	0	None

114798	114799	Excess	0	None
114799	114800	of	0	None
114800	114801	cholesterol	0	None
114801	114802	converted	0	None
114802	114803	into	0	None
114803	114804	24OHC	0	None
114804	114805	may	0	None
114805	114806	up-regulate	0	None
114806	114807	ApoE	0	None
114807	114808	synthesis	0	None
114808	114809	which	0	None
114809	114810	is	0	None
114810	114811	a	0	None
114811	114812	scavenger	0	None
114812	114813	for	0	None
114813	114814	Aβ	0	None
114814	114815	and	0	None
114815	114816	Tau	1	GENE-Y
114816	114817	.	0	None

114818	114819	In	0	None
114819	114820	AD	0	None
114820	114821	this	0	None
114821	114822	protective	0	None
114822	114823	mechanism	0	None
114823	114824	seems	0	None
114824	114825	to	0	None
114825	114826	be	0	None
114826	114827	inefficient	0	None
114827	114828	,	0	None
114828	114829	probably	0	None
114829	114830	due	0	None
114830	114831	to	0	None
114831	114832	the	0	None
114832	114833	presence	0	None
114833	114834	of	0	None
114834	114835	high	0	None
114835	114836	concentrations	0	None
114836	114837	of	0	None
114837	114838	27OHC	0	None
114838	114839	,	0	None
114839	114840	microvascular	0	None
114840	114841	dysfunction	0	None
114841	114842	and	0	None
114842	114843	the	0	None
114843	114844	decreased	0	None
114844	114845	efficiency	0	None
114845	114846	of	0	None
114846	114847	ApoE4	0	None
114847	114848	as	0	None
114848	114849	lipid	0	None
114849	114850	transporter	0	None
114850	114851	and	0	None
114851	114852	Aβ	0	None
114852	114853	scavenger	0	None
114853	114854	.	0	None

114855	114856	24OHC	0	None
114856	114857	itself	0	None
114857	114858	was	0	None
114858	114859	cytotoxic	0	None
114859	114860	.	0	None

114861	114862	Analysis	0	None
114862	114863	of	0	None
114863	114864	side	0	None
114864	114865	chain	0	None
114865	114866	oxysterols	0	None
114866	114867	in	0	None
114867	114868	the	0	None
114868	114869	CSF	0	None
114869	114870	is	0	None
114870	114871	likely	0	None
114871	114872	to	0	None
114872	114873	provided	0	None
114873	114874	useful	0	None
114874	114875	information	0	None
114875	114876	about	0	None
114876	114877	cholesterol	0	None
114877	114878	metabolism	0	None
114878	114879	and	0	None
114879	114880	ApoE	0	None
114880	114881	function	0	None
114881	114882	in	0	None
114882	114883	the	0	None
114883	114884	pathogenesis	0	None
114884	114885	of	0	None
114885	114886	AD	0	None
114886	114887	.	0	None
114887	114888	Preincubation	0	None
114888	114889	(	0	None
114889	114890	30	0	None
114890	114891	min	0	None
114891	114892	)	0	None
114892	114893	of	0	None
114893	114894	bovine	0	None
114894	114895	tracheal	0	None
114895	114896	smooth	0	None
114896	114897	muscle	0	None
114897	114898	with	0	None
114898	114899	various	0	None
114899	114900	concentrations	0	None
114900	114901	(	0	None
114901	114902	0	0	None
114902	114903	.	0	None
114903	114904	1	0	None
114904	114905	,	0	None
114905	114906	1	0	None
114906	114907	and	0	None
114907	114908	10	0	None
114908	114909	microM	0	None
114909	114910	)	0	None
114910	114911	of	0	None
114911	114912	fenoterol	2	CHEMICAL
114912	114913	decreased	0	None
114913	114914	isoprenaline-induced	0	None
114914	114915	maximal	0	None
114915	114916	relaxation	0	None
114916	114917	(	0	None
114917	114918	E	0	None
114918	114919	(	0	None
114919	114920	max	0	None
114920	114921	)	0	None
114921	114922	)	0	None
114922	114923	of	0	None
114923	114924	methacholine-contracted	0	None
114924	114925	preparations	0	None
114925	114926	in	0	None
114926	114927	a	0	None
114927	114928	concentration	0	None
114928	114929	dependent	0	None
114929	114930	fashion	0	None
114930	114931	,	0	None
114931	114932	indicating	0	None
114932	114933	desensitization	0	None
114933	114934	of	0	None
114934	114935	the	0	None
114935	114936	beta	0	None
114936	114937	(	0	None
114937	114938	2	0	None
114938	114939	)	0	None
114939	114940	-adrenoceptor	0	None
114940	114941	.	0	None

114942	114943	Preincubation	0	None
114943	114944	with	0	None
114944	114945	1	0	None
114945	114946	microM	0	None
114946	114947	of	0	None
114947	114948	the	0	None
114948	114949	protein	0	None
114949	114950	kinase	0	None
114950	114951	C	0	None
114951	114952	(	0	None
114952	114953	PKC	0	None
114953	114954	)	0	None
114954	114955	activator	0	None
114955	114956	phorbol	0	None
114956	114957	12-myristate	0	None
114957	114958	13-acetate	0	None
114958	114959	(	0	None
114959	114960	PMA	0	None
114960	114961	)	0	None
114961	114962	caused	0	None
114962	114963	a	0	None
114963	114964	small	0	None
114964	114965	but	0	None
114965	114966	significant	0	None
114966	114967	decrease	0	None
114967	114968	in	0	None
114968	114969	isoprenaline-induced	0	None
114969	114970	E	0	None
114970	114971	(	0	None
114971	114972	max	0	None
114972	114973	)	0	None
114973	114974	,	0	None
114974	114975	indicating	0	None
114975	114976	activated	0	None
114976	114977	PKC-mediated	0	None
114977	114978	heterologous	0	None
114978	114979	beta	0	None
114979	114980	(	0	None
114980	114981	2	0	None
114981	114982	)	0	None
114982	114983	-adrenoceptor	0	None
114983	114984	desensitization	0	None
114984	114985	.	0	None

114986	114987	To	0	None
114987	114988	investigate	0	None
114988	114989	the	0	None
114989	114990	capacity	0	None
114990	114991	of	0	None
114991	114992	activated	0	None
114992	114993	PKC	0	None
114993	114994	to	0	None
114994	114995	regulate	0	None
114995	114996	homologous	0	None
114996	114997	desensitization	0	None
114997	114998	,	0	None
114998	114999	we	0	None
114999	115000	incubated	0	None
115000	115001	the	0	None
115001	115002	smooth	0	None
115002	115003	muscle	0	None
115003	115004	strips	0	None
115004	115005	with	0	None
115005	115006	the	0	None
115006	115007	combination	0	None
115007	115008	of	0	None
115008	115009	both	0	None
115009	115010	1	0	None
115010	115011	microM	0	None
115011	115012	PMA	0	None
115012	115013	and	0	None
115013	115014	1	0	None
115014	115015	microM	0	None
115015	115016	fenoterol	2	CHEMICAL
115016	115017	.	0	None

115018	115019	This	0	None
115019	115020	combined	0	None
115020	115021	treatment	0	None
115021	115022	synergistically	0	None
115022	115023	decreased	0	None
115023	115024	the	0	None
115024	115025	isoprenaline-induced	0	None
115025	115026	maximal	0	None
115026	115027	relaxation	0	None
115027	115028	,	0	None
115028	115029	as	0	None
115029	115030	compared	0	None
115030	115031	to	0	None
115031	115032	the	0	None
115032	115033	individual	0	None
115033	115034	effects	0	None
115034	115035	of	0	None
115035	115036	PMA	0	None
115036	115037	and	0	None
115037	115038	fenoterol	2	CHEMICAL
115038	115039	alone	0	None
115039	115040	,	0	None
115040	115041	indicating	0	None
115041	115042	a	0	None
115042	115043	common	0	None
115043	115044	pathway	0	None
115044	115045	for	0	None
115045	115046	heterologous	0	None
115046	115047	and	0	None
115047	115048	homologous	0	None
115048	115049	desensitization	0	None
115049	115050	.	0	None

115051	115052	Moreover	0	None
115052	115053	,	0	None
115053	115054	the	0	None
115054	115055	specific	0	None
115055	115056	PKC-inhibitor	0	None
115056	115057	2-	0	None
115057	115058	[	0	None
115058	115059	1-	0	None
115059	115060	(	0	None
115060	115061	3-dimethylaminopropyl	0	None
115061	115062	)	0	None
115062	115063	-1H-indol-3-yl	0	None
115063	115064	]	0	None
115064	115065	-3-	0	None
115065	115066	(	0	None
115066	115067	1H-indol-3-yl	0	None
115067	115068	)	0	None
115068	115069	maleimide	0	None
115069	115070	(	0	None
115070	115071	GF	0	None
115071	115072	109203X	0	None
115072	115073	)	0	None
115073	115074	markedly	0	None
115074	115075	increased	0	None
115075	115076	the	0	None
115076	115077	potency	0	None
115077	115078	and	0	None
115078	115079	E	0	None
115079	115080	(	0	None
115080	115081	max	0	None
115081	115082	)	0	None
115082	115083	of	0	None
115083	115084	isoprenaline	2	CHEMICAL
115084	115085	for	0	None
115085	115086	all	0	None
115086	115087	conditions	0	None
115087	115088	used	0	None
115088	115089	,	0	None
115089	115090	including	0	None
115090	115091	control	0	None
115091	115092	conditions	0	None
115092	115093	,	0	None
115093	115094	and	0	None
115094	115095	the	0	None
115095	115096	synergistic	0	None
115096	115097	effects	0	None
115097	115098	of	0	None
115098	115099	PMA	0	None
115099	115100	and	0	None
115100	115101	fenoterol	2	CHEMICAL
115101	115102	were	0	None
115102	115103	completely	0	None
115103	115104	prevented	0	None
115104	115105	.	0	None

115106	115107	In	0	None
115107	115108	conclusion	0	None
115108	115109	,	0	None
115109	115110	the	0	None
115110	115111	present	0	None
115111	115112	study	0	None
115112	115113	demonstrates	0	None
115113	115114	that	0	None
115114	115115	homologous	0	None
115115	115116	desensitization	0	None
115116	115117	of	0	None
115117	115118	the	0	None
115118	115119	beta	0	None
115119	115120	(	0	None
115120	115121	2	0	None
115121	115122	)	0	None
115122	115123	-adrenergic	0	None
115123	115124	receptor	0	None
115124	115125	can	0	None
115125	115126	be	0	None
115126	115127	enhanced	0	None
115127	115128	by	0	None
115128	115129	PKC	0	None
115129	115130	activation	0	None
115130	115131	.	0	None

115132	115133	For	0	None
115133	115134	the	0	None
115134	115135	first	0	None
115135	115136	time	0	None
115136	115137	we	0	None
115137	115138	have	0	None
115138	115139	provided	0	None
115139	115140	evidence	0	None
115140	115141	that	0	None
115141	115142	this	0	None
115142	115143	concept	0	None
115143	115144	is	0	None
115144	115145	functionally	0	None
115145	115146	operative	0	None
115146	115147	in	0	None
115147	115148	airway	0	None
115148	115149	smooth	0	None
115149	115150	muscle	0	None
115150	115151	,	0	None
115151	115152	and	0	None
115152	115153	it	0	None
115153	115154	may	0	None
115154	115155	explain	0	None
115155	115156	the	0	None
115156	115157	reduced	0	None
115157	115158	bronchodilator	0	None
115158	115159	response	0	None
115159	115160	to	0	None
115160	115161	beta	0	None
115161	115162	(	0	None
115162	115163	2	0	None
115163	115164	)	0	None
115164	115165	-adrenoceptor	0	None
115165	115166	agonists	0	None
115166	115167	in	0	None
115167	115168	patients	0	None
115168	115169	with	0	None
115169	115170	asthma	0	None
115170	115171	during	0	None
115171	115172	a	0	None
115172	115173	severe	0	None
115173	115174	exacerbation	0	None
115174	115175	.	0	None
115175	115176	Inhibition	0	None
115176	115177	pathways	0	None
115177	115178	of	0	None
115178	115179	the	0	None
115179	115180	potent	0	None
115180	115181	organophosphate	2	CHEMICAL
115181	115182	CBDP	0	None
115182	115183	with	0	None
115183	115184	cholinesterases	0	None
115184	115185	revealed	0	None
115185	115186	by	0	None
115186	115187	X-ray	0	None
115187	115188	crystallographic	0	None
115188	115189	snapshots	0	None
115189	115190	and	0	None
115190	115191	mass	0	None
115191	115192	spectrometry	0	None
115192	115193	.	0	None
115193	115194	Disrupted	0	None
115194	115195	cytoskeletal	0	None
115195	115196	homeostasis	0	None
115196	115197	,	0	None
115197	115198	astrogliosis	0	None
115198	115199	and	0	None
115199	115200	apoptotic	0	None
115200	115201	cell	0	None
115201	115202	death	0	None
115202	115203	in	0	None
115203	115204	the	0	None
115204	115205	cerebellum	0	None
115205	115206	of	0	None
115206	115207	preweaning	0	None
115207	115208	rats	0	None
115208	115209	injected	0	None
115209	115210	with	0	None
115210	115211	diphenyl	0	None
115211	115212	ditelluride	0	None
115212	115213	.	0	None
115213	115214	Investigating	0	None
115214	115215	the	0	None
115215	115216	enteroenteric	0	None
115216	115217	recirculation	0	None
115217	115218	of	0	None
115218	115219	apixaban	2	CHEMICAL
115219	115220	,	0	None
115220	115221	a	0	None
115221	115222	factor	0	None
115222	115223	Xa	0	None
115223	115224	inhibitor	0	None
115224	115225	:	0	None
115225	115226	administration	0	None
115226	115227	of	0	None
115227	115228	activated	0	None
115228	115229	charcoal	0	None
115229	115230	to	0	None
115230	115231	bile	0	None
115231	115232	duct-cannulated	0	None
115232	115233	rats	0	None
115233	115234	and	0	None
115234	115235	dogs	0	None
115235	115236	receiving	0	None
115236	115237	an	0	None
115237	115238	intravenous	0	None
115238	115239	dose	0	None
115239	115240	and	0	None
115240	115241	use	0	None
115241	115242	of	0	None
115242	115243	drug	0	None
115243	115244	transporter	0	None
115244	115245	knockout	0	None
115245	115246	rats	0	None
115246	115247	.	0	None
115247	115248	Mutations	0	None
115248	115249	in	0	None
115249	115253	leucine-rich repeat kinase 2	3	GENE-N
115253	115254	(	0	None
115254	115255	LRRK2	0	None
115255	115256	)	0	None
115256	115257	are	0	None
115257	115258	associated	0	None
115258	115259	with	0	None
115259	115260	familial	0	None
115260	115261	Parkinson's	0	None
115261	115262	disease	0	None
115262	115263	(	0	None
115263	115264	PD	0	None
115264	115265	)	0	None
115265	115266	.	0	None

115267	115268	The	0	None
115268	115269	kinase	0	None
115269	115270	activity	0	None
115270	115271	of	0	None
115271	115272	this	0	None
115272	115273	complex	0	None
115273	115274	protein	0	None
115274	115275	is	0	None
115275	115276	increased	0	None
115276	115277	by	0	None
115277	115278	pathogenic	0	None
115278	115279	mutations	0	None
115279	115280	.	0	None

115281	115282	Inhibition	0	None
115282	115283	of	0	None
115283	115284	LRRK2	0	None
115284	115285	kinase	0	None
115285	115286	activity	0	None
115286	115287	has	0	None
115287	115288	therefore	0	None
115288	115289	emerged	0	None
115289	115290	as	0	None
115290	115291	a	0	None
115291	115292	promising	0	None
115292	115293	approach	0	None
115293	115294	for	0	None
115294	115295	the	0	None
115295	115296	treatment	0	None
115296	115297	of	0	None
115297	115298	PD	0	None
115298	115299	.	0	None

115300	115301	Herein	0	None
115301	115302	we	0	None
115302	115303	report	0	None
115303	115304	our	0	None
115304	115305	findings	0	None
115305	115306	on	0	None
115306	115307	a	0	None
115307	115308	series	0	None
115308	115309	of	0	None
115309	115310	4-alkylamino-7-aryl-3-cyanoquinolines	0	None
115310	115311	that	0	None
115311	115312	exhibit	0	None
115312	115313	kinase	0	None
115313	115314	inhibitory	0	None
115314	115315	activity	0	None
115315	115316	against	0	None
115316	115317	both	0	None
115317	115318	wild	0	None
115318	115319	type	0	None
115319	115320	and	0	None
115320	115321	G2019S	0	None
115321	115322	mutant	0	None
115322	115323	LRRK2	0	None
115323	115324	.	0	None

115325	115326	Activity	0	None
115326	115327	was	0	None
115327	115328	determined	0	None
115328	115329	in	0	None
115329	115330	both	0	None
115330	115331	biochemical	0	None
115331	115332	and	0	None
115332	115333	cellular	0	None
115333	115334	assays	0	None
115334	115335	.	0	None

115336	115337	Compound	0	None
115337	115338	14	0	None
115338	115339	was	0	None
115339	115340	further	0	None
115340	115341	evaluated	0	None
115341	115342	in	0	None
115342	115343	an	0	None
115343	115344	in	0	None
115344	115345	vivo	0	None
115345	115346	pharmacodynamic	0	None
115346	115347	study	0	None
115347	115348	and	0	None
115348	115349	found	0	None
115349	115350	to	0	None
115350	115351	significantly	0	None
115351	115352	inhibit	0	None
115352	115353	Ser935	0	None
115353	115354	phosphorylation	0	None
115354	115355	after	0	None
115355	115356	oral	0	None
115356	115357	dosing	0	None
115357	115358	.	0	None
115358	115359	Endocrine	0	None
115359	115360	disrupting	0	None
115360	115361	effects	0	None
115361	115362	of	0	None
115362	115363	ochratoxin	0	None
115363	115364	A	0	None
115364	115365	at	0	None
115365	115366	the	0	None
115366	115367	level	0	None
115367	115368	of	0	None
115368	115370	nuclear receptor	3	GENE-N
115370	115371	activation	0	None
115371	115372	and	0	None
115372	115373	steroidogenesis	0	None
115373	115374	.	0	None
115374	115375	Zolmitriptan	0	None
115375	115376	and	0	None
115376	115377	human	0	None
115377	115378	aggression	0	None
115378	115379	:	0	None
115379	115380	interaction	0	None
115380	115381	with	0	None
115381	115382	alcohol	2	CHEMICAL
115382	115383	.	0	None
115383	115384	The	0	None
115384	115385	fidelity	0	None
115385	115386	of	0	None
115386	115387	transcription	0	None
115387	115388	:	0	None
115388	115389	RPB1	0	None
115389	115390	(	0	None
115390	115391	RPO21	0	None
115391	115392	)	0	None
115392	115393	mutations	0	None
115393	115394	that	0	None
115394	115395	increase	0	None
115395	115396	transcriptional	0	None
115396	115397	slippage	0	None
115397	115398	in	0	None
115398	115399	S	0	None
115399	115400	.	0	None

115401	115402	cerevisiae	0	None
115402	115403	.	0	None
115403	115404	The	0	None
115404	115405	effects	0	None
115405	115406	of	0	None
115406	115407	kisspeptin	0	None
115407	115408	in	0	None
115408	115409	human	0	None
115409	115410	reproductive	0	None
115410	115411	function	0	None
115411	115412	-	0	None
115412	115413	therapeutic	0	None
115413	115414	implications	0	None
115414	115415	.	0	None
115415	115416	Carvedilol	0	None
115416	115417	selectively	0	None
115417	115418	inhibits	0	None
115418	115419	oscillatory	0	None
115419	115420	intracellular	0	None
115420	115421	calcium	0	None
115421	115422	changes	0	None
115422	115423	evoked	0	None
115423	115424	by	0	None
115424	115425	human	0	None
115425	115429	alpha1D- and alpha1B-adrenergic receptors	1	GENE-Y
115429	115430	.	0	None
115430	115431	Twelve	0	None
115431	115432	alkyl	0	None
115432	115433	analogues	0	None
115433	115434	(	0	None
115434	115435	1-12	0	None
115435	115436	)	0	None
115436	115437	of	0	None
115437	115438	the	0	None
115438	115439	high-affinity	0	None
115439	115441	serotonin transporter	1	GENE-Y
115441	115442	(	0	None
115442	115443	SERT	0	None
115443	115444	)	0	None
115444	115445	inhibitor	0	None
115445	115446	6-nitroquipazine	0	None
115446	115447	(	0	None
115447	115448	6-NQ	0	None
115448	115449	)	0	None
115449	115450	were	0	None
115450	115451	synthesized	0	None
115451	115452	and	0	None
115452	115453	studied	0	None
115453	115454	using	0	None
115454	115455	in	0	None
115455	115456	vitro	0	None
115456	115457	radioligand	0	None
115457	115458	competition	0	None
115458	115459	binding	0	None
115459	115460	assays	0	None
115460	115461	to	0	None
115461	115462	determine	0	None
115462	115463	their	0	None
115463	115464	binding	0	None
115464	115465	affinity	0	None
115465	115466	(	0	None
115466	115467	Ki	0	None
115467	115468	)	0	None
115468	115469	.	0	None

115470	115471	The	0	None
115471	115472	putative	0	None
115472	115473	antidepressant	0	None
115473	115474	activity	0	None
115474	115475	of	0	None
115475	115476	five	0	None
115476	115477	of	0	None
115477	115478	the	0	None
115478	115479	binders	0	None
115479	115480	with	0	None
115480	115481	the	0	None
115481	115482	highest	0	None
115482	115483	SERT	0	None
115483	115484	binding	0	None
115484	115485	affinities	0	None
115485	115486	was	0	None
115486	115487	studied	0	None
115487	115488	by	0	None
115488	115489	the	0	None
115489	115490	forced	0	None
115490	115491	swim	0	None
115491	115492	and	0	None
115492	115493	locomotor	0	None
115493	115494	activity	0	None
115494	115495	mouse	0	None
115495	115496	tests	0	None
115496	115497	.	0	None

115498	115499	The	0	None
115499	115500	three-dimensional	0	None
115500	115501	(	0	None
115501	115502	3D	0	None
115502	115503	)	0	None
115503	115504	structures	0	None
115504	115505	of	0	None
115505	115506	8	0	None
115506	115507	and	0	None
115507	115508	9	0	None
115508	115509	were	0	None
115509	115510	determined	0	None
115510	115511	using	0	None
115511	115512	NOE	0	None
115512	115513	NMR	0	None
115513	115514	technique	0	None
115514	115515	.	0	None

115516	115517	Flexible	0	None
115517	115518	docking	0	None
115518	115519	of	0	None
115519	115520	the	0	None
115520	115521	compounds	0	None
115521	115522	was	0	None
115522	115523	undertaken	0	None
115523	115524	to	0	None
115524	115525	illustrate	0	None
115525	115526	the	0	None
115526	115527	binding	0	None
115527	115528	of	0	None
115528	115529	the	0	None
115529	115530	compounds	0	None
115530	115531	in	0	None
115531	115532	the	0	None
115532	115533	SERT	0	None
115533	115534	model	0	None
115534	115535	.	0	None

115536	115537	Our	0	None
115537	115538	results	0	None
115538	115539	showed	0	None
115539	115540	that	0	None
115540	115541	several	0	None
115541	115542	of	0	None
115542	115543	the	0	None
115543	115544	6-NQ	0	None
115544	115545	analogues	0	None
115545	115546	are	0	None
115546	115547	high-affinity	0	None
115547	115548	SERT	0	None
115548	115549	inhibitors	0	None
115549	115550	and	0	None
115550	115551	indicated	0	None
115551	115552	that	0	None
115552	115553	the	0	None
115553	115554	octyl	0	None
115554	115555	(	0	None
115555	115556	8	0	None
115556	115557	)	0	None
115557	115558	,	0	None
115558	115559	decyl	0	None
115559	115560	(	0	None
115560	115561	10	0	None
115561	115562	)	0	None
115562	115563	and	0	None
115563	115564	dodecyl	2	CHEMICAL
115564	115565	(	0	None
115565	115566	12	0	None
115566	115567	)	0	None
115567	115568	6-NQ	0	None
115568	115569	analogues	0	None
115569	115570	exhibit	0	None
115570	115571	moderate	0	None
115571	115572	antidepressant	0	None
115572	115573	activity	0	None
115573	115574	.	0	None
115574	115575	Involvement	0	None
115575	115576	of	0	None
115576	115579	serotonin 5-HT3 receptors	1	GENE-Y
115579	115580	in	0	None
115580	115581	the	0	None
115581	115582	modulation	0	None
115582	115583	of	0	None
115583	115584	noradrenergic	0	None
115584	115585	transmission	0	None
115585	115586	by	0	None
115586	115587	serotonin	0	None
115587	115588	reuptake	0	None
115588	115589	inhibitors	0	None
115589	115590	:	0	None
115590	115591	a	0	None
115591	115592	microdialysis	0	None
115592	115593	study	0	None
115593	115594	in	0	None
115594	115595	rat	0	None
115595	115596	brain	0	None
115596	115597	.	0	None
115597	115598	A	0	None
115598	115599	base	0	None
115599	115600	substitution	0	None
115600	115601	at	0	None
115601	115602	a	0	None
115602	115603	splice	0	None
115603	115604	site	0	None
115604	115605	in	0	None
115605	115606	the	0	None
115606	115607	COL3A1	0	None
115607	115608	gene	0	None
115608	115609	causes	0	None
115609	115610	exon	0	None
115610	115611	skipping	0	None
115611	115612	and	0	None
115612	115613	generates	0	None
115613	115614	abnormal	0	None
115614	115615	type	0	None
115615	115616	III	0	None
115616	115617	procollagen	0	None
115617	115618	in	0	None
115618	115619	a	0	None
115619	115620	patient	0	None
115620	115621	with	0	None
115621	115622	Ehlers-Danlos	0	None
115622	115623	syndrome	0	None
115623	115624	type	0	None
115624	115625	IV	0	None
115625	115626	.	0	None
115626	115627	ADEPT	0	None
115627	115628	:	0	None
115628	115629	Addition	0	None
115629	115630	of	0	None
115630	115631	the	0	None
115631	115632	AT1	0	None
115632	115633	receptor	0	None
115633	115634	antagonist	0	None
115634	115635	eprosartan	0	None
115635	115636	to	0	None
115636	115637	ACE	0	None
115637	115638	inhibitor	0	None
115638	115639	therapy	0	None
115639	115640	in	0	None
115640	115641	chronic	0	None
115641	115642	heart	0	None
115642	115643	failure	0	None
115643	115644	trial	0	None
115644	115645	:	0	None
115645	115646	hemodynamic	0	None
115646	115647	and	0	None
115647	115648	neurohormonal	0	None
115648	115649	effects	0	None
115649	115650	.	0	None
115650	115651	Ntp	0	None
115651	115652	and	0	None
115652	115653	Ctp	0	None
115653	115654	,	0	None
115654	115655	synthetic	0	None
115655	115656	peptides	0	None
115656	115657	based	0	None
115657	115658	on	0	None
115658	115659	the	0	None
115659	115660	N-	0	None
115660	115661	and	0	None
115661	115662	C-terminal	0	None
115662	115663	sequences	0	None
115663	115664	of	0	None
115664	115665	K	0	None
115665	115666	(	0	None
115666	115667	IR	0	None
115667	115668	)	0	None
115668	115669	6	0	None
115669	115670	.	0	None
115670	115671	0	0	None
115671	115672	,	0	None
115672	115673	respectively	0	None
115673	115674	,	0	None
115674	115675	were	0	None
115675	115676	used	0	None
115676	115677	to	0	None
115677	115678	probe	0	None
115678	115679	gating	0	None
115679	115680	of	0	None
115680	115681	K	0	None
115681	115682	(	0	None
115682	115683	IR	0	None
115683	115684	)	0	None
115684	115685	6	0	None
115685	115686	.	0	None
115686	115687	0	0	None
115687	115688	/	0	None
115688	115689	SUR	0	None
115689	115690	K	0	None
115690	115691	(	0	None
115691	115692	ATP	0	None
115692	115693	)	0	None
115693	115694	channels	0	None
115694	115695	.	0	None

115696	115697	Micromolar	0	None
115697	115698	Ntp	0	None
115698	115699	dose-dependently	0	None
115699	115700	increased	0	None
115700	115701	the	0	None
115701	115702	mean	0	None
115702	115703	open	0	None
115703	115704	channel	0	None
115704	115705	probability	0	None
115705	115706	in	0	None
115706	115707	ligand-free	0	None
115707	115708	solution	0	None
115708	115709	(	0	None
115709	115710	P	0	None
115710	115711	(	0	None
115711	115712	O	0	None
115712	115713	(	0	None
115713	115714	max	0	None
115714	115715	)	0	None
115715	115716	)	0	None
115716	115717	)	0	None
115717	115718	and	0	None
115718	115719	attenuated	0	None
115719	115720	the	0	None
115720	115721	ATP	0	None
115721	115722	inhibition	0	None
115722	115723	of	0	None
115723	115724	K	0	None
115724	115725	(	0	None
115725	115726	IR	0	None
115726	115727	)	0	None
115727	115728	6	0	None
115728	115729	.	0	None
115729	115730	2	0	None
115730	115731	/	0	None
115731	115732	SUR1	0	None
115732	115733	,	0	None
115733	115734	but	0	None
115734	115735	had	0	None
115735	115736	no	0	None
115736	115737	effect	0	None
115737	115738	on	0	None
115738	115739	homomeric	0	None
115739	115740	K	0	None
115740	115741	(	0	None
115741	115742	IR	0	None
115742	115743	)	0	None
115743	115744	6	0	None
115744	115745	.	0	None
115745	115746	2	0	None
115746	115747	channels	0	None
115747	115748	.	0	None

115749	115750	Ntp	0	None
115750	115751	(	0	None
115751	115752	up	0	None
115752	115753	to	0	None
115753	115754	approximately	0	None
115754	115755	10	0	None
115755	115756	(	0	None
115756	115757	-4	0	None
115757	115758	)	0	None
115758	115759	m	0	None
115759	115760	)	0	None
115760	115761	did	0	None
115761	115762	not	0	None
115762	115763	affect	0	None
115763	115764	significantly	0	None
115764	115765	the	0	None
115765	115766	mean	0	None
115766	115767	open	0	None
115767	115768	or	0	None
115768	115769	"fast	0	None
115769	115770	,	0	None
115770	115771	"	0	None
115771	115772	K	0	None
115772	115773	(	0	None
115773	115774	+	0	None
115774	115775	)	0	None
115775	115776	driving	0	None
115776	115777	force-dependent	0	None
115777	115778	,	0	None
115778	115779	intraburst	0	None
115779	115780	closed	0	None
115780	115781	times	0	None
115781	115782	,	0	None
115782	115783	verifying	0	None
115783	115784	that	0	None
115784	115785	Ntp	0	None
115785	115786	selectively	0	None
115786	115787	modulates	0	None
115787	115788	the	0	None
115788	115789	ratio	0	None
115789	115790	of	0	None
115790	115791	mean	0	None
115791	115792	burst	0	None
115792	115793	to	0	None
115793	115794	interburst	0	None
115794	115795	times	0	None
115795	115796	.	0	None

115797	115798	Ctp	0	None
115798	115799	and	0	None
115799	115800	Rnp	0	None
115800	115801	,	0	None
115801	115802	a	0	None
115802	115803	randomized	0	None
115803	115804	Ntp	0	None
115804	115805	,	0	None
115805	115806	had	0	None
115806	115807	no	0	None
115807	115808	effect	0	None
115808	115809	,	0	None
115809	115810	indicating	0	None
115810	115811	that	0	None
115811	115812	the	0	None
115812	115813	effects	0	None
115813	115814	of	0	None
115814	115815	Ntp	0	None
115815	115816	are	0	None
115816	115817	structure	0	None
115817	115818	specific	0	None
115818	115819	.	0	None

115820	115821	Ntp	0	None
115821	115822	opened	0	None
115822	115823	K	0	None
115823	115824	(	0	None
115824	115825	IR	0	None
115825	115826	)	0	None
115826	115827	6	0	None
115827	115828	.	0	None
115828	115829	1	0	None
115829	115830	/	0	None
115830	115831	SUR1	0	None
115831	115832	channels	0	None
115832	115833	normally	0	None
115833	115834	silent	0	None
115834	115835	in	0	None
115835	115836	the	0	None
115836	115837	absence	0	None
115837	115838	of	0	None
115838	115839	stimulatory	0	None
115839	115840	Mg	2	CHEMICAL
115840	115841	(	0	None
115841	115842	-	0	None
115842	115843	)	0	None
115843	115844	nucleotide	0	None
115844	115845	(	0	None
115845	115846	s	0	None
115846	115847	)	0	None
115847	115848	and	0	None
115848	115849	attenuated	0	None
115849	115850	the	0	None
115850	115851	coupling	0	None
115851	115852	of	0	None
115852	115853	high-affinity	0	None
115853	115854	sulfonylurea	2	CHEMICAL
115854	115855	binding	0	None
115855	115856	with	0	None
115856	115857	K	0	None
115857	115858	(	0	None
115858	115859	ATP	0	None
115859	115860	)	0	None
115860	115861	pore	0	None
115861	115862	closure	0	None
115862	115863	.	0	None

115864	115865	These	0	None
115865	115866	effects	0	None
115866	115867	resemble	0	None
115867	115868	those	0	None
115868	115869	seen	0	None
115869	115870	with	0	None
115870	115871	N-terminal	0	None
115871	115872	deletions	0	None
115872	115873	(	0	None
115873	115874	DeltaN	0	None
115874	115875	)	0	None
115875	115876	of	0	None
115876	115877	K	0	None
115877	115878	(	0	None
115878	115879	IR	0	None
115879	115880	)	0	None
115880	115881	6	0	None
115881	115882	.	0	None
115882	115883	0	0	None
115883	115884	,	0	None
115884	115885	and	0	None
115885	115886	application	0	None
115886	115887	of	0	None
115887	115888	Ntp	0	None
115888	115889	to	0	None
115889	115890	DeltaNK	0	None
115890	115891	(	0	None
115891	115892	ATP	0	None
115892	115893	)	0	None
115893	115894	channels	0	None
115894	115895	decreased	0	None
115895	115896	their	0	None
115896	115897	P	0	None
115897	115898	(	0	None
115898	115899	O	0	None
115899	115900	(	0	None
115900	115901	max	0	None
115901	115902	)	0	None
115902	115903	)	0	None
115903	115904	and	0	None
115904	115905	apparent	0	None
115905	115906	IC	0	None
115906	115907	(	0	None
115907	115908	50	0	None
115908	115909	)	0	None
115909	115910	for	0	None
115910	115911	ATP	0	None
115911	115912	in	0	None
115912	115913	the	0	None
115913	115914	absence	0	None
115914	115915	of	0	None
115915	115916	Mg	2	CHEMICAL
115916	115917	(	0	None
115917	115918	2	0	None
115918	115919	+	0	None
115919	115920	)	0	None
115920	115921	.	0	None

115922	115923	The	0	None
115923	115924	results	0	None
115924	115925	are	0	None
115925	115926	consistent	0	None
115926	115927	with	0	None
115927	115928	a	0	None
115928	115929	competition	0	None
115929	115930	between	0	None
115930	115931	Ntp	0	None
115931	115932	and	0	None
115932	115933	the	0	None
115933	115934	endogenous	0	None
115934	115935	N	0	None
115935	115936	terminus	0	None
115936	115937	for	0	None
115937	115938	a	0	None
115938	115939	site	0	None
115939	115940	of	0	None
115940	115941	interaction	0	None
115941	115942	on	0	None
115942	115943	the	0	None
115943	115944	cytoplasmic	0	None
115944	115945	face	0	None
115945	115946	of	0	None
115946	115947	the	0	None
115947	115948	channel	0	None
115948	115949	or	0	None
115949	115950	with	0	None
115950	115951	partial	0	None
115951	115952	replacement	0	None
115952	115953	of	0	None
115953	115954	the	0	None
115954	115955	deleted	0	None
115955	115956	N	0	None
115956	115957	terminus	0	None
115957	115958	by	0	None
115958	115959	Ntp	0	None
115959	115960	,	0	None
115960	115961	respectively	0	None
115961	115962	.	0	None

115963	115964	The	0	None
115964	115965	K	0	None
115965	115966	(	0	None
115966	115967	IR	0	None
115967	115968	)	0	None
115968	115969	N	0	None
115969	115970	terminus	0	None
115970	115971	and	0	None
115971	115972	the	0	None
115972	115973	TMD0-L0	0	None
115973	115974	segment	0	None
115974	115975	of	0	None
115975	115976	SUR1	0	None
115976	115977	are	0	None
115977	115978	known	0	None
115978	115979	to	0	None
115979	115980	control	0	None
115980	115981	the	0	None
115981	115982	P	0	None
115982	115983	(	0	None
115983	115984	O	0	None
115984	115985	(	0	None
115985	115986	max	0	None
115986	115987	)	0	None
115987	115988	)	0	None
115988	115989	.	0	None

115990	115991	The	0	None
115991	115992	L0	0	None
115992	115993	linker	0	None
115993	115994	has	0	None
115994	115995	been	0	None
115995	115996	reported	0	None
115996	115997	to	0	None
115997	115998	be	0	None
115998	115999	required	0	None
115999	116000	for	0	None
116000	116001	glibenclamide	0	None
116001	116002	binding	0	None
116002	116003	,	0	None
116003	116004	and	0	None
116004	116005	DeltaNK	0	None
116005	116006	(	0	None
116006	116007	IR	0	None
116007	116008	)	0	None
116008	116009	6	0	None
116009	116010	.	0	None
116010	116011	2	0	None
116011	116012	/	0	None
116012	116013	SUR1	0	None
116013	116014	channels	0	None
116014	116015	exhibit	0	None
116015	116016	reduced	0	None
116016	116017	labeling	0	None
116017	116018	of	0	None
116018	116019	K	0	None
116019	116020	(	0	None
116020	116021	IR	0	None
116021	116022	)	0	None
116022	116023	with	0	None
116023	116024	(	0	None
116024	116025	125	0	None
116025	116026	)	0	None
116026	116027	I-azidoglibenclamide	0	None
116027	116028	,	0	None
116028	116029	implying	0	None
116029	116030	that	0	None
116030	116031	the	0	None
116031	116032	K	0	None
116032	116033	(	0	None
116033	116034	IR	0	None
116034	116035	)	0	None
116035	116036	N	0	None
116036	116037	terminus	0	None
116037	116038	and	0	None
116038	116039	L0	0	None
116039	116040	of	0	None
116040	116041	SUR1	0	None
116041	116042	are	0	None
116042	116043	in	0	None
116043	116044	proximity	0	None
116044	116045	.	0	None

116046	116047	We	0	None
116047	116048	hypothesize	0	None
116048	116049	that	0	None
116049	116050	L0	0	None
116050	116051	interacts	0	None
116051	116052	with	0	None
116052	116053	the	0	None
116053	116054	K	0	None
116054	116055	(	0	None
116055	116056	IR	0	None
116056	116057	)	0	None
116057	116058	N	0	None
116058	116059	terminus	0	None
116059	116060	in	0	None
116060	116061	ligand-inhibited	0	None
116061	116062	K	0	None
116062	116063	(	0	None
116063	116064	ATP	0	None
116064	116065	)	0	None
116065	116066	channels	0	None
116066	116067	and	0	None
116067	116068	put	0	None
116068	116069	forward	0	None
116069	116070	a	0	None
116070	116071	model	0	None
116071	116072	,	0	None
116072	116073	based	0	None
116073	116074	on	0	None
116074	116075	the	0	None
116075	116076	architecture	0	None
116076	116077	of	0	None
116077	116078	BtuCD	0	None
116078	116079	,	0	None
116079	116080	MsbA	0	None
116080	116081	,	0	None
116081	116082	and	0	None
116082	116083	the	0	None
116083	116084	KcsA	0	None
116084	116085	channel	0	None
116085	116086	,	0	None
116086	116087	in	0	None
116087	116088	which	0	None
116088	116089	TMD0-L0	0	None
116089	116090	links	0	None
116090	116091	the	0	None
116091	116092	MDR-like	0	None
116092	116093	core	0	None
116093	116094	of	0	None
116094	116095	SUR	0	None
116095	116096	with	0	None
116096	116097	the	0	None
116097	116098	K	0	None
116098	116099	(	0	None
116099	116100	IR	0	None
116100	116101	)	0	None
116101	116102	pore	0	None
116102	116103	.	0	None
116103	116104	Generation	0	None
116104	116105	and	0	None
116105	116106	analysis	0	None
116106	116107	of	0	None
116107	116108	constitutively	0	None
116108	116109	active	0	None
116109	116110	and	0	None
116110	116111	physically	0	None
116111	116112	destabilized	0	None
116112	116113	mutants	0	None
116113	116114	of	0	None
116114	116115	the	0	None
116115	116116	human	0	None
116116	116117	beta	0	None
116117	116118	(	0	None
116118	116119	1	0	None
116119	116120	)	0	None
116120	116121	-adrenoceptor	0	None
116121	116122	.	0	None
116122	116123	Amide	0	None
116123	116124	hydrolysis	0	None
116124	116125	of	0	None
116125	116126	a	0	None
116126	116127	novel	0	None
116127	116128	chemical	0	None
116128	116129	series	0	None
116129	116130	of	0	None
116130	116131	microsomal	0	None
116131	116132	prostaglandin	0	None
116132	116133	E	0	None
116133	116134	synthase-1	0	None
116134	116135	inhibitors	0	None
116135	116136	induces	0	None
116136	116137	kidney	0	None
116137	116138	toxicity	0	None
116138	116139	in	0	None
116139	116140	the	0	None
116140	116141	rat	0	None
116141	116142	.	0	None
116142	116143	The	0	None
116143	116144	assembly	0	None
116144	116145	and	0	None
116145	116146	activation	0	None
116146	116147	of	0	None
116147	116148	oligomeric	0	None
116148	116149	complexes	0	None
116149	116150	of	0	None
116150	116151	FGF	0	None
116151	116152	,	0	None
116152	116153	the	0	None
116153	116154	transmembrane	0	None
116154	116155	receptor	0	None
116155	116156	kinase	0	None
116156	116157	(	0	None
116157	116158	FGFR	0	None
116158	116159	)	0	None
116159	116160	,	0	None
116160	116161	and	0	None
116161	116162	heparan	0	None
116162	116163	sulfate	2	CHEMICAL
116163	116164	transmit	0	None
116164	116165	intracellular	0	None
116165	116166	signals	0	None
116166	116167	regulating	0	None
116167	116168	growth	0	None
116168	116169	and	0	None
116169	116170	function	0	None
116170	116171	of	0	None
116171	116172	cells	0	None
116172	116173	.	0	None

116174	116175	An	0	None
116175	116176	understanding	0	None
116176	116177	of	0	None
116177	116178	the	0	None
116178	116179	structural	0	None
116179	116180	relationships	0	None
116180	116181	between	0	None
116181	116182	the	0	None
116182	116183	three	0	None
116183	116184	subunits	0	None
116184	116185	and	0	None
116185	116186	their	0	None
116186	116187	redundancy	0	None
116187	116188	and	0	None
116188	116189	specificity	0	None
116189	116190	is	0	None
116190	116191	essential	0	None
116191	116192	for	0	None
116192	116193	understanding	0	None
116193	116194	the	0	None
116194	116195	ubiquitous	0	None
116195	116196	FGF	0	None
116196	116197	signaling	0	None
116197	116198	system	0	None
116198	116199	in	0	None
116199	116200	health	0	None
116200	116201	and	0	None
116201	116202	disease	0	None
116202	116203	.	0	None

116204	116205	Previously	0	None
116205	116206	,	0	None
116206	116207	we	0	None
116207	116208	reported	0	None
116208	116209	that	0	None
116209	116210	a	0	None
116210	116211	primary	0	None
116211	116212	heparin	0	None
116212	116213	or	0	None
116213	116214	heparan	0	None
116214	116215	sulfate	2	CHEMICAL
116215	116216	binding	0	None
116216	116217	site	0	None
116217	116218	resides	0	None
116218	116219	in	0	None
116219	116220	a	0	None
116220	116221	distinct	0	None
116221	116222	sequence	0	None
116222	116223	in	0	None
116223	116224	immunoglobulin	0	None
116224	116225	(	0	None
116225	116226	Ig	0	None
116226	116227	)	0	None
116227	116228	-like	0	None
116228	116229	module	0	None
116229	116230	II	0	None
116230	116231	of	0	None
116231	116232	the	0	None
116232	116233	three	0	None
116233	116234	modules	0	None
116234	116235	of	0	None
116235	116236	FGFR	0	None
116236	116237	.	0	None

116238	116239	Here	0	None
116239	116240	we	0	None
116240	116241	report	0	None
116241	116242	that	0	None
116242	116243	in	0	None
116243	116244	the	0	None
116244	116245	absence	0	None
116245	116246	of	0	None
116246	116247	flanking	0	None
116247	116248	sequences	0	None
116248	116249	,	0	None
116249	116250	isolated	0	None
116250	116251	Ig	0	None
116251	116252	module	0	None
116252	116253	II	0	None
116253	116254	of	0	None
116254	116255	FGFR1	0	None
116255	116256	supports	0	None
116256	116257	the	0	None
116257	116258	binding	0	None
116258	116259	of	0	None
116259	116260	FGF-1	0	None
116260	116261	,	0	None
116261	116262	FGF-2	0	None
116262	116263	,	0	None
116263	116264	and	0	None
116264	116265	FGF-7	0	None
116265	116266	in	0	None
116266	116267	respective	0	None
116267	116268	order	0	None
116268	116269	of	0	None
116269	116270	affinity	0	None
116270	116271	.	0	None

116272	116273	None	0	None
116273	116274	of	0	None
116274	116275	the	0	None
116275	116276	three	0	None
116276	116277	FGFs	0	None
116277	116278	detectably	0	None
116278	116279	bind	0	None
116279	116280	Ig	0	None
116280	116281	module	0	None
116281	116282	I	0	None
116282	116283	or	0	None
116283	116284	the	0	None
116284	116285	IIIb	0	None
116285	116286	and	0	None
116286	116287	IIIc	0	None
116287	116288	splice	0	None
116288	116289	variants	0	None
116289	116290	of	0	None
116290	116291	Ig	0	None
116291	116292	module	0	None
116292	116293	III	0	None
116293	116294	in	0	None
116294	116295	the	0	None
116295	116296	absence	0	None
116296	116297	of	0	None
116297	116298	flanking	0	None
116298	116299	sequences	0	None
116299	116300	.	0	None

116301	116302	Ig	0	None
116302	116303	module	0	None
116303	116304	I	0	None
116304	116305	and	0	None
116305	116306	the	0	None
116306	116307	C-terminus	0	None
116307	116308	of	0	None
116308	116309	Ig	0	None
116309	116310	module	0	None
116310	116311	III	0	None
116311	116312	are	0	None
116312	116313	dispensable	0	None
116313	116314	for	0	None
116314	116315	high-affinity	0	None
116315	116316	binding	0	None
116316	116317	of	0	None
116317	116318	FGF-1	0	None
116318	116319	,	0	None
116319	116320	FGF-2	0	None
116320	116321	,	0	None
116321	116322	and	0	None
116322	116323	FGF-7	0	None
116323	116324	.	0	None

116325	116326	Alterations	0	None
116326	116327	in	0	None
116327	116328	highly	0	None
116328	116329	conserved	0	None
116329	116330	Ig	0	None
116330	116331	module	0	None
116331	116332	II	0	None
116332	116333	in	0	None
116333	116334	the	0	None
116334	116335	heparin	0	None
116335	116336	binding	0	None
116336	116337	domain	0	None
116337	116338	and	0	None
116338	116339	substitution	0	None
116339	116340	of	0	None
116340	116341	individual	0	None
116341	116342	sequence	0	None
116342	116343	domains	0	None
116343	116344	spanning	0	None
116344	116345	the	0	None
116345	116346	entire	0	None
116346	116347	sequence	0	None
116347	116348	of	0	None
116348	116349	Ig	0	None
116349	116350	module	0	None
116350	116351	II	0	None
116351	116352	with	0	None
116352	116353	those	0	None
116353	116354	from	0	None
116354	116355	Ig	0	None
116355	116356	module	0	None
116356	116357	I	0	None
116357	116358	obliterated	0	None
116358	116359	FGF	0	None
116359	116360	binding	0	None
116360	116361	.	0	None

116362	116363	Addition	0	None
116363	116364	of	0	None
116364	116365	a	0	None
116365	116366	specific	0	None
116366	116367	number	0	None
116367	116368	of	0	None
116368	116369	FGFR	0	None
116369	116370	sequences	0	None
116370	116371	to	0	None
116371	116372	the	0	None
116372	116373	C-terminus	0	None
116373	116374	of	0	None
116374	116375	Ig	0	None
116375	116376	module	0	None
116376	116377	II	0	None
116377	116378	resulted	0	None
116378	116379	in	0	None
116379	116380	a	0	None
116380	116381	gain	0	None
116381	116382	in	0	None
116382	116383	affinity	0	None
116383	116384	for	0	None
116384	116385	FGF-7	0	None
116385	116386	.	0	None

116387	116388	Several	0	None
116388	116389	site-specific	0	None
116389	116390	alterations	0	None
116390	116391	in	0	None
116391	116392	the	0	None
116392	116393	C-terminus	0	None
116393	116394	of	0	None
116394	116395	full-length	0	None
116395	116396	FGFR1IIIc	0	None
116396	116397	,	0	None
116397	116398	an	0	None
116398	116399	isoform	0	None
116399	116400	that	0	None
116400	116401	otherwise	0	None
116401	116402	absolutely	0	None
116402	116403	rejects	0	None
116403	116404	FGF-7	0	None
116404	116405	,	0	None
116405	116406	resulted	0	None
116406	116407	in	0	None
116407	116408	gain	0	None
116408	116409	of	0	None
116409	116410	FGF-7	0	None
116410	116411	binding	0	None
116411	116412	.	0	None

116413	116414	These	0	None
116414	116415	results	0	None
116415	116416	suggest	0	None
116416	116417	that	0	None
116417	116418	a	0	None
116418	116419	complex	0	None
116419	116420	of	0	None
116420	116421	Ig	0	None
116421	116422	module	0	None
116422	116423	II	0	None
116423	116424	and	0	None
116424	116425	heparan	0	None
116425	116426	sulfate	2	CHEMICAL
116426	116427	is	0	None
116427	116428	the	0	None
116428	116429	base	0	None
116429	116430	common	0	None
116430	116431	active	0	None
116431	116432	core	0	None
116432	116433	of	0	None
116433	116434	the	0	None
116434	116435	FGFR	0	None
116435	116436	ectodomain	0	None
116436	116437	and	0	None
116437	116438	that	0	None
116438	116439	flanking	0	None
116439	116440	structural	0	None
116440	116441	domains	0	None
116441	116442	modify	0	None
116442	116443	FGF	0	None
116443	116444	affinity	0	None
116444	116445	and	0	None
116445	116446	determine	0	None
116446	116447	specificity	0	None
116447	116448	.	0	None
116448	116449	Estramustine	0	None
116449	116450	,	0	None
116450	116451	and	0	None
116451	116452	derivatives	0	None
116452	116453	of	0	None
116453	116454	estramustine	0	None
116454	116455	with	0	None
116455	116456	a	0	None
116456	116457	charged	0	None
116457	116458	substituent	0	None
116458	116459	at	0	None
116459	116460	position	0	None
116460	116461	17	0	None
116461	116462	on	0	None
116462	116463	the	0	None
116463	116464	estrogen	0	None
116464	116465	moiety	0	None
116465	116466	,	0	None
116466	116467	have	0	None
116467	116468	been	0	None
116468	116469	investigated	0	None
116469	116470	for	0	None
116470	116471	their	0	None
116471	116472	effects	0	None
116472	116473	on	0	None
116473	116474	bovine	0	None
116474	116475	brain	0	None
116475	116476	microtubules	0	None
116476	116477	in	0	None
116477	116478	vitro	0	None
116478	116479	.	0	None

116480	116481	The	0	None
116481	116482	negatively	0	None
116482	116483	charged	0	None
116483	116484	estramustine	0	None
116484	116485	phosphate	0	None
116485	116486	has	0	None
116486	116487	been	0	None
116487	116488	found	0	None
116488	116489	previously	0	None
116489	116490	to	0	None
116490	116491	be	0	None
116491	116492	a	0	None
116492	116493	microtubule-associated	0	None
116493	116494	protein	0	None
116494	116495	(	0	None
116495	116496	MAP	0	None
116496	116497	)	0	None
116497	116498	-dependent	0	None
116498	116499	microtubule	0	None
116499	116500	inhibitor	0	None
116500	116501	[	0	None
116501	116502	Wallin	0	None
116502	116503	M	0	None
116503	116504	,	0	None
116504	116505	Deinum	0	None
116505	116506	J	0	None
116506	116507	and	0	None
116507	116508	Friden	0	None
116508	116509	B	0	None
116509	116510	,	0	None
116510	116511	FEBS	0	None
116511	116512	Lett	0	None
116512	116513	179	0	None
116513	116514	:	0	None
116514	116515	289-293	0	None
116515	116516	,	0	None
116516	116517	1985	0	None
116517	116518	]	0	None
116518	116519	.	0	None

116520	116521	In	0	None
116521	116522	the	0	None
116522	116523	present	0	None
116523	116524	study	0	None
116524	116525	the	0	None
116525	116526	binding	0	None
116526	116527	of	0	None
116527	116528	estramustine	0	None
116528	116529	phosphate	0	None
116529	116530	to	0	None
116530	116531	MAP2	0	None
116531	116532	and	0	None
116532	116533	tau	1	GENE-Y
116533	116534	was	0	None
116534	116535	investigated	0	None
116535	116536	.	0	None

116537	116538	Both	0	None
116538	116539	these	0	None
116539	116540	MAPs	0	None
116540	116541	were	0	None
116541	116542	found	0	None
116542	116543	to	0	None
116543	116544	have	0	None
116544	116545	two	0	None
116545	116546	to	0	None
116546	116547	three	0	None
116547	116548	binding	0	None
116548	116549	sites	0	None
116549	116550	for	0	None
116550	116551	estramustine	0	None
116551	116552	phosphate	0	None
116552	116553	which	0	None
116553	116554	is	0	None
116554	116555	compatible	0	None
116555	116556	with	0	None
116556	116557	the	0	None
116557	116558	reported	0	None
116558	116559	number	0	None
116559	116560	of	0	None
116560	116561	basic	0	None
116561	116563	amino acid	2	CHEMICAL
116563	116564	repeats	0	None
116564	116565	of	0	None
116565	116566	these	0	None
116566	116567	MAPs	0	None
116567	116568	,	0	None
116568	116569	considered	0	None
116569	116570	to	0	None
116570	116571	be	0	None
116571	116572	the	0	None
116572	116573	ultimate	0	None
116573	116574	tubulin	0	None
116574	116576	binding domains	3	GENE-N
116576	116577	.	0	None

116578	116579	The	0	None
116579	116580	Kd	0	None
116580	116581	for	0	None
116581	116582	the	0	None
116582	116583	binding	0	None
116583	116584	of	0	None
116584	116585	estramustine	0	None
116585	116586	phosphate	0	None
116586	116587	to	0	None
116587	116588	MAP2	0	None
116588	116589	was	0	None
116589	116590	estimated	0	None
116590	116591	to	0	None
116591	116592	be	0	None
116592	116593	20	0	None
116593	116594	microM	0	None
116594	116595	at	0	None
116595	116596	4	0	None
116596	116597	degrees	0	None
116597	116598	,	0	None
116598	116599	and	0	None
116599	116600	for	0	None
116600	116601	the	0	None
116601	116602	binding	0	None
116602	116603	of	0	None
116603	116604	tau	1	GENE-Y
116604	116605	,	0	None
116605	116606	200	0	None
116606	116607	microM	0	None
116607	116608	.	0	None

116609	116610	The	0	None
116610	116611	rate	0	None
116611	116612	of	0	None
116612	116613	dissociation	0	None
116613	116614	was	0	None
116614	116615	very	0	None
116615	116616	low	0	None
116616	116617	(	0	None
116617	116618	T1	0	None
116618	116619	/	0	None
116619	116620	2	0	None
116620	116621	greater	0	None
116621	116622	than	0	None
116622	116623	2	0	None
116623	116624	hr	3	GENE-N
116624	116625	)	0	None
116625	116626	,	0	None
116626	116627	which	0	None
116627	116628	indicates	0	None
116628	116629	that	0	None
116629	116630	the	0	None
116630	116631	binding	0	None
116631	116632	of	0	None
116632	116633	estramustine	0	None
116633	116634	phosphate	0	None
116634	116635	may	0	None
116635	116636	stabilize	0	None
116636	116637	the	0	None
116637	116638	protein-drug	0	None
116638	116639	complex	0	None
116639	116640	by	0	None
116640	116641	changing	0	None
116641	116642	the	0	None
116642	116643	protein	0	None
116643	116644	conformation	0	None
116644	116645	.	0	None

116646	116647	Two	0	None
116647	116648	new	0	None
116648	116649	negatively	0	None
116649	116650	charged	0	None
116650	116651	estramustine	0	None
116651	116652	derivatives	0	None
116652	116653	,	0	None
116653	116654	estramustine	0	None
116654	116655	sulphate	0	None
116655	116656	and	0	None
116656	116657	estramustine	0	None
116657	116658	glucuronide	0	None
116658	116659	,	0	None
116659	116660	were	0	None
116660	116661	found	0	None
116661	116662	to	0	None
116662	116663	be	0	None
116663	116664	similar	0	None
116664	116665	MAP-dependent	0	None
116665	116666	microtubule	0	None
116666	116667	inhibitors	0	None
116667	116668	.	0	None

116669	116670	The	0	None
116670	116671	concentration	0	None
116671	116672	for	0	None
116672	116673	50%	0	None
116673	116674	inhibition	0	None
116674	116675	of	0	None
116675	116676	assembly	0	None
116676	116677	was	0	None
116677	116678	100	0	None
116678	116679	microM	0	None
116679	116680	for	0	None
116680	116681	the	0	None
116681	116682	sulphate	0	None
116682	116683	derivative	0	None
116683	116684	,	0	None
116684	116685	the	0	None
116685	116686	same	0	None
116686	116687	as	0	None
116687	116688	found	0	None
116688	116689	previously	0	None
116689	116690	for	0	None
116690	116691	estramustine	0	None
116691	116692	phosphate	0	None
116692	116693	,	0	None
116693	116694	and	0	None
116694	116695	250	0	None
116695	116696	microM	0	None
116696	116697	for	0	None
116697	116698	the	0	None
116698	116699	more	0	None
116699	116700	bulky	0	None
116700	116701	estramustine	0	None
116701	116702	glucuronide	0	None
116702	116703	.	0	None

116704	116705	A	0	None
116705	116706	positively	0	None
116706	116707	charged	0	None
116707	116708	derivative	0	None
116708	116709	,	0	None
116709	116710	estramustine	0	None
116710	116711	sarcosinate	0	None
116711	116712	,	0	None
116712	116713	did	0	None
116713	116714	not	0	None
116714	116715	inhibit	0	None
116715	116716	microtubule	0	None
116716	116717	assembly	0	None
116717	116718	or	0	None
116718	116719	alter	0	None
116719	116720	the	0	None
116720	116721	composition	0	None
116721	116722	of	0	None
116722	116723	the	0	None
116723	116724	coassembled	0	None
116724	116725	MAPs	0	None
116725	116726	.	0	None

116727	116728	The	0	None
116728	116729	morphology	0	None
116729	116730	of	0	None
116730	116731	the	0	None
116731	116732	microtubules	0	None
116732	116733	was	0	None
116733	116734	,	0	None
116734	116735	however	0	None
116735	116736	,	0	None
116736	116737	affected	0	None
116737	116738	.	0	None

116739	116740	The	0	None
116740	116741	uncharged	0	None
116741	116742	estramustine	0	None
116742	116743	bound	0	None
116743	116744	to	0	None
116744	116745	both	0	None
116745	116746	tubulin	0	None
116746	116747	and	0	None
116747	116748	MAPs	0	None
116748	116749	,	0	None
116749	116750	but	0	None
116750	116751	no	0	None
116751	116752	effects	0	None
116752	116753	were	0	None
116753	116754	seen	0	None
116754	116755	on	0	None
116755	116756	microtubule	0	None
116756	116757	assembly	0	None
116757	116758	,	0	None
116758	116759	the	0	None
116759	116760	composition	0	None
116760	116761	of	0	None
116761	116762	coassembled	0	None
116762	116763	MAPs	0	None
116763	116764	or	0	None
116764	116765	the	0	None
116765	116766	microtubule	0	None
116766	116767	morphology	0	None
116767	116768	.	0	None

116769	116770	Our	0	None
116770	116771	results	0	None
116771	116772	suggest	0	None
116772	116773	that	0	None
116773	116774	only	0	None
116774	116775	negatively	0	None
116775	116776	charged	0	None
116776	116777	estramustine	0	None
116777	116778	derivatives	0	None
116778	116779	have	0	None
116779	116780	a	0	None
116780	116781	MAP-dependent	0	None
116781	116782	microtubule	0	None
116782	116783	inhibitory	0	None
116783	116784	effect	0	None
116784	116785	.	0	None

116786	116787	The	0	None
116787	116788	two	0	None
116788	116789	new	0	None
116789	116790	negatively	0	None
116790	116791	charged	0	None
116791	116792	derivatives	0	None
116792	116793	could	0	None
116793	116794	therefore	0	None
116794	116795	be	0	None
116795	116796	valuable	0	None
116796	116797	tools	0	None
116797	116798	in	0	None
116798	116799	the	0	None
116799	116800	study	0	None
116800	116801	of	0	None
116801	116802	tubulin-MAP	0	None
116802	116803	interactions	0	None
116803	116804	.	0	None

116805	116806	The	0	None
116806	116807	results	0	None
116807	116808	also	0	None
116808	116809	confirm	0	None
116809	116810	that	0	None
116810	116811	these	0	None
116811	116812	interactions	0	None
116812	116813	between	0	None
116813	116814	tubulin	0	None
116814	116815	and	0	None
116815	116816	MAPs	0	None
116816	116817	are	0	None
116817	116818	mainly	0	None
116818	116819	electrostatic	0	None
116819	116820	.	0	None
116820	116821	The	0	None
116821	116822	Tumor	0	None
116822	116823	Suppressor	0	None
116823	116824	Kruppel-Like	0	None
116824	116825	Factor	0	None
116825	116826	6	0	None
116826	116827	is	0	None
116827	116828	a	0	None
116828	116829	Novel	0	None
116829	116830	Aryl	0	None
116830	116831	Hydrocarbon	0	None
116831	116832	Receptor	0	None
116832	116833	DNA	0	None
116833	116834	Binding	0	None
116834	116835	Partner	0	None
116835	116836	.	0	None
116836	116837	S100A4	0	None
116837	116838	,	0	None
116838	116839	a	0	None
116839	116840	member	0	None
116840	116841	of	0	None
116841	116842	the	0	None
116842	116843	S100	0	None
116843	116844	family	0	None
116844	116845	of	0	None
116845	116846	Ca	0	None
116846	116847	(	0	None
116847	116848	2	0	None
116848	116849	+	0	None
116849	116850	)	0	None
116850	116851	-binding	0	None
116851	116852	proteins	0	None
116852	116853	,	0	None
116853	116854	regulates	0	None
116854	116855	carcinoma	0	None
116855	116856	cell	0	None
116856	116857	motility	0	None
116857	116858	via	0	None
116858	116859	interactions	0	None
116859	116860	with	0	None
116860	116861	myosin-IIA	0	None
116861	116862	.	0	None

116863	116864	Numerous	0	None
116864	116865	studies	0	None
116865	116866	indicate	0	None
116866	116867	that	0	None
116867	116868	S100A4	0	None
116868	116869	is	0	None
116869	116870	not	0	None
116870	116871	simply	0	None
116871	116872	a	0	None
116872	116873	marker	0	None
116873	116874	for	0	None
116874	116875	metastatic	0	None
116875	116876	disease	0	None
116876	116877	,	0	None
116877	116878	but	0	None
116878	116879	rather	0	None
116879	116880	has	0	None
116880	116881	a	0	None
116881	116882	direct	0	None
116882	116883	role	0	None
116883	116884	in	0	None
116884	116885	metastatic	0	None
116885	116886	progression	0	None
116886	116887	.	0	None

116888	116889	These	0	None
116889	116890	observations	0	None
116890	116891	suggest	0	None
116891	116892	that	0	None
116892	116893	S100A4	0	None
116893	116894	is	0	None
116894	116895	an	0	None
116895	116896	excellent	0	None
116896	116897	target	0	None
116897	116898	for	0	None
116898	116899	therapeutic	0	None
116899	116900	intervention	0	None
116900	116901	.	0	None

116902	116903	Using	0	None
116903	116904	a	0	None
116904	116905	unique	0	None
116905	116906	biosensor-based	0	None
116906	116907	assay	0	None
116907	116908	,	0	None
116908	116909	trifluoperazine	0	None
116909	116910	(	0	None
116910	116911	TFP	0	None
116911	116912	)	0	None
116912	116913	was	0	None
116913	116914	identified	0	None
116914	116915	as	0	None
116915	116916	an	0	None
116916	116917	inhibitor	0	None
116917	116918	that	0	None
116918	116919	disrupts	0	None
116919	116920	the	0	None
116920	116921	S100A4	0	None
116921	116922	/	0	None
116922	116923	myosin-IIA	0	None
116923	116924	interaction	0	None
116924	116925	.	0	None

116926	116927	To	0	None
116927	116928	examine	0	None
116928	116929	the	0	None
116929	116930	interaction	0	None
116930	116931	of	0	None
116931	116932	S100A4	0	None
116932	116933	with	0	None
116933	116934	TFP	0	None
116934	116935	,	0	None
116935	116936	we	0	None
116936	116937	determined	0	None
116937	116938	the	0	None
116938	116939	2	0	None
116939	116940	.	0	None
116940	116941	3	0	None
116941	116942	A	0	None
116942	116943	crystal	0	None
116943	116944	structure	0	None
116944	116945	of	0	None
116945	116946	human	0	None
116946	116947	Ca	0	None
116947	116948	(	0	None
116948	116949	2	0	None
116949	116950	+	0	None
116950	116951	)	0	None
116951	116952	-S100A4	0	None
116952	116953	bound	0	None
116953	116954	to	0	None
116954	116955	TFP	0	None
116955	116956	.	0	None

116957	116958	Two	0	None
116958	116959	TFP	0	None
116959	116960	molecules	0	None
116960	116961	bind	0	None
116961	116962	within	0	None
116962	116963	the	0	None
116963	116964	hydrophobic	0	None
116964	116965	target	0	None
116965	116966	binding	0	None
116966	116967	pocket	0	None
116967	116968	of	0	None
116968	116969	Ca	0	None
116969	116970	(	0	None
116970	116971	2	0	None
116971	116972	+	0	None
116972	116973	)	0	None
116973	116974	-S100A4	0	None
116974	116975	with	0	None
116975	116976	no	0	None
116976	116977	significant	0	None
116977	116978	conformational	0	None
116978	116979	changes	0	None
116979	116980	observed	0	None
116980	116981	in	0	None
116981	116982	the	0	None
116982	116983	protein	0	None
116983	116984	upon	0	None
116984	116985	complex	0	None
116985	116986	formation	0	None
116986	116987	.	0	None

116988	116989	NMR	0	None
116989	116990	chemical	0	None
116990	116991	shift	0	None
116991	116992	perturbations	0	None
116992	116993	are	0	None
116993	116994	consistent	0	None
116994	116995	with	0	None
116995	116996	the	0	None
116996	116997	crystal	0	None
116997	116998	structure	0	None
116998	116999	and	0	None
116999	117000	demonstrate	0	None
117000	117001	that	0	None
117001	117002	TFP	0	None
117002	117003	binds	0	None
117003	117004	to	0	None
117004	117005	the	0	None
117005	117006	target	0	None
117006	117007	binding	0	None
117007	117008	cleft	0	None
117008	117009	of	0	None
117009	117010	S100A4	0	None
117010	117011	in	0	None
117011	117012	solution	0	None
117012	117013	.	0	None

117014	117015	Remarkably	0	None
117015	117016	,	0	None
117016	117017	TFP	0	None
117017	117018	binding	0	None
117018	117019	results	0	None
117019	117020	in	0	None
117020	117021	the	0	None
117021	117022	assembly	0	None
117022	117023	of	0	None
117023	117024	five	0	None
117024	117025	Ca	0	None
117025	117026	(	0	None
117026	117027	2	0	None
117027	117028	+	0	None
117028	117029	)	0	None
117029	117030	-S100A4	0	None
117030	117031	/	0	None
117031	117032	TFP	0	None
117032	117033	dimers	0	None
117033	117034	into	0	None
117034	117035	a	0	None
117035	117036	tightly	0	None
117036	117037	packed	0	None
117037	117038	pentameric	0	None
117038	117039	ring	0	None
117039	117040	.	0	None

117041	117042	Within	0	None
117042	117043	each	0	None
117043	117044	pentamer	0	None
117044	117045	most	0	None
117045	117046	of	0	None
117046	117047	the	0	None
117047	117048	contacts	0	None
117048	117049	between	0	None
117049	117050	S100A4	0	None
117050	117051	dimers	0	None
117051	117052	occurs	0	None
117052	117053	through	0	None
117053	117054	the	0	None
117054	117055	TFP	0	None
117055	117056	moieties	0	None
117056	117057	.	0	None

117058	117059	The	0	None
117059	117060	Ca	0	None
117060	117061	(	0	None
117061	117062	2	0	None
117062	117063	+	0	None
117063	117064	)	0	None
117064	117065	-S100A4	0	None
117065	117066	/	0	None
117066	117067	prochlorperazine	0	None
117067	117068	(	0	None
117068	117069	PCP	0	None
117069	117070	)	0	None
117070	117071	complex	0	None
117071	117072	exhibits	0	None
117072	117073	a	0	None
117073	117074	similar	0	None
117074	117075	pentameric	0	None
117075	117076	assembly	0	None
117076	117077	.	0	None

117078	117079	Equilibrium	0	None
117079	117080	sedimentation	0	None
117080	117081	and	0	None
117081	117082	cross-linking	0	None
117082	117083	studies	0	None
117083	117084	demonstrate	0	None
117084	117085	the	0	None
117085	117086	cooperative	0	None
117086	117087	formation	0	None
117087	117088	of	0	None
117088	117089	a	0	None
117089	117090	similarly	0	None
117090	117091	sized	0	None
117091	117092	S100A4	0	None
117092	117093	/	0	None
117093	117094	TFP	0	None
117094	117095	oligomer	0	None
117095	117096	in	0	None
117096	117097	solution	0	None
117097	117098	.	0	None

117099	117100	Assays	0	None
117100	117101	examining	0	None
117101	117102	the	0	None
117102	117103	ability	0	None
117103	117104	of	0	None
117104	117105	TFP	0	None
117105	117106	to	0	None
117106	117107	block	0	None
117107	117108	S100A4-mediated	0	None
117108	117109	disassembly	0	None
117109	117110	of	0	None
117110	117111	myosin-IIA	0	None
117111	117112	filaments	0	None
117112	117113	demonstrate	0	None
117113	117114	that	0	None
117114	117115	significant	0	None
117115	117116	inhibition	0	None
117116	117117	of	0	None
117117	117118	S100A4	0	None
117118	117119	function	0	None
117119	117120	occurs	0	None
117120	117121	only	0	None
117121	117122	at	0	None
117122	117123	TFP	0	None
117123	117124	concentrations	0	None
117124	117125	that	0	None
117125	117126	promote	0	None
117126	117127	S100A4	0	None
117127	117128	oligomerization	0	None
117128	117129	.	0	None

117130	117131	Together	0	None
117131	117132	these	0	None
117132	117133	studies	0	None
117133	117134	support	0	None
117134	117135	a	0	None
117135	117136	unique	0	None
117136	117137	mode	0	None
117137	117138	of	0	None
117138	117139	inhibition	0	None
117139	117140	in	0	None
117140	117141	which	0	None
117141	117142	phenothiazines	2	CHEMICAL
117142	117143	disrupt	0	None
117143	117144	the	0	None
117144	117145	S100A4	0	None
117145	117146	/	0	None
117146	117147	myosin-IIA	0	None
117147	117148	interaction	0	None
117148	117149	by	0	None
117149	117150	sequestering	0	None
117150	117151	S100A4	0	None
117151	117152	via	0	None
117152	117153	small	0	None
117153	117154	molecule-induced	0	None
117154	117155	oligomerization	0	None
117155	117156	.	0	None
117156	117157	A	0	None
117157	117158	series	0	None
117158	117159	of	0	None
117159	117160	epidemiological	0	None
117160	117161	,	0	None
117161	117162	experimental	0	None
117162	117163	and	0	None
117163	117164	preliminary	0	None
117164	117165	clinical	0	None
117165	117166	trials	0	None
117166	117167	strongly	0	None
117167	117168	suggest	0	None
117168	117169	that	0	None
117169	117170	mesalazine	2	CHEMICAL
117170	117171	or	0	None
117171	117172	5-aminosalicyclic	0	None
117172	117173	acid	0	None
117173	117174	(	0	None
117174	117175	5-ASA	2	CHEMICAL
117175	117176	)	0	None
117176	117177	may	0	None
117177	117178	have	0	None
117178	117179	antineoplastic	0	None
117179	117180	and	0	None
117180	117181	potentially	0	None
117181	117182	prophylactic	0	None
117182	117183	chemopreventive	0	None
117183	117184	properties	0	None
117184	117185	.	0	None

117186	117187	It	0	None
117187	117188	is	0	None
117188	117189	assumed	0	None
117189	117190	that	0	None
117190	117191	mesalazine	2	CHEMICAL
117191	117192	may	0	None
117192	117193	have	0	None
117193	117194	similar	0	None
117194	117195	genetic	0	None
117195	117196	and	0	None
117196	117197	molecular	0	None
117197	117198	targets	0	None
117198	117199	as	0	None
117199	117200	nonsteroidal	0	None
117200	117201	anti-inflammatory	0	None
117201	117202	drugs	0	None
117202	117203	(	0	None
117203	117204	NSAIDs	0	None
117204	117205	)	0	None
117205	117206	,	0	None
117206	117207	which	0	None
117207	117208	is	0	None
117208	117209	further	0	None
117209	117210	supported	0	None
117210	117211	by	0	None
117211	117212	its	0	None
117212	117213	close	0	None
117213	117214	similarity	0	None
117214	117215	with	0	None
117215	117216	aspirin	2	CHEMICAL
117216	117217	,	0	None
117217	117218	differing	0	None
117218	117219	only	0	None
117219	117220	in	0	None
117220	117221	its	0	None
117221	117222	structure	0	None
117222	117223	by	0	None
117223	117224	the	0	None
117224	117225	presence	0	None
117225	117226	of	0	None
117226	117227	an	0	None
117227	117228	amino	0	None
117228	117229	group	0	None
117229	117230	at	0	None
117230	117231	position	0	None
117231	117232	5	0	None
117232	117233	of	0	None
117233	117234	the	0	None
117234	117235	benzene	0	None
117235	117236	ring	0	None
117236	117237	.	0	None

117238	117239	The	0	None
117239	117240	putative	0	None
117240	117241	chemopreventive	0	None
117241	117242	actions	0	None
117242	117243	include	0	None
117243	117244	the	0	None
117244	117245	inhibition	0	None
117245	117246	of	0	None
117246	117247	inflammatory	0	None
117247	117248	cascades	0	None
117248	117249	and	0	None
117249	117250	/	0	None
117250	117251	or	0	None
117251	117252	reactions	0	None
117252	117253	involved	0	None
117253	117254	in	0	None
117254	117255	cell	0	None
117255	117256	growth	0	None
117256	117257	and	0	None
117257	117258	proliferation	0	None
117258	117259	,	0	None
117259	117260	such	0	None
117260	117261	as	0	None
117261	117262	cyclo-oxygenase	0	None
117262	117263	(	0	None
117263	117264	COX-1	1	GENE-Y
117264	117265	and	0	None
117265	117266	COX-2	0	None
117266	117267	)	0	None
117267	117268	,	0	None
117268	117269	which	0	None
117269	117270	regulate	0	None
117270	117271	cell	0	None
117271	117272	proliferation	0	None
117272	117273	through	0	None
117273	117274	the	0	None
117274	117275	formation	0	None
117275	117276	of	0	None
117276	117277	prostaglandins;	0	None
117277	117278	lipoxygenase;	0	None
117278	117280	nuclear factor	0	None
117280	117281	kappaB	0	None
117281	117282	(	0	None
117282	117283	NFkappaB	0	None
117283	117284	)	0	None
117284	117285	,	0	None
117285	117286	responsible	0	None
117286	117287	for	0	None
117287	117288	the	0	None
117288	117289	subsequent	0	None
117289	117290	expression	0	None
117290	117291	of	0	None
117291	117292	pro-inflammatory	0	None
117292	117293	molecules;	0	None
117293	117294	MAP	0	None
117294	117295	kinases	0	None
117295	117296	and	0	None
117296	117297	Bcl-2	1	GENE-Y
117297	117298	,	0	None
117298	117299	as	0	None
117299	117300	well	0	None
117300	117301	as	0	None
117301	117302	the	0	None
117302	117303	activation	0	None
117303	117304	of	0	None
117304	117305	apoptotic	0	None
117305	117306	processes	0	None
117306	117307	,	0	None
117307	117308	such	0	None
117308	117309	as	0	None
117309	117310	the	0	None
117310	117311	stimulation	0	None
117311	117312	of	0	None
117312	117313	intestinal	0	None
117313	117314	sphingomyelinase	1	GENE-Y
117314	117315	.	0	None

117316	117317	The	0	None
117317	117320	peroxisome-proliferator-activated receptor delta	1	GENE-Y
117320	117321	(	0	None
117321	117322	PPARdelta	1	GENE-Y
117322	117323	)	0	None
117323	117324	,	0	None
117324	117325	which	0	None
117325	117326	also	0	None
117326	117327	regulates	0	None
117327	117328	gene	0	None
117328	117329	transcription	0	None
117329	117330	,	0	None
117330	117331	is	0	None
117331	117332	thought	0	None
117332	117333	to	0	None
117333	117334	play	0	None
117334	117335	a	0	None
117335	117336	role	0	None
117336	117337	in	0	None
117337	117338	both	0	None
117338	117339	inflammatory	0	None
117339	117340	and	0	None
117340	117341	non-inflammatory	0	None
117341	117342	driven	0	None
117342	117343	carcinogenesis	0	None
117343	117344	.	0	None

117345	117346	This	0	None
117346	117347	may	0	None
117347	117348	be	0	None
117348	117349	another	0	None
117349	117350	significant	0	None
117350	117351	target	0	None
117351	117352	.	0	None

117353	117354	It	0	None
117354	117355	is	0	None
117355	117356	hypothesized	0	None
117356	117357	that	0	None
117357	117358	5-ASAs	0	None
117358	117359	may	0	None
117359	117360	prevent	0	None
117360	117361	the	0	None
117361	117362	enhancing	0	None
117362	117363	effect	0	None
117363	117364	of	0	None
117364	117365	prostaglandins	2	CHEMICAL
117365	117366	on	0	None
117366	117367	PPARdelta	1	GENE-Y
117367	117368	binding	0	None
117368	117369	to	0	None
117369	117370	DNA	0	None
117370	117371	by	0	None
117371	117372	its	0	None
117372	117373	COX	3	GENE-N
117373	117374	inhibitory	0	None
117374	117375	properties	0	None
117375	117376	,	0	None
117376	117377	decreasing	0	None
117377	117378	proliferation	0	None
117378	117379	of	0	None
117379	117380	colorectal	0	None
117380	117381	mucosal	0	None
117381	117382	cells	0	None
117382	117383	in	0	None
117383	117384	non-inflammatory	0	None
117384	117385	bowel	0	None
117385	117386	disease	0	None
117386	117387	patients	0	None
117387	117388	with	0	None
117388	117389	sporadic	0	None
117389	117390	polyps	0	None
117390	117391	of	0	None
117391	117392	the	0	None
117392	117393	large	0	None
117393	117394	bowel	0	None
117394	117395	.	0	None
117395	117396	Antithrombin	0	None
117396	117397	binding	0	None
117397	117398	of	0	None
117398	117399	low	0	None
117399	117400	molecular	0	None
117400	117401	weight	0	None
117401	117402	heparins	0	None
117402	117403	and	0	None
117403	117404	inhibition	0	None
117404	117405	of	0	None
117405	117406	factor	0	None
117406	117407	Xa	0	None
117407	117408	.	0	None
117408	117409	Locally	0	None
117409	117410	administered	0	None
117410	117411	prostaglandin	0	None
117411	117412	E2	0	None
117412	117413	prevents	0	None
117413	117414	aeroallergen-induced	0	None
117414	117415	airway	0	None
117415	117416	sensitization	0	None
117416	117417	in	0	None
117417	117418	mice	0	None
117418	117419	through	0	None
117419	117420	immunomodulatory	0	None
117420	117421	mechanisms	0	None
117421	117422	.	0	None
117422	117424	Argininosuccinate synthetase	1	GENE-Y
117424	117425	(	0	None
117425	117426	ASS	0	None
117426	117427	,	0	None
117427	117428	EC	0	None
117428	117429	6	0	None
117429	117430	.	0	None
117430	117431	3	0	None
117431	117432	.	0	None
117432	117433	4	0	None
117433	117434	.	0	None
117434	117435	5	0	None
117435	117436	)	0	None
117436	117437	catalyses	0	None
117437	117438	the	0	None
117438	117439	condensation	0	None
117439	117440	of	0	None
117440	117441	citrulline	0	None
117441	117442	and	0	None
117442	117443	aspartate	0	None
117443	117444	to	0	None
117444	117445	form	0	None
117445	117446	argininosuccinate	2	CHEMICAL
117446	117447	,	0	None
117447	117448	the	0	None
117448	117449	immediate	0	None
117449	117450	precursor	0	None
117450	117451	of	0	None
117451	117452	arginine	2	CHEMICAL
117452	117453	.	0	None

117454	117455	First	0	None
117455	117456	identified	0	None
117456	117457	in	0	None
117457	117458	the	0	None
117458	117459	liver	0	None
117459	117460	as	0	None
117460	117461	the	0	None
117461	117462	limiting	0	None
117462	117463	enzyme	0	None
117463	117464	of	0	None
117464	117465	the	0	None
117465	117466	urea	2	CHEMICAL
117466	117467	cycle	0	None
117467	117468	,	0	None
117468	117469	ASS	0	None
117469	117470	is	0	None
117470	117471	now	0	None
117471	117472	recognized	0	None
117472	117473	as	0	None
117473	117474	a	0	None
117474	117475	ubiquitous	0	None
117475	117476	enzyme	0	None
117476	117477	in	0	None
117477	117478	mammalian	0	None
117478	117479	tissues	0	None
117479	117480	.	0	None

117481	117482	Indeed	0	None
117482	117483	,	0	None
117483	117484	discovery	0	None
117484	117485	of	0	None
117485	117486	the	0	None
117486	117487	citrulline-NO	0	None
117487	117488	cycle	0	None
117488	117489	has	0	None
117489	117490	increased	0	None
117490	117491	interest	0	None
117491	117492	in	0	None
117492	117493	this	0	None
117493	117494	enzyme	0	None
117494	117495	that	0	None
117495	117496	was	0	None
117496	117497	found	0	None
117497	117498	to	0	None
117498	117499	represent	0	None
117499	117500	a	0	None
117500	117501	potential	0	None
117501	117502	limiting	0	None
117502	117503	step	0	None
117503	117504	in	0	None
117504	117505	NO	0	None
117505	117506	synthesis	0	None
117506	117507	.	0	None

117508	117509	Depending	0	None
117509	117510	on	0	None
117510	117511	arginine	2	CHEMICAL
117511	117512	utilization	0	None
117512	117513	,	0	None
117513	117514	location	0	None
117514	117515	and	0	None
117515	117516	regulation	0	None
117516	117517	of	0	None
117517	117518	ASS	0	None
117518	117519	are	0	None
117519	117520	quite	0	None
117520	117521	different	0	None
117521	117522	.	0	None

117523	117524	In	0	None
117524	117525	the	0	None
117525	117526	liver	0	None
117526	117527	,	0	None
117527	117528	where	0	None
117528	117529	arginine	2	CHEMICAL
117529	117530	is	0	None
117530	117531	hydrolyzed	0	None
117531	117532	to	0	None
117532	117533	form	0	None
117533	117534	urea	2	CHEMICAL
117534	117535	and	0	None
117535	117536	ornithine	2	CHEMICAL
117536	117537	,	0	None
117537	117538	the	0	None
117538	117539	ASS	0	None
117539	117540	gene	0	None
117540	117541	is	0	None
117541	117542	highly	0	None
117542	117543	expressed	0	None
117543	117544	,	0	None
117544	117545	and	0	None
117545	117546	hormones	2	CHEMICAL
117546	117547	and	0	None
117547	117548	nutrients	0	None
117548	117549	constitute	0	None
117549	117550	the	0	None
117550	117551	major	0	None
117551	117552	regulating	0	None
117552	117553	factors	0	None
117553	117554	:	0	None
117554	117555	(	0	None
117555	117556	a	0	None
117556	117557	)	0	None
117557	117558	glucocorticoids	0	None
117558	117559	,	0	None
117559	117560	glucagon	1	GENE-Y
117560	117561	and	0	None
117561	117562	insulin	0	None
117562	117563	,	0	None
117563	117564	particularly	0	None
117564	117565	,	0	None
117565	117566	control	0	None
117566	117567	the	0	None
117567	117568	expression	0	None
117568	117569	of	0	None
117569	117570	this	0	None
117570	117571	gene	0	None
117571	117572	both	0	None
117572	117573	during	0	None
117573	117574	development	0	None
117574	117575	and	0	None
117575	117576	adult	0	None
117576	117577	life;	0	None
117577	117578	(	0	None
117578	117579	b	0	None
117579	117580	)	0	None
117580	117581	dietary	0	None
117581	117582	protein	0	None
117582	117583	intake	0	None
117583	117584	stimulates	0	None
117584	117585	ASS	0	None
117585	117586	gene	0	None
117586	117587	expression	0	None
117587	117588	,	0	None
117588	117589	with	0	None
117589	117590	a	0	None
117590	117591	particular	0	None
117591	117592	efficiency	0	None
117592	117593	of	0	None
117593	117594	specific	0	None
117594	117596	amino acids	2	CHEMICAL
117596	117597	like	0	None
117597	117598	glutamine	0	None
117598	117599	.	0	None

117600	117601	In	0	None
117601	117602	contrast	0	None
117602	117603	,	0	None
117603	117604	in	0	None
117604	117605	NO-producing	0	None
117605	117606	cells	0	None
117606	117607	,	0	None
117607	117608	where	0	None
117608	117609	arginine	2	CHEMICAL
117609	117610	is	0	None
117610	117611	the	0	None
117611	117612	direct	0	None
117612	117613	substrate	0	None
117613	117614	in	0	None
117614	117615	the	0	None
117615	117616	NO	0	None
117616	117617	synthesis	0	None
117617	117618	,	0	None
117618	117619	ASS	0	None
117619	117620	gene	0	None
117620	117621	is	0	None
117621	117622	expressed	0	None
117622	117623	at	0	None
117623	117624	a	0	None
117624	117625	low	0	None
117625	117626	level	0	None
117626	117627	and	0	None
117627	117628	in	0	None
117628	117629	this	0	None
117629	117630	way	0	None
117630	117631	,	0	None
117631	117632	proinflammatory	0	None
117632	117633	signals	0	None
117633	117634	constitute	0	None
117634	117635	the	0	None
117635	117636	main	0	None
117636	117637	factors	0	None
117637	117638	of	0	None
117638	117639	regulation	0	None
117639	117640	of	0	None
117640	117641	the	0	None
117641	117642	gene	0	None
117642	117643	expression	0	None
117643	117644	.	0	None

117645	117646	In	0	None
117646	117647	most	0	None
117647	117648	cases	0	None
117648	117649	,	0	None
117649	117650	regulation	0	None
117650	117651	of	0	None
117651	117652	ASS	0	None
117652	117653	gene	0	None
117653	117654	expression	0	None
117654	117655	is	0	None
117655	117656	exerted	0	None
117656	117657	at	0	None
117657	117658	a	0	None
117658	117659	transcriptional	0	None
117659	117660	level	0	None
117660	117661	,	0	None
117661	117662	but	0	None
117662	117663	molecular	0	None
117663	117664	mechanisms	0	None
117664	117665	are	0	None
117665	117666	still	0	None
117666	117667	poorly	0	None
117667	117668	understood	0	None
117668	117669	.	0	None
117669	117670	The	0	None
117670	117671	2	0	None
117671	117672	,	0	None
117672	117673	2'	0	None
117673	117674	,	0	None
117674	117675	4	0	None
117675	117676	,	0	None
117676	117677	4'-tetrabromodiphenyl	0	None
117677	117678	ether	0	None
117678	117679	hydroxylated	0	None
117679	117680	metabolites	0	None
117680	117681	5-OH-BDE-47	0	None
117681	117682	and	0	None
117682	117683	6-OH-BDE-47	2	CHEMICAL
117683	117684	stimulate	0	None
117684	117685	estradiol	0	None
117685	117686	secretion	0	None
117686	117687	in	0	None
117687	117688	the	0	None
117688	117689	ovary	0	None
117689	117690	by	0	None
117690	117691	activating	0	None
117691	117692	aromatase	0	None
117692	117693	expression	0	None
117693	117694	.	0	None
117694	117695	Coronary	0	None
117695	117696	heart	0	None
117696	117697	disease	0	None
117697	117698	(	0	None
117698	117699	CHD	0	None
117699	117700	)	0	None
117700	117701	is	0	None
117701	117702	the	0	None
117702	117703	leading	0	None
117703	117704	cause	0	None
117704	117705	of	0	None
117705	117706	death	0	None
117706	117707	worldwide	0	None
117707	117708	,	0	None
117708	117709	and	0	None
117709	117710	effective	0	None
117710	117711	treatment	0	None
117711	117712	of	0	None
117712	117713	hyperlipidaemia	0	None
117713	117714	can	0	None
117714	117715	prevent	0	None
117715	117716	development	0	None
117716	117717	of	0	None
117717	117718	CHD	0	None
117718	117719	and	0	None
117719	117720	significantly	0	None
117720	117721	reduce	0	None
117721	117722	the	0	None
117722	117723	risk	0	None
117723	117724	for	0	None
117724	117725	cardiovascular	0	None
117725	117726	events	0	None
117726	117727	and	0	None
117727	117728	mortality	0	None
117728	117729	in	0	None
117729	117730	this	0	None
117730	117731	disease	0	None
117731	117732	.	0	None

117733	117734	The	0	None
117734	117735	advent	0	None
117735	117736	of	0	None
117736	117737	3-hydroxy-3-methylglutaryl	0	None
117737	117739	coenzyme A	2	CHEMICAL
117739	117740	(	0	None
117740	117741	HMG-CoA	0	None
117741	117742	)	0	None
117742	117743	reductase	0	None
117743	117744	inhibitors	0	None
117744	117745	(	0	None
117745	117746	statins	2	CHEMICAL
117746	117747	)	0	None
117747	117748	has	0	None
117748	117749	revolutionised	0	None
117749	117750	the	0	None
117750	117751	treatment	0	None
117751	117752	of	0	None
117752	117753	hyperlipidaemia	0	None
117753	117754	,	0	None
117754	117755	but	0	None
117755	117756	many	0	None
117756	117757	patients	0	None
117757	117758	receiving	0	None
117758	117759	these	0	None
117759	117760	drugs	0	None
117760	117761	still	0	None
117761	117762	do	0	None
117762	117763	not	0	None
117763	117764	achieve	0	None
117764	117765	their	0	None
117765	117766	therapeutic	0	None
117766	117767	goals	0	None
117767	117768	.	0	None

117769	117770	Rosuvastatin	0	None
117770	117771	(	0	None
117771	117772	Crestor;	0	None
117772	117773	formerly	0	None
117773	117774	ZD4522	0	None
117774	117775	)	0	None
117775	117776	is	0	None
117776	117777	a	0	None
117777	117778	new	0	None
117778	117779	,	0	None
117779	117780	potent	0	None
117780	117781	and	0	None
117781	117782	long-lasting	0	None
117782	117783	inhibitor	0	None
117783	117784	of	0	None
117784	117785	HMG-CoA	0	None
117785	117786	reductase	0	None
117786	117787	that	0	None
117787	117788	is	0	None
117788	117789	highly	0	None
117789	117790	selective	0	None
117790	117791	for	0	None
117791	117792	hepatocytes	0	None
117792	117793	.	0	None

117794	117795	Its	0	None
117795	117796	pharmacokinetics	0	None
117796	117797	permit	0	None
117797	117798	once-daily	0	None
117798	117799	dosing	0	None
117799	117800	,	0	None
117800	117801	and	0	None
117801	117802	a	0	None
117802	117803	lack	0	None
117803	117804	of	0	None
117804	117805	oxidative	0	None
117805	117806	hepatic	0	None
117806	117807	metabolism	0	None
117807	117808	results	0	None
117808	117809	in	0	None
117809	117810	a	0	None
117810	117811	reduced	0	None
117811	117812	potential	0	None
117812	117813	for	0	None
117813	117814	drug-drug	0	None
117814	117815	interactions	0	None
117815	117816	.	0	None

117817	117818	Preliminary	0	None
117818	117819	clinical	0	None
117819	117820	results	0	None
117820	117821	indicate	0	None
117821	117822	that	0	None
117822	117823	it	0	None
117823	117824	produces	0	None
117824	117825	rapid	0	None
117825	117826	dose-related	0	None
117826	117827	reductions	0	None
117827	117828	in	0	None
117828	117829	total	0	None
117829	117830	cholesterol	0	None
117830	117831	,	0	None
117831	117832	low-density	0	None
117832	117833	lipoprotein	3	GENE-N
117833	117834	cholesterol	0	None
117834	117835	,	0	None
117835	117836	triglycerides	0	None
117836	117837	,	0	None
117837	117838	and	0	None
117838	117839	apolipoprotein	0	None
117839	117840	B	0	None
117840	117841	that	0	None
117841	117842	may	0	None
117842	117843	exceed	0	None
117843	117844	those	0	None
117844	117845	achieved	0	None
117845	117846	with	0	None
117846	117847	other	0	None
117847	117848	currently	0	None
117848	117849	available	0	None
117849	117850	statins	2	CHEMICAL
117850	117851	.	0	None

117852	117853	Increases	0	None
117853	117854	in	0	None
117854	117855	high-density	0	None
117855	117856	lipoprotein	3	GENE-N
117856	117857	cholesterol	0	None
117857	117858	have	0	None
117858	117859	also	0	None
117859	117860	been	0	None
117860	117861	observed	0	None
117861	117862	.	0	None

117863	117864	Rosuvastatin	0	None
117864	117865	is	0	None
117865	117866	also	0	None
117866	117867	well	0	None
117867	117868	tolerated	0	None
117868	117869	,	0	None
117869	117870	with	0	None
117870	117871	no	0	None
117871	117872	evidence	0	None
117872	117873	of	0	None
117873	117874	either	0	None
117874	117875	hepato-	0	None
117875	117876	or	0	None
117876	117877	myotoxicity	0	None
117877	117878	.	0	None

117879	117880	It	0	None
117880	117881	is	0	None
117881	117882	hoped	0	None
117882	117883	that	0	None
117883	117884	new	0	None
117884	117885	agents	0	None
117885	117886	such	0	None
117886	117887	as	0	None
117887	117888	rosuvastatin	2	CHEMICAL
117888	117889	may	0	None
117889	117890	help	0	None
117890	117891	to	0	None
117891	117892	reduce	0	None
117892	117893	the	0	None
117893	117894	high	0	None
117894	117895	global	0	None
117895	117896	morbidity	0	None
117896	117897	,	0	None
117897	117898	mortality	0	None
117898	117899	and	0	None
117899	117900	associated	0	None
117900	117901	costs	0	None
117901	117902	of	0	None
117902	117903	CHD	0	None
117903	117904	and	0	None
117904	117905	related	0	None
117905	117906	vascular	0	None
117906	117907	disorders	0	None
117907	117908	.	0	None
117908	117909	Changes	0	None
117909	117910	of	0	None
117910	117911	phosphorylation	0	None
117911	117912	of	0	None
117912	117913	cAMP	0	None
117913	117914	response	0	None
117914	117915	element	0	None
117915	117916	binding	0	None
117916	117917	protein	0	None
117917	117918	in	0	None
117918	117919	rat	0	None
117919	117920	nucleus	0	None
117920	117921	accumbens	0	None
117921	117922	after	0	None
117922	117923	chronic	0	None
117923	117924	ethanol	2	CHEMICAL
117924	117925	intake	0	None
117925	117926	:	0	None
117926	117927	naloxone	0	None
117927	117928	reversal	0	None
117928	117929	.	0	None
117929	117930	Acute	0	None
117930	117931	alcohol	2	CHEMICAL
117931	117932	effects	0	None
117932	117933	on	0	None
117933	117934	subtypes	0	None
117934	117935	of	0	None
117935	117936	impulsivity	0	None
117936	117937	and	0	None
117937	117938	the	0	None
117938	117939	role	0	None
117939	117940	of	0	None
117940	117941	alcohol-outcome	0	None
117941	117942	expectancies	0	None
117942	117943	.	0	None
117943	117944	BACKGROUND	0	None
117944	117945	:	0	None
117945	117946	Motor	0	None
117946	117947	vehicle	0	None
117947	117948	accidents	0	None
117948	117949	(	0	None
117949	117950	MVAs	0	None
117950	117951	)	0	None
117951	117952	are	0	None
117952	117953	a	0	None
117953	117954	leading	0	None
117954	117955	cause	0	None
117955	117956	of	0	None
117956	117957	posttraumatic	0	None
117957	117958	stress	0	None
117958	117959	disorder	0	None
117959	117960	(	0	None
117960	117961	PTSD	0	None
117961	117962	)	0	None
117962	117963	in	0	None
117963	117964	the	0	None
117964	117965	general	0	None
117965	117966	population	0	None
117966	117967	.	0	None

117968	117969	Alterations	0	None
117969	117970	in	0	None
117970	117971	norepinephrine	2	CHEMICAL
117971	117972	and	0	None
117972	117973	serotonin	0	None
117973	117974	systems	0	None
117974	117975	have	0	None
117975	117976	been	0	None
117976	117977	proposed	0	None
117977	117978	as	0	None
117978	117979	mechanisms	0	None
117979	117980	involved	0	None
117980	117981	in	0	None
117981	117982	the	0	None
117982	117983	pathophysiology	0	None
117983	117984	of	0	None
117984	117985	the	0	None
117985	117986	condition	0	None
117986	117987	,	0	None
117987	117988	with	0	None
117988	117989	treatment	0	None
117989	117990	directed	0	None
117990	117991	at	0	None
117991	117992	these	0	None
117992	117993	neurotransmitter	0	None
117993	117994	systems	0	None
117994	117995	.	0	None

117996	117997	Reboxetine	0	None
117997	117998	,	0	None
117998	117999	a	0	None
117999	118000	selective	0	None
118000	118001	norepinephrine	2	CHEMICAL
118001	118002	reuptake	0	None
118002	118003	inhibitor	0	None
118003	118004	,	0	None
118004	118005	exhibits	0	None
118005	118006	high	0	None
118006	118007	affinity	0	None
118007	118008	and	0	None
118008	118009	selectivity	0	None
118009	118010	for	0	None
118010	118011	the	0	None
118011	118014	human norepinephrine transporter	3	GENE-N
118014	118015	.	0	None

118016	118017	Inasmuch	0	None
118017	118018	as	0	None
118018	118019	PTSD	0	None
118019	118020	may	0	None
118020	118021	be	0	None
118021	118022	associated	0	None
118022	118023	with	0	None
118023	118024	dysregulation	0	None
118024	118025	of	0	None
118025	118026	noradrenergic	0	None
118026	118027	activity	0	None
118027	118028	,	0	None
118028	118029	the	0	None
118029	118030	present	0	None
118030	118031	double-blind	0	None
118031	118032	randomized	0	None
118032	118033	clinical	0	None
118033	118034	trial	0	None
118034	118035	intended	0	None
118035	118036	to	0	None
118036	118037	evaluate	0	None
118037	118038	reboxetine's	0	None
118038	118039	efficacy	0	None
118039	118040	in	0	None
118040	118041	the	0	None
118041	118042	management	0	None
118042	118043	of	0	None
118043	118044	MVA-related	0	None
118044	118045	PTSD	0	None
118045	118046	and	0	None
118046	118047	to	0	None
118047	118048	compare	0	None
118048	118049	its	0	None
118049	118050	efficacy	0	None
118050	118051	with	0	None
118051	118052	a	0	None
118052	118053	medication	0	None
118053	118054	commonly	0	None
118054	118055	used	0	None
118055	118056	in	0	None
118056	118057	PTSD	0	None
118057	118058	,	0	None
118058	118059	the	0	None
118059	118060	selective	0	None
118060	118061	serotonin	0	None
118061	118062	reuptake	0	None
118062	118063	inhibitor	0	None
118063	118064	fluvoxamine	0	None
118064	118065	.	0	None

118066	118067	METHODS	0	None
118067	118068	:	0	None
118068	118069	Forty	0	None
118069	118070	patients	0	None
118070	118071	with	0	None
118071	118072	MVA-related	0	None
118072	118073	PTSD	0	None
118073	118074	attending	0	None
118074	118075	a	0	None
118075	118076	local	0	None
118076	118077	community	0	None
118077	118078	mental	0	None
118078	118079	health	0	None
118079	118080	outpatient	0	None
118080	118081	clinic	0	None
118081	118082	were	0	None
118082	118083	randomized	0	None
118083	118084	to	0	None
118084	118085	receive	0	None
118085	118086	a	0	None
118086	118087	fixed	0	None
118087	118088	dose	0	None
118088	118089	of	0	None
118089	118090	either	0	None
118090	118091	reboxetine	0	None
118091	118092	(	0	None
118092	118093	8	0	None
118093	118094	mg	2	CHEMICAL
118094	118095	/	0	None
118095	118096	d	0	None
118096	118097	)	0	None
118097	118098	or	0	None
118098	118099	fluvoxamine	0	None
118099	118100	(	0	None
118100	118101	150	0	None
118101	118102	mg	2	CHEMICAL
118102	118103	/	0	None
118103	118104	d	0	None
118104	118105	)	0	None
118105	118106	in	0	None
118106	118107	a	0	None
118107	118108	double-blind	0	None
118108	118109	fashion	0	None
118109	118110	for	0	None
118110	118111	a	0	None
118111	118112	period	0	None
118112	118113	of	0	None
118113	118114	8	0	None
118114	118115	weeks	0	None
118115	118116	.	0	None

118117	118118	RESULTS	0	None
118118	118119	:	0	None
118119	118120	At	0	None
118120	118121	baseline	0	None
118121	118122	and	0	None
118122	118123	at	0	None
118123	118124	study	0	None
118124	118125	end	0	None
118125	118126	point	0	None
118126	118127	,	0	None
118127	118128	the	0	None
118128	118129	2	0	None
118129	118130	subgroups	0	None
118130	118131	demonstrated	0	None
118131	118132	no	0	None
118132	118133	statistical	0	None
118133	118134	differences	0	None
118134	118135	in	0	None
118135	118136	scores	0	None
118136	118137	on	0	None
118137	118138	PTSD	0	None
118138	118139	,	0	None
118139	118140	depression	0	None
118140	118141	,	0	None
118141	118142	and	0	None
118142	118143	anxiety	0	None
118143	118144	rating	0	None
118144	118145	scales	0	None
118145	118146	.	0	None

118147	118148	Both	0	None
118148	118149	medications	0	None
118149	118150	led	0	None
118150	118151	to	0	None
118151	118152	significant	0	None
118152	118153	improvements	0	None
118153	118154	in	0	None
118154	118155	all	0	None
118155	118156	clinical	0	None
118156	118157	scales	0	None
118157	118158	measured	0	None
118158	118159	.	0	None

118160	118161	Nine	0	None
118161	118162	patients	0	None
118162	118163	receiving	0	None
118163	118164	reboxetine	0	None
118164	118165	and	0	None
118165	118166	3	0	None
118166	118167	receiving	0	None
118167	118168	fluvoxamine	0	None
118168	118169	withdrew	0	None
118169	118170	from	0	None
118170	118171	the	0	None
118171	118172	study	0	None
118172	118173	because	0	None
118173	118174	of	0	None
118174	118175	side	0	None
118175	118176	effects	0	None
118176	118177	.	0	None

118178	118179	CONCLUSIONS	0	None
118179	118180	:	0	None
118180	118181	Study	0	None
118181	118182	observations	0	None
118182	118183	indicate	0	None
118183	118184	comparable	0	None
118184	118185	efficacy	0	None
118185	118186	of	0	None
118186	118187	reboxetine	0	None
118187	118188	and	0	None
118188	118189	fluvoxamine	0	None
118189	118190	in	0	None
118190	118191	the	0	None
118191	118192	management	0	None
118192	118193	of	0	None
118193	118194	MVA-related	0	None
118194	118195	PTSD	0	None
118195	118196	despite	0	None
118196	118197	reboxetine's	0	None
118197	118198	selective	0	None
118198	118199	noradrenergic	0	None
118199	118200	activity	0	None
118200	118201	.	0	None

118202	118203	Reboxetine	0	None
118203	118204	appears	0	None
118204	118205	to	0	None
118205	118206	be	0	None
118206	118207	at	0	None
118207	118208	least	0	None
118208	118209	as	0	None
118209	118210	effective	0	None
118210	118211	as	0	None
118211	118212	fluvoxamine	0	None
118212	118213	and	0	None
118213	118214	may	0	None
118214	118215	offer	0	None
118215	118216	an	0	None
118216	118217	alternative	0	None
118217	118218	management	0	None
118218	118219	option	0	None
118219	118220	in	0	None
118220	118221	this	0	None
118221	118222	often	0	None
118222	118223	difficult-to-treat	0	None
118223	118224	and	0	None
118224	118225	disabling	0	None
118225	118226	condition	0	None
118226	118227	.	0	None

118228	118229	A	0	None
118229	118230	lower	0	None
118230	118231	and	0	None
118231	118232	flexible	0	None
118232	118233	reboxetine	0	None
118233	118234	dosing	0	None
118234	118235	schedule	0	None
118235	118236	will	0	None
118236	118237	be	0	None
118237	118238	recommended	0	None
118238	118239	for	0	None
118239	118240	future	0	None
118240	118241	research	0	None
118241	118242	to	0	None
118242	118243	improve	0	None
118243	118244	its	0	None
118244	118245	tolerability	0	None
118245	118246	in	0	None
118246	118247	PTSD	0	None
118247	118248	patients	0	None
118248	118249	.	0	None
118249	118250	EphB1	0	None
118250	118251	null	0	None
118251	118252	mice	0	None
118252	118253	exhibit	0	None
118253	118254	neuronal	0	None
118254	118255	loss	0	None
118255	118256	in	0	None
118256	118257	substantia	0	None
118257	118258	nigra	0	None
118258	118259	pars	0	None
118259	118260	reticulata	0	None
118260	118261	and	0	None
118261	118262	spontaneous	0	None
118262	118263	locomotor	0	None
118263	118264	hyperactivity	0	None
118264	118265	.	0	None
118265	118266	Two	0	None
118266	118267	alleles	0	None
118267	118268	of	0	None
118268	118269	the	0	None
118269	118270	HG1	0	None
118270	118271	gene	0	None
118271	118272	,	0	None
118272	118273	which	0	None
118273	118274	encodes	0	None
118274	118275	a	0	None
118275	118276	putative	0	None
118276	118277	GABA	2	CHEMICAL
118277	118278	receptor	0	None
118278	118279	alpha	0	None
118279	118280	/	0	None
118280	118281	gamma	0	None
118281	118282	subunit	0	None
118282	118283	,	0	None
118283	118284	were	0	None
118284	118285	isolated	0	None
118285	118286	from	0	None
118286	118287	Haemonchus	0	None
118287	118288	contortus	0	None
118288	118289	.	0	None

118290	118291	These	0	None
118291	118292	two	0	None
118292	118293	alleles	0	None
118293	118294	were	0	None
118294	118295	shown	0	None
118295	118296	previously	0	None
118296	118297	to	0	None
118297	118298	be	0	None
118298	118299	associated	0	None
118299	118300	with	0	None
118300	118301	ivermectin	2	CHEMICAL
118301	118302	susceptibility	0	None
118302	118303	(	0	None
118303	118304	HG1A	0	None
118304	118305	)	0	None
118305	118306	and	0	None
118306	118307	resistance	0	None
118307	118308	(	0	None
118308	118309	HG1E	0	None
118309	118310	)	0	None
118310	118311	,	0	None
118311	118312	respectively	0	None
118312	118313	.	0	None

118314	118315	Sequence	0	None
118315	118316	analysis	0	None
118316	118317	indicates	0	None
118317	118318	that	0	None
118318	118319	they	0	None
118319	118320	differ	0	None
118320	118321	in	0	None
118321	118322	four	0	None
118322	118324	amino acids	2	CHEMICAL
118324	118325	.	0	None

118326	118327	To	0	None
118327	118328	explore	0	None
118328	118329	the	0	None
118329	118330	functional	0	None
118330	118331	properties	0	None
118331	118332	of	0	None
118332	118333	the	0	None
118333	118334	two	0	None
118334	118335	alleles	0	None
118335	118336	,	0	None
118336	118337	a	0	None
118337	118338	full-length	0	None
118338	118339	cDNA	0	None
118339	118340	encoding	0	None
118340	118341	the	0	None
118341	118342	beta	0	None
118342	118343	subunit	0	None
118343	118344	,	0	None
118344	118345	a	0	None
118345	118346	key	0	None
118346	118347	functional	0	None
118347	118348	component	0	None
118348	118349	of	0	None
118349	118350	the	0	None
118350	118351	GABA	2	CHEMICAL
118351	118352	receptor	0	None
118352	118353	,	0	None
118353	118354	was	0	None
118354	118355	isolated	0	None
118355	118356	from	0	None
118356	118357	Caenorhabditis	0	None
118357	118358	elegans	0	None
118358	118359	(	0	None
118359	118360	gab-1	0	None
118360	118361	,	0	None
118361	118362	corresponding	0	None
118362	118363	to	0	None
118363	118364	the	0	None
118364	118365	GenBank	0	None
118365	118366	locus	0	None
118366	118367	ZC482	0	None
118367	118368	.	0	None
118368	118369	1	0	None
118369	118370	)	0	None
118370	118371	and	0	None
118371	118372	coexpressed	0	None
118372	118373	in	0	None
118373	118374	Xenopus	0	None
118374	118375	oocytes	0	None
118375	118376	with	0	None
118376	118377	the	0	None
118377	118378	HG1	0	None
118378	118379	alleles	0	None
118379	118380	.	0	None

118381	118382	When	0	None
118382	118383	gab-1	0	None
118383	118384	was	0	None
118384	118385	coexpressed	0	None
118385	118386	with	0	None
118386	118387	either	0	None
118387	118388	the	0	None
118388	118389	HG1A	0	None
118389	118390	allele	0	None
118390	118391	or	0	None
118391	118392	the	0	None
118392	118393	HG1E	0	None
118393	118394	allele	0	None
118394	118395	in	0	None
118395	118396	Xenopus	0	None
118396	118397	oocytes	0	None
118397	118398	,	0	None
118398	118399	gamma-aminobutyric	0	None
118399	118400	acid	0	None
118400	118401	(	0	None
118401	118402	GABA	2	CHEMICAL
118402	118403	)	0	None
118403	118404	-responsive	0	None
118404	118405	channels	0	None
118405	118406	with	0	None
118406	118407	different	0	None
118407	118408	sensitivity	0	None
118408	118409	to	0	None
118409	118410	the	0	None
118410	118411	agonist	0	None
118411	118412	were	0	None
118412	118413	formed	0	None
118413	118414	.	0	None

118415	118416	The	0	None
118416	118417	effects	0	None
118417	118418	of	0	None
118418	118419	ivermectin	2	CHEMICAL
118419	118420	on	0	None
118420	118421	the	0	None
118421	118422	hetero-oligomeric	0	None
118422	118423	receptors	0	None
118423	118424	were	0	None
118424	118425	determined	0	None
118425	118426	.	0	None

118427	118428	Application	0	None
118428	118429	of	0	None
118429	118430	ivermectin	2	CHEMICAL
118430	118431	alone	0	None
118431	118432	had	0	None
118432	118433	no	0	None
118433	118434	effect	0	None
118434	118435	on	0	None
118435	118436	the	0	None
118436	118437	receptors	0	None
118437	118438	.	0	None

118439	118440	However	0	None
118440	118441	,	0	None
118441	118442	when	0	None
118442	118443	coapplied	0	None
118443	118444	with	0	None
118444	118445	10	0	None
118445	118446	micro	0	None
118446	118447	m	0	None
118447	118448	GABA	2	CHEMICAL
118448	118449	,	0	None
118449	118450	ivermectin	2	CHEMICAL
118450	118451	potentiated	0	None
118451	118452	the	0	None
118452	118453	GABA-evoked	0	None
118453	118454	current	0	None
118454	118455	of	0	None
118455	118456	the	0	None
118456	118457	GAB-1	0	None
118457	118458	/	0	None
118458	118459	HG1A	0	None
118459	118460	receptor	0	None
118460	118461	,	0	None
118461	118462	but	0	None
118462	118463	attenuated	0	None
118463	118464	the	0	None
118464	118465	GABA	2	CHEMICAL
118465	118466	response	0	None
118466	118467	of	0	None
118467	118468	the	0	None
118468	118469	GAB-1	0	None
118469	118470	/	0	None
118470	118471	HG1E	0	None
118471	118472	receptor	0	None
118472	118473	.	0	None

118474	118475	We	0	None
118475	118476	demonstrated	0	None
118476	118477	that	0	None
118477	118478	the	0	None
118478	118479	coexpressed	0	None
118479	118480	HG1	0	None
118480	118481	and	0	None
118481	118482	GAB-1	0	None
118482	118483	receptors	0	None
118483	118484	are	0	None
118484	118485	GABA-responsive	0	None
118485	118486	,	0	None
118486	118487	and	0	None
118487	118488	provide	0	None
118488	118489	evidence	0	None
118489	118490	for	0	None
118490	118491	the	0	None
118491	118492	possible	0	None
118492	118493	involvement	0	None
118493	118494	of	0	None
118494	118495	GABA	2	CHEMICAL
118495	118496	receptors	0	None
118496	118497	in	0	None
118497	118498	the	0	None
118498	118499	mechanism	0	None
118499	118500	of	0	None
118500	118501	ivermectin	2	CHEMICAL
118501	118502	resistance	0	None
118502	118503	.	0	None
118503	118504	Late	0	None
118504	118505	in	0	None
118505	118506	an	0	None
118506	118507	adenovirus	0	None
118507	118508	infection	0	None
118508	118509	,	0	None
118509	118510	the	0	None
118510	118511	viral	0	None
118511	118512	proteinase	0	None
118512	118513	(	0	None
118513	118514	AVP	0	None
118514	118515	)	0	None
118515	118516	becomes	0	None
118516	118517	activated	0	None
118517	118518	to	0	None
118518	118519	process	0	None
118519	118520	virion	0	None
118520	118521	precursor	0	None
118521	118522	proteins	0	None
118522	118523	used	0	None
118523	118524	in	0	None
118524	118525	virus	0	None
118525	118526	assembly	0	None
118526	118527	.	0	None

118528	118529	AVP	0	None
118529	118530	is	0	None
118530	118531	activated	0	None
118531	118532	by	0	None
118532	118533	two	0	None
118533	118534	cofactors	0	None
118534	118535	,	0	None
118535	118536	the	0	None
118536	118537	viral	0	None
118537	118538	DNA	0	None
118538	118539	and	0	None
118539	118540	pVIc	0	None
118540	118541	,	0	None
118541	118542	an	0	None
118542	118543	11-amino	0	None
118543	118544	acid	0	None
118544	118545	peptide	0	None
118545	118546	originating	0	None
118546	118547	from	0	None
118547	118548	the	0	None
118548	118549	C	0	None
118549	118550	terminus	0	None
118550	118551	of	0	None
118551	118552	the	0	None
118552	118553	precursor	0	None
118553	118554	protein	0	None
118554	118555	pVI	0	None
118555	118556	.	0	None

118557	118558	There	0	None
118558	118559	is	0	None
118559	118560	a	0	None
118560	118561	conundrum	0	None
118561	118562	in	0	None
118562	118563	the	0	None
118563	118564	activation	0	None
118564	118565	of	0	None
118565	118566	AVP	0	None
118566	118567	in	0	None
118567	118568	that	0	None
118568	118569	AVP	0	None
118569	118570	and	0	None
118570	118571	pVI	0	None
118571	118572	are	0	None
118572	118573	sequence-independent	0	None
118573	118574	DNA-binding	0	None
118574	118575	proteins	0	None
118575	118576	with	0	None
118576	118577	nm	0	None
118577	118578	equilibrium	0	None
118578	118579	dissociation	0	None
118579	118580	constants	0	None
118580	118581	such	0	None
118581	118582	that	0	None
118582	118583	in	0	None
118583	118584	the	0	None
118584	118585	virus	0	None
118585	118586	particle	0	None
118586	118587	,	0	None
118587	118588	they	0	None
118588	118589	are	0	None
118589	118590	predicted	0	None
118590	118591	to	0	None
118591	118592	be	0	None
118592	118593	essentially	0	None
118593	118594	irreversibly	0	None
118594	118595	bound	0	None
118595	118596	to	0	None
118596	118597	the	0	None
118597	118598	viral	0	None
118598	118599	DNA	0	None
118599	118600	.	0	None

118601	118602	Here	0	None
118602	118603	,	0	None
118603	118604	we	0	None
118604	118605	resolve	0	None
118605	118606	that	0	None
118606	118607	conundrum	0	None
118607	118608	by	0	None
118608	118609	showing	0	None
118609	118610	that	0	None
118610	118611	activation	0	None
118611	118612	of	0	None
118612	118613	AVP	0	None
118613	118614	takes	0	None
118614	118615	place	0	None
118615	118616	on	0	None
118616	118617	the	0	None
118617	118618	one-dimensional	0	None
118618	118619	contour	0	None
118619	118620	of	0	None
118620	118621	DNA	0	None
118621	118622	.	0	None

118623	118624	In	0	None
118624	118625	vitro	0	None
118625	118626	,	0	None
118626	118627	pVI	0	None
118627	118628	,	0	None
118628	118629	a	0	None
118629	118630	substrate	0	None
118630	118631	,	0	None
118631	118632	slides	0	None
118632	118633	on	0	None
118633	118634	DNA	0	None
118634	118635	via	0	None
118635	118636	one-dimensional	0	None
118636	118637	diffusion	0	None
118637	118638	,	0	None
118638	118639	D	0	None
118639	118640	(	0	None
118640	118641	1	0	None
118641	118642	)	0	None
118642	118643	=	0	None
118643	118644	1	0	None
118644	118645	.	0	None
118645	118646	45	0	None
118646	118647	×	0	None
118647	118648	10	0	None
118648	118649	(	0	None
118649	118650	6	0	None
118650	118651	)	0	None
118651	118652	bp	0	None
118652	118653	(	0	None
118653	118654	2	0	None
118654	118655	)	0	None
118655	118656	/	0	None
118656	118657	s	0	None
118657	118658	,	0	None
118658	118659	until	0	None
118659	118660	it	0	None
118660	118661	binds	0	None
118661	118662	to	0	None
118662	118663	AVP	0	None
118663	118664	also	0	None
118664	118665	on	0	None
118665	118666	the	0	None
118666	118667	same	0	None
118667	118668	DNA	0	None
118668	118669	molecule	0	None
118669	118670	.	0	None

118671	118672	AVP	0	None
118672	118673	,	0	None
118673	118674	partially	0	None
118674	118675	activated	0	None
118675	118676	by	0	None
118676	118677	being	0	None
118677	118678	bound	0	None
118678	118679	to	0	None
118679	118680	DNA	0	None
118680	118681	,	0	None
118681	118682	excises	0	None
118682	118683	pVIc	0	None
118683	118684	,	0	None
118684	118685	which	0	None
118685	118686	binds	0	None
118686	118687	to	0	None
118687	118688	the	0	None
118688	118689	AVP	0	None
118689	118690	molecule	0	None
118690	118691	that	0	None
118691	118692	cut	0	None
118692	118693	it	0	None
118693	118694	out	0	None
118694	118695	.	0	None

118696	118697	pVIc	0	None
118697	118698	then	0	None
118698	118699	forms	0	None
118699	118700	a	0	None
118700	118701	disulfide	0	None
118701	118702	bond	0	None
118702	118703	with	0	None
118703	118704	AVP	0	None
118704	118705	forming	0	None
118705	118706	the	0	None
118706	118707	fully	0	None
118707	118708	active	0	None
118708	118709	AVP-pVIc	0	None
118709	118710	complex	0	None
118710	118711	bound	0	None
118711	118712	to	0	None
118712	118713	DNA	0	None
118713	118714	.	0	None

118715	118716	In	0	None
118716	118717	vivo	0	None
118717	118718	,	0	None
118718	118719	in	0	None
118719	118720	heat-disrupted	0	None
118720	118721	immature	0	None
118721	118722	virus	0	None
118722	118723	,	0	None
118723	118724	AVP	0	None
118724	118725	was	0	None
118725	118726	also	0	None
118726	118727	activated	0	None
118727	118728	by	0	None
118728	118729	pVI	0	None
118729	118730	in	0	None
118730	118731	DNA-dependent	0	None
118731	118732	reactions	0	None
118732	118733	.	0	None

118734	118735	This	0	None
118735	118736	activation	0	None
118736	118737	mechanism	0	None
118737	118738	illustrates	0	None
118738	118739	a	0	None
118739	118740	new	0	None
118740	118741	paradigm	0	None
118741	118742	for	0	None
118742	118743	virion	0	None
118743	118744	maturation	0	None
118744	118745	and	0	None
118745	118746	a	0	None
118746	118747	new	0	None
118747	118748	way	0	None
118748	118749	,	0	None
118749	118750	by	0	None
118750	118751	sliding	0	None
118751	118752	on	0	None
118752	118753	DNA	0	None
118753	118754	,	0	None
118754	118755	for	0	None
118755	118756	bimolecular	0	None
118756	118757	complexes	0	None
118757	118758	to	0	None
118758	118759	form	0	None
118759	118760	among	0	None
118760	118761	proteins	0	None
118761	118762	not	0	None
118762	118763	involved	0	None
118763	118764	in	0	None
118764	118765	DNA	0	None
118765	118766	metabolism	0	None
118766	118767	.	0	None
118767	118768	The	0	None
118768	118769	thiopurine	2	CHEMICAL
118769	118770	drugs-azathioprine	0	None
118770	118771	(	0	None
118771	118772	AZA	0	None
118772	118773	)	0	None
118773	118774	,	0	None
118774	118775	6-mercaptopurine	0	None
118775	118776	(	0	None
118776	118777	6-MP	0	None
118777	118778	)	0	None
118778	118779	,	0	None
118779	118780	and	0	None
118780	118781	thioguanine-are	0	None
118781	118782	widely	0	None
118782	118783	used	0	None
118783	118784	to	0	None
118784	118785	treat	0	None
118785	118786	malignancies	0	None
118786	118787	,	0	None
118787	118788	rheumatic	0	None
118788	118789	diseases	0	None
118789	118790	,	0	None
118790	118791	dermatologic	0	None
118791	118792	conditions	0	None
118792	118793	,	0	None
118793	118794	inflammatory	0	None
118794	118795	bowel	0	None
118795	118796	disease	0	None
118796	118797	,	0	None
118797	118798	and	0	None
118798	118799	solid	0	None
118799	118800	organ	0	None
118800	118801	transplant	0	None
118801	118802	rejection	0	None
118802	118803	.	0	None

118804	118805	However	0	None
118805	118806	,	0	None
118806	118807	thiopurine	2	CHEMICAL
118807	118808	drugs	0	None
118808	118809	have	0	None
118809	118810	a	0	None
118810	118811	relatively	0	None
118811	118812	narrow	0	None
118812	118813	therapeutic	0	None
118813	118814	index	0	None
118814	118815	and	0	None
118815	118816	are	0	None
118816	118817	capable	0	None
118817	118818	of	0	None
118818	118819	causing	0	None
118819	118820	life-threatening	0	None
118820	118821	toxicity	0	None
118821	118822	,	0	None
118822	118823	most	0	None
118823	118824	often	0	None
118824	118825	myelosuppression	0	None
118825	118826	.	0	None

118827	118828	Thiopurine	2	CHEMICAL
118828	118829	S-methyltransferase	0	None
118829	118830	(	0	None
118830	118831	TPMT;	0	None
118831	118832	EC	0	None
118832	118833	2	0	None
118833	118834	.	0	None
118834	118835	1	0	None
118835	118836	.	0	None
118836	118837	1	0	None
118837	118838	.	0	None
118838	118839	67	0	None
118839	118840	)	0	None
118840	118841	,	0	None
118841	118842	an	0	None
118842	118843	enzyme	0	None
118843	118844	that	0	None
118844	118845	catalyzes	0	None
118845	118846	S-methylation	0	None
118846	118847	of	0	None
118847	118848	these	0	None
118848	118849	drugs	0	None
118849	118850	,	0	None
118850	118851	exhibits	0	None
118851	118852	a	0	None
118852	118853	genetic	0	None
118853	118854	polymorphism	0	None
118854	118855	in	0	None
118855	118856	10%	0	None
118856	118857	of	0	None
118857	118858	Caucasians	0	None
118858	118859	,	0	None
118859	118860	with	0	None
118860	118861	1	0	None
118861	118862	/	0	None
118862	118863	300	0	None
118863	118864	individuals	0	None
118864	118865	having	0	None
118865	118866	complete	0	None
118866	118867	deficiency	0	None
118867	118868	.	0	None

118869	118870	Patients	0	None
118870	118871	with	0	None
118871	118872	intermediate	0	None
118872	118873	or	0	None
118873	118874	deficient	0	None
118874	118875	TPMT	0	None
118875	118876	activity	0	None
118876	118877	are	0	None
118877	118878	at	0	None
118878	118879	risk	0	None
118879	118880	for	0	None
118880	118881	excessive	0	None
118881	118882	toxicity	0	None
118882	118883	after	0	None
118883	118884	receiving	0	None
118884	118885	standard	0	None
118885	118886	doses	0	None
118886	118887	of	0	None
118887	118888	thiopurine	2	CHEMICAL
118888	118889	medications	0	None
118889	118890	.	0	None

118891	118892	This	0	None
118892	118893	report	0	None
118893	118894	reviews	0	None
118894	118895	the	0	None
118895	118896	recent	0	None
118896	118897	advances	0	None
118897	118898	in	0	None
118898	118899	the	0	None
118899	118900	knowledge	0	None
118900	118901	of	0	None
118901	118902	the	0	None
118902	118903	mechanism	0	None
118903	118904	of	0	None
118904	118905	action	0	None
118905	118906	as	0	None
118906	118907	well	0	None
118907	118908	as	0	None
118908	118909	the	0	None
118909	118910	molecular	0	None
118910	118911	basis	0	None
118911	118912	and	0	None
118912	118913	interethnic	0	None
118913	118914	variations	0	None
118914	118915	of	0	None
118915	118916	TPMT	0	None
118916	118920	and inosine triphosphate pyrophosphatase	0	None
118920	118921	(	0	None
118921	118922	ITPase;	0	None
118922	118923	EC	0	None
118923	118924	3	0	None
118924	118925	.	0	None
118925	118926	6	0	None
118926	118927	.	0	None
118927	118928	1	0	None
118928	118929	.	0	None
118929	118930	19	0	None
118930	118931	)	0	None
118931	118932	,	0	None
118932	118933	another	0	None
118933	118934	enzyme	0	None
118934	118935	implicated	0	None
118935	118936	in	0	None
118936	118937	thiopurine	2	CHEMICAL
118937	118938	toxicity	0	None
118938	118939	.	0	None

118940	118941	In	0	None
118941	118942	addition	0	None
118942	118943	,	0	None
118943	118944	an	0	None
118944	118945	update	0	None
118945	118946	on	0	None
118946	118947	pharmacokinetics	0	None
118947	118948	,	0	None
118948	118949	metabolism	0	None
118949	118950	,	0	None
118950	118951	drug-drug	0	None
118951	118952	interactions	0	None
118952	118953	,	0	None
118953	118954	safety	0	None
118954	118955	,	0	None
118955	118956	and	0	None
118956	118957	tolerability	0	None
118957	118958	of	0	None
118958	118959	thiopurine	2	CHEMICAL
118959	118960	drugs	0	None
118960	118961	is	0	None
118961	118962	provided	0	None
118962	118963	.	0	None
118963	118964	Management	0	None
118964	118965	of	0	None
118965	118966	psoriasis	0	None
118966	118967	:	0	None
118967	118968	the	0	None
118968	118969	position	0	None
118969	118970	of	0	None
118970	118971	retinoid	0	None
118971	118972	drugs	0	None
118972	118973	.	0	None
118973	118974	Mortality	0	None
118974	118975	risk	0	None
118975	118976	in	0	None
118976	118977	men	0	None
118977	118978	is	0	None
118978	118979	associated	0	None
118979	118980	with	0	None
118980	118981	a	0	None
118981	118982	common	0	None
118982	118983	mutation	0	None
118983	118984	in	0	None
118984	118985	the	0	None
118985	118986	methylene-tetrahydrofolate	0	None
118986	118987	reductase	0	None
118987	118988	gene	0	None
118988	118989	(	0	None
118989	118990	MTHFR	0	None
118990	118991	)	0	None
118991	118992	.	0	None
118992	118995	Hydroxysafflor yellow A	2	CHEMICAL
118995	118996	(	0	None
118996	118997	HSYA	2	CHEMICAL
118997	118998	)	0	None
118998	118999	is	0	None
118999	119000	an	0	None
119000	119001	active	0	None
119001	119002	ingredient	0	None
119002	119003	obtained	0	None
119003	119004	from	0	None
119004	119005	the	0	None
119005	119006	flower	0	None
119006	119007	of	0	None
119007	119008	Carthamus	0	None
119008	119009	tinctorius	0	None
119009	119010	L	0	None
119010	119011	.	0	None

119012	119013	The	0	None
119013	119014	present	0	None
119014	119015	study	0	None
119015	119016	investigated	0	None
119016	119017	the	0	None
119017	119018	effects	0	None
119018	119019	of	0	None
119019	119020	HSYA	2	CHEMICAL
119020	119021	on	0	None
119021	119022	lipopolysaccharide	0	None
119022	119023	(	0	None
119023	119024	LPS	0	None
119024	119025	)	0	None
119025	119026	-induced	0	None
119026	119027	inflammatory	0	None
119027	119028	signal	0	None
119028	119029	transduction	0	None
119029	119030	in	0	None
119030	119031	human	0	None
119031	119032	alveolar	0	None
119032	119033	epithelial	0	None
119033	119034	A549	0	None
119034	119035	cells	0	None
119035	119036	.	0	None

119037	119038	A549	0	None
119038	119039	cells	0	None
119039	119040	stimulated	0	None
119040	119041	with	0	None
119041	119042	LPS	0	None
119042	119043	were	0	None
119043	119044	incubated	0	None
119044	119045	with	0	None
119045	119046	three	0	None
119046	119047	doses	0	None
119047	119048	of	0	None
119048	119049	HSYA	2	CHEMICAL
119049	119050	(	0	None
119050	119051	1	0	None
119051	119052	,	0	None
119052	119053	4	0	None
119053	119054	and	0	None
119054	119055	16μmol	0	None
119055	119056	/	0	None
119056	119057	L	0	None
119057	119058	)	0	None
119058	119059	.	0	None

119060	119061	HSYA	2	CHEMICAL
119061	119062	suppressed	0	None
119062	119063	the	0	None
119063	119064	expression	0	None
119064	119065	of	0	None
119065	119066	TLR-4	0	None
119066	119067	,	0	None
119067	119068	Myd88	0	None
119068	119069	,	0	None
119069	119070	ICAM-1	1	GENE-Y
119070	119071	,	0	None
119071	119072	TNFα	0	None
119072	119073	,	0	None
119073	119074	IL-1β	0	None
119074	119075	and	0	None
119075	119076	IL-6	0	None
119076	119077	at	0	None
119077	119078	the	0	None
119078	119079	mRNA	0	None
119079	119080	and	0	None
119080	119081	protein	0	None
119081	119082	level	0	None
119082	119083	,	0	None
119083	119084	and	0	None
119084	119085	inhibited	0	None
119085	119086	the	0	None
119086	119087	adhesion	0	None
119087	119088	of	0	None
119088	119089	leukocytes	0	None
119089	119090	to	0	None
119090	119091	A549	0	None
119091	119092	cells	0	None
119092	119093	.	0	None

119094	119095	HSYA	2	CHEMICAL
119095	119096	treatment	0	None
119096	119097	also	0	None
119097	119098	decreased	0	None
119098	119099	NF-κB	0	None
119099	119100	p65	0	None
119100	119101	nuclear	0	None
119101	119102	translocation	0	None
119102	119103	and	0	None
119103	119104	inhibited	0	None
119104	119105	the	0	None
119105	119106	phosphorylation	0	None
119106	119107	of	0	None
119107	119111	p38 mitogen-activated protein kinase	3	GENE-N
119111	119112	(	0	None
119112	119113	p38	0	None
119113	119114	MAPK	3	GENE-N
119114	119115	)	0	None
119115	119116	.	0	None

119117	119118	These	0	None
119118	119119	findings	0	None
119119	119120	suggest	0	None
119120	119121	that	0	None
119121	119122	HSYA	2	CHEMICAL
119122	119123	effectively	0	None
119123	119124	inhibits	0	None
119124	119125	LPS-induced	0	None
119125	119126	inflammatory	0	None
119126	119127	signal	0	None
119127	119128	transduction	0	None
119128	119129	in	0	None
119129	119130	A549	0	None
119130	119131	cells	0	None
119131	119132	.	0	None
119132	119133	Charge	0	None
119133	119134	screening	0	None
119134	119135	between	0	None
119135	119136	anionic	0	None
119136	119137	and	0	None
119137	119138	cationic	0	None
119138	119139	surfactants	0	None
119139	119140	in	0	None
119140	119141	ionic	0	None
119141	119142	liquids	0	None
119142	119143	.	0	None
119143	119144	RATIONALE	0	None
119144	119145	:	0	None
119145	119146	A	0	None
119146	119147	substantial	0	None
119147	119148	body	0	None
119148	119149	of	0	None
119149	119150	research	0	None
119150	119151	suggests	0	None
119151	119152	that	0	None
119152	119153	the	0	None
119153	119154	neuropeptide	0	None
119154	119155	oxytocin	2	CHEMICAL
119155	119156	promotes	0	None
119156	119157	social	0	None
119157	119158	affiliative	0	None
119158	119159	behaviors	0	None
119159	119160	in	0	None
119160	119161	a	0	None
119161	119162	wide	0	None
119162	119163	range	0	None
119163	119164	of	0	None
119164	119165	animals	0	None
119165	119166	including	0	None
119166	119167	humans	0	None
119167	119168	.	0	None

119169	119170	However	0	None
119170	119171	,	0	None
119171	119172	its	0	None
119172	119173	antiaggressive	0	None
119173	119174	action	0	None
119174	119175	has	0	None
119175	119176	not	0	None
119176	119177	been	0	None
119177	119178	unequivocally	0	None
119178	119179	demonstrated	0	None
119179	119180	in	0	None
119180	119181	male	0	None
119181	119182	laboratory	0	None
119182	119183	rodents	0	None
119183	119184	.	0	None

119185	119186	OBJECTIVE	0	None
119186	119187	:	0	None
119187	119188	Our	0	None
119188	119189	primary	0	None
119189	119190	goal	0	None
119190	119191	was	0	None
119191	119192	to	0	None
119192	119193	examine	0	None
119193	119194	the	0	None
119194	119195	putative	0	None
119195	119196	serenic	0	None
119196	119197	effect	0	None
119197	119198	of	0	None
119198	119199	oxytocin	2	CHEMICAL
119199	119200	in	0	None
119200	119201	a	0	None
119201	119202	feral	0	None
119202	119203	strain	0	None
119203	119204	(	0	None
119204	119205	wild	0	None
119205	119206	type	0	None
119206	119207	Groningen	0	None
119207	119208	,	0	None
119208	119209	WTG	0	None
119209	119210	)	0	None
119210	119211	of	0	None
119211	119212	rats	0	None
119212	119213	that	0	None
119213	119214	generally	0	None
119214	119215	show	0	None
119215	119216	a	0	None
119216	119217	much	0	None
119217	119218	broader	0	None
119218	119219	variation	0	None
119219	119220	and	0	None
119220	119221	higher	0	None
119221	119222	levels	0	None
119222	119223	of	0	None
119223	119224	intermale	0	None
119224	119225	aggression	0	None
119225	119226	than	0	None
119226	119227	commonly	0	None
119227	119228	used	0	None
119228	119229	laboratory	0	None
119229	119230	strains	0	None
119230	119231	of	0	None
119231	119232	rats	0	None
119232	119233	.	0	None

119234	119235	METHODS	0	None
119235	119236	:	0	None
119236	119237	Resident	0	None
119237	119238	animals	0	None
119238	119239	were	0	None
119239	119240	intracerebroventricularly	0	None
119240	119241	(	0	None
119241	119242	icv	0	None
119242	119243	)	0	None
119243	119244	administered	0	None
119244	119245	with	0	None
119245	119246	different	0	None
119246	119247	doses	0	None
119247	119248	of	0	None
119248	119249	synthetic	0	None
119249	119250	oxytocin	2	CHEMICAL
119250	119251	and	0	None
119251	119252	oxytocin	2	CHEMICAL
119252	119253	receptor	0	None
119253	119254	antagonist	0	None
119254	119255	,	0	None
119255	119256	alone	0	None
119256	119257	and	0	None
119257	119258	in	0	None
119258	119259	combination	0	None
119259	119260	,	0	None
119260	119261	in	0	None
119261	119262	order	0	None
119262	119263	to	0	None
119263	119264	manipulate	0	None
119264	119265	brain	0	None
119265	119266	oxytocin	2	CHEMICAL
119266	119267	functioning	0	None
119267	119268	and	0	None
119268	119269	to	0	None
119269	119270	assess	0	None
119270	119271	their	0	None
119271	119272	behavioral	0	None
119272	119273	response	0	None
119273	119274	to	0	None
119274	119275	an	0	None
119275	119276	intruder	0	None
119276	119277	.	0	None

119278	119279	RESULTS	0	None
119279	119280	:	0	None
119280	119281	Our	0	None
119281	119282	data	0	None
119282	119283	clearly	0	None
119283	119284	demonstrate	0	None
119284	119285	that	0	None
119285	119286	acute	0	None
119286	119287	icv	0	None
119287	119288	administered	0	None
119288	119289	oxytocin	2	CHEMICAL
119289	119290	produces	0	None
119290	119291	dose-dependent	0	None
119291	119292	and	0	None
119292	119293	receptor-selective	0	None
119293	119294	changes	0	None
119294	119295	in	0	None
119295	119296	social	0	None
119296	119297	behavior	0	None
119297	119298	,	0	None
119298	119299	reducing	0	None
119299	119300	aggression	0	None
119300	119301	and	0	None
119301	119302	potentiating	0	None
119302	119303	social	0	None
119303	119304	exploration	0	None
119304	119305	.	0	None

119306	119307	These	0	None
119307	119308	antiaggressive	0	None
119308	119309	effects	0	None
119309	119310	are	0	None
119310	119311	stronger	0	None
119311	119312	in	0	None
119312	119313	the	0	None
119313	119314	more	0	None
119314	119315	offensive	0	None
119315	119316	rats	0	None
119316	119317	.	0	None

119318	119319	On	0	None
119319	119320	the	0	None
119320	119321	other	0	None
119321	119322	hand	0	None
119322	119323	,	0	None
119323	119324	administration	0	None
119324	119325	of	0	None
119325	119326	an	0	None
119326	119327	oxytocin	2	CHEMICAL
119327	119328	receptor	0	None
119328	119329	antagonist	0	None
119329	119330	tends	0	None
119330	119331	to	0	None
119331	119332	increase	0	None
119332	119333	(	0	None
119333	119334	nonsignificantly	0	None
119334	119335	)	0	None
119335	119336	aggression	0	None
119336	119337	only	0	None
119337	119338	in	0	None
119338	119339	low-medium	0	None
119339	119340	aggressive	0	None
119340	119341	animals	0	None
119341	119342	.	0	None

119343	119344	CONCLUSIONS	0	None
119344	119345	:	0	None
119345	119346	These	0	None
119346	119347	results	0	None
119347	119348	suggest	0	None
119348	119349	that	0	None
119349	119350	transiently	0	None
119350	119351	enhancing	0	None
119351	119352	brain	0	None
119352	119353	oxytocin	2	CHEMICAL
119353	119354	function	0	None
119354	119355	has	0	None
119355	119356	potent	0	None
119356	119357	antiaggressive	0	None
119357	119358	effects	0	None
119358	119359	,	0	None
119359	119360	whereas	0	None
119360	119361	its	0	None
119361	119362	attenuation	0	None
119362	119363	tends	0	None
119363	119364	to	0	None
119364	119365	enhance	0	None
119365	119366	aggressiveness	0	None
119366	119367	.	0	None

119368	119369	In	0	None
119369	119370	addition	0	None
119370	119371	,	0	None
119371	119372	a	0	None
119372	119373	possible	0	None
119373	119374	inverse	0	None
119374	119375	relationship	0	None
119375	119376	between	0	None
119376	119377	trait	0	None
119377	119378	aggression	0	None
119378	119379	and	0	None
119379	119380	endogenous	0	None
119380	119381	oxytocinergic	0	None
119381	119382	signaling	0	None
119382	119383	is	0	None
119383	119384	revealed	0	None
119384	119385	.	0	None

119386	119387	Overall	0	None
119387	119388	,	0	None
119388	119389	this	0	None
119389	119390	study	0	None
119390	119391	emphasizes	0	None
119391	119392	the	0	None
119392	119393	importance	0	None
119393	119394	of	0	None
119394	119395	brain	0	None
119395	119396	oxytocinergic	0	None
119396	119397	signaling	0	None
119397	119398	for	0	None
119398	119399	regulating	0	None
119399	119400	intermale	0	None
119400	119401	offensive	0	None
119401	119402	aggression	0	None
119402	119403	.	0	None

119404	119405	This	0	None
119405	119406	study	0	None
119406	119407	supports	0	None
119407	119408	the	0	None
119408	119409	suggestion	0	None
119409	119410	that	0	None
119410	119411	oxytocin	2	CHEMICAL
119411	119412	receptor	0	None
119412	119413	agonists	0	None
119413	119414	could	0	None
119414	119415	clinically	0	None
119415	119416	be	0	None
119416	119417	useful	0	None
119417	119418	for	0	None
119418	119419	curbing	0	None
119419	119420	heightened	0	None
119420	119421	aggression	0	None
119421	119422	seen	0	None
119422	119423	in	0	None
119423	119424	a	0	None
119424	119425	range	0	None
119425	119426	of	0	None
119426	119427	neuropsychiatric	0	None
119427	119428	disorders	0	None
119428	119429	like	0	None
119429	119430	antisocial	0	None
119430	119431	personality	0	None
119431	119432	disorder	0	None
119432	119433	,	0	None
119433	119434	autism	0	None
119434	119435	,	0	None
119435	119436	and	0	None
119436	119437	addiction	0	None
119437	119438	.	0	None
119438	119439	Probing	0	None
119439	119440	the	0	None
119440	119441	Role	0	None
119441	119442	of	0	None
119442	119443	the	0	None
119443	119444	Vancomycin	0	None
119444	119445	E-Ring	0	None
119445	119446	Aryl	0	None
119446	119447	Chloride	0	None
119447	119448	:	0	None
119448	119449	Selective	0	None
119449	119450	Divergent	0	None
119450	119451	Synthesis	0	None
119451	119452	and	0	None
119452	119453	Evaluation	0	None
119453	119454	of	0	None
119454	119455	Alternatively	0	None
119455	119456	Substituted	0	None
119456	119457	E-Ring	0	None
119457	119458	Analogues	0	None
119458	119459	.	0	None
119459	119460	Podocyte	0	None
119460	119461	apoptosis	0	None
119461	119462	is	0	None
119462	119463	a	0	None
119463	119464	critical	0	None
119464	119465	mechanism	0	None
119465	119466	for	0	None
119466	119467	excessive	0	None
119467	119468	loss	0	None
119468	119469	of	0	None
119469	119470	urinary	0	None
119470	119471	albumin	0	None
119471	119472	that	0	None
119472	119473	eventuates	0	None
119473	119474	in	0	None
119474	119475	kidney	0	None
119475	119476	fibrosis	0	None
119476	119477	.	0	None

119478	119479	Pharmacological	0	None
119479	119480	doses	0	None
119480	119481	of	0	None
119481	119482	the	0	None
119482	119483	mTOR	0	None
119483	119484	inhibitor	0	None
119484	119485	rapamycin	3	GENE-N
119485	119486	reduce	0	None
119486	119487	albuminura	0	None
119487	119488	in	0	None
119488	119489	diabetes	0	None
119489	119490	.	0	None

119491	119492	We	0	None
119492	119493	explored	0	None
119493	119494	the	0	None
119494	119495	hypothesis	0	None
119495	119496	that	0	None
119496	119497	mTOR	0	None
119497	119498	mediates	0	None
119498	119499	podocyte	0	None
119499	119500	injury	0	None
119500	119501	in	0	None
119501	119502	diabetes	0	None
119502	119503	.	0	None

119504	119505	High	0	None
119505	119506	glucose	0	None
119506	119507	(	0	None
119507	119508	HG	0	None
119508	119509	)	0	None
119509	119510	induces	0	None
119510	119511	apoptosis	0	None
119511	119512	of	0	None
119512	119513	podocytes	0	None
119513	119514	,	0	None
119514	119515	inhibits	0	None
119515	119516	AMPK	0	None
119516	119517	activation	0	None
119517	119518	,	0	None
119518	119519	inactivates	0	None
119519	119520	tuberin	0	None
119520	119521	and	0	None
119521	119522	activates	0	None
119522	119523	mTOR	0	None
119523	119524	.	0	None

119525	119526	HG	0	None
119526	119527	also	0	None
119527	119528	increases	0	None
119528	119529	the	0	None
119529	119530	levels	0	None
119530	119531	of	0	None
119531	119532	Nox4	0	None
119532	119533	and	0	None
119533	119534	Nox1	0	None
119534	119535	and	0	None
119535	119536	NADPH	0	None
119536	119537	oxidase	0	None
119537	119538	activity	0	None
119538	119539	.	0	None

119540	119541	Inhibition	0	None
119541	119542	of	0	None
119542	119543	mTOR	0	None
119543	119544	by	0	None
119544	119545	low	0	None
119545	119546	dose	0	None
119546	119547	rapamycin	3	GENE-N
119547	119548	decreases	0	None
119548	119549	HG-induced	0	None
119549	119550	Nox4	0	None
119550	119551	and	0	None
119551	119552	Nox1	0	None
119552	119553	,	0	None
119553	119554	NADPH	0	None
119554	119555	oxidase	0	None
119555	119556	activity	0	None
119556	119557	and	0	None
119557	119558	podocyte	0	None
119558	119559	apoptosis	0	None
119559	119560	.	0	None

119561	119562	Inhibition	0	None
119562	119563	of	0	None
119563	119564	mTOR	0	None
119564	119565	had	0	None
119565	119566	no	0	None
119566	119567	effect	0	None
119567	119568	on	0	None
119568	119569	AMPK	0	None
119569	119570	or	0	None
119570	119571	tuberin	0	None
119571	119572	phosphorylation	0	None
119572	119573	indicating	0	None
119573	119574	that	0	None
119574	119575	mTOR	0	None
119575	119576	is	0	None
119576	119577	downstream	0	None
119577	119578	of	0	None
119578	119579	these	0	None
119579	119580	signaling	0	None
119580	119581	molecules	0	None
119581	119582	.	0	None

119583	119584	In	0	None
119584	119585	isolated	0	None
119585	119586	glomeruli	0	None
119586	119587	of	0	None
119587	119588	OVE26	0	None
119588	119589	mice	0	None
119589	119590	,	0	None
119590	119591	there	0	None
119591	119592	is	0	None
119592	119593	similar	0	None
119593	119594	decrease	0	None
119594	119595	in	0	None
119595	119596	the	0	None
119596	119597	activation	0	None
119597	119598	of	0	None
119598	119599	AMPK	0	None
119599	119600	and	0	None
119600	119601	tuberin	0	None
119601	119602	and	0	None
119602	119603	activation	0	None
119603	119604	of	0	None
119604	119605	mTOR	0	None
119605	119606	with	0	None
119606	119607	increase	0	None
119607	119608	in	0	None
119608	119609	Nox4	0	None
119609	119610	and	0	None
119610	119611	NADPH	0	None
119611	119612	oxidase	0	None
119612	119613	activity	0	None
119613	119614	.	0	None

119615	119616	Inhibition	0	None
119616	119617	of	0	None
119617	119618	mTOR	0	None
119618	119619	by	0	None
119619	119620	small	0	None
119620	119621	dose	0	None
119621	119622	of	0	None
119622	119623	rapamycin	3	GENE-N
119623	119624	reduces	0	None
119624	119625	podocyte	0	None
119625	119626	apoptosis	0	None
119626	119627	,	0	None
119627	119628	attenuates	0	None
119628	119629	glomerular	0	None
119629	119630	injury	0	None
119630	119631	and	0	None
119631	119632	albuminuria	0	None
119632	119633	.	0	None

119634	119635	Our	0	None
119635	119636	data	0	None
119636	119637	provide	0	None
119637	119638	evidence	0	None
119638	119639	for	0	None
119639	119640	a	0	None
119640	119641	novel	0	None
119641	119642	function	0	None
119642	119643	of	0	None
119643	119644	mTOR	0	None
119644	119645	in	0	None
119645	119646	Nox4-derived	0	None
119646	119647	ROS	0	None
119647	119648	generation	0	None
119648	119649	and	0	None
119649	119650	podocyte	0	None
119650	119651	apoptosis	0	None
119651	119652	that	0	None
119652	119653	contributes	0	None
119653	119654	to	0	None
119654	119655	urinary	0	None
119655	119656	albumin	0	None
119656	119657	excretion	0	None
119657	119658	in	0	None
119658	119659	type	0	None
119659	119660	1	0	None
119660	119661	diabetes	0	None
119661	119662	.	0	None

119663	119664	Thus	0	None
119664	119665	mTOR	0	None
119665	119666	and	0	None
119666	119667	or	0	None
119667	119668	NADPH	0	None
119668	119669	oxidase	0	None
119669	119670	inhibition	0	None
119670	119671	may	0	None
119671	119672	represent	0	None
119672	119673	a	0	None
119673	119674	therapeutic	0	None
119674	119675	modality	0	None
119675	119676	of	0	None
119676	119677	diabetic	0	None
119677	119678	kidney	0	None
119678	119679	disease	0	None
119679	119680	.	0	None
119680	119681	6-Chloro-3-alkylamino-4H-thieno	0	None
119681	119682	[	0	None
119682	119683	3	0	None
119683	119684	,	0	None
119684	119685	2-e	0	None
119685	119686	]	0	None
119686	119687	-1	0	None
119687	119688	,	0	None
119688	119689	2	0	None
119689	119690	,	0	None
119690	119691	4-thiadiazine	0	None
119691	119692	1	0	None
119692	119693	,	0	None
119693	119694	1-dioxide	0	None
119694	119695	derivatives	0	None
119695	119696	potently	0	None
119696	119697	and	0	None
119697	119698	selectively	0	None
119698	119699	activate	0	None
119699	119700	ATP	0	None
119700	119701	sensitive	0	None
119701	119702	potassium	0	None
119702	119703	channels	0	None
119703	119704	of	0	None
119704	119705	pancreatic	0	None
119705	119706	beta-cells	0	None
119706	119707	.	0	None
119707	119708	The	0	None
119708	119709	dermis	0	None
119709	119710	of	0	None
119710	119711	a	0	None
119711	119712	child	0	None
119712	119713	with	0	None
119713	119714	Ehlers-Danlos	0	None
119714	119715	syndrome	0	None
119715	119716	type	0	None
119716	119717	IV	0	None
119717	119718	(	0	None
119718	119719	EDS-IV	0	None
119719	119720	)	0	None
119720	119721	contained	0	None
119721	119722	about	0	None
119722	119723	11%	0	None
119723	119724	of	0	None
119724	119725	the	0	None
119725	119726	normal	0	None
119726	119727	amount	0	None
119727	119728	of	0	None
119728	119729	type	0	None
119729	119730	III	0	None
119730	119731	collagen	3	GENE-N
119731	119732	and	0	None
119732	119733	cultured	0	None
119733	119734	dermal	0	None
119734	119735	fibroblasts	0	None
119735	119736	produced	0	None
119736	119737	a	0	None
119737	119738	reduced	0	None
119738	119739	amount	0	None
119739	119740	of	0	None
119740	119741	type	0	None
119741	119742	III	0	None
119742	119743	procollagen	0	None
119743	119744	which	0	None
119744	119745	was	0	None
119745	119746	secreted	0	None
119746	119747	poorly	0	None
119747	119748	.	0	None

119749	119750	Type	0	None
119750	119751	III	0	None
119751	119752	collagen	3	GENE-N
119752	119753	produced	0	None
119753	119754	by	0	None
119754	119755	these	0	None
119755	119756	cells	0	None
119756	119757	contained	0	None
119757	119758	normal	0	None
119758	119759	and	0	None
119759	119760	abnormal	0	None
119760	119761	alpha-chains	0	None
119761	119762	and	0	None
119762	119763	cyanogen	0	None
119763	119764	bromide	0	None
119764	119765	peptides	0	None
119765	119766	.	0	None

119767	119768	The	0	None
119768	119769	site	0	None
119769	119770	of	0	None
119770	119771	the	0	None
119771	119772	structural	0	None
119772	119773	defect	0	None
119773	119774	in	0	None
119774	119775	the	0	None
119775	119776	abnormal	0	None
119776	119777	alpha	0	None
119777	119778	1	0	None
119778	119779	(	0	None
119779	119780	III	0	None
119780	119781	)	0	None
119781	119782	chains	0	None
119782	119783	was	0	None
119783	119784	localized	0	None
119784	119785	to	0	None
119785	119786	the	0	None
119786	119787	region	0	None
119787	119788	of	0	None
119788	119789	Met797	0	None
119789	119790	,	0	None
119790	119791	which	0	None
119791	119792	is	0	None
119792	119793	at	0	None
119793	119794	the	0	None
119794	119795	junction	0	None
119795	119796	of	0	None
119796	119797	the	0	None
119797	119798	two	0	None
119798	119799	carboxyl-terminal	0	None
119799	119800	CB5	0	None
119800	119801	and	0	None
119801	119802	CB9	0	None
119802	119803	cyanogen	0	None
119803	119804	bromide	0	None
119804	119805	peptides	0	None
119805	119806	.	0	None

119807	119808	Chemical	0	None
119808	119809	cleavage	0	None
119809	119810	of	0	None
119810	119811	heteroduplexes	0	None
119811	119812	formed	0	None
119812	119813	between	0	None
119813	119814	EDS-IV	0	None
119814	119815	mRNA	0	None
119815	119816	and	0	None
119816	119817	a	0	None
119817	119818	normal	0	None
119818	119819	cDNA	0	None
119819	119820	clone	0	None
119820	119821	covering	0	None
119821	119822	the	0	None
119822	119823	CB5	0	None
119823	119824	and	0	None
119824	119825	CB9	0	None
119825	119826	region	0	None
119826	119827	showed	0	None
119827	119828	that	0	None
119828	119829	about	0	None
119829	119830	100	0	None
119830	119831	nucleotides	0	None
119831	119832	were	0	None
119832	119833	mismatched	0	None
119833	119834	.	0	None

119835	119836	Sequencing	0	None
119836	119837	of	0	None
119837	119838	amplified	0	None
119838	119839	and	0	None
119839	119840	cloned	0	None
119840	119841	cDNA	0	None
119841	119842	spanning	0	None
119842	119843	the	0	None
119843	119844	mutant	0	None
119844	119845	region	0	None
119845	119846	revealed	0	None
119846	119847	a	0	None
119847	119848	108	0	None
119848	119849	nucleotide	0	None
119849	119850	deletion	0	None
119850	119851	corresponding	0	None
119851	119852	to	0	None
119852	119854	amino acid	2	CHEMICAL
119854	119855	residues	0	None
119855	119856	Gly775	0	None
119856	119857	to	0	None
119857	119858	Lys810	0	None
119858	119859	.	0	None

119860	119861	The	0	None
119861	119862	deleted	0	None
119862	119863	nucleotide	0	None
119863	119864	sequence	0	None
119864	119865	corresponded	0	None
119865	119866	to	0	None
119866	119867	sequences	0	None
119867	119868	that	0	None
119868	119869	,	0	None
119869	119870	by	0	None
119870	119871	analogy	0	None
119871	119872	to	0	None
119872	119873	the	0	None
119873	119874	organization	0	None
119874	119875	of	0	None
119875	119876	the	0	None
119876	119877	type	0	None
119877	119878	I	0	None
119878	119879	collagen	3	GENE-N
119879	119880	genes	0	None
119880	119881	,	0	None
119881	119882	should	0	None
119882	119883	be	0	None
119883	119884	precisely	0	None
119884	119885	encoded	0	None
119885	119886	by	0	None
119886	119887	exon	0	None
119887	119888	41	0	None
119888	119889	of	0	None
119889	119890	the	0	None
119890	119891	COL3A1	0	None
119891	119892	gene	0	None
119892	119893	.	0	None

119894	119895	Sequencing	0	None
119895	119896	of	0	None
119896	119897	amplified	0	None
119897	119898	genomic	0	None
119898	119899	DNA	0	None
119899	119900	,	0	None
119900	119901	prepared	0	None
119901	119902	using	0	None
119902	119903	disimilar	0	None
119903	119904	amounts	0	None
119904	119905	of	0	None
119905	119906	primers	0	None
119906	119907	specific	0	None
119907	119908	for	0	None
119908	119909	exons	0	None
119909	119910	41	0	None
119910	119911	and	0	None
119911	119912	42	0	None
119912	119913	,	0	None
119913	119914	displayed	0	None
119914	119915	a	0	None
119915	119916	base	0	None
119916	119917	substitution	0	None
119917	119918	(	0	None
119918	119919	G-to-A	0	None
119919	119920	)	0	None
119920	119921	in	0	None
119921	119922	the	0	None
119922	119923	highly	0	None
119923	119924	conserved	0	None
119924	119925	GT	0	None
119925	119926	dinucleotide	0	None
119926	119927	of	0	None
119927	119928	the	0	None
119928	119929	5'	0	None
119929	119930	splice	0	None
119930	119931	site	0	None
119931	119932	of	0	None
119932	119933	intron	0	None
119933	119934	41	0	None
119934	119935	.	0	None

119936	119937	Normal	0	None
119937	119938	sequences	0	None
119938	119939	were	0	None
119939	119940	also	0	None
119940	119941	obtained	0	None
119941	119942	from	0	None
119942	119943	the	0	None
119943	119944	normal	0	None
119944	119945	allele	0	None
119945	119946	.	0	None

119947	119948	It	0	None
119948	119949	is	0	None
119949	119950	likely	0	None
119950	119951	that	0	None
119951	119952	the	0	None
119952	119953	GT-to-AT	0	None
119953	119954	transition	0	None
119954	119955	at	0	None
119955	119956	the	0	None
119956	119957	splice	0	None
119957	119958	donor	0	None
119958	119959	site	0	None
119959	119960	of	0	None
119960	119961	intron	0	None
119961	119962	41	0	None
119962	119963	generated	0	None
119963	119964	an	0	None
119964	119965	abnormally	0	None
119965	119966	spliced	0	None
119966	119967	mRNA	0	None
119967	119968	in	0	None
119968	119969	which	0	None
119969	119970	sequences	0	None
119970	119971	of	0	None
119971	119972	exon	0	None
119972	119973	40	0	None
119973	119974	and	0	None
119974	119975	42	0	None
119975	119976	were	0	None
119976	119977	joined	0	None
119977	119978	together	0	None
119978	119979	with	0	None
119979	119980	maintenance	0	None
119980	119981	of	0	None
119981	119982	the	0	None
119982	119983	reading	0	None
119983	119984	frame	0	None
119984	119985	.	0	None

119986	119987	The	0	None
119987	119988	corresponding	0	None
119988	119989	peptide	0	None
119989	119990	deletion	0	None
119990	119991	included	0	None
119991	119992	the	0	None
119992	119993	cyanogen	0	None
119993	119996	bromide cleavage site	0	None
119996	119997	Met797-Pro798	0	None
119997	119998	and	0	None
119998	119999	the	0	None
119999	120000	mammalian	0	None
120000	120001	collagenase	0	None
120001	120003	cleavage site	0	None
120003	120004	at	0	None
120004	120005	Gly781-Ile782	0	None
120005	120006	.	0	None

120007	120008	These	0	None
120008	120009	losses	0	None
120009	120010	account	0	None
120010	120011	for	0	None
120011	120012	the	0	None
120012	120013	resistance	0	None
120013	120014	of	0	None
120014	120015	EDS-IV	0	None
120015	120016	collagen	3	GENE-N
120016	120017	to	0	None
120017	120018	cyanogen	0	None
120018	120019	bromide	0	None
120019	120020	and	0	None
120020	120021	mammalian	0	None
120021	120022	collagenase	0	None
120022	120023	digestion	0	None
120023	120024	.	0	None

120025	120026	Cultured	0	None
120026	120027	fibroblasts	0	None
120027	120028	produced	0	None
120028	120029	normal	0	None
120029	120030	homotrimer	0	None
120030	120031	,	0	None
120031	120032	mutant	0	None
120032	120033	homotrimer	0	None
120033	120034	,	0	None
120034	120035	and	0	None
120035	120036	mixed	0	None
120036	120037	heterotrimer	0	None
120037	120038	type	0	None
120038	120039	III	0	None
120039	120040	collagen	3	GENE-N
120040	120041	molecules	0	None
120041	120042	.	0	None

120043	120044	The	0	None
120044	120045	mutant	0	None
120045	120046	homotrimer	0	None
120046	120047	molecules	0	None
120047	120048	were	0	None
120048	120049	the	0	None
120049	120050	major	0	None
120050	120051	pepsin-resistant	0	None
120051	120052	species	0	None
120052	120053	and	0	None
120053	120054	about	0	None
120054	120055	69%	0	None
120055	120056	of	0	None
120056	120057	the	0	None
120057	120058	alpha	0	None
120058	120059	1	0	None
120059	120060	(	0	None
120060	120061	III	0	None
120061	120062	)	0	None
120062	120063	mRNA	0	None
120063	120064	was	0	None
120064	120065	in	0	None
120065	120066	the	0	None
120066	120067	mutant	0	None
120067	120068	form	0	None
120068	120069	.	0	None
120069	120070	Obesity	0	None
120070	120071	increases	0	None
120071	120072	prostanoid-mediated	0	None
120072	120073	vasoconstriction	0	None
120073	120074	and	0	None
120074	120077	vascular thromboxane receptor	1	GENE-Y
120077	120078	gene	0	None
120078	120079	expression	0	None
120079	120080	.	0	None
120080	120081	A	0	None
120081	120082	Re-evaluation	0	None
120082	120083	of	0	None
120083	120084	the	0	None
120084	120085	Role	0	None
120085	120086	of	0	None
120086	120087	hCTR1	0	None
120087	120088	,	0	None
120088	120089	the	0	None
120089	120090	Human	0	None
120090	120091	High	0	None
120091	120092	Affinity	0	None
120092	120093	Cu	2	CHEMICAL
120093	120094	Transporter	0	None
120094	120095	in	0	None
120095	120096	Pt-Drug	0	None
120096	120097	Entry	0	None
120097	120098	into	0	None
120098	120099	Human	0	None
120099	120100	Cells	0	None
120100	120101	.	0	None
120101	120102	There	0	None
120102	120103	has	0	None
120103	120104	been	0	None
120104	120105	a	0	None
120105	120106	steep	0	None
120106	120107	increase	0	None
120107	120108	in	0	None
120108	120109	the	0	None
120109	120110	prevalence	0	None
120110	120111	of	0	None
120111	120112	dementia	0	None
120112	120113	in	0	None
120113	120114	recent	0	None
120114	120115	decades	0	None
120115	120116	,	0	None
120116	120117	which	0	None
120117	120118	has	0	None
120118	120119	roughly	0	None
120119	120120	followed	0	None
120120	120121	an	0	None
120121	120122	increase	0	None
120122	120123	in	0	None
120123	120124	pesticide	0	None
120124	120125	use	0	None
120125	120126	some	0	None
120126	120127	decades	0	None
120127	120128	earlier	0	None
120128	120129	,	0	None
120129	120130	a	0	None
120130	120131	time	0	None
120131	120132	when	0	None
120132	120133	it	0	None
120133	120134	is	0	None
120134	120135	probable	0	None
120135	120136	that	0	None
120136	120137	current	0	None
120137	120138	dementia	0	None
120138	120139	patients	0	None
120139	120140	could	0	None
120140	120141	have	0	None
120141	120142	been	0	None
120142	120143	exposed	0	None
120143	120144	to	0	None
120144	120145	pesticides	0	None
120145	120146	.	0	None

120147	120148	This	0	None
120148	120149	raises	0	None
120149	120150	the	0	None
120150	120151	question	0	None
120151	120152	whether	0	None
120152	120153	pesticides	0	None
120153	120154	contribute	0	None
120154	120155	to	0	None
120155	120156	dementia	0	None
120156	120157	pathogenesis	0	None
120157	120158	.	0	None

120159	120160	Indeed	0	None
120160	120161	,	0	None
120161	120162	many	0	None
120162	120163	studies	0	None
120163	120164	have	0	None
120164	120165	found	0	None
120165	120166	increased	0	None
120166	120167	prevalence	0	None
120167	120168	of	0	None
120168	120169	cognitive	0	None
120169	120170	,	0	None
120170	120171	behavioral	0	None
120171	120172	and	0	None
120172	120173	psychomotor	0	None
120173	120174	dysfunction	0	None
120174	120175	in	0	None
120175	120176	individuals	0	None
120176	120177	chronically	0	None
120177	120178	exposed	0	None
120178	120179	to	0	None
120179	120180	pesticides	0	None
120180	120181	.	0	None

120182	120183	Furthermore	0	None
120183	120184	,	0	None
120184	120185	evidence	0	None
120185	120186	from	0	None
120186	120187	recent	0	None
120187	120188	studies	0	None
120188	120189	shows	0	None
120189	120190	a	0	None
120190	120191	possible	0	None
120191	120192	association	0	None
120192	120193	between	0	None
120193	120194	chronic	0	None
120194	120195	pesticide	0	None
120195	120196	exposure	0	None
120196	120197	and	0	None
120197	120198	an	0	None
120198	120199	increased	0	None
120199	120200	prevalence	0	None
120200	120201	of	0	None
120201	120202	dementia	0	None
120202	120203	,	0	None
120203	120204	including	0	None
120204	120205	Alzheimer's	0	None
120205	120206	disease	0	None
120206	120207	(	0	None
120207	120208	AD	0	None
120208	120209	)	0	None
120209	120210	dementia	0	None
120210	120211	.	0	None

120212	120213	At	0	None
120213	120214	the	0	None
120214	120215	cellular	0	None
120215	120216	and	0	None
120216	120217	molecular	0	None
120217	120218	level	0	None
120218	120219	,	0	None
120219	120220	the	0	None
120220	120221	mechanism	0	None
120221	120222	of	0	None
120222	120223	action	0	None
120223	120224	of	0	None
120224	120225	many	0	None
120225	120226	classes	0	None
120226	120227	of	0	None
120227	120228	pesticides	0	None
120228	120229	suggests	0	None
120229	120230	that	0	None
120230	120231	these	0	None
120231	120232	compounds	0	None
120232	120233	could	0	None
120233	120234	be	0	None
120234	120235	,	0	None
120235	120236	at	0	None
120236	120237	least	0	None
120237	120238	partly	0	None
120238	120239	,	0	None
120239	120240	accountable	0	None
120240	120241	for	0	None
120241	120242	the	0	None
120242	120243	neurodegeneration	0	None
120243	120244	accompanying	0	None
120244	120245	AD	0	None
120245	120246	and	0	None
120246	120247	other	0	None
120247	120248	dementias	0	None
120248	120249	.	0	None

120250	120251	For	0	None
120251	120252	example	0	None
120252	120253	,	0	None
120253	120254	organophosphates	0	None
120254	120255	,	0	None
120255	120256	which	0	None
120256	120257	inhibit	0	None
120257	120258	acetylcholinesterase	0	None
120258	120259	as	0	None
120259	120260	do	0	None
120260	120261	the	0	None
120261	120262	drugs	0	None
120262	120263	used	0	None
120263	120264	in	0	None
120264	120265	treating	0	None
120265	120266	AD	0	None
120266	120267	symptoms	0	None
120267	120268	,	0	None
120268	120269	have	0	None
120269	120270	also	0	None
120270	120271	been	0	None
120271	120272	shown	0	None
120272	120273	to	0	None
120273	120274	lead	0	None
120274	120275	to	0	None
120275	120276	microtubule	0	None
120276	120277	derangements	0	None
120277	120278	and	0	None
120278	120279	tau	1	GENE-Y
120279	120280	hyperphosphorylation	0	None
120280	120281	,	0	None
120281	120282	a	0	None
120282	120283	hallmark	0	None
120283	120284	of	0	None
120284	120285	AD	0	None
120285	120286	.	0	None

120287	120288	This	0	None
120288	120289	emerging	0	None
120289	120290	association	0	None
120290	120291	is	0	None
120291	120292	of	0	None
120292	120293	considerable	0	None
120293	120294	public	0	None
120294	120295	health	0	None
120295	120296	importance	0	None
120296	120297	,	0	None
120297	120298	given	0	None
120298	120299	the	0	None
120299	120300	increasing	0	None
120300	120301	dementia	0	None
120301	120302	prevalence	0	None
120302	120303	and	0	None
120303	120304	pesticide	0	None
120304	120305	use	0	None
120305	120306	.	0	None

120307	120308	Here	0	None
120308	120309	we	0	None
120309	120310	review	0	None
120310	120311	the	0	None
120311	120312	epidemiological	0	None
120312	120313	links	0	None
120313	120314	between	0	None
120314	120315	dementia	0	None
120315	120316	and	0	None
120316	120317	pesticide	0	None
120317	120318	exposure	0	None
120318	120319	and	0	None
120319	120320	discuss	0	None
120320	120321	the	0	None
120321	120322	possible	0	None
120322	120323	pathophysiological	0	None
120323	120324	mechanisms	0	None
120324	120325	and	0	None
120325	120326	clinical	0	None
120326	120327	implications	0	None
120327	120328	of	0	None
120328	120329	this	0	None
120329	120330	association	0	None
120330	120331	.	0	None
120331	120332	NMDA	0	None
120332	120333	Receptor	0	None
120333	120334	Activation	0	None
120334	120335	Down-Regulates	0	None
120335	120336	Expression	0	None
120336	120337	of	0	None
120337	120338	δ	0	None
120338	120339	Subunit-Containing	0	None
120339	120340	GABA-A	0	None
120340	120341	Receptors	0	None
120341	120342	in	0	None
120342	120343	Cultured	0	None
120343	120344	Hippocampal	0	None
120344	120345	Neurons	0	None
120345	120346	.	0	None
120346	120347	The	0	None
120347	120348	human	0	None
120348	120349	liver	0	None
120349	120350	cell	0	None
120350	120351	line	0	None
120351	120352	HepaRG	0	None
120352	120353	has	0	None
120353	120354	been	0	None
120354	120355	recognized	0	None
120355	120356	as	0	None
120356	120357	a	0	None
120357	120358	promising	0	None
120358	120359	source	0	None
120359	120360	for	0	None
120360	120361	in	0	None
120361	120362	vitro	0	None
120362	120363	testing	0	None
120363	120364	of	0	None
120364	120365	metabolism	0	None
120365	120366	and	0	None
120366	120367	toxicity	0	None
120367	120368	of	0	None
120368	120369	compounds	0	None
120369	120370	.	0	None

120371	120372	However	0	None
120372	120373	,	0	None
120373	120374	currently	0	None
120374	120375	the	0	None
120375	120376	hepatic	0	None
120376	120377	differentiation	0	None
120377	120378	of	0	None
120378	120379	these	0	None
120379	120380	cells	0	None
120380	120381	relies	0	None
120381	120382	on	0	None
120382	120383	exposure	0	None
120383	120384	to	0	None
120384	120385	dimethylsulfoxide	0	None
120385	120386	(	0	None
120386	120387	DMSO	2	CHEMICAL
120387	120388	)	0	None
120388	120389	,	0	None
120389	120390	which	0	None
120390	120391	,	0	None
120391	120392	as	0	None
120392	120393	a	0	None
120393	120394	side	0	None
120394	120395	effect	0	None
120395	120396	,	0	None
120396	120397	has	0	None
120397	120398	a	0	None
120398	120399	cytotoxic	0	None
120399	120400	effect	0	None
120400	120401	and	0	None
120401	120402	represses	0	None
120402	120403	an	0	None
120403	120404	all-round	0	None
120404	120405	hepatic	0	None
120405	120406	functionality	0	None
120406	120407	.	0	None

120408	120409	The	0	None
120409	120410	AMC-bioartificial	0	None
120410	120411	liver	0	None
120411	120412	(	0	None
120412	120413	AMC-BAL	0	None
120413	120414	)	0	None
120414	120415	is	0	None
120415	120416	a	0	None
120416	120417	three-dimensional	0	None
120417	120418	bioreactor	0	None
120418	120419	that	0	None
120419	120420	has	0	None
120420	120421	previously	0	None
120421	120422	been	0	None
120422	120423	shown	0	None
120423	120424	to	0	None
120424	120425	upregulate	0	None
120425	120426	various	0	None
120426	120427	liver	0	None
120427	120428	functions	0	None
120428	120429	of	0	None
120429	120430	cultured	0	None
120430	120431	cells	0	None
120431	120432	.	0	None

120433	120434	We	0	None
120434	120435	therefore	0	None
120435	120436	cultured	0	None
120436	120437	HepaRG	0	None
120437	120438	cells	0	None
120438	120439	in	0	None
120439	120440	the	0	None
120440	120441	AMC-BAL	0	None
120441	120442	without	0	None
120442	120443	DMSO	2	CHEMICAL
120443	120444	and	0	None
120444	120445	characterized	0	None
120445	120446	the	0	None
120446	120447	drug	0	None
120447	120448	metabolism	0	None
120448	120449	.	0	None

120450	120451	Within	0	None
120451	120452	14	0	None
120452	120453	days	0	None
120453	120454	of	0	None
120454	120455	culture	0	None
120455	120456	,	0	None
120456	120457	the	0	None
120457	120458	HepaRG-AMC-BALs	0	None
120458	120459	contained	0	None
120459	120460	highly	0	None
120460	120461	polarized	0	None
120461	120462	viable	0	None
120462	120463	liver-like	0	None
120463	120464	tissue	0	None
120464	120465	with	0	None
120465	120466	heterogeneous	0	None
120466	120467	expression	0	None
120467	120468	of	0	None
120468	120469	CYP3A4	0	None
120469	120470	.	0	None

120471	120472	We	0	None
120472	120473	found	0	None
120473	120474	a	0	None
120474	120475	substantial	0	None
120475	120476	metabolism	0	None
120476	120477	of	0	None
120477	120478	the	0	None
120478	120479	tested	0	None
120479	120480	substrates	0	None
120480	120481	,	0	None
120481	120482	ranging	0	None
120482	120483	from	0	None
120483	120484	26%	0	None
120484	120485	(	0	None
120485	120486	UDP-glucuronosyltransferase	0	None
120486	120487	1A1	0	None
120487	120488	)	0	None
120488	120489	,	0	None
120489	120490	47%	0	None
120490	120491	(	0	None
120491	120492	CYP3A4	0	None
120492	120493	)	0	None
120493	120494	,	0	None
120494	120495	to	0	None
120495	120496	240%	0	None
120496	120497	(	0	None
120497	120498	CYP2C9	0	None
120498	120499	)	0	None
120499	120500	of	0	None
120500	120501	primary	0	None
120501	120502	human	0	None
120502	120503	hepatocytes	0	None
120503	120504	.	0	None

120505	120506	The	0	None
120506	120507	CYP3A4	0	None
120507	120508	activity	0	None
120508	120509	could	0	None
120509	120510	be	0	None
120510	120511	induced	0	None
120511	120512	2-fold	0	None
120512	120513	by	0	None
120513	120514	rifampicin	2	CHEMICAL
120514	120515	,	0	None
120515	120516	whereas	0	None
120516	120517	CYP2C9	0	None
120517	120518	activity	0	None
120518	120519	remained	0	None
120519	120520	equally	0	None
120520	120521	high	0	None
120521	120522	.	0	None

120523	120524	The	0	None
120524	120525	HepaRG-AMC-BAL	0	None
120525	120526	secreted	0	None
120526	120528	bile acids	2	CHEMICAL
120528	120529	at	0	None
120529	120530	43%	0	None
120530	120531	the	0	None
120531	120532	rate	0	None
120532	120533	of	0	None
120533	120534	primary	0	None
120534	120535	human	0	None
120535	120536	hepatocytes	0	None
120536	120537	and	0	None
120537	120538	demonstrated	0	None
120538	120539	hydroxylation	0	None
120539	120540	,	0	None
120540	120541	conjugation	0	None
120541	120542	,	0	None
120542	120543	and	0	None
120543	120544	transport	0	None
120544	120545	of	0	None
120545	120546	bile	0	None
120546	120547	salts	0	None
120547	120548	.	0	None

120549	120550	Concluding	0	None
120550	120551	,	0	None
120551	120552	culturing	0	None
120552	120553	HepaRG	0	None
120553	120554	cells	0	None
120554	120555	in	0	None
120555	120556	the	0	None
120556	120557	AMC-BAL	0	None
120557	120558	yields	0	None
120558	120559	substantial	0	None
120559	120560	phase	0	None
120560	120561	1	0	None
120561	120562	and	0	None
120562	120563	phase	0	None
120563	120564	2	0	None
120564	120565	drug	0	None
120565	120566	metabolism	0	None
120566	120567	,	0	None
120567	120568	while	0	None
120568	120569	maintaining	0	None
120569	120570	high	0	None
120570	120571	viability	0	None
120571	120572	,	0	None
120572	120573	rendering	0	None
120573	120574	DMSO	2	CHEMICAL
120574	120575	addition	0	None
120575	120576	superfluous	0	None
120576	120577	for	0	None
120577	120578	the	0	None
120578	120579	promotion	0	None
120579	120580	of	0	None
120580	120581	drug	0	None
120581	120582	metabolism	0	None
120582	120583	.	0	None

120584	120585	Therefore	0	None
120585	120586	,	0	None
120586	120587	AMC-BAL	0	None
120587	120588	culturing	0	None
120588	120589	makes	0	None
120589	120590	the	0	None
120590	120591	HepaRG	0	None
120591	120592	cells	0	None
120592	120593	more	0	None
120593	120594	suitable	0	None
120594	120595	for	0	None
120595	120596	testing	0	None
120596	120597	metabolism	0	None
120597	120598	and	0	None
120598	120599	toxicity	0	None
120599	120600	of	0	None
120600	120601	drugs	0	None
120601	120602	.	0	None
120602	120603	Stimulatory	0	None
120603	120604	effect	0	None
120604	120605	of	0	None
120605	120606	insulin	0	None
120606	120607	on	0	None
120607	120608	theca-interstitial	0	None
120608	120609	cell	0	None
120609	120610	proliferation	0	None
120610	120611	and	0	None
120611	120612	cell	0	None
120612	120613	cycle	0	None
120613	120614	regulatory	0	None
120614	120615	proteins	0	None
120615	120616	through	0	None
120616	120617	MTORC1	0	None
120617	120618	dependent	0	None
120618	120619	pathway	0	None
120619	120620	.	0	None
120620	120621	Higher	0	None
120621	120622	farnesyl	0	None
120622	120623	diphosphate	0	None
120623	120624	synthase	0	None
120624	120625	activity	0	None
120625	120626	in	0	None
120626	120627	human	0	None
120627	120628	colorectal	0	None
120628	120629	cancer	0	None
120629	120630	inhibition	0	None
120630	120631	of	0	None
120631	120632	cellular	0	None
120632	120633	apoptosis	0	None
120633	120634	.	0	None
120634	120635	Chloride	0	None
120635	120636	channels	0	None
120636	120637	in	0	None
120637	120638	renal	0	None
120638	120639	disease	0	None
120639	120640	.	0	None
120640	120641	Gonadotropin	0	None
120641	120642	Regulated	0	None
120642	120643	Testicular	0	None
120643	120644	RNA	0	None
120644	120645	Helicase	0	None
120645	120646	(	0	None
120646	120647	GRTH	0	None
120647	120648	/	0	None
120648	120649	Ddx25	0	None
120649	120650	)	0	None
120650	120651	is	0	None
120651	120652	a	0	None
120652	120653	post-transcriptional	0	None
120653	120654	regulator	0	None
120654	120655	of	0	None
120655	120656	genes	0	None
120656	120657	that	0	None
120657	120658	are	0	None
120658	120659	essential	0	None
120659	120660	for	0	None
120660	120661	spermatid	0	None
120661	120662	elongation	0	None
120662	120663	and	0	None
120663	120664	completion	0	None
120664	120665	of	0	None
120665	120666	spermatogenesis	0	None
120666	120667	.	0	None

120668	120669	It	0	None
120669	120670	also	0	None
120670	120671	prevents	0	None
120671	120672	Leydig	0	None
120672	120673	cells	0	None
120673	120674	(	0	None
120674	120675	LC	0	None
120675	120676	)	0	None
120676	120677	from	0	None
120677	120678	gonadotropin	0	None
120678	120679	overstimulation	0	None
120679	120680	of	0	None
120680	120681	androgen	0	None
120681	120682	production	0	None
120682	120683	.	0	None

120684	120685	In	0	None
120685	120686	transgenic	0	None
120686	120687	(	0	None
120687	120688	Tg	0	None
120688	120689	)	0	None
120689	120690	mice	0	None
120690	120691	carrying	0	None
120691	120692	deletions	0	None
120692	120693	of	0	None
120693	120694	the	0	None
120694	120695	GRTH	0	None
120695	120696	5'	0	None
120696	120697	flanking	0	None
120697	120698	regions	0	None
120698	120699	we	0	None
120699	120700	previously	0	None
120700	120701	demonstrated	0	None
120701	120702	that	0	None
120702	120703	the	0	None
120703	120704	-1085	0	None
120704	120705	bp	0	None
120705	120706	to	0	None
120706	120707	ATG	0	None
120707	120708	contains	0	None
120708	120709	the	0	None
120709	120710	elements	0	None
120710	120711	for	0	None
120711	120712	basal	0	None
120712	120713	and	0	None
120713	120714	androgen-induced	0	None
120714	120715	LC	0	None
120715	120716	specific	0	None
120716	120717	expression	0	None
120717	120718	.	0	None

120719	120720	No	0	None
120720	120721	expression	0	None
120721	120722	in	0	None
120722	120723	germ	0	None
120723	120724	cells	0	None
120724	120725	(	0	None
120725	120726	GC	0	None
120726	120727	)	0	None
120727	120728	was	0	None
120728	120729	found	0	None
120729	120730	with	0	None
120730	120731	sequences	0	None
120731	120732	extended	0	None
120732	120733	up	0	None
120733	120734	to	0	None
120734	120735	-3	0	None
120735	120736	.	0	None
120736	120737	6	0	None
120737	120738	Kb	0	None
120738	120739	.	0	None

120740	120741	To	0	None
120741	120742	define	0	None
120742	120743	regulatory	0	None
120743	120744	regions	0	None
120744	120745	of	0	None
120745	120746	GRTH	0	None
120746	120747	required	0	None
120747	120748	for	0	None
120748	120749	expression	0	None
120749	120750	in	0	None
120750	120751	GC	0	None
120751	120752	,	0	None
120752	120753	Tg	0	None
120753	120754	mice	0	None
120754	120755	were	0	None
120755	120756	generated	0	None
120756	120757	with	0	None
120757	120758	5'	0	None
120758	120759	flanking	0	None
120759	120760	sequence	0	None
120760	120761	6	0	None
120761	120762	.	0	None
120762	120763	4	0	None
120763	120764	Kb	0	None
120764	120765	(	0	None
120765	120766	6	0	None
120766	120767	.	0	None
120767	120768	4	0	None
120768	120769	Kb-Tg	0	None
120769	120770	)	0	None
120770	120771	and	0	None
120771	120772	/	0	None
120772	120773	or	0	None
120773	120774	deletion	0	None
120774	120775	using	0	None
120775	120776	GFP	0	None
120776	120777	as	0	None
120777	120778	reporter	0	None
120778	120779	gene	0	None
120779	120780	in	0	None
120780	120781	the	0	None
120781	120782	present	0	None
120782	120783	study	0	None
120783	120784	.	0	None

120785	120786	GFP	0	None
120786	120787	was	0	None
120787	120788	expressed	0	None
120788	120789	in	0	None
120789	120790	all	0	None
120790	120791	lines	0	None
120791	120792	.	0	None

120793	120794	Immuno-histochemistry	0	None
120794	120795	analysis	0	None
120795	120796	showed	0	None
120796	120797	that	0	None
120797	120798	6	0	None
120798	120799	.	0	None
120799	120800	4Kb-Tg	0	None
120800	120801	directed	0	None
120801	120802	GFP	0	None
120802	120803	expression	0	None
120803	120804	in	0	None
120804	120805	both	0	None
120805	120806	GC	0	None
120806	120807	and	0	None
120807	120808	LC	0	None
120808	120809	.	0	None

120810	120811	Deletion	0	None
120811	120812	of	0	None
120812	120813	the	0	None
120813	120814	sequence	0	None
120814	120815	-205	0	None
120815	120816	bp	0	None
120816	120817	to	0	None
120817	120818	-3	0	None
120818	120819	.	0	None
120819	120820	6	0	None
120820	120821	Kb	0	None
120821	120822	(	0	None
120822	120823	6	0	None
120823	120824	.	0	None
120824	120825	4Kb	0	None
120825	120826	/	0	None
120826	120827	del-Tg	0	None
120827	120828	)	0	None
120828	120829	directs	0	None
120829	120830	GFP	0	None
120830	120831	expression	0	None
120831	120832	only	0	None
120832	120833	in	0	None
120833	120834	meiotic	0	None
120834	120835	and	0	None
120835	120836	haploid	0	None
120836	120837	GCs	0	None
120837	120838	.	0	None

120839	120840	This	0	None
120840	120841	indicated	0	None
120841	120842	that	0	None
120842	120843	the	0	None
120843	120844	distal	0	None
120844	120845	region	0	None
120845	120846	-6	0	None
120846	120847	.	0	None
120847	120848	4	0	None
120848	120849	Kb	0	None
120849	120850	/	0	None
120850	120851	-3	0	None
120851	120852	.	0	None
120852	120853	6	0	None
120853	120854	Kb	0	None
120854	120855	is	0	None
120855	120856	required	0	None
120856	120857	for	0	None
120857	120858	GRTH	0	None
120858	120859	cell	0	None
120859	120860	specific	0	None
120860	120861	expression	0	None
120861	120862	in	0	None
120862	120863	GC	0	None
120863	120864	.	0	None

120865	120866	Also	0	None
120866	120867	,	0	None
120867	120868	it	0	None
120868	120869	inhibits	0	None
120869	120870	the	0	None
120870	120871	expression	0	None
120871	120872	of	0	None
120872	120873	GRTH	0	None
120873	120874	in	0	None
120874	120875	LC	0	None
120875	120876	directed	0	None
120876	120877	by	0	None
120877	120878	the	0	None
120878	120879	205	0	None
120879	120880	bp	0	None
120880	120881	promoter	0	None
120881	120882	,	0	None
120882	120883	an	0	None
120883	120884	effect	0	None
120884	120885	that	0	None
120885	120886	is	0	None
120886	120887	neutralized	0	None
120887	120888	by	0	None
120888	120889	the	0	None
120889	120890	-3	0	None
120890	120891	.	0	None
120891	120892	6Kb	0	None
120892	120893	/	0	None
120893	120894	-205bp	0	None
120894	120895	sequence	0	None
120895	120896	.	0	None

120897	120898	Flutamide	2	CHEMICAL
120898	120899	treatment	0	None
120899	120900	prevents	0	None
120900	120901	GFP	0	None
120901	120902	/	0	None
120902	120903	GRTH	0	None
120903	120904	expression	0	None
120904	120905	in	0	None
120905	120906	Tg	0	None
120906	120907	lines	0	None
120907	120908	demonstrating	0	None
120908	120909	in	0	None
120909	120910	vivo	0	None
120910	120911	direct	0	None
120911	120912	and	0	None
120912	120913	indirect	0	None
120913	120914	effects	0	None
120914	120915	of	0	None
120915	120916	endogenous	0	None
120916	120917	androgen	0	None
120917	120918	on	0	None
120918	120919	GC	0	None
120919	120920	and	0	None
120920	120921	LC	0	None
120921	120922	,	0	None
120922	120923	respectively	0	None
120923	120924	.	0	None

120925	120926	Our	0	None
120926	120927	studies	0	None
120927	120928	have	0	None
120928	120929	generated	0	None
120929	120930	and	0	None
120930	120931	characterized	0	None
120931	120932	transgenic	0	None
120932	120933	lines	0	None
120933	120934	that	0	None
120934	120935	can	0	None
120935	120936	be	0	None
120936	120937	utilized	0	None
120937	120938	to	0	None
120938	120939	define	0	None
120939	120940	requirements	0	None
120940	120941	for	0	None
120941	120942	cell	0	None
120942	120943	specific	0	None
120943	120944	expression	0	None
120944	120945	of	0	None
120945	120946	the	0	None
120946	120947	GRTH	0	None
120947	120948	gene	0	None
120948	120949	and	0	None
120949	120950	to	0	None
120950	120951	further	0	None
120951	120952	advance	0	None
120952	120953	our	0	None
120953	120954	knowledge	0	None
120954	120955	on	0	None
120955	120956	the	0	None
120956	120957	regulation	0	None
120957	120958	of	0	None
120958	120959	GRTH	0	None
120959	120960	by	0	None
120960	120961	androgen	0	None
120961	120962	in	0	None
120962	120963	germ	0	None
120963	120964	cells	0	None
120964	120965	.	0	None
120965	120966	Guided	0	None
120966	120967	by	0	None
120967	120968	the	0	None
120968	120969	acetylcholinesterase	0	None
120969	120970	inhibiting	0	None
120970	120971	activity	0	None
120971	120972	,	0	None
120972	120973	the	0	None
120973	120974	bisindole	0	None
120974	120975	alkaloid	0	None
120975	120976	3'-R	0	None
120976	120977	/	0	None
120977	120978	S-hydroxyvoacamine	0	None
120978	120979	was	0	None
120979	120980	isolated	0	None
120980	120981	from	0	None
120981	120982	a	0	None
120982	120983	stem	0	None
120983	120984	extract	0	None
120984	120985	of	0	None
120985	120986	Tabernaemontana	0	None
120986	120987	divaricata	0	None
120987	120988	,	0	None
120988	120989	a	0	None
120989	120990	plant	0	None
120990	120991	used	0	None
120991	120992	in	0	None
120992	120993	Thailand	0	None
120993	120994	in	0	None
120994	120995	traditional	0	None
120995	120996	rejuvenation	0	None
120996	120997	remedies	0	None
120997	120998	for	0	None
120998	120999	improving	0	None
120999	121000	the	0	None
121000	121001	memory	0	None
121001	121002	.	0	None

121003	121004	The	0	None
121004	121005	structure	0	None
121005	121006	of	0	None
121006	121007	the	0	None
121007	121008	alkaloid	0	None
121008	121009	was	0	None
121009	121010	elucidated	0	None
121010	121011	by	0	None
121011	121012	extensive	0	None
121012	121013	use	0	None
121013	121014	of	0	None
121014	121015	NMR	0	None
121015	121016	spectroscopy	0	None
121016	121017	and	0	None
121017	121018	the	0	None
121018	121019	complete	0	None
121019	121020	assignment	0	None
121020	121021	of	0	None
121021	121022	the	0	None
121022	121023	(	0	None
121023	121024	1	0	None
121024	121025	)	0	None
121025	121026	H	0	None
121026	121027	and	0	None
121027	121028	(	0	None
121028	121029	13	0	None
121029	121030	)	0	None
121030	121031	C	0	None
121031	121032	NMR	0	None
121032	121033	spectra	0	None
121033	121034	is	0	None
121034	121035	reported	0	None
121035	121036	.	0	None

121037	121038	The	0	None
121038	121039	alkaloid	0	None
121039	121040	acted	0	None
121040	121041	as	0	None
121041	121042	a	0	None
121042	121043	non-competitive	0	None
121043	121044	inhibitor	0	None
121044	121045	against	0	None
121045	121046	AChE	1	GENE-Y
121046	121047	with	0	None
121047	121048	an	0	None
121048	121049	IC50	0	None
121049	121050	value	0	None
121050	121051	of	0	None
121051	121052	7	0	None
121052	121053	.	0	None
121053	121054	00±1	0	None
121054	121055	.	0	None
121055	121056	99μM	0	None
121056	121057	.	0	None

121058	121059	An	0	None
121059	121060	HPLC	0	None
121060	121061	method	0	None
121061	121062	was	0	None
121062	121063	developed	0	None
121063	121064	for	0	None
121064	121065	the	0	None
121065	121066	quantitative	0	None
121066	121067	analysis	0	None
121067	121068	of	0	None
121068	121069	the	0	None
121069	121070	AChE	1	GENE-Y
121070	121071	inhibitor	0	None
121071	121072	.	0	None

121073	121074	It	0	None
121074	121075	suggested	0	None
121075	121076	that	0	None
121076	121077	there	0	None
121077	121078	was	0	None
121078	121079	12	0	None
121079	121080	.	0	None
121080	121081	4%	0	None
121081	121082	(	0	None
121082	121083	w	0	None
121083	121084	/	0	None
121084	121085	w	0	None
121085	121086	)	0	None
121086	121087	of	0	None
121087	121088	3'-R	0	None
121088	121089	/	0	None
121089	121090	S-hydroxyvoacamine	0	None
121090	121091	in	0	None
121091	121092	the	0	None
121092	121093	alkaloid	0	None
121093	121094	enriched	0	None
121094	121095	fraction	0	None
121095	121096	of	0	None
121096	121097	T	0	None
121097	121098	.	0	None

121099	121100	divaricata	0	None
121100	121101	stem	0	None
121101	121102	.	0	None
121102	121103	Imiquimod	0	None
121103	121104	is	0	None
121104	121105	a	0	None
121105	121106	topical	0	None
121106	121107	immune	0	None
121107	121108	response	0	None
121108	121109	modifier	0	None
121109	121110	that	0	None
121110	121111	binds	0	None
121111	121112	to	0	None
121112	121113	Toll-like	0	None
121113	121114	receptor-7	0	None
121114	121115	and	0	None
121115	121116	-8	0	None
121116	121117	,	0	None
121117	121118	inducing	0	None
121118	121119	interferon-alpha	0	None
121119	121120	.	0	None

121121	121122	We	0	None
121122	121123	treated	0	None
121123	121124	superficial	0	None
121124	121125	basal	0	None
121125	121126	cell	0	None
121126	121127	carcinomas	0	None
121127	121128	(	0	None
121128	121129	BCC	0	None
121129	121130	)	0	None
121130	121131	with	0	None
121131	121132	imiquimod	0	None
121132	121133	5%	0	None
121133	121134	cream	0	None
121134	121135	daily	0	None
121135	121136	for	0	None
121136	121137	5-8	0	None
121137	121138	days	0	None
121138	121139	.	0	None

121140	121141	The	0	None
121141	121142	BCC	0	None
121142	121143	lesions	0	None
121143	121144	were	0	None
121144	121145	biopsied	0	None
121145	121146	before	0	None
121146	121147	treatment	0	None
121147	121148	and	0	None
121148	121149	following	0	None
121149	121150	imiquimod	0	None
121150	121151	treatment	0	None
121151	121152	,	0	None
121152	121153	when	0	None
121153	121154	the	0	None
121154	121155	lesion	0	None
121155	121156	showed	0	None
121156	121157	the	0	None
121157	121158	signs	0	None
121158	121159	of	0	None
121159	121160	erosion	0	None
121160	121161	.	0	None

121162	121163	We	0	None
121163	121164	applied	0	None
121164	121165	histology	0	None
121165	121166	,	0	None
121166	121167	immunohistochemistry	0	None
121167	121168	and	0	None
121168	121169	gene	0	None
121169	121170	array	0	None
121170	121171	technology	0	None
121171	121172	(	0	None
121172	121173	Affymetrix	0	None
121173	121174	)	0	None
121174	121175	to	0	None
121175	121176	gain	0	None
121176	121177	further	0	None
121177	121178	insight	0	None
121178	121179	into	0	None
121179	121180	the	0	None
121180	121181	mode	0	None
121181	121182	of	0	None
121182	121183	action	0	None
121183	121184	of	0	None
121184	121185	imiquimod	0	None
121185	121186	.	0	None

121187	121188	Our	0	None
121188	121189	findings	0	None
121189	121190	demonstrate	0	None
121190	121191	that	0	None
121191	121192	imiquimod-induced	0	None
121192	121193	BCC	0	None
121193	121194	regression	0	None
121194	121195	is	0	None
121195	121196	associated	0	None
121196	121197	with	0	None
121197	121198	a	0	None
121198	121199	strong	0	None
121199	121200	activity	0	None
121200	121201	of	0	None
121201	121202	the	0	None
121202	121203	innate	0	None
121203	121204	immune	0	None
121204	121205	response	0	None
121205	121206	,	0	None
121206	121207	mediated	0	None
121207	121208	by	0	None
121208	121209	cells	0	None
121209	121210	of	0	None
121210	121211	macrophage-monocyte	0	None
121211	121212	origin	0	None
121212	121213	and	0	None
121213	121214	is	0	None
121214	121215	associated	0	None
121215	121216	with	0	None
121216	121217	the	0	None
121217	121218	induction	0	None
121218	121219	of	0	None
121219	121220	apoptosis	0	None
121220	121221	.	0	None
121221	121222	Quercetin	0	None
121222	121223	suppressed	0	None
121223	121224	CYP2E1-dependent	0	None
121224	121225	ethanol	2	CHEMICAL
121225	121226	hepatotoxicity	0	None
121226	121227	via	0	None
121227	121228	depleting	0	None
121228	121229	heme	0	None
121229	121230	pool	0	None
121230	121231	and	0	None
121231	121232	releasing	0	None
121232	121233	CO	0	None
121233	121234	.	0	None
121234	121235	Non-selective	0	None
121235	121236	inhibition	0	None
121236	121237	of	0	None
121237	121239	monoamine oxidase	3	GENE-N
121239	121240	(	0	None
121240	121241	MAO	3	GENE-N
121241	121242	)	0	None
121242	121243	enzymes	0	None
121243	121244	(	0	None
121244	121245	ie	0	None
121245	121246	,	0	None
121246	121247	isoforms	0	None
121247	121248	A	0	None
121248	121249	and	0	None
121249	121250	B	0	None
121250	121251	)	0	None
121251	121252	in	0	None
121252	121253	the	0	None
121253	121254	brain	0	None
121254	121255	are	0	None
121255	121256	associated	0	None
121256	121257	with	0	None
121257	121258	clinically	0	None
121258	121259	significant	0	None
121259	121260	antidepressant	0	None
121260	121261	effects	0	None
121261	121262	.	0	None

121263	121264	In	0	None
121264	121265	the	0	None
121265	121266	US	0	None
121266	121267	,	0	None
121267	121268	the	0	None
121268	121269	selegiline	0	None
121269	121270	transdermal	0	None
121270	121271	system	0	None
121271	121272	(	0	None
121272	121273	STS;	0	None
121273	121274	EMSAM	0	None
121274	121275	)	0	None
121275	121276	is	0	None
121276	121277	the	0	None
121277	121278	first	0	None
121278	121279	antidepressant	0	None
121279	121280	transdermal	0	None
121280	121281	delivery	0	None
121281	121282	system	0	None
121282	121283	to	0	None
121283	121284	receive	0	None
121284	121285	Food	0	None
121285	121286	and	0	None
121286	121287	Drug	0	None
121287	121288	Administration	0	None
121288	121289	(	0	None
121289	121290	FDA	0	None
121290	121291	)	0	None
121291	121292	approved	0	None
121292	121293	labeling	0	None
121293	121294	for	0	None
121294	121295	the	0	None
121295	121296	treatment	0	None
121296	121297	of	0	None
121297	121298	major	0	None
121298	121299	depressive	0	None
121299	121300	disorder	0	None
121300	121301	(	0	None
121301	121302	MDD	0	None
121302	121303	)	0	None
121303	121304	.	0	None

121305	121306	Currently	0	None
121306	121307	,	0	None
121307	121308	the	0	None
121308	121309	use	0	None
121309	121310	of	0	None
121310	121311	orally	0	None
121311	121312	administered	0	None
121312	121313	MAO	3	GENE-N
121313	121314	inhibitor	0	None
121314	121315	antidepressants	0	None
121315	121316	(	0	None
121316	121317	eg	0	None
121317	121318	,	0	None
121318	121319	phenelzine	2	CHEMICAL
121319	121320	,	0	None
121320	121321	tranylcypromine	0	None
121321	121322	)	0	None
121322	121323	is	0	None
121323	121324	limited	0	None
121324	121325	by	0	None
121325	121326	the	0	None
121326	121327	risk	0	None
121327	121328	of	0	None
121328	121329	tyramine-provoked	0	None
121329	121330	events	0	None
121330	121331	(	0	None
121331	121332	eg	0	None
121332	121333	,	0	None
121333	121334	acute	0	None
121334	121335	hypertension	0	None
121335	121336	and	0	None
121336	121337	headache	0	None
121337	121338	,	0	None
121338	121339	also	0	None
121339	121340	known	0	None
121340	121341	as	0	None
121341	121342	the	0	None
121342	121343	"cheese	0	None
121343	121344	reaction"	0	None
121344	121345	)	0	None
121345	121346	when	0	None
121346	121347	combined	0	None
121347	121348	with	0	None
121348	121349	dietary	0	None
121349	121350	tyramine	0	None
121350	121351	.	0	None

121352	121353	The	0	None
121353	121354	selegiline	0	None
121354	121355	transdermal	0	None
121355	121356	system	0	None
121356	121357	is	0	None
121357	121358	the	0	None
121358	121359	only	0	None
121359	121360	MAOI	0	None
121360	121361	available	0	None
121361	121362	in	0	None
121362	121363	the	0	None
121363	121364	US	0	None
121364	121365	for	0	None
121365	121366	the	0	None
121366	121367	treatment	0	None
121367	121368	of	0	None
121368	121369	MDD	0	None
121369	121370	that	0	None
121370	121371	does	0	None
121371	121372	not	0	None
121372	121373	require	0	None
121373	121374	dietary	0	None
121374	121375	restriction	0	None
121375	121376	at	0	None
121376	121377	the	0	None
121377	121378	clinically	0	None
121378	121379	effective	0	None
121379	121380	dose	0	None
121380	121381	of	0	None
121381	121382	6	0	None
121382	121383	mg	2	CHEMICAL
121383	121384	/	0	None
121384	121385	24	0	None
121385	121386	hours	0	None
121386	121387	.	0	None

121388	121389	Delivery	0	None
121389	121390	of	0	None
121390	121391	selegiline	0	None
121391	121392	transdermally	0	None
121392	121393	(	0	None
121393	121394	EMSAM	0	None
121394	121395	(	0	None
121395	121396	(	0	None
121396	121397	R	0	None
121397	121398	)	0	None
121398	121399	)	0	None
121399	121400	)	0	None
121400	121401	bypasses	0	None
121401	121402	hepatic	0	None
121402	121403	first	0	None
121403	121404	pass	0	None
121404	121405	metabolism	0	None
121405	121406	,	0	None
121406	121407	thereby	0	None
121407	121408	avoiding	0	None
121408	121409	significant	0	None
121409	121410	inhibition	0	None
121410	121411	of	0	None
121411	121412	gastrointestinal	0	None
121412	121413	and	0	None
121413	121414	hepatic	0	None
121414	121415	MAO-A	0	None
121415	121416	activity	0	None
121416	121417	(	0	None
121417	121418	ie	0	None
121418	121419	,	0	None
121419	121420	reduced	0	None
121420	121421	risk	0	None
121421	121422	of	0	None
121422	121423	tyramine-provoked	0	None
121423	121424	events	0	None
121424	121425	)	0	None
121425	121426	while	0	None
121426	121427	still	0	None
121427	121428	providing	0	None
121428	121429	sufficient	0	None
121429	121430	levels	0	None
121430	121431	of	0	None
121431	121432	selegiline	0	None
121432	121433	in	0	None
121433	121434	the	0	None
121434	121435	brain	0	None
121435	121436	to	0	None
121436	121437	produce	0	None
121437	121438	an	0	None
121438	121439	antidepressant	0	None
121439	121440	effect	0	None
121440	121441	.	0	None

121442	121443	At	0	None
121443	121444	dosages	0	None
121444	121445	of	0	None
121445	121446	6-12	0	None
121446	121447	mg	2	CHEMICAL
121447	121448	/	0	None
121448	121449	24	0	None
121449	121450	hours	0	None
121450	121451	,	0	None
121451	121452	EMSAM	0	None
121452	121453	has	0	None
121453	121454	been	0	None
121454	121455	shown	0	None
121455	121456	to	0	None
121456	121457	improve	0	None
121457	121458	symptoms	0	None
121458	121459	of	0	None
121459	121460	depression	0	None
121460	121461	,	0	None
121461	121462	have	0	None
121462	121463	good	0	None
121463	121464	tolerability	0	None
121464	121465	,	0	None
121465	121466	and	0	None
121466	121467	have	0	None
121467	121468	high	0	None
121468	121469	rates	0	None
121469	121470	of	0	None
121470	121471	medication	0	None
121471	121472	adherence	0	None
121472	121473	.	0	None

121474	121475	However	0	None
121475	121476	,	0	None
121476	121477	at	0	None
121477	121478	higher	0	None
121478	121479	doses	0	None
121479	121480	of	0	None
121480	121481	EMSAM	0	None
121481	121482	(	0	None
121482	121483	ie	0	None
121483	121484	,	0	None
121484	121485	9	0	None
121485	121486	mg	2	CHEMICAL
121486	121487	/	0	None
121487	121488	24	0	None
121488	121489	hours	0	None
121489	121490	or	0	None
121490	121491	more	0	None
121491	121492	)	0	None
121492	121493	,	0	None
121493	121494	dietary	0	None
121494	121495	restriction	0	None
121495	121496	of	0	None
121496	121497	tyramine	0	None
121497	121498	intake	0	None
121498	121499	is	0	None
121499	121500	recommended	0	None
121500	121501	.	0	None

121502	121503	The	0	None
121503	121504	introduction	0	None
121504	121505	of	0	None
121505	121506	EMSAM	0	None
121506	121507	overcomes	0	None
121507	121508	many	0	None
121508	121509	of	0	None
121509	121510	the	0	None
121510	121511	safety	0	None
121511	121512	concerns	0	None
121512	121513	affiliated	0	None
121513	121514	with	0	None
121514	121515	the	0	None
121515	121516	conventional	0	None
121516	121517	oral	0	None
121517	121518	MAO	3	GENE-N
121518	121519	inhibitors	0	None
121519	121520	and	0	None
121520	121521	EMSAM	0	None
121521	121522	may	0	None
121522	121523	be	0	None
121523	121524	considered	0	None
121524	121525	another	0	None
121525	121526	strategy	0	None
121526	121527	for	0	None
121527	121528	the	0	None
121528	121529	treatment	0	None
121529	121530	of	0	None
121530	121531	MDD	0	None
121531	121532	,	0	None
121532	121533	especially	0	None
121533	121534	in	0	None
121534	121535	patients	0	None
121535	121536	who	0	None
121536	121537	cannot	0	None
121537	121538	tolerate	0	None
121538	121539	oral	0	None
121539	121540	antidepressants	0	None
121540	121541	,	0	None
121541	121542	are	0	None
121542	121543	poorly	0	None
121543	121544	adherent	0	None
121544	121545	,	0	None
121545	121546	who	0	None
121546	121547	present	0	None
121547	121548	with	0	None
121548	121549	atypical	0	None
121549	121550	depressive	0	None
121550	121551	symptoms	0	None
121551	121552	,	0	None
121552	121553	or	0	None
121553	121554	have	0	None
121554	121555	failed	0	None
121555	121556	other	0	None
121556	121557	antidepressants	0	None
121557	121558	.	0	None
121558	121559	Aldehyde	2	CHEMICAL
121559	121560	oxidase	0	None
121560	121561	importance	0	None
121561	121562	in	0	None
121562	121563	vivo	0	None
121563	121564	in	0	None
121564	121565	xenobiotic	0	None
121565	121566	metabolism	0	None
121566	121567	:	0	None
121567	121568	imidacloprid	0	None
121568	121569	nitroreduction	0	None
121569	121570	in	0	None
121570	121571	mice	0	None
121571	121572	.	0	None
121572	121573	The	0	None
121573	121574	polyamines	0	None
121574	121575	spermidine	0	None
121575	121576	,	0	None
121576	121577	spermine	0	None
121577	121578	,	0	None
121578	121579	and	0	None
121579	121580	their	0	None
121580	121581	precursor	0	None
121581	121582	putrescine	0	None
121582	121583	are	0	None
121583	121584	essential	0	None
121584	121585	for	0	None
121585	121586	cell	0	None
121586	121587	growth	0	None
121587	121588	and	0	None
121588	121589	the	0	None
121589	121590	regulation	0	None
121590	121591	of	0	None
121591	121592	the	0	None
121592	121593	cell	0	None
121593	121594	cycle	0	None
121594	121595	.	0	None

121596	121597	Recent	0	None
121597	121598	studies	0	None
121598	121599	suggest	0	None
121599	121600	that	0	None
121600	121601	excessive	0	None
121601	121602	accumulation	0	None
121602	121603	of	0	None
121603	121604	polyamines	0	None
121604	121605	favors	0	None
121605	121606	either	0	None
121606	121607	malignant	0	None
121607	121608	transformation	0	None
121608	121609	or	0	None
121609	121610	apoptosis	0	None
121610	121611	,	0	None
121611	121612	depending	0	None
121612	121613	on	0	None
121613	121614	the	0	None
121614	121615	cell	0	None
121615	121616	type	0	None
121616	121617	and	0	None
121617	121618	the	0	None
121618	121619	stimulus	0	None
121619	121620	.	0	None

121621	121622	This	0	None
121622	121623	study	0	None
121623	121624	examines	0	None
121624	121625	the	0	None
121625	121626	involvement	0	None
121626	121627	of	0	None
121627	121628	polyamines	0	None
121628	121629	in	0	None
121629	121630	the	0	None
121630	121631	induction	0	None
121631	121632	of	0	None
121632	121633	apoptosis	0	None
121633	121634	by	0	None
121634	121635	the	0	None
121635	121638	DNA topoisomerase I	1	GENE-Y
121638	121639	inhibitor	0	None
121639	121640	,	0	None
121640	121641	camptothecin	0	None
121641	121642	.	0	None

121643	121644	In	0	None
121644	121645	IEC-6	0	None
121645	121646	cells	0	None
121646	121647	,	0	None
121647	121648	camptothecin	0	None
121648	121649	induced	0	None
121649	121650	apoptosis	0	None
121650	121651	within	0	None
121651	121652	6	0	None
121652	121653	h	0	None
121653	121654	,	0	None
121654	121655	accompanied	0	None
121655	121656	by	0	None
121656	121657	detachment	0	None
121657	121658	of	0	None
121658	121659	cells	0	None
121659	121660	.	0	None

121661	121662	Detached	0	None
121662	121663	cells	0	None
121663	121664	showed	0	None
121664	121665	DNA	0	None
121665	121666	laddering	0	None
121666	121667	and	0	None
121667	121668	caspase	3	GENE-N
121668	121669	3	0	None
121669	121670	induction	0	None
121670	121671	,	0	None
121671	121672	characteristic	0	None
121672	121673	features	0	None
121673	121674	of	0	None
121674	121675	apoptosis	0	None
121675	121676	.	0	None

121677	121678	Depletion	0	None
121678	121679	of	0	None
121679	121680	putrescine	0	None
121680	121681	,	0	None
121681	121682	spermidine	0	None
121682	121683	,	0	None
121683	121684	and	0	None
121684	121685	spermine	0	None
121685	121686	by	0	None
121686	121687	DL-alpha-difluoromethylornithine	0	None
121687	121688	(	0	None
121688	121689	DFMO	0	None
121689	121690	)	0	None
121690	121691	,	0	None
121691	121692	a	0	None
121692	121693	specific	0	None
121693	121694	inhibitor	0	None
121694	121695	of	0	None
121695	121696	ornithine	2	CHEMICAL
121696	121697	decarboxylase	0	None
121697	121698	(	0	None
121698	121699	ODC	1	GENE-Y
121699	121700	)	0	None
121700	121701	that	0	None
121701	121702	is	0	None
121702	121703	the	0	None
121703	121704	first	0	None
121704	121705	rate-limiting	0	None
121705	121706	enzyme	0	None
121706	121707	for	0	None
121707	121708	polyamine	0	None
121708	121709	biosynthesis	0	None
121709	121710	,	0	None
121710	121711	decreased	0	None
121711	121712	the	0	None
121712	121713	apoptotic	0	None
121713	121714	index	0	None
121714	121715	.	0	None

121716	121717	Delayed	0	None
121717	121718	apoptosis	0	None
121718	121719	was	0	None
121719	121720	accompanied	0	None
121720	121721	by	0	None
121721	121722	a	0	None
121722	121723	decrease	0	None
121723	121724	in	0	None
121724	121725	caspase	3	GENE-N
121725	121726	3	0	None
121726	121727	activity	0	None
121727	121728	in	0	None
121728	121729	polyamine-depleted	0	None
121729	121730	cells	0	None
121730	121731	.	0	None

121732	121733	Addition	0	None
121733	121734	of	0	None
121734	121735	putrescine	0	None
121735	121736	restored	0	None
121736	121737	the	0	None
121737	121738	induction	0	None
121738	121739	of	0	None
121739	121740	apoptosis	0	None
121740	121741	as	0	None
121741	121742	indicated	0	None
121742	121743	by	0	None
121743	121744	an	0	None
121744	121745	increase	0	None
121745	121746	in	0	None
121746	121747	the	0	None
121747	121748	number	0	None
121748	121749	of	0	None
121749	121750	detached	0	None
121750	121751	cells	0	None
121751	121752	and	0	None
121752	121753	caspase	3	GENE-N
121753	121754	3	0	None
121754	121755	activity	0	None
121755	121756	.	0	None

121757	121758	Polyamine	0	None
121758	121759	depletion	0	None
121759	121760	did	0	None
121760	121761	not	0	None
121761	121762	change	0	None
121762	121763	the	0	None
121763	121764	level	0	None
121764	121765	of	0	None
121765	121766	caspase	3	GENE-N
121766	121767	3	0	None
121767	121768	protein	0	None
121768	121769	.	0	None

121770	121771	Inhibition	0	None
121771	121772	of	0	None
121772	121773	S-adenosylmethionine	2	CHEMICAL
121773	121774	decarboxylase	0	None
121774	121775	by	0	None
121775	121776	a	0	None
121776	121777	specific	0	None
121777	121778	inhibitor	0	None
121778	121779	[	0	None
121779	121780	diethylglyoxal	0	None
121780	121781	bis-	0	None
121781	121782	(	0	None
121782	121783	guanylhydrazone	0	None
121783	121784	)	0	None
121784	121785	;	0	None
121785	121786	DEGBG	0	None
121786	121787	]	0	None
121787	121788	led	0	None
121788	121789	to	0	None
121789	121790	depletion	0	None
121790	121791	of	0	None
121791	121792	spermidine	0	None
121792	121793	and	0	None
121793	121794	spermine	0	None
121794	121795	with	0	None
121795	121796	a	0	None
121796	121797	significant	0	None
121797	121798	accumulation	0	None
121798	121799	of	0	None
121799	121800	putrescine	0	None
121800	121801	and	0	None
121801	121802	induction	0	None
121802	121803	of	0	None
121803	121804	ODC	1	GENE-Y
121804	121805	.	0	None

121806	121807	The	0	None
121807	121808	DEGBG-treated	0	None
121808	121809	cells	0	None
121809	121810	showed	0	None
121810	121811	an	0	None
121811	121812	increase	0	None
121812	121813	in	0	None
121813	121814	apoptosis	0	None
121814	121815	,	0	None
121815	121816	suggesting	0	None
121816	121817	the	0	None
121817	121818	importance	0	None
121818	121819	of	0	None
121819	121820	putrescine	0	None
121820	121821	in	0	None
121821	121822	the	0	None
121822	121823	apoptotic	0	None
121823	121824	process	0	None
121824	121825	.	0	None

121826	121827	Addition	0	None
121827	121828	of	0	None
121828	121829	putrescine	0	None
121829	121830	to	0	None
121830	121831	DFMO-treated	0	None
121831	121832	cell	0	None
121832	121833	extracts	0	None
121833	121834	did	0	None
121834	121835	not	0	None
121835	121836	increase	0	None
121836	121837	caspase	3	GENE-N
121837	121838	3	0	None
121838	121839	activity	0	None
121839	121840	.	0	None

121841	121842	The	0	None
121842	121843	above	0	None
121843	121844	results	0	None
121844	121845	indicate	0	None
121845	121846	that	0	None
121846	121847	polyamine	0	None
121847	121848	depletion	0	None
121848	121849	delays	0	None
121849	121850	the	0	None
121850	121851	onset	0	None
121851	121852	of	0	None
121852	121853	apoptosis	0	None
121853	121854	in	0	None
121854	121855	IEC-6	0	None
121855	121856	cells	0	None
121856	121857	and	0	None
121857	121858	confers	0	None
121858	121859	protection	0	None
121859	121860	against	0	None
121860	121861	DNA	0	None
121861	121862	damaging	0	None
121862	121863	agents	0	None
121863	121864	,	0	None
121864	121865	suggesting	0	None
121865	121866	that	0	None
121866	121867	polyamines	0	None
121867	121868	might	0	None
121868	121869	be	0	None
121869	121870	involved	0	None
121870	121871	in	0	None
121871	121872	the	0	None
121872	121873	caspase	3	GENE-N
121873	121874	activating	0	None
121874	121875	signal	0	None
121875	121876	cascade	0	None
121876	121877	.	0	None
121877	121878	Levothyroxine	0	None
121878	121879	replacement	0	None
121879	121880	therapy	0	None
121880	121881	with	0	None
121881	121883	vitamin E	2	CHEMICAL
121883	121884	supplementation	0	None
121884	121885	prevents	0	None
121885	121886	oxidative	0	None
121886	121887	stress	0	None
121887	121888	and	0	None
121888	121889	cognitive	0	None
121889	121890	deficit	0	None
121890	121891	in	0	None
121891	121892	experimental	0	None
121892	121893	hypothyroidism	0	None
121893	121894	.	0	None
121894	121895	Iron	0	None
121895	121896	oxide	0	None
121896	121897	particles	0	None
121897	121898	modulate	0	None
121898	121899	the	0	None
121899	121900	ovalbumin-induced	0	None
121900	121901	Th2	0	None
121901	121902	immune	0	None
121902	121903	response	0	None
121903	121904	in	0	None
121904	121905	mice	0	None
121905	121906	.	0	None
121906	121907	Inhibition	0	None
121907	121908	of	0	None
121908	121909	monoamine	0	None
121909	121910	oxidase	0	None
121910	121911	by	0	None
121911	121912	phthalide	0	None
121912	121913	analogues	0	None
121913	121914	.	0	None
121914	121915	Ellagic	0	None
121915	121916	acid	0	None
121916	121917	attenuates	0	None
121917	121918	bleomycin	0	None
121918	121919	and	0	None
121919	121920	cyclophosphamide-induced	0	None
121920	121921	pulmonary	0	None
121921	121922	toxicity	0	None
121922	121923	in	0	None
121923	121924	Wistar	0	None
121924	121925	rats	0	None
121925	121926	.	0	None
121926	121927	Molecular	0	None
121927	121928	mechanism	0	None
121928	121929	of	0	None
121929	121930	terbinafine	0	None
121930	121931	resistance	0	None
121931	121932	in	0	None
121932	121933	Saccharomyces	0	None
121933	121934	cerevisiae	0	None
121934	121935	.	0	None
121935	121936	Acetylcholinesterase	0	None
121936	121937	(	0	None
121937	121938	AChE	1	GENE-Y
121938	121939	)	0	None
121939	121940	is	0	None
121940	121941	a	0	None
121941	121942	most	0	None
121942	121943	remarkable	0	None
121943	121944	protein	0	None
121944	121945	,	0	None
121945	121946	not	0	None
121946	121947	only	0	None
121947	121948	because	0	None
121948	121949	it	0	None
121949	121950	is	0	None
121950	121951	one	0	None
121951	121952	of	0	None
121952	121953	the	0	None
121953	121954	fastest	0	None
121954	121955	enzymes	0	None
121955	121956	in	0	None
121956	121957	nature	0	None
121957	121958	,	0	None
121958	121959	but	0	None
121959	121960	also	0	None
121960	121961	since	0	None
121961	121962	it	0	None
121962	121963	appears	0	None
121963	121964	in	0	None
121964	121965	many	0	None
121965	121966	molecular	0	None
121966	121967	forms	0	None
121967	121968	and	0	None
121968	121969	is	0	None
121969	121970	regulated	0	None
121970	121971	by	0	None
121971	121972	elaborate	0	None
121972	121973	genetic	0	None
121973	121974	networks	0	None
121974	121975	.	0	None

121976	121977	AChE	1	GENE-Y
121977	121978	is	0	None
121978	121979	expressed	0	None
121979	121980	in	0	None
121980	121981	many	0	None
121981	121982	tissues	0	None
121982	121983	during	0	None
121983	121984	development	0	None
121984	121985	and	0	None
121985	121986	in	0	None
121986	121987	mature	0	None
121987	121988	organisms	0	None
121988	121989	,	0	None
121989	121990	as	0	None
121990	121991	well	0	None
121991	121992	as	0	None
121992	121993	in	0	None
121993	121994	healthy	0	None
121994	121995	and	0	None
121995	121996	diseased	0	None
121996	121997	states	0	None
121997	121998	.	0	None

121999	122000	In	0	None
122000	122001	search	0	None
122001	122002	for	0	None
122002	122003	alternative	0	None
122003	122004	,	0	None
122004	122005	"non-classical"	0	None
122005	122006	functions	0	None
122006	122007	of	0	None
122007	122008	cholinesterases	0	None
122008	122009	(	0	None
122009	122010	ChEs	0	None
122010	122011	)	0	None
122011	122012	,	0	None
122012	122013	AChE	1	GENE-Y
122013	122014	could	0	None
122014	122015	either	0	None
122015	122016	work	0	None
122016	122017	within	0	None
122017	122018	the	0	None
122018	122019	frame	0	None
122019	122020	of	0	None
122020	122021	classic	0	None
122021	122022	cholinergic	0	None
122022	122023	systems	0	None
122023	122024	,	0	None
122024	122025	but	0	None
122025	122026	in	0	None
122026	122027	non-neural	0	None
122027	122028	tissues	0	None
122028	122029	(	0	None
122029	122030	"non-synaptic	0	None
122030	122031	function"	0	None
122031	122032	)	0	None
122032	122033	,	0	None
122033	122034	or	0	None
122034	122035	act	0	None
122035	122036	non-enzymatically	0	None
122036	122037	.	0	None

122038	122039	Here	0	None
122039	122040	,	0	None
122040	122041	we	0	None
122041	122042	review	0	None
122042	122043	briefly	0	None
122043	122044	some	0	None
122044	122045	of	0	None
122045	122046	the	0	None
122046	122047	major	0	None
122047	122048	ideas	0	None
122048	122049	and	0	None
122049	122050	advances	0	None
122050	122051	of	0	None
122051	122052	this	0	None
122052	122053	field	0	None
122053	122054	,	0	None
122054	122055	and	0	None
122055	122056	report	0	None
122056	122057	on	0	None
122057	122058	some	0	None
122058	122059	recent	0	None
122059	122060	progress	0	None
122060	122061	from	0	None
122061	122062	our	0	None
122062	122063	own	0	None
122063	122064	experimental	0	None
122064	122065	work	0	None
122065	122066	,	0	None
122066	122067	e	0	None
122067	122068	.	0	None

122069	122070	g	0	None
122070	122071	.	0	None

122072	122073	that	0	None
122073	122074	(	0	None
122074	122075	i	0	None
122075	122076	)	0	None
122076	122077	non-neural	0	None
122077	122078	ChEs	0	None
122078	122079	have	0	None
122079	122080	pronounced	0	None
122080	122081	,	0	None
122081	122082	predominantly	0	None
122082	122083	enzymatic	0	None
122083	122084	effects	0	None
122084	122085	on	0	None
122085	122086	early	0	None
122086	122087	embryonic	0	None
122087	122088	(	0	None
122088	122089	limb	0	None
122089	122090	)	0	None
122090	122091	development	0	None
122091	122092	in	0	None
122092	122093	chick	0	None
122093	122094	and	0	None
122094	122095	mouse	0	None
122095	122096	,	0	None
122096	122097	that	0	None
122097	122098	(	0	None
122098	122099	ii	0	None
122099	122100	)	0	None
122100	122101	retinal	2	CHEMICAL
122101	122102	R28	0	None
122102	122103	cells	0	None
122103	122104	of	0	None
122104	122105	the	0	None
122105	122106	rat	0	None
122106	122107	overexpressing	0	None
122107	122108	synaptic	0	None
122108	122109	AChE	1	GENE-Y
122109	122110	present	0	None
122110	122111	a	0	None
122111	122112	significantly	0	None
122112	122113	decreased	0	None
122113	122114	cell	0	None
122114	122115	proliferation	0	None
122115	122116	,	0	None
122116	122117	and	0	None
122117	122118	that	0	None
122118	122119	(	0	None
122119	122120	iii	0	None
122120	122121	)	0	None
122121	122122	in	0	None
122122	122123	developing	0	None
122123	122124	chick	0	None
122124	122125	retina	0	None
122125	122126	ACh-synthesizing	0	None
122126	122127	and	0	None
122127	122128	ACh-degrading	0	None
122128	122129	cells	0	None
122129	122130	originate	0	None
122130	122131	from	0	None
122131	122132	the	0	None
122132	122133	same	0	None
122133	122134	postmitotic	0	None
122134	122135	precursor	0	None
122135	122136	cells	0	None
122136	122137	,	0	None
122137	122138	which	0	None
122138	122139	later	0	None
122139	122140	form	0	None
122140	122141	two	0	None
122141	122142	locally	0	None
122142	122143	opposing	0	None
122143	122144	cell	0	None
122144	122145	populations	0	None
122145	122146	.	0	None

122147	122148	We	0	None
122148	122149	suggest	0	None
122149	122150	that	0	None
122150	122151	such	0	None
122151	122152	distinct	0	None
122152	122153	distributions	0	None
122153	122154	of	0	None
122154	122155	ChAT	0	None
122155	122156	(	0	None
122156	122157	+	0	None
122157	122158	)	0	None
122158	122159	vs	0	None
122159	122160	.	0	None

122161	122162	AChE	1	GENE-Y
122162	122163	(	0	None
122163	122164	+	0	None
122164	122165	)	0	None
122165	122166	cells	0	None
122166	122167	in	0	None
122167	122168	the	0	None
122168	122169	inner	0	None
122169	122170	half	0	None
122170	122171	retina	0	None
122171	122172	provide	0	None
122172	122173	graded	0	None
122173	122174	distributions	0	None
122174	122175	of	0	None
122175	122176	ACh	0	None
122176	122177	,	0	None
122177	122178	which	0	None
122178	122179	can	0	None
122179	122180	direct	0	None
122180	122181	cell	0	None
122181	122182	differentiation	0	None
122182	122183	and	0	None
122183	122184	network	0	None
122184	122185	formation	0	None
122185	122186	.	0	None

122187	122188	Thus	0	None
122188	122189	,	0	None
122189	122190	as	0	None
122190	122191	corroborated	0	None
122191	122192	by	0	None
122192	122193	works	0	None
122193	122194	from	0	None
122194	122195	many	0	None
122195	122196	labs	0	None
122196	122197	,	0	None
122197	122198	AChE	1	GENE-Y
122198	122199	can	0	None
122199	122200	be	0	None
122200	122201	considered	0	None
122201	122202	a	0	None
122202	122203	highly	0	None
122203	122204	co-opting	0	None
122204	122205	protein	0	None
122205	122206	,	0	None
122206	122207	which	0	None
122207	122208	can	0	None
122208	122209	combine	0	None
122209	122210	enzymatic	0	None
122210	122211	and	0	None
122211	122212	non-enzymatic	0	None
122212	122213	functions	0	None
122213	122214	within	0	None
122214	122215	one	0	None
122215	122216	molecule	0	None
122216	122217	.	0	None
122217	122218	In	0	None
122218	122219	vitro	0	None
122219	122220	and	0	None
122220	122221	in	0	None
122221	122222	vivo	0	None
122222	122223	functional	0	None
122223	122224	characterization	0	None
122224	122225	of	0	None
122225	122226	bovine	0	None
122226	122227	vitamin	0	None
122227	122228	K-dependent	0	None
122228	122229	gamma-carboxylase	0	None
122229	122230	expressed	0	None
122230	122231	in	0	None
122231	122232	Chinese	0	None
122232	122233	hamster	0	None
122233	122234	ovary	0	None
122234	122235	cells	0	None
122235	122236	.	0	None
122236	122237	Allosteric	0	None
122237	122238	interaction	0	None
122238	122239	of	0	None
122239	122240	the	0	None
122240	122241	neuromuscular	0	None
122241	122242	blockers	0	None
122242	122243	vecuronium	0	None
122243	122244	and	0	None
122244	122245	pancuronium	0	None
122245	122246	with	0	None
122246	122247	recombinant	0	None
122247	122248	human	0	None
122248	122249	muscarinic	0	None
122249	122250	M2	0	None
122250	122251	receptors	0	None
122251	122252	.	0	None
122252	122253	ETHNOPHARMACOLOGICAL	0	None
122253	122254	RELEVANCE	0	None
122254	122255	:	0	None
122255	122256	Antrodia	0	None
122256	122257	camphorata	0	None
122257	122258	(	0	None
122258	122259	AC	3	GENE-N
122259	122260	)	0	None
122260	122261	is	0	None
122261	122262	well	0	None
122262	122263	known	0	None
122263	122264	in	0	None
122264	122265	Taiwan	0	None
122265	122266	as	0	None
122266	122267	a	0	None
122267	122268	traditional	0	None
122268	122269	Chinese	0	None
122269	122270	medicinal	0	None
122270	122271	fungus	0	None
122271	122272	.	0	None

122273	122274	However	0	None
122274	122275	,	0	None
122275	122276	the	0	None
122276	122277	anticancer	0	None
122277	122278	activity	0	None
122278	122279	of	0	None
122279	122280	AC	3	GENE-N
122280	122281	against	0	None
122281	122282	human	0	None
122282	122283	HER-2	0	None
122283	122284	/	0	None
122284	122285	neu-overexpressing	0	None
122285	122286	ovarian	0	None
122286	122287	cancers	0	None
122287	122288	is	0	None
122288	122289	poorly	0	None
122289	122290	understood	0	None
122290	122291	.	0	None

122292	122293	MATERIALS	0	None
122293	122294	AND	0	None
122294	122295	METHODS	0	None
122295	122296	:	0	None
122296	122297	The	0	None
122297	122298	aim	0	None
122298	122299	of	0	None
122299	122300	this	0	None
122300	122301	study	0	None
122301	122302	is	0	None
122302	122303	to	0	None
122303	122304	investigate	0	None
122304	122305	whether	0	None
122305	122306	a	0	None
122306	122307	submerged	0	None
122307	122308	fermentation	0	None
122308	122309	culture	0	None
122309	122310	of	0	None
122310	122311	AC	3	GENE-N
122311	122312	can	0	None
122312	122313	inhibit	0	None
122313	122314	human	0	None
122314	122315	ovarian	0	None
122315	122316	carcinoma	0	None
122316	122317	cell	0	None
122317	122318	(	0	None
122318	122319	SKOV-3	0	None
122319	122320	)	0	None
122320	122321	proliferation	0	None
122321	122322	by	0	None
122322	122323	suppressing	0	None
122323	122324	the	0	None
122324	122325	HER-2	0	None
122325	122326	/	0	None
122326	122327	neu	1	GENE-Y
122327	122328	signaling	0	None
122328	122329	pathway	0	None
122329	122330	.	0	None

122331	122332	Cell	0	None
122332	122333	viability	0	None
122333	122334	,	0	None
122334	122335	colony	0	None
122335	122336	formation	0	None
122336	122337	,	0	None
122337	122338	DCFH-DA	0	None
122338	122339	fluorescence	0	None
122339	122340	microscopy	0	None
122340	122341	,	0	None
122341	122342	western	0	None
122342	122343	blotting	0	None
122343	122344	,	0	None
122344	122345	HER-2	0	None
122345	122346	/	0	None
122346	122347	neu	1	GENE-Y
122347	122348	immunofluorescence	0	None
122348	122349	imaging	0	None
122349	122350	,	0	None
122350	122351	flow	0	None
122351	122352	cytometry	0	None
122352	122353	,	0	None
122353	122354	and	0	None
122354	122355	TUNEL	0	None
122355	122356	assays	0	None
122356	122357	were	0	None
122357	122358	carried	0	None
122358	122359	out	0	None
122359	122360	to	0	None
122360	122361	determine	0	None
122361	122362	the	0	None
122362	122363	anti-cancer	0	None
122363	122364	effects	0	None
122364	122365	of	0	None
122365	122366	AC	3	GENE-N
122366	122367	.	0	None

122368	122369	RESULTS	0	None
122369	122370	:	0	None
122370	122371	MTT	0	None
122371	122372	and	0	None
122372	122373	colony	0	None
122373	122374	formation	0	None
122374	122375	assays	0	None
122375	122376	showed	0	None
122376	122377	that	0	None
122377	122378	AC	3	GENE-N
122378	122379	induced	0	None
122379	122380	a	0	None
122380	122381	dose-dependent	0	None
122381	122382	reduction	0	None
122382	122383	in	0	None
122383	122384	SKOV-3	0	None
122384	122385	cell	0	None
122385	122386	growth	0	None
122386	122387	.	0	None

122388	122389	Immunoblot	0	None
122389	122390	analysis	0	None
122390	122391	demonstrated	0	None
122391	122392	that	0	None
122392	122393	HER-2	0	None
122393	122394	/	0	None
122394	122395	neu	1	GENE-Y
122395	122396	activity	0	None
122396	122397	and	0	None
122397	122398	tyrosine	2	CHEMICAL
122398	122399	phosphorylation	0	None
122399	122400	were	0	None
122400	122401	significantly	0	None
122401	122402	inhibited	0	None
122402	122403	by	0	None
122403	122404	AC	3	GENE-N
122404	122405	.	0	None

122406	122407	Furthermore	0	None
122407	122408	,	0	None
122408	122409	AC	3	GENE-N
122409	122410	treatment	0	None
122410	122411	significantly	0	None
122411	122412	inhibited	0	None
122412	122413	the	0	None
122413	122414	activation	0	None
122414	122415	of	0	None
122415	122416	PI3K	0	None
122416	122417	/	0	None
122417	122418	Akt	0	None
122418	122419	and	0	None
122419	122420	their	0	None
122420	122421	downstream	0	None
122421	122422	effector	0	None
122422	122423	β-catenin	0	None
122423	122424	.	0	None

122425	122426	We	0	None
122426	122427	also	0	None
122427	122428	observed	0	None
122428	122429	that	0	None
122429	122430	AC	3	GENE-N
122430	122431	caused	0	None
122431	122432	G2	0	None
122432	122433	/	0	None
122433	122434	M	0	None
122434	122435	arrest	0	None
122435	122436	mediated	0	None
122436	122437	by	0	None
122437	122438	down-regulation	0	None
122438	122439	of	0	None
122439	122441	cyclin D1	1	GENE-Y
122441	122442	,	0	None
122442	122444	cyclin A	1	GENE-Y
122444	122445	,	0	None
122445	122446	cyclin	0	None
122446	122447	B1	0	None
122447	122448	,	0	None
122448	122449	and	0	None
122449	122450	Cdk1	0	None
122450	122451	and	0	None
122451	122452	increased	0	None
122452	122453	p27	0	None
122453	122454	expression	0	None
122454	122455	.	0	None

122456	122457	Notably	0	None
122457	122458	,	0	None
122458	122459	AC	3	GENE-N
122459	122460	induced	0	None
122460	122461	apoptosis	0	None
122461	122462	,	0	None
122462	122463	which	0	None
122463	122464	was	0	None
122464	122465	associated	0	None
122465	122466	with	0	None
122466	122467	DNA	0	None
122467	122468	fragmentation	0	None
122468	122469	,	0	None
122469	122470	cytochrome	3	GENE-N
122470	122471	c	0	None
122471	122472	release	0	None
122472	122473	,	0	None
122473	122474	caspase-9	0	None
122474	122475	/	0	None
122475	122476	-3	0	None
122476	122477	activation	0	None
122477	122478	,	0	None
122478	122479	PARP	0	None
122479	122480	degradation	0	None
122480	122481	,	0	None
122481	122482	and	0	None
122482	122483	Bcl-2	1	GENE-Y
122483	122484	/	0	None
122484	122485	Bax	0	None
122485	122486	dysregulation	0	None
122486	122487	.	0	None

122488	122489	An	0	None
122489	122490	increase	0	None
122490	122491	in	0	None
122491	122492	intracellular	0	None
122492	122493	reactive	0	None
122493	122494	oxygen	0	None
122494	122495	species	0	None
122495	122496	(	0	None
122496	122497	ROS	0	None
122497	122498	)	0	None
122498	122499	was	0	None
122499	122500	observed	0	None
122500	122501	in	0	None
122501	122502	AC-treated	0	None
122502	122503	cells	0	None
122503	122504	,	0	None
122504	122505	whereas	0	None
122505	122506	the	0	None
122506	122507	antioxidant	0	None
122507	122508	N-acetylcysteine	0	None
122508	122509	(	0	None
122509	122510	NAC	2	CHEMICAL
122510	122511	)	0	None
122511	122512	prevented	0	None
122512	122513	AC-induced	0	None
122513	122514	cell	0	None
122514	122515	death	0	None
122515	122516	,	0	None
122516	122517	HER-2	0	None
122517	122518	/	0	None
122518	122519	neu	1	GENE-Y
122519	122520	depletion	0	None
122520	122521	,	0	None
122521	122522	PI3K	0	None
122522	122523	/	0	None
122523	122524	Akt	0	None
122524	122525	inactivation	0	None
122525	122526	,	0	None
122526	122527	and	0	None
122527	122528	Bcl-2	1	GENE-Y
122528	122529	/	0	None
122529	122530	Bax	0	None
122530	122531	dysregulation	0	None
122531	122532	,	0	None
122532	122533	indicating	0	None
122533	122534	that	0	None
122534	122535	AC-induced	0	None
122535	122536	cell	0	None
122536	122537	death	0	None
122537	122538	was	0	None
122538	122539	mediated	0	None
122539	122540	by	0	None
122540	122541	ROS	0	None
122541	122542	generation	0	None
122542	122543	.	0	None

122544	122545	CONCLUSIONS	0	None
122545	122546	:	0	None
122546	122547	These	0	None
122547	122548	results	0	None
122548	122549	suggest	0	None
122549	122550	that	0	None
122550	122551	AC	3	GENE-N
122551	122552	may	0	None
122552	122553	exert	0	None
122553	122554	anti-tumor	0	None
122554	122555	activity	0	None
122555	122556	against	0	None
122556	122557	human	0	None
122557	122558	ovarian	0	None
122558	122559	carcinoma	0	None
122559	122560	by	0	None
122560	122561	suppressing	0	None
122561	122562	HER-2	0	None
122562	122563	/	0	None
122563	122564	neu	1	GENE-Y
122564	122565	signaling	0	None
122565	122566	pathways	0	None
122566	122567	.	0	None
122567	122568	BACKGROUND	0	None
122568	122569	&	0	None
122569	122570	AIMS	0	None
122570	122571	:	0	None
122571	122572	It	0	None
122572	122573	has	0	None
122573	122574	been	0	None
122574	122575	variably	0	None
122575	122576	suggested	0	None
122576	122577	that	0	None
122577	122578	nonselective	0	None
122578	122579	NSAIDs	0	None
122579	122580	and	0	None
122580	122581	cyclooxygenase	3	GENE-N
122581	122582	(	0	None
122582	122583	COX	3	GENE-N
122583	122584	)	0	None
122584	122585	-2	0	None
122585	122586	selective	0	None
122586	122587	inhibitors	0	None
122587	122588	aggravate	0	None
122588	122589	or	0	None
122589	122590	ameliorate	0	None
122590	122591	clinical	0	None
122591	122592	disease	0	None
122592	122593	activity	0	None
122593	122594	in	0	None
122594	122595	patients	0	None
122595	122596	with	0	None
122596	122597	inflammatory	0	None
122597	122598	bowel	0	None
122598	122599	disease	0	None
122599	122600	.	0	None

122601	122602	We	0	None
122602	122603	assessed	0	None
122603	122604	the	0	None
122604	122605	effect	0	None
122605	122606	of	0	None
122606	122607	these	0	None
122607	122608	drugs	0	None
122608	122609	in	0	None
122609	122610	patients	0	None
122610	122611	with	0	None
122611	122612	inflammatory	0	None
122612	122613	bowel	0	None
122613	122614	disease	0	None
122614	122615	(	0	None
122615	122616	n	0	None
122616	122617	=	0	None
122617	122618	209	0	None
122618	122619	)	0	None
122619	122620	and	0	None
122620	122621	the	0	None
122621	122622	possible	0	None
122622	122623	mechanisms	0	None
122623	122624	.	0	None

122625	122626	METHODS	0	None
122626	122627	:	0	None
122627	122628	First	0	None
122628	122629	,	0	None
122629	122630	patients	0	None
122630	122631	with	0	None
122631	122632	quiescent	0	None
122632	122633	Crohn's	0	None
122633	122634	disease	0	None
122634	122635	and	0	None
122635	122636	ulcerative	0	None
122636	122637	colitis	0	None
122637	122638	received	0	None
122638	122639	the	0	None
122639	122640	non-NSAID	0	None
122640	122641	analgesic	0	None
122641	122642	acetaminophen	0	None
122642	122643	(	0	None
122643	122644	n	0	None
122644	122645	=	0	None
122645	122646	26	0	None
122646	122647	)	0	None
122647	122648	and	0	None
122648	122649	the	0	None
122649	122650	conventional	0	None
122650	122651	NSAIDs	0	None
122651	122652	naproxen	0	None
122652	122653	(	0	None
122653	122654	n	0	None
122654	122655	=	0	None
122655	122656	32	0	None
122656	122657	)	0	None
122657	122658	,	0	None
122658	122659	diclofenac	0	None
122659	122660	(	0	None
122660	122661	n	0	None
122661	122662	=	0	None
122662	122663	29	0	None
122663	122664	)	0	None
122664	122665	,	0	None
122665	122666	and	0	None
122666	122667	indomethacin	0	None
122667	122668	(	0	None
122668	122669	n	0	None
122669	122670	=	0	None
122670	122671	22	0	None
122671	122672	)	0	None
122672	122673	for	0	None
122673	122674	4	0	None
122674	122675	weeks	0	None
122675	122676	.	0	None

122677	122678	The	0	None
122678	122679	Harvey-Bradshaw	0	None
122679	122680	index	0	None
122680	122681	was	0	None
122681	122682	used	0	None
122682	122683	to	0	None
122683	122684	define	0	None
122684	122685	relapse	0	None
122685	122686	.	0	None

122687	122688	Second	0	None
122688	122689	,	0	None
122689	122690	to	0	None
122690	122691	assess	0	None
122691	122692	the	0	None
122692	122693	mechanism	0	None
122693	122694	of	0	None
122694	122695	relapse	0	None
122695	122696	,	0	None
122696	122697	intestinal	0	None
122697	122698	inflammation	0	None
122698	122699	was	0	None
122699	122700	quantitated	0	None
122700	122701	(	0	None
122701	122702	fecal	0	None
122702	122703	calprotectin	0	None
122703	122704	)	0	None
122704	122705	before	0	None
122705	122706	and	0	None
122706	122707	during	0	None
122707	122708	treatment	0	None
122708	122709	(	0	None
122709	122710	20	0	None
122710	122711	patients	0	None
122711	122712	/	0	None
122712	122713	group	0	None
122713	122714	)	0	None
122714	122715	with	0	None
122715	122716	acetaminophen	0	None
122716	122717	,	0	None
122717	122718	naproxen	0	None
122718	122719	(	0	None
122719	122720	topical	0	None
122720	122721	effect	0	None
122721	122722	,	0	None
122722	122723	COX-1	1	GENE-Y
122723	122724	and	0	None
122724	122725	-2	0	None
122725	122726	inhibitor	0	None
122726	122727	)	0	None
122727	122728	,	0	None
122728	122729	nabumetone	0	None
122729	122730	(	0	None
122730	122731	COX-1	1	GENE-Y
122731	122732	and	0	None
122732	122733	-2	0	None
122733	122734	inhibitor	0	None
122734	122735	)	0	None
122735	122736	,	0	None
122736	122737	nimesulide	2	CHEMICAL
122737	122738	(	0	None
122738	122739	selective	0	None
122739	122740	COX-2	0	None
122740	122741	inhibitor	0	None
122741	122742	)	0	None
122742	122743	,	0	None
122743	122744	and	0	None
122744	122745	low-dose	0	None
122745	122746	aspirin	2	CHEMICAL
122746	122747	(	0	None
122747	122748	selective	0	None
122748	122749	COX-1	1	GENE-Y
122749	122750	inhibition	0	None
122750	122751	)	0	None
122751	122752	.	0	None

122753	122754	RESULTS	0	None
122754	122755	:	0	None
122755	122756	Nonselective	0	None
122756	122757	NSAIDs	0	None
122757	122758	were	0	None
122758	122759	associated	0	None
122759	122760	with	0	None
122760	122761	a	0	None
122761	122762	17%-28%	0	None
122762	122763	relapse	0	None
122763	122764	rate	0	None
122764	122765	within	0	None
122765	122766	9	0	None
122766	122767	days	0	None
122767	122768	of	0	None
122768	122769	ingestion	0	None
122769	122770	.	0	None

122771	122772	No	0	None
122772	122773	patient	0	None
122773	122774	had	0	None
122774	122775	an	0	None
122775	122776	early	0	None
122776	122777	relapse	0	None
122777	122778	on	0	None
122778	122779	acetaminophen	0	None
122779	122780	,	0	None
122780	122781	nimesulide	2	CHEMICAL
122781	122782	,	0	None
122782	122783	or	0	None
122783	122784	aspirin	2	CHEMICAL
122784	122785	,	0	None
122785	122786	whereas	0	None
122786	122787	those	0	None
122787	122788	on	0	None
122788	122789	naproxen	0	None
122789	122790	and	0	None
122790	122791	nabumetone	0	None
122791	122792	(	0	None
122792	122793	20%	0	None
122793	122794	)	0	None
122794	122795	experienced	0	None
122795	122796	relapse	0	None
122796	122797	.	0	None

122798	122799	These	0	None
122799	122800	clinical	0	None
122800	122801	relapses	0	None
122801	122802	were	0	None
122802	122803	associated	0	None
122803	122804	with	0	None
122804	122805	escalating	0	None
122805	122806	intestinal	0	None
122806	122807	inflammatory	0	None
122807	122808	activity	0	None
122808	122809	.	0	None

122810	122811	CONCLUSIONS	0	None
122811	122812	:	0	None
122812	122813	NSAID	0	None
122813	122814	ingestion	0	None
122814	122815	is	0	None
122815	122816	associated	0	None
122816	122817	with	0	None
122817	122818	frequent	0	None
122818	122819	and	0	None
122819	122820	early	0	None
122820	122821	clinical	0	None
122821	122822	relapse	0	None
122822	122823	of	0	None
122823	122824	quiescent	0	None
122824	122825	inflammatory	0	None
122825	122826	bowel	0	None
122826	122827	disease	0	None
122827	122828	,	0	None
122828	122829	and	0	None
122829	122830	the	0	None
122830	122831	mechanism	0	None
122831	122832	appears	0	None
122832	122833	to	0	None
122833	122834	be	0	None
122834	122835	due	0	None
122835	122836	to	0	None
122836	122837	dual	0	None
122837	122838	inhibition	0	None
122838	122839	of	0	None
122839	122840	the	0	None
122840	122841	COX	3	GENE-N
122841	122842	enzymes	0	None
122842	122843	.	0	None

122844	122845	Selective	0	None
122845	122846	COX-2	0	None
122846	122847	inhibition	0	None
122847	122848	with	0	None
122848	122849	nimesulide	2	CHEMICAL
122849	122850	and	0	None
122850	122851	COX-1	1	GENE-Y
122851	122852	inhibition	0	None
122852	122853	with	0	None
122853	122854	low-dose	0	None
122854	122855	aspirin	2	CHEMICAL
122855	122856	appear	0	None
122856	122857	to	0	None
122857	122858	be	0	None
122858	122859	well-tolerated	0	None
122859	122860	in	0	None
122860	122861	the	0	None
122861	122862	short-term	0	None
122862	122863	.	0	None
122863	122864	Zearalenone	0	None
122864	122865	(	0	None
122865	122866	ZEA	0	None
122866	122867	,	0	None
122867	122868	F2	0	None
122868	122869	)	0	None
122869	122870	is	0	None
122870	122871	one	0	None
122871	122872	of	0	None
122872	122873	the	0	None
122873	122874	most	0	None
122874	122875	common	0	None
122875	122876	mycotoxins	0	None
122876	122877	and	0	None
122877	122878	the	0	None
122878	122879	only	0	None
122879	122880	known	0	None
122880	122881	mycoestrogen	0	None
122881	122882	.	0	None

122883	122884	It	0	None
122884	122885	enters	0	None
122885	122886	the	0	None
122886	122887	food	0	None
122887	122888	and	0	None
122888	122889	feed	0	None
122889	122890	chain	0	None
122890	122891	from	0	None
122891	122892	contaminated	0	None
122892	122893	cereals	0	None
122893	122894	and	0	None
122894	122895	infiltrates	0	None
122895	122896	into	0	None
122896	122897	sewage	0	None
122897	122898	or	0	None
122898	122899	natural	0	None
122899	122900	waters	0	None
122900	122901	posing	0	None
122901	122902	potential	0	None
122902	122903	threat	0	None
122903	122904	to	0	None
122904	122905	exposed	0	None
122905	122906	livestock	0	None
122906	122907	,	0	None
122907	122908	wildlife	0	None
122908	122909	and	0	None
122909	122910	humans	0	None
122910	122911	.	0	None

122912	122913	Therefore	0	None
122913	122914	evaluation	0	None
122914	122915	of	0	None
122915	122916	its	0	None
122916	122917	biological	0	None
122917	122918	effects	0	None
122918	122919	is	0	None
122919	122920	of	0	None
122920	122921	international	0	None
122921	122922	importance	0	None
122922	122923	.	0	None

122924	122925	We	0	None
122925	122926	performed	0	None
122926	122927	toxicological	0	None
122927	122928	tests	0	None
122928	122929	on	0	None
122929	122930	zebrafish	0	None
122930	122931	(	0	None
122931	122932	Danio	0	None
122932	122933	rerio	0	None
122933	122934	)	0	None
122934	122935	larvae	0	None
122935	122936	and	0	None
122936	122937	adults	0	None
122937	122938	.	0	None

122939	122940	Developmental	0	None
122940	122941	toxicity	0	None
122941	122942	was	0	None
122942	122943	assessed	0	None
122943	122944	by	0	None
122944	122945	an	0	None
122945	122946	extended	0	None
122946	122947	(	0	None
122947	122948	5	0	None
122948	122949	days	0	None
122949	122950	)	0	None
122950	122951	fish	0	None
122951	122952	embryo	0	None
122952	122953	toxicity	0	None
122953	122954	test	0	None
122954	122955	(	0	None
122955	122956	FET	0	None
122956	122957	)	0	None
122957	122958	.	0	None

122959	122960	Effects	0	None
122960	122961	of	0	None
122961	122962	early	0	None
122962	122963	ZEA	0	None
122963	122964	exposure	0	None
122964	122965	were	0	None
122965	122966	concentration-dependent	0	None
122966	122967	with	0	None
122967	122968	LC50	0	None
122968	122969	and	0	None
122969	122970	LC10	0	None
122970	122971	values	0	None
122971	122972	of	0	None
122972	122973	893	0	None
122973	122974	and	0	None
122974	122975	335μg	0	None
122975	122976	/	0	None
122976	122977	L	0	None
122977	122978	.	0	None

122979	122980	In	0	None
122980	122981	larvae	0	None
122981	122982	exposed	0	None
122982	122983	to	0	None
122983	122984	500μg	0	None
122984	122985	/	0	None
122985	122986	L	0	None
122986	122987	and	0	None
122987	122988	above	0	None
122988	122989	,	0	None
122989	122990	ZEA	0	None
122990	122991	induced	0	None
122991	122992	similar	0	None
122992	122993	phenotype	0	None
122993	122994	to	0	None
122994	122995	has	0	None
122995	122996	(	0	None
122996	122997	heart-and	0	None
122997	122998	soul	0	None
122998	122999	)	0	None
122999	123000	showing	0	None
123000	123001	defects	0	None
123001	123002	in	0	None
123002	123003	heart	0	None
123003	123004	and	0	None
123004	123005	eye	0	None
123005	123006	development	0	None
123006	123007	and	0	None
123007	123008	upward	0	None
123008	123009	curvature	0	None
123009	123010	of	0	None
123010	123011	the	0	None
123011	123012	body	0	None
123012	123013	axis	0	None
123013	123014	.	0	None

123015	123016	From	0	None
123016	123017	250μg	0	None
123017	123018	/	0	None
123018	123019	L	0	None
123019	123020	at	0	None
123020	123021	72hpf	0	None
123021	123022	the	0	None
123022	123023	gap	0	None
123023	123024	in	0	None
123024	123025	the	0	None
123025	123026	melanophore	0	None
123026	123027	streak	0	None
123027	123028	at	0	None
123028	123029	the	0	None
123029	123030	base	0	None
123030	123031	of	0	None
123031	123032	the	0	None
123032	123033	tail	0	None
123033	123034	fin	0	None
123034	123035	was	0	None
123035	123036	missing	0	None
123036	123037	and	0	None
123037	123038	the	0	None
123038	123039	fin	0	None
123039	123040	fold	0	None
123040	123041	was	0	None
123041	123042	abnormal	0	None
123042	123043	,	0	None
123043	123044	suggesting	0	None
123044	123045	disturbance	0	None
123045	123046	in	0	None
123046	123047	the	0	None
123047	123048	development	0	None
123048	123049	of	0	None
123049	123050	the	0	None
123050	123051	adult	0	None
123051	123052	tail	0	None
123052	123053	fin	0	None
123053	123054	primordium	0	None
123054	123055	.	0	None

123056	123057	Estrogenic	0	None
123057	123058	potency	0	None
123058	123059	was	0	None
123059	123060	measured	0	None
123060	123061	on	0	None
123061	123062	the	0	None
123062	123063	basis	0	None
123063	123064	of	0	None
123064	123065	Vitellogenin	3	GENE-N
123065	123066	(	0	None
123066	123067	Vtg	0	None
123067	123068	)	0	None
123068	123069	protein	0	None
123069	123070	(	0	None
123070	123071	adults	0	None
123071	123072	)	0	None
123072	123073	levels	0	None
123073	123074	and	0	None
123074	123075	relative	0	None
123075	123076	abundance	0	None
123076	123077	of	0	None
123077	123078	vitellogenin-1	0	None
123078	123079	mRNA	0	None
123079	123080	(	0	None
123080	123081	vtg-1	0	None
123081	123082	)	0	None
123082	123083	(	0	None
123083	123084	larvae	0	None
123084	123085	and	0	None
123085	123086	adults	0	None
123086	123087	)	0	None
123087	123088	.	0	None

123089	123090	qRT-PCR	0	None
123090	123091	in	0	None
123091	123092	larvae	0	None
123092	123093	proved	0	None
123093	123094	to	0	None
123094	123095	be	0	None
123095	123096	sufficient	0	None
123096	123097	substitute	0	None
123097	123098	to	0	None
123098	123099	adult	0	None
123099	123100	tests	0	None
123100	123101	and	0	None
123101	123102	sensitive	0	None
123102	123103	enough	0	None
123103	123104	to	0	None
123104	123105	detect	0	None
123105	123106	ZEA	0	None
123106	123107	in	0	None
123107	123108	0	0	None
123108	123109	.	0	None
123109	123110	1μg	0	None
123110	123111	/	0	None
123111	123112	L	0	None
123112	123113	concentrations	0	None
123113	123114	,	0	None
123114	123115	that	0	None
123115	123116	is	0	None
123116	123117	close	0	None
123117	123118	to	0	None
123118	123119	levels	0	None
123119	123120	observed	0	None
123120	123121	in	0	None
123121	123122	wastewaters	0	None
123122	123123	.	0	None

123124	123125	Developmental	0	None
123125	123126	defects	0	None
123126	123127	reveal	0	None
123127	123128	that	0	None
123128	123129	besides	0	None
123129	123130	direct	0	None
123130	123131	estrogenic	0	None
123131	123132	effects	0	None
123132	123133	,	0	None
123133	123134	zearalenone	0	None
123134	123135	might	0	None
123135	123136	interact	0	None
123136	123137	with	0	None
123137	123138	other	0	None
123138	123139	ontogenic	0	None
123139	123140	pathways	0	None
123140	123141	.	0	None
123141	123142	Identification	0	None
123142	123143	of	0	None
123143	123144	benzofuran	0	None
123144	123145	central	0	None
123145	123146	cores	0	None
123146	123147	for	0	None
123147	123148	the	0	None
123148	123149	inhibition	0	None
123149	123150	of	0	None
123150	123151	leukotriene	2	CHEMICAL
123151	123152	A	0	None
123152	123153	(	0	None
123153	123154	4	0	None
123154	123155	)	0	None
123155	123156	hydrolase	0	None
123156	123157	.	0	None
123157	123158	Alendronate	0	None
123158	123159	(	0	None
123159	123160	4-amino-1-hydroxybutylidene-1	0	None
123160	123161	,	0	None
123161	123162	1-bisphosphonate	0	None
123162	123163	)	0	None
123163	123164	is	0	None
123164	123165	a	0	None
123165	123166	potent	0	None
123166	123167	bisphosphonate	0	None
123167	123168	that	0	None
123168	123169	inhibits	0	None
123169	123170	osteoclastic	0	None
123170	123171	bone	0	None
123171	123172	resorption	0	None
123172	123173	and	0	None
123173	123174	has	0	None
123174	123175	proven	0	None
123175	123176	effective	0	None
123176	123177	for	0	None
123177	123178	the	0	None
123178	123179	treatment	0	None
123179	123180	of	0	None
123180	123181	osteoporosis	0	None
123181	123182	.	0	None

123183	123184	Its	0	None
123184	123185	molecular	0	None
123185	123186	mechanism	0	None
123186	123187	of	0	None
123187	123188	action	0	None
123188	123189	,	0	None
123189	123190	however	0	None
123190	123191	,	0	None
123191	123192	has	0	None
123192	123193	not	0	None
123193	123194	been	0	None
123194	123195	defined	0	None
123195	123196	precisely	0	None
123196	123197	.	0	None

123198	123199	Here	0	None
123199	123200	we	0	None
123200	123201	report	0	None
123201	123202	that	0	None
123202	123203	alendronate	0	None
123203	123204	is	0	None
123204	123205	a	0	None
123205	123206	potent	0	None
123206	123207	inhibitor	0	None
123207	123208	of	0	None
123208	123209	the	0	None
123209	123210	protein-tyrosine-phosphatase-meg1	0	None
123210	123211	(	0	None
123211	123212	PTPmeg1	0	None
123212	123213	)	0	None
123213	123214	.	0	None

123215	123216	Two	0	None
123216	123217	substrates	0	None
123217	123218	were	0	None
123218	123219	employed	0	None
123219	123220	in	0	None
123220	123221	this	0	None
123221	123222	study	0	None
123222	123223	:	0	None
123223	123224	fluorescein	0	None
123224	123225	diphosphate	0	None
123225	123226	and	0	None
123226	123227	the	0	None
123227	123228	phosphotyrosyl	0	None
123228	123229	peptide	0	None
123229	123230	src-pY527	0	None
123230	123231	.	0	None

123232	123233	With	0	None
123233	123234	either	0	None
123234	123235	substrate	0	None
123235	123236	,	0	None
123236	123237	alendronate	0	None
123237	123238	was	0	None
123238	123239	a	0	None
123239	123240	slow	0	None
123240	123241	binding	0	None
123241	123242	inhibitor	0	None
123242	123243	of	0	None
123243	123244	PTPmeg1	0	None
123244	123245	.	0	None

123246	123247	Among	0	None
123247	123248	the	0	None
123248	123249	other	0	None
123249	123250	bisphosphonates	2	CHEMICAL
123250	123251	studied	0	None
123251	123252	,	0	None
123252	123253	alendronate	0	None
123253	123254	was	0	None
123254	123255	more	0	None
123255	123256	potent	0	None
123256	123257	and	0	None
123257	123258	selective	0	None
123258	123259	for	0	None
123259	123260	PTPmeg1	0	None
123260	123261	.	0	None

123262	123263	The	0	None
123263	123264	hydrolysis	0	None
123264	123265	of	0	None
123265	123266	fluorescein	0	None
123266	123267	diphosphate	0	None
123267	123268	by	0	None
123268	123269	PTP	0	None
123269	123270	epsilon	0	None
123270	123271	and	0	None
123271	123272	PTPmeg1	0	None
123272	123273	was	0	None
123273	123274	sensitive	0	None
123274	123275	to	0	None
123275	123276	alendronate	0	None
123276	123277	,	0	None
123277	123278	with	0	None
123278	123279	IC50	0	None
123279	123280	values	0	None
123280	123281	of	0	None
123281	123282	less	0	None
123282	123283	than	0	None
123283	123284	1	0	None
123284	123285	microM;	0	None
123285	123286	PTPsigma	0	None
123286	123287	,	0	None
123287	123288	however	0	None
123288	123289	,	0	None
123289	123290	under	0	None
123290	123291	the	0	None
123291	123292	same	0	None
123292	123293	conditions	0	None
123293	123294	,	0	None
123294	123295	was	0	None
123295	123296	inhibited	0	None
123296	123297	by	0	None
123297	123298	only	0	None
123298	123299	50%	0	None
123299	123300	with	0	None
123300	123301	141	0	None
123301	123302	microM	0	None
123302	123303	alendronate	0	None
123303	123304	.	0	None

123305	123306	Similarly	0	None
123306	123307	,	0	None
123307	123308	with	0	None
123308	123309	the	0	None
123309	123310	src-pY527	0	None
123310	123311	substrate	0	None
123311	123312	,	0	None
123312	123313	alendronate	0	None
123313	123314	inhibition	0	None
123314	123315	was	0	None
123315	123316	also	0	None
123316	123317	PTP	0	None
123317	123318	dependent	0	None
123318	123319	.	0	None

123320	123321	Alendronate	0	None
123321	123322	inhibited	0	None
123322	123323	PTPmeg1	0	None
123323	123324	with	0	None
123324	123325	an	0	None
123325	123326	IC50	0	None
123326	123327	value	0	None
123327	123328	of	0	None
123328	123329	23	0	None
123329	123330	microM	0	None
123330	123331	,	0	None
123331	123332	PTPsigma	0	None
123332	123333	with	0	None
123333	123334	an	0	None
123334	123335	IC50	0	None
123335	123336	value	0	None
123336	123337	of	0	None
123337	123338	2	0	None
123338	123339	microM	0	None
123339	123340	,	0	None
123340	123341	and	0	None
123341	123342	did	0	None
123342	123343	not	0	None
123343	123344	inhibit	0	None
123344	123345	PTP	0	None
123345	123346	epsilon	0	None
123346	123347	at	0	None
123347	123348	concentrations	0	None
123348	123349	up	0	None
123349	123350	to	0	None
123350	123351	1	0	None
123351	123352	mM	0	None
123352	123353	.	0	None

123354	123355	The	0	None
123355	123356	alendronate	0	None
123356	123357	inhibition	0	None
123357	123358	of	0	None
123358	123359	these	0	None
123359	123360	three	0	None
123360	123361	PTPs	0	None
123361	123362	and	0	None
123362	123363	two	0	None
123363	123364	substrates	0	None
123364	123365	is	0	None
123365	123366	consistent	0	None
123366	123367	with	0	None
123367	123368	the	0	None
123368	123369	formation	0	None
123369	123370	of	0	None
123370	123371	a	0	None
123371	123372	ternary	0	None
123372	123373	complex	0	None
123373	123374	comprised	0	None
123374	123375	of	0	None
123375	123376	enzyme	0	None
123376	123377	,	0	None
123377	123378	substrate	0	None
123378	123379	,	0	None
123379	123380	and	0	None
123380	123381	inhibitor	0	None
123381	123382	.	0	None

123383	123384	PTP	0	None
123384	123385	inhibition	0	None
123385	123386	by	0	None
123386	123387	hisphosphonates	0	None
123387	123388	or	0	None
123388	123389	vanadate	2	CHEMICAL
123389	123390	was	0	None
123390	123391	diminished	0	None
123391	123392	by	0	None
123392	123393	the	0	None
123393	123394	metal	0	None
123394	123395	chelating	0	None
123395	123396	agent	0	None
123396	123397	EDTA	0	None
123397	123398	,	0	None
123398	123399	or	0	None
123399	123400	by	0	None
123400	123401	the	0	None
123401	123402	reducing	0	None
123402	123403	agent	0	None
123403	123404	dithiothreitol	2	CHEMICAL
123404	123405	,	0	None
123405	123406	suggesting	0	None
123406	123407	that	0	None
123407	123408	a	0	None
123408	123409	metal	0	None
123409	123410	ion	0	None
123410	123411	and	0	None
123411	123412	the	0	None
123412	123413	oxidation	0	None
123413	123414	of	0	None
123414	123415	a	0	None
123415	123416	cysteine	0	None
123416	123417	residue	0	None
123417	123418	are	0	None
123418	123419	required	0	None
123419	123420	for	0	None
123420	123421	full	0	None
123421	123422	inhibition	0	None
123422	123423	.	0	None

123424	123425	These	0	None
123425	123426	observations	0	None
123426	123427	show	0	None
123427	123428	substrate-	0	None
123428	123429	and	0	None
123429	123430	enzyme-specific	0	None
123430	123431	PTP	0	None
123431	123432	inhibition	0	None
123432	123433	by	0	None
123433	123434	alendronate	0	None
123434	123435	and	0	None
123435	123436	support	0	None
123436	123437	the	0	None
123437	123438	possibility	0	None
123438	123439	that	0	None
123439	123440	a	0	None
123440	123441	certain	0	None
123441	123442	PTP	0	None
123442	123443	(	0	None
123443	123444	s	0	None
123444	123445	)	0	None
123445	123446	may	0	None
123446	123447	be	0	None
123447	123448	the	0	None
123448	123449	molecular	0	None
123449	123450	target	0	None
123450	123451	for	0	None
123451	123452	alendronate	0	None
123452	123453	action	0	None
123453	123454	.	0	None
123454	123455	The	0	None
123455	123456	bone	0	None
123456	123457	morphogenetic	0	None
123457	123458	protein	0	None
123458	123459	(	0	None
123459	123460	BMP	0	None
123460	123461	)	0	None
123461	123462	signaling	0	None
123462	123463	pathway	0	None
123463	123464	has	0	None
123464	123465	essential	0	None
123465	123466	functions	0	None
123466	123467	in	0	None
123467	123468	development	0	None
123468	123469	,	0	None
123469	123470	homeostasis	0	None
123470	123471	,	0	None
123471	123472	and	0	None
123472	123473	the	0	None
123473	123474	normal	0	None
123474	123475	and	0	None
123475	123476	pathophysiologic	0	None
123476	123477	remodeling	0	None
123477	123478	of	0	None
123478	123479	tissues	0	None
123479	123480	.	0	None

123481	123482	Small	0	None
123482	123483	molecule	0	None
123483	123484	inhibitors	0	None
123484	123485	of	0	None
123485	123486	the	0	None
123486	123487	BMP	0	None
123487	123488	receptor	0	None
123488	123489	kinase	0	None
123489	123490	family	0	None
123490	123491	have	0	None
123491	123492	been	0	None
123492	123493	useful	0	None
123493	123494	for	0	None
123494	123495	probing	0	None
123495	123496	physiologic	0	None
123496	123497	functions	0	None
123497	123498	of	0	None
123498	123499	BMP	0	None
123499	123500	signaling	0	None
123500	123501	in	0	None
123501	123502	vitro	0	None
123502	123503	and	0	None
123503	123504	in	0	None
123504	123505	vivo	0	None
123505	123506	and	0	None
123506	123507	may	0	None
123507	123508	have	0	None
123508	123509	roles	0	None
123509	123510	in	0	None
123510	123511	the	0	None
123511	123512	treatment	0	None
123512	123513	of	0	None
123513	123514	BMP-mediated	0	None
123514	123515	diseases	0	None
123515	123516	.	0	None

123517	123518	Here	0	None
123518	123519	we	0	None
123519	123520	describe	0	None
123520	123521	the	0	None
123521	123522	development	0	None
123522	123523	of	0	None
123523	123524	a	0	None
123524	123525	selective	0	None
123525	123526	and	0	None
123526	123527	potent	0	None
123527	123528	inhibitor	0	None
123528	123529	of	0	None
123529	123530	the	0	None
123530	123531	BMP	0	None
123531	123532	type	0	None
123532	123533	I	0	None
123533	123534	receptor	0	None
123534	123535	kinases	0	None
123535	123536	,	0	None
123536	123537	LDN-212854	0	None
123537	123538	,	0	None
123538	123539	which	0	None
123539	123540	in	0	None
123540	123541	contrast	0	None
123541	123542	to	0	None
123542	123543	previously	0	None
123543	123544	described	0	None
123544	123545	BMP	0	None
123545	123546	receptor	0	None
123546	123547	kinase	0	None
123547	123548	inhibitors	0	None
123548	123549	exhibits	0	None
123549	123550	nearly	0	None
123550	123551	4	0	None
123551	123552	orders	0	None
123552	123553	of	0	None
123553	123554	selectivity	0	None
123554	123555	for	0	None
123555	123556	BMP	0	None
123556	123557	versus	0	None
123557	123558	the	0	None
123558	123559	closely	0	None
123559	123560	related	0	None
123560	123561	TGF-β	0	None
123561	123562	and	0	None
123562	123563	Activin	0	None
123563	123564	type	0	None
123564	123565	I	0	None
123565	123566	receptors	0	None
123566	123567	.	0	None

123568	123569	In	0	None
123569	123570	vitro	0	None
123570	123571	,	0	None
123571	123572	LDN-212854	0	None
123572	123573	exhibits	0	None
123573	123574	some	0	None
123574	123575	selectivity	0	None
123575	123576	for	0	None
123576	123577	ALK2	0	None
123577	123578	in	0	None
123578	123579	preference	0	None
123579	123580	to	0	None
123580	123581	other	0	None
123581	123582	BMP	0	None
123582	123583	type	0	None
123583	123584	I	0	None
123584	123585	receptors	0	None
123585	123586	,	0	None
123586	123587	ALK1	0	None
123587	123588	and	0	None
123588	123589	ALK3	0	None
123589	123590	,	0	None
123590	123591	which	0	None
123591	123592	may	0	None
123592	123593	permit	0	None
123593	123594	the	0	None
123594	123595	interrogation	0	None
123595	123596	of	0	None
123596	123597	ALK2-mediated	0	None
123597	123598	signaling	0	None
123598	123599	,	0	None
123599	123600	transcriptional	0	None
123600	123601	activity	0	None
123601	123602	,	0	None
123602	123603	and	0	None
123603	123604	function	0	None
123604	123605	.	0	None

123606	123607	LDN-212854	0	None
123607	123608	potently	0	None
123608	123609	inhibits	0	None
123609	123610	heterotopic	0	None
123610	123611	ossification	0	None
123611	123612	in	0	None
123612	123613	an	0	None
123613	123614	inducible	0	None
123614	123615	transgenic	0	None
123615	123616	mutant	0	None
123616	123617	ALK2	0	None
123617	123618	mouse	0	None
123618	123619	model	0	None
123619	123620	of	0	None
123620	123621	fibrodysplasia	0	None
123621	123622	ossificans	0	None
123622	123623	progressiva	0	None
123623	123624	.	0	None

123625	123626	These	0	None
123626	123627	findings	0	None
123627	123628	represent	0	None
123628	123629	a	0	None
123629	123630	significant	0	None
123630	123631	step	0	None
123631	123632	toward	0	None
123632	123633	developing	0	None
123633	123634	selective	0	None
123634	123635	inhibitors	0	None
123635	123636	targeting	0	None
123636	123637	individual	0	None
123637	123638	members	0	None
123638	123639	of	0	None
123639	123640	the	0	None
123640	123641	highly	0	None
123641	123642	homologous	0	None
123642	123643	BMP	0	None
123643	123644	type	0	None
123644	123645	I	0	None
123645	123646	receptor	0	None
123646	123647	family	0	None
123647	123648	.	0	None

123649	123650	Such	0	None
123650	123651	inhibitors	0	None
123651	123652	would	0	None
123652	123653	provide	0	None
123653	123654	greater	0	None
123654	123655	resolution	0	None
123655	123656	as	0	None
123656	123657	probes	0	None
123657	123658	of	0	None
123658	123659	physiologic	0	None
123659	123660	function	0	None
123660	123661	and	0	None
123661	123662	improved	0	None
123662	123663	selectivity	0	None
123663	123664	against	0	None
123664	123665	therapeutic	0	None
123665	123666	targets	0	None
123666	123667	.	0	None
123667	123668	Our	0	None
123668	123669	purpose	0	None
123669	123670	was	0	None
123670	123671	to	0	None
123671	123672	test	0	None
123672	123673	the	0	None
123673	123674	impact	0	None
123674	123675	of	0	None
123675	123676	single	0	None
123676	123677	and	0	None
123677	123678	/	0	None
123678	123679	or	0	None
123679	123680	combined	0	None
123680	123681	treatment	0	None
123681	123682	with	0	None
123682	123683	the	0	None
123683	123684	AT	0	None
123684	123685	(	0	None
123685	123686	1	0	None
123686	123687	)	0	None
123687	123688	-receptor	0	None
123688	123689	blocker	0	None
123689	123690	candesartan	0	None
123690	123691	and	0	None
123691	123692	the	0	None
123692	123693	HMG-CoA	0	None
123693	123694	reductase	0	None
123694	123695	inhibitor	0	None
123695	123696	rosuvastatin	2	CHEMICAL
123696	123697	on	0	None
123697	123698	infarct	0	None
123698	123699	size	0	None
123699	123700	and	0	None
123700	123701	neuroscore	0	None
123701	123702	in	0	None
123702	123703	transient	0	None
123703	123704	cerebral	0	None
123704	123705	ischemia	0	None
123705	123706	in	0	None
123706	123707	rats	0	None
123707	123708	.	0	None

123709	123710	L-NAME	0	None
123710	123711	was	0	None
123711	123712	used	0	None
123712	123713	to	0	None
123713	123714	test	0	None
123714	123715	whether	0	None
123715	123716	any	0	None
123716	123717	potential	0	None
123717	123718	effect	0	None
123718	123719	was	0	None
123719	123720	due	0	None
123720	123721	to	0	None
123721	123722	activation	0	None
123722	123723	of	0	None
123723	123727	endothelial nitric oxide synthase	1	GENE-Y
123727	123728	(	0	None
123728	123729	eNOS	0	None
123729	123730	)	0	None
123730	123731	.	0	None

123732	123733	Therefore	0	None
123733	123734	,	0	None
123734	123735	the	0	None
123735	123736	middle	0	None
123736	123737	cerebral	0	None
123737	123738	artery	0	None
123738	123739	was	0	None
123739	123740	occluded	0	None
123740	123741	for	0	None
123741	123742	1	0	None
123742	123743	h	0	None
123743	123744	(	0	None
123744	123745	MCAO	0	None
123745	123746	)	0	None
123746	123747	followed	0	None
123747	123748	by	0	None
123748	123749	7	0	None
123749	123750	days	0	None
123750	123751	reperfusion	0	None
123751	123752	.	0	None

123753	123754	Rats	0	None
123754	123755	received	0	None
123755	123756	candesartan	0	None
123756	123757	2h	0	None
123757	123758	before	0	None
123758	123759	and	0	None
123759	123760	daily	0	None
123760	123761	after	0	None
123761	123762	MCAO	0	None
123762	123763	(	0	None
123763	123764	pretreatment	0	None
123764	123765	)	0	None
123765	123766	or	0	None
123766	123767	daily	0	None
123767	123768	after	0	None
123768	123769	MCAO	0	None
123769	123770	(	0	None
123770	123771	posttreatment	0	None
123771	123772	)	0	None
123772	123773	;	0	None
123773	123774	rosuvastatin	2	CHEMICAL
123774	123775	was	0	None
123775	123776	given	0	None
123776	123777	daily	0	None
123777	123778	for	0	None
123778	123779	7	0	None
123779	123780	days	0	None
123780	123781	before	0	None
123781	123782	MCAO	0	None
123782	123783	without	0	None
123783	123784	or	0	None
123784	123785	with	0	None
123785	123786	candesartan	0	None
123786	123787	pre-	0	None
123787	123788	and	0	None
123788	123789	posttreatment	0	None
123789	123790	.	0	None

123791	123792	In	0	None
123792	123793	addition	0	None
123793	123794	,	0	None
123794	123795	candesartan	0	None
123795	123796	and	0	None
123796	123797	rosuvastatin	2	CHEMICAL
123797	123798	were	0	None
123798	123799	combined	0	None
123799	123800	with	0	None
123800	123801	L-NAME	0	None
123801	123802	.	0	None

123803	123804	Infarct	0	None
123804	123805	size	0	None
123805	123806	and	0	None
123806	123807	neuroscore	0	None
123807	123808	at	0	None
123808	123809	day	0	None
123809	123810	7	0	None
123810	123811	were	0	None
123811	123812	compared	0	None
123812	123813	to	0	None
123813	123814	those	0	None
123814	123815	of	0	None
123815	123816	controls	0	None
123816	123817	.	0	None

123818	123819	As	0	None
123819	123820	result	0	None
123820	123821	,	0	None
123821	123822	compared	0	None
123822	123823	to	0	None
123823	123824	controls	0	None
123824	123825	(	0	None
123825	123826	109	0	None
123826	123827	+	0	None
123827	123828	/	0	None
123828	123829	-12	0	None
123829	123830	mm	0	None
123830	123831	(	0	None
123831	123832	3	0	None
123832	123833	)	0	None
123833	123834	)	0	None
123834	123835	infarct	0	None
123835	123836	size	0	None
123836	123837	with	0	None
123837	123838	candesartan	0	None
123838	123839	(	0	None
123839	123840	pretreatment	0	None
123840	123841	:	0	None
123841	123842	21	0	None
123842	123843	+	0	None
123843	123844	/	0	None
123844	123845	-5	0	None
123845	123846	mm	0	None
123846	123847	(	0	None
123847	123848	3	0	None
123848	123849	)	0	None
123849	123850	;	0	None
123850	123851	posttreatment	0	None
123851	123852	:	0	None
123852	123853	68	0	None
123853	123854	+	0	None
123854	123855	/	0	None
123855	123856	-29	0	None
123856	123857	mm	0	None
123857	123858	(	0	None
123858	123859	3	0	None
123859	123860	)	0	None
123860	123861	;	0	None
123861	123862	P<0	0	None
123862	123863	.	0	None
123863	123864	05	0	None
123864	123865	)	0	None
123865	123866	or	0	None
123866	123867	rosuvastatin	2	CHEMICAL
123867	123868	(	0	None
123868	123869	69	0	None
123869	123870	+	0	None
123870	123871	/	0	None
123871	123872	-14	0	None
123872	123873	mm	0	None
123873	123874	(	0	None
123874	123875	3	0	None
123875	123876	)	0	None
123876	123877	;	0	None
123877	123878	P<0	0	None
123878	123879	.	0	None
123879	123880	05	0	None
123880	123881	)	0	None
123881	123882	was	0	None
123882	123883	smaller	0	None
123883	123884	.	0	None

123885	123886	Combined	0	None
123886	123887	treatment	0	None
123887	123888	also	0	None
123888	123889	reduced	0	None
123889	123890	infarct	0	None
123890	123891	size	0	None
123891	123892	(	0	None
123892	123893	pretreatment	0	None
123893	123894	:	0	None
123894	123895	37	0	None
123895	123896	+	0	None
123896	123897	/	0	None
123897	123898	-15	0	None
123898	123899	mm	0	None
123899	123900	(	0	None
123900	123901	3	0	None
123901	123902	)	0	None
123902	123903	;	0	None
123903	123904	posttreatment	0	None
123904	123905	57	0	None
123905	123906	+	0	None
123906	123907	/	0	None
123907	123908	-20mm	0	None
123908	123909	(	0	None
123909	123910	3	0	None
123910	123911	)	0	None
123911	123912	;	0	None
123912	123913	P<0	0	None
123913	123914	.	0	None
123914	123915	05	0	None
123915	123916	)	0	None
123916	123917	;	0	None
123917	123918	but	0	None
123918	123919	there	0	None
123919	123920	was	0	None
123920	123921	no	0	None
123921	123922	benefit	0	None
123922	123923	of	0	None
123923	123924	combined	0	None
123924	123925	treatment	0	None
123925	123926	over	0	None
123926	123927	candesartan	0	None
123927	123928	pretreatment	0	None
123928	123929	alone	0	None
123929	123930	.	0	None

123931	123932	Compared	0	None
123932	123933	to	0	None
123933	123934	controls	0	None
123934	123935	(	0	None
123935	123936	2	0	None
123936	123937	.	0	None
123937	123938	08	0	None
123938	123939	+	0	None
123939	123940	/	0	None
123940	123941	-0	0	None
123941	123942	.	0	None
123942	123943	28	0	None
123943	123944	)	0	None
123944	123945	only	0	None
123945	123946	candesartan	0	None
123946	123947	pretreatment	0	None
123947	123948	and	0	None
123948	123949	combined	0	None
123949	123950	treatment	0	None
123950	123951	improved	0	None
123951	123952	the	0	None
123952	123953	neuroscore	0	None
123953	123954	(	0	None
123954	123955	0	0	None
123955	123956	.	0	None
123956	123957	97	0	None
123957	123958	+	0	None
123958	123959	/	0	None
123959	123960	-0	0	None
123960	123961	.	0	None
123961	123962	05	0	None
123962	123963	,	0	None
123963	123964	1	0	None
123964	123965	.	0	None
123965	123966	10	0	None
123966	123967	+	0	None
123967	123968	/	0	None
123968	123969	-0	0	None
123969	123970	.	0	None
123970	123971	33;	0	None
123971	123972	P<0	0	None
123972	123973	.	0	None
123973	123974	05	0	None
123974	123975	)	0	None
123975	123976	.	0	None

123977	123978	L-NAME	0	None
123978	123979	abolished	0	None
123979	123980	the	0	None
123980	123981	reduction	0	None
123981	123982	in	0	None
123982	123983	infarct	0	None
123983	123984	size	0	None
123984	123985	and	0	None
123985	123986	improvement	0	None
123986	123987	in	0	None
123987	123988	neuroscore	0	None
123988	123989	.	0	None

123990	123991	In	0	None
123991	123992	conclusion	0	None
123992	123993	,	0	None
123993	123994	both	0	None
123994	123995	,	0	None
123995	123996	candesartan	0	None
123996	123997	or	0	None
123997	123998	rosuvastatin	2	CHEMICAL
123998	123999	treatment	0	None
123999	124000	alone	0	None
124000	124001	reduced	0	None
124001	124002	infarct	0	None
124002	124003	size	0	None
124003	124004	in	0	None
124004	124005	transient	0	None
124005	124006	cerebral	0	None
124006	124007	ischemia	0	None
124007	124008	,	0	None
124008	124009	and	0	None
124009	124010	the	0	None
124010	124011	best	0	None
124011	124012	result	0	None
124012	124013	was	0	None
124013	124014	achieved	0	None
124014	124015	with	0	None
124015	124016	candesartan	0	None
124016	124017	pretreatment	0	None
124017	124018	.	0	None

124019	124020	Combined	0	None
124020	124021	treatment	0	None
124021	124022	was	0	None
124022	124023	superior	0	None
124023	124024	to	0	None
124024	124025	rosuvastatin	2	CHEMICAL
124025	124026	alone	0	None
124026	124027	,	0	None
124027	124028	but	0	None
124028	124029	not	0	None
124029	124030	to	0	None
124030	124031	candesartan	0	None
124031	124032	.	0	None

124033	124034	The	0	None
124034	124035	therapeutic	0	None
124035	124036	benefit	0	None
124036	124037	of	0	None
124037	124038	both	0	None
124038	124039	agents	0	None
124039	124040	was	0	None
124040	124041	at	0	None
124041	124042	least	0	None
124042	124043	in	0	None
124043	124044	parts	0	None
124044	124045	mediated	0	None
124045	124046	by	0	None
124046	124047	eNOS-activation	0	None
124047	124048	.	0	None
124048	124049	The	0	None
124049	124050	plasminogen	0	None
124050	124051	binding	0	None
124051	124052	with	0	None
124052	124053	streptokinase	0	None
124053	124054	decapeptides	0	None
124054	124055	,	0	None
124055	124056	modeling	0	None
124056	124057	the	0	None
124057	124058	primary	0	None
124058	124059	structure	0	None
124059	124060	of	0	None
124060	124061	molecule	0	None
124061	124062	,	0	None
124062	124063	and	0	None
124063	124064	chymotryptic	0	None
124064	124065	fragments	0	None
124065	124066	of	0	None
124066	124067	streptokinase	0	None
124067	124068	have	0	None
124068	124069	been	0	None
124069	124070	investigated	0	None
124070	124071	.	0	None

124072	124073	The	0	None
124073	124074	immunoenzymatic	0	None
124074	124075	assay	0	None
124075	124076	has	0	None
124076	124077	shown	0	None
124077	124078	that	0	None
124078	124079	plasminogen	0	None
124079	124080	binds	0	None
124080	124081	to	0	None
124081	124082	all	0	None
124082	124083	streptokinase	0	None
124083	124084	fragments	0	None
124084	124085	with	0	None
124085	124086	the	0	None
124086	124087	decreasing	0	None
124087	124088	affinity	0	None
124088	124089	in	0	None
124089	124090	the	0	None
124090	124091	set	0	None
124091	124092	of	0	None
124092	124093	fragments	0	None
124093	124094	:	0	None
124094	124095	36	0	None
124095	124096	>	0	None
124096	124097	30	0	None
124097	124098	>	0	None
124098	124099	17	0	None
124099	124100	>	0	None
124100	124101	7	0	None
124101	124102	>	0	None
124102	124103	11	0	None
124103	124104	kDa	0	None
124104	124105	.	0	None

124106	124107	Location	0	None
124107	124108	of	0	None
124108	124109	the	0	None
124109	124110	binding	0	None
124110	124111	sites	0	None
124111	124112	in	0	None
124112	124113	streptokinase	0	None
124113	124114	primary	0	None
124114	124115	structure	0	None
124115	124116	was	0	None
124116	124117	performed	0	None
124117	124118	using	0	None
124118	124119	the	0	None
124119	124120	immobilized	0	None
124120	124121	decapeptides	0	None
124121	124122	on	0	None
124122	124123	plastic	0	None
124123	124124	pins	0	None
124124	124125	adopted	0	None
124125	124126	to	0	None
124126	124127	IEA	0	None
124127	124128	.	0	None

124129	124130	In	0	None
124130	124131	the	0	None
124131	124132	presence	0	None
124132	124133	of	0	None
124133	124134	10	0	None
124134	124135	mM	0	None
124135	124136	6-aminohexanoic	0	None
124136	124137	acid	0	None
124137	124138	11	0	None
124138	124139	sites	0	None
124139	124140	for	0	None
124140	124141	human	0	None
124141	124142	Glu-	0	None
124142	124143	and	0	None
124143	124144	mini-plasminogens	0	None
124144	124145	,	0	None
124145	124146	pig	0	None
124146	124147	and	0	None
124147	124148	bovine	0	None
124148	124149	plasminogens	0	None
124149	124150	binding	0	None
124150	124151	have	0	None
124151	124152	been	0	None
124152	124153	found	0	None
124153	124154	.	0	None

124155	124156	They	0	None
124156	124157	were	0	None
124157	124158	of	0	None
124158	124159	the	0	None
124159	124160	same	0	None
124160	124161	location	0	None
124161	124162	for	0	None
124162	124163	human	0	None
124163	124164	,	0	None
124164	124165	bovine	0	None
124165	124166	and	0	None
124166	124167	pig	0	None
124167	124168	plasminogens	0	None
124168	124169	.	0	None

124170	124171	3	0	None
124171	124172	sites	0	None
124172	124173	were	0	None
124173	124174	located	0	None
124174	124175	in	0	None
124175	124177	plasminogen alpha-domain--T43-A72	0	None
124177	124178	,	0	None
124178	124179	N113-T126	0	None
124179	124180	,	0	None
124180	124181	Q133-V158	0	None
124181	124182	,	0	None
124182	124183	5	0	None
124183	124184	sites	0	None
124184	124185	in	0	None
124185	124186	beta-domain--T163-L188	0	None
124186	124187	,	0	None
124187	124188	A203-S222	0	None
124188	124189	,	0	None
124189	124190	Q239-I264	0	None
124190	124191	,	0	None
124191	124192	Y275-L294	0	None
124192	124193	,	0	None
124193	124194	T315-L340	0	None
124194	124195	,	0	None
124195	124196	and	0	None
124196	124197	3	0	None
124197	124198	sites	0	None
124198	124199	in	0	None
124199	124200	gamma-domain--T361-R362	0	None
124200	124201	,	0	None
124201	124202	N377-E392	0	None
124202	124203	,	0	None
124203	124204	T397-N410	0	None
124204	124205	.	0	None

124206	124207	Participation	0	None
124207	124208	of	0	None
124208	124209	linear	0	None
124209	124210	part	0	None
124210	124211	of	0	None
124211	124214	streptokinase polypeptide chain	1	GENE-Y
124214	124215	in	0	None
124215	124216	plasminogen--streptokinase	0	None
124216	124217	complex	0	None
124217	124218	formation	0	None
124218	124219	is	0	None
124219	124220	suggested	0	None
124220	124221	.	0	None
124221	124222	Although	0	None
124222	124224	interleukin 2	1	GENE-Y
124224	124225	(	0	None
124225	124226	IL-2	0	None
124226	124227	)	0	None
124227	124228	and	0	None
124228	124229	IL-15	0	None
124229	124230	signal	0	None
124230	124231	through	0	None
124231	124232	the	0	None
124232	124233	common	0	None
124233	124234	gamma	0	None
124234	124235	chain	0	None
124235	124236	(	0	None
124236	124237	gammac	0	None
124237	124238	)	0	None
124238	124239	and	0	None
124239	124240	through	0	None
124240	124241	IL-2	0	None
124241	124242	receptor	0	None
124242	124243	beta-chain	0	None
124243	124244	(	0	None
124244	124245	CD122	0	None
124245	124246	)	0	None
124246	124247	subunits	0	None
124247	124248	,	0	None
124248	124249	they	0	None
124249	124250	direct	0	None
124250	124251	distinct	0	None
124251	124252	physiologic	0	None
124252	124253	and	0	None
124253	124254	immunotherapeutic	0	None
124254	124255	responses	0	None
124255	124256	in	0	None
124256	124257	T	0	None
124257	124258	cells	0	None
124258	124259	.	0	None

124260	124261	The	0	None
124261	124262	present	0	None
124262	124263	study	0	None
124263	124264	provides	0	None
124264	124265	some	0	None
124265	124266	insight	0	None
124266	124267	into	0	None
124267	124268	why	0	None
124268	124269	IL-2	0	None
124269	124270	and	0	None
124270	124271	IL-15	0	None
124271	124272	differentially	0	None
124272	124273	regulate	0	None
124273	124274	T-cell	0	None
124274	124275	function	0	None
124275	124276	by	0	None
124276	124277	revealing	0	None
124277	124278	that	0	None
124278	124279	these	0	None
124279	124280	cytokines	3	GENE-N
124280	124281	are	0	None
124281	124282	strikingly	0	None
124282	124283	distinct	0	None
124283	124284	in	0	None
124284	124285	their	0	None
124285	124286	ability	0	None
124286	124287	to	0	None
124287	124288	control	0	None
124288	124289	protein	0	None
124289	124290	synthesis	0	None
124290	124291	and	0	None
124291	124292	T-cell	0	None
124292	124293	mass	0	None
124293	124294	.	0	None

124295	124296	IL-2	0	None
124296	124297	and	0	None
124297	124298	IL-15	0	None
124298	124299	are	0	None
124299	124300	shown	0	None
124300	124301	to	0	None
124301	124302	be	0	None
124302	124303	equivalent	0	None
124303	124304	mitogens	0	None
124304	124305	for	0	None
124305	124306	antigen-stimulated	0	None
124306	124307	CD8	0	None
124307	124308	(	0	None
124308	124309	+	0	None
124309	124310	)	0	None
124310	124311	T	0	None
124311	124312	cells	0	None
124312	124313	but	0	None
124313	124314	not	0	None
124314	124315	for	0	None
124315	124316	equivalent	0	None
124316	124317	growth	0	None
124317	124318	factors	0	None
124318	124319	.	0	None

124320	124321	Antigen-primed	0	None
124321	124322	T	0	None
124322	124323	cells	0	None
124323	124324	cannot	0	None
124324	124325	autonomously	0	None
124325	124326	maintain	0	None
124326	124328	amino acid	2	CHEMICAL
124328	124329	incorporation	0	None
124329	124330	or	0	None
124330	124331	de	0	None
124331	124332	novo	0	None
124332	124333	protein	0	None
124333	124334	synthesis	0	None
124334	124335	without	0	None
124335	124336	exogenous	0	None
124336	124337	cytokine	0	None
124337	124338	stimulation	0	None
124338	124339	.	0	None

124340	124341	Both	0	None
124341	124342	IL-2	0	None
124342	124343	and	0	None
124343	124344	IL-15	0	None
124344	124345	induce	0	None
124345	124347	amino acid	2	CHEMICAL
124347	124348	uptake	0	None
124348	124349	and	0	None
124349	124350	protein	0	None
124350	124351	synthesis	0	None
124351	124352	in	0	None
124352	124353	antigen-activated	0	None
124353	124354	T	0	None
124354	124355	cells;	0	None
124355	124356	however	0	None
124356	124357	,	0	None
124357	124358	the	0	None
124358	124359	IL-2	0	None
124359	124360	response	0	None
124360	124361	is	0	None
124361	124362	strikingly	0	None
124362	124363	more	0	None
124363	124364	potent	0	None
124364	124365	than	0	None
124365	124366	the	0	None
124366	124367	IL-15	0	None
124367	124368	response	0	None
124368	124369	.	0	None

124370	124371	The	0	None
124371	124372	differential	0	None
124372	124373	action	0	None
124373	124374	of	0	None
124374	124375	IL-2	0	None
124375	124376	and	0	None
124376	124377	IL-15	0	None
124377	124378	on	0	None
124378	124380	amino acid	2	CHEMICAL
124380	124381	uptake	0	None
124381	124382	and	0	None
124382	124383	protein	0	None
124383	124384	synthesis	0	None
124384	124385	is	0	None
124385	124386	explained	0	None
124386	124387	by	0	None
124387	124388	temporal	0	None
124388	124389	differences	0	None
124389	124390	in	0	None
124390	124391	signaling	0	None
124391	124392	induced	0	None
124392	124393	by	0	None
124393	124394	these	0	None
124394	124395	2	0	None
124395	124396	cytokines	3	GENE-N
124396	124397	.	0	None

124398	124399	Hence	0	None
124399	124400	,	0	None
124400	124401	the	0	None
124401	124402	present	0	None
124402	124403	results	0	None
124403	124404	show	0	None
124404	124405	that	0	None
124405	124406	cytokines	3	GENE-N
124406	124407	that	0	None
124407	124408	are	0	None
124408	124409	equivalent	0	None
124409	124410	mitogens	0	None
124410	124411	can	0	None
124411	124412	have	0	None
124412	124413	different	0	None
124413	124414	potency	0	None
124414	124415	in	0	None
124415	124416	terms	0	None
124416	124417	of	0	None
124417	124418	regulating	0	None
124418	124419	protein	0	None
124419	124420	synthesis	0	None
124420	124421	and	0	None
124421	124422	cell	0	None
124422	124423	growth	0	None
124423	124424	.	0	None
124424	124425	Association	0	None
124425	124426	of	0	None
124426	124427	DRD2	0	None
124427	124428	polymorphisms	0	None
124428	124429	and	0	None
124429	124430	chlorpromazine-induced	0	None
124430	124431	extrapyramidal	0	None
124431	124432	syndrome	0	None
124432	124433	in	0	None
124433	124434	Chinese	0	None
124434	124435	schizophrenic	0	None
124435	124436	patients	0	None
124436	124437	.	0	None
124437	124438	Purification	0	None
124438	124439	and	0	None
124439	124440	characterization	0	None
124440	124441	of	0	None
124441	124442	membrane-bound	0	None
124442	124443	polyphenoloxidase	0	None
124443	124444	(	0	None
124444	124445	mPPO	0	None
124445	124446	)	0	None
124446	124447	from	0	None
124447	124448	Snake	0	None
124448	124449	fruit	0	None
124449	124450	[	0	None
124450	124451	Salacca	0	None
124451	124452	zalacca	0	None
124452	124453	(	0	None
124453	124454	Gaertn	0	None
124454	124455	.	0	None

124456	124457	)	0	None
124457	124458	Voss	0	None
124458	124459	]	0	None
124459	124460	.	0	None
124460	124461	OBJECTIVE	0	None
124461	124462	:	0	None
124462	124463	To	0	None
124463	124464	determine	0	None
124464	124465	the	0	None
124465	124466	efficacy	0	None
124466	124467	and	0	None
124467	124468	safety	0	None
124468	124469	of	0	None
124469	124470	the	0	None
124470	124471	cyclooxygenase	3	GENE-N
124471	124472	2	0	None
124472	124473	(	0	None
124473	124474	COX-2	0	None
124474	124475	)	0	None
124475	124476	specific	0	None
124476	124477	inhibitor	0	None
124477	124478	,	0	None
124478	124479	rofecoxib	0	None
124479	124480	in	0	None
124480	124481	patients	0	None
124481	124482	with	0	None
124482	124483	osteoarthritis	0	None
124483	124484	(	0	None
124484	124485	OA	0	None
124485	124486	)	0	None
124486	124487	of	0	None
124487	124488	the	0	None
124488	124489	knee	0	None
124489	124490	.	0	None

124491	124492	METHODS	0	None
124492	124493	:	0	None
124493	124494	Rofecoxib	0	None
124494	124495	,	0	None
124495	124496	25	0	None
124496	124497	mg	2	CHEMICAL
124497	124498	or	0	None
124498	124499	125	0	None
124499	124500	mg	2	CHEMICAL
124500	124501	once	0	None
124501	124502	daily	0	None
124502	124503	,	0	None
124503	124504	was	0	None
124504	124505	compared	0	None
124505	124506	with	0	None
124506	124507	placebo	0	None
124507	124508	in	0	None
124508	124509	a	0	None
124509	124510	6	0	None
124510	124511	week	0	None
124511	124512	,	0	None
124512	124513	double	0	None
124513	124514	blind	0	None
124514	124515	,	0	None
124515	124516	parallel	0	None
124516	124517	group	0	None
124517	124518	,	0	None
124518	124519	randomized	0	None
124519	124520	,	0	None
124520	124521	multicenter	0	None
124521	124522	study	0	None
124522	124523	of	0	None
124523	124524	219	0	None
124524	124525	patients	0	None
124525	124526	with	0	None
124526	124527	knee	0	None
124527	124528	OA	0	None
124528	124529	.	0	None

124530	124531	RESULTS	0	None
124531	124532	:	0	None
124532	124533	Both	0	None
124533	124534	doses	0	None
124534	124535	of	0	None
124535	124536	rofecoxib	0	None
124536	124537	produced	0	None
124537	124538	clinically	0	None
124538	124539	significant	0	None
124539	124540	improvement	0	None
124540	124541	as	0	None
124541	124542	assessed	0	None
124542	124543	by	0	None
124543	124544	primary	0	None
124544	124545	(	0	None
124545	124546	e	0	None
124546	124547	.	0	None

124548	124549	g	0	None
124549	124550	.	0	None

124551	124552	,	0	None
124552	124553	WOMAC	0	None
124553	124554	Pain	0	None
124554	124555	Subscale	0	None
124555	124556	0-100	0	None
124556	124557	mm	0	None
124557	124558	,	0	None
124558	124559	decrease	0	None
124559	124560	from	0	None
124560	124561	baseline	0	None
124561	124562	:	0	None
124562	124563	placebo	0	None
124563	124564	:	0	None
124564	124565	7	0	None
124565	124566	.	0	None
124566	124567	1	0	None
124567	124568	mm;	0	None
124568	124569	rofecoxib	0	None
124569	124570	25	0	None
124570	124571	mg	2	CHEMICAL
124571	124572	:	0	None
124572	124573	28	0	None
124573	124574	.	0	None
124574	124575	1	0	None
124575	124576	mm	0	None
124576	124577	,	0	None
124577	124578	rofecoxib	0	None
124578	124579	125	0	None
124579	124580	mg	2	CHEMICAL
124580	124581	:	0	None
124581	124582	28	0	None
124582	124583	.	0	None
124583	124584	0	0	None
124584	124585	mm;	0	None
124585	124586	p	0	None
124586	124587	<	0	None
124587	124588	0	0	None
124588	124589	.	0	None
124589	124590	001	0	None
124590	124591	rofecoxib	0	None
124591	124592	vs	0	None
124592	124593	placebo	0	None
124593	124594	)	0	None
124594	124595	and	0	None
124595	124596	secondary	0	None
124596	124597	efficacy	0	None
124597	124598	(	0	None
124598	124599	p	0	None
124599	124600	<	0	None
124600	124601	0	0	None
124601	124602	.	0	None
124602	124603	05	0	None
124603	124604	)	0	None
124604	124605	criteria	0	None
124605	124606	compared	0	None
124606	124607	with	0	None
124607	124608	placebo	0	None
124608	124609	.	0	None

124610	124611	Clinical	0	None
124611	124612	improvement	0	None
124612	124613	with	0	None
124613	124614	the	0	None
124614	124615	25	0	None
124615	124616	mg	2	CHEMICAL
124616	124617	dose	0	None
124617	124618	was	0	None
124618	124619	similar	0	None
124619	124620	to	0	None
124620	124621	that	0	None
124621	124622	with	0	None
124622	124623	the	0	None
124623	124624	125	0	None
124624	124625	mg	2	CHEMICAL
124625	124626	dose	0	None
124626	124627	.	0	None

124628	124629	Both	0	None
124629	124630	rofecoxib	0	None
124630	124631	doses	0	None
124631	124632	were	0	None
124632	124633	generally	0	None
124633	124634	well	0	None
124634	124635	tolerated	0	None
124635	124636	.	0	None

124637	124638	CONCLUSION	0	None
124638	124639	:	0	None
124639	124640	Specific	0	None
124640	124641	inhibition	0	None
124641	124642	of	0	None
124642	124643	COX-2	0	None
124643	124644	by	0	None
124644	124645	25	0	None
124645	124646	and	0	None
124646	124647	125	0	None
124647	124648	mg	2	CHEMICAL
124648	124649	rofecoxib	0	None
124649	124650	,	0	None
124650	124651	administered	0	None
124651	124652	once	0	None
124652	124653	daily	0	None
124653	124654	,	0	None
124654	124655	resulted	0	None
124655	124656	in	0	None
124656	124657	clinically	0	None
124657	124658	meaningful	0	None
124658	124659	improvements	0	None
124659	124660	in	0	None
124660	124661	patients	0	None
124661	124662	with	0	None
124662	124663	OA	0	None
124663	124664	.	0	None

124665	124666	This	0	None
124666	124667	study	0	None
124667	124668	confirms	0	None
124668	124669	that	0	None
124669	124670	COX-2	0	None
124670	124671	derived	0	None
124671	124672	prostanoids	2	CHEMICAL
124672	124673	are	0	None
124673	124674	important	0	None
124674	124675	clinical	0	None
124675	124676	mediators	0	None
124676	124677	of	0	None
124677	124678	pain	0	None
124678	124679	and	0	None
124679	124680	other	0	None
124680	124681	symptoms	0	None
124681	124682	of	0	None
124682	124683	knee	0	None
124683	124684	OA	0	None
124684	124685	and	0	None
124685	124686	that	0	None
124686	124687	inhibition	0	None
124687	124688	of	0	None
124688	124689	COX-1	1	GENE-Y
124689	124690	is	0	None
124690	124691	not	0	None
124691	124692	required	0	None
124692	124693	to	0	None
124693	124694	provide	0	None
124694	124695	clinical	0	None
124695	124696	benefit	0	None
124696	124697	.	0	None
124697	124698	Neuroendocrine	0	None
124698	124699	tumors	0	None
124699	124700	are	0	None
124700	124701	very	0	None
124701	124702	heterogeneous	0	None
124702	124703	,	0	None
124703	124704	develop	0	None
124704	124705	from	0	None
124705	124706	a	0	None
124706	124707	variety	0	None
124707	124708	of	0	None
124708	124709	tissues	0	None
124709	124710	,	0	None
124710	124711	and	0	None
124711	124712	can	0	None
124712	124713	be	0	None
124713	124714	difficult	0	None
124714	124715	to	0	None
124715	124716	diagnose	0	None
124716	124717	.	0	None

124718	124719	Without	0	None
124719	124720	the	0	None
124720	124721	clinical	0	None
124721	124722	manifestation	0	None
124722	124723	of	0	None
124723	124724	metastases	0	None
124724	124725	,	0	None
124725	124726	it	0	None
124726	124727	is	0	None
124727	124728	often	0	None
124728	124729	difficult	0	None
124729	124730	to	0	None
124730	124731	characterize	0	None
124731	124732	them	0	None
124732	124733	as	0	None
124733	124734	malignant	0	None
124734	124735	.	0	None

124736	124737	Even	0	None
124737	124738	so-called	0	None
124738	124739	completely	0	None
124739	124740	(	0	None
124740	124741	R0	0	None
124741	124742	)	0	None
124742	124743	resected	0	None
124743	124744	tumors	0	None
124744	124745	can	0	None
124745	124746	spread	0	None
124746	124747	clinically	0	None
124747	124748	visible	0	None
124748	124749	metastases	0	None
124749	124750	within	0	None
124750	124751	a	0	None
124751	124752	few	0	None
124752	124753	months	0	None
124753	124754	after	0	None
124754	124755	initial	0	None
124755	124756	surgery	0	None
124756	124757	.	0	None

124758	124759	Treatment	0	None
124759	124760	options	0	None
124760	124761	for	0	None
124761	124762	neuroendocrine	0	None
124762	124763	tumors	0	None
124763	124764	including	0	None
124764	124765	pheochromocytoma	0	None
124765	124766	are	0	None
124766	124767	limited	0	None
124767	124768	.	0	None

124769	124770	Molecular	0	None
124770	124771	targeted	0	None
124771	124772	therapies	0	None
124772	124773	using	0	None
124773	124774	tyrosine	2	CHEMICAL
124774	124775	kinase	0	None
124775	124776	inhibitors	0	None
124776	124777	might	0	None
124777	124778	prove	0	None
124778	124779	to	0	None
124779	124780	be	0	None
124780	124781	helpful	0	None
124781	124782	in	0	None
124782	124783	patients	0	None
124783	124784	with	0	None
124784	124785	these	0	None
124785	124786	tumors	0	None
124786	124787	.	0	None

124788	124789	In	0	None
124789	124790	an	0	None
124790	124791	immunohistochemical	0	None
124791	124792	study	0	None
124792	124793	,	0	None
124793	124794	we	0	None
124794	124795	examined	0	None
124795	124796	KIT	0	None
124796	124797	in	0	None
124797	124798	26	0	None
124798	124799	pheochromocytomas	0	None
124799	124800	,	0	None
124800	124801	8	0	None
124801	124802	of	0	None
124802	124803	which	0	None
124803	124804	were	0	None
124804	124805	malignant	0	None
124805	124806	(	0	None
124806	124807	3	0	None
124807	124808	adrenal	0	None
124808	124809	pheochromocytomas	0	None
124809	124810	,	0	None
124810	124811	5	0	None
124811	124812	paragangliomas	0	None
124812	124813	)	0	None
124813	124814	.	0	None

124815	124816	KIT	0	None
124816	124817	expression	0	None
124817	124818	was	0	None
124818	124819	found	0	None
124819	124820	in	0	None
124820	124821	one	0	None
124821	124822	of	0	None
124822	124823	these	0	None
124823	124824	8	0	None
124824	124825	malignant	0	None
124825	124826	tumors	0	None
124826	124827	.	0	None

124828	124829	This	0	None
124829	124830	2	0	None
124830	124831	.	0	None
124831	124832	5-cm-large	0	None
124832	124833	adrenal	0	None
124833	124834	pheochromocytoma	0	None
124834	124835	originated	0	None
124835	124836	from	0	None
124836	124837	a	0	None
124837	124838	woman	0	None
124838	124839	with	0	None
124839	124840	neurofibromatosis	0	None
124840	124841	type	0	None
124841	124842	1	0	None
124842	124843	and	0	None
124843	124844	spread	0	None
124844	124845	into	0	None
124845	124846	spine	0	None
124846	124847	,	0	None
124847	124848	skull	0	None
124848	124849	,	0	None
124849	124850	and	0	None
124850	124851	lung	0	None
124851	124852	.	0	None

124853	124854	KIT	0	None
124854	124855	expression	0	None
124855	124856	could	0	None
124856	124857	be	0	None
124857	124858	demonstrated	0	None
124858	124859	in	0	None
124859	124860	5%	0	None
124860	124861	of	0	None
124861	124862	tumor	0	None
124862	124863	cells	0	None
124863	124864	.	0	None

124865	124866	On	0	None
124866	124867	the	0	None
124867	124868	basis	0	None
124868	124869	of	0	None
124869	124870	KIT	0	None
124870	124871	expression	0	None
124871	124872	immunohistochemically	0	None
124872	124873	,	0	None
124873	124874	we	0	None
124874	124875	treated	0	None
124875	124876	patients	0	None
124876	124877	with	0	None
124877	124878	neuroendocrine	0	None
124878	124879	(	0	None
124879	124880	i	0	None
124880	124881	.	0	None

124882	124883	e	0	None
124883	124884	.	0	None

124885	124886	,	0	None
124886	124887	medullary	0	None
124887	124888	thyroid	0	None
124888	124889	cancer	0	None
124889	124890	)	0	None
124890	124891	and	0	None
124891	124892	other	0	None
124892	124893	tumors	0	None
124893	124894	with	0	None
124894	124895	imatinib	0	None
124895	124896	400	0	None
124896	124897	mg	2	CHEMICAL
124897	124898	per	0	None
124898	124899	day	0	None
124899	124900	,	0	None
124900	124901	but	0	None
124901	124902	without	0	None
124902	124903	efficacy	0	None
124903	124904	after	0	None
124904	124905	2	0	None
124905	124906	months	0	None
124906	124907	of	0	None
124907	124908	therapy	0	None
124908	124909	.	0	None

124910	124911	Similar	0	None
124911	124912	results	0	None
124912	124913	were	0	None
124913	124914	shown	0	None
124914	124915	by	0	None
124915	124916	other	0	None
124916	124917	investigators	0	None
124917	124918	.	0	None

124919	124920	Therefore	0	None
124920	124921	,	0	None
124921	124922	monotherapy	0	None
124922	124923	with	0	None
124923	124924	imatinib	0	None
124924	124925	may	0	None
124925	124926	not	0	None
124926	124927	be	0	None
124927	124928	efficacious	0	None
124928	124929	in	0	None
124929	124930	patients	0	None
124930	124931	with	0	None
124931	124932	neuroendocrine	0	None
124932	124933	tumors	0	None
124933	124934	that	0	None
124934	124935	express	0	None
124935	124936	KIT	0	None
124936	124937	.	0	None

124938	124939	Tyrosine	2	CHEMICAL
124939	124940	kinase	0	None
124940	124941	inhibitors	0	None
124941	124942	such	0	None
124942	124943	as	0	None
124943	124944	sorafenib	0	None
124944	124945	that	0	None
124945	124946	targets	0	None
124946	124947	several	0	None
124947	124948	receptors	0	None
124948	124949	in	0	None
124949	124950	addition	0	None
124950	124951	to	0	None
124951	124952	KIT	0	None
124952	124953	may	0	None
124953	124954	be	0	None
124954	124955	more	0	None
124955	124956	efficacious	0	None
124956	124957	in	0	None
124957	124958	treating	0	None
124958	124959	patients	0	None
124959	124960	with	0	None
124960	124961	neuroendocrine	0	None
124961	124962	tumors	0	None
124962	124963	.	0	None
124963	124964	A	0	None
124964	124965	series	0	None
124965	124966	of	0	None
124966	124967	xanthine	0	None
124967	124968	derivatives	0	None
124968	124969	in	0	None
124969	124970	which	0	None
124970	124971	a	0	None
124971	124972	methylene	0	None
124972	124973	was	0	None
124973	124974	inserted	0	None
124974	124975	at	0	None
124975	124976	position	0	None
124976	124977	8	0	None
124977	124978	of	0	None
124978	124979	xanthine	0	None
124979	124980	scaffold	0	None
124980	124981	was	0	None
124981	124982	synthesized	0	None
124982	124983	and	0	None
124983	124984	evaluated	0	None
124984	124985	as	0	None
124985	124986	inhibitors	0	None
124986	124987	of	0	None
124987	124990	dipeptidyl peptidase 4	1	GENE-Y
124990	124991	(	0	None
124991	124992	DPP-4	0	None
124992	124993	)	0	None
124993	124994	for	0	None
124994	124995	the	0	None
124995	124996	treatment	0	None
124996	124997	of	0	None
124997	124998	type	0	None
124998	124999	2	0	None
124999	125000	diabetes	0	None
125000	125001	.	0	None

125002	125003	As	0	None
125003	125004	the	0	None
125004	125005	results	0	None
125005	125006	of	0	None
125006	125007	structure-activity	0	None
125007	125008	relationship	0	None
125008	125009	(	0	None
125009	125010	SAR	0	None
125010	125011	)	0	None
125011	125012	study	0	None
125012	125013	of	0	None
125013	125014	the	0	None
125014	125015	series	0	None
125015	125016	,	0	None
125016	125017	the	0	None
125017	125018	compounds	0	None
125018	125019	with	0	None
125019	125020	4-methyl-quinazoline-2-yl-methyl	0	None
125020	125021	group	0	None
125021	125022	at	0	None
125022	125023	N-1	0	None
125023	125024	position	0	None
125024	125025	and	0	None
125025	125026	2-aminoethylaminomethyl	0	None
125026	125027	group	0	None
125027	125028	gave	0	None
125028	125029	better	0	None
125029	125030	activities	0	None
125030	125031	.	0	None

125032	125033	Compounds	0	None
125033	125034	H4	0	None
125034	125035	and	0	None
125035	125036	H9	0	None
125036	125037	showed	0	None
125037	125038	good	0	None
125038	125039	DPP-4	0	None
125039	125040	inhibition	0	None
125040	125041	and	0	None
125041	125042	more	0	None
125042	125043	than	0	None
125043	125044	100-fold	0	None
125044	125045	selectivity	0	None
125045	125046	over	0	None
125046	125047	DPP-7	0	None
125047	125048	and	0	None
125048	125049	DPP-8	0	None
125049	125050	.	0	None
125050	125051	Orlistat	0	None
125051	125052	,	0	None
125052	125053	a	0	None
125053	125054	new	0	None
125054	125055	lipase	3	GENE-N
125055	125056	inhibitor	0	None
125056	125057	for	0	None
125057	125058	the	0	None
125058	125059	management	0	None
125059	125060	of	0	None
125060	125061	obesity	0	None
125061	125062	.	0	None
125062	125063	Effects	0	None
125063	125064	of	0	None
125064	125065	the	0	None
125065	125066	tricyclic	0	None
125066	125067	antidepressant	0	None
125067	125068	clomipramine	2	CHEMICAL
125068	125069	on	0	None
125069	125070	plasma	0	None
125070	125071	glucose	0	None
125071	125072	levels	0	None
125072	125073	in	0	None
125073	125074	mice	0	None
125074	125075	were	0	None
125075	125076	studied	0	None
125076	125077	.	0	None

125078	125079	Clomipramine	0	None
125079	125080	at	0	None
125080	125081	doses	0	None
125081	125082	ranging	0	None
125082	125083	5	0	None
125083	125084	-	0	None
125084	125085	20	0	None
125085	125086	mg	2	CHEMICAL
125086	125087	/	0	None
125087	125088	kg	0	None
125088	125089	elicited	0	None
125089	125090	significant	0	None
125090	125091	hyperglycemia	0	None
125091	125092	in	0	None
125092	125093	mice	0	None
125093	125094	.	0	None

125095	125096	Hyperglycemia	0	None
125096	125097	elicited	0	None
125097	125098	by	0	None
125098	125099	clomipramine	2	CHEMICAL
125099	125100	was	0	None
125100	125101	not	0	None
125101	125102	reduced	0	None
125102	125103	by	0	None
125103	125104	pretreatment	0	None
125104	125105	with	0	None
125105	125106	the	0	None
125106	125107	5-hydroxytryptamine	0	None
125107	125108	(	0	None
125108	125109	5-HT	0	None
125109	125110	)	0	None
125110	125111	depleter	0	None
125111	125112	p-chlorophenylalanine	0	None
125112	125113	.	0	None

125114	125115	The	0	None
125115	125116	5-HT	0	None
125116	125117	(	0	None
125117	125118	1	0	None
125118	125119	/	0	None
125119	125120	2	0	None
125120	125121	/	0	None
125121	125122	5	0	None
125122	125123	/	0	None
125123	125124	7	0	None
125124	125125	)	0	None
125125	125126	-receptor	0	None
125126	125127	antagonist	0	None
125127	125128	methysergide	0	None
125128	125129	and	0	None
125129	125130	the	0	None
125130	125131	5-HT	0	None
125131	125132	(	0	None
125132	125133	2A	0	None
125133	125134	/	0	None
125134	125135	2B	0	None
125135	125136	/	0	None
125136	125137	2C	0	None
125137	125138	)	0	None
125138	125139	-receptor	0	None
125139	125140	antagonist	0	None
125140	125141	LY	0	None
125141	125142	53857	0	None
125142	125143	enhanced	0	None
125143	125144	clomipramine-induced	0	None
125144	125145	hyperglycemia	0	None
125145	125146	,	0	None
125146	125147	while	0	None
125147	125148	the	0	None
125148	125149	5-HT	0	None
125149	125150	(	0	None
125150	125151	1A	0	None
125151	125152	/	0	None
125152	125153	1B	0	None
125153	125154	)	0	None
125154	125155	-receptor	0	None
125155	125156	antagonist	0	None
125156	125157	(	0	None
125157	125158	-	0	None
125158	125159	)	0	None
125159	125160	-propranolol	0	None
125160	125161	and	0	None
125161	125162	the	0	None
125162	125163	5-HT	0	None
125163	125164	(	0	None
125164	125165	3	0	None
125165	125166	/	0	None
125166	125167	4	0	None
125167	125168	)	0	None
125168	125169	-receptor	0	None
125169	125170	antagonist	0	None
125170	125171	tropisetron	0	None
125171	125172	did	0	None
125172	125173	not	0	None
125173	125174	affect	0	None
125174	125175	it	0	None
125175	125176	.	0	None

125177	125178	The	0	None
125178	125179	5-HT	0	None
125179	125180	(	0	None
125180	125181	2B	0	None
125181	125182	/	0	None
125182	125183	2C	0	None
125183	125184	)	0	None
125184	125185	-receptor	0	None
125185	125186	antagonist	0	None
125186	125187	SB	0	None
125187	125188	206553	0	None
125188	125189	facilitated	0	None
125189	125190	hyperglycemia	0	None
125190	125191	induced	0	None
125191	125192	by	0	None
125192	125193	clomipramine	2	CHEMICAL
125193	125194	,	0	None
125194	125195	although	0	None
125195	125196	the	0	None
125196	125197	5-HT	0	None
125197	125198	(	0	None
125198	125199	2A	0	None
125199	125200	)	0	None
125200	125201	-receptor	0	None
125201	125202	antagonist	0	None
125202	125203	ketanserin	2	CHEMICAL
125203	125204	was	0	None
125204	125205	without	0	None
125205	125206	effect	0	None
125206	125207	.	0	None

125208	125209	Clomipramine-induced	0	None
125209	125210	hyperglycemia	0	None
125210	125211	was	0	None
125211	125212	reduced	0	None
125212	125213	by	0	None
125213	125214	prior	0	None
125214	125215	adrenalectomy	0	None
125215	125216	.	0	None

125217	125218	These	0	None
125218	125219	results	0	None
125219	125220	suggest	0	None
125220	125221	that	0	None
125221	125222	clomipramine	2	CHEMICAL
125222	125223	induces	0	None
125223	125224	hyperglycemia	0	None
125224	125225	in	0	None
125225	125226	mice	0	None
125226	125227	by	0	None
125227	125228	blocking	0	None
125228	125229	the	0	None
125229	125230	5-HT	0	None
125230	125231	(	0	None
125231	125232	2B	0	None
125232	125233	)	0	None
125233	125234	and	0	None
125234	125235	/	0	None
125235	125236	or	0	None
125236	125237	5-HT	0	None
125237	125238	(	0	None
125238	125239	2C	0	None
125239	125240	)	0	None
125240	125241	receptors	0	None
125241	125242	,	0	None
125242	125243	which	0	None
125243	125244	results	0	None
125244	125245	in	0	None
125245	125246	facilitation	0	None
125246	125247	of	0	None
125247	125248	adrenaline	0	None
125248	125249	release	0	None
125249	125250	.	0	None

